PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Crassard, R; Petraglia, MD; Drake, NA; Breeze, P; Gratuze, B; Alsharekh, A; Arbach, M; Groucutt, HS; Khalidi, L; Michelsen, N; Robin, CJ; Schiettecatte, J				Crassard, Remy; Petraglia, Michael D.; Drake, Nick A.; Breeze, Paul; Gratuze, Bernard; Alsharekh, Abdullah; Arbach, Mounir; Groucutt, Huw S.; Khalidi, Lamya; Michelsen, Nils; Robin, Christian J.; Schiettecatte, Jeremie			Middle Palaeolithic and Neolithic Occupations around Mundafan Palaeolake, Saudi Arabia: Implications for Climate Change and Human Dispersals	PLOS ONE			English	Article							SULTANATE-OF-OMAN; WAHIBA SAND SEA; SOUTHERN ARABIA; INDIAN MONSOON; LATE PLEISTOCENE; HOLOCENE LAKES; YEMEN; AFRICA; INTERIOR; DESERT	Arabian Peninsula is a key region for understanding climate change and human occupation history in a marginal environment. The Mundafan palaeolake is situated in southern Saudi Arabia, in the Rub' al-Khali (the 'Empty Quarter'), the world's largest sand desert. Here we report the first discoveries of Middle Palaeolithic and Neolithic archaeological sites in association with the palaeolake. We associate the human occupations with new geochronological data, and suggest the archaeological sites date to the wet periods of Marine Isotope Stage 5 and the Early Holocene. The archaeological sites indicate that humans repeatedly penetrated the ameliorated environments of the Rub' al-Khali. The sites probably represent short-term occupations, with the Neolithic sites focused on hunting, as indicated by points and weaponry. Middle Palaeolithic assemblages at Mundafan support a lacustrine adaptive focus in Arabia. Provenancing of obsidian artifacts indicates that Neolithic groups at Mundafan had a wide wandering range, with transport of artifacts from distant sources.	[Crassard, Remy; Khalidi, Lamya] Maison Orient & Mediterranee, CNRS, UMR Archeorient 5133, Lyon, France; [Petraglia, Michael D.; Groucutt, Huw S.] Univ Oxford, Sch Archaeol, Res Lab Archaeol & Hist Art, Oxford, England; [Petraglia, Michael D.] Smithsonian Inst, Human Origins Program, Washington, DC 20560 USA; [Drake, Nick A.; Breeze, Paul] Kings Coll London, Dept Geog, London WC2R 2LS, England; [Gratuze, Bernard] Ctr Ernest Babelon, CNRS, UMR Iramat 5060, Orleans, France; [Alsharekh, Abdullah] King Saud Univ, Coll Tourism & Archaeol, Dept Archaeol, Riyadh, Saudi Arabia; [Alsharekh, Abdullah] Minist Higher Educ, Riyadh, Saudi Arabia; [Arbach, Mounir; Robin, Christian J.; Schiettecatte, Jeremie] CNRS, UMR Orient & Mediterranee Mondes Semit 8167, Ivry, France; [Michelsen, Nils] Tech Univ Darmstadt, Inst Angew Geowissensch, Darmstadt, Germany	Centre National de la Recherche Scientifique (CNRS); University of Oxford; Smithsonian Institution; Smithsonian National Museum of Natural History; University of London; King's College London; Centre National de la Recherche Scientifique (CNRS); King Saud University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Technical University of Darmstadt	Crassard, R (corresponding author), Maison Orient & Mediterranee, CNRS, UMR Archeorient 5133, Lyon, France.	remy.crassard@mom.fr	Jacobs, Zenobia/B-2721-2012; Alsharekh, Abdullah M/AAH-3718-2019; Petraglia, Michael/ABA-9748-2021; Gratuze, Bernard/P-4002-2019; Roberts, Richard Graham/B-8245-2013; Parker, Adrian/X-2596-2019; Groucutt, Huw/GNM-5500-2022; Schiettecatte, Jérémie/AAX-3403-2020; Parker, Adrian/T-3421-2019	Jacobs, Zenobia/0000-0001-5424-5837; Gratuze, Bernard/0000-0001-6136-8085; Roberts, Richard Graham/0000-0002-0128-4119; Schiettecatte, Jérémie/0000-0001-6691-5922; Parker, Adrian/0000-0003-2989-7344; Khalidi, Lamya/0000-0003-1205-7525; Crassard, Remy/0000-0002-2403-1894; Hilbert, Yamandu/0000-0002-5469-2933; Petraglia, Michael/0000-0003-2522-5727; Jennings, Richard/0000-0001-9996-7518	French Embassy in Saudi Arabia; French Ministry of Foreign Affairs; Fondation Fyssen grant 'Subvention de Recherche; Natural Environment Research Council [NE/J500306/1]; European Research Council [295719]; IRAMAT- Universite d'Orleans - UTBM; CEPAM - Universite de Nice Sophia-Antipolis; CRAHM - Universite de Caen; CAA - Universite de Rennes	French Embassy in Saudi Arabia; French Ministry of Foreign Affairs; Fondation Fyssen grant 'Subvention de Recherche; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); European Research Council(European Research Council (ERC)European Commission); IRAMAT- Universite d'Orleans - UTBM; CEPAM - Universite de Nice Sophia-Antipolis; CRAHM - Universite de Caen; CAA - Universite de Rennes	This research was funded by the French Embassy in Saudi Arabia (to CJR), the French Ministry of Foreign Affairs (to CJR), the Fondation Fyssen grant 'Subvention de Recherche 2013' (to RC), the Natural Environment Research Council grant no. NE/J500306/1 (to PB) and the European Research Council grant no. 295719 (to MDP). Obsidian analyses were funded by a Plan Pluri-Formation entitled "CODAI Archeomateriaux inorganiques'' (IRAMAT- Universite d'Orleans - UTBM, CEPAM - Universite de Nice Sophia-Antipolis, CRAHM - Universite de Caen, CAA - Universite de Rennes). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton D., 1984, QUATERNARY PERIOD SA, V2, P275; Armitage SJ, 2011, SCIENCE, V331, P453, DOI 10.1126/science.1199113; Atkinson OAC, 2012, QUAT INT IN PRESS, DOI [10.1016/ j. quaint. 2012.12.014., DOI 10.1016/J.QUAINT.2012.12.014.]; Blechschmidt I, 2009, GEOMORPHOLOGY, V110, P128, DOI 10.1016/j.geomorph.2009.04.002; Boardman J, 1995, JPL PUBLICATION, V95- 1, P23; Burns SJ, 2001, GEOLOGY, V29, P623, DOI 10.1130/0091-7613(2001)029<0623:SEFOFC>2.0.CO;2; Charpentier V., 2002, LITHIC TECHNOL, V27, P39; Charpentier V, 2004, P SEMINAR ARABIAN ST, V34, P53; Charpentier V., 2008, P SEMINAR ARABIAN ST, V38, P93; Chataigner C, 2013, ARCHAEOMETR IN PRESS, DOI [10.1111/ arcm. 12006, DOI 10.1111/ARCM.12006.]; Cleuziou S., 1992, PALEORIENT, V18, P5; Crassard R, 2007, P SEM AR STUD, V37, P43; Crassard R, 2008, BAR INT SERIES; Crassard R, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0069665, 10.1371/journal.pone.0069221, 10.1371/journal.pone.0068061]; Crassard R, 2013, ARAB ARCHAEOL EPIGR, V24, P3, DOI 10.1111/aae.12021; Crassard R, 2009, VERTEBR PALEOBIOL PA, P151, DOI 10.1007/978-90-481-2719-1_12; Crassard R, 2009, CR GEOSCI, V341, P713, DOI 10.1016/j.crte.2009.05.003; Czernik J, 2001, RADIOCARBON, V43, P283; Delagnes A, 2013, QUATERN INT, V300, P234, DOI 10.1016/j.quaint.2012.12.012; Delagnes A, 2012, J HUM EVOL, V63, P452, DOI 10.1016/j.jhevol.2012.03.008; Drake NA, 2012, QUAT INT IN PRESS, DOI [10.1016/ j. quaint. 2012.12.018, DOI 10.1016/J.QUAINT.2012.12.018.]; Edens C., 1982, ATLAL, V6, P109; Edgell H.S., 1989, J KING ABDULAZIZ U E, V3, P109, DOI DOI 10.4197/Ear.3-1.9; Edgell HS., 2006, ARABINA DESERTS NATU; Fleitmann D, 2003, SCIENCE, V300, P1737, DOI 10.1126/science.1083130; Fleitmann D, 2003, QUATERNARY RES, V60, P223, DOI 10.1016/S0033-5894(03)00086-3; Fleitmann D, 2007, QUATERNARY SCI REV, V26, P170, DOI 10.1016/j.quascirev.2006.04.012; Fleitmann D, 2011, QUATERNARY SCI REV, V30, P783, DOI 10.1016/j.quascirev.2011.01.004; Fleitmann D, 2009, CR GEOSCI, V341, P633, DOI 10.1016/j.crte.2009.01.006; Gennari G, 2011, J FORAMIN RES, V41, P248, DOI 10.2113/gsjfr.41.3.248; Glennie KW, 2002, QUATERNARY SCI REV, V21, P853, DOI 10.1016/S0277-3791(01)00133-0; Goslar T, 2004, NUCL INSTRUM METH B, V223, P5, DOI 10.1016/j.nimb.2004.04.005; Groucutt HS, 2012, EVOL ANTHROPOL, V21, P113, DOI 10.1002/evan.21308; Inizan Marie -Louise, 1997, PALEORIENT, V23, P137; Jarvis A, 2008, HOLE FILLED SEAMLESS; Jennings R, 2013, ANTIQUITY IN PRESS; JENSON SK, 1988, PHOTOGRAMM ENG REM S, V54, P1593; Juyal N, 1998, QUATERNARY DESERTS AND CLIMATIC CHANGE, P315; Khalidi L, 2010, J ARCHAEOL SCI, V37, P2332, DOI 10.1016/j.jas.2010.04.007; Khan M., 2007, ROCK ART SAUDI ARABI; KRUSE FA, 1993, REMOTE SENS ENVIRON, V44, P145, DOI 10.1016/0034-4257(93)90013-N; Lehner B., 2008, EOS T AM GEOPHYS UN, P93, DOI [DOI 10.1029/2008EO100001, 10.1029/2008EO100001]; Lezine AM, 1998, QUATERNARY RES, V50, P290, DOI 10.1006/qres.1998.1996; Lezine AM, 2007, PALAEOGEOGR PALAEOCL, V243, P235, DOI 10.1016/j.palaeo.2006.05.019; Lezine AM, 2010, GLOBAL PLANET CHANGE, V72, P412, DOI 10.1016/j.gloplacha.2010.01.016; Maher LA, 2009, VERTEBR PALEOBIOL PA, P187, DOI 10.1007/978-90-481-2719-1_14; McClure H. A., 1978, QUATERNARY PERIOD SA, V1, P252; MCCLURE H.A., 1984, THESIS; McClure H.A., 1980, ANN MINES GEOLOGIE, V28, P427; MCCLURE HA, 1976, NATURE, V263, P755, DOI 10.1038/263755a0; MCCLURE HA, 1994, ARAB ARCHAEOL EPIGR, V5, P1, DOI 10.1111/j.1600-0471.1994.tb00052.x; McClure HA, 1988, ARABY THE BLEST, P9; McCorriston J., 2002, HOLOCENE PALEOECOLOG, V28, P61, DOI [10.3406/paleo.2002.4739, DOI 10.3406/PALEO.2002.4739]; McLaren SJ, 2009, J QUATERNARY SCI, V24, P198, DOI 10.1002/jqs.1199; Parker A., 2006, P SEMIN ARAB STUD, V36, P243; Parker AG, 2006, QUATERNARY RES, V66, P465, DOI 10.1016/j.yqres.2006.07.001; Parker AG, 2009, VERTEBR PALEOBIOL PA, P39, DOI 10.1007/978-90-481-2719-1_3; Parker AG, 2004, J QUATERNARY SCI, V19, P665, DOI 10.1002/jqs.880; Petit-Maire N, 2010, GLOBAL PLANET CHANGE, V72, P368, DOI 10.1016/j.gloplacha.2010.01.012; Petraglia MD, 2003, ANTIQUITY, V77, P671, DOI 10.1017/S0003598X00061639; Petraglia MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049840; Petraglia MD, 2011, QUATERNARY SCI REV, V30, P1555, DOI 10.1016/j.quascirev.2011.04.006; Petraglia MD, 2011, NATURE, V470, P50, DOI 10.1038/470050a; Petraglia MD, 2010, ANN HUM BIOL, V37, P288, DOI 10.3109/03014461003639249; Preusser F, 2002, SCIENCE, V296, P2018, DOI 10.1126/science.1069875; Preusser F, 2009, CR GEOSCI, V341, P621, DOI 10.1016/j.crte.2009.02.003; Radies D, 2005, J ARID ENVIRON, V62, P109, DOI 10.1016/j.jaridenv.2004.09.021; Radies D, 2004, SEDIMENTOLOGY, V51, P1359, DOI 10.1111/j.1365-3091.2004.00678.x; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Robinson TJ, 1999, ANIM CONSERV, V2, P165, DOI 10.1111/j.1469-1795.1999.tb00062.x; Rose JI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028239; Rose JI, 2009, VERTEBR PALEOBIOL PA, P1, DOI 10.1007/978-90-481-2719-1_1; Rosenberg TM, 2011, GEOLOGY, V39, P1115, DOI 10.1130/G32281.1; Rosenberg TM, 2012, J QUATERNARY SCI, V27, P13, DOI 10.1002/jqs.1560; Scerri EleanorM.L., 2012, P SEMINAR ARABIAN ST, V42, P357; SCHULZ E, 1986, HYDROBIOLOGIA, V143, P175, DOI 10.1007/BF00026660; Uerpmann HP, 2009, VERTEBR PALEOBIOL PA, P205, DOI 10.1007/978-90-481-2719-1_15; Usik VI, 2012, QUAT INT IN PRESS, DOI [10.1016/ j. quaint. 2012.08.2111, DOI 10.1016/J.QUAINT.2012.08.2111.]; White K.H., 2006, SOC LIBYAN STUDIES M, V6, P123; Whitney JW, 1983, 041 USGS; Zarins J., 1981, ATLAL, V5, P9	82	108	108	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69665	10.1371/journal.pone.0069665	http://dx.doi.org/10.1371/journal.pone.0069665			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	188BY	23894519	Green Published, gold			2022-12-27	WOS:000322167900088
J	Crassard, R; Hilbert, YH				Crassard, Remy; Hilbert, Yamandu Hieronymus			A Nubian Complex Site from Central Arabia: Implications for Levallois Taxonomy and Human Dispersals during the Upper Pleistocene	PLOS ONE			English	Article							MIDDLE PALEOLITHIC SITE; SOUTHERN ARABIA; WADI SURDUD; RED-SEA; DESERT; OMAN; VARIABILITY; PALAEOLAKE; STRATEGIES; PREHISTORY	Archaeological survey undertaken in central Saudi Arabia has revealed 29 surface sites attributed to the Arabian Middle Paleolithic based on the presence of Levallois blank production methods. Technological analyses on cores retrieved from Al-Kharj 22 have revealed specific reduction modalities used to produce flakes with predetermined shapes. The identified modalities, which are anchored within the greater Levallois concept of core convexity preparation and exploitation, correspond with those utilized during the Middle Stone Age Nubian Complex of northeast Africa and southern Arabia. The discovery of Nubian technology at the Al-Kharj 22 site represents the first appearance of this blank production method in central Arabia. Here we demonstrate how a rigorous use of technological and taxonomic analysis may enable intra-regional comparisons across the Arabian Peninsula. The discovery of Al-Kharj 22 increases the complexity of the Arabian Middle Paleolithic archaeological record and suggests new dynamics of population movements between the southern and central regions of the Peninsula. This study also addresses the dichotomy within Nubian core typology (Types 1 and 2), which was originally defined for African assemblages.	[Crassard, Remy; Hilbert, Yamandu Hieronymus] CNRS, UMR Archeorient 5133, Lyon, France	Centre National de la Recherche Scientifique (CNRS)	Crassard, R (corresponding author), CNRS, UMR Archeorient 5133, Lyon, France.	remy.crassard@mom.fr	Jacobs, Zenobia/B-2721-2012; Alsharekh, Abdullah M/AAH-3718-2019; Petraglia, Michael/ABA-9748-2021; Gratuze, Bernard/P-4002-2019; Roberts, Richard Graham/B-8245-2013; Parker, Adrian/X-2596-2019; Groucutt, Huw/GNM-5500-2022; Schiettecatte, Jérémie/AAX-3403-2020; Parker, Adrian/T-3421-2019	Jacobs, Zenobia/0000-0001-5424-5837; Gratuze, Bernard/0000-0001-6136-8085; Roberts, Richard Graham/0000-0002-0128-4119; Schiettecatte, Jérémie/0000-0001-6691-5922; Parker, Adrian/0000-0003-2989-7344; Khalidi, Lamya/0000-0003-1205-7525; Crassard, Remy/0000-0002-2403-1894; Hilbert, Yamandu/0000-0002-5469-2933; Petraglia, Michael/0000-0003-2522-5727; Jennings, Richard/0000-0001-9996-7518	Saudi Commission for Tourism and Antiquities (Riyadh); King Saud University (Riyadh); French Ministry of Foreign Affairs; French Embassy in Riyadh; Centre National de la Recherche Scientifique (CNRS) [UMR 8167, UMR 5133]; Fondation Fyssen	Saudi Commission for Tourism and Antiquities (Riyadh); King Saud University (Riyadh); French Ministry of Foreign Affairs; French Embassy in Riyadh; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Fondation Fyssen	This research was funded by the Saudi Commission for Tourism and Antiquities (Riyadh), the King Saud University (Riyadh), French Ministry of Foreign Affairs, the French Embassy in Riyadh, the Centre National de la Recherche Scientifique (CNRS), UMR 8167 'Orient & Mediterranee' and UMR 5133 'Archeorient'. The authors acknowledge the Fondation Fyssen for financial support with the 'Subvention de Recherche 2013' grant (to RC) and the 'Postdoctoral Grant 2013' (to YHH). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Juaidi F, 2003, GEOGR J, V169, P117, DOI 10.1111/1475-4959.04973; AMIRKHANOV H, 1994, ARAB ARCHAEOL EPIGR, V5, P217, DOI 10.1111/j.1600-0471.1994.tb00069.x; AMIRKHANOV H, 1991, PALEOLITHIC S ARABIA; Amirkhanov HA, 2006, STONE AGE S ARABIA; Armitage SJ, 2011, SCIENCE, V331, P453, DOI 10.1126/science.1199113; Bailey G.N., 2007, J ISL COAST ARCHAEOL, V2, P127, DOI DOI 10.1080/15564890701623449; Bailey G, 2009, VERTEBR PALEOBIOL PA, P15, DOI 10.1007/978-90-481-2719-1_2; Bar-Yosef O, 1998, NEANDERTALS AND MODERN HUMANS IN WESTERN ASIA, P39; Bar-Yosef O., 1992, MIDDLE PALEOLITHIC A, P163; Bar-Yosef O, 2009, CURR ANTHROPOL, V50, P103, DOI 10.1086/592234; Barham L., 2008, 1 AFRICANS AFRICAN A; Beyin A, 2013, QUATERN INT, V300, P195, DOI 10.1016/j.quaint.2013.02.015; Beyin Amanuel, 2011, Int J Evol Biol, V2011, P615094, DOI 10.4061/2011/615094; Bo?da E., 1988, HOMME NEANDERTAL, V4, P13; Boeda E., 1994, MONOGRAPHIE CRA, V9; Boeda E., 1991, TECHNIQUES CULTURE, V17, P37; Bolus M, 2001, QUATERN INT, V75, P29, DOI 10.1016/S1040-6182(00)00075-6; Bordes F., 1961, TYPOLOGIE PALEOLITHI; Bordes F., 1980, B SOC PREHISTORIQUE, V77, P45, DOI [10.3406/BSPF.1980.5242, DOI 10.3406/BSPF.1980.5242]; Burroni D, 2002, J ARCHAEOL SCI, V29, P1277, DOI 10.1006/jasc.2001.0771; Caton-Thompson G, 1939, GEOGR J, V93, P18, DOI 10.2307/1787159; Caton-Thompson G., 1954, P PREHIST SOC, V19, P189; Chiotti L., 2007, ARCHAEOLOGY ART ANCI, P169; Chiotti L, 2009, J FIELD ARCHAEOL, V34, P307, DOI 10.1179/009346909791070862; Clark J.D., 1954, PREHISTORIC CULTURES; Clark J.D., 1966, S AFRICAN ARCHAEOLOG, V21, P114, DOI [https://doi.org/10.2307/3888427, DOI 10.2307/3888427]; Copeland L., 1975, PROBLEMS PREHISTORY, P317; Crassard R, 2013, PLOS ONE IN PRESS; Crassard R, 2011, LOWER MIDDLE PALAEOL, P131; Crassard R, 2009, VERTEBR PALEOBIOL PA, P151, DOI 10.1007/978-90-481-2719-1_12; Crew HL, 1975, THESIS U CALIFORNIA; Delagnes A., 2007, NEANDERTALIENS BIOL, P213; Delagnes A, 1992, THESIS U PARIS NANTE; Delagnes A, 2006, INTERD CONTRIB ARCH, P85, DOI 10.1007/0-387-24661-4_5; Delagnes A, 2013, QUATERN INT, V300, P234, DOI 10.1016/j.quaint.2012.12.012; Delagnes A, 2012, J HUM EVOL, V63, P452, DOI 10.1016/j.jhevol.2012.03.008; Demidenko Y.E., 1993, PALEORIENT, V19, P5, DOI DOI 10.3406/PALEO.1993.4593; Dibble E., 1995, DEFINITION INTERPRET, P41; Dibble H., 1995, MONOGRAPHS WORLD ARC, V23; Dibble HL, 1995, MONOGRAPHS WORLD ARC, V23, P439; Fernandes P, 2007, CR PALEVOL, V6, P557, DOI 10.1016/j.crpv.2007.09.015; Fleitmann D., 2004, SPELEOTHEM RECORD CL; Fleitmann D, 2011, QUATERNARY SCI REV, V30, P783, DOI 10.1016/j.quascirev.2011.01.004; Fleitmann D, 2009, CR GEOSCI, V341, P633, DOI 10.1016/j.crte.2009.01.006; Glennie K, 2005, DESERT SO ARABIA ENV; Groucutt HS, 2012, EVOL ANTHROPOL, V21, P113, DOI 10.1002/evan.21308; Guichard G, 1989, DOCUMENTS ARCHEOLOGI, V4, P5; Guichard J., 1965, CONTRIBUTIONS PREHIS, P57; Hahn J, 1993, ERKENNEN BESTIMMEN S; Herold M, 2009, CLIM DYNAM, V33, P1075, DOI 10.1007/s00382-008-0515-2; Hilbert Y, 2012, P SEMINAR ARABIAN ST, V42, P101; Hilbert YH, 2012, THESIS U BIRMINGHAM; HUNT CB, 1954, SCIENCE, V120, P183, DOI 10.1126/science.120.3109.183; Inizan M.-L., 1987, PALEORIENT, V13, P5, DOI DOI 10.3406/PALE0.1987.4414; Inizan Marie-Louise, 1999, TECHNOLOGY TERMINOLO, V5; Jagher R, 2009, VERTEBR PALEOBIOL PA, P139, DOI 10.1007/978-90-481-2719-1_11; Jamme A, 1963, ARCHAEOLOGICAL RECON, V1963, P521; Kleindienst M.R., 1967, BACKGROUND EVOLUTION, P821; Marks A.E., 2008, BAR INT SERIES S, VS1831, P123; Marks A.E., 1968, PREHISTORY NUBIA, V1, P194; Marks AE, 1968, PREHISTORY NUBIA, P392; Marks AE, 2008, P SEMINAR ARABIAN ST, V38, P15; Marks AE, 2009, VERTEBR PALEOBIOL PA, P295, DOI 10.1007/978-90-481-2719-1_20; MCCLURE HA, 1976, NATURE, V263, P755, DOI 10.1038/263755a0; McLaren SJ, 2009, J QUATERNARY SCI, V24, P198, DOI 10.1002/jqs.1199; Meignen L., 1995, DEFINITION INTERPRET, P361; Miller R, 1982, PALEORIENT, V8, P105; Morales A, 2011, SAND SEA ARCHAEOLOGY, P21; Neff U, 2001, NATURE, V411, P290, DOI 10.1038/35077048; Olszewski DI, 2010, J HUM EVOL, V59, P188, DOI 10.1016/j.jhevol.2010.06.001; Otte M, 1988, HOMME NEANDERTAL, V4, P81; Parker AG, 2009, VERTEBR PALEOBIOL PA, P39, DOI 10.1007/978-90-481-2719-1_3; Parsons A.J., 2009, GEOMORPHOLOGY DESERT; Parton A, 2013, QUATERN INT, V300, P62, DOI 10.1016/j.quaint.2013.02.016; Petraglia MD, 2003, ANTIQUITY, V77, P671, DOI 10.1017/S0003598X00061639; Petraglia MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049840; Petraglia MD, 2011, QUATERNARY SCI REV, V30, P1555, DOI 10.1016/j.quascirev.2011.04.006; Petraglia MD, 2011, NATURE, V470, P50, DOI 10.1038/470050a; Powers R. W., 1966, GEOLOGICAL SURVEY PR, P1; Preusser F, 2009, CR GEOSCI, V341, P621, DOI 10.1016/j.crte.2009.02.003; Rose J.I., 2007, P SEMINAR ARABIAN ST, V37, P219; Rose J.I., 2006, THESIS SO METHODIST; Rose JI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028239; Rose JI, 2010, CURR ANTHROPOL, V51, P849, DOI 10.1086/657397; Rose JI, 2009, VERTEBR PALEOBIOL PA, P1, DOI 10.1007/978-90-481-2719-1_1; Rose JI, 2008, P SEM AR STUD, V38, P65; Rosenberg TM, 2011, GEOLOGY, V39, P1115, DOI 10.1130/G32281.1; Rosenberg TM, 2013, QUATERNARY SCI REV, V70, P109, DOI 10.1016/j.quascirev.2013.03.017; Rosenberg TM, 2012, J QUATERNARY SCI, V27, P13, DOI 10.1002/jqs.1560; ROTTLANDER R, 1975, ARCHAEOMETRY, V17, P106, DOI 10.1111/j.1475-4754.1975.tb00120.x; Schiettecatte J, 2013, P SEM AR ST IN PRESS; SCHULZ E, 1986, HYDROBIOLOGIA, V143, P175, DOI 10.1007/BF00026660; Scott-Jackson J, 2009, VERTEBR PALEOBIOL PA, P125, DOI 10.1007/978-90-481-2719-1_10; Shimelmitz R, 2011, J HUM EVOL, V61, P458, DOI 10.1016/j.jhevol.2011.06.003; Sitzia L, 2012, GEOARCHAEOLOGY, V27, P471, DOI 10.1002/gea.21419; Stokes S, 2005, GEOL SOC AM BULL, V117, P1466, DOI 10.1130/B25554.1; Tostevin G, 2000, THESIS HARVARD U ANN; Usik VI, 2004, BAR INT SERIES S, VS1239, P148; Usik VI, 2013, QUATERN INT, V300, P244, DOI 10.1016/j.quaint.2012.08.2111; Vaks A, 2007, GEOLOGY, V35, P831, DOI 10.1130/G23794A.1; Van Peer P, 1992, MONOGRAPHS WORLD PRE, V13; Van Peer P, 2010, CHERT QUARRYING LITH; Van Peer P., 2007, RETHINKING HUMAN REV, P187; Van Peer P., 1991, PALEO, V17, P133, DOI [10.3406/paleo.1991.4557, DOI 10.3406/PALEO.1991.4557]; VANPEER P, 1991, J ANTHROPOL ARCHAEOL, V10, P107, DOI 10.1016/0278-4165(91)90017-R; Vaslet D, 1991, GEOSCI MAP, V121, P1; Vermeersch P. M., 1990, AFR ARCHAEOL REV, V8, P77, DOI DOI 10.1007/BF01116872; Waldmann N, 2010, GEOLOGY, V38, P567, DOI 10.1130/G30654.1; Wendorf F., 1974, MIDDLE STONE AGE SEQ; Whittaker J.C., 1994, FLINTKNAPPING MAKING; Yellen John, 2005, Paleoanthropology, V3, P25; ZARINS J, 1980, ATLAL, V4, P9; Zarins J., 2001, LAND INCENSE ARCHAEO	113	108	108	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69221	10.1371/journal.pone.0069221	http://dx.doi.org/10.1371/journal.pone.0069221			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	188BY	23894519	Green Published, Green Submitted, gold			2022-12-27	WOS:000322167900049
J	Crassard, R; Petraglia, MD; Parker, AG; Parton, A; Roberts, RG; Jacobs, Z; Alsharekh, A; Al-Omari, A; Breeze, P; Drake, NA; Groucutt, HS; Jennings, R; Regagnon, E; Shipton, C				Crassard, Remy; Petraglia, Michael D.; Parker, Adrian G.; Parton, Ash; Roberts, Richard G.; Jacobs, Zenobia; Alsharekh, Abdullah; Al-Omari, Abdulaziz; Breeze, Paul; Drake, Nick A.; Groucutt, Huw S.; Jennings, Richard; Regagnon, Emmanuelle; Shipton, Ceri			Beyond the Levant: First Evidence of a Pre-Pottery Neolithic Incursion into the Nefud Desert, Saudi Arabia	PLOS ONE			English	Article							HOLOCENE HUMID PERIOD; RUB AL-KHALI; AGRICULTURAL ORIGINS; SOUTHERN ARABIA; CAL BC; DOMESTICATION; PLEISTOCENE; PREHISTORY; SEDIMENTS; LUMINESCENCE	Pre-Pottery Neolithic assemblages are best known from the fertile areas of the Mediterranean Levant. The archaeological site of Jebel Qattar 101 (JQ-101), at Jubbah in the southern part of the Nefud Desert of northern Saudi Arabia, contains a large collection of stone tools, adjacent to an Early Holocene palaeolake. The stone tool assemblage contains lithic types, including El-Khiam and Helwan projectile points, which are similar to those recorded in Pre-Pottery Neolithic A and Pre-Pottery Neolithic B assemblages in the Fertile Crescent. Jebel Qattar lies similar to 500 kilometres outside the previously identified geographic range of Pre-Pottery Neolithic cultures. Technological analysis of the typologically diagnostic Jebel Qattar 101 projectile points indicates a unique strategy to manufacture the final forms, thereby raising the possibility of either direct migration of Levantine groups or the acculturation of mobile communities in Arabia. The discovery of the Early Holocene site of Jebel Qattar suggests that our view of the geographic distribution and character of Pre-Pottery Neolithic cultures may be in need of revision.	[Crassard, Remy; Regagnon, Emmanuelle] CNRS, UMR Archeorient 5133, Lyon, France; [Petraglia, Michael D.; Parton, Ash; Groucutt, Huw S.; Jennings, Richard] Univ Oxford, Sch Archaeol, Res Lab Archaeol & Hist Art, Oxford, England; [Petraglia, Michael D.] Smithsonian Inst, Human Origins Program, Washington, DC 20560 USA; [Parker, Adrian G.] Oxford Brookes Univ, Human Origins & Palaeoenvironm Res Grp, Oxford OX3 0BP, England; [Roberts, Richard G.; Jacobs, Zenobia] Univ Wollongong, Ctr Archaeol Sci, Sch Earth & Environm Sci, Wollongong, NSW, Australia; [Alsharekh, Abdullah] King Saud Univ, Coll Tourism & Archaeol, Dept Archaeol, Riyadh, Saudi Arabia; [Alsharekh, Abdullah] Minist Higher Educ, Riyadh, Saudi Arabia; [Al-Omari, Abdulaziz] Saudi Commiss Tourism & Antiqu, Taif Antiqu Off, At Taif, Saudi Arabia; [Breeze, Paul; Drake, Nick A.] Kings Coll London, Dept Geog, London, England; [Shipton, Ceri] Univ Queensland, Sch Social Sci, Brisbane, Qld 4072, Australia	Centre National de la Recherche Scientifique (CNRS); University of Oxford; Smithsonian Institution; Smithsonian National Museum of Natural History; Oxford Brookes University; University of Wollongong; King Saud University; University of London; King's College London; University of Queensland	Crassard, R (corresponding author), CNRS, UMR Archeorient 5133, Lyon, France.	remy.crassard@mom.fr	Jacobs, Zenobia/B-2721-2012; Alsharekh, Abdullah M/AAH-3718-2019; Petraglia, Michael/ABA-9748-2021; Gratuze, Bernard/P-4002-2019; Roberts, Richard Graham/B-8245-2013; Parker, Adrian/X-2596-2019; Groucutt, Huw/GNM-5500-2022; Schiettecatte, Jérémie/AAX-3403-2020; Parker, Adrian/T-3421-2019	Jacobs, Zenobia/0000-0001-5424-5837; Gratuze, Bernard/0000-0001-6136-8085; Roberts, Richard Graham/0000-0002-0128-4119; Schiettecatte, Jérémie/0000-0001-6691-5922; Parker, Adrian/0000-0003-2989-7344; Khalidi, Lamya/0000-0003-1205-7525; Crassard, Remy/0000-0002-2403-1894; Hilbert, Yamandu/0000-0002-5469-2933; Petraglia, Michael/0000-0003-2522-5727; Jennings, Richard/0000-0001-9996-7518	National Geographic Society; Leakey Foundation; European Research Council [295719]; Australian Research Council; Fondation Fyssen ('Subvention de Recherche')	National Geographic Society(National Geographic Society); Leakey Foundation; European Research Council(European Research Council (ERC)European Commission); Australian Research Council(Australian Research Council); Fondation Fyssen ('Subvention de Recherche')	This research was funded by the National Geographic Society (to MDP), the Leakey Foundation (to MDP), the European Research Council (number 295719, to MDP), the Australian Research Council (to RGR and ZJ) and the Fondation Fyssen ('Subvention de Recherche 2013', to RC). The authors acknowledge the Australian Research Council for OSL sample collection and dating through laboratory analysis. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbes F, 2003, BAR INT SERIES S, VS1150; Abbo S, 2010, CRIT REV PLANT SCI, V29, P317, DOI 10.1080/07352689.2010.502823; Abe Y, 1977, B NAT SCI MUS, V3, P1; Adams R., 1977, ATLAL, V1, P21; Al-Abri A, 2012, AM J PHYS ANTHROPOL, V149, P291, DOI 10.1002/ajpa.22131; [Anonymous], [No title captured]; Arimura M, 2003, ARCHAEOLOGY ROUJ BAS, P155; Arz HW, 2003, SCIENCE, V300, P118, DOI 10.1126/science.1080325; AURENCHE O, 1999, NAISSANCE NEOLITHIQU; Aurenche O, 2011, STATE STONE TERMINOL, V13, P449; Banning EB, 2011, CURR ANTHROPOL, V52, P619, DOI 10.1086/661207; Bar-Yosef O, 1981, BEITRAGE UMWELTGESCH, P217; Bar-Yosef O, 1987, J ISRAEL PREHISTORIC, V20, P151; Bar-Yosef O., 1992, TRANSITIONS AGR PREH, P21; Bar-Yosef O., 1981, PREHISTOIRE LEVANT C, P555; BARYOSEF O, 1980, ANNU REV ANTHROPOL, V9, P101, DOI 10.1146/annurev.an.09.100180.000533; BarYosef O, 1995, SCH AM RES, V354, P39; Barzilai O, 2010, BAR INT SERIES S, VS2180; Besler H, 2009, Z GEOMORPHOL, V53, P487, DOI 10.1127/0372-8854/2009/0053-0487; Betts A. V. G., 1982, LEVANT, V14, P1, DOI DOI 10.1179/007589182790211974; Bocquentin F, 2006, B CTR RECHERCHE FRAN, V17, P41; Bocquet-Appel JP, 2011, SCIENCE, V333, P560, DOI 10.1126/science.1208880; BocquetAppel JP, 2008, NEOLITHIC DEMOGRAPHIC TRANSITION AND ITS CONSEQUENCES, P1, DOI 10.1007/978-1-4020-8539-0; Borrell F, 2011, J FIELD ARCHAEOL, V36, P132, DOI 10.1179/009346911X12991472411240; Braidwood R., 1960, STUDIES ANCIENT ORIE, V31; Cauvin J, 1968, FOUILLES BYBLOS 4 OU; Cauvin J., 2000, BIRTH GODS ORIGINS A; Cauvin M.C., 1993, PALEORIENT, V19, P23, DOI DOI 10.3406/PALEO.1993.4579; Cauvin MC, 2008, BAR INT SERIES, VI; Cauvin MC, 1974, PALEORIENT, V2, P311, DOI DOI 10.3406/PALEO.1974.1056; Charpentier V., 2008, P SEMINAR ARABIAN ST, V38, P59; Charpentier V, 2004, P SEMINAR ARABIAN ST, V34, P53; Charpentier V, 2013, ARAB ARCHAEOL EPIGR, V24, P28, DOI 10.1111/aae.12011; Childe V. G., 1935, NEW LIGHT MOST ANCIE; Crabtree PJ., 1993, ARCHAEOLOGICAL METHO, V5, P201; Crassard R, 2013, PLOS ONE IN PRESS; Crassard R, 2008, BAR INT SERIES S, VS1842; Crassard R, 2013, ARAB ARCHAEOL EPIGR, V24, P3, DOI 10.1111/aae.12021; Crassard R, 2009, CR GEOSCI, V341, P713, DOI 10.1016/j.crte.2009.05.003; Damania A, 1999, ORIGINS AGR CROP DOM; DEAN WE, 1974, J SEDIMENT PETROL, V44, P242; Dearing J., 1999, QUATERNARY RES ASS, V6, P35, DOI DOI 10.1086/427092; Diamond J, 2003, SCIENCE, V300, P597, DOI 10.1126/science.1078208; Drechsler P, 2009, BAR INT SERIES S, VS1969; Engel M, 2012, QUATERN INT, V266, P131, DOI 10.1016/j.quaint.2011.04.028; Fedele FG, 2009, VERTEBR PALEOBIOL PA, P215, DOI 10.1007/978-90-481-2719-1_16; Fernandes V, 2012, AM J HUM GENET, V90, P347, DOI 10.1016/j.ajhg.2011.12.010; Fernandez E, 2008, FORENS SCI INT-GEN S, V1, P271, DOI 10.1016/j.fsigss.2007.10.009; Field H, 1960, PAP PEABODY MUS, V45; Finlayson B, 2011, P NATL ACAD SCI USA, V108, P8183, DOI 10.1073/pnas.1017642108; Fleitmann D, 2011, QUATERNARY SCI REV, V30, P783, DOI 10.1016/j.quascirev.2011.01.004; Fuller DQ, 2012, J EXP BOT, V63, P617, DOI 10.1093/jxb/err307; Galbraith RF, 2012, QUAT GEOCHRONOL, V11, P1, DOI 10.1016/j.quageo.2012.04.020; Galbraith RF, 1999, ARCHAEOMETRY, V41, P339, DOI 10.1111/j.1475-4754.1999.tb00987.x; Garfinkel Yossi, 1989, PALEORIENT, V15, P139; Garrard A.N., 1981, ATLAL, V5, P137; Gilmore M., 1982, ATLAL, V6, P9; Goldberg P., 1993, FORMATION PROCESSES, P165; Gonzalez-Echegaray JG, 1964, EXCAVACIONES TERRAZA, V1; Gonzalez-Echegaray JG, 1966, EXCAVACIONES TERRAZA, V2; Gopher A., 1989, PEOPLE CULTURE CHANG, P91; Gopher A, 1994, DISSERTATION SERIES, V10; Goudie AS, 2000, SEDIMENTOLOGY, V47, P1011, DOI 10.1046/j.1365-3091.2000.00336.x; Groucutt HS, 2012, EVOL ANTHROPOL, V21, P113, DOI 10.1002/evan.21308; Heiri O, 2001, J PALEOLIMNOL, V25, P101, DOI 10.1023/A:1008119611481; Helmer D., 1989, PALEORIENT, V15, P111; Hilbert Y, 2012, P SEMINAR ARABIAN ST, V42, P101; Hole F., 1984, PALEORIENT, V10, P49, DOI DOI 10.3406/PALEO.1984.939; Horwitz Liora Kolska, 2000, Paleorient, V25, P63; HUNTLEY DJ, 1985, NATURE, V313, P105, DOI 10.1038/313105a0; Inghraham M, 1981, ATLAL, V5, P59; Inizan M.-L., 1980, PALEORIENT, V6, P233, DOI [10.3406/paleo.1980.4275, DOI 10.3406/PALEO.1980.4275]; Inizan M-L, 1988, PREHISTOIRE QATAR, V2; Jacobs Z, 2007, EVOL ANTHROPOL, V16, P210, DOI 10.1002/evan.20150; Jacobs Z, 2013, J ARCHAEOL SCI, V40, P579, DOI 10.1016/j.jas.2012.06.037; Jarvis A, 2008, HOLE FILLED SEAMLESS; Jennings R, 2013, ANTIQUITY IN PRESS; Kapel H., 1967, ATLAS STONE AGE CULT; Kenyon K., 1957, DIGGING JERICHO; Khan M., 2007, ROCK ART SAUDI ARABI; Kozlowski S. K., 2005, BAR INT SERIES, V1362; Kuijt I, 1996, J ANTHROPOL ARCHAEOL, V15, P313, DOI 10.1006/jaar.1996.0012; Kuijt I, 2000, J ANTHROPOL ARCHAEOL, V19, P75, DOI 10.1006/jaar.1999.0352; Lehner B., 2008, EOS T AM GEOPHYS UN, V89, P93, DOI [10.1029/2008EO100001, DOI 10.1029/2008EO100001, DOI 10.1111/j.1469-8137.2009.03092.x]; MacDonald E, 1932, BETH PELET 2, P1; MCCLURE HA, 1976, NATURE, V263, P755, DOI 10.1038/263755a0; MOORE AMT, 1982, WORLD ARCHAEOL, V14, P224, DOI 10.1080/00438243.1982.9979863; MORTENSEN P, 1970, ACTA ARCHAEOL-DEN, V41, P1; Neuville R, 1951, ARCH I PALEONTHOLOGI, V24; Nishiaki Y, 2000, BAR INT SERIES S, VS840; Noy T, 1994, NEOLITHIC CHIPPED ST, P423; Parker AG, 2004, J QUATERNARY SCI, V19, P665, DOI 10.1002/jqs.880; Parr P.J., 1978, ATLAL, V2, P29; Pelegrin J, 2013, ARAB ARCHAEOL EPIGR, V24, P79, DOI 10.1111/aae.12016; Perrot J, 1952, BULL SOC PREHIST FR, V49, P439, DOI 10.3406/bspf.1952.5086; Perrot J, 2000, PALEORIENT, V26, P5; Petraglia MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049840; Petraglia MD, 2011, QUATERNARY SCI REV, V30, P1555, DOI 10.1016/j.quascirev.2011.04.006; Powell R, 2002, CHEM GEOL, V185, P191, DOI 10.1016/S0009-2541(01)00403-X; PRESCOTT JR, 1994, RADIAT MEAS, V23, P497, DOI 10.1016/1350-4487(94)90086-8; Preusser F, 2009, CR GEOSCI, V341, P621, DOI 10.1016/j.crte.2009.02.003; Quintero L.A., 1995, PAL ORIENT, V21, P17, DOI [DOI 10.3406/PALE0.1995.4607, https://doi.org/10.3406/paleo.1995.4607, DOI 10.3406/PALEO.1995.4607]; Radies D, 2005, J ARID ENVIRON, V62, P109, DOI 10.1016/j.jaridenv.2004.09.021; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Rhotert H, 1938, TRANSJORDANIEN VORGE; Rollefson GO, 2004, STUDIES EARLY NEAR E, V5, P145; Rose JI, 2013, ARAB ARCHAEOL EPIGR, V24, P95, DOI 10.1111/aae.12017; Rose JI, 2010, CURR ANTHROPOL, V51, P849, DOI 10.1086/657397; Rose JI, 2009, VERTEBR PALEOBIOL PA, P1, DOI 10.1007/978-90-481-2719-1_1; Rosen SA, 1997, HDB STONE TOOLS LEVA; Rosenberg TM, 2011, GEOLOGY, V39, P1115, DOI 10.1130/G32281.1; Scarre C, 2005, HUMAN WORLD PREHISTO, P183; SCHULZ E, 1986, HYDROBIOLOGIA, V143, P175, DOI 10.1007/BF00026660; Seton-Williams VM, 1938, J PALESTINE ORIENTAL, V18, P172; Stordeur D, 2003, PALEORIENT, V29, P109; Uerpmann HP, 2009, VERTEBR PALEOBIOL PA, P205, DOI 10.1007/978-90-481-2719-1_15; Vigne JD, 2012, P NATL ACAD SCI USA, V109, P8445, DOI 10.1073/pnas.1201693109; Whitney JW, 1983, 83749 USGS; Willcox G, 2012, VEG HIST ARCHAEOBOT, V21, P81, DOI 10.1007/s00334-012-0348-0; Willcox G, 2012, ANTIQUITY, V86, P99, DOI 10.1017/S0003598X00062487; WRIGHT GA, 1971, CURR ANTHROPOL, V12, P447, DOI 10.1086/201233; Yartah T, 2001, PREHISTOIRE APPROCHE, P281; Zeder MA, 2006, TRENDS GENET, V22, P139, DOI 10.1016/j.tig.2006.01.007; Zeder MA, 2008, P NATL ACAD SCI USA, V105, P11597, DOI 10.1073/pnas.0801317105; Zeder MA, 2012, BIODIVERSITY IN AGRICULTURE: DOMESTICATION, EVOLUTION, AND SUSTAINABILITY, P227; Zeder MA, 2011, CURR ANTHROPOL, V52, pS221, DOI 10.1086/659307; Zohary D., 1988, DOMESTICATION PLANTS	127	108	108	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e68061	10.1371/journal.pone.0068061	http://dx.doi.org/10.1371/journal.pone.0068061			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	191CY	23894519	Green Submitted, Green Published, gold			2022-12-27	WOS:000322391400004
J	Cunze, S; Heydel, F; Tackenberg, O				Cunze, Sarah; Heydel, Felix; Tackenberg, Oliver			Are Plant Species Able to Keep Pace with the Rapidly Changing Climate?	PLOS ONE			English	Article							LONG-DISTANCE DISPERSAL; SEED-DISPERSAL; CHANGE IMPACTS; RANGE SHIFTS; MIGRATION RATES; DISTRIBUTIONS; PREDICTION; EUROPE; BIODIVERSITY; PROTEACEAE	Future climate change is predicted to advance faster than the postglacial warming. Migration may therefore become a key driver for future development of biodiversity and ecosystem functioning. For 140 European plant species we computed past range shifts since the last glacial maximum and future range shifts for a variety of Intergovernmental Panel on Climate Change (IPCC) scenarios and global circulation models (GCMs). Range shift rates were estimated by means of species distribution modelling (SDM). With process-based seed dispersal models we estimated species-specific migration rates for 27 dispersal modes addressing dispersal by wind (anemochory) for different wind conditions, as well as dispersal by mammals (dispersal on animal's coat - epizoochory and dispersal by animals after feeding and digestion - endozoochory) considering different animal species. Our process-based modelled migration rates generally exceeded the postglacial range shift rates indicating that the process-based models we used are capable of predicting migration rates that are in accordance with realized past migration. For most of the considered species, the modelled migration rates were considerably lower than the expected future climate change induced range shift rates. This implies that most plant species will not entirely be able to follow future climate-change-induced range shifts due to dispersal limitation. Animals with large day-and home-ranges are highly important for achieving high migration rates for many plant species, whereas anemochory is relevant for only few species.	[Cunze, Sarah] Biodivers & Climate Res Ctr Frankfurt BiK F, Frankfurt, Germany; [Cunze, Sarah; Heydel, Felix; Tackenberg, Oliver] Goethe Univ Frankfurt, Inst Ecol Evolut & Div, Frankfurt, Germany	Goethe University Frankfurt	Cunze, S (corresponding author), Biodivers & Climate Res Ctr Frankfurt BiK F, Frankfurt, Germany.	scunze@senckenberg.de	Tackenberg, Oliver/AAY-1345-2020; Tackenberg, Oliver/L-5481-2013	Tackenberg, Oliver/0000-0001-6717-7474	German Research Foundation DFG; LOEWE-Landes-Offensive zur Entwicklung Wissenschaftlich-o "konomischer Exzellenz	German Research Foundation DFG(German Research Foundation (DFG)); LOEWE-Landes-Offensive zur Entwicklung Wissenschaftlich-o "konomischer Exzellenz	The present study was conducted at the Biodiversity and Climate Research Centre (BiK-F, http://www. bik-f.de/), Frankfurt a. M., and funded by the research funding programme "LOEWE-Landes-Offensive zur Entwicklung Wissenschaftlich-o "konomischer Exzellenz'' (http://www.hmwk.hessen.de/irj/HMWK_Internet?uid=fa560c0b-ed11-9311-1010-43bf5aa60dfa) of Hesse's Ministry of Higher Education, Research, and the Arts, as well as by the German Research Foundation DFG (http://www.dfg.de/,grant no. TA 311/2-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blass C, 2010, J ARID ENVIRON, V74, P991, DOI 10.1016/j.jaridenv.2009.12.002; Bonn S, 2005, THESIS U REGENSBURG; Breitbach N, 2012, OECOLOGIA, V168, P425, DOI 10.1007/s00442-011-2090-1; Clark JS, 1998, BIOSCIENCE, V48, P13, DOI 10.2307/1313224; Clark JS, 2001, AM NAT, V157, P537, DOI 10.1086/319934; Cunze S, 2013, ISRN ECOL, V2013, P1; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Ellison AM, 2002, AM J BOT, V89, P1024, DOI 10.3732/ajb.89.6.1024; Engler R, 2009, ECOGRAPHY, V32, P34, DOI 10.1111/j.1600-0587.2009.05789.x; Fitzpatrick MC, 2008, GLOBAL CHANGE BIOL, V14, P1337, DOI 10.1111/j.1365-2486.2008.01559.x; Higgins SI, 2003, OIKOS, V101, P354, DOI 10.1034/j.1600-0706.2003.12141.x; Hintze C, 2013, PERSPECTIVES PLANT E; IPCC, 2007, CONTRIBUTION WORKING; Jalas J., 1972, ATLAS FLORAE EUROPAE; Jongman RHG, 2004, LANDSCAPE URBAN PLAN, V68, P305, DOI 10.1016/S0169-2046(03)00163-4; Klimesova J, 2009, J VEG SCI, V20, P511, DOI 10.1111/j.1654-1103.2009.01050.x; Kuemmerle T, 2011, ECOL APPL, V21, P830, DOI 10.1890/10-0073.1; Kuemmerle T, 2010, BIOL CONSERV, V143, P908, DOI 10.1016/j.biocon.2009.12.038; Lischke H, 2006, ECOL MODEL, V199, P409, DOI 10.1016/j.ecolmodel.2005.11.046; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; MAC ARTHUR ROBERT H., 1967; Malcolm JR, 2002, J BIOGEOGR, V29, P835, DOI 10.1046/j.1365-2699.2002.00702.x; Mckenney DW, 2007, BIOSCIENCE, V57, P939, DOI 10.1641/B571106; McLachlan JS, 2005, ECOLOGY, V86, P2088, DOI 10.1890/04-1036; Meier ES, 2012, GLOBAL ECOL BIOGEOGR, V21, P164, DOI 10.1111/j.1466-8238.2011.00669.x; Midgley GF, 2006, DIVERS DISTRIB, V12, P555, DOI 10.1111/j.1366-9516.2006.00273.x; Morin X, 2009, ECOLOGY, V90, P1301, DOI 10.1890/08-0134.1; Nathan R, 2008, TRENDS ECOL EVOL, V23, P638, DOI 10.1016/j.tree.2008.08.003; Nathan R, 2006, SCIENCE, V313, P786, DOI 10.1126/science.1124975; Normand S, 2011, P ROY SOC B-BIOL SCI, V278, P3644, DOI 10.1098/rspb.2010.2769; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pompe S, 2008, BIOL LETTERS, V4, P564, DOI 10.1098/rsbl.2008.0231; Poschlod P, 1998, ACTA BOT NEERL, V47, P27; Skov F, 2004, ECOGRAPHY, V27, P366, DOI 10.1111/j.0906-7590.2004.03823.x; Tackenberg O, 2003, ECOL MONOGR, V73, P173, DOI 10.1890/0012-9615(2003)073[0173:MLDOPD]2.0.CO;2; Tackenberg O, 2006, BASIC APPL ECOL, V7, P45, DOI 10.1016/j.baae.2005.05.001; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Thuiller W, 2008, PERSPECT PLANT ECOL, V9, P137, DOI 10.1016/j.ppees.2007.09.004; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Will H, 2008, J ECOL, V96, P1011, DOI 10.1111/j.1365-2745.2007.01341.x; Yates CJ, 2010, AUSTRAL ECOL, V35, P374, DOI 10.1111/j.1442-9993.2009.02044.x	45	47	48	3	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e67909	10.1371/journal.pone.0067909	http://dx.doi.org/10.1371/journal.pone.0067909			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894290	Green Published, Green Submitted, gold			2022-12-27	WOS:000322167900006
J	Sved, JA; Cameron, EC; Gilchrist, AS				Sved, John A.; Cameron, Emilie C.; Gilchrist, A. Stuart			Estimating Effective Population Size from Linkage Disequilibrium between Unlinked Loci: Theory and Application to Fruit Fly Outbreak Populations	PLOS ONE			English	Article							BACTROCERA-TRYONI; ALLELES; MARKERS	There is a substantial literature on the use of linkage disequilibrium (LD) to estimate effective population size using unlinked loci. The N-e estimates are extremely sensitive to the sampling process, and there is currently no theory to cope with the possible biases. We derive formulae for the analysis of idealised populations mating at random with multi-allelic (microsatellite) loci. The 'Burrows composite index' is introduced in a novel way with a 'composite haplotype table'. We show that in a sample of diploid size S, the mean value of chi(2) or r(2) from the composite haplotype table is biased by a factor of 1-1/(2S-1)(2), rather than the usual factor 1+1/(2S-1) for a conventional haplotype table. But analysis of population data using these formulae leads to N-e estimates that are unrealistically low. We provide theory and simulation to show that this bias towards low N-e estimates is due to null alleles, and introduce a randomised permutation correction to compensate for the bias. We also consider the effect of introducing a within-locus disequilibrium factor to r(2), and find that this factor leads to a bias in the N-e estimate. However this bias can be overcome using the same randomised permutation correction, to yield an altered r(2) with lower variance than the original r(2), and one that is also insensitive to null alleles. The resulting formulae are used to provide N-e estimates on 40 samples of the Queensland fruit fly, Bactrocera tryoni, from populations with widely divergent N-e expectations. Linkage relationships are known for most of the microsatellite loci in this species. We find that there is little difference in the estimated N-e values from using known unlinked loci as compared to using all loci, which is important for conservation studies where linkage relationships are unknown.	[Sved, John A.; Gilchrist, A. Stuart] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Cameron, Emilie C.] Univ Newcastle, Fac Hlth, Callaghan, NSW 2308, Australia	University of New South Wales Sydney; University of Newcastle	Sved, JA (corresponding author), Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia.	j.sved@unsw.edu.au		Gilchrist, Anthony/0000-0002-8774-4664	Australian Research Council [LP0219420]	Australian Research Council(Australian Research Council)	Funding from Australian Research Council Grant LP0219420. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cameron EC, 2010, B ENTOMOL RES, V100, P197, DOI 10.1017/S0007485309990150; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; COCKERHAM CC, 1977, GENET RES, V30, P121, DOI 10.1017/S0016672300017547; Gilchrist AS, 2010, HEREDITY, V105, P165, DOI 10.1038/hdy.2009.163; Haldane JBS, 1940, BIOMETRIKA, V31, P346, DOI 10.2307/2332614; Hayes BJ, 2003, GENOME RES, V13, P635, DOI 10.1101/gr.387103; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; HILL WG, 1974, HEREDITY, V33, P229, DOI 10.1038/hdy.1974.89; HILL WG, 1981, GENET RES, V38, P209, DOI 10.1017/S0016672300020553; HILL WG, 1975, THEOR POPUL BIOL, V8, P117, DOI 10.1016/0040-5809(75)90028-3; NEI M, 1973, GENETICS, V75, P213; Peel D, 2013, MOL ECOL RESOUR, V13, P243, DOI 10.1111/1755-0998.12049; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; SINNOCK P, 1972, AM J HUM GENET, V24, P393; SVED J A, 1971, Theoretical Population Biology, V2, P125; SVED JA, 1973, THEOR POPUL BIOL, V4, P129, DOI 10.1016/0040-5809(73)90008-7; Sved JA, 2008, AM J HUM GENET, V83, P737, DOI 10.1016/j.ajhg.2008.10.019; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 2006, CONSERV GENET, V7, P167, DOI 10.1007/s10592-005-9100-y; Waples RS, 2011, GENETICS, V189, P633, DOI 10.1534/genetics.111.132233; WEIR BS, 1979, BIOMETRICS, V35, P235, DOI 10.2307/2529947; WEIR BS, 1980, GENETICS, V95, P477; Zaykin DV, 2008, GENETICS, V180, P533, DOI 10.1534/genetics.108.089409; Zhao H, 2005, GENET RES, V86, P77, DOI 10.1017/S001667230500769X; Zhao JT, 2003, J HERED, V94, P416, DOI 10.1093/jhered/esg088	25	26	27	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69078	10.1371/journal.pone.0069078	http://dx.doi.org/10.1371/journal.pone.0069078			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894410	Green Published, gold			2022-12-27	WOS:000325211000074
J	Lu, MH; Hu, CJ; Chen, L; Peng, X; Chen, J; Hu, JY; Teng, M; Liang, GP				Lu, Mu-Han; Hu, Chang-Jiang; Chen, Ling; Peng, Xi; Chen, Jian; Hu, Jiong-Yu; Teng, Miao; Liang, Guang-Ping			miR-27b Represses Migration of Mouse MSCs to Burned Margins and Prolongs Wound Repair through Silencing SDF-1a	PLOS ONE			English	Article							IMPORTANT DOWNSTREAM COMPONENT; ENDOTHELIAL PROGENITOR CELLS; MARROW-DERIVED CELLS; STEM-CELLS; INJURY; SITES; SKIN; DIFFERENTIATION; MICRORNA-21; RECRUITMENT	Background: Interactions between stromal cell-derived factor-1 alpha (SDF-1 alpha) and its cognate receptor CXCR4 are crucial for the recruitment of mesenchymal stem cells (MSCs) from bone marrow ( BM) reservoirs to damaged tissues for repair during alarm situations. MicroRNAs are differentially expressed in stem cell niches, suggesting a specialized role in stem cell regulation. Here, we gain insight into the molecular mechanisms involved in regulating SDF-1 alpha. Methods: MSCs from green fluorescent protein transgenic male mice were transfused to irradiated recipient female C57BL/6 mice, and skin burn model of bone marrow-chimeric mice were constructed. Six miRNAs with differential expression in burned murine skin tissue compared to normal skin tissue were identified using microarrays and bioinformatics. The expression of miR-27b and SDF-1 alpha was examined in burned murine skin tissue using quantitative real-time PCR (qPCR) and immunohistochemistry (IHC), enzyme-linked immunosorbent assay (ELISA). The Correlation of miR-27b and SDF-1 alpha expression was analyzed by Pearson analysis Correlation. miRNAs suppressed SDF-1 alpha protein expression by binding directly to its 3'UTR using western blot and luciferase reporter assay. The importance of miRNAs in MSCs chemotaxis was further estimated by decreasing SDF-1 alpha in vivo and in vitro. Results: miR-23a, miR-27a and miR-27b expression was significantly lower in the burned skin than in the normal skin (p<0.05). We also found that several miRNAs suppressed SDF-1 alpha protein expression, while just miR-27a and miR-27b directly bound to the SDF-1 alpha 3'UTR. Moreover, the forced over-expression of miR-27a and miR-27b significantly reduced the directional migration of mMSCs in vitro. However, only miR-27b in burn wound margins significantly inhibited the mobilization of MSCs to the epidermis. Conclusion: miR-27b may be a unique signature of the stem cell niche in burned mouse skin and can suppress the directional migration of mMSCs by targeting SDF-1 alpha by binding directly to its 3'UTR.	[Lu, Mu-Han; Hu, Chang-Jiang; Peng, Xi; Chen, Jian; Hu, Jiong-Yu; Teng, Miao; Liang, Guang-Ping] Third Mil Med Univ, Southwest Hosp, Inst Burn Res, Chongqing, Peoples R China; [Lu, Mu-Han; Hu, Chang-Jiang; Chen, Ling] Third Mil Med Univ, Xinqiao Hosp, Dept Gastroenterol, Chongqing, Peoples R China	Army Medical University; Army Medical University	Chen, J (corresponding author), Third Mil Med Univ, Southwest Hosp, Inst Burn Res, Chongqing, Peoples R China.	hhhcc@aliyun.com; gpl12@yahoo.cn			National Nature Science Foundation of China [NSFC30772252]; Science Fund from the State Key Laboratory [SKLKF 200923]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Fund from the State Key Laboratory	This study was supported by a Grant from the National Nature Science Foundation of China (NSFC30772252) and Science Fund from the State Key Laboratory (SKLKF 200923). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MI, 2011, J INVEST DERMATOL, V131, pS22; Ahmed MI, 2011, J CELL SCI, V124, P3399, DOI 10.1242/jcs.086710; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Brugge VAT, 2008, J EXP BIOL, V211, P382, DOI 10.1242/jeb.013771; Dar A, 2006, EXP HEMATOL, V34, P967, DOI 10.1016/j.exphem.2006.04.002; De Falco E, 2009, J CELL MOL MED, V13, P3405, DOI 10.1111/j.1582-4934.2009.00655.x; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Emanuele NV, 2005, CYTOKINE, V30, P109, DOI 10.1016/j.cyto.2004.11.004; Golan K, 2012, BLOOD, V119, P2478, DOI 10.1182/blood-2011-06-358614; Hunt S, 2011, FEBS LETT, V585, P187, DOI 10.1016/j.febslet.2010.11.038; Jurmeister S, 2012, MOL CELL BIOL, V32, P633, DOI 10.1128/MCB.06212-11; Kim SK, 2012, PROCEEDINGS OF THE ASME PACIFIC RIM TECHNICAL CONFERENCE AND EXHIBITION ON PACKAGING AND INTEGRATION OF ELECTRONIC AND PHOTONIC SYSTEMS, MEMS AND NEMS 2011, VOL 2, P7; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lee I, 2009, GENOME RES, V19, P1175, DOI 10.1101/gr.089367.108; Li N, 2009, STEM CELLS, V27, P961, DOI 10.1002/stem.6; Li Q, 2010, J CELL SCI, V123, P2444, DOI 10.1242/jcs.067165; Liu DQ, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/164986; Liu J, 2012, J CELL MOL MED, V16, P2379, DOI 10.1111/j.1582-4934.2012.01551.x; Liu XL, 2011, PROTEIN CELL, V2, P845, DOI 10.1007/s13238-011-1097-z; Lu MH, 2012, BIOCHEM BIOPH RES CO, V421, P389, DOI 10.1016/j.bbrc.2012.04.027; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Nayyer L, 2012, PLAST RECONSTR SURG, V129, P1123, DOI 10.1097/PRS.0b013e31824a2c1c; Okamoto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043800; Palma CA, 2012, J CELL MOL MED, V16, P978, DOI 10.1111/j.1582-4934.2011.01514.x; Papagiannouli F, 2012, BIOTECHNOL J, V7, P723, DOI 10.1002/biot.201100352; Pillai MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014304; Qin ZH, 2012, J CELL MOL MED; Sato Y, 2005, BLOOD, V106, P756, DOI 10.1182/blood-2005-02-0572; Schuh A, 2012, J CELL MOL MED, V16, P2311, DOI 10.1111/j.1582-4934.2012.01539.x; Shatseva T, 2011, J CELL SCI, V124, P2826, DOI 10.1242/jcs.077529; Teta M, 2012, DEVELOPMENT, V139, P1405, DOI 10.1242/dev.070920; Tran DH, 2010, BIOINFORMATION, V4, P371, DOI 10.6026/97320630004371; Verstappen J, 2010, ORAL DIS, V16, P788, DOI 10.1111/j.1601-0825.2010.01689.x; Verstappen J, 2011, WOUND REPAIR REGEN, V19, P260, DOI 10.1111/j.1524-475X.2011.00671.x; Wu QL, 2009, J CELL MOL MED, V13, P3764, DOI 10.1111/j.1582-4934.2009.00691.x; Yamaguchi R, 2007, WOUND REPAIR REGEN, V15, P87, DOI 10.1111/j.1524-475X.2006.00189.x; Yang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021679; Zernecke A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000610; Zong ZW, 2008, RADIAT RES, V170, P444, DOI 10.1667/RR0744.1	39	21	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e68972	10.1371/journal.pone.0068972	http://dx.doi.org/10.1371/journal.pone.0068972			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894385	Green Submitted, gold, Green Published			2022-12-27	WOS:000322132100035
J	Tariq, M; Wright, DJ; Bruce, TJA; Staley, JT				Tariq, Muhammad; Wright, Denis J.; Bruce, Toby J. A.; Staley, Joanna T.			Drought and Root Herbivory Interact to Alter the Response of Above-Ground Parasitoids to Aphid Infested Plants and Associated Plant Volatile Signals	PLOS ONE			English	Article							BELOW-GROUND HERBIVORY; DIAERETIELLA-RAPAE HYMENOPTERA; MEDIATED INTERACTIONS; HOST-PLANT; DELIA-RADICUM; WATER-STRESS; MYZUS-PERSICAE; MULTITROPHIC INTERACTIONS; COLEMANI HYMENOPTERA; EXTREME TEMPERATURES	Multitrophic interactions are likely to be altered by climate change but there is little empirical evidence relating the responses of herbivores and parasitoids to abiotic factors. Here we investigated the effects of drought on an above/below-ground system comprising a generalist and a specialist aphid species (foliar herbivores), their parasitoids, and a dipteran species (root herbivore). We tested the hypotheses that: (1) high levels of drought stress and below-ground herbivory interact to reduce the performance of parasitoids developing in aphids; (2) drought stress and root herbivory change the profile of volatile organic chemicals (VOCs) emitted by the host plant; (3) parasitoids avoid ovipositing in aphids feeding on plants under drought stress and root herbivory. We examined the effect of drought, with and without root herbivory, on the olfactory response of parasitoids (preference), plant volatile emissions, parasitism success (performance), and the effect of drought on root herbivory. Under drought, percentage parasitism of aphids was reduced by about 40-55% compared with well watered plants. There was a significant interaction between drought and root herbivory on the efficacy of the two parasitoid species, drought stress partially reversing the negative effect of root herbivory on percent parasitism. In the absence of drought, root herbivory significantly reduced the performance (e. g. fecundity) of both parasitoid species developing in foliar herbivores. Plant emissions of VOCs were reduced by drought and root herbivores, and in olfactometer experiments parasitoids preferred the odour from well-watered plants compared with other treatments. The present work demonstrates that drought stress can change the outcome of interactions between herbivores feeding above-and below-ground and their parasitoids, mediated by changes in the chemical signals from plants to parasitoids. This provides a new insight into how the structure of terrestrial communities may be affected by drought.	[Tariq, Muhammad; Wright, Denis J.; Staley, Joanna T.] Imperial Coll London, Fac Nat Sci, Div Biol, Ascot, Berks, England; [Bruce, Toby J. A.] Rothamsted Res, Dept Biol Chem, Harpenden, Herts, England; [Staley, Joanna T.] NERC Ctr Ecol & Hydrol, Wallingford, Oxon, England	Imperial College London; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; UK Centre for Ecology & Hydrology (UKCEH)	Tariq, M (corresponding author), Imperial Coll London, Fac Nat Sci, Div Biol, Silwood Pk Campus, Ascot, Berks, England.	m.tariq06@imperial.ac.uk	Staley, Joanna T/E-8814-2010; Bruce, Toby JA/H-3131-2011	Staley, Joanna T/0000-0001-6467-3712; Bruce, Toby JA/0000-0002-9912-0605	Higher Education Commission of Pakistan; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005194] Funding Source: researchfish; Natural Environment Research Council [CEH010021] Funding Source: researchfish; BBSRC [BBS/E/C/00005194] Funding Source: UKRI	Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Muhammad Tariq was supported financially by the Higher Education Commission of Pakistan and this project was carried out at Silwood Park Campus, Imperial College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja I, 2010, AGRON SUSTAIN DEV, V30, P311, DOI 10.1051/agro/2009025; [Anonymous], 1984, BEHAV ECOLOGY; [Anonymous], 2007, AR4 CLIM CHANG 2007; Aslam TJ, 2013, J APPL ENTOMOL, V137, P136, DOI 10.1111/j.1439-0418.2012.01747.x; Bardgett RD, 1999, ECOL LETT, V2, P357; BATTAGLIA D, 1995, J INSECT BEHAV, V8, P739, DOI 10.1007/BF02009503; Bayhan SO, 2007, PHYTOPARASITICA, V35, P146, DOI 10.1007/BF02981109; Bezemer TM, 2005, TRENDS ECOL EVOL, V20, P617, DOI 10.1016/j.tree.2005.08.006; Bezemer TM, 2005, ECOL LETT, V8, P652, DOI 10.1111/j.1461-0248.2005.00762.x; Bezemer TM, 2003, OIKOS, V101, P555, DOI 10.1034/j.1600-0706.2003.12424.x; Bjorkman M, 2009, ARTHROPOD-PLANT INTE, V3, P55, DOI 10.1007/s11829-009-9055-x; Blande JD, 2004, J CHEM ECOL, V30, P1781, DOI 10.1023/B:JOEC.0000042401.52088.54; Blossey B, 2003, ANNU REV ENTOMOL, V48, P521, DOI 10.1146/annurev.ento.48.091801.112700; Borowicz VA, 2005, APPL SOIL ECOL, V28, P113, DOI 10.1016/j.apsoil.2004.07.007; Bouchereau A, 1996, EUR J AGRON, V5, P19, DOI 10.1016/S1161-0301(96)02005-9; Brabson BB, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005156; Brown V.K., 1990, Advances in Ecological Research, V20, P1, DOI 10.1016/S0065-2504(08)60052-5; Brudenell AJP, 1999, J EXP BOT, V50, P745, DOI 10.1093/jexbot/50.335.745; Calatayud PA, 2002, ENTOMOL EXP APPL, V102, P163, DOI 10.1023/A:1015870018236; Chau A, 2001, BIOL CONTROL, V20, P30, DOI 10.1006/bcon.2000.0881; Chen SX, 2001, PLANT PHYSIOL, V127, P194, DOI 10.1104/pp.127.1.194; Crawley M.J., 2007, R BOOK; Crawley MJ, 2005, STAT INTRO USING R; Crespo E, 2012, PHYTOCHEMISTRY, V84, P68, DOI 10.1016/j.phytochem.2012.08.013; Dai AG, 2011, WIRES CLIM CHANGE, V2, P45, DOI 10.1002/wcc.81; Derbali E, 1998, POSTHARVEST BIOL TEC, V13, P191, DOI 10.1016/S0925-5214(98)00016-7; Desneux N, 2009, J PEST SCI, V82, P335, DOI 10.1007/s10340-009-0258-9; Dicke M, 2003, BASIC APPL ECOL, V4, P3, DOI 10.1078/1439-1791-00129; Dicke M, 2010, TRENDS PLANT SCI, V15, P167, DOI 10.1016/j.tplants.2009.12.002; Digweed SC, 2006, ENTOMOL EXP APPL, V120, P41, DOI 10.1111/j.1570-7458.2006.00418.x; Douloumpaka S, 2003, PHYSIOL ENTOMOL, V28, P108, DOI 10.1046/j.1365-3032.2003.00323.x; Erb M, 2008, PLANT PHYSIOL, V146, P867, DOI 10.1104/pp.107.112169; Erb M, 2011, J ECOL, V99, P7, DOI 10.1111/j.1365-2745.2010.01757.x; Erb M, 2011, NEW PHYTOL, V189, P308, DOI 10.1111/j.1469-8137.2010.03450.x; Ferry A, 2009, BIOL CONTROL, V49, P219, DOI 10.1016/j.biocontrol.2009.01.013; Ferry A, 2007, J CHEM ECOL, V33, P2064, DOI 10.1007/s10886-007-9373-3; FINCH S, 1969, B ENTOMOL RES, V58, P619, DOI 10.1017/S0007485300057345; FOX LR, 1990, OECOLOGIA, V83, P414, DOI 10.1007/BF00317569; Fox LR, 1996, ENTOMOL EXP APPL, V80, P289, DOI 10.1007/BF00194777; GANGE AC, 1989, OECOLOGIA, V81, P38, DOI 10.1007/BF00377007; Gentry GL, 2006, ENTOMOL EXP APPL, V121, P115, DOI 10.1111/j.1570-8703.2006.00472.x; Gols R, 2009, PHYTOCHEM REV, V8, P187, DOI 10.1007/s11101-008-9104-6; Hale BK, 2003, ECOL ENTOMOL, V28, P666, DOI 10.1111/j.1365-2311.2003.00563.x; Hance T, 2007, ANNU REV ENTOMOL, V52, P107, DOI 10.1146/annurev.ento.52.110405.091333; Harren FJM, 2013, AOB PLANTS, V5, DOI 10.1093/aobpla/plt003; Heil M, 2008, NEW PHYTOL, V178, P41, DOI 10.1111/j.1469-8137.2007.02330.x; Hladun KR, 2009, ECOL ENTOMOL, V34, P144, DOI 10.1111/j.1365-2311.2008.01060.x; Holopainen JK, 2010, TRENDS PLANT SCI, V15, P176, DOI 10.1016/j.tplants.2010.01.006; Hopkins RJ, 2009, ANNU REV ENTOMOL, V54, P57, DOI 10.1146/annurev.ento.54.110807.090623; Huberty AF, 2004, ECOLOGY, V85, P1383, DOI 10.1890/03-0352; Hunter MD, 2003, AGR FOREST ENTOMOL, V5, P1, DOI 10.1046/j.1461-9563.2003.00168.x; JAENIKE J, 1978, THEOR POPUL BIOL, V14, P350, DOI 10.1016/0040-5809(78)90012-6; Jarosik VC, 2001, EUR J ENTOMOL, V98, P295, DOI 10.14411/eje.2001.050; Johnson SN, 2012, ECOLOGY, V93, P2208, DOI 10.1890/11-2272.1; Johnson SN, 2011, J ECOL, V99, P57, DOI 10.1111/j.1365-2745.2010.01748.x; Johnson SN, 2010, APPL SOIL ECOL, V44, P75, DOI 10.1016/j.apsoil.2009.10.002; Jones CG, 1999, OIKOS, V86, P27, DOI 10.2307/3546567; Kai M, 2010, APPL MICROBIOL BIOT, V88, P965, DOI 10.1007/s00253-010-2810-1; Kallis G, 2008, ANNU REV ENV RESOUR, V33, P85, DOI 10.1146/annurev.environ.33.081307.123117; Kalule T, 2004, J APPL ENTOMOL, V128, P120, DOI 10.1111/j.1439-0418.2004.00821.x; Kalule T, 2002, B ENTOMOL RES, V92, P53, DOI 10.1079/BER201132; Kaori S, 2002, JPN J APPL ENTOMOL Z, V46, P117, DOI 10.1303/jjaez.2002.117; Kaplan I, 2008, ECOL LETT, V11, P841, DOI 10.1111/j.1461-0248.2008.01200.x; KARBAN R, 1980, NATURE, V287, P326, DOI 10.1038/287326a0; Kugimiya S, 2010, J CHEM ECOL, V36, P620, DOI 10.1007/s10886-010-9802-6; LEATHER SR, 1989, FUNCT ECOL, V3, P237, DOI 10.2307/2389306; Leather SR, 2002, OIKOS, V96, P192, DOI 10.1034/j.1600-0706.2002.960122.x; Leps J, 2003, MULTIVARIATE ANAL EC; Loreto F, 2010, TRENDS PLANT SCI, V15, P154, DOI 10.1016/j.tplants.2009.12.006; Lukwinski AT, 2006, CAN J MICROBIOL, V52, P197, DOI [10.1139/w05-123, 10.1139/W05-123]; MASTERS GJ, 1993, OIKOS, V66, P148, DOI 10.2307/3545209; MASTERS GJ, 1992, FUNCT ECOL, V6, P175, DOI 10.2307/2389752; MASTERS GJ, 1995, ACTA OECOL, V16, P135; MASTERS GJ, 1995, ECOL RES, V10, P125, DOI 10.1007/BF02347934; MATTSON WJ, 1987, BIOSCIENCE, V37, P110, DOI 10.2307/1310365; MORAN NA, 1990, ECOLOGY, V71, P1050, DOI 10.2307/1937373; MORAN NA, 1988, ECOLOGY, V69, P1214, DOI 10.2307/1941276; Muller C, 2005, J CHEM ECOL, V31, P2621, DOI 10.1007/s10886-005-7617-7; MULLERSCHARER H, 1991, J APPL ECOL, V28, P759, DOI 10.2307/2404206; MULLERSCHARER H, 1995, OIKOS, V72, P36, DOI 10.2307/3546035; Newingham BA, 2007, OECOLOGIA, V153, P913, DOI 10.1007/s00442-007-0791-2; Ohgushi T, 2005, ANNU REV ECOL EVOL S, V36, P81, DOI 10.1146/annurev.ecolsys.36.091704.175523; Penuelas J, 2010, TRENDS PLANT SCI, V15, P133, DOI 10.1016/j.tplants.2009.12.005; PETTERSSON J, 1970, Entomologica Scandinavica, V1, P63; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Radovich TJK, 2005, J AM SOC HORTIC SCI, V130, P943, DOI 10.21273/JASHS.130.6.943; Rasmann S, 2008, OIKOS, V117, P362, DOI 10.1111/j.2007.0030-1299.16204.x; Rasmann S, 2007, ECOL LETT, V10, P926, DOI 10.1111/j.1461-0248.2007.01084.x; READ DP, 1970, CAN ENTOMOL, V102, P1567, DOI 10.4039/Ent1021567-12; REED HC, 1995, J CHEM ECOL, V21, P407, DOI 10.1007/BF02036738; Rhoades D.F., 1979, HERBIVORES THEIR INT; Sampaio MV, 2008, EUR J ENTOMOL, V105, P489, DOI 10.14411/eje.2008.063; Schreiner M, 2009, J AGR FOOD CHEM, V57, P7259, DOI 10.1021/jf901076h; SMITH TJR, 1977, J APPL ECOL, V14, P73, DOI 10.2307/2401828; Soler R, 2005, J ANIM ECOL, V74, P1121, DOI 10.1111/j.1365-2656.2005.01006.x; Soler R, 2007, OECOLOGIA, V152, P257, DOI 10.1007/s00442-006-0649-z; Soler R, 2007, OIKOS, V116, P367, DOI 10.1111/j.0030-1299.2007.15501.x; Soler R, 2013, TRENDS PLANT SCI, V18, P149, DOI 10.1016/j.tplants.2012.08.010; Soler R, 2012, J CHEM ECOL, V38, P755, DOI 10.1007/s10886-012-0104-z; Soroka JJ, 2004, CAN J PLANT SCI, V84, P1171, DOI 10.4141/P02-174; Staley JT, 2008, ROOT FEEDERS: AN ECOSYSTEM PERSPECTIVE, P192, DOI 10.1079/9781845934613.0192; Staley JT, 2008, BASIC APPL ECOL, V9, P673, DOI 10.1016/j.baae.2007.10.006; Staley JT, 2007, EUR J SOIL BIOL, V43, P189, DOI 10.1016/j.ejsobi.2007.02.010; Staley JT, 2007, GLOBAL CHANGE BIOL, V13, P866, DOI 10.1111/j.1365-2486.2007.01338.x; Staley JT, 2006, ECOL ENTOMOL, V31, P460, DOI 10.1111/j.1365-2311.2006.00808.x; Steidle JLM, 2003, ENTOMOL EXP APPL, V108, P133, DOI 10.1046/j.1570-7458.2003.00080.x; Tariq M, 2013, OECOLOGIA; Tariq M, 2012, AGR FOREST ENTOMOL, V14, P177, DOI 10.1111/j.1461-9563.2011.00557.x; Tariq M, 2010, AGR FOREST ENTOMOL, V12, P107, DOI 10.1111/j.1461-9563.2009.00458.x; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; Tindall KV, 2001, ENTOMOL EXP APPL, V101, P9, DOI 10.1023/A:1019293403417; Trotter RT, 2008, ECOL ENTOMOL, V33, P1, DOI 10.1111/j.1365-2311.2007.00941.x; Turlings TCJ, 1998, BIOL CONTROL, V11, P122, DOI 10.1006/bcon.1997.0591; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Utsumi S, 2009, J ANIM ECOL, V78, P953, DOI 10.1111/j.1365-2656.2009.01570.x; van Dam NM, 2012, AOB PLANTS, DOI 10.1093/aobpla/pls021; van Dam NM, 2006, CHEMOECOLOGY, V16, P17, DOI 10.1007/s00049-005-0323-7; van Dam NM, 2005, ENTOMOL EXP APPL, V115, P161, DOI 10.1111/j.1570-7458.2005.00241.x; Van der Putten WH, 2001, TRENDS ECOL EVOL, V16, P547, DOI 10.1016/S0169-5347(01)02265-0; Van der Putten WH, 2010, PHILOS T R SOC B, V365, P2025, DOI 10.1098/rstb.2010.0037; van der Putten WH, 2009, J ECOL, V97, P1131, DOI 10.1111/j.1365-2745.2009.01561.x; Van Emden HF, 2002, BIOCONTROL, V47, P607, DOI 10.1023/A:1020546621967; Vandegehuchte ML, 2010, OIKOS, V119, P1011, DOI 10.1111/j.1600-0706.2009.18360.x; VET LEM, 1992, ANNU REV ENTOMOL, V37, P141, DOI 10.1146/annurev.en.37.010192.001041; Vickers CE, 2009, NAT CHEM BIOL, V5, P283, DOI 10.1038/nchembio.158; VINSON SB, 1976, ANNU REV ENTOMOL, V21, P109, DOI 10.1146/annurev.en.21.010176.000545; Vinson SB, 1998, BIOL CONTROL, V11, P76; Wackers FL, 2003, ECOL LETT, V6, P9, DOI 10.1046/j.1461-0248.2003.00396.x; WEARING CH, 1967, NATURE, V213, P1051, DOI 10.1038/2131051a0; Webster B, 2008, J CHEM ECOL, V34, P1153, DOI 10.1007/s10886-008-9510-7; Webster B, 2010, ANIM BEHAV, V79, P451, DOI 10.1016/j.anbehav.2009.11.028; White TCR, 2008, BIOL REV, V83, P227, DOI 10.1111/j.1469-185X.2008.00041.x; WHITE TCR, 1984, OECOLOGIA, V63, P90, DOI 10.1007/BF00379790; WHITE TCR, 1974, OECOLOGIA, V16, P279, DOI 10.1007/BF00344738; Wurst S, 2003, PEDOBIOLOGIA, V47, P91, DOI 10.1078/0031-4056-00173; Wurst S, 2008, J CHEM ECOL, V34, P1360, DOI 10.1007/s10886-008-9537-9; Yang LH, 2009, AM NAT, V173, P105, DOI 10.1086/593360; YOUNG S, 1987, PHYSIOL ENTOMOL, V12, P373, DOI 10.1111/j.1365-3032.1987.tb00763.x	138	42	42	3	123	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e69013	10.1371/journal.pone.0069013	http://dx.doi.org/10.1371/journal.pone.0069013			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894394	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000322391400033
J	Kuan, YC; Wang, KC; Yuan, WH; Tsai, CP				Kuan, Yi-Chun; Wang, Kai-Chen; Yuan, Wei-Hsin; Tsai, Ching-Piao			Tumefactive Multiple Sclerosis in Taiwan	PLOS ONE			English	Article							DEMYELINATING LESIONS; DIAGNOSTIC-CRITERIA; GUIDELINES	Background: Multiple sclerosis (MS) is less common in Asia, including Taiwan, and some characteristics of MS in Asians differ from those of Caucasians. Tumefactive brain lesion is even rarer in MS patients. Objective: To review patients with tumefactive MS and compare them with those in other studies investigating tumefactive demyelinating lesions and our Taiwanese typical MS patients. Methods: Twelve patients (6.3%) from the 190 MS patients visiting Taipei Veterans General Hospital from 1985 to 2010 were enrolled. They all fulfilled the McDonald or Poser criteria for MS and had at least one brain lesion larger than 2 centimeters with or without a mass effect. Results: Eleven patients (91.7%) were female and presented tumefactive brain lesions during the first attack. The clinical course of all patients was relapsing-remitting with a second attack within 2 years. Their initial extended disability status score was higher, but the prognosis was better after more than 2 years of follow-up, than in other studies. Moreover, our patients did not have optic or spinal involvement as well as positive neuromyelitis optica immunoglobulin or aquaporin-4 antibody, which is very common in Taiwanese MS patients. Conclusion: Tumefactive MS is not common in Taiwan. Although the tumefactive demyelinating lesions seem to be terrible initially, their prognosis is relatively more favorable than expected.	[Kuan, Yi-Chun] Taipei Med Univ, Shuang Ho Hosp, Dept Neurol, Taipei, Taiwan; [Kuan, Yi-Chun; Wang, Kai-Chen; Tsai, Ching-Piao] Taipei Vet Gen Hosp, Neurol Inst, Dept Neurol, Taipei, Taiwan; [Wang, Kai-Chen; Yuan, Wei-Hsin; Tsai, Ching-Piao] Natl Yang Ming Univ, Taipei 112, Taiwan; [Wang, Kai-Chen] Cheng Hsin Gen Hosp, Dept Neurol, Taipei, Taiwan; [Yuan, Wei-Hsin] Taipei Municipal Gan Dau Hosp TVGH, Div Radiol, Taipei, Taiwan; [Yuan, Wei-Hsin] Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan	Taipei Medical University; Shuang Ho Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Cheng Hsin General Hospital; Taipei Veterans General Hospital	Tsai, CP (corresponding author), Taipei Vet Gen Hosp, Neurol Inst, Dept Neurol, Taipei, Taiwan.	cptsai@vghtpe.gov.tw						Barkhof F, 2003, ANN NEUROL, V53, P718, DOI 10.1002/ana.10551; Chang KH, 2006, MULT SCLER J, V12, P501, DOI 10.1191/1352458506ms1297oa; Comi G, 2004, LANCET NEUROL, V25, pS374; Dagher AP, 1996, NEURORADIOLOGY, V38, P560; HUNG TP, 1976, J NEUROL SCI, V27, P459, DOI 10.1016/0022-510X(76)90214-8; Kiriyama T, 2011, J NEUROIMAGING, V21, pe69, DOI 10.1111/j.1552-6569.2010.00502.x; KUROIWA Y, 1977, NEUROLOGY, V27, P188, DOI 10.1212/WNL.27.2.188; KUROIWA Y, 1975, NEUROLOGY, V25, P845, DOI 10.1212/WNL.25.9.845; Lucchinetti CF, 2008, BRAIN, V131, P1759, DOI 10.1093/brain/awn098; Matsuoka T, 2007, BRAIN, V130, P1206, DOI 10.1093/brain/awm027; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; PATY DW, 1988, NEUROLOGY, V38, P180, DOI 10.1212/WNL.38.2.180; Poppe AY, 2008, CAN J NEUROL SCI, V35, P593, DOI 10.1017/S0317167100009380; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; POSER S, 1992, ACTA NEUROL SCAND, V86, P579, DOI 10.1111/j.1600-0404.1992.tb05490.x; Tsai Ching-Piao, 2004, J Chin Med Assoc, V67, P500; Wattamwar PR, 2010, J NEUROL SCI, V297, P29, DOI 10.1016/j.jns.2010.06.030; Xia L, 2009, NEUROSURG REV, V32, P171, DOI 10.1007/s10143-009-0185-5	18	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e69919	10.1371/journal.pone.0069919	http://dx.doi.org/10.1371/journal.pone.0069919			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23875010	Green Published, Green Submitted, gold			2022-12-27	WOS:000324146200085
J	Baan, E; de Ronde, A; Stax, M; Sanders, RW; Luchters, S; Vyankandondera, J; Lange, JM; Pollakis, G; Paxton, WA				Baan, Elly; de Ronde, Anthony; Stax, Martijn; Sanders, Rogier W.; Luchters, Stanley; Vyankandondera, Joseph; Lange, Joep M.; Pollakis, Georgios; Paxton, William A.			HIV-1 Autologous Antibody Neutralization Associates with Mother to Child Transmission	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; GP120 ENVELOPE GLYCOPROTEIN; BINDS DC-SIGN; VERTICAL TRANSMISSION; PERINATAL TRANSMISSION; TYPE-1 ENVELOPE; INFANT PAIRS; FUNCTIONAL-PROPERTIES; HYPERIMMUNE GLOBULIN; ESCAPE VARIANTS	The HIV-1 characteristics associated with mother to child transmission (MTCT) are still poorly understood and if known would indicate where intervention strategies should be targeted. In contrast to horizontally infected individuals, exposed infants possess inherited antibodies (Abs) from their mother with the potential to protect against infection. We investigated the HIV-1 gp160 envelope proteins from seven transmitting mothers (TM) whose children were infected either during gestation or soon after delivery and from four non-transmitting mothers (NTM) with similar viral loads and CD4 counts. Using pseudo-typed viruses we tested gp160 envelope glycoproteins for TZM-bl infectivity, CD4 and CCR5 interactions, DC-SIGN capture and transfer and neutralization with an array of common neutralizing Abs (NAbs) (2F5, 2G12, 4E10 and b12) as well as mother and infant plasma. We found no viral correlates associated with HIV-1 MTCT nor did we find differences in neutralization with the panel of NAbs. We did, however, find that TM possessed significantly higher plasma neutralization capacities than NTM (P = 0.002). Furthermore, we found that in utero (IU) TM had a higher neutralization capacity than mothers transmitting either peri-partum (PP) or via breastfeeding (BF) (P = 0.002). Plasma from children infected IU neutralized viruses carrying autologous gp160 viral envelopes as well as those from their corresponding mothers whilst plasma from children infected PP and/or BF demonstrated poor neutralizing capacity. Our results demonstrate heightened autologous NAb responses against gp120/gp41 can associate with a greater risk of HIV-1 MTCT and more specifically in those infants infected IU. Although the number of HIV-1 transmitting pairs is low our results indicate that autologous NAb responses in mothers and infants do not protect against MTCT and may in fact be detrimental when considering IU HIV-1 transmissions.	[Baan, Elly; de Ronde, Anthony; Stax, Martijn; Sanders, Rogier W.; Pollakis, Georgios; Paxton, William A.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Lab Expt Virol,Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Sanders, Rogier W.] Cornell Univ, Dept Microbiol & Immunol, Weill Med Coll, New York, NY 10021 USA; [Luchters, Stanley; Vyankandondera, Joseph; Lange, Joep M.] IATEC, Amsterdam, Netherlands; [Vyankandondera, Joseph] CHUK, Kigali, Rwanda; [Vyankandondera, Joseph] Belgian Tech Cooperat, Kigali, Rwanda	University of Amsterdam; Academic Medical Center Amsterdam; Cornell University	Paxton, WA (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Lab Expt Virol,Dept Med Microbiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	w.a.paxton@amc.uva.nl	paxton, william/R-9747-2019; Georgios, Pollakis/Y-2341-2019	Paxton, William/0000-0002-2654-5186; Paxton, William/0000-0001-5200-0801; Pollakis, Georgios/0000-0002-9659-5461; Luchters, Stanley/0000-0001-5235-5629	Netherlands Organization for Scientific Research (NWO); Starting Investigator Grant from the European Research Council [ERC-StG-2-11-280829-SHEV]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Starting Investigator Grant from the European Research Council(European Research Council (ERC))	Rogier W. Sanders is a recipient of a Vidi fellowship from the Netherlands Organization for Scientific Research (NWO) and a Starting Investigator Grant from the European Research Council (ERC-StG-2-11-280829-SHEV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors gratefully acknowledge the contribution to this work of the Victorian Operational Infrastructure Support Program received by the Burnet Institute.	Alexander M, 2010, J VIROL, V84, P4100, DOI 10.1128/JVI.02068-09; Baan E, 2012, AIDS RES HUM RETROV, V28, P715, DOI [10.1089/aid.2011.0023, 10.1089/AID.2011.0023]; Barin F, 2006, J INFECT DIS, V193, P1504, DOI 10.1086/503778; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; Bobkov AF, 2004, J MED VIROL, V74, P191, DOI 10.1002/jmv.20177; Boily-Larouche G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040706; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Chaillon A, 2012, J VIROL, V86, P10540, DOI 10.1128/JVI.00518-12; Chalmet K, 2012, J INFECT DIS, V205, P174, DOI 10.1093/infdis/jir714; Chen WZ, 2013, EXPERT OPIN BIOL TH, V13, P657, DOI 10.1517/14712598.2013.761969; Chohan B, 2005, J VIROL, V79, P6528, DOI 10.1128/JVI.79.10.6528-6531.2005; Derdeyn CA, 2008, CURR OPIN HIV AIDS, V3, P16, DOI 10.1097/COH.0b013e3282f2982c; Dickover R, 2006, J VIROL, V80, P6525, DOI 10.1128/JVI.02658-05; Eggink D, 2010, VIROLOGY, V401, P236, DOI 10.1016/j.virol.2010.02.019; EMINI EA, 1992, NATURE, V355, P728, DOI 10.1038/355728a0; Ferrantelli F, 2004, J INFECT DIS, V189, P2167, DOI 10.1086/420833; Frost SDW, 2005, P NATL ACAD SCI USA, V102, P18514, DOI 10.1073/pnas.0504658102; Frost SDW, 2005, J VIROL, V79, P6523, DOI 10.1128/JVI.79.10.6523-6527.2005; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; GIRARD M, 1995, J VIROL, V69, P6239, DOI 10.1128/JVI.69.10.6239-6248.1995; Guay LA, 2002, AIDS, V16, P1391, DOI 10.1097/00002030-200207050-00011; Haase AT, 2005, NAT REV IMMUNOL, V5, P783, DOI 10.1038/nri1706; Hedskog C, 2012, J INFECT DIS, V205, P163, DOI 10.1093/infdis/jir719; Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302; HOMSY J, 1989, SCIENCE, V244, P1357, DOI 10.1126/science.2786647; Huang W, 2009, AIDS, V23, P1903, DOI 10.1097/QAD.0b013e32832f1802; HUSSON RN, 1995, J PEDIATR-US, V126, P865, DOI 10.1016/S0022-3476(95)70198-2; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Keele BF, 2009, CURR OPIN HIV AIDS, V4, P352, DOI 10.1097/COH.0b013e32832d9fef; Kishko M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-67; Kittinunvorakoon C, 2009, J MED VIROL, V81, P768, DOI 10.1002/jmv.21465; KLIKS SC, 1994, JAMA-J AM MED ASSOC, V272, P467, DOI 10.1001/jama.272.6.467; Kong XH, 2008, J VIROL, V82, P11609, DOI 10.1128/JVI.00952-08; Kourtis AP, 2006, LANCET INFECT DIS, V6, P726, DOI 10.1016/S1473-3099(06)70629-6; Lagaye S, 2001, J VIROL, V75, P4780, DOI 10.1128/JVI.75.10.4780-4791.2001; LALLEMANT M, 1994, LANCET, V343, P1001, DOI 10.1016/S0140-6736(94)90126-0; Lynch JB, 2011, J VIROL, V85, P5252, DOI 10.1128/JVI.02216-10; Mann AM, 2009, AIDS, V23, P1659, DOI 10.1097/QAD.0b013e32832e9408; Moore PL, 2012, NAT MED, V18, P1688, DOI 10.1038/nm.2985; Naarding MA, 2006, ANTIMICROB AGENTS CH, V50, P3367, DOI 10.1128/AAC.00593-06; NEWELL ML, 1992, LANCET, V339, P1007; Onyango-Makumbi C, 2011, JAIDS-J ACQ IMM DEF, V58, P399, DOI 10.1097/QAI.0b013e31822f8914; Pancino G, 1998, J INFECT DIS, V177, P1737, DOI 10.1086/517435; Pereira L, 2005, TRENDS MICROBIOL, V13, P164, DOI 10.1016/j.tim.2005.02.009; Pollakis G, 2001, J BIOL CHEM, V276, P13433, DOI 10.1074/jbc.M009779200; Provine NM, 2009, J VIROL, V83, P9002, DOI 10.1128/JVI.00423-09; Raymond S, 2010, AIDS, V24, P2305, DOI 10.1097/QAD.0b013e32833e50bb; Rieder P, 2011, CLIN INFECT DIS, V53, P1271, DOI 10.1093/cid/cir725; ROBINSON WE, 1988, LANCET, V1, P790; Ruijter JM, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-2; Russell ES, 2011, J VIROL, V85, P8253, DOI 10.1128/JVI.00197-11; Sabatte J, 2011, J IMMUNOL, V187, P5299, DOI 10.4049/jimmunol.1101889; Saeland E, 2009, MOL IMMUNOL, V46, P2309, DOI 10.1016/j.molimm.2009.03.025; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Samleerat T, 2008, J INFECT DIS, V198, P868, DOI 10.1086/591251; Samleerat T, 2009, VIROLOGY, V387, P388, DOI 10.1016/j.virol.2009.02.024; Sapsutthipas S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053920; SCARLATTI G, 1993, J INFECT DIS, V168, P207, DOI 10.1093/infdis/168.1.207; Simister NE, 2003, VACCINE, V21, P3365, DOI 10.1016/S0264-410X(03)00334-7; Stax MJ, 2009, VIROLOGY, V391, P203, DOI 10.1016/j.virol.2009.06.011; Thenin S, 2012, VIROLOGY, V426, P12, DOI 10.1016/j.virol.2012.01.017; Tugizov SM, 2012, J VIROL, V86, P2556, DOI 10.1128/JVI.06578-11; van Montfort T, 2007, J IMMUNOL, V178, P3177, DOI 10.4049/jimmunol.178.5.3177; VANTWOUT AB, 1994, J CLIN INVEST, V94, P2060, DOI 10.1172/JCI117560; Vidricaire G, 2004, J VIROL, V78, P11904, DOI 10.1128/JVI.78.21.11904-11915.2004; WEISS RA, 1988, J ACQ IMMUN DEF SYND, V1, P536; WIGZELL H, 1988, J ACQ IMMUN DEF SYND, V1, P559; Willey R, 2010, AIDS RES HUM RETROV, V26, P89, DOI 10.1089/aid.2009.0144; WOLINSKY SM, 1992, SCIENCE, V255, P1134, DOI 10.1126/science.1546316; Wu XL, 2006, J VIROL, V80, P835, DOI 10.1128/JVI.80.2.835-844.2006; Zhang H, 2010, VIROLOGY, V400, P164, DOI 10.1016/j.virol.2009.12.019	71	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e69274	10.1371/journal.pone.0069274	http://dx.doi.org/10.1371/journal.pone.0069274			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23874931	Green Submitted, Green Published, gold			2022-12-27	WOS:000322000600050
J	Botto, LD; Flood, T; Little, J; Fluchel, MN; Krikov, S; Feldkamp, ML; Wu, Y; Goedken, R; Puzhankara, S; Romitti, PA				Botto, Lorenzo D.; Flood, Timothy; Little, Julian; Fluchel, Mark N.; Krikov, Sergey; Feldkamp, Marcia L.; Wu, Yuan; Goedken, Rhinda; Puzhankara, Soman; Romitti, Paul A.			Cancer Risk in Children and Adolescents with Birth Defects: A Population-Based Cohort Study	PLOS ONE			English	Article							CHILDHOOD-CANCER; CONGENITAL-ABNORMALITIES; MULTIPLE COMPARISONS; RECORD-LINKAGE; ACUTE-LEUKEMIA; DOWN-SYNDROME; WILMS-TUMOR; MALFORMATIONS; ANOMALIES; MORTALITY	Objective: Birth defects are an increasing health priority worldwide, and the subject of a major 2010 World Health Assembly Resolution. Excess cancer risk may be an added burden in this vulnerable group of children, but studies to date have provided inconsistent findings. This study assessed the risk for cancer in children and young adolescents with major birth defects. Methods and Findings: This retrospective, statewide, population-based, cohort study was conducted in three US states (Utah, Arizona, Iowa). A cohort of 44,151 children and young adolescents (0 through 14 years of age) with selected major, non-chromosomal birth defects or chromosomal anomalies was compared to a reference cohort of 147,940 children without birth defects randomly sampled from each state's births and frequency matched by year of birth. The primary outcome was rate of cancer prior to age 15 years, by type of cancer and type of birth defect. The incidence of cancer was increased 2.9-fold (95% CI, 2.3 to 3.7) in children with birth defects (123 cases of cancer) compared to the reference cohort; the incidence rates were 33.8 and 11.7 per 100,000 person-years, respectively. However, the excess risk varied markedly by type of birth defect. Increased risks were seen in children with microcephaly, cleft palate, and selected eye, cardiac, and renal defects. Cancer risk was not increased with many common birth defects, including hypospadias, cleft lip with or without cleft palate, or hydrocephalus. Conclusion: Children with some structural, non-chromosomal birth defects, but not others, have a moderately increased risk for childhood cancer. Information on such selective risk can promote more effective clinical evaluation, counseling, and research.	[Botto, Lorenzo D.; Krikov, Sergey; Feldkamp, Marcia L.] Univ Utah, Dept Pediat, Div Med Genet, Salt Lake City, UT USA; [Flood, Timothy] Arizona Dept Hlth Serv, Phoenix, AZ 85007 USA; [Little, Julian] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON K1N 6N5, Canada; [Fluchel, Mark N.] Univ Utah, Dept Pediat, Div Pediat Hematol & Oncol, Salt Lake City, UT USA; [Wu, Yuan; Goedken, Rhinda; Puzhankara, Soman; Romitti, Paul A.] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Iowa City, IA USA	Utah System of Higher Education; University of Utah; Arizona Department of Health Services; University of Ottawa; Utah System of Higher Education; University of Utah; University of Iowa	Botto, LD (corresponding author), Univ Utah, Dept Pediat, Div Med Genet, Salt Lake City, UT USA.	Lorenzo.botto@hsc.utah.edu	Little, Julian/AAR-6117-2020	Little, Julian/0000-0001-5026-5531; Wu, Yuan/0000-0001-8925-555X	Utah Cancer Registry; National Cancer Institute's SEER Program [HHSN261201000026C]; Utah Department of Health; University of Utah; Centers for Disease Control and Prevention, National Center on Birth Defects and Developmental Disabilities [MM-1079-09/09]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	Utah Cancer Registry; National Cancer Institute's SEER Program; Utah Department of Health; University of Utah; Centers for Disease Control and Prevention, National Center on Birth Defects and Developmental Disabilities(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Partial support for all datasets within the Utah Population Database was provided by the Huntsman Cancer Institute at the University of Utah. This research was supported by the Utah Cancer Registry, which is funded by Contract #HHSN261201000026C from the National Cancer Institute's SEER Program, with additional support from the Utah Department of Health and the University of Utah. The research was also supported by the Centers for Disease Control and Prevention, National Center on Birth Defects and Developmental Disabilities Grant # MM-1079-09/09. JL holds the Canada Research Chair in Human Genome Epidemiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abla O, 2010, CANCER TREAT REV, V36, P354, DOI 10.1016/j.ctrv.2010.02.012; Agha MM, 2005, CANCER-AM CANCER SOC, V103, P1939, DOI 10.1002/cncr.20985; Altmann AE, 1998, BRIT J CANCER, V78, P1244, DOI 10.1038/bjc.1998.662; Anderson CE, 2003, AM J MED GENET A, V121A, P52, DOI 10.1002/ajmg.a.20141; Antonopoulos CN, 2011, INT J CANCER, V129, P2694, DOI 10.1002/ijc.25929; Auerbach AD, 2009, MUTAT RES-FUND MOL M, V668, P4, DOI 10.1016/j.mrfmmm.2009.01.013; Bille C, 2005, AM J EPIDEMIOL, V161, P1047, DOI 10.1093/aje/kwi132; Bjorge T, 2008, CANCER EPIDEM BIOMAR, V17, P500, DOI 10.1158/1055-9965.EPI-07-2630; Botto LD, 2007, BIRTH DEFECTS RES A, V79, P714, DOI 10.1002/bdra.20403; Carey J., 2010, MANAGEMENT GENETIC S, P807, DOI [10.1002/9780470893159.ch54, DOI 10.1002/9780470893159.CH54]; Carozza SE, 2012, AM J EPIDEMIOL, V175, P1217, DOI 10.1093/aje/kwr470; Christianson A., 2006, GLOBAL REPORT BIRTH; Citak FE, 2011, PEDIATR BLOOD CANCER, V56, P258, DOI 10.1002/pbc.22689; Clark EB, 1996, SEMIN PERINATOL, V20, P465, DOI 10.1016/S0146-0005(96)80062-0; CLARK EB, 2001, MOSS ADAMS HEART DIS, P64; Durmaz A, 2011, PEDIATR BLOOD CANCER, V56, P1098, DOI 10.1002/pbc.23049; Egeler RM, 2010, IMMUNOL REV, V234, P213, DOI 10.1111/j.0105-2896.2009.00883.x; FAUCETTE KJ, 1991, CLIN RES, V39, pA96; FISHER PG, 2012, J PEDIAT; Green DM, 1997, ARCH PEDIAT ADOL MED, V151, P379, DOI 10.1001/archpedi.1997.02170410053007; Greenland S, 2008, INT J EPIDEMIOL, V37, P430, DOI 10.1093/ije/dyn064; HARTLEY AL, 1994, PAEDIATR PERINAT EP, V8, P423, DOI 10.1111/j.1365-3016.1994.tb00481.x; Hoyert DL, 2006, PEDIATRICS, V117, P168, DOI 10.1542/peds.2005-2587; Infante-Rivard C, 2001, INT J EPIDEMIOL, V30, P350, DOI 10.1093/ije/30.2.350; Johnson KJ, 2010, PEDIATR BLOOD CANCER, V55, P95, DOI 10.1002/pbc.22495; Klimentopoulou A, 2012, PEDIATR BLOOD CANCER, V58, P344, DOI 10.1002/pbc.23347; Linabery AM, 2008, CANCER EPIDEM BIOMAR, V17, P2572, DOI 10.1158/1055-9965.EPI-08-0284; Linet MS, 1999, JNCI-J NATL CANCER I, V91, P1051, DOI 10.1093/jnci/91.12.1051; Little J, 2004, B WORLD HEALTH ORGAN, V82, P213; LITTLE J, 1999, IARC SCI PUBL, V149, P306; Mallol-Mesnard N, 2008, CANCER DETECT PREV, V32, P79, DOI 10.1016/j.cdp.2008.02.003; MASTROIACOVO P, 2010, ANN REPORT 2010 INT; Mehes K, 1998, AM J MED GENET, V75, P22, DOI 10.1002/(SICI)1096-8628(19980106)75:1<22::AID-AJMG6>3.3.CO;2-D; Merks JHM, 2008, JAMA-J AM MED ASSOC, V299, P61, DOI 10.1001/jama.2007.66; Mertens AC, 1998, J PEDIATR-US, V133, P617, DOI 10.1016/S0022-3476(98)70100-3; MILI F, 1993, AM J EPIDEMIOL, V137, P629, DOI 10.1093/oxfordjournals.aje.a116720; MILI F, 1993, AM J EPIDEMIOL, V137, P639, DOI 10.1093/oxfordjournals.aje.a116721; Milne E, 2013, INT J CANCER, V133, P253, DOI 10.1002/ijc.28004; Narod SA, 1997, AM J HUM GENET, V60, P474; *NAT BIRTH DEF PRE, 2011, 2004 2008 BIRTH DE A, V91, P1028; Nishi M, 2000, MED PEDIATR ONCOL, V34, P250, DOI 10.1002/(SICI)1096-911X(200004)34:4<250::AID-MPO3>3.0.CO;2-W; OLSON JM, 1995, MED PEDIATR ONCOL, V24, P305, DOI 10.1002/mpo.2950240507; PARKIN DM, 1988, INT J CANCER, V42, P511, DOI 10.1002/ijc.2910420408; Patja K, 2006, INT J CANCER, V118, P1769, DOI 10.1002/ijc.21518; POWELL JE, 1995, BRIT J CANCER, V72, P1563, DOI 10.1038/bjc.1995.549; Rankin J, 2008, PEDIATR BLOOD CANCER, V51, P608, DOI 10.1002/pbc.21682; Romitti PA, 2010, ARCH ENVIRON OCCUP H, V65, P154, DOI 10.1080/19338241003730903; Rosano A, 2000, J EPIDEMIOL COMMUN H, V54, P660, DOI 10.1136/jech.54.9.660; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Rynn L., 2008, Morbidity and Mortality Weekly Report, V57, P1; Spector LG, 2012, PEDIATR BLOOD CANCER, V59, P776, DOI 10.1002/pbc.24215; Steliarova-Foucher E, 2005, CANCER-AM CANCER SOC, V103, P1457, DOI 10.1002/cncr.20910; Sullivan SG, 2007, J INTELL DISABIL RES, V51, P228, DOI 10.1111/j.1365-2788.2006.00862.x; Tabares-Seisdedos R, 2011, LANCET ONCOL, V12, P604, DOI 10.1016/S1470-2045(11)70041-9; Thompson JR, 1998, AM J EPIDEMIOL, V147, P801, DOI 10.1093/oxfordjournals.aje.a009530; Weksberg R, 2010, EUR J HUM GENET, V18, P8, DOI 10.1038/ejhg.2009.106; *WHO, 2010, RES 63 WORLD ASS; WINDHAM GC, 1985, AM J EPIDEMIOL, V121, P49, DOI 10.1093/oxfordjournals.aje.a113982; Yang QH, 2002, LANCET, V359, P1019, DOI 10.1016/S0140-6736(02)08092-3; Yoon PW, 1997, ARCH PEDIAT ADOL MED, V151, P1096, DOI 10.1001/archpedi.1997.02170480026004	60	51	52	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e69077	10.1371/journal.pone.0069077	http://dx.doi.org/10.1371/journal.pone.0069077			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23874873	Green Published, gold, Green Submitted			2022-12-27	WOS:000322000600040
J	Bryan, JE; Shearman, PL; Asner, GP; Knapp, DE; Aoro, G; Lokes, B				Bryan, Jane E.; Shearman, Philip L.; Asner, Gregory P.; Knapp, David E.; Aoro, Geraldine; Lokes, Barbara			Extreme Differences in Forest Degradation in Borneo: Comparing Practices in Sarawak, Sabah, and Brunei	PLOS ONE			English	Article							RAIN-FOREST; LAND-USE; CONSERVATION; MANAGEMENT; CONVERSION; BIOMASS; IMPACT; TREES; ASIA	The Malaysian states of Sabah and Sarawak are global hotspots of forest loss and degradation due to timber and oil palm industries; however, the rates and patterns of change have remained poorly measured by conventional field or satellite approaches. Using 30 m resolution optical imagery acquired since 1990, forest cover and logging roads were mapped throughout Malaysian Borneo and Brunei using the Carnegie Landsat Analysis System. We uncovered similar to 364,000 km of roads constructed through the forests of this region. We estimated that in 2009 there were at most 45,400 km(2) of intact forest ecosystems in Malaysian Borneo and Brunei. Critically, we found that nearly 80% of the land surface of Sabah and Sarawak was impacted by previously undocumented, high-impact logging or clearing operations from 1990 to 2009. This contrasted strongly with neighbouring Brunei, where 54% of the land area remained covered by unlogged forest. Overall, only 8% and 3% of land area in Sabah and Sarawak, respectively, was covered by intact forests under designated protected areas. Our assessment shows that very few forest ecosystems remain intact in Sabah or Sarawak, but that Brunei, by largely excluding industrial logging from its borders, has been comparatively successful in protecting its forests.	[Bryan, Jane E.] Univ Tasmania, Sch Geog & Environm Studies, Hobart, Tas, Australia; [Bryan, Jane E.; Shearman, Philip L.; Aoro, Geraldine; Lokes, Barbara] Univ Papua New Guinea, UPNG Remote Sensing Ctr, Waigani, National Capita, Papua N Guinea; [Shearman, Philip L.] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [Asner, Gregory P.; Knapp, David E.] Carnegie Inst Sci, Dept Global Ecol, Stanford, CA USA	University of Tasmania; University of Papua New Guinea; Australian National University; Carnegie Institution for Science	Bryan, JE (corresponding author), Univ Tasmania, Sch Geog & Environm Studies, Hobart, Tas, Australia.	jane.bryan@utas.edu.au	Asner, Gregory/G-9268-2013	Asner, Gregory/0000-0001-7893-6421				Angelsen A, 2011, MOVING AHEAD REDD IS; [Anonymous], 2011, ITTO TECHNICAL SERIE; ASH J, 1988, NEW ZEAL J BOT, V26, P245, DOI 10.1080/0028825X.1988.10410116; Asner GP, 2005, SCIENCE, V310, P480, DOI 10.1126/science.1118051; Asner GP, 2009, CONSERV BIOL, V23, P1386, DOI 10.1111/j.1523-1739.2009.01333.x; Asner GP, 2009, J APPL REMOTE SENS, V3, DOI 10.1117/1.3223675; Berry NJ, 2010, BIODIVERS CONSERV, V19, P985, DOI 10.1007/s10531-010-9779-z; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Bryan J, 2010, ECOL APPL, V20, P2096, DOI 10.1890/09-1818.1; Chambers JQ, 1998, NATURE, V391, P135, DOI 10.1038/34325; Didham RK, 2011, BIOTROPICA, V43, P393, DOI 10.1111/j.1744-7429.2011.00790.x; Eckstein D, 1981, YALE U FORESTRY ENV, V94, P83; Edwards DP, 2011, P ROY SOC B-BIOL SCI, V278, P82, DOI 10.1098/rspb.2010.1062; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Hansen MC, 2008, P NATL ACAD SCI USA, V105, P9439, DOI 10.1073/pnas.0804042105; Kammesheidt L, 2003, FOREST ECOL MANAG, V174, P437, DOI 10.1016/S0378-1127(02)00077-4; Koh LP, 2011, P NATL ACAD SCI USA, V108, P5127, DOI 10.1073/pnas.1018776108; Laporte NT, 2007, SCIENCE, V316, P1451, DOI 10.1126/science.1141057; Laurance WF, 2004, FOREST ECOL MANAG, V190, P131, DOI 10.1016/j.foreco.2003.09.011; Laurance WF, 2000, NATURE, V404, P836, DOI 10.1038/35009032; Lindenmayer DB, 2012, SCIENCE, V338, P1305, DOI 10.1126/science.1231070; Makarieva AM, 2007, HYDROL EARTH SYST SC, V11, P1013, DOI 10.5194/hess-11-1013-2007; Miettinen J, 2010, REMOTE SENS LETT, V3, P11; Miettinen J, 2011, GLOBAL CHANGE BIOL, V17, P2261, DOI 10.1111/j.1365-2486.2011.02398.x; Oliveira PJC, 2007, SCIENCE, V317, P1233, DOI 10.1126/science.1146324; Pinard MA, 1996, BIOTROPICA, V28, P278, DOI 10.2307/2389193; Putz FE, 2008, FOREST ECOL MANAG, V256, P1427, DOI 10.1016/j.foreco.2008.03.036; Putz FE, 2000, CONSERV BIOL, V14, P951, DOI 10.1046/j.1523-1739.2000.99137.x; Putz FE, 2012, CONSERV LETT, V5, P296, DOI 10.1111/j.1755-263X.2012.00242.x; Reynolds G, 2011, PHILOS T R SOC B, V366, P3168, DOI 10.1098/rstb.2011.0154; Shearman PL, 2009, BIOTROPICA, V41, P379, DOI 10.1111/j.1744-7429.2009.00495.x; Shearman P, 2012, BIOL CONSERV, V151, P17, DOI 10.1016/j.biocon.2011.10.036; Sist P, 2003, ENVIRON CONSERV, V30, P364, DOI 10.1017/S0376892903000389; Taylor PW, 1954, J ECOL, V45, P23; UCN and UNEP, 2010, WORLD DAT PROT AR WD; Wake D, 1991, P NATL ACAD SCI USA, V105, P11466; Whitmore T.C., 1984, TROPICAL RAM FORESTS	38	154	164	2	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e69679	10.1371/journal.pone.0069679	http://dx.doi.org/10.1371/journal.pone.0069679			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23874983	Green Published, gold, Green Submitted			2022-12-27	WOS:000322000600055
J	Finstermeier, K; Zinner, D; Brameier, M; Meyer, M; Kreuz, E; Hofreiter, M; Roos, C				Finstermeier, Knut; Zinner, Dietmar; Brameier, Markus; Meyer, Matthias; Kreuz, Eva; Hofreiter, Michael; Roos, Christian			A Mitogenomic Phylogeny of Living Primates	PLOS ONE			English	Article							EVOLUTIONARY HISTORY; DIVERGENCE DATES; ASIAN COLOBINES; DNA-SEQUENCES; DATA SUPPORT; TIME-SCALE; MITOCHONDRIAL; NUCLEAR; FOSSIL; HYBRIDIZATION	Primates, the mammalian order including our own species, comprise 480 species in 78 genera. Thus, they represent the third largest of the 18 orders of eutherian mammals. Although recent phylogenetic studies on primates are increasingly built on molecular datasets, most of these studies have focused on taxonomic subgroups within the order. Complete mitochondrial (mt) genomes have proven to be extremely useful in deciphering within-order relationships even up to deep nodes. Using 454 sequencing, we sequenced 32 new complete mt genomes adding 20 previously not represented genera to the phylogenetic reconstruction of the primate tree. With 13 new sequences, the number of complete mt genomes within the parvorder Platyrrhini was widely extended, resulting in a largely resolved branching pattern among New World monkey families. We added 10 new Strepsirrhini mt genomes to the 15 previously available ones, thus almost doubling the number of mt genomes within this clade. Our data allow precise date estimates of all nodes and offer new insights into primate evolution. One major result is a relatively young date for the most recent common ancestor of all living primates which was estimated to 66-69 million years ago, suggesting that the divergence of extant primates started close to the K/T-boundary. Although some relationships remain unclear, the large number of mt genomes used allowed us to reconstruct a robust primate phylogeny which is largely in agreement with previous publications. Finally, we show that mt genomes are a useful tool for resolving primate phylogenetic relationships on various taxonomic levels.	[Finstermeier, Knut; Meyer, Matthias; Kreuz, Eva; Hofreiter, Michael] Max Planck Inst Evolutionary Anthropol, Res Grp Mol Ecol, Leipzig, Germany; [Zinner, Dietmar] Leibniz Inst Primate Res, German Primate Ctr, Cognit Ethol Lab, Gottingen, Germany; [Brameier, Markus; Roos, Christian] Leibniz Inst Primate Res, German Primate Ctr, Primate Genet Lab, Gottingen, Germany; [Roos, Christian] Leibniz Inst Primate Res, German Primate Ctr, Gene Bank Primates, Gottingen, Germany	Max Planck Society; Deutsches Primatenzentrum (DPZ); Deutsches Primatenzentrum (DPZ); Deutsches Primatenzentrum (DPZ)	Roos, C (corresponding author), Leibniz Inst Primate Res, German Primate Ctr, Primate Genet Lab, Gottingen, Germany.	croos@dpz.eu	Hofreiter, Michael/A-3996-2017	Hofreiter, Michael/0000-0003-0441-4705	Max Planck Society; German Primate Center	Max Planck Society(Max Planck SocietyFoundation CELLEX); German Primate Center	This work was funded by the Max Planck Society and the German Primate Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, THESIS U TEXAS AUSTI; Arnason U, 1998, J MOL EVOL, V47, P718, DOI 10.1007/PL00006431; Arnason U, 2000, HEREDITAS, V133, P217, DOI 10.1111/j.1601-5223.2000.00217.x; Arnason U, 2008, GENE, V421, P37, DOI 10.1016/j.gene.2008.05.024; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Avise John C., 1994, pi; Bjork A, 2011, MOL BIOL EVOL, V28, P615, DOI 10.1093/molbev/msq227; BROWN WM, 1982, J MOL EVOL, V18, P225, DOI 10.1007/BF01734101; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chan YC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014419; Chatterjee HJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-259; DeFilippis VR, 2000, MOL PHYLOGENET EVOL, V16, P143, DOI 10.1006/mpev.2000.0780; dos Reis M, 2012, P ROY SOC B-BIOL SCI, V279, P3491, DOI 10.1098/rspb.2012.0683; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Duchene S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027138; Eizirik Eduardo, 2004, P45; Fabre PH, 2009, MOL PHYLOGENET EVOL, V53, P808, DOI 10.1016/j.ympev.2009.08.004; Franzen JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005723; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gonder MK, 2007, MOL BIOL EVOL, V24, P757, DOI 10.1093/molbev/msl209; Goodman M, 1998, MOL PHYLOGENET EVOL, V9, P585, DOI 10.1006/mpev.1998.0495; Hasegawa M, 2003, GENES GENET SYST, V78, P267, DOI 10.1266/ggs.78.267; Herke SW, 2007, GENE, V390, P39, DOI 10.1016/j.gene.2006.08.015; Hodgson JA, 2009, P NATL ACAD SCI USA, V106, P5534, DOI 10.1073/pnas.0810346106; Horvath JE, 2008, GENOME RES, V18, P489, DOI 10.1101/gr.7265208; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Israfil H, 2011, MOL PHYLOGENET EVOL, V58, P447, DOI 10.1016/j.ympev.2010.11.005; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kay RF, 2008, J HUM EVOL, V54, P323, DOI 10.1016/j.jhevol.2007.09.002; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Konkel MK, 2010, EVOL ANTHROPOL, V19, P236, DOI 10.1002/evan.20283; Li J, 2009, GENE, V448, P242, DOI 10.1016/j.gene.2009.05.013; Liedigk R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037418; MADDISON W.P., 2001, MESQUITE MODULAR SYS; Matsudaira K, 2010, MOL PHYLOGENET EVOL, V55, P454, DOI 10.1016/j.ympev.2010.01.032; Matsui A, 2009, GENE, V441, P53, DOI 10.1016/j.gene.2008.08.024; Melnick Don J., 1993, Evolutionary Anthropology, V2, P2, DOI 10.1002/evan.1360020103; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Meyer M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm566; Meyer M, 2008, NAT PROTOC, V3, P267, DOI 10.1038/nprot.2007.520; Mittermeier R., 2013, HDB MAMMALS WORLD, V3; MOORE WS, 1995, EVOLUTION, V49, P718, DOI 10.1111/j.1558-5646.1995.tb02308.x; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Opazo JC, 2006, MOL PHYLOGENET EVOL, V40, P274, DOI 10.1016/j.ympev.2005.11.015; Osterholz M, 2009, MOL PHYLOGENET EVOL, V50, P507, DOI 10.1016/j.ympev.2008.12.014; Osterholz M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-58; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Posada D, 2009, METHODS MOL BIOL, V537, P93, DOI 10.1007/978-1-59745-251-9_5; Poux C, 2004, AM J PHYS ANTHROPOL, V124, P1, DOI 10.1002/ajpa.10322; Raaum RL, 2005, J HUM EVOL, V48, P237, DOI 10.1016/j.jhevol.2004.11.007; Rambaut A., 2007, TRACE 1 4; Rambaut A., 2008, FIGTREE TREE FIGURE; Ray DA, 2005, MOL PHYLOGENET EVOL, V35, P117, DOI 10.1016/j.ympev.2004.10.023; Rohland N, 2007, PLOS BIOL, V5, P1663, DOI 10.1371/journal.pbio.0050207; Rokas A, 2005, MOL BIOL EVOL, V22, P1337, DOI 10.1093/molbev/msi121; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roos C, 2001, MOL PHYLOGENET EVOL, V19, P486, DOI 10.1006/mpev.2001.0939; Roos C, 2004, P NATL ACAD SCI USA, V101, P10650, DOI 10.1073/pnas.0403852101; Roos C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-77; Rumpler Y, 2011, CHROMOSOME RES, V19, P209, DOI 10.1007/s10577-011-9188-5; Rumpler Y, 2008, CHROMOSOME RES, V16, P1143, DOI 10.1007/s10577-008-1265-z; Salem AH, 2003, P NATL ACAD SCI USA, V100, P12787, DOI 10.1073/pnas.2133766100; Schmitz J, 2005, CYTOGENET GENOME RES, V108, P26, DOI 10.1159/000080799; Schrago CG, 2007, AM J PHYS ANTHROPOL, V132, P344, DOI 10.1002/ajpa.20459; Seiffert ER, 2003, NATURE, V422, P421, DOI 10.1038/nature01489; Shekelle M, 2010, INT J PRIMATOL, V31, P1083, DOI 10.1007/s10764-010-9457-8; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shultz S, 2011, NATURE, V479, P219, DOI 10.1038/nature10601; Smith T, 2006, P NATL ACAD SCI USA, V103, P11223, DOI 10.1073/pnas.0511296103; Springer MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049521; Steiper ME, 2004, P NATL ACAD SCI USA, V101, P17021, DOI 10.1073/pnas.0407270101; Steiper ME, 2006, MOL PHYLOGENET EVOL, V41, P384, DOI 10.1016/j.ympev.2006.05.021; Steiper ME, 2012, P NATL ACAD SCI USA, V109, P6006, DOI 10.1073/pnas.1119506109; Sterner KN, 2006, MOL PHYLOGENET EVOL, V40, P1, DOI 10.1016/j.ympev.2006.01.017; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Tavare S, 2002, NATURE, V416, P726, DOI 10.1038/416726a; Thinh VN, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-74; Ting N, 2008, MOL PHYLOGENET EVOL, V46, P466, DOI 10.1016/j.ympev.2007.11.008; Tosi AJ, 2005, MOL PHYLOGENET EVOL, V36, P58, DOI 10.1016/j.ympev.2005.01.009; Tosi AJ, 2004, J HUM EVOL, V46, P223, DOI 10.1016/j.jhevol.2003.11.006; Vignaud P, 2002, NATURE, V418, P152, DOI 10.1038/nature00880; Vilstrup JT, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-65; Wang XG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0051667, 10.1371/journal.pone.0029469, 10.1371/journal.pone.0047703, 10.1371/journal.pone.0036274, 10.1371/journal.pone.0048069, 10.1371/journal.pone.0032405]; Williams BA, 2010, P NATL ACAD SCI USA, V107, P4797, DOI 10.1073/pnas.0908320107; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xing J, 2005, MOL PHYLOGENET EVOL, V37, P872, DOI 10.1016/j.ympev.2005.04.015; Xing J, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-5; Yoder AD, 2000, MOL BIOL EVOL, V17, P1081, DOI 10.1093/oxfordjournals.molbev.a026389; Yoder AD, 2004, MOL ECOL, V13, P757, DOI 10.1046/j.1365-294X.2004.02106.x; Yoder AD, 2003, RUT HUM EVO, P161; Zalmout IS, 2010, NATURE, V466, P360, DOI 10.1038/nature09094; Zinner D, 2013, AM J PHYS ANTHROPOL, V150, P133, DOI 10.1002/ajpa.22185; Zinner D, 2011, EVOL ANTHROPOL, V20, P96, DOI 10.1002/evan.20301; Zinner D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-83	95	128	130	3	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e69504	10.1371/journal.pone.0069504	http://dx.doi.org/10.1371/journal.pone.0069504			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874967	Green Published, Green Submitted, gold			2022-12-27	WOS:000322064300104
J	Fruciano, C; Franchini, P; Meyer, A				Fruciano, Carmelo; Franchini, Paolo; Meyer, Axel			Resampling-Based Approaches to Study Variation in Morphological Modularity	PLOS ONE			English	Article							MANDIBULAR MORPHOLOGY; INTEGRATION; MOUSE; EVOLVABILITY; EVOLUTION; LANDMARKS	Modularity has been suggested to be connected to evolvability because a higher degree of independence among parts allows them to evolve as separate units. Recently, the Escoufier RV coefficient has been proposed as a measure of the degree of integration between modules in multivariate morphometric datasets. However, it has been shown, using randomly simulated datasets, that the value of the RV coefficient depends on sample size. Also, so far there is no statistical test for the difference in the RV coefficient between a priori defined groups of observations. Here, we (1), using a rarefaction analysis, show that the value of the RV coefficient depends on sample size also in real geometric morphometric datasets; (2) propose a permutation procedure to test for the difference in the RV coefficient between a priori defined groups of observations; (3) show, through simulations, that such a permutation procedure has an appropriate Type I error; (4) suggest that a rarefaction procedure could be used to obtain sample-size-corrected values of the RV coefficient; and (5) propose a nearest-neighbor procedure that could be used when studying the variation of modularity in geographic space. The approaches outlined here, readily extendable to non-morphometric datasets, allow study of the variation in the degree of integration between a priori defined modules. A Java application - that will allow performance of the proposed test using a software with graphical user interface - has also been developed and is available at the Morphometrics at Stony Brook Web page (http://life.bio.sunysb.edu/morph/).	[Fruciano, Carmelo; Franchini, Paolo; Meyer, Axel] Univ Konstanz, Dept Biol, Constance, Germany	University of Konstanz	Fruciano, C (corresponding author), Univ Konstanz, Dept Biol, Constance, Germany.	Carmelo.Fruciano@uni-konstanz.de	Franchini, Paolo/M-6581-2016; Fruciano, Carmelo/HHM-5130-2022; Fruciano, Carmelo/O-5175-2018; Meyer, Axel/C-9826-2009	Franchini, Paolo/0000-0002-8184-1463; Fruciano, Carmelo/0000-0002-1659-9746; Fruciano, Carmelo/0000-0002-1659-9746; Meyer, Axel/0000-0002-0888-8193	DAAD [A/11/78461]; Marie Curie IEF fellowship [GA 327875]; University of Konstanz	DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); Marie Curie IEF fellowship(European Commission); University of Konstanz	CF received support from a DAAD postdoctoral fellowship (A/11/78461) and a Marie Curie IEF fellowship (GA 327875). AM and PF have been supported by the University of Konstanz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Sans-Fuentes MA, 2009, BIOL J LINN SOC, V97, P555, DOI 10.1111/j.1095-8312.2009.01237.x; ATCHLEY WR, 1985, GENETICS, V111, P555; Bookstein F L, 1997, Med Image Anal, V1, P225; Cardini A, 2008, BIOL J LINN SOC, V93, P813, DOI 10.1111/j.1095-8312.2008.01011.x; Cheverud JM, 1997, EVOLUTION, V51, P2006, DOI [10.1111/j.1558-5646.1997.tb05122.x, 10.2307/2411021]; Ehrich TH, 2003, J EXP ZOOL PART B, V296B, P58, DOI 10.1002/jez.b.00009; ESCOUFIER Y, 1973, BIOMETRICS, V29, P751, DOI 10.2307/2529140; Friedman J. H., 1977, ACM Transactions on Mathematical Software, V3, P209, DOI 10.1145/355744.355745; Goswami A., 2010, PALEONTOL SOC PAP, V16, P213, DOI [10.1017/S1089332600001881, DOI 10.1017/S1089332600001881, 10.1017/s1089332600001881]; Hansen TF, 2003, BIOSYSTEMS, V69, P83, DOI 10.1016/S0303-2647(02)00132-6; Jojic V, 2012, J EVOLUTION BIOL, V25, P2489, DOI 10.1111/j.1420-9101.2012.02612.x; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 2009, EVOL DEV, V11, P405, DOI 10.1111/j.1525-142X.2009.00347.x; Klingenberg CP, 2008, ANNU REV ECOL EVOL S, V39, P115, DOI 10.1146/annurev.ecolsys.37.091305.110054; Klingenberg CP, 2003, EVOL DEV, V5, P522, DOI 10.1046/j.1525-142X.2003.03057.x; Klingenberg CP, 2013, PLOS ONE; LEAMY L, 1993, GENETICA, V89, P139, DOI 10.1007/BF02424510; Makedonska J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040398; Munoz-Munoz F, 2011, J EVOLUTION BIOL, V24, P1763, DOI 10.1111/j.1420-9101.2011.02312.x; Neaux D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057026; Olson E. C., 1958, MORPHOLOGICAL INTEGR; ROBERT P, 1985, COMPUT STAT DATA AN, V3, P25, DOI 10.1016/0167-9473(85)90055-6; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Rohlf FJ., 2006, TPSDIG DIGITIZE LAND; Rohlf FJ, 2007, TPSRELW RELATIVE WAR; Smilde AK, 2009, BIOINFORMATICS, V25, P401, DOI 10.1093/bioinformatics/btn634; Wagner GP, 1996, AM ZOOL, V36, P36; Wagner GP, 1996, EVOLUTION, V50, P967, DOI [10.2307/2410639, 10.1111/j.1558-5646.1996.tb02339.x]; Wagner GP, 2007, NAT REV GENET, V8, P921, DOI 10.1038/nrg2267; Yang AS, 2001, EVOL DEV, V3, P59, DOI 10.1046/j.1525-142x.2001.003002059.x; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR	31	32	33	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e69376	10.1371/journal.pone.0069376	http://dx.doi.org/10.1371/journal.pone.0069376			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874956	Green Submitted, Green Published, gold			2022-12-27	WOS:000322064300101
J	Minozzo, FC; Rassier, DE				Minozzo, Fabio C.; Rassier, Dilson E.			The Effects of Ca2+ and MgADP on Force Development during and after Muscle Length Changes	PLOS ONE			English	Article							NON-CROSSBRIDGE CONTRIBUTIONS; VERTEBRATE SKELETAL-MUSCLE; CROSS-BRIDGE CYCLE; FROG-MUSCLE; MECHANICAL-PROPERTIES; POWER STROKE; TENSION DEVELOPMENT; MAMMALIAN MUSCLE; ISOMETRIC FORCE; STRIATED-MUSCLE	The goal of this study was to compare the effects of Ca2+ and MgADP activation on force development in skeletal muscles during and after imposed length changes. Single fibres dissected from the rabbit psoas were (i) activated in pCa(2+) 4.5 and pCa(2+) 6.0, or (ii) activated in pCa(2+) 4.5 before and after administration of 10 mM MgADP. Fibres were activated in sarcomere lengths (SL) of 2.65 mu m and 2.95 mu m, and subsequently stretched or shortened (5% SL at 1.0 SL.s(-1)) to reach a final SL of 2.80 mu m. The kinetics of force during stretch were not altered by pCa(2+) or MgADP, but the fast change in the slope of force development (P-1) observed during shortening and the corresponding SL extension required to reach the change (L-1) were higher in pCa(2+) 6.0 (P-1 = 0.22 +/- 0.02 P-o; L-1 = 5.26 +/- 0.24 nm. HS-1) than in pCa(2+) 4.5 (P-1 = 0.1560.01 Po; L-1 = e4.48 +/- 0.25 nm. HS-1). L-1 was also increased by MgADP activation during shortening. Force enhancement after stretch was lower in pCa(2+) 4.5 (14.9 +/- 5.4%) than in pCa(2+) 6.0 (38.8 +/- 7.5%), while force depression after shortening was similar in both Ca2+ concentrations. The stiffness accompanied the force behavior after length changes in all situations. MgADP did not affect the force behavior after length changes, and stiffness did not accompany the changes in force development after stretch. Altogether, these results suggest that the mechanisms of force generation during and after stretch are different from those obtained during and after shortening.	[Minozzo, Fabio C.; Rassier, Dilson E.] McGill Univ, Dept Kinesiol & Phys Educ, Montreal, PQ, Canada; [Rassier, Dilson E.] McGill Univ, Dept Physiol, Montreal, PQ, Canada; [Rassier, Dilson E.] McGill Univ, Meakins Christie Labs, Montreal, PQ, Canada; [Rassier, Dilson E.] McGill Univ, Dept Phys, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University	Rassier, DE (corresponding author), McGill Univ, Dept Kinesiol & Phys Educ, Montreal, PQ, Canada.	dilson.rassier@mcgill.ca	Minozzo, Fabio/D-9988-2014	Minozzo, Fabio/0000-0003-0733-8744	Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council of Canada (NSERC)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Canadian Institutes of Health Research (CIHR) and Natural Sciences and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT BC, 1952, J PHYSIOL-LONDON, V117, P77; Bagni MA, 2005, J PHYSIOL-LONDON, V565, P261, DOI 10.1113/jphysiol.2005.085209; Bagni MA, 2004, AM J PHYSIOL-CELL PH, V286, pC1353, DOI 10.1152/ajpcell.00493.2003; Bershitsky SY, 2002, J PHYSIOL-LONDON, V540, P971, DOI 10.1113/jphysiol.2001.013483; Bickham DC, 2011, BIOPHYS J, V101, P2445, DOI 10.1016/j.bpj.2011.10.007; BREMEL RD, 1972, NATURE-NEW BIOL, V238, P97, DOI 10.1038/newbio238097a0; Brunello E, 2007, P NATL ACAD SCI USA, V104, P20114, DOI 10.1073/pnas.0707626104; Campbell KS, 2002, BIOPHYS J, V82, P929, DOI 10.1016/S0006-3495(02)75454-4; Colombini B, 2005, ADV EXP MED BIOL, V565, P127; Colombini B, 2009, BIOPHYS J, V97, P2922, DOI 10.1016/j.bpj.2009.09.018; COLOMO F, 1986, J PHYSIOL-LONDON, V380, P227, DOI 10.1113/jphysiol.1986.sp016282; Cornachione AS, 2012, AM J PHYSIOL-CELL PH, V302, pC566, DOI 10.1152/ajpcell.00355.2011; Dantzig JA, 1999, BIOPHYS J, V77, P386, DOI 10.1016/S0006-3495(99)76897-9; Edman KAP, 2012, J PHYSIOL-LONDON, V590, P1339, DOI 10.1113/jphysiol.2011.222729; Edman KAP, 1996, ACTA PHYSIOL SCAND, V156, P183, DOI 10.1046/j.1365-201X.1996.t01-1-198000.x; EDMAN KAP, 1975, J PHYSIOL-LONDON, V246, P255, DOI 10.1113/jphysiol.1975.sp010889; EDMAN KAP, 1993, J PHYSIOL-LONDON, V466, P535; EDMAN KAP, 1978, J PHYSIOL-LONDON, V281, P139, DOI 10.1113/jphysiol.1978.sp012413; Edman KAP, 1996, J PHYSIOL-LONDON, V490, P191, DOI 10.1113/jphysiol.1996.sp021135; FABIATO A, 1988, METHODS ENZYMOL, V157, P378; Fitzsimons DP, 2001, J GEN PHYSIOL, V117, P133, DOI 10.1085/jgp.117.2.133; FORD LE, 1977, J PHYSIOL-LONDON, V269, P441, DOI 10.1113/jphysiol.1977.sp011911; Fukuda N, 1998, J MUSCLE RES CELL M, V19, P909, DOI 10.1023/A:1005437517287; Fusi L, 2010, J PHYSIOL-LONDON, V588, P495, DOI 10.1113/jphysiol.2009.178137; Getz EB, 1998, BIOPHYS J, V75, P2971, DOI 10.1016/S0006-3495(98)77738-0; Herzog W, 2002, J EXP BIOL, V205, P1275; Herzog W, 2000, J BIOMECH, V33, P531, DOI 10.1016/S0021-9290(99)00221-3; HUXLEY HE, 1994, BIOPHYS J, V67, P2411, DOI 10.1016/S0006-3495(94)80728-3; JULIAN FJ, 1979, J PHYSIOL-LONDON, V293, P379, DOI 10.1113/jphysiol.1979.sp012895; Labeit D, 2003, P NATL ACAD SCI USA, V100, P13716, DOI 10.1073/pnas.2235652100; Leonard TR, 2010, AM J PHYSIOL-CELL PH, V299, pC14, DOI 10.1152/ajpcell.00049.2010; Liu XM, 2002, BIOPHYS J, V83, P2705, DOI 10.1016/S0006-3495(02)75280-6; LOMBARDI V, 1990, J PHYSIOL-LONDON, V431, P141, DOI 10.1113/jphysiol.1990.sp018324; MARECHAL G, 1979, J GEN PHYSIOL, V73, P453, DOI 10.1085/jgp.73.4.453; Minozzo FC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029356; Minozzo FC, 2010, AM J PHYSIOL-CELL PH, V299, pC1127, DOI 10.1152/ajpcell.00073.2010; MORGAN DL, 1994, EXP PHYSIOL, V79, P831, DOI 10.1113/expphysiol.1994.sp003811; Neumann T, 1998, BIOPHYS J, V75, P938, DOI 10.1016/S0006-3495(98)77582-4; Pinniger GJ, 2006, J PHYSIOL-LONDON, V573, P627, DOI 10.1113/jphysiol.2005.095448; Pun C, 2010, P ROY SOC B-BIOL SCI, V277, P475, DOI 10.1098/rspb.2009.1579; RACK PMH, 1974, J PHYSIOL-LONDON, V240, P331, DOI 10.1113/jphysiol.1974.sp010613; Radocaj A, 2009, BIOPHYS J, V96, P1430, DOI 10.1016/j.bpj.2008.11.023; Ranatunga KW, 2010, ADV EXP MED BIOL, V682, P207, DOI 10.1007/978-1-4419-6366-6_12; Ranatunga KW, 1996, BIOPHYS J, V71, P1905, DOI 10.1016/S0006-3495(96)79389-X; Rassier DE, 2005, J APPL PHYSIOL, V99, P1769, DOI 10.1152/japplphysiol.00010.2005; Rassier DE, 2003, J BIOMECH, V36, P1309, DOI 10.1016/S0021-9290(03)00155-6; Rassier DE, 2008, P ROY SOC B-BIOL SCI, V275, P2577, DOI 10.1098/rspb.2008.0719; Rassier DE, 2012, P ROY SOC B-BIOL SCI, V279, P2705, DOI 10.1098/rspb.2012.0467; Roots H, 2007, J MUSCLE RES CELL M, V28, P123, DOI 10.1007/s10974-007-9110-0; Shimamoto Y, 2009, P NATL ACAD SCI USA, V106, P11954, DOI 10.1073/pnas.0813288106; SHIMIZU H, 1992, BIOPHYS J, V61, P1087, DOI 10.1016/S0006-3495(92)81918-5; STIENEN GJM, 1992, J PHYSIOL-LONDON, V451, P503, DOI 10.1113/jphysiol.1992.sp019176; Stuyvers BD, 1998, PROG BIOPHYS MOL BIO, V69, P425, DOI 10.1016/S0079-6107(98)00018-2; SUGI H, 1988, J PHYSIOL-LONDON, V407, P215, DOI 10.1113/jphysiol.1988.sp017411; Tsuchiya T, 1988, Adv Exp Med Biol, V226, P503; Yamasaki R, 2001, BIOPHYS J, V81, P2297, DOI 10.1016/S0006-3495(01)75876-6; ZHAO Y, 1994, BIOPHYS J, V67, P1655, DOI 10.1016/S0006-3495(94)80638-1	57	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68866	10.1371/journal.pone.0068866	http://dx.doi.org/10.1371/journal.pone.0068866			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874795	gold, Green Published			2022-12-27	WOS:000322064300075
J	Wu, SC; Wong, SL				Wu, Sau-Ching; Wong, Sui-Lam			Structure-Guided Design of an Engineered Streptavidin with Reusability to Purify Streptavidin-Binding Peptide Tagged Proteins or Biotinylated Proteins	PLOS ONE			English	Article							TANDEM AFFINITY PURIFICATION; MONOMERIC STREPTAVIDIN; RECOMBINANT PROTEINS; BACILLUS-SUBTILIS; MAMMALIAN-CELLS; SECRETORY PRODUCTION; SINGLE-STEP; SBP-TAG; COMPLEXES; DEHYDROGENASE	Development of a high-affinity streptavidin-binding peptide (SBP) tag allows the tagged recombinant proteins to be affinity purified using the streptavidin matrix without the need of biotinylation. The major limitation of this powerful technology is the requirement to use biotin to elute the SBP-tagged proteins from the streptavidin matrix. Tight biotin binding by streptavidin essentially allows the matrix to be used only once. To address this problem, differences in interactions of biotin and SBP with streptavidin were explored. Loop(3-4) which serves as a mobile lid for the biotin binding pocket in streptavidin is in the closed state with biotin binding. In contrast, this loop is in the open state with SBP binding. Replacement of glycine-48 with a bulkier residue (threonine) in this loop selectively reduces the biotin binding affinity (K-d) from 4x10(-14) M to 4.45x10(-10) M without affecting the SBP binding affinity. Introduction of a second mutation (S27A) to the first mutein (G48T) results in the development of a novel engineered streptavidin SAVSBPM18 which could be recombinantly produced in the functional form from Bacillus subtilis via secretion. To form an intact binding pocket for tight binding of SBP, two diagonally oriented subunits in a tetrameric streptavidin are required. It is vital for SAVSBPM18 to be stably in the tetrameric state in solution. This was confirmed using an HPLC/Laser light scattering system. SAVSBPM18 retains high binding affinity to SBP but has reversible biotin binding capability. The SAVSBPM18 matrix can be applied to affinity purify SBP-tagged proteins or biotinylated molecules to homogeneity with high recovery in a reusable manner. A mild washing step is sufficient to regenerate the matrix which can be reused for multiple rounds. Other applications including development of automated protein purification systems, lab-on-a-chip micro-devices, reusable biosensors, bioreactors and microarrays, and strippable detection agents for various blots are possible.	[Wu, Sau-Ching; Wong, Sui-Lam] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University of Calgary	Wong, SL (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	slwong@ucalgary.ca			Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was funded by a discovery grant from Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnau J, 2006, PROTEIN EXPRES PURIF, V48, P1, DOI 10.1016/j.pep.2005.12.002; Barrette-Ng IH, 2013, ACTA CRYSTALLOGR D, V69, P879, DOI 10.1107/S0907444913002576; Burckstummer T, 2006, NAT METHODS, V3, P1013, DOI 10.1038/nmeth968; Cull MG, 2000, METHOD ENZYMOL, V326, P430; Elia G, 2010, PROTEIN BIOTINYLATIO, P361; Freitag S, 1997, PROTEIN SCI, V6, P1157, DOI 10.1002/pro.5560060604; GREEN NM, 1990, METHOD ENZYMOL, V184, P51; Halliwell CM, 2001, ANAL BIOCHEM, V295, P257, DOI 10.1006/abio.2001.5182; Harding SE, 2001, CURRENT PROTOCOLS PR; Heal WP, 2012, NAT PROTOC, V7, P105, DOI 10.1038/nprot.2011.425; HENDRICKSON WA, 1989, P NATL ACAD SCI USA, V86, P2190, DOI 10.1073/pnas.86.7.2190; HOFMANN K, 1980, P NATL ACAD SCI-BIOL, V77, P4666, DOI 10.1073/pnas.77.8.4666; Huang X, 2007, J BIOCHEM BIOPH METH, V70, P435, DOI 10.1016/j.jbbm.2006.10.006; Iversen L, 2008, LANGMUIR, V24, P6375, DOI 10.1021/la7037075; Julien M, 2000, BIOCHEMISTRY-US, V39, P75, DOI 10.1021/bi991726e; Junttila MR, 2005, PROTEOMICS, V5, P1199, DOI 10.1002/pmic.200400991; Keefe AD, 2001, PROTEIN EXPRES PURIF, V23, P440, DOI 10.1006/prep.2001.1515; Khan F, 2006, ANAL CHEM, V78, P3072, DOI 10.1021/ac060184l; Kim JH, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-50; Klumb LA, 1998, BIOCHEMISTRY-US, V37, P7657, DOI 10.1021/bi9803123; Kobayashi T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003822; Kopetzki E, 2001, US, Patent No. [6312916 B1, 6312916]; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Lamla T, 2004, PROTEIN EXPRES PURIF, V33, P39, DOI 10.1016/j.pep.2003.08.014; Ledent P, 1997, FEBS LETT, V413, P194, DOI 10.1016/S0014-5793(97)00908-3; Li YF, 2011, PROTEIN SCI, V20, P140, DOI 10.1002/pro.546; Li YF, 2011, BIOTECHNOL LETT, V33, P1487, DOI 10.1007/s10529-011-0592-x; Lichty JJ, 2005, PROTEIN EXPRES PURIF, V41, P98, DOI 10.1016/j.pep.2005.01.019; Narmandakh A, 2010, PROTEIN EXPRES PURIF, V69, P39, DOI 10.1016/j.pep.2009.06.022; Nieba L, 1997, ANAL BIOCHEM, V252, P217, DOI 10.1006/abio.1997.2326; Pekrun K, 1995, EUR J BIOCHEM, V234, P811, DOI 10.1111/j.1432-1033.1995.811_a.x; Perbandt M, 2007, PROTEINS, V67, P1147, DOI 10.1002/prot.21236; Pouny Y, 1998, BIOCHEMISTRY-US, V37, P15713, DOI 10.1021/bi981519z; Qureshi MH, 2002, PROTEIN EXPRES PURIF, V25, P409, DOI 10.1016/S1046-5928(02)00021-9; Qureshi MH, 2001, J BIOL CHEM, V276, P46422, DOI 10.1074/jbc.M107398200; Reichel A, 2007, ANAL CHEM, V79, P8590, DOI 10.1021/ac0714922; SANO T, 1995, P NATL ACAD SCI USA, V92, P3180, DOI 10.1073/pnas.92.8.3180; Slessor KE, 2010, BIOORG CHEM, V38, P81, DOI 10.1016/j.bioorg.2009.12.003; Stayton PS, 1999, BIOMOL ENG, V16, P39, DOI 10.1016/S1050-3862(99)00042-X; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; Van Leene J, 2008, TRENDS PLANT SCI, V13, P517, DOI 10.1016/j.tplants.2008.08.002; Voss S, 1997, PROTEIN ENG, V10, P975, DOI 10.1093/protein/10.8.975; WALLER JR, 1984, ANAL BIOCHEM, V141, P189, DOI 10.1016/0003-2697(84)90444-5; WEBER PC, 1989, SCIENCE, V243, P85, DOI 10.1126/science.2911722; WILLIAMS RW, 1987, BIOCHIM BIOPHYS ACTA, V916, P200, DOI 10.1016/0167-4838(87)90109-9; WILMOT CM, 1988, J MOL BIOL, V203, P221, DOI 10.1016/0022-2836(88)90103-9; Wilson DS, 2001, P NATL ACAD SCI USA, V98, P3750, DOI 10.1073/pnas.061028198; Wu SC, 2005, J BIOL CHEM, V280, P23225, DOI 10.1074/jbc.M501733200; Wu SC, 2002, APPL ENVIRON MICROB, V68, P3261, DOI 10.1128/AEM.68.7.3261-3269.2002; Wu SC, 2002, PROTEIN EXPRES PURIF, V24, P348, DOI 10.1006/prep.2001.1582; Wu SC, 2002, APPL ENVIRON MICROB, V68, P1102, DOI 10.1128/AEM.68.3.1102-1108.2002; Xia H, 2012, BIOMED MICRODEVICES, V14, P67, DOI 10.1007/s10544-011-9586-7	52	29	34	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e69530	10.1371/journal.pone.0069530	http://dx.doi.org/10.1371/journal.pone.0069530			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874971	Green Published, Green Submitted, gold			2022-12-27	WOS:000322064300105
J	Lee, DY; Choi, BK; Lee, DG; Kim, YH; Kim, CH; Lee, SJ; Kwon, BS				Lee, Do Y.; Choi, Beom K.; Lee, Don G.; Kim, Young H.; Kim, Chang H.; Lee, Seung J.; Kwon, Byoung S.			4-1BB Signaling Activates the T Cell Factor 1 Effector/beta-Catenin Pathway with Delayed Kinetics via ERK Signaling and Delayed PI3K/AKT Activation to Promote the Proliferation of CD8(+) T Cells	PLOS ONE			English	Article							IN-VIVO; CYTOKINE PRODUCTION; BETA-CATENIN; RESPONSES; EXPRESSION; WNT; COSTIMULATION; KINASE; EXPANSION; MEMORY	4-1BB (CD137), an inducible costimulatory molecule, strongly enhances the proliferation and effector function of CD8(+) T cells. Since the serine/threonine kinase, glycogen synthase kinase-3 (GSK-3), is involved in a variety of signaling pathways of cellular proliferation, migration, immune responses, and apoptosis, we examined whether 4-1BB signaling activates GSK-3/beta-catenin signaling and downstream transcription factors to enhance the proliferation of CD8(+) T cells. 4-1BB signaling induces rapid activation of ERK and I kappa B degradation, and shows delayed activation of AKT at 24 h post 4-1BB stimulation on anti-CD3 activated T cells. ERK and AKT signals were required for sustained beta-catenin levels by inactivating GSK-3, which was also observed with delayed kinetics after 4-1BB stimulation. As a transcriptional partner of beta-catenin, 4-1BB signaling decreased levels of FOXO1 and increased levels of stimulatory TCF1 in CD8(+) T cells at 2-3 days but not at early time points after 4-1BB engagement. The enhanced proliferation of CD8(+) T cells due to 4-1BB signaling was completely abolished by treatment with the TCF1/beta-catenin inhibitor quercetin. These results show that 4-1BB signaling enhances the proliferation of activated CD8(+) T cells by activating the TCF1/beta-catenin axis via the PI3K/AKT/ERK pathway. As effects of 4-1BB on AKT, FOXO1, beta-catenin and GSK-3 beta showed delayed kinetics it is likely that an intervening molecule induced by 4-1BB and ERK signaling in activated T cells is responsible for these effects. These effects were observed on CD8(+) but not on CD4(+) T cells. Moreover, 4-1BB appeared to be unique among several TNFRs tested in inducing increase in stimulatory over inhibitory TCF1.	[Lee, Do Y.; Choi, Beom K.; Lee, Don G.; Kim, Chang H.; Lee, Seung J.; Kwon, Byoung S.] Natl Canc Ctr, Div Canc Biol, Canc Immunol Branch, Goyang, Gyeonggi Do, South Korea; [Kim, Young H.] Natl Canc Ctr, Program Immunotherapeut Res, Immune Cell Prod Unit, Goyang, Gyeonggi Do, South Korea; [Kwon, Byoung S.] Tulane Univ, Hlth Sci Ctr, Dept Med, Sect Clin Immunol Allergy & Rheumatol, New Orleans, LA 70118 USA	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); Tulane University	Kwon, BS (corresponding author), Natl Canc Ctr, Div Canc Biol, Goyang, Gyeonggi Do, South Korea.	bskwon@ncc.re.kr			National Cancer Center, Korea [NCC-1210370-1]; National Research Foundation of Korea (NRF); Korean government (MEST) [2005-084-E00001, 2006-2004212]	National Cancer Center, Korea; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by a research grant from the National Cancer Center, Korea (NCC-1210370-1) and a National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (2005-084-E00001 and 2006-2004212). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allam A, 2009, BLOOD, V114, P2121, DOI 10.1182/blood-2009-05-220087; Austin TW, 1997, BLOOD, V89, P3624, DOI 10.1182/blood.V89.10.3624.3624_3624_3635; Bertram EM, 2002, J IMMUNOL, V168, P3777, DOI 10.4049/jimmunol.168.8.3777; Beurel E, 2010, TRENDS IMMUNOL, V31, P24, DOI 10.1016/j.it.2009.09.007; Borst J, 2005, CURR OPIN IMMUNOL, V17, P275, DOI 10.1016/j.coi.2005.04.004; Bowen MA, 1996, J IMMUNOL, V156, P442; Du Qiang, 2010, For Immunopathol Dis Therap, V1, P155; Foulds KE, 2002, J IMMUNOL, V168, P1528, DOI 10.4049/jimmunol.168.4.1528; Gilfillan MC, 1998, J IMMUNOL, V160, P2180; Halstead ES, 2002, NAT IMMUNOL, V3, P536, DOI 10.1038/ni798; Hurtado JC, 1997, J IMMUNOL, V158, P2600; Jeannet G, 2010, P NATL ACAD SCI USA, V107, P9777, DOI 10.1073/pnas.0914127107; Jin TR, 2008, CELL SIGNAL, V20, P1697, DOI 10.1016/j.cellsig.2008.04.014; Kim YH, 2005, CELL IMMUNOL, V238, P76, DOI 10.1016/j.cellimm.2006.01.004; Kohn DB, 2011, MOL THER, V19, P432, DOI 10.1038/mt.2011.1; Kwon BS, 2002, J IMMUNOL, V168, P5483, DOI 10.4049/jimmunol.168.11.5483; Lee HW, 2003, EUR J IMMUNOL, V33, P2133, DOI 10.1002/eji.200323996; Lee HW, 2002, J IMMUNOL, V169, P4882, DOI 10.4049/jimmunol.169.9.4882; Lin GHY, 2009, J IMMUNOL, V182, P934, DOI 10.4049/jimmunol.182.2.934; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Ohteki T, 2000, J EXP MED, V192, P99, DOI 10.1084/jem.192.1.99; Park CH, 2005, BIOCHEM BIOPH RES CO, V328, P227, DOI 10.1016/j.bbrc.2004.12.151; Parry RV, 1997, EUR J IMMUNOL, V27, P2495, DOI 10.1002/eji.1830271006; Ramakrishnan P, 2004, IMMUNITY, V21, P477, DOI 10.1016/j.immuni.2004.08.009; Sabbagh L, 2008, J IMMUNOL, V180, P8093, DOI 10.4049/jimmunol.180.12.8093; Saegusa M, 2007, J PATHOL, V213, P35, DOI 10.1002/path.2198; SAGERSTROM CG, 1993, P NATL ACAD SCI USA, V90, P8987, DOI 10.1073/pnas.90.19.8987; Shuford WW, 1997, J EXP MED, V186, P47, DOI 10.1084/jem.186.1.47; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Stittrich AB, 2010, NAT IMMUNOL, V11, P1057, DOI 10.1038/ni.1945; Tan JT, 1999, J IMMUNOL, V163, P4859; Toualbi K, 2007, ONCOGENE, V26, P3492, DOI 10.1038/sj.onc.1210133; Vinay DS, 2012, MOL CANCER THER, V11, P1062, DOI 10.1158/1535-7163.MCT-11-0677; Wang HZ, 2011, CYTOKINE, V53, P130, DOI 10.1016/j.cyto.2010.10.009; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Willinger T, 2006, J IMMUNOL, V176, P1439, DOI 10.4049/jimmunol.176.3.1439; YANG L, 1992, CURR OPIN IMMUNOL, V4, P265, DOI 10.1016/0952-7915(92)90075-P; Zhang BY, 2007, J CLIN INVEST, V117, P3029, DOI 10.1172/JCI32426; Zhao Y, 2012, IMMUNOL LETT, V141, P220, DOI 10.1016/j.imlet.2011.10.008; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002	40	21	24	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e69677	10.1371/journal.pone.0069677	http://dx.doi.org/10.1371/journal.pone.0069677			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874982	gold, Green Submitted, Green Published			2022-12-27	WOS:000322218800071
J	Pan, HM; Niu, WQ; He, L; Wang, B; Cao, J; Zhao, F; Liu, Y; Li, S; Wu, HJ				Pan, Hongming; Niu, Wenquan; He, Lan; Wang, Bin; Cao, Jun; Zhao, Feng; Liu, Ying; Li, Shen; Wu, Huijian			Contributory Role of Five Common Polymorphisms of RAGE and APE1 Genes in Lung Cancer among Han Chinese	PLOS ONE			English	Article							MULTIFACTOR DIMENSIONALITY REDUCTION; GLYCATION END-PRODUCTS; ENVIRONMENT INTERACTIONS; RECEPTOR; EPISTASIS; CELLS; DISEASES	Background: Lung cancer is the leading cause of cancer mortality in China. Given the ubiquitous nature of gene-to-gene interaction in lung carcinogenesis, we sought to evaluate five common polymorphisms from advanced glycosylation end product-specific receptor (RAGE) and apurinic/apyrimidinic endonuclease 1 (APE1) genes in association with lung cancer among Han Chinese. Methods and Results: 819 patients with lung cancer and 803 cancer-free controls were recruited from Qiqihar city. Genotypes of five examined polymorphisms (RAGE gene: rs1800625, rs1800624, rs2070600; APE1 gene: rs1760944, rs1130409) were determined by ligase detection reaction method. Data were analyzed by R software and multifactor dimensionality reduction (MDR). Hardy-Weinberg equilibrium was satisfied for all five polymorphisms. Overall differences in the genotype and allele distributions were significant for rs1800625 (P-genotype<0.0005; P-allele<0.0005), rs2070600 (P-genotype = 0.005; P-allele = 0.004) and rs1130409 (P-genotype = 0.009; P-allele = 0.004) polymorphisms. Haplotype C-A-A (alleles in order of rs1800625, rs1800624 and rs2070600) of RAGE gene was overrepresented in patients, and conferred a 2.1-fold increased risk of lung cancer (95% confidence interval: 1.52-2.91), independent of confounding factors. Further application of MDR method to five examined polymorphisms identified the overall best interaction model including rs2070600 and rs1130409 polymorphisms. This model had a maximal testing accuracy of 64.63% and a maximal cross-validation consistency of 9 out of 10 at the significant level of 0.006. Conclusions: Our findings demonstrated a potential interactive contribution of RAGE and APE1 genes to the pathogenesis of lung cancer among Han Chinese. Further studies are warranted to confirm or refute these findings.	[Pan, Hongming; Zhao, Feng; Liu, Ying; Li, Shen; Wu, Huijian] Dalian Univ Technol, Sch Life Sci & Biotechnol, Dalian, Liaoning, Peoples R China; [Pan, Hongming; He, Lan; Wang, Bin; Cao, Jun] Qiqihar Med Univ, Basic Med Sci Coll, Qiqihar, Heilongjiang, Peoples R China; [Niu, Wenquan] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China	Dalian University of Technology; Qiqihar Medical University; Chinese Academy of Sciences; Shanghai Jiao Tong University	Wu, HJ (corresponding author), Dalian Univ Technol, Sch Life Sci & Biotechnol, Dalian, Liaoning, Peoples R China.	wuhj@dlut.edu.cn	Liu, Ying/ABF-6380-2021	Liu, Ying/0000-0003-1699-9309; Li, Shen/0000-0003-2968-068X; Zhao, Feng/0000-0002-7959-0394	National Natural Science Foundation of China [31171353, 31271500]; Ministry of Science and Technology of China (973 Program) [2011CB504201]; Project of Department of Education of Heilongjiang Province [12531780]; Opening Project of Key Laboratory of Antitumor Nature Products R&D, College of Heilongjiang Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China (973 Program)(Ministry of Science and Technology, ChinaNational Basic Research Program of China); Project of Department of Education of Heilongjiang Province; Opening Project of Key Laboratory of Antitumor Nature Products R&D, College of Heilongjiang Province	This work was supported by the National Natural Science Foundation of China (31171353, 31271500), the Ministry of Science and Technology of China (973 Program: 2011CB504201), the Project of Department of Education of Heilongjiang Province (12531780), and the Opening Project of Key Laboratory of Antitumor Nature Products R&D, College of Heilongjiang Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartling B, 2006, AM J RESP CELL MOL, V34, P83, DOI 10.1165/rcmb.2005-0194OC; Buckley ST, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/917108; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; Gu ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037970; Gui JA, 2010, HUM HERED, V70, P219, DOI 10.1159/000319175; Guo SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056213; Guo SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039814; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Ihsan R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029431; Jing R, 2010, NEOPLASMA, V57, P55, DOI 10.4149/neo_2010_01_055; Jing RR, 2010, GENET TEST MOL BIOMA, V14, P355, DOI 10.1089/gtmb.2009.0064; Lu J, 2009, FASEB J, V23, P3459, DOI 10.1096/fj.09-136549; Moore JH, 2010, ADV GENET, V72, P101, DOI [10.1016/B978-0-12-380862-2.00005-9, 10.1016/S0065-2660(10)72005-8]; Moore JH, 2009, AM J HUM GENET, V85, P309, DOI 10.1016/j.ajhg.2009.08.006; Moore JH, 2004, JAMA-J AM MED ASSOC, V291, P1642, DOI 10.1001/jama.291.13.1642; Pattin KA, 2009, GENET EPIDEMIOL, V33, P87, DOI 10.1002/gepi.20360; Ritchie MD, 2005, PHARMACOGENOMICS, V6, P823, DOI 10.2217/14622416.6.8.823; Schenk S, 2001, LUNG CANCER-J IASLC, V32, P7, DOI 10.1016/S0169-5002(00)00209-9; Sha QY, 2011, GENET EPIDEMIOL, V35, P671, DOI 10.1002/gepi.20617; Shirasawa M, 2004, GENES CELLS, V9, P165, DOI 10.1111/j.1356-9597.2004.00712.x; Stram DO, 2003, HUM HERED, V55, P179, DOI 10.1159/000073202; Wei W, 2012, MOL BIOL REP, V39, P11249, DOI 10.1007/s11033-012-2035-8; Yang ZZ, 2010, CANCER SCI, V101, P180, DOI 10.1111/j.1349-7006.2009.01366.x; Yokota J, 2010, ADV CANCER RES, V109, P51, DOI 10.1016/B978-0-12-380890-5.00002-8	24	30	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e69018	10.1371/journal.pone.0069018	http://dx.doi.org/10.1371/journal.pone.0069018			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874853	Green Published, Green Submitted, gold			2022-12-27	WOS:000322218800059
J	Li, JH; Loukili, N; Rosenblatt-Velin, N; Pacher, P; Feihl, F; Waeber, B; Liaudet, L				Li, Jianhui; Loukili, Noureddine; Rosenblatt-Velin, Nathalie; Pacher, Pal; Feihl, Francois; Waeber, Bernard; Liaudet, Lucas			Peroxynitrite Is a Key Mediator of the Cardioprotection Afforded by Ischemic Postconditioning In Vivo	PLOS ONE			English	Article							REPERFUSION INJURY; NITRIC-OXIDE; REACTIVE OXYGEN; MYOCARDIAL-INFARCTION; MECHANISM; HEART; VITRO; ACTIVATION; PROTECTS; RECEPTOR	Myocardial ischemic postconditioning (PosC) describes an acquired resistance to lethal ischemia-reperfusion (I/R) injury afforded by brief episodes of I/R applied immediately after the ischemic insult. Cardioprotection is conveyed by parallel signaling pathways converging to prevent mitochondria permeability transition. Recent observations indicated that PostC is associated with free radicals generation, including nitric oxide (NO.) and superoxide (O-2.(-)), and that cardioprotection is abrogated by antioxidants. Since NO. And O-2.(-) react to form peroxynitrite, we hypothesized that postC might trigger the formation of peroxyntrite to promote cardioprotection in vivo. Rats were exposed to 45 min of myocardial ischemia followed by 3h reperfusion. PostC (3 cycles of 30 seconds ischemia/30 seconds reperfusion) was applied at the end of index ischemia. In a subgroup of rats, the peroxynitrite decomposition catalyst 5,10,15,20-tetrakis(4-sulphonatophenyl) porphyrinato iron (FeTPPS) was given intravenously (10 mg/kg(-1)) 5 minutes before PostC. Myocardial nitrotyrosine was determined as an index of peroxynitrite formation. Infarct size (colorimetric technique and plasma creatine kinase-CK-levels) and left ventricle (LV) function (micro-tip pressure transducer), were determined. A significant generation of 3-nitrotyrosine was detected just after the PostC manoeuvre. PostC resulted in a marked reduction of infarct size, CK release and LV systolic dysfunction. Treatment with FeTPPS before PostC abrogated the beneficial effects of PostC on myocardial infarct size and LV function. Thus, peroxynitrite formed in the myocardium during PostC induces cardioprotective mechanisms improving both structural and functional integrity of the left ventricle exposed to ischemia and reperfusion in vivo.	[Li, Jianhui] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Hepatobiliary Surg, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Jianhui; Loukili, Noureddine; Liaudet, Lucas] Univ Lausanne Hosp, Med Ctr, Dept Intens Care Med, Lausanne, Switzerland; [Li, Jianhui; Loukili, Noureddine; Liaudet, Lucas] Univ Lausanne Hosp, Med Ctr, Burn Ctr, Lausanne, Switzerland; [Rosenblatt-Velin, Nathalie; Feihl, Francois; Waeber, Bernard; Liaudet, Lucas] Univ Lausanne Hosp, Med Ctr, Dept Internal Med, Div Clin Pathophysiol, Lausanne, Switzerland; [Pacher, Pal] NIAAA, Lab Physiol Studies, NIH, Bethesda, MD USA	Zhejiang University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Liaudet, L (corresponding author), Univ Lausanne Hosp, Med Ctr, Dept Intens Care Med, Lausanne, Switzerland.	lucas.liaudet@chuv.ch	Liaudet, Lucas/E-1322-2017; Pacher, Pal/B-6378-2008	Liaudet, Lucas/0000-0003-2670-4930; Pacher, Pal/0000-0001-7036-8108; Rosenblatt, Nathalie/0000-0003-2011-2862	Swiss National Fund for Scientific Research [320000/118174]; National Natural Science Foundation of China [81000137]; Qianjiang Talent Program of Zhejiang Province, China [2012R10045]; Scientific Research program for the Returned Overseas Chinese Scholars, Ministry of Health, Zhejiang Province, China [491010-G51104]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000375] Funding Source: NIH RePORTER	Swiss National Fund for Scientific Research(Swiss National Science Foundation (SNSF)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Qianjiang Talent Program of Zhejiang Province, China; Scientific Research program for the Returned Overseas Chinese Scholars, Ministry of Health, Zhejiang Province, China; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in part, by a grant from the Swiss National Fund for Scientific Research (Nr 320000/118174) to Lucas Liaudet and grants from the National Natural Science Foundation of China (Nr 81000137), the Qianjiang Talent Program of Zhejiang Province, China (Nr2012R10045), and the Scientific Research program for the Returned Overseas Chinese Scholars, Ministry of Health, Zhejiang Province, China (Nr 491010-G51104) to Jianhui Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altug S, 2000, BRIT J PHARMACOL, V130, P125, DOI 10.1038/sj.bjp.0703280; Altup S, 2001, EUR J PHARMACOL, V415, P239, DOI 10.1016/S0014-2999(01)00843-3; Balafanova Z, 2002, J BIOL CHEM, V277, P15021, DOI 10.1074/jbc.M112451200; Cohen MV, 2011, ANTIOXID REDOX SIGN, V14, P821, DOI 10.1089/ars.2010.3318; Duplain H, 2008, J PHYSIOL-LONDON, V586, P4011, DOI 10.1113/jphysiol.2008.154302; Fantinelli JC, 2007, MOL CELL BIOCHEM, V296, P45, DOI 10.1007/s11010-006-9296-2; Ferdinandy P, 2003, BRIT J PHARMACOL, V138, P532, DOI 10.1038/sj.bjp.0705080; Figueira TR, 2013, ANTIOXID REDOX SIGN, V18, P2029, DOI 10.1089/ars.2012.4729; GONZALEZFLECHA B, 1993, J CLIN INVEST, V91, P456, DOI 10.1172/JCI116223; Heusch G, 2013, LANCET, V381, P166, DOI 10.1016/S0140-6736(12)60916-7; Klassen S, 2009, N-S ARCH PHARMACOL, V379, P149, DOI 10.1007/s00210-008-0342-3; Kupai K, 2009, AM J PHYSIOL-HEART C, V297, pH1729, DOI 10.1152/ajpheart.00484.2009; Lefer DJ, 1997, J CLIN INVEST, V99, P684, DOI 10.1172/JCI119212; Lemoine S, 2010, BMC ANESTHESIOL, V10, DOI 10.1186/1471-2253-10-12; Levrand S, 2007, BIOCHEM BIOPH RES CO, V359, P445, DOI 10.1016/j.bbrc.2007.05.147; Levrand S, 2006, FREE RADICAL BIO MED, V41, P886, DOI 10.1016/j.freeradbiomed.2006.04.034; Liaudet L, 2001, BRIT J PHARMACOL, V133, P1424, DOI 10.1038/sj.bjp.0704185; Liaudet L, 2001, MOL MED, V7, P406, DOI 10.1007/BF03402187; Liaudet Lucas, 2009, Front Biosci (Landmark Ed), V14, P4809, DOI 10.2741/3569; Loukili N, 2011, CARDIOVASC RES, V89, P586, DOI 10.1093/cvr/cvq373; Manintveld OC, 2007, AM J PHYSIOL-HEART C, V292, pH1551, DOI 10.1152/ajpheart.00151.2006; Mewton N, 2013, CIRC J, V77, P1123, DOI 10.1253/circj.CJ-13-0385; Nossuli TO, 1997, CIRCULATION, V96, P2317; Ovize M, 2010, CARDIOVASC RES, V87, P406, DOI 10.1093/cvr/cvq129; Pacher P, 2005, TRENDS PHARMACOL SCI, V26, P302, DOI 10.1016/j.tips.2005.04.003; Pacher P, 2003, CIRCULATION, V107, P896, DOI 10.1161/01.CIR.0000048192.52098.DD; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Pagliaro P, 2011, ANTIOXID REDOX SIGN, V14, P833, DOI 10.1089/ars.2010.3245; Penna C, 2006, BASIC RES CARDIOL, V101, P180, DOI 10.1007/s00395-006-0584-5; Penna C, 2013, ANTIOXID REDOX SIGN, V18, P556, DOI 10.1089/ars.2011.4459; Penna C, 2009, BBA-BIOENERGETICS, V1787, P781, DOI 10.1016/j.bbabio.2009.02.008; Penna C, 2009, BASIC RES CARDIOL, V104, P390, DOI 10.1007/s00395-008-0762-8; Pesse B, 2005, J MOL CELL CARDIOL, V38, P765, DOI 10.1016/j.yjmcc.2005.02.020; Sanada S, 2011, AM J PHYSIOL-HEART C, V301, pH1723, DOI 10.1152/ajpheart.00553.2011; Shi WW, 2012, CARDIOVASC RES, V94, P206, DOI 10.1093/cvr/cvs088; Tsutsumi YM, 2007, LIFE SCI, V81, P1223, DOI 10.1016/j.lfs.2007.08.031; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Zhao ZQ, 2003, AM J PHYSIOL-HEART C, V285, pH579, DOI 10.1152/ajpheart.01064.2002; ZWEIER JL, 1995, NAT MED, V1, P804, DOI 10.1038/nm0895-804	39	22	22	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e70331	10.1371/journal.pone.0070331	http://dx.doi.org/10.1371/journal.pone.0070331			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23875026	Green Published, gold			2022-12-27	WOS:000321765300085
J	Chen, BR; Li, YH; Eisenstatt, JR; Runge, KW				Chen, Bo-Ruei; Li, Yanhui; Eisenstatt, Jessica R.; Runge, Kurt W.			Identification of a Lifespan Extending Mutation in the Schizosaccharomyces pombe Cyclin Gene clg1(+) by Direct Selection of Long-Lived Mutants	PLOS ONE			English	Article							FISSION YEAST; STATIONARY-PHASE; TUMOR-SUPPRESSOR; PROTEIN-KINASE; NONQUIESCENT CELLS; FUNCTIONAL HOMOLOG; DEPENDENT KINASE; LONGEVITY; PHO85; PCR	Model organisms such as budding yeast, worms and flies have proven instrumental in the discovery of genetic determinants of aging, and the fission yeast Schizosaccharomyces pombe is a promising new system for these studies. We devised an approach to directly select for long-lived S. pombe mutants from a random DNA insertion library. Each insertion mutation bears a unique sequence tag called a bar code that allows one to determine the proportion of an individual mutant in a culture containing thousands of different mutants. Aging these mutants in culture allowed identification of a long-lived mutant bearing an insertion mutation in the cyclin gene clg1(+). Clg1p, like Pas1p, physically associates with the cyclin-dependent kinase Pef1p. We identified a third Pef1p cyclin, Psl1p, and found that only loss of Clg1p or Pef1p extended lifespan. Genetic and co-immunoprecipitation results indicate that Pef1p controls lifespan through the downstream protein kinase Cek1p. While Pef1p is conserved as Pho85p in Saccharomyces cerevisiae, and as cdk5 in humans, genome-wide searches for lifespan regulators in S. cerevisiae have never identified Pho85p. Thus, the S. pombe system can be used to identify novel, evolutionarily conserved lifespan extending mutations, and our results suggest a potential role for mammalian cdk5 as a lifespan regulator.	[Chen, Bo-Ruei; Li, Yanhui; Eisenstatt, Jessica R.; Runge, Kurt W.] Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Dept Mol Genet, Cleveland, OH 44106 USA; [Chen, Bo-Ruei; Li, Yanhui; Runge, Kurt W.] Case Western Reserve Univ, Dept Genet & Genome Sci, Sch Med, Cleveland, OH 44106 USA; [Chen, Bo-Ruei; Eisenstatt, Jessica R.] Case Western Reserve Univ, Dept Biochem, Sch Med, Cleveland, OH 44106 USA	Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Case Western Reserve University	Runge, KW (corresponding author), Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Dept Mol Genet, Cleveland, OH 44106 USA.	rungek@ccf.org	Runge, Kurt/AAW-9308-2021	Runge, Kurt/0000-0001-8492-0530; Li, Yanhui/0000-0002-1505-5843; Eisenstatt, Jessica/0000-0003-1562-0408	NIH [R01 AG019960]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019960] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by NIH grant R01 AG019960 to KWR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen C, 2006, J CELL BIOL, V174, P89, DOI 10.1083/jcb.200604072; APOLINARIO E, 1993, CURR GENET, V24, P491, DOI 10.1007/BF00351711; Aragon AD, 2008, MOL BIOL CELL, V19, P1271, DOI 10.1091/mbc.E07-07-0666; Baker DJ, 2005, CURR OPIN CELL BIOL, V17, P583, DOI 10.1016/j.ceb.2005.09.011; Barker MG, 1999, YEAST, V15, P1511, DOI 10.1002/(SICI)1097-0061(199910)15:14<1511::AID-YEA482>3.3.CO;2-P; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Burtner CR, 2011, CELL CYCLE, V10, P1385, DOI 10.4161/cc.10.9.15464; Burtner CR, 2009, CELL CYCLE, V8, P1256, DOI 10.4161/cc.8.8.8287; Cameroni E, 2004, CELL CYCLE, V3, P462; Carroll AS, 2002, TRENDS BIOCHEM SCI, V27, P87, DOI 10.1016/S0968-0004(01)02040-0; Chen BR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-161; Chen BR, 2009, EXP GERONTOL, V44, P493, DOI 10.1016/j.exger.2009.04.004; Contreras-Vallejos E, 2012, CELL SIGNAL, V24, P44, DOI 10.1016/j.cellsig.2011.08.022; Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056; DEVON RS, 1995, NUCLEIC ACIDS RES, V23, P1644, DOI 10.1093/nar/23.9.1644; Dou XW, 2003, GENETICS, V165, P1105; Erjavec N, 2008, P NATL ACAD SCI USA, V105, P18764, DOI 10.1073/pnas.0804550105; Fabrizio P, 2004, J CELL BIOL, V166, P1055, DOI 10.1083/jcb.200404002; Fabrizio P, 2003, AGING CELL, V2, P73, DOI 10.1046/j.1474-9728.2003.00033.x; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Fabrizio P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001024; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Giaever G, 1999, NAT GENET, V21, P278, DOI 10.1038/6791; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Hedges SB, 2002, NAT REV GENET, V3, P838, DOI 10.1038/nrg929; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Horn C, 2007, NAT GENET, V39, P933, DOI 10.1038/ng0807-933; Huang DQ, 1999, P NATL ACAD SCI USA, V96, P14445, DOI 10.1073/pnas.96.25.14445; Iida S, 2004, ONCOGENE, V23, P5266, DOI 10.1038/sj.onc.1207623; JAZWINSKI SM, 1990, MOL MICROBIOL, V4, P337, DOI 10.1111/j.1365-2958.1990.tb00601.x; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kaeberlein M, 2010, NATURE, V464, P513, DOI 10.1038/nature08981; Keeney JTR, 2012, NEUROTOX RES, V22, P220, DOI 10.1007/s12640-011-9287-2; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kosoy A, 2007, J BIOL CHEM, V282, P20388, DOI 10.1074/jbc.M702652200; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; MacLean M, 2001, YEAST, V18, P499, DOI 10.1002/yea.701; Mao DQ, 2010, J BIOL CHEM, V285, P14671, DOI 10.1074/jbc.M109.066118; Matecic M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000921; Measday V, 1997, MOL CELL BIOL, V17, P1212, DOI 10.1128/MCB.17.3.1212; MORENO S, 1991, METHOD ENZYMOL, V194, P795; MORTIMER RK, 1959, NATURE, V183, P1751, DOI 10.1038/1831751a0; Nishiyama Y, 1999, FEBS LETT, V459, P159, DOI 10.1016/S0014-5793(99)01224-7; Nishizawa M, 1999, J BIOL CHEM, V274, P33859, DOI 10.1074/jbc.274.48.33859; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Reinders A, 1998, GENE DEV, V12, P2943, DOI 10.1101/gad.12.18.2943; Rose MD., 1990, METHODS YEAST GENETI; Roux AE, 2006, AGING CELL, V5, P345, DOI 10.1111/j.1474-9726.2006.00225.x; Roux AE, 2010, J GERONTOL A-BIOL, V65, P1, DOI 10.1093/gerona/glp152; SAMEJIMA I, 1994, MOL CELL BIOL, V14, P6361, DOI 10.1128/MCB.14.9.6361; Sinclair DA, 2005, MECH AGEING DEV, V126, P987, DOI 10.1016/j.mad.2005.03.019; Singer T, 2003, METH MOL B, V236, P241; Sipiczki M, 2003, MOLECULAR BIOLOGY OF SCHIZOSACCHAROMYCES POMBE, P431; Swinnen E, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-3; Tanaka K, 2000, MOL BIOL CELL, V11, P2845, DOI 10.1091/mbc.11.9.2845; Tao WF, 1999, NAT GENET, V21, P177, DOI 10.1038/5960; Trunova S, 2012, DIS MODEL MECH, V5, P210, DOI 10.1242/dmm.008847; Vidan S, 1997, MOL CELL BIOL, V17, P2688, DOI 10.1128/MCB.17.5.2688; Voets E, 2010, CELL CYCLE, V9, P3591, DOI 10.4161/cc.9.17.12832; Wanke V, 2005, EMBO J, V24, P4271, DOI 10.1038/sj.emboj.7600889; Wei M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000467; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Yang ZF, 2010, MOL CELL, V38, P250, DOI 10.1016/j.molcel.2010.02.033; Yoshikawa K, 2011, YEAST, V28, P349, DOI 10.1002/yea.1843; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206; Zuin A, 2010, EMBO J, V29, P981, DOI 10.1038/emboj.2009.407	70	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e69084	10.1371/journal.pone.0069084	http://dx.doi.org/10.1371/journal.pone.0069084			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874875	Green Published, gold, Green Submitted			2022-12-27	WOS:000321736900134
J	Lee, D; Vanden Broeck, J; Lange, AB				Lee, Dohee; Vanden Broeck, Jozef; Lange, Angela B.			Identification and Expression of the CCAP Receptor in the Chagas' Disease Vector, Rhodnius prolixus, and Its Involvement in Cardiac Control	PLOS ONE			English	Article							CRUSTACEAN CARDIOACTIVE PEPTIDE; PROTEIN-COUPLED RECEPTORS; MOSQUITO ANOPHELES-GAMBIAE; RED FLOUR BEETLE; MANDUCA-SEXTA; TRIBOLIUM-CASTANEUM; LOCUSTA-MIGRATORIA; ECDYSIS BEHAVIOR; ALPHA-AMYLASE; ADULT ECDYSIS	Rhodnius prolixus is the vector of Chagas' disease, by virtue of transmitting the parasite Trypanosoma cruzi. There is no cure for Chagas' disease and therefore controlling R. prolixus is currently the only method of prevention. Understanding the physiology of the disease vector is an important step in developing control measures. Crustacean cardioactive peptide (CCAP) is an important neuropeptide in insects because it has multiple physiological roles such as controlling heart rate and modulating ecdysis behaviour. In this study, we have cloned the cDNA sequence of the CCAP receptor (RhoprCCAPR) from 5th instar R. prolixus and found it to be a G-protein coupled receptor (GPCR). The spatial expression pattern in 5th instars reveals that the RhoprCCAPR transcript levels are high in the central nervous system, hindgut and female reproductive systems, and lower in the salivary glands, male reproductive tissues and a pool of tissues including the dorsal vessel, trachea, and fat body. Interestingly, the RhoprCCAPR expression is increased prior to ecdysis and decreased post-ecdysis. A functional receptor expression assay confirms that the RhoprCCAPR is activated by CCAP (EC50 = 12 nM) but not by adipokinetic hormone, corazonin or an extended FMRFamide. The involvement of CCAP in controlling heartbeat frequency was studied in vivo and in vitro by utilizing RNA interference. In vivo, the basal heartbeat frequency is decreased by 31% in bugs treated with dsCCAPR. Knocking down the receptor in dsCCAPR-treated bugs also resulted in loss of function of applied CCAP in vitro. This is the first report of a GPCR knock-down in R. prolixus and the first report showing that a reduction in CCAPR transcript levels leads to a reduction in cardiac output in any insect.	[Lee, Dohee; Lange, Angela B.] Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada; [Vanden Broeck, Jozef] Katholieke Univ Leuven, Louvain, Belgium	University of Toronto; University Toronto Mississauga; KU Leuven	Lee, D (corresponding author), Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada.	dohee.lee@utoronto.ca		Vanden Broeck, Jozef/0000-0001-7653-0516	Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakane Y, 2008, MECH DEVELOP, V125, P984, DOI 10.1016/j.mod.2008.09.002; Baker JD, 1999, J EXP BIOL, V202, P3037; Belmont M, 2006, BIOCHEM BIOPH RES CO, V344, P160, DOI 10.1016/j.bbrc.2006.03.117; Cazzamali G, 2003, BIOCHEM BIOPH RES CO, V303, P146, DOI 10.1016/S0006-291X(03)00302-4; Donini A, 2002, PEPTIDES, V23, P1915, DOI 10.1016/S0196-9781(02)00174-2; Donini A, 2001, J INSECT PHYSIOL, V47, P277, DOI 10.1016/S0022-1910(00)00112-8; Estevez-Lao TY, 2013, J EXP BIOL, V216, P601, DOI 10.1242/jeb.077164; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gade G, 1997, PHYSIOL REV, V77, P963, DOI 10.1152/physrev.1997.77.4.963; Gammie SC, 1997, J NEUROSCI, V17, P4389; Grimmelikhuijzen CJP, 2013, ARTHROPOD GENOMICS P, P165; Heilker R, 2009, DRUG DISCOV TODAY, V14, P231, DOI 10.1016/j.drudis.2008.11.011; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kawabata A, 2001, YAKUGAKU ZASSHI, V121, P1, DOI 10.1248/yakushi.121.1; Kobilka BK, 2007, BBA-BIOMEMBRANES, V1768, P794, DOI 10.1016/j.bbamem.2006.10.021; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; KOZAK M, 1990, P NATL ACAD SCI USA, V87, P8301, DOI 10.1073/pnas.87.21.8301; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee DH, 2011, PEPTIDES, V32, P475, DOI 10.1016/j.peptides.2010.06.035; Lee DH, 2011, GEN COMP ENDOCR, V174, P36, DOI 10.1016/j.ygcen.2011.08.007; Li B, 2011, J INSECT PHYSIOL, V57, P1190, DOI 10.1016/j.jinsphys.2011.05.011; Liebmann C, 2004, CURR PHARM DESIGN, V10, P1937, DOI 10.2174/1381612043384367; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loi PK, 2001, J EXP BIOL, V204, P2803; Orchard I, 2002, PEPTIDES, V23, P693, DOI 10.1016/S0196-9781(01)00663-5; Paluzzi JP, 2008, ENDOCRINOLOGY, V149, P4638, DOI 10.1210/en.2008-0353; Paluzzi JP, 2012, MOL CELL ENDOCRINOL, V363, P36, DOI 10.1016/j.mce.2012.07.007; Park JH, 2003, DEVELOPMENT, V130, P2645, DOI 10.1242/dev.00503; Park Y, 2002, P NATL ACAD SCI USA, V99, P11423, DOI 10.1073/pnas.162276199; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rozengurt E, 2010, CLIN CANCER RES, V16, P2505, DOI 10.1158/1078-0432.CCR-09-2229; Russell JL, 2012, ACS CHEM BIOL, V7, P1077, DOI 10.1021/cb300001m; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sakai T, 2004, ENDOCRINOLOGY, V145, P5671, DOI 10.1210/en.2004-0722; Sakai T, 2006, PEPTIDES, V27, P2157, DOI 10.1016/j.peptides.2006.04.009; Schoneberg T, 1999, MOL CELL ENDOCRINOL, V151, P181, DOI 10.1016/S0303-7207(99)00017-9; STANGIER J, 1987, P NATL ACAD SCI USA, V84, P575, DOI 10.1073/pnas.84.2.575; TUBLITZ N, 1989, J EXP BIOL, V142, P31; TUBLITZ NJ, 1986, J NEUROSCI, V6, P2451; Vaughan M, 1998, J BIOL CHEM, V273, P667, DOI 10.1074/jbc.273.2.667; Veelaert D, 1997, ENDOCRINOLOGY, V138, P138, DOI 10.1210/en.138.1.138; Zhang QR, 2011, P NATL ACAD SCI USA, V108, P16922, DOI 10.1073/pnas.1113863108; Zitnan D, 2000, J EXP BIOL, V203, P1329	44	22	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68897	10.1371/journal.pone.0068897	http://dx.doi.org/10.1371/journal.pone.0068897			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874803	Green Published, Green Submitted, gold			2022-12-27	WOS:000321736900119
J	Lloyd, RE; McGeehan, JE				Lloyd, Rhiannon E.; McGeehan, John E.			Structural Analysis of Mitochondrial Mutations Reveals a Role for Bigenomic Protein Interactions in Human Disease	PLOS ONE			English	Article							CYTOCHROME-C-OXIDASE; PROTONMOTIVE Q-CYCLE; B GENE; MISSENSE MUTATION; CRYSTAL-STRUCTURE; EXERCISE INTOLERANCE; BC(1) COMPLEX; SUBUNIT I; MTDNA; EVOLUTION	Mitochondria are the energy producing organelles of the cell, and mutations within their genome can cause numerous and often severe human diseases. At the heart of every mitochondrion is a set of five large multi-protein machines collectively known as the mitochondrial respiratory chain (MRC). This cellular machinery is central to several processes important for maintaining homeostasis within cells, including the production of ATP. The MRC is unique due to the bigenomic origin of its interacting proteins, which are encoded in the nucleus and mitochondria. It is this, in combination with the sheer number of protein-protein interactions that occur both within and between the MRC complexes, which makes the prediction of function and pathological outcome from primary sequence mutation data extremely challenging. Here we demonstrate how 3D structural analysis can be employed to predict the functional importance of mutations in mtDNA protein-coding genes. We mined the MITOMAP database and, utilizing the latest structural data, classified mutation sites based on their location within the MRC complexes III and IV. Using this approach, four structural classes of mutation were identified, including one underexplored class that interferes with nuclear-mitochondrial protein interactions. We demonstrate that this class currently eludes existing predictive approaches that do not take into account the quaternary structural organization inherent within and between the MRC complexes. The systematic and detailed structural analysis of disease-associated mutations in the mitochondrial Complex III and IV genes significantly enhances the predictive power of existing approaches and our understanding of how such mutations contribute to various pathologies. Given the general lack of any successful therapeutic approaches for disorders of the MRC, these findings may inform the development of new diagnostic and prognostic biomarkers, as well as new drugs and targets for gene therapy.	[Lloyd, Rhiannon E.] Univ Portsmouth, Cellular & Mol Neurooncol Grp, Inst Biomed & Biomol Sci, Sch Pharm & Biomed Sci, Portsmouth, Hants, England; [McGeehan, John E.] Univ Portsmouth, Biophys Labs, Inst Biomed & Biomol Sci, Sch Biol Sci, Portsmouth, Hants, England	University of Portsmouth; University of Portsmouth	McGeehan, JE (corresponding author), Univ Portsmouth, Biophys Labs, Inst Biomed & Biomol Sci, Sch Biol Sci, Portsmouth, Hants, England.	john.mcgeehan@port.ac.uk		Lloyd, Rhiannon/0000-0002-0107-8534; McGeehan, John/0000-0002-6750-1462	Leverhulme Trust Early Career Fellowship [ECF/2009/0123]; Leverhulme Trust; Institute of Zoology (Zoological Society of London); Brain Tumour Research, UK; Engineering and Physical Sciences Research Council [EP/E500595/1] Funding Source: researchfish	Leverhulme Trust Early Career Fellowship(Leverhulme Trust); Leverhulme Trust(Leverhulme Trust); Institute of Zoology (Zoological Society of London); Brain Tumour Research, UK; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	REL was supported by a Leverhulme Trust Early Career Fellowship (ECF/2009/0123), co-funded by the Leverhulme Trust and the Institute of Zoology (Zoological Society of London), and Brain Tumour Research, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Abu-Amero KK, 2006, INVEST OPHTH VIS SCI, V47, P4211, DOI 10.1167/iovs.06-0295; Althoff T, 2011, EMBO J, V30, P4652, DOI 10.1038/emboj.2011.324; Andreu AL, 1998, NEUROLOGY, V51, P1444, DOI 10.1212/WNL.51.5.1444; Andreu AL, 1999, ANN NEUROL, V45, P127, DOI 10.1002/1531-8249(199901)45:1<127::AID-ART20>3.0.CO;2-Y; Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607; BRANDT U, 1994, CRIT REV BIOCHEM MOL, V29, P165, DOI 10.3109/10409239409086800; Broker S, 1998, EUR J BIOCHEM, V258, P132, DOI 10.1046/j.1432-1327.1998.2580132.x; Cai W, 2008, J GENET GENOMICS, V35, P649, DOI 10.1016/S1673-8527(08)60086-7; Castellana S, 2011, GENOME BIOL EVOL, V3, P1067, DOI 10.1093/gbe/evr040; Chin L, 2011, NAT MED, V17, P297, DOI 10.1038/nm.2323; Chinnery PF, 2001, NEUROLOGY, V56, P1101, DOI 10.1212/WNL.56.8.1101; Comi GP, 1998, ANN NEUROL, V43, P110, DOI 10.1002/ana.410430119; Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392; Dudkina NV, 2010, BBA-BIOENERGETICS, V1797, P664, DOI 10.1016/j.bbabio.2009.12.013; DUNBAR DR, 1995, P NATL ACAD SCI USA, V92, P6562, DOI 10.1073/pnas.92.14.6562; Efremov RG, 2011, NATURE, V476, P414, DOI 10.1038/nature10330; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FergusonMiller S, 1996, CHEM REV, V96, P2889, DOI 10.1021/cr950051s; Gao XG, 2003, BIOCHEMISTRY-US, V42, P9067, DOI 10.1021/bi0341814; Gattermann N, 1997, BLOOD, V90, P4961, DOI 10.1182/blood.V90.12.4961.4961_4961_4972; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Helling S, 2012, PROTEOMICS, V12, P950, DOI 10.1002/pmic.201100618; Herrero-Martin Maria D, 2008, Hum Mutat, V29, pE112, DOI 10.1002/humu.20800; HOLT IJ, 1990, AM J HUM GENET, V46, P428; Hosler J, 2012, BBA-BIOENERGETICS, V1817, P849, DOI 10.1016/j.bbabio.2012.04.014; Huang LS, 2005, J MOL BIOL, V351, P573, DOI 10.1016/j.jmb.2005.05.053; Huttemann M, 2003, GENE, V312, P95, DOI 10.1016/S0378-1119(03)00604-8; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Joosten RP, 2011, NUCLEIC ACIDS RES, V39, pD411, DOI 10.1093/nar/gkq1105; Junge W, 2009, NATURE, V459, P364, DOI 10.1038/nature08145; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kadenbach B, 2000, FREE RADICAL BIO MED, V29, P211, DOI 10.1016/S0891-5849(00)00305-1; Khusnutdinova E, 2008, ANN NY ACAD SCI, V1147, P1, DOI 10.1196/annals.1427.001; Lamantea E, 2002, NEUROMUSCULAR DISORD, V12, P49, DOI 10.1016/S0960-8966(01)00244-9; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larman TC, 2012, P NATL ACAD SCI USA, V109, P14087, DOI 10.1073/pnas.1211502109; Lee I, 2012, J PHYSIOL-LONDON, V590, P5231, DOI 10.1113/jphysiol.2012.239707; Little AG, 2010, PHYSIOL GENOMICS, V42, P76, DOI 10.1152/physiolgenomics.00015.2010; MALMSTROM BG, 1990, CHEM REV, V90, P1247, DOI 10.1021/cr00105a008; Marotta R, 2011, J CLIN NEUROSCI, V18, P290, DOI 10.1016/j.jocn.2010.06.001; Mazzio EA, 2012, CANCER SCI, V103, P422, DOI 10.1111/j.1349-7006.2012.02206.x; McFarland R, 2007, CURR TOP DEV BIOL, V77, P113, DOI 10.1016/S0070-2153(06)77005-3; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Mileykovskaya E, 2012, J BIOL CHEM, V287, P23095, DOI 10.1074/jbc.M112.367888; MITCHELL P, 1976, J THEOR BIOL, V62, P327, DOI 10.1016/0022-5193(76)90124-7; Muramoto K, 2010, P NATL ACAD SCI USA, V107, P7740, DOI 10.1073/pnas.0910410107; Musatov A, 2002, BIOCHEMISTRY-US, V41, P4371, DOI 10.1021/bi016080g; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Osada N, 2012, MOL BIOL EVOL, V29, P337, DOI 10.1093/molbev/msr211; Pereira L, 2011, AM J HUM GENET, V88, P433, DOI 10.1016/j.ajhg.2011.03.006; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; Pfeffer G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004426.pub3; Pierron D, 2012, BBA-BIOENERGETICS, V1817, P590, DOI 10.1016/j.bbabio.2011.07.007; Pilkington GJ, 2008, SEMIN CANCER BIOL, V18, P226, DOI 10.1016/j.semcancer.2007.12.006; Rahman S, 1999, AM J HUM GENET, V65, P1030, DOI 10.1086/302590; Rastogi VK, 1999, NATURE, V402, P263, DOI 10.1038/46224; REIG C, 1994, HUM GENET, V94, P283; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; Schmidt TR, 2001, MOL BIOL EVOL, V18, P563, DOI 10.1093/oxfordjournals.molbev.a003836; Schnaufer A, 2000, CURR GENET, V37, P234, DOI 10.1007/s002940050525; Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275; Schuelke M, 2002, ANN NEUROL, V51, P388, DOI 10.1002/ana.10151; Sedlak E, 2009, BIOCHEMISTRY-US, V48, P8143, DOI 10.1021/bi900773r; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Takasaki S, 2008, COMPUT BIOL CHEM, V32, P332, DOI 10.1016/j.compbiolchem.2008.03.014; Tam EWY, 2008, NEUROPEDIATRICS, V39, P328, DOI 10.1055/s-0029-1202287; Tang S, 2013, HUM MUTAT; Tiranti V, 2000, HUM MOL GENET, V9, P2733, DOI 10.1093/hmg/9.18.2733; TRUMPOWER BL, 1990, J BIOL CHEM, V265, P11409; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Tsukihara T, 2003, P NATL ACAD SCI USA, V100, P15304, DOI 10.1073/pnas.2635097100; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; Uusimaa J, 2004, PEDIATRICS, V114, P443, DOI 10.1542/peds.114.2.443; Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707; Wang J, 2012, GENET MED, V14, P620, DOI 10.1038/gim.2012.4; Wibrand F, 2001, ANN NEUROL, V50, P540, DOI 10.1002/ana.1224; Yang JH, 2009, BIOCHEM BIOPH RES CO, V386, P693, DOI 10.1016/j.bbrc.2009.06.102	84	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e69003	10.1371/journal.pone.0069003	http://dx.doi.org/10.1371/journal.pone.0069003			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874847	Green Published, Green Submitted, gold			2022-12-27	WOS:000321736900126
J	Mohr, G; Hong, W; Zhang, J; Cui, GZ; Yang, YF; Cui, Q; Liu, YJ; Lambowitz, AM				Mohr, Georg; Hong, Wei; Zhang, Jie; Cui, Gu-zhen; Yang, Yunfeng; Cui, Qiu; Liu, Ya-jun; Lambowitz, Alan M.			A Targetron System for Gene Targeting in Thermophiles and Its Application in Clostridium thermocellum	PLOS ONE			English	Article							GROUP-II INTRONS; LACTOCOCCUS-LACTIS; KNOCKOUT SYSTEM; CELLULOSE; RESTRICTION; BACTERIUM; SEQUENCE; ETHANOL; BIOSYNTHESIS; ENDONUCLEASE	Background: Targetrons are gene targeting vectors derived from mobile group II introns. They consist of an autocatalytic intron RNA (a "ribozyme") and an intron-encoded reverse transcriptase, which use their combined activities to achieve highly efficient site-specific DNA integration with readily programmable DNA target specificity. Methodology/Principal Findings: Here, we used a mobile group II intron from the thermophilic cyanobacterium Thermosynechococcus elongatus to construct a thermotargetron for gene targeting in thermophiles. After determining its DNA targeting rules by intron mobility assays in Escherichia coli at elevated temperatures, we used this thermotargetron in Clostridium thermocellum, a thermophile employed in biofuels production, to disrupt six different chromosomal genes (cipA, hfat, hyd, ldh, pta, and pyrF). High integration efficiencies (67-100% without selection) were achieved, enabling detection of disruptants by colony PCR screening of a small number of transformants. Because the thermotargetron functions at high temperatures that promote DNA melting, it can recognize DNA target sequences almost entirely by base pairing of the intron RNA with less contribution from the intron-encoded protein than for mesophilic targetrons. This feature increases the number of potential targetron-insertion sites, while only moderately decreasing DNA target specificity. Phenotypic analysis showed that thermotargetron disruption of the genes encoding lactate dehydrogenase (ldh; Clo1313_1160) and phosphotransacetylase (pta; Clo1313_1185) increased ethanol production in C. thermocellum by decreasing carbon flux toward lactate and acetate. Conclusions/Significance: Thermotargetron provides a new, rapid method for gene targeting and genetic engineering of C. thermocellum, an industrially important microbe, and should be readily adaptable for gene targeting in other thermophiles.	[Mohr, Georg; Lambowitz, Alan M.] Univ Texas Austin, Sect Mol Genet & Microbiol, Dept Chem & Biochem, Inst Cellular & Mol Biol,Sch Biol Sci, Austin, TX 78712 USA; [Hong, Wei; Zhang, Jie; Cui, Gu-zhen; Cui, Qiu; Liu, Ya-jun] Chinese Acad Sci, Shandong Prov Key Lab Energy Genet, Qingdao Inst Bioenergy & Bioproc Technol, Qingdao, Peoples R China; [Hong, Wei; Zhang, Jie; Cui, Gu-zhen; Cui, Qiu; Liu, Ya-jun] Chinese Acad Sci, Key Lab Biofuels, Qingdao Inst Bioenergy & Bioproc Technol, Qingdao, Peoples R China; [Yang, Yunfeng] Tsinghua Univ, State Key Joint Lab Environm Simulat & Pollut Con, Sch Environm, Beijing 100084, Peoples R China; [Hong, Wei; Zhang, Jie] Chinese Acad Sci, Univ Chinese Acad Sci, Beijing, Peoples R China	University of Texas System; University of Texas Austin; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; Tsinghua University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, YJ (corresponding author), Chinese Acad Sci, Shandong Prov Key Lab Energy Genet, Qingdao Inst Bioenergy & Bioproc Technol, Qingdao, Peoples R China.	liuyj@qibebt.ac.cn; lambowitz@austin.utexas.edu	yujie, su/A-9883-2014; Liu, Ya-Jun/ABF-9182-2022	Mohr, Georg/0000-0002-6411-0685; liu, ya jun/0000-0002-0899-5968	NIH grant [GM37949]; Welch Foundation [F-1607]; National Basic Research Program of China (973 Program) [2011CB707404]; Key Technologies R&D Program from Ministry of Science and Tech-nology of China [2011BAD22B02]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037949] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Key Technologies R&D Program from Ministry of Science and Tech-nology of China; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM37949 and Welch Foundation grant F-1607 to AML, and the National Basic Research Program of China (973 Program, grant 2011CB707404) and the Key Technologies R&D Program from Ministry of Science and Tech-nology of China (grant 2011BAD22B02) to QC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar P, 2012, PLASMID, V67, P111, DOI 10.1016/j.plasmid.2011.12.012; Alonzo F, 2009, INFECT IMMUN, V77, P2612, DOI 10.1128/IAI.00280-09; Argyros DA, 2011, APPL ENVIRON MICROB, V77, P8288, DOI 10.1128/AEM.00646-11; Ausubel F. M., 2002, SHORT PROTOCOLS MOL; Berger E, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-62; Blocker FJH, 2005, RNA, V11, P14, DOI 10.1261/rna.7181105; Carter GP, 2011, INFECT IMMUN, V79, P1025, DOI 10.1128/IAI.00968-10; Chang TH, 2011, APPL MICROBIOL BIOT, V92, P13, DOI 10.1007/s00253-011-3456-3; Chen Y, 2005, APPL ENVIRON MICROB, V71, P7542, DOI 10.1128/AEM.71.11.7542-7547.2005; Ciruela A, 1997, GENE, V186, P143, DOI 10.1016/S0378-1119(96)00814-1; Corvaglia AR, 2010, P NATL ACAD SCI USA, V107, P11954, DOI 10.1073/pnas.1000489107; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cui Q, 2008, NAT BIOTECHNOL, V26, P162, DOI 10.1038/nbt0208-162; Eskes R, 1997, CELL, V88, P865, DOI 10.1016/S0092-8674(00)81932-7; Frazier CL, 2003, APPL ENVIRON MICROB, V69, P1121, DOI 10.1128/AEM.69.2.1121-1128.2003; FREIER D, 1988, APPL ENVIRON MICROB, V54, P204, DOI 10.1128/AEM.54.1.204-211.1988; Frey M, 2002, CHEMBIOCHEM, V3, P153, DOI 10.1002/1439-7633(20020301)3:2/3<153::AID-CBIC153>3.0.CO;2-B; Garcia-Rodriguez FM, 2011, APPL ENVIRON MICROB, V77, P854, DOI 10.1128/AEM.02319-10; Guo HT, 2000, SCIENCE, V289, P452, DOI 10.1126/science.289.5478.452; Guo HT, 1997, EMBO J, V16, P6835, DOI 10.1093/emboj/16.22.6835; Haki GD, 2003, BIORESOURCE TECHNOL, V89, P17, DOI 10.1016/S0960-8524(03)00033-6; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Hoffert MI, 2010, SCIENCE, V329, P1292, DOI 10.1126/science.1195449; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Jang YS, 2012, MBIO, V3, DOI 10.1128/mBio.00314-12; Jiang Y, 2009, METAB ENG, V11, P284, DOI 10.1016/j.ymben.2009.06.002; Karberg M, 2001, NAT BIOTECHNOL, V19, P1162, DOI 10.1038/nbt1201-1162; King NP, 2011, MICROBIOL-SGM, V157, P1161, DOI 10.1099/mic.0.047639-0; Lambowitz AM, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003616; LAMED R, 1983, J BACTERIOL, V156, P828, DOI 10.1128/JB.156.2.828-836.1983; Li YC, 2012, BIOTECHNOL BIOFUELS, V5, DOI [10.1186/1754-6834-5-71, 10.1186/1754-6834-5-2]; Lynd LR, 2005, CURR OPIN BIOTECH, V16, P577, DOI 10.1016/j.copbio.2005.08.009; LYND LR, 1989, APPL ENVIRON MICROB, V55, P3131, DOI 10.1128/AEM.55.12.3131-3139.1989; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Mai V, 1997, FEMS MICROBIOL LETT, V148, P163, DOI 10.1016/S0378-1097(97)00028-1; Malhotra M, 2008, ANTON LEEUW INT J G, V93, P425, DOI 10.1007/s10482-007-9207-x; Malik HS, 1999, MOL BIOL EVOL, V16, P793, DOI 10.1093/oxfordjournals.molbev.a026164; Maltz MA, 2012, APPL ENVIRON MICROB, V78, P7760, DOI 10.1128/AEM.01858-12; MCBEE RH, 1954, J BACTERIOL, V67, P505, DOI 10.1128/JB.67.4.505-506.1954; Mohr G, 2000, GENE DEV, V14, P559; Mohr G, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000391; MOHR S, 2013, RNA IN PRESS, DOI DOI 10.1261/RNA.039743.113; Nakamura Y, 2002, DNA RES, V9, P123, DOI 10.1093/dnares/9.4.123; Olson DG, 2010, P NATL ACAD SCI USA, V107, P17727, DOI 10.1073/pnas.1003584107; Palonen E, 2012, APPL ENVIRON MICROB, V78, P1298, DOI 10.1128/AEM.07278-11; Palonen E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025063; Park JM, 2010, FEMS MICROBIOL LETT, V309, P193, DOI 10.1111/j.1574-6968.2010.02041.x; PAYTON MA, 1984, TRENDS BIOTECHNOL, V2, P153, DOI 10.1016/0167-7799(84)90032-5; Perutka J, 2004, J MOL BIOL, V336, P421, DOI 10.1016/j.jmb.2003.12.009; Plante I, 2006, RNA, V12, P1980, DOI 10.1261/rna.193306; Qin PZ, 1999, J MOL BIOL, V291, P15, DOI 10.1006/jmbi.1999.2922; Rawsthorne H, 2006, APPL ENVIRON MICROB, V72, P6088, DOI 10.1128/AEM.02992-05; Rodriguez SA, 2008, APPL ENVIRON MICROB, V74, P2619, DOI 10.1128/AEM.02905-07; Sambrook J, 1989, MOL CLONING; Singh NN, 2001, J MOL BIOL, V309, P361, DOI 10.1006/jmbi.2001.4658; Smith D, 2005, GENE DEV, V19, P2477, DOI 10.1101/gad.1345105; Steen JA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000750; Tourasse NJ, 2008, NUCLEIC ACIDS RES, V36, P4529, DOI 10.1093/nar/gkn372; Tripathi SA, 2010, APPL ENVIRON MICROB, V76, P6591, DOI 10.1128/AEM.01484-10; Turner P, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-9; Tyurin MV, 2004, APPL ENVIRON MICROB, V70, P883, DOI 10.1128/AEM.70.2.883-890.2004; Ueda K, 2004, NUCLEIC ACIDS RES, V32, P4937, DOI 10.1093/nar/gkh830; Upadhyay A, 2011, MICROBIOL RES, V166, P323, DOI 10.1016/j.micres.2010.06.001; Vellore J, 2004, APPL ENVIRON MICROB, V70, P7140, DOI 10.1128/AEM.70.12.7140-7147.2004; YAMAOKA T, 1978, PLANT CELL PHYSIOL, V19, P943, DOI 10.1093/oxfordjournals.pcp.a075684; Yao J, 2007, APPL ENVIRON MICROB, V73, P2735, DOI 10.1128/AEM.02829-06; Yao J, 2006, RNA, V12, P1271, DOI 10.1261/rna.68706; Yao J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003469; Zaldivar J, 2001, APPL MICROBIOL BIOT, V56, P17, DOI 10.1007/s002530100624; Zarschler K, 2009, APPL ENVIRON MICROB, V75, P3077, DOI 10.1128/AEM.00087-09; Zhong J, 2003, NUCLEIC ACIDS RES, V31, P1656, DOI 10.1093/nar/gkg248; Zhuang FL, 2009, RNA, V15, P432, DOI 10.1261/rna.1378909; Zoraghi R, 2010, BIOCHEMISTRY-US, V49, P7733, DOI 10.1021/bi100780t; Zverlov VV, 2008, J BACTERIOL, V190, P4321, DOI 10.1128/JB.00097-08	74	45	54	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e69032	10.1371/journal.pone.0069032	http://dx.doi.org/10.1371/journal.pone.0069032			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874856	Green Submitted, Green Published, gold			2022-12-27	WOS:000321736900129
J	Pagan, I; Holguin, A				Pagan, Israel; Holguin, Africa			Reconstructing the Timing and Dispersion Routes of HIV-1 Subtype B Epidemics in The Caribbean and Central America: A Phylogenetic Story	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; REVERSE-TRANSCRIPTASE; POL SEQUENCES; DRUG-USERS; TYPE-1; IDENTIFICATION; POPULATION; DYNAMICS; TRANSMISSION; CONSERVATION	The Caribbean and Central America are among the regions with highest HIV-1B prevalence worldwide. Despite of this high virus burden, little is known about the timing and the migration patterns of HIV-1B in these regions. Migration is one of the major processes shaping the genetic structure of virus populations. Thus, reconstruction of epidemiological network may contribute to understand HIV-1B evolution and reduce virus prevalence. We have investigated the spatio-temporal dynamics of the HIV-1B epidemic in The Caribbean and Central America using 1,610 HIV-1B partial pol sequences from 13 Caribbean and 5 Central American countries. Timing of HIV-1B introduction and virus evolutionary rates, as well as the spatial genetic structure of the HIV-1B populations and the virus migration patterns were inferred. Results revealed that in The Caribbean and Central America most of the HIV-1B variability was generated since the 80 s. At odds with previous data suggesting that Haiti was the origin of the epidemic in The Caribbean, our reconstruction indicated that the virus could have been disseminated from Puerto Rico and Antigua. These two countries connected two distinguishable migration areas corresponding to the (mainly Spanish-colonized) Easter and (mainly British-colonized) Western islands, which indicates that virus migration patterns are determined by geographical barriers and by the movement of human populations among culturally related countries. Similar factors shaped the migration of HIV-1B in Central America. The HIV-1B population was significantly structured according to the country of origin, and the genetic diversity in each country was associated with the virus prevalence in both regions, which suggests that virus populations evolve mainly through genetic drift. Thus, our work contributes to the understanding of HIV-1B evolution and dispersion pattern in the Americas, and its relationship with the geography of the area and the movements of human populations.	[Pagan, Israel] Univ Politecn Madrid, Ctr Biotecnol Genom Plantas UPM INIA, Madrid, Spain; [Pagan, Israel] Univ Politecn Madrid, ETSI Agronomos, Madrid, Spain; [Holguin, Africa] Hosp Ramon Cajal IRYCIS, HIV Mol Epidemiol Lab 1, Dept Microbiol, Madrid, Spain; [Holguin, Africa] CIBER ESP, Madrid, Spain	Universidad Politecnica de Madrid; Universidad Politecnica de Madrid; Hospital Universitario Ramon y Cajal; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Pagan, I (corresponding author), Univ Politecn Madrid, Ctr Biotecnol Genom Plantas UPM INIA, Madrid, Spain.	jesusisrael.pagan@upm.es	Holguín, Africa/AAF-9001-2021; Pagán, Israel/H-1843-2015	Holguín, Africa/0000-0002-1330-8050; Pagán, Israel/0000-0001-8876-1194	Marie Curie Fellowship [PIOF-GA-2009-236470]; Spanish Government FIS grant [FIS-PI12/00240]	Marie Curie Fellowship(European Commission); Spanish Government FIS grant	This work was supported by a Marie Curie Fellowship PIOF-GA-2009-236470 to IP and a Spanish Government FIS grant FIS-PI12/00240 to AH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahumada-Ruiz S, 2009, INFECT GENET EVOL, V9, P933, DOI 10.1016/j.meegid.2009.06.013; [Anonymous], 2006, OECS AIDS HIV ANN RE; Brown AJL, 1997, P NATL ACAD SCI USA, V94, P1862, DOI 10.1073/pnas.94.5.1862; Camara B, 2001, 20 YEARS HIV AIDS EP, P1; Castro-Nallar E, 2012, MOL PHYLOGENET EVOL, V62, P777, DOI 10.1016/j.ympev.2011.11.019; Ceccherini-Silberstein F, 2005, J VIROL, V79, P10718, DOI 10.1128/JVI.79.16.10718-10729.2005; Cohen J, 2006, SCIENCE, V313, P470; de Oliveira T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009311; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dyer RJ, 2004, MOL ECOL, V13, P1713, DOI 10.1111/j.1365-294X.2004.02177.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Esbjornsson J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017025; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Eyzaguirre L, 2007, AIDS RES HUM RETROV, V23, P331, DOI 10.1089/aid.2006.0166; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Freed EO, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-77; Gilbert MTP, 2007, P NATL ACAD SCI USA, V104, P18566, DOI 10.1073/pnas.0705329104; Gittens MV, 2003, AIDS RES HUM RETROV, V19, P313, DOI 10.1089/088922203764969519; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haggerty RA, 1990, EL SALVADOR COUNTRY; Holguin A, 2011, PEDIATR INFECT DIS J, V30, pE82, DOI 10.1097/INF.0b013e3182117289; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Hue S, 2004, AIDS, V18, P719, DOI [10.1097/00002030-200403260-00002, 10.1097/01.aids.0000111455.61782.c3]; Hue S, 2009, J VIROL, V83, P2645, DOI 10.1128/JVI.01556-08; Hughes GJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000590; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Junqueira DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027489; Lemey P, 2003, P NATL ACAD SCI USA, V100, P6588, DOI 10.1073/pnas.0936469100; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Machado LY, 2011, IDS RES HUM RETROVIR, V28, P956; Mahler S., 2006, CENTRAL AM CROSSROAD; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Maynar-Smith J, 1989, EVOLUTIONARY GENETIC; Mehta SR, 2010, AIDS RES HUM RETROV, V26, P1273, DOI 10.1089/aid.2010.0021; Nadai Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004814; Nei M., 2000, MOL EVOLUTION PHYLOG; Noel RJ, 2003, CELL MOL BIOL, V49, P1193; Pagan I, 2010, J VIROL, V84, P6177, DOI 10.1128/JVI.02160-09; Pape Jean William, 2008, Proc Natl Acad Sci U S A, V105, pE13, DOI 10.1073/pnas.0711141105; Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; PIOT P, 1984, LANCET, V2, P65; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583; RAMBAUT A, 2009, PATH O GEN TEMPORAL; Rambaut A., 1996, SEQUENCE ALIGNMENT E; Report G., 2010, UNAIDS REPORT GLOBAL; Salemi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001390; Sanchez J, 2009, JAIDS-J ACQ IMM DEF, V51, pS47, DOI 10.1097/QAI.0b013e3181a2671d; Santos AFA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001781; Skar H, 2011, J VIROL, V85, P510, DOI 10.1128/JVI.01413-10; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Strathdee SA, 2008, JAMA-J AM MED ASSOC, V300, P571, DOI 10.1001/jama.300.5.571; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; UNAIDS, 2012, UNAIDS REP GLOB AIDS; UNAIDS, GLOB HIV AIDS RESP E; Valle-Bahena OM, 2006, ARCH MED RES, V37, P1022, DOI 10.1016/j.arcmed.2006.05.014; Vaughan HE, 2003, AIDS RES HUM RETROV, V19, P929, DOI 10.1089/088922203322493120; Wang TH, 2001, J VIROL, V75, P11686, DOI 10.1128/JVI.75.23.11686-11699.2001; Wertheim JO, 2012, MOL BIOL EVOL, V29, P451, DOI 10.1093/molbev/msr266; Yebra G, 2013, INFECT GENET EVOL, V14, P232, DOI 10.1016/j.meegid.2012.12.006; Yebra G, 2012, J CLIN MICROBIOL, V50, P407, DOI 10.1128/JCM.05798-11; [No title captured]	65	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e69218	10.1371/journal.pone.0069218	http://dx.doi.org/10.1371/journal.pone.0069218			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874917	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000321736900142
J	Kim, EK; Seok, JH; Oh, JS; Lee, HW; Kim, KH				Kim, Eui-Ki; Seok, Jong Hyeon; Oh, Jang Seok; Lee, Hyong Woo; Kim, Kyung Hyun			Use of Hangeul Twitter to Track and Predict Human Influenza Infection	PLOS ONE			English	Article							SALES; SURVEILLANCE; REMEDIES	Influenza epidemics arise through the accumulation of viral genetic changes. The emergence of new virus strains coincides with a higher level of influenza-like illness (ILI), which is seen as a peak of a normal season. Monitoring the spread of an epidemic influenza in populations is a difficult and important task. Twitter is a free social networking service whose messages can improve the accuracy of forecasting models by providing early warnings of influenza outbreaks. In this study, we have examined the use of information embedded in the Hangeul Twitter stream to detect rapidly evolving public awareness or concern with respect to influenza transmission and developed regression models that can track levels of actual disease activity and predict influenza epidemics in the real world. Our prediction model using a delay mode provides not only a real-time assessment of the current influenza epidemic activity but also a significant improvement in prediction performance at the initial phase of ILI peak when prediction is of most importance.	[Kim, Eui-Ki; Seok, Jong Hyeon; Kim, Kyung Hyun] Korea Univ, Coll Sci & Technol, Dept Biotechnol & Bioinformat, Sejong, South Korea; [Oh, Jang Seok; Lee, Hyong Woo] Korea Univ, Coll Sci & Technol, Dept Elect & Informat Engn, Sejong, South Korea	Korea University; Korea University	Lee, HW (corresponding author), Korea Univ, Coll Sci & Technol, Dept Elect & Informat Engn, Sejong, South Korea.	hwlee@korea.ac.kr; khkim@korea.ac.kr			National Research Foundation of Korea (NRF); MEST [2010-0029242]; Transgovermental Enterprise for Pandemic Influenza in Korea (TEPIK) [2011-A103001]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea); Transgovermental Enterprise for Pandemic Influenza in Korea (TEPIK)	This work was supported by grants from the Mid-career Researcher Program through the National Research Foundation of Korea (NRF, http://www.nrf.re.kr/nrf_eng_cms/) funded by the MEST (2010-0029242) and from Transgovermental Enterprise for Pandemic Influenza in Korea (TEPIK, 2011-A103001, http://www.tepik.or.kr/eng/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], TWITT ENG BLOG ENG T; Chau M, 2007, INT J HUM-COMPUT ST, V65, P57, DOI 10.1016/j.ijhcs.2006.08.009; Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118; Cook AR, 2010, EMERG INFECT DIS, V16, P1647, DOI 10.3201/eid1610.100840; Davies GR, 2003, CLIN MICROBIOL INFEC, V9, P858, DOI 10.1046/j.1469-0691.2003.00693.x; Espino Jeremy U, 2003, AMIA Annu Symp Proc, P215; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Hogan WR, 2003, J AM MED INFORM ASSN, V10, P555, DOI 10.1197/jamia.M1377; Lee JS, 2007, EPIDEMIOL INFECT, V135, P1117, DOI 10.1017/S0950268807007820; LENAWAY DD, 1995, PUBLIC HEALTH REP, V110, P333; Magruder SF, 2003, J HOPKINS APL TECH D, V24, P349; Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467; Taylor I, 1980, FACEBOOK I JUST YOUN, V2; Thompson WW, 2006, J INFECT DIS, V194, pS82, DOI 10.1086/507558; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Twitter, 2010, LECT NOTES I COMPUTE, DOI DOI 10.1007/978-3-642-11745-9; Weisberg S., 2005, APPL LINEAR REGRESSI, DOI DOI 10.1002/0471704091; WELLIVER RC, 1979, PEDIATR RES, V13, P1015, DOI 10.1203/00006450-197909000-00014	18	32	32	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69305	10.1371/journal.pone.0069305	http://dx.doi.org/10.1371/journal.pone.0069305			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894447	Green Submitted, Green Published, gold			2022-12-27	WOS:000322167900055
J	Hernandez-Alcantara, G; Torres-Larios, A; Enriquez-Flores, S; Garcia-Torres, I; Castillo-Villanueva, A; Mendez, ST; de la Mora-de la Mora, I; Gomez-Manzo, S; Torres-Arroyo, A; Lopez-Velazquez, G; Reyes-Vivas, H; Oria-Hernandez, J				Hernandez-Alcantara, Gloria; Torres-Larios, Alfredo; Enriquez-Flores, Sergio; Garcia-Torres, Itzhel; Castillo-Villanueva, Adriana; Mendez, Sara T.; de la Mora-de la Mora, Ignacio; Gomez-Manzo, Saul; Torres-Arroyo, Angelica; Lopez-Velazquez, Gabriel; Reyes-Vivas, Horacio; Oria-Hernandez, Jesus			Structural and Functional Perturbation of Giardia lamblia Triosephosphate Isomerase by Modification of a Non-Catalytic, Non-Conserved Region	PLOS ONE			English	Article							SPECIES-SPECIFIC INHIBITION; ACTIVE-SITE LOOP; CHEMICAL-MODIFICATION; CRYSTAL-STRUCTURES; HUMAN PARASITE; FLEXIBLE LOOP; RESOLUTION; MOTION; STATE; 2-PHOSPHOGLYCOLATE	Background: We have previously proposed triosephosphate isomerase of Giardia lamblia (GlTIM) as a target for rational drug design against giardiasis, one of the most common parasitic infections in humans. Since the enzyme exists in the parasite and the host, selective inhibition is a major challenge because essential regions that could be considered molecular targets are highly conserved. Previous biochemical evidence showed that chemical modification of the non-conserved non-catalytic cysteine 222 (C222) inactivates specifically GlTIM. The inactivation correlates with the physicochemical properties of the modifying agent: addition of a non-polar, small chemical group at C222 reduces the enzyme activity by one half, whereas negatively charged, large chemical groups cause full inactivation. Results: In this work we used mutagenesis to extend our understanding of the functional and structural effects triggered by modification of C222. To this end, six GlTIM C222 mutants with side chains having diverse physicochemical characteristics were characterized. We found that the polarity, charge and volume of the side chain in the mutant amino acid differentially alter the activity, the affinity, the stability and the structure of the enzyme. The data show that mutagenesis of C222 mimics the effects of chemical modification. The crystallographic structure of C222D GlTIM shows the disruptive effects of introducing a negative charge at position 222: the mutation perturbs loop 7, a region of the enzyme whose interactions with the catalytic loop 6 are essential for TIM stability, ligand binding and catalysis. The amino acid sequence of TIM in phylogenetic diverse groups indicates that C222 and its surrounding residues are poorly conserved, supporting the proposal that this region is a good target for specific drug design. Conclusions: The results demonstrate that it is possible to inhibit species-specifically a ubiquitous, structurally highly conserved enzyme by modification of a non-conserved, non-catalytic residue through long-range perturbation of essential regions.	[Hernandez-Alcantara, Gloria; Enriquez-Flores, Sergio; Garcia-Torres, Itzhel; Castillo-Villanueva, Adriana; Mendez, Sara T.; de la Mora-de la Mora, Ignacio; Gomez-Manzo, Saul; Torres-Arroyo, Angelica; Lopez-Velazquez, Gabriel; Reyes-Vivas, Horacio; Oria-Hernandez, Jesus] Inst Nacl Pediat, Lab Bioquim Genet, Mexico City, DF, Mexico; [Torres-Larios, Alfredo] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Oria-Hernandez, J (corresponding author), Inst Nacl Pediat, Lab Bioquim Genet, Mexico City, DF, Mexico.	hreyesvivas@yahoo.com.mx; jesus.oria.inp@gmail.com	Lopez-Velazquez, Gabriel/F-2411-2013; De la Mora, José Ignacio De la Mora/AAB-5370-2020; Oria-Hernández, Jesús/AAG-1243-2019	Lopez-Velazquez, Gabriel/0000-0003-0470-1069; De la Mora, José Ignacio De la Mora/0000-0002-5654-8089; Oria-Hernández, Jesús/0000-0001-7147-1879; Garcia, Itzhel/0000-0002-3018-060X; Castillo-Villanueva, Adriana/0000-0001-5582-6940; Torres-Arroyo, Angelica/0000-0003-3236-5779; enriquez flores, sergio/0000-0003-2058-5707; Gomez-Manzo, Saul/0000-0003-2095-9182; Hernandez-Alcantara, Gloria/0000-0002-7029-6033; Torres-Larios, Alfredo/0000-0002-0702-350X; Mendez-Cruz, Sara Teresa/0000-0001-8619-1220; Reyes-Vivas, Horacio/0000-0002-3604-9629	Consejo Nacional de Ciencia y Tecnologia [106126, 104841, 60127-Q]; Programa de Apoyo a Proyectos de Investigacion e Inovacion Tecnologica, Universidad Nacional Autonoma de Mexico (PAPIIT) [IN202910]; Instituto de Ciencia y Tecnologia del Distrito Federal [PIFUTP09-279]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacion e Inovacion Tecnologica, Universidad Nacional Autonoma de Mexico (PAPIIT); Instituto de Ciencia y Tecnologia del Distrito Federal	JOH is supported by Consejo Nacional de Ciencia y Tecnologia grant 106126. HRV is supported by Consejo Nacional de Ciencia y Tecnologia grant 104841. ATL is supported by Consejo Nacional de Ciencia y Tecnologia grant 60127-Q, Programa de Apoyo a Proyectos de Investigacion e Inovacion Tecnologica, Universidad Nacional Autonoma de Mexico (PAPIIT) grant IN202910 and Instituto de Ciencia y Tecnologia del Distrito Federal grant PIFUTP09-279. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; Aparicio R, 2003, J MOL BIOL, V334, P1023, DOI 10.1016/j.jmb.2003.10.022; BENNER SA, 1994, PROTEIN ENG, V7, P1323, DOI 10.1093/protein/7.11.1323; Busatti HGNO, 2009, BIOL-TARGETS THER, V3, P273; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Dunn LA, 2010, INT J ANTIMICROB AG, V36, P37, DOI 10.1016/j.ijantimicag.2010.03.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enriquez-Flores S, 2008, MOL BIOCHEM PARASIT, V157, P179, DOI 10.1016/j.molbiopara.2007.10.013; Enriquez-Flores S, 2011, PROTEINS, V79, P2711, DOI 10.1002/prot.23100; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Eyal E, 2005, J MOL BIOL, V351, P431, DOI 10.1016/j.jmb.2005.05.066; Galkin A, 2007, J BIOL CHEM, V282, P4859, DOI 10.1074/jbc.M609534200; Garcia-Torres I, 2012, CURRENT TOPICS DRUG, P49; Gardner TB, 2001, CLIN MICROBIOL REV, V14, P114, DOI 10.1128/CMR.14.1.114-128.2001; GomezPuyou A, 1995, CHEM BIOL, V2, P847, DOI 10.1016/1074-5521(95)90091-8; Gonzalez-Mondragon E, 2004, BIOCHEMISTRY-US, V43, P3255, DOI 10.1021/bi036077s; Hiltpold A, 1999, MOL BIOCHEM PARASIT, V104, P157, DOI 10.1016/S0166-6851(99)00145-0; Kursula I, 2003, J BIOL CHEM, V278, P9544, DOI 10.1074/jbc.M211389200; Kursula I, 2004, PROTEIN ENG DES SEL, V17, P375, DOI 10.1093/protein/gzh048; Lalle Marco, 2010, Infectious Disorders - Drug Targets, V10, P283; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; LOLIS E, 1990, BIOCHEMISTRY-US, V29, P6619, DOI 10.1021/bi00480a010; LOLIS E, 1990, BIOCHEMISTRY-US, V29, P6609, DOI 10.1021/bi00480a009; Lopez-Velazquez G, 2004, PROTEINS, V55, P824, DOI 10.1002/prot.20097; Maithal K, 2002, J BIOL CHEM, V277, P25106, DOI 10.1074/jbc.M202419200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; NOBLE MEM, 1993, PROTEINS, V16, P311, DOI 10.1002/prot.340160402; OESPER P, 1950, ARCH BIOCHEM, V27, P223; Olivares-Illana V, 2006, BIOCHEMISTRY-US, V45, P2556, DOI 10.1021/bi0522293; Ouzounis C, 1996, FEBS LETT, V390, P119, DOI 10.1016/0014-5793(96)00631-X; Parthasarathy S, 2002, BIOCHEMISTRY-US, V41, P13178, DOI 10.1021/bi025783a; Petri William A, 2005, Curr Treat Options Gastroenterol, V8, P13, DOI 10.1007/s11938-005-0047-3; POMPLIANO DL, 1990, BIOCHEMISTRY-US, V29, P3186, DOI 10.1021/bi00465a005; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Reyes-Vivas H, 2007, J MOL BIOL, V365, P752, DOI 10.1016/j.jmb.2006.10.053; Rodriguez-Romero A, 2002, J MOL BIOL, V322, P669, DOI 10.1016/S0022-2836(02)00809-4; Rossignol JF, 2010, EXP PARASITOL, V124, P45, DOI 10.1016/j.exppara.2009.07.005; Rozovsky S, 2001, J MOL BIOL, V310, P259, DOI 10.1006/jmbi.2001.4672; Rozovsky S, 2001, J MOL BIOL, V310, P271, DOI 10.1006/jmbi.2001.4673; SAMPSON NS, 1992, BIOCHEMISTRY-US, V31, P8482, DOI 10.1021/bi00151a014; Smith E, 2004, P NATL ACAD SCI USA, V101, P13168, DOI 10.1073/pnas.0404922101; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Upcroft P, 2001, CLIN MICROBIOL REV, V14, P150, DOI 10.1128/CMR.14.1.150-164.2001; Wang Y, 2009, BIOCHEMISTRY-US, V48, P4548, DOI 10.1021/bi9002887; WILLIAMS JC, 1995, BIOCHEMISTRY-US, V34, P8309, DOI 10.1021/bi00026a012	47	19	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69031	10.1371/journal.pone.0069031	http://dx.doi.org/10.1371/journal.pone.0069031			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894402	Green Published, Green Submitted, gold			2022-12-27	WOS:000322132100041
J	Lee, J; Hong, YS; Jeong, JH; Yang, EJ; Jhun, JY; Park, MK; Jung, YO; Min, JK; Kim, HY; Park, SH; Cho, ML				Lee, Jennifer; Hong, Yeon Sik; Jeong, Jeong Hee; Yang, Eun Ji; Jhun, Joo Yeon; Park, Mi Kyoung; Jung, Young Ok; Min, Jun Ki; Kim, Ho Youn; Park, Sung Hwan; Cho, Mi-La			Coenzyme Q10 Ameliorates Pain and Cartilage Degradation in a Rat Model of Osteoarthritis by Regulating Nitric Oxide and Inflammatory Cytokines	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; FACTOR-KAPPA-B; MITOCHONDRIAL DYSFUNCTION; ARTICULAR-CARTILAGE; METABOLIC SYNDROME; GENE-EXPRESSION; SYNOVIAL-FLUID; RECEPTOR; CHONDROCYTES; INCREASES	Objective: To investigate the effect of CoenzymeQ10 (CoQ10) on pain severity and cartilage degeneration in an experimental model of rat osteoarthritis (OA). Materials and Methods: OA was induced in rats by intra-articular injection of monosodium iodoacetate (MIA) to the knee. Oral administration of CoQ10 was initiated on day 4 after MIA injection. Pain severity was assessed by measuring secondary tactile allodynia using the von Frey assessment test. The degree of cartilage degradation was determined by measuring cartilage thickness and the amount of proteoglycan. The mankin scoring system was also used. Expressions of matrix metalloproteinase-13 (MMP-13), interleukin-1 beta (IL-1 beta), IL-6, IL-15, inducible nitric oxide synthase (iNOS), nitrotyrosine and receptor for advanced glycation end products (RAGE) were analyzed using immunohistochemistry. Results: Treatment with CoQ10 demonstrated an antinociceptive effect in the OA animal model. The reduction in secondary tactile allodynia was shown by an increased pain withdrawal latency and pain withdrawal threshold. CoQ10 also attenuated cartilage degeneration in the osteoarthritic joints. MMP-13, IL-1b, IL-6, IL-15, iNOS, nitrotyrosine and RAGE expressions were upregulated in OA joints and significantly reduced with CoQ10 treatment. Conclusion: CoQ10 exerts a therapeutic effect on OA via pain suppression and cartilage degeneration by inhibiting inflammatory mediators, which play a vital role in OA pathogenesis.	[Lee, Jennifer; Hong, Yeon Sik; Min, Jun Ki; Kim, Ho Youn; Park, Sung Hwan; Cho, Mi-La] Catholic Univ Korea, Dept Internal Med, Div Rheumatol, Seoul, South Korea; [Jeong, Jeong Hee; Yang, Eun Ji; Jhun, Joo Yeon; Park, Mi Kyoung] Catholic Univ Korea, Coll Med, Rheumatism Res Ctr, Seoul, South Korea; [Jung, Young Ok] Hallym Univ, Kang Nam Sacred Heart Hosp, Dept Internal Med, Div Rheumatol, Seoul, South Korea; [Cho, Mi-La] Catholic Univ Korea, Coll Med, Conversant Res Consortium Immunol Dis, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Hallym University; Catholic University of Korea	Park, SH (corresponding author), Catholic Univ Korea, Dept Internal Med, Div Rheumatol, Seoul, South Korea.	rapark@catholic.ac.kr; iammila@catholic.ac.kr			Korea Health Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [A092258]; Bio & Medical Technology Development Program of the National Research Foundation (NRF); Korean government (MEST) [2012049783]	Korea Health Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea; Bio & Medical Technology Development Program of the National Research Foundation (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This research was supported by a grant from the Korea Health Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (grant number A092258), Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MEST) (grant number 2012049783). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson SB, 2008, OSTEOARTHR CARTILAGE, V16, pS15, DOI 10.1016/S1063-4584(08)60008-4; Bauerova K, 2010, ACTA BIOCHIM POL, V57, P347; Berenbaum F, 2012, OSTEOARTHR CARTILAGE, V20, pS5, DOI 10.1016/j.joca.2012.02.621; Berenbaum F, 2013, CURR OPIN RHEUMATOL, V25, P114, DOI 10.1097/BOR.0b013e32835a9414; Blanco FJ, 2011, NAT REV RHEUMATOL, V7, P161, DOI 10.1038/nrrheum.2010.213; BULSTRA SK, 1989, CLIN ORTHOP RELAT R, P294; Burr DB, 2012, NAT REV RHEUMATOL, V8, P665, DOI 10.1038/nrrheum.2012.130; Cake MA, 2004, OSTEOARTHR CARTILAGE, V12, P974, DOI 10.1016/j.joca.2004.08.012; Chadjichristos C, 2003, J BIOL CHEM, V278, P39762, DOI 10.1074/jbc.M303541200; Cordero MD, 2012, NUTRITION, V28, P1200, DOI 10.1016/j.nut.2012.03.018; de Lange-Brokaar BJE, 2012, OSTEOARTHR CARTILAGE, V20, P1484, DOI 10.1016/j.joca.2012.08.027; Doss F, 2007, SCAND J RHEUMATOL, V36, P136, DOI 10.1080/03009740701250785; Fuller Bryan, 2006, J Cosmet Dermatol, V5, P30, DOI 10.1111/j.1473-2165.2006.00220.x; Gavriilidis C, 2013, ARTHRITIS RHEUM-US, V65, P378, DOI 10.1002/art.37782; GREEN DE, 1963, BIOCHEM Z, V338, P335; Hirose J, 2011, ACTA HISTOCHEM, V113, P613, DOI 10.1016/j.acthis.2010.06.007; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Hu F, 2011, CELL SIGNAL, V23, P1528, DOI 10.1016/j.cellsig.2011.05.008; Jiang LP, 2013, J ORTHOP RES, V31, P364, DOI 10.1002/jor.22250; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Kunitomo M, 2008, J PHARMACOL SCI, V107, P128, DOI 10.1254/jphs.FP0072365; Leclerc E, 2009, BBA-MOL CELL RES, V1793, P993, DOI 10.1016/j.bbamcr.2008.11.016; Lee HK, 2011, DIABETES METAB J, V35, P207, DOI 10.4093/dmj.2011.35.3.207; Loeser RF, 2005, ARTHRITIS RHEUM, V52, P2376, DOI 10.1002/art.21199; Mach DB, 2002, NEUROSCIENCE, V113, P155, DOI 10.1016/S0306-4522(02)00165-3; MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523, DOI 10.2106/00004623-197153030-00009; Mengshol JA, 2000, ARTHRITIS RHEUM, V43, P801, DOI 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4; Mitchell T, 2012, FREE RADICAL BIO MED, V52, P838, DOI 10.1016/j.freeradbiomed.2011.12.014; Nah SS, 2007, FEBS LETT, V581, P1928, DOI 10.1016/j.febslet.2007.03.090; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Rasheed Z, 2011, RHEUMATOLOGY, V50, P838, DOI 10.1093/rheumatology/keq380; Rowan AD, 2001, ARTHRITIS RHEUM-US, V44, P1620, DOI 10.1002/1529-0131(200107)44:7<1620::AID-ART285>3.0.CO;2-B; Scanzello CR, 2009, OSTEOARTHR CARTILAGE, V17, P1040, DOI 10.1016/j.joca.2009.02.011; Schmelzer C, 2008, BIOFACTORS, V32, P179, DOI 10.1002/biof.5520320121; Steenvoorden MMC, 2006, ARTHRITIS RHEUM-US, V54, P253, DOI 10.1002/art.21523; STOCKER R, 1991, P NATL ACAD SCI USA, V88, P1646, DOI 10.1073/pnas.88.5.1646; Sukkar MB, 2012, BRIT J PHARMACOL, V167, P1161, DOI 10.1111/j.1476-5381.2012.01984.x; Tsai KL, 2012, J NUTR BIOCHEM, V23, P458, DOI 10.1016/j.jnutbio.2011.01.011; Vaamonde-Garcia C, 2012, ARTHRITIS RHEUM-US, V64, P2927, DOI 10.1002/art.34508; Verzijl N, 2002, ARTHRITIS RHEUM, V46, P114, DOI 10.1002/1529-0131(200201)46:1<114::AID-ART10025>3.0.CO;2-P; Wang CH, 2013, FEBS J, V280, P1039, DOI 10.1111/febs.12096; Zhuo Q, 2012, NAT REV RHEUMATOL, V8, P729, DOI 10.1038/nrrheum.2012.135	42	27	31	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69362	10.1371/journal.pone.0069362	http://dx.doi.org/10.1371/journal.pone.0069362			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894457	Green Published, gold			2022-12-27	WOS:000322132100055
J	Pathak, GK; Love, JM; Chetta, J; Shah, SB				Pathak, Gunja K.; Love, James M.; Chetta, Joshua; Shah, Sameer B.			A Comparative Quantitative Assessment of Axonal and Dendritic mRNA Transport in Maturing Hippocampal Neurons	PLOS ONE			English	Article							LOCAL PROTEIN-SYNTHESIS; SYNAPTIC PLASTICITY; MYELINATED AXONS; RETARDATION PROTEIN; TRANSLATION; GRANULES; TRAFFICKING; REGENERATION; FACILITATION; SYNAPSES	Translation of mRNA in axons and dendrites enables a rapid supply of proteins to specific sites of localization within the neuron. Distinct mRNA-containing cargoes, including granules and mitochondrial mRNA, are transported within neuronal projections. The distributions of these cargoes appear to change during neuronal development, but details on the dynamics of mRNA transport during these transitions remain to be elucidated. For this study, we have developed imaging and image processing methods to quantify several transport parameters that can define the dynamics of RNA transport and localization. Using these methods, we characterized the transport of mitochondrial and non-mitochondrial mRNA in differentiated axons and dendrites of cultured hippocampal neurons varying in developmental maturity. Our results suggest differences in the transport profiles of mitochondrial and non-mitochondrial mRNA, and differences in transport parameters at different time points, and between axons and dendrites. Furthermore, within the non-mitochondrial mRNA pool, we observed two distinct populations that differed in their fluorescence intensity and velocity. The net axonal velocity of the brighter pool was highest at day 7 (0.002 +/- 0.001 mu m/s, mean +/- SEM), raising the possibility of a presynaptic requirement for mRNA during early stages of synapse formation. In contrast, the net dendritic velocity of the brighter pool increased steadily as neurons matured, with a significant difference between day 12 (0.0013 +/- 0.0006 mu m/s) and day 4 (-0.003 +/- 0.001 mu m/s) suggesting a postsynaptic role for mRNAs in more mature neurons. The dim population showed similar trends, though velocities were two orders of magnitude higher than of the bright particles. This study provides a baseline for further studies on mRNA transport, and has important implications for the regulation of neuronal plasticity during neuronal development and in response to neuronal injury.	[Pathak, Gunja K.; Love, James M.; Chetta, Joshua; Shah, Sameer B.] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA; [Shah, Sameer B.] Univ Calif San Diego, Dept Orthopaed Surg, La Jolla, CA 92093 USA; [Shah, Sameer B.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	University System of Maryland; University of Maryland College Park; University of California System; University of California San Diego; University of California System; University of California San Diego	Shah, SB (corresponding author), Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.	sbshah@ucsd.edu			National Science Foundation [CBET0932590, DGE0750616]	National Science Foundation(National Science Foundation (NSF))	This research was supported by funding from the National Science Foundation (CBET0932590 and DGE0750616). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronov S, 2002, J CELL SCI, V115, P3817, DOI 10.1242/jcs.00058; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bramham CR, 2008, CURR OPIN NEUROBIOL, V18, P524, DOI 10.1016/j.conb.2008.09.013; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Cambray S, 2009, MOL CELL BIOL, V29, P726, DOI 10.1128/MCB.01180-08; Chetta J, 2011, J NEUROSCI METH, V199, P230, DOI 10.1016/j.jneumeth.2011.05.013; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; Davidovic L, 2007, HUM MOL GENET, V16, P3047, DOI 10.1093/hmg/ddm263; DAVIS L, 1987, NATURE, V330, P477, DOI 10.1038/330477a0; Desgroseillers L, 2008, PROG BRAIN RES, V169, P41; Dynes JL, 2007, J COMP NEUROL, V500, P433, DOI 10.1002/cne.21189; Elvira G, 2006, MOL CELL PROTEOMICS, V5, P635, DOI 10.1074/mcp.M500255-MCP200; FINK DJ, 1980, J CELL BIOL, V85, P175, DOI 10.1083/jcb.85.2.175; FLETCHER TL, 1991, J NEUROSCI, V11, P1617; Hanz S, 2003, NEURON, V40, P1095, DOI 10.1016/S0896-6273(03)00770-0; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Knowles RB, 1997, P NATL ACAD SCI USA, V94, P14804, DOI 10.1073/pnas.94.26.14804; Knowles RB, 1996, J NEUROSCI, V16, P7812; Koenig E, 2000, J NEUROSCI, V20, P8390, DOI 10.1523/JNEUROSCI.20-22-08390.2000; Li CX, 2004, J NEUROSCI, V24, P6161, DOI 10.1523/JNEUROSCI.1476-04.2004; Ligon LA, 2000, J COMP NEUROL, V427, P340, DOI 10.1002/1096-9861(20001120)427:3<340::AID-CNE2>3.0.CO;2-Y; Lin AC, 2008, CURR OPIN NEUROBIOL, V18, P60, DOI 10.1016/j.conb.2008.05.004; Ling SC, 2004, P NATL ACAD SCI USA, V101, P17428, DOI 10.1073/pnas.0408114101; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Martin KC, 2004, CURR OPIN NEUROBIOL, V14, P305, DOI 10.1016/j.conb.2004.05.009; Martin KC, 2006, J NEUROSCI, V26, P7131, DOI 10.1523/JNEUROSCI.1801-06.2006; Matus A, 2001, NAT NEUROSCI, V4, P967, DOI 10.1038/nn1001-967; Miller S, 2002, NEURON, V36, P507, DOI 10.1016/S0896-6273(02)00978-9; MORRIS RL, 1993, J CELL SCI, V104, P917; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; PHILLIPS LL, 1990, J NEUROSCI RES, V26, P474, DOI 10.1002/jnr.490260410; Roegiers F, 2000, TRENDS CELL BIOL, V10, P220, DOI 10.1016/S0962-8924(00)01767-0; Shan JG, 2003, J NEUROSCI, V23, P8859; Si K, 2003, CELL, V115, P893, DOI 10.1016/S0092-8674(03)01021-3; Skup M, 2008, ACTA NEUROBIOL EXP, V68, P305; Sotelo-Silveira J, 2008, J NEUROCHEM, V104, P545, DOI 10.1111/j.1471-4159.2007.04999.x; Sotelo-Silveira JR, 2006, TRAFFIC, V7, P508, DOI 10.1111/j.1600-0854.2006.00405.x; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Swanger SA, 2011, CURR OPIN GENET DEV, V21, P414, DOI 10.1016/j.gde.2011.04.002; Taylor AM, 2009, J NEUROSCI, V29, P4697, DOI 10.1523/JNEUROSCI.6130-08.2009; Tiruchinapalli DM, 2003, J NEUROSCI, V23, P3251; Twiss JL, 2006, J NEUROTRAUM, V23, P295, DOI 10.1089/neu.2006.23.295; Wang WL, 2007, DEV NEUROBIOL, V67, P1166, DOI 10.1002/dneu.20511; Willis D, 2005, J NEUROSCI, V25, P778, DOI 10.1523/JNEUROSCI.4235-04.2005; Willis DE, 2006, CURR OPIN NEUROBIOL, V16, P111, DOI 10.1016/j.conb.2006.01.002; Woo NH, 2003, J NEUROSCI, V23, P1125, DOI 10.1523/JNEUROSCI.23-04-01125.2003; Yoo S, 2010, EXP NEUROL, V223, P19, DOI 10.1016/j.expneurol.2009.08.011; Yoon BC, 2009, RESULTS PROBL CELL D, V48, P269, DOI 10.1007/400_2009_5; ZELENA J, 1972, Z ZELLFORSCH MIK ANA, V124, P217, DOI 10.1007/BF00335680; ZELENA J, 1970, Brain Research, V24, P359, DOI 10.1016/0006-8993(70)90120-4; ZELENA J, 1972, Folia Morphologica (Prague), V20, P91; Zhang HL, 2001, NEURON, V31, P261, DOI 10.1016/S0896-6273(01)00357-9; Zhang XH, 2002, NEURON, V36, P675, DOI 10.1016/S0896-6273(02)01023-1	57	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e65917	10.1371/journal.pone.0065917	http://dx.doi.org/10.1371/journal.pone.0065917			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894274	gold, Green Published			2022-12-27	WOS:000322132100002
J	Freundt, MIE; Ritter, M; Al-Zghloul, M; Groden, C; Kerl, HU				Freundt, Miriam I. E.; Ritter, Manuel; Al-Zghloul, Mansour; Groden, Christoph; Kerl, Hans U.			Laser-Guided Cervical Selective Nerve Root Block with the Dyna-CT: Initial Experience of Three-Dimensional Puncture Planning with an Ex-Vivo Model	PLOS ONE			English	Article							NONOPERATIVE MANAGEMENT; GUIDANCE-SYSTEM; DORSAL APPROACH; NECK PAIN; RADICULOPATHY; INJECTION; SAFETY	Background: Cervical selective nerve root block (CSNRB) is a well-established, minimally invasive procedure to treat radicular cervical pain. However, the procedure is technically challenging and might lead to major complications. The objective of this study was to evaluate the feasibility of a three-dimensional puncture planning and two-dimensional laser-guidance system for CSNRB in an ex-vivo model. Methods: Dyna-CT of the cervical spine of an ex-vivo lamb model was performed with the Artis Zee(R) Ceiling (Siemens Medical Solutions, Erlangen, Germany) to acquire multiplanar reconstruction images. 15 cervical nerve root punctures were planned and conducted with the syngo iGuide(R) laser-guidance system. Needle tip location and contrast dye distribution were analyzed by two independent investigators. Procedural, planning, and fluoroscopic time, tract length, and dose area product (DAP) were acquired for each puncture. Results: All 15 punctures were rated as successful with 12 punctures on the first attempt. Total procedural time was approximately 5 minutes. Mean planning time for the puncture was 2.03 (+/-0.39) min. Mean puncture time was 2.16 (+/-0.32) min, while mean fluoroscopy time was 0.17 (+/-0.06) min. Mean tract length was 2.68 (+/-0.23) cm. Mean total DAP was 397.45 (+/-15.63) mu Gy m(2). Conclusion: CSNRB performed with Dyna-CT and the tested laser guidance system is feasible. 3D pre-puncture planning is easy and fast and the laser-guiding system ensures very accurate and intuitive puncture control.	[Freundt, Miriam I. E.; Al-Zghloul, Mansour; Groden, Christoph; Kerl, Hans U.] Heidelberg Univ, Med Fac Mannheim, Dept Neuroradiol, Mannheim, Germany; [Ritter, Manuel] Heidelberg Univ, Med Fac Mannheim, Dept Urol, Mannheim, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Kerl, HU (corresponding author), Heidelberg Univ, Med Fac Mannheim, Dept Neuroradiol, Theodor Kutzer Ufer 1-3, Mannheim, Germany.	Ulrich.Kerl@umm.de	Freundt, Miriam/ABB-5994-2020; Ritter, Manuel/AGB-4526-2022					Bogduk N, 2011, PHYS MED REH CLIN N, V22, P367, DOI 10.1016/j.pmr.2011.03.008; Braak SJ, 2013, CARDIOVASCULAR INTER; Brabrand K, 2004, ACTA RADIOL, V45, P308, DOI 10.1080/02841850410005039; Brouwers PJAM, 2001, PAIN, V91, P397, DOI 10.1016/S0304-3959(00)00437-1; Bush K, 1996, Eur Spine J, V5, P319, DOI 10.1007/BF00304347; Cyteval C, 2004, AM J NEURORADIOL, V25, P441; Eubanks JD, 2010, AM FAM PHYSICIAN, V81, P33; Fessler RG, 2002, NEUROSURGERY, V51, pS37, DOI 10.1227/01.NEU.0000030928.34393.63; Hilibrand AS, 1999, J BONE JOINT SURG AM, V81A, P519, DOI 10.2106/00004623-199904000-00009; Jacobi V, 1999, EUR RADIOL, V9, P137, DOI 10.1007/s003300050644; Jee H, SKELETAL RADIOLOGY, P1; Karasek M, 2004, PAIN MED, V5, P202, DOI 10.1111/j.1526-4637.2004.04028.x; Kempfert J, 2009, ANN THORAC SURG, V88, P2041, DOI 10.1016/j.athoracsur.2009.01.029; Kozak Lola Jean, 2006, Vital Health Stat 13, P1; Kranz PG, 2012, AM J NEURORADIOL, V33, P1221, DOI 10.3174/ajnr.A2954; Kuijper B, 2009, EUR J NEUROL, V16, P15, DOI 10.1111/j.1468-1331.2008.02365.x; Lee MH, 2010, KOREAN J ANESTHESIOL, V59, pS95, DOI 10.4097/kjae.2010.59.S.S95; LEES F, 1963, BRIT MED J, P1607, DOI 10.1136/bmj.2.5373.1607; LESTINI WF, 1989, CLIN ORTHOP RELAT R, P69; Ma DJ, 2005, J BONE JOINT SURG AM, V87A, P1025, DOI 10.2106/JBJS.D.02139; Miller TS, 2013, AM J NEURORADIOL, V34, P23, DOI 10.3174/ajnr.A3158; Miller TS, 2012, AM J NEURORADIOLOGY; Nakagawa Misato, 2009, Masui, V58, P1506; Oeppen RS, 2003, BRIT J ORAL MAX SURG, V41, P243; Pedicelli A, 2011, SKELETAL RADIOL, V40, P1595, DOI 10.1007/s00256-011-1282-4; Plank C, EUROPEAN J RADIOLOGY; RADHAKRISHNAN K, 1994, BRAIN, V117, P325, DOI 10.1093/brain/117.2.325; Rangel-Castilla L, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.8.FOCUS09170; Ritter M., 2012, WORLD J UROL, P1; Saal JS, 1996, SPINE, V21, P1877, DOI 10.1097/00007632-199608150-00008; Slipman CW, 2000, ARCH PHYS MED REHAB, V81, P741, DOI 10.1016/S0003-9993(00)90104-7; Theodoridis T, 2007, ORTHOPADE, V36, P73, DOI 10.1007/s00132-006-1033-8; Tiso Robert L, 2004, Spine J, V4, P468, DOI 10.1016/j.spinee.2003.10.007; Vallee JN, 2001, RADIOLOGY, V218, P886, DOI 10.1148/radiology.218.3.r01mr17886; Wallace MA, 2007, AM J ROENTGENOL, V188, P1218, DOI 10.2214/AJR.04.1541; Windsor Robert E, 2003, Pain Physician, V6, P457; Wolff AP, 2001, REGION ANESTH PAIN M, V26, P147, DOI 10.1053/rapm.2001.21436; Wolter T, 2010, AM J NEURORADIOL, V31, P1831, DOI 10.3174/ajnr.A2230; Wolter T, 2009, AM J NEURORADIOL, V30, P336, DOI 10.3174/ajnr.A1222	39	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e69311	10.1371/journal.pone.0069311	http://dx.doi.org/10.1371/journal.pone.0069311			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894448	Green Submitted, Green Published, gold			2022-12-27	WOS:000322391400048
J	Han, F; Yan, SN; Shi, YX				Han, Fang; Yan, Shengnan; Shi, YuXiu			Single-Prolonged Stress Induces Endoplasmic Reticulum - Dependent Apoptosis in the Hippocampus in a Rat Model of Post-Traumatic Stress Disorder	PLOS ONE			English	Article							ER STRESS; CELL-DEATH; PROTEIN; CALCIUM; ACTIVATION; EXPRESSION; CASPASE-12; INDUCTION; RESPONSES; CHAPERONE	Background: Our previous research indicated that apoptosis induced atrophy in the hippocampus of post-traumatic stress disorder (PTSD) rats. Endoplasmic reticulum (ER) stress-induced apoptosis has been implicated in the development of several disorder diseases. The aim of this study was to investigate whether endoplasmic reticulum-related pathway is involved in single-prolonged stress (SPS) induces apoptosis in the hippocampus of PTSD rats by examining the expression levels of three important indicators in the ER-related apoptotic pathway: Glucose-regulated protein (GRP) 78, caspase-12 and Ca2+/CaM/CaMkinaseII alpha (CaMkII alpha). Methods: Wistar rats were sacrificed at 1, 4 and 7 days after SPS. SPS is a reliable animal model of PTSD. The apoptotic cells in the hippocampus were assessed by TUNEL method and transmission electron microscopy (TEM). Free intracellular Ca2+ concentration was measured. GRP78 expression was examined by immunohistochemistry, western blotting and RT-PCR. mRNA of caspase-12 and CaM/CaMkII alpha were determined by RT-PCR. Results: Our results showed that apoptotic cells were increased in the SPS rats. TEM analysis revealed characteristic morphological changes of apoptosis in these cells. We observed that GRP78 was significantly up-regulated during early PTSD, and then recovered at 7 days after SPS. By RT-PCR, we observed that the change in caspase-12 expression level was similar to that in GRP78. Moreover, the free intracellular Ca2+ concentration was significantly higher at 1 day after SPS and decreased in 7 days. CaM expression increased significantly, while CaMKII alpha expression decreased significantly in the hippocampus at 1 day after SPS. Conclusion: SPS induced change in the expression levels of GRP78, caspase-12 and Ca2+/CaM/CaMkII alpha in the hippocampus of PTSD rats indicated that the endoplasmic reticulum pathway may be involved in PTSD-induced apoptosis.	[Han, Fang; Yan, Shengnan; Shi, YuXiu] China Med Univ, Inst Pathol & Pathophysiol, PTSD Lab, Dept Histol & Embryol, Shenyang, Peoples R China	China Medical University	Shi, YX (corresponding author), China Med Univ, Inst Pathol & Pathophysiol, PTSD Lab, Dept Histol & Embryol, Shenyang, Peoples R China.	shiyuxiu@163.com			National Natural Science Foundation of China [81171282]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by a grant from the National Natural Science Foundation of China (No. 81171282). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adami P, 2006, ACTA PSYCHIAT SCAND, V113, P360, DOI 10.1111/j.1600-0447.2005.00737.x; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Del Puerto HL, 2010, GENET MOL RES, V9, P151, DOI 10.4238/vol9-1gmr717; Devireddy LR, 2003, MOL CELL BIOL, V23, P4532, DOI 10.1128/MCB.23.13.4532-4541.2003; DILDY JE, 1989, BRAIN RES, V499, P383, DOI 10.1016/0006-8993(89)90789-0; Ding JL, 2010, J PSYCHIATR RES, V44, P48, DOI 10.1016/j.jpsychires.2009.06.001; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Forman MS, 2003, TRENDS NEUROSCI, V26, P407, DOI 10.1016/S0166-2236(03)00197-8; Hedges Dawson W, 2003, Cogn Behav Neurol, V16, P219, DOI 10.1097/00146965-200312000-00003; Hendershot LM, 2004, MT SINAI J MED, V71, P289; Hughes KC, 2011, EXPERT REV NEUROTHER, V11, P275, DOI 10.1586/ERN.10.198; Jyoti D, 2009, INT J BIOCHEM CELL B, V41, P1817; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Koenigs M, 2009, NEUROSCIENTIST, V15, P540, DOI 10.1177/1073858409333072; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Kruman I, 1998, J NEUROSCI RES, V51, P293, DOI 10.1002/(SICI)1097-4547(19980201)51:3<293::AID-JNR3>3.0.CO;2-B; Ledoux S, 2003, CANCER RES, V63, P7284; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Li XM, 2010, J CHEM NEUROANAT, V40, P248, DOI 10.1016/j.jchemneu.2010.07.001; Liberzon I, 2006, ANN NY ACAD SCI, V1071, P87, DOI 10.1196/annals.1364.009; Lindauer RJL, 2005, PSYCHOL MED, V35, P1421, DOI 10.1017/S0033291705005246; Liu F, 2006, ENVIRON HEALTH PERSP, V114, P859, DOI 10.1289/ehp.8920; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Ouyang Yi-Bing, 2012, INT J CELL BIOL, V2; Pitman RK, 1997, ANN NY ACAD SCI, V821, P1, DOI 10.1111/j.1749-6632.1997.tb48264.x; Rokhlin OW, 2007, CANCER BIOL THER, V6, P732, DOI 10.4161/cbt.6.5.3975; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schindler CK, 2004, NEUROSCI LETT, V356, P163, DOI 10.1016/j.neulet.2003.11.048; Shibata M, 2003, NEUROSCIENCE, V118, P491, DOI 10.1016/S0306-4522(02)00910-7; Shin LM, 2005, ARCH GEN PSYCHIAT, V62, P273, DOI 10.1001/archpsyc.62.3.273; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Villarreal G, 2002, CAN J PSYCHIAT, V47, P666, DOI 10.1177/070674370204700709; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Werstuck GH, 2001, J CLIN INVEST, V107, P1263, DOI 10.1172/JCI11596; Wignall EL, 2004, BIOL PSYCHIAT, V56, P832, DOI 10.1016/j.biopsych.2004.09.015; Wright SC, 1997, FASEB J, V11, P843, DOI 10.1096/fasebj.11.11.9285482; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Yan Q, 2006, DIFFERENTIATION, V74, P195, DOI 10.1111/j.1432-0436.2006.00068.x; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147; Yao K, 2007, BIOCHEM BIOPH RES CO, V354, P278, DOI 10.1016/j.bbrc.2006.12.198; Yu ZF, 1999, EXP NEUROL, V155, P302, DOI 10.1006/exnr.1998.7002; Zirpel L, 1998, J NEUROPHYSIOL, V79, P2288, DOI 10.1152/jn.1998.79.5.2288; Zong WX, 2003, J CELL BIOL, V162, P59, DOI 10.1083/jcb.200302084	47	55	59	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e69340	10.1371/journal.pone.0069340	http://dx.doi.org/10.1371/journal.pone.0069340			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894451	Green Published, Green Submitted, gold			2022-12-27	WOS:000322391400050
J	Macphail, M; Carpenter, RJ; Iglesias, A; Wilf, P				Macphail, Mike; Carpenter, Raymond J.; Iglesias, Ari; Wilf, Peter			First Evidence for Wollemi Pine-type Pollen (Dilwynites: Araucariaceae) in South America	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; AGATHIS ARAUCARIACEAE; HUITRERA FORMATION; 40AR/39AR AGE; FOSSIL POLLEN; SP NOV.; PATAGONIA; EOCENE; PALEOGENE; RECORD	We report the first fossil pollen from South America of the lineage that includes the recently discovered, extremely rare Australian Wollemi Pine, Wollemia nobilis (Araucariaceae). The grains are from the late Paleocene to early middle Eocene Ligorio Marquez Formation of Santa Cruz, Patagonia, Argentina, and are assigned to Dilwynites, the fossil pollen type that closely resembles the pollen of modern Wollemia and some species of its Australasian sister genus, Agathis. Dilwynites was formerly known only from Australia, New Zealand, and East Antarctica. The Patagonian Dilwynites occurs with several taxa of Podocarpaceae and a diverse range of cryptogams and angiosperms, but not Nothofagus. The fossils greatly extend the known geographic range of Dilwynites and provide important new evidence for the Antarctic region as an early Paleogene portal for biotic interchange between Australasia and South America.	[Macphail, Mike] Australian Natl Univ, Coll Asia & Pacific, Dept Archaeol & Nat Hist, Canberra, ACT, Australia; [Carpenter, Raymond J.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA 5005, Australia; [Iglesias, Ari] Univ Nacl La Plata, Fac Ciencias Nat & Museo, Div Palaeobot, La Plata, Buenos Aires, Argentina; [Iglesias, Ari] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina; [Wilf, Peter] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA	Australian National University; University of Adelaide; National University of La Plata; Museo La Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Macphail, M (corresponding author), Australian Natl Univ, Coll Asia & Pacific, Dept Archaeol & Nat Hist, Canberra, ACT, Australia.	mike.macphail@anu.edu.au		Iglesias, Ari/0000-0002-9098-8758; Wilf, Peter/0000-0001-6813-1937; Carpenter, Raymond/0000-0001-7129-2870	NSF [DEB-0919071]; Direct For Biological Sciences [0919071] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding provided by NSF DEB-0919071 to PW and AI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASKIN RA, 1990, REV PALAEOBOT PALYNO, V65, P105, DOI 10.1016/0034-6667(90)90061-M; Barreda V, 2007, BOT REV, V73, P31, DOI 10.1663/0006-8101(2007)73[31:PVTDTP]2.0.CO;2; Barreda Viviana D., 1996, Ameghiniana, V33, P35; Biffin E, 2010, SYST BIOL, V59, P594, DOI 10.1093/sysbio/syq030; BIGWOOD AJ, 1985, AUST J BOT, V33, P645, DOI 10.1071/BT9850645; Blisniuk PM, 2005, EARTH PLANET SC LETT, V230, P125, DOI 10.1016/j.epsl.2004.11.015; Busteros AG, 1983, REV ASOC GEOL ARGENT, V38, P427; Cantrill DJ, 2006, INT J PLANT SCI, V167, P1259, DOI 10.1086/507608; Cantrill DJ, 2001, REV PALAEOBOT PALYNO, V115, P119, DOI 10.1016/S0034-6667(01)00053-7; Carpenter RJ, 2012, BOT REV, V78, P261, DOI 10.1007/s12229-012-9099-y; Carpenter RJ, 2012, GEOLOGY, V40, P267, DOI 10.1130/G32584.1; Casadio S, 2000, J S AM EARTH SCI, V13, P123, DOI 10.1016/S0895-9811(00)00013-4; Chambers TC, 1998, INT J PLANT SCI, V159, P160, DOI 10.1086/297534; CHARRIER R, 1979, GEOLOGY, V7, P436, DOI 10.1130/0091-7613(1979)7<436:KAOBFO>2.0.CO;2; Zamaloa MD, 2006, INT J PLANT SCI, V167, P1279, DOI 10.1086/507873; Del Fueyo GM, 2012, REV PALAEOBOT PALYNO, V173, P57, DOI 10.1016/j.revpalbo.2011.12.010; Del Fueyo GM, 2005, CRETACEOUS RES, V26, P757, DOI 10.1016/j.cretres.2005.04.005; Dettmann ME, 2012, ALCHERINGA, V36, P217, DOI 10.1080/03115518.2012.622155; Dettmann ME, 2005, AUSTR FOREST HIST SO, V2, P1; Dettmann ME, 2000, POLLEN SPORES MORPHO, P187; Drinnan AN, 1986, MEMOIRS ASS AUSTR PA, V3, P1, DOI DOI 10.1016/S0012-821X(03)00287-5; Erdtman G., 1952, POLLEN MORPHOLOGY PL; Escapa IH, 2013, INT J PLANT SCI, V174, P458, DOI 10.1086/668612; Escapa IH, 2012, AM J BOT, V99, P1058, DOI 10.3732/ajb.1100544; Escosteguy L, 2003, SERV GEOL MIN ARGENT, P339; Escosteguy L, 2001, 11 C LAT GEOL 3 C UR, P10; Gandolfo MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021084; Gilmore S., 1997, Telopea, V7, P275; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1, DOI 10.1016/B978-0-444-59425-9.00001-9; Harris WK, 1965, PALAEONTOGR ABT B, V115, P75; Hermsen EJ, 2012, AM J BOT, V99, P1356, DOI 10.3732/ajb.1200025; Heusser CJ., 1971, POLLEN SPORES CHILE; Hill RS, 2008, AUST SYST BOT, V21, P162, DOI 10.1071/SB08006; Hill RS, 1999, AUST J BOT, V47, P639, DOI 10.1071/BT98093; HILL RS, 1987, ALCHERINGA, V11, P325, DOI 10.1080/03115518708619142; Hill RS, 1991, PAPERS P ROYAL SOC T, V125, P239; Jones W. G., 1995, Telopea, V6, P173; Kunzmann L, 2007, ZOOL ANZ, V246, P257, DOI 10.1016/j.jcz.2007.08.001; Leslie AB, 2012, P NATL ACAD SCI USA, V109, P16217, DOI 10.1073/pnas.1213621109; Linares E, 1990, PUBL ESPEC ASOC GE B, V19, P1; Liu N, 2009, CHINESE SCI BULL, V54, P2648, DOI 10.1007/s11434-009-0373-2; Macphail M.K., 1994, HIST AUSTR VEGETATIO, P189, DOI DOI 10.20851/AUSTRALIAN-VEGETATION; Macphail M, 2006, PALAEOGEOGR PALAEOCL, V240, P602, DOI 10.1016/j.palaeo.2006.03.010; Macphail M, 2012, ALCHERINGA, V36, P283, DOI 10.1080/03115518.2012.667989; MACPHAIL MK, 1980, NEW ZEAL J BOT, V18, P453, DOI 10.1080/0028825X.1980.10425165; Macphail MK, 2007, 151 CRC LEME, P1; Macphail MK, 1995, GEOL TODAY, V11, P48; Melendi DL, 2003, NEUES JAHRB GEOL P-A, V228, P205; OKUDA M, 2006, POSTCRETACEOUS FLORI, P37; Panti C, 2012, ALCHERINGA, V36, P1, DOI 10.1080/03115518.2011.564562; Petford N, 1996, INT S AND GEOD 3 ACT, P629; Pole M, 1995, AUST SYST BOT, V8, P1067, DOI 10.1071/SB9951067; Pole M, 2008, ALCHERINGA, V32, P405, DOI 10.1080/03115510802417935; Quattrocchio Mirta, 2006, Revista Brasileira de Paleontologia, V9, P101; Quattrocchio ME, 2012, REV BRAS PALEONTOLOG, V15, P67, DOI 10.4072/rbp.2012.1.06; Rai HS, 2008, BOTANY, V86, P658, DOI 10.1139/B08-062; Raine JI, 2011, GNS SCI MISC SER, V4; Ramos V, 1987, 10 C GEOL ARG ACT 1, V1, P143; Ramos VA, 1994, 7 C GEOL CHIL CONC A, V2, P1172; Spegazzini C, 1924, ANUALES SOCIEDAD CIE, V97, P125; Stefanovic S, 1998, AM J BOT, V85, P688, DOI 10.2307/2446539; STOCKEY RA, 1975, AM J BOT, V62, P856, DOI 10.2307/2441898; Suarez M, 2000, J GEOL SOC LONDON, V157, P995, DOI 10.1144/jgs.157.5.995; Suarez M, 2000, J S AM EARTH SCI, V13, P527, DOI 10.1016/S0895-9811(00)00042-0; Suarez M, 1996, ACT 13 C GEOL ARG 3, VI, P425; Troncoso A, 2002, REV GEOL CHILE, V29, P113; TRONCOSO A, 1998, MONOGRAPHS SYSTEMATI, V68, P149; Truswell EM, 2009, AUST SYST BOT, V22, P57, DOI 10.1071/SB08046; Turner S, 2009, GFF, V131, P49, DOI 10.1080/11035890902924877; Ugarte F.R.E., 1956, REV ASOCIACI N GEOL, V11, P202; WHITE M E, 1981, Records of the Australian Museum, V33, P695; Wilf P, 2005, AM NAT, V165, P634, DOI 10.1086/430055; Wilf P, 2012, BOT SOC AM 2012 COL, V2012; Wilf P, 2013, ANNU REV EARTH PL SC, V41, P561, DOI 10.1146/annurev-earth-050212-124217; Wilf P, 2012, AM J BOT, V99, P562, DOI 10.3732/ajb.1100367; Wilf P, 2010, AMEGHINIANA, V47, P207, DOI 10.5710/AMGH.v47i2.7; Wilf P, 2009, AM J BOT, V96, P2031, DOI 10.3732/ajb.0900085; Woodford J, 2005, WOLLEMI PINE INCREDI; Yabe A, 2006, POSTCRETACEOUS FLORI, P29	79	17	20	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e69281	10.1371/journal.pone.0069281	http://dx.doi.org/10.1371/journal.pone.0069281			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894439	Green Published, Green Submitted, gold			2022-12-27	WOS:000322391400044
J	Gersbacher, MT; Goodger, ZV; Trutzel, A; Bundschuh, D; Nitsch, RM; Konietzko, U				Gersbacher, Manuel T.; Goodger, Zoe V.; Trutzel, Annette; Bundschuh, Diana; Nitsch, Roger M.; Konietzko, Uwe			Turnover of Amyloid Precursor Protein Family Members Determines Their Nuclear Signaling Capability	PLOS ONE			English	Article							APP INTRACELLULAR DOMAIN; CENTRAL-NERVOUS-SYSTEM; C-TERMINAL FRAGMENT; ALZHEIMERS-DISEASE; CASPASE CLEAVAGE; APOLIPOPROTEIN-E; GENE-EXPRESSION; MICE LACKING; MOUSE-BRAIN; BETA-LIKE	The amyloid precursor protein (APP) as well as its homologues, APP-like protein 1 and 2 (APLP1 and APLP2), are cleaved by alpha-, beta-, and gamma-secretases, resulting in the release of their intracellular domains (ICDs). We have shown that the APP intracellular domain (AICD) is transported to the nucleus by Fe65 where they jointly bind the histone acetyltransferase Tip60 and localize to spherical nuclear complexes (AFT complexes), which are thought to be sites of transcription. We have now analyzed the subcellular localization and turnover of the APP family members. Similarly to AICD, the ICD of APLP2 localizes to spherical nuclear complexes together with Fe65 and Tip60. In contrast, the ICD of APLP1, despite binding to Fe65, does not translocate to the nucleus. In addition, APLP1 predominantly localizes to the plasma membrane, whereas APP and APLP2 are detected in vesicular structures. APLP1 also demonstrates a much slower turnover of the full-length protein compared to APP and APLP2. We further show that the ICDs of all APP family members are degraded by the proteasome and that the N-terminal amino acids of ICDs determine ICD degradation rate. Together, our results suggest that different nuclear signaling capabilities of APP family members are due to different rates of full-length protein processing and ICD proteasomal degradation. Our results provide evidence in support of a common nuclear signaling function for APP and APLP2 that is absent in APLP1, but suggest that APLP1 has a regulatory role in the nuclear translocation of APP family ICDs due to the sequestration of Fe65.	[Gersbacher, Manuel T.; Goodger, Zoe V.; Trutzel, Annette; Bundschuh, Diana; Nitsch, Roger M.; Konietzko, Uwe] Univ Zurich, Zurich, Switzerland	University of Zurich	Konietzko, U (corresponding author), Univ Zurich, Zurich, Switzerland.	uwekon@bli.uzh.ch			SNF [31003A_130148]; NCCR on Neural Plasticity and Repair; Gottfried und Julia Bangerter-Rhyner-Stiftung	SNF; NCCR on Neural Plasticity and Repair; Gottfried und Julia Bangerter-Rhyner-Stiftung	This work was supported by the SNF No. 31003A_130148 (http://www.snf.ch/E/Pages/default.aspx), the NCCR on Neural Plasticity and Repair (http://www.nccr-neuro.ethz.ch/), and the Gottfried und Julia Bangerter-Rhyner-Stiftung (http://www.bangerter-stiftung.ch/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbagallo APM, 2011, J BIOL CHEM, V286, P8717, DOI 10.1074/jbc.C111.219873; Barbagallo APM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015503; Bayer TA, 1999, MOL PSYCHIATR, V4, P524, DOI 10.1038/sj.mp.4000552; Buoso E, 2010, PHARMACOL RES, V62, P308, DOI 10.1016/j.phrs.2010.05.002; BUSH AI, 1994, J BIOL CHEM, V269, P26618; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Coulson EJ, 2000, NEUROCHEM INT, V36, P175, DOI 10.1016/S0197-0186(99)00125-4; da Costa CA, 2006, J NEUROSCI, V26, P6377, DOI 10.1523/JNEUROSCI.0651-06.2006; De Strooper B, 2000, J CELL SCI, V113, P1857; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; Eggert S, 2004, J BIOL CHEM, V279, P18146, DOI 10.1074/jbc.M311601200; Galvan V, 2002, J NEUROCHEM, V82, P283, DOI 10.1046/j.1471-4159.2002.00970.x; Gersbacher MT, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-61; Ghosal K, 2009, P NATL ACAD SCI USA, V106, P18367, DOI 10.1073/pnas.0907652106; Goodger ZV, 2009, J CELL SCI, V122, P3703, DOI 10.1242/jcs.048090; Gu YJ, 2001, J BIOL CHEM, V276, P35235, DOI 10.1074/jbc.C100357200; Guenette S, 2006, EMBO J, V25, P420, DOI 10.1038/sj.emboj.7600926; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harris JA, 2010, J NEUROSCI, V30, P372, DOI 10.1523/JNEUROSCI.5341-09.2010; Heber S, 2000, J NEUROSCI, V20, P7951; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Herms J, 2004, EMBO J, V23, P4106, DOI 10.1038/sj.emboj.7600390; Kaden D, 2009, J CELL SCI, V122, P368, DOI 10.1242/jcs.034058; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kim MY, 2011, J CELL SCI, V124, P1831, DOI 10.1242/jcs.076117; Kohli BM, 2012, J PROTEOME RES; Konietzko U, 2010, NEUROBIOL AGING, V31, P58, DOI 10.1016/j.neurobiolaging.2008.03.001; Kuan YH, 2006, J BIOL CHEM, V281, P40114, DOI 10.1074/jbc.M605407200; Lenkkeri U, 1998, HUM GENET, V102, P192, DOI 10.1007/s004390050676; Li HM, 2010, P NATL ACAD SCI USA, V107, P17362, DOI 10.1073/pnas.1012568107; Li QM, 2004, J BIOL CHEM, V279, P10542, DOI 10.1074/jbc.M310001200; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; LORENT K, 1995, NEUROSCIENCE, V65, P1009, DOI 10.1016/0306-4522(94)00555-J; Lyckman AW, 1998, J BIOL CHEM, V273, P11100, DOI 10.1074/jbc.273.18.11100; Merdes G, 2004, EMBO J, V23, P4082, DOI 10.1038/sj.emboj.7600413; Muller T, 2008, PROG NEUROBIOL, V85, P393, DOI 10.1016/j.pneurobio.2008.05.002; Nunan J, 2001, EUR J BIOCHEM, V268, P5329, DOI 10.1046/j.0014-2956.2001.02465.x; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Pardossi-Piquard R, 2012, J NEUROCHEM, V120, P109, DOI 10.1111/j.1471-4159.2011.07475.x; Pastorino L, 2004, MOL CELL NEUROSCI, V25, P642, DOI 10.1016/j.mcn.2003.12.013; Pinnix I, 2001, J BIOL CHEM, V276, P481, DOI 10.1074/jbc.M005968200; Radzimanowski J, 2008, EMBO REP, V9, P1134, DOI 10.1038/embor.2008.188; Scheinfeld MH, 2002, J BIOL CHEM, V277, P44195, DOI 10.1074/jbc.M208110200; Scheinfeld MH, 2003, P NATL ACAD SCI USA, V100, P1729, DOI 10.1073/pnas.0437908100; SLUNT HH, 1994, J BIOL CHEM, V269, P2637; Soba P, 2005, EMBO J, V24, P3624, DOI 10.1038/sj.emboj.7600824; TANZI R E, 1988, Genomics, V3, P129, DOI 10.1016/0888-7543(88)90143-7; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; VANNOSTRAND WE, 1994, BBA-PROTEIN STRUCT M, V1209, P165, DOI 10.1016/0167-4838(94)90180-5; Varshavsky A, 1996, MOL BIOL CELL, V7, P2946; Vingtdeux V, 2007, NEUROBIOL DIS, V25, P686, DOI 10.1016/j.nbd.2006.09.019; Von Koch CS, 1997, NEUROBIOL AGING, V18, P661, DOI 10.1016/S0197-4580(97)00151-6; von Rotz RC, 2004, J CELL SCI, V117, P4435, DOI 10.1242/jcs.01323; Walsh DM, 2003, BIOCHEMISTRY-US, V42, P6664, DOI 10.1021/bi027375c; Wang P, 2005, J NEUROSCI, V25, P1219, DOI 10.1523/JNEUROSCI.4660-04.2005; WASCO W, 1993, NAT GENET, V5, P95, DOI 10.1038/ng0993-95; WASCO W, 1992, P NATL ACAD SCI USA, V89, P10758, DOI 10.1073/pnas.89.22.10758; Weidemann A, 2002, BIOCHEMISTRY-US, V41, P2825, DOI 10.1021/bi015794o; Weyer SW, 2011, EMBO J, V30, P2266, DOI 10.1038/emboj.2011.119; Yanagida K, 2009, EMBO MOL MED, V1, P223, DOI 10.1002/emmm.200900026; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X	61	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e69363	10.1371/journal.pone.0069363	http://dx.doi.org/10.1371/journal.pone.0069363			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874953	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000324146200074
J	Kuramae, EE; Verbruggen, E; Hillekens, R; de Hollander, M; Roling, WFM; van der Heijden, MGA; Kowalchuk, GA				Kuramae, Eiko E.; Verbruggen, Erik; Hillekens, Remy; de Hollander, Mattias; Roling, Wilfred F. M.; van der Heijden, Marcel G. A.; Kowalchuk, George A.			Tracking Fungal Community Responses to Maize Plants by DNA- and RNA-Based Pyrosequencing	PLOS ONE			English	Article							RIBOSOMAL-RNA; MYCORRHIZAL COLONIZATION; BT-MAIZE; IMPACT; BACTERIAL; SOILS; CORN; RHIZOSPHERE; ASSESSMENTS; SYMBIOSIS	We assessed soil fungal diversity and community structure at two sampling times (t1 = 47 days and t2 = 104 days of plant age) in pots associated with four maize cultivars, including two genetically modified (GM) cultivars by high-throughput pyrosequencing of the 18S rRNA gene using DNA and RNA templates. We detected no significant differences in soil fungal diversity and community structure associated with different plant cultivars. However, DNA-based analyses yielded lower fungal OTU richness as compared to RNA-based analyses. Clear differences in fungal community structure were also observed in relation to sampling time and the nucleic acid pool targeted (DNA versus RNA). The most abundant soil fungi, as recovered by DNA-based methods, did not necessary represent the most "active" fungi (as recovered via RNA). Interestingly, RNA-derived community compositions at t1 were highly similar to DNA-derived communities at t2, based on presence/absence measures of OTUs. We recovered large proportions of fungal sequences belonging to arbuscular mycorrhizal fungi and Basidiomycota, especially at the RNA level, suggesting that these important and potentially beneficial fungi are not affected by the plant cultivars nor by GM traits (Bt toxin production). Our results suggest that even though DNA-and RNA-derived soil fungal communities can be very different at a given time, RNA composition may have a predictive power of fungal community development through time.	[Kuramae, Eiko E.; Hillekens, Remy; de Hollander, Mattias; Kowalchuk, George A.] Netherlands Inst Ecol NIOO KNAW, Dept Microbial Ecol, Wageningen, Netherlands; [Kuramae, Eiko E.; Verbruggen, Erik] Vrije Univ Amsterdam, Dept Ecol Sci, Amsterdam, Netherlands; [Roling, Wilfred F. M.] Vrije Univ Amsterdam, Dept Mol Cell Physiol, Amsterdam, Netherlands; [van der Heijden, Marcel G. A.] Agroscope Reckenholz Tanikon, Res Stn ART, Zurich, Switzerland; [van der Heijden, Marcel G. A.; Kowalchuk, George A.] Univ Utrecht, Dept Biol, Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Swiss Federal Research Station Agroscope; Swiss Federal Research Station for Agroecology & Agriculture; Utrecht University	Kuramae, EE (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Microbial Ecol, Wageningen, Netherlands.	e.kuramae@nioo.knaw.nl	Kuramae, Eiko Eurya/F-4738-2012; van der Heijden, Marcel/AAY-1593-2021; van der Heijden, Marcel G.A./H-5243-2011; Verbruggen, Erik/AAF-1018-2019; Kowalchuk, George A/C-4298-2011; Verbruggen, Erik/A-5351-2012; KNAW, NIOO-KNAW/A-4320-2012	Kuramae, Eiko Eurya/0000-0001-6701-8668; Verbruggen, Erik/0000-0001-7015-1515; KNAW, NIOO-KNAW/0000-0002-3835-159X; Kowalchuk, George/0000-0003-3866-0832; van der Heijden, Marcel/0000-0001-7040-1924	Ecology Regarding Genetically Modified Organisms - Netherlands Organisation for Scientific Research (ERGO-NWO) program	Ecology Regarding Genetically Modified Organisms - Netherlands Organisation for Scientific Research (ERGO-NWO) program	This work was supported by the the Ecology Regarding Genetically Modified Organisms - Netherlands Organisation for Scientific Research (ERGO-NWO) program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnelli A, 2007, BIOL FERT SOILS, V44, P353, DOI 10.1007/s00374-007-0213-y; Anderson IC, 2008, SOIL BIOL BIOCHEM, V40, P2358, DOI 10.1016/j.soilbio.2008.05.015; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castaldini M, 2005, APPL ENVIRON MICROB, V71, P6719, DOI 10.1128/AEM.71.11.6719-6729.2005; de Boer W, 2005, FEMS MICROBIOL REV, V29, P795, DOI 10.1016/j.femsre.2004.11.005; de Vaufleury A, 2007, PEDOBIOLOGIA, V51, P185, DOI 10.1016/j.pedobi.2007.04.005; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Dumbrell AJ, 2011, NEW PHYTOL, V190, P794, DOI 10.1111/j.1469-8137.2010.03636.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Girvan MS, 2004, APPL ENVIRON MICROB, V70, P2692, DOI 10.1128/AEM.70.5.2692-2701.2004; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Graham JH, 1997, NEW PHYTOL, V135, P335, DOI 10.1046/j.1469-8137.1997.00636.x; Hannula SE, 2012, NEW PHYTOL, V194, P784, DOI 10.1111/j.1469-8137.2012.04089.x; Hannula SE, 2010, SOIL BIOL BIOCHEM, V42, P2211, DOI 10.1016/j.soilbio.2010.08.020; Hannula SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033819; Hirsch PR, 2010, SOIL BIOL BIOCHEM, V42, P878, DOI 10.1016/j.soilbio.2010.02.019; Hur M, 2012, J MICROBIOL, V50, P910, DOI 10.1007/s12275-012-2491-9; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Jumpponen A, 2011, MYCORRHIZA, V21, P453, DOI 10.1007/s00572-010-0358-7; Kiers ET, 2006, ECOLOGY, V87, P1627, DOI 10.1890/0012-9658(2006)87[1627:MSITAM]2.0.CO;2; Knox OGG, 2008, FIELD CROP RES, V109, P57, DOI 10.1016/j.fcr.2008.06.005; Kowalchuk GA, 1999, CURR OPIN BIOTECH, V10, P247, DOI 10.1016/S0958-1669(99)80043-3; Lim YW, 2010, J MICROBIOL, V48, P284, DOI 10.1007/s12275-010-9369-5; Liu WK, 2010, ECOTOXICOLOGY, V19, P229, DOI 10.1007/s10646-009-0423-1; Lueders T, 2004, ENVIRON MICROBIOL, V6, P60, DOI 10.1046/j.1462-2920.2003.00535.x; Mahmood S, 2005, ENVIRON MICROBIOL, V7, P1349, DOI 10.1111/j.1462-2920.2005.00822.x; Martinez AT, 2005, INT MICROBIOL, V8, P195; Mello A, 2011, MYCOLOGIA, V103, P1184, DOI 10.3852/11-027; Powell JR, 2007, APPL ENVIRON MICROB, V73, P4365, DOI 10.1128/AEM.00594-07; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rangel-Castro JI, 2005, ENVIRON MICROBIOL, V7, P828, DOI 10.1111/j.1462-2920.2005.00756.x; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Tan FX, 2011, SOIL BIOL BIOCHEM, V43, P2473, DOI 10.1016/j.soilbio.2011.08.014; Turrini A, 2004, PLANT SOIL, V266, P69; Vainio EJ, 2000, MYCOL RES, V104, P927, DOI 10.1017/S0953756200002471; Verbruggen E, 2012, APPL ENVIRON MICROB, V78, P7384, DOI 10.1128/AEM.01372-12; VIERHEILIG H, 1995, APPL ENVIRON MICROB, V61, P3031, DOI 10.1128/AEM.61.8.3031-3034.1995	39	33	36	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e69973	10.1371/journal.pone.0069973	http://dx.doi.org/10.1371/journal.pone.0069973			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23875012	Green Published, gold, Green Submitted			2022-12-27	WOS:000324146200086
J	Pe, ML; Raes, F; Kuppens, P				Pe, Madeline Lee; Raes, Filip; Kuppens, Peter			The Cognitive Building Blocks of Emotion Regulation: Ability to Update Working Memory Moderates the Efficacy of Rumination and Reappraisal on Emotion	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; REPETITIVE THOUGHT; DEPRESSION; INTERFERENCE; CAPACITY; TOOLS	The ability to regulate emotions is a critical component of healthy emotional functioning. Therefore, it is important to determine factors that contribute to the efficacy of emotion regulation. The present article examined whether the ability to update emotional information in working memory is a predictor of the efficacy of rumination and reappraisal on affective experience both at the trait level (Study 1) and in daily life (Study 2). In both studies, results revealed that the relationship between use of reappraisal and high arousal negative emotions was moderated by updating ability. Specifically, use of reappraisal was associated with decreased high arousal negative emotions for participants with high updating ability, while no significant relationship was found for those with low updating ability. In addition, both studies also revealed that the relationship between rumination and high arousal negative emotions was moderated by updating ability. In general, use of rumination was associated with elevated high arousal negative emotions. However, this relationship was blunted for participants with high updating ability. That is, use of rumination was associated with less elevated high arousal negative emotions for participants with high updating ability. These results identify the ability to update emotional information in working memory as a crucial process modulating the efficacy of emotion regulation efforts.	[Pe, Madeline Lee; Raes, Filip; Kuppens, Peter] Katholieke Univ Leuven, Fac Psychol & Educ Sci, Louvain, Belgium; [Kuppens, Peter] Univ Melbourne, Sch Psychol Sci, Parkville, Vic 3052, Australia	KU Leuven; University of Melbourne	Pe, ML (corresponding author), Katholieke Univ Leuven, Fac Psychol & Educ Sci, Louvain, Belgium.	madeline.pe@ppw.kuleuven.be	kuppens, peter/DHG-5268-2022	kuppens, peter/0000-0002-2363-2356	KU Leuven Research Council [PF/10/005, GOA/10/02, OT/11/31]; Fund for Scientific Research-Flanders (FWO)	KU Leuven Research Council(KU Leuven); Fund for Scientific Research-Flanders (FWO)(FWO)	This research is supported by KU Leuven Research Council grants PF/10/005 awarded to FR, and GOA/10/02 and OT/11/31 and by a Fund for Scientific Research-Flanders (FWO) grant awarded to PK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, C1 CTR RES PSYCH, DOI DOI 10.1002/PER.2410010304; Barrett DJ, 2005, ESP EXPERIENCE SAMPL; Beilock SL, 2008, J EXP PSYCHOL-APPL, V14, P340, DOI 10.1037/a0012859; Conner TS, 2009, SOC PERSONAL PSYCHOL, V3, P292, DOI 10.1111/j.1751-9004.2009.00170.x; De Lissnyder E, 2011, COGNITION EMOTION, V25, P886, DOI 10.1080/02699931.2010.514711; Gevins A, 2000, CEREB CORTEX, V10, P829, DOI 10.1093/cercor/10.9.829; Gotlib IH, 2010, ANNU REV CLIN PSYCHO, V6, P285, DOI 10.1146/annurev.clinpsy.121208.131305; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Jaeggi SM, 2010, MEMORY, V18, P394, DOI 10.1080/09658211003702171; Joormann J, 2008, J ABNORM PSYCHOL, V117, P182, DOI 10.1037/0021-843X.117.1.182; Joormann J, 2011, SOC PERSONAL PSYCHOL, V5, P13, DOI 10.1111/j.1751-9004.2010.00335.x; Joormann J, 2010, COGNITION EMOTION, V24, P913, DOI 10.1080/02699931003784939; Joormann J, 2010, COGNITION EMOTION, V24, P281, DOI 10.1080/02699930903407948; Kahneman D, 2006, J ECON PERSPECT, V20, P3, DOI 10.1257/089533006776526030; Levens SM, 2010, J EXP PSYCHOL GEN, V139, P654, DOI 10.1037/a0020283; Levens SM, 2009, DEPRESS ANXIETY, V26, P403, DOI 10.1002/da.20565; McRae K, 2012, J RES PERS, V46, P2, DOI 10.1016/j.jrp.2011.10.003; Meiran N, 2011, PSYCHIAT RES, V185, P149, DOI 10.1016/j.psychres.2010.04.044; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; MORRIS N, 1990, BRIT J PSYCHOL, V81, P111, DOI 10.1111/j.2044-8295.1990.tb02349.x; Nolen-Hoeksema S, 2008, PERSPECT PSYCHOL SCI, V3, P400, DOI 10.1111/j.1745-6924.2008.00088.x; Parkinson B, 1999, COGNITION EMOTION, V13, P277, DOI 10.1080/026999399379285; Pe ML, 2013, COGNITION EMOTION, V27, P492, DOI 10.1080/02699931.2012.719489; Pe ML, EMOTION IN PRESS; Pe ML, COGNITIVE P IN PRESS; Pe ML, COGNITION IN PRESS; Pessoa L, 2009, TRENDS COGN SCI, V13, P160, DOI 10.1016/j.tics.2009.01.006; Preacher KJ, 2006, J EDUC BEHAV STAT, V31, P437, DOI 10.3102/10769986031004437; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raes F., 2009, GEDRAGSTHERAPIE, V42, P205; Russell JA, 1999, J PERS SOC PSYCHOL, V76, P805, DOI 10.1037/0022-3514.76.5.805; Schmeichel BJ, 2007, J EXP PSYCHOL GEN, V136, P241, DOI 10.1037/0096-3445.136.2.241; Schmeichel BJ, 2008, J PERS SOC PSYCHOL, V95, P1526, DOI 10.1037/a0013345; Segerstrom SC, 2000, COGNITIVE THER RES, V24, P671, DOI 10.1023/A:1005587311498; Treynor W, 2003, COGNITIVE THER RES, V27, P247, DOI 10.1023/A:1023910315561; Watkins ER, 2008, PSYCHOL BULL, V134, P163, DOI 10.1037/0033-2909.134.2.163; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063	37	88	93	6	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e69071	10.1371/journal.pone.0069071	http://dx.doi.org/10.1371/journal.pone.0069071			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	214PM	23874872	Green Published, gold			2022-12-27	WOS:000324146200054
J	Shin, YS; Shin, HA; Kang, SU; Kim, JH; Oh, YT; Park, KH; Kim, CH				Shin, Yoo Seob; Shin, Hyang Ae; Kang, Sung Un; Kim, Jang Hee; Oh, Young-Taek; Park, Keun Hyung; Kim, Chul-Ho			Effect of Epicatechin against Radiation-Induced Oral Mucositis: In Vitro and In Vivo Study	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; GREEN TEA; ULCERATIVE MUCOSITIS; DOUBLE-BLIND; NECK-CANCER; HEAD; CELLS; RADIOTHERAPY; POLYPHENOLS; PREVENTION	Purpose: Radiation-induced oral mucositis limits the delivery of high-dose radiation to head and neck cancer. This study investigated the effectiveness of epicatechin (EC), a component of green tea extracts, on radiation-induced oral mucositis in vitro and in vivo. Experimental Design: The effect of EC on radiation-induced cytotoxicity was analyzed in the human keratinocyte line HaCaT. Radiation-induced apoptosis, change in mitochondrial membrane potential (MMP), reactive oxygen species (ROS) generation and changes in the signaling pathway were investigated. In vivo therapeutic effects of EC for oral mucositis were explored in a rat model. Rats were monitored by daily inspections of the oral cavity, amount of oral intake, weight change and survival rate. For histopathologic evaluation, hematoxylin-eosin staining and TUNEL staining were performed. Results: EC significantly inhibited radiation-induced apoptosis, change of MMP, and intracellular ROS generation in HaCaT cells. EC treatment markedly attenuated the expression of p-JNK, p-38, and cleaved caspase-3 after irradiation in the HaCaT cells. Rats with radiation-induced oral mucositis showed decreased oral intake, weight and survival rate, but oral administration of EC significantly restored all three parameters. Histopathologic changes were significantly decreased in the EC-treated irradiated rats. TUNEL staining of rat oral mucosa revealed that EC treatment significantly decreased radiation-induced apoptotic cells. Conclusions: This study suggests that EC significantly inhibited radiation-induced apoptosis in keratinocytes and rat oral mucosa and may be a safe and effective candidate treatment for the prevention of radiation-induced mucositis.	[Shin, Yoo Seob; Kang, Sung Un; Park, Keun Hyung; Kim, Chul-Ho] Ajou Univ, Sch Med, Dept Otolaryngol, Suwon 441749, South Korea; [Shin, Hyang Ae] Ilsan Hosp, Natl Hlth Insurance Corp, Dept Otorhinolaryngol Head & Neck Surg, Goyang, South Korea; [Kim, Jang Hee] Ajou Univ, Sch Med, Dept Pathol, Suwon 441749, South Korea; [Oh, Young-Taek] Ajou Univ, Sch Med, Dept Radiat Oncol, Suwon 441749, South Korea	Ajou University; NHIS Ilsan Hospital; Ajou University; Ajou University	Kim, CH (corresponding author), Ajou Univ, Sch Med, Dept Otolaryngol, Suwon 441749, South Korea.	ostium@ajou.ac.kr	Kim, Jang-Hee/AAI-9917-2020; kang, sung un/AAK-8050-2021	Kim, Jang-Hee/0000-0001-5825-1361	National Research Foundation of Korea (NRF); Korea government (MEST) [2010-0012821]; CCRB through the "GRRC" Project of Gyeonggi Provincial Government, Korea [GRRC Ajou-2012-A03]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); CCRB through the "GRRC" Project of Gyeonggi Provincial Government, Korea	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (2010-0012821) and CCRB through the "GRRC" Project of Gyeonggi Provincial Government, Korea (GRRC Ajou-2012-A03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes HS, 2007, BLOOD, V109, P2250, DOI 10.1182/blood-2006-07-035022; Artali R, 2009, J ENZYM INHIB MED CH, V24, P287, DOI 10.1080/14756360802177282 ; Brizel DM, 2000, J CLIN ONCOL, V18, P3339, DOI 10.1200/JCO.2000.18.19.3339; Cai JY, 1998, BBA-BIOENERGETICS, V1366, P139, DOI 10.1016/S0005-2728(98)00109-1; Cho SA, 2006, EXP TOXICOL PATHOL, V57, P321, DOI 10.1016/j.etp.2005.09.006; Chung JY, 1999, CANCER RES, V59, P4610; Chung JY, 2001, FASEB J, V15, P2022, DOI 10.1096/fj.01-0031fje; de Mejia EG, 2009, BRAIN BEHAV IMMUN, V23, P721, DOI 10.1016/j.bbi.2009.02.013; Epstein JB, 2000, CANCER-AM CANCER SOC, V89, P2258, DOI 10.1002/1097-0142(20001201)89:11<2258::AID-CNCR14>3.0.CO;2-Z; Epstein JB, 2001, HEAD NECK-J SCI SPEC, V23, P389, DOI 10.1002/hed.1049; Epstein JB, 2001, CANCER, V92, P875, DOI 10.1002/1097-0142(20010815)92:4<875::AID-CNCR1396>3.0.CO;2-1; Guo QN, 1996, BBA-LIPID LIPID MET, V1304, P210, DOI 10.1016/S0005-2760(96)00122-1; Higdon JV, 2003, CRIT REV FOOD SCI, V43, P89, DOI 10.1080/10408690390826464; Hille A, 2003, INT J RADIAT BIOL, V79, P119, DOI 10.1080/0955300021000045682; Kim CH, 2008, APOPTOSIS, V13, P1184, DOI 10.1007/s10495-008-0242-5; Kuo YC, 2009, CANCER CAUSE CONTROL, V20, P57, DOI 10.1007/s10552-008-9217-7; Lalla RV, 2006, CANCER J, V12, P348, DOI 10.1097/00130404-200609000-00004; Leborgne JH, 1998, RADIOTHER ONCOL, V47, P145, DOI 10.1016/S0167-8140(97)00174-6; Lee JS, 2010, TOXICOL LETT, V199, P308, DOI 10.1016/j.toxlet.2010.09.013; Lee SW, 2007, INT J RADIAT ONCOL, V67, P1172, DOI 10.1016/j.ijrobp.2006.10.038; Mann CD, 2009, EUR J CANCER PREV, V18, P13, DOI 10.1097/CEJ.0b013e3282f0c090; Murphy CK, 2008, CLIN CANCER RES, V14, P4292, DOI 10.1158/1078-0432.CCR-07-4669; Pignon JP, 2000, LANCET, V355, P949, DOI 10.1016/S0140-6736(00)90011-4; Plevova P, 1999, ORAL ONCOL, V35, P453, DOI 10.1016/S1368-8375(99)00033-0; Prince PSM, 2013, FOOD CHEM TOXICOL, V53, P409, DOI 10.1016/j.fct.2012.12.010; Pyun JH, 2011, NEUROSCIENCE, V199, P410, DOI 10.1016/j.neuroscience.2011.09.012; Rosenthal DI, 2009, SEMIN RADIAT ONCOL, V19, P29, DOI 10.1016/j.semradonc.2008.09.006; Rovirosa A, 1998, INT J RADIAT ONCOL, V41, P747, DOI 10.1016/S0360-3016(98)00109-6; Sankaranarayanan R, 1998, ANTICANCER RES, V18, P4779; Schroeder P, 2003, BIOCHEM BIOPH RES CO, V307, P69, DOI 10.1016/S0006-291X(03)01132-X; Schroeter H, 2007, J NEUROCHEM, V101, P1596, DOI 10.1111/j.1471-4159.2006.04434.x; Sheng-Tanner X, 1998, RADIAT RES, V150, P636, DOI 10.2307/3579886; Shin YS, 2013, NEUROSCIENCE, V232, P1, DOI 10.1016/j.neuroscience.2012.12.008; Siomek A, 2006, INT J CANCER, V119, P2228, DOI 10.1002/ijc.22088; Sonis SL, 2002, CRIT REV ORAL BIOL M, V13, P380, DOI 10.1177/154411130201300502; SONIS ST, 1994, CANCER RES, V54, P1135; Spielberger R, 2004, NEW ENGL J MED, V351, P2590, DOI 10.1056/NEJMoa040125; Suntharalingam M, 2004, SEMIN ONCOL, V31, P2, DOI 10.1053/j.seminoncol.2005.02.001; Trotti A, 2004, INT J RADIAT ONCOL, V58, P674, DOI 10.1016/S0360-3016(03)01627-4; Wilkes JD, 1998, SEMIN ONCOL, V25, P538	40	30	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e69151	10.1371/journal.pone.0069151	http://dx.doi.org/10.1371/journal.pone.0069151			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874895	Green Published, Green Submitted, gold			2022-12-27	WOS:000324146200062
J	Vasylyeva, TL; Singh, R; Sheehan, C; Chennasamudram, SP; Hernandez, AP				Vasylyeva, Tetyana L.; Singh, Ruchi; Sheehan, Christopher; Chennasamudram, Sudha P.; Hernandez, Anne P.			Self-Reported Adherence to Medications in a Pediatric Renal Clinic: Psychological Aspects	PLOS ONE			English	Article							IMPROVE ADHERENCE; CHRONIC ILLNESS; ADOLESCENTS; CHILDREN; THERAPY; INTERVENTIONS; NONADHERENCE; DISEASES; BELIEFS; HIV	Background: Chronically ill children and adolescents comprise a vulnerable population that requires specific considerations in order to positively impact their treatment outcome. Pediatric renal patients can be non-compliant and also forgetful in taking their medications. Objective: The objectives of the study were to (a) assess medication adherence and (b) to identify emotionality and variables that influence non-adherence by use of "The Child & Adolescent Adherence to Medication Questionnaire" (CAAMQ), which was constructed at Texas Tech University Health Sciences Center. Methods: Pediatric renal patients from 10 to 21 years-of-age, taking three or more medications, for longer than a three-month period, were eligible to complete the CAAMQ. Results: Thirty-four patients participated in the study. Many of the respondents had problems remembering to take their medications on weekends (P = 0.021). The majority of the patients stated that they were not bothered about having to take their medications (70.6%); and that taking pills did not interfere with their daily activities (85.3%). Open-ended questions in the CAAMQ identified patients' feelings of sadness, distress, and the importance of strong family support systems. The study participants reported that they preferred to take their medications at school, in the nurses' office or in a place where privacy was assured. The results indicated that Prednisone was the most disliked of all of the medications. Female patients were more reactive and secretive than males regarding peers knowing about their disease and medication schedules (P<0.017). Conclusions: Non-adherence in pediatric patients is a complex and serious problem, which ultimately affects the patients' health. Privacy and daily routine were found to impact the patients' adherence to medications. Creative and individualized reminders for teenagers need to be developed and validated. Further studies that take into consideration developmental and motivational factors may help researchers identify modifiable psychosocial predictors that will lead to improved medication adherence.	[Vasylyeva, Tetyana L.; Singh, Ruchi; Sheehan, Christopher; Chennasamudram, Sudha P.] Texas Tech Univ, Hlth Sci Ctr Amarillo, Dept Pediat, Amarillo, TX USA; [Hernandez, Anne P.] Texas Tech Univ, Dept Educ Psychol & Leadership, Lubbock, TX 79409 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Texas Tech University System; Texas Tech University	Vasylyeva, TL (corresponding author), Texas Tech Univ, Hlth Sci Ctr Amarillo, Dept Pediat, Amarillo, TX USA.	tetyana.vasylyeva@ttuhsc.edu	Vasylyeva, Tetyana/ABB-8957-2020	Vasylyeva, Tetyana L./0000-0003-3236-985X				Bain-Brickley D, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009513; Barner JC, 2011, CURR MED RES OPIN, V27, P13, DOI 10.1185/03007995.2011.603303; Bell L, 2007, NEPHROL DIAL TRANSPL, V22, P988, DOI 10.1093/ndt/gfl770; Bender B, 2008, J ALLERGY CLIN IMMUN, V122, P490, DOI 10.1016/j.jaci.2008.05.041; Bhattacharya M, 2011, ANN TROP PAEDIATR, V31, P331, DOI 10.1179/1465328111Y.0000000031; Bugni VM, 2012, J PEDIAT-BRAZIL, V88, P483, DOI [10.2223/JPED.2227, 10.1590/S0021-75572012000600007]; Butz Arlene M, 2006, J Pediatr Health Care, V20, P338, DOI 10.1016/j.pedhc.2006.05.003; Cecka J M, 1997, Pediatr Transplant, V1, P55; Chisholm-Burns MA, 2009, AM J TRANSPLANT, V9, P2497, DOI 10.1111/j.1600-6143.2009.02793.x; De Geest Sabina, 2003, Eur J Cardiovasc Nurs, V2, P323; Dean AJ, 2010, ARCH DIS CHILD, V95, P717, DOI 10.1136/adc.2009.175125; Ettenger R, 2008, AD KIDN TRANSPL DOES; Fiese BH, 2006, CURR OPIN PEDIATR, V18, P551, DOI 10.1097/01.mop.0000245357.68207.9b; Gerson ACSD, 2007, PAS ANN M TOR CAN; Griva K, 2012, ANN BEHAV MED, V44, P85, DOI 10.1007/s12160-012-9359-4; Hsiau M, 2011, TRANSPLANTATION, V92, P918, DOI 10.1097/TP.0b013e31822dc34f; Jellinek M S, 1998, Pediatr Rev, V19, P255, DOI 10.1542/pir.19-8-255; Kimmel PL, 2003, AM J KIDNEY DIS, V42, P713, DOI 10.1016/S0272-6386(03)00907-7; Koneru S, 2008, JCR-J CLIN RHEUMATOL, V14, P195, DOI 10.1097/RHU.0b013e31817a242a; Kyngas HA, 2000, J ADOLESCENT HEALTH, V26, P379, DOI 10.1016/S1054-139X(99)00042-7; MacDonell K, 2013, AIDS BEHAV, V17, P86, DOI 10.1007/s10461-012-0364-1; Marx G, 2011, PATIENT EDUC COUNS, V85, P468, DOI 10.1016/j.pec.2011.04.011; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Smith BA, 2005, CURR OPIN PEDIATR, V17, P613, DOI 10.1097/01.mop.0000176443.26872.6e; Tucker CM, 2002, PEDIATR NEPHROL, V17, P251, DOI 10.1007/s00467-001-0806-x; Vervloet M, 2012, INT J MED INFORM, V81, P594, DOI 10.1016/j.ijmedinf.2012.05.005; Vitolins MZ, 2000, CONTROL CLIN TRIALS, V21, p188S, DOI 10.1016/S0197-2456(00)00077-5; Wassner SJ, 1994, CONSERVATIVE MANAGEM, P1314; Zedler BK, 2011, CLIN THER, V33, P62, DOI 10.1016/j.clinthera.2011.02.003; Zerah L, 2012, REV MED INTERNE, V33, P300, DOI 10.1016/j.revmed.2012.02.001	30	10	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e69060	10.1371/journal.pone.0069060	http://dx.doi.org/10.1371/journal.pone.0069060			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	214PM	23874868	Green Published, Green Submitted, gold			2022-12-27	WOS:000324146200053
J	Kim, SU; Song, KJ; Chang, HY; Shin, EC; Park, JY; Kim, DY; Han, KH; Chon, CY; Ahn, SH				Kim, Seung Up; Song, Ki Jun; Chang, Hye Young; Shin, Eui-Cheol; Park, Jun Yong; Kim, Do Young; Han, Kwang-Hyub; Chon, Chae Yoon; Ahn, Sang Hoon			Association between IL28B Polymorphisms and Spontaneous Clearance of Hepatitis B Virus Infection	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENETIC-VARIATION; C VIRUS; INTERFERON-LAMBDA; REPLICATION; EXPRESSION; THERAPY; ALPHA	Background/Aims: Single-nucleotide polymorphisms (SNPs) near the interleukin 28B gene (IL28B; interferon [IFN]-lambda-3) are associated with outcomes of chronic hepatitis C virus (HCV) and hepatitis B virus (HBV) infection treated with peginterferon (PEG-IFN) alpha-based antiviral therapy. In this study, we investigated the influence of IL28B polymorphisms on spontaneous clearance of HBV infection in a large Korean cohort. Methods: Between January 2007 and June 2010, a total of 208 patients with chronic HBV infection and newly diagnosed HBV-related hepatocellular carcinoma were recruited as the CC group [HBsAg(+) for >6 months, anti-HBc(+), and anti-HBs()]. In addition, 351 organ donors were stratified into the UE group [n = 106; HBsAg(-), anti-HBc(-), and anti-HBs(-)] or the SC group [n = 245; HBsAg(-), anti-HBc(+), and anti-HBs(+)]. The SNaPshot ddNTP Primer Extension Kit (Applied Biosystems, Foster City, CA) was used for SNP detection. Direct full sequencing of the IL28B coding region was attempted. Results: Regardless of group, rs12979860 CC was most frequently identified (85.0% in UE, 85.9% in SC, and 93.5% in CC, respectively), whereas rs12979860 TT was not identified in any group. Similarly, rs12980275 AA and rs8099917 TT were most frequently identified (>= 85%) regardless of group, whereas rs12980275 GG was identified in only one subject in the SC group. In addition, rs8099917 GG was not identified. The prevalences of CC in rs12979860, AA in rs12980275, and TT in rs8099917 were significantly higher in the CC group when compared with the UE and SC group (all P<0.05). Among 19 novel SNPs in the IL28B coding region, the proportions of 6 SNPs were significantly different among the UE, SC, and CC groups (all P<0.05). Conclusions: The SNP upstream of IL28B that has the strongest genetic association with HCV recovery has an inverse influence on HBV recovery. Additional studies are needed to understand the mechanisms of this SNP in HBV infection.	[Kim, Seung Up; Chang, Hye Young; Park, Jun Yong; Kim, Do Young; Han, Kwang-Hyub; Chon, Chae Yoon; Ahn, Sang Hoon] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Seung Up; Park, Jun Yong; Kim, Do Young; Han, Kwang-Hyub; Chon, Chae Yoon; Ahn, Sang Hoon] Yonsei Univ, Coll Med, Inst Gastroenterol, Seoul, South Korea; [Song, Ki Jun] Yonsei Univ, Coll Med, Dept Biostat, Seoul, South Korea; [Kim, Seung Up; Song, Ki Jun; Park, Jun Yong; Kim, Do Young; Han, Kwang-Hyub; Chon, Chae Yoon; Ahn, Sang Hoon] Liver Cirrhosis Clin Res Ctr, Seoul, South Korea; [Han, Kwang-Hyub; Ahn, Sang Hoon] Brain Korea 21 Project Med Sci, Seoul, South Korea; [Shin, Eui-Cheol] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Lab Immunol & Infect Dis, Taejon 305701, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Korea Advanced Institute of Science & Technology (KAIST)	Ahn, SH (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	ahnsh@yuhs.ac	Park, Jun Yong/H-7127-2019; Shin, Eui-Cheol/C-1690-2011	Shin, Eui-Cheol/0000-0002-6308-9503; Park, Jun Yong/0000-0001-6324-2224; Song, Ki Jun/0000-0003-2505-4112; Kim, Seung Up/0000-0002-9658-8050; Ahn, Sang Hoon/0000-0002-3629-4624; Han, Kwang-Hyub/0000-0003-3960-6539	Liver Cirrhosis Clinical Research Center; Korea Healthcare Technology R & D project, Ministry of Health and Welfare, Republic of Korea [A102065]; Yonsei Liver Blood Bank (YLBB); Sanofi-aventis Korea; Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A101923]	Liver Cirrhosis Clinical Research Center; Korea Healthcare Technology R & D project, Ministry of Health and Welfare, Republic of Korea; Yonsei Liver Blood Bank (YLBB); Sanofi-aventis Korea(Sanofi-Aventis); Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This study was supported by the Liver Cirrhosis Clinical Research Center, in part by a grant from the Korea Healthcare Technology R & D project, Ministry of Health and Welfare, Republic of Korea (no. A102065), and by the Yonsei Liver Blood Bank (YLBB), in part by a grant from Sanofi-aventis Korea. This study was also supported by a grant of the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A101923). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ank N, 2006, J INTERF CYTOK RES, V26, P373, DOI 10.1089/jir.2006.26.373; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Guidotti LG, 2002, J VIROL, V76, P2617, DOI 10.1128/JVI.76.6.2617-2621.2002; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; Hong SH, 2007, VIRUS RES, V126, P245, DOI 10.1016/j.virusres.2007.03.006; Lampertico P, 2012, HEPATOLOGY      0402, V2, DOI [10.1002/hep.25749, DOI 10.1002/HEP.25749.[]; Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052; Martin MP, 2010, J INFECT DIS, V202, P1749, DOI 10.1086/657146; Morrow MP, 2009, BLOOD, V113, P5868, DOI 10.1182/blood-2008-11-190520; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Robek MD, 2005, J VIROL, V79, P3851, DOI 10.1128/JVI.79.6.3851-3854.2005; Sonneveld MJ, 2012, GASTROENTEROLOGY, V142, P513, DOI 10.1053/j.gastro.2011.11.025; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Tillmann HL, 2010, GASTROENTEROLOGY, V139, P1586, DOI 10.1053/j.gastro.2010.07.005; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; Wieland SF, 2005, J VIROL, V79, P9369, DOI 10.1128/JVI.79.15.9369-9380.2005	18	18	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e69166	10.1371/journal.pone.0069166	http://dx.doi.org/10.1371/journal.pone.0069166			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23874902	Green Submitted, Green Published, gold			2022-12-27	WOS:000322000600045
J	Liu, N; Zhang, L; Zhou, HK; Zhang, ML; Yan, X; Wang, Q; Long, YH; Xie, L; Wang, SY; Huang, YP; Zhou, ZH				Liu, Ning; Zhang, Lei; Zhou, Haokui; Zhang, Meiling; Yan, Xing; Wang, Qian; Long, Yanhua; Xie, Lei; Wang, Shengyue; Huang, Yongping; Zhou, Zhihua			Metagenomic Insights into Metabolic Capacities of the Gut Microbiota in a Fungus-Cultivating Termite (Odontotermes yunnanensis)	PLOS ONE			English	Article							MACROTERMES-MICHAELSENI SJOSTEDT; CELL-WALL; GROWING TERMITES; SYMBIOTIC FUNGUS; BACTERIAL DIVERSITY; LIGNIN DEGRADATION; INTESTINAL-TRACT; COMMUNITIES; FORMOSANUS; ISOPTERA	Macrotermitinae (fungus-cultivating termites) are major decomposers in tropical and subtropical areas of Asia and Africa. They have specifically evolved mutualistic associations with both a Termitomyces fungi on the nest and a gut microbiota, providing a model system for probing host-microbe interactions. Yet the symbiotic roles of gut microbes residing in its major feeding caste remain largely undefined. Here, by pyrosequencing the whole gut metagenome of adult workers of a fungus-cultivating termite (Odontotermes yunnanensis), we showed that it did harbor a broad set of genes or gene modules encoding carbohydrate-active enzymes (CAZymes) relevant to plant fiber degradation, particularly debranching enzymes and oligosaccharide-processing enzymes. Besides, it also contained a considerable number of genes encoding chitinases and glycoprotein oligosaccharide-processing enzymes for fungal cell wall degradation. To investigate the metabolic divergence of higher termites of different feeding guilds, a SEED subsystem-based gene-centric comparative analysis of the data with that of a previously sequenced wood-feeding Nasutitermes hindgut microbiome was also attempted, revealing that SEED classifications of nitrogen metabolism, and motility and chemotaxis were significantly overrepresented in the wood-feeder hindgut metagenome, while Bacteroidales conjugative transposons and subsystems related to central aromatic compounds metabolism were apparently overrepresented here. This work fills up our gaps in understanding the functional capacities of fungus-cultivating termite gut microbiota, especially their roles in the symbiotic digestion of lignocelluloses and utilization of fungal biomass, both of which greatly add to existing understandings of this peculiar symbiosis.	[Liu, Ning; Wang, Qian; Xie, Lei; Huang, Yongping] Chinese Acad Sci, Key Lab Insect Dev & Evolutionary Biol, Inst Plant Physiol & Ecol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Zhang, Lei; Yan, Xing; Zhou, Zhihua] Chinese Acad Sci, Key Lab Synthet Biol, Inst Plant Physiol & Ecol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Zhou, Haokui] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Dept Microbiol, Shatin, Hong Kong, Peoples R China; [Zhang, Meiling] E China Normal Univ, Coll Life Sci, Dept Biochem & Mol Biol, Shanghai 200062, Peoples R China; [Long, Yanhua] Anhui Agr Univ, Coll life Sci, Dept Biochem, Hefei, Peoples R China; [Wang, Shengyue] Chinese Natl Human Genome Ctr Shanghai, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese University of Hong Kong; Prince of Wales Hospital; East China Normal University; Anhui Agricultural University	Zhou, ZH (corresponding author), Chinese Acad Sci, Key Lab Synthet Biol, Inst Plant Physiol & Ecol, Shanghai Inst Biol Sci, Shanghai, Peoples R China.	zhouzhihua@sippe.ac.cn	Zhang, Meiling/AEQ-4299-2022		Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-G-13-1]; National Basic Research Program of China (973 Program) [2011CB707403]; National Natural Science Foundation of China [30900150, 31172153]	Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-G-13-1), National Basic Research Program of China (973 Program) (2011CB707403) and the National Natural Science Foundation of China (30900150 and 31172153). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanen DK, 2006, BIOL LETT-UK, V2, P209, DOI 10.1098/rsbl.2005.0424; Adams DJ, 2004, MICROBIOL-SGM, V150, P2029, DOI 10.1099/mic.0.26980-0; ANKLINMUHLEMANN R, 1995, J INSECT PHYSIOL, V41, P929, DOI 10.1016/0022-1910(95)00062-Y; Aylward F., 2012, ISME J, P1; Bagiyan FG, 1997, EUR J BIOCHEM, V249, P286, DOI 10.1111/j.1432-1033.1997.t01-1-00286.x; Bignell DE, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P363; Bowman SM, 2006, BIOESSAYS, V28, P799, DOI 10.1002/bies.20441; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; BRUNE A, 1995, APPL ENVIRON MICROB, V61, P2688, DOI 10.1128/AEM.61.7.2688-2695.1995; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Duan J, 1999, Zhong Yao Cai, V22, P489; Fontaine T, 2000, J BIOL CHEM, V275, P27594; Gooday GW, 1990, BIODEGRADATION, V1, P177, DOI 10.1007/BF00058835; Hongoh Y, 2006, MOL ECOL, V15, P505, DOI 10.1111/j.1365-294X.2005.02795.x; Hongoh Y, 2005, APPL ENVIRON MICROB, V71, P6590, DOI 10.1128/AEM.71.11.6590-6599.2005; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Hyodo F, 2000, SOIL BIOL BIOCHEM, V32, P653, DOI 10.1016/S0038-0717(99)00192-3; Hyodo F, 2003, FUNCT ECOL, V17, P186, DOI 10.1046/j.1365-2435.2003.00718.x; Johjima T, 2006, APPL MICROBIOL BIOT, V73, P195, DOI 10.1007/s00253-006-0570-8; KIRSHTEIN JD, 1991, APPL ENVIRON MICROB, V57, P2645, DOI 10.1128/AEM.57.9.2645-2650.1991; Kohler T, 2012, APPL ENVIRON MICROB, V78, P4691, DOI 10.1128/AEM.00683-12; Kollar R, 1997, J BIOL CHEM, V272, P17762, DOI 10.1074/jbc.272.28.17762; Latge JP, 2007, MOL MICROBIOL, V66, P279, DOI 10.1111/j.1365-2958.2007.05872.x; Latge JP, 2010, CELL MICROBIOL, V12, P863, DOI 10.1111/j.1462-5822.2010.01474.x; Li HJ, 2012, J INSECT PHYSIOL, V58, P1368, DOI 10.1016/j.jinsphys.2012.07.012; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Liu N, 2011, APPL ENVIRON MICROB, V77, P48, DOI 10.1128/AEM.01521-10; Long YH, 2010, INSECT SCI, V17, P265, DOI 10.1111/j.1744-7917.2010.01327.x; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Mackenzie LM, 2007, AFR J BIOTECHNOL, V6, P658; Muller J, 2010, NUCLEIC ACIDS RES, V38, pD190, DOI 10.1093/nar/gkp951; Ngugi DK, 2007, J BASIC MICROB, V47, P87, DOI 10.1002/jobm.200610142; Nobre T, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P193, DOI 10.1007/978-90-481-3977-4_8; Ohkuma M, 2004, MOL PHYLOGENET EVOL, V31, P701, DOI 10.1016/j.ympev.2003.09.009; Ohkuma M, 2003, APPL MICROBIOL BIOT, V61, P1, DOI 10.1007/s00253-002-1189-z; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pan CY, 2009, SOCIOBIOLOGY, V53, P177; Park BH, 2010, GLYCOBIOLOGY, V20, P1574, DOI 10.1093/glycob/cwq106; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Pope PB, 2010, P NATL ACAD SCI USA, V107, P14793, DOI 10.1073/pnas.1005297107; ROULAND C, 1991, COMP BIOCHEM PHYS A, V99, P657, DOI 10.1016/0300-9629(91)90146-4; Rouland-Lefevre C, 2002, CELL OR EX, V4, P731; Rouland-Lefevre C, 2006, SOIL BIOL, P335; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Shinzato N, 2007, BIOSCI BIOTECH BIOCH, V71, P906, DOI 10.1271/bbb.60540; Suen G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001129; Taprab Y, 2005, APPL ENVIRON MICROB, V71, P7696, DOI 10.1128/AEM.71.12.7696-7704.2005; Thompson JR, 2002, NUCLEIC ACIDS RES, V30, P2083, DOI 10.1093/nar/30.9.2083; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; YARA K, 1989, SOCIOBIOLOGY, V15, P247; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996; Zhou XG, 2008, PESTIC BIOCHEM PHYS, V90, P31, DOI 10.1016/j.pestbp.2007.07.011; 劳燕文, 2004, [氨基酸和生物资源, Amino acids & biotic resources], V26, P14	60	58	63	4	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e69184	10.1371/journal.pone.0069184	http://dx.doi.org/10.1371/journal.pone.0069184			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23874908	gold, Green Submitted, Green Published			2022-12-27	WOS:000322000600046
J	McDonald, DC; Carlson, KE				McDonald, Douglas C.; Carlson, Kenneth E.			Estimating the Prevalence of Opioid Diversion by "Doctor Shoppers'' in the United States	PLOS ONE			English	Article							PRESCRIPTION MONITORING PROGRAMS; CHRONIC NONCANCER PAIN; GEOGRAPHIC-VARIATION; AMERICAN SOCIETY; ANALGESICS; ABUSE; GUIDELINES; KNOWLEDGE; ATTITUDES; PATTERNS	Background: Abuse of prescription opioid analgesics is a serious threat to public health, resulting in rising numbers of overdose deaths and admissions to emergency departments and treatment facilities. Absent adequate patient information systems, "doctor shopping'' patients can obtain multiple opioid prescriptions for nonmedical use from different unknowing physicians. Our study estimates the prevalence of doctor shopping in the US and the amounts and types of opioids involved. Methods and Findings: The sample included records for 146.1 million opioid prescriptions dispensed during 2008 by 76% of US retail pharmacies. Prescriptions were linked to unique patients and weighted to estimate all prescriptions and patients in the nation. Finite mixture models were used to estimate different latent patient populations having different patterns of using prescribers. On average, patients in the extreme outlying population (0.7% of purchasers), presumed to be doctor shoppers, obtained 32 opioid prescriptions from 10 different prescribers. They bought 1.9% of all opioid prescriptions, constituting 4% of weighed amounts dispensed. Conclusions: Our data did not provide information to make a clinical diagnosis of individuals. Very few of these patients can be classified with certainty as diverting drugs for nonmedical purposes. However, even patients with legitimate medical need for opioids who use large numbers of prescribers may signal dangerously uncoordinated care. To close the information gap that makes doctor shopping and uncoordinated care possible, states have created prescription drug monitoring programs to collect records of scheduled drugs dispensed, but the majority of physicians do not access this information. To facilitate use by busy practitioners, most monitoring programs should improve access and response time, scan prescription data to flag suspicious purchasing patterns and alert physicians and pharmacists. Physicians could also prevent doctor shopping by adopting procedures to screen new patients for their risk of abuse and to monitor patients' adherence to prescribed treatments.	[McDonald, Douglas C.; Carlson, Kenneth E.] ABT Associates Inc, US Hlth Div, Cambridge, MA 02138 USA	ABT Associates	McDonald, DC (corresponding author), ABT Associates Inc, US Hlth Div, Cambridge, MA 02138 USA.	doug_mcdonald@abtassoc.com			Office of the Director, National Institutes of Health, National Institute on Drug Abuse [RC2 DA028920]; NATIONAL INSTITUTE ON DRUG ABUSE [RC2DA028920] Funding Source: NIH RePORTER	Office of the Director, National Institutes of Health, National Institute on Drug Abuse; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by grant RC2 DA028920 awarded to Abt Associates Inc. by the Office of the Director, National Institutes of Health, National Institute on Drug Abuse (http://www.drugabuse.gov). Prescription LRx Data, 2008 was obtained by Abt Associates under license from IMS Health Incorporated; all rights reserved. County location of prescribers' offices obtained from Physician Professional Data, 2008, American Medical Association; all rights reserved. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buurma H, 2008, J CLIN PHARM THER, V33, P17, DOI 10.1111/j.1365-2710.2008.00878.x; Campbell J, 1996, PRESIDENTIAL ADDRESS; Cepeda M, 2012, DRUG SAFETY, V35, P9; Cepeda MS, 2012, J CLIN PHARM; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Cicero TJ, 2007, PHARMACOEPIDEM DR S, V16, P827, DOI 10.1002/pds.1452; Curtis LH, 2006, HEALTH SERV RES, V41, P837, DOI 10.1111/j.1475-6773.2006.00511.x; Curtis LH, 2006, HEALTH SERV RES, V41, P856, DOI 10.1111/j.1475-6773.2006.00573.x; Deb P, 2012, ECONPAPERS; Drug Enforcement Administration, CONTR SUBST AGGR PRO; Drug Enforcement Administration, 2008, AUT REP CONS ORD SYS; Drug Enforcement Administration, 1997, AUT REP CONS ORD SYS; *FED STAT MED BOAR, 2004, MOD POL US CONTR SUB; Federation of State Medical Boards of the United States, 1998, MOD GUID US CONTR SU; Fishman SM, 2004, PAIN MED, V5, P309, DOI 10.1111/j.1526-4637.2004.04049.x; Fishman SM, 2007, RESPONSIBLE OPIOID P; Food and Drug Administration, 2012, FDA BRIEF DOC; Hall AJ, 2008, JAMA-J AM MED ASSOC, V300, P2613, DOI 10.1001/jama.2008.802; Institute of Medicine, 2011, REL PAIN AM BLUEPR T; Katz N, 2010, PHARMACOEPIDEM DR S, V19, P115, DOI 10.1002/pds.1878; Lebovits AH, 1997, CLIN J PAIN, V13, P237, DOI 10.1097/00002508-199709000-00009; Lembke A, 2012, NEW ENGL J MED, V367, P1580, DOI 10.1056/NEJMp1208498; Manchikanti L, 2000, Pain Physician, V3, P7; Manchikanti L, 2008, PAIN PHYSICIAN, V79, P1031; Manchikanti Laxmaiah, 2005, Pain Physician, V8, P335; Manchikanti L, 2012, PAIN PHYSICIAN, V15, pS1; McDonald DC, 2012, J PAIN, V13, P988, DOI 10.1016/j.jpain.2012.07.007; McLachlan G., 2000, WILEY SER PROB STAT; National Alliance For Model State Drug Laws, 2012, STAT REQ PRESCR DISP; National Alliance for Model State Drug Laws, 2013, STAT REQ ID REC PRIO; New York State Office of the Attorney General, 2013, AG SCHNEID AL MED PR; Office of National Drug Control Policy, 2012, ADAM 2 2011 ANN REP; Parente ST, 2004, AM J MANAG CARE, V10, P783; Paulozzi LJ, 2006, AM J PREV MED, V31, P506, DOI 10.1016/j.amepre.2006.08.017; Paulozzi LJ, 2011, MMWR MORB MORTAL WKL, V60; Peirce GL, 2012, MED CARE, V50, P494, DOI 10.1097/MLR.0b013e31824ebd81; Pergolizzi Joseph, 2008, Pain Pract, V8, P287, DOI 10.1111/j.1533-2500.2008.00204.x; Pradel V, 2009, PHARMACOEPIDEM DR S, V18, P36, DOI 10.1002/pds.1681; Rigg KK, 2012, DRUG-EDUC PREV POLIC, V19, P145, DOI 10.3109/09687637.2011.631197; Rigg KK, 2010, J DRUG ISSUES, V40, P681, DOI 10.1177/002204261004000307; Simoni-Wastila L, 2004, CLIN THER, V26, P322, DOI 10.1016/S0149-2918(04)90030-6; *SUBST AB MENT HLT, 2003, EM DEP TRENDS DRUG A; Substance Abuse and Mental Health Services Administration, 2011, DRUG AB WARN NETW 20; Substance Abuse and Mental Health Services Administration, 2012, RES 2010 NAT SURV DR; Substance Abuse and Mental Health Services Administration, 2010, RES 2009 NAT SURV DR, VII; Substance Abuse and Mental Health Services Administration, 2012, TREATM EP DAT SET TE; Substance Abuse and Mental Health Services Administration Center for Behavioral Health Statistics and Quality, 2013, DAWN REP HIGHL 2011; Substance Abuse and Mental Health Services Administration Center for Behavioral Health Statistics and Quality, 2011, DAWN REP ILL DRUG RE; Substance Abuse and Mental Health Services Administration & Center for Behavioral Health Statistics and Quality (Producer), 2011, RES 2010 NAT SURV DR; Substance Abuse and Mental Health Services Administration Office of Applied Studies, 2009, TREATM EP DAT SET TE; The MTTRE Corporation, 2012, ENH ACC PRESCR DRUG; Trescot AM, 2008, PAIN PHYSICIAN, V11, pS5; Trescot Andrea M, 2006, Pain Physician, V9, P1; United Nations Office on Drugs and Crime, 2011, WORLD DRUG REP 2011; Von Korff M, 2008, PAIN, V138, P267, DOI 10.1016/j.pain.2007.12.010; Warner M, 2011, DRUG POISONING DEATH; White AG, 2009, AM J MANAG CARE, V15, P897; Wilsey BL, 2010, DRUG ALCOHOL DEPEN, V112, P99, DOI 10.1016/j.drugalcdep.2010.05.007; Wilsey BL, 2011, PHARMACOEPIDEM DR S, V20, P1262, DOI 10.1002/pds.2129; Wolfert MZ, 2010, PAIN MED, V11, P425, DOI 10.1111/j.1526-4637.2009.00761.x; Zacny J, 2003, DRUG ALCOHOL DEPEN, V69, P215, DOI 10.1016/S0376-8716(03)00003-6; Zee AV, 2009, AM J PUBLIC HEALTH, V99, P221, DOI 10.2105/AJPH.2007.131714	62	72	72	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e69241	10.1371/journal.pone.0069241	http://dx.doi.org/10.1371/journal.pone.0069241			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	185WH	23874923	Green Published, gold, Green Submitted			2022-12-27	WOS:000322000600048
J	Stylianides, GA; Dalleau, G; Begon, M; Rivard, CH; Allard, P				Stylianides, Georgios A.; Dalleau, Georges; Begon, Mickael; Rivard, Charles-Hilaire; Allard, Paul			Pelvic Morphology, Body Posture and Standing Balance Characteristics of Adolescent Able-Bodied and Idiopathic Scoliosis Girls	PLOS ONE			English	Article							GAIT; INSTRUMENTATION; SEVERITY	The purpose of this study was to determine how pelvic morphology, body posture, and standing balance variables of scoliotic girls differ from those of able-bodied girls, and to classify neuro-biomechanical variables in terms of a lower number of unobserved variables. Twenty-eight scoliotic and twenty-five non-scoliotic able-bodied girls participated in this study. 3D coordinates of ten anatomic body landmarks were used to describe pelvic morphology and trunk posture using a Flock of Birds system. Standing balance was measured using a force plate to identify the center of pressure (COP), and its anteroposterior (AP) and mediolateral (ML) displacements. A multivariate analysis of variance (MANOVA) was performed to determine differences between the two groups. A factor analysis was used to identify factors that best describe both groups. Statistical differences were identified between the groups for each of the parameter types. While spatial orientation of the pelvis was similar in both groups, five of the eight trunk postural variables of the scoliotic group were significantly different that the able-bodied group. Also, five out of the seven standing balance variables were higher in the scoliotic girls. Approximately 60% of the variation is supported by 4 factors that can be associated with a set of variables; standing balance variables (factor 1), body posture variables (factor 2), and pelvic morphology variables (factors 3 and 4). Pelvic distortion, body posture asymmetry, and standing imbalance are more pronounced in scoliotic girls, when compared to able-bodied girls. These findings may be beneficial when addressing balance and ankle proprioception exercises for the scoliotic population.	[Stylianides, Georgios A.] Towson Univ, Dept Kinesiol, Towson, MD USA; [Dalleau, Georges] Univ Reunion, CURAPS DIMPS, Fac Sci Homme & Environm, Le Tampon, France; [Begon, Mickael; Allard, Paul] Univ Montreal, Dept Kinesiol, Montreal, PQ, Canada; [Rivard, Charles-Hilaire; Allard, Paul] Hop St Justine, Human Movement Lab, Res Ctr, Montreal, PQ H3T 1C5, Canada; [Rivard, Charles-Hilaire] Hop St Justine, Dept Orthoped Surg, Montreal, PQ H3T 1C5, Canada	University System of Maryland; Towson University; University of La Reunion; Universite de Montreal; Universite de Montreal; Universite de Montreal	Stylianides, GA (corresponding author), Towson Univ, Dept Kinesiol, Towson, MD USA.	gstylianides@yahoo.com	BEGON, Mickael/M-9574-2013; Allard, Paul/ABA-3257-2021; Begon, Mickaël/AAH-9887-2019; Stylianides, Georgios/N-1858-2013	BEGON, Mickael/0000-0002-4107-9160; Begon, Mickaël/0000-0002-4107-9160; Stylianides, Georgios/0000-0001-8118-7783	Natural Science and Engineering Council of Canada (NSERC)	Natural Science and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this project was obtained from Natural Science and Engineering Council of Canada (NSERC). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard P, 2004, AM J PHYS MED REHAB, V83, P689, DOI 10.1097/01.PHM.0000137344.95784.15; Allard P, 2001, ANN HUM BIOL, V28, P624, DOI 10.1080/03014460110047946; Astephen JL, 2008, J BIOMECH, V41, P868, DOI 10.1016/j.jbiomech.2007.10.016; Beaulieu M, 2010, AM J PHYS MED REHAB, V89, P809, DOI 10.1097/PHM.0b013e3181f1b4af; BELLEFLEUR C, 1994, ANN CHIR, V48, P723; Bruyneel AV, 2009, EUR SPINE J, V18, P188, DOI 10.1007/s00586-008-0864-x; BUNNELL WP, 1986, SPINE, V11, P773, DOI 10.1097/00007632-198610000-00003; Burwell R G, 1992, Acta Orthop Belg, V58 Suppl 1, P33; Dalleau G, 2011, EUR SPINE J, V20, P123, DOI 10.1007/s00586-010-1554-z; Dalleau G, 2007, EUR SPINE J, V16, P1593, DOI 10.1007/s00586-007-0404-0; Dalleau G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036755; Deluzio KJ, 1997, HUM MOVEMENT SCI, V16, P201, DOI 10.1016/S0167-9457(96)00051-6; Farenc I, 2003, ANN HUM BIOL, V30, P279, DOI 10.1080/0301446031000068842; Gauchard GC, 2001, SPINE, V26, P1052, DOI 10.1097/00007632-200105010-00014; Goldberg CJ, 2001, SPINE, V26, P42, DOI 10.1097/00007632-200101010-00009; Haumont T, 2011, SPINE, V36, pE847, DOI 10.1097/BRS.0b013e3181ff5837; HOLLAND BS, 1988, PSYCHOL BULL, V104, P145, DOI 10.1037/0033-2909.104.1.145; Joliffe I T, 1992, Stat Methods Med Res, V1, P69, DOI 10.1177/096228029200100105; Kleinbaum DG, 1989, APPL REGRESSION ANAL; Mac-Thiong JM, 2007, EUR SPINE J, V16, P227, DOI 10.1007/s00586-005-0013-8; Mac-Thiong JM, 2003, SPINE, V28, P1404, DOI 10.1097/01.BRS.0000067118.60199.D1; Mahaudens P, 2009, EUR SPINE J, V18, P512, DOI 10.1007/s00586-009-0899-7; MAKI BE, 1994, J GERONTOL, V49, pM72, DOI 10.1093/geronj/49.2.M72; Masso PD, 2000, SPINE, V25, P457, DOI 10.1097/00007632-200002150-00011; Maurice B, 2011, EUR SPINE J, V20, P1780, DOI 10.1007/s00586-011-1899-y; McIlroy WE, 1997, CLIN BIOMECH, V12, P66, DOI 10.1016/S0268-0033(96)00040-X; Nault ML, 2002, SPINE, V27, P1911, DOI 10.1097/00007632-200209010-00018; Pasha S, 2010, SPINE, V35, pE820, DOI 10.1097/BRS.0b013e3181e6856d; Ramirez L, 2006, IEEE T INF TECHNOL B, V10, P84, DOI 10.1109/TITB.2005.855526; Roaf R, 1966, SCOLIOSIS; Sadeghi H, 2002, KNEE, V9, P47, DOI 10.1016/S0968-0160(01)00134-X; Sadeghi H, 2000, PHYS THER, V80, P1188, DOI 10.1093/ptj/80.12.1188; SAHLSTRAND T, 1978, ACTA ORTHOP SCAND, V49, P354, DOI 10.3109/17453677809050088; Sawatzky B, 1997, GAIT POSTURE, V5, P116, DOI 10.1016/S0966-6362(96)01081-8; Sharma S., 1996, APPL MULTIVARIATE TE; Silferi V, 2004, REV CHIR ORTHOP, V90, P215; Simoneau M, 2006, EXP BRAIN RES, V170, P576, DOI 10.1007/s00221-005-0246-0; Simoneau M, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-68; Stylianides GA, 2012, EUR SPINE J, V21, P725, DOI 10.1007/s00586-011-2070-5; Weinstein SL, 1989, PEDIAT SPINE PRINCIP, V1, P463; Weiss HR, 2006, SCOLIOSIS SPINAL DIS, V1, DOI [10.1186/1748-7161-1-5, 10.1186/1748-7161-1-1]; Weiss HR, 2010, SCOLIOSIS, V5, P5; Zabjek KF, 2005, CLIN BIOMECH, V20, P483, DOI 10.1016/j.clinbiomech.2005.01.003	43	13	14	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e70205	10.1371/journal.pone.0070205	http://dx.doi.org/10.1371/journal.pone.0070205			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23875021	gold, Green Submitted, Green Published			2022-12-27	WOS:000322000600064
J	Tornevi, A; Axelsson, G; Forsberg, B				Tornevi, Andreas; Axelsson, Gosta; Forsberg, Bertil			Association between Precipitation Upstream of a Drinking Water Utility and Nurse Advice Calls Relating to Acute Gastrointestinal Illnesses	PLOS ONE			English	Article							TURBIDITY; OUTBREAKS; RAINFALL; DISEASE; RISK	Background: The River Gota Alv is a source of fresh-water for the City of Gothenburg (Sweden). We recently identified a clear association between upstream precipitation and indicator bacteria concentrations in the river water outside the intake to the drinking water utility. This study aimed to determine if variation in the incidence of acute gastrointestinal illnesses is associated with upstream precipitation. Methods: We acquired data, covering 1494 days, on the daily number of telephone calls to the nurse advice line from citizens in Gothenburg living in areas with Gota Alv as a fresh-water supply. We separated calls relating to gastrointestinal illnesses from other medical concerns, and analyzed their association with precipitation using a distributed lag non-linear Poisson regression model, adjusting for seasonal patterns and covariates. We used a 0-21-day lag period for precipitation to account for drinking water delivery times and incubation periods of waterborne pathogens. Results: The study period contained 25,659 nurse advice calls relating to gastrointestinal illnesses. Heavy rainfall was associated with increased calls the same day and around 5-6 days later. Consecutive days of wet weather were also found to be associated with an increase in the daily number of gastrointestinal concerns. No associations were identified between precipitation and nurse advice calls relating to other medical concerns. Conclusion: An increase in nurse advice calls relating to gastrointestinal illnesses around 5-6 days after heavy rainfall is consistent with a hypothesis that the cause could be related to drinking water due to insufficient barriers in the drinking water production, suggesting the need for improved drinking water treatment.	[Tornevi, Andreas; Forsberg, Bertil] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Axelsson, Gosta] Univ Gothenburg, Dept Publ Hlth & Community Med, Gothenburg, Sweden	Umea University; University of Gothenburg	Tornevi, A (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden.	andreas.tornevi@envmed.umu.se			Swedish Water & Wastewater Association; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning	Swedish Water & Wastewater Association; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas)	The Swedish Water & Wastewater Association; The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astrom J, 2007, J WATER HEALTH, V5, P81, DOI 10.2166/wh.2007.139; CHIN J, 2000, CONTROL COMMUNICABLE; Curriero FC, 2001, AM J PUBLIC HEALTH, V91, P1194, DOI 10.2105/AJPH.91.8.1194; Delpla I, 2009, ENVIRON INT, V35, P1225, DOI 10.1016/j.envint.2009.07.001; DIEHL AK, 1981, SOUTHERN MED J, V74, P709, DOI 10.1097/00007611-198106000-00020; Drayna P, 2010, ENVIRON HEALTH PERSP, V118, P1439, DOI 10.1289/ehp.0901671; Egorov AI, 2003, INT J ENVIRON HEAL R, V13, P81, DOI 10.1080/0960312021000071567; Gasparrini A, 2010, STAT MED, V29, P2224, DOI 10.1002/sim.3940; Gilbert Marie-Line, 2006, Journal of Water and Health, V4, P225, DOI 10.2166/wh.2006.0019; Hunter PR, 2001, EMERG INFECT DIS, V7, P544; Morris RD, 1998, EPIDEMIOLOGY, V9, P264, DOI 10.1097/00001648-199805000-00009; Morris RD, 1996, AM J PUBLIC HEALTH, V86, P237, DOI 10.2105/AJPH.86.2.237; Naumova Elena N., 2005, Journal of Water and Health, V3, P185; Nichols G, 2009, J WATER HEALTH, V7, P1, DOI 10.2166/wh.2009.143; Payment P, 1999, CAN J MICROBIOL, V45, P709, DOI 10.1139/cjm-45-8-709; Reynolds KA, 2008, REV ENVIRON CONTAM T, V192, P117, DOI 10.1007/978-0-387-71724-1_4; Schwartz J, 2000, J EPIDEMIOL COMMUN H, V54, P45, DOI 10.1136/jech.54.1.45; Schwartz J, 1997, EPIDEMIOLOGY, V8, P615, DOI 10.1097/00001648-199710000-00001; Swedish Commission on Climate and Vulnerability, 2007, SWEDISH GOVERNMENTAL, V2007, P60; Team R, 2010, R LANG ENV STAT COMP; Thomas MK, 2006, INT J ENVIRON HEAL R, V16, P167, DOI 10.1080/09603120600641326; Tinker SC, 2010, J EXPO SCI ENV EPID, V20, P19, DOI 10.1038/jes.2008.68; Toljander J., 2012, Journal of Public Health and Epidemiology, V4, P30; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x	24	18	18	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e69918	10.1371/journal.pone.0069918	http://dx.doi.org/10.1371/journal.pone.0069918			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23875009	Green Published, gold, Green Submitted			2022-12-27	WOS:000322064300125
J	Jonsdottir-Buch, SM; Lieder, R; Sigurjonsson, OE				Jonsdottir-Buch, Sandra Mjoll; Lieder, Ramona; Sigurjonsson, Olafur Eysteinn			Platelet Lysates Produced from Expired Platelet Concentrates Support Growth and Osteogenic Differentiation of Mesenchymal Stem Cells	PLOS ONE			English	Article							FETAL BOVINE SERUM; SCALE EXPANSION; STROMAL CELLS; BONE-MARROW; CULTURE; ALTERNATIVES; SEROTONIN	Background: Mesenchymal stem cells are promising candidates in regenerative cell therapy. Conventional culture methods involve the use of animal substances, specifically fetal bovine serum as growth supplement. Since the use of animal-derived products is undesirable for human applications, platelet lysates produced from human platelets are an attractive alternative. This is especially true if platelet lysates from already approved transfusion units at blood banks can be utilized. The purpose of this study was to produce human platelet lysates from expired, blood bank-approved platelet concentrates and evaluate their use as growth supplement in the culture of mesenchymal stem cells. Methodology/Principal Findings: In this study, bone marrow-derived mesenchymal stem cells were cultured with one of three culture supplements; fetal bovine serum, lysates from freshly prepared human platelet concentrates, or lysates from expired human platelet concentrates. The effects of these platelet-derived culture supplements on basic mesenchymal stem cell characteristics were evaluated. All cultures maintained the typical mesenchymal stem cell surface marker expression, trilineage differentiation potential, and the ability to suppress in vitro immune responses. However, mesenchymal stem cells supplemented with platelet lysates proliferated faster than traditionally cultured cells and increased the expression of the osteogenic marker gene RUNX-2; yet no difference between the use of fresh and expired platelet concentrates was observed. Conclusion/Significance: Our findings suggest that human platelet lysates produced from expired platelet concentrates can be used as an alternative to fetal bovine serum for mesenchymal stem cell culture to the same extent as lysates from fresh platelets.	[Jonsdottir-Buch, Sandra Mjoll; Lieder, Ramona; Sigurjonsson, Olafur Eysteinn] Landspitali Univ Hosp, Blood Bank, REModel Lab, Reykjavik, Iceland; [Jonsdottir-Buch, Sandra Mjoll; Sigurjonsson, Olafur Eysteinn] Univ Iceland, Dept Biomed Sci, Fac Med, Reykjavik, Iceland; [Lieder, Ramona; Sigurjonsson, Olafur Eysteinn] Univ Reykjavik, Sch Sci & Engn, Reykjavik, Iceland	Landspitali National University Hospital; University of Iceland; University of Iceland	Sigurjonsson, OE (corresponding author), Landspitali Univ Hosp, Blood Bank, REModel Lab, Reykjavik, Iceland.	oes@landspitali.is	Sigurjonsson, Olafur/T-8190-2019	Sigurjonsson, Olafur/0000-0002-4968-842X; Jonsdottir-Buch, Sandra Mjoll/0000-0002-1845-5420	Landspitali University Hospital research fund	Landspitali University Hospital research fund	This work was supported by Landspitali University Hospital research fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nbaheen M, 2013, STEM CELL REV REP, V9, P32, DOI 10.1007/s12015-012-9365-8; Benisch P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045142; Bieback K, 2009, STEM CELLS, V27, P2331, DOI 10.1002/stem.139; Biousse V, 2003, J NEURO-OPHTHALMOL, V23, P50, DOI 10.1097/00041327-200303000-00011; Bliziotes M, 2010, J CLIN ENDOCR METAB, V95, P4124, DOI 10.1210/jc.2010-0861; Brinchmann JE, 2008, J NEUROL SCI, V265, P127, DOI 10.1016/j.jns.2007.05.006; Burnouf T, 2013, BLOOD REV, V27, P77, DOI 10.1016/j.blre.2013.02.001; Cholewa D, 2011, CELL TRANSPLANT, V20, P1409, DOI 10.3727/096368910X557218; Colnot C, 2011, TISSUE ENG PART B-RE, V17, P449, DOI [10.1089/ten.teb.2011.0243, 10.1089/ten.TEB.2011.0243]; Daubert EA, 2010, TRENDS NEUROSCI, V33, P424, DOI 10.1016/j.tins.2010.05.005; de Leon JM, 2011, ADV SKIN WOUND CARE, V24, P357, DOI 10.1097/01.ASW.0000403249.85131.6f; Dumont LJ, 2003, TRANSFUSION, V43, P143, DOI 10.1046/j.1537-2995.2003.00286.x; Eriksen EF, 2010, REV ENDOCR METAB DIS, V11, P219, DOI 10.1007/s11154-010-9153-1; Even MS, 2006, TRENDS BIOTECHNOL, V24, P105, DOI 10.1016/j.tibtech.2006.01.001; Vallone VBF, 2013, DIFFERENTIATION, V85, P1, DOI 10.1016/j.diff.2012.08.004; Filardo G, 2013, KNEE SURG SPORT TR A, DOI [10.1007/s00167-012-2329-3, DOI 10.1007/S00167-012-2329-3.27]; Freireich EJ, 2011, TRANSFUS MED REV, V25, P252, DOI 10.1016/j.tmrv.2011.01.003; Gerdoni E, 2007, ANN NEUROL, V61, P219, DOI 10.1002/ana.21076; Gustafsson BI, 2006, J CELL BIOCHEM, V98, P139, DOI 10.1002/jcb.20734; Hao L, 2012, INT J HEMATOL, V95, P34, DOI 10.1007/s12185-011-0991-8; Harmening DM, 2009, CLIN HEMATOLOGY FUND, P543; Horn P, 2010, CYTOTHERAPY, V12, P888, DOI 10.3109/14653249.2010.501788; Jimi E, 2012, INT J DENT, V2012, DOI 10.1155/2012/148261; Le Blanc K, 2007, J INTERN MED, V262, P509, DOI 10.1111/j.1365-2796.2007.01844.x; Le Blanc K, 2005, TRANSPLANTATION, V79, P1607, DOI 10.1097/01.TP.0000159029.48678.93; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Liles DK, 2009, CLINICAL HEMATOLOGY, P577; Murphy WG, 2008, VOX SANG, V95, P13, DOI 10.1111/j.1423-0410.2008.01051.x; Noth U, 2008, NAT CLIN PRACT RHEUM, V4, P371, DOI 10.1038/ncprheum0816; Perez-Ilzarbe M, 2009, TRANSFUSION, V49, P1901, DOI 10.1111/j.1537-2995.2009.02226.x; Posel C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050293; Pretheeban T, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-20; Rauch C, 2011, ALTEX-ALTERN ANIM EX, V28, P305, DOI 10.14573/altex.2011.4.305; Redler LH, 2011, PHYSICIAN SPORTSMED, V39, P42, DOI 10.3810/psm.2011.02.1861; Riley W, 2007, TRANSFUSION, V47, P1180, DOI 10.1111/j.1537-2995.2007.01252.x; Schallmoser K, 2008, TISSUE ENG PT C-METH, V14, P185, DOI 10.1089/ten.tec.2008.0060; Schallmoser K, 2007, TRANSFUSION, V47, P1436, DOI 10.1111/j.1537-2995.2007.01220.x; Schallmoser Katharina, 2013, Methods Mol Biol, V946, P349, DOI 10.1007/978-1-62703-128-8_22; Sensebe L, 2008, BIO-MED MATER ENG, V18, pS3; Sweeney J, 1998, VOX SANG, V74, P201, DOI 10.1111/j.1423-0410.1998.tb05421.x; Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; van der Valk J, 2010, TOXICOL IN VITRO, V24, P1053, DOI 10.1016/j.tiv.2010.03.016; van Laar JM, 2006, RHEUMATOLOGY, V45, P1187, DOI 10.1093/rheumatology/kel158; Verma A, 2009, TRANSFUS APHER SCI, V41, P145, DOI 10.1016/j.transci.2009.07.005; Warnke PH, 2013, J CRANIO MAXILL SURG, V41, P153, DOI 10.1016/j.jcms.2012.07.003; Weiss RA, 2003, CURR TOP MICROBIOL, V278, P47	47	65	67	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e68984	10.1371/journal.pone.0068984	http://dx.doi.org/10.1371/journal.pone.0068984			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874839	Green Published, Green Submitted, gold			2022-12-27	WOS:000322218800058
J	Berger, SS; Turner, L; Wang, CW; Petersen, JEV; Kraft, M; Lusingu, JPA; Mmbando, B; Marquard, AM; Bengtsson, DBAC; Hviid, L; Nielsen, MA; Theander, TG; Lavstsen, T				Berger, Sanne S.; Turner, Louise; Wang, Christian W.; Petersen, Jens E. V.; Kraft, Maria; Lusingu, John P. A.; Mmbando, Bruno; Marquard, Andrea M.; Bengtsson, Dominique B. A. C.; Hviid, Lars; Nielsen, Morten A.; Theander, Thor G.; Lavstsen, Thomas			Plasmodium falciparum Expressing Domain Cassette 5 Type PfEMP1 (DC5-PfEMP1) Bind PECAM1	PLOS ONE			English	Article							ERYTHROCYTE-MEMBRANE PROTEIN-1; NATURALLY ACQUIRED-IMMUNITY; VARIANT SURFACE-ANTIGENS; VAR GENE-TRANSCRIPTION; INFECTED ERYTHROCYTES; CHONDROITIN SULFATE; SEVERE MALARIA; IN-VITRO; DIFFERENTIAL EXPRESSION; ADHESION MOLECULE-1	Members of the Plasmodium falciparum Erythrocyte Membrane protein 1 (PfEMP1) family expressed on the surface of malaria-infected erythrocytes mediate binding of the parasite to different receptors on the vascular lining. This process drives pathologies, and severe childhood malaria has been associated with the expression of particular subsets of PfEMP1 molecules. PfEMP1 are grouped into subtypes based on upstream sequences and the presence of semi-conserved PfEMP1 domain compositions named domain cassettes (DCs). Earlier studies have indicated that DC5-containing PfEMP1 (DC5-PfEMP1) are more likely to be expressed in children with severe malaria disease than in children with uncomplicated malaria, but these PfEMP1 subtypes only dominate in a relatively small proportion of the children with severe disease. In this study, we have characterised the genomic sequence characteristic for DC5, and show that two genetically different parasite lines expressing DC5-PfEMP1 bind PECAM1, and that anti-DC5-specific antibodies inhibit binding of DC5-PfEMP1-expressing parasites to transformed human bone marrow endothelial cells (TrHBMEC). We also show that antibodies against each of the four domains characteristic for DC5 react with native PfEMP1 expressed on the surface of infected erythrocytes, and that some of these antibodies are cross-reactive between the two DC5-containing PfEMP1 molecules tested. Finally, we confirm that anti-DC5 antibodies are acquired early in life by individuals living in malaria endemic areas, that individuals having high levels of these antibodies are less likely to develop febrile malaria episodes and that the antibody levels correlate positively with hemoglobin levels.	[Berger, Sanne S.; Turner, Louise; Wang, Christian W.; Petersen, Jens E. V.; Kraft, Maria; Marquard, Andrea M.; Bengtsson, Dominique B. A. C.; Hviid, Lars; Nielsen, Morten A.; Theander, Thor G.; Lavstsen, Thomas] Univ Copenhagen, Rigshosp, Copenhagen Univ Hosp, Ctr Med Parasitol,Dept Int Hlth Immunol & Microbi, DK-2100 Copenhagen, Denmark; [Lusingu, John P. A.; Mmbando, Bruno] Natl Inst Med Res, Tanga Med Res Ctr, Tanga, Tanzania	Rigshospitalet; University of Copenhagen; National Institute of Medical Research	Berger, SS (corresponding author), Univ Copenhagen, Rigshosp, Copenhagen Univ Hosp, Ctr Med Parasitol,Dept Int Hlth Immunol & Microbi, DK-2100 Copenhagen, Denmark.	sansch@sund.ku.dk; thomasl@sund.ku.dk	Lusingu, John P. A./GSJ-3228-2022; Theander, Thor/F-6714-2015; Hviid, Lars/G-3705-2012	Theander, Thor/0000-0002-3509-7514; Hviid, Lars/0000-0002-1698-4927; Berger, Sanne Schou/0000-0002-1440-4909; Wang, Christian/0000-0003-3140-6989; Turner, Louise/0000-0003-4494-2289; Mmbando, Bruno/0000-0001-7232-8708; Lavstsen, Thomas/0000-0002-3044-4249; Lusingu, John P. A./0000-0002-9407-0602; Petersen, Jens Emil Vang/0000-0001-5567-465X; Nielsen, Morten Agertoug/0000-0003-2668-4992; Marquard, Andrea/0000-0003-2928-6017				Albrecht L, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-17; Avril M, 2012, P NATL ACAD SCI USA, V109, pE1782, DOI 10.1073/pnas.1120534109; Barfod L, 2006, INFECT IMMUN, V74, P4357, DOI 10.1128/IAI.01617-05; Barfod L, 2010, J IMMUNOL, V185, P7553, DOI 10.4049/jimmunol.1002390; BARNWELL JW, 1989, J CLIN INVEST, V84, P765, DOI 10.1172/JCI114234; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Bengtsson A, 2013, J IMMUNOL, V190, P240, DOI 10.4049/jimmunol.1202578; Bengtsson D, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-101; BERENDT AR, 1989, NATURE, V341, P57, DOI 10.1038/341057a0; Bian ZQ, 2000, CHINESE MED J-PEKING, V113, P981; Bigey P, 2011, J INFECT DIS, V204, P1125, DOI 10.1093/infdis/jir499; Brown A, 2013, J BIOL CHEM, V288, P5992, DOI 10.1074/jbc.M112.416347; Bull PC, 2000, J INFECT DIS, V182, P252, DOI 10.1086/315652; Bull PC, 1999, INFECT IMMUN, V67, P733, DOI 10.1128/IAI.67.2.733-739.1999; Bull PC, 2002, TRENDS MICROBIOL, V10, P55, DOI 10.1016/S0966-842X(01)02278-8; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; Bull PC, 2008, MOL MICROBIOL, V68, P1519, DOI 10.1111/j.1365-2958.2008.06248.x; Bull PC, 2005, PLOS PATHOG, V1, P202, DOI 10.1371/journal.ppat.0010026; Cham GKK, 2010, INFECT IMMUN, V78, P4653, DOI 10.1128/IAI.00593-10; Cham GKK, 2009, J IMMUNOL, V183, P3356, DOI 10.4049/jimmunol.0901331; Cham GKK, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-108; Chen QJ, 2000, J EXP MED, V192, P1, DOI 10.1084/jem.192.1.1; Claessens A, 2012, P NATL ACAD SCI USA, V109, pE1772, DOI 10.1073/pnas.1120461109; Clausen TM, 2012, J BIOL CHEM, V287, P23332, DOI 10.1074/jbc.M112.348839; Cranmer SL, 1997, T ROY SOC TROP MED H, V91, P363, DOI 10.1016/S0035-9203(97)90110-3; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dahlback M, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.191510; Dahlback M, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-78; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Falk N, 2009, J INFECT DIS, V200, P347, DOI 10.1086/600071; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Ghumra A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002665; Gupta S, 1999, NAT MED, V5, P340, DOI 10.1038/6560; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Heddini A, 2001, AM J TROP MED HYG, V65, P47, DOI 10.4269/ajtmh.2001.65.47; Hviid L, 2005, ACTA TROP, V95, P270, DOI 10.1016/j.actatropica.2005.06.012; Hviid L, 2011, EXPERT REV VACCINES, V10, P1405, DOI [10.1586/ERV.11.113, 10.1586/erv.11.113]; Hviid L, 2010, HUM VACCINES, V6, P84, DOI 10.4161/hv.6.1.9602; Jensen ATR, 2004, J EXP MED, V199, P1179, DOI 10.1084/jem.20040274; Joergensen L, 2007, J IMMUNOL, V178, P428, DOI 10.4049/jimmunol.178.1.428; Joergensen L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001083; Kaestli M, 2006, J INFECT DIS, V193, P1567, DOI 10.1086/503776; Kalmbach Y, 2010, J INFECT DIS, V202, P313, DOI 10.1086/653586; Kirchgatter K, 2002, MOL MED, V8, P16, DOI 10.1007/BF03401999; Kyriacou HM, 2006, MOL BIOCHEM PARASIT, V150, P211, DOI 10.1016/j.molbiopara.2006.08.005; Lavstsen T, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-21; Lavstsen T, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-27; Lavstsen T, 2012, P NATL ACAD SCI USA, V109, pE1791, DOI 10.1073/pnas.1120455109; Magistrado P, 2008, J INFECT DIS, V198, P1071, DOI 10.1086/591502; Magistrado PA, 2007, INFECT IMMUN, V75, P2415, DOI 10.1128/IAI.00951-06; Mmbando BP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-216; Mmbando BP, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-75; Moll K, 2009, METHODS MALAR RES; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Nielsen MA, 2002, J IMMUNOL, V168, P3444, DOI 10.4049/jimmunol.168.7.3444; Nielsen MA, 2009, INFECT IMMUN, V77, P2482, DOI 10.1128/IAI.00159-09; Rask TS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000933; Rottmann M, 2006, INFECT IMMUN, V74, P3904, DOI 10.1128/IAI.02073-05; Rowe JA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001082; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Salanti A, 2002, MOL BIOCHEM PARASIT, V122, P111, DOI 10.1016/S0166-6851(02)00080-4; Salanti A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-11; Sander AF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006667; Schweitzer KM, 1997, LAB INVEST, V76, P25; Smith J D, 1995, Cell, V82, P101; Staalsoe T, 2003, PARASITE IMMUNOL, V25, P421, DOI 10.1111/j.1365-3024.2003.00652.x; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Treutiger CJ, 1997, NAT MED, V3, P1405, DOI 10.1038/nm1297-1405; Vigan-Womas I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002781; Wang CW, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-129; Warimwe GM, 2009, P NATL ACAD SCI USA, V106, P21801, DOI 10.1073/pnas.0907590106; WHO, 2011, WORLD MALARIA REPORT 2011, P1	74	30	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e69117	10.1371/journal.pone.0069117	http://dx.doi.org/10.1371/journal.pone.0069117			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874884	Green Submitted, gold, Green Published			2022-12-27	WOS:000321736900136
J	Chen, C; Xu, T; Zhou, JX; Yan, Y; Li, WQ; Yu, HY; Hu, GH; Ding, XH; Chen, JX; Lu, YC				Chen, Chao; Xu, Tao; Zhou, Jinxu; Yan, Yong; Li, Weiqing; Yu, Hongyu; Hu, Guohan; Ding, Xuehua; Chen, Juxiang; Lu, Yicheng			High Cytoplasmic FOXO1 and pFOXO1 Expression in Astrocytomas Are Associated with Worse Surgical Outcome	PLOS ONE			English	Article							FORKHEAD TRANSCRIPTION FACTORS; NUCLEAR EXPORT; CONSTITUTIVE PHOSPHORYLATION; ADJUVANT TEMOZOLOMIDE; DRUG-RESISTANCE; CYTOSOLIC FOXO1; PROSTATE-CANCER; TUMOR-CELLS; INHIBITORS; FKHR	FOXO1 is at a convergence point of receptor tyrosine kinase (RTK) signaling, which is one of the three core pathways implicated in glioblastoma. It was recently shown that FOXO1 can effectively induce glioma cell death and inhibit tumor growth through cell cycle arrest and apoptosis. We therefore evaluated FOXO1 and pFOXO1 protein expression in 181 primary astrocytoma samples and 16 normal brain samples. Astrocytoma samples expressed higher cytoplasmic FOXO1 and pFOXO1 than normal brain samples. Nuclear pFOXO1 level was significantly higher than nuclear FOXO1 in astrocytomas. High cytoplasmic FOXO1 expression was associated with older onset age (P = 0.001) and higher WHO grade (P = 0.001). The trend was also observed between cytoplasmic pFOXO1 expression and WHO grade although not significant. Univariate survival analysis showed that both high cytoplasmic FOXO1 and pFOXO1 expression indicated a significantly shorter median overall survival and progression-free survival. Multivariate survival analysis revealed cytoplasmic FOXO1 expression, cytoplasmic pFOXO1 expression, WHO grade, gender, extent of resection and radiotherapy to be independent prognostic factors for overall survival and progression-free survival. Thus, our data suggested that cytoplasmic FOXO1 and pFOXO1 expression may serve as valuable prognostic variables in astrocytomas and may have significant implications for the development and application of targeted therapy.	[Chen, Chao; Xu, Tao; Zhou, Jinxu; Yan, Yong; Hu, Guohan; Ding, Xuehua; Chen, Juxiang; Lu, Yicheng] Second Mil Med Univ, Changzheng Hosp, Shanghai Inst Neurosurg, Dept Neurosurg, Shanghai, Peoples R China; [Li, Weiqing; Yu, Hongyu] Second Mil Med Univ, Changzheng Hosp, Dept Pathol, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Chen, JX (corresponding author), Second Mil Med Univ, Changzheng Hosp, Shanghai Inst Neurosurg, Dept Neurosurg, Shanghai, Peoples R China.	juxiangchen.cz@gmail.com; lyc305@126.com		Ding, Xuehua/0000-0002-7117-0328	National Natural Science Foundation [30930094, 81101907, 30973076]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation ( No. 30930094, 81101907, 30973076). (http://www.nsfc.gov.cn/Portal0/default166.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheong JW, 2003, LEUKEMIA RES, V27, P1159, DOI 10.1016/S0145-2126(03)00102-4; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Fu W, 2009, J BIOL CHEM, V284, P13987, DOI 10.1074/jbc.M901758200; Fukunaga K, 2005, J PHARMACOL SCI, V98, P205, DOI 10.1254/jphs.FMJ05001X3; Goto T, 2008, BRIT J CANCER, V98, P1068, DOI 10.1038/sj.bjc.6604279; Goto T, 2008, ONCOGENE, V27, P9, DOI 10.1038/sj.onc.1210626; Goto T, 2009, ADV EXP MED BIOL, V665, P171; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Kau TR, 2003, CANCER CELL, V4, P463, DOI 10.1016/S1535-6108(03)00303-9; Kim JH, 2007, MODERN PATHOL, V20, P835, DOI 10.1038/modpathol.3800789; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Lau CJ, 2009, CANCER RES, V69, P5433, DOI 10.1158/0008-5472.CAN-08-4540; Li R, 2007, HUM PATHOL, V38, P1501, DOI 10.1016/j.humpath.2007.02.016; Lu HR, 2011, CURR DRUG TARGETS, V12, P1235, DOI 10.2174/138945011796150280; MCCLELLAND RA, 1990, CANCER RES, V50, P3545; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Modur V, 2002, J BIOL CHEM, V277, P47928, DOI 10.1074/jbc.M207509200; Mutka SC, 2009, CANCER RES, V69, P510, DOI 10.1158/0008-5472.CAN-08-0858; Ohgaki H, 2005, ACTA NEUROPATHOL, V109, P93, DOI 10.1007/s00401-005-0991-y; Ramaswamy S, 2002, CANCER CELL, V2, P81, DOI 10.1016/S1535-6108(02)00086-7; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; Schmidt M, 2002, MOL CELL BIOL, V22, P7842, DOI 10.1128/MCB.22.22.7842-7852.2002; Schroeder FC, 2005, J NAT PROD, V68, P574, DOI 10.1021/np049624z; Sorensen PHB, 2002, J CLIN ONCOL, V20, P2672, DOI 10.1200/JCO.2002.03.137; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Tzivion G, 2011, BIOCH BIOPHYS ACTA; Uhm JH, 2011, INT J RADIAT ONCOL, V80, P347, DOI 10.1016/j.ijrobp.2010.01.070; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Zhang B, 2009, ANN SURG ONCOL, V16, P1925, DOI 10.1245/s10434-009-0481-x; Zhao XS, 2004, BIOCHEM J, V378, P839, DOI 10.1042/BJ20031450; Zhao Y, 2010, AUTOPHAGY, V6, P988, DOI 10.4161/auto.6.7.13289; Zhao Y, 2010, NAT CELL BIOL, V12, P665, DOI 10.1038/ncb2069	36	5	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e69260	10.1371/journal.pone.0069260	http://dx.doi.org/10.1371/journal.pone.0069260			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874926	gold, Green Submitted, Green Published			2022-12-27	WOS:000321736900144
J	de Puig, H; Rius, AC; Flemister, D; Baxamusa, SH; Hamad-Schifferli, K				de Puig, Helena; Cifuentes Rius, Anna; Flemister, Dorma; Baxamusa, Salmaan H.; Hamad-Schifferli, Kimberly			Selective Light-Triggered Release of DNA from Gold Nanorods Switches Blood Clotting On and Off	PLOS ONE			English	Article							NANOPARTICLES	Blood clotting is a precise cascade engineered to form a clot with temporal and spatial control. Current control of blood clotting is achieved predominantly by anticoagulants and thus inherently one-sided. Here we use a pair of nanorods (NRs) to provide a two-way switch for the blood clotting cascade by utilizing their ability to selectively release species on their surface under two different laser excitations. We selectively trigger release of a thrombin binding aptamer from one nanorod, inhibiting blood clotting and resulting in increased clotting time. We then release the complementary DNA as an antidote from the other NR, reversing the effect of the aptamer and restoring blood clotting. Thus, the nanorod pair acts as an on/off switch. One challenge for nanobiotechnology is the bio-nano interface, where coronas of weakly adsorbed proteins can obscure biomolecular function. We exploit these adsorbed proteins to increase aptamer and antidote loading on the nanorods.	[de Puig, Helena; Hamad-Schifferli, Kimberly] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Cifuentes Rius, Anna; Baxamusa, Salmaan H.; Hamad-Schifferli, Kimberly] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Flemister, Dorma] MIT, Dept Biol, Cambridge, MA 02139 USA; [Cifuentes Rius, Anna] Univ Ramon Llull, Inst Quim Sarria, Barcelona, Spain	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Universitat Ramon Llull; Institut Quimic de Sarria	Hamad-Schifferli, K (corresponding author), Lawrence Livermore Natl Lab, Livermore, CA 94550 USA.	schiffer@mit.edu	Cifuentes-Rius, Anna/E-1994-2015; Cifuentes-Rius, Anna/AAD-6028-2019	Cifuentes-Rius, Anna/0000-0002-9478-2239; Cifuentes-Rius, Anna/0000-0002-9478-2239; /0000-0002-5368-6996; , Salmaan/0000-0003-3774-9560	National Science Foundation [0906838]; La Caixa Foundation (Spain)	National Science Foundation(National Science Foundation (NSF)); La Caixa Foundation (Spain)(La Caixa Foundation)	This work was funded by the National Science Foundation grant# DMR #0906838. http://www.nsf.gov/.HdP was supported by a fellowship from La Caixa Foundation (Spain). http://obrasocial.lacaixa.es/laCaixaFoundation/home_en.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barhoumi A, 2009, CHEM PHYS LETT, V482, P171, DOI 10.1016/j.cplett.2009.09.076; Blossom DB, 2008, N ENGL J MED, V359; BOCK LC, 1992, NATURE, V355, P564, DOI 10.1038/355564a0; de Puig H, 2011, SMALL, V7, P2477, DOI 10.1002/smll.201100530; Guerrini M, 2008, NAT BIOTECHNOL, V26, P669, DOI 10.1038/nbt1407; Huschka R, 2011, J AM CHEM SOC, V133, P12247, DOI 10.1021/ja204578e; Kim YM, 2009, P NATL ACAD SCI USA, V106, P6489, DOI 10.1073/pnas.0812402106; Kishimoto TK, 2008, N ENGL J MED, V358; Lee SE, 2012, ACS NANO, V6, P7770, DOI 10.1021/nn301744x; LEFKOVITS J, 1994, CIRCULATION, V90, P1522, DOI 10.1161/01.CIR.90.3.1522; PADMANABHAN K, 1993, J BIOL CHEM, V268, P17651; Pagano B, 2008, BIOPHYS J, V94, P562, DOI 10.1529/biophysj.107.117382; Shepherd G, 2012, ANN PHARMACOTHER, V46, P169, DOI 10.1345/aph.1P592; Wijaya A, 2009, ACS NANO, V3, P80, DOI 10.1021/nn800702n; Wysowski DK, 2007, ARCH INTERN MED, V167, P1414, DOI 10.1001/archinte.167.13.1414; Yamashita S, 2011, BIOORGAN MED CHEM, V19, P2130, DOI 10.1016/j.bmc.2011.02.042	16	24	26	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e68511	10.1371/journal.pone.0068511	http://dx.doi.org/10.1371/journal.pone.0068511			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894311	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000322167900013
J	Chanda, D; Kim, YH; Li, T; Misra, J; Kim, DK; Kim, JR; Kwon, J; Jeong, WI; Ahn, SH; Park, TS; Koo, SH; Chiang, JYL; Lee, CH; Choi, HS				Chanda, Dipanjan; Kim, Yong-Hoon; Li, Tiangang; Misra, Jagannath; Kim, Don-Kyu; Kim, Jung Ran; Kwon, Joseph; Jeong, Won-Il; Ahn, Sung-Hoon; Park, Tae-Sik; Koo, Seung-Hoi; Chiang, John Y. L.; Lee, Chul-Ho; Choi, Hueng-Sik			Hepatic Cannabinoid Receptor Type 1 Mediates Alcohol-Induced Regulation of Bile Acid Enzyme Genes Expression Via CREBH	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; ELEMENT-BINDING PROTEIN; BOUND TRANSCRIPTION FACTOR; ER STRESS; ENDOCANNABINOID SYSTEM; INSULIN-RESISTANCE; CHOLESTEROL 7-ALPHA-HYDROXYLASE; CB1 RECEPTORS; ETHANOL; LIVER	Bile acids concentration in liver is tightly regulated to prevent cell damage. Previous studies have demonstrated that deregulation of bile acid homeostasis can lead to cholestatic liver disease. Recently, we have shown that ER-bound transcription factor Crebh is a downstream effector of hepatic Cb1r signaling pathway. In this study, we have investigated the effect of alcohol exposure on hepatic bile acid homeostasis and elucidated the mediatory roles of Cb1r and Crebh in this process. We found that alcohol exposure or Cb1r-agonist 2-AG treatment increases hepatic bile acid synthesis and serum ALT, AST levels in vivo alongwith significant increase in Crebh gene expression and activation. Alcohol exposure activated Cb1r, Crebh, and perturbed bile acid homeostasis. Overexpression of Crebh increased the expression of key bile acid synthesis enzyme genes via direct binding of Crebh to their promoters, whereas Cb1r knockout and Crebh-knockdown mice were protected against alcohol-induced perturbation of bile acid homeostasis. Interestingly, insulin treatment protected against Cb1r-mediated Crebh-induced disruption of bile acid homeostasis. Furthermore, Crebh expression and activation was found to be markedly increased in insulin resistance conditions and Crebh knockdown in diabetic mice model (db/db) significantly reversed alcohol-induced disruption of bile acid homeostasis. Overall, our study demonstrates a novel regulatory mechanism of hepatic bile acid metabolism by alcohol via Cb1r-mediated activation of Crebh, and suggests that targeting Crebh can be of therapeutic potential in ameliorating alcohol-induced perturbation of bile acid homeostasis.	[Chanda, Dipanjan; Misra, Jagannath; Kim, Don-Kyu; Choi, Hueng-Sik] Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Natl Creat Res Initiat Ctr Nucl Receptor Signals, Kwangju, South Korea; [Choi, Hueng-Sik] Chonnam Natl Univ, Sch Med, Dept Biomed Sci, Res Inst Med Sci, Kwangju, South Korea; [Kim, Yong-Hoon; Lee, Chul-Ho] Korea Res Inst Biosci & Biotechnol, Taejon, South Korea; [Li, Tiangang; Chiang, John Y. L.] Northeast Ohio Med Univ, Dept Integrat Med Sci, Rootstown, OH USA; [Koo, Seung-Hoi] Korea Univ, Coll Life Sci & Biotechnol, Div Life Sci, Seoul, South Korea; [Kim, Jung Ran; Park, Tae-Sik] Gachon Univ, Dept Life Sci, Songnam, South Korea; [Kwon, Joseph] Korea Basic Sci Inst, Gwangju Ctr, Kwangju, South Korea; [Jeong, Won-Il] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Taejon 305701, South Korea; [Ahn, Sung-Hoon] Korea Res Inst Chem Technol, Drug Discovery Platform Technol Team, Taejon 305606, South Korea	Chonnam National University; Chonnam National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Northeast Ohio Medical University (NEOMED); Korea University; Gachon University; Korea Basic Science Institute (KBSI); Korea Advanced Institute of Science & Technology (KAIST); Korea Research Institute of Chemical Technology (KRICT)	Lee, CH (corresponding author), Korea Res Inst Biosci & Biotechnol, Taejon, South Korea.	chullee@kribb.re.kr; hsc@chonnam.ac.kr	Chiang, John Y. L./G-2658-2011; Misra, Jagannath/AAW-8774-2021; JEONG, WON IL/B-6615-2011; Chanda, Dipanjan/AAU-3996-2021; Koo, Seung-Hoi/E-2763-2015	Chiang, John Y. L./0000-0001-9360-7650; Chanda, Dipanjan/0000-0003-0685-187X; Koo, Seung-Hoi/0000-0001-8769-2879; Misra, Jagannath/0000-0001-9713-0298	National Creative Research Initiatives Grant [20110018305]; Future-based Technology Development Program (BIO Fields) through the National Research Foundation of Korea (NRF) [20100019512]; Korean Government (MSIP); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044442] Funding Source: NIH RePORTER	National Creative Research Initiatives Grant; Future-based Technology Development Program (BIO Fields) through the National Research Foundation of Korea (NRF); Korean Government (MSIP); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Creative Research Initiatives Grant (20110018305) and Future-based Technology Development Program (BIO Fields) (20100019512) through the National Research Foundation of Korea (NRF) funded by the Korean Government (MSIP) (H.-S.C).	Aranha MM, 2008, EUR J GASTROEN HEPAT, V20, P519, DOI 10.1097/MEG.0b013e3282f4710a; AXELSON M, 1991, FEBS LETT, V281, P155, DOI 10.1016/0014-5793(91)80382-D; Bluher M, 2006, DIABETES, V55, P3053, DOI 10.2337/db06-0812; Bochkis IM, 2008, NAT MED, V14, P828, DOI 10.1038/nm.1853; Chanda D, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.377978; Chanda D, 2011, J BIOL CHEM, V286, P27971, DOI 10.1074/jbc.M111.224352; Chen G, 2008, J NEUROSCI RES, V86, P937, DOI 10.1002/jnr.21540; Chiang JYL, 2002, ENDOCR REV, V23, P443, DOI 10.1210/er.2000-0035; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Engeli S, 2005, DIABETES, V54, P2838, DOI 10.2337/diabetes.54.10.2838; Hofmann AF, 2009, HEPATOLOGY, V49, P1403, DOI 10.1002/hep.22789; Jeong WI, 2008, CELL METAB, V7, P227, DOI 10.1016/j.cmet.2007.12.007; Ji C, 2005, ALCOHOL CLIN EXP RES, V29, P1496, DOI 10.1097/01.alc.0000174691.03751.11; Kim DK, 2013, GUT, V62, P1044, DOI 10.1136/gutjnl-2012-303347; Kim I, 2007, J LIPID RES, V48, P2664, DOI 10.1194/jlr.M700330-JLR200; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lee JH, 2011, NAT MED, V17, P812, DOI 10.1038/nm.2347; Lee MW, 2010, CELL METAB, V11, P331, DOI 10.1016/j.cmet.2010.02.016; Li TG, 2012, J BIOL CHEM, V287, P1861, DOI 10.1074/jbc.M111.305789; Li TG, 2011, HEPATOLOGY, V53, P996, DOI 10.1002/hep.24107; Liu J, 2012, GASTROENTEROLOGY, V142, P1218, DOI 10.1053/j.gastro.2012.01.032; Matias I, 2006, J CLIN ENDOCR METAB, V91, P3171, DOI 10.1210/jc.2005-2679; Nakatani Y, 2005, J BIOL CHEM, V280, P847, DOI 10.1074/jbc.M411860200; NESTEL PJ, 1976, AM J CLIN NUTR, V29, P1007, DOI 10.1093/ajcn/29.9.1007; Nguyen P, 2008, J ANIM PHYSIOL AN N, V92, P272, DOI 10.1111/j.1439-0396.2007.00752.x; Nilsson LM, 2007, BIOCHEM BIOPH RES CO, V364, P743, DOI 10.1016/j.bbrc.2007.10.039; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Osei-Hyiaman D, 2008, J CLIN INVEST, V118, P3160, DOI 10.1172/JCI34827; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Ozawa K, 2005, DIABETES, V54, P657, DOI 10.2337/diabetes.54.3.657; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Park YJ, 2008, HEPATOLOGY, V47, P1578, DOI 10.1002/hep.22196; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Song KH, 2007, HEPATOLOGY, V46, P1993, DOI 10.1002/hep.21878; Tam J, 2012, CELL METAB, V16, P167, DOI 10.1016/j.cmet.2012.07.002; Tung B Y, 1999, Clin Liver Dis, V3, P585, DOI 10.1016/S1089-3261(05)70086-6; Vecchi C, 2009, SCIENCE, V325, P877, DOI 10.1126/science.1176639; Waszkiewicz N, 2009, HEPATOLOGY, V50, P1676, DOI 10.1002/hep.23178; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Zhang CB, 2012, HEPATOLOGY, V55, P1070, DOI 10.1002/hep.24783; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040	43	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e68845	10.1371/journal.pone.0068845	http://dx.doi.org/10.1371/journal.pone.0068845			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894352	Green Published, gold, Green Submitted			2022-12-27	WOS:000322132100028
J	Sridharan, V; Tripathi, P; Sharma, S; Corry, PM; Moros, EG; Singh, A; Compadre, CM; Hauer-Jensen, M; Boerma, M				Sridharan, Vijayalakshmi; Tripathi, Preeti; Sharma, Sunil; Corry, Peter M.; Moros, Eduardo G.; Singh, Awantika; Compadre, Cesar M.; Hauer-Jensen, Martin; Boerma, Marjan			Effects of Late Administration of Pentoxifylline and Tocotrienols in an Image-Guided Rat Model of Localized Heart Irradiation	PLOS ONE			English	Article							VITAMIN-E; ENDOTHELIAL DYSFUNCTION; RADIATION-INJURY; CARDIAC-FUNCTION; EARLY-STAGE; THROMBOMODULIN; RADIOTHERAPY; DISEASE; DAMAGE; ALPHA	Radiation-induced heart disease (RIHD) is a long-term side effect of radiotherapy of intrathoracic, chest wall and breast tumors when radiation fields encompass all or part of the heart. Previous studies have shown that pentoxifylline (PTX) in combination with alpha-tocopherol reduced manifestations of RIHD in rat models of local heart irradiation. The relative contribution of PTX and alpha-tocopherol to these beneficial effects are not known. This study examined the effects of PTX alone or in combination with tocotrienols, forms of vitamin E with potential potent radiation mitigation properties. Rats received localized X-irradiation of the heart with an image-guided irradiation technique. At 3 months after irradiation rats received oral treatment with vehicle, PTX, or PTX in combination with a tocotrienol-enriched formulation. At 6 months after irradiation, PTX-treated rats showed arrhythmia in 5 out of 14 animals. PTX alone or in combination with tocotrienols did not alter cardiac radiation fibrosis, left ventricular protein expression of the endothelial markers von Willebrand factor and neuregulin-1, or phosphorylation of the signal mediators Akt, Erk1/2, or PKC alpha. On the other hand, tocotrienols reduced cardiac numbers of mast cells and macrophages, but enhanced the expression of tissue factor. While this new rat model of localized heart irradiation does not support the use of PTX alone, the effects of tocotrienols on chronic manifestations of RIHD deserve further investigation.	[Sridharan, Vijayalakshmi; Tripathi, Preeti; Hauer-Jensen, Martin; Boerma, Marjan] Univ Arkansas Med Sci, Div Radiat Hlth, Little Rock, AR 72205 USA; [Sharma, Sunil; Corry, Peter M.] Univ Arkansas Med Sci, Dept Radiat Oncol, Little Rock, AR 72205 USA; [Moros, Eduardo G.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Radiat Oncol, Tampa, FL 33612 USA; [Singh, Awantika; Compadre, Cesar M.] Univ Arkansas Med Sci, Dept Pharmaceut Sci, Little Rock, AR 72205 USA; [Hauer-Jensen, Martin] Cent Arkansas Vet Healthcare Syst, Surg Serv, Little Rock, AR USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System	Boerma, M (corresponding author), Univ Arkansas Med Sci, Div Radiat Hlth, Little Rock, AR 72205 USA.	mboerma@uams.edu	Moros, Eduardo G./AAY-2771-2020; Compadre, Cesar M/D-1286-2009	Moros, Eduardo G./0000-0003-1964-2460; Compadre, Cesar M/0000-0002-5652-0203	American Cancer Society [RSG-10-125-01-CCE]; National Institutes of Health [CA148679, CA71382]; National Center for Research Resources [1UL1RR029884]; NATIONAL CANCER INSTITUTE [R01CA148679, R37CA071382, R01CA071382] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029884] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by the American Cancer Society (RSG-10-125-01-CCE to MB), the National Institutes of Health (CA148679 to MB, CA71382 to MH-J), and the National Center for Research Resources (1UL1RR029884 to CMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berbee M, 2012, GENES NUTR, V7, P75, DOI 10.1007/s12263-011-0228-8; Berbee M, 2011, RADIAT RES, V175, P297, DOI 10.1667/RR2399.1; Berbee M, 2011, INT J RADIAT ONCOL, V79, P884, DOI 10.1016/j.ijrobp.2010.08.032; Berbee M, 2009, RADIAT RES, V171, P596, DOI 10.1667/RR1632.1; Bian Y, 2009, AM J PHYSIOL-HEART C, V297, pH1974, DOI 10.1152/ajpheart.01010.2008; Boerma M, 2005, CANCER RES, V65, P3100, DOI 10.1158/0008-5472.CAN-04-4333; Boerma M, 2004, STRAHLENTHER ONKOL, V180, P109, DOI 10.1007/s00066-004-1138-0; Boerma M, 2008, INT J RADIAT ONCOL, V72, P170, DOI 10.1016/j.ijrobp.2008.04.042; Chera BS, 2009, INT J RADIAT ONCOL, V75, P1173, DOI 10.1016/j.ijrobp.2008.12.048; Coe DA, 1997, J SURG RES, V67, P21, DOI 10.1006/jsre.1996.4940; Conway EM, 2012, SEMIN IMMUNOPATHOL, V34, P107, DOI 10.1007/s00281-011-0282-8; Delanian S, 1999, J CLIN ONCOL, V17, P3283, DOI 10.1200/JCO.1999.17.10.3283; Devic S, 2005, MED PHYS, V32, P2245, DOI 10.1118/1.1929253; Early Breast Canc Trialists Collaborat, 2000, LANCET, V355, P1757, DOI 10.1016/S0140-6736(00)02263-7; FAJARDO LF, 1973, LAB INVEST, V29, P244; Fang CC, 2003, PERITON DIALYSIS INT, V23, P228; Galper SL, 2011, BLOOD, V117, P412, DOI 10.1182/blood-2010-06-291328; Ghobadi G, 2012, INT J RADIAT ONCOL, V84, pE639, DOI 10.1016/j.ijrobp.2012.07.2362; Heidenreich PA, 2009, HEART, V95, P252, DOI 10.1136/hrt.2008.149088; Hille A, 2005, STRAHLENTHER ONKOL, V181, P606, DOI 10.1007/s00066-005-1390-y; Hopewell JW, 1980, RAD BIOL CANCER RES, P449; Khosla P, 2006, ANTIOXID REDOX SIGN, V8, P1059, DOI 10.1089/ars.2006.8.1059; Kole TP, 2012, INT J RADIAT ONCOL, V83, P1580, DOI 10.1016/j.ijrobp.2011.10.053; Koutsi A, 2008, INT J BIOCHEM CELL B, V40, P1669, DOI 10.1016/j.biocel.2007.06.024; Lemmens K, 2004, CIRCULATION, V109, P324, DOI 10.1161/01.CIR.0000114521.88547.5E; Leroy J, 2011, J CLIN INVEST, V121, P2651, DOI 10.1172/JCI44747; Li XM, 2009, CLIN EXP PHARMACOL P, V36, P1054, DOI 10.1111/j.1440-1681.2009.05243.x; Liu H, 2009, INT J RADIAT ONCOL, V73, P1552, DOI 10.1016/j.ijrobp.2008.12.005; Liu QH, 2011, J MOL CELL CARDIOL, V51, P474, DOI 10.1016/j.yjmcc.2010.10.004; Liu XF, 2006, J AM COLL CARDIOL, V48, P1438, DOI 10.1016/j.jacc.2006.05.057; Ma CM, 2001, MED PHYS, V28, P868, DOI 10.1118/1.1374247; Malerba M, 2011, J BIOL REG HOMEOS AG, V25, P443; Moriwaki H, 2004, CIRC RES, V95, P637, DOI 10.1161/01.RES.0000141427.61023.f4; Naito Y, 2005, ATHEROSCLEROSIS, V180, P19, DOI 10.1016/j.atherosclerosis.2004.11.017; National Research Council, 2011, GUIDE CARE USE LAB A; OHDAMA S, 1991, THROMB RES, V62, P745, DOI 10.1016/0049-3848(91)90378-A; Ozturk B, 2004, INT J RADIAT ONCOL, V58, P213, DOI 10.1016/S0360-3016(03)01444-5; PARKER RA, 1993, J BIOL CHEM, V268, P11230; Ravens U, 1996, MOL CELL BIOCHEM, V157, P245; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Rube CE, 2002, RADIOTHER ONCOL, V64, P177, DOI 10.1016/S0167-8140(02)00077-4; Satyamitra MM, 2011, RADIAT RES, V175, P736, DOI 10.1667/RR2460.1; Sbroggio M, 2011, CARDIOVASC RES, V91, P456, DOI 10.1093/cvr/cvr103; SCHUBOTZ R, 1977, CURR MED RES OPIN, V4, P609, DOI 10.1185/03007997709115279; Seemann I, 2012, RADIOTHER ONCOL, V103, P143, DOI 10.1016/j.radonc.2011.10.011; Seigneur M, 1995, J CARDIOVASC PHARM, V25, pS85, DOI 10.1097/00005344-199500252-00018; Sharma S, 2013, TCRT EXPRESS, V1, P47; Song BL, 2006, J BIOL CHEM, V281, P25054, DOI 10.1074/jbc.M605575200; Sridharan V, 2013, INT J RAD B IN PRESS; Sridharan V, 2012, CANCER RES, V72, P4984, DOI 10.1158/0008-5472.CAN-12-1831; VERHEIJ M, 1995, THROMB HAEMOSTASIS, V73, P894; Verstegen NE, 2012, ANN ONCOL, V23, P46, DOI 10.1093/annonc/mds301; Wang JR, 2002, AM J PATHOL, V160, P2063, DOI 10.1016/S0002-9440(10)61156-X; Wang JR, 2007, WORLD J GASTROENTERO, V13, P3047, DOI 10.3748/wjg.v13.i22.3047; Wu WC, 2010, BRIT J RADIOL, V83, P252, DOI 10.1259/bjr/33094251; Zingg JM, 2007, VITAM HORM, V76, P393, DOI 10.1016/S0083-6729(07)76015-6	56	22	26	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e68762	10.1371/journal.pone.0068762	http://dx.doi.org/10.1371/journal.pone.0068762			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894340	Green Published, Green Submitted, gold			2022-12-27	WOS:000322132100023
J	Sun, J; Ding, ZN; Qian, YN; Peng, YG				Sun, Jie; Ding, Zhengnian; Qian, Yanning; Peng, Yong G.			Central-Radial Artery Pressure Gradient after Cardiopulmonary Bypass Is Associated with Cardiac Function and May Affect Therapeutic Direction	PLOS ONE			English	Article							HEART-FAILURE; DIAMETER; SURGERY	Objective: To investigate the risk factors involved in radial-femoral artery pressure gradient after cardiac surgery. Methods: In this retrospective study, we reviewed 412 cardiac surgeries with both femoral artery pressure and radial artery pressure monitoring before cardiopulmonary bypass. 138 patients had radial-femoral artery pressure gradient after cardiopulmonary bypass (group P) but 263 were not (group N). Their hemodynamic data and other demographic data were analyzed. Results: Phenylephrine usage was 1.7 +/- 1.1 mg in group N and 2.9 +/- 1.2 mg in group P (P<0.001). Total adrenaline usage was 229.2 +/- 116.9 mu g in group N and 400.6 +/- 145.1 mu g in group P (P<0.001). SBP gradient was -4 +/- 3, 14 +/- 9, 10 +/- 4, 0 +/- 11 mmHg in group P and -3 +/- 3, 0 +/- 1, -1 +/- 9, -6 +/- 4 mmHg in group N after induction, during discontinuation of CPB, at the end of surgery and 1 postoperative day respectively. DBP gradient was 3 +/- 3, -1 +/- 9, 4 +/- 5, 0 +/- 8 mmHg in group P and 3 +/- 3, 5 +/- 2, 7 +/- 5, 0 +/- 8 mmHg in group N after induction, during discontinuation of CPB, at the end of surgery and 1 postoperative day respectively. MAP gradient was 1 +/- 2, 4 +/- 6, 6 +/- 4, 0 +/- 8 mmHg in group P and 1 +/- 2, 3 +/- 1, 1 +/- 4, -2 +/- 5 mmHg in group N after induction, during discontinuation of CPB, at the end of surgery and 1 postoperative day respectively. Significant arterial pressure gradient emerged during discontinuation of CPB and at the end of surgery, which was more obvious in group P(P<0.01). CI was 2.0 +/- 0.3, 2.3 +/- 0.4,2.3 +/- 0.4, 2.2 +/- 0.4 L/min/m(2) in group P and 2.1 +/- 0.3, 2.8 +/- 0.5,2.8 +/- 0.5, 2.8 +/- 0.5 L/min/m(2) in group N at baseline, after discontinuation of CPB, at the end of surgery and the first postoperative day (P<0.001). Conclusion: Detecting the exact central artery pressure is most important when patients have artery pressure gradients after cardiac surgery. Use inotropic agents to improve cardiac output, avoiding excessive vasoconstriction might reduce artery pressure gradient.	[Sun, Jie; Ding, Zhengnian; Qian, Yanning] Nanjing Med Univ, Jiangsu Prov Hosp, Affiliated Hosp 1, Dept Anesthesiol, Nanjing, Jiangsu, Peoples R China; [Peng, Yong G.] Univ Florida, Shands Hosp, Dept Anesthesiol & Surg, Gainesville, FL 32610 USA	Nanjing Medical University; State University System of Florida; University of Florida	Peng, YG (corresponding author), Univ Florida, Shands Hosp, Dept Anesthesiol & Surg, Gainesville, FL 32610 USA.	dzndingding@hotmail.com			Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This study was supported by a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 1997, ANESTH ANALG, V85, P252, DOI 10.1097/00000539-199708000-00003; DEHERT SG, 1994, ACTA ANAESTH SCAND, V38, P479, DOI 10.1111/j.1399-6576.1994.tb03933.x; Denault A, 2009, CAN J ANAESTH, V56, P534, DOI 10.1007/s12630-009-9088-8; DREXLER H, 1993, AM HEART J, V126, P761, DOI 10.1016/0002-8703(93)90926-Z; Fattouch K, 2005, J CARDIAC SURG, V20, P171, DOI 10.1111/j.0886-0440.2005.200383w.x; Joannides R, 2001, HYPERTENSION, V38, P1446, DOI 10.1161/hy1201.096529; Kanazawa M, 2003, ANESTHESIOLOGY, V99, P48, DOI 10.1097/00000542-200307000-00011; Le VP, 2011, AM J PHYSIOL-HEART C, V301, pH221, DOI 10.1152/ajpheart.00119.2011; Loukanov T, 2011, CARDIOL YOUNG, V21, P161, DOI 10.1017/S1047951110001630; Manecke GR, 2004, J CARDIOTHOR VASC AN, V18, P175, DOI 10.1053/j.jvca.2004.01.023; Nakayama R, 1993, J Anesth, V7, P8, DOI 10.1007/s0054030070008; Narimatsu N, 1999, Masui, V48, P599; PAUCA AL, 1994, CHEST, V105, P69, DOI 10.1378/chest.105.1.69; RICH GF, 1992, ANESTHESIOLOGY, V77, P63, DOI 10.1097/00000542-199207000-00009; Seki M, 2012, EUR J CARDIO-THORAC, V41, P277, DOI 10.1016/j.ejcts.2011.05.024; URZUA J, 1990, ANESTH ANALG, V71, P710; Vercauteren M, 2006, CIRCULATION, V114, P2498, DOI 10.1161/CIRCULATIONAHA.106.630129; Yazigi A, 2002, ACTA ANAESTH SCAND, V46, P173, DOI 10.1034/j.1399-6576.2002.460208.x; Zhao J, 1997, Masui, V46, P1235	19	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e68890	10.1371/journal.pone.0068890	http://dx.doi.org/10.1371/journal.pone.0068890			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894368	Green Published, Green Submitted, gold			2022-12-27	WOS:000322132100029
J	Tang, S; Buriro, R; Liu, ZJ; Zhang, M; Ali, I; Adam, A; Hartung, J; Bao, ED				Tang, Shu; Buriro, Rehana; Liu, Zhijun; Zhang, Miao; Ali, Islam; Adam, Abdelnasir; Hartung, Joerg; Bao, Endong			Localization and Expression of Hsp27 and alpha B-Crystallin in Rat Primary Myocardial Cells during Heat Stress In Vitro	PLOS ONE			English	Article							SHOCK PROTEINS PROTECT; CREATINE-KINASE; APOPTOSIS; ISCHEMIA; HYPERTHERMIA; TISSUES; STROKE; HSP70; LIVER	Neonatal rat primary myocardial cells were subjected to heat stress in vitro, as a model for investigating the distribution and expression of Hsp27 and alpha B-crystallin. After exposure to heat stress at 42 degrees C for different durations, the activities of enzymes expressed during cell damage increased in the supernatant of the heat-stressed myocardial cells from 10 min, and the pathological lesions were characterized by karyopyknosis and acute degeneration. Thus, cell damage was induced at the onset of heat stress. Immunofluorescence analysis showed stronger positive signals for both Hsp27 and alpha B-crystallin from 10 min to 240 min of exposure compared to the control cells. According to the Western blotting results, during the 480 min of heat stress, no significant variation was found in Hsp27 and alpha B-crystallin expression; however, significant differences were found in the induction of their corresponding mRNAs. The expression of these small heat shock proteins (sHsps) was probably delayed or overtaxed due to the rapid consumption of sHsps in myocardial cells at the onset of heat stress. Our findings indicate that Hsp27 and alpha B-crystallin do play a role in the response of cardiac cells to heat stress, but the details of their function remain to be investigated.	[Tang, Shu; Buriro, Rehana; Liu, Zhijun; Ali, Islam; Adam, Abdelnasir; Bao, Endong] Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China; [Zhang, Miao] Jinling Inst Technol, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Hartung, Joerg] Univ Vet Med Hannover, Inst Anim Hyg Anim Welf & Farm Anim Behav, Hannover, Germany	Nanjing Agricultural University; Jinling Institute of Technology; University of Veterinary Medicine Hannover, Foundation	Bao, ED (corresponding author), Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China.	b_endong@njau.edu.cn			National Natural Science Foundation of China [30972165, 30430420]; National Department Public Benefit Research Foundation (Agriculture) [201003060-11]; Sino-German Agricultural Cooperation Project of the Federal Ministry of Food, the Agriculture and Consumer Production, Berlin, Germany; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Department Public Benefit Research Foundation (Agriculture); Sino-German Agricultural Cooperation Project of the Federal Ministry of Food, the Agriculture and Consumer Production, Berlin, Germany; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Funding provided by the National Natural Science Foundation of China (30972165, 30430420), the National Department Public Benefit Research Foundation (Agriculture) (201003060-11), the Sino-German Agricultural Cooperation Project of the Federal Ministry of Food, the Agriculture and Consumer Production, Berlin, Germany, and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acunzo J, 2012, INT J BIOCHEM CELL B, V44, P1622, DOI 10.1016/j.biocel.2012.04.002; Bao ED, 2008, CELL STRESS CHAPERON, V13, P459, DOI 10.1007/s12192-008-0042-4; Bettaieb A, 2008, BIOCHEM CELL BIOL, V86, P521, DOI 10.1139/O08-136; BHAT SP, 1989, BIOCHEM BIOPH RES CO, V158, P319, DOI 10.1016/S0006-291X(89)80215-3; Bluhm WF, 1998, AM J PHYSIOL-HEART C, V275, pH2243, DOI 10.1152/ajpheart.1998.275.6.H2243; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Buyukokuroglu ME, 2004, HUM EXP TOXICOL, V23, P251, DOI 10.1191/0960327104ht443oa; Christians ES, 2012, INT J BIOCHEM CELL B, V44, P1632, DOI 10.1016/j.biocel.2012.06.006; De Maio A, 1999, SHOCK, V11, P1, DOI 10.1097/00024382-199901000-00001; Garrido C, 2012, INT J BIOCHEM CELL B, V44, P1588, DOI 10.1016/j.biocel.2012.02.022; GEORGOPOULOS C, 1993, ANNU REV CELL BIOL, V9, P601, DOI 10.1146/annurev.cb.09.110193.003125; GERNOLD M, 1993, DEV GENET, V14, P103, DOI 10.1002/dvg.1020140204; Geum D, 2002, J BIOL CHEM, V277, P19913, DOI 10.1074/jbc.M104396200; Haslbeck M, 2002, CELL MOL LIFE SCI, V59, P1649, DOI 10.1007/PL00012492; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Hekimsoy Z, 2005, ENDOCR RES, V31, P171, DOI 10.1080/07435800500371706; Herbst J, 2011, J FORENSIC SCI, V56, P1062, DOI 10.1111/j.1556-4029.2011.01760.x; Hildebrandt B, 2002, CRIT REV ONCOL HEMAT, V43, P33, DOI 10.1016/S1040-8428(01)00179-2; Huot J, 1996, CANCER RES, V56, P273; IWAKI T, 1989, CELL, V57, P71, DOI 10.1016/0092-8674(89)90173-6; Kargul J, 2012, INT J BIOCHEM CELL B, V44, P1587, DOI 10.1016/j.biocel.2012.06.022; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; Kourtis N, 2012, NATURE, V490, P213, DOI 10.1038/nature11417; LAVOIE JN, 1995, MOL CELL BIOL, V15, P505, DOI 10.1128/MCB.15.1.505; Lepock JR, 2004, INT J HYPERTHER, V20, P115, DOI 10.1080/02656730310001637334; Lin YH, 2001, J SURG RES, V99, P328, DOI 10.1006/jsre.2001.6177; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Maloyan A, 2005, CIRCULATION, V112, P3451, DOI 10.1161/CIRCULATIONAHA.105.572552; Mearow KM, 2002, J NEUROCHEM, V83, P452, DOI 10.1046/j.1471-4159.2002.01151.x; Mehlen P, 1996, EMBO J, V15, P2695, DOI 10.1002/j.1460-2075.1996.tb00630.x; MITCHELL MA, 1995, RES VET SCI, V59, P30, DOI 10.1016/0034-5288(95)90026-8; OSWALD GA, 1986, BMJ-BRIT MED J, V293, P917, DOI 10.1136/bmj.293.6552.917; Parcellier A, 2005, ANTIOXID REDOX SIGN, V7, P404, DOI 10.1089/ars.2005.7.404; POLLA BS, 1993, EUR RESPIR J, V6, P483; Ray PS, 2001, FASEB J, V15, P393, DOI 10.1096/fj.00-0199com; Sains AG, 1980, PIG FARMING, V28, P40; Santoro MG, 2000, BIOCHEM PHARMACOL, V59, P55, DOI 10.1016/S0006-2952(99)00299-3; Saravanan G, 2013, INT J CARDIOL, V165, P494, DOI 10.1016/j.ijcard.2011.09.005; Schlattner U, 2006, BBA-MOL BASIS DIS, V1762, P164, DOI 10.1016/j.bbadis.2005.09.004; Sinha AK, 2001, RENAL FAILURE, V23, P727, DOI 10.1081/JDI-100107370; Srivastava P., 2004, CURR PROTOC IMMUNOL; Sugiyama Y, 2000, J BIOL CHEM, V275, P1095, DOI 10.1074/jbc.275.2.1095; Taba K, 2010, ANTICANCER RES, V30, P2539; Thomes P, 2010, PHYTOMEDICINE, V18, P52, DOI 10.1016/j.phymed.2010.06.006; Van Montfort R, 2002, ADV PROTEIN CHEM, V59, P105; Wettstein G, 2012, INT J BIOCHEM CELL B, V44, P1680, DOI 10.1016/j.biocel.2012.05.024; Yu JM, 2008, CELL STRESS CHAPERON, V13, P327, DOI 10.1007/s12192-008-0031-7; Yu Rong-jun, 2006, Fa Yi Xue Za Zhi, V22, P21; Zhang M, 2012, J VET SCI, V13, P253, DOI 10.4142/jvs.2012.13.3.253; Zhang M, 2011, RES VET SCI, V90, P432, DOI 10.1016/j.rvsc.2010.06.028; Zhu L, 2009, CELL STRESS CHAPERON, V14, P61, DOI 10.1007/s12192-008-0055-z	51	22	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e69066	10.1371/journal.pone.0069066	http://dx.doi.org/10.1371/journal.pone.0069066			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894407	gold, Green Published, Green Submitted			2022-12-27	WOS:000322391400039
J	Rivero-Juarez, A; Camacho, A; Merchante, N; Perez-Camacho, I; Macias, J; Ortiz-Garcia, C; Cifuentes, C; Torre-Cisneros, J; Pena, J; Pineda, JA; Rivero, A				Rivero-Juarez, Antonio; Camacho, Angela; Merchante, Nicolas; Perez-Camacho, Ines; Macias, Juan; Ortiz-Garcia, Carmen; Cifuentes, Celia; Torre-Cisneros, Julian; Pena, Jose; Pineda, Juan A.; Rivero, Antonio		Grp Estudio Hepatitis Viricas HEPA	Incidence of Liver Damage of Uncertain Origin in HIV Patients Not Co-Infected with HCV/HBV	PLOS ONE			English	Article							NODULAR REGENERATIVE HYPERPLASIA; VIRAL-HEPATITIS; NONALCOHOLIC STEATOHEPATITIS; ANTIRETROVIRAL THERAPY; PORTAL-HYPERTENSION; INSULIN-RESISTANCE; DISEASE; COINFECTION; PREVALENCE; FIBROSIS	Background and Aims: Several studies have reported that a significant number of HIV patients not co-infected with HCV/HBV develop liver damage of uncertain origin (LDUO). The objective of our study was to evaluate the incidence of and risk factors for the development of LDUO in HIV infected patients not co-infected with HCV/HBV. Methods: Prospective longitudinal study that included HIV-infected patients free of previous liver damage and viral hepatitis B or C co-infections. Patients were followed up at 6-monthly intervals. Liver stiffness was measured at each visit. Abnormal liver stiffness (ALS) was defined as a liver stiffness value greater than 7.2 kPa at two consecutive measurements. For patients who developed ALS, a protocol was followed to diagnose the cause of liver damage. Those patients who could not be diagnosed with any specific cause of liver disease were diagnosed as LDUO and liver biopsy was proposed. Results: 210 patients matched the inclusion criteria and were included. 198 patients completed the study. After a median (Q1-Q3) follow-up of 18 (IQR 12-26) months, 21 patients (10.6%) developed ALS. Of these, fifteen patients were diagnosed as LDUO. The incidence of LDUO was 7.64 cases/100 patient-years. Histological studies were performed on ten (66.6%) patients and all showed liver steatosis. A higher HOMA-IR value and body mass index were independently associated with the development of LDUO. Conclusion: We found a high incidence of LDUO in HIV-infected patients associated with metabolic risk factors. The leading cause of LDUO in our study was non-alcoholic fatty liver disease.	[Rivero-Juarez, Antonio; Camacho, Angela; Torre-Cisneros, Julian; Rivero, Antonio] Hosp Univ Reina Sofia, Inst Maimonides Invest Biomed Cordoba IMIBIC, Infect Dis Unit, Cordoba, Spain; [Merchante, Nicolas; Macias, Juan; Cifuentes, Celia; Pineda, Juan A.] Hosp Univ Valme, Inst Invest Sanitaria Sevilla IBIS, Infect Dis Unit, Seville, Spain; [Perez-Camacho, Ines] Hosp Poniente, Dept Internal Med, Almeria, Spain; [Ortiz-Garcia, Carmen] Hosp Univ Reina Sofia, Inst Maimonides Invest Biomed Cordoba IMIBIC, Clin Anal Unit, Cordoba, Spain; [Pena, Jose] Hosp Univ Reina Sofia, Inst Maimonides Invest Biomed Cordoba IMIBIC, Immunol Unit, Cordoba, Spain	Hospital Valme	Rivero, A (corresponding author), Hosp Univ Reina Sofia, Inst Maimonides Invest Biomed Cordoba IMIBIC, Infect Dis Unit, Cordoba, Spain.	ariveror@gmail.com	Pineda, Juan A./AAO-9312-2021; Espejo, Angela Camacho/AAM-9991-2021; DE LA TORRE CISNEROS, JULIAN/AAL-5723-2021; Rivero-Juarez, Antonio/E-4528-2019; Macias, Juan/I-9133-2019; Rivero, Antonio/ABE-5294-2020	Pineda, Juan A./0000-0002-3751-0296; Rivero-Juarez, Antonio/0000-0002-5813-6889; Macias, Juan/0000-0002-4778-790X; Merchante, Nicolas/0000-0003-1120-8942; Rivero Roman, Antonio/0000-0002-8643-4250; Rivero, Antonio/0000-0001-5005-8268	Consejeria de Salud de la Junta de Andalucia [PI: 0036/2010, PI-0247/2010, PI-0208/2008, PI-0124/2008, PI-0305/2009]; Spanish Minister of Health ISCIII-RETIC [RD06/006, PI-10/164, PI-509/0024, PI-10/01232]; Fundacion para la Investigacion y Prevencion del SIDA en Espana [FIPSE-3536/05]; Programa de Intensificacion de la Actividad de Investigacion del Servicio Nacional de salud espanol (I3SNS); Consejeria de Salud, Innovacion y Ciencia from the Junta de Andalucia; Instituto de Salud Carlos III [Programa-I3SNS]; Fundacion Progreso y Salud	Consejeria de Salud de la Junta de Andalucia(Junta de Andalucia); Spanish Minister of Health ISCIII-RETIC; Fundacion para la Investigacion y Prevencion del SIDA en Espana; Programa de Intensificacion de la Actividad de Investigacion del Servicio Nacional de salud espanol (I3SNS); Consejeria de Salud, Innovacion y Ciencia from the Junta de Andalucia; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fundacion Progreso y Salud	This work was supported by Fundacion Progreso y Salud, Consejeria de Salud de la Junta de Andalucia (grants for health research projects: refs. PI: 0036/2010; PI-0247/2010; PI-0208/2008; PI-0124/2008; PI-0305/2009), Spanish Minister of Health ISCIII-RETIC RD06/006 projects PI-10/164, PI-509/0024 and PI-10/01232, Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE-3536/05). J.A.P. has received a Research Extension Grant from the Programa de Intensificacion de la Actividad de Investigacion del Servicio Nacional de salud espanol (I3SNS). A.R. has received a Research Extension Grant from the Consejeria de Salud, Innovacion y Ciencia from the Junta de Andalucia. J.A.P. is the recipient of extension grant from the Instituto de Salud Carlos III (grant number Programa-I3SNS). J.M. has received the Reserach Grant Refuerzo con recursos humanos de la actividad investigadora de las Unidades de Gestion Clinica del SAS mediante contratos de larga duracion, para el desarrollo de programas de investigacion, desarrollo e innovacion (Exp. B0037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Ascaso JF, 2003, DIABETES CARE, V26, P3320, DOI 10.2337/diacare.26.12.3320; Branch AD, 2012, CLIN INFECT DIS, V55, P137, DOI 10.1093/cid/cis404; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Crum-Cianflone N, 2009, JAIDS-J ACQ IMM DEF, V50, P464, DOI 10.1097/QAI.0b013e318198a88a; Guaraldi G, 2008, CLIN INFECT DIS, V47, P250, DOI 10.1086/589294; Guaraldi G, 2011, ARCH MED RES, V42, P690, DOI 10.1016/j.arcmed.2011.12.009; Hamaguchi M, 2005, ANN INTERN MED, V143, P722, DOI 10.7326/0003-4819-143-10-200511150-00009; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hernando V, 2012, AIDS, V26, P1829, DOI 10.1097/QAD.0b013e328352ada4; Ingiliz P, 2009, HEPATOLOGY, V49, P436, DOI 10.1002/hep.22665; Kim AY, 2009, GASTROENTEROLOGY, V137, P795, DOI 10.1053/j.gastro.2009.06.040; Maida I, 2008, ANTIVIR THER, V13, P103; Maida I, 2006, JAIDS-J ACQ IMM DEF, V42, P177, DOI 10.1097/01.qai.0000221683.44940.62; Mallet V, 2007, AIDS, V21, P187, DOI 10.1097/QAD.0b013e3280119e47; Merchante N, 2010, ANTIVIR THER, V15, P753, DOI 10.3851/IMP1612; Neuman MG, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/760706; SCHEUER PJ, 1991, J HEPATOL, V13, P372, DOI 10.1016/0168-8278(91)90084-O; Schiano TD, 2007, AM J GASTROENTEROL, V102, P2536, DOI 10.1111/j.1572-0241.2007.01428.x; Soriano V, 2010, ANTIVIR RES, V85, P303, DOI 10.1016/j.antiviral.2009.10.021; Stabinski L, 2011, ANTIVIR THER, V16, P405, DOI 10.3851/IMP1783; Suzuki A, 2005, HEPATOLOGY, V41, P64, DOI 10.1002/hep.20543; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Vecchi VL, 2012, INT J INFECT DIS, V16, pE397, DOI 10.1016/j.ijid.2012.01.011; Vergara S, 2007, CLIN INFECT DIS, V45, P969, DOI 10.1086/521857; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; WANLESS IR, 1990, HEPATOLOGY, V11, P787, DOI 10.1002/hep.1840110512; Whalley S, 2007, CLIN MED, V7, P119, DOI 10.7861/clinmedicine.7-2-119	30	30	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e68953	10.1371/journal.pone.0068953	http://dx.doi.org/10.1371/journal.pone.0068953			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874824	gold, Green Published			2022-12-27	WOS:000324146200045
J	Soderlund, C; Nelson, W; Willer, M; Gang, DR				Soderlund, Carol; Nelson, William; Willer, Mark; Gang, David R.			TCW: Transcriptome Computational Workbench	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; GENE-EXPRESSION; SEQUENCE; ALIGNMENT; PACKAGE; BIOCONDUCTOR; ANNOTATION; DATABASE	Background: The analysis of transcriptome data involves many steps and various programs, along with organization of large amounts of data and results. Without a methodical approach for storage, analysis and query, the resulting ad hoc analysis can lead to human error, loss of data and results, inefficient use of time, and lack of verifiability, repeatability, and extensibility. Methodology: The Transcriptome Computational Workbench (TCW) provides Java graphical interfaces for methodical analysis for both single and comparative transcriptome data without the use of a reference genome (e.g. for non-model organisms). The singleTCW interface steps the user through importing transcript sequences (e.g. Illumina) or assembling long sequences (e.g. Sanger, 454, transcripts), annotating the sequences, and performing differential expression analysis using published statistical programs in R. The data, metadata, and results are stored in a MySQL database. The multiTCW interface builds a comparison database by importing sequence and annotation from one or more single TCW databases, executes the ESTscan program to translate the sequences into proteins, and then incorporates one or more clusterings, where the clustering options are to execute the orthoMCL program, compute transitive closure, or import clusters. Both singleTCW and multiTCW allow extensive query and display of the results, where singleTCW displays the alignment of annotation hits to transcript sequences, and multiTCW displays multiple transcript alignments with MUSCLE or pairwise alignments. The query programs can be executed on the desktop for fastest analysis, or from the web for sharing the results. Conclusion: It is now affordable to buy a multi-processor machine, and easy to install Java and MySQL. By simply downloading the TCW, the user can interactively analyze, query and view their data. The TCW allows in-depth data mining of the results, which can lead to a better understanding of the transcriptome. TCW is freely available from www.agcol.arizona.edu/software/tcw.	[Soderlund, Carol; Nelson, William; Willer, Mark] Univ Arizona, Inst BIO5, Tucson, AZ 85719 USA; [Gang, David R.] Washington State Univ, Pullman, WA 99164 USA	University of Arizona; Washington State University	Soderlund, C (corresponding author), Univ Arizona, Inst BIO5, Tucson, AZ 85719 USA.	cari@agcol.arizona.edu			National Science Foundation [IOS-1044821, 1044821]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation grant IOS-1044821 (http://www.nsf.gov/awardsearch/showAward?AWD_ID = 1044821). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P304, DOI 10.1093/nar/28.1.304; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Blake JA, 2012, NUCLEIC ACIDS RES, V40, pD559, DOI 10.1093/nar/gkr1028; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Dimmer EC, 2012, NUCLEIC ACIDS RES, V40, pD565, DOI 10.1093/nar/gkr1048; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goff SA, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00034; Goncalves A, 2011, BIOINFORMATICS, V27, P867, DOI 10.1093/bioinformatics/btr012; Hardcastle TJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-422; He RF, 2012, AM J BOT, V99, P232, DOI 10.3732/ajb.1100429; Howe EA, 2011, BIOINFORMATICS, V27, P3209, DOI 10.1093/bioinformatics/btr490; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Langmead B, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r83; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Linard B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-11; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Rhee SY, 2008, NAT REV GENET, V9, P509, DOI 10.1038/nrg2363; Risso D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-480; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sarachu M, 2005, BIOINFORMATICS, V21, P540, DOI 10.1093/bioinformatics/bti031; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Soderlund C, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr123; Soderlund C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-400; Stekel DJ, 2000, GENOME RES, V10, P2055, DOI 10.1101/gr.GR-1325RR; Aoki Kiyoko F, 2005, Curr Protoc Bioinformatics, VChapter 1, DOI [10.1002/0471250953.bi0112s38, 10.1002/0471250953.bi0112s11]; Theocharidis A, 2009, NAT PROTOC, V4, P1535, DOI 10.1038/nprot.2009.177; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang H, 2011, NUCLEIC ACIDS RES, V39, pD1114, DOI 10.1093/nar/gkq1141; Zheng Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-453	40	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e69401	10.1371/journal.pone.0069401	http://dx.doi.org/10.1371/journal.pone.0069401			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23874959	Green Submitted, Green Published, gold			2022-12-27	WOS:000322000600051
J	Gaston, MA; Pellino, CA; Weiss, AA				Gaston, Marsha A.; Pellino, Christine A.; Weiss, Alison A.			Failure of Manganese to Protect from Shiga Toxin	PLOS ONE			English	Article							HEMOLYTIC-UREMIC-SYNDROME; ESCHERICHIA-COLI; DEVELOPMENTAL TOXICITY; EXPOSURE; MICE; VIRULENCE; SYSTEM; CELLS; ENTRY	Shiga toxin (Stx), the main virulence factor of Shiga toxin producing Escherichia coli, is a major public health threat, causing hemorrhagic colitis and hemolytic uremic syndrome. Currently, there are no approved therapeutics for these infections; however manganese has been reported to provide protection from the Stx1 variant isolated from Shigella dysenteriae (Stx1-S) both in vitro and in vivo. We investigated the efficacy of manganese protection from Stx1-S and the more potent Stx2a isoform, using experimental systems well-established for studying Stx: in vitro responses of Vero monkey kidney cells, and in vivo toxicity to CD-1 outbred mice. Manganese treatment at the reported therapeutic concentration was toxic to Vero cells in culture and to CD-1 mice. At lower manganese concentrations that were better tolerated, we observed no protection from Stx1-S or Stx2a toxicity. The ability of manganese to prevent the effects of Stx may be particular to certain cell lines, mouse strains, or may only be manifested at high, potentially toxic manganese concentrations.	[Gaston, Marsha A.; Pellino, Christine A.; Weiss, Alison A.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA	University of Cincinnati	Weiss, AA (corresponding author), Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA.	alison.weiss@uc.edu		Weiss, Alison/0000-0002-4726-8376	National Institutes of Health [R01 AI 064893]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064893] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding provided by National Institutes of Health Grants R01 AI 064893. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, INTEGRATED RISK INFO; Besio R, 2012, BIOCH BIOPHYS ACTA; Betz J, 2011, J LIPID RES, V52, P618, DOI 10.1194/jlr.M010819; Boerlin P, 1999, J CLIN MICROBIOL, V37, P497, DOI 10.1128/JCM.37.3.497-503.1999; BORGSTAHL GEO, 1992, CELL, V71, P107, DOI 10.1016/0092-8674(92)90270-M; Colomina MT, 1996, VET HUM TOXICOL, V38, P7; Crossgrove J, 2004, NMR BIOMED, V17, P544, DOI 10.1002/nbm.931; ENDO Y, 1988, EUR J BIOCHEM, V171, P45, DOI 10.1111/j.1432-1033.1988.tb13756.x; Engedal N, 2011, MICROB BIOTECHNOL, V4, P32, DOI 10.1111/j.1751-7915.2010.00180.x; Fuller CA, 2011, INFECT IMMUN, V79, P1329, DOI 10.1128/IAI.01182-10; Hudnell HK, 1999, NEUROTOXICOLOGY, V20, P379; Kanyo ZF, 1996, NATURE, V383, P554, DOI 10.1038/383554a0; LAUWERYS R, 1985, AM J IND MED, V7, P171, DOI 10.1002/ajim.4700070208; McGannon CM, 2010, ANTIMICROB AGENTS CH, V54, P3790, DOI 10.1128/AAC.01783-09; McKenzie J, 2009, FEBS J, V276, P1581, DOI 10.1111/j.1742-4658.2009.06890.x; Mukhopadhyay S, 2012, SCIENCE, V335, P332, DOI 10.1126/science.1215930; Obata F, 2008, J INFECT DIS, V198, P1398, DOI 10.1086/591911; OBRIG TG, 1993, J BIOL CHEM, V268, P15484; Papp-Wallace KM, 2006, ANNU REV MICROBIOL, V60, P187, DOI 10.1146/annurev.micro.60.080805.142149; Ponnapakkam TP, 2003, REPROD TOXICOL, V17, P547, DOI 10.1016/S0890-6238(03)00101-1; PUDYMAITIS A, 1992, J CELL PHYSIOL, V150, P632, DOI 10.1002/jcp.1041500324; Sandvig K, 2000, EMBO J, V19, P5943, DOI 10.1093/emboj/19.22.5943; SANDVIG K, 1987, INFECT IMMUN, V55, P298, DOI 10.1128/IAI.55.2.298-303.1987; Sandvig K., 2005, COMPREHENSIVE SOURCE, P310; Siegler RL, 2003, PEDIATR NEPHROL, V18, P92, DOI 10.1007/s00467-002-1035-7; Stearns-Kurosawa DJ, 2010, INFECT IMMUN, V78, P2497, DOI 10.1128/IAI.01435-09; SYMONDS HW, 1983, RES VET SCI, V35, P5, DOI 10.1016/S0034-5288(18)32193-3; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; TESH VL, 1993, INFECT IMMUN, V61, P3392, DOI 10.1128/IAI.61.8.3392-3402.1993; TORGERSEN ML, 2010, OPEN TOXINOL J, V3, P3, DOI DOI 10.2174/1875414701003020003; TREINEN KA, 1995, TERATOLOGY, V52, P109, DOI 10.1002/tera.1420520207; WHO,, 1999, CONCISE INT CHEM ASS; Wirth JJ, 2007, EPIDEMIOLOGY, V18, P270, DOI 10.1097/01.ede.0000253939.06166.7e	33	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e69823	10.1371/journal.pone.0069823	http://dx.doi.org/10.1371/journal.pone.0069823			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23875002	Green Published, Green Submitted, gold			2022-12-27	WOS:000322064300120
J	Laurens, MB; Billingsley, P; Richman, A; Eappen, AG; Adams, M; Li, T; Chakravarty, S; Gunasekera, A; Jacob, CG; Sim, BKL; Edelman, R; Plowe, CV; Hoffman, SL; Lyke, KE				Laurens, Matthew B.; Billingsley, Peter; Richman, Adam; Eappen, Abraham G.; Adams, Matthew; Li, Tao; Chakravarty, Sumana; Gunasekera, Anusha; Jacob, Christopher G.; Sim, B. Kim Lee; Edelman, Robert; Plowe, Christopher V.; Hoffman, Stephen L.; Lyke, Kirsten E.			Successful Human Infection with P. falciparum Using Three Aseptic Anopheles stephensi Mosquitoes: A New Model for Controlled Human Malaria Infection	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; PHASE 2A TRIAL; PLASMODIUM-FALCIPARUM; NAIVE ADULTS; VACCINE; SPOROZOITE; EFFICACY; CHALLENGE; SAFETY; PARASITEMIA	Controlled human malaria infection (CHMI) is a powerful method for assessing the efficacy of anti-malaria vaccines and drugs targeting pre-erythrocytic and erythrocytic stages of the parasite. CHMI has heretofore required the bites of 5 Plasmodium falciparum (Pf) sporozoite (SPZ)-infected mosquitoes to reliably induce Pf malaria. We reported that CHMI using the bites of 3 PfSPZ-infected mosquitoes reared aseptically in compliance with current good manufacturing practices (cGMP) was successful in 6 participants. Here, we report results from a subsequent CHMI study using 3 PfSPZ-infected mosquitoes reared aseptically to validate the initial clinical trial. We also compare results of safety, tolerability, and transmission dynamics in participants undergoing CHMI using 3 PfSPZ-infected mosquitoes reared aseptically to published studies of CHMI using 5 mosquitoes. Nineteen adults aged 18-40 years were bitten by 3 Anopheles stephensi mosquitoes infected with the chloroquine-sensitive NF54 strain of Pf. All 19 participants developed malaria (100%); 12 of 19 (63%) on Day 11. The mean pre-patent period was 258.3 hours (range 210.5-333.8). The geometric mean parasitemia at first diagnosis by microscopy was 9.5 parasites/mL (range 2-44). Quantitative polymerase chain reaction (qPCR) detected parasites an average of 79.8 hours (range 43.8-116.7) before microscopy. The mosquitoes had a geometric mean of 37,894 PfSPZ/ mosquito (range 3,500-152,200). Exposure to the bites of 3 aseptically-raised, PfSPZ-infected mosquitoes is a safe, effective procedure for CHMI in malaria-naive adults. The aseptic model should be considered as a new standard for CHMI trials in non-endemic areas. Microscopy is the gold standard used for the diagnosis of Pf malaria after CHMI, but qPCR identifies parasites earlier. If qPCR continues to be shown to be highly specific, and can be made to be practical, rapid, and standardized, it should be considered as an alternative for diagnosis.	[Laurens, Matthew B.; Adams, Matthew; Jacob, Christopher G.; Edelman, Robert; Plowe, Christopher V.; Lyke, Kirsten E.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Howard Hughes Med Inst, Baltimore, MD 21201 USA; [Billingsley, Peter; Richman, Adam; Eappen, Abraham G.; Li, Tao; Chakravarty, Sumana; Gunasekera, Anusha; Sim, B. Kim Lee; Hoffman, Stephen L.] Sanaria Inc, Rockville, MD USA; [Sim, B. Kim Lee] Prot Potential LLC, Rockville, MD USA	Howard Hughes Medical Institute; University System of Maryland; University of Maryland Baltimore; Sanaria Inc.	Lyke, KE (corresponding author), Univ Maryland, Sch Med, Ctr Vaccine Dev, Howard Hughes Med Inst, Baltimore, MD 21201 USA.	klyke@medicine.umaryland.edu	Laurens, Matthew/E-7293-2013	Laurens, Matthew/0000-0003-3874-581X	NIAID/NIH VTEU [HHSN272200800057C, N01-AI-80001]; Howard Hughes Medical Institute; NIAID/NIH [AI-067954]; Doris Duke Charitable Foundation; National Institutes of Health; National Institute of Allergy and Infectious Diseases; Small Business Innovative Research Grants [R44AI055229, R44AI058375]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R44AI055229, R01AI067954, R44AI058375] Funding Source: NIH RePORTER	NIAID/NIH VTEU; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Small Business Innovative Research Grants; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was funded by NIAID/NIH VTEU contract HHSN272200800057C, N01-AI-80001; Aseptic-raised mosquitoes were provided by Sanaria, Inc. CVP, ML and MA are supported by the Howard Hughes Medical Institute, which also supported the molecular work. KEL is also supported by an R01 grant, AI-067954, from NIAID/NIH. KEL and CVP were further supported by the Doris Duke Charitable Foundation. Sanaria received funding from National Institutes of Health, National Institute of Allergy and Infectious Diseases, Small Business Innovative Research Grants R44AI055229 and R44AI058375. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. These affiliations do not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Andrews L, 2005, AM J TROP MED HYG, V73, P191, DOI 10.4269/ajtmh.2005.73.191; [Anonymous], 2010, LANCET, V375, P1407, DOI 10.1016/S0140-6736(10)60601-0; BALLOU WR, 1987, LANCET, V1, P1277; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Bejon P, 2005, J INFECT DIS, V191, P619, DOI 10.1086/427243; Bejon P, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-104; Blanford S, 2005, SCIENCE, V308, P1638, DOI 10.1126/science.1108423; Brown EM, 2000, HIST PSYCHIATR, V11, P371, DOI 10.1177/0957154X0001104403; CHULAY JD, 1986, AM J TROP MED HYG, V35, P66, DOI 10.4269/ajtmh.1986.35.66; Church LWP, 1997, J INFECT DIS, V175, P915, DOI 10.1086/513990; CLYDE DF, 1973, AM J MED SCI, V266, P169, DOI 10.1097/00000441-197309000-00002; Collins WE, 2003, AM J TROP MED HYG, V68, P366, DOI 10.4269/ajtmh.2003.68.366; DRIVER JR, 1926, J AM MED ASS; Eichner M, 2001, T ROY SOC TROP MED H, V95, P497, DOI 10.1016/S0035-9203(01)90016-1; Epstein JE, 2011, SCIENCE, V334, P475, DOI 10.1126/science.1211548; Epstein JE, 2007, J INFECT DIS, V196, P145, DOI 10.1086/518510; Gaziano TA, 2008, LANCET, V371, P923, DOI 10.1016/S0140-6736(08)60418-3; George J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-219; GUNDERSON JH, 1987, SCIENCE, V238, P933, DOI 10.1126/science.3672135; Hermsen CC, 2004, AM J TROP MED HYG, V71, P196, DOI 10.4269/ajtmh.2004.71.2.0700196; HERRINGTON DA, 1988, TROP GEOGR MED, V40, P124; HERRINGTON DA, 1987, NATURE, V328, P257, DOI 10.1038/328257a0; Hoffman SL, 2010, HUM VACCINES, V6, P97, DOI 10.4161/hv.6.1.10396; Jarra W, 1998, INFECT IMMUN, V66, P3783, DOI 10.1128/IAI.66.8.3783-3787.1998; JEFFERY G. M., 1959, ANN TROP MED AND PARASITOL, V53, P51; Kester KE, 2001, J INFECT DIS, V183, P640, DOI 10.1086/318534; Kester KE, 2008, VACCINE, V26, P2191, DOI 10.1016/j.vaccine.2008.02.048; Kester KE, 2007, VACCINE, V25, P5359, DOI 10.1016/j.vaccine.2007.05.005; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; Laurens MB, 2012, VACCINE, DOI [10.1016/j.vac-cine.2012.04.088, DOI 10.1016/J.VAC-CINE.2012.04.088]; Lavstsen T, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-21; Lyke KE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013490; MAGUIRE T, 1970, Journal of Hygiene, V68, P625; McCall MBB, 2007, J IMMUNOL, V179, P162, DOI 10.4049/jimmunol.179.1.162; MCCUTCHAN TF, 1995, PARASITOL TODAY, V11, P134, DOI 10.1016/0169-4758(95)80132-4; McKenzie FE, 2007, J PARASITOL, V93, P627, DOI 10.1645/GE-1052R.1; Medica DL, 2005, INFECT IMMUN, V73, P4363, DOI 10.1128/IAI.73.7.4363-4369.2005; Menard R, 2000, MICROBES INFECT, V2, P633, DOI 10.1016/S1286-4579(00)00362-2; Moorthy V S, 2009, Vaccine, V27, P5719, DOI 10.1016/j.vaccine.2009.07.049; MURPHY JR, 1990, ANTIMICROB AGENTS CH, V34, P676, DOI 10.1128/AAC.34.4.676; Nieman AE, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-277; Porter DW, 2011, VACCINE, V29, P7514, DOI 10.1016/j.vaccine.2011.03.083; RIECKMANN KH, 1974, T ROY SOC TROP MED H, V68, P258, DOI 10.1016/0035-9203(74)90129-1; Rockett RJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-48; Roestenbeng M, 2013, AM J TROP MED HYG, V88, P5, DOI 10.4269/ajtmh.2012.12-0613; Roestenberg M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038434; Roestenberg M, 2011, LANCET, V377, P1770, DOI 10.1016/S0140-6736(11)60360-7; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; Ross R, 1910, P R SOC LOND B-CONTA, V83, P159, DOI 10.1098/rspb.1910.0075; Sauerwein RW, 2011, NAT REV IMMUNOL, V11, P57, DOI 10.1038/nri2902; Shapiro TA, 1999, AM J TROP MED HYG, V60, P831, DOI 10.4269/ajtmh.1999.60.831; Spring MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005254; Thompson FM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001493; Weissenbock H, 2010, VET MICROBIOL, V140, P271, DOI 10.1016/j.vetmic.2009.08.025; Yoshida S, 2001, MOL BIOCHEM PARASIT, V113, P89, DOI 10.1016/S0166-6851(00)00387-X	55	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68969	10.1371/journal.pone.0068969	http://dx.doi.org/10.1371/journal.pone.0068969			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874828	Green Submitted, Green Published, gold			2022-12-27	WOS:000322064300080
J	Liu, RL; Li, J; Teng, ZG; Zhang, ZH; Xu, Y				Liu, Ranlu; Li, Jing; Teng, Zhigang; Zhang, Zhihong; Xu, Yong			Overexpressed MicroRNA-182 Promotes Proliferation and Invasion in Prostate Cancer PC-3 Cells by Down-Regulating N-myc Downstream Regulated Gene 1 (NDRG1)	PLOS ONE			English	Article							METASTASIS SUPPRESSOR; PANCREATIC-CANCER; TUMOR-METASTASIS; PROFILE ANALYSIS; EXPRESSION; DIFFERENTIATION; CARCINOMA; DRG-1; METHYLATION; GROWTH	MicroRNAs, non-coding 20-22 nucleotide single-stranded RNAs, result in translational repression or degradation and gene silencing of their target genes, and significantly contribute to the regulation of gene expression. In the current study, we report that miR-182 expression was significantly upregulated in prostate cancer tissues and four cell lines, compared to benign prostatic hyperplasia tissues and normal prostatic epithelial (RWPE-1) cells. Ectopic overexpression of miR-182 significantly promotes the proliferation, increases the invasion, promotes the G1/S cell cycle transition and reduces early apotosis of PC-3 cells, while suppression of miR-182 decreased the proliferation and invasion, inhibits the G1/S cell cycle transition and increase early apotosis of PC-3 cells. Additionally, we demonstrated that miR-182 could downregulate expression of NDRG1 by directly targeting the NDRG1 3'-untranslated region. In conclusion, our results suggest that miR-182 plays an important role in the proliferation of human prostate cancer cells by directly suppressing the tumor supressor gene NDRG1. We uncovered a new epigenetic regulation of NDRG1.	[Liu, Ranlu; Zhang, Zhihong; Xu, Yong] Tianjin Med Univ, Tianjin Inst Urol, Hosp 2, Tianjin, Peoples R China; [Liu, Ranlu; Zhang, Zhihong; Xu, Yong] Tianjin Med Univ, Dept Urol, Hosp 2, Tianjin, Peoples R China; [Li, Jing] Zhengzhou Univ, Dept Urol, Affiliated Canc Hosp, Henan Canc Hosp, Zhengzhou 450052, Peoples R China; [Teng, Zhigang] Kaifeng Peoples Hosp, Dept Urol, Kaifeng, Peoples R China	Tianjin Medical University; Tianjin Medical University; Zhengzhou University	Xu, Y (corresponding author), Tianjin Med Univ, Tianjin Inst Urol, Hosp 2, Tianjin, Peoples R China.	xuyong1955@126.com	zhang, zh/GWV-4677-2022		National Natural Science Foundation of China [30800226]; Tianjin Municipal Science and Technology Commission [12ZCDZSY17200]; Second Hospital of Tianjin Medical University [y1003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Municipal Science and Technology Commission; Second Hospital of Tianjin Medical University	This study was supported by grants from National Natural Science Foundation of China (No: 30800226), Tianjin Municipal Science and Technology Commission (No: 12ZCDZSY17200) and the Second Hospital of Tianjin Medical University (No: y1003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Angst E, 2006, BRIT J CANCER, V95, P307, DOI 10.1038/sj.bjc.6603256; Angst E, 2010, PANCREAS, V39, P675, DOI 10.1097/MPA.0b013e3181c8b476; Bandyopadhyay S, 2004, CANCER RES, V64, P7655, DOI 10.1158/0008-5472.CAN-04-1623; Bandyopadhyay S, 2003, CANCER RES, V63, P1731; Bandyopadhyay S, 2006, CANCER RES, V66, P11983, DOI 10.1158/0008-5472.CAN-06-0943; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chang XJ, 2013, CELL BIOCHEM BIOPHYS, V66, P93, DOI 10.1007/s12013-012-9457-8; CRAWFORD ED, 1989, NEW ENGL J MED, V321, P419, DOI 10.1056/NEJM198908173210702; Kovacevic Z, 2011, CARCINOGENESIS, V32, P732, DOI 10.1093/carcin/bgr046; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Li Q, 2011, CLIN EXP METASTAS, V28, P127, DOI 10.1007/s10585-010-9366-4; Li SX, 2008, INDIAN J MED RES, V127, P453; Liu DF, 2012, ASIAN PAC J CANCER P, V13, P3313, DOI 10.7314/APJCP.2012.13.7.3313; Liu W, 2012, EMBO MOL ME IN PRESS; Liu W, 2011, J BIOL CHEM, V286, P18949, DOI 10.1074/jbc.M111.232637; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Maruyama Y, 2006, CANCER RES, V66, P6233, DOI 10.1158/0008-5472.CAN-06-0183; Mihelich BL, 2011, J BIOL CHEM, V286, P44503, DOI 10.1074/jbc.M111.262915; Musiyenko A, 2008, J MOL MED, V86, P313, DOI 10.1007/s00109-007-0296-9; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Park JY, 2008, PANCREAS, V36, pE32, DOI 10.1097/MPA.0b013e3181630ffe; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Rasheed SA, 2013, J BIOL CHEM IN PRESS; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Shi XB, 2008, J CELL MOL MED, V12, P1456, DOI 10.1111/j.1582-4934.2008.00420.x; Shi XB, 2007, P NATL ACAD SCI USA, V104, P19983, DOI 10.1073/pnas.0706641104; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Stein S, 2004, J BIOL CHEM, V279, P48930, DOI 10.1074/jbc.M400386200; Sun YH, 2010, BIOCHEM BIOPH RES CO, V396, P501, DOI 10.1016/j.bbrc.2010.04.127; Tay YMS, 2008, STEM CELLS, V26, P17, DOI 10.1634/stemcells.2007-0295; Tong AW, 2009, CANCER GENE THER, V16, P206, DOI 10.1038/cgt.2008.77; van Belzen N, 1998, HISTOL HISTOPATHOL, V13, P1233, DOI 10.14670/HH-13.1233; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Vrba L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008697; Wu ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045825; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	38	29	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68982	10.1371/journal.pone.0068982	http://dx.doi.org/10.1371/journal.pone.0068982			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874837	gold, Green Published, Green Submitted			2022-12-27	WOS:000322064300081
J	Tricarico, D; Mele, A; Calzolaro, S; Cannone, G; Camerino, GM; Dinardo, MM; Latorre, R; Camerino, DC				Tricarico, Domenico; Mele, Antonietta; Calzolaro, Sara; Cannone, Gianluigi; Maria Camerino, Giulia; Maddalena Dinardo, Maria; Latorre, Ramon; Camerino, Diana Conte			Emerging Role of Calcium-Activated Potassium Channel in the Regulation of Cell Viability Following Potassium Ions Challenge in HEK293 Cells and Pharmacological Modulation	PLOS ONE			English	Article							HYPOKALEMIC PERIODIC PARALYSIS; CARBONIC-ANHYDRASE INHIBITORS; CHRONIC KIDNEY-DISEASE; SKELETAL-MUSCLE; BK CHANNEL; ANDERSENS-SYNDROME; LARGE-CONDUCTANCE; RATS; CHANNELOPATHIES; HYPERKALEMIA	Emerging evidences suggest that Ca2+ activated-K+-(BK) channel is involved in the regulation of cell viability. The changes of the cell viability observed under hyperkalemia (15 mEq/L) or hypokalemia (0.55 mEq/L) conditions were investigated in HEK293 cells expressing the hslo subunit (hslo-HEK293) in the presence or absence of BK channel modulators. The BK channel openers(10(-11)-10(-3)M) were: acetazolamide(ACTZ), Dichlorphenamide(DCP), methazolamide(MTZ), bendroflumethiazide(BFT), ethoxzolamide(ETX), hydrochlorthiazide(HCT), quercetin(QUERC), resveratrol(RESV) and NS1619; and the BK channel blockers(2x10(-7)M-5x10(-3)M) were: tetraethylammonium(TEA), iberiotoxin(IbTx) and charybdotoxin(ChTX). Experiments on cell viability and channel currents were performed using cell counting kit-8 and patch-clamp techniques, respectively. Hslo whole-cell current was potentiated by BK channel openers with different potency and efficacy in hslo-HEK293. The efficacy ranking of the openers at -60 mV(Vm) was BFT> ACTZ >DCP >= RESV >= ETX> NS1619> MTZ >= QUERC; HCT was not effective. Cell viability after 24 h of incubation under hyperkalemia was enhanced by 82 +/- 6% and 33 +/- 7% in hslo-HEK293 cells and HEK293 cells, respectively. IbTx, ChTX and TEA enhanced cell viability in hslo-HEK293. BK openers prevented the enhancement of the cell viability induced by hyperkalemia or IbTx in hslo-HEK293 showing an efficacy which was comparable with that observed as BK openers. BK channel modulators failed to affect cell currents and viability under hyperkalemia conditions in the absence of hslo subunit. In contrast, under hypokalemia cell viability was reduced by -22 +/- 4% and -23 +/- 6% in hslo-HEK293 and HEK293 cells, respectively; the BK channel modulators failed to affect this parameter in these cells. In conclusion, BK channel regulates cell viability under hyperkalemia but not hypokalemia conditions. BFT and ACTZ were the most potent drugs either in activating the BK current and in preventing the cell proliferation induced by hyperkalemia. These findings may have relevance in disorders associated with abnormal K+ ion homeostasis including periodic paralysis and myotonia.	[Tricarico, Domenico; Mele, Antonietta; Calzolaro, Sara; Cannone, Gianluigi; Maria Camerino, Giulia; Maddalena Dinardo, Maria; Latorre, Ramon; Camerino, Diana Conte] Univ Bari, Dept Pharm Drug Sci, Bari, Italy; [Tricarico, Domenico; Mele, Antonietta; Calzolaro, Sara; Cannone, Gianluigi; Maria Camerino, Giulia; Maddalena Dinardo, Maria; Latorre, Ramon; Camerino, Diana Conte] Univ Valparaiso, Fac Ciencias, Ctr Neurociencias Valparaiso, Valparaiso, Chile	Universita degli Studi di Bari Aldo Moro; Universidad de Valparaiso	Tricarico, D (corresponding author), Univ Bari, Dept Pharm Drug Sci, Bari, Italy.	domenico.tricarico@uniba.it	Camerino, Giulia Maria/I-6896-2013	Conte, Diana/0000-0003-0162-9698; Camerino, Giulia Maria/0000-0003-1410-6327	Telethon	Telethon(Fondazione Telethon)	This work is supported by Telethon Grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRIAN RH, 1974, J PHYSIOL-LONDON, V240, P505, DOI 10.1113/jphysiol.1974.sp010620; Burg ED, 2008, BRIT J PHARMACOL, V153, P2007; Cannon SC, 1996, ANNU REV NEUROSCI, V19, P141, DOI 10.1146/annurev.ne.19.030196.001041; Cannon SC, 2010, J PHYSIOL-LONDON, V588, P1887, DOI 10.1113/jphysiol.2010.186874; Chang H, 2011, J CELL PHYSIOL, V226, P1660, DOI 10.1002/jcp.22497; Clausen T, 2010, FUND CLIN PHARMACOL, V24, P595, DOI 10.1111/j.1472-8206.2010.00859.x; Dinardo MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040235; Ghatta S, 2006, PHARMACOL THERAPEUT, V110, P103, DOI 10.1016/j.pharmthera.2005.10.007; Green D, 2013, NEPHROL DIAL TRANSPL, V28, P99, DOI 10.1093/ndt/gfs129; Hayes J, 2012, NEPHRON CLIN PRACT, V120, pC8, DOI 10.1159/000329511; Henney NC, 2009, AM J PHYSIOL-CELL PH, V297, pC1397, DOI 10.1152/ajpcell.00311.2009; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Jia XL, 2013, PFLUG ARCH EUR J PHY, V465, P221, DOI 10.1007/s00424-012-1182-z; Kingston Robert E, 2003, Curr Protoc Mol Biol, VChapter 9, DOI 10.1002/0471142727.mb0901s63; Krick S, 2002, AM J PHYSIOL-HEART C, V282, pH184, DOI 10.1152/ajpheart.2002.282.1.H184; Lippiat JD, 1998, PFLUG ARCH EUR J PHY, V436, P810, DOI 10.1007/s004240050708; McVeigh G, 2005, GUIDELINES TREATMENT; Meyer T, 2008, MUSCLE NERVE, V37, P120, DOI 10.1002/mus.20825; Nardi A, 2008, CURR MED CHEM, V15, P1126, DOI 10.2174/092986708784221412; Naresh VVSai, 2008, INDIAN J NEPHROL, V18, P22, DOI [10.4103/0971-4065.41284, DOI 10.4103/0971-4065.41284]; Oberleithner H, 2009, P NATL ACAD SCI USA, V106, P2829, DOI 10.1073/pnas.0813069106; Orio P, 2005, J GEN PHYSIOL, V125, P395, DOI 10.1085/jgp.200409236; Pere AK, 2000, SURGERY, V128, P67, DOI 10.1067/msy.2000.106530; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; Platt D, 2009, CURR OPIN NEUROL, V22, P524, DOI 10.1097/WCO.0b013e32832efa8f; TAWIL R, 1994, ANN NEUROL, V35, P326, DOI 10.1002/ana.410350313; Treistman SN, 2009, TRENDS NEUROSCI, V32, P629, DOI 10.1016/j.tins.2009.08.001; Tricarico D, 2008, BRIT J PHARMACOL, V154, P183, DOI 10.1038/bjp.2008.42; Tricarico D, 2006, NEUROMUSCULAR DISORD, V16, P39, DOI 10.1016/j.nmd.2005.10.005; Tricarico D, 2004, FASEB J, V18, P760, DOI 10.1096/fj.03-0722fje; Tricarico D, 2000, ANN NEUROL, V48, P304, DOI 10.1002/1531-8249(200009)48:3<304::AID-ANA4>3.0.CO;2-A; Tricarico D, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00008; TRUDELL RG, 1987, NEUROLOGY, V37, P488, DOI 10.1212/WNL.37.3.488; Wang W, 2007, AM J PHYSIOL-RENAL, V293, pF1123, DOI 10.1152/ajprenal.00104.2007; Webster A, 2002, EMERG MED J, V19, P74, DOI 10.1136/emj.19.1.74	35	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e69551	10.1371/journal.pone.0069551	http://dx.doi.org/10.1371/journal.pone.0069551			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874973	Green Published, gold, Green Submitted			2022-12-27	WOS:000322064300107
J	Zhang, NG; Jiang, YJ; Mao, QL; Demeler, B; Tao, YJ; Pati, D				Zhang, Nenggang; Jiang, Yunyun; Mao, Qilong; Demeler, Borries; Tao, Yizhi Jane; Pati, Debananda			Characterization of the Interaction between the Cohesin Subunits Rad21 and SA1/2	PLOS ONE			English	Article							SISTER-CHROMATID COHESION; POLO-LIKE KINASE; HUMAN-CELLS; SORORIN; ANAPHASE; SEPARATION; CLEAVAGE; COMPLEX; PROTEIN; CHROMOSOMES	The cohesin complex is responsible for the fidelity of chromosomal segregation during mitosis. It consists of four core subunits, namely Rad21/Mcd1/Scc1, Smc1, Smc3, and one of the yeast Scc3 orthologs SA1 or SA2. Sister chromatid cohesion is generated during DNA replication and maintained until the onset of anaphase. Among the many proposed models of the cohesin complex, the 'core' cohesin subunits Smc1, Smc3, and Rad21 are almost universally displayed as tripartite ring. However, other than its supportive role in the cohesin ring, little is known about the fourth core subunit SA1/SA2. To gain deeper insight into the function of SA1/SA2 in the cohesin complex, we have mapped the interactive regions of SA2 and Rad21 in vitro and ex vivo. Whereas SA2 interacts with Rad21 through a broad region (301-750 aa), Rad21 binds to SA proteins through two SA-binding motifs on Rad21, namely N-terminal (NT) and middle part (MP) SA-binding motif, located at 60-81 aa of the N-terminus and 383-392 aa of the MP of Rad21, respectively. The MP SA-binding motif is a 10 amino acid, alpha-helical motif. Deletion of these 10 amino acids or mutation of three conserved amino acids (L 385, F 389, and T 390) in this alpha-helical motif significantly hinders Rad21 from physically interacting with SA1/2. Besides the MP SA-binding motif, the NT SA-binding motif is also important for SA1/2 interaction. Although mutations on both SA-binding motifs disrupt Rad21-SA1/2 interaction, they had no apparent effect on the Smc1-Smc3-Rad21 interaction. However, the Rad21-Rad21 dimerization was reduced by the mutations, indicating potential involvement of the two SA-binding motifs in the formation of the two-ring handcuff for chromosomal cohesion. Furthermore, mutant Rad21 proteins failed to significantly rescue precocious chromosome separation caused by depletion of endogenous Rad21 in mitotic cells, further indicating the physiological significance of the two SA-binding motifs of Rad21.	[Zhang, Nenggang; Jiang, Yunyun; Mao, Qilong; Pati, Debananda] Baylor Coll Med, Texas Children Canc Ctr, Dept Pediat Hematol Oncol, Houston, TX 77030 USA; [Jiang, Yunyun; Tao, Yizhi Jane; Pati, Debananda] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA; [Demeler, Borries] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	Baylor College of Medicine; Texas Children's Cancer Center; Rice University; University of Texas System; University of Texas Health San Antonio	Tao, YJ (corresponding author), Rice Univ, Dept Biochem & Cell Biol, POB 1892, Houston, TX 77251 USA.	ytao@rice.edu; pati@bcm.edu	Jiang, Yunyun/E-8127-2016	Jiang, Yunyun/0000-0003-4427-8103; Demeler, Borries/0000-0002-2414-9518	National Cancer Institute [1RO1 CA109330]; Virginia and L.E. Simmons Family Foundation Collaborative research award; Welch Foundation [R4079]; National Institutes of Health [RO1 RR022200]; NATIONAL CANCER INSTITUTE [R01CA109478] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR022200] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Virginia and L.E. Simmons Family Foundation Collaborative research award; Welch Foundation(The Welch Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by award 1RO1 CA109330 from the National Cancer Institute to D. Pati, the 2008 Virginia and L.E. Simmons Family Foundation Collaborative research award (https://www.collaborativeresearchfund.org/) to D. Pati and Y. J. Tao, and the Welch Foundation award R4079 to Y. J. Tao. The Ultrascan development is supported by National Institutes of Health grant RO1 RR022200 to B. Demeler. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DE, 2002, J CELL BIOL, V156, P419, DOI 10.1083/jcb.200111002; Arumugam P, 2003, CURR BIOL, V13, P1941, DOI 10.1016/j.cub.2003.10.036; Brookes E, 2010, EUR BIOPHYS J BIOPHY, V39, P405, DOI 10.1007/s00249-009-0413-5; Canudas S, 2009, J CELL BIOL, V187, P165, DOI 10.1083/jcb.200903096; Demeler B, 2004, ANAL BIOCHEM, V335, P279, DOI 10.1016/j.ab.2004.08.039; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; Freshney R.I, 2010, CULTURE ANIMAL CELLS, Vsixth, P732; Gimenez-Abian JF, 2004, CURR BIOL, V14, P1187, DOI 10.1016/j.cub.2004.06.052; Haering CH, 2003, BIOESSAYS, V25, P1178, DOI 10.1002/bies.10361; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Hagstrom KA, 2003, NAT REV GENET, V4, P520, DOI 10.1038/nrg1110; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Losada A, 2005, J CELL SCI, V118, P2133, DOI 10.1242/jcs.02355; Lowe J, 2001, J MOL BIOL, V306, P25, DOI 10.1006/jmbi.2000.4379; Nishiyama T, 2010, CELL, V143, P737, DOI 10.1016/j.cell.2010.10.031; Panigrahi AK, 2009, CRIT REV ONCOL HEMAT; Panigrahi AK, 2011, MOL CELL BIOL, V31, P4335, DOI 10.1128/MCB.06075-11; Panizza S, 2000, CURR BIOL, V10, P1557, DOI 10.1016/S0960-9822(00)00854-X; Pati D, 2002, MOL CELL BIOL, V22, P8267, DOI 10.1128/MCB.22.23.8267-8277.2002; Pezzi N, 2000, FASEB J, V14, P581, DOI 10.1096/fasebj.14.3.581; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Rowland BD, 2009, MOL CELL, V33, P763, DOI 10.1016/j.molcel.2009.02.028; Shintomi K, 2009, GENE DEV, V23, P2224, DOI 10.1101/gad.1844309; Solomon DA, 2011, SCIENCE, V333, P1039, DOI 10.1126/science.1203619; Sumara I, 2002, MOL CELL, V9, P515, DOI 10.1016/S1097-2765(02)00473-2; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 2001, CURR OPIN CELL BIOL, V13, P754, DOI 10.1016/S0955-0674(00)00279-9; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Zhang NG, 2012, CELL CYCLE, V11, P2073, DOI 10.4161/cc.20241; Zhang NG, 2011, J BIOL CHEM, V286, P41826, DOI 10.1074/jbc.M111.305888; Zhang NG, 2009, CELL CYCLE, V8, P399, DOI 10.4161/cc.8.3.7586; Zhang NG, 2008, J CELL BIOL, V183, P1019, DOI 10.1083/jcb.200801157	39	28	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e69458	10.1371/journal.pone.0069458	http://dx.doi.org/10.1371/journal.pone.0069458			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	23874961	Green Published, gold, Green Submitted			2022-12-27	WOS:000321718700052
J	Clarke, JP; Mearow, KM				Clarke, Joseph P.; Mearow, Karen M.			Cell Stress Promotes the Association of Phosphorylated HspB1 with F-Actin	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; P38 MAP KINASE; HETEROOLIGOMERIC COMPLEXES; ESSENTIAL INTERPLAY; CHAPERONE FUNCTION; FILAMENT DYNAMICS; HSP27; CYTOSKELETON; GROWTH; MODULATION	Previous studies have suggested that the small heat shock protein, HspB1, has a direct influence on the dynamics of cytoskeletal elements, in particular, filamentous actin (F-actin) polymerization. In this study we have assessed the influence of HspB1 phosphorylation on its interaction(s) with F-actin. We first determined the distribution of endogenous non-phosphorylated HspB1, phosphorylated HspB1 and F-actin in neuroendocrine PC12 cells by immunocytochemistry and confocal microscopy. We then investigated a potential direct interaction between HspB1 with F-actin by precipitating F-actin directly with biotinylated phalloidin followed by Western analyses; the reverse immunoprecipitation of HspB1 was also carried out. The phosphorylation influence of HspB1 in this interaction was investigated by using pharmacologic inhibition of p38 MAPK. In control cells, HspB1 interacts with F-actin as a predominantly non-phosphorylated protein, but subsequent to stress there is a redistribution of HspB1 to the cytoskeletal fraction and a significantly increased association of pHspB1 with F-actin. Our data demonstrate HspB1 is found in a complex with F-actin both in phosphorylated and non-phosphorylated forms, with an increased association of pHspB1 with F-actin after heat stress. Overall, our study combines both cellular and biochemical approaches to show cellular localization and direct demonstration of an interaction between endogenous HspB1 and F-actin using methodolgy that specifically isolates F-actin.	[Clarke, Joseph P.; Mearow, Karen M.] Mem Univ Newfoundland, Fac Med, Grad Program Neurosci, Div Biomed Sci, St John, NF, Canada	Memorial University Newfoundland	Mearow, KM (corresponding author), Mem Univ Newfoundland, Fac Med, Grad Program Neurosci, Div Biomed Sci, St John, NF, Canada.	kmearow@mun.ca		Clarke, Joseph-Patrick/0000-0001-5473-7479	NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by an NSERC Discovery Grant to KMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benn SC, 2002, NEURON, V36, P45, DOI 10.1016/S0896-6273(02)00941-8; BENNDORF R, 1994, J BIOL CHEM, V269, P20780; Bryantsev AL, 2002, CELL STRESS CHAPERON, V7, P146, DOI 10.1379/1466-1268(2002)007<0146:DPAAOH>2.0.CO;2; Bryantsev AL, 2007, BIOCHEM J, V407, P407, DOI 10.1042/BJ20070195; Costigan M, 1998, J NEUROSCI, V18, P5891; Datskevich PN, 2012, BIOCHIMIE, V94, P1794, DOI 10.1016/j.biochi.2012.04.012; Doshi BM, 2010, ANN NY ACAD SCI, V1197, P76, DOI 10.1111/j.1749-6632.2010.05191.x; Doshi BM, 2009, CELL STRESS CHAPERON, V14, P445, DOI 10.1007/s12192-008-0098-1; During RL, 2007, EMBO J, V26, P2240, DOI 10.1038/sj.emboj.7601687; Ehrnsperger M, 1999, J BIOL CHEM, V274, P14867, DOI 10.1074/jbc.274.21.14867; Ehrnsperger M, 1997, EMBO J, V16, P221, DOI 10.1093/emboj/16.2.221; Fabrizi GM, 2007, BRAIN, V130, P394, DOI 10.1093/brain/awl284; Fulga TA, 2007, NAT CELL BIOL, V9, P139, DOI 10.1038/ncb1528; Graceffa P, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/901572; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Guay J, 1997, J CELL SCI, V110, P357; Hsiao VC, 2005, J CELL SCI, V118, P2057, DOI 10.1242/jcs.02339; Huot J, 1996, CANCER RES, V56, P273; Jia YF, 2010, CELL STRESS CHAPERON, V15, P165, DOI 10.1007/s12192-009-0130-0; Jog NR, 2007, J IMMUNOL, V178, P2421, DOI 10.4049/jimmunol.178.4.2421; KOBAYASHI R, 1982, METABOLISM, V31, P133, DOI 10.1016/0026-0495(82)90124-X; Kostenko S, 2009, CELL MOL LIFE SCI, V66, P3289, DOI 10.1007/s00018-009-0086-3; Lambert H, 1999, J BIOL CHEM, V274, P9378, DOI 10.1074/jbc.274.14.9378; LANDRY J, 1992, J BIOL CHEM, V267, P794; Landry J, 1995, BIOCHEM CELL BIOL, V73, P703, DOI 10.1139/o95-078; Landry J, 1999, BIOCHEM SOC SYMP, P79; LAVOIE JN, 1993, J BIOL CHEM, V268, P24210; LAVOIE JN, 1995, MOL CELL BIOL, V15, P505, DOI 10.1128/MCB.15.1.505; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; Lee JH, 2007, J CANCER RES CLIN, V133, P37, DOI 10.1007/s00432-006-0143-3; Li T, 2012, TOXICOL SCI, V128, P147, DOI 10.1093/toxsci/kfs141; Mearow KM, 2002, J NEUROCHEM, V83, P452, DOI 10.1046/j.1471-4159.2002.01151.x; MEHLEN P, 1994, EUR J BIOCHEM, V221, P327, DOI 10.1111/j.1432-1033.1994.tb18744.x; MIRON T, 1991, J CELL BIOL, V114, P255, DOI 10.1083/jcb.114.2.255; Mymrikov EV, 2012, CELL STRESS CHAPERON, V17, P157, DOI 10.1007/s12192-011-0296-0; Mymrikov EV, 2011, PHYSIOL REV, V91, P1123, DOI 10.1152/physrev.00023.2010; Nollen EAA, 2001, J BIOL CHEM, V276, P4677, DOI 10.1074/jbc.M009745200; Nomura N, 2007, BIOCHEM PHARMACOL, V74, P690, DOI 10.1016/j.bcp.2007.06.018; Okada M, 2004, J BIOL CHEM, V279, P4221, DOI 10.1074/jbc.M309014200; Pichon S, 2004, J CELL SCI, V117, P2569, DOI 10.1242/jcs.01110; Piotrowicz RS, 1998, FASEB J, V12, P1481, DOI 10.1096/fasebj.12.14.1481; Pivovarova AV, 2007, FEBS J, V274, P5937, DOI 10.1111/j.1742-4658.2007.06117.x; Pivovarova AV, 2005, BIOCHEM BIOPH RES CO, V331, P1548, DOI 10.1016/j.bbrc.2005.04.077; Quinlan Roy, 2002, Prog Mol Subcell Biol, V28, P219; Rogalla T, 1999, J BIOL CHEM, V274, P18947, DOI 10.1074/jbc.274.27.18947; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; Rousseau S, 2000, J BIOL CHEM, V275, P10661, DOI 10.1074/jbc.275.14.10661; Schafer C, 1999, AM J PHYSIOL-CELL PH, V277, pC1032; Schneider GB, 1998, J CELL PHYSIOL, V177, P575, DOI 10.1002/(SICI)1097-4652(199812)177:4<575::AID-JCP8>3.0.CO;2-1; Seit-Nebi AS, 2013, INT J BIOCHEM CELL B, V45, P344, DOI 10.1016/j.biocel.2012.11.011; STOKOE D, 1992, FEBS LETT, V313, P307, DOI 10.1016/0014-5793(92)81216-9; Sun Y, 2011, TOXICOL LETT, V207, P270, DOI 10.1016/j.toxlet.2011.09.025; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; Van Why SK, 2003, J AM SOC NEPHROL, V14, P98, DOI 10.1097/01.ASN.0000038687.24289.83; Verschuure P, 2002, J MOL CELL CARDIOL, V34, P117, DOI 10.1006/jmcc.2001.1493; Vigilanza P, 2008, CELL MOL LIFE SCI, V65, P991, DOI 10.1007/s00018-008-7526-3; WATSON DF, 1994, NEUROLOGY, V44, P2383, DOI 10.1212/WNL.44.12.2383; Wettstein G, 2012, INT J BIOCHEM CELL B, V44, P1680, DOI 10.1016/j.biocel.2012.05.024; Williams KL, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-24; Williams KL, 2006, J NEUROSCI RES, V84, P716, DOI 10.1002/jnr.20983; Williams KL, 2011, J NEUROSCI RES, V89, P1160, DOI 10.1002/jnr.22634	61	34	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68978	10.1371/journal.pone.0068978	http://dx.doi.org/10.1371/journal.pone.0068978			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874834	gold, Green Published, Green Submitted			2022-12-27	WOS:000321765300073
J	Ivanov, VZ; Mataix-Cols, D; Serlachius, E; Lichtenstein, P; Anckarsater, H; Chang, Z; Gumpert, CH; Lundstrom, S; Langstrom, N; Ruck, C				Ivanov, Volen Z.; Mataix-Cols, David; Serlachius, Eva; Lichtenstein, Paul; Anckarsater, Henrik; Chang, Zheng; Gumpert, Clara Hellner; Lundstrom, Sebastian; Langstrom, Niklas; Ruck, Christian			Prevalence, Comorbidity and Heritability of Hoarding Symptoms in Adolescence: A Population Based Twin Study in 15-Year Olds	PLOS ONE			English	Article							OBSESSIVE-COMPULSIVE DISORDER; ENVIRONMENTAL-INFLUENCES; CLINICAL-FEATURES; SEX-DIFFERENCES; TELEPHONE INTERVIEW; AUTISM-TICS; A-TAC; CHILDHOOD; ADULTHOOD; CHILDREN	Background: Hoarding Disorder (HD) is often assumed to be an 'old age' problem, but many individuals diagnosed with HD retrospectively report first experiencing symptoms in childhood or adolescence. We examined the prevalence, comorbidity and etiology of hoarding symptoms in adolescence. Methods: To determine the presence of clinically significant hoarding symptoms, a population-based sample of 15-year old twins (N = 3,974) completed the Hoarding Rating Scale-Self Report. Co-occurring Obsessive Compulsive Disorder (OCD), Autism Spectrum Disorders (ASD) and Attention Deficit Hyperactivity Disorder (ADHD) were estimated from parental report. Model-fitting analyses divided hoarding symptom scores into additive genetic, shared, and non-shared environmental effects. Results: The prevalence of clinically significant hoarding symptoms was 2% (95% CI 1.6-2.5%), with a significantly higher prevalence in girls than boys. Exclusion of the clutter criterion (as adolescents do not have control over their environment) increased the prevalence rate to 3.7% (95% CI 3.1-4.3%). Excessive acquisition was reported by 30-40% among those with clinically significant hoarding symptoms. The prevalence of co-occurring OCD (2.9%), ASD (2.9%) and ADHD (10.0%) was comparable in hoarding and non-hoarding teenagers. Model-fitting analyses suggested that, in boys, additive genetic (32%; 95% CI 13-44%) and non-shared environmental effects accounted for most of the variance. In contrast, among girls, shared and non-shared environmental effects explained most of the variance, while additive genetic factors played a negligible role. Conclusions: Hoarding symptoms are relatively prevalent in adolescents, particularly in girls, and cause distress and/or impairment. Hoarding was rarely associated with other common neurodevelopmental disorders, supporting its DSM-5 status as an independent diagnosis. The relative importance of genetic and shared environmental factors for hoarding differed across sexes. The findings are suggestive of dynamic developmental genetic and environmental effects operating from adolescence onto adulthood.	[Ivanov, Volen Z.; Serlachius, Eva; Gumpert, Clara Hellner; Ruck, Christian] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Ivanov, Volen Z.; Lichtenstein, Paul; Chang, Zheng; Langstrom, Niklas] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Mataix-Cols, David] Kings Coll London, Inst Psychiat, Dept Psychosis Studies & Psychol, London WC2R 2LS, England; [Anckarsater, Henrik; Lundstrom, Sebastian] Univ Gothenburg, Ctr Eth Law & Mental Hlth, Gothenburg, Sweden; [Lundstrom, Sebastian] Univ Gothenburg, Gillberg Neuropsychiat Ctr, Inst Neurosci & Physiol, Gothenburg, Sweden	Karolinska Institutet; Karolinska Institutet; University of London; King's College London; University of Gothenburg; University of Gothenburg	Ivanov, VZ (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.	volen.ivanov@ki.se	Mataix-Cols, David/AAF-3347-2021; Rück, Christian/J-4396-2012; Langstrom, Niklas/C-5615-2009; Lundström, Sebastian/N-2303-2015; Mataix-Cols, David/G-3843-2010; Serlachius, Eva/E-8956-2013	Mataix-Cols, David/0000-0002-4545-0924; Rück, Christian/0000-0002-8742-0168; Langstrom, Niklas/0000-0002-2686-6799; Mataix-Cols, David/0000-0002-4545-0924; Serlachius, Eva/0000-0001-7115-6422; lichtenstein, paul/0000-0003-3037-5287	Swedish Council for Working Life; Research Council of the Swedish National Alcohol Monopoly; Swedish Research Council; Swedish Society of Medicine (Stiftelsen Soderstrom-Konigska Sjukhemmet); Riksbankens Jubileumsfond; funds under the Agreement on Medical Training and Research Agreement	Swedish Council for Working Life(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Research Council of the Swedish National Alcohol Monopoly; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society of Medicine (Stiftelsen Soderstrom-Konigska Sjukhemmet); Riksbankens Jubileumsfond; funds under the Agreement on Medical Training and Research Agreement	This study was supported by the Swedish Council for Working Life (http://www.fas.se/en/), the Research Council of the Swedish National Alcohol Monopoly, funds under the Agreement on Medical Training and Research Agreement, the Swedish Research Council (http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html) and the Swedish Society of Medicine (Stiftelsen Soderstrom-Konigska Sjukhemmet)(http://www.sls.se/Om-SLS/In-English/) and Riksbankens Jubileumsfond (http://www.rj.se/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; American Psychiatric Association. (n.d.), DSM 5 DEV; Anckarsater H, 2011, TWIN RES HUM GENET, V14, P495, DOI 10.1375/twin.14.6.495; Ayers CR, 2010, INT J GERIATR PSYCH, V25, P142, DOI 10.1002/gps.2310; Chong SA, 1996, CAN J PSYCHIAT, V41, P315, DOI 10.1177/070674379604100511; Cornes BK, 2007, BEHAV GENET, V37, P648, DOI 10.1007/s10519-007-9165-0; FLAMENT MF, 1988, J AM ACAD CHILD PSY, V27, P764, DOI 10.1097/00004583-198811000-00018; Frost RO, 2011, J CLIN PSYCHOL, V67, P456, DOI 10.1002/jclp.20790; Frost RO, 2011, DEPRESS ANXIETY, V28, P876, DOI 10.1002/da.20861; Frost RO, 2009, J ANXIETY DISORD, V23, P632, DOI 10.1016/j.janxdis.2009.01.013; Frost RO, 1996, BEHAV RES THER, V34, P341, DOI 10.1016/0005-7967(95)00071-2; Grisham JR, 2006, J ANXIETY DISORD, V20, P675, DOI 10.1016/j.janxdis.2005.07.004; Hacker LE, 2012, J ATTEN DISORD, V2012; HANNA GL, 1995, J AM ACAD CHILD PSY, V34, P19, DOI 10.1097/00004583-199501000-00009; Hannelius U, 2007, TWIN RES HUM GENET, V10, P604, DOI 10.1375/twin.10.4.604; Hansson SL, 2005, BRIT J PSYCHIAT, V187, P262, DOI 10.1192/bjp.187.3.262; Hur YM, 2008, TWIN RES HUM GENET, V11, P314, DOI 10.1375/twin.11.3.314; Iervolino AC, 2011, ARCH GEN PSYCHIAT, V68, P637, DOI 10.1001/archgenpsychiatry.2011.54; Iervolino AC, 2009, AM J PSYCHIAT, V166, P1156, DOI 10.1176/appi.ajp.2009.08121789; Jacobson KC, 2002, DEV PSYCHOPATHOL, V14, P395, DOI 10.1017/S0954579402002110; Kendler KS, 2008, PSYCHOL MED, V38, P1567, DOI 10.1017/S003329170800384X; Kendler KS, 2008, PSYCHOL MED, V38, P1759, DOI 10.1017/S0033291708002936; Kendler KS, 2008, ARCH GEN PSYCHIAT, V65, P421, DOI 10.1001/archpsyc.65.4.421; Landau D, 2011, J ANXIETY DISORD, V25, P192, DOI 10.1016/j.janxdis.2010.09.002; Larson T, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-1; LEONARD HL, 1990, J AM ACAD CHILD PSY, V29, P17, DOI 10.1097/00004583-199001000-00004; Lichtenstein P, 2006, TWIN RES HUM GENET, V9, P875, DOI 10.1375/twin.9.6.875; Mataix-Cols D, 2012, PSYCHOL MED, V43, P1; Mataix-Cols D, 2011, PSYCHOL MED, V41, P1; Mataix-Cols D, 2008, J AM ACAD CHILD PSY, V47, P773, DOI 10.1097/CHI.0b013e31816b73c0; Mataix-Cols D, 2012, J CHILD PSYCHOL PSYC, V53, P608, DOI 10.1111/j.1469-7610.2011.02464.x; Mataix-Cols D, 2010, DEPRESS ANXIETY, V27, P556, DOI 10.1002/da.20693; Moore J, 2010, J ABNORM CHILD PSYCH, V38, P921, DOI 10.1007/s10802-010-9414-1; Mueller A, 2009, BEHAV RES THER, V47, P705, DOI 10.1016/j.brat.2009.04.005; Mustanski BS, 2004, DEV PSYCHOL, V40, P1188, DOI 10.1037/0012-1649.40.6.1188; Neale M. C., 1992, METHODOLOGY GENETIC, Vxxv; O'Sullivan SS, 2010, MOVEMENT DISORD, V25, P1026, DOI 10.1002/mds.23016; Pertusa A, 2008, AM J PSYCHIAT, V165, P1289, DOI 10.1176/appi.ajp.2008.07111730; Pertusa A, 2012, DEPRESS ANXIETY, V29, P210, DOI 10.1002/da.20902; Seedat S, 2002, PSYCHIAT CLIN NEUROS, V56, P17, DOI 10.1046/j.1440-1819.2002.00926.x; Steketee Gail, 2003, Clin Psychol Rev, V23, P905, DOI 10.1016/j.cpr.2003.08.002; Storch EA, 2007, COMPR PSYCHIAT, V48, P313, DOI 10.1016/j.comppsych.2007.03.001; Taylor S, 2010, J ABNORM PSYCHOL, V119, P672, DOI 10.1037/a0021132; Timpano KR, 2011, J CLIN PSYCHIAT, V72, P780, DOI 10.4088/JCP.10m06380; Timpano KR, 2012, PSYCHOL ASSESS; Tolin DF, 2008, PSYCHIAT RES, V160, P200, DOI 10.1016/j.psychres.2007.08.008; Tolin DF, 2011, BEHAV RES THER, V49, P120, DOI 10.1016/j.brat.2010.12.002; Tolin DF, 2010, DEPRESS ANXIETY, V27, P829, DOI 10.1002/da.20684; Tolin DF, 2010, PSYCHIAT RES, V178, P147, DOI 10.1016/j.psychres.2009.05.001; VALLENIBASILE LA, 1994, J AM ACAD CHILD PSY, V33, P782, DOI 10.1097/00004583-199407000-00002; Winsberg ME, 1999, J CLIN PSYCHIAT, V60, P591, DOI 10.4088/JCP.v60n0905	51	50	51	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e69140	10.1371/journal.pone.0069140	http://dx.doi.org/10.1371/journal.pone.0069140			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182SU	23874893	Green Published, gold, Green Submitted			2022-12-27	WOS:000321765300078
J	Papuchon, J; Pinson, P; Lazaro, E; Reigadas, S; Guidicelli, G; Taupin, JL; Neau, D; Fleury, H				Papuchon, Jennifer; Pinson, Patricia; Lazaro, Estibaliz; Reigadas, Sandrine; Guidicelli, Gwendaline; Taupin, Jean-Luc; Neau, Didier; Fleury, Herve		Provir Latitude 45 Project	Resistance Mutations and CTL Epitopes in Archived HIV-1 DNA of Patients on Antiviral Treatment: Toward a New Concept of Vaccine	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; IMMUNE-RESPONSES; RESERVOIRS; ADAPTATION; LEVEL; CURE	Eleven patients responding successfully to first-line antiretroviral therapy (ART) were investigated for proviral drug resistance mutations (DRMs) in RT by ultra-deep pyrosequencing (UDPS). After molecular typing of the class I alleles A and B, the CTL epitopes in the Gag, Nef and Pol regions of the provirus were sequenced and compared to the reference HXB2 HIV-1 epitopes. They were then matched with the HLA alleles with determination of theoretical affinity (TA). For 3 patients, the results could be compared with an RNA sample of the circulating virus at initiation of therapy. Five out of 11 patients exhibited DRMs by UDPS. The issue is whether a therapeutic switch is relevant in these patients by taking into account the identity of the archived resistance mutations. When the archived CTL epitopes were determined on the basis of the HLA alleles, different patterns were observed. Some epitopes were identical to those reported for the reference with the same TA, while others were mutated with a decrease in TA. In 2 cases, an epitope was observed as a combination of subpopulations at entry and was retrieved as a single population with lower TA at success. With regard to immunological stimulation and given the variability of the archived CTL epitopes, we propose a new concept of curative vaccine based on identification of HIV-1 CTL epitopes after prior sequencing of proviral DNA and matching with HLA class I alleles.	[Papuchon, Jennifer; Pinson, Patricia; Reigadas, Sandrine; Fleury, Herve] Univ Bordeaux Segalen, Lab Virol, Hop Pellegrin, CHU Bordeaux, Bordeaux, France; [Papuchon, Jennifer; Pinson, Patricia; Reigadas, Sandrine; Fleury, Herve] Univ Bordeaux Segalen, CNRS, MFP, UMR 5234, Bordeaux, France; [Lazaro, Estibaliz] CHU Bordeaux, Hop Haut Leveque, Serv Med Interne, Pessac, France; [Guidicelli, Gwendaline; Taupin, Jean-Luc] CHU Bordeaux, Hop Pellegrin, Lab Immunol & Immunogenet, Pessac, France; [Guidicelli, Gwendaline; Taupin, Jean-Luc] CNRS, UMR 5164, Bordeaux, France; [Neau, Didier] Univ Bordeaux Segalen, CHU Bordeaux, Hop Pellegrin, Serv Malad Infect & Trop, Bordeaux, France; [Neau, Didier] Univ Bordeaux Segalen, CNRS, UMR 5234, Bordeaux, France	CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; CHU Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Fleury, H (corresponding author), Univ Bordeaux Segalen, Lab Virol, Hop Pellegrin, CHU Bordeaux, Bordeaux, France.	herve.fleury@viro.u-bordeaux2.fr			Merck company	Merck company(Merck & Company)	This study was funded by Merck company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by Merck company. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Brumme ZL, 2012, CURR OPIN VIROL, V2, P599, DOI 10.1016/j.coviro.2012.08.003; Carlson JM, 2012, J VIROL, V86, P5230, DOI 10.1128/JVI.06728-11; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262; Eisele E, 2012, IMMUNITY, V37, P377, DOI 10.1016/j.immuni.2012.08.010; Garcia F, 2012, HUM VACC IMMUNOTHER, V8, P569, DOI 10.4161/hv.19555; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Liu Y, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015639, 10.1371/journal.pone.0022241]; McMichael AJ, 2001, NATURE, V410, P980, DOI 10.1038/35073658; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Mothe B, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-208; Palmer S, 2008, P NATL ACAD SCI USA, V105, P3879, DOI 10.1073/pnas.0800050105; Palmisano L, 2009, HIV MED, V10, P477, DOI 10.1111/j.1468-1293.2009.00715.x; Pialoux G, 2008, CLIN VACCINE IMMUNOL, V15, P562, DOI 10.1128/CVI.00165-07; Queen SE, 2011, J VIROL, V85, P9167, DOI 10.1128/JVI.00366-11; Recordon-Pinson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036549; Salmon-Ceron D, 2010, AIDS, V24, P2211, DOI 10.1097/QAD.0b013e32833ce566; Vallejo A, 2012, AIDS, V26, P1885, DOI 10.1097/QAD.0b013e3283584521; Wood N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000414	19	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e69029	10.1371/journal.pone.0069029	http://dx.doi.org/10.1371/journal.pone.0069029			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874854	Green Submitted, Green Published, gold			2022-12-27	WOS:000321736900128
J	Santos, ESA; Nakagawa, S				Santos, Eduardo S. A.; Nakagawa, Shinichi			Breeding Biology and Variable Mating System of a Population of Introduced Dunnocks (Prunella modularis) in New Zealand	PLOS ONE			English	Article							EXTRA-PAIR PATERNITY; REPRODUCTIVE SUCCESS; GENETIC BENEFITS; FEMALE DUNNOCKS; PARENTAL CARE; HELPERS; BIRDS; BEHAVIOR; MALES; POLYANDRY	Species with variable mating systems provide a unique opportunity to investigate whether females receive direct fitness benefits from additional male partners. The direct benefits provide an obvious explanation for why females would breed polyandrously, in a situation where males clearly do not attain their optimal reproductive success. Evidence for these direct benefits is, however, mixed. Here, we present a detailed study of the breeding biology of the dunnock, Prunella modularis, which inform an investigation into the effects of the social mating system on the reproductive success in a population of dunnocks in Southern New Zealand. We studied 80 different social groups over the course of three breeding seasons. Dunnocks in our population presented a variable mating system, with socially monogamous (45%), socially polyandrous (54%) and socially polygynandrous (1%) groups being observed in the same breeding season. We did not observe any polygynous social units in our study period although polygyny exists in the population. We found little difference in the numbers of eggs laid, and egg volume between monogamous and polyandrous nests. However, polyandrous groups had better hatching and fledging success than monogamous groups (composite d = 0.385, 95% CI: 0.307 to 0.463). Overall our results support the notion that polyandry is beneficial for females.	[Santos, Eduardo S. A.; Nakagawa, Shinichi] Univ Otago, Dept Zool, Dunedin, New Zealand; [Santos, Eduardo S. A.] Univ Sao Paulo, Dept Ecol, Sao Paulo, Brazil	University of Otago; Universidade de Sao Paulo	Santos, ESA (corresponding author), Univ Otago, Dept Zool, POB 56, Dunedin, New Zealand.	e.salves@gmail.com	Nakagawa, Shinichi/B-5571-2011; Santos, Eduardo/B-4449-2008	Nakagawa, Shinichi/0000-0002-7765-5182; Santos, Eduardo/0000-0002-0434-3655	Association for the Study of Animal Behaviour (ASAB); Department of Zoology of the University of Otago; University of Otago Postgraduate Scholarship	Association for the Study of Animal Behaviour (ASAB); Department of Zoology of the University of Otago; University of Otago Postgraduate Scholarship	The Association for the Study of Animal Behaviour (ASAB) and the Department of Zoology of the University of Otago for research grants. The University of Otago Postgraduate Scholarship to ESAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnqvist G, 2005, AM NAT, V165, pS26, DOI 10.1086/429350; BIRKHEAD ME, 1981, IBIS, V123, P75, DOI 10.1111/j.1474-919X.1981.tb00174.x; Blomqvist D, 2005, BEHAVIOUR, V142, P1133, DOI 10.1163/156853905774405272; BROWN JL, 1982, SCIENCE, V215, P421, DOI 10.1126/science.215.4531.421; BURKE T, 1989, NATURE, V338, P249, DOI 10.1038/338249a0; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Cleasby IR, 2011, BEHAV ECOL SOCIOBIOL, V65, P2361, DOI 10.1007/s00265-011-1254-7; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Davies N. B., 1992, DUNNOCK BEHAV SOCIAL; DAVIES NB, 1983, NATURE, V302, P334, DOI 10.1038/302334a0; DAVIES NB, 1992, J ANIM ECOL, V61, P259, DOI 10.2307/5319; DAVIES NB, 1986, J ANIM ECOL, V55, P139, DOI 10.2307/4698; Dinsmore SJ, 2002, ECOLOGY, V83, P3476, DOI 10.1890/0012-9658(2002)083[3476:ATFMAN]2.0.CO;2; Du B, 2009, MOL ECOL, V18, P3929, DOI 10.1111/j.1365-294X.2009.04336.x; EMLEN ST, 1991, J ANIM ECOL, V60, P309, DOI 10.2307/5462; Griffin AS, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001520; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; HATCHWELL BJ, 1990, BEHAV ECOL SOCIOBIOL, V27, P199; Hatchwell BJ, 2004, BEHAV ECOL, V15, P1, DOI 10.1093/beheco/arg091; HOYT DF, 1979, AUK, V96, P73; JAMIESON IG, 1994, P ROY SOC B-BIOL SCI, V257, P271, DOI 10.1098/rspb.1994.0125; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Karanjia WK, 1982, BIOL DUNNOCK PRUNELL; KOMDEUR J, 1994, BEHAV ECOL SOCIOBIOL, V34, P175, DOI 10.1007/BF00167742; Laake J. L., 2011, RMARK R CODE MARK AN; Langmore NE, 1997, ANIM BEHAV, V53, P881, DOI 10.1006/anbe.1996.0306; Langmore NE, 1996, BEHAV ECOL, V7, P183, DOI 10.1093/beheco/7.2.183; Liker A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2600; Long JL, 1981, INTRO BIRDS WORLD; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; MOHR CO, 1947, AM MIDL NAT, V37, P223, DOI 10.2307/2421652; MUMME RL, 1992, BEHAV ECOL SOCIOBIOL, V31, P319; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Nakagawa S, 2012, EVOL ECOL, V26, P1253, DOI 10.1007/s10682-012-9555-5; R Development Core Team, 2012, R LANG ENV STAT COMP; Robertson C.J.R., 2007, ATLAS BIRD DISTRIBUT; Russell AF, 2007, SCIENCE, V317, P941, DOI 10.1126/science.1146037; Santos ESA, 2013, BIOL INVASIONS, V15, P185, DOI 10.1007/s10530-012-0278-x; Santos Eduardo S. A., 2012, Notornis, V59, P79; Santos ESA, 2011, ETHOLOGY, V117, P547, DOI 10.1111/j.1439-0310.2011.01905.x; Slatyer RA, 2012, BIOL REV, V87, P1, DOI 10.1111/j.1469-185X.2011.00182.x; Snow B.K., 1982, Journal of the Yamashina Institute for Ornithology, V14, P281; Thomson GM, 1922, NATURALISATION PLANT; TUOMENPURO J, 1989, ORNIS FENNICA, V66, P133; Westneat DF, 2003, ANNU REV ECOL EVOL S, V34, P365, DOI 10.1146/annurev.ecolsys.34.011802.132439; Zimmerling JR, 2004, WILSON BULL, V116, P240, DOI 10.1676/04-029	47	17	18	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e69329	10.1371/journal.pone.0069329	http://dx.doi.org/10.1371/journal.pone.0069329			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874945	Green Published, Green Submitted, gold			2022-12-27	WOS:000321736900152
J	Attali, R; Aharoni, S; Treves, S; Rokach, O; Cohen, MB; Fellig, Y; Straussberg, R; Dor, T; Daana, M; Mitrani-Rosenbaum, S; Nevo, Y				Attali, Ruben; Aharoni, Sharon; Treves, Susan; Rokach, Ori; Cohen, Michal Becker; Fellig, Yakov; Straussberg, Rachel; Dor, Talya; Daana, Muhannad; Mitrani-Rosenbaum, Stella; Nevo, Yoram			Variable Myopathic Presentation in a Single Family with Novel Skeletal RYR1 Mutation	PLOS ONE			English	Article							CENTRAL CORE DISEASE; RYANODINE RECEPTOR RYR1; CA2+ RELEASE CHANNEL; MALIGNANT HYPERTHERMIA; SARCOPLASMIC-RETICULUM; CONGENITAL MYOPATHIES; COMMON-CAUSE; MUSCLE; IDENTIFICATION; DEPLETION	We describe an autosomal recessive heterogeneous congenital myopathy in a large consanguineous family. The disease is characterized by variable severity, progressive course in 3 of 4 patients, myopathic face without ophthalmoplegia and proximal muscle weakness. Absence of cores was noted in all patients. Genome wide linkage analysis revealed a single locus on chromosome 19q13 with Zmax = 3.86 at theta = 0.0 and homozygosity of the polymorphic markers at this locus in patients. Direct sequencing of the main candidate gene within the candidate region, RYR1, was performed. A novel homozygous A to G nucleotide substitution (p. Y3016C) within exon 60 of the RYR1 gene was found in patients. ARMS PCR was used to screen for the mutation in all available family members and in an additional 150 healthy individuals. This procedure confirmed sequence analysis and did not reveal the A to G mutation (p.Y3016C) in 300 chromosomes from healthy individuals. Functional analysis on EBV immortalized cell lines showed no effect of the mutation on RyR1 pharmacological activation or the content of intracellular Ca2+ stores. Western blot analysis demonstrated a significant reduction of the RyR1 protein in the patient's muscle concomitant with a reduction of the DHPR alpha 1.1 protein. This novel mutation resulting in RyR1 protein decrease causes heterogeneous clinical presentation, including slow progression course and absence of centrally localized cores on muscle biopsy. We suggest that RYR1 related myopathy should be considered in a wide variety of clinical and pathological presentation in childhood myopathies.	[Attali, Ruben; Cohen, Michal Becker; Mitrani-Rosenbaum, Stella] Hadassah Hebrew Univ, Med Ctr, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel; [Aharoni, Sharon; Straussberg, Rachel] Schneider Childrens Med Ctr Israel, Inst Pediat Neurol, Petah Tiqwa, Israel; [Treves, Susan; Rokach, Ori] Univ Basel Hosp, Dept Anesthesia & Biomed, CH-4031 Basel, Switzerland; [Fellig, Yakov] Hadassah Hebrew Univ, Med Ctr, Dept Pathol, Jerusalem, Israel; [Dor, Talya; Daana, Muhannad; Nevo, Yoram] Hadassah Hebrew Univ, Med Ctr, Unit Neuropediatr & Child Dev, Div Pediat, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; University of Basel; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center	Nevo, Y (corresponding author), Hadassah Hebrew Univ, Med Ctr, Unit Neuropediatr & Child Dev, Div Pediat, Jerusalem, Israel.	nevo@hadassah.org.il		Mitrani-Rosenbaum, Stella/0000-0001-5335-8709; Treves, Susan/0000-0002-0007-9631; Rokach, Ori/0000-0003-3225-6708	Association Francaise contre les Myopathies; SNF (Schweizerische Nationalfonds) [310030-129785]; Bettencourt Schueller Foundation	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); SNF (Schweizerische Nationalfonds); Bettencourt Schueller Foundation	This project was supported in part by the Association Francaise contre les Myopathies, the SNF (Schweizerische Nationalfonds) (grant number 310030-129785) and the Bettencourt Schueller Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Bohm J, 2012, ACTA NEUROPATHOL, V124, P575, DOI 10.1007/s00401-012-1007-3; Clarke NF, 2010, HUM MUTAT, V31, pE1544, DOI 10.1002/humu.21278; Delbono O, 2007, P NATL ACAD SCI USA, V104, P20108, DOI 10.1073/pnas.0707389104; Dirksen RT, 2004, BIOPHYS J, V87, P3193, DOI 10.1529/biophysj.104.049447; FERGUSON DG, 1984, J CELL BIOL, V99, P1735, DOI 10.1083/jcb.99.5.1735; Girard T, 2001, J BIOL CHEM, V276, P48077, DOI 10.1074/jbc.M107134200; Hwang JH, 2012, TRENDS MOL MED, V18, P644, DOI 10.1016/j.molmed.2012.09.006; Klein A, 2012, HUM MUTAT, V33, P981, DOI 10.1002/humu.22056; LAI FA, 1988, NATURE, V331, P315, DOI 10.1038/331315a0; Lynch PJ, 1999, P NATL ACAD SCI USA, V96, P4164, DOI 10.1073/pnas.96.7.4164; MACLENNAN D H, 1989, American Journal of Human Genetics, V45, pA205; MENEGAZZI P, 1994, BIOCHEMISTRY-US, V33, P9078, DOI 10.1021/bi00197a008; Monnier N, 2003, HUM MOL GENET, V12, P1171, DOI 10.1093/hmg/ddg121; Monnier N, 2008, HUM MUTAT, V29, P670, DOI 10.1002/humu.20696; Nakai J, 1998, J BIOL CHEM, V273, P13403, DOI 10.1074/jbc.273.22.13403; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; North K, 2008, NEUROMUSCULAR DISORD, V18, P433, DOI 10.1016/j.nmd.2008.04.002; North KN, 2011, SEMIN PEDIATR NEUROL, V18, P216, DOI 10.1016/j.spen.2011.10.002; OTSU K, 1994, J BIOL CHEM, V269, P9413; Phillips MS, 1996, GENOMICS, V34, P24, DOI 10.1006/geno.1996.0238; Quinlivan RM, 2003, ARCH DIS CHILD, V88, P1051, DOI 10.1136/adc.88.12.1051; Robinson R, 2006, HUM MUTAT, V27, P977, DOI 10.1002/humu.20356; Rossi AE, 2006, MUSCLE NERVE, V33, P715, DOI 10.1002/mus.20512; Ruschendorf F, 2005, BIOINFORMATICS, V21, P2123, DOI 10.1093/bioinformatics/bti264; Sato I, 2008, NEUROLOGY, V70, P114, DOI 10.1212/01.wnl.0000269792.63927.86; Sei Y, 1999, J BIOL CHEM, V274, P5995, DOI 10.1074/jbc.274.9.5995; Sewry CA, 2002, NEUROMUSCULAR DISORD, V12, P930, DOI 10.1016/S0960-8966(02)00135-9; Tilgen N, 2001, HUM MOL GENET, V10, P2879, DOI 10.1093/hmg/10.25.2879; Treves S, 2005, NEUROMUSCULAR DISORD, V15, P577, DOI 10.1016/j.nmd.2005.06.008; TREVES S, 1994, BIOCHEM J, V301, P661, DOI 10.1042/bj3010661; Treves S, 2008, CURR OPIN PHARMACOL, V8, P319, DOI 10.1016/j.coph.2008.01.005; Wilmshurst JM, 2010, ANN NEUROL, V68, P717, DOI 10.1002/ana.22119; Zhou H, 2007, BRAIN, V130, P2024, DOI 10.1093/brain/awm096; Zhou HY, 2006, HUM MOL GENET, V15, P2791, DOI 10.1093/hmg/ddl221; Zorzato F, 2003, HUM MOL GENET, V12, P379, DOI 10.1093/hmg/ddg032	36	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69296	10.1371/journal.pone.0069296	http://dx.doi.org/10.1371/journal.pone.0069296			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894444	Green Accepted, gold, Green Published			2022-12-27	WOS:000322167900054
J	Echigoya, Y; Lee, J; Rodrigues, M; Nagata, T; Tanihata, J; Nozohourmehrabad, A; Panesar, D; Miskew, B; Aoki, Y; Yokota, T				Echigoya, Yusuke; Lee, Joshua; Rodrigues, Merryl; Nagata, Tetsuya; Tanihata, Jun; Nozohourmehrabad, Ashkan; Panesar, Dharminder; Miskew, Bailey; Aoki, Yoshitsugu; Yokota, Toshifumi			Mutation Types and Aging Differently Affect Revertant Fiber Expansion in Dystrophic Mdx and Mdx52 Mice	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; SOMATIC REVERSION SUPPRESSION; FRAMESHIFT DELETIONS; POSITIVE FIBERS; SKELETAL-MUSCLE; MOUSE MUSCLE; DMD LOCUS; EXON; GENE; EXPRESSION	Duchenne muscular dystrophy (DMD), one of the most common and lethal genetic disorders, and the mdx mouse myopathies are caused by a lack of dystrophin protein. These dystrophic muscles contain sporadic clusters of dystrophin-expressing revertant fibers (RFs), as detected by immunohistochemistry. RFs are known to arise from muscle precursor cells with spontaneous exon skipping (alternative splicing) and clonally expand in size with increasing age through the process of muscle degeneration/regeneration. The expansion of revertant clusters is thought to represent the cumulative history of muscle regeneration and proliferation of such precursor cells. However, the precise mechanisms by which RFs arise and expand are poorly understood. Here, to test the effects of mutation types and aging on RF expansion and muscle regeneration, we examined the number of RFs in mdx mice (containing a nonsense mutation in exon 23) and mdx52 mice (containing deletion mutation of exon 52) with the same C57BL/6 background at 2, 6, 12, and 18 months of age. Mdx mice displayed a significantly higher number of RFs compared to mdx52 mice in all age groups, suggesting that revertant fiber expansion largely depends on the type of mutation and/or location in the gene. A significant increase in the expression and clustering levels of RFs was found beginning at 6 months of age in mdx mice compared with mdx52 mice. In contrast to the significant expansion of RFs with increasing age, the number of centrally nucleated fibers and embryonic myosin heavy chain-positive fibers (indicative of cumulative and current muscle regeneration, respectively) decreased with age in both mouse strains. These results suggest that mutation types and aging differently affect revertant fiber expansion in mdx and mdx52 mice.	[Echigoya, Yusuke; Lee, Joshua; Rodrigues, Merryl; Nozohourmehrabad, Ashkan; Panesar, Dharminder; Miskew, Bailey; Yokota, Toshifumi] Univ Alberta, Fac Med & Dent, Dept Med Genet, Edmonton, AB, Canada; [Nagata, Tetsuya; Tanihata, Jun; Aoki, Yoshitsugu] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mol Therapy, Kodaira, Tokyo 187, Japan; [Aoki, Yoshitsugu] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Yokota, Toshifumi] Friends Garrett Cumming Res & Muscular Dystrophy, Edmonton, AB, Canada	University of Alberta; National Center for Neurology & Psychiatry - Japan; University of Oxford	Yokota, T (corresponding author), Univ Alberta, Fac Med & Dent, Dept Med Genet, Edmonton, AB, Canada.	toshifum@ualberta.ca		Nagata, Tetsuya/0000-0003-4111-2693; Yokota, Toshifumi/0000-0001-7316-3546; Aoki, MD, PhD, Yoshitsugu/0000-0002-9038-7506; , toshifumi/0000-0001-6672-6742; Echigoya, Yusuke/0000-0003-1573-4819	University of Alberta Faculty of Medicine and Dentistry; Parent Project Muscular Dystrophy (USA); Friends of Garrett Cumming Research Fund; HM Toupin Neurological Science Research Fund; Muscular Dystrophy Canada; Canada Foundation for Innovation; Alberta Advanced Education and Technology; Women and Children's Health Research Institute (WCHRI)	University of Alberta Faculty of Medicine and Dentistry(University of Alberta); Parent Project Muscular Dystrophy (USA); Friends of Garrett Cumming Research Fund; HM Toupin Neurological Science Research Fund; Muscular Dystrophy Canada(Muscular Dystrophy Association); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Alberta Advanced Education and Technology; Women and Children's Health Research Institute (WCHRI)	This work was supported by the University of Alberta Faculty of Medicine and Dentistry, Parent Project Muscular Dystrophy (USA), The Friends of Garrett Cumming Research Fund, HM Toupin Neurological Science Research Fund, Muscular Dystrophy Canada, Canada Foundation for Innovation, Alberta Advanced Education and Technology, and the Women and Children's Health Research Institute (WCHRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki Y, 2012, P NATL ACAD SCI USA, V109, P13763, DOI 10.1073/pnas.1204638109; Aoki Y, 2010, MOL THER, V18, P1995, DOI 10.1038/mt.2010.186; Araki E, 1997, BIOCHEM BIOPH RES CO, V238, P492, DOI 10.1006/bbrc.1997.7328; Arechavala-Gomeza V, 2010, NEUROMUSCULAR DISORD, V20, P295, DOI 10.1016/j.nmd.2010.03.007; AUSTIN RC, 1995, HUM MOL GENET, V4, P1475; Bhasin N, 2005, J MOL BIOL, V352, P795, DOI 10.1016/j.jmb.2005.07.064; BIES RD, 1992, J CLIN INVEST, V90, P666, DOI 10.1172/JCI115909; Biggar WD, 2002, CLIN ORTHOP RELAT R, P88, DOI 10.1097/01.blo.0000022197.37246.64; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; BYERS TJ, 1993, NAT GENET, V4, P77, DOI 10.1038/ng0593-77; COVONE AE, 1991, HUM GENET, V87, P353; Crawford GE, 2001, HUM MOL GENET, V10, P2745, DOI 10.1093/hmg/10.24.2745; DANKO I, 1992, PEDIATR RES, V32, P128, DOI 10.1203/00006450-199207000-00025; DSOUZA VN, 1995, HUM MOL GENET, V4, P837, DOI 10.1093/hmg/4.5.837; Duchenne, 1867, Br Med J, V2, P541; Fall Abbie M, 2006, Genet Vaccines Ther, V4, P3, DOI 10.1186/1479-0556-4-3; FANIN M, 1995, MUSCLE NERVE, V18, P1115, DOI 10.1002/mus.880181007; FEENER CA, 1989, NATURE, V338, P509, DOI 10.1038/338509a0; FRALEY SM, 1981, BEHAV NEURAL BIOL, V31, P1, DOI 10.1016/S0163-1047(81)90986-9; Garcia L, 1999, J GENE MED, V1, P43, DOI 10.1002/(SICI)1521-2254(199901/02)1:1<43::AID-JGM7>3.3.CO;2-1; GORECKI DC, 1992, HUM MOL GENET, V1, P505, DOI 10.1093/hmg/1.7.505; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HOFFMAN EP, 1990, J NEUROL SCI, V99, P9, DOI 10.1016/0022-510X(90)90195-S; Hoffman EP, 2011, AM J PATHOL, V179, P12, DOI 10.1016/j.ajpath.2011.03.050; Holder E, 1996, HUM GENET, V97, P232, DOI 10.1007/BF02265272; HYSER CL, 1988, NEUROL CLIN, V6, P429, DOI 10.1016/S0733-8619(18)30853-3; KLEIN CJ, 1992, AM J HUM GENET, V50, P950; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; LEDERFEIN D, 1992, P NATL ACAD SCI USA, V89, P5346, DOI 10.1073/pnas.89.12.5346; LIDOV HGW, 1995, HUM MOL GENET, V4, P329, DOI 10.1093/hmg/4.3.329; Lovering RM, 2005, PHYS THER, V85, P1372, DOI 10.1093/ptj/85.12.1372; Lu QL, 2011, MOL THER, V19, P9, DOI 10.1038/mt.2010.219; Lu QL, 2000, J CELL BIOL, V148, P985, DOI 10.1083/jcb.148.5.985; MCGEACHIE JK, 1993, J NEUROL SCI, V119, P169, DOI 10.1016/0022-510X(93)90130-Q; McNally EM, 2007, ANNU REV PATHOL-MECH, V2, P87, DOI 10.1146/annurev.pathol.2.010506.091936; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; MUNTONI F, 1993, HUM GENET, V92, P103, DOI 10.1007/BF00216157; Narita S, 1999, NEUROREPORT, V10, P3233, DOI 10.1097/00001756-199910190-00020; NICHOLSON LVB, 1993, NEUROPEDIATRICS, V24, P93, DOI 10.1055/s-2008-1071521; NISHIO H, 1994, J CLIN INVEST, V94, P1037, DOI 10.1172/JCI117417; NUDEL U, 1989, NATURE, V337, P76, DOI 10.1038/337076a0; Pagel CN, 1999, J NEUROL SCI, V164, P103, DOI 10.1016/S0022-510X(99)00061-1; Pichavant C, 2011, MOL THER, V19, P830, DOI 10.1038/mt.2011.59; Rybakova IN, 2000, J CELL BIOL, V150, P1209, DOI 10.1083/jcb.150.5.1209; Sakamoto M, 2002, BIOCHEM BIOPH RES CO, V293, P1265, DOI 10.1016/S0006-291X(02)00362-5; Shavlakadze T, 2004, J HISTOCHEM CYTOCHEM, V52, P873, DOI 10.1369/jhc.3A6177.2004; SHERRAT TG, 1993, AM J HUM GENET, V53, P1007; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; TINSLEY JM, 1993, HUM MOL GENET, V2, P521, DOI 10.1093/hmg/2.5.521; Tinsley JM, 1996, NATURE, V384, P349, DOI 10.1038/384349a0; WAKEFORD S, 1991, MUSCLE NERVE, V14, P42, DOI 10.1002/mus.880140108; Walmsley GL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008647; Wang B., 2011, PLOS CURR, V3; Watkins SC, 2000, MICROSC RES TECHNIQ, V48, P131, DOI 10.1002/(SICI)1097-0029(20000201/15)48:3/4<131::AID-JEMT2>3.0.CO;2-G; Wheway JM, 2003, NEUROMUSCULAR DISORD, V13, P17, DOI 10.1016/S0960-8966(02)00195-5; WINNARD AV, 1995, AM J HUM GENET, V56, P158; WROBLEWSKI R, 1982, J SUBMICR CYTOL PATH, V14, P377; Yokota T, 2012, EXPERT OPIN BIOL THE; Yokota T, 2011, METHODS MOL BIOL, V709, P299, DOI 10.1007/978-1-61737-982-6_20; Yokota T, 2009, ANN NEUROL, V65, P667, DOI 10.1002/ana.21627; Yokota T, 2009, ARCH NEUROL-CHICAGO, V66, P32, DOI 10.1001/archneurol.2008.540	62	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69194	10.1371/journal.pone.0069194	http://dx.doi.org/10.1371/journal.pone.0069194			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894429	Green Published, gold, Green Submitted			2022-12-27	WOS:000322167900045
J	Liao, YL; Liu, P; Guo, FY; Zhang, ZY; Zhang, ZR				Liao, Yiliu; Liu, Peng; Guo, Fangyuan; Zhang, Zhi-Yuan; Zhang, Zhiren			Oxidative Burst of Circulating Neutrophils Following Traumatic Brain Injury in Human	PLOS ONE			English	Article							SYSTEMIC INFLAMMATORY RESPONSE; SPINAL-CORD-INJURY; SEVERE HEAD-INJURY; MULTIPLE ORGAN FAILURE; C-REACTIVE PROTEIN; LEUKOCYTE MOBILIZATION; ANTIOXIDANT THERAPIES; BLOOD NEUTROPHILS; BLUNT TRAUMA; RATS	Besides secondary injury at the lesional site, Traumatic brain injury (TBI) can cause a systemic inflammatory response, which may cause damage to initially unaffected organs and potentially further exacerbate the original injury. Here we investigated plasma levels of important inflammatory mediators, oxidative activity of circulating leukocytes, particularly focusing on neutrophils, from TBI subjects and control subjects with general trauma from 6 hours to 2 weeks following injury, comparing with values from uninjured subjects. We observed increased plasma level of inflammatory cytokines/molecules TNF-alpha, IL-6 and CRP, dramatically increased circulating leukocyte counts and elevated expression of TNF-alpha and iNOS in circulating leukocytes from TBI patients, which suggests a systemic inflammatory response following TBI. Our data further showed increased free radical production in leukocyte homogenates and elevated expression of key oxidative enzymes iNOS, COX-2 and NADPH oxidase (gp91(phox)) in circulating leukocytes, indicating an intense induction of oxidative burst following TBI, which is significantly greater than that in control subjects with general trauma. Furthermore, flow cytometry assay proved neutrophils as the largest population in circulation after TBI and showed significantly up-regulated oxidative activity and suppressed phagocytosis rate for circulating neutrophils following brain trauma. It suggests that the highly activated neutrophils might play an important role in the secondary damage, even outside the injured brain. Taken together, the potent systemic inflammatory response induced by TBI, especially the intensively increase oxidative activity of circulating leukocytes, mainly neutrophils, may lead to a systemic damage, dysfunction/damage of bystander tissues/organs and even further exacerbate secondary local damage. Controlling these pathophysiological processes may be a promising therapeutic strategy and will protect unaffected organs and the injured brain from the secondary damage.	[Liao, Yiliu; Liu, Peng; Guo, Fangyuan] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Traumat Surg, Wuhan 430074, Peoples R China; [Zhang, Zhi-Yuan] Univ Tubingen, Dept Neuropathol, Tubingen, Germany; [Zhang, Zhiren] Third Mil Med Univ PLA, Inst Immunol, Chongqing, Peoples R China	Huazhong University of Science & Technology; Eberhard Karls University of Tubingen; Army Medical University	Zhang, ZY (corresponding author), Univ Tubingen, Dept Neuropathol, Tubingen, Germany.	zhiyuan.zhang@medizin.uni-tuebingen.de; zhangzhiren@yahoo.com	zhang, zhiren/I-1046-2014; Zhang, Zhiren/O-1012-2019; zhang, zhiyuan/GRS-2141-2022	zhang, zhiren/0000-0002-5238-2835; Zhang, Zhiren/0000-0002-5238-2835; 	Natural Science Foundation of China; CQ CSTC [2010BB5025]; State Science and Technology Major Projects of New Drugs [2012ZX09103301-035]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CQ CSTC(Natural Science Foundation Project of CQ CSTC); State Science and Technology Major Projects of New Drugs	The present study was partially supported by two project fundings as following: Natural Science Foundation of China (http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm), Project of CQ CSTC (No. 2010BB5025); and State Science and Technology Major Projects of New Drugs (http://www.nmp.gov.cn/) (No. 2012ZX09103301-035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Bao F, 2005, J NEUROCHEM, V94, P1361, DOI 10.1111/j.1471-4159.2005.03280.x; Bao F, 2004, J NEUROCHEM, V88, P1335, DOI 10.1046/j.1471-4159.2003.02240.x; Bao F, 2009, EXP NEUROL, V215, P308, DOI 10.1016/j.expneurol.2008.10.022; Baskaran H, 2000, J SURG RES, V93, P88, DOI 10.1006/jsre.2000.5955; Basu S, 2009, FREE RADICAL RES, V43, P85, DOI 10.1080/10715760802610851; Bhatia R, 2006, J TRAUMA, V60, P590, DOI 10.1097/01.ta.0000205614.51885.ff; Bhatia RK, 2005, INJURY, V36, P956, DOI 10.1016/j.injury.2005.03.009; Bone RC, 1996, CRIT CARE MED, V24, P163, DOI 10.1097/00003246-199601000-00026; BOTHA AJ, 1995, J TRAUMA, V39, P411; Campbell SJ, 2003, FASEB J, V17, P1168, DOI 10.1096/fj.02-0757fje; Campbell SJ, 2005, AM J PATHOL, V166, P1487, DOI 10.1016/S0002-9440(10)62365-6; Castelli GP, 2004, CRIT CARE, V8, pR234, DOI 10.1186/cc2877; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Cocks RA, 1998, J TRAUMA, V45, P1, DOI 10.1097/00005373-199807000-00001; D'Aiuto F, 2010, J DENT RES, V89, P1241, DOI 10.1177/0022034510375830; Furlan JC, 2006, SPINE, V31, P2674, DOI 10.1097/01.brs.0000244569.91204.01; Gaforio JJ, 2002, CYTOMETRY, V48, P93, DOI 10.1002/cyto.10107; Gahm C, 2006, J NEUROTRAUM, V23, P1343, DOI 10.1089/neu.2006.23.1343; Gris D, 2008, EXP NEUROL, V211, P259, DOI 10.1016/j.expneurol.2008.01.033; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Kanyilmaz S, 2013, ARCH PHYS MED REHAB, V94, P369, DOI 10.1016/j.apmr.2012.09.015; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; LaPar DJ, 2012, J AM COLL SURGEONS, V214, P478, DOI 10.1016/j.jamcollsurg.2011.12.015; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Lo EH, 2002, J NEUROSCI RES, V69, P1, DOI 10.1002/jnr.10270; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI [10.2735/3489, 10.2741/3489]; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Mimoz O, 1998, INTENS CARE MED, V24, P185, DOI 10.1007/s001340050543; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Motoyama T, 2003, CRIT CARE MED, V31, P1048, DOI 10.1097/01.CCM.0000055371.27268.36; Namas R, 2009, LIBYAN J MED, V4, P97, DOI 10.4176/090325; Nowotarski PJ, 2000, J BONE JOINT SURG AM, V82A, P781, DOI 10.2106/00004623-200006000-00004; OTT L, 1994, J NEUROTRAUM, V11, P447, DOI 10.1089/neu.1994.11.447; Pasquale MD, 1996, CRIT CARE MED, V24, P1238, DOI 10.1097/00003246-199607000-00029; Peluso I, 2013, J IMMUNOL METHODS, V390, P113, DOI 10.1016/j.jim.2013.02.005; Peluso I, 2012, J IMMUNOL METHODS, V379, P61, DOI 10.1016/j.jim.2012.02.015; Pillay J, 2007, INJURY, V38, P1365, DOI 10.1016/j.injury.2007.09.016; Rovlias A, 2001, SURG NEUROL, V55, P190, DOI 10.1016/S0090-3019(01)00414-1; Rovlias A, 2004, J NEUROTRAUM, V21, P886, DOI 10.1089/0897715041526249; Siesjo BK, 1996, EUR J ANAESTH, V13, P247, DOI 10.1046/j.1365-2346.1996.00976.x; Sunil VR, 2002, RESP RES, V3, DOI 10.1186/rr171; TEASDALE G, 1974, LANCET, V2, P81; Utagawa A, 2008, EXP NEUROL, V211, P283, DOI 10.1016/j.expneurol.2008.02.001; Vecil GG, 2000, J NEUROSCI RES, V61, P212, DOI 10.1002/1097-4547(20000715)61:2<212::AID-JNR12>3.0.CO;2-9; Venetsanou K, 2007, EUR CYTOKINE NETW, V18, P206, DOI 10.1684/ecn.2007.0112; Wilcockson DC, 2002, J CEREBR BLOOD F MET, V22, P318, DOI 10.1097/00004647-200203000-00009; Woiciechowsky C, 2002, J TRAUMA, V52, P339, DOI 10.1097/00005373-200202000-00021; Xie LK, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-53	49	94	96	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e68963	10.1371/journal.pone.0068963	http://dx.doi.org/10.1371/journal.pone.0068963			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894384	Green Published, Green Submitted, gold			2022-12-27	WOS:000322167900033
J	Nekaris, KAI; Campbell, N; Coggins, TG; Rode, EJ; Nijman, V				Nekaris, K. Anne-Isola; Campbell, Nicola; Coggins, Tim G.; Rode, E. Johanna; Nijman, Vincent			Tickled to Death: Analysing Public Perceptions of 'Cute' Videos of Threatened Species (Slow Lorises - Nycticebus spp.) on Web 2.0 Sites	PLOS ONE			English	Article							WILDLIFE TRADE; CONSERVATION; INTERNET; PRIMATES; TURTLES; SLENDER; SOUTH	Background: The internet is gaining importance in global wildlife trade and changing perceptions of threatened species. There is little data available to examine the impact that popular Web 2.0 sites play on public perceptions of threatened species. YouTube videos portraying wildlife allow us to quantify these perceptions. Methodology/Principal Findings: Focussing on a group of threatened and globally protected primates, slow lorises, we quantify public attitudes towards wildlife conservation by analysing 12,411 comments and associated data posted on a viral YouTube video 'tickling slow loris' over a 33-months period. In the initial months a quarter of commentators indicated wanting a loris as a pet, but as facts about their conservation and ecology became more prevalent this dropped significantly. Endorsements, where people were directed to the site by celebrities, resulted mostly in numerous neutral responses with few links to conservation or awareness. Two conservation-related events, linked to Wikipedia and the airing of a television documentary, led to an increase in awareness, and ultimately to the removal of the analysed video. Conclusions/Significance: Slow loris videos that have gone viral have introduced these primates to a large cross-section of society that would not normally come into contact with them. Analyses of webometric data posted on the internet allow us quickly to gauge societal sentiments. We showed a clear temporal change in some views expressed but without an apparent increase in knowledge about the conservation plight of the species, or the illegal nature of slow loris trade. Celebrity endorsement of videos showing protected wildlife increases visits to such sites, but does not educate about conservation issues. The strong desire of commentators to express their want for one as a pet demonstrates the need for Web 2.0 sites to provide a mechanism via which illegal animal material can be identified and policed.	[Nekaris, K. Anne-Isola; Campbell, Nicola; Rode, E. Johanna; Nijman, Vincent] Oxford Brookes Univ, Nocturnal Primate Res Grp, Oxford OX3 0BP, England; [Coggins, Tim G.] Sonicated LTD, Dept Software Dev, Oxford, England	Oxford Brookes University	Nekaris, KAI (corresponding author), Oxford Brookes Univ, Nocturnal Primate Res Grp, Oxford OX3 0BP, England.	anekaris@brookes.ac.uk	Nijman, Vincent/AHD-8685-2022	Nijman, Vincent/0000-0002-5600-4276	Leverhulme Trust [RPG-084]; Cleveland Zoo Asian Seed Fund; Dierenpark Amersfoort; People's Trust for Endangered Species	Leverhulme Trust(Leverhulme Trust); Cleveland Zoo Asian Seed Fund; Dierenpark Amersfoort; People's Trust for Endangered Species	This project was funded in part by grants to Nekaris from the Leverhulme Trust (RPG-084, http://www.leverhulme.ac.uk/), the Cleveland Zoo Asian Seed Fund (http://www.clemetzoo.com/conservation/grants/), Dierenpark Amersfoort (http://www.dierenparkamersfoort.nl/), and People's Trust for Endangered Species (http://www.ptes.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRAWAL J, 1995, J MARKETING, V59, P56, DOI 10.2307/1252119; Alacs E, 2008, AUST J FORENSIC SCI, V40, P147, DOI 10.1080/00450610802491382; Alexa Traffic Rank, 2013, LIST OF MOST POPULAR; [Anonymous], 2012, MEN ARRESTED HIDING; [Anonymous], 2013, INTERNET WORLD STATS; [Anonymous], 2009, PRIMATES PERIL WORLD; Boyd DM, 2007, J COMPUT-MEDIAT COMM, V13, P210, DOI 10.1111/j.1083-6101.2007.00393.x; Ceballos CP, 2004, WILDLIFE SOC B, V32, P881, DOI 10.2193/0091-7648(2004)032[0881:TTINAE]2.0.CO;2; Councils of Europe, 2004, CONVENTION ON CYBERC; Derraik JGB, 2010, BIOL INVASIONS, V12, P1477, DOI 10.1007/s10530-009-9595-0; Duggan IC, 2010, BIOL INVASIONS, V12, P3757, DOI 10.1007/s10530-010-9768-x; Eudey A.A., 1995, Primate Report, V41, P33; Fong JJ, 2010, CONSERV GENET, V11, P2061, DOI 10.1007/s10592-010-0066-z; Freeman B, 2008, J EPIDEMIOL COMMUN H, V62, P778, DOI 10.1136/jech.2008.073759; Freeman B, 2007, TOB CONTROL, V16, P207, DOI 10.1136/tc.2007.020024; FRIEDMAN HH, 1979, J ADVERTISING RES, V19, P63; Fuller G, 2013, ZOO BIOL, V32, P88, DOI 10.1002/zoo.21049; Google Developers, 2019, VAR; Izzo J. B, 2010, WM MARY ENVTL L POLY, V965, P965; Jenssen BP, 2009, PEDIATRICS, V124, pE180, DOI 10.1542/peds.2008-3838; KAMINS MA, 1989, J ADVERTISING, V18, P4, DOI 10.1080/00913367.1989.10673146; Karesh WB, 2005, EMERG INFECT DIS, V11, P1000; Kay SH, 2001, J AQUAT PLANT MANAGE, V39, P88; Mankoff J, 2007, 47 HUM COMP INT I; Mason Robin, 2007, Internet and Higher Education, V10, P196, DOI 10.1016/j.iheduc.2007.06.003; Masopustova Renata, 2001, Gazella, V28, P63; Moore RS, 2011, THESIS; Mwambui E, 2010, THESIS; Nekaris KAI, 2007, FOLIA PRIMATOL, V78, P211, DOI 10.1159/000102316; Nekaris KAI, 2012, ORYX, V46, P169, DOI 10.1017/S0030605312000427; Nekaris KAI, 2010, AM J PRIMATOL, V72, P877, DOI 10.1002/ajp.20842; Nekaris KAI, 2003, FOLIA PRIMATOL, V74, P312, DOI 10.1159/000073317; Nijman V., 2009, WILDLIFE TRADE ASEAN, P1; Nijman V, 2011, ORYX, V45, P472; Paek HJ, 2010, HEALTH EDUC RES, V25, P1085, DOI 10.1093/her/cyq063; Ross SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022050; Sakamoto M, 2007, SLOW LORISES FLY SO; Schroepfer KK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026048; Schulze Helga, 2004, P33; Shepherd CR, 2004, OPEN SEASON AN ANALY; Sodhi NS, 2010, BIODIVERS CONSERV, V19, P317, DOI 10.1007/s10531-009-9607-5; Starr Carly, 2010, Endangered Species Research, V12, P17, DOI 10.3354/esr00285; Streicher U., 2004, THESIS; Todd M, 2011, TRADE IN MALAGASY RE; UNEP- WCMC, 2013, CITES TRADE DATABASE; Van Borm S, 2005, EMERG INFECT DIS, V11, P702, DOI 10.3201/eid1105.050211; Vance K, 2009, DERMATOL CLIN, V27, P133, DOI 10.1016/j.det.2008.11.010; Voinov A, 1999, J ENVIRON MANAGE, V56, P231, DOI 10.1006/jema.1999.0281; Wikimedia Foundation Inc, 2013, CONSERVATION OF SLOW; Wu J., 2007, Traffic Bulletin, V21, P75	50	88	89	1	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69215	10.1371/journal.pone.0069215	http://dx.doi.org/10.1371/journal.pone.0069215			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	188BY	23894432	Green Published, gold, Green Submitted			2022-12-27	WOS:000322167900047
J	Kumar, C; Rai, RK; Singh, PK; Singh, L				Kumar, Chandan; Rai, Rajesh Kumar; Singh, Prashant Kumar; Singh, Lucky			Socioeconomic Disparities in Maternity Care among Indian Adolescents, 1990-2006	PLOS ONE			English	Article							HEALTH-CARE; CHILD HEALTH; WOMEN; DIFFERENTIALS; SERVICES	Background: India, with a population of more than 1.21 billion, has the highest maternal mortality in the world (estimated to be 56000 in 2010); and adolescent (aged 15-19) mortality shares 9% of total maternal deaths. Addressing the maternity care needs of adolescents may have considerable ramifications for achieving the Millennium Development Goal (MDG)-5. This paper assesses the socioeconomic differentials in accessing full antenatal care and professional attendance at delivery by adolescent mothers (aged 15-19) in India during 1990-2006. Methods and Findings: Data from three rounds of the National Family Health Survey of India conducted during 1992-93, 1998-99, and 2005-06 were analyzed. The Cochran-Armitage and Chi-squared test for linear and non-linear time trends were applied, respectively, to understand the trend in the proportion of adolescent mothers utilizing select maternity care services during 1990-2006. Using pooled multivariate logistic regression models, the probability of select maternal healthcare utilization among women by key socioeconomic characteristics was appraised. After adjusting for potential socio-demographic and economic characteristics, the likelihood of adolescents accessing full antenatal care increased by only 4% from 1990 to 2006. However, the probability of adolescent women availing themselves of professional attendance at delivery increased by 79% during the same period. The study also highlights the desolate disparities in maternity care services among adolescents across the most and the least favoured groups. Conclusion: Maternal care interventions in India need focused programs for rural, uneducated, poor adolescent women so that they can avail themselves of measures to delay child bearing, and for better antenatal consultation and delivery care in case of pregnancy. This study strongly advocates the promotion of a comprehensive 'adolescent scheme' along the lines of 'Continuum of Maternal, Newborn and Child health Care' to address the unmet need of reproductive and maternal healthcare services among adolescent women in India.	[Kumar, Chandan] IITR, Dept Humanities & Social Sci, Roorkee, Uttarakhand, India; [Rai, Rajesh Kumar] TISS, Bombay, Maharashtra, India; [Singh, Prashant Kumar] IIPS, Bombay, Maharashtra, India; [Singh, Lucky] TISS, Sch Hlth Syst Studies, Bombay, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee; Tata Institute of Social Sciences; International Institute for Population Sciences; Tata Institute of Social Sciences	Kumar, C (corresponding author), IITR, Dept Humanities & Social Sci, Roorkee, Uttarakhand, India.	c.kumar803@gmail.com	Kumar, Chandan/AAS-4525-2020	Kumar, Chandan/0000-0002-2351-2442; Singh, Lucky/0000-0003-2590-6135; Rai, Rajesh Kumar/0000-0002-5249-9937; Singh, Prashant Kumar/0000-0003-1742-5534				Agha S, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-31; Amin R, 2010, INT J EQUITY HEALTH, V9, DOI 10.1186/1475-9276-9-9; Andrade MV, 2012, HEALTH PLACE, V18, P942, DOI 10.1016/j.healthplace.2012.06.014; Armitage P., 2002, STAT METHODS MED RES; Bhutta ZA, 2012, INT J GYNECOL OBSTET, V119, pS13, DOI 10.1016/j.ijgo.2012.04.001; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Corsi DJ, 2012, SOC SCI MED, V75, P311, DOI 10.1016/j.socscimed.2012.02.014; Dangal G., 2005, INTERNET J GYNECOLOG, V5, P13; Fotso Jean-Christophe, 2006, Int J Equity Health, V5, P9, DOI 10.1186/1475-9276-5-9; Fotso JC, 2007, HEALTH PLACE, V13, P205, DOI 10.1016/j.healthplace.2006.01.004; Government of India, 2006, JAN SURK YOJ; Government of India, 2011, MAT MORT IND 2007 09; Hampton T, 2010, JAMA-J AM MED ASSOC, V304, P509, DOI 10.1001/jama.2010.1009; Howe LD, 2009, J EPIDEMIOL COMMUN H, V63, P871, DOI 10.1136/jech.2009.088021; *INT I POP SCI, 2000, NAT FAM HLTH SURV IN; International Institute for Population Sciences, 2010, DISTR LEV HOUS FAC S; International Institute for Population Sciences ORC Macro, 2007, NAT FAM HLTH SURV IN; International Institute of Population Sciences, 1995, NAT FAM HLTH SURV IN; James KS, 2011, SCIENCE, V333, P576, DOI 10.1126/science.1207969; Jeffrey C, 2001, T I BRIT GEOGR, V26, P217, DOI 10.1111/1475-5661.00016; Jensen R., 2003, GENDER DEV, V11, P9, DOI DOI 10.1080/741954311; KORN EL, 1990, AM STAT, V44, P270, DOI 10.2307/2684345; Kumar C, 2013, J COMMUN HEALTH, V38, P120, DOI 10.1007/s10900-012-9590-8; LEGRAND TK, 1993, STUD FAMILY PLANN, V24, P137, DOI 10.2307/2939229; Machel G, 2012, WASHINGTON POST; Mavalankar DV, 2005, AM J PUBLIC HEALTH, V95, P200, DOI 10.2105/AJPH.2003.036715; Ministry of Health and Family Welfare, 2010, RUR HLTH STAT IND 20; Mishra V, 2004, POPUL DEV REV, V30, P269, DOI 10.1111/j.1728-4457.2004.013_1.x; Navaneetham K, 2002, SOC SCI MED, V55, P1849, DOI 10.1016/S0277-9536(01)00313-6; Ogunlesi TA, 2012, MATERN CHILD HLTH J, V16, P677, DOI 10.1007/s10995-011-0765-1; Pallikadavath S, 2004, SOC SCI MED, V59, P1147, DOI 10.1016/j.socscimed.2003.11.045; Paul VK, 2011, LANCET, V377, P332, DOI 10.1016/S0140-6736(10)61492-4; Paxton A, 2011, NEW ENGL J MED, V364, P1990, DOI 10.1056/NEJMp1012860; Planning Commission, 2011, HIGH LEV EXP GROUP R; Rai RK, 2015, ASIA-PAC J PUBLIC HE, V27, pNP1161, DOI [10.1177/1010539512436883, 10.1177/101053951]; Rai RK, 2013, J PUBLIC HEALTH-HEID, V21, P379, DOI 10.1007/s10389-012-0551-6; Rai RK, 2012, WOMEN HEALTH ISS, V22, pE407, DOI 10.1016/j.whi.2012.05.001; Raj A, 2009, LANCET, V373, P1883, DOI 10.1016/S0140-6736(09)60246-4; RAO JNK, 1984, ANN STAT, V12, P46, DOI 10.1214/aos/1176346391; Reddy KS, 2012, NATL MED J INDIA, V25, P65; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Santhya KG, 2008, EARLY MARRIAGE SEXUA; Singh L, 2012, J BIOSOC SCI, V44, P1, DOI 10.1017/S0021932011000472; Singh PK, 2014, HEALTH POLICY PLANN, V29, P542, DOI 10.1093/heapol/czt039; Singh PK, 2013, J PUBLIC HEALTH-HEID, V21, P15, DOI 10.1007/s10389-012-0516-9; Singh PK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044901; Singh PK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031666; Statacorp, 2007, STAT STAT SOFTW REL; Subramanyam MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011392; United Nations, 2011, STESASERA303 UN DEP; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; World Health Organization, 2012, RIO POL DECL SOC DET; World Health Organization United Nations Children's Fund, 2012, COUNT DOWN 2015 MAT; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990; World Health Organization(WHO), 2006, PROV EFF ANT CAR INT	55	8	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69094	10.1371/journal.pone.0069094	http://dx.doi.org/10.1371/journal.pone.0069094			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	228SX	23894412	Green Submitted, Green Published, gold			2022-12-27	WOS:000325211000076
J	Wong, ESW; Hardy, MC; Wood, D; Bailey, T; King, GF				Wong, Emily S. W.; Hardy, Margaret C.; Wood, David; Bailey, Timothy; King, Glenn F.			SVM-Based Prediction of Propeptide Cleavage Sites in Spider Toxins Identifies Toxin Innovation in an Australian Tarantula	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; HIDDEN MARKOV MODEL; CYSTINE KNOT; SIGNAL PEPTIDES; VENOM; PROTEASE; MOTIF	Spider neurotoxins are commonly used as pharmacological tools and are a popular source of novel compounds with therapeutic and agrochemical potential. Since venom peptides are inherently toxic, the host spider must employ strategies to avoid adverse effects prior to venom use. It is partly for this reason that most spider toxins encode a protective proregion that upon enzymatic cleavage is excised from the mature peptide. In order to identify the mature toxin sequence directly from toxin transcripts, without resorting to protein sequencing, the propeptide cleavage site in the toxin precursor must be predicted bioinformatically. We evaluated different machine learning strategies (support vector machines, hidden Markov model and decision tree) and developed an algorithm (SpiderP) for prediction of propeptide cleavage sites in spider toxins. Our strategy uses a support vector machine (SVM) framework that combines both local and global sequence information. Our method is superior or comparable to current tools for prediction of propeptide sequences in spider toxins. Evaluation of the SVM method on an independent test set of known toxin sequences yielded 96% sensitivity and 100% specificity. Furthermore, we sequenced five novel peptides (not used to train the final predictor) from the venom of the Australian tarantula Selenotypus plumipes to test the accuracy of the predictor and found 80% sensitivity and 99.6% 8-mer specificity. Finally, we used the predictor together with homology information to predict and characterize seven groups of novel toxins from the deeply sequenced venom gland transcriptome of S. plumipes, which revealed structural complexity and innovations in the evolution of the toxins. The precursor prediction tool (SpiderP) is freely available on ArachnoServer (http://www.arachnoserver.org/spiderP.html), a web portal to a comprehensive relational database of spider toxins. All training data, test data, and scripts used are available from the SpiderP website.	[Wong, Emily S. W.; Hardy, Margaret C.; King, Glenn F.] Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, St Lucia, Qld, Australia; [Wood, David; Bailey, Timothy] Univ Queensland, Inst Mol Biosci, Div Genom & Computat Biol, St Lucia, Qld, Australia	University of Queensland; University of Queensland	Wong, ESW (corresponding author), European Bioinformat Inst, European Mol Biol Lab, Wellcome Trust Genome Campus, Cambridge, England.	em6@ebi.ac.uk; glenn.king@imb.uq.edu.au	Wong, Emily/C-2302-2018; Hardy, Margaret C/A-5576-2009; King, Glenn F/J-5059-2012	Wong, Emily/0000-0003-0315-2942; Hardy, Margaret C/0000-0001-5033-4322; King, Glenn F/0000-0002-2308-2200; Wood, David/0000-0002-1001-2019	Australian Research Council [DP1095728]; University of Queensland; International Development Research Centre	Australian Research Council(Australian Research Council); University of Queensland(University of Queensland); International Development Research Centre	This work was supported by the Australian Research Council (Discovery Grant DP1095728 to GFK) and The University of Queensland (Postdoctoral Fellowship to EW). This study was also funded by the International Development Research Centre (http://www.idrc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Balaji RA, 2000, FEBS LETT, V474, P208, DOI 10.1016/S0014-5793(00)01593-3; Bandyopadhyay PK, 1998, J BIOL CHEM, V273, P5447, DOI 10.1074/jbc.273.10.5447; Ben-Hur A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000173; Buczek O, 2004, BIOCHEMISTRY-US, V43, P1093, DOI 10.1021/bi0354233; Chen J, 2008, CELL MOL LIFE SCI, V65, P2431, DOI 10.1007/s00018-008-8135-x; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Craik DJ, 2001, TOXICON, V39, P43, DOI 10.1016/S0041-0101(00)00160-4; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; duVerle DA, 2012, BRIEF BIOINFORM, V13, P337, DOI 10.1093/bib/bbr059; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Herzig V, 2011, NUCLEIC ACIDS RES, V39, pD653, DOI 10.1093/nar/gkq1058; Kaas Q, 2012, NUCLEIC ACIDS RES, V40, pD325, DOI 10.1093/nar/gkr886; King GF, 2013, ANNU REV ENTOMOL, V58, P475, DOI 10.1146/annurev-ento-120811-153650; King GF, 2011, EXPERT OPIN BIOL TH, V11, P1469, DOI 10.1517/14712598.2011.621940; Koua D, 2013, BBA-PROTEINS PROTEOM, V1834, P717, DOI 10.1016/j.bbapap.2012.12.015; Kozlov S, 2005, PROTEINS, V59, P131, DOI 10.1002/prot.20390; Kozlov SA, 2007, TOXICON, V49, P721, DOI 10.1016/j.toxicon.2006.11.007; Milne TJ, 2003, J BIOL CHEM, V278, P31105, DOI 10.1074/jbc.M304843200; PALLAGHY PK, 1994, PROTEIN SCI, V3, P1833, DOI 10.1002/pro.5560031022; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rognvaldsson T, 2004, BIOINFORMATICS, V20, P1702, DOI 10.1093/bioinformatics/bth144; Saez NJ, 2010, TOXINS, V2, P2851, DOI 10.3390/toxins2122851; Sollod BL, 2005, PEPTIDES, V26, P131, DOI 10.1016/j.peptides.2004.07.016; Suchyna TM, 2000, J GEN PHYSIOL, V115, P583, DOI 10.1085/jgp.115.5.583; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yuan Z, 2005, PROTEINS, V58, P905, DOI 10.1002/prot.20375; Zhang YQ, 2010, ZOOLOGY, V113, P10, DOI 10.1016/j.zool.2009.04.001; Zhang ZM, 2003, BIOINFORMATICS, V19, P307, DOI 10.1093/bioinformatics/19.2.307	31	22	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e66279	10.1371/journal.pone.0066279	http://dx.doi.org/10.1371/journal.pone.0066279			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894279	Green Published, gold, Green Submitted			2022-12-27	WOS:000322132100005
J	Kapiga, SH; Ewings, FM; Ao, T; Chilongani, J; Mongi, A; Baisley, K; Francis, S; Andreasen, A; Hashim, R; Watson-Jones, D; Changalucha, J; Hayes, R				Kapiga, Saidi H.; Ewings, Fiona M.; Ao, Tony; Chilongani, Joseph; Mongi, Aika; Baisley, Kathy; Francis, Suzanna; Andreasen, Aura; Hashim, Ramadhan; Watson-Jones, Deborah; Changalucha, John; Hayes, Richard			The Epidemiology of HIV and HSV-2 Infections among Women Participating in Microbicide and Vaccine Feasibility Studies in Northern Tanzania	PLOS ONE			English	Article							SIMPLEX-VIRUS TYPE-2; RISK-FACTORS; BACTERIAL VAGINOSIS; HOTEL WORKERS; MBEYA REGION; FEMALE BAR; PREVALENCE; COHORT; METAANALYSIS; ACQUISITION	Objectives: To prepare for future HIV prevention trials, we conducted prospective cohort studies among women working in food and recreational facilities in northern Tanzania. We examined the prevalence and incidence of HIV and HSV-2, and associated risk factors. Methods: Women aged 18-44 years working in food and recreational facilities were screened to determine their eligibility for the studies. Between 2008-2010, HIV-negative women were enrolled and followed for 12 months. At enrolment and 3-monthly, we collected socio-demographic and behavioural data, and performed clinical examinations for collection of biological specimens that were tested for reproductive tract infections. Risk factors for HIV and HSV-2 incidence were investigated using Poisson regression models. Results: We screened 2,229 and enrolled 1,378 women. The median age was 27 years (interquartile range, IQR 22, 33), and median duration working at current facility was 2 years. The prevalences of HIV at screening and HSV-2 at enrolment were 16% and 67%, respectively. Attendance at the 12-month visit was 86%. HIV and HSV-2 incidence rates were 3.7 (95% confidence interval, CI: 2.8,5.1) and 28.6 (95% CI: 23.5,35.0)/100 person-years, respectively. Women who were separated, divorced, or widowed were at increased risk of HIV (adjusted incidence rate ratio, aRR = 6.63; 95% CI: 1.97,22.2) and HSV-2 (aRR = 2.00; 95% CI: 1.15,3.47) compared with married women. Women reporting >= 3 partners in the past 3 months were at higher HIV risk compared with women with 0-1 partner (aRR = 4.75; 95% CI: 2.10,10.8), while those who had reached secondary education or above were at lower risk of HSV-2 compared with women with incomplete primary education (aRR = 0.42; 95% CI: 0.22,0.82). Conclusions: HIV and HSV-2 rates remain substantially higher in this cohort than in the general population, indicating urgent need for effective interventions. These studies demonstrate the feasibility of conducting trials to test new interventions in this highly-mobile population.	[Kapiga, Saidi H.; Ewings, Fiona M.; Baisley, Kathy; Francis, Suzanna; Andreasen, Aura; Watson-Jones, Deborah; Hayes, Richard] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Kapiga, Saidi H.; Ewings, Fiona M.; Ao, Tony; Mongi, Aika; Andreasen, Aura; Hashim, Ramadhan; Watson-Jones, Deborah] Mwanza Intervent Trials Unit, Mwanza, Tanzania; [Chilongani, Joseph; Changalucha, John] Natl Inst Med Res, Mwanza, Tanzania	University of London; London School of Hygiene & Tropical Medicine; National Institute of Medical Research	Kapiga, SH (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	Saidi.Kapiga@lshtm.ac.uk		Hayes, Richard/0000-0002-1729-9892; Francis, Suzanna Carter/0000-0002-3724-4813; Kapiga, Saidi/0000-0003-1753-4060; Andreasen, Aura/0000-0003-0664-7342	European and Developing Countries Clinical Trials Partnership (EDCTP) [CT_ct_05_32070_002]; EDCTP; Bill and Melinda Gates Foundation [CG_ct_06_33111]; MRC [G0700837, G1002369, G0901756, G0701039] Funding Source: UKRI; Medical Research Council [G0700837, G0901756, G0701039, G1002369] Funding Source: researchfish	European and Developing Countries Clinical Trials Partnership (EDCTP); EDCTP; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The microbicides-preparedness study was funded by the European and Developing Countries Clinical Trials Partnership (EDCTP; project code: CT_ct_05_32070_002) and the vaccines-preparedness study was funded by EDCTP and the Bill and Melinda Gates Foundation (project code: CG_ct_06_33111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsel R., 1983, AM J MED, V14, P74, DOI DOI 10.1016/0002-9343(83)91112-9.PUBMED:6600371; Biraro S, 2011, SEX TRANSM DIS, V38, P140, DOI 10.1097/OLQ.0b013e3181f0bafb; Chohan V, 2009, SEX TRANSM INFECT, V85, P489, DOI 10.1136/sti.2009.036103; Clift S, 2003, SEX TRANSM INFECT, V79, P307, DOI 10.1136/sti.79.4.307; Donders G, 2010, OBSTET GYNECOL SURV, V65, P462, DOI 10.1097/OGX.0b013e3181e09621; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Feldblum PJ, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000626; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Gallo MF, 2008, SEX TRANSM DIS, V35, P679, DOI 10.1097/OLQ.0b013e31816fcaf8; Higgins-Biddle J., 2010, ALCOHOL USE DISORDER; Kalichman SC, 2007, PREV SCI, V8, P141, DOI 10.1007/s11121-006-0061-2; Kapiga SH, 2007, J INFECT DIS, V195, P1260, DOI 10.1086/513566; Kapiga SH, 2002, J ACQ IMMUN DEF SYND, V29, P409, DOI 10.1097/00126334-200204010-00013; Kapiga SH, 1998, AIDS, V12, P75, DOI 10.1097/00002030-199801000-00009; Karim QA, 2010, CLIN INFECT DIS, V50, pS122, DOI 10.1086/651483; Mahony JB, 2001, J CLIN MICROBIOL, V39, P1429, DOI 10.1128/JCM.39.4.1429-1435.2001; National bureau of Statistics (NBS), 2004, TANZ DEM HLTH SURV; Nel A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035278; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Okuku HS, 2011, SEX TRANSM DIS, V38, P837, DOI 10.1097/OLQ.0b013e31821a6225; Ramjee G, 2012, AIDS BEHAV, V16, P2062, DOI 10.1007/s10461-011-0043-7; Ray R, 2012, J BIOSOC SCI, V44, P321, DOI 10.1017/S0021932011000733; Riedner G, 2006, AIDS, V20, P609, DOI 10.1097/01.aids.0000210616.90954.47; Riedner G, 2003, SEX TRANSM INFECT, V79, P382, DOI 10.1136/sti.79.5.382; Schwebke JR, 2004, CLIN MICROBIOL REV, V17, P794, DOI 10.1128/CMR.17.4.794-803.2004; Tanzania Commission for AIDS (TACAIDS) Zanzibar AIDS Commission (ZAC) National Bureau of Statistics (NBS) Office of the Chief Government Statistician and Macro International Inc, 2007, TANZ HIV AIDS MAL IN; Tassiopoulos KK, 2007, J INFECT DIS, V195, P493, DOI 10.1086/510537; Vallely A, 2007, SEX TRANSM DIS, V34, P638, DOI 10.1097/OLQ.0b013e3180325120; Vallely A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010661; Watson-Jones D, 2009, AIDS, V23, P415, DOI 10.1097/QAD.0b013e32831ef523; Watson-Jones D, 2007, JAIDS-J ACQ IMM DEF, V46, P631, DOI 10.1097/QAI.0b013e31815b2d9c; Weiss HA, 2009, LANCET INFECT DIS, V9, P669, DOI 10.1016/S1473-3099(09)70235-X; WHO UNAIDS and UNICEF, 2011, EP UPD HLTH SECT PRO	33	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e68825	10.1371/journal.pone.0068825	http://dx.doi.org/10.1371/journal.pone.0068825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874780	gold, Green Accepted, Green Published			2022-12-27	WOS:000324146200032
J	Stock, C; Hoffmeister, M; Birkner, B; Brenner, H				Stock, Christian; Hoffmeister, Michael; Birkner, Berndt; Brenner, Hermann			Inter-Physician Variation in Follow-Up Colonoscopies after Screening Colonoscopy	PLOS ONE			English	Article							COLORECTAL-CANCER; SURVEILLANCE; GUIDELINES; POLYPECTOMY; ADENOMAS; UPDATE; RISK; US	Background and Aims: Surveillance is an integral part of the colorectal cancer (CRC) screening process. We aimed to investigate inter-physician variation in follow-up procedures after screening colonoscopy in an opportunistic CRC screening program. Methods: A historical cohort study in the German statutory health insurance system was conducted. 55,301 individuals who underwent screening colonoscopy in 2006 in Bavaria, Germany, and who were not diagnosed with CRC were included. Utilization of follow-up colonoscopies performed by the same physician (328 physicians overall) within 3 years was ascertained. Mixed effects logistic regression modelling was used to assess the effect of physicians and other potential predictors (screening result, age group, and sex) on re-utilization of colonoscopy. Physicians were grouped into quintiles according to individual effects estimated in a preliminary model. Predicted probabilities of follow-up colonoscopy by screening result and physician group were calculated. Results: The observed rate of follow-up colonoscopy was 6.2% (95% confidence interval: 5.9-6.4%), 18.6% (17.8-19.4%), and 37.0% (35.5-38.4%) after negative colonoscopy, low-risk adenoma and high-risk adenoma detection, respectively. All considered predictors were statistically significantly associated with follow-up colonoscopy. The predicted probabilities of follow-up colonoscopy ranged from 1.7% (1.4-2.0%) to 11.0% (10.2-11.7%), from 7.3% (6.2-8.5%) to 35.1% (32.6-37.7%), and from 17.9% (15.5-20.6%) to 56.9% (53.5-60.3%) in the 1st quintile (lowest rates of follow-up) and 5th quintile (highest rates of follow-up) of physicians after negative colonoscopy, low-risk adenoma and high-risk adenoma detection, respectively. Conclusions: This study suggests substantial inter-physician variation in follow-up habits after screening colonoscopy. Interventions, including organizational changes in CRC screening should be considered to reduce this variation.	[Stock, Christian; Hoffmeister, Michael; Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Stock, Christian] Heidelberg Univ, Inst Med Biometry & Informat, Heidelberg, Germany; [Birkner, Berndt] Bavarian Assoc Statutory Hlth Insurance Phys, Munich, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Stock, C (corresponding author), German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany.	c.stock@dkfz.de	Hoffmeister, Michael/B-5745-2012; Hoffmeister, Michael/AAB-2321-2022; Hoffmeister, Michael/T-7187-2019; Brenner, Hermann/ABE-6383-2020; Stock, Christian/F-6180-2015; Brenner, Hermann/B-4627-2017	Hoffmeister, Michael/0000-0002-8307-3197; Hoffmeister, Michael/0000-0002-8307-3197; Hoffmeister, Michael/0000-0002-8307-3197; Brenner, Hermann/0000-0002-6129-1572; Stock, Christian/0000-0002-3493-3234; Brenner, Hermann/0000-0002-6129-1572				Arditi C, 2009, ENDOSCOPY, V41, P209, DOI 10.1055/s-0028-1119646; Brenner H, 2012, J CLIN ONCOL, V30, P2969, DOI 10.1200/JCO.2011.41.3377; Brenner H, 2011, J CLIN ONCOL, V29, P3761, DOI 10.1200/JCO.2011.35.9307; Brenner H, 2011, ANN INTERN MED, V154, P22, DOI 10.7326/0003-4819-154-1-201101040-00004; Crispin A, 2007, GASTROINTEST ENDOSC, V65, pAB311, DOI 10.1016/j.gie.2007.03.750; Crispin A, 2009, ENDOSCOPY, V41, P1018, DOI 10.1055/s-0029-1215214; Ferlitsch M, 2011, JAMA-J AM MED ASSOC, V306, P1352, DOI 10.1001/jama.2011.1362; Goodwin JS, 2011, ARCH INTERN MED, V171, P1335, DOI 10.1001/archinternmed.2011.212; Heitman SJ, 2009, CLIN GASTROENTEROL H, V7, P1272, DOI 10.1016/j.cgh.2009.05.032; Hoff G, 2010, GUT, V59, P407, DOI 10.1136/gut.2009.192948; Ko CW, 2010, AM J GASTROENTEROL, V105, P2670, DOI 10.1038/ajg.2010.344; Kolligs FT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020076; Laiyemo AO, 2009, CLIN GASTROENTEROL H, V7, P562, DOI 10.1016/j.cgh.2008.12.009; Lieberman DA, 2005, GASTROINTEST ENDOSC, V62, P875, DOI 10.1016/j.gie.2005.06.037; Mansmann U, 2008, DTSCH ARZTEBL INT, V105, P434, DOI 10.3238/arztebl.2008.0434; Miles A, 2004, CANCER-AM CANCER SOC, V101, P1201, DOI 10.1002/cncr.20505; Mysliwiec PA, 2004, ANN INTERN MED, V141, P264, DOI 10.7326/0003-4819-141-4-200408170-00006; Pox CP, 2012, GASTROENTEROLOGY, V142, P1460, DOI 10.1053/j.gastro.2012.03.022; Saini SD, 2010, GASTROENTEROLOGY, V138, P2292, DOI 10.1053/j.gastro.2010.03.004; Saini SD, 2009, J CLIN GASTROENTEROL, V43, P554, DOI 10.1097/MCG.0b013e31818242ad; Schmiegel W, 2008, Z GASTROENTEROL, V46, P799, DOI 10.1055/s-2008-1027726; Schmiegel W, 2004, Z GASTROENTEROL, V42, P1129, DOI 10.1055/s-2004-813699; Schmiegel W, 2010, Z GASTROENTEROL, V48, P65, DOI 10.1055/s-0028-1109936; Schoen RE, 2010, GASTROENTEROLOGY, V138, P73, DOI 10.1053/j.gastro.2009.09.062; Steyerberg E., 2008, STAT BIOL HLTH; Stock C, 2011, ENDOSCOPY, V43, P771, DOI 10.1055/s-0030-1256504; Winawer SJ, 2006, GASTROENTEROLOGY, V130, P1872, DOI 10.1053/j.gastro.2006.03.012; Winawer SJ, 2012, NAT REV GASTRO HEPAT, V9, P130, DOI 10.1038/nrgastro.2012.20	28	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e69312	10.1371/journal.pone.0069312	http://dx.doi.org/10.1371/journal.pone.0069312			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874941	Green Submitted, Green Published, gold			2022-12-27	WOS:000324146200071
J	Chen, JL; Ge, YY; Zhang, J; Qiu, XY; Qiu, JF; Wu, JP; Wang, Y				Chen, Jin-ling; Ge, Yi-yue; Zhang, Jie; Qiu, Xiao-yan; Qiu, Jing-fan; Wu, Jiang-ping; Wang, Yong			The Dysfunction of CD4(+)CD25(+) Regulatory T Cells Contributes to the Abortion of Mice Caused by Toxoplasma gondii Excreted-Secreted Antigens in Early Pregnancy	PLOS ONE			English	Article							FAS-DEPENDENT APOPTOSIS; MATERNAL TOLERANCE; GAMMA-INTERFERON; FETAL REJECTION; MURINE ABORTION; DENDRITIC CELLS; INFECTION; MODEL; TRANSPLANTATION; SUPPRESSION	Toxoplasma gondii is an opportunistic intracellular parasite that is highly prevalent in human and warm-blooded animals throughout the world, leading to potentially severe congenital infections. Although the abortion caused by T. gondii is believed to be dependent on the timing of maternal infection during pregnancy, the mechanism remains unclear. This study was focused on the effects of T. gondii excreted-secreted antigens on pregnant outcomes and CD4(+)CD25(+) Foxp3(+) regulatory T cells at different stages of pregnancy. The results showed that in mice the frequency and suppressive function of CD4(+)CD25(+) regulatory cells were diminished after injection of T. gondii excreted-secreted antigens at early and intermediate stages of pregnancy. The abortion caused by T. gondii excreted-secreted antigens at early pregnancy could be partly prevented by adoptively transferring of CD4(+)CD25(+) cells from the mice injected with T. gondii excreted-secreted antigens at late pregnancy, but not from the mice with the same treatment at early pregnancy. Furthermore, T. gondii excreted-secreted antigens induced apoptosis of CD4(+)CD25(+) regulatory cells of mice in early and intermediate stages of pregnancy by down-regulating their Bcl-2 expressions and Bcl-2/Bax ratio. This study provides new insights into the mechanism that T. gondii infection is the high risk factor for abortion in early pregnancy.	[Chen, Jin-ling; Ge, Yi-yue; Zhang, Jie; Qiu, Xiao-yan; Qiu, Jing-fan; Wang, Yong] Nanjing Med Univ, Dept Pathogen Biol, Key Lab Pathogen Biol Jiangsu Prov, Nanjing, Jiangsu, Peoples R China; [Chen, Jin-ling] Nantong Univ, Sch Med, Dept Microbiol & Parasitol, Nantong, Jiangsu, Peoples R China; [Ge, Yi-yue] Jiangsu Prov Ctr Dis Prevent & Control, Inst Pathogen Microbiol, Nanjing, Jiangsu, Peoples R China; [Wu, Jiang-ping] Nanjing Med Univ, Nanjing Matern & Child Hlth Care Hosp, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nantong University; Nanjing Medical University	Wang, Y (corresponding author), Nanjing Med Univ, Dept Pathogen Biol, Key Lab Pathogen Biol Jiangsu Prov, Nanjing, Jiangsu, Peoples R China.	yongwsh@njmu.edu.cn	ge, yiyue/AAW-9914-2021	Chen, Jinling/0000-0003-2992-6571	National Basic Research Program of China (973 Program) [2010CB530001]; Science and Technology Fund of Nanjing Medical University [09NJMU214]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Science and Technology Fund of Nanjing Medical University; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by National Basic Research Program of China (973 Program) (No. 2010CB530001), the Science and Technology Fund of Nanjing Medical University (No. 09NJMU214) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Bacar A, 2004, INFECT IMMUN, V72, P1397, DOI 10.1128/IAI.72.3.1397-1401.2004; Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; Banz A, 2002, J IMMUNOL, V169, P750, DOI 10.4049/jimmunol.169.2.750; Begum-Haque S, 2009, MICROB PATHOGENESIS, V47, P281, DOI 10.1016/j.micpath.2009.09.004; Blois SM, 2008, J MOL MED, V86, P837, DOI 10.1007/s00109-008-0342-2; Boothroyd JC, 2009, INT J PARASITOL, V39, P935, DOI 10.1016/j.ijpara.2009.02.003; Capuzzo E, 1995, Minerva Ginecol, V47, P557; Cerezo A, 1999, CELL DEATH DIFFER, V6, P87, DOI 10.1038/sj.cdd.4400458; CESBRONDELAUW MF, 1993, RES IMMUNOL, V144, P41, DOI 10.1016/S0923-2494(05)80096-3; Chan PH, 2004, NEUROCHEM RES, V29, P1943, DOI 10.1007/s11064-004-6869-x; Chen X, 2004, EUR J IMMUNOL, V34, P859, DOI 10.1002/eji.200324506; Couper KN, 2009, J IMMUNOL, V182, P3985, DOI 10.4049/jimmunol.0803053; Ge YY, 2008, PARASITE IMMUNOL, V30, P471, DOI 10.1111/j.1365-3024.2008.01044.x; Hafid J, 2005, VET PARASITOL, V128, P23, DOI 10.1016/j.vetpar.2004.11.002; Hall AO, 2012, IMMUNITY, V37, P511, DOI 10.1016/j.immuni.2012.06.014; Heikkinen J, 2004, CLIN EXP IMMUNOL, V136, P373, DOI 10.1111/j.1365-2249.2004.02441.x; Hu MS, 1999, INFECT IMMUN, V67, P928, DOI 10.1128/IAI.67.2.928-935.1999; HUGHES HPA, 1986, INT J PARASITOL, V16, P317, DOI 10.1016/0020-7519(86)90109-8; Joachim RA, 2001, AM J REPROD IMMUNOL, V45, P303, DOI 10.1111/j.8755-8920.2001.450506.x; Khan IA, 1996, INT IMMUNOL, V8, P887, DOI 10.1093/intimm/8.6.887; Kusakabe K, 2008, FERTIL STERIL, V90, P1451, DOI 10.1016/j.fertnstert.2007.07.1331; Li XJ, 2007, J IMMUNOL, V179, P939, DOI 10.4049/jimmunol.179.2.939; Liesenfeld O, 1997, INFECT IMMUN, V65, P4682, DOI 10.1128/IAI.65.11.4682-4689.1997; Makrigiannakis A, 2001, NAT IMMUNOL, V2, P1018, DOI 10.1038/ni719; Merry DE, 1997, ANNU REV NEUROSCI, V20, P245, DOI 10.1146/annurev.neuro.20.1.245; Mjosberg J, 2007, IMMUNOLOGY, V120, P456, DOI 10.1111/j.1365-2567.2006.02529.x; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Petersen E, 2001, INT J PARASITOL, V31, P115, DOI 10.1016/S0020-7519(00)00140-5; Edlich Richard F, 2005, J Long Term Eff Med Implants, V15, P319; RouasFreiss N, 1997, P NATL ACAD SCI USA, V94, P11520, DOI 10.1073/pnas.94.21.11520; Rudra D, 2009, NAT IMMUNOL, V10, P1170, DOI 10.1038/ni.1795; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sasaki Y, 2004, MOL HUM REPROD, V10, P347, DOI 10.1093/molehr/gah044; Senegas A, 2009, INT J PARASITOL, V39, P481, DOI 10.1016/j.ijpara.2008.08.009; Shaw MH, 2009, NAT IMMUNOL, V10, P1267, DOI 10.1038/ni.1816; Shima T, 2010, J REPROD IMMUNOL, V85, P121, DOI 10.1016/j.jri.2010.02.006; Shiono Y, 2007, PARASITOL INT, V56, P141, DOI 10.1016/j.parint.2007.01.008; Somerset DA, 2004, IMMUNOLOGY, V112, P38, DOI 10.1111/j.1365-2567.2004.01869.x; Sun X, 2010, PARASITE IMMUNOL, V32, P739, DOI 10.1111/j.1365-3024.2010.01240.x; Taams LS, 2001, EUR J IMMUNOL, V31, P1122, DOI 10.1002/1521-4141(200104)31:4<1122::AID-IMMU1122>3.0.CO;2-P; TAFURI A, 1995, SCIENCE, V270, P630, DOI 10.1126/science.270.5236.630; Tang CL, 2011, PARASITOL RES, V108, P477, DOI 10.1007/s00436-010-2089-2; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Thellin O, 2000, CURR OPIN IMMUNOL, V12, P731, DOI 10.1016/S0952-7915(00)00170-9; Waldmann H, 2004, SEMIN IMMUNOL, V16, P119, DOI 10.1016/j.smim.2003.12.007; Wang T, 2011, EXP PARASITOL, V127, P107, DOI 10.1016/j.exppara.2010.07.003; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wood KJ, 2003, NAT REV IMMUNOL, V3, P199, DOI 10.1038/nri1027; Xu XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055432; Zenclussen AC, 2005, AM J PATHOL, V166, P811, DOI 10.1016/S0002-9440(10)62302-4; Zenclussen AC, 2002, SCAND J IMMUNOL, V55, P560, DOI 10.1046/j.1365-3083.2002.01091.x; Zenclussen AC, 2006, SPRINGER SEMIN IMMUN, V28, P31, DOI 10.1007/s00281-006-0023-6	54	24	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e69012	10.1371/journal.pone.0069012	http://dx.doi.org/10.1371/journal.pone.0069012			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23874852	Green Submitted, gold, Green Published			2022-12-27	WOS:000322000600039
J	Gliwicka, M; Nowak, K; Balazadeh, S; Mueller-Roeber, B; Gaj, MD				Gliwicka, Marta; Nowak, Katarzyna; Balazadeh, Salma; Mueller-Roeber, Bernd; Gaj, Malgorzata D.			Extensive Modulation of the Transcription Factor Transcriptome during Somatic Embryogenesis in Arabidopsis thaliana	PLOS ONE			English	Article							TO-EMBRYONIC TRANSITION; PLURIPOTENT STEM-CELLS; GENOME-WIDE ANALYSIS; GENE-EXPRESSION; INSERTIONAL MUTAGENESIS; MEDICAGO-TRUNCATULA; RESPONSE REGULATORS; AUXIN HOMEOSTASIS; TISSUE-CULTURE; PLANT	Molecular mechanisms controlling plant totipotency are largely unknown and studies on somatic embryogenesis (SE), the process through which already differentiated cells reverse their developmental program and become embryogenic, provide a unique means for deciphering molecular mechanisms controlling developmental plasticity of somatic cells. Among various factors essential for embryogenic transition of somatic cells transcription factors (TFs), crucial regulators of genetic programs, are believed to play a central role. Herein, we used quantitative real-time polymerase chain reaction (qRT-PCR) to identify TF genes affected during SE induced by in vitro culture in Arabidopsis thaliana. Expression profiles of 1,880 TFs were evaluated in the highly embryogenic Col-0 accession and the non-embryogenic tanmei/emb2757 mutant. Our study revealed 729 TFs whose expression changes during the 10-days incubation period of SE; 141 TFs displayed distinct differences in expression patterns in embryogenic versus non-embryogenic cultures. The embryo-induction stage of SE occurring during the first 5 days of culture was associated with a robust and dramatic change of the TF transcriptome characterized by the drastic up-regulation of the expression of a great majority (over 80%) of the TFs active during embryogenic culture. In contrast to SE induction, the advanced stage of embryo formation showed attenuation and stabilization of transcript levels of many TFs. In total, 519 of the SE-modulated TFs were functionally annotated and transcripts related with plant development, phytohormones and stress responses were found to be most abundant. The involvement of selected TFs in SE was verified using T-DNA insertion lines and a significantly reduced embryogenic response was found for the majority of them. This study provides comprehensive data focused on the expression of TF genes during SE and suggests directions for further research on functional genomics of SE.	[Gliwicka, Marta; Nowak, Katarzyna; Gaj, Malgorzata D.] Univ Silesia, Dept Genet, Katowice, Poland; [Balazadeh, Salma; Mueller-Roeber, Bernd] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Balazadeh, Salma; Mueller-Roeber, Bernd] Max Planck Inst Mol Plant Physiol, Potsdam, Germany	University of Silesia in Katowice; University of Potsdam; Max Planck Society	Gaj, MD (corresponding author), Univ Silesia, Dept Genet, Katowice, Poland.	malgorzata.gaj@us.edu.pl	Mueller-Roeber, Bernd/Z-4052-2019; Nowak, Katarzyna/S-1348-2019	Nowak, Katarzyna/0000-0003-3657-6119; Gaj, Malgorzata/0000-0003-2995-4134	Polish Ministry of Science and Higher Education [N N301 283537]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by research grant No. N N301 283537 of the Polish Ministry of Science and Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsson M, 2012, PLANT CELL TISS ORG, V109, P391, DOI 10.1007/s11240-011-0103-8; Achard P, 2008, CURR BIOL, V18, P656, DOI 10.1016/j.cub.2008.04.034; Aida M, 2002, DEVELOPMENT, V129, P3965; Alexandrova KS, 2002, PLANT SCI, V162, P301, DOI 10.1016/S0168-9452(01)00571-4; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Asahina M, 2011, P NATL ACAD SCI USA, V108, P16128, DOI 10.1073/pnas.1110443108; Balazadeh S, 2008, PLANT BIOLOGY, V10, P63, DOI 10.1111/j.1438-8677.2008.00088.x; Balazadeh S, 2010, PLANT J, V62, P250, DOI 10.1111/j.1365-313X.2010.04151.x; Bao YH, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-132; Baster P, 2009, PLANT CELL TISS ORG, V99, P305, DOI 10.1007/s11240-009-9605-z; Bishopp A, 2011, CURR OPIN PLANT BIOL, V14, P10, DOI 10.1016/j.pbi.2010.08.014; Boutilier K, 2002, PLANT CELL, V14, P1737, DOI 10.1105/tpc.001941; Busch W, 2007, CURR OPIN PLANT BIOL, V10, P136, DOI 10.1016/j.pbi.2007.01.002; Caldana C, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-7; Casson S, 2005, PLANT J, V42, P111, DOI 10.1111/j.1365-313X.2005.02355.x; Chakrabarty D, 2010, PLANT BIOLOGY, V12, P46, DOI 10.1111/j.1438-8677.2009.00213.x; Che P, 2006, PLANT MOL BIOL, V62, P1, DOI 10.1007/s11103-006-9013-2; Che P, 2006, PLANT PHYSIOL, V141, P620, DOI 10.1104/pp.106.081240; Cheng X, 2010, GENET MOL RES, V9, P348, DOI 10.4238/vol9-1gmr739; Choi YE, 2001, PLANT SCI, V160, P1183, DOI 10.1016/S0168-9452(01)00357-0; Costa S, 2007, TRENDS CELL BIOL, V17, P101, DOI 10.1016/j.tcb.2006.12.005; Curaba J, 2004, PLANT PHYSIOL, V136, P3660, DOI 10.1104/pp.104.047266; Czechowski T, 2004, PLANT J, V38, P366, DOI 10.1111/j.1365-313X.2004.02051.x; Denekamp M, 2003, PLANT PHYSIOL, V132, P1415, DOI 10.1104/pp.102.019273; Ding ZJ, 2010, P NATL ACAD SCI USA, V107, P12046, DOI 10.1073/pnas.1000672107; Dodeman VL, 1997, J EXP BOT, V48, P1493, DOI 10.1093/jexbot/48.313.1493; Domoki M, 2006, BBA-GENE STRUCT EXPR, V1759, P543, DOI 10.1016/j.bbaexp.2006.11.005; Feher A, 2003, PLANT CELL TISS ORG, V74, P201, DOI 10.1023/A:1024033216561; Feher Attila, 2008, Acta Biologica Szegediensis, V52, P53; FRANZMANN LH, 1995, PLANT J, V7, P341, DOI 10.1046/j.1365-313X.1995.7020341.x; Fridborg I, 2001, PLANT PHYSIOL, V127, P937, DOI 10.1104/pp.010388; Gaj MD, 2006, PLANT GROWTH REGUL, V49, P183, DOI 10.1007/s10725-006-9104-8; Gaj MD, 2011, METHODS MOL BIOL, V710, P257, DOI 10.1007/978-1-61737-988-8_18; Gaj MD, 2005, PLANTA, V222, P977, DOI 10.1007/s00425-005-0041-y; Gaj MD, 2004, PLANT GROWTH REGUL, V43, P27, DOI 10.1023/B:GROW.0000038275.29262.fb; GAMBORG OL, 1968, EXP CELL RES, V50, P151, DOI 10.1016/0014-4827(68)90403-5; Grabowska A, 2009, J PLANT PHYSIOL, V166, P310, DOI 10.1016/j.jplph.2008.06.005; Grafi G, 2011, PLANTA, V233, P433, DOI 10.1007/s00425-011-1366-3; Hadfi K, 1998, DEVELOPMENT, V125, P879; Harada JJ, 2012, SEED SCI RES, V22, pS15, DOI 10.1017/S0960258511000304; Harding EW, 2003, PLANT PHYSIOL, V133, P653, DOI 10.1104/pp.103.023499; Horak Christine E, 2002, Funct Integr Genomics, V2, P171; Imin N, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-110; Ishida K, 2008, PLANT CELL PHYSIOL, V49, P47, DOI 10.1093/pcp/pcm165; Iwase A, 2011, CURR BIOL, V21, P508, DOI 10.1016/j.cub.2011.02.020; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jenik PD, 2005, DEVELOPMENT, V132, P3577, DOI 10.1242/dev.01952; Jiang C, 2007, CURR OPIN PLANT BIOL, V10, P461, DOI 10.1016/j.pbi.2007.08.011; Kakar K, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-18; Karami O, 2010, MOL BIOL REP, V37, P2493, DOI 10.1007/s11033-009-9764-3; Kieffer M, 2010, CURR OPIN PLANT BIOL, V13, P12, DOI 10.1016/j.pbi.2009.10.006; Kim SG, 2008, PLANT J, V55, P77, DOI 10.1111/j.1365-313X.2008.03493.x; Krebs J, 2009, THESIS U POTSDAM; Krishnaswamy S, 2011, PLANT MOL BIOL, V75, P107, DOI 10.1007/s11103-010-9711-7; Kurczynska EU, 2007, PLANTA, V226, P619, DOI 10.1007/s00425-007-0510-6; Lara-Chavez A, 2012, IN VITRO CELL DEV-PL, V48, P341, DOI 10.1007/s11627-012-9440-5; Larsson E, 2008, NEW PHYTOL, V177, P356, DOI 10.1111/j.1469-8137.2007.02289.x; Le BH, 2010, P NATL ACAD SCI USA, V107, P8063, DOI 10.1073/pnas.1003530107; Legrand S, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-27; Li HW, 2011, PLANTA, V234, P1007, DOI 10.1007/s00425-011-1458-0; Lin HC, 2009, PLANT MOL BIOL, V70, P173, DOI 10.1007/s11103-009-9464-3; Long TA, 2006, CURR OPIN CELL BIOL, V18, P710, DOI 10.1016/j.ceb.2006.09.004; Low ETL, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-62; Lu JR, 2011, PLANT CELL TISS ORG, V107, P25, DOI 10.1007/s11240-011-9952-4; Malik MR, 2007, PLANT PHYSIOL, V144, P134, DOI 10.1104/pp.106.092932; Mallory AC, 2005, PLANT CELL, V17, P1360, DOI 10.1105/tpc.105.031716; Mantiri FR, 2008, PLANT PHYSIOL, V146, P1622, DOI 10.1104/pp.107.110379; McElver J, 2001, GENETICS, V159, P1751; Mitsuda N, 2009, PLANT CELL PHYSIOL, V50, P1232, DOI 10.1093/pcp/pcp075; Morcuende R, 2007, PLANT CELL ENVIRON, V30, P85, DOI 10.1111/j.1365-3040.2006.01608.x; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Nezames CD, 2012, PLANT CELL, V24, P608, DOI 10.1105/tpc.112.095596; Nolan KE, 2006, PLANT CELL REP, V25, P711, DOI 10.1007/s00299-006-0135-4; Olsson ASB, 2004, PLANT MOL BIOL, V55, P663, DOI 10.1007/s11103-004-1581-4; Osuna D, 2007, PLANT J, V49, P463, DOI 10.1111/j.1365-313X.2006.02979.x; Park JE, 2007, J BIOL CHEM, V282, P10036, DOI 10.1074/jbc.M610524200; Patel M, 2010, STEM CELL REV REP, V6, P367, DOI 10.1007/s12015-010-9123-8; Pernisova M, 2009, P NATL ACAD SCI USA, V106, P3609, DOI 10.1073/pnas.0811539106; Puigderrajols P, 2002, J EXP BOT, V53, P1445, DOI 10.1093/jexbot/53.373.1445; R Core Team, 2012, R LANG ENV STAT COMP; Rademacher EH, 2011, PLANT J, V68, P597, DOI 10.1111/j.1365-313X.2011.04710.x; Rashotte AM, 2006, P NATL ACAD SCI USA, V103, P11081, DOI 10.1073/pnas.0602038103; Rensing SA, 2005, J PLANT GROWTH REGUL, V24, P102, DOI 10.1007/s00344-005-0033-y; Riechmann JL, 2000, CURR OPIN PLANT BIOL, V3, P423, DOI 10.1016/S1369-5266(00)00107-2; Rohrmann J, 2011, PLANT J, V68, P999, DOI 10.1111/j.1365-313X.2011.04750.x; Sharma SK, 2008, PLANT MOL BIOL, V68, P185, DOI 10.1007/s11103-008-9360-2; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Singla B, 2007, PLANT MOL BIOL, V65, P677, DOI 10.1007/s11103-007-9234-z; Spencer MWB, 2007, PLANT PHYSIOL, V143, P924, DOI 10.1104/pp.106.087668; Stasolla C, 2004, J EXP BOT, V55, P695, DOI 10.1093/jxb/erh074; Stone SL, 2001, P NATL ACAD SCI USA, V98, P11806, DOI 10.1073/pnas.201413498; Su N, 2007, PLANT MOL BIOL, V63, P337, DOI 10.1007/s11103-006-9092-0; Sun LF, 2012, PLANT CELL TISS ORG, V109, P271, DOI 10.1007/s11240-011-0093-6; Taguchi-Shiobara F, 2006, THEOR APPL GENET, V112, P968, DOI 10.1007/s00122-005-0200-3; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thachter LF, 2012, PLANT PHYSIOL, V60, P407; Thakare D, 2008, PLANT PHYSIOL, V146, P1663, DOI 10.1104/pp.108.115832; Thibaud-Nissen FO, 2003, PLANT PHYSIOL, V132, P118, DOI 10.1104/pp.103.019968; Tian C, 2004, PLANT J, V40, P333, DOI 10.1111/j.1365-313X.2004.02220.x; Tsuwamoto R, 2010, PLANT MOL BIOL, V73, P481, DOI 10.1007/s11103-010-9634-3; Tzafrir I, 2004, PLANT PHYSIOL, V135, P1206, DOI 10.1104/pp.104.045179; van Zyl L, 2003, GENE EXPR PATTERNS, V3, P83, DOI 10.1016/S1567-133X(02)00068-6; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001; Venkatesh K., 2009, African Journal of Plant Science, V3, P288; Wang XC, 2009, CELL RES, V19, P224, DOI 10.1038/cr.2008.276; Werner T, 2009, CURR OPIN PLANT BIOL, V12, P527, DOI 10.1016/j.pbi.2009.07.002; Whittle CA, 2010, PLANT MOL BIOL, V72, P279, DOI 10.1007/s11103-009-9567-x; Wisniewska A, 2012, PLANT PHYSIOL BIOCH, V50, P54, DOI 10.1016/j.plaphy.2011.09.017; Wu XM, 2009, J PLANT PHYSIOL, V166, P1275, DOI 10.1016/j.jplph.2009.01.012; Xiang DQ, 2011, PLANT PHYSIOL, V156, P346, DOI 10.1104/pp.110.171702; Yamagishi K, 2005, PLANT PHYSIOL, V139, P163, DOI 10.1104/pp.105.060467; Yamamoto A, 2009, PLANT J, V58, P843, DOI 10.1111/j.1365-313X.2009.03817.x; Zavattieri MA, 2010, ELECTRON J BIOTECHN, V13, DOI 10.2225/vol13-issue1-fulltext-4; Zeitlinger J, 2010, DEV BIOL, V339, P230, DOI 10.1016/j.ydbio.2009.12.039; Zeng FC, 2006, PLANT MOL BIOL, V60, P167, DOI 10.1007/s11103-005-3381-x; Zhang JZ, 2003, CURR OPIN PLANT BIOL, V6, P430, DOI 10.1016/S1369-5266(03)00081-5; Zheng QL, 2013, PLANT PHYSIOL, V161, P2113, DOI 10.1104/pp.113.216275; ZIMMERMAN JL, 1993, PLANT CELL, V5, P1411, DOI 10.1105/tpc.5.10.1411; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x; Zuo JR, 2002, PLANT J, V30, P349, DOI 10.1046/j.1365-313X.2002.01289.x	121	76	79	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e69261	10.1371/journal.pone.0069261	http://dx.doi.org/10.1371/journal.pone.0069261			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23874927	Green Published, Green Submitted, gold			2022-12-27	WOS:000322000600049
J	Lee, DY; Xun, ZY; Platt, V; Budworth, H; Canaria, CA; McMurray, CT				Lee, Do Yup; Xun, Zhiyin; Platt, Virginia; Budworth, Helen; Canaria, Christie A.; McMurray, Cynthia T.			Distinct Pools of Non-Glycolytic Substrates Differentiate Brain Regions and Prime Region-Specific Responses of Mitochondria	PLOS ONE			English	Article							CEREBRAL GLUCOSE-UTILIZATION; ENERGY-METABOLISM; OXIDATIVE STRESS; CLUSTER-ANALYSIS; HUNTINGTONS; NETWORKS; SYSTEM; ALZHEIMERS; DISEASE; CELLS	Many hereditary diseases are characterized by region-specific toxicity, despite the fact that disease-linked proteins are generally ubiquitously expressed. The underlying basis of the region-specific vulnerability remains enigmatic. Here, we evaluate the fundamental features of mitochondrial and glucose metabolism in synaptosomes from four brain regions in basal and stressed states. Although the brain has an absolute need for glucose in vivo, we find that synaptosomes prefer to respire on non-glycolytic substrates, even when glucose is present. Moreover, glucose is metabolized differently in each brain region, resulting in region-specific "signature'' pools of non-glycolytic substrates. The use of non-glycolytic resources increases and dominates during energy crisis, and triggers a marked region-specific metabolic response. We envision that disease-linked proteins confer stress on all relevant brain cells, but region-specific susceptibility stems from metabolism of non-glycolytic substrates, which limits how and to what extent neurons respond to the stress.	[Lee, Do Yup; Xun, Zhiyin; Platt, Virginia; Budworth, Helen; Canaria, Christie A.; McMurray, Cynthia T.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Lee, Do Yup] Kookmin Univ, Dept Adv Fermentat Fus Sci & Technol, Seuol, South Korea; [Platt, Virginia] Buck Inst Res Aging, Novato, CA USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Kookmin University; Buck Institute for Research on Aging	McMurray, CT (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA.	ctmcmurray@lbl.gov	Classen, Scott/AAY-8176-2020		National Institutes of Health [NS40738, GM066359, NS062384, NS069177, CA092584, T32 AG000266]; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040738, RC1NS069177, R01NS062384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000266] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors wish to acknowledge support from the National Institutes of Health NS40738 (to CTM), GM066359 (to CTM), NS062384 (to CTM), NS069177 (to CTM) and CA092584 (to CTM), and T32 AG000266 (VP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvestad S, 2011, J CEREBR BLOOD F MET, V31, P1675, DOI 10.1038/jcbfm.2011.36; Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Cepeda-Prado E, 2012, J NEUROSCI, V32, P6456, DOI 10.1523/JNEUROSCI.0388-12.2012; Choi SW, 2009, J NEUROCHEM, V109, P1179, DOI 10.1111/j.1471-4159.2009.06055.x; Chung S, 2010, J MOL CELL CARDIOL, V48, P725, DOI 10.1016/j.yjmcc.2009.12.014; Chung S, 2008, ANN NY ACAD SCI, V1147, P254, DOI 10.1196/annals.1427.004; Correia SC, 2012, ADV EXP MED BIOL, V724, P205, DOI 10.1007/978-1-4614-0653-2_16; DABENDER, 2012, AMINO ACID METABOLIS; DALBY A, 1992, J CHEM INF COMP SCI, V32, P244, DOI 10.1021/ci00007a012; Dienel G.A., 2012, ASN NEURO, P4, DOI DOI 10.01042/AN20120021; Dranka BP, 2010, FREE RADICAL BIO MED, V48, P905, DOI 10.1016/j.freeradbiomed.2010.01.015; Dzeja PP, 2003, J EXP BIOL, V206, P2039, DOI 10.1242/jeb.00426; Ebert D, 2003, J NEUROSCI, V23, P5928; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Estrada-Sanchez AM, 2009, NEUROBIOL DIS, V34, P78, DOI 10.1016/j.nbd.2008.12.017; Fiehn O, 2005, LECT NOTES COMPUT SC, V3615, P224; Fiehn O, 2011, J BIOL CHEM, V286, P23637, DOI 10.1074/jbc.R110.173617; Floratos A, 2010, BIOINFORMATICS, V26, P1779, DOI 10.1093/bioinformatics/btq282; Gibson GE, 2010, BBA-MOL BASIS DIS, V1802, P122, DOI 10.1016/j.bbadis.2009.08.010; HOLLSTEIN U, 1974, CHEM REV, V74, P625, DOI 10.1021/cr60292a002; Hur J, 2008, CHEM CENT J, V2, DOI 10.1186/1752-153X-2-11; Jacobi H, 2012, CEREBELLUM, V11, P155, DOI 10.1007/s12311-011-0292-z; Johri A, 2012, J PHARMACOL EXP THER, V342, P619, DOI 10.1124/jpet.112.192138; Kalia J, 2008, ANGEW CHEM INT EDIT, V47, P7523, DOI 10.1002/anie.200802651; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lazarov O, 2002, J NEUROSCI, V22, P9785; Lee DY, 2012, MOL CELL PROTEOMICS, V11, P973, DOI 10.1074/mcp.M111.016733; Lee DY, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-7; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; MINN A, 1982, NEUROSCIENCE, V7, P2859, DOI 10.1016/0306-4522(82)90108-7; Mochel F, 2011, J CLIN INVEST, V121, P493, DOI 10.1172/JCI45691; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Mosconi Lisa, 2005, Eur J Nucl Med Mol Imaging, V32, P486, DOI 10.1007/s00259-005-1762-7; Mosconi L, 2008, ANN NY ACAD SCI, V1147, P180, DOI 10.1196/annals.1427.007; NAKATA M, 1995, B CHEM SOC JPN, V68, P967, DOI 10.1246/bcsj.68.967; NICHOLLS DG, 2002, BIOENERGETICS; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; OWICKI JC, 1992, BIOSENS BIOELECTRON, V7, P255, DOI 10.1016/0956-5663(92)87004-9; Pellerin L, 2007, GLIA, V55, P1251, DOI 10.1002/glia.20528; Pinto M, 2012, BIOL CHEM, V393, P275, DOI 10.1515/hsz-2011-0236; REIVICH M, 1979, CIRC RES, V44, P127, DOI 10.1161/01.RES.44.1.127; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sauer U, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100109; Sauerbeck A, 2011, J NEUROSCI METH, V198, P36, DOI 10.1016/j.jneumeth.2011.03.007; SCHOLZ M, 2007, SETUPX PUBLIC STUDY, P169; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; Sokoloff L, 1999, NEUROCHEM RES, V24, P321, DOI 10.1023/A:1022534709672; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Sysi-Aho M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-93; TILLAKARATNE NJK, 1995, COMP BIOCHEM PHYS A, V112, P247, DOI 10.1016/0300-9629(95)00099-2; Trushina E, 2007, NEUROSCIENCE, V145, P1233, DOI 10.1016/j.neuroscience.2006.10.056; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Wang YL, 2009, NUCLEIC ACIDS RES, V37, pW623, DOI 10.1093/nar/gkp456; Willett P, 1998, J CHEM INF COMP SCI, V38, P983, DOI 10.1021/ci9800211; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Xun ZY, 2012, CELL REP, V2, P1137, DOI 10.1016/j.celrep.2012.10.001; Zhang J, 2012, NAT PROTOC, V7, P1068, DOI 10.1038/nprot.2012.048	62	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e68831	10.1371/journal.pone.0068831	http://dx.doi.org/10.1371/journal.pone.0068831			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23874783	Green Submitted, Green Published, gold			2022-12-27	WOS:000322000600031
J	Fukumori, R; Takarada, T; Nakazato, R; Fujikawa, K; Kou, M; Hinoi, E; Yoneda, Y				Fukumori, Ryo; Takarada, Takeshi; Nakazato, Ryota; Fujikawa, Koichi; Kou, Miki; Hinoi, Eiichi; Yoneda, Yukio			Selective Inhibition by Ethanol of Mitochondrial Calcium Influx Mediated by Uncoupling Protein-2 in Relation to N-Methyl-D-Aspartate Cytotoxicity in Cultured Neurons	PLOS ONE			English	Article							RECEPTOR CHANNELS; HIPPOCAMPAL-NEURONS; GLUTAMATE NEUROTOXICITY; CA2+ INFLUX; CELL-DEATH; UNIPORTER; MEMBRANE; PERMEABILITY; EXPRESSION; ALCOHOL	Background: We have shown the involvement of mitochondrial uncoupling protein-2 (UCP2) in the cytotoxicity by N-methyl-D-aspartate receptor (NMDAR) through a mechanism relevant to the increased mitochondrial Ca2+ levels in HEK293 cells with acquired NMDAR channels. Here, we evaluated pharmacological profiles of ethanol on the NMDA-induced increase in mitochondrial Ca2+ levels in cultured murine neocortical neurons. Methodology/Principal Findings: In neurons exposed to glutamate or NMDA, a significant increase was seen in mitochondrial Ca2+ levels determined by Rhod-2 at concentrations of 0.1 to 100 mu M. Further addition of 250 mM ethanol significantly inhibited the increase by glutamate and NMDA in Rhod-2 fluorescence, while similarly potent inhibition of the NMDA-induced increase was seen after exposure to ethanol at 50 to 250 mM in cultured neurons. Lentiviral overexpression of UCP2 significantly accelerated the increase by NMDA in Rhod-2 fluorescence in neurons, without affecting Fluo-3 fluorescence for intracellular Ca2+ levels. In neurons overexpressing UCP2, exposure to ethanol resulted in significantly more effective inhibition of the NMDA-induced increase in mitochondrial free Ca2+ levels than in those without UCP2 overexpression, despite a similarly efficient increase in intracellular Ca2+ levels irrespective of UCP2 overexpression. Overexpression of UCP2 significantly increased the number of dead cells in a manner prevented by ethanol in neurons exposed to glutamate. In HEK293 cells with NMDAR containing GluN2B subunit, more efficient inhibition was similarly induced by ethanol at 50 and 250 mM on the NMDA-induced increase in mitochondrial Ca2+ levels than in those with GluN2A subunit. Decreased protein levels of GluN2B, but not GluN2A, subunit were seen in immunoprecipitates with UCP2 from neurons with brief exposure to ethanol at concentrations over 50 mM. Conclusions/Significance: Ethanol could inhibit the interaction between UCP2 and NMDAR channels to prevent the mitochondrial Ca2+ incorporation and cell death after NMDAR activation in neurons.	[Fukumori, Ryo; Takarada, Takeshi; Nakazato, Ryota; Fujikawa, Koichi; Kou, Miki; Hinoi, Eiichi; Yoneda, Yukio] Kanazawa Univ, Mol Pharmacol Lab, Div Pharmaceut Sci, Grad Sch, Kanazawa, Ishikawa, Japan	Kanazawa University	Yoneda, Y (corresponding author), Kanazawa Univ, Mol Pharmacol Lab, Div Pharmaceut Sci, Grad Sch, Kanazawa, Ishikawa, Japan.	yyoneda@p.kanazawa-u.ac.jp	Yoneda, Yukio/ABI-1864-2020	Yoneda, Yukio/0000-0002-4624-177X; Takarada, Takeshi/0000-0002-2363-7704	Ministry of Education, Culture, Sports, Science and Technology, Japan [22500330, 24650196]; Grants-in-Aid for Scientific Research [24650196] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research to TT (No. 22500330) and YY (No. 24650196) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badanich KA, 2011, GENES BRAIN BEHAV, V10, P805, DOI 10.1111/j.1601-183X.2011.00720.x; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Boss O, 2000, DIABETES, V49, P143, DOI 10.2337/diabetes.49.2.143; Chavin KD, 1999, J BIOL CHEM, V274, P5692, DOI 10.1074/jbc.274.9.5692; CIK M, 1993, BIOCHEM J, V296, P877, DOI 10.1042/bj2960877; Coba MP, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000102; Crews FT, 1996, INT REV NEUROBIOL, V39, P283, DOI 10.1016/S0074-7742(08)60670-4; de Bilbao F, 2004, J NEUROCHEM, V89, P1283, DOI 10.1111/j.1471-4159.2004.02432.x; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Degasperi GR, 2008, FEBS LETT, V582, P3103, DOI 10.1016/j.febslet.2008.08.006; Diano S, 2003, ENDOCRINOLOGY, V144, P5014, DOI 10.1210/en.2003-0667; Elias GM, 2007, TRENDS CELL BIOL, V17, P343, DOI 10.1016/j.tcb.2007.07.005; Fukumori R, 2012, NEUROCHEM INT, V61, P498, DOI 10.1016/j.neuint.2012.03.019; Fukumori R, 2010, NEUROCHEM INT, V57, P730, DOI 10.1016/j.neuint.2010.08.009; Fukumori R, 2010, J PHARMACOL SCI, V112, P273, DOI 10.1254/jphs.09294FP; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Graier WF, 2008, CELL CALCIUM, V44, P36, DOI 10.1016/j.ceca.2008.01.001; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Halestrap AP, 2006, BIOCHEM SOC T, V34, P232, DOI 10.1042/BST0340232; HOFFMAN PL, 1989, J NEUROCHEM, V52, P1937, DOI 10.1111/j.1471-4159.1989.tb07280.x; HUNTER DR, 1976, J BIOL CHEM, V251, P5069; Kambe Y, 2008, J NEUROCHEM, V105, P1886, DOI 10.1111/j.1471-4159.2008.05270.x; Kambe Y, 2011, NEUROCHEM INT, V59, P10, DOI 10.1016/j.neuint.2011.03.018; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Korde AS, 2012, J BIOL CHEM, V287, P35192, DOI 10.1074/jbc.M111.322032; LOVINGER DM, 1989, SCIENCE, V243, P1721, DOI 10.1126/science.2467382; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Nakamichi N, 2010, J NEUROSCI RES, V88, P2483, DOI 10.1002/jnr.22399; Nicholls DG, 2004, J BIOENERG BIOMEMBR, V36, P277, DOI 10.1023/B:JOBB.0000041753.52832.f3; Pang ZP, 2010, J NEUROSCI, V30, P4132, DOI 10.1523/JNEUROSCI.3129-09.2010; Peng TI, 1998, MOL PHARMACOL, V53, P974; Ren H, 2012, J BIOL CHEM, V287, P27302, DOI 10.1074/jbc.M111.338921; Schinder AF, 1996, J NEUROSCI, V16, P6125; Shalbuyeva N, 2006, J BIOL CHEM, V281, P37547, DOI 10.1074/jbc.M607263200; Stout AK, 1998, NAT NEUROSCI, V1, P366, DOI 10.1038/1577; Trenker M, 2007, NAT CELL BIOL, V9, P445, DOI 10.1038/ncb1556; Waldeck-Weiermair M, 2010, CELL CALCIUM, V47, P433, DOI 10.1016/j.ceca.2010.03.004; Wallner M, 2008, BRIT J PHARMACOL, V154, P288, DOI 10.1038/bjp.2008.32; Wills TA, 2012, P NATL ACAD SCI USA, V109, pE278, DOI 10.1073/pnas.1113820109; Woodward JJ, 2000, CRIT REV NEUROBIOL, V14, P69; Wu PH, 2005, J PHARMACOL EXP THER, V312, P1082, DOI 10.1124/jpet.104.075663; Yang JL, 2010, J BIOL CHEM, V285, P28191, DOI 10.1074/jbc.M109.082883; Young KW, 2008, CELL CALCIUM, V43, P296, DOI 10.1016/j.ceca.2007.06.007	45	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e69718	10.1371/journal.pone.0069718	http://dx.doi.org/10.1371/journal.pone.0069718			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874988	Green Published, gold, Green Submitted			2022-12-27	WOS:000322064300113
J	Zhang, YM; Chen, H; He, CL; Wang, Q				Zhang, Yun-Ming; Chen, Hui; He, Chen-Liu; Wang, Qiang			Nitrogen Starvation Induced Oxidative Stress in an Oil-Producing Green Alga Chlorella sorokiniana C3	PLOS ONE			English	Article							BIODIESEL PRODUCTION; LIPID-ACCUMULATION; PHOTOSYSTEM-I; MICROALGAE; FLUORESCENCE; VULGARIS; ENERGY; LIGHT; ANTIOXIDANTS; CAROTENOIDS	Microalgal lipid is one of the most promising feedstocks for biodiesel production. Chlorella appears to be a particularly good option, and nitrogen (N) starvation is an efficient environmental pressure used to increase lipid accumulation in Chlorella cells. The effects of N starvation of an oil-producing wild microalga, Chlorella sorokiniana C3, on lipid accumulation were investigated using thin layer chromatography (TLC), confocal laser scanning microscopy (CLSM) and flow cytometry (FCM). The results showed that N starvation resulted in lipid accumulation in C. sorokiniana C3 cells, oil droplet (OD) formation and significant lipid accumulation in cells were detected after 2 d and 8 d of N starvation, respectively. During OD formation, reduced photosynthetic rate, respiration rate and photochemistry efficiency accompanied by increased damage to PSII were observed, demonstrated by chlorophyll (Chl) fluorescence, 77K fluorescence and oxygen evolution tests. In the mean time the rate of cyclic electron transportation increased correspondingly to produce more ATP for triacylglycerols (TAGs) synthesis. And 0.5 d was found to be the turning point for the early stress response and acclimation of cells to N starvation. Increased level of membrane peroxidation was also observed during OD formation, and superoxide dismutase (SOD), peroxide dismutase (POD) and catalase (CAT) enzyme activity assays suggested impaired reactive oxygen species (ROS) scavenging ability. Significant neutral lipid accumulation was also observed by artificial oxidative stress induced by H2O2 treatment. These results suggested coupled neutral lipid accumulation and oxidative stress during N starvation in C. sorokiniana C3.	[Zhang, Yun-Ming; Chen, Hui; He, Chen-Liu; Wang, Qiang] Chinese Acad Sci, Key Lab Algal Biol, Inst Hydrobiol, Wuhan, Hubei Province, Peoples R China; [Zhang, Yun-Ming] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, Q (corresponding author), Chinese Acad Sci, Key Lab Algal Biol, Inst Hydrobiol, Wuhan, Hubei Province, Peoples R China.	wangqiang@ihb.ac.cn	Wang, Qiang/P-7806-2016; Chen, Hui/T-4383-2019	Wang, Qiang/0000-0002-7388-4703; 	National Program on Key Basic Research Project [2012CB224803]; Chinese Academy of Sciences [Y05101-1-601]	National Program on Key Basic Research Project(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported jointly by the National Program on Key Basic Research Project (2012CB224803) and the 100 Talents Program of the Chinese Academy of Sciences (Y05101-1-601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad AL, 2011, RENEW SUST ENERG REV, V15, P584, DOI 10.1016/j.rser.2010.09.018; Ali MB, 2005, PLANT SCI, V169, P83, DOI 10.1016/j.plantsci.2005.02.027; Amaro HM, 2011, APPL ENERG, V88, P3402, DOI 10.1016/j.apenergy.2010.12.014; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Brussaard CPD, 1997, J PHYCOL, V33, P980, DOI 10.1111/j.0022-3646.1997.00980.x; Chen CY, 2011, BIORESOURCE TECHNOL, V102, P71, DOI 10.1016/j.biortech.2010.06.159; Chen H, 2011, CHEMOSPHERE, V84, P664, DOI 10.1016/j.chemosphere.2011.03.032; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; Converti A, 2009, CHEM ENG PROCESS, V48, P1146, DOI 10.1016/j.cep.2009.03.006; Cooper MS, 2010, J BIOSCI BIOENG, V109, P198, DOI 10.1016/j.jbiosc.2009.08.004; Davey HM, 1996, MICROBIOL REV, V60, P641, DOI 10.1128/MMBR.60.4.641-696.1996; Demirbas A, 2011, APPL ENERG, V88, P3541, DOI 10.1016/j.apenergy.2010.12.050; DemmigAdams B, 1996, AUST J PLANT PHYSIOL, V23, P649, DOI 10.1071/PP9960649; Edge R, 1997, J PHOTOCH PHOTOBIO B, V41, P189, DOI 10.1016/S1011-1344(97)00092-4; Elstner EF., 1991, ACTIVE OXYGEN OXIDAT, V6, P13, DOI [10.1017/S0269727000014068, DOI 10.1016/J.PBI.2005.05.014]; Farrell AE, 2006, SCIENCE, V311, P506, DOI 10.1126/science.1121416; FENG C, 1991, J APPL PHYCOL, V3, P203; Gao H, 2009, FEMS MICROBIOL LETT, V292, P63, DOI 10.1111/j.1574-6968.2008.01470.x; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Gouveia L, 2009, J IND MICROBIOL BIOT, V36, P269, DOI 10.1007/s10295-008-0495-6; Heredia-Arroyo T, 2011, BIOMASS BIOENERG, V35, P2245, DOI 10.1016/j.biombioe.2011.02.036; Hsieh CH, 2009, BIORESOURCE TECHNOL, V100, P3921, DOI 10.1016/j.biortech.2009.03.019; Hyka P, 2012, BIOTECHNOLO IN PRESS; Illman AM, 2000, ENZYME MICROB TECH, V27, P631, DOI 10.1016/S0141-0229(00)00266-0; Kramer DM, 2004, PHOTOSYNTH RES, V79, P209, DOI 10.1023/B:PRES.0000015391.99477.0d; LATASA M, 1994, J PLANKTON RES, V16, P83, DOI 10.1093/plankt/16.1.83; Li YJ, 2012, BIOMASS BIOENERG, V42, P199, DOI 10.1016/j.biombioe.2012.03.010; Li YQ, 2008, APPL MICROBIOL BIOT, V81, P629, DOI 10.1007/s00253-008-1681-1; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Mata TM, 2010, RENEW SUST ENERG REV, V14, P217, DOI 10.1016/j.rser.2009.07.020; Murakami A, 1997, PHOTOSYNTH RES, V53, P141, DOI 10.1023/A:1005818317797; Ngangkham M, 2012, SPRINGERPLUS, V1, DOI 10.1186/2193-1801-1-33; O'Grady J, 2011, BIOPROC BIOSYST ENG, V34, P121, DOI 10.1007/s00449-010-0474-y; Petkov G, 2007, BIOCHEM SYST ECOL, V35, P281, DOI 10.1016/j.bse.2006.10.017; Reiser S, 1997, J BACTERIOL, V179, P2969, DOI 10.1128/jb.179.9.2969-2975.1997; Rodolfi L, 2009, BIOTECHNOL BIOENG, V102, P100, DOI 10.1002/bit.22033; Rosenberg JN, 2008, CURR OPIN BIOTECH, V19, P430, DOI 10.1016/j.copbio.2008.07.008; Scott SA, 2010, CURR OPIN BIOTECH, V21, P277, DOI 10.1016/j.copbio.2010.03.005; Shi SY, 2009, CURR MICROBIOL, V59, P107, DOI 10.1007/s00284-009-9404-0; Shikanai T, 1998, P NATL ACAD SCI USA, V95, P9705, DOI 10.1073/pnas.95.16.9705; STANIER RY, 1971, BACTERIOL REV, V35, P171, DOI 10.1128/MMBR.35.2.171-205.1971; Takagi M, 2000, APPL MICROBIOL BIOT, V54, P112, DOI 10.1007/s002530000333; Toepel J, 2004, METHOD CELL BIOL, V75, P375; Tsihlis ND, 2010, J VASC SURG, V51, P1248, DOI 10.1016/j.jvs.2009.12.028; VAULOT D, 1992, DEEP-SEA RES, V39, P727, DOI 10.1016/0198-0149(92)90117-C; Vigeolas H, 2012, J BIOTECHNOL, V162, P3, DOI 10.1016/j.jbiotec.2012.03.017; Vona V, 1999, PHYSL PLANTARUM; Wan MX, 2012, BIOTECHNOL BIOENG, V109, P1958, DOI 10.1002/bit.24477; Wang Q, 2008, PLANT PHYSIOL, V147, P1239, DOI 10.1104/pp.108.121087; White S, 2011, BIORESOURCE TECHNOL, V102, P1675, DOI 10.1016/j.biortech.2010.09.097; Widjaja A, 2009, J TAIWAN INST CHEM E, V40, P13, DOI 10.1016/j.jtice.2008.07.007	51	140	146	8	162	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e69225	10.1371/journal.pone.0069225	http://dx.doi.org/10.1371/journal.pone.0069225			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874918	Green Published, Green Submitted, gold			2022-12-27	WOS:000322064300093
J	Kleinrouweler, CE; van Uitert, M; Moerland, PD; Ris-Stalpers, C; van der Post, JAM; Afink, GB				Kleinrouweler, C. Emily; van Uitert, Miranda; Moerland, Perry D.; Ris-Stalpers, Carrie; van der Post, Joris A. M.; Afink, Gijs B.			Differentially Expressed Genes in the Pre-Eclamptic Placenta: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							MATERNAL SERUM INHIBIN; MICROARRAY ANALYSIS; UP-REGULATION; MICRORNAS; TISSUE; DYSREGULATION; HYPERTENSION; CONTRIBUTE; DIAGNOSIS; PROFILES	Objective: To systematically review the literature on human gene expression data of placental tissue in pre-eclampsia and to characterize a meta-signature of differentially expressed genes in order to identify novel putative diagnostic markers. Data Sources: Medline through 11 February 2011 using MeSH terms and keywords related to placenta, gene expression and gene expression arrays; GEO database using the term "placent*''; and reference lists of eligible primary studies, without constraints. Methods: From 1068 studies retrieved from the search, we included original publications that had performed gene expression array analyses of placental tissue in the third trimester and that reported on differentially expressed genes in pre-eclampsia versus normotensive controls. Two reviewers independently identified eligible studies, extracted descriptive and gene expression data and assessed study quality. Using a vote-counting method based on a comparative meta-profiling algorithm, we determined a meta-signature that characterizes the significant intersection of differentially expressed genes from the collection of independent gene signatures. Results: We identified 33 eligible gene expression array studies of placental tissue in the 3rd trimester comprising 30 datasets on mRNA expression and 4 datasets on microRNA expression. The pre-eclamptic placental meta-signature consisted of 40 annotated gene transcripts and 17 microRNAs. At least half of the mRNA transcripts encode a protein that is secreted from the cell and could potentially serve as a biomarker. Conclusions: In addition to well-known and validated genes, we identified 14 transcripts not reported previously in relation to pre-eclampsia of which the majority is also expressed in the 1st trimester placenta, and three encode a secreted protein.	[Kleinrouweler, C. Emily; Ris-Stalpers, Carrie; van der Post, Joris A. M.] Univ Amsterdam, Acad Med Ctr, Dept Obstet, Womens & Childrens Clin, NL-1105 AZ Amsterdam, Netherlands; [van Uitert, Miranda; Ris-Stalpers, Carrie; Afink, Gijs B.] Univ Amsterdam, Acad Med Ctr, Reprod Biol Lab, NL-1105 AZ Amsterdam, Netherlands; [Moerland, Perry D.] Univ Amsterdam, Acad Med Ctr, Bioinformat Lab, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Afink, GB (corresponding author), Univ Amsterdam, Acad Med Ctr, Reprod Biol Lab, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	g.b.afink@amc.uva.nl	Moerland, Perry/AAG-1425-2020; Afink, Gijs/AAB-2832-2021; van der Post, Joris A M/A-8991-2008; Afink, Gijs/A-2025-2009	Moerland, Perry/0000-0002-2357-3659; Afink, Gijs/0000-0002-2155-725X; van der Post, Joris/0000-0003-3311-2116	AMC Graduate School	AMC Graduate School	C. Emily Kleinrouweler is supported by a PhD Scholarship from the AMC Graduate School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahr A, 2006, Zentralbl Gynakol, V128, P138, DOI 10.1055/s-2006-933377; Askelund KJ, 2011, PLACENTA, V32, P716, DOI 10.1016/j.placenta.2011.07.081; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Centlow M, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/472354; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; El-Gharib MN, 2011, J MATERN-FETAL NEO M, V24, P595, DOI 10.3109/14767058.2010.511345; Enquobahrie Daniel A, 2011, Am J Obstet Gynecol, V204, DOI 10.1016/j.ajog.2010.09.004; Enquobahrie DA, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.04.020; Farina A, 2009, PRENATAL DIAG, V29, P1038, DOI 10.1002/pd.2344; Fitzgerald B, 2011, PLACENTA, V32, P339, DOI 10.1016/j.placenta.2011.01.018; Foidart JM, 2009, J REPROD IMMUNOL, V82, P106, DOI 10.1016/j.jri.2009.09.001; Founds SA, 2009, PLACENTA, V30, P15, DOI 10.1016/j.placenta.2008.09.015; Gack S, 2005, J MOL MED, V83, P887, DOI 10.1007/s00109-005-0714-9; Guo J, 2012, J OBSTET GYNAECOL RE, V38, P988, DOI 10.1111/j.1447-0756.2011.01823.x; Han JY, 2006, MOL CELLS, V22, P168; Hansson SR, 2006, MOL HUM REPROD, V12, P169, DOI 10.1093/molehr/gal011; Heikkila A, 2005, ACTA OBSTET GYN SCAN, V84, P679; Herse F, 2007, HYPERTENSION, V49, P604, DOI 10.1161/01.HYP.0000257797.49289.71; Hoegh AM, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/787545; Hu YL, 2009, CLIN CHEM LAB MED, V47, P923, DOI 10.1515/CCLM.2009.228; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Huppertz B, 2008, HYPERTENSION, V51, P970, DOI 10.1161/HYPERTENSIONAHA.107.107607; Jarvenpaa J, 2007, GYNECOL ENDOCRINOL, V23, P351, DOI 10.1080/09513590701350291; Jarvenpaa J, 2009, J PERINAT MED, V37, P257, DOI 10.1515/JPM.2009.046; Kang JH, 2011, J HYPERTENS, V29, P928, DOI 10.1097/HJH.0b013e328344a82c; Lee GSR, 2010, ARCH GYNECOL OBSTET, V282, P363, DOI 10.1007/s00404-009-1222-x; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Liu YX, 2008, MOL MED, V14, P561, DOI 10.2119/2008-00009.Liu; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Maynard SE, 2011, SEMIN NEPHROL, V31, P33, DOI 10.1016/j.semnephrol.2010.10.004; Mayor-Lynn K, 2011, REPROD SCI, V18, P46, DOI 10.1177/1933719110374115; Mikheev AM, 2008, REPROD SCI, V15, P866, DOI 10.1177/1933719108322425; Morris Rachel K, 2008, BMC Pregnancy Childbirth, V8, P33, DOI 10.1186/1471-2393-8-33; Nishizawa H, 2007, PLACENTA, V28, P487, DOI 10.1016/j.placenta.2006.05.010; Nishizawa H, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-107; Olsen RN, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.06.006; Pang Zhan-Jun, 2004, Archives of Gynecology and Obstetrics, V269, P91, DOI 10.1007/s00404-002-0413-5; Pang ZJ, 2004, J PERINAT MED, V32, P25, DOI 10.1515/JPM.2004.004; Pang ZJ, 2003, BRIT J BIOMED SCI, V60, P97, DOI 10.1080/09674845.2003.11783682; Pang ZJ, 2003, J PERINAT MED, V31, P153, DOI 10.1515/JPM.2003.021; PERKINS AV, 1995, BRIT J OBSTET GYNAEC, V102, P118, DOI 10.1111/j.1471-0528.1995.tb09063.x; Rajakumar A, 2012, HYPERTENSION, V59, P256, DOI 10.1161/HYPERTENSIONAHA.111.182170; Reimer T, 2002, MOL HUM REPROD, V8, P674, DOI 10.1093/molehr/8.7.674; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Roberts J M, 2009, Placenta, V30 Suppl A, pS32, DOI 10.1016/j.placenta.2008.11.009; Rumer KK, 2013, REPROD SCI, V20, P646, DOI 10.1177/1933719112461185; Shen ZJ, 2011, J OBSTET GYNAECOL RE, V37, P1290, DOI 10.1111/j.1447-0756.2010.01513.x; Sitras V, 2009, PLACENTA, V30, P424, DOI 10.1016/j.placenta.2009.01.012; Soleymanlou N, 2005, J CLIN ENDOCR METAB, V90, P4299, DOI 10.1210/jc.2005-0078; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tsai S, 2011, PLACENTA, V32, P175, DOI 10.1016/j.placenta.2010.11.014; Tsoi SM, 2003, J SOC GYNECOL INVEST, V10, P496, DOI 10.1016/S1071-5576(03)00154-0; Vaiman D, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-111; Varkonyi T, 2011, PLACENTA, V32, pS21, DOI 10.1016/j.placenta.2010.04.014; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Verlohren S, 2012, CLIN SCI, V122, P43, DOI 10.1042/CS20110097; Winn VD, 2009, ENDOCRINOLOGY, V150, P452, DOI 10.1210/en.2008-0990; Zhou RR, 2006, GYNECOL OBSTET INVES, V62, P108, DOI 10.1159/000092857; Zhu XM, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.12.045	62	60	62	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e68991	10.1371/journal.pone.0068991	http://dx.doi.org/10.1371/journal.pone.0068991			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	23874842	gold, Green Published, Green Submitted			2022-12-27	WOS:000321718700045
J	Yang, X; Yu, XY; Li, YF				Yang, Xia; Yu, Xin-Yan; Li, Yong-Feng			De novo Assembly and Characterization of the Barnyardgrass (Echinochloa crus-galli) Transcriptome Using Next-Generation Pyrosequencing	PLOS ONE			English	Article							ACETOLACTATE SYNTHASE; HERBICIDE RESISTANCE; CROP IMPROVEMENT; GENES; EXPRESSION; GENOME; TUBERCULATUS; ANNOTATION; SEQUENCES; BIOTYPES	Background: Barnyardgrass (Echinochloa crus-galli) is an important weed that is a menace to rice cultivation and production. Rapid evolution of herbicide resistance in this weed makes it one of the most difficult to manage using herbicides. Since genome-wide sequence data for barnyardgrass is limited, we sequenced the transcriptomes of susceptible and resistant barnyardgrass biotypes using the 454 GS-FLX platform. Results: 454 pyrosequencing generated 371,281 raw reads with an average length of 341.8 bp, which made a total length of 126.89 Mb (SRX160526). De novo assembly produced 10,142 contigs (similar to 5.92 Mb) with an average length of 583 bp and 68,940 singletons (similar to 22.13 Mb) with an average length of 321 bp. About 244,653 GO term assignments to the biological process, cellular component and molecular function categories were obtained. A total of 6,092 contigs and singletons with 2,515 enzyme commission numbers were assigned to 151 predicted KEGG metabolic pathways. Digital abundance analysis using Illumina sequencing identified 78,124 transcripts among susceptible, resistant, herbicide-treated susceptible and herbicide-treated resistant barnyardgrass biotypes. From these analyses, eight herbicide target-site gene groups and four non-target-site gene groups were identified in the resistant biotype. These could be potential candidate genes involved in the herbicide resistance of barnyardgrass and could be used for further functional genomics research. C-4 photosynthesis genes including RbcS, RbcL, NADP-me and MDH with complete CDS were identified using PCR and RACE technology. Conclusions: This is the first large-scale transcriptome sequencing of E. crus-galli performed using the 454 GS-FLX platform. Potential candidate genes involved in the evolution of herbicide resistance were identified from the assembled sequences. This transcriptome data may serve as a reference for further gene expression and functional genomics studies, and will facilitate the study of herbicide resistance at the molecular level in this species as well as other weeds.	[Yang, Xia; Yu, Xin-Yan; Li, Yong-Feng] Jiangsu Acad Agr Sci, Inst Plant Protect, Nanjing, Jiangsu, Peoples R China	Jiangsu Academy of Agricultural Sciences	Li, YF (corresponding author), Jiangsu Acad Agr Sci, Inst Plant Protect, Nanjing, Jiangsu, Peoples R China.	liyongfeng_2010@hotmail.com			National Natural Science Foundation of China [30971926]; Special Fund for Agro-scientific Research in the Public Interest [201303031]; Jiangsu Agriculture Science and Technology Innovation Fund [CX(12)1003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; Jiangsu Agriculture Science and Technology Innovation Fund	This work was supported by National Natural Science Foundation of China (No. 30971926), Special Fund for Agro-scientific Research in the Public Interest (No. 201303031) and Jiangsu Agriculture Science and Technology Innovation Fund (No. CX(12)1003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Bouchenak-Khelladi Y, 2009, GLOBAL CHANGE BIOL, V15, P2397, DOI 10.1111/j.1365-2486.2009.01860.x; Chauhan B. S., 2012, The Scientific World Journal, V2012, P123071; Christin PA, 2007, CURR BIOL, V17, P1241, DOI 10.1016/j.cub.2007.06.036; Christin PA, 2009, GENOME BIOL EVOL, V1, P221, DOI 10.1093/gbe/evp020; Delano-Frier JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-363; Delye C, 2004, PLANT PHYSIOL, V136, P3920, DOI 10.1104/pp.103.037432; Duke SO, 2010, PEST MANAG SCI, V66, P1041, DOI 10.1002/ps.1980; Edwards D, 2010, PLANT BIOTECHNOL J, V8, P2, DOI 10.1111/j.1467-7652.2009.00459.x; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; He HB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037201; Heap I., 2013, INT SURVEY HERBICIDE; Hilu KW, 1999, ANN MO BOT GARD, V86, P835, DOI 10.2307/2666171; Iwakami S, 2012, PEST MANAG SCI, V68, P1098, DOI 10.1002/ps.3287; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Juliano LM, 2010, INT J PEST MANAGE, V56, P299, DOI 10.1080/09670874.2010.495795; Lai Z, 2012, AM J BOT, V99, P209, DOI 10.3732/ajb.1100313; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malik MS, 2010, WEED TECHNOL, V24, P226, DOI 10.1614/WT-09-053.1; Mochida K, 2010, PLANT CELL PHYSIOL, V51, P497, DOI 10.1093/pcp/pcq027; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Patek M, 2005, MICROBIOL MONOGR, V5, P129; Peng YH, 2010, PEST MANAG SCI, V66, P1053, DOI 10.1002/ps.2004; Powles SB, 2010, ANNU REV PLANT BIOL, V61, P317, DOI 10.1146/annurev-arplant-042809-112119; Rahman MM, 2010, AUST J CROP SCI, V4, P107; Riar DS, 2013, J AGR FOOD CHEM, V61, P278, DOI 10.1021/jf304675j; Riggins CW, 2010, PEST MANAG SCI, V66, P1042, DOI 10.1002/ps.2006; Schaefer H, 2011, ECOL LETT, V14, P389, DOI 10.1111/j.1461-0248.2011.01600.x; Sterky F, 2000, J BIOTECHNOL, V76, P1, DOI 10.1016/S0168-1656(99)00176-5; Varshney RK, 2009, TRENDS BIOTECHNOL, V27, P522, DOI 10.1016/j.tibtech.2009.05.006; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wang JM, 2008, AFR J BIOTECHNOL, V7, P783; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang YX, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034225, 10.1371/journal.pone.0039525, 10.1371/journal.pone.0037152]; Wilhelm BT, 2009, METHODS, V48, P249, DOI 10.1016/j.ymeth.2009.03.016; Yamamoto E, 1999, PLANT MOL BIOL, V39, P45, DOI 10.1023/A:1006108412801; Yammoto E, 1998, PLANT CELL, V10, P29; Yu XinYan, 2010, Jiangsu Journal of Agricultural Sciences, V26, P1438	40	29	38	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e69168	10.1371/journal.pone.0069168	http://dx.doi.org/10.1371/journal.pone.0069168			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874903	Green Published, gold, Green Submitted			2022-12-27	WOS:000321765300079
J	Thomas, S; Thurn, KT; Raha, P; Chen, S; Munster, PN				Thomas, Scott; Thurn, K. Ted; Raha, Paromita; Chen, Stephanie; Munster, Pamela N.			Efficacy of Histone Deacetylase and Estrogen Receptor Inhibition in Breast Cancer Cells Due to Concerted down Regulation of Akt	PLOS ONE			English	Article							CHAPERONE FUNCTION; PHASE-II; SURVIVAL; KINASE; TRICHOSTATIN; DEGRADATION; ACTIVATION; PATHWAY; HEAT-SHOCK-PROTEIN-90; PHOSPHORYLATION	Hormonal therapy resistance remains a considerable barrier in the treatment of breast cancer. Activation of the Akt-PI3K-mTOR pathway plays an important role in hormonal therapy resistance. Our recent preclinical and clinical studies showed that the addition of a histone deacetylase inhibitor re-sensitized hormonal therapy resistant breast cancer to tamoxifen. As histone deacetylases are key regulators of Akt, we evaluated the effect of combined treatment with the histone deacetylase inhibitor PCI-24781 and tamoxifen on Akt in breast cancer cells. We demonstrate that while both histone deacetylase and estrogen receptor inhibition down regulate AKT mRNA and protein, their concerted effort results in down regulation of AKT activity with induction of cell death. Histone deacetylase inhibition exerts its effect on AKT mRNA through an estrogen receptor-dependent mechanism, primarily down regulating the most abundant isoform AKT1. Although siRNA depletion of AKT modestly induces cell death, when combined with an anti-estrogen, cytotoxicity is significantly enhanced. Thus, histone deacetylase regulation of AKT mRNA is a key mediator of this therapeutic combination and may represent a novel biomarker for predicting response to this regimen.	[Thomas, Scott; Thurn, K. Ted; Raha, Paromita; Chen, Stephanie; Munster, Pamela N.] Univ Calif San Francisco, Dept Med, Div Hematol & Oncol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Munster, PN (corresponding author), Univ Calif San Francisco, Dept Med, Div Hematol & Oncol, San Francisco, CA 94143 USA.	pmunster@medicine.ucsf.edu	Raha, Paromita/AAJ-1559-2020; Thomas, Scott/AAF-2683-2020	Chen, Stephanie/0000-0002-9004-3682; Raha, Paromita/0000-0002-6941-1495	National Institutes of Health [5 R01 CA152989]; Pharmacyclics Inc.; NATIONAL CANCER INSTITUTE [R01CA152989] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pharmacyclics Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded largely by the National Institutes of Health grant: 5 R01 CA152989. This work was further funded by a research grant from Pharmacyclics Inc. http://www.pharmacyclics.com/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alao JP, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-40; Alao JP, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-8; Alao JP, 2004, CLIN CANCER RES, V10, P8094, DOI 10.1158/1078-0432.CCR-04-1023; Bachelot T, 2012, J CLIN ONCOL, V30, P2718, DOI 10.1200/JCO.2011.39.0708; Bali P, 2005, J BIOL CHEM, V280, P26729, DOI 10.1074/jbc.C500186200; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; BELLACOSA A, 1995, INT J CANCER, V64, P280, DOI 10.1002/ijc.2910640412; Bicaku E, 2008, CANCER RES, V68, P1513, DOI 10.1158/0008-5472.CAN-07-2822; Bradley EW, 2013, J BIOL CHEM, V288, P9572, DOI 10.1074/jbc.M112.423723; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Buggy JJ, 2006, MOL CANCER THER, V5, P1309, DOI 10.1158/1535-7163.MCT-05-0442; Carlson RW, 2011, J NATL COMPR CANC NE, V9, P136, DOI 10.6004/jnccn.2011.0016; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Chen CS, 2005, J BIOL CHEM, V280, P38879, DOI 10.1074/jbc.M505733200; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Erlich RB, 2012, BRIT J CANCER, V106, P107, DOI 10.1038/bjc.2011.495; Fiskus W, 2007, CLIN CANCER RES, V13, P4882, DOI 10.1158/1078-0432.CCR-06-3093; Foley NH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-83; Hodges-Gallagher L, 2006, TREAT BREAST CANC RE; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kawai H, 2003, INT J CANCER, V107, P353, DOI 10.1002/ijc.11403; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Lee Rachel S, 2011, Enzyme Res, V2011, P720985, DOI 10.4061/2011/720985; Li JA, 2011, CANCER LETT, V304, P52, DOI 10.1016/j.canlet.2011.02.003; Lin RJ, 2010, MOL CARCINOGEN, V49, P719, DOI 10.1002/mc.20647; Margueron R, 2004, BIOCHEM PHARMACOL, V68, P1239, DOI 10.1016/j.bcp.2004.04.031; Munster PN, 2011, BRIT J CANCER, V104, P1828, DOI 10.1038/bjc.2011.156; Osborne CK, 2011, CLIN CANCER RES, V17, P1147, DOI 10.1158/1078-0432.CCR-10-1869; Ozaki K, 2010, BIOCHEM BIOPH RES CO, V391, P1610, DOI 10.1016/j.bbrc.2009.12.086; Raha P, 2011, EPIGENOMICS-UK, V3, P451, DOI [10.2217/epi.11.72, 10.2217/EPI.11.72]; Rahmani M, 2005, CANCER RES, V65, P2422, DOI 10.1158/0008-5472.CAN-04-2440; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scott GK, 2006, CANCER RES, V66, P1277, DOI 10.1158/0008-5472.CAN-05-3632; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Sun M, 2001, AM J PATHOL, V159, P431, DOI 10.1016/S0002-9440(10)61714-2; Thomas S, 2011, BREAST CANCER RES TR, V130, P437, DOI 10.1007/s10549-011-1364-y; Thomas S, 2009, CANCER LETT, V280, P184, DOI 10.1016/j.canlet.2008.12.026; Undevia SD, 2008, J CLIN ONCOL S, V26; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wada T, 2012, EMBO REP, V13, P142, DOI 10.1038/embor.2011.247; Yi X, 2008, BIOCHEM PHARMACOL, V75, P1697, DOI 10.1016/j.bcp.2007.10.035	44	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68973	10.1371/journal.pone.0068973	http://dx.doi.org/10.1371/journal.pone.0068973			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874830	Green Submitted, Green Published, gold			2022-12-27	WOS:000321736900124
J	Schroder, PM; Khattar, M; Deng, RH; Xie, AN; Chen, WH; Stepkowski, SM				Schroder, Paul M.; Khattar, Mithun; Deng, Ronghai; Xie, Aini; Chen, Wenhao; Stepkowski, Stanislaw M.			Transient Combination Therapy Targeting the Immune Synapse Abrogates T Cell Responses and Prolongs Allograft Survival in Mice	PLOS ONE			English	Article							ANTIGEN-1 MONOCLONAL-ANTIBODY; LONG-TERM SURVIVAL; RECEPTOR INTERNALIZATION; RENAL-TRANSPLANTATION; ISLET TRANSPLANTATION; CARDIAC ALLOGRAFTS; MULTICENTER TRIAL; LFA-1; EFALIZUMAB; ACTIVATION	T cells play a major role in allograft rejection, which occurs after T cell activation by the engagement of several functional molecules to form an immune synapse with alloantigen presenting cells. In this study, the immune synapse was targeted using mAbs directed to the TCR beta-chain (TCR beta) and lymphocyte function-associated antigen-1 (LFA1) to induce long-term allograft survival. Evaluation of antigen-specific T cell responses was performed by adoptively transferring CFSE labeled transgenic OT-II cells into wild-type mice and providing OVA peptide by intravenous injection. Graft survival studies were performed in mice by transplanting BALB/c ear skins onto the flanks of C57BL/6 recipients. The anti-TCR beta plus anti-LFA1 mAb combination (but not either mAb alone) abrogated antigen-specific T cell responses invitro and invivo. Transient combination therapy with these agents resulted in significantly prolonged skin allograft survival in mice (51 +/- 10 days; p<0.01) when compared to treatment with either anti-TCRb mAb (24 +/- 5 days) or anti-LFA1 mAb (19 +/- 3 days) alone or no treatment (10 +/- 1 days). When lymphoid tissues from these mice were analyzed at different times post-transplant, only those receiving the combination of anti-TCR beta and anti-LFA1 mAbs demonstrated long-lasting reductions in total T cell numbers, cellular and humoral anti-donor responses, and expression of CD3 on the surface of T cells. These results demonstrate that transient anti-TCR beta and anti-LFA1 mAb combination therapy abrogates antigen-reactive T cell responses with long-lasting effects that significantly prolong allograft survival.	[Schroder, Paul M.; Khattar, Mithun; Deng, Ronghai; Chen, Wenhao; Stepkowski, Stanislaw M.] Univ Toledo, Dept Med Microbiol & Immunol, Coll Med, Toledo, OH 43606 USA; [Deng, Ronghai] Sun Yat Sen Univ, Affiliated Hosp 1, Organ Transplantat Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Xie, Aini; Chen, Wenhao] Baylor Coll Med, Dept Med, Div Diabet Endocrinol & Metab, Houston, TX 77030 USA; [Xie, Aini] Huazhong Univ Sci & Technol, Dept Cardiovasc Surg, Union Hosp, Wuhan 430074, Peoples R China	University System of Ohio; University of Toledo; Sun Yat Sen University; Baylor College of Medicine; Huazhong University of Science & Technology	Chen, WH (corresponding author), Univ Toledo, Dept Med Microbiol & Immunol, Coll Med, 2801 W Bancroft St, Toledo, OH 43606 USA.	wenhaoc@bcm.edu; Stanislaw.Stepkowski@utoledo.edu	Chen, Wenhao/J-6553-2019; Khattar, Mithun/AAD-4760-2020; Khattar, Mithun/O-4415-2014	Chen, Wenhao/0000-0002-0626-3739; Khattar, Mithun/0000-0002-4355-4623	National Institutes of Health [5RO1AI090244-02]; American Heart Association [11SDG7690000]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090244] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funding from the National Institutes of Health (grant number 5RO1AI090244-02) and the American Heart Association (grant number 11SDG7690000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann MF, 1997, IMMUNITY, V7, P549, DOI 10.1016/S1074-7613(00)80376-3; Behrens GMN, 2004, J IMMUNOL, V172, P5420, DOI 10.4049/jimmunol.172.9.5420; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Burrell BE, 2012, AM J TRANSPLANT, V12, P576, DOI 10.1111/j.1600-6143.2011.03879.x; Carson KR, 2009, LANCET ONCOL, V10, P816, DOI 10.1016/S1470-2045(09)70161-5; Crotzer VL, 2004, J EXP MED, V199, P981, DOI 10.1084/jem.20031105; Durrbach A, 2010, NAT REV NEPHROL, V6, P160, DOI 10.1038/nrneph.2009.233; Ferguson R, 2011, AM J TRANSPLANT, V11, P66, DOI 10.1111/j.1600-6143.2010.03338.x; FERRARESSO M, 1994, J IMMUNOL, V153, P3307; Fooksman DR, 2010, ANNU REV IMMUNOL, V28, P79, DOI 10.1146/annurev-immunol-030409-101308; Garrod Kym R, 2008, J Vis Exp, DOI 10.3791/634; GOTOH M, 1994, TRANSPLANTATION, V57, P123; GOUGEON ML, 1985, CELL IMMUNOL, V95, P75, DOI 10.1016/0008-8749(85)90296-5; Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; Hourmant M, 1996, TRANSPLANTATION, V62, P1565, DOI 10.1097/00007890-199612150-00006; Isobe M, 1996, TRANSPLANTATION, V62, P411, DOI 10.1097/00007890-199608150-00019; ISOBE M, 1992, SCIENCE, V255, P1125, DOI 10.1126/science.1347662; Kitchens WH, 2011, IMMUNOTHERAPY-UK, V3, P305, DOI 10.2217/IMT.10.113; KNIGHT RJ, 1994, TRANSPLANTATION, V57, P1581; KNOBLOCH C, 1991, CELL IMMUNOL, V138, P150, DOI 10.1016/0008-8749(91)90140-7; Krieger NR, 1996, J EXP MED, V184, P2013, DOI 10.1084/jem.184.5.2013; Lebwohl M, 2003, NEW ENGL J MED, V349, P2004, DOI 10.1056/NEJMoa030002; LIN H, 1993, J EXP MED, V178, P1801, DOI 10.1084/jem.178.5.1801; Lunsford KE, 2005, J IMMUNOL, V175, P7855, DOI 10.4049/jimmunol.175.12.7855; Martinez-Martin N, 2011, IMMUNITY, V35, P208, DOI 10.1016/j.immuni.2011.06.003; Miyahara Y, 2012, AM J TRANSPLANT, V12, P1409, DOI 10.1111/j.1600-6143.2012.04006.x; Nakakura EK, 1996, TRANSPLANTATION, V62, P547, DOI 10.1097/00007890-199609150-00001; Nicolls MR, 2000, J IMMUNOL, V164, P3627, DOI 10.4049/jimmunol.164.7.3627; PAUL LC, 1993, TRANSPLANTATION, V55, P1196; Posselt AM, 2010, AM J TRANSPLANT, V10, P1870, DOI 10.1111/j.1600-6143.2010.03073.x; Reichardt P, 2007, IMMUNOL REV, V218, P165, DOI 10.1111/j.1600-065X.2007.00526.x; Reisman NM, 2011, BLOOD, V118, P5851, DOI 10.1182/blood-2011-04-347252; Schwab N, 2012, NEUROLOGY, V78, P458, DOI 10.1212/WNL.0b013e3182478d4b; Setoguchi K, 2011, AM J TRANSPLANT, V11, P923, DOI 10.1111/j.1600-6143.2011.03492.x; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Trulock EP, 2007, J HEART LUNG TRANSPL, V26, P782, DOI 10.1016/j.healun.2007.06.003; Turgeon NA, 2010, AM J TRANSPLANT, V10, P2082, DOI 10.1111/j.1600-6143.2010.03212.x; United States Renal Data System, 2011, USRDS 2011 ANN DAT R; Vincenti F, 2008, AM J TRANSPLANT, V8, P1972, DOI 10.1111/j.1600-6143.2008.02403.x; Vincenti F, 2007, AM J TRANSPLANT, V7, P1770, DOI 10.1111/j.1600-6143.2007.01845.x; Viola A, 1996, SCIENCE, V273, P104, DOI 10.1126/science.273.5271.104; Waid TH, 1997, J HEART LUNG TRANSPL, V16, P913; WAID TH, 1992, TRANSPLANTATION, V53, P80, DOI 10.1097/00007890-199201000-00015; Waid TH, 2009, DRUG DES DEV THER, V3, P205; Wang Y, 2009, J BIOL CHEM, V284, P12645, DOI 10.1074/jbc.M807207200; Willenborg DO, 1996, J IMMUNOL, V157, P1973; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657	47	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69397	10.1371/journal.pone.0069397	http://dx.doi.org/10.1371/journal.pone.0069397			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894468	gold, Green Submitted, Green Published			2022-12-27	WOS:000322167900064
J	Shore, AM; Karamitri, A; Kemp, P; Speakman, JR; Graham, NS; Lomax, MA				Shore, Andrew M.; Karamitri, Angeliki; Kemp, Paul; Speakman, John R.; Graham, Neil S.; Lomax, Michael A.			Cold-Induced Changes in Gene Expression in Brown Adipose Tissue, White Adipose Tissue and Liver	PLOS ONE			English	Article							THYROID-HORMONE; LIPOATROPHIC MICE; TRANSCRIPT LEVELS; EXPOSURE; LEPTIN; THERMOGENESIS; PROTEIN; RAT; IDENTIFICATION; PREADIPOCYTES	Cold exposure imposes a metabolic challenge to mammals that is met by a coordinated response in different tissues to prevent hypothermia. This study reports a transcriptomic analysis in brown adipose tissue (BAT), white adipose (WAT) and liver of mice in response to 24 h cold exposure at 8 degrees C. Expression of 1895 genes were significantly (P<0.05) up- or down-regulated more than two fold by cold exposure in all tissues but only 5 of these genes were shared by all three tissues, and only 19, 14 and 134 genes were common between WAT and BAT, WAT and liver, and BAT and liver, respectively. We confirmed using qRT-PCR, the increased expression of a number of characteristic BAT genes during cold exposure. In both BAT and the liver, the most common direction of change in gene expression was suppression (496 genes in BAT and 590 genes in liver). Gene ontology analysis revealed for the first time significant (P<0.05) down regulation in response to cold, of genes involved in oxidoreductase activity, lipid metabolic processes and protease inhibitor activity, in both BAT and liver, but not WAT. The results reveal an unexpected importance of down regulation of cytochrome P450 gene expression and apolipoprotein, in both BAT and liver, but not WAT, in response to cold exposure. Pathway analysis suggests a model in which down regulation of the nuclear transcription factors HNF4 alpha and PPAR alpha in both BAT and liver may orchestrate the down regulation of genes involved in lipoprotein and steroid metabolism as well as Phase I enzymes belonging to the cytochrome P450 group in response to cold stress in mice. We propose that the response to cold stress involves decreased gene expression in a range of cellular processes in order to maximise pathways involved in heat production.	[Shore, Andrew M.] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Karamitri, Angeliki] INSERM, Inst Cochin, Paris, France; [Kemp, Paul] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Speakman, John R.] Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland; [Graham, Neil S.; Lomax, Michael A.] Univ Nottingham, Sch Biosci, Loughborough, Leics, England	Cardiff University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Imperial College London; University of Aberdeen; University of Nottingham	Lomax, MA (corresponding author), Univ Nottingham, Sch Biosci, Loughborough, Leics, England.	michael.lomax@nottingham.ac.uk	Speakman, John R./A-9494-2008; Graham, Neil/C-5489-2008	Speakman, John R./0000-0002-2457-1823; Graham, Neil/0000-0001-9080-8967; Karamitri, Angeliki/0000-0002-8397-5529; Kemp, Paul/0000-0001-8975-7293	BBSRC; Imperial College	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Imperial College	This work was supported by BBSRC (http://www.bbsrc.ac.uk/home/home.aspx) and Imperial College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi S, 1997, J BIOL CHEM, V272, P30583, DOI 10.1074/jbc.272.48.30583; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Daikoku T, 2000, BBA-BIOENERGETICS, V1457, P263, DOI 10.1016/S0005-2728(00)00107-9; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gabova A V, 2000, Aviakosm Ekolog Med, V34, P35; Gavrilova O, 2000, J CLIN INVEST, V105, P271, DOI 10.1172/JCI7901; Gavrilova O, 1997, J BIOL CHEM, V272, P30546, DOI 10.1074/jbc.272.48.30546; Gavrilova O, 1999, P NATL ACAD SCI USA, V96, P14623, DOI 10.1073/pnas.96.25.14623; Gavrilova O, 2000, NATURE, V403, P850, DOI 10.1038/35002663; Gavrilova O A, 1998, Stomatologiia (Mosk), V77, P37; Gong DW, 2000, J BIOL CHEM, V275, P16251, DOI 10.1074/jbc.M910177199; Hall JR, 2011, AM J PHYSIOL-REG I, V301, pR995, DOI 10.1152/ajpregu.00210.2011; Kajimoto K, 2003, MOL GENET METAB, V80, P255, DOI 10.1016/j.ymgme.2003.08.006; Karamanlidis G, 2007, J BIOL CHEM, V282, P24660, DOI 10.1074/jbc.M703101200; Karamitri A, 2009, J BIOL CHEM, V284, P20738, DOI 10.1074/jbc.M109.021766; Kim JK, 2000, J BIOL CHEM, V275, P8456, DOI 10.1074/jbc.275.12.8456; Liu JR, 2012, AM J PHYSIOL-ENDOC M, V303, pE908, DOI 10.1152/ajpendo.00663.2011; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Ohguchi H, 2008, MOL CELL BIOL, V28, P3917, DOI 10.1128/MCB.02154-07; PENNER PE, 1968, CAN J BIOCHEM CELL B, V46, P1205, DOI 10.1139/o68-180; Shore A, 2010, DIABETOLOGIA, V53, P1164, DOI 10.1007/s00125-010-1701-4; Silva JE, 2006, PHYSIOL REV, V86, P435, DOI 10.1152/physrev.00009.2005; SOLTER M, 1989, J CLIN ENDOCR METAB, V68, P168, DOI 10.1210/jcem-68-1-168; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; SYMONDS ME, 1992, P NUTR SOC, V51, P165, DOI 10.1079/PNS19920026; Tairbekov MG, 1997, IZV AKAD NAUK BIOL+, P266; Thorne MAS, 2010, MAR GENOM, V3, P35, DOI 10.1016/j.margen.2010.02.002; Unami A, 2004, BIOCHEM PHARMACOL, V67, P555, DOI 10.1016/j.bcp.2003.09.010; VALLERAND AL, 1990, AM J PHYSIOL, V259, pR1043, DOI 10.1152/ajpregu.1990.259.5.R1043; Walden TB, 2012, AM J PHYSIOL-ENDOC M, V302, pE19, DOI 10.1152/ajpendo.00249.2011; Watanabe M, 2008, BIOL PHARM BULL, V31, P775, DOI 10.1248/bpb.31.775; Watanabe M, 2008, BBA-BIOENERGETICS, V1777, P104, DOI 10.1016/j.bbabio.2007.10.014; Watanabe M, 2011, APPL BIOCHEM BIOTECH, V165, P538, DOI 10.1007/s12010-011-9273-4; Yamamoto T, 2011, BIOTECHNOL LETT, V33, P237, DOI 10.1007/s10529-010-0444-0; YAMAZAKI N, 1995, FEBS LETT, V363, P41, DOI 10.1016/0014-5793(95)00277-G; Yu SH, 2000, J CLIN INVEST, V105, P615, DOI 10.1172/JCI8437	37	51	53	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e68933	10.1371/journal.pone.0068933	http://dx.doi.org/10.1371/journal.pone.0068933			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894377	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000322132100031
J	Dai, J; Krasnow, RE; Liu, L; Sawada, SG; Reed, T				Dai, Jun; Krasnow, Ruth E.; Liu, Lei; Sawada, Stephen G.; Reed, Terry			The Association between Postload Plasma Glucose Levels and 38-Year Mortality Risk of Coronary Heart Disease: The Prospective NHLBI Twin Study	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; FOLLOW-UP; MEDITERRANEAN DIET; FINNISH TWINS; MIGRATION; MEN; ATHEROSCLEROSIS; ADHERENCE; MODELS; STROKE	Background: Due to the paucity of direct evidence, we aimed to evaluate whether the association between postload plasma glucose levels (ppGlucose) and long-term risk of mortality from coronary heart disease was independent of or attributable to genes and common environment. Methods and Findings: From the prospective National Heart, Lung, and Blood Institute (NHLBI) Twin Study, we included 903 middle-aged male twins, who were nondiabetic, free of coronary heart disease at baseline (1969-1973), and followed for up to 38 years for coronary heart, cardiovascular, and all-cause mortality. Frailty survival models were used to estimate hazard ratio (HR) for various associations: overall (equivalent to singleton population association), within-pair (controlling for genes and environment common to co-twins), and between-pair association (reflecting influences of common factors). Overall associations were statistically significant for coronary heart and cardiovascular but not all-cause deaths after controlling for known risk factors. The associations were not statistically significant in within-pair analyses. The within-pair association was not statistically different by zygosity for specific and all-cause death risk. After the full adjustment for known risk factors, HR (95% confidence interval) for within-pair association was 1.07 (0.90, 1.28), 1.06 (0.94, 1.19), and 0.99 (0.94, 1.05) for coronary heart, cardiovascular, and all-cause mortality, respectively. The fully adjusted between-pair associations were statistically significant for specific and all-cause death risk: a 50 mg/dL increase in the mean value of ppGlucose for a twin pair was associated with a raised death risk [ HR (95% confidence interval) 1.15 (1.02, 1.30), 1.10 (1.02, 1.20), and 1.05 (1.01, 1.09) for coronary heart, cardiovascular, and all-cause mortality, respectively]. Between-pair association was significant in dizygotic but not in monozygotic twins. Conclusion: The positive association between ppGlucose and long-term coronary heart mortality risk is largely explained by factors shared between co-twins, including familial factors; however, within-pair effects cannot be absolutely excluded.	[Dai, Jun] Vanderbilt Univ, Med Ctr, Div Epidemiol, Dept Med, Nashville, TN 37212 USA; [Dai, Jun] Indiana Univ, Dept Appl Hlth Sci, Sch Publ Hlth Bloomington, Bloomington, IN 47405 USA; [Dai, Jun] Indiana Univ, Dept Epidemiol & Biostat, Sch Publ Hlth Bloomington, Bloomington, IN USA; [Dai, Jun] Indiana Ctr Vasc Biol & Med, Indianapolis, IN USA; [Krasnow, Ruth E.] SRI Int, Ctr Hlth Sci, Menlo Pk, CA 94025 USA; [Liu, Lei] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Sawada, Stephen G.] Indiana Univ, Med Ctr, Krannert Inst Cardiol, Dept Med, Indianapolis, IN USA; [Reed, Terry] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA	Vanderbilt University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; SRI International; Northwestern University; Feinberg School of Medicine; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington	Dai, J (corresponding author), Vanderbilt Univ, Med Ctr, Div Epidemiol, Dept Med, Nashville, TN 37212 USA.	jun.dai@vanderbilt.edu	Liu, Lei/B-4968-2009	Liu, Lei/0000-0003-1844-338X; Dai, Jun/0000-0001-7930-2885	American Heart Association Scientist Development Grant [10SDG2630182]; Intramural Research Fund from Indiana University Department of Applied Health Science; National Heart, Lung, and Blood Institute Grant [HL51429]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051429] Funding Source: NIH RePORTER	American Heart Association Scientist Development Grant(American Heart Association); Intramural Research Fund from Indiana University Department of Applied Health Science; National Heart, Lung, and Blood Institute Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the American Heart Association Scientist Development Grant (10SDG2630182 to Dr. Dai) and the Intramural Research Fund from Indiana University Department of Applied Health Science (Dr. Dai). The NHLBI Twin Study was supported by National Heart, Lung, and Blood Institute Grant (HL51429). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JL, 2000, J AM COLL CARDIOL, V36, P1248, DOI 10.1016/S0735-1097(00)00850-0; Borch-Johnsen K, 2001, ARCH INTERN MED, V161, P397, DOI 10.1001/archinte.161.3.397; Brown A, 2010, NAT REV CARDIOL, V7, P369, DOI 10.1038/nrcardio.2010.35; Brunner EJ, 2006, DIABETES CARE, V29, P26; Carlin JB, 2005, INT J EPIDEMIOL, V34, P1089, DOI 10.1093/ije/dyi153; CARMELLI D, 1992, NEW ENGL J MED, V327, P829, DOI 10.1056/NEJM199209173271201; Carmelli Dorit, 1994, Annals of Epidemiology, V4, P198; Centers for Disease Control and Prevention, 1980, NON POP DIAGN DIAB A; Christiansen L, 2004, EUR J HUM GENET, V12, P843, DOI 10.1038/sj.ejhg.5201235; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; Dai J, 2008, AM J CLIN NUTR, V88, P1364, DOI 10.3945/ajcn.2008.26528; Dai J, 2008, CIRCULATION, V117, P169, DOI 10.1161/CIRCULATIONAHA.107.710699; Dai J, 2010, CIRC-CARDIOVASC QUAL, V3, P366, DOI 10.1161/CIRCOUTCOMES.109.905810; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; FEINLEIB M, 1976, ACTA GENET MED GEMEL, V25, P125, DOI 10.1017/S0001566000013970; Gerstein HC, 2011, NEW ENGL J MED, V364, P818, DOI 10.1056/NEJMoa1006524; Gharibvand L, 2009, SAS I INC 2009 SAS G, P231; Goodarzi MO, 2005, DIABETES, V54, P1222, DOI 10.2337/diabetes.54.4.1222; Gurrin LC, 2006, BIOMETRICS, V62, P745, DOI 10.1111/j.1541-0420.2006.00561.x; Hammar N, 2009, EUR J CLIN NUTR, V63, P312, DOI 10.1038/sj.ejcn.1602931; Hedlund E, 2007, SCAND J PUBLIC HEALT, V35, P468, DOI 10.1080/14034940701256875; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Horwitz AV, 2003, J HEALTH SOC BEHAV, V44, P111, DOI 10.2307/1519802; Jartti L, 2009, J INTERN MED, V265, P345, DOI 10.1111/j.1365-2796.2008.02018.x; KALOUSDIAN S, 1987, GENET EPIDEMIOL, V4, P1, DOI 10.1002/gepi.1370040102; Keller MC, 2010, BEHAV GENET, V40, P377, DOI 10.1007/s10519-009-9320-x; Koulis C, 2012, EXPERT REV CARDIOVAS, V10, P323, DOI [10.1586/erc.12.13, 10.1586/ERC.12.13]; Kyle UG, 2006, CURR OPIN CLIN NUTR, V9, P388, DOI 10.1097/01.mco.0000232898.74415.42; Leduc L, 2010, EUR J OBSTET GYN R B, V149, P127, DOI 10.1016/j.ejogrb.2009.12.005; MacKinnon D P, 2000, Prev Sci, V1, P173, DOI 10.1023/A:1026595011371; MARMOT MG, 1975, AM J EPIDEMIOL, V102, P514, DOI 10.1093/oxfordjournals.aje.a112189; Mikulec KH, 2004, J CLIN ENDOCR METAB, V89, P1240, DOI 10.1210/jc.2003-031333; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Orencia AJ, 1997, J CLIN EPIDEMIOL, V50, P1369, DOI 10.1016/S0895-4356(97)00201-1; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; PHILLIPS DIW, 1993, LANCET, V341, P1008, DOI 10.1016/0140-6736(93)91086-2; Poulsen P, 2006, DIABETES, V55, P1819, DOI 10.2337/db05-1462; Qiao Q, 2002, EUR HEART J, V23, P1267, DOI 10.1053/euhj.2001.3113; REED T, 1993, GENET EPIDEMIOL, V10, P513, DOI 10.1002/gepi.1370100630; Regieli JJ, 2009, J AM COLL CARDIOL, V54, P1238, DOI 10.1016/j.jacc.2009.05.061; Rijsdijk Fruhling V, 2002, Brief Bioinform, V3, P119, DOI 10.1093/bib/3.2.119; Rodriguez CJ, 2005, AM J CARDIOL, V96, P1273, DOI 10.1016/j.amjcard.2005.06.070; Sarwar N, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000278; VACCARO O, 1992, DIABETES CARE, V15, P1328, DOI 10.2337/diacare.15.10.1328; Van den Berg SW, 2008, DIABETIC MED, V25, P186, DOI 10.1111/j.1464-5491.2007.02328.x; van Leeuwen M, 2012, BJOG-INT J OBSTET GY, V119, P393, DOI 10.1111/j.1471-0528.2011.03254.x; Verhaeghe J, 1996, AM J OBSTET GYNECOL, V175, P1180, DOI 10.1016/S0002-9378(96)70025-X	47	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e69332	10.1371/journal.pone.0069332	http://dx.doi.org/10.1371/journal.pone.0069332			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894450	Green Published, Green Submitted, gold			2022-12-27	WOS:000322391400049
J	Wong, LLY; Lam, IPY; Wong, TYN; Lai, WL; Liu, HF; Yeung, LL; Ching, YP				Wong, Leo Lap-Yan; Lam, Ian Pak-Yan; Wong, Tracy Yuk-Nar; Lai, Wai-Lung; Liu, Heong-Fai; Yeung, Lam-Lung; Ching, Yick-Pang			IPA-3 Inhibits the Growth of Liver Cancer Cells By Suppressing PAK1 and NF-kappa B Activation	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; KINASE; PHOSPHORYLATION; PAXILLIN; TARGETS	Hepatocellular carcinoma (HCC) is one of the major malignancies worldwide and is associated with poor prognosis due to the high incidences of metastasis and tumor recurrence. Our previous study showed that overexpression of p21-activated protein kinase 1 (PAK1) is frequently observed in HCC and is associated with a more aggressive tumor behavior, suggesting that PAK1 is a potential therapeutic target in HCC. In the current study, an allosteric small molecule PAK1 inhibitor, IPA-3, was evaluated for the potential in suppressing hepatocarcinogenesis. Consistent with other reports, inhibition of PAK1 activity was observed in several human HCC cell lines treated with various dosages of IPA-3. Using cell proliferation, colony formation and BrdU incorporation assays, we demonstrated that IPA-3 treatment significantly inhibited the growth of HCC cells. The mechanisms through which IPA-3 treatment suppresses HCC cell growth are enhancement of apoptosis and blockage of activation of NF-kappa B. Furthermore, our data suggested that IPA-3 not only inhibits the HCC cell growth, but also suppresses the metastatic potential of HCC cells. Nude mouse xenograft assay demonstrated that IPA-3 treatment significantly reduced the tumor growth rate and decreased tumor volume, indicating that IPA-3 can suppress the in vivo tumor growth of HCC cells. Taken together, our demonstration of the potential preclinical efficacy of IPA-3 in HCC provides the rationale for cancer therapy.	[Wong, Leo Lap-Yan; Lam, Ian Pak-Yan; Wong, Tracy Yuk-Nar; Lai, Wai-Lung; Liu, Heong-Fai; Ching, Yick-Pang] Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Wong, Leo Lap-Yan; Lam, Ian Pak-Yan; Lai, Wai-Lung] Univ Hong Kong, Li Ka Shing Fac Med, Ctr Canc Res, Hong Kong, Hong Kong, Peoples R China; [Yeung, Lam-Lung] Hong Kong Univ Sci & Technol, Dept Chem, Hong Kong, Hong Kong, Peoples R China; [Ching, Yick-Pang] Univ Hong Kong, Li Ka Shing Fac Med, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China; [Ching, Yick-Pang] Univ Hong Kong, Li Ka Shing Fac Med, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; Hong Kong University of Science & Technology; University of Hong Kong; University of Hong Kong	Ching, YP (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Hong Kong, Hong Kong, Peoples R China.	ypching@hku.hk		CHING, Yick Pang/0000-0002-6461-8358	Hong Kong Research Fund for the Control of Infectious Disease [09080782]; Hong Kong Research Grant Council [HKU7/CRF/09]; University of Hong Kong [201109176021]	Hong Kong Research Fund for the Control of Infectious Disease; Hong Kong Research Grant Council(Hong Kong Research Grants Council); University of Hong Kong(University of Hong Kong)	This work was supported by the Hong Kong Research Fund for the Control of Infectious Disease (No. 09080782) and the Hong Kong Research Grant Council (HKU7/CRF/09), The University of Hong Kong (Small Project Funding 201109176021 to LLY Wong and YP Ching). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ching YP, 2007, CANCER RES, V67, P3601, DOI 10.1158/0008-5472.CAN-06-3994; Deacon SW, 2008, CHEM BIOL, V15, P322, DOI 10.1016/j.chembiol.2008.03.005; Dummler B, 2009, CANCER METAST REV, V28, P51, DOI 10.1007/s10555-008-9168-1; Fan SJ, 2005, ONCOGENE, V24, P1749, DOI 10.1038/sj.onc.1208327; Frost JA, 2000, J BIOL CHEM, V275, P19693, DOI 10.1074/jbc.M909860199; Hu L, 2004, ONCOGENE, V23, P298, DOI 10.1038/sj.onc.1206483; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Kalin S, 2010, J VIROL, V84, P5336, DOI 10.1128/JVI.02494-09; Kichina JV, 2010, EXPERT OPIN THER TAR, V14, P703, DOI 10.1517/14728222.2010.492779; King CC, 2000, J BIOL CHEM, V275, P41201, DOI 10.1074/jbc.M006553200; Koga H, 1999, HEPATOLOGY, V29, P688, DOI 10.1002/hep.510290355; Koh CG, 2002, CURR BIOL, V12, P317, DOI 10.1016/S0960-9822(02)00652-8; Lai WL, 2012, HEPATOLOGY, V56, P1770, DOI 10.1002/hep.25851; Li Y, 2001, WORLD J GASTROENTERO, V7, P630; Maeda S, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/367694; Mak GWY, 2011, CANCER RES, V71, P2949, DOI 10.1158/0008-5472.CAN-10-4046; Molli PR, 2009, ONCOGENE, V28, P2545, DOI 10.1038/onc.2009.119; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Porchia LM, 2007, MOL PHARMACOL, V72, P1124, DOI 10.1124/mol.107.037556; Schurmann A, 2000, MOL CELL BIOL, V20, P453, DOI 10.1128/MCB.20.2.453-461.2000; Sherman M, 2005, SEMIN LIVER DIS, V25, P143, DOI 10.1055/s-2005-871194; Takahashi K, 2009, CELL SIGNAL, V21, P695, DOI 10.1016/j.cellsig.2009.01.007; Tang ZY, 2001, WORLD J GASTROENTERO, V7, P445; Viaud J, 2009, MOL CANCER THER, V8, P2559, DOI 10.1158/1535-7163.MCT-09-0102; Wu R, 2010, INT J CANCER, V127, P2230, DOI 10.1002/ijc.25226; Yeh CB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031055; Zenke FT, 1999, J BIOL CHEM, V274, P32565, DOI 10.1074/jbc.274.46.32565; Zhou LC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-49	28	24	24	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e68843	10.1371/journal.pone.0068843	http://dx.doi.org/10.1371/journal.pone.0068843			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894351	Green Published, Green Submitted, gold			2022-12-27	WOS:000322391400025
J	Ai, D; Gravel, D; Chu, CJ; Wang, G				Ai, Dexiecuo; Gravel, Dominique; Chu, Chengjin; Wang, Gang			Spatial Structures of the Environment and of Dispersal Impact Species Distribution in Competitive Metacommunities	PLOS ONE			English	Article							LANDSCAPE CONNECTIVITY; RICHNESS RELATIONSHIP; MODELS PREDICT; NICHE; COEXISTENCE; DIVERSITY; COMMUNITIES; SPECIATION; NEUTRALITY; PATTERNS	The correspondence between species distribution and the environment depends on species' ability to track favorable environmental conditions (via dispersal) and to maintain competitive hierarchy against the constant influx of migrants (mass effect) and demographic stochasticity (ecological drift). Here we report a simulation study of the influence of landscape structure on species distribution. We consider lottery competition for space in a spatially heterogeneous environment, where the landscape is represented as a network of localities connected by dispersal. We quantified the contribution of neutrality and species sorting to their spatial distribution. We found that neutrality increases and the strength of species-sorting decreases with the centrality of a community in the landscape when the average dispersal among communities is low, whereas the opposite was found at elevated dispersal. We also found that the strength of species-sorting increases with environmental heterogeneity. Our results illustrate that spatial structure of the environment and of dispersal must be taken into account for understanding species distribution. We stress the importance of spatial geographic structure on the relative importance of niche vs. neutral processes in controlling community dynamics.	[Ai, Dexiecuo; Chu, Chengjin; Wang, Gang] Lanzhou Univ, Sch Life Sci, State Key Lab Grassland & Agroecosyst, Lanzhou 730000, Peoples R China; [Gravel, Dominique] Univ Quebec, Dept Biol Chim & Geog, Rimouski, PQ G5L 3A1, Canada	Lanzhou University; University of Quebec	Wang, G (corresponding author), Lanzhou Univ, Sch Life Sci, State Key Lab Grassland & Agroecosyst, Lanzhou 730000, Peoples R China.	wgmg36@lzu.edu.cn	Chu, Chu/T-6038-2019	Chu, Chengjin/0000-0002-0606-449X	National Natural Science Foundation of China [31270472]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was financially supported by the National Natural Science Foundation of China (No. 31270472). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai DXC, 2013, ECOL MODEL, V258, P33, DOI 10.1016/j.ecolmodel.2013.03.001; Allouche O, 2009, ECOL LETT, V12, P1; Anderson RP, 2002, OIKOS, V98, P3, DOI 10.1034/j.1600-0706.2002.t01-1-980116.x; Araujo MB, 2005, ECOGRAPHY, V28, P693, DOI 10.1111/j.2005.0906-7590.04253.x; Araujo MB, 2004, GLOBAL CHANGE BIOL, V10, P1618, DOI 10.1111/j.1365-2486.2004.00828.x; Araujo MB, 2006, SCIENCE, V313, P1396, DOI 10.1126/science.1131758; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; AUSTIN MP, 1990, ECOL MONOGR, V60, P161, DOI 10.2307/1943043; Beck J, 2012, ECOGRAPHY, V35, P673, DOI 10.1111/j.1600-0587.2012.07364.x; BONACICH P, 1972, J MATH SOCIOL, V2, P113, DOI 10.1080/0022250X.1972.9989806; Boulangeat I, 2012, ECOL LETT, V15, P584, DOI 10.1111/j.1461-0248.2012.01772.x; CASWELL H, 1978, AM NAT, V112, P127, DOI 10.1086/283257; Caylor KK, 2005, ADV WATER RESOUR, V28, P69, DOI 10.1016/j.advwatres.2004.08.013; CHESSON PL, 1981, AM NAT, V117, P923, DOI 10.1086/283778; COMINS HN, 1985, AM NAT, V126, P706, DOI 10.1086/284448; Csardi G, 2011, NETWORK ANAL VISUALI; Dale MRT, 2010, ANNU REV ECOL EVOL S, V41, P21, DOI 10.1146/annurev-ecolsys-102209-144718; Desjardins-Proulx P, 2012, ECOL EVOL, V2, P1781, DOI 10.1002/ece3.292; Desjardins-Proulx P, 2012, AM NAT, V179, P137, DOI 10.1086/663196; Economo EP, 2008, ECOL LETT, V11, P52, DOI 10.1111/j.1461-0248.2007.01126.x; Economo EP, 2010, OIKOS, V119, P1355, DOI 10.1111/j.1600-0706.2010.18272.x; Forbes AE, 2002, OIKOS, V96, P433, DOI 10.1034/j.1600-0706.2002.960305.x; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Gilpin M.E., 1991, METAPOPULATION DYNAM; Gravel D, 2006, ECOL LETT, V9, P399, DOI 10.1111/j.1461-0248.2006.00884.x; Gravel D, 2011, ECOL LETT, V14, P828, DOI 10.1111/j.1461-0248.2011.01643.x; GRUBB PJ, 1977, BIOL REV, V52, P107, DOI 10.1111/j.1469-185X.1977.tb01347.x; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hubbell SP, 2003, OIKOS, V100, P193, DOI 10.1034/j.1600-0706.2003.12450.x; Hubbell Stephen P., 2001, V32, pi; Hugueny B, 2007, ECOLOGY, V88, P1696, DOI 10.1890/06-1884.1; HURTT GC, 1995, J THEOR BIOL, V176, P1, DOI 10.1006/jtbi.1995.0170; Langenheder S, 2011, ISME J, V5, P1086, DOI 10.1038/ismej.2010.207; Leathwick JR, 1998, J VEG SCI, V9, P719, DOI 10.2307/3237290; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Logue JB, 2011, TRENDS ECOL EVOL, V26, P482, DOI 10.1016/j.tree.2011.04.009; Loreau M, 1999, AM NAT, V154, P427, DOI 10.1086/303252; Maurer BA, 2004, BASIC APPL ECOL, V5, P413, DOI 10.1016/j.baae.2004.08.006; May R., 2007, THEORETICAL ECOLOGY, V3rd; McKane AJ, 2004, THEOR POPUL BIOL, V65, P67, DOI 10.1016/j.tpb.2003.08.001; Minor ES, 2008, CONSERV BIOL, V22, P297, DOI 10.1111/j.1523-1739.2007.00871.x; Mouquet N, 2003, AM NAT, V162, P544, DOI 10.1086/378857; Mouquet N, 2002, AM NAT, V159, P420, DOI 10.1086/338996; Mouquet N, 2013, ECOL LETT, V16, P1, DOI 10.1111/ele.12014; Muneepeerakul R, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR005857; Muneepeerakul R, 2008, NATURE, V453, P220, DOI 10.1038/nature06813; Muneepeerakul R, 2011, J THEOR BIOL, V269, P256, DOI 10.1016/j.jtbi.2010.11.003; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Pearce J, 1998, RESTOR ECOL, V6, P238, DOI 10.1046/j.1526-100X.1998.00636.x; Penrose M., 2003, OXFORD STUDIES PROBA; Proulx SR, 2005, TRENDS ECOL EVOL, V20, P345, DOI 10.1016/j.tree.2005.04.004; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; Purves Drew W., 2005, P107, DOI 10.1017/CBO9780511541971.006; Ruokolainen L, 2009, ECOL LETT, V12, P909, DOI 10.1111/j.1461-0248.2009.01346.x; Schwilk DW, 2005, ECOL LETT, V8, P272, DOI 10.1111/j.1461-0248.2004.00720.x; Snyder RE, 2003, ECOL LETT, V6, P301, DOI 10.1046/j.1461-0248.2003.00434.x; Team RDC, 2009, R LANG ENV STAT COMP; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Tilman D., 1982, Monographs in Population Biology, pi; Urban D, 2001, ECOLOGY, V82, P1205, DOI 10.1890/0012-9658(2001)082[1205:LCAGTP]2.0.CO;2; Urban DL, 2009, ECOL LETT, V12, P260, DOI 10.1111/j.1461-0248.2008.01271.x; Vallade M, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.051914; WILSON DS, 1992, ECOLOGY, V73, P1984, DOI 10.2307/1941449	66	15	16	5	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e68927	10.1371/journal.pone.0068927	http://dx.doi.org/10.1371/journal.pone.0068927			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874815	gold, Green Published, Green Submitted			2022-12-27	WOS:000324146200039
J	Geretti, AM; Fox, Z; Johnson, JA; Booth, C; Lipscomb, J; Stuyver, LJ; Tachedjian, G; Baxter, J; Touloumi, G; Lehmann, C; Owen, A; Phillips, A				Geretti, Anna Maria; Fox, Zoe; Johnson, Jeffrey A.; Booth, Clare; Lipscomb, Jonathan; Stuyver, Lieven J.; Tachedjian, Gilda; Baxter, John; Touloumi, Giota; Lehmann, Clara; Owen, Andrew; Phillips, Andrew		INSIGHT Strategies Management Anti	Sensitive Assessment of the Virologic Outcomes of Stopping and Restarting Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy	PLOS ONE			English	Article							DRUG-RESISTANCE MUTATIONS; PLASMA PHARMACOKINETICS; INFECTED INDIVIDUALS; HIV; EFAVIRENZ; VARIANTS; REGIMEN; INTERRUPTION; ASSOCIATION; NEVIRAPINE	Background: Non-nucleoside reverse transcriptase inhibitor (NNRTI)-resistant mutants have been shown to emerge after interruption of suppressive NNRTI-based antiretroviral therapy (ART) using routine testing. The aim of this study was to quantify the risk of resistance by sensitive testing and correlate the detection of resistance with NNRTI concentrations after treatment interruption and virologic responses after treatment resumption. Methods: Resistance-associated mutations (RAMs) and NNRTI concentrations were studied in plasma from 132 patients who interrupted suppressive ART within SMART. RAMs were detected by Sanger sequencing, allele-specific PCR, and ultra-deep sequencing. NNRTI concentrations were measured by sensitive high-performance liquid chromatography. Results: Four weeks after NNRTI interruption, 19/31 (61.3%) and 34/39 (87.2%) patients showed measurable nevirapine (>0.25 ng/ml) or efavirenz (>5 ng/ml) concentrations, respectively. Median eight weeks after interruption, 22/131 (16.8%) patients showed >= 1 NNRTI-RAM, including eight patients with NNRTI-RAMs detected only by sensitive testing. The adjusted odds ratio (OR) of NNRTI-RAM detection was 7.62 (95% confidence interval [CI] 1.52, 38.30; p = 0.01) with nevirapine or efavirenz concentrations above vs. below the median measured in the study population. Staggered interruption, whereby nucleos(t)ide reverse transcriptase inhibitors (NRTIs) were continued for median nine days after NNRTI interruption, did not prevent NNRTI-RAMs, but increased detection of NRTI-RAMs (OR 4.25; 95% CI 1.02, 17.77; p = 0.03). After restarting NNRTI-based ART (n = 90), virologic suppression rates <400 copies/ml were 8/13 (61.5%) with NNRTI-RAMs, 7/11 (63.6%) with NRTI-RAMs only, and 51/59 (86.4%) without RAMs. The ORs of re-suppression were 0.18 (95% CI 0.03, 0.89) and 0.17 (95% CI 0.03, 1.15) for patients with NNRTI-RAMs or NRTI-RAMs only respectively vs. those without RAMs (p = 0.04). Conclusions: Detection of resistant mutants in the rebound viremia after interruption of efavirenz-or nevirapine-based ART affects outcomes once these drugs are restarted. Further studies are needed to determine RAM persistence in untreated patients and impact on newer NNRTIs.	[Geretti, Anna Maria] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Fox, Zoe] UCL, Inst Neurol, London, England; [Johnson, Jeffrey A.; Lipscomb, Jonathan] Ctr Dis Control, Div HIV AIDS Prevent, Atlanta, GA 30333 USA; [Booth, Clare] Royal Free London NHS Fdn Trust, Dept Virol, London, England; [Stuyver, Lieven J.] Janssen Diagnost BVBA, Beerse, Belgium; [Tachedjian, Gilda] Burnet Inst, Tachedjian Lab, Melbourne, Vic, Australia; [Baxter, John] Cooper Univ Hosp, Dept Infect Dis, Camden, NJ USA; [Touloumi, Giota] Univ Athens, Sch Med, Dept Epidemiol & Stat, GR-11527 Athens, Greece; [Lehmann, Clara] Univ Cologne, Dept Internal Med, D-50931 Cologne, Germany; [Owen, Andrew] Univ Liverpool, Dept Mol & Clin Pharmacol, Liverpool L69 3BX, Merseyside, England; [Phillips, Andrew] UCL, Inst Epidemiol & Hlth, London, England	University of Liverpool; University of London; University College London; Centers for Disease Control & Prevention - USA; University of London; University College London; Royal Free London NHS Foundation Trust; Burnet Institute; Cooper University Hospital; Athens Medical School; National & Kapodistrian University of Athens; University of Cologne; University of Liverpool; University of London; University College London	Geretti, AM (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England.	geretti@liverpool.ac.uk	Owen, Andrew/M-7509-2017; Tachedjian, Gilda/AAF-1327-2020; Phillips, Andrew N/B-4427-2008	Owen, Andrew/0000-0002-9819-7651; Tachedjian, Gilda/0000-0002-7733-7037; Phillips, Andrew N/0000-0003-2384-4807; Geretti, Anna Maria/0000-0002-3670-6588	NIH [U01-AI068641, U01-AI046362, U01-AI042170]; British HIV Association; MRC [G0800247] Funding Source: UKRI; Medical Research Council [G0800247] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI046362, U01AI068641, U01AI042170] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British HIV Association; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	SMART funding sources include NIH Grants U01-AI068641, U01-AI046362, and U01-AI042170 (www.nih.gov). This sub-study study was supported by a British HIV Association (www.bhiva.org) Research Award (AMG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almond LM, 2005, J ANTIMICROB CHEMOTH, V56, P738, DOI 10.1093/jac/dki308; Almond LM, 2005, CLIN PHARMACOL THER, V78, P132, DOI 10.1016/j.clpt.2005.04.004; Boffito M, 2005, CURR OPIN INFECT DIS, V18, P543, DOI 10.1097/01.qco.0000191507.48481.10; Cressey TR, 2008, CLIN INFECT DIS, V46, P1601, DOI 10.1086/587657; Delobel P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021655; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Fox Z, 2008, AIDS, V22, P2279, DOI 10.1097/QAD.0b013e328311d16f; Gianella S, 2011, J VIROL, V85, P8359, DOI 10.1128/JVI.02582-10; Gianella S, 2010, J INFECT DIS, V202, P657, DOI 10.1086/655397; Hoetelmans RM, 1994, ANTIVIR THER S, V4, P29; Holzinger ER, 2012, PHARMACOGENET GENOM, V22, P858, DOI 10.1097/FPC.0b013e32835a450b; Johnson J, 2009, PERSPECT POLIT, V7, P1, DOI 10.1017/S153759270909001X; Johnson JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000638; Johnson JA, 2010, J ANTIMICROB CHEMOTH, V65, P1322, DOI 10.1093/jac/dkq139; Li JZ, 2013, J INFECT DIS, V207, P893, DOI 10.1093/infdis/jis925; Li JZ, 2011, JAMA-J AM MED ASSOC, V305, P1327, DOI 10.1001/jama.2011.375; Messiaen P, 2012, VIROLOGY, V426, P7, DOI 10.1016/j.virol.2012.01.002; Miller V, 2001, ANTIVIR THER, V6, P25; Pirillo M, 2010, AIDS RES HUM RETROV, V26, P541, DOI 10.1089/aid.2009.0116; Trancart S, 2012, ANTIMICROB AGENTS CH, V56, P1655, DOI 10.1128/AAC.05452-11; Wainberg MA, 2003, JAIDS-J ACQ IMM DEF, V34, pS2, DOI 10.1097/00126334-200309011-00002; Williams I, 2012, HIV MED, V13, P1, DOI [10.1111/j.1468-1293.2012.01029_1.x, 10.1111/j.1468-1293.2012.01029.x]	22	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e69266	10.1371/journal.pone.0069266	http://dx.doi.org/10.1371/journal.pone.0069266			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874928	gold, Green Published			2022-12-27	WOS:000324146200069
J	Liu, Y; Liu, QD; Jia, WW; Chen, J; Wang, JM; Ye, D; Guo, XD; Chen, W; Li, GP; Wang, GY; Deng, AM; Kang, JH				Liu, Yang; Liu, Qidong; Jia, Wenwen; Chen, Jie; Wang, Jianmin; Ye, Dan; Guo, Xudong; Chen, Wen; Li, Guoping; Wang, Guiying; Deng, Anmei; Kang, Jiuhong			MicroRNA-200a Regulates Grb2 and Suppresses Differentiation of Mouse Embryonic Stem Cells into Endoderm and Mesoderm	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; MIR-200 FAMILY; SELF-RENEWAL; NUCLEAR EXPORT; MORPHOGENETIC MOVEMENT; PRIMITIVE ENDODERM; RNA-INTERFERENCE; REPRESSORS ZEB1; RECEPTOR; PROMOTES	The mechanisms by which microRNAs (miRNAs) affect cell fate decisions remain poorly understood. Herein, we report that miR-200a can suppress the differentiation of mouse embryonic stem (ES) cells into endoderm and mesoderm. Interestingly, miR-200a directly targets growth factor receptor-bound protein 2 (Grb2), which is a key adaptor in the Erk signaling pathway. Furthermore, high levels of miR-200a dramatically decrease Grb2 levels and suppress the appearance of mesoderm and endoderm lineages in embryoid body formation, as well as suppressing the activation of Erk. Finally, Grb2 supplementation significantly rescues the miR-200a-induced layer-formation bias and the Erk suppression. Collectively, our results demonstrate that miR-200a plays critical roles in ES cell lineage commitment by directly regulating Grb2 expression and Erk signaling.	[Liu, Yang; Chen, Jie; Wang, Jianmin; Deng, Anmei] Second Mil Med Univ, Changhai Hosp, Dept Lab Med, Shanghai, Peoples R China; [Liu, Yang; Chen, Jie; Wang, Jianmin; Deng, Anmei] Second Mil Med Univ, Changhai Hosp, Dept Hematol, Shanghai, Peoples R China; [Liu, Qidong; Jia, Wenwen; Ye, Dan; Guo, Xudong; Chen, Wen; Li, Guoping; Wang, Guiying; Kang, Jiuhong] Tongji Univ, Sch Life Sci & Technol, Shanghai Matern & Infant Hlth Hosp 1, Clin & Translat Res Ctr,Shanghai Key Lab Signalin, Shanghai 200092, Peoples R China	Naval Medical University; Naval Medical University; Tongji University	Deng, AM (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Lab Med, Shanghai, Peoples R China.	amdeng70@163.com; jhkang@tongji.edu.cn	Li, Guoping/ABL-4233-2022; Li, Guoping/Z-4014-2019; wang, jian/GVS-0711-2022	Li, Guoping/0000-0003-3874-0744; Li, Guoping/0000-0003-3874-0744; 	Ministry of Science and Technology [2011CB965100, 2011DFA30480, 2010CB944900, 2010CB945000, 2012CB966603, 2011CBA01100, 2013CB967401, 2013CB531606]; National Natural Science Foundation of China [31210103905, 91219305, 31201107, 31101061, 81170499, 31071306, 31000378, 31171432, 81273282]; Science and Technology Commission of Shanghai Municipality [12ZR1450900, 11ZR1438500, 11XD1405300, 11JC1410902]; Ministry of Education [IRT1168, 20110072110039]; Fundamental Research Funds for the Central Universities [2000219066, 2000219067, 2000219077]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Ministry of Education; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from the Ministry of Science and Technology (2011CB965100, 2011DFA30480, 2010CB944900, 2010CB945000, 2012CB966603, 2011CBA01100, 2013CB967401 and 2013CB531606), the National Natural Science Foundation of China (31210103905, 91219305, 31201107, 31101061, 81170499, 31071306, 31000378, 31171432, and 81273282), the Science and Technology Commission of Shanghai Municipality (12ZR1450900, 11ZR1438500, 11XD1405300 and 11JC1410902), and IRT1168 and 20110072110039 from Ministry of Education. The work was also supported by Fundamental Research Funds for the Central Universities (2000219066, 2000219067 and 2000219077). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2011, CANCER RES, V71, P3400, DOI 10.1158/0008-5472.CAN-10-0965; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Arman E, 1998, P NATL ACAD SCI USA, V95, P5082, DOI 10.1073/pnas.95.9.5082; Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; Buller B, 2012, GLIA, V60, P1906, DOI 10.1002/glia.22406; Burdon T, 1999, DEV BIOL, V210, P30, DOI 10.1006/dbio.1999.9265; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Chen SB, 2006, P NATL ACAD SCI USA, V103, P17266, DOI 10.1073/pnas.0608156103; Chen Y, 2000, ONCOGENE, V19, P3750, DOI 10.1038/sj.onc.1203726; Cheng AM, 1998, CELL, V95, P793, DOI 10.1016/S0092-8674(00)81702-X; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; Ciruna BG, 1997, DEVELOPMENT, V124, P2829; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Du ZW, 2013, DEVELOPMENT, V140, P2611, DOI 10.1242/dev.092809; Dykxhoorn DM, 2010, CANCER RES, V70, P6401, DOI 10.1158/0008-5472.CAN-10-1346; Eades G, 2011, J BIOL CHEM, V286, P25992, DOI 10.1074/jbc.M111.229401; GARDNER RL, 1983, INT REV EXP PATHOL, V24, P63; Gill JG, 2012, STEM CELLS DEV, V21, P167, DOI 10.1089/scd.2011.0194; Gill JG, 2011, STEM CELLS, V29, P764, DOI 10.1002/stem.628; Giubellino A, 2008, EXPERT OPIN THER TAR, V12, P1021, DOI 10.1517/14728222.12.8.1021 ; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hamazaki T, 2006, MOL CELL BIOL, V26, P7539, DOI 10.1128/MCB.00508-06; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Iliopoulos D, 2010, MOL CELL, V39, P761, DOI 10.1016/j.molcel.2010.08.013; Ivey KN, 2008, CELL STEM CELL, V2, P219, DOI 10.1016/j.stem.2008.01.016; Ivey KN, 2010, CELL STEM CELL, V7, P36, DOI 10.1016/j.stem.2010.06.012; Jiang F, 2005, GENE DEV, V19, P1674, DOI 10.1101/gad.1334005; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; Klimanskaya I, 2008, NAT REV DRUG DISCOV, V7, P131, DOI 10.1038/nrd2403; Korpal M, 2008, RNA BIOL, V5, P115, DOI 10.4161/rna.5.3.6558; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Leskela S, 2011, ENDOCR-RELAT CANCER, V18, P85, DOI 10.1677/ERC-10-0148; Li L, 2004, DEVELOPMENT, V131, P5277, DOI 10.1242/dev.01415; Lingel A, 2005, CURR OPIN STRUC BIOL, V15, P107, DOI 10.1016/j.sbi.2005.01.010; Liu XL, 2012, MOL CELL BIOL, V32, P2934, DOI 10.1128/MCB.00134-12; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; Mateescu B, 2011, NAT MED, V17, P1627, DOI 10.1038/nm.2512; Morrison GM, 2008, CELL STEM CELL, V3, P402, DOI 10.1016/j.stem.2008.07.021; Nichols J, 2011, DEVELOPMENT, V138, P3, DOI 10.1242/dev.050831; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; PALMIERI SL, 1994, DEV BIOL, V166, P259, DOI 10.1006/dbio.1994.1312; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peng CG, 2012, J NEUROSCI, V32, P13292, DOI 10.1523/JNEUROSCI.2124-12.2012; Radisky DC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2885; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; Saito K, 2005, PLOS BIOL, V3, P1202, DOI 10.1371/journal.pbio.0030235; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Stavridis MP, 2007, DEVELOPMENT, V134, P2889, DOI 10.1242/dev.02858; Tsang JS, 2010, MOL CELL, V38, P140, DOI 10.1016/j.molcel.2010.03.007; Wang B, 2011, DIABETES, V60, P280, DOI 10.2337/db10-0892; Wang GY, 2013, P NATL ACAD SCI USA, V110, P2858, DOI 10.1073/pnas.1212769110; Wang Y, 2011, DEV DYNAM, V240, P566, DOI 10.1002/dvdy.22447; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Yao Y, 2003, P NATL ACAD SCI USA, V100, P12759, DOI 10.1073/pnas.2134254100; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yoshida-Koide U, 2004, BIOCHEM BIOPH RES CO, V313, P475, DOI 10.1016/j.bbrc.2003.11.138; Zhao C, 2010, P NATL ACAD SCI USA, V107, P1876, DOI 10.1073/pnas.0908750107	76	18	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e68990	10.1371/journal.pone.0068990	http://dx.doi.org/10.1371/journal.pone.0068990			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874841	Green Submitted, gold, Green Published			2022-12-27	WOS:000324146200046
J	Olivier, N; Keller, D; Gonczy, P; Manley, S				Olivier, Nicolas; Keller, Debora; Goenczy, Pierre; Manley, Suliana			Resolution Doubling in 3D-STORM Imaging through Improved Buffers	PLOS ONE			English	Article							SINGLE-MOLECULE FLUORESCENCE; OPTICAL RECONSTRUCTION MICROSCOPY; OXYGEN SCAVENGING SYSTEM; DIFFRACTION-LIMIT; FLUOROPHORES; DYES; PHOTOSTABILITY; PERFORMANCE	Super-resolution imaging methods have revolutionized fluorescence microscopy by revealing the nanoscale organization of labeled proteins. In particular, single-molecule methods such as Stochastic Optical Reconstruction Microscopy (STORM) provide resolutions down to a few tens of nanometers by exploiting the cycling of dyes between fluorescent and non-fluorescent states to obtain a sparse population of emitters and precisely localizing them individually. This cycling of dyes is commonly induced by adding different chemicals, which are combined to create a STORM buffer. Despite their importance, the composition of these buffers has scarcely evolved since they were first introduced, fundamentally limiting what can be resolved with STORM. By identifying a new chemical suitable for STORM and optimizing the buffer composition for Alexa-647, we significantly increased the number of photons emitted per cycle by each dye, providing a simple means to enhance the resolution of STORM independently of the optical setup used. Using this buffer to perform 3D-STORM on biological samples, we obtained images with better than 10 nanometer lateral and 30 nanometer axial resolution.	[Olivier, Nicolas; Manley, Suliana] Swiss Fed Inst Technol EPFL, Sch Basic Sci, Lab Expt Biophys, Lausanne, Switzerland; [Keller, Debora; Goenczy, Pierre] Swiss Fed Inst Technol EPFL, Sch Life Sci, Swiss Inst Expt Canc Res ISREC, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research	Olivier, N (corresponding author), Swiss Fed Inst Technol EPFL, Sch Basic Sci, Lab Expt Biophys, Lausanne, Switzerland.	nicolas.olivier@polytechnique.ed	Manley, Suliana/D-3818-2012; Olivier, Nicolas/AAM-4414-2021	Manley, Suliana/0000-0002-4755-4778; Keller, Debora/0000-0002-5284-3195; Olivier, Nicolas/0000-0001-9042-5456; Gonczy, Pierre/0000-0002-6305-6883	ERC [243016-PALMassembly]; Swiss Cancer League [02024-2007, 02584-02-2010]	ERC(European Research Council (ERC)European Commission); Swiss Cancer League	N.O. and S.M. received funding from the ERC (243016-PALMassembly) and D.K. from the Swiss Cancer League (grants 02024-2007 and 02584-02-2010 to P.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken CE, 2008, BIOPHYS J, V94, P1826, DOI 10.1529/biophysj.107.117689; Altman RB, 2012, NAT METHODS, V9, P428, DOI 10.1038/nmeth.1988; Altman RB, 2012, NAT METHODS, V9, P68, DOI [10.1038/nmeth.1774, 10.1038/NMETH.1774]; Aquino D, 2011, NAT METHODS, V8, P353, DOI [10.1038/NMETH.1583, 10.1038/nmeth.1583]; Bates M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.108101; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Cordes T, 2009, J AM CHEM SOC, V131, P5018, DOI 10.1021/ja809117z; Dave R, 2009, BIOPHYS J, V96, P2371, DOI 10.1016/j.bpj.2008.11.061; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/NMETH.1768, 10.1038/nmeth.1768]; GILOH H, 1982, SCIENCE, V217, P1252, DOI 10.1126/science.7112126; Heilemann M, 2005, J AM CHEM SOC, V127, P3801, DOI 10.1021/ja044686x; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huang B, 2009, ANNU REV BIOCHEM, V78, P993, DOI 10.1146/annurev.biochem.77.061906.092014; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; Juette MF, 2008, NAT METHODS, V5, P527, DOI 10.1038/nmeth.1211; Kasper R, 2010, SMALL, V6, P1379, DOI 10.1002/smll.201000203; Lawo S, 2012, NAT CELL BIOL, V14, P1148, DOI 10.1038/ncb2591; Mlodzianoski MJ, 2011, OPT EXPRESS, V19, P15009, DOI 10.1364/OE.19.015009; Nogales E, 2012, COMPREHENSIVE BIOPHY; Pavani SRP, 2009, P NATL ACAD SCI USA, V106, P2995, DOI 10.1073/pnas.0900245106; Rasnik I, 2006, NAT METHODS, V3, P891, DOI 10.1038/NMETH934; Robbins MS, 2003, IEEE T ELECTRON DEV, V50, P1227, DOI 10.1109/TED.2003.813462; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Shi XH, 2010, ANAL CHEM, V82, P6132, DOI 10.1021/ac1008749; Shtengel G, 2009, P NATL ACAD SCI USA, V106, P3125, DOI 10.1073/pnas.0813131106; Swoboda M, 2012, ACS NANO, V6, P6364, DOI 10.1021/nn301895c; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; van de Linde S, 2011, NAT PROTOC, V6, P991, DOI 10.1038/nprot.2011.336; Vaughan JC, 2013, J AM CHEM SOC, V135, P1197, DOI 10.1021/ja3105279; Vaughan JC, 2012, NAT METHODS, V9, P1181, DOI [10.1038/NMETH.2214, 10.1038/nmeth.2214]; Vogelsang J, 2009, PHOTOCH PHOTOBIO SCI, V8, P486, DOI 10.1039/b822318c; Vogelsang J, 2009, P NATL ACAD SCI USA, V106, P8107, DOI 10.1073/pnas.0811875106; Xu K, 2012, NAT METHODS, V9, P185, DOI [10.1038/NMETH.1841, 10.1038/nmeth.1841]; Zheng QS, 2012, J PHYS CHEM LETT, V3, P2200, DOI 10.1021/jz300670p	35	121	124	1	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e69004	10.1371/journal.pone.0069004	http://dx.doi.org/10.1371/journal.pone.0069004			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23874848	gold, Green Published, Green Submitted			2022-12-27	WOS:000322000600038
J	Tukiendorf, A; Kazmierski, R; Michalak, S				Tukiendorf, Andrzej; Kazmierski, Radoslaw; Michalak, Slawomir			The Taxonomy Statistic Uncovers Novel Clinical Patterns in a Population of Ischemic Stroke Patients	PLOS ONE			English	Article							TRIAL	In this paper, we describe a simple taxonomic approach for clinical data mining elaborated by Marczewski and Steinhaus (M-S), whose performance equals the advanced statistical methodology known as the expectation-maximization (E-M) algorithm. We tested these two methods on a cohort of ischemic stroke patients. The comparison of both methods revealed strong agreement. Direct agreement between M-S and E-M classifications reached 83%, while Cohen's coefficient of agreement was kappa = 0.766 (P < 0.0001). The statistical analysis conducted and the outcomes obtained in this paper revealed novel clinical patterns in ischemic stroke patients. The aim of the study was to evaluate the clinical usefulness of Marczewski-Steinhaus' taxonomic approach as a tool for the detection of novel patterns of data in ischemic stroke patients and the prediction of disease outcome. In terms of the identification of fairly frequent types of stroke patients using their age, National Institutes of Health Stroke Scale (NIHSS), and diabetes mellitus (DM) status, when dealing with rough characteristics of patients, four particular types of patients are recognized, which cannot be identified by means of routine clinical methods. Following the obtained taxonomical outcomes, the strong correlation between the health status at moment of admission to emergency department (ED) and the subsequent recovery of patients is established. Moreover, popularization and simplification of the ideas of advanced mathematicians may provide an unconventional explorative platform for clinical problems.	[Tukiendorf, Andrzej] Canc Ctr Inst Oncol, Dept Epidemiol, Gliwice, Poland; [Kazmierski, Radoslaw] Poznan Univ Med Sci, Dept Neurol & Cerebrovasc Disorders, Poznan, Poland; [Michalak, Slawomir] Poznan Univ Med Sci, Dept Neurochem & Neuropathol, Poznan, Poland	Maria Sklodowska-Curie National Research Institute of Oncology; Poznan University of Medical Sciences; Poznan University of Medical Sciences	Tukiendorf, A (corresponding author), Canc Ctr Inst Oncol, Dept Epidemiol, Gliwice, Poland.	atukiendorf@io.gliwice.pl						[Anonymous], PARTIBUS ANIMALIUM, p639a; Bailey K.D., 1994, TYPOLOGIES TAXONOMIE, DOI [10.4135/9781412986397, DOI 10.4135/9781412986397]; Capes SE, 2001, STROKE, V32, P2426, DOI 10.1161/hs1001.096194; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Core R Team, 2012, R LANG ENV STAT COMP; De Silva DA, 2010, CEREBROVASC DIS, V29, P14, DOI 10.1159/000255969; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Fraley C., 2012, PACKAGE MCLUST NORMA; Guidone L, 2008, B INSECTOL, V61, P207; Kazmierski R, 2012, NEUROLOGY, V79, P1677, DOI 10.1212/WNL.0b013e31826e9a83; Linnaeus C., 1758, SYSTEMA NATURAE REGN, DOI [10.5962/bhl.title.542, DOI 10.5962/BHL.TITLE.542]; Lyden P, 1999, STROKE, V30, P2347, DOI 10.1161/01.STR.30.11.2347; Maechler M, 2012, PACKAGE CLUSTER CLUS; Mahalanobis P.C., 1936, P NAT I SCI INDIA, V2, P49; MAHONEY F I, 1965, Md State Med J, V14, P61; MARCZEWSKI E, 1958, C MATH, V6, P319; Michalak S, 2011, CEREBROVASC DIS, V32, P124, DOI 10.1159/000328227; Rankin L., 1957, SCOTT MED J 2 PROGNOSIS SCOTT ME, V2, P200, DOI [10.1177/003693305700200504, DOI 10.1177/003693305700200504]; Redfors P, 2012, ACTA NEUROL SCAND, V126, P329, DOI 10.1111/j.1600-0404.2012.01653.x; Reeves MJ, 2008, LANCET NEUROL, V7, P915, DOI 10.1016/S1474-4422(08)70193-5; Ryan TP, 2005, J APPL STAT, V32, P461, DOI 10.1080/02664760500079373; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Tryon R, 1939, ANN ARBOR MI EDWARDS, P122; Ulam S, 1990, ANALOGIES ANALOGIES, P477; Zhai C., 2007, NOTE EXPECTATION MAX	25	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e69816	10.1371/journal.pone.0069816	http://dx.doi.org/10.1371/journal.pone.0069816			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23875000	Green Submitted, gold, Green Published			2022-12-27	WOS:000322064300118
J	Cheng, SH; Kesavan, C; Mohan, S; Qin, XZ; Alarcon, CM; Wergedal, J; Xing, WR				Cheng, Shaohong; Kesavan, Chandrasekhar; Mohan, Subburaman; Qin, Xuezhong; Alarcon, Catrina M.; Wergedal, Jon; Xing, Weirong			Transgenic Overexpression of Ephrin B1 in Bone Cells Promotes Bone Formation and an Anabolic Response to Mechanical Loading in Mice	PLOS ONE			English	Article							OSTERIX EXPRESSION; COMMISSURAL AXONS; IN-VITRO; PROLIFERATION; RECEPTORS; GENE; OSTEOBLAST; MUTATIONS; EFNB1; EPHA4	To test if ephrin B1 overexpression enhances bone mass, we generated transgenic mice overexpressing ephrin B1 under the control of a 3.6 kb rat collagen 1A1 promoter (Col3.6-Tg(efnb1)). Col3.6-Tg(efnb1) mice express 6-, 12- and 14-fold greater levels of full-length ephrin B1 protein in bone marrow stromal cells, calvarial osteoblasts, and osteoclasts, respectively. The long bones of both genders of Col3.6-Tg(efnb1) mice have increased trabecular bone volume, trabecular number, and trabecular thickness and decreased trabecular separation. Enhanced bone formation and decreased bone resorption contributed to this increase in trabecular bone mass in Col3.6-Tg(efnb1) mice. Consistent with these findings, our in vitro studies showed that overexpression of ephrin B1 increased osteoblast differentiation and mineralization, osterix and collagen 1A1 expression in bone marrow stromal cells. Interaction of ephrin B1 with soluble clustered EphB2-Fc decreased osteoclast precursor differentiation into multinucleated cells. Furthermore, we demonstrated that the mechanical loading-induced increase in EphB2 expression and newly formed bone were significantly greater in the Col3.6-Tg(efnb1) mice than in WT littermate controls. Our findings that overexpression of ephrin B1 in bone cells enhances bone mass and promotes a skeletal anabolic response to mechanical loading suggest that manipulation of ephrin B1 actions in bone may provide a means to sensitize the skeleton to mechanical strain to stimulate new bone formation.	[Cheng, Shaohong; Kesavan, Chandrasekhar; Mohan, Subburaman; Qin, Xuezhong; Alarcon, Catrina M.; Wergedal, Jon; Xing, Weirong] Jerry L Pettis VA Med Ctr, Musculoskeletal Dis Ctr, Loma Linda, CA USA; [Kesavan, Chandrasekhar; Mohan, Subburaman; Qin, Xuezhong; Wergedal, Jon; Xing, Weirong] Loma Linda Univ, Dept Med, Loma Linda, CA 92350 USA; [Mohan, Subburaman; Wergedal, Jon] Loma Linda Univ, Dept Biochem, Loma Linda, CA 92350 USA; [Mohan, Subburaman] Loma Linda Univ, Dept Physiol, Loma Linda, CA 92350 USA	Loma Linda University; Loma Linda University; Loma Linda University	Xing, WR (corresponding author), Jerry L Pettis VA Med Ctr, Musculoskeletal Dis Ctr, Loma Linda, CA USA.	Weirong.Xing@va.gov			NIAMS/NIH [R21AR056833]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR056833, R01AR048139] Funding Source: NIH RePORTER	NIAMS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grant number R21AR056833 from NIAMS/NIH (to WX) and merit review 10826917 from the Veterans Administration (to SM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhter MP, 1998, CALCIFIED TISSUE INT, V63, P442, DOI 10.1007/s002239900554; Beamer WG, 1996, BONE, V18, P397, DOI 10.1016/8756-3282(96)00047-6; Benson MD, 2012, DEV DYNAM, V241, P1901, DOI 10.1002/dvdy.23874; Boban I, 2006, BONE, V39, P1302, DOI 10.1016/j.bone.2006.06.025; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Bush JO, 2010, GENE DEV, V24, P2068, DOI 10.1101/gad.1963210; Cheng SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032887; Compagni A, 2003, DEV CELL, V5, P217, DOI 10.1016/S1534-5807(03)00198-9; Davy A, 2004, GENE DEV, V18, P572, DOI 10.1101/gad.1171704; Davy A, 2006, PLOS BIOL, V4, P1763, DOI 10.1371/journal.pbio.0040315; Dottori M, 1998, P NATL ACAD SCI USA, V95, P13248, DOI 10.1073/pnas.95.22.13248; Glaser DL, 1997, SPINE, V22, p12S, DOI 10.1097/00007632-199712151-00003; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Holmberg J, 2006, CELL, V125, P1151, DOI 10.1016/j.cell.2006.04.030; Irie N, 2009, J BIOL CHEM, V284, P14637, DOI 10.1074/jbc.M807598200; Jensen PL, 2000, STEM CELLS, V18, P63, DOI 10.1634/stemcells.18-1-63; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Kesavan C, 2006, BONE, V39, P634, DOI 10.1016/j.bone.2006.03.005; Kesavan C, 2011, AM J PHYSIOL-ENDOC M, V301, pE1191, DOI 10.1152/ajpendo.00440.2011; Lin KT, 2008, J BIOL CHEM, V283, P28969, DOI 10.1074/jbc.M804401200; Marquardt T, 2005, CELL, V121, P127, DOI 10.1016/j.cell.2005.01.020; Munro KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037635; North HA, 2009, DEVELOPMENT, V136, P2467, DOI 10.1242/dev.034405; Ogawa K, 2011, HISTOCHEM CELL BIOL, V136, P617, DOI 10.1007/s00418-011-0867-2; Orioli D, 1996, EMBO J, V15, P6035, DOI 10.1002/j.1460-2075.1996.tb00992.x; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Qin XZ, 2006, ENDOCRINOLOGY, V147, P5653, DOI 10.1210/en.2006-1055; Scheller EL, 2011, CELLS TISSUES ORGANS, V194, P268, DOI 10.1159/000324745; Sugiyama T, 2008, BONE, V43, P238, DOI 10.1016/j.bone.2008.04.012; Takyar FM, 2013, J BONE MINER RES, V28, P912, DOI 10.1002/jbmr.1820; Twigg SRF, 2004, P NATL ACAD SCI USA, V101, P8652, DOI 10.1073/pnas.0402819101; Twigg SRF, 2006, AM J HUM GENET, V78, P999, DOI 10.1086/504440; Williams SE, 2003, NEURON, V39, P919, DOI 10.1016/j.neuron.2003.08.017; WONG GL, 1975, P NATL ACAD SCI USA, V72, P3167, DOI 10.1073/pnas.72.8.3167; Xing WR, 2007, J BIOL CHEM, V282, P22052, DOI 10.1074/jbc.M702614200; Xing WR, 2011, PHYSIOL GENOMICS, V43, P749, DOI 10.1152/physiolgenomics.00229.2010; Xing WR, 2010, MOL CELL BIOL, V30, P711, DOI 10.1128/MCB.00610-09; Xing WR, 2005, J CELL BIOCHEM, V96, P1049, DOI 10.1002/jcb.20606; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012	39	20	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e69051	10.1371/journal.pone.0069051	http://dx.doi.org/10.1371/journal.pone.0069051			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874863	Green Published, gold, Green Submitted			2022-12-27	WOS:000322218800062
J	Schonberger, K; Ludwig, MS; Wildner, M; Weissbrich, B				Schoenberger, Katharina; Ludwig, Maria-Sabine; Wildner, Manfred; Weissbrich, Benedikt			Epidemiology of Subacute Sclerosing Panencephalitis (SSPE) in Germany from 2003 to 2009: A Risk Estimation	PLOS ONE			English	Article							MEASLES; ENGLAND	Subacute sclerosing panencephalitis (SSPE) is a fatal long-term complication of measles infection. We performed an estimation of the total number of SSPE cases in Germany for the period 2003 to 2009 and calculated the risk of SSPE after an acute measles infection. SSPE cases were collected from the Surveillance Unit for Rare Paediatric Diseases in Germany and the Institute of Virology and Immunobiology at the University of Wurzburg. The total number of SSPE cases was estimated by capture-recapture analysis. For the period 2003 to 2009, 31 children with SSPE who were treated at German hospitals were identified. The capture-recapture estimate was 39 cases (95% confidence interval: 29.2-48.0). The risk of developing SSPE for children contracting measles infection below 5 years of age was calculated as 1:1700 to 1:3300. This risk is in the same order of magnitude as the risk of a fatal acute measles infection.	[Schoenberger, Katharina; Wildner, Manfred] Bavarian Hlth & Food Safety Author, Dept Publ Hlth, Oberschleissheim, Germany; [Ludwig, Maria-Sabine] Bavarian Hlth & Food Safety Author, Dept Publ Hlth, Erlangen, Germany; [Weissbrich, Benedikt] Univ Wurzburg, Inst Virol & Immunobiol, Wurzburg, Germany	Bavarian Health & Food Safety Authority; Bavarian Health & Food Safety Authority; University of Wurzburg	Weissbrich, B (corresponding author), Univ Wurzburg, Inst Virol & Immunobiol, Versbacher Str 7, Wurzburg, Germany.	weissbrich@vim.uni-wuerzburg.de			Robert-Koch-Institute from funds of the Federal Ministry of Health [FKZ 1369-400]	Robert-Koch-Institute from funds of the Federal Ministry of Health	The study was supported by the Bavarian State Ministry of the Environment and Public Health for the ESPED data collection and by the Robert-Koch-Institute from funds of the Federal Ministry of Health (FKZ 1369-400). Employees of the Robert-Koch-Institute provided data on measles infections in Germany, which were reported to the Robert-Koch-Institute based on the German Infection Protection Act. These data were used for further analysis by the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellini WJ, 2005, J INFECT DIS, V192, P1686, DOI 10.1086/497169; Campbell Craig, 2005, BMC Pediatr, V5, P47, DOI 10.1186/1471-2431-5-47; Campbell H, 2007, INT J EPIDEMIOL, V36, P1334, DOI 10.1093/ije/dym207; Garg RK, 2008, J NEUROL, V255, P1861, DOI 10.1007/s00415-008-0032-6; Gascon G G, 1996, Semin Pediatr Neurol, V3, P260, DOI 10.1016/S1071-9091(96)80030-1; Gobel U, 2010, KLIN PADIATR, V222, P92, DOI 10.1055/s-0030-1247587; Gutierrez J, 2010, DEV MED CHILD NEUROL, V52, P901, DOI 10.1111/j.1469-8749.2010.03717.x; HALSEY NA, 1980, AM J EPIDEMIOL, V111, P415, DOI 10.1093/oxfordjournals.aje.a112916; Hook EB, 1995, EPIDEMIOL REV, V17, P243, DOI 10.1093/oxfordjournals.epirev.a036192; LAPORTE RE, 1992, LANCET, V339, P494, DOI 10.1016/0140-6736(92)91103-F; Mette A, 2011, DTSCH ARZTEBL INT, V108, P191, DOI 10.3238/arztebl.2011.0191; Miller C, 2004, ARCH DIS CHILD, V89, P1145, DOI 10.1136/adc.2003.038489; MILLER C, 1992, INT J EPIDEMIOL, V21, P998, DOI 10.1093/ije/21.5.998; MODLIN JF, 1977, PEDIATRICS, V59, P505; Reuter D, 2010, MED MICROBIOL IMMUN, V199, P261, DOI 10.1007/s00430-010-0153-2; Rima BK, 2005, VIRUS RES, V111, P132, DOI 10.1016/j.virusres.2005.04.005; Ruckinger S, 2008, BUNDESGESUNDHEITSBLA, V51, P483, DOI 10.1007/s00103-008-0533-6; WEISSBRICH B, 2003, CLIN NEUROVIROLOGY, P401	18	60	60	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68909	10.1371/journal.pone.0068909	http://dx.doi.org/10.1371/journal.pone.0068909			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874807	Green Submitted, Green Published, gold			2022-12-27	WOS:000321736900120
J	Cao, HZ; Wu, JH; Wang, Y; Jiang, H; Zhang, T; Liu, X; Xu, YY; Liang, DQ; Gao, P; Sun, YP; Gifford, B; D'Ascenzo, M; Liu, XM; Tellier, LCAM; Yang, F; Tong, X; Chen, D; Zheng, J; Li, WY; Richmond, T; Xu, X; Wang, J; Li, YR				Cao, Hongzhi; Wu, Jinghua; Wang, Yu; Jiang, Hui; Zhang, Tao; Liu, Xiao; Xu, Yinyin; Liang, Dequan; Gao, Peng; Sun, Yepeng; Gifford, Benjamin; D'Ascenzo, Mark; Liu, Xiaomin; Tellier, Laurent C. A. M.; Yang, Fang; Tong, Xin; Chen, Dan; Zheng, Jing; Li, Weiyang; Richmond, Todd; Xu, Xun; Wang, Jun; Li, Yingrui			An Integrated Tool to Study MHC Region: Accurate SNV Detection and HLA Genes Typing in Human MHC Region Using Targeted High-Throughput Sequencing	PLOS ONE			English	Article							FRAMEWORK; PROJECT; MAP	The major histocompatibility complex (MHC) is one of the most variable and gene-dense regions of the human genome. Most studies of the MHC, and associated regions, focus on minor variants and HLA typing, many of which have been demonstrated to be associated with human disease susceptibility and metabolic pathways. However, the detection of variants in the MHC region, and diagnostic HLA typing, still lacks a coherent, standardized, cost effective and high coverage protocol of clinical quality and reliability. In this paper, we presented such a method for the accurate detection of minor variants and HLA types in the human MHC region, using high-throughput, high-coverage sequencing of target regions. A probe set was designed to template upon the 8 annotated human MHC haplotypes, and to encompass the 5 megabases (Mb) of the extended MHC region. We deployed our probes upon three, genetically diverse human samples for probe set evaluation, and sequencing data show that similar to 97% of the MHC region, and over 99% of the genes in MHC region, are covered with sufficient depth and good evenness. 98% of genotypes called by this capture sequencing prove consistent with established HapMap genotypes. We have concurrently developed a one-step pipeline for calling any HLA type referenced in the IMGT/HLA database from this target capture sequencing data, which shows over 96% typing accuracy when deployed at 4 digital resolution. This cost-effective and highly accurate approach for variant detection and HLA typing in the MHC region may lend further insight into immune-mediated diseases studies, and may find clinical utility in transplantation medicine research. This one-step pipeline is released for general evaluation and use by the scientific community.	[Cao, Hongzhi; Wu, Jinghua; Wang, Yu; Jiang, Hui; Zhang, Tao; Liu, Xiao; Xu, Yinyin; Liang, Dequan; Gao, Peng; Sun, Yepeng; Liu, Xiaomin; Tellier, Laurent C. A. M.; Yang, Fang; Tong, Xin; Chen, Dan; Zheng, Jing; Li, Weiyang; Xu, Xun; Wang, Jun; Li, Yingrui] BGI Shenzhen, Sci & Technol Dept, Shenzhen, Peoples R China; [Gifford, Benjamin; D'Ascenzo, Mark; Richmond, Todd] Roche NimbleGen Inc, Madison, WI USA; [Cao, Hongzhi; Jiang, Hui; Liu, Xiao; Tellier, Laurent C. A. M.; Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Wang, Jun] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia; [Wang, Jun] Univ Copenhagen, Fac Hlth Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark	Beijing Genomics Institute (BGI); Roche Holding; University of Copenhagen; King Abdulaziz University; Novo Nordisk Foundation; University of Copenhagen	Wang, J (corresponding author), BGI Shenzhen, Sci & Technol Dept, Shenzhen, Peoples R China.	liyr@genomics.cn; wangj@genomics.cn	Li, Yingrui/K-1064-2015; Liu, Xiao/P-2732-2015; Xu, Xun/AAI-6763-2020; Li, Weiyang/GRO-0563-2022; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Liu, Xiao/0000-0002-8073-0534; Xu, Xun/0000-0002-5338-5173; Wang, Jun/0000-0002-2113-5874; Liu, Xiaomin/0000-0003-2155-3627; Zhang, Tao/0000-0003-2765-2802; Wang, Jun/0000-0002-8540-8931; Melchior Tellier, Laurent Christian Asker/0000-0003-3240-4926	National High Technology Research and Development Program of China [2012AA02A201]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	The study was supported by the National High Technology Research and Development Program of China (NO. 2012AA02A201), and the funder's website is: http://www.863.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, SCI TRANSL MED; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; Bray RA, 2008, BIOL BLOOD MARROW TR, V14, P45, DOI 10.1016/j.bbmt.2008.06.014; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dunckley Heather, 2012, Methods Mol Biol, V882, P9, DOI 10.1007/978-1-61779-842-9_2; Erlich RL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-42; Fernando MMA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000024; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Horton R, 2008, IMMUNOGENETICS, V60, P1, DOI 10.1007/s00251-007-0262-2; Lee SJ, 2007, BLOOD, V110, P4576, DOI 10.1182/blood-2007-06-097386; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Morishima Y, 2002, BLOOD, V99, P4200, DOI 10.1182/blood.V99.11.4200; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Rioux JD, 2009, P NATL ACAD SCI USA, V106, P18680, DOI 10.1073/pnas.0909307106; Shearer AE, 2010, P NATL ACAD SCI USA, V107, P21104, DOI 10.1073/pnas.1012989107; Stewart CA, 2004, GENOME RES, V14, P1176, DOI 10.1101/gr.2188104; Trowsdale J, 2011, IMMUNOL LETT, V137, P1, DOI 10.1016/j.imlet.2011.01.002; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484	22	15	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69388	10.1371/journal.pone.0069388	http://dx.doi.org/10.1371/journal.pone.0069388			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894464	Green Published, Green Submitted, gold			2022-12-27	WOS:000322167900061
J	de Santana, CD; Vari, RP; Wosiacki, WB				de Santana, Carlos David; Vari, Richard P.; Wosiacki, Wolmar B.			The Untold Story of the Caudal Skeleton in the Electric Eel (Ostariophysi: Gymnotiformes: Electrophorus)	PLOS ONE			English	Article							APTERONOTIDAE; INTERRELATIONSHIPS; MORPHOLOGY; DIVERSITY; TELEOSTEI; ECOLOGY	Alternative hypotheses had been advanced as to the components forming the elongate fin coursing along the ventral margin of much of the body and tail from behind the abdominal region to the posterior margin of the tail in the Electric Eel, Electrophorus electricus. Although the original species description indicated that this fin was a composite of the caudal fin plus the elongate anal fin characteristic of other genera of the Gymnotiformes, subsequent researchers proposed that the posterior region of the fin was formed by the extension of the anal fin posteriorly to the tip of the tail, thereby forming a "false caudal fin." Examination of ontogenetic series of the genus reveal that Electrophorus possesses a true caudal fin formed of a terminal centrum, hypural plate and a low number of caudal-fin rays. The confluence of the two fins is proposed as an additional autapomorphy for the genus. Under all alternative proposed hypotheses of relationships within the order Gymnotiformes, the presence of a caudal fin in Electrophorus optimized as being independent of the occurence of the morphologically equivalent structure in the Apteronotidae. Possible functional advantages to the presence of a caudal fin in the genus are discussed.	[de Santana, Carlos David; Vari, Richard P.] Smithsonian Inst, Natl Museum Nat Hist, Dept Vertebrate Zool, Div Fishes, Washington, DC 20560 USA; [de Santana, Carlos David; Wosiacki, Wolmar B.] Museu Paraense Emilio Goeldi, Setor Ictiol, Belem, Para, Brazil	Smithsonian Institution; Smithsonian National Museum of Natural History; Museu Paraense Emilio Goeldi	de Santana, CD (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Vertebrate Zool, Div Fishes, Washington, DC 20560 USA.	apteronotidae@ig.com.br	Wosiacki, Wolmar/I-1724-2012	Wosiacki, Wolmar/0000-0002-4013-8501	Herbert R. and Evelyn Axelrod Chair in Systematic Ichthyology of the National Museum of Natural History; Smithsonian Institution; Conselho Nacional de Pesquisa (CNPq); CNPq/Ciencia sem Fronteiras [245622/2012-8]	Herbert R. and Evelyn Axelrod Chair in Systematic Ichthyology of the National Museum of Natural History; Smithsonian Institution(Smithsonian Institution); Conselho Nacional de Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq/Ciencia sem Fronteiras(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding for the research was provided to RPV and CDS by the Herbert R. and Evelyn Axelrod Chair in Systematic Ichthyology of the National Museum of Natural History, Smithsonian Institution, and to WBW by Conselho Nacional de Pesquisa (CNPq). CDS was supported by a Posdoctoral Fellowship from the CNPq/Ciencia sem Fronteiras (245622/2012-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert JS, 2007, J VERTEBR PALEONTOL, V27, P17, DOI 10.1671/0272-4634(2007)27[17:PROFNE]2.0.CO;2; Albert James S., 1998, P419; Albert JS, 2001, MISC PUBL MUS ZOOL U; [Anonymous], 1864, P ACAD NAT SCI PHILA, V20, P151; Arnegard ME, 2010, P NATL ACAD SCI USA, V107, P22172, DOI 10.1073/pnas.1011803107; Arratia F. G., 1984, Museo Nacional de Historia Natural Boletin (Santiago), P49; Arratia G, 1987, BONN ZOOL MONOGR, V24, P1, DOI DOI 10.1093/NAR/25.22.4692; Assunu║ao M.I.S., 1995, ICHTHYOL EXPLOR FRES, V6, P175; Campos-da-Paz R, 2003, CHECK LIST FRESHWATE, P483; CAMPOSDAPAZ R, 1995, P BIOL SOC WASH, V108, P29; Crampton W.G.R., 2007, FISH LIFE SPECIAL EN, P283; Cuvier G, 1817, REGNE ANIMAL DISTRIB, VIV; de Pinna Mario C.C., 1998, P279; De Santana CD, 2011, ZOOL J LINN SOC-LOND, V163, P1096, DOI 10.1111/j.1096-3642.2011.00736.x; De Santana CD, 2010, ZOOL J LINN SOC-LOND, V159, P223, DOI 10.1111/j.1096-3642.2009.00588.x; Devaere S, 2005, CYBIUM, V29, P281; Eigenmann CH, 1912, MEMOIRS CARNEGIE MUS, V5, P1; Ellis MM, 1913, MEM CARNEGIE MUS, V6, P109, DOI DOI 10.5962/BHL.TITLE.12969; Eschmeyer W. N. E., 2013, CATALOG FISHES; Fernandes CC, 2004, SCIENCE, V305, P1960, DOI 10.1126/science.1101240; Fernandez L, 2007, ZOOTAXA, P51, DOI 10.11646/zootaxa.1626.1.4; Finger S., 2011, SHOCKING HIST ELECT; FINK SV, 1981, ZOOL J LINN SOC-LOND, V72, P297, DOI 10.1111/j.1096-3642.1981.tb01575.x; Fujita K., 1990, CAUDAL SKELETON TELE; Funk V. A., 2009, Bulletin of the Biological Society of Washington, V17, P1; Gayet Mireille, 1994, Cybium, V18, P273; Gronovius L. T., 1763, ZOOPHYLACII GRONOVIA; Hilton EL, 2007, P ACAD NAT SCI PHILA, V156, P1, DOI 10.1635/0097-3157(2007)156[1:ROOTBG]2.0.CO;2; LANNOO MJ, 1993, ENVIRON BIOL FISH, V36, P157, DOI 10.1007/BF00002795; Linnaeus C., 1766, SYSTEMA NATURAE REGN, V1; Lundberg J.G., 1969, American Museum Novitates, VNo. 2398, P1; Mago-Leccia F., 1994, ELECT FISHES CONTINE; MEUNIER FJ, 1978, ACTA ZOOL-STOCKHOLM, V59, P215, DOI 10.1111/j.1463-6395.1978.tb01036.x; MEUNIER FJ, 1984, ACTA ZOOL-STOCKHOLM, V65, P135, DOI 10.1111/j.1463-6395.1984.tb00819.x; Meunier FJ, 1991, GEOBIOS, V3, P223; Moller P., 1995, ELECT FISHES HIST BE; Monod T., 1968, Memoires de l'Institut Fond Afr Noire, VNo. 81, P1; Nanjappa P, 2000, ENVIRON BIOL FISH, V58, P97, DOI 10.1023/A:1007656801949; Regan CT, 1911, ANN MAG NAT HIST, V8, P120; REICHEL MANFRED, 1927, REV SUISSE ZOOL, V34, P285; Reis RE., 2003, CLOFFSCA CHECK LIST; Sfakiotakis M, 1999, IEEE J OCEANIC ENG, V24, P237, DOI 10.1109/48.757275; Shibatta Oscar Akio, 2007, Pap. Avulsos Zool. (São Paulo), V47, P191, DOI 10.1590/S0031-10492007001700001; Sullivan JP, 2006, MOL PHYLOGENET EVOL, V41, P636, DOI 10.1016/j.ympev.2006.05.044; TAYLOR W R, 1985, Cybium, V9, P107; Triques Mauro L., 2005, Lundiana, V6, P121; Triques Mauro Luis, 1993, Comunicacoes do Museu de Ciencias da PUCRS Serie Zoologia, V6, P85; Vari RP, 2012, ZOOL J LINN SOC-LOND, V165, P670, DOI 10.1111/j.1096-3642.2012.00827.x	48	11	11	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e68719	10.1371/journal.pone.0068719	http://dx.doi.org/10.1371/journal.pone.0068719			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894337	Green Submitted, Green Published, gold			2022-12-27	WOS:000322167900023
J	Saber, AT; Lamson, JS; Jacobsen, NR; Ravn-Haren, G; Hougaard, KS; Nyendi, AN; Wahlberg, P; Madsen, AM; Jackson, P; Wallin, H; Vogel, U				Saber, Anne Thoustrup; Lamson, Jacob Stuart; Jacobsen, Nicklas Raun; Ravn-Haren, Gitte; Hougaard, Karin Sorig; Nyendi, Allen Njimeri; Wahlberg, Pia; Madsen, Anne Mette; Jackson, Petra; Wallin, Hakan; Vogel, Ulla			Particle-Induced Pulmonary Acute Phase Response Correlates with Neutrophil Influx Linking Inhaled Particles and Cardiovascular Risk	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; PARTICULATE AIR-POLLUTION; SERUM-AMYLOID-A; REVERSE CHOLESTEROL TRANSPORT; ULTRAFINE CARBON-BLACK; SYSTEMIC INFLAMMATION; MESSENGER-RNA; MOUSE LUNG; IN-VIVO	Background: Particulate air pollution is associated with cardiovascular disease. Acute phase response is causally linked to cardiovascular disease. Here, we propose that particle-induced pulmonary acute phase response provides an underlying mechanism for particle-induced cardiovascular risk. Methods: We analysed the mRNA expression of Serum Amyloid A (Saa3) in lung tissue from female C57BL/6J mice exposed to different particles including nanomaterials (carbon black and titanium dioxide nanoparticles, multi-and single walled carbon nanotubes), diesel exhaust particles and airborne dust collected at a biofuel plant. Mice were exposed to single or multiple doses of particles by inhalation or intratracheal instillation and pulmonary mRNA expression of Saa3 was determined at different time points of up to 4 weeks after exposure. Also hepatic mRNA expression of Saa3, SAA3 protein levels in broncheoalveolar lavage fluid and in plasma and high density lipoprotein levels in plasma were determined in mice exposed to multiwalled carbon nanotubes. Results: Pulmonary exposure to particles strongly increased Saa3 mRNA levels in lung tissue and elevated SAA3 protein levels in broncheoalveolar lavage fluid and plasma, whereas hepatic Saa3 levels were much less affected. Pulmonary Saa3 expression correlated with the number of neutrophils in BAL across different dosing regimens, doses and time points. Conclusions: Pulmonary acute phase response may constitute a direct link between particle inhalation and risk of cardiovascular disease. We propose that the particle-induced pulmonary acute phase response may predict risk for cardiovascular disease.	[Saber, Anne Thoustrup; Lamson, Jacob Stuart; Jacobsen, Nicklas Raun; Hougaard, Karin Sorig; Nyendi, Allen Njimeri; Madsen, Anne Mette; Jackson, Petra; Wallin, Hakan; Vogel, Ulla] Natl Res Ctr Working Environm, Copenhagen, Denmark; [Ravn-Haren, Gitte] Tech Univ Denmark, Natl Food Inst, Soborg, Denmark; [Wahlberg, Pia] Danish Technol Inst, Taastrup, Denmark; [Wallin, Hakan] Univ Copenhagen, Inst Publ Hlth, Copenhagen, Denmark; [Vogel, Ulla] Tech Univ Denmark, Dept Micro & Nanotechnol, DK-2800 Lyngby, Denmark	National Research Centre for the Working Environment; Technical University of Denmark; University of Copenhagen; Technical University of Denmark	Saber, AT (corresponding author), Natl Res Ctr Working Environm, Copenhagen, Denmark.	ats@nrcwe.dk	Ravn-Haren, Gitte/I-8551-2018; Wallin, Håkan/I-6459-2012; Vogel, Ulla B/I-5048-2012; Vogel, Ulla/ABC-2212-2020; Hougaard, Karin S/F-3606-2014	Ravn-Haren, Gitte/0000-0002-4587-089X; Wallin, Håkan/0000-0001-7716-0166; Vogel, Ulla B/0000-0001-6807-1524; Vogel, Ulla/0000-0001-6807-1524; Hougaard, Karin S/0000-0002-3386-0512; Jacobsen, Nicklas Raun/0000-0002-2504-2229; Madsen, Anne Mette/0000-0002-5895-7521	The Danish Working Environment Research Fund (NanoKem) [20060068816]; The Danish Working Environment Research Fund (NanoPlast) [22-2007-03]; The Danish Working Environment Research Fund (Danish Centre for Nanosafety) [20110092173/3]	The Danish Working Environment Research Fund (NanoKem); The Danish Working Environment Research Fund (NanoPlast); The Danish Working Environment Research Fund (Danish Centre for Nanosafety)	The Danish Working Environment Research Fund supported the study (NanoKem, grant #20060068816 and NanoPlast, grant 22-2007-03 and Danish Centre for Nanosafety grant 20110092173/3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annema W, 2010, J LIPID RES, V51, P743, DOI 10.1194/jlr.M000323; BADOLATO R, 1994, J EXP MED, V180, P203, DOI 10.1084/jem.180.1.203; Bai N, 2011, ATHEROSCLEROSIS; Balci B, 2011, CURR CARDIOL REV, V7, P272, DOI 10.2174/157340311799960690; Barregard L, 2006, INHAL TOXICOL, V18, P845, DOI 10.1080/08958370600685798; Bourdon JA, 2012, TOXICOL SCI, V127, P474, DOI 10.1093/toxsci/kfs119; Bourdon JA, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-5; Chang CC, 2007, PROTEOMICS, V7, P4388, DOI 10.1002/pmic.200700164; Chen LC, 2005, INHAL TOXICOL, V17, P217, DOI 10.1080/08958370590912815; Chiba T, 2009, J LIPID RES, V50, P1353, DOI 10.1194/jlr.M900089-JLR200; Danesh J, 1999, EUR HEART J, V20, P954, DOI 10.1053/euhj.1998.1309; Danesh J, 2000, BMJ-BRIT MED J, V321, P199, DOI 10.1136/bmj.321.7255.199; Delfino RJ, 2008, ENVIRON HEALTH PERSP, V116, P898, DOI 10.1289/ehp.11189; Dong Z, 2011, MOL MED; Duffin R, 2007, INHAL TOXICOL, V19, P849, DOI 10.1080/08958370701479323; Elliott P, 2009, JAMA-J AM MED ASSOC, V302, P37, DOI 10.1001/jama.2009.954; Eriksen N, 1992, P NATL ACAD SCI US, V89, P7949; Estabragh ZR, 2013, INT J CARDIOL; Fang SC, 2010, INT J ENV RES PUB HE, V7, P1773, DOI 10.3390/ijerph7041773; Feingold KR, 2010, J LIPID RES, V51, P682, DOI 10.1194/jlr.E005454; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Gitlin JM, 2009, CARDIOVASC RES, V81, P400, DOI 10.1093/cvr/cvn286; Halappanavar S, 2011, ENVIRON MOL MUTAGEN, V52, P425, DOI 10.1002/em.20639; Hertel S, 2010, EUR J EPIDEMIOL, V25, P581, DOI 10.1007/s10654-010-9477-x; Hougaard KS, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-16; Husain M, 2013, TOXICOL APPL PHARM, V269, P250, DOI 10.1016/j.taap.2013.03.018; Huttunen K, 2012, ENVIRON RES, V116, P44, DOI 10.1016/j.envres.2012.04.004; Jackson P, 2012, MUTAT RES-GEN TOX EN, V745, P73, DOI 10.1016/j.mrgentox.2011.09.018; Jackson P, 2012, NANOTOXICOLOGY, V6, P486, DOI 10.3109/17435390.2011.587902; Jahangiri A, 2009, ARTERIOSCL THROM VAS, V29, P261, DOI 10.1161/ATVBAHA.108.178681; Kaptoge S, 2012, NEW ENGL J MED, V367, P1310, DOI 10.1056/NEJMoa1107477; King VL, 2011, CURR OPIN LIPIDOL, V22, P302, DOI 10.1097/MOL.0b013e3283488c39; Lalla E, 2003, ARTERIOSCL THROM VAS, V23, P1405, DOI 10.1161/01.ATV.0000082462.26258.FE; Li L, 2002, CIRCULATION, V105, P861, DOI 10.1161/hc0702.104178; Li Z, 2007, ENVIRON HEALTH PERSP, V115, P377, DOI 10.1289/ehp.9688; Libby P, 2010, CIRC J, V74, P213, DOI 10.1253/circj.CJ-09-0706; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowe G D, 2001, Ann Periodontol, V6, P1, DOI 10.1902/annals.2001.6.1.1; Madsen AM, 2008, SCAND J WORK ENV HEA, V34, P278, DOI 10.5271/sjweh.1272; MEEK RL, 1994, P NATL ACAD SCI USA, V91, P3186, DOI 10.1073/pnas.91.8.3186; Mezaki T, 2003, JPN HEART J, V44, P601, DOI 10.1536/jhj.44.601; Mikkelsen L, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-32; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Packard RRS, 2008, CLIN CHEM, V54, P24, DOI 10.1373/clinchem.2007.097360; Pai JK, 2004, NEW ENGL J MED, V351, P2599, DOI 10.1056/NEJMoa040967; Peters A, 2001, EUR HEART J, V22, P1198, DOI 10.1053/euhj.2000.2483; Pfohl M, 1999, ATHEROSCLEROSIS, V142, P389, DOI 10.1016/S0021-9150(98)00242-1; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; Pope CA, 2004, ENVIRON HEALTH PERSP, V112, P339, DOI 10.1289/ehp.6588; Pussinen PJ, 2007, ARTERIOSCL THROM VAS, V27, P1433, DOI 10.1161/ATVBAHA.106.138743; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Riediker M, 2004, AM J RESP CRIT CARE, V169, P934, DOI 10.1164/rccm.200310-1463OC; Saber AT, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-12; Saber AT, 2012, NANOTOXICOLOGY, V6, P453, DOI 10.3109/17435390.2011.587900; Saber AT, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-4; Saber AT, 2005, ARCH TOXICOL, V79, P177, DOI 10.1007/s00204-004-0613-9; Stulnig TM, 2013, NEW ENGL J MED, V368, P84, DOI 10.1056/NEJMc1213688; Taubes G, 2002, SCIENCE, V296, P242, DOI 10.1126/science.296.5566.242; Teeguarden JG, 2011, TOXICOL SCI, V120, P123, DOI 10.1093/toxsci/kfq363; TERPSTRA AHM, 1981, ANAL BIOCHEM, V111, P149, DOI 10.1016/0003-2697(81)90243-8; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Vogel U, COMMENTARY IN PRESS; Vogel U, 2011, ATHEROSCLEROSIS, V219, P200, DOI 10.1016/j.atherosclerosis.2011.06.018; Wang XW, 2008, AM J PHYSIOL-HEART C, V295, pH2399, DOI 10.1152/ajpheart.00238.2008; WHITEHEAD AS, 1990, BIOCHEM J, V266, P283, DOI 10.1042/bj2660283; Wuyts A, 1996, IMMUNOBIOLOGY, V195, P499	66	81	81	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69020	10.1371/journal.pone.0069020	http://dx.doi.org/10.1371/journal.pone.0069020			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894396	Green Published, Green Submitted, gold			2022-12-27	WOS:000322167900036
J	Marsh, AJ; O'Sullivan, O; Hill, C; Ross, RP; Cotter, PD				Marsh, Alan J.; O'Sullivan, Orla; Hill, Colin; Ross, R. Paul; Cotter, Paul D.			Sequencing-Based Analysis of the Bacterial and Fungal Composition of Kefir Grains and Milks from Multiple Sources	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; RIBOSOMAL-RNA GENE; CULTURE-INDEPENDENT METHODS; FERMENTED MILK; MICROBIAL DIVERSITY; CHEMICAL-PROPERTIES; TAIWANESE KEFIR; NEXT-GENERATION; CANDIDA-KEFYR; YEASTS	Kefir is a fermented milk-based beverage to which a number of health-promoting properties have been attributed. The microbes responsible for the fermentation of milk to produce kefir consist of a complex association of bacteria and yeasts, bound within a polysaccharide matrix, known as the kefir grain. The consistency of this microbial population, and that present in the resultant beverage, has been the subject of a number of previous, almost exclusively culture-based, studies which have indicated differences depending on geographical location and culture conditions. However, culture-based identification studies are limited by virtue of only detecting species with the ability to grow on the specific medium used and thus culture-independent, molecular-based techniques offer the potential for a more comprehensive analysis of such communities. Here we describe a detailed investigation of the microbial population, both bacterial and fungal, of kefir, using high-throughput sequencing to analyse 25 kefir milks and associated grains sourced from 8 geographically distinct regions. This is the first occasion that this technology has been employed to investigate the fungal component of these populations or to reveal the microbial composition of such an extensive number of kefir grains or milks. As a result several genera and species not previously identified in kefir were revealed. Our analysis shows that the bacterial populations in kefir are dominated by 2 phyla, the Firmicutes and the Proteobacteria. It was also established that the fungal populations of kefir were dominated by the genera Kazachstania, Kluyveromyces and Naumovozyma, but that a variable sub-dominant population also exists.	[Marsh, Alan J.; O'Sullivan, Orla; Ross, R. Paul; Cotter, Paul D.] TEAGASC, Food Res Ctr, Fermoy, Cork, Ireland; [Marsh, Alan J.; Hill, Colin; Ross, R. Paul; Cotter, Paul D.] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland; [Marsh, Alan J.; Hill, Colin] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland	Teagasc; University College Cork; University College Cork	Hill, C (corresponding author), Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland.	c.hill@ucc.ie; paul.cotter@teagasc.ie	O'Sullivan, Orla/ABE-5980-2020; Hill, Colin/A-5611-2012; Cotter, Paul/AAX-5449-2021; Ross, Paul/A-7584-2015; Cotter, Paul/B-7781-2008; STANTON, CATHERINE/A-9549-2015	O'Sullivan, Orla/0000-0002-4332-1109; Hill, Colin/0000-0002-8527-1445; Cotter, Paul/0000-0002-5465-9068; Ross, Paul/0000-0003-4876-8839; Cotter, Paul/0000-0002-5465-9068; STANTON, CATHERINE/0000-0002-6724-7011	Science Foundation Ireland (SFI), through the Irish Government's National Development Plan; SFI CSET grant APC CSET 2 [07/CE/B1368]	Science Foundation Ireland (SFI), through the Irish Government's National Development Plan(Science Foundation Ireland); SFI CSET grant APC CSET 2(Science Foundation Ireland)	The Alimentary Pharmabiotic Centre is a research centre funded by Science Foundation Ireland (SFI), through the Irish Government's National Development Plan. The authors and their work were supported by SFI CSET grant APC CSET 2 grant 07/CE/B1368. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abellana M, 1999, J APPL MICROBIOL, V87, P371, DOI 10.1046/j.1365-2672.1999.00828.x; ANGULO L, 1993, J DAIRY RES, V60, P263, DOI 10.1017/S002202990002759X; Asiegbu FO, 2005, MOL PLANT PATHOL, V6, P395, DOI 10.1111/J.1364-3703.2005.00295.X; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chang HJ, 1998, NEW ENGL J MED, V338, P706, DOI 10.1056/NEJM199803123381102; Chen HC, 2008, FOOD MICROBIOL, V25, P492, DOI 10.1016/j.fm.2008.01.003; Chen MJ, 2005, ASIAN AUSTRAL J ANIM, V18, P711, DOI 10.5713/ajas.2005.711; Chen TH, 2009, J DAIRY SCI, V92, P3002, DOI 10.3168/jds.2008-1669; Chen VB, 2009, PROTEIN SCI, V18, P2403, DOI 10.1002/pro.250; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Czerucka D, 2007, ALIMENT PHARM THER, V26, P767, DOI 10.1111/j.1365-2036.2007.03442.x; Miguel MGDP, 2010, FOOD RES INT, V43, P1523, DOI 10.1016/j.foodres.2010.04.031; Desreumaux P, 2011, GASTROENTEROLOGY, V140, pS50; Dobson A, 2011, FEMS MICROBIOL LETT, V320, P56, DOI 10.1111/j.1574-6968.2011.02290.x; ENGEL G, 1986, MILCHWISSENSCHAFT, V41, P418; Etienne-Mesmin L, 2011, APPL ENVIRON MICROB, V77, P1127, DOI 10.1128/AEM.02130-10; Farnworth E. R., 2005, Food Science and Technology Bulletin:  Functional Foods, V2, P1, DOI 10.1616/1476-2137.13938; Foligne B, 2010, WORLD J GASTROENTERO, V16, P2134, DOI 10.3748/wjg.v16.i17.2134; Gadaga TH, 2001, INT J FOOD MICROBIOL, V68, P21, DOI 10.1016/S0168-1605(01)00466-4; Gao J, 2012, J FOOD SCI, V77, pM425, DOI 10.1111/j.1750-3841.2012.02805.x; Garbers IM, 2004, WORLD J MICROB BIOT, V20, P687, DOI 10.1007/s11274-004-2624-3; Garrote GL, 2001, J DAIRY RES, V68, P639, DOI 10.1017/S0022029901005210; Gonzalez-Sanchez F, 2010, INT J DAIRY TECHNOL, V63, P431, DOI 10.1111/j.1471-0307.2010.00604.x; Guzel-Seydim ZB, 2011, CRIT REV FOOD SCI, V51, P261, DOI 10.1080/10408390903579029; Hansen K, 2005, MOL PHYLOGENET EVOL, V36, P1, DOI 10.1016/j.ympev.2005.03.010; Hawksworth DL, 2011, IMA FUNGUS, V2, P155, DOI 10.5598/imafungus.2011.02.02.06; Heras-Vazquez FJL, 2003, FEMS YEAST RES, V3, P3; Humblot C, 2009, APPL ENVIRON MICROB, V75, P4354, DOI 10.1128/AEM.00451-09; Hunter GC, 2009, MOL PLANT PATHOL, V10, P1, DOI 10.1111/j.1364-3703.2008.00516.x; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Ivanova G, 2012, J U CHEM TECHNOL MET, V47, P59; Kesmen Z, 2011, J FOOD SCI, V76, pM276, DOI 10.1111/j.1750-3841.2011.02191.x; Koutinas AA, 2005, BIOTECHNOL BIOENG, V89, P788, DOI 10.1002/bit.20394; Koyanagi T, 2011, LETT APPL MICROBIOL, V53, P635, DOI 10.1111/j.1472-765X.2011.03155.x; Kumura H, 2004, J DAIRY SCI, V87, P4050, DOI 10.3168/jds.S0022-0302(04)73546-8; Kurtzman CP, 2003, FEMS YEAST RES, V4, P233, DOI 10.1016/S1567-1356(03)00175-2; Kurtzman CP, 2003, FEMS YEAST RES, V3, P417, DOI 10.1016/S1567-1356(03)00012-6; Kwak HS, 1996, J DAIRY SCI, V79, P937, DOI 10.3168/jds.S0022-0302(96)76444-5; Kwon CS, 2003, FOOD SCI BIOTECHNOL, V12, P476; LARIVIERE JW, 1967, ARCH MIKROBIOL, V59, P269; Latorre-Garcia L, 2007, WORLD J MICROB BIOT, V23, P785, DOI 10.1007/s11274-006-9298-y; Lee BK, 2001, AQUACULT ENG, V25, P111, DOI 10.1016/S0144-8609(01)00075-9; Leite AMO, 2012, FOOD MICROBIOL, V31, P215, DOI 10.1016/j.fm.2012.03.011; Lin CW, 1999, AUST J DAIRY TECHNOL, V54, P14; Listemann H, 1998, MYCOSES, V41, P343, DOI 10.1111/j.1439-0507.1998.tb00349.x; Lopitz-Otsoa Fernando, 2006, Revista Iberoamericana de Micologia, V23, P67; Loretan T, 2003, S AFR J SCI, V99, P92; LUNDBERG KS, 1991, GENE, V108, P1, DOI 10.1016/0378-1119(91)90480-Y; Magalhaes KT, 2011, BRAZ J MICROBIOL, V42, P693, DOI [10.1590/S1517-83822011000200034, 10.1590/S1517-838220110002000034]; Mainville I, 2006, SYST APPL MICROBIOL, V29, P59, DOI 10.1016/j.syapm.2005.07.001; MARTINI AV, 1988, MYCOLOGIA, V80, P241, DOI 10.2307/3807799; Masoud W, 2011, INT DAIRY J, V21, P142, DOI 10.1016/j.idairyj.2010.10.007; Miyamoto M, 2010, FOOD SCI TECHNOL RES, V16, P319, DOI 10.3136/fstr.16.319; Montanari G, 1996, J DAIRY RES, V63, P327, DOI 10.1017/S0022029900031836; Motaghi M, 1997, WORLD J MICROB BIOT, V13, P579, DOI 10.1023/A:1018577728412; Park EJ, 2012, FOOD MICROBIOL, V30, P197, DOI 10.1016/j.fm.2011.10.011; Parvez S, 2006, J APPL MICROBIOL, V100, P1171, DOI 10.1111/j.1365-2672.2006.02963.x; Pintado ME, 1996, INT J FOOD SCI TECH, V31, P15, DOI 10.1111/j.1365-2621.1996.16-316.x; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quigley L, 2012, J APPL MICROBIOL, V113, P96, DOI 10.1111/j.1365-2672.2012.05294.x; Quigley L, 2012, APPL ENVIRON MICROB, V78, P5717, DOI 10.1128/AEM.00918-12; Rea MC, 1996, J APPL BACTERIOL, V81, P83, DOI 10.1111/j.1365-2672.1996.tb03286.x; Renker C, 2004, FEMS YEAST RES, V4, P597, DOI 10.1016/j.femsyr.2004.01.001; Roh SW, 2010, ISME J, V4, P1, DOI 10.1038/ismej.2009.83; Sakamoto N, 2011, INT J FOOD MICROBIOL, V144, P352, DOI 10.1016/j.ijfoodmicro.2010.10.017; Santamaria M, 2012, BRIEF BIOINFORM, V13, P682, DOI 10.1093/bib/bbs036; Simova E, 2002, J IND MICROBIOL BIOT, V28, P1, DOI [10.1038/sj/jim/7000186, 10.1038/sj.jim.7000186]; Steels H, 1999, J APPL MICROBIOL, V87, P520, DOI 10.1046/j.1365-2672.1999.00844.x; Tas TK, 2012, INT J DAIRY TECHNOL, V65, P126, DOI 10.1111/j.1471-0307.2011.00733.x; Wang SY, 2008, J DAIRY SCI, V91, P3798, DOI 10.3168/jds.2007-0468; Witthuhn RC, 2005, INT DAIRY J, V15, P383, DOI 10.1016/j.idairyj.2004.07.016; Wyder MT, 1997, FOOD TECHNOL BIOTECH, V35, P299; You SJ, 2006, J ANIM SCI, V84, P310; Yuksekdag ZN, 2004, LEBENSM-WISS TECHNOL, V37, P663, DOI 10.1016/j.lwt.2004.02.004; Zhou JZ, 2009, FOOD MICROBIOL, V26, P770, DOI 10.1016/j.fm.2009.04.009	77	131	136	3	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e69371	10.1371/journal.pone.0069371	http://dx.doi.org/10.1371/journal.pone.0069371			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894461	Green Submitted, Green Published, gold			2022-12-27	WOS:000322391400055
J	D'Emic, MD; Whitlock, JA; Smith, KM; Fisher, DC; Wilson, JA				D'Emic, Michael D.; Whitlock, John A.; Smith, Kathlyn M.; Fisher, Daniel C.; Wilson, Jeffrey A.			Evolution of High Tooth Replacement Rates in Sauropod Dinosaurs	PLOS ONE			English	Article							NECK POSTURE; BIOMECHANICS; HYPSODONTY; PHYLOGENY; ANATOMY	Background: Tooth replacement rate can be calculated in extinct animals by counting incremental lines of deposition in tooth dentin. Calculating this rate in several taxa allows for the study of the evolution of tooth replacement rate. Sauropod dinosaurs, the largest terrestrial animals that ever evolved, exhibited a diversity of tooth sizes and shapes, but little is known about their tooth replacement rates. Methodology/Principal Findings: We present tooth replacement rate, formation time, crown volume, total dentition volume, and enamel thickness for two coexisting but distantly related and morphologically disparate sauropod dinosaurs Camarasaurus and Diplodocus. Individual tooth formation time was determined by counting daily incremental lines in dentin. Tooth replacement rate is calculated as the difference between the number of days recorded in successive replacement teeth. Each tooth family in Camarasaurus has a maximum of three replacement teeth, whereas each Diplodocus tooth family has up to five. Tooth formation times are about 1.7 times longer in Camarasaurus than in Diplodocus (315 vs. 185 days). Average tooth replacement rate in Camarasaurus is about one tooth every 62 days versus about one tooth every 35 days in Diplodocus. Despite slower tooth replacement rates in Camarasaurus, the volumetric rate of Camarasaurus tooth replacement is 10 times faster than in Diplodocus because of its substantially greater tooth volumes. A novel method to estimate replacement rate was developed and applied to several other sauropodomorphs that we were not able to thin section. Conclusions/Significance: Differences in tooth replacement rate among sauropodomorphs likely reflect disparate feeding strategies and/or food choices, which would have facilitated the coexistence of these gigantic herbivores in one ecosystem. Early neosauropods are characterized by high tooth replacement rates (despite their large tooth size), and derived titanosaurs and diplodocoids independently evolved the highest known tooth replacement rates among archosaurs.	[D'Emic, Michael D.] SUNY Stony Brook, Hlth Sci Ctr, Sch Med, Dept Anat Sci, Stony Brook, NY 11794 USA; [Whitlock, John A.] Mt Aloysius Coll, Sci & Math Dept, Cresson, PA USA; [Smith, Kathlyn M.] Georgia So Univ, Dept Geol & Geog, Statesboro, GA 30460 USA; [Smith, Kathlyn M.] Georgia So Univ, Georgia Southern Univ Museum, Statesboro, GA 30460 USA; [Fisher, Daniel C.; Wilson, Jeffrey A.] Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA; [Fisher, Daniel C.; Wilson, Jeffrey A.] Univ Michigan, Dept Earth & Environm Sci, Ann Arbor, MI 48109 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University System of Georgia; Georgia Southern University; University System of Georgia; Georgia Southern University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	D'Emic, MD (corresponding author), SUNY Stony Brook, Hlth Sci Ctr, Sch Med, Dept Anat Sci, Stony Brook, NY 11794 USA.	michael.demic@stonybrook.edu	Wilson, Jeffrey/C-2737-2008; Whitlock, John/G-5814-2018	Whitlock, John/0000-0002-1118-2925	Scott D. Turner Award (University of Michigan)	Scott D. Turner Award (University of Michigan)	Funding was provided by the Scott D. Turner Award (University of Michigan) to MDD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Allain R, 2008, GEODIVERSITAS, V30, P345; Barrett PM, 2007, SPEC PAP PALAEONTOL, P91; Barrett PM, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P125; Barrett Paul M., 2000, P42, DOI 10.1017/CBO9780511549717.004; Carlson S.J., 1990, P531; Chure D, 2010, NATURWISSENSCHAFTEN, V97, P379, DOI 10.1007/s00114-010-0650-6; Coria RA, 2001, AMEGHINIANA, V38, P463; Damuth J, 2011, BIOL REV, V86, P733, DOI 10.1111/j.1469-185X.2011.00176.x; Dodson P., 1990, P593; Erickson GM, 1996, J MORPHOL, V228, P189, DOI 10.1002/(SICI)1097-4687(199605)228:2<189::AID-JMOR7>3.0.CO;2-0; Erickson GM, 1996, P NATL ACAD SCI USA, V93, P14623, DOI 10.1073/pnas.93.25.14623; Erickson GM, 2012, SCIENCE, V338, P98, DOI 10.1126/science.1224495; Fiorillo A. R, 1991, 5 S MES TERR ECOS BI, P23; Fiorillo Anthony R., 1998, Historical Biology, V13, P1; FitzGerald CM, 1998, J HUM EVOL, V35, P371, DOI 10.1006/jhev.1998.0232; Gallina PA, 2011, ACTA PALAEONTOL POL, V56, P45, DOI 10.4202/app.2010.0011; Ganse Bergita, 2011, P105; Holland W. J., 1924, Memoirs of the Carnegie Museum, V9, P379; Hughes SW, 2006, PHYS TEACH, V40, P468; Martinez RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004397; Martinez RN, 2009, J VERTEBR PALEONTOL, V29, P142, DOI 10.1671/039.029.0102; Norman DB, 2004, DINOSAURIA, 2ND EDITION, P413; Ouyang H., 2002, 1 MAMENCHISAURID SKE, P111; Owen-Smith R.N., 1992, MEGAHERBIVORES INFLU; Paladino Frank V., 1997, P491; Rasband W., 2006, IMAGEJ; Richman JM, 2013, STEM CELLS IN CRANIOFACIAL DEVELOPMENT AND REGENERATION, P135; Rountrey A.N, 2009, LIFE HIST JUVENILE W; Scheyer TM, 2011, SWISS J GEOSCI, V104, pS147, DOI 10.1007/s00015-011-0076-y; Sereno PC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001230; Sereno PC, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P157; Sereno PC, 1999, SCIENCE, V286, P1342, DOI 10.1126/science.286.5443.1342; Smith TM, 2006, J ANAT, V208, P125, DOI 10.1111/j.1469-7580.2006.00500.x; SPOTILA JR, 1973, AM NAT, V107, P391, DOI 10.1086/282842; Stevens KA, 1999, SCIENCE, V284, P798, DOI 10.1126/science.284.5415.798; Stevens KA, 2005, LIFE O PAST, P212; Stromberg CAE, 2006, PALEOBIOLOGY, V32, P236, DOI 10.1666/0094-8373(2006)32[236:EOHIET]2.0.CO;2; Sues HD, 1998, TRENDS ECOL EVOL, V13, P141, DOI 10.1016/S0169-5347(97)01257-3; Teaford FT, 2000, DEV FUNCTION EVOLUTI; Ungar PS, 1996, J HUM EVOL, V31, P335, DOI 10.1006/jhev.1996.0065; Upchurch Paul, 2000, P79, DOI 10.1017/CBO9780511549717.005; Upchurch P, 2004, DINOSAURIA, 2ND EDITION, P259; White T. E., 1959, CONTRIBUTIONS MUSEUM, V13, P211; Whitlock JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018304; Whitlock JA, 2011, ZOOL J LINN SOC-LOND, V161, P872, DOI 10.1111/j.1096-3642.2010.00665.x; Wilson JA, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011115; Wilson JA, 2002, ZOOL J LINN SOC-LOND, V136, P217; Yates Adam M., 2004, Postilla, V230, P1; Young MT, 2012, NATURWISSENSCHAFTEN, V99, P637, DOI 10.1007/s00114-012-0944-y	50	59	60	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e69235	10.1371/journal.pone.0069235	http://dx.doi.org/10.1371/journal.pone.0069235			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23874921	Green Published, gold			2022-12-27	WOS:000322000600047
J	Egecioglu, E; Engel, JA; Jerlhag, E				Egecioglu, Emil; Engel, Jorgen A.; Jerlhag, Elisabet			The Glucagon-Like Peptide 1 Analogue, Exendin-4, Attenuates the Rewarding Properties of Psychostimulant Drugs in Mice	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS; GLP-1 RECEPTOR; FOOD-INTAKE; DOPAMINE; ADDICTION; BRAIN; RAT; SENSITIZATION; EXPRESSION; LOCOMOTION	Glucagon-like peptide 1 (GLP-1) is an incretine hormone that controls consummatory behavior and glucose homeostasis. It is released in response to nutrient ingestion from the intestine and production in the brain has also been identified. Given that GLP-1 receptors are expressed in reward areas, such as the nucleus accumbens and ventral tegmental area, and that common mechanisms regulate food and drug-induced reward we hypothesize that GLP-1 receptors are involved in reward regulation. Herein the effect of the GLP-1 receptor agonist Exendin-4 (Ex4), on amphetamine-and cocaine-induced activation of the mesolimbic dopamine system was investigated in mice. In a series of experiments we show that treatment with Ex4, at a dose with no effect per se, reduce amphetamine-as well as cocaine-induced locomotor stimulation, accumbal dopamine release as well as conditioned place preference in mice. Collectively these data propose a role for GLP-1 receptors in regulating drug reward. Moreover, the GLP-1 signaling system may be involved in the development of drug dependence since the rewarding effects of addictive drugs involves interferences with the mesolimbic dopamine system. Given that GLP-1 analogues, such as exenatide and liraglutide, are clinically available for treatment of type II diabetes, we propose that these should be elucidated as treatments of drug dependence.	[Egecioglu, Emil; Engel, Jorgen A.; Jerlhag, Elisabet] Univ Gothenburg, Inst Neurosci & Physiol, Dept Pharmacol, Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg	Engel, JA (corresponding author), Univ Gothenburg, Inst Neurosci & Physiol, Dept Pharmacol, Sahlgrenska Acad, Gothenburg, Sweden.	jorgen.engel@pharm.gu.se			Swedish Research Council [K2006-21X-04247-33-3, 2009-2782, K2010-80X-21496-01-6]; Swedish brain foundation, LUA/ALF [148251]; Sahlgrenska University Hospital; Alcohol research council of the Swedish alcohol retailing monopoly; foundations of Adlerbertska; Fredrik and Ingrid Thuring; Tore Nilsson; Langmanska; Torsten and Ragnar Soderberg; Wilhelm and Martina Lundgren; NovoNordisk; Knut and Alice Wallenberg; Magnus Bergvall; Aners; Jeansons; Ake Wiberg; Swedish Society of Medicine; Swedish Society for Medical Research	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish brain foundation, LUA/ALF; Sahlgrenska University Hospital; Alcohol research council of the Swedish alcohol retailing monopoly; foundations of Adlerbertska; Fredrik and Ingrid Thuring; Tore Nilsson; Langmanska; Torsten and Ragnar Soderberg; Wilhelm and Martina Lundgren; NovoNordisk(Novo Nordisk); Knut and Alice Wallenberg(Knut & Alice Wallenberg Foundation); Magnus Bergvall; Aners; Jeansons; Ake Wiberg; Swedish Society of Medicine; Swedish Society for Medical Research	The research was supported by grants from the Swedish Research Council (grant no. K2006-21X-04247-33-3, 2009-2782 and K2010-80X-21496-01-6), The Swedish brain foundation, LUA/ALF (grant no. 148251) from the Sahlgrenska University Hospital, Alcohol research council of the Swedish alcohol retailing monopoly and the foundations of Adlerbertska, Fredrik and Ingrid Thuring, Tore Nilsson, Langmanska, Torsten and Ragnar Soderberg, Wilhelm and Martina Lundgren, NovoNordisk, Knut and Alice Wallenberg, Magnus Bergvall, Aners, Jeansons, Ake Wiberg, the Swedish Society of Medicine, Swedish Society for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhadeff AL, 2012, ENDOCRINOLOGY, V153, P647, DOI 10.1210/en.2011-1443; Alvarez E, 1996, J NEUROCHEM, V66, P920; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Borgland SL, 2006, NEURON, V49, P589, DOI 10.1016/j.neuron.2006.01.016; Brubaker PL, 2003, CAN J PHYSIOL PHARM, V81, P1005, DOI 10.1139/Y03-107; Cagniard B, 2013, BEHAV BRAIN RES, V236, P289, DOI 10.1016/j.bbr.2012.08.021; Clifford PS, 2012, ADDICT BIOL, V17, P956, DOI 10.1111/j.1369-1600.2011.00339.x; Dickson SL, 2012, J NEUROSCI, V32, P4812, DOI 10.1523/JNEUROSCI.6326-11.2012; Dossat AM, 2011, J NEUROSCI, V31, P14453, DOI 10.1523/JNEUROSCI.3262-11.2011; Egecioglu E, 2013, PSYCHONEUROENDOCRINO, V38, P1259, DOI 10.1016/j.psyneuen.2012.11.009; Erreger K, 2012, PHYSIOL BEHAV, V106, P574, DOI 10.1016/j.physbeh.2012.03.014; Everitt BJ, 2002, J NEUROSCI, V22, P3312; Franklin K. B. J., 1996, MOUSE BRAIN STEREOTA; GOKE R, 1995, EUR J NEUROSCI, V7, P2294, DOI 10.1111/j.1460-9568.1995.tb00650.x; Graham DL, 2013, MOL PSYCHIATR, V18, P961, DOI 10.1038/mp.2012.141; GUTNIAK M, 1992, NEW ENGL J MED, V326, P1316, DOI 10.1056/NEJM199205143262003; Hayes MR, 2009, ENDOCRINOLOGY, V150, P2654, DOI 10.1210/en.2008-1479; Heusner CL, 2003, BRAIN RES, V980, P266, DOI 10.1016/S0006-8993(03)02986-X; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Holst JJ, 2009, MOL CELL ENDOCRINOL, V297, P127, DOI 10.1016/j.mce.2008.08.012; Jerlhag E, 2006, ADDICT BIOL, V11, P45, DOI 10.1111/j.1369-1600.2006.00002.x; Jerlhag E, 2011, DRUG ALCOHOL DEPEN, V117, P126, DOI 10.1016/j.drugalcdep.2011.01.010; Jerlhag E, 2010, PSYCHOPHARMACOLOGY, V211, P415, DOI 10.1007/s00213-010-1907-7; Jerlhag E, 2009, P NATL ACAD SCI USA, V106, P11318, DOI 10.1073/pnas.0812809106; Kanoski SE, 2012, NEUROPHARMACOLOGY, V62, P1916, DOI 10.1016/j.neuropharm.2011.12.022; Kastin AJ, 2003, INT J OBESITY, V27, P313, DOI 10.1038/sj.ijo.0802206; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Koob GF, 2001, NEUROPSYCHOPHARMACOL, V24, P97, DOI 10.1016/S0893-133X(00)00195-0; KREYMANN B, 1987, LANCET, V2, P1300; Larsson A, 2004, NEUROSCI BIOBEHAV R, V27, P713, DOI 10.1016/j.neubiorev.2003.11.010; MATSUYAMA T, 1988, DIABETES RES CLIN PR, V5, P281, DOI 10.1016/S0168-8227(88)80063-9; McMahon LR, 1998, AM J PHYSIOL-REG I, V274, pR23, DOI 10.1152/ajpregu.1998.274.1.R23; Merchenthaler I, 1999, J COMP NEUROL, V403, P261, DOI 10.1002/(SICI)1096-9861(19990111)403:2<261::AID-CNE8>3.0.CO;2-5; Morganstern Irene, 2011, Curr Drug Abuse Rev, V4, P163; NOVAK U, 1987, EUR J BIOCHEM, V164, P553, DOI 10.1111/j.1432-1033.1987.tb11162.x; Opland DM, 2010, BRAIN RES, V1350, P65, DOI 10.1016/j.brainres.2010.04.028; Owens WA, 2005, J NEUROCHEM, V94, P1402, DOI 10.1111/j.1471-4159.2005.03289.x; Rawson RA, 2007, ADDICTION, V102, P1, DOI 10.1111/j.1360-0443.2006.01781.x; Rinaman L, 2010, BRAIN RES, V1350, P18, DOI 10.1016/j.brainres.2010.03.059; Ruttimann EB, 2009, ENDOCRINOLOGY, V150, P1174, DOI 10.1210/en.2008-1221; Sandoval DA, 2008, DIABETES, V57, P2046, DOI 10.2337/db07-1824; Schirra J, 1997, P ASSOC AM PHYSICIAN, V109, P84; Srisurapanont M., 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003022; TangChristensen M, 1996, AM J PHYSIOL-REG I, V271, pR848, DOI 10.1152/ajpregu.1996.271.4.R848; Thompson D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011038; THORENS B, 1993, DIABETES, V42, P1678, DOI 10.2337/diabetes.42.11.1678; Tupala E, 2004, PROG NEURO-PSYCHOPH, V28, P1221, DOI 10.1016/j.pnpbp.2004.06.022; Turton MD, 1996, NATURE, V379, P69, DOI 10.1038/379069a0; Volkow ND, 2004, NAT REV NEUROSCI, V5, P963, DOI 10.1038/nrn1539; Wellman PJ, 2007, PHARMACOL BIOCHEM BE, V88, P89, DOI 10.1016/j.pbb.2007.07.008; Wellman PJ, 2005, REGUL PEPTIDES, V125, P151, DOI 10.1016/j.regpep.2004.08.013; WISE RA, 1989, ANNU REV PSYCHOL, V40, P191, DOI 10.1146/annurev.ps.40.020189.001203; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; WISE RA, 1987, PSYCHOL REV, V94, P469, DOI 10.1037/0033-295X.94.4.469	54	81	82	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e69010	10.1371/journal.pone.0069010	http://dx.doi.org/10.1371/journal.pone.0069010			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874851	Green Published, Green Submitted, gold			2022-12-27	WOS:000322064300082
J	Feruglio, SL; Troseid, M; Damas, JK; Kvale, D; Dyrhol-Riise, AM				Feruglio, Siri L.; Troseid, Marius; Damas, Jan Kristian; Kvale, Dag; Dyrhol-Riise, Anne Ma			Soluble Markers of the Toll-Like Receptor 4 Pathway Differentiate between Active and Latent Tuberculosis and Are Associated with Treatment Responses	PLOS ONE			English	Article							SERUM CONCENTRATIONS; HIV-INFECTION; LIPOPOLYSACCHARIDE; TB; DIAGNOSIS; LIPOARABINOMANNAN; ANTIGEN; ASSAY; CD14; BIOSYNTHESIS	Background: Biomarkers to differentiate between active tuberculosis (TB) and latent TB infection (LTBI) and to monitor treatment responses are requested to complement TB diagnostics and control, particularly in patients with multi-drug resistant TB. We have studied soluble markers of the Toll-like-receptor 4 (TLR-4) pathway in various stages of TB disease and during anti-TB treatment. Methods: Plasma samples from patients with culture confirmed drug-sensitive TB (n = 19) were collected before and after 2, 8 and 24 weeks of efficient anti-TB treatment and in a LTBI group (n = 6). Soluble (s) CD14 and myeloid differentiation-2 (MD-2) were analyzed by the Enzyme-linked immunosorbent assay (ELISA). Lipopolysaccharide (LPS) was analyzed by the Limulus Amebocyte Lysate colorimetric assay. Nonparametric statistics were applied. Results: Plasma levels of sCD14 (p<0.001), MD-2 (p = 0.036) and LPS (p = 0.069) were elevated at baseline in patients with untreated active TB compared to the LTBI group. MD-2 concentrations decreased after 2 weeks of treatment (p = 0.011), while LPS levels decreased after 8 weeks (p = 0.005). In contrast, sCD14 levels increased after 2 weeks (p = 0.047) with a subsequent modest decrease throughout the treatment period. There was no significant difference in concentrations of any of these markers between patients with pulmonary and extrapulmonary TB or between patients with or without symptoms. Conclusion: Our data suggest that plasma levels of LPS, MD-2 and sCD14 can discriminate between active TB and LTBI. A decline in LPS and MD-2 concentrations was associated with response to anti-TB treatment. The clinical potential of these soluble TLR-4 pathway proteins needs to be further explored.	[Feruglio, Siri L.; Kvale, Dag; Dyrhol-Riise, Anne Ma] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway; [Troseid, Marius; Kvale, Dag; Dyrhol-Riise, Anne Ma] Oslo Univ Hosp, Dept Infect Dis, Oslo, Norway; [Damas, Jan Kristian] St Olavs Hosp, Dept Infect Dis, Trondheim, Norway; [Damas, Jan Kristian] Norwegian Univ Sci & Technol, Inst Canc Res & Mol Med, N-7034 Trondheim, Norway; [Dyrhol-Riise, Anne Ma] Univ Bergen, Dept Clin Sci, Bergen, Norway	University of Oslo; University of Oslo; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Bergen	Dyrhol-Riise, AM (corresponding author), Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway.	a.m.d.riise@medisin.uio.no	St Olav Hospital, Medisinsk Klinikk -/AAD-6414-2022	Kvale, Dag/0000-0001-6410-2530	Oslo University Hospital; University of Oslo, Norway; University of Trondheim, Norway; University of Tromso, Norway; University of Bergen, Norway	Oslo University Hospital; University of Oslo, Norway; University of Trondheim, Norway; University of Tromso, Norway; University of Bergen, Norway	The work has been funded by the Oslo University Hospital and the Universities of Oslo, Bergen, Trondheim and Tromso, Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achkar JM, 2011, J INFECT DIS, V204, pS1130, DOI 10.1093/infdis/jir450; Anuradha R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002749; Bekker LG, 1998, J INFECT DIS, V178, P580, DOI 10.1086/517479; Brenchley JM, 2008, MUCOSAL IMMUNOL, V1, P23, DOI 10.1038/mi.2007.1; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Briken V, 2004, MOL MICROBIOL, V53, P391, DOI 10.1111/j.1365-2958.2004.04183.x; Chegou NN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038501; Chegou NN, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-10; Correia JD, 2002, J BIOL CHEM, V277, P1845, DOI 10.1074/jbc.M109910200; Court N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024631; Dyrhol-Riise AM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-57; Jackson M, 2009, J BIOL CHEM, V284, P1949, DOI 10.1074/jbc.R800047200; Juffermans NP, 1998, J INFECT DIS, V178, P1839, DOI 10.1086/314492; Kaur D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005447; Kirkland TN, 1998, PROG CLIN BIOL RES, V397, P79; Kleinnijenhuis J, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/405310; Kumar NP, 2013, CLIN VACCINE IMMUNOL, V20, P704, DOI 10.1128/CVI.00038-13; Lawn SD, 2000, CLIN EXP IMMUNOL, V120, P483, DOI 10.1046/j.1365-2249.2000.01246.x; Lawn SD, 2000, INT J TUBERC LUNG D, V4, P340; Lawn SD, 2013, LANCET INFECT DIS, V13, P349, DOI 10.1016/S1473-3099(13)70008-2; Lawn SD, 2012, LANCET INFECT DIS, V12, P201, DOI 10.1016/S1473-3099(11)70251-1; Meena LS, 2002, J CLIN LAB ANAL, V16, P151, DOI 10.1002/jcla.10031; Mendes V, 2012, NAT PROD REP, V29, P834, DOI 10.1039/c2np20014g; Mishra AK, 2011, FEMS MICROBIOL REV, V35, P1126, DOI 10.1111/j.1574-6976.2011.00276.x; Miyake K, 2006, J ENDOTOXIN RES, V12, P195, DOI 10.1179/096805106X118807; Nienhaus A, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-247; Ottenhoff THM, 2012, TUBERCULOSIS, V92, pS17, DOI 10.1016/S1472-9792(12)70007-0; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Parida SK, 2010, DRUG DISCOV TODAY, V15, P148, DOI 10.1016/j.drudis.2009.10.005; Phillips PPJ, 2010, LANCET INFECT DIS, V10, P69, DOI 10.1016/S1473-3099(09)70256-7; Pugin J, 2004, BLOOD, V104, P4071, DOI 10.1182/blood-2003-04-1290; Rangaka MX, 2012, LANCET INFECT DIS, V12, P45, DOI 10.1016/S1473-3099(11)70210-9; Redford PS, 2011, MUCOSAL IMMUNOL, V4, P261, DOI 10.1038/mi.2011.7; Sandanger O, 2009, J IMMUNOL, V182, P588, DOI 10.4049/jimmunol.182.1.588; Sandler NG, 2011, GASTROENTEROLOGY, V141, P1220, DOI 10.1053/j.gastro.2011.06.063; Steingart KR, 2007, PLOS MED, V4, P1041, DOI 10.1371/journal.pmed.0040202; Swaminathan S, 2012, FUTURE MICROBIOL, V7, P559, DOI [10.2217/FMB.12.34, 10.2217/fmb.12.34]; Troseid M, 2013, INNATE IMMUN-LONDON, V19, P290, DOI 10.1177/1753425912461042; Troseid M, 2010, AIDS, V24, P1733, DOI 10.1097/QAD.0b013e32833b254d; Wood R, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-47; World Health Organization, 2010, WHO GLOB TUB REP; World Health Organization (WHO), 2010, COMM SER TESTS DIAGN; ZIEGLERHEITBROCK HWL, 1993, IMMUNOL TODAY, V14, P121, DOI 10.1016/0167-5699(93)90212-4	44	18	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e69896	10.1371/journal.pone.0069896	http://dx.doi.org/10.1371/journal.pone.0069896			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23875007	Green Published, gold, Green Submitted			2022-12-27	WOS:000322064300123
J	Velazquez-Villegas, LA; Tovar, AR; Lopez-Barradas, AM; Torres, N				Velazquez-Villegas, Laura A.; Tovar, Armando R.; Lopez-Barradas, Adriana M.; Torres, Nimbe			The Dietary Protein/Carbohydrate Ratio Differentially Modifies Lipogenesis and Protein Synthesis in the Mammary Gland, Liver and Adipose Tissue during Gestation and Lactation	PLOS ONE			English	Article							LIPOPROTEIN-LIPASE ACTIVITY; GENE-EXPRESSION; LACTOGENIC HORMONES; MAMMALIAN TARGET; EPITHELIAL-CELLS; MILK SECRETION; PREGNANCY; RESTRICTION; IDENTIFICATION; PROLIFERATION	During gestation and lactation, a series of metabolic changes that are affected by the diet occurs in various organs of the mother. However, little is known about how the dietary protein (DP)/carbohydrate (DCH) ratio regulates the expression of metabolic genes in the mother. Therefore, the purpose of this work was to study the effect of consuming different percentages of DP/DCH, specifically 10/73, 20/63 and 30/53%, on the expression of genes involved in lipogenesis and protein synthesis in the mammary gland, liver and adipose tissue during gestation and lactation in dams. While the amount of weight gained during gestation was similar for all groups, only dams fed with 30/53% DP/DCH maintained their weight during lactation. In the mammary gland, the expression of the genes involved in lipogenesis, specifically SREBP1 and FAS, was dramatically increased, and the expression of the genes involved in protein synthesis, such as mTOR1, and the phosphorylation of its target protein, S6K, were also increased throughout pregnancy and lactation, regardless of the concentration of DP/DCH. In the liver and adipose tissue, the expression of the genes and proteins involved in lipid metabolism was dependent on the proportion of DP/DCH. The consumption of a low-protein/high-carbohydrate diet increased the expression of lipogenic genes in the liver and adipose tissue and the amount of lipid deposition in the liver. Conversely, the consumption of a high-protein/low-carbohydrate diet increased the expression of genes involved in amino acid oxidation in the liver during gestation. The metabolic adaptations reflected by the changes in the expression of metabolic genes indicate that the mammary gland has a priority for milk synthesis, whereas the adaptations in the liver and adipose tissue are responsible for providing nutrients to the mammary gland to sustain milk synthesis.	[Velazquez-Villegas, Laura A.; Tovar, Armando R.; Lopez-Barradas, Adriana M.; Torres, Nimbe] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Fisiol Nutr, Mexico City, DF, Mexico	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico	Torres, N (corresponding author), Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Fisiol Nutr, Mexico City, DF, Mexico.	nimbester@gmail.com	Torres, Nimbe/AAY-8821-2020; Torres, Nimbe/AAI-4340-2020	Torres, Nimbe/0000-0002-1741-0984; Velazquez-Villegas, Laura/0000-0002-5310-5637				Appuhamy JADRN, 2012, J NUTR, V142, P484, DOI 10.3945/jn.111.152595; Bachelot A, 2007, REPRODUCTION, V133, P361, DOI 10.1530/REP-06-0299; Baratta M, 2003, REGUL PEPTIDES, V113, P101, DOI 10.1016/S0167-0115(03)00006-5; Baratta M, 2000, J ENDOCRINOL, V167, P53, DOI 10.1677/joe.0.1670053; Bionaz M, 2011, BIOINFORM BIOL INSIG, V5, P83, DOI 10.4137/BBI.S7003; Bionaz M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-366; Brisken C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003178; Burgos SA, 2010, J DAIRY SCI, V93, P153, DOI 10.3168/jds.2009-2444; Cheng GJ, 2004, P NATL ACAD SCI USA, V101, P3739, DOI 10.1073/pnas.0307864100; DULBECCO R, 1983, P NATL ACAD SCI-BIOL, V80, P1033, DOI 10.1073/pnas.80.4.1033; FARID M, 1978, J NUTR, V108, P514, DOI 10.1093/jn/108.3.514; GEURSEN A, 1987, J NUTR, V117, P769, DOI 10.1093/jn/117.4.769; GRIGOR MR, 1987, J NUTR, V117, P1247, DOI 10.1093/jn/117.7.1247; HAMOSH M, 1970, BIOCHIM BIOPHYS ACTA, V210, P473, DOI 10.1016/0005-2760(70)90044-5; Hsieh CW, 2011, J LIPID RES, V52, P1352, DOI 10.1194/jlr.M012666; Jiang WQ, 2008, CANCER RES, V68, P5492, DOI 10.1158/0008-5472.CAN-07-6721; Kwon DH, 2012, J NUTR BIOCHEM, V23, P791, DOI 10.1016/j.jnutbio.2011.04.002; Lain KY, 2007, CLIN OBSTET GYNECOL, V50, P938, DOI 10.1097/GRF.0b013e31815a5494; Lemay DG, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-56; Ling C, 2003, J CLIN ENDOCR METAB, V88, P1804, DOI 10.1210/jc.2002-021137; Lopez A, 2006, AM J PHYSIOL-ENDOC M, V291, pE1059, DOI 10.1152/ajpendo.00062.2006; Martin-Hidalgo A, 2005, J LIPID RES, V46, P658, DOI 10.1194/jlr.M400370-JLR200; Masso-Welch PA, 2000, J MAMMARY GLAND BIOL, V5, P165, DOI 10.1023/A:1026491221687; McFadden JW, 2009, BIOCHEM BIOPH RES CO, V390, P388, DOI 10.1016/j.bbrc.2009.09.017; Morroni M, 2004, P NATL ACAD SCI USA, V101, P16801, DOI 10.1073/pnas.0407647101; Neville MC, 2002, J MAMMARY GLAND BIOL, V7, P49, DOI 10.1023/A:1015770423167; Ollier S, 2007, J NUTR, V137, P560, DOI 10.1093/jn/137.3.560; Rawson P, 2012, J PROTEOMICS, V75, P4429, DOI 10.1016/j.jprot.2012.04.019; Reeves PG, 1997, J NUTR, V127, pS838; Richert MM, 2000, J MAMMARY GLAND BIOL, V5, P227, DOI 10.1023/A:1026499523505; Rius AG, 2010, J DAIRY SCI, V93, P3114, DOI 10.3168/jds.2009-2743; ROH SG, 1994, INT J BIOCHEM, V26, P479, DOI 10.1016/0020-711X(94)90003-5; Rudolph MC, 2003, J MAMMARY GLAND BIOL, V8, P287, DOI 10.1023/B:JOMG.0000010030.73983.57; Rudolph MC, 2007, J MAMMARY GLAND BIOL, V12, P269, DOI 10.1007/s10911-007-9061-5; Rudolph MC, 2007, PHYSIOL GENOMICS, V28, P323, DOI 10.1152/physiolgenomics.00020.2006; Rudolph MC, 2010, AM J PHYSIOL-ENDOC M, V299, pE918, DOI 10.1152/ajpendo.00376.2010; Shu DP, 2012, OMICS, V16, P123, DOI 10.1089/omi.2011.0116; Smith JL, 1998, J LIPID RES, V39, P2237; Toerien CA, 2010, J NUTR, V140, P285, DOI 10.3945/jn.109.114033; Vernon RG, 2005, J DAIRY RES, V72, P460, DOI 10.1017/S0022029905001299; Vernon RG, 1997, J MAMMARY GLAND BIOL, V2, P231, DOI 10.1023/A:1026380220364; WEINSTEIN I, 1986, BIOCHEM J, V237, P593, DOI 10.1042/bj2370593	42	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e69338	10.1371/journal.pone.0069338	http://dx.doi.org/10.1371/journal.pone.0069338			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874950	Green Published, gold, Green Submitted			2022-12-27	WOS:000322064300099
J	Di Luccia, B; Manzo, N; Baccigalupi, L; Calabro, V; Crescenzi, E; Ricca, E; Pollice, A				Di Luccia, Blanda; Manzo, Nicola; Baccigalupi, Loredana; Calabro, Viola; Crescenzi, Elvira; Ricca, Ezio; Pollice, Alessandra			Lactobacillus gasseri SF1183 Affects Intestinal Epithelial Cell Survival and Growth	PLOS ONE			English	Article							HUMAN GUT MICROBIOTA; INDUCED APOPTOSIS; COLON; BIFIDOBACTERIUM; RHAMNOSUS; DIVERSITY; CLEAVAGE; BACTERIA; IMPACT; CASEI	It is now commonly accepted that the intestinal microbiota plays a crucial role in the gut physiology and homeostasis, and that both qualitative and quantitative alterations in the compositions of the gut flora exert profound effects on the host's intestinal cells. In spite of this, the details of the interaction between commensal bacteria and intestinal cells are still largely unknown and only in few cases the molecular mechanisms have been elucidated. Here we analyze the effects of molecules produced and secreted by Lactobacillus gasseri SF1183 on human intestinal HCT116 cells. L. gasseri is a well known species of lactic acid bacteria, commonly associated to the human intestine and SF1183 is a human strain previously isolated from an ileal biopsy of an healthy volunteer. SF1183 produces and secretes, in a growth phase-dependent way, molecule(s) able to drastically interfere with HCT116 cell proliferation. Although several attempts to purify and identify the bioactive molecule(s) have been so far unsuccessful, a partial characterization has indicated that it is smaller than 3 kDa, thermostable and of proteinaceous nature. L. gasseri molecule(s) stimulate a G1-phase arrest of the cell cycle by up-regulation of p21WAF1 rendering cells protected from intrinsic and extrinsic apoptosis. A L. gasseri-mediated reduction of apoptosis and of cell proliferation could be relevant in protecting epithelial barrier integrity and helping in reconstituting tissutal homeostasis.	[Di Luccia, Blanda; Manzo, Nicola; Baccigalupi, Loredana; Calabro, Viola; Ricca, Ezio; Pollice, Alessandra] Univ Naples Federico II, Dept Biol, MSA, Naples, Italy; [Crescenzi, Elvira] CNR, Ist Endocrinol & Oncol Sperimentale, I-80125 Naples, Italy	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR)	Pollice, A (corresponding author), Univ Naples Federico II, Dept Biol, MSA, Via Cinthia, Naples, Italy.	apollice@unina.it	Ricca, Ezio/AAG-2998-2020; Calabro, Viola/H-6156-2013	Ricca, Ezio/0000-0002-7355-0332; CRESCENZI, ELVIRA/0000-0002-9258-8053; Calabro, Viola/0000-0002-6508-8889; Baccigalupi, Loredana/0000-0003-3070-161X	University of Naples; Istituto San Paolo	University of Naples; Istituto San Paolo	This work was supported by the FARO project (terza tornata) of the University of Naples and Istituto San Paolo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biagi E, 2011, AGEING RES REV, V10, P428, DOI 10.1016/j.arr.2011.03.004; Biffi A, 1997, NUTR CANCER, V28, P93, DOI 10.1080/01635589709514558; Bloom J, 2003, CELL, V115, P71, DOI 10.1016/S0092-8674(03)00755-4; Candela M, 2011, CRIT REV MICROBIOL, V37, P1, DOI 10.3109/1040841X.2010.501760; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; D'Amours D, 2001, J CELL SCI, V114, P3771; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Di Luccia B, 2013, PHYTOTHER RES, V27, P1819, DOI 10.1002/ptr.4939; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fakhry S, 2009, RES MICROBIOL, V160, P817, DOI 10.1016/j.resmic.2009.09.009; FICHERA GA, 1994, CANCER LETT, V85, P93, DOI 10.1016/0304-3835(94)90244-5; Fujiya M, 2007, CELL HOST MICROBE, V1, P299, DOI 10.1016/j.chom.2007.05.004; GILLILAND SE, 1985, APPL ENVIRON MICROB, V49, P377, DOI 10.1128/AEM.49.2.377-381.1985; Guarner F, 2006, NAT CLIN PRACT GASTR, V3, P275, DOI 10.1038/ncpgasthep0471; Isolauri E, 2004, BEST PRACT RES CL GA, V18, P299, DOI 10.1016/j.bpg.2003.10.006; Iyer C, 2008, CELL MICROBIOL, V10, P1442, DOI 10.1111/j.1462-5822.2008.01137.x; Kato I, 1998, LIFE SCI, V63, P635, DOI 10.1016/S0024-3205(98)00315-4; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Kim JY, 2002, BIOTECHNOL LETT, V24, P1431, DOI 10.1023/A:1019875204323; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Lim BK, 2002, JPN J CANCER RES, V93, P36, DOI 10.1111/j.1349-7006.2002.tb01198.x; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Mahowald MA, 2009, P NATL ACAD SCI USA, V106, P5859, DOI 10.1073/pnas.0901529106; Mahyar-Roemer M, 2001, ONCOGENE, V20, P3387, DOI 10.1038/sj.onc.1204440; Matsumoto M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023652; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Merritt J, 2003, INFECT IMMUN, V71, P1972, DOI 10.1128/IAI.71.4.1972-1979.2003; O'Mahony L, 2005, GASTROENTEROLOGY, V128, P541, DOI 10.1053/j.gastro.2004.11.050; Orlando A, 2012, NUTR CANCER, V64, P1103, DOI 10.1080/01635581.2012.717676; Perdigon G, 2001, Curr Issues Intest Microbiol, V2, P27; Pollice A, 2008, FEBS LETT, V582, P3257, DOI 10.1016/j.febslet.2008.09.026; Rafter J, 2003, BEST PRACT RES CL GA, V17, P849, DOI 10.1016/S1521-6918(03)00056-8; REDDY BS, 1993, CANCER RES, V53, P3914; Salminen S, 1998, BRIT J NUTR, V80, pS147, DOI 10.1079/BJN19980108; Sheil B, 2004, GUT, V53, P694, DOI 10.1136/gut.2003.027789; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Sperandio V, 2002, MOL MICROBIOL, V43, P809, DOI 10.1046/j.1365-2958.2002.02803.x; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vivo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053631; Vivo M, 2009, CELL CYCLE, V8, P3545, DOI 10.4161/cc.8.21.9954; Weinberg WC, 2002, CRIT REV ORAL BIOL M, V13, P453, DOI 10.1177/154411130201300603; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Yan F, 2001, CANCER RES, V61, P8668; Yan F, 2002, J BIOL CHEM, V277, P50959, DOI 10.1074/jbc.M207050200; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106; Zwacka RM, 2000, J GENE MED, V2, P334, DOI 10.1002/1521-2254(200009/10)2:5<334::AID-JGM129>3.0.CO;2-Q	50	13	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69102	10.1371/journal.pone.0069102	http://dx.doi.org/10.1371/journal.pone.0069102			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894414	Green Published, Green Submitted, gold			2022-12-27	WOS:000325211000077
J	Stevens, NE; Fraser, CK; Alsharifi, M; Brown, MP; Diener, KR; Hayball, JD				Stevens, Natalie E.; Fraser, Cara K.; Alsharifi, Mohammed; Brown, Michael P.; Diener, Kerrilyn R.; Hayball, John D.			An Empirical Approach towards the Efficient and Optimal Production of Influenza-Neutralizing Ovine Polyclonal Antibodies Demonstrates That the Novel Adjuvant CoVaccine HT (TM) Is Functionally Superior to Freund's Adjuvant	PLOS ONE			English	Article							IMMUNE-RESPONSE; VACCINE ADJUVANTS; DENDRITIC CELLS; IMMUNIZATION; PROTECTION; VIRUS; ROUTE; IMMUNOGENICITY; ADENOVIRUS; CHALLENGE	Passive immunotherapies utilising polyclonal antibodies could have a valuable role in preventing and treating infectious diseases such as influenza, particularly in pandemic situations but also in immunocompromised populations such as the elderly, the chronically immunosuppressed, pregnant women, infants and those with chronic diseases. The aim of this study was to optimise current methods used to generate ovine polyclonal antibodies. Polyclonal antibodies to baculovirus-expressed recombinant influenza haemagglutinin from A/Puerto Rico/8/1934 H1N1 (PR8) were elicited in sheep using various immunisation regimens designed to investigate the priming immunisation route, adjuvant formulation, sheep age, and antigen dose, and to empirically ascertain which combination maximised antibody output. The novel adjuvant CoVaccine HT (TM) was compared to Freund's adjuvant which is currently the adjuvant of choice for commercial production of ovine polyclonal Fab therapies. CoVaccine HT (TM) induced significantly higher titres of functional ovine anti-haemagglutinin IgG than Freund's adjuvant but with fewer side effects, including reduced site reactions. Polyclonal hyperimmune sheep sera effectively neutralised influenza virus in vitro and, when given before or after influenza virus challenge, prevented the death of infected mice. Neither the age of the sheep nor the route of antigen administration appeared to influence antibody titre. Moreover, reducing the administrated dose of haemagglutinin antigen minimally affected antibody titre. Together, these results suggest a cost effective way of producing high and sustained yields of functional ovine polyclonal antibodies specifically for the prevention and treatment of globally significant diseases.	[Stevens, Natalie E.; Brown, Michael P.; Diener, Kerrilyn R.; Hayball, John D.] Hanson Inst, Expt Therapeut Lab, Adelaide, SA, Australia; [Stevens, Natalie E.; Fraser, Cara K.; Brown, Michael P.; Diener, Kerrilyn R.; Hayball, John D.] Univ S Australia, Sansom Inst, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia; [Fraser, Cara K.] South Australian Hlth & Med Res Inst, Preclin Imaging & Res Labs, Gilles Plains, SA, Australia; [Alsharifi, Mohammed] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia; [Brown, Michael P.] Royal Adelaide Hosp, Canc Clin Trials Unit, Adelaide, SA 5000, Australia; [Brown, Michael P.; Hayball, John D.] Univ Adelaide, Sch Med, Adelaide, SA, Australia; [Diener, Kerrilyn R.] Univ Adelaide, Sch Paediat & Reprod Hlth, Adelaide, SA, Australia	Hanson Institute; University of South Australia; University of Adelaide; Royal Adelaide Hospital; University of Adelaide; University of Adelaide	Diener, KR (corresponding author), Hanson Inst, Expt Therapeut Lab, Adelaide, SA, Australia.	kerrilyn.diener@adelaide.edu.au; john.hayball@unisa.edu.au	Hayball, John D/F-4137-2013; Stevens, Natalie/R-3831-2016; Brown, Michael/C-2081-2014	Hayball, John D/0000-0002-3089-4506; Stevens, Natalie/0000-0002-7637-8013; Brown, Michael/0000-0002-5796-1932; Diener, Kerrilyn/0000-0001-8417-5542	'Researchers-in-Business' scheme (Enterprise Connect, Aust Fed Gov); University of South Australia (Div Health Sciences)	'Researchers-in-Business' scheme (Enterprise Connect, Aust Fed Gov); University of South Australia (Div Health Sciences)	This project was supported in part by funding from the 'Researchers-in-Business' scheme (Enterprise Connect, Aust Fed Gov) (to JDH and BTG Australasia Pty Ltd) and the University of South Australia (Div Health Sciences) (to JDH). We also acknowledge the substantive technical, research administrative and material support of BTG Australasia Pty Ltd (Rosedale, South Australia). Accordingly BTG Australasia Pty Ltd (Rosedale, South Australia) had some role in study design and data collection but no role in the analysis, decision to publish, or preparation of the manuscript.	Aucouturier J, 2001, VACCINE, V19, P2666, DOI 10.1016/S0264-410X(00)00498-9; Barnhill AE, 2012, ANTIMICROB AGENTS CH; Berry JD, 2011, NEW BIOTECHNOL, V28, P489, DOI 10.1016/j.nbt.2011.03.018; Blom AG, 2004, VACCINE, V23, P743, DOI 10.1016/j.vaccine.2004.07.021; Bodewes R, 2010, J VIROL, V84, P7943, DOI 10.1128/JVI.00549-10; Bodewes R, 2009, VACCINE, V27, P6833, DOI 10.1016/j.vaccine.2009.09.015; Buckwalter MR, 2009, CURR BIOL, V19, pR355, DOI 10.1016/j.cub.2009.03.012; Chang JCC, 1998, ADV DRUG DELIVER REV, V32, P173, DOI 10.1016/S0169-409X(98)00009-X; Chang YT, 2012, VACCINE, V30, P5009, DOI 10.1016/j.vaccine.2012.05.016; Chhatre S, 2008, BIOTECHNOL APPL BIOC, V51, P79, DOI 10.1042/BA20070228; Committee AWA, 2012, GUID HARV BLOOD LIV; Cooper HM, 2009, CURR PROTOC NEUROSCI; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; Cox JC, 1997, VACCINE, V15, P248, DOI 10.1016/S0264-410X(96)00183-1; Cresswell C, 2005, BIOTECHNOL APPL BIOC, V42, P163, DOI 10.1042/BA20050020; de Cassan SC, 2011, J IMMUNOL, V187, P2602, DOI 10.4049/jimmunol.1101004; Dormitzer PR, 2011, IMMUNOL REV, V239, P167, DOI 10.1111/j.1600-065X.2010.00974.x; Draper SJ, 2010, J IMMUNOL, V185, P7583, DOI 10.4049/jimmunol.1001760; Fraser CK, 2007, EXPERT REV VACCINES, V6, P559, DOI 10.1586/14760584.6.4.559; Fry A, 2011, ASSAY METHOD CONDU S; Grant LM, 2012, CURR OPIN GASTROEN, V28, P198, DOI 10.1097/MOG.0b013e3283528b5d; Guan J, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-506; Hamid MMA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020547; Hinkula J, 2009, VACCINE, V27, P6424, DOI 10.1016/j.vaccine.2009.06.016; Hong DK, 2011, PEDIATR INFECT DIS J, V30, P67, DOI 10.1097/INF.0b013e3181f127be; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Klechevsky E, 2008, IMMUNITY, V29, P497, DOI 10.1016/j.immuni.2008.07.013; Kourti A, 2012, INT J ANTIMICROB AG, V40, P72, DOI 10.1016/j.ijantimicag.2012.03.021; Leenaars M, 2005, ILAR J, V46, P269, DOI 10.1093/ilar.46.3.269; Luytjes W, 2012, VACCINE, V30, P5262, DOI 10.1016/j.vaccine.2012.05.060; Lynch MJ, 2010, J MED TOXICOL, V7, P44; Martin-Gomez S, 2006, PARASITOL RES, V98, P119, DOI 10.1007/s00436-005-0031-9; McElhaney JE, 2012, VACCINE, V30, P2060, DOI 10.1016/j.vaccine.2012.01.015; McMillin GA, 2002, CLIN CHEM, V48, P1580; Mine Y, 2007, BBA-PROTEINS PROTEOM, V1774, P200, DOI 10.1016/j.bbapap.2006.12.003; Nakagawa Y, 2011, ENDOSCOPY, V43, pE261, DOI 10.1055/s-0030-1256524; Newcombe AR, 2005, J CHROMATOGR B, V814, P209, DOI 10.1016/j.jchromb.2004.10.027; Newcombe C, 2007, J CHROMATOGR B, V848, P2, DOI 10.1016/j.jchromb.2006.07.004; Ng WC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013622; O'Donnell CD, 2012, MBIO, V3, DOI 10.1128/mBio.00120-12; Ochsenbein AF, 2000, IMMUNOL TODAY, V21, P624, DOI 10.1016/S0167-5699(00)01754-0; OGONUKI H, 1967, B WORLD HEALTH ORGAN, V37, P729; Papenburg J, 2011, CLIN VACCINE IMMUNOL, V18, P520, DOI 10.1128/CVI.00449-10; Patria MF, 2012, EXPERT REV VACCINES, V11, P461, DOI [10.1586/erv.12.2, 10.1586/ERV.12.2]; Redwan ERM, 2009, COMP IMMUNOL MICROB, V32, P9, DOI 10.1016/j.cimid.2007.11.004; Santiago FW, 2011, VACCINE, V29, P8888, DOI 10.1016/j.vaccine.2011.09.069; SCIBIENS.RJ, 1973, J IMMUNOL, V111, P114; Singh M, 2003, CURR HIV RES, V1, P309, DOI 10.2174/1570162033485195; SJOSTROM L, 1994, TOXICON, V32, P427, DOI 10.1016/0041-0101(94)90294-1; Suda T, 2011, ANTIVIR RES, V91, P252, DOI 10.1016/j.antiviral.2011.06.008; THATTE J, 1995, INFECT IMMUN, V63, P99, DOI 10.1128/IAI.63.1.99-103.1995; Turkstra JA, 2011, VACCINE, V29, P3791, DOI 10.1016/j.vaccine.2011.03.023; Ueno H, 2010, IMMUNOL CELL BIOL, V88, P376, DOI 10.1038/icb.2010.28; van Ierssel SH, 2012, ACTA CLIN BELG, V67, P1, DOI 10.2143/ACB.67.1.2062618; VIDARD L, 1992, J IMMUNOL, V149, P1905; Wang TT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000796; Wu JT, 2011, INFLUENZA OTHER RESP, V5, P226; Ye JQ, 2012, IMMUNOTHERAPY-UK, V4, P175, DOI [10.2217/IMT.11.167, 10.2217/imt.11.167]; Zinkernagel RM, 1997, IMMUNOL REV, V156, P199, DOI 10.1111/j.1600-065X.1997.tb00969.x	59	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e68895	10.1371/journal.pone.0068895	http://dx.doi.org/10.1371/journal.pone.0068895			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894371	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000325211000056
J	Baquiran, JP; Thater, B; Sedky, S; De Ley, P; Crowley, D; Orwin, PM				Baquiran, Jean-Paul; Thater, Brian; Sedky, Sammy; De Ley, Paul; Crowley, David; Orwin, Paul M.			Culture-Independent Investigation of the Microbiome Associated with the Nematode Acrobeloides maximus	PLOS ONE			English	Article							PHOTORHABDUS-LUMINESCENS; OLIGONUCLEOTIDE PROBES; BACTERIA; HETERORHABDITIS; DIVERSITY; PATHOGENS; COMMUNITY; SEQUENCE	Background: Symbioses between metazoans and microbes are widespread and vital to many ecosystems. Recent work with several nematode species has suggested that strong associations with microbial symbionts may also be common among members of this phylu. In this work we explore possible symbiosis between bacteria and the free living soil bacteriovorous nematode Acrobeloides maximus. Methodology: We used a soil microcosm approach to expose A. maximus populations grown monoxenically on RFP labeled Escherichia coli in a soil slurry. Worms were recovered by density gradient separation and examined using both culture-independent and isolation methods. A 16S rRNA gene survey of the worm-associated bacteria was compared to the soil and to a similar analysis using Caenorhabditis elegans N2. Recovered A. maximus populations were maintained on cholesterol agar and sampled to examine the population dynamics of the microbiome. Results: A consistent core microbiome was extracted from A. maximus that differed from those in the bulk soil or the C. elegans associated set. Three genera, Ochrobactrum, Pedobacter, and Chitinophaga, were identified at high levels only in the A. maximus populations, which were less diverse than the assemblage associated with C. elegans. Putative symbiont populations were maintained for at least 4 months post inoculation, although the levels decreased as the culture aged. Fluorescence in situ hybridization (FISH) using probes specific for Ochrobactrum and Pedobacter stained bacterial cells in formaldehyde fixed nematode guts. Conclusions: Three microorganisms were repeatedly observed in association with Acrobeloides maximus when recovered from soil microcosms. We isolated several Ochrobactrum sp. and Pedobacter sp., and demonstrated that they inhabit the nematode gut by FISH. Although their role in A. maximus is not resolved, we propose possible mutualistic roles for these bacteria in protection of the host against pathogens and facilitating enzymatic digestion of other ingested bacteria.	[Baquiran, Jean-Paul; Thater, Brian; Crowley, David] Univ Calif Riverside, Dept Environm Sci, Riverside, CA 92521 USA; [Sedky, Sammy; De Ley, Paul] Univ Calif Riverside, Dept Nematol, Riverside, CA 92521 USA; [Orwin, Paul M.] Calif State Univ San Bernardino, Dept Biol, San Bernardino, CA 92407 USA	University of California System; University of California Riverside; University of California System; University of California Riverside; California State University System; California State University San Bernardino	Orwin, PM (corresponding author), Calif State Univ San Bernardino, Dept Biol, San Bernardino, CA 92407 USA.	porwin@csusb.edu	Crowley, David/C-1216-2014	Crowley, David/0000-0002-1805-8599	United States Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA) [2009-65106-05644]	United States Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA)(United States Department of Agriculture (USDA))	This work was funded by United States Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA) grant 2009-65106-05644. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013154; An RS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-433; Babic I, 2000, MICROBIOL-UK, V146, P709, DOI 10.1099/00221287-146-3-709; Burnell AM, 2000, NEMATOLOGY, V2, P31, DOI 10.1163/156854100508872; Clarke DJ, 2008, CELL MICROBIOL, V10, P2159, DOI 10.1111/j.1462-5822.2008.01209.x; Demaneche S, 2008, P NATL ACAD SCI USA, V105, P3957, DOI 10.1073/pnas.0800072105; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Duchaud E, 2003, NAT BIOTECHNOL, V21, P1307, DOI 10.1038/nbt886; Dunbar J, 1999, APPL ENVIRON MICROB, V65, P1662; Entchev EV, 2005, SEMIN CELL DEV BIOL, V16, P175, DOI 10.1016/j.semcdb.2005.01.004; Friedrich U, 2003, ENVIRON MICROBIOL, V5, P183, DOI 10.1046/j.1462-2920.2003.00397.x; Hall-Stoodley L, 2005, TRENDS MICROBIOL, V13, P7, DOI 10.1016/j.tim.2004.11.004; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hilbi H, 2007, ENVIRON MICROBIOL, V9, P563, DOI 10.1111/j.1462-2920.2007.01238.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Landmann F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002351; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Lauer A, 2008, ISME J, V2, P145, DOI 10.1038/ismej.2007.110; Loy A, 2007, NUCLEIC ACIDS RES, V35, pD800, DOI 10.1093/nar/gkl856; McFall-Ngai M, 2008, NAT REV MICROBIOL, V6, P789, DOI 10.1038/nrmicro1982; Nour SM, 2003, APPL ENVIRON MICROB, V69, P607, DOI 10.1128/AEM.69.1.607-615.2003; Ruby EG, 2008, NAT REV MICROBIOL, V6, P752, DOI 10.1038/nrmicro1958; Schloter M, 2000, FEMS MICROBIOL REV, V24, P647, DOI 10.1111/j.1574-6976.2000.tb00564.x; Tian XL, 2011, CURR MICROBIOL, V62, P117, DOI 10.1007/s00284-010-9681-7; Troemel ER, 2008, PLOS BIOL, V6, P2736, DOI 10.1371/journal.pbio.0060309; van Bezooijen J., 2006, METHODS TECHNIQUES N; Vancoppenolle B, 1999, NEMATOLOGY, V1, P15, DOI 10.1163/156854199507938; Vandekerckhove TTM, 2002, APPL ENVIRON MICROB, V68, P3121, DOI 10.1128/AEM.68.6.3121-3125.2002	29	39	40	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e67425	10.1371/journal.pone.0067425	http://dx.doi.org/10.1371/journal.pone.0067425			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894287	Green Published, Green Submitted, gold			2022-12-27	WOS:000322132100010
J	Bichsel, KJ; Gogia, N; Malouff, T; Pena, Z; Forney, E; Hammiller, B; Watson, P; Hansen, LA				Bichsel, Kyle J.; Gogia, Navdeep; Malouff, Timothy; Pena, Zachary; Forney, Eric; Hammiller, Brianna; Watson, Patrice; Hansen, Laura A.			Role for the Epidermal Growth Factor Receptor in Chemotherapy-Induced Alopecia	PLOS ONE			English	Article							CELL LUNG-CANCER; PHASE-III TRIAL; METASTATIC COLORECTAL-CANCER; INDUCED HAIR LOSS; TRANSGENIC MICE; BREAST-CANCER; EGF RECEPTOR; P53; FOLLICLE; GEFITINIB	Treatment of cancer patients with chemotherapeutics like cyclophosphamide often causes alopecia as a result of premature and aberrant catagen. Because the epidermal growth factor receptor (EGFR) signals anagen hair follicles to enter catagen, we hypothesized that EGFR signaling may be involved in cyclophosphamide-induced alopecia. To test this hypothesis, skin-targeted Egfr mutant mice were generated by crossing floxed Egfr and Keratin 14 promoter-driven Cre recombinase mice. Cyclophosphamide treatment of control mice resulted in alopecia while Egfr mutant skin was resistant to cyclophosphamide-induced alopecia. Egfr mutant skin entered catagen normally, as indicated by dermal papilla condensation and decreased follicular proliferation, but did not progress to telogen as did Egfr wild type follicles. Egfr mutant follicles responded with less proliferation, apoptosis, and fewer p53-positive cells after cyclophosphamide. Treatment of control mice with the EGFR inhibitors erlotinib or gefitinib similarly suppressed alopecia and catagen progression by cyclophosphamide. Secondary analysis of clinical trials utilizing EGFR-targeted therapies and alopecia-inducing chemotherapy also revealed evidence for involvement of EGFR in chemotherapy-induced alopecia. Taken together, our results demonstrated the involvement of EGFR signaling in chemotherapy-induced alopecia, which will help in the design of novel therapeutic regimens to minimize chemotherapy-induced alopecia.	[Bichsel, Kyle J.; Gogia, Navdeep; Malouff, Timothy; Pena, Zachary; Forney, Eric; Hammiller, Brianna; Hansen, Laura A.] Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA; [Watson, Patrice] Creighton Univ, Sch Med, Dept Preventat Med & Publ Hlth, Omaha, NE USA	Creighton University; Creighton University	Hansen, LA (corresponding author), Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA.	LHansen@creighton.edu			National Institutes of Health [1 R01 ES015585]; State of Nebraska LB595; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015585] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Nebraska LB595; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Dr. Hansen's research is funded by the National Institutes of Health (1 R01 ES015585) and the State of Nebraska LB595 (no number). Mr. Gogia received an Alpha Omega Alpha student research fellowship (no number). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERS CJ, 1961, BMJ-BRIT MED J, V2, P1516, DOI 10.1136/bmj.2.5266.1516; Bitomsky N, 2009, FEBS J, V276, P6074, DOI 10.1111/j.1742-4658.2009.07331.x; Bodo E, 2007, AM J PATHOL, V171, P1153, DOI 10.2353/ajpath.2007.061164; Botchkarev VA, 2000, CANCER RES, V60, P5002; Botchkarev VA, 2003, J INVEST DERM SYMP P, V8, P72, DOI 10.1046/j.1523-1747.2003.12175.x; Botchkarev VA, 1999, FASEB J, V13, P395, DOI 10.1096/fasebj.13.2.395; Frohna P, 2006, J CLIN PHARMACOL, V46, P282, DOI 10.1177/0091270005284193; Graves JE, 2006, J AM ACAD DERMATOL, V55, P349, DOI 10.1016/j.jaad.2005.12.016; Guarneri V, 2008, BREAST CANCER RES TR, V110, P127, DOI 10.1007/s10549-007-9688-3; HANDJISKI BK, 1994, BRIT J DERMATOL, V131, P303, DOI 10.1111/j.1365-2133.1994.tb08515.x; Hansen LA, 1996, INT CONGR SER, V1111, P425; Hansen LA, 1997, AM J PATHOL, V150, P1959; Hecht JR, 2009, J CLIN ONCOL, V27, P672, DOI 10.1200/JCO.2008.19.8135; Hendrix S, 2005, J INVEST DERMATOL, V125, P42, DOI 10.1111/j.0022-202X.2005.23787.x; Herbst RS, 2004, J CLIN ONCOL, V22, P785, DOI 10.1200/JCO.2004.07.215; Herbst RS, 2005, J CLIN ONCOL, V23, P5892, DOI 10.1200/JCO.2005.02.840; HUSSEIN AM, 1993, SOUTH MED J, V86, P489, DOI 10.1097/00007611-199305000-00001; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Komarova EA, 1997, EMBO J, V16, P1391, DOI 10.1093/emboj/16.6.1391; Kwon YW, 2002, J BIOL CHEM, V277, P1837, DOI 10.1074/jbc.M105033200; Lacouture ME, 2006, NAT REV CANCER, V6, P803, DOI 10.1038/nrc1970; Lee TC, 2009, GENESIS, V47, P85, DOI 10.1002/dvg.20464; Lu JF, 2006, CLIN PHARMACOL THER, V80, P136, DOI 10.1016/j.clpt.2006.04.007; Macquart-Moulin G, 1997, BRIT J CANCER, V76, P1640, DOI 10.1038/bjc.1997.610; Maklad A, 2009, J INVEST DERMATOL, V129, P690, DOI 10.1038/jid.2008.281; Messersmith WA, 2007, CLIN CANCER RES, V13, P4664, DOI 10.1158/1078-0432.CCR-07-0065; Mill P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000748; MILNE DM, 1994, J BIOL CHEM, V269, P9253; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; MURILLAS R, 1995, EMBO J, V14, P5216, DOI 10.1002/j.1460-2075.1995.tb00206.x; Okines AFC, 2010, J CLIN ONCOL, V28, P3945, DOI 10.1200/JCO.2010.29.2847; PAUS R, 1994, AM J PATHOL, V144, P719; Pirker R, 2009, LANCET, V373, P1525, DOI 10.1016/S0140-6736(09)60569-9; Rodust PM, 2009, BRIT J DERMATOL, V161, P107, DOI 10.1111/j.1365-2133.2009.09458.x; Schneider MR, 2008, AM J PATHOL, V173, P14, DOI 10.2353/ajpath.2008.070942; Seo MR, 2007, J BIOL CHEM, V282, P24720, DOI 10.1074/jbc.M702343200; Sharov AA, 2004, CANCER RES, V64, P6266, DOI 10.1158/0008-5472.CAN-04-1367; Shimada K, 2003, CARCINOGENESIS, V24, P1067, DOI 10.1093/carcin/bgg058; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Swaisland HC, 2005, CLIN PHARMACOKINET, V44, P1165, DOI 10.2165/00003088-200544110-00004; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Vermorken JB, 2008, NEW ENGL J MED, V359, P1116, DOI 10.1056/NEJMoa0802656	46	10	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e69368	10.1371/journal.pone.0069368	http://dx.doi.org/10.1371/journal.pone.0069368			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894460	Green Published, gold, Green Submitted			2022-12-27	WOS:000322391400054
J	Kim, DJ; Yogendrakumar, V; Chiang, J; Ty, E; Wang, ZJ; McKeown, MJ				Kim, Diana J.; Yogendrakumar, Vignan; Chiang, Joyce; Ty, Edna; Wang, Z. Jane; McKeown, Martin J.			Noisy Galvanic Vestibular Stimulation Modulates the Amplitude of EEG Synchrony Patterns	PLOS ONE			English	Article							NONINVASIVE BRAIN-STIMULATION; EXTERNAL GLOBUS-PALLIDUS; SUBTHALAMIC NUCLEUS; BETA-OSCILLATIONS; BASAL GANGLIA; PHASE SYNCHRONIZATION; STOCHASTIC RESONANCE; PARKINSONS-DISEASE; FUNCTIONAL MRI; EYE-MOVEMENTS	Noisy galvanic vestibular stimulation has been associated with numerous cognitive and behavioural effects, such as enhancement of visual memory in healthy individuals, improvement of visual deficits in stroke patients, as well as possibly improvement of motor function in Parkinson's disease; yet, the mechanism of action is unclear. Since Parkinson's and other neuropsychiatric diseases are characterized by maladaptive dynamics of brain rhythms, we investigated whether noisy galvanic vestibular stimulation was associated with measurable changes in EEG oscillatory rhythms within theta (4-7.5 Hz), low alpha (8-10 Hz), high alpha (10.5-12 Hz), beta (13-30 Hz) and gamma (31-50 Hz) bands. We recorded the EEG while simultaneously delivering noisy bilateral, bipolar stimulation at varying intensities of imperceptible currents - at 10, 26, 42, 58, 74 and 90% of sensory threshold - to ten neurologically healthy subjects. Using standard spectral analysis, we investigated the transient aftereffects of noisy stimulation on rhythms. Subsequently, using robust artifact rejection techniques and the Least Absolute Shrinkage Selection Operator regression and cross-validation, we assessed the combinations of channels and power spectral features within each EEG frequency band that were linearly related with stimulus intensity. We show that noisy galvanic vestibular stimulation predominantly leads to a mild suppression of gamma power in lateral regions immediately after stimulation, followed by delayed increase in beta and gamma power in frontal regions approximately 20-25 s after stimulation ceased. Ongoing changes in the power of each oscillatory band throughout frontal, central/parietal, occipital and bilateral electrodes predicted the intensity of galvanic vestibular stimulation in a stimulus-dependent manner, demonstrating linear effects of stimulation on brain rhythms. We propose that modulation of neural oscillations is a potential mechanism for the previously-described cognitive and motor effects of vestibular stimulation, and noisy galvanic vestibular stimulation may provide an additional non-invasive means for neuromodulation of functional brain networks.	[Kim, Diana J.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Yogendrakumar, Vignan; Ty, Edna; McKeown, Martin J.] Pacific Parkinsons Res Ctr, Vancouver, BC, Canada; [Chiang, Joyce; Wang, Z. Jane; McKeown, Martin J.] Univ British Columbia, Dept Elect & Comp Engn, Vancouver, BC V5Z 1M9, Canada; [McKeown, Martin J.] Univ British Columbia, Dept Med Neurol, Vancouver, BC V5Z 1M9, Canada; [McKeown, Martin J.] Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	McKeown, MJ (corresponding author), Pacific Parkinsons Res Ctr, Vancouver, BC, Canada.	martin.mckeown@ubc.ca	Yogendrakumar, Vignan/ABC-4597-2021; McKeown, Martin J./Z-1253-2018	Yogendrakumar, Vignan/0000-0001-8814-6853; McKeown, Martin J./0000-0002-4048-0817; Kim, Diana/0000-0002-0243-799X	Michael Smith Foundation for Health Research (MSFHR)	Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research)	This work was supported by a Michael Smith Foundation for Health Research (MSFHR) Team Startup Award (MJM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelnour AF, 2009, NEUROIMAGE, V46, P133, DOI 10.1016/j.neuroimage.2009.01.033; Angelaki DE, 2008, ANNU REV NEUROSCI, V31, P125, DOI 10.1146/annurev.neuro.31.060407.125555; Aqil M., 2012, 2012 IEEE International Conference on Mechatronics and Automation (ICMA), P1370, DOI 10.1109/ICMA.2012.6284336; Bense S, 2001, J NEUROPHYSIOL, V85, P886, DOI 10.1152/jn.2001.85.2.886; Bent LR, 2000, NEUROSCI LETT, V279, P157, DOI 10.1016/S0304-3940(99)00989-1; Bevan MD, 2002, TRENDS NEUROSCI, V25, P525, DOI 10.1016/S0166-2236(02)02235-X; Brown P, 2001, J NEUROSCI, V21, P1033, DOI 10.1523/JNEUROSCI.21-03-01033.2001; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G., 2006, RHYTHMS BRAIN, Vxiv; Cauquil AS, 2003, EXP BRAIN RES, V148, P414, DOI 10.1007/s00221-002-1326-z; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Day BL, 1999, J PHYSIOL-LONDON, V517, P631, DOI 10.1111/j.1469-7793.1999.0631s.x; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Doesburg SM, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006142, 10.1371/journal.pone.0006802]; Dostrovsky J, 2004, BRAIN, V127, P721, DOI 10.1093/brain/awh164; Eusebio A, 2009, BRAIN, V132, P2139, DOI 10.1093/brain/awp079; Eusebio A, 2009, EXP NEUROL, V217, P1, DOI 10.1016/j.expneurol.2009.02.003; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; Fitzpatrick RC, 2004, J APPL PHYSIOL, V96, P2301, DOI 10.1152/japplphysiol.00008.2004; Fregni F, 2007, NAT CLIN PRACT NEURO, V3, P383, DOI 10.1038/ncpneuro0530; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fuentes R, 2009, SCIENCE, V323, P1578, DOI 10.1126/science.1164901; GOLDBERG JM, 1984, J NEUROPHYSIOL, V51, P1236, DOI 10.1152/jn.1984.51.6.1236; Gross J, 2007, PLOS BIOL, V5, P1168, DOI 10.1371/journal.pbio.0050133; Guillery RW, 1995, J ANAT, V187, P583; Guldin WO, 1998, TRENDS NEUROSCI, V21, P254, DOI 10.1016/S0166-2236(97)01211-3; Hernandez-Pavon JC, 2012, J NEUROSCI METH, V209, P144, DOI 10.1016/j.jneumeth.2012.05.029; Hipp JF, 2011, NEURON, V69, P387, DOI 10.1016/j.neuron.2010.12.027; HOMAN RW, 1987, ELECTROEN CLIN NEURO, V66, P376, DOI 10.1016/0013-4694(87)90206-9; Hummel F, 2005, BRAIN, V128, P490, DOI 10.1093/brain/awh369; Jenkinson N, 2011, TRENDS NEUROSCI, V34, P611, DOI 10.1016/j.tins.2011.09.003; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Keinrath C, 2006, INT J PSYCHOPHYSIOL, V62, P321, DOI 10.1016/j.ijpsycho.2006.06.001; Kuhn AA, 2009, EXP NEUROL, V215, P380, DOI 10.1016/j.expneurol.2008.11.008; Leventhal DK, 2012, NEURON, V73, P523, DOI 10.1016/j.neuron.2011.11.032; Levy R, 2002, J NEUROSCI, V22, P2855, DOI 10.1523/JNEUROSCI.22-07-02855.2002; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Lobel E, 1998, J NEUROPHYSIOL, V80, P2699, DOI 10.1152/jn.1998.80.5.2699; Lobel E, 1999, ANN NY ACAD SCI, V871, P313, DOI 10.1111/j.1749-6632.1999.tb09194.x; Lopez C, 2012, NEUROSCIENCE, V212, P159, DOI 10.1016/j.neuroscience.2012.03.028; Lopez C, 2011, BRAIN RES REV, V67, P119, DOI 10.1016/j.brainresrev.2010.12.002; Makeig S, 1996, ADV NEUR IN, V8, P145; Mallet N, 2008, J NEUROSCI, V28, P4795, DOI 10.1523/JNEUROSCI.0123-08.2008; Mallet N, 2008, J NEUROSCI, V28, P14245, DOI 10.1523/JNEUROSCI.4199-08.2008; McDonnell MD, 2011, NAT REV NEUROSCI, V12, P415, DOI 10.1038/nrn3061; McDonnell MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000348; McGeoch PD, 2008, SPINAL CORD, V46, P756, DOI 10.1038/sc.2008.47; McGeoch PD, 2008, J NEUROL NEUROSUR PS, V79, P1298, DOI 10.1136/jnnp.2008.146738; Meng H, 2007, J NEUROSCI, V27, P13590, DOI 10.1523/JNEUROSCI.3931-07.2007; Miller SM, 2007, ACTA NEUROPSYCHIATR, V19, P183, DOI 10.1111/j.1601-5215.2007.00208.x; Moss F, 2004, CLIN NEUROPHYSIOL, V115, P267, DOI 10.1016/j.clinph.2003.09.014; Nuwer M R, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P11; Ozen S, 2010, J NEUROSCI, V30, P11476, DOI 10.1523/JNEUROSCI.5252-09.2010; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Pan WD, 2008, J NEUROL, V255, P1657, DOI 10.1007/s00415-008-0950-3; Parra LC, 2005, NEUROIMAGE, V28, P326, DOI 10.1016/j.neuroimage.2005.05.032; Pogosyan A, 2009, CURR BIOL, V19, P1637, DOI 10.1016/j.cub.2009.07.074; Rorsman I, 1999, SCAND J REHABIL MED, V31, P117; RUSH S, 1968, ANESTH ANAL CURR RES, V47, P717; Samoudi G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029308; Sherman SM, 2005, PROG BRAIN RES, V149, P107, DOI 10.1016/S0079-6123(05)49009-3; Singer W, 2011, NEURON, V69, P191, DOI 10.1016/j.neuron.2011.01.008; Smith AT, 2012, CEREB CORTEX, V22, P1068, DOI 10.1093/cercor/bhr179; Smith Paul F, 2010, Front Neurol, V1, P141, DOI 10.3389/fneur.2010.00141; Soma R, 2003, P SOC PHOTO-OPT INS, V5110, P69, DOI 10.1117/12.500315; Stephan T, 2005, NEUROIMAGE, V26, P721, DOI 10.1016/j.neuroimage.2005.02.049; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tropini G, 2011, NEUROIMAGE, V56, P2144, DOI 10.1016/j.neuroimage.2011.03.018; Utz KS, 2011, BRAIN INJURY, V25, P1058, DOI 10.3109/02699052.2011.607789; Utz KS, 2010, NEUROPSYCHOLOGIA, V48, P2789, DOI 10.1016/j.neuropsychologia.2010.06.002; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vaudano AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006475; Ward LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014371; Wilkinson D, 2005, J INT NEUROPSYCH SOC, V11, P925, DOI 10.1017/S1355617705051076; Wilkinson D, 2008, EXP BRAIN RES, V189, P243, DOI 10.1007/s00221-008-1463-0; Wilkinson D, 2012, VISUAL NEUROSCI, V29, P255, DOI 10.1017/S0952523812000235; Wilkinson D, 2010, J NEUROPSYCHOL, V4, P107, DOI 10.1348/174866409X468205; Wilkinson D, 2009, BRAIN INJURY, V23, P841, DOI 10.1080/02699050903232541; Wingeier B, 2006, EXP NEUROL, V197, P244, DOI 10.1016/j.expneurol.2005.09.016; Yamamoto Y, 2005, ANN NEUROL, V58, P175, DOI 10.1002/ana.20574; Zheng N, 2012, 2012 IEEE VISUAL COMMUNICATIONS AND IMAGE PROCESSING (VCIP); Zink R, 1998, ELECTROEN CLIN NEURO, V107, P200, DOI 10.1016/S0013-4694(98)00056-X; Zink R, 1997, NEUROSCI LETT, V232, P171, DOI 10.1016/S0304-3940(97)00610-1	84	39	42	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e69055	10.1371/journal.pone.0069055	http://dx.doi.org/10.1371/journal.pone.0069055			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874865	gold, Green Published, Green Submitted			2022-12-27	WOS:000324146200051
J	Takehara, S; Yanagishita, M; Podyma-Inoue, KA; Kawaguchi, Y				Takehara, Sachiko; Yanagishita, Masaki; Podyma-Inoue, Katarzyna Anna; Kawaguchi, Yoko			Degradation of MUC7 and MUC5B in Human Saliva	PLOS ONE			English	Article							SIALIC-ACID; PEPTIDE; MUCINS	Background: Two types of mucins, MUC7 and MUC5B constitute the major salivary glycoproteins, however their metabolic turnover has not been elucidated in detail to date. This study was conducted to examine turnover of MUC7 and MUC5B in saliva, by focusing on the relationship between their deglycosylation and proteolysis. Methodology/Principal Findings: Whole saliva samples were collected from healthy individuals and incubated at 37 degrees C in the presence of various protease inhibitors, sialidase, or a sialidase inhibitor. General degradation patterns of salivary proteins and glycoproteins were examined by SDS-polyacrylamide-gel-electrophoresis. Furthermore, changes of molecular sizes of MUC7 and MUC5B were examined by Western blot analysis. A protein band was identified as MUC7 by Western blot analysis using an antibody recognizing an N-terminal epitope. The MUC7 signal disappeared rapidly after 20-minutes of incubation. In contrast, the band of MUC7 stained for its carbohydrate components remained visible near its original position for a longer time indicating that the rapid loss of Western blot signal was due to the specific removal of the N-termimal epitope. Pretreatment of saliva with sialidase facilitated MUC7 protein degradation when compared with samples without treatment. Furthermore, addition of sialidase inhibitor to saliva prevented proteolysis of N-terminus of MUC7, suggesting that the desialylation is a prerequisite for the degradation of the N-terminal region of MUC7. The protein band corresponding to MUC5B detected in both Western blotting and glycoprotein staining showed little sign of significant degradation upon incubation in saliva up to 9 hours. Conclusions/Significance: MUC7 was highly susceptible to specific proteolysis in saliva, though major part of MUC5B was more resistant to degradation. The N-terminal region of MUC7, particularly sensitive to proteolytic degradation, has also been proposed to have distinct biological function such as antibacterial activities. Quick removal of this region may have biologically important implication.	[Takehara, Sachiko; Kawaguchi, Yoko] Tokyo Med & Dent Univ, Grad Sch Dent & Med Sci, Dept Int Hlth Dev,Div Publ Hlth, Sect Oral Hlth Promot, Tokyo, Japan; [Yanagishita, Masaki; Podyma-Inoue, Katarzyna Anna] Tokyo Med & Dent Univ, Grad Sch Dent & Med Sci, Dept Hard Tissue Engn, Sect Biochem,Div Biomatrix, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Takehara, S (corresponding author), Tokyo Med & Dent Univ, Grad Sch Dent & Med Sci, Dept Int Hlth Dev,Div Publ Hlth, Sect Oral Hlth Promot, Tokyo, Japan.	takehara.ohp@tmd.ac.jp	Inoue, Katarzyna A./ABD-9622-2020		Japanese Government; JSPS [25463236]; Grants-in-Aid for Scientific Research [25463236] Funding Source: KAKEN	Japanese Government; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japanese Government. This work was partly supported by JSPS Grant-in-Aid for Scientific Research (C) grant number 25463236. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADSHAW DJ, 1994, MICROBIOL-UK, V140, P3407, DOI 10.1099/13500872-140-12-3407; Bucki R, 2008, J ANTIMICROB CHEMOTH, V62, P329, DOI 10.1093/jac/dkn176; Byers HL, 1996, J DENT RES, V75, P1564, DOI 10.1177/00220345960750080701; Byers HL, 2000, J MED MICROBIOL, V49, P235, DOI 10.1099/0022-1317-49-3-235; Gururaja TL, 1999, BBA-PROTEIN STRUCT M, V1431, P107, DOI 10.1016/S0167-4838(99)00034-5; Helmerhorst EJ, 2007, J DENT RES, V86, P680, DOI 10.1177/154405910708600802; Kirkbride HJ, 2001, EUR J HUM GENET, V9, P347, DOI 10.1038/sj.ejhg.5200642; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LECOMTE P, 1987, J DENT RES, V66, P1614, DOI 10.1177/00220345870660110101; Lis M, 2008, FEMS IMMUNOL MED MIC, V54, P80, DOI 10.1111/j.1574-695X.2008.00450.x; Oppenheim FG, 2007, ANN NY ACAD SCI, V1098, P22, DOI 10.1196/annals.1384.030; Perez-Vilar J, 2004, GLYCOBIOLOGY, V14, P325, DOI 10.1093/glycob/cwh041; Ponnio M, 1999, CLIN CHEM, V45, P1842; Silverman HS, 2001, GLYCOBIOLOGY, V11, P459, DOI 10.1093/glycob/11.6.459; Sterer N, 2006, J DENT RES, V85, P910, DOI 10.1177/154405910608501007; Sterer N, 2002, INT DENT J, V52, P229, DOI 10.1002/j.1875-595X.2002.tb00930.x; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; VANDERHOEVEN JS, 1991, J DENT RES, V70, P1041, DOI 10.1177/00220345910700070401; Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002; Wickstrom C, 2009, MICROBIOL-SGM, V155, P2866, DOI 10.1099/mic.0.030536-0; Zalewska A, 2000, ACTA BIOCHIM POL, V47, P1067, DOI 10.18388/abp.2000_3960	21	34	34	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e69059	10.1371/journal.pone.0069059	http://dx.doi.org/10.1371/journal.pone.0069059			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874867	Green Published, gold, Green Submitted			2022-12-27	WOS:000324146200052
J	Vogler, M; Vogel, S; Krull, S; Farhat, K; Leisering, P; Lutz, S; Wuertz, CM; Katschinski, DM; Zieseniss, A				Vogler, Melanie; Vogel, Sabine; Krull, Sabine; Farhat, Katja; Leisering, Pia; Lutz, Susanne; Wuertz, Christina M.; Katschinski, Doerthe M.; Zieseniss, Anke			Hypoxia Modulates Fibroblastic Architecture, Adhesion and Migration: A Role for HIF-1 alpha in Cofilin Regulation and Cytoplasmic Actin Distribution	PLOS ONE			English	Article							CELL-ADHESION; PROTEIN-KINASE; UP-REGULATION; RHO GTPASES; HIF-ALPHA; DYNAMICS; EXPRESSION; MOTILITY; O-2; PHOSPHORYLATION	Cells can adapt to hypoxia by various mechanisms. Yet, hypoxia-induced effects on the cytoskeleton-based cell architecture and functions are largely unknown. Here we present a comprehensive analysis of the architecture and function of L929 fibroblasts under hypoxic conditions (1% O-2). Cells cultivated in hypoxia showed striking morphological differences as compared to cells cultivated under normoxic conditions (20% O-2). These changes include an enlargement of cell area and volume, increased numbers of focal contacts and loss of cell polarization. Furthermore the beta- and gamma-actin distribution is greatly altered. These hypoxic adjustments are associated with enhanced cell spreading and a decline of cell motility in wound closure and single cell motility assays. As the hypoxia-inducible factor-1 alpha (HIF-1 alpha) is stabilised in hypoxia and plays a pivotal role in the transcriptional response to changes in oxygen availability we used an shRNA-approach to examine the role of HIF-1 alpha in cytoskeleton-related architecture and functions. We show that the observed increase in cell area, actin filament rearrangement, decrease of single cell migration in hypoxia and the maintenance of p-cofilin levels is dependent on HIF-1 alpha stabilisation.	[Vogler, Melanie; Vogel, Sabine; Krull, Sabine; Farhat, Katja; Leisering, Pia; Katschinski, Doerthe M.; Zieseniss, Anke] Univ Goettingen, Univ Med Ctr, Inst Cardiovasc Physiol, Gottingen, Germany; [Lutz, Susanne; Wuertz, Christina M.] Univ Goettingen, Univ Med Ctr, Inst Pharmacol, Gottingen, Germany	University of Gottingen; University of Gottingen	Zieseniss, A (corresponding author), Univ Goettingen, Univ Med Ctr, Inst Cardiovasc Physiol, Gottingen, Germany.	anke.zieseniss@med.uni-goettingen.de						Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Aslam M, 2012, J PHYSL, V591, P461; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Breit S, 2011, J PHYSIOL BIOCHEM, V67, P1, DOI 10.1007/s13105-010-0043-5; Brillault J, 2008, AM J PHYSIOL-CELL PH, V294, pC88, DOI 10.1152/ajpcell.00148.2007; Chen EY, 1999, TERATOLOGY, V60, P215; de Curtis I, 2012, J CELL SCI, V125, P4435, DOI 10.1242/jcs.108266; Dugina V, 2009, J CELL SCI, V122, P2980, DOI 10.1242/jcs.041970; Dunphy JL, 2006, CURR BIOL, V16, P315, DOI 10.1016/j.cub.2005.12.032; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Eul B, 2005, FASEB J, V19, P163, DOI 10.1096/fj.05-4104fje; FERNANDEZ JLR, 1992, CELL MOTIL CYTOSKEL, V22, P127, DOI 10.1002/cm.970220206; Hall A, 2000, PHILOS T R SOC B, V355, P965, DOI 10.1098/rstb.2000.0632; Hayashi M, 2005, J CLIN ENDOCR METAB, V90, P1712, DOI 10.1210/jc.2004-1547; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jin HG, 2006, NEUROSCI LETT, V408, P62, DOI 10.1016/j.neulet.2006.08.038; Kayyali US, 2002, J BIOL CHEM, V277, P42596, DOI 10.1074/jbc.M205863200; Li W, 2007, EMBO J, V26, P1221, DOI 10.1038/sj.emboj.7601579; Mogford JE, 2002, J CELL PHYSIOL, V190, P259, DOI 10.1002/JCP.10060; Mole DR, 2003, BIOORG MED CHEM LETT, V13, P2677, DOI 10.1016/S0960-894X(03)00539-0; Negash S, 2009, AM J PHYSIOL-HEART C, V297, pH304, DOI 10.1152/ajpheart.00077.2008; Nishita M, 2002, MOL CELL BIOL, V22, P774, DOI 10.1128/MCB.22.3.774-783.2002; Pacary E, 2007, MOL CELL NEUROSCI, V35, P409, DOI 10.1016/j.mcn.2007.04.002; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2010, CURR OPIN CELL BIOL, V22, P50, DOI 10.1016/j.ceb.2009.11.010; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rieder F, 2007, GUT, V56, P130, DOI 10.1136/gut.2006.090456; Rutkowsky JM, 2011, AM J PHYSIOL-CELL PH, V301, pC204, DOI 10.1152/ajpcell.00399.2010; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; Simon MC, 2008, NAT REV MOL CELL BIO, V9, P285, DOI 10.1038/nrm2354; Tandara AA, 2004, WORLD J SURG, V28, P294, DOI 10.1007/s00268-003-7400-2; Turcotte S, 2003, J CELL SCI, V116, P2247, DOI 10.1242/jcs.00427; van den Borne SWM, 2010, NAT REV CARDIOL, V7, P30, DOI 10.1038/nrcardio.2009.199; Veith C, 2013, PROTEOMICS, V13, P75, DOI 10.1002/pmic.201200206; Vogel S, 2010, J BIOL CHEM, V285, P33756, DOI 10.1074/jbc.M110.132985	39	38	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e69128	10.1371/journal.pone.0069128	http://dx.doi.org/10.1371/journal.pone.0069128			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874890	Green Published, Green Submitted, gold			2022-12-27	WOS:000324146200061
J	Sreenivasan, N; Basit, S; Wohlfahrt, J; Pasternak, B; Munch, TN; Nielsen, LP; Melbye, M				Sreenivasan, Nandini; Basit, Saima; Wohlfahrt, Jan; Pasternak, Bjorn; Munch, Tina N.; Nielsen, Lars P.; Melbye, Mads			The Short- and Long-Term Risk of Stroke after Herpes Zoster - A Nationwide Population-Based Cohort Study	PLOS ONE			English	Article							VIRUS VASCULOPATHY; VARICELLA; PATHOGENESIS; FEATURES; LATENCY; DISEASE; SYSTEM	Background and Objective: Varicella zoster virus (VZV) is known to cause VZV vasculopathy, which may be associated with stroke. A recent study found an increased risk of stroke within one year of herpes zoster. We aimed to investigate the short and long-term effects of herpes zoster on the risk of stroke. Methods: Using Danish national registers, we constructed a cohort consisting of all Danish adults >= 18 years old between 1995 and 2008 (n = 4.6 million; person-years of follow-up = 52.9 million). Individual-level information on prescriptions for herpes zoster antiviral treatment and diagnoses of stroke was obtained from national registers. We compared the risk of stroke in persons who had received the specific dosage of acyclovir for herpes zoster with persons who had never received antiviral treatment by Poisson regression. Results: During follow-up, 2.5% received treatment for herpes zoster and 5.0% were diagnosed with stroke. Individuals who had received medication had a 127% (95% CI 83-182%) increased risk the first two weeks, 17% (CI 9-24%) between two weeks and one year, and 5% (2-9%) after the first year. The increased risk was greatest in the youngest age group (<40). To control for healthcare-seeking behaviour, we conducted parallel analyses investigating the risk of selected fractures after herpes zoster and found no similar increased risks. Conclusions: This large nationwide cohort study found an increased risk of stroke after treatment for herpes zoster. Although the short-term risk was particularly high, we cannot rule out the possibility of a small but important long-term risk.	[Sreenivasan, Nandini; Basit, Saima; Wohlfahrt, Jan; Pasternak, Bjorn; Munch, Tina N.; Melbye, Mads] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Nielsen, Lars P.] Statens Serum Inst, Dept Virol, DK-2300 Copenhagen, Denmark	Statens Serum Institut; Statens Serum Institut	Pasternak, B (corresponding author), Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark.	bjp@ssi.dk	Pasternak, Bjorn/H-5739-2012	Pasternak, Bjorn/0000-0002-2097-8466; melbye, mads/0000-0001-8264-6785; Munch, Tina Norgaard/0000-0001-5938-000X	Danish Heart Foundation	Danish Heart Foundation	This work was supported by the Danish Heart Foundation (http://www.hjerteforeningen.dk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cohrs RJ, 2004, FRONT BIOSCI-LANDMRK, V9, P751, DOI 10.2741/1275; Farge D, 1993, Eur J Med, V2, P123; Gershon AA, 2010, J CLIN VIROL, V48, pS2, DOI 10.1016/S1386-6532(10)70002-0; Gilden D, 2008, EUR J NEUROL, V15, pE88, DOI 10.1111/j.1468-1331.2008.02268.x; Gilden D, 2009, LANCET NEUROL, V8, P731, DOI 10.1016/S1474-4422(09)70134-6; Kang JH, 2009, STROKE, V40, P3443, DOI 10.1161/STROKEAHA.109.562017; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Kleinschmidt-DeMasters BK, 2001, ARCH PATHOL LAB MED, V125, P770; Limb J, 2009, INT J INFECT DIS, V13, pE498, DOI 10.1016/j.ijid.2009.02.007; Lin HC, 2010, NEUROLOGY, V74, P792, DOI 10.1212/WNL.0b013e3181d31e5c; Massano J, 2008, EUR J NEUROL, V15, pE90, DOI 10.1111/j.1468-1331.2008.02267.x; Mueller NH, 2008, NEUROL CLIN, V26, P675, DOI 10.1016/j.ncl.2008.03.011; Nagel MA, 2008, NEUROLOGY, V70, P853, DOI 10.1212/01.wnl.0000304747.38502.e8; Nagel MA, 2011, NEUROLOGY, V77, P364, DOI 10.1212/WNL.0b013e3182267bfa; Nagel M. A., 2010, Infectious Disorders - Drug Targets, V10, P105; Ostergaard Keld, 2009, Ugeskr Laeger, V171, P2194; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Salazar R, 2011, ARCH NEUROL-CHICAGO, V68, P517, DOI 10.1001/archneurol.2011.64; Wareham DW, 2007, BMJ-BRIT MED J, V334, P1211, DOI 10.1136/bmj.39206.571042.AE; WHO (World Health Organization), ATLAS HEART DIS STRO	20	68	69	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e69156	10.1371/journal.pone.0069156	http://dx.doi.org/10.1371/journal.pone.0069156			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23874897	Green Published, gold, Green Submitted			2022-12-27	WOS:000322000600042
J	Trimpalis, P; Koumandou, VL; Pliakou, E; Anagnou, NP; Kossida, S				Trimpalis, Philip; Koumandou, Vassiliki Lila; Pliakou, Evangelia; Anagnou, Nicholas P.; Kossida, Sophia			Gene Fusion Analysis in the Battle against the African Endemic Sleeping Sickness	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; COMPLETE GENOME SEQUENCE; TRYPANOSOMA-BRUCEI; EVOLUTION; TOPOISOMERASE; SULFOXIDE; DATABASE; ORIGIN; YEAST; IB	The protozoan Trypanosoma brucei causes African Trypanosomiasis or sleeping sickness in humans, which can be lethal if untreated. Most available pharmacological treatments for the disease have severe side-effects. The purpose of this analysis was to detect novel protein-protein interactions (PPIs), vital for the parasite, which could lead to the development of drugs against this disease to block the specific interactions. In this work, the Domain Fusion Analysis (Rosetta Stone method) was used to identify novel PPIs, by comparing T. brucei to 19 organisms covering all major lineages of the tree of life. Overall, 49 possible protein-protein interactions were detected, and classified based on (a) statistical significance (BLAST e-value, domain length etc.), (b) their involvement in crucial metabolic pathways, and (c) their evolutionary history, particularly focusing on whether a protein pair is split in T. brucei and fused in the human host. We also evaluated fusion events including hypothetical proteins, and suggest a possible molecular function or involvement in a certain biological process. This work has produced valuable results which could be further studied through structural biology or other experimental approaches so as to validate the protein-protein interactions proposed here. The evolutionary analysis of the proteins involved showed that, gene fusion or gene fission events can happen in all organisms, while some protein domains are more prone to fusion and fission events and present complex evolutionary patterns.	[Trimpalis, Philip; Koumandou, Vassiliki Lila; Pliakou, Evangelia; Anagnou, Nicholas P.; Kossida, Sophia] Acad Athens, Bioinformat & Med Informat Team, Biomed Res Fdn, Athens, Greece	Academy of Athens	Kossida, S (corresponding author), Acad Athens, Bioinformat & Med Informat Team, Biomed Res Fdn, Athens, Greece.	skossida@bioacademy.gr	Anagnou, Nicholas/GLR-3609-2022; Kossida, Sofia/ABG-3526-2020; Koumandou, V. Lila/AAP-4224-2021	Koumandou, V. Lila/0000-0002-0624-0190	Biomedical Research Foundation; Academy of Athens; FP7-PEOPLE-2011-IEF Marie Curie fellowship	Biomedical Research Foundation; Academy of Athens; FP7-PEOPLE-2011-IEF Marie Curie fellowship	The authors acknowledge institutional funds from the Biomedical Research Foundation, Academy of Athens, for the publication of the article (http://www.bioacademy.gr). VLK is funded through an FP7-PEOPLE-2011-IEF Marie Curie fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen MS, 2004, SCIENCE, V304, P441, DOI 10.1126/science.1094786; Alsford S, 2012, NATURE, V482, P232, DOI 10.1038/nature10771; Anderson I, 2011, STAND GENOMIC SCI, V5, P12, DOI 10.4056/sigs.2054696; [Anonymous], 2012, HUMAN AFRICAN TRYPAN; Azevedo C, 2002, SCIENCE, V295, P2073, DOI 10.1126/science.1067554; Bakshi RP, 2004, MOL BIOCHEM PARASIT, V136, P249, DOI 10.1016/j.molbiopara.2004.04.006; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Bodley AL, 2003, P NATL ACAD SCI USA, V100, P7539, DOI 10.1073/pnas.1330762100; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Carvalho J, 2008, BMC P, V2, pP9; Clarke JL, 2003, MOL BIOCHEM PARASIT, V127, P1, DOI 10.1016/S0166-6851(02)00298-0; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Crooke A, 2006, FEBS J, V273, P1537, DOI 10.1111/j.1742-4658.2006.05174.x; Dacks JB, 2007, J CELL SCI, V120, P2977, DOI 10.1242/jcs.013250; DelVecchio VG, 2002, P NATL ACAD SCI USA, V99, P443, DOI 10.1073/pnas.221575398; Deng W, 2002, J BACTERIOL, V184, P4601, DOI 10.1128/JB.184.16.4601-4611.2002; Dimitriadis D, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-193; Durrens P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000200; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Enright AJ, 2001, GENOME BIOL, V2; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Holt BF, 2003, CURR OPIN IMMUNOL, V15, P20, DOI 10.1016/S0952-7915(02)00014-6; Hur S, 2006, J BIOL CHEM, V281, P38969, DOI 10.1074/jbc.R600034200; Kamburov A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-460; KEALEY JT, 1994, BIOCHIMIE, V76, P1133, DOI 10.1016/0300-9084(94)90042-6; Kryukov GV, 2002, P NATL ACAD SCI USA, V99, P4245, DOI 10.1073/pnas.072603099; Lee BC, 2008, J BIOL CHEM, V283, P28361, DOI 10.1074/jbc.M805059200; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; Ma LJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000549; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; Morales J, 2009, J BIOL CHEM, V284, P7255, DOI 10.1074/jbc.M806623200; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Rasko DA, 2005, FEMS MICROBIOL REV, V29, P303, DOI 10.1016/j.femsre.2004.12.005; Read TD, 2000, NUCLEIC ACIDS RES, V28, P1397, DOI 10.1093/nar/28.6.1397; Rison SCG, 2002, CURR OPIN STRUC BIOL, V12, P374, DOI 10.1016/S0959-440X(02)00331-7; Samuel BS, 2007, P NATL ACAD SCI USA, V104, P10643, DOI 10.1073/pnas.0704189104; Stijlemans B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002072; Tsagrasoulis D, 2012, EVOL BIOINFORM, V8, P47, DOI 10.4137/EBO.S8018; VOSS H, 1991, J BIOL CHEM, V266, P13706; Wheelan SJ, 2000, BIOINFORMATICS, V16, P613, DOI 10.1093/bioinformatics/16.7.613; Wilming LG, 2008, NUCLEIC ACIDS RES, V36, pD753, DOI 10.1093/nar/gkm987; Wu JC, 2005, FEBS LETT, V579, P421, DOI 10.1016/j.febslet.2004.12.005; Yanai I, 2001, P NATL ACAD SCI USA, V98, P7940, DOI 10.1073/pnas.141236298; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038; Zhang DP, 2010, GENE, V469, P18, DOI 10.1016/j.gene.2010.08.006	51	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e68854	10.1371/journal.pone.0068854	http://dx.doi.org/10.1371/journal.pone.0068854			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23874788	Green Submitted, gold, Green Published			2022-12-27	WOS:000322000600032
J	Hussain, A; Li, YF; Cheng, Y; Liu, Y; Chen, CC; Wen, SY				Hussain, Abid; Li, Yi-Feng; Cheng, Yu; Liu, Yang; Chen, Chuan-Cheng; Wen, Shuo-Yang			Immune-Related Transcriptome of Coptotermes formosanus Shiraki Workers: The Defense Mechanism	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTOR; GENE-EXPRESSION; ANTIBACTERIAL PEPTIDE; SUBTERRANEAN TERMITES; BINDING-PROTEIN; APOLIPOPHORIN-III; FUNGAL-INFECTION; DAMPWOOD TERMITE; INSECT IMMUNITY; INNATE IMMUNITY	Formosan subterranean termites, Coptotermes formosanus Shiraki, live socially in microbial-rich habitats. To understand the molecular mechanism by which termites combat pathogenic microbes, a full-length normalized cDNA library and four Suppression Subtractive Hybridization (SSH) libraries were constructed from termite workers infected with entomopathogenic fungi (Metarhizium anisopliae and Beauveria bassiana), Gram-positive Bacillus thuringiensis and Gram-negative Escherichia coli, and the libraries were analyzed. From the high quality normalized cDNA library, 439 immune-related sequences were identified. These sequences were categorized as pattern recognition receptors (47 sequences), signal modulators (52 sequences), signal transducers (137 sequences), effectors (39 sequences) and others (164 sequences). From the SSH libraries, 27, 17, 22 and 15 immune-related genes were identified from each SSH library treated with M. anisopliae, B. bassiana, B. thuringiensis and E. coli, respectively. When the normalized cDNA library was compared with the SSH libraries, 37 immune-related clusters were found in common; 56 clusters were identified in the SSH libraries, and 259 were identified in the normalized cDNA library. The immune-related gene expression pattern was further investigated using quantitative real time PCR (qPCR). Important immune-related genes were characterized, and their potential functions were discussed based on the integrated analysis of the results. We suggest that normalized cDNA and SSH libraries enable us to discover functional genes transcriptome. The results remarkably expand our knowledge about immune-inducible genes in C. formosanus Shiraki and enable the future development of novel control strategies for the management of Formosan subterranean termites.	[Hussain, Abid; Li, Yi-Feng; Cheng, Yu; Liu, Yang; Chen, Chuan-Cheng; Wen, Shuo-Yang] South China Agr Univ, Coll Nat Resources & Environm, Dept Entomol, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Wen, SY (corresponding author), South China Agr Univ, Coll Nat Resources & Environm, Dept Entomol, Guangzhou, Guangdong, Peoples R China.	shywen@scau.edu.cn	Hussain, Abid/A-5503-2014	Hussain, Abid/0000-0001-8210-6973; Wen, Shuoyang/0000-0001-5533-0638	China Post Doctorate Foundation [20100480764]; Department of Entomology, South China Agricultural University	China Post Doctorate Foundation; Department of Entomology, South China Agricultural University	This work was supported by the China Post Doctorate Foundation (20100480764) and the Department of Entomology, South China Agricultural University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aggarwal K, 2008, BMB REP, V41, P267, DOI 10.5483/BMBRep.2008.41.4.267; Altincicek B, 2008, INSECT MOL BIOL, V17, P711, DOI 10.1111/j.1365-2583.2008.00835.x; Avulova S, 2011, J INSECT PHYSIOL, V57, P966, DOI 10.1016/j.jinsphys.2011.04.009; Blanchard H, 1997, NAT STRUCT BIOL, V4, P532, DOI 10.1038/nsb0797-532; Boehnisch C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024619; Bulet P, 1999, DEV COMP IMMUNOL, V23, P329, DOI 10.1016/S0145-305X(99)00015-4; Bulmer MS, 2009, P NATL ACAD SCI USA, V106, P12652, DOI 10.1073/pnas.0904063106; Bulmer MS, 2006, MOL BIOL EVOL, V23, P317, DOI 10.1093/molbev/msj037; Calleri DV, 2007, PHYSIOL ENTOMOL, V32, P136, DOI 10.1111/j.1365-3032.2007.00559.x; Carton Y, 2001, IMMUNOGENETICS, V52, P157; Choe KM, 2002, SCIENCE, V296, P359, DOI 10.1126/science.1070216; Conus S, 2010, SWISS MED WKLY, V140, P4, DOI 10.4414/smw.2010.13042; Culliney TW, 2000, B ENTOMOL RES, V90, P9, DOI 10.1017/S0007485300000031; Damiano JS, 2004, BIOCHEM J, V381, P213, DOI 10.1042/BJ20031506; Dimopoulos G, 2003, CELL MICROBIOL, V5, P3, DOI 10.1046/j.1462-5822.2003.00252.x; Dimopoulos G, 1997, P NATL ACAD SCI USA, V94, P11508, DOI 10.1073/pnas.94.21.11508; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Fabrick JA, 2004, J BIOL CHEM, V279, P26605, DOI 10.1074/jbc.M403382200; Furukawa S, 1997, BIOCHEM BIOPH RES CO, V238, P769, DOI 10.1006/bbrc.1997.7386; Furukawa S, 1999, BIOCHEM J, V340, P265, DOI 10.1042/0264-6021:3400265; Gao Q, 2012, ARCH INSECT BIOCHEM, V80, P63, DOI 10.1002/arch.21026; Garcia Eloi S., 2009, Parasites & Vectors, V2, P1; Gerardo NM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r21; Gorman MJ, 2001, INSECT BIOCHEM MOLEC, V31, P257, DOI 10.1016/S0965-1748(00)00145-4; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hamilton C, 2012, DEV COMP IMMUNOL, V36, P372, DOI 10.1016/j.dci.2011.07.008; Hamilton C, 2011, J INSECT PHYSIOL, V57, P1259, DOI 10.1016/j.jinsphys.2011.05.016; Hamilton C, 2011, BIOL LETTERS, V7, P89, DOI 10.1098/rsbl.2010.0466; Hoffmann JA, 1997, TRENDS CELL BIOL, V7, P309, DOI 10.1016/S0962-8924(97)01087-8; Hultmark D, 2003, CURR OPIN IMMUNOL, V15, P12, DOI 10.1016/S0952-7915(02)00005-5; Hussain A, 2012, FORMOSAN SUBTERRANEA; Hussain A, 2013, INT J AGRIC BIOL, V15, P319; Hussain A, 2012, AFR J MICROBIOL RES, V6, P995, DOI 10.5897/AJMR11.1078; Hussain A, 2010, BIOL CONTROL, V55, P166, DOI 10.1016/j.biocontrol.2010.08.009; Hussain A, 2010, J INVERTEBR PATHOL, V104, P166, DOI 10.1016/j.jip.2010.03.004; Husseneder C, 2012, COMP BIOCHEM PHYS D, V7, P14, DOI 10.1016/j.cbd.2011.10.002; Johnson DS, 2012, CURR OPIN PHARMACOL, V12, P458, DOI 10.1016/j.coph.2012.02.003; JOLLES P, 1984, MOL CELL BIOCHEM, V63, P165; JOMORI T, 1992, FEBS LETT, V296, P283, DOI 10.1016/0014-5793(92)80305-Z; Kaneko Y, 2007, BIOSCI BIOTECH BIOCH, V71, P2233, DOI 10.1271/bbb.70212; Kanost MR, 1999, DEV COMP IMMUNOL, V23, P291, DOI 10.1016/S0145-305X(99)00012-9; Kilpatrick DC, 2002, BBA-GEN SUBJECTS, V1572, P187, DOI 10.1016/S0304-4165(02)00308-2; Kim JH, 2011, INSECT BIOCHEM MOLEC, V41, P332, DOI 10.1016/j.ibmb.2011.01.011; Kim YS, 2000, J BIOL CHEM, V275, P32721, DOI 10.1074/jbc.M003934200; Kuraishi T, 2007, EXP CELL RES, V313, P500, DOI 10.1016/j.yexcr.2006.10.027; Lamberty M, 2001, J BIOL CHEM, V276, P4085, DOI 10.1074/jbc.M002998200; Lee S, 2011, J INSECT PHYSIOL, V57, P356, DOI 10.1016/j.jinsphys.2010.12.003; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Ligoxygakis P, 2002, SCIENCE, V297, P114, DOI 10.1126/science.1072391; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MALEHORN DE, 1994, PLANT PHYSIOL, V106, P1471, DOI 10.1104/pp.106.4.1471; Rojas AM, 2012, J CELL BIOL, V196, P189, DOI 10.1083/jcb.201103008; Matsuura K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000813; Meepagala KM, 2011, PEST MANAG SCI, V67, P1446, DOI 10.1002/ps.2196; Mittl PRE, 2007, CELL SIGNAL, V19, P20, DOI 10.1016/j.cellsig.2006.05.034; Neerincx A, 2010, J BIOL CHEM, V285, P26223, DOI 10.1074/jbc.M110.109736; Nikapitiya C, 2010, FISH SHELLFISH IMMUN, V29, P334, DOI 10.1016/j.fsi.2010.04.004; Ntwasa Monde, 2012, Int J Microbiol, V2012, P101989, DOI 10.1155/2012/101989; Ochiai M, 2000, J BIOL CHEM, V275, P4995, DOI 10.1074/jbc.275.7.4995; Oh CS, 2010, PLANT PATHOLOGY J, V26, P1, DOI 10.5423/PPJ.2010.26.1.001; Oizumi Y, 2005, BBA-PROTEINS PROTEOM, V1752, P83, DOI 10.1016/j.bbapap.2005.07.013; Pauchet Y, 2009, J BIOL CHEM, V284, P2214, DOI 10.1074/jbc.M806204200; Peiser L, 2002, CURR OPIN IMMUNOL, V14, P123, DOI 10.1016/S0952-7915(01)00307-7; Ramet M, 2001, IMMUNITY, V15, P1027, DOI 10.1016/S1074-7613(01)00249-7; Rosengaus RB, 1999, NATURWISSENSCHAFTEN, V86, P588, DOI 10.1007/s001140050679; Rosengaus RB, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P165, DOI 10.1007/978-90-481-3977-4_7; Rosengaus RB, 2007, NATURWISSENSCHAFTEN, V94, P25, DOI 10.1007/s00114-006-0151-9; SAS Institute, 2000, SAS US GUID STAT; Sritunyalucksana K, 2002, DEV COMP IMMUNOL, V26, P237, DOI 10.1016/S0145-305X(01)00074-X; Tanaka H, 2008, INSECT BIOCHEM MOLEC, V38, P1087, DOI 10.1016/j.ibmb.2008.09.001; Thompson GJ, 2003, INSECT MOL BIOL, V12, P1, DOI 10.1046/j.1365-2583.2003.00381.x; Ulvila J, 2011, J LEUKOCYTE BIOL, V89, P649, DOI 10.1189/jlb.0410195; Ursic-Bedoya R, 2011, INSECT MOL BIOL, V20, P775, DOI 10.1111/j.1365-2583.2011.01107.x; Wang WX, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.1701; Wang Y, 2011, INSECT BIOCHEM MOLEC, V41, P322, DOI 10.1016/j.ibmb.2011.01.010; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; Whitten MMA, 2004, J IMMUNOL, V172, P2177, DOI 10.4049/jimmunol.172.4.2177; Wright MS, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-291; Xu P, 2012, GENET MOL RES, V11, P2247, DOI 10.4238/2012.May.10.2; Yan YL, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-405, 10.1186/1471-2164-11-11]; Yuki M, 2008, ZOOL SCI, V25, P401, DOI 10.2108/zsj.25.401; Zdybicka-Barabas A, 2012, J INSECT PHYSIOL, V58, P164, DOI 10.1016/j.jinsphys.2011.11.003; Zettervall CJ, 2004, P NATL ACAD SCI USA, V101, P14192, DOI 10.1073/pnas.0403789101; Zhang D, 2012, INSECT MOL BIOL, V21, P235, DOI 10.1111/j.1365-2583.2011.01130.x; Zhang DH, 2011, INSECT BIOCHEM MOLEC, V41, P211, DOI 10.1016/j.ibmb.2010.12.006; Zhang R, 2003, J BIOL CHEM, V278, P42072, DOI 10.1074/jbc.M307475200; Zhong J, 2001, P 2 INT S COPT FORM; Zhou X, 2006, GENE, V376, P47, DOI 10.1016/j.gene.2006.02.002; Zou Z, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r177	90	31	34	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e69543	10.1371/journal.pone.0069543	http://dx.doi.org/10.1371/journal.pone.0069543			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874972	Green Published, Green Submitted, gold			2022-12-27	WOS:000322064300106
J	Landraud, P; Chuzeville, S; Billon-Grande, G; Poussereau, N; Bruel, C				Landraud, Patricia; Chuzeville, Sarah; Billon-Grande, Genevieve; Poussereau, Nathalie; Bruel, Christophe			Adaptation to pH and Role of PacC in the Rice Blast Fungus Magnaporthe oryzae	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION PATHWAY; AMBIENT PH; ASPERGILLUS-NIDULANS; TRANSCRIPTION FACTOR; COLLETOTRICHUM-ACUTATUM; CANDIDA-ALBICANS; SCLEROTINIA-SCLEROTIORUM; ANAEROBIC FUNGI; GENE; GRISEA	Fungi are known to adapt to pH partly via specific activation of the Pal signaling pathway and subsequent gene regulation through the transcription factor PacC. The role of PacC in pathogenic fungi has been explored in few species, and each time its partaking in virulence has been found. We studied the impact of pH and the role of PacC in the biology of the rice pathogen Magnaporthe oryzae. Conidia formation and germination were affected by pH whereas fungal growth and appressorium formation were not. Growth in vitro and in planta was characterized by alkalinization and ammonia accumulation in the surrounding medium. Expression of the MoPACC gene increased when the fungus was placed under alkaline conditions. Except for MoPALF, expression of the MoPAL genes encoding the pH-signaling components was not influenced by pH. Deletion of PACC caused a progressive loss in growth rate from pH 5 to pH 8, a loss in conidia production at pH 8 in vitro, a loss in regulation of the MoPALF gene, a decreased production of secreted lytic enzymes and a partial loss in virulence towards barley and rice. PacC therefore plays a significant role in M. oryzae's biology, and pH is revealed as one component at work during interaction between the fungus and its host plants.	[Landraud, Patricia; Chuzeville, Sarah; Billon-Grande, Genevieve; Poussereau, Nathalie; Bruel, Christophe] Univ Lyon 1, CNRS, UMR Microbiol Adaptat & Pathogenie 5240, Bayer CropSci, F-69622 Villeurbanne, France	Bayer AG; Bayer CropScience; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Bruel, C (corresponding author), Univ Lyon 1, CNRS, UMR Microbiol Adaptat & Pathogenie 5240, Bayer CropSci, F-69622 Villeurbanne, France.	christophe.bruel@univ-lyon1.fr			CNRS; University Lyon 1; Bayer CropScience; French ministry of Industry	CNRS(Centre National de la Recherche Scientifique (CNRS)); University Lyon 1; Bayer CropScience(Bayer AG); French ministry of Industry	This work was supported by the CNRS, the University Lyon 1 and Bayer CropScience. P. Landraud was supported by a grant from the French ministry of Industry and Bayer CropScience. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Vu BA, 2012, MOL PLANT MICROBE IN, V25, P1135, DOI 10.1094/MPMI-02-12-0043-R; Bohnert HU, 2004, PLANT CELL, V16, P2499, DOI 10.1105/tpc.104.022715; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chung KR, 2002, FEMS MICROBIOL LETT, V213, P33, DOI 10.1111/j.1574-6968.2002.tb11282.x; Collemare J, 2008, NEW PHYTOL, V179, P196, DOI 10.1111/j.1469-8137.2008.02459.x; Davis D, 2000, INFECT IMMUN, V68, P5953, DOI 10.1128/IAI.68.10.5953-5959.2000; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; DENISON SH, 1995, J BIOL CHEM, V270, P28519, DOI 10.1074/jbc.270.48.28519; Denison SH, 1998, MOL MICROBIOL, V30, P259, DOI 10.1046/j.1365-2958.1998.01058.x; Dieguez-Uribeondo J, 2008, PHYTOPATHOLOGY, V98, P1171, DOI 10.1094/PHYTO-98-11-1171; EKWAMU A, 1991, TROP PEST MANAGE, V37, P122, DOI 10.1080/09670879109371556; Eshel D, 2002, MOL PLANT MICROBE IN, V15, P774, DOI 10.1094/MPMI.2002.15.8.774; Galindo A, 2012, J CELL SCI, V125, P1784, DOI 10.1242/jcs.098897; HEBRAUD M, 1988, J GEN MICROBIOL, V134, P1123; Herranz S, 2005, P NATL ACAD SCI USA, V102, P12141, DOI 10.1073/pnas.0504776102; Hervas-Aguilar A, 2007, J BIOL CHEM, V282, P34735, DOI 10.1074/jbc.M706723200; Hua X, 2010, CORNEA, V29, P1440, DOI 10.1097/ICO.0b013e3181d8383a; Kankanala P, 2007, PLANT CELL, V19, P706, DOI 10.1105/tpc.106.046300; Kim YT, 2007, MOL PLANT PATHOL, V8, P611, DOI 10.1111/J.1364-3703.2007.00423.X; Lamb TM, 2003, MOL CELL BIOL, V23, P677, DOI 10.1128/MCB.23.2.677-686.2003; Lambert M, 1997, MOL CELL BIOL, V17, P3966, DOI 10.1128/MCB.17.7.3966; Li Y, 2010, MOL PLANT MICROBE IN, V23, P317, DOI 10.1094/MPMI-23-3-0317; Liu WD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001261; Martinez-Rossi NM, 2012, MYCOSES, V55, P381, DOI 10.1111/j.1439-0507.2011.02162.x; Mingot JM, 2001, MOL CELL BIOL, V21, P1688, DOI 10.1128/MCB.21.5.1688-1699.2001; Miyara I, 2008, MOL PLANT PATHOL, V9, P281, DOI 10.1111/J.1364-3703.2007.00462.X; Negrete-Urtasun S, 1999, MOL MICROBIOL, V33, P994, DOI 10.1046/j.1365-2958.1999.01540.x; NegreteUrtasun S, 1997, J BACTERIOL, V179, P1832, DOI 10.1128/jb.179.5.1832-1835.1997; Ou SH, 1985, RICE DIS; Penalva MA, 2008, TRENDS MICROBIOL, V16, P291, DOI 10.1016/j.tim.2008.03.006; Penas MM, 2007, EUKARYOT CELL, V6, P960, DOI 10.1128/EC.00047-07; Porta A, 1999, J BACTERIOL, V181, P7516, DOI 10.1128/JB.181.24.7516-7523.1999; Prusky D, 2003, MOL PLANT PATHOL, V4, P509, DOI [10.1046/j.1364-3703.2003.00196.x, 10.1046/J.1364-3703.2003.00196.X]; Prusky D, 2001, MOL PLANT MICROBE IN, V14, P1105, DOI 10.1094/MPMI.2001.14.9.1105; Ramanujam R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000897; Ramon AM, 1999, J BACTERIOL, V181, P7524, DOI 10.1128/JB.181.24.7524-7530.1999; Rho HS, 2009, MOL PLANT PATHOL, V10, P337, DOI [10.1111/J.1364-3703.2009.00536.X, 10.1111/j.1364-3703.2009.00536.x]; Rollins JA, 2003, MOL PLANT MICROBE IN, V16, P785, DOI 10.1094/MPMI.2003.16.9.785; Rollins JA, 2001, APPL ENVIRON MICROB, V67, P75, DOI 10.1128/AEM.67.1.75-81.2001; Scardaci SC, 1997, AGRONOMY FACT SHEET; Selvig Kyla, 2011, Mycobiology, V39, P249, DOI 10.5941/MYCO.2011.39.4.249; St Leger RJ, 1999, MICROBIOL-SGM, V145, P2691, DOI 10.1099/00221287-145-10-2691; Sweigard JA, 1997, FUNGAL GENET NEWSL, V44, P52, DOI DOI 10.4148/1941-4765.1287; Takeda T, 2010, APPL MICROBIOL BIOT, V88, P1113, DOI 10.1007/s00253-010-2781-2; Talbot NJ, 2003, ANNU REV MICROBIOL, V57, P177, DOI 10.1146/annurev.micro.57.030502.090957; TEUNISSEN MJ, 1991, ARCH MICROBIOL, V156, P290, DOI 10.1007/BF00263000; TILBURN J, 1995, EMBO J, V14, P779, DOI 10.1002/j.1460-2075.1995.tb07056.x; VERHOEFF K, 1988, J PHYTOPATHOL, V122, P327, DOI 10.1111/j.1439-0434.1988.tb01024.x; VERWOERD TC, 1989, NUCLEIC ACIDS RES, V17, P2362, DOI 10.1093/nar/17.6.2362; Villalba F, 2008, FUNGAL GENET BIOL, V45, P68, DOI 10.1016/j.fgb.2007.06.006; Werber G, 1997, ACUTE LEUKEMIAS 6 PR, pS512; You BJ, 2007, MOL PLANT MICROBE IN, V20, P1149, DOI 10.1094/MPMI-20-9-1149; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; Zhang HF, 2010, CURR GENET, V56, P517, DOI 10.1007/s00294-010-0319-x; Zhao XH, 2005, PLANT CELL, V17, P1317, DOI 10.1105/tpc.104.029116; Zou CG, 2010, ENVIRON MICROBIOL, V12, P1868, DOI 10.1111/j.1462-2920.2010.02191.x	56	41	48	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e69236	10.1371/journal.pone.0069236	http://dx.doi.org/10.1371/journal.pone.0069236			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874922	Green Published, gold, Green Submitted			2022-12-27	WOS:000322064300094
J	Lee, YW; Stachowiak, EK; Birkaya, B; Terranova, C; Capacchietti, M; Claus, P; Aletta, JM; Stachowiak, MK				Lee, Yu-Wei; Stachowiak, Ewa K.; Birkaya, Barbara; Terranova, Christopher; Capacchietti, Mariolina; Claus, Peter; Aletta, John M.; Stachowiak, Michal K.			NGF-Induced Cell Differentiation and Gene Activation Is Mediated by Integrative Nuclear FGFR1 Signaling (INFS)	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; TYROSINE-HYDROXYLASE GENE; FACTOR RECEPTOR-1 FGFR1; PC12 CELLS; PROTEIN-KINASE; PHEOCHROMOCYTOMA CELLS; ANGIOTENSIN-II; NEURONAL DIFFERENTIATION; DOPAMINERGIC-NEURONS; S6 KINASE	Nerve growth factor (NGF) is the founding member of the polypeptide neurotrophin family responsible for neuronal differentiation. To determine whether the effects of NGF rely upon novel Integrative Nuclear FGF Receptor-1 (FGFR1) Signaling (INFS) we utilized the PC12 clonal cell line, a long-standing benchmark model of sympathetic neuronal differentiation. We demonstrate that NGF increases expression of the fgfr1 gene and promotes trafficking of FGFR1 protein from cytoplasm to nucleus by inhibiting FGFR1 nuclear export. Nuclear-targeted dominant negative FGFR1 antagonizes NGF-induced neurite outgrowth, doublecortin (dcx) expression and activation of the tyrosine hydroxylase (th) gene promoter, while active constitutive nuclear FGFR1 mimics the effects of NGF. NGF increases the expression of dcx, th, beta III tubulin, nurr1 and nur77, fgfr1 and fibroblast growth factor-2 (fgf-2) genes, while enhancing binding of FGFR1 and Nur77/Nurr1 to those genes. NGF activates transcription from isolated NurRE and NBRE motifs. Nuclear FGFR1 transduces NGF activation of the Nur dimer and raises basal activity of the Nur monomer. Cooperation of nuclear FGFR1 with Nur77/Nurr1 in NGF signaling expands the integrative functions of INFS to include NGF, the first discovered pluripotent neurotrophic factor.	[Lee, Yu-Wei; Stachowiak, Ewa K.; Birkaya, Barbara; Terranova, Christopher; Capacchietti, Mariolina; Stachowiak, Michal K.] SUNY Buffalo, Dept Pathol & Anat Sci, Buffalo, NY 14260 USA; [Stachowiak, Ewa K.; Terranova, Christopher; Stachowiak, Michal K.] Western New York Stem Cells Culture & Anal Ctr, Buffalo, NY USA; [Aletta, John M.] New York State Ctr Excellence Bioinformat & Life, BioSyst LLC CH3, Buffalo, NY 14203 USA; [Claus, Peter] Hannover Med Sch, Inst Neuroanat, Hannover, Germany; [Claus, Peter] Univ Vet Med Hannover, Ctr Syst Neurosci, Hannover, Germany	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Hannover Medical School; University of Veterinary Medicine Hannover, Foundation	Aletta, JM (corresponding author), New York State Ctr Excellence Bioinformat & Life, BioSyst LLC CH3, Buffalo, NY 14203 USA.	jmaletta@ch3biosystems.com; mks4@buffalo.edu	Claus, Peter/A-7978-2008	Claus, Peter/0000-0003-3824-9445; Terranova, Christopher/0000-0002-3674-7013	NYSTEM [C026415, C026714]	NYSTEM	This work was supported by a grant from NYSTEM; Grant numbers: C026415, C026714 (http://stemcell.ny.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelastro JM, 2000, P NATL ACAD SCI USA, V97, P10424, DOI 10.1073/pnas.97.19.10424; Backman C, 1999, BRAIN RES, V851, P125, DOI 10.1016/S0006-8993(99)02149-6; Baron O, 2012, J BIOL CHEM, V287, P19827, DOI 10.1074/jbc.M112.347831; Bharali DJ, 2005, P NATL ACAD SCI USA, V102, P11539, DOI 10.1073/pnas.0504926102; Casado M, 1996, J PHYSIOL-LONDON, V490, P391, DOI 10.1113/jphysiol.1996.sp021153; Castillo SO, 1998, MOL CELL NEUROSCI, V11, P36, DOI 10.1006/mcne.1998.0673; Chevet E, 1999, J BIOL CHEM, V274, P20901, DOI 10.1074/jbc.274.30.20901; Chioni AM, 2012, J CELL BIOL, V197, P801, DOI 10.1083/jcb.201108077; Dunham-Ems SM, 2006, MOL BIOL CELL, V17, P2223, DOI 10.1091/mbc.E05-08-0749; Dunham-Ems SM, 2009, MOL BIOL CELL; Dunham-Ems SM, 2009, MOL BIOL CELL, V20, P2401, DOI 10.1091/mbc.E08-06-0600; Fang XH, 2005, J BIOL CHEM, V280, P28451, DOI 10.1074/jbc.M504400200; FISCHER I, 1991, EXP CELL RES, V194, P195, DOI 10.1016/0014-4827(91)90354-W; Ghee M, 1998, MOL BRAIN RES, V55, P101, DOI 10.1016/S0169-328X(97)00370-7; GREENE LA, 1984, TRENDS NEUROSCI, V7, P91, DOI 10.1016/S0166-2236(84)80164-2; GREENE LA, 1978, J CELL BIOL, V78, P747, DOI 10.1083/jcb.78.3.747; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Greene LA, 1982, ADV CELL NEUROBIOL; HANNEKEN A, 1995, J CELL BIOL, V128, P1221, DOI 10.1083/jcb.128.6.1221; HIRATA Y, 1995, J NEUROCHEM, V65, P1780; Horbinski C, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-2; Hu YF, 2004, J BIOL CHEM, V279, P29325, DOI 10.1074/jbc.M311144200; JOSHI HC, 1989, J CELL BIOL, V109, P663, DOI 10.1083/jcb.109.2.663; Kang SA, 2010, BIOCHEM PHARMACOL, V80, P867, DOI 10.1016/j.bcp.2010.04.026; Kim EL, 1996, J NEUROCHEM, V67, P26; Kolluri SK, 2003, MOL CELL BIOL, V23, P8651, DOI 10.1128/MCB.23.23.8651-8667.2003; Kornberg MD, 2010, NAT CELL BIOL, V12, P1094, DOI 10.1038/ncb2114; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; LEE V, 1982, BRAIN RES, V238, P169, DOI 10.1016/0006-8993(82)90779-X; Lee YW, 2012, J CELL BIOCHEM, V113, P2920, DOI 10.1002/jcb.24170; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; LINDENBAUM MH, 1987, J BIOL CHEM, V262, P605; Maira M, 2003, MOL CELL BIOL, V23, P763, DOI 10.1128/MCB.23.3.763-776.2003; Maira M, 1999, MOL CELL BIOL, V19, P7549; Maruoka H, 2010, J BIOCHEM, V148, P93, DOI 10.1093/jb/mvq036; Meisinger C, 1996, MOL BRAIN RES, V36, P70, DOI 10.1016/0169-328X(95)00246-O; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; Myers JM, 2003, J CELL BIOCHEM, V88, P1273, DOI 10.1002/jcb.10476; Nacher J, 2001, EUR J NEUROSCI, V14, P629, DOI 10.1046/j.0953-816x.2001.01683.x; NEUFELD G, 1987, J CELL PHYSIOL, V131, P131, DOI 10.1002/jcp.1041310119; NIKODIJEVIC B, 1991, J NEUROSCI RES, V28, P192, DOI 10.1002/jnr.490280206; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; OLAGUE PH, 1985, J NEUROSCI RES, V13, P301, DOI 10.1002/jnr.490130120; Peng H, 2002, J NEUROCHEM, V81, P506, DOI 10.1046/j.1471-4159.2002.00833.x; Peng H, 2001, MOL BIOL CELL, V12, P449, DOI 10.1091/mbc.12.2.449; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Popovici C, 2006, EXP CELL RES, V312, P1484, DOI 10.1016/j.yexcr.2006.01.012; Reilly JF, 2001, J CELL BIOL, V152, P1307, DOI 10.1083/jcb.152.6.1307; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; ROGERS SW, 1992, J NEUROSCI, V12, P4611; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; SCIMECA JC, 1992, J BIOL CHEM, V267, P17369; Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747; Silverman E, 2004, MOL CELL BIOL, V24, P10573, DOI 10.1128/MCB.24.24.10573-10583.2004; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Somanathan S, 2003, J CELL BIOCHEM, V90, P856, DOI 10.1002/jcb.10672; Stachowiak EK, 2003, J NEUROCHEM, V84, P1296, DOI 10.1046/j.1471-4159.2003.01624.x; Stachowiak EK, 1997, ONCOGENE, V14, P2201, DOI 10.1038/sj.onc.1201057; Stachowiak EK, 2011, STEM CELLS MECH TECH; Stachowiak EK, 2009, INTEGR BIOL-UK, V1, P394, DOI 10.1039/b902617g; Stachowiak MK, 2007, DNA CELL BIOL, V26, P811, DOI 10.1089/dna.2007.0664; Stachowiak Michal K, 2011, STEM CELLS MECH TECH; Stachowiak MK, 1996, MOL BIOL CELL, V7, P1299, DOI 10.1091/mbc.7.8.1299; Stachowiak MK, 2003, J CELL BIOCHEM, V90, P662, DOI 10.1002/jcb.10606; Stachowiak MK, 1997, MOL NEUROBIOL, V15, P257, DOI 10.1007/BF02740663; SZEBERENYI J, 1994, BBA-MOL CELL RES, V1222, P187, DOI 10.1016/0167-4889(94)90168-6; WATSON MA, 1990, DEVELOPMENT, V110, P173; Wingate AD, 2006, BIOCHEM J, V393, P715, DOI 10.1042/BJ20050967; WORONICZ JD, 1994, NATURE, V367, P277, DOI 10.1038/367277a0; Xing J, 1998, MOL CELL BIOL, V18, P1946, DOI 10.1128/MCB.18.4.1946; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248; Zhang T, 2007, NEUROSCI LETT, V423, P118, DOI 10.1016/j.neulet.2007.06.041	73	15	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68931	10.1371/journal.pone.0068931	http://dx.doi.org/10.1371/journal.pone.0068931			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874817	Green Submitted, Green Published, gold			2022-12-27	WOS:000321765300071
J	Frange, P; Meyer, L; Jung, M; Goujard, C; Zucman, D; Abel, S; Hochedez, P; Gousset, M; Gascuel, O; Rouzioux, C; Chaix, ML				Frange, Pierre; Meyer, Laurence; Jung, Matthieu; Goujard, Cecile; Zucman, David; Abel, Sylvie; Hochedez, Patrick; Gousset, Marine; Gascuel, Olivier; Rouzioux, Christine; Chaix, Marie-Laure		ANRS PRIMO Cohort Study Grp	Sexually-Transmitted/Founder HIV-1 Cannot Be Directly Predicted from Plasma or PBMC-Derived Viral Quasispecies in the Transmitting Partner	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SUBTYPE-C; SELECTIVE TRANSMISSION; GENITAL SECRETIONS; INFECTION; DIVERSITY; IDENTIFICATION; POPULATION; VARIANTS; BLOOD	Objective: Characterization of HIV-1 sequences in newly infected individuals is important for elucidating the mechanisms of viral sexual transmission. We report the identification of transmitted/founder viruses in eight pairs of HIV-1 sexually-infected patients enrolled at the time of primary infection ("recipients'') and their transmitting partners ("donors''). Methods: Using a single genome-amplification approach, we compared quasispecies in donors and recipients on the basis of 316 and 376 C2V5 env sequences amplified from plasma viral RNA and PBMC-associated DNA, respectively. Results: Both DNA and RNA sequences indicated very homogeneous viral populations in all recipients, suggesting transmission of a single variant, even in cases of recent sexually transmitted infections (STIs) in donors (n = 2) or recipients (n = 3). In all pairs, the transmitted/founder virus was derived from an infrequent variant population within the blood of the donor. The donor variant sequences most closely related to the recipient sequences were found in plasma samples in 3/8 cases and/or in PBMC samples in 6/8 cases. Although donors were exclusively (n = 4) or predominantly (n = 4) infected by CCR5-tropic (R5) strains, two recipients were infected with highly homogeneous CXCR4/dual-mixed-tropic (X4/DM) viral populations, identified in both DNA and RNA. The proportion of X4/DM quasispecies in donors was higher in cases of X4/DM than R5 HIV transmission (16.7-22.0% versus 0-2.6%), suggesting that X4/DM transmission may be associated with a threshold population of X4/DM circulating quasispecies in donors. Conclusions: These suggest that a severe genetic bottleneck occurs during subtype B HIV-1 heterosexual and homosexual transmission. Sexually-transmitted/founder virus cannot be directly predicted by analysis of the donor's quasispecies in plasma and/or PBMC. Additional studies are required to fully understand the traits that confer the capacity to transmit and establish infection, and determine the role of concomitant STIs in mitigating the genetic bottleneck in mucosal HIV transmission.	[Frange, Pierre; Gousset, Marine; Rouzioux, Christine; Chaix, Marie-Laure] Univ Paris 05, Equipe Accueil 3620, Sorbonne Paris Cite, Paris, France; [Frange, Pierre] Hop Necker Enfants Malad, Assistance Publ Hop Paris, Unite Immunol Hematol & Rhumatol Pediat, Paris, France; [Meyer, Laurence; Goujard, Cecile] Univ Paris 11, Hop Bicetre, Assistance Publ Hop Paris, Fac Med Paris Sud,INSERM,Ctr Rech Epidemiol & San, Le Kremlin Bicetre, France; [Jung, Matthieu; Gascuel, Olivier] CNRS, Inst Biol Computat, Lab Informat Robot & Microelect Montpellier, Unite Mixte Rech 5506, Montpellier, France; [Jung, Matthieu; Gascuel, Olivier] Univ Montpellier 2, Montpellier, France; [Goujard, Cecile] Hop Bicetre, Assistance Publ Hop Paris, Serv Med Interne, Le Kremlin Bicetre, France; [Zucman, David] Hop Foch, Serv Med Interne, Suresnes, France; [Abel, Sylvie; Hochedez, Patrick] Ctr Hosp Univ Ft de France, Serv Malad Infect & Trop, Fort De France, Martinique, France; [Gousset, Marine; Rouzioux, Christine; Chaix, Marie-Laure] Hop Necker Enfants Malad, Assistance Publ Hop Paris, Virol Lab, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Saclay; Hospital Foch; CHU Martinique; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite	Frange, P (corresponding author), Univ Paris 05, Equipe Accueil 3620, Sorbonne Paris Cite, Paris, France.	pierre.frange@nck.aphp.fr	Frange, Pierre/O-6311-2017	Cabie, Andre/0000-0003-0117-3061; Sotto, Albert/0000-0002-6463-9386; Prendki, Virginie/0000-0003-1315-2938; ABEL, Sylvie/0000-0002-3351-0547; Genet, Philippe/0000-0002-0253-9435	French National Agency for Research on AIDS and viral hepatitis [ANRS PRIMO CO06]; SIDACTION [BI22-1-01851]	French National Agency for Research on AIDS and viral hepatitis(ANRS); SIDACTION	This work was supported by grants from the French National Agency for Research on AIDS and viral hepatitis [ANRS PRIMO CO06] and by a scholarship (P. Frange) from SIDACTION [BI22-1-01851]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Abrahams MR, 2009, J VIROL, V83, P3556, DOI 10.1128/JVI.02132-08; Barin F, 2005, J CLIN MICROBIOL, V43, P4441, DOI 10.1128/JCM.43.9.4441-4447.2005; Bello G, 2008, AIDS, V22, P1993, DOI 10.1097/QAD.0b013e328315e0aa; Boeras DI, 2011, P NATL ACAD SCI USA, V108, pE1156, DOI 10.1073/pnas.1103764108; Chaix ML, 2003, AIDS, V17, P2635, DOI 10.1097/00002030-200312050-00011; Chalmet K, 2012, J INFECT DIS, V205, P174, DOI 10.1093/infdis/jir714; Delwart E, 2002, AIDS, V16, P189, DOI 10.1097/00002030-200201250-00007; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Frange P, 2010, J CLIN MICROBIOL, V48, P3487, DOI 10.1128/JCM.00704-10; Gottlieb GS, 2008, J INFECT DIS, V197, P1011, DOI 10.1086/529206; Grivel JC, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S6; Grobler J, 2004, J INFECT DIS, V190, P1355, DOI 10.1086/423940; Haaland RE, 2012, AIDS RES HUM RETROV, V28, P1524, DOI [10.1089/aid.2012.0004, 10.1089/AID.2012.0004]; Haaland RE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000274; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Le Vu S, 2009, AIDS, V23, P1771, DOI 10.1097/QAD.0b013e32832d8754; Learn GH, 2002, J VIROL, V76, P11953, DOI 10.1128/JVI.76.23.11953-11959.2002; Lee HY, 2009, J THEOR BIOL, V261, P341, DOI 10.1016/j.jtbi.2009.07.038; Li H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000890; Long EM, 2002, AIDS RES HUM RETROV, V18, P567, DOI 10.1089/088922202753747914; Long EM, 2000, NAT MED, V6, P71; Margolis L, 2006, NAT REV MICROBIOL, V4, P312, DOI 10.1038/nrmicro1387; Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090; Parker S R, 1997, Methods Mol Biol, V70, P145; Pillai SK, 2005, J VIROL, V79, P1734, DOI 10.1128/JVI.79.3.1734-1742.2005; POSS M, 1995, J VIROL, V69, P8118, DOI 10.1128/JVI.69.12.8118-8122.1995; Redd AD, 2012, J INFECT DIS, V206, P1433, DOI 10.1093/infdis/jis503; Rieder P, 2011, CLIN INFECT DIS, V53, P1271, DOI 10.1093/cid/cir725; Ritola K, 2004, J VIROL, V78, P11208, DOI 10.1128/JVI.78.20.11208-11218.2004; Rodrigo AG, 1997, AIDS RES HUM RETROV, V13, P737, DOI 10.1089/aid.1997.13.737; Sagar M, 2004, J VIROL, V78, P7279, DOI 10.1128/JVI.78.13.7279-7283.2004; Sagar M, 2004, AIDS, V18, P615, DOI 10.1097/00002030-200403050-00005; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Schuitemaker H, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S5; Shriner D, 2004, GENETICS, V167, P1573, DOI 10.1534/genetics.103.023382; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Troude P, 2009, AIDS, V23, P1261, DOI 10.1097/QAD.0b013e32832b51ef; Whitney JB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001293; WOLFS TFW, 1992, VIROLOGY, V189, P103, DOI 10.1016/0042-6822(92)90685-I; ZHANG LQ, 1993, J VIROL, V67, P3345, DOI 10.1128/JVI.67.6.3345-3356.1993; ZHU TF, 1993, SCIENCE, V261, P1179, DOI 10.1126/science.8356453; Zhu TF, 1996, J VIROL, V70, P3098, DOI 10.1128/JVI.70.5.3098-3107.1996	48	14	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e69144	10.1371/journal.pone.0069144	http://dx.doi.org/10.1371/journal.pone.0069144			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874894	gold, Green Published, Green Submitted			2022-12-27	WOS:000321736900138
J	Hill, E; Han, D; Dumouchel, P; Dehak, N; Quatieri, T; Moehs, C; Oscar-Berman, M; Giordano, J; Simpatico, T; Blum, K				Hill, Edward; Han, David; Dumouchel, Pierre; Dehak, Najim; Quatieri, Thomas; Moehs, Charles; Oscar-Berman, Marlene; Giordano, John; Simpatico, Thomas; Blum, Kenneth			Long Term Suboxone (TM) Emotional Reactivity As Measured by Automatic Detection in Speech	PLOS ONE			English	Article							POSITIVE EMOTIONS; SUBSTANCE-ABUSE; BUPRENORPHINE; DEPRESSION; DYSREGULATION; PREVALENCE; METHADONE; BENEFITS; ALCOHOL; CUES	Addictions to illicit drugs are among the nation's most critical public health and societal problems. The current opioid prescription epidemic and the need for buprenorphine/naloxone (Suboxone (R); SUBX) as an opioid maintenance substance, and its growing street diversion provided impetus to determine affective states ("true ground emotionality'') in long-term SUBX patients. Toward the goal of effective monitoring, we utilized emotion-detection in speech as a measure of "true'' emotionality in 36 SUBX patients compared to 44 individuals from the general population (GP) and 33 members of Alcoholics Anonymous (AA). Other less objective studies have investigated emotional reactivity of heroin, methadone and opioid abstinent patients. These studies indicate that current opioid users have abnormal emotional experience, characterized by heightened response to unpleasant stimuli and blunted response to pleasant stimuli. However, this is the first study to our knowledge to evaluate "true ground'' emotionality in long-term buprenorphine/naloxone combination (Suboxone (TM)). We found in long-term SUBX patients a significantly flat affect (p<0.01), and they had less self-awareness of being happy, sad, and anxious compared to both the GP and AA groups. We caution definitive interpretation of these seemingly important results until we compare the emotional reactivity of an opioid abstinent control using automatic detection in speech. These findings encourage continued research strategies in SUBX patients to target the specific brain regions responsible for relapse prevention of opioid addiction.	[Hill, Edward; Dumouchel, Pierre] Univ Quebec, Dept Software & Informat Technol Engn, Ecole Technol Super, Montreal, PQ H3C 3P8, Canada; [Han, David] Univ Texas San Antonio, Dept Management Sci & Stat, San Antonio, TX USA; [Dehak, Najim] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Quatieri, Thomas] MIT, Lincoln Lab, Lexington, MA 02173 USA; [Moehs, Charles] Occupat Med Associates, Watertown, NY USA; [Oscar-Berman, Marlene] Boston Univ, Dept Psychol, Sch Med, Boston, MA 02215 USA; [Oscar-Berman, Marlene] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Oscar-Berman, Marlene] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Oscar-Berman, Marlene] Boston Veteran Affaires Healthcare Syst, Boston, MA USA; [Giordano, John; Blum, Kenneth] G&G Holist Hlth Care Serv LLC, North Miami Beach, FL USA; [Simpatico, Thomas; Blum, Kenneth] Univ Vermont, Coll Med, Ctr Clin & Translat Sci, Global Integrated Serv Unit, Burlington, VT USA; [Blum, Kenneth] Univ Florida, Dept Psychiat, Coll Med, Gainesville, FL 32611 USA; [Blum, Kenneth] Univ Florida, Coll Med, McKnight Brain Inst, Gainesville, FL USA; [Blum, Kenneth] Dominion Diagnost LLC, North Kingstown, RI USA; [Blum, Kenneth] Path Fdn New York, Dept Clin Neurol, New York, NY USA; [Blum, Kenneth] Malibu Beach Recovery Ctr, Dept Addict Res & Therapy, Malibu Beach, CA USA; [Blum, Kenneth] Inst Integrat Omics & Appl Biotechnol, Purba Medinipur, W Bengal, India	University of Quebec; Ecole de Technologie Superieure - Canada; University of Quebec Montreal; University of Texas System; University of Texas at San Antonio (UTSA); Massachusetts Institute of Technology (MIT); Lincoln Laboratory; Massachusetts Institute of Technology (MIT); Boston University; Boston University; Boston University; University of Vermont; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Blum, K (corresponding author), G&G Holist Hlth Care Serv LLC, North Miami Beach, FL USA.	drd2gene@gmail.com	Simpatico, Thomas/O-1971-2019	Dehak, Najim/0000-0002-4489-5753; Berman, Marlene Oscar/0000-0003-0100-8883	National Institutes of Health, NIAAA [RO1-AA07112, K05-AA00219]; Medical Research Service of the US Department of Veterans Affairs; Assistant Secretary of Defense for Research & Engineering under Air Force [FA8721-05-C-0002]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA007112, K05AA000219] Funding Source: NIH RePORTER	National Institutes of Health, NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Medical Research Service of the US Department of Veterans Affairs(US Department of Veterans Affairs); Assistant Secretary of Defense for Research & Engineering under Air Force; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Marlene Oscar-Berman is the recipient of grants from the National Institutes of Health, NIAAA (RO1-AA07112 and K05-AA00219) and the Medical Research Service of the US Department of Veterans Affairs. Thomas Quatieri's work is sponsored by the Assistant Secretary of Defense for Research & Engineering under Air Force contract #FA8721-05-C-0002. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Arnott MI, 1993, J ACOUSTICAL SOC SPE, V93, P1097; Baroni M, 2012, REGRESSION 3 LOGISTI; Bates D., 2012, COMPUTATIONAL METHOD; Bates D., 2011, PACKAGE LME4 LINEAR; Blum K, 2012, ADDICTION RES THERAP, V3; Blum K, 2011, MOL NEUROBIOL, V44, P250, DOI 10.1007/s12035-011-8206-0; Bowirrat A, 2012, MOL NEUROBIOL, V45, P298, DOI 10.1007/s12035-012-8247-z; Cannizzaro MS, 2005, CLIN LINGUIST PHONET, V19, P649, DOI 10.1080/02699200412331271125; Centers for Disease Control and Prevention, 2007, BEST PRACT COMPR TOB; Cheetham A, 2010, CLIN PSYCHOL REV, V30, P621, DOI 10.1016/j.cpr.2010.04.005; Chiang CN, 2003, DRUG ALCOHOL DEPEN, V70, pS39, DOI 10.1016/S0376-8716(03)00058-9; COMINGS DE, 1995, BIOL PSYCHIAT, V37, P798, DOI 10.1016/0006-3223(94)00222-O; Connell J, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-138; de Arcos FA, 2008, PSYCHOPHARMACOLOGY, V198, P159, DOI 10.1007/s00213-008-1110-2; Dehak N, 2011, IEEE T AUDIO SPEECH, V19, P788, DOI 10.1109/TASL.2010.2064307; Dodge R, 2005, J SUBST ABUSE TREAT, V28, P189, DOI 10.1016/j.jsat.2004.12.005; Dumouchel P, 2009, INTERSPEECH 2009: 10TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2009, VOLS 1-5, P344; Fredrickson BL, 2001, AM PSYCHOL, V56, P218, DOI 10.1037/0003-066X.56.3.218; Goldstein RZ, 2007, NEUROIMAGE, V35, P194, DOI 10.1016/j.neuroimage.2006.12.004; Graham C, 2004, J ECON BEHAV ORGAN, V55, P319, DOI 10.1016/j.jebo.2003.09.002; Grant BF, 2004, ARCH GEN PSYCHIAT, V61, P807, DOI 10.1001/archpsyc.61.8.807; Hill E, 2011, STUDIES HLTH TECHNOL, V167; Horyniak D, 2011, INT J DRUG POLICY, V22, P167, DOI 10.1016/j.drugpo.2010.10.004; Hufford Michael R, 2007, SCI REAL TIME DATA C, P54; Institute for Signal and Information Processing Mississippi State University, 2012, ISIP TOOLK; Jaffe JH, 2003, DRUG ALCOHOL DEPEN, V70, pS3, DOI 10.1016/S0376-8716(03)00055-3; Luo RC, 2002, IEEE SENS J, V2, P107, DOI 10.1109/JSEN.2002.1000251; Lynch F, 2012, CLIN MED RES, V10, P170; Lyubomirsky S, 2005, PSYCHOL BULL, V131, P803, DOI 10.1037/0033-2909.131.6.803; Madrid GA, 2001, ALCOHOL, V23, P117, DOI 10.1016/S0741-8329(00)00138-5; Mei W, 2010, NEUROSCIENCE, V170, P808, DOI 10.1016/j.neuroscience.2010.07.033; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; Monette G, 2012, SUMMER PROGRAM DATA; Mundt JC, 2007, J NEUROLINGUIST, V20, P50, DOI 10.1016/j.jneuroling.2006.04.001; Office of National Drug Control Policy, 2004, EC COSTS DRUG AB US; Ozdas A, 2004, IEEE T BIO-MED ENG, V51, P1530, DOI 10.1109/TBME.2004.827544; Piette JD, 2000, AM J MANAG CARE, V6, P817; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; REYNOLDS DA, 1995, IEEE T SPEECH AUDI P, V3, P72, DOI 10.1109/89.365379; Reynolds DA, 2000, DIGIT SIGNAL PROCESS, V10, P19, DOI 10.1006/dspr.1999.0361; Savvas SM, 2012, ADDICTION, V107, P388, DOI 10.1111/j.1360-0443.2011.03634.x; Schuller B., 2009, INTERSPEECH 2009 EMO; Scott RL, 2001, ADDICTION RECOVERY T, P191; Snijders T. A. B., 2011, MULTILEVEL ANAL INTR; Steenbergen MR, 2002, AM J POLIT SCI, V46, P218, DOI 10.2307/3088424; Steidl S, 2005, INT CONF ACOUST SPEE, P317; Stone AA, 2002, ANN BEHAV MED, V24, P236, DOI 10.1207/S15324796ABM2403_09; Stone AA., 2007, SCI REAL TIME DATA C, P3; Sturim D, 2011, 12 ANN C INT SPEECH; Tato R, 2002, P INT C SPOK LANG PR; Tugade MM, 2004, J PERS, V72, P1161, DOI 10.1111/j.1467-6494.2004.00294.x; Verstraete AG, 2004, THER DRUG MONIT, V26, P200, DOI 10.1097/00007691-200404000-00020; von Ahn L, 2008, SCIENCE, V321, P1465, DOI 10.1126/science.1160379; Weisberg S., 2010, R COMPANION APPL REG; Wesson DR, 2010, J PSYCHOACTIVE DRUGS, V42, P161, DOI 10.1080/02791072.2010.10400689; Winstock AR, 2008, INT J DRUG POLICY, V19, P450, DOI 10.1016/j.drugpo.2007.03.002; WURMSER L, 1974, J AM PSYCHOANAL ASS, V22, P820, DOI 10.1177/000306517402200407; Young S, 2006, HTKBOOK	59	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e69043	10.1371/journal.pone.0069043	http://dx.doi.org/10.1371/journal.pone.0069043			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874860	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000321736900131
J	Wang, GB; Shi, J; Chen, N; Xu, LZ; Li, JL; Li, P; Sun, Y; Lu, L				Wang, Guibin; Shi, Jie; Chen, Na; Xu, Lingzhi; Li, Jiali; Li, Peng; Sun, Yan; Lu, Lin			Effects of Length of Abstinence on Decision-Making and Craving in Methamphetamine Abusers	PLOS ONE			English	Article							HEROIN; INCUBATION; COCAINE; SEEKING; STRESS; USERS; INDIVIDUALS; IMPULSIVITY; WITHDRAWAL; ADDICTION	Rationale: The majority of drug abusers are incapable of sustaining abstinence over any length of time. Accumulating evidence has linked intense and involuntary craving, Impulsive decision-making and mood disturbances to risk for relapse. However, little is known about temporal changes of these neuropsychological functions in methamphetamine (METH)dependent individuals. Objectives: To investigate the effect of length of abstinence on decision-making, craving (baseline and cue-induced), and emotional state in METH-addicted individuals. Methods: In this cross-sectional study, 183 adult METH-dependent patients at an addiction rehabilitation center who were abstinent for 6 days (n = 37), 14 days (n = 33), 1 month (n = 31), 3 months (n = 30), 6 months (n = 26), or 1 year (n = 30) and 39 healthy subjects were administered the Iowa Gambling Task (IGT) to assess decision-making performance. Depression, anxiety, and impulsivity were also examined. One hundred thirty-nine METH abusers who were abstinent for the aforementioned times then underwent a cue session, and subjective and physiological measures were assessed. Results: METH dependent individuals who were abstinent for longer periods of time exhibited better decision-making than those who were abstinent for shorter periods of time. And self-reported emotional symptoms improved with abstinence. METH abusers' ratings of craving decreased with the duration of abstinence, while cue-induced craving increased until 3 months of abstinence and decreased at 6 months and 1 year of abstinence. Conclusions: We present time-dependent alterations in decision-making, emotional state, and the incubation of cue-induced craving in METH-dependent individuals, which might have significant clinical implications for the prevention of relapse.	[Wang, Guibin; Shi, Jie; Chen, Na; Xu, Lingzhi; Li, Jiali; Li, Peng; Sun, Yan; Lu, Lin] Peking Univ, Natl Inst Drug Dependence, Beijing 100871, Peoples R China	Peking University	Wang, GB (corresponding author), Peking Univ, Natl Inst Drug Dependence, Beijing 100871, Peoples R China.	wangguibin@bjmu.edu.cn; shijie@bjmu.edu.cn	SHI, JIE/GXG-3394-2022; li, Jiali/HGF-2395-2022	li, Jiali/0000-0001-6202-7741	Natural Science Foundation of China [81000571]; National Science foundation for Distinguished Young Scholars of China [81225009]; National Basic Program of China [2009CB522000, 91132719]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Basic Program of China(National Basic Research Program of China)	This work was supported by the Natural Science Foundation of China (number 81000571), National Science foundation for Distinguished Young Scholars of China (number 81225009), National Basic Program of China (numbers 2009CB522000 and 91132719). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdolahi A, 2010, EUR J NEUROSCI, V31, P733, DOI 10.1111/j.1460-9568.2010.07114.x; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bolla KI, 2005, NEUROIMAGE, V26, P480, DOI 10.1016/j.neuroimage.2005.02.012; Buxton JA, 2008, CAN MED ASSOC J, V178, P1537, DOI 10.1503/cmaj.071234; Clark L, 2006, BIOL PSYCHIAT, V60, P515, DOI 10.1016/j.biopsych.2005.11.007; Darke S, 2008, DRUG ALCOHOL REV, V27, P253, DOI 10.1080/09595230801923702; Elkashef A, 2008, SUBST ABUS, V29, P31, DOI 10.1080/08897070802218554; Fatseas M, 2011, BIOL PSYCHIAT, V70, P720, DOI 10.1016/j.biopsych.2011.05.015; Gonzalez R, 2007, J CLIN EXP NEUROPSYC, V29, P155, DOI 10.1080/13803390600582446; Goudriaan AE, 2007, ALCOHOL CLIN EXP RES, V31, P928, DOI 10.1111/j.1530-0277.2007.00378.x; Grimm JW, 2005, PHYSIOL BEHAV, V84, P73, DOI 10.1016/j.physbeh.2004.10.011; Grimm JW, 2001, NATURE, V412, P141, DOI 10.1038/35084134; London ED, 2004, ARCH GEN PSYCHIAT, V61, P73, DOI 10.1001/archpsyc.61.1.73; Melega WP, 2008, NEUROPSYCHOPHARMACOL, V33, P1441, DOI 10.1038/sj.npp.1301502; Nakama H, 2008, AM J ADDICTION, V17, P441, DOI 10.1080/10550490802268462; Newton TF, 2004, AM J ADDICTION, V13, P248, DOI 10.1080/10550490490459915; OBRIEN CP, 1992, ANN NY ACAD SCI, V654, P400, DOI 10.1111/j.1749-6632.1992.tb25984.x; Rawson RA, 2004, ADDICTION, V99, P708, DOI 10.1111/j.1360-0443.2004.00707.x; Scott JC, 2007, NEUROPSYCHOL REV, V17, P275, DOI 10.1007/s11065-007-9031-0; Shalev U, 2001, PSYCHOPHARMACOLOGY, V156, P98, DOI 10.1007/s002130100748; Shepard JD, 2004, BIOL PSYCHIAT, V55, P1082, DOI 10.1016/j.biopsych.2004.02.032; Sinha R, 2001, PSYCHOPHARMACOLOGY, V158, P343, DOI 10.1007/s002130100917; Verdejo-Garcia A, 2007, DRUG ALCOHOL DEPEN, V86, P139, DOI 10.1016/j.drugalcdep.2006.05.024; Verdejo-Garcia AJ, 2007, ADDICT BEHAV, V32, P950, DOI 10.1016/j.addbeh.2006.06.032; Woicik PA, 2009, NEUROPSYCHOPHARMACOL, V34, P1112, DOI 10.1038/npp.2008.60; Zhang XL, 2011, AM J PSYCHIAT, V168, P610, DOI 10.1176/appi.ajp.2010.10040499	26	128	131	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e68791	10.1371/journal.pone.0068791	http://dx.doi.org/10.1371/journal.pone.0068791			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	188BY	23894345	Green Published, Green Submitted, gold			2022-12-27	WOS:000322167900025
J	Chen, H; Zhang, JP; Huang, H; Wang, ZH; Cheng, R; Cai, WB				Chen, Hui; Zhang, Jian-Ping; Huang, Hui; Wang, Zhen-Hua; Cheng, Rui; Cai, Wei-Bin			Leptin Promotes Fetal Lung Maturity and Upregulates SP-A Expression in Pulmonary Alveoli Type-II Epithelial Cells Involving TTF-1 Activation	PLOS ONE			English	Article							SURFACTANT-PROTEIN-A; GLUCOCORTICOIDS INCREASES; PRENATAL EXPOSURE; PLACENTAL LEPTIN; CYCLIC-AMP; MATURATION; GENE; GROWTH; SUSCEPTIBILITY; IDENTIFICATION	The placental hormone leptin has important functions in fetal and neonatal growth, and prevents depressed respiration in leptin-deficient mice. The effect of leptin on respiratory distress suffered by low birth weight and premature infants has been studied. However, it is unclear how leptin enhances lung maturity in the fetus and ameliorates neonatal respiratory distress. In the present study, we found that antenatal treatment with leptin for 2 d significantly enhanced the relative alveolus area and improved the maturity of fetal lungs in a rat model of fetal growth restriction (FGR). Mean birth weight and lung wet weight were higher in the leptin-treated group than in the PBS-treated group, indicating promotion of fetal growth. Leptin upregulated the intracellular expression and extracellular secretion of surfactant protein (SP) A in type-II alveolar epithelial cells (AECs) in vivo and in vitro. Dual positive effects of leptin were found on protein expression and transcriptional activity of thyroid transcription factor-1 (TTF-1), a nuclear transcription essential for branching morphogenesis of the lung and expression of SP-A in type-II AECs. Knockdown of TTF-1 by RNA interference indicated that TTF-1 may play a vital role in leptin-induced SP-A expression. These results suggest that leptin may have great therapeutic potential for the treatment of FGR, and leptin-mediated SP-A induction and lung maturity of the fetus are TTF-1 dependent.	[Chen, Hui; Zhang, Jian-Ping; Wang, Zhen-Hua] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Obstet & Gynecol, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Hui; Zhang, Jian-Ping] Sun Yat Sen Univ, Guangdong Higher Educ Inst, Key Lab Malignant Tumor Gene Regulat & Target The, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Hui] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Cardiol, Guangzhou 510275, Guangdong, Peoples R China; [Cheng, Rui; Cai, Wei-Bin] Sun Yat Sen Univ, Zhongshan Med Sch, Dept Biochem, Guangzhou 510275, Guangdong, Peoples R China; [Cai, Wei-Bin] Sun Yat Sen Univ, Ctr Dis Model Anim, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Cai, WB (corresponding author), Sun Yat Sen Univ, Zhongshan Med Sch, Dept Biochem, Guangzhou 510275, Guangdong, Peoples R China.	caiwb@mail.sysu.edu.cn			National Nature Science Foundation of China [81000259, 30973207, 81070746]; Guangdong Natural Science Foundation [10151008901000007, 10451008901004246]; Fundamental Research Funds for the Central Universities [09YKPY73, 12ykpy29]; Research Fund for the Doctoral Program of Higher Education of China [20090171120075]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This study was supported partially by National Nature Science Foundation of China (Nos. 81000259, 30973207 and 81070746), Guangdong Natural Science Foundation (Nos. 10151008901000007 and 10451008901004246), Fundamental Research Funds for the Central Universities (Youth Program 09YKPY73, 12ykpy29) and Research Fund for the Doctoral Program of Higher Education of China (No. 20090171120075). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlbom E, 2000, P NATL ACAD SCI USA, V97, P14726, DOI 10.1073/pnas.260501697; Bajoria R, 2002, PLACENTA, V23, P103, DOI 10.1053/plac.2001.0769; Bamfo JEAK, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/640715; Bergen HT, 2002, AM J RESP CELL MOL, V27, P71, DOI 10.1165/ajrcmb.27.1.4540; BOGGARAM V, 1988, J BIOL CHEM, V263, P2939; Boggaram V, 2009, CLIN SCI, V116, P27, DOI 10.1042/CS20080068; Bose C, 2009, PEDIATRICS, V124, pE450, DOI 10.1542/peds.2008-3249; BRUNO MD, 1995, J BIOL CHEM, V270, P6531, DOI 10.1074/jbc.270.12.6531; Bry K, 1997, J CLIN INVEST, V99, P2992, DOI 10.1172/JCI119494; Cai WB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053152; Chen M, 2004, AM J NEPHROL, V24, P497, DOI 10.1159/000080726; Christensen HD, 1997, J SOC GYNECOL INVEST, V4, P130, DOI 10.1177/107155769700400303; Cohen SL, 1996, NATURE, V382, P589, DOI 10.1038/382589a0; CROWLEY PA, 1995, AM J OBSTET GYNECOL, V173, P322, DOI 10.1016/0002-9378(95)90222-8; CUNNINGHAM AC, 1994, J CELL SCI, V107, P443; Dasgupta C, 2009, AM J PHYSIOL-LUNG C, V296, pL1031, DOI 10.1152/ajplung.90392.2008; Garbrecht MR, 2006, BIOL NEONATE, V89, P109, DOI 10.1159/000088653; Handy JA, 2010, J CELL BIOCHEM, V110, P1195, DOI 10.1002/jcb.22634; Hardie L, 1997, CLIN ENDOCRINOL, V47, P101, DOI 10.1046/j.1365-2265.1997.2441017.x; Hassink SG, 1997, PEDIATRICS, V100, part. no., DOI 10.1542/peds.100.1.e1; Huang K, 2008, J APPL PHYSIOL, V105, P249, DOI 10.1152/japplphysiol.00052.2007; Kaneko K, 2001, EARLY HUM DEV, V62, P11, DOI 10.1016/S0378-3782(00)00133-X; Kirwin SM, 2006, PEDIATR RES, V60, P200, DOI 10.1203/01.pdr.0000227478.29271.52; Klein JM, 2002, AM J PHYSIOL-LUNG C, V282, pL386, DOI 10.1152/ajplung.00410.2000; LAZZARO D, 1991, DEVELOPMENT, V113, P1093; Leroy P, 1996, J BIOL CHEM, V271, P2365, DOI 10.1074/jbc.271.5.2365; Li JX, 1998, J BIOL CHEM, V273, P4592, DOI 10.1074/jbc.273.8.4592; Lipsett J, 2006, PEDIATR PULM, V41, P1138, DOI 10.1002/ppul.20480; Malli F, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-152; Mancuso P, 2002, J IMMUNOL, V168, P4018, DOI 10.4049/jimmunol.168.8.4018; Maritz GS, 2005, EARLY HUM DEV, V81, P763, DOI 10.1016/j.earlhumdev.2005.07.002; Masuzaki H, 1997, NAT MED, V3, P1029, DOI 10.1038/nm0997-1029; O'Donnell CP, 1999, AM J RESP CRIT CARE, V159, P1477, DOI 10.1164/ajrccm.159.5.9809025; Otero M, 2005, FEBS LETT, V579, P295, DOI 10.1016/j.febslet.2004.11.024; Paraskevas KI, 2006, CURR DRUG TARGETS, V7, P761, DOI 10.2174/138945006777435371; Pas ABT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000192; Pogach MS, 2007, J CELL BIOCHEM, V100, P1415, DOI 10.1002/jcb.21142; Samtani MN, 2006, J PHARMACOL EXP THER, V317, P117, DOI 10.1124/jpet.105.095851; Sato A, 2011, AM J PHYSIOL-LUNG C, V300, pL498, DOI 10.1152/ajplung.00418.2010; Stewart JD, 1998, AM J OBSTET GYNECOL, V179, P1241, DOI 10.1016/S0002-9378(98)70140-1; Tagne JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029907; Tankersley CG, 1998, J APPL PHYSIOL, V85, P2261, DOI 10.1152/jappl.1998.85.6.2261; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Torday JS, 2002, AM J PHYSIOL-LUNG C, V282, pL405, DOI 10.1152/ajplung.2002.282.3.L405; Torday S, 2009, EVOL DEV, V11, P219, DOI 10.1111/j.1525-142X.2009.00321.x; Yi M, 2002, J BIOL CHEM, V277, P2997, DOI 10.1074/jbc.M109793200	47	20	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69297	10.1371/journal.pone.0069297	http://dx.doi.org/10.1371/journal.pone.0069297			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894445	gold, Green Published, Green Submitted			2022-12-27	WOS:000322132100053
J	Kim, H; Jebrail, MJ; Sinha, A; Bent, ZW; Solberg, OD; Williams, KP; Langevin, SA; Renzi, RF; Van De Vreugde, JL; Meagher, RJ; Schoeniger, JS; Lane, TW; Branda, SS; Bartsch, MS; Patel, KD				Kim, Hanyoup; Jebrail, Mais J.; Sinha, Anupama; Bent, Zachary W.; Solberg, Owen D.; Williams, Kelly P.; Langevin, Stanley A.; Renzi, Ronald F.; Van De Vreugde, James L.; Meagher, Robert J.; Schoeniger, Joseph S.; Lane, Todd W.; Branda, Steven S.; Bartsch, Michael S.; Patel, Kamlesh D.			A Microfluidic DNA Library Preparation Platform for Next-Generation Sequencing	PLOS ONE			English	Article							PLURONIC ADDITIVES; SAMPLE PREPARATION; READ ALIGNMENT; CHEMISTRY; DROPLETS	Next-generation sequencing (NGS) is emerging as a powerful tool for elucidating genetic information for a wide range of applications. Unfortunately, the surging popularity of NGS has not yet been accompanied by an improvement in automated techniques for preparing formatted sequencing libraries. To address this challenge, we have developed a prototype microfluidic system for preparing sequencer-ready DNA libraries for analysis by Illumina sequencing. Our system combines droplet-based digital microfluidic (DMF) sample handling with peripheral modules to create a fully-integrated, sample-in library-out platform. In this report, we use our automated system to prepare NGS libraries from samples of human and bacterial genomic DNA. E. coli libraries prepared on-device from 5 ng of total DNA yielded excellent sequence coverage over the entire bacterial genome, with >99% alignment to the reference genome, even genome coverage, and good quality scores. Furthermore, we produced a de novo assembly on a previously unsequenced multi-drug resistant Klebsiella pneumoniae strain BAA-2146 (KpnNDM). The new method described here is fast, robust, scalable, and automated. Our device for library preparation will assist in the integration of NGS technology into a wide variety of laboratories, including small research laboratories and clinical laboratories.	[Kim, Hanyoup; Jebrail, Mais J.; Meagher, Robert J.; Branda, Steven S.] Sandia Natl Labs, Dept Biotechnol & Bioengn, Livermore, CA USA; [Sinha, Anupama; Bent, Zachary W.; Solberg, Owen D.; Williams, Kelly P.; Langevin, Stanley A.; Schoeniger, Joseph S.; Lane, Todd W.] Sandia Natl Labs, Dept Syst Biol, Livermore, CA USA; [Renzi, Ronald F.; Van De Vreugde, James L.; Bartsch, Michael S.; Patel, Kamlesh D.] Sandia Natl Labs, Livermore, CA USA	United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Sandia National Laboratories	Patel, KD (corresponding author), Sandia Natl Labs, Livermore, CA USA.	kdpatel@sandia.gov		Meagher, Robert/0000-0002-6262-2126; Lane, Todd/0000-0002-5816-2649; Bartsch, Michael/0000-0002-0409-5129; Branda, Steven/0000-0001-8763-1013	Sandia National Laboratories' Grand Challenge LDRD (Laboratory-Directed Research and Development) [142042]; U.S. Department of Energy's National Nuclear Security Administration [DE-AC04-94AL85000]	Sandia National Laboratories' Grand Challenge LDRD (Laboratory-Directed Research and Development); U.S. Department of Energy's National Nuclear Security Administration(National Nuclear Security Administration)	This work was funded by Sandia National Laboratories' Grand Challenge LDRD (Laboratory-Directed Research and Development, grant number 142042) program. Sandia is a multiprogram laboratory operated by Sandia Corporation, a Lockheed Martin company, for the U.S. Department of Energy's National Nuclear Security Administration under Contract DE-AC04-94AL85000. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelgawad M, 2008, LAB CHIP, V8, P672, DOI 10.1039/b801516c; Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119; [Anonymous], 2010, ILLUMINA SAMPLE PREP; [Anonymous], 2012, NEXTERA XT DNA SAMPL; [Anonymous], 2012, INTRO NEXT GENERATIO; [Anonymous], 2013, ILM 32I DNA LIB PROT; [Anonymous], 2013, SEQCAP EZ HUMAN EXOM; [Anonymous], 2010, DNA SAMPLE PREPARATI; Au SH, 2011, LANGMUIR, V27, P8586, DOI 10.1021/la201185c; Baum A, 2010, P NATL ACAD SCI USA, V107, P16303, DOI 10.1073/pnas.1005077107; Bokulich NA, 2012, PLOS ONE, V7; Boles DJ, 2011, ANAL CHEM, V83, P8439, DOI 10.1021/ac201416j; Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310; Grunenwald H, 2010, NAT METHODS, V7, pIII, DOI 10.1038/nmeth.f.310; Hua ZS, 2010, ANAL CHEM, V82, P2310, DOI 10.1021/ac902510u; Jebrail M. J., 2009, JOVE-J VIS EXP, pe1603, DOI DOI 10.3791/1603; Jebrail MJ, 2012, J FLOW CHEM, V2, P103, DOI 10.1556/JFC-D-12-00012; Jebrail MJ, 2012, LAB CHIP, V12, P2452, DOI 10.1039/c2lc40318h; Jebrail MJ, 2011, LAB CHIP, V11, P3218, DOI 10.1039/c1lc20524b; Jebrail MJ, 2009, ANAL CHEM, V81, P330, DOI 10.1021/ac8021554; Kim H, 2011, JALA-J LAB AUTOM, V16, P405, DOI 10.1016/j.jala.2011.07.001; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lennon NJ, 2010, GENOME BIOL, V11; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Luk VN, 2008, LANGMUIR, V24, P6382, DOI 10.1021/la7039509; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Miller EM, 2008, ANAL CHEM, V80, P1614, DOI 10.1021/ac702269d; Moon H, 2006, LAB CHIP, V6, P1213, DOI 10.1039/b601954d; Mousa NA, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000105; Najmabadi H, 2011, NATURE, V478, P57, DOI 10.1038/nature10423; Nakamura S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004219; Nextera&REG, 2012, NEXTERA SAMPLE PREP; Nextera&TRADE, 2011, NEXTERA DNA SAMPLE P; Ng AHC, 2012, ANAL CHEM, V84, P8805, DOI 10.1021/ac3020627; Pollack MG, 2000, APPL PHYS LETT, V77, P1725, DOI 10.1063/1.1308534; Rodrigue S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011840; Scholz MB, 2012, CURR OPIN BIOTECH, V23, P9, DOI 10.1016/j.copbio.2011.11.013; Shih SCC, 2011, LAB CHIP, V11, P535, DOI 10.1039/c0lc00223b; Sista R, 2008, LAB CHIP, V8, P2091, DOI 10.1039/b814922d; Sista RS, 2008, LAB CHIP, V8, P2188, DOI 10.1039/b807855f; Thaitrong N, 2012, ELECTROPHORESIS, V33, P3506, DOI 10.1002/elps.201200441; Vergauwe N, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/5/054026; Wheeler AR, 2008, SCIENCE, V322, P539, DOI 10.1126/science.1165719; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	45	42	52	5	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e68988	10.1371/journal.pone.0068988	http://dx.doi.org/10.1371/journal.pone.0068988			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894387	Green Submitted, Green Published, gold			2022-12-27	WOS:000322132100036
J	Liu, DM; Yang, J; Li, YJ; Zhang, M; Wang, L				Liu, Dongmei; Yang, Jian; Li, Yingjun; Zhang, Meng; Wang, Lan			Cd-Induced Apoptosis through the Mitochondrial Pathway in the Hepatopancreas of the Freshwater Crab Sinopotamon henanense	PLOS ONE			English	Article							CADMIUM-INDUCED APOPTOSIS; CYTOCHROME-C; ENDOPLASMIC-RETICULUM; CASPASE-9 ACTIVATION; DEPENDENT APOPTOSIS; OXIDATIVE STRESS; CELLS; DEATH; ACCUMULATION; PROTEIN	Cd is one of the most common pollutants in the environment that also induces the apoptosis. To explore the mechanism of apoptosis in the hepatopancreas, freshwater crab S. henanense were treated with 0, 3.56, 7.12, 14.25, 28.49 and 56.98 mg/L Cd for 72 h. Apoptosis was noticeable in every treatment group and necrosis was observed clearly in the high concentration Cd groups. Classical apoptotic bodies were found by transmission electronic microscopy, which revealed chromatin condensation under nuclear membrane and mitochondrial membrane rupture. An increasing number of autolysosomes, damaged rough endoplamic reticulum and Golgi complex were observed as the Cd concentration increase. Brown colored apoptotic cells were detected by the TUNEL test in all Cd-treatment groups. The apoptosis index increased following the elevation of Cd concentration and got 32.9% in the highest Cd group. Caspase-9 and caspase-3 activities increased in the lower Cd treatment groups but no changes in the higher Cd concentration groups (comparing to the control group). The activity of caspase-8 did not change significantly. No significant change in the content of mitochondrial cytochrome c (cyt c) in Cd exposed groups except the decrease in the 56.98 mg/L group. In crabs treated with 3.56, 7.12 and 14.25 mg/L Cd, hyperpolarization of mitochondrial membrane potential (Delta psi(m)) significantly increased. These results implied that apoptosis in the hepatopancreas induced by Cd occurrs through the mitochondrial caspase-dependent pathway. However, whether there are other apoptotic pathways needs to be studied further.	[Liu, Dongmei; Yang, Jian; Li, Yingjun; Wang, Lan] Shanxi Univ, Sch Life Sci, Lab Bioeffect & Mol Mech Class Environm Pollutan, Taiyuan, Shanxi Province, Peoples R China; [Zhang, Meng] Nankai Univ, Inst Mol Biol, Tianjin 300071, Peoples R China	Shanxi University; Nankai University	Wang, L (corresponding author), Shanxi Univ, Sch Life Sci, Lab Bioeffect & Mol Mech Class Environm Pollutan, Taiyuan, Shanxi Province, Peoples R China.	lanwang@sxu.edu.cn			National Nature Science Foundation [30870267]; Shanxi Province Nature Science Foundation [2008011069]	National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); Shanxi Province Nature Science Foundation	This work was sponsored by National Nature Science Foundation (No. 30870267) and Shanxi Province Nature Science Foundation (No. 2008011069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balzan R, 2004, MICROBIOL-SGM, V150, P109, DOI 10.1099/mic.0.26578-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cande C, 2002, BIOCHIMIE, V84, P215, DOI 10.1016/S0300-9084(02)01374-3; Cannino G, 2009, MOL CELL BIOCHEM, V328, P75, DOI 10.1007/s11010-009-0076-7; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P1396, DOI 10.1038/sj.cdd.4401963; Devi M, 1996, ECOTOX ENVIRON SAFE, V33, P38, DOI 10.1006/eesa.1996.0004; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Eeva J, 2009, APOPTOSIS, V14, P687, DOI 10.1007/s10495-009-0337-7; Eichler T, 2006, TOXICOL SCI, V90, P392, DOI 10.1093/toxsci/kfj106; Fang Y, 2010, COMP BIOCHEM PHYS C, V151, P325, DOI 10.1016/j.cbpc.2009.12.005; Gogvadze V, 2006, BBA-BIOENERGETICS, V1757, P639, DOI 10.1016/j.bbabio.2006.03.016; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; HAMADA T, 1991, TOXICOL PATHOL, V19, P138, DOI 10.1177/019262339101900208; Hart BA, 2001, TOXICOLOGY, V160, P65, DOI 10.1016/S0300-483X(00)00436-4; Hewitson Tim D, 2006, Methods Mol Biol, V326, P227; Hewitson TD, 2010, METHODS MOL BIOL, V611, P161, DOI 10.1007/978-1-60327-345-9_13; Hossain S, 2009, NEUROTOXICOLOGY, V30, P544, DOI 10.1016/j.neuro.2009.06.001; JACOBS EE, 1960, J BIOL CHEM, V235, P531; Jarup L, 2009, TOXICOL APPL PHARM, V238, P201, DOI 10.1016/j.taap.2009.04.020; Kadenbach B, 2004, BBA-BIOENERGETICS, V1655, P400, DOI 10.1016/j.bbabio.2003.06.005; Kim J, 2009, TOXICOL LETT, V188, P45, DOI 10.1016/j.toxlet.2009.03.006; Kim S, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-4; Kondoh M, 2002, TOXICOLOGY, V170, P111, DOI 10.1016/S0300-483X(01)00536-4; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Lee HJ, 2008, CANCER LETT, V270, P342, DOI 10.1016/j.canlet.2008.05.040; Lee WK, 2006, AM J PHYSIOL-RENAL, V291, pF823, DOI 10.1152/ajprenal.00276.2005; Lemarie A, 2004, FREE RADICAL BIO MED, V36, P1517, DOI 10.1016/j.freeradbiomed.2004.03.020; Li K, 2000, CELL, V101, P389, DOI 10.1016/S0092-8674(00)80849-1; Li RJ, 2011, AQUAC RES, V42, P506, DOI 10.1111/j.1365-2109.2010.02646.x; Li Y, 2007, ENVIRON TOXICOL PHAR, V24, P231, DOI 10.1016/j.etap.2007.05.010; Liu DM, 2013, MICRON, V47, P24, DOI 10.1016/j.micron.2013.01.002; Liu DM, 2011, AQUAT TOXICOL, V105, P394, DOI 10.1016/j.aquatox.2011.07.013; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; MAO XW, 2007, CHINESE J HLTH LAB T, V17, P2288; Mathur A, 2000, CARDIOVASC RES, V46, P126, DOI 10.1016/S0008-6363(00)00002-X; Matsumura M, 2010, TRANSPL IMMUNOL, V23, P174, DOI 10.1016/j.trim.2010.06.003; McPherson R, 2001, SCI TOTAL ENVIRON, V279, P223, DOI 10.1016/S0048-9697(01)00799-9; Nargund AM, 2008, APOPTOSIS, V13, P811, DOI 10.1007/s10495-008-0215-8; Oh SH, 2006, TOXICOL APPL PHARM, V212, P212, DOI 10.1016/j.taap.2005.07.018; Oh SH, 2006, TOXICOLOGY, V220, P1, DOI 10.1016/j.tox.2005.08.025; Orrenius S, 2004, TOXICOL LETT, V149, P19, DOI 10.1016/j.toxlet.2003.12.017; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Pulkkanen KJ, 2000, APOPTOSIS, V5, P329, DOI 10.1023/A:1009631424351; Reinecke AJ, 2003, WATER AIR SOIL POLL, V145, P395, DOI 10.1023/A:1023602121272; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Salvesen GS, 1999, STRUCT FOLD DES, V7, pR225, DOI 10.1016/S0969-2126(00)80048-9; Sancho P, 2006, APOPTOSIS, V11, P673, DOI 10.1007/s10495-006-5879-3; Schuwerack PMM, 2003, CELL TISSUE RES, V312, P249, DOI 10.1007/s00441-002-0630-z; Schuwerack PMM, 2001, ECOTOXICOLOGY, V10, P159, DOI 10.1023/A:1016689810391; Shen HM, 2001, TOXICOL APPL PHARM, V171, P12, DOI 10.1006/taap.2000.9092; SHI Y, 2005, J CANC MOL, V1, P9; Silvestre F, 2005, COMP BIOCHEM PHYS C, V140, P39, DOI 10.1016/j.cca.2005.01.004; Stiban J, 2008, J LIPID RES, V49, P625, DOI 10.1194/jlr.M700480-JLR200; Tokumoto Maki, 2012, Nihon Eiseigaku Zasshi, V67, P472; Wang JX, 2012, COMP BIOCHEM PHYS C, V156, P195, DOI 10.1016/j.cbpc.2012.05.006; Wang MJ, 2009, AQUAT TOXICOL, V95, P99, DOI 10.1016/j.aquatox.2009.08.006; Wang Qian, 2003, Shanxi Daxue Xuebao Ziran Kexue Ban, V26, P176; Wang SH, 2009, CHEM-BIOL INTERACT, V181, P45, DOI 10.1016/j.cbi.2009.05.004; Wang SC, 2008, TOXICOL SCI, V102, P345, DOI 10.1093/toxsci/kfm220; Willers S, 2005, RESP MED, V99, P1521, DOI 10.1016/j.rmed.2005.03.017; Wu H, 2013, ENVIRON SCI POLLUT R, V20, P4085, DOI 10.1007/s11356-012-1362-6; Xuan RJ, 2013, ECOTOX ENVIRON SAFE, V89, P29, DOI 10.1016/j.ecoenv.2012.10.022; Zhang L, 2007, AQUAT TOXICOL, V85, P143, DOI 10.1016/j.aquatox.2007.08.008; Zhang WW, 2011, MOL CELL BIOCHEM, V354, P29, DOI 10.1007/s11010-011-0802-9	64	22	27	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e68770	10.1371/journal.pone.0068770	http://dx.doi.org/10.1371/journal.pone.0068770			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894343	Green Submitted, Green Published, gold			2022-12-27	WOS:000322132100025
J	Zhuang, HY; Gao, J; Hu, ZH; Liu, JJ; Liu, DW; Lin, B				Zhuang, Huiyu; Gao, Jian; Hu, Zhenhua; Liu, Juanjuan; Liu, Dawo; Lin, Bei			Co-Expression of Lewis y Antigen with Human Epididymis Protein 4 in Ovarian Epithelial Carcinoma	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; ALPHA-FETOPROTEIN; PELVIC MASS; HE-4 WFDC2; CANCER; EXPRESSION; MULTIPLE; ADHESION; GROWTH; CELLS	Objective: The main aims of this study were to explore the molecular structural relationship between Human epididymis protein 4 (HE4) and Lewis y antigen by determining their expression patterns and clinical significance in ovarian epithelial carcinoma. Methods: The structural relationship between HE4 and Lewis y antigen was examined using immunoprecipitation and confocal laser scanning microscopy. HE4 and Lewis y were detected in tissues from malignant (53 cases), borderline (27 cases), benign (15 cases) and normal ovarian tissues (15 cases) using immunohistochemical analysis. Results: HE4 was present in ovarian cancer, benign tumor tissues, ovarian carcinoma cells, and culture medium, and contained Lewis y antigen. Moreover, expression of Lewis y antigen in HE4 from ovarian cancer was higher than that from benign tumor (P<0.05). HE4 possibly exists as two protein isoforms, both containing Lewis y antigen. Our immunohistochemistry data revealed significantly higher positive expression rates of HE4 in malignant ovarian tissues, compared to benign tumor and normal tissue (P<0.05), similar to Lewis y antigen levels in ovarian cancer (P<0.05). Notably, tissues displaying marked expression of HE4 simultaneously expressed high levels of Lewis y antigen. A linear correlation between the expression patterns of HE4 and Lewis y antigen was evident. Consistently, double-labeling immunofluorescence experiments illustrated co-localization of HE4 and Lewis y antigen within the same area. Conclusions: HE4 contains Lewis y antigen. Our results further demonstrate a close correlation between the expression levels of the two antigens, which are significantly high in ovarian cancer.	[Zhuang, Huiyu; Gao, Jian; Hu, Zhenhua; Liu, Juanjuan; Liu, Dawo; Lin, Bei] China Med Univ, Shengjing Hosp, Dept Obstet & Gynecol, Shenyang, Liaoning Provin, Peoples R China	China Medical University	Lin, B (corresponding author), China Med Univ, Shengjing Hosp, Dept Obstet & Gynecol, Shenyang, Liaoning Provin, Peoples R China.	linbei88@hotmail.com			National Natural Science Foundation of China [30872757, 81072118, 81172491, 81101527]; Ph. D. Programs Foundation of Ministry of Education of China [20112104110016, 20112104120019]; Science Committee Foundation of Shenyang City, China [F10-14-9-9-52]; Shengjing Free Researcher Project [200807]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph. D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Science Committee Foundation of Shenyang City, China; Shengjing Free Researcher Project	This work is supported by the National Natural Science Foundation of China (No. 30872757, 81072118, 81172491, 81101527); Ph. D. Programs Foundation of Ministry of Education of China (No. 20112104110016, 20112104120019); Science Committee Foundation of Shenyang City, China (No. F10-14-9-9-52); Shengjing Free Researcher Project (No. 200807). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bingle L, 2002, ONCOGENE, V21, P2768, DOI 10.1038/sj.onc.1205363; Chhieng DC, 2003, HUM PATHOL, V34, P1016, DOI 10.1053/S0046-8177(03)00355-1; Drapkin R, 2005, CANCER RES, V65, P2162, DOI 10.1158/0008-5472.CAN-04-3924; Food and Drug Administration HHS, 2005, FED REGISTER, V70, P57748; Gao LL, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-15; Hellstrom I, 2003, CANCER RES, V63, P3695; Klinger M, 2004, CANCER RES, V64, P1087, DOI 10.1158/0008-5472.CAN-03-2435; Li QR, 2010, INT J GYNECOL CANCER, V20, P1482, DOI 10.1111/IGC.0b013e3181ea7ecb; Liu JJ, 2010, ONCOL REP, V23, P833, DOI 10.3892/or_00000705; Lu RQ, 2012, BIOCHEM BIOPH RES CO, V419, P274, DOI 10.1016/j.bbrc.2012.02.008; Mita Y, 2000, J HEPATOL, V32, P946, DOI 10.1016/S0168-8278(00)80099-9; Moore RG, 2008, GYNECOL ONCOL, V108, P402, DOI 10.1016/j.ygyno.2007.10.017; Moore RG, 2009, GYNECOL ONCOL, V112, P40, DOI 10.1016/j.ygyno.2008.08.031; Moriwaki K, 2010, WORLD J HEPATOL, V2, P151, DOI 10.4254/wjh.v2.i4.151; Orczyk-Pawilowicz Magdalena, 2007, Postepy Hig Med Dosw (Online), V61, P240; Roseman S, 2001, J BIOL CHEM, V276, P41527, DOI 10.1074/jbc.R100053200; Schummer M, 1999, GENE, V238, P375, DOI 10.1016/S0378-1119(99)00342-X; SHIRAKI K, 1995, HEPATOLOGY, V22, P802, DOI 10.1002/hep.1840220317; Tokuishi K, 2012, TUMOR BIOL, V33, P103, DOI 10.1007/s13277-011-0252-8; Wang XC, 2006, J BIOL CHEM, V281, P2572, DOI 10.1074/jbc.M510893200; Yan LM, 2010, BIOCHIMIE, V92, P852, DOI 10.1016/j.biochi.2010.02.012; Yin BWT, 1996, INT J CANCER, V65, P406, DOI 10.1002/(SICI)1097-0215(19960208)65:4<406::AID-IJC2>3.3.CO;2-5	22	25	28	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e68994	10.1371/journal.pone.0068994	http://dx.doi.org/10.1371/journal.pone.0068994			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894390	Green Published, gold, Green Submitted			2022-12-27	WOS:000322132100037
J	Cizelsky, W; Hempel, A; Metzig, M; Tao, S; Hollemann, T; Kuhl, M; Kuhl, SJ				Cizelsky, Wiebke; Hempel, Annemarie; Metzig, Marlen; Tao, Si; Hollemann, Thomas; Kuehl, Michael; Kuehl, Susanne J.			sox4 And sox11 Function during Xenopus laevis Eye Development	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SOX11; SRY-RELATED GENES; CELL-DIFFERENTIATION; EXPRESSION PATTERNS; ZEBRAFISH; INDUCTION; SPECIFICATION; PROGENITORS; SURVIVAL; REVEALS	SoxC genes are involved in many developmental processes such as cardiac, lymphoid, and bone development. The SoxC gene family is represented by Sox4, Sox11, and Sox12. Loss of either Sox4 or Sox11 function is lethal during mouse embryogenesis. Here, we demonstrate that sox4 and sox11 are strongly expressed in the developing eye, heart as well as brain in Xenopus laevis. Morpholino oligonucleotide mediated knock-down approaches in anterior neural tissue revealed that interference with either Sox4 or Sox11 function affects eye development. A detailed analysis demonstrated strong effects on eye size and retinal lamination. Neural induction was unaffected upon Sox4 or Sox11 MO injection and early eye field differentiation and cell proliferation were only mildly affected. Depletion of both genes, however, led independently to a significant increase in cell apoptosis in the eye. In summary, Sox4 and Sox11 are required for Xenopus visual system development.	[Cizelsky, Wiebke; Hempel, Annemarie; Tao, Si; Kuehl, Michael; Kuehl, Susanne J.] Univ Ulm, Inst Biochem & Mol Biol, D-89069 Ulm, Germany; [Cizelsky, Wiebke; Hempel, Annemarie; Tao, Si] Univ Ulm, Int Grad Sch Mol Med Ulm, D-89069 Ulm, Germany; [Metzig, Marlen; Hollemann, Thomas] Univ Halle Wittenberg, Inst Physiol Chem, D-06108 Halle, Germany	Ulm University; Ulm University; Martin Luther University Halle Wittenberg	Kuhl, SJ (corresponding author), Univ Ulm, Inst Biochem & Mol Biol, D-89069 Ulm, Germany.	susanne.kuehl@uni-ulm.de			Deutsche Forschungsgemeinschaft (DFG) [SFB 497, TPA6, DFG HO1879]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG; SFB 497, TPA6 to MK) and (DFG HO1879 to TH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergsland M, 2006, GENE DEV, V20, P3475, DOI 10.1101/gad.403406; Bhattaram P, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1008; Bugner V, 2011, DEVELOPMENT, V138, P2369, DOI 10.1242/dev.060160; Chang WS, 1998, J NEUROBIOL, V35, P227; Chow RL, 2001, ANNU REV CELL DEV BI, V17, P255, DOI 10.1146/annurev.cellbio.17.1.255; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; De Martino S, 2000, DEV DYNAM, V217, P279, DOI 10.1002/(SICI)1097-0177(200003)217:3<279::AID-DVDY6>3.0.CO;2-S; Dy P, 2008, NUCLEIC ACIDS RES, V36, P3101, DOI 10.1093/nar/gkn162; Gessert S, 2008, BIOL CELL, V100, P659, DOI 10.1042/BC20080023; Gessert S, 2007, DEV BIOL, V310, P99, DOI 10.1016/j.ydbio.2007.07.037; GRINDLEY JC, 1995, DEVELOPMENT, V121, P1433; Hayashi T, 2000, GENOMICS, V67, P128, DOI 10.1006/geno.2000.6248; Hiraoka Y, 1997, GENE, V197, P65, DOI 10.1016/S0378-1119(97)00242-4; Hitchcock PF, 1996, J NEUROBIOL, V29, P399; Hoser M, 2008, MOL CELL BIOL, V28, P4675, DOI 10.1128/MCB.00338-08; Hur W, 2010, CARCINOGENESIS, V31, P1298, DOI 10.1093/carcin/bgq072; Hyodo-Miura J, 2002, GENES CELLS, V7, P487, DOI 10.1046/j.1365-2443.2002.00536.x; Kiefer JC, 2007, DEV DYNAM, V236, P2356, DOI 10.1002/dvdy.21218; Kormish JD, 2010, DEV DYNAM, V239, P56, DOI 10.1002/dvdy.22046; Liu W, 2000, DEVELOPMENT, V127, P3237; Mavropoulos A, 2005, DEV BIOL, V285, P211, DOI 10.1016/j.ydbio.2005.06.024; Miyata S, 1996, BBA-GENE STRUCT EXPR, V1308, P23, DOI 10.1016/0167-4781(96)00091-7; MOODY SA, 1990, ANAT EMBRYOL, V182, P347, DOI 10.1007/BF02433495; Murugan S, 2012, EXP CELL RES; Nieuwkoop P, 1975, EXTERNAL INTERNAL ST; Pan X, 2009, P NATL ACAD SCI USA, V106, P3788, DOI 10.1073/pnas.0810147106; Penzo-Mendez AI, 2010, INT J BIOCHEM CELL B, V42, P425, DOI 10.1016/j.biocel.2009.07.018; Potzner MR, 2010, DEVELOPMENT, V137, P775, DOI 10.1242/dev.042101; RUPP RAW, 1991, CELL, V65, P927, DOI 10.1016/0092-8674(91)90545-A; Schilham MW, 1996, NATURE, V380, P711, DOI 10.1038/380711a0; Schneider M, 2010, DEVELOPMENT, V137, P4073, DOI 10.1242/dev.053405; Sock E, 2004, MOL CELL BIOL, V24, P6635, DOI 10.1128/mcb.24.15.6635-6644.2004; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thein DC, 2010, J NEUROCHEM, V115, P131, DOI 10.1111/j.1471-4159.2010.06910.x; Wang JCC, 2005, DEV BIOL, V285, P101, DOI 10.1016/j.ydbio.2005.05.041; Wu HY, 2009, DEV BIOL, V327, P352, DOI 10.1016/j.ydbio.2008.12.017; Wurm A, 2008, EXP EYE RES, V86, P895, DOI 10.1016/j.exer.2008.03.004; Zhang C, 2004, DEV BIOL, V273, P23, DOI 10.1016/j.ydbio.2004.05.019; Zuber ME, 2003, DEVELOPMENT, V130, P5155, DOI 10.1242/dev.00723	39	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e69372	10.1371/journal.pone.0069372	http://dx.doi.org/10.1371/journal.pone.0069372			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874955	Green Submitted, gold, Green Published			2022-12-27	WOS:000324146200075
J	Gupta, N; Sarkar, S; David, A; Gangwar, PK; Gupta, R; Khanna, G; Sankhwar, SN; Khanna, A; Rajender, S				Gupta, Nishi; Sarkar, Saumya; David, Archana; Gangwar, Pravin Kumar; Gupta, Richa; Khanna, Gita; Sankhwar, Satya Narayan; Khanna, Anil; Rajender, Singh			Significant Impact of the MTHFR Polymorphisms and Haplotypes on Male Infertility Risk	PLOS ONE			English	Article							METHYLENETETRAHYDROFOLATE REDUCTASE C677T; COMMON MUTATION; FOLIC-ACID; HOMOCYSTEINE METABOLISM; GENETIC POLYMORPHISMS; A1298C POLYMORPHISM; GSTM1 DELETION; SEMINAL PLASMA; ENZYME GENES; ZINC-SULFATE	Background: Methylenetetrahydrofolate reductase (MTHFR) converts 5,10-methylene tetrahydrofolate to 5-methyl tetrahydrofolate and affects the activity of cellular cycles participating in nucleotide synthesis, DNA repair, genome stability, maintenance of methyl pool, and gene regulation. Genetically compromised MTHFR activity has been suggested to affect male fertility. The objective of the present study was to find the impact on infertility risk of c.203G>A, c.1298A>C, and c.1793G>A polymorphisms in the MTHFR gene. Methods: PCR-RFLP and DNA sequencing were used to genotype the common SNPs in the MTHFR gene in 630 infertile and 250 fertile males. Chi-square test was applied for statistical comparison of genotype data. Linkage disequilibrium between the SNPs and the frequency of common haplotypes were assessed using Haploview software. Biochemical levels of total homocysteine (tHcy) and folic acid were measured. Meta-analysis on c.1298A>C polymorphism was performed using data from ten studies, comprising 2734 cases and 2737 controls. Results: c.203G>A and c.1298A>C were found to be unrelated to infertility risk. c.1793G>A was protective against infertility (P = 0.0008). c.677C>T and c.1793G>A were in significant LD (D' = 0.9). Folic acid and tHcy level did not correlate with male infertility. Pooled estimate on c.1298A>C data from all published studies including our data showed no association of this polymorphism with male infertility (Odds ratio = 1.035, P = 0.56), azoospermia (Odds ratio = 0.97, P = 0.74), or oligoasthenoteratozoospermia (Odds ratio = 0.92, p = 0.29). Eight haplotypes with more than 1% frequency were detected, of which CCGA was protective against infertility (p = 0.02), but the significance of the latter was not seen after applying Bonferroni correction. Conclusion: Among MTHFR polymorphisms, c.203G>A and c.1298A>C do not affect infertility risk and c.1793G>A is protective against infertility. Haplotype analysis suggested that risk factors on the MTHFR locus do not extend too long on the DNA string.	[Gupta, Nishi; Sarkar, Saumya; Gupta, Richa; Rajender, Singh] Cent Drug Res Inst, Div Endocrinol, Lucknow 226001, Uttar Pradesh, India; [David, Archana; Khanna, Gita; Khanna, Anil] Ajanta Hosp & IVF Ctr Pvt Ltd, Lucknow, Uttar Pradesh, India; [Gangwar, Pravin Kumar; Sankhwar, Satya Narayan] King George Med Univ, Dept Urol, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); King George's Medical University	Rajender, S (corresponding author), Cent Drug Res Inst, Div Endocrinol, Lucknow 226001, Uttar Pradesh, India.	rajender_singh@cdri.res.in	Singh, Rajender/ABE-3512-2020	Sarkar, Saumya/0000-0003-2247-8796; Rajender, Singh/0000-0002-4592-6566	Council of Scientific and Industrial Research (CSIR), Govt. of India, under network project (PROGRAM-BSC0101) scheme	Council of Scientific and Industrial Research (CSIR), Govt. of India, under network project (PROGRAM-BSC0101) scheme	The study was supported by the Council of Scientific and Industrial Research (CSIR), Govt. of India, under network project (PROGRAM-BSC0101) scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A ZC, 2007, ASIAN J ANDROL, V9, P57, DOI 10.1111/j.1745-7262.2007.00225.x; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BENTIVOGLIO G, 1993, FERTIL STERIL, V60, P698; Bezold G, 2001, NEW ENGL J MED, V344, P1172, DOI 10.1056/NEJM200104123441517; Blom HJ, 2011, J INHERIT METAB DIS, V34, P75, DOI 10.1007/s10545-010-9177-4; Boxmeer JC, 2009, FERTIL STERIL, V92, P548, DOI 10.1016/j.fertnstert.2008.06.010; Chellat D, 2012, GENET TEST MOL BIOMA, V16, P874, DOI 10.1089/gtmb.2011.0367; Chen ZT, 2001, HUM MOL GENET, V10, P433, DOI 10.1093/hmg/10.5.433; Christensen B, 1997, ARTERIOSCL THROM VAS, V17, P569, DOI 10.1161/01.ATV.17.3.569; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; Dhillon VS, 2007, MOL HUM REPROD, V13, P213, DOI 10.1093/molehr/gal118; Ebisch IMW, 2003, FERTIL STERIL, V80, P1190, DOI 10.1016/S0015-0282(03)02157-5; Eloualid A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034111; Forges T, 2007, HUM REPROD UPDATE, V13, P225, DOI 10.1093/humupd/dml063; Forti G, 1998, J CLIN ENDOCR METAB, V83, P4177, DOI 10.1210/jc.83.12.4177; Fowler B, 2001, KIDNEY INT, V59, pS221, DOI 10.1046/j.1523-1755.2001.07851.x; Friso S, 2002, J NUTR, V132, p2382S, DOI 10.1093/jn/132.8.2382S; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Gava MM, 2011, REPROD SCI, V18, P1267, DOI 10.1177/1933719111411729; Gava MM, 2011, GENET TEST MOL BIOMA, V15, P153, DOI 10.1089/gtmb.2010.0128; Grodnitskaya EE, 2012, GYNECOL ENDOCRINOL, V28, P186, DOI 10.3109/09513590.2011.589927; Gupta N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022277; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Jungwirth A, 2012, EUR UROL, V62, P324, DOI 10.1016/j.eururo.2012.04.048; Kelly TLJ, 2005, BIOL REPROD, V72, P667, DOI 10.1095/biolreprod.104.035238; Kobayashi H, 2007, HUM MOL GENET, V16, P2542, DOI 10.1093/hmg/ddm187; Kodama H, 1997, FERTIL STERIL, V68, P519, DOI 10.1016/S0015-0282(97)00236-7; Lee HC, 2006, HUM REPROD, V21, P3162, DOI 10.1093/humrep/del280; Mills JL, 2000, NEW ENGL J MED, V342, P1442, DOI 10.1056/NEJM200005113421911; Minocherhomji S, 2010, OBSTET GYNECOL INT, V2010, DOI 10.1155/2010/198709; O'Brien KLO, 2010, FERTIL STERIL, V93, P1, DOI 10.1016/j.fertnstert.2009.10.045; Oliva A, 2001, HUM REPROD, V16, P1768, DOI 10.1093/humrep/16.8.1768; Paracchini V, 2006, BIOMARKERS, V11, P53, DOI 10.1080/13547500500442050; Park Chan Woo, 2011, Clin Exp Reprod Med, V38, P168, DOI 10.5653/cerm.2011.38.3.168; Park JH, 2005, J ASSIST REPROD GEN, V22, P361, DOI 10.1007/s10815-005-6795-0; Petitti DB, 2001, STAT MED, V20, P3625, DOI 10.1002/sim.1091; RAMAN R, 1995, MOL REPROD DEV, V42, P284, DOI 10.1002/mrd.1080420304; Ravel C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006540; Safarinejad MR, 2011, REPROD SCI, V18, P304, DOI 10.1177/1933719110385135; Shen OX, 2012, ANN HUM GENET, V76, P25, DOI 10.1111/j.1469-1809.2011.00691.x; Singh K, 2005, INT J ANDROL, V28, P115, DOI 10.1111/j.1365-2605.2004.00513.x; Singh K, 2010, J POSTGRAD MED, V56, P267, DOI 10.4103/0022-3859.70935; Stuppia L, 2003, J ENDOCRINOL INVEST, V26, P620, DOI 10.1007/BF03347018; Thangaraj K, 2003, CURR BIOL, V13, P86, DOI 10.1016/S0960-9822(02)01336-2; Thangaraj K, 2002, J ANDROL, V23, P815; Tuttelmann F, 2007, REPROD BIOMED ONLINE, V15, P643, DOI 10.1016/s1472-6483(10)60531-7; van der Put NMJ, 1998, AM J HUM GENET, V62, P1044, DOI 10.1086/301825; Vani GT, 2012, ANDROLOGIA, V44, P252, DOI 10.1111/j.1439-0272.2011.01172.x; Wallock LM, 2001, FERTIL STERIL, V75, P252, DOI 10.1016/S0015-0282(00)01697-6; Wei BB, 2012, MOL BIOL REP, V39, P1997, DOI 10.1007/s11033-011-0946-4; Weisberg I, 1998, MOL GENET METAB, V64, P169, DOI 10.1006/mgme.1998.2714; Wong WY, 2002, FERTIL STERIL, V77, P491, DOI 10.1016/S0015-0282(01)03229-0; World Health Organization (WHO), 1999, WHO LAB MANUAL EXAMI, V4th; Wu W, 2012, INT J ANDROL, V35, P18, DOI 10.1111/j.1365-2605.2011.01147.x; Yilmaz N, 2012, ARCH MED SCI, V8, P138, DOI 10.5114/aoms.2012.27294	55	21	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e69180	10.1371/journal.pone.0069180	http://dx.doi.org/10.1371/journal.pone.0069180			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874907	Green Published, gold, Green Submitted			2022-12-27	WOS:000324146200065
J	Yang, SH; Pan, CL; Tschaplinski, TJ; Hurst, GB; Engle, NL; Zhou, W; Dam, P; Xu, Y; Rodriguez, M; Dice, L; Johnson, CM; Davison, BH; Brown, SD				Yang, Shihui; Pan, Chongle; Tschaplinski, Timothy J.; Hurst, Gregory B.; Engle, Nancy L.; Zhou, Wen; Dam, PhuongAn; Xu, Ying; Rodriguez, Miguel, Jr.; Dice, Lezlee; Johnson, Courtney M.; Davison, Brian H.; Brown, Steven D.			Systems Biology Analysis of Zymomonas mobilis ZM4 Ethanol Stress Responses	PLOS ONE			English	Article							HOPANOID BIOSYNTHESIS; PROTEIN ABUNDANCE; GENOME SEQUENCE; MICROARRAY DATA; SCALE ANALYSIS; FUEL ETHANOL; TOLERANCE; EXPRESSION; STRAIN; IDENTIFICATION	Background: Zymomonas mobilis ZM4 is a capable ethanologenic bacterium with high ethanol productivity and ethanol tolerance. Previous studies indicated that several stress-related proteins and changes in the ZM4 membrane lipid composition may contribute to ethanol tolerance. However, the molecular mechanisms of its ethanol stress response have not been elucidated fully. Methodology/Principal Findings: In this study, ethanol stress responses were investigated using systems biology approaches. Medium supplementation with an initial 47 g/L (6% v/v) ethanol reduced Z. mobilis ZM4 glucose consumption, growth rate and ethanol productivity compared to that of untreated controls. A proteomic analysis of early exponential growth identified about one thousand proteins, or approximately 55% of the predicted ZM4 proteome. Proteins related to metabolism and stress response such as chaperones and key regulators were more abundant in the early ethanol stress condition. Transcriptomic studies indicated that the response of ZM4 to ethanol is dynamic, complex and involves many genes from all the different functional categories. Most down-regulated genes were related to translation and ribosome biogenesis, while the ethanol-upregulated genes were mostly related to cellular processes and metabolism. Transcriptomic data were used to update Z. mobilis ZM4 operon models. Furthermore, correlations among the transcriptomic, proteomic and metabolic data were examined. Among significantly expressed genes or proteins, we observe higher correlation coefficients when fold-change values are higher. Conclusions: Our study has provided insights into the responses of Z. mobilis to ethanol stress through an integrated "omics'' approach for the first time. This systems biology study elucidated key Z. mobilis ZM4 metabolites, genes and proteins that form the foundation of its distinctive physiology and its multifaceted response to ethanol stress.	[Yang, Shihui; Tschaplinski, Timothy J.; Engle, Nancy L.; Rodriguez, Miguel, Jr.; Dice, Lezlee; Johnson, Courtney M.; Davison, Brian H.; Brown, Steven D.] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37831 USA; [Yang, Shihui; Pan, Chongle; Tschaplinski, Timothy J.; Engle, Nancy L.; Zhou, Wen; Dam, PhuongAn; Xu, Ying; Rodriguez, Miguel, Jr.; Dice, Lezlee; Johnson, Courtney M.; Davison, Brian H.; Brown, Steven D.] Oak Ridge Natl Lab, BioEnergy Sci Ctr, Oak Ridge, TN USA; [Pan, Chongle] Oak Ridge Natl Lab, Comp Sci & Math Div, Oak Ridge, TN USA; [Hurst, Gregory B.] Oak Ridge Natl Lab, Div Chem Sci, Oak Ridge, TN USA; [Zhou, Wen; Dam, PhuongAn; Xu, Ying] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Zhou, Wen; Dam, PhuongAn; Xu, Ying] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; BioEnergy Science Center (BESC); United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Brown, SD (corresponding author), Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37831 USA.	brownsd@ornl.gov	Yang, Shihui/AAE-4100-2020; Tschaplinski, Timothy/D-6382-2018; Pan, Chongle/C-6960-2008; Davison, Brian/D-7617-2013; Engle, Nancy L/D-6494-2018; Brown, Steven D/A-6792-2011	Yang, Shihui/0000-0002-9394-9148; Tschaplinski, Timothy/0000-0002-9540-6622; Pan, Chongle/0000-0003-2860-0334; Davison, Brian/0000-0002-7408-3609; Engle, Nancy L/0000-0003-0290-7987; Brown, Steven D/0000-0002-9281-3898; Hurst, Gregory/0000-0002-7650-8009	Laboratory Directed Research and Development Program of Oak Ridge National Laboratory; Office of Biological and Environmental Research in the Department of Energy Office of Science; United States Department of Energy [DE-AC05-00OR22725]	Laboratory Directed Research and Development Program of Oak Ridge National Laboratory; Office of Biological and Environmental Research in the Department of Energy Office of Science; United States Department of Energy(United States Department of Energy (DOE))	This work is sponsored by the Laboratory Directed Research and Development Program of Oak Ridge National Laboratory. The BioEnergy Science Center is a United States Department of Energy Bioenergy Research Center supported by the Office of Biological and Environmental Research in the Department of Energy Office of Science. This manuscript has been authored by UT-Battelle, LLC, under Contract No. DE-AC05-00OR22725 with the United States Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AN HJ, 1991, J BACTERIOL, V173, P5975, DOI 10.1128/jb.173.19.5975-5982.1991; Brouwer RWW, 2008, BRIEF BIOINFORM, V9, P367, DOI 10.1093/bib/bbn019; Brown SD, 2011, P NATL ACAD SCI USA, V108, P13752, DOI 10.1073/pnas.1102444108; Cooper B, 2010, J AM SOC MASS SPECTR, V21, P1534, DOI 10.1016/j.jasms.2010.05.001; DAM P, 2008, COMPUTATIONAL METHOD, P233; Dam P, 2007, NUCLEIC ACIDS RES, V35, P288, DOI 10.1093/nar/gkl1018; Deanda K, 1996, APPL ENVIRON MICROB, V62, P4465, DOI 10.1128/AEM.62.12.4465-4470.1996; Dien BS, 2003, APPL MICROBIOL BIOT, V63, P258, DOI 10.1007/s00253-003-1444-y; Ding JM, 2009, APPL MICROBIOL BIOT, V85, P253, DOI 10.1007/s00253-009-2223-1; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Farrell AE, 2006, SCIENCE, V311, P506, DOI 10.1126/science.1121416; FLESCH G, 1989, BIOCHEM J, V262, P673, DOI 10.1042/bj2620673; Gnansounou E, 2010, BIORESOURCE TECHNOL, V101, P4980, DOI 10.1016/j.biortech.2010.02.009; Gunasekaran P, 1999, CURR SCI INDIA, V77, P56; Hahn-Hagerdal B, 2006, TRENDS BIOTECHNOL, V24, P549, DOI 10.1016/j.tibtech.2006.10.004; Hallsworth JE, 2003, APPL ENVIRON MICROB, V69, P7032, DOI 10.1128/AEM.69.12.7032-7034.2003; He MX, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-75; He MX, 2012, APPL MICROBIOL BIOT, V95, P189, DOI 10.1007/s00253-012-4155-4; Hendrickson EL, 2006, ANALYST, V131, P1335, DOI 10.1039/b610957h; HERMANS MAF, 1991, J BACTERIOL, V173, P5592, DOI 10.1128/jb.173.17.5592-5595.1991; Hirasawa T, 2007, J BIOTECHNOL, V131, P34, DOI 10.1016/j.jbiotec.2007.05.010; HORBACH S, 1991, FEMS MICROBIOL LETT, V79, P347, DOI 10.1016/0378-1097(91)90110-V; INGRAM LO, 1990, CRIT REV BIOTECHNOL, V9, P305; JAVED M, 2011, INCREASED ETHANOL PR; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; KANNAN TR, 1993, J FERMENT BIOENG, V75, P265, DOI 10.1016/0922-338X(93)90149-3; Kannenberg EL, 1999, NATURWISSENSCHAFTEN, V86, P168, DOI 10.1007/s001140050592; Kerr AL, 2011, APPL MICROBIOL BIOT, V89, P761, DOI 10.1007/s00253-010-2936-1; KONDO Y, 1994, BIOSCI BIOTECH BIOCH, V58, P526, DOI 10.1271/bbb.58.526; Kouvelis VN, 2011, J BACTERIOL, V193, P5049, DOI 10.1128/JB.05273-11; Kouvelis VN, 2009, J BACTERIOL, V191, P7140, DOI 10.1128/JB.01084-09; Krall L, 2009, J CHROMATOGR B, V877, P2952, DOI 10.1016/j.jchromb.2009.07.006; Lee KY, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-94; Li GJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp491; Linger JG, 2010, APPL ENVIRON MICROB, V76, P6360, DOI 10.1128/AEM.00230-10; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; MacCoss MJ, 2002, P NATL ACAD SCI USA, V99, P7900, DOI 10.1073/pnas.122231399; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; McDonald WH, 2004, RAPID COMMUN MASS SP, V18, P2162, DOI 10.1002/rcm.1603; Moreau RA, 1997, CURR MICROBIOL, V35, P124, DOI 10.1007/s002849900224; Nie L, 2006, GENETICS, V174, P2229, DOI 10.1534/genetics.106.065862; Pan C, 2008, MOL CELL PROTEOMICS, V7, P938, DOI 10.1074/mcp.M700147-MCP200; Panesar PS, 2006, J CHEM TECHNOL BIOT, V81, P623, DOI 10.1002/jctb.1448; Pappas KM, 2011, J BACTERIOL, V193, P5051, DOI 10.1128/JB.05395-11; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Rogers PL, 2007, ADV BIOCHEM ENG BIOT, V108, P263, DOI 10.1007/10_2007_060; ROGERS PL, 1984, MICROBIOL SCI, V1, P133; Rohmer M, 2007, PURE APPL CHEM, V79, P739, DOI 10.1351/pac200779040739; Schena M, 1996, P NATL ACAD SCI USA, V93, P10614, DOI 10.1073/pnas.93.20.10614; Service RF, 2007, SCIENCE, V315, P1488, DOI 10.1126/science.315.5818.1488; SHIGERI Y, 1991, AGR BIOL CHEM TOKYO, V55, P589, DOI 10.1080/00021369.1991.10870622; Stanley D, 2010, J APPL MICROBIOL, V109, P13, DOI 10.1111/j.1365-2672.2009.04657.x; Stephanopoulos G, 2007, SCIENCE, V315, P801, DOI 10.1126/science.1139612; STRAZDINA I, 2012, ARCH MICROBIOL, DOI DOI 10.1007/S00203-00011-00785-00207; SWINGS J, 1977, BACTERIOL REV, V41, P1; Tabb DL, 2006, J AM SOC MASS SPECTR, V17, P903, DOI 10.1016/j.jasms.2006.02.003; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Thanonkeo Pornthap, 2007, Pak J Biol Sci, V10, P13; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Welander PV, 2009, J BACTERIOL, V191, P6145, DOI 10.1128/JB.00460-09; Widiastuti H, 2011, BIOTECHNOL BIOENG, V108, P655, DOI 10.1002/bit.22965; Yang SH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-336; Yang SH, 2010, P NATL ACAD SCI USA, V107, P10395, DOI 10.1073/pnas.0914506107; Yang SH, 2010, BMC MICROBIOL, V10, DOI [10.1186/1471-2180-10-135, 10.1186/1471-2229-10-85]; Yang SH, 2009, NAT BIOTECHNOL, V27, P893, DOI 10.1038/nbt1009-893; Yang SH, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-34; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yazdani SS, 2007, CURR OPIN BIOTECH, V18, P213, DOI 10.1016/j.copbio.2007.05.002; Zhang B, 2006, J PROTEOME RES, V5, P2909, DOI 10.1021/pr0600273; ZHANG M, 1995, SCIENCE, V267, P240, DOI 10.1126/science.267.5195.240; Zhang Y, 2010, J MICROBIOL BIOTECHN, V20, P1156, DOI 10.4014/jmb.0912.12036	73	39	44	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68886	10.1371/journal.pone.0068886	http://dx.doi.org/10.1371/journal.pone.0068886			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874800	gold, Green Published, Green Submitted			2022-12-27	WOS:000322064300076
J	Angeler, DG; Gothe, E; Johnson, RK				Angeler, David G.; Gothe, Emma; Johnson, Richard K.			Hierarchical Dynamics of Ecological Communities: Do Scales of Space and Time Match?	PLOS ONE			English	Article							POPULATION GENETIC-STRUCTURE; SPATIAL PROCESSES; COMPREHENSIVE FRAMEWORK; METACOMMUNITY STRUCTURE; NEIGHBOR MATRICES; TREE DIVERSITY; DISPERSAL; BIODIVERSITY; PATTERNS; HISTORY	Theory posits that community dynamics organize at distinct hierarchical scales of space and time, and that the spatial and temporal patterns at each scale are commensurate. Here we use time series modeling to investigate fluctuation frequencies of species groups within invertebrate metacommunities in 26 boreal lakes over a 20-year period, and variance partitioning analysis to study whether species groups with different fluctuation patterns show spatial signals that are commensurate with the scale-specific fluctuation patterns identified. We identified two groups of invertebrates representing hierarchically organized temporal dynamics: one species group showed temporal variability at decadal scales (slow patterns of change), whilst another group showed fluctuations at 3 to 5-year intervals (faster change). This pattern was consistently found across all lakes studied. A spatial signal was evident in the slow but not faster-changing species groups. As expected, the spatial signal for the slow-changing group coincided with broad-scale spatial patterns that could be explained with historical biogeography (ecoregion delineation, and dispersal limitation assessed through a dispersal trait analysis). In addition to spatial factors, the slow-changing groups correlated with environmental variables, supporting the conjecture that boreal lakes are undergoing environmental change. Taken together our results suggest that regionally distinct sets of taxa, separated by biogeographical boundaries, responded similarly to broad-scale environmental change. Not only does our approach allow testing theory about hierarchically structured space-time patterns; more generally, it allows assessing the relative role of the ability of communities to track environmental change and dispersal constraints limiting community structure and biodiversity at macroecological scales.	[Angeler, David G.; Gothe, Emma; Johnson, Richard K.] Swedish Univ Agr Sci, Dept Aquat Sci & Assessment, Uppsala, Sweden	Swedish University of Agricultural Sciences	Angeler, DG (corresponding author), Swedish Univ Agr Sci, Dept Aquat Sci & Assessment, Uppsala, Sweden.	david.angeler@slu.se	Göthe, Emma/A-6310-2016; Johnson, Richard K./P-4991-2014	Göthe, Emma/0000-0002-7387-6770; Johnson, Richard K./0000-0001-7979-6563	Swedish Environmental Protection Agency	Swedish Environmental Protection Agency	This study was supported by the Swedish Environmental Protection Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2003, ECOL LETT, V6, P749, DOI 10.1046/j.1461-0248.2003.00497.x; Allen CR, 2006, ECOL LETT, V9, P630, DOI 10.1111/j.1461-0248.2006.00902.x; Angeler DG, 2012, ECOL APPL, V22, P1172, DOI 10.1890/11-1474.1; Angeler DG, 2011, ECOL SOC, V16, DOI 10.5751/ES-04175-160305; Angeler DG, 2009, ECOLOGY, V90, P3245, DOI 10.1890/07-0391.1; Angeler DG, 2013, OECOLOGIA IN PRESS, DOI [10.1007/s00442-012-2554-y, DOI 10.1007/S00442-012-2554-Y]; [Anonymous], 2001, PANARCHY UNDERSTANDI; Beisner BE, 2006, ECOLOGY, V87, P2985, DOI 10.1890/0012-9658(2006)87[2985:TROEAS]2.0.CO;2; Blanchet FG, 2008, ECOL MODEL, V215, P325, DOI 10.1016/j.ecolmodel.2008.04.001; Bohonak AJ, 2003, ECOL LETT, V6, P783, DOI 10.1046/j.1461-0248.2003.00486.x; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; De Bie T, 2012, ECOL LETT, V15, P740, DOI 10.1111/j.1461-0248.2012.01794.x; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Finn DS, 2006, MOL ECOL, V15, P3553, DOI 10.1111/j.1365-294X.2006.03034.x; Gilbert B, 2010, J APPL ECOL, V47, P1071, DOI 10.1111/j.1365-2664.2010.01861.x; Goransson E, 2004, ENVIRON MONIT ASSESS, V95, P221, DOI 10.1023/B:EMAS.0000029905.07072.b0; Gothe E, 2013, J ANIM ECOL, V82, P449, DOI 10.1111/1365-2656.12004; Graham CH, 2006, P NATL ACAD SCI USA, V103, P632, DOI 10.1073/pnas.0505754103; Hawkins BA, 2003, ECOLOGY, V84, P1608, DOI 10.1890/0012-9658(2003)084[1608:PAHAPO]2.0.CO;2; Heino J, 2003, J ANIM ECOL, V72, P425, DOI 10.1046/j.1365-2656.2003.00711.x; HOLLING CS, 1992, ECOL MONOGR, V62, P447, DOI 10.2307/2937313; Hubbell Stephen P., 2001, V32, pi; Hughes JM, 2003, FRESHWATER BIOL, V48, P2149, DOI 10.1046/j.1365-2427.2003.01150.x; Johnson RK, 2000, J N AM BENTHOL SOC, V19, P475, DOI 10.2307/1468108; Kauffman S.A., 1993, ORIGINS ORDER; Keitt TH, 2006, ECOLOGY, V87, P2895, DOI 10.1890/0012-9658(2006)87[2895:DOSCDU]2.0.CO;2; Laliberte E, 2009, OECOLOGIA, V159, P377, DOI 10.1007/s00442-008-1214-8; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Leibold MA, 2010, ECOL LETT, V13, P1290, DOI 10.1111/j.1461-0248.2010.01523.x; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Logue JB, 2011, TRENDS ECOL EVOL, V26, P482, DOI 10.1016/j.tree.2011.04.009; McGlone MS, 1996, GLOBAL ECOL BIOGEOGR, V5, P309, DOI 10.2307/2997586; Monaghan MT, 2002, J N AM BENTHOL SOC, V21, P114, DOI 10.2307/1468304; Ng ISY, 2009, HYDROBIOLOGIA, V619, P133, DOI 10.1007/s10750-008-9605-8; O'Dwyer JP, 2010, ECOL LETT, V13, P87, DOI 10.1111/j.1461-0248.2009.01404.x; Oksanen J., 2016, R PACKAG; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Poff NL, 2006, J N AM BENTHOL SOC, V25, P730, DOI 10.1899/0887-3593(2006)025[0730:FTNONA]2.0.CO;2; R Development Core Team, 2008, R LANG ENV STAT COMP; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; Smith TW, 2010, ECOGRAPHY, V33, P648, DOI 10.1111/j.1600-0587.2009.06105.x; Svenning JC, 2007, ECOL LETT, V10, P453, DOI 10.1111/j.1461-0248.2007.01038.x; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Wilander A., 2003, RIKSINVENTERING 2000	47	17	18	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e69174	10.1371/journal.pone.0069174	http://dx.doi.org/10.1371/journal.pone.0069174			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874905	Green Published, gold, Green Submitted			2022-12-27	WOS:000321736900140
J	Huang, CR; Kan, JT; Liu, X; Ma, FF; Tran, H; Zou, YZ; Wang, SJ; Zhu, YZ				Huang, Chengrong; Kan, Juntao; Liu, Xu; Ma, Fenfen; Tran, Hieu; Zou, Yunzeng; Wang, Shujun; Zhu, Yi Zhun			Cardioprotective Effects of a Novel Hydrogen Sulfide Agent-Controlled Release Formulation of S-Propargyl-Cysteine on Heart Failure Rats and Molecular Mechanisms	PLOS ONE			English	Article							OXIDATIVE STRESS; MYOCARDIAL-ISCHEMIA; H2S; PROTECTS; APOPTOSIS; MICE; CARDIOMYOCYTES; VASORELAXANT; HYPERTROPHY; MYOCYTES	Objective: Heart failure (HF) is one of the most serious diseases worldwide. S-propargyl-cysteine (SPRC), a novel modulator of endogenous hydrogen sulfide, is proved to be able to protect against acute myocardial ischemia. In order to produce more stable and sustainable hydrogen sulfide, we used controlled release formulation of SPRC (CR-SPRC) to elucidate possible cardioprotective effects on HF rats and investigate involved mechanisms on apoptosis and oxidation. Methods: Left coronary artery was occluded to induce HF model of rat. The survival rats were randomly divided into 7 groups after 24 hours and treated with drugs for 6 weeks. Echocardiographic indexes were recorded to determine cardiac function. TTC staining was performed to determine infarct size. Plasmatic level of hydrogen sulfide was detected by modified sulfide electrode. Activity of enzyme and expression of protein were determined by colorimetry and Western blot, respectively. Results: The cardioprotective effects of CR-SPRC on HF rats were confirmed by significant reduction of infarct size and improvement of cardiac function, with better effects compared to normal SPRC. CR-SPRC modulated antioxidant defenses by preserving levels of GSH, CAT and SOD and reducing CK leakage. In addition, CR-SPRC elevated ratio of Bcl-2/Bax and inhibited activity of caspases to protect against myocardial apoptosis. The cardioprotective effects of CR-SPRC were mediated by hydrogen sulfide. Conclusions: All experiment data indicated cardioprotective effects of CR-SPRC on HF rats. More importantly, CR-SPRC exerted better effects than normal SPRC in all respects, providing a new perspective on hydrogen sulfide-mediated drug therapy.	[Huang, Chengrong; Kan, Juntao; Ma, Fenfen; Tran, Hieu; Zhu, Yi Zhun] Fudan Univ, Sch Pharm, Shanghai 200433, Peoples R China; [Kan, Juntao; Zou, Yunzeng; Zhu, Yi Zhun] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Zou, Yunzeng] Fudan Univ, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Liu, Xu; Wang, Shujun] Shenyang Pharmaceut Univ, Sch Pharm, Shenyang, Liaoning, Peoples R China	Fudan University; Fudan University; Fudan University; Shenyang Pharmaceutical University	Wang, SJ (corresponding author), Shenyang Pharmaceut Univ, Sch Pharm, Shenyang, Liaoning, Peoples R China.	wangshujun@syphu.edu.cn; zhuyz@fudan.edu.cn	Zhu, Yi Zhun/ABG-8449-2021	Zhu, Yi Zhun/0000-0001-7700-8041	National Basic Research Program of China (973 Program) [2010CB912600]; National Science Fund for Distinguished Young Scholars [30888002]; Key Program of Shanghai Committee of Science and Technology in China [10431900100]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Key Program of Shanghai Committee of Science and Technology in China	This work was supported by the National Basic Research Program of China (973 Program, No.: 2010CB912600), the National Science Fund for Distinguished Young Scholars (No.: 30888002), and the Key Program of Shanghai Committee of Science and Technology in China (No.: 10431900100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1996, J NEUROSCI, V16, P1066; Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165; Calvert JW, 2010, CIRCULATION, V122, P11, DOI 10.1161/CIRCULATIONAHA.109.920991; Calvert JW, 2009, CIRC RES, V105, P365, DOI 10.1161/CIRCRESAHA.109.199919; Cohn JN, 1996, NEW ENGL J MED, V335, P490, DOI 10.1056/NEJM199608153350707; Dhalla AK, 1996, J AM COLL CARDIOL, V28, P506, DOI 10.1016/0735-1097(96)00140-4; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; Kang PM, 2000, CIRC RES, V86, P1107; Keith M, 1998, J AM COLL CARDIOL, V31, P1352, DOI 10.1016/S0735-1097(98)00101-6; Kimura Y, 2004, FASEB J, V18, P1165, DOI 10.1096/fj.04-1815fje; Lefer DJ, 2007, P NATL ACAD SCI USA, V104, P17907, DOI 10.1073/pnas.0709010104; Mallat Z, 1998, CIRCULATION, V97, P1536, DOI 10.1161/01.CIR.97.16.1536; Mishra PK, 2010, AM J PHYSIOL-HEART C, V298, pH451, DOI 10.1152/ajpheart.00682.2009; Narula J, 1996, NEW ENGL J MED, V335, P1182, DOI 10.1056/NEJM199610173351603; Sawyer DB, 2002, J MOL CELL CARDIOL, V34, P379, DOI 10.1006/jmcc.2002.1526; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Takano H, 2003, ANTIOXID REDOX SIGN, V5, P789, DOI 10.1089/152308603770380098; Varshosaz J, 2006, DRUG DELIV, V13, P295, DOI 10.1080/10717540500459308; Wang Q, 2010, ANTIOXID REDOX SIGN, V12, P1155, DOI 10.1089/ars.2009.2947; Wang Q, 2009, J CARDIOVASC PHARM, V54, P139, DOI 10.1097/FJC.0b013e3181ac8e12; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Wang XL, 2011, BIOSCIENCE REP, V31, P87, DOI 10.1042/BSR20100003; Wang YF, 2009, ARTERIOSCL THROM VAS, V29, P173, DOI 10.1161/ATVBAHA.108.179333; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yao LL, 2010, AM J PHYSIOL-HEART C, V298, pH1310, DOI 10.1152/ajpheart.00339.2009; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008; Zhu YZ, 2007, J APPL PHYSIOL, V102, P261, DOI 10.1152/japplphysiol.00096.2006	28	38	40	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e69205	10.1371/journal.pone.0069205	http://dx.doi.org/10.1371/journal.pone.0069205			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874913	Green Published, gold, Green Submitted			2022-12-27	WOS:000321736900141
J	Matsumoto, Y; Hirashima, D; Terao, K; Mizunami, M				Matsumoto, Yukihisa; Hirashima, Daisuke; Terao, Kanta; Mizunami, Makoto			Roles of NO Signaling in Long-Term Memory Formation in Visual Learning in an Insect	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; DEPENDENT PROTEIN-KINASE; DOPAMINERGIC-NEURONS; OLFACTORY MEMORY; CENTRAL COMPLEX; DROSOPHILA; HONEYBEE; PARTICIPATION; INVOLVEMENT; ACTIVATION	Many insects exhibit excellent capability of visual learning, but the molecular and neural mechanisms are poorly understood. This is in contrast to accumulation of information on molecular and neural mechanisms of olfactory learning in insects. In olfactory learning in insects, it has been shown that cyclic AMP (cAMP) signaling critically participates in the formation of protein synthesis-dependent long-term memory (LTM) and, in some insects, nitric oxide (NO)-cyclic GMP (cGMP) signaling also plays roles in LTM formation. In this study, we examined the possible contribution of NO-cGMP signaling and cAMP signaling to LTM formation in visual pattern learning in crickets. Crickets that had been subjected to 8-trial conditioning to associate a visual pattern with water reward exhibited memory retention 1 day after conditioning, whereas those subjected to 4-trial conditioning exhibited 30-min memory retention but not 1-day retention. Injection of cycloheximide, a protein synthesis inhibitor, into the hemolymph prior to 8-trial conditioning blocked formation of 1-day memory, whereas it had no effect on 30-min memory formation, indicating that 1-day memory can be characterized as protein synthesis-dependent long-term memory (LTM). Injection of an inhibitor of the enzyme producing an NO or cAMP prior to 8-trial visual conditioning blocked LTM formation, whereas it had no effect on 30-min memory formation. Moreover, injection of an NO donor, cGMP analogue or cAMP analogue prior to 4-trial conditioning induced LTM. Induction of LTM by an NO donor was blocked by DDA, an inhibitor of adenylyl cyclase, an enzyme producing cAMP, but LTM induction by a cAMP analogue was not impaired by L-NAME, an inhibitor of NO synthase. The results indicate that cAMP signaling is downstream of NO signaling for visual LTM formation. We conclude that visual learning and olfactory learning share common biochemical cascades for LTM formation.	[Matsumoto, Yukihisa; Terao, Kanta; Mizunami, Makoto] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido, Japan; [Hirashima, Daisuke] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 980, Japan	Hokkaido University; Tohoku University	Mizunami, M (corresponding author), Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido, Japan.	mizunami@sci.hokudai.ac.jp		TERAO, Kanta/0000-0002-2037-2464; Mizunami, Makoto/0000-0003-4168-2610	Ministry of Education, Science, Culture, Sports and Technology of Japan	Ministry of Education, Science, Culture, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by grants from the the Ministry of Education, Science, Culture, Sports and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avargues-Weber A, 2011, ANNU REV ENTOMOL, V56, P423, DOI 10.1146/annurev-ento-120709-144855; Benard J, 2006, ANIM COGN, V9, P257, DOI 10.1007/s10071-006-0032-9; Bhattacharya A, 2004, J BIOL CHEM, V279, P37291, DOI 10.1074/jbc.M403819200; Bicker G, 2001, ARCH INSECT BIOCHEM, V48, P100, DOI 10.1002/arch.1062; Dacher M, 2008, PHYSIOL BEHAV, V95, P200, DOI 10.1016/j.physbeh.2008.05.019; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; Davis RL, 2011, NEURON, V70, P8, DOI 10.1016/j.neuron.2011.03.012; Dukas R, 2008, ANNU REV ENTOMOL, V53, P145, DOI 10.1146/annurev.ento.53.103106.093343; GARTHWAITE J, 1995, ANNU REV PHYSIOL, V57, P683, DOI 10.1146/annurev.ph.57.030195.003343; Giurfa M, 2007, J COMP PHYSIOL A, V193, P801, DOI 10.1007/s00359-007-0235-9; Ito E, 2013, NEUROSCI LETT, V541, P1, DOI 10.1016/j.neulet.2013.02.021; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kemenes I, 2002, J NEUROSCI, V22, P1414, DOI 10.1523/JNEUROSCI.22-04-01414.2002; Kendrick KM, 1997, NATURE, V388, P670, DOI 10.1038/41765; Kinoshita M, 2000, J EXP BIOL, V203, P3521; Kurylas AE, 2005, J COMP NEUROL, V484, P206, DOI 10.1002/cne.20467; Leboulle G, 2004, FEBS LETT, V576, P216, DOI 10.1016/j.febslet.2004.08.079; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; Matsumoto CS, 2013, NEUROSCI LETT, V541, P4, DOI 10.1016/j.neulet.2013.01.010; Matsumoto Y, 2003, ZOOL SCI, V20, P409, DOI 10.2108/zsj.20.409; Matsumoto Y, 2006, LEARN MEMORY, V13, P35, DOI 10.1101/lm.130506; Matsumoto Y, 2009, NEUROSCI LETT, V467, P81, DOI 10.1016/j.neulet.2009.10.008; Menzel R, 2012, NAT REV NEUROSCI, V13, P758, DOI 10.1038/nrn3357; Mizunami M, 1998, J COMP NEUROL, V402, P520; Mizunami M, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00172; Mizunami M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-46; Muller U, 1996, NEURON, V16, P541, DOI 10.1016/S0896-6273(00)80073-2; Muller U, 2000, NEURON, V27, P159, DOI 10.1016/S0896-6273(00)00017-9; MULLER U, 1994, EUR J NEUROSCI, V6, P1362, DOI 10.1111/j.1460-9568.1994.tb00327.x; Nakatani Y, 2009, NEUROBIOL LEARN MEM, V92, P370, DOI 10.1016/j.nlm.2009.05.003; Ott SR, 2002, J COMP NEUROL, V448, P165, DOI 10.1002/cne.10235; Pan YF, 2009, LEARN MEMORY, V16, P289, DOI 10.1101/lm.1331809; Schnaitmann C, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00010; Srinivasan MV, 2010, ANNU REV ENTOMOL, V55, P267, DOI 10.1146/annurev.ento.010908.164537; Takahashi T, 2009, J NEUROSCI METH, V179, P9, DOI 10.1016/j.jneumeth.2009.01.002; Unoki S, 2006, EUR J NEUROSCI, V24, P2031, DOI 10.1111/j.1460-9568.2006.05099.x; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Wang ZP, 2008, LEARN MEMORY, V15, P133, DOI 10.1101/lm.873008; Watanabe T, 2007, DEV NEUROBIOL, V67, P456, DOI 10.1002/dneu.20359; Wehner R, 1996, J EXP BIOL, V199, P129; Wessnitzer J, 2008, P ROY SOC B-BIOL SCI, V275, P915, DOI 10.1098/rspb.2007.1647; WOLF R, 1991, J COMP PHYSIOL A, V169, P699; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5	44	11	14	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e68538	10.1371/journal.pone.0068538	http://dx.doi.org/10.1371/journal.pone.0068538			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894314	Green Published, gold			2022-12-27	WOS:000322167900015
J	Bharde, AA; Palankar, R; Fritsch, C; Klaver, A; Kanger, JS; Jovin, TM; Arndt-Jovin, DJ				Bharde, Atul A.; Palankar, Raghavendra; Fritsch, Cornelia; Klaver, Arjen; Kanger, Johannes S.; Jovin, Thomas M.; Arndt-Jovin, Donna J.			Magnetic Nanoparticles as Mediators of Ligand-Free Activation of EGFR Signaling	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CELL-SURFACE; MONOCLONAL-ANTIBODIES; ERBB RECEPTORS; QUANTUM DOTS; ION CHANNELS; IN-VITRO; TRANSDUCTION; CANCER; BINDING	Background: Magnetic nanoparticles (NPs) are of particular interest in biomedical research, and have been exploited for molecular separation, gene/drug delivery, magnetic resonance imaging, and hyperthermic cancer therapy. In the case of cultured cells, magnetic manipulation of NPs provides the means for studying processes induced by mechanotransduction or by local clustering of targeted macromolecules, e. g. cell surface receptors. The latter are normally activated by binding of their natural ligands mediating key signaling pathways such as those associated with the epidermal growth factor (EGFR). However, it has been reported that EGFR may be dimerized and activated even in the absence of ligands. The present study assessed whether receptor clustering induced by physical means alone suffices for activating EGFR in quiescent cells. Methodology/Principal Findings: The EGFR on A431 cells was specifically targeted by superparamagnetic iron oxide NPs (SPIONs) carrying either a ligand-blocking monoclonal anti-EGFR antibody or a streptavidin molecule for targeting a chimeric EGFR incorporating a biotinylated amino-terminal acyl carrier peptide moiety. Application of a magnetic field led to SPION magnetization and clustering, resulting in activation of the EGFR, a process manifested by auto and transphosphorylation and downstream signaling. The magnetically-induced early signaling events were similar to those inherent to the ligand dependent EGFR pathways. Magnetization studies indicated that the NPs exerted magnetic dipolar forces in the sub-piconewton range with clustering dependent on Brownian motion of the receptor-SPION complex and magnetic field strength. Conclusions/Significance: We demonstrate that EGFR on the cell surface that have their ligand binding-pocket blocked by an antibody are still capable of transphosphorylation and initiation of signaling cascades if they are clustered by SPIONs either attached locally or targeted to another site of the receptor ectodomain. The results suggest that activation of growth factor receptors may be triggered by ligand-independent molecular crowding resulting from overexpression and/or sequestration in membrane microdomains.	[Bharde, Atul A.; Palankar, Raghavendra; Fritsch, Cornelia; Jovin, Thomas M.; Arndt-Jovin, Donna J.] Max Planck Inst Biophys Chem, Lab Cellular Dynam, D-37077 Gottingen, Germany; [Klaver, Arjen; Kanger, Johannes S.] Univ Twente, Fac Sci & Technol, NL-7500 AE Enschede, Netherlands	Max Planck Society; University of Twente	Arndt-Jovin, DJ (corresponding author), Max Planck Inst Biophys Chem, Lab Cellular Dynam, D-37077 Gottingen, Germany.	djovin@gwdg.de	Demchuk, Andrew M/E-1103-2012; Palankar, Raghavendra/C-6240-2013	Demchuk, Andrew M/0000-0002-4930-7789; Palankar, Raghavendra/0000-0002-8957-1103	EU FP6 FLUOROMAG [037465]; German Research Council (DFG) Cluster of Excellence Microscopy at the Nanometer Range; Research Center Molecular Physiology of the Brain; Hessen Agentur Projekt [193/09-23]	EU FP6 FLUOROMAG; German Research Council (DFG) Cluster of Excellence Microscopy at the Nanometer Range; Research Center Molecular Physiology of the Brain; Hessen Agentur Projekt	This work was supported by EU FP6 FLUOROMAG #037465 Project; German Research Council (DFG) Cluster of Excellence Microscopy at the Nanometer Range and the Research Center Molecular Physiology of the Brain; and Hessen Agentur Projekt 193/09-23. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexi X, 2011, BIOCHEM SOC T, V39, P568, DOI 10.1042/BST0390568; Alivisatos AP, 2005, ANNU REV BIOMED ENG, V7, P55, DOI 10.1146/annurev.bioeng.7.060804.100432; Astsaturov I, 2007, CURR CANCER DRUG TAR, V7, P650, DOI 10.2174/156800907782418365; Authier F, 1999, FEBS LETT, V461, P25, DOI 10.1016/S0014-5793(99)01413-1; Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Balagopalan L, 2009, IMMUNOL REV, V232, P84, DOI 10.1111/j.1600-065X.2009.00840.x; Brock R, 2001, J CELL SCI, V114, P2437; Chen CS, 2008, J CELL SCI, V121, P3285, DOI 10.1242/jcs.023507; Cho MH, 2012, NAT MATER, V11, P1038, DOI [10.1038/NMAT3430, 10.1038/nmat3430]; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Colombo M, 2012, CHEM SOC REV, V41, P4306, DOI 10.1039/c2cs15337h; Duncan RR, 2004, J MICROSC-OXFORD, V215, P1, DOI 10.1111/j.0022-2720.2004.01343.x; Etoc F, 2013, NAT NANOTECHNOL, V8, P193, DOI [10.1038/NNANO.2013.23, 10.1038/nnano.2013.23]; Friedlander E, 2005, CYTOM PART A, V67A, P161, DOI 10.1002/cyto.a.20173; GILL GN, 1984, J BIOL CHEM, V259, P7755; Goh LK, 2010, J CELL BIOL, V189, P871, DOI 10.1083/jcb.201001008; Guardia P, 2010, LANGMUIR, V26, P5843, DOI 10.1021/la903767e; Hoffmann C, 2013, NAT NANOTECHNOL, V8, P199, DOI [10.1038/NNANO.2012.246, 10.1038/nnano.2012.246]; Huang H, 2010, NAT NANOTECHNOL, V5, P602, DOI [10.1038/nnano.2010.125, 10.1038/NNANO.2010.125]; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jun YW, 2008, ACCOUNTS CHEM RES, V41, P179, DOI 10.1021/ar700121f; Jura N, 2011, MOL CELL, V42, P9, DOI 10.1016/j.molcel.2011.03.004; Kantelhardt SR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011323; Kim J, 2008, ADV MATER, V20, P478, DOI 10.1002/adma.200701726; Lalatonne Y, 2004, NAT MATER, V3, P121, DOI 10.1038/nmat1054; LAX I, 1991, CELL REGUL, V2, P337, DOI 10.1091/mbc.2.5.337; Lemmon MA, 2009, EXP CELL RES, V315, P638, DOI 10.1016/j.yexcr.2008.10.024; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; Lidke DS, 2004, NAT BIOTECHNOL, V22, P198, DOI 10.1038/nbt929; Lu CF, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.414391; Mannix RJ, 2008, NAT NANOTECHNOL, V3, P36, DOI 10.1038/nnano.2007.418; MASUI H, 1984, CANCER RES, V44, P1002; Matthews BD, 2010, INTEGR BIOL-UK, V2, P435, DOI 10.1039/c0ib00034e; METZGER H, 1992, J IMMUNOL, V149, P1477; Ng K, 2008, CRIT REV ONCOL HEMAT, V65, P8, DOI 10.1016/j.critrevonc.2007.09.006; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Overby DR, 2005, ACTA BIOMATER, V1, P295, DOI 10.1016/j.actbio.2005.02.003; Pankhurst QA, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/22/224001; Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201; Parak WJ, 2005, NANOTECHNOLOGY, V16, pR9, DOI 10.1088/0957-4484/16/2/R01; Perez JM, 2002, NAT BIOTECHNOL, V20, P816, DOI 10.1038/nbt720; Rauch J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00868; Roca AG, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/22/224002; Russell Jeffery S, 2012, Chemother Res Pract, V2012, P761518, DOI 10.1155/2012/761518; Sahoo Y, 2005, J PHYS CHEM B, V109, P3879, DOI 10.1021/jp045402y; Sakaguchi K, 1998, MOL ENDOCRINOL, V12, P536, DOI 10.1210/me.12.4.536; Sato J D, 1983, Mol Biol Med, V1, P511; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Schulze WX, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100012; Seeney C, 2012, NANOMEDICINE-UK, V7, P289, DOI [10.2217/nnm.11.183, 10.2217/NNM.11.183]; Shih Andrew J, 2011, Cancers (Basel), V3, P1195, DOI 10.3390/cancers3011195; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Takahashi M, 2008, BBA-GEN SUBJECTS, V1780, P520, DOI 10.1016/j.bbagen.2007.10.019; Vivero-Pol L, 2005, J AM CHEM SOC, V127, P12770, DOI 10.1021/ja0533850; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; Yin J, 2005, P NATL ACAD SCI USA, V102, P15815, DOI 10.1073/pnas.0507705102; Yokoyama T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025507; Yu X, 2000, J CELL SCI, V113, P2139; Zeineldin R, 2010, J HISTOCHEM CYTOCHEM, V58, P529, DOI 10.1369/jhc.2010.955104; Ziomkiewicz I, 2013, CYTOM PART A, DOI [10.1002/cyto.a.22311, DOI 10.1002/CYT0.A.22311]	60	27	28	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e68879	10.1371/journal.pone.0068879	http://dx.doi.org/10.1371/journal.pone.0068879			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894364	Green Published, Green Submitted, gold			2022-12-27	WOS:000325211000053
J	Bock, A; Sparks, TH; Estrella, N; Menzel, A				Bock, Anna; Sparks, Tim H.; Estrella, Nicole; Menzel, Annette			Climate-Induced Changes in Grapevine Yield and Must Sugar Content in Franconia (Germany) between 1805 and 2010	PLOS ONE			English	Article							DECIDUOUS FOREST TREES; VITIS-VINIFERA L.; HARVEST DATES; ELEVATED CO2; WINE; PHENOLOGY; QUALITY; TEMPERATURE; GROWTH; CONSEQUENCES	When attempting to estimate the impacts of future climate change it is important to reflect on information gathered during the past. Understanding historical trends may also aid in the assessment of likely future agricultural and horticultural changes. The timing of agricultural activities, such as grape harvest dates, is known to be influenced by climate and weather. However, fewer studies have been carried out on grapevine yield and quality. In this paper an analysis is undertaken of long-term data from the period 1805-2010 on grapevine yield (hl/ha) and must sugar content (degrees Oe) and their relation to temperature. Monthly mean temperatures were obtained for the same time period. Multiple regression was used to relate the viticulture variables to temperature, and long-term trends were calculated. Overall, the observed trends over time are compatible with results from other long term studies. The findings confirm a relationship between yield, must sugar content and temperature data; increased temperatures were associated with higher yields and higher must sugar content. However, the potential increase in yield is currently limited by legislation, while must sugar content is likely to further increase with rising temperatures.	[Bock, Anna; Sparks, Tim H.; Estrella, Nicole; Menzel, Annette] Tech Univ Munich, Chair Ecoclimatol, Freising Weihenstephan, Germany; [Bock, Anna; Sparks, Tim H.; Estrella, Nicole; Menzel, Annette] Tech Univ Munich, Inst Adv Study, Garching, Germany; [Sparks, Tim H.] Poznan Univ Life Sci, Inst Zool, Poznan, Poland; [Sparks, Tim H.] Univ Cambridge, Dept Zool, Cambridge, England; [Sparks, Tim H.] Coventry Univ, Fac Engn & Comp, Coventry, W Midlands, England	Technical University of Munich; Technical University of Munich; Poznan University of Life Sciences; University of Cambridge; Coventry University	Bock, A (corresponding author), Tech Univ Munich, Chair Ecoclimatol, Freising Weihenstephan, Germany.	anna.bock@wzw.tum.de	Menzel, Annette/B-1105-2013	Menzel, Annette/0000-0002-7175-2512; Estrella, Nicole/0000-0002-1028-0048; Sparks, Tim/0000-0003-4382-7051	Technische Universitat Munchen - Institute for Advanced Study; German Excellence Initiative	Technische Universitat Munchen - Institute for Advanced Study; German Excellence Initiative	This work was supported by the Technische Universitat Munchen - Institute for Advanced Study, funded by the German Excellence Initiative (www.tum-ias.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, JAHR, V1994; [Anonymous], 1977, FESTSCHR ZUM 75JAHR, P220; Asshoff R, 2006, GLOBAL CHANGE BIOL, V12, P848, DOI 10.1111/j.1365-2486.2006.01133.x; Bader MKF, 2010, PLANTA, V232, P1115, DOI 10.1007/s00425-010-1240-8; Bayerische Landesanstalt fur Weinbau und Gartenbau, 1982, 198182 BAY LAND WEIN, V1981; Bindi M, 1996, CLIMATE RES, V7, P213, DOI 10.3354/cr007213; Bindi M, 2001, EUR J AGRON, V14, P145, DOI 10.1016/S1161-0301(00)00093-9; Bock A, 2011, CLIM RES, V50, P69, DOI 10.3354/cr01048; Chapman SC, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2012.0287; Chuine I, 2004, NATURE, V432, P289, DOI 10.1038/432289a; Conde C, 2007, FOOD, V22, DOI DOI 10.1186/S12864-016-2660-Z; de Cortazar-Atauri IG, 2010, HOLOCENE, V20, P599, DOI 10.1177/0959683609356585; Draper N.R, 1998, WILEY SERIES PROBABI, Vthird; Duchene E, 2005, AGRON SUSTAIN DEV, V25, P93, DOI 10.1051/agro:2004057; Eifler E, 1908, ARARIALISCHE WEINGUT; Etien N, 2009, CLIMATIC CHANGE, V94, P429, DOI 10.1007/s10584-008-9516-8; Fischer EE, 2007, BALLETTANZ, P34; Garnier E, 2011, CLIMATIC CHANGE, V104, P703, DOI 10.1007/s10584-010-9810-0; Hollerl H, 1997, NEUE BUCH FRANKENWEI; JACKSON DI, 1993, AM J ENOL VITICULT, V44, P409; Jones GV, 2000, AM J ENOL VITICULT, V51, P249; Jones GV, 2005, CLIMATIC CHANGE, V73, P319, DOI 10.1007/s10584-005-4704-2; KEELING CD, 1976, TELLUS, V28, P538, DOI 10.1111/j.2153-3490.1976.tb00701.x; Kiss A, 2011, INT J BIOMETEOROL, V55, P595, DOI 10.1007/s00484-010-0367-4; Korner C, 2005, SCIENCE, V309, P1360, DOI 10.1126/science.1113977; Laget F, 2008, J INT SCI VIGNE VIN, V42, P113; Lauer W, 1986, PALAOKLIMAFORSCHUNG; Luterbacher J, 2004, SCIENCE, V303, P1499, DOI 10.1126/science.1093877; Maurer C, 2011, THEOR APPL CLIMATOL, V106, P55, DOI 10.1007/s00704-011-0410-3; Maurer C, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD011730; Meier N, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031381; Menzel A, 2005, CLIM RES, V30, P21, DOI 10.3354/cr030021; Menzel A, 2005, METEOROL Z, V14, P75, DOI 10.1127/0941-2948/2005/0014-0075; Menzel A, 2006, CLIM RES, V32, P201; Moutinho-Pereira J, 2009, VITIS, V48, P159; Nicholls N, 1997, NATURE, V387, P484, DOI 10.1038/387484a0; Oppenheimer C, 2003, PROG PHYS GEOG, V27, P230, DOI 10.1191/0309133303pp379ra; PFISTER C, 1981, SCHWEIZ Z GESCH, V31, P445; Pfister C., 1992, CLIMATE AD, V1500, P118; Rapp J, 2000, BER DTSCH WETTERD, V212; Robinson J., 2006, OXFORD COMPANION WIN; Santos JA, 2011, INT J BIOMETEOROL, V55, P119, DOI 10.1007/s00484-010-0318-0; Schenk W, 1992, J WINE RES, V3, P105; Schmuck, 2002, HEFTE WURZBURG, V2; Schultz H. R., 2000, Australian Journal of Grape and Wine Research, V6, P2, DOI 10.1111/j.1755-0238.2000.tb00156.x; Seguin B, 2005, ACTA HORTIC, P61, DOI 10.17660/ActaHortic.2005.689.3; Shabalova MV, 2003, CLIMATIC CHANGE, V58, P219, DOI 10.1023/A:1023474032539; Storchmann Karl, 2005, Journal of Wine Research, V16, P105, DOI 10.1080/09571260500327648; Urhausen S, 2011, CLIMATIC CHANGE, V109, P349, DOI 10.1007/s10584-011-0059-z; van Leeuwen C, 2004, AM J ENOL VITICULT, V55, P207; Webb LB, 2008, CLIM RES, V36, P99, DOI 10.3354/cr00740; Webb LB, 2012, NAT CLIM CHANGE, V2, P259, DOI [10.1038/nclimate1417, 10.1038/NCLIMATE1417]; Weigand E, 1925, 50 JAHRE WEINGUT WEI; Weisensee B, 1982, WINZERS FREUD WINZER	54	41	41	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69015	10.1371/journal.pone.0069015	http://dx.doi.org/10.1371/journal.pone.0069015			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894395	Green Submitted, Green Published, gold			2022-12-27	WOS:000325211000067
J	Davies, LO; Schafer, H; Marshall, S; Bramke, I; Oliver, RG; Bending, GD				Davies, Lawrence O.; Schaefer, Hendrik; Marshall, Samantha; Bramke, Irene; Oliver, Robin G.; Bending, Gary D.			Light Structures Phototroph, Bacterial and Fungal Communities at the Soil Surface	PLOS ONE			English	Article							NITROGEN-FIXATION; SUCCESSIONAL STAGES; COLORADO PLATEAU; TENGGER-DESERT; CRUSTS; DIVERSITY; SEQUENCES; CYANOBACTERIA; PRIMERS; IDENTIFICATION	The upper few millimeters of soil harbour photosynthetic microbial communities that are structurally distinct from those of underlying bulk soil due to the presence of light. Previous studies in arid zones have demonstrated functional importance of these communities in reducing soil erosion, and enhancing carbon and nitrogen fixation. Despite being widely distributed, comparative understanding of the biodiversity of the soil surface and underlying soil is lacking, particularly in temperate zones. We investigated the establishment of soil surface communities on pasture soil in microcosms exposed to light or dark conditions, focusing on changes in phototroph, bacterial and fungal communities at the soil surface (0-3 mm) and bulk soil (3-12 mm) using ribosomal marker gene analyses. Microbial community structure changed with time and structurally similar phototrophic communities were found at the soil surface and in bulk soil in the light exposed microcosms suggesting that light can influence phototroph community structure even in the underlying bulk soil. 454 pyrosequencing showed a significant selection for diazotrophic cyanobacteria such as Nostoc punctiforme and Anabaena spp., in addition to the green alga Scenedesmus obliquus. The soil surface also harboured distinct heterotrophic bacterial and fungal communities in the presence of light, in particular, the selection for the phylum Firmicutes. However, these light driven changes in bacterial community structure did not extend to the underlying soil suggesting a discrete zone of influence, analogous to the rhizosphere.	[Davies, Lawrence O.; Schaefer, Hendrik; Bending, Gary D.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Davies, Lawrence O.; Marshall, Samantha; Bramke, Irene; Oliver, Robin G.] Syngenta, Prod Safety, Jealotts Hill Int Res Ctr, Bracknell, Berks, England	University of Warwick; Syngenta	Davies, LO (corresponding author), Univ Warwick, Sch Life Sci, Gibbet Hill Campus, Coventry CV4 7AL, W Midlands, England.	l.o.davies@warwick.ac.uk	Schaefer, Hendrik/A-5711-2009	Schaefer, Hendrik/0000-0001-8450-7893; Bending, Gary/0000-0002-9740-5244	Biological and Biotechnology Research Council [BB/H530970/2]	Biological and Biotechnology Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors wish to thank the Biological and Biotechnology Research Council for funding (Training Grant Reference Number: BB/H530970/2). URL: http://www.bbsrc.ac.uk/home/home.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed RMM, 2010, FEMS MICROBIOL ECOL, V72, P418, DOI 10.1111/j.1574-6941.2010.00854.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bates ST, 2012, MYCOLOGIA, V104, P353, DOI 10.3852/11-232; Bates ST, 2009, ENVIRON MICROBIOL, V11, P56, DOI 10.1111/j.1462-2920.2008.01738.x; BELNAP J, 1993, GREAT BASIN NAT, V53, P89; Belnap J, 1997, LAND DEGRAD DEV, V8, P355, DOI 10.1002/(SICI)1099-145X(199712)8:4<355::AID-LDR266>3.0.CO;2-H; Belnap J, 2002, BIOL FERT SOILS, V35, P128, DOI 10.1007/s00374-002-0452-x; BENVENUTI S, 1995, WEED SCI, V43, P389, DOI 10.1017/S0043174500081376; Beraldi-Campesi H, 2009, GEOBIOLOGY, V7, P348, DOI 10.1111/j.1472-4669.2009.00204.x; Blodgett R, 2006, BACTERIOLOGICAL ANAL, P135; BOLD HAROLD C., 1949, BULL TORREY BOT CLUB, V76, P101, DOI 10.2307/2482218; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Castillo-Monroy AP, 2011, ECOSYSTEMS, V14, P835, DOI 10.1007/s10021-011-9449-3; Chamizo S, 2012, SOIL BIOL BIOCHEM, V49, P96, DOI 10.1016/j.soilbio.2012.02.017; CHAO A, 1984, SCAND J STAT, V11, P265; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eldridge DJ, 2003, J ARID ENVIRON, V53, P457, DOI 10.1006/jare.2002.1068; Faithfull N. T., 2002, METHODS AGR CHEM ANA; Fierer N, 2003, MICROB ECOL, V45, P63, DOI 10.1007/s00248-002-1007-2; Garcia-Pichel F, 2001, APPL ENVIRON MICROB, V67, P1902, DOI 10.1128/AEM.67.4.1902-1910.2001; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gordon H, 2008, SOIL BIOL BIOCHEM, V40, P302, DOI 10.1016/j.soilbio.2007.08.008; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; HANSSON LA, 1988, FRESHWATER BIOL, V20, P347, DOI 10.1111/j.1365-2427.1988.tb00460.x; Harper KT, 2001, J ARID ENVIRON, V47, P347, DOI 10.1006/jare.2000.0713; Hauben L, 1997, INT J SYST BACTERIOL, V47, P328, DOI 10.1099/00207713-47-2-328; Hawkes CV, 2002, MICROBIAL ECOL, V43, P1, DOI 10.1007/s00248-001-1017-5; Hilton S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059859; Housman DC, 2006, J ARID ENVIRON, V66, P620, DOI 10.1016/j.jaridenv.2005.11.014; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Jeffery S, 2009, SOIL BIOL BIOCHEM, V41, P553, DOI 10.1016/j.soilbio.2008.12.014; Johnson SL, 2005, ENVIRON MICROBIOL, V7, P1, DOI 10.1111/j.1462-2920.2004.00649.x; Knapen A, 2007, EARTH SURF PROC LAND, V32, P1884, DOI 10.1002/esp.1504; LANGE OL, 1992, FUNCT ECOL, V6, P519, DOI 10.2307/2390048; Langhans TM, 2009, MICROB ECOL, V58, P394, DOI 10.1007/s00248-009-9532-x; Langhans TM, 2009, FLORA, V204, P157, DOI 10.1016/j.flora.2008.01.001; Li XR, 2010, EARTH SURF PROC LAND, V35, P932, DOI 10.1002/esp.1963; Li XR, 2005, PLANT SOIL, V277, P375, DOI 10.1007/s11104-005-8162-4; Li XR, 2002, BIOL FERT SOILS, V35, P147, DOI 10.1007/s00374-002-0453-9; Marchesi JR, 1998, APPL ENVIRON MICROB, V64, P795; Morgan JAW, 2005, J EXP BOT, V56, P1729, DOI 10.1093/jxb/eri205; Nagy ML, 2005, FEMS MICROBIOL ECOL, V54, P233, DOI 10.1016/j.femsec.2005.03.011; Placella SA, 2012, P NATL ACAD SCI USA, V109, P10931, DOI 10.1073/pnas.1204306109; Pointing SB, 2012, NAT REV MICROBIOL, V10, P551, DOI 10.1038/nrmicro2831; Redfield E, 2002, FEMS MICROBIOL ECOL, V40, P55, DOI 10.1111/j.1574-6941.2002.tb00936.x; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Ritchie RJ, 2006, PHOTOSYNTH RES, V89, P27, DOI 10.1007/s11120-006-9065-9; Sait L, 2003, APPL ENVIRON MICROB, V69, P2100, DOI 10.1128/AEM.69.4.2100-2109.2003; Sherwood AR, 2007, J PHYCOL, V43, P605, DOI 10.1111/j.1529-8817.2007.00341.x; Steven B, 2012, ENV MICROBIOL REP, V4, P248, DOI 10.1111/j.1758-2229.2012.00328.x; Stewart KJ, 2011, SOIL BIOL BIOCHEM, V43, P133, DOI 10.1016/j.soilbio.2010.09.023; Thomas KA, 2012, ENVIRON TOXICOL CHEM, V31, P2138, DOI 10.1002/etc.1928; Tisdall JM, 2012, SOIL BIOL BIOCHEM, V50, P134, DOI 10.1016/j.soilbio.2012.02.035; Veluci RM, 2006, MICROB ECOL, V51, P189, DOI 10.1007/s00248-005-0121-3; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; White T.J., 1990, PCR PROTOCOL GUIDE M; Yeager CM, 2004, APPL ENVIRON MICROB, V70, P973, DOI 10.1128/AEM.70.2.973-983.2004; Yoshitake S, 2010, NEW PHYTOL, V186, P451, DOI 10.1111/j.1469-8137.2010.03180.x; Zaady E, 2010, SOIL BIOL BIOCHEM, V42, P842, DOI 10.1016/j.soilbio.2010.02.002; Zhang BC, 2011, ARID LAND RES MANAG, V25, P275, DOI 10.1080/15324982.2011.565858; Zhang J, 2009, J HYDROL, V379, P220, DOI 10.1016/j.jhydrol.2009.09.053; Zhao Y, 2010, J ARID ENVIRON, V74, P1186, DOI 10.1016/j.jaridenv.2010.04.006	66	8	8	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e69048	10.1371/journal.pone.0069048	http://dx.doi.org/10.1371/journal.pone.0069048			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894406	Green Published, Green Submitted, gold			2022-12-27	WOS:000322391400038
J	Imanishi, Y; Miyagawa, S; Fukushima, S; Ishimaru, K; Sougawa, N; Saito, A; Sakai, Y; Sawa, Y				Imanishi, Yukiko; Miyagawa, Shigeru; Fukushima, Satsuki; Ishimaru, Kazuhiko; Sougawa, Nagako; Saito, Atsuhiro; Sakai, Yoshiki; Sawa, Yoshiki			Sustained-Release Delivery of Prostacyclin Analogue Enhances Bone Marrow-Cell Recruitment and Yields Functional Benefits for Acute Myocardial Infarction in Mice	PLOS ONE			English	Article							ISCHEMIC CARDIOMYOPATHY; HEART; ANGIOGENESIS; EXPRESSION; GROWTH; REPAIR; CXCR4	Background: A prostacyclin analogue, ONO-1301, is reported to upregulate beneficial proteins, including stromal cell derived factor-1 (SDF-1). We hypothesized that the sustained-release delivery of ONO-1301 would enhance SDF-1 expression in the acute myocardial infarction (MI) heart and induce bone marrow cells (BMCs) to home to the myocardium, leading to improved cardiac function in mice. Methods and Results: ONO-1301 significantly upregulated SDF-1 secretion by fibroblasts. BMC migration was greater to ONO-1301-stimulated than unstimulated conditioned medium. This increase was diminished by treating the BMCs with a CXCR4-neutralizing antibody or CXCR4 antagonist (AMD3100). Atelocollagen sheets containing a sustained-release form of ONO-1301 (n = 33) or ONO-1301-free vehicle (n = 48) were implanted on the left ventricular (LV) anterior wall immediately after permanent left-anterior descending artery occlusion in C57BL6/N mice (male, 8-weeks-old). The SDF-1 expression in the infarct border zone was significantly elevated for 1 month in the ONO-1301-treated group. BMC accumulation in the infarcted hearts, detected by in vivo imaging after intravenous injection of labeled BMCs, was enhanced in the ONO-1301-treated hearts. This increase was inhibited by AMD3100. The accumulated BMCs differentiated into capillary structures. The survival rates and cardiac function were significantly improved in the ONO-1301-treated group (fractional area change 23+/-1%; n = 22) compared to the vehicle group (19+/-1%; n = 20; P = 0.004). LV anterior wall thinning, expansion of infarction, and fibrosis were lower in the ONO-1301-treated group. Conclusions: Sustained-release delivery of ONO-1301 promoted BMC recruitment to the acute MI heart via SDF-1/CXCR4 signaling and restored cardiac performance, suggesting a novel mechanism for ONO-1301-mediated acute-MI heart repair.	[Imanishi, Yukiko; Miyagawa, Shigeru; Fukushima, Satsuki; Ishimaru, Kazuhiko; Sougawa, Nagako; Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Osaka, Japan; [Saito, Atsuhiro] Osaka Univ Hosp, Med Ctr Translat Res, Osaka 553, Japan; [Sakai, Yoshiki] ONO Pharmaceut CO LTD, Res Headquarters, Osaka, Japan	Osaka University; Osaka University; Ono Pharmaceutical Co Ltd	Sawa, Y (corresponding author), Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Osaka, Japan.	sawa@surg1.med.osaka-u.ac.jp	Fukushima, Satsuki/ABE-6582-2020	Fukushima, Satsuki/0000-0002-9481-8860; Imanishi, Yukiko/0000-0001-6241-0644; Miyagawa, Shigeru/0000-0003-0015-6569	Japan Society for the Promotion of Science [21003]; Ministry of Health; Labour and Welfare, Health and Labour Sciences Research Grant [H23-002]; New Energy and Industrial Technology Development Organization [P10004]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health; Labour and Welfare, Health and Labour Sciences Research Grant; New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO))	This study was funded by grant-in-aid for Core-to-Core Program (21003) from the Japan Society for the Promotion of Science (http://jsps-osaka-u.jpn.org/en/index.html), early-stage and exploratory clinical trial centers project from the Ministry of Health (http://jsps-osaka-u.jpn.org/en/index.html), Labour and Welfare, Health and Labour Sciences Research Grant (H23-002, http://jsps-osaka-u.jpn.org/en/index.html), and from New Energy and Industrial Technology Development Organization (P10004, http://www.nedo.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Goichberg P, 2006, BLOOD, V107, P870, DOI 10.1182/blood-2005-03-0941; Hirata Y, 2009, BIOMED PHARMACOTHER, V63, P781, DOI 10.1016/j.biopha.2009.09.003; Imanishi Y, 2008, J MOL CELL CARDIOL, V44, P662, DOI 10.1016/j.yjmcc.2007.11.001; Imanishi Y, 2011, CIRCULATION, V124, pS10, DOI 10.1161/CIRCULATIONAHA.110.009993; Kajstura J, 2012, CIRCULATION, V126, P1869, DOI 10.1161/CIRCULATIONAHA.112.118380; Kawabe J, 2010, ARTERIOSCL THROM VAS, V30, P464, DOI 10.1161/ATVBAHA.109.193730; Knoops S, 2001, CYTOKINE, V14, P184, DOI 10.1006/cyto.2001.0869; Leri A, 2011, CIRC RES, V109, P941, DOI 10.1161/CIRCRESAHA.111.243154; Matysiak M, 2011, J NEUROIMMUNOL, V233, P106, DOI 10.1016/j.jneuroim.2010.12.004; Mollova M, 2013, P NATL ACAD SCI USA, V110, P1446, DOI 10.1073/pnas.1214608110; Nakamura K, 2007, CLIN SCI, V112, P607, DOI 10.1042/CS20060301; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Sanganalmath SK, 2011, BASIC RES CARDIOL, V106, P709, DOI 10.1007/s00395-011-0183-y; Smart N, 2008, CIRC RES, V102, P1155, DOI 10.1161/CIRCRESAHA.108.175158; Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22; YAMANAKA S, 1992, CIRC RES, V70, P893, DOI 10.1161/01.RES.70.5.893; Yamasaki H, 2011, PROSTAG LEUKOTR ESS, V84, P99, DOI 10.1016/j.plefa.2010.11.005; Zaruba MM, 2010, EXPERT OPIN BIOL TH, V10, P321, DOI 10.1517/14712590903460286	25	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e69302	10.1371/journal.pone.0069302	http://dx.doi.org/10.1371/journal.pone.0069302			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894446	Green Submitted, gold, Green Published			2022-12-27	WOS:000322391400047
J	Rand, MK; Heuer, H				Rand, Miya K.; Heuer, Herbert			Implicit and Explicit Representations of Hand Position in Tool Use	PLOS ONE			English	Article							POSTERIOR PARIETAL CORTEX; VISUAL CAPTURE; MOVEMENTS; VISION; ARM; PROPRIOCEPTION; INTEGRATION; MIRROR; CONSEQUENCES; INFORMATION	Understanding the interactions of visual and proprioceptive information in tool use is important as it is the basis for learning of the tool's kinematic transformation and thus skilled performance. This study investigated how the CNS combines seen cursor positions and felt hand positions under a visuo-motor rotation paradigm. Young and older adult participants performed aiming movements on a digitizer while looking at rotated visual feedback on a monitor. After each movement, they judged either the proprioceptively sensed hand direction or the visually sensed cursor direction. We identified asymmetric mutual biases with a strong visual dominance. Furthermore, we found a number of differences between explicit and implicit judgments of hand directions. The explicit judgments had considerably larger variability than the implicit judgments. The bias toward the cursor direction for the explicit judgments was about twice as strong as for the implicit judgments. The individual biases of explicit and implicit judgments were uncorrelated. Biases of these judgments exhibited opposite sequential effects. Moreover, age-related changes were also different between these judgments. The judgment variability was decreased and the bias toward the cursor direction was increased with increasing age only for the explicit judgments. These results indicate distinct explicit and implicit neural representations of hand direction, similar to the notion of distinct visual systems.	[Rand, Miya K.; Heuer, Herbert] IfADo Leibniz Res Ctr Working Environm & Human Fa, Dortmund, Germany	Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO)	Rand, MK (corresponding author), IfADo Leibniz Res Ctr Working Environm & Human Fa, Dortmund, Germany.	rand@ifado.de		Lauwereyns, Jan/0000-0003-0551-2550; Heuer, Herbert/0000-0002-0488-2878	Deutsche Forschungsgemeinschaft (DFG) [He 1187/15-3, Ra 2183/1-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by He 1187/15-3 and Ra 2183/1-1 of the Deutsche Forschungsgemeinschaft (DFG) (http://www.dfg.de/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balslev D, 2004, J NEUROSCI, V24, P9698, DOI 10.1523/JNEUROSCI.1738-04.2004; Bernier PM, 2009, CEREB CORTEX, V19, P2106, DOI 10.1093/cercor/bhn233; BOCK O, 1986, EXP BRAIN RES, V62, P451; Boisgontier MP, 2012, AGE, V34, P1179, DOI 10.1007/s11357-011-9300-y; BRIDGEMAN B, 1979, J EXP PSYCHOL HUMAN, V5, P692, DOI 10.1037/0096-1523.5.4.692; Cheng K, 2007, PSYCHOL BULL, V133, P625, DOI 10.1037/0033-2909.133.4.625; Cohen YE, 2002, NAT REV NEUROSCI, V3, P553, DOI 10.1038/nrn873; Collins T, 2008, COGNITION, V109, P363, DOI 10.1016/j.cognition.2008.10.001; Desmurget M, 1999, NAT NEUROSCI, V2, P563, DOI 10.1038/9219; Ernst M. O., 2006, HUMAN BODY PERCEPTIO, P105; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Falk R, 1997, PSYCHOL REV, V104, P301, DOI 10.1037/0033-295X.104.2.301; Fecteau JH, 2003, NAT REV NEUROSCI, V4, P435, DOI 10.1038/nrn1114; Franz V, 2008, COGN NEUROPSYCHOL, V25, P920, DOI 10.1080/02643290701862449; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Goble DJ, 2009, NEUROSCI BIOBEHAV R, V33, P271, DOI 10.1016/j.neubiorev.2008.08.012; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; HAALAND KY, 1993, PSYCHOL AGING, V8, P617, DOI 10.1037/0882-7974.8.4.617; HAY JC, 1965, PSYCHON SCI, V2, P215, DOI 10.3758/BF03343413; Helbig HB, 2007, PERCEPTION, V36, P1523, DOI 10.1068/p5851; Helbig HB, 2008, J VISION, V8, DOI 10.1167/8.1.21; Heuer H, 1998, EXP BRAIN RES, V119, P224, DOI 10.1007/s002210050336; Heuer H, 2005, Q J EXP PSYCHOL-A, V58, P275, DOI 10.1080/02724980343000855; Heuer H, 2012, NEUROSCIENCE, V207, P137, DOI 10.1016/j.neuroscience.2012.01.035; Heuer H., 2013, AGE DIFFERENTIATED W, P369, DOI DOI 10.1007/978-3-642-35057-3_16; Heuer H, 2008, PSYCHOL AGING, V23, P190, DOI 10.1037/0882-7974.23.1.190; Heuer H, 2013, ACTION SCIENCE: FOUNDATIONS OF AN EMERGING DISCIPLINE, P37; Heuer H, 2012, EXP BRAIN RES, V218, P129, DOI 10.1007/s00221-012-3013-z; Heuer H, 2012, PSYCHOL RES-PSYCH FO, V76, P159, DOI 10.1007/s00426-011-0332-9; Heuer H, 2010, Q J EXP PSYCHOL, V63, P465, DOI 10.1080/17470210902974138; Holmes NP, 2004, COGN AFFECT BEHAV NE, V4, P193, DOI 10.3758/CABN.4.2.193; Holmes NP, 2005, EXP BRAIN RES, V166, P489, DOI 10.1007/s00221-005-2389-4; JOHANSSON RS, 1988, EXP BRAIN RES, V71, P59; Kirby N. H., 1980, REACTION TIMES, P129; LAJOIE Y, 1992, NEUROLOGY, V42, P1104, DOI 10.1212/WNL.42.5.1104; Li SC, 2002, NEUROSCI BIOBEHAV R, V26, P795, DOI 10.1016/S0149-7634(02)00066-0; Lukos JR, 2013, J NEUROPHYSIOL, V109, P2937, DOI 10.1152/jn.00060.2013; Medendorp WP, 2005, J NEUROPHYSIOL, V93, P954, DOI 10.1152/jn.00725.2004; Milner A. D., 1995, VISUAL BRAIN ACTION; Mittenecker E, 1953, Z EXPT ANGEWANDTE PS, V1, P5; Musseler J, 2009, CONSCIOUS COGN, V18, P359, DOI 10.1016/j.concog.2009.02.004; Neggers SFW, 2000, J NEUROPHYSIOL, V83, P639, DOI 10.1152/jn.2000.83.2.639; Paillard J, 1968, NEUROPSYCHOLOGY SPAT, P37; Plooy A, 1998, EXP BRAIN RES, V118, P415, DOI 10.1007/s002210050295; Rand MK, 2013, NEUROBIOL AGING, V34, P1864, DOI 10.1016/j.neurobiolaging.2013.01.021; Rand MK, 2011, BEHAV BRAIN RES, V219, P39, DOI 10.1016/j.bbr.2010.12.008; Reed CL, 2010, ATTEN PERCEPT PSYCHO, V72, P236, DOI 10.3758/APP.72.1.236; ROSSETTI Y, 1995, J NEUROPHYSIOL, V74, P457, DOI 10.1152/jn.1995.74.1.457; Seidler-Dobrin RD, 1998, EXP BRAIN RES, V119, P467, DOI 10.1007/s002210050362; Shanks D. R., 2005, HDB COGNITION, P203, DOI [10.4135/9781848608177.n8, DOI 10.4135/9781848608177.N8]; Simoneau M, 1999, J AM GERIATR SOC, V47, P235, DOI 10.1111/j.1532-5415.1999.tb04584.x; Smeets JBJ, 2006, J EXP PSYCHOL HUMAN, V32, P1501, DOI 10.1037/0096-1523.32.6.1501; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; Tewes U., 1994, HAMBURG WECHSLER INT; van Beers RJ, 2002, CURR BIOL, V12, P834, DOI 10.1016/S0960-9822(02)00836-9; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; Wang L, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00289; WELFORD AT, 1981, HUM FACTORS, V23, P97, DOI 10.1177/001872088102300109	59	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e68471	10.1371/journal.pone.0068471	http://dx.doi.org/10.1371/journal.pone.0068471			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	191CY	23894307	Green Published, gold, Green Submitted			2022-12-27	WOS:000322391400008
J	Knouf, EC; Wyman, SK; Tewari, M				Knouf, Emily C.; Wyman, Stacia K.; Tewari, Muneesh			The Human TUT1 Nucleotidyl Transferase as a Global Regulator of microRNA Abundance	PLOS ONE			English	Article							MIRNA VARIANTS; 3' ADENYLATION; EXPRESSION; BIOGENESIS; GENERATION; URIDYLATION; METHYLATION; DISCOVERY; TURNOVER; SIRNAS	Post-transcriptional modifications of miRNAs with 3' non-templated nucleotide additions (NTA) are a common phenomenon, and for a handful of miRNAs the additions have been demonstrated to modulate miRNA stability. However, it is unknown for the vast majority of miRNAs whether nucleotide additions are associated with changes in miRNA expression levels. We previously showed that miRNA 3' additions are regulated by multiple nucleotidyl transferase enzymes. Here we examine the changes in abundance of miRNAs that exhibit altered 3' NTA following the suppression of a panel of nucleotidyl transferases in cancer cell lines. Among the miRNAs examined, those with increased 3' additions showed a significant decrease in abundance. More specifically, miRNAs that gained a 3' uridine were associated with the greatest decrease in expression, consistent with a model in which 3' uridylation influences miRNA stability. We also observed that suppression of one nucleotidyl transferase, TUT1, resulted in a global decrease in miRNA levels of approximately 40% as measured by qRT-PCR-based miRNA profiling. The mechanism of this global miRNA suppression appears to be indirect, as it occurred irrespective of changes in 3' nucleotide addition. Also, expression of miRNA primary transcripts did not decrease following TUT1 knockdown, indicating that the mechanism is post-transcriptional. In conclusion, our results suggest that TUT1 affects miRNAs through both a direct effect on 3' nucleotide additions to specific miRNAs and a separate, indirect effect on miRNA abundance more globally.	[Knouf, Emily C.; Wyman, Stacia K.; Tewari, Muneesh] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98104 USA; [Knouf, Emily C.] Univ Washington, Mol & Cellular Biol Grad Program, Seattle, WA USA; [Tewari, Muneesh] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Tewari, Muneesh] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Tewari, Muneesh] Univ Washington, Dept Med, Seattle, WA USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Tewari, M (corresponding author), Fred Hutchinson Canc Res Ctr, Human Biol Div, 1124 Columbia St, Seattle, WA 98104 USA.	mtewari@fhcrc.org			Public Health Service from National Institute of General Medical Sciences (NIGMS) [NRSA T32 GM07270];  [NIH-DK 085714]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085714] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270] Funding Source: NIH RePORTER	Public Health Service from National Institute of General Medical Sciences (NIGMS); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was performed with support from the Public Health Service NRSA T32 GM07270 from National Institute of General Medical Sciences (NIGMS) to ECK and a Transformative R01 grant (NIH-DK 085714) to MT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccarini A, 2011, CURR BIOL, V21, P369, DOI 10.1016/j.cub.2011.01.067; Bail S, 2010, RNA, V16, P1032, DOI 10.1261/rna.1851510; Bar M, 2008, STEM CELLS, V26, P2496, DOI 10.1634/stemcells.2008-0356; Berezikov E, 2011, GENOME RES; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Berezikov E, 2006, GENOME RES, V16, P1289, DOI 10.1101/gr.5159906; Burroughs AM, 2010, GENOME RES, V20, P1398, DOI 10.1101/gr.106054.110; Burroughs AM, 2011, RNA BIOL, V8, P158, DOI 10.4161/rna.8.1.14300; Chatterjee S, 2009, NATURE, V461, P546, DOI 10.1038/nature08349; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Cloonan N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r126; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Fehniger TA, 2010, GENOME RES, V20, P1590, DOI 10.1101/gr.107995.110; Fernandez-Valverde SL, 2010, RNA, V16, P1881, DOI 10.1261/rna.2379610; Gantier MP, 2011, NUCLEIC ACIDS RES, V39, P5692, DOI 10.1093/nar/gkr148; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Guo L, 2010, COMPUT BIOL CHEM, V34, P165, DOI 10.1016/j.compbiolchem.2010.06.001; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Ibrahim F, 2010, P NATL ACAD SCI US; Jones MR, 2009, NAT CELL BIOL, V11, P1157, DOI 10.1038/ncb1931; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee LW, 2010, RNA, V16, P2170, DOI 10.1261/rna.2225110; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Li W, 2012, MOL CELL, V45, P25, DOI 10.1016/j.molcel.2011.11.017; Marti E, 2010, NUCLEIC ACIDS RES, V38, P7219, DOI 10.1093/nar/gkq575; Mellman DL, 2008, NATURE, V451, P1013, DOI 10.1038/nature06666; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Newman MA, 2011, DEEP SEQUENCING MICR; Ramachandran V, 2008, SCIENCE, V321, P1490, DOI 10.1126/science.1163728; Ren GD, 2012, CURR BIOL, V22, P695, DOI 10.1016/j.cub.2012.02.052; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Trippe R, 1998, NUCLEIC ACIDS RES, V26, P3119, DOI 10.1093/nar/26.13.3119; Westholm JO, 2012, RNA, V18, P177, DOI 10.1261/rna.030627.111; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wyman SK, 2011, GENOME RES, V21, P1450, DOI 10.1101/gr.118059.110; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130; Zhao YY, 2012, CURR BIOL, V22, P689, DOI 10.1016/j.cub.2012.02.051; Zhou HJ, 2012, NUCLEIC ACIDS RES, V40, P5864, DOI 10.1093/nar/gks247	42	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e69630	10.1371/journal.pone.0069630	http://dx.doi.org/10.1371/journal.pone.0069630			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874977	Green Published, Green Submitted, gold			2022-12-27	WOS:000324146200080
J	Uddin, RK; Singh, SM				Uddin, Raihan K.; Singh, Shiva M.			Hippocampal Gene Expression Meta-Analysis Identifies Aging and Age-Associated Spatial Learning Impairment (ASLI) Genes and Pathways	PLOS ONE			English	Article							LONG-TERM POTENTIATION; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; APOLIPOPROTEIN-E; LIFE-SPAN; BRAIN; MEMORY; RECEPTORS; CALCIUM; CONSOLIDATION	A number of gene expression microarray studies have been carried out in the past, which studied aging and age-associated spatial learning impairment (ASLI) in the hippocampus in animal models, with varying results. Data from such studies were never integrated to identify the most significant ASLI genes and to understand their effect. In this study we integrated these data involving rats using meta-analysis. Our results show that proper removal of batch effects from microarray data generated from different laboratories is necessary before integrating them for meta-analysis. Our meta-analysis has identified a number of significant differentially expressed genes across age or across ASLI. These genes affect many key functions in the aged compared to the young rats, which include viability of neurons, cell-to-cell signalling and interaction, migration of cells, neuronal growth, and synaptic plasticity. These functional changes due to the altered gene expression may manifest into various neurodegenerative diseases and disorders, some of which leading into syndromic memory impairments. While other aging related molecular changes can result into altered synaptic plasticity simply causing normal aging related non-syndromic learning or spatial learning impairments such as ASLI.	[Uddin, Raihan K.; Singh, Shiva M.] Univ Western Ontario, Dept Biol, Mol Genet Unit, London, ON, Canada	Western University (University of Western Ontario)	Uddin, RK (corresponding author), Univ Western Ontario, Dept Biol, Mol Genet Unit, London, ON, Canada.	ruddin@uwo.ca; ssingh@uwo.ca			Natural Sciences and Engineering Research Council; University of Western Ontario	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Western Ontario	The authors acknowledge support from the Natural Sciences and Engineering Research Council grant and the University of Western Ontario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzheimers Assoc, 2012, ALZHEIMERS DEMENT, V8, P131, DOI 10.1016/j.jalz.2012.02.001; Angelo M, 2006, J NEUROCHEM, V99, P353, DOI 10.1111/j.1471-4159.2006.04040.x; Arnold AC, 2013, HYPERTENS RES, V36, P5, DOI 10.1038/hr.2012.161; Bartus K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057292; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blalock EM, 2003, J NEUROSCI, V23, P3807; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bolstad BM, 2005, STAT BIOL HEALTH, P33; Borenstein M, 2009, INTRO META ANAL; Borghese F, 2011, EXPERT OPIN THER TAR, V15, P237, DOI 10.1517/14728222.2011.550879; Bramham CR, 2010, EXP BRAIN RES, V200, P125, DOI 10.1007/s00221-009-1959-2; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Burger C, 2008, NEUROBIOL LEARN MEM, V89, P379, DOI 10.1016/j.nlm.2007.11.006; Burger C, 2007, NEUROBIOL LEARN MEM, V87, P21, DOI 10.1016/j.nlm.2006.05.003; Burgess N, 2002, Q J EXP PSYCHOL-A, V55, P1057, DOI 10.1080/02724980244000224; Cazander G, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/534291; Chen C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017238; Chen DY, 2011, NATURE, V469, P491, DOI 10.1038/nature09667; Chen LH, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.09.016; COCHRAN W. G., 1937, J. Roy. Statist. Soc. 1937., (Suppl.), V4, P102; COLEMAN GL, 1977, J GERONTOL, V32, P258, DOI 10.1093/geronj/32.3.258; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cushion TD, 2013, BRAIN, V136, P536, DOI 10.1093/brain/aws338; Daniels MP, 2012, NEUROCHEM INT, V61, P848, DOI 10.1016/j.neuint.2012.02.028; Derfuss T, 2009, P NATL ACAD SCI USA, V106, P8302, DOI 10.1073/pnas.0901496106; Donnelly N, 2013, CELL MOL LIFE SCI; Ebstein RP, 2012, HORM BEHAV, V61, P359, DOI 10.1016/j.yhbeh.2011.12.014; Ferrari R., 2012, NEUROBIOL AGING, V33; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; Fleiss J L, 1993, Stat Methods Med Res, V2, P121, DOI 10.1177/096228029300200202; Foster TC, 2012, PROG NEUROBIOL, V96, P283, DOI 10.1016/j.pneurobio.2012.01.007; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gay EA, 2008, J PHARMACOL EXP THER, V327, P884, DOI 10.1124/jpet.108.144758; Genoud S, 1999, J NEUROCHEM, V72, P1699, DOI 10.1046/j.1471-4159.1999.721699.x; Glorioso C, 2011, NEUROBIOL DIS, V41, P279, DOI 10.1016/j.nbd.2010.09.016; Glorioso C, 2011, PROG NEUROBIOL, V93, P165, DOI 10.1016/j.pneurobio.2010.11.006; Goldstein DR, 2010, CH CRC MATH COMP BIO, P3; Guzowski JF, 2000, J NEUROSCI, V20, P3993; He HJ, 2012, CNS NEUROSCI THER, V18, P994, DOI 10.1111/cns.12018; Iida Y., 2013, NEUROSCI RES; Ishii N, 2010, ADV IMMUNOL, V105, P63, DOI 10.1016/S0065-2776(10)05003-0; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kadish I, 2009, J NEUROSCI, V29, P1805, DOI 10.1523/JNEUROSCI.4599-08.2009; Kenwrick S, 2000, HUM MOL GENET, V9, P879, DOI 10.1093/hmg/9.6.879; Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune; LANDFIELD PW, 1992, J NEUROBIOL, V23, P1247, DOI 10.1002/neu.480230914; Lee TW, 2008, J NEUROSCI RES, V86, P1243, DOI 10.1002/jnr.21592; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Lin JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052376; Liu CC, 2013, NAT REV NEUROL; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Maeda S, 2006, NEUROSCI RES, V54, P197, DOI 10.1016/j.neures.2005.11.009; Maier M, 2008, J NEUROSCI, V28, P6333, DOI 10.1523/JNEUROSCI.0829-08.2008; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Mattson MP, 2006, NAT REV NEUROSCI, V7, P278, DOI 10.1038/nrn1886; Menard C, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00182; Mesulam NM, 1999, NEURON, V24, P521, DOI 10.1016/S0896-6273(00)81109-5; Mihelic M, 2008, J BIOL CHEM, V283, P14453, DOI 10.1074/jbc.M801283200; Miller BC, 2003, P NATL ACAD SCI USA, V100, P6221, DOI 10.1073/pnas.1031520100; Monfort P, 2004, NEUROCHEM INT, V45, P895, DOI 10.1016/j.neuint.2004.03.020; Montmayeur JP, 2011, PHARMACOL RES, V64, P258, DOI 10.1016/j.phrs.2011.04.003; Moreau Y, 2003, TRENDS GENET, V19, P570, DOI 10.1016/j.tig.2003.08.006; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Moscarello MA, 2007, NEUROCHEM RES, V32, P251, DOI 10.1007/s11064-006-9144-5; Nalivaeva NN, 2012, J NEUROCHEM, V120, P167, DOI 10.1111/j.1471-4159.2011.07510.x; O'Neill C, 2012, BIOCHEM SOC T, V40, P721, DOI 10.1042/BST20120080; Osterwalder T, 1996, EMBO J, V15, P2944, DOI 10.1002/j.1460-2075.1996.tb00657.x; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Pawlowski TL, 2009, BRAIN RES, V1256, P101, DOI 10.1016/j.brainres.2008.12.039; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Poplawski GHD, 2012, MOL CELL NEUROSCI, V50, P169, DOI 10.1016/j.mcn.2012.03.010; POULIN P, 1993, J NEUROENDOCRINOL, V5, P23, DOI 10.1111/j.1365-2826.1993.tb00360.x; Ramasamy A, 2008, PLOS MED, V5, P1320, DOI 10.1371/journal.pmed.0050184; RAMSDELL JS, 1986, J BIOL CHEM, V261, P5301; Rhodes DR, 2002, CANCER RES, V62, P4427; Roesler Rafael, 2012, Front Endocrinol (Lausanne), V3, P159, DOI 10.3389/fendo.2012.00159; Romaniello R, 2012, DEV MED CHILD NEUROL, V54, P765, DOI 10.1111/j.1469-8749.2012.04316.x; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Rowe WB, 2007, J NEUROSCI, V27, P3098, DOI 10.1523/JNEUROSCI.4163-06.2007; SASS B, 1975, J NATL CANCER I, V54, P1449, DOI 10.1093/jnci/54.6.1449; Scotland PB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044252; Shen F, 2012, NEUROBIOL LEARN MEM, V98, P130, DOI 10.1016/j.nlm.2012.07.005; Shepherd JD, 2011, NAT NEUROSCI, V14, P279, DOI 10.1038/nn.2708; Shukla V, 2012, ARCH MED RES, V43, P655, DOI 10.1016/j.arcmed.2012.10.015; Sirbu A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013822; Small SA, 2002, ANN NEUROL, V51, P290, DOI 10.1002/ana.10105; SMOGORZEWSKI M, 1995, AM J KIDNEY DIS, V26, P814, DOI 10.1016/0272-6386(95)90449-2; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Tanzi RE, 2001, NEURON, V32, P181, DOI 10.1016/S0896-6273(01)00476-7; Timofeeva OA, 2010, BRAIN RES, V1308, P147, DOI 10.1016/j.brainres.2009.10.040; Verbitsky M, 2004, LEARN MEMORY, V11, P253, DOI 10.1101/lm.68204; Wyeth MS, 2012, NEUROSCIENCE, V202, P371, DOI 10.1016/j.neuroscience.2011.11.056; Xiao QL, 2012, J BIOL CHEM, V287, P21279, DOI 10.1074/jbc.M111.338376; Zwanzger P, 2012, DEPRESS ANXIETY, V29, P762, DOI 10.1002/da.21919	95	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e69768	10.1371/journal.pone.0069768	http://dx.doi.org/10.1371/journal.pone.0069768			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874995	gold, Green Published, Green Submitted			2022-12-27	WOS:000324146200082
J	Yang, YZ; Jittayasothorn, Y; Chronis, D; Wang, XH; Cousins, P; Zhong, GY				Yang, Yingzhen; Jittayasothorn, Yingyos; Chronis, Demosthenis; Wang, Xiaohong; Cousins, Peter; Zhong, Gan-Yuan			Molecular Characteristics and Efficacy of 16D10 siRNAs in Inhibiting Root-Knot Nematode Infection in Transgenic Grape Hairy Roots	PLOS ONE			English	Article							PLANT-PARASITIC NEMATODES; GC PREFERENCE; SMALL RNA; GENE; RESISTANCE; EXPRESSION; DESIGN; SYSTEM; INTERFERENCE; PARAMETERS	Root-knot nematodes (RKNs) infect many annual and perennial crops and are the most devastating soil-born pests in vineyards. To develop a biotech-based solution for controlling RKNs in grapes, we evaluated the efficacy of plant-derived RNA interference (RNAi) silencing of a conserved RKN effector gene, 16D10, for nematode resistance in transgenic grape hairy roots. Two hairpin-based silencing constructs, containing a stem sequence of 42 bp (pART27-42) or 271 bp (pART27-271) of the 16D10 gene, were transformed into grape hairy roots and compared for their small interfering RNA (siRNA) production and efficacy on suppression of nematode infection. Transgenic hairy root lines carrying either of the two RNAi constructs showed less susceptibility to nematode infection compared with control. Small RNA libraries from four pART27-42 and two pART27-271 hairy root lines were sequenced using an Illumina sequencing technology. The pART27-42 lines produced hundred times more 16D10-specific siRNAs than the pART27-271 lines. On average the 16D10 siRNA population had higher GC content than the 16D10 stem sequences in the RNAi constructs, supporting previous observation that plant dicer-like enzymes prefer GC-rich sequences as substrates for siRNA production. The stems of the 16D10 RNAi constructs were not equally processed into siRNAs. Several hot spots for siRNA production were found in similar positions of the hairpin stems in pART27-42 and pART27-271. Interestingly, stem sequences at the loop terminus produced more siRNAs than those at the stem base. Furthermore, the relative abundance of guide and passenger single-stranded RNAs from putative siRNA duplexes was largely correlated with their 59 end thermodynamic strength. This study demonstrated the feasibility of using a plant-derived RNAi approach for generation of novel nematode resistance in grapes and revealed several interesting molecular characteristics of transgene siRNAs important for optimizing plant RNAi constructs.	[Yang, Yingzhen; Jittayasothorn, Yingyos; Cousins, Peter; Zhong, Gan-Yuan] USDA ARS, Grape Genet Res Unit, Geneva, NY USA; [Jittayasothorn, Yingyos] NEI, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Chronis, Demosthenis; Wang, Xiaohong] USDA ARS, Robert W Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA; [Cousins, Peter] E&J Gallo Winery, Modesto, CA USA	United States Department of Agriculture (USDA); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); United States Department of Agriculture (USDA)	Zhong, GY (corresponding author), USDA ARS, Grape Genet Res Unit, Geneva, NY USA.	ganyuan.zhong@ars.usda.gov			United States Department of Agriculture-Agricultural Research Service Project [1910-21220-004-00D]	United States Department of Agriculture-Agricultural Research Service Project	This project was supported by the United States Department of Agriculture-Agricultural Research Service Project 1910-21220-004-00D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Boudreau RL, 2012, NUCLEIC ACIDS RES, DOI [10.1093/nar/gks1797, DOI 10.1093/NAR/GKS1797]; Boudreau RL, 2008, RNA, V14, P1834, DOI 10.1261/rna.1062908; CAIN DW, 1984, J NEMATOL, V16, P207; Carra A, 2007, ANAL BIOCHEM, V360, P318, DOI 10.1016/j.ab.2006.09.022; Chan CY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S33; Charlton WL, 2010, INT J PARASITOL, V40, P855, DOI 10.1016/j.ijpara.2010.01.003; Claverie M, 2011, PLANT PHYSIOL, V156, P779, DOI 10.1104/pp.111.176230; Cousins P, 2002, THEOR APPL GENET, V105, P802, DOI 10.1007/s00122-002-0977-2; Cousins P, 2007, ACTA HORTIC, P51, DOI 10.17660/ActaHortic.2007.733.5; Davis EL, 2008, CURR OPIN PLANT BIOL, V11, P360, DOI 10.1016/j.pbi.2008.04.003; Daykin M. E., 1985, An advanced treatise on Meloidogyne.Volume II: Methodology., P39; Elbashir SM, 2002, METHODS, V26, P199, DOI 10.1016/S1046-2023(02)00023-3; Fellmann C, 2011, MOL CELL, V41, P733, DOI 10.1016/j.molcel.2011.02.008; FREIER SM, 1986, P NATL ACAD SCI USA, V83, P9373, DOI 10.1073/pnas.83.24.9373; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Hirai S., 2008, Open Plant Science Journal, V2, P21, DOI 10.2174/1874294700802010021; Ho T, 2008, BIOCHEM BIOPH RES CO, V368, P433, DOI 10.1016/j.bbrc.2008.01.110; Ho T, 2007, FEBS LETT, V581, P3267, DOI 10.1016/j.febslet.2007.06.022; Holen T, 2002, NUCLEIC ACIDS RES, V30, P1757, DOI 10.1093/nar/30.8.1757; Huang GZ, 2006, P NATL ACAD SCI USA, V103, P14302, DOI 10.1073/pnas.0604698103; Huang GZ, 2006, MOL PLANT MICROBE IN, V19, P463, DOI 10.1094/MPMI-19-0463; Hussey R. S., 2002, P43, DOI 10.1079/9780851994666.0043; Hutvagner G, 2005, FEBS LETT, V579, P5850, DOI 10.1016/j.febslet.2005.08.071; Hwang CF, 2010, THEOR APPL GENET, V121, P789, DOI 10.1007/s00122-010-1349-y; Ibrahim HMM, 2011, EXP PARASITOL, V127, P90, DOI 10.1016/j.exppara.2010.06.037; Jensen SMR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043095; Jittayasothorn Y, 2011, VITIS, V50, P107; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim YK, 2012, MOL CELL, V46, P893, DOI 10.1016/j.molcel.2012.05.036; Klink VP, 2009, PLANTA, V230, P53, DOI 10.1007/s00425-009-0926-2; Lamarcq LH, 2006, J BIOMOL SCREEN, V11, P236, DOI 10.1177/1087057105284342; LAMBERT KN, 1992, PHYTOPATHOLOGY, V82, P512, DOI 10.1094/Phyto-82-512; Leibman D, 2011, MOL PLANT MICROBE IN, V24, P1220, DOI 10.1094/MPMI-05-11-0128; Li JR, 2010, PLANTA, V232, P775, DOI 10.1007/s00425-010-1209-7; Li LM, 2007, RNA, V13, P1765, DOI 10.1261/rna.599107; Li Z, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn953; Lilley CJ, 2012, PARASITOLOGY, V139, P630, DOI 10.1017/S0031182011002071; Liu YP, 2007, NUCLEIC ACIDS RES, V35, P5683, DOI 10.1093/nar/gkm596; Liu YP, 2009, MOL THER, V17, P1712, DOI 10.1038/mt.2009.176; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Mcintyre GJ, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-34; Miyagishi M, 2004, J GENE MED, V6, P715, DOI 10.1002/jgm.556; Molnar A, 2010, SCIENCE, V328, P872, DOI 10.1126/science.1187959; Nicol J. M., 1999, Australian Journal of Grape and Wine Research, V5, P109, DOI 10.1111/j.1755-0238.1999.tb00295.x; Park JE, 2011, NATURE, V475, P201, DOI 10.1038/nature10198; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Runo S, 2011, PEST MANAG SCI, V67, P129, DOI 10.1002/ps.2052; Saayman S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002602; Schauer SE, 2002, TRENDS PLANT SCI, V7, P487, DOI 10.1016/S1360-1385(02)02355-5; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Sen GL, 2006, FASEB J, V20, P1293, DOI 10.1096/fj.06-6014rev; Sindhu AS, 2009, J EXP BOT, V60, P315, DOI 10.1093/jxb/ern289; Steeves RM, 2006, FUNCT PLANT BIOL, V33, P991, DOI 10.1071/FP06130; Vlassov AV, 2007, OLIGONUCLEOTIDES, V17, P223, DOI 10.1089/oli.2006.0069; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Wubben MJ, 2009, PLANT CELL REP, V28, P1399, DOI 10.1007/s00299-009-0739-6; Xu K, 2008, THEOR APPL GENET, V116, P305, DOI 10.1007/s00122-007-0670-6; Yadav BC, 2006, MOL BIOCHEM PARASIT, V148, P219, DOI 10.1016/j.molbiopara.2006.03.013	59	44	47	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e69463	10.1371/journal.pone.0069463	http://dx.doi.org/10.1371/journal.pone.0069463			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874962	Green Published, gold, Green Submitted			2022-12-27	WOS:000322064300102
J	Khaw, LT; Ball, HJ; Golenser, J; Combes, V; Grau, GE; Wheway, J; Mitchell, AJ; Hunt, NH				Khaw, Loke Tim; Ball, Helen J.; Golenser, Jacob; Combes, Valery; Grau, Georges E.; Wheway, Julie; Mitchell, Andrew J.; Hunt, Nicholas H.			Endothelial Cells Potentiate Interferon-gamma Production in a Novel Tripartite Culture Model of Human Cerebral Malaria	PLOS ONE			English	Article							FALCIPARUM-INFECTED ERYTHROCYTES; TUMOR-NECROSIS-FACTOR; INTERCELLULAR-ADHESION MOLECULE-1; HUMAN NK CELLS; IFN-GAMMA; IMMUNE-RESPONSES; HYALURONIC-ACID; FACTOR-ALPHA; BLOOD-STAGE; T-CELLS	We have established a novel in vitro co-culture system of human brain endothelial cells (HBEC), Plasmodium falciparum parasitised red blood cells (iRBC) and peripheral blood mononuclear cells (PBMC), in order to simulate the chief pathophysiological lesion in cerebral malaria (CM). This approach has revealed a previously unsuspected pro-inflammatory role of the endothelial cell through potentiating the production of interferon (IFN)-gamma by PBMC and concurrent reduction of interleukin (IL)-10. The IFN-gamma increased the expression of CXCL10 and intercellular adhesion molecule (ICAM)-1, both of which have been shown to be crucial in the pathogenesis of CM. There was a shift in the ratio of IL-10:IFN-gamma protein from >1 to <1 in the presence of HBEC, associated with the pro-inflammatory process in this model. For this to occur, a direct contact between PBMC and HBEC, but not PBMC and iRBC, was necessary. These results support HBEC playing an active role in the pathogenesis of CM. Thus, if these findings reflect the pathogenesis of CM, inhibition of HBEC and PBMC interactions might reduce the occurrence, or improve the prognosis, of the condition.	[Khaw, Loke Tim; Ball, Helen J.; Combes, Valery; Grau, Georges E.; Wheway, Julie; Mitchell, Andrew J.; Hunt, Nicholas H.] Univ Sydney, Sch Med Sci, Sydney, NSW 2006, Australia; [Khaw, Loke Tim; Ball, Helen J.; Combes, Valery; Grau, Georges E.; Wheway, Julie; Mitchell, Andrew J.; Hunt, Nicholas H.] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia; [Golenser, Jacob] Hebrew Univ Jerusalem, Kuvin Ctr Res Trop & Infect Dis, Dept Microbiol & Mol Genet, Jerusalem, Israel; [Khaw, Loke Tim] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia	University of Sydney; University of Sydney; Hebrew University of Jerusalem; Universiti Malaya	Hunt, NH (corresponding author), Univ Sydney, Sch Med Sci, Sydney, NSW 2006, Australia.	nicholas.hunt@sydney.edu.au	Mitchell, Andrew/C-2714-2009; Ball, Helen J/A-4242-2010; Grau, Georges/AGR-7139-2022	Mitchell, Andrew/0000-0003-4454-853X; Ball, Helen J/0000-0003-3733-9748; Grau, Georges/0000-0002-0442-0462; Combes, Valery/0000-0003-2178-3596	National Health and Medical Research Council of Australia; Sir Zelman Cowen Universities Fund; Ministry of Science, Technology and Innovation, Malaysia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Sir Zelman Cowen Universities Fund; Ministry of Science, Technology and Innovation, Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia)	This work was supported by a grant from the National Health and Medical Research Council of Australia to NH and a Sir Zelman Cowen Universities Fund grant to JG and NH. LTK was supported by a scholarship from the Ministry of Science, Technology and Innovation, Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amani V, 2000, EUR J IMMUNOL, V30, P1646, DOI 10.1002/1521-4141(200006)30:6&lt;1646::AID-IMMU1646&gt;3.0.CO;2-0; Amante FH, 2010, J IMMUNOL, V185, P3632, DOI 10.4049/jimmunol.1000944; Anstey NM, 1996, J EXP MED, V184, P557, DOI 10.1084/jem.184.2.557; Artavanis-Tsakonas K, 2003, J IMMUNOL, V171, P5396, DOI 10.4049/jimmunol.171.10.5396; Artavanis-Tsakonas K, 2002, J IMMUNOL, V169, P2956, DOI 10.4049/jimmunol.169.6.2956; Baratin M, 2005, P NATL ACAD SCI USA, V102, P14747, DOI 10.1073/pnas.0507355102; Baratin M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000228; Barbier M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019651; Beeson JG, 2004, J INFECT DIS, V189, P169, DOI 10.1086/380975; Beeson JG, 2000, NAT MED, V6, P86, DOI 10.1038/71582; BERENDT AR, 1989, NATURE, V341, P57, DOI 10.1038/341057a0; Booth V, 2002, BIOCHEMISTRY-US, V41, P10418, DOI 10.1021/bi026020q; Bridges DJ, 2010, BLOOD, V115, P1472, DOI 10.1182/blood-2009-07-235150; Caligiuri MA, 2008, BLOOD, V112, P461, DOI 10.1182/blood-2007-09-077438; Campanella GSV, 2008, P NATL ACAD SCI USA, V105, P4814, DOI 10.1073/pnas.0801544105; CHIZZOLINI C, 1990, CLIN EXP IMMUNOL, V79, P95, DOI 10.1111/j.1365-2249.1990.tb05133.x; Claser C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018720; Couper KN, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000744; D'Ombrain MC, 2007, CELL HOST MICROBE, V2, P130, DOI 10.1016/j.chom.2007.06.012; D'Ombrain MC, 2007, EUR J IMMUNOL, V37, P1864, DOI 10.1002/eji.200636889; Day NPJ, 1999, J INFECT DIS, V180, P1288, DOI 10.1086/315016; de Souza JB, 2010, PARASITOLOGY, V137, P755, DOI 10.1017/S0031182009991715; de Souza JB, 2002, MICROBES INFECT, V4, P291, DOI 10.1016/S1286-4579(02)01541-1; Dostert C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006510; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Engwerda CR, 2002, J EXP MED, V195, P1371, DOI 10.1084/jem.20020128; Faille D, 2009, FASEB J, V23, P3449, DOI 10.1096/fj.09-135822; Favre N, 1999, MICROBES INFECT, V1, P961, DOI 10.1016/S1286-4579(99)80513-9; Golenser J, 2006, J PARASITOL, V92, P170, DOI 10.1645/GE-3517.1; Good MF, 2005, ANNU REV IMMUNOL, V23, P69, DOI 10.1146/annurev.immunol.23.021704.115638; GRAU GE, 1989, NEW ENGL J MED, V320, P1586, DOI 10.1056/NEJM198906153202404; GRAU GE, 1989, P NATL ACAD SCI USA, V86, P5572, DOI 10.1073/pnas.86.14.5572; Greene JA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-47; Griffith JW, 2009, J IMMUNOL, V183, P5208, DOI 10.4049/jimmunol.0713552; Hansen DS, 2004, INT J PARASITOL, V34, P15, DOI 10.1016/j.ijpara.2003.09.007; HO M, 1995, J INFECT DIS, V172, P838, DOI 10.1093/infdis/172.3.838; Horowitz A, 2010, J IMMUNOL, V184, P6043, DOI 10.4049/jimmunol.1000106; Horowitz A, 2010, METHODS MOL BIOL, V612, P429, DOI 10.1007/978-1-60761-362-6_29; Hunt NH, 2003, TRENDS IMMUNOL, V24, P491, DOI 10.1016/S1471-4906(03)00229-1; Hunt NH, 2006, INT J PARASITOL, V36, P569, DOI 10.1016/j.ijpara.2006.02.016; ISHIKURA H, 1991, TRANSPLANTATION, V51, P1272, DOI 10.1097/00007890-199106000-00024; Jambou R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001021; John CC, 2008, AM J TROP MED HYG, V78, P198, DOI 10.4269/ajtmh.2008.78.198; John CC, 2007, AM J PATHOL, V171, P1729, DOI 10.2353/ajpath.2007.070917; John CC, 2006, J INFECT DIS, V194, P837, DOI 10.1086/506623; Korbel DS, 2005, J IMMUNOL, V175, P7466, DOI 10.4049/jimmunol.175.11.7466; Kordes M, 2011, INFECT IMMUN, V79, P3633, DOI 10.1128/IAI.05459-11; Kroczek RA, 2004, CURR OPIN IMMUNOL, V16, P321, DOI 10.1016/j.coi.2004.03.002; Kurtzhals JAL, 1998, LANCET, V351, P1768, DOI 10.1016/S0140-6736(97)09439-7; KWIATKOWSKI D, 1990, LANCET, V336, P1201, DOI 10.1016/0140-6736(90)92827-5; Lou J, 2001, CLIN MICROBIOL REV, V14, P810, DOI 10.1128/CMR.14.4.810-820.2001; Mannel DN, 1997, J CLIN PATHOL-MOL PA, V50, P175, DOI 10.1136/mp.50.4.175; May J, 2000, J INFECT DIS, V182, P1570, DOI 10.1086/315857; McCall MBB, 2010, J LEUKOCYTE BIOL, V88, P1131, DOI 10.1189/jlb.0310137; Milner DA, 2012, J INFECT DIS, V205, P1601, DOI 10.1093/infdis/jis001; Miu J, 2008, J IMMUNOL, V180, P1217, DOI 10.4049/jimmunol.180.2.1217; MonsoHinard C, 1997, IMMUNOLOGY, V92, P53, DOI 10.1046/j.1365-2567.1997.00297.x; MOST J, 1992, J IMMUNOL, V148, P1635; Newman KC, 2007, NAT REV IMMUNOL, V7, P279, DOI 10.1038/nri2057; Newton CRJC, 1998, PHARMACOL THERAPEUT, V79, P1, DOI 10.1016/S0163-7258(98)00008-4; Nie CQ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000369; Noviyanti R, 2001, MOL BIOCHEM PARASIT, V114, P227, DOI 10.1016/S0166-6851(01)00266-3; Ochola LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014741; Orengo JM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000013; Othoro C, 1999, J INFECT DIS, V179, P279, DOI 10.1086/314548; Rowe JA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001082; Rudin W, 1997, AM J PATHOL, V150, P257; Sam-Agudu NA, 2010, AM J TROP MED HYG, V82, P548, DOI 10.4269/ajtmh.2010.09-0467; Sanni LA, 1998, AM J PATHOL, V152, P611; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Schofield L, 1999, SCIENCE, V283, P225, DOI 10.1126/science.283.5399.225; Shio MT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000559; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Tripathi AK, 2009, BLOOD, V114, P4243, DOI 10.1182/blood-2009-06-226415; Van den Steen PE, 2008, EUR J IMMUNOL, V38, P1082, DOI 10.1002/eji.200737906; WALLIKER D, 1987, SCIENCE, V236, P1661, DOI 10.1126/science.3299700; Walther M, 2006, J IMMUNOL, V177, P5736, DOI 10.4049/jimmunol.177.8.5736; Wassmer SC, 2006, INFECT IMMUN, V74, P645, DOI 10.1128/IAI.74.1.645-653.2006; Wassmer SC, 2004, J INFECT DIS, V189, P180, DOI 10.1086/380761; Wilson NO, 2011, DIS MARKERS, V30, P39, DOI [10.1155/2011/828256, 10.3233/DMA-2011-0763]; Yanez DM, 1996, J IMMUNOL, V157, P1620	81	13	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e69521	10.1371/journal.pone.0069521	http://dx.doi.org/10.1371/journal.pone.0069521			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	23874969	Green Published, gold, Green Submitted			2022-12-27	WOS:000321718700054
J	Chen, WW; Wang, F; Xu, RH				Chen, Wei-Wei; Wang, Feng; Xu, Rui-Hua			Platinum-Based Versus Non-Platinum-Based Chemotherapy as First Line Treatment of Inoperable, Advanced Gastric Adenocarcinoma: A Meta-Analysis	PLOS ONE			English	Article							PROSPECTIVE RANDOMIZED-TRIAL; ITALIAN-ONCOLOGY-GROUP; MULTICENTER PHASE-II; EUROPEAN ORGANIZATION; FOLINIC ACID; JUNCTION ADENOCARCINOMA; PLUS CISPLATIN; CANCER; FLUOROURACIL; DOXORUBICIN	Background: Although the platinum regimen is adopted widely nowadays in spite of the excessive side effects, there is still no international standard for palliative chemotherapy of advanced gastric cancer. This meta-analysis assessed the efficacy and tolerability of platinum versus non-platinum chemotherapy as first-line palliative treatment in patients with inoperable, advanced gastric cancer. Methods: Randomized phase II and III clinical trials on first-line palliative chemotherapy in inoperable, advanced gastric cancer were identified by electronic searches of PubMed, Embase, and the Cochrane Controlled Trial Register, and hand searches of relevant abstract books and reference lists. Response rates, overall survival, and toxicity were analyzed. Depending on whether new-generation agents (S-1, taxanes and irinotecan) were utilized, the non-platinum regimens were divided into two subgroup. Results: Compared to non-platinum regimens containing new-generation agents, the use of platinum-based regimens was associated with better response (risk ratio (RR) = 1.94, 95% CI[1.48, 2.55], p<0.001), an increase of overall survival (hazard ratio (HR) = 0.85, 95% CI[0.78, 0.92], p<0.001), a higher risk of hematological and non-hematological toxicity. No statistically significant increase in response (RR = 1.03, 95% CI [0.85, 1.24], p = 0.76) or overall survival (HR = 1.07, 95% CI [0.88, 1.30], p = 0.49) was found when platinum therapies were compared to new-generation agent based combination regimens. The toxicity of platinum-based regimens was significantly higher for hematologic toxicity, nausea and vomiting, and neurotoxicity, but not for diarrhea and toxic death rate. Conclusion: New-generation agent based combination regimens achieved similar response rate and overall survival as platinum-based therapy that had generally higher side effects. S-1, taxanes and irinotecan seemed to be valid options for patients with inoperable, advanced gastric cancer as first-line chemotherapy.	[Xu, Rui-Hua] Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China; Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Xu, RH (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China.	xurh@mail.sysu.edu.cn	Xu, Rui-Hua/AAW-4766-2021; xu, rui/GRX-5734-2022	Xu, Rui-Hua/0000-0001-9771-8534; 	National High Technology Research and Development Program of China (863 Program) [2012AA02A5060]; Science and Technology Department of Guangdong Province [2012B031800088]; Medical Scientific Research Foundation of Guangdong Province [C2011019]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Science and Technology Department of Guangdong Province; Medical Scientific Research Foundation of Guangdong Province	This work was supported by the National High Technology Research and Development Program of China (863 Program)(No.2012AA02A5060), the Science and Technology Department of Guangdong Province(No. 2012B031800088), and the Medical Scientific Research Foundation of Guangdong Province (No.C2011019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1988, J Natl Cancer Inst, V80, P1011; Barone C, 1998, CANCER-AM CANCER SOC, V82, P1460, DOI 10.1002/(SICI)1097-0142(19980415)82:8<1460::AID-CNCR5>3.0.CO;2-D; Boku N, 2009, LANCET ONCOL, V10, P1063, DOI 10.1016/S1470-2045(09)70259-1; Bouche O, 2004, J CLIN ONCOL, V22, P4319, DOI 10.1200/JCO.2004.01.140; Brown Linda Morris, 2002, Surg Oncol Clin N Am, V11, P235, DOI 10.1016/S1055-3207(02)00002-9; COCCONI G, 1994, J CLIN ONCOL, V12, P2687, DOI 10.1200/JCO.1994.12.12.2687; Cocconi G, 2003, ANN ONCOL, V14, P1258, DOI 10.1093/annonc/mdg329; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; CULLINAN SA, 1994, J CLIN ONCOL, V12, P412, DOI 10.1200/JCO.1994.12.2.412; Dank M, 2008, ANN ONCOL, V19, P1450, DOI 10.1093/annonc/mdn166; DeLisi V, 1996, CANCER, V77, P245, DOI 10.1002/(SICI)1097-0142(19960115)77:2<245::AID-CNCR4>3.0.CO;2-L; Field K, 2008, DRUGS, V68, P299, DOI 10.2165/00003495-200868030-00004; Hou AnJi, 2009, Tumor, V29, P160; Jeung HC, 2011, CANCER-AM CANCER SOC, V117, P2050, DOI 10.1002/cncr.25729; KELSEN D, 1992, J CLIN ONCOL, V10, P541, DOI 10.1200/JCO.1992.10.4.541; Kikuchi K, 1990, Gan To Kagaku Ryoho, V17, P655; Kim JA, 2011, CANCER CHEMOTH PHARM, V68, P177, DOI 10.1007/s00280-010-1452-4; KIM NK, 1993, CANCER, V71, P3813, DOI 10.1002/1097-0142(19930615)71:12<3813::AID-CNCR2820711205>3.0.CO;2-5; Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI 10.1016/S1470-2045(08)70035-4; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lutz MP, 2007, J CLIN ONCOL, V25, P2580, DOI 10.1200/JCO.2007.11.1666; Maiello E, 2011, J CLIN ONCOL SUPPL 4, V29; Maiello E, 2011, EPIRUBICIN E IN COMB; Mochiki E, 2012, BRIT J CANCER, V107, P31, DOI 10.1038/bjc.2012.222; Moehler M, 2010, ANN ONCOL, V21, P71, DOI 10.1093/annonc/mdp269; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Park JO, 2003, JPN J CLIN ONCOL, V33, P533, DOI 10.1093/jjco/hyg093; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Popov IP, 2008, MED ONCOL, V25, P73, DOI 10.1007/s12032-007-0042-8; Pozzo C, 2004, ANN ONCOL, V15, P1773, DOI 10.1093/annonc/mdh473; Tebbutt NC, 2010, BRIT J CANCER, V102, P475, DOI 10.1038/sj.bjc.6605522; Thuss-Patience PC, 2005, J CLIN ONCOL, V23, P494, DOI 10.1200/JCO.2005.02.163; Van Cutsem E, 2008, EUR J CANCER, V44, P182, DOI 10.1016/j.ejca.2007.11.001; Vanhoefer U, 2000, J CLIN ONCOL, V18, P2648, DOI 10.1200/JCO.2000.18.14.2648; Wagner AD, 2006, J CLIN ONCOL, V24, P2903, DOI 10.1200/JCO.2005.05.0245; Waters JS, 1999, BRIT J CANCER, V80, P269, DOI 10.1038/sj.bjc.6690350; Webb A, 1997, J CLIN ONCOL, V15, P261, DOI 10.1200/JCO.1997.15.1.261; Yang Jian-Wei, 2005, Ai Zheng, V24, P1531; Zhao Wen-ying, 2011, Zhonghua Zhong Liu Za Zhi, V33, P295	39	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e68974	10.1371/journal.pone.0068974	http://dx.doi.org/10.1371/journal.pone.0068974			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874831	Green Published, Green Submitted, gold			2022-12-27	WOS:000322218800055
J	Guo, LH; Xu, HX; Fu, HJ; Peng, A; Zhang, YF; Liu, LN				Guo, Le-Hang; Xu, Hui-Xiong; Fu, Hui-Jun; Peng, Ai; Zhang, Yi-Feng; Liu, Lin-Na			Acoustic Radiation Force Impulse Imaging for Noninvasive Evaluation of Renal Parenchyma Elasticity: Preliminary Findings	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; LIVER FIBROSIS; TISSUE QUANTIFICATION; ELASTOGRAPHY; DIAGNOSIS; STIFFNESS; POPULATION; PREVALENCE; BIOMARKERS; EQUATION	Objective: To evaluate the diagnostic value of acoustic radiation force impulse (ARFI) to test the elasticity of renal parenchyma by measuring the shear wave velocity (SWV) which might be used to detect chronic kidney disease (CKD). Methods: 327 healthy volunteers and 64 CKD patients were enrolled in the study. The potential influencing factors and measurement reproducibility were evaluated in the healthy volunteers. Correlations between SWV and laboratory tests were analyzed in CKD patients.? Receiver-operating characteristic curve (ROC) analyses were performed to assess the diagnostic performance of ARFI. Results: The SWV of healthy volunteers correlated significantly to age (r = -0.22, P < 0.001, n = 327) and differed significantly between men and women (2.06 +/- 0.48 m/s vs. 2.2 +/- 0.52 m/s, P = 0.018, n = 327). However, it did not correlate significantly to height, weight, body mass index, waistline, kidney dimension and the depth for SWV measurement (n = 30). Inter- and intraobserver agreement expressed as intraclass coefficient correlation were 0.64 (95% CI: 0.13 to 0.82, P = 0.011) and 0.6 (95% CI: 0.31 to 0.81, P = 0.001) (n = 40). The mean SWV in healthy volunteers was 2.15 +/- 0.51 m/s, while was 1.81 +/- 0.43 m/s, 1.79 +/- 0.29 m/s, 1.81 +/- 0.44 m/s, 1.64 +/- 0.55 m/s, and 1.36 +/- 0.17 m/s for stage 1, 2, 3, 4 and 5 in CKD patients respectively. The SWV was significantly higher for healthy volunteers compared with each stage in CKD patients. ARFI could not predict the different stages of CKD except stage 5. In CKD patients, SWV correlated to e-GFR (r = 0.3, P = 0.018), to urea nitrogen (r = -0.3, P = 0.016), and to creatinine (r = -0.41, P = 0.001). ROC analyses indicated that the area under the ROC curve was 0.752 (95% CI: 0.704 to 0.797) (P < 0.001). The cut-off value for predicting CKD was 1.88 m/s (sensitivity 71.87% and specificity 69.69%). Conclusion: ARFI may be a potentially useful tool in detecting CKD.	[Guo, Le-Hang; Xu, Hui-Xiong; Zhang, Yi-Feng; Liu, Lin-Na] Tongji Univ, Peoples Hosp 10, Shanghai Peoples Hosp 10, Dept Med Ultrasound, Shanghai 200092, Peoples R China; [Fu, Hui-Jun; Peng, Ai] Tongji Univ, Peoples Hosp 10, Shanghai Peoples Hosp 10, Dept Nephrol, Shanghai 200092, Peoples R China	Tongji University; Tongji University	Xu, HX (corresponding author), Tongji Univ, Peoples Hosp 10, Shanghai Peoples Hosp 10, Dept Med Ultrasound, Shanghai 200092, Peoples R China.	xuhuixiong@hotmail.com; pengai@hotmail.com			Chinese Ministry of Education [NCET-06-0723]	Chinese Ministry of Education(Ministry of Education, China)	This work was supported in part by grant NCET-06-0723 from the Chinese Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Bai M, 2012, J ULTRAS MED, V31, P289, DOI 10.7863/jum.2012.31.2.289; Bello AK, 2005, KIDNEY INT, V68, pS11, DOI 10.1111/j.1523-1755.2005.09802.x; BOHLE A, 1987, AM J NEPHROL, V7, P421, DOI 10.1159/000167514; Bota S, 2013, ULTRASOUND MED BIOL, V39, P407, DOI 10.1016/j.ultrasmedbio.2012.09.017; Cai LJ, 2010, CLIN J AM SOC NEPHRO, V5, P2229, DOI 10.2215/CJN.00980110; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; D'Anastasi M, 2011, CLIN HEMORHEOL MICRO, V49, P105, DOI 10.3233/CH-2011-1461; D'Onofrio M, 2010, AM J ROENTGENOL, V195, P132, DOI 10.2214/AJR.09.3923; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fassett RG, 2011, KIDNEY INT, V80, P806, DOI 10.1038/ki.2011.198; Friedrich-Rust M, 2013, J VIRAL HEPATITIS, V20, P240, DOI 10.1111/j.1365-2893.2012.01646.x; Friedrich-Rust M, 2012, J VIRAL HEPATITIS, V19, pE212, DOI 10.1111/j.1365-2893.2011.01537.x; Garra Brian Stephen, 2007, Ultrasound Q, V23, P255, DOI 10.1097/ruq.0b013e31815b7ed6; Gennisson JL, 2012, ULTRASOUND MED BIOL, V38, P1559, DOI 10.1016/j.ultrasmedbio.2012.04.013; Goertz RS, 2011, EUR J RADIOL, V80, pE226, DOI 10.1016/j.ejrad.2010.09.025; Inoue T, 2011, J AM SOC NEPHROL, V22, P1429, DOI 10.1681/ASN.2010111143; Junyent M, 2010, NEFROLOGIA, V30, P119, DOI 10.3265/Nefrologia.pre2010.Jan.10216; Kircheis G, 2012, WORLD J GASTROENTERO, V18, P1077, DOI 10.3748/wjg.v18.i10.1077; Lee MJ, 2013, EUR J RADIOL, V82, pE290, DOI 10.1016/j.ejrad.2013.01.018; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Levey AS, 2009, AM J KIDNEY DIS, V54, P205, DOI 10.1053/j.ajkd.2009.04.029; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Ma F, 2012, NEPHROL DIAL TRANSPL, V27, P2891, DOI 10.1093/ndt/gfr789; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; MOCCIA WA, 1980, UROL RADIOL, V2, P1; Mounier-Vehier C, 2002, KIDNEY INT, V61, P591, DOI 10.1046/j.1523-1755.2002.00167.x; Nugent RA, 2011, NEPHRON CLIN PRACT, V118, pC269, DOI 10.1159/000321382; Palmeri ML, 2011, INTERFACE FOCUS, V1, P553, DOI 10.1098/rsfs.2011.0023; Sanusi AA, 2009, NEPHROL DIAL TRANSPL, V24, P1690, DOI 10.1093/ndt/gfp055; Shankar A, 2011, KIDNEY INT, V80, P1231, DOI 10.1038/ki.2011.283; Solez K, 2007, AM J TRANSPLANT, V7, P518, DOI 10.1111/j.1600-6143.2006.01688.x; Stock KF, 2010, CLIN HEMORHEOL MICRO, V46, P139, DOI 10.3233/CH-2010-1340; Syversveen T, 2012, EUR RADIOL, V22, P2130, DOI 10.1007/s00330-012-2476-4; Syversveen T, 2011, TRANSPL INT, V24, P100, DOI 10.1111/j.1432-2277.2010.01165.x; Van Den Noortgate N, 2003, J NEPHROL, V16, P658; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zhang YF, 2012, PLOS ONE, V7; Zheng XZ, 2011, J ULTRAS MED, V30, P387, DOI 10.7863/jum.2011.30.3.387	38	82	95	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e68925	10.1371/journal.pone.0068925	http://dx.doi.org/10.1371/journal.pone.0068925			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874814	gold, Green Published, Green Submitted			2022-12-27	WOS:000322218800053
J	Yang, B; He, MH; Melvin, TM; Zhao, Y; Briffa, KR				Yang, Bao; He, Minhui; Melvin, Thomas M.; Zhao, Yan; Briffa, Keith R.			Climate Control on Tree Growth at the Upper and Lower Treelines: A Case Study in the Qilian Mountains, Tibetan Plateau	PLOS ONE			English	Article							FAGUS-SYLVATICA L.; LAST 400 YEARS; ALTITUDINAL GRADIENT; RING WIDTH; TIANSHAN MOUNTAINS; RADIAL GROWTH; TEMPERATURE; VARIABILITY; ELEVATION; EVENTS	It is generally hypothesized that tree growth at the upper treeline is normally controlled by temperature while that at the lower treeline is precipitation limited. However, uniform patterns of inter-annual ring-width variations along altitudinal gradients are also observed in some situations. How changing elevation influences tree growth in the cold and arid Qilian Mountains, on the northeastern Tibetan Plateau, is of considerable interest because of the sensitivity of the region's local climate to different atmospheric circulation patterns. Here, a network of four Qilian juniper (Sabina przewalskii Kom.) ring-width chronologies was developed from trees distributed on a typical mountain slope at elevations ranging from 3000 to 3520 m above sea level (a.s.l.). The statistical characteristics of the four tree-ring chronologies show no significant correlation with increasing elevation. All the sampled tree growth was controlled by a common climatic signal (local precipitation) across the investigated altitudinal gradient (520 m). During the common reliable period, covering the past 450 years, the four chronologies have exhibited coherent growth patterns in both the high-and low-frequency domains. These results contradict the notion of contrasting climate growth controls at higher and lower elevations, and specifically the assumption that inter-annual tree-growth variability is controlled by temperature at the upper treeline. It should be stressed that these results relate to the relatively arid conditions at the sampling sites in the Qilian Mountains.	[Yang, Bao; He, Minhui] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Key Lab Desert & Desertificat, Lanzhou, Peoples R China; [Melvin, Thomas M.; Briffa, Keith R.] Univ E Anglia, Sch Environm Sci, Climat Res Unit, Norwich NR4 7TJ, Norfolk, England; [Zhao, Yan] Chinese Acad Sci, Inst Geog Sci & Nat Resources, Beijing, Peoples R China	Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; University of East Anglia; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Yang, B (corresponding author), Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Key Lab Desert & Desertificat, Lanzhou, Peoples R China.	yangbao@lzb.ac.cn	Zhao, Yan/B-1785-2014; He, Minhui/AAA-6207-2019; Yang, Bao/O-1541-2013	Zhao, Yan/0000-0003-1693-9795; He, Minhui/0000-0001-7998-1152; Briffa, Keith/0000-0003-3323-3639; , Minhui/0000-0002-9224-5990	National Science Foundation of China [41071130]; CAS Strategic Priority Research Program Grant [XDA05080801]; CAS 100 Talents Project [29082762]; CAS Visiting Professorship for Senior International Scientists [2009S1-38]; NERC [NE/G018863/1]; Natural Environment Research Council [NE/G018863/1] Funding Source: researchfish	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS Strategic Priority Research Program Grant; CAS 100 Talents Project(Chinese Academy of Sciences); CAS Visiting Professorship for Senior International Scientists; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The study was jointly funded by the National Science Foundation of China (Grant Nos. 41071130), the CAS Strategic Priority Research Program Grant (Grant No. XDA05080801), the CAS 100 Talents Project (29082762), and the CAS Visiting Professorship for Senior International Scientists (Grant No. 2009S1-38). KRB and TMM acknowledge support from NERC (NE/G018863/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affolter P, 2010, EUR J FOREST RES, V129, P289, DOI 10.1007/s10342-009-0327-x; Babst F, 2013, GLOBAL ECOL BIOGEOGR, V22, P706, DOI 10.1111/geb.12023; Bell JL, 2004, J CLIMATE, V17, P81, DOI 10.1175/1520-0442(2004)017<0081:RCIECE>2.0.CO;2; Beniston M, 2004, GLOBAL PLANET CHANGE, V44, P1, DOI 10.1016/j.gloplacha.2004.06.001; Biondi F, 2004, COMPUT GEOSCI-UK, V30, P303, DOI 10.1016/j.cageo.2003.11.004; Biondi F, 2001, AMBIO, V30, P162, DOI 10.1639/0044-7447(2001)030[0162:AYTRCF]2.0.CO;2; Biondi F, 2002, PAGES NEWS, V10, P1; Brauning A, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020793; Bretherton CS, 1999, J CLIMATE, V12, P1990, DOI 10.1175/1520-0442(1999)012<1990:TENOSD>2.0.CO;2; Briffa K.R., 1990, METHODS DENDROCHRONO, P137, DOI DOI 10.1007/978-94-015-7879-0; Briffa KR, 2002, HOLOCENE, V12, P759, DOI 10.1191/0959683602hl588rp; Buckley BM, 2010, P NATL ACAD SCI USA, V107, P6748, DOI 10.1073/pnas.0910827107; Carrer M, 2007, J ECOL, V95, P1072, DOI 10.1111/j.1365-2745.2007.01281.x; Chen F, 2011, J ARID ENVIRON, V75, P1121, DOI 10.1016/j.jaridenv.2011.06.010; Chen L, 2011, TREES-STRUCT FUNCT, V25, P1133, DOI 10.1007/s00468-011-0588-0; Cook ER, 2010, SCIENCE, V328, P486, DOI 10.1126/science.1185188; Cook ER, 1997, HOLOCENE, V7, P361, DOI 10.1177/095968369700700314; Cook ER, 1990, METHODS OF DENDROCHR; Dai A, 2004, J HYDROMETEOROL, V5, P1117, DOI 10.1175/JHM-386.1; Dang HS, 2013, CLIMATIC CHANGE, V117, P903, DOI 10.1007/s10584-012-0611-5; Di Filippo A, 2007, J BIOGEOGR, V34, P1873, DOI 10.1111/j.1365-2699.2007.01747.x; Dittmar C, 2003, FOREST ECOL MANAG, V173, P63, DOI 10.1016/S0378-1127(01)00816-7; Easterling DR, 2000, B AM METEOROL SOC, V81, P417, DOI 10.1175/1520-0477(2000)081<0417:OVATIE>2.3.CO;2; Esper J, 2007, TREES-STRUCT FUNCT, V21, P141, DOI 10.1007/s00468-006-0104-0; Fang KY, 2010, CLIM DYNAM, V35, P577, DOI 10.1007/s00382-009-0636-2; Fritts H.C., 1976, TREE RINGS AND CLIMA; FRITTS HC, 1965, ECOLOGY, V46, P393, DOI 10.2307/1934872; Gou X, 2005, J ARID ENVIRON, V61, P513, DOI 10.1016/j.jaridenv.2004.09.011; Gou XH, 2007, INT J CLIMATOL, V27, P1497, DOI 10.1002/joc.1480; He MH, 2013, TREES-STRUCT FUNCT, V27, P429, DOI 10.1007/s00468-012-0813-5; HOLMES R L, 1983, Tree-Ring Bulletin, V43, P69; Holmgren M, 2006, FRONT ECOL ENVIRON, V4, P87, DOI 10.1890/1540-9295(2006)004[0087:ECESAA]2.0.CO;2; Huang JG, 2007, CLIMATIC CHANGE, V80, P369, DOI 10.1007/s10584-006-9135-1; Jones PD, 2009, HOLOCENE, V19, P3, DOI 10.1177/0959683608098952; Korner C, 2004, J BIOGEOGR, V31, P713, DOI 10.1111/j.1365-2699.2003.01043.x; LaMarche V. C. Jr., 1974, Tree-ring Bulletin, V34, P1; LAMARCHE VC, 1974, SCIENCE, V183, P1043, DOI 10.1126/science.183.4129.1043; LAUER W, 1978, ARCTIC ALPINE RES, V10, P383, DOI 10.2307/1550769; Leal S, 2007, BOREAS, V36, P426, DOI 10.1080/03009480701267063; Li ZS, 2012, TREES-STRUCT FUNCT, V26, P1373, DOI 10.1007/s00468-012-0712-9; Liang EY, 2010, TREES-STRUCT FUNCT, V24, P363, DOI 10.1007/s00468-009-0406-0; Liang EY, 2009, TREE-RING RES, V65, P95, DOI 10.3959/2008-2.1; Liu JJ, 2013, DENDROCHRONOLOGIA; Liu LS, 2006, J INTEGR PLANT BIOL, V48, P278, DOI 10.1111/j.1744-7909.2006.00158.x; Liu XH, 2005, SCI CHINA SER D, V48, P521, DOI 10.1360/03yd0063; Liu Y, 2009, SCI CHINA SER D, V52, P348, DOI 10.1007/s11430-009-0025-z; Lo YH, 2010, FOREST ECOL MANAG, V259, P932, DOI 10.1016/j.foreco.2009.11.033; Mann ME, 1996, CLIMATIC CHANGE, V33, P409, DOI 10.1007/BF00142586; Meehl GA, 2000, B AM METEOROL SOC, V81, P413, DOI 10.1175/1520-0477(2000)081<0413:AITTIE>2.3.CO;2; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Morales MS, 2004, ECOLOGY, V85, P3080, DOI 10.1890/04-0139; Osborn T. J., 1997, Dendrochronologia, V15, P89; Palmer WC, 1965, WEATHER BUREAU RESEA; Rangwala I, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037245; Rasmussen SH, 2012, J HYDROMETEOROL, V13, P1817, DOI 10.1175/JHM-D-12-07.1; Rinn F, 2003, TSAP WIN TIME SERIES; Salzer MW, 2009, P NATL ACAD SCI USA, V106, P20348, DOI 10.1073/pnas.0903029106; Sang WG, 2007, CHINESE SCI BULL, V52, P2954, DOI 10.1007/s11434-007-0443-2; Savva Y, 2006, TREES-STRUCT FUNCT, V20, P735, DOI 10.1007/s00468-006-0088-9; Smiley T, 1968, AN INTRODUCTION TO T; Splechtna BE, 2000, ANN FOREST SCI, V57, P89; Takahashi K, 2003, ECOL RES, V18, P549, DOI 10.1046/j.1440-1703.2003.00577.x; Tian Q, 2007, TREE-RING RES, V63, P27, DOI 10.3959/1536-1098-63.1.27; Tranquilini W, 1979, ECOLOGICAL STUDIES, V31; WANG T, 2005, TREES-STRUCT FUNCT, V19, P735, DOI DOI 10.1007/s00468-005-0003-9; Wei CC, 2013, WEATHER FORECAST, V28, P614, DOI 10.1175/WAF-D-12-00089.1; WIGLEY TML, 1984, J CLIM APPL METEOROL, V23, P201, DOI 10.1175/1520-0450(1984)023<0201:OTAVOC>2.0.CO;2; Woolhiser DA, 2008, J CLIMATE, V21, P1139, DOI 10.1175/2007JCLI1862.1; Yang B, 2011, INT J CLIMATOL, V31, P1166, DOI 10.1002/joc.2143; Yang B, 2010, HOLOCENE, V20, P1235, DOI 10.1177/0959683610371997; Yang B, 2010, HOLOCENE, V20, P181, DOI 10.1177/0959683609350388; Yu DP, 2006, SCI CHINA SER E, V49, P150, DOI 10.1007/s11434-006-8116-0; Zhu HF, 2008, CHINESE SCI BULL, V53, P3914, DOI 10.1007/s11434-008-0400-8	73	49	59	1	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e69065	10.1371/journal.pone.0069065	http://dx.doi.org/10.1371/journal.pone.0069065			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874871	gold, Green Published, Green Submitted			2022-12-27	WOS:000322218800064
J	Gianola, S; Pecoraro, V; Lambiase, S; Gatti, R; Banfi, G; Moja, L				Gianola, Silvia; Pecoraro, Valentina; Lambiase, Simone; Gatti, Roberto; Banfi, Giuseppe; Moja, Lorenzo			Efficacy of Muscle Exercise in Patients with Muscular Dystrophy: A Systematic Review Showing a Missed Opportunity to Improve Outcomes	PLOS ONE			English	Review							MYOTONIC-DYSTROPHY; STRENGTH; ENDURANCE; ALBUTEROL; PROTOCOL; THERAPY; FATIGUE; TRIALS; ADULTS	Background: Although muscular dystrophy causes muscle weakness and muscle loss, the role of exercise in the management of this disease remains controversial. Objective: The purpose of this systematic review is to evaluate the role of exercise interventions on muscle strength in patients with muscular dystrophy. Methods: We performed systematic electronic searches in Medline, Embase, Web of Science, Scopus and Pedro as well as a list of reference literature. We included trials assessing muscle exercise in patients with muscular dystrophy. Two reviewers independently abstracted data and appraised risk of bias. Results: We identified five small (two controlled and three randomized clinical) trials comprising 242 patients and two ongoing randomized controlled trials. We were able to perform two meta-analyses. We found an absence of evidence for a difference in muscle strength (MD 4.18, 95% CIs - 2.03 to 10.39; p = 0.91) and in endurance (MD -0.53, 95% CIs -1.11 to 0.05; p = 0.26). In both, the direction of effects favored muscle exercise. Conclusions: The first included trial about the efficacy of muscular exercise was published in 1978. Even though some benefits of muscle exercise were consistently reported across studies, the benefits might be due to the small size of studies and other biases. Detrimental effects are still possible. After several decades of research, doctors cannot give advice and patients are, thus, denied basic information. A multi-center randomized trial investigating the strength of muscles, fatigue, and functional limitations is needed.	[Gianola, Silvia; Pecoraro, Valentina; Moja, Lorenzo] IRCCS Orthoped Inst Galeazzi, Clin Epidemiol Unit, Milan, Italy; [Lambiase, Simone] Fdn Ctr San Raffaele Monte Tabor, Unit Funct Recovery, Milan, Italy; [Gatti, Roberto] Univ Vita Salute San Raffaele, Lab Movement Anal, Milan, Italy; [Banfi, Giuseppe] IRCCS Orthoped Inst Galeazzi, Milan, Italy; [Banfi, Giuseppe; Moja, Lorenzo] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy	Vita-Salute San Raffaele University; University of Milan	Gianola, S (corresponding author), IRCCS Orthoped Inst Galeazzi, Clin Epidemiol Unit, Milan, Italy.	silvia.gianola@gmail.com	gianola, silvia/S-7883-2016; Gatti, Roberto/J-6452-2018; Gianola, Silvia/AAB-2659-2022; Moja, Pasquale Lorenzo/CAH-0318-2022; Banfi, Giuseppe/K-6585-2015	gianola, silvia/0000-0003-3770-0011; Gatti, Roberto/0000-0002-4669-1287; Gianola, Silvia/0000-0003-3770-0011; Moja, Pasquale Lorenzo/0000-0001-6680-6507; Pecoraro, Valentina/0000-0002-1800-0936; Banfi, Giuseppe/0000-0001-9578-5338				Abramson AS, 1952, P 2 MED C MDAA, P123; Aldehag Anna Sandin, 2005, Occup Ther Int, V12, P14, DOI 10.1002/oti.12; Alemdaroglui I, 2012, FIZYOTERAPI REHABILI, V23, P10; Ansved T, 2001, ACTA PHYSIOL SCAND, V171, P359, DOI 10.1046/j.1365-201x.2001.00839.x; Brazzelli M, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003316.pub4; Chalmers I, 2003, J ROY SOC MED, V96, P575, DOI 10.1258/jrsm.96.12.575; Chalmers I, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f105; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; EDWARDS RHT, 1987, MUSCLE NERVE, V10, P6, DOI 10.1002/mus.880100104; Engvall E, 2003, FASEB J, V17, P1579, DOI 10.1096/fj.02-1215rev; Evetovich TK, 2001, J STRENGTH COND RES, V15, P439; Ferreira ML, 2012, J PHYSIOTHER, V58, P145, DOI 10.1016/S1836-9553(12)70105-4; FLORENCE JM, 1984, PHYS THER, V64, P41, DOI 10.1093/ptj/64.1.41; FOWLER WM, 1965, NEW ENGL J MED, V272, P875, DOI 10.1056/NEJM196504292721702; FOWLER WM, 1984, MUSCLE NERVE, V7, P496; Harper PS, 2001, MYOTONIC DYSTROPHY; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; HOBERMAN M, 1955, Am J Phys Med, V34, P109; Hortobagyi T, 1997, MED SCI SPORT EXER, V29, P107, DOI 10.1097/00005768-199701000-00015; Jansen M, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-55; JOHNSON E W, 1971, Archives of Physical Medicine and Rehabilitation, V52, P333; Kierkegaard M, 2011, J REHABIL MED, V43, P695, DOI 10.2340/16501977-0833; Kilmer DD, 2001, MUSCLE NERVE, V24, P1181, DOI 10.1002/mus.1130; Kubiakc D-M, 2011, ANN ONCOL S; LATEUR BJD, 1979, AM J PHYS MED REHAB, V58, P26; Liberati A, 2011, LANCET, V378, P1777, DOI 10.1016/S0140-6736(11)61772-8; Lindeman E, 1999, J ELECTROMYOGR KINES, V9, P379, DOI 10.1016/S1050-6411(99)00003-6; LINDEMAN E, 1995, ARCH PHYS MED REHAB, V76, P612, DOI 10.1016/S0003-9993(95)80629-6; Moon Jae Ho, 1996, Yonsei Medical Journal, V37, P237; Munn J, 2004, J APPL PHYSIOL, V96, P1861, DOI 10.1152/japplphysiol.00541.2003; Natterlund B, 2001, J REHABIL MED, V33, P206; Naugle KM, 2012, J PAIN; Olsen DB, 2005, NEUROLOGY, V64, P1064, DOI 10.1212/01.WNL.0000150584.45055.27; Pak S, 2008, TOP STROKE REHABIL, V15, P177, DOI 10.1310/tsr1503-177; Petrof BJ, 1998, MOL CELL BIOCHEM, V179, P111, DOI 10.1023/A:1006812004945; Reeves B., 2011, COCHRANE HDB SYSTEMA; Sarparanta J, 2012, NAT GENET, V44, P450, DOI 10.1038/ng.1103; Scime A, 2008, MOL DIAGN THER, V12, P99, DOI 10.1007/BF03256275; Scott O M, 1981, Physiotherapy, V67, P174; Sjogreen L, 2010, INT J PEDIATR OTORHI, V74, P1126, DOI 10.1016/j.ijporl.2010.06.013; Smith SM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5205; Snook EM, 2009, NEUROREHAB NEURAL RE, V23, P108, DOI 10.1177/1545968308320641; Sutton AL, 2009, MOVEMENT DISORDERS S; Sveen ML, 2007, NEUROLOGY, V68, P59, DOI 10.1212/01.wnl.0000250358.32199.24; Sveen ML, 2008, BRAIN, V131, P2824, DOI 10.1093/brain/awn189; Tollback A, 1999, SCAND J REHABIL MED, V31, P9; van der Kooi EL, 2007, J NEUROL, V254, P931, DOI 10.1007/s00415-006-0432-4; van der Kooi EL, 2004, NEUROLOGY, V63, P702, DOI 10.1212/01.WNL.0000134660.30793.1F; van't Riet A, 2001, INT J MED INFORM, V64, P1, DOI 10.1016/S1386-5056(01)00185-X; VIGNOS PJ, 1983, MUSCLE NERVE, V6, P323, DOI 10.1002/mus.880060502; Voet NBM, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-56; Voet NBM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003907.pub3; WAGNER MB, 1986, PHYS THER, V66, P1110, DOI 10.1093/ptj/66.7.1110; Wratney MJ, 1958, PHYS THER REV	54	36	36	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65414	10.1371/journal.pone.0065414	http://dx.doi.org/10.1371/journal.pone.0065414			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23894268	Green Published, gold			2022-12-27	WOS:000320322400024
J	Liyanage, SS; Rahman, B; Ridda, I; Newall, AT; Tabrizi, SN; Garland, SM; Segelov, E; Seale, H; Crowe, PJ; Moa, A; Maclntyre, CR				Liyanage, Surabhi S.; Rahman, Bayzidur; Ridda, Iman; Newall, Anthony T.; Tabrizi, Sepehr N.; Garland, Suzanne M.; Segelov, Eva; Seale, Holly; Crowe, Philip J.; Moa, Aye; Maclntyre, C. Raina			The Aetiological Role of Human Papillomavirus in Oesophageal Squamous Cell Carcinoma: A Meta-Analysis	PLOS ONE			English	Article							RISK HUMAN-PAPILLOMAVIRUS; NO ASSOCIATION; HPV INFECTION; CANCER; PREVALENCE; VACCINE; VIRUS; AREA; DNA; EXPRESSION	Background: The aetiological role of human papillomavirus (HPV) in oesophageal squamous cell carcinoma (OSCC) has been widely researched for more than three decades, with conflicting findings. In the absence of a large, adequately powered single case-control study, a meta-analysis of all available case-control studies is the most rigorous way of identifying any potential association between HPV and OSCC. We present the first global meta-analysis of case-control studies investigating the role of HPV in OSCC. Methods: Case-control studies investigating OSCC tissue for presence of HPV DNA were identified. 21 case-control studies analyzing a total of 1223 cases and 1415 controls, met our inclusion criteria. HPV detection rates were tabulated for each study and all studies were assessed for quality. The random effects method was used to pool the odds ratios (OR). Results: From all OSCC specimens included in this meta-analysis, 35% (426/1223) were positive for HPV DNA. The pooled OR for an HPV-OSCC association was 3.04 (95% CI 2.20 to 4.20). Meta-regression analysis did not find a significant association between OR and any of the quality domains. Influence analysis was non-significant for the effect of individual studies on the pooled estimate. Studies conducted in countries with low to medium OSCC incidence showed a stronger relationship (OR 4.65, 95% CI 2.47 to 8.76) than regions of high OSCC incidence (OR 2.65, 95% CI 1.80 to 3.91). Conclusions: Uncertainty around the aetiological role of HPV in OSCC is due largely to the small number and scale of appropriately designed studies. Our meta-analysis of these studies suggests that HPV increases the risk of OSCC three-fold. This study provides the strongest evidence to date of an HPV-OSCC association. The importance of these findings is that prophylactic vaccination could be of public health benefit in prevention of OSCC in countries with high OSCC incidence.	[Liyanage, Surabhi S.; Rahman, Bayzidur; Ridda, Iman; Newall, Anthony T.; Seale, Holly; Moa, Aye; Maclntyre, C. Raina] Univ New S Wales, Sch Publ Hlth & Community Med, UNSW Med, Sydney, NSW, Australia; [Tabrizi, Sepehr N.; Garland, Suzanne M.] Royal Womens Hosp, Dept Microbiol & Infect Dis, Melbourne, Australia; [Segelov, Eva] Univ New S Wales, Dept Med, St Vincents Hosp Clin Sch, Sydney, NSW, Australia; [Crowe, Philip J.] Univ New S Wales, Prince Wales Hosp Clin Sch, Dept Surg, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Liyanage, SS (corresponding author), Univ New S Wales, Sch Publ Hlth & Community Med, UNSW Med, Sydney, NSW, Australia.	surabhi_liyanage@hotmail.com	Rahman, Bayzidur/G-5910-2015; Seale, Holly/D-4200-2011; Segelov, Eva/Q-7611-2019	Seale, Holly/0000-0002-1877-5395; Segelov, Eva/0000-0002-4410-6144; Crowe, Philip/0000-0002-0927-3721; Newall, Anthony/0000-0003-0836-1065; MacIntyre, C Raina/0000-0002-3060-0555	NHMRC [630724]; manufacturer of HPV vaccine; National Health and Medical Research Council (NHMRC) [1012631]; CSL; GlaxoSmithKline; Merck; GSK; Sanofi Pasteur; MSD; CSL Biotherapies; Pfizer	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); manufacturer of HPV vaccine; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); CSL; GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); GSK(GlaxoSmithKline); Sanofi Pasteur; MSD; CSL Biotherapies; Pfizer(Pfizer)	ATN holds an NHMRC Training Fellowship (630724 - Australian Based Public Health Fellowship) and has previously received research funding for other projects from a manufacturer of HPV vaccine. HS currently holds a National Health and Medical Research Council (NHMRC) Training Fellowship (1012631) - Australian Based Public Health Fellowship). SG has received advisory board fees and grants support from CSL and GlaxoSmithKline, and lecture fees from Merck, GSK and Sanofi Pasteur; in addition, she has also received funding through her institution to conduct HPV vaccine studies for MSD and GSK. She is a member of the Merck Global Advisory Board as well as the Merck Scientific Advisory Committee for HPV. CRM has been on advisory boards for Merck, GSK and Pfizer for vaccines other than HPV. She has received funding for investigator-driven research on HPV vaccine from Merck. She has received funding for investigator driven research for other vaccines from GSK, CSL Biotherapies and Pfizer. The other authors have no competing interests to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Agarwal S. K., 1998, Indian Journal of Experimental Biology, V36, P559; Antonsson A, 2010, CANCER EPIDEM BIOMAR, V19, P2080, DOI 10.1158/1055-9965.EPI-10-0033; ASHWORTH MT, 1993, J CLIN PATHOL, V46, P573, DOI 10.1136/jcp.46.6.573; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BENAMOUZIG R, 1992, INT J CANCER, V50, P549, DOI 10.1002/ijc.2910500409; Cao BW, 2005, CARCINOGENESIS, V26, P1280, DOI 10.1093/carcin/bgi071; COOPER K, 1995, J PATHOL, V175, P273, DOI 10.1002/path.1711750304; Curado MP, 2007, CANC INCIDENCE 5 CON; Damin APS, 2006, DIS ESOPHAGUS, V19, P64, DOI 10.1111/j.1442-2050.2006.00541.x; Department of Health and Aging, 2012, HPV VACC PROGR; DOLL R, 1950, BRIT MED J, V2, P739, DOI 10.1136/bmj.2.4682.739; DOLL R, 1954, BMJ-BRIT MED J, V1, P1451, DOI 10.1136/bmj.1.4877.1451; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Egger M, 2001, SYSTEMATIC REV HLTH; Farhadi M, 2005, WORLD J GASTROENTERO, V11, P1200, DOI 10.3748/wjg.v11.i8.1200; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; FIDALGO PO, 1995, CANCER, V76, P1522, DOI 10.1002/1097-0142(19951101)76:9<1522::AID-CNCR2820760904>3.0.CO;2-3; Friis R, 2009, STUDY DESIGNS ECOLOG; Gao GF, 2006, INT J CANCER, V119, P1354, DOI 10.1002/ijc.21980; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Guimaraes DP, 2001, CANCER LETT, V162, P231, DOI 10.1016/S0304-3835(00)00643-1; Hennekens C, 1987, EPIDEMIOL MED; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; HILLE JJ, 1986, S AFR MED J, V69, P417; HORWITZ RI, 1979, AM J MED, V66, P556, DOI 10.1016/0002-9343(79)91164-1; IBM Corp, 2011, IBM SPSS STAT WIND V; Joura EA, 2007, LANCET, V369, P1693, DOI 10.1016/S0140-6736(07)60777-6; Khurshid A, 1998, J Pak Med Assoc, V48, P138; Koh JS, 2008, DIS ESOPHAGUS, V21, P114, DOI 10.1111/j.1442-2050.2007.00726.x; Lambot MA, 2000, ACTA GASTRO-ENT BELG, V63, P154; Lenhart D, 1991, DIS ESOPHAGUS, V4, P123; Li T, 2001, CARCINOGENESIS, V22, P929, DOI 10.1093/carcin/22.6.929; Liu WK, 2010, EUR J GASTROEN HEPAT, V22, P67, DOI 10.1097/MEG.0b013e32832c7e76; Liyanage SS, 2013, ASIA-PAC J CLIN ONCO, V9, P12, DOI 10.1111/j.1743-7563.2012.01555.x; Lyronis ID, 2005, INT J BIOL MARKER, V20, P5, DOI 10.1177/172460080502000102; MARGETTS BM, 1995, NUTR CANCER, V24, P231, DOI 10.1080/01635589509514412; MORI M, 1989, AM J GASTROENTEROL, V84, P1126; Paavonen J, 2007, LANCET, V374, P304; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Rahman M, 2010, INT J EPIDEMIOL; StataCorp, 2007, STAT STAT SOFTW REL; Syrjanen K, 2013, SCAND J INFECT DIS, V45, P1, DOI 10.3109/00365548.2012.702281; SYRJANEN K, 1982, DIAGN HISTOPATHOL, V5, P291; Syrjanen K, 2006, PAPILLOMAVIRUS RESEARCH: FROM NATURAL HISTORY TO VACCINES AND BEYOND, P229; Syrjanen KJ, 2002, J CLIN PATHOL, V55, P721, DOI 10.1136/jcp.55.10.721; Villa LL, 2007, J INFECT DIS, V196, P1438, DOI 10.1086/522864; Weston AC, 2003, DIS ESOPHAGUS, V16, P224, DOI 10.1046/j.1442-2050.2003.00333.x; WILLIAMSON AL, 1991, ANTICANCER RES, V11, P263; World Health Organization, 2007, SMOK TOB SOM TOB SPE; Zhang DH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-650; Zhang HX, 2010, DIS ESOPHAGUS, V23, P392, DOI 10.1111/j.1442-2050.2009.01020.x; Zhao P, 2010, JPN J CLIN ONCOL, V40, P281, DOI 10.1093/jjco/hyp187	53	54	54	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69238	10.1371/journal.pone.0069238	http://dx.doi.org/10.1371/journal.pone.0069238			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894436	Green Published, gold			2022-12-27	WOS:000322167900051
J	Stein, M; Hayashi, S; Sander, M				Stein, Martina; Hayashi, Shoji; Sander, Martin			Long Bone Histology and Growth Patterns in Ankylosaurs: Implications for Life History and Evolution	PLOS ONE			English	Article							COLLAGEN FIBER ORIENTATION; CORTICAL BONE; ORNITHISCHIA ANKYLOSAURIA; STEGOSAURUS ORNITHISCHIA; HUNGAROSAURUS-TORMAI; ONTOGENIC HISTOLOGY; BODY-SIZE; DINOSAURIA; OSTEODERMS; ARCHOSAURS	The ankylosaurs are one of the major dinosaur groups and are characterized by unique body armor. Previous studies on other dinosaur taxa have revealed growth patterns, life history and evolutionary mechanisms based on their long bone histology. However, to date nothing is known about long bone histology in the Ankylosauria. This study is the first description of ankylosaurian long bone histology based on several limb elements, which were sampled from different individuals from the Ankylosauridae and Nodosauridae. The histology is compared to that of other dinosaur groups, including other Thyreophora and Sauropodomorpha. Ankylosaur long bone histology is characterized by a fibrolamellar bone architecture. The bone matrix type in ankylosaurs is closest to that of Stegosaurus. A distinctive mixture of woven and parallel-fibered bone together with overall poor vascularization indicates slow growth rates compared to other dinosaurian taxa. Another peculiar characteristic of ankylosaur bone histology is the extensive remodeling in derived North American taxa. In contrast to other taxa, ankylosaurs substitute large amounts of their primary tissue early in ontogeny. This anomaly may be linked to the late ossification of the ankylosaurian body armor. Metabolically driven remodeling processes must have liberated calcium to ossify the protective osteodermal structures in juveniles to subadult stages, which led to further remodeling due to increased mechanical loading. Abundant structural fibers observed in the primary bone and even in remodeled bone may have improved the mechanical properties of the Haversian bone.	[Stein, Martina; Hayashi, Shoji; Sander, Martin] Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, Bonn, Germany	University of Bonn	Hayashi, S (corresponding author), Osaka Museum Nat Hist, Osaka, Japan.	hayashi@mus-nh.city.osaka.jp			University of Bonn; Japan Society for the Promotion of Science (JSPS)	University of Bonn; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	University of Bonn and the Japan Society for the Promotion of Science (JSPS) provided funding to this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbour VM, 2009, J VERTEBR PALEONTOL, V29, P1117, DOI 10.1671/039.029.0405; Arbour VM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006738; Arbour VM, 2011, J VERT PAL, P64; Bouvier M, 1996, ARCH ORAL BIOL, V41, P941, DOI 10.1016/S0003-9969(96)00047-7; Burns M.E., 2011, NEW MEXICO MUSEUM NA, V53, P169; Burns ME, 2008, J VERTEBR PALEONTOL, V28, P1102, DOI 10.1671/0272-4634-28.4.1102; Bybee PJ, 2006, J MORPHOL, V267, P347, DOI 10.1002/jmor.10406; CHINSAMY A, 1995, J VERTEBR PALEONTOL, V15, P96, DOI 10.1080/02724634.1995.10011209; Chinsamy A, 2005, THE MICROSTRUCTURE O; Churches AE, 1981, MECHANICAL PROPERTIE, V45, P69; Currey J.D., 2002, BONES STRUCTURE AND; CURREY JD, 1960, Q J MICROSC SCI, V101, P351; Currie PJ, 2011, ACTA PALAEONTOL POL, V56, P489, DOI 10.4202/app.2010.0055; Currie PJ, 1991, GEOTIMES, P19; Curry KA, 1999, J VERTEBR PALEONTOL, V19, P654, DOI 10.1080/02724634.1999.10011179; de Ricqles A, 2008, ANN PALEONTOL, V94, P57, DOI 10.1016/j.annpal.2008.03.002; DEBUFFRENIL V, 1986, PALEOBIOLOGY, V12, P459, DOI 10.1017/S0094837300003171; Enlow D.H., 1963, PRINCIPLES OF BONE R; ENLOW DH, 1962, AM J ANAT, V110, P269, DOI 10.1002/aja.1001100305; Erickson GM, 2004, NATURE, V430, P772, DOI 10.1038/nature02699; Erickson GM, 2000, ZOOL J LINN SOC-LOND, V130, P551, DOI 10.1006/zjls.2000.0243; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; Farlow JO, 2010, SWISS J GEOSCI, V103, P173, DOI 10.1007/s00015-010-0021-5; FARLOW JO, 1976, SCIENCE, V192, P1123, DOI 10.1126/science.192.4244.1123; Ford Tracy L., 2000, Bulletin of the New Mexico Museum of Natural History and Science, V17, P157; Francillon-Vieillot H., 1990, P471; Hayashi S, 2012, J VERT PAL, P108; Hayashi S, 2012, PALAEONTOLOGY, V55, P145, DOI 10.1111/j.1475-4983.2011.01122.x; Hayashi S, 2010, ACTA PALAEONTOL POL, V55, P213, DOI 10.4202/app.2009.0103; Hayashi S, 2009, J VERTEBR PALEONTOL, V29, P123, DOI 10.1080/02724634.2009.10010366; Horner JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007626; Horner JR, 2000, J VERTEBR PALEONTOL, V20, P115, DOI 10.1671/0272-4634(2000)020[0115:LBHOTH]2.0.CO;2; Horner JR, 2001, PALEOBIOLOGY, V27, P39, DOI 10.1666/0094-8373(2001)027<0039:COOSEA>2.0.CO;2; Klein N, 2008, PALEOBIOLOGY, V34, P247, DOI 10.1666/0094-8373(2008)034[0247:OSITLB]2.0.CO;2; Klein N, 2007, SP PALAEONT, P169; Knoll F, 2010, GONDWANA RES, V17, P171, DOI 10.1016/j.gr.2009.03.010; Lee AH, 2008, P NATL ACAD SCI USA, V105, P582, DOI 10.1073/pnas.0708903105; Lee AH, 2013, BONE HISTOLOGY OF FOSSIL TETRAPODS: ADVANCING METHODS, ANALYSIS, AND INTERPRETATION, P217; Maidment SCR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036904; Main RP, 2005, PALEOBIOLOGY, V31, P291, DOI 10.1666/0094-8373(2005)031[0291:TEAFOT]2.0.CO;2; MAROTTI G, 1993, CALCIFIED TISSUE INT, V53, pS47, DOI 10.1007/BF01673402; MORI S, 1993, BONE, V14, P103, DOI 10.1016/8756-3282(93)90235-3; Osi A, 2009, PALAEONTOL Z, V83, P227, DOI 10.1007/s12542-009-0017-5; Osi A, 2005, J VERTEBR PALEONTOL, V25, P370, DOI 10.1671/0272-4634(2005)025[0370:HTANAD]2.0.CO;2; Otter MW, 1999, MED HYPOTHESES, V53, P363, DOI 10.1054/mehy.1998.0782; Padian K, 2004, J VERTEBR PALEONTOL, V24, P555, DOI 10.1671/0272-4634(2004)024[0555:GISDAP]2.0.CO;2; Padian K, 2001, NATURE, V412, P405, DOI 10.1038/35086500; Penkalski P, 2014, ACTA PALAEONTOL POL, V59, P617, DOI 10.4202/app.2012.0125; Penkalski P, 2013, CAN J EARTH SCI, V50, P171, DOI 10.1139/cjes-2012-0098; Pfretzschner HU, 2004, CR PALEVOL, V3, P605, DOI 10.1016/j.crpv.2004.07.006; Redelstorff R, 2009, J VERTEBR PALEONTOL, V29, P1087, DOI 10.1671/039.029.0420; RIGGS CM, 1993, ANAT EMBRYOL, V187, P239; RIGGS CM, 1993, ANAT EMBRYOL, V187, P231; Sander P.M., 2003, PALAEONTOL Z, V77, P161, DOI DOI 10.1007/BF03004566; Sander P. Martin, 2011, P276; Sander PM, 2006, NATURE, V441, P739, DOI 10.1038/nature04633; Sander PM, 2004, ORG DIVERS EVOL, V4, P165, DOI 10.1016/j.ode.2003.12.002; Sander PM, 2000, PALEOBIOLOGY, V26, P466, DOI 10.1666/0094-8373(2000)026<0466:LHOTTS>2.0.CO;2; Scheyer TM, 2004, J VERTEBR PALEONTOL, V24, P874, DOI 10.1671/0272-4634(2004)024[0874:HOAOIF]2.0.CO;2; Schweitzer MH, 2007, BONE, V40, P1152, DOI 10.1016/j.bone.2006.10.029; Schweitzer MH, 2005, SCIENCE, V308, P1456, DOI 10.1126/science.1112158; Stein K., 2009, METHODS FOSSIL PREPA, P69; Stein K, 2010, P NATL ACAD SCI USA, V107, P9258, DOI 10.1073/pnas.1000781107; Thompson RS, 2012, J SYST PALAEONTOL, V10, P301, DOI 10.1080/14772019.2011.569091	64	20	20	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e68590	10.1371/journal.pone.0068590	http://dx.doi.org/10.1371/journal.pone.0068590			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894321	gold, Green Published, Green Submitted			2022-12-27	WOS:000322167900018
J	Hansen, LB; Buus, S; Schafer-Nielsen, C				Hansen, Lajla Bruntse; Buus, Soren; Schafer-Nielsen, Claus			Identification and Mapping of Linear Antibody Epitopes in Human Serum Albumin Using High-Density Peptide Arrays	PLOS ONE			English	Article							PARALLEL CHEMICAL SYNTHESIS; MAGNETIC-RESONANCE; GENERAL-METHOD; AMINO-ACIDS; PROTEIN; MICROARRAYS; RESOLUTION; COMPLEXES; MIMICRY	We have recently developed a high-density photolithographic, peptide array technology with a theoretical upper limit of 2 million different peptides per array of 2 cm(2). Here, we have used this to perform complete and exhaustive analyses of linear B cell epitopes of a medium sized protein target using human serum albumin (HSA) as an example. All possible overlapping 15-mers from HSA were synthesized and probed with a commercially available polyclonal rabbit anti-HSA antibody preparation. To allow for identification of even the weakest epitopes and at the same time perform a detailed characterization of key residues involved in antibody binding, the array also included complete single substitution scans (i.e. including each of the 20 common amino acids) at each position of each 15-mer peptide. As specificity controls, all possible 15-mer peptides from bovine serum albumin (BSA) and from rabbit serum albumin (RSA) were included as well. The resulting layout contained more than 200.000 peptide fields and could be synthesized in a single array on a microscope slide. More than 20 linear epitope candidates were identified and characterized at high resolution i.e. identifying which amino acids in which positions were needed, or not needed, for antibody interaction. As expected, moderate cross-reaction with some peptides in BSA was identified whereas no cross-reaction was observed with peptides from RSA. We conclude that high-density peptide microarrays are a very powerful methodology to identify and characterize linear antibody epitopes, and should advance detailed description of individual specificities at the single antibody level as well as serologic analysis at the proteome-wide level.	[Hansen, Lajla Bruntse; Buus, Soren] Univ Copenhagen, Expt Immunol Lab, Copenhagen, Denmark; [Hansen, Lajla Bruntse; Schafer-Nielsen, Claus] Schafer N, Copenhagen, Denmark	University of Copenhagen	Buus, S (corresponding author), Univ Copenhagen, Expt Immunol Lab, Copenhagen, Denmark.	sbuus@sund.ku.dk; peptides@schafer-n.com	Buus, Soren/F-5446-2010	Buus, Soren/0000-0001-8363-1999	European Union Seventh Framework Programme [222773, 278832]	European Union Seventh Framework Programme(European Commission)	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007 2011] under grant agreements 222773 (PepChipOmics) and 278832 (HiPAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamin David C., 1996, Methods (Orlando), V9, P508, DOI 10.1006/meth.1996.0058; Bhushan KR, 2003, TETRAHEDRON LETT, V44, P8585, DOI 10.1016/j.tetlet.2003.09.155; Breitling F, 2009, CHEMBIOCHEM, V10, P803, DOI 10.1002/cbic.200800735; Buus S, 2012, MOL CELL PROTEOMICS, V11, P1790, DOI 10.1074/mcp.M112.020800; Chandra H, 2010, PROTEOMICS, V10, P717, DOI 10.1002/pmic.200900462; Cretich M, 2006, BIOMOL ENG, V23, P77, DOI 10.1016/j.bioeng.2006.02.001; Dhungana S, 2009, METHODS MOL BIOL, V524, P87, DOI 10.1007/978-1-59745-450-6_7; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; FURKA A, 1991, INT J PEPT PROT RES, V37, P487, DOI 10.1111/j.1399-3011.1991.tb00765.x; GEYSEN HM, 1984, P NATL ACAD SCI-BIOL, V81, P3998, DOI 10.1073/pnas.81.13.3998; GOETZE AM, 1977, BIOCHEMISTRY-US, V16, P228, DOI 10.1021/bi00621a011; Hasan A, 1997, TETRAHEDRON, V53, P4247, DOI 10.1016/S0040-4020(97)00154-3; HOUGHTEN RA, 1985, P NATL ACAD SCI USA, V82, P5131, DOI 10.1073/pnas.82.15.5131; Kramer A, 1998, METH MOL B, V87, P25; LAM KS, 1991, NATURE, V354, P82, DOI 10.1038/354082a0; Li SW, 2005, CHEM COMMUN, P581, DOI 10.1039/b415578e; Liu HL, 2005, PROTEOMICS, V5, P2056, DOI 10.1002/pmic.200401104; Pande J, 2010, BIOTECHNOL ADV, V28, P849, DOI 10.1016/j.biotechadv.2010.07.004; Rosen O, 2009, METHODS MOL BIOL, V524, P37, DOI 10.1007/978-1-59745-450-6_3; Saul F A, 1996, Methods Mol Biol, V66, P11; Singh-Gasson S, 1999, NAT BIOTECHNOL, V17, P974, DOI 10.1038/13664; Timmerman P, 2005, CHEMBIOCHEM, V6, P821, DOI 10.1002/cbic.200400374; Timmerman P, 2007, J MOL RECOGNIT, V20, P283, DOI 10.1002/jmr.846; Van Regenmortel MHV, 2009, METHODS MOL BIOL, V524, P3, DOI 10.1007/978-1-59745-450-6_1; YXFELDT G, 1994, MICROBIOL-UK, V140, P815, DOI 10.1099/00221287-140-4-815	26	32	39	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e68902	10.1371/journal.pone.0068902	http://dx.doi.org/10.1371/journal.pone.0068902			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894373	Green Published, Green Submitted, gold			2022-12-27	WOS:000325211000059
J	Admiraal, WM; Vlaar, EM; Nierkens, V; Holleman, F; Middelkoop, BJC; Stronks, K; van Valkengoed, IGM				Admiraal, Wanda M.; Vlaar, Everlina M.; Nierkens, Vera; Holleman, Frits; Middelkoop, Barend J. C.; Stronks, Karien; van Valkengoed, Irene G. M.			Intensive Lifestyle Intervention in General Practice to Prevent Type 2 Diabetes among 18 to 60-Year-Old South Asians: 1-Year Effects on the Weight Status and Metabolic Profile of Participants in a Randomized Controlled Trial	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; CARDIOVASCULAR-DISEASE; PROGRAM; PREVALENCE; REDUCTION; MELLITUS; RISK	Aim: To study 1-year effectiveness of an intensive, culturally targeted lifestyle intervention in general practice for weight status and metabolic profile of South-Asians at risk of type 2 diabetes. Methods: 536 South-Asians at risk of type 2 diabetes were randomized to an intervention (n = 283) or control (n = 253) group. The intervention, which was targeted culturally to the South-Asian population, consisted of individual lifestyle counselling, a family session, cooking classes, and supervised physical activity programme. All components of the intervention were carried out by professionals as part of their daily clinical practice. The control group received generic lifestyle advice. Change in weight status and metabolic profile were assessed after 1 year. Results: After 1 year, 201 participants were lost to follow-up. Remaining participants in intervention (n = 177) and control (n = 158) group had similar baseline characteristics. Weight loss in the intervention group was 0.2 +/- 3.3 kg, weight gain in the control group was 0.4 +/- 3.1 kg (p = 0.08). Changes in other weight-related measurements did not differ significantly between groups. Furthermore, there were no differences between groups in changes of metabolic profile. All results remained similar after repeating analyses in a multiple imputed dataset. Discussion: An intensive, culturally targeted, lifestyle intervention of 1 year did not improve weight status and metabolic profile of South-Asians at risk of type 2 diabetes. The laborious recruitment, high drop-out, and lack of effectiveness emphasise the difficulty of realising health benefits in practice and suggest that this strategy might not be the optimal approach for this population.	[Admiraal, Wanda M.; Vlaar, Everlina M.; Nierkens, Vera; Stronks, Karien; van Valkengoed, Irene G. M.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Admiraal, Wanda M.; Holleman, Frits] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Middelkoop, Barend J. C.] Leiden Univ, Med Ctr, Leiden, Netherlands; [Middelkoop, Barend J. C.] Publ Hlth Serv, The Hague, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Admiraal, WM (corresponding author), Univ Amsterdam, Acad Med Ctr, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	w.m.admiraal@amc.nl	van Valkengoed, Irene/ABA-1551-2021; van Valkengoed, Irene G.M./B-2974-2013	van Valkengoed, Irene/0000-0002-9306-7831; van Valkengoed, Irene G.M./0000-0002-9306-7831; Stronks, Karien/0000-0002-0921-2232; Holleman, Frits/0000-0001-5858-5089	Dutch organisation for Health Research and Development (ZonMW) [120620023]	Dutch organisation for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development)	The Dutch organisation for Health Research and Development (ZonMW, project number 120620023) funded the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann RT, 2008, AM J PREV MED, V35, P357, DOI 10.1016/j.amepre.2008.06.035; Bos V, 2004, INT J EPIDEMIOL, V33, P1112, DOI 10.1093/ije/dyh189; Choenni C, 2007, PLACE BIRTH ETHNIC C; Chowdhury TA, 2003, BRIT MED J, V327, P1059, DOI 10.1136/bmj.327.7423.1059; Gholap N, 2011, PRIM CARE DIABETES, V5, P45, DOI 10.1016/j.pcd.2010.08.002; Hawthorne K, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006424.pub2; Hosper K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-406; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Laatikainen T, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-249; Lindstrom J, 2003, DIABETES CARE, V26, P3230, DOI 10.2337/diacare.26.12.3230; Mangalmurti SS, 2010, ETHNIC DIS, V20, P474; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mensink M, 2003, DIABETES RES CLIN PR, V61, P49, DOI 10.1016/S0168-8227(03)00067-6; Nicolaou M, 2012, DEV DIABETES PREVENT; Oldroyd J, 2005, POSTGRAD MED J, V81, P486, DOI 10.1136/pgmj.2004.029124; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Resnicow K, 2000, HEALTH EDUC BEHAV, V27, P616, DOI 10.1177/109019810002700507; Riste L, 2001, DIABETES CARE, V24, P1377, DOI 10.2337/diacare.24.8.1377; ROSE G, 1981, BMJ-BRIT MED J, V282, P1847, DOI 10.1136/bmj.282.6279.1847; Roumen C, 2008, DIABETIC MED, V25, P597, DOI 10.1111/j.1464-5491.2008.02417.x; Saaristo T, 2010, DIABETES CARE, V33, P2146, DOI 10.2337/dc10-0410; SAMANTA A, 1987, DIABETES RES CLIN PR, V4, P1, DOI 10.1016/S0168-8227(87)80026-8; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Schmidt M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-371; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Vermunt PWA, 2011, DIABETES CARE, V34, P1919, DOI 10.2337/dc10-2293; Vlaar EMA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-371; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047	29	41	41	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e68605	10.1371/journal.pone.0068605	http://dx.doi.org/10.1371/journal.pone.0068605			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894322	Green Published, Green Submitted, gold			2022-12-27	WOS:000322132100020
J	Guerrero, CC; Gunthardt-Goerg, MS; Vollenweider, P				Calderon Guerrero, Carlos; Guenthardt-Goerg, Madeleine S.; Vollenweider, Pierre			Foliar Symptoms Triggered by Ozone Stress in Irrigated Holm Oaks from the City of Madrid, Spain	PLOS ONE			English	Article							LEAF GAS-EXCHANGE; QUERCUS-ILEX; WATER RELATIONS; NATIVE PLANTS; EVERGREEN; FOREST; RESPONSES; LEAVES; INJURY; SOIL	Background: Despite abatement programs of precursors implemented in many industrialized countries, ozone remains the principal air pollutant throughout the northern hemisphere with background concentrations increasing as a consequence of economic development in former or still emerging countries and present climate change. Some of the highest ozone concentrations are measured in regions with a Mediterranean climate but the effect on the natural vegetation is alleviated by low stomatal uptake and frequent leaf xeromorphy in response to summer drought episodes characteristic of this climate. However, there is a lack of understanding of the respective role of the foliage physiology and leaf xeromorphy on the mechanistic effects of ozone in Mediterranean species. Particularly, evidence about morphological and structural changes in evergreens in response to ozone stress is missing. Results: Our study was started after observing ozone -like injury in foliage of holm oak during the assessment of air pollution mitigation by urban trees throughout the Madrid conurbation. Our objectives were to confirm the diagnosis, investigate the extent of symptoms and analyze the ecological factors contributing to ozone injury, particularly, the site water supply. Symptoms consisted of adaxial and intercostal stippling increasing with leaf age. Underlying stippling, cells in the upper mesophyll showed HR-like reactions typical of ozone stress. The surrounding cells showed further oxidative stress markers. These morphological and micromorphological markers of ozone stress were similar to those recorded in deciduous broadleaved species. However, stippling became obvious already at an AOT40 of 21 ppm.h and was primarily found at irrigated sites. Subsequent analyses showed that irrigated trees had their stomatal conductance increased and leaf life -span reduced whereas the leaf xeromorphy remained unchanged. These findings suggest a central role of water availability versus leaf xeromorphy for ozone symptom expression by cell injury in holm oak.	[Calderon Guerrero, Carlos; Guenthardt-Goerg, Madeleine S.; Vollenweider, Pierre] Forest Dynam Swiss Fed Res Inst WSL, Birmensdorf, Switzerland; [Calderon Guerrero, Carlos] Univ Politecn Madrid, Dept Silvopasture, Fac Forest Engn EUIT Forestal, Madrid, Spain	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Universidad Politecnica de Madrid	Gunthardt-Goerg, MS (corresponding author), Forest Dynam Swiss Fed Res Inst WSL, Birmensdorf, Switzerland.	madeleine.goerg@wsl.ch	Guerrero, Carlos Calderón/H-6298-2011; Günthardt-Goerg, Madeleine S./L-6461-2013; Vollenweider, Pierre/L-9315-2013; Günthardt-Goerg, Madeleine Silvia/S-2562-2019	Guerrero, Carlos Calderón/0000-0003-3000-4187; Vollenweider, Pierre/0000-0002-4995-1419; Günthardt-Goerg, Madeleine Silvia/0000-0003-0468-5302	Social Council of the Universidad Politecnica de Madrid	Social Council of the Universidad Politecnica de Madrid	The work was supported by the Social Council of the Universidad Politecnica de Madrid. http://www.upm.es/institucional/UPM/ConsejoSocial. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asensio D, 2007, ATMOS ENVIRON, V41, P2447, DOI 10.1016/j.atmosenv.2006.05.008; Bombelli A, 2003, PHOTOSYNTHETICA, V41, P619, DOI 10.1023/B:PHOT.0000027529.82395.86; Bortier K, 2000, ENVIRONMENTAL POLLUTION AND PLANT RESPONSES, P153; Bussotti F, 2005, NEW PHYTOL, V166, P941, DOI 10.1111/j.1469-8137.2005.01385.x; Bussotti F, 2002, ENVIRON EXP BOT, V47, P11, DOI 10.1016/S0098-8472(01)00111-3; Calatayud V, 2011, ENVIRON POLLUT, V159, P55, DOI 10.1016/j.envpol.2010.09.024; Calatayud V, 2010, ENVIRON POLLUT, V158, P3580, DOI 10.1016/j.envpol.2010.08.013; Calderon Guerrero C, 2009, ACT 5 C FOR ESP, P1; Cunningham SA, 1999, ECOL MONOGR, V69, P569, DOI 10.1890/0012-9615(1999)069[0569:EDILSA]2.0.CO;2; DAVIS DD, 1977, PLANT DIS REP, V61, P640; EEA, 2007, 52007 EUR ENV AG; EEA, 2003, 32003 EUR ENV AG; EEA, 2005, 32005 EUR ENV AG; EEA, 2006, 32006 EUR ENV AG; EEA, 2008, 52008 EUR ENV AG; ELSTNER EF, 1996, STRESS BEI PFLANZEN, P347; FEDER N, 1968, AM J BOT, V55, P123, DOI 10.2307/2440500; FINK S, 1999, ENCY PLANT ANATOMY, V14; Foyer CH, 2005, PLANT CELL ENVIRON, V28, P1056, DOI 10.1111/j.1365-3040.2005.01327.x; FOYER CH, 1994, PHYSIOL PLANTARUM, V92, P696, DOI 10.1111/j.1399-3054.1994.tb03042.x; Fuhrer J, 1997, ENVIRON POLLUT, V97, P91, DOI 10.1016/S0269-7491(97)00067-5; Galle A, 2011, J EXP BOT, V62, P5207, DOI 10.1093/jxb/err233; Gerosa G, 2005, ATMOS ENVIRON, V39, P3255, DOI 10.1016/j.atmosenv.2005.01.056; Gerosa G, 2007, ENVIRON POLLUT, V145, P629, DOI 10.1016/j.envpol.2006.02.030; Gratani L, 1998, PHOTOSYNTHETICA, V35, P445, DOI 10.1023/A:1006924621078; Gratani L, 2006, PHOTOSYNTHETICA, V44, P161, DOI 10.1007/s11099-006-0001-1; GRATANI L, 1995, PHOTOSYNTHETICA, V31, P335; Gravano E, 2004, PHYSIOL PLANTARUM, V121, P620, DOI 10.1111/j.1399-3054.2004.00363.x; Gunthardt-Goerg MS, 2007, ENVIRON POLLUT, V147, P467, DOI 10.1016/j.envpol.2006.08.033; Gulias J, 2009, FLORA, V204, P169, DOI 10.1016/j.flora.2008.01.011; Gunthardt-Goerg MS, 2000, ENVIRON POLLUT, V109, P489, DOI 10.1016/S0269-7491(00)00052-X; GunthardtGoerg MS, 1996, CAN J FOREST RES, V26, P649, DOI 10.1139/x26-075; GunthardtGoerg MS, 1997, CAN J FOREST RES, V27, P453, DOI 10.1139/cjfr-27-4-453; ICP, 2004, MOD MAPP MAN METH CR; Inclan R, 1999, WATER AIR SOIL POLL, V116, P273, DOI 10.1023/A:1005214005416; Innes JL., 2001, OZONE BROADLEAVED SP; Karenlampi L, 1996, UN ECE WORKSH U KUOP; Karnosky DF, 2005, PLANT CELL ENVIRON, V28, P965, DOI 10.1111/j.1365-3040.2005.01362.x; Kivimaenpaa M, 2003, ANN BOT-LONDON, V92, P779, DOI 10.1093/aob/mcg202; Manes F, 1998, CHEMOSPHERE, V36, P801, DOI 10.1016/S0045-6535(97)10127-8; Millan MM, 1997, J GEOPHYS RES-ATMOS, V102, P8811, DOI 10.1029/96JD03610; Miller P. R., 1997, Forest decline and ozone. A comparison of controlled chamber and field experiments., P39; Murakami PF, 2005, NE327 USDA; Niinemets U, 2005, PLANT CELL ENVIRON, V28, P1552, DOI 10.1111/j.1365-3040.2005.01392.x; Niinemets U, 2003, NEW PHYTOL, V158, P75, DOI 10.1046/j.1469-8137.2003.00712.x; Novak K, 2003, ENVIRON POLLUT, V125, P41, DOI 10.1016/S0269-7491(03)00085-X; Ogaya R, 2003, FOREST ECOL MANAG, V180, P175, DOI 10.1016/S0378-1127(02)00598-4; Ogaya R, 2007, ACTA OECOL, V31, P168, DOI 10.1016/j.actao.2006.07.004; Oksanen E, 2004, NEW PHYTOL, V161, P791, DOI 10.1111/j.1469-8137.2003.00981.x; Orendovici T, 2003, ENVIRON POLLUT, V125, P31, DOI 10.1016/S0269-7491(03)00089-7; Paoletti E, 2006, ENVIRON POLLUT, V144, P463, DOI 10.1016/j.envpol.2005.12.051; Paoletti E, 2009, SCI TOTAL ENVIRON, V407, P1631, DOI 10.1016/j.scitotenv.2008.11.061; Pardos M, 2005, NEW FOREST, V30, P75, DOI 10.1007/s11056-004-2553-x; Porter E, 2003, OZ SENS PLANT SPEC N; Rao MV, 2001, PLANTA, V213, P682, DOI 10.1007/s004250100618; Reich PB, 1999, ECOLOGY, V80, P1955, DOI 10.1890/0012-9658(1999)080[1955:GOLTRA]2.0.CO;2; Reig-Arminana J, 2004, ENVIRON POLLUT, V132, P321, DOI 10.1016/j.envpol.2004.04.006; Ribas A, 2005, ATMOS ENVIRON, V39, P685, DOI 10.1016/j.atmosenv.2004.10.022; Romane F, 1992, VEGETATIO, V99; Sandermann H, 2004, TRENDS PLANT SCI, V9, P406, DOI 10.1016/j.tplants.2004.06.001; Sandermann H, 1998, TRENDS PLANT SCI, V3, P47, DOI 10.1016/S1360-1385(97)01162-X; Sanz M J, 2001, ScientificWorldJournal, V1, P785; Sanz MJ, 1998, CHEMOSPHERE, V36, P1089, DOI 10.1016/S0045-6535(97)10177-1; Sanz MJ, 2012, OZONE INJURY EUROPEA; Schaub M, 2003, ENVIRON POLLUT, V124, P307, DOI 10.1016/S0269-7491(02)00462-1; Schraudner M, 1996, BIOCHEM SOC T, V24, P456, DOI 10.1042/bst0240456; TRETIACH M, 1993, ACTA OECOL, V14, P341; TURNER IM, 1994, FUNCT ECOL, V8, P669, DOI 10.2307/2390225; VanderHeyden D, 2001, ENVIRON POLLUT, V111, P321, DOI 10.1016/S0269-7491(00)00060-9; Vollenweider P, 2003, ENVIRON POLLUT, V125, P467, DOI 10.1016/S0269-7491(03)00079-4; Vollenweider P, 2003, ENVIRON POLLUT, V124, P101, DOI 10.1016/S0269-7491(02)00412-8; Vollenweider Pierre, 2006, Environ Pollut, V140, P562, DOI 10.1016/j.envpol.2006.01.002; Yamasaki H, 1997, PLANT PHYSIOL, V115, P1405, DOI 10.1104/pp.115.4.1405; Zazo J, 2000, CARACTERES CULTURE 1	74	16	16	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69171	10.1371/journal.pone.0069171	http://dx.doi.org/10.1371/journal.pone.0069171			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894424	Green Published, gold			2022-12-27	WOS:000322132100049
J	de Blecourt, M; Brumme, R; Xu, JC; Corre, MD; Veldkamp, E				de Blecourt, Marleen; Brumme, Rainer; Xu, Jianchu; Corre, Marife D.; Veldkamp, Edzo			Soil Carbon Stocks Decrease following Conversion of Secondary Forests to Rubber (Hevea brasiliensis) Plantations	PLOS ONE			English	Article							LAND-USE CHANGE; ORGANIC-CARBON; COVER CHANGE; XISHUANGBANNA; CULTIVATION; STORAGE; TURNOVER; NITROGEN	Forest-to-rubber plantation conversion is an important land-use change in the tropical region, for which the impacts on soil carbon stocks have hardly been studied. In montane mainland southeast Asia, monoculture rubber plantations cover 1.5 million ha and the conversion from secondary forests to rubber plantations is predicted to cause a fourfold expansion by 2050. Our study, conducted in southern Yunnan province, China, aimed to quantify the changes in soil carbon stocks following the conversion from secondary forests to rubber plantations. We sampled 11 rubber plantations ranging in age from 5 to 46 years and seven secondary forest plots using a space-for-time substitution approach. We found that forest-to-rubber plantation conversion resulted in losses of soil carbon stocks by an average of 37.4+/-4.7 (SE) Mg C ha(-1) in the entire 1.2-m depth over a time period of 46 years, which was equal to 19.3+/-2.7% of the initial soil carbon stocks in the secondary forests. This decline in soil carbon stocks was much larger than differences between published aboveground carbon stocks of rubber plantations and secondary forests, which range from a loss of 18 Mg C ha(-1) to an increase of 8 Mg C ha(-1). In the topsoil, carbon stocks declined exponentially with years since deforestation and reached a steady state at around 20 years. Although the IPCC tier 1 method assumes that soil carbon changes from forest-to-rubber plantation conversions are zero, our findings show that they need to be included to avoid errors in estimating overall ecosystem carbon fluxes.	[de Blecourt, Marleen; Brumme, Rainer; Corre, Marife D.; Veldkamp, Edzo] Univ Gottingen, Busgen Inst, Soil Sci Trop & Subtrop Ecosyst, D-37073 Gottingen, Germany; [Xu, Jianchu] World Agroforestry Ctr, East Asia Node, Kunming, Peoples R China	University of Gottingen	de Blecourt, M (corresponding author), Univ Gottingen, Busgen Inst, Soil Sci Trop & Subtrop Ecosyst, D-37073 Gottingen, Germany.	mblecou@gwdg.de	Xu, Jianchu/Y-2890-2019; Veldkamp, Edzo/A-6660-2008	Veldkamp, Edzo/0000-0002-8318-8349; Corre, Marife D./0000-0003-0359-2104	German Ministry for Economic Cooperation and Development; Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ) [08.7860.3-001.00]	German Ministry for Economic Cooperation and Development; Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ)	This study is funded by the German Ministry for Economic Cooperation and Development (http://www.bmz.de) and the Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ)(http://www.giz.de) for the project "Making the Mekong Connected" (No. 08.7860.3-001.00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalde H., 2006, 2006 IPCC GUIDELINES; Araujo QR, 2005, AGROFOREST SYST, V63, P193, DOI 10.1007/s10457-004-3198-7; Bruun TB, 2009, HUM ECOL, V37, P375, DOI 10.1007/s10745-009-9257-y; DALAL RC, 1986, AUST J SOIL RES, V24, P281, DOI 10.1071/SR9860281; DAVIDSON EA, 1993, BIOGEOCHEMISTRY, V20, P161, DOI 10.1007/BF00000786; de Koning GHJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2003GB002099; DETWILER RP, 1986, BIOGEOCHEMISTRY, V2, P67, DOI 10.1007/BF02186966; Fearnside PM, 1998, FOREST ECOL MANAG, V108, P147, DOI 10.1016/S0378-1127(98)00222-9; Fox J, 2005, ENVIRON MANAGE, V36, P394, DOI 10.1007/s00267-003-0288-7; Fox Jefferson, 2012, Environ Manage, V49, P968, DOI 10.1007/s00267-012-9828-3; Hertge KH., 1986, METHODS SOIL ANAL 1, P377; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Houghton RA, 1999, GLOB CHANGE BIOL, V5, P481, DOI 10.1046/j.1365-2486.1999.00244.x; IUSS Working Group WRB, 2006, WORLD SOIL RESOURCES, V103, P145, DOI DOI 10.1017/S0014479706394902; Jenny H., 1941, FACTORS SOIL FORMATI, DOI 10.1097/00010694-194111000-00009; Konig N, 1996, BERICHTE FORSCHUNGSZ; Lasco RD, 2006, 2006 IPCC GUIDELINES, P51; Li HM, 2008, FOREST ECOL MANAG, V255, P16, DOI 10.1016/j.foreco.2007.06.051; Li Z, 2012, APPL GEOGR, V32, P420, DOI 10.1016/j.apgeog.2011.06.018; Lobe I, 2001, EUR J SOIL SCI, V52, P93, DOI 10.1046/j.1365-2389.2001.t01-1-00362.x; Marin-Spiotta E, 2013, GLOBAL ECOL BIOGEOGR, V22, P105, DOI 10.1111/j.1466-8238.2012.00788.x; Mertz O, 2009, CURR OPIN ENV SUST, V1, P156, DOI 10.1016/j.cosust.2009.10.002; Pinheiro J., 2021, NLME LINEAR NONLINEA; Powers JS, 2011, P NATL ACAD SCI USA, V108, P6318, DOI 10.1073/pnas.1016774108; R Core Team, 2021, R LANGUAGE ENV STAT; SALIMON CI, 2009, REV AMBIENT AGUA, V4, P57; SCHIMEL DS, 1994, GLOBAL BIOGEOCHEM CY, V8, P279, DOI 10.1029/94GB00993; van der Werf GR, 2009, NAT GEOSCI, V2, P737, DOI 10.1038/ngeo671; VELDKAMP E, 1994, SOIL SCI SOC AM J, V58, P175, DOI 10.2136/sssaj1994.03615995005800010025x; Xu J, 2012, ECOLOGICAL IN PRESS; Xu JC, 2005, ENVIRON MANAGE, V36, P404, DOI 10.1007/s00267-003-0289-6; Xu JC, 2006, MT RES DEV, V26, P254, DOI 10.1659/0276-4741(2006)26[254:TPSAET]2.0.CO;2; Yang JC, 2004, J ENVIRON SCI-CHINA, V16, P256; Ziegler AD, 2009, SCIENCE, V324, P1024, DOI 10.1126/science.1173833; Zingore S, 2005, EUR J SOIL SCI, V56, P727, DOI 10.1111/j.1365-2389.2005.00707.x; Zuur Alain F., 2009, P1	36	117	118	7	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e69357	10.1371/journal.pone.0069357	http://dx.doi.org/10.1371/journal.pone.0069357			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894456	Green Submitted, Green Published, gold			2022-12-27	WOS:000322391400052
J	Matsumoto, Y; Matsuura, T; Aoyagi, H; Matsuda, M; Hmwe, SS; Date, T; Watanabe, N; Watashi, K; Suzuki, R; Ichinose, S; Wake, K; Suzuki, T; Miyamura, T; Wakita, T; Aizaki, H				Matsumoto, Yoshihiro; Matsuura, Tomokazu; Aoyagi, Haruyo; Matsuda, Mami; Hmwe, Su Su; Date, Tomoko; Watanabe, Noriyuki; Watashi, Koichi; Suzuki, Ryosuke; Ichinose, Shizuko; Wake, Kenjiro; Suzuki, Tetsuro; Miyamura, Tatsuo; Wakita, Takaji; Aizaki, Hideki			Antiviral Activity of Glycyrrhizin against Hepatitis C Virus In Vitro	PLOS ONE			English	Article							RNA REPLICATION COMPLEX; GLYCYRRHETINIC ACID; PHOSPHOLIPASE A(2); LIPID DROPLET; MECHANISM; INFECTION; MEMBRANE; PROTEINS; DERIVATIVES; EXPRESSION	Glycyrrhizin (GL) has been used in Japan to treat patients with chronic viral hepatitis, as an anti-inflammatory drug to reduce serum alanine aminotransferase levels. GL is also known to exhibit various biological activities, including antiviral effects, but the anti-hepatitis C virus (HCV) effect of GL remains to be clarified. In this study, we demonstrated that GL treatment of HCV-infected Huh7 cells caused a reduction of infectious HCV production using cell culture-produced HCV (HCVcc). To determine the target step in the HCV lifecycle of GL, we used HCV pseudoparticles (HCVpp), replicon, and HCVcc systems. Significant suppressions of viral entry and replication steps were not observed. Interestingly, extracellular infectivity was decreased, and intracellular infectivity was increased. By immunofluorescence and electron microscopic analysis of GL treated cells, HCV core antigens and electron-dense particles had accumulated on endoplasmic reticulum attached to lipid droplet (LD), respectively, which is thought to act as platforms for HCV assembly. Furthermore, the amount of HCV core antigen in LD fraction increased. Taken together, these results suggest that GL inhibits release of infectious HCV particles. GL is known to have an inhibitory effect on phospholipase A2 (PLA2). We found that group 1B PLA2 (PLA2G1B) inhibitor also decreased HCV release, suggesting that suppression of virus release by GL treatment may be due to its inhibitory effect on PLA2G1B. Finally, we demonstrated that combination treatment with GL augmented IFN-induced reduction of virus in the HCVcc system. GL is identified as a novel anti-HCV agent that targets infectious virus particle release.	[Matsumoto, Yoshihiro; Aoyagi, Haruyo; Matsuda, Mami; Hmwe, Su Su; Date, Tomoko; Watanabe, Noriyuki; Watashi, Koichi; Suzuki, Ryosuke; Miyamura, Tatsuo; Wakita, Takaji; Aizaki, Hideki] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan; [Matsumoto, Yoshihiro] Jikei Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo, Japan; [Matsuura, Tomokazu] Jikei Univ, Sch Med, Dept Lab Med, Tokyo, Japan; [Ichinose, Shizuko; Wake, Kenjiro] Tokyo Med & Dent Univ, Res Ctr Med & Dent Sci, Tokyo, Japan; [Wake, Kenjiro] Minophagen Pharmaceut Co Ltd, Liver Res Unit, Tokyo, Japan; [Suzuki, Tetsuro] Hamamatsu Univ Sch Med, Dept Infect Dis, Hamamatsu, Shizuoka 4313192, Japan	National Institute of Infectious Diseases (NIID); Jikei University; Jikei University; Tokyo Medical & Dental University (TMDU); Hamamatsu University School of Medicine	Aizaki, H (corresponding author), Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan.	aizaki@nih.go.jp			Japan Society for the Promotion of Science; Ministry of Health, Labour, and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology; National Institute of Biomedical Innovation; Research on Health Sciences Focusing on Drug Innovation of the Japan Health Sciences Foundation; Grants-in-Aid for Scientific Research [24115003] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Research on Health Sciences Focusing on Drug Innovation of the Japan Health Sciences Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science, the Ministry of Health, Labour, and Welfare of Japan, the Ministry of Education, Culture, Sports, Science, and Technology, the National Institute of Biomedical Innovation, and Research on Health Sciences Focusing on Drug Innovation of the Japan Health Sciences Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE N, 1982, MICROBIOL IMMUNOL, V26, P535, DOI 10.1111/j.1348-0421.1982.tb00207.x; Aizaki H, 2004, VIROLOGY, V324, P450, DOI 10.1016/j.virol.2004.03.034; Aizaki H, 2008, J VIROL, V82, P5715, DOI 10.1128/JVI.02530-07; Akazawa D, 2007, J VIROL, V81, P5036, DOI 10.1128/JVI.01573-06; Ashfaq UA, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-112; BABA M, 1987, ANTIVIR RES, V7, P99, DOI 10.1016/0166-3542(87)90025-8; Brown WJ, 2003, TRAFFIC, V4, P214, DOI 10.1034/j.1600-0854.2003.00078.x; Burke JE, 2009, J LIPID RES, V50, pS237, DOI 10.1194/jlr.R800033-JLR200; Calland N, 2012, VIRUSES-BASEL, V4, P2197, DOI 10.3390/v4102197; Coller KE, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002466; CRANCE JM, 1994, ANTIVIR RES, V23, P63, DOI 10.1016/0166-3542(94)90033-7; Fujisawa Y, 2000, MICROBIOL IMMUNOL, V44, P799, DOI 10.1111/j.1348-0421.2000.tb02566.x; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gao L, 2004, J VIROL, V78, P3480, DOI 10.1128/JVI.78.7.3480-3488.2004; Goto K, 2006, BIOCHEM BIOPH RES CO, V343, P879, DOI 10.1016/j.bbrc.2006.03.059; Harada H, 2005, EUR J IMMUNOL, V35, P3599, DOI 10.1002/eji.200535125; Harada S, 2005, BIOCHEM J, V392, P191, DOI 10.1042/BJ20051069; Hibasami H, 2006, INT J MOL MED, V17, P215; Hoever G, 2005, J MED CHEM, V48, P1256, DOI 10.1021/jm0493008; INOUE H, 1987, CHEM PHARM BULL, V35, P3888; Kato T, 2008, HEPATOLOGY, V48, P732, DOI 10.1002/hep.22422; Kimoto Michiko, 2005, Nucleic Acids Symp Ser (Oxf), P287; Koutsoudakis G, 2007, J VIROL, V81, P588, DOI 10.1128/JVI.01534-06; Lin JC, 2003, ANTIVIR RES, V59, P41, DOI 10.1016/S0166-3542(03)00030-5; Manns MP, 2012, J VIRAL HEPATITIS, V19, P537, DOI 10.1111/j.1365-2893.2011.01579.x; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Mauricio I, 1997, BIOCHEM BIOPH RES CO, V235, P259, DOI 10.1006/bbrc.1997.6735; McLauchlan J, 2009, BIOCHEM SOC T, V37, P986, DOI 10.1042/BST0370986; Menzel N, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002829; Miyamoto M, 2005, INTERVIROLOGY, V49, P37, DOI 10.1159/000087261; Miyamoto Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016054; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Ohtsuki K, 1998, BIOL PHARM BULL, V21, P574, DOI 10.1248/bpb.21.574; OHUCHI K, 1981, PROSTAG LEUKOTR ESS, V7, P457, DOI 10.1016/0161-4630(81)90033-1; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; POMPEI R, 1979, NATURE, V281, P689, DOI 10.1038/281689a0; Sato S, 2006, J BIOCHEM, V139, P921, DOI 10.1093/jb/mvj104; Sekizawa T, 2001, ACTA VIROL, V45, P51; SHIKI Y, 1992, J GASTROEN HEPATOL, V7, P12, DOI 10.1111/j.1440-1746.1992.tb00927.x; Sui XW, 2010, ANTIVIR RES, V85, P346, DOI 10.1016/j.antiviral.2009.10.014; TAKAHARA T, 1994, J HEPATOL, V21, P601, DOI 10.1016/S0168-8278(94)80108-8; Takeuchi T, 1999, GASTROENTEROLOGY, V116, P636, DOI 10.1016/S0016-5085(99)70185-X; Utsunomiya T, 1997, ANTIMICROB AGENTS CH, V41, P551, DOI 10.1128/AAC.41.3.551; van Rossum TGJ, 1999, CLIN THER, V21, P2080, DOI 10.1016/S0149-2918(00)87239-2; van Rossum TGJ, 2001, AM J GASTROENTEROL, V96, P2432, DOI 10.1111/j.1572-0241.2001.04049.x; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wolkerstorfer A, 2009, ANTIVIR RES, V83, P171, DOI 10.1016/j.antiviral.2009.04.012; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	48	75	85	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e68992	10.1371/journal.pone.0068992	http://dx.doi.org/10.1371/journal.pone.0068992			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874843	Green Published, Green Submitted, gold			2022-12-27	WOS:000324146200047
J	Pioli, PD; Dahlem, TJ; Weis, JJ; Weis, JH				Pioli, Peter D.; Dahlem, Timothy J.; Weis, Janis J.; Weis, John H.			Deletion of Snai2 and Snai3 Results in Impaired Physical Development Compounded by Lymphocyte Deficiency	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SLUG; HEMATOPOIETIC PROGENITORS; MESENCHYMAL TRANSITION; BONE-MARROW; FACTOR GENE; EXPRESSION; APOPTOSIS; SUPPRESSES; PROTEINS; ENCODES	The Snail family of transcriptional regulators consists of three highly conserved members. These proteins regulate (repress) transcription via the recruitment of histone deacetylases to target gene promoters that possess the appropriate E-box binding sequences. Murine Snai1 is required for mouse development while Snai2 deficient animals survive with some anomalies. Less is known about the third member of the family, Snai3. To investigate the function of Snai3, we generated a conditional knockin mouse. Utilizing Cre-mediated deletion to facilitate the ablation of Snai3 in T cells or the entire animal, we found little to no effect of the loss of Snai3 in the entire animal or in T cell lineages. This finding provided the hypothesis that absence of Snai3 was mitigated, in part, by the presence of Snai2. To test this hypothesis we created Snai2/Snai3 double deficient mice. The developmental consequences of lacking both of these proteins was manifested in stunted growth, a paucity of offspring including a dramatic deficiency of female mice, and impaired immune cell development within the lymphoid lineages.	[Pioli, Peter D.; Dahlem, Timothy J.; Weis, Janis J.; Weis, John H.] Univ Utah, Sch Med, Dept Pathol, Div Cell Biol & Immunol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Weis, JH (corresponding author), Univ Utah, Sch Med, Dept Pathol, Div Cell Biol & Immunol, Salt Lake City, UT 84112 USA.	john.weis@path.utah.edu	Pioli, Peter/AAU-3614-2021; Pioli, Peter Dion/GRR-3563-2022	Pioli, Peter/0000-0002-3321-2216	NIH [AI24158, AI AI088451, AI-32223, AR-43521]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI032223, R01AI032223, R01AI024158, R21AI088451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007115] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the NIH (JHW: AI24158 and AI AI088451)(JJW: AI-32223 and AR-43521). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034863; Bain G, 1997, MOL CELL BIOL, V17, P4782, DOI 10.1128/MCB.17.8.4782; Barrallo-Gimeno A, 2009, TRENDS GENET, V25, P248, DOI 10.1016/j.tig.2009.04.001; BOULAY JL, 1987, NATURE, V330, P395, DOI 10.1038/330395a0; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Cobaleda C, 2007, ANNU REV GENET, V41, P41, DOI 10.1146/annurev.genet.41.110306.130146; Dahlem T, 2012, EUR J IMMUNOL, V42, P1038, DOI 10.1002/eji.201142193; Debnath I, 2007, MOL IMMUNOL, V44, P2388, DOI 10.1016/j.molimm.2006.10.019; Deed RW, 1998, J BIOL CHEM, V273, P8278, DOI 10.1074/jbc.273.14.8278; Diamond RA, 1997, J IMMUNOL, V158, P4052; Egawa T, 2009, BLOOD CELL MOL DIS, V43, P27, DOI 10.1016/j.bcmd.2009.03.004; Egawa T, 2009, J CELL BIOCHEM, V107, P1037, DOI 10.1002/jcb.22212; Frasca D, 2003, FRONT BIOSCI, V8, pA110, DOI 10.2741/1059; Gatzka M, 2009, J IMMUNOL, V183, P285, DOI 10.4049/jimmunol.0803530; Geier JK, 2006, SEMIN IMMUNOL, V18, P31, DOI 10.1016/j.smim.2005.11.001; Hagenbeek TJ, 2008, LEUKEMIA, V22, P608, DOI 10.1038/sj.leu.2405056; Hemavathy K, 2000, GENE, V257, P1, DOI 10.1016/S0378-1119(00)00371-1; Ikawa T, 2006, J EXP MED, V203, P1329, DOI 10.1084/jem.20060268; Inoue A, 2002, CANCER CELL, V2, P279, DOI 10.1016/S1535-6108(02)00155-1; Inukai T, 1999, MOL CELL, V4, P343, DOI 10.1016/S1097-2765(00)80336-6; Larriba MJ, 2009, CARCINOGENESIS, V30, P1459, DOI 10.1093/carcin/bgp140; Jiang RL, 1998, DEV BIOL, V198, P277, DOI 10.1016/S0012-1606(98)80005-5; Kataoka H, 2000, NUCLEIC ACIDS RES, V28, P626, DOI 10.1093/nar/28.2.626; Katoh M, 2005, ONCOL REP, V14, P1083; Katoh M, 2005, INT J ONCOL, V27, P1677; Kumarswamy R, 2012, INT J CANCER, V130, P2044, DOI 10.1002/ijc.26218; Lam QLK, 2007, INT IMMUNOL, V19, P267, DOI 10.1093/intimm/dxl143; Lee J, 2012, J BIOL CHEM, V287, P18182, DOI 10.1074/jbc.M111.328831; Lee JT, 2000, CELL, V103, P17, DOI 10.1016/S0092-8674(00)00101-X; Lin YW, 2010, EMBO J, V29, P1803, DOI 10.1038/emboj.2010.63; Lomeli Hilda, 2009, BMC Res Notes, V2, P22, DOI 10.1186/1756-0500-2-22; Manzanares M, 2004, DEV GENES EVOL, V214, P47, DOI 10.1007/s00427-003-0373-1; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Metzstein MM, 1999, MOL CELL, V4, P309, DOI 10.1016/S1097-2765(00)80333-0; Morrison TB, 1999, J CLIN MICROBIOL, V37, P987, DOI 10.1128/JCM.37.4.987-992.1999; Nguyen TV, 2006, J IMMUNOL, V177, P5990, DOI 10.4049/jimmunol.177.9.5990; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Parent AE, 2004, J HISTOCHEM CYTOCHEM, V52, P959, DOI 10.1369/jhc.4A6277.2004; Parent AE, 2010, J INVEST DERMATOL, V130, P1737, DOI 10.1038/jid.2010.22; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Perez-Losada J, 2003, ONCOGENE, V22, P4205, DOI 10.1038/sj.onc.1206467; Perez-Losada J, 2002, BLOOD, V100, P1274, DOI 10.1182/blood.V100.4.1274.h81602001274_1274_1286; Saito Y, 2008, IMMUNOLOGY, V125, P570, DOI 10.1111/j.1365-2567.2008.02872.x; Shirley SH, 2010, MOL CARCINOGEN, V49, P851, DOI 10.1002/mc.20674; Siggs OM, 2006, CURR OPIN IMMUNOL, V18, P175, DOI 10.1016/j.coi.2006.01.001; SOLEIMANI VD, 2012, SNAIL REGULATES MYOD; Suh HC, 2008, ONCOGENE, V27, P5612, DOI 10.1038/onc.2008.175; Sun Y, 2010, BLOOD, V115, P1709, DOI 10.1182/blood-2009-07-232934; Tan S S, 1992, PCR Methods Appl, V2, P137; Tang SHE, 2002, GENESIS, V32, P199, DOI 10.1002/gene.10030; Tian D, 2010, CELL, V143, P390, DOI 10.1016/j.cell.2010.09.049; Wang SP, 2009, NAT CELL BIOL, V11, P694, DOI 10.1038/ncb1875; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Zhang KJ, 2011, MED ONCOL, V28, pS301, DOI 10.1007/s12032-010-9759-x; Zhuge X, 2005, INT J MOL MED, V15, P945	57	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e69216	10.1371/journal.pone.0069216	http://dx.doi.org/10.1371/journal.pone.0069216			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874916	gold, Green Published, Green Submitted			2022-12-27	WOS:000322064300092
J	Usta, OB; Kim, Y; Ozer, S; Bruinsma, BG; Lee, J; Demir, E; Berendsen, TA; Puts, CF; Izamis, ML; Uygun, K; Uygun, BE; Yarmush, ML				Usta, O. Berk; Kim, Yeonhee; Ozer, Sinan; Bruinsma, Bote G.; Lee, Jungwoo; Demir, Esin; Berendsen, Tim A.; Puts, Catheleyne F.; Izamis, Maria-Louisa; Uygun, Korkut; Uygun, Basak E.; Yarmush, Martin L.			Supercooling as a Viable Non-Freezing Cell Preservation Method of Rat Hepatocytes	PLOS ONE			English	Article							UNIVERSITY-OF-WISCONSIN; SUBZERO NONFREEZING STORAGE; UREA CYCLE ENZYMES; LIVER PRESERVATION; HYPOTHERMIC PRESERVATION; SANDWICH CONFIGURATION; ANTIFREEZE PROTEIN; COLLAGEN SANDWICH; GENE-EXPRESSION; COLD-STORAGE	Supercooling preservation holds the potential to drastically extend the preservation time of organs, tissues and engineered tissue products, and fragile cell types that do not lend themselves well to cryopreservation or vitrification. Here, we investigate the effects of supercooling preservation (SCP at -4 degrees C) on primary rat hepatocytes stored in cryovials and compare its success (high viability and good functional characteristics) to that of static cold storage (CS at +4 degrees C) and cryopreservation. We consider two prominent preservation solutions a) Hypothermosol (HTS-FRS) and b) University of Wisconsin solution (UW) and a range of preservation temperatures (-4 to -10 degrees C). We find that there exists an optimum temperature (-4 degrees C) for SCP of rat hepatocytes which yields the highest viability; at this temperature HTS-FRS significantly outperforms UW solution in terms of viability and functional characteristics (secretions and enzymatic activity in suspension and plate culture). With the HTS-FRS solution we show that the cells can be stored for up to a week with high viability (similar to 56%); moreover we also show that the preservation can be performed in large batches (50 million cells) with equal or better viability and no loss of functionality as compared to smaller batches (1.5 million cells) performed in cryovials.	[Usta, O. Berk] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Engn Med, Boston, MA 02115 USA; Shriners Hosp Children, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Usta, OB (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Engn Med, Boston, MA 02115 USA.	berkusta@gmail.com	Uygun, Korkut/AAH-3950-2020; Demir, Esin/AAN-3842-2020; Usta, Berk/A-5818-2008; Uygun, Basak/I-1792-2012; Berendsen, Tim/AAM-7105-2020	Uygun, Korkut/0000-0003-2088-7860; Demir, Esin/0000-0001-7871-2129; Usta, Berk/0000-0001-9328-568X; Uygun, Basak/0000-0002-2600-7900; Yarmush, Martin/0000-0003-4986-8444; Bruinsma, Bote/0000-0003-1537-4948	NIH [R01DK096075, R01EB008678, R00DK080942, K99DK088962]; Shriners Fellowship [84202]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK096075, K99DK088962, R00DK088962, R00DK080942] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Fellowship; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	NIH #R01DK096075, NIH #R01EB008678, NIH #R00DK080942, NIH #K99DK088962, Shriners Fellowship #84202. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2006, ANN THORAC SURG, V82, P1085, DOI 10.1016/j.athoracsur.2006.03.016; Almada L, 2006, CRYOBIOLOGY, V52, P393, DOI 10.1016/j.cryobiol.2006.02.001; Amir G, 2004, CRYOBIOLOGY, V48, P273, DOI 10.1016/j.crybiol.2004.02.009; Bale JS, 2002, PHILOS T R SOC B, V357, P849, DOI 10.1098/rstb.2002.1074; Boutilier RG, 2001, J EXP BIOL, V204, P3171; Dai J, 2011, J BIOCHEM, V149, P739, DOI 10.1093/jb/mvr030; Dimitrievski K, 2010, COLLOID SURFACE B, V75, P454, DOI 10.1016/j.colsurfb.2009.09.019; DUNN JCY, 1989, FASEB J, V3, P174, DOI 10.1096/fasebj.3.2.2914628; DUNN JCY, 1991, BIOTECHNOL PROGR, V7, P237, DOI 10.1021/bp00009a007; DUNN JCY, 1992, J CELL BIOL, V116, P1043, DOI 10.1083/jcb.116.4.1043; ESCHWEGE P, 1995, TRANSPLANT P, V27, P2514; Fowler A, 2005, ANN NY ACAD SCI, V1066, P119, DOI 10.1196/annals.1363.010; Guarrera JV, 2008, CURR OPIN ORGAN TRAN, V13, P148, DOI 10.1097/MOT.0b013e3282f63930; Guibert EE, 2009, ANN HEPATOL, V8, P129, DOI 10.1016/S1665-2681(19)31791-0; HAZEL JR, 1995, ANNU REV PHYSIOL, V57, P19, DOI 10.1146/annurev.ph.57.030195.000315; Hotamisligil S, 1996, BIOL REPROD, V55, P161, DOI 10.1095/biolreprod55.1.161; Ishine N, 1999, CRYOBIOLOGY, V39, P271, DOI 10.1006/cryo.1999.2205; Jahania MS, 1999, ANN THORAC SURG, V68, P1983, DOI 10.1016/S0003-4975(99)01028-0; Kim JS, 1999, TRANSPLANTATION, V68, P938, DOI 10.1097/00007890-199910150-00007; Li X, 2011, ACT MECH PROTOCATECH, V7, P232; Margesin R, 2007, NATURWISSENSCHAFTEN, V94, P77, DOI 10.1007/s00114-006-0162-6; MATHIAS SF, 1985, CRYOBIOLOGY, V22, P537, DOI 10.1016/0011-2240(85)90030-6; Matsuda H, 1997, TRANSPLANT P, V29, P3466, DOI 10.1016/S0041-1345(97)01107-X; Matsuda H, 1999, TRANSPLANTATION, V67, P186, DOI 10.1097/00007890-199901150-00032; Matsumoto N, 2002, BONE MARROW TRANSPL, V30, P777, DOI 10.1038/sj.bmt.1703692; Meng Q, 2003, BIOTECHNOL PROGR, V19, P1118, DOI 10.1021/bp025628n; Monzen K, 2005, BIOCHEM BIOPH RES CO, V337, P534, DOI 10.1016/j.bbrc.2005.09.082; Ostrowska A, 2009, ARCH TOXICOL, V83, P493, DOI 10.1007/s00204-009-0419-x; Pless-Petig G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040444; RASMUSSEN DH, 1975, CRYOBIOLOGY, V12, P328, DOI 10.1016/0011-2240(75)90006-1; Rauen U, 1997, HEPATOLOGY, V26, P351, DOI 10.1002/hep.510260215; Rodriguez JV, 2009, EVOLUTION; Rubinsky B, 2003, HEART FAIL REV, V8, P277, DOI 10.1023/A:1024734003814; Russotti G, 1996, CRYOBIOLOGY, V33, P567, DOI 10.1006/cryo.1996.0060; SALT RW, 1961, ANNU REV ENTOMOL, V6, P55, DOI 10.1146/annurev.en.06.010161.000415; Scotte M, 1996, CRYOBIOLOGY, V33, P54, DOI 10.1006/cryo.1996.0006; Serrar H, 1999, LIVER TRANSPLANT SUR, V5, P119, DOI 10.1002/lt.500050213; Soltys KA, 2001, J SURG RES, V96, P30, DOI 10.1006/jsre.2000.6053; SOUTHARD JH, 1995, ANNU REV MED, V46, P235; Stoll C, 2011, MOL MEMBR BIOL, V28, P454, DOI 10.3109/09687688.2011.622304; Stoll C, 2011, TRANSFUS MED HEMOTH, V38, P89, DOI 10.1159/000326900; Stoll C, 2011, BBA-BIOMEMBRANES, V1808, P474, DOI 10.1016/j.bbamem.2010.09.012; Toledo-Pereyra L. H., 2010, ORGAN PRESERVATION T; Tsvetkova NM, 2002, P NATL ACAD SCI USA, V99, P13504, DOI 10.1073/pnas.192468399; WANG TC, 1991, CRYOBIOLOGY, V28, P171, DOI 10.1016/0011-2240(91)90019-K; Whyte JJ, 2000, CRIT REV TOXICOL, V30, P347, DOI 10.1080/10408440091159239; Zavos M, 1981, EXP ANIM, V505, P497; ZAVOS PM, 1983, CRYOBIOLOGY, V20, P553, DOI 10.1016/0011-2240(83)90043-3	48	25	30	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e69334	10.1371/journal.pone.0069334	http://dx.doi.org/10.1371/journal.pone.0069334			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874947	Green Published, gold, Green Submitted			2022-12-27	WOS:000322064300098
J	Tang, J; Lee, CA; Du, YP; Sun, Y; Pearlman, E; Sheibani, N; Kern, TS				Tang, Jie; Lee, Chieh Allen; Du, Yunpeng; Sun, Yan; Pearlman, Eric; Sheibani, Nader; Kern, Timothy S.			MyD88-Dependent Pathways in Leukocytes Affect the Retina in Diabetes	PLOS ONE			English	Article							TACTILE ALLODYNIA; MOUSE MODEL; RETINOPATHY; DEGENERATION; PATHOGENESIS; INFLAMMATION; CAPILLARIES	Background: Previous studies by us and other have provided evidence that leukocytes play a critical role in the development of diabetic retinopathy, suggesting a possible role of the innate immune system in development of the retinopathy. Since MyD88 is a convergence point for signaling pathways of the innate immune system (including Toll-Like Receptors (TLRs) and interleukin-1 beta (IL-1 beta)), the purpose of this study was to assess the role of MyD88 and its dependent pathways on abnormalities that develop in retina and white blood cells related to diabetic retinopathy. Methods: C57BL/6J mice were made diabetic with streptozotocin. Chimeric mice were generated in which MyD88-dependent pathways were deleted from bone marrow-derived only. Mice were sacrificed at 2 mos of diabetes for assessment of, leukostasis, albumin accumulation in neural retina, leukocyte-mediated killing of retinal endothelial cells, and cytokine/chemokine generation by retinas of diabetic mice in response to TLR agonists, Results: IL-6 and CXCL1 were generated in retinas from diabetic (but not nondiabetic mice) following incubation with Pam3CysK/TLR2, but incubation with other TLR ligands or IL-1 beta did not induce cytokine production in retinas from nondiabetic or diabetic mice. Diabetes-induced abnormalities (leukostasis, ICAM-1 expression on the luminal surface of the vascular endothelium, retinal superoxide generation) were significantly inhibited by removing either MyD88 or the signaling pathways regulated by it (TLRs 2 and 4, and IL-1 beta) from bone marrow-derived cells only. Leukocyte-mediated killing of endothelial cells tended to be decreased in the marrow-derived cells lacking TLR2/4, but the killing was significantly exacerbated if the marrow cells lacked MyD88 or the receptor for IL-1 beta (IL-1 beta r). Conclusions: MyD88-dependent pathways play an important role in the development of diabetes-induced inflammation in the retina, and inhibition of MyD88 might be a novel target to inhibit early abnormalities of diabetic retinopathy and other complications of diabetes.	[Tang, Jie; Lee, Chieh Allen; Du, Yunpeng; Kern, Timothy S.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Sun, Yan; Pearlman, Eric] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Sheibani, Nader] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Madison, WI USA; [Kern, Timothy S.] Stokes Vet Adm Med Ctr, Cleveland, OH USA	Case Western Reserve University; Case Western Reserve University; University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Kern, TS (corresponding author), Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA.	tsk@case.edu	Sheibani, Nader/AAG-2379-2020	Sheibani, Nader/0000-0003-2723-9217	National Institute of Health [EY000300]; Medical Research Service of the Department of Veterans Affairs; Case Western Reserve University Visual Science Research Center core facility [P30EY11373]; NATIONAL EYE INSTITUTE [R01EY000300, R56EY000300, P30EY011373] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Service of the Department of Veterans Affairs(US Department of Veterans Affairs); Case Western Reserve University Visual Science Research Center core facility; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by National Institute of Health EY000300 and the Medical Research Service of the Department of Veterans Affairs. Support was also provided by the Case Western Reserve University Visual Science Research Center core facility (P30EY11373). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamis AP, 2008, SEMIN IMMUNOPATHOL, V30, P65, DOI 10.1007/s00281-008-0111-x; Du YP, 2003, FREE RADICAL BIO MED, V35, P1491, DOI 10.1016/j.freeradbiomed.2003.08.018; Du YP, 2010, INVEST OPHTH VIS SCI, V51, P2158, DOI 10.1167/iovs.09-3674; Gubitosi-Klug RA, 2008, DIABETES, V57, P1387, DOI 10.2337/db07-1217; Joussen AM, 2004, FASEB J, V18, P1450, DOI 10.1096/fj.03-1476fje; KAUL K, 2010, CURR DIABETES REV; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kern TS, 2010, MOL VIS, V16, P1629; Kern TS, 2007, EXP DIABETES RES, DOI 10.1155/2007/95103; Kern TS, 2007, DIABETES, V56, P373, DOI 10.2337/db05-1621; Li GY, 2012, DIABETES, V61, P3294, DOI 10.2337/db11-1249; Li GY, 2011, MOL VIS, V17, P3156; Su XJ, 2003, MOL VIS, V9, P171; Talahalli R, 2013, J LEUKOCYTE BIOL, V93, P135, DOI 10.1189/jlb.0112025; Talahalli R, 2010, INVEST OPHTH VIS SCI, V51, P1699, DOI 10.1167/iovs.09-3557; Tang DL, 2012, IMMUNOL REV, V249, P158, DOI 10.1111/j.1600-065X.2012.01146.x; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; Zheng L, 2007, DIABETOLOGIA, V50, P1987, DOI 10.1007/s00125-007-0734-9	18	39	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e68871	10.1371/journal.pone.0068871	http://dx.doi.org/10.1371/journal.pone.0068871			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874797	Green Submitted, gold, Green Published			2022-12-27	WOS:000322218800049
J	Gangaas, KE; Kaltenborn, BP; Andreassen, HP				Gangaas, Kristin E.; Kaltenborn, Bjorn P.; Andreassen, Harry P.			Geo-Spatial Aspects of Acceptance of Illegal Hunting of Large Carnivores in Scandinavia	PLOS ONE			English	Article							LYNX LYNX-LYNX; HUMAN DENSITIES; DOMESTIC SHEEP; NATIONAL-PARK; URSUS-ARCTOS; CANIS-LUPUS; ATTITUDES; WOLVES; CONFLICT; WOLF	Human-carnivore conflicts are complex and are influenced by: the spatial distribution of the conflict species; the organisation and intensity of management measures such as zoning; historical experience with wildlife; land use patterns; and local cultural traditions. We have used a geographically stratified sampling of social values and attitudes to provide a novel perspective to the human - wildlife conflict. We have focused on acceptance by and disagreements between residents (measured as Potential Conflict Index; PCI) towards illegal hunting of four species of large carnivores (bear, lynx, wolf, wolverine). The study is based on surveys of residents in every municipality in Sweden and Norway who were asked their opinion on illegal hunting. Our results show how certain social values are associated with acceptance of poaching, and how these values differ geographically independent of carnivore abundance. Our approach differs from traditional survey designs, which are often biased towards urban areas. Although these traditional designs intend to be representative of a region (i.e. a random sample from a country), they tend to receive relatively few respondents from rural areas that experience the majority of conflict with carnivores. Acceptance of poaching differed significantly between Norway (12.7-15.7% of respondents) and Sweden (3.3-4.1% of respondents). We found the highest acceptance of illegal hunting in rural areas with free-ranging sheep and strong hunting traditions. Disagreements between residents (as measured by PCI) were highest in areas with intermediate population density. There was no correlation between carnivore density and either acceptance of illegal hunting or PCI. A strong positive correlation between acceptance of illegal hunting and PCI showed that areas with high acceptance of illegal hunting are areas with high potential conflict between people. Our results show that spatially-stratified surveys are required to reveal the large scale patterns in social dynamics of human-wildlife conflicts.	[Gangaas, Kristin E.; Andreassen, Harry P.] Hedmark Univ Coll, Fac Appl Ecol & Agr Sci, Koppang, Norway; [Kaltenborn, Bjorn P.] Norwegian Inst Nat Res, Lillehammer, Norway	Inland Norway University of Applied Sciences; Norwegian Institute Nature Research	Andreassen, HP (corresponding author), Hedmark Univ Coll, Fac Appl Ecol & Agr Sci, Campus Evenstad, Koppang, Norway.	kristin.gangas@hihm.no		Mathiesen, Kristin Evensen/0000-0002-3276-1088	Hedmark University College	Hedmark University College	The project was funded by the authors (Hedmark University College). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andren H, 2006, BIOL CONSERV, V131, P23, DOI 10.1016/j.biocon.2006.01.025; [Anonymous], 1999, CRONBACHS ALPHA A TO; Barnes RFW, 1999, MAMMAL REV, V29, P175, DOI 10.1046/j.1365-2907.1999.00044.x; Basille M, 2009, ECOGRAPHY, V32, P683, DOI 10.1111/j.1600-0587.2009.05712.x; Bisi J, 2007, EUR J WILDLIFE RES, V53, P304, DOI 10.1007/s10344-007-0092-4; Bjerke T, 1998, SOC NATUR RESOUR, V11, P169, DOI 10.1080/08941929809381070; Bjerke T, 1999, J ENVIRON PSYCHOL, V19, P415, DOI 10.1006/jevp.1999.0135; Breitenmoser U, 1998, BIOL CONSERV, V83, P279, DOI 10.1016/S0006-3207(97)00084-0; Chapron G, 2008, J APPL ECOL, V45, P1667, DOI 10.1111/j.1365-2664.2008.01538.x; Dahle B, 1998, WILDLIFE BIOL, V4, P147, DOI 10.2981/wlb.1998.017; Damania R, 2005, P ROY SOC B-BIOL SCI, V272, P259, DOI 10.1098/rspb.2004.2945; Dar NI, 2009, BIOL CONSERV, V142, P2076, DOI 10.1016/j.biocon.2009.04.003; Eliason S., 1999, HUM DIMENS WILDL, V4, P27, DOI [10.1080/10871209909359149, DOI 10.1080/10871209909359149]; Ericsson G, 2008, SOC NATUR RESOUR, V21, P294, DOI 10.1080/08941920701861266; Fascione N, 2004, PEOPLE AND PREDATORS, Vxvi; Hazzah L, 2009, BIOL CONSERV, V142, P2428, DOI 10.1016/j.biocon.2009.06.006; Heberlein TA, 2008, WILDLIFE BIOL, V14, P391, DOI 10.2981/0909-6396(2008)14[391:PAATFO]2.0.CO;2; Hedmark E, 2006, CONSERVATION GENETIC; Hilborn R, 2006, SCIENCE, V314, P1266, DOI 10.1126/science.1132780; Kaltenborn BP, 2006, BIODIVERS CONSERV, V15, P4633, DOI 10.1007/s10531-005-6196-9; Karlsson J, 2010, J APPL ECOL, V47, P166, DOI 10.1111/j.1365-2664.2009.01747.x; Krange O, 2012, HOLDINGER TIL STORE; Lagendijk DDG, 2008, ENVIRON MANAGE, V42, P971, DOI 10.1007/s00267-008-9204-5; Liberg O, 2011, PROC R SOC B; Liberg O, 2012, P ROY SOC B-BIOL SCI, V279, P910, DOI 10.1098/rspb.2011.1275; Linnell JDC, 2001, ANIM CONSERV, V4, P345, DOI 10.1017/S1367943001001408; Linnell JDC, 2007, WILDLIFE BIOL, V13, P447, DOI 10.2981/0909-6396(2007)13[447:DRFMCO]2.0.CO;2; Linnell JDC, 2010, ENVIRON MANAGE, V45, P1142, DOI 10.1007/s00267-010-9455-9; Majic A, 2010, BIOL CONSERV, V143, P255, DOI 10.1016/j.biocon.2009.09.010; Manfredo MJ, 2003, RES HUMAN DIMENSIONS, V8, P219; Marucco F, 2010, J APPL ECOL, V47, P789, DOI 10.1111/j.1365-2664.2010.01831.x; May R, 2008, J APPL ECOL, V45, P1382, DOI 10.1111/j.1365-2664.2008.01527.x; Mayer CC, 2001, J ECOTOURISM, V6, P91; Muth RM, 1998, SOC NATUR RESOUR, V11, P9, DOI 10.1080/08941929809381058; Naughton-Treves L, 2003, CONSERV BIOL, V17, P1500, DOI 10.1111/j.1523-1739.2003.00060.x; Nyhus PJ, 2004, ORYX, V38, P68, DOI 10.1017/S0030605304000110; Odden J, 2002, J WILDLIFE MANAGE, V66, P98, DOI 10.2307/3802876; Persson J, 2009, BIOL CONSERV, V142, P325, DOI 10.1016/j.biocon.2008.10.028; Randi E, 2011, MAMMAL REV, V41, P99, DOI 10.1111/j.1365-2907.2010.00176.x; Roskaft E, 2003, EVOL HUM BEHAV, V24, P184, DOI 10.1016/S1090-5138(03)00011-4; Roskaft E, 2007, WILDLIFE BIOL, V13, P172, DOI 10.2981/0909-6396(2007)13[172:HATLCI]2.0.CO;2; Sagor JT, 1997, BIOL CONSERV, V81, P91, DOI 10.1016/S0006-3207(96)00165-6; Sexton NR, 2005, 200513GEOL SURV; Skogen K, 2001, RURAL SOCIOL, V66, P203, DOI 10.1111/j.1549-0831.2001.tb00064.x; Skogen K, 2003, SOCIOLOGIA RURALIS, V43; Skogen K, 2008, RURAL SOCIOL, V73, P105, DOI 10.1526/003601108783575916; Teel TL, 2010, CONSERV BIOL, V24, P128, DOI 10.1111/j.1523-1739.2009.01374.x; Thornton Clarisse, 2009, Human-Wildlife Conflicts, V3, P282; Treves A, 2011, SOC NATUR RESOUR, V24, P984, DOI 10.1080/08941920.2011.559654; Vaske JJ, 2006, WILDLIFE SOC B, V34, P44, DOI 10.2193/0091-7648(2006)34[44:PFCIHR]2.0.CO;2; Vaske JJ, 2010, LEISURE SCI, V32, P240, DOI 10.1080/01490401003712648; Vatn S, 2009, SMALL RUMINANT RES, V86, P80, DOI 10.1016/j.smallrumres.2009.09.023; Wikramanayake ED, 1998, CONSERV BIOL, V12, P865, DOI 10.1046/j.1523-1739.1998.96428.x; Woodroffe R, 2000, ANIM CONSERV, V3, P165, DOI 10.1111/j.1469-1795.2000.tb00241.x; Woodroffe R, 2005, PEOPLE WILDLIFE CONF, VXVII; Zuur Alain F., 2009, P1	56	57	58	3	127	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e68849	10.1371/journal.pone.0068849	http://dx.doi.org/10.1371/journal.pone.0068849			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	188BY	23894353	gold, Green Published			2022-12-27	WOS:000322167900028
J	Reed, K; Wood, C; Barton, J; Pretty, JN; Cohen, D; Sandercock, GRH				Reed, Katharine; Wood, Carly; Barton, Jo; Pretty, Jules N.; Cohen, Daniel; Sandercock, Gavin R. H.			A Repeated Measures Experiment of Green Exercise to Improve Self-Esteem in UK School Children	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; PERCEIVED EXERTION; MENTAL-HEALTH; PROMOTION; EDUCATION; PEOPLE; STATE; MOOD	Exercising in natural, green environments creates greater improvements in adult's self-esteem than exercise undertaken in urban or indoor settings. No comparable data are available for children. The aim of this study was to determine whether so called 'green exercise' affected changes in self-esteem; enjoyment and perceived exertion in children differently to urban exercise. We assessed cardiorespiratory fitness (20 m shuttle-run) and self-reported physical activity (PAQ-A) in 11 and 12 year olds (n = 75). Each pupil completed two 1.5 mile timed runs, one in an urban and another in a rural environment. Trials were completed one week apart during scheduled physical education lessons allocated using a repeated measures design. Self-esteem was measured before and after each trial, ratings of perceived exertion (RPE) and enjoyment were assessed after completing each trial. We found a significant main effect (F (1,74), = 12.2, p<0.001), for the increase in self-esteem following exercise but there was no condition by exercise interaction (F (1,74), = 0.13, p = 0.72). There were no significant differences in perceived exertion or enjoyment between conditions. There was a negative correlation (r = -0.26, p = 0.04) between habitual physical activity and RPE during the control condition, which was not evident in the green exercise condition (r = -0.07, p = 0.55). Contrary to previous studies in adults, green exercise did not produce significantly greater increases in self-esteem than the urban exercise condition. Green exercise was enjoyed more equally by children with differing levels of habitual physical activity and has the potential to engage less active children in exercise.	[Reed, Katharine; Wood, Carly; Barton, Jo; Pretty, Jules N.; Sandercock, Gavin R. H.] Univ Essex, Sch Biol Sci, Colchester CO4 3SQ, Essex, England; [Cohen, Daniel] Univ Santander, Escuela Med, Inst Invest, Santander, Colombia	University of Essex; Universidad Industrial de Santander	Wood, C (corresponding author), Univ Essex, Sch Biol Sci, Colchester CO4 3SQ, Essex, England.	cjwood@essex.ac.uk	Pretty, Jules/D-4071-2012	Barton, Jo/0000-0003-3548-9478; Pretty, Jules/0000-0002-3897-6581; Sandercock, Gavin/0000-0002-5443-6518; Wood, Carly/0000-0003-1723-552X				[Anonymous], 2007, NATURAL THINKING INV; Bagley C, 2001, INT J ADOLESCENCE YO, V9, P117, DOI [10.1080/02673843.2001.9747871, DOI 10.1080/02673843.2001.9747871]; Barton J, 2010, ENVIRON SCI TECHNOL, V44, P3947, DOI 10.1021/es903183r; Berger BG, 2000, J APPL SPORT PSYCHOL, V12, P69, DOI 10.1080/10413200008404214; Biddle SJH, 2004, J SPORT SCI, V22, P679, DOI 10.1080/02640410410001712412; BORG GAV, 1973, MED SCI SPORT EXER, V5, P90; Bouchard C, 2001, MED SCI SPORT EXER, V33, pS446, DOI 10.1097/00005768-200106001-00013; Bowler DE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/147-2458-10-456; Bratman GN, 2012, ANN NY ACAD SCI, V1249, P118, DOI 10.1111/j.1749-6632.2011.06400.x; Coon JT, 2011, J EPIDEMIOL COMMUN H, V65, pA38, DOI 10.1136/jech.2011.143586.85; Crocker P.R.E., 2004, DEV SPORT EXERCISE P, P197; Department for Children Schools and Families and Department for Culture Media and Sport, 2008, THE PLAY STRATEGY; Deslandes A, 2009, NEUROPSYCHOBIOLOGY, V59, P191, DOI 10.1159/000223730; Ekeland E, 2004, Cochrane Database Syst Rev.; Green H., 2005, MENTAL HEALTH OF CHI; Gruber J, 1986, EFFECTS PHYS ACTIVIT, P330; Hansen CJ, 2001, HEALTH PSYCHOL, V20, P267, DOI 10.1037//0278-6133.20.4.267; HEATHERTON TF, 1991, J PERS SOC PSYCHOL, V60, P895, DOI 10.1037/0022-3514.60.6.895; Jensen K, 1999, J SPORT SCI, V17, P945, DOI 10.1080/026404199365335; Kimball J, 2009, EUR PHYS EDUC REV, V15, P249, DOI 10.1177/1356336X09345226; Kowalski KC, 1997, PEDIATR EXERC SCI, V9, P342, DOI 10.1123/pes.9.4.342; LaCaille RA, 2004, PSYCHOL SPORT EXERC, V5, P461, DOI 10.1016/S1469-0292(03)00039-6; Maas J, 2006, J EPIDEMIOL COMMUN H, V60, P587, DOI 10.1136/jech.2005.043125; Maller C, 2006, HEALTH PROMOT INT, V21, P45, DOI 10.1093/heapro/dai032; MARGARIA R, 1963, J APPL PHYSIOL, V18, P367, DOI 10.1152/jappl.1963.18.2.367; Meredith MD, 2004, FITNESSGRAM ACTIVITY, P59; Natural England, 2009, CHILDHOOD AND NATURE; NHS Information Centre, 2011, HEALTH SURVEY FOR EN; Office for National Statistics, 2007, ENGLISH INDICES DEPR; Pretty J, 2005, INT J ENVIRON HEAL R, V15, P319, DOI 10.1080/09603120500155963; Pretty J, 2009, NATURE CHILDHOOD AND; Rees DI, 2010, J MENT HEALTH POLICY, V13, P13; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Sallis JF, 1999, HEALTH PSYCHOL, V18, P410, DOI 10.1037/0278-6133.18.4.410; Voss C, 2009, PEDIATR EXERC SCI, V21, P55, DOI 10.1123/pes.21.1.55; Wallhead TL, 2004, QUEST, V56, P285, DOI 10.1080/00336297.2004.10491827; Watson AC, 2007, SCHIZOPHRENIA BULL, V33, P1312, DOI 10.1093/schbul/sbl076; Wells NM, 2000, ENVIRON BEHAV, V32, P775, DOI 10.1177/00139160021972793; Wells NM, 2003, ENVIRON BEHAV, V35, P311, DOI 10.1177/0013916503035003001	40	31	32	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69176	10.1371/journal.pone.0069176	http://dx.doi.org/10.1371/journal.pone.0069176			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	188BY	23894426	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000322167900043
J	Kirkbride-Smith, AE; Wheeler, PM; Johnson, ML				Kirkbride-Smith, Anne E.; Wheeler, Philip M.; Johnson, Magnus L.			The Relationship between Diver Experience Levels and Perceptions of Attractiveness of Artificial Reefs - Examination of a Potential Management Tool	PLOS ONE			English	Article							MARINE PROTECTED AREAS; DIVING IMPACTS; CORAL-REEFS; SCUBA-DIVERS; TOURISM; DAMAGE; EILAT; SPECIALIZATION; CONSERVATION; BRIEFINGS	Artificial reefs are increasingly used worldwide as a method for managing recreational diving since they have the potential to satisfy both conservation goals and economic interests. In order to help maximize their utility, further information is needed to drive the design of stimulating resources for scuba divers. We used a questionnaire survey to explore divers' perceptions of artificial reefs in Barbados. In addition, we examined reef resource substitution behaviour among scuba divers. Divers expressed a clear preference for large shipwrecks or sunken vessels that provided a themed diving experience. Motives for diving on artificial reefs were varied, but were dominated by the chance of viewing concentrated marine life, increased photographic opportunities, and the guarantee of a 'good dive'. Satisfaction with artificial reef diving was high amongst novices and declined with increasing experience. Experienced divers had an overwhelming preference for natural reefs. As a management strategy, our results emphasize the capacity of well designed artificial reefs to contribute towards the management of coral reef diving sites and highlight a number of important areas for future research. Suggested work should validate the present findings in different marine tourism settings and ascertain support of artificial reefs in relationship to level of diver specialization.	[Kirkbride-Smith, Anne E.; Wheeler, Philip M.; Johnson, Magnus L.] Univ Hull, Ctr Environm & Marine Sci, Scarborough, N Yorkshire, England	University of Hull	Kirkbride-Smith, AE (corresponding author), Univ Hull, Ctr Environm & Marine Sci, Scarborough, N Yorkshire, England.	A.Kirkbride-Smith@2009.hull.ac.uk		Wheeler, Philip/0000-0002-2056-6605				Agace L, 2005, BARBADOS DIVE GUIDE; Baine M, 2001, OCEAN COAST MANAGE, V44, P241, DOI 10.1016/S0964-5691(01)00048-5; Barbados Government Information Service, 2009, ART COR LINK LOC EC; Barbados Statistical Service, 2010, BARB POP HOUS CENS 2; Barker NHL, 2004, BIOL CONSERV, V120, P481, DOI 10.1016/j.biocon.2004.03.021; Belle N., 2005, Journal of Travel Research, V44, P32, DOI 10.1177/0047287505276589; Blout S., 1981, ARTIFICIAL REEFS C P, P72; BROCK RE, 1989, B MAR SCI, V44, P934; BRYAN H, 1977, J LEISURE RES, V9, P174, DOI 10.1080/00222216.1977.11970328; Burke L., 2004, REEFS RISK CARIBBEAN; Burke L., 2002, REEFS RISK SE ASIA; Burke L., 2011, REEFS RISK REVISITED; Camp E, 2012, OCEAN COAST MANAGE, V61, P30, DOI 10.1016/j.ocecoaman.2012.02.002; Caribbean Tourism Organization, 2012, ARR MAIN MARK LAT ST; Chapman MR, 1999, MAR ECOL PROG SER, V181, P81, DOI 10.3354/meps181081; Dearden P, 2007, COAST MANAGE, V35, P305, DOI 10.1080/08920750601169584; Dearden P, 2006, ENVIRON CONSERV, V33, P353, DOI 10.1017/S0376892906003419; Dearden P, 2011, DISAPPEARING DESTINATIONS: CLIMATE CHANGE AND FUTURE CHALLENGES FOR COASTAL TOURISM, P144, DOI 10.1079/9781845935481.0144; Dharmaratne G. S., 1998, Journal of Travel Research, V37, P138, DOI 10.1177/004728759803700205; DITTON RB, 1992, J LEISURE RES, V24, P33, DOI 10.1080/00222216.1992.11969870; Ditton RB, 2002, ICES J MAR SCI, V59, pS186, DOI 10.1006/jmsc.2002.1188; Dowling RK, 2001, ANN TOURISM RES, V28, P226, DOI 10.1016/S0160-7383(00)00019-0; Edgar GJ, 2011, AQUAT CONSERV, V21, P313, DOI 10.1002/aqc.1187; Edney J., 2012, Tourism in Marine Environments, V8, P7, DOI 10.3727/154427312X13262430523983; Fitzsimmons C, 2009, TOURISM MARINE ENV, V5, P159; Ghazali Musa, 2005, Tourism in Marine Environments, V2, P89, DOI 10.3727/154427306779436273; Harriott V, 1997, AMBIO, V26, P173; Hasler H, 2008, MAR POLLUT BULL, V56, P1788, DOI 10.1016/j.marpolbul.2008.06.002; Hawkins JP, 2005, COAST MANAGE, V33, P373, DOI 10.1080/08920750500217518; Hawkins JP, 1999, CONSERV BIOL, V13, P888, DOI 10.1046/j.1523-1739.1999.97447.x; Hawkins Julie P., 1997, P1923; Hime SP, 2008, THESIS U E ANGLIA UK; Johns GM., 2001, REPORT PREPARED BROW; Johns GM., 2004, SOCIOECONOMIC STUDY; Leeworthy VR, 2006, B MAR SCI, V78, P29; McCool S, 1998, P LIM ACC CHANG REL; Medio D, 1997, BIOL CONSERV, V79, P91, DOI 10.1016/S0006-3207(96)00074-2; Milton JW, 1989, B MAR SCI, V44, P853; Musa G., 2002, Tourism Geographies, V4, P195, DOI 10.1080/14616680210124927; Oh CO, 2008, SOC NATUR RESOUR, V21, P455, DOI 10.1080/08941920701681953; Ong TF, 2011, CURR ISSUES TOUR, V1, P1; PADI Worldwide Certification, 2012, STATISTICS; Pendleton LH, 2005, MAR TECHNOL SOC J, V39, P47, DOI 10.4031/002533205787443944; Polak O, 2012, OCEAN COAST MANAGE, V55, P94, DOI 10.1016/j.ocecoaman.2011.10.006; Roberts L., 1994, RECENT ADV MARINE SC, P695; Rouphael A. B., 2007, Journal of Sustainable Tourism, V15, P91, DOI 10.2167/jost611.0; Rouphael AB, 1997, BIOL CONSERV, V82, P329, DOI 10.1016/S0006-3207(97)00047-5; Rouphael AB, 2002, ECOL APPL, V12, P427, DOI 10.1890/1051-0761(2002)012[0427:ISATVI]2.0.CO;2; Rouphael AB, 2001, BIOL CONSERV, V100, P281, DOI 10.1016/S0006-3207(01)00032-5; Rudd MA, 2002, COAST MANAGE, V30, P133, DOI 10.1080/089207502753504670; Schleyer MH, 2000, B MAR SCI, V67, P1025; Schuhmann P, 2008, P 11 INT COR REEF S, P1149; Schuhmann PW, 2010, EC VALUE COASTAL RES; Shafer CS, 2000, ENVIRON MANAGE, V26, P73, DOI 10.1007/s002670010072; Shani A, 2011, TOURISM GEOGR, V1, P1; Sorice MG, 2007, AMBIO, V36, P316, DOI 10.1579/0044-7447(2007)36[316:MSDTME]2.0.CO;2; STANLEY DR, 1989, B MAR SCI, V44, P767; Stolk P, 2005, ANN LEIS RES, V8, P153, DOI 10.1080/11745398.2005.10600968; Tabata R. S., 1992, Special interest tourism., P171; Tratalos JA, 2001, BIOL CONSERV, V102, P67, DOI 10.1016/S0006-3207(01)00085-4; Uyarra M, 2009, ENVIRON MANAGE, V43, P1, DOI 10.1007/s00267-008-9198-z; Uyarra MC, 2005, ENVIRON CONSERV, V32, P11, DOI 10.1017/S0376892904001808; Van Treeck P., 2008, NEW FRONTIERS MARINE, P153; Walters RDM, 2001, BIODIVERS CONSERV, V10, P2167, DOI 10.1023/A:1013197926580; Wells S, 2006, CONSERV BIOL SER, P314; Wilhelmsson D, 1998, AMBIO, V27, P764; Williams ID, 2000, ENVIRON CONSERV, V27, P382, DOI 10.1017/S0376892900000436; Worachananant S, 2008, J SUSTAIN TOUR, V16, P645, DOI [10.2167/jost771.0, 10.1080/09669580802159677]; Zakai D, 2002, BIOL CONSERV, V105, P179, DOI 10.1016/S0006-3207(01)00181-1	69	38	39	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e68899	10.1371/journal.pone.0068899	http://dx.doi.org/10.1371/journal.pone.0068899			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	228SX	23894372	gold, Green Submitted, Green Published			2022-12-27	WOS:000325211000057
J	Fraser, CI; Zuccarello, GC; Spencer, HG; Salvatore, LC; Garcia, GR; Waters, JM				Fraser, Ceridwen I.; Zuccarello, Giuseppe C.; Spencer, Hamish G.; Salvatore, Laura C.; Garcia, Gabriella R.; Waters, Jonathan M.			Genetic Affinities between Trans-Oceanic Populations of Non-Buoyant Macroalgae in the High Latitudes of the Southern Hemisphere	PLOS ONE			English	Article							LONG-DISTANCE DISPERSAL; STICTOSIPHONIA HOOKERI RHODOMELACEAE; MARINE-ENVIRONMENT; NOV PHAEOPHYCEAE; NEW-ZEALAND; KELP; RHODOPHYTA; PHYLOGENIES; ECOLOGY; ICE	Marine biologists and biogeographers have long been puzzled by apparently non-dispersive coastal taxa that nonetheless have extensive transoceanic distributions. We here carried out a broad-scale phylogeographic study to test whether two widespread Southern Hemisphere species of non-buoyant littoral macroalgae are capable of long-distance dispersal. Samples were collected from along the coasts of southern Chile, New Zealand and several subAntarctic islands, with the focus on high latitude populations in the path of the Antarctic Circumpolar Current or West Wind Drift. We targeted two widespread littoral macroalgal species: the brown alga Adenocystis utricularis (Ectocarpales, Heterokontophyta) and the red alga Bostrychia intricata (Ceramiales, Rhodophyta). Phylogenetic analyses were performed using partial mitochondrial (COI), chloroplast (rbcL) and ribosomal nuclear (LSU / 28S) DNA sequence data. Numerous deeply-divergent clades were resolved across all markers in each of the target species, but close phylogenetic relationships - even shared haplotypes - were observed among some populations separated by large oceanic distances. Despite not being particularly buoyant, both Adenocystis utricularis and Bostrychia intricata thus show genetic signatures of recent dispersal across vast oceanic distances, presumably by attachment to floating substrata such as wood or buoyant macroalgae.	[Fraser, Ceridwen I.; Spencer, Hamish G.; Waters, Jonathan M.] Univ Otago, Dept Zool, Allan Wilson Ctr Mol Ecol & Evolut, Dunedin, New Zealand; [Zuccarello, Giuseppe C.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Salvatore, Laura C.; Garcia, Gabriella R.] Univ Otago, Dept Zool, Dunedin, New Zealand	University of Otago; Victoria University Wellington; University of Otago	Fraser, CI (corresponding author), Univ Otago, Dept Zool, Allan Wilson Ctr Mol Ecol & Evolut, POB 56, Dunedin, New Zealand.	ceridwen.fraser@gmail.com	Spencer, Hamish G/B-9637-2008; Zuccarello, Giuseppe C./D-8323-2015; Waters, Jon/B-4983-2009	Spencer, Hamish G/0000-0001-7531-597X; Zuccarello, Giuseppe C./0000-0003-0028-7227; Waters, Jon/0000-0002-1514-7916; Fraser, Ceridwen/0000-0002-6918-8959	New Zealand Marsden [07-UOO-099]; Department of Zoology; University of Otago; CIF; Shackleton Scholarship; Allan Wilson Centre for Molecular Ecology and Evolution; Australian Antarctic Division AAS project [2914]	New Zealand Marsden(Royal Society of New ZealandMarsden Fund (NZ)); Department of Zoology; University of Otago; CIF; Shackleton Scholarship; Allan Wilson Centre for Molecular Ecology and Evolution; Australian Antarctic Division AAS project	This work was funded by New Zealand Marsden contract 07-UOO-099, Department of Zoology and University of Otago Research grants to JMW and CIF; a Shackleton Scholarship to CIF; an Allan Wilson Centre for Molecular Ecology and Evolution postdoctoral grant to CIF; Australian Antarctic Division AAS project #2914. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asensi A, 2004, POLAR BIOL, V28, P82, DOI 10.1007/s00300-004-0650-0; Boedeker C, 2010, PHYCOLOGIA, V49, P525, DOI 10.2216/09-98.1; Censky EJ, 1998, NATURE, V395, P556, DOI 10.1038/26886; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Collins CJ, 2010, MOL ECOL, V19, P4572, DOI 10.1111/j.1365-294X.2010.04842.x; Donald KM, 2005, EVOLUTION, V59, P1701, DOI 10.1554/04-553.1; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Foighil DO, 1999, BIOL BULL-US, V196, P122, DOI 10.2307/1542557; Fraser Ceridwen I., 2012, Papers and Proceedings of the Royal Society of Tasmania, V146, P89; Fraser CI, 2012, TRENDS ECOL EVOL, V27, P462, DOI 10.1016/j.tree.2012.04.011; Fraser CI, 2011, P ROY SOC B-BIOL SCI, V278, P649, DOI 10.1098/rspb.2010.1117; Fraser CI, 2010, MOL PHYLOGENET EVOL, V57, P1301, DOI 10.1016/j.ympev.2010.10.011; Fraser CI, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-203; Fraser CI, 2009, P NATL ACAD SCI USA, V106, P3249, DOI 10.1073/pnas.0810635106; Fu YX, 1997, GENETICS, V147, P915; Gillespie RG, 2012, TRENDS ECOL EVOL, V27, P47, DOI 10.1016/j.tree.2011.08.009; Gonzalez-Wevar CA, 2011, MOL ECOL, V20, P1936, DOI 10.1111/j.1365-294X.2011.05065.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guiry MD, 2011, ALGAEBASE, p[1845, 179]; Harper JT, 2001, CAH BIOL MAR, V42, P25; Harper JT, 2001, J PHYCOL, V37, P1073, DOI 10.1046/j.1529-8817.2001.00160.x; HEATWOLE H, 1972, ECOLOGY, V53, P112, DOI 10.2307/1935715; HELMUTH B, 1994, MAR BIOL, V120, P421, DOI 10.1007/BF00680216; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; JOHANNESSON K, 1988, MAR BIOL, V99, P507, DOI 10.1007/BF00392558; Karsten U, 1996, EUR J PHYCOL, V31, P361, DOI 10.1080/09670269600651591; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lane CE, 2006, J PHYCOL, V42, P493, DOI 10.1111/j.1529-8817.2006.00204.x; Macaya EC, 2010, MAR ECOL PROG SER, V420, P103, DOI 10.3354/meps08893; Macaya EC, 2010, J PHYCOL, V46, P736, DOI 10.1111/j.1529-8817.2010.00845.x; Mattio L, 2009, J PHYCOL, V45, P1374, DOI 10.1111/j.1529-8817.2009.00760.x; McDevit DC, 2009, PHYCOL RES, V57, P131, DOI 10.1111/j.1440-1835.2009.00530.x; Muhlin JF, 2008, MOL ECOL, V17, P1198, DOI 10.1111/j.1365-294X.2007.03624.x; MULLER DG, 1984, PHYCOLOGIA, V23, P87, DOI 10.2216/i0031-8884-23-1-87.1; Nikula R, 2011, MOL ECOL, V20, P4915, DOI 10.1111/j.1365-294X.2011.05332.x; Nikula R, 2010, MAR ECOL PROG SER, V405, P221, DOI 10.3354/meps08523; Nikula R, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0821; Nikula R, 2011, ECOL EVOL, V1, P169, DOI 10.1002/ece3.16; Papenfuss, 1964, ANTARCT RES SER, V1, P1; PETERS AF, 1992, J PHYCOL, V28, P428, DOI 10.1111/j.0022-3646.1992.00428.x; Peters AF, 1997, J PHYCOL, V33, P294, DOI 10.1111/j.0022-3646.1997.00294.x; Pickett-Heaps JD, 2001, EUR J PHYCOL, V36, P9, DOI 10.1080/09670260110001735148; Quartino ML, 2005, BOT MAR, V48, P187, DOI 10.1515/BOT.2005.029; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rousseau F, 2000, EUR J PHYCOL, V35, P35, DOI 10.1017/S0967026200002638; Silberfeld T, 2010, MOL PHYLOGENET EVOL, V56, P659, DOI 10.1016/j.ympev.2010.04.020; Smith SDA, 2002, GLOBAL ECOL BIOGEOGR, V11, P67, DOI 10.1046/j.1466-822X.2001.00259.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thiel M, 2005, OCEANOGR MAR BIOL, V43, P279; Thiel M, 2006, OCEANOGR MAR BIOL, V44, P323, DOI 10.1201/9781420006391.ch7; Tronholm A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030813; VANDENHOEK C, 1987, HELGOLANDER MEERESUN, V41, P261; Waters JM, 2013, TRENDS ECOL EVOL, V28, P78, DOI 10.1016/j.tree.2012.08.024; West JA, 1996, HYDROBIOLOGIA, V327, P277; Winston JE, 2012, INTEGR COMP BIOL, V52, P447, DOI 10.1093/icb/ics040; Wyatt ASJ, 2005, DIVERS DISTRIB, V11, P33, DOI 10.1111/j.1366-9516.2005.00109.x; Zuccarello GC, 2006, PHYCOLOGIA, V45, P24, DOI 10.2216/05-07.1; Zuccarello GC, 2008, NEW ZEAL J MAR FRESH, V42, P315, DOI 10.1080/00288330809509959	61	41	41	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69138	10.1371/journal.pone.0069138	http://dx.doi.org/10.1371/journal.pone.0069138			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894421	Green Published, gold, Green Submitted			2022-12-27	WOS:000322132100048
J	Mundt, AP; Alvarado, R; Fritsch, R; Poblete, C; Villagra, C; Kastner, S; Priebe, S				Mundt, Adrian P.; Alvarado, Ruben; Fritsch, Rosemarie; Poblete, Catalina; Villagra, Carolina; Kastner, Sinja; Priebe, Stefan			Prevalence Rates of Mental Disorders in Chilean Prisons	PLOS ONE			English	Article							NEUROPSYCHIATRIC INTERVIEW MINI; PSYCHIATRIC MORBIDITY; SUBSTANCE-ABUSE; HEALTH; IMPRISONMENT; ASSESSMENTS; CONCORDANCE; LIFETIME; VALIDITY; INMATES	Objective: High rates of mental disorders have been reported for prison populations worldwide, particularly in low- and middle-income countries (LMICs). The present study aimed to establish prevalence rates of mental disorders in Chilean prisoners. Method: A nationwide random sample of 1008 prisoners was assessed in 7 penal institutions throughout Chile. Twelve-month prevalence rates were established using the Composite International Diagnostic Interview (CIDI) and compared to the prevalence rates previously published for the general population. Results: Prevalence rates were 12.2% (95% CI, 10.2-14.1) for any substance use disorder, 8.3% (6.6-10.0) for anxiety disorders, 8.1% (6.5-9.8) for affective disorders, 5.7% (4.4-7.1) for intermittent explosive disorders, 2.2% (1.4-3.2) for ADHD of the adult, and 0.8% (0.3-1.3) for non-affective psychoses. Significantly higher prevalence rates among prisoners as compared to the general population in Chile were seen for major depression (6.1% vs. 3.7% males, Z=2.58, p<0.05) and illicit drug use (3.3% vs. 0.6% males with drug abuse, Z=2.04, p<0.05; 2.6% vs. 0.1% females with drug abuse, Z=5.36, p<0.001; 3.4% vs. 1.1% males with drug dependence, Z=3.70; p<0.001). Dysthymia (6.5% vs. 15.6%, Z=-2.39, p<0.05), simple (3.3% vs. 11.5%, Z=-3.13, p<0.001) and social phobias (3.9% vs. 9.7%, Z=2.38, p<0.05) were significantly less frequent in the female prison population than in the general population. One-year prevalence rates of alcohol abuse (2.3% vs. 3.9%; Z=-2.04; p<0.05) and dependence (2.7% vs. 8.2%; Z=-5.24; p<0.001) were less prevalent in the male prison population than in the general population. Conclusions: Service provision for prison populations in Chile should acknowledge high rates of depression and illicit drug use. Overall prevalence rates are lower than reported in other LMICs. Previous research in prison populations in LMICs might have overestimated prevalence rates of mental disorders.	[Mundt, Adrian P.; Fritsch, Rosemarie] Univ Chile, Hosp Clin, Dept Psychiat & Mental Hlth, Santiago, Chile; [Mundt, Adrian P.; Priebe, Stefan] Univ London, Unit Social & Community Psychiat, Barts & London Sch Med & Dent, London, England; [Alvarado, Ruben] Univ Chile, Fac Med, Sch Publ Hlth, Santiago, Chile; [Fritsch, Rosemarie] Univ Los Andes, Fac Med, Dept Psychiat, Santiago, Chile; [Poblete, Catalina] Univ Chile, Dept Child & Adolescent Psychiat, Santiago, Chile; [Villagra, Carolina] Univ Chile, Dept Psychol, Santiago, Chile; [Mundt, Adrian P.; Kastner, Sinja] Univ Med Berlin, Dept Psychiat & Psychotherapy, Charite Campus Mitte, Berlin, Germany	Universidad de Chile; University of London; Queen Mary University London; Universidad de Chile; Universidad de los Andes - Chile; Universidad de Chile; Universidad de Chile; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Mundt, AP (corresponding author), Univ Chile, Hosp Clin, Dept Psychiat & Mental Hlth, Santiago, Chile.	a.mundt@qmul.ac.uk	Mundt, Adrian/AAN-4641-2020; Villagra, Carolina/AAR-4516-2021; Montero, Rosemarie Fritsch/C-3519-2009	Mundt, Adrian/0000-0001-8763-4601; Montero, Rosemarie Fritsch/0000-0001-7694-1470; Priebe, Stefan/0000-0001-9864-3394	Ministry of Justice, Republic of Chile; Marie Curie International Outgoing Fellow of the European Union [PIOF-GA-2011-302346]	Ministry of Justice, Republic of Chile; Marie Curie International Outgoing Fellow of the European Union	The Ministry of Justice, Republic of Chile, financed the study (http://www.minjusticia.gob.cl/). APM is a Marie Curie International Outgoing Fellow of the European Union, grant number PIOF-GA-2011-302346 INCAS (http://ec.europa.eu/research/mariecurieactions/). The funders had no role in study design, data collection and analysis, or preparation of the manuscript. The Ministry of Justice formally allowed the publication of the data; the European Union had no role in the decision to publish the data.	Adesanya A, 1997, DRUG ALCOHOL DEPEN, V47, P39, DOI 10.1016/S0376-8716(97)00067-7; Agbahowe SA, 1998, E AFR MED J, V75, P19; Amorim P, 1998, EUR PSYCHIAT, V13, P26, DOI 10.1016/S0924-9338(97)86748-X; Assadi SM, 2006, BRIT J PSYCHIAT, V188, P159, DOI 10.1192/bjp.188.2.159; Baillargeon J, 2009, AM J PSYCHIAT, V166, P103, DOI 10.1176/appi.ajp.2008.08030416; Baillargeon J, 2010, ADM POLICY MENT HLTH, V37, P367, DOI 10.1007/s10488-009-0252-9; BANERJEE A, 2009, J INDIAN MED ASSOC, V14, P88681; Bermudez EC, 2007, SALUD MENT, V30, P53; Binswanger IA, 2007, NEW ENGL J MED, V356, P157, DOI 10.1056/NEJMsa064115; Case B, 2009, BEHAV SCI LAW, V27, P661, DOI 10.1002/bsl.883; Dettbarn E, 2012, INT J LAW PSYCHIAT, V35, P236, DOI 10.1016/j.ijlp.2012.02.014; Dudeck M, 2009, PSYCHIAT PRAX, V36, P219, DOI 10.1055/s-0028-1090217; Dumont DM, 2012, ANNU REV PUBL HEALTH, V33, P325, DOI 10.1146/annurev-publhealth-031811-124614; Exworthy T, 2012, PSYCHIAT SERV, V63, P270, DOI 10.1176/appi.ps.201100256; Fazel S., 2012, British Journal of Psychiatry, V200, P364, DOI 10.1192/bjp.bp.111.096370; Fazel S, 2002, LANCET, V359, P545, DOI 10.1016/S0140-6736(02)07740-1; Fotiadou M, 2006, INT J LAW PSYCHIAT, V29, P68, DOI 10.1016/j.ijlp.2004.06.009; George S, 2009, BMJ CASE REP; Ginsberg Y, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-112; Haro JM, 2006, INT J METH PSYCH RES, V15, P167, DOI 10.1002/mpr.196; *INT CTR PRIS, 2012, STUD CHILD WORLD PRI; Kessler RC, 2007, WORLD PSYCHIATRY, V6, P168; Mundt AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038490; Naidoo S, 2012, AFR J PSYCHIATRY, V15, P30, DOI [http://dx.doi.org/10.4314/ajpsy.v15i1.4, 10.4314/ajpsy.v15i1.4]; Ponde MP, 2011, J FORENSIC SCI, V56, P679, DOI 10.1111/j.1556-4029.2010.01691.x; Priebe S, 2008, PSYCHIAT SERV, V59, P570, DOI 10.1176/ps.2008.59.5.570; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sirotich F, 2009, J AM ACAD PSYCHIATRY, V37, P461; van den Bergh BJ, 2011, B WORLD HEALTH ORGAN, V89, P689, DOI 10.2471/BLT.10.082842; Vicente B, 2006, AM J PSYCHIAT, V163, P1362, DOI 10.1176/appi.ajp.163.8.1362; Walmsley R, 2011, WORLD PRISON POPULAT; WITTCHEN HU, 1994, J PSYCHIAT RES, V28, P57, DOI 10.1016/0022-3956(94)90036-1; Zahari MM, 2010, AM J DRUG ALCOHOL AB, V36, P31, DOI 10.3109/00952990903544828	33	39	40	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69109	10.1371/journal.pone.0069109	http://dx.doi.org/10.1371/journal.pone.0069109			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	187PW	23894415	Green Published, Green Submitted, gold			2022-12-27	WOS:000322132100046
J	Pannebakker, BA; Trivedi, U; Blaxter, MA; Watt, R; Shuker, DM				Pannebakker, Bart A.; Trivedi, Urmi; Blaxter, Mark A.; Watt, Rebekah; Shuker, David M.			The Transcriptomic Basis of Oviposition Behaviour in the Parasitoid Wasp Nasonia vitripennis	PLOS ONE			English	Article							FEMALE DROSOPHILA-MELANOGASTER; LOCAL MATE COMPETITION; GENOME-WIDE ANALYSIS; GENE-EXPRESSION; NEXT-GENERATION; SEX-RATIOS; EVOLUTION; PROTEINS; TRAITS; ARCHITECTURE	Linking behavioural phenotypes to their underlying genotypes is crucial for uncovering the mechanisms that underpin behaviour and for understanding the origins and maintenance of genetic variation in behaviour. Recently, interest has begun to focus on the transcriptome as a route for identifying genes and gene pathways associated with behaviour. For many behavioural traits studied at the phenotypic level, we have little or no idea of where to start searching for "candidate" genes: the transcriptome provides such a starting point. Here we consider transcriptomic changes associated with oviposition in the parasitoid wasp Nasonia vitripennis. Oviposition is a key behaviour for parasitoids, as females are faced with a variety of decisions that will impact offspring fitness. These include choosing between hosts of differing quality, as well as making decisions regarding clutch size and offspring sex ratio. We compared the whole-body transcriptomes of resting or ovipositing female Nasonia using a "DeepSAGE" gene expression approach on the Illumina sequencing platform. We identified 332 tags that were significantly differentially expressed between the two treatments, with 77% of the changes associated with greater expression in resting females. Oviposition therefore appears to focus gene expression away from a number of physiological processes, with gene ontologies suggesting that aspects of metabolism may be down-regulated during egg-laying. Nine of the most abundant differentially expressed tags showed greater expression in ovipositing females though, including the genes purity-of-essence (associated with behavioural phenotypes in Drosophila) and glucose dehydrogenase (GLD). The GLD protein has been implicated in sperm storage and release in Drosophila and so provides a possible candidate for the control of sex allocation by female Nasonia during oviposition. Oviposition in Nasonia therefore clearly modifies the transcriptome, providing a starting point for the genetic dissection of oviposition.	[Pannebakker, Bart A.] Wageningen Univ, Genet Lab, NL-6700 AP Wageningen, Netherlands; [Trivedi, Urmi; Blaxter, Mark A.; Watt, Rebekah] Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland; [Shuker, David M.] Univ St Andrews, Sch Biol, St Andrews, Fife, Scotland	Wageningen University & Research; University of Edinburgh; University of St Andrews	Pannebakker, BA (corresponding author), Wageningen Univ, Genet Lab, NL-6700 AP Wageningen, Netherlands.	bart.pannebakker@wur.nl	Blaxter, Mark L/B-4113-2010; GenePool, The/D-8812-2012; Blaxter, Mark/O-2535-2019; Pannebakker, Bart A./D-3823-2012	Blaxter, Mark L/0000-0003-2861-949X; Pannebakker, Bart A./0000-0001-8503-3896	Natural Environment Research Council (NERC); Netherlands Organization for Scientific Research (NWO) [863.08.008]; Netherlands Genomics Initiative (NGI) [935.19.006, 935.11.041]; MRC [MR/K001744/1] Funding Source: UKRI; NERC [NE/D009979/2, NBAF010003] Funding Source: UKRI; Medical Research Council [MR/K001744/1] Funding Source: researchfish; Natural Environment Research Council [NBAF010003, NE/D009979/2] Funding Source: researchfish	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Genomics Initiative (NGI); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The authors are very grateful to the Natural Environment Research Council (NERC: http://www.nerc.ac.uk/) for funding this work. BAP was also funded by the Netherlands Organization for Scientific Research (NWO: http://www.nwo.nl/. Veni grant no. 863.08.008) and the Netherlands Genomics Initiative (NGI: http://www.genomics.nl/. Horizon Breakthrough and Zenith grants no. 935.19.006 and 935.11.041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Anholt R. R., 2009, PRINCIPLES BEHAV GEN; Anholt RRH, 2004, NAT REV GENET, V5, P838, DOI 10.1038/nrg1472; Aspiras AC, 2011, DEV BIOL, V360, P369, DOI 10.1016/j.ydbio.2011.09.026; Behrouzian B, 2002, CURR OPIN CHEM BIOL, V6, P577, DOI 10.1016/S1367-5931(02)00365-4; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boake CRB, 2002, AM NAT, V160, pS143, DOI 10.1086/342902; Bono JM, 2011, P NATL ACAD SCI USA, V108, P7878, DOI 10.1073/pnas.1100388108; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Desjardins CA, 2010, HEREDITY, V104, P270, DOI 10.1038/hdy.2009.145; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Erickson DL, 2004, MOL ECOL, V13, P2505, DOI 10.1111/j.1365-294X.2004.02254.x; Falconer D. S., 1996, INTRO QUANTITATIVE G; Faurobert E, 1996, J BIOL CHEM, V271, P10256, DOI 10.1074/jbc.271.17.10256; Flanagan KE, 1998, ANIM BEHAV, V56, P191, DOI 10.1006/anbe.1998.0768; Flint J., 2010, GENES INFLUENCE BEHA; Forister ML, 2007, J EVOLUTION BIOL, V20, P985, DOI 10.1111/j.1420-9101.2007.01310.x; Gibson G, 2002, MOL ECOL, V11, P17, DOI 10.1046/j.0962-1083.2001.01425.x; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; Gomulski LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030857; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; Griffiths A. J. F., 2011, INTRO GENETIC ANAL; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; Hoheisel JD, 2006, NAT REV GENET, V7, P200, DOI 10.1038/nrg1809; Houle D, 2010, P NATL ACAD SCI USA, V107, P1793, DOI 10.1073/pnas.0906195106; Hrycaj S, 2008, EVOL DEV, V10, P705, DOI 10.1111/j.1525-142X.2008.00284.x; Iida K, 2004, J EXP BIOL, V207, P675, DOI 10.1242/jeb.00816; Immonen E, 2012, P ROY SOC B-BIOL SCI, V279, P1359, DOI 10.1098/rspb.2011.1644; Innocenti P, 2009, J EVOLUTION BIOL, V22, P964, DOI 10.1111/j.1420-9101.2009.01708.x; Jervis MA, 2008, ANNU REV ENTOMOL, V53, P361, DOI 10.1146/annurev.ento.53.103106.093433; Jonassen T, 1998, J BIOL CHEM, V273, P3351, DOI 10.1074/jbc.273.6.3351; Kocher SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009116; Kocher SD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-232; Konuma T, 2012, ENDOCRINOLOGY, V153, P3111, DOI 10.1210/en.2011-1533; Lawniczak MKN, 2004, GENOME, V47, P900, DOI 10.1139/G04-050; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Long P, 2010, BRAIN RES, V1315, P11, DOI 10.1016/j.brainres.2009.11.083; Lynch JA, 2006, NATURE, V439, P728, DOI 10.1038/nature04445; Lynch JA, 2006, NAT PROTOC, V1, P486, DOI 10.1038/nprot.2006.70; Lynch M., 1998, GENETICS ANAL QUANTI; Mack PD, 2006, P NATL ACAD SCI USA, V103, P10358, DOI 10.1073/pnas.0604046103; Mackay TFC, 2001, ANNU REV GENET, V35, P303, DOI 10.1146/annurev.genet.35.102401.090633; Marshall JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007537; McGraw LA, 2004, CURR BIOL, V14, P1509, DOI 10.1016/j.cub.2004.08.028; McGraw LA, 2008, GENETICS, V179, P1395, DOI 10.1534/genetics.108.086934; Murias AR, 2007, CHEM SENSES, V32, P673, DOI 10.1093/chemse/bjm033; Nylin S, 2005, BIOL J LINN SOC, V84, P755, DOI 10.1111/j.1095-8312.2004.00433.x; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; Pannebakker BA, 2011, J EVOLUTION BIOL, V24, P12, DOI 10.1111/j.1420-9101.2010.02129.x; Pannebakker BA, 2008, EVOLUTION, V62, P1921, DOI 10.1111/j.1558-5646.2008.00434.x; Pavey SA, 2012, TRENDS ECOL EVOL, V27, P673, DOI 10.1016/j.tree.2012.07.014; Perrot-Minnot MJ, 1999, J EVOLUTION BIOL, V12, P272, DOI 10.1046/j.1420-9101.1999.00025.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Ranz JM, 2006, TRENDS ECOL EVOL, V21, P29, DOI 10.1016/j.tree.2005.09.002; Richards S, 1996, GENETICS, V142, P1215; Rivero A, 2005, ANIM BEHAV, V69, P1293, DOI 10.1016/j.anbehav.2004.10.008; Rockman MV, 2012, EVOLUTION, V66, P1, DOI 10.1111/j.1558-5646.2011.01486.x; Rokas A, 2009, TRENDS ECOL EVOL, V24, P192, DOI 10.1016/j.tree.2008.11.004; Schurmann D, 2009, NATURWISSENSCHAFTEN, V96, P383, DOI 10.1007/s00114-008-0490-9; Shuker DM, 2005, AM NAT, V166, P301, DOI 10.1086/432562; Shuker DM, 2004, P NATL ACAD SCI USA, V101, P10363, DOI 10.1073/pnas.0308034101; Sokolowski MB, 2001, NAT REV GENET, V2, P879, DOI 10.1038/35098592; Sorensen JG, 2005, CELL STRESS CHAPERON, V10, P312, DOI 10.1379/CSC-128R1.1; Springer SA, 2011, MOL ECOL, V20, P2240, DOI 10.1111/j.1365-294X.2011.05116.x; Stapley J, 2010, TRENDS ECOL EVOL, V25, P705, DOI 10.1016/j.tree.2010.09.002; Tanner EA, 2011, DEVELOPMENT, V138, P327, DOI 10.1242/dev.057943; Watt R, 2012, TRANSCRIPTOMIC BASIS; WERREN JH, 1983, EVOLUTION, V37, P116, DOI [10.2307/2408180, 10.1111/j.1558-5646.1983.tb05520.x]; WERREN JH, 1980, SCIENCE, V208, P1157, DOI 10.1126/science.208.4448.1157; WERREN JH, 1984, NETH J ZOOL, V34, P123, DOI 10.1163/002829684X00100; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; WHITING AR, 1967, Q REV BIOL, V42, P333, DOI 10.1086/405402; Williams JA, 2001, ANNU REV PHYSIOL, V63, P729, DOI 10.1146/annurev.physiol.63.1.729; Xu XZS, 1998, J BIOL CHEM, V273, P31297, DOI 10.1074/jbc.273.47.31297; Yager J, 2001, P NATL ACAD SCI USA, V98, P10445, DOI 10.1073/pnas.191107698; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zwier MV, 2012, INSECT MOL BIOL, V21, P129, DOI 10.1111/j.1365-2583.2011.01121.x	78	20	20	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e68608	10.1371/journal.pone.0068608	http://dx.doi.org/10.1371/journal.pone.0068608			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894324	Green Published, gold, Green Submitted			2022-12-27	WOS:000322391400015
J	Li, WQ; Hu, N; Wang, ZM; Yu, K; Su, H; Wang, LM; Wang, CY; Chanock, SJ; Burdett, L; Ding, T; Qiao, YL; Fan, JH; Wang, Y; Xu, Y; Giffen, C; Xiong, XQ; Murphy, G; Tucker, MA; Dawsey, SM; Freedman, ND; Abnet, CC; Goldstein, AM; Taylor, PR				Li, Wen-Qing; Hu, Nan; Wang, Zhaoming; Yu, Kai; Su, Hua; Wang, Lemin; Wang, Chaoyu; Chanock, Stephen J.; Burdett, Laurie; Ding, Ti; Qiao, You-Lin; Fan, Jin-Hu; Wang, Yuan; Xu, Yi; Giffen, Carol; Xiong, Xiaoqin; Murphy, Gwen; Tucker, Margaret A.; Dawsey, Sanford M.; Freedman, Neal D.; Abnet, Christian C.; Goldstein, Alisa M.; Taylor, Philip R.			Genetic Variants in Epidermal Growth Factor Receptor Pathway Genes and Risk of Esophageal Squamous Cell Carcinoma and Gastric Cancer in a Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; SOMATIC MUTATIONS; KINASE DOMAIN; HELICOBACTER-PYLORI; ADENOCARCINOMA; POLYMORPHISMS; TARGETS; MDM2; P53	The epidermal growth factor receptor (EGFR) signaling pathway regulates cell proliferation, differentiation, and survival, and is frequently dysregulated in esophageal and gastric cancers. Few studies have comprehensively examined the association between germline genetic variants in the EGFR pathway and risk of esophageal and gastric cancers. Based on a genome-wide association study in a Han Chinese population, we examined 3443 SNPs in 127 genes in the EGFR pathway for 1942 esophageal squamous cell carcinomas (ESCCs), 1758 gastric cancers (GCs), and 2111 controls. SNP-level analyses were conducted using logistic regression models. We applied the resampling-based adaptive rank truncated product approach to determine the gene- and pathway-level associations. The EGFR pathway was significantly associated with GC risk (P = 2.16x10(-3)). Gene-level analyses found 10 genes to be associated with GC, including FYN, MAPK8, MAP2K4, GNAI3, MAP2K1, TLN1, PRLR, PLCG2, RPS6KB2, and PIK3R3 (P<0.05). For ESCC, we did not observe a significant pathway-level association (P = 0.72), but gene-level analyses suggested associations between GNAI3, CHRNE, PAK4, WASL, and ITCH, and ESCC (P<0.05). Our data suggest an association between specific genes in the EGFR signaling pathway and risk of GC and ESCC. Further studies are warranted to validate these associations and to investigate underlying mechanisms.	[Li, Wen-Qing; Hu, Nan; Wang, Zhaoming; Yu, Kai; Su, Hua; Wang, Lemin; Wang, Chaoyu; Murphy, Gwen; Tucker, Margaret A.; Dawsey, Sanford M.; Freedman, Neal D.; Abnet, Christian C.; Goldstein, Alisa M.; Taylor, Philip R.] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Wang, Zhaoming; Chanock, Stephen J.; Burdett, Laurie] SAIC Frederick Inc, NCI Frederick, Canc Genom Res Lab, Frederick, MD USA; [Ding, Ti; Wang, Yuan; Xu, Yi] Shanxi Canc Hosp, Taiyuan, Shanxi, Peoples R China; [Qiao, You-Lin; Fan, Jin-Hu] Chinese Acad Med Sci, Canc Inst Hosp, Dept Epidemiol, Beijing 100730, Peoples R China; [Giffen, Carol; Xiong, Xiaoqin] Informat Management Serv Inc, Silver Spring, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Information Management Services, Inc.	Li, WQ (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA.	liw9@mail.nih.gov	Wang, Zhaoming/R-5527-2018; Murphy, Gwen/G-7443-2015; Freedman, Neal David/B-9741-2015; Abnet, Christian C/C-4111-2015; Murphy, Gwen/GQB-3897-2022; Tucker, Margaret A/B-4297-2015; Murphy, Gwen/AFR-8275-2022; Qiao, You-Lin/B-4139-2012; Li, Wenqing/N-2293-2014	Wang, Zhaoming/0000-0001-7556-3869; Freedman, Neal David/0000-0003-0074-1098; Abnet, Christian C/0000-0002-3008-7843; Murphy, Gwen/0000-0003-0118-5337; Qiao, You-Lin/0000-0001-6380-0871; Li, Wenqing/0000-0002-1283-4091; fan, jinhu/0000-0003-3159-7893; Li, Wen-Qing/0000-0002-8336-5552	National Cancer Institute (NCI) [NO2-SC-66211]; Shanxi Cancer Hospital; Shanxi Cancer Institute; NCI [NO1-SC-91030, HHSN261200477001C]; Cancer Institute of the Chinese Academy of Medical Sciences; Intramural Research Program of the National Institutes of Health (NIH), NCI; Division of Cancer Epidemiology and Genetics; DIVISION OF CLINICAL SCIENCES - NCI [N01SC091030] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Shanxi Cancer Hospital; Shanxi Cancer Institute; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Institute of the Chinese Academy of Medical Sciences; Intramural Research Program of the National Institutes of Health (NIH), NCI; Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); DIVISION OF CLINICAL SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Shanxi Upper Gastrointestinal Cancer Genetics Project was supported by the National Cancer Institute (NCI) contract NO2-SC-66211 with the Shanxi Cancer Hospital and Institute. The Nutrition Intervention Trials were supported by NCI contracts NO1-SC-91030 and HHSN261200477001C with the Cancer Institute of the Chinese Academy of Medical Sciences. The current analysis was supported by the Intramural Research Program of the National Institutes of Health (NIH), NCI, and the Division of Cancer Epidemiology and Genetics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2012, HUM MOL GENET, V21, P2132, DOI 10.1093/hmg/dds029; Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Cescon DW, 2009, CLIN CANCER RES, V15, P3103, DOI 10.1158/1078-0432.CCR-08-3120; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Corso G, 2011, EUR J CANCER, V47, P443, DOI 10.1016/j.ejca.2010.09.008; Cui R, 2009, GASTROENTEROLOGY, V137, P1768, DOI 10.1053/j.gastro.2009.07.070; Deng NT, 2012, GUT, V61, P673, DOI 10.1136/gutjnl-2011-301839; Dong LM, 2008, JAMA-J AM MED ASSOC, V299, P2423, DOI 10.1001/jama.299.20.2423; Dulak AM, 2012, CANCER RES, V72, P4383, DOI 10.1158/0008-5472.CAN-11-3893; Eguchi R, 2012, CARCINOGENESIS, V33, P969, DOI 10.1093/carcin/bgs109; Gao Y, 2011, CANCER EPIDEMIOL, V35, pE91, DOI 10.1016/j.canep.2011.06.006; Hildebrandt MAT, 2009, J CLIN ONCOL, V27, P857, DOI 10.1200/JCO.2008.17.6297; Hong Y, 2005, CANCER RES, V65, P9582, DOI 10.1158/0008-5472.CAN-05-1460; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; Kwak EL, 2006, CLIN CANCER RES, V12, P4283, DOI 10.1158/1078-0432.CCR-06-0189; Lanuti M, 2008, CLIN CANCER RES, V14, P3216, DOI 10.1158/1078-0432.CCR-07-4932; Lee JW, 2006, CLIN CANCER RES, V12, P57, DOI 10.1158/1078-0432.CCR-05-0976; Li DH, 2012, CARCINOGENESIS, V33, P1384, DOI 10.1093/carcin/bgs151; Ma J, 2012, J HUM GENET, V57, P261, DOI 10.1038/jhg.2012.15; Ma JL, 2012, J NATL CANCER I, V104, P488, DOI 10.1093/jnci/djs003; Ma S, 2012, GASTROENTEROLOGY, V143, P675, DOI 10.1053/j.gastro.2012.06.007; Menke V, 2012, J HUM GENET, V57, P26, DOI 10.1038/jhg.2011.124; Michel A, 2009, HELICOBACTER, V14, P525, DOI 10.1111/j.1523-5378.2009.00723.x; Ohmiya N, 2006, J CLIN ONCOL, V24, P4434, DOI 10.1200/JCO.2005.04.1459; Okines A, 2011, NAT REV CLIN ONCOL, V8, P492, DOI 10.1038/nrclinonc.2011.45; Paterson A.L., 2012, GUT; Qiao YL, 2009, JNCI-J NATL CANCER I, V101, P507, DOI 10.1093/jnci/djp037; Sakamoto H, 2008, NAT GENET, V40, P730, DOI 10.1038/ng.152; Shi YY, 2011, NAT GENET, V43, P1215, DOI 10.1038/ng.978; Slattery ML, 2012, CARCINOGENESIS, V33, P2398, DOI 10.1093/carcin/bgs305; Soung YH, 2006, INT J CANCER, V118, P1426, DOI 10.1002/ijc.21507; Tanaka F, 2010, GUT, V59, P1457, DOI 10.1136/gut.2009.205724; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wang LD, 2010, NAT GENET, V42, P759, DOI 10.1038/ng.648; Wu C, 2012, NAT GENET, V44, P1090, DOI 10.1038/ng.2411; Wu C, 2011, NAT GENET, V43, P679, DOI 10.1038/ng.849; Yang JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021155; Yu K, 2009, GENET EPIDEMIOL, V33, P700, DOI 10.1002/gepi.20422; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246	41	20	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e68999	10.1371/journal.pone.0068999	http://dx.doi.org/10.1371/journal.pone.0068999			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874846	Green Published, Green Submitted, gold			2022-12-27	WOS:000324146200050
J	Lindenberg, JJ; Oosterhoff, D; Sombroek, CC; Lougheed, SM; Hooijberg, E; Stam, AGM; Santegoets, SJAM; Tijssen, HJ; Buter, J; Pinedo, HM; van den Eertwegh, AJM; Scheper, RJ; Koenen, HJPM; van de Ven, R; de Gruijl, TD				Lindenberg, Jelle J.; Oosterhoff, Dinja; Sombroek, Claudia C.; Lougheed, Sinead M.; Hooijberg, Erik; Stam, Anita G. M.; Santegoets, Saskia J. A. M.; Tijssen, Henk J.; Buter, Jan; Pinedo, Herbert M.; van den Eertwegh, Alfons J. M.; Scheper, Rik J.; Koenen, Hans J. P. M.; van de Ven, Rieneke; de Gruijl, Tanja D.			IL-10 Conditioning of Human Skin Affects the Distribution of Migratory Dendritic Cell Subsets and Functional T Cell Differentiation	PLOS ONE			English	Article							HUMAN LANGERHANS CELLS; BIOACTIVE IL-12P70; BREAST-CANCER; EXPRESSION; RESPONSES; MACROPHAGES; ACTIVATION; IMMUNITY; IMPACT; MODEL	In cancer patients pervasive systemic suppression of Dendritic Cell (DC) differentiation and maturation can hinder vaccination efficacy. In this study we have extensively characterized migratory DC subsets from human skin and studied how their migration and T cell-stimulatory abilities were affected by conditioning of the dermal microenvironment through cancer-related suppressive cytokines. To assess effects in the context of a complex tissue structure, we made use of a near-physiological skin explant model. By 4-color flow cytometry, we identified migrated Langerhans Cells (LC) and five dermis-derived DC populations in differential states of maturation. From a panel of known tumor-associated suppressive cytokines, IL-10 showed a unique ability to induce predominant migration of an immature CD14(+)CD141(+)DC-SIGN(+) DC subset with low levels of co-stimulatory molecules, up-regulated expression of the co-inhibitory molecule PD-L1 and the M2-associated macrophage marker CD163. A similarly immature subset composition was observed for DC migrating from explants taken from skin overlying breast tumors. Whereas predominant migration of mature CD1a(+) subsets was associated with release of IL-12p70, efficient Th cell expansion with a Th1 profile, and expansion of functional MART-1-specific CD8(+) T cells, migration of immature CD14(+) DDC was accompanied by increased release of IL-10, poor expansion of CD4(+) and CD8(+) T cells, and skewing of Th responses to favor coordinated FoxP3 and IL-10 expression and regulatory T cell differentiation and outgrowth. Thus, high levels of IL-10 impact the composition of skin-emigrated DC subsets and appear to favor migration of M2-like immature DC with functional qualities conducive to T cell tolerance.	[Lindenberg, Jelle J.; Oosterhoff, Dinja; Lougheed, Sinead M.; Stam, Anita G. M.; Santegoets, Saskia J. A. M.; Buter, Jan; Pinedo, Herbert M.; van den Eertwegh, Alfons J. M.; van de Ven, Rieneke; de Gruijl, Tanja D.] Vrije Univ Amsterdam Med Ctr, Dept Med Oncol, Amsterdam, Netherlands; [Sombroek, Claudia C.; Hooijberg, Erik; Stam, Anita G. M.; Scheper, Rik J.] Vrije Univ Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Tijssen, Henk J.; Koenen, Hans J. P. M.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Lab Med Immunol, NL-6525 ED Nijmegen, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Radboud University Nijmegen	de Gruijl, TD (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Med Oncol, Amsterdam, Netherlands.	td.degruijl@vumc.nl	van de Ven, Rieneke/J-4951-2015; Tijssen, Henk/K-1376-2016; Hooijberg, Erik/F-4503-2011; Koenen, Hans J.P.M./A-2852-2014	Hooijberg, Erik/0000-0002-4482-2191; Santegoets, Saskia/0000-0002-2874-4402	Netherlands Organization for Scientific Research (NWO VIDI) [917-56-321]	Netherlands Organization for Scientific Research (NWO VIDI)(Netherlands Organization for Scientific Research (NWO))	This study was supported by a grant from the Netherlands Organization for Scientific Research (NWO VIDI grant 917-56-321). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 2012, P NATL ACAD SCI USA, V109, P18885, DOI 10.1073/pnas.1205785109; Banchereau J, 2012, BLOOD, V119, P5742, DOI 10.1182/blood-2011-08-371245; Camporeale A, 2003, CANCER RES, V63, P3688; Chu CC, 2012, J EXP MED, V209, P935, DOI 10.1084/jem.20112583; de Gruijl TD, 2006, J IMMUNOL, V176, P7232, DOI 10.4049/jimmunol.176.12.7232; de Jong A, 2010, NAT IMMUNOL, V11, P1102, DOI 10.1038/ni.1956; Dominguez-Soto A, 2011, J IMMUNOL, V186, P2192, DOI 10.4049/jimmunol.1000475; Fujita H, 2009, P NATL ACAD SCI USA, V106, P21795, DOI 10.1073/pnas.0911472106; Furio L, 2010, J INVEST DERMATOL, V130, P1345, DOI 10.1038/jid.2009.424; Haniff M, 2009, J EXP MED, V206, P371, DOI 10.1084/jem.20081633; Haniffa M, 2012, IMMUNITY, V37, P60, DOI 10.1016/j.immuni.2012.04.012; Honkoop A H, 1999, Oncologist, V4, P106; Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140; Kang KF, 1996, J IMMUNOL, V156, P1402; Kaplan DH, 2008, EUR J IMMUNOL, V38, P2369, DOI 10.1002/eji.200838397; Klechevsky E, 2008, IMMUNITY, V29, P497, DOI 10.1016/j.immuni.2008.07.013; Koenen HJPM, 2008, BLOOD, V112, P2340, DOI 10.1182/blood-2008-01-133967; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; Larregina AT, 2001, NAT IMMUNOL, V2, P1151, DOI 10.1038/ni731; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mathers AR, 2006, IMMUNOL RES, V36, P127, DOI 10.1385/IR:36:1:127; Mathers AR, 2009, J IMMUNOL, V182, P921, DOI 10.4049/jimmunol.182.2.921; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Molenkamp BG, 2005, AM J PATHOL, V167, P1301, DOI 10.1016/S0002-9440(10)61217-5; Morelli AE, 2005, J IMMUNOL, V175, P7905, DOI 10.4049/jimmunol.175.12.7905; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; Nolan KF, 2004, J IMMUNOL, V172, P2201, DOI 10.4049/jimmunol.172.4.2201; Oosterhoff D, 2012, CURR TOP MICROBIOL, V351, P181, DOI 10.1007/82_2011_136; Ouwehand K, 2011, J INVEST DERMATOL, V131, P418, DOI 10.1038/jid.2010.336; Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258; Peiser M, 2004, J LEUKOCYTE BIOL, V76, P616, DOI 10.1189/jlb.0703327; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinedo HM, 2003, EUR J CANCER, V39, P1061, DOI 10.1016/S0959-8049(03)00131-X; Ramanathapuram LV, 2011, CANC MICROENVIRON; Randolph GJ, 1998, SCIENCE, V282, P480, DOI 10.1126/science.282.5388.480; Ratzinger G, 2004, J IMMUNOL, V173, P2780, DOI 10.4049/jimmunol.173.4.2780; Relloso M, 2002, J IMMUNOL, V168, P2634, DOI 10.4049/jimmunol.168.6.2634; Romani N, 2012, CURR TOP MICROBIOL, V351, P113, DOI 10.1007/82_2010_118; Santegoets SJAM, 2008, J LEUKOCYTE BIOL, V84, P143, DOI 10.1189/jlb.1107750; Santegoets SJAM, 2008, J IMMUNOL, V180, P4540, DOI 10.4049/jimmunol.180.7.4540; Seneschal J, 2012, IMMUNITY, V36, P873, DOI 10.1016/j.immuni.2012.03.018; Sombroek CC, 2002, J IMMUNOL, V168, P4333, DOI 10.4049/jimmunol.168.9.4333; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Steinman RM, 2007, DENDRITIC CELLS VERS; Takayama T, 2001, J IMMUNOL, V166, P7136, DOI 10.4049/jimmunol.166.12.7136; Teunissen MBM, 2012, CURR TOP MICROBIOL, V351, P25, DOI 10.1007/82_2011_169; Ueno H, 2011, SEMIN IMMUNOL, V23, P21, DOI 10.1016/j.smim.2011.01.004; van der Aar AMG, 2011, J IMMUNOL, V187, P3488, DOI 10.4049/jimmunol.1101105; Velten FW, 2004, EUR J IMMUNOL, V34, P2800, DOI 10.1002/eji.200324732; Vieira PL, 1998, J IMMUNOL, V161, P5245; WILSON AJ, 1991, J PATHOL, V163, P25, DOI 10.1002/path.1711630106; Zaba LC, 2007, J CLIN INVEST, V117, P2517, DOI 10.1172/JCI32282	52	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e70237	10.1371/journal.pone.0070237	http://dx.doi.org/10.1371/journal.pone.0070237			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23875023	Green Published, gold			2022-12-27	WOS:000324146200090
J	Maftei, M; Thurm, F; Schnack, C; Tumani, H; Otto, M; Elbert, T; Kolassa, IT; Przybylski, M; Manea, M; von Arnim, CAF				Maftei, Madalina; Thurm, Franka; Schnack, Cathrin; Tumani, Hayrettin; Otto, Markus; Elbert, Thomas; Kolassa, Iris-Tatjana; Przybylski, Michael; Manea, Marilena; von Arnim, Christine A. F.			Increased Levels of Antigen-Bound beta-Amyloid Autoantibodies in Serum and Cerebrospinal Fluid of Alzheimer's Disease Patients	PLOS ONE			English	Article							A-BETA; MOUSE MODEL; INTRAVENOUS IMMUNOGLOBULINS; COGNITIVE DECLINE; FOLLOW-UP; PEPTIDE; PLASMA; ANTIBODIES; IMMUNIZATION; DIAGNOSIS	Recent studies have suggested a protective role of physiological beta-amyloid autoantibodies (A beta-autoantibodies) in Alzheimer's disease (AD). However, the determination of both free and dissociated A beta-autoantibodies in serum hitherto has yielded inconsistent results regarding their function and possible biomarker value. Here we report the application of a new sandwich enzyme-linked immunosorbent assay (ELISA) for the determination of antigen-bound A beta-autoantibodies (intact A beta-IgG immune complexes) in serum and cerebrospinal fluid (CSF) of a total number of 112 AD patients and age- and gender-matched control subjects. Both serum and CSF levels of A beta-IgG immune complexes were found to be significantly higher in AD patients compared to control subjects. Moreover, the levels of A beta-IgG complexes were negatively correlated with the cognitive status across the groups, increasing with declining cognitive test performance of the subjects. Our results suggest a contribution of IgG-type autoantibodies to A beta clearance in vivo and an increased immune response in AD, which may be associated with deficient A beta-IgG removal. These findings may contribute to elucidating the role of A beta-autoantibodies in AD pathophysiology and their potential application in AD diagnosis.	[Maftei, Madalina; Przybylski, Michael; Manea, Marilena] Univ Konstanz, Dept Chem, Lab Analyt Chem & Biopolymer Struct Anal, Constance, Germany; [Maftei, Madalina] Univ Konstanz, Steinbeis Res Ctr Biopolymer Anal, Constance, Germany; [Thurm, Franka; Elbert, Thomas] Univ Konstanz, Dept Psychol, Constance, Germany; [Thurm, Franka; Kolassa, Iris-Tatjana] Univ Ulm, Inst Psychol & Educ, D-89069 Ulm, Germany; [Thurm, Franka] Tech Univ Dresden, Dept Psychol, Dresden, Germany; [Schnack, Cathrin; Tumani, Hayrettin; Otto, Markus; von Arnim, Christine A. F.] Univ Ulm, Dept Neurol, D-89069 Ulm, Germany; [Kolassa, Iris-Tatjana; Manea, Marilena] Univ Konstanz, Zukunftskolleg, Constance, Germany	University of Konstanz; University of Konstanz; University of Konstanz; Ulm University; Technische Universitat Dresden; Ulm University; University of Konstanz	Kolassa, IT (corresponding author), Univ Ulm, Inst Psychol & Educ, D-89069 Ulm, Germany.	iris.kolassa@uni-ulm.de; michael.przybylski@uni-konstanz.de; marilena.manea@uni-konstanz.de; christine.arnim@uni-ulm.de	Kolassa, Iris Tatjana/Y-3032-2018; Elbert, Thomas/C-8556-2009; Otto, Markus/F-4304-2015	Elbert, Thomas/0000-0003-1332-4939; Otto, Markus/0000-0003-4273-4267; Glockner, Franka/0000-0001-9684-7705	Heidelberg Academy of Sciences, Heidelberg, Germany within the WIN-Kolleg (Junior Academy for Young Scholars and Scientists); Zukunftskolleg; Research Center Proteostasis, University of Konstanz	Heidelberg Academy of Sciences, Heidelberg, Germany within the WIN-Kolleg (Junior Academy for Young Scholars and Scientists); Zukunftskolleg; Research Center Proteostasis, University of Konstanz	This research was funded as an interdisciplinary project within the WIN-Kolleg (Junior Academy for Young Scholars and Scientists) of the Heidelberg Academy of Sciences, Heidelberg, Germany, awarded to I.-T. Kolassa, M. Manea and C.A.F. von Arnim, by the Zukunftskolleg (I.-T. Kolassa, now alumna, and M. Manea) and Research Center Proteostasis (M. Przybylski), University of Konstanz. I.-T. Kolassa is now at the University of Ulm, F. Thurm is now at the TU Dresden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Bacher M, 2009, NEUROSCI LETT, V449, P240, DOI 10.1016/j.neulet.2008.08.083; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Baril L, 2004, NEUROSCI LETT, V355, P226, DOI 10.1016/j.neulet.2003.10.071; Bjorkqvist M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029868; Braak E, 1999, EUR ARCH PSY CLIN N, V249, P14; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brettschneider J, 2006, DEMENT GERIATR COGN, V21, P291, DOI 10.1159/000091436; Brettschneider S, 2005, BIOL PSYCHIAT, V57, P813, DOI 10.1016/j.biopsych.2004.12.008; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; Dodel R, 2008, European Patent Office, Patent No. [WO/2008/084402, 2008084402]; Dodel RC, 2004, J NEUROL NEUROSUR PS, V75, P1472, DOI 10.1136/jnnp.2003.033399; Dodel R, 2011, J NEUROSCI, V31, P5847, DOI 10.1523/JNEUROSCI.4401-10.2011; Dodel R, 2010, DRUGS, V70, P513, DOI 10.2165/11533070-000000000-00000; Du Y, 2001, NEUROLOGY, V57, P801, DOI 10.1212/WNL.57.5.801; Du YS, 2003, BRAIN, V126, P1935, DOI 10.1093/brain/awg191; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Finder VH, 2007, NEURODEGENER DIS, V4, P13, DOI 10.1159/000100355; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fukumoto H, 2003, ARCH NEUROL-CHICAGO, V60, P958, DOI 10.1001/archneur.60.7.958; Garber K, 2012, NAT BIOTECHNOL, V30, P731, DOI 10.1038/nbt0812-731; Gilman S, 2005, NEUROLOGY, V64, P1553, DOI 10.1212/01.WNL.0000159740.16984.3C; Gustaw KA, 2008, J NEUROCHEM, V106, P1350, DOI 10.1111/j.1471-4159.2008.05477.x; Gustaw-Rothenberg KA, 2010, EXP GERONTOL, V45, P47, DOI 10.1016/j.exger.2009.10.003; Hock C, 2003, NEURON, V38, P547, DOI 10.1016/S0896-6273(03)00294-0; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Holtzman DM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006312; Hyman BT, 2001, ANN NEUROL, V49, P808, DOI 10.1002/ana.1061; Ihl R., 1993, ALZHEIMER DIS ASSESS; Irizarry Michael C, 2004, NeuroRx, V1, P226; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Jolles S, 2005, CLIN EXP IMMUNOL, V142, P1, DOI 10.1111/j.1365-2249.2005.02834.X; Klaver AC, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-93; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; Lindsay J, 2002, AM J EPIDEMIOL, V156, P445, DOI 10.1093/aje/kwf074; Lv JP, 2006, ALZ DIS ASSOC DIS, V20, P127, DOI 10.1097/00002093-200607000-00001; Maftei M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044516; Magga J, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-90; Mangialasche F, 2010, LANCET NEUROL, V9, P702, DOI 10.1016/S1474-4422(10)70119-8; Matsubara E, 1999, ANN NEUROL, V45, P537, DOI 10.1002/1531-8249(199904)45:4<537::AID-ANA20>3.0.CO;2-2; Mayeux R, 1999, ANN NEUROL, V46, P412, DOI 10.1002/1531-8249(199909)46:3<412::AID-ANA19>3.0.CO;2-A; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McLaurin J, 2002, NAT MED, V8, P1263, DOI 10.1038/nm790; Mehta PD, 2007, CURR ALZHEIMER RES, V4, P359, DOI 10.2174/156720507781788891; Mehta PD, 2005, NEURODEGENER DIS, V2, P242, DOI 10.1159/000090363; Mehta PD, 2001, NEUROSCI LETT, V304, P102, DOI 10.1016/S0304-3940(01)01754-2; Mehta PD, 2000, ARCH NEUROL-CHICAGO, V57, P100, DOI 10.1001/archneur.57.1.100; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Morgan D, 2011, J INTERN MED, V269, P54, DOI 10.1111/j.1365-2796.2010.02315.x; Mruthinti S, 2004, NEUROBIOL AGING, V25, P1023, DOI 10.1016/j.neurobiolaging.2003.11.001; Potapov Sergej, 2009, DAIM DIAGNOSTIC ACCU; Przybylski M, 2007, 7 AUSTR PEPT S CAIRN, P32; Relkin NR, 2009, NEUROBIOL AGING, V30, P1728, DOI 10.1016/j.neurobiolaging.2007.12.021; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Schenk D, 2002, NAT REV NEUROSCI, V3, P824, DOI 10.1038/nrn938; Selkoe DJ, 2000, ANN NY ACAD SCI, V924, P17; Seppala TT, 2010, J NEUROL NEUROSUR PS, V81, P1123, DOI 10.1136/jnnp.2010.205757; Sigurdsson EM, 2001, AM J PATHOL, V159, P439, DOI 10.1016/S0002-9440(10)61715-4; Song MS, 2007, J INT MED RES, V35, P301, DOI 10.1177/147323000703500303; Sundelof J, 2008, ARCH NEUROL-CHICAGO, V65, P256, DOI 10.1001/archneurol.2007.57; Taguchi H, 2008, J BIOL CHEM, V283, P4714, DOI 10.1074/jbc.M707983200; Tamaoka A, 1996, J NEUROL SCI, V141, P65, DOI 10.1016/0022-510X(96)00143-8; Tapiola T, 2009, ARCH NEUROL-CHICAGO, V66, P382, DOI 10.1001/archneurol.2008.596; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; Villemagne VL, 2013, LANCET NEUROL, V12, P357, DOI 10.1016/S1474-4422(13)70044-9; Wang YJ, 2006, DRUG DISCOV TODAY, V11, P931, DOI 10.1016/j.drudis.2006.08.004; Weksler ME, 2002, EXP GERONTOL, V37, P943, DOI 10.1016/S0531-5565(02)00029-3; Xu WH, 2008, BRAIN RES, V1219, P169, DOI 10.1016/j.brainres.2008.02.060; Zetterberg H, 2010, EXP GERONTOL, V45, P23, DOI 10.1016/j.exger.2009.08.002	72	33	35	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e68996	10.1371/journal.pone.0068996	http://dx.doi.org/10.1371/journal.pone.0068996			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874844	Green Published, gold, Green Submitted			2022-12-27	WOS:000324146200048
J	Wittig, C; Laschke, MW; Scheuer, C; Menger, MD				Wittig, Christine; Laschke, Matthias W.; Scheuer, Claudia; Menger, Michael D.			Incorporation of Bone Marrow Cells in Pancreatic Pseudoislets Improves Posttransplant Vascularization and Endocrine Function	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; ISLET TRANSPLANTATION; REVASCULARIZATION; LANGERHANS; ISOGRAFTS; MICROVASCULATURE; MICROCIRCULATION; ANGIOGENESIS; PREVENTION; INHIBITOR	Failure of revascularization is known to be the major reason for the poor outcome of pancreatic islet transplantation. In this study, we analyzed whether pseudoislets composed of islet cells and bone marrow cells can improve vascularization and function of islet transplants. Pancreatic islets isolated from Syrian golden hamsters were dispersed into single cells for the generation of pseudoislets containing 4 x 10(3) cells. To create bone marrow cell-enriched pseudoislets 2 x 10(3) islet cells were co-cultured with 2 x 10(3) bone marrow cells. Pseudoislets and bone marrow cell-enriched pseudoislets were transplanted syngeneically into skinfold chambers to study graft vascularization by intravital fluorescence microscopy. Native islet transplants served as controls. Bone marrow cell-enriched pseudoislets showed a significantly improved vascularization compared to native islets and pseudoislets. Moreover, bone marrow cell-enriched pseudoislets but not pseudoislets normalized blood glucose levels after transplantation of 1000 islet equivalents under the kidney capsule of streptozotocin-induced diabetic animals, although the bone marrow cell-enriched pseudoislets contained only 50% of islet cells compared to pseudoislets and native islets. Fluorescence microscopy of bone marrow cell-enriched pseudoislets composed of bone marrow cells from GFP-expressing mice showed a distinct fraction of cells expressing both GFP and insulin, indicating a differentiation of bone marrow-derived cells to an insulin-producing cell-type. Thus, enrichment of pseudoislets by bone marrow cells enhances vascularization after transplantation and increases the amount of insulin-producing tissue. Accordingly, bone marrow cell-enriched pseudoislets may represent a novel approach to increase the success rate of islet transplantation.	[Wittig, Christine; Laschke, Matthias W.; Scheuer, Claudia; Menger, Michael D.] Univ Saarland, Inst Clin & Expt Surg, Homburg, Germany	Saarland University	Wittig, C (corresponding author), Univ Saarland, Inst Clin & Expt Surg, Homburg, Germany.	christine.wittig@uks.eu						Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Balestrieri ML, 2010, ATHEROSCLEROSIS, V209, P403, DOI 10.1016/j.atherosclerosis.2009.10.022; Beger C, 1998, DIABETES, V47, P559, DOI 10.2337/diabetes.47.4.559; Bonner-Weir S, 2005, NAT BIOTECHNOL, V23, P857, DOI 10.1038/nbt1115; Brissova M, 2004, DIABETES, V53, P1318, DOI 10.2337/diabetes.53.5.1318; Brissova M, 2008, DIABETES, V57, P2269, DOI 10.2337/db08-0814; Cavallari G, 2007, TRANSPL P, V39, P2018, DOI 10.1016/j.transproceed.2007.05.016; Cui YF, 2005, WORLD J GASTROENTERO, V11, P545, DOI 10.3748/wjg.v11.i4.545; Dobson T, 2000, CELL TRANSPLANT, V9, P857, DOI 10.1177/096368970000900612; Dor Y, 2013, NEW ENGL J MED, V368, P572, DOI 10.1056/NEJMcibr1214034; Faust A, 1996, TRANSPLANTATION, V62, P648, DOI 10.1097/00007890-199609150-00019; Furuya H, 2003, CELL TRANSPLANT, V12, P537, DOI 10.3727/000000003108746993; GOTOH M, 1987, TRANSPLANTATION, V43, P725, DOI 10.1097/00007890-198705000-00024; Gurney AM, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-4; Haider Husnain Kh, 2006, Expert Rev Cardiovasc Ther, V4, P557, DOI 10.1586/14779072.4.4.557; Hess D, 2003, NAT BIOTECHNOL, V21, P763, DOI 10.1038/nbt841; Ianus A, 2003, J CLIN INVEST, V111, P843, DOI 10.1172/JCI200316502; Johansson U, 2008, DIABETES, V57, P2393, DOI 10.2337/db07-0981; Katsuta H, 2010, DIABETOLOGIA, V53, P128, DOI 10.1007/s00125-009-1570-x; Korsgren O, 2005, TRANSPLANTATION, V79, P1289, DOI 10.1097/01.TP.0000157273.60147.7C; LIPOWSKY HH, 1978, MICROVASC RES, V15, P93, DOI 10.1016/0026-2862(78)90009-2; Lu YR, 2010, CELL BIOCHEM FUNCT, V28, P637, DOI 10.1002/cbf.1701; LUKINIUS A, 1995, AM J PATHOL, V146, P429; Mathews V, 2004, DIABETES, V53, P91, DOI 10.2337/diabetes.53.1.91; Mattsson G, 2002, DIABETES, V51, P1362, DOI 10.2337/diabetes.51.5.1362; Menger MD, 2001, WORLD J SURG, V25, P509, DOI 10.1007/s002680020345; MENGER MD, 1989, DIABETES, V38, P199, DOI 10.2337/diab.38.1.S199; MENGER MD, 1994, J CLIN INVEST, V93, P2280, DOI 10.1172/JCI117228; MENGER MD, 1992, J CLIN INVEST, V90, P1361, DOI 10.1172/JCI116002; Miller R, 2008, DIABETES, V57, P2402, DOI 10.2337/db08-0244; Naftanel MA, 2004, PLOS MED, V1, P198, DOI 10.1371/journal.pmed.0010058; Noguchi H, 2007, DIABETOLOGIA, V50, P612, DOI 10.1007/s00125-006-0563-2; Nyqvist D, 2005, DIABETES, V54, P2287, DOI 10.2337/diabetes.54.8.2287; Penko D, 2011, ISLETS, V3, P73, DOI 10.4161/isl.3.3.15392; Rackham CL, 2011, DIABETOLOGIA, V54, P1127, DOI 10.1007/s00125-011-2053-4; Ranjan AK, 2009, ISLETS, V1, P2, DOI 10.4161/isl.1.1.9054; RICORDI C, 1990, ACTA DIABETOL LAT, V27, P185, DOI 10.1007/BF02581331; Ryan EA, 2004, DIABETES, V53, P955, DOI 10.2337/diabetes.53.4.955; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Tuche F, 2012, MICROCIRCULATION, V19, P739, DOI 10.1111/j.1549-8719.2012.00212.x; VAJKOCZY P, 1995, AM J PATHOL, V146, P1397	41	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e69975	10.1371/journal.pone.0069975	http://dx.doi.org/10.1371/journal.pone.0069975			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23875013	Green Submitted, Green Published, gold			2022-12-27	WOS:000324146200087
J	Yu, XD; Lu, L; Luo, TH; Zhou, HZ				Yu, Xiao-Dong; Lu, Liang; Luo, Tian-Hong; Zhou, Hong-Zhang			Elevational Gradient in Species Richness Pattern of Epigaeic Beetles and Underlying Mechanisms at East Slope of Balang Mountain in Southwestern China	PLOS ONE			English	Article							SMALL MAMMAL DIVERSITY; CARABID BEETLES; GEOMETRIC CONSTRAINTS; ALTITUDINAL GRADIENTS; GEOGRAPHIC PATTERNS; HENGDUAN MOUNTAINS; PITFALL TRAPS; COLEOPTERA; CLIMATE; ASSEMBLAGES	We report on the species richness patterns of epigaeic beetles (Coleoptera: Carabidae and Staphylinidae) along a subtropical elevational gradient of Balang Mountain, southwestern China. We tested the roles of environmental factors (e. g. temperature, area and litter cover) and direct biotic interactions (e. g. foods and antagonists) that shape elevational diversity gradients. Beetles were sampled at 19 sites using pitfall traps along the studied elevational gradient ranging from 1500 m-4000 m during the 2004 growing season. A total of 74416 specimens representing 260 species were recorded. Species richness of epigaeic beetles and two families showed unimodal patterns along the elevational gradient, peaking at mid-elevations (c. 2535 m), and the ranges of most beetle species were narrow along the gradient. The potential correlates of both species richness and environmental variables were examined using linear and second order polynomial regressions. The results showed that temperature, area and litter cover had strong explanatory power of beetle species richness for nearly all richness patterns, of beetles as a whole and of Carabidae and Staphylinidae, but the density of antagonists was associated with species richness of Carabidae only. Multiple regression analyses suggested that the three environmental factors combined contributed most to richness patterns for most taxa. The results suggest that environmental factors associated with temperature, area and habitat heterogeneity could account for most variation in richness pattern of epigaeic beetles. Additionally, the mid-elevation peaks and the small range size of most species indicate that conservation efforts should give attention to the entire gradient rather than just mid-elevations.	[Yu, Xiao-Dong; Lu, Liang; Luo, Tian-Hong; Zhou, Hong-Zhang] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS	Yu, XD (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China.	yuxd@ioz.ac.cn; zhouhz@ioz.ac.cn		Lu, Liang/0000-0001-7533-6244	CAS Innovation Program [KSCX2-EW-Z-5]; National Natural Science Foundation of China [NSFC-31272358, J1210002]; Key Laboratory of Zoological Systematics and Evolution of CAS [O529YX5105]	CAS Innovation Program(Knowledge Innovation Program of the Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Zoological Systematics and Evolution of CAS	This study was supported in part by CAS Innovation Program (KSCX2-EW-Z-5), National Natural Science Foundation of China (NSFC-31272358, J1210002), a grant from the Key Laboratory of Zoological Systematics and Evolution of CAS (O529YX5105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya BK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029097; Allen AP, 2002, SCIENCE, V297, P1545, DOI 10.1126/science.1072380; Beck J, 2008, J BIOGEOGR, V35, P1452, DOI 10.1111/j.1365-2699.2008.01886.x; Beck J, 2009, GLOBAL ECOL BIOGEOGR, V18, P361, DOI 10.1111/j.1466-8238.2009.00447.x; Brehm G, 2003, ECOGRAPHY, V26, P456, DOI 10.1034/j.1600-0587.2003.03498.x; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Colwell RK, 2004, AM NAT, V163, pE1, DOI 10.1086/382056; Colwell RK, 2013, ESTIMATES STAT ESTIM; Colwell RK, 2008, ECOGRAPHY, V31, P4, DOI 10.1111/j.2008.0906-7590.05347.x; Currie DJ, 2008, ECOL MONOGR, V78, P3, DOI 10.1890/06-1302.1; Digweed SC, 1995, PEDOBIOLOGIA, V39, P561; Diniz JAF, 2003, GLOBAL ECOL BIOGEOGR, V12, P53, DOI 10.1046/j.1466-822X.2003.00322.x; DUTILLEUL P, 1993, BIOMETRICS, V49, P305, DOI 10.2307/2532625; Escobar F, 2005, GLOBAL ECOL BIOGEOGR, V14, P327, DOI 10.1111/j.1466-822x.2005.00161.x; Escobar F, 2007, ECOGRAPHY, V30, P193, DOI [10.1111/j.2007.0906-7590.04818.x, 10.1111/j.0906-7590.2007.04818.x]; Evans KL, 2005, BIOL REV, V80, P1, DOI 10.1017/S1464793104006517; Fu CZ, 2007, BIODIVERS CONSERV, V16, P707, DOI 10.1007/s10531-005-4382-4; Fu CZ, 2006, ECOGRAPHY, V29, P919, DOI 10.1111/j.2006.0906-7590.04802.x; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Gonzalez-Espinosa M, 2004, ECOGRAPHY, V27, P741, DOI 10.1111/j.0906-7590.2004.04103.x; Gotelli N.J., 1996, NULL MODELS ECOLOGY; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Hawkins BA, 2004, ECOGRAPHY, V27, P268, DOI 10.1111/j.0906-7590.2004.03883.x; Hawkins BA, 2007, AM NAT, V170, pS16, DOI 10.1086/519009; HERMAN LH, 2001, B AM MUS NAT HIST, P1; Hortal J, 2006, J ANIM ECOL, V75, P274, DOI 10.1111/j.1365-2656.2006.01048.x; Jenness JS, 2004, WILDLIFE SOC B, V32, P829, DOI 10.2193/0091-7648(2004)032[0829:CLSAFD]2.0.CO;2; Jetz W, 2002, SCIENCE, V297, P1548, DOI 10.1126/science.1072779; Kaspari M, 2000, AM NAT, V155, P280, DOI 10.1086/303313; Kerr JT, 1997, NATURE, V385, P252, DOI 10.1038/385252a0; Kluge J, 2006, GLOBAL ECOL BIOGEOGR, V15, P358, DOI [10.1111/j.1466-822X.2006.00223.x, 10.1111/j.1466-822x.2006.00223.x]; Koivula M, 2002, BIODIVERS CONSERV, V11, P1269, DOI 10.1023/A:1016018702894; Koivula M, 2002, FOREST ECOL MANAG, V167, P103, DOI 10.1016/S0378-1127(01)00717-4; LEITH CE, 1975, J ATMOS SCI, V32, P2022, DOI 10.1175/1520-0469(1975)032<2022:CRAFD>2.0.CO;2; Li JS, 2003, GLOBAL ECOL BIOGEOGR, V12, P449, DOI 10.1046/j.1466-822X.2003.00052.x; Li J, 2009, GLOBAL ECOL BIOGEOGR, V18, P264, DOI 10.1111/j.1466-8238.2008.00430.x; Lindroth C. H., 1961, Opuscula Entomologica Suppl, V20, P1; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; Lovei GL, 1996, ANNU REV ENTOMOL, V41, P231, DOI 10.1146/annurev.en.41.010196.001311; Luo TH, 2013, ENVIRON ENTOMOL, V42, P7, DOI 10.1603/EN11298; Machac A, 2011, ECOGRAPHY, V34, P364, DOI 10.1111/j.1600-0587.2010.06629.x; McGeoch MA, 1998, BIOL REV, V73, P181, DOI 10.1017/S000632319700515X; Niemela J, 1997, CONSERV BIOL, V11, P601, DOI 10.1046/j.1523-1739.1997.06008.x; Nogues-Bravo D, 2008, NATURE, V453, P216, DOI 10.1038/nature06812; Pohl GR, 2007, BIOL CONSERV, V137, P294, DOI 10.1016/j.biocon.2007.02.011; Pyrcz TW, 2002, GLOBAL ECOL BIOGEOGR, V11, P211, DOI 10.1046/j.1466-822X.2002.00285.x; R Development Core Team, 2012, R LANG ENV STAT COMP; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; Rahbek C, 2005, ECOL LETT, V8, P224, DOI 10.1111/j.1461-0248.2004.00701.x; Rahbek C, 2001, P NATL ACAD SCI USA, V98, P4534, DOI 10.1073/pnas.071034898; Rahbek C, 1997, AM NAT, V149, P875, DOI 10.1086/286028; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; ROHDE K, 1992, OIKOS, V65, P514, DOI 10.2307/3545569; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rosenzweig ML, 1999, ECOGRAPHY, V22, P614, DOI 10.1111/j.1600-0587.1999.tb00510.x; ROSENZWEIG ML, 1968, AM NAT, V102, P67, DOI 10.1086/282523; Rowe R, 2009, ECOGRAPHY, V32, P411, DOI 10.1111/j.1600-0587.2008.05538.x; Sanders NJ, 2007, GLOBAL ECOL BIOGEOGR, V16, P640, DOI 10.1111/j.1466-8238.2007.00316.x; Sanders NJ, 2012, ECOGRAPHY, V35, P1, DOI 10.1111/j.1600-0587.2011.07338.x; Sanders NJ, 2002, ECOGRAPHY, V25, P25, DOI 10.1034/j.1600-0587.2002.250104.x; Sanders NJ, 2003, GLOBAL ECOL BIOGEOGR, V12, P93, DOI 10.1046/j.1466-822X.2003.00324.x; SPENCE JR, 1994, CAN ENTOMOL, V126, P881, DOI 10.4039/Ent126881-3; Srivastava DS, 1998, AM NAT, V152, P510, DOI 10.1086/286187; THAYER MK, 2005, HDB ZOOLOGY, V4, P296, DOI 10.1515/9783110904550; Thornthwaite CW, 1948, GEOGR REV, V38, P55, DOI 10.2307/210739; TURC L., 1954, Annales Agronomiques, V5, P491; Wang ZH, 2007, DIVERS DISTRIB, V13, P845, DOI 10.1111/j.1472-4642.2007.00335.x; Yu XD, 2008, FOREST ECOL MANAG, V255, P2617, DOI 10.1016/j.foreco.2008.01.019; Yu XD, 2007, ENVIRON ENTOMOL, V36, P348, DOI 10.1603/0046-225X(2007)36[348:DOCBCC]2.0.CO;2; Yu XD, 2006, FOREST ECOL MANAG, V231, P169, DOI 10.1016/j.foreco.2006.05.043; Yu XD, 2009, ENVIRON ENTOMOL, V38, P1053, DOI 10.1603/022.038.0412; Zheng SW, 2006, J CHENGDU U NATURAL, V25, P210; 1987, WOLONG VEGETATION RE	75	13	16	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e69177	10.1371/journal.pone.0069177	http://dx.doi.org/10.1371/journal.pone.0069177			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874906	Green Published, gold, Green Submitted			2022-12-27	WOS:000324146200064
J	Chen, WH; Hillyer, JF				Chen, Weihan; Hillyer, Julian F.			FlyNap (Triethylamine) Increases the Heart Rate of Mosquitoes and Eliminates the Cardioacceleratory Effect of the Neuropeptide CCAP	PLOS ONE			English	Article							WESTERN EQUINE ENCEPHALOMYELITIS; CRUSTACEAN CARDIOACTIVE PEPTIDE; ANOPHELES-GAMBIAE; VECTOR COMPETENCE; TENEBRIO-MOLITOR; AEDES-AEGYPTI; GENE; INFECTION; REVERSAL; DIPTERA	FlyNap (triethylamine) is commonly used to anesthetize Drosophila melanogaster fruit flies. The purpose of this study was to determine whether triethylamine is a suitable anesthetic agent for research into circulatory physiology and immune competence in the mosquito, Anopheles gambiae (Diptera: Culicidae). Recovery experiments showed that mosquitoes awaken from traditional cold anesthesia in less than 7 minutes, but that recovery from FlyNap anesthesia does not begin for several hours. Relative to cold anesthesia, moderate exposures to FlyNap induce an increase in the heart rate, a decrease in the percentage of the time the heart contracts in the anterograde direction, and a decrease in the frequency of heartbeat directional reversals. Experiments employing various combinations of cold and FlyNap anesthesia then showed that cold exposure does not affect basal heart physiology, and that the differences seen between the cold and the FlyNap groups are due to a FlyNap-induced alteration of heart physiology. Furthermore, exposure to FlyNap eliminated the cardioacceleratory effect of crustacean cardioactive peptide (CCAP), and reduced a mosquito's ability to survive a bacterial infection. Together, these data show that FlyNap is not a suitable substitute to cold anesthesia in experiments assessing mosquito heart function or immune competence. Moreover, these data also illustrate the intricate biology of the insect heart. Specifically, they confirm that the neurohormone CCAP modulates heart rhythms and that it serves as an anterograde pacemaker.	[Chen, Weihan; Hillyer, Julian F.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	Vanderbilt University	Hillyer, JF (corresponding author), Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.	julian.hillyer@vanderbilt.edu		Hillyer, Julian/0000-0002-3178-0201	U.S. National Science Foundation (NSF) [IOS-1051636, IOS-1257936]; REU [IOS-1051636]; Division Of Integrative Organismal Systems [1257936] Funding Source: National Science Foundation	U.S. National Science Foundation (NSF)(National Science Foundation (NSF)); REU; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was funded by U.S. National Science Foundation (NSF) grants IOS-1051636 and IOS-1257936 to JFH, including an REU supplement to IOS-1051636. The NSF had no role in study design, data collection and analysis, or the preparation of this manuscript.	Andereck JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012943; Babcock DT, 2008, P NATL ACAD SCI USA, V105, P10017, DOI 10.1073/pnas.0709951105; Blandin SA, 2008, CELL HOST MICROBE, V3, P364, DOI 10.1016/j.chom.2008.05.007; Choma MA, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3503418; Cirimotich CM, 2010, DEV COMP IMMUNOL, V34, P387, DOI 10.1016/j.dci.2009.12.005; Coggins SA, 2012, DEV COMP IMMUNOL, V37, P390, DOI 10.1016/j.dci.2012.01.005; Coleman Judy, 2007, J Vis Exp, P228, DOI 10.3791/228; Corby-Harris V, 2010, PLOS PATHOG, V6, DOI [10.1371/journal.ppat.1001003, 10.1371/annotation/738ac91f-8c41-4bf5-9a39-bddf0b777a89]; da Silva SR, 2011, GEN COMP ENDOCR, V171, P218, DOI 10.1016/j.ygcen.2011.01.015; De Bruin A, 1976, BIOCH TOXICOLOGY ENV, P1554; Dodson BL, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-199; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Douglas A.E., 2013, INSECT STRUCTURE FUN, P107; Drake LL, 2012, JOVE-J VIS EXP, DOI 10.3791/3479; Drexler A, 2013, J EXP BIOL, V216, P208, DOI 10.1242/jeb.078873; Dulcis D, 2005, J NEUROBIOL, V64, P259, DOI 10.1002/neu.20136; Dulcis D, 2005, J NEUROSCI, V25, P271, DOI 10.1523/JNEUROSCI.2906-04.2005; Dulcis D, 2001, J COMP PHYSIOL A, V187, P837, DOI 10.1007/s00359-001-0254-x; Estevez-Lao TY, 2013, J EXP BIOL, V216, P601, DOI 10.1242/jeb.077164; FURUYA K, 1993, BIOL CHEM H-S, V374, P1065, DOI 10.1515/bchm3.1993.374.7-12.1065; Garver Lindsey, 2007, J Vis Exp, P230, DOI 10.3791/230; Glenn JD, 2010, J EXP BIOL, V213, P541, DOI 10.1242/jeb.035014; Goodman David S, 2003, Filaria J, V2, P11, DOI 10.1186/1475-2883-2-11; Hillyer JF, 2012, INSECT MOL BIOL, V21, P343, DOI 10.1111/j.1365-2583.2012.01140.x; Hillyer JF, 2007, INT J PARASITOL, V37, P673, DOI 10.1016/j.ijpara.2006.12.007; Hillyer JF, 2010, ADV EXP MED BIOL, V708, P218; Hillyer JF, 2010, DEV COMP IMMUNOL, V34, P141, DOI 10.1016/j.dci.2009.08.014; Johansen CA, 2001, J MED ENTOMOL, V38, P581, DOI 10.1603/0022-2585-38.4.581; Johnson AD, 2009, 40 INQUIRY EXERCISE; Johnson E, 1997, J COMP PHYSIOL B, V167, P89, DOI 10.1007/s003600050051; King JG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003058; King T., 2001, PRACTICAL ADV BIOL; Klowden AJ, 2007, CIRCULATORY SYSTEMS, P357; KRAMER LD, 1990, J MED ENTOMOL, V27, P1008, DOI 10.1093/jmedent/27.6.1008; Lamacchia Marina, 2013, Methods Mol Biol, V923, P161; Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160; Lee DH, 2011, GEN COMP ENDOCR, V174, P36, DOI 10.1016/j.ygcen.2011.08.007; LEHMAN HK, 1993, PEPTIDES, V14, P735, DOI 10.1016/0196-9781(93)90106-Q; Lo PCH, 2007, DEV BIOL, V311, P287, DOI 10.1016/j.ydbio.2007.08.024; Mahmood F, 2004, J AM MOSQUITO CONTR, V20, P277; Nation JL, 2008, CIRCULATORY SYSTEM I, P339; Neckameyer WS, 2008, NEUROSCIENCE, V156, P841, DOI 10.1016/j.neuroscience.2008.08.020; O'Guinn ML, 2002, J MED ENTOMOL, V39, P806, DOI 10.1603/0022-2585-39.5.806; Paternostro G, 2001, CIRC RES, V88, P1053, DOI 10.1161/hh1001.090857; Pellegrino Maurizio, 2010, J Vis Exp, P1, DOI 10.3791/1725; Shih JC, 1999, ANNU REV NEUROSCI, V22, P197, DOI 10.1146/annurev.neuro.22.1.197; Slama K, 2011, J INSECT PHYSIOL, V57, P251, DOI 10.1016/j.jinsphys.2010.11.004; STANGIER J, 1987, P NATL ACAD SCI USA, V84, P575, DOI 10.1073/pnas.84.2.575; Tartes U, 2002, COMP BIOCHEM PHYS A, V133, P611, DOI 10.1016/S1095-6433(02)00173-3; Tsai MT, 2011, J BIOPHOTONICS, V4, P610, DOI 10.1002/jbio.201100009; Wasielewski O, 2008, J COMP PHYSIOL B, V178, P877, DOI 10.1007/s00360-008-0276-6; Wasserthal LT, 2007, J EXP BIOL, V210, P3707, DOI 10.1242/jeb.007864; Wessel RJ, 2004, BIOTECHNIQUES, V37, P58, DOI 10.2144/04371ST01; Xu JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061181; Zenz C., 1994, OCCUPATIONAL MED, V3rd	55	16	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e70414	10.1371/journal.pone.0070414	http://dx.doi.org/10.1371/journal.pone.0070414			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23875027	gold, Green Submitted, Green Published			2022-12-27	WOS:000322064300129
J	Marques, JP; Gruetter, R				Marques, Jose P.; Gruetter, Rolf			New Developments and Applications of the MP2RAGE Sequence - Focusing the Contrast and High Spatial Resolution R-1 Mapping	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; RF-PULSE; 7 TESLA; MRI; FIELD; T-1; SEGMENTATION; INVERSION; T1; RADIOFREQUENCY	MR structural T1-weighted imaging using high field systems (>3T) is severely hampered by the existing large transmit field inhomogeneities. New sequences have been developed to better cope with such nuisances. In this work we show the potential of a recently proposed sequence, the MP2RAGE, to obtain improved grey white matter contrast with respect to conventional T1-w protocols, allowing for a better visualization of thalamic nuclei and different white matter bundles in the brain stem. Furthermore, the possibility to obtain high spatial resolution (0.65 mm isotropic) R-1 maps fully independent of the transmit field inhomogeneities in clinical acceptable time is demonstrated. In this high resolution R-1 maps it was possible to clearly observe varying properties of cortical grey matter throughout the cortex and observe different hippocampus fields with variations of intensity that correlate with known myelin concentration variations.	[Marques, Jose P.; Gruetter, Rolf] Univ Lausanne, Dept Radiol, Lausanne, Switzerland; [Marques, Jose P.; Gruetter, Rolf] Ecole Polytech Fed Lausanne, Lab Funct & Metab Imaging, Lausanne, Switzerland; [Gruetter, Rolf] Univ Geneva, Dept Radiol, Geneva, Switzerland	University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva	Marques, JP (corresponding author), Univ Lausanne, Dept Radiol, Lausanne, Switzerland.	jose.marques@epfl.ch	Marques, José Pedro/R-3616-2018; Marques, Jose/B-4922-2015; Jovicich, Jorge/D-2293-2010; Gruetter, Rolf/H-6260-2011	Marques, José Pedro/0000-0001-8157-8864; Marques, Jose/0000-0001-8157-8864; Gruetter, Rolf/0000-0003-1870-4025	Centre d'Imagerie BioMedicale (CIBM) of the UNIL; UNIGE; HUG; CHUV; EPFL; Leenaards Foundation; Jeantet Foundation	Centre d'Imagerie BioMedicale (CIBM) of the UNIL; UNIGE; HUG; CHUV; EPFL; Leenaards Foundation; Jeantet Foundation	This work was supported by Centre d'Imagerie BioMedicale (CIBM) of the UNIL, UNIGE, HUG, CHUV, EPFL, and the Leenaards and Jeantet Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abosch A, 2010, NEUROSURGERY, V67, P1745, DOI 10.1227/NEU.0b013e3181f74105; Abraham H, 2012, INT J DEV NEUROSCI, V30, P147, DOI 10.1016/j.ijdevneu.2011.11.005; Baudrexel S, 2010, NEUROIMAGE, V51, P512, DOI 10.1016/j.neuroimage.2010.03.005; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Braak H, 2004, NEUROBIOL AGING, V25, P713, DOI 10.1016/j.neurobiolaging.2003.12.015; Braak H, 2004, NEUROBIOL AGING, V25, P19, DOI 10.1016/j.neurobiolaging.2003.04.001; Cho ZH, 2011, J NUCL MED, V52, P401, DOI 10.2967/jnumed.110.081281; Deichmann R, 2005, MAGNET RESON MED, V54, P20, DOI 10.1002/mrm.20552; Deoni SCL, 2007, NEUROIMAGE, V34, P117, DOI 10.1016/j.neuroimage.2006.09.016; Deoni SCL, 2011, MAGN RESON MED, V65, P1021, DOI 10.1002/mrm.22685; Dick F, 2012, J NEUROSCI, V32, P16095, DOI 10.1523/JNEUROSCI.1712-12.2012; Duyn JH, 2007, P NATL ACAD SCI USA, V104, P11796, DOI 10.1073/pnas.0610821104; Eggenschwiler F, 2012, MAGN RESON MED, V67, P1609, DOI 10.1002/mrm.23145; Fleysher R, 2008, MAGN RESON IMAGING, V26, P781, DOI 10.1016/j.mri.2008.01.024; Friehs Gerhard M, 2007, Neurosurg Focus, V23, pE3; Geyer S, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00019; Glasser MF, 2011, J NEUROSCI, V31, P11597, DOI 10.1523/JNEUROSCI.2180-11.2011; Helms G, 2009, NEUROIMAGE, V47, P194, DOI 10.1016/j.neuroimage.2009.03.053; Hsu JJ, 2009, MAGN RESON MED, V61, P1319, DOI 10.1002/mrm.21900; Hurley AC, 2010, MAGN RESON MED, V63, P51, DOI 10.1002/mrm.22167; Jubault T, 2009, PLOS ONE, V4; Krauth A, 2010, NEUROIMAGE, V49, P2053, DOI 10.1016/j.neuroimage.2009.10.042; Li TQ, 2006, NEUROIMAGE, V32, P1032, DOI 10.1016/j.neuroimage.2006.05.053; Marques JP, 2010, NEUROIMAGE, V49, P1271, DOI 10.1016/j.neuroimage.2009.10.002; Marques JP, 2013, P 21 ISMRM ANN M; Pinsker MO, 2008, ZBL NEUROCHIR, V69, P71, DOI 10.1055/s-2007-1004583; Pinsker MO, 2009, ACTA NEUROCHIR, V151, P751, DOI 10.1007/s00701-009-0375-5; Preibisch C, 2009, MAGN RESON MED, V61, P125, DOI 10.1002/mrm.21776; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Sereno MI, CEREB CORTEX; Sudhyadhom A, 2009, NEUROIMAGE, V47, pT44, DOI 10.1016/j.neuroimage.2009.04.018; Tanner M, 2012, J MAGN RESON IMAGING, V35, P1063, DOI 10.1002/jmri.23532; Teeuwisse WM, 2012, MAGN RESON MED, V67, P912, DOI 10.1002/mrm.24176; Teeuwisse WM, 2012, MAGN RESON MED, V67, P1285, DOI 10.1002/mrm.23108; Traynor CR, 2011, NEUROIMAGE, V56, P939, DOI 10.1016/j.neuroimage.2011.01.083; Van de Moortele PF, 2009, NEUROIMAGE; Van Leemput K, 2009, HIPPOCAMPUS, V19, P549, DOI 10.1002/hipo.20615; Vaughan JT, 2001, MAGN RESON MED, V46, P24, DOI 10.1002/mrm.1156; Yarnykh VL, 2010, MAGN RESON MED, V63, P1610, DOI 10.1002/mrm.22394	40	107	109	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e69294	10.1371/journal.pone.0069294	http://dx.doi.org/10.1371/journal.pone.0069294			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874936	Green Published, gold, Green Submitted			2022-12-27	WOS:000322064300097
J	Zhao, Q; Zou, J; Meng, JL; Mei, SY; Wang, JB				Zhao, Qin; Zou, Jun; Meng, Jinling; Mei, Shiyong; Wang, Jianbo			Tracing the Transcriptomic Changes in Synthetic Trigenomic allohexaploids of Brassica Using an RNA-Seq Approach	PLOS ONE			English	Article							NONADDITIVE GENE-REGULATION; CYTOSINE METHYLATION; DUPLICATED GENES; EXPRESSION; GENOME; HYBRIDIZATION; NAPUS; POLYPLOIDY; ANNOTATION; ALLOPOLYPLOIDY	Polyploidization has played an important role in plant evolution and speciation, and newly formed allopolyploids have experienced rapid transcriptomic changes. Here, we compared the transcriptomic differences between a synthetic Brassica allohexaploid and its parents using a high-throughput RNA-Seq method. A total of 35,644,409 sequence reads were generated, and 32,642 genes were aligned from the data. Totals of 29,260, 29,060, and 29,697 genes were identified in Brassica rapa, Brassica carinata, and Brassica allohexaploid, respectively. We compared 7,397 differentially expressed genes (DEGs) between Brassica hexaploid and its parents, as well as 2,545 nonadditive genes of Brassica hexaploid. We hypothesized that the higher ploidy level as well as secondary polyploidy might have influenced these changes. The majority of the 3,184 DEGs between Brassica hexaploid and its paternal parent, B. rapa, were involved in the biosynthesis of secondary metabolites, plant-pathogen interactions, photosynthesis, and circadian rhythm. Among the 2,233 DEGs between Brassica hexaploid and its maternal parent, B. carinata, several played roles in plant-pathogen interactions, plant hormone signal transduction, ribosomes, limonene and pinene degradation, photosynthesis, and biosynthesis of secondary metabolites. There were more significant differences in gene expression between the allohexaploid and its paternal parent than between it and its maternal parent, possibly partly because of cytoplasmic and maternal effects. Specific functional categories were enriched among the 2,545 nonadditive genes of Brassica hexaploid compared with the additive genes; the categories included response to stimulus, immune system process, cellular process, metabolic process, rhythmic process, and pigmentation. Many transcription factor genes, methyltransferases, and methylation genes showed differential expression between Brassica hexaploid and its parents. Our results demonstrate that the Brassica allohexaploid can generate extensive transcriptomic diversity compared with its parents. These changes may contribute to the normal growth and reproduction of allohexaploids.	[Zhao, Qin; Wang, Jianbo] Wuhan Univ, Coll Life Sci, Natl Key Lab Hybrid Rice, Wuhan 430072, Peoples R China; [Zou, Jun; Meng, Jinling] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Mei, Shiyong] Hubei Acad Agr Sci, Wuhan, Peoples R China	Wuhan University; Huazhong Agricultural University; Hubei Academy of Agricultural Sciences	Wang, JB (corresponding author), Wuhan Univ, Coll Life Sci, Natl Key Lab Hybrid Rice, Wuhan 430072, Peoples R China.	jbwang@whu.edu.cn			National Natural Science Foundation of China [31070204]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (31070204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2003, P NATL ACAD SCI USA, V100, P4649, DOI 10.1073/pnas.0630618100; Adams KL, 2004, GENETICS, V168, P2217, DOI 10.1534/genetics.104.033522; Albertin W, 2006, GENETICS, V173, P1101, DOI 10.1534/genetics.106.057554; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bassene JB, 2010, HEREDITY, V105, P299, DOI 10.1038/hdy.2009.162; Bento M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001402; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Blanc G, 2003, GENOME RES, V13, P137, DOI 10.1101/gr.751803; Chaudhary B, 2009, GENETICS, V182, P503, DOI 10.1534/genetics.109.102608; Cheung F, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-272; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; Fujimoto R, 2011, PLANT MOL BIOL, V77, P419, DOI 10.1007/s11103-011-9820-y; Gaeta RT, 2007, PLANT CELL, V19, P3403, DOI 10.1105/tpc.107.054346; Gaeta RT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004760; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Hegarty MJ, 2011, MOL ECOL, V20, P105, DOI 10.1111/j.1365-294X.2010.04926.x; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jiang Y, 2007, PLANT BREEDING, V126, P487, DOI 10.1111/j.1439-0523.2007.01393.x; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kashkush K, 2002, GENETICS, V160, P1651; Kashkush K, 2003, NAT GENET, V33, P102, DOI 10.1038/ng1063; Kosugi S, 1997, PLANT CELL, V9, P1607, DOI 10.1105/tpc.9.9.1607; Lu TT, 2010, GENOME RES, V20, P1238, DOI 10.1101/gr.106120.110; Lukens LN, 2006, PLANT PHYSIOL, V140, P336, DOI 10.1104/pp.105.066308; Luo D, 1996, NATURE, V383, P794, DOI 10.1038/383794a0; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Martin-Trillo M, 2010, TRENDS PLANT SCI, V15, P31, DOI 10.1016/j.tplants.2009.11.003; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mutasa-Gottgens ES, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-99; Osabe K, 2012, INT J MOL SCI, V13, P8696, DOI 10.3390/ijms13078696; PELOQUIN SJ, 1992, PLANT BREEDING IN THE 1990S, P485; Pikaard CS, 2001, TRENDS GENET, V17, P675, DOI 10.1016/S0168-9525(01)02545-8; Pumphrey M, 2009, GENETICS, V181, P1147, DOI 10.1534/genetics.108.096941; Rastogi S, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-28; Rieseberg LH, 2003, SCIENCE, V301, P1211, DOI 10.1126/science.1086949; Salmon A, 2005, MOL ECOL, V14, P1163, DOI 10.1111/j.1365-294X.2005.02488.x; Severin AJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-160; Shaked H, 2001, PLANT CELL, V13, P1749, DOI 10.1105/tpc.13.8.1749; Soltis DE, 2004, NEW PHYTOL, V161, P173, DOI 10.1046/j.1469-8137.2003.00948.x; Soltis PS, 2009, ANNU REV PLANT BIOL, V60, P561, DOI 10.1146/annurev.arplant.043008.092039; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Tian ET, 2010, THEOR APPL GENET, V121, P1431, DOI 10.1007/s00122-010-1399-1; Wall PK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-347; Wang JL, 2006, GENETICS, V172, P507, DOI 10.1534/genetics.105.047894; Wang QX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031033; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Weber APM, 2007, PLANT PHYSIOL, V144, P32, DOI 10.1104/pp.107.096677; Wolfe KH, 2001, NAT REV GENET, V2, P333, DOI 10.1038/35072009; Wu T, 2010, J PLANT PHYSIOL, V167, P905, DOI 10.1016/j.jplph.2010.02.004; Xu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030646; Xu Y, 2012, PLANT BIOLOGY, V14, P734, DOI 10.1111/j.1438-8677.2011.00553.x; Xu YH, 2009, PLANTA, V229, P471, DOI 10.1007/s00425-008-0844-8; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zenoni S, 2010, PLANT PHYSIOL, V152, P1787, DOI 10.1104/pp.109.149716; Zhao JW, 2009, PLANT PHYSIOL BIOCH, V47, P653, DOI 10.1016/j.plaphy.2009.03.002	58	8	10	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e68883	10.1371/journal.pone.0068883	http://dx.doi.org/10.1371/journal.pone.0068883			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874799	Green Submitted, gold, Green Published			2022-12-27	WOS:000322218800051
J	Zhang, FS; Yin, GH; Wang, ZY; McLaughlin, N; Geng, XY; Liu, ZX				Zhang, Fasheng; Yin, Guanghua; Wang, Zhenying; McLaughlin, Neil; Geng, Xiaoyuan; Liu, Zuoxin			Quantifying Spatial Variability of Selected Soil Trace Elements and Their Scaling Relationships Using Multifractal Techniques	PLOS ONE			English	Article							WATER-RETENTION PARAMETERS; MICRONUTRIENTS; SINGULARITY; ZINC; CU	Multifractal techniques were utilized to quantify the spatial variability of selected soil trace elements and their scaling relationships in a 10.24-ha agricultural field in northeast China. 1024 soil samples were collected from the field and available Fe, Mn, Cu and Zn were measured in each sample. Descriptive results showed that Mn deficiencies were widespread throughout the field while Fe and Zn deficiencies tended to occur in patches. By estimating single multifractal spectra, we found that available Fe, Cu and Zn in the study soils exhibited high spatial variability and the existence of anomalies ([alpha(q)(max)-alpha(q)(min)]>= 0.54), whereas available Mn had a relatively uniform distribution ([alpha(q)(max)-alpha(q)(min)]approximate to 0.10). The joint multifractal spectra revealed that the strong positive relationships (r >= 0.86, P<0.001) among available Fe, Cu and Zn were all valid across a wider range of scales and over the full range of data values, whereas available Mn was weakly related to available Fe and Zn (r >= 0.18, P<0.01) but not related to available Cu (r = -0.03, P = 0.40). These results show that the variability and singularities of selected soil trace elements as well as their scaling relationships can be characterized by single and joint multifractal parameters. The findings presented in this study could be extended to predict selected soil trace elements at larger regional scales with the aid of geographic information systems.	[Zhang, Fasheng; Yin, Guanghua; Wang, Zhenying; Liu, Zuoxin] Chinese Acad Sci, Inst Appl Ecol, Shenyang 110016, Peoples R China; [Zhang, Fasheng; McLaughlin, Neil; Geng, Xiaoyuan] Agr & Agri Food Canada, Eastern Cereal & Oilseed Res Ctr, Ottawa, ON, Canada	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Agriculture & Agri Food Canada	Zhang, FS (corresponding author), Chinese Acad Sci, Inst Appl Ecol, Shenyang 110016, Peoples R China.	fasheng.zhang@yahoo.com; liuzuoxin@iae.ac.cn			National Natural Science Foundation of China [41201212]; National Food Production Project of China [2011BAD16B12]; National Major Technology Program of China [2012BAD09B02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Food Production Project of China; National Major Technology Program of China	This work was funded by the National Natural Science Foundation of China (41201212), the National Food Production Project of China (2011BAD16B12) and the National Major Technology Program of China (2012BAD09B02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agterberg F.P., 1995, INT GEOL REV, V37, P1, DOI DOI 10.1080/00206819509465388; Alloway Brian J., 2008, P1, DOI 10.1007/978-1-4020-6860-7_1; Behera SK, 2011, GEODERMA, V162, P242, DOI 10.1016/j.geoderma.2011.01.016; Biswas A., 2012, FRACTAL ANAL CHAOS G, V6, P109, DOI [DOI 10.5772/51437, 10.5772/51437]; Caniego FJ, 2005, ECOL MODEL, V182, P291, DOI 10.1016/j.ecolmodel.2004.04.014; Cheng QM, 2008, VADOSE ZONE J, V7, P525, DOI 10.2136/vzj2007.0034; Cheng QM, 2005, QUANT GEO G, V14, P1017; Fageria NK, 2002, ADV AGRON, V77, P185, DOI 10.1016/S0065-2113(02)77015-6; Goovaerts P, 1999, GEODERMA, V89, P1, DOI 10.1016/S0016-7061(98)00078-0; Gringarten E, 2001, MATH GEOL, V33, P507, DOI 10.1023/A:1011093014141; Guan XY, 2007, NEW ZEAL J AGR RES, V50, P789; Havlin JL., 2005, SOIL FERTILITY FERTI, V7th; Heuvelink GBM, 2001, GEODERMA, V100, P269, DOI 10.1016/S0016-7061(01)00025-8; Hood PS, 2010, TRACE ELEMENTS SOILS; HOODA PS, 1994, SCI TOTAL ENVIRON, V149, P39, DOI 10.1016/0048-9697(94)90003-5; Jenny H., 1941, FACTORS SOIL FORMATI; Jesus AP, 2013, J GEOCHEM EXPLOR, V126, P23, DOI 10.1016/j.gexplo.2012.12.010; Kravchenko AN, 2000, AGRON J, V92, P1279, DOI 10.2134/agronj2000.9261279x; Kravchenko AN, 1999, AGRON J, V91, P1033, DOI 10.2134/agronj1999.9161033x; LINDSAY WL, 1978, SOIL SCI SOC AM J, V42, P421, DOI 10.2136/sssaj1978.03615995004200030009x; Liu XM, 2008, ENVIRON GEOL, V55, P1569, DOI 10.1007/s00254-007-1107-x; LIU Z, 1996, MICROELEMENTS SOILS; McBratney AB, 2003, GEODERMA, V117, P3, DOI 10.1016/S0016-7061(03)00223-4; MENEVEAU C, 1990, PHYS REV A, V41, P894, DOI 10.1103/PhysRevA.41.894; Panahi A, 2004, MATH GEOL, V36, P827, DOI 10.1023/B:MATG.0000041181.32596.5d; Perrier E, 2010, BIOGEOSCIENCES DISCU, V7, P2997; Perrier EMA, 2002, SOIL TILL RES, V64, P91, DOI 10.1016/S0167-1987(01)00247-1; Shi JC, 2008, J SOIL SEDIMENT, V8, P415, DOI 10.1007/s11368-008-0045-x; SOLE RV, 2006, SELF ORG COMPLEX ECO; Umesh C.Gupta, 2008, [地学前缘, Earth Science Frontiers], V15, P110; Wang ZY, 2011, PEDOSPHERE, V21, P373, DOI 10.1016/S1002-0160(11)60138-0; Wang ZY, 2009, AUST J SOIL RES, V47, P821, DOI 10.1071/SR09036; White JG, 1999, FIELD CROP RES, V60, P11, DOI 10.1016/S0378-4290(98)00130-0; Wu CF, 2010, GEODERMA, V156, P200, DOI 10.1016/j.geoderma.2010.02.018; Xie SY, 2010, GEODERMA, V160, P36, DOI 10.1016/j.geoderma.2010.01.009; Zeleke TB, 2005, SOIL SCI SOC AM J, V69, P1691, DOI 10.2136/sssaj2005.0072	37	11	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e69326	10.1371/journal.pone.0069326	http://dx.doi.org/10.1371/journal.pone.0069326			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874944	gold, Green Published, Green Submitted			2022-12-27	WOS:000321736900151
J	Lee, SH; Nam, KW; Jeong, JY; Yoo, SJ; Koh, YS; Lee, S; Heo, ST; Seong, SY; Lee, KH				Lee, Su Hyun; Nam, Kwang Woo; Jeong, Ji Yeon; Yoo, Seung Jin; Koh, Young-Sang; Lee, Seogjae; Heo, Sang Taek; Seong, Seung-Yong; Lee, Keun Hwa			The Effects of Climate Change and Globalization on Mosquito Vectors: Evidence from Jeju Island, South Korea on the Potential for Asian Tiger Mosquito (Aedes albopictus) Influxes and Survival from Vietnam Rather Than Japan	PLOS ONE			English	Article							GLOBAL CLIMATE; DIPTERA; TEMPERATURE; INVASION; DENGUE	Background: Climate change affects the survival and transmission of arthropod vectors as well as the development rates of vector-borne pathogens. Increased international travel is also an important factor in the spread of vector-borne diseases (VBDs) such as dengue, West Nile, yellow fever, chikungunya, and malaria. Dengue is the most important vector-borne viral disease. An estimated 2.5 billion people are at risk of infection in the world and there are approximately 50 million dengue infections and an estimated 500,000 individuals are hospitalized with dengue haemorrhagic fever annually. The Asian tiger mosquito (Aedes albopictus) is one of the vectors of dengue virus, and populations already exist on Jeju Island, South Korea. Currently, colder winter temperatures kill off Asian tiger mosquito populations and there is no evidence of the mosquitos being vectors for the dengue virus in this location. However, dengue virus-bearing mosquito vectors can inflow to Jeju Island from endemic area such as Vietnam by increased international travel, and this mosquito vector's survival during colder winter months will likely occur due to the effects of climate change. Methods and Results: In this section, we show the geographical distribution of medically important mosquito vectors such as Ae. albopictus, a vector of both dengue and chikungunya viruses; Culex pipiens, a vector of West Nile virus; and Anopheles sinensis, a vector of Plasmodium vivax, within Jeju Island, South Korea. We found a significant association between the mean temperature, amount of precipitation, and density of mosquitoes. The phylogenetic analyses show that an Ae. albopictus, collected in southern area of Jeju Island, was identical to specimens found in Ho Chi Minh, Vietnam, and not Nagasaki, Japan. Conclusion: Our results suggest that mosquito vectors or virus-bearing vectors can transmit from epidemic regions of Southeast Asia to Jeju Island and can survive during colder winter months. Therefore, Jeju Island is no longer safe from vector borne diseases (VBDs) due to the effects of globalization and climate change, and we should immediately monitor regional climate change to identify newly emerging VBDs.	[Lee, Su Hyun; Nam, Kwang Woo; Jeong, Ji Yeon; Yoo, Seung Jin; Koh, Young-Sang; Lee, Seogjae; Heo, Sang Taek; Lee, Keun Hwa] Jeju Natl Univ, Sch Med, Cheju, South Korea; [Seong, Seung-Yong] Seoul Natl Univ, Coll Med, Wide River Inst Immunol, Seoul, South Korea; [Seong, Seung-Yong] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Dept Microbiol & Immunol, Seoul, South Korea	Jeju National University; Seoul National University (SNU); Seoul National University (SNU)	Lee, KH (corresponding author), Jeju Natl Univ, Sch Med, Cheju, South Korea.	yomust7@jejunu.ac.kr	Lee, Keun/L-6703-2019; Seong, Seung Yong/J-2764-2012	Seong, Seung Yong/0000-0002-3671-1029; Heo, Sang Taek/0000-0001-8947-5069; Yoo, Seung Jin/0000-0003-4871-9412	Korea Center for Disease Control and Prevention [2010E0065500, 2011E5500100]; Environmental Health Center Jeju National University School of Medicine	Korea Center for Disease Control and Prevention; Environmental Health Center Jeju National University School of Medicine	This study was funded partly by a research grant from Korea Center for Disease Control and Prevention (2010E0065500, 2011E5500100) and The Environmental Health Center Jeju National University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armbruster P, 2009, J MED ENTOMOL, V46, P271, DOI 10.1603/033.046.0211; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Birungi J, 2002, ANN ENTOMOL SOC AM, V95, P125, DOI 10.1603/0013-8746(2002)095[0125:GSOAAD]2.0.CO;2; Cameron AC., 2013, REGRESSION ANAL COUN, V2nd ed, DOI 10.1017/CBO9781139013567; Colwell RR, 1996, SCIENCE, V274, P2025, DOI 10.1126/science.274.5295.2025; Domingo C, 2011, FUTURE VIROL, V6, P1059, DOI 10.2217/FVL.11.77; GILLIES M. T., 1953, EAST AFRICAN MED JOUR, V30, P129; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6; Health Effects of Climate Change in the UK, 2012, 8 EFF CLIM CHANG VEC, P159; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; IPCC 4th, 2007, CLIM CHANG 2007 SYNT, P403; Kamgang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020257; Kim H. C., 2005, Entomological Research, V35, P55, DOI 10.1111/j.1748-5967.2005.tb00137.x; Komar Nicholas, 2003, Adv Virus Res, V61, P185; Korea Centers for Disease Control and Prevention, 2009, ID MOSQ SPEC ACC MAN; Kovats RS, 2001, PHILOS T R SOC B, V356, P1057, DOI 10.1098/rstb.2001.0894; Murdock CC, 2012, NAT REV MICROBIOL, V10, P869, DOI 10.1038/nrmicro2900; RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shuman EK, 2010, NEW ENGL J MED, V362, P1061, DOI 10.1056/NEJMp0912931; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Watson R.T., 1997, REGIONAL IMPACTS CLI, DOI 10.1029/2007eo500004	23	26	28	2	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e68512	10.1371/journal.pone.0068512	http://dx.doi.org/10.1371/journal.pone.0068512			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894312	Green Published, gold, Green Submitted			2022-12-27	WOS:000322167900014
J	Lu, CX; Lei, L; Peng, B; Tang, LL; Ding, HL; Gong, SQ; Li, ZY; Wu, YM; Zhong, GM				Lu, Chunxue; Lei, Lei; Peng, Bo; Tang, Lingli; Ding, Honglei; Gong, Siqi; Li, Zhongyu; Wu, Yimou; Zhong, Guangming			Chlamydia trachomatis GlgA Is Secreted into Host Cell Cytoplasm	PLOS ONE			English	Article							HUMAN-ANTIBODY RESPONSES; EARLY-CYCLE DEVELOPMENT; INCLUSION MEMBRANE; INFECTED CELLS; PROTEINS; PLASMID; GENOME; LOCALIZATION; INHIBITION; ACTIVATION	Glycogen has been localized both inside and outside Chlamydia trachomatis organisms. We now report that C. trachomatis glycogen synthase (GlgA) was detected in both chlamydial organism-associated and -free forms. The organism-free GlgA molecules were localized both in the lumen of chlamydial inclusions and in the cytosol of host cells. The cytosolic GlgA displayed a distribution pattern similar to that of a known C. trachomatis-secreted protease, CPAF. The detection of GlgA was specific since the anti-GlgA antibody labeling was only removed by preabsorption with GlgA but not CPAF fusion proteins. GlgA was detectable at 12h and its localization into host cell cytosol only became apparent at 24h after infection. The cytosolic localization of GlgA was conserved among all C. trachomatis serovars. However, the significance of the GlgA secretion into host cell cytoplasm remains unclear since, while expression of chlamydial GlgA in HeLa cells increased glycogen stores, it did not affect a subsequent infection with C. trachomatis. Similar to several other C. trachomatis-secreted proteins, GlgA is immunogenic in women urogenitally infected with C. trachomatis, suggesting that GlgA is expressed and may be secreted into host cell cytosol during C. trachomatis infection in humans. These findings have provided important information for further understanding C. trachomatis pathogenic mechanisms.	[Lu, Chunxue; Peng, Bo; Li, Zhongyu; Wu, Yimou] Univ South China, Dept Pathogen Biol, Hengyang, Hunan, Peoples R China; [Lu, Chunxue; Lei, Lei; Peng, Bo; Tang, Lingli; Ding, Honglei; Gong, Siqi; Zhong, Guangming] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA	University of South China; University of Texas System; University of Texas Health San Antonio	Wu, YM (corresponding author), Univ South China, Dept Pathogen Biol, Hengyang, Hunan, Peoples R China.	Yimouwu@sina.com; zhongg@uthscsa.edu	Gong, Siqi/ABD-9207-2020; Gong, Siqi/AAM-1568-2021; Lei, Lei/I-3002-2013	Gong, Siqi/0000-0002-1111-6039; 	US NIH [R01AI47997, R01AI64537]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064537, R01AI047997] Funding Source: NIH RePORTER	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding: R01AI47997 and R01AI64537 both from US NIH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Budrys NM, 2012, OBSTET GYNECOL, V119, P1009, DOI 10.1097/AOG.0b013e3182519326; Carlson JH, 2008, INFECT IMMUN, V76, P2273, DOI 10.1128/IAI.00102-08; [Centers for Disease Control and Prevention C Services USDoHaH], 2009, SEX TRANSM DIS SURV; Chen CQ, 2006, INFECT IMMUN, V74, P4826, DOI 10.1128/IAI.00081-06; Chen LL, 2010, J IMMUNOL, V184, P2602, DOI 10.4049/jimmunol.0901593; Cheng W, 2008, INFECT IMMUN, V76, P515, DOI 10.1128/IAI.01064-07; CHIAPPINO ML, 1995, J BACTERIOL, V177, P5358, DOI 10.1128/jb.177.18.5358-5363.1995; Clifton DR, 2004, P NATL ACAD SCI USA, V101, P10166, DOI 10.1073/pnas.0402829101; Engel J, 2004, P NATL ACAD SCI USA, V101, P9947, DOI 10.1073/pnas.0403633101; Fan T, 1998, J EXP MED, V187, P487, DOI 10.1084/jem.187.4.487; Fields KA, 2003, MOL MICROBIOL, V48, P671, DOI 10.1046/j.1365-2958.2003.03462.x; GILKES M J, 1958, Br J Ophthalmol, V42, P473, DOI 10.1136/bjo.42.8.473; Gong S, 2011, MICROBIOLOGY; Hackstadt T, 1997, TRENDS MICROBIOL, V5, P288, DOI 10.1016/S0966-842X(97)01061-5; Hower S, 2009, MOL MICROBIOL, V72, P1423, DOI 10.1111/j.1365-2958.2009.06732.x; Lei L, 2011, MICROB PATHOGENESIS, V51, P101, DOI 10.1016/j.micpath.2011.05.002; Li ZY, 2008, INFECT IMMUN, V76, P3415, DOI 10.1128/IAI.01377-07; Li ZY, 2008, INFECT IMMUN, V76, P2746, DOI 10.1128/IAI.00010-08; O'Connell CM, 2007, J IMMUNOL, V179, P4027, DOI 10.4049/jimmunol.179.6.4027; Peng XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032997, 10.1371/journal.pone.0040120]; Peterman TA, 2006, ANN INTERN MED, V145, P564, DOI 10.7326/0003-4819-145-8-200610170-00005; Qi M., 2011, INFECT IMMUN; Qi ML, 2011, J BACTERIOL, V193, P2498, DOI 10.1128/JB.01301-10; Rockey DD, 2002, MICROBES INFECT, V4, P333, DOI 10.1016/S1286-4579(02)01546-0; Scidmore MA, 2003, INFECT IMMUN, V71, P973, DOI 10.1128/IAI.71.2.973-984.2003; Sharma J, 2006, INFECT IMMUN, V74, P1490, DOI 10.1128/IAI.74.3.1490-1499.2006; Sharma J, 2004, INFECT IMMUN, V72, P7164, DOI 10.1128/IAI.72.12.7164-7171.2004; SHERMAN KJ, 1990, SEX TRANSM DIS, V17, P115, DOI 10.1097/00007435-199007000-00001; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Stephens RS, 2003, TRENDS MICROBIOL, V11, P44, DOI 10.1016/S0966-842X(02)00011-2; Valdivia RH, 2008, CURR OPIN MICROBIOL, V11, P53, DOI 10.1016/j.mib.2008.01.003; Wang J, 2010, J IMMUNOL, V185, P1670, DOI 10.4049/jimmunol.1001240; Wu X, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-87; Yang C, 1998, J CLIN MICROBIOL, V36, P1081, DOI 10.1128/JCM.36.4.1081-1082.1998; Zhong GM, 2001, J EXP MED, V193, P935, DOI 10.1084/jem.193.8.935; Zhong GM, 2009, TRENDS MICROBIOL, V17, P467, DOI 10.1016/j.tim.2009.07.007; Zhong YM, 2006, J INFECTION, V53, P408, DOI 10.1016/j.jinf.2005.12.028	37	28	32	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e68764	10.1371/journal.pone.0068764	http://dx.doi.org/10.1371/journal.pone.0068764			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894341	gold, Green Submitted, Green Published			2022-12-27	WOS:000322167900024
J	Sagi-Schwartz, A; Bakermans-Kranenburg, MJ; Linn, S; van IJzendoorn, MH				Sagi-Schwartz, Abraham; Bakermans-Kranenburg, Marian J.; Linn, Shai; van IJzendoorn, Marinus H.			Against All Odds: Genocidal Trauma Is Associated with Longer Life-Expectancy of the Survivors	PLOS ONE			English	Article							HOLOCAUST; STRESS; TRANSMISSION; CHILDREN; TWIN; WAR	Does surviving genocidal experiences, like the Holocaust, lead to shorter life-expectancy? Such an effect is conceivable given that most survivors not only suffered psychosocial trauma but also malnutrition, restriction in hygienic and sanitary facilities, and lack of preventive medical and health services, with potentially damaging effects for later health and life-expectancy. We explored whether genocidal survivors have a higher risk to die younger than comparisons without such background. This is the first population-based retrospective cohort study of the Holocaust, based on the entire population of immigrants from Poland to Israel (N = 55,220), 4-20 years old when the World War II started (1939), immigrating to Israel either between 1945 and 1950 (Holocaust group) or before 1939 (comparison group; not exposed to the Holocaust). Hazard of death - a long-term outcome of surviving genocidal trauma - was derived from the population-wide official data base of the National Insurance Institute of Israel. Cox regression yielded a significant hazard ratio (HR = 0.935, CI (95%) = 0.910-0.960), suggesting that the risk of death was reduced by 6.5 months for Holocaust survivors compared to non-Holocaust comparisons. The lower hazard was most substantial in males who were aged 10-15 (HR = 0.900, CI (95%) = 0.842-0.962, i.e., reduced by 10 months) or 16-20 years at the onset of the Holocaust (HR = 0.820, CI (95%) = 0.782-0.859, i.e., reduced by18 months). We found that against all odds genocidal survivors were likely to live longer. We suggest two explanations: Differential mortality during the Holocaust and "Posttraumatic Growth" associated with protective factors in Holocaust survivors or in their environment after World War II.	[Sagi-Schwartz, Abraham] Univ Haifa, Ctr Study Child Dev, IL-31999 Haifa, Israel; [Sagi-Schwartz, Abraham] Univ Haifa, Dept Psychol, IL-31999 Haifa, Israel; [Bakermans-Kranenburg, Marian J.; van IJzendoorn, Marinus H.] Leiden Univ, Ctr Child & Family Studies, Rommert Casimir Inst Dev Psychopathol, AK Leiden, NL-2300 RA Leiden, Netherlands; [Linn, Shai] Univ Haifa, Sch Publ Hlth, IL-31999 Haifa, Israel; [Linn, Shai] Rambam Med Ctr, Clin Epidemiol Unit, Haifa, Israel	University of Haifa; University of Haifa; Leiden University; Leiden University - Excl LUMC; University of Haifa; Rambam Health Care Campus; Technion Israel Institute of Technology	Sagi-Schwartz, A (corresponding author), Univ Haifa, Ctr Study Child Dev, IL-31999 Haifa, Israel.	sagi@psy.haifa.ac.il	van IJzendoorn, Marinus/P-4907-2019; Linn, Shai/N-3079-2019; Bakermans-Kranenburg, Marian/AAF-7746-2020	van IJzendoorn, Marinus/0000-0003-1144-454X; Linn, Shai/0000-0002-0867-2958; Bakermans-Kranenburg, Marian/0000-0001-7763-0711	Netherlands Organization for Scientific Research; Center for Advanced Holocaust Studies, United States Holocaust Memorial Museum	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Center for Advanced Holocaust Studies, United States Holocaust Memorial Museum	MHVIJ and MJB-K were supported by research awards from The Netherlands Organization for Scientific Research (NWO SPINOZA prize and VIDI and VICI grants, respectively). AS-S was supported as a Phyllis Greenberg Heideman and Richard D. Heideman Fellow, Center for Advanced Holocaust Studies, United States Holocaust Memorial Museum. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviezer O, 1994, PSYCHOL BULL, V136, P99; Barel E, 2010, PSYCHOL BULL, V136, P677, DOI 10.1037/a0020339; Collins C, 2004, J TRAUMA STRESS, V17, P403, DOI 10.1023/B:JOTS.0000048953.27980.18; Drury SS, 2012, MOL PSYCHIATR, V17, P719, DOI 10.1038/mp.2011.53; Elder GlenH., 1999, CHILDREN GREAT DEPRE; GOLDBERG J, 1990, JAMA-J AM MED ASSOC, V263, P1227, DOI 10.1001/jama.263.9.1227; Kananen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010826; Keinan-Boker L, 2009, JNCI-J NATL CANCER I, V101, P1489, DOI 10.1093/jnci/djp327; Leon DA, 2011, INT J EPIDEMIOL, V40, P271, DOI 10.1093/ije/dyr061; Lev-Wiesel R, 2003, J LOSS TRAUMA, V8, P229, DOI 10.1080/15325020305884; Mitchell MM, 2013, J LOSS TRAUMA, V18, P383, DOI 10.1080/15325024.2013.768847; Sagi-Schwartz A, 2003, AM J PSYCHIAT, V160, P1086, DOI 10.1176/appi.ajp.160.6.1086; Sagi-Schwartz A, 2008, ATTACH HUM DEV, V10, P105, DOI 10.1080/14616730802113661; SCHWARTZ S, 1994, J HEALTH SOC BEHAV, V35, P385, DOI 10.2307/2137216; Shalev I, 2013, MOL PSYCHIATR, V18, P576, DOI 10.1038/mp.2012.32; Shalev I, 2012, BIOESSAYS, V34, P943, DOI 10.1002/bies.201200084; SLAGBOOM PE, 1994, AM J HUM GENET, V55, P876; van IJzendoorn MH, 2003, J TRAUMA STRESS, V16, P459, DOI 10.1023/A:1025706427300	18	35	35	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69179	10.1371/journal.pone.0069179	http://dx.doi.org/10.1371/journal.pone.0069179			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	188BY	23894427	Green Published, gold, Green Submitted			2022-12-27	WOS:000322167900044
J	Frantz, ED; Crespo-Mascarenhas, C; Barreto-Vianna, ARC; Aguila, MB; Mandarim-de-Lacerda, CA				Frantz, Eliete Dalla Corte; Crespo-Mascarenhas, Camila; Barreto-Vianna, Andre Rodrigues C.; Aguila, Marcia Barbosa; Mandarim-de-Lacerda, Carlos Alberto			Renin-Angiotensin System Blockers Protect Pancreatic Islets against Diet-Induced Obesity and Insulin Resistance in Mice	PLOS ONE			English	Article							BETA-CELL FUNCTION; BODY-WEIGHT GAIN; CONVERTING-ENZYME; DIABETES-MELLITUS; RECEPTOR BLOCKADE; GLUCOSE-TOLERANCE; INHIBITION; EXPRESSION; CAPTOPRIL; HYPERTENSION	Background: The associations between obesity, hypertension and diabetes are well established, and the renin-angiotensin system (RAS) may provide a link among them. The effect of RAS inhibition on type 2 diabetes is still unclear; however, RAS seems to play an important role in the regulation of the pancreas and glucose intolerance of mice fed high-fat (HF) diet. Methods: C57BL/6 mice fed a HF diet (8 weeks) were treated with aliskiren (50 mg/kg/day), enalapril (30 mg/kg/day) or losartan (10 mg/kg/day) for 6 weeks, and the protective effects were extensively compared among groups by morphometry, stereological tools, immunostaining, Western blotting and hormonal analysis. Results: All RAS inhibitors significantly attenuated the increased blood pressure in mice fed a HF diet. Treatment with enalapril, but not aliskiren or losartan, significantly attenuated body mass (BM) gain, glucose intolerance and insulin resistance, improved the alpha and beta cell mass and prevented the reduction of plasma adiponectin. Furthermore, enalapril treatment improved the protein expression of the pancreatic islet Pdx1, GLUT2, ACE2 and Mas receptors. Losartan treatment showed the greatest AT2R expression. Conclusion: Our findings indicate that ACE inhibition with enalapril attenuated several of the deleterious effects of the HF diet. In summary, enalapril appears to be responsible for the normalization of islet morphology and function, of alpha and beta cell mass and of Pdx1 and GLUT2 expression. These protective effects of enalapril were attributed, primarily, to the reduction in body mass gain and food intake and the enhancement of the ACE2/Ang (1-7) /Mas receptor axis and adiponectin levels.	[Frantz, Eliete Dalla Corte; Crespo-Mascarenhas, Camila; Barreto-Vianna, Andre Rodrigues C.; Aguila, Marcia Barbosa; Mandarim-de-Lacerda, Carlos Alberto] Univ Estado Rio De Janeiro, Inst Biol, Biomed Ctr, Lab Morphometry Metab & Cardiovasc Dis, Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro	Mandarim-de-Lacerda, CA (corresponding author), Univ Estado Rio De Janeiro, Inst Biol, Biomed Ctr, Lab Morphometry Metab & Cardiovasc Dis, Rio De Janeiro, Brazil.	mandarim@uerj.br	Aguila, Marcia Barbosa/ABF-6505-2020; Mandarim-de-Lacerda, Carlos A/F-7125-2012; Frantz, Eliete/AAL-9092-2021; da Cunha Barreto Vianna, André Rodrigues/AAB-1058-2019; Mandarim-de-Lacerda, Carlos Alberto/P-2360-2019; Aguila, Marcia/P-2349-2019	Aguila, Marcia Barbosa/0000-0003-3994-4589; Frantz, Eliete/0000-0002-1747-5614; Mandarim-de-Lacerda, Carlos Alberto/0000-0003-4134-7978; Rodrigues da Cunha Barreto Vianna, Andre/0000-0001-8354-3163	CNPq (Brazilian Council of Science and Technology) [E26/110.549/2010]; FAPERJ (Rio de Janeiro State Foundation for Scientific Research) [302154/2011-6]	CNPq (Brazilian Council of Science and Technology)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ (Rio de Janeiro State Foundation for Scientific Research)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	The present work received financial support by the agencies CNPq (Brazilian Council of Science and Technology, www.cnpq.br) [grant number E26/110.549/2010, C.A.M.L.] and FAPERJ (Rio de Janeiro State Foundation for Scientific Research, www.faperj.br) [grant number 302154/2011-6, C.A.M.L.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu DA, 2007, MOL GENET METAB, V92, P43, DOI 10.1016/j.ymgme.2007.06.008; Barros CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040573; Barzilay JI, 2006, ARCH INTERN MED, V166, P2191, DOI 10.1001/archinte.166.20.2191; Bernardo AS, 2008, MOL CELL ENDOCRINOL, V294, P1, DOI 10.1016/j.mce.2008.07.006; Bindom SM, 2010, DIABETES, V59, P2540, DOI 10.2337/db09-0782; Bonora E, 2008, NUTR METAB CARDIOVAS, V18, P74, DOI 10.1016/j.numecd.2007.05.004; Carvalho CRO, 1997, DIABETES, V46, P1950, DOI 10.2337/diabetes.46.12.1950; Chu KY, 2006, DIABETES, V55, P367, DOI 10.2337/diabetes.55.02.06.db05-1022; Frantz EDC, 2011, MECH AGEING DEV, V132, P110, DOI 10.1016/j.mad.2011.01.003; de Kloet AD, 2010, PHYSIOL BEHAV, V100, P525, DOI 10.1016/j.physbeh.2010.03.018; Dong YF, 2010, DIABETOLOGIA, V53, P180, DOI 10.1007/s00125-009-1575-5; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Folli F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028050; Giani JF, 2009, AM J PHYSIOL-ENDOC M, V296, pE262, DOI 10.1152/ajpendo.90678.2008; Hansson L, 1999, LANCET, V353, P611, DOI 10.1016/S0140-6736(98)05012-0; Henriksen EJ, 1999, AM J PHYSIOL-REG I, V277, pR332, DOI 10.1152/ajpregu.1999.277.1.R332; Santos SHS, 2008, DIABETES, V57, P340, DOI 10.2337/db07-0953; Janssen SWJ, 2001, EXP CLIN ENDOCR DIAB, V109, P273, DOI 10.1055/s-2001-16347; Jayasooriya AP, 2008, P NATL ACAD SCI USA, V105, P6531, DOI 10.1073/pnas.0802690105; Kintscher U, 2012, HYPERTENS RES, V35, P704, DOI 10.1038/hr.2012.35; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; Leung Po Sing, 2003, JOP, V4, P89; Liu Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016096; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Luther JM, 2011, TRENDS PHARMACOL SCI, V32, P734, DOI 10.1016/j.tips.2011.07.006; Mandarim-de-Lacerda CA, 2010, METHODS MOL BIOL, V611, P211, DOI 10.1007/978-1-60327-345-9_17; Mario EG, 2012, PEPTIDES, V33, P174, DOI 10.1016/j.peptides.2011.11.014; Masuo K, 2001, AM J HYPERTENS, V14, P530, DOI 10.1016/S0895-7061(00)01279-6; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Munoz MC, 2012, REGUL PEPTIDES, V177, P1, DOI 10.1016/j.regpep.2012.04.001; Navarro-Tableros V, 2007, AM J PHYSIOL-ENDOC M, V292, pE1018, DOI 10.1152/ajpendo.00457.2006; Oh YB, 2012, PEPTIDES, V37, P79, DOI 10.1016/j.peptides.2012.06.005; Ohshima K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048387; Passos-Silva DG, 2013, CLIN SCI, V124, P443, DOI 10.1042/CS20120461; PEACH MJ, 1977, PHYSIOL REV, V57, P313, DOI 10.1152/physrev.1977.57.2.313; Pereira LMM, 2004, CLIN SCI, V106, P337, DOI 10.1042/CS20030268; Perlstein TS, 2012, CLIN SCI, V122, P193, DOI 10.1042/CS20110284; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Richard D, 2009, INT J OBESITY, V33, pS1, DOI 10.1038/ijo.2009.63; Santos EL, 2009, BIOCHEM PHARMACOL, V78, P951, DOI 10.1016/j.bcp.2009.06.018; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; Santos RAS, 2008, EXP PHYSIOL, V93, P519, DOI 10.1113/expphysiol.2008.042002; Santos SHS, 2010, ARTERIOSCL THROM VAS, V30, P953, DOI 10.1161/ATVBAHA.109.200493; Shindler DM, 1996, AM J CARDIOL, V77, P1017, DOI 10.1016/S0002-9149(97)89163-1; Souza-Mello V, 2010, CLIN SCI, V119, P239, DOI 10.1042/CS20100061; Staessen JA, 2006, LANCET, V368, P1449, DOI 10.1016/S0140-6736(06)69442-7; Takeda M, 2013, DIABETES, V62, P223, DOI 10.2337/db12-0177; Tschanz SA, 2011, J MICROSC-OXFORD, V243, P47, DOI 10.1111/j.1365-2818.2010.03481.x; van der Zijl NJ, 2012, DIABETES OBES METAB, V14, P586, DOI 10.1111/j.1463-1326.2012.01559.x; Velloso LA, 2006, DIABETES-METAB RES, V22, P98, DOI 10.1002/dmrr.611; Weisinger RS, 2009, PHYSIOL BEHAV, V98, P192, DOI 10.1016/j.physbeh.2009.05.009; Yang BT, 2012, MOL ENDOCRINOL, V26, P1203, DOI 10.1210/me.2012-1004; Yuan L, 2010, J ENDOCRINOL INVEST, V33, P13, DOI 10.1007/BF03346544; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Yvan-Charvet L, 2005, DIABETES, V54, P991, DOI 10.2337/diabetes.54.4.991; Yvan-Charvet L, 2011, KIDNEY INT, V79, P162, DOI 10.1038/ki.2010.391	56	51	53	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e67192	10.1371/journal.pone.0067192	http://dx.doi.org/10.1371/journal.pone.0067192			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894285	Green Published, gold, Green Submitted			2022-12-27	WOS:000322132100008
J	Suits, MD; Boraston, AB				Suits, Michael D.; Boraston, Alisdair B.			Structure of the Streptococcus pneumoniae Surface Protein and Adhesin PfbA	PLOS ONE			English	Article							SMALL-ANGLE SCATTERING; BIOLOGICAL MACROMOLECULES; POLYSACCHARIDE LYASES; CRYSTAL-STRUCTURE; CRYSTALLOGRAPHY; PREDICTION; COMPLEXES; INSIGHTS; PROGRAM; MODULES	PfbA (plasmin- and fibronectin-binding protein A) is an extracellular Streptococcus pneumoniae cell-wall attached surface protein that binds to fibronectin, plasmin, and plasminogen. Here we present a structural analysis of the surface exposed domains of PfbA using a combined approach of X-ray crystallography and small-angle X-ray scattering (SAXS). The crystal structure of the PfbA core domain, here called PfbA beta, determined to 2.28 angstrom resolution revealed an elongated 12-stranded parallel beta-helix fold, which structure-based comparisons reveal is most similar to proteins with carbohydrate modifying activity. A notable feature of the PfbA beta is an extensive cleft on one face of the protein with electrochemical and spatial features that are analogous to structurally similar carbohydrate-active enzymes utilizing this feature for substrate accommodation. Though this cleft displays a combination of basic amino acid residues and solvent exposed aromatic amino acids that are distinct features for recognition of carbohydrates, no obvious arrangement of amino acid side chains that would constitute catalytic machinery is evident. The pseudo-atomic SAXS model of a larger fragment of PfbA suggests that it has a relatively well-ordered structure with the N-terminal and core domains of PfbA adopting an extend organization and reveals a novel structural class of surface exposed pneumococcal matrix molecule adhesins.	[Suits, Michael D.; Boraston, Alisdair B.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada	University of Victoria	Boraston, AB (corresponding author), Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada.	boraston@uvic.ca		Boraston, Alisdair/0000-0001-6417-0592	Canadian Institutes of Health Research Operating Grant [FRN 86610]	Canadian Institutes of Health Research Operating Grant(Canadian Institutes of Health Research (CIHR))	This work was supported by a Canadian Institutes of Health Research Operating Grant (FRN 86610). MDLS is a Michael Smith Foundation for Health Research (MSFHR) Scholar. ABB is an E.W.R Steacie Memorial Fellow and a MSFHR Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal V, 2013, J BIOL CHEM; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barbirz S, 2008, MOL MICROBIOL, V69, P303, DOI 10.1111/j.1365-2958.2008.06311.x; Borgstahl Gloria E O, 2007, Methods Mol Biol, V363, P109, DOI 10.1007/978-1-59745-209-0_6; Buckwalter CM, 2012, TRENDS MICROBIOL, V20, P517, DOI 10.1016/j.tim.2012.08.008; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Charnock SJ, 2002, P NATL ACAD SCI USA, V99, P12067, DOI 10.1073/pnas.182431199; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Emsley P, 1996, NATURE, V381, P90, DOI 10.1038/381090a0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Ficko-Blean E, 2012, CURR OPIN STRUC BIOL, V22, P570, DOI 10.1016/j.sbi.2012.07.009; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Garron ML, 2010, GLYCOBIOLOGY, V20, P1547, DOI 10.1093/glycob/cwq122; Guinier A., 1955, SMALL ANGLE SCATTERI; Jacques DA, 2010, PROTEIN SCI, V19, P642, DOI 10.1002/pro.351; Jenkins J, 2004, J BIOL CHEM, V279, P9139, DOI 10.1074/jbc.M311390200; Jung WS, 2007, J BIOL CHEM, V282, P8414, DOI 10.1074/jbc.M607143200; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Lofling J, 2011, CELL MICROBIOL, V13, P186, DOI 10.1111/j.1462-5822.2010.01560.x; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Michel G, 2004, J BIOL CHEM, V279, P32882, DOI 10.1074/jbc.M403421200; Michel G, 2001, J BIOL CHEM, V276, P40202, DOI 10.1074/jbc.M100670200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pallen MJ, 2001, TRENDS MICROBIOL, V9, P97, DOI 10.1016/S0966-842X(01)01956-4; Paterson GK, 2010, MOL MICROBIOL, V77, P1, DOI 10.1111/j.1365-2958.2010.07190.x; Perez-Dorado I, 2012, MOL ORAL MICROBIOL, V27, P221, DOI 10.1111/j.2041-1014.2012.00655.x; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Pluvinage B, 2013, J MOL BIOL, V425, P334, DOI 10.1016/j.jmb.2012.11.005; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Robb CS, 2010, ACTA CRYSTALLOGR F, V66, P1596, DOI 10.1107/S1744309110034378; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rozeboom HJ, 2008, J BIOL CHEM, V283, P23819, DOI 10.1074/jbc.M804119200; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; VanOudenhove J, 2009, J MOL BIOL, V387, P910, DOI 10.1016/j.jmb.2009.02.019; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Yamaguchi M, 2008, J BIOL CHEM, V283, P36272, DOI 10.1074/jbc.M807087200	46	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e67190	10.1371/journal.pone.0067190	http://dx.doi.org/10.1371/journal.pone.0067190			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894284	gold, Green Submitted, Green Published			2022-12-27	WOS:000322132100007
J	West, JD; Jacquet, J; King, MM; Correll, SJ; Bergstrom, CT				West, Jevin D.; Jacquet, Jennifer; King, Molly M.; Correll, Shelley J.; Bergstrom, Carl T.			The Role of Gender in Scholarly Authorship	PLOS ONE			English	Article							WOMEN; GAP	Gender disparities appear to be decreasing in academia according to a number of metrics, such as grant funding, hiring, acceptance at scholarly journals, and productivity, and it might be tempting to think that gender inequity will soon be a problem of the past. However, a large-scale analysis based on over eight million papers across the natural sciences, social sciences, and humanities reveals a number of understated and persistent ways in which gender inequities remain. For instance, even where raw publication counts seem to be equal between genders, close inspection reveals that, in certain fields, men predominate in the prestigious first and last author positions. Moreover, women are significantly underrepresented as authors of single-authored papers. Academics should be aware of the subtle ways that gender disparities can occur in scholarly authorship.	[West, Jevin D.; Bergstrom, Carl T.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Jacquet, Jennifer] NYU, New York, NY USA; [King, Molly M.; Correll, Shelley J.] Stanford Univ, Dept Sociol, Stanford, CA 94305 USA; [Bergstrom, Carl T.] Santa Fe Inst, Santa Fe, NM 87501 USA	University of Washington; University of Washington Seattle; New York University; Stanford University; The Santa Fe Institute	West, JD (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	jevinw@u.washington.edu	King, Molly M./O-3300-2019; Bergstrom, Carl T./H-2299-2011	King, Molly M./0000-0002-9558-8622; Bergstrom, Carl T./0000-0002-2070-385X; West, Jevin/0000-0002-4118-0322	NSF [SBE-0915005]; NSF Graduate Research Fellowship [DGE-1147470]	NSF(National Science Foundation (NSF)); NSF Graduate Research Fellowship(National Science Foundation (NSF))	This work was supported in part by NSF grant SBE-0915005 to CTB, NSF Graduate Research Fellowship grant DGE-1147470 to MMK, and a generous gift from JSTOR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABCOCK LINDA, 2007, WOMEN DONT ASK HIGH; Boschini A, 2007, J LABOR ECON, V25, P325, DOI 10.1086/510764; Burrelli J., 2008, 08308 NSF; Ceci SJ, 2011, P NATL ACAD SCI USA, V108, P3157, DOI 10.1073/pnas.1014871108; Conley D, 2012, NATURE, V488, P590, DOI 10.1038/488590a; Correll SJ, 2007, AM J SOCIOL, V112, P1297, DOI 10.1086/511799; Dolado JJ, 2005, TECHNICAL REPORT; Dotson B, 2011, AM J HEALTH-SYST PH, V68, P1736, DOI 10.2146/ajhp100597; Endersby JW, 1996, SOC SCI QUART, V77, P375; England P, 2006, GENDER SOC, V20, P657, DOI 10.1177/0891243206290753; Etzkowitz H., 2000, ATHENA UNBOUND ADV W; Feramisco JD, 2009, J AM ACAD DERMATOL, V60, P63, DOI 10.1016/j.jaad.2008.06.044; Fox MF, 2001, GENDER SOC, V15, P654, DOI 10.1177/089124301015005002; Goldin C, 2000, AM ECON REV, V90, P715, DOI 10.1257/aer.90.4.715; Jagsi R, 2006, NEW ENGL J MED, V355, P281, DOI 10.1056/NEJMsa053910; Lancichinetti A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056117; Lieberson S, 2000, AM J SOCIOL, V105, P1249, DOI 10.1086/210431; Moss-Racusin CA, 2012, P NATL ACAD SCI USA, V109, P16474, DOI 10.1073/pnas.1211286109; National Academy of Sciences (US) National Academy of Engineering (US) and Institute of Medicine (US) Committee on Maximizing the Potential of Women in Academic Science and Engineering, 2007, BIAS BARR FULF POT W; 2010, GEND DIFF CRIT TRANS; PRICE DJD, 1965, SCIENCE, V149, P510; Rosvall M, 2009, EUR PHYS J-SPEC TOP, V178, P13, DOI 10.1140/epjst/e2010-01179-1; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Rosvall M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018209; Rudman LA, 1998, J PERS SOC PSYCHOL, V74, P629, DOI 10.1037/0022-3514.74.3.629; Sidhu R, 2009, J ROY SOC MED, V102, P337, DOI 10.1258/jrsm.2009.080378; Spelke ES, 2006, WHY ARENT MORE WOMEN; Waltman L, 2012, J INFORMETR, V6, P700, DOI 10.1016/j.joi.2012.07.008; Wenneras C, 1997, NATURE, V387, P341, DOI 10.1038/387341a0; West M, 2006, TECHNICAL REPORT; Wren JD, 2007, EMBO REP, V8, P988, DOI 10.1038/sj.embor.7401095; Wuchty S, 2007, SCIENCE, V316, P1036, DOI 10.1126/science.1136099; ZUCKERMAN HA, 1968, AM J SOCIOL, V74, P276, DOI 10.1086/224641	33	417	421	6	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e66212	10.1371/journal.pone.0066212	http://dx.doi.org/10.1371/journal.pone.0066212			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	187PW	23894278	Green Submitted, gold, Green Published			2022-12-27	WOS:000322132100004
J	Landman, M; Schoeman, DS; Kerley, GIH				Landman, Marietjie; Schoeman, David S.; Kerley, Graham I. H.			Shift in Black Rhinoceros Diet in the Presence of Elephant: Evidence for Competition?	PLOS ONE			English	Article							NATIONAL-PARK; EASTERN CAPE; SOUTH-AFRICA; DRY SEASON; FOOD; MEGAHERBIVORES; BIODIVERSITY; CONSUMPTION; DYNAMICS; HABITAT	In African large herbivore assemblages, megaherbivores dominate the biomass and utilise the greatest share of available resources. Consequently, they are considered a separate trophic guild that structures the food niches of coexisting large herbivores. However, there exists little empirical evidence on how food resources are shared within this guild, and none for direct competition for food between megaherbivores. Using the histological analysis of faeces, we explore this phenomenon for African elephant Loxodonta africana and black rhinoceros Diceros bicornis in the Addo Elephant National Park, South Africa, where the accumulated impacts of elephant have reduced browse availability. Despite being unable to generalise beyond our study sites, our observations support the predictions of competition theory (as opposed to optimality theory) by showing (1) a clear seasonal separation in resource use between these megaherbivores that increased as resource availability declined, and (2) rhinoceros changed their selectivity in the absence of elephant (using an adjacent site) by expanding and shifting their diet along the grass-browse continuum, and in relation to availability. Although black rhinoceros are generally considered strict browsers, the most significant shift in diet occurred as rhinoceros increased their preferences for grasses in the presence of elephant. We speculate that the lack of specialised grazing adaptations may increase foraging costs in rhinoceros, through reduced harvest- and handling-efficiencies of grasses. In the short-term, this may be off-set by an enhanced tolerance for low quality food and by seasonally mobilising fat reserves; however, the long-term fitness consequences require further study. Our data suggest that managing elephant at high densities may compromise the foraging opportunities of coexisting browsers. This may be particularly important in small, fenced areas and overlapping preferred habitats where impacts intensify.	[Landman, Marietjie; Schoeman, David S.; Kerley, Graham I. H.] Nelson Mandela Metropolitan Univ, Ctr African Conservat Ecol, Dept Zool, Port Elizabeth, South Africa; [Schoeman, David S.] Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Maroochydore, Qld, Australia	Nelson Mandela University; University of the Sunshine Coast	Landman, M (corresponding author), Nelson Mandela Metropolitan Univ, Ctr African Conservat Ecol, Dept Zool, Port Elizabeth, South Africa.	marietjie.landman@nmmu.ac.za		Schoeman, David/0000-0003-1258-0885	International Fund for Animal Welfare, Centre for the Reproduction of Endangered Species (San Diego); National Research Foundation and Nelson Mandela Metropolitan University; Mazda Wildlife Fund	International Fund for Animal Welfare, Centre for the Reproduction of Endangered Species (San Diego); National Research Foundation and Nelson Mandela Metropolitan University; Mazda Wildlife Fund	The International Fund for Animal Welfare, Centre for the Reproduction of Endangered Species (San Diego), National Research Foundation and Nelson Mandela Metropolitan University provided financial support. Mazda Wildlife Fund provided field transportation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addy JE, 1993, THESIS; AOAC, 1990, OFFICIAL METHODS ANA, VI, DOI DOI 10.1016/J.AQREP.2019.100268; Berger J, 1998, ANIM CONSERV, V1, P33, DOI 10.1111/j.1469-1795.1998.tb00223.x; BOND WJ, 1993, ECOL STU AN, V99, P237; Christianson D, 2009, OECOLOGIA, V158, P603, DOI 10.1007/s00442-008-1200-1; Clarke K.R., 2006, PRIMER V6 USER MANUA; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; CONNELL JH, 1980, OIKOS, V35, P131, DOI 10.2307/3544421; De Klerk C, 2009, THESIS; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; Foggo A, 2003, MAR ECOL PROG SER, V248, P15, DOI 10.3354/meps248015; Foose TJ, 1982, THESIS; Fritz H, 2002, OECOLOGIA, V131, P620, DOI 10.1007/s00442-002-0919-3; Fritz H, 1997, ECOGRAPHY, V20, P417, DOI 10.1111/j.1600-0587.1997.tb00387.x; Fritz H, 2011, ECOGRAPHY, V34, P196, DOI 10.1111/j.1600-0587.2010.06537.x; Goddard J, 1970, AFR J ECOL, V6, P1; Goering H.K., 1970, AGR HDB USDA; Gough KF, 2006, ORYX, V40, P434, DOI 10.1017/S0030605306001189; Grant C. C., 1995, Koedoe, V38, P17; Hall-Martin AJ, 1982, KOEDOE, V25, P63; Hayward MW, 2009, BIOL CONSERV, V142, P1, DOI 10.1016/j.biocon.2008.09.022; HOLECHEK JL, 1982, J RANGE MANAGE, V35, P309, DOI 10.2307/3898308; Hulbert IAR, 2001, OECOLOGIA, V128, P499, DOI 10.1007/s004420100683; JARMAN PJ, 1971, OECOLOGIA, V8, P157, DOI 10.1007/BF00345811; Kerley GIH, 2006, S AFR J SCI, V102, P395; Kerley Graham I.H., 2008, P146; Kerley GIH, 2010, FUNCT ECOL, V24, P670, DOI 10.1111/j.1365-2435.2009.01675.x; Lamprey H. F., 1963, East African Wildlife Journal, V1, P63; Landman M, 2008, J ZOOL, V274, P51, DOI 10.1111/j.1469-7998.2007.00356.x; Landman M, BIOTROPICA IN PRESS; Landman M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045334; Makhabu SW, 2006, ACTA OECOL, V30, P136, DOI 10.1016/j.actao.2006.02.005; Makhabu SW, 2005, J TROP ECOL, V21, P641, DOI 10.1017/S0266467405002701; Mketeni FG, 2012, THESIS; Mucina Ladislav, 2006, V19, P2; Murray M.G., 1996, P247; NEU CW, 1974, J WILDLIFE MANAGE, V38, P541, DOI 10.2307/3800887; Owen-Smith R.N., 1988, MEGAHERBIVORES INFLU, DOI [10.1017/CBO9780511565441, DOI 10.1017/CBO9780511565441]; Parker DM, 2009, AFR J ECOL, V47, P454, DOI 10.1111/j.1365-2028.2008.01012.x; Penzhorn B.L., 1974, Koedoe, V17, P137; PETRIDES G A, 1975, Biological Conservation, V7, P161, DOI 10.1016/0006-3207(75)90012-9; Pianka E.R., 1976, P114; Pianka ER, 1973, ANNU REV ECOL SYST, V4, P53, DOI [DOI 10.1146/ANNUREV.ES.04.110173.000413, 10.1146/annurev.es.04.110173.000413]; Putman RJ, 1996, COMPETITION RESOURCE; PYKE GH, 1977, Q REV BIOL, V52, P137, DOI 10.1086/409852; SANBI, 2012, PLANT SO AFR ONL CHE; SCHOENER TW, 1982, AM SCI, V70, P586; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Shrader AM, 2006, FUNCT ECOL, V20, P376, DOI 10.1111/j.1365-2435.2006.01107.x; Simard MA, 2008, J ANIM ECOL, V77, P678, DOI 10.1111/j.1365-2656.2008.01374.x; SINCLAIR ARE, 1975, J ANIM ECOL, V44, P497, DOI 10.2307/3608; Sinclair ARE, 2003, NATURE, V425, P288, DOI 10.1038/nature01934; Skarpe C, 2004, AMBIO, V33, P276, DOI 10.1639/0044-7447(2004)033[0276:TROTGE]2.0.CO;2; SPARKS DR, 1968, J RANGE MANAGE, V21, P264, DOI 10.2307/3895829; Steinheim G, 2005, J ZOOL, V265, P377, DOI 10.1017/S0952836905006448; STUARTHILL GC, 1992, J APPL ECOL, V29, P699, DOI 10.2307/2404479; Suryawanshi KR, 2010, OECOLOGIA, V162, P453, DOI 10.1007/s00442-009-1467-x; Valeix M, 2007, OECOLOGIA, V153, P739, DOI 10.1007/s00442-007-0764-5; Van Soest P.J, 1994, NUTR ECOLOGY RUMINAN; Wilson SL, 2002, THESIS; Young TP, 2005, BIOL CONSERV, V122, P351, DOI 10.1016/j.biocon.2004.08.007	61	36	37	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e69771	10.1371/journal.pone.0069771	http://dx.doi.org/10.1371/journal.pone.0069771			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23874997	gold, Green Published, Green Submitted			2022-12-27	WOS:000322000600059
J	Sancheti, H; Akopian, G; Yin, F; Brinton, RD; Walsh, JP; Cadenas, E				Sancheti, Harsh; Akopian, Garnik; Yin, Fei; Brinton, Roberta D.; Walsh, John P.; Cadenas, Enrique			Age-Dependent Modulation of Synaptic Plasticity and Insulin Mimetic Effect of Lipoic Acid on a Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; LONG-TERM POTENTIATION; RECEPTOR SUBSTRATE-1; GLUCOSE-METABOLISM; AEROBIC GLYCOLYSIS; SIGNALING PATHWAY; ENERGY-METABOLISM; OLD RATS; A-BETA; BRAIN	Alzheimer's disease is a progressive neurodegenerative disease that entails impairments of memory, thinking and behavior and culminates into brain atrophy. Impaired glucose uptake (accumulating into energy deficits) and synaptic plasticity have been shown to be affected in the early stages of Alzheimer's disease. This study examines the ability of lipoic acid to increase brain glucose uptake and lead to improvements in synaptic plasticity on a triple transgenic mouse model of Alzheimer's disease (3xTg-AD) that shows progression of pathology as a function of age; two age groups: 6 months (young) and 12 months (old) were used in this study. 3xTg-AD mice fed 0.23% w/v lipoic acid in drinking water for 4 weeks showed an insulin mimetic effect that consisted of increased brain glucose uptake, activation of the insulin receptor substrate and of the PI3K/Akt signaling pathway. Lipoic acid supplementation led to important changes in synaptic function as shown by increased input/output (I/O) and long term potentiation (LTP) (measured by electrophysiology). Lipoic acid was more effective in stimulating an insulin-like effect and reversing the impaired synaptic plasticity in the old mice, wherein the impairment of insulin signaling and synaptic plasticity was more pronounced than those in young mice.	[Sancheti, Harsh; Yin, Fei; Brinton, Roberta D.; Cadenas, Enrique] Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA USA; [Akopian, Garnik; Walsh, John P.] Univ So Calif, Davis Sch Gerontol, Los Angeles, CA USA; [Akopian, Garnik; Walsh, John P.] Univ So Calif, Program Neurosci, Los Angeles, CA USA	University of Southern California; University of Southern California; University of Southern California	Cadenas, E (corresponding author), Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA USA.	cadenas@usc.edu	Walsh, John/GQI-2785-2022	Sancheti, Harsh/0000-0001-8084-4550; Brinton, Roberta/0000-0001-8450-772X; Yin, Fei/0000-0002-5996-2410	NIH [RO1AG016718, PO1AG026572]; NATIONAL INSTITUTE ON AGING [R01AG016718, P01AG026572] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH grant RO1AG016718 (to Enrique Cadenas) and PO1AG026572 (to Roberta D. Brinton). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Apelt J, 1999, J NEUROSCI RES, V57, P693, DOI 10.1002/(SICI)1097-4547(19990901)57:5<693::AID-JNR11>3.0.CO;2-X; BIERER LM, 1995, J NEUROCHEM, V64, P749; Blass JP, 2000, ANN NY ACAD SCI, V903, P204, DOI 10.1111/j.1749-6632.2000.tb06370.x; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brinton RD, 2008, ADV DRUG DELIVER REV, V60, P1504, DOI 10.1016/j.addr.2008.06.003; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; Cho KJ, 2003, BIOCHEM PHARMACOL, V66, P849, DOI 10.1016/S0006-2952(03)00395-2; Esposito DL, 2003, J CLIN ENDOCR METAB, V88, P1468, DOI 10.1210/jc.2002-020933; Estrada DE, 1996, DIABETES, V45, P1798, DOI 10.2337/diabetes.45.12.1798; Farr SA, 2003, J NEUROCHEM, V84, P1173, DOI 10.1046/j.1471-4159.2003.01580.x; Ferreira JM, 2011, J NEUROSCI, V31, P1991, DOI 10.1523/JNEUROSCI.1850-09.2011; Fitzjohn SM, 2001, J NEUROSCI, V21, P4691, DOI 10.1523/JNEUROSCI.21-13-04691.2001; Galindo MF, 2010, J NEUROCHEM, V114, P933, DOI 10.1111/j.1471-4159.2010.06814.x; Gibson GE, 1998, J NEURAL TRANSM, V105, P855, DOI 10.1007/s007020050099; Goldstein BJ, 1998, MOL CELL BIOCHEM, V182, P91, DOI 10.1023/A:1006812218502; Grillo CA, 2009, BRAIN RES, V1296, P35, DOI 10.1016/j.brainres.2009.08.005; Habeck C, 2012, BRAIN IMAGING BEHAV, V6, P568, DOI 10.1007/s11682-012-9208-x; Hager K, 2001, ARCH GERONTOL GERIAT, V32, P275, DOI 10.1016/S0167-4943(01)00104-2; Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6; Hauptmann S, 2009, NEUROBIOL AGING, V30, P1574, DOI 10.1016/j.neurobiolaging.2007.12.005; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; HYMAN BT, 1987, ANN NEUROL, V22, P37, DOI 10.1002/ana.410220110; Jacob S, 1999, FREE RADICAL BIO MED, V27, P309, DOI 10.1016/S0891-5849(99)00089-1; Khan AH, 2002, DIABETOLOGIA, V45, P1475, DOI 10.1007/s00125-002-0974-7; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; Leino RL, 1997, J NEUROSCI RES, V49, P617; Liu JK, 2002, P NATL ACAD SCI USA, V99, P1876, DOI 10.1073/pnas.261709098; Liu JK, 2002, P NATL ACAD SCI USA, V99, P2356, DOI 10.1073/pnas.261709299; Liu L, 2008, NEUROBIOL DIS, V31, P46, DOI 10.1016/j.nbd.2008.03.005; Liu Y, 2011, J PATHOL, V225, P54, DOI 10.1002/path.2912; MAHER F, 1994, BIOCHEM J, V301, P379, DOI 10.1042/bj3010379; MALENKA RC, 1994, CELL, V78, P535, DOI 10.1016/0092-8674(94)90517-7; McGahon BM, 1999, NEUROBIOL AGING, V20, P655, DOI 10.1016/S0197-4580(99)00050-0; Mosconi L, 2005, EUR J NUCL MED MOL I, V32, P486, DOI [10.1007/s00259-008-1039-z, 10.1007/s00259-005-1762-7]; Mosconi L, 2008, J NUCL MED, V49, P390, DOI 10.2967/jnumed.107.045385; Mosconi Lisa, 2005, Eur J Nucl Med Mol Imaging, V32, P486, DOI 10.1007/s00259-005-1762-7; Mosconi L, 2011, J ALZHEIMERS DIS, V27, P483, DOI 10.3233/JAD-2011-110866; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Packer L, 2011, J CLIN BIOCHEM NUTR, V48, P26, DOI 10.3164/jcbn.11-005FR; PERRY EK, 1980, NEUROSCI LETT, V18, P105, DOI 10.1016/0304-3940(80)90220-7; Plum L, 2005, TRENDS ENDOCRIN MET, V16, P59, DOI 10.1016/j.tem.2005.01.008; Quinn JF, 2007, NEUROBIOL AGING, V28, P213, DOI 10.1016/j.neurobiolaging.2005.12.014; Schubert D, 2005, AGEING RES REV, V4, P240, DOI 10.1016/j.arr.2005.02.003; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shay KP, 2009, BBA-GEN SUBJECTS, V1790, P1149, DOI 10.1016/j.bbagen.2009.07.026; Shenk JC, 2009, J NEUROL SCI, V283, P199, DOI 10.1016/j.jns.2009.03.002; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; STOLL S, 1993, PHARMACOL BIOCHEM BE, V46, P799, DOI 10.1016/0091-3057(93)90204-7; Swerdlow RH, 2004, MED HYPOTHESES, V63, P8, DOI 10.1016/j.mehy.2003.12.045; Swerdlow RH, 2011, BBA-MOL BASIS DIS, V1812, P1630, DOI 10.1016/j.bbadis.2011.08.012; Takashima A, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P309; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; Vaishnavi SN, 2010, P NATL ACAD SCI USA, V107, P17757, DOI 10.1073/pnas.1010459107; van der Heide LP, 2006, PROG NEUROBIOL, V79, P205, DOI 10.1016/j.pneurobio.2006.06.003; Vlassenko AG, 2010, P NATL ACAD SCI USA, V107, P17763, DOI 10.1073/pnas.1010461107; Wang QH, 1999, MOL CELL BIOL, V19, P4008; Yamada M, 1997, J BIOL CHEM, V272, P30334, DOI 10.1074/jbc.272.48.30334; Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106; Yaworsky K, 2000, DIABETOLOGIA, V43, P294, DOI 10.1007/s001250050047	62	64	66	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e69830	10.1371/journal.pone.0069830	http://dx.doi.org/10.1371/journal.pone.0069830			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23875003	gold, Green Published, Green Submitted			2022-12-27	WOS:000322000600060
J	Darias, MJ; Andree, KB; Boglino, A; Rotllant, J; Cerda-Reverter, JM; Estevez, A; Gisbert, E				Darias, Maria J.; Andree, Karl B.; Boglino, Anais; Rotllant, Josep; Miguel Cerda-Reverter, Jose; Estevez, Alicia; Gisbert, Enric			Morphological and Molecular Characterization of Dietary-Induced Pseudo-Albinism during Post-Embryonic Development of Solea senegalensis (Kaup, 1858)	PLOS ONE			English	Article							AGOUTI-SIGNALING PROTEIN; ZEBRAFISH NEURAL CREST; PIGMENT PATTERN; HIPPOGLOSSUS-HIPPOGLOSSUS; HUMAN MELANOCYTES; ARACHIDONIC-ACID; ATLANTIC HALIBUT; LIVE PREY; CELL FATE; C-KIT	The appearance of the pseudo-albino phenotype was investigated in developing Senegalese sole (Solea senegalensis, Kaup 1858) larvae at morphological and molecular levels. In order to induce the development of pseudo-albinos, Senegalese sole larvae were fed Artemia enriched with high levels of arachidonic acid (ARA). The development of their skin pigmentation was compared to that of a control group fed Artemia enriched with a reference commercial product. The relative amount of skin melanophores, xanthophores and iridophores revealed that larval pigmentation developed similarly in both groups. However, results from different relative proportions, allocation patterns, shapes and sizes of skin chromatophores revealed changes in the pigmentation pattern between ARA and control groups from 33 days post hatching onwards. The new populations of chromatophores that should appear at post-metamorphosis were not formed in the ARA group. Further, spatial patterns of distribution between the already present larval xanthophores and melanophores were suggestive of short-range interaction that seemed to be implicated in the degradation of these chromatophores, leading to the appearance of the pseudo-albino phenotype. The expression profile of several key pigmentation-related genes revealed that melanophore development was promoted in pseudo-albinos without a sufficient degree of terminal differentiation, thus preventing melanogenesis. Present results suggest the potential roles of asip1 and slc24a5 genes on the down-regulation of trp1 expression, leading to defects in melanin production. Moreover, gene expression data supports the involvement of pax3, mitf and asip1 genes in the developmental disruption of the new post-metamorphic populations of melanophores, xanthophores and iridophores.	[Darias, Maria J.; Andree, Karl B.; Boglino, Anais; Estevez, Alicia; Gisbert, Enric] Inst Recerca & Tecnol Agroalimentaries, San Carlos de la Rapita, Catalunya, Spain; [Rotllant, Josep] CSIC, Inst Invest Marinas, Vigo, Galicia, Spain; [Miguel Cerda-Reverter, Jose] CSIC, Inst Acuicultura Torre Sal, Valencia, Spain	IRTA; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Acuicultura de Torre de la Sal (IATS)	Darias, MJ (corresponding author), Inst Recerca & Tecnol Agroalimentaries, San Carlos de la Rapita, Catalunya, Spain.	maria.darias@ird.fr	Cerda-Reverter, Jose Miguel/K-4934-2014; Rotllant, Josep/K-1146-2014; Gisbert, Enric/B-3654-2011; Estevez, Alicia/AAE-1471-2021; Gisbert, Enric/I-7224-2019; Darias, Maria J./D-5715-2012; Andree, Karl/L-7465-2014	Cerda-Reverter, Jose Miguel/0000-0003-1405-5750; Rotllant, Josep/0000-0001-5331-807X; Gisbert, Enric/0000-0002-7457-8468; Estevez, Alicia/0000-0002-7776-0521; Gisbert, Enric/0000-0002-7457-8468; Darias, Maria J./0000-0003-1954-6284; Estevez, Alicia/0000-0002-3690-0532; Andree, Karl/0000-0001-6564-0015	Ministry of Science and Innovation (MICIIN) of the Spanish Government [AGL2008-03897-C04-01/ACU]; Juan de la Cierva post-doctoral contract (MICIIN, Spain)	Ministry of Science and Innovation (MICIIN) of the Spanish Government; Juan de la Cierva post-doctoral contract (MICIIN, Spain)	This work was funded by the Ministry of Science and Innovation (MICIIN) of the Spanish Government (project AGL2008-03897-C04-01/ACU). MD was supported by a Juan de la Cierva post-doctoral contract (MICIIN, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeev V, 2006, J INVEST DERMATOL, V126, P1102, DOI 10.1038/sj.jid.5700125; Aoki H, 2002, LIFE SCI, V71, P2171, DOI 10.1016/S0024-3205(02)01996-3; Boglino A, 2012, AQUACULTURE, V324, P290, DOI 10.1016/j.aquaculture.2011.11.018; Bondurand N, 2000, HUM MOL GENET, V9, P1907, DOI 10.1093/hmg/9.13.1907; Canavate JP, 2006, AQUACULTURE, V258, P368, DOI 10.1016/j.aquaculture.2006.04.009; Cerda-Reverter JM, 2003, ENDOCRINOLOGY, V144, P2336, DOI 10.1210/en.2002-0213; Cerda-Reverter JM, 2005, ENDOCRINOLOGY, V146, P1597, DOI 10.1210/en.2004-1346; Chen AS, 2000, NAT GENET, V26, P97, DOI 10.1038/79254; Curran K, 2010, DEV BIOL, V344, P107, DOI 10.1016/j.ydbio.2010.04.023; Darias MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063005; Fernandez-Diaz C, 2001, J FISH BIOL, V58, P1086, DOI [10.1006/jfbi.2000.1514, 10.1111/j.1095-8649.2001.tb00557.x]; Fujii R, 2000, PIGM CELL RES, V13, P300, DOI 10.1034/j.1600-0749.2000.130502.x; Fukamachi S, 2004, P NATL ACAD SCI USA, V101, P10661, DOI 10.1073/pnas.0401278101; Fukamachi S, 2009, GENE, V442, P81, DOI 10.1016/j.gene.2009.04.010; Galibert MD, 1999, J BIOL CHEM, V274, P26894, DOI 10.1074/jbc.274.38.26894; Gimenez G, 2006, AQUAC RES, V37, P1130, DOI 10.1111/j.1365-2109.2006.01537.x; Ginger RS, 2008, J BIOL CHEM, V283, P5486, DOI 10.1074/jbc.M707521200; Guillot R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048526; Guo XL, 2010, PIGM CELL MELANOMA R, V23, P252, DOI 10.1111/j.1755-148X.2010.00677.x; Hathaway Jessica Diann, 2011, Open Cancer J, V4, P1; Hofreiter M, 2010, CELL MOL LIFE SCI, V67, P2591, DOI 10.1007/s00018-010-0333-7; HUNT G, 1995, J INVEST DERMATOL, V104, P83, DOI 10.1111/1523-1747.ep12613565; Kelsh RN, 1996, DEVELOPMENT, V123, P369; Kelsh RN, 2004, PIGM CELL RES, V17, P326, DOI 10.1111/j.1600-0749.2004.00174.x; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Klovins J, 2004, MOL BIOL EVOL, V21, P563, DOI 10.1093/molbev/msh050; Kubic JD, 2008, PIGM CELL MELANOMA R, V21, P627, DOI 10.1111/j.1755-148X.2008.00514.x; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Levy C, 2011, TRANSCR-AUSTIN, V2, P19, DOI 10.4161/trns.2.1.13650; Lister JA, 2002, MICROSC RES TECHNIQ, V58, P435, DOI 10.1002/jemt.10161; Lister JA, 1999, DEVELOPMENT, V126, P3757; Logan DW, 2003, GENOMICS, V81, P184, DOI 10.1016/S0888-7543(02)00037-x; Lund I, 2010, AQUACULTURE, V308, P159, DOI 10.1016/j.aquaculture.2010.08.004; LUO D, 1995, MELANOMA RES, V5, P303, DOI 10.1097/00008390-199510000-00002; Manchado M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-107; Mellgren EM, 2002, TRENDS GENET, V18, P128, DOI 10.1016/S0168-9525(01)02614-2; Minchin JEN, 2008, DEV BIOL, V317, P508, DOI 10.1016/j.ydbio.2008.02.058; Montoliu L, 2011, COLOR GENES; Nadeau N, 2008, GENETICS, V178, P777, DOI 10.1534/genetics.107.077073; Nakamasu A, 2009, P NATL ACAD SCI USA, V106, P8429, DOI 10.1073/pnas.0808622106; Parichy DM, 2001, DEV GENES EVOL, V211, P319, DOI 10.1007/s004270100155; Parichy DM, 2003, DEVELOPMENT, V130, P817, DOI 10.1242/dev.00307; Patton EE, 2010, PIGM CELL MELANOMA R, V23, P314, DOI 10.1111/j.1755-148X.2010.00693.x; Schallreuter KU, 2008, EXP DERMATOL, V17, P395, DOI 10.1111/j.1600-0625.2007.00675.x; Seikai Tadahisa, 1994, Journal of the World Aquaculture Society, V25, P78, DOI 10.1111/j.1749-7345.1994.tb00807.x; Solbakken JS, 1999, ENVIRON BIOL FISH, V56, P53, DOI 10.1023/A:1007542526040; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Sviderskaya EV, 2001, DEV DYNAM, V221, P373, DOI 10.1002/dvdy.1153; Uong A, 2010, J CELL PHYSIOL, V222, P38, DOI 10.1002/jcp.21935; Villalta M, 2008, AQUACULT NUTR, V14, P120, DOI 10.1111/j.1365-2095.2007.00511.x; Villalta M, 2005, AQUACULTURE, V245, P193, DOI 10.1016/j.aquaculture.2004.11.035; Vogel P, 2008, VET PATHOL, V45, P264, DOI 10.1354/vp.45-2-264; Yamada T, 2010, DEV DYNAM, V239, P3147, DOI 10.1002/dvdy.22440	53	18	18	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68844	10.1371/journal.pone.0068844	http://dx.doi.org/10.1371/journal.pone.0068844			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874785	Green Published, Green Submitted, gold			2022-12-27	WOS:000322064300074
J	Dunstan, F; Fone, DL; Glickman, M; Palmer, S				Dunstan, Frank; Fone, David L.; Glickman, Myer; Palmer, Stephen			Objectively Measured Residential Environment and Self-Reported Health: A Multilevel Analysis of UK Census Data	PLOS ONE			English	Article							BUILT ENVIRONMENT; MENTAL-HEALTH; NEIGHBORHOOD; PLACES; INEQUALITIES; MORTALITY; COMMUNITY; CRIME; SPACE; FEAR	Little is known about the association between health and the quality of the residential environment. What is known is often based on subjective assessments of the environment rather than on measurements by independent observers. The aim of this study, therefore, was to determine the association between self-reported general health and an objectively assessed measure of the residential environment. We studied over 30,000 residents aged 18 or over living in 777 neighbourhoods in south Wales. Built environment quality was measured by independent observers using a validated tool, the Residential Environment Assessment Tool (REAT), at unit postcode level. UK Census data on each resident, which included responses to a question which assessed self-reported general health, was linked to the REAT score. The Census data also contained detailed information on socio-economic and demographic characteristics of all respondents and was also linked to the Welsh Index of Multiple Deprivation. After adjusting for both the individual characteristics and area deprivation, respondents in the areas of poorest neighbourhood quality were more likely to report poor health compared to those living in areas of highest quality (OR 1.36, 95% confidence interval 1.22-1.49). The particular neighbourhood characteristics associated with poor health were physical incivilities and measures of how well the residents maintained their properties. Measures of green space were not associated with self-reported health. This is the first full population study to examine such associations and the results demonstrate the importance for health of the quality of the neighbourhood area in which people live and particularly the way in which residents behave towards their own and their neighbours' property. A better understanding of causal pathways that allows the development of interventions to improve neighbourhood quality would offer significant potential health gains.	[Dunstan, Frank; Fone, David L.; Palmer, Stephen] Cardiff Univ, Inst Primary Care & Publ Hlth, Sch Med, Cardiff CF10 3AX, S Glam, Wales; [Glickman, Myer] Off Natl Stat, Newport, England	Cardiff University	Dunstan, F (corresponding author), Cardiff Univ, Inst Primary Care & Publ Hlth, Sch Med, Cardiff CF10 3AX, S Glam, Wales.	DunstanFD@cardiff.ac.uk		Glickman, Myer/0000-0001-6067-3811				Araya R, 2007, BRIT J PSYCHIAT, V190, P394, DOI 10.1192/bjp.bp.106.024596; Boarnet MG, 2006, AM J PREV MED, V30, P153, DOI 10.1016/j.amepre.2005.09.018; Brown B, 2003, J ENVIRON PSYCHOL, V23, P259, DOI 10.1016/S0272-4944(02)00117-2; Brownson RC, 2009, AM J PREV MED, V36, pS99, DOI 10.1016/j.amepre.2009.01.005; Burton E, 2005, ENVIRON PLANN B, V32, P265, DOI 10.1068/b3038; Burton EJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-839; Buzzelli M, 2006, SOC SCI MED, V62, P1215, DOI 10.1016/j.socscimed.2005.06.056; Chow CK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014294; Clark C, 2006, EPIDEMIOLOGY, V17, pS527, DOI 10.1097/00001648-200611001-01418; Daly BP, 2009, J YOUTH ADOLESCENCE, V38, P63, DOI 10.1007/s10964-008-9294-7; Doyle S, 2006, J AM PLANN ASSOC, V72, P19, DOI 10.1080/01944360608976721; Dunstan F, 2005, J ENVIRON PSYCHOL, V25, P293, DOI 10.1016/j.jenvp.2005.07.004; ELWOOD PC, 1984, J EPIDEMIOL COMMUN H, V38, P259, DOI 10.1136/jech.38.3.259; Evans GW, 2003, J URBAN HEALTH, V80, P536, DOI 10.1093/jurban/jtg063; Fayers PM, 2002, LANCET, V359, P187, DOI 10.1016/S0140-6736(02)07466-4; Fone D, 2007, SOC SCI MED, V64, P633, DOI 10.1016/j.socscimed.2006.09.020; Fone DL, 2013, INT J EPIDEMIOL, V42, P1620, DOI 10.1093/ije/dys175; Frumkin H, 2003, AM J PUBLIC HEALTH, V93, P1451, DOI 10.2105/AJPH.93.9.1451; Hincks S., 2010, REGENERATING COMMUNI; Jordan K, 2003, J EPIDEMIOL COMMUN H, V57, P109, DOI 10.1136/jech.57.2.109; Kim D, 2008, EPIDEMIOL REV, V30, P101, DOI 10.1093/epirev/mxn009; Lebel A, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-27; LEWIS G, 1992, PSYCHOL MED, V22, P465, DOI 10.1017/S0033291700030415; Macintyre S., 2003, NEIGHBORHOODS HLTH, V20, P42; Marmot M, 2010, FAIR SOC HLTH LIVES; McKinnon RA, 2009, AM J PREV MED, V36, pS124, DOI 10.1016/j.amepre.2009.01.012; Mitchell R, 2008, LANCET, V372, P1655, DOI 10.1016/S0140-6736(08)61689-X; National Assembly for Wales, 2005, WELSH IND MULT DEPR; Newman O, 1972, DEFENSIBLE SPACE; O'Reilly D, 2005, BMJ-BRIT MED J, V331, P938, DOI 10.1136/bmj.38594.490532.AE; O'Reilly D, 2010, SOC SCI MED, V71, P1011, DOI 10.1016/j.socscimed.2010.05.042; Office for National Statistics, NAT STAT SOCI CLASS; Office for National Statistics, NEIGHB STAT SUP OUTP; Office of National Statistics (UK), 2001, 2001 CENS; Poortinga W, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-285; Purciel M, 2009, J ENVIRON PSYCHOL, V29, P457, DOI 10.1016/j.jenvp.2009.03.004; Rao M, 2007, LANCET, V370, P1111, DOI 10.1016/S0140-6736(07)61260-4; Ritchie Felix., 2008, EC LABOUR MARKET REV, V2, P29, DOI [10.1057/elmr.2008.73, DOI 10.1057/ELMR.2008.73]; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Roux AVD, 2010, ANN NY ACAD SCI, V1186, P125, DOI 10.1111/j.1749-6632.2009.05333.x; Stafford M, 2007, AM J PUBLIC HEALTH, V97, P2076, DOI 10.2105/AJPH.2006.097154; Sugiyama T, 2008, J EPIDEMIOL COMMUN H, V62, DOI 10.1136/jech.2007.064287; TAYLOR RB, 1984, J RES CRIME DELINQ, V21, P303, DOI 10.1177/0022427884021004003; Thomas H, 2007, BRIT J PSYCHIAT, V191, P500, DOI 10.1192/bjp.bp.107.039438; van den Berg AE, 2010, SOC SCI MED, V70, P1203, DOI 10.1016/j.socscimed.2010.01.002; Weich S, 2002, BRIT J PSYCHIAT, V180, P428, DOI 10.1192/bjp.180.5.428; Weich S, 2001, HEALTH PLACE, V7, P283, DOI 10.1016/S1353-8292(01)00019-3; World Health Organisation, 2010, HIDD CIT UNM OV HLTH; Young Harriet, 2010, Popul Trends, P11, DOI 10.1057/pt.2010.3	49	24	24	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e69045	10.1371/journal.pone.0069045	http://dx.doi.org/10.1371/journal.pone.0069045			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	186SF	23874861	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000322064300084
J	Malagnini, V; Pedrazzoli, F; Papetti, C; Cainelli, C; Zasso, R; Gualandri, V; Pozzebon, A; Ioriatti, C				Malagnini, Valeria; Pedrazzoli, Federico; Papetti, Chiara; Cainelli, Christian; Zasso, Rosaly; Gualandri, Valeria; Pozzebon, Alberto; Ioriatti, Claudio			Ecological and Genetic Differences between Cacopsylla melanoneura (Hemiptera, Psyllidae) Populations Reveal Species Host Plant Preference	PLOS ONE			English	Article							APPLE PROLIFERATION PHYTOPLASMA; EVOLUTIONARY GENETICS; MICROSATELLITE LOCI; BEHAVIORAL EVIDENCE; HOMOPTERA; VECTOR; RACES; APHID; DISCRIMINATION; CRYPTOMYZUS	The psyllid Cacopsylla melanoneura is considered one of the vectors of 'Candidatus Phytoplasma mali', the causal agent of apple proliferation disease. In Northern Italy, overwintered C. melanoneura adults reach apple and hawthorn around the end of January. Nymph development takes place between March and the end of April. The new generation adults migrate onto conifers around mid-June and come back to the host plant species after overwintering. In this study we investigated behavioural differences, genetic differentiation and gene flow between samples of C. melanoneura collected from the two different host plants. Further analyses were performed on some samples collected from conifers. To assess the ecological differences, host-switching experiments were conducted on C. melanoneura samples collected from apple and hawthorn. Furthermore, the genetic structure of the samples was studied by genotyping microsatellite markers. The examined C. melanoneura samples performed better on their native host plant species. This was verified in terms of oviposition and development of the offspring. Data resulting from microsatellite analysis indicated a low, but statistically significant difference between collected-from-apple and hawthorn samples. In conclusion, both ecological and genetic results indicate a differentiation between C. melanoneura samples associated with the two host plants.	[Malagnini, Valeria; Pedrazzoli, Federico; Cainelli, Christian; Zasso, Rosaly; Gualandri, Valeria; Ioriatti, Claudio] FEM IASMA, Ctr Technol Transfer, San Michele All Adige, TN, Italy; [Papetti, Chiara] Univ Padua, Dept Biol, Padua, Italy; [Pozzebon, Alberto] Univ Padua, AGRIPOLIS, Dept Agron Food Nat Resources Anim & Environm, Legnaro, PD, Italy	Fondazione Edmund Mach; University of Padua; University of Padua	Malagnini, V (corresponding author), FEM IASMA, Ctr Technol Transfer, San Michele All Adige, TN, Italy.	valeria.malagnini@iasma.it	Malagnini, Valeria/H-8470-2012; Pozzebon, Alberto/B-7328-2009; ioriatti, claudio/H-5938-2019	Malagnini, Valeria/0000-0001-9686-0299; Pozzebon, Alberto/0000-0002-2445-7211; ioriatti, claudio/0000-0002-8919-9217; Papetti, Chiara/0000-0002-4567-459X; Pedrazzoli, Federico/0000-0002-3841-4650	DEMARCATE project; Provincia Autonoma di Trento (Italy)	DEMARCATE project; Provincia Autonoma di Trento (Italy)(Autonomous Province of Trento)	This research was financed by DEMARCATE project, funded by Provincia Autonoma di Trento (Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison P. D., 1995, SURVIVAL ANAL USING; Amos W, 2007, MOL ECOL NOTES, V7, P10, DOI 10.1111/j.1471-8286.2006.01560.x; Belkhir K, 1996, 5171 CNRS UMR U MONT; Bonferroni C.E, 1936, PUBBL R 1 SUPER SCI, V8, P3; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Clark L. R., 1962, Australian Journal of Zoology, V10, P537, DOI 10.1071/ZO9620537; CONCI C, 1992, ATTI ACC ROV AGIA 7B, V2, P33; Conci C, 1995, ATTI ACCADEMIA ROV 7, VV, P5; CRAIG TP, 1993, EVOLUTION, V47, P1696, DOI 10.1111/j.1558-5646.1993.tb01262.x; Dorn S, 1999, AGR ECOSYST ENVIRON, V73, P111, DOI 10.1016/S0167-8809(99)00020-1; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Dres M, 2002, PHILOS T R SOC B, V357, P471, DOI 10.1098/rstb.2002.1059; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; *EPPO CABI, 1996, QUAR PESTS EUR, P959; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FEDER JL, 1994, P NATL ACAD SCI USA, V91, P7990, DOI 10.1073/pnas.91.17.7990; Filchak KE, 2000, NATURE, V407, P739, DOI 10.1038/35037578; GEGECHKORI AM, 1990, PSYLLIDS HOMOPTERA P; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; GULDEMOND JA, 1990, ENTOMOL EXP APPL, V57, P65, DOI 10.1007/BF00349596; GULDEMOND JA, 1990, ECOL ENTOMOL, V15, P43, DOI 10.1111/j.1365-2311.1990.tb00782.x; Hodkinson I, 2009, J NAT HIST, V43, P65, DOI 10.1080/00222930802354167; HODKINSON ID, 1974, B ENTOMOL RES, V64, P325, DOI 10.1017/S0007485300031217; Lauterer Pavel, 1999, Acta Musei Moraviae Scientiae Biologicae, V84, P71; Lazarev MA, 1972, P ALL UN VI LEN AC A, V61, P101; Lazarev MA, 1974, CRIMEAN APPLE SUCKER, P23; Lazarev MA, 1974, THESIS ACAD SCI MOLD; Linn CE, 2012, EVOLUTION, V66, P3632, DOI 10.1111/j.1558-5646.2012.01719.x; Malagnini V, 2006, P 8 EUR C ENT IZM TU; Malagnini V, 2007, MOL ECOL NOTES, V7, P495, DOI 10.1111/j.1471-8286.2006.01632.x; Mattedi L., 2007, SCOPAZZI MELO CONOSC; Mayer CJ, 2011, AGR FOREST ENTOMOL, V13, P25, DOI 10.1111/j.1461-9563.2010.00495.x; Mayer CJ, 2009, PHYTOPATHOLOGY, V99, P729, DOI 10.1094/PHYTO-99-6-0729; Miller JA, 2004, CAN J FISH AQUAT SCI, V61, P1723, DOI 10.1139/F04-111; Miller NJ, 2003, HEREDITY, V91, P217, DOI 10.1038/sj.hdy.6800331; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Ossiannilsson F., 1992, FAUNA ENTOMOL SCAD; Pizzinat A, 2011, B INSECTOL, V64, pS135; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SAS Institute, 1999, SAS STAT US GUID VER; Sauvion N, 2007, B INSECTOL, V60, P185; Sauvion N, 2009, MOL ECOL RESOUR, V9, P1196, DOI 10.1111/j.1755-0998.2009.02604.x; Seemuller E, 2004, INT J SYST EVOL MICR, V54, P1217, DOI 10.1099/ijs.0.02823-0; Seemuller E., 2002, ATTI GIORNATE FITOPA, P3; SLATKIN M, 1995, GENETICS, V139, P457; Sun Jie-Ru, 2011, Acta Entomologica Sinica, V54, P820; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tedeschi R, 2004, J ECON ENTOMOL, V97, P8, DOI 10.1603/0022-0493-97.1.8; Tedeschi R, 2010, B ENTOMOL RES, V100, P741, DOI 10.1017/S0007485310000118; Tedeschi R, 2002, J ECON ENTOMOL, V95, P544, DOI 10.1603/0022-0493-95.3.544; TEDESCHI R, 2005, PETRIA, V15, P47; Tedeschi R, 2012, J ECON ENTOMOL, V105, P322, DOI 10.1603/EC11237; Tedeschi R, 2009, EUR J PLANT PATHOL, V123, P301, DOI 10.1007/s10658-008-9367-1; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Via S, 2001, TRENDS ECOL EVOL, V16, P381, DOI 10.1016/S0169-5347(01)02188-7; Wahlund S, 1928, HEREDITAS, V11, P65, DOI 10.1111/j.1601-5223.1928.tb02483.x	59	5	5	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e69663	10.1371/journal.pone.0069663	http://dx.doi.org/10.1371/journal.pone.0069663			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874980	Green Published, Green Submitted, gold			2022-12-27	WOS:000322064300109
J	Portevin, D; Young, D				Portevin, Damien; Young, Douglas			Natural Killer Cell Cytokine Response to M. bovis BCG Is Associated with Inhibited Proliferation, Increased Apoptosis and Ultimate Depletion of NKp44(+)CD56(bright) Cells	PLOS ONE			English	Article							BACILLUS-CALMETTE-GUERIN; HUMAN NK CELLS; MYCOBACTERIUM-BOVIS; TUBERCULOUS PLEURISY; BLADDER-CANCER; IMMUNOTHERAPY; VIVO; RECOGNITION; ACTIVATION; DISTINCT	Mycobacterium bovis BCG, a live attenuated strain of M. bovis initially developed as a vaccine against tuberculosis, is also used as an adjuvant for immunotherapy of cancers and for treatment of parasitic infections. The underlying mechanisms are thought to rely on its immunomodulatory properties including the recruitment of natural killer (NK) cells. In that context, we aimed to study the impact of M. bovis BCG on NK cell functions. We looked at cytotoxicity, cytokine production, proliferation and cell survival of purified human NK cells following exposure to single live particles of mycobacteria. We found that M. bovis BCG mediates apoptosis of NK cells only in the context of IL-2 stimulation during which CD56(bright) NK cells are releasing IFN-gamma in response to mycobacteria. We found that the presence of mycobacteria prevented the IL-2 induced proliferation and surface expression of NKp44 receptor by the CD56(bright) population. In summary, we observed that M. bovis BCG is modulating the functions of CD56(bright) NK cells to drive this subset to produce IFN-gamma before subsequent programmed cell death. Therefore, IFN-gamma production by CD56(bright) cells constitutes the main effector mechanism of NK cells that would contribute to the benefits observed for M. bovis BCG as an immunotherapeutic agent.	[Portevin, Damien; Young, Douglas] MRC Natl Inst Med Res, Div Mycobacterial Res, London, England	MRC National Institute for Medical Research	Portevin, D (corresponding author), Swiss Trop & Publ Hlth Inst, Clin Immunol Unit, Basel, Switzerland.	damien.portevin@unibas.ch	Portevin, Damien/ABB-4546-2021	Portevin, Damien/0000-0003-2949-9557	MRC [U117581288]; MRC; Medical Research Council [MC_U117581288] Funding Source: researchfish; MRC [MC_U117581288] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was entirely supported by the MRC core funds (U117581288). DP was holding a Career Development Fellowship from the MRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandroff AB, 2010, IMMUNOTHERAPY-UK, V2, P551, DOI 10.2217/IMT.10.32; Batoni G, 2005, SCAND J IMMUNOL, V62, P498, DOI 10.1111/j.1365-3083.2005.01692.x; Brandau S, 2001, EUR UROL, V39, P518, DOI 10.1159/000052497; Brandau S, 2001, INT J CANCER, V92, P697, DOI 10.1002/1097-0215(20010601)92:5<697::AID-IJC1245>3.0.CO;2-Z; Brandt L, 2002, INFECT IMMUN, V70, P672, DOI 10.1128/IAI.70.2.672-678.2002; CALIGIURI MA, 1993, J CLIN INVEST, V91, P123, DOI 10.1172/JCI116161; Cantoni C, 1999, J EXP MED, V189, P787, DOI 10.1084/jem.189.5.787; Chalifour A, 2004, BLOOD, V104, P1778, DOI 10.1182/blood-2003-08-2820; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Esin S, 2004, IMMUNOLOGY, V112, P143, DOI 10.1111/j.1365-2567.2004.01858.x; Esin S, 2008, INFECT IMMUN, V76, P1719, DOI 10.1128/IAI.00870-07; Evans JH, 2011, EUR J IMMUNOL, V41, P1924, DOI 10.1002/eji.201041180; Fauriat C, 2010, BLOOD, V115, P2167, DOI 10.1182/blood-2009-08-238469; Feng CG, 2006, J IMMUNOL, V177, P7086, DOI 10.4049/jimmunol.177.10.7086; Gregoire C, 2007, IMMUNOL REV, V220, P169, DOI 10.1111/j.1600-065X.2007.00563.x; Hayashi D, 2009, FEMS IMMUNOL MED MIC, V56, P116, DOI 10.1111/j.1574-695X.2009.00559.x; JACKSON AM, 1995, CLIN EXP IMMUNOL, V99, P369, DOI 10.1111/j.1365-2249.1995.tb05560.x; Marcenaro E, 2008, INT IMMUNOL, V20, P1155, DOI 10.1093/intimm/dxn073; Mmajla Manzanilla-Garcia HA, 2009, REV MEX UROL, P307; Pereira LIA, 2009, AM J TROP MED HYG, V81, P378, DOI 10.4269/ajtmh.2009.81.378; Pokkali S, 2009, FEMS IMMUNOL MED MIC, V55, P352, DOI 10.1111/j.1574-695X.2008.00520.x; Poli A, 2009, IMMUNOLOGY, V126, P458, DOI 10.1111/j.1365-2567.2008.03027.x; Portevin D, 2012, CELL MICROBIOL, V14, P1734, DOI 10.1111/j.1462-5822.2012.01834.x; Portevin D, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-82; Reefman E, 2010, J IMMUNOL, V184, P4852, DOI 10.4049/jimmunol.0803954; Rhoades ER, 2005, TUBERCULOSIS, V85, P159, DOI 10.1016/j.tube.2004.10.001; ROBERTSON MJ, 1990, J IMMUNOL, V145, P3194; Ross ME, 1997, BLOOD, V89, P910, DOI 10.1182/blood.V89.3.910; Schierloh P, 2005, J IMMUNOL, V175, P6852, DOI 10.4049/jimmunol.175.10.6852; Schierlohl P, 2009, EUR J IMMUNOL, V39, P2450, DOI 10.1002/eji.200939515; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Uyl-de Groot CA, 2005, VACCINE, V23, P2379, DOI 10.1016/j.vaccine.2005.01.015; van den Biggelaar AHJ, 2009, J ALLERGY CLIN IMMUN, V124, P544, DOI 10.1016/j.jaci.2009.03.040; Watkins MLV, 2008, CLIN VACCINE IMMUNOL, V15, P1666, DOI 10.1128/CVI.00202-08; World Health Organization, 2011, WEEKL EP REC GLOB RO	35	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2013	8	7							e68864	10.1371/journal.pone.0068864	http://dx.doi.org/10.1371/journal.pone.0068864			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZN	23874793	gold, Green Published, Green Submitted			2022-12-27	WOS:000323110600032
J	Knuppel, S; Rohde, K; Meidtner, K; Drogan, D; Holzhutter, HG; Boeing, H; Fisher, E				Knueppel, Sven; Rohde, Klaus; Meidtner, Karina; Drogan, Dagmar; Holzhuetter, Hermann-Georg; Boeing, Heiner; Fisher, Eva			Evaluation of 41 Candidate Gene Variants for Obesity in the EPIC-Potsdam Cohort by Multi-Locus Stepwise Regression	PLOS ONE			English	Article							ASSOCIATION; POLYMORPHISM; HAPLOTYPES; CHILDHOOD; ADULT; MASS; INFORMATION; MUTATION; LINKAGE; TRAITS	Objective: Obesity has become a leading preventable cause of morbidity and mortality in many parts of the world. It is thought to originate from multiple genetic and environmental determinants. The aim of the current study was to introduce haplotype-based multi-locus stepwise regression (MSR) as a method to investigate combinations of unlinked single nucleotide polymorphisms (SNPs) for obesity phenotypes. Methods: In 2,122 healthy randomly selected men and women of the EPIC-Potsdam cohort, the association between 41 SNPs from 18 obesity-candidate genes and either body mass index (BMI, mean = 25.9 kg/m(2), SD = 4.1) or waist circumference (WC, mean = 85.2 cm, SD = 12.6) was assessed. Single SNP analyses were done by using linear regression adjusted for age, sex, and other covariates. Subsequently, MSR was applied to search for the 'best' SNP combinations. Combinations were selected according to specific AIC(c) and p-value criteria. Model uncertainty was accounted for by a permutation test. Results: The strongest single SNP effects on BMI were found for TBC1D1 rs637797 (beta = -0.33, SE = 0.13), FTO rs9939609 (beta = 0.28, SE = 0.13), MC4R rs17700144 (beta = 0.41, SE = 0.15), and MC4R rs10871777 (beta = 0.34, SE = 0.14). All these SNPs showed similar effects on waist circumference. The two 'best' six-SNP combinations for BMI (global p-value = 3.45.10(-6) and 6.82.10(-6)) showed effects ranging from -1.70 (SE = 0.34) to 0.74 kg/m(2) (SE = 0.21) per allele combination. We selected two six-SNP combinations on waist circumference (global p-value = 7.80.10(-6) and 9.76.10(-6)) with an allele combination effect of -2.96 cm (SE = 0.76) at maximum. Additional adjustment for BMI revealed 15 three-SNP combinations (global p-values ranged from 3.09.10(-4) to 1.02.10(-2)). However, after carrying out the permutation test all SNP combinations lost significance indicating that the statistical associations might have occurred by chance. Conclusion: MSR provides a tool to search for risk-related SNP combinations of common traits or diseases. However, the search process does not always find meaningful SNP combinations in a dataset.	[Knueppel, Sven; Drogan, Dagmar; Boeing, Heiner] German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany; [Rohde, Klaus] Max Delbruck Ctr Mol Med Berlin Buch, Berlin, Germany; [Meidtner, Karina] German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Epidemiol, Nuthetal, Germany; [Holzhuetter, Hermann-Georg] Charite, Inst Biochem, D-13353 Berlin, Germany; [Fisher, Eva] Robert Koch Inst, Adm Off, Commiss Genet Testing, Berlin, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Robert Koch Institute	Knuppel, S (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany.	sven.knueppel@dife.de	Knüppel, Sven/AAI-7195-2020	Knüppel, Sven/0000-0001-9006-9906; Holzhutter, Hermann-Georg/0000-0002-5054-6023; Meidtner, Karina/0000-0001-5810-4062	Federal Ministry of Science, Germany [01 EA 9401]; European Union [SOC 95201408 05F02]; Federal Ministry of Education and Science (NGFNplus [01GS0821, 01GI1121B]	Federal Ministry of Science, Germany; European Union(European Commission); Federal Ministry of Education and Science (NGFNplus	The recruitment phase of the EPIC-Potsdam Study was supported by the Federal Ministry of Science, Germany (01 EA 9401), and the European Union (SOC 95201408 05F02). This study is supported by grants from the Federal Ministry of Education and Science (NGFNplus: 01GS0821 and Competence Network Obesity: 01GI1121B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo R, 2008, BIOINFORMATICS, V24, P2105, DOI 10.1093/bioinformatics/btn359; Boeing H, 1999, ANN NUTR METAB, V43, P205, DOI 10.1159/000012787; Brouillette C, 2004, J HUM GENET, V49, P424, DOI 10.1007/s10038-004-0171-2; Chadt A, 2008, NAT GENET, V40, P1354, DOI 10.1038/ng.244; Curtin K, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-170; Dina C, 2008, CURR OPIN CLIN NUTR, V11, P378, DOI 10.1097/MCO.0b013e328303e5e6; Draper N.R, 1998, WILEY SERIES PROBABI, Vthird; Eberle D, 2004, DIABETES, V53, P2153, DOI 10.2337/diabetes.53.8.2153; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Fisher E, 2009, OBESITY, V17, P330, DOI 10.1038/oby.2008.465; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Grant SFA, 2009, OBESITY, V17, P1461, DOI 10.1038/oby.2009.53; Hampe J, 2001, BIOINFORMATICS, V17, P654, DOI 10.1093/bioinformatics/17.7.654; Hani E, 1997, DIABETES, V46, P688, DOI 10.2337/diabetes.46.4.688; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Knuppel S, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-8; Kroke A, 1999, ANN NUTR METAB, V43, P216, DOI 10.1159/000012788; Li SX, 2008, CURR OPIN LIPIDOL, V19, P113, DOI 10.1097/MOL.0b013e3282f6a7f3; Lindner I, 2007, MOL NUTR FOOD RES, V51, P1447, DOI 10.1002/mnfr.200700144; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Narisawa S, 2003, MOL CELL BIOL, V23, P7525, DOI 10.1128/MCB.23.21.7525-7530.2003; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rankinen T, 2006, OBESITY, V14, P529, DOI 10.1038/oby.2006.71; Rebhan M, 1997, TRENDS GENET, V13, P163, DOI 10.1016/S0168-9525(97)01103-7; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Scherag A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000916; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; SUGIURA N, 1978, COMMUN STAT A-THEOR, V7, P13, DOI 10.1080/03610927808827599; Sun G, 1999, INT J OBESITY, V23, P929, DOI 10.1038/sj.ijo.0801021; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Xia Q, 2013, ANN N Y ACAD SCI; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	36	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e68941	10.1371/journal.pone.0068941	http://dx.doi.org/10.1371/journal.pone.0068941			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	23874820	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000321718700043
J	Rich, JL; Chojenta, C; Loxton, D				Rich, Jane Louise; Chojenta, Catherine; Loxton, Deborah			Quality, Rigour and Usefulness of Free-Text Comments Collected by a Large Population Based Longitudinal Study - ALSWH	PLOS ONE			English	Article								While it is common practice for health surveys to include an open-ended question asking for additional comments, the responses to these questions are often not analysed or used by researchers as data. The current project employed an automated semantic program to assess the useability and thematic content of the responses to an open-ended free response item included in the Australian Longitudinal Study on Women's Health (ALSWH) surveys. The study examined the comments of three cohorts of women, born between 1973-78, 1946-51, and 1921-26, from Survey 1 (in 1996) and Survey 5 (in 2007-2009). Findings revealed important differences in the health status of responders compared to non-responders. Across all three cohorts, and at both time points, women who commented tended to have poorer physical health (except for women aged 82-87) and social functioning, experienced more life events, were less likely to be partnered, and (except for women aged 18-23 years) more likely to have higher levels of education, than women who did not comment. Results for mental health were mixed. The analysis revealed differences between cohorts as well as changes over time. The most common themes to emerge for the 1973-78 cohort were health, time, pregnant and work, for the 1946-51 cohort, the most common themes were health, life, time and work, while for the 1921-26 cohort, the most common themes were husband, health and family. The concepts and frequency of concepts changed from the first to the fifth survey. For women in the 1973-78 cohort, pregnant emerged as a prevalent theme, while eating disappeared. Among women in the 1946-51 cohort, cancer, operation and medication emerged as prevalent themes, while for women in the 1921-26 cohort, the concept children disappeared, while family emerged. This analysis suggests that free-text comments are a valuable data source, suitable for content, thematic and narrative analysis, particularly when collected over time.	[Rich, Jane Louise; Chojenta, Catherine; Loxton, Deborah] Univ Newcastle, Res Ctr Gender Hlth & Ageing, Callaghan, NSW 2308, Australia	University of Newcastle	Rich, JL (corresponding author), Univ Newcastle, Res Ctr Gender Hlth & Ageing, Callaghan, NSW 2308, Australia.	jane.rich@newcastle.edu.au	Chojenta, Catherine L/B-2521-2008	Chojenta, Catherine L/0000-0002-2541-4491	Australian Government Department of Health and Ageing [1201195]	Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing)	The Australian Longitudinal Study on Women's Health is funded by the Australian Government Department of Health and Ageing (Grant number: 1201195; http://www.health.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown WJBL, 1996, J WOMENS HEALTH, V5, P467, DOI DOI 10.1089/JWH.1996.5.467; Elliott J, 2008, QUAL RES, V8, P411, DOI 10.1177/1468794106093637; Garcia J, 2004, QUAL QUANT, V38, P113, DOI 10.1023/B:QUQU.0000019394.78970.df; Grech M., 2002, P HUMAN FACTORS ERGO; Holland J., 2006, QUALITATIVE LONGITUD; Kitto S., 2008, MED J AUST, V188; NORBECK JS, 1984, RES NURS HEALTH, V7, P61, DOI 10.1002/nur.4770070110; O'Cathain Alicia, 2004, BMC Med Res Methodol, V4, P25, DOI 10.1186/1471-2288-4-25; Ogden J, 2012, J HEALTH PSYCHOL, V17, P350, DOI 10.1177/1359105311417192; Oliver KL, 1998, J TEACH PHYS EDUC, V17, P244, DOI 10.1123/jtpe.17.2.244; Powers J, 2010, ANN EPIDEMIOL, V20, P318, DOI 10.1016/j.annepidem.2010.01.002; Rich J, 2012, AUST J RURA IN PRESS; Riiskjaer E, 2012, INT J QUAL HEALTH C, V24, P509, DOI 10.1093/intqhc/mzs039; Smith AE, 2006, BEHAV RES METHODS, V38, P262, DOI 10.3758/BF03192778; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; York GS, 2012, AM J HOSP PALLIAT ME, V29, P98, DOI 10.1177/1049909111409564	16	41	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e68832	10.1371/journal.pone.0068832	http://dx.doi.org/10.1371/journal.pone.0068832			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	188UA	23874784	Green Published, gold			2022-12-27	WOS:000322218800047
J	Butin-Israeli, V; Adam, SA; Goldman, RD				Butin-Israeli, Veronika; Adam, Stephen A.; Goldman, Robert D.			Regulation of Nucleotide Excision Repair by Nuclear Lamin B1	PLOS ONE			English	Article							DNA-DAMAGE RESPONSES; A-TYPE LAMINS; DEFECTIVE MATURATION; SENESCENCE; CHROMATIN; PROGERIA; B2; PROLIFERATION; ORGANIZATION; RECOGNITION	The nuclear lamins play important roles in the structural organization and function of the metazoan cell nucleus. Recent studies on B-type lamins identified a requirement for lamin B1 (LB1) in the regulation of cell proliferation in normal diploid cells. In order to further investigate the function of LB1 in proliferation, we disrupted its normal expression in U-2 OS human osteosarcoma and other tumor cell lines. Silencing LB1 expression induced G1 cell cycle arrest without significant apoptosis. The arrested cells are unable to mount a timely and effective response to DNA damage induced by UV irradiation. Several proteins involved in the detection and repair of UV damage by the nucleotide excision repair (NER) pathway are downregulated in LB1 silenced cells including DDB1, CSB and PCNA. We propose that LB1 regulates the DNA damage response to UV irradiation by modulating the expression of specific genes and activating persistent DNA damage signaling. Our findings are relevant to understanding the relationship between the loss of LB1 expression, DNA damage signaling, and replicative senescence.	[Butin-Israeli, Veronika; Adam, Stephen A.; Goldman, Robert D.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Goldman, RD (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA.	r-goldman@northwestern.edu	Butin-Israeli, Veronika/AAQ-2391-2020	Adam, Stephen/0000-0003-3444-7655	National Cancer Institute [R01CA031760]; Progeria Research Foundation; Grus-Lipper Fellowship; NATIONAL CANCER INSTITUTE [R01CA031760] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Progeria Research Foundation; Grus-Lipper Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding came from a National Cancer Institute grant R01CA031760 Progeria Research Foundation http://www.progeriaresearch.org/ and a Grus-Lipper Fellowship http://www.eglcf.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barascu A, 2012, EMBO J, V31, P1080, DOI 10.1038/emboj.2011.492; BROERS JLV, 1993, AM J PATHOL, V143, P211; Brussino A, 2010, EUR J NEUROL, V17, P541, DOI 10.1111/j.1468-1331.2009.02844.x; Butin-Israeli V, 2010, J VIROL, V84, P3431, DOI 10.1128/JVI.01735-09; CHANG LMS, 1986, CRC CR REV BIOCH MOL, V21, P27, DOI 10.3109/10409238609113608; Cleaver JE, 2011, PHOTOCHEM PHOTOBIOL, V87, P1230, DOI 10.1111/j.1751-1097.2011.00995.x; Coffinier C, 2011, MOL BIOL CELL, V22, P4683, DOI 10.1091/mbc.E11-06-0504; Coffinier C, 2010, P NATL ACAD SCI USA, V107, P5076, DOI 10.1073/pnas.0908790107; Constantinescu D, 2010, EXP CELL RES, V316, P2747, DOI 10.1016/j.yexcr.2010.05.015; Dechat T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000547; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Dittmer T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-222; Dreesen O, 2013, J CELL BIOL, V200, P605, DOI 10.1083/jcb.201206121; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; FitzGerald JE, 2009, BIOCHEM SOC T, V37, P897, DOI 10.1042/BST0370897; Freund A, 2012, MOL BIOL CELL, V23, P2066, DOI 10.1091/mbc.E11-10-0884; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Jiang KC, 2003, J BIOL CHEM, V278, P25207, DOI 10.1074/jbc.M300070200; Kim Y, 2011, SCIENCE, V334, P1706, DOI 10.1126/science.1211222; Komatsu Y, 1997, NUCLEIC ACIDS RES, V25, P3889, DOI 10.1093/nar/25.19.3889; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lagerwerf S, 2011, DNA REPAIR, V10, P743, DOI 10.1016/j.dnarep.2011.04.024; Lee KY, 2008, MOL CELLS, V26, P5; Liu Y, 2008, FASEB J, V22, P603, DOI 10.1096/fj.07-8598com; Liu YY, 2006, J CELL SCI, V119, P4644, DOI 10.1242/jcs.03263; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Marteijn JA, 2009, J CELL BIOL, V186, P835, DOI 10.1083/jcb.200902150; Martin SA, 2008, CURR OPIN GENET DEV, V18, P80, DOI 10.1016/j.gde.2008.01.016; MOIR RD, 1994, J CELL BIOL, V125, P1201, DOI 10.1083/jcb.125.6.1201; Moss SF, 1999, GUT, V45, P723, DOI 10.1136/gut.45.5.723; Muck JS, 2012, J CELL BIOCHEM, V113, P2607, DOI 10.1002/jcb.24136; Muralikrishna B, 2012, MOL CELL BIOCHEM, V365, P323, DOI 10.1007/s11010-012-1272-4; Musich PR, 2009, AGING-US, V1, P28, DOI 10.18632/aging.100012; Nam EA, 2011, BIOCHEM J, V436, P527, DOI 10.1042/BJ20102162; Osorio FG, 2012, GENE DEV, V26, P2311, DOI 10.1101/gad.197954.112; Overmeer RM, 2011, J CELL BIOL, V192, P401, DOI 10.1083/jcb.201006011; Padiath QS, 2006, NAT GENET, V38, P1114, DOI 10.1038/ng1872; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Sertic S, 2012, CELL CYCLE, V11, P668, DOI 10.4161/cc.11.4.19117; Shimi T, 2012, CURR OPIN CELL BIOL, V24, P71, DOI 10.1016/j.ceb.2011.11.007; Shimi T, 2011, GENE DEV, V25, P2579, DOI 10.1101/gad.179515.111; Shimi T, 2008, GENE DEV, V22, P3409, DOI 10.1101/gad.1735208; SINENSKY M, 1994, J CELL SCI, V107, P61; STEWART C, 1987, CELL, V51, P383, DOI 10.1016/0092-8674(87)90634-9; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Sugasawa K, 2011, BIOCHEMISTRY-MOSCOW+, V76, P16, DOI 10.1134/S0006297911010044; Tang CW, 2008, J CELL SCI, V121, P1014, DOI 10.1242/jcs.020982; Toledo LI, 2008, GENE DEV, V22, P297, DOI 10.1101/gad.452308; Varela I, 2005, NATURE, V437, P564, DOI 10.1038/nature04019; Walmacq C, 2012, MOL CELL, V46, P18, DOI 10.1016/j.molcel.2012.02.006; Yamamoto A, 2007, DNA REPAIR, V6, P649, DOI 10.1016/j.dnarep.2006.12.006; Yang SH, 2011, HUM MOL GENET, V20, P3537, DOI 10.1093/hmg/ddr266; Yang XH, 2009, CELL CYCLE, V8, P191, DOI 10.4161/cc.8.2.7357; Zullo JM, 2012, CELL, V149, P1474, DOI 10.1016/j.cell.2012.04.035	55	24	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69169	10.1371/journal.pone.0069169	http://dx.doi.org/10.1371/journal.pone.0069169			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894423	Green Published, Green Submitted, gold			2022-12-27	WOS:000322167900041
J	Wang, YP; Yang, L; Zheng, ZM; Grumet, R; Loescher, W; Zhu, JK; Yang, PF; Hu, YL; Chan, ZL				Wang, Yanping; Yang, Li; Zheng, Zhimin; Grumet, Rebecca; Loescher, Wayne; Zhu, Jian-Kang; Yang, Pingfang; Hu, Yuanlei; Chan, Zhulong			Transcriptomic and Physiological Variations of Three Arabidopsis Ecotypes in Response to Salt Stress	PLOS ONE			English	Article							ACCESSIONS LANDSBERG ERECTA; BOX PROTEIN TIR1; NATURAL VARIATION; THALIANA ACCESSIONS; GENE-EXPRESSION; FREEZING TOLERANCE; SEED-GERMINATION; OXIDATIVE STRESS; OVEREXPRESSION; RESISTANCE	Salt stress is one of the major abiotic stresses in agriculture worldwide. Analysis of natural genetic variation in Arabidopsis is an effective approach to characterize candidate salt responsive genes. Differences in salt tolerance of three Arabidopsis ecotypes were compared in this study based on their responses to salt treatments at two developmental stages: seed germination and later growth. The Sha ecotype had higher germination rates, longer roots and less accumulation of superoxide radical and hydrogen peroxide than the Ler and Col ecotypes after short term salt treatment. With long term salt treatment, Sha exhibited higher survival rates and lower electrolyte leakage. Transcriptome analysis revealed that many genes involved in cell wall, photosynthesis, and redox were mainly down-regulated by salinity effects, while transposable element genes, microRNA and biotic stress related genes were significantly changed in comparisons of Sha vs. Ler and Sha vs. Col. Several pathways involved in tricarboxylic acid cycle, hormone metabolism and development, and the Gene Ontology terms involved in response to stress and defense response were enriched after salt treatment, and between Sha and other two ecotypes. Collectively, these results suggest that the Sha ecotype is preconditioned to withstand abiotic stress. Further studies about detailed gene function are needed. These comparative transcriptomic and analytical results also provide insight into the complexity of salt stress tolerance mechanisms.	[Wang, Yanping; Yang, Li; Yang, Pingfang; Chan, Zhulong] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan, Hubei Province, Peoples R China; [Yang, Li] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zheng, Zhimin; Zhu, Jian-Kang] Chinese Acad Sci, Shanghai Ctr Plant Stress Biol, Shanghai, Peoples R China; [Zheng, Zhimin; Zhu, Jian-Kang] Chinese Acad Sci, Inst Plant Physiol & Ecol, Shanghai, Peoples R China; [Grumet, Rebecca; Loescher, Wayne] Michigan State Univ, Dept Hort, E Lansing, MI 48824 USA; [Zhu, Jian-Kang] Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA; [Hu, Yuanlei] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Michigan State University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Peking University	Hu, YL (corresponding author), Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China.	huyl@pku.edu.cn; zhulongch@wbgcas.cn	Zhu, Jian-Kang/F-7658-2011; Chan, Zhulong/AAM-5018-2020	Zhu, Jian-Kang/0000-0001-5134-731X; Chan, Zhulong/0000-0002-1933-6837; Wang, Yanping/0000-0003-4391-0883	Chinese Academy of Sciences [54Y154761O01076]	Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was supported by "the Hundred Talents Program", the Knowledge Innovative Key Program of Chinese Academy of Sciences (grant number 54Y154761O01076) to Zhulong Chan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H E, 1983, METHOD ENZYMATIC ANA, P273, DOI DOI 10.1016/B978-0-12-091302-2.50032-3; Alonso-Blanco C, 2000, TRENDS PLANT SCI, V5, P22, DOI 10.1016/S1360-1385(99)01510-1; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Becker A, 2003, MOL PHYLOGENET EVOL, V29, P464, DOI 10.1016/S1055-7903(03)00207-0; Bouchabke O, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001705; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Chan ZL, 2012, GENOMICS, V100, P110, DOI 10.1016/j.ygeno.2012.06.004; Chan ZL, 2012, PLANT BIOTECHNOL J, V10, P284, DOI 10.1111/j.1467-7652.2011.00661.x; Chan ZL, 2011, J EXP BOT, V62, P4787, DOI 10.1093/jxb/err130; Clerkx EJM, 2004, PLANT PHYSIOL, V135, P432, DOI 10.1104/pp.103.036814; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Delker C, 2010, PLANT CELL, V22, P2184, DOI 10.1105/tpc.110.073957; DeRose-Wilson L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022832; Des Marais DL, 2012, PLANT CELL, V24, P893, DOI 10.1105/tpc.112.096180; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Galpaz N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015198; Gilmour SJ, 2000, PLANT PHYSIOL, V124, P1854, DOI 10.1104/pp.124.4.1854; Hannah MA, 2006, PLANT PHYSIOL, V142, P98, DOI 10.1104/pp.106.081141; Harada H, 2006, J EXP BOT, V57, P953, DOI 10.1093/jxb/erj081; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Hu LX, 2012, J PLANT PHYSIOL, V169, P146, DOI 10.1016/j.jplph.2011.08.020; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; Katori T, 2010, J EXP BOT, V61, P1125, DOI 10.1093/jxb/erp376; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Kesari R, 2012, P NATL ACAD SCI USA, V109, P9197, DOI 10.1073/pnas.1203433109; Khraiwesh Basel, 2012, Biochim Biophys Acta, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Kotak S, 2004, PLANT J, V39, P98, DOI 10.1111/j.1365-313X.2004.02111.x; Lee S, 2008, PLANT PHYSIOL, V147, P156, DOI 10.1104/pp.107.114256; Loescher W, 2011, HORTSCIENCE, V46, P1085, DOI 10.21273/HORTSCI.46.8.1085; McClintock B, 1968, CARNEGIE I WASHINGTO, V66, P20; Millenaar FF, 2005, PLANT PHYSIOL, V137, P998, DOI 10.1104/pp.104.053967; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Nishizawa A, 2006, PLANT J, V48, P535, DOI 10.1111/j.1365-313X.2006.02889.x; Prieto-Dapena P, 2008, PLANT J, V54, P1004, DOI 10.1111/j.1365-313X.2008.03465.x; Provart NJ., 2003, CURRENT COMPUTER MOL, V2003, P271; Quesada V, 2002, PLANT PHYSIOL, V130, P951, DOI 10.1104/pp.006536; Ramel F, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-450; Ren ZH, 2010, P NATL ACAD SCI USA, V107, P5669, DOI 10.1073/pnas.0910798107; Rus A, 2006, PLOS GENET, V2, P1964, DOI 10.1371/journal.pgen.0020210; Schramke V, 2003, SCIENCE, V301, P1069, DOI 10.1126/science.1086870; Sharma S, 2013, PLANT CELL ENVIRON, V36, P994, DOI 10.1111/pce.12032; Shi HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053422; Shi HZ, 2003, NAT BIOTECHNOL, V21, P81, DOI 10.1038/nbt766; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Ukeda H, 2002, ANAL SCI, V18, P1151, DOI 10.2116/analsci.18.1151; Vallejo AJ, 2010, ANN BOT-LONDON, V106, P833, DOI 10.1093/aob/mcq179; van Leeuwen H, 2007, PLANT CELL, V19, P2099, DOI 10.1105/tpc.107.050641; Van Poecke RMP, 2007, PLANT CELL, V19, P4046, DOI 10.1105/tpc.107.053827; Verslues PE, 2006, PLANT J, V45, P523, DOI 10.1111/j.1365-313X.2005.02593.x; Wang YP, 2011, PLANT J, V68, P249, DOI 10.1111/j.1365-313X.2011.04683.x; Whitelaw E, 2001, NAT GENET, V27, P361, DOI 10.1038/86850; Zhifang G, 2003, PLANT CELL ENVIRON, V26, P275, DOI 10.1046/j.1365-3040.2003.00958.x; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	55	38	39	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69036	10.1371/journal.pone.0069036	http://dx.doi.org/10.1371/journal.pone.0069036			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894403	Green Published, Green Submitted, gold			2022-12-27	WOS:000325211000068
J	Amegah, AK; Damptey, OK; Sarpong, GA; Duah, E; Vervoorn, DJ; Jaakkola, JJK				Amegah, Adeladza K.; Damptey, Obed K.; Sarpong, Gideon A.; Duah, Emmanuel; Vervoorn, David J.; Jaakkola, Jouni J. K.			Malaria Infection, Poor Nutrition and Indoor Air Pollution Mediate Socioeconomic Differences in Adverse Pregnancy Outcomes in Cape Coast, Ghana	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; PRETERM BIRTH; AREA DEPRIVATION; EPIDEMIOLOGY; DETERMINANTS; DISPARITIES; HEALTH; INEQUALITIES; DELIVERY; ACCRA	Background: The epidemiological evidence linking socioeconomic deprivation with adverse pregnancy outcomes has been conflicting mainly due to poor measurement of socioeconomic status (SES). Studies have also failed to evaluate the plausible pathways through which socioeconomic disadvantage impacts on pregnancy outcomes. We investigated the importance of maternal SES as determinant of birth weight and gestational duration in an urban area and evaluated main causal pathways for the influence of SES. Methods: A population-based cross-sectional study was conducted among 559 mothers accessing postnatal services at the four main health facilities in Cape Coast, Ghana in 2011. Information on socioeconomic characteristics of the mothers was collected in a structured questionnaire. Results: In multivariate linear regression adjusting for maternal age, parity and gender of newborn, low SES resulted in 292 g (95% CI: 440-145) reduction in birth weight. Important SES-related determinants were neighborhood poverty (221 g; 95% CI: 355-87), low education (187 g; 95% CI: 355-20), studentship during pregnancy (291 g; 95% CI: 506-76) and low income (147 g; 95% CI: 277-17). In causal pathway analysis, malaria infection (6-20%), poor nutrition (2-51%) and indoor air pollution (10-62%) mediated substantial proportions of the observed effects of socioeconomic deprivation on birth weight. Generalized linear models adjusting for confounders indicated a 218% (RR: 3.18; 95% CI: 1.41-7.21) risk increase of LBW and 83% (RR: 1.83; 95% CI: 1.31-2.56) of PTB among low income mothers. Low and middle SES was associated with 357% (RR: 4.57; 95% CI: 1.67-12.49) and 278% (RR: 3.78; 95% CI: 1.39-10.27) increased risk of LBW respectively. Malaria infection, poor nutrition and indoor air pollution respectively mediated 10-21%, 16-44% and 31-52% of the observed effects of socioeconomic disadvantage on LBW risk. Conclusion: We provide evidence of the effects of socioeconomic deprivation, substantially mediated by malaria infection, poor nutrition and indoor air pollution, on pregnancy outcomes in a developing country setting.	[Amegah, Adeladza K.; Jaakkola, Jouni J. K.] Univ Oulu, Fac Med, Ctr Environm & Resp Hlth Res, Oulu, Finland; [Amegah, Adeladza K.; Damptey, Obed K.; Sarpong, Gideon A.; Duah, Emmanuel; Vervoorn, David J.] Univ Cape Coast, Dept Human Biol, Sch Biol Sci, Cape Coast, Ghana; [Amegah, Adeladza K.] Radel Consulting, Accra, Ghana; [Amegah, Adeladza K.; Jaakkola, Jouni J. K.] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Jaakkola, Jouni J. K.] Oulu Univ Hosp, Resp Med Unit, Oulu, Finland	University of Oulu; University of Cape Coast; University of Oulu; University of Oulu	Amegah, AK (corresponding author), Univ Oulu, Fac Med, Ctr Environm & Resp Hlth Res, Oulu, Finland.	adeladza.amegah@oulu.fi	Amegah, AK/L-8952-2016; Jaakkola, Jouni J.K./G-4314-2012	Amegah, AK/0000-0001-5868-6402; Jaakkola, Jouni/0000-0003-4168-4683				Amegah AK, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-78; Ananth CV, 2006, J MATERN-FETAL NEO M, V19, P773, DOI 10.1080/14767050600965882; Blumenshine P, 2010, AM J PREV MED, V39, P263, DOI 10.1016/j.amepre.2010.05.012; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Deshmukh J S, 1998, Indian Pediatr, V35, P33; Dibben C, 2006, J EPIDEMIOL COMMUN H, V60, P1053, DOI 10.1136/jech.2005.042853; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; JUDD CM, 1981, EVALUATION REV, V5, P602, DOI 10.1177/0193841X8100500502; Karim E, 1997, ANN HUM BIOL, V24, P387, DOI 10.1080/03014469700005152; Khatun Selina, 2008, Bangladesh Med Res Counc Bull, V34, P81; Koupilova I, 2000, INT J EPIDEMIOL, V29, P118, DOI 10.1093/ije/29.1.118; Kramer MS, 2000, PAEDIATR PERINAT EP, V14, P194, DOI 10.1046/j.1365-3016.2000.00266.x; Lynch CD, 2007, PAEDIATR PERINAT EP, V21, P86, DOI 10.1111/j.1365-3016.2007.00865.x; Mumbare SS, 2012, INDIAN PEDIATR, V49, P25, DOI 10.1007/s13312-012-0010-z; Nordstrom ML, 1996, SCAND J SOC MED, V24, P55, DOI 10.1177/140349489602400109; OLSEN P, 1995, AM J EPIDEMIOL, V142, P1184, DOI 10.1093/oxfordjournals.aje.a117577; Olusanya BO, 2010, MATERN CHILD HLTH J, V14, P978, DOI 10.1007/s10995-009-0528-4; Parker Jennifer D., 1994, Annals of Epidemiology, V4, P271; Pattenden S, 1999, J EPIDEMIOL COMMUN H, V53, P355, DOI 10.1136/jech.53.6.355; PEACOCK JL, 1995, BRIT MED J, V311, P531, DOI 10.1136/bmj.311.7004.531; Pojda J, 2000, 18 ACCSCN UN ADM COM; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Shavers VL, 2007, J NATL MED ASSOC, V99, P1013; Thompson JMD, 2006, PAEDIATR PERINAT EP, V20, P182, DOI 10.1111/j.1365-3016.2006.00711.x; Torres-Arreola LP, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-20; Tuntiseranee P, 1999, J EPIDEMIOL COMMUN H, V53, P624, DOI 10.1136/jech.53.10.624; vandeMheen H, 1997, SOC SCI MED, V44, P13, DOI 10.1016/S0277-9536(96)00090-1; Zhou Z, 2011, P NATL ACAD SCI USA, V108, P11028, DOI 10.1073/pnas.1019183108	28	25	25	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69181	10.1371/journal.pone.0069181	http://dx.doi.org/10.1371/journal.pone.0069181			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	187PW	23894428	Green Submitted, Green Published, gold			2022-12-27	WOS:000322132100050
J	Ghosh, A; Cannon, JF				Ghosh, Anuprita; Cannon, John F.			Analysis of Protein Phosphatase-1 and Aurora Protein Kinase Suppressors Reveals New Aspects of Regulatory Protein Function in Saccharomyces cerevisiae	PLOS ONE			English	Article							DIVERGENT GAL1-GAL10 PROMOTER; CHROMOSOME BI-ORIENTATION; UBIQUITIN LIGASE TOM1; MITOTIC CELL-CYCLE; TOR COMPLEX 1; BUDDING YEAST; GLYCOGEN-METABOLISM; MESSENGER-RNA; INHIBITOR-2 FUNCTIONS; GLC7/PP1 PHOSPHATASE	Protein phosphatase-1 (PP1) controls many processes in eukaryotic cells. Modulation of mitosis by reversing phosphorylation of proteins phosphorylated by aurora protein kinase is a critical function for PP1. Overexpression of the sole PP1, Glc7, in budding yeast, Saccharomyces cerevisiae, is lethal. This work shows that lethality requires the function of Glc7 regulatory proteins Sds22, Reg2, and phosphorylated Glc8. This finding shows that Glc7 overexpression induced cell death requires a specific subset of the many Glc7-interacting proteins and therefore is likely caused by promiscuous dephosphorylation of a variety of substrates. Additionally, suppression can occur by reducing Glc7 protein levels by high-copy Fpr3 without use of its proline isomerase domain. This divulges a novel function of Fpr3. Most suppressors of GLC7 overexpression also suppress aurora protein kinase, ipl1, temperature-sensitive mutations. However, high-copy mutant SDS22 genes show reciprocal suppression of GLC7 overexpression induced cell death or ipl1 temperature sensitivity. Sds22 binds to many proteins besides Glc7. The N-terminal 25 residues of Sds22 are sufficient to bind, directly or indirectly, to seven proteins studied here including the spindle assembly checkpoint protein, Bub3. These data demonstrate that Sds22 organizes several proteins in addition to Glc7 to perform functions that counteract Ipl1 activity or lead to hyper Glc7 induced cell death. These data also emphasize that Sds22 targets Glc7 to nuclear locations distinct from Ipl1 substrates.	[Ghosh, Anuprita; Cannon, John F.] Univ Missouri, Dept Mol Microbiol & Immunol, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Cannon, JF (corresponding author), Univ Missouri, Dept Mol Microbiol & Immunol, Columbia, MO 65211 USA.	CannonJ@Missouri.edu		Cannon, John/0000-0001-6698-176X	National Science Foundation; Department of Molecular Microbiology and Immunology	National Science Foundation(National Science Foundation (NSF)); Department of Molecular Microbiology and Immunology	This work was supported by the National Science Foundation and the Department of Molecular Microbiology and Immunology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi B, 2009, GENE DEV, V23, P2887, DOI 10.1101/gad.1865909; ALESSI DR, 1993, EUR J BIOCHEM, V213, P1055, DOI 10.1111/j.1432-1033.1993.tb17853.x; Arie JP, 2001, MOL MICROBIOL, V39, P199, DOI 10.1046/j.1365-2958.2001.02250.x; Bharucha JP, 2008, MOL BIOL CELL, V19, P1032, DOI 10.1091/mbc.E07-05-0499; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; Bloecher A, 2000, J CELL BIOL, V149, P125, DOI 10.1083/jcb.149.1.125; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Bolanos-Garcia VM, 2011, TRENDS BIOCHEM SCI, V36, P141, DOI 10.1016/j.tibs.2010.08.004; CANNON JF, 1994, GENETICS, V136, P485; CANNON JF, 1987, MOL CELL BIOL, V7, P2653, DOI 10.1128/MCB.7.8.2653; Cannon JF, 2010, ADV APPL MICROBIOL, V73, P27, DOI 10.1016/S0065-2164(10)73002-1; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Ceulemans H, 2002, J BIOL CHEM, V277, P47331, DOI 10.1074/jbc.M206838200; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Cheng YL, 2010, J CELL SCI, V123, P2024, DOI 10.1242/jcs.066043; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Cohen PTW, 2002, J CELL SCI, V115, P241; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Davey M, 2000, MOL GEN GENET, V263, P520, DOI 10.1007/s004380051197; Deng CH, 2009, MOL CELL PROTEOMICS, V8, P1413, DOI 10.1074/mcp.M800397-MCP200; DEPAOLIROACH AA, 1993, FASEB J, V7, pA1157; Dolinski K, 1997, P NATL ACAD SCI USA, V94, P13093, DOI 10.1073/pnas.94.24.13093; Duncan K, 2000, CURR BIOL, V10, P687, DOI 10.1016/S0960-9822(00)00527-3; Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118; FRANCISCO L, 1994, MOL CELL BIOL, V14, P4731, DOI 10.1128/MCB.14.7.4731; FRANCOIS JM, 1992, EMBO J, V11, P87, DOI 10.1002/j.1460-2075.1992.tb05031.x; Frederick DL, 1996, MOL CELL BIOL, V16, P2922; Gilbert W, 2004, MOL CELL, V13, P201, DOI 10.1016/S1097-2765(04)00030-9; He XY, 2005, MOL CELL, V19, P619, DOI 10.1016/j.molcel.2005.07.016; Hedbacker K, 2008, FRONT BIOSCI-LANDMRK, V13, P2408, DOI 10.2741/2854; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hochwagen A, 2005, CELL, V122, P861, DOI 10.1016/j.cell.2005.07.010; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; James P, 1996, GENETICS, V144, P1425; Jiang H, 2000, MOL GEN GENET, V263, P411, DOI 10.1007/s004380051185; JOHNSTON M, 1984, MOL CELL BIOL, V4, P1440, DOI 10.1128/MCB.4.8.1440; Garcia-Gomez JJ, 2011, RNA BIOL, V8, P112, DOI 10.4161/rna.8.1.14143; Kakihara Y, 2012, BBA-MOL CELL RES, V1823, P101, DOI 10.1016/j.bbamcr.2011.08.016; Kamiya H, 2007, BIOL PHARM BULL, V30, P842, DOI 10.1248/bpb.30.842; Kim DH, 2012, J BIOL CHEM, V287, P44212, DOI 10.1074/jbc.M112.401778; Kim DH, 2012, MOL BIOL CELL, V23, P4203, DOI 10.1091/mbc.E12-07-0548; Kramer G, 2004, J BIOL CHEM, V279, P14165, DOI 10.1074/jbc.M313635200; LIU HP, 1992, GENETICS, V132, P665; London N, 2012, CURR BIOL, V22, P900, DOI 10.1016/j.cub.2012.03.052; MA H, 1987, GENE, V58, P201, DOI 10.1016/0378-1119(87)90376-3; MacQueen AJ, 2009, CURR BIOL, V19, P1519, DOI 10.1016/j.cub.2009.08.048; MANIVASAKAM P, 1995, NUCLEIC ACIDS RES, V23, P2799, DOI 10.1093/nar/23.14.2799; Martzen MR, 1999, SCIENCE, V286, P1153, DOI 10.1126/science.286.5442.1153; Meadows JC, 2011, DEV CELL, V20, P739, DOI 10.1016/j.devcel.2011.05.008; NASMYTH KA, 1980, CELL, V19, P753, DOI 10.1016/S0092-8674(80)80051-1; Nedea E, 2008, MOL CELL, V29, P577, DOI 10.1016/j.molcel.2007.12.031; Nelson CJ, 2006, CELL, V126, P905, DOI 10.1016/j.cell.2006.07.026; Nigavekar SS, 2002, ARCH BIOCHEM BIOPHYS, V404, P71, DOI 10.1016/S0003-9861(02)00231-X; ORRWEAVER TL, 1981, P NATL ACAD SCI-BIOL, V78, P6354, DOI 10.1073/pnas.78.10.6354; Padmanabhan N, 2009, MOL BIOL CELL, V20, P68, DOI 10.1091/mbc.E08-02-0178; Pedelini L, 2007, J BIOL CHEM, V282, P3282, DOI 10.1074/jbc.M607171200; Peggie MW, 2002, J CELL SCI, V115, P195; Peti W, 2013, FEBS J, V280, P596, DOI 10.1111/j.1742-4658.2012.08509.x; Pinsky BA, 2006, MOL CELL BIOL, V26, P2648, DOI 10.1128/MCB.26.7.2648-2660.2006; Pinsky BA, 2009, CURR BIOL, V19, P1182, DOI 10.1016/j.cub.2009.06.043; Ramaswamy NT, 1998, METH MOL B, V93, P251; Ramaswamy NT, 1998, GENETICS, V149, P57; ROSE MD, 1987, GENE, V60, P237, DOI 10.1016/0378-1119(87)90232-0; Rose MD., 1990, METHODS YEAST GENETI; Rosenberg JS, 2011, CURR BIOL, V21, P942, DOI 10.1016/j.cub.2011.04.011; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; Sassoon I, 1999, GENE DEV, V13, P545, DOI 10.1101/gad.13.5.545; SCHMID FX, 1993, ADV PROTEIN CHEM, V44, P25, DOI 10.1016/S0065-3233(08)60563-X; SCHNEIDER BL, 1995, YEAST, V11, P1265, DOI 10.1002/yea.320111306; SHAN XY, 1994, J CELL BIOL, V126, P853, DOI 10.1083/jcb.126.4.853; SIKORSKI RS, 1989, GENETICS, V122, P19; Song XY, 2012, GENE DEV, V26, P615, DOI 10.1101/gad.182683.111; Stark MJR, 1996, YEAST, V12, P1647, DOI 10.1002/(SICI)1097-0061(199612)12:16<1647::AID-YEA71>3.0.CO;2-Q; STRUHL K, 1979, P NATL ACAD SCI USA, V76, P1035, DOI 10.1073/pnas.76.3.1035; STUART JS, 1994, MOL CELL BIOL, V14, P896, DOI 10.1128/MCB.14.2.896; Tan YSH, 2003, J BIOL CHEM, V278, P147, DOI 10.1074/jbc.M208058200; TANAKA K, 1992, MOL CELL BIOL, V12, P631, DOI 10.1128/MCB.12.2.631; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Tatchell K, 2011, P NATL ACAD SCI USA, V108, P3994, DOI 10.1073/pnas.1014406108; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; TUNG HYL, 1995, MOL CELL BIOL, V15, P6064; Westermann S, 2003, J CELL BIOL, V163, P215, DOI 10.1083/jcb.200305100; Wilson LK, 1997, J BIOL CHEM, V272, P12961, DOI 10.1074/jbc.272.20.12961; Wu X, 2001, MOL GENET GENOMICS, V265, P622, DOI 10.1007/s004380100455; Yan GH, 2012, MOL CELL, V45, P743, DOI 10.1016/j.molcel.2012.01.028; YOCUM RR, 1984, MOL CELL BIOL, V4, P1985, DOI 10.1128/MCB.4.10.1985; ZHANG SR, 1995, MOL CELL BIOL, V15, P2037; Zich J, 2010, TRENDS BIOCHEM SCI, V35, P18, DOI 10.1016/j.tibs.2009.09.002	89	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69133	10.1371/journal.pone.0069133	http://dx.doi.org/10.1371/journal.pone.0069133			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894419	gold, Green Published, Green Submitted			2022-12-27	WOS:000322132100047
J	Vicentini, F; Denadai, W; Gomes, YM; Rose, TL; Ferreira, MSR; Le Moullac-Vaidye, B; Le Pendu, J; Leite, JPG; Miagostovich, MP; Spano, LC				Vicentini, Fernando; Denadai, Wilson; Gomes, Yohanna Mayelle; Rose, Tatiana L.; Ferreira, Moenica S. R.; Le Moullac-Vaidye, Beatrice; Le Pendu, Jacques; Gagliardi Leite, Jose Paulo; Miagostovich, Marize Pereira; Spano, Liliana Cruz			Molecular Characterization of Noroviruses and HBGA from Infected Quilombola Children in Espirito Santo State, Brazil	PLOS ONE			English	Article							BLOOD GROUP ANTIGENS; NONSENSE MUTATION; GII.4 NOROVIRUS; SECRETOR STATUS; UNITED-STATES; GENOGROUP-I; GENE FUT2; STRAIN; LEWIS; GASTROENTERITIS	Noroviruses (NoV) are the main etiological agents of gastroenteritis outbreaks worldwide and susceptibility to NoV infection has been related to the histo-blood group antigen (HBGA). This study aimed to determine the prevalence of NoV strains and to evaluate the HBGA phenotype and genotype of children from semi-isolated Quilombola communities, descendents of black slaves in Brazil. A total of 397 children up to eleven years old, with and without diarrhea, from Quilombola Communities in the Espirito Santo State, Brazil, were investigated for the presence of NoV from August 2007 to September 2009. Feces were collected from all the children, and blood from the NoV positive children. NoV was screened by reverse transcription-PCR with primers for the RNA-dependent RNA polymerase region; genogroup was determined by PCR with primers for the C and D regions and genotyped by sequencing. HBGA phenotype was performed by gel-spinning and FUT2 and FUT3 were analyzed by PCR or sequencing analysis. NoV were detected in 9.2% (12/131) of diarrheic and 1.5% (4/266) of non-diarrheic children (p<0.05, Fishers exact test). GI and GII genogroups were present in 12.5% and 87.5% of the samples, respectively. The following genotypes were characterized: GII.4 (25%), GII.12 (25%), GII.6 (12.5%) and GI.1 (6.3%), GI.3 (12.5%) and GI.4 (6.3%). Children infected with NoV showed the A (n = 6), O (n = 6), and B (n = 2) HBGA phenotypes, and 13 of them were classified as secretors (Se) and one as a non secretor (se). Mutations of Se-40,Se- 171,Se-216,Se-357,Se-428,Se-739,Se-960 were found for the FUT2 gene and mutations of Le(59, 202, 314) for the FUT3 gene. The only se child was infected by NoV GI, whereas the Se children were indiscriminately infected by GI or GII. This study showed rates of NoV infection in symptomatic and asymptomatic Quilombola children consistent with other studies. However, children under 12 months were seven times more affected than those between 1 and 5 years old. GII.12 was as frequent as GII.4 and GI.1 and GI.4 were described for the first time in Brazil. Owing to the small number of cases studied, no clear pattern of susceptibility and/or HBGA resistance could be inferred.	[Vicentini, Fernando; Denadai, Wilson] Univ Fed Espirito Santo, Dept Ciencias Saude, Sao Mateus, ES, England; [Vicentini, Fernando] Univ Fed Espirito Santo, Programa Posgrad Doencas Infecciosas, Vitoria, ES, Brazil; [Gomes, Yohanna Mayelle; Spano, Liliana Cruz] Univ Fed Espirito Santo, Dept Patol, Vitoria, ES, Brazil; [Rose, Tatiana L.; Ferreira, Moenica S. R.; Gagliardi Leite, Jose Paulo; Miagostovich, Marize Pereira] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Virol Comparada & Ambiental, Rio De Janeiro, Brazil; [Le Moullac-Vaidye, Beatrice; Le Pendu, Jacques] Inst Natl Sante & Rech Med, Nantes, France; [Le Moullac-Vaidye, Beatrice; Le Pendu, Jacques] Ctr Rech Cancerol, Nantes, France; [Le Moullac-Vaidye, Beatrice; Le Pendu, Jacques] Univ Nantes, Nantes, France	Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo; Fundacao Oswaldo Cruz; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite	Vicentini, F (corresponding author), Univ Fed Espirito Santo, Dept Ciencias Saude, Sao Mateus, ES, England.	fernandovicentini@ceunes.ufes.br	LEITE, JOSE PAULO GAGLIARDI/AAY-1230-2020; Le Pendu, Jacques/F-4760-2013	Le Pendu, Jacques/0000-0002-4856-0387	National Council of Scientific and Technological Development (CNPq); Foundation for Research Support of the State of Espirito Santo (FAPES); Oswaldo Cruz Institute (IOC-PROEP/CNPq); Oswaldo Cruz Foundation (FIOCRUZ); Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State (FAPERJ); Brazilian Federal Agency for Support and Evaluation of Graduate Education (CAPES)	National Council of Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Foundation for Research Support of the State of Espirito Santo (FAPES); Oswaldo Cruz Institute (IOC-PROEP/CNPq); Oswaldo Cruz Foundation (FIOCRUZ); Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Brazilian Federal Agency for Support and Evaluation of Graduate Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported with funds from the National Council of Scientific and Technological Development (CNPq), Foundation for Research Support of the State of Espirito Santo (FAPES), Oswaldo Cruz Institute (IOC-PROEP/CNPq), Oswaldo Cruz Foundation (FIOCRUZ), and Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State (FAPERJ). Fernando Vicentini is a doctoral student in the Graduate Program in Infectious Diseases (PPGDI), Federal University of Espirito Santo, and received a fellowship from Brazilian Federal Agency for Support and Evaluation of Graduate Education (CAPES) for development of part of these studies at INSERM/CNRS/Universite de Nantes, France. Fernando Vicentini also has a fellowship from CNPq for the development of part of these studies at Oswaldo Cruz Institute/Oswaldo Cruz Foundation(IOC/FIOCRUZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELRAHMAN SZ, 1994, J BIOCHEM TOXICOL, V9, P191, DOI 10.1002/jbt.2570090404; Aragao GC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056608; Bennett S, 2013, EUROSURVEILLANCE, V18, P20349, DOI DOI 10.1017/S0950268813000435; Beuret C, 2002, APPL ENVIRON MICROB, V68, P1925, DOI 10.1128/AEM.68.4.1925-1931.2002; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Boon D, 2011, J VIROL, V85, P8656, DOI 10.1128/JVI.00472-11; Bucardo F, 2009, J MED VIROL, V81, P728, DOI 10.1002/jmv.21426; Bull RA, 2011, TRENDS MICROBIOL, V19, P233, DOI 10.1016/j.tim.2011.01.002; de Rougemont A, 2011, J VIROL, V85, P4057, DOI 10.1128/JVI.02077-10; Desai R, 2011, MEM I OSWALDO CRUZ, V106, P907, DOI 10.1590/S0074-02762011000800002; Donaldson EF, 2010, NAT REV MICROBIOL, V8, P231, DOI 10.1038/nrmicro2296; Ferrer-Admetlla A, 2009, MOL BIOL EVOL, V26, P1993, DOI 10.1093/molbev/msp108; Fioretti JM, 2011, MEM I OSWALDO CRUZ, V106, P942, DOI 10.1590/S0074-02762011000800008; Fukuda S, 2010, ARCH VIROL, V155, P111, DOI 10.1007/s00705-009-0528-0; Fumian TM, 2012, ARCH VIROL, V157, P2389, DOI 10.1007/s00705-012-1428-2; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Barreira DMPG, 2010, J CLIN VIROL, V47, P60, DOI 10.1016/j.jcv.2009.11.012; Grahn A, 2001, Hum Mutat, V18, P358, DOI 10.1002/humu.1204; Harrington PR, 2002, J VIROL, V76, P12335, DOI 10.1128/JVI.76.23.12335-12343.2002; Huang PW, 2005, J VIROL, V79, P6714, DOI 10.1128/JVI.79.11.6714-6722.2005; Huang PW, 2003, J INFECT DIS, V188, P19, DOI 10.1086/375742; Hutson AM, 2005, J MED VIROL, V77, P116, DOI 10.1002/jmv.20423; KELLY RJ, 1995, J BIOL CHEM, V270, P4640, DOI 10.1074/jbc.270.9.4640; Koda Y, 2001, GENETICS, V158, P747; Kojima S, 2002, J VIROL METHODS, V100, P107, DOI 10.1016/S0166-0934(01)00404-9; Kubota T, 2012, J VIROL, V86, P11138, DOI 10.1128/JVI.00278-12; Lau CS, 2004, J MED VIROL, V73, P113, DOI 10.1002/jmv.20066; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; Lindesmith LC, 2008, PLOS MED, V5, P269, DOI 10.1371/journal.pmed.0050031; Marionneau S, 2002, GASTROENTEROLOGY, V122, P1967, DOI 10.1053/gast.2002.33661; Marionneau S, 2001, BIOCHIMIE, V83, P565, DOI 10.1016/S0300-9084(01)01321-9; Marshall JA, 2003, J MED VIROL, V69, P568, DOI 10.1002/jmv.10346; Monica B, 2007, J MED VIROL, V79, P544, DOI 10.1002/jmv.20862; Nilsson J, 2009, GLYCOCONJUGATE J, V26, P1171, DOI 10.1007/s10719-009-9237-x; Noel JS, 1997, J MED VIROL, V53, P372, DOI 10.1002/(SICI)1096-9071(199712)53:4&lt;372::AID-JMV10&gt;3.0.CO;2-H; Nordgren J, 2010, EMERG INFECT DIS, V16, P81, DOI 10.3201/eid1601.090633; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Patnaik SK, 2011, NUCLEIC ACIDS RES, V13, P1; Procter J, 1997, TISSUE ANTIGENS, V50, P475, DOI 10.1111/j.1399-0039.1997.tb02902.x; Ferreira MSR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033754; Rydell GE, 2009, GLYCOBIOLOGY, V19, P309, DOI 10.1093/glycob/cwn139; Siebenga JJ, 2009, J INFECT DIS, V200, P802, DOI 10.1086/605127; Soares CC, 2007, EMERG INFECT DIS, V13, P1244, DOI 10.3201/eid1308.070300; Tan M, 2008, J MED VIROL, V80, P1296, DOI 10.1002/jmv.21200; Thorven M, 2005, J VIROL, V79, P15351, DOI 10.1128/JVI.79.24.15351-15355.2005; Trivedi TK, 2013, AM J INFECT CONTROL, V41, P654, DOI 10.1016/j.ajic.2012.08.002; Vega E, 2011, EMERG INFECT DIS, V17, P1516, DOI 10.3201/eid1708.110025; Victoria M, 2009, INFECT GENET EVOL, V9, P927, DOI 10.1016/j.meegid.2009.06.014; Vinje J, 2004, J VIROL METHODS, V116, P109, DOI 10.1016/j.jviromet.2003.11.001; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1; XI JA, 1992, J VIROL, V66, P6527, DOI 10.1128/JVI.66.11.6527-6532.1992; Zakikhany K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041625	52	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69348	10.1371/journal.pone.0069348	http://dx.doi.org/10.1371/journal.pone.0069348			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894453	gold, Green Published, Green Submitted			2022-12-27	WOS:000322132100054
J	Wells, CE; Bhaskara, S; Stengel, KR; Zhao, Y; Sirbu, B; Chagot, B; Cortez, D; Khabele, D; Chazin, WJ; Cooper, A; Jacques, V; Rusche, J; Eischen, CM; McGirt, LY; Hiebert, SW				Wells, Christina E.; Bhaskara, Srividya; Stengel, Kristy R.; Zhao, Yue; Sirbu, Bianca; Chagot, Benjamin; Cortez, David; Khabele, Dineo; Chazin, Walter J.; Cooper, Andrew; Jacques, Vincent; Rusche, James; Eischen, Christine M.; McGirt, Laura Y.; Hiebert, Scott W.			Inhibition of Histone Deacetylase 3 Causes Replication Stress in Cutaneous T Cell Lymphoma	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; HDAC INHIBITORS; MECHANISMS; CANCER; DNA; PROTEIN; YEAST; TRANSCRIPTION; PROGRESSION; VORINOSTAT	Given the fundamental roles of histone deacetylases (HDACs) in the regulation of DNA repair, replication, transcription and chromatin structure, it is fitting that therapies targeting HDAC activities are now being explored as anti-cancer agents. In fact, two histone deacetylase inhibitors (HDIs), SAHA and Depsipeptide, are FDA approved for single-agent treatment of refractory cutaneous T cell lymphoma (CTCL). An important target of these HDIs, histone deacetylase 3 (HDAC3), regulates processes such as DNA repair, metabolism, and tumorigenesis through the regulation of chromatin structure and gene expression. Here we show that HDAC3 inhibition using a first in class selective inhibitor, RGFP966, resulted in decreased cell growth in CTCL cell lines due to increased apoptosis that was associated with DNA damage and impaired S phase progression. Through isolation of proteins on nascent DNA (iPOND), we found that HDAC3 was associated with chromatin and is present at and around DNA replication forks. DNA fiber labeling analysis showed that inhibition of HDAC3 resulted in a significant reduction in DNA replication fork velocity within the first hour of drug treatment. These results suggest that selective inhibition of HDAC3 could be useful in treatment of CTCL by disrupting DNA replication of the rapidly cycling tumor cells, ultimately leading to cell death.	[Wells, Christina E.; Stengel, Kristy R.; Zhao, Yue; Sirbu, Bianca; Chagot, Benjamin; Cortez, David; Chazin, Walter J.; Hiebert, Scott W.] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA; [Bhaskara, Srividya] Univ Utah, Sch Med, Dept Radiat Oncol, Huntsman Canc Inst, Salt Lake City, UT USA; [Bhaskara, Srividya] Univ Utah, Sch Med, Dept Oncol Sci, Huntsman Canc Inst, Salt Lake City, UT USA; [Chagot, Benjamin] Univ Lorraine, Lab AREMS UL CNRS UMR7214, Vandoeuvre Les Nancy, France; [Cortez, David; Khabele, Dineo; Eischen, Christine M.; McGirt, Laura Y.; Hiebert, Scott W.] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Khabele, Dineo] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA; [Khabele, Dineo] Vanderbilt Univ, Med Ctr, Div Gynecol Oncol, Dept Obstet & Gynecol, Nashville, TN USA; [Cooper, Andrew; Jacques, Vincent; Rusche, James] Repligen Corp, Waltham, MA USA; [Eischen, Christine M.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA; [McGirt, Laura Y.] Vanderbilt Univ, Med Ctr, Dept Med, Div Dermatol, Nashville, TN USA	Vanderbilt University; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Universite de Lorraine; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	McGirt, LY (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA.	laura.y.mcgirt@Vanderbilt.Edu; scott.hiebert@vanderbilt.edu	Chagot, Benjamin/AAC-6495-2019; Chagot, Benjamin/H-3258-2011	Chagot, Benjamin/0000-0002-9153-0060; Bhaskara, Srividya/0000-0002-2182-9585; Stengel, Kristy/0000-0002-8330-5744	T. J. Martell Foundation; Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation; National Institutes of Health [R01-CA64140, RO1-CA164605, RO1-CA109355]; Vanderbilt Digestive Disease Research grant [P30DK058404]; Vanderbilt-Ingram Cancer Center support grant [NCI P30CA68485]; National Cancer Institute [1F32CA138091]; Dermatology Foundation; NIH (Vanderbilt Clinical Oncology) [5K12CA090625]; NATIONAL CANCER INSTITUTE [F32CA138091, R01CA164605, R01CA064140, R01CA148950, P30CA068485, R01CA141071, K08CA148887, R01CA109355, K12CA090625, T32CA009582, R01CA136933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007028, P30ES000267] Funding Source: NIH RePORTER	T. J. Martell Foundation; Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Digestive Disease Research grant; Vanderbilt-Ingram Cancer Center support grant; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Dermatology Foundation; NIH (Vanderbilt Clinical Oncology)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the T. J. Martell Foundation, the Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation, National Institutes of Health grants (R01-CA64140, RO1-CA164605, RO1-CA109355) and core services performed through Vanderbilt Digestive Disease Research grant P30DK058404 and the Vanderbilt-Ingram Cancer Center support grant NCI P30CA68485. SB was supported by a fellowship (1F32CA138091) from the National Cancer Institute. LYM is supported by career development awards through the Dermatology Foundation and the NIH (Vanderbilt Clinical Oncology; 5K12CA090625). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RA, 2009, BRIT J DERMATOL, V160, P1299, DOI 10.1111/j.1365-2133.2009.09037.x; Ahmad A, 2003, BIOCHEM BIOPH RES CO, V312, P1266, DOI 10.1016/j.bbrc.2003.11.073; Barneda-Zahonero B, 2012, MOL ONCOL, V6, P579, DOI 10.1016/j.molonc.2012.07.003; Bernstein BE, 2000, P NATL ACAD SCI USA, V97, P13708, DOI 10.1073/pnas.250477697; Bhaskara S, 2008, MOL CELL, V30, P61, DOI 10.1016/j.molcel.2008.02.030; Bhaskara S, 2010, CANCER CELL, V18, P436, DOI 10.1016/j.ccr.2010.10.022; Chou CJ, 2008, J BIOL CHEM, V283, P35402, DOI 10.1074/jbc.M807045200; Conti C, 2010, CANCER RES, V70, P4470, DOI 10.1158/0008-5472.CAN-09-3028; Cotto M, 2010, CLIN TRANSL ONCOL, V12, P401, DOI 10.1007/s12094-010-0527-3; Dorn ES, 2009, NUCLEIC ACIDS RES, V37, P60, DOI 10.1093/nar/gkn912; Drogaris P, 2012, SCI REP-UK, V2, DOI 10.1038/srep00220; Emiliani S, 1998, P NATL ACAD SCI USA, V95, P2795, DOI 10.1073/pnas.95.6.2795; Fernandez-Capetillo O, 2004, P NATL ACAD SCI USA, V101, P1427, DOI 10.1073/pnas.0307342101; Gallinari P, 2007, CELL RES, V17, P195, DOI 10.1038/sj.cr.7310149; Goodarzi AA, 2009, BIOCHEM SOC T, V37, P569, DOI 10.1042/BST0370569; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Hagelkruys Astrid, 2011, Handb Exp Pharmacol, V206, P13, DOI 10.1007/978-3-642-21631-2_2; Insinga A, 2005, CELL CYCLE, V4, P741, DOI 10.4161/cc.4.6.1717; Insinga A, 2005, NAT MED, V11, P71, DOI 10.1038/nm1160; Khan O, 2012, IMMUNOL CELL BIOL, V90, P85, DOI 10.1038/icb.2011.100; Knutson SK, 2008, EMBO J, V27, P1017, DOI 10.1038/emboj.2008.51; Lansigan F, 2010, DRUGS, V70, P273, DOI 10.2165/11532190-000000000-00000; Li Janet Y, 2012, Cancer Manag Res, V4, P75, DOI 10.2147/CMAR.S9660; Malvaez M, 2013, P NATL ACAD SCI USA, V110, P2647, DOI 10.1073/pnas.1213364110; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; Mann BS, 2007, CLIN CANCER RES, V13, P2318, DOI 10.1158/1078-0432.CCR-06-2672; McQuown SC, 2011, J NEUROSCI, V31, P764, DOI 10.1523/JNEUROSCI.5052-10.2011; Melnick A, 2002, CURR OPIN HEMATOL, V9, P322, DOI 10.1097/00062752-200207000-00010; Prince HM, 2009, CLIN CANCER RES, V15, P3958, DOI 10.1158/1078-0432.CCR-08-2785; Rai M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008825; Rosato RR, 2003, MOL CANCER THER, V2, P1273; Rosato RR, 2005, EXPERT OPIN THER TAR, V9, P809, DOI 10.1517/14728222.9.4.809; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Shen S, 2012, AUSTRALAS J DERMATOL, V53, P1, DOI 10.1111/j.1440-0960.2011.00839.x; Sirbu BM, 2012, NAT PROTOC, V7, P594, DOI 10.1038/nprot.2012.010; Sirbu BM, 2011, GENE DEV, V25, P1320, DOI 10.1101/gad.2053211; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Tyler JK, 1996, MOL CELL BIOL, V16, P6149; Whittaker SJ, 2010, J CLIN ONCOL, V28, P4485, DOI 10.1200/JCO.2010.28.9066; Wilcox RA, 2011, AM J HEMATOL, V86, P929, DOI 10.1002/ajh.22139; Willemze R, 2005, BLOOD, V105, P3768, DOI 10.1182/blood-2004-09-3502; Wollina U, 2012, INT J DERMATOL, V51, P1019, DOI 10.1111/j.1365-4632.2011.05337.x; Xu CP, 2009, CHEM BIOL, V16, P980, DOI 10.1016/j.chembiol.2009.07.010; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yamaguchi T, 2010, GENE DEV, V24, P455, DOI 10.1101/gad.552310; Yang WM, 1997, J BIOL CHEM, V272, P28001, DOI 10.1074/jbc.272.44.28001; Yang WM, 2002, J BIOL CHEM, V277, P9447, DOI 10.1074/jbc.M105993200; Yoshida M, 2001, CANCER CHEMOTH PHARM, V48, pS20, DOI 10.1007/s002800100300; Zhang Chunlei, 2003, Dermatol Ther, V16, P322, DOI 10.1111/j.1396-0296.2003.01644.x; Zhang Y, 1997, CELL, V89, P357, DOI 10.1016/S0092-8674(00)80216-0	50	61	63	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e68915	10.1371/journal.pone.0068915	http://dx.doi.org/10.1371/journal.pone.0068915			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894374	Green Submitted, Green Published, gold			2022-12-27	WOS:000322132100030
J	de Carvalho-Neto, PB; dos Santos, M; de Carvalho, MB; Mercante, AMD; dos Santos, VPP; Severino, P; Tajara, EH; Louro, ID; da Silva-Conforti, AMA				de Carvalho-Neto, Paulo Bentes; dos Santos, Marcelo; de Carvalho, Marcos Brasilino; da Cunha Mercante, Ana Maria; Pina dos Santos, Viviane Priscila; Severino, Patricia; Tajara, Eloiza Helena; Louro, Iuri Drumond; Alvares da Silva-Conforti, Adriana Madeira			FAS/FASL Expression Profile as a Prognostic Marker in Squamous Cell Carcinoma of the Oral Cavity	PLOS ONE			English	Article							PATHWAY GENES FAS; LUNG-CANCER; TISSUE MICROARRAYS; PROTEIN EXPRESSION; LIGAND SYSTEM; APOPTOSIS; DEATH; NECK; HEAD; DIFFERENTIATION	FAS/FASL altered expression may cause tumor protecting immunomodulation, with a direct impact on patient prognosis. FAS expression was studied in 60 squamous cell carcinomas of the oral cavity. FAS expression did not show a significant association with tumor histopathological characteristics, but was significantly associated with lymph node positivity. FAS expression was significantly associated with disease specific death and negative FAS expression was an independent risk factor, increasing risk 4 times when compared to positive expression. When FAS and FASL expression results were combined, we were able to define high, intermediate and low risk profiles. Disease-free and disease-specific survival were significantly correlated with FAS/FASL expression profiles. The high risk category was an independent marker for earlier disease relapse and disease-specific death, with approximately 4- and 6-fold increased risk, respectively, when compared to the low risk profile. Risk profiles based on FAS/FASL expression showed that high risk was significantly associated with increased disease relapse and death, as well as shorter disease-free or disease-specific survival. This categorization, added to patient clinical data, may facilitate the choice of therapy, minimizing treatment failure and increasing disease control.	[de Carvalho-Neto, Paulo Bentes] Hosp Heliopolis, Serv Cirurgia Cabeca & Pescoco, Sao Paulo, Brazil; [dos Santos, Marcelo; Louro, Iuri Drumond; Alvares da Silva-Conforti, Adriana Madeira] Univ Fed Espirito Santo, Programa Pos Grad Biotecnol, Vitoria, ES, Brazil; [de Carvalho, Marcos Brasilino; Pina dos Santos, Viviane Priscila] Hosp Heliopolis, Lab Biol Mol, Sao Paulo, Brazil; [da Cunha Mercante, Ana Maria] Hosp Heliopolis, Dept Anat Patol, Sao Paulo, Brazil; [Severino, Patricia] Inst Israelita Ensino & Pesquisa Albert Einstein, Ctr Pesquisa Expt, Sao Paulo, Brazil; [Tajara, Eloiza Helena] Univ Sao Paulo, Fac Med, Dept Biol Mol, Sao Paulo, Brazil	Universidade Federal do Espirito Santo; Hospital Israelita Albert Einstein; Universidade de Sao Paulo	da Silva-Conforti, AMA (corresponding author), Univ Fed Espirito Santo, Programa Pos Grad Biotecnol, Vitoria, ES, Brazil.	adriana.biomol@gmail.com	Tajara, Eloiza H/G-7586-2012; Louro, Iuri D/I-8641-2012; Álvares-da-Silva, Adriana M/J-2912-2018; dos Santos, Marcelo/K-2582-2012; Severino, Patricia/H-2013-2012; Brasilino de Carvalho, Marcos/C-1869-2014	Tajara, Eloiza H/0000-0002-2603-2057; Álvares-da-Silva, Adriana M/0000-0002-8078-0304; dos Santos, Marcelo/0000-0001-7321-7479; Severino, Patricia/0000-0002-6682-9343; Brasilino de Carvalho, Marcos/0000-0001-6854-2680; Louro, Iuri/0000-0001-5160-9615	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [04/12054-9]; Conselho Nacional de Pesquisas (CNPq); Fundacao de Amparo a Pesquisa do Estado do Espirito Santo (FAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisas (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Espirito Santo (FAPES)	Authors acknowledge the financial support from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Grants 04/12054-9) and researcher fellowships from Conselho Nacional de Pesquisas (CNPq) and Fundacao de Amparo a Pesquisa do Estado do Espirito Santo (FAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accomando WP, 2012, CLIN CANCER RES, V18, P6147, DOI 10.1158/1078-0432.CCR-12-1008; [Anonymous], 2010, GLOBOCAN 2008 CANC I; Asensio C, 2007, ANTICANCER RES, V27, P4083; Ashe PC, 2003, PROG NEURO-PSYCHOPH, V27, P199, DOI 10.1016/S0278-5846(03)00016-2; Ashkenazi A, 1999, CURR OPIN CELL BIOL, V11, P255, DOI 10.1016/S0955-0674(99)80034-9; Bauman JE, 2012, CURR OPIN ONCOL, V24, P235, DOI 10.1097/CCO.0b013e3283517920; Blagosklonny MV, 2003, SEMIN CANCER BIOL, V13, P97, DOI 10.1016/S1044-579X(02)00127-X; Brill A, 1999, J ASSIST REPROD GEN, V16, P512, DOI 10.1023/A:1020541019347; Campos AHJFM, 2009, MOL CELL BIOCHEM, V321, P95, DOI 10.1007/s11010-008-9923-1; Delong MJ, 1998, ANN NY ACAD SCI, V842, P82, DOI 10.1111/j.1749-6632.1998.tb09635.x; Deschler DG, 2008, POCKET GUIDE NECK DI; Doseff AI, 2004, STEM CELLS DEV, V13, P473, DOI 10.1089/1547328042417255; Fan CF, 2011, FOLIA HISTOCHEM CYTO, V49, P231, DOI 10.5603/FHC.2011.0032; Farshadpour F, 2011, HEAD NECK-J SCI SPEC, V33, P817, DOI 10.1002/hed.21549; French LE, 2003, CELL DEATH DIFFER, V10, P117, DOI 10.1038/sj.cdd.4401185; Gastman BR, 1999, CANCER RES, V59, P5356; Gerl R, 2005, CARCINOGENESIS, V26, P263, DOI 10.1093/carcin/bgh283; GONCALVES RB, 2011, MECH INFLAMM RES, V60, P409, DOI DOI 10.1007/S00011-011-0308-7; Gratas C, 1998, CANCER RES, V58, P2057; Hedvat CV, 2002, HUM PATHOL, V33, P968, DOI 10.1053/hupa.2002.127438; Hsu FD, 2002, MODERN PATHOL, V15, P1374, DOI 10.1097/01.MP.0000039571.02827.CE; KING KL, 1995, J CELL BIOCHEM, V58, P175, DOI 10.1002/jcb.240580206; Koornstra JJ, 2003, CRIT REV ONCOL HEMAT, V45, P37, DOI 10.1016/S1040-8428(01)00228-1; Lee SH, 1999, ONCOGENE, V18, P3754, DOI 10.1038/sj.onc.1202769; Li Q, 2010, WORLD J GASTROENTERO, V16, P1274, DOI 10.3748/wjg.v16.i10.1274; McGill G., 1997, FRONT BIOSCI, V2, P353; Mian MF, 2008, J LEUKOCYTE BIOL, V83, P774, DOI 10.1189/jlb.0707481; MOLLER P, 1994, INT J CANCER, V57, P371, DOI 10.1002/ijc.2910570314; Morita Y, 2001, ENDOCR J, V48, P289, DOI 10.1507/endocrj.48.289; Myers EN, 1998, OTOLARYNG CLIN N AM, V31, P671, DOI 10.1016/S0030-6665(05)70079-7; Nagao M, 1999, HEPATOLOGY, V30, P413, DOI 10.1002/hep.510300237; Nambu Y, 1998, J CLIN INVEST, V101, P1102, DOI 10.1172/JCI1692; Niehans GA, 1997, CANCER RES, V57, P1007; Ohno S, 2000, ANN SURG ONCOL, V7, P750, DOI 10.1007/s10434-000-0750-1; Owen-Schaub LB, 1998, J EXP MED, V188, P1717, DOI 10.1084/jem.188.9.1717; Pentenero M, 2005, HEAD NECK-J SCI SPEC, V27, P1080, DOI 10.1002/hed.20275; Pryczynicz A, 2010, FOLIA HISTOCHEM CYTO, V48, P425, DOI 10.2478/v10042-010-0058-3; Rimm DL, 2001, EXP MOL PATHOL, V70, P255, DOI 10.1006/exmp.2001.2363; Severino Patricia, 2008, BMC Res Notes, V1, P113, DOI 10.1186/1756-0500-1-113; Shibakita M, 2000, CLIN CANCER RES, V6, P4755; Sjostrom J, 2001, BRIT MED J, V322, P1538, DOI 10.1136/bmj.322.7301.1538; Soini Y, 2000, BRIT J CANCER, V83, P880, DOI 10.1054/bjoc.2000.1384; Sun T, 2004, JNCI-J NATL CANCER I, V96, P1030, DOI 10.1093/jnci/djh187; Szabo G, 1999, ALCOHOL ALCOHOLISM, V34, P830, DOI 10.1093/alcalc/34.6.830; Vermeulen K, 2005, ANN HEMATOL, V84, P627, DOI 10.1007/s00277-005-1065-x; Volm M, 2000, BRIT J CANCER, V82, P1747; Watson GA, 2011, NEOPLASIA, V13, P198, DOI 10.1593/neo.101304; Yuo A, 2001, INT J HEMATOL, V73, P438, DOI 10.1007/BF02994005; Zhang X, 2005, J MED GENET, V42, P479, DOI 10.1136/jmg.2004.030106; Zhen WN, 2004, HEAD NECK-J SCI SPEC, V26, P660, DOI 10.1002/hed.20064	50	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e69024	10.1371/journal.pone.0069024	http://dx.doi.org/10.1371/journal.pone.0069024			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894399	Green Published, gold, Green Submitted			2022-12-27	WOS:000322391400037
J	Tan, SM; Sharma, A; Yuen, DYC; Stefanovic, N; Krippner, G; Mugesh, G; Chai, ZL; de Haan, JB				Tan, Sih Min; Sharma, Arpeeta; Yuen, Derek Y. C.; Stefanovic, Nada; Krippner, Guy; Mugesh, Govindasamy; Chai, Zhonglin; de Haan, Judy B.			The Modified Selenenyl Amide, M-hydroxy Ebselen, Attenuates Diabetic Nephropathy and Diabetes-Associated Atherosclerosis in ApoE/GPx1 Double Knockout Mice	PLOS ONE			English	Article							GLUTATHIONE-PEROXIDASE MIMETICS; CORONARY-ARTERY-DISEASE; OXIDATIVE STRESS; ANTIOXIDANT ACTIVITY; SIGNALING PATHWAYS; PODOCYTE NUMBER; P38 MAPK; PEROXYNITRITE; COMPLICATIONS; ACTIVATION	Seleno-organic glutathione peroxidase (GPx) mimetics, including ebselen (Eb), have been tested in in vitro studies for their ability to scavenge reactive oxygen and nitrogen species, including hydrogen peroxide and peroxynitrite. In this study, we investigated the efficacies of two Eb analogues, m-hydroxy ebselen (ME) and ethanol-ebselen (EtE) and compared these with Eb in cell based assays. We found that ME is superior in attenuating the activation of hydrogen peroxide-induced pro-inflammatory mediators, ERK and P38 in human aortic endothelial cells. Consequently, we investigated the effects of ME in an in vivo model of diabetes, the ApoE/GPx1 double knockout (dKO) mouse. We found that ME attenuates plaque formation in the aorta and lesion deposition within the aortic sinus of diabetic dKO mice. Oxidative stress as assessed by 8-OHdG in urine and nitrotyrosine immunostaining in the aortic sinus and kidney tubules, was reduced by ME in diabetic dKO mice. ME also attenuated diabetes-associated renal injury which included tubulointerstitial fibrosis and glomerulosclerosis. Furthermore, the bioactivity of the pro-fibrotic cytokine transforming growth factor-beta (TGF-beta) as assessed by phospho-Smad2/3 immunostaining was attenuated after treatment with ME. TGF-beta-stimulated increases in collagen I and IV gene expression and protein levels were attenuated by ME in rat kidney tubular cells. However, in contrast to the superior activity of ME in in vitro and cell based assays, ME did not further augment the attenuation of diabetes-associated atherosclerosis and renal injury in our in vivo model when compared with Eb. In conclusion, this study strengthens the notion that bolstering GPx-like activity using synthetic mimetics may be a useful therapeutic strategy in lessening the burden of diabetic complications. However, these studies highlight the importance of in vivo analyses to test the efficacies of novel Eb analogues, as in vitro and cell based assays are only partly predictive of the in vivo situation.	[Tan, Sih Min; Sharma, Arpeeta; Yuen, Derek Y. C.; Stefanovic, Nada; de Haan, Judy B.] Baker IDI Heart & Diabet Inst, Oxidat Stress Grp, Diabet Complicat Div, Melbourne, Vic, Australia; [Krippner, Guy] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Mugesh, Govindasamy] Indian Inst Sci, Dept Inorgan & Phys Chem, Bangalore 560012, Karnataka, India; [Chai, Zhonglin] Baker IDI Heart & Diabet Inst, Proliferat & Fibrosis Grp, Diabet Complicat Div, Melbourne, Vic, Australia	Baker Heart and Diabetes Institute; Baker Heart and Diabetes Institute; Indian Institute of Science (IISC) - Bangalore; Baker Heart and Diabetes Institute	de Haan, JB (corresponding author), Baker IDI Heart & Diabet Inst, Oxidat Stress Grp, Diabet Complicat Div, Melbourne, Vic, Australia.	judy.dehaan@bakeridi.edu.au	CHAI, ZHONGLIN/X-1342-2019; Mugesh, Govindasamy/B-4613-2008	CHAI, ZHONGLIN/0000-0001-8182-8579; Mugesh, Govindasamy/0000-0002-5389-5309; de Haan, Judy B./0000-0002-2749-7833; Tan, Sih Min/0000-0003-4195-0523	Juvenile Diabetes Research Foundation; National Health and Medical Research Council [526656]; Baker IDI Medicinal Chemistry Grant; Victorian Government's OIS Program	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Baker IDI Medicinal Chemistry Grant; Victorian Government's OIS Program	SMT is supported by a Juvenile Diabetes Research Foundation International Postdoctoral Fellowship. JBdH is supported by National Health and Medical Research Council Grant (#526656) and Baker IDI Medicinal Chemistry Grant. This study was supported in part by the Victorian Government's OIS Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batthyany C, 2005, BIOCHEMISTRY-US, V44, P8038, DOI 10.1021/bi0474620; BAYNES JW, 1991, DIABETES, V40, P405, DOI 10.2337/diabetes.40.4.405; Bhabak KP, 2008, CHEM-EUR J, V14, P8640, DOI 10.1002/chem.200800963; Bhabak KP, 2007, CHEM-EUR J, V13, P4594, DOI 10.1002/chem.200601584; Bhabak KP, 2011, ORG BIOMOL CHEM, V9, P5193, DOI 10.1039/c0ob01234c; Blanchard-Fillion B, 2001, J BIOL CHEM, V276, P46017, DOI 10.1074/jbc.M105564200; Blankenberg S, 2003, NEW ENGL J MED, V349, P1605, DOI 10.1056/NEJMoa030535; Blauwkamp MN, 2008, BMC NEPHROL, V9, DOI 10.1186/1471-2369-9-7; Breton-Romero R, 2012, FREE RADICAL BIO MED, V52, P1093, DOI 10.1016/j.freeradbiomed.2011.12.026; Ceriello A, 2003, DIABETES CARE, V26, P1589, DOI 10.2337/diacare.26.5.1589; Chew P, 2010, DIABETES, V59, P3198, DOI 10.2337/db10-0195; Chew P, 2009, ARTERIOSCL THROM VAS, V29, P823, DOI 10.1161/ATVBAHA.109.186619; Day BJ, 2009, BIOCHEM PHARMACOL, V77, P285, DOI 10.1016/j.bcp.2008.09.029; Douki T, 1996, CHEM RES TOXICOL, V9, P3, DOI 10.1021/tx950126n; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039; Forstermann U, 2008, NAT CLIN PRACT CARD, V5, P338, DOI 10.1038/ncpcardio1211; GALET V, 1994, J MED CHEM, V37, P2903, DOI 10.1021/jm00044a011; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Gilbert RE, 1998, DIABETES, V47, P414, DOI 10.2337/diabetes.47.3.414; Giugliano D, 1996, DIABETES CARE, V19, P257, DOI 10.2337/diacare.19.3.257; Hamanishi T, 2004, DIABETES, V53, P2455, DOI 10.2337/diabetes.53.9.2455; Hort MA, 2011, J CARDIOVASC PHARM, V58, P91, DOI 10.1097/FJC.0b013e31821d1149; Jauslin ML, 2002, HUM MOL GENET, V11, P3055, DOI 10.1093/hmg/11.24.3055; Lee HB, 2003, J AM SOC NEPHROL, V14, pS241, DOI 10.1097/01.ASN.0000077410.66390.0F; Lewis P, 2007, CIRCULATION, V115, P2178, DOI 10.1161/CIRCULATIONAHA.106.664250; Masumoto K, 1996, FEBS LETT, V398, P179, DOI 10.1016/S0014-5793(96)01237-9; Messali M., 2011, ORG CHEM INT, V2011; Meyer TW, 1999, DIABETOLOGIA, V42, P1341, DOI 10.1007/s001250051447; MOORE KP, 1995, ADV PROSTAG THROMB L, V23, P225; Palomba L, 1999, BIOCHEM PHARMACOL, V58, P1743, DOI 10.1016/S0006-2952(99)00271-3; Rhyu DY, 2005, J AM SOC NEPHROL, V16, P667, DOI 10.1681/ASN.2004050425; Saito Y, 2006, FREE RADICAL RES, V40, P619, DOI 10.1080/10715760600632552; Sanden SK, 2003, J AM SOC NEPHROL, V14, P2484, DOI 10.1097/01.ASN.0000089829.45296.7C; Sarma BK, 2005, J AM CHEM SOC, V127, P11477, DOI 10.1021/ja052794t; Sies H, 1997, J BIOL CHEM, V272, P27812, DOI 10.1074/jbc.272.44.27812; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.01.06.db05-0894; Wang B, 2012, J AM SOC NEPHROL, V23, P252, DOI 10.1681/ASN.2011010055; Werle M, 2002, CARDIOVASC RES, V56, P284, DOI 10.1016/S0008-6363(02)00600-4; Winter JP, 2003, CORONARY ARTERY DIS, V14, P149, DOI 10.1097/00019501-200304000-00007; Wu J, 2009, AM J PHYSIOL-RENAL, V297, pF1622, DOI 10.1152/ajprenal.00078.2009	41	19	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e69193	10.1371/journal.pone.0069193	http://dx.doi.org/10.1371/journal.pone.0069193			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874911	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000322064300091
J	Baab, KL; McNulty, KP; Harvati, K				Baab, Karen L.; McNulty, Kieran P.; Harvati, Katerina			Homo floresiensis Contextualized: A Geometric Morphometric Comparative Analysis of Fossil and Pathological Human Samples	PLOS ONE			English	Article							LIANG-BUA; BRAIN SIZE; TAXONOMIC AFFINITIES; LATE PLEISTOCENE; SOUTHEAST-ASIA; LB1; HOMININ; GROWTH; SKULL; MORPHOLOGY	The origin of hominins found on the remote Indonesian island of Flores remains highly contentious. These specimens may represent a new hominin species, Homo floresiensis, descended from a local population of Homo erectus or from an earlier (pre-H. erectus) migration of a small-bodied and small-brained hominin out of Africa. Alternatively, some workers suggest that some or all of the specimens recovered from Liang Bua are pathological members of a small-bodied modern human population. Pathological conditions proposed to explain their documented anatomical features include microcephaly, myxoedematous endemic hypothyroidism ("cretinism") and Laron syndrome (primary growth hormone insensitivity). This study evaluates evolutionary and pathological hypotheses through comparative analysis of cranial morphology. Geometric morphometric analyses of landmark data show that the sole Flores cranium (LB1) is clearly distinct from healthy modern humans and from those exhibiting hypothyroidism and Laron syndrome. Modern human microcephalic specimens converge, to some extent, on crania of extinct species of Homo. However in the features that distinguish these two groups, LB1 consistently groups with fossil hominins and is most similar to H. erectus. Our study provides further support for recognizing the Flores hominins as a distinct species, H. floresiensis, whose affinities lie with archaic Homo.	[Baab, Karen L.] SUNY Stony Brook, Dept Anthropol, Stony Brook, NY 11794 USA; [Baab, Karen L.] SUNY Stony Brook, Interdept Doctoral Program Anthropol Sci, Stony Brook, NY 11794 USA; [McNulty, Kieran P.] Univ Minnesota, Evolut Anthropol Lab, Minneapolis, MN USA; [McNulty, Kieran P.] Univ Minnesota, Dept Anthropol, Minneapolis, MN USA; [Harvati, Katerina] Univ Tubingen, Senckenberg Ctr Human Evolut & Paleoecol, Dept Early Prehist & Quaternary Ecol, Tubingen, Germany	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Eberhard Karls University of Tubingen; Senckenberg Gesellschaft fur Naturforschung (SGN)	Baab, KL (corresponding author), SUNY Stony Brook, Dept Anthropol, Stony Brook, NY 11794 USA.	Karen.Baab@StonyBrook.edu	Harvati, Katerina/A-5197-2008; Baab, Karen/I-4019-2019	Baab, Karen/0000-0002-6434-3681	Deutsche Forschungsgemeinschaft [DFG INST 37/706-1 FUGG]; National Science Foundation (DDI Grant) [BCS 04-24262]; LSB Leakey Foundation; Sigma Xi	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Science Foundation (DDI Grant); LSB Leakey Foundation; Sigma Xi	Part of this research was made possible by the Deutsche Forschungsgemeinschaft (DFG INST 37/706-1 FUGG). Funding was also provided by the National Science Foundation (DDI Grant BCS 04-24262), the LSB Leakey Foundation and Sigma Xi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuelo Dianne, 2007, Semin Pediatr Neurol, V14, P118, DOI 10.1016/j.spen.2007.07.003; Argue D, 2009, J HUM EVOL, V57, P623, DOI 10.1016/j.jhevol.2009.05.002; Argue D, 2006, J HUM EVOL, V51, P360, DOI 10.1016/j.jhevol.2006.04.013; Baab KL, 2008, J HUM EVOL, V55, P741, DOI 10.1016/j.jhevol.2008.02.013; Baab KL, 2010, VERTEBR PALEOBIOL PA, P57, DOI 10.1007/978-90-481-9094-2_6; Baab KL, 2009, J HUM EVOL, V57, P608, DOI 10.1016/j.jhevol.2008.08.011; Baab KL, 2007, CRANIAL SHAPE VARIAT; Barker G, 2007, J HUM EVOL, V52, P243, DOI 10.1016/j.jhevol.2006.08.011; Barker T M, 1994, Australas Radiol, V38, P106, DOI 10.1111/j.1440-1673.1994.tb00146.x; BEALS KL, 1984, CURR ANTHROPOL, V25, P301, DOI 10.1086/203138; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; BOYAGES SC, 1993, THYROID, V3, P59, DOI 10.1089/thy.1993.3.59; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; Brown P, 2012, J HUM EVOL, V62, P201, DOI 10.1016/j.jhevol.2011.10.011; Brown P, 2009, J HUM EVOL, V57, P571, DOI 10.1016/j.jhevol.2009.06.002; Choi JY, 2002, INT J ORAL MAX SURG, V31, P23, DOI 10.1054/ijom.2000.0135; Dattani M, 2004, LANCET, V363, P1977, DOI 10.1016/S0140-6736(04)16413-1; Demeter F, 2012, P NATL ACAD SCI USA, V109, P14375, DOI 10.1073/pnas.1208104109; Eckhardt RB, 2010, AM J PHYS ANTHROPOL, V143, P331, DOI 10.1002/ajpa.21369; Falk D, 2005, SCIENCE, V308, P242, DOI 10.1126/science.1109727; Falk D, 2007, P NATL ACAD SCI USA, V104, P2513, DOI 10.1073/pnas.0609185104; Falk D, 2009, J HUM EVOL, V57, P597, DOI 10.1016/j.jhevol.2008.10.008; Falk D, 2009, AM J PHYS ANTHROPOL, V140, P52, DOI 10.1002/ajpa.21035; Gordon AD, 2008, P NATL ACAD SCI USA, V105, P4650, DOI 10.1073/pnas.0710041105; Gunz P, 2009, J HUM EVOL, V57, P48, DOI 10.1016/j.jhevol.2009.04.004; Harvati K, 2003, AM J PHYS ANTHROPOL, V120, P323, DOI 10.1002/ajpa.10122; Harvati K, 2006, ANAT REC PART A, V288A, P1225, DOI 10.1002/ar.a.20395; Henneberg M, 2004, FARMING, V1, P2; Hershkovitz I, 2007, AM J PHYS ANTHROPOL, V134, P198, DOI 10.1002/ajpa.20655; HOFMAN MA, 1984, J NEUROL, V231, P87, DOI 10.1007/BF00313723; Hrdlicka A, 1939, AM J PHYS ANTHROPOL, V25, P1, DOI 10.1002/ajpa.1330250117; Hrdlicka A, 1943, AM J PHYS ANTHROP-NE, V1, P77, DOI 10.1002/ajpa.1330010116; Humphry G, 1895, J Anat Physiol, V29, P304; Hunter A. G. W., 2006, HUMAN MALFORMATIONS, P469; Jacob T, 2006, P NATL ACAD SCI USA, V103, P13421, DOI 10.1073/pnas.0605563103; Janney NW, 1922, ENDOCRINOL METAB, P441; Jungers WL, 2009, J HUM EVOL, V57, P538, DOI 10.1016/j.jhevol.2008.08.014; Jungers WL, 2009, NATURE, V459, P81, DOI 10.1038/nature07989; Jungers W, 2010, AM J PHYS ANTHROPOL, P137; Kaifu Y, 2011, J HUM EVOL, V61, P644, DOI 10.1016/j.jhevol.2011.08.008; Kaifu Y, 2010, AM J PHYS ANTHROPOL, V143, P335, DOI 10.1002/ajpa.21387; Kaifu Y, 2009, AM J PHYS ANTHROPOL, V140, P177, DOI 10.1002/ajpa.21066; Kubo D, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0338; Laron Z, 2004, J CLIN ENDOCR METAB, V89, P1031, DOI 10.1210/jc.2003-031033; Larson SG, 2007, AM J PHYS ANTHROPOL, P151; Lyras GA, 2009, ANTHROPOL SCI, V117, P33, DOI 10.1537/ase.080411; Martin RD, 2006, SCIENCE, V312, DOI 10.1126/science.1121144; Martin RD, 2006, ANAT REC PART A, V288A, P1123, DOI 10.1002/ar.a.20389; McNulty KP, 2010, AM J PHYS ANTHROPOL, V143, P337, DOI 10.1002/ajpa.21393; Mitteroecker P, 2011, EVOL BIOL, V38, P100, DOI 10.1007/s11692-011-9109-8; Morwood MJ, 2009, J HUM EVOL, V57, P640, DOI 10.1016/j.jhevol.2009.08.003; Morwood MJ, 2005, NATURE, V437, P1012, DOI 10.1038/nature04022; Moseley Chanda T, 2002, Rev Endocr Metab Disord, V3, P339, DOI 10.1023/A:1020953608174; O'Higgins P, 1998, J ANAT, V193, P251, DOI 10.1046/j.1469-7580.1998.19320251.x; Obendorf PJ, 2008, P ROY SOC B-BIOL SCI, V275, P1287, DOI 10.1098/rspb.2007.1488; Orr CM, J HUM EVOL IN PRESS; Ortner D. J., 2003, IDENTIFICATION PATHO, DOI DOI 10.1016/B978-012528628-2/50057-0; Ortner DJ, 2005, AM J PHYS ANTHROPOL, V127, P1, DOI 10.1002/ajpa.20033; Ortner DJ, 1993, BONE, V7, P159; Ortner DJ, 2002, HIST HLTH EURO UNPUB; Oxnard C, 2012, HOMO, V63, P407, DOI 10.1016/j.jchb.2012.09.005; Oxnard C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013018; Relvas C, 2012, P I MECH ENG B-J ENG, V226, P2023, DOI [10.1177/0954405412461865, 10.1177/095440541246186S]; RICHARDS GD, 1985, AM J PHYS ANTHROPOL, V68, P343, DOI 10.1002/ajpa.1330680305; Rightmire GP, 2006, J HUM EVOL, V50, P115, DOI 10.1016/j.jhevol.2005.07.009; Roberts E, 2002, J MED GENET, V39, P718, DOI 10.1136/jmg.39.10.718; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Santler G, 1998, Comput Aided Surg, V3, P248, DOI 10.1002/(SICI)1097-0150(1998)3:5<248::AID-IGS4>3.0.CO;2-A; Tocheri MW, 2007, SCIENCE, V317, P1743, DOI 10.1126/science.1147143; Vannucci RC, 2011, P NATL ACAD SCI; Vannucci RC, 2013, ANATOMICAL RECORD; Vekua A, 2002, SCIENCE, V297, P85, DOI 10.1126/science.1072953; Weber J, 2005, SCIENCE, V310, DOI 10.1126/science.1114789; Wells JR, 1942, AM J PHYS ANTHROPOL, V29, P425, DOI 10.1002/ajpa.1330290305; Weston EM, 2009, NATURE, V459, P85, DOI 10.1038/nature07922; Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930	76	22	22	1	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e69119	10.1371/journal.pone.0069119	http://dx.doi.org/10.1371/journal.pone.0069119			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182SU	23874886	gold, Green Submitted, Green Published			2022-12-27	WOS:000321765300077
J	Zhang, L; Peng, WW; Zhang, ZG; Hu, L				Zhang, Li; Peng, Weiwei; Zhang, Zhiguo; Hu, Li			Distinct Features of Auditory Steady-State Responses as Compared to Transient Event-Related Potentials	PLOS ONE			English	Article							EVOKED-POTENTIALS; CLICK TRAINS; SOMATOSENSORY CORTEX; EEG RESPONSES; SPINE SURGERY; GAMMA-BAND; BRAIN; COMPONENTS; DESYNCHRONIZATION; OSCILLATIONS	Transient event-related potentials (ERPs) and steady-state responses (SSRs) have been popularly employed to investigate the function of the human brain, but their relationship still remains a matter of debate. Some researchers believed that SSRs could be explained by the linear summation of successive transient ERPs (superposition hypothesis), while others believed that SSRs were the result of the entrainment of a neural rhythm driven by the periodic repetition of a sensory stimulus (oscillatory entrainment hypothesis). In the present study, taking auditory modality as an example, we aimed to clarify the distinct features of SSRs, evoked by the 40-Hz and 60-Hz periodic auditory stimulation, as compared to transient ERPs, evoked by a single click. We observed that (1) SSRs were mainly generated by phase synchronization, while late latency responses (LLRs) in transient ERPs were mainly generated by power enhancement; (2) scalp topographies of LLRs in transient ERPs were markedly different from those of SSRs; (3) the powers of both 40-Hz and 60-Hz SSRs were significantly correlated, while they were not significantly correlated with the N1 power in transient ERPs; (4) whereas SSRs were dominantly modulated by stimulus intensity, middle latency responses (MLRs) were not significantly modulated by both stimulus intensity and subjective loudness judgment, and LLRs were significantly modulated by subjective loudness judgment even within the same stimulus intensity. All these findings indicated that high-frequency SSRs were different from both MLRs and LLRs in transient ERPs, thus supporting the possibility of oscillatory entrainment hypothesis to the generation of SSRs. Therefore, SSRs could be used to explore distinct neural responses as compared to transient ERPs, and help us reveal novel and reliable neural mechanisms of the human brain.	[Zhang, Li; Hu, Li] Southwest Univ, Minist Educ, Key Lab Cognit & Personal, Chongqing, Peoples R China; [Zhang, Li; Hu, Li] Southwest Univ, Sch Psychol, Chongqing, Peoples R China; [Peng, Weiwei] Univ Hong Kong, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China; [Zhang, Zhiguo] Univ Hong Kong, Dept Elect & Elect Engn, Hong Kong, Hong Kong, Peoples R China	Southwest University - China; Southwest University - China; University of Hong Kong; University of Hong Kong	Hu, L (corresponding author), Southwest Univ, Minist Educ, Key Lab Cognit & Personal, Chongqing, Peoples R China.	huli@swu.edu.cn			National Natural Science Foundation of China [31200856]; Natural Science Foundation Project of CQ CSTC; China Postdoctoral Science Foundation [2012T50755]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of CQ CSTC(Natural Science Foundation Project of CQ CSTC); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	LH was supported by the National Natural Science Foundation of China (31200856), Natural Science Foundation Project of CQ CSTC, and Special Financial Grant from the China Postdoctoral Science Foundation (2012T50755). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEGLEITER H, 1967, ARCH GEN PSYCHIAT, V17, P755; Bohorquez J, 2008, CLIN NEUROPHYSIOL, V119, P2598, DOI 10.1016/j.clinph.2008.08.002; Callaway E, 1978, EVENT RELATED BRAIN; Capilla A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014543; Colon E, 2012, NEUROPHYSIOL CLIN, V42, P315, DOI 10.1016/j.neucli.2012.05.005; Colon E, 2012, NEUROIMAGE, V60, P571, DOI 10.1016/j.neuroimage.2011.12.015; Conti G, 1999, CLIN NEUROPHYSIOL, V110, P62, DOI 10.1016/S0168-5597(98)00045-8; Deletis V, 2008, CLIN NEUROPHYSIOL, V119, P248, DOI 10.1016/j.clinph.2007.09.135; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Fell J, 2004, J COGNITIVE NEUROSCI, V16, P1595, DOI 10.1162/0898929042568514; FORSS N, 1993, HEARING RES, V68, P89, DOI 10.1016/0378-5955(93)90067-B; GALAMBOS R, 1981, P NATL ACAD SCI-BIOL, V78, P2643, DOI 10.1073/pnas.78.4.2643; Gonzalez AA, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.8.FOCUS09150; Gustafsson F, 1996, IEEE T SIGNAL PROCES, V44, P988, DOI 10.1109/78.492552; Herrmann CS, 2001, EXP BRAIN RES, V137, P346, DOI 10.1007/s002210100682; Hu L, 2012, NEUROIMAGE, V62, P217, DOI 10.1016/j.neuroimage.2012.03.094; Jung TP, 2001, HUM BRAIN MAPP, V14, P166, DOI 10.1002/hbm.1050; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Makeig S, 1997, P NATL ACAD SCI USA, V94, P10979, DOI 10.1073/pnas.94.20.10979; MAKELA JP, 1987, ELECTROEN CLIN NEURO, V66, P539, DOI 10.1016/0013-4694(87)90101-5; Meigen T, 1999, DOC OPHTHALMOL, V98, P207, DOI 10.1023/A:1002097208337; Mouraux A, 2008, MAGN RESON IMAGING, V26, P1041, DOI 10.1016/j.mri.2008.01.011; Mouraux A, 2011, J NEUROSCI, V31, P6079, DOI 10.1523/JNEUROSCI.3977-10.2011; Nangini C, 2006, NEUROIMAGE, V33, P252, DOI 10.1016/j.neuroimage.2006.05.045; PANTEV C, 1993, ELECTROEN CLIN NEURO, V88, P389, DOI 10.1016/0168-5597(93)90015-H; Peng WW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034163; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Picton TW, 2003, INT J AUDIOL, V42, P177, DOI 10.3109/14992020309101316; Piotr J., 2004, IEEE T BIOMED ENG, V51, P1167; PLOURDE G, 1991, ACTA OTO-LARYNGOL, P153; Presacco A, 2010, CLIN NEUROPHYSIOL, V121, P1540, DOI 10.1016/j.clinph.2010.03.020; REGAN D, 1966, ELECTROEN CLIN NEURO, V20, P238, DOI 10.1016/0013-4694(66)90088-5; REGAN D, 1982, ANN NY ACAD SCI, V388, P45, DOI 10.1111/j.1749-6632.1982.tb50784.x; Regan D., 1989, HUMAN BRAIN ELECTROP; Ross B, 2005, J NEUROPHYSIOL, V94, P4082, DOI 10.1152/jn.00469.2005; Ross B, 2003, HEARING RES, V186, P57, DOI 10.1016/S0378-5955(03)00299-5; SANTARELLI R, 1995, HEARING RES, V83, P9, DOI 10.1016/0378-5955(94)00185-S; Sauseng P, 2007, NEUROSCIENCE, V146, P1435, DOI 10.1016/j.neuroscience.2007.03.014; SUZUKI T, 1994, AUDIOLOGY, V33, P274; Vialatte FB, 2010, PROG NEUROBIOL, V90, P418, DOI 10.1016/j.pneurobio.2009.11.005; Zhang ZG, 2012, J NEUROSCI, V32, P7429, DOI 10.1523/JNEUROSCI.5877-11.2012	42	21	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e69164	10.1371/journal.pone.0069164	http://dx.doi.org/10.1371/journal.pone.0069164			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874901	Green Published, gold			2022-12-27	WOS:000321736900139
J	Cobo, T; Kacerovsky, M; Andrys, C; Drahosova, M; Musilova, I; Hornychova, H; Jacobsson, B				Cobo, Teresa; Kacerovsky, Marian; Andrys, Ctirad; Drahosova, Marcela; Musilova, Ivana; Hornychova, Helena; Jacobsson, Bo			Umbilical Cord Blood IL-6 as Predictor of Early-Onset Neonatal Sepsis in Women with Preterm Prelabour Rupture of Membranes	PLOS ONE			English	Article							FETAL INFLAMMATORY RESPONSE; INTERLEUKIN-6 CONCENTRATIONS; INTRAAMNIOTIC INFLAMMATION; PROTEOMIC BIOMARKERS; EARLY-DIAGNOSIS; PREGNANCY; FUNISITIS	Objective: To evaluate umbilical cord interleukin (IL)-6 and funisitis as independent predictors of early-onset neonatal sepsis (EONS) in preterm prelabor rupture of membranes (PPROM). Design: Prospective cohort study. Setting: Evaluation of umbilical cord IL-6 and funisitis as predictors of early-onset neonatal sepsis in PPROM. Population: 176 women with PPROM between 23+0236+6 weeks of gestation. Methods: Umbilical cord IL-6 was assayed by ELISA. Funisitis was defined according to the Salafia classification. Data was adjusted by gestational age at delivery and prenatal administration of corticosteroids and antibiotics. Main Outcome Measures: Binary logistic regression was performed to assess the independence of umbilical cord IL-6 and funisitis to predict EONS in women complicated with PPROM. Results: The rate of EONS was 7%. Funisitis was present in 18% of women. Umbilical cord IL-6 was significantly higher in women complicated with EONS than without [ median (range) 389.5 pg/mL (13.9-734.8) vs 5.2 (0.1-801-4), p<0.001]. Umbilical cord IL-6 was the only independent predictor of early-onset neonatal sepsis (odds ratio 13.6, p = 0.004). Conclusion: Umbilical cord IL-6 was the only predictor of early-onset neonatal sepsis in PPROM. Contrary to what is reported, funisitis was not.	[Cobo, Teresa] Univ Barcelona, Inst Invest Biomed August Pi i Sunyer IDIBAPS, Hosp Clin, Maternal Fetal Med Dept, Barcelona, Spain; [Kacerovsky, Marian] Univ Hosp Hradec Kralove, Biomed Res Ctr, Hradec Kralove, Czech Republic; [Kacerovsky, Marian; Musilova, Ivana] Univ Hosp Hradec Kralove, Dept Obstet & Gynaecol, Hradec Kralove, Czech Republic; [Andrys, Ctirad; Drahosova, Marcela] Univ Hosp Hradec Kralove, Dept Immunol, Hradec Kralove, Czech Republic; [Musilova, Ivana] Hosp Pardubice, Dept Obstet & Gynecol, Pardubice, Czech Republic; [Hornychova, Helena] Univ Hosp Hradec Kralove, Fingerlands Dept Pathol, Hradec Kralove, Czech Republic; [Jacobsson, Bo] Sahlgrens Univ Hosp, Dept Obstet & Gynecol, Gothenburg, Sweden; [Jacobsson, Bo] Inst Publ Hlth, Oslo, Norway; [Cobo, Teresa] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University Hospital Hradec Kralove; University Hospital Hradec Kralove; University Hospital Hradec Kralove; University Hospital Hradec Kralove; Sahlgrenska University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Cobo, T (corresponding author), Univ Barcelona, Inst Invest Biomed August Pi i Sunyer IDIBAPS, Hosp Clin, Maternal Fetal Med Dept, Barcelona, Spain.	tcobo@clinic.ub.es	Kacerovsky, Marian/ABE-3437-2020; Musilová, Ivana Kacerovská/I-6204-2017; Hornychová, Helena/M-9470-2017; Jacobsson, Bo/O-8007-2014; Kacerovsky, Marian/A-7586-2011; Cobo, Teresa/K-2770-2017	Musilová, Ivana Kacerovská/0000-0002-6960-8319; Hornychová, Helena/0000-0002-2487-1754; Jacobsson, Bo/0000-0001-5079-2374; Kacerovsky, Marian/0000-0001-9858-7900; Andrys, Ctirad/0000-0001-6489-8786; Cobo, Teresa/0000-0003-3130-1829	Instituto de Salud Carlos III in Spain [CM09/00213]; Ministry of Health of the Czech Republic [NS 13461-4/2012]; Faculty Hospital in Hradec Kralove; Charles University in Prague, Faculty of Medicine in Hradec Kralove, Czech Republic [P37/10]; Spanish government [FIS PI041258]; Swedish Medical Society [SLS 2008-21198, ALFGBG-2863, ALFGBG-11522]	Instituto de Salud Carlos III in Spain(Instituto de Salud Carlos III); Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); Faculty Hospital in Hradec Kralove; Charles University in Prague, Faculty of Medicine in Hradec Kralove, Czech Republic; Spanish government(Spanish GovernmentEuropean Commission); Swedish Medical Society	This work was supported by a Rio Hortega grant from Instituto de Salud Carlos III in Spain (CM09/00213); a grant from the Ministry of Health of the Czech Republic (NS 13461-4/2012), Faculty Hospital in Hradec Kralove (long-term organization development plan), and by Charles University in Prague, Faculty of Medicine in Hradec Kralove, Czech Republic, project "PRVOUK" P37/10. Additional support came from grants from the Spanish government (FIS PI041258) and the Swedish Medical Society (SLS 2008-21198, ALFGBG-2863, ALFGBG-11522). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrys C, 2010, NEUROENDOCRINOL LETT, V31, P857; Bhandari V, 2008, PEDIATRICS, V121, P129, DOI 10.1542/peds.2007-1308; Buhimschi CS, 2009, BJOG-INT J OBSTET GY, V116, P257, DOI 10.1111/j.1471-0528.2008.01925.x; Buhimschi CS, 2007, PEDIATR RES, V61, P318, DOI 10.1203/01.pdr.0000252439.48564.37; Cernada M, 2012, ACTA PAEDIATR, V101, pe203, DOI 10.1111/j.1651-2227.2011.02577.x; Doellner H, 1998, J PEDIATR-US, V132, P295, DOI 10.1016/S0022-3476(98)70448-2; Fan Y, 2012, WORLD J PEDIATR, V8, P101, DOI 10.1007/s12519-012-0347-3; Gomez R, 1998, AM J OBSTET GYNECOL, V179, P194, DOI 10.1016/S0002-9378(98)70272-8; Gotsch F, 2007, CLIN OBSTET GYNECOL, V50, P652, DOI 10.1097/GRF.0b013e31811ebef6; Katzman PJ, 2010, PEDIATR DEVEL PATHOL, V13, P265, DOI 10.2350/09-02-0604-OA.1; Lau J, 2005, AM J OBSTET GYNECOL, V193, P708, DOI 10.1016/j.ajog.2005.01.017; Lee SE, 2006, J MATERN-FETAL NEO M, V19, P693, DOI 10.1080/14767050600927353; Lehrnbecher T, 1996, BIOL NEONATE, V70, P206; Matoba N, 2009, PEDIATRICS, V123, P1320, DOI 10.1542/peds.2008-1222; Mestan K, 2009, J MATERN-FETAL NEO M, V22, P379, DOI 10.1080/14767050802609759; Nelson Karin B., 2000, Current Opinion in Neurology, V13, P133, DOI 10.1097/00019052-200004000-00004; Ng PC, 2006, CLIN CHEM, V52, P1181, DOI 10.1373/clinchem.2005.062075; Park CW, 2009, PLACENTA, V30, P56, DOI 10.1016/j.placenta.2008.09.017; RODWELL RL, 1993, PEDIATR INFECT DIS J, V12, P372, DOI 10.1097/00006454-199305000-00004; RODWELL RL, 1988, J PEDIATR-US, V112, P761, DOI 10.1016/S0022-3476(88)80699-1; Romagnoli C, 2001, EUR J PEDIATR, V160, P345, DOI 10.1007/PL00008445; Romero R, 2000, AM J OBSTET GYNECOL, V183, P1070, DOI 10.1067/mob.2000.108885; Rovira N, 2011, EARLY HUM DEV, V87, P253, DOI 10.1016/j.earlhumdev.2011.01.024; SALAFIA CM, 1989, OBSTET GYNECOL, V73, P383; Smulian J C, 1997, J Matern Fetal Med, V6, P254, DOI 10.1002/(SICI)1520-6661(199709/10)6:5<254::AID-MFM2>3.0.CO;2-F; Smulian JC, 1996, J MATERN-FETAL INVES, V6, P67; The czech society of obstetrics and gynecology, 2007, CLIN GUID OBST; Tsiartas P, 2013, J MATERN FETAL NEONA; Weeks JW, 1997, OBSTET GYNECOL, V90, P815, DOI 10.1016/S0029-7844(97)00421-3; Weston EJ, 2011, PEDIATR INFECT DIS J, V30, P937, DOI 10.1097/INF.0b013e318223bad2; Wharton KN, 2004, EARLY HUM DEV, V77, P77, DOI 10.1016/j.earlhumdev.2004.02.001; Yoon BH, 1996, AM J OBSTET GYNECOL, V174, P1433, DOI 10.1016/S0002-9378(96)70585-9	32	31	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69341	10.1371/journal.pone.0069341	http://dx.doi.org/10.1371/journal.pone.0069341			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894452	Green Submitted, Green Published, gold			2022-12-27	WOS:000322167900057
J	Salesses, P; Schechtner, K; Hidalgo, CA				Salesses, Philip; Schechtner, Katja; Hidalgo, Cesar A.			The Collaborative Image of The City: Mapping the Inequality of Urban Perception	PLOS ONE			English	Article							BROKEN WINDOWS; PREFERENCE	A traveler visiting Rio, Manila or Caracas does not need a report to learn that these cities are unequal; she can see it directly from the taxicab window. This is because in most cities inequality is conspicuous, but also, because cities express different forms of inequality that are evident to casual observers. Cities are highly heterogeneous and often unequal with respect to the income of their residents, but also with respect to the cleanliness of their neighborhoods, the beauty of their architecture, and the liveliness of their streets, among many other evaluative dimensions. Until now, however, our ability to understand the effect of a city's built environment on social and economic outcomes has been limited by the lack of quantitative data on urban perception. Here, we build on the intuition that inequality is partly conspicuous to create quantitative measure of a city's contrasts. Using thousands of geo-tagged images, we measure the perception of safety, class and uniqueness; in the cities of Boston and New York in the United States, and Linz and Salzburg in Austria, finding that the range of perceptions elicited by the images of New York and Boston is larger than the range of perceptions elicited by images from Linz and Salzburg. We interpret this as evidence that the cityscapes of Boston and New York are more contrasting, or unequal, than those of Linz and Salzburg. Finally, we validate our measures by exploring the connection between them and homicides, finding a significant correlation between the perceptions of safety and class and the number of homicides in a NYC zip code, after controlling for the effects of income, population, area and age. Our results show that online images can be used to create reproducible quantitative measures of urban perception and characterize the inequality of different cities.	[Salesses, Philip; Schechtner, Katja; Hidalgo, Cesar A.] MIT, MIT Media Lab, Cambridge, MA 02139 USA; [Schechtner, Katja] Austrian Inst Technol, Mobil Dept, Vienna, Austria; [Schechtner, Katja] Vienna Univ Technol, Inst Urban Design & Landscape Architecture, A-1040 Vienna, Austria; [Hidalgo, Cesar A.] MIT, Engn Syst Div, Cambridge, MA 02139 USA; [Hidalgo, Cesar A.] Inst Sistemas Complejos Valparaiso, Valparaiso, Chile	Massachusetts Institute of Technology (MIT); Austrian Institute of Technology (AIT); Technische Universitat Wien; Massachusetts Institute of Technology (MIT)	Hidalgo, CA (corresponding author), MIT, MIT Media Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	hidalgo@mit.edu	Hidalgo, Cesar A./B-5155-2009; Ginieis, Matías/AAG-8658-2020	Hidalgo, Cesar A./0000-0002-6977-9492; Ginieis, Matías/0000-0003-4459-2899; /0000-0002-6031-5982	Massachusetts Institute of Technology Media Lab Consortia Funding	Massachusetts Institute of Technology Media Lab Consortia Funding	Massachusetts Institute of Technology Media Lab Consortia Funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselin L, 2010, ADV SPAT SCI, P35, DOI 10.1007/978-3-642-01976-0_3; Batty M, 2007, CITIES AND COMPLEXIT; Batty M., 1994, FRACTAL CITIES A GEO; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bratton W, 2006, NATIONAL REVIEW, V28; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Chapin FS, 1966, URBAN GROWTH DYNAMIC; Cohen D, 2000, AM J PUBLIC HEALTH, V90, P230, DOI 10.2105/AJPH.90.2.230; de Montjoye YA, 2013, SCIENTIFIC REPORTS 3; DEVLIN K, 1989, J ENVIRON PSYCHOL, V9, P333, DOI 10.1016/S0272-4944(89)80013-1; Eagle N, 2010, SCIENCE, V328, P1029, DOI 10.1126/science.1186605; Eagle N, 2009, P NATL ACAD SCI USA, V106, P15274, DOI 10.1073/pnas.0900282106; Ellison G, 1997, J POLIT ECON, V105, P889, DOI 10.1086/262098; Fujita M, 2004, PAP REG SCI, V83, P139, DOI 10.1007/s10110-003-0180-0; GETIS A, 1990, PAP REG SCI ASSOC, P69; Glaeser EL, 1992, JOURNAL OF POLITICAL, V100; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Harcourt BE, 2006, U CHICAGO LAW REV, V73, P271; Harcourt BE, 1998, MICH LAW REV, V97, P291, DOI 10.2307/1290289; HERZOG TR, 1976, ENVIRON BEHAV, V8, P627, DOI 10.1177/001391657684008; Hidalgo CA, 2008, PHYSICA A, V387, P3017, DOI 10.1016/j.physa.2008.01.073; Howard E, 1965, GARDEN CITIES OF TO, V23; Jacobs J, 1970, EC CITIES; Jacobs J., 1961, THE DEATH AND LIFE O; Jacobs J, 1985, CITIES AND THE WEALT; Jean PKS, 2007, POCKETS OF CRIME BRO; Keizer K, 2008, SCIENCE, V322, P1681, DOI 10.1126/science.1161405; Kelling G.L., 1982, ATLANTIC, V249, P29, DOI DOI 10.4135/9781412959193.n281; Krugman P, 1998, OXFORD REV ECON POL, V14, P7, DOI 10.1093/oxrep/14.2.7; Lomax RG, 2007, AN INTRODUCTION TO S; Lynch K, 1960, THE IMAGE OF THE CIT, V1; Milgram Stanley, 1976, ENV PSYCHOL PEOPLE T; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Nasar JL, 1997, THE EVALUATIVE IMAGE; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; Park J, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/10/P10014; PETERSON GL, 1967, J REGIONAL SCI, V7, P19, DOI 10.1111/j.1467-9787.1967.tb01420.x; Robinson CM, 1909, MODERN CIVIC ART OR; Ross CE, 2001, J HEALTH SOC BEHAV, V42, P258, DOI 10.2307/3090214; Roth M, 2005, PROCEEDINGS AT ANHAL, P121; Rybczynski W., 2010, MAKESHIFT METROPOLIS; SCHROEDER HW, 1984, J LEISURE RES, V16, P178, DOI 10.1080/00222216.1984.11969584; Scott James C., 1998, SEEING LIKE A STATE; Wherrett J.R., 2000, LANDSCAPE RES, V25, P79, DOI [10.1080/014263900113181, DOI 10.1080/014263900113181]; Wilson RL, 1962, URBAN GROWTH DYNAMIC, P359	46	212	225	7	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e68400	10.1371/journal.pone.0068400	http://dx.doi.org/10.1371/journal.pone.0068400			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	188BY	23894301	Green Published, Green Submitted, gold			2022-12-27	WOS:000322167900010
J	Nery, AA; Magdesian, MH; Trujillo, CA; Sathler, LB; Juliano, MA; Juliano, L; Ulrich, H; Ferreira, ST				Nery, Arthur A.; Magdesian, Margaret H.; Trujillo, Cleber A.; Sathler, Luciana B.; Juliano, Maria A.; Juliano, Luiz; Ulrich, Henning; Ferreira, Sergio T.			Rescue of Amyloid-Beta-Induced Inhibition of Nicotinic Acetylcholine Receptors by a Peptide Homologous to the Nicotine Binding Domain of the Alpha 7 Subtype	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; LIGAND-BINDING; AMINO-ACIDS; IN-VITRO; BETA-AMYLOID(1-42); AGONIST; COCAINE; PROTEIN; IDENTIFICATION	Alzheimer's disease (AD) is characterized by brain accumulation of the neurotoxic amyloid-beta peptide (A beta) and by loss of cholinergic neurons and nicotinic acetylcholine receptors (nAChRs). Recent evidence indicates that memory loss and cognitive decline in AD correlate better with the amount of soluble A beta than with the extent of amyloid plaque deposits in affected brains. Inhibition of nAChRs by soluble A beta 40 is suggested to contribute to early cholinergic dysfunction in AD. Using phage display screening, we have previously identified a heptapeptide, termed IQ, homologous to most nAChR subtypes, binding with nanomolar affinity to soluble A beta 40 and blocking A beta-induced inhibition of carbamylcholine-induced currents in PC12 cells expressing alpha 7 nAChRs. Using alanine scanning mutagenesis and whole-cell current recording, we have now defined the amino acids in IQ essential for reversal of A beta 40 inhibition of carbamylcholine-induced responses in PC12 cells, mediated by alpha 7 subtypes and other endogenously expressed nAChRs. We further investigated the effects of soluble A beta, IQ and analogues of IQ on alpha 3 beta 4 nAChRs recombinantly expressed in HEK293 cells. Results show that nanomolar concentrations of soluble A beta 40 potently inhibit the function of alpha 3 beta 4 nAChRs, and that subsequent addition of IQ or its analogues does not reverse this effect. However, co-application of IQ makes the inhibition of alpha 3 beta 4 nAChRs by A beta 40 reversible. These findings indicate that A beta 40 inhibits different subtypes of nAChRs by interacting with specific receptor domains homologous to the IQ peptide, suggesting that IQ may be a lead for novel drugs to block the inhibition of cholinergic function in AD.	[Nery, Arthur A.; Trujillo, Cleber A.; Ulrich, Henning] Univ Sao Paulo, Inst Chem, Dept Biochem, Sao Paulo, Brazil; [Magdesian, Margaret H.; Sathler, Luciana B.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem, Rio De Janeiro, RJ, Brazil; [Juliano, Maria A.; Juliano, Luiz] Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro; Universidade Federal de Sao Paulo (UNIFESP)	Ulrich, H (corresponding author), Univ Sao Paulo, Inst Chem, Dept Biochem, Sao Paulo, Brazil.	henning@iq.usp.br; ferreira@bioqmed.ufrj.br	Ferreira, Sergio/AAZ-1576-2020; Ulrich, Henning/C-5245-2013; Juliano, Luiz/D-7204-2012; Ulrich, Henning/AAX-8586-2021	Ferreira, Sergio/0000-0001-7160-9866; Ulrich, Henning/0000-0002-2114-3815; Juliano, Luiz/0000-0002-5589-2822; Ulrich, Henning/0000-0002-2114-3815	National Institute for Translational Neuroscience/Brazil; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro; Fundacao Universitaria Jose Bonifacio; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2006/61285-9, 2012/50880-4]	National Institute for Translational Neuroscience/Brazil; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao Universitaria Jose Bonifacio; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by grants from National Institute for Translational Neuroscience/Brazil (STF), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (STF and HU), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (STF and MHM), Fundacao Universitaria Jose Bonifacio (MHM), and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (HU) (project No. 2006/61285-9 and 2012/50880-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias HR, 2000, NEUROCHEM INT, V36, P595, DOI 10.1016/S0197-0186(99)00154-0; Association A.s., 2010, ALZHEIMERS DEMENT, P158, DOI [10.1016/j.jalz.2010.01.009, DOI 10.1016/J.JALZ.2010.01.009]; Azam L, 2009, ACTA PHARMACOL SIN, V30, P771, DOI 10.1038/aps.2009.47; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Buckingham SD, 2009, PHARMACOL REV, V61, P39, DOI 10.1124/pr.108.000562; Cheffer A, 2012, J NEUROSCI RES, V90, P1607, DOI 10.1002/jnr.23047; Cheffer A, 2011, BIOCHEMISTRY-US, V50, P1763, DOI 10.1021/bi101789y; Chiara DC, 1997, J BIOL CHEM, V272, P32940, DOI 10.1074/jbc.272.52.32940; Clementi F, 2000, EUR J PHARMACOL, V393, P3, DOI 10.1016/S0014-2999(00)00066-2; CORRINGER PJ, 1995, J BIOL CHEM, V270, P11749, DOI 10.1074/jbc.270.20.11749; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; D'Andrea MR, 2006, CURR PHARM DESIGN, V12, P677, DOI 10.2174/138161206775474224; DENNIS M, 1988, BIOCHEMISTRY-US, V27, P2346, DOI 10.1021/bi00407a016; Dineley KT, 2007, FRONT BIOSCI-LANDMRK, V12, P5030, DOI 10.2741/2445; Dineley KT, 2002, J BIOL CHEM, V277, P25056, DOI 10.1074/jbc.M200066200; Dougherty JJ, 2003, J NEUROSCI, V23, P6740; Dziewczapolski G, 2009, J NEUROSCI, V29, P8805, DOI 10.1523/JNEUROSCI.6159-08.2009; Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882; Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003; FU DX, 1994, J BIOL CHEM, V269, P26152; Fu W, 2003, J NEUROPHYSIOL, V90, P3130, DOI 10.1152/jn.00616.2003; GALZI JL, 1990, J BIOL CHEM, V265, P10430; Gotti C, 2006, NEUROBIOL DIS, V23, P481, DOI 10.1016/j.nbd.2006.04.005; Grassi F, 2003, J PHYSIOL-LONDON, V547, P147, DOI 10.1113/jphysiol.2002.035436; Greenwald J, 2010, STRUCTURE, V18, P1244, DOI 10.1016/j.str.2010.08.009; Hess GP, 2000, P NATL ACAD SCI USA, V97, P13895, DOI 10.1073/pnas.240459497; HO PL, 1992, J CELL PHYSIOL, V150, P647, DOI 10.1002/jcp.1041500326; Jurgensen S, 2010, J MOL NEUROSCI, V40, P221, DOI 10.1007/s12031-009-9237-0; Kadir A, 2006, PSYCHOPHARMACOLOGY, V188, P509, DOI 10.1007/s00213-006-0447-7; Krivoshein AV, 2004, BIOCHEMISTRY-US, V43, P481, DOI 10.1021/bi034838l; Lamb PW, 2005, J MOL NEUROSCI, V27, P13, DOI 10.1385/JMN:27:1:013; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lindstrom JM, 2003, ANN NY ACAD SCI, V998, P41, DOI 10.1196/annals.1254.007; Liu QS, 2001, P NATL ACAD SCI USA, V98, P4734, DOI 10.1073/pnas.081553598; Magdesian MH, 2005, J BIOL CHEM, V280, P31085, DOI 10.1074/jbc.M502406200; Martin-Ruiz CM, 1999, J NEUROCHEM, V73, P1635, DOI 10.1046/j.1471-4159.1999.0731635.x; Mehta PD, 2001, NEUROSCI LETT, V304, P102, DOI 10.1016/S0304-3940(01)01754-2; Moaddel R, 2004, J CHROMATOGR B, V813, P235, DOI 10.1016/j.jchromb.2004.09.042; Mura E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029661; Nagele RG, 2002, NEUROSCIENCE, V110, P199, DOI 10.1016/S0306-4522(01)00460-2; Nery AA, 2010, J MOL NEUROSCI, V41, P329, DOI 10.1007/s12031-010-9369-2; Niu L, 1995, P NATL ACAD SCI USA, V92, P12008, DOI 10.1073/pnas.92.26.12008; Nordberg A, 2001, BIOL PSYCHIAT, V49, P200, DOI 10.1016/S0006-3223(00)01125-2; Nunes-Alves A, 2013, J MOL NEUROSCI, V49, P52, DOI 10.1007/s12031-012-9859-5; Pettit DL, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-01-j0003.2001; Puzzo D, 2008, J NEUROSCI, V28, P14537, DOI 10.1523/JNEUROSCI.2692-08.2008; Pym L, 2005, BRIT J PHARMACOL, V146, P964, DOI 10.1038/sj.bjp.0706403; Riek R, 2006, NATURE, V444, P429, DOI 10.1038/444429a; Salas R, 2004, NEUROPHARMACOLOGY, V47, P401, DOI 10.1016/j.neuropharm.2004.05.002; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Small DH, 2007, J NEUROCHEM, V101, P1527, DOI 10.1111/j.1471-4159.2006.04444.x; Tayeb HO, 2013, EXPERT OPIN BIOL THE; UDGAONKAR JB, 1987, P NATL ACAD SCI USA, V84, P8758, DOI 10.1073/pnas.84.24.8758; Ulrich H, 2008, J NEUROSCI RES, V86, P93, DOI 10.1002/jnr.21468; Ulrich H, 1998, P NATL ACAD SCI USA, V95, P14051, DOI 10.1073/pnas.95.24.14051; Wang H, 2000, ADV IND CON; Wang HY, 2010, BIOL PSYCHIAT, V67, P522, DOI 10.1016/j.biopsych.2009.09.031; Wang HY, 2000, J BIOL CHEM, V275, P5626, DOI 10.1074/jbc.275.8.5626; Williams DK, 2009, J PHARMACOL EXP THER, V330, P40, DOI 10.1124/jpet.109.151225; Wu J, 2004, J BIOL CHEM, V279, P37842, DOI 10.1074/jbc.M400335200; Wu JL, 2007, BRAIN RES, V1182, P82, DOI 10.1016/j.brainres.2007.08.079; Xiao YX, 1998, MOL PHARMACOL, V54, P322, DOI 10.1124/mol.54.2.322; Zappettini S, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00146	63	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e67194	10.1371/journal.pone.0067194	http://dx.doi.org/10.1371/journal.pone.0067194			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894286	Green Published, gold, Green Submitted			2022-12-27	WOS:000322132100009
J	Pillay, P; Ford, N; Shubber, Z; Ferrand, RA				Pillay, Prinitha; Ford, Nathan; Shubber, Zara; Ferrand, Rashida A.			Outcomes for Efavirenz versus Nevirapine-Containing Regimens for Treatment of HIV-1 Infection: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							1ST-LINE ANTIRETROVIRAL THERAPY; CLINICAL-PRACTICE; INITIAL THERAPY; SAFETY; EFFICACY; TUBERCULOSIS; ADHERENCE; COMBINATION; DURABILITY; ANALOGS	Introduction: There is conflicting evidence and practice regarding the use of the non-nucleoside reverse transcriptase inhibitors (NNRTI) efavirenz (EFV) and nevirapine (NVP) in first-line antiretroviral therapy (ART). Methods: We systematically reviewed virological outcomes in HIV-1 infected, treatment-naive patients on regimens containing EFV versus NVP from randomised trials and observational cohort studies. Data sources include PubMed, Embase, the Cochrane Central Register of Controlled Trials and conference proceedings of the International AIDS Society, Conference on Retroviruses and Opportunistic Infections, between 1996 to May 2013. Relative risks (RR) and 95% confidence intervals were synthesized using random-effects meta-analysis. Heterogeneity was assessed using the I-2 statistic, and subgroup analyses performed to assess the potential influence of study design, duration of follow up, location, and tuberculosis treatment. Sensitivity analyses explored the potential influence of different dosages of NVP and different viral load thresholds. Results: Of 5011 citations retrieved, 38 reports of studies comprising 114 391 patients were included for review. EFV was significantly less likely than NVP to lead to virologic failure in both trials (RR 0.85 [0.73-0.99] I-2 = 0%) and observational studies (RR 0.65 [0.59-0.71] I-2 = 54%). EFV was more likely to achieve virologic success than NVP, though marginally significant, in both randomised controlled trials (RR 1.04 [1.00-1.08] I-2 = 0%) and observational studies (RR 1.06 [1.00-1.12] I-2 = 68%). Conclusion: EFV-based first line ART is significantly less likely to lead to virologic failure compared to NVP-based ART. This finding supports the use of EFV as the preferred NNRTI in first-line treatment regimen for HIV treatment, particularly in resource limited settings.	[Pillay, Prinitha] Univ Witwatersrand, Fac Hlth Sci, Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa; [Pillay, Prinitha; Ford, Nathan] Med Sans Frontieres, Johannesburg, South Africa; [Pillay, Prinitha; Ferrand, Rashida A.] London Sch Hyg & Trop Med, London WC1, England; [Ford, Nathan] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, ZA-7925 Cape Town, South Africa; [Shubber, Zara] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis Epidemiol, London, England	University of Witwatersrand; University of London; London School of Hygiene & Tropical Medicine; University of Cape Town; Imperial College London	Pillay, P (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa.	prinithapillay@yahoo.co.uk		Perez Elias/0000-0001-5700-5257	Medecins Sans Frontieres(MSF); Wits Reproductive Health and HIV Institute; Wellcome Trust	Medecins Sans Frontieres(MSF); Wits Reproductive Health and HIV Institute; Wellcome Trust(Wellcome TrustEuropean Commission)	PP conducted this review for her MSc through the LSHTM, which was financially supported by Medecins Sans Frontieres(MSF). PP receives a salary from Wits Reproductive Health and HIV Institute and is an unpaid Board member for MSF South Africa. RF receives a grant from Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoroso A, 2012, JAIDS-J ACQ IMM DEF, V60, P314, DOI 10.1097/QAI.0b013e31824e5256; Annan NT, 2009, JAIDS-J ACQ IMM DEF, V51, P140, DOI 10.1097/QAI.0b013e3181a56e81; [Anonymous], 2005, IMPORTANT CHANGE SUS; Antiretroviral Therapy Cohort Collaboration ( ART CC), 2006, J INFECT DSI, V194, P612; Bock P, 2010, J INT AIDS SOC S4, P10; Bonnet M, 2013, LANCET INFECT DIS, V13, P303, DOI 10.1016/S1473-3099(13)70007-0; Braithwaite RS, 2007, AIDS, V21, P1579, DOI 10.1097/QAD.0b013e3281532b31; Cain L, 2012, AIDS, V26, P1691, DOI 10.1097/QAD.0b013e328354f497; Castelnuovo B, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/736938; Castillo-Mancilla JR, 2012, J COMP EFFECT RES, V1, P157, DOI 10.2217/CER.12.6; Cescon AM, 2011, HIV MED, V12, P352, DOI 10.1111/j.1468-1293.2010.00890.x; Chung U, 2002, 14 INT AIDS C; *COCHR COLL, 2008, REV MAN REVMAN VERS; Cortes C, 2010, INT J INFECT DIS, V14, pE242, DOI 10.1016/j.ijid.2010.02.2026; Cozzi-Lepri A, 2002, J INFECT DIS, V185, P1062, DOI 10.1086/339821; Darin K, 2010, 18 INT AIDS C; de Beaudrap P, 2008, AIDS RES HUM RETROV, V24, P753, DOI 10.1089/aid.2007.0295; Ford N, 2011, AIDS, V25, P2301, DOI 10.1097/QAD.0b013e32834cdb71; Fox MP, 2012, JAIDS-J ACQ IMM DEF, V60, P428, DOI 10.1097/QAI.0b013e3182557785; Gaytan J, 2004, MED INTERNA MEXICO, V20, P24; Hamers RL, 2012, LANCET INFECT DIS, V12, P307, DOI 10.1016/S1473-3099(11)70255-9; Hartmann M, 2005, INT J STD AIDS, V16, P404, DOI 10.1258/0956462054094060; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Keiser Philip, 2002, HIV Clin Trials, V3, P296; Landman R, 2011, 6 IAS C HIV PATH TRE; Manfredi R, 2004, JAIDS-J ACQ IMM DEF, V35, P492, DOI 10.1097/00126334-200404150-00007; Manosuthi W, 2008, HIV MED, V9, P294, DOI 10.1111/j.1468-1293.2008.00563.x; Manosuthi W, 2004, HIV MED, V5, P105, DOI 10.1111/j.1468-1293.2004.00195.x; Manosuthi W, 2009, CLIN INFECT DIS, V48, P1752, DOI 10.1086/599114; Matteelli A, 2013, 20 C RETR OPP INF; Mbuagbaw LCE, 2009, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004246.PUB2; Mugavero MJ, 2008, AIDS, V22, P2481, DOI 10.1097/QAD.0b013e328318f130; Nachega JB, 2008, AIDS, V22, P2117, DOI 10.1097/QAD.0b013e328310407e; Nachega JB, 2007, ANN INTERN MED, V146, P564, DOI 10.7326/0003-4819-146-8-200704170-00007; Nunez Marina, 2002, HIV Clin Trials, V3, P186; Parienti JJ, 2009, CLIN INFECT DIS, V48, P484, DOI 10.1086/596482; Perez-Elias MJ, 2005, HIV CLIN TRIALS, V6, P312, DOI 10.1310/B3NK-V5XQ-6VX9-5DEK; Reekie J, 2011, HIV MED, V12, P259, DOI 10.1111/j.1468-1293.2010.00877.x; Shipton LK, 2009, INT J TUBERC LUNG D, V13, P360; Shubber Z, 2013, AIDS, V27, P1403, DOI 10.1097/QAD.0b013e32835f1db0; Swaminathan S, 2011, CLIN INFECT DIS, V53, P716, DOI 10.1093/cid/cir447; Tang MW, 2012, CLIN INFECT DIS, V54, P862, DOI 10.1093/cid/cir1034; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; US Department of Health and Human Services, WHAT START IN COMB R; van den Berg-Wolf M, 2008, HIV CLIN TRIALS, V9, P324, DOI 10.1310/hct0905-324; van Leth F, 2004, LANCET, V363, P1253, DOI 10.1016/S0140-6736(04)15997-7; Villar J, 2011, HIV CLIN TRIALS, V12, P171, DOI 10.1310/hct1203-171; von Giesen HJ, 2003, HIV CLIN TRIALS, V4, P382; Wallis CL, 2012, ANTIVIR THER, P313; Wester CW, 2010, AIDS S1, pS27; WHO, 2010, ANT THER HIV INF AD; Wit F, 2007, 4 IAS C HIV PATH TRE; World Health Organisation, 2012, WHO US EF PREGN PUBL	53	48	50	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e68995	10.1371/journal.pone.0068995	http://dx.doi.org/10.1371/journal.pone.0068995			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894391	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000322132100038
J	Dawson, NJ; Biggar, KK; Storey, KB				Dawson, Neal J.; Biggar, Kyle K.; Storey, Kenneth B.			Characterization of Fructose-1,6-Bisphosphate Aldolase during Anoxia in the Tolerant Turtle, Trachemys scripta elegans: An Assessment of Enzyme Activity, Expression and Structure	PLOS ONE			English	Article							FRUCTOSE DIPHOSPHATE ALDOLASE; CHRYSEMYS-PICTA-BELLII; ACID-BASE; PURIFICATION; OXYGEN; WATER; SUBMERGENCE; VARIANTS	One of the most adaptive facultative anaerobes among vertebrates is the freshwater turtle, Trachemys scripta elegans. Upon a decrease in oxygen supply and oxidative phosphorylation, these turtles are able to reduce their metabolic rate and recruit anaerobic glycolysis to meet newly established ATP demands. Within the glycolytic pathway, aldolase enzymes cleave fructose-1,6-bisphosphate to triose phosphates facilitating an increase in anaerobic production of ATP. Importantly, this enzyme exists primarily as tissue-specific homotetramers of aldolase A, B or C located in skeletal muscle, liver and brain tissue, respectively. The present study characterizes aldolase activity and structure in the liver tissue of a turtle whose survival greatly depends on increased glycolytic output during anoxia. Immunoblot and mass spectrometry analysis verified the presence of both aldolase A and B in turtle liver tissue, and results from co-immunoprecipitation experiments suggested that in the turtle aldolase proteins may exist as an uncommon heterotetramer. Expression levels of aldolase A protein increased significantly in liver tissue to 1.59 +/- 0.11-fold after 20 h anoxia, when compared to normoxic control values (P<0.05). A similar increase was seen for aldolase B expression. The overall kinetic properties of aldolase, when using fructose-1,6-bisphosphate as substrate, were similar to that of a previously studied aldolase A and aldolase B heterotetramer, with a K-m of 240 and 180 nM (for normoxic and anoxic turtle liver, respectively). Ligand docking of fructose-1,6-bisphosphate to the active site of aldolase A and B demonstrated minor differences in both protein: ligand interactions compared to rabbit models. It is likely that the turtle is unique in its ability to regulate a heterotetramer of aldolase A and B, with a higher overall enzymatic activity, to achieve greater rates of glycolytic output and support anoxia survival.	[Storey, Kenneth B.] Carleton Univ, Inst Biochem, Ottawa, ON K1S 5B6, Canada; Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada	Carleton University; Carleton University	Storey, KB (corresponding author), Carleton Univ, Inst Biochem, Ottawa, ON K1S 5B6, Canada.	kenneth_storey@carleton.ca			NSERC Canada [6793]	NSERC Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	The research was funded by NSERC Canada (#6793). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakaki TL, 2004, PROTEIN SCI, V13, P3077, DOI 10.1110/ps.04915904; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BERTHIAUME L, 1993, J BIOL CHEM, V268, P10826; BROOKS SPJ, 1989, AM J PHYSIOL, V257, pR278, DOI 10.1152/ajpregu.1989.257.2.R278; Chown SL, 2006, PHYSIOL BIOCHEM ZOOL, V79, P314, DOI 10.1086/499989; COX TM, 1983, J CLIN INVEST, V72, P201, DOI 10.1172/JCI110958; Cristobal S, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-5; DOYLE SA, 1995, BIOCHEM BIOPH RES CO, V206, P902, DOI 10.1006/bbrc.1995.1128; Fushinobu S, 2011, NATURE, V478, P538, DOI 10.1038/nature10457; Galkin A, 2007, J BIOL CHEM, V282, P4859, DOI 10.1074/jbc.M609534200; HERBERT CV, 1985, PHYSIOL ZOOL, V58, P670, DOI 10.1086/physzool.58.6.30156071; Hochachka PW, 1996, P NATL ACAD SCI USA, V93, P9493, DOI 10.1073/pnas.93.18.9493; Jackson DC, 2002, J PHYSIOL-LONDON, V543, P731, DOI 10.1113/jphysiol.2002.024729; JACKSON DC, 1968, J APPL PHYSIOL, V24, P503, DOI 10.1152/jappl.1968.24.4.503; KELLY DA, 1988, AM J PHYSIOL, V255, pR774, DOI 10.1152/ajpregu.1988.255.5.R774; KOCHMAN M, 1970, INT J BIOCHEM, V2, P221; KOCHMAN M, 1972, ARCH BIOCHEM BIOPHYS, V152, P856, DOI 10.1016/0003-9861(72)90282-2; LEBHERZ HG, 1969, BIOCHEMISTRY-US, V8, P109, DOI 10.1021/bi00829a016; LUTZ PL, 1997, HDB PHYSL 13, P1479; MacDonald JA, 2002, ARCH BIOCHEM BIOPHYS, V408, P279, DOI 10.1016/S0003-9861(02)00579-9; Nakamura H, 1996, PLANT MOL BIOL, V30, P381, DOI 10.1007/BF00020125; Pezza JA, 2003, J BIOL CHEM, V278, P17307, DOI 10.1074/jbc.M209185200; Rellos P, 2000, J BIOL CHEM, V275, P1145, DOI 10.1074/jbc.275.2.1145; RUTTER WJ, 1968, ANN NY ACAD SCI, V151, P102, DOI 10.1111/j.1749-6632.1968.tb11881.x; Rutter WJ, 1965, DEV METABOLIC CONTRO, P192; St-Jean M, 2005, J BIOL CHEM, V280, P27262, DOI 10.1074/jbc.M502413200; Storey KB, 1996, COMP BIOCHEM PHYS B, V113, P23, DOI 10.1016/0305-0491(95)02043-8; Storey KB, 2004, BIOL REV, V79, P207, DOI 10.1017/S1464793103006195; ULTSCH GR, 1982, J EXP BIOL, V96, P11; Willmore WG, 2001, CAN J ZOOL, V79, P1822, DOI 10.1139/cjz-79-10-1822; Xiong ZJ, 2012, COMP BIOCHEM PHYS B, V163, P221, DOI 10.1016/j.cbpb.2012.06.001; Zhang R, 1997, ARCH BIOCHEM BIOPHYS, V341, P170, DOI 10.1006/abbi.1997.9918	32	18	19	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e68830	10.1371/journal.pone.0068830	http://dx.doi.org/10.1371/journal.pone.0068830			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874782	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000324146200033
J	Leicht, H; Konig, HH; Stuhldreher, N; Bachmann, C; Bickel, H; Fuchs, A; Heser, K; Jessen, F; Kohler, M; Luppa, M; Mosch, E; Pentzek, M; Riedel-Heller, S; Scherer, M; Werle, J; Weyerer, S; Wiese, B; Maier, W				Leicht, Hanna; Koenig, Hans-Helmut; Stuhldreher, Nina; Bachmann, Cadja; Bickel, Horst; Fuchs, Angela; Heser, Kathrin; Jessen, Frank; Koehler, Mirjam; Luppa, Melanie; Moesch, Edelgard; Pentzek, Michael; Riedel-Heller, Steffi; Scherer, Martin; Werle, Jochen; Weyerer, Siegfried; Wiese, Birgitt; Maier, Wolfgang		AgeCoDe Study Grp	Predictors of Costs in Dementia in a Longitudinal Perspective	PLOS ONE			English	Article							ECONOMIC-EVALUATION; ALZHEIMERS-DISEASE; CARE; EUROPE; MILD; TIME	Objective: To analyse predictors of costs in dementia from a societal perspective in a longitudinal setting. Method: Healthcare resource use and costs were assessed retrospectively using a questionnaire in four waves at 6-month intervals in a sample of dementia patients (N = 175). Sociodemographic data, dementia severity and comorbidity at baseline, cognitive impairment and impairment in basic and instrumental activities of daily living were also recorded. Linear mixed regression models with random intercepts for individuals were used to analyse predictors of total and sector-specific costs. Results: Impairment in activities of daily living significantly predicted total costs in dementia patients, with associations between basic activities of daily living and formal care costs on the one and instrumental activities of daily living and informal care costs on the other hand. Nursing home residence was associated with lower total costs than residence in the community. There was no effect of cognition on total or sector-specific costs. Conclusion: Cognitive deficits in dementia are associated with costs only via their effect on the patients' capacity for activities of daily living. Transition into a nursing home may reduce total costs from a societal perspective, owing to the fact that a high amount of informal care required by severely demented patients prior to transition into a nursing home may cause higher costs than inpatient nursing care.	[Leicht, Hanna; Koenig, Hans-Helmut; Stuhldreher, Nina] Univ Med Ctr Hamburg Eppendorf, Hamburg Ctr Hlth Econ, Dept Hlth Econ & Hlth Serv Res, Hamburg, Germany; [Bachmann, Cadja; Koehler, Mirjam; Scherer, Martin] Univ Med Ctr Hamburg Eppendorf, Dept Primary Med Care, Hamburg, Germany; [Bickel, Horst; Moesch, Edelgard] Tech Univ Munich, Clin & Policlin Psychiat & Psychotherapy, D-80290 Munich, Germany; [Fuchs, Angela; Pentzek, Michael] Univ Dusseldorf, Fac Med, Dept Gen Practice, D-40225 Dusseldorf, Germany; [Heser, Kathrin; Jessen, Frank; Maier, Wolfgang] Univ Bonn, Dept Psychiat, Bonn, Germany; [Jessen, Frank; Maier, Wolfgang] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Luppa, Melanie; Riedel-Heller, Steffi] Univ Leipzig, Inst Social Med & Occupat Hlth, D-04109 Leipzig, Germany; [Werle, Jochen; Weyerer, Siegfried] Heidelberg Univ, Cent Inst Mental Hlth, Med Fac Mannheim, Mannheim, Germany; [Wiese, Birgitt] Hannover Med Sch, Inst Biometr, Hannover, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Technical University of Munich; Heinrich Heine University Dusseldorf; University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Leipzig University; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Hannover Medical School	Konig, HH (corresponding author), Univ Med Ctr Hamburg Eppendorf, Hamburg Ctr Hlth Econ, Dept Hlth Econ & Hlth Serv Res, Hamburg, Germany.	h.koenig@uke.de	König, Hans-Helmut/P-1211-2018; Brettschneider, Christian/H-5920-2019; Riedel-Heller, Steffi/ABG-1537-2021; Luppa, Melanie/AAQ-7338-2021; Jessen, Frank/AAK-6170-2020	König, Hans-Helmut/0000-0001-5711-6862; Brettschneider, Christian/0000-0002-5280-1075; Pentzek, Michael/0000-0001-6538-0241; Luck, Tobias/0000-0001-7551-4397	German Federal Ministry of Education and Research [KND: 01GI0102, 01GI0420, 01GI0422, 01GI0423, 01GI0429, 01GI0431, 01GI0433, 01GI0434, KNDD: O1GI0710, 01GI0711, 01GI0712, 01GI0713, 01GI0714, 01GI0715, 01GI0716]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This study is part of the German Research Network on Dementia (KND) and the German Research Network on Degenerative Dementia (KNDD) and was funded by the German Federal Ministry of Education and Research (grants KND: 01GI0102, 01GI0420, 01GI0422, 01GI0423, 01GI0429, 01GI0431, 01GI0433, 01GI0434; grants KNDD: O1GI0710, 01GI0711, 01GI0712, 01GI0713, 01GI0714, 01GI0715, 01GI0716). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CK, 2003, SCAND J PUBLIC HEALT, V31, P119, DOI 10.1080/14034940210134059; der Ersatzkassen Verband, 2002, VERG ERG LEIST; der Ersatzkassen Verband, 2001, VERG LOG SPRACHTH LE; der Ersatzkassen Verband, 2007, VERG POD LEIST; Desgagne A, 1998, PHARMACOECONOMICS, V13, P487, DOI 10.2165/00019053-199813050-00002; Deutsch Krankenhausgesellschafte, 2009, BEST KRANK INV BUND; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fratiglioni L, 2000, NEUROLOGY, V54, pS10; GKV- Spitzenverband, 2007, FESTB; Heinrich S, 2008, VALUE HEALTH, V11, P611, DOI 10.1111/j.1524-4733.2007.00285.x; Jonsson L, 2009, PHARMACOECONOMICS, V27, P391, DOI 10.2165/00019053-200927050-00004; KassenzahnuErztliche Bundesvereinigung, 2009, ABR FESTZ; Konig HH, 2009, BRIT J PSYCHIAT, V195, P308, DOI 10.1192/bjp.bp.108.058032; Krauth C, 2005, GESUNDHEITSWESEN, V67, P736, DOI 10.1055/s-2005-858698; LAWTON MP, 1969, GERONTOLOGIST, V9, P9, DOI 10.1093/geront/9.1.9; Leicht H, 2011, ACTA PSYCHIAT SCAND, V124, P384, DOI 10.1111/j.1600-0447.2011.01741.x; Luck T, 2010, ACTA PSYCHIAT SCAND, V121, P260, DOI 10.1111/j.1600-0447.2009.01481.x; MAHONEY F I, 1965, Md State Med J, V14, P61; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Neubauer S, 2009, INT J GERIATR PSYCH, V24, P275, DOI 10.1002/gps.2103; Organisation for Economic Co-operation and Development, 2012, MAIN EC IND FIN IND; Posnett J, 1996, HEALTH ECON, V5, P13, DOI 10.1002/(SICI)1099-1050(199601)5:1<13::AID-HEC182>3.0.CO;2-J; Quentin W, 2010, ACTA PSYCHIAT SCAND, V121, P243, DOI 10.1111/j.1600-0447.2009.01461.x; Rapp T, 2012, VALUE HEALTH, V15, P412, DOI 10.1016/j.jval.2012.02.003; REISBERG B, 1982, AM J PSYCHIAT, V139, P1136; Rote Liste Service GmbH, 2008, ROT LIST 2008 ARZN D; Schwarzkopf L, 2011, VALUE HEALTH, V14, P827, DOI 10.1016/j.jval.2011.04.005; Statistisches Bundesamt, 2010, VOLKSW GES 2009; Statistisches Bundesamt, 2009, GRUNDD KRANK 2008; Statistisches Bundesamt, 2008, PFLEG 2007; Statistisches Bundesamt, 2010, DEM WAND DEUTSCHL; Statistisches Bundesamt, 2009, VERD ARB 2008; Statistisches Bundesamt, 2010, VERBR DEUTSCHL; Statistisches Bundesamt, 2009, KOST KRANK 2008; Statistisches Bundesamt, 2009, STAT JB 2009; van den Berg Bernard, 2004, Eur J Health Econ, V5, P36, DOI 10.1007/s10198-003-0189-y; Weyerer S, 2007, EPIDEMIOLOGIE PSYCHI; Wimo A, 2007, ARCH GERONTOL GERIAT, V44, P71, DOI 10.1016/j.archger.2006.03.001; ZAUDIG M, 1991, PSYCHOL MED, V21, P225, DOI 10.1017/S0033291700014811; Zhu CW, 2006, NEUROLOGY, V67, P998, DOI 10.1212/01.wnl.0000230160.13272.1b; Zhu CW, 2008, DEMENT GERIATR COGN, V26, P416, DOI 10.1159/000164797; Zhu CW, 2006, J AM GERIATR SOC, V54, P1596, DOI 10.1111/j.1532-5415.2006.00871.x	42	44	45	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e70018	10.1371/journal.pone.0070018	http://dx.doi.org/10.1371/journal.pone.0070018			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	214PM	23875017	Green Published, gold, Green Submitted			2022-12-27	WOS:000324146200089
J	Reeves, PR; Cunneen, MM; Liu, B; Wang, L				Reeves, Peter R.; Cunneen, Monica M.; Liu, Bin; Wang, Lei			Genetics and Evolution of the Salmonella Galactose-Initiated Set of O Antigens	PLOS ONE			English	Article							GROUP-B; ENZYMATIC-SYNTHESIS; MOLECULAR ANALYSIS; CHAIN-LENGTH; RFB REGIONS; ENTERICA; CLUSTER; LIPOPOLYSACCHARIDE; BIOSYNTHESIS; CONVERSION	This paper covers eight Salmonella serogroups, that are defined by O antigens with related structures and gene clusters. They include the serovars that are now most frequently isolated. Serogroups A, B1, B2, C2-C3, D1, D2, D3 and E have O antigens that are distinguished by having galactose as first sugar, and not N-acetyl glucosamine or N-acetyl galactosamine as in the other 38 serogroups, and indeed in most Enterobacteriaceae. The gene clusters for these galactose-initiated appear to have entered S. enterica since its divergence from E. coli, but sequence comparisons show that much of the diversification occurred long before this. We conclude that the gene clusters must have entered S. enterica in a series of parallel events. The individual gene clusters are discussed, followed by analysis of the divergence for those genes shared by two or more gene clusters, and a putative phylogenic tree for the gene clusters is presented. This set of O antigens provides a rare case where it is possible to examine in detail the relationships of a significant number of O antigens. In contrast the more common pattern of O-antigen diversity within a species is for there to be only a few cases of strains having related gene clusters, suggesting that diversity arose through gain of individual O-antigen gene clusters by lateral gene transfer, and under these circumstances the evolution of the diversity is not accessible. This paper on the galactose-initiated set of gene clusters gives new insights into the origins of O-antigen diversity generally.	[Reeves, Peter R.; Cunneen, Monica M.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Liu, Bin; Wang, Lei] Nankai Univ, TEDA Sch Biol Sci & Biotechnol, TEDA, Tianjin 300071, Peoples R China	University of Sydney; Nankai University	Reeves, PR (corresponding author), Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia.	peter.reeves@sydney.edu.au	Reeves, Peter R/A-6064-2008; Wang, Lei/C-5176-2009	Reeves, Peter R/0000-0003-4479-7974; Wang, Lei/0000-0003-4427-0881	Australian Research Council; National Health and Medical Research Council; National Natural Science Foundation of China (NSFC) [31030002]; NSFC [30870070, 30870078]; National 973 Program of China [2009CB522603]; National Key Program for Infectious Diseases of China [2009ZX10004-108]	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC(National Natural Science Foundation of China (NSFC)); National 973 Program of China(National Basic Research Program of China); National Key Program for Infectious Diseases of China	The authors research in this area was supported by grants from the Australian Research Council and the National Health and Medical Research Council to PR, and The National Natural Science Foundation of China (NSFC) Key Program Grant 31030002, NSFC General Program Grants 30870070 and 30870078, the National 973 Program of China Grant 2009CB522603, and the National Key Program for Infectious Diseases of China 2009ZX10004-108, to LW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASTIN DA, 1995, GENE, V164, P17, DOI 10.1016/0378-1119(95)00459-J; Bentley SD, 2004, ANNU REV GENET, V38, P771, DOI 10.1146/annurev.genet.38.072902.094318; Boyd EF, 1996, APPL ENVIRON MICROB, V62, P804, DOI 10.1128/AEM.62.3.804-808.1996; BRAY D, 1967, J MOL BIOL, V30, P457, DOI 10.1016/S0022-2836(67)80037-8; BROWN PK, 1991, MOL MICROBIOL, V5, P1873, DOI 10.1111/j.1365-2958.1991.tb00811.x; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; COLLINS LV, 1991, J BACTERIOL, V173, P2521, DOI 10.1128/jb.173.8.2521-2529.1991; Cunneen MM, 2008, FEMS MICROBIOL LETT, V287, P76, DOI 10.1111/j.1574-6968.2008.01295.x; Curd H, 1998, J BACTERIOL, V180, P1002, DOI 10.1128/JB.180.4.1002-1007.1998; Daniels C, 1998, MOL MICROBIOL, V28, P1211, DOI 10.1046/j.1365-2958.1998.00884.x; De Castro C, 2011, INNATE IMMUN-LONDON, V17, P183, DOI 10.1177/1753425910364425; Drummelsmith J, 1999, MOL MICROBIOL, V31, P1321, DOI 10.1046/j.1365-2958.1999.01277.x; Falush D, 2006, PHILOS T R SOC B, V361, P2045, DOI 10.1098/rstb.2006.1925; Feldman MF, 1999, J BIOL CHEM, V274, P35129, DOI 10.1074/jbc.274.49.35129; GLASER L, 1961, J BIOL CHEM, V236, P1795; Guibourdenche M, 2010, RES MICROBIOL, V161, P26, DOI 10.1016/j.resmic.2009.10.002; Hong YQ, 2012, MOL MICROBIOL, V84, P620, DOI 10.1111/j.1365-2958.2012.08048.x; Hvorup RN, 2003, EUR J BIOCHEM, V270, P799, DOI 10.1046/j.1432-1033.2003.03418.x; JIANG XM, 1991, MOL MICROBIOL, V5, P695, DOI 10.1111/j.1365-2958.1991.tb00741.x; KAUFFMANN F, 1966, ENTEROBACTERIACEAE; Kenyon JJ, 2011, GLYCOBIOLOGY, V21, P1131, DOI 10.1093/glycob/cwr006; KORNFELD RH, 1966, BIOCHIM BIOPHYS ACTA, V117, P79, DOI 10.1016/0304-4165(66)90154-1; Kropinski AM, 2007, VIROLOGY, V369, P234, DOI 10.1016/j.virol.2007.07.027; Lan RT, 2009, INFECT GENET EVOL, V9, P996, DOI 10.1016/j.meegid.2009.04.011; LEMINOR L, 1962, ANN I PASTEUR PARIS, V103, P684; LEMINOR L, 1961, ANN I PASTEUR PARIS, V101, P571; Li Q, 2000, MICROBIOL-UK, V146, P2291, DOI 10.1099/00221287-146-9-2291; Liu B, 2006, GENE, V380, P46, DOI 10.1016/j.gene.2006.05.024; LIU D, 1993, J BACTERIOL, V175, P3408, DOI 10.1128/jb.175.11.3408-3413.1993; LIU D, 1995, J BACTERIOL, V177, P4084, DOI 10.1128/jb.177.14.4084-4088.1995; Liu D, 1996, J BACTERIOL, V178, P2102, DOI 10.1128/jb.178.7.2102-2107.1996; LIU D, 1991, J BACTERIOL, V173, P4814, DOI 10.1128/jb.173.15.4814-4819.1991; LOSICK R, 1967, J MOL BIOL, V30, P445, DOI 10.1016/0022-2836(67)90361-0; MACPHERSON DF, 1995, GENE, V155, P9, DOI 10.1016/0378-1119(94)00918-I; Makela P. H., 1984, HDB ENDOTOXIN, P59; MAKELA PH, 1969, ANNU REV GENET, V3, P291, DOI 10.1146/annurev.ge.03.120169.001451; Mann S, 2010, GENOMICS, V95, P7, DOI 10.1016/j.ygeno.2009.09.002; Marolda CL, 2004, MICROBIOL-SGM, V150, P4095, DOI 10.1099/mic.0.27456-0; Marolda CL, 2006, J BACTERIOL, V188, P5124, DOI 10.1128/JB.00461-06; McQuiston JR, 2008, J BACTERIOL, V190, P7060, DOI 10.1128/JB.01552-07; Murray GL, 2003, MOL MICROBIOL, V47, P1395, DOI 10.1046/j.1365-2958.2003.03383.x; Neidhardt F.C., 1996, ESCHERICHIA SALMONEL; NIKAIDO H, 1966, J BIOL CHEM, V241, P1376; NIKAIDO H, 1967, P NATL ACAD SCI USA, V57, P1825, DOI 10.1073/pnas.57.6.1825; OSBORN MJ, 1968, J BIOL CHEM, V243, P2631; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rahn A, 1999, J BACTERIOL, V181, P2307, DOI 10.1128/JB.181.7.2307-2313.1999; Reams AB, 2010, GENETICS, V184, P1077, DOI 10.1534/genetics.109.111963; Reeves PR, 2009, MICROBIAL GLYCOBIOLOGY: STRUCTURES, RELEVANCE AND APPLICATIONS, P319; Reeves PR, 2003, ADV EXP MED BIOL, V529, P199; ROBBINS PW, 1965, J BIOL CHEM, V240, P384; Rush JS, 2010, J BIOL CHEM, V285, P1671, DOI 10.1074/jbc.M109.061630; Samuel G, 2003, CARBOHYD RES, V338, P2503, DOI 10.1016/j.carres.2003.07.009; Santoyo G, 2005, FEMS MICROBIOL REV, V29, P169, DOI 10.1016/j.femsre.2004.10.004; Valvano MA, 2003, FRONT BIOSCI-LANDMRK, V8, pS452, DOI 10.2741/1079; VERMA N, 1989, J BACTERIOL, V171, P5694, DOI 10.1128/jb.171.10.5694-5701.1989; VERMA NK, 1988, J BACTERIOL, V170, P103, DOI 10.1128/jb.170.1.103-107.1988; Villafane R, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-227; Wang L, 1996, J BACTERIOL, V178, P2598, DOI 10.1128/jb.178.9.2598-2604.1996; WANG L, 1994, J BACTERIOL, V176, P4348, DOI 10.1128/jb.176.14.4348-4356.1994; Wang L, 2002, J BACTERIOL, V184, P1669, DOI 10.1128/JB.184.6.1669-1677.2002; WANG L, 1992, GENETICS, V130, P429; Wang L, 1998, INFECT IMMUN, V66, P3545, DOI 10.1128/IAI.66.8.3545-3551.1998; WYK P, 1989, J BACTERIOL, V171, P5687, DOI 10.1128/jb.171.10.5687-5693.1989; XIANG SH, 1994, J BACTERIOL, V176, P4357, DOI 10.1128/jb.176.14.4357-4365.1994	65	33	34	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e69306	10.1371/journal.pone.0069306	http://dx.doi.org/10.1371/journal.pone.0069306			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874940	Green Submitted, Green Published, gold			2022-12-27	WOS:000324146200070
J	Allen, HG; Stanton, TR; Di Pietro, F; Moseley, GL				Allen, Heidi G.; Stanton, Tasha R.; Di Pietro, Flavia; Moseley, G. Lorimer			Social Media Release Increases Dissemination of Original Articles in the Clinical Pain Sciences	PLOS ONE			English	Article							APOMEDIATION	A barrier to dissemination of research is that it depends on the end-user searching for or 'pulling' relevant knowledge from the literature base. Social media instead 'pushes' relevant knowledge straight to the end-user, via blogs and sites such as Facebook and Twitter. That social media is very effective at improving dissemination seems well accepted, but, remarkably, there is no evidence to support this claim. We aimed to quantify the impact of social media release on views and downloads of articles in the clinical pain sciences. Sixteen PLOS ONE articles were blogged and released via Facebook, Twitter, LinkedIn and ResearchBlogging.org on one of two randomly selected dates. The other date served as a control. The primary outcomes were the rate of HTML views and PDF downloads of the article, over a seven-day period. The critical result was an increase in both outcome variables in the week after the blog post and social media release. The mean +/- SD rate of HTML views in the week after the social media release was 18 +/- 18 per day, whereas the rate during the other three weeks was no more than 6 +/- 3 per day. The mean +/- SD rate of PDF downloads in the week after the social media release was 4 +/- 4 per day, whereas the rate during the other three weeks was less than 1 +/- 1 per day (p<0.05 for all comparisons). However, none of the recognized measures of social media reach, engagement or virality related to either outcome variable, nor to citation count one year later (p>0.3 for all). We conclude that social media release of a research article in the clinical pain sciences increases the number of people who view or download that article, but conventional social media metrics are unrelated to the effect.	[Allen, Heidi G.; Stanton, Tasha R.; Moseley, G. Lorimer] Univ S Australia, Sansom Inst Hlth Res, Adelaide, SA 5001, Australia; [Allen, Heidi G.; Stanton, Tasha R.; Di Pietro, Flavia; Moseley, G. Lorimer] Neurosci Res Australia, Sydney, NSW, Australia; [Di Pietro, Flavia] Univ New S Wales, Sydney, NSW, Australia	University of South Australia; Neuroscience Research Australia; University of New South Wales Sydney	Moseley, GL (corresponding author), Univ S Australia, Sansom Inst Hlth Res, Adelaide, SA 5001, Australia.	lorimer.moseley@gmail.com	Moseley, Lorimer/A-7095-2009; Stanton, Tasha/F-4038-2013; Di Pietro, Flavia/P-5415-2018	Moseley, Lorimer/0000-0002-3750-4945; Stanton, Tasha/0000-0001-7106-4456; Di Pietro, Flavia/0000-0002-9642-0805	Canadian Institutes of Health Research [223354]; National Health & Medical Research Council [571090]; Australian Government	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Government(Australian GovernmentCGIAR)	Tasha Stanton is supported by the Canadian Institutes of Health Research Postdoctoral Training Fellowship [ID 223354]; G. Lorimer Moseley is supported by the National Health & Medical Research Council Research Fellowship [ID 571090]. Flavia Di Pietro is supported by a Australian Government Postgraduate award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PLOS; Cheston Christine C, 2012, MED 2 0 C MED 2 0; Creamer M., 2012, STUDY ONLY 1 FACEBOO; Eysenbach G, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.2012; Eysenbach G, 2007, STUD HEALTH TECHNOL, V129, P162; Eysenbach G, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.1030; Lavis JN, 2003, MILBANK Q, V81, P221, DOI 10.1111/1468-0009.t01-1-00052; Priem J, 2012, ALTMETRICS WILD USIN; Priem J, 2011, ALTMETRICS MANIFEST; Salganik MJ, 2006, SCIENCE, V311, P854, DOI 10.1126/science.1121066; Van de Belt TH, 2012, J MED INTERNET RES, V14, P227, DOI 10.2196/jmir.1992; Vaughan P, 2011, 23 REASONS INBOUND M	12	121	123	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e68914	10.1371/journal.pone.0068914	http://dx.doi.org/10.1371/journal.pone.0068914			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23874810	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000322000600034
J	Fei, SJ; Zhang, XC; Dong, S; Cheng, H; Zhang, YF; Huang, L; Zhou, HY; Xie, Z; Chen, ZH; Wu, YL				Fei, Shi-Jiang; Zhang, Xu-Chao; Dong, Song; Cheng, Hua; Zhang, Yi-Fang; Huang, Ling; Zhou, Hai-Yu; Xie, Zhi; Chen, Zhi-Hong; Wu, Yi-Long			Targeting mTOR to Overcome Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance in Non-Small Cell Lung Cancer Cells	PLOS ONE			English	Article							PROSPECTIVE PHASE-II; MET AMPLIFICATION; COLORIMETRIC ASSAY; MAMMALIAN TARGET; RAPAMYCIN MTOR; EGFR MUTANTS; GEFITINIB; MUTATIONS; AKT; RICTOR	Aims: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have shown dramatic clinical benefits in advanced non-small cell lung cancer (NSCLC); however, resistance remains a serious problem in clinical practice. The present study analyzed mTOR-associated signaling-pathway differences between the EGFR TKI-sensitive and -resistant NSCLC cell lines and investigated the feasibility of targeting mTOR with specific mTOR inhibitor in EGFR TKI resistant NSCLC cells. Methods: We selected four different types of EGFR TKI-sensitive and -resistant NSCLC cells: PC9, PC9GR, H1650 and H1975 cells as models to detect mTOR-associated signaling-pathway differences by western blot and Immunoprecipitation and evaluated the antiproliferative effect and cell cycle arrest of ku-0063794 by MTT method and flow cytometry. Results: In the present study, we observed that mTORC2-associated Akt ser473-FOXO1 signaling pathway in a basal state was highly activated in resistant cells. In vitro mTORC1 and mTORC2 kinase activities assays showed that EGFR TKI-resistant NSCLC cell lines had higher mTORC2 kinase activity, whereas sensitive cells had higher mTORC1 kinase activity in the basal state. The ATP-competitive mTOR inhibitor ku-0063794 showed dramatic antiproliferative effects and G1-cell cycle arrest in both sensitive and resistant cells. Ku-0063794 at the IC50 concentration effectively inhibited both mTOR and p70S6K phosphorylation levels; the latter is an mTORC1 substrate and did not upregulate Akt ser473 phosphorylation which would be induced by rapamycin and resulted in partial inhibition of FOXO1 phosphorylation. We also observed that EGFR TKI-sensitive and -resistant clinical NSCLC tumor specimens had higher total and phosphorylated p70S6K expression levels. Conclusion: Our results indicate mTORC2-associated signaling-pathway was hyperactivated in EGFR TKI-resistant cells and targeting mTOR with specific mTOR inhibitors is likely a good strategy for patients with EGFR mutant NSCLC who develop EGFR TKI resistance; the potential specific roles of mTORC2 in EGFR TKI-resistant NSCLC cells were still unknown and should be further investigated.	[Fei, Shi-Jiang; Zhang, Xu-Chao; Dong, Song; Zhang, Yi-Fang; Huang, Ling; Zhou, Hai-Yu; Xie, Zhi; Chen, Zhi-Hong; Wu, Yi-Long] Guangdong Gen Hosp, Guangdong Lung Canc Inst, Med Res Ctr, Guangzhou, Guangdong, Peoples R China; [Fei, Shi-Jiang; Zhang, Xu-Chao; Dong, Song; Zhang, Yi-Fang; Huang, Ling; Zhou, Hai-Yu; Xie, Zhi; Chen, Zhi-Hong; Wu, Yi-Long] Guangdong Acad Med Sci, Guangzhou, Guangdong, Peoples R China; [Fei, Shi-Jiang] Southern Med Univ, Grad Sch, Guangzhou, Guangdong, Peoples R China; [Cheng, Hua] Sun Yat Sen Univ, Affiliated Hosp 5, Zhuhai, Guangdong, Peoples R China	Guangdong Academy of Medical Sciences & Guangdong General Hospital; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Southern Medical University - China; Sun Yat Sen University	Wu, YL (corresponding author), Guangdong Gen Hosp, Guangdong Lung Canc Inst, Med Res Ctr, Guangzhou, Guangdong, Peoples R China.	syylwu@live.cn	Wu, Yi-Long/C-3396-2008; Wu, Yi-Long/AAB-9137-2022; Wu, Yi-Long/AAW-9832-2020; Wu, Yi-Long/GRJ-9238-2022	Wu, Yi-Long/0000-0002-3611-0258; Wu, Yi-Long/0000-0002-3611-0258	National Natural Science Foundation of China [30772531, 81071699]; Guangdong social development of science and technology plan projects [2011A030400010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong social development of science and technology plan projects	This work was supported by the grants from the National Natural Science Foundation of China (No. 30772531 and No. 81071699, www.nsfc.gov.cn), Guangdong social development of science and technology plan projects (No: 2011A030400010, www.gdstc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelnour-Berchtold E, 2010, ANTICANCER RES, V30, P799; Araujo A, 2007, ONCOLOGIST, V12, P201, DOI 10.1634/theoncologist.12-2-201; Baselga J, 2002, J CLIN ONCOL, V20, P4292, DOI 10.1200/JCO.2002.03.100; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Breuleux M, 2009, MOL CANCER THER, V8, P742, DOI 10.1158/1535-7163.MCT-08-0668; Carey KD, 2006, CANCER RES, V66, P8163, DOI 10.1158/0008-5472.CAN-06-0453; CARMICHAEL J, 1987, CANCER RES, V47, P936; Chen YR, 2006, ONCOGENE, V25, P1205, DOI 10.1038/sj.onc.1209159; Cheng H, 2011, CANCER CHEMOTH PHARM, V67, P637, DOI 10.1007/s00280-010-1347-4; Choi SH, 2007, ONCOGENE, V26, P1567, DOI 10.1038/sj.onc.1209957; Choo AY, 2009, CELL CYCLE, V8, P567, DOI 10.4161/cc.8.4.7659; Costa DB, 2007, LUNG CANCER, V58, P95, DOI 10.1016/j.lungcan.2007.05.017; Dong S, 2012, CANCER CHEMOTH PHARM, V70, P707, DOI 10.1007/s00280-012-1946-3; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Foster KG, 2010, J BIOL CHEM, V285, P14071, DOI 10.1074/jbc.R109.094003; Garcia-Martinez JM, 2009, BIOCHEM J, V421, P29, DOI 10.1042/BJ20090489; Ghobrial IM, 2010, CLIN CANCER RES, V16, P1033, DOI 10.1158/1078-0432.CCR-09-1837; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Inoue A, 2006, J CLIN ONCOL, V24, P3340, DOI 10.1200/JCO.2005.05.4692; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jeong EH, 2012, TUBERC RESPIR DIS, V72, P343, DOI 10.4046/trd.2012.72.4.343; Kimura H, 2006, CANCER SCI, V97, P642, DOI 10.1111/j.1349-7006.2006.00216.x; La Monica S, 2009, BIOCHEM PHARMACOL, V78, P460, DOI 10.1016/j.bcp.2009.04.033; Masri J, 2007, CANCER RES, V67, P11712, DOI 10.1158/0008-5472.CAN-07-2223; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Pines G, 2010, FEBS LETT, V584, P2699, DOI 10.1016/j.febslet.2010.04.019; Riely GJ, 2008, J THORAC ONCOL, V3, pS146, DOI 10.1097/JTO.0b013e318174e96e; Roulin D, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-57; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shih JY, 2005, NEW ENGL J MED, V353, P207, DOI 10.1056/NEJM200507143530217; Shtiegman K, 2007, ONCOGENE, V26, P6968, DOI 10.1038/sj.onc.1210503; Soria JC, 2009, ANN ONCOL, V20, P1674, DOI 10.1093/annonc/mdp060; Tamura K, 2008, BRIT J CANCER, V98, P907, DOI 10.1038/sj.bjc.6604249; Taylor CR, 2006, APPL IMMUNOHISTO M M, V14, P253, DOI 10.1097/00129039-200609000-00001; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yamada T, 2010, CLIN CANCER RES, V16, P174, DOI 10.1158/1078-0432.CCR-09-1204; Yamamoto C, 2010, CANCER RES, V70, P8715, DOI 10.1158/0008-5472.CAN-10-0043; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105	48	38	39	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e69104	10.1371/journal.pone.0069104	http://dx.doi.org/10.1371/journal.pone.0069104			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874880	Green Submitted, gold, Green Published			2022-12-27	WOS:000322064300086
J	Lai, LM; Li, YF; Tian, Y; Jiang, LH; Zhao, XC; Zhu, LH; Chen, X; Gao, Y; Wang, SM; Zheng, YR; Rimmington, GM				Lai, Liming; Li, Yufei; Tian, Yuan; Jiang, Lianhe; Zhao, Xuechun; Zhu, Linhai; Chen, Xi; Gao, Yong; Wang, Shaoming; Zheng, Yuanrun; Rimmington, Glyn M.			Effects of Added Organic Matter and Water on Soil Carbon Sequestration in an Arid Region	PLOS ONE			English	Article							FINE-ROOT GROWTH; MICROBIAL BIOMASS; CLIMATE-CHANGE; DESERT SHRUBS; CO2 FLUX; RESPIRATION; TEMPERATURE; ECOSYSTEMS; RESPONSES; PRECIPITATION	It is generally predicted that global warming will stimulate primary production and lead to more carbon (C) inputs to soil. However, many studies have found that soil C does not necessarily increase with increased plant litter input. Precipitation has increased in arid central Asia, and is predicted to increase more, so we tested the effects of adding fresh organic matter (FOM) and water on soil C sequestration in an arid region in northwest China. The results suggested that added FOM quickly decomposed and had minor effects on the soil organic carbon (SOC) pool to a depth of 30 cm. Both FOM and water addition had significant effects on the soil microbial biomass. The soil microbial biomass increased with added FOM, reached a maximum, and then declined as the FOM decomposed. The FOM had a more significant stimulating effect on microbial biomass with water addition. Under the soil moisture ranges used in this experiment (21.0%-29.7%), FOM input was more important than water addition in the soil C mineralization process. We concluded that short-term FOM input into the belowground soil and water addition do not affect the SOC pool in shrubland in an arid region.	[Lai, Liming; Zhao, Xuechun; Zhu, Linhai; Zheng, Yuanrun] Chinese Acad Sci, Key Lab Resource Plants, West China Subalpine Bot Garden, Beijing Bot Garden,Inst Bot, Beijing, Peoples R China; [Li, Yufei] Peking Univ, Inst RS & GIS, Beijing 100871, Peoples R China; [Tian, Yuan; Chen, Xi] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Urumqi, Xinjiang, Peoples R China; [Jiang, Lianhe] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Gao, Yong] Inner Mongolia Agr Univ, Hohhot, Peoples R China; [Wang, Shaoming] Key Lab Oasis Ecol Agr Xinjiang Bingtuan, Shihezi, Xinjiang, Peoples R China; [Rimmington, Glyn M.] Wichita State Univ, Coll Liberal Arts & Sci, Global Learning Off, Wichita, KS USA	Chinese Academy of Sciences; Institute of Botany, CAS; Peking University; Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; Inner Mongolia Agricultural University; Wichita State University	Zheng, YR (corresponding author), Chinese Acad Sci, Key Lab Resource Plants, West China Subalpine Bot Garden, Beijing Bot Garden,Inst Bot, Beijing, Peoples R China.	zhengyr@ibcas.ac.cn	liming, lai/HGB-0743-2022; Zhu, Linhai/B-8551-2011	Zhu, Linhai/0000-0001-7064-9022	China National Key Basic Research Program [2009CB825103, 2012CB956204]	China National Key Basic Research Program(National Basic Research Program of China)	This work was supported by China National Key Basic Research Program (2009CB825103, 2012CB956204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BINGEMAN CW, 1953, SOIL SCI SOC AM PRO, V17, P34, DOI 10.2136/sssaj1953.03615995001700010008x; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Domingo F, 2011, J ARID ENVIRON, V75, P1271, DOI 10.1016/j.jaridenv.2011.06.018; Eswaran H, 2000, GLOBAL CLIMATE CHANGE AND PEDOGENIC CARBONATES, P15; Fontaine S, 2004, ECOL LETT, V7, P314, DOI 10.1111/j.1461-0248.2004.00579.x; Fontaine S, 2003, SOIL BIOL BIOCHEM, V35, P837, DOI 10.1016/S0038-0717(03)00123-8; Fontaine S, 2007, NATURE, V450, P277, DOI 10.1038/nature06275; Garten CT, 2009, ACTA OECOL, V35, P218, DOI 10.1016/j.actao.2008.10.004; Gill RA, 2002, NATURE, V417, P279, DOI 10.1038/417279a; *IPCC, CLIM CHANG 2001 SCI; JONES CD, 2003, GEOPHYS RES LETT, V30, P321; KATTERER T, 1995, FOREST ECOL MANAG, V74, P1, DOI 10.1016/0378-1127(95)03529-J; Keeney R.D., 1982, METHODS SOIL ANAL, P101; Kuzyakov Y, 2000, SOIL BIOL BIOCHEM, V32, P1485, DOI 10.1016/S0038-0717(00)00084-5; Lai LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048011; Lal R, 2009, LAND DEGRAD DEV, V20, P441, DOI 10.1002/ldr.934; MELILLO JM, 1993, NATURE, V363, P234, DOI 10.1038/363234a0; Myers RT, 2001, SOIL SCI SOC AM J, V65, P359, DOI 10.2136/sssaj2001.652359x; Niu SL, 2008, NEW PHYTOL, V177, P209, DOI 10.1111/j.1469-8137.2007.02237.x; Qian WH, 2001, CLIMATIC CHANGE, V50, P419, DOI 10.1023/A:1010673212131; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Reichstein M, 2002, FUNCT ECOL, V16, P27, DOI 10.1046/j.0269-8463.2001.00597.x; Rietz DN, 2003, SOIL BIOL BIOCHEM, V35, P845, DOI 10.1016/S0038-0717(03)00125-1; Robertson GP, 1997, ECOL APPL, V7, P158, DOI 10.1890/1051-0761(1997)007[0158:SRMAAP]2.0.CO;2; Lima TTS, 2010, NEW PHYTOL, V187, P622, DOI 10.1111/j.1469-8137.2010.03299.x; Sayer EJ, 2006, PLANT SOIL, V281, P5, DOI 10.1007/s11104-005-6334-x; Sayer EJ, 2011, NAT CLIM CHANGE, V1, P304, DOI 10.1038/NCLIMATE1190; Schenk HJ, 2002, J ECOL, V90, P480, DOI 10.1046/j.1365-2745.2002.00682.x; Sharma P, 2004, PEDOBIOLOGIA, V48, P83, DOI 10.1016/j.pedobi.2003.09.002; Shemesh H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010824; Six J, 2004, SOIL TILL RES, V79, P7, DOI 10.1016/j.still.2004.03.008; Smith SD, 2000, NATURE, V408, P79, DOI 10.1038/35040544; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P19; Sponseller RA, 2007, GLOBAL CHANGE BIOL, V13, P426, DOI 10.1111/j.1365-2486.2006.01307.x; SPSS, 2000, SPSS WIND VERS 13 0; Starr J.L., 2002, METHODS SOIL ANAL 4, P463; Trumbore SE, 2008, SCIENCE, V321, P1455, DOI 10.1126/science.1160232; Wagai R, 1998, SOIL BIOL BIOCHEM, V30, P1501, DOI 10.1016/S0038-0717(98)00041-8; WARDLE DA, 1992, BIOL REV, V67, P321, DOI 10.1111/j.1469-185X.1992.tb00728.x; Weltzin JF, 2003, BIOSCIENCE, V53, P941, DOI 10.1641/0006-3568(2003)053[0941:ATROTE]2.0.CO;2; Wilcox CS, 2004, J ARID ENVIRON, V56, P129, DOI 10.1016/S0140-1963(02)00324-5; Xia JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032088; Xiao CW, 2007, NEW PHYTOL, V174, P835, DOI 10.1111/j.1469-8137.2007.02054.x; Xu H, 2006, PLANT SOIL, V285, P5, DOI 10.1007/s11104-005-5108-9; Yuste JC, 2007, GLOBAL CHANGE BIOL, V13, P2018, DOI 10.1111/j.1365-2486.2007.01415.x; Yuste JC, 2003, TREE PHYSIOL, V23, P1263, DOI 10.1093/treephys/23.18.1263; Zheng Y, 2006, J ARID ENVIRON, V66, P113, DOI 10.1016/j.jaridenv.2005.09.005	49	9	9	10	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e70224	10.1371/journal.pone.0070224	http://dx.doi.org/10.1371/journal.pone.0070224			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23875022	Green Published, gold, Green Submitted			2022-12-27	WOS:000322064300128
J	Samaan, G; McPherson, M; Partridge, J				Samaan, Gina; McPherson, Michelle; Partridge, Jeffrey			A Review of the Evidence to Support Influenza Vaccine Introduction in Countries and Areas of WHO's Western Pacific Region	PLOS ONE			English	Article							PANDEMIC H1N1 2009; HEALTH-CARE WORKERS; CULTURE-CONFIRMED INFLUENZA; COST-EFFECTIVENESS ANALYSIS; WELFARE NURSING-HOMES; AGED 50-64 YEARS; HONG-KONG; A H1N1; ANTIBODY-RESPONSES; ELDERLY PERSONS	Background: Immunization against influenza is considered an essential public health intervention to control both seasonal epidemics and pandemic influenza. According to the World Health Organization (WHO), there are five key policy and three key programmatic issues that decision-makers should consider before introducing a vaccine. These are (a) public health priority, (b) disease burden, (c) efficacy, quality and safety of the vaccine, (d) other inventions, (e) economic and financial issues, (f) vaccine presentation, (g) supply availability and (h) programmatic strength. We analyzed the body of evidence currently available on these eight issues in the WHO Western Pacific Region. Methodology/Principal Findings: Studies indexed in PubMed and published in English between 1 January 2000 and 31 December 2010 from the 37 countries and areas of the Western Pacific Region were screened for keywords pertaining to the five policy and three programmatic issues. Studies were grouped according to country income level and vaccine target group. There were 133 articles that met the selection criteria, with most (90%) coming from high-income countries. Disease burden (n = 34), vaccine efficacy, quality and safety (n = 27) and public health priority (n = 27) were most frequently addressed by studies conducted in the Region. Many studies assessed influenza vaccine policy and programmatic issues in the general population (42%), in the elderly (24%) and in children (17%). Few studies (2%) addressed the eight issues relating to pregnant women. Conclusions/Significance: The evidence for vaccine introduction in countries and areas in this Region remains limited, particularly in low-and middle-income countries that do not currently have influenza vaccination programmes. Surveillance activities and specialized studies can be used to assess the eight issues including disease burden among vaccine target groups and the cost-effectiveness of influenza vaccine. Multi-country studies should be considered to maximize resource utilization for cross-cutting issues such as vaccine presentation and other inventions.	[Samaan, Gina; McPherson, Michelle; Partridge, Jeffrey] World Hlth Org, DSE, Western Pacific Reg Off, Manila, Philippines	World Health Organization	Samaan, G (corresponding author), World Hlth Org, DSE, Western Pacific Reg Off, Manila, Philippines.	ginasamaan@yahoo.com		McPherson, Michelle/0000-0003-2707-2138				[Anonymous], 2012, Wkly Epidemiol Rec, V87, P461; Ballestas T, 2009, J HOSP INFECT, V73, P203, DOI 10.1016/j.jhin.2009.07.028; Beard F, 2006, ARCH DIS CHILD, V91, P20, DOI 10.1136/adc.2004.060707; Blackmore Tim, 2005, N Z Med J, V118, pU1601; Block SL, 2009, CLIN THER, V31, P2140, DOI 10.1016/j.clinthera.2009.09.014; BRUNTON C, 2005, NZ MED J, V118, pU1434; Cai Li, 2006, Kobe Journal of Medical Sciences, V52, P97; Carlson SJ, 2010, VACCINE, V28, P6809, DOI 10.1016/j.vaccine.2010.08.051; Cheng VC, 2009, J HOSP INFECT, V74, P271; Cheong HJ, 2011, VACCINE, V29, P523, DOI 10.1016/j.vaccine.2010.10.060; Chiu SS, 2002, NEW ENGL J MED, V347, P2097, DOI 10.1056/NEJMoa020546; Chiu SS, 2009, CLIN INFECT DIS, V49, P1016, DOI 10.1086/605570; Chor JSY, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3391; Chow A, 2006, EMERG INFECT DIS, V12, P114, DOI 10.3201/eid1201.050826; Chu DWS, 2009, VACCINE, V27, P7428, DOI 10.1016/j.vaccine.2009.07.102; Cowling BJ, 2008, EMERG INFECT DIS, V14, P1660, DOI 10.3201/eid1410.080646; Cowling BJ, 2010, CLIN INFECT DIS, V51, P1370, DOI 10.1086/657311; Cowling BJ, 2009, ANN INTERN MED, V151, P437, DOI 10.7326/0003-4819-151-7-200910060-00142; Crawford NW, 2010, PEDIATR BLOOD CANCER, V54, P128, DOI 10.1002/pbc.22256; Curry Elizabeth, 2006, N Z Med J, V119, pU2254; D'Onise K, 2008, MED J AUSTRALIA, V188, P510, DOI 10.5694/j.1326-5377.2008.tb01763.x; Dan YY, 2009, EMERG INFECT DIS, V15, P1909, DOI 10.3201/eid1512.090902; de Lataillade C, 2009, J PUBLIC HEALTH POL, V30, P83, DOI 10.1057/jphp.2008.40; Deguchi Y, 2001, J GERONTOL A-BIOL, V56, pM391, DOI 10.1093/gerona/56.6.M391; Deguchi Y, 2000, EPIDEMIOL INFECT, V125, P393, DOI 10.1017/S0950268899004410; Di BA, 2010, CLIN VACCINE IMMUNOL, V17, P1478, DOI 10.1128/CVI.00137-10; Drennan K, 2010, CRIT CARE RESUSC, V12, P223; Fedson DS, 2005, VACCINE, V23, P5133, DOI 10.1016/j.vaccine.2005.06.010; Feng LZ, 2010, VACCINE, V28, P6778, DOI 10.1016/j.vaccine.2010.07.064; Fitzner KA, 2001, HEALTH POLICY, V56, P215, DOI 10.1016/S0168-8510(00)00140-8; Flint SM, 2010, MED J AUSTRALIA, V192, P617, DOI 10.5694/j.1326-5377.2010.tb03654.x; Gill T, 2005, AUST NZ J PUBL HEAL, V29, P38, DOI 10.1111/j.1467-842X.2005.tb00746.x; Gill TK, 2007, VACCINE, V25, P5428, DOI 10.1016/j.vaccine.2007.04.073; Gonzalez-Block Miguel A, 2004, Health Res Policy Syst, V2, P6, DOI 10.1186/1478-4505-2-6; Gotoh K, 2011, PEDIATR TRANSPLANT, V15, P112, DOI 10.1111/j.1399-3046.2010.01420.x; Gronvall GK, 2006, BIOSECUR BIOTERROR, V4, P168, DOI 10.1089/bsp.2006.4.168; Hara M, 2006, VACCINE, V24, P5546, DOI 10.1016/j.vaccine.2006.04.027; Hara M, 2010, VACCINE, V28, P5664, DOI 10.1016/j.vaccine.2010.06.061; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Hirota Y, 2008, VACCINE, V26, P6451, DOI 10.1016/j.vaccine.2008.06.042; Hirota Y, 2008, VACCINE, V26, P6473, DOI 10.1016/j.vaccine.2008.06.036; Hoang LP, 2010, SE ASIAN J TROP MED, V41, P1116; Hoshi SL, 2007, VACCINE, V25, P6511, DOI 10.1016/j.vaccine.2007.05.067; Huang QS, 2008, INFLUENZA OTHER RESP, V2, P139, DOI 10.1111/j.1750-2659.2008.00050.x; Hung IFN, 2010, CLIN INFECT DIS, V51, P1007, DOI 10.1086/656587; Igari H, 2010, MICROBIOL IMMUNOL, V54, P618, DOI 10.1111/j.1348-0421.2010.00254.x; Ikematsu H, 2010, HUM VACCINES, V6, P888, DOI 10.4161/hv.6.11.12851; Kamada M, 2006, VACCINE, V24, P3618, DOI 10.1016/j.vaccine.2006.01.067; Kawai N, 2003, VACCINE, V21, P4507, DOI 10.1016/S0264-410X(03)00508-5; Kee SY, 2007, J INFECTION, V55, P273, DOI 10.1016/j.jinf.2007.04.354; Kelly H, 2004, VACCINE, V22, P2192, DOI 10.1016/j.vaccine.2003.11.052; Kelly H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005079; Kelso JK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013797; Kheok SW, 2008, ANN ACAD MED SINGAP, V37, P465; Kondo M, 2009, HEALTH POLICY, V91, P269, DOI 10.1016/j.healthpol.2008.12.014; Kwong EWY, 2010, J ADV NURS, V66, P2297, DOI 10.1111/j.1365-2648.2010.05397.x; Kwong Enid Wai-yung, 2008, Nurs Older People, V20, P29; Kwong EWY, 2009, J CLIN NURS, V18, P960, DOI 10.1111/j.1365-2702.2008.02548.x; Kwong KL, 2009, J PAEDIATR CHILD H, V45, P660, DOI 10.1111/j.1440-1754.2009.01591.x; Lau EHY, 2008, EMERG INFECT DIS, V14, P1154, DOI 10.3201/eid1407.080060; Lau JTF, 2008, J INFECTION, V56, P460, DOI 10.1016/j.jinf.2008.03.008; Lau JTF, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4164; Lau JTF, 2010, VACCINE, V28, P5389, DOI 10.1016/j.vaccine.2010.05.071; Lau JTF, 2006, VACCINE, V24, P5526, DOI 10.1016/j.vaccine.2006.04.014; Lee CS, 2008, JPN J INFECT DIS, V61, P457; Lee HY, 2007, AM J INFECT CONTROL, V35, P481, DOI 10.1016/j.ajic.2006.10.007; Lee VJ, 2010, VACCINE, V28, P6852, DOI 10.1016/j.vaccine.2010.08.031; Lee VJ, 2010, J INFECT DIS, V202, P1319, DOI 10.1086/656480; Lee VJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008096; Lee VJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007108; Leo YS, 2010, EMERG INFECT DIS, V16, P103, DOI 10.3201/eid1601.091164; Li CK, 2006, PUBLIC HEALTH, V120, P517, DOI 10.1016/j.puhe.2006.03.004; Liang XF, 2010, LANCET, V375, P56, DOI 10.1016/S0140-6736(09)62003-1; Liu W, 2010, CLIN INFECT DIS, V51, P1028, DOI 10.1086/656588; Lu CJ, 2010, CHIN J INTEGR MED, V16, P493, DOI 10.1007/s11655-010-0563-4; Mahajan D, 2010, COMMUN DIS INTELL, V34, P259; Masuda M, 2009, LANCET INFECT DIS, V9, P266, DOI 10.1016/S1473-3099(09)70106-9; Mermond S, 2010, TROP MED INT HEALTH, V15, P1517, DOI 10.1111/j.1365-3156.2010.02653.x; Miyagawa K, 2008, GERIATR GERONTOL INT, V8, P243, DOI 10.1111/j.1447-0594.2008.00483.x; Mogasale V, 2011, AUST NZ J PUBL HEAL, V35, P180, DOI 10.1111/j.1753-6405.2010.00639.x; Mok E, 2006, PUBLIC HEALTH NURS, V23, P506, DOI 10.1111/j.1525-1446.2006.00590.x; Morimoto Tomoko, 2010, Nihon Eiseigaku Zasshi, V65, P459; Murray SB, 2002, AUST NZ J PUBL HEAL, V26, P65, DOI 10.1111/j.1467-842X.2002.tb00273.x; Nelson Edmund A. S., 2007, Hong Kong Medical Journal, V13, P114; Newall AT, 2008, VACCINE, V26, P2142, DOI 10.1016/j.vaccine.2008.01.050; Newall AT, 2010, EMERG INFECT DIS, V16, P224, DOI 10.3201/eid1602.090571; Ng TP, 2002, ANN ACAD MED SINGAP, V31, P182; NOLAN T, 2009, JAMA-J AM MED ASSOC, V303, P37; Nolan T, 2009, INFLUENZA OTHER RESP, V3, P315, DOI 10.1111/j.1750-2659.2009.00108.x; Ochiai H, 2009, VACCINE, V27, P7031, DOI 10.1016/j.vaccine.2009.09.067; Ohkusa Y, 2005, VACCINE, V23, P2256, DOI 10.1016/j.vaccine.2005.01.042; Ong MP, 2010, J INFECTION, V61, P440, DOI 10.1016/j.jinf.2010.08.001; Ono S, 2003, PEDIATR INT, V45, P680, DOI 10.1111/j.1442-200X.2003.01813.x; Otsuka T, 2007, VACCINE, V25, P4521, DOI 10.1016/j.vaccine.2007.03.041; Ozasa K, 2006, VACCINE, V24, P2537, DOI 10.1016/j.vaccine.2005.12.022; Park JH, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-222; Park SW, 2011, AM J INFECT CONTROL, V39, P69, DOI 10.1016/j.ajic.2010.08.007; Partridge J, 2010, VACCINE, V28, P4709, DOI 10.1016/j.vaccine.2010.04.083; Puzelli S, 2006, J MED VIROL, V78, P820, DOI 10.1002/jmv.20629; Reichert TA, 2001, NEW ENGL J MED, V344, P889, DOI 10.1056/NEJM200103223441204; Ridda I, 2008, VACCINE, V26, P5633, DOI 10.1016/j.vaccine.2008.07.070; Sasaki A, 2009, EMERG INFECT DIS, V15, P1841, DOI 10.3201/eid1511.090798; Sasaki Y, 2006, VACCINE, V24, P2208, DOI 10.1016/j.vaccine.2005.11.001; Seah SGK, 2010, J CLIN VIROL, V47, P289, DOI 10.1016/j.jcv.2009.12.011; Seale H, OCCUP MED LOND, V60, P335; Seale H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-99; Seale H, 2010, INFLUENZA OTHER RESP, V4, P41, DOI 10.1111/j.1750-2659.2009.00112.x; Shin SY, 2010, PEDIATR PULM, V45, P1014, DOI 10.1002/ppul.21288; Siu W, HLTH COMMUN, V25, P580; Song JY, 2006, AM J NEPHROL, V26, P206, DOI 10.1159/000093306; Sugaya N, 2005, CLIN INFECT DIS, V41, P939, DOI 10.1086/432938; Sugimura T, 2008, VACCINE, V26, P2700, DOI 10.1016/j.vaccine.2008.03.016; Takahashi H, 2001, JPN J INFECT DIS, V54, P184; Takahashi O, 2003, FAM PRACT, V20, P162, DOI 10.1093/fampra/20.2.162; Tam JS, 2007, PEDIATR INFECT DIS J, V26, P619, DOI 10.1097/INF.0b013e31806166f8; Tan EK, SINGAPORE MED J, V51, P623; Tang JW, 2010, EPIDEMIOL INFECT, V138, P226, DOI 10.1017/S0950268809990410; Tang JW, 2010, J MED VIROL, V82, P1958, DOI 10.1002/jmv.21892; Tomizuka T, 2010, EMERG INFECT DIS, V16, P1646, DOI 10.3201/eid1610.091755; Verrall A, 2010, EMERG INFECT DIS, V16, P100, DOI 10.3201/eid1601.090994; Wada T, 2009, MICROBIOL IMMUNOL, V53, P83, DOI 10.1111/j.1348-0421.2008.00100.x; Ward K, 2011, INFLUENZA OTHER RESP, V5, P135, DOI 10.1111/j.1750-2659.2010.00158.x; White SW, 2010, MED J AUSTRALIA, V193, P405, DOI 10.5694/j.1326-5377.2010.tb03970.x; Wong CM, 2006, PLOS MED, V3, P485, DOI 10.1371/journal.pmed.0030121; Wong CM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002108; Wong CM, 2004, CLIN INFECT DIS, V39, P1611, DOI 10.1086/425315; Wong SYS, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-316; *WORLD BANK, 2011, COUNTR CLASS; World Health Organization, 2005, GLOB INFL SURV RESP; World Health Organization, 2005, COUNTR AR; World Health Organization, 2005, VACC INTR GUIDE ADD; World Health Organization, 2011, GLOB ACT PLAN INFL V; Wu JA, 2011, VACCINE, V29, P1009, DOI 10.1016/j.vaccine.2010.11.058; Wu JT, 2010, P NATL ACAD SCI USA, V107, P3269, DOI 10.1073/pnas.0911596107; Yamada H, 2006, J ALTERN COMPLEM MED, V12, P669, DOI 10.1089/acm.2006.12.669; Yamaguchi S, 2010, J INFECT CHEMOTHER, V16, P407, DOI 10.1007/s10156-010-0070-8; Yang L, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-133; Yap FHY, 2004, J MED VIROL, V73, P617, DOI 10.1002/jmv.20135; Yu HJ, 2009, INFLUENZA OTHER RESP, V3, P223, DOI 10.1111/j.1750-2659.2009.00093.x; Zhu FC, 2008, VACCINE, V26, P4579, DOI 10.1016/j.vaccine.2008.05.082	140	12	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e70003	10.1371/journal.pone.0070003	http://dx.doi.org/10.1371/journal.pone.0070003			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	186SF	23875015	Green Published, gold, Green Submitted			2022-12-27	WOS:000322064300127
J	Smits, SL; Schapendonk, CME; van Leeuwen, M; Kuiken, T; Bodewes, R; Raj, VS; Haagmans, BL; das Neves, CG; Tryland, M; Osterhaus, ADME				Smits, Saskia L.; Schapendonk, Claudia M. E.; van Leeuwen, Marije; Kuiken, Thijs; Bodewes, Rogier; Raj, V. Stalin; Haagmans, Bart L.; das Neves, Carlos G.; Tryland, Morten; Osterhaus, Albert D. M. E.			Identification and Characterization of Two Novel Viruses in Ocular Infections in Reindeer	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; RED DEER; PREVALENCE; DISEASE; HEAD	A thorough understanding of virus diversity in wildlife provides epidemiological baseline information about pathogens. In this study, eye swab samples were obtained from semi-domesticated reindeer (Rangifer tarandus tarandus) in Norway during an outbreak of infectious eye disease, possibly a very early stage of infectious keratoconjunctivitis (IKC). Large scale molecular virus screening, based on host nucleic acid depletion, sequence-independent amplification and next-generation sequencing of partially purified viral nucleic acid, revealed the presence of a new papillomavirus in 2 out of 8 eye swab samples and a new betaherpesvirus in 3 out of 8 eye swab samples collected from animals with clinical signs and not in similar samples in 9 animals without clinical signs. Whether either virus was responsible for causing the clinical signs or in any respect was associated to the disease condition remains to be determined.	[Smits, Saskia L.; van Leeuwen, Marije; Osterhaus, Albert D. M. E.] ViroClin BioSci BV, Rotterdam, Netherlands; [Smits, Saskia L.; Schapendonk, Claudia M. E.; Kuiken, Thijs; Bodewes, Rogier; Raj, V. Stalin; Haagmans, Bart L.; Osterhaus, Albert D. M. E.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [das Neves, Carlos G.; Tryland, Morten] Norwegian Sch Vet Sci, Dept Food Safety & Infect Biol, Sect Arctic Vet Med, Tromso, Norway; [das Neves, Carlos G.] Norwegian Vet Inst, Dept Hlth Surveillance, Sect Vet Publ Hlth, Oslo, Norway; [Tryland, Morten] Genok Ctr Biosafety, Tromso, Norway	Erasmus University Rotterdam; Erasmus MC; Norwegian University of Life Sciences; Norwegian Veterinary Institute	Smits, SL (corresponding author), ViroClin BioSci BV, Rotterdam, Netherlands.	s.smits@erasmusmc.nl	Haagmans, Bart/E-9791-2015; Neves, Carlos G Das/H-9115-2016; Smits, Saskia/A-2953-2014; Raj, Victor Stalin/E-9670-2016	Haagmans, Bart/0000-0001-6221-2015; Neves, Carlos G Das/0000-0003-0348-4808; Kuiken, Thijs/0000-0001-5501-9049; Tryland, Morten/0000-0001-5394-5196; Osterhaus, Albert/0000-0002-6074-1172; Bodewes, Rogier/0000-0002-0689-7889; Raj, Victor Stalin/0000-0003-2250-8481	Norwegian Reindeer Development Fund (RUF); European Community [223498]	Norwegian Reindeer Development Fund (RUF); European Community(European Commission)	The research leading to these results has received funding from the Norwegian Reindeer Development Fund (RUF) and the European Community's Seventh Framework Programme (FP7/2007 - 2013) under the project "European Management Platform for Emerging and Re-emerging Infectious disease Entities" (EMPERIE) EC grant agreement number 223498. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergman A, 1912, SKAND VET T, V2; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Caselli E, 2007, NEW MICROBIOL, V30, P173; das Neves CG, 2010, VET MICROBIOL, V143, P70, DOI 10.1016/j.vetmic.2010.02.015; das Neves CG, 2009, CLIN VACCINE IMMUNOL, V16, P1758, DOI 10.1128/CVI.00218-09; das Neves CG, 2009, VIRUS RES, V145, P321, DOI 10.1016/j.virusres.2009.08.002; das Neves CG, 2009, J CLIN MICROBIOL, V47, P1309, DOI 10.1128/JCM.02416-08; De Villiers EM, 2004, INT J CANCER, V109, P253, DOI 10.1002/ijc.11685; ERIKSSON A, 1994, J VIROL, V68, P8365, DOI 10.1128/JVI.68.12.8365-8373.1994; INGLIS DM, 1983, VET REC, V113, P182, DOI 10.1136/vr.113.8.182; Kalogeropoulos C, 2012, CLIN OPHTHALMOL, V6, P1553, DOI 10.2147/OPTH.S34999; Kuiken T, 2005, SCIENCE, V309, P1680, DOI 10.1126/science.1113310; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; NETTLETON PF, 1986, VET REC, V118, P267, DOI 10.1136/vr.118.10.267; Postma GC, 2008, COMP IMMUNOL MICROB, V31, P449, DOI 10.1016/j.cimid.2008.04.001; REID HW, 1986, VET REC, V118, P156; RIIS R, 2008, DIS DAIRY CATTLE, P561; Sjo NC, 2001, BRIT J OPHTHALMOL, V85, P785, DOI 10.1136/bjo.85.7.785; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thiry J, 2006, VET RES, V37, P169, DOI 10.1051/vetres:2005052; Tryland M, 2009, J CLIN MICROBIOL, V47, P3707, DOI 10.1128/JCM.01198-09; van den Brand JMA, 2012, J VIROL, V86, P2360, DOI 10.1128/JVI.06373-11; van Leeuwen M, 2010, J CLIN MICROBIOL, V48, P1787, DOI 10.1128/JCM.02452-09; Watanabe S, 2010, EMERG INFECT DIS, V16, P986, DOI 10.3201/eid1606.091567; Wei W, 2012, ONCOL REP, V28, P1750, DOI 10.3892/or.2012.1990	25	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e69711	10.1371/journal.pone.0069711	http://dx.doi.org/10.1371/journal.pone.0069711			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874987	Green Submitted, Green Published, gold			2022-12-27	WOS:000322064300112
J	Maxwell, JA; Holsen, TM; Mondal, S				Maxwell, J. Alexander; Holsen, Thomas M.; Mondal, Sumona			Gaseous Elemental Mercury (GEM) Emissions from Snow Surfaces in Northern New York	PLOS ONE			English	Article							FLUX CHAMBER MEASUREMENT; ATMOSPHERIC MERCURY; SIMULATION; SOILS	Snow surface-to-air exchange of gaseous elemental mercury (GEM) was measured using a modified Teflon fluorinated ethylene propylene (FEP) dynamic flux chamber (DFC) in a remote, open site in Potsdam, New York. Sampling was conducted during the winter months of 2011. The inlet and outlet of the DFC were coupled with a Tekran Model 2537A mercury (Hg) vapor analyzer using a Tekran Model 1110 two port synchronized sampler. The surface GEM flux ranged from -4.47 ng m(-2) hr(-1) to 9.89 ng m(-2) hr(-1). For most sample periods, daytime GEM flux was strongly correlated with solar radiation. The average nighttime GEM flux was slightly negative and was not well correlated with any of the measured meteorological variables. Preliminary, empirical models were developed to estimate GEM emissions from snow surfaces in northern New York. These models suggest that most, if not all, of the Hg deposited with and to snow is reemitted to the atmosphere.	[Maxwell, J. Alexander] Clarkson Univ, Inst Sustainable Environm, Potsdam, NY USA; [Holsen, Thomas M.] Clarkson Univ, Dept Civil & Environm Engn, Potsdam, NY 13699 USA; [Mondal, Sumona] Clarkson Univ, Dept Math, Potsdam, NY USA	Clarkson University; Clarkson University; Clarkson University	Holsen, TM (corresponding author), Clarkson Univ, Dept Civil & Environm Engn, Potsdam, NY 13699 USA.	holsen@clarkson.edu	Maxwell, J. Alexander/J-8265-2019	Holsen, Thomas/0000-0001-9599-6733	New York State Energy Research and Development Authority (NYSERDA)	New York State Energy Research and Development Authority (NYSERDA)	New York State Energy Research and Development Authority (NYSERDA http://www.nyserda.ny.gov/) financially supported this research (Charles Driscoll, Syracuse University PI). It has not been subject to the NYSERDA's peer and policy review and, therefore, does not necessarily reflect the views of NYSERDA and no official endorsement should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariya PA, 2004, TELLUS B, V56, P397, DOI 10.1111/j.1600-0889.2004.00118.x; Carpi A, 2007, ANAL BIOANAL CHEM, V388, P361, DOI 10.1007/s00216-006-1111-0; Choi HD, 2009, ENVIRON POLLUT, V157, P592, DOI 10.1016/j.envpol.2008.08.020; Dommergue A, 2003, ENVIRON SCI TECHNOL, V37, P3289, DOI 10.1021/es026242b; Eckley CS, 2010, ATMOS ENVIRON, V44, P194, DOI 10.1016/j.atmosenv.2009.10.013; Fain X, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2007JD008520; Ferrari CP, 2005, ATMOS ENVIRON, V39, P7633, DOI 10.1016/j.atmosenv.2005.06.058; Gbor PK, 2006, ATMOS ENVIRON, V40, P973, DOI 10.1016/j.atmosenv.2005.10.040; Lalonde JD, 2002, ENVIRON SCI TECHNOL, V36, P174, DOI 10.1021/es010786g; Lalonde JD, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD001534; Lin CJ, 1999, ATMOS ENVIRON, V33, P2067, DOI 10.1016/S1352-2310(98)00387-2; Lindberg SE, 2002, ENVIRON SCI TECHNOL, V36, P1245, DOI 10.1021/es0111941; Lindberg SE, 2002, ATMOS ENVIRON, V36, P847, DOI 10.1016/S1352-2310(01)00502-7; LINDQVIST O, 1985, TELLUS B, V37, P136, DOI 10.1111/j.1600-0889.1985.tb00062.x; Mergler D, 2007, AMBIO, V36, P3, DOI 10.1579/0044-7447(2007)36[3:MEAHEI]2.0.CO;2; Nelson SJ, 2010, HYDROL PROCESS, V24, P1971, DOI 10.1002/hyp.7660; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Schroeder WH, 1998, ATMOS ENVIRON, V32, P809, DOI 10.1016/S1352-2310(97)00293-8; Selin NE, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003040; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Skov H, 2004, ENVIRON SCI TECHNOL, V38, P2373, DOI 10.1021/es030080h; Steffen A, 2008, ATMOSPHERIC CHEM PHY, V8; Zhang H, 2002, ATMOS ENVIRON, V36, P835, DOI 10.1016/S1352-2310(01)00501-5	23	7	7	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e69342	10.1371/journal.pone.0069342	http://dx.doi.org/10.1371/journal.pone.0069342			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	23874951	Green Submitted, gold, Green Published			2022-12-27	WOS:000321718700051
J	Buzzell, G; Chubb, L; Safford, AS; Thompson, JC; McDonald, CG				Buzzell, George; Chubb, Laura; Safford, Ashley S.; Thompson, James C.; McDonald, Craig G.			Speed of Human Biological Form and Motion Processing	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; SENSORY GAIN-CONTROL; ATTENTIONAL MODULATION; BRAIN POTENTIALS; PERCEPTION; RECOGNITION; MECHANISMS; NOVELTY; MODEL; P3A	Recent work suggests that biological motion processing can begin within similar to 110 ms of stimulus onset, as indexed by the P1 component of the event-related potential (ERP). Here, we investigated whether modulation of the P1 component reflects configural processing alone, rather than the processing of both configuration and motion cues. A three-stimulus oddball task was employed to evaluate bottom-up processing of biological motion. Intact point-light walkers (PLWs) or scrambled PLWs served as distractor stimuli, whereas point-light displays of tool motion served as standard and target stimuli. In a second experiment, the same design was used, but the dynamic stimuli were replaced with static point-light displays. The first experiment revealed that dynamic PLWs elicited a larger P1 as compared to scrambled PLWs. A similar P1 increase was also observed for static PLWs in the second experiment, indicating that these stimuli were more salient than static, scrambled PLWs. These findings suggest that the visual system can rapidly extract global form information from static PLWs and that the observed P1 effect for dynamic PLWs is not dependent on the presence of motion cues. Finally, we found that the N1 component was sensitive to dynamic, but not static, PLWs, suggesting that this component reflects the processing of both form and motion information. The sensitivity of P1 to static PLWs has implications for dynamic form models of biological motion processing that posit temporal integration of configural cues present in individual frames of PLW animations.	[Buzzell, George; Chubb, Laura; Safford, Ashley S.; Thompson, James C.; McDonald, Craig G.] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA	George Mason University	McDonald, CG (corresponding author), George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA.	cmcdona3@gmu.edu			George Mason University, USA	George Mason University, USA	This research project received financial support from George Mason University, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccus W, 2009, NEUROREPORT, V20, P1334, DOI 10.1097/WNR.0b013e328330a867; Beintema JA, 2002, P NATL ACAD SCI USA, V99, P5661, DOI 10.1073/pnas.082483699; Blake R, 2007, ANNU REV PSYCHOL, V58, P47, DOI 10.1146/annurev.psych.57.102904.190152; Chong H, 2008, J COGNITIVE NEUROSCI, V20, P120, DOI 10.1162/jocn.2008.20003; Comerchero MD, 1999, CLIN NEUROPHYSIOL, V110, P24, DOI 10.1016/S0168-5597(98)00033-1; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dering B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00093; Fedota JR, 2012, PSYCHOPHYSIOLOGY, V49, P1384, DOI 10.1111/j.1469-8986.2012.01455.x; Friedman D, 2001, NEUROSCI BIOBEHAV R, V25, P355, DOI 10.1016/S0149-7634(01)00019-7; Giese MA, 2003, NAT REV NEUROSCI, V4, P179, DOI 10.1038/nrn1057; Hagen GF, 2006, INT J PSYCHOPHYSIOL, V59, P8, DOI 10.1016/j.ijpsycho.2005.08.003; Handy TC, 2005, J COGNITIVE NEUROSCI, V17, P1936, DOI 10.1162/089892905775008715; Hillyard SA, 1998, PHILOS T ROY SOC B, V353, P1257, DOI 10.1098/rstb.1998.0281; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; Hirai M, 2006, COGNITION, V99, pB15, DOI 10.1016/j.cognition.2005.05.003; Hirai M, 2003, NEUROSCI LETT, V344, P41, DOI 10.1016/S0304-3940(03)00413-0; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Jokisch D, 2005, BEHAV BRAIN RES, V157, P195, DOI 10.1016/j.bbr.2004.06.025; Krakowski AI, 2011, NEUROIMAGE, V56, P373, DOI 10.1016/j.neuroimage.2011.01.058; Lange J, 2006, J NEUROSCI, V26, P2894, DOI 10.1523/JNEUROSCI.4915-05.2006; MANGUN GR, 1991, J EXP PSYCHOL HUMAN, V17, P1057, DOI 10.1037/0096-1523.17.4.1057; McLeod P, 1996, VIS COGN, V3, P363, DOI 10.1080/135062896395634; Pavlova M, 2006, CEREB CORTEX, V16, P321, DOI 10.1093/cercorbhi108; Pavlova M, 2004, CEREB CORTEX, V14, P181, DOI 10.1093/cercor/bhg117; Pazo-Alvarez P, 2003, BIOL PSYCHOL, V63, P199, DOI 10.1016/S0301-0511(03)00049-8; Rosburg T, 2010, PSYCHOPHYSIOLOGY, V47, P147, DOI 10.1111/j.1469-8986.2009.00881.x; Rousselet GA, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00156; Safford AS, 2010, J NEUROSCI, V30, P9064, DOI 10.1523/JNEUROSCI.1779-10.2010; Thompson J, 2012, NEUROIMAGE, V59, P4, DOI 10.1016/j.neuroimage.2011.05.044; Thornton IM, 2004, CURR BIOL, V14, P1084, DOI 10.1016/j.cub.2004.06.025; VAINA LM, 1990, VISUAL NEUROSCI, V5, P353, DOI 10.1017/S0952523800000444; Zhang WW, 2009, NAT NEUROSCI, V12, P24, DOI 10.1038/nn.2223	32	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69396	10.1371/journal.pone.0069396	http://dx.doi.org/10.1371/journal.pone.0069396			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	188BY	23894467	gold, Green Published, Green Submitted			2022-12-27	WOS:000322167900063
J	Sanabria-Diaz, G; Martinez-Montes, E; Melie-Garcia, L				Sanabria-Diaz, Gretel; Martinez-Montes, Eduardo; Melie-Garcia, Lester		Alzheimer's Dis Neuroimaging Initi	Glucose Metabolism during Resting State Reveals Abnormal Brain Networks Organization in the Alzheimer's Disease and Mild Cognitive Impairment	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; FUNCTIONAL CONNECTIVITY; FDG-PET; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; CLINICAL-DIAGNOSIS; NATIONAL INSTITUTE; CORTICAL THICKNESS; LOW-FREQUENCY; DEMENTIA	This paper aims to study the abnormal patterns of brain glucose metabolism co-variations in Alzheimer disease (AD) and Mild Cognitive Impairment (MCI) patients compared to Normal healthy controls (NC) using the Alzheimer Disease Neuroimaging Initiative (ADNI) database. The local cerebral metabolic rate for glucose (CMRgl) in a set of 90 structures belonging to the AAL atlas was obtained from Fluro-Deoxyglucose Positron Emission Tomography data in resting state. It is assumed that brain regions whose CMRgl values are significantly correlated are functionally associated; therefore, when metabolism is altered in a single region, the alteration will affect the metabolism of other brain areas with which it interrelates. The glucose metabolism network (represented by the matrix of the CMRgl co-variations among all pairs of structures) was studied using the graph theory framework. The highest concurrent fluctuations in CMRgl were basically identified between homologous cortical regions in all groups. Significant differences in CMRgl co-variations in AD and MCI groups as compared to NC were found. The AD and MCI patients showed aberrant patterns in comparison to NC subjects, as detected by global and local network properties (global and local efficiency, clustering index, and others). MCI network's attributes showed an intermediate position between NC and AD, corroborating it as a transitional stage from normal aging to Alzheimer disease. Our study is an attempt at exploring the complex association between glucose metabolism, CMRgl covariations and the attributes of the brain network organization in AD and MCI.	[Sanabria-Diaz, Gretel] Cuban Neurosci Ctr, Neurodiagnost Dept, Havana, Cuba; [Martinez-Montes, Eduardo; Melie-Garcia, Lester] Cuban Neurosci Ctr, Neuroinformat Dept, Havana, Cuba		Melie-Garcia, L (corresponding author), Cuban Neurosci Ctr, Neuroinformat Dept, Havana, Cuba.	lester@cneuro.edu.cu	Melie-Garcia, Lester/U-5804-2019; Martínez-Montes, Eduardo/AAA-9485-2020	Martínez-Montes, Eduardo/0000-0002-5852-964X; Melie-Garcia, Lester/0000-0001-5602-8916	Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; National Institutes of Health (NIH) [P30 AG010129, K01 AG030514]; NATIONAL INSTITUTE ON AGING [U01AG024904, K01AG030514, P30AG010129] Funding Source: NIH RePORTER	Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is Rev March 26, 2012 coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles. This research was also supported by National Institutes of Health (NIH) grants P30 AG010129 and K01 AG030514. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, EFFICIENCY COST EC B; Acosta-Cabronero J, 2010, BRAIN, V133, P529, DOI 10.1093/brain/awp257; Agosta F, 2012, NEUROBIOL AGING, V33, P1564, DOI 10.1016/j.neurobiolaging.2011.06.007; Alemn-Gmez Y., 2006, 12 ANN M ORG HUM BRA; Alexander GE, 2002, AM J PSYCHIAT, V159, P738, DOI 10.1176/appi.ajp.159.5.738; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; BARBAS H, 1988, J COMP NEUROL, V276, P313, DOI 10.1002/cne.902760302; Bassett DS, 2012, NEUROIMAGE, V59, P2196, DOI 10.1016/j.neuroimage.2011.10.002; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Becker JT, 1996, NEUROLOGY, V46, P692, DOI 10.1212/WNL.46.3.692; Blesa R, 1996, DEMENTIA, V7, P239, DOI 10.1159/000106886; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Borghammer P, 2009, NEUROIMAGE, V46, P981, DOI 10.1016/j.neuroimage.2009.03.021; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Chen KW, 2010, NEUROIMAGE, V51, P654, DOI 10.1016/j.neuroimage.2010.02.064; Choo IH, 2007, ALZ DIS ASSOC DIS, V21, P77, DOI 10.1097/WAD.0b013e3180687418; Cohen J., 1983, APPL MULTIPLE REGRES; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; de Haan W, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-101; Delbeuck X, 2003, NEUROPSYCHOL REV, V13, P79, DOI 10.1023/A:1023832305702; Di X, 2012, BRAIN CONNECT; Dolan RJ, 1996, NEUROIMAGE, V4, P194, DOI 10.1006/nimg.1996.0070; Duffy CJ, 2009, ANN NY ACAD SCI, V1170, P736, DOI 10.1111/j.1749-6632.2009.04021.x; Eidelberg D, 2009, TRENDS NEUROSCI, V32, P548, DOI 10.1016/j.tins.2009.06.003; ENGLUND E, 1988, BRAIN, V111, P1425, DOI 10.1093/brain/111.6.1425; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Freeman LC, 1977, SET MEASURES CENTRAL; Geday J, 2003, NEUROIMAGE, V18, P675, DOI 10.1016/S1053-8119(02)00038-1; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gili T, 2011, J NEUROL NEUROSUR PS, V82, P58, DOI 10.1136/jnnp.2009.199935; Ginestet CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021570; Grady CL, 2003, J NEUROSCI, V23, P986, DOI 10.1523/jneurosci.23-03-00986.2003; Gray KR, 2012, NEUROIMAGE, V60, P221, DOI 10.1016/j.neuroimage.2011.12.071; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; He Y, 2009, BRAIN, V132, P3366, DOI 10.1093/brain/awp089; Herholz K, 2002, NEUROIMAGE, V17, P302, DOI 10.1006/nimg.2002.1208; HORWITZ B, 1984, J CEREBR BLOOD F MET, V4, P484, DOI 10.1038/jcbfm.1984.73; HORWITZ B, 1987, BRAIN RES, V407, P294, DOI 10.1016/0006-8993(87)91107-3; Huang SA, 2010, NEUROIMAGE, V50, P935, DOI 10.1016/j.neuroimage.2009.12.120; Illan IA, 2011, INFORM SCIENCES, V181, P903, DOI 10.1016/j.ins.2010.10.027; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Jagust W, 2007, NEUROLOGY, V69, P871, DOI 10.1212/01.wnl.0000269790.05105.16; Jagust WJ, 2010, ALZHEIMERS DEMENT, V6, P221, DOI 10.1016/j.jalz.2010.03.003; Jovicich J, 2006, NEUROIMAGE, V30, P436, DOI 10.1016/j.neuroimage.2005.09.046; Kerrouche N, 2006, J CEREBR BLOOD F MET, V26, P1213, DOI 10.1038/sj.jcbfm.9600296; Kogure D, 2000, J NUCL MED, V41, P1155; Kuczynski B, 2010, ALZHEIMERS DEMENT, V6, P54, DOI 10.1016/j.jalz.2009.04.1228; Landau SM, 2011, NEUROBIOL AGING, V32, P1207, DOI 10.1016/j.neurobiolaging.2009.07.002; Langbaum JBS, 2009, NEUROIMAGE, V45, P1107, DOI 10.1016/j.neuroimage.2008.12.072; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Lee DS, 2008, EUR J NUCL MED MOL I, V35, P1681, DOI 10.1007/s00259-008-0808-z; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Lo CY, 2010, J NEUROSCI, V30, P16876, DOI 10.1523/JNEUROSCI.4136-10.2010; Markiewicz PJ, 2011, NEUROIMAGE, V56, P1382, DOI 10.1016/j.neuroimage.2011.02.036; Maslov S, 2002, SPECIFICITY STABILIT; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Melie-Garcia L, 2013, NEUROIMAGE, V64, P173, DOI 10.1016/j.neuroimage.2012.08.082; Mesulam M., 2000, PRINCIPLES BEHAV COG; METTER EJ, 1984, J CEREBR BLOOD F MET, V4, P500, DOI 10.1038/jcbfm.1984.74; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Minoshima S, 1997, ANN NEUROL, V42, P85, DOI 10.1002/ana.410420114; Moeller C, 2013, NEUROBIOL AGING, DOI DOI 10.1016/J.NEUR0BI0LAGING.2013.02.013; Morbelli S, 2012, NEUROBIOL AGING, V33, P2533, DOI 10.1016/j.neurobiolaging.2012.01.005; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Mosconi L, 2004, NEUROLOGY, V63, P2332, DOI 10.1212/01.WNL.0000147469.18313.3B; Mosconi L, 2005, EUR J NUCL MED MOL I, V32, P486, DOI [10.1007/s00259-008-1039-z, 10.1007/s00259-005-1762-7]; Mosconi L, 2008, J NUCL MED, V49, P390, DOI 10.2967/jnumed.107.045385; Mosconi Lisa, 2005, Eur J Nucl Med Mol Imaging, V32, P486, DOI 10.1007/s00259-005-1762-7; Mueller Susanne G, 2005, Alzheimers Dement, V1, P55, DOI 10.1016/j.jalz.2005.06.003; Nobili F, 2010, OPEN NUCL MED J, V2, P46; Pagani M, 2009, PSYCHIAT RES-NEUROIM, V173, P8, DOI 10.1016/j.pscychresns.2008.07.016; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; PIETRINI P, 1993, DEMENTIA, V4, P94, DOI 10.1159/000107349; Qi ZG, 2010, NEUROIMAGE, V50, P48, DOI 10.1016/j.neuroimage.2009.12.025; Raj A, 2012, NEURON, V73, P1204, DOI 10.1016/j.neuron.2011.12.040; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; RAPOPORT SI, 1991, ADV EXP MED BIOL, V291, P231; Rasmussen JM, 2012, BBA-MOL BASIS DIS, V1822, P457, DOI 10.1016/j.bbadis.2011.09.008; Reiman EM, 2011, J ALZHEIMERS DIS, V26, P321, DOI 10.3233/JAD-2011-0059; Reiman EM, 2010, BIOMARK MED, V4, P3, DOI [10.2217/bmm.09.91, 10.2217/BMM.09.91]; Resnick SM, 2003, J NEUROSCI, V23, P3295; Rizzo M, 2000, NEUROPSYCHOLOGIA, V38, P1157, DOI 10.1016/S0028-3932(00)00023-3; Rocher AB, 2003, NEUROIMAGE, V20, P1894, DOI 10.1016/j.neuroimage.2003.07.002; Rombouts SARB, 2005, HUM BRAIN MAPP, V26, P231, DOI 10.1002/hbm.20160; Ronnback A, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.07.012; Salmon E, 2009, NEUROBIOL AGING, V30, P186, DOI 10.1016/j.neurobiolaging.2007.06.010; Sanabria-Diaz G, 2010, NEUROIMAGE, V50, P1497, DOI 10.1016/j.neuroimage.2010.01.028; Sanz-Arigita EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013788; Schwarz AJ, 2011, NEUROIMAGE, V55, P1132, DOI 10.1016/j.neuroimage.2010.12.047; Silverman DHS, 2001, JAMA-J AM MED ASSOC, V286, P2120, DOI 10.1001/jama.286.17.2120; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Sporns O, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00005; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Stern Y, 2006, ALZ DIS ASSOC DIS, V20, pS69, DOI 10.1097/00002093-200607001-00010; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Tetewsky SJ, 1999, NEUROLOGY, V52, P958, DOI 10.1212/WNL.52.5.958; Tijms BM, 2013, NEUROBIOL AGING; Toussaint PJ, 2012, NEUROIMAGE, V63, P936, DOI 10.1016/j.neuroimage.2012.03.091; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; Villain N, 2008, J NEUROSCI, V28, P6174, DOI 10.1523/JNEUROSCI.1392-08.2008; Wang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021976; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Watts D.J., 1999, SMALL WORLDS DYNAMIC; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weiner Michael W, 2012, Alzheimers Dement, V8, pS1, DOI [10.1016/j.jalz.2013.05.1769, 10.1016/j.jalz.2011.09.172]; Wu K., 2011, HUM BRAIN MAPP; Yakushev I, 2009, NEUROIMAGE, V44, P43, DOI 10.1016/j.neuroimage.2008.07.015; Yakushev I, 2008, PSYCHIAT RES-NEUROIM, V164, P143, DOI 10.1016/j.pscychresns.2007.11.004; Yao ZJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001006; Yu QB, 2013, SCHIZOPHR RES, V143, P165, DOI 10.1016/j.schres.2012.11.001; Zalesky A, 2012, HUM BRAIN MAPP, V33, P2535, DOI 10.1002/hbm.21379; Zhang Fang, 2011, Zhongguo Yi Liao Qi Xie Za Zhi, V35, P164; Zhou J, 2012, NEURON, V73, P1216, DOI 10.1016/j.neuron.2012.03.004; Zhu W, 2010, NEUROBIOL AGING	127	73	73	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e68860	10.1371/journal.pone.0068860	http://dx.doi.org/10.1371/journal.pone.0068860			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894356	Green Published, gold, Green Submitted			2022-12-27	WOS:000325211000046
J	Xia, YP; He, QW; Li, YN; Chen, SC; Huang, M; Wang, Y; Gao, Y; Huang, Y; Wang, MD; Mao, L; Hu, B				Xia, Yuan-peng; He, Quan-wei; Li, Ya-nan; Chen, Sheng-cai; Huang, Ming; Wang, Yong; Gao, Yuan; Huang, Yan; Wang, Meng-die; Mao, Ling; Hu, Bo			Recombinant Human Sonic Hedgehog Protein Regulates the Expression of ZO-1 and Occludin by Activating Angiopoietin-1 in Stroke Damage	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; TIGHT JUNCTION PERMEABILITY; CEREBRAL-ARTERY OCCLUSION; ENDOTHELIAL-CELLS; IN-VITRO; ISCHEMIC-STROKE; GROWTH; ANGIOGENESIS; PATHWAY; LEAKAGE	This study examines the regulating effect of Sonic Hedgehog (Shh) on the permeability of the blood-brain barrier (BBB) in cerebral ischemia. By employing permanent middle cerebral artery occlusion (pMCAO) model, we find that Shh significantly decreases brain edema and preserves BBB permeability. Moreover, Shh increases zonula occludens-1 (ZO-1), occludin and angiopiotetin-1 (Ang-1) expression in the ischemic penumbra. Blockage of Shh with cyclopamine abolishes the effects of Shh on brain edema, BBB permeability and ZO-1, occludin, Ang-1 expression. Primary brain microvessel endothelial cells (BMECs) and astrocytes were pre-treated with Shh, cyclopamine, Ang-1-neutralizing antibody, and subjected to oxygen-glucose deprivation (OGD). Results show that the Ang-1 protein level in the culture medium of Shh-treated astrocytes is significantly higher. Shh also increased ZO-1, occludin and Ang-1 expression in BMECs, while cyclopamine and Ang-1-neutralizing antibody inhibited the effects of Shh on the ZO-1 and occludin expression, respectively. This study suggests that, under ischemic insults, Shh triggers Ang-1 production predominantly in astrocytes, and the secreted Ang-1 acts on BMECs, thereby upregulating ZO-1 and occludin to repair the tight junction and ameliorate the brain edema and BBB leakage.	[Xia, Yuan-peng; He, Quan-wei; Li, Ya-nan; Chen, Sheng-cai; Huang, Ming; Wang, Yong; Gao, Yuan; Huang, Yan; Wang, Meng-die; Mao, Ling; Hu, Bo] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Neurol, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Hu, B (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Neurol, Wuhan 430074, Peoples R China.	hubo@mail.hust.edu.cn	xia, yuanpeng/S-7988-2019	He, Quan-Wei/0000-0002-8318-6976	Program of National Natural Science Foundation of China [81070938, 81101905]; New Century Excellent Talents in University [NCET-10-0406]; Fundamental Research Funds for the Central Universities, HUST [2010JC028, 2011JC069]	Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities, HUST(Fundamental Research Funds for the Central Universities)	This work was supported by grants 81070938 from the Program of National Natural Science Foundation of China, grant 81101905 from the Program of National Natural Science Foundation of China, New Century Excellent Talents in University NCET-10-0406 and the Fundamental Research Funds for the Central Universities, HUST No.2010JC028, HUST No. 2011JC069. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JI, 2011, SCIENCE, V334, P1727, DOI 10.1126/science.1206936; Belayev L, 1996, STROKE, V27, P1616, DOI 10.1161/01.STR.27.9.1616; Chen WW, 2011, P NATL ACAD SCI USA, V108, P9589, DOI 10.1073/pnas.1017945108; Dai RL, 2012, J HUAZHONG U SCI-MED, V32, P856, DOI 10.1007/s11596-012-1047-x; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; DIGLIO CA, 1982, LAB INVEST, V46, P554; Fischer S, 2002, MICROVASC RES, V63, P70, DOI 10.1006/mvre.2001.2367; Fujii T, 2010, IN VITRO CELL DEV-AN, V46, P487, DOI 10.1007/s11626-009-9270-x; Gamble JR, 2000, CIRC RES, V87, P603, DOI 10.1161/01.RES.87.7.603; Gritli-Linde A, 2002, DEVELOPMENT, V129, P5323, DOI 10.1242/dev.00100; Hang Y, 2012, J MOL NEUROSCI, V46, P236, DOI 10.1007/s12031-011-9584-5; Hashizume A, 2006, BIOCHEM BIOPH RES CO, V339, P996, DOI 10.1016/j.bbrc.2005.11.106; He QW, 2013, MOL NEUROBIOL, V47, P976, DOI 10.1007/s12035-013-8396-8; Hirase T, 1997, J CELL SCI, V110, P1603; Hori S, 2004, J NEUROCHEM, V89, P503, DOI 10.1111/j.1471-4159.2004.02343.x; Incardona JP, 1998, DEVELOPMENT, V125, P3553; Ji H, 2012, NEUROSCI LETT, V506, P1, DOI 10.1016/j.neulet.2011.11.027; Krishnan V, 1997, SCIENCE, V278, P1947, DOI 10.1126/science.278.5345.1947; Lawson ND, 2002, DEV CELL, V3, P127, DOI 10.1016/S1534-5807(02)00198-3; Lee SW, 2007, INT J MOL MED, V19, P445; Lee SW, 2009, INT J MOL MED, V23, P279, DOI 10.3892/ijmm_00000128; Lee SW, 2003, NAT MED, V9, P900, DOI 10.1038/nm889; Li YN, 2013, MOL NEUROBIOL, V47, P967, DOI 10.1007/s12035-013-8395-9; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Mammoto T, 2007, J BIOL CHEM, V282, P23910, DOI 10.1074/jbc.M702169200; McCarthy KM, 1996, J CELL SCI, V109, P2287; Nag S, 2002, TRENDS MOL MED, V8, P38, DOI 10.1016/S1471-4914(01)02221-3; Nusrat A, 2000, J CELL SCI, V113, P1771; Osterlund T, 2006, TRENDS CELL BIOL, V16, P176, DOI 10.1016/j.tcb.2006.02.004; Petty MA, 2001, BRAIN RES REV, V36, P23, DOI 10.1016/S0165-0173(01)00062-5; Pola R, 2001, NAT MED, V7, P706, DOI 10.1038/89083; Rosenstein JM, 1998, P NATL ACAD SCI USA, V95, P7086, DOI 10.1073/pnas.95.12.7086; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Shen FX, 2011, J CEREBR BLOOD F MET, V31, P2343, DOI 10.1038/jcbfm.2011.97; Sims JR, 2009, STROKE, V40, P3618, DOI 10.1161/STROKEAHA.109.561951; Teng H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033444; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Wolburg H, 2002, VASC PHARMACOL, V38, P323, DOI 10.1016/S1537-1891(02)00200-8; Xia YP, 2012, NEUROSCIENCE, V209, P1, DOI 10.1016/j.neuroscience.2012.02.019; Zhang ZG, 2002, NEUROSCIENCE, V113, P683, DOI 10.1016/S0306-4522(02)00175-6	41	63	66	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e68891	10.1371/journal.pone.0068891	http://dx.doi.org/10.1371/journal.pone.0068891			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894369	Green Submitted, Green Published, gold			2022-12-27	WOS:000325211000055
J	Gu, C; Zhou, L; Yu, JP				Gu, Chao; Zhou, Liang; Yu, Jianping			Quantitative Assessment of 2q35-rs13387042 Polymorphism and Hormone Receptor Status with Breast Cancer Risk	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; GENETIC-VARIANTS; AFRICAN-AMERICAN; COMMON VARIANTS; CONFER SUSCEPTIBILITY; METAANALYSIS; FGFR2; WOMEN; 2Q35	Background: The association between rs13387042 polymorphism on 2q35 and breast cancer (BC) has been widely evaluated since it was first identified through genome-wide association approach. However, the results have been inconclusive. To investigate this inconsistency, we performed a meta-analysis of all available studies dealing with the relationship between the 2q35-rs13387042 polymorphism and BC. Methods: Databases including MEDLINE, PubMed, EMBASE, ISI web of science and CNKI (China National Knowledge Infrastructure) were searched to find relevant studies. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the strength of association. The random-effects model was applied, addressing heterogeneity and publication bias. Results: A total of 24 articles involving 99,772 cases and 164,985 controls were included. In a combined analysis, the summary per-allele odds ratio (OR) for BC of 2q35-rs13387042 polymorphism was 1.13 (95% CI: 1.11-1.16; P<10(-5)). Significant associations were also detected under co-dominant, dominant and recessive genetic models. In the subgroup analysis by ethnicity, significantly increased risks were found in Asians, Caucasians and Hispanic whites for the polymorphism in all comparisons; whereas no significant associations were found among Africans. In addition, we find 2q35-rs13387042 polymorphism conferred significantly risks for both ER-positive and ER-negative tumors. Furthermore, significant associations were also detected both in PR-positive and PR-negative cancer. Conclusions: Our findings demonstrated that rs13387042-A allele is a risk-conferring factors for the development of BC, especially in Asians, Caucasians and Hispanic whites.	[Gu, Chao; Zhou, Liang; Yu, Jianping] Fudan Univ, Jinshan Hosp, Dept Gen Surg, Shanghai 200433, Peoples R China	Fudan University	Yu, JP (corresponding author), Fudan Univ, Jinshan Hosp, Dept Gen Surg, Shanghai 200433, Peoples R China.	jianping_yu001@126.com						Antoniou AC, 2009, HUM MOL GENET, V18, P4442, DOI 10.1093/hmg/ddp372; Barnholtz-Sloan JS, 2010, CARCINOGENESIS, V31, P1417, DOI 10.1093/carcin/bgq128; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Benson JR, 2012, FUTURE ONCOL, V8, P697, DOI [10.2217/fon.12.61, 10.2217/FON.12.61]; Cai Y, 2011, MUTAGENESIS, V26, P309, DOI 10.1093/mutage/geq095; Campa D, 2011, JNCI-J NATL CANCER I, V103, P1252, DOI 10.1093/jnci/djr265; Chen F, 2011, HUM MOL GENET, V20, P4491, DOI 10.1093/hmg/ddr367; Chen W, 2012, BREAST CANCER RES TR, V136, P847, DOI 10.1007/s10549-012-2309-9; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Coughlin SS, 2009, CANCER EPIDEMIOL, V33, P315, DOI 10.1016/j.canep.2009.10.003; Dai JC, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3101; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fletcher O, 2011, JNCI-J NATL CANCER I, V103, P425, DOI 10.1093/jnci/djq563; Garcia-Closas M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000054; Harlid S, 2012, BRIT J CANCER, V106, P389, DOI 10.1038/bjc.2011.461; He CY, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3155; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Huo DZ, 2012, CARCINOGENESIS, V33, P835, DOI 10.1093/carcin/bgs093; Hutter CM, 2011, CANCER EPIDEM BIOMAR, V20, P1950, DOI 10.1158/1055-9965.EPI-11-0524; Jiang YD, 2011, BREAST CANCER RES TR, V128, P251, DOI 10.1007/s10549-010-1327-8; Kim HC, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3158; Li DW, 2006, HUM MOL GENET, V15, P1995, DOI 10.1093/hmg/ddl122; Li JM, 2011, BREAST CANCER RES TR, V126, P717, DOI 10.1007/s10549-010-1172-9; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lin CY, 2012, ANTICANCER RES, V32, P475; Liu L, 2011, BREAST CANCER RES TR, V125, P479, DOI 10.1007/s10549-010-0959-z; Milne RL, 2009, JNCI-J NATL CANCER I, V101, P1012, DOI 10.1093/jnci/djp167; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Reeves GK, 2010, JAMA-J AM MED ASSOC, V304, P426, DOI 10.1001/jama.2010.1042; Shan JX, 2012, BREAST CANCER RES TR, V135, P715, DOI 10.1007/s10549-012-2202-6; Shulman LN, 2010, J ONCOL, V2010, DOI 10.1155/2010/595167; Slattery ML, 2011, BREAST CANCER RES TR, V129, P531, DOI 10.1007/s10549-011-1498-y; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Stevens KN, 2011, CANCER RES, V71, P6240, DOI 10.1158/0008-5472.CAN-11-1266; Sueta A, 2012, BREAST CANCER RES TR, V132, P711, DOI 10.1007/s10549-011-1904-5; Teraoka SN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3057; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; Walsh T, 2006, JAMA-J AM MED ASSOC, V295, P1379, DOI 10.1001/jama.295.12.1379; Walsh T, 2010, P NATL ACAD SCI USA, V107, P12629, DOI 10.1073/pnas.1007983107; Wang H, 2013, BREAST CANCER RES TR, V137, P511, DOI 10.1007/s10549-012-2343-7; Zheng W, 2010, JNCI-J NATL CANCER I, V102, P972, DOI 10.1093/jnci/djq170; Zheng W, 2009, CANCER EPIDEM BIOMAR, V18, P2761, DOI 10.1158/1055-9965.EPI-09-0624; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	46	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e66979	10.1371/journal.pone.0066979	http://dx.doi.org/10.1371/journal.pone.0066979			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894282	Green Published, gold, Green Submitted			2022-12-27	WOS:000322132100006
J	Mitchell, G; Ballinger, ML; Wong, S; Hewitt, C; James, P; Young, MA; Cipponi, A; Pang, T; Goode, DL; Dobrovic, A; Thomas, DM				Mitchell, Gillian; Ballinger, Mandy L.; Wong, Stephen; Hewitt, Chelsee; James, Paul; Young, Mary-Anne; Cipponi, Arcadi; Pang, Tiffany; Goode, David L.; Dobrovic, Alex; Thomas, David M.		Int Sarcoma Kindred Study	High Frequency of Germline TP53 Mutations in a Prospective Adult-Onset Sarcoma Cohort	PLOS ONE			English	Article							LI-FRAUMENI-SYNDROME; TUMOR-SUPPRESSOR GENE; BREAST-CANCER; RELATIVE FREQUENCY; P53 GENE; FAMILIES; CHILDREN; CARRIERS; POPULATION; PREVALENCE	Sarcomas are a key feature of Li-Fraumeni and related syndromes (LFS/LFL), associated with germline TP53 mutations. Current penetrance estimates for TP53 mutations are subject to significant ascertainment bias. The International Sarcoma Kindred Study is a clinic-based, prospective cohort of adult-onset sarcoma cases, without regard to family history. The entire cohort was screened for mutations in TP53 using high-resolution melting analysis and Sanger sequencing, and multiplex-ligation-dependent probe amplification and targeted massively parallel sequencing for copy number changes. Pathogenic TP53 mutations were detected in blood DNA of 20/559 sarcoma probands (3.6%); 17 were germline and 3 appeared to be somatically acquired. Of the germline carriers, one appeared to be mosaic, detectable in the tumor and blood, but not epithelial tissues. Germline mutation carriers were more likely to have multiple cancers (47% vs 15% for non-carriers, P = 3.0 x 10(-3)), and earlier cancer onset (33 vs 48 years, P = 1.19 x 10(-3)). The median survival of mutation carriers following first cancer diagnosis was not significantly different from non-carriers. Only 10/17 (59%) pedigrees met classical or Chompret criteria for LFS. In summary, germline TP53 mutations are not rare in adult patients with sarcoma, with implications for screening, surveillance, treatment and genetic counselling of carriers and family members.	[Mitchell, Gillian; James, Paul; Young, Mary-Anne; Thomas, David M.] Peter MacCallum Canc Ctr, Dept Canc Med, Melbourne, Vic, Australia; [Ballinger, Mandy L.; Cipponi, Arcadi; Pang, Tiffany; Goode, David L.; Thomas, David M.] Peter MacCallum Canc Ctr, Div Res, Melbourne, Vic, Australia; [Wong, Stephen; Hewitt, Chelsee] Peter MacCallum Canc Ctr, Dept Pathol, Melbourne, Vic, Australia; [Mitchell, Gillian; Ballinger, Mandy L.; James, Paul; Young, Mary-Anne; Cipponi, Arcadi; Pang, Tiffany; Goode, David L.; Dobrovic, Alex; Thomas, David M.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia; [Dobrovic, Alex] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia	Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; University of Melbourne	Thomas, DM (corresponding author), Peter MacCallum Canc Ctr, Dept Canc Med, Melbourne, Vic, Australia.	david.thomas@petermac.org	James, Paul/G-2943-2014; Porceddu, Sandro V/M-2109-2014; Thomas, David/AAD-2877-2019	Thomas, David/0000-0002-2527-5428; Ballinger, Mandy/0000-0002-9706-0514; James, Paul/0000-0002-4361-4657; Dobrovic, Alexander/0000-0003-3414-112X; Goode, David/0000-0002-3277-6562; Wong, Stephen Q./0000-0002-7335-2168	Johanna Sewell Research Grant; Rainbows for Kate Foundation; Victorian Cancer Agency; National Health and Medical Research Council [1004017]	Johanna Sewell Research Grant; Rainbows for Kate Foundation; Victorian Cancer Agency; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a Johanna Sewell Research Grant, the Rainbows for Kate Foundation, the Victorian Cancer Agency, and the National Health and Medical Research Council (Project Grant 1004017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birch JM, 1998, ONCOGENE, V17, P1061, DOI 10.1038/sj.onc.1202033; BIRCH JM, 1994, CANCER RES, V54, P1298; Birch JM, 2001, ONCOGENE, V20, P4621, DOI 10.1038/sj.onc.1204621; Bougeard G, 2008, J MED GENET, V45, P535, DOI 10.1136/jmg.2008.057570; Chompret A, 2000, BRIT J CANCER, V82, P1932; Chompret A, 2001, J MED GENET, V38, P43, DOI 10.1136/jmg.38.1.43; Eeles RA, 1995, CANCER SURV, V25, P101; Evans DG, 2010, FAM CANCER, V9, P65, DOI 10.1007/s10689-009-9245-9; Gonzalez KD, 2009, J CLIN ONCOL, V27, P1250, DOI 10.1200/JCO.2008.16.6959; Kato S, 2003, P NATL ACAD SCI USA, V100, P8424, DOI 10.1073/pnas.1431692100; Krypuy M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-168; Lalloo F, 2006, EUR J CANCER, V42, P1143, DOI 10.1016/j.ejca.2005.11.032; Leach MO, 2005, LANCET, V365, P1769, DOI 10.1016/S0140-6736(05)66481-1; LI FP, 1988, CANCER RES, V48, P5358; Li J, 2012, BIOINFORMATICS, V28, P1307, DOI 10.1093/bioinformatics/bts146; MALKIN D, 1992, NEW ENGL J MED, V326, P1309, DOI 10.1056/NEJM199205143262002; MCINTYRE JF, 1994, J CLIN ONCOL, V12, P925, DOI 10.1200/JCO.1994.12.5.925; Mouchawar J, 2010, CANCER RES, V70, P4795, DOI 10.1158/0008-5472.CAN-09-0851; Nichols KE, 2001, CANCER EPIDEM BIOMAR, V10, P83; Offit K, 2006, J CLIN ONCOL, V24, P4775, DOI 10.1200/JCO.2006.06.6100; Ognjanovic S, 2012, CANCER-AM CANCER SOC, V118, P1387, DOI 10.1002/cncr.26390; Olivier M, 2003, CANCER RES, V63, P6643; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Prochazkova K, 2009, AM J MED GENET A, V149A, P206, DOI 10.1002/ajmg.a.32574; Ribeiro RC, 2001, P NATL ACAD SCI USA, V98, P9330, DOI 10.1073/pnas.161479898; Ruijs MWG, 2010, J MED GENET, V47, P421, DOI 10.1136/jmg.2009.073429; Tabori U, 2010, J CLIN ONCOL, V28, P1995, DOI 10.1200/JCO.2009.26.8169; Tinat J, 2009, J CLIN ONCOL, V27, pE108, DOI 10.1200/JCO.2009.22.7967; Tischkowitz M, 2004, EUR J CANCER, V40, P2459, DOI 10.1016/j.ejca.2004.06.005; TOGUCHIDA J, 1992, NEW ENGL J MED, V326, P1301, DOI 10.1056/NEJM199205143262001; Villani A, 2011, LANCET ONCOL, V12, P559, DOI 10.1016/S1470-2045(11)70119-X; Wu L, 2002, APPL IMMUNOHISTO M M, V10, P269, DOI 10.1097/00022744-200209000-00015	33	45	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69026	10.1371/journal.pone.0069026	http://dx.doi.org/10.1371/journal.pone.0069026			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894400	Green Published, Green Submitted, gold			2022-12-27	WOS:000322132100040
J	Westbrook, A; Kester, D; Braver, TS				Westbrook, Andrew; Kester, Daria; Braver, Todd S.			What Is the Subjective Cost of Cognitive Effort? Load, Trait, and Aging Effects Revealed by Economic Preference	PLOS ONE			English	Article							DELAYED REWARDS; PREFRONTAL CORTEX; DECISION-MAKING; MEMORY; INTELLIGENCE; METAANALYSIS; DOPAMINE; AGE	It has long been assumed that people treat cognitive effort as costly, but also that such effort costs may vary greatly across individuals. Individual differences in subjective effort could present a major and pervasive confound in behavioral and neuroscience assessments, by conflating cognitive ability with cognitive motivation. Self-report cognitive effort scales have been developed, but objective measures are lacking. In this study, we use the behavioral economic approach of revealed preferences to quantify subjective effort. Specifically, we adapted a well-established discounting paradigm to measure the extent to which cognitive effort causes participants to discount monetary rewards. The resulting metrics are sensitive to both within-individual factors, including objective load and reward amount, and between-individual factors, including age and trait cognitive engagement. We further validate cognitive effort discounting by benchmarking it against well-established measures of delay discounting. The results highlight the promise and utility of behavioral economic tools for assessing trait and state influences on cognitive motivation.	[Westbrook, Andrew; Kester, Daria; Braver, Todd S.] Washington Univ, Dept Psychol, St Louis, MO 63130 USA	Washington University (WUSTL)	Westbrook, A (corresponding author), Washington Univ, Dept Psychol, St Louis, MO 63130 USA.	jawestbrook@wustl.edu	Westbrook, Andrew/O-4418-2018	Westbrook, Andrew/0000-0002-7956-2609; Braver, Todd/0000-0002-2631-3393	National Institutes of Health (NIH) [R01 MH66078]; Cognitive, Computational, and Systems Neuroscience Pathway Fellowship (NSF-IGERT and the McDonnell Center for Systems Neuroscience); NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066078, F31MH100855] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cognitive, Computational, and Systems Neuroscience Pathway Fellowship (NSF-IGERT and the McDonnell Center for Systems Neuroscience); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by National Institutes of Health (NIH) R01 MH66078, and the Cognitive, Computational, and Systems Neuroscience Pathway Fellowship (NSF-IGERT and the McDonnell Center for Systems Neuroscience). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allport G. W., 1954, NATURE PREJUDICE; Altgassen M, 2009, COGNITION EMOTION, V23, P1041, DOI 10.1080/02699930802284158; Ariely D, 2003, Q J ECON, V118, P73, DOI 10.1162/00335530360535153; Backman L, 2006, NEUROSCI BIOBEHAV R, V30, P791, DOI 10.1016/j.neubiorev.2006.06.005; Baltes PB, 1999, ANNU REV PSYCHOL, V50, P471, DOI 10.1146/annurev.psych.50.1.471; Botvinick MM, 2009, COGN AFFECT BEHAV NE, V9, P16, DOI 10.3758/CABN.9.1.16; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; CACIOPPO JT, 1984, J PERS ASSESS, V48, P306, DOI 10.1207/s15327752jpa4803_13; Charles ST, 2010, PSYCHOL BULL, V136, P1068, DOI 10.1037/a0021232; Cocker PJ, 2012, NEUROPSYCHOPHARMACOL, V37, P1825, DOI 10.1038/npp.2012.30; Duncan J, 1996, COGNITIVE PSYCHOL, V30, P257, DOI 10.1006/cogp.1996.0008; Emery L, 2008, NEUROIMAGE, V42, P1577, DOI 10.1016/j.neuroimage.2008.06.021; Ewing K., 2010, HUMAN FACTORS SYSTEM; Gelman A., 2007, DATA ANAL USING REGR; GREEN L, 1994, PSYCHOL SCI, V5, P33, DOI 10.1111/j.1467-9280.1994.tb00610.x; Green L, 1996, PSYCHOL AGING, V11, P79, DOI 10.1037/0882-7974.11.1.79; Hammar A, 2011, NORD J PSYCHIAT, V65, P74, DOI 10.3109/08039488.2010.494311; HART S G, 1988, P139; HARTLAGE S, 1993, PSYCHOL BULL, V113, P247, DOI 10.1037/0033-2909.113.2.247; HERTEL PT, 1994, CURR DIR PSYCHOL SCI, V3, P190, DOI 10.1111/1467-8721.ep10770707; Hess T. M., 2011, J GERONTOL B-PSYCHOL, V67, P447, DOI [10.1093/geronb/gbr129, DOI 10.1093/GER0NB/GBR129]; Holt DD, 2012, BEHAV PROCESS, V90, P302, DOI 10.1016/j.beproc.2012.03.003; Hull C., 1943, PRINCIPLES BEHAV; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; KATZMAN R, 1983, AM J PSYCHIAT, V140, P734; KIRBY KN, 1995, PSYCHOL SCI, V6, P83, DOI 10.1111/j.1467-9280.1995.tb00311.x; Kool W, PLOS ONE; Kool W, 2010, J EXP PSYCHOL GEN, V139, P665, DOI 10.1037/a0020198; Kurzban R., 2013, BEHAV BRAIN SCI, V36; Mai B, 2012, COGN AFFECT BEHAV NE, V12, P74, DOI 10.3758/s13415-011-0068-4; McClure SM, 2007, J NEUROSCI, V27, P5796, DOI 10.1523/JNEUROSCI.4246-06.2007; McGuire JT, 2010, P NATL ACAD SCI USA, V107, P7922, DOI 10.1073/pnas.0910662107; MISCHEL W, 1989, SCIENCE, V244, P933, DOI 10.1126/science.2658056; Mohr PNC, 2010, NEUROSCI BIOBEHAV R, V34, P678, DOI 10.1016/j.neubiorev.2009.05.010; MYERSON J, 1995, J EXP ANAL BEHAV, V64, P263, DOI 10.1901/jeab.1995.64-263; Myerson J, 2001, J EXP ANAL BEHAV, V76, P235, DOI 10.1901/jeab.2001.76-235; Niv Y, 2007, PSYCHOPHARMACOLOGY, V191, P507, DOI 10.1007/s00213-006-0502-4; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Peters J, 2009, J NEUROSCI, V29, P15727, DOI 10.1523/JNEUROSCI.3489-09.2009; Pinheiro J., 2019, NLME LINEAR NONLINEA; Prevost C, 2010, J NEUROSCI, V30, P14080, DOI 10.1523/JNEUROSCI.2752-10.2010; Roberts BW, 2006, PSYCHOL BULL, V132, P1, DOI 10.1037/0033-2909.132.1.1; Salamone JD, 2007, PSYCHOPHARMACOLOGY, V191, P389, DOI 10.1007/s00213-006-0623-9; Schmidt L, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001266; Shamosh NA, 2008, INTELLIGENCE, V36, P289, DOI 10.1016/j.intell.2007.09.004; Taylor S.E., 1981, COGNITION SOCIAL BEH, P189; THALER R, 1981, ECON LETT, V8, P201, DOI 10.1016/0165-1765(81)90067-7; Walton ME, 2006, NEURAL NETWORKS, V19, P1302, DOI 10.1016/j.neunet.2006.03.005; West R., 2008, HDB AGING COGNITION, P311; Westbrook JA, 2013, BEHAV BRAIN SCI, V36, P704, DOI 10.1017/S0140525X13001179	51	222	224	5	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e68210	10.1371/journal.pone.0068210	http://dx.doi.org/10.1371/journal.pone.0068210			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	187PW	23894295	Green Published, gold, Green Submitted			2022-12-27	WOS:000322132100012
J	Zou, P; Xu, HT; Chen, P; Yan, Q; Zhao, L; Zhao, P; Gu, AH				Zou, Peng; Xu, Haitao; Chen, Pin; Yan, Qing; Zhao, Lin; Zhao, Peng; Gu, Aihua			IDH1/IDH2 Mutations Define the Prognosis and Molecular Profiles of Patients with Gliomas: A Meta-Analysis	PLOS ONE			English	Article							ISOCITRATE DEHYDROGENASE 1; CODON 132 MUTATION; PROMOTER HYPERMETHYLATION; COLORECTAL TUMORIGENESIS; IDH1 MUTATIONS; GLIOBLASTOMA; TUMORS; MGMT; INACTIVATION; TEMOZOLOMIDE	Background: Isocitrate dehydrogenase isoforms 1 and 2 (IDH1 and IDH2) mutations have received considerable attention since the discovery of their relation with human gliomas. The predictive value of IDH1 and IDH2 mutations in gliomas remains controversial. Here, we present the results of a meta-analysis of the associations between IDH mutations and both progression-free survival (PFS) and overall survival (OS) in gliomas. The interrelationship between the IDH mutations and MGMT promoter hypermethylation, EGFR amplification, codeletion of chromosomes 1p/19q and TP53 gene mutation were also revealed. Methodology and Principal Findings: An electronic literature search of public databases (PubMed, Embase databases) was performed. In total, 10 articles, including 12 studies in English, with 2,190 total cases were included in the meta-analysis. The IDH mutations were frequent in WHO grade II and III glioma (59.5%) and secondary glioblastomas (63.4%) and were less frequent in primary glioblastomas (7.13%). Our study provides evidence that IDH mutations are tightly associated with MGMT promoter hypermethylation (P<0.001), 1p/19q codeletion (P<0.001) and TP53 gene mutation (P<0.001) but are mutually exclusive with EGFR amplification (P<0.001). This meta-analysis showed that the combined hazard ratio (HR) estimate for overall survival and progression-free survival in patients with IDH mutations was 0.33 (95% CI: 0.25-0.42) and 0.38 (95% CI: 0.21-0.68), compared with glioma patients whose tumours harboured the wild-type IDH. Subgroup analyses based on tumour grade also revealed that the presence of IDH mutations was associated with a better outcome. Conclusion: Our study suggests that IDH mutations, which are closely linked to the genomic profile of gliomas, are potential prognostic biomarkers for gliomas.	[Zou, Peng; Xu, Haitao; Chen, Pin; Yan, Qing; Zhao, Lin; Zhao, Peng] Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China; [Gu, Aihua] Nanjing Med Univ, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Zhao, P (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China.	zhaopeng@njmu.edu.cn; aihuagu@njmu.edu.cn	Zhao, Peng/HDO-7507-2022		National Natural Science Foundation of China [81172694]; 135 Key Medical Project of Jiangsu Province [XK201117]; practice innovation training program projects for the Jiangsu College students; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 135 Key Medical Project of Jiangsu Province; practice innovation training program projects for the Jiangsu College students; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the National Natural Science Foundation of China (grant No. 81172694); the Grant for the 135 Key Medical Project of Jiangsu Province (No. XK201117); the practice innovation training program projects for the Jiangsu College students; and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis.	[Anonymous], 2008, NATURE, V455, P1061; Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bleeker FE, 2010, ACTA NEUROPATHOL, V119, P487, DOI 10.1007/s00401-010-0645-6; BOLDUC JM, 1995, SCIENCE, V268, P1312, DOI 10.1126/science.7761851; Bralten LBC, 2011, ANN NEUROL, V69, P455, DOI 10.1002/ana.22390; Cai XM, 2005, INT J CANCER, V117, P905, DOI 10.1002/ijc.21251; Christensen BC, 2011, JNCI-J NATL CANCER I, V103, DOI 10.1093/jnci/djq497; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Esteller M, 2001, CANCER RES, V61, P4689; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Esteller M, 2000, CANCER RES, V60, P2368; Gerson SL, 2004, NAT REV CANCER, V4, P296, DOI 10.1038/nrc1319; Gravendeel LAM, 2009, CANCER RES, V69, P9065, DOI 10.1158/0008-5472.CAN-09-2307; Hartmann C, 2009, ACTA NEUROPATHOL, V118, P469, DOI 10.1007/s00401-009-0561-9; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Ichimura K, 2009, NEURO-ONCOLOGY, V11, P341, DOI 10.1215/15228517-2009-025; Kim SY, 2007, MOL CELL BIOCHEM, V302, P27, DOI 10.1007/s11010-007-9421-x; KRAUS JA, 1995, J NEUROPATH EXP NEUR, V54, P91, DOI 10.1097/00005072-199501000-00011; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li SW, 2012, NEURO-ONCOLOGY, V14, P109, DOI 10.1093/neuonc/nor185; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Mukasa A, 2012, CANCER SCI, V103, P587, DOI 10.1111/j.1349-7006.2011.02175.x; Nobusawa S, 2009, CLIN CANCER RES, V15, P6002, DOI 10.1158/1078-0432.CCR-09-0715; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Ozben T, 2007, J PHARM SCI-US, V96, P2181, DOI 10.1002/jps.20874; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Reitman ZJ, 2010, JNCI-J NATL CANCER I, V102, P932, DOI 10.1093/jnci/djq187; Sanson M, 2009, J CLIN ONCOL, V27, P4150, DOI 10.1200/JCO.2009.21.9832; Shibahara I, 2011, INT J CLIN ONCOL; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Watanabe T, 2009, AM J PATHOL, V174, P1149, DOI 10.2353/ajpath.2009.080958; Weller M, 2009, J CLIN ONCOL, V27, P5743, DOI 10.1200/JCO.2009.23.0805; Wick W, 2009, J CLIN ONCOL, V27, P5874, DOI 10.1200/JCO.2009.23.6497; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yan W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030339; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	42	74	79	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e68782	10.1371/journal.pone.0068782	http://dx.doi.org/10.1371/journal.pone.0068782			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894344	Green Submitted, gold, Green Published			2022-12-27	WOS:000322132100026
J	Jarvis, JN; Harrison, TS; Lawn, SD; Meintjes, G; Wood, R; Cleary, S				Jarvis, Joseph N.; Harrison, Thomas S.; Lawn, Stephen D.; Meintjes, Graeme; Wood, Robin; Cleary, Susan			Cost Effectiveness of Cryptococcal Antigen Screening as a Strategy to Prevent HIV-Associated Cryptococcal Meningitis in South Africa	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; SYSTEMIC FUNGAL-INFECTIONS; PRIMARY PROPHYLAXIS; ANTIRETROVIRAL THERAPY; DOUBLE-BLIND; ITRACONAZOLE PROPHYLAXIS; OPPORTUNISTIC INFECTIONS; FLUCONAZOLE PROPHYLAXIS; ACTIVE SURVEILLANCE; CONTROLLED TRIAL	Objectives: Cryptococcal meningitis (CM)-related mortality may be prevented by screening patients for sub-clinical cryptococcal antigenaemia (CRAG) at antiretroviral-therapy (ART) initiation and pre-emptively treating those testing positive. Prior to programmatic implementation in South Africa we performed a cost-effectiveness analysis of alternative preventive strategies for CM. Design: Cost-effectiveness analysis. Methods: Using South African data we modelled the cost-effectiveness of four strategies for patients with CD4 cell-counts <100 cells/mu l starting ART 1) no screening or prophylaxis (standard of care), 2) universal primary fluconazole prophylaxis, 3) CRAG screening with fluconazole treatment if antigen-positive, 4) CRAG screening with lumbar puncture if antigen-positive and either amphotericin-B for those with CNS disease or fluconazole for those without. Analysis was limited to the first year of ART. Results: The least costly strategy was CRAG screening followed by high-dose fluconazole treatment of all CRAG-positive individuals. This strategy dominated the standard of care at CRAG prevalence >= 0.6%. Although CRAG screening followed by lumbar puncture in all antigen-positive individuals was the most effective strategy clinically, the incremental benefit of LPs and amphotericin therapy for those with CNS disease was small and additional costs were large (US$158 versus US$51per person year; incremental cost effectiveness ratio(ICER) US$889,267 per life year gained). Both CRAG screening strategies are less costly and more clinically effective than current practice. Primary prophylaxis is more effective than current practice, but relatively cost-ineffective (ICER US$20,495). Conclusions: CRAG screening would be a cost-effective strategy to prevent CM-related mortality among patients initiating ART in South Africa. These findings provide further justification for programmatic implementation of CRAG screening.	[Jarvis, Joseph N.; Lawn, Stephen D.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, London WC1, England; [Jarvis, Joseph N.; Lawn, Stephen D.; Wood, Robin] Univ Cape Town, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa; [Jarvis, Joseph N.; Harrison, Thomas S.] St Georges Univ London, Res Ctr Infect & Immun, Div Clin Sci, London, England; [Meintjes, Graeme; Wood, Robin] Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa; [Meintjes, Graeme] Univ Cape Town, Inst Infect Dis & Mol Med, Clin Infect Dis Res Initiat, ZA-7925 Cape Town, South Africa; [Meintjes, Graeme] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Cleary, Susan] Univ Cape Town, Hlth Econ Unit, ZA-7925 Cape Town, South Africa	University of London; London School of Hygiene & Tropical Medicine; University of Cape Town; St Georges University London; University of Cape Town; University of Cape Town; Imperial College London; University of Cape Town	Jarvis, JN (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, London WC1, England.	joejarvis@doctors.net.uk	Cleary, Susan/AHE-7259-2022; hlupeni, admire/M-1539-2018	Cleary, Susan/0000-0002-9071-7958; Meintjes, Graeme/0000-0003-1196-4414; Harrison, Thomas/0000-0003-3619-4348; Jarvis, Joseph/0000-0003-1459-5554	Wellcome Trust, UK; National Institute for Health Research [CL-2012-20-001] Funding Source: researchfish	Wellcome Trust, UK(Wellcome Trust); National Institute for Health Research(National Institute for Health Research (NIHR))	JNJ, GM and SL are supported by the Wellcome Trust, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apisarnthanarak A, 2008, JAIDS-J ACQ IMM DEF, V47, P644, DOI 10.1097/QAI.0b013e31815bad0c; Bekondi C, 2006, INT J INFECT DIS, V10, P387, DOI 10.1016/j.ijid.2005.07.004; Berg J, 1998, CLIN INFECT DIS, V26, P186, DOI 10.1086/517056; Bicanic T, 2008, CLIN INFECT DIS, V47, P123, DOI 10.1086/588792; Bicanic T, 2007, CLIN INFECT DIS, V45, P76, DOI 10.1086/518607; BRIGGS A, 1994, HEALTH ECON, V3, P95, DOI 10.1002/hec.4730030206; Briggs A, 1998, PHARMACOECONOMICS, V13, P397, DOI 10.2165/00019053-199813040-00003; Chang LW, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004773.pub2; Chariyalertsak S, 2002, CLIN INFECT DIS, V34, P277, DOI 10.1086/338154; Chetchotisakd P, 2004, HIV MED, V5, P140, DOI 10.1111/j.1468-1293.2004.00201.x; Cleary Susan M, 2006, Cost Eff Resour Alloc, V4, P20, DOI 10.1186/1478-7547-4-20; DESMET P, 1989, AIDS, V3, P77, DOI 10.1097/00002030-198902000-00004; Dromer F, 1996, CLIN INFECT DIS, V23, P82, DOI 10.1093/clinids/23.1.82; Feldmesser M, 1996, CLIN INFECT DIS, V23, P827, DOI 10.1093/clinids/23.4.827; Freedberg KA, 1998, JAMA-J AM MED ASSOC, V279, P130, DOI 10.1001/jama.279.2.130; French N, 2002, AIDS, V16, P1031, DOI 10.1097/00002030-200205030-00009; Goldman M, 2000, ANTIMICROB AGENTS CH, V44, P1585, DOI 10.1128/AAC.44.6.1585-1587.2000; Hajjeh RA, 1999, J INFECT DIS, V179, P449, DOI 10.1086/314606; Harling G, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-80; Holmes CB, 2006, JAIDS-J ACQ IMM DEF, V42, P464, DOI 10.1097/01.qai.0000225729.79610.b7; Jarvis JN, 2012, AIDS, V26, P1105, DOI 10.1097/QAD.0b013e3283536a93; Jarvis JN, 2011, CLIN INFECT DIS, V53, P1019, DOI 10.1093/cid/cir613; Jarvis JN, 2010, CLIN INFECT DIS, V51, P1463, DOI 10.1086/657405; Jarvis JN, 2010, J INFECTION, V60, P496, DOI 10.1016/j.jinf.2010.03.007; Jarvis JN, 2010, AIDS, V24, P1233, DOI 10.1097/QAD.0b013e3283383aeb; Jarvis JN, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-67; Jarvis JN, 2009, CLIN INFECT DIS, V48, P856, DOI 10.1086/597262; John L, 2004, HIV MED, V5, P131, DOI 10.1111/j.1468-1293.2004.00199.x; Kambugu A, 2008, CLIN INFECT DIS, V46, P1694, DOI 10.1086/587667; Kevany S, 2009, SAMJ S AFR MED J, V99, P320; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lessells RJ, 2011, SAMJ S AFR MED J, V101, P251, DOI 10.7196/SAMJ.4378; Liechty CA, 2007, TROP MED INT HEALTH, V12, P929, DOI 10.1111/j.1365-3156.2007.01874.x; Lightowler JVJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008630; Manosuthi Weerawat, 2006, Journal of the Medical Association of Thailand, V89, P795; McKinsey DS, 1999, CLIN INFECT DIS, V28, P1049, DOI 10.1086/514744; Meya DB, 2010, CLIN INFECT DIS, V51, P448, DOI 10.1086/655143; Meyer ACL, 2013, TROP MED INT HEALTH, V18, P495, DOI 10.1111/tmi.12067; Micol R, 2007, JAIDS-J ACQ IMM DEF, V45, P555, DOI 10.1097/QAI.0b013e31811ed32c; Micol R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013856; Mirza SA, 2003, CLIN INFECT DIS, V36, P789, DOI 10.1086/368091; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Parkes-Ratanshi R, 2011, LANCET INFECT DIS, V11, P933, DOI 10.1016/S1473-3099(11)70245-6; Pongsai P, 2010, J INFECTION, V60, P474, DOI 10.1016/j.jinf.2010.03.015; POWDERLY WG, 1995, NEW ENGL J MED, V332, P700, DOI 10.1056/NEJM199503163321102; Scarborough M, 2007, NEW ENGL J MED, V357, P2441, DOI 10.1056/NEJMoa065711; Scharfstein JA, 1997, MED DECIS MAKING, V17, P373, DOI 10.1177/0272989X9701700402; Smith D E, 2001, HIV Med, V2, P78, DOI 10.1046/j.1468-1293.2001.00060.x; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; Tassie JM, 2003, JAIDS-J ACQ IMM DEF, V33, P411, DOI 10.1097/00126334-200307010-00019; Yazdanpanah Y, 2003, CLIN INFECT DIS, V36, P86, DOI 10.1086/344902; Yuen C, 1994, CLIN INFECT DIS, V19, P579	53	92	96	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e69288	10.1371/journal.pone.0069288	http://dx.doi.org/10.1371/journal.pone.0069288			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894442	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000322391400045
J	Huang, YY; Yang, Q; Zhou, SW; Wei, Y; Chen, YX; Xie, DR; Zhang, B				Huang, Yuan-Yuan; Yang, Qiong; Zhou, Si-Wei; Wei, Ying; Chen, Yan-Xian; Xie, De-Rong; Zhang, Bei			Postoperative Chemoradiotherapy versus Postoperative Chemotherapy for Completely Resected Gastric Cancer with D2 Lymphadenectomy: A Meta-Analysis	PLOS ONE			English	Article							PHASE-III TRIAL; RANDOMIZED CLINICAL-TRIALS; LYMPH-NODE DISSECTION; ADJUVANT CHEMOTHERAPY; CHEMORADIATION; BENEFIT; ADENOCARCINOMA; CAPECITABINE; RADIOTHERAPY; GASTRECTOMY	Background: Both chemoradiotherapy and chemotherapy are used in postoperative adjuvant therapy for resected gastric cancer. However, it is controversial whether chemoradiotherapy or chemotherapy is the optimal strategy for patients with gastric cancer after D2 lymphadenectomy. The present meta-analysis aims to provide more evidence on the relative benefits of adjuvant therapies in this setting. Methods: We conducted a systematic review of randomized controlled trials, extracted time-to-event data using Tierney methods (when not reported), and performed meta-analysis to obtain the relative hazards of adjuvant chemoradiotherapy to chemotherapy on efficacy and toxicities. Results: A total of 895 patients from 3 randomized controlled trials were identified for this meta-analysis. All patients were from Asian countries. Our results showed that postoperative chemoradiotherapy significantly improved locoregional recurrence-free survival [LRRFS: hazard ratio (HR) = 0.53, 95% CI = 0.32-0.87, p = 0.01] and disease-free survival (DFS: HR = 0.72, 95% CI = 0.59-0.89, p = 0.002); however, the improvement of distant metastasis recurrence-free survival (DMRFS: HR = 0.86; 95% CI = 0.66-1.11, p = 0.25) and overall survival (OS: HR = 0.79, 95% CI = 0.61-1.03, p = 0.08) were non-significant. The main grade 3 or 4 toxicities were equivalent between the two groups. Conclusion: In non-selected Asian patients with resected gastric cancer who underwent D2 lymphadenectomy, postoperative chemoradiotherapy improved LRRFS and DFS but might not improve OS compared to postoperative chemotherapy.	[Huang, Yuan-Yuan; Zhang, Bei] Sun Yat Sen Univ, Sun Yat Sen Univ Canc Ctr, Dept VIP, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Qiong; Zhou, Si-Wei; Wei, Ying; Chen, Yan-Xian; Xie, De-Rong] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Oncol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zhang, B (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Univ Canc Ctr, Dept VIP, Guangzhou 510275, Guangdong, Peoples R China.	sumsdoctor@hotmail.com						Bang YJ, 2012, LANCET, V379, P315, DOI 10.1016/S0140-6736(11)61873-4; Bria E, 2007, J CLIN ONCOL, V25; Brooks GA, 2012, J CLIN ONCOL, V30, P2297, DOI 10.1200/JCO.2012.42.4069; Cirera L, 1999, J CLIN ONCOL, V17, P3810, DOI 10.1200/JCO.1999.17.12.3810; Costa WL, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-169; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Hartgrink HH, 2004, J CLIN ONCOL, V22, P2069, DOI 10.1200/JCO.2004.08.026; Hsu C, 2012, GASTRIC CANCER, V15, P265, DOI [10.1007/s10120-012-0151-8, 10.1007/s10120-011-0106-5]; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kim S, 2005, INT J RADIAT ONCOL, V63, P1279, DOI 10.1016/j.ijrobp.2005.05.005; Kim TH, 2012, INT J RADIAT ONCOL, V84, pE585, DOI 10.1016/j.ijrobp.2012.07.2378; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Lee J, 2012, J CLIN ONCOL, V30, P268, DOI 10.1200/JCO.2011.39.1953; Macdonald JS, 2005, J SURG ONCOL, V90, P166, DOI 10.1002/jso.20223; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Paoletti X, 2010, JAMA-J AM MED ASSOC, V303, P1729, DOI 10.1001/jama.2010.534; Qi WX, 2013, INT J CANCER, V132, pE66, DOI 10.1002/ijc.27775; Sasako M, 2011, J CLIN ONCOL, V29, P4387, DOI 10.1200/JCO.2011.36.5908; Smalley SR, 2012, J CLIN ONCOL, V30, P2327, DOI 10.1200/JCO.2011.36.7136; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Tsujinaka T, 2008, INT J CLIN ONCOL, V13, P117, DOI 10.1007/s10147-007-0743-1; Wu CW, 2006, LANCET ONCOL, V7, P309, DOI 10.1016/S1470-2045(06)70623-4; Zhu WG, 2012, RADIOTHER ONCOL, V104, P361, DOI 10.1016/j.radonc.2012.08.024	25	24	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e68939	10.1371/journal.pone.0068939	http://dx.doi.org/10.1371/journal.pone.0068939			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874819	Green Published, Green Submitted, gold			2022-12-27	WOS:000324146200041
J	Li, XH; Liu, Z; Yan, XL; Zhang, XJ; Li, Y; Zhao, B; Wang, SD; Zhou, XY; Gao, GF; Meng, SD				Li, Xinghui; Liu, Zhen; Yan, Xiaoli; Zhang, Xiaojun; Li, Yang; Zhao, Bao; Wang, Shengdian; Zhou, Xuyu; Gao, George F.; Meng, Songdong			Induction of Regulatory T Cells by High-Dose gp96 Suppresses Murine Liver Immune Hyperactivation	PLOS ONE			English	Article							CHRONIC HEPATITIS-B; SHOCK-PROTEIN GP96; TOLL-LIKE RECEPTORS; FOXP3 TRANSCRIPTION FACTOR; NF-KAPPA-B; VIRUS INFECTION; CONCANAVALIN-A; MEDIATED HEPATITIS; TREG CELLS; MICE	Immunization with high-dose heat shock protein gp96, an endoplasmic reticulum counterpart of the Hsp90 family, significantly enhances regulatory T cell (Treg) frequency and suppressive function. Here, we examined the potential role and mechanism of gp96 in regulating immune-mediated hepatic injury in mice. High-dose gp96 immunization elicited rapid and long-lasting protection of mice against concanavalin A (Con A)-and anti-CD137-induced liver injury, as evidenced by decreased alanine aminotransaminase (ALT) levels, hepatic necrosis, serum pro-inflammatory cytokines (IFN-gamma, TNF-alpha, and IL-6), and number of IFN-gamma(+) CD4(+) and IFN-gamma(+) CD8(+) T cells in the spleen and liver. In contrast, CD4(+)CD25(+)Foxp3(+) Treg frequency and suppressive function were both increased, and the protective effect of gp96 could be generated by adoptive transfer of Treg cells from gp96-immunized mice. In vitro co-culture experiments demonstrated that gp96 stimulation enhanced Treg proliferation and suppressive function, and up-regulation of Foxp3, IL-10, and TGF-beta 1 induced by gp96 was dependent on TLR2- and TLR4-mediated NF-kappa B activation. Our work shows that activation of Tregs by high-dose gp96 immunization protects against Con A- and anti-CD137-induced T cell-hepatitis and provides therapeutic potential for the development of a gp96-based anti-immune hyperactivation vaccine against immune-mediated liver destruction.	[Li, Xinghui; Liu, Zhen; Yan, Xiaoli; Zhang, Xiaojun; Li, Yang; Zhao, Bao; Zhou, Xuyu; Gao, George F.; Meng, Songdong] Chinese Acad Sci, Key Lab Pathogen Microbiol & Immunol, Inst Microbiol, Beijing, Peoples R China; [Li, Xinghui; Meng, Songdong] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Shengdian] Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun, Beijing 100080, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS	Meng, SD (corresponding author), Chinese Acad Sci, Key Lab Pathogen Microbiol & Immunol, Inst Microbiol, Beijing, Peoples R China.	mengsd@im.ac.cn	Gao, George Fu/ABD-5229-2021; zhang, jin/GXV-9154-2022; Zhou, Xuyu/L-7422-2019	Zhou, Xuyu/0000-0002-6626-0898	National Natural Science Foundation of China [31230026, 91029724, 30970146, 81021003, 81102018]; Key Projects in the National Science & Technology Program [2013ZX10002001-003-003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects in the National Science & Technology Program	This work was supported by grants from the National Natural Science Foundation of China (Grant Nos. 31230026, 91029724, 30970146, 81021003, and 81102018), and a grant from Key Projects in the National Science & Technology Program (2013ZX10002001-003-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alatrakchi N, 2009, J VIRAL HEPATITIS, V16, P223, DOI 10.1111/j.1365-2893.2009.01081.x; Baban B, 2009, J IMMUNOL, V183, P2475, DOI 10.4049/jimmunol.0900986; Bettini ML, 2012, IMMUNITY, V36, P717, DOI 10.1016/j.immuni.2012.03.020; Bolhassani A, 2008, EXPERT REV VACCINES, V7, P1185, DOI 10.1586/14760584.7.8.1185; Caramalho I, 2003, J EXP MED, V197, P403, DOI 10.1084/jem.20021633; Chandawarkar RY, 2004, INT IMMUNOL, V16, P615, DOI 10.1093/intimm/dxh063; Chen Q, 2009, J IMMUNOL, V183, P4458, DOI 10.4049/jimmunol.0901465; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Conroy H, 2008, ONCOGENE, V27, P168, DOI 10.1038/sj.onc.1210910; Dai J, 2007, J IMMUNOL, V178, P3219, DOI 10.4049/jimmunol.178.5.3219; Dunn C, 2007, J EXP MED, V204, P667, DOI 10.1084/jem.20061287; Erhardt A, 2007, HEPATOLOGY, V45, P475, DOI 10.1002/hep.21498; Erridge C, 2008, J BIOL CHEM, V283, P24748, DOI 10.1074/jbc.M800352200; Feng IC, 2007, J BIOMED SCI, V14, P43, DOI 10.1007/s11373-006-9129-z; Goswami B, 2009, CLIN CHIM ACTA, V408, P14, DOI 10.1016/j.cca.2009.06.029; Kanters E, 2003, J CLIN INVEST, V112, P1176, DOI 10.1172/JCI18580; Koay LB, 2011, HUM IMMUNOL, V72, P687, DOI 10.1016/j.humimm.2010.11.001; Lee KY, 2006, J IMMUNOL, V176, P603, DOI 10.4049/jimmunol.176.1.603; Li J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039307; Liang XS, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-43; Liu Z, 2009, EUR J IMMUNOL, V39, P3110, DOI 10.1002/eji.200939593; Long MX, 2009, IMMUNITY, V31, P921, DOI 10.1016/j.immuni.2009.09.022; Maini MK, 2000, J EXP MED, V191, P1269, DOI 10.1084/jem.191.8.1269; Manigold T, 2007, LANCET INFECT DIS, V7, P804, DOI 10.1016/S1473-3099(07)70289-X; Meng SD, 2001, LANCET, V357, P528, DOI 10.1016/S0140-6736(00)04050-2; Netea MG, 2004, J IMMUNOL, V172, P3712, DOI 10.4049/jimmunol.172.6.3712; Olivier A, 2011, EUR J IMMUNOL, V41, P2303, DOI 10.1002/eji.201041387; Passoja A, 2010, J CLIN PERIODONTOL, V37, P881, DOI 10.1111/j.1600-051X.2010.01602.x; Randazzo M, 2012, INT J CANCER, V130, P2219, DOI 10.1002/ijc.27332; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Schmidt A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00051; Sekar D, 2012, EUR J IMMUNOL, V42, P1585, DOI 10.1002/eji.201142093; Srivastava P, 2002, NAT REV IMMUNOL, V2, P185, DOI 10.1038/nri749; Stoop JN, 2005, HEPATOLOGY, V41, P771, DOI 10.1002/hep.20649; Stross L, 2012, HEPATOLOGY, V56, P873, DOI 10.1002/hep.25765; Sun R, 2004, J IMMUNOL, V172, P5648, DOI 10.4049/jimmunol.172.9.5648; Sutmuller RPM, 2006, TRENDS IMMUNOL, V27, P387, DOI 10.1016/j.it.2006.06.005; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; TIEGS G, 1992, J CLIN INVEST, V90, P196, DOI 10.1172/JCI115836; Volarevic V, 2012, J HEPATOL, V56, P26, DOI 10.1016/j.jhep.2011.03.022; Wang D, 2012, P NATL ACAD SCI USA, V109, P9493, DOI 10.1073/pnas.1207293109; Wang J, 2006, J HEPATOL, V44, P446, DOI 10.1016/j.jhep.2005.08.015; Wang J, 2010, J IMMUNOL, V185, P7654, DOI 10.4049/jimmunol.1000927; Wang LW, 2010, HEPATOB PANCREAT DIS, V9, P499; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Zhang JY, 2010, HEPATOLOGY, V51, P81, DOI 10.1002/hep.23273; Zou T, 2012, J IMMUNOL, V189, P28, DOI 10.4049/jimmunol.1200507; Zuo DM, 2013, HEPATOLOGY, V57, P228, DOI 10.1002/hep.25983	48	11	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e68997	10.1371/journal.pone.0068997	http://dx.doi.org/10.1371/journal.pone.0068997			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874845	gold, Green Submitted, Green Published			2022-12-27	WOS:000324146200049
J	Keeley, RJ; Tyndall, AV; Scott, GA; Saucier, DM				Keeley, Robin J.; Tyndall, Amanda V.; Scott, Gavin A.; Saucier, Deborah M.			Sex Difference in Cue Strategy in a Modified Version of the Morris Water Task: Correlations between Brain and Behaviour	PLOS ONE			English	Article							SPATIAL WORKING-MEMORY; LONG-EVANS RATS; FEMALE RATS; MENSTRUAL-CYCLE; NAVIGATION TASK; ESTROUS-CYCLE; GENDER-DIFFERENCES; ENTORHINAL CORTEX; LEARNING-STRATEGY; GONADAL-HORMONES	Background: Sex differences in spatial memory function have been reported with mixed results in the literature, with some studies showing male advantages and others showing no differences. When considering estrus cycle in females, results are mixed at to whether high or low circulating estradiol results in an advantage in spatial navigation tasks. Research involving humans and rodents has demonstrated males preferentially employ Euclidean strategies and utilize geometric cues in order to spatially navigate, whereas females employ landmark strategies and cues in order to spatially navigate. Methodology/Principal Findings: This study used the water-based snowcone maze in order to assess male and female preference for landmark or geometric cues, with specific emphasis placed on the effects of estrus cycle phase for female rat. Performance and preference for the geometric cue was examined in relation to total hippocampal and hippocampal subregions (CA1&2, CA3 and dentate gyrus) volumes and entorhinal cortex thickness in order to determine the relation between strategy and spatial performance and brain area size. The study revealed that males outperformed females overall during training trials, relied on the geometric cue when the platform was moved and showed significant correlations between entorhinal cortex thickness and spatial memory performance. No gross differences in behavioural performance was observed within females when accounting for cyclicity, and only total hippocampal volume was correlated with performance during the learning trials. Conclusions/Significance: This study demonstrates the sex-specific use of cues and brain areas in a spatial learning task.	[Keeley, Robin J.] Univ Lethbridge, Dept Neurosci, Lethbridge, AB T1K 3M4, Canada; [Tyndall, Amanda V.] Univ Calgary, Calgary, AB, Canada; [Scott, Gavin A.; Saucier, Deborah M.] Univ Western Ontario, Inst Technol, Fac Sci, Oshawa, ON, Canada	University of Lethbridge; University of Calgary; Western University (University of Western Ontario)	Saucier, DM (corresponding author), Univ Western Ontario, Inst Technol, Fac Sci, Oshawa, ON, Canada.	Deborah.Saucier@uoit.ca			National Sciences and Engineering Research Council of Canada Discovery Grant; Canadian Foundation for Innovation grant; Canada Research Chair; National Sciences and Engineering Research Council of Canada Research Tools and Instruments grant	National Sciences and Engineering Research Council of Canada Discovery Grant; Canadian Foundation for Innovation grant; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); National Sciences and Engineering Research Council of Canada Research Tools and Instruments grant	This research was supported by a National Sciences and Engineering Research Council of Canada Discovery Grant to DMS, Canadian Foundation for Innovation grant and Canada Research Chair to DMS and an National Sciences and Engineering Research Council of Canada Research Tools and Instruments grant to DMS, A. Iwaniuk and R.J. McDonald. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blokland A, 2006, BEHAV BRAIN RES, V171, P216, DOI 10.1016/j.bbr.2006.03.033; Cain DP, 1997, BEHAV BRAIN RES, V84, P179, DOI 10.1016/S0166-4328(96)00149-0; Chamizo VD, 2011, BEHAV PROCESS, V88, P20, DOI 10.1016/j.beproc.2011.06.007; Chow C, 2012, PSYCHONEUROENDOCRINO; Coutureau E, 2009, PROG NEURO-PSYCHOPH, V33, P753, DOI 10.1016/j.pnpbp.2009.03.038; Dabbs JM, 1998, EVOL HUM BEHAV, V19, P89, DOI 10.1016/S1090-5138(97)00107-4; Faraji J, 2010, BRAIN RES BULL, V81, P164, DOI 10.1016/j.brainresbull.2009.10.017; Frye CA, 2007, NEUROBIOL LEARN MEM, V88, P208, DOI 10.1016/j.nlm.2007.04.003; Galea LAM, 1999, BRAIN RES, V821, P383, DOI 10.1016/S0006-8993(99)01100-2; GAULIN SJC, 1989, ANIM BEHAV, V37, P322, DOI 10.1016/0003-3472(89)90121-8; HAMPSON E, 1990, BRAIN COGNITION, V14, P26, DOI 10.1016/0278-2626(90)90058-V; Hausmann M, 2000, BEHAV NEUROSCI, V114, P1245, DOI 10.1037/0735-7044.114.6.1245; Hawley WR, 2012, PHYSIOL BEHAV, V105, P1014, DOI 10.1016/j.physbeh.2011.11.021; Jonasson Z, 2005, NEUROSCI BIOBEHAV R, V28, P811, DOI 10.1016/j.neubiorev.2004.10.006; Korol DL, 2004, NEUROBIOL LEARN MEM, V82, P309, DOI 10.1016/j.nlm.2004.07.006; Korol DL, 2004, HORM BEHAV, V45, P330, DOI 10.1016/j.yhbeh.2004.01.005; LAWTON CA, 1994, SEX ROLES, V30, P765, DOI 10.1007/BF01544230; Martin SJ, 2007, CELL MOL LIFE SCI, V64, P401, DOI 10.1007/s00018-007-6336-3; MAYHEW TM, 1992, J NEUROCYTOL, V21, P313, DOI 10.1007/BF01191700; McFadden LM, 2011, PHYSIOL BEHAV, V102, P266, DOI 10.1016/j.physbeh.2010.10.022; Mendez-Lopez M, 2009, PHYSIOL BEHAV, V98, P307, DOI 10.1016/j.physbeh.2009.06.006; Mendez-Lopez M, 2009, NEUROSCI RES, V65, P28, DOI 10.1016/j.neures.2009.05.001; Mendez-Lopez M, 2009, BRAIN RES BULL, V79, P187, DOI 10.1016/j.brainresbull.2009.02.007; Mouton P.R., 2001, PRINCIPLES PRACTICES; Parducz A, 2006, NEUROSCIENCE, V138, P977, DOI 10.1016/j.neuroscience.2005.07.008; Piccardi L, 2011, NEUROSCI LETT, V503, P181, DOI 10.1016/j.neulet.2011.08.031; Protopopescu X, 2008, HIPPOCAMPUS, V18, P985, DOI 10.1002/hipo.20468; Rodriguez CA, 2011, PSICOLOGICA, V32, P279; Rodriguez CA, 2011, LEARN BEHAV, V39, P324, DOI 10.3758/s13420-011-0027-5; Rodriguez CA, 2010, J EXP PSYCHOL-ANIM B, V36, P395, DOI 10.1037/a0017297; ROOF RL, 1993, BEHAV BRAIN RES, V57, P47, DOI 10.1016/0166-4328(93)90060-4; Rosenberg L, 2002, PSYCHONEUROENDOCRINO, V27, P835, DOI 10.1016/S0306-4530(01)00083-X; Sandstrom NJ, 1998, COGNITIVE BRAIN RES, V6, P351, DOI 10.1016/S0926-6410(98)00002-0; Saucier DM, 2008, ANIM COGN, V11, P129, DOI 10.1007/s10071-007-0096-1; Saucier DM, 2002, BEHAV NEUROSCI, V116, P403, DOI 10.1037//0735-7044.116.3.403; Sneider JT, 2011, PERCEPT MOTOR SKILL, V113, P461, DOI 10.2466/04.22.24.27.PMS.113.5.461-480; Snihur AWK, 2008, BEHAV BRAIN RES, V187, P56, DOI 10.1016/j.bbr.2007.08.023; Spritzer MD, 2013, HORM BEHAV; Stackman RW, 1997, NEUROBIOL LEARN MEM, V67, P167, DOI 10.1006/nlme.1996.3753; WOOLLEY CS, 1992, J NEUROSCI, V12, P2549; Woolley CS, 1998, HORM BEHAV, V34, P140, DOI 10.1006/hbeh.1998.1466; Woolley DG, 2010, BEHAV BRAIN RES, V208, P408, DOI 10.1016/j.bbr.2009.12.019; Yener T, 2007, ANAT HISTOL EMBRYOL, V36, P75, DOI 10.1111/j.1439-0264.2006.00743.x; Zurkovsky L, 2007, NEUROSCIENCE, V144, P26, DOI 10.1016/j.neuroscience.2006.09.002	45	30	31	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e69727	10.1371/journal.pone.0069727	http://dx.doi.org/10.1371/journal.pone.0069727			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23874990	Green Published, gold, Green Submitted			2022-12-27	WOS:000322000600057
J	Liu, HW; Shi, RF; Wang, XF; Pan, YX; Li, ZK; Yang, XL; Zhang, GY; Ma, ZY				Liu, Hengwei; Shi, Ruifeng; Wang, Xingfen; Pan, Yuxin; Li, Zhikun; Yang, Xinlei; Zhang, Guiyin; Ma, Zhiying			Characterization and Expression Analysis of a Fiber Differentially Expressed Fasciclin-like Arabinogalactan Protein Gene in Sea Island Cotton Fibers	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; TIME RT-PCR; WALL BIOSYNTHESIS; LOBLOLLY-PINE; UPLAND COTTON; TENSION WOOD; SALT STRESS; ARABIDOPSIS; IDENTIFICATION; STRENGTH	Fasciclin-like arabinogalactan (FLA) protein is a cell-wall-associated protein playing crucial roles in regulating plant growth and development, and it was characterized in different plants including Upland cotton (Gossypium hirsutum L.). In cDNA-AFLP analysis of 25 DPA (days post anthesis) fiber mRNA, two FLA gene-related transcripts exhibit differential expression between Sea Island cotton (G. barbadense L.) and Upland cotton. Based on the transcript-derived fragment, RACE-PCR and realtime PCR technique, GbFLA5 full-length cDNA was isolated and its expression profiles were characterized in both cotton plant tissues and secondary cell wall (SCW) fibers in this study. The 1154 bp GbFLA5 cDNA contains an ORF of 720 bp, encoding GbFLA5 protein of 239 amino acids residues in length with an estimated molecular mass of 25.41 kDa and isoelectric point of 8.63. The deduced GbFLA5 protein contains an N-terminal signal sequence, two AGP-like domains, a single fasciclin-like domain, and a GPI anchor signal sequence. Phylogenetic analysis shows that GbFLA5 protein is homologous to some known SCW-specific expressed FLAs of plant developing xylem, tension wood and cotton fibers. In the SCW deposition stage from 15 to 45 DPA detected, FLA5 maintains a significantly higher expression level in Sea Island cotton fibers than in Upland cotton fibers. The increasing FLA5 transcript abundance coincided with the SCW deposition process and the expression intensity differences coincided with their fiber strength differences between Sea Island cotton and Upland cotton. These expression profile features of GbFLA5 in cotton fibers revealed its tissue-specific and SCW developmental stage-specific expression characters. Further analysis suggested that GbFLA5 is a crucial SCW-specific protein which may contribute to fiber strength by affecting cellulose synthesis and microfibril deposition orientation.	[Liu, Hengwei; Shi, Ruifeng; Wang, Xingfen; Pan, Yuxin; Li, Zhikun; Yang, Xinlei; Zhang, Guiyin; Ma, Zhiying] Agr Univ Hebei, North China Key Lab Crop Germplasm Resources, Educ Minist, Baoding, Peoples R China; [Liu, Hengwei] Suzhou Univ Sci & Technol, Sch Chem & Biol Engn, Suzhou, Peoples R China	Hebei Agricultural University; Suzhou University of Science & Technology	Ma, ZY (corresponding author), Agr Univ Hebei, North China Key Lab Crop Germplasm Resources, Educ Minist, Baoding, Peoples R China.	mzhy@hebau.edu.cn			National Basic Research Program of China [2010CB126000]; National Natural Science Foundation of China [31071467]; Ministry of Agriculture of China for Transgenic Research [2011ZX08009-003]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Agriculture of China for Transgenic Research	This research was supported by the National Basic Research Program of China (Grant no.2010CB126000), the National Natural Science Foundation of China (Grant no. 31071467), and a project from Ministry of Agriculture of China for Transgenic Research (Grant no. 2011ZX08009-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson-Gunneras S, 2006, PLANT J, V45, P144, DOI 10.1111/j.1365-313X.2005.02584.x; Arioli T., 2005, Pflanzenschutz-Nachrichten Bayer, V58, P140; Barnett JR, 2004, BIOL REV, V79, P461, DOI 10.1017/S1464793103006377; BASRA AS, 1984, INT REV CYTOL, V89, P65, DOI 10.1016/S0074-7696(08)61300-5; BENEDICT CR, 1994, BIOCH COTTON, P115; Dahiya P, 2006, PLANTA, V223, P1281, DOI 10.1007/s00425-005-0177-9; ELKINS T, 1990, CELL, V60, P565, DOI 10.1016/0092-8674(90)90660-7; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gao MG, 2000, PLANTA, V210, P865, DOI 10.1007/s004250050691; Gaspar Y, 2001, PLANT MOL BIOL, V47, P161, DOI 10.1023/A:1010683432529; Girault R, 2000, PLANTA, V211, P256, DOI 10.1007/s004250000281; Huang GQ, 2008, PHYSIOL PLANTARUM, V134, P348, DOI 10.1111/j.1399-3054.2008.01139.x; HUBER O, 1994, EMBO J, V13, P4212, DOI 10.1002/j.1460-2075.1994.tb06741.x; Ito S, 2005, BIOSCI BIOTECH BIOCH, V69, P1963, DOI 10.1271/bbb.69.1963; Ji SJ, 2003, NUCLEIC ACIDS RES, V31, P2534, DOI 10.1093/nar/gkg358; Johnson KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025154; Johnson KL, 2003, PLANT PHYSIOL, V133, P1911, DOI 10.1104/pp.103.031237; Kawamoto T, 1998, BBA-GENE STRUCT EXPR, V1395, P288, DOI 10.1016/S0167-4781(97)00172-3; Lafarguette F, 2004, NEW PHYTOL, V164, P107, DOI 10.1111/j.1469-8137.2004.01175.x; Lamport DTA, 2006, NEW PHYTOL, V169, P479, DOI 10.1111/j.1469-8137.2005.01591.x; Lee KJD, 2005, PLANT CELL, V17, P3051, DOI 10.1105/tpc.105.034413; Li J, 2010, PLANT J, V64, P482, DOI 10.1111/j.1365-313X.2010.04344.x; Liu DQ, 2008, PLANT MOL BIOL REP, V26, P98, DOI 10.1007/s11105-008-0026-7; Liu HW, 2009, CHINESE SCI BULL, V54, P4651, DOI 10.1007/s11434-009-0708-z; Ma HL, 2010, J EXP BOT, V61, P2647, DOI 10.1093/jxb/erq104; MacMillan CP, 2010, PLANT J, V62, P689, DOI 10.1111/j.1365-313X.2010.04181.x; Majewska-Sawka A, 2000, PLANT PHYSIOL, V122, P3, DOI 10.1104/pp.122.1.3; Motose H, 2004, NATURE, V429, P873, DOI 10.1038/nature02613; Nguema-Ona E, 2012, ANN BOT-LONDON, V110, P383, DOI 10.1093/aob/mcs143; Pan YX, 2007, CHINESE SCI BULL, V52, P2358, DOI 10.1007/s11434-007-0365-z; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; Paulsrud P, 2002, APPL ENVIRON MICROB, V68, P2036, DOI 10.1128/AEM.68.4.2036-2039.2002; Persson S, 2005, P NATL ACAD SCI USA, V102, P8633, DOI 10.1073/pnas.0503392102; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qiu D, 2008, NEW PHYTOL, V179, P94, DOI 10.1111/j.1469-8137.2008.02439.x; SCHOLL RL, 1976, CROP SCI, V16, P780, DOI 10.2135/cropsci1976.0011183X001600060010x; Schultz CJ, 2002, PLANT PHYSIOL, V129, P1448, DOI 10.1104/pp.003459; Shi HZ, 2003, PLANT CELL, V15, P19, DOI 10.1105/tpc.007872; Smith CW, 1997, CROP SCI, V37, P1775, DOI 10.2135/cropsci1997.0011183X003700060019x; Wang YH, 2009, PLANT GROWTH REGUL, V57, P203, DOI 10.1007/s10725-008-9337-9; Yang J, 2007, PLANT J, V49, P629, DOI 10.1111/j.1365-313X.2006.02985.x; Yang SH, 2005, PHYSIOL PLANTARUM, V124, P91, DOI 10.1111/j.1399-3054.2005.00479.x; Yuan SN, 2013, J AGR SCI-CAMBRIDGE, V151, P57, DOI 10.1017/S0021859612000172; Zhang WJ, 2009, ACTA PHYSIOL PLANT, V31, P927, DOI 10.1007/s11738-009-0306-3; Zhang Y, 2003, PLANT MOL BIOL, V52, P91, DOI 10.1023/A:1023978210001; Zhong RQ, 2001, PLANT PHYSIOL, V126, P477, DOI 10.1104/pp.126.2.477	46	8	12	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e70185	10.1371/journal.pone.0070185	http://dx.doi.org/10.1371/journal.pone.0070185			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23875019	Green Published, Green Submitted, gold			2022-12-27	WOS:000322000600063
J	Toubarro, D; Avila, MM; Hao, YJ; Balasubramanian, N; Jing, YJ; Montiel, R; Faria, TQ; Brito, RM; Simoes, N				Toubarro, Duarte; Avila, Monica M.; Hao, YouJin; Balasubramanian, Natesan; Jing, Yingjun; Montiel, Rafael; Faria, Tiago Q.; Brito, Rui M.; Simoes, Nelson			A Serpin Released by an Entomopathogen Impairs Clot Formation in Insect Defense System	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; STEINERNEMA; HOST; COAGULATION; ENCAPSULATION; CARPOCAPSAE; SUPPRESSION; XENORHABDUS	Steinernema carpocapsae is an entomopathogenic nematode widely used for the control of insect pests due to its virulence, which is mainly attributed to the ability the parasitic stage has to overcome insect defences. To identify the mechanisms underlying such a characteristic, we studied a novel serpin-like inhibitor (sc-srp-6) that was detected in a transcriptome analysis. Recombinant Sc-SRP-6 produced in Escherichia coli had a native fold of serpins belonging to the alpha-1-peptidase family and exhibited inhibitory activity against trypsin and alpha-chymotrypsin with Ki of 0.426x10(-7) M and 1.226x10(-7) M, respectively. Functional analysis revealed that Sc-SRP-6 inhibits insect digestive enzymes, thus preventing the hydrolysis of ingested particles. Moreover, Sc-SRP-6 impaired the formation of hard clots at the injury site, a major insect defence mechanism against invasive pathogens. Sc-SRP-6 does not prevent the formation of clot fibres and the activation of prophenoloxidases but impairs the incorporation of the melanin into the clot. Binding assays showed a complex formation between Sc-SRP-6 and three proteins in the hemolymph of lepidopteran required for clotting, apolipophorin, hexamerin and trypsin-like, although the catalytic inhibition occurred exclusively in trypsin-like. This data allowed the conclusion that Sc-SRP-6 promotes nematode virulence by inhibiting insect gut juices and by impairing immune clot reaction.	[Toubarro, Duarte; Avila, Monica M.; Hao, YouJin; Balasubramanian, Natesan; Jing, Yingjun; Simoes, Nelson] Univ Azores, Ctr Invest Recursos Nat, Ctr Biotecnol Acores, Associate Lab Inst Biotechnol & Bioengn,Dept Biol, Ponta Delgada, Portugal; [Montiel, Rafael] Inst Politecn Nacl, Lab Nacl Genom Biodiversidad, Ctr Invest & Estudios Avanzados, Guanajuato, Mexico; [Faria, Tiago Q.; Brito, Rui M.] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal	Universidade dos Acores; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Universidade de Coimbra	Simoes, N (corresponding author), Univ Azores, Ctr Invest Recursos Nat, Ctr Biotecnol Acores, Associate Lab Inst Biotechnol & Bioengn,Dept Biol, Ponta Delgada, Portugal.	simoes@uac.pt	Simões, Nelson/K-3843-2013; Toubarro, Duarte/K-3881-2013; Faria, Tiago/A-4223-2015; Faria, Tiago/AHA-2757-2022; Montiel, Rafael/A-6774-2008; Natesan, Balasubramanian/M-3016-2014	Simões, Nelson/0000-0003-3612-6759; Toubarro, Duarte/0000-0003-2025-9696; Faria, Tiago/0000-0003-0564-8415; Faria, Tiago/0000-0003-0564-8415; Montiel, Rafael/0000-0001-8052-0679; Natesan, Balasubramanian/0000-0003-1819-0730; Brito, Rui/0000-0001-9128-2557	Fundacao para a Ciencia e Tecnologia (FCT) [PDCT/AGR/AAM/104487/2008]; FLAD [223/2006]; Regional Government of Acores (RGA) [M3.1.2/F/005/2007, M112/F/031/2007]; FCT [PDCT/AGR/AAM/104487/2008, 441]; Conacyt-Hidalgo State Government [Fomix-Hgo-2008-C01-97032]; RGA [M3.1.7/F/009A/2009]	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FLAD; Regional Government of Acores (RGA); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Conacyt-Hidalgo State Government; RGA	This research was supported by Fundacao para a Ciencia e Tecnologia (FCT) (PDCT/AGR/AAM/104487/2008) and by FLAD (Proj. 223/2006) accorded to NS; a fellowship from the Regional Government of Acores (RGA) (M3.1.2/F/005/2007) to MMA; a mobility grant from FCT (Proco 441 Ac. C. Mexico) to NS and RM; a grant from Conacyt-Hidalgo State Government (Fomix-Hgo-2008-C01-97032) to RM. DT received a fellowship from FCT (PDCT/AGR/AAM/104487/2008); NB from RGA (M3.1.7/F/009A/2009) and YJ from RGA (M112/F/031/2007); Y-JH from FCT (SFRH/BPD/21079/2004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JE, 1998, PARASITE IMMUNOL, V20, P241, DOI 10.1046/j.1365-3024.1998.00151.x; An CJ, 2011, CELL MOL LIFE SCI, V68, P1929, DOI 10.1007/s00018-010-0543-z; Babcock DT, 2008, P NATL ACAD SCI USA, V105, P10017, DOI 10.1073/pnas.0709951105; Balasubramanian N, 2010, PARASITE IMMUNOL, V32, P165, DOI 10.1111/j.1365-3024.2009.01172.x; Balasubramanian N, 2009, INT J PARASITOL, V39, P975, DOI 10.1016/j.ijpara.2009.01.012; Bidla G, 2005, DEV COMP IMMUNOL, V29, P669, DOI 10.1016/j.dci.2004.11.007; Bidla G, 2009, J INNATE IMMUN, V1, P301, DOI 10.1159/000168009; Blaxter M, 1998, SCIENCE, V282, P2041, DOI 10.1126/science.282.5396.2041; Brivio MF, 2006, DEV COMP IMMUNOL, V30, P627, DOI 10.1016/j.dci.2005.09.008; Brivio MF, 2010, DEV COMP IMMUNOL, V34, P991, DOI 10.1016/j.dci.2010.05.002; BURMAN M, 1982, NEMATOLOGICA, V28, P62, DOI 10.1163/187529282X00510; Chmelar J, 2011, BLOOD, V117, P736, DOI 10.1182/blood-2010-06-293241; Cruz N, 2001, J INVERTEBR PATHOL, V78, P272, DOI 10.1006/jipa.2001.5033; Dzik JM, 2006, ACTA BIOCHIM POL, V53, P33; Eleftherianos I, 2011, J INNATE IMMUN, V3, P28, DOI 10.1159/000321931; ffrench-Constant RH, 2007, TOXICON, V49, P436, DOI 10.1016/j.toxicon.2006.11.019; Forst S, 1997, ANNU REV MICROBIOL, V51, P47, DOI 10.1146/annurev.micro.51.1.47; GRAY SP, 1983, CLIN CHEM, V29, P447; Hao YJ, 2010, MOL BIOCHEM PARASIT, V169, P79, DOI 10.1016/j.molbiopara.2009.10.002; Holland MJ, 2000, EUR J IMMUNOL, V30, P1977, DOI 10.1002/1521-4141(200007)30:7&lt;1977::AID-IMMU1977&gt;3.0.CO;2-3; Hyrsl P, 2011, J INNATE IMMUN, V3, P65, DOI 10.1159/000320634; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Karlsson C, 2004, J BIOL CHEM, V279, P52033, DOI 10.1074/jbc.M408220200; Lacey LA, 2008, ANNU REV ENTOMOL, V53, P121, DOI 10.1146/annurev.ento.53.103106.093419; Laumond C, 1989, PROSPECTS GENETICS E; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Li D, 2002, INSECT BIOCHEM MOLEC, V32, P919, DOI 10.1016/S0965-1748(02)00030-9; McCarthy BJ, 1997, J MOL BIOL, V267, P561, DOI 10.1006/jmbi.1996.0909; Peters A, 1997, J INVERTEBR PATHOL, V69, P218, DOI 10.1006/jipa.1996.4648; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Rosa JS, 2002, J INVERTEBR PATHOL, V80, P46, DOI 10.1016/S0022-2011(02)00038-1; Scherfer C, 2004, CURR BIOL, V14, P625, DOI 10.1016/j.cub.2004.03.030; Schmidt O, 2010, ANNU REV ENTOMOL, V55, P485, DOI 10.1146/annurev.ento.54.110807.090618; Sicard M, 2004, APPL ENVIRON MICROB, V70, P6473, DOI 10.1128/AEM.70.11.6473-6480.2004; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; TAKAHARA H, 1984, TOHOKU J EXP MED, V142, P261, DOI 10.1620/tjem.142.261; Theopold U, 2004, TRENDS IMMUNOL, V25, P289, DOI 10.1016/j.it.2004.03.004; Tong YR, 2005, J BIOL CHEM, V280, P14932, DOI 10.1074/jbc.M500532200; Toubarro D, 2010, J BIOL CHEM, V285, P30666, DOI 10.1074/jbc.M110.129346; Toubarro D, 2009, INT J PARASITOL, V39, P1319, DOI 10.1016/j.ijpara.2009.04.013; WANG Y, 1994, J NEMATOL, V26, P11; Wang Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000763; Zang XX, 1999, BLOOD, V94, P1418, DOI 10.1182/blood.V94.4.1418.416k03_1418_1428; Zang XX, 2001, TRENDS BIOCHEM SCI, V26, P191, DOI 10.1016/S0968-0004(00)01761-8; Zhou A, 2001, J BIOL CHEM, V276, P9115, DOI 10.1074/jbc.M010631200	46	36	37	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e69161	10.1371/journal.pone.0069161	http://dx.doi.org/10.1371/journal.pone.0069161			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874900	Green Submitted, Green Published, gold			2022-12-27	WOS:000322064300088
J	Varnum, MEW				Varnum, Michael E. W.			What Are Lay Theories of Social Class?	PLOS ONE			English	Article							PERSONALITY; ACCURACY	Numerous studies have documented the effects of social class on psychological and behavioral variables. However, lay beliefs about how social class affects these dimensions have not been systematically tested. Studies 1 and 2 assessed lay beliefs about the association between social class and 8 variables (including psychological and behavioral tendencies and cognitive ability). Study 3 assessed lay beliefs about the Big five personality traits and social class, and study 4 reframed the 8 variables from study 1 in opposite terms and yielded similar results. Study 5 contained the variables framed as in both studies 1 and 4, and replicated those results suggesting that framing effects were not responsible for the effects observed. Interestingly, for the most part lay beliefs about social class did not differ as a function of participants' own social class. In general people held relatively accurate and consistent stereotypes about the relationship between social class and well-being, health, intelligence, and neuroticism. In contrast lay beliefs regarding social class and reasoning styles, as well as relational, social, and emotional tendencies were less consistent and coherent. This work suggests that on the whole people's beliefs about social class are not particularly accurate, and further that in some domains there are contradictory stereotypes about the consequences of social class.	Peking Univ, Dept Psychol, Beijing 100871, Peoples R China	Peking University	Varnum, MEW (corresponding author), Peking Univ, Dept Psychol, Beijing 100871, Peoples R China.	michael.e.w.varnum@gmail.com	Varnum, Michael/AAR-7119-2021	Varnum, Michael/0000-0002-2088-6086	China Postdoctoral Science Foundation [95799]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	The preparation of this manuscript was supported by a grant from the China Postdoctoral Science Foundation, No. 95799. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NE, 2000, HEALTH PSYCHOL, V19, P586, DOI 10.1037/0278-6133.19.6.586; Allen R. E., 2006, PLATO REPUBLIC; Allport G. W., 1954, NATURE PREJUDICE; Butler R., 2008, LONGEVITY REVOLUTION; Chapman BP, 2010, AM J EPIDEMIOL, V171, P83, DOI 10.1093/aje/kwp323; Chiu CY, 1997, J PERS SOC PSYCHOL, V73, P19, DOI 10.1037/0022-3514.73.1.19; Croizet JC, 1998, PERS SOC PSYCHOL B, V24, P588, DOI 10.1177/0146167298246003; Fiske ST, 2002, J PERS SOC PSYCHOL, V82, P878, DOI 10.1037//0022-3514.82.6.878; Grossmann I, 2011, SOC PSYCHOL PERS SCI, V2, P81, DOI 10.1177/1948550610377119; Kraus MW, 2010, PSYCHOL SCI, V21, P1716, DOI 10.1177/0956797610387613; Kraus MW, 2009, J PERS SOC PSYCHOL, V97, P992, DOI 10.1037/a0016357; Lareau A, 2012, FACING SOCIAL CLASS: HOW SOCIETAL RANK INFLUENCES INTERACTION, P61; Levy BR, 1994, J PERS SOC PSYCHOL, V66, P935, DOI DOI 10.1037/0022-3514.66.6.989; Madon S, 1998, PERS SOC PSYCHOL B, V24, P1304, DOI 10.1177/01461672982412005; Na JY, 2011, PSYCHOL SCI, V22, P1025, DOI 10.1177/0956797611414727; Na J, 2010, P NATL ACAD SCI USA, V107, P6192, DOI 10.1073/pnas.1001911107; Neisser U, 1996, AM PSYCHOL, V51, P77, DOI 10.1037/0003-066X.51.2.77; Parker K, 2012, YES RICH ARE DIFFERE; Piff PK, 2012, P NATL ACAD SCI USA, V109, P4086, DOI 10.1073/pnas.1118373109; Rosenthal R., 1968, PYGMALION CLASSROOM; Stellar JE, 2012, EMOTION, V12, P449, DOI 10.1037/a0026508; Stephens NM, 2007, J PERS SOC PSYCHOL, V93, P814, DOI 10.1037/0022-3514.93.5.814	22	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e70589	10.1371/journal.pone.0070589	http://dx.doi.org/10.1371/journal.pone.0070589			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	186SF	23875029	gold, Green Published, Green Submitted			2022-12-27	WOS:000322064300131
J	Talluri, R; Shete, S				Talluri, Rajesh; Shete, Sanjay			A Linkage Disequilibrium-Based Approach to Selecting Disease-Associated Rare Variants	PLOS ONE			English	Article							COMMON DISEASES	Rare variants have increasingly been cited as major contributors in the disease etiology of several complex disorders. Recently, several approaches have been proposed for analyzing the association of rare variants with disease. These approaches include collapsing rare variants, summing rare variant test statistics within a particular locus to improve power, and selecting a subset of rare variants for association testing, e.g., the step-up approach. We found that (a) if the variants being pooled are in linkage disequilibrium, the standard step-up method of selecting the best subset of variants results in loss of power compared to a model that pools all rare variants and (b) if the variants are in linkage equilibrium, performing a subset selection using step-based selection methods results in a gain of power of association compared to a model that pools all rare variants. Therefore, we propose an approach to selecting the best subset of variants to include in the model that is based on the linkage disequilibrium pattern among the rare variants. The proposed linkage disequilibrium-based variant selection model is flexible and borrows strength from the model that pools all rare variants when the rare variants are in linkage disequilibrium and from step-based selection methods when the variants are in linkage equilibrium. We performed simulations under three different realistic scenarios based on: (1) the HapMap3 dataset of the DRD2 gene, and CHRNA3/A5/B4 gene cluster (2) the block structure of linkage disequilibrium, and (3) linkage equilibrium. We proposed a permutation-based approach to control the type 1 error rate. The power comparisons after controlling the type 1 error show that the proposed linkage disequilibrium-based subset selection approach is an attractive alternative method for subset selection of rare variants.	[Talluri, Rajesh; Shete, Sanjay] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Shete, Sanjay] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Shete, S (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA.	sshete@mdanderson.org		Talluri, Rajesh/0000-0002-6987-967X	National Institutes of Health [R01CA131324, R01DE022891, R25DA026120]; cancer prevention fellowship; NIH from the National Institute of Drug Abuse [R25 DA026120]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R25DA026120] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); cancer prevention fellowship; NIH from the National Institute of Drug Abuse; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants R01CA131324 (SS), R01DE022891 (SS), and R25DA026120 (SS). This research was supported in part by a cancer prevention fellowship for Rajesh Talluri supported by an NIH R25 DA026120 grant from the National Institute of Drug Abuse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Han F, 2010, HUM HERED, V70, P42, DOI 10.1159/000288704; HOCKING RR, 1976, BIOMETRICS, V32, P1, DOI 10.2307/2529336; Hoffmann TJ, 2010, GENET EPIDEMIOL, V34, P918; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Montana G, 2005, BIOINFORMATICS, V21, P4309, DOI 10.1093/bioinformatics/bti689; Morgenthaler S, 2007, MUTAT RES-FUND MOL M, V615, P28, DOI 10.1016/j.mrfmmm.2006.09.003; Morris AP, 2010, GENET EPIDEMIOL, V34, P188, DOI 10.1002/gepi.20450; Mueller JC, 2004, BRIEF BIOINFORM, V5, P355, DOI 10.1093/bib/5.4.355; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029	13	10	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e69226	10.1371/journal.pone.0069226	http://dx.doi.org/10.1371/journal.pone.0069226			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874919	gold, Green Submitted, Green Published			2022-12-27	WOS:000322218800068
J	Chiu, HH; Whittaker, P				Chiu, Holly H.; Whittaker, Peter			Venous Thromboembolism in an Industrial North American City: Temporal Distribution and Association with Particulate Matter Air Pollution	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; SEASONAL-VARIATION; TIME-SERIES; MORTALITY; DETROIT; PM10	Background: Emerging evidence, mainly from Europe and Asia, indicates that venous thromboembolism (VTE) occurs most often in winter. Factors implicated in such seasonality are low temperature-mediated exacerbation of coagulation and high levels of particulate matter (PM) air pollution. However, in contrast to most European and Asian cities, particulate matter pollution peaks in the summer in many North American cities. Objectives: We aimed to exploit this geographical difference and examine the temporal distribution of VTE in a cold-weather, North American city, Detroit, with a summer PM peak. Our goal was thereby to resolve the influence of temperature and PM levels on VTE. Methods: Our retrospective, analytical semi-ecological study used chart review to confirm 1,907 acute, ambulatory VTE cases, divided them by location (Detroit versus suburban), and plotted monthly VTE frequency distributions. We used Environmental Protection Agency data to determine the temporal distribution of PM pollution components in Detroit. Suburban PM air pollution is presumed negligible and therefore not monitored. Results: Acute VTE cases in Detroit (1,490) exhibited a summer peak (June 24th) and differed from both a uniform distribution (P < 0.01) and also that of 1,123 no-VTE cases (P < 0.02). Levels of 10 mu m diameter PM and coarse particle (2.5 to 10 mu m) PM also exhibited summer peaks versus a winter peak for 2.5 mu m diameter PM. Contrary to their urban counterparts, suburban cases of acute VTE (417) showed no monthly variation . Conclusions: The summer peak of acute VTE in Detroit indicates that low temperature is not a major factor in VTE pathogenesis. In contrast, concordance of the 10 mu m diameter PM, coarse particle, and the Detroit VTE monthly distributions, combined with no monthly suburban VTE variation, is consistent with a role for PM pollution. Furthermore, divergence of the VTE and 2.5 mu m PM distributions suggests that particle size may play a role.	[Chiu, Holly H.] Harper Univ Hosp, Detroit Med Ctr, Dept Pharm, Detroit, MI USA; [Whittaker, Peter] Wayne State Univ, Cardiovasc Res Inst, Detroit, MI 48202 USA; [Whittaker, Peter] Wayne State Univ, Dept Emergency Med, Detroit, MI USA	Detroit Medical Center; Wayne State University; Wayne State University	Whittaker, P (corresponding author), Wayne State Univ, Cardiovasc Res Inst, Detroit, MI 48202 USA.	peter.whittaker@wayne.edu	Whittaker, Peter/F-1234-2011	Whittaker, Peter/0000-0002-5627-2166				Angchaisuksiri P, 2011, THROMB HAEMOSTASIS, V106, P585, DOI 10.1160/TH11-03-0184; Ayd Y., 2011, ADV TOP ENVIR HEALTH, P251, DOI DOI 10.5772/20016; Baccarelli A, 2008, ARCH INTERN MED, V168, P920, DOI 10.1001/archinte.168.9.920; Batschelet E, 1981, CIRCULAR STAT BIOL; Bell K.N.I., 2008, ANAL CYCLES BIOL MED; Bell ML, 2007, ENVIRON HEALTH PERSP, V115, P989, DOI 10.1289/ehp.9621; Bell ML, 2009, EPIDEMIOLOGY, V20, P682, DOI 10.1097/EDE.0b013e3181aba749; Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Brown HK, 2009, THROMB HAEMOSTASIS, V102, P676, DOI 10.1160/TH09-04-0214; Carnevale C, 2010, SCI TOTAL ENVIRON, V409, P182, DOI 10.1016/j.scitotenv.2010.09.038; Chuang KJ, 2007, AM J RESP CRIT CARE, V176, P370, DOI 10.1164/rccm.200611-1627OC; Deitelzweig SB, 2011, AM J HEMATOL, V86, P217, DOI 10.1002/ajh.21917; Dentali F, 2011, THROMB HAEMOSTASIS, V106, P439, DOI 10.1160/TH11-02-0116; Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127; Fisher N., 1995, STAT ANAL CIRCULAR D; Gallerani M, 2004, MED SCI MONITOR, V10, pCR191; Gallerani M, 2007, CHRONOBIOL INT, V24, P143, DOI 10.1080/07420520601139755; Gehrig R, 2003, ATMOS ENVIRON, V37, P2571, DOI 10.1016/S1352-2310(03)00221-8; Hamper UM, 2007, RADIOL CLIN N AM, V45, P525, DOI 10.1016/j.rcl.2007.04.013; Kunzli N, 1997, ENVIRON HEALTH PERSP, V105, P1078, DOI 10.2307/3433849; Kwok RHF, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012809; Martinelli N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034831; Mojtabazadeh H, 2005, SUSTAINABLE DEV PLAN; Mustafic H, 2012, JAMA-J AM MED ASSOC, V307, P713, DOI 10.1001/jama.2012.126; Oanh NTK, 2006, ATMOS ENVIRON, V40, P3367, DOI 10.1016/j.atmosenv.2006.01.050; Peng RD, 2005, AM J EPIDEMIOL, V161, P585, DOI 10.1093/aje/kwi075; Peng RD, 2010, BIOSTATISTICS, V11, P720, DOI 10.1093/biostatistics/kxq017; Robinson WS, 1950, AM SOCIOL REV, V15, P351, DOI 10.2307/2087176; Sacks JD, 2011, ENVIRON HEALTH PERSP, V119, P446, DOI 10.1289/ehp.1002255; SCHWARTZ J, 1995, AM J EPIDEMIOL, V142, P23, DOI 10.1093/oxfordjournals.aje.a117541; Shih RA, 2011, ENVIRON HEALTH PERSP, V119, P326, DOI 10.1289/ehp.1002256; Stein PD, 2004, AM J CARDIOL, V93, P511, DOI 10.1016/j.amjcard.2003.10.061; Turalioglu FS, 2005, ENVIRON MONIT ASSESS, V104, P119, DOI 10.1007/s10661-005-1607-7; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8; WHITTAKER P, 1989, AM HEART J, V118, P341, DOI 10.1016/0002-8703(89)90195-6; WHITTAKER P, 1991, MATRIX, V11, P56, DOI 10.1016/S0934-8832(11)80227-1; Zhou JA, 2011, ENVIRON HEALTH PERSP, V119, P461, DOI 10.1289/ehp.1002613; Zoller B, 2012, J THROMB THROMBOLYS, V34, P374, DOI 10.1007/s11239-012-0728-4	39	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68829	10.1371/journal.pone.0068829	http://dx.doi.org/10.1371/journal.pone.0068829			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874781	Green Published, Green Submitted, gold			2022-12-27	WOS:000321765300068
J	Song, LQ; Jiang, LL; Han, HM; Gao, AN; Yang, XM; Li, LH; Liu, WH				Song, Liqiang; Jiang, Lili; Han, Haiming; Gao, Ainong; Yang, Xinming; Li, Lihui; Liu, Weihua			Efficient Induction of Wheat-Agropyron cristatum 6P Translocation Lines and GISH Detection	PLOS ONE			English	Article							CHROMOSOME-TRANSLOCATION; CONFERRING RESISTANCE; RECOMBINATION; IDENTIFICATION; REARRANGEMENTS; MECHANISM; SEGMENTS; ORIGIN	The narrow genetic background restricts wheat yield and quality improvement. The wild relatives of wheat are the huge gene pools for wheat improvement and can broaden its genetic basis. Production of wheat-alien translocation lines can transfer alien genes to wheat. So it is important to develop an efficient method to induce wheat-alien chromosome translocation. Agropyron cristatum (P genome) carries many potential genes beneficial to disease resistance, stress tolerance and high yield. Chromosome 6P possesses the desirable genes exhibiting good agronomic traits, such as high grain number per spike, powdery mildew resistance and stress tolerance. In this study, the wheat-A. cristatum disomic addition was used as bridge material to produce wheat-A. cristatum translocation lines induced by Co-60-gamma irradiation. The results of genomic in situ hybridization showed that 216 plants contained alien chromosome translocation among 571 self-pollinated progenies. The frequency of translocation was 37.83%, much higher than previous reports. Moreover, various alien translocation types were identified. The analysis of M-2 showed that 62.5% of intergeneric translocation lines grew normally without losing the translocated chromosomes. The paper reported a high efficient technical method for inducing alien translocation between wheat and Agropyron cristatum. Additionally, these translocation lines will be valuable for not only basic research on genetic balance, interaction and expression of different chromosome segments of wheat and alien species, but also wheat breeding programs to utilize superior agronomic traits and good compensation effect from alien chromosomes.	[Song, Liqiang; Jiang, Lili; Han, Haiming; Gao, Ainong; Yang, Xinming; Li, Lihui; Liu, Weihua] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Li, LH (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China.	lilihui@caas.cn; liuweihua@caas.cn			National High Technology Research and Development Program of China [2011AA100102]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	Funded by The National High Technology Research and Development Program of China (2011AA100102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BADAEVA ED, 1995, GENOME, V38, P976, DOI 10.1139/g95-128; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Cao AH, 2011, P NATL ACAD SCI USA, V108, P7727, DOI 10.1073/pnas.1016981108; Carmona S, 2010, BIOL PLANTARUM, V54, P69, DOI 10.1007/s10535-010-0010-6; Chen PD, 2005, THEOR APPL GENET, V111, P941, DOI 10.1007/s00122-005-0026-z; Chen SW, 2008, SCI CHINA SER C, V51, P346, DOI 10.1007/s11427-008-0048-2; Cuadrado A, 2000, THEOR APPL GENET, V101, P711, DOI 10.1007/s001220051535; DEWEY DR, 1984, P 6 STADL GEN S COL, P209; DONG YS, 1992, HEREDITAS, V116, P175, DOI 10.1111/j.1601-5223.1992.tb00224.x; Dong YS, 2000, PREFACE, P1; Du WL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053921; Faris JD, 2008, CHROMOSOME RES, V16, P1097, DOI 10.1007/s10577-008-1261-3; Feuillet C, 2008, TRENDS GENET, V24, P24, DOI 10.1016/j.tig.2007.11.001; Friebe B, 2000, CHROMOSOME RES, V8, P501, DOI 10.1023/A:1009219722418; Friebe B, 1996, EUPHYTICA, V91, P59, DOI 10.1007/BF00035277; Fu SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054057; Jauhar PP, 2006, CROP SCI, V46, P1841, DOI 10.2135/cropsci2005.07-0223; Kang HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021802; Li L.H., 1997, ACTA GENET SIN, V24, P154; Li Li-hui, 1998, Acta Genetica Sinica, V25, P538; Li Lihui, 1995, Acta Genetica Sinica, V22, P109; Liu WH, 2010, GENOME, V53, P472, DOI [10.1139/G10-023, 10.1139/g10-023]; Luan Y, 2010, PLANTA, V232, P501, DOI 10.1007/s00425-010-1187-9; LUKASZEWSKI AJ, 1993, GENOME, V36, P821, DOI 10.1139/g93-109; Molnar-Lang M, 2012, CEREAL RES COMMUN, P1, DOI DOI 10.1556/CRC.2012.0038; Munns R, 2012, NAT BIOTECHNOL, V30, P360, DOI 10.1038/nbt.2120; Pacher M, 2007, GENETICS, V175, P21, DOI 10.1534/genetics.106.065185; Qi LL, 2007, CHROMOSOME RES, V15, P3, DOI 10.1007/s10577-006-1108-8; Rajaram S., 1983, P 6 INT WHEAT GENETI, P613; Sears E, 1956, TRANSFER LEAF RUST R, P1; SEARS ER, 1993, CROP SCI, V33, P897, DOI 10.2135/cropsci1993.0011183X003300050004x; Shi F, 2000, CHROMOSOMA, V109, P358, DOI 10.1007/s004120000085; Wang L, 2004, INDUCING ALIEN CHROM, P300; Wang LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029432; Wang RRC, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES: CEREALS, P77, DOI 10.1007/978-3-642-14228-4_2; Wang XP, 2003, ACTA GENET SIN, P30; Wu J, 2006, THEOR APPL GENET, V114, P13, DOI 10.1007/s00122-006-0405-0; Zhang P, 2008, GENETICS, V179, P1169, DOI 10.1534/genetics.108.089599; Zhang XL, 2011, THEOR APPL GENET, V122, P263, DOI 10.1007/s00122-010-1441-3	39	32	35	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e69501	10.1371/journal.pone.0069501	http://dx.doi.org/10.1371/journal.pone.0069501			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23874966	Green Submitted, gold, Green Published			2022-12-27	WOS:000321341000192
J	Esposito-Bauer, L; Saam, T; Ghodrati, I; Pelisek, J; Heider, P; Bauer, M; Wolf, P; Bockelbrink, A; Feurer, R; Sepp, D; Winkler, C; Zepper, P; Boeckh-Behrens, T; Riemenschneider, M; Hemmer, B; Poppert, H				Esposito-Bauer, Lorena; Saam, Tobias; Ghodrati, Iman; Pelisek, Jaroslav; Heider, Peter; Bauer, Matthias; Wolf, Petra; Bockelbrink, Angelina; Feurer, Regina; Sepp, Dominik; Winkler, Claudia; Zepper, Peter; Boeckh-Behrens, Tobias; Riemenschneider, Matthias; Hemmer, Bernhard; Poppert, Holger			MRI Plaque Imaging Detects Carotid Plaques with a High Risk for Future Cerebrovascular Events in Asymptomatic Patients	PLOS ONE			English	Article							HIGH-RESOLUTION MRI; ATHEROSCLEROTIC PLAQUE; INTRAPLAQUE HEMORRHAGE; IN-VIVO; ARTERY STENOSIS; VASCULAR-LESIONS; ISCHEMIC EVENTS; ASSOCIATION; SYMPTOMS; RUPTURE	Purpose: The aim of this study was to investigate prospectively whether MRI plaque imaging can identify patients with asymptomatic carotid artery stenosis who have an increased risk for future cerebral events. MRI plaque imaging allows categorization of carotid stenosis into different lesion types (I-VIII). Within these lesion types, lesion types IV-V and VI are regarded as rupture-prone plaques, whereas the other lesion types represent stable ones. Methods: Eighty-three consecutive patients (45 male (54.2%); age 54-88 years (mean 73.2 years)) presenting with an asymptomatic carotid stenosis of 50-99% according to ECST-criteria were recruited. Patients were imaged with a 1.5-T scanner. T1-, T2-, time-of-flight-, and proton-density weighted studies were performed. The carotid plaques were classified as lesion type I-VIII. Clinical endpoints were ischemic stroke, TIA or amaurosis fugax. Survival analysis and log rank test were used to ascertain statistical significance. Results: Six out of 83 patients (7.2%) were excluded: 4 patients had insufficient MR image quality; 1 patient was lost-tofollow- up; 1 patient died shortly after the baseline MRI plaque imaging. The following results were obtained by analyzing the remaining 77 patients. The mean time of follow-up was 41.1 months. During follow-up, n = 9 (11.7%) ipsilateral ischemic cerebrovascular events occurred. Only patients presenting with the high-risk lesion types IV-V and VI developed an ipsilateral cerebrovascular event versus none of the patients presenting with the stable lesion types III, VII, and VIII (n = 9 (11.7%) vs. n = 0 (0%) during follow-up). Event-free survival was higher among patients with the MRI-defined stable lesion types (III, VII, and VIII) than in patients with the high-risk lesion types (IV-V and VI) (log rank test P<0.0001). Conclusions: MRI plaque imaging has the potential to identify patients with asymptomatic carotid stenosis who are particularly at risk of developing future cerebral ischemia. MRI could improve selection criteria for invasive therapy in the future.	[Esposito-Bauer, Lorena; Ghodrati, Iman; Feurer, Regina; Sepp, Dominik; Winkler, Claudia; Zepper, Peter; Hemmer, Bernhard; Poppert, Holger] Tech Univ Munich, Dept Neurol, D-80290 Munich, Germany; [Saam, Tobias] Univ Hosp Munich, Inst Clin Radiol, Munich, Germany; [Pelisek, Jaroslav] Tech Univ Munich, Dept Vasc Surg, D-80290 Munich, Germany; [Heider, Peter] Isar Med Zentrum Muchen, Dept Vasc Surg, Munich, Germany; [Bauer, Matthias] Bethesda Spital Basel, Dept Neurol, Basel, Switzerland; [Wolf, Petra] Tech Univ Munich, Inst Med Stat & Epidemiol, D-80290 Munich, Germany; [Bockelbrink, Angelina] Charite, Inst Social Med Epidemiol, D-13353 Berlin, Germany; [Boeckh-Behrens, Tobias] Tech Univ Munich, Dept Neuroradiol, D-80290 Munich, Germany; [Riemenschneider, Matthias] Univ Saarlandes Kliniken, Dept Psychiat & Psychotherapy, Homburg, Germany	Technical University of Munich; University of Munich; Technical University of Munich; Technical University of Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technical University of Munich; Universitatsklinikum des Saarlandes	Esposito-Bauer, L (corresponding author), Tech Univ Munich, Dept Neurol, D-80290 Munich, Germany.	lorenaesposito@web.de	Hemmer, Bernhard/GPX-8451-2022; TUM, Forschung Neurorad/C-1202-2014; Hemmer, Bernhard/AAT-8388-2021	Hemmer, Bernhard/0000-0001-5985-6784; Poppert, Holger/0000-0003-2189-7681	committee for clinical research (Komission fur Klinische Forschung; KKF) [66-04]; Technische Universitat Munchen	committee for clinical research (Komission fur Klinische Forschung; KKF); Technische Universitat Munchen	This study was supported by the committee for clinical research (Komission fur Klinische Forschung; KKF) number 66-04 of the Technische Universitat Munchen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altaf N, 2008, J VASC SURG, V47, P337, DOI 10.1016/j.jvs.2007.09.064; Altaf N, 2007, STROKE, V38, P1633, DOI 10.1161/STROKEAHA.106.473066; Altaf N, 2011, RADIOLOGY, V258, P538, DOI 10.1148/radiol.10100198; Bassiouny HS, 1997, J VASC SURG, V26, P585, DOI 10.1016/S0741-5214(97)70056-9; Bassiouny HS, 1996, J VASC SURG, V23, P765; Cai JM, 2002, CIRCULATION, V106, P1368, DOI 10.1161/01.CIR.0000028591.44554.F9; Carr S, 1996, J VASC SURG, V23, P755, DOI 10.1016/S0741-5214(96)70237-9; Chu BC, 2004, STROKE, V35, P1079, DOI 10.1161/01.STR.0000125856.25309.86; DeMarco JK, 2010, AM J NEURORADIOL, V31, P1395, DOI 10.3174/ajnr.A2213; Esposito L, 2010, BMC Med Imaging, V10, P27, DOI 10.1186/1471-2342-10-27; Esposito L, 2007, J NEUROL, V254, P1714, DOI 10.1007/s00415-007-0634-4; FALK E, 1992, CIRCULATION, V86, P30; Goessens BMB, 2007, STROKE, V38, P1470, DOI 10.1161/STROKEAHA.106.477091; Halliday A, 2004, LANCET, V363, P1491; Hatsukami Thomas S, 2010, Imaging Med, V2, P63, DOI 10.2217/iim.09.33; Hatsukami TS, 2000, CIRCULATION, V102, P959, DOI 10.1161/01.CIR.102.9.959; Kurosaki Y, 2011, NEUROSURGERY, V68, P62, DOI 10.1227/NEU.0b013e3181fc60a8; Lin K, 2006, ACAD RADIOL, V13, P1180, DOI 10.1016/j.acra.2006.07.004; LUSBY RJ, 1982, ARCH SURG-CHICAGO, V117, P1479; Marquardt L, 2010, STROKE, V41, pE11, DOI 10.1161/STROKEAHA.109.561837; Mofidi R, 2001, BRIT J SURG, V88, P945, DOI 10.1046/j.0007-1323.2001.01823.x; Nicolaides AN, 2005, EUR J VASC ENDOVASC, V30, P275, DOI 10.1016/j.ejvs.2005.04.031; Parmar JP, 2010, CIRCULATION, V122, P2031, DOI 10.1161/CIRCULATIONAHA.109.866053; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Qiao Y, 2011, AM J NEURORADIOL, V32, P454, DOI 10.3174/ajnr.A2320; Robless P, 1998, INT ANGIOL, V17, P194; Sepp Dominik, 2009, J Angiogenes Res, V1, P10, DOI 10.1186/2040-2384-1-10; Singh N, 2009, RADIOLOGY, V252, P502, DOI 10.1148/radiol.2522080792; Spence JD, 2010, ARCH NEUROL-CHICAGO, V67, P180, DOI 10.1001/archneurol.2009.289; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; STARY HC, 1994, ARTERIOSCLER THROMB, V14, P840, DOI 10.1161/01.ATV.14.5.840; Takaya N, 2006, STROKE, V37, P818, DOI 10.1161/01.STR.0000204638.91099.91; Tartari S, 2011, AM J ROENTGENOL, V196, P1164, DOI 10.2214/AJR.10.4751; Touze E, 2007, STROKE, V38, P1812, DOI 10.1161/STROKEAHA.106.479139; Underhill HR, 2010, AM J NEURORADIOL, V31, P487, DOI 10.3174/ajnr.A1842; Underhill HR, 2008, AM HEART J, V155, DOI 10.1016/j.ahj.2007.11.018; Virmani R, 2005, ARTERIOSCL THROM VAS, V25, P2054, DOI 10.1161/01.ATV.0000178991.71605.18; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035; Wang Yong, 2011, Nan Fang Yi Ke Da Xue Xue Bao, V31, P299; Wasserman BA, 2010, STROKE, V41, pS12, DOI 10.1161/STROKEAHA.110.596288; WIDDER B, 1986, ULTRASCHALL MED, V7, P70, DOI 10.1055/s-2007-1011918; Yuan C, 2001, RADIOLOGY, V221, P285, DOI 10.1148/radiol.2212001612; Yuan C, 2001, CIRCULATION, V104, P2051, DOI 10.1161/hc4201.097839	43	37	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e67927	10.1371/journal.pone.0067927	http://dx.doi.org/10.1371/journal.pone.0067927			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894291	Green Published, Green Submitted, gold			2022-12-27	WOS:000322167900007
J	Fung, AM; Wilson, DL; Lappas, M; Howard, M; Barnes, M; O'Donoghue, F; Tong, S; Esdale, H; Fleming, G; Walker, SP				Fung, Alison M.; Wilson, Danielle L.; Lappas, Martha; Howard, Mark; Barnes, Maree; O'Donoghue, Fergal; Tong, Stephen; Esdale, Helen; Fleming, Gabrielle; Walker, Susan P.			Effects of Maternal Obstructive Sleep Apnoea on Fetal Growth: A Prospective Cohort Study	PLOS ONE			English	Article							GESTATIONAL-AGE INFANTS; BIRTH-WEIGHT CENTILES; RISK-FACTORS; CORD BLOOD; PREGNANCY; STILLBIRTH; PREDICTION; TERM; RESTRICTION; INTERLEUKIN-6	Objective: The objective of this study is to determine whether obstructive sleep apnea (OSA) is associated with reduced fetal growth, and whether nocturnal oxygen desaturation precipitates acute fetal heart rate changes. Study Design: We performed a prospective observational study, screening 371 women in the second trimester for OSA symptoms. 41 subsequently underwent overnight sleep studies to diagnose OSA. Third trimester fetal growth was assessed using ultrasound. Fetal heart rate monitoring accompanied the sleep study. Cord blood was taken at delivery, to measure key regulators of fetal growth. Results: Of 371 women screened, 108 (29%) were high risk for OSA. 26 high risk and 15 low risk women completed the longitudinal study; 14 had confirmed OSA (cases), and 27 were controls. The median (interquartile range) respiratory disturbance index (number of apnoeas, hypopnoeas or respiratory related arousals/hour of sleep) was 7.9 (6.1-13.8) for cases and 2.2 (1.3-3.5) for controls (p<0.001). Impaired fetal growth was observed in 43% (6/14) of cases, vs 11% (3/27) of controls (RR 2.67; 1.25-5.7; p = 0.04). Using logistic regression, only OSA (OR 6; 1.2-29.7, p = 0.03) and body mass index (OR 2.52; 1.09-5.80, p = 0.03) were significantly associated with impaired fetal growth. After adjusting for body mass index on multivariate analysis, the association between OSA and impaired fetal growth was not appreciably altered (OR 5.3; 0.93-30.34, p = 0.06), although just failed to achieve statistical significance. Prolonged fetal heart rate decelerations accompanied nocturnal oxygen desaturation in one fetus, subsequently found to be severely growth restricted. Fetal growth regulators showed changes in the expected direction-with IGF-1 lower, and IGFBP-1 and IGFBP-2 higher-in the cord blood of infants of cases vs controls, although were not significantly different. Conclusion: OSA may be associated with reduced fetal growth in late pregnancy. Further evaluation is warranted to establish whether OSA may be an important contributor to adverse perinatal outcome, including stillbirth.	[Fung, Alison M.; Esdale, Helen; Walker, Susan P.] Mercy Hosp Women, Dept Perinatal Med, Melbourne, Vic, Australia; [Lappas, Martha; Tong, Stephen; Fleming, Gabrielle; Walker, Susan P.] Univ Melbourne, Mercy Hosp Women, Dept Obstet & Gynaecol, Melbourne, Vic, Australia; [Howard, Mark; Barnes, Maree; O'Donoghue, Fergal] Austin Hlth, Inst Breathing & Sleep, Melbourne, Vic, Australia; [Howard, Mark; Barnes, Maree; O'Donoghue, Fergal] Univ Melbourne, Dept Med, Melbourne, Vic, Australia	University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Institute for Breathing & Sleep (IBAS); University of Melbourne	Walker, SP (corresponding author), Mercy Hosp Women, Dept Perinatal Med, Melbourne, Vic, Australia.	spwalker@unimelb.edu.au	Wilson, Danielle/AAF-4258-2019	Howard, Mark/0000-0001-7772-1496; Walker, Susan Phillipa/0000-0001-9075-4655; Tong, Stephen/0000-0002-2319-0586	Victorian Managed Insurance Agency; Australian Stillbirth Alliance; Medical Research Foundation for Women and Babies; Austin Medical Research Foundation	Victorian Managed Insurance Agency; Australian Stillbirth Alliance; Medical Research Foundation for Women and Babies; Austin Medical Research Foundation	The authors acknowledge the funding support for this project from the Victorian Managed Insurance Agency, the Australian Stillbirth Alliance, the Medical Research Foundation for Women and Babies and the Austin Medical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NH, 2012, BJOG-INT J OBSTET GY, V119, P848, DOI 10.1111/j.1471-0528.2012.03313.x; Arendas K, 2008, J OBSTET GYNAECOL CA, V30, P477, DOI 10.1016/S1701-2163(16)32863-8; Bardien N, 2012, J PAEDIAT CHILD HL S, V48; Boers KE, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c7087; Chen YH, 2012, AM J OBSTET GYNECOL, V206, pE1, DOI 10.1016/j.ajog.2011.12.013; Chu SY, 2007, AM J OBSTET GYNECOL, V197, P223, DOI 10.1016/j.ajog.2007.03.027; Chung F., 2011, OPEN ANESTH J, V5, P7; Cockerill R, 2012, PAEDIATR PERINAT EP, V26, P117, DOI 10.1111/j.1365-3016.2011.01247.x; Cox SM, 2001, INT J GYNECOL OBSTET, V72, P85; de Jong CLD, 1999, ULTRASOUND OBST GYN, V13, P86, DOI 10.1046/j.1469-0705.1999.13020086.x; Epstein LJ, 2009, J CLIN SLEEP MED, V5, P263; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; Forbes K, 2008, HORM RES, V69, P129, DOI 10.1159/000112585; Franco CMR, 2012, J MOL NEUROSCI, V47, P300, DOI 10.1007/s12031-012-9738-0; Franklin KA, 2000, CHEST, V117, P137, DOI 10.1378/chest.117.1.137; Garcia-Rio F, 2000, CHEST, V117, P1417, DOI 10.1378/chest.117.5.1417; Gardosi J, 2005, BMJ-BRIT MED J, V331, P1113, DOI 10.1136/bmj.38629.587639.7C; Gardosi J, 1998, BRIT J OBSTET GYNAEC, V105, P524, DOI 10.1111/j.1471-0528.1998.tb10153.x; Gardosi J, 2009, BJOG-INT J OBSTET GY, V116, P1356, DOI 10.1111/j.1471-0528.2009.02245.x; Gardosi J., 2009, CUSTOMISED WEIGHT CE; Gardosi J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f108; Guilleminault C, 2005, SLEEP, V5, P43; Iber C., 2007, AASM MANUAL SCORING; Illa M, 2009, J PERINAT MED, V37, P48, DOI 10.1515/JPM.2009.003; Iraola A, 2008, J PERINAT MED, V36, P531, DOI 10.1515/JPM.2008.100; Keyes LE, 2003, PEDIATR RES, V54, P20, DOI 10.1203/01.PDR.0000069846.64389.DC; Ko HS, 2013, ARCH GYNECOL OBSTET, V287, P429, DOI 10.1007/s00404-012-2602-1; Kovo M, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.012; Loube DI, 1996, CHEST, V109, P885, DOI 10.1378/chest.109.4.885; Louis JM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.10.867; MAISLIN G, 1995, SLEEP, V18, P158, DOI 10.1093/sleep/18.3.158; McCowan LME, 2010, BJOG-INT J OBSTET GY, V117, P1599, DOI 10.1111/j.1471-0528.2010.02737.x; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; Odibo AO, 2012, ULTRASOUND OBST GYN, V39, P288, DOI 10.1002/uog.9036; Olivarez SA, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.12.008; Ong K, 2000, J CLIN ENDOCR METAB, V85, P4266, DOI 10.1210/jc.85.11.4266; Sahin FK, 2008, INT J GYNECOL OBSTET, V100, P141, DOI 10.1016/j.ijgo.2007.08.012; Smerieri A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029562; Smith-Bindman R, 2002, RADIOLOGY, V223, P153, DOI 10.1148/radiol.2231010876; Street ME, 2006, EUR J ENDOCRINOL, V155, P567, DOI 10.1530/eje.1.02251; Ugur MG, 2012, CLIN EXP OBSTET GYN, V39, P214; Umbers AJ, 2011, J INFECT DIS, V203, P561, DOI 10.1093/infdis/jiq080; Wilson DL, 2011, J SLEEP RES S1, V20, P27; Yokoe T, 2003, CIRCULATION, V107, P1129, DOI 10.1161/01.CIR.0000052627.99976.18	45	68	69	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e68057	10.1371/journal.pone.0068057	http://dx.doi.org/10.1371/journal.pone.0068057			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894293	gold, Green Submitted, Green Published			2022-12-27	WOS:000322167900008
J	Jamilloux, Y; Liozon, E; Pugnet, G; Nadalon, S; Ly, KH; Dumonteil, S; Gondran, G; Fauchais, AL; Vidal, E				Jamilloux, Yvan; Liozon, Eric; Pugnet, Gregory; Nadalon, Sylvie; Ly, Kim Heang; Dumonteil, Stephanie; Gondran, Guillaume; Fauchais, Anne-Laure; Vidal, Elisabeth			Recovery of Adrenal Function after Long-Term Glucocorticoid Therapy for Giant Cell Arteritis: A Cohort Study	PLOS ONE			English	Article							CORTISOL; INSUFFICIENCY; AXIS	Objectives: Giant cell arteritis (GCA) is a chronic systemic vasculitis of large and medium-sized arteries, for which long-term glucocorticoid (GC) treatment is needed. During GC withdrawal patients can suffer adrenal insufficiency. We sought to determine the time until recovery of adrenal function after long-term GC therapy, and to assess the prevalence and predictors for secondary adrenal insufficiency. Subjects and Design: 150 patients meeting the ACR criteria for GCA between 1984 and 2012 were analyzed. All received the same GC treatment protocol. The low-dose ACTH stimulation test was repeated annually until adrenal recovery. Biographical, clinical and laboratory data were collected prospectively and compared. Results: At the first ACTH test, 74 (49%) patients were non-responders: of these, the mean time until recovery of adrenal function was 14 months (max: 51 months). A normal test response occurred within 36 months in 85% of patients. However, adrenal function never recovered in 5% of patients. GC of >15 mg/day at 6 months, GC of >9.5 mg/day at 12 months, treatment duration of >19 months, a cumulative GC dose of >8.5 g, and a basal cortisol concentration of <386 nmol/L were all statistically associated with a negative response in the first ACTH test (p <0.05). Conclusion: Adrenal insufficiency in patients with GCA, treated long-term with GC, was frequent but transitory. Thus, physicians' vigilance should be increased and an ACTH test should be performed when GC causes the above associated statistical factors.	[Jamilloux, Yvan; Liozon, Eric; Nadalon, Sylvie; Ly, Kim Heang; Dumonteil, Stephanie; Gondran, Guillaume; Fauchais, Anne-Laure; Vidal, Elisabeth] Limoges Univ Hosp, Dept Internal Med, Limoges, France; [Pugnet, Gregory] Univ Toulouse, Hop Purpan, Dept Internal Med, Toulouse, France	CHU Limoges; CHU de Toulouse; Universite de Toulouse	Jamilloux, Y (corresponding author), Limoges Univ Hosp, Dept Internal Med, Limoges, France.	yvanjamilloux@hotmail.com	Jamilloux, Yvan/F-6601-2019; Pugnet, Gregory/V-2867-2019; Ly, Kim/AAN-4092-2021	Jamilloux, Yvan/0000-0001-5249-3650; Ly, Kim Heang/0000-0002-8511-903X; Fauchais, Anne Laure/0000-0002-0489-8570				Borchers AT, 2012, AUTOIMMUN REV, V11, pA544, DOI 10.1016/j.autrev.2012.01.003; Bornstein SR, 2009, NEW ENGL J MED, V360, P2328, DOI 10.1056/NEJMra0804635; DICKSTEIN G, 1991, J CLIN ENDOCR METAB, V72, P773, DOI 10.1210/jcem-72-4-773; Dorin RI, 2003, ANN INTERN MED, V139, P194, DOI 10.7326/0003-4819-139-3-200308050-00009; Giordano R, 2001, CLIN ENDOCRINOL, V55, P259, DOI 10.1046/j.1365-2265.2001.01317.x; Goichot B, 2000, ANN ENDOCRINOL-PARIS, V61, P452; Huber BM, 2010, ACTA PAEDIATR, V99, P1889, DOI 10.1111/j.1651-2227.2010.01936.x; HUNDER GG, 1975, ANN INTERN MED, V82, P613, DOI 10.7326/0003-4819-82-5-613; Kazlauskaite R, 2008, J CLIN ENDOCR METAB, V93, P4245, DOI 10.1210/jc.2008-0710; Lansang MC, 2011, CLEV CLIN J MED, V78, P748, DOI 10.3949/ccjm.78a.10180; LAROCHELLE GE, 1993, AM J MED, V95, P258, DOI 10.1016/0002-9343(93)90277-V; LIVANOU T, 1967, LANCET, V2, P856; Luca F, 2013, REV MED INTERNE, V34, P324, DOI 10.1016/j.revmed.2012.12.001; Pacheco MJB, 2003, SEMIN ARTHRITIS RHEU, V32, P266, DOI 10.1053/sarh.2003.49993; Pugnet G, 2010, REV MED INTERNE, V31, P332, DOI 10.1016/j.revmed.2009.12.006; SAMPSON PA, 1962, LANCET, V2, P322; Straub RH, 2002, ARTHRITIS RHEUM, V46, P654, DOI 10.1002/art.10177; WALTMAN C, 1991, J CLIN ENDOCR METAB, V73, P495, DOI 10.1210/jcem-73-3-495; WOOD JB, 1965, LANCET, V1, P243	19	39	39	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e68713	10.1371/journal.pone.0068713	http://dx.doi.org/10.1371/journal.pone.0068713			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894335	Green Published, gold, Green Submitted			2022-12-27	WOS:000322167900021
J	Sperati, F; Vici, P; Maugeri-Sacca, M; Stranges, S; Santesso, N; Mariani, L; Giordano, A; Sergi, D; Pizzuti, L; Di Lauro, L; Montella, M; Crispo, A; Mottolese, M; Barba, M				Sperati, Francesca; Vici, Patrizia; Maugeri-Sacca, Marcello; Stranges, Saverio; Santesso, Nancy; Mariani, Luciano; Giordano, Antonio; Sergi, Domenico; Pizzuti, Laura; Di Lauro, Luigi; Montella, Maurizio; Crispo, Anna; Mottolese, Marcella; Barba, Maddalena			Vitamin D Supplementation and Breast Cancer Prevention: A Systematic Review and Meta-Analysis of Randomized Clinical Trials	PLOS ONE			English	Review							SERUM 25-HYDROXYVITAMIN D; FAT DIETARY PATTERN; PLACEBO-CONTROLLED TRIAL; BONE-MINERAL DENSITY; PROSTATE-CANCER; POSTMENOPAUSAL WOMEN; COLORECTAL-CANCER; CALCIUM SUPPLEMENTATION; ANTIOXIDANT VITAMINS; CARDIOVASCULAR-DISEASE	In recent years, the scientific evidence linking vitamin D status or supplementation to breast cancer has grown notably. To investigate the role of vitamin D supplementation on breast cancer incidence, we conducted a systematic review and meta-analysis of randomized controlled trials comparing vitamin D with placebo or no treatment. We used OVID to search MEDLINE (R), EMBASE and CENTRAL until April 2012. We screened the reference lists of included studies and used the "Related Article'' feature in PubMed to identify additional articles. No language restrictions were applied. Two reviewers independently extracted data on methodological quality, participants, intervention, comparison and outcomes. Risk Ratios and 95% Confident Intervals for breast cancer were pooled using a random-effects model. Heterogeneity was assessed using the I-2 test. In sensitivity analysis, we assessed the impact of vitamin D dosage and mode of administration on treatment effects. Only two randomized controlled trials fulfilled the pre-set inclusion criteria. The pooled analysis included 5372 postmenopausal women. Overall, Risk Ratios and 95% Confident Intervals were 1.11 and 0.74-1.68. We found no evidence of heterogeneity. Neither vitamin D dosage nor mode of administration significantly affected breast cancer risk. However, treatment efficacy was somewhat greater when vitamin D was administered at the highest dosage and in combination with calcium (Risk Ratio 0.58, 95% Confident Interval 0.23-1.47 and Risk Ratio 0.93, 95% Confident Interval 0.54-1.60, respectively). In conclusions, vitamin D use seems not to be associated with a reduced risk of breast cancer development in postmenopausal women. However, the available evidence is still limited and inadequate to draw firm conclusions. Study protocol code: FARM8L2B5L.	[Sperati, Francesca] Regina Elena Inst Canc Res, Bostat Sci Direct, Rome, Italy; [Vici, Patrizia; Sergi, Domenico; Pizzuti, Laura; Di Lauro, Luigi] Regina Elena Inst Canc Res, Div Med Oncol B, Rome, Italy; [Maugeri-Sacca, Marcello; Barba, Maddalena] Regina Elena Inst Canc Res, Div Med Oncol B, Sci Direct, Rome, Italy; [Stranges, Saverio] Warwick Med Sch, Coventry, W Midlands, England; [Santesso, Nancy] McMaster Univ, Hlth Sci Ctr, Dept Clin Epidemiol & Biostat, Hamilton, ON L8S 4L8, Canada; [Mariani, Luciano] Regina Elena Inst Canc Res, Div Gynecol Oncol, Rome, Italy; [Giordano, Antonio] Temple Univ, Sbarro Inst Canc Res & Mol Med, Philadelphia, PA 19122 USA; [Giordano, Antonio] Temple Univ, Ctr Biotechnol, Philadelphia, PA 19122 USA; [Montella, Maurizio; Crispo, Anna] Natl Canc Inst, G Pascale Fdn, Epidemiol Unit, Naples, Italy; [Mottolese, Marcella] Regina Elena Inst Canc Res, Dept Pathol, Rome, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; University of Warwick; McMaster University; University of Manitoba; Children's Hospital Research Institute of Manitoba; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; IRCCS Fondazione Pascale; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena	Barba, M (corresponding author), Regina Elena Inst Canc Res, Div Med Oncol B, Sci Direct, Rome, Italy.	maddalena.barba@gmail.com	Maugeri-Saccà, Marcello/K-2350-2014; Giordano, Antonio/F-1927-2010; Sergi, Domenico/K-5832-2016; Crispo, Anna/ABA-7435-2020; Sperati, Francesca/K-5843-2016; Giordano, Antonio/AAU-1201-2020; Barba, Maddalena/K-7277-2018	Maugeri-Saccà, Marcello/0000-0003-2287-9581; Giordano, Antonio/0000-0002-5959-016X; Sergi, Domenico/0000-0002-8639-5378; Sperati, Francesca/0000-0002-6038-2798; Giordano, Antonio/0000-0002-5959-016X; Crispo, Anna/0000-0002-8455-3328; Barba, Maddalena/0000-0001-9050-2917; Stranges, Saverio/0000-0001-5226-8373; Vici, Patrizia/0000-0001-7528-9783	Italian Medicines Agency (AIFA) [FARM8L2B5L]	Italian Medicines Agency (AIFA)	This project was supported by grant code FARM8L2B5L from the Italian Medicines Agency (AIFA). The content is solely the responsibility of the authors and does not necessarily represent the official views of the financing institution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir E, 2012, BREAST CANCER RES TR, V133, P1077, DOI 10.1007/s10549-012-2012-x; Attia S, 2008, CLIN CANCER RES, V14, P2437, DOI 10.1158/1078-0432.CCR-07-4274; Autier P, 2007, ARCH INTERN MED, V167, P1730, DOI 10.1001/archinte.167.16.1730; Avenell A, 2012, J CLIN ENDOCR METAB, V97, P614, DOI 10.1210/jc.2011-1309; Beer TM, 2005, CLIN CANCER RES, V11, P7794, DOI 10.1158/1078-0432.CCR-05-0552; Beer TM, 2004, AM J CLIN ONCOL-CANC, V27, P535, DOI 10.1097/01.coc.0000136020.27904.9c; Beer TM, 2008, CANCER, V112, P2377, DOI 10.1002/cncr.23461; Beer TM, 2007, CANCER CHEMOTH PHARM, V59, P581, DOI 10.1007/s00280-006-0299-1; Beresford SAA, 2006, JAMA-J AM MED ASSOC, V295, P643, DOI 10.1001/jama.295.6.643; Bischoff-Ferrari HA, 2006, AM J CLIN NUTR, V84, P18, DOI 10.1093/ajcn/84.1.18; Bjelakovic G, 2008, COCHRANE DATABASE SY, V4; Boscoe FP, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-264; Chlebowski RT, 2008, JNCI-J NATL CANCER I, V100, P1581, DOI 10.1093/jnci/djn360; Chung M, 2011, ANN INTERN MED, V155, P827, DOI 10.7326/0003-4819-155-12-201112200-00005; Ding EL, 2008, INT J CANCER, V122, P1690, DOI 10.1002/ijc.23311; Dizdar O, 2008, BREAST, V17, P120, DOI 10.1016/j.breast.2007.10.013; Egger M, 2001, SYSTEMATIC REV HLTH; Eliassen AH, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2880; Ellis GK, 2008, J CLIN ONCOL, V26, P4875, DOI 10.1200/JCO.2008.16.3832; Fakih MG, 2007, CLIN CANCER RES, V13, P1216, DOI 10.1158/1078-0432.CCR-06-1165; Fedirko V, 2012, CANCER CAUSE CONTROL, V23, P1149, DOI 10.1007/s10552-012-9984-z; Fedirko V, 2009, CANCER PREV RES, V2, P213, DOI 10.1158/1940-6207.CAPR-08-0157; Femiano F, 2001, INT J ORAL MAX SURG, V30, P402, DOI 10.1054/ijom.2001.0107; Finkelstein JS, 2006, NEW ENGL J MED, V354, P750, DOI 10.1056/NEJMe068007; Forman MR, 2006, NEW ENGL J MED, V354, P752, DOI 10.1056/NEJMe068006; Freedman DM, 2010, CANCER RES, V70, P8587, DOI 10.1158/0008-5472.CAN-10-1420; Freedman DM, 1999, CANCER EPIDEM BIOMAR, V8, P1115; Frost P, 2009, J NATL MED ASSOC, V101, P1310, DOI 10.1016/S0027-9684(15)31151-2; Galan P, 2003, REV EPIDEMIOL SANTE, V51, P147; Garland CF, 2007, NUTR REV, V65, pS91, DOI 10.1111/j.1753-4887.2007.tb00349.x; GARLAND FC, 1990, PREV MED, V19, P614, DOI 10.1016/0091-7435(90)90058-R; Garssen J, 1998, J PHOTOCH PHOTOBIO B, V42, P167, DOI 10.1016/S1011-1344(97)00122-X; Giovannucci E, 2005, CANCER CAUSE CONTROL, V16, P83, DOI 10.1007/s10552-004-1661-4; Glen H, 2006, EXPERT REV ANTICANC, V6, P305, DOI 10.1586/14737140.6.3.305; Glinghammar B, 1997, AM J CLIN NUTR, V66, P1277, DOI 10.1093/ajcn/66.5.1277; Goodwin PJ, 2009, J CLIN ONCOL, V27, P2117, DOI 10.1200/JCO.2008.20.8629; GORHAM ED, 1990, INT J EPIDEMIOL, V19, P820, DOI 10.1093/ije/19.4.820; Grant WB, 2003, RECENT RESULTS CANC, V164, P371; Grant WB, 2002, CANCER-AM CANCER SOC, V94, P272, DOI 10.1002/cncr.10196; Grant WB, 2008, AM J PATHOL, V173, P1589, DOI 10.2353/ajpath.2008.080579; Grant WB, 2008, INT J EPIDEMIOL, V37, P1209, DOI 10.1093/ije/dyn172; Grau MV, 2003, J NATL CANCER I, V95, P1765, DOI 10.1093/jnci/djg110; GROBER U, 2009, DTSCH APOTH-ZTG, V149, P62; Gross C, 1998, J UROLOGY, V159, P2035, DOI 10.1016/S0022-5347(01)63236-1; Hager ED, 2006, DTSCH Z ONKOLOGIE, V38, P32; Harstrick A, 2000, ONKOLOGE, V6, P443; Hartman AL, 2002, CLIN PEDIATR, V41, P731, DOI 10.1177/000992280204100916; Hartman J J, 2000, Orthop Nurs, V19, P63, DOI 10.1097/00006416-200019010-00013; Hartman TJ, 2005, J NUTR, V135, P252; Harvey JA, 2009, MENOPAUSE, V16, P1193, DOI 10.1097/gme.0b013e3181a7fb1e; Heinonen OP, 1998, J NATL CANCER I, V90, P440, DOI 10.1093/jnci/90.6.440; HELLSTROM E, 1990, EUR J HAEMATOL, V45, P255; Henriksen DB, 2009, BONE, V45, P833, DOI 10.1016/j.bone.2009.07.008; Hercberg S, 2004, ARCH INTERN MED, V164, P2335, DOI 10.1001/archinte.164.21.2335; Hercberg S, 1999, FOOD CHEM TOXICOL, V37, P925, DOI 10.1016/S0278-6915(99)00078-2; Hercberg S, 2007, J NUTR, V137, P2098, DOI 10.1093/jn/137.9.2098; Hercberg S, 2006, BRIT J NUTR, V96, pS28, DOI 10.1079/BJN20061695; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hines SL, 2010, NUTRITION, V26, P255, DOI 10.1016/j.nut.2009.08.020; Hines SL, 2009, BREAST CANCER RES TR, V117, P603, DOI 10.1007/s10549-009-0332-2; Hines SL, 2009, J CLIN ONCOL, V27, P1047, DOI 10.1200/JCO.2008.19.1783; Holick MF, 2004, AM J CLIN NUTR, V79, P362; Holick MF, 2006, NEW ENGL J MED, V354, P2287; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Hollis BW, 2004, AM J CLIN NUTR, V80, p1752S, DOI 10.1093/ajcn/80.6.1752S; Holt PR, 2002, CANCER EPIDEM BIOMAR, V11, P113; Howard BV, 2006, JAMA-J AM MED ASSOC, V295, P655, DOI 10.1001/jama.295.6.655; Inanir A, 2004, J INT MED RES, V32, P570, DOI 10.1177/147323000403200602; Ingraham BA, 2008, CURR MED RES OPIN, V24, P139, DOI 10.1185/030079907X253519; Jacobs ET, 2009, CANCER PREV RES, V2, P197, DOI 10.1158/1940-6207.CAPR-09-0019; Jacobs TP, 2005, J CLIN ENDOCR METAB, V90, P6316, DOI 10.1210/jc.2005-0675; Ji Y, 2002, CELL CYCLE, V1, P410, DOI 10.4161/cc.1.6.269; Jorde R, 2010, AM J EPIDEMIOL, V171, P903, DOI 10.1093/aje/kwq005; Kerst A, 2007, GENEESMIDDELENBULLET, V41, P133; Kuhn T, 2013, INT J CANCER, DOI [10.1002/ijc.28172.2013, DOI 10.1002/IJC.28172.2013]; Kulbersh JS, 2009, OTOLARYNG HEAD NECK, V140, P235, DOI 10.1016/j.otohns.2008.11.011; LaCroix AZ, 2009, J GERONTOL A-BIOL, V64, P559, DOI 10.1093/gerona/glp006; Lappe JM, 2007, AM J CLIN NUTR, V85, P1586, DOI 10.1093/ajcn/85.6.1586; Lehmann B, 2004, EXP DERMATOL, V13, P11, DOI 10.1111/j.1600-0625.2004.00257.x; Lin J, 2007, ARCH INTERN MED, V167, P1050, DOI 10.1001/archinte.167.10.1050; Lips P, 2001, J CLIN ENDOCR METAB, V86, P1212, DOI 10.1210/jc.86.3.1212; Manson JE, 2012, CONTEMP CLIN TRIALS, V33, P159, DOI 10.1016/j.cct.2011.09.009; Markopoulos C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2565; Millen AE, 2010, AM J CLIN NUTR, V91, P1324, DOI 10.3945/ajcn.2009.28908; Mohr SB, 2011, ANTICANCER RES, V31, P2939; Neuhouser ML, 2001, NUTR CANCER, V39, P12, DOI 10.1207/S15327914nc391_2; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Perez EA, 2006, J CLIN ONCOL, V24, P3629, DOI 10.1200/JCO.2005.05.4882; Prentice RL, 2008, ANNU REV PUBL HEALTH, V29, P131, DOI 10.1146/annurev.publhealth.29.020907.090947; Price Nancy, 2004, Clin Prostate Cancer, V2, P202; Pritchard RS, 1996, CANCER EPIDEM BIOMAR, V5, P897; Qiao SJ, 2003, J STEROID BIOCHEM, V85, P1, DOI 10.1016/S0960-0760(03)00142-0; Raimondi S, 2009, CARCINOGENESIS, V30, P1170, DOI 10.1093/carcin/bgp103; Recker RR, 1999, ANN INTERN MED, V130, P897, DOI 10.7326/0003-4819-130-11-199906010-00005; Rejnmark L, 2012, J CLIN ENDOCR METAB, V97, P2670, DOI 10.1210/jc.2011-3328; Roh JL, 2009, CANCER-AM CANCER SOC, V115, P251, DOI 10.1002/cncr.24027; Rohan TE, 2008, CANCER PREV RES, V1, P275, DOI 10.1158/1940-6207.CAPR-08-0003; Ryan CW, 2007, UROLOGY, V70, P122, DOI 10.1016/j.urology.2007.03.026; Schilsky RL, 2010, ONCOLOGIST, V15, P484, DOI 10.1634/theoncologist.2010-0079; Schumann SA, 2007, J FAM PRACTICE, V56, P907; Schwartz GG, 2007, CURR OPIN CLIN NUTR, V10, P6; Schwartz GG, 2006, J NATL CANCER I, V98, P428, DOI 10.1093/jnci/djj127; Sidelnikov E, 2010, CANCER EPIDEM BIOMAR, V19, P1022, DOI 10.1158/1055-9965.EPI-09-0526; Sieg J, 2006, ANTICANCER RES, V26, P2729; Skinner HG, 2008, CANCER BIOL THER, V7, P437, DOI 10.4161/cbt.7.3.5585; Spina CS, 2006, ANTICANCER RES, V26, P2515; STERN PH, 1991, MOL PHARMACOL, V39, P557; Sutton AJAK, 2000, METHODS METAANALYSIS; Trivedi DP, 2003, BMJ-BRIT MED J, V326, P469, DOI 10.1136/bmj.326.7387.469; Van Veldhuizen PJ, 2000, J UROLOGY, V163, P187, DOI 10.1016/S0022-5347(05)68001-9; VANDERWIELEN RPJ, 1995, LANCET, V346, P207, DOI 10.1016/S0140-6736(95)91266-5; Verner AM, 2007, COCHRANE DATABASE SY, V4; Wactawski-Wende J, 2006, NEW ENGL J MED, V354, P684, DOI 10.1056/NEJMoa055222; Williamson CS, 2006, NUTR BULL, V31, P77, DOI 10.1111/j.1467-3010.2006.00558.x; Witham MD, 2010, CIRC-HEART FAIL, V3, P195, DOI 10.1161/CIRCHEARTFAILURE.109.907899; Wong SSL, 2006, J MED LIBR ASSOC, V94, P451; Woo TCS, 2005, NUTR CANCER, V51, P32, DOI 10.1207/s15327914nc5101_5; Wood HM, 2000, PROSTATE J, V2, P6; Yin L, 2010, EUR J CANCER, V46, P2196, DOI 10.1016/j.ejca.2010.03.037; YOSHIDA Y, 1993, INT J CLIN PHARM RES, V13, P21; Zhou FL, 2008, J EXPT HEMATOLOGY, V13, P8961; Zhou W, 2005, CANCER EPIDEM BIOMAR, V14, P2303, DOI 10.1158/1055-9965.EPI-05-0335; Zittermann A, 2005, BRIT J NUTR, V94, P483, DOI 10.1079/BJN20051544	124	39	40	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69269	10.1371/journal.pone.0069269	http://dx.doi.org/10.1371/journal.pone.0069269			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894438	Green Submitted, Green Published, gold			2022-12-27	WOS:000322132100051
J	Wotus, C; Lilley, TR; Neal, AS; Suleiman, NL; Schmuck, SC; Smarr, BL; Fischer, BJ; de la Iglesia, HO				Wotus, Cheryl; Lilley, Travis R.; Neal, Adam S.; Suleiman, Nicole L.; Schmuck, Stefanie C.; Smarr, Benjamin L.; Fischer, Brian J.; de la Iglesia, Horacio O.			Forced Desynchrony Reveals Independent Contributions of Suprachiasmatic Oscillators to the Daily Plasma Corticosterone Rhythm in Male Rats	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; CIRCADIAN-RHYTHMS; ADRENAL SENSITIVITY; SHIFT WORK; ADRENOCORTICOTROPIC HORMONE; LOCOMOTOR-ACTIVITY; BODY-TEMPERATURE; GENE-EXPRESSION; NEURAL ACTIVITY; DIURNAL RHYTHM	The suprachiasmatic nucleus (SCN) is required for the daily rhythm of plasma glucocorticoids; however, the independent contributions from oscillators within the different subregions of the SCN to the glucocorticoid rhythm remain unclear. Here, we use genetically and neurologically intact, forced desynchronized rats to test the hypothesis that the daily rhythm of the glucocorticoid, corticosterone, is regulated by both light responsive and light-dissociated circadian oscillators in the ventrolateral (vl-) and dorsomedial (dm-) SCN, respectively. We show that when the vlSCN and dmSCN are in maximum phase misalignment, the peak of the plasma corticosterone rhythm is shifted and the amplitude reduced; whereas, the peak of the plasma adrenocorticotropic hormone (ACTH) rhythm is also reduced, the phase is dissociated from that of the corticosterone rhythm. These data support previous studies suggesting an ACTH-independent pathway contributes to the corticosterone rhythm. To determine if either SCN subregion independently regulates corticosterone through the sympathetic nervous system, we compared unilateral adrenalectomized, desynchronized rats that had undergone either transection of the thoracic splanchnic nerve or sham transection to the remaining adrenal. Splanchnicectomy reduced and phase advanced the peak of both the corticosterone and ACTH rhythms. These data suggest that both the vlSCN and dmSCN contribute to the corticosterone rhythm by both reducing plasma ACTH and differentially regulating plasma corticosterone through an ACTH- and sympathetic nervous system-independent pathway.	[Wotus, Cheryl; Neal, Adam S.; Suleiman, Nicole L.; Schmuck, Stefanie C.] Seattle Univ, Dept Biol, Seattle, WA 98122 USA; [Lilley, Travis R.; Smarr, Benjamin L.; de la Iglesia, Horacio O.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Smarr, Benjamin L.; de la Iglesia, Horacio O.] Univ Washington, Program Neurobiol & Behav, Seattle, WA 98195 USA; [Fischer, Brian J.] Seattle Univ, Dept Math, Seattle, WA 98122 USA	Seattle University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle University	Wotus, C (corresponding author), Seattle Univ, Dept Biol, Seattle, WA 98122 USA.	wotusc@seattleu.edu		Smarr, Benjamin/0000-0003-4442-3956	Murdock College Research Program for Life Sciences Grant [2008363:JVZ:02/26/09]; NIH [R01MH075016, R03HD061853]; NIGMS NRSA [2T32 GM007270]; NSF [DDIG 0909716]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD061853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH075016] Funding Source: NIH RePORTER	Murdock College Research Program for Life Sciences Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported by Murdock College Research Program for Life Sciences Grant (http://www.murdock-trust.org/): 2008363:JVZ:02/26/09 to Cheryl Wotus; NIH (http://www.nih.gov/): R01MH075016 and R03HD061853 to Horacio de la Iglesia, NIGMS NRSA 2T32 GM007270 to Travis Lilley; NSF (http://www.nsf.gov/) DDIG 0909716 to Horacio de la Iglesia and Benjamin Smarr. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE K, 1979, NEUROENDOCRINOLOGY, V29, P119, DOI 10.1159/000122913; AKANA SF, 1986, ENDOCRINOLOGY, V119, P2325, DOI 10.1210/endo-119-5-2325; ALEXANDER LD, 1994, REGUL PEPTIDES, V51, P221, DOI 10.1016/0167-0115(94)90068-X; BUIJS RM, 1993, AM J PHYSIOL, V264, pR1186, DOI 10.1152/ajpregu.1993.264.6.R1186; Buijs RM, 1999, EUR J NEUROSCI, V11, P1535, DOI 10.1046/j.1460-9568.1999.00575.x; Cambras T, 2007, P NATL ACAD SCI USA, V104, P7634, DOI 10.1073/pnas.0702424104; CASCIO CS, 1987, BRAIN RES, V423, P173, DOI 10.1016/0006-8993(87)90837-7; Colwell CS, 2011, NAT REV NEUROSCI, V12, P553, DOI 10.1038/nrn3086; DALLMAN MF, 1978, AM J PHYSIOL, V235, pR210, DOI 10.1152/ajpregu.1978.235.5.R210; de la Iglesia HO, 2004, CURR BIOL, V14, P796, DOI 10.1016/j.cub.2004.04.034; Dijkstra I, 1996, ENDOCRINOLOGY, V137, P540, DOI 10.1210/en.137.2.540; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Gomez F, 1997, J NEUROSCI RES, V50, P565, DOI 10.1002/(SICI)1097-4547(19971115)50:4<565::AID-JNR7>3.0.CO;2-C; Haus E, 2006, CANCER CAUSE CONTROL, V17, P489, DOI 10.1007/s10552-005-9015-4; Ishida A, 2005, CELL METAB, V2, P297, DOI 10.1016/j.cmet.2005.09.009; JASPER MS, 1991, AM J PHYSIOL, V261, pR1257, DOI 10.1152/ajpregu.1991.261.5.R1257; JASPER MS, 1994, NEUROENDOCRINOLOGY, V59, P97, DOI 10.1159/000126645; Jasper MS, 1997, AM J PHYSIOL-ENDOC M, V273, pE363, DOI 10.1152/ajpendo.1997.273.2.E363; KALSBEEK A, 1992, BRAIN RES, V580, P62, DOI 10.1016/0006-8993(92)90927-2; Kalsbeek A, 2012, MOL CELL ENDOCRINOL, V349, P20, DOI 10.1016/j.mce.2011.06.042; Kalsbeek A, 1996, J NEUROSCI, V16, P5555, DOI 10.1523/jneurosci.16-17-05555.1996; Kalsbeek A, 1996, J NEUROENDOCRINOL, V8, P299, DOI 10.1046/j.1365-2826.1996.04597.x; KANEKO M, 1981, ENDOCRINOLOGY, V109, P70, DOI 10.1210/endo-109-1-70; KANEKO M, 1980, AM J PHYSIOL, V239, pR309, DOI 10.1152/ajpregu.1980.239.3.R309; Karlsson B, 2001, OCCUP ENVIRON MED, V58, P747, DOI 10.1136/oem.58.11.747; KRIEGER DT, 1977, SCIENCE, V197, P398, DOI 10.1126/science.877566; Kroenke CH, 2007, AM J EPIDEMIOL, V165, P175, DOI 10.1093/aje/kwj355; Lee ML, 2009, CURR BIOL, V19, P848, DOI 10.1016/j.cub.2009.03.051; Lilley TR, 2012, ENDOCRINOLOGY, V153, P732, DOI 10.1210/en.2011-1624; Loh DH, 2008, NEUROENDOCRINOLOGY, V88, P246, DOI 10.1159/000140676; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Morikawa Y, 2007, SCAND J WORK ENV HEA, V33, P45, DOI 10.5271/sjweh.1063; Oster H, 2006, CELL METAB, V4, P163, DOI 10.1016/j.cmet.2006.07.002; OTTENWELLER JE, 1982, ENDOCRINOLOGY, V111, P1334, DOI 10.1210/endo-111-4-1334; Reinberg A, 2008, CHRONOBIOL INT, V25, P625, DOI 10.1080/07420520802256101; SACK RL, 1992, SLEEP, V15, P434, DOI 10.1093/sleep/15.5.434; Scheer FAJL, 2010, P NATL ACAD SCI USA, V107, P20541, DOI 10.1073/pnas.1006749107; Schwartz MD, 2009, P NATL ACAD SCI USA, V106, P17540, DOI 10.1073/pnas.0906382106; Schwartz WJ, 2009, CURR BIOL, V19, pR460, DOI 10.1016/j.cub.2009.04.044; Smarr BL, 2012, ENDOCRINOLOGY, V153, P2839, DOI 10.1210/en.2011-1857; Son GH, 2008, P NATL ACAD SCI USA, V105, P20970, DOI 10.1073/pnas.0806962106; SZAFARCZYK A, 1979, J ENDOCRINOL, V83, P1, DOI 10.1677/joe.0.0830001; Ulrich-Lai YM, 2006, AM J PHYSIOL-REG I, V290, pR1128, DOI 10.1152/ajpregu.00042.2003; Ulrich-Lai YM, 2002, NEUROENDOCRINOLOGY, V76, P79, DOI 10.1159/000064426; WATANABE K, 1981, NEUROENDOCRINOLOGY, V33, P52, DOI 10.1159/000123200; WILKINSON CW, 1981, ENDOCRINOLOGY, V109, P162, DOI 10.1210/endo-109-1-162; WOOD CE, 1982, ENDOCRINOLOGY, V110, P1422, DOI 10.1210/endo-110-4-1422; Yan L, 1999, NEUROSCIENCE, V94, P141, DOI 10.1016/S0306-4522(99)00223-7	49	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e68793	10.1371/journal.pone.0068793	http://dx.doi.org/10.1371/journal.pone.0068793			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894346	gold, Green Published, Green Submitted			2022-12-27	WOS:000322132100027
J	Gross, SM; Lehman, SL				Gross, Sean M.; Lehman, Steven L.			Accessibility of Myofilament Cysteines and Effects on ATPase Depend on the Activation State during Exposure to Oxidants	PLOS ONE			English	Article							SKELETAL-MUSCLE FIBERS; CALCIUM SENSITIVITY; HYDROGEN-PEROXIDE; CA2+ SENSITIVITY; REACTIVE OXYGEN; CONTRACTILE APPARATUS; CELLULAR MECHANISMS; DISULFIDE FORMATION; SULFHYDRYL-GROUPS; OXIDATIVE STRESS	Signaling by reactive oxygen species has emerged as a major physiological process. Due to its high metabolic rate, striated muscle is especially subject to oxidative stress, and there are multiple examples in cardiac and skeletal muscle where oxidative stress modulates contractile function. Here we assessed the potential of cysteine oxidation as a mechanism for modulating contractile function in skeletal and cardiac muscle. Analyzing the cysteine content of the myofilament proteins in striated muscle, we found that cysteine residues are relatively rare, but are very similar between different muscle types and different vertebrate species. To refine this list of cysteines to those that may modulate function, we estimated the accessibility of oxidants to cysteine residues using protein crystal structures, and then sharpened these estimates using fluorescent labeling of cysteines in cardiac and skeletal myofibrils. We demonstrate that cysteine accessibility to oxidants and ATPase rates depend on the contractile state in which preparations are exposed. Oxidant exposure of skeletal and cardiac myofibrils in relaxing solution exposes myosin cysteines not accessible in rigor solution, and these modifications correspond to a decrease in maximum ATPase. Oxidant exposure under rigor conditions produces modifications that increase basal ATPase and calcium sensitivity in ventricular myofibrils, but these effects were muted in fast twitch muscle. These experiments reveal how structural and sequence variations can lead to divergent effects from oxidants in different muscle types.	[Gross, Sean M.; Lehman, Steven L.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Lehman, SL (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	slehman@berkeley.edu						Andrade FH, 1998, J PHYSIOL-LONDON, V509, P565, DOI 10.1111/j.1469-7793.1998.565bn.x; Andrade FH, 2001, FASEB J, V15, P309; Arrell DK, 2001, CIRC RES, V89, P480, DOI 10.1161/hh1801.097240; BARANY M, 1973, COLD SPRING HARB SYM, V37, P157, DOI 10.1101/SQB.1973.037.01.024; BARANY M, 1971, J BIOL CHEM, V246, P3241; Baty JW, 2002, PROTEOMICS, V2, P1261, DOI 10.1002/1615-9861(200209)2:9<1261::AID-PROT1261>3.0.CO;2-Q; Bolli R, 1999, PHYSIOL REV, V79, P609, DOI 10.1152/physrev.1999.79.2.609; Brennan JP, 2004, J BIOL CHEM, V279, P41352, DOI 10.1074/jbc.M403827200; Brenner B, 1999, BIOPHYS J, V77, P2677, DOI 10.1016/S0006-3495(99)77102-X; Canton M, 2004, AM J PHYSIOL-HEART C, V286, pH870, DOI 10.1152/ajpheart.00714.2003; CHONG PCS, 1982, J BIOL CHEM, V257, P2549; CHOTHIA C, 1976, J MOL BIOL, V105, P1, DOI 10.1016/0022-2836(76)90191-1; Dai TY, 2007, J PHYSIOL-LONDON, V580, P951, DOI 10.1113/jphysiol.2007.129254; DUKE J, 1976, P NATL ACAD SCI USA, V73, P302, DOI 10.1073/pnas.73.2.302; Dutka TL, 2011, J APPL PHYSIOL, V110, P705, DOI 10.1152/japplphysiol.00739.2010; Dutka TL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035226; Evangelista AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011209; Fitzsimons DP, 2001, J PHYSIOL-LONDON, V530, P263, DOI 10.1111/j.1469-7793.2001.0263l.x; FUCHS F, 1989, J BIOL CHEM, V264, P20344; Gao WD, 1996, CIRCULATION, V94, P2597, DOI 10.1161/01.CIR.94.10.2597; GAO WD, 1995, CIRC RES, V76, P1036, DOI 10.1161/01.RES.76.6.1036; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Hertelendi Z, 2008, ANTIOXID REDOX SIGN, V10, P1175, DOI 10.1089/ars.2007.2014; HOFMANN PA, 1993, CIRC RES, V72, P50, DOI 10.1161/01.RES.72.1.50; HUBER PAJ, 1989, BIOCHEMISTRY-US, V28, P9116, DOI 10.1021/bi00449a024; INGRAHAM RH, 1988, BIOCHEMISTRY-US, V27, P5891, DOI 10.1021/bi00416a011; KATOH T, 1989, J CELL BIOL, V109, P1549, DOI 10.1083/jcb.109.4.1549; Kloner RA, 2001, CIRCULATION, V104, P2981, DOI 10.1161/hc4801.100038; KODAMA T, 1986, J BIOCHEM-TOKYO, V99, P1465, DOI 10.1093/oxfordjournals.jbchem.a135616; Lamb GD, 2003, J PHYSIOL-LONDON, V546, P149, DOI 10.1113/jphysiol.2002.027896; Lamb GD, 2011, J PHYSIOL-LONDON, V589, P2119, DOI 10.1113/jphysiol.2010.199059; LEHRER SS, 1975, P NATL ACAD SCI USA, V72, P3377, DOI 10.1073/pnas.72.9.3377; MACFARLANE NG, 1994, PFLUG ARCH EUR J PHY, V428, P561, DOI 10.1007/BF00374578; MACFARLANE NG, 1992, CIRC RES, V70, P1217, DOI 10.1161/01.RES.70.6.1217; MCDONALD KS, 1995, CIRC RES, V77, P964, DOI 10.1161/01.RES.77.5.964; Mekhfi H, 1996, CIRC RES, V78, P1016, DOI 10.1161/01.RES.78.6.1016; Mollica JP, 2012, J PHYSIOL-LONDON, V590, P1443, DOI 10.1113/jphysiol.2011.224535; Moopanar TR, 2006, J PHYSIOL-LONDON, V571, P191, DOI 10.1113/jphysiol.2005.101105; Moss RL, 2004, CIRC RES, V94, P1290, DOI 10.1161/01.RES.0000127125.61647.4F; MULHERN S, 1975, BIOCHEMISTRY-US, V14, P3863, DOI 10.1021/bi00688a020; Murphy RM, 2008, J PHYSIOL-LONDON, V586, P2203, DOI 10.1113/jphysiol.2007.150516; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; Nogueira L, 2009, BIOCHEM J, V424, P221, DOI 10.1042/BJ20091144; O'Connell B, 2006, AM J PHYSIOL-CELL PH, V290, pC515, DOI 10.1152/ajpcell.00307.2005; Plant DR, 2000, J MUSCLE RES CELL M, V21, P747, DOI 10.1023/A:1010344008224; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Prochniewicz E, 2008, AM J PHYSIOL-CELL PH, V294, pC613, DOI 10.1152/ajpcell.00232.2007; Putkey JA, 1997, BIOCHEMISTRY-US, V36, P970, DOI 10.1021/bi9617466; Reddie KG, 2008, CURR OPIN CHEM BIOL, V12, P746, DOI 10.1016/j.cbpa.2008.07.028; REID MB, 1992, J APPL PHYSIOL, V73, P1797, DOI 10.1152/jappl.1992.73.5.1797; ROBERT V, 1991, AM J PHYSIOL, V261, pH1785, DOI 10.1152/ajpheart.1991.261.6.H1785; Saurin AT, 2004, P NATL ACAD SCI USA, V101, P17982, DOI 10.1073/pnas.0404762101; Schroder E, 2008, CURR OPIN PHARMACOL, V8, P153, DOI 10.1016/j.coph.2007.12.012; Spencer T, 2009, AM J PHYSIOL-CELL PH, V296, pC1015, DOI 10.1152/ajpcell.00251.2008; Sun YB, 2009, J PHYSIOL-LONDON, V587, P155, DOI 10.1113/jphysiol.2008.164707; van der Velden J, 2004, CIRC RES, V95, pE85, DOI 10.1161/01.RES.0000149531.02904.09; Van Eyk JE, 1998, CIRC RES, V82, P261; WESTFALL MV, 1992, CIRC RES, V70, P302, DOI 10.1161/01.RES.70.2.302	58	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e69110	10.1371/journal.pone.0069110	http://dx.doi.org/10.1371/journal.pone.0069110			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894416	Green Published, Green Submitted			2022-12-27	WOS:000322391400040
J	Huang, SW; Hsu, CM; Jeng, WJ; Yen, TC; Su, MY; Chiu, CT				Huang, Shu-Wei; Hsu, Chen-Ming; Jeng, Wen-Juei; Yen, Tzu-Chen; Su, Ming-Yao; Chiu, Cheng-Tang			A Comparison of Positron Emission Tomography and Colonoscopy for the Detection of Advanced Colorectal Neoplasms in Subjects Undergoing a Health Check-Up	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; FDG PET DETECTION; CANCER; WHOLE; COLON; POLYPS; SURVEILLANCE; METAANALYSIS; PREVENTION; GUIDELINE	Background & Aims: There is no agreement as to whether F-18 fluorodeoxyglucose positron emission tomography and computed tomography (FDG PET/CT) screening for advanced colorectal neoplasms is meaningful. This retrospective study was undertaken to determine whether FDG PET/CT may be a valuable screening tool for the detection of advanced colorectal neoplasms. Methods: A retrospective review of the records of 1,109 FDG PET/CT scans acquired from January 2007 to December 2011 was performed. Colonoscopy and FDG PET/CT imaging were performed within two days of each other. The results of colonoscopy were taken as the gold standard, either with or without the results of the histopathological examination. An advanced neoplasm was defined as the presence of a malignant tumor, an adenoma >= 1 cm, or histological evidence of high-grade dysplasia or significant villous components. Results: A total of 36 subjects had advanced colorectal neoplasms detected by colonoscopy (totaling 38 neoplasms). Six of the 38 neoplasms were also detected by FDG PET/CT. The sensitivity, specificity, positive predictive value, negative predictive value, and overall accuracy of FDG PET/CT in the detection of advanced colorectal neoplasms were 15.8% (6/38), 99.1% (1063/1073), 37.5% (6/16), 97.1% (1063/1095), and 96.2% (1069/1111) respectively. The presence of lesions with an endoscopic size <= 1.5 cm (P<0.001) and low-grade dysplasia (P<0.001) were the main predictors of false-negative FDG PET/CT findings. Conclusions: We conclude that FDG PET/CT screening of advanced colorectal neoplasms is unwarranted, especially in the presence of lesions with an endoscopic size <= 1.5 cm or low-grade dysplasia.	[Huang, Shu-Wei; Hsu, Chen-Ming; Jeng, Wen-Juei; Su, Ming-Yao; Chiu, Cheng-Tang] Chang Gung Mem Hosp Linkou, Dept Gastroenterol & Hepatol, Tao Yuan, Taiwan; [Yen, Tzu-Chen] Chang Gung Mem Hosp Linkou, Dept Nucl Med, Tao Yuan, Taiwan; [Yen, Tzu-Chen] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Hsu, CM (corresponding author), Chang Gung Mem Hosp Linkou, Dept Gastroenterol & Hepatol, Tao Yuan, Taiwan.	hsu3060e@adm.cgmh.org.tw; yentc1110@gmail.com		Hsu, Chen-Ming/0000-0001-5838-8886				Adler A, 2013, GUT, V62, P236, DOI 10.1136/gutjnl-2011-300167; [Anonymous], 2003, GASTROINTEST ENDOSC, V58, pS3; Chin HM, 2005, GASTROINTEST ENDOSC, V61, P547, DOI 10.1016/S0016-5107(05)00121-5; Davila RE, 2006, GASTROINTEST ENDOSC, V63, P546, DOI 10.1016/j.gie.2006.02.002; Delbeke D, 2004, SEMIN NUCL MED, V34, P209, DOI 10.1053/j.semnuclmed.2004.03.006; Diederichs CG, 1998, J NUCL MED, V39, P1030; El Sayed AMA, 2003, GASTROINTEST ENDOSC, V58, P36, DOI 10.1067/mge.2003.318; Friedland S, 2005, GASTROINTEST ENDOSC, V61, P395, DOI 10.1016/S0016-5107(04)02775-0; Halligan S, 2005, RADIOLOGY, V237, P893, DOI 10.1148/radiol.2373050176; Heitman SJ, 2009, CLIN GASTROENTEROL H, V7, P1272, DOI 10.1016/j.cgh.2009.05.032; Hirakawa T, 2012, J GASTROENTEROL, V47, P127, DOI 10.1007/s00535-011-0473-z; Hsu CM, 2012, J GASTROEN HEPATOL, V27, P76, DOI 10.1111/j.1440-1746.2011.06795.x; Huebner RH, 2000, J NUCL MED, V41, P1177; Jass JR, 1989, WHO INT HISTOLOGICAL, V2nd; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Liao CT, 2011, J NUCL MED, V52, P180, DOI 10.2967/jnumed.110.082370; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Lin M, 2011, CLIN GASTROENTEROL H, V9, P1025, DOI 10.1016/j.cgh.2011.06.028; Minamimoto R, 2007, ANN NUCL MED, V21, P481, DOI 10.1007/s12149-007-0061-8; MUTO T, 1975, CANCER, V36, P2251, DOI 10.1002/cncr.2820360944; Nakajo M, 2009, AM J ROENTGENOL, V192, P754, DOI 10.2214/AJR.08.1304; Peng J, 2011, COLORECTAL DIS, V13, pE374, DOI 10.1111/j.1463-1318.2011.02727.x; Ravizza D, 2010, DIGEST LIVER DIS, V42, P185, DOI 10.1016/j.dld.2009.06.018; Schlemper RJ, 2000, GUT, V47, P251, DOI 10.1136/gut.47.2.251; Su MY, 2006, AM J GASTROENTEROL, V101, P2711, DOI 10.1111/j.1572-0241.2006.00932.x; Sung JJY, 2008, GUT, V57, P1166, DOI 10.1136/gut.2007.146316; Tatsumi M, 2003, EUR J NUCL MED MOL I, V30, P40, DOI 10.1007/s00259-002-0980-5; Terauchi T, 2008, ANN NUCL MED, V22, P379, DOI 10.1007/s12149-008-0130-7; Treglia G, 2012, COLORECTAL DIS, V14, P174, DOI 10.1111/j.1463-1318.2011.02588.x; van Kouwen MCA, 2005, J CLIN ONCOL, V23, P3713, DOI 10.1200/JCO.2005.02.401; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Winawer SJ, 2000, NEW ENGL J MED, V342, P1766, DOI 10.1056/NEJM200006153422401; Yasuda S, 2001, J NUCL MED, V42, P989; Yen TC, 2004, J NUCL MED, V45, P22; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370	36	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e69111	10.1371/journal.pone.0069111	http://dx.doi.org/10.1371/journal.pone.0069111			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894417	Green Published, gold, Green Submitted			2022-12-27	WOS:000322391400041
J	Liao, QY; Wong, WS; Fielding, R				Liao, Qiuyan; Wong, Wing Sze; Fielding, Richard			Comparison of Different Risk Perception Measures in Predicting Seasonal Influenza Vaccination among Healthy Chinese Adults in Hong Kong: A Prospective Longitudinal Study	PLOS ONE			English	Article							PROTECTION MOTIVATION THEORY; BELIEF MODEL; BEHAVIOR; METAANALYSIS; PREVALENCE; MORTALITY; FEELINGS; CHILDREN; BURDEN; SCALES	Background: Risk perception is a reported predictor of vaccination uptake, but which measures of risk perception best predict influenza vaccination uptake remain unclear. Methodology: During the main influenza seasons (between January and March) of 2009 (Wave 1) and 2010 (Wave 2), 505 Chinese students and employees from a Hong Kong university completed an online survey. Multivariate logistic regression models were conducted to assess how well different risk perceptions measures in Wave 1 predicted vaccination uptake against seasonal influenza in Wave 2. Principal Findings: The results of the multivariate logistic regression models showed that feeling at risk (beta = 0.25, p = 0.021) was the better predictor compared with probability judgment while probability judgment (beta = 0.25, p = 0.029) was better than beliefs about risk in predicting subsequent influenza vaccination uptake. Beliefs about risk and feeling at risk seemed to predict the same aspect of subsequent vaccination uptake because their associations with vaccination uptake became insignificant when paired into the logistic regression model. Similarly, to compare the four scales for assessing probability judgment in predicting vaccination uptake, the 7-point verbal scale remained a significant and stronger predictor for vaccination uptake when paired with other three scales; the 6-point verbal scale was a significant and stronger predictor when paired with the percentage scale or the 2-point verbal scale; and the percentage scale was a significant and stronger predictor only when paired with the 2-point verbal scale. Conclusions/Significance: Beliefs about risk and feeling at risk are not well differentiated by Hong Kong Chinese people. Feeling at risk, an affective-cognitive dimension of risk perception predicts subsequent vaccination uptake better than do probability judgments. Among the four scales for assessing risk probability judgment, the 7-point verbal scale offered the best predictive power for subsequent vaccination uptake.	[Liao, Qiuyan; Fielding, Richard] Univ Hong Kong, Sch Publ Hlth, Hlth Behav Res Grp, Hong Kong, Hong Kong, Peoples R China; [Wong, Wing Sze] Hong Kong Inst Educ, Dept Psychol Studies, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Education University of Hong Kong (EdUHK)	Wong, WS (corresponding author), Hong Kong Inst Educ, Dept Psychol Studies, Hong Kong, Hong Kong, Peoples R China.	wingwong@ied.edu.hk		WONG, Wing Sze/0000-0002-0083-5601; Liao, Qiuyan/0000-0002-1105-6857	Strategic Grants of City University of Hong Kong [7008008]	Strategic Grants of City University of Hong Kong	This study was supported by the Strategic Grants of City University of Hong Kong (Grant no: 7008008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blank PR, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-272; Brewer NT, 2007, HEALTH PSYCHOL, V26, P136, DOI 10.1037/0278-6133.26.2.136; Brewer NT, 2004, ANN BEHAV MED, V27, P125, DOI 10.1207/s15324796abm2702_7; Carpenter CJ, 2010, HEALTH COMMUN, V25, P661, DOI 10.1080/10410236.2010.521906; *CDCP, 2010, FIN EST 2009 10 SEAS; Center for Health Protection Hong Kong, 2011, REC SEAS INFL VACC 2; Center for Health Protection Hong Kong, 2009, INFL VACC COV SURV K; Chapman GB, 2006, HEALTH PSYCHOL, V25, P82, DOI 10.1037/0278-6133.25.1.82; Chapman GB, 1999, PREV MED, V29, P249, DOI 10.1006/pmed.1999.0535; Chiu SS, 2002, NEW ENGL J MED, V347, P2097, DOI 10.1056/NEJMoa020546; Cowling BJ, 2010, J INFECT DIS, V202, P867, DOI 10.1086/655811; DIEFENBACH MA, 1993, HEALTH EDUC RES, V8, P181, DOI 10.1093/her/8.2.181; Floyd DL, 2000, J APPL SOC PSYCHOL, V30, P407, DOI 10.1111/j.1559-1816.2000.tb02323.x; Haomiao Jia, 2004, J Ambul Care Manage, V27, P314; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Jefferson T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001269.pub4; Kline RB, 2005, PRINCIPLES PRACTICE; Lau JTF, 2012, AM J INFECT CONTROL, V40, pE225, DOI 10.1016/j.ajic.2012.01.036; Lau JTF, 2006, VACCINE, V24, P5526, DOI 10.1016/j.vaccine.2006.04.014; Leppin A, 2009, INT J BEHAV MED, V16, P7, DOI 10.1007/s12529-008-9002-8; Liao QY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017713; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; Lupton Deborah, 2013, RISK, V2nd; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Ouellette JA, 1998, PSYCHOL BULL, V124, P54, DOI 10.1037/0033-2909.124.1.54; ROGERS RW, 1975, J PSYCHOL, V91, P93, DOI 10.1080/00223980.1975.9915803; Schapira MM, 2004, RISK ANAL, V24, P665, DOI 10.1111/j.0272-4332.2004.00466.x; Slovic P, 2004, RISK ANAL, V24, P311, DOI 10.1111/j.0272-4332.2004.00433.x; Slovic P, 2005, HEALTH PSYCHOL, V24, pS35, DOI 10.1037/0278-6133.24.4.S35; Tarek B, 2011, J RISK RES, V14, P351; Weinstein ND, 1998, PSYCHOL HEALTH, V13, P479, DOI 10.1080/08870449808407305; Weinstein ND, 2007, HEALTH PSYCHOL, V26, P146, DOI 10.1037/0278-6133.26.2.146; Wilde JA, 1999, JAMA-J AM MED ASSOC, V281, P908, DOI 10.1001/jama.281.10.908; Windschitl PD, 1996, J EXP PSYCHOL-APPL, V2, P343, DOI 10.1037/1076-898X.2.4.343; Wong CM, 2006, PLOS MED, V3, P485, DOI 10.1371/journal.pmed.0030121; Wong CM, 2004, CLIN INFECT DIS, V39, P1611, DOI 10.1086/425315; World Health Organization, 2009, WORLD NOW START 2009; Wu P, 2012, J INFECT DIS, V206, P1862, DOI 10.1093/infdis/jis628	39	8	8	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e68019	10.1371/journal.pone.0068019	http://dx.doi.org/10.1371/journal.pone.0068019			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	191CY	23894292	Green Published, gold, Green Submitted			2022-12-27	WOS:000322391400003
J	Zhang, XF; Tan, M; Chhabra, M; Dai, YC; Meller, J; Jiang, X				Zhang, Xu-Fu; Tan, Ming; Chhabra, Monica; Dai, Ying-Chun; Meller, Jarek; Jiang, Xi			Inhibition of Histo-blood Group Antigen Binding as a Novel Strategy to Block Norovirus Infections	PLOS ONE			English	Article							CAPSID PROTEIN FORMS; STRUCTURAL BASIS; RECEPTOR-BINDING; HOST INTERACTION; HBGA RECEPTORS; NORWALK VIRUS; P-DOMAIN; GASTROENTERITIS; RECOGNITION; DOCKING	Noroviruses (NoVs) are the most important viral pathogens that cause epidemic acute gastroenteritis. NoVs recognize human histo-blood group antigens (HBGAs) as receptors or attachment factors. The elucidation of crystal structures of the HBGA-binding interfaces of a number of human NoVs representing different HBGA binding patterns opens a new strategy for the development of antiviral compounds against NoVs through rational drug design and computer-aided virtual screening methods. In this study, docking simulations and virtual screening were used to identify hit compounds targeting the A and B antigens binding sites on the surface of the capsid P protein of a GII.4 NoV (VA387). Following validation by re-docking of the A and B ligands, these structural models and AutoDock suite of programs were used to screen a large drug-like compound library (derived from ZINC library) for inhibitors blocking GII.4 binding to HBGAs. After screening >2 million compounds using multistage protocol, 160 hit compounds with best predicted binding affinities and representing a number of distinct chemical classes have been selected for subsequent experimental validation. Twenty of the 160 compounds were found to be able to block the VA387 P dimers binding to the A and/or B HBGAs at an IC50 <40.0 mu M, with top 5 compounds blocking the HBGA binding at an IC50 <10.0 mu M in both oligosaccharide-and saliva-based blocking assays. Interestingly, 4 of the top-5 compounds shared the basic structure of cyclopenta [a] dimethyl phenanthren, indicating a promising structural template for further improvement by rational design.	[Zhang, Xu-Fu; Tan, Ming; Dai, Ying-Chun; Jiang, Xi] Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA; [Zhang, Xu-Fu] Southern Med Univ, Sch Tradit Chinese Med, Guangzhou, Guangdong, Peoples R China; [Tan, Ming; Jiang, Xi] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Chhabra, Monica] Univ Cincinnati, Dept Comp Sci, Coll Engn, Cincinnati, OH 45221 USA; [Dai, Ying-Chun] Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, Guangzhou, Guangdong, Peoples R China; [Meller, Jarek] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Southern Medical University - China; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Southern Medical University - China; University System of Ohio; University of Cincinnati	Tan, M (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA.	ming.tan@cchmc.org; jason.jiang@cchmc.org	Meller, Jaroslaw/A-1971-2011	Meller, Jaroslaw/0000-0002-1162-8253; Zhang, Xufu/0000-0002-7178-2412	Guangdong Province '211 Project'; National Natural Science Foundation of China [30901992]; National Institutes of Health [R01 AI055649, R01 AI089634, P01 HD13021]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD013021] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055649, R01AI089634] Funding Source: NIH RePORTER	Guangdong Province '211 Project'; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was partially funded by Guangdong Province '211 Project' and the National Natural Science Foundation of China (30901992) to Xu-Fu Zhang, and National Institutes of Health R01 AI055649, R01 AI089634, and P01 HD13021 to Xi Jiang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biesiada Jacek, 2012, Methods Mol Biol, V928, P1, DOI 10.1007/978-1-62703-008-3_1; Biesiada Jacek, 2011, Hum Genomics, V5, P497; Bu WM, 2008, J VIROL, V82, P5340, DOI 10.1128/JVI.00135-08; Cao S, 2007, J VIROL, V81, P5949, DOI 10.1128/JVI.00219-07; Cavasotto CN, 2007, CURR TOP MED CHEM, V7, P1006, DOI 10.2174/156802607780906753; Chang DTH, 2005, NUCLEIC ACIDS RES, V33, pW233, DOI 10.1093/nar/gki586; Chen JH, 2007, BIOINFORMATICS, V23, P2348, DOI 10.1093/bioinformatics/btm341; Chen YT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002152; Choi JM, 2008, P NATL ACAD SCI USA, V105, P9175, DOI 10.1073/pnas.0803275105; de Rougemont A, 2011, J VIROL, V85, P4057, DOI 10.1128/JVI.02077-10; Feng XZ, 2007, ANTIMICROB AGENTS CH, V51, P324, DOI 10.1128/AAC.00627-06; Feng ZK, 2004, BIOINFORMATICS, V20, P2153, DOI 10.1093/bioinformatics/bth214; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Hansman GS, 2011, J VIROL, V85, P6687, DOI 10.1128/JVI.00246-11; Hetenyi C, 2002, PROTEIN SCI, V11, P1729, DOI 10.1110/ps.0202302; Huang PW, 2005, J VIROL, V79, P6714, DOI 10.1128/JVI.79.11.6714-6722.2005; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Kubota T, 2012, J VIROL, V86, P11138, DOI 10.1128/JVI.00278-12; Lopman B, 2012, CURR OPIN VIROL, V2, P96, DOI 10.1016/j.coviro.2011.11.005; Ming Tan, 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000348; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Shanker S, 2011, J VIROL, V85, P8635, DOI 10.1128/JVI.00848-11; Tan M, 2005, J VIROL, V79, P14017, DOI 10.1128/JVI.79.22.14017-14030.2005; Tan M, 2005, TRENDS MICROBIOL, V13, P285, DOI 10.1016/j.tim.2005.04.004; Tan M, 2004, J VIROL, V78, P6233, DOI 10.1128/JVI.78.12.6233-6242.2004; Tan M, 2003, J VIROL, V77, P12562, DOI 10.1128/JVI.77.23.12562-12571.2003; Tan M, 2008, VIROLOGY, V382, P115, DOI 10.1016/j.virol.2008.08.047; Tan M, 2008, VIROLOGY, V379, P324, DOI 10.1016/j.virol.2008.06.041; Tan M, 2006, J VIROL, V80, P7322, DOI 10.1128/JVI.00233-06; Tan M, 2011, TRENDS MICROBIOL, V19, P382, DOI 10.1016/j.tim.2011.05.007; Tan M, 2011, VIROLOGY, V410, P345, DOI 10.1016/j.virol.2010.11.017; Tan M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000983; Tan M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005058; Taube S, 2012, J VIROL, V86, P5584, DOI 10.1128/JVI.06854-11; Villoutreix BO, 2009, COMB CHEM HIGH T SCR, V12, P1000, DOI 10.2174/138620709789824682; Wolf A, 2010, CURR CLIN PHARMACOL, V5, P37, DOI 10.2174/157488410790410560; Zhang XF, 2012, BIOORGAN MED CHEM, V20, P1616, DOI 10.1016/j.bmc.2011.11.040; Zheng DP, 2010, J CLIN MICROBIOL, V48, P168, DOI 10.1128/JCM.01622-09	39	32	36	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e69379	10.1371/journal.pone.0069379	http://dx.doi.org/10.1371/journal.pone.0069379			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894462	Green Submitted, gold, Green Published			2022-12-27	WOS:000322391400056
J	Qi, W; White, MC; Choi, W; Guo, C; Dinney, C; McConkey, DJ; Siefker-Radtke, A				Qi, Wei; White, Matthew C.; Choi, Woonyoung; Guo, Charles; Dinney, Colin; McConkey, David J.; Siefker-Radtke, Arlene			Inhibition of Inducible Heat Shock Protein-70 (Hsp72) Enhances Bortezomib-Induced Cell Death in Human Bladder Cancer Cells	PLOS ONE			English	Article							HEAT-SHOCK FACTOR-1; TRANSCRIPTION FACTOR HSF1; PROTEASOME INHIBITORS; MOLECULAR CHAPERONES; GENOME BROWSER; STRESS; PROTEINS; GROWTH; EXPRESSION; RESISTANCE	The proteasome inhibitor bortezomib (Velcade) is a promising new agent for bladder cancer therapy, but inducible cytoprotective mechanisms may limit its potential efficacy. We used whole genome mRNA expression profiling to study the effects of bortezomib on stress-induced gene expression in a panel of human bladder cancer cell lines. Bortezomib induced strong upregulation of the inducible HSP70 isoforms HSPA1A and HSPA1B isoforms of Hsp72 in 253J B-V and SW780 (HSPA1A(high)) cells, but only induced the HSPA1B isoform in UM-UC10 and UM-UC13 (HSPA1A(low)) cells. Bortezomib stimulated the binding of heat shock factor-1 (HSF1) to the HSPA1A promoter in 253JB-V but not in UM-UC13 cells. Methylation-specific PCR revealed that the HSPA1A promoter was methylated in the HSPA1A(low) cell lines (UM-UC10 and UM-UC13), and exposure to the chromatin demethylating agent 5-aza-2'-deoxycytidine restored HSPA1A expression. Overexpression of Hsp72 promoted bortezomib resistance in the UM-UC10 and UM-UC13 cells, whereas transient knockdown of HSPA1B further sensitized these cells to bortezomib, and exposure to the chemical HSF1 inhibitor KNK-437 promoted bortezomib sensitivity in the 253J B-V cells. Finally, shRNA-mediated stable knockdown of Hsp72 in 253J B-V promoted sensitivity to bortezomib in vitro and in tumor xenografts in vivo. Together, our results provide proof-of-concept for using Hsp72 inhibitors to promote bortezomib sensitivity in bladder cancers and suggest that selective targeting of HSPA1B could produce synthetic lethality in tumors that display HSPA1A promoter methylation.	[Qi, Wei; White, Matthew C.; McConkey, David J.] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA; [White, Matthew C.; Choi, Woonyoung; Dinney, Colin; McConkey, David J.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Guo, Charles] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Siefker-Radtke, Arlene] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [White, Matthew C.] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	McConkey, DJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA.	dmcconke@mdanderson.org; asiefker@mdanderson.org		Siefker-Radtke, Arlene/0000-0002-6328-9599; White, Matthew/0000-0002-8274-0453; Dinney, Colin/0000-0002-8969-711X	M. D. Anderson SPORE in Genitourinary Cancer [P50 CA091846]; Cancer Center Support Grant [CA016672]; Proteasome inhibition and ER Stress [R01 CA127494]; NATIONAL CANCER INSTITUTE [R01CA127494, P50CA091846, P30CA016672] Funding Source: NIH RePORTER	M. D. Anderson SPORE in Genitourinary Cancer; Cancer Center Support Grant; Proteasome inhibition and ER Stress; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the M. D. Anderson SPORE in Genitourinary Cancer (P50 CA091846), Cancer Center Support Grant (CA016672), and Proteasome inhibition and ER Stress (R01 CA127494). The funders had no role in the study design, data collection and analysis, decision to publish, or perparation of the manuscript.	Akerfelt M, 2007, ANN NY ACAD SCI, V1113, P15, DOI 10.1196/annals.1391.005; Anckar J, 2007, ADV EXP MED BIOL, V594, P78; Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Bush KT, 1997, J BIOL CHEM, V272, P9086; Chiong E, 2009, J UROLOGY, V181, P2737, DOI 10.1016/j.juro.2009.01.108; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; DINNEY CPN, 1995, J UROLOGY, V154, P1532, DOI 10.1016/S0022-5347(01)66923-4; Dreszer TR, 2012, NUCLEIC ACIDS RES, V40, pD918, DOI 10.1093/nar/gkr1055; Fewell SW, 2004, J BIOL CHEM, V279, P51131, DOI 10.1074/jbc.M404857200; Garrido C, 2006, CELL CYCLE, V5, P2592, DOI 10.4161/cc.5.22.3448; Gyrd-Hansen M, 2004, CELL CYCLE, V3, P1484, DOI 10.4161/cc.3.12.1287; Hideshima T, 2005, P NATL ACAD SCI USA, V102, P8567, DOI 10.1073/pnas.0503221102; Jaattela M, 1999, ANN MED, V31, P261, DOI 10.3109/07853899908995889; Jego G, 2013, CANCER LETT, V332, P275, DOI 10.1016/j.canlet.2010.10.014; Kamat AM, 2004, MOL CANCER THER, V3, P279; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Kawazoe Y, 1998, EUR J BIOCHEM, V255, P356, DOI 10.1046/j.1432-1327.1998.2550356.x; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kirkegaard T, 2010, NATURE, V463, P549, DOI 10.1038/nature08710; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; Massey AJ, 2010, CANCER CHEMOTH PHARM, V66, P535, DOI 10.1007/s00280-009-1194-3; Mathew A, 1998, ANN NY ACAD SCI, V851, P99, DOI 10.1111/j.1749-6632.1998.tb08982.x; Meng L, 2010, ONCOGENE, V29, P5204, DOI 10.1038/onc.2010.277; MORGAN WD, 1987, MOL CELL BIOL, V7, P1129, DOI 10.1128/MCB.7.3.1129; Mosser DD, 2004, ONCOGENE, V23, P2907, DOI 10.1038/sj.onc.1207529; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Nawrocki ST, 2005, CANCER RES, V65, P11510, DOI 10.1158/0008-5472.CAN-05-2394; Nollen EAA, 2002, J CELL SCI, V115, P2809; Nylandsted J, 2004, J EXP MED, V200, P425, DOI 10.1084/jem.20040531; Nylandsted J, 2002, CANCER RES, V62, P7139; Nylandsted J, 2000, P NATL ACAD SCI USA, V97, P7871, DOI 10.1073/pnas.97.14.7871; Powers MV, 2007, FEBS LETT, V581, P3758, DOI 10.1016/j.febslet.2007.05.040; Qi W, 2007, EMBO J, V26, P65, DOI 10.1038/sj.emboj.7601483; Sabichi A, 2006, J UROLOGY, V175, P1133, DOI 10.1016/S0022-5347(05)00323-X; Schmitt E, 2006, CANCER RES, V66, P4191, DOI 10.1158/0008-5472.CAN-05-3778; Smith RS, 2007, DNA SEQUENCE, V18, P47, DOI 10.1080/10425170601060707; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Whitesell L, 2009, EXPERT OPIN THER TAR, V13, P469, DOI [10.1517/14728220902832697, 10.1517/14728220902832697 ]; Whitley D, 1999, J VASC SURG, V29, P748, DOI 10.1016/S0741-5214(99)70329-0; WU B, 1985, MOL CELL BIOL, V5, P330, DOI 10.1128/MCB.5.2.330; WU BJ, 1986, P NATL ACAD SCI USA, V83, P629, DOI 10.1073/pnas.83.3.629; Wu WKK, 2010, DRUG RESIST UPDATE, V13, P87, DOI 10.1016/j.drup.2010.04.003; Wu WK, DRUG RESISTANCE UPDA, V13, P87; Zeller C, 2012, ONCOGENE, V31, P4567, DOI 10.1038/onc.2011.611; Zhu K, 2010, ONCOGENE, V29, P451, DOI 10.1038/onc.2009.343	46	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e69509	10.1371/journal.pone.0069509	http://dx.doi.org/10.1371/journal.pone.0069509			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874968	Green Published, gold, Green Submitted			2022-12-27	WOS:000324146200078
J	Simonsen, KA; Hunskaar, S; Sandvik, H; Rortveit, G				Simonsen, Kristian A.; Hunskaar, Steinar; Sandvik, Hogne; Rortveit, Guri			Capacity and Adaptations of General Practice during an Influenza Pandemic	PLOS ONE			English	Article							PRIMARY-CARE; A H1N1; NORWAY; INFECTIONS; ENGLAND; ILLNESS; BURDEN	Background: GPs play a major role in influenza epidemics, and most patients with influenza-like-illness (ILI) are treated in general practice or by primary care doctors on duty in out-of-hours services (OOH). Little is known about the surge capacity in primary care services during an influenza pandemic, and how the relationship between them changes. Aim: To investigate how general practice and OOH services were used by patients during the 2009 pandemic in Norway and the impact of the pandemic on primary care services in comparison to a normal influenza season. Materials: Data from electronic remuneration claims from all OOH doctors and regular GPs for 2009. Methods: We conducted a registry-based study of all ILI consultations in the 2009 pandemic with the 2008/09 influenza season (normal season) as baseline for comparison. Results: The majority (82.2%) of ILI consultations during the 2009 pandemic took place in general practice. The corresponding number in the 2008/09 season was 89.3%. Compared with general practice, the adjusted odds ratio for ILI with all other diagnoses as reference in OOH services was 1.23 (95% CI, 1.18, 1.27) for the 2008/2009 season and 1.87 (95% CI, 1.84, 1.91) for the pandemic influenza season. In total there was a 3.3-fold increase in ILI consultations during the pandemic compared to the 2008/09 season. A 5.5-fold increase of ILI consultations were observed in OOH services in comparison to the 2008/09 season. Children and young adults with ILI were the most frequent users of OOH services during influenza periods. Conclusions: The autumn pandemic wave resulted in a significantly increased demand on primary care services. However, GPs in primary care services in Norway showed the ability to increase capacity in a situation with increased patient demand.	[Simonsen, Kristian A.; Hunskaar, Steinar; Sandvik, Hogne; Rortveit, Guri] Univ Bergen, Dept Global Publ Hlth & Primary Care, Res Grp Gen Practice, Bergen, Norway; [Simonsen, Kristian A.; Rortveit, Guri] Uni Res, Res Unit Gen Practice Uni Hlth, Bergen, Norway; [Hunskaar, Steinar; Sandvik, Hogne] Uni Res, Natl Ctr Emergency Primary Hlth Care Uni Hlth, Bergen, Norway	University of Bergen	Simonsen, KA (corresponding author), Univ Bergen, Dept Global Publ Hlth & Primary Care, Res Grp Gen Practice, Bergen, Norway.	kristian.simonsen@igs.uib.no			Norwegian Medical Association's Funds for Research in General Practice; Norwegian Directorate of Health; University of Bergen	Norwegian Medical Association's Funds for Research in General Practice; Norwegian Directorate of Health; University of Bergen	This work was supported by Norwegian Medical Association's Funds for Research in General Practice, the Norwegian Directorate of Health and the University of Bergen. KAS received a PhD grant from the University of Bergen, committing him to write three peer-reviewed articles. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldaz P, 2011, REV ESP SALUD PUBLIC, V85, P113, DOI 10.1590/S1135-57272011000100014; Anestad G, 2011, MED HYPOTHESES, V77, P1132, DOI 10.1016/j.mehy.2011.09.021; Bocquet J, 2010, AUST FAM PHYSICIAN, V39, P313; Gran JM, 2010, EPIDEMIOL INFECT, V138, P1559, DOI 10.1017/S0950268810000671; Hansen EH, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-62; HOPESIMPSON RE, 1981, J HYG-CAMBRIDGE, V86, P35, DOI 10.1017/S0022172400068728; Kacelnik O, 2011, REPORT DEATHS INFLUE; Michiels B, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-4; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Molbak K, 2011, VACCINE, V29, pB63, DOI 10.1016/j.vaccine.2011.03.064; Nossen J, 2007, 0407 NAV; Patel MS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002269; Peiris JSM, 2009, J CLIN VIROL, V45, P169, DOI 10.1016/j.jcv.2009.06.006; Pitman RJ, 2007, J INFECTION, V54, P530, DOI 10.1016/j.jinf.2006.09.017; Press K, 2010, 32010 NAT CTR EM PRI; Rortveit Sverre, 2011, Tidsskr Nor Laegeforen, V131, P675, DOI 10.4045/tidsskr.10.0858; Sauro Alfonso, 2006, Eur J Gen Pract, V12, P34, DOI 10.1080/13814780600757153; Simonsen KA, 2012, FAM PRACT, V29, P139, DOI 10.1093/fampra/cmr064; Temte Jonathan L, 2010, WMJ, V109, P193; The Norwegian Institute of Public Health, 2013, SURV INFL ACT NORW; [No title captured]	21	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e69408	10.1371/journal.pone.0069408	http://dx.doi.org/10.1371/journal.pone.0069408			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874960	Green Published, gold			2022-12-27	WOS:000324146200076
J	Das, M; Prasad, SB; Yadav, SS; Govardhan, HB; Pandey, LK; Singh, S; Pradhan, S; Narayan, G				Das, Mitali; Prasad, Shyam Babu; Yadav, Suresh Singh; Govardhan, H. B.; Pandey, Lakshmi Kant; Singh, Sunita; Pradhan, Satyajit; Narayan, Gopeshwar			Over Expression of Minichromosome Maintenance Genes is Clinically Correlated to Cervical Carcinogenesis	PLOS ONE			English	Article							MCM PROTEINS; DNA-REPLICATION; CANCER-CELL; DOSAGE; IDENTIFICATION; CARCINOMA; FREQUENT; MARKERS	Minichromosome Maintenance (MCM) proteins play important roles in cell cycle progression by mediating DNA replication initiation and elongation. Among 10 MCM homologues MCM 2-7 form a hexamer and assemble to the pre-replication complex acting as replication licensing factors. Binding and function of MCM2-7 to pre-replication complex is regulated by MCM10 mediated binding of RECQL4 with MCM2-7. The purpose of this study is to explore the role of MCMs in cervical cancer and their correlation with the clinical parameters of cervical cancer. We have investigated sixty primary cervical cancer tissue samples, eight cervical cancer cell lines and thirty hysterectomised normal cervical tissue. The expression profiling of MCMs was done using semi-quantitative RT-PCR, immunoblotting and immunohistochemistry. MCM2, 4, 5, 6, 7, 10 and RECQL4 are significantly over-expressed in cervical cancer. Among these, MCM4, 6 and 10 show increased frequency of over expression along with advancement of tumor stages. MCM4, 5 and 6 also show differential expression in different types of lesion, while MCM2 and MCM10 are over expressed in cervical cancer irrespective of clinico-pathological parameters. Our data indicates the role of MCM4, MCM5, MCM6, MCM10 and RECQL4 in the progression of cervical cancer.	[Das, Mitali; Prasad, Shyam Babu; Yadav, Suresh Singh; Narayan, Gopeshwar] Banaras Hindu Univ, Canc Genet Lab, Dept Mol & Human Genet, Varanasi 221005, Uttar Pradesh, India; [Govardhan, H. B.; Pradhan, Satyajit] Banaras Hindu Univ, Dept Radiotherapy & Radiat Med, Varanasi 221005, Uttar Pradesh, India; [Pandey, Lakshmi Kant] Banaras Hindu Univ, Dept Obstet & Gynaecol, Varanasi 221005, Uttar Pradesh, India; [Singh, Sunita] Banaras Hindu Univ, Dept Zool, Mahila Mahavidyalaya, Varanasi 221005, Uttar Pradesh, India	Banaras Hindu University (BHU); Banaras Hindu University (BHU); Banaras Hindu University (BHU); Banaras Hindu University (BHU)	Narayan, G (corresponding author), Banaras Hindu Univ, Canc Genet Lab, Dept Mol & Human Genet, Varanasi 221005, Uttar Pradesh, India.	gnarayan@bhu.ac.in	Yadav, Suresh Singh/GQI-4093-2022		Department of Biotechnology, Government of India [BT/PR9246/Med/30/17/2007]; Banaras Hindu University(XIth Plan); Council for Scientific and Industrial Research, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Banaras Hindu University(XIth Plan); Council for Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	The study was supported by a grant from the Department of Biotechnology, Government of India vide project no. BT/PR9246/Med/30/17/2007 to GN; from Banaras Hindu University(XIth Plan) to GN and SS and Research fellowship from Council for Scientific and Industrial Research, Government of India to MD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blow JJ, 2002, TRENDS CELL BIOL, V12, P72, DOI 10.1016/S0962-8924(01)02203-6; Douglas IL, 2008, P NATL ACAD SCI USA, V105, P8079; Dudderidge TJ, 2010, BRIT J CANCER, V103, P701, DOI 10.1038/sj.bjc.6605785; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Freeman A, 1999, CLIN CANCER RES, V5, P2121; Giaginis C, 2011, DIGEST DIS SCI, V56, P777, DOI 10.1007/s10620-010-1348-5; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; Harris CP, 2003, GENE CHROMOSOME CANC, V36, P233, DOI 10.1002/gcc.10158; Hunt DPJ, 2002, BRIT J NEUROSURG, V16, P10, DOI 10.1080/02688690120114174; Ishimi Y, 2003, EUR J BIOCHEM, V270, P1089, DOI 10.1046/j.1432-1033.2003.03440.x; Jun-Sub Im, 2009, Proceedings of the National Academy of Sciences of the United States of America, V106, P15628, DOI 10.1073/pnas.0908039106; Kawabe T, 2000, ONCOGENE, V19, P4764, DOI 10.1038/sj.onc.1203841; Kobierzycki C, 2012, ANTICANCER RES, V32, P773; Kuijjer ML, 2012, GENE CHROMOSOME CANC, V51, P696, DOI 10.1002/gcc.21956; Laskey R, 2005, PHILOS T R SOC B, V360, P1119, DOI 10.1098/rstb.2005.1656; Lau KM, 2010, ONCOGENE, V29, P5475, DOI 10.1038/onc.2010.287; Lei M, 1996, MOL CELL BIOL, V16, P5081; Liang DT, 1999, J CELL SCI, V112, P559; Narayan G, 2007, GENE CHROMOSOME CANC, V46, P373, DOI 10.1002/gcc.20418; Narayan G, 2009, GENE CHROMOSOME CANC, V48, P983, DOI 10.1002/gcc.20703; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; Nicol AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032936; Rao PH, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-5; Rodins K, 2002, CLIN CANCER RES, V8, P1075; Tamura T, 2010, J ORAL PATHOL MED, V39, P328, DOI 10.1111/j.1600-0714.2009.00861.x; Tan DF, 2001, BMC CANCER, V1, DOI 10.1186/1471-2407-1-6; Williams GH, 1998, P NATL ACAD SCI USA, V95, P14932, DOI 10.1073/pnas.95.25.14932; Xu XH, 2009, EMBO J, V28, P3005, DOI 10.1038/emboj.2009.235; Yan H, 1991, GENE DEV, V4, P968	29	74	78	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e69607	10.1371/journal.pone.0069607	http://dx.doi.org/10.1371/journal.pone.0069607			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23874974	gold, Green Published, Green Submitted			2022-12-27	WOS:000322000600052
J	Bharadwaj, P; McInnis, C; Madden, AMK; Bonthuis, PJ; Zup, S; Rissman, EF; Park, JH				Bharadwaj, Pranay; McInnis, Christine; Madden, Amanda M. K.; Bonthuis, Paul J.; Zup, Susan; Rissman, Emilie F.; Park, Jin Ho			Increased Dendritic Spine Density and Tau Expression Are Associated with Individual Differences in Steroidal Regulation of Male Sexual Behavior	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; LONG-TERM POTENTIATION; TRANSGENIC MICE; COPULATORY-BEHAVIOR; PREFRONTAL CORTEX; ESTROUS-CYCLE; SPINOPHILIN; ESTRADIOL; CASTRATION; RETENTION	Male sexual behavior (MSB) is modulated by gonadal steroids, yet this relationship is highly variable across species and between individuals. A significant percentage (similar to 30%) of B6D2F1 hybrid male mice demonstrate MSB after long-term orchidectomy (herein after referred to as "maters''), providing an opportunity to examine the mechanisms that underlie individual differences in steroidal regulation of MSB. Use of gene expression arrays comparing maters and non-maters has provided a first pass look at the genetic underpinnings of steroid-independent MSB. Surprisingly, of the similar to 500 genes in the medial preoptic area (MPOA) that differed between maters and non-maters, no steroid hormone or receptor genes were differentially expressed between the two groups. Interestingly, best known for their association with Alzheimer's disease, amyloid precursor protein (APP) and the microtubule-associated protein tau (MAPT) were elevated in maters. Increased levels of their protein products (APP and tau) in their non-pathological states have been implicated in cell survival, neuroprotection, and supporting synaptic integrity. Here we tested transgenic mice that overexpress tau and found facilitated mounting and intromission behavior after long-term orchidectomy relative to littermate controls. In addition, levels of synaptophysin and spinophilin, proteins generally enriched in synapses and dendritic spines respectively, were elevated in the MPOA of maters. Dendritic morphology was also assessed in Golgi-impregnated brains of orchidectomized B6D2F1 males, and hybrid maters exhibited greater dendritic spine density in MPOA neurons. In sum, we show for the first time that retention of MSB in the absence of steroids is correlated with morphological differences in neurons.	[Bharadwaj, Pranay; Madden, Amanda M. K.; Zup, Susan; Park, Jin Ho] Univ Massachusetts, Dept Psychol, Boston, MA 02125 USA; [McInnis, Christine] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA; [Bonthuis, Paul J.] Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT USA; [Rissman, Emilie F.] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	University of Massachusetts System; University of Massachusetts Boston; Brandeis University; Utah System of Higher Education; University of Utah; University of Virginia	Park, JH (corresponding author), Univ Massachusetts, Dept Psychol, Boston, MA 02125 USA.	JinHo.Park@umb.edu		McInnis, Christine/0000-0002-8449-4954; Madden, Amanda/0000-0002-3878-4600; Bharadwaj, Pranay/0000-0003-3768-3557	NIH [5R00HD056041, R01MH057759]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R00HD056041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK091317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057759] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIH grants 5R00HD056041 (JHP) and R01MH057759 (EFR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; Boekhoorn K, 2006, J NEUROSCI, V26, P3514, DOI 10.1523/JNEUROSCI.5425-05.2006; Castagna C, 1999, BRAIN RES BULL, V50, P241, DOI 10.1016/S0361-9230(99)00193-8; CHERRY JA, 1992, J COMP NEUROL, V323, P577, DOI 10.1002/cne.903230410; Christensen A, 2011, J NEUROSCI, V31, P17583, DOI 10.1523/JNEUROSCI.3030-11.2011; CLEMENS LG, 1988, PHYSIOL BEHAV, V42, P69, DOI 10.1016/0031-9384(88)90262-4; Dawson GR, 1999, NEUROSCIENCE, V90, P1, DOI 10.1016/S0306-4522(98)00410-2; Duff K, 2000, NEUROBIOL DIS, V7, P87, DOI 10.1006/nbdi.1999.0279; Evans GJO, 2005, BIOCHEM SOC T, V33, P1350, DOI 10.1042/BST0331350; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fester Lars, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS123, DOI 10.1016/j.psyneuen.2009.08.013; Fitzjohn SM, 2000, NEUROSCI LETT, V288, P9, DOI 10.1016/S0304-3940(00)01204-0; GOMEZ DM, 1992, J COMP NEUROL, V317, P195, DOI 10.1002/cne.903170208; Hao JD, 2003, J COMP NEUROL, V465, P540, DOI 10.1002/cne.10837; HIROKAWA N, 1994, CURR OPIN CELL BIOL, V6, P74, DOI 10.1016/0955-0674(94)90119-8; Hull EM, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P1729; Ishihara T, 1999, NEURON, V24, P751, DOI 10.1016/S0896-6273(00)81127-7; Kim D, 2009, CELL, V137, P997, DOI 10.1016/j.cell.2009.05.042; Kwon SE, 2011, NEURON, V70, P847, DOI 10.1016/j.neuron.2011.04.001; Leuner B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011597; Macknin JB, 2004, BRAIN RES, V1000, P174, DOI 10.1016/j.brainres.2004.01.047; MALMNAS CO, 1976, PHARMACOL BIOCHEM BE, V4, P521, DOI 10.1016/0091-3057(76)90191-X; MANNING A, 1976, ANIM BEHAV, V24, P523, DOI 10.1016/S0003-3472(76)80065-6; McCarthy MM, 2003, ANN NY ACAD SCI, V1007, P283, DOI 10.1196/annals.1286.027; MCGILL TE, 1976, ANIM BEHAV, V24, P507, DOI 10.1016/S0003-3472(76)80063-2; Morgan D, 2008, J ALZHEIMERS DIS, V15, P605; Muly EC, 2004, J COMP NEUROL, V469, P185, DOI 10.1002/cne.11001; Park JH, 2004, HORM BEHAV, V45, P214, DOI 10.1016/j.yhbeh.2003.11.001; Park JH, 2011, HORMONES AND REPRODUCTION OF VERTEBRATES, VOL 5: MAMMALS, P139; Park JH, 2010, J NEUROSCI, V30, P9967, DOI 10.1523/JNEUROSCI.1988-10.2010; Park JH, 2009, HORM BEHAV, V56, P254, DOI 10.1016/j.yhbeh.2009.05.007; Pfaus JG, 2012, ARCH SEX BEHAV, V41, P31, DOI 10.1007/s10508-012-9935-5; Pitchers KK, 2010, BIOL PSYCHIAT, V67, P872, DOI 10.1016/j.biopsych.2009.09.036; Polydoro M, 2009, J NEUROSCI, V29, P10741, DOI 10.1523/JNEUROSCI.1065-09.2009; Rademakers R, 2004, HUM MUTAT, V24, P277, DOI 10.1002/humu.20086; Reinhard C, 2005, EMBO J, V24, P3996, DOI 10.1038/sj.emboj.7600860; SCALETTA LL, 1990, PHARMACOL BIOCHEM BE, V37, P471, DOI 10.1016/0091-3057(90)90015-A; Senechal Y, 2007, J NEUROCHEM, V102, P1928, DOI 10.1111/j.1471-4159.2007.04672.x; Sinchak K, 1996, BEHAV NEUROSCI, V110, P593; Smith FD, 1999, J BIOL CHEM, V274, P19894, DOI 10.1074/jbc.274.28.19894; Spires-Jones T, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/319836; Tang Y, 2004, CEREB CORTEX, V14, P215, DOI 10.1093/cercor/bhg121; Turner PR, 2003, PROG NEUROBIOL, V70, P1, DOI 10.1016/S0301-0082(03)00089-3; Vila-Ortiz GJ, 2001, CELL MOL NEUROBIOL, V21, P535, DOI 10.1023/A:1013823524302; Wang JZ, 2008, PROG NEUROBIOL, V85, P148, DOI 10.1016/j.pneurobio.2008.03.002; WEE BEF, 1988, PHYSIOL BEHAV, V42, P77, DOI 10.1016/0031-9384(88)90263-6; Wersinger SR, 2000, J NEUROSCI, V20, P4248; WOOD RI, 1995, J NEUROSCI, V15, P7261; WOOLLEY CS, 1992, J NEUROSCI, V12, P2549; WOOLLEY CS, 1993, J COMP NEUROL, V336, P293, DOI 10.1002/cne.903360210; Yuan A, 2008, J NEUROSCI, V28, P1682, DOI 10.1523/JNEUROSCI.5242-07.2008	54	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e69672	10.1371/journal.pone.0069672	http://dx.doi.org/10.1371/journal.pone.0069672			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874981	Green Published, gold, Green Submitted			2022-12-27	WOS:000322064300110
J	Gopichandran, V; Chetlapalli, SK				Gopichandran, Vijayaprasad; Chetlapalli, Satish Kumar			Dimensions and Determinants of Trust in Health Care in Resource Poor Settings - A Qualitative Exploration	PLOS ONE			English	Article							PATIENT; PHYSICIANS; PAYMENT	Background: Trust in health care has been intensely researched in resource rich settings. Some studies in resource poor settings suggest that the dimensions and determinants of trust are likely to be different. Objectives: This study was done as a qualitative exploration of the dimensions and determinants of trust in health care in Tamil Nadu, a state in south India to assess the differences from dimensions and determinants in resource rich settings. Methodology: The participants included people belonging to marginalized communities with poor access to health care services and living in conditions of resource deprivation. A total of thirty five in depth interviews were conducted. The interviews were summarized and transcribed and data were analyzed following thematic analysis and grounded theory approach. Results: The key dimensions of trust in health care identified during the interviews were perceived competence, assurance of treatment irrespective of ability to pay or at any time of the day, patients' willingness to accept drawbacks in health care, loyalty to the physician and respect for the physician. Comfort with the physician and health facility, personal involvement of the doctor with the patient, behavior and approach of doctor, economic factors, and health awareness were identified as factors determining the levels of trust in health care. Conclusions: The dimensions and determinants of trust in health care in resource poor settings are different from that in resource rich settings. There is a need to develop scales to measure trust in health care in resource poor settings using these specific dimensions and determinants.	[Gopichandran, Vijayaprasad; Chetlapalli, Satish Kumar] Sri Ramaswamy Mem Univ, Sch Publ Hlth, Kancheepuram, Tamil Nadu, India	SRM Institute of Science & Technology Chennai	Gopichandran, V (corresponding author), Sri Ramaswamy Mem Univ, Sch Publ Hlth, Kancheepuram, Tamil Nadu, India.	vijay.gopichandran@gmail.com	Gopichandran, Vijayaprasad/ABH-3853-2020	Gopichandran, Vijayaprasad/0000-0003-2635-9583	INSPIRE Fellowship of the Department of Science and Technology, Government of India	INSPIRE Fellowship of the Department of Science and Technology, Government of India	VG is supported by the INSPIRE Fellowship of the Department of Science and Technology, Government of India for his PhD Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abildsnes E, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X630043; Balabanova D, 2013, LANCET, V381, P2118, DOI 10.1016/S0140-6736(12)62000-5; Barber B, 1983, LOGIC LIMITS TRUST; Becker ER, 2008, MED CARE, V46, P795, DOI 10.1097/MLR.0b013e31817919c0; Bhattacharya R, 1998, ACAD MANAGE REV, V23, P459, DOI 10.2307/259289; Bryman A., 2008, SOCIAL RES METHODS; Calnan M, 2004, TRUST IN HEALTH CARE; CATERINICCHIO RP, 1979, SOC SCI MED-MED SOC, VA13, P81, DOI 10.1016/0160-7979(79)90011-0; DeWalt DA, 2007, AM J HEALTH BEHAV, V31, pS27; Ferguson WJ, 2002, FAM MED, V34, P353; Fochsen G, 2006, QUAL HEALTH RES, V16, P1236, DOI 10.1177/1049732306293776; Fugelli P, 2001, BRIT J GEN PRACT, V51, P575; Galletly CA, 2004, MED J AUSTRALIA, V181, P380, DOI 10.5694/j.1326-5377.2004.tb06334.x; Gatter Robert, 2004, Wake Forest Law Rev, V39, P395; Goold SD, 1999, J GEN INTERN MED, V14, pS26, DOI 10.1046/j.1525-1497.1999.00267.x; Goudge J, 2005, SOC SCI MED, V61, P1439, DOI 10.1016/j.socscimed.2004.11.071; Grande D, 2012, J GEN INTERN MED, V27, P274, DOI 10.1007/s11606-011-1760-3; Gupta I, 2009, OUT OF POCKET EXPEND; Gutheil TG, 2002, PSYCHIAT CLIN N AM, V25, P585; Hall MA, 2001, MILBANK Q, V79, P613, DOI 10.1111/1468-0009.00223; Jones R.T., 2006, METHODS DISASTER MEN, P265; Kao AC, 1998, JAMA-J AM MED ASSOC, V280, P1708, DOI 10.1001/jama.280.19.1708; Kao AC, 1998, J GEN INTERN MED, V13, P681, DOI 10.1046/j.1525-1497.1998.00204.x; Lee YY, 2009, HEALTH CARE ANAL, V17, P244, DOI 10.1007/s10728-008-0100-1; OECD, 2012, OECD HEALTH DATA 201; Pearson SD, 2000, J GEN INTERN MED, V15, P509, DOI 10.1046/j.1525-1497.2000.11002.x; Peters DH, 2002, BETTER HEALTH SYSTEM; Ramani K V, 2006, J Health Organ Manag, V20, P560, DOI 10.1108/14777260610702307; Riewpaiboon W, 2005, SOC SCI MED, V61, P1408, DOI 10.1016/j.socscimed.2004.11.075; Russell S, 2005, SOC SCI MED, V61, P1396, DOI 10.1016/j.socscimed.2004.11.077; Subha B, 2012, INT J GYNECOL OBSTET, V118, pS33, DOI 10.1016/j.ijgo.2012.05.008; Thom DH, 1997, J FAM PRACTICE, V44, P169; Wofford MM, 2004, ACAD MED, V79, P134, DOI 10.1097/00001888-200402000-00008	33	24	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e69170	10.1371/journal.pone.0069170	http://dx.doi.org/10.1371/journal.pone.0069170			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	186SF	23874904	gold, Green Submitted, Green Published			2022-12-27	WOS:000322064300089
J	Marathe, HG; Mehta, G; Zhang, XL; Datar, I; Mehrotra, A; Yeung, KC; de la Serna, IL				Marathe, Himangi G.; Mehta, Gaurav; Zhang, Xiaolu; Datar, Ila; Mehrotra, Aanchal; Yeung, Kam C.; de la Serna, Ivana L.			SWI/SNF Enzymes Promote SOX10-Mediated Activation of Myelin Gene Expression	PLOS ONE			English	Article							CHROMATIN-REMODELING COMPLEX; TRANSCRIPTION FACTOR SOX10; PROTEIN ZERO; SCHWANN-CELLS; NEURAL CREST; BRG1; DIFFERENTIATION; EGR2; INDUCTION; TRANSACTIVATION	SOX10 is a Sry-related high mobility (HMG)-box transcriptional regulator that promotes differentiation of neural crest precursors into Schwann cells, oligodendrocytes, and melanocytes. Myelin, formed by Schwann cells in the peripheral nervous system, is essential for propagation of nerve impulses. SWI/SNF complexes are ATP dependent chromatin remodeling enzymes that are critical for cellular differentiation. It was recently demonstrated that the BRG1 subunit of SWI/SNF complexes activates SOX10 expression and also interacts with SOX10 to activate expression of OCT6 and KROX20, two transcriptional regulators of Schwann cell differentiation. To determine the requirement for SWI/SNF enzymes in the regulation of genes that encode components of myelin, which are downstream of these transcriptional regulators, we introduced SOX10 into fibroblasts that inducibly express dominant negative versions of the SWI/SNF ATPases, BRM or BRG1. Dominant negative BRM and BRG1 have mutations in the ATP binding site and inhibit gene activation events that require SWI/SNF function. Ectopic expression of SOX10 in cells derived from NIH 3T3 fibroblasts led to the activation of the endogenous Schwann cell specific gene, myelin protein zero (MPZ) and the gene that encodes myelin basic protein (MBP). Thus, SOX10 reprogrammed these cells into myelin gene expressing cells. Ectopic expression of KROX20 was not sufficient for activation of these myelin genes. However, KROX20 together with SOX10 synergistically activated MPZ and MBP expression. Dominant negative BRM and BRG1 abrogated SOX10 mediated activation of MPZ and MBP and synergistic activation of these genes by SOX10 and KROX20. SOX10 was required to recruit BRG1 to the MPZ locus. Similarly, in immortalized Schwann cells, BRG1 recruitment to SOX10 binding sites at the MPZ locus was dependent on SOX10 and expression of dominant negative BRG1 inhibited expression of MPZ and MBP in these cells. Thus, SWI/SNF enzymes cooperate with SOX10 to directly activate genes that encode components of peripheral myelin.	[Marathe, Himangi G.; Mehta, Gaurav; Zhang, Xiaolu; Datar, Ila; Mehrotra, Aanchal; Yeung, Kam C.; de la Serna, Ivana L.] Univ Toledo, Coll Med & Life Sci, Dept Biochem & Canc Biol, Toledo, OH 43606 USA	University System of Ohio; University of Toledo	de la Serna, IL (corresponding author), Univ Toledo, Coll Med & Life Sci, Dept Biochem & Canc Biol, 2801 W Bancroft St, Toledo, OH 43606 USA.	ivana.delaserna@utoledo.edu	Mehta, Gaurav/L-3117-2019	Mehta, Gaurav/0000-0002-1634-1980	National Institute of Health [ARO59379]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059379] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	National Institute of Health R01(ARO59379). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belandia B, 2002, EMBO J, V21, P4094, DOI 10.1093/emboj/cdf412; Berger P, 2006, GLIA, V54, P243, DOI 10.1002/glia.20386; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; Bryant GO, 2008, PLOS BIOL, V6, P2928, DOI 10.1371/journal.pbio.0060317; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; De la Serna IL, 2000, MOL CELL BIOL, V20, P2839, DOI 10.1128/MCB.20.8.2839-2851.2000; de la Serna IL, 2001, NAT GENET, V27, P187, DOI 10.1038/84826; de la Serna IL, 2005, MOL CELL BIOL, V25, P3997, DOI 10.1128/MCB.25.10.3997-4009.2005; de la Serna IL, 2006, J BIOL CHEM, V281, P20233, DOI 10.1074/jbc.M512052200; de la Serna IL, 2006, NAT REV GENET, V7, P461, DOI 10.1038/nrg1882; Eroglu B, 2006, DEV DYNAM, V235, P2722, DOI 10.1002/dvdy.20911; Forcales SV, 2012, EMBO J, V31, P301, DOI 10.1038/emboj.2011.391; Ghislain J, 2006, EMBO REP, V7, P52, DOI 10.1038/sj.embor.7400573; Guidi CJ, 2001, MOL CELL BIOL, V21, P3598, DOI 10.1128/MCB.21.10.3598-3603.2001; Guth SIE, 2008, CELL MOL LIFE SCI, V65, P3000, DOI 10.1007/s00018-008-8138-7; Hsiao PW, 2003, MOL CELL BIOL, V23, P6210, DOI 10.1128/MCB.23.17.6210-6220.2003; Imbalzano AN, 1998, CRIT REV EUKAR GENE, V8, P225, DOI 10.1615/CritRevEukarGeneExpr.v8.i3-4.10; Ito T, 2001, J BIOL CHEM, V276, P2852, DOI 10.1074/jbc.M009633200; Jagalur NB, 2011, J NEUROSCI, V31, P8585, DOI 10.1523/JNEUROSCI.0659-11.2011; Jang SW, 2009, J BIOL CHEM, V284, P20111, DOI 10.1074/jbc.M109.022426; Jones EA, 2007, NEURON GLIA BIOL, V3, P377, DOI 10.1017/S1740925X08000173; Keenen B, 2010, ONCOGENE, V29, P81, DOI 10.1038/onc.2009.304; Klochendler-Yeivin A, 2000, EMBO REP, V1, P500, DOI 10.1093/embo-reports/kvd129; Kowenz-Leutz E, 1999, MOL CELL, V4, P735, DOI 10.1016/S1097-2765(00)80384-6; Kuspert M, 2012, J NEUROSCI, V32, P5472, DOI 10.1523/JNEUROSCI.5759-11.2012; LeBlanc SE, 2007, MOL CELL BIOL, V27, P3521, DOI 10.1128/MCB.01689-06; LeBlanc SE, 2006, J BIOL CHEM, V281, P5453, DOI 10.1074/jbc.M512159200; Lee MJ, 1997, MOL CELL NEUROSCI, V8, P336, DOI 10.1006/mcne.1996.0589; Limpert AS, 2013, J NEUROSCI, V33, P2388, DOI 10.1523/JNEUROSCI.3223-12.2013; Link KA, 2005, MOL CELL BIOL, V25, P2200, DOI 10.1128/MCB.25.6.2200-2215.2005; Matsumoto S, 2006, DEV BIOL, V289, P372, DOI 10.1016/j.ydbio.2005.10.044; Nagarajan R, 2001, NEURON, V30, P355, DOI 10.1016/S0896-6273(01)00282-3; Ohkawa Y, 2006, EMBO J, V25, P490, DOI 10.1038/sj.emboj.7600943; Park J, 2002, MOL CELL BIOL, V22, P1307, DOI 10.1128/MCB.22.5.1307-1316.2002; Pedersen TA, 2001, GENE DEV, V15, P3208, DOI 10.1101/gad.209901; Peirano RI, 2000, MOL CELL BIOL, V20, P3198, DOI 10.1128/MCB.20.9.3198-3209.2000; Penn BH, 2004, GENE DEV, V18, P2348, DOI 10.1101/gad.1234304; Pereira JA, 2012, TRENDS NEUROSCI, V35, P123, DOI 10.1016/j.tins.2011.11.006; Phelan ML, 1999, MOL CELL, V3, P247, DOI 10.1016/S1097-2765(00)80315-9; Potterf SB, 2000, HUM GENET, V107, P1, DOI 10.1007/s004390050001; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979; Roberts CWM, 2000, P NATL ACAD SCI USA, V97, P13796, DOI 10.1073/pnas.250492697; Salma N, 2004, MOL CELL BIOL, V24, P4651, DOI 10.1128/MCB.24.11.4651-4663.2004; Seo S, 2005, GENE DEV, V19, P1723, DOI 10.1101/gad.1319105; Seo S, 2005, DEVELOPMENT, V132, P105, DOI 10.1242/dev.01548; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Soutoglou E, 2002, SCIENCE, V295, P1901, DOI 10.1126/science.1068356; STEWART HJS, 1993, EUR J NEUROSCI, V5, P1136, DOI 10.1111/j.1460-9568.1993.tb00968.x; Stys PK, 2012, NAT REV NEUROSCI, V13, P507, DOI 10.1038/nrn3275; Svaren J, 2008, GLIA, V56, P1541, DOI 10.1002/glia.20767; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; Wegner M, 2005, PIGM CELL RES, V18, P74, DOI 10.1111/j.1600-0749.2005.00218.x; Wei Q, 2004, J NEUROSCI RES, V78, P796, DOI 10.1002/jnr.20342; Weider M, 2012, DEV CELL, V23, P193, DOI 10.1016/j.devcel.2012.05.017; WEINTRAUB H, 1991, GENE DEV, V5, P1377, DOI 10.1101/gad.5.8.1377; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Yu Y, 2013, CELL, V152, P248, DOI 10.1016/j.cell.2012.12.006; ZHANG SM, 1995, J NEUROSCI RES, V40, P241, DOI 10.1002/jnr.490400213	59	30	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e69037	10.1371/journal.pone.0069037	http://dx.doi.org/10.1371/journal.pone.0069037			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874858	gold, Green Published, Green Submitted			2022-12-27	WOS:000322064300083
J	Sagi, E; Diermeier, D; Kaufmann, S				Sagi, Eyal; Diermeier, Daniel; Kaufmann, Stefan			Identifying Issue Frames in Text	PLOS ONE			English	Article								Framing, the effect of context on cognitive processes, is a prominent topic of research in psychology and public opinion research. Research on framing has traditionally relied on controlled experiments and manually annotated document collections. In this paper we present a method that allows for quantifying the relative strengths of competing linguistic frames based on corpus analysis. This method requires little human intervention and can therefore be efficiently applied to large bodies of text. We demonstrate its effectiveness by tracking changes in the framing of terror over time and comparing the framing of abortion by Democrats and Republicans in the U.S.	[Sagi, Eyal; Diermeier, Daniel] Northwestern Univ, Kellogg Sch Management, Evanston, IL 60208 USA; [Kaufmann, Stefan] Northwestern Univ, Dept Linguist, Evanston, IL USA	Northwestern University; Northwestern University	Sagi, E (corresponding author), Northwestern Univ, Kellogg Sch Management, Evanston, IL 60208 USA.	eyal@u.northwestern.edu						Baumgartner F. R., 1993, AGENDAS INSTABILITY; Baumgartner FR, 2008, THE DECLINE OF THE D; BAUMGARTNER FR, 2002, POLICY DYNAMICS; Chong D, 2007, ANNU REV POLIT SCI, V10, P103, DOI 10.1146/annurev.polisci.10.072805.103054; Diermeier D, 2012, BRIT J POLIT SCI, V42, P31, DOI 10.1017/S0007123411000160; Firth J.R., 1957, MODES MEANING PAPERS; Gentzkow M, 2010, ECONOMETRICA, V78, P35, DOI 10.3982/ECTA7195; Howell, 2009, OXFORD HDB AM PRESID, P160; Hu X, 2007, THE HANDBOOK OF LATE, P401; Infomap, 2007, COMPUTER SOFTWARE; Iyengar S., 1987, NEWS MATTERS TELEVIS; Lakoff G, 2008, HE POLITICAL MIND WH; Lakoff George, 2004, DONT THINK OF AN ELE; Landauer TK, 1997, PSYCHOL REV, V104, P211, DOI 10.1037/0033-295X.104.2.211; Levin E, 2006, P HLT NAACL, P77; Lucks N, 2008, QUEEN SHEBA; Marcu D, 2003, ENCY LIB INFORMATION, P245; Monroe BL, 2008, POLIT ANAL, V16, P351, DOI 10.1093/pan/mpn017; Quinn KM, 2010, AM J POLIT SCI, V54, P209, DOI 10.1111/j.1540-5907.2009.00427.x; Riedel E., 2006, Journal of Educational Computing Research, V35, P267, DOI 10.2190/U552-M54Q-5771-M677; Sagi Eyal, 2009, P WORKSH GEOM MOD NA, P104, DOI DOI 10.3115/1705415.1705429; Schattschneider E.E., 1960, SEMISOVEREIGN PEOPLE; Schutze H, 1998, COMPUT LINGUIST, V24, P97; Schutze H, 1997, AMBIGUITY IN LANGUAG; Shapiro RY, 2011, PUBLIC OPIN QUART, V75, P982, DOI 10.1093/poq/nfr053; Takayama Y, 1998, INFORMATION MAPPING, P8; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yu B, 2008, J INF TECHNOL POLITI, V5, P33, DOI 10.1080/19331680802149608	31	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e69185	10.1371/journal.pone.0069185	http://dx.doi.org/10.1371/journal.pone.0069185			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	186SF	23874909	Green Submitted, Green Published, gold			2022-12-27	WOS:000322064300090
J	Verdu, JR; Casas, JL; Cortez, V; Gallego, B; Lobo, JM				Verdu, Jose R.; Casas, Jose L.; Cortez, Vieyle; Gallego, Belen; Lobo, Jorge M.			Acorn Consumption Improves the Immune Response of the Dung Beetle Thorectes lusitanicus	PLOS ONE			English	Article							PROPHENOLOXIDASE-ACTIVATING SYSTEM; LARVAL COMPETITIVE ABILITY; MELANOTIC ENCAPSULATION; METARHIZIUM-ANISOPLIAE; PARASITOID RESISTANCE; DISEASE RESISTANCE; PROTEIN-QUALITY; TRADE-OFF; DROSOPHILA; PHENOLOXIDASE	Thorectes lusitanicus, a typically coprophagous species is also actively attracted to oak acorns, consuming, burying them, and conferring ecophysiological and reproductive advantages to both the beetle and the tree. In this study, we explored the possible relation between diet shift and the health status of T. lusitanicus using a generalist entomopathogenic fungus (Metarhizium anisopliae) as a natural pathogen. To measure the health condition and immune response of beetles, we analysed the protein content in the haemolymph, prophenoloxidase (proPO) content, phenoloxidase (PO) activity and mortality of beetles with diets based on either acorns or cow dung. Protein content, proPO levels and PO levels in the haemolymph of T. lusitanicus were found to be dependent on the type of diet. Furthermore, the beetles fed with acorns developed a more effective proPO-PO system than the beetles fed with cow dung. Furthermore, a significant decrease in mortality was observed when infected individuals were submitted to an acorn-based diet. In addition to enhancing an understanding of the relevance of dietary change to the evolutionary biology of dung beetles, these results provide a more general understanding of the ecophysiological implications of differential dietary selection in the context of fitness.	[Verdu, Jose R.; Casas, Jose L.; Cortez, Vieyle; Gallego, Belen] Univ Alicante, IUI Ctr Iberoamericano Biodiversidad, E-03080 Alicante, Spain; [Cortez, Vieyle] Inst Ecol AC, Red Ecoetol, Xalapa, Veracruz, Mexico; [Lobo, Jorge M.] CSIC, Museo Nacl Ciencias Nat, Dept Biodiversidad & Biol Evolutiva, Madrid, Spain	Universitat d'Alacant; Instituto de Ecologia - Mexico; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Verdu, JR (corresponding author), Univ Alicante, IUI Ctr Iberoamericano Biodiversidad, E-03080 Alicante, Spain.	jr.verdu@ua.es	Casas, Jose Luis/L-9869-2014; Gallardo, Vieyle Cortez/L-4692-2014; Lobo, Jorge M/E-2309-2013; Verdú, José/F-8269-2010	Casas, Jose Luis/0000-0001-8929-1331; Gallardo, Vieyle Cortez/0000-0003-0217-3899; Lobo, Jorge M/0000-0002-3152-4769; Verdú, José/0000-0002-0805-8341	Secretaria de Estado de Investigacion-Ministerio de Educacion, Ciencia e Innovacion [CGL2008/03878/BOS, CGL2011-25544]; Ministerio de Agricultura, Alimentacion y Medio Ambiente [OAPN 762/2012]	Secretaria de Estado de Investigacion-Ministerio de Educacion, Ciencia e Innovacion; Ministerio de Agricultura, Alimentacion y Medio Ambiente	Financial support was provided by the Projects CGL2008/03878/BOS and CGL2011-25544 of the Secretaria de Estado de Investigacion-Ministerio de Educacion, Ciencia e Innovacion (http://www.mecd.gob.es/portada-mecd/) and OAPN 762/2012, Ministerio de Agricultura, Alimentacion y Medio Ambiente (http://www.magrama.gob.es/es/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo SA, 2004, J INSECT PHYSIOL, V50, P209, DOI 10.1016/j.jinsphys.2003.11.011; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Boa-Amponsem K, 1999, AVIAN PATHOL, V28, P379, DOI 10.1080/03079459994641; Bocher A, 2007, J EVOLUTION BIOL, V20, P2228, DOI 10.1111/j.1420-9101.2007.01424.x; Boggs CL, 2009, FUNCT ECOL, V23, P27, DOI 10.1111/j.1365-2435.2009.01527.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROADWAY RM, 1988, J INSECT PHYSIOL, V34, P1111, DOI 10.1016/0022-1910(88)90213-2; Cantos E, 2003, J AGR FOOD CHEM, V51, P6248, DOI 10.1021/jf030216v; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Chambers MC, 2012, CURR OPIN IMMUNOL, V24, P10, DOI 10.1016/j.coi.2011.11.003; Chosa N, 1997, INSECT BIOCHEM MOLEC, V27, P61, DOI 10.1016/S0965-1748(96)00070-7; Cloyd R. A., 1999, MIDWEST BIOL CONTROL, VVI; Cotter SC, 2002, HEREDITY, V88, P229, DOI 10.1038/sj.hdy.6800031; Cotter SC, 2011, FUNCT ECOL, V25, P186, DOI 10.1111/j.1365-2435.2010.01766.x; Cowan MM, 1999, CLIN MICROBIOL REV, V12, P564, DOI 10.1128/CMR.12.4.564; Engqvist L, 2005, ANIM BEHAV, V70, P967, DOI 10.1016/j.anbehav.2005.01.016; Soukup SF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000532; Feder D, 1997, J INSECT PHYSIOL, V43, P513, DOI 10.1016/S0022-1910(97)00010-3; Felton GW, 1996, ARCH INSECT BIOCHEM, V32, P107, DOI 10.1002/(SICI)1520-6327(1996)32:1&lt;107::AID-ARCH7&gt;3.0.CO;2-X; Ghafour N., 2010, J ZANKOY SULAIMANI, V13, P129; Gonzalez-Santoyo I, 2012, ENTOMOL EXP APPL, V142, P1, DOI 10.1111/j.1570-7458.2011.01187.x; Gorman MJ, 1996, EXP PARASITOL, V84, P380, DOI 10.1006/expr.1996.0126; HIRUMA K, 1988, DEV BIOL, V130, P87, DOI 10.1016/0012-1606(88)90416-2; Jacot A, 2005, P ROY SOC B-BIOL SCI, V272, P63, DOI 10.1098/rspb.2004.2919; KAROWE DN, 1989, J INSECT PHYSIOL, V35, P699, DOI 10.1016/0022-1910(89)90089-9; Kraaijeveld AR, 1997, NATURE, V389, P278, DOI 10.1038/38483; Kraaijeveld AR, 2001, P ROY SOC B-BIOL SCI, V268, P259, DOI 10.1098/rspb.2000.1354; Laughton AM, 2011, APIDOLOGIE, V42, P140, DOI 10.1051/apido/2010046; Lee KP, 2006, P ROY SOC B-BIOL SCI, V273, P823, DOI 10.1098/rspb.2005.3385; Lee KP, 2007, J EXP BIOL, V210, P3236, DOI 10.1242/jeb.008060; Moslim R., 1999, Journal of Oil Palm Research, V11, P25; Nappi AJ, 1995, EUR J CELL BIOL, V68, P450; Nigam Y, 1997, J INVERTEBR PATHOL, V69, P279, DOI 10.1006/jipa.1996.4652; Perez-Ramos IM, 2007, ECOL ENTOMOL, V32, P349, DOI 10.1111/j.1365-2311.2007.00874.x; Povey S, 2009, J ANIM ECOL, V78, P437, DOI 10.1111/j.1365-2656.2008.01499.x; Reeson AF, 1998, P ROY SOC B-BIOL SCI, V265, P1787, DOI 10.1098/rspb.1998.0503; Rolff J, 2003, SCIENCE, V301, P472, DOI 10.1126/science.1080623; Romoser W. S., 1998, SCI ENTOMOLOGY; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Schwarzenbach GA, 2005, J EVOLUTION BIOL, V18, P455, DOI 10.1111/j.1420-9101.2004.00820.x; SEYBOLD WD, 1975, BIOCHEM GENET, V13, P85, DOI 10.1007/BF00486009; Siva-Jothy MT, 2001, PHYSIOL ENTOMOL, V26, P1, DOI 10.1046/j.1365-3032.2001.00206.x; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; Srygley RB, 2009, ECOL ENTOMOL, V34, P663, DOI 10.1111/j.1365-2311.2009.01117.x; StatSoft Inc, 2014, STATISTICA DAT AN SO; Theunis W, 1998, BIOCONTROL SCI TECHN, V8, P187, DOI 10.1080/09583159830252; TYNDALEBISCOE M, 1984, B ENTOMOL RES, V74, P341, DOI 10.1017/S0007485300015637; Verdu JR, 2007, ANIM BEHAV, V74, P1697, DOI 10.1016/j.anbehav.2007.03.016; Verdu JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010114; VILLANI MG, 1994, ENVIRON ENTOMOL, V23, P502, DOI 10.1093/ee/23.2.502; West HM, 2009, ENVIRON POLLUT, V157, P955, DOI 10.1016/j.envpol.2008.10.017; Wilson K, 2001, ECOL LETT, V4, P637, DOI 10.1046/j.1461-0248.2001.00279.x; Wilson-Rich N, 2008, J INSECT PHYSIOL, V54, P1392, DOI 10.1016/j.jinsphys.2008.07.016; YONEMURA M, 1991, ZOOL SCI, V8, P865	54	7	9	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e69277	10.1371/journal.pone.0069277	http://dx.doi.org/10.1371/journal.pone.0069277			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874934	Green Published, gold			2022-12-27	WOS:000322064300096
J	Piatek, MJ; Schramm, MC; Burra, DD; binShbreen, A; Jankovic, BR; Chowdhary, R; Archer, JAC; Bajic, VB				Piatek, Marek J.; Schramm, Michael C.; Burra, Dharani D.; binShbreen, Abdulaziz; Jankovic, Boris R.; Chowdhary, Rajesh; Archer, John A. C.; Bajic, Vladimir B.			Simplified Method for Predicting a Functional Class of Proteins in Transcription Factor Complexes	PLOS ONE			English	Article							DATABASE	Background: Initiation of transcription is essential for most of the cellular responses to environmental conditions and for cell and tissue specificity. This process is regulated through numerous proteins, their ligands and mutual interactions, as well as interactions with DNA. The key such regulatory proteins are transcription factors (TFs) and transcription co-factors (TcoFs). TcoFs are important since they modulate the transcription initiation process through interaction with TFs. In eukaryotes, transcription requires that TFs form different protein complexes with various nuclear proteins. To better understand transcription regulation, it is important to know the functional class of proteins interacting with TFs during transcription initiation. Such information is not fully available, since not all proteins that act as TFs or TcoFs are yet annotated as such, due to generally partial functional annotation of proteins. In this study we have developed a method to predict, using only sequence composition of the interacting proteins, the functional class of human TF binding partners to be (i) TF, (ii) TcoF, or (iii) other nuclear protein. This allows for complementing the annotation of the currently known pool of nuclear proteins. Since only the knowledge of protein sequences is required in addition to protein interaction, the method should be easily applicable to many species. Results: Based on experimentally validated interactions between human TFs with different TFs, TcoFs and other nuclear proteins, our two classification systems (implemented as a web-based application) achieve high accuracies in distinguishing TFs and TcoFs from other nuclear proteins, and TFs from TcoFs respectively. Conclusion: As demonstrated, given the fact that two proteins are capable of forming direct physical interactions and using only information about their sequence composition, we have developed a completely new method for predicting a functional class of TF interacting protein partners with high precision and accuracy.	[Piatek, Marek J.; Schramm, Michael C.; Burra, Dharani D.; binShbreen, Abdulaziz; Jankovic, Boris R.; Archer, John A. C.; Bajic, Vladimir B.] King Abdullah Univ Sci & Technol KAUST, Comp Elect & Math Sci & Engn Div, Computat Biosci Res Ctr, Thuwal, Saudi Arabia; [Chowdhary, Rajesh] Marshfield Clin Fdn Med Res & Educ, MCRF, Biomed Informat Res Ctr, Marshfield, WI USA	King Abdullah University of Science & Technology; Marshfield Clinic	Bajic, VB (corresponding author), King Abdullah Univ Sci & Technol KAUST, Comp Elect & Math Sci & Engn Div, Computat Biosci Res Ctr, Thuwal, Saudi Arabia.	vladimir.bajic@kaust.edu.sa	Archer, John/D-5200-2012; Archer, John/AAW-1990-2021; Bajic, Vladimir/D-2810-2009	Archer, John/0000-0002-3302-3933; Jankovic, Boris/0000-0003-1868-6007; Bajic, Vladimir/0000-0001-5435-4750	King Abdullah University of Science and Technology	King Abdullah University of Science and Technology(King Abdullah University of Science & Technology)	The research was supported from the base research funds of VBB at King Abdullah University of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Blow N, 2009, NATURE, V460, P415, DOI 10.1038/460415a; CRICK F, 1970, NATURE, V227, P561, DOI 10.1038/227561a0; De Las Rivas J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000807; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Ezkurdia L, 2009, BRIEF BIOINFORM, V10, P233, DOI 10.1093/bib/bbp021; Goodrich JA, 2010, NAT REV GENET, V11, P549, DOI 10.1038/nrg2847; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Kawashima S, 1999, NUCLEIC ACIDS RES, V27, P368, DOI 10.1093/nar/27.1.368; Keskin O, 2008, CHEM REV; Kohavi R., 1998, MACH LEARN, V30-2, P271, DOI [DOI 10.1023/A:1017181826899, 10.1023/A:1017181826899]; Lemons D, 2006, SCIENCE, V313, P1918, DOI 10.1126/science.1132040; Rausell A, 2010, P NATL ACAD SCI USA, V107, P1995, DOI 10.1073/pnas.0908044107; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Schaefer U, 2011, NUCLEIC ACIDS RES, V39, pD106, DOI 10.1093/nar/gkq945; Schmeier S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021887; Shamovsky I, 2008, CELL MOL LIFE SCI, V65, P855, DOI 10.1007/s00018-008-7458-y; Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P595, DOI 10.1371/journal.pcbi.0030043; Skrabanek L, 2008, MOL BIOTECHNOL, V38, P1, DOI 10.1007/s12033-007-0069-2; Stormo GD, 2010, NAT REV GENET, V11, P751, DOI 10.1038/nrg2845; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tasan M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s8; Zhou HX, 2007, BIOINFORMATICS, V23, P2203, DOI 10.1093/bioinformatics/btm323	24	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e68857	10.1371/journal.pone.0068857	http://dx.doi.org/10.1371/journal.pone.0068857			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	23874789	Green Submitted, Green Published, gold			2022-12-27	WOS:000321718700042
J	Berezowska, S; Novotny, A; Bauer, K; Feuchtinger, A; Slotta-Huspenina, J; Becker, K; Langer, R; Walch, A				Berezowska, Sabina; Novotny, Alexander; Bauer, Karina; Feuchtinger, Annette; Slotta-Huspenina, Julia; Becker, Karen; Langer, Rupert; Walch, Axel			Association between HSP90 and Her2 in Gastric and Gastroesophageal Carcinomas	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; HER-2/NEU GENE AMPLIFICATION; PROTEIN 90 INHIBITOR; HEAT-SHOCK PROTEINS; BREAST-CANCER; ANTITUMOR-ACTIVITY; TISSUE MICROARRAY; JUNCTION CANCER; TUMOR-GROWTH; PHASE-II	Background: Her2 expression and amplification occurs in a significant subset of gastro-esophageal carcinomas. Her2 is a client protein of molecular chaperones, e.g. heat shock protein (HSP) 90, rendering targeted therapies against Her2/HSP90 an interesting approach. This study aimed to investigate the role and relationship of Her2 and HSP90 in gastric and gastro-esophageal adenocarcinomas. Material and Methods: Immunohistochemical determination of HSP90 and Her2 expression was performed on 347 primary resected tumors. Her2 amplification was additionally determined by fluorescence in situ hybridization for all cases. Expression and amplification results were correlated with pathologic parameters (UICC pTNM category, tumor grading) and survival. Results: Elevated Her2 copy numbers were observed in 87 tumors, 21 of them showing amplification. 174 tumors showed Her2 immunoreactivity/expression. HSP 90 immunoreactivity was found in 125 tumors. There was no difference between gastric carcinomas and carcinomas of the gastroesophageal junction regarding Her2 or HSP90. Both high HSP90 and Her2 expression/amplification were associated with earlier tumor stages (p<0.01), absence of lymph node metastases (p<0.02) and Laurens intestinal type (p<0.001). HSP90 correlated with Her2 expression and amplification (p<0.001 each). Expressions of HSP90 and Her2, but not Her2 amplification were associated with better prognosis (p=0.02; p=0.004; p=0.802). Moreover, Her2 expression was an independent prognostic factor for overall survival in the subgroup of gastric carcinoma patients (p=0.014) besides pT category, pN category and distant metastases. Conclusion: Her2 expression and gene amplification occurred in a significant subset of cases. Our results suggest a favorable prognostic impact of Her2 expression. This warrants further investigations regarding the significance of Her2 non-amplified tumors showing Her2 immunoreactivity and the definition of Her2 status in gastric cancers. Moreover, the correlation of Her2 expression with the expression of Her2 chaperoning HSP90 may indicate a synergistic regulation. Targeting HSP90 with or without Her2 may offer additional therapeutic options for gastric carcinoma treatment.	[Berezowska, Sabina; Langer, Rupert] Univ Bern, Inst Pathol, Bern, Switzerland; [Novotny, Alexander] Tech Univ Munich, Dept Surg, Klinikum Rechts Isar, D-80290 Munich, Germany; [Bauer, Karina; Slotta-Huspenina, Julia; Becker, Karen] Tech Univ Munich, Inst Pathol, D-80290 Munich, Germany; [Feuchtinger, Annette; Walch, Axel] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Pathol, Res Unit Analyt Pathol, Neuherberg, Germany	University of Bern; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Berezowska, S (corresponding author), Univ Bern, Inst Pathol, Bern, Switzerland.	sabina.berezowska@pathology.unibe.ch	Feuchtinger, Annette/O-4569-2014; Walch, Axel/B-4554-2012; Berezowska, Sabina/AAJ-4557-2021; Langer, Rupert/AAU-1174-2021	Walch, Axel/0000-0001-5578-4023; Berezowska, Sabina/0000-0001-5442-9791; Langer, Rupert/0000-0001-9491-3609	Deutsche Forschungsgemeinschaft (DFG) [LA2706/1-1]; DFG [SFB 824 TP B1, SFB 824 TP Z2, WA 1656/3-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft (DFG), grant number LA2706/1-1. AW and AF gratefully acknowledge the financial support of the DFG (SFB 824 TP B1, SFB 824 TP Z2, and WA 1656/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balluff B, 2010, J PROTEOME RES, V9, P6317, DOI 10.1021/pr100573s; Bang YJ, 2010, LANCET, V376, P1302; Buffart TE, 2012, ONCOLOGIST, V17, P653, DOI 10.1634/theoncologist.2010-0379; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Chandarlapaty S, 2010, ONCOGENE, V29, P325, DOI 10.1038/onc.2009.337; Chen CY, 2010, J MOL GRAPH MODEL, V29, P21, DOI 10.1016/j.jmgm.2010.04.002; Cho EY, 2013, MODERN PATHOL, V26, P677, DOI 10.1038/modpathol.2012.205; Chua TC, 2012, INT J CANCER, V130, P2845, DOI 10.1002/ijc.26292; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Citri A, 2004, CELL CYCLE, V3, P51; Citri A, 2006, J BIOL CHEM, V281, P14361, DOI 10.1074/jbc.M512613200; Dekker TJA, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3208; Dowsett M, 2007, MODERN PATHOL, V20, P584, DOI 10.1038/modpathol.3800774; *EMEA, 2009, COMM MED PROD HUM US; Giaginis C, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-14; Grabsch H, 2010, CELL ONCOL, V32, P57, DOI 10.3233/CLO-2009-0497; Gravalos C, 2011, CLIN TRANSL ONCOL, V13, P179, DOI 10.1007/s12094-011-0637-6; Grillo F, 2013, TRANSL ONCOL, V6, P10, DOI 10.1593/tlo.12334; Hechtman JF, 2012, ARCH PATHOL LAB MED, V136, P691, DOI 10.5858/arpa.2011-0168-RS; Hicks DG, 2008, AM J CLIN PATHOL, V129, P263, DOI 10.1309/99AE032R9FM8WND1; Hicks DG, 2005, HUM PATHOL, V36, P250, DOI 10.1016/j.humpath.2004.11.010; Hofmann M, 2008, HISTOPATHOLOGY, V52, P797, DOI 10.1111/j.1365-2559.2008.03028.x; Hong DS, 2013, CANCER TREAT REV, V39, P375, DOI 10.1016/j.ctrv.2012.10.001; Ilyas M, 2013, HISTOPATHOLOGY, V62, P827, DOI 10.1111/his.12118; Janjigian YY, 2012, ANN ONCOL, V23, P2656, DOI 10.1093/annonc/mds104; Jego G, 2013, CANCER LETT, V332, P275, DOI 10.1016/j.canlet.2010.10.014; Jhaveri K, 2012, BBA-MOL CELL RES, V1823, P742, DOI 10.1016/j.bbamcr.2011.10.008; Jorgensen JT, 2012, J CANCER, V3, P137, DOI 10.7150/jca.4090; Lang SA, 2007, MOL CANCER THER, V6, P1123, DOI 10.1158/1535-7163.MCT-06-0628; Langer R, 2011, MODERN PATHOL, V24, P908, DOI 10.1038/modpathol.2011.52; Lee HE, 2013, EUR J CANCER, V49, P1448, DOI 10.1016/j.ejca.2012.10.018; Lee KH, 2011, CANCER SCI, V102, P1388, DOI 10.1111/j.1349-7006.2011.01944.x; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Lu CW, 2013, BIOCHEM PHARMACOL, V85, P1246, DOI 10.1016/j.bcp.2013.02.003; Lu XY, 2012, BIOCHEM PHARMACOL, V83, P995, DOI 10.1016/j.bcp.2011.11.011; Marchio C, 2009, J PATHOL, V219, P16, DOI 10.1002/path.2574; Maresch J, 2012, CRIT REV ONCOL HEMAT, V82, P310, DOI 10.1016/j.critrevonc.2011.06.003; Modi S, 2011, CLIN CANCER RES, V17, P5132, DOI 10.1158/1078-0432.CCR-11-0072; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; Ono N, 2012, CANCER SCI, V103, P342, DOI 10.1111/j.1349-7006.2011.02144.x; Patel HJ, 2011, EXPERT OPIN DRUG DIS, V6, P559, DOI 10.1517/17460441.2011.563296; Pirrelli M, 2013, DIGEST DIS SCI, V58, P397, DOI 10.1007/s10620-012-2357-3; Porter JR, 2010, CURR OPIN CHEM BIOL, V14, P412, DOI 10.1016/j.cbpa.2010.03.019; Rauser S, 2007, CLIN CANCER RES, V13, P5115, DOI 10.1158/1078-0432.CCR-07-0465; Ruschoff J, 2012, MODERN PATHOL, V25, P637, DOI 10.1038/modpathol.2011.198; Sauter G, 2009, J CLIN ONCOL, V27, P1323, DOI 10.1200/JCO.2007.14.8197; Scaltriti M, 2012, CLIN CANCER RES, V18, P4508, DOI 10.1158/1078-0432.CCR-11-2138; Scaltriti M, 2011, MOL CANCER THER, V10, P817, DOI 10.1158/1535-7163.MCT-10-0966; Shitara K, 2013, GASTRIC CANCER, V16, P261, DOI 10.1007/s10120-012-0179-9; Sidera K, 2008, J BIOL CHEM, V283, P2031, DOI 10.1074/jbc.M701803200; Sobin LH., 2010, TNM CLASSIFICATION M; Tanner M, 2005, ANN ONCOL, V16, P273, DOI 10.1093/annonc/mdi064; Terashima M, 2012, CLIN CANCER RES, V18, P5992, DOI 10.1158/1078-0432.CCR-12-1318; Thomson TA, 2009, AM J CLIN PATHOL, V132, P899, DOI 10.1309/AJCPW37QGECDYCDO; Tse CH, 2011, J CLIN ONCOL, V29, P4168, DOI 10.1200/JCO.2011.36.0107; Vani K, 2008, ARCH PATHOL LAB MED, V132, P211, DOI 10.1043/1543-2165(2008)132[211:NHPTRU]2.0.CO;2; Vranic S, 2011, CANCER-AM CANCER SOC, V117, P48, DOI 10.1002/cncr.25580; Wainberg ZA, 2013, MOL CANCER THER, V12, P509, DOI 10.1158/1535-7163.MCT-12-0507; Walch A, 2004, INT J CANCER, V112, P747, DOI 10.1002/ijc.20411; Walch A, 2001, LAB INVEST, V81, P791, DOI 10.1038/labinvest.3780289; Wang JH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0062876, 10.1371/journal.pone.0080980]; Warneke VS, 2013, ANN ONCOL, V24, P725, DOI 10.1093/annonc/mds528; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Yang JY, 2012, CELL BIOCHEM BIOPHYS, V62, P221, DOI 10.1007/s12013-011-9286-1; Yoon HH, 2012, CLIN CANCER RES, V18, P546, DOI 10.1158/1078-0432.CCR-11-2272; Zhang DH, 2003, HUM PATHOL, V34, P362, DOI 10.1053/hupa.2003.60	66	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e69098	10.1371/journal.pone.0069098	http://dx.doi.org/10.1371/journal.pone.0069098			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874879	Green Published, Green Submitted, gold			2022-12-27	WOS:000322218800065
J	Keller, JP; Homma, K; Dallos, P				Keller, Jacob Pearson; Homma, Kazuaki; Dallos, Peter			Pixels as ROIs (PAR): A Less-Biased and Statistically Powerful Approach for Gleaning Functional Information from Image Stacks	PLOS ONE			English	Article							INDICATOR; PRESTIN; CA2+; PH	Especially in the last decade or so, there have been dramatic advances in fluorescence-based imaging methods designed to measure a multitude of functions in living cells. Despite this, many of the methods used to analyze the resulting images are limited. Perhaps the most common mode of analysis is the choice of regions of interest (ROIs), followed by quantification of the signal contained therein in comparison with another "control" ROI. While this method has several advantages, such as flexibility and capitalization on the power of human visual recognition capabilities, it has the drawbacks of potential subjectivity and lack of precisely defined criteria for ROI selection. This can lead to analyses which are less precise or accurate than the data might allow for, and generally a regrettable loss of information. Herein, we explore the possibility of abandoning the use of conventional ROIs, and instead propose treating individual pixels as ROIs, such that all information can be extracted systematically with the various statistical cutoffs we discuss. As a test case for this approach, we monitored intracellular pH in cells transfected with the chloride/bicarbonate transporter slc26a3 using the ratiometric dye SNARF-5F under various conditions. We performed a parallel analysis using two different levels of stringency in conventional ROI analysis as well as the pixels-as-ROIs (PAR) approach, and found that pH differences between control and transfected cells were accentuated by similar to 50-100% by using the PAR approach. We therefore consider this approach worthy of adoption, especially in cases in which higher accuracy and precision are required.	[Keller, Jacob Pearson; Homma, Kazuaki; Dallos, Peter] Northwestern Univ, Dept Commun Sci & Disorders, Evanston, IL USA; Northwestern Univ, Dept Neurobiol, Evanston, IL USA; Northwestern Univ, Dept Otolaryngol Head & Neck Surg, Chicago, IL USA	Northwestern University; Northwestern University; Northwestern University	Keller, JP (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA USA.	j-keller2@northwestern.edu	Dallos, Peter/Q-9360-2019	Dallos, Peter/0000-0002-9731-6591; Keller, Jacob/0000-0001-7487-4104	National Institutes of Health [DC00089]; Hugh Knowles Center for Clinical and Basic Science in Hearing and Its Disorders; CCSG [P30 CA060553]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hugh Knowles Center for Clinical and Basic Science in Hearing and Its Disorders; CCSG; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was provided by National Institutes of Health grant DC00089 to PD and the Hugh Knowles Center for Clinical and Basic Science in Hearing and Its Disorders. Imaging work was performed at the Northwestern University Cell Imaging Facility supported by CCSG P30 CA060553 awarded to the Robert H Lurie Comprehensive Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; BUCKLER KJ, 1990, PFLUG ARCH EUR J PHY, V417, P234, DOI 10.1007/BF00370705; Cheatham MA, 2005, J PHYSIOL-LONDON, V569, P229, DOI 10.1113/jphysiol.2005.093518; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Kuner T, 2000, NEURON, V27, P447, DOI 10.1016/S0896-6273(00)00056-8; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Muallem D, 2006, BIOPHYS J, V90, P4035, DOI 10.1529/biophysj.105.073254; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Niino Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009164; RINK TJ, 1982, J CELL BIOL, V95, P189, DOI 10.1083/jcb.95.1.189; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089	12	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e69047	10.1371/journal.pone.0069047	http://dx.doi.org/10.1371/journal.pone.0069047			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874862	Green Submitted, Green Published, gold			2022-12-27	WOS:000322218800061
J	Shih, YT; Ko, CC; Pan, KT; Lin, SC; Polaszek, A				Shih, Yuan Tung; Ko, Chiun Cheng; Pan, Kuang Tao; Lin, Sue Cheng; Polaszek, Andrew			Hydrophylita (Lutzimicron) emporos Shih & Polaszek (Hymenoptera: Trichogrammatidae) from Taiwan, Parasitising Eggs, and Phoretic on Adults, of the Damselfly Psolodesmus mandarinus mandarinus (Zygoptera: Calopterygidae)	PLOS ONE			English	Article							WASPS HYMENOPTERA; CHALCIDOIDEA; GENUS	Hydrophylita emporos n. sp. reared from eggs of Psolodesmus mandarinus mandarinus McLachlan (Zygoptera: Calopterygidae) in Taiwan is described. This is the first species of Hydrophylita to be described from the Old World, and the first record of phoresy in the genus. Adult females were observed aggregating at the base of the female damselfly's abdomen. When the damselfly begins ovipositing, females move to the tip of the abdomen, enter the water and quickly locate eggs for parasitising. The article contains links to video footage of this process.	[Shih, Yuan Tung; Ko, Chiun Cheng; Pan, Kuang Tao] Natl Taiwan Univ, Dept Entomol, Taipei 10764, Taiwan; [Lin, Sue Cheng] Endem Species Res Inst, Taichung, Taiwan; [Polaszek, Andrew] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England; [Polaszek, Andrew] Imperial Coll Sci Technol & Med, London, England	National Taiwan University; Natural History Museum London; Imperial College London	Polaszek, A (corresponding author), Nat Hist Museum, Dept Life Sci, Cromwell Rd, London SW7 5BD, England.	ap@nhm.ac.uk		KO, CHIUN-CHENG/0000-0001-8815-3981	National Science Council, Taiwan (NSC) [100-2313-B-002-014]	National Science Council, Taiwan (NSC)(Ministry of Science and Technology, Taiwan)	The study was supported by a grant (NSC, 100-2313-B-002-014) from National Science Council, Taiwan, to the 1st author. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff DM, 2008, MOL ECOL, V17, P3917, DOI 10.1111/j.1365-294X.2008.03874.x; [Anonymous], 2010, PROGR BIOL CONTROL; [Anonymous], 1999, MEMOIRS ENTOMOLOGICA; Burks BD, 1979, CATALOG HYMENOPTERA, V1, P748; CLAUSEN CP, 1976, ANNU REV ENTOMOL, V21, P343, DOI 10.1146/annurev.en.21.010176.002015; De Santis L, 1964, NOTAS COMISION INVES, V2, P3; DOUTT R L, 1968, Proceedings of the California Academy of Sciences, V35, P477; Fatouros NE, 2005, NATURE, V433, P704, DOI 10.1038/433704a; Ghesquiere J, 1946, REV ZOO BOT AFR, V39, P371; Gillespie JJ, 2005, MOL BIOL EVOL, V22, P1593, DOI 10.1093/molbev/msi152; Kaartinen R, 2010, ECOL ENTOMOL, V35, P623, DOI 10.1111/j.1365-2311.2010.01224.x; Lima Ada Costa, 1960, ARQ I BIOL-SAO PAULO, V27, P197; MALO F, 1961, J ECON ENTOMOL, V54, P465, DOI 10.1093/jee/54.3.465; Matheson Robert, 1912, Annals of the Entomological Society of America, V5; NOYES JS, 1982, J NAT HIST, V16, P315, DOI 10.1080/00222938200770261; PINTO JD, 1994, P ENTOMOL SOC WASH, V96, P120; Pinto JD, 1997, ANNOTATED KEYS GENER, V794, p[726, 11]; Pinto JD, 2006, J HYMENOPT RES, V15, P38; Querino RB, 2007, ZOOTAXA, P47; YOSHIMOTO CM, 1976, CAN ENTOMOL, V108, P419, DOI 10.4039/Ent108419-4; Zucchi RA, 2010, PROG BIOL CONTROL, V9, P219, DOI 10.1007/978-1-4020-9110-0_8	21	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69331	10.1371/journal.pone.0069331	http://dx.doi.org/10.1371/journal.pone.0069331			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894449	Green Published, gold, Green Submitted			2022-12-27	WOS:000322167900056
J	Tan, SJ; Phan, H; Gerry, BM; Kuhn, A; Hong, LZ; Ong, YM; Poon, PSY; Unger, MA; Jones, RC; Quake, SR; Burkholder, WF				Tan, Swee Jin; Phan, Huan; Gerry, Benjamin Michael; Kuhn, Alexandre; Hong, Lewis Zuocheng; Ong, Yao Min; Poon, Polly Suk Yean; Unger, Marc Alexander; Jones, Robert C.; Quake, Stephen R.; Burkholder, William F.			A Microfluidic Device for Preparing Next Generation DNA Sequencing Libraries and for Automating Other Laboratory Protocols That Require One or More Column Chromatography Steps	PLOS ONE			English	Article							MESSENGER-RNA ISOLATION; SOLID-PHASE; LIQUID-CHROMATOGRAPHY; NUCLEIC-ACIDS; A-CHIP; PURIFICATION; CONSTRUCTION; INTEGRATION; SEPARATION; BIOLOGY	Library preparation for next-generation DNA sequencing (NGS) remains a key bottleneck in the sequencing process which can be relieved through improved automation and miniaturization. We describe a microfluidic device for automating laboratory protocols that require one or more column chromatography steps and demonstrate its utility for preparing Next Generation sequencing libraries for the Illumina and Ion Torrent platforms. Sixteen different libraries can be generated simultaneously with significantly reduced reagent cost and hands-on time compared to manual library preparation. Using an appropriate column matrix and buffers, size selection can be performed on-chip following end-repair, dA tailing, and linker ligation, so that the libraries eluted from the chip are ready for sequencing. The core architecture of the device ensures uniform, reproducible column packing without user supervision and accommodates multiple routine protocol steps in any sequence, such as reagent mixing and incubation; column packing, loading, washing, elution, and regeneration; capture of eluted material for use as a substrate in a later step of the protocol; and removal of one column matrix so that two or more column matrices with different functional properties can be used in the same protocol. The microfluidic device is mounted on a plastic carrier so that reagents and products can be aliquoted and recovered using standard pipettors and liquid handling robots. The carrier-mounted device is operated using a benchtop controller that seals and operates the device with programmable temperature control, eliminating any requirement for the user to manually attach tubing or connectors. In addition to NGS library preparation, the device and controller are suitable for automating other time-consuming and error-prone laboratory protocols requiring column chromatography steps, such as chromatin immunoprecipitation.	[Tan, Swee Jin; Kuhn, Alexandre; Hong, Lewis Zuocheng; Ong, Yao Min; Poon, Polly Suk Yean; Burkholder, William F.] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Proteos, Singapore; [Phan, Huan; Gerry, Benjamin Michael; Unger, Marc Alexander; Jones, Robert C.] Fluidigm Corp, San Francisco, CA USA; [Quake, Stephen R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Quake, Stephen R.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Quake, Stephen R.] Howard Hughes Med Inst, Stanford, CA USA; [Quake, Stephen R.] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Stanford University; Stanford University; Howard Hughes Medical Institute; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Burkholder, WF (corresponding author), Agcy Sci Technol & Res, Inst Mol & Cell Biol, Proteos, Singapore.	wfburkholder@gmail.com		Kuhn, Alexandre/0000-0003-3839-5282; Jones, Robert C/0000-0001-7235-9854	Joint Council Office of the Agency for Science, Technology and Research in Singapore [092 110 0080]	Joint Council Office of the Agency for Science, Technology and Research in Singapore	This work was supported by a Visiting Investigator Program grant from the Joint Council Office of the Agency for Science, Technology and Research in Singapore (http://www.a-star.edu.sg/tabid/73/default.aspx) to S.R.Q. [grant no. 092 110 0080]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashley EA, 2010, LANCET, V375, P1525, DOI 10.1016/S0140-6736(10)60452-7; Borgstrom E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019119; Breadmore MC, 2003, ANAL CHEM, V75, P1880, DOI 10.1021/ac0204855; Cady NC, 2003, BIOSENS BIOELECTRON, V19, P59, DOI 10.1016/S0956-5663(03)00123-4; Cho SK, 2003, J MICROELECTROMECH S, V12, P70, DOI 10.1109/JMEMS.2002.807467; Chou CF, 1999, P NATL ACAD SCI USA, V96, P13762, DOI 10.1073/pnas.96.24.13762; Christel LA, 1999, J BIOMECH ENG-T ASME, V121, P22, DOI 10.1115/1.2798037; Chung YC, 2004, LAB CHIP, V4, P141, DOI 10.1039/b310849j; Dittrich PS, 2006, NAT REV DRUG DISCOV, V5, P210, DOI 10.1038/nrd1985; El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063; Fair RB, 2007, MICROFLUID NANOFLUID, V3, P245, DOI 10.1007/s10404-007-0161-8; Farias-Hesson E, 2010, J BIOMED BIOTECHNOL, V2010, P2010; Fisher S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r1; Giordano C, 2000, J BIOMOL SCREEN, V5, P406; Gomez FA, 2011, METHODS MOL BIOL, V681, P137, DOI 10.1007/978-1-60761-913-0_8; HARRISON DJ, 1993, SCIENCE, V261, P895, DOI 10.1126/science.261.5123.895; HAWKINS TL, 1994, NUCLEIC ACIDS RES, V22, P4543, DOI 10.1093/nar/22.21.4543; Hindson BJ, 2008, ANALYST, V133, P248, DOI 10.1039/b713332d; Hong JW, 2006, J PHYS-CONDENS MAT, V18, pS691, DOI 10.1088/0953-8984/18/18/S14; Hong JW, 2004, NAT BIOTECHNOL, V22, P435, DOI 10.1038/nbt951; Huang LR, 2004, SCIENCE, V304, P987, DOI 10.1126/science.1094567; Huft J, 2013, ANAL CHEM, V85, P2999, DOI 10.1021/ac400163u; Huft J, 2013, ANAL CHEM, V85, P1797, DOI 10.1021/ac303153a; Jiang GF, 2000, ANALYST, V125, P2176, DOI 10.1039/b005999o; Kim J, 2009, INTEGR BIOL-UK, V1, P574, DOI 10.1039/b905844c; Kutter JP, 2012, J CHROMATOGR A, V1221, P72, DOI 10.1016/j.chroma.2011.10.044; Lam HYK, 2012, NAT BIOTECHNOL, V30, P562, DOI 10.1038/nbt0612-562e; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lavrik NV, 2011, ANAL CHIM ACTA, V694, P6, DOI 10.1016/j.aca.2011.03.059; Lennon NJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r15; Loman NJ, 2012, NAT BIOTECHNOL, V30, P562, DOI 10.1038/nbt0612-562f; Lundin S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010029; Marcus JS, 2006, ANAL CHEM, V78, P3084, DOI 10.1021/ac0519460; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Melin J, 2007, ANNU REV BIOPH BIOM, V36, P213, DOI 10.1146/annurev.biophys.36.040306.132646; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mitchell P, 2001, NAT BIOTECHNOL, V19, P717, DOI 10.1038/90754; Mugele F, 2005, J PHYS-CONDENS MAT, V17, pR705, DOI 10.1088/0953-8984/17/28/R01; PONTEN J, 1967, INT J CANCER, V2, P434, DOI 10.1002/ijc.2910020505; Quail MA, 2012, ELECTROPHORESIS, V33, P3521, DOI 10.1002/elps.201200128; Rahman MM, 2012, DRUG DISCOV TODAY, V17, P1199, DOI 10.1016/j.drudis.2012.07.001; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Rodrigue S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011840; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Spurgeon SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001662; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; Wen J, 2008, ANAL CHEM, V80, P6472, DOI 10.1021/ac8014998; Wolfe KA, 2002, ELECTROPHORESIS, V23, P727, DOI 10.1002/1522-2683(200203)23:5<727::AID-ELPS727>3.0.CO;2-O; Wu AR, 2009, LAB CHIP, V9, P1365, DOI 10.1039/b819648f; Zhong JF, 2008, LAB CHIP, V8, P68, DOI 10.1039/b712116d	52	21	21	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e64084	10.1371/journal.pone.0064084	http://dx.doi.org/10.1371/journal.pone.0064084			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894273	Green Published, gold, Green Submitted			2022-12-27	WOS:000322167900001
J	Yu, GX; Yagi, S; Carrion, R; Chen, EC; Lanford, RE; Brasky, KM; Lanford, RE; Kelly, KR; Bales, KL; Schnurr, DP; Canfield, DR; Patterson, JL; Chiu, CY				Yu, Guixia; Yagi, Shigeo; Carrion, Ricardo, Jr.; Chen, Eunice C.; Liu, Maria; Brasky, Kathleen M.; Lanford, Robert E.; Kelly, Kristi R.; Bales, Karen L.; Schnurr, David P.; Canfield, Don R.; Patterson, Jean L.; Chiu, Charles Y.			Experimental Cross-Species Infection of Common Marmosets by Titi Monkey Adenovirus	PLOS ONE			English	Article							CALLITHRIX-JACCHUS; ANIMAL-MODEL; DISEASE; HUMANS; ANTIBODIES; MACAQUES; PROTEIN	Adenoviruses are DNA viruses that infect a number of vertebrate hosts and are associated with both sporadic and epidemic disease in humans. We previously identified a novel adenovirus, titi monkey adenovirus (TMAdV), as the cause of a fulminant pneumonia outbreak in a colony of titi monkeys (Callicebus cupreus) at a national primate center in 2009. Serological evidence of infection by TMAdV was also found in a human researcher at the facility and household family member, raising concerns for potential cross-species transmission of the virus. Here we present experimental evidence of cross-species TMAdV infection in common marmosets (Callithrix jacchus). Nasal inoculation of a cell cultured-adapted TMAdV strain into three marmosets produced an acute, mild respiratory illness characterized by low-grade fever, reduced activity, anorexia, and sneezing. An increase in virus-specific neutralization antibody titers accompanied the development of clinical signs. Although serially collected nasal swabs were positive for TMAdV for at least 8 days, all 3 infected marmosets spontaneously recovered by day 12 post-inoculation, and persistence of the virus in tissues could not be established. Thus, the pathogenesis of experimental inoculation of TMAdV in common marmosets resembled the mild, self-limiting respiratory infection typically seen in immunocompetent human hosts rather than the rapidly progressive, fatal pneumonia observed in 19 of 23 titi monkeys during the prior 2009 outbreak. These findings further establish the potential for adenovirus cross-species transmission and provide the basis for development of a monkey model useful for assessing the zoonotic potential of adenoviruses.	[Yu, Guixia; Chen, Eunice C.; Chiu, Charles Y.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Yu, Guixia; Chen, Eunice C.; Chiu, Charles Y.] UCSF Abbott Viral Diagnost & Discovery Ctr, San Francisco, CA USA; [Yagi, Shigeo; Liu, Maria; Schnurr, David P.] Viral & Rickettsial Dis Lab, Calif Dept Publ Hlth, Richmond, CA USA; [Carrion, Ricardo, Jr.; Brasky, Kathleen M.; Lanford, Robert E.; Patterson, Jean L.] Texas Biomed Res Inst, San Antonio, TX USA; [Carrion, Ricardo, Jr.; Brasky, Kathleen M.; Lanford, Robert E.] Southwest Natl Primate Res Ctr, San Antonio, TX USA; [Kelly, Kristi R.; Bales, Karen L.; Canfield, Don R.] Calif Natl Primate Res Ctr, Davis, CA USA; [Bales, Karen L.] Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA; [Chiu, Charles Y.] Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA USA	University of California System; University of California San Francisco; California Department of Public Health; Texas Biomedical Research Institute; Texas Biomedical Research Institute; University of California System; University of California Davis; University of California System; University of California San Francisco	Chiu, CY (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.	charles.chiu@ucsf.edu		Chiu, Charles/0000-0003-2915-2094	National Institutes of Health (NIH) for Regional Centers of Excellence for Biodefense and Emerging Infectious Diseases [U54-AI057156, U54-AI57168]; NIH Office of Research Infrastructure Programs [P51-0D011107]; NIH [R56-AI089532, R01-HL105704]; Abbott Viral Discovery Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057156, R56AI089532, U54AI057168] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107, P51OD011133] Funding Source: NIH RePORTER	National Institutes of Health (NIH) for Regional Centers of Excellence for Biodefense and Emerging Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH Office of Research Infrastructure Programs; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abbott Viral Discovery Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is supported by the National Institutes of Health (NIH) for Regional Centers of Excellence for Biodefense and Emerging Infectious Diseases (grants U54-AI057156 and U54-AI57168), NIH Office of Research Infrastructure Programs, grant P51-0D011107 to the California National Primate Research Center, NIH Grant R56-AI089532 (to J.L.P. and C.Y.C.), NIH grant R01-HL105704 (to C.Y.C.), and an Abbott Viral Discovery Award (to C. Y. C.). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Blackford AN, 2009, J VIROL, V83, P4000, DOI 10.1128/JVI.02417-08; Carrion R, 2012, CURR OPIN VIROL, V2, P357, DOI 10.1016/j.coviro.2012.02.007; Carrion R, 2011, VIROLOGY, V420, P117, DOI 10.1016/j.virol.2011.08.022; CEPKO CL, 1983, J CLIN MICROBIOL, V17, P360, DOI 10.1128/JCM.17.2.360-364.1983; Chen EC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002155; David JM, 2009, J MED PRIMATOL, V38, P347, DOI 10.1111/j.1600-0684.2009.00362.x; Ersching J, 2010, VIROLOGY, V407, P1, DOI 10.1016/j.virol.2010.07.043; Fredricks DN, 1996, CLIN MICROBIOL REV, V9, P18, DOI 10.1128/CMR.9.1.18; Harrach B., 2011, VIRUS TAXONOMY CLASS, P95; Ho MS, 2005, EMERG INFECT DIS, V11, P1730, DOI 10.3201/eid1111.040659; Huff JL, 2003, EMERG INFECT DIS, V9, P246; Jacobs SC, 2004, J GEN VIROL, V85, P3361, DOI 10.1099/vir.0.80386-0; Jones MS, 2007, J CLIN MICROBIOL, V45, P2144, DOI 10.1128/JCM.00174-07; Jones MS, 2007, J VIROL, V81, P5978, DOI 10.1128/JVI.02650-06; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kojaoghlanian T, 2003, REV MED VIROL, V13, P155, DOI 10.1002/rmv.386; Lewis PF, 2009, J INFECT DIS, V199, P1427, DOI 10.1086/598521; Mansfield K, 2003, COMPARATIVE MED, V53, P383; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; PRINCE GA, 1993, J VIROL, V67, P101, DOI 10.1128/JVI.67.1.101-111.1993; Rivers TM, 1937, J BACTERIOL, V33, P1; Roy S, 2012, EMERG INFECT DIS, V18, P1081, DOI 10.3201/eid1807.111665; Roy S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000503; Schwartz RA, 2008, J VIROL, V82, P9043, DOI 10.1128/JVI.00925-08; TSAI JC, 1992, ARCH OPHTHALMOL-CHIC, V110, P1167, DOI 10.1001/archopht.1992.01080200147043; Wevers D, 2011, J VIROL, V85, P10774, DOI 10.1128/JVI.00810-11; WOLD WSM, 2007, FIELD VIROLOGY, P02395; Wolfe-Coote S, 2005, THE LABORATORY PRIMA; Xiang ZQ, 2006, EMERG INFECT DIS, V12, P1596, DOI 10.3201/eid1210.060078	30	16	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e68558	10.1371/journal.pone.0068558	http://dx.doi.org/10.1371/journal.pone.0068558			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894316	Green Published, Green Submitted, gold			2022-12-27	WOS:000322167900017
J	Montes, J; Gomez, E; Merchan-Perez, A; DeFelipe, J; Pena, JM				Montes, Jesus; Gomez, Elena; Merchan-Perez, Angel; DeFelipe, Javier; Pena, Jose-Maria			A Machine Learning Method for the Prediction of Receptor Activation in the Simulation of Synapses	PLOS ONE			English	Article							NMDA RECEPTORS; MOLECULAR-DYNAMICS; GLUTAMATE; DIFFUSION; RELEASE; AMPA; NETWORKS; MOBILITY; REVEALS; BIOLOGY	Chemical synaptic transmission involves the release of a neurotransmitter that diffuses in the extracellular space and interacts with specific receptors located on the postsynaptic membrane. Computer simulation approaches provide fundamental tools for exploring various aspects of the synaptic transmission under different conditions. In particular, Monte Carlo methods can track the stochastic movements of neurotransmitter molecules and their interactions with other discrete molecules, the receptors. However, these methods are computationally expensive, even when used with simplified models, preventing their use in large-scale and multi-scale simulations of complex neuronal systems that may involve large numbers of synaptic connections. We have developed a machine-learning based method that can accurately predict relevant aspects of the behavior of synapses, such as the percentage of open synaptic receptors as a function of time since the release of the neurotransmitter, with considerably lower computational cost compared with the conventional Monte Carlo alternative. The method is designed to learn patterns and general principles from a corpus of previously generated Monte Carlo simulations of synapses covering a wide range of structural and functional characteristics. These patterns are later used as a predictive model of the behavior of synapses under different conditions without the need for additional computationally expensive Monte Carlo simulations. This is performed in five stages: data sampling, fold creation, machine learning, validation and curve fitting. The resulting procedure is accurate, automatic, and it is general enough to predict synapse behavior under experimental conditions that are different to the ones it has been trained on. Since our method efficiently reproduces the results that can be obtained with Monte Carlo simulations at a considerably lower computational cost, it is suitable for the simulation of high numbers of synapses and it is therefore an excellent tool for multi-scale simulations.	[Montes, Jesus; Gomez, Elena; Merchan-Perez, Angel; Pena, Jose-Maria] Univ Politecn Madrid, Dept Arquitectura & Tecnol Sistemas Informat, Fac Informat, Madrid, Spain; [Merchan-Perez, Angel; DeFelipe, Javier] Univ Politecn Madrid, Ctr Tecnol Biomed, Lab Cajal Circuitos Corticales, Madrid, Spain; [DeFelipe, Javier] CSIC, Inst Cajal, E-28002 Madrid, Spain	Universidad Politecnica de Madrid; Universidad Politecnica de Madrid; Centro de Tecnologia Biomedica (CTB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Pena, JM (corresponding author), Univ Politecn Madrid, Dept Arquitectura & Tecnol Sistemas Informat, Fac Informat, Madrid, Spain.	jmpena@fi.upm.es	Merchan-Perez, Angel/D-7417-2014; Montes, Jesus/AAF-2479-2021; DEFELIPE, JAVIER/D-1195-2014; Merchan-Perez, Angel/AAY-8947-2020	Merchan-Perez, Angel/0000-0002-7228-5821; Montes, Jesus/0000-0002-1454-4784; DEFELIPE, JAVIER/0000-0001-5484-0660; Merchan-Perez, Angel/0000-0002-7228-5821; Pena, Jose Maria/0000-0002-3303-0455	Spanish Ministry of Science [TIN2010-21289-C02-02]; Cajal Blue Brain Project	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Cajal Blue Brain Project	This work was financed by the Spanish Ministry of Science (www.micinn.es) (grant TIN2010-21289-C02-02) and supported by the Cajal Blue Brain Project (cajalbbp.cesvima.upm.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allam SL, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00070; Alonso-Nanclares L, 2008, P NATL ACAD SCI USA, V105, P14615, DOI 10.1073/pnas.0803652105; Andrews SS, 2004, PHYS BIOL, V1, P137, DOI 10.1088/1478-3967/1/3/001; Andrews SS, 2010, PLOS COMPUTATIONAL B, V6, P10; Atasoy D, 2008, J NEUROSCI, V28, P10151, DOI 10.1523/JNEUROSCI.2432-08.2008; Boucher J, 2010, BRAIN STRUCT FUNCT, V215, P49, DOI 10.1007/s00429-010-0273-x; Bouteiller JMC, 2011, IEEE T BIO-MED ENG, V58, P3008, DOI 10.1109/TBME.2011.2158605; Bower JM, 1998, BOOK GENESIS EXPLORI; Brette R, 2007, J COMPUT NEUROSCI, V23, P349, DOI 10.1007/s10827-007-0038-6; BRUNS D, 1995, NATURE, V377, P62, DOI 10.1038/377062a0; Carnevale NT, 2006, NEURON BOOK; Chaplain MAJ, 2011, IMA J APPL MATH, V76, P371, DOI 10.1093/imamat/hxr025; Dasarathy B. V., 1991, NEAREST NEIGHBOR NN; Drasdo D, 2011, P 8 EUR C MATH THEOR; ELKAREH AW, 1993, BIOPHYS J, V64, P1638, DOI 10.1016/S0006-3495(93)81532-7; Engquist B., 2003, NOT AM MATH SOC, V50, P1062; Franks KM, 2002, BIOPHYS J, V83, P2333, DOI 10.1016/S0006-3495(02)75248-X; FRIEDMAN JH, 1981, J AM STAT ASSOC, V76, P817, DOI 10.2307/2287576; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Fuxe K, 2007, BRAIN RES REV, V55, P17, DOI 10.1016/j.brainresrev.2007.02.009; Harris KM, 2012, COLD SPRING HARB PER, V4, P5, DOI DOI 10.1101/CSHPERSPECT.A005587; Haykin S, 1999, P842; Hines ML, 2001, NEUROSCIENTIST, V7, P123, DOI 10.1177/107385840100700207; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; Kerr RA, 2008, SIAM J SCI COMPUT, V30, P3126, DOI 10.1137/070692017; Kharazia VN, 1999, J COMP NEUROL, V412, P292, DOI 10.1002/(SICI)1096-9861(19990920)412:2<292::AID-CNE8>3.0.CO;2-G; Lehre KP, 1998, J NEUROSCI, V18, P8751, DOI 10.1523/jneurosci.18-21-08751.1998; Lindley DV, 1987, NEW PALGRAVE DICT EC, V4, P120; Lu G, 2004, OVERVIEW MULTISCALE; MATLAB, 2013, MATLAB LANG TECHN CO; Momiyama A, 2003, J PHYSIOL-LONDON, V549, P75, DOI 10.1113/jphysiol.2002.033472; Morra G, 2008, CURR PROTEIN PEPT SC, V9, P181, DOI 10.2174/138920308783955234; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Nicholson C, 1998, TRENDS NEUROSCI, V21, P207, DOI 10.1016/S0166-2236(98)01261-2; Nielsen TA, 2004, NEURON, V42, P757, DOI 10.1016/j.neuron.2004.04.003; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Peters A., 1991, FINE STRUCTURE NERVO; Plimpton SJ, 2005, J PHYS CONF SER, V16, P305, DOI 10.1088/1742-6596/16/1/042; Praprotnik Matej, 2013, Methods Mol Biol, V924, P567, DOI 10.1007/978-1-62703-017-5_21; Quinlan J. R., 1992, Proceedings of the 5th Australian Joint Conference on Artificial Intelligence. AI '92, P343; Renner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025731; Rusakov DA, 1998, J NEUROSCI, V18, P3158; Rusakov DA, 2011, TRENDS NEUROSCI, V34, P359, DOI 10.1016/j.tins.2011.03.002; Savtchenko LP, 2007, P NATL ACAD SCI USA, V104, P1823, DOI 10.1073/pnas.0606636104; Savtchenko LP, 2013, NAT NEUROSCI, V16, P10, DOI 10.1038/nn.3285; Schikorski T, 1997, J NEUROSCI, V17, P5858; Schnell S, 2007, AM SCI, V95, P134, DOI 10.1511/2007.64.1018; Shrivastava IH, 2000, BIOPHYS J, V78, P557, DOI 10.1016/S0006-3495(00)76616-1; Southern J, 2008, PROG BIOPHYS MOL BIO, V96, P60, DOI 10.1016/j.pbiomolbio.2007.07.019; Stiles JR, 2001, METH NE FRO NEUROSCI, P87; Stiles JR, 2013, MCELL MONTECARLO SIM; Sykova E, 2008, PHYSIOL REV, V88, P1277, DOI 10.1152/physrev.00027.2007; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Tarusawa E, 2009, J NEUROSCI, V29, P12896, DOI 10.1523/JNEUROSCI.6160-08.2009; Thorne RG, 2006, P NATL ACAD SCI USA, V103, P5567, DOI 10.1073/pnas.0509425103; Wang Y, 1996, 9 EUR C MACH LEARN; Witten IH, 2011, MOR KAUF D, P1; Wolpert DH, 1996, NEURAL COMPUT, V8, P1341, DOI 10.1162/neco.1996.8.7.1341; Zheng KY, 2008, BIOPHYS J, V95, P4584, DOI 10.1529/biophysj.108.129874	59	4	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e68888	10.1371/journal.pone.0068888	http://dx.doi.org/10.1371/journal.pone.0068888			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894367	gold, Green Published			2022-12-27	WOS:000325211000054
J	van der Flier, M; Sharma, DB; Estevao, S; Emonts, M; Rook, D; Hazelzet, JA; van Goudoever, JB; Hartwig, NG				van der Flier, Michiel; Sharma, Dyana B.; Estevao, Silvia; Emonts, Marieke; Rook, Denise; Hazelzet, Jan A.; van Goudoever, Johannes B.; Hartwig, Nico G.			Increased CD4(+) T Cell Co-Inhibitory Immune Receptor CEACAM1 in Neonatal Sepsis and Soluble-CEACAM1 in Meningococcal Sepsis: A Role in Sepsis-Associated Immune Suppression?	PLOS ONE			English	Article							PROLIFERATION; ACTIVATION; APOPTOSIS; RESPONSES; CHILDREN; SURVIVAL; PROTEIN	The co-inhibitory immune receptor carcinoembryonic antigen-related cell-adhesion molecule 1 (CEACAM1) and its self-ligand CEACAM1 can suppress T cell function. Suppression of T cell function in sepsis is well documented. Late-onset neonatal sepsis in VLBW-infants was associated with an increased percentage CEACAM1 positive CD4(+) T-cells. Meningococcal septic shock in children was associated with increased serum soluble CEACAM1. In conclusion our data demonstrate increased surface expression of the co-inhibitory immune receptor CEACAM1 in late-onset neonatal sepsis in VLBW-infants, and increased circulating soluble CEACAM1 in children with meningococcal sepsis. Increased T-cell CEACAM1 expression and increased circulating soluble CEACAM1 may contribute to sepsis-associated immune suppression.	[van der Flier, Michiel; Sharma, Dyana B.; Emonts, Marieke; Hartwig, Nico G.] Erasmus MC Sophia, Dept Pediat Infect Dis & Immunol, Rotterdam, Netherlands; [van der Flier, Michiel; Sharma, Dyana B.; Estevao, Silvia; Hartwig, Nico G.] Erasmus MC Sophia, Pediat Infect Dis Grp, Pediat Lab, Rotterdam, Netherlands; [Rook, Denise; van Goudoever, Johannes B.] Erasmus MC Sophia, Neonatal Intens Care Unit, Rotterdam, Netherlands; [Hazelzet, Jan A.] Erasmus MC Sophia, Pediat Intens Care Unit, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	van der Flier, M (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Pediat, NL-6525 ED Nijmegen, Netherlands.	m.flier@cukz.umcn.nl	van Goudoever, Johannes Bernard/Y-4520-2018; van der Flier, M./L-4307-2015; Hartwig, Nico/ABI-5467-2020; Hazelzet, Jan A/L-2888-2015	van der Flier, M./0000-0003-1296-0159; van Goudoever, Johannes (Hans)/0000-0003-3960-1703; Emonts, Marieke/0000-0002-2822-3527; Hazelzet, Jan/0000-0002-9414-5539	European Society of Paediatric Infectious Diseases (ESPID)	European Society of Paediatric Infectious Diseases (ESPID)	MvdF was supported by a Fellowship of the European Society of Paediatric Infectious Diseases (ESPID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; Boomer JS, 2012, CRIT CARE, V16, DOI 10.1186/cc11404; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Boulton IC, 2002, NAT IMMUNOL, V3, P229, DOI 10.1038/ni769; Chen CJ, 2004, J IMMUNOL, V172, P3544, DOI 10.4049/jimmunol.172.6.3544; de Kleijn ED, 2003, CRIT CARE MED, V31, P1839, DOI 10.1097/01.CCM.0000072121.61120.D8; Donda A, 2000, EUR J IMMUNOL, V30, P2593, DOI 10.1002/1521-4141(200009)30:9<2593::AID-IMMU2593>3.0.CO;2-0; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; GREENWOOD BM, 1979, CLIN EXP IMMUNOL, V38, P9; Inoue S, 2010, J IMMUNOL, V184, P1401, DOI 10.4049/jimmunol.0902307; Lu RZ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002597; Markel G, 2004, EUR J IMMUNOL, V34, P2138, DOI 10.1002/eji.200425021; Morales VM, 1999, J IMMUNOL, V163, P1363; Nagaishi T, 2006, ANN NY ACAD SCI, V1072, P155, DOI 10.1196/annals.1326.004; Nolan A, 2008, AM J RESP CRIT CARE, V177, P301, DOI 10.1164/rccm.200703-515OC; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Singer BB, 2005, EUR J IMMUNOL, V35, P1949, DOI 10.1002/eji.200425691; Slevogt H, 2008, NAT IMMUNOL, V9, P1270, DOI 10.1038/ni.1661; Unsinger J, 2010, J IMMUNOL, V184, P3768, DOI 10.4049/jimmunol.0903151; van der Flier M, 2001, J INFECT DIS, V183, P149, DOI 10.1086/317643; van der Zwet WC, 2005, J HOSP INFECT, V61, P300, DOI 10.1016/j.jhin.2005.03.014; Wagner TH, 2007, AM J PHYSIOL-REG I, V292, pR1751, DOI 10.1152/ajpregu.00656.2006; Watson RS, 2003, AM J RESP CRIT CARE, V167, P695, DOI 10.1164/rccm.200207-682OC; Youssef AR, 2009, INFECT IMMUN, V77, P5170, DOI 10.1128/IAI.00355-09; Yu QG, 2006, J BIOL CHEM, V281, P39179, DOI 10.1074/jbc.M608864200	27	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e68294	10.1371/journal.pone.0068294	http://dx.doi.org/10.1371/journal.pone.0068294			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894299	Green Submitted, Green Published, gold			2022-12-27	WOS:000322132100014
J	Fu, CW; Wang, YP; Fang, TY; Lin, TH				Fu, Chien-wei; Wang, Yu-Ping; Fang, Tsuei-Yun; Lin, Thy-Hou			Interaction between Trehalose and MTHase from Sulfolobus solfataricus Studied by Theoretical Computation and Site-Directed Mutagenesis	PLOS ONE			English	Article							FREE-ENERGY DECOMPOSITION; BINDING FREE-ENERGIES; MALTOOLIGOSYLTREHALOSE TREHALOHYDROLASE; MOLECULAR-MECHANICS; GENETIC ALGORITHM; DIELECTRIC MEDIUM; CRYSTAL-STRUCTURE; SOLVENT MODELS; LIQUID WATER; MM-PBSA	Maltooligosyltrehalose trehalohydrolase (MTHase) catalyzes the release of trehalose by cleaving the alpha-1,4-glucosidic linkage next to the alpha-1,1-linked terminal disaccharide of maltooligosyltrehalose. Computer simulation using the hydrogen bond analysis, free energy decomposition, and computational alanine scanning were employed to investigate the interaction between maltooligosyltrehalose and the enzyme. The same residues that were chosen for theoretical investigation were also studied by site-directed mutagenesis and enzyme kinetic analysis. The importance of residues determined either experimentally or computed theoretically were in good accord with each other. It was found that residues Y155, D156, and W218 of subsites -2 and -3 of the enzyme might play an important role in interacting with the ligand. The theoretically constructed structure of the enzyme-ligand complex was further validated through an ab initio quantum chemical calculation using the Gaussian09 package. The activation energy computed from this latter study was very similar to those reported in literatures for the same type of hydrolysis reactions.	[Fu, Chien-wei; Lin, Thy-Hou] Natl Tsing Hua Univ, Inst Mol Med, Hsinchu, Taiwan; [Fu, Chien-wei; Lin, Thy-Hou] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan; [Wang, Yu-Ping; Fang, Tsuei-Yun] Natl Taiwan Ocean Univ, Dept Food Sci, Keelung, Taiwan; [Wang, Yu-Ping; Fang, Tsuei-Yun] Natl Taiwan Ocean Univ, Ctr Excellence Marine Bioenvironm & Biotechnol, Keelung, Taiwan	National Tsing Hua University; National Tsing Hua University; National Taiwan Ocean University; National Taiwan Ocean University	Fang, TY (corresponding author), Natl Taiwan Ocean Univ, Dept Food Sci, Keelung, Taiwan.	tyfang@mail.ntou.edu.tw; thlin@life.nthu.edu.tw			National Science Council of Taiwan, R.O.C. [NSC99-2627-B007-005, NSC99-2628-B007-001-MY3]	National Science Council of Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan)	This work was supported by Grants NSC99-2627-B007-005 and NSC99-2628-B007-001-MY3 from the National Science Council of Taiwan, R.O.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Case D.A., 2022, AMBER 2020; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chong LT, 2006, J MOL BIOL, V357, P1039, DOI 10.1016/j.jmb.2005.12.083; Crowe JH, 2007, ADV EXP MED BIOL, V594, P143; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Fang TY, 2008, J AGR FOOD CHEM, V56, P5628, DOI 10.1021/jf073320b; Fang TY, 2007, J AGR FOOD CHEM, V55, P5588, DOI 10.1021/jf0701279; Fang TY, 2006, J AGR FOOD CHEM, V54, P7105, DOI 10.1021/jf061318z; Feese MD, 2000, J MOL BIOL, V301, P451, DOI 10.1006/jmbi.2000.3977; FERSHT AR, 1985, NATURE, V314, P235, DOI 10.1038/314235a0; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; Hawkins GD, 1996, J PHYS CHEM-US, V100, P19824, DOI 10.1021/jp961710n; HAWKINS GD, 1995, CHEM PHYS LETT, V246, P122, DOI 10.1016/0009-2614(95)01082-K; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huo S, 2002, J COMPUT CHEM, V23, P15, DOI 10.1002/jcc.1153; Huo SH, 2002, J MED CHEM, V45, P1412, DOI 10.1021/jm010338j; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; JORGENSEN WL, 1982, J CHEM PHYS, V77, P4156, DOI 10.1063/1.444325; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kato M, 1999, J MOL CATAL B-ENZYM, V6, P223, DOI 10.1016/S1381-1177(98)00132-5; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kuhn B, 2000, J MED CHEM, V43, P3786, DOI 10.1021/jm000241h; Kuhn B, 2005, J MED CHEM, V48, P4040, DOI 10.1021/jm049081q; Lepsik M, 2004, PROTEINS, V57, P279, DOI 10.1002/prot.20192; Li T, 2008, J MOL GRAPH MODEL, V26, P813, DOI 10.1016/j.jmgm.2007.04.007; Luo C, 2005, PROTEINS, V59, P742, DOI 10.1002/prot.20443; Manuel RC, 1997, BIOCHEMISTRY-US, V36, P11140, DOI 10.1021/bi9709708; Massova I, 1999, J AM CHEM SOC, V121, P8133, DOI 10.1021/ja990935j; Mishra RS, 1996, J BIOSCIENCE, V21, P653, DOI 10.1007/BF02703143; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Moreira IS, 2006, J PHYS CHEM B, V110, P10962, DOI 10.1021/jp054760d; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Onufriev A, 2000, J PHYS CHEM B, V104, P3712, DOI 10.1021/jp994072s; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Rao JLUM, 2007, APPL BIOCHEM BIOTECH, V142, P179, DOI 10.1007/s12010-007-0017-4; Richards AB, 2002, FOOD CHEM TOXICOL, V40, P871, DOI 10.1016/S0278-6915(02)00011-X; Saharay M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012947; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Swanson JMJ, 2004, BIOPHYS J, V86, P67, DOI 10.1016/S0006-3495(04)74084-9; Thorsteinsdottir HB, 2006, PROTEINS, V65, P407, DOI 10.1002/prot.21096; Timmins J, 2005, J MOL BIOL, V347, P949, DOI 10.1016/j.jmb.2005.02.011; Tseng WC, 2008, ANAL BIOCHEM, V375, P376, DOI 10.1016/j.ab.2007.12.013; Villacanas O, 2006, PROTEINS, V63, P797, DOI 10.1002/prot.20943; Wang JM, 2001, J AM CHEM SOC, V123, P5221, DOI 10.1021/ja003834q; Weiser J, 1999, J COMPUT CHEM, V20, P217, DOI 10.1002/(SICI)1096-987X(19990130)20:2<217::AID-JCC4>3.0.CO;2-A; WILKINSON AJ, 1983, BIOCHEMISTRY-US, V22, P3581, DOI 10.1021/bi00284a007; Xu Y, 2006, PROTEINS, V64, P1058, DOI 10.1002/prot.21044; Zoete V, 2005, PROTEINS, V61, P79, DOI 10.1002/prot.20528; Zoete V, 2007, PROTEINS, V67, P1026, DOI 10.1002/prot.21395; Zoete V, 2006, J COMPUT CHEM, V27, P1843, DOI 10.1002/jcc.20512	54	6	7	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e68565	10.1371/journal.pone.0068565	http://dx.doi.org/10.1371/journal.pone.0068565			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894317	Green Published, Green Submitted, gold			2022-12-27	WOS:000322391400010
J	Chiang, DJ; Roychowdhury, S; Bush, K; McMullen, MR; Pisano, S; Niese, K; Olman, MA; Pritchard, MT; Nagy, LE				Chiang, Dian J.; Roychowdhury, Sanjoy; Bush, Katelyn; McMullen, Megan R.; Pisano, Sorana; Niese, Kathryn; Olman, Mitchell A.; Pritchard, Michele T.; Nagy, Laura E.			Adenosine 2A Receptor Antagonist Prevented and Reversed Liver Fibrosis in a Mouse Model of Ethanol-Exacerbated Liver Fibrosis	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; ENDOTHELIAL GROWTH-FACTOR; EXTRACELLULAR ADENOSINE; ALCOHOL-CONSUMPTION; PULMONARY-FIBROSIS; A(2A) RECEPTORS; INJURY; INFLAMMATION; METABOLISM; ACTIVATION	The effect of moderate alcohol consumption on liver fibrosis is not well understood, but evidence suggests that adenosine may play a role in mediating the effects of moderate ethanol on tissue injury. Ethanol increases the concentration of adenosine in the liver. Adenosine 2A receptor (A2AR) activation is known to enhance hepatic stellate cell (HSC) activation and A2AR deficient mice are protected from fibrosis in mice. Making use of a novel mouse model of moderate ethanol consumption in which female C57BL/6J mice were allowed continued access to 2% (vol/vol) ethanol (11% calories) or pair-fed control diets for 2 days, 2 weeks or 5 weeks and superimposed with exposure to CCl4, we tested the hypothesis that moderate ethanol consumption increases fibrosis in response to carbon tetrachloride (CCl4) and that treatment of mice with an A2AR antagonist prevents and/or reverses this ethanol-induced increase in liver fibrosis. Neither the expression or activity of CYP2E1, required for bio-activation of CCl4, nor AST and ALT activity in the plasma were affected by ethanol, indicating that moderate ethanol did not increase the direct hepatotoxicity of CCl4. However, ethanol feeding enhanced HSC activation and exacerbated liver fibrosis upon exposure to CCl4. This was associated with an increased sinusoidal angiogenic response in the liver. Treatment with A2AR antagonist both prevented and reversed the ability of ethanol to exacerbate liver fibrosis. Conclusion: Moderate ethanol consumption exacerbates hepatic fibrosis upon exposure to CCl4. A2AR antagonism may be a potential pharmaceutical intervention to decrease hepatic fibrosis in response to ethanol.	[Chiang, Dian J.; Nagy, Laura E.] Cleveland Clin, Ctr Liver Dis Res, Dept Gastroenterol & Hepatol, Cleveland, OH 44106 USA; [Roychowdhury, Sanjoy; Bush, Katelyn; McMullen, Megan R.; Pisano, Sorana; Niese, Kathryn; Olman, Mitchell A.; Pritchard, Michele T.; Nagy, Laura E.] Cleveland Clin, Dept Pathobiol, Cleveland, OH 44106 USA; [Nagy, Laura E.] Cleveland Clin, Lerner Coll Med, Coll Med, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Nagy, LE (corresponding author), Cleveland Clin, Ctr Liver Dis Res, Dept Gastroenterol & Hepatol, Cleveland, OH 44106 USA.	nagyL3@ccf.org		Pritchard, Michele/0000-0002-0095-0685	DOD [W81XWH-10-1-0100]; NIH [P20 AA17069, K99/R00 AA017918, HL103553, HL085324]; American Liver Foundation; Case Western Reserve University/Cleveland Clinic [CTSA UL1RR024989]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085324, R01HL103553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K99AA017918] Funding Source: NIH RePORTER	DOD(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Liver Foundation; Case Western Reserve University/Cleveland Clinic; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The study was supported by DOD grant W81XWH-10-1-0100 to LEN, NIH P20 AA17069 to LEN, NIH K99/R00 AA017918 to MTP, NIH HL103553 and HL085324 to MAO and American Liver Foundation Postdoctoral Fellowship Award to DJC and additional support from the Case Western Reserve University/Cleveland Clinic CTSA UL1RR024989. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arteel GE, 1997, HEPATOLOGY, V25, P920, DOI 10.1002/hep.510250422; ASHLEY MJ, 1977, ARCH INTERN MED, V137, P883, DOI 10.1001/archinte.137.7.883; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Becker U, 1996, HEPATOLOGY, V23, P1025, DOI 10.1002/hep.510230513; Brun P, 2005, AM J PHYSIOL-GASTR L, V289, pG571, DOI 10.1152/ajpgi.00537.2004; Burnstock G, 2007, CELL MOL LIFE SCI, V64, P1471, DOI 10.1007/s00018-007-6497-0; Carini R, 2004, GASTROENTEROLOGY, V127, P914, DOI 10.1053/j.gastro.2004.06.018; Chan ESL, 2006, BRIT J PHARMACOL, V148, P1144, DOI 10.1038/sj.bjp.0706812; Che J, 2007, MOL PHARMACOL, V72, P1626, DOI 10.1124/mol.107.038760; Cheung O, 2011, J CLIN GASTROENTEROL, V45, P76, DOI 10.1097/MCG.0b013e3181e12511; Corrao G, 1997, SCAND J GASTROENTERO, V32, P1174, DOI 10.3109/00365529709002999; Ding Q, 2013, AM J PATHOL, V182, P1572, DOI 10.1016/j.ajpath.2013.01.026; Fernandez M, 2009, J HEPATOL, V50, P604, DOI 10.1016/j.jhep.2008.12.011; Folkesson HG, 2012, AM J PHYSIOL-LUNG C, V303, pL259, DOI 10.1152/ajplung.00395.2011; Garcia GE, 2011, KIDNEY INT, V80, P378, DOI 10.1038/ki.2011.101; Hall P, 1995, ALCOHOLIC LIVER DIS, P299; Hashmi AZ, 2007, AM J PHYSIOL-GASTR L, V292, pG395, DOI 10.1152/ajpgi.00208.2006; HASUMURA Y, 1974, GASTROENTEROLOGY, V66, P415, DOI 10.1016/s0016-5085(74)80142-3; Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009; Jeong WI, 2008, GASTROENTEROLOGY, V134, P248, DOI 10.1053/j.gastro.2007.09.034; Keshavarzian A, 1999, AM J GASTROENTEROL, V94, P200; Leibovich SJ, 2002, AM J PATHOL, V160, P2231, DOI 10.1016/S0002-9440(10)61170-4; Lieber CS, 2000, ANNU REV NUTR, V20, P395, DOI 10.1146/annurev.nutr.20.1.395; Mandal P, 2010, J IMMUNOL, V185, P4928, DOI 10.4049/jimmunol.1002060; McGaraughty S, 2005, CURR TOP MED CHEM, V5, P43, DOI 10.2174/1568026053386845; McMullen MR, 2005, GASTROENTEROLOGY, V128, P2066, DOI 10.1053/j.gastro.2005.02.065; Mihara T, 2007, J PHARMACOL EXP THER, V323, P708, DOI 10.1124/jpet.107.121962; Montesinos MC, 2004, AM J PATHOL, V164, P1887, DOI 10.1016/S0002-9440(10)63749-2; Montesinos MC, 2002, AM J PATHOL, V160, P2009, DOI 10.1016/S0002-9440(10)61151-0; NAGY LE, 1992, AM J PHYSIOL, V262, pC1175, DOI 10.1152/ajpcell.1992.262.5.C1175; NAGY LE, 1990, J BIOL CHEM, V265, P1946; Novo E, 2007, AM J PATHOL, V170, P1942, DOI 10.2353/ajpath.2007.060887; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Ong A, 2011, LIVER INT, V31, P1047, DOI 10.1111/j.1478-3231.2011.02555.x; Peng ZS, 2008, NUCLEOS NUCLEOT NUCL, V27, P821, DOI 10.1080/15257770802146403; Pinhal-Enfield G, 2003, AM J PATHOL, V163, P711, DOI 10.1016/S0002-9440(10)63698-X; PUIG JG, 1984, J CLIN INVEST, V74, P936, DOI 10.1172/JCI111512; Raskovalova T, 2005, J IMMUNOL, V175, P4383, DOI 10.4049/jimmunol.175.7.4383; Roychowdhury S, 2012, ALCOHOL CLIN EXP RES, V36, P1139, DOI 10.1111/j.1530-0277.2011.01720.x; Siegmund SV, 2005, ALCOHOL CLIN EXP RES, V29, p102S, DOI 10.1097/01.alc.0000189275.97419.58; Sisson TH, 2010, AM J RESP CRIT CARE, V181, P254, DOI 10.1164/rccm.200810-1615OC; Wu Defeng, 2008, V447, P137, DOI 10.1007/978-1-59745-242-7_11; Yang M, 2007, N-S ARCH PHARMACOL, V375, P133, DOI 10.1007/s00210-007-0135-0; Yoshiji H, 2003, GUT, V52, P1347, DOI 10.1136/gut.52.9.1347; Zein CO, 2011, J HEPATOL, V54, P753, DOI 10.1016/j.jhep.2010.07.040; Zimmermann H, 2000, N-S ARCH PHARMACOL, V362, P299, DOI 10.1007/s002100000309	46	54	58	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e69114	10.1371/journal.pone.0069114	http://dx.doi.org/10.1371/journal.pone.0069114			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874883	gold, Green Submitted, Green Published			2022-12-27	WOS:000324146200058
J	Shinahara, W; Takahashi, E; Sawabuchi, T; Arai, M; Hirotsu, N; Takasaki, Y; Shindo, S; Shibao, K; Yokoyama, T; Nishikawa, K; Mino, M; Iwaya, M; Yamashita, Y; Suzuki, S; Mizuno, D; Kido, H				Shinahara, Wakako; Takahashi, Etsuhisa; Sawabuchi, Takako; Arai, Masaru; Hirotsu, Nobuo; Takasaki, Yoshio; Shindo, Shizuo; Shibao, Kyoko; Yokoyama, Takashi; Nishikawa, Kiyoshi; Mino, Masahiro; Iwaya, Minako; Yamashita, Yuji; Suzuki, Satoshi; Mizuno, Dai; Kido, Hiroshi			Immunomodulator Clarithromycin Enhances Mucosal and Systemic Immune Responses and Reduces Re-Infection Rate in Pediatric Patients with Influenza Treated with Antiviral Neuraminidase Inhibitors: A Retrospective Analysis	PLOS ONE			English	Article							MODIFIED PULMONARY SURFACTANT; IGA; VIRUS; INFECTION; SERUM; ERYTHROMYCIN; RESISTANCE; INDUCTION; AIRWAY; CELLS	Background/Aims: Treatment with antiviral neuraminidase inhibitors suppresses influenza viral replication and antigen production, resulting in marked attenuation of mucosal immunity and mild suppression of systemic immunity in mice. This study investigated the effects of immunomodulator clarithromycin (CAM) supplementation on mucosal and systemic immunity in pediatric patients with influenza treated with neuraminidase inhibitors. Methods: A retrospective, non-randomized case series study was conducted among five treatment groups of 195 children aged 5.9 +/- 3.3 years infected with influenza A in 2008/2009 season. The five treatment groups were oseltamivir (OSV), zanamivir (ZNV), OSV+CAM, ZNV+CAM and untreated groups. Anti-viral secretory IgA (S-IgA) levels in nasal washes and IgG levels in sera were measured. The re-infection rate was analyzed among the same five treatment groups in the 2009/2010 season. Results: Treatment of influenza with OSV and ZNV for 5 days attenuated the induction of anti-viral S-IgA in nasal washes and anti-viral IgG in serum, compared with the untreated group. The combination of CAM plus OSV or ZNV boosted and restored the production of mucosal S-IgA and systemic IgG. The re-infection rates in the subsequent season were significantly higher in the OSV and ZNV groups than the untreated, while CAM+OSV and CAM+ZNV tended to reduce such rate. Conclusions: CAM restored the attenuated anti-viral mucosal and systemic immunity and reduced the re-infection rate in the subsequent year in pediatric patients with influenza treated with OSV and ZNV.	[Shinahara, Wakako; Takahashi, Etsuhisa; Sawabuchi, Takako; Mizuno, Dai; Kido, Hiroshi] Univ Tokushima, Inst Enzyme Res, Div Enzyme Chem, Tokushima 770, Japan; [Arai, Masaru] Arai Clin, Chichibu, Saitama, Japan; [Hirotsu, Nobuo] Hirotsu Clin, Kawasaki, Kanagawa, Japan; [Takasaki, Yoshio] Takasaki Childrens Clin, Fukuoka, Japan; [Shindo, Shizuo] Shindo Childrens Clin, Fukuoka, Japan; [Shibao, Kyoko] Shibao Clin, Fukuoka, Japan; [Yokoyama, Takashi] Yokoyama Childrens Clin, Kasuga, Fukuoka, Japan; [Nishikawa, Kiyoshi] Nishikawa Clin, Zentsuji, Japan; [Mino, Masahiro] Mino Childrens Clin, Kannonji, Japan; [Iwaya, Minako] Iwaya Childrens Clin, Fukuoka, Japan; [Yamashita, Yuji] Yamashita Childrens Clin, Maebaru, Japan; [Suzuki, Satoshi] Nagoya City Jouhoku Hosp, Nagoya, Aichi, Japan	Tokushima University	Kido, H (corresponding author), Univ Tokushima, Inst Enzyme Res, Div Enzyme Chem, Tokushima 770, Japan.	kido@ier.tokushima-u.ac.jp			Special Coordination Funds for Promoting Science and Technology of Ministry of Education, Culture, Sports, Science and Technology of Japan; SENTAN Japan Science and Technology Agency;  [21249061]	Special Coordination Funds for Promoting Science and Technology of Ministry of Education, Culture, Sports, Science and Technology of Japan; SENTAN Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); 	This study was supported in part by a Grant in-Aid (21249061), the Special Coordination Funds for Promoting Science and Technology of Ministry of Education, Culture, Sports, Science and Technology of Japan and SENTAN Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CLEMENTS ML, 1986, J CLIN MICROBIOL, V24, P157, DOI 10.1128/JCM.24.1.157-160.1986; Doherty PC, 1997, IMMUNOL REV, V159, P105, DOI 10.1111/j.1600-065X.1997.tb01010.x; Fujimoto C, 2012, INFLUENZA OTHER RESP, V6, P396, DOI 10.1111/j.1750-2659.2011.00330.x; Fujimoto C, 2009, AURIS NASUS LARYNX, V36, P300, DOI 10.1016/j.anl.2008.09.005; HASHISAKI GT, 1995, AM J OTOLARYNG, V16, P153, DOI 10.1016/0196-0709(95)90094-2; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Ison MG, 2011, CURR OPIN VIROL, V1, P563, DOI 10.1016/j.coviro.2011.09.002; Kido H, 2007, CURR PHARM DESIGN, V13, P405, DOI 10.2174/138161207780162971; Kudoh S, 1987, Nihon Kyobu Shikkan Gakkai Zasshi, V25, P632; Kunkel EJ, 2003, NAT REV IMMUNOL, V3, P822, DOI 10.1038/nri1203; Labro MT, 2001, ANTIMICROB AGENTS CH, V45, P44; LIEW FY, 1984, EUR J IMMUNOL, V14, P350, DOI 10.1002/eji.1830140414; Maeda S, 1999, PEDIATR INT, V41, P274, DOI 10.1046/j.1442-200x.1999.01069.x; Ministry of Health Labour and Welfare National Institute of Infectious Diseases, 2009, INFECT AGENTS SURVEI, V30, P285; Mizuno D, 2006, J IMMUNOL, V176, P1122, DOI 10.4049/jimmunol.176.2.1122; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; MURPHY BR, 1989, CURR TOP MICROBIOL, V146, P107; Nishino M, 2009, VACCINE, V27, P5620, DOI 10.1016/j.vaccine.2009.07.024; Sato K, 1998, AM J RESP CRIT CARE, V157, P853, DOI 10.1164/ajrccm.157.3.9703098; Sawabuchi T, 2009, RESPIROLOGY, V14, P1173, DOI 10.1111/j.1440-1843.2009.01639.x; Suzuki T, 2002, AM J RESP CRIT CARE, V165, P1113, DOI 10.1164/ajrccm.165.8.2103094; Tahan F, 2007, EUR RESPIR J, V29, P91, DOI 10.1183/09031936.00029206; Takahashi E, 2012, J VIROL, V86, P10924, DOI 10.1128/JVI.01207-12; Takahashi E, 2010, MICROBES INFECT, V12, P778, DOI 10.1016/j.micinf.2010.04.013; Tsurita M, 2001, J PHARMACOL EXP THER, V298, P362	26	18	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e70060	10.1371/journal.pone.0070060	http://dx.doi.org/10.1371/journal.pone.0070060			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23875018	gold, Green Published, Green Submitted			2022-12-27	WOS:000322000600062
J	Seike, T; Nakamura, T; Shimoda, C				Seike, Taisuke; Nakamura, Taro; Shimoda, Chikashi			Distal and Proximal Actions of Peptide Pheromone M-Factor Control Different Conjugation Steps in Fission Yeast	PLOS ONE			English	Article							FACTOR MATING PHEROMONE; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; FARNESYL CYSTEINE; GENE-EXPRESSION; IDENTIFICATION; ENCODES; PROTEIN; TRANSPORTER; CELLS	Mating pheromone signaling is essential for conjugation between haploid cells of P-type (P-cells) and haploid cells of M-type (M-cells) in Schizosaccharomyces pombe. A peptide pheromone, M-factor, produced by M-cells is recognized by the receptor of P-cells. An M-factor-less mutant, in which the M-factor-encoding genes are deleted, is completely sterile. In liquid culture, sexual agglutination was not observed in the mutant, but it could be recovered by adding exogenous synthetic M-factor, which stimulated expression of the P-type-specific cell adhesion protein, Map4. Exogenous M-factor, however, failed to recover the cell fusion defect in the M-factor-less mutant. When M-factor-less cells were added to a mixture of wild-type P-and M-cells, marked cell aggregates were formed. Notably, M-factorless mutant cells were also incorporated in these aggregates. In this mixed culture, P-cells conjugated preferentially with M-cells secreting M-factor, and rarely with M-factor-less M-cells. The kinetics of mating parameters in liquid culture revealed that polarized growth commenced from the contact region of opposite mating-type cells. Taken together, these findings indicate that M-factor at a low concentration induces adhesin expression, leading to initial cell-cell adhesion in a type of "distal pheromone action", but M-factor that is secreted directly in the proximity of the adhered P-cells may be necessary for cell fusion in a type of "proximal pheromone action".	[Seike, Taisuke; Nakamura, Taro; Shimoda, Chikashi] Osaka City Univ, Grad Sch Sci, Dept Biol, Osaka 558, Japan	Osaka Metropolitan University	Seike, T (corresponding author), Osaka City Univ, Grad Sch Sci, Dept Biol, Osaka 558, Japan.	saysay@sci.osaka-cu.ac.jp	Seike, Taisuke/T-9653-2019	Seike, Taisuke/0000-0002-8738-7759; Nakamura, Taro/0000-0002-3343-7765	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science (JSPS)	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by Grant-in-Aid for Publication of Scientific Research Results to T. N. from the Ministry of Education, Culture, Sports, Science and Technology of Japan. T. S. was supported by the exploratory research grant from the Japan Society for the Promotion of Science (JSPS).	ANDEREGG RJ, 1988, J BIOL CHEM, V263, P18236; AONO T, 1994, YEAST, V10, P757, DOI 10.1002/yea.320100607; Barr MM, 1996, MOL CELL BIOL, V16, P5597; Bendezu FO, 2013, CURR BIOL, V23, P42, DOI 10.1016/j.cub.2012.10.042; Christensen PU, 1997, MOL GEN GENET, V255, P226, DOI 10.1007/s004380050493; DAVEY J, 1992, EMBO J, V11, P951, DOI 10.1002/j.1460-2075.1992.tb05134.x; DAVEY J, 1991, YEAST, V7, P357, DOI 10.1002/yea.320070406; Davey J, 1997, BIOCHEM SOC T, V25, pS224, DOI 10.1042/bst025224s; Egel R, 2003, MOLECULAR BIOLOGY OF SCHIZOSACCHAROMYCES POMBE, P1; EGEL R, 1974, EXP CELL RES, V88, P127, DOI 10.1016/0014-4827(74)90626-0; Egel R., 1989, MOL BIOL FISSION YEA, P31; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Forsburg SL, 1997, GENE, V191, P191, DOI 10.1016/S0378-1119(97)00058-9; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; Heitman J, 2007, MOL BIOL FISSION YEA; IMAI Y, 1994, GENE DEV, V8, P328, DOI 10.1101/gad.8.3.328; Imai Y, 1997, MOL CELL BIOL, V17, P1543, DOI 10.1128/MCB.17.3.1543; JACKSON CL, 1990, CELL, V63, P1039, DOI 10.1016/0092-8674(90)90507-B; Johnson JM, 2011, CURR OPIN GENET DEV, V21, P740, DOI 10.1016/j.gde.2011.09.007; KITAMURA K, 1991, EMBO J, V10, P3743, DOI 10.1002/j.1460-2075.1991.tb04943.x; KJAERULFF S, 1994, MOL CELL BIOL, V14, P3895, DOI 10.1128/MCB.14.6.3895; Kjaerulff S, 2005, BIOCHEM BIOPH RES CO, V338, P1853, DOI 10.1016/j.bbrc.2005.10.156; Kjaerulff S, 2005, MOL CELL BIOL, V25, P2045, DOI 10.1128/MCB.25.5.2045-2059.2005; KLAR AJS, 1993, CURR OPIN GENET DEV, V3, P745, DOI 10.1016/S0959-437X(05)80093-0; Ladds G, 1995, BIOCHEM SOC T, V23, pS565, DOI 10.1042/bst023565s; Loprieno N, 1974, HDB GENETICS, P395; Mata J, 2006, P NATL ACAD SCI USA, V103, P15517, DOI 10.1073/pnas.0603403103; Miller JH., 1972, EXPERIMENTS IN MOLEC; Miyata M, 1997, J GEN APPL MICROBIOL, V43, P169, DOI 10.2323/jgam.43.169; MOORE SA, 1983, J BIOL CHEM, V258, P3849; Moore TI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003865; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Naider F, 2004, PEPTIDES, V25, P1441, DOI 10.1016/j.peptides.2003.11.028; PETERSEN J, 1995, MOL CELL BIOL, V15, P3697; Sharifmoghadam MR, 2006, FEBS LETT, V580, P4457, DOI 10.1016/j.febslet.2006.07.016; SEGALL JE, 1993, P NATL ACAD SCI USA, V90, P8332, DOI 10.1073/pnas.90.18.8332; Seike T, 2012, GENETICS, V191, P815, DOI 10.1534/genetics.112.140483; SHIMODA C, 1974, PLANT CELL PHYSIOL, V15, P767; SUGIMOTO A, 1991, GENE DEV, V5, P1990, DOI 10.1101/gad.5.11.1990; TANAKA K, 1993, MOL CELL BIOL, V13, P80, DOI 10.1128/MCB.13.1.80; WANG SH, 1994, YEAST, V10, P595, DOI 10.1002/yea.320100504; Xue-Franzen YT, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-303; YOSHIDA K, 1978, PLANT CELL PHYSIOL, V19, P1519	43	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e69491	10.1371/journal.pone.0069491	http://dx.doi.org/10.1371/journal.pone.0069491			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874965	Green Published, Green Submitted, gold			2022-12-27	WOS:000322064300103
J	Zhang, Q; Ge, HA; Zhou, JJ; Cheng, B				Zhang, Qiang; Ge, Heng'an; Zhou, Jiaojiao; Cheng, Biao			Are Platelet-Rich Products Necessary during the Arthroscopic Repair of Full-Thickness Rotator Cuff Tears: A Meta-Analysis	PLOS ONE			English	Article							GROWTH-FACTORS; FIBRIN MATRIX; PLASMA; TENDON; SUPRASPINATUS; AUGMENTATION; INTEGRITY; INJURIES; AGE; BB	Background: Platelet-rich products (PRP) are widely used for rotator cuff tears. However, whether platelet-rich products produce superior clinical or radiological outcomes is controversial. This study aims to use meta-analysis to compare clinical and radiological outcomes between groups with or without platelet-rich products. Methods: The Pubmed, Embase, and Cochrane library databases were searched for relevant studies published before April 20, 2013. Studies were selected that clearly reported a comparison between the use or not of platelet-rich products. The Constant, ASES, UCLA, and SST scale systems and the rotator cuff retear rate were evaluated. The weighted mean differences and relative risks were calculated using a fixed-effects model. Results: Seven studies were enrolled in this meta-analysis. No significant differences were found for the Constant scale (0.73, 95% CI, -1.82 to 3.27, P = 0.58), ASES scale (-2.89, 95% CI, -6.31 to 0.53, P = 0.1), UCLA scale (-0.79, 95% CI, -2.20 to 0.63, P = 0.28), SST scale (0.34, 95% CI, -0.01 to 0.69, P = 0.05), and the overall rotator cuff retear rate (0.71, 95% CI, 0.48 to 1.05, P = 0.08). Subgroup analysis according to the initial tear size showed a lower retear rate in small- and medium-sized tears (0.33, 95% CI, 0.12 to 0.91, P = 0.03) after platelet-rich product application but no difference for large- and massive-sized tears (0.86, 95% CI, 0.60 to 1.23, P = 0.42). Conclusion: In conclusion, the meta-analysis suggests that the platelet-rich products have no benefits on the overall clinical outcomes and retear rate for the arthroscopic repair of full-thickness rotator cuff tears. However, a decrease occurred in the rate of retears among patients treated with PRP for small- and medium-sized rotator cuff tears but not for large- and massive-sized tears.	[Zhang, Qiang; Ge, Heng'an; Zhou, Jiaojiao; Cheng, Biao] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Orthoped, Shanghai 200092, Peoples R China; [Zhang, Qiang; Ge, Heng'an; Zhou, Jiaojiao] Nanjing Med Univ, Clin Med Coll 1, Nanjing, Jiangsu, Peoples R China	Tongji University; Nanjing Medical University	Cheng, B (corresponding author), Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Orthoped, Shanghai 200092, Peoples R China.	cbiaob@163.com						Antuna S, 2013, ACTA ORTHOP BELG, V79, P25; Aspenberg P, 1999, ACTA ORTHOP SCAND, V70, P51, DOI 10.3109/17453679909000958; Barber FA, 2011, ARTHROSCOPY, V27, P1029, DOI 10.1016/j.arthro.2011.06.010; Bergeson AG, 2012, AM J SPORT MED, V40, P286, DOI 10.1177/0363546511424402; Boileau P, 2005, J BONE JOINT SURG AM, V87A, P1229, DOI 10.2106/JBJS.D.02035; Bosch G, 2010, J ORTHOP RES, V28, P211, DOI 10.1002/jor.20980; Castricini R, 2011, AM J SPORT MED, V39, P258, DOI 10.1177/0363546510390780; Chahal J, 2012, ARTHROSCOPY, V28, P1718, DOI 10.1016/j.arthro.2012.03.007; de Mos M, 2008, AM J SPORT MED, V36, P1171, DOI 10.1177/0363546508314430; Demidova-Rice TN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032146; Eppley BL, 2004, PLAST RECONSTR SURG, V114, P1502, DOI 10.1097/01.PRS.0000138251.07040.51; Franchini M, 2005, ORTHOPEDICS, V28, P161, DOI 10.3928/0147-7447-20050201-19; Galatz LM, 2004, J BONE JOINT SURG AM, V86A, P219, DOI 10.2106/00004623-200402000-00002; Galatz LM, 2005, J ORTHOP RES, V23, P1441, DOI 10.1016/j.orthres.2005.05.005; Gumina S, 2012, J BONE JOINT SURG AM, V94A, P1345, DOI [10.2106/JBJS.K.00394, 10.2106/JBJS.k.00394]; Hall MP, 2009, J AM ACAD ORTHOP SUR, V17, P602, DOI 10.5435/00124635-200910000-00002; Han B, 2009, J BONE JOINT SURG AM, V91A, P1459, DOI 10.2106/JBJS.H.00246; Hee CK, 2011, AM J SPORT MED, V39, P1630, DOI 10.1177/0363546511404942; Hee HT, 2003, EUR SPINE J, V12, P400, DOI 10.1007/s00586-003-0548-5; Ide J, 2009, J SHOULDER ELB SURG, V18, P391, DOI 10.1016/j.jse.2009.01.013; Ide J, 2009, ARTHROSCOPY, V25, P608, DOI 10.1016/j.arthro.2008.11.011; Jo CH, 2011, AM J SPORT MED, V39, P2082, DOI 10.1177/0363546511413454; Lehman Christopher, 1995, Bulletin Hospital for Joint Diseases, V54, P30; Manning CN, 2011, J ORTHOP RES, V29, P1099, DOI 10.1002/jor.21301; McCarrel T, 2009, J ORTHOP RES, V27, P1033, DOI 10.1002/jor.20853; Mei-Dan O, 2011, SPORTS MED ARTHROSC, V19, P244, DOI 10.1097/JSA.0b013e318227b2dc; MILGROM C, 1995, J BONE JOINT SURG BR, V77B, P296, DOI 10.1302/0301-620X.77B2.7706351; Newsham-West R, 2007, J ANAT, V210, P318, DOI 10.1111/j.1469-7580.2007.00699.x; Pauly S, 2012, J SHOULDER ELB SURG, V21, P464, DOI 10.1016/j.jse.2011.01.015; Randelli P, 2011, J SHOULDER ELB SURG, V20, P518, DOI 10.1016/j.jse.2011.02.008; Rodeo SA, 2012, AM J SPORT MED, V40, P1234, DOI 10.1177/0363546512442924; Sanchez M, 2003, MED SCI SPORT EXER, V35, P1648, DOI 10.1249/01.MSS.0000089344.44434.50; Seeherman HJ, 2008, J BONE JOINT SURG AM, V90A, P2206, DOI [10.2106/JBJS.G.00742, 10.2106/0S.G.00742]; Silva MJ, 2006, J ORTHOP RES, V24, P990, DOI 10.1002/jor.20084; Tempelhof S, 1999, J SHOULDER ELB SURG, V8, P296, DOI 10.1016/S1058-2746(99)90148-9; Thomopoulos S, 2002, J SHOULDER ELB SURG, V11, P239, DOI 10.1067/mse.2002.122228; Uggen C, 2010, ARTHROSCOPY, V26, P1456, DOI 10.1016/j.arthro.2010.02.025; Weber SC, 2012, AM J SPORTS MED; Zhong WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040833	39	32	33	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e69731	10.1371/journal.pone.0069731	http://dx.doi.org/10.1371/journal.pone.0069731			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	23874991	Green Published, gold, Green Submitted			2022-12-27	WOS:000321718700055
J	Hao, GX; Boyle, M; Zhou, LJ; Duan, YP				Hao, Guixia; Boyle, Michael; Zhou, Lijuan; Duan, Yongping			The Intracellular Citrus Huanglongbing Bacterium, 'Candidatus Liberibacter asiaticus' Encodes Two Novel Autotransporters	PLOS ONE			English	Article							LEUCINE-RICH REPEAT; PLANT PATHOGEN; PROTEIN; DOMAIN; EXPRESSION; ADHESIN; LOCALIZATION; DIVERSITY; RECOGNIZE; ICSA	Proteins secreted by the type V secretion system (T5SS), known as autotransporters, are large extracellular virulence proteins localized to the bacterial poles. In this study, we characterized two novel autotransporter proteins of 'Candidatus Liberibacter asiaticus' (Las), and redesignated them as LasA(I) and LasA(II) in lieu of the previous names Hyv(I) and Hyv(II). As a phloem-limited, intracellular bacterial pathogen, Las has a significantly reduced genome and causes huanglongbing (HLB), a devastating disease of citrus worldwide. Bioinformatic analyses revealed that LasA(I) and LasA(II) share the structural features of an autotransporter family containing large repeats of a passenger domain and a unique C-terminal translocator domain. When fused to the GFP gene and expressed in E. coli, the LasA(I) C-terminus and the full length LasA(II) were localized to the bacterial poles, similar to other members of autotransporter family. Despite the absence of a typical signal peptide, LasA(I) was found to localize at the cell surface by immuno-dot blot using a monoclonal antibody against the partial LasA(I) protein. Its surface localization was also confirmed by the removal of the LasA(I) antigen using a proteinase K treatment of the intact bacterial cells. When co-inoculated with a P19 gene silencing suppressor and transiently expressed in tobacco leaves, the GFP-LasA(I) translocator targeted to the mitochondria. This is the first report that Las encodes novel autotransporters that target to mitochondria when expressed in the plants. These findings may lead to a better understanding of the pathogenesis of this intracellular bacterium.	[Hao, Guixia; Zhou, Lijuan; Duan, Yongping] USDA ARS, United States Hort Res Lab, Ft Pierce, FL USA; [Boyle, Michael] Smithsonian Marine Stn, Ft Pierce, FL USA	United States Department of Agriculture (USDA); Smithsonian Institution; Smithsonian National Museum of Natural History	Duan, YP (corresponding author), USDA ARS, United States Hort Res Lab, Ft Pierce, FL USA.	yongping.duan@ars.usda.gov	Zhou, Li/GSE-4531-2022		Florida Citrus Advanced Technology Program [162, 310]	Florida Citrus Advanced Technology Program	Funding for this work was provided by the Florida Citrus Advanced Technology Program award 162 and 310. Mention of trade names or commercial products in this article is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the U.S. Department of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akula N, 2011, BIOORG MED CHEM LETT, V21, P4183, DOI 10.1016/j.bmcl.2011.05.086; Boyd EF, 2002, TRENDS MICROBIOL, V10, P521, DOI 10.1016/S0966-842X(02)02459-9; Caldwell RB, 2004, APPL ENVIRON MICROB, V70, P610, DOI 10.1128/AEM.70.1.610-612.2004; CARLONE GM, 1986, J CLIN MICROBIOL, V24, P330, DOI 10.1128/JCM.24.3.330-332.1986; CARROLL JA, 2010, CURR PROTOC MICROBIO, V16, pC12; Charles M, 2001, P NATL ACAD SCI USA, V98, P9871, DOI 10.1073/pnas.171310498; Domanska G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000878; Duan YP, 2009, MOL PLANT MICROBE IN, V22, P1011, DOI 10.1094/MPMI-22-8-1011; GOLDBERG MB, 1993, J BACTERIOL, V175, P2189, DOI 10.1128/JB.175.8.2189-2196.1993; Goodin MM, 2002, PLANT J, V31, P375, DOI 10.1046/j.1365-313X.2002.01360.x; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; Henderson IR, 1998, TRENDS MICROBIOL, V6, P370, DOI 10.1016/S0966-842X(98)01318-3; Hendrixson DR, 1997, MOL MICROBIOL, V26, P505, DOI 10.1046/j.1365-2958.1997.5921965.x; Ikegami A, 2004, INFECT IMMUN, V72, P4619, DOI 10.1128/IAI.72.8.4619-4627.2004; Iyer D, 2010, INFECT IMMUN, V78, P2385, DOI 10.1128/IAI.00510-09; JAGOUEIX S, 1994, INT J SYST BACTERIOL, V44, P379, DOI 10.1099/00207713-44-3-379; Jain S, 2006, J BACTERIOL, V188, P4841, DOI 10.1128/JB.00326-06; Johansen LK, 2001, PLANT PHYSIOL, V126, P930, DOI 10.1104/pp.126.3.930; Kim DSH, 2006, J BACTERIOL, V188, P5655, DOI 10.1128/JB.01596-05; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; Koh EJ, 2012, PROTOPLASMA, V249, P687, DOI 10.1007/s00709-011-0312-3; Laarmann S, 2002, MOL MICROBIOL, V46, P731, DOI 10.1046/j.1365-2958.2002.03189.x; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Matsumoto A, 2012, MICROBIOLOGYOPEN, V1, P33, DOI 10.1002/mbo3.6; Muller JEN, 2011, MOL BIOL CELL, V22, P1638, DOI 10.1091/mbc.E10-12-0943; Nicolay T, 2012, APPL ENVIRON MICROB, V78, P2533, DOI 10.1128/AEM.07690-11; Nummelin H, 2004, EMBO J, V23, P701, DOI 10.1038/sj.emboj.7600100; Onishi S, 2008, INFECT IMMUN, V76, P198, DOI 10.1128/IAI.01139-07; Oomen CJ, 2004, EMBO J, V23, P1257, DOI 10.1038/sj.emboj.7600148; Roggenkamp A, 2003, J BACTERIOL, V185, P3735, DOI 10.1128/JB.185.13.3735-3744.2003; Rojas CM, 2002, P NATL ACAD SCI USA, V99, P13142, DOI 10.1073/pnas.202358699; Rudel T, 2010, NAT REV MICROBIOL, V8, P693, DOI 10.1038/nrmicro2421; Schubert WD, 2002, CELL, V111, P825, DOI 10.1016/S0092-8674(02)01136-4; Scott-Tucker Anthony, 2009, P139; Silhavy D, 2002, EMBO J, V21, P3070, DOI 10.1093/emboj/cdf312; St Geme JW, 2000, J BACTERIOL, V182, P6005, DOI 10.1128/JB.182.21.6005-6013.2000; Surana NK, 2004, J BIOL CHEM, V279, P14679, DOI 10.1074/jbc.M311496200; Szczesny P, 2008, BIOINFORMATICS, V24, P1251, DOI 10.1093/bioinformatics/btn118; Vahling CM, 2010, J BACTERIOL, V192, P834, DOI 10.1128/JB.01279-09; Zhang SJ, 2011, MOL PLANT MICROBE IN, V24, P458, DOI 10.1094/MPMI-11-10-0256; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhou LJ, 2011, APPL ENVIRON MICROB, V77, P6663, DOI 10.1128/AEM.05111-11; Zou HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046447	44	28	31	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e68921	10.1371/journal.pone.0068921	http://dx.doi.org/10.1371/journal.pone.0068921			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874813	Green Submitted, gold, Green Published			2022-12-27	WOS:000322218800052
J	Pan, HS; Lu, YH; Wyckhuys, KAG; Wu, KM				Pan, Hongsheng; Lu, Yanhui; Wyckhuys, Kris A. G.; Wu, Kongming			Preference of a Polyphagous Mirid Bug, Apolygus lucorum (Meyer-Dur) for Flowering Host Plants	PLOS ONE			English	Article							HEMIPTERA-MIRIDAE; PEST-MANAGEMENT; OVIPOSITION PREFERENCE; LARVAL PERFORMANCE; NORTHERN CHINA; BT COTTON; HELICOVERPA-ARMIGERA; HETEROPTERA MIRIDAE; SEASONAL ABUNDANCE; CENTRAL TEXAS	Apolygus lucorum (Meyer-Dur) (Hemiptera: Miridae) is one of the most important herbivores in a broad range of cultivated plants, including cotton, cereals, vegetables, and fruit crops in China. In this manuscript, we report on a 6-year long study in which (adult) A. lucorum abundance was recorded on 174 plant species from 39 families from early July to mid-September. Through the study period per year, the proportion of flowering plants exploited by adult A. lucorum was significantly greater than that of non-flowering plants. For a given plant species, A. lucorum adults reached peak abundance at the flowering stage, when the plant had the greatest attraction to the adults. More specifically, mean adult abundance on 26 species of major host plants and their relative standard attraction were 10.3-28.9 times and 9.3-19.5 times higher at flowering stage than during non-flowering periods, respectively. Among all the tested species, A. lucorum adults switched food plants according to the succession of flowering plant species. In early July, A. lucorum adults preferred some plant species in bloom, such as Vigna radiata, Gossypium hirsutum, Helianthus annuus and Chrysanthemum coronarium; since late July, adults dispersed into other flowering hosts (e. g. Ricinus communis, Impatiens balsamina, Humulus scandens, Ocimum basilicum, Agastache rugosus and Coriandrum sativum); in early September, they largely migrated to flowering Artemisia spp. (e.g. A. argyi, A. lavandulaefolia, A. annua and A. scoparia). Our findings underscore the important role of flowering plays in the population dynamics and inter-plant migration of this mirid bug. Also, our work helps understand evolutionary aspects of host plant use in polyphagous insects such as A. lucorum, and provides baseline information for the development of sustainable management strategies of this key agricultural pest.	[Pan, Hongsheng; Lu, Yanhui; Wu, Kongming] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Wyckhuys, Kris A. G.] Int Ctr Trop Agr CIAT Asia, Hanoi, Vietnam	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Wu, KM (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	kmwu@ippcaas.cn	Wyckhuys, Kris/AAJ-4352-2020	Wyckhuys, Kris/0000-0003-0922-488X; Lu, Yanhui/0000-0002-6552-0248	National Basic Research Program of China [2012CB114104]; Special Fund for Agro-scientific Research in the Public Interest [201103012]; National Natural Science Funds [31222046]	National Basic Research Program of China(National Basic Research Program of China); Special Fund for Agro-scientific Research in the Public Interest; National Natural Science Funds(National Natural Science Foundation of China (NSFC))	This research was supported by the National Basic Research Program of China (No. 2012CB114104), and the Special Fund for Agro-scientific Research in the Public Interest (201103012), the National Natural Science Funds (No. 31222046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barman AK, 2010, INSECT SCI, V17, P542, DOI 10.1111/j.1744-7917.2010.01334.x; Blackmer JL, 2005, ENVIRON ENTOMOL, V34, P1524, DOI 10.1603/0046-225X-34.6.1524; Bradley Jr JR, 1993, EVOLUTION INSECT PES, P375; BRANDENBURG RL, 1982, ENTOMOL EXP APPL, V32, P269, DOI 10.1111/j.1570-7458.1982.tb03217.x; Brazzle JR, 1997, ENVIRON ENTOMOL, V26, P995, DOI 10.1093/ee/26.5.995; Bruce TJA, 2005, TRENDS PLANT SCI, V10, P269, DOI 10.1016/j.tplants.2005.04.003; Carriere Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039862; Chen Zhan-Ce, 2010, Acta Entomologica Sinica, V53, P47; CHU H. F., 1958, ACTA ENT SINICA, V8, P97; Cook SM, 2007, ANNU REV ENTOMOL, V52, P375, DOI 10.1146/annurev.ento.52.110405.091407; Dixon AFG, 1987, APHIDS THEIR BIOL NA, P197; Dong JW, 2013, ARTHROPOD-PLANT INTE, V7, P83, DOI 10.1007/s11829-012-9222-3; Esquivel JF, 2007, ENVIRON ENTOMOL, V36, P725, DOI 10.1603/0046-225X(2007)36[725:HPOTTP]2.0.CO;2; Esquivel JF, 2009, ENVIRON ENTOMOL, V38, P766, DOI 10.1603/022.038.0329; Feng HQ, 2010, ECOL MODEL, V221, P1819, DOI 10.1016/j.ecolmodel.2010.04.003; FLEISCHER SJ, 1987, ENVIRON ENTOMOL, V16, P379, DOI 10.1093/ee/16.2.379; Foster SP, 1997, ANNU REV ENTOMOL, V42, P123, DOI 10.1146/annurev.ento.42.1.123; Geng HH, 2012, APPL ENTOMOL ZOOL, V47, P191, DOI 10.1007/s13355-012-0107-9; HOKKANEN HMT, 1991, ANNU REV ENTOMOL, V36, P119, DOI 10.1146/annurev.en.36.010191.001003; Holzschuh A, 2007, J APPL ECOL, V44, P41, DOI 10.1111/j.1365-2664.2006.01259.x; Jackson RE, 2008, ENTOMOL EXP APPL, V126, P89, DOI 10.1111/j.1570-7458.2007.00653.x; Kennedy G. G., 1985, Bulletin of the Entomological Society of America, V31, P21; Kennedy GG, 2000, ANNU REV ENTOMOL, V45, P467, DOI 10.1146/annurev.ento.45.1.467; Kullenberg B, 1944, ZOOL BIDR UPPS, V23, P1; Liu ZD, 2010, ENVIRON ENTOMOL, V39, P552, DOI 10.1603/EN09129; Lu Y., 2008, BIOL CONTROL COTTON; Lu YH, 2008, CROP PROT, V27, P465, DOI 10.1016/j.cropro.2007.07.017; Lu YH, 2009, CROP PROT, V28, P77, DOI 10.1016/j.cropro.2008.08.018; Lu YH, 2012, J ECON ENTOMOL, V105, P1603, DOI 10.1603/EC12003; Lu YanHui, 2011, Outlooks on Pest Management, V22, P248, DOI 10.1564/22dec02; Lu YH, 2011, APPL ENTOMOL ZOOL, V46, P421, DOI 10.1007/s13355-011-0058-6; Lu YH, 2010, APPL ENTOMOL ZOOL, V45, P387, DOI 10.1303/aez.2010.387; Lu YH, 2010, CROP PROT, V29, P1026, DOI 10.1016/j.cropro.2010.03.017; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; [陆宴辉 LU YanHui], 2008, [生态学报, Acta Ecologica Sinica], V28, P5113; Pack T. M., 1976, ARK AGR EXP STN REP, V226, P1; Rajapakse CNK, 2007, ARTHROPOD-PLANT INTE, V1, P17, DOI 10.1007/s11829-007-9003-6; Rwomushana I, 2008, ANN ENTOMOL SOC AM, V101, P331, DOI 10.1603/0013-8746(2008)101[331:HPAHPP]2.0.CO;2; Santos JC, 2008, EVOL ECOL, V22, P123, DOI 10.1007/s10682-007-9162-z; Schoonhoven L. M., 2005, Insect-plant biology; Shelton AM, 2006, ANNU REV ENTOMOL, V51, P285, DOI 10.1146/annurev.ento.51.110104.150959; STEWART SD, 1994, J ENTOMOL SCI, V29, P231, DOI 10.18474/0749-8004-29.2.231; SUDBRINK DL, 1995, ENVIRON ENTOMOL, V24, P1080, DOI 10.1093/ee/24.5.1080; Ting YQ, 1964, ACTA ENTOMOL SINICA, V13, P298; VELASCO LRI, 1995, J AUST ENTOMOL SOC, V34, P193; VELASCO LRI, 1993, ENVIRON ENTOMOL, V22, P326, DOI 10.1093/ee/22.2.326; Wang ZR., 1990, FARMLAND WEEDS CHINA; Wheeler Jr A. G., 2001, BIOL PLANT BUGS; WOMACK CL, 1987, ENVIRON ENTOMOL, V16, P1266, DOI 10.1093/ee/16.6.1266; Wu Guo-Qiang, 2012, Chinese Journal of Applied Entomology, V49, P641; Zheng L. Y., 2004, FAUNA SINICA INSECTA, V33	51	42	59	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68980	10.1371/journal.pone.0068980	http://dx.doi.org/10.1371/journal.pone.0068980			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874835	Green Published, gold, Green Submitted			2022-12-27	WOS:000321765300074
J	Strobel, A; Graeve, M; Poertner, HO; Mark, FC				Strobel, Anneli; Graeve, Martin; Poertner, Hans O.; Mark, Felix C.			Mitochondrial Acclimation Capacities to Ocean Warming and Acidification Are Limited in the Antarctic Nototheniid Fish, Notothenia rossii and Lepidonotothen squamifrons	PLOS ONE			English	Article							CYTOCHROME-C-OXIDASE; THERMAL-ACCLIMATION; ENVIRONMENTAL HYPERCAPNIA; OXIDATIVE CAPACITIES; LIVER-MITOCHONDRIA; METABOLIC-RATE; TEMPERATURE-ACCLIMATION; BIOLOGICAL-MEMBRANES; MUSCLE MITOCHONDRIA; LIPID-COMPOSITION	Antarctic notothenioid fish are characterized by their evolutionary adaptation to the cold, thermostable Southern Ocean, which is associated with unique physiological adaptations to withstand the cold and reduce energetic requirements but also entails limited compensation capacities to environmental change. This study compares the capacities of mitochondrial acclimation to ocean warming and acidification between the Antarctic nototheniid Notothenia rossii and the sub-Antarctic Lepidonotothen squamifrons, which share a similar ecology, but different habitat temperatures. After acclimation of L. squamifrons to 9 degrees C and N. rossii to 7 degrees C (normocapnic/hypercapnic, 0.2 kPa CO2/2000 ppm CO2) for 4-6 weeks, we compared the capacities of their mitochondrial respiratory complexes I (CI) and II (CII), their P/O ratios (phosphorylation efficiency), proton leak capacities and mitochondrial membrane fatty acid compositions. Our results reveal reduced CII respiration rates in warm-acclimated L. squamifrons and cold hypercapnia-acclimated N. rossii. Generally, L. squamifrons displayed a greater ability to increase CI contribution during acute warming and after warm-acclimation than N. rossii. Membrane unsaturation was not altered by warm or hypercapnia-acclimation in both species, but membrane fatty acids of warm-acclimated L. squamifrons were less saturated than in warm normocapnia-/hypercapnia-acclimated N. rossii. Proton leak capacities were not affected by warm or hypercapnia-acclimation of N. rossii. We conclude that an acclimatory response of mitochondrial capacities may include higher thermal plasticity of CI supported by enhanced utilization of anaplerotic substrates (via oxidative decarboxylation reactions) feeding into the citrate cycle. L. squamifrons possesses higher relative CI plasticities than N. rossii, which may facilitate the usage of energy efficient NADH-related substrates under conditions of elevated energy demand, possibly induced by ocean warming and acidification. The observed adjustments of electron transport system complexes with a higher flux through CI under warming and acidification suggest a metabolic acclimation potential of the sub-Antarctic L. squamifrons, but only limited acclimation capacities for N. rossii.	[Strobel, Anneli; Graeve, Martin; Poertner, Hans O.; Mark, Felix C.] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Bremerhaven, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Strobel, A (corresponding author), Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Bremerhaven, Germany.	anneli.strobel@awi.de	Pörtner, Hans-O./K-9429-2016; Strobel, Anneli/S-5853-2016; Mark, Felix Christopher/P-4759-2016; Graeve, Martin/B-5751-2017	Pörtner, Hans-O./0000-0001-6535-6575; Mark, Felix Christopher/0000-0002-5586-6704; Graeve, Martin/0000-0002-2294-1915	Deutsche Forschungsgemeinschaft DFG [PO 278/13-1]	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft DFG grants PO 278/13-1 to HO Poertner and FC Mark. DFG website: http://www.spp-antarktisforschung.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAND MD, 1993, BIOCHEM J, V291, P739, DOI 10.1042/bj2910739; Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2; BRAND MD, 1994, BBA-BIOENERGETICS, V1187, P132, DOI 10.1016/0005-2728(94)90099-X; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; Brauner CJ, 2004, J EXP BIOL, V207, P3381, DOI 10.1242/jeb.01144; Brookes PS, 1998, COMP BIOCHEM PHYS B, V119, P325, DOI 10.1016/S0305-0491(97)00357-X; CASAUX RJ, 1990, POLAR BIOL, V11, P63; Chamberlin ME, 2004, AM J PHYSIOL-REG I, V287, pR794, DOI 10.1152/ajpregu.00240.2004; Deigweiher K, 2008, AM J PHYSIOL-REG I, V295, pR1660, DOI 10.1152/ajpregu.90403.2008; Deigweiher K, 2010, J COMP PHYSIOL B, V180, P347, DOI 10.1007/s00360-009-0413-x; DEY I, 1993, P NATL ACAD SCI USA, V90, P7498, DOI 10.1073/pnas.90.16.7498; Duchen MR, 1999, J PHYSIOL-LONDON, V516, P1, DOI 10.1111/j.1469-7793.1999.001aa.x; Duhamel G, 1985, 5 C EUR ICTH STOCKH; Echtay KS, 2003, EMBO J, V22, P4103, DOI 10.1093/emboj/cdg412; Eckerle LG, 2008, J EXP BIOL, V211, P1262, DOI 10.1242/jeb.013474; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; EGGINTON S, 1989, AM J PHYSIOL, V256, pR1, DOI 10.1152/ajpregu.1989.256.1.R1; Enzor LA, 2013, COMP BIOCHEM PHYS A, V164, P154, DOI 10.1016/j.cbpa.2012.07.016; FOLCH J, 1957, J BIOL CHEM, V226, P497; Franklin CE, 2007, J EXP BIOL, V210, P3068, DOI 10.1242/jeb.003137; Fuller A, 2010, PHYSIOL BIOCHEM ZOOL, V83, P713, DOI 10.1086/652242; GON O, 1990, FISHES SO OCEAN; Grim JM, 2010, J EXP BIOL, V213, P445, DOI 10.1242/jeb.036939; Guderley H, 1996, J EXP BIOL, V199, P1311; Guderley H, 2002, J EXP BIOL, V205, P2237; Hardewig I, 1999, J COMP PHYSIOL B, V169, P597, DOI 10.1007/s003600050260; HAZEL JR, 1995, ANNU REV PHYSIOL, V57, P19, DOI 10.1146/annurev.ph.57.030195.000315; HAZEL JR, 1990, PROG LIPID RES, V29, P167, DOI 10.1016/0163-7827(90)90002-3; HAZEL JR, 1972, COMP BIOCHEM PHYSIOL, V43, P837, DOI 10.1016/0305-0491(72)90230-1; Heise K, 2003, COMP BIOCHEM PHYS C, V134, P79, DOI 10.1016/S1532-0456(02)00212-0; Hilton Z, 2010, J COMP PHYSIOL B, V180, P979, DOI 10.1007/s00360-010-0477-7; Iftikar FI, 2010, J EXP MAR BIOL ECOL, V395, P232, DOI 10.1016/j.jembe.2010.09.005; Jastroch M, 2007, J COMP PHYSIOL B, V177, P743, DOI 10.1007/s00360-007-0171-6; Johnston IA, 2003, COMP BIOCHEM PHYS B, V136, P701, DOI 10.1016/S1096-4959(03)00258-6; Johnston IA, 1998, J EXP BIOL, V201, P1; Kamler E, 2001, POLAR BIOL, V24, P735; Keller M, 2004, J EXP BIOL, V207, P2529, DOI 10.1242/jeb.01050; Kraffe E, 2007, J EXP BIOL, V210, P149, DOI 10.1242/jeb.02628; Langenbuch M, 2002, J EXP BIOL, V205, P1153; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Lucassen M, 2006, J EXP BIOL, V209, P2462, DOI 10.1242/jeb.02268; Mark FC, 2005, POLAR BIOL, V28, P805, DOI 10.1007/s00300-005-0018-0; Mark FC, 2012, AM J PHYSIOL-REG I, V271, pR1550; Mark FC, 2006, COMP BIOCHEM PHYS D, V1, P365, DOI 10.1016/j.cbd.2006.08.004; Meredith PM, 2005, GEOPHYS RES LETT, V32; Michaelidis B, 2007, MAR BIOL, V150, P1417, DOI 10.1007/s00227-006-0436-8; Mueller IA, 2011, J EXP BIOL, V214, P3732, DOI 10.1242/jeb.062042; Noack S, 1980, STAT AUSWERTUNG MENU; Papetti C, 2007, J MOL EVOL, V65, P519, DOI 10.1007/s00239-007-9030-z; Pierrot D., 2006, ORNLCDIAC105A US DEP; Portner HO, 2010, J EXP BIOL, V213, P881, DOI 10.1242/jeb.037523; Porter RK, 1996, AM J PHYSIOL-REG I, V271, pR1550, DOI 10.1152/ajpregu.1996.271.6.R1550; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; PORTNER HO, 1987, J EXP BIOL, V131, P69; Portner HO, 1999, COMP BIOCHEM PHYS A, V124, P179, DOI 10.1016/S1095-6433(99)00105-1; ROBINSON BH, 1977, J BIOL CHEM, V252, P5661; Robinson E, 2008, POLAR BIOL, V31, P317, DOI 10.1007/s00300-007-0361-4; SIMPSON DP, 1967, J CLIN INVEST, V46, P225, DOI 10.1172/JCI105525; Sosinski JSK, 1987, B SEA FISH I, V5-6, P8; Strobel A, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-28; TRIGARI G, 1992, LIPIDS, V27, P371, DOI 10.1007/BF02536152; Trzcionka M, 2008, J EXP BIOL, V211, P1911, DOI 10.1242/jeb.016519; Turner J, 2005, INT J CLIMATOL, V25, P279, DOI 10.1002/joc.1130; Turner J, 2006, SCIENCE, V311, P1914, DOI 10.1126/science.1121652; Urschel MR, 2009, POLAR BIOL, V32, P1323, DOI 10.1007/s00300-009-0629-y; Verde C, 2006, GENE, V385, P137, DOI 10.1016/j.gene.2006.04.006; WANDERS RJA, 1983, EUR J BIOCHEM, V133, P245, DOI 10.1111/j.1432-1033.1983.tb07455.x; Weinstein RB, 1998, J COMP PHYSIOL B, V168, P190, DOI 10.1007/s003600050136; Windisch HS, 2011, AM J PHYSIOL-REG I, V301, pR1453, DOI 10.1152/ajpregu.00158.2011; WODTKE E, 1981, BIOCHIM BIOPHYS ACTA, V640, P710, DOI 10.1016/0005-2736(81)90101-2; Zhuang X, 2010, MOL BIOL EVOL, V27, P1391, DOI 10.1093/molbev/msq026	72	63	65	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68865	10.1371/journal.pone.0068865	http://dx.doi.org/10.1371/journal.pone.0068865			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874794	Green Published, Green Submitted, gold			2022-12-27	WOS:000321765300070
J	Murata, Y; Nishio, K; Mochiyama, T; Konishi, M; Shimada, M; Ohta, H; Itoh, N				Murata, Yusuke; Nishio, Kyoji; Mochiyama, Takayuki; Konishi, Morichika; Shimada, Masaya; Ohta, Hiroya; Itoh, Nobuyuki			Fgf21 Impairs Adipocyte Insulin Sensitivity in Mice Fed a Low-Carbohydrate, High-Fat Ketogenic Diet	PLOS ONE			English	Article							HEPATIC GLUCONEOGENESIS; MEDIATED INDUCTION; PPAR-ALPHA; METABOLISM; RESISTANCE; FIBROBLAST-GROWTH-FACTOR-21; PGC-1-ALPHA; FGF-21; GAMMA	Background: A low-carbohydrate, high-fat ketogenic diet (KD) induces hepatic ketogenesis and is believed to affect energy metabolism in mice. As hepatic Fgf21 expression was markedly induced in mice fed KD, we examined the effects of KD feeding on metabolism and the roles of Fgf21 in metabolism in mice fed KD using Fgf21 knockout mice. Methodology/Principal Findings: We examined C57BL/6 mice fed KD for 6 or 14 days. Blood beta-hydroxybutyrate levels were greatly increased at 6 days, indicating that hepatic ketogenesis was induced effectively by KD feeding for 6 days. KD feeding for 6 and 14 days impaired glucose tolerance and insulin sensitivity, although it did not affect body weight, blood NEFA, and triglyceride levels. Hepatic Fgf21 expression and blood Fgf21 levels were markedly increased in mice fed KD for 6 days. Blood beta-hydroxybutyrate levels in the knockout mice fed KD for 6 days were comparable to those in wild-type mice fed KD, indicating that Fgf21 is not required for ketogenesis. However, the impaired glucose tolerance and insulin sensitivity caused by KD feeding were improved in the knockout mice. Insulin-stimulated Akt phosphorylation was significantly decreased in the white adipose tissue in wild-type mice fed KD compared with those fed normal chow, but not in the muscle and liver. Its phosphorylation in the white adipose tissue was significantly increased in the knockout mice fed KD compared with wild-type mice fed KD. In contrast, hepatic gluconeogenic gene expression in Fgf21 knockout mice fed KD was comparable to those in the wild-type mice fed KD. Conclusions/Significance: The present findings indicate that KD feeding impairs insulin sensitivity in mice due to insulin resistance in white adipose tissue. In addition, our findings indicate that Fgf21 induced to express by KD is a negative regulator of adipocyte insulin sensitivity in adaptation to a low-carbohydrate malnutritional state.	[Murata, Yusuke; Nishio, Kyoji; Mochiyama, Takayuki; Konishi, Morichika; Shimada, Masaya; Ohta, Hiroya; Itoh, Nobuyuki] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biochem Genet, Sakyo Ku, Kyoto, Japan; [Konishi, Morichika] Kobe Pharmaceut Univ, Dept Microbial Chem, Kobe, Hyogo 658, Japan	Kyoto University; Kobe Pharmaceutical University	Konishi, M (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biochem Genet, Sakyo Ku, Kyoto, Japan.	mkonishi@kobepharma-u.ac.jp; itohnobu@pharm.kyoto-u.ac.jp			Ministry of Education, Science, Culture and Sports of Japan; Takeda Science Foundation, Japan	Ministry of Education, Science, Culture and Sports of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation, Japan(Takeda Science Foundation (TSF))	This work was supported by a Grant-in-aid for Scientific Research from the Ministry of Education, Science, Culture and Sports of Japan and the Takeda Science Foundation, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a Grant-in-aid for Scientific Research from the Ministry of Education, Science, Culture and Sports of Japan and the Takeda Science Foundation, Japan.	Andrews RC, 1999, CLIN SCI, V96, P513, DOI 10.1042/cs0960513; Astrup A, 2004, LANCET, V364, P897, DOI 10.1016/S0140-6736(04)16986-9; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Badman MK, 2009, ENDOCRINOLOGY, V150, P4931, DOI 10.1210/en.2009-0532; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Fisher FM, 2011, ENDOCRINOLOGY, V152, P2996, DOI 10.1210/en.2011-0281; Hotta Y, 2009, ENDOCRINOLOGY, V150, P4625, DOI 10.1210/en.2009-0119; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Itoh N, 2008, DEV DYNAM, V237, P18, DOI 10.1002/dvdy.21388; Itoh N, 2011, J BIOCHEM, V149, P121, DOI 10.1093/jb/mvq121; JAMES DE, 1985, DIABETES, V34, P1049, DOI 10.2337/diabetes.34.10.1049; Kennedy AR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1724, DOI 10.1152/ajpendo.00717.2006; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2011, TRENDS ENDOCRIN MET, V22, P81, DOI 10.1016/j.tem.2010.11.003; Kim YD, 2012, J BIOL CHEM, V287, P37098, DOI 10.1074/jbc.M112.339887; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Lee MW, 2010, CELL METAB, V11, P331, DOI 10.1016/j.cmet.2010.02.016; Melvin RG, 2009, TRENDS ENDOCRIN MET, V20, P490, DOI 10.1016/j.tem.2009.09.005; Murata Y, 2011, J NUTR METAB, V2011, DOI 10.1155/2011/981315; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Oishi K, 2010, NEUROENDOCRINOL LETT, V31, P198; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Wei W, 2012, P NATL ACAD SCI USA, V109, P3143, DOI 10.1073/pnas.1200797109	25	40	42	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e69330	10.1371/journal.pone.0069330	http://dx.doi.org/10.1371/journal.pone.0069330			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874946	gold, Green Published, Green Submitted			2022-12-27	WOS:000321736900153
J	Mesmoudi, S; Perlbarg, V; Rudrauf, D; Messe, A; Pinsard, B; Hasboun, D; Cioli, C; Marrelec, G; Toro, R; Benali, H; Burnod, Y				Mesmoudi, Salma; Perlbarg, Vincent; Rudrauf, David; Messe, Arnaud; Pinsard, Basile; Hasboun, Dominique; Cioli, Claudia; Marrelec, Guillaume; Toro, Roberto; Benali, Habib; Burnod, Yves			Resting State Networks' Corticotopy: The Dual Intertwined Rings Architecture	PLOS ONE			English	Article							INTRINSIC FUNCTIONAL CONNECTIVITY; INDEPENDENT COMPONENT ANALYSIS; DEFAULT-MODE NETWORK; HUMAN BRAIN; COMMUNITY STRUCTURE; ALZHEIMERS-DISEASE; PREFRONTAL CORTEX; CEREBRAL-CORTEX; FMRI; MRI	How does the brain integrate multiple sources of information to support normal sensorimotor and cognitive functions? To investigate this question we present an overall brain architecture (called "the dual intertwined rings architecture'') that relates the functional specialization of cortical networks to their spatial distribution over the cerebral cortex (or "corticotopy''). Recent results suggest that the resting state networks (RSNs) are organized into two large families: 1) a sensorimotor family that includes visual, somatic, and auditory areas and 2) a large association family that comprises parietal, temporal, and frontal regions and also includes the default mode network. We used two large databases of resting state fMRI data, from which we extracted 32 robust RSNs. We estimated: (1) the RSN functional roles by using a projection of the results on task based networks (TBNs) as referenced in large databases of fMRI activation studies; and (2) relationship of the RSNs with the Brodmann Areas. In both classifications, the 32 RSNs are organized into a remarkable architecture of two intertwined rings per hemisphere and so four rings linked by homotopic connections. The first ring forms a continuous ensemble and includes visual, somatic, and auditory cortices, with interspersed bimodal cortices (auditory-visual, visualsomatic and auditory-somatic, abbreviated as VSA ring). The second ring integrates distant parietal, temporal and frontal regions (PTF ring) through a network of association fiber tracts which closes the ring anatomically and ensures a functional continuity within the ring. The PTF ring relates association cortices specialized in attention, language and working memory, to the networks involved in motivation and biological regulation and rhythms. This "dual intertwined architecture'' suggests a dual integrative process: the VSA ring performs fast real-time multimodal integration of sensorimotor information whereas the PTF ring performs multi-temporal integration (i.e., relates past, present, and future representations at different temporal scales).	[Mesmoudi, Salma; Perlbarg, Vincent; Rudrauf, David; Messe, Arnaud; Pinsard, Basile; Cioli, Claudia; Marrelec, Guillaume; Benali, Habib; Burnod, Yves] Univ Paris 06, INSERM, Lab Imagerie Fonct, UMR S 678, Paris, France; [Mesmoudi, Salma] Univ Paris 01, MATRICE Program, Paris, France; [Perlbarg, Vincent; Pinsard, Basile] Hop La Pitie Salpetriere, CENIR, Inst Cerveau & Moelle Epiniere, Paris, France; [Perlbarg, Vincent; Pinsard, Basile] Hop La Pitie Salpetriere, ICM Inst Cerveau & Moelle Epiniere, Paris, France; [Hasboun, Dominique] INSERM, UMR S 975, Paris, France; [Hasboun, Dominique] Univ Paris 06, Hop La Pitie Salpetriere, UMR 7225, CNRS, Paris, France; [Toro, Roberto] Inst Pasteur, Human Genet & Cognit Funct, Paris, France; [Toro, Roberto] Inst Pasteur, CNRS URA Genes Synapses & Cognit 2182, Paris, France; [Toro, Roberto] Univ Paris Diderot, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; heSam Universite; Universite Pantheon-Sorbonne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite	Mesmoudi, S (corresponding author), Univ Paris 06, INSERM, Lab Imagerie Fonct, UMR S 678, Paris, France.	salma.mesmoudi@iscpif.fr; yburnod@gmail.com	Messé, Arnaud/I-1738-2019	Messé, Arnaud/0000-0001-9081-3088; Rudrauf, David/0000-0002-9621-1800; Toro, Roberto/0000-0002-6671-858X	National Natural Science Foundation of China [30770594]; National High Technology Program of China (863) [2008AA02Z405]; National Institute of Dental and Craniofacial Research (NIDCR); National Institute of Mental Health (NIMH); National Institute of Neurological Disorders and Stroke (NINDS)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Program of China (863)(National High Technology Research and Development Program of China); National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a grant from the National Natural Science Foundation of China (30770594) and a grant from the National High Technology Program of China (863) (2008AA02Z405) and National Institute of Dental and Craniofacial Research (NIDCR), the National Institute of Mental Health (NIMH) and the National Institute of Neurological Disorders and Stroke (NINDS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna C, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00062; Andrews-Hanna JR, 2010, J NEUROPHYSIOL, V104, P322, DOI 10.1152/jn.00830.2009; Beckmann CF, 2005, NEUROIMAGE, V25, P294, DOI 10.1016/j.neuroimage.2004.10.043; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Bellec P, 2010, NEUROIMAGE, V51, P1126, DOI 10.1016/j.neuroimage.2010.02.082; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 1997, NMR BIOMED, V10, P165, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<165::AID-NBM454>3.0.CO;2-7; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Chang C, 2010, FILM COMMENT, V46, P81; Corduneanu A., 2001, ARTIF INTELL, P27, DOI DOI 10.1016/J.CSDA.2006.07.020; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Decety J, 2003, TRENDS COGN SCI, V7, P527, DOI 10.1016/j.tics.2003.10.004; Doria V, 2010, P NATL ACAD SCI USA, V107, P20015, DOI 10.1073/pnas.1007921107; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Doucet G, 2011, J NEUROPHYSIOL, V105, P2753, DOI 10.1152/jn.00895.2010; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Ferstl EC, 2007, NEUROSCI LETT, V427, P159, DOI 10.1016/j.neulet.2007.09.046; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Fransson P, 2007, P NATL ACAD SCI USA, V104, P15531, DOI 10.1073/pnas.0704380104; Fuster J., 1989, DISSERT ABSTRACTS IN, V60, P255; Fuster JM, 2006, INT J PSYCHOPHYSIOL, V60, P125, DOI 10.1016/j.ijpsycho.2005.12.015; Fuster JM, 2012, TRENDS COGN SCI, V16, P207, DOI 10.1016/j.tics.2012.03.005; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Golland Y, 2007, CEREB CORTEX, V17, P766, DOI 10.1093/cercor/bhk030; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hill J, 2010, P NATL ACAD SCI USA, V107, P13135, DOI 10.1073/pnas.1001229107; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Hutchison RM, 2012, J NEUROPHYSIOL, V107, P2463, DOI 10.1152/jn.00891.2011; Kelly AMC, 2009, CEREB CORTEX, V19, P640, DOI 10.1093/cercor/bhn117; Kelly C, 2010, EUR J NEUROSCI, V32, P383, DOI 10.1111/j.1460-9568.2010.07279.x; Kiviniemi V, 2011, BRAIN CONNECT, V1, P339, DOI 10.1089/brain.2011.0036; Kovach CK, 2012, J NEUROSCI, V32, P8434, DOI 10.1523/JNEUROSCI.5468-11.2012; Kravitz DJ, 2011, NAT REV NEUROSCI, V12, P217, DOI 10.1038/nrn3008; Laird AR, 2011, J COGNITIVE NEUROSCI, V23, P4022, DOI 10.1162/jocn_a_00077; Lee MS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040370, 10.1371/journal.pone.0035710]; Li R, 2011, NEUROIMAGE, V56, P1035, DOI 10.1016/j.neuroimage.2011.03.010; Luria A. R., 2012, HIGHER CORTICAL FUNC; Mantini D, 2013, J NEUROSCI, V33, P3259, DOI 10.1523/JNEUROSCI.4392-12.2013; Mantini D, 2011, J NEUROSCI, V31, P12954, DOI 10.1523/JNEUROSCI.2318-11.2011; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Mennes M., 2012, NEUROIMAGE; Mennes M, 2013, CEREB CORTEX, V23, P223, DOI 10.1093/cercor/bhs010; Mesulam MM, 2002, NEUROSCIENCE, V110, P627, DOI 10.1016/S0306-4522(01)00613-3; MILNER B, 1985, HUM NEUROBIOL, V4, P137; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, EUR PHYS J B, V38, P321, DOI 10.1140/epjb/e2004-00124-y; Nooner KB, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00152; Norman D.A., 1986, CONSCIOUSNESS SELF R, P1, DOI DOI 10.1007/978-1-4757-0629-1_1; Northoff G, 2004, TRENDS COGN SCI, V8, P102, DOI 10.1016/j.tics.2004.01.004; Ochsner KN, 2004, J COGNITIVE NEUROSCI, V16, P1746, DOI 10.1162/0898929042947829; Perlbarg V, 2008, I S BIOMED IMAGING, P1247, DOI 10.1109/ISBI.2008.4541229; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Power JD, 2010, NEURON, V67, P735, DOI 10.1016/j.neuron.2010.08.017; Preuss TM, 2007, PRIMATE ORIGINS EVOL; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Schmahmann JD, 2007, BRAIN, V130, P630, DOI 10.1093/brain/awl359; Sepulcre J, 2012, J NEUROSCI, V32, P10649, DOI 10.1523/JNEUROSCI.0759-12.2012; Sepulcre J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000808; Simpson JR, 2001, P NATL ACAD SCI USA, V98, P683, DOI 10.1073/pnas.98.2.683; Skudlarski P, 2008, NEUROIMAGE, V43, P554, DOI 10.1016/j.neuroimage.2008.07.063; Smith K. S., 2010, HEDONIC HOTSPOTS GEN, P27; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Smyser CD, 2010, CEREB CORTEX, V20, P2852, DOI 10.1093/cercor/bhq035; Supekar K, 2010, NEUROIMAGE, V52, P290, DOI 10.1016/j.neuroimage.2010.04.009; Tononi G, 2004, BMC NEUROSCIENCE, V5; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Van Essen DC, 2007, NEURON, V56, P209, DOI 10.1016/j.neuron.2007.10.015; Van Hoesen G W, 1993, Curr Opin Neurobiol, V3, P150, DOI 10.1016/0959-4388(93)90202-A; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Vogel AC, 2010, NEUROPSYCHOL REV, V20, P362, DOI 10.1007/s11065-010-9145-7; Vogeley K, 2003, TRENDS COGN SCI, V7, P38, DOI 10.1016/S1364-6613(02)00003-7; Yan H, 2009, NEUROIMAGE, V47, P1579, DOI 10.1016/j.neuroimage.2009.05.080; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011	87	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e67444	10.1371/journal.pone.0067444	http://dx.doi.org/10.1371/journal.pone.0067444			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894288	Green Published, Green Submitted, gold			2022-12-27	WOS:000322167900005
J	Suami, H; Yamashita, S; Soto-Miranda, MA; Chang, DW				Suami, Hiroo; Yamashita, Shuji; Soto-Miranda, Miguel A.; Chang, David W.			Lymphatic Territories (Lymphosomes) in a Canine: An Animal Model for Investigation of Postoperative Lymphatic Alterations	PLOS ONE			English	Article							CADAVER INJECTION TECHNIQUE; RECURRENT BREAST-CANCER; NODE BIOPSY; CLINICAL-IMPLICATIONS; AXILLARY SURGERY; UPPER-LIMB; MELANOMA; LYMPHEDEMA; DRAINAGE; CARCINOMA	Background: Lymph node dissection is often performed as a part of surgical treatment for breast cancer and malignant melanoma to prevent malignant cells from traveling via the lymphatic system. Currently little is known about postoperative lymphatic drainage pattern alterations. This knowledge may be useful for management of recurrent cancer and prevention of breast cancer related lymphedema. We mapped the complete superficial lymphatic system of a dog and used this canine model to perform preliminary studies of lymphatic architectural changes in postoperative condition. Methods: Lymphatic territories (lymphosomes) were mapped with 4 female mongrel carcasses using an indocyanine green (ICG) fluorescent lymphography and a radiographic microinjection technique. Two live dogs were then subjected to unilateral lymph node dissection of lymph basins of the forelimb, and ICG lymphography and lymphangiogram were performed 6 months after the surgery to investigate lymphatic changes. Lymphatic patterns in the carcass were then compared with postoperative lymphatic patterns in the live dogs. Results: Ten lymphosomes were identified, corresponding with ten lymphatic basins. Postoperative fluorescent lymphographic images and lymphangiograms in the live dogs revealed small caliber lymphatic network fulfilling gaps in the surgical area and collateral lymphatic vessels arising from the network connecting to lymph nodes in the contralateral and ipsilateral neck in one dog and the ipsilateral subclavicular vein in another dog. Conclusion: Our canine lymphosome map allowed us to observe lymphatic collateral formations after lymph node dissection in live dogs. This canine model may help clarify our understanding of postoperative lymphatic changes in humans in future studies.	[Suami, Hiroo; Yamashita, Shuji; Soto-Miranda, Miguel A.; Chang, David W.] Univ Texas MD Anderson Canc Ctr, Dept Plast Surg, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Suami, H (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Plast Surg, Houston, TX 77030 USA.	hsuami@mdanderson.org	Suami, Hiroo/H-7371-2019	Suami, Hiroo/0000-0002-4841-3328	Kyte Plastic Surgery Research Fund; University of Texas MD Anderson Cancer Center; National Institutes of Health [CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Kyte Plastic Surgery Research Fund; University of Texas MD Anderson Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Kyte Plastic Surgery Research Fund and an Institutional Research Grant of The University of Texas MD Anderson Cancer Center provided financial support for this project. The University of Texas MD Anderson Cancer Center is supported in part by a Cancer Center Support Grant (CA016672) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOULENEIN A, 1984, SURGERY, V95, P562; ALEX JC, 1993, SURG ONCOL, V2, P303, DOI 10.1016/S0960-7404(06)80006-X; [Anonymous], 2006, FOLDIS TXB LYMPHOLOG; Axelsson CK, 2008, EJSO-EUR J SURG ONC, V34, P626, DOI 10.1016/j.ejso.2007.09.004; Bartels P, 1909, LYMPHGEFASSSYSTEM; Baum H, 1938, LYMPHGEFASSSYSTEM SC; Baum H, 1918, LYMPHGEFASSSYSTEM HU; Baum H, 1912, LYMPHGEFASSSYSTEM RI; Bobbio P., 1962, ATENEO PARMENSE, V33, P95; CABANAS RM, 1977, CANCER, V39, P456, DOI 10.1002/1097-0142(197702)39:2<456::AID-CNCR2820390214>3.0.CO;2-I; Delamere G, 1904, LYMPHATICS; Dhar SC, 1999, PLAST RECONSTR SURG, V104, P2079, DOI 10.1097/00006534-199912000-00021; Dinan D, 2005, AM J SURG, V190, P614, DOI 10.1016/j.amjsurg.2005.06.025; Ellenberger W., 1926, HDB VERGLEICHENDEN A, V16; Hadarnitzky C, 2008, CANCER RES, V68, P343, DOI 10.1158/0008-5472.CAN-07-2454; Herd-Smith A, 2001, CANCER-AM CANCER SOC, V92, P1783, DOI 10.1002/1097-0142(20011001)92:7<1783::AID-CNCR1694>3.0.CO;2-G; Jossifow GM, 1930, LYMPHGEFASSSYSTEM ME; Kaur P, 2011, ANN SURG ONCOL, V18, P727, DOI 10.1245/s10434-010-1120-2; Lee TS, 2008, BREAST CANCER RES TR, V110, P19, DOI 10.1007/s10549-007-9710-9; Mascagni P, 1787, VASORUM LYMPHATICORU; Moore C H, 1867, Med Chir Trans, V50, P245; MORTON DL, 1992, ARCH SURG-CHICAGO, V127, P392; Pan WR, 2008, PLAST RECONSTR SURG, V121, P1614, DOI 10.1097/PRS.0b013e31816aa072; Port ER, 2007, ANN SURG ONCOL, V14, P2209, DOI 10.1245/s10434-006-9237-z; Reynolds HM, 2007, LANCET ONCOL, V8, P806, DOI 10.1016/S1470-2045(07)70176-6; Rockson SG, 2001, AM J MED, V110, P288, DOI 10.1016/S0002-9343(00)00727-0; Rouviere H, 1938, ANATOMY HUMAN LYMPHA; Sappey MPC, 1874, ANATOMIE PHYSL PATHO; Schrenk P, 2008, EJSO-EUR J SURG ONC, V34, P851, DOI 10.1016/j.ejso.2007.11.006; Shin William S, 2003, Lymphat Res Biol, V1, P159, DOI 10.1089/153968503321642642; Suami H, 2005, PLAST RECONSTR SURG, V115, P2007, DOI 10.1097/01.PRS.0000163325.06437.B0; Suami H, 2008, PLAST RECONSTR SURG, V121, P1231, DOI 10.1097/01.prs.0000302511.21140.36; Suami H, 2008, ANN SURG ONCOL, V15, P863, DOI 10.1245/s10434-007-9709-9; Suami H, 2008, PLAST RECONSTR SURG, V121, P31, DOI 10.1097/01.prs.0000293753.93274.21; Suami H, 2007, PLAST RECONSTR SURG, V120, P61, DOI 10.1097/01.prs.0000263321.64228.53; Suami H, 2007, PLAST RECONSTR SURG, V119, P1813, DOI 10.1097/01.prs.0000246516.64780.61; Suami H, 2012, PLAST RECONSTR SURG, V129, P612, DOI 10.1097/PRS.0b013e3182402c6d; SUGARBAKER EV, 1976, SURGERY, V80, P22; Szuba A, 1997, Vasc Med, V2, P321; Taylor GI, 2011, PLAST RECONSTR SURG, V127, P1447, DOI 10.1097/PRS.0b013e318208d21b; Uren RF, 2004, ANN SURG ONCOL, V11, p179S, DOI 10.1245/ASO.2004.11.916; Uren RF, 1998, ANN SURG ONCOL, V5, P384, DOI 10.1007/BF02303504	42	47	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69222	10.1371/journal.pone.0069222	http://dx.doi.org/10.1371/journal.pone.0069222			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894435	Green Published, Green Submitted, gold			2022-12-27	WOS:000322167900050
J	Nakahara, M; Okumura, N; Kay, EP; Hagiya, M; Imagawa, K; Hosoda, Y; Kinoshita, S; Koizumi, N				Nakahara, Makiko; Okumura, Naoki; Kay, EunDuck P.; Hagiya, Michio; Imagawa, Kiwamu; Hosoda, Yuuki; Kinoshita, Shigeru; Koizumi, Noriko			Corneal Endothelial Expansion Promoted by Human Bone Marrow Mesenchymal Stem Cell-Derived Conditioned Medium	PLOS ONE			English	Article							SURVIVAL IN-VITRO; PHOSPHATIDYLINOSITOL 3-KINASE; AMNIOTIC MEMBRANE; ROCK INHIBITOR; STROMAL CELLS; KERATOPLASTY; TRANSPLANTATION; VIVO; CULTIVATION; TISSUE	Healthy corneal endothelium is essential for maintaining corneal clarity, as the damage of corneal endothelial cells and loss of cell count causes severe visual impairment. Corneal transplantation is currently the only therapy for severe corneal disorders. The greatly limited proliferative ability of human corneal endothelial cells (HCECs), even in vitro, has challenged researchers to establish efficient techniques for the cultivating HCECs, a pivotal issue for clinical applications. The aim of this study was to evaluate conditioned medium (CM) obtained from human bone marrow-derived mesenchymal stem cells (MSCs) (MSC-CM) for use as a consistent expansion protocol of HCECs. When HCECs were maintained in the presence of MSC-CM, cell morphology assumed a hexagonal shape similar to corneal endothelial cells in vivo, as opposed to the irregular cell shape observed in control cultures in the absence of MSC-CM. They also maintained the functional protein phenotypes; ZO-1 and Na+/K+-ATPase were localized at the intercellular adherent junctions and pump proteins of corneal endothelium were accordingly expressed. In comparison to the proliferative potential observed in the control cultures, HCECs maintained in MSC-CM were found to have more than twice as many Ki67-positive cells and a greatly increased incorporation of BrdU into DNA. MSC-CM further facilitated the cell migration of HCECs. Lastly, the mechanism of cell proliferation mediated by MSC-CM was investigated, and phosphorylation of Akt and ERK1/2 was observed in HCECs after exposure to MSC-CM. The inhibitor to PI 3-kinase maintained the level of p27(Kip1) for up to 24 hours and greatly blocked the expression of cyclin D1 and D3 during the early G1 phase, leading to the reduction of cell density. These findings indicate that MSC-CM not only stimulates the proliferation of HCECs by regulating the G1 proteins of the cell cycle but also maintains the characteristic differentiated phenotypes necessary for the endothelial functions.	[Nakahara, Makiko; Okumura, Naoki; Kay, EunDuck P.; Koizumi, Noriko] Doshisha Univ, Fac Life & Med Sci, Dept Biomed Engn, Kyotanabe, Japan; [Okumura, Naoki; Hagiya, Michio; Hosoda, Yuuki; Kinoshita, Shigeru] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan; [Hagiya, Michio; Imagawa, Kiwamu; Hosoda, Yuuki] JCR Pharmaceut Co Ltd, Div Res, Kobe, Hyogo, Japan	Doshisha University; Kyoto Prefectural University of Medicine	Koizumi, N (corresponding author), Doshisha Univ, Fac Life & Med Sci, Dept Biomed Engn, Kyotanabe, Japan.	nkoizumi@mail.doshisha.ac.jp			Highway Program for realization of regenerative medicine; Funding Program for Next Generation World-Leading Researchers from the Cabinet Office in Japan [Koizumi: LS117]; Grants-in-Aid for Scientific Research [23390404] Funding Source: KAKEN	Highway Program for realization of regenerative medicine; Funding Program for Next Generation World-Leading Researchers from the Cabinet Office in Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The work was supported in part by the Highway Program for realization of regenerative medicine (Kinoshita and Okumura); http://www.mext.go.jp/english/; and the Funding Program for Next Generation World-Leading Researchers from the Cabinet Office in Japan (Koizumi: LS117); http://www.jsps.go.jp/english/e-jisedai/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshari NA, 2006, ARCH OPHTHALMOL-CHIC, V124, P777, DOI 10.1001/archopht.124.6.777; Anshu A, 2012, SURV OPHTHALMOL, V57, P236, DOI 10.1016/j.survophthal.2011.10.005; Boomsma RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035685; Bourne W M, 1998, Trans Am Ophthalmol Soc, V96, P229; Edelhauser HF, 2000, CORNEA, V19, P263, DOI 10.1097/00003226-200005000-00002; Gorovoy MS, 2006, CORNEA, V25, P886, DOI 10.1097/01.ico.0000214224.90743.01; Hayashi Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014099; Ishino Y, 2004, INVEST OPHTH VIS SCI, V45, P800, DOI 10.1167/iovs.03-0016; Joyce NC, 2003, PROG RETIN EYE RES, V22, P359, DOI 10.1016/S1350-9462(02)00065-4; Joyce NC, 1996, INVEST OPHTH VIS SCI, V37, P1566; KAUFMAN HE, 1977, INVEST OPHTH VIS SCI, V16, P265; Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC; Klintworth Gordon K, 2009, Orphanet J Rare Dis, V4, P7, DOI 10.1186/1750-1172-4-7; Koizumi N, 2000, INVEST OPHTH VIS SCI, V41, P2506; Koizumi N, 2007, INVEST OPHTH VIS SCI, V48, P4519, DOI 10.1167/iovs.07-0567; Lee JG, 2007, J BIOL CHEM, V282, P6444, DOI 10.1074/jbc.M607808200; Lee JG, 2011, INVEST OPHTH VIS SCI, V52, P8216, DOI 10.1167/iovs.11-8213; Lee JG, 2006, INVEST OPHTH VIS SCI, V47, P1376, DOI 10.1167/iovs.05-1223; Lu XY, 2010, MOL VIS, V16, P611; Mehta JS, 2008, CORNEA, V27, P722, DOI 10.1097/QAI.0b013e31815e92ac; Melles GRJ, 2008, AM J OPHTHALMOL, V145, P222, DOI 10.1016/j.ajo.2007.09.021; Melles GRJ, 2000, OPHTHALMOLOGY, V107, P1850, DOI 10.1016/S0161-6420(00)00253-0; Mimura T, 2004, INVEST OPHTH VIS SCI, V45, P2992, DOI 10.1167/iovs.03-1174; Okumura N, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058000, 10.1371/journal.pone.0075961]; Okumura N, 2012, AM J PATHOL, V181, P268, DOI 10.1016/j.ajpath.2012.03.033; Okumura N, 2009, INVEST OPHTH VIS SCI, V50, P3680, DOI 10.1167/iovs.08-2634; Peh GSL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028310; Peh GSL, 2011, TRANSPLANTATION, V91, P811, DOI 10.1097/TP.0b013e3182111f01; Phinney DG, 2006, STEM CELLS, V24, P186, DOI 10.1634/stemcells.2004-0236; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Price FW, 2005, J REFRACT SURG, V21, P339; Price MO, 2010, CLIN EXP OPHTHALMOL, V38, P128, DOI 10.1111/j.1442-9071.2010.02213.x; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Sumide T, 2006, FASEB J, V20, P392, DOI 10.1096/fj.04-3035fje; Tan DTH, 2012, LANCET, V379, P1749, DOI 10.1016/S0140-6736(12)60437-1; Terry MA, 2008, OPHTHALMOLOGY, V115, P488, DOI 10.1016/j.ophtha.2007.10.035; Yokoi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029677; Zhu C, 2004, INVEST OPHTH VIS SCI, V45, P1743, DOI 10.1167/iovs.03-0814; Zhu YT, 2008, INVEST OPHTH VIS SCI, V49, P3879, DOI 10.1167/iovs.08-1693	39	67	72	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69009	10.1371/journal.pone.0069009	http://dx.doi.org/10.1371/journal.pone.0069009			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894393	Green Submitted, Green Published, gold			2022-12-27	WOS:000325211000066
J	Metzger, S; Walter, C; Riess, O; Roos, RAC; Nielsen, JE; Craufurd, D; Nguyen, HP				Metzger, Silke; Walter, Carolin; Riess, Olaf; Roos, Raymund A. C.; Nielsen, Jorgen E.; Craufurd, David; Huu Phuc Nguyen		REGISTRY Investigators European Hu	The V471A Polymorphism in Autophagy-Related Gene ATG7 Modifies Age at Onset Specifically in Italian Huntington Disease Patients	PLOS ONE			English	Article							BDNF VAL66MET POLYMORPHISM; OF-ONSET; TRINUCLEOTIDE REPEAT; NEUROTROPHIC FACTOR; PARKINSONS-DISEASE; ASSOCIATION; POLYGLUTAMINE; LENGTH; EXPANSIONS; PROTEINS	The cause of Huntington disease (HD) is a polyglutamine repeat expansion of more than 36 units in the huntingtin protein, which is inversely correlated with the age at onset of the disease. However, additional genetic factors are believed to modify the course and the age at onset of HD. Recently, we identified the V471A polymorphism in the autophagy-related gene ATG7, a key component of the autophagy pathway that plays an important role in HD pathogenesis, to be associated with the age at onset in a large group of European Huntington disease patients. To confirm this association in a second independent patient cohort, we analysed the ATG7 V471A polymorphism in additional 1,464 European HD patients of the "REGISTRY'' cohort from the European Huntington Disease Network (EHDN). In the entire REGISTRY cohort we could not confirm a modifying effect of the ATG7 V471A polymorphism. However, analysing a modifying effect of ATG7 in these REGISTRY patients and in patients of our previous HD cohort according to their ethnic origin, we identified a significant effect of the ATG7 V471A polymorphism on the HD age at onset only in the Italian population (327 patients). In these Italian patients, the polymorphism is associated with a 6-years earlier disease onset and thus seems to have an aggravating effect. We could specify the role of ATG7 as a genetic modifier for HD particularly in the Italian population. This result affirms the modifying influence of the autophagic pathway on the course of HD, but also suggests population-specific modifying mechanisms in HD pathogenesis.	[Metzger, Silke; Walter, Carolin; Riess, Olaf; Huu Phuc Nguyen] Univ Tubingen, Inst Med Genet & Appl Genom, Tubingen, Germany; [Metzger, Silke; Walter, Carolin; Riess, Olaf; Huu Phuc Nguyen] Univ Tubingen, Rare Dis Ctr, Tubingen, Germany; [Roos, Raymund A. C.] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands; [Nielsen, Jorgen E.] Copenhagen Univ Hosp, Rigshosp, Neurogenet Clin, Memory Disorders Res Unit,Sect 6702, Copenhagen, Denmark; [Nielsen, Jorgen E.] Univ Copenhagen, Panum Inst, Inst Cellular & Mol Med, Neurogenet Sect, DK-2200 Copenhagen, Denmark; [Craufurd, David] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Craufurd, David] Manchester Univ Hosp NHS Fdn Trust, St Marys Hosp, Manchester, Lancs, England	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Manchester; University of Manchester; Wythenshawe Hospital NHS Foundation Trust	Nguyen, HP (corresponding author), Univ Tubingen, Inst Med Genet & Appl Genom, Tubingen, Germany.	hoa.nguyen@med.uni-tuebingen.de	BAS, JORDI/K-6656-2017; Nguyen, Huu Phuc/F-5390-2015; Taylor, Catherine/B-9152-2014; Wild, Edward/G-1436-2016; Gago, Miguel/F-2355-2015; Dec-Cwiek, Malgorzata/AAL-4040-2020; Romano, Silvia/P-7984-2015; Catalli, Claudio/L-4020-2017; Mir, Pablo/C-8662-2013; Mariotti, Caterina/AAP-9425-2021; Gellera, Cinzia/J-7887-2016; amico, enrico/AAA-8797-2019; Klempir, Jiri/P-3897-2017; Rakowicz, Maria/U-9134-2018; Scaglione, Cesa/AAB-7825-2020; Sitek, Emilia/I-6913-2013; Maglione, Vittorio/AAA-5455-2019; Martin Bastida, Antonio/E-3061-2018; de Almeida Garrett, Maria Carolina L Lobo/A-5332-2012; Di Pardo, Alba/AAC-9393-2020; nanetti, lorenzo/A-7361-2013; Uhrová, Tereza/P-3615-2017; Dujardin, Kathy/H-5037-2011; Nguyen, Huu Phuc/HDO-3462-2022; Marchese, Roberta/AAB-9484-2019; Janik, Piotr/M-5836-2018; Martin-Bastida, Antonio/P-6097-2017; Busse, Monica/C-2103-2009; Hernández, Francisco Javier Barrero/J-4142-2018; Di Maria, Emilio/AFK-2153-2022; Seliverstov, Yury A/F-8362-2015; Sitek, Emilia/AAJ-2666-2021; Massano, João/B-8086-2012; Di Bella, Daniela/K-2270-2016; Squitieri, Ferdinando/F-1561-2016; Dunnett, Stephen/A-5869-2010; Roth, Jan/O-1817-2017; Fasano, Alfonso/K-2558-2018; Januario Santos, Maria Cristina/O-5939-2015	BAS, JORDI/0000-0002-4478-421X; Nguyen, Huu Phuc/0000-0001-6139-788X; Wild, Edward/0000-0002-6921-7887; Gago, Miguel/0000-0003-0894-6207; Romano, Silvia/0000-0003-0499-8843; Catalli, Claudio/0000-0002-0183-2226; Mir, Pablo/0000-0003-1656-302X; Mariotti, Caterina/0000-0003-2405-3564; Gellera, Cinzia/0000-0002-3582-665X; amico, enrico/0000-0002-0160-3634; Klempir, Jiri/0000-0002-0735-7155; Rakowicz, Maria/0000-0003-3998-8936; Scaglione, Cesa/0000-0002-5213-3089; Sitek, Emilia/0000-0003-4141-072X; Maglione, Vittorio/0000-0002-6906-7372; Martin Bastida, Antonio/0000-0002-8480-7009; de Almeida Garrett, Maria Carolina L Lobo/0000-0003-3336-3302; Di Pardo, Alba/0000-0002-9514-0086; nanetti, lorenzo/0000-0002-1952-4539; Uhrová, Tereza/0000-0002-3633-3347; Dujardin, Kathy/0000-0002-0110-574X; Nguyen, Huu Phuc/0000-0001-6139-788X; Marchese, Roberta/0000-0003-2321-088X; Janik, Piotr/0000-0002-2701-191X; Martin-Bastida, Antonio/0000-0002-8480-7009; Busse, Monica/0000-0002-5331-5909; Hernández, Francisco Javier Barrero/0000-0001-8490-2789; Di Maria, Emilio/0000-0002-8357-2658; Seliverstov, Yury A/0000-0002-6400-6378; Sitek, Emilia/0000-0003-4141-072X; Massano, João/0000-0002-5791-7149; capellari, sabina/0000-0003-1631-1439; Landwehrmeyer, Georg Bernhard/0000-0003-3375-790X; Godefroy, Olivier/0000-0001-6789-6620; Ganos, Christos/0000-0001-8077-8530; Delval, Arnaud/0000-0003-0642-3541; Di Bella, Daniela/0000-0003-0912-5136; Vivancos Moreau, Laura/0000-0002-8677-5119; Bachoud-Levi, Anne-Catherine/0000-0003-3000-2210; Rosser, Anne/0000-0002-4716-4753; Barker, Roger Alistair/0000-0001-8843-7730; Slawek, Jaroslaw/0000-0001-6816-0877; Klimberg, Aneta/0000-0002-8050-086X; Zinzi, Paola/0000-0001-5379-4674; Squitieri, Ferdinando/0000-0002-7397-1727; Bandmann, Oliver/0000-0003-3149-0252; Ure, Alexandra Margaret/0000-0003-4217-4933; Wojcik-Pedziwiatr, Magdalena/0000-0003-0600-6780; Hensman Moss, Davina/0000-0003-2467-0917; Guerrero, Rosa/0000-0002-4138-4667; Sulek, Anna/0000-0003-2975-4888; Bojakowska, Kamila/0000-0002-7448-5667; Dunnett, Stephen/0000-0003-1826-1578; Simonin, Clemence/0000-0002-2282-4372; Sablonniere, Bernard/0000-0003-0384-4076; NOGUERA-PEREA, FUENSANTA/0000-0001-8498-5131; ALLAIN, Philiooe/0000-0003-0668-0986; Zaremba, Jacek/0000-0002-9546-7767; Sienkiewicz-Jarosz, Halina/0000-0002-2953-1943; , IDA_2/0000-0002-1068-4763; Marcinkowski, Jerzy/0000-0001-6495-8988; Calopa, Matilde/0000-0002-6943-3707; Rizzo, Giovanni/0000-0002-9718-2044; Roth, Jan/0000-0002-5247-7746; Murphy, Helen/0000-0002-5489-0614; Rudolf, Gabrielle/0000-0002-2050-3911; GOROSPE OSINALDE, MARIA ARANZAZU/0000-0002-1502-3059; SCIRUICCHIO, VITTORIO/0000-0003-2388-573X; Elifani, Francesca/0000-0002-0824-9543; Bek, Judith/0000-0003-3926-1788; Nemeth, Andrea/0000-0002-2941-7657; Thompson, Jennifer/0000-0002-7512-7570; Saft, Carsten/0000-0002-3983-7292; Goizet, Cyril/0000-0002-1913-889X; Zielonka, Daniel/0000-0002-4599-5377; Lahiri, Nayana/0000-0002-6260-7700; Nielsen, Jorgen Erik/0000-0003-0453-5582; Fasano, Alfonso/0000-0001-5346-0180; Januario Santos, Maria Cristina/0000-0001-5402-3978	GeNeMove Network for hereditary movement disorders [01GM0603]; MRC [G1001257] Funding Source: UKRI; Medical Research Council [G1001257] Funding Source: researchfish; National Institute for Health Research [CL-2009-18-005] Funding Source: researchfish; Novo Nordisk Fonden [NNF11OC1014514] Funding Source: researchfish	GeNeMove Network for hereditary movement disorders; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Novo Nordisk Fonden(Novo Nordisk Foundation)	The study was supported by the GeNeMove Network for hereditary movement disorders (01GM0603). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberch J, 2005, NEUROLOGY, V65, P964, DOI 10.1212/01.wnl.0000175977.57661.b1; Andresen JM, 2007, J MED GENET, V44, P44, DOI 10.1136/jmg.2006.045153; ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; Arning L, 2005, NEUROGENETICS, V6, P25, DOI 10.1007/s10048-004-0198-8; Arning L, 2012, FUTUR NEUROL, V7, P93, DOI 10.2217/FNL.11.65; Aziz NA, 2011, MOVEMENT DISORD, V26, P2450, DOI 10.1002/mds.23849; Bates G, 2002, HUNTINGTONS DIS, P3; Brinkman RR, 1997, AM J HUM GENET, V60, P1202; Chattopadhyay B, 2005, NEUROSCI LETT, V374, P81, DOI 10.1016/j.neulet.2004.10.018; Che HV, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-1; den Dunnen JT, 2001, HUM GENET, V109, P121, DOI 10.1007/s004390100505; Di Maria E, 2006, NEUROBIOL DIS, V24, P274, DOI 10.1016/j.nbd.2006.07.002; Djousse L, 2003, AM J MED GENET A, V119A, P279, DOI 10.1002/ajmg.a.20190; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; Gayan J, 2008, GENET EPIDEMIOL, V32, P445, DOI 10.1002/gepi.20317; Guerini FR, 2009, EUR J NEUROL, V16, P1240, DOI 10.1111/j.1468-1331.2009.02706.x; Hakansson A, 2003, ANN NEUROL, V53, P823, DOI 10.1002/ana.10585; Holbert S, 2001, P NATL ACAD SCI USA, V98, P1811, DOI 10.1073/pnas.041566798; Karakasis C, 2011, J CLIN NEUROSCI, V18, P1744, DOI 10.1016/j.jocn.2011.03.015; Kehoe P, 1999, J MED GENET, V36, P108; Kishikawa S, 2006, NEUROBIOL DIS, V24, P280, DOI 10.1016/j.nbd.2006.07.008; Klempir J, 2011, MOVEMENT DISORD, V26, P125, DOI 10.1002/mds.23436; Klionsky DT, 1999, ANNU REV CELL DEV BI, V15, P1, DOI 10.1146/annurev.cellbio.15.1.1; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Lee JH, 2012, BIOCHEM BIOPH RES CO, V424, P404, DOI 10.1016/j.bbrc.2012.06.120; Li JL, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-71; Li JL, 2003, AM J HUM GENET, V73, P682, DOI 10.1086/378133; LUCOTTE G, 1995, HUM GENET, V95, P231; MacDonald ME, 1999, NEUROLOGY, V53, P1330, DOI 10.1212/WNL.53.6.1330; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Metzger S, 2006, NEUROGENETICS, V7, P27, DOI 10.1007/s10048-005-0023-z; Metzger S, 2008, HUM MOL GENET, V17, P1137, DOI 10.1093/hmg/ddn003; Metzger S, 2006, HUM GENET, V120, P285, DOI 10.1007/s00439-006-0221-2; Metzger S, 2010, HUM GENET, V128, P453, DOI 10.1007/s00439-010-0873-9; Naze P, 2002, NEUROSCI LETT, V328, P1, DOI 10.1016/S0304-3940(02)00231-8; NOVELLETTO A, 1994, HUM MOL GENET, V3, P93, DOI 10.1093/hmg/3.1.93; Orth M, 2011, J NEUROL NEUROSUR PS, V82, P1409, DOI 10.1136/jnnp.2010.209668; Ramos EM, 2012, HUM GENET, V131, P1833, DOI 10.1007/s00439-012-1205-z; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Rosenblatt A, 2001, AM J MED GENET, V105, P399, DOI 10.1002/ajmg.1400; Rubinsztein DC, 1997, P NATL ACAD SCI USA, V94, P3872, DOI 10.1073/pnas.94.8.3872; Saarela MS, 2006, FOLIA NEUROPATHOL, V44, P12; Saft Carsten, 2011, PLoS Curr, V3, pRRN1247, DOI 10.1371/currents.RRN1247; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; STINE OC, 1993, HUM MOL GENET, V2, P1547, DOI 10.1093/hmg/2.10.1547; Taherzadeh-Fard E, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-10; Trembath MK, 2010, MOVEMENT DISORD, V25, P1444, DOI 10.1002/mds.23108; Verhoef LGGC, 2002, HUM MOL GENET, V11, P2689, DOI 10.1093/hmg/11.22.2689; Wexler NS, 2004, P NATL ACAD SCI USA, V101, P3498, DOI 10.1073/pnas.0308479101; Weydt P, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-3	52	41	41	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e68951	10.1371/journal.pone.0068951	http://dx.doi.org/10.1371/journal.pone.0068951			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894380	Green Published, Green Accepted, gold			2022-12-27	WOS:000322132100032
J	Tamaki, S; Mano, T; Sakata, Y; Ohtani, T; Takeda, Y; Kamimura, D; Omori, Y; Tsukamoto, Y; Ikeya, Y; Kawai, M; Kumanogoh, A; Hagihara, K; Ishii, R; Higashimori, M; Kaneko, M; Hasuwa, H; Miwa, T; Yamamoto, K; Komuro, I				Tamaki, Shunsuke; Mano, Toshiaki; Sakata, Yasushi; Ohtani, Tomohito; Takeda, Yasuharu; Kamimura, Daisuke; Omori, Yosuke; Tsukamoto, Yasumasa; Ikeya, Yukitoshi; Kawai, Mari; Kumanogoh, Atsushi; Hagihara, Keisuke; Ishii, Ryohei; Higashimori, Mitsuru; Kaneko, Makoto; Hasuwa, Hidetoshi; Miwa, Takeshi; Yamamoto, Kazuhiro; Komuro, Issei			Interleukin-16 Promotes Cardiac Fibrosis and Myocardial Stiffening in Heart Failure with Preserved Ejection Fraction	PLOS ONE			English	Article							INFLAMMATORY MEDIATORS; DIASTOLIC DYSFUNCTION; HYPERTROPHY; STIFFNESS; OVEREXPRESSION; LYMPHOCYTES; MACROPHAGES; DEFICIENCY; ACTIVATION; INDUCTION	Background: Chronic heart failure (CHF) with preserved left ventricular (LV) ejection fraction (HFpEF) is observed in half of all patients with CHF and carries the same poor prognosis as CHF with reduced LV ejection fraction (HFrEF). In contrast to HFrEF, there is no established therapy for HFpEF. Chronic inflammation contributes to cardiac fibrosis, a crucial factor in HFpEF; however, inflammatory mechanisms and mediators involved in the development of HFpEF remain unclear. Therefore, we sought to identify novel inflammatory mediators involved in this process. Methods and Results: An analysis by multiplex-bead array assay revealed that serum interleukin-16 (IL-16) levels were specifically elevated in patients with HFpEF compared with HFrEF and controls. This was confirmed by enzyme-linked immunosorbent assay in HFpEF patients and controls, and serum IL-16 levels showed a significant association with indices of LV diastolic dysfunction. Serum IL-16 levels were also elevated in a rat model of HFpEF and positively correlated with LV end-diastolic pressure, lung weight and LV myocardial stiffness constant. The cardiac expression of IL-16 was upregulated in the HFpEF rat model. Enhanced cardiac expression of IL-16 in transgenic mice induced cardiac fibrosis and LV myocardial stiffening accompanied by increased macrophage infiltration. Treatment with anti-IL-16 neutralizing antibody ameliorated cardiac fibrosis in the mouse model of angiotensin II-induced hypertension. Conclusion: Our data indicate that IL-16 is a mediator of LV myocardial fibrosis and stiffening in HFpEF, and that the blockade of IL-16 could be a possible therapeutic option for HFpEF.	[Tamaki, Shunsuke; Mano, Toshiaki; Sakata, Yasushi; Ohtani, Tomohito; Takeda, Yasuharu; Omori, Yosuke; Tsukamoto, Yasumasa; Ikeya, Yukitoshi; Komuro, Issei] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka, Japan; [Tamaki, Shunsuke; Mano, Toshiaki; Kamimura, Daisuke; Omori, Yosuke; Tsukamoto, Yasumasa; Hasuwa, Hidetoshi; Miwa, Takeshi] Osaka Univ, Genome Informat Res Ctr, Suita, Osaka, Japan; [Kamimura, Daisuke] Yokohama City Univ, Grad Sch Med, Dept Med Sci & Cardiorenal Med, Yokohama, Kanagawa 232, Japan; [Ikeya, Yukitoshi] Nihon Univ, Sch Med, Dept Internal Med, Div Cardiol, Tokyo, Japan; [Kawai, Mari; Kumanogoh, Atsushi] Osaka Univ, Grad Sch Med, Dept Resp Med Allergy & Rheumat Dis, Suita, Osaka, Japan; [Hagihara, Keisuke] Osaka Univ, Grad Sch Med, Dept Kampo Med, Suita, Osaka, Japan; [Ishii, Ryohei; Higashimori, Mitsuru; Kaneko, Makoto] Osaka Univ, Dept Mech Engn, Suita, Osaka, Japan; [Yamamoto, Kazuhiro] Tottori Univ, Fac Med, Dept Mol Med & Therapeut, Yonago, Tottori 683, Japan	Osaka University; Osaka University; Yokohama City University; Nihon University; Osaka University; Osaka University; Osaka University; Tottori University	Mano, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka, Japan.	mano@medone.med.osaka-u.ac.jp	Hasuwa, Hidetoshi/B-1083-2009	Tamaki, Shunsuke/0000-0001-5642-3836; Ohtani, Tomohito/0000-0002-2963-7895; Sakata, Yasushi/0000-0002-5618-4721	Japanese Society for the Promotion of Science [23591042, 21590893]; Grants-in-Aid for Scientific Research [23591042] Funding Source: KAKEN	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from the Japanese Society for the Promotion of Science (No. 23591042 and No. 21590893) (http://www.jsps.go.jp/j-grantsinaid/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Anker SD, 2004, HEART, V90, P464, DOI 10.1136/hrt.2002.007005; Aukrust P, 1998, CIRCULATION, V97, P1136, DOI 10.1161/01.CIR.97.12.1136; Berk BC, 2007, J CLIN INVEST, V117, P568, DOI 10.1172/JCI31044; Bhatia RS, 2006, NEW ENGL J MED, V355, P260, DOI 10.1056/NEJMoa051530; CENTER DM, 1982, J IMMUNOL, V128, P2563; Cieslik KA, 2011, J MOL CELL CARDIOL, V50, P248, DOI 10.1016/j.yjmcc.2010.10.019; Cruikshank W, 2008, CRIT REV IMMUNOL, V28, P467; CRUIKSHANK WW, 1987, J IMMUNOL, V138, P3817; Deswal A, 2001, CIRCULATION, V103, P2055; Doser TA, 2009, CIRCULATION, V119, P1941, DOI 10.1161/CIRCULATIONAHA.108.823799; Hermann E, 1999, IMMUNOLOGY, V97, P241; Hessel EM, 1998, J IMMUNOL, V160, P2998; HINGLAIS N, 1994, LAB INVEST, V70, P286; Ishii R, 2011, IEEE ENG MED BIO, P904, DOI 10.1109/IEMBS.2011.6090202; Kamimura D, 2012, EUR HEART J, V33, P1408, DOI 10.1093/eurheartj/ehr106; Keates AC, 2000, GASTROENTEROLOGY, V119, P972, DOI 10.1053/gast.2000.18164; Kimura N, 2011, J HEART LUNG TRANSPL, V30, P1409, DOI 10.1016/j.healun.2011.08.017; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lester SJ, 1999, AM J CARDIOL, V84, P829, DOI 10.1016/S0002-9149(99)00446-4; Mann DL, 2002, CIRC RES, V91, P988, DOI 10.1161/01.RES.0000043825.01705.1B; Masuyama T, 2000, J AM COLL CARDIOL, V36, P2333, DOI 10.1016/S0735-1097(00)01000-7; Maurer MS, 2007, J AM COLL CARDIOL, V49, P972, DOI 10.1016/j.jacc.2006.10.061; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; Meagher C, 2010, DIABETES, V59, P2862, DOI 10.2337/db09-0131; Melendez GC, 2010, HYPERTENSION, V56, P225, DOI 10.1161/HYPERTENSIONAHA.109.148635; Moriwaki H, 2004, CIRC RES, V95, P637, DOI 10.1161/01.RES.0000141427.61023.f4; Ohtani T, 2012, EUR HEART J, V33, P1742, DOI 10.1093/eurheartj/ehs135; Ohtani T, 2009, J HYPERTENS, V27, P1074, DOI 10.1097/HJH.0b013e328326cb04; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Roger VL, 2004, JAMA-J AM MED ASSOC, V292, P344, DOI 10.1001/jama.292.3.344; Shimoyama M, 1999, CIRCULATION, V100, P2449, DOI 10.1161/01.CIR.100.24.2449; Skundric DS, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-13; Takeda Y, 2009, J CARD FAIL, V15, P68, DOI 10.1016/j.cardfail.2008.09.004; Terui T, 2010, J GEN PHYSIOL, V136, P469, DOI 10.1085/jgp.201010502; Westermann D, 2011, CIRC-HEART FAIL, V4, P44, DOI 10.1161/CIRCHEARTFAILURE.109.931451; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Xu JA, 2010, AM J PHYSIOL-HEART C, V299, pH1328, DOI 10.1152/ajpheart.00538.2010; Yamamoto K, 2002, CARDIOVASC RES, V55, P76, DOI 10.1016/S0008-6363(02)00341-3; Yoshida J, 2004, HYPERTENSION, V43, P686, DOI 10.1161/01.HYP.0000118017.02160.fa; Yu QL, 2009, AM J PHYSIOL-HEART C, V297, pH76, DOI 10.1152/ajpheart.01285.2008; Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7; Zile MR, 2004, NEW ENGL J MED, V350, P1953, DOI 10.1056/NEJMoa032566	42	54	59	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e68893	10.1371/journal.pone.0068893	http://dx.doi.org/10.1371/journal.pone.0068893			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894370	Green Published, Green Submitted, gold			2022-12-27	WOS:000322391400030
J	Duarte, ST; Armstrong, J; Roche, A; Ortez, C; Perez, A; O'Callaghan, MD; Pereira, A; Sanmarti, F; Ormazabal, A; Artuch, R; Pineda, M; Garcia-Cazorla, A				Temudo Duarte, Sofia; Armstrong, Judith; Roche, Ana; Ortez, Carlos; Perez, Ana; del Mar O'Callaghan, Maria; Pereira, Antonina; Sanmarti, Francesc; Ormazabal, Aida; Artuch, Rafael; Pineda, Mercedes; Garcia-Cazorla, Angels			Abnormal Expression of Cerebrospinal Fluid Cation Chloride Cotransporters in Patients with Rett Syndrome	PLOS ONE			English	Article							MECP2-NULL MICE; BRAIN; HYPEREXCITABILITY; HIPPOCAMPUS; AUTISM; DYSFUNCTION; BUMETANIDE; EPILEPSY; CHILDREN; SEIZURES	Objective: Rett Syndrome is a progressive neurodevelopmental disorder caused mainly by mutations in the gene encoding methyl-CpG-binding protein 2. The relevance of MeCP2 for GABAergic function was previously documented in animal models. In these models, animals show deficits in brain-derived neurotrophic factor, which is thought to contribute to the pathogenesis of this disease. Neuronal Cation Chloride Cotransporters (CCCs) play a key role in GABAergic neuronal maturation, and brain-derived neurotrophic factor is implicated in the regulation of CCCs expression during development. Our aim was to analyse the expression of two relevant CCCs, NKCC1 and KCC2, in the cerebrospinal fluid of Rett syndrome patients and compare it with a normal control group. Methods: The presence of bumetanide sensitive NKCC1 and KCC2 was analysed in cerebrospinal fluid samples from a control pediatric population (1 day to 14 years of life) and from Rett syndrome patients (2 to 19 years of life), by immunoblot analysis. Results: Both proteins were detected in the cerebrospinal fluid and their levels are higher in the early postnatal period. However, Rett syndrome patients showed significantly reduced levels of KCC2 and KCC2/NKCC1 ratio when compared to the control group. Conclusions: Reduced KCC2/NKCC1 ratio in the cerebrospinal fluid of Rett Syndrome patients suggests a disturbed process of GABAergic neuronal maturation and open up a new therapeutic perspective.	[Temudo Duarte, Sofia; Armstrong, Judith; Roche, Ana; Ortez, Carlos; Perez, Ana; del Mar O'Callaghan, Maria; Sanmarti, Francesc; Pineda, Mercedes; Garcia-Cazorla, Angels] Hosp St Joan de Deu HSJD, Dept Neurol, Barcelona, Spain; [Ormazabal, Aida; Artuch, Rafael] Hosp St Joan de Deu HSJD, Dept Biochem, Barcelona, Spain; [Armstrong, Judith; Ortez, Carlos; Ormazabal, Aida; Artuch, Rafael; Pineda, Mercedes; Garcia-Cazorla, Angels] Inst Salud Carlos III, CIBER ER Biomed Network Res Ctr Rare Dis, Madrid, Spain; [Temudo Duarte, Sofia; Pereira, Antonina] Univ Lisbon, Fac Med, Inst Med Mol, P-1699 Lisbon, Portugal; [Temudo Duarte, Sofia] Gulbenkian Inst Sci, Oeiras, Portugal	CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Universidade de Lisboa	Duarte, ST (corresponding author), Hosp St Joan de Deu HSJD, Dept Neurol, Barcelona, Spain.	sofia.duarte22@hotmail.com	Pereira, Antonina/H-1241-2016; Pereira, Antonina/AAA-4225-2021	Pereira, Antonina/0000-0001-5206-4063; Pereira, Antonina/0000-0001-5206-4063; Ortez Gonzalez, Carlos Ignacio/0000-0001-8187-8103; Artuch, Rafael/0000-0002-3422-9685; Duarte, Ana Sofia/0000-0002-6918-9636	"Real Patronato" (Spanish Ministry of Health and Social Policy); Tecnifar Epilepsy Research grant; FIS [PS09/01132]; Portuguese League Against Epilepsy; Tecnifar S.A.; Calouste Gulbenkian Foundation; Portuguese Foundation for Science and Technology; Caja Navarra; "Real Patronato", Spanish Ministry of Social Politics;  [FIS PS09/01132]	"Real Patronato" (Spanish Ministry of Health and Social Policy); Tecnifar Epilepsy Research grant; FIS(Instituto de Salud Carlos III); Portuguese League Against Epilepsy; Tecnifar S.A.; Calouste Gulbenkian Foundation; Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Caja Navarra; "Real Patronato", Spanish Ministry of Social Politics; 	This study was funded by "Real Patronato" (Spanish Ministry of Health and Social Policy), Tecnifar Epilepsy Research grant and FIS PS09/01132. Dr. Sofia T. Duarte has received a research grant from Portuguese League Against Epilepsy and from Tecnifar S.A. (Epilepsy research grant). Currently, Dr. Sofia Duarte integrates the Portuguese Programme for Advanced Medical Education, sponsored by Calouste Gulbenkian Foundation and Portuguese Foundation for Science and Technology. Dr. Carlos Ortez was supported by a grant from Caja Navarra. Dr. Mercedes Pineda is funded by a grant from "Real Patronato", Spanish Ministry of Social Politics. Dr. Angels Garcia-Cazorla is funded by the grant FIS PS09/01132. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado F, 2003, BDNF REGULATES SPONT; Biou D, 2000, CLIN CHEM, V46, P399; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Boggio Elena M, 2010, Front Synaptic Neurosci, V2, P28, DOI 10.3389/fnsyn.2010.00028; Carmona MA, 2006, CEREB CORTEX, V16, P47, DOI 10.1093/cercor/bhi083; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Danglot L, 2006, HIPPOCAMPUS, V16, P1032, DOI 10.1002/hipo.20225; Deng V, 2007, HUM MOL GENET, V16, P640, DOI 10.1093/hmg/ddm007; Duarte ST, 2011, J INHERIT METAB DIS, V34, P523, DOI 10.1007/s10545-010-9256-6; Dzhala VI, 2005, NAT MED, V11, P1205, DOI 10.1038/nm1301; Galanopoulou AS, 2008, EPILEPSY RES, V80, P99, DOI 10.1016/j.eplepsyres.2008.04.013; Galanopoulou AS, 2008, CURR NEUROPHARMACOL, V6, P1, DOI 10.2174/157015908783769653; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; Harrington MG, 2009, FLUIDS BARRIERS CNS, V6, DOI 10.1186/1743-8454-6-10; JELLINGER K, 1988, ACTA NEUROPATHOL, V76, P142, DOI 10.1007/BF00688098; Kahle KT, 2009, J CHILD NEUROL, V24, P572, DOI 10.1177/0883073809333526; Kline DD, 2010, J NEUROSCI, V30, P5303, DOI 10.1523/JNEUROSCI.5503-09.2010; Kron M, 2012, J NEUROSCI, V32, P13860, DOI 10.1523/JNEUROSCI.2159-12.2012; Lemonnier E, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.124; Maroco J., 2007, ANALISE ESTATISTICA, V3rd; Medrihan L, 2008, J NEUROPHYSIOL, V99, P112, DOI 10.1152/jn.00826.2007; Monteggia LM, 2009, BIOL PSYCHIAT, V65, P204, DOI 10.1016/j.biopsych.2008.10.036; Munoz A, 2007, EPILEPSIA, V48, P663, DOI 10.1111/j.1528-1167.2007.00986.x; Neul JL, 2010, ANN NEUROL, V68, P944, DOI 10.1002/ana.22124; Nissenkorn A, 2010, EPILEPSIA, V51, P1252, DOI 10.1111/j.1528-1167.2010.02597.x; Ormazabal A, 2005, J NEUROSCI METH, V142, P153, DOI 10.1016/j.jneumeth.2004.08.007; Plotkin MD, 1997, J NEUROBIOL, V33, P781, DOI 10.1002/(SICI)1097-4695(19971120)33:6<781::AID-NEU6>3.0.CO;2-5; REISS AL, 1993, ANN NEUROL, V34, P227, DOI 10.1002/ana.410340220; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Talos DM, 2012, ANN NEUROL, V71, P539, DOI 10.1002/ana.22696; Thouvenot E, 2008, J PROTEOME RES, V7, P4409, DOI 10.1021/pr8003858; Wang H, 2006, J NEUROSCI, V26, P10911, DOI 10.1523/JNEUROSCI.1810-06.2006; Woo NS, 2002, HIPPOCAMPUS, V12, P258, DOI 10.1002/hipo.10014; Zhang L, 2008, HIPPOCAMPUS, V18, P294, DOI 10.1002/hipo.20389	35	52	53	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e68851	10.1371/journal.pone.0068851	http://dx.doi.org/10.1371/journal.pone.0068851			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894354	Green Published, gold, Green Submitted			2022-12-27	WOS:000322391400026
J	Upstill-Goddard, R; Eccles, D; Ennis, S; Rafiq, S; Tapper, W; Fliege, J; Collins, A				Upstill-Goddard, Rosanna; Eccles, Diana; Ennis, Sarah; Rafiq, Sajjad; Tapper, William; Fliege, Joerg; Collins, Andrew			Support Vector Machine Classifier for Estrogen Receptor Positive and Negative Early-Onset Breast Cancer	PLOS ONE			English	Article							INFLAMMATION; ASSOCIATION; GROWTH; PROLIFERATION; INFILTRATION; MECHANISMS; CROSSTALK; PROGNOSIS; VARIANTS; SEQUENCE	Two major breast cancer sub-types are defined by the expression of estrogen receptors on tumour cells. Cancers with large numbers of receptors are termed estrogen receptor positive and those with few are estrogen receptor negative. Using genome-wide single nucleotide polymorphism genotype data for a sample of early-onset breast cancer patients we developed a Support Vector Machine (SVM) classifier from 200 germline variants associated with estrogen receptor status (p<0.0005). Using a linear kernel Support Vector Machine, we achieved classification accuracy exceeding 93%. The model indicates that polygenic variation in more than 100 genes is likely to underlie the estrogen receptor phenotype in early-onset breast cancer. Functional classification of the genes involved identifies enrichment of functions linked to the immune system, which is consistent with the current understanding of the biological role of estrogen receptors in breast cancer.	[Upstill-Goddard, Rosanna; Eccles, Diana; Ennis, Sarah; Rafiq, Sajjad; Tapper, William; Collins, Andrew] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [Fliege, Joerg] Univ Southampton, Ctr Operat Res Management Sci & Informat Syst, Southampton, Hants, England	University of Southampton; University of Southampton	Collins, A (corresponding author), Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England.	arc@soton.ac.uk	Collins, Andrew/A-6595-2010; Collins, Andrew/S-2196-2019; Eccles, Diana/K-6327-2019	Collins, Andrew/0000-0001-7108-0771; Collins, Andrew/0000-0001-7108-0771; Eccles, Diana/0000-0002-9935-3169; Rafiq, Sajjad/0000-0003-4873-4540; Fliege, Jorg/0000-0002-4459-5419; Upstill-Goddard, Rosie/0000-0002-2666-0934; Tapper, William/0000-0002-5896-1889	Breast Cancer Campaign; EPSRC [EP/I016945/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I016945/1] Funding Source: researchfish	Breast Cancer Campaign; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Breast Cancer Campaign. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN TI, 1994, HUM GENET, V94, P665; Anderson WF, 2001, J CLIN ONCOL, V19, P18, DOI 10.1200/JCO.2001.19.1.18; Ban HJ, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-26; Ben-Hur A, 2010, METHODS MOL BIOL, V609, P223, DOI 10.1007/978-1-60327-241-4_13; Bjornstrom L, 2005, MOL ENDOCRINOL, V19, P833, DOI 10.1210/me.2004-0486; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Ch'ng E., 2013, VISUAL HERITAGE DIGI, P1; Chen R, 2007, AM J REPROD IMMUNOL, V57, P93, DOI 10.1111/j.1600-0897.2006.00441.x; Chen SH, 2008, GENET EPIDEMIOL, V32, P152, DOI 10.1002/gepi.20272; Clemons M, 2001, NEW ENGL J MED, V344, P276, DOI 10.1056/NEJM200101253440407; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cruz JA, 2006, CANCER INFORM, V2, P59; DeNardo DG, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1746; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Dunnwald LK, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1639; Easton DF, 2008, HUM MOL GENET, V17, pR109, DOI 10.1093/hmg/ddn287; Eccles D, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-160; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gupta PB, 2007, CANCER RES, V67, P2062, DOI 10.1158/0008-5472.CAN-06-3895; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Hahnel R, 2004, ANZ J SURG, V74, P957, DOI 10.1111/j.1445-1433.2004.03215.x; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Harburg GC, 2011, J MAMMARY GLAND BIOL, V16, P257, DOI 10.1007/s10911-011-9225-1; HGNC Database HUGO Gene Nomenclature Committee (HGNC), HGNC DAT; Hindorff LA, CATALOG PUBLISHED GE; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Iwase H, 1996, CANCER LETT, V108, P179, DOI 10.1016/S0304-3835(96)04406-0; Klagsbrun M, 2005, CYTOKINE GROWTH F R, V16, P535, DOI 10.1016/j.cytogfr.2005.05.002; Lee WJ, 2006, BBA-REV CANCER, V1765, P235, DOI 10.1016/j.bbcan.2005.12.001; Leek RD, 1996, CANCER RES, V56, P4625; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Listgarten J, 2004, CLIN CANCER RES, V10, P2725, DOI 10.1158/1078-0432.CCR-1115-03; Maguire P, BREAST CANC RES TREA, V94, P145; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Menard S, 1997, CLIN CANCER RES, V3, P817; Mor G, 1998, J STEROID BIOCHEM, V67, P403, DOI 10.1016/S0960-0760(98)00143-5; Osborne CK, 2005, CLIN CANCER RES, V11, p865S; Paruthiyil S, 2004, CANCER RES, V64, P423, DOI 10.1158/0008-5472.CAN-03-2446; Pequeux C, 2012, CANCER RES, V72, P3010, DOI 10.1158/0008-5472.CAN-11-3768; Purcell S., PLINK V1 07; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rafiq S, 2013, CANC RES; Reed MJ, 1997, ENDOCR REV, V18, P701, DOI 10.1210/er.18.5.701; ROODI N, 1995, JNCI-J NATL CANCER I, V87, P446, DOI 10.1093/jnci/87.6.446; Seal RL, 2011, NUCLEIC ACIDS RES, V39, pD514, DOI 10.1093/nar/gkq892; Solinas G, 2009, J LEUKOCYTE BIOL, V86, P1065, DOI 10.1189/jlb.0609385; Strom A, 2004, P NATL ACAD SCI USA, V101, P1566, DOI 10.1073/pnas.0308319100; VAPNIK V, 1994, NEURAL COMPUT, V6, P851, DOI 10.1162/neco.1994.6.5.851; Waddell M., 2005, P 5 INT WORKSH BIOIN, P21; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Yu KD, 2011, BREAST CANCER RES TR, V126, P37, DOI 10.1007/s10549-010-0891-2	58	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e68606	10.1371/journal.pone.0068606	http://dx.doi.org/10.1371/journal.pone.0068606			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894323	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000322391400014
J	Javed, MA; Poshtiban, S; Arutyunov, D; Evoy, S; Szymanski, CM				Javed, Muhammad A.; Poshtiban, Somayyeh; Arutyunov, Denis; Evoy, Stephane; Szymanski, Christine M.			Bacteriophage Receptor Binding Protein Based Assays for the Simultaneous Detection of Campylobacter jejuni and Campylobacter coli	PLOS ONE			English	Article							PHAGE-TYPING SCHEME; TAILSPIKE PROTEIN; GENOME SEQUENCE; C-LARI; IDENTIFICATION; TIME; PCR; UPSALIENSIS; DETERMINANT; INFECTION	Campylobacter jejuni and Campylobacter coli are the most common bacterial causes of foodborne gastroenteritis which is occasionally followed by a debilitating neuropathy known as Guillain-Barre syndrome. Rapid and specific detection of these pathogens is very important for effective control and quick treatment of infection. Most of the diagnostics available for these organisms are time consuming and require technical expertise with expensive instruments and reagents to perform. Bacteriophages bind to their host specifically through their receptor binding proteins (RBPs), which can be exploited for pathogen detection. We recently sequenced the genome of C. jejuni phage NCTC12673 and identified its putative host receptor binding protein, Gp047. In the current study, we localized the receptor binding domain to the C-terminal quarter of Gp047. CC-Gp047 could be produced recombinantly and was capable of agglutinating both C. jejuni and C. coli cells unlike the host range of the parent phage which is limited to a subset of C. jejuni isolates. The agglutination procedure could be performed within minutes on a glass slide at room temperature and was not hindered by the presence of buffers or nutrient media. This agglutination assay showed 100% specificity and the sensitivity was 95% for C. jejuni (n = 40) and 90% for C. coli (n = 19). CC-Gp047 was also expressed as a fusion with enhanced green fluorescent protein (EGFP). Chimeric EGFP_CC-Gp047 was able to specifically label C. jejuni and C. coli cells in mixed cultures allowing for the detection of these pathogens by fluorescent microscopy. This study describes a simple and rapid method for the detection of C. jejuni and C. coli using engineered phage RBPs and offers a promising new diagnostics platform for healthcare and surveillance laboratories.	[Javed, Muhammad A.; Arutyunov, Denis; Szymanski, Christine M.] Univ Alberta, Alberta Glyc Ctr, Edmonton, AB, Canada; [Javed, Muhammad A.; Arutyunov, Denis; Szymanski, Christine M.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Poshtiban, Somayyeh; Evoy, Stephane] Univ Alberta, Dept Elect & Comp Engn, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Javed, MA (corresponding author), Univ Alberta, Alberta Glyc Ctr, Edmonton, AB, Canada.	majaved@ualberta.ca; cszymans@ualberta.ca		Evoy, Stephane/0000-0003-4587-3502	Natural Sciences and Engineering Research Council of Canada [397260]; Alberta Innovates Scholar Award	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Innovates Scholar Award	This study was funded by the Natural Sciences and Engineering Research Council of Canada Strategic Grant #397260 and an Alberta Innovates Scholar Award to CMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Amri A, 2007, J MED MICROBIOL, V56, P1350, DOI 10.1099/jmm.0.47220-0; Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Arya SK, 2011, ANALYST, V136, P486, DOI 10.1039/c0an00697a; Bessede E, 2011, J CLIN MICROBIOL, V49, P941, DOI 10.1128/JCM.01489-10; BLACK RE, 1988, J INFECT DIS, V157, P472, DOI 10.1093/infdis/157.3.472; Carvalho CM, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-35; Champion OL, 2005, P NATL ACAD SCI USA, V102, P16043, DOI 10.1073/pnas.0503252102; Churruca E, 2007, INT J FOOD MICROBIOL, V117, P85, DOI 10.1016/j.ijfoodmicro.2007.02.007; COVACCI A, 1993, P NATL ACAD SCI USA, V90, P5791, DOI 10.1073/pnas.90.12.5791; Duplessis M, 2001, MOL MICROBIOL, V41, P325, DOI 10.1046/j.1365-2958.2001.02521.x; Dupont K, 2004, APPL ENVIRON MICROB, V70, P5818, DOI 10.1128/AEM.70.10.5818-5824.2004; FELIX A, 1956, J GEN MICROBIOL, V14, P208, DOI 10.1099/00221287-14-1-208; Fouts DE, 2005, PLOS BIOL, V3, P72, DOI 10.1371/journal.pbio.0030015; Freiberg A, 2003, J BIOL CHEM, V278, P1542, DOI 10.1074/jbc.M205294200; Frost JA, 1999, EPIDEMIOL INFECT, V123, P47, DOI 10.1017/S095026889900254X; GRAJEWSKI BA, 1985, J CLIN MICROBIOL, V22, P13, DOI 10.1128/JCM.22.1.13-18.1985; Hammerl JA, 2012, J VIROL, V86, P8896, DOI 10.1128/JVI.01252-12; Hammerl JA, 2011, J VIROL, V85, P8597, DOI 10.1128/JVI.00395-11; Humphrey T, 2007, INT J FOOD MICROBIOL, V117, P237, DOI 10.1016/j.ijfoodmicro.2007.01.006; Javed MA, 2013, ARCH VIROLO IN PRESS; Keramas G, 2004, J CLIN MICROBIOL, V42, P3985, DOI 10.1128/JCM.42.9.3985-3991.2004; KHAKHRIA R, 1992, EPIDEMIOL INFECT, V108, P403, DOI 10.1017/S0950268800049918; KHAKHRIA R, 1990, EPIDEMIOL INFECT, V105, P511, DOI 10.1017/S0950268800048135; Kreisberg JF, 2002, PROTEIN SCI, V11, P820, DOI 10.1110/ps.3440102; Kropinski AM, 2011, APPL ENVIRON MICROB, V77, P8265, DOI 10.1128/AEM.05562-11; Kulkarni SP, 2002, J CLIN PATHOL, V55, P749, DOI 10.1136/jcp.55.10.749; LOESSNER MJ, 1990, APPL ENVIRON MICROB, V56, P1912, DOI 10.1128/AEM.56.6.1912-1918.1990; Lu XN, 2012, J CLIN MICROBIOL, V50, P2932, DOI 10.1128/JCM.01144-12; Mandrell RE, 2005, APPL ENVIRON MICROB, V71, P6292, DOI 10.1128/AEM.71.10.6292-6307.2005; McNally DJ, 2007, J BIOL CHEM, V282, P28566, DOI 10.1074/jbc.M704413200; Miller WG, 2005, J CLIN MICROBIOL, V43, P2315, DOI 10.1128/JCM.43.5.2315-2329.2005; Misawa N, 2000, INFECT IMMUN, V68, P6168, DOI 10.1128/IAI.68.11.6168-6175.2000; Naidoo Ravendra, 2012, Bacteriophage, V2, P15; O'Flaherty S, 2005, J BACTERIOL, V187, P7161, DOI 10.1128/JB.187.20.7161-7164.2005; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Poppert S, 2008, J CLIN MICROBIOL, V46, P2133, DOI 10.1128/JCM.01512-07; Ridley AM, 2008, APPL ENVIRON MICROB, V74, P2492, DOI 10.1128/AEM.01242-07; Schmelcher M, 2010, APPL ENVIRON MICROB, V76, P5745, DOI 10.1128/AEM.00801-10; Singh A, 2009, BIOSENS BIOELECTRON, V24, P3645, DOI 10.1016/j.bios.2009.05.028; Singh A, 2012, ANALYST, V137, P3405, DOI 10.1039/c2an35371g; Singh A, 2011, ANALYST, V136, P4780, DOI 10.1039/c1an15547d; Singh A, 2010, BIOSENS BIOELECTRON, V26, P131, DOI 10.1016/j.bios.2010.05.024; Sorensen MCH, 2011, J BACTERIOL, V193, P6742, DOI 10.1128/JB.05276-11; Stuer-Lauridsen B, 2003, VIROLOGY, V309, P10, DOI 10.1016/S0042-6822(03)00012-6; Timms AR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-214; Volokhov D, 2003, J CLIN MICROBIOL, V41, P4071, DOI 10.1128/JCM.41.9.4071-4080.2003; Wang J, 2000, J BACTERIOL, V182, P508, DOI 10.1128/JB.182.2.508-512.2000; Young VB, 2005, CAMPYLOBACTER: MOLECULAR AND CELLULAR BIOLOGY, P1	48	37	39	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e69770	10.1371/journal.pone.0069770	http://dx.doi.org/10.1371/journal.pone.0069770			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874996	Green Published, Green Submitted, gold			2022-12-27	WOS:000324146200083
J	Flora, AD; Teel, LD; Smith, MA; Sinclair, JF; Melton-Celsa, AR; O'Brien, AD				Flora, Alyssa D.; Teel, Louise D.; Smith, Mark A.; Sinclair, James F.; Melton-Celsa, Angela R.; O'Brien, Alison D.			Ricin Crosses Polarized Human Intestinal Cells and Intestines of Ricin-Gavaged Mice without Evident Damage and Then Disseminates to Mouse Kidneys	PLOS ONE			English	Article							EPITHELIAL-CELLS; TISSUE-CULTURE; INTOXICATION; MODEL; ENDOCYTOSIS; TOXICITY; STRAINS; LACTOSE	Ricin is a potent toxin found in the beans of Ricinus communis and is often lethal for animals and humans when aerosolized or injected and causes significant morbidity and occasional death when ingested. Ricin has been proposed as a bioweapon because of its lethal properties, environmental stability, and accessibility. In oral intoxication, the process by which the toxin transits across intestinal mucosa is not completely understood. To address this question, we assessed the impact of ricin on the gastrointestinal tract and organs of mice after dissemination of toxin from the gut. We first showed that ricin adhered in a specific pattern to human small bowel intestinal sections, the site within the mouse gut in which a variable degree of damage has been reported by others. We then monitored the movement of ricin across polarized human HCT-8 intestinal monolayers grown in transwell inserts and in HCT-8 cell organoids. We observed that, in both systems, ricin trafficked through the cells without apparent damage until 24 hours post intoxication. We delivered a lethal dose of purified fluorescently-labeled ricin to mice by oral gavage and followed transit of the toxin from the gastrointestinal tracts to the internal organs by in vivo imaging of whole animals over time and ex vivo imaging of organs at various time points. In addition, we harvested organs from unlabeled ricin-gavaged mice and assessed them for the presence of ricin and for histological damage. Finally, we compared serum chemistry values from buffer-treated versus ricin-intoxicated animals. We conclude that ricin transverses human intestinal cells and mouse intestinal cells in situ prior to any indication of enterocyte damage and that ricin rapidly reaches the kidneys of intoxicated mice. We also propose that mice intoxicated orally with ricin likely die from distributive shock.	[Flora, Alyssa D.; Teel, Louise D.; Smith, Mark A.; Sinclair, James F.; Melton-Celsa, Angela R.; O'Brien, Alison D.] Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA	O'Brien, AD (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD 20814 USA.	alison.obrien@usuhs.edu		O'Brien, Alison/0000-0002-1315-3204	National Institute for Allergy and Infectious Diseases [2U54 AI057168]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057168] Funding Source: NIH RePORTER	National Institute for Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by 2U54 AI057168 from the National Institute for Allergy and Infectious Diseases to ADO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audi J, 2005, JAMA-J AM MED ASSOC, V294, P2342, DOI 10.1001/jama.294.18.2342; Baluna R, 1999, J IMMUNOTHER, V22, P41, DOI 10.1097/00002371-199901000-00006; Barrila J, 2010, NAT REV MICROBIOL, V8, P791, DOI 10.1038/nrmicro2423; Carvalho HM, 2005, CELL MICROBIOL, V7, P1771, DOI 10.1111/j.1462-5822.2004.00594.x; CHALLONER KR, 1990, ANN EMERG MED, V19, P1177, DOI 10.1016/S0196-0644(05)81525-2; Cook DL, 2006, TOXICOLOGY, V223, P61, DOI 10.1016/j.tox.2006.03.010; ENDO Y, 1987, J BIOL CHEM, V262, P8128; He XH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012858; HENLE G, 1957, J IMMUNOL, V79, P54; Hurley BP, 1999, INFECT IMMUN, V67, P6670; Inoue Y, 2008, MOL IMAGING, V7, P21, DOI 10.2310/7290.2008.0003; ISHIGURO M, 1992, J PHARMACOBIO-DYNAM, V15, P147, DOI 10.1248/bpb1978.15.147; JACKMAN MR, 1994, J CELL SCI, V107, P2547; Jaeger GJKaJJ, 1990, SEED CASTOR POISONIN; Kumar O, 2003, TOXICON, V41, P333, DOI 10.1016/S0041-0101(02)00313-6; Mantis NJ, 2006, INFECT IMMUN, V74, P3455, DOI 10.1128/IAI.02088-05; Mantis NJ, 2004, J IMMUNOL, V172, P6838, DOI 10.4049/jimmunol.172.11.6838; Nagatsuka T, 2010, ACS APPL MATER INTER, V2, P1081, DOI 10.1021/am900846r; Roels S, 2010, J VET DIAGN INVEST, V22, P466, DOI 10.1177/104063871002200325; Roxas-Duncan V. I., 2012, J BIOTERR BIODEF S, V7, P2, DOI DOI 10.4172/2157-2526.S7-002; Smallshaw JE, 2007, VACCINE, V25, P7459, DOI 10.1016/j.vaccine.2007.08.018; TOMPKINS WA, 1974, J NATL CANCER I, V52, P1101, DOI 10.1093/jnci/52.4.1101; VANDEURS B, 1988, J CELL BIOL, V106, P253, DOI 10.1083/jcb.106.2.253; VANDEURS B, 1990, EUR J CELL BIOL, V51, P96; Yoder JM, 2007, INFECT IMMUN, V75, P1745, DOI 10.1128/IAI.01528-06; ZENTZ C, 1978, BIOCHIM BIOPHYS ACTA, V536, P18, DOI 10.1016/0005-2795(78)90047-8	26	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e69706	10.1371/journal.pone.0069706	http://dx.doi.org/10.1371/journal.pone.0069706			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23874986	Green Published, gold, Green Submitted			2022-12-27	WOS:000322000600056
J	Parejo, D; Aviles, JM; Pena, A; Sanchez, L; Ruano, F; Zamora-Munoz, C; Martin-Vivaldi, M				Parejo, Deseada; Aviles, Jesus M.; Pena, Aranzazu; Sanchez, Lourdes; Ruano, Francisca; Zamora-Munoz, Carmen; Martin-Vivaldi, Manuel			Armed Rollers: Does Nestling's Vomit Function as a Defence against Predators?	PLOS ONE			English	Article							CHEMICAL DEFENSE; PHENOLIC-ACIDS; REGURGITATION; GRASSHOPPER; RESISTANCE; BIRD; SUBSTANCES; CHEMISTRY; MECHANISM; ECOLOGY	Chemical defences against predators are widespread in the animal kingdom although have been seldom reported in birds. Here, we investigate the possibility that the orange liquid that nestlings of an insectivorous bird, the Eurasian roller (Coracias garrulus), expel when scared at their nests acts as a chemical defence against predators. We studied the diet of nestling rollers and vomit origin, its chemical composition and deterrent effect on a mammal generalist predator. We also hypothesized that nestling rollers, as their main prey (i.e. grasshoppers) do from plants, could sequester chemicals from their prey for their use. Grasshoppers, that also regurgitate when facing to a threat, store the harmful substances used by plants to defend themselves against herbivores. We found that nestling rollers only vomit after being grasped and moved. The production of vomit depended on food consumption and the vomit contained two deterrent chemicals (hydroxycinnamic and hydroxybenzoic acids) stored by grasshoppers and used by plants to diminish herbivory, suggesting that they originate from the rollers' prey. Finally, we showed for the first time that the oral secretion of a vertebrate had a deterrent effect on a model predator because vomit of nestling rollers made meat distasteful to dogs. These results support the idea that the vomit of nestling rollers is a chemical defence against predators.	[Parejo, Deseada; Aviles, Jesus M.] Estn Expt Zonas Aridas EEZA CSIC, La Canada De San Urbano, Almeria, Spain; [Pena, Aranzazu] IACT CSIC UGR, Granada, Spain; [Sanchez, Lourdes] Estn Expt Zaidin EEZ CSIC, Granada, Spain; [Ruano, Francisca; Zamora-Munoz, Carmen; Martin-Vivaldi, Manuel] Univ Granada, Fac Ciencias, Dept Biol Anim & Ecol, Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Zonas Aridas (EEZA); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Andaluz de Ciencias de la Tierra (IACT); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ); University of Granada	Parejo, D (corresponding author), Estn Expt Zonas Aridas EEZA CSIC, Ctra Sacramento S-N, La Canada De San Urbano, Almeria, Spain.	parejo@eeza.csic.es	Ruano, Francisca/M-1028-2014; Martín-Vivaldi, Manuel/F-8256-2016; Martínez, Manuel Martín-Vivaldi/AAJ-6736-2021; Avilés, Jesús/K-3332-2014; Zamora-Muñoz, Carmen/K-7050-2014; Ruano, Francisca/L-1301-2019; Parejo, Deseada/L-3953-2014	Ruano, Francisca/0000-0002-9806-7267; Martín-Vivaldi, Manuel/0000-0002-5432-425X; Martínez, Manuel Martín-Vivaldi/0000-0002-5432-425X; Avilés, Jesús/0000-0002-1463-8393; Zamora-Muñoz, Carmen/0000-0002-3037-1529; Ruano, Francisca/0000-0002-9806-7267; Parejo, Deseada/0000-0002-7368-2378; Pena, Aranzazu/0000-0002-3464-2250	Junta de Andalucia [P06-RNM-02177]; Spanish Ministry of Science and Education/FEDER [CGL2008-00718, CGL2011-27561]	Junta de Andalucia(Junta de Andalucia); Spanish Ministry of Science and Education/FEDER	Financial support was provided by the Junta de Andalucia (project P06-RNM-02177) and the Spanish Ministry of Science and Education/FEDER (projects CGL2008-00718 and CGL2011-27561). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviles J. M., 1997, ARDEOLA, V44, P234; Aviles JM, 2011, BEHAV ECOL SOCIOBIOL, V65, P1549, DOI 10.1007/s00265-011-1164-8; BERNAYS EA, 1993, COMP BIOCHEM PHYS A, V104, P125, DOI 10.1016/0300-9629(93)90019-Z; Bradshaw JWS, 2006, J NUTR, V136, p1927S, DOI 10.1093/jn/136.7.1927S; Calcagno MP, 2004, PHYSIOL ENTOMOL, V29, P123, DOI 10.1111/j.1365-3032.2004.00374.x; Chapman R.F., 1990, P39; DALY JW, 1995, P NATL ACAD SCI USA, V92, P9, DOI 10.1073/pnas.92.1.9; Despland E, 2005, ANIM BEHAV, V69, P471, DOI 10.1016/j.anbehav.2004.04.018; Despres L, 2007, TRENDS ECOL EVOL, V22, P298, DOI 10.1016/j.tree.2007.02.010; Dumbacher John P., 1996, Current Ornithology, V13, P137; DUMBACHER JP, 1992, SCIENCE, V258, P799, DOI 10.1126/science.1439786; Dumbacher JP, 2004, P NATL ACAD SCI USA, V101, P15857, DOI 10.1073/pnas.0407197101; EISNER T, 1971, SCIENCE, V172, P277, DOI 10.1126/science.172.3980.277; Eisner T., 1970, CHEM ECOL, P157; Fry C, 2011, HDB BIRDS WORLD, P342; Hagelin JC, 2007, AUK, V124, P741, DOI 10.1642/0004-8038(2007)124[741:BOAOCS]2.0.CO;2; HARTLEY RD, 1977, PHYTOCHEMISTRY, V16, P1531, DOI 10.1016/0031-9422(77)84017-X; JONES CG, 1987, J CHEM ECOL, V13, P283, DOI 10.1007/BF01025888; LEVIN DA, 1976, ANNU REV ECOL SYST, V7, P121, DOI 10.1146/annurev.es.07.110176.001005; LIGON JD, 1978, NATURE, V276, P496, DOI 10.1038/276496a0; LYMBERY A, 1980, J AUST ENTOMOL SOC, V19, P129; Machado G, 2005, J CHEM ECOL, V31, P2519, DOI 10.1007/s10886-005-7611-0; Nishida R, 2002, ANNU REV ENTOMOL, V47, P57, DOI 10.1146/annurev.ento.47.091201.145121; ODonnell CFJ, 1996, NEW ZEAL J ZOOL, V23, P213, DOI 10.1080/03014223.1996.9518080; Opitz SEW, 2009, CHEMOECOLOGY, V19, P117, DOI 10.1007/s00049-009-0018-6; Ortego F, 1997, J CHEM ECOL, V23, P1941, DOI 10.1023/B:JOEC.0000006481.86889.78; Oueslati O, 2009, ALLELOPATHY J, V23, P157; Parejo D, 2012, BIOL LETTERS, V8, P502, DOI 10.1098/rsbl.2012.0124; PASTEELS JM, 1983, ANNU REV ENTOMOL, V28, P263, DOI 10.1146/annurev.en.28.010183.001403; PETERSON SC, 1987, ECOLOGY, V68, P1268, DOI 10.2307/1939211; PLEGUEZUELOS JM, 2006, ENCICLOPEDIA VIRTUAL; Poulsen JG, 1995, AUK, V112, P1070, DOI 10.2307/4089046; ROTH LM, 1962, ANNU REV ENTOMOL, V7, P107, DOI 10.1146/annurev.en.07.010162.000543; Sanchez L, 2004, ANAL BIOANAL CHEM, V378, P764, DOI 10.1007/s00216-003-2378-z; Savitzky AH, 2012, CHEMOECOLOGY, V22, P141, DOI 10.1007/s00049-012-0112-z; Sword GA, 2000, P ROY SOC B-BIOL SCI, V267, P63, DOI 10.1098/rspb.2000.0967; Sword GA, 2001, OECOLOGIA, V128, P416, DOI 10.1007/s004420100666; Warham J., 1977, Proceedings of the New Zealand Ecological Society, V24, P84; Whitman D.W., 1990, P289; Wittstock U, 2002, CURR OPIN PLANT BIOL, V5, P300, DOI 10.1016/S1369-5266(02)00264-9; WOODHEAD S, 1978, ENTOMOL EXP APPL, V24, P123, DOI 10.1007/BF00290800; WOODHEAD S, 1979, BIOCHEM SYST ECOL, V7, P309, DOI 10.1016/0305-1978(79)90009-7	42	12	12	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68862	10.1371/journal.pone.0068862	http://dx.doi.org/10.1371/journal.pone.0068862			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874791	Green Published, Green Submitted, gold			2022-12-27	WOS:000321765300069
J	Bernier, A; Ligier, C; Guillemot, D; Watier, L				Bernier, Adeline; Ligier, Caroline; Guillemot, Didier; Watier, Laurence			Did Media Attention of the 2009 A(H1N1) Influenza Epidemic Increase Outpatient Antibiotic Use in France?: A Time-Series Analysis	PLOS ONE			English	Article							VIRUS	Background: In France, the 2009 A(H1N1) influenza epidemic occurred between September 2009 and January 2010. Sparking widespread controversy, it was intensely reported in the media. Despite therapeutic inefficacy, antibiotic consumption and viral respiratory infections are positively correlated, particularly in France, where antibiotic overconsumption is well-known. We first determined the period when media coverage was high, and then compared, during this period, observed outpatient antibiotic consumption to estimated outpatient antibiotic consumption "without media attention". Materials and Methods: To evaluate media coverage, two online databases were consulted: Factiva and Europresse. To quantify outpatient antibiotic consumption, we used data on reimbursements of outpatient systemic antibiotics from the computerized databases of the two main National Health Insurance agencies. Influenza-like syndromes data came from the French GPs Sentinelles Network. Weekly time-series of antibiotic consumption were modeled by autoregressive moving-average models with exogenous inputs and interventions. Analyses were computed for the entire series and by age group (0-5, 6-15, 16-60, and >60 years). Results: Media coverage was intense between April 2009 and January 2010. No effect on total outpatient antibiotic consumption was observed during the whole mediatic period. However, during the epidemic in France (September 2009-January 2010), we found an antibiotic underconsumption for the entire series, 0-5 and >60 years. Additionally, at the beginning of the pandemic, when cases were still outside France (June 2009-August 2009), we found an antibiotic overconsumption for patients >16 years. Conclusion: The early period of A(H1N1) virus circulation compared with seasonal influenza or an overdeclaration of ILS cases might explain the antibiotic underconsumption observed during the period of active A(H1N1) virus transmission in France. At the pandemic onset, when uncertainty was high, the overconsumption observed for individuals >16 years might have been caused by alarmist media reporting. Additional analyses are needed to understand the determinants of antibiotic consumption during this period.	[Bernier, Adeline; Ligier, Caroline; Guillemot, Didier; Watier, Laurence] INSERM, U657, Paris, France; [Bernier, Adeline; Ligier, Caroline; Guillemot, Didier; Watier, Laurence] Inst Pasteur, PhEMI, Paris, France; [Bernier, Adeline; Ligier, Caroline; Guillemot, Didier; Watier, Laurence] Univ Versailles St Quentin, Fac Med, Paris, France; [Guillemot, Didier] Hop Raymond Poincare, AP HP, Unite Fonct Sante Publ, Garches, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP	Watier, L (corresponding author), INSERM, U657, Paris, France.	laurence.watier@rpc.aphp.fr	, Watier/K-8213-2013; Guillemot, Didier/AAN-3051-2020	, Watier/0000-0002-4057-1102; Bernier, Adeline/0000-0003-3023-429X; Guillemot, Didier/0000-0002-8497-1765	Inserm; Institut Pasteur; Ecole Normale Superieure; Universite Versailles Saint Quentin	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut Pasteur(European Commission); Ecole Normale Superieure; Universite Versailles Saint Quentin	This work was funded by Inserm, Institut Pasteur, Ecole Normale Superieure, Universite Versailles Saint Quentin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Box G. E. P., 1970, Time series analysis, forecasting and control; BOX GEP, 1975, J AM STAT ASSOC, V70, P70, DOI 10.2307/2285379; Casalegno JS, 2010, CLIN MICROBIOL INFEC, V16, P326, DOI 10.1111/j.1469-0691.2010.03167.x; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P277; de Sande-Bruinsma NV, 2008, EMERG INFECT DIS, V14, P1722, DOI 10.3201/eid1411.070467; degli Atti MLC, 2006, EUR J CLIN PHARMACOL, V62, P1055, DOI 10.1007/s00228-006-0198-8; European Centre for Disease Prevention and Control European Medicines Agency, 2009, BACT CHALL TIM REACT; French GL, 2010, INT J ANTIMICROB AG, V36, pS3, DOI 10.1016/S0924-8579(10)70003-0; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Groupes Regionaux d'Observation de la Grippe, 2009, B SEM; Helfenstein U, 1996, Stat Methods Med Res, V5, P3, DOI 10.1177/096228029600500102; Hulscher MEJL, 2010, INT J MED MICROBIOL, V300, P351, DOI 10.1016/j.ijmm.2010.04.003; Institut de Veille Sanitaire, 2009, DONN SURV PAND A H1N; Keramarou M, 2011, EURO SURVEILL, V16; Low D, 2008, CLIN MICROBIOL INFEC, V14, P298, DOI 10.1111/j.1469-0691.2007.01910.x; Nougairede A, 2010, CLIN MICROBIOL INFEC, V16, P322, DOI 10.1111/j.1469-0691.2010.03168.x; Pavia Andrew T, 2011, Clin Infect Dis, V52 Suppl 4, pS284, DOI 10.1093/cid/cir043; Sabuncu E, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000084; Shumway R.H., 2006, TIME SERIES ANAL ITS; VALLERON AJ, 1986, AM J PUBLIC HEALTH, V76, P1289, DOI 10.2105/AJPH.76.11.1289	20	7	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69075	10.1371/journal.pone.0069075	http://dx.doi.org/10.1371/journal.pone.0069075			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894409	Green Published, Green Submitted, gold			2022-12-27	WOS:000322167900038
J	Montarolo, F; Parolisi, R; Hoxha, E; Boda, E; Tempia, F				Montarolo, Francesca; Parolisi, Roberta; Hoxha, Eriola; Boda, Enrica; Tempia, Filippo			Early Enriched Environment Exposure Protects Spatial Memory and Accelerates Amyloid Plaque Formation in APP(Swe)/PS1(L166P) Mice	PLOS ONE			English	Article							INTRANEURONAL A-BETA; ALZHEIMERS-DISEASE; MOUSE MODEL; COGNITIVE DEFICITS; PHYSICAL-ACTIVITY; IMPROVES COGNITION; TRANSGENIC MICE; DEPOSITION; ONSET; RATS	Enriched environment exposure improves several aspects of cognitive performance in Alzheimer's disease patients and in animal models and, although the role of amyloid plaques is questionable, several studies also assessed their response to enriched environment, with contrasting results. Here we report that rearing APP(Swe)/PS1(L166P) mice in an enriched environment since birth rescued the spatial memory impairment otherwise present at 6 months of age. At the same time, the exposure to the enriched environment caused a transient acceleration of plaque formation, while there was no effect on intracellular staining with the 6E10 antibody, which recognizes beta-amyloid, full length amyloid precursor protein and its C-terminal fragments. The anticipation of plaque formation required exposure during early development, suggesting an action within critical periods for circuits formation. On the other hand, chronic neuronal activity suppression by tetrodotoxin decreased the number of plaques without affecting intracellular amyloid. These results indicate that enriched environment exposure since early life has a protective effect on cognitive deterioration although transiently accelerates amyloid deposition. In addition, the effects of the enriched environment might be due to increased neuronal activity, because plaques were reduced by suppression of electrical signaling by tetrodotoxin.	[Montarolo, Francesca; Parolisi, Roberta; Hoxha, Eriola; Boda, Enrica; Tempia, Filippo] Univ Turin, Inst Cavalieri Ottolenghi NICO, Turin, Italy; [Tempia, Filippo] Univ Turin, Dept Neurosci, Turin, Italy; [Tempia, Filippo] Univ Turin, Natl Inst Neurosci Italy INN, Turin, Italy	University of Turin; University of Turin; University of Turin	Tempia, F (corresponding author), Univ Turin, Inst Cavalieri Ottolenghi NICO, Turin, Italy.	filippo.tempia@unito.it	Montarolo, F/K-3331-2018; Hoxha, Eriola/N-1752-2017; Boda, Enrica/AFM-7909-2022	Montarolo, F/0000-0002-3633-8746; Hoxha, Eriola/0000-0002-4452-889X; Tempia, Filippo/0000-0003-2778-0943; Parolisi, Roberta/0000-0002-1948-7766; BODA, Enrica/0000-0002-1006-2577	Ministero dell'Istruzione, Universita e Ricerca scientifica (PRIN); Fondazione Cassa di Risparmio di Torino (Progetto Alfieri bando)	Ministero dell'Istruzione, Universita e Ricerca scientifica (PRIN); Fondazione Cassa di Risparmio di Torino (Progetto Alfieri bando)	The experiments were supported by grants from: Ministero dell'Istruzione, Universita e Ricerca scientifica (PRIN-2007) and Fondazione Cassa di Risparmio di Torino (Progetto Alfieri bando 2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlard PA, 2005, J NEUROSCI, V25, P4217, DOI 10.1523/JNEUROSCI.0496-05.2005; Ambree O, 2006, AM J PATHOL, V169, P544, DOI 10.2353/ajpath.2006.051107; Arendash GW, 2004, NEUROREPORT, V15, P1751, DOI 10.1097/01.wnr.0000137183.68847.4e; Bennett JC, 2006, NEUROBIOL LEARN MEM, V85, P139, DOI 10.1016/j.nlm.2005.09.003; Berardi N, 2007, J ALZHEIMERS DIS, V11, P359; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Bolmont T, 2008, J NEUROSCI, V28, P4283, DOI 10.1523/JNEUROSCI.4814-07.2008; BONAIUTO S, 1995, NEUROEPIDEMIOLOGY, V14, P101, DOI 10.1159/000109785; Braak H, 1998, J NEURAL TRANSM-SUPP, P97; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Colcombe SJ, 2004, J MOL NEUROSCI, V24, P9, DOI 10.1385/JMN:24:1:009; Costa DA, 2007, NEUROBIOL AGING, V28, P831, DOI 10.1016/j.neurobiolaging.2006.04.009; Cotel MC, 2012, NEUROBIOL AGING, V33, P96, DOI 10.1016/j.neurobiolaging.2010.02.012; Cracchiolo JR, 2007, NEUROBIOL LEARN MEM, V88, P277, DOI 10.1016/j.nlm.2007.07.007; Friedland RP, 2001, P NATL ACAD SCI USA, V98, P3440, DOI 10.1073/pnas.061002998; Frisoni GB, 2007, BRAIN, V130, P720, DOI 10.1093/brain/awl377; GREENOUGH WT, 1973, EXP NEUROL, V40, P491, DOI 10.1016/0014-4886(73)90090-3; Hardy J, 2001, BIOCHEM SOC SYMP, V67, P51; Herring A, 2011, NEUROBIOL DIS, V42, P530, DOI 10.1016/j.nbd.2011.03.007; HOLLOWAY RALPH L., 1966, BRAIN RES, V2, P393, DOI 10.1016/0006-8993(66)90009-6; Jankowsky JL, 2005, J NEUROSCI, V25, P5217, DOI 10.1523/JNEUROSCI.5080-04.2005; Jankowsky JL, 2003, J NEUROPATH EXP NEUR, V62, P1220, DOI 10.1093/jnen/62.12.1220; JORM AF, 1987, ACTA PSYCHIAT SCAND, V76, P465, DOI 10.1111/j.1600-0447.1987.tb02906.x; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Katzman R, 1988, Ann Neurol, V24, P384; Knobloch M, 2007, NEUROBIOL AGING, V28, P1297, DOI 10.1016/j.neurobiolaging.2006.06.019; Koenig J, 2008, HIPPOCAMPUS, V18, P99, DOI 10.1002/hipo.20368; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; Melnikova T, 2013, J NEUROSCI, V33, P3765, DOI 10.1523/JNEUROSCI.4251-12.2013; Mirochnic S, 2009, HIPPOCAMPUS, V19, P1008, DOI 10.1002/hipo.20560; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; ROSEN WG, 1984, AM J PSYCHIAT, V141, P1356; ROSENZWEIG MR, 1964, J COMP PHYSIOL PSYCH, V57, P438, DOI 10.1037/h0046387; Selkoe DJ, 2000, JAMA-J AM MED ASSOC, V283, P1615, DOI 10.1001/jama.283.12.1615; STERN Y, 1994, JAMA-J AM MED ASSOC, V271, P1004, DOI 10.1001/jama.271.13.1004; Tampellini D, 2010, J NEUROSCI, V30, P14299, DOI 10.1523/JNEUROSCI.3383-10.2010; Tampellini D, 2009, J NEUROSCI, V29, P9704, DOI 10.1523/JNEUROSCI.2292-09.2009; Ting JT, 2007, P NATL ACAD SCI USA, V104, P353, DOI 10.1073/pnas.0608807104; Um HS, 2008, INT J MOL MED, V22, P529, DOI 10.3892/ijmm_00000052; WEST RW, 1972, BEHAV BIOL, V7, P279, DOI 10.1016/S0091-6773(72)80207-4; Wilson RS, 2002, NEUROLOGY, V59, P1910, DOI 10.1212/01.WNL.0000036905.59156.A1; Winton MJ, 2011, J NEUROSCI, V31, P7691, DOI 10.1523/JNEUROSCI.6637-10.2011; Wolf SA, 2006, BIOL PSYCHIAT, V60, P1314, DOI 10.1016/j.biopsych.2006.04.004; Wolfe KJ, 2011, SEMIN CELL DEV BIOL, V22, P476, DOI 10.1016/j.semcdb.2011.03.011	46	24	24	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69381	10.1371/journal.pone.0069381	http://dx.doi.org/10.1371/journal.pone.0069381			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894463	Green Published, gold, Green Submitted			2022-12-27	WOS:000322167900060
J	Radulescu, AR; Mujica-Parodi, LR				Radulescu, Anca R.; Mujica-Parodi, Lilianne R.			Human Gender Differences in the Perception of Conspecific Alarm Chemosensory Cues	PLOS ONE			English	Article							ANXIETY; CHEMOSIGNALS; PHEROMONES; AMYGDALA; ODOR; FEAR; SIGNALS; RECOGNITION	It has previously been established that, in threatening situations, animals use alarm pheromones to communicate danger. There is emerging evidence of analogous chemosensory "stress'' cues in humans. For this study, we collected alarm and exercise sweat from "donors,'' extracted it, pooled it and presented it to 16 unrelated "detector'' subjects undergoing fMRI. The fMRI protocol consisted of four stimulus runs, with each combination of stimulus condition and donor gender represented four times. Because olfactory stimuli do not follow the canonical hemodynamic response, we used a model-free approach. We performed minimal preprocessing and worked directly with block-average time series and step-function estimates. We found that, while male stress sweat produced a comparably strong emotional response in both detector genders, female stress sweat produced a markedly stronger arousal in female than in male detectors. Our statistical tests pinpointed this gender-specificity to the right amygdala (strongest in the superficial nuclei). When comparing the olfactory bulb responses to the corresponding stimuli, we found no significant differences between male and female detectors. These imaging results complement existing behavioral evidence, by identifying whether gender differences in response to alarm chemosignals are initiated at the perceptual versus emotional level. Since we found no significant differences in the olfactory bulb (primary processing site for chemosensory signals in mammals), we infer that the specificity in responding to female fear is likely based on processing meaning, rather than strength, of chemosensory cues from each gender.	[Radulescu, Anca R.] Univ Colorado, Dept Math, Boulder, CO 80309 USA; [Mujica-Parodi, Lilianne R.] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA	University of Colorado System; University of Colorado Boulder; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Mujica-Parodi, LR (corresponding author), SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA.	lilianne.strey@stonybrook.edu	Radulescu, Anca/GYR-1316-2022	Mujica-Parodi, Lilianne Rivka/0000-0002-3752-5519; Radulescu, Anca/0000-0002-2681-7233	U.S. Army Soldier Systems Center Natick [DAAD16-99-C-1033]; Office of Naval Research [N0014-04-1-005]; National Institutes of Health (Stony Brook University General Clinical Research Center) [5-MO1-RR-10710]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR010710] Funding Source: NIH RePORTER	U.S. Army Soldier Systems Center Natick; Office of Naval Research(Office of Naval Research); National Institutes of Health (Stony Brook University General Clinical Research Center); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by funding from the U.S. Army Soldier Systems Center Natick DAAD16-99-C-1033 (LRMP), the Office of Naval Research N0014-04-1-005 (LRMP), and the National Institutes of Health 5-MO1-RR-10710 (Stony Brook University General Clinical Research Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerl K, 2002, NEUROENDOCRINOL LETT, V23, P79; Albrecht J, 2011, CHEM SENSES, V36, P19, DOI 10.1093/chemse/bjq087; Ball T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000307; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; Chen D, 2000, PERCEPT MOTOR SKILL, V91, P771, DOI 10.2466/pms.2000.91.3.771; Chen D, 2006, CHEM SENSES, V31, P415, DOI 10.1093/chemse/bjj046; CHRISTIANSEN E, 1976, P 7 VERT PEST C, P11; de Groot JHB, 2012, PSYCHOL SCI, V23, P1417, DOI 10.1177/0956797612445317; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Ferguson JN, 2001, J NEUROSCI, V21, P8278; Graves BM, 2000, J HERPETOL, V34, P287, DOI 10.2307/1565427; Gutierrez-Garcia A, 2013, ANXIETY ADAPTIVE EMO; Haegler K, 2010, NEUROPSYCHOLOGIA, V48, P3901, DOI 10.1016/j.neuropsychologia.2010.09.019; Hauser R, 2011, MED HYPOTHESES, V77, P1062, DOI 10.1016/j.mehy.2011.09.003; Kiyokawa Y, 2006, PHYSIOL BEHAV, V87, P383, DOI 10.1016/j.physbeh.2005.11.003; Kiyokawa Y, 2005, BRAIN RES, V1043, P145, DOI 10.1016/j.brainres.2005.02.061; Kiyokawa Y, 2004, HORM BEHAV, V45, P122, DOI 10.1016/j.yhbeh.2003.09.007; Kobayashi T, 2012, BEHAV BRAIN RES; Krames L, 1969, PSYCHONOMIC SCI; Larsen CM, 2010, VITAM HORM, V83, P137, DOI 10.1016/S0083-6729(10)83005-5; Lastein S, 2006, CHEM SENSES, V31, P69, DOI 10.1093/chemse/bjj007; LICHT G, 1987, EXP BRAIN RES, V69, P7; Lubke KT, 2012, BEHAV BRAIN RES, V228, P375, DOI 10.1016/j.bbr.2011.12.018; Lundstrom JN, 2010, VITAM HORM, V83, P1, DOI 10.1016/S0083-6729(10)83001-8; McClintock M., 1996, FDN ANIMAL BEHAV CLA, V229, P438; McDonald AJ, 1996, NEUROSCIENCE, V71, P55, DOI 10.1016/0306-4522(95)00417-3; Mujica-Parodi LR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006415; Owen P, 1980, OLFACTORY CORRELATES; Pause BM, 2012, CHEMOSENS PERCEPT, V5, P55, DOI 10.1007/s12078-011-9108-2; Pause BM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010342; Pause BM, 2004, CHEM SENSES, V29, P797, DOI 10.1093/chemse/bjh245; Prehn A, 2006, NEUROSCI LETT, V394, P127, DOI 10.1016/j.neulet.2005.10.012; Prehn-Kristensen A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005987; Radulescu A, 2011, HUMAN BRAIN MAPPING; Savic I, 2001, NEURON, V31, P661, DOI 10.1016/S0896-6273(01)00390-7; Tolkunov D, 2010, NEUROIMAGE, V50, P72, DOI 10.1016/j.neuroimage.2009.12.021; Verheggen FJ, 2010, VITAM HORM, V83, P215, DOI 10.1016/S0083-6729(10)83009-2; Winston JS, 2005, J NEUROSCI, V25, P8903, DOI 10.1523/JNEUROSCI.1569-05.2005; Wysocki CJ, 2009, FLAVOUR FRAG J, V24, P209, DOI 10.1002/ffj.1927; Wysocki CJ, 2004, ANAT REC PART A, V281A, P1201, DOI 10.1002/ar.a.20125; Yousem DM, 1999, BRAIN RES, V818, P480, DOI 10.1016/S0006-8993(98)01276-1; Zald DH, 1997, P NATL ACAD SCI USA, V94, P4119, DOI 10.1073/pnas.94.8.4119; Zald DH, 2000, INT J PSYCHOPHYSIOL, V36, P165, DOI 10.1016/S0167-8760(99)00110-5; Zernecke R, 2011, J PSYCHOPHYSIOL, V25, P116, DOI 10.1027/0269-8803/a000047; Zhou W, 2009, PSYCHOL SCI, V20, P177, DOI 10.1111/j.1467-9280.2009.02263.x	45	32	34	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e68485	10.1371/journal.pone.0068485	http://dx.doi.org/10.1371/journal.pone.0068485			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	188BY	23894310	Green Submitted, gold, Green Published			2022-12-27	WOS:000322167900012
J	Zelner, JL; Lopman, BA; Hall, AJ; Ballesteros, S; Grenfell, BT				Zelner, Jonathan L.; Lopman, Benjamin A.; Hall, Aron J.; Ballesteros, Sebastien; Grenfell, Bryan T.			Linking Time-Varying Symptomatology and Intensity of Infectiousness to Patterns of Norovirus Transmission	PLOS ONE			English	Article								Background: Norovirus (NoV) transmission may be impacted by changes in symptom intensity. Sudden onset of vomiting, which may cause an initial period of hyper-infectiousness, often marks the beginning of symptoms. This is often followed by: a 1-3 day period of milder symptoms, environmental contamination following vomiting, and post-symptomatic shedding that may result in transmission at progressively lower rates. Existing models have not included time-varying infectiousness, though representing these features could add utility to models of NoV transmission. Methods: We address this by comparing the fit of three models (Models 1-3) of NoV infection to household transmission data from a 2009 point-source outbreak of GII. 12 norovirus in North Carolina. Model 1 is an SEIR compartmental model, modified to allow Gamma-distributed sojourn times in the latent and infectious classes, where symptomatic cases are uniformly infectious over time. Model 2 assumes infectiousness decays exponentially as a function of time since onset, while Model 3 is discontinuous, with a spike concentrating 50% of transmissibility at onset. We use Bayesian data augmentation techniques to estimate transmission parameters for each model, and compare their goodness of fit using qualitative and quantitative model comparison. We also assess the robustness of our findings to asymptomatic infections. Results: We find that Model 3 (initial spike in shedding) best explains the household transmission data, using both quantitative and qualitative model comparisons. We also show that these results are robust to the presence of asymptomatic infections. Conclusions: Explicitly representing explosive NoV infectiousness at onset should be considered when developing models and interventions to interrupt and prevent outbreaks of norovirus in the community. The methods presented here are generally applicable to the transmission of pathogens that exhibit large variation in transmissibility over an infection.	[Zelner, Jonathan L.; Ballesteros, Sebastien; Grenfell, Bryan T.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Lopman, Benjamin A.; Hall, Aron J.] Ctr Dis Control & Prevent, Epidemiol Branch, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Zelner, Jonathan L.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	Princeton University; Centers for Disease Control & Prevention - USA; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Zelner, JL (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	jzelner@princeton.edu			Fogarty International Center, National Institutes of Health; RAPIDD program of the Science & Technology Directorate, Department of Homeland Security; Bill and Melinda Gates Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD047879] Funding Source: NIH RePORTER	Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); RAPIDD program of the Science & Technology Directorate, Department of Homeland Security(United States Department of Homeland Security (DHS)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	J. Zelner and B. Grenfell were supported by the RAPIDD program of the Science & Technology Directorate, Department of Homeland Security and the Fogarty International Center, National Institutes of Health. B Grenfell and S. Ballesteros were supported by the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Rockx B, 2002, CLIN INFECT DIS, V35, P246, DOI 10.1086/341408; van Beek J, 2013, J HOSP INFECT, V18, DOI DOI 10.1093/CID/CIR144.CHEESBR0UGH	2	17	17	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e68413	10.1371/journal.pone.0068413	http://dx.doi.org/10.1371/journal.pone.0068413			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894302	Green Submitted, Green Published, gold			2022-12-27	WOS:000322167900011
J	Lai, CY; Hsieh, LL; Sung, FC; Tang, RP; Bai, CH; Wu, FY; Chiou, HY; Yeh, CC				Lai, Ching-Yu; Hsieh, Ling-Ling; Sung, Fung-Chang; Tang, Reiping; Bai, Chyi-Huey; Wu, Fang-Yang; Chiou, Hung-Yi; Yeh, Chih-Ching			Tumor Site- and Stage-Specific Associations between Allelic Variants of Glutathione S-Transferase and DNA-Repair Genes and Overall Survival in Colorectal Cancer Patients Receiving 5-Fluorouracil-Based Chemotherapy	PLOS ONE			English	Article							PLATINUM-BASED CHEMOTHERAPY; 1ST-LINE FOLFOX-4 CHEMOTHERAPY; NUCLEOTIDE EXCISION-REPAIR; CELL LUNG-CANCER; THYMIDYLATE SYNTHASE; XPD POLYMORPHISMS; GASTRIC-CANCER; RECTAL-CANCER; RISK; XRCC1	Introduction: Our retrospective cohort study investigated the effect of tumor site and stage on the associations between the allelic variants of glutathione S-transferase (GST) and DNA-repair genes and overall survival (OS) in CRC patients treated with 5-fluorouracil (5-FU)-based adjuvant chemotherapy. Material and Methods: We genotyped GSTM1, GSTT1, GSTP1 Ile105Val, XRCC1 Arg399Gln, XRCC3 Thr241Met, and XPD Lys751Gln in 491 CRC patients between 1995 and 2001. A Cox proportional-hazards model was used to calculate the hazard ratios (HRs) and 95% confidence intervals (CIs) for the relationships between the allelic variants and OS. Survival analyses were performed for each allelic variant by using the log-rank test and Kaplan-Meier analysis. Results: The CRC patients with the XPD Gln allelic variants had poorer survival than patients with the Lys/Lys genotype (HR = 1.38, 95% CI = 1.02-1.87), and rectal cancer patients had the poorest survival among them (HR = 1.87, 95% CI = 1.18-2.95). A significantly shorter OS was observed among stage II/III colon cancer patients with the XRCC1 Gln allelic variants (HR = 1.69, 95% CI = 1.06-2.71), compared to those with XRCC1 Arg/Arg genotype. In the combined analysis of the XRCC1 and XPD genes patients with stage II/III tumors, the poorest OS occurred in colon cancer patients with the XRCC1 Gln and XPD Gln allelic variants (HR = 2.60, 95% CI = 1.19-5.71) and rectal cancer patients with the XRCC1 Arg/Arg and XPD Gln allelic variants (HR = 2.77, 95% CI = 1.25-6.17). Conclusion: The XPD and XRCC1 allelic variants may be prognostic markers for CRC patients receiving 5-FU based chemotherapy. The contributions of the XPD and XRCC1 allelic variants to OS are tumor site-and/or stage-dependent.	[Lai, Ching-Yu; Sung, Fung-Chang; Wu, Fang-Yang; Yeh, Chih-Ching] China Med Univ, Dept Publ Hlth, Coll Publ Hlth, Taichung, Taiwan; [Hsieh, Ling-Ling] Chang Gung Univ, Dept Publ Hlth, Guieshan, Taoyuan County, Taiwan; [Tang, Reiping] Chang Gung Mem Hosp, Colorectal Sect, Guieshan, Taoyuan County, Taiwan; [Bai, Chyi-Huey; Chiou, Hung-Yi; Yeh, Chih-Ching] Taipei Med Univ, Coll Publ Hlth & Nutr, Sch Publ Hlth, Taipei, Taiwan; [Chiou, Hung-Yi] Taipei Med Univ, Ctr Excellence Canc Res, Taipei, Taiwan	China Medical University Taiwan; Chang Gung University; Chang Gung Memorial Hospital; Taipei Medical University; Taipei Medical University	Yeh, CC (corresponding author), China Med Univ, Dept Publ Hlth, Coll Publ Hlth, Taichung, Taiwan.	ccyeh@tmu.edu.tw		Chiou, Hung Yi/0000-0002-4545-9697	Taipei Medical University [TMU98-AE1-B05]; National Science Council, Taiwan [NSC97-2314-B-039-020-MY3, NSC97-2314-B-038-050-MY3]; China Medical University [CMU97-259, CMU97-156]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH102-TD-B-111-004]; Center of Excellence for Cancer Research of the Taiwan Department of Health at Taipei Medical University [DOH101-TD-C-111-008]	Taipei Medical University; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); China Medical University(China Medical University); Taiwan Department of Health Clinical Trial and Research Center of Excellence; Center of Excellence for Cancer Research of the Taiwan Department of Health at Taipei Medical University	The authors' study was supported by grants from Taipei Medical University (TMU98-AE1-B05), the National Science Council, Taiwan (NSC97-2314-B-039-020-MY3 and NSC97-2314-B-038-050-MY3), China Medical University (CMU97-259 and CMU97-156), Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH102-TD-B-111-004), and the Center of Excellence for Cancer Research of the Taiwan Department of Health at Taipei Medical University (DOH101-TD-C-111-008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artac M, 2010, J CANCER RES CLIN, V136, P803, DOI 10.1007/s00432-009-0720-3; Cecchin E, 2011, PHARMACOGENOMICS J, V11, P214, DOI 10.1038/tpj.2010.25; Chen YC, 2010, CANCER SCI, V101, P530, DOI 10.1111/j.1349-7006.2009.01418.x; Chua W, 2009, BRIT J CANCER, V101, P998, DOI 10.1038/sj.bjc.6605239; Duldulao MP, 2013, CANCER-AM CANCER SOC, V119, P1106, DOI 10.1002/cncr.27862; Dybdahl M, 1999, CANCER EPIDEM BIOMAR, V8, P77; Geng LY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028862; Hitomi K, 2007, DNA REPAIR, V6, P410, DOI 10.1016/j.dnarep.2006.10.004; Hu JJ, 2001, CARCINOGENESIS, V22, P917, DOI 10.1093/carcin/22.6.917; Huang MY, 2011, PHARMACOGENET GENOM, V21, P18, DOI 10.1097/FPC.0b013e3283415124; Huang YS, 2009, MUTAGENESIS, V24, P331, DOI 10.1093/mutage/gep013; Lamas MJ, 2012, INT J RADIAT ONCOL, V82, P138, DOI 10.1016/j.ijrobp.2010.09.053; Liu L, 2013, MOL CARCINOGEN, V52, P923, DOI 10.1002/mc.21942; Liu L, 2011, LUNG CANCER, V73, P110, DOI 10.1016/j.lungcan.2010.11.004; Lunn RM, 2000, CARCINOGENESIS, V21, P551, DOI 10.1093/carcin/21.4.551; Mahimkar MB, 2012, MOL CARCINOGEN, V51, pE94, DOI 10.1002/mc.21868; Martinez-Balibrea E, 2008, EUR J CANCER, V44, P1229, DOI 10.1016/j.ejca.2008.03.025; Matullo G, 2001, INT J CANCER, V92, P562, DOI 10.1002/ijc.1228; Matullo G, 2003, CANCER EPIDEM BIOMAR, V12, P674; Melis JPM, 2011, MUTAT RES-REV MUTAT, V728, P107, DOI 10.1016/j.mrrev.2011.07.001; MEYER DJ, 1991, BIOCHEM J, V274, P409, DOI 10.1042/bj2740409; Moore HCF, 1999, SEMIN ONCOL, V26, P545; Moreno V, 2006, CLIN CANCER RES, V12, P2101, DOI 10.1158/1078-0432.CCR-05-1363; Ohrling K, 2008, ANTICANCER RES, V28, P1741; Ott K, 2011, ANN SURG ONCOL, V18, P2688, DOI 10.1245/s10434-011-1601-y; Park DJ, 2001, CANCER RES, V61, P8654; Romero A, 2012, ANN ONCOL, V23, P1750, DOI 10.1093/annonc/mdr483; Rouillon C, 2011, RES MICROBIOL, V162, P19, DOI 10.1016/j.resmic.2010.09.003; Ruzzo A, 2007, CLIN CHEM LAB MED, V45, P822, DOI 10.1515/CCLM.2007.143; Ruzzo A, 2007, J CLIN ONCOL, V25, P1247, DOI 10.1200/JCO.2006.08.1844; Shuck SC, 2008, CELL RES, V18, P64, DOI 10.1038/cr.2008.2; Soong R, 2008, ANN ONCOL, V19, P915, DOI 10.1093/annonc/mdm599; Spitz MR, 2001, CANCER RES, V61, P1354; Stewart Josephine M., 1998, Current Opinion in Oncology, V10, P367, DOI 10.1097/00001622-199807000-00015; Stoehlmacher J, 2002, J NATL CANCER I, V94, P936; Wang Z, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-137; Watson MA, 1998, CARCINOGENESIS, V19, P275, DOI 10.1093/carcin/19.2.275; Wolpin BM, 2007, CA-CANCER J CLIN, V57, P168, DOI 10.3322/canjclin.57.3.168; Yamada Takeshi, 2008, Journal of Nippon Medical School, V75, P23, DOI 10.1272/jnms.75.23; Ye FH, 2013, CANCER CHEMOTH PHARM, V71, P733, DOI 10.1007/s00280-012-2067-8; Yeh CC, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-12; Yeh CC, 2007, J BIOMED SCI, V14, P183, DOI 10.1007/s11373-006-9139-x; Yeh CC, 2005, WORLD J GASTROENTERO, V11, P1473, DOI 10.3748/wjg.v11.i10.1473; Yeh CC, 2010, CARCINOGENESIS, V31, P228, DOI 10.1093/carcin/bgp286	44	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69039	10.1371/journal.pone.0069039	http://dx.doi.org/10.1371/journal.pone.0069039			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894404	Green Submitted, Green Published, gold			2022-12-27	WOS:000325211000069
J	Jakobsen, TH; Hansen, MA; Jensen, PO; Hansen, L; Riber, L; Cockburn, A; Kolpen, M; Hansen, CR; Ridderberg, W; Eickhardt, S; Hansen, M; Kerpedjiev, P; Alhede, M; Qvortrup, K; Burmolle, M; Moser, C; Kuhl, M; Ciofu, O; Givskov, M; Sorensen, SJ; Hoiby, N; Bjarnsholt, T				Jakobsen, Tim Holm; Hansen, Martin Asser; Jensen, Peter Ostrup; Hansen, Lars; Riber, Leise; Cockburn, April; Kolpen, Mette; Hansen, Christine Ronne; Ridderberg, Winnie; Eickhardt, Steffen; Hansen, Marlene; Kerpedjiev, Peter; Alhede, Morten; Qvortrup, Klaus; Burmolle, Mette; Moser, Claus; Kuhl, Michael; Ciofu, Oana; Givskov, Michael; Sorensen, Soren J.; Hoiby, Niels; Bjarnsholt, Thomas			Complete Genome Sequence of the Cystic Fibrosis Pathogen Achromobacter xylosoxidans NH44784-1996 Complies with Important Pathogenic Phenotypes	PLOS ONE			English	Article							METALLO-BETA-LACTAMASE; PSEUDOMONAS-AERUGINOSA; ALCALIGENES-XYLOSOXIDANS; STENOTROPHOMONAS-MALTOPHILIA; ANTIMICROBIAL SUSCEPTIBILITY; POLYMORPHONUCLEAR LEUKOCYTES; STAPHYLOCOCCUS-EPIDERMIDIS; BACTERIAL BIOFILMS; NITRITE REDUCTASE; RESPIRATORY-TRACT	Achromobacter xylosoxidans is an environmental opportunistic pathogen, which infects an increasing number of immunocompromised patients. In this study we combined genomic analysis of a clinical isolated A. xylosoxidans strain with phenotypic investigations of its important pathogenic features. We present a complete assembly of the genome of A. xylosoxidans NH44784-1996, an isolate from a cystic fibrosis patient obtained in 1996. The genome of A. xylosoxidans NH44784-1996 contains approximately 7 million base pairs with 6390 potential protein-coding sequences. We identified several features that render it an opportunistic human pathogen, We found genes involved in anaerobic growth and the pgaABCD operon encoding the biofilm adhesin poly-beta-1,6-N-acetyl-D-glucosamin. Furthermore, the genome contains a range of antibiotic resistance genes coding efflux pump systems and antibiotic modifying enzymes. In vitro studies of A. xylosoxidans NH44784-1996 confirmed the genomic evidence for its ability to form biofilms, anaerobic growth via denitrification, and resistance to a broad range of antibiotics. Our investigation enables further studies of the functionality of important identified genes contributing to the pathogenicity of A. xylosoxidans and thereby improves our understanding and ability to treat this emerging pathogen.	[Jakobsen, Tim Holm; Eickhardt, Steffen; Hansen, Marlene; Kerpedjiev, Peter; Alhede, Morten; Ciofu, Oana; Givskov, Michael; Hoiby, Niels; Bjarnsholt, Thomas] Univ Copenhagen, Costerton Biofilm Ctr, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Hansen, Martin Asser; Hansen, Lars; Riber, Leise; Cockburn, April; Burmolle, Mette; Sorensen, Soren J.] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Jensen, Peter Ostrup; Kolpen, Mette; Alhede, Morten; Moser, Claus; Hoiby, Niels; Bjarnsholt, Thomas] Rigshosp, Dept Clin Microbiol, DK-2100 Copenhagen, Denmark; [Hansen, Christine Ronne] Rigshosp, Dept Pediat, DK-2100 Copenhagen, Denmark; [Ridderberg, Winnie] Aarhus Univ Hosp, Dept Clin Microbiol, DK-8000 Aarhus, Denmark; [Qvortrup, Klaus] Univ Copenhagen, Dept Biomed Sci, CFIM, Copenhagen, Denmark; [Kuhl, Michael] Univ Copenhagen, Dept Biol, Helsingor, Denmark; [Kuhl, Michael; Givskov, Michael] Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore 639798, Singapore	University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Aarhus University; University of Copenhagen; University of Copenhagen; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Bjarnsholt, T (corresponding author), Univ Copenhagen, Costerton Biofilm Ctr, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark.	tbjarnsholt@sund.ku.dk	Burmølle, Mette/L-8002-2014; Moser, Claus Ernst/N-5951-2017; Sørensen, Søren J/J-5015-2014; Bjarnsholt, Thomas/ABD-6178-2021; Moser, Claus Ernst/GPK-5546-2022; Kühl, Michael/A-1977-2009; Sørensen, Søren Johannes/N-2120-2019; Ciofu, Oana/AAE-2413-2020; Jensen, Peter Ostrup/HGD-7725-2022	Burmølle, Mette/0000-0003-1870-632X; Moser, Claus Ernst/0000-0002-7664-8570; Sørensen, Søren J/0000-0001-6227-9906; Moser, Claus Ernst/0000-0002-7664-8570; Kühl, Michael/0000-0002-1792-4790; Sørensen, Søren Johannes/0000-0001-6227-9906; Ciofu, Oana/0000-0001-5648-4858; Hoiby, Niels/0000-0002-1347-725X; Qvortrup, Klaus/0000-0001-8811-0260; Givskov, Michael/0000-0001-5004-8609; Kolpen, Mette/0000-0001-5575-0384; Kerpedjiev, Peter/0000-0002-0454-1803; Jensen, Peter Ostrup/0000-0003-1648-7186; Riber, Leise/0000-0003-4793-6095; Bjarnsholt, Thomas/0000-0002-8003-7414; Jakobsen, Tim Holm/0000-0002-1671-2155	Lundbeck Foundation; Danish Strategic Research Council	Lundbeck Foundation(Lundbeckfonden); Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF))	This work was supported by a grant from the Lundbeck Foundation to TB and by a grant from the Danish Strategic Research Council to MG. CFIM (Core Facility for Integrated Microscopy, The Faculty of Health, University of Copenhagen) is acknowledged for access to SEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aisenberg G, 2004, CANCER-AM CANCER SOC, V101, P2134, DOI 10.1002/cncr.20604; Alhede M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027943; Alhede M, 2009, MICROBIOL-SGM, V155, P3500, DOI 10.1099/mic.0.031443-0; Almuzara M, 2010, INT J ANTIMICROB AG, V35, P68, DOI 10.1016/j.ijantimicag.2009.08.015; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; BACHMANN BJ, 1996, ESCHERICHIA COLI SAL, P2460; Bador J, 2011, ANTIMICROB AGENTS CH, V55, P4912, DOI 10.1128/AAC.00341-11; Bjarnsholt T, 2005, MICROBIOL-SGM, V151, P373, DOI 10.1099/mic.0.27463-0; Bjarnsholt T, 2010, NAT PROTOC, V5, P282, DOI 10.1038/nprot.2009.205; Bjarnsholt T, 2009, PEDIATR PULM, V44, P547, DOI 10.1002/ppul.21011; Burmolle M, 2012, MICROBIAL BIOFILM: CURRENT RESEARCH AND APPLICATIONS, P61; Burmolle M, 2010, FEMS IMMUNOL MED MIC, V59, P324, DOI 10.1111/j.1574-695X.2010.00714.x; Busse HJ, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P675, DOI 10.1007/0-387-30745-1_28; Ceri H, 1999, J CLIN MICROBIOL, V37, P1771, DOI 10.1128/JCM.37.6.1771-1776.1999; Christensen BB, 1999, METHOD ENZYMOL, V310, P20; Cianciotto NP, 2005, TRENDS MICROBIOL, V13, P581, DOI 10.1016/j.tim.2005.09.005; CLARK DJ, 1967, J MOL BIOL, V23, P99, DOI 10.1016/S0022-2836(67)80070-6; Costerton JW, 1999, INT J ANTIMICROB AG, V11, P217, DOI 10.1016/S0924-8579(99)00018-7; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Costerton JW, 2001, TRENDS MICROBIOL, V9, P50, DOI 10.1016/S0966-842X(00)01918-1; COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251; Crossman LC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r74; De Baets F, 2007, J CYST FIBROS, V6, P75, DOI 10.1016/j.jcf.2006.05.011; DECRE D, 1992, J ANTIMICROB CHEMOTH, V30, P769, DOI 10.1093/jac/30.6.769; Dodd FE, 1997, ACTA CRYSTALLOGR D, V53, P406, DOI 10.1107/S0907444997002667; Doi Y, 2008, ANTIMICROB AGENTS CH, V52, P1952, DOI 10.1128/AAC.01463-07; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; FABBRI A, 1987, CHEMIOTERAPIA, V6, P32; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; GLUPCZYNSKI Y, 1988, ANTIMICROB AGENTS CH, V32, P276, DOI 10.1128/AAC.32.2.276; GODDEN JW, 1991, SCIENCE, V253, P438, DOI 10.1126/science.1862344; Gomez-Cerezo J, 2003, EUR J CLIN MICROBIOL, V22, P360, DOI 10.1007/s10096-003-0925-3; Hansen CR, 2010, J CYST FIBROS, V9, P51, DOI 10.1016/j.jcf.2009.10.005; Hansen CR, 2006, J CYST FIBROS, V5, P245, DOI 10.1016/j.jcf.2006.04.002; Hayes CS, 2010, ANNU REV GENET, V44, P71, DOI 10.1146/annurev.genet.42.110807.091449; HOIBY N, 1977, SCAND J RESPIR DIS, V58, P65; Holden MTG, 2009, J BACTERIOL, V191, P261, DOI 10.1128/JB.01230-08; IGRASIEGMAN Y, 1980, J CLIN MICROBIOL, V11, P141, DOI 10.1128/JCM.11.2.141-145.1980; Iyobe S, 2002, ANTIMICROB AGENTS CH, V46, P2014, DOI 10.1128/AAC.46.6.2014-2016.2002; Jensen PO, 2007, MICROBIOL-SGM, V153, P1329, DOI 10.1099/mic.0.2006/003863-0; KALDORF M, 1993, ARCH MICROBIOL, V160, P432, DOI 10.1007/BF00245303; Kanellopoulou M, 2004, EUR J CLIN MICROBIOL, V23, P336, DOI 10.1007/s10096-004-1105-9; Kay SE, 2001, J CLIN MICROBIOL, V39, P808, DOI 10.1128/JCM.39.2.808-810.2001; KLINGER JD, 1985, DIAGN MICR INFEC DIS, V3, P149, DOI 10.1016/0732-8893(85)90025-2; Kolpen M, 2010, THORAX, V65, P57, DOI 10.1136/thx.2009.114512; Kostakioti M, 2005, J BACTERIOL, V187, P4306, DOI 10.1128/JB.187.13.4306-4314.2005; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Lin J, 2002, ANTIMICROB AGENTS CH, V46, P2124, DOI 10.1128/AAC.46.7.2124-2131.2002; Liu LX, 2002, J CLIN MICROBIOL, V40, P1210, DOI 10.1128/JCM.40.4.1210-1213.2002; LIU Y, 1993, MOL PLANT MICROBE IN, V6, P299, DOI 10.1094/MPMI-6-299; Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; MARTIN P, 1988, MOL MICROBIOL, V2, P615, DOI 10.1111/j.1365-2958.1988.tb00070.x; McKenney D, 1998, INFECT IMMUN, V66, P4711, DOI 10.1128/IAI.66.10.4711-4720.1998; Neuwirth C, 2006, EMERG INFECT DIS, V12, P1737, DOI 10.3201/eid1211.060143; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; OJENIYI B, 1991, APMIS, V99, P492, DOI 10.1111/j.1699-0463.1991.tb05181.x; Ojeniyi B, 2000, PEDIATR PULM, V29, P177, DOI 10.1002/(SICI)1099-0496(200003)29:3<177::AID-PPUL4>3.0.CO;2-U; OTOOLE GA, 1998, MOL MICROBIOL, V30, P295, DOI [10.1046/j.1365-2958.1998.01062.x, DOI 10.1046/J.1365-2958.1998.01062.X]; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; PEEL MM, 1988, J CLIN MICROBIOL, V26, P1580, DOI 10.1128/JCM.26.8.1580-1581.1988; Peltroche-Llacsahuanga H, 1998, EUR J CLIN MICROBIOL, V17, P132, DOI 10.1007/s100960050034; Philippon LN, 1997, ANTIMICROB AGENTS CH, V41, P2188, DOI 10.1128/AAC.41.10.2188; PIEN FD, 1978, J CLIN MICROBIOL, V7, P239; Poole K, 2005, J ANTIMICROB CHEMOTH, V56, P20, DOI 10.1093/jac/dki171; Poole K, 2005, ANTIMICROB AGENTS CH, V49, P479, DOI 10.1128/AAC.49.2.479-487.2005; Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; QVORTRUP K, 1995, ANN OTO RHINOL LARYN, V104, P120, DOI 10.1177/000348949510400207; Raso T, 2008, APMIS, V116, P837, DOI 10.1111/j.1600-0463.2008.00995.x; Ridderberg W, 2012, J CLIN MICROBIOL, V50, P2688, DOI 10.1128/JCM.00728-12; Rudkjobing VB, 2011, J CLIN MICROBIOL, V49, P4352, DOI 10.1128/JCM.06092-11; Saiman L, 2001, J CLIN MICROBIOL, V39, P3942, DOI 10.1128/JCM.39.11.3942-3945.2001; Schnappinger D, 1996, ARCH MICROBIOL, V165, P359, DOI 10.1007/s002030050339; Schobert M, 2010, INT J MED MICROBIOL, V300, P549, DOI 10.1016/j.ijmm.2010.08.007; Shin KS, 2005, DIAGN MICR INFEC DIS, V53, P215, DOI 10.1016/j.diagmicrobio.2005.06.018; Sofianou D, 2005, EUR J CLIN MICROBIOL, V24, P854, DOI 10.1007/s10096-005-0054-2; Spilker T, 2012, J CLIN MICROBIOL, V50, P3010, DOI 10.1128/JCM.00814-12; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Stothard P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/bioinformatics/bti054; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Strnad H, 2011, J BACTERIOL, V193, P791, DOI 10.1128/JB.01299-10; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan K, 2002, PEDIATR PULM, V34, P101, DOI 10.1002/ppul.10143; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Tunney MM, 2008, AM J RESP CRIT CARE, V177, P995, DOI 10.1164/rccm.200708-1151OC; Turton JF, 2011, DIAGN MICR INFEC DIS, V70, P408, DOI 10.1016/j.diagmicrobio.2011.02.007; Van Daele S, 2005, J CLIN MICROBIOL, V43, P2998, DOI 10.1128/JCM.43.6.2998-3002.2005; Van Gennip M, 2009, APMIS, V117, P537, DOI 10.1111/j.1600-0463.2009.02466.x; VuThien H, 1996, EUR J CLIN MICROBIOL, V15, P876, DOI 10.1007/BF01691221; Wang X, 2004, J BACTERIOL, V186, P2724, DOI 10.1128/JB.186.9.2724-2734.2004; WILLIAMS RJ, 1984, J MED MICROBIOL, V17, P283, DOI 10.1099/00222615-17-3-283; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Yabuuchi E, 1973, Rinsho Byori, V21, P102; Yoon SS, 2002, DEV CELL, V3, P593, DOI 10.1016/S1534-5807(02)00295-2	96	62	63	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e68484	10.1371/journal.pone.0068484	http://dx.doi.org/10.1371/journal.pone.0068484			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894309	Green Published, gold			2022-12-27	WOS:000322132100019
J	Fioramonti, X; Deak, A; Deshpande, S; Carneiro, L; Zhou, CX; Sayed, N; Orban, B; Berlin, JR; Penicaud, L; Leloup, C; Beuve, A; Routh, VH				Fioramonti, Xavier; Deak, Adam; Deshpande, Srinidhi; Carneiro, Lionel; Zhou, Chunxue; Sayed, Nazish; Orban, Branly; Berlin, Joshua R.; Penicaud, Luc; Leloup, Corinne; Beuve, Annie; Routh, Vanessa H.			Hypothalamic S-Nitrosylation Contributes to the Counter-Regulatory Response Impairment following Recurrent Hypoglycemia	PLOS ONE			English	Article							GLUCOSE-INHIBITED NEURONS; SOLUBLE GUANYLYL CYCLASE; NITRIC-OXIDE; VENTROMEDIAL HYPOTHALAMUS; N-ACETYLCYSTEINE; INSULIN-RESISTANCE; COUNTERREGULATION; NUCLEUS; RATS; DESENSITIZATION	Aims: Hypoglycemia is a severe side effect of intensive insulin therapy. Recurrent hypoglycemia (RH) impairs the counter-regulatory response (CRR) which restores euglycemia. During hypoglycemia, ventromedial hypothalamus (VMH) production of nitric oxide (NO) and activation of its receptor soluble guanylyl cyclase (sGC) are critical for the CRR. Hypoglycemia also increases brain reactive oxygen species (ROS) production. NO production in the presence of ROS causes protein S-nitrosylation. S-nitrosylation of sGC impairs its function and induces desensitization to NO. We hypothesized that during hypoglycemia, the interaction between NO and ROS increases VMH sGC S-nitrosylation levels and impairs the CRR to subsequent episodes of hypoglycemia. VMH ROS production and S-nitrosylation were quantified following three consecutive daily episodes of insulin-hypoglycemia (RH model). The CRR was evaluated in rats in response to acute insulin-induced hypoglycemia or via hypoglycemic-hyperinsulinemic clamps. Pretreatment with the anti-oxidant N-acetyl-cysteine (NAC) was used to prevent increased VMH S-nitrosylation. Results: Acute insulin-hypoglycemia increased VMH ROS levels by 49 +/- 6.3%. RH increased VMH sGC S-nitrosylation. Increasing VMH S-nitrosylation with intracerebroventricular injection of the nitrosylating agent S-nitroso-L-cysteine (CSNO) was associated with decreased glucagon secretion during hypoglycemic clamp. Finally, in RH rats pre-treated with NAC (0.5% in drinking water for 9 days) hypoglycemia-induced VMH ROS production was prevented and glucagon and epinephrine production was not blunted in response to subsequent insulin-hypoglycemia. Conclusion: These data suggest that NAC may be clinically useful in preventing impaired CRR in patients undergoing intensive-insulin therapy.	[Fioramonti, Xavier; Deak, Adam; Deshpande, Srinidhi; Zhou, Chunxue; Sayed, Nazish; Orban, Branly; Berlin, Joshua R.; Beuve, Annie; Routh, Vanessa H.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07103 USA; [Fioramonti, Xavier; Carneiro, Lionel; Penicaud, Luc; Leloup, Corinne] Univ Bourgogne, INRA 1324, CNRS, Ctr Taste & Feeding Behav CSGA,UMR 6265, Dijon, France	Rutgers State University New Brunswick; Rutgers State University Medical Center; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne	Routh, VH (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, 185 S Orange Ave, Newark, NJ 07103 USA.	routhvh@umdnj.edu	Carneiro, Lionel/AAE-9251-2020; leloup, corinne/T-3769-2017	Carneiro, Lionel/0000-0001-8493-4879; leloup, corinne/0000-0003-0900-4991; Fioramonti, Xavier/0000-0003-1713-4817; Sayed, Nazish/0000-0002-8229-721X	Juvenile Diabetes Research Foundation (JDRF); National Health Institute [1RO1DK64566, 1RO1DK81358, 5RO1-GM067640, 1F31DK86681]; Alfred P. Sloan Foundation; F.M. Kirby Foundation; European Commission [PCIG-GA-2011-293738 NeuROSens]; Agence Nationale de la Recherche [ANR-06-PHYSIO-Oox]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL098049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064566, R01DK081538, R01DK081358, F31DK086681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067640] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); National Health Institute; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); F.M. Kirby Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); Agence Nationale de la Recherche(French National Research Agency (ANR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Juvenile Diabetes Research Foundation (JDRF) (XF, VHR and AD) and the National Health Institute (VHR: 1RO1DK64566 and 1RO1DK81358; AB: 5RO1-GM067640; BO: 1F31DK86681). BO was also supported by the Alfred P. Sloan Foundation. AB was also supported by the F.M. Kirby Foundation. XF was also supported by the European Commission (PCIG-GA-2011-293738 NeuROSens). CL and LP were supported by the Agence Nationale de la Recherche (ANR-06-PHYSIO-Oox, "Meta-DisMitoDyn"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS J, 1991, AM J MED, V91, pS106, DOI 10.1016/0002-9343(91)90292-6; AMIEL SA, 1987, NEW ENGL J MED, V316, P1376, DOI 10.1056/NEJM198705283162205; Barglow KT, 2011, P NATL ACAD SCI USA, V108, pE600, DOI 10.1073/pnas.1110736108; Borg MA, 1997, J CLIN INVEST, V99, P361, DOI 10.1172/JCI119165; BORG WP, 1994, J CLIN INVEST, V93, P1677, DOI 10.1172/JCI117150; BORG WP, 1995, DIABETES, V44, P180, DOI 10.2337/diabetes.44.2.180; Canabal DD, 2007, AM J PHYSIOL-REG I, V292, pR1418, DOI 10.1152/ajpregu.00216.2006; Carneiro L, 2012, ANTIOXID REDOX SIGN, V17, P433, DOI 10.1089/ars.2011.4254; Cooper CE, 2003, IUBMB LIFE, V55, P591, DOI 10.1080/15216540310001628663; CRYER PE, 1981, DIABETES, V30, P261, DOI 10.2337/diab.30.3.261; Cryer PE, 2008, DIABETES, V57, P3169, DOI 10.2337/db08-1084; DEGROOTE J, 1995, ACTA GASTRO-ENT BELG, V58, P326; DEVRIES N, 1993, J CELL BIOCHEM, P270; Fioramonti X, 2007, DIABETES, V56, P1219, DOI 10.2337/db06-0567; Fioramonti X, 2011, ANTIOXID REDOX SIGN, V14, P505, DOI 10.1089/ars.2010.3331; Fioramonti X, 2010, DIABETES, V59, P519, DOI 10.2337/db09-0421; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jaillard T, 2009, DIABETES, V58, P1544, DOI 10.2337/db08-1039; Kamboj SS, 2008, METAB BRAIN DIS, V23, P427, DOI 10.1007/s11011-008-9104-7; McCrimmon RJ, 2006, J CLIN INVEST, V116, P1723, DOI 10.1172/JCI27775; Monteiro HP, 2008, ANTIOXID REDOX SIGN, V10, P843, DOI 10.1089/ars.2007.1853; Murphy BA, 2009, AM J PHYSL CELL PHYS; Ridnour LA, 2004, BIOL CHEM, V385, P1, DOI 10.1515/BC.2004.001; Routh VH, 2002, PHYSIOL BEHAV, V76, P403, DOI 10.1016/S0031-9384(02)00761-8; Saberi M, 2008, DIABETES, V57, P1380, DOI 10.2337/db07-1528; Sayed N, 2008, CIRC RES, V103, P606, DOI 10.1161/CIRCRESAHA.108.175133; Sayed N, 2007, P NATL ACAD SCI USA, V104, P12312, DOI 10.1073/pnas.0703944104; Shinozaki S, 2011, J BIOL CHEM, V286, P34959, DOI 10.1074/jbc.M110.187666; Singh P, 2004, MOL CELL BIOCHEM, V260, P153, DOI 10.1023/B:MCBI.0000026067.08356.13; Song DZ, 2005, EUR J PHARMACOL, V508, P205, DOI 10.1016/j.ejphar.2004.12.018; Song Z, 2005, DIABETES, V54, P15, DOI 10.2337/diabetes.54.1.15; Song ZT, 2006, AM J PHYSIOL-REG I, V291, pR1283, DOI 10.1152/ajpregu.00148.2006; Song ZT, 2001, DIABETES, V50, P2673, DOI 10.2337/diabetes.50.12.2673; Stamler JS, 2010, NAT CELL BIOL, V12, P1024, DOI 10.1038/ncb1110-1024; Stamler JS, 2004, CIRC RES, V94, P414, DOI 10.1161/01.RES.0000122071.55721.BC; Suh SW, 2008, J CEREBR BLOOD F MET, V28, P1697, DOI 10.1038/jcbfm.2008.61; Szabados E, 1999, FREE RADICAL BIO MED, V26, P309, DOI 10.1016/S0891-5849(98)00199-3; Wang R, 2001, ABSTR SOC NEUROSCI, V31, P947; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001	40	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e68709	10.1371/journal.pone.0068709	http://dx.doi.org/10.1371/journal.pone.0068709			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894333	Green Published, gold			2022-12-27	WOS:000322391400021
J	Li, HY; Liang, YX; Chiu, K; Yuan, QJ; Lin, B; Chang, RCC; So, KF				Li, Hongying; Liang, Yuxiang; Chiu, Kin; Yuan, Qiuju; Lin, Bin; Chang, Raymond Chuen-Chung; So, Kwok-Fai			Lycium Barbarum (Wolfberry) Reduces Secondary Degeneration and Oxidative Stress, and Inhibits JNK Pathway in Retina after Partial Optic Nerve Transection	PLOS ONE			English	Article							GANGLION-CELL DEATH; AMYLOID PEPTIDE NEUROTOXICITY; FACTOR MESSENGER-RNA; NEUROTROPHIC FACTOR; OCULAR HYPERTENSION; IN-VIVO; NEURONS; INJURY; MODEL; APOPTOSIS	Our group has shown that the polysaccharides extracted from Lycium barbarum (LBP) are neuroprotective for retinal ganglion cells (RGCs) in different animal models. Protecting RGCs from secondary degeneration is a promising direction for therapy in glaucoma management. The complete optic nerve transection (CONT) model can be used to study primary degeneration of RGCs, while the partial optic nerve transection (PONT) model can be used to study secondary degeneration of RGCs because primary degeneration of RGCs and secondary degeneration can be separated in location in the same retina in this model; in other situations, these types of degeneration can be difficult to distinguish. In order to examine which kind of degeneration LBP could delay, both CONT and PONT models were used in this study. Rats were fed with LBP or vehicle daily from 7 days before surgery until sacrifice at different time-points and the surviving numbers of RGCs were evaluated. The expression of several proteins related to inflammation, oxidative stress, and the c-jun N-terminal kinase (JNK) pathways were detected with Western-blot analysis. LBP did not delay primary degeneration of RGCs after either CONT or PONT, but it did delay secondary degeneration of RGCs after PONT. We found that LBP appeared to exert these protective effects by inhibiting oxidative stress and the JNK/c-jun pathway and by transiently increasing production of insulin-like growth factor-1 (IGF-1). This study suggests that LBP can delay secondary degeneration of RGCs and this effect may be linked to inhibition of oxidative stress and the JNK/c-jun pathway in the retina.	[Li, Hongying; Liang, Yuxiang; Chiu, Kin; Yuan, Qiuju; Lin, Bin; Chang, Raymond Chuen-Chung; So, Kwok-Fai] Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Li, Hongying; Liang, Yuxiang; Chiu, Kin; Yuan, Qiuju; Lin, Bin; Chang, Raymond Chuen-Chung; So, Kwok-Fai] Univ Hong Kong, Li Ka Shing Fac Med, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China; [Chang, Raymond Chuen-Chung; So, Kwok-Fai] Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Heart Brain Hormone & Hlth Aging, Hong Kong, Hong Kong, Peoples R China; [So, Kwok-Fai] Jinan Univ, GMH Inst Cent Nervous Syst Regenerat, Guangzhou, Guangdong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; Jinan University	So, KF (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Hong Kong, Hong Kong, Peoples R China.	hrmaskf@hkucc.hku.hk	Li, Hong-Ying/AAH-2462-2019; Li, Hongying/AAU-2379-2021; Chiu, Kin/ABI-7938-2020; Chang, Raymond Chuen-Chung/C-1107-2009; Li, Hongying/Q-1909-2016; Li, Hong-Ying/C-5762-2014; Yuan, Qiuju/AAJ-3101-2020; Lin, Bin/E-9871-2010	Li, Hong-Ying/0000-0002-1109-0799; Chiu, Kin/0000-0001-6581-9007; Chang, Raymond Chuen-Chung/0000-0001-8538-7993; Li, Hongying/0000-0002-1109-0799; Li, Hong-Ying/0000-0002-1109-0799; So, Kwok-Fai/0000-0003-4039-4246; Lin, Bin/0000-0003-1309-3480	Research Grants Council of the Hong Kong Special Administrative Region, China [HKU 10208849]; Fundamental Research Funds for The Central Universities [21609101]; Azalea (1972) Foundation	Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); Fundamental Research Funds for The Central Universities(Fundamental Research Funds for the Central Universities); Azalea (1972) Foundation	The work described in this paper was substantially supported by a grant from the Research Grants Council of the Hong Kong Special Administrative Region, China (HKU 10208849). In addition, this work was partially supported by the Fundamental Research Funds for The Central Universities Grant 21609101 and the Azalea (1972) Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicheng W, 2002, GOU QI; Chan HC, 2007, EXP NEUROL, V203, P269, DOI 10.1016/j.expneurol.2006.05.031; Cheng D, 2011, MOLECULES, V16, P2542, DOI 10.3390/molecules16032542; Chiu K, 2008, J VIS EXP; COHENCORY S, 1994, NEURON, V12, P747, DOI 10.1016/0896-6273(94)90328-X; Cui BK, 2011, MOLECULES, V16, P9116, DOI 10.3390/molecules16119116; Degterev A, 2008, NAT REV MOL CELL BIO, V9, P378, DOI 10.1038/nrm2393; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Fitzgerald M, 2010, J NEUROTRAUM, V27, P2107, DOI 10.1089/neu.2010.1426; Fitzgerald M, 2010, J NEUROTRAUM, V27, P439, DOI 10.1089/neu.2009.1112; Fitzgerald M, 2009, INVEST OPHTH VIS SCI, V50, P5456, DOI 10.1167/iovs.09-3717; Fitzgerald M, 2009, EXP NEUROL, V216, P219, DOI 10.1016/j.expneurol.2008.11.026; Fu QL, 2009, NEUROSCIENCE, V162, P375, DOI 10.1016/j.neuroscience.2009.04.075; Fu QL, 2008, INVEST OPHTH VIS SCI, V49, P975, DOI 10.1167/iovs.07-1199; Gao H, 1997, INVEST OPHTH VIS SCI, V38, P1840; GODEMENT P, 1987, DEVELOPMENT, V101, P697; GRASLKRAUPP B, 1995, HEPATOLOGY, V21, P1465, DOI 10.1016/0270-9139(95)90071-3; Hajali M, 2009, DOC OPHTHALMOL, V118, P233, DOI 10.1007/s10633-008-9151-8; Ho YS, 2009, CELL MOL NEUROBIOL, V29, P1233, DOI 10.1007/s10571-009-9419-x; HOFER M, 1990, EMBO J, V9, P2459, DOI 10.1002/j.1460-2075.1990.tb07423.x; Homma K, 2007, NEUROCHEM INT, V50, P741, DOI 10.1016/j.neuint.2007.01.011; Lee JJ, 2012, MOL VIS, V18, P838; Levkovitch-Verbin H, 2001, INVEST OPHTH VIS SCI, V42, P975; Levkovitch-Verbin H, 2003, INVEST OPHTH VIS SCI, V44, P3388, DOI 10.1167/iovs.02-0646; Levkovitch-Verbin H, 2011, GRAEF ARCH CLIN EXP, V249, P849, DOI 10.1007/s00417-010-1608-2; Li SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016380; Liu Y, 2012, FREE RADICAL BIO MED, V52, P909, DOI 10.1016/j.freeradbiomed.2011.12.013; Mi XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045469; Mura M, 2007, ARCH OPHTHALMOL-CHIC, V125, P1107, DOI 10.1001/archopht.125.8.1107; Nakatani M, 2011, EXP EYE RES, V93, P873, DOI 10.1016/j.exer.2011.09.024; Ogata-Iwao M, 2011, INVEST OPHTH VIS SCI, V52, P6671, DOI 10.1167/iovs.11-7559; Prilloff S, 2012, INVEST OPHTH VIS SCI, V53, P1460, DOI 10.1167/iovs.11-8306; QUIGLEY HA, 1995, INVEST OPHTH VIS SCI, V36, P774; Swanson KI, 2005, INVEST OPHTH VIS SCI, V46, P3737, DOI 10.1167/iovs.05-0155; Tan MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032330; Tzekov RT, 2003, INVEST OPHTH VIS SCI, V44, P3993, DOI 10.1167/iovs.02-1104; Vander S, 2012, CURR EYE RES, V37, P740, DOI 10.3109/02713683.2012.673679; VIDALSANZ M, 1988, EXP NEUROL, V102, P92, DOI 10.1016/0014-4886(88)90081-7; Vincent A, 2011, MOL VIS, V17, P3262; Wells J, 2012, J NEUROSCI RES, V90, P606, DOI 10.1002/jnr.22784; WETMORE C, 1990, EXP NEUROL, V109, P141, DOI 10.1016/0014-4886(90)90068-4; Yoles E, 1998, EXP NEUROL, V153, P1, DOI 10.1006/exnr.1998.6811; Yu MS, 2006, NEUROSIGNALS, V15, P145; Yu MS, 2007, INT J MOL MED, V20, P261; Yu MS, 2005, EXP GERONTOL, V40, P716, DOI 10.1016/j.exger.2005.06.010	45	52	55	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e68881	10.1371/journal.pone.0068881	http://dx.doi.org/10.1371/journal.pone.0068881			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894366	Green Submitted, Green Published, gold			2022-12-27	WOS:000322391400029
J	Rossner, P; Mrhalkova, A; Uhlirova, K; Spatova, M; Rossnerova, A; Libalova, H; Schmuczerova, J; Milcova, A; Topinka, J; Sram, RJ				Rossner, Pavel, Jr.; Mrhalkova, Andrea; Uhlirova, Katerina; Spatova, Milada; Rossnerova, Andrea; Libalova, Helena; Schmuczerova, Jana; Milcova, Alena; Topinka, Jan; Sram, Radim J.			Nucleotide Excision Repair Is Not Induced in Human Embryonic Lung Fibroblasts Treated with Environmental Pollutants	PLOS ONE			English	Article							DNA-DAMAGE; PARTICULATE MATTER; IN-VITRO; AROMATIC-HYDROCARBONS; ORGANIC EXTRACTS; OXIDATIVE DAMAGE; GENE-EXPRESSION; AIR PARTICLES; HUMAN-CELLS; ADDUCTS	The cellular response to genotoxic treatment depends on the cell line used. Although tumor cell lines are widely used for genotoxicity tests, the interpretation of the results may be potentially hampered by changes in cellular processes caused by malignant transformation. In our study we used normal human embryonic lung fibroblasts (HEL12469 cells) and tested their response to treatment with benzo[a]pyrene (B[a]P) and extractable organic matter (EOM) from ambient air particles < 2.5 mu m (PM2.5) collected in two Czech cities differing in levels and sources of air pollution. We analyzed multiple endpoints associated with exposure to polycyclic aromatic hydrocarbons (PAHs) including the levels of bulky DNA adducts and the nucleotide excision repair (NER) response [expression of XPE, XPC and XPA genes on the level of mRNA and proteins, unscheduled DNA synthesis (UDS)]. EOMs were collected in the winter and summer of 2011 in two Czech cities with different levels and sources of air pollution. The effects of the studied compounds were analyzed in the presence (+S9) and absence (-S9) of the rat liver microsomal S9 fraction. The levels of bulky DNA adducts were highest after treatment with B[a]P, followed by winter EOMs; their induction by summer EOMs was weak. The induction of both mRNA and protein expression was observed, with the most pronounced effects after treatment with B[a]P (-S9); the response induced by EOMs from both cities and seasons was substantially weaker. The expression of DNA repair genes was not accompanied by the induction of UDS activity. In summary, our results indicate that the tested compounds induced low levels of DNA damage and affected the expression of NER genes; however, nucleotide excision repair was not induced.	[Rossner, Pavel, Jr.; Mrhalkova, Andrea; Uhlirova, Katerina; Spatova, Milada; Rossnerova, Andrea; Libalova, Helena; Schmuczerova, Jana; Milcova, Alena; Topinka, Jan; Sram, Radim J.] Inst Expt Med AS CR, Dept Genet Ecotoxicol, Prague, Czech Republic; [Uhlirova, Katerina] Biol Ctr AS CR, Inst Plant Mol Biol, Ceske Budejovice, Czech Republic	Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Rossner, P (corresponding author), Inst Expt Med AS CR, Dept Genet Ecotoxicol, Prague, Czech Republic.	prossner@biomed.cas.cz	Sram, Radim J/H-2455-2014; Rossnerova, Andrea/AAI-4471-2021; Topinka, Jan/H-2551-2014; Rossner, Pavel/AAI-5789-2020; Sram, Radim/S-9574-2019; Rossnerova, Andrea/H-2591-2014; Rossnerova, Andrea/AAQ-8369-2021; Schmuczerova, Jana/H-2587-2014; Rossner, Pavel/H-2569-2014	Sram, Radim J/0000-0003-4256-3816; Topinka, Jan/0000-0001-6860-7253; Rossner, Pavel/0000-0001-6921-5446; Sram, Radim/0000-0002-2500-4572; Rossnerova, Andrea/0000-0001-8576-6950; Rossner, Pavel/0000-0001-6921-5446; Hrustincova, Andrea/0000-0002-3310-5824	Grant Agency of the Czech Republic [P503/11/0084]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	The study was supported by the Grant Agency of the Czech Republic (P503/11/0084) (http://www.gacr.cz/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimoolam S, 2003, DNA REPAIR, V2, P947, DOI 10.1016/S1568-7864(03)00087-9; Baird WM, 2005, ENVIRON MOL MUTAGEN, V45, P106, DOI 10.1002/em.20095; Binkova B, 2004, MUTAT RES-FUND MOL M, V547, P109, DOI 10.1016/j.mrfmmm.2003.12.006; Binkova B, 2000, MUTAT RES-GEN TOX EN, V471, P57, DOI 10.1016/S1383-5718(00)00111-X; Binkova B, 2007, MUTAT RES-FUND MOL M, V620, P49, DOI 10.1016/j.mrfmmm.2007.02.022; Brockmann R, 2007, PLOS COMPUT BIOL, V3, P531, DOI 10.1371/journal.pcbi.0030057; Chen JK, 2000, CHEMOSPHERE, V41, P139, DOI 10.1016/S0045-6535(99)00401-4; Croteau DL, 2008, DNA REPAIR, V7, P819, DOI 10.1016/j.dnarep.2008.01.018; Feng ZH, 2004, P NATL ACAD SCI USA, V101, P8598, DOI 10.1073/pnas.0402794101; Feng ZH, 2006, MUTAT RES-FUND MOL M, V601, P125, DOI 10.1016/j.mrfmmm.2006.06.003; Hanzalova K, 2010, MUTAT RES-GEN TOX EN, V696, P114, DOI 10.1016/j.mrgentox.2009.12.018; HARGROVE JL, 1991, BIOESSAYS, V13, P667, DOI 10.1002/bies.950131209; Harrison RM, 2004, OCCUP ENVIRON MED, V61, P799, DOI 10.1136/oem.2003.010504; IARC, 2012, ARSENIC METALS FIBRE, V100C; Lagerwerf S, 2011, DNA REPAIR, V10, P743, DOI 10.1016/j.dnarep.2011.04.024; Libalova H, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-1; Limsirichaikul S, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp023; Luijsterburg MS, 2007, J CELL SCI, V120, P2706, DOI 10.1242/jcs.008367; MICHALOPOULOS G, 1978, CANCER RES, V38, P1866; PAYNE A, 1994, MUTAT RES-FUND MOL M, V310, P89, DOI 10.1016/0027-5107(94)90012-4; Pelucchi C, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-453; Phillips DH, 1999, MUTAGENESIS, V14, P301, DOI 10.1093/mutage/14.3.301; REDDY MV, 1986, CARCINOGENESIS, V7, P1543, DOI 10.1093/carcin/7.9.1543; Rossner P, 2003, MUTAT RES-GEN TOX EN, V542, P105, DOI 10.1016/j.mrgentox.2003.09.005; Rossner P, 2002, MUTAT RES-GEN TOX EN, V517, P239, DOI 10.1016/S1383-5718(02)00081-5; Rossner P, 2011, MUTAT RES-FUND MOL M, V713, P76, DOI 10.1016/j.mrfmmm.2011.06.001; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Schlesinger RB, 2007, INHAL TOXICOL, V19, P811, DOI 10.1080/08958370701402382; Sevastyanova O, 2007, MUTAT RES-FUND MOL M, V620, P123, DOI 10.1016/j.mrfmmm.2007.03.002; Shell SM, 2008, ADV EXP MED BIOL, V637, P103; Sugasawa K, 2010, MUTAT RES-FUND MOL M, V685, P29, DOI 10.1016/j.mrfmmm.2009.08.004; Valavanidis A, 2008, J ENVIRON SCI HEAL C, V26, P339, DOI 10.1080/10590500802494538; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Wittschieben BO, 2005, J BIOL CHEM, V280, P39982, DOI 10.1074/jbc.M507854200; Xue WL, 2005, TOXICOL APPL PHARM, V206, P73, DOI 10.1016/j.taap.2004.11.006; Yang J, 2007, TOXICOL LETT, V174, P10, DOI 10.1016/j.toxlet.2007.08.004; Zhao XS, 2002, MUTAT RES-GEN TOX EN, V514, P177, DOI 10.1016/S1383-5718(01)00338-2	37	10	10	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e69197	10.1371/journal.pone.0069197	http://dx.doi.org/10.1371/journal.pone.0069197			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894430	Green Published, gold, Green Submitted			2022-12-27	WOS:000322391400043
J	Telkoparan, P; Erkek, S; Yaman, E; Alotaibi, H; Bayik, D; Tazebay, UH				Telkoparan, Pelin; Erkek, Serap; Yaman, Elif; Alotaibi, Hani; Bayik, Defne; Tazebay, Uygar H.			Coiled-Coil Domain Containing Protein 124 Is a Novel Centrosome and Midbody Protein That Interacts with the Ras-Guanine Nucleotide Exchange Factor 1B and Is Involved in Cytokinesis	PLOS ONE			English	Article							POLO-LIKE KINASE-1; T-CELL ADHESION; ESCRT MACHINERY; MITOTIC CENTROSOMES; GAMMA-TUBULIN; RECRUITMENT; ABSCISSION; CEP55; MATURATION; CENTRIOLE	Cytokinetic abscission is the cellular process leading to physical separation of two postmitotic sister cells by severing the intercellular bridge. The most noticeable structural component of the intercellular bridge is a transient organelle termed as midbody, localized at a central region marking the site of abscission. Despite its major role in completion of cytokinesis, our understanding of spatiotemporal regulation of midbody assembly is limited. Here, we report the first characterization of coiled-coil domain-containing protein-124 (Ccdc124), a eukaryotic protein conserved from fungi-to-man, which we identified as a novel centrosomal and midbody protein. Knockdown of Ccdc124 in human HeLa cells leads to accumulation of enlarged and multinucleated cells; however, centrosome maturation was not affected. We found that Ccdc124 interacts with the Ras-guanine nucleotide exchange factor 1B (RasGEF1B), establishing a functional link between cytokinesis and activation of localized Rap2 signaling at the midbody. Our data indicate that Ccdc124 is a novel factor operating both for proper progression of late cytokinetic stages in eukaryotes, and for establishment of Rap2 signaling dependent cellular functions proximal to the abscission site.	[Telkoparan, Pelin; Erkek, Serap; Yaman, Elif; Alotaibi, Hani; Bayik, Defne; Tazebay, Uygar H.] Bilkent Univ, Fac Sci, Dept Mol Biol & Genet, Ankara, Turkey; [Tazebay, Uygar H.] Gebze Inst Technol, Dept Mol Biol & Genet, Kocaeli, Turkey	Ihsan Dogramaci Bilkent University; Gebze Technical University	Tazebay, UH (corresponding author), Bilkent Univ, Fac Sci, Dept Mol Biol & Genet, Ankara, Turkey.	tazebay@gyte.edu.tr	Alotaibi, Hani/R-3158-2016; Erkek, Serap/AAV-5549-2020; Alotaibi, Hani/W-7129-2019	Alotaibi, Hani/0000-0001-7423-9653; Alotaibi, Hani/0000-0001-7423-9653; Bayik, Defne/0000-0002-4740-8869; Erkek, Serap/0000-0003-4439-5203; TAZEBAY, UYGAR HALIS/0000-0003-1999-8213; TELKOPARAN-AKILLILAR, Pelin/0000-0003-0337-0763	Turkish Scientific and Technological Research Council (TUBITAK) [109T049, 109T925]; European Science Foundation-Functional Genomics Programme	Turkish Scientific and Technological Research Council (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); European Science Foundation-Functional Genomics Programme	The Turkish Scientific and Technological Research Council (TUBITAK) has supported the study with grants 109T049 and 109T925. The European Science Foundation-Functional Genomics Programme provided a mobility grant to P. T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrade WA, 2010, GENES IMMUN, V11, P447, DOI 10.1038/gene.2009.107; Bastos RN, 2010, J CELL BIOL, V191, P751, DOI 10.1083/jcb.201008108; Bivona TG, 2004, J CELL BIOL, V164, P461, DOI 10.1083/jcb.200311093; Burkard ME, 2007, P NATL ACAD SCI USA, V104, P4383, DOI 10.1073/pnas.0701140104; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Cascone I, 2008, EMBO J, V27, P2375, DOI 10.1038/emboj.2008.166; Choi SC, 2008, DEV CELL, V15, P49, DOI 10.1016/j.devcel.2008.05.004; COHEN C, 1990, PROTEINS, V7, P1, DOI 10.1002/prot.340070102; Conduit PT, 2010, CURR BIOL, V20, P2178, DOI 10.1016/j.cub.2010.11.011; Dambournet D, 2011, NAT CELL BIOL, V13, P981, DOI 10.1038/ncb2279; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Debec A, 2010, CELL MOL LIFE SCI, V67, P2173, DOI 10.1007/s00018-010-0323-9; Elia N, 2011, P NATL ACAD SCI USA, V108, P4846, DOI 10.1073/pnas.1102714108; Epting D, 2007, GENE EXPR PATTERNS, V7, P389, DOI 10.1016/j.modgep.2006.11.010; Fabbro M, 2005, DEV CELL, V9, P477, DOI 10.1016/j.devcel.2005.09.003; Fededa JP, 2012, NAT CELL BIOL, V14, P440, DOI 10.1038/ncb2482; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Ghandour H, 2007, BLOOD, V110, P3682, DOI 10.1182/blood-2007-03-077628; Gloerich M, 2011, TRENDS CELL BIOL, V21, P615, DOI 10.1016/j.tcb.2011.07.001; Gloerich M, 2010, MOL CELL BIOL, V30, P5421, DOI 10.1128/MCB.00463-10; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; Gromley A, 2003, J CELL BIOL, V161, P535, DOI 10.1083/jcb.200301105; Guizetti J, 2011, SCIENCE, V331, P1616, DOI 10.1126/science.1201847; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Haren L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005976; Hu CK, 2012, MOL BIOL CELL, V23, P1024, DOI 10.1091/mbc.E11-08-0721; Jakobsen L, 2011, EMBO J, V30, P1520, DOI 10.1038/emboj.2011.63; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; Lee HH, 2008, SCIENCE, V322, P576, DOI 10.1126/science.1162042; Lee K, 2011, J CELL BIOL, V195, P1093, DOI 10.1083/jcb.201106093; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Nigg EA, 2011, NAT CELL BIOL, V13, P1154, DOI 10.1038/ncb2345; OAKLEY BR, 1990, CELL, V61, P1289, DOI 10.1016/0092-8674(90)90693-9; Paddison PJ, 2004, NAT METHODS, V1, P163, DOI 10.1038/nmeth1104-163; Piel M, 2001, SCIENCE, V291, P1550, DOI 10.1126/science.1057330; Sagona AP, 2010, NAT CELL BIOL, V12, P362, DOI 10.1038/ncb2036; Schatten H, 2010, SEMIN CELL DEV BIOL, V21, P174, DOI 10.1016/j.semcdb.2010.01.012; Schiel JA, 2013, TRENDS CELL IN PRESS, DOI DOI 10.1016/J.TCB.2013.02.003); Schiel JA, 2013, CURR OPIN CELL BIOL, V25, P92, DOI 10.1016/j.ceb.2012.10.012; Schiel JA, 2012, NAT CELL BIOL, V14, P1068, DOI 10.1038/ncb2577; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; Stearns T, 1997, CELL, V91, P303, DOI 10.1016/S0092-8674(00)80414-6; Steigemann P, 2009, TRENDS CELL BIOL, V19, P606, DOI 10.1016/j.tcb.2009.07.008; Tong C, 2002, BIOL REPROD, V67, P546, DOI 10.1095/biolreprod67.2.546; Uetake Y, 2007, J CELL BIOL, V176, P173, DOI 10.1083/jcb.200607073; van der Horst A, 2009, CELL CYCLE, V8, P3742, DOI 10.4161/cc.8.22.10047; van Triest Miranda, 2004, Methods Mol Biol, V250, P97; Yaman E, 2009, FEBS J, V276, P4607, DOI 10.1111/j.1742-4658.2009.07166.x	51	12	16	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e69289	10.1371/journal.pone.0069289	http://dx.doi.org/10.1371/journal.pone.0069289			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894443	Green Published, gold, Green Submitted			2022-12-27	WOS:000322391400046
J	Buffet, JP; Pisanu, B; Brisse, S; Roussel, S; Felix, B; Halos, L; Chapuis, JL; Vayssier-Taussat, M				Buffet, Jean-Philippe; Pisanu, Benoit; Brisse, Sylvain; Roussel, Sophie; Felix, Benjamin; Halos, Lenaig; Chapuis, Jean-Louis; Vayssier-Taussat, Muriel			Deciphering Bartonella Diversity, Recombination, and Host Specificity in a Rodent Community	PLOS ONE			English	Article							INTRODUCED SIBERIAN CHIPMUNKS; WOODLAND RODENTS; SMALL MAMMALS; SEQUENCE DATA; CLASSIFICATION; DYNAMICS; HENSELAE; DNA; EXPLOITATION; POPULATIONS	Host-specificity is an intrinsic feature of many bacterial pathogens, resulting from a long history of co-adaptation between bacteria and their hosts. Alpha-proteobacteria belonging to the genus Bartonella infect the erythrocytes of a wide range of mammal orders, including rodents. In this study, we performed genetic analysis of Bartonella colonizing a rodent community dominated by bank voles (Myodes glareolus) and wood mice (Apodemus sylvaticus) in a French suburban forest to evaluate their diversity, their capacity to recombine and their level of host specificity. Following the analysis of 550 rodents, we detected 63 distinct genotypes related to B. taylorii, B. grahamii, B. doshiae and a new B. rochalimae-like species. Investigating the most highly represented species, we showed that B. taylorii strain diversity was markedly higher than that of B. grahamii, suggesting a possible severe bottleneck for the latter species. The majority of recovered genotypes presented a strong association with either bank voles or wood mice, with the exception of three B. taylorii genotypes which had a broader host range. Despite the physical barriers created by host specificity, we observed lateral gene transfer between Bartonella genotypes associated with wood mice and Bartonella adapted to bank voles, suggesting that those genotypes might co-habit during their life cycle.	[Buffet, Jean-Philippe; Vayssier-Taussat, Muriel] USC INRA Bipar, Maisons Alfort, France; [Pisanu, Benoit; Chapuis, Jean-Louis] Museum Natl Hist Nat, MNHN CNRS P6, UMR 7204, F-75231 Paris, France; [Brisse, Sylvain] Inst Pasteur, Paris, France; [Roussel, Sophie; Felix, Benjamin] Agence Natl Securite Sanitaire Alimentat, Lab Food Safety, Maisons Alfort, France; [Halos, Lenaig] MERIAL, Lyon, France	INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de Securite Aliments; Ecole Nationale Veterinaire d'Alfort (ENVA); Merial SASU	Vayssier-Taussat, M (corresponding author), USC INRA Bipar, Maisons Alfort, France.	mvayssier@vet-alfort.fr	Brisse, Sylvain/M-8723-2013	Brisse, Sylvain/0000-0002-2516-2108; Felix, Benjamin/0000-0002-8658-8874; Roussel, Sophie/0000-0003-1830-5526; Halos, Lenaig/0000-0002-2623-2008	Regional Council of Ile-de-France; Animal Health department of INRA; EU [FP7-261504 EDENext]	Regional Council of Ile-de-France(Region Ile-de-France); Animal Health department of INRA; EU(European Commission)	This study was partially funded by the Regional Council of Ile-de-France, the Animal Health department of INRA and the EU grant FP7-261504 EDENext. It is catalogued by the EDENext Steering Committee as EDENext 078G (http://www.edenext.eu). The contents of this publication are the sole responsibility of the authors and do not necessarily reflect the views of the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvand M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001346; Arvand M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009765; Bai Y, 2011, APPL ENVIRON MICROB, V77, P1728, DOI 10.1128/AEM.02203-10; Berglund EC, 2010, MOL ECOL, V19, P2241, DOI 10.1111/j.1365-294X.2010.04646.x; Berglund EC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-152; Berglund EC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000546; Birtles RJ, 2001, EPIDEMIOL INFECT, V126, P323, DOI 10.1017/S095026880100526X; Bouchouicha R, 2009, EMERG INFECT DIS, V15, P813, DOI 10.3201/eid1505.080995; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Buffet JP, 2012, COMP IMMUNOL MICROBI; Chaloner GL, 2011, J CLIN MICROBIOL, V49, P2132, DOI 10.1128/JCM.00275-11; Colborn JM, 2010, J CLIN MICROBIOL, V48, P4630, DOI 10.1128/JCM.00470-10; Dehio C, 2004, ANNU REV MICROBIOL, V58, P365, DOI 10.1146/annurev.micro.58.030603.123700; Deng HK, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-15; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Engel P, 2009, GENOME DYNAM, V6, P158, DOI 10.1159/000235769; Engel P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001296; Finlay BB, 1997, SCIENCE, V276, P718, DOI 10.1126/science.276.5313.718; Foucault C, 2005, J CLIN MICROBIOL, V43, P41, DOI 10.1128/JCM.43.1.41-48.2005; Gil H, 2010, APPL ENVIRON MICROB, V76, P8062, DOI 10.1128/AEM.01963-10; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Holmberg M, 2003, EPIDEMIOL INFECT, V130, P149, DOI 10.1017/S0950268802008075; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Inoue K, 2011, VET MICROBIOL, V148, P60, DOI 10.1016/j.vetmic.2010.08.007; Inoue K, 2009, MICROB ECOL, V57, P534, DOI 10.1007/s00248-009-9488-x; Jardine C, 2005, VECTOR-BORNE ZOONOT, V5, P402, DOI 10.1089/vbz.2005.5.402; Kosoy M, 2003, J CLIN MICROBIOL, V41, P645, DOI 10.1128/JCM.41.2.645-650.2003; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Marmet J, 2011, J ETHOL, V29, P23, DOI 10.1007/s10164-010-0215-3; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Palys T, 1997, INT J SYST BACTERIOL, V47, P1145, DOI 10.1099/00207713-47-4-1145; Paziewska A, 2012, PARASITOLOGY, V139, P881, DOI 10.1017/S0031182012000170; Paziewska A, 2012, MICROB ECOL, V64, P525, DOI 10.1007/s00248-012-0033-y; Paziewska A, 2011, MICROB ECOL, V61, P134, DOI 10.1007/s00248-010-9735-1; Pisanu B, 2008, PARASITE, V15, P35, DOI 10.1051/parasite/2008151035; Pisanu B, 2010, INT J PARASITOL, V40, P1277, DOI 10.1016/j.ijpara.2010.03.012; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Renesto P, 2001, J CLIN MICROBIOL, V39, P430, DOI 10.1128/JCM.39.2.430-437.2001; Saenz HL, 2007, NAT GENET, V39, P1469, DOI 10.1038/ng.2007.38; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Tamura K, 2011, MOL BIOL EVOL; Telfer S, 2007, PARASITOLOGY, V134, P413, DOI 10.1017/S0031182006001624; Vayssier-Taussat M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000946; Vayssier-Taussat M, 2009, ANN NY ACAD SCI, V1166, P127, DOI 10.1111/j.1749-6632.2009.04531.x; Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93; Ying B, 2002, AM J TROP MED HYG, V66, P622, DOI 10.4269/ajtmh.2002.66.622; Zeaiter Z, 2002, J CLIN MICROBIOL, V40, P3641, DOI 10.1128/JCM.40.10.3641-3647.2002; Zeaiter Z, 2002, INT J SYST EVOL MICR, V52, P165, DOI 10.1099/00207713-52-1-165	49	31	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e68956	10.1371/journal.pone.0068956	http://dx.doi.org/10.1371/journal.pone.0068956			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894381	Green Published, Green Submitted, gold			2022-12-27	WOS:000322167900032
J	Zhu, LY; Su, TW; Xu, M; Xu, Y; Li, M; Wang, TG; Sun, JC; Zhang, J; Xu, BH; Lu, JL; Bi, YF; Wang, WQ; Xu, YP				Zhu, Liying; Su, Tingwei; Xu, Min; Xu, Yu; Li, Mian; Wang, Tiange; Sun, Jichao; Zhang, Jie; Xu, Baihui; Lu, Jieli; Bi, Yufang; Wang, Weiqing; Xu, Yiping			Eosinophil Inversely Associates with Type 2 Diabetes and Insulin Resistance in Chinese Adults	PLOS ONE			English	Article							GLUCOSE-TOLERANCE; INFLAMMATION; DISEASE; HOMEOSTASIS; RATS; ATHEROSCLEROSIS; SENSITIVITY; OBESITY	Context: Limited population-based study focused on relationship between eosinophil and type 2 diabetes (T2D). Objectives: We aimed to evaluate the relationship between peripheral eosinophil percentage and glucose metabolism and insulin resistance in a large sample size of Chinese population aged 40 and older. Design and Methods: A cross-sectional study was performed among 9,111 Chinese adults including 3,561 men and 5,550 women. The glucose metabolism status was confirmed by 75-g oral glucose tolerance test. Homeostasis model assessment of insulin resistance index and serum insulin levels were used to evaluate insulin resistance. Homeostasis model assessment-B was used to evaluate beta cell function. Results: The average age of participants was 58.5 years. The prevalence of T2D decreased across the tertiles of eosinophil percentage (21.3%, 18.2% and 16.9%, P<0.0001). Each one tertile increase of eosinophil percentage inversely associated with risk of T2D when referred not only to normal glucose tolerance (NGT) (odds ratio (OR) 0.81, 95% CI 0.76-0.87, P<0.0001), but also to impaired glucose regulation (OR 0.89, 95% CI 0.83-0.97, P = 0.006), respectively, after adjustment for the confounding factors. Compared with the first tertile, the third tertile of eosinophil percentage associated with a 23% decrease of insulin resistance in NGT participants after full adjustments (P = 0.005). Each 1-standard deviation of increment of eosinophil percentage associated with a 37% decrease of insulin resistance (P = 0.005). Conclusions: Higher peripheral eosinophil percentage was associated with decreased risk of T2D. The inverse relation to insulin resistance was detected in NGT participants.	[Zhu, Liying; Su, Tingwei; Xu, Min; Xu, Yu; Li, Mian; Wang, Tiange; Zhang, Jie; Xu, Baihui; Lu, Jieli; Bi, Yufang; Wang, Weiqing] Shanghai Univ E Inst, Shanghai Jiao Tong Univ,Minist Hlth, Sch Med,Rui Jin Hosp, Key Lab Endocrine & Metab Dis, Shanghai, Peoples R China; [Zhu, Liying; Su, Tingwei; Xu, Min; Xu, Yu; Zhang, Jie; Xu, Baihui; Lu, Jieli; Bi, Yufang; Wang, Weiqing] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp,Shanghai Clin Ctr Endocrine & Metab, Dept Endocrinol & Metab,Shanghai Inst Endocrine &, Shanghai 200030, Peoples R China; [Xu, Yiping] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Res & Dev, Shanghai 200030, Peoples R China; [Sun, Jichao] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [Sun, Jichao] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University	Xu, YP (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Res & Dev, Shanghai 200030, Peoples R China.	cammon@vip.sina.com			Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health [1994DP131044]; Sector Funds of Ministry of Health [201002002]; National Key New Drug Creation and Manufacturing Program of Ministry of Science and Technology [2012ZX09303006-001]; 863 Project [2012AA02A509]; National Natural Science Foundation of China [81222008, 81270877]	Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health; Sector Funds of Ministry of Health; National Key New Drug Creation and Manufacturing Program of Ministry of Science and Technology; 863 Project(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the grants from the Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health (1994DP131044), the Sector Funds of Ministry of Health (201002002), the National Key New Drug Creation and Manufacturing Program of Ministry of Science and Technology (2012ZX09303006-001), the 863 Project (2012AA02A509), and the National Natural Science Foundation of China (No. 81222008, 81270877). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMKIEWICZ VW, 1959, AM J PHYSIOL, V197, P377, DOI 10.1152/ajplegacy.1959.197.2.377; Belmonte KE, 1998, J APPL PHYSIOL, V85, P1708, DOI 10.1152/jappl.1998.85.5.1708; Boichot E, 1999, PULM PHARMACOL THER, V12, P285, DOI 10.1006/pupt.1999.0212; Bonora E, 2000, DIABETES CARE, V23, P57, DOI 10.2337/diacare.23.1.57; Diaz BL, 1997, MEM I OSWALDO CRUZ, V92, P219, DOI 10.1590/S0074-02761997000800031; Duncan BB, 2003, DIABETES, V52, P1799, DOI 10.2337/diabetes.52.7.1799; Duncan BB, 2009, RECENT PAT INFLAMM A, V3, P73; Festa A, 2002, DIABETES, V51, P1131, DOI 10.2337/diabetes.51.4.1131; GILBERT HS, 1978, METABOLISM, V27, P889, DOI 10.1016/0026-0495(78)90132-4; Gkrania-Klotsas E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013405; Gulcan E, 2009, J ASTHMA, V46, P207, DOI 10.1080/02770900802627302; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Kim DJ, 2008, J KOREAN MED SCI, V23, P193, DOI 10.3346/jkms.2008.23.2.193; Kolahian S, 2011, EUR J PHARMACOL, V659, P252, DOI 10.1016/j.ejphar.2011.03.014; Kundan L, 2007, NATURE, V447, P1116; LEME J G, 1973, European Journal of Pharmacology, V23, P74; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Maizels RM, 2011, SCIENCE, V332, P186, DOI 10.1126/science.1205313; Meagher LC, 1996, J IMMUNOL, V156, P4422; Peeke PM, 1995, ANN NY ACAD SCI, V771, P665, DOI 10.1111/j.1749-6632.1995.tb44719.x; PETERSON AP, 1981, J ALLERGY CLIN IMMUN, V68, P212, DOI 10.1016/0091-6749(81)90186-X; Pickup JC, 1998, DIABETOLOGIA, V41, P1241, DOI 10.1007/s001250051058; Rask E, 2012, CLIN ENDOCRINOL OXF, DOI [10.1111/j.1365-2265, DOI 10.1111/J.1365-2265]; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; VIANNA EO, 1995, AM J RESP CRIT CARE, V151, P809; Vozarova B, 2002, DIABETES, V51, P455, DOI 10.2337/diabetes.51.2.455; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Yudkin JS, 2004, METABOLISM, V53, P852, DOI 10.1016/j.metabol.2004.02.004	28	20	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e67613	10.1371/journal.pone.0067613	http://dx.doi.org/10.1371/journal.pone.0067613			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894289	gold, Green Submitted, Green Published			2022-12-27	WOS:000322132100011
J	Chand, S; Holle, JU; Hilhorst, M; Simmonds, MJ; Smith, S; Kamesh, L; Hewins, P; McKnight, AJ; Maxwell, AP; Tervaert, JWC; Wieczorek, S; Harper, L; Borrows, R				Chand, Sourabh; Holle, Julia U.; Hilhorst, Marc; Simmonds, Matthew J.; Smith, Stuart; Kamesh, Lavanya; Hewins, Peter; McKnight, Amy Jayne; Maxwell, Alexander P.; Tervaert, Jan Willem Cohen; Wieczorek, Stefan; Harper, Lorraine; Borrows, Richard			Caveolin-1 Single Nucleotide Polymorphism in Antineutrophil Cytoplasmic Antibody Associated Vasculitis	PLOS ONE			English	Article								Objective: Immunosuppression is cornerstone treatment of antineutrophil cytoplasmic antibody associated vasculitis (AAV) but is later complicated by infection, cancer, cardiovascular and chronic kidney disease. Caveolin-1 is an essential structural protein for small cell membrane invaginations known as caveolae. Its functional role has been associated with these complications. For the first time, caveolin-1 (CAV1) gene variation is studied in AAV. Methods: CAV1 single nucleotide polymorphism rs4730751 was analysed in genomic DNA from 187 white patients with AAV from Birmingham, United Kingdom. The primary outcome measure was the composite endpoint of time to all-cause mortality or renal replacement therapy. Secondary endpoints included time to all-cause mortality, death from sepsis or vascular disease, cancer and renal replacement therapy. Validation of results was sought from 589 white AAV patients, from two European cohorts. Results: The primary outcome occurred in 41.7% of Birmingham patients. In a multivariate model, non-CC genotype variation at the studied single nucleotide polymorphism was associated with increased risk from: the primary outcome measure [HR 1.86; 95% CI: 1.14-3.04; p=0.013], all-cause mortality [HR: 1.83; 95% CI: 1.02-3.27; p=0.042], death from infection [HR: 3.71; 95% CI: 1.28-10.77; p=0.016], death from vascular disease [HR: 3.13; 95% CI: 1.07-9.10; p=0.037], and cancer [HR: 5.55; 95% CI: 1.59-19.31; p=0.007]. In the validation cohort, the primary outcome rate was far lower (10.4%); no association between genotype and the studied endpoints was evident. Conclusions: The presence of a CC genotype in Birmingham is associated with protection from adverse outcomes of immunosuppression treated AAV. Lack of replication in the European cohort may have resulted from low clinical event rates. These findings are worthy of further study in larger cohorts.	[Chand, Sourabh; Smith, Stuart; Harper, Lorraine; Borrows, Richard] Univ Birmingham, Ctr Translat Inflammat Res, Birmingham, W Midlands, England; [Holle, Julia U.; Wieczorek, Stefan] Ruhr Univ Bochum, Bochum, Germany; [Hilhorst, Marc; Tervaert, Jan Willem Cohen] Maastricht Univ Med Ctr, Div Clin & Expt Immunol, Maastricht, Netherlands; [Simmonds, Matthew J.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Chand, Sourabh; Kamesh, Lavanya; Hewins, Peter; Borrows, Richard] Queen Elizabeth Hosp, Dept Nephrol, Birmingham B15 2TH, W Midlands, England; [McKnight, Amy Jayne; Maxwell, Alexander P.] Belfast City Hosp, Reg Nephrol Unit, Belfast BT9 7AD, Antrim, North Ireland	University of Birmingham; Ruhr University Bochum; Maastricht University; Maastricht University Medical Centre (MUMC); University of Oxford; University of Birmingham; Belfast City Hospital	Chand, S (corresponding author), Univ Birmingham, Ctr Translat Inflammat Res, Birmingham, W Midlands, England.	sourabh.chand@nhs.net	tervaert, jan willem cohen/AAB-1111-2019; Wieczorek, Stefan/F-7721-2014; Hilhorst, Marc/U-2257-2019; McKnight, Amy Jayne/ABF-4492-2020	Hilhorst, Marc/0000-0003-3712-7171; McKnight, Amy Jayne/0000-0002-7482-709X; Chand, Sourabh/0000-0002-6126-3678; harper, lorraine/0000-0003-1343-9234; Simmonds, Matt/0000-0003-3154-3510; Maxwell, Alexander P./0000-0002-6110-7253	Deutsche Forschungsgescheinschaft [KFO170]; Academy of Medical Sciences (AMS) [AMS-SGCL8-Smith] Funding Source: researchfish; Public Health Agency [STL/3714/07] Funding Source: researchfish	Deutsche Forschungsgescheinschaft; Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Public Health Agency	Recruiting and analyses of the German cohort were funded by a grant from Deutsche Forschungsgescheinschaft (KFO170). The United Kingdom research was carried out at the National Institute for Health Research (NIHR)/Wellcome Trust Birmingham Clinical Research Facility. The views expressed are those of the authors(s) and not necessarily those of the National Health Service, the NIHR of the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Del Galdo F, 2008, CURR OPIN RHEUMATOL, V20, P713, DOI 10.1097/BOR.0b013e3283103d27; Flossmann O, 2011, ANN RHEUM DIS, V70, P488, DOI 10.1136/ard.2010.137778; Gadjeva M, 2010, J IMMUNOL, V184, P296, DOI 10.4049/jimmunol.0900604; Guo Q, 2012, EUR J IMMUNOL, V42, P1500, DOI 10.1002/eji.201142051; Jayne DRW, 2007, J AM SOC NEPHROL, V18, P2180, DOI 10.1681/ASN.2007010090; LYONS PA, 2012, NEW ENGL J MED, V367, DOI DOI 10.1056/NEJM0A1108735.PUBMED:22808956; Moore J, 2010, JAMA-J AM MED ASSOC, V303, P1282, DOI 10.1001/jama.2010.356; Pepper RJ, 2013, CLIN J AM SOC NEPHRO, V8, P219, DOI 10.2215/CJN.03680412; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Schwencke C, 2006, CARDIOVASC RES, V70, P42, DOI 10.1016/j.cardiores.2005.11.029; Schwencke C, 2005, CARDIOVASC RES, V68, P128, DOI 10.1016/j.cardiores.2005.05.004; Sotgia F, 2012, ANNU REV PATHOL-MECH, V7, P423, DOI 10.1146/annurev-pathol-011811-120856; Testa A, 2012, AM J HYPERTENS, V25, P103, DOI 10.1038/ajh.2011.178; Thomas CM, 2008, J CELL MOL MED, V12, P796, DOI 10.1111/j.1582-4934.2008.00295.x; Tsai TH, 2011, SHOCK, V35, P92, DOI 10.1097/SHK.0b013e3181ea45ca; Xu YQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011004	16	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e69022	10.1371/journal.pone.0069022	http://dx.doi.org/10.1371/journal.pone.0069022			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894397	Green Published, gold, Green Accepted			2022-12-27	WOS:000322391400035
J	Chen, QR; Braun, R; Hu, Y; Yan, CH; Brunt, EM; Meerzaman, D; Sanyal, AJ; Buetow, K				Chen, Qing-Rong; Braun, Rosemary; Hu, Ying; Yan, Chunhua; Brunt, Elizabeth M.; Meerzaman, Daoud; Sanyal, Arun J.; Buetow, Kenneth			Multi-SNP Analysis of GWAS Data Identifies Pathways Associated with Nonalcoholic Fatty Liver Disease	PLOS ONE			English	Article							STEATOHEPATITIS; DYSREGULATION; POPULATION; SEVERITY	Non-alcoholic fatty liver disease (NAFLD) is a common liver disease; the histological spectrum of which ranges from steatosis to steatohepatitis. Nonalcoholic steatohepatitis (NASH) often leads to cirrhosis and development of hepatocellular carcinoma. To better understand pathogenesis of NAFLD, we performed the pathway of distinction analysis (PoDA) on a genome-wide association study dataset of 250 non-Hispanic white female adult patients with NAFLD, who were enrolled in the NASH Clinical Research Network (CRN) Database Study, to investigate whether biologic process variation measured through genomic variation of genes within these pathways was related to the development of steatohepatitis or cirrhosis. Pathways such as Recycling of eIF2:GDP, biosynthesis of steroids, Terpenoid biosynthesis and Cholesterol biosynthesis were found to be significantly associated with NASH. SNP variants in Terpenoid synthesis, Cholesterol biosynthesis and biosynthesis of steroids were associated with lobular inflammation and cytologic ballooning while those in Terpenoid synthesis were also associated with fibrosis and cirrhosis. These were also related to the NAFLD activity score (NAS) which is derived from the histological severity of steatosis, inflammation and ballooning degeneration. Eukaryotic protein translation and recycling of eIF2:GDP related SNP variants were associated with ballooning, steatohepatitis and cirrhosis. Il2 signaling events mediated by PI3K, Mitotic metaphase/anaphase transition, and Prostanoid ligand receptors were also significantly associated with cirrhosis. Taken together, the results provide evidence for additional ways, beyond the effects of single SNPs, by which genetic factors might contribute to the susceptibility to develop a particular phenotype of NAFLD and then progress to cirrhosis. Further studies are warranted to explain potential important genetic roles of these biological processes in NAFLD.	[Chen, Qing-Rong; Braun, Rosemary; Hu, Ying; Yan, Chunhua; Meerzaman, Daoud; Buetow, Kenneth] NCI, Ctr Biomed Informat & Informat Technol, NIH, Bethesda, MD 20892 USA; [Braun, Rosemary] Northwestern Univ, Dept Prevent Med, Div Biostat, Evanston, IL USA; [Braun, Rosemary] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL USA; [Brunt, Elizabeth M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Sanyal, Arun J.] Virginia Commonwealth Univ, Med Ctr, Dept Internal Med, Div Gastroenterol Hepatol & Nutr, Richmond, VA USA; [Buetow, Kenneth] Arizona State Univ, Complex Adapt Syst Initiat, Computat Sci & Informat Program, Phoenix, AZ USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Washington University (WUSTL); Virginia Commonwealth University; Arizona State University; Arizona State University-Downtown Phoenix	Chen, QR (corresponding author), NCI, Ctr Biomed Informat & Informat Technol, NIH, Bethesda, MD 20892 USA.	chenqi@mail.nih.gov		Braun, Rosemary/0000-0001-9668-9866	Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [U01DK061718, U01DK061728, U01DK061731, U01DK061732, U01DK061734, U01DK061737, U01DK061738, U01DK061730, U01DK061713]; National Institute of Child Health and Human Development (NICHD); NATIONAL CANCER INSTITUTE [K22CA148779] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK061734, U01DK061732, U01DK061731, U01DK061718, U01DK061730, U01DK061737, U01DK061738, U01DK061713, U01DK061728] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. This study utilized the high-performance computational capabilities of the Biowulf Linux cluster at the National Institutes of Health, Bethesda, MD. The Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) is supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (grants U01DK061718, U01DK061728, U01DK061731, U01DK061732, U01DK061734, U01DK061737, U01DK061738, U01DK061730, U01DK061713), and the National Institute of Child Health and Human Development (NICHD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Ascha MS, 2010, HEPATOLOGY, V51, P1972, DOI 10.1002/hep.23527; Braun R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002101; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Chalasani N, 2010, GASTROENTEROLOGY, V139, P1567, DOI 10.1053/j.gastro.2010.07.057; Cheung O, 2008, HEPATOLOGY, V48, P1810, DOI 10.1002/hep.22569; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lane KT, 2006, J LIPID RES, V47, P681, DOI 10.1194/jlr.R600002-JLR200; Min HK, 2012, CELL METAB, V15, P665, DOI 10.1016/j.cmet.2012.04.004; Nettschwander-Tetri BA, 2010, HEPATOLOGY, V52, P913, DOI 10.1002/hep.23784; Paradis V, 2009, HEPATOLOGY, V49, P851, DOI 10.1002/hep.22734; Pollier J, 2011, NAT PROD REP, V28, P1897, DOI 10.1039/c1np00049g; Puri P, 2008, GASTROENTEROLOGY, V134, P568, DOI 10.1053/j.gastro.2007.10.039; Puri P, 2007, HEPATOLOGY, V46, P1081, DOI 10.1002/hep.21763; Romeo S, 2010, CURR OPIN LIPIDOL, V21, P247, DOI 10.1097/MOL.0b013e328338ca61; Sanyal AJ, 2006, HEPATOLOGY, V43, P682, DOI 10.1002/hep.21103; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Sookoian S, 2009, J LIPID RES, V50, P2111, DOI 10.1194/jlr.P900013-JLR200; Speliotes EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001324; Tsukamoto H, 2008, J GASTROEN HEPATOL, V23, pS104, DOI 10.1111/j.1440-1746.2007.05294.x; Yanagitani A, 2004, HEPATOLOGY, V40, P366, DOI 10.1002/hep.20335	22	20	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e65982	10.1371/journal.pone.0065982	http://dx.doi.org/10.1371/journal.pone.0065982			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894275	Green Submitted, Green Published, gold			2022-12-27	WOS:000322391400001
J	Del Viva, MM; Punzi, G; Benedetti, D				Del Viva, Maria M.; Punzi, Giovanni; Benedetti, Daniele			Information and Perception of Meaningful Patterns	PLOS ONE			English	Article							RECEPTIVE-FIELDS; NATURAL IMAGES; ORIENTATION; RECOGNITION; STATISTICS; SPEED	The visual system needs to extract the most important elements of the external world from a large flux of information in a short time for survival purposes. It is widely believed that in performing this task, it operates a strong data reduction at an early stage, by creating a compact summary of relevant information that can be handled by further levels of processing. In this work we formulate a model of early vision based on a pattern-filtering architecture, partly inspired by high-speed digital data reduction in experimental high-energy physics (HEP). This allows a much stronger data reduction than models based just on redundancy reduction. We show that optimizing this model for best information preservation under tight constraints on computational resources yields surprisingly specific a-priori predictions for the shape of biologically plausible features, and for experimental observations on fast extraction of salient visual features by human observers. Interestingly, applying the same optimized model to HEP data acquisition systems based on pattern-filtering architectures leads to specific a-priori predictions for the relevant data patterns that these devices extract from their inputs. These results suggest that the limitedness of computing resources can play an important role in shaping the nature of perception, by determining what is perceived as "meaningful features" in the input data.	[Del Viva, Maria M.; Benedetti, Daniele] Univ Florence, Area Farmaco & Salute Bambino, Sez Psicol, NEUROFARBA Dipartimento Neurosci, Florence, Italy; [Del Viva, Maria M.] Univ Chicago, IMB, Chicago, IL 60637 USA; [Punzi, Giovanni; Benedetti, Daniele] Univ Pisa, Dipartimento Fis E Fermi, Pisa, Italy; [Punzi, Giovanni] Fermilab Natl Accelerator Lab, Batavia, IL 60510 USA	University of Florence; University of Chicago; University of Pisa; United States Department of Energy (DOE); University of Chicago; Fermi National Accelerator Laboratory	Del Viva, MM (corresponding author), Univ Florence, Area Farmaco & Salute Bambino, Sez Psicol, NEUROFARBA Dipartimento Neurosci, Florence, Italy.	Michela@in.cnr.it	Punzi, Giovanni/AGG-1935-2022; Punzi, Giovanni/J-4947-2012	Punzi, Giovanni/0000-0002-8346-9052; Punzi, Giovanni/0000-0002-8346-9052; DEL VIVA, MARIA/0000-0001-6332-4959	Italian Ministry of Research Grant; MIUR-PRIN [2007WMC8ZY_001, 20083N7YWS_004]; University of Chicago	Italian Ministry of Research Grant; MIUR-PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); University of Chicago(University of Chicago)	This work was supported by an Italian Ministry of Research Grant, MIUR-PRIN # 2007WMC8ZY_001 (http://www.istruzione.it), MIUR-PRIN # 20083N7YWS_004 (http://www.istruzione.it), and University of Chicago: Support for research on rapid recognition of meaningful patterns (http://imb.uchicago.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annovi A, 2001, IEEE T NUCL SCI, V48, P575, DOI 10.1109/23.940122; Aticky JJ, 2011, NETWORK-COMP NEURAL, V22, P4, DOI [10.1088/0954-898X/3/2/009, 10.3109/0954898X.2011.638888]; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BLAKEMORE C, 1969, J PHYSIOL-LONDON, V203, P237, DOI 10.1113/jphysiol.1969.sp008862; BLAKEMORE C, 1975, J PHYSIOL-LONDON, V248, P663, DOI 10.1113/jphysiol.1975.sp010995; DELLORSO M, 1989, NUCL INSTRUM METH A, V278, P436, DOI 10.1016/0168-9002(89)90862-0; Echeverri E, 2006, IEEE T INF TECHNOL B, V10, P803, DOI 10.1109/TITB.2006.879585; Felsen G, 2005, PLOS BIOL, V3, P1819, DOI 10.1371/journal.pbio.0030342; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; FIORENTINI A, 1980, NATURE, V287, P43, DOI 10.1038/287043a0; Geisler WS, 2001, VISION RES, V41, P711, DOI 10.1016/S0042-6989(00)00277-7; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; HARE RD, 1973, PSYCHOPHYSIOLOGY, V10, P453, DOI 10.1111/j.1469-8986.1973.tb00532.x; HIRSCH HVB, 1970, SCIENCE, V168, P869, DOI 10.1126/science.168.3933.869; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P229, DOI 10.1152/jn.1965.28.2.229; Kirchner H, 2006, VISION RES, V46, P1762, DOI 10.1016/j.visres.2005.10.002; Koch K, 2006, CURR BIOL, V16, P1428, DOI 10.1016/j.cub.2006.05.056; Kubat M, 1998, MACH LEARN, V30, P195, DOI 10.1023/A:1007452223027; Lamming D., 1991, VIS VIS DYSFUNCT LIM, V5, P6; Lennie P, 2003, CURR BIOL, V13, P493, DOI 10.1016/S0960-9822(03)00135-0; Levy WB, 1996, NEURAL COMPUT, V8, P531, DOI 10.1162/neco.1996.8.3.531; MALPASS RS, 1969, J PERS SOC PSYCHOL, V13, P330, DOI 10.1037/h0028434; MARR D, 1980, PROC R SOC SER B-BIO, V207, P187, DOI 10.1098/rspb.1980.0020; Marr D., 1982, VISION; Maurer D, 1999, SCIENCE, V286, P108, DOI 10.1126/science.286.5437.108; Morgan MJ, 2011, VISION RES, V51, P738, DOI 10.1016/j.visres.2010.08.002; MORRONE MC, 1988, PROC R SOC SER B-BIO, V235, P221, DOI 10.1098/rspb.1988.0073; MOVSHON JA, 1979, NATURE, V278, P850, DOI 10.1038/278850a0; Niven JE, 2008, J EXP BIOL, V211, P1792, DOI 10.1242/jeb.017574; Olmos A, 2004, PERCEPTION, V33, P1463, DOI 10.1068/p5321; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Ratliff CP, 2010, P NATL ACAD SCI USA, V107, P17368, DOI 10.1073/pnas.1005846107; Ristori L, 2010, ANNU REV NUCL PART S, V60, P595, DOI 10.1146/annurev.nucl.012809.104501; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Smith EC, 2006, NATURE, V439, P978, DOI 10.1038/nature04485; Sowden PT, 2000, J EXP PSYCHOL HUMAN, V26, P379, DOI 10.1037/0096-1523.26.1.379; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; WATT RJ, 1983, VISION RES, V23, P1465, DOI 10.1016/0042-6989(83)90158-X; Whalen PJ, 1998, J NEUROSCI, V18, P411; Zhaoping L, 2007, PLOS COMPUT BIOL, V3, P616, DOI 10.1371/journal.pcbi.0030062; Zhaoping L, 2006, NETWORK-COMP NEURAL, V17, P301, DOI 10.1080/09548980600931995	47	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e69154	10.1371/journal.pone.0069154	http://dx.doi.org/10.1371/journal.pone.0069154			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894422	gold, Green Published, Green Submitted			2022-12-27	WOS:000322391400042
J	Xia, XF; Zheng, DD; Zhong, HZ; Qin, BC; Gurr, GM; Vasseur, L; Lin, HL; Bai, JL; He, WY; You, MS				Xia, Xiaofeng; Zheng, Dandan; Zhong, Huanzi; Qin, Bingcai; Gurr, Geoff M.; Vasseur, Liette; Lin, Hailan; Bai, Jianlin; He, Weiyi; You, Minsheng			DNA Sequencing Reveals the Midgut Microbiota of Diamondback Moth, Plutella xylostella (L.) and a Possible Relationship with Insecticide Resistance	PLOS ONE			English	Article							QUANTITATIVE PCR; GUT MICROBIOTA; BACTERIA; MANAGEMENT; DIVERSITY; LEPIDOPTERA; MECHANISMS; SYMBIONTS; INSIGHTS; COST	Background: Insect midgut microbiota is important in host nutrition, development and immune response. Recent studies indicate possible links between insect gut microbiota and resistance to biological and chemical toxins. Studies of this phenomenon and symbionts in general have been hampered by difficulties in culture-based approach. In the present study, DNA sequencing was used to examine the midgut microbiota of diamondback moth (DBM), Plutella xylostella (L.), a destructive pest that attacks cruciferous crops worldwide. Its ability to develop resistance to many types of synthetic insecticide and even Bacillus thuringiensis toxins makes it an important species to study. Methodology/Principal Findings: Bacteria of the DBM larval midgut in a susceptible and two insecticide (chlorpyrifos and fipronil) resistant lines were examined by Illumina sequencing sampled from an insect generation that was not exposed to insecticide. This revealed that more than 97% of the bacteria were from three orders: Enterobacteriales, Vibrionales and Lactobacillales. Both insecticide-resistant lines had more Lactobacillales and the much scarcer taxa Pseudomonadales and Xanthomonadales with fewer Enterobacteriales compared with the susceptible strain. Consistent with this, a second study observed an increase in the proportion of Lactobacillales in the midgut of DBM individuals from a generation treated with insecticides. Conclusions/Significance: This is the first report of high-throughput DNA sequencing of the entire microbiota of DBM. It reveals differences related to inter-and intra-generational exposure to insecticides. Differences in the midgut microbiota among susceptible and insecticide-resistant lines are independent of insecticide exposure in the sampled generations. While this is consistent with the hypothesis that Lactobacillales or other scarcer taxa play a role in conferring DBM insecticide resistance, further studies are necessary to rule out other possibilities. Findings constitute the basis for future molecular work on the functions of insect midgut microbiota taxa and their possible role in conferring host resistance to toxins.	[Xia, Xiaofeng; Zheng, Dandan; Gurr, Geoff M.; Vasseur, Liette; Lin, Hailan; Bai, Jianlin; He, Weiyi; You, Minsheng] Fujian Agr & Forestry Univ, Inst Appl Ecol, Fuzhou, Peoples R China; [Xia, Xiaofeng; Zheng, Dandan; Lin, Hailan; Bai, Jianlin; He, Weiyi; You, Minsheng] Minist Agr, Key Lab Integrated Pest Management Fujian Taiwan, Fuzhou, Peoples R China; [Xia, Xiaofeng] Ctr Dis Control & Prevent, Fuzhou, Peoples R China; [Zhong, Huanzi; Qin, Bingcai] BGI Shenzhen, Shenzhen, Peoples R China; [Gurr, Geoff M.] Charles Sturt Univ, EH Graham Ctr, Orange, NSW, Australia; [Vasseur, Liette] Brock Univ, Dept Biol Sci, St Catharines, ON L2S 3A1, Canada	Fujian Agriculture & Forestry University; Ministry of Agriculture & Rural Affairs; Chinese Center for Disease Control & Prevention; Beijing Genomics Institute (BGI); Charles Sturt University; Brock University	You, MS (corresponding author), Fujian Agr & Forestry Univ, Inst Appl Ecol, Fuzhou, Peoples R China.	msyou@iae.fjau.edu.cn	GURR, GEOFFREY M/F-3519-2011	Gurr, Geoff/0000-0001-5008-7966	Natural Scientific Foundation of China [32230061]	Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	The authors are grateful for the financial support through a project (32230061) by the Natural Scientific Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand AAP, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.10701; Arboleya S, 2012, ANAEROBE, V18, P378, DOI 10.1016/j.anaerobe.2012.04.013; Armougom F., 2009, J COMPUT SCI SYST BI, V2, P74, DOI DOI 10.4172/JCSB.1000019; Barron MG, 1995, REV ENVIRON CONTAM T, V144, P1; Baxter SW, 2008, INSECT BIOCHEM MOLEC, V38, P125, DOI 10.1016/j.ibmb.2007.09.014; Baxter SW, 2005, INSECT MOL BIOL, V14, P327, DOI 10.1111/j.1365-2583.2005.00563.x; Behar A, 2008, J INSECT PHYSIOL, V54, P1377, DOI 10.1016/j.jinsphys.2008.07.011; Broderick NA, 2004, APPL ENVIRON MICROB, V70, P293, DOI 10.1128/AEM.70.1.293-300.2004; Broderick NA, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-11; Chahine S, 2011, J EXP BIOL, V214, P462, DOI 10.1242/jeb.048884; Chakravorty S, 2007, J MICROBIOL METH, V69, P330, DOI 10.1016/j.mimet.2007.02.005; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Dillon RJ, 2005, ECOL LETT, V8, P1291, DOI 10.1111/j.1461-0248.2005.00828.x; Gloor GB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015406; Hainzl D, 1998, CHEM RES TOXICOL, V11, P1529, DOI 10.1021/tx980157t; He WY, 2012, GENOMICS, V99, P169, DOI 10.1016/j.ygeno.2011.12.009; Hernandez-Martinez P, 2010, ENVIRON MICROBIOL, V12, P2730, DOI 10.1111/j.1462-2920.2010.02241.x; Hui XA, 2006, CAN J MICROBIOL, V52, P1085, DOI 10.1139/W06-064; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Indiragandhi P, 2007, J APPL MICROBIOL, V103, P2664, DOI 10.1111/j.1365-2672.2007.03506.x; Kemp PF, 2004, FEMS MICROBIOL ECOL, V47, P161, DOI 10.1016/S0168-6496(03)00257-5; Kikuchi Y, 2013, APPL ENVIRON MICROB, V79, P2088, DOI 10.1128/AEM.03299-12; Kikuchi Y, 2012, P NATL ACAD SCI USA, V109, P8618, DOI 10.1073/pnas.1200231109; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McLean AHC, 2011, P ROY SOC B-BIOL SCI, V278, P760, DOI 10.1098/rspb.2010.1654; Nardini L, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-113; Oliver KM, 2005, P NATL ACAD SCI USA, V102, P12795, DOI 10.1073/pnas.0506131102; Osei-Poku J, 2012, MOL ECOL, V21, P5138, DOI 10.1111/j.1365-294X.2012.05759.x; Pardo-Lopez L, 2013, FEMS MICROBIOL REV, V37, P3, DOI 10.1111/j.1574-6976.2012.00341.x; Pryde SE, 1999, APPL ENVIRON MICROB, V65, P5372; Reddy GVP, 2000, PEST MANAG SCI, V56, P882, DOI 10.1002/1526-4998(200010)56:10<882::AID-PS226>3.0.CO;2-T; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sharon G, 2010, P NATL ACAD SCI USA, V107, P20051, DOI 10.1073/pnas.1009906107; Shelton AM, 2004, CROP PROT, V23, P497, DOI 10.1016/j.cropro.2003.10.005; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Sonoda S, 2010, PESTIC BIOCHEM PHYS, V98, P121, DOI 10.1016/j.pestbp.2010.05.010; TALEKAR NS, 1993, ANNU REV ENTOMOL, V38, P275, DOI 10.1146/annurev.en.38.010193.001423; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tsuchida T, 2004, SCIENCE, V303, P1989, DOI 10.1126/science.1094611; Xiang Hui, 2007, Acta Entomologica Sinica, V50, P222; You MS, 2013, NAT GENET, V45, P220, DOI 10.1038/ng.2524; Zalucki MP, 2012, J ECON ENTOMOL, V105, P1115, DOI 10.1603/EC12107; Zhang HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006108; Zhou HW, 2011, ISME J, V5, P741, DOI 10.1038/ismej.2010.160	44	101	122	7	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e68852	10.1371/journal.pone.0068852	http://dx.doi.org/10.1371/journal.pone.0068852			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894355	Green Submitted, Green Published, gold			2022-12-27	WOS:000322391400027
J	McEwen, JR; Vamosi, JC; Rogers, SM				McEwen, Jamie R.; Vamosi, Jana C.; Rogers, Sean M.			Natural Selection and Neutral Evolution Jointly Drive Population Divergence between Alpine and Lowland Ecotypes of the Allopolyploid Plant Anemone multifida (Ranunculaceae)	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; COMPARATIVE GENOME SCAN; GENE FLOW; LOCAL ADAPTATION; ECOLOGICAL SPECIATION; PHENOTYPIC PLASTICITY; ADAPTIVE EVOLUTION; QUANTITATIVE TRAIT; SPECIES COMPLEX; CANDIDATE LOCI	Population differentiation can be driven in large part by natural selection, but selectively neutral evolution can play a prominent role in shaping patters of population divergence. The decomposition of the evolutionary history of populations into the relative effects of natural selection and selectively neutral evolution enables an understanding of the causes of population divergence and adaptation. In this study, we examined heterogeneous genomic divergence between alpine and lowland ecotypes of the allopolyploid plant, Anemone multifida. Using peak height and dominant AFLP data, we quantified population differentiation at non-outlier (neutral) and outlier loci to determine the potential contribution of natural selection and selectively neutral evolution to population divergence. We found 13 candidate loci, corresponding to 2.7% of loci, with signatures of divergent natural selection between alpine and lowland populations and between alpine populations (Fst = 0.074-0.445 at outlier loci), but neutral population differentiation was also evident between alpine populations (F-ST = 0.041-0.095 at neutral loci). By examining population structure at both neutral and outlier loci, we determined that the combined effects of selection and neutral evolution are associated with the divergence of alpine populations, which may be linked to extreme abiotic conditions and isolation between alpine sites. The presence of outlier levels of genetic variation in structured populations underscores the importance of separately analyzing neutral and outlier loci to infer the relative role of divergent natural selection and neutral evolution in population divergence.	[McEwen, Jamie R.] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Vamosi, Jana C.; Rogers, Sean M.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University of British Columbia; University of Calgary	McEwen, JR (corresponding author), Univ British Columbia, Dept Bot, Vancouver, BC, Canada.	jamie.r.mcewen@gmail.com			Alberta 440 Conservation Association; NSERC Discovery Grant; Alberta Innovates Technology Futures New Faculty Award	Alberta 440 Conservation Association; NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Innovates Technology Futures New Faculty Award	Funding for this project was provided by Alberta 440 Conservation Association, NSERC Discovery Grant, and the Alberta Innovates Technology Futures New Faculty Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEgisdottir HH, 2009, ANN BOT-LONDON, V104, P1313, DOI 10.1093/aob/mcp242; Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; Alberto F, 2010, MOL ECOL, V19, P2626, DOI 10.1111/j.1365-294X.2010.04631.x; Alvarez N, 2009, ECOL LETT, V12, P632, DOI 10.1111/j.1461-0248.2009.01312.x; [Anonymous], 2003, ALPINE PLANT LIFE, DOI DOI 10.1007/978-3-642-18970-8; Apple JL, 2010, MOL ECOL, V19, P4012, DOI 10.1111/j.1365-294X.2010.04792.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernatchez L, 2010, PHILOS T R SOC B, V365, P1783, DOI 10.1098/rstb.2009.0274; Bierne N, 2011, MOL ECOL, V20, P2044, DOI 10.1111/j.1365-294X.2011.05080.x; BILLINGS W D, 1974, Arctic and Alpine Research, V6, P129, DOI 10.2307/1550081; Bonhomme M, 2010, GENETICS, V186, P241, DOI 10.1534/genetics.104.117275; Bonin A, 2007, MOL ECOL, V16, P3737, DOI 10.1111/j.1365-294X.2007.03435.x; Bonin A, 2006, MOL BIOL EVOL, V23, P773, DOI 10.1093/molbev/msj087; Bradbury IR, 2010, P ROY SOC B-BIOL SCI, V277, P3725, DOI 10.1098/rspb.2010.0985; BROWN AHD, 1980, GENETICS, V96, P523; Bryc K, 2010, P NATL ACAD SCI USA, V107, P786, DOI 10.1073/pnas.0909559107; Buehler D, 2012, ANN BOT-LONDON, V109, P1359, DOI 10.1093/aob/mcs066; Burke JM, 1998, EVOLUTION, V52, P1304, DOI 10.2307/2411300; Byars SG, 2007, EVOLUTION, V61, P2925, DOI 10.1111/j.1558-5646.2007.00248.x; Campbell D, 2004, MOL BIOL EVOL, V21, P945, DOI 10.1093/molbev/msh101; CARTER AJ, 1993, BIOL J LINN SOC, V48, P55, DOI 10.1111/j.1095-8312.1993.tb00876.x; Chapman MA, 2010, NEW PHYTOL, V186, P63, DOI 10.1111/j.1469-8137.2009.03091.x; Charlesworth B, 1997, GENET RES, V70, P155, DOI 10.1017/S0016672397002954; Cox K, 2011, MOL ECOL, V20, P2724, DOI 10.1111/j.1365-294X.2011.05137.x; Coyne J.A., 2004, SPECIATION; DOBZHANSKY T, 1957, EVOLUTION, V11, P311, DOI 10.2307/2405795; Egan SP, 2008, EVOLUTION, V62, P1162, DOI 10.1111/j.1558-5646.2008.00352.x; EMERY RJN, 1994, INT J PLANT SCI, V155, P203, DOI 10.1086/297160; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Feder JL, 2010, EVOLUTION, V64, P1729, DOI [10.1111/j.1558-5646.2009.00943.x, 10.1111/j.1558-5646.2010.00943.x]; Fischer MC, 2011, MOL ECOL, V20, P1450, DOI 10.1111/j.1365-294X.2011.05015.x; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Foll M, 2010, MOL ECOL, V19, P4638, DOI 10.1111/j.1365-294X.2010.04820.x; Freedman AH, 2010, MOL ECOL, V19, P3773, DOI 10.1111/j.1365-294X.2010.04684.x; Funk DJ, 2011, MOL ECOL, V20, P4671, DOI 10.1111/j.1365-294X.2011.05311.x; Gandon S, 2009, AM NAT, V173, P212, DOI 10.1086/593706; Garant D, 2007, FUNCT ECOL, V21, P434, DOI 10.1111/j.1365-2435.2006.01228.x; Gaudeul M, 2004, HEREDITY, V92, P508, DOI 10.1038/sj.hdy.6800443; Gavrilets S, 1996, AM NAT, V147, P466, DOI 10.1086/285861; Gonzalo-Turpin H, 2009, J ECOL, V97, P742, DOI 10.1111/j.1365-2745.2009.01509.x; Hamilton MB, 2009, POPOULATION GENETICS; Haubold B, 1998, GENETICS, V150, P1341; Hofer T, 2009, ANN HUM GENET, V73, P95, DOI 10.1111/j.1469-1809.2008.00489.x; Honnay O, 2009, J ECOL, V97, P131, DOI 10.1111/j.1365-2745.2008.01452.x; HOOT SB, 1994, SYST BOT, V19, P169, DOI 10.2307/2419720; Huang CC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-108; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hughes C, 2006, P NATL ACAD SCI USA, V103, P10334, DOI 10.1073/pnas.0601928103; Ikeda H, 2010, MOL ECOL, V19, P2779, DOI 10.1111/j.1365-294X.2010.04700.x; Keller SR, 2008, ECOL LETT, V11, P852, DOI 10.1111/j.1461-0248.2008.01188.x; Khanuja SPS, 1999, PLANT MOL BIOL REP, V17, P74, DOI 10.1023/A:1007528101452; Kimura M., 1983, NEUTRAL THEORY MOL E; Klopfstein S, 2006, MOL BIOL EVOL, V23, P482, DOI 10.1093/molbev/msj057; Leinonen T, 2008, J EVOLUTION BIOL, V21, P1, DOI 10.1111/j.1420-9101.2007.01445.x; Lenormand T, 2002, TRENDS ECOL EVOL, V17, P183, DOI 10.1016/S0169-5347(02)02497-7; Lewontin RC, 1974, GENETIC BASIS EVOLUT; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; MARUYAMA T, 1985, GENETICS, V111, P675; McEwen JR, 2010, P ROY SOC B-BIOL SCI, V277, P2957, DOI 10.1098/rspb.2010.0501; Meirmans PG, 2011, MOL ECOL, V20, P3144, DOI 10.1111/j.1365-294X.2011.05164.x; Meyer KM, 2010, INT J PLANT SCI, V171, P323, DOI 10.1086/650153; Mraz P, 2007, J BIOGEOGR, V34, P2100, DOI 10.1111/j.1365-2699.2007.01765.x; Nicotra AB, 2010, TRENDS PLANT SCI, V15, P684, DOI 10.1016/j.tplants.2010.09.008; Nosil P, 2009, MOL ECOL, V18, P375, DOI 10.1111/j.1365-294X.2008.03946.x; Nunes VL, 2011, MOL ECOL, V20, P193, DOI 10.1111/j.1365-294X.2010.04936.x; Orr HA, 1998, GENETICS, V149, P2099; Paris M, 2012, MOL ECOL, V21, P1672, DOI 10.1111/j.1365-294X.2012.05499.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peichel CL, 2001, NATURE, V414, P901, DOI 10.1038/414901a; Piepho HP, 2000, GENETICS, V155, P1459; Pinceel J, 2005, MOL ECOL, V14, P1133, DOI 10.1111/j.1365-294X.2005.02479.x; Poncet BN, 2010, MOL ECOL, V19, P2896, DOI 10.1111/j.1365-294X.2010.04696.x; Presgraves DC, 2003, NATURE, V423, P715, DOI 10.1038/nature01679; Pritchard JK, 2000, GENETICS, V155, P945; R Core Development Team, 2008, R LANG ENV STAT COMP; Rasanen K, 2008, ECOL LETT, V11, P624, DOI 10.1111/j.1461-0248.2008.01176.x; Renaut S, 2012, PHILOS T R SOC B, V367, P354, DOI 10.1098/rstb.2011.0197; Riquet F, 2013, MOL ECOL, V22, P1003, DOI 10.1111/mec.12161; Rogers SM, 2007, GENETICS, V175, P375, DOI 10.1534/genetics.106.061457; Rogers SM, 2006, J EVOLUTION BIOL, V19, P1979, DOI 10.1111/j.1420-9101.2006.01150.x; Rogers SM, 2005, MOL ECOL, V14, P351, DOI 10.1111/j.1365-294X.2004.02396.x; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Schemske DW, 1999, P NATL ACAD SCI USA, V96, P11910, DOI 10.1073/pnas.96.21.11910; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Schluter D, 2010, PHILOS T R SOC B, V365, P2479, DOI 10.1098/rstb.2010.0036; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Schonswetter P, 2003, MOL ECOL, V12, P3373, DOI 10.1046/j.1365-294X.2003.01984.x; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Stern DL, 2009, SCIENCE, V323, P746, DOI 10.1126/science.1158997; Stinchcombe JR, 2008, HEREDITY, V100, P158, DOI 10.1038/sj.hdy.6800937; Strasburg JL, 2012, PHILOS T R SOC B, V367, P364, DOI 10.1098/rstb.2011.0199; Svedin N, 2008, P ROY SOC B-BIOL SCI, V275, P735, DOI 10.1098/rspb.2007.0967; Vekemans X, 2002, MOL ECOL, V11, P139, DOI 10.1046/j.0962-1083.2001.01415.x; Via S, 2008, MOL ECOL, V17, P4334, DOI 10.1111/j.1365-294X.2008.03921.x; White TA, 2010, MOL ECOL, V19, P216, DOI 10.1111/j.1365-294X.2009.04446.x; Whitehead A, 2006, P NATL ACAD SCI USA, V103, P5425, DOI 10.1073/pnas.0507648103; Whitlock MC, 2008, MOL ECOL, V17, P1885, DOI 10.1111/j.1365-294X.2008.03712.x; Yeaman S, 2011, EVOLUTION, V65, P2123, DOI 10.1111/j.1558-5646.2011.01277.x; Zhivotovsky LA, 1999, MOL ECOL, V8, P907, DOI 10.1046/j.1365-294x.1999.00620.x	102	7	7	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e68889	10.1371/journal.pone.0068889	http://dx.doi.org/10.1371/journal.pone.0068889			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874801	Green Published, gold, Green Submitted			2022-12-27	WOS:000324146200035
J	Zhu, JM; Zhang, JF; Ji, M; Gu, HW; Xu, Y; Chen, C; Hu, N				Zhu, Juming; Zhang, Junfang; Ji, Min; Gu, Hongwei; Xu, Yue; Chen, Chen; Hu, Nan			The Role of Peroxisome Proliferator-Activated Receptor and Effects of Its Agonist, Pioglitazone, on a Rat Model of Optic Nerve Crush: PPAR gamma in Retinal Neuroprotection	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; GANGLION-CELL DAMAGE; MOUSE MODEL; ROSIGLITAZONE; GLAUCOMA; INHIBITION; MECHANISMS; EXPRESSION; PROTECTION; NEUROPATHY	It has been shown that peroxisome proliferators-activated receptor gamma (PPAR gamma) is beneficial for central nervous system injury. However its role on optic nerve injury remains unknown. In the present study, we examined the change of PPAR gamma expression in rat retina following optic nerve injury and investigated the effect of pioglitazone (Pio), a PPAR gamma agonist, on retinal ganglion cells (RGCs) neuroprotection using a rat optic nerve crush (ONC) model. Our results showed that PPAR gamma mRNA and protein levels were increased after ONC, and most of PPAR gamma-immunoreactive cells colocalized with Muller cells. Pio treatment significantly enhanced the number of surviving RGCs and inhibited RGCs apoptosis induced by ONC. However, when PPAR gamma antagonist GW9662 was used, these neuroprotective effects were abolished. In addition, pio attenuated Muller cell activation after ONC. These results indicate that PPAR gamma appears to protect RGCs from ONC possibly via the reduction of Muller glial activation. It provides evidence that activation of PPAR gamma may be a potential alternative treatment for RGCs neuroprotection.	[Zhu, Juming; Zhang, Junfang; Ji, Min; Gu, Hongwei; Xu, Yue; Chen, Chen; Hu, Nan] Nantong Univ, Inst Eye, Nantong, Peoples R China	Nantong University	Hu, N (corresponding author), Nantong Univ, Inst Eye, Nantong, Peoples R China.	hunaneye@hotmail.com			science and technology project of Nantong, China [BK2012070]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); National Natural Science Foundation of China [81200680]	science and technology project of Nantong, China; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the science and technology project of Nantong, China (No. BK2012070), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) and the National Natural Science Foundation of China (No: 81200680). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoun P, 2003, INVEST OPHTH VIS SCI, V44, P2999, DOI 10.1167/iovs.02-1060; Bernardo A, 2000, EUR J NEUROSCI, V12, P2215, DOI 10.1046/j.1460-9568.2000.00110.x; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Bringmann A, 2012, OPHTHALMOLOGICA, V227, P1, DOI 10.1159/000328979; Carta AR, 2011, NEUROSCIENCE, V194, P250, DOI 10.1016/j.neuroscience.2011.07.046; Chidlow G, 2007, DRUGS, V67, P725, DOI 10.2165/00003495-200767050-00006; Escher P, 2000, MUTAT RES-FUND MOL M, V448, P121, DOI 10.1016/S0027-5107(99)00231-6; Escribano L, 2009, BIOCHEM BIOPH RES CO, V379, P406, DOI 10.1016/j.bbrc.2008.12.071; Esposito E, 2011, EXPERT OPIN THER TAR, V15, P943, DOI 10.1517/14728222.2011.581231; Fu QL, 2009, NEUROSCIENCE, V162, P375, DOI 10.1016/j.neuroscience.2009.04.075; Goldblum D, 2002, VISION RES, V42, P471, DOI 10.1016/S0042-6989(01)00194-8; Herzlich Alexandra A, 2009, Open Biol J, V2, P141; Kiaei M, 2005, EXP NEUROL, V191, P331, DOI 10.1016/j.expneurol.2004.10.007; Kisiswa L, 2010, OPHTHALMIC RES, V43, P61, DOI 10.1159/000247591; Kusari J, 2007, INVEST OPHTH VIS SCI, V48, P5152, DOI 10.1167/iovs.07-0427; Lee CH, 2011, J NEUROL SCI, V300, P120, DOI 10.1016/j.jns.2010.09.005; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Leung CKS, 2008, INVEST OPHTH VIS SCI, V49, P4898, DOI 10.1167/iovs.07-1447; Mabuchi F, 2004, INVEST OPHTH VIS SCI, V45, P4352, DOI 10.1167/iovs.04-0355; Mackenzie P, 2008, SURV OPHTHALMOL, V53, pS39, DOI 10.1016/j.survophthal.2008.08.008; Michalik L, 2002, INT J DEV BIOL, V46, P105; Nakazawa T, 2006, MOL VIS, V12, P867; Neufeld AH, 2003, NEUROSCIENTIST, V9, P485, DOI 10.1177/1073858403253460; Pershadsingh HA, 2008, PPAR RES, V2008, DOI 10.1155/2008/164273; Qi L, 2010, INT J CLIN EXP MED, V3, P283; Quigley HA, 2000, INVEST OPHTH VIS SCI, V41, P3460; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Sarayba MA, 2005, EXP EYE RES, V80, P435, DOI 10.1016/j.exer.2004.10.009; Schmidt KG, 2008, CURR NEUROPHARMACOL, V6, P164, DOI 10.2174/157015908784533851; Schwartz M, 2004, BRAIN RES BULL, V62, P467, DOI 10.1016/S0361-9230(03)00076-5; Sucher NJ, 1997, VISION RES, V37, P3483, DOI 10.1016/S0042-6989(97)00047-3; Tezel G, 2006, PROG RETIN EYE RES, V25, P490, DOI 10.1016/j.preteyeres.2006.07.003; Tura A, 2009, INVEST OPHTH VIS SCI, V50, P452, DOI 10.1167/iovs.08-1973; Victor NA, 2006, EUR J NEUROSCI, V24, P1653, DOI 10.1111/j.1460-9568.2006.05037.x; Vidal-Sanz M, 2000, NEUROTOX RES, V2, P215, DOI 10.1007/BF03033795; Vigneswara V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053473; Wilhelm B, 2006, GRAEF ARCH CLIN EXP, V244, P551, DOI 10.1007/s00417-005-0102-8; Yi JH, 2008, BRAIN RES, V1244, P164, DOI 10.1016/j.brainres.2008.09.074; Zhao Y, 2006, FASEB J, V20, P1162, DOI 10.1096/fj.05-5007com	39	20	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e68935	10.1371/journal.pone.0068935	http://dx.doi.org/10.1371/journal.pone.0068935			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874818	Green Published, Green Submitted, gold			2022-12-27	WOS:000324146200040
J	Tomar, P; Bhatia, A; Ramdas, S; Diao, LY; Bhanot, G; Sinha, H				Tomar, Parul; Bhatia, Aatish; Ramdas, Shweta; Diao, Liyang; Bhanot, Gyan; Sinha, Himanshu			Sporulation Genes Associated with Sporulation Efficiency in Natural Isolates of Yeast	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; POPULATION-STRUCTURE; GENOME; PROGRAM; GROWTH	Yeast sporulation efficiency is a quantitative trait and is known to vary among experimental populations and natural isolates. Some studies have uncovered the genetic basis of this variation and have identified the role of sporulation genes (IME1, RME1) and sporulation-associated genes (FKH2, PMS1, RAS2, RSF1, SWS2), as well as non-sporulation pathway genes (MKT1, TAO3) in maintaining this variation. However, these studies have been done mostly in experimental populations. Sporulation is a response to nutrient deprivation. Unlike laboratory strains, natural isolates have likely undergone multiple selections for quick adaptation to varying nutrient conditions. As a result, sporulation efficiency in natural isolates may have different genetic factors contributing to phenotypic variation. Using Saccharomyces cerevisiae strains in the genetically and environmentally diverse SGRP collection, we have identified genetic loci associated with sporulation efficiency variation in a set of sporulation and sporulation-associated genes. Using two independent methods for association mapping and correcting for population structure biases, our analysis identified two linked clusters containing 4 non-synonymous mutations in genes - HOS4, MCK1, SET3, and SPO74. Five regulatory polymorphisms in five genes such as MLS1 and CDC10 were also identified as putative candidates. Our results provide candidate genes contributing to phenotypic variation in the sporulation efficiency of natural isolates of yeast.	[Tomar, Parul; Ramdas, Shweta; Bhanot, Gyan; Sinha, Himanshu] Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India; [Bhatia, Aatish; Bhanot, Gyan] Rutgers State Univ, Dept Phys & Astron, Piscataway, NJ USA; [Diao, Liyang; Bhanot, Gyan] Rutgers State Univ, BioMaPS Inst Quantitat Biol, Piscataway, NJ USA; [Bhanot, Gyan] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08855 USA; [Bhanot, Gyan] Canc Inst New Jersey, New Brunswick, NJ USA; [Bhanot, Gyan] Inst Adv Study, Simons Ctr Syst Biol, Princeton, NJ 08540 USA	Tata Institute of Fundamental Research (TIFR); Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Institute for Advanced Study - USA	Sinha, H (corresponding author), Tata Inst Fundamental Res, Dept Biol Sci, Homi Bhabha Rd, Bombay 400005, Maharashtra, India.	hsinha@tifr.res.in	Ramdas, Shweta/J-7712-2019; Sinha, Himanshu/AAT-7853-2021	Ramdas, Shweta/0000-0001-8888-4661; Sinha, Himanshu/0000-0001-7031-0491	Tata Institute of Fundamental Research; National Science Foundation [NSF PHY11-25915]; National Institutes of Health [R00HG004515]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R00HG004515] Funding Source: NIH RePORTER	Tata Institute of Fundamental Research(Tata Institute of Fundamental Research (TIFR)); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by intra-mural funds from Tata Institute of Fundamental Research to HS. The work of GB was supported in part by the National Science Foundation (NSF PHY11-25915). The work of LD was partially funded by the National Institutes of Health grant (R00HG004515) to her supervisor Kevin C. Chen, Rutgers University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; Ben-Ari G, 2006, PLOS GENET, V2, P1815, DOI 10.1371/journal.pgen.0020195; Broman KW, 2009, STAT BIOL HEALTH, P1, DOI 10.1007/978-0-387-92125-9_1; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; CODON AC, 1995, APPL ENVIRON MICROB, V61, P630; Connelly CF, 2012, GENETICS, V191, P1345, DOI 10.1534/genetics.112.141168; Cubillos FA, 2009, FEMS YEAST RES, V9, P1217, DOI 10.1111/j.1567-1364.2009.00583.x; Deutschbauer AM, 2005, NAT GENET, V37, P1333, DOI 10.1038/ng1674; Deutschbauer AM, 2002, P NATL ACAD SCI USA, V99, P15530, DOI 10.1073/pnas.202604399; Diao LY, 2012, GENETICS, V192, P1503, DOI 10.1534/genetics.112.144790; Enyenihi AH, 2003, GENETICS, V163, P47; Gerke J, 2009, SCIENCE, V323, P498, DOI 10.1126/science.1166426; Gerke JP, 2006, GENETICS, V174, P985, DOI 10.1534/genetics.106.058453; KALLAL LA, 1990, CURR GENET, V18, P293, DOI 10.1007/BF00318210; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Mortimer RK, 2000, GENOME RES, V10, P403, DOI 10.1101/gr.10.4.403; NEIGEBORN L, 1991, GENE DEV, V5, P533, DOI 10.1101/gad.5.4.533; Neiman AM, 2011, GENETICS, V189, P737, DOI 10.1534/genetics.111.127126; Neiman AM, 2005, MICROBIOL MOL BIOL R, V69, P565, DOI 10.1128/MMBR.69.4.565-584.2005; Nickas ME, 2003, EUKARYOT CELL, V2, P431, DOI 10.1128/EC.2.3.431-445.2003; Pijnappel WWMP, 2001, GENE DEV, V15, P2991, DOI 10.1101/gad.207401; Primig M, 2000, NAT GENET, V26, P415, DOI 10.1038/82539; Pritchard JK, 2000, GENETICS, V155, P945; Rose MD., 1990, METHODS YEAST GENETI; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a	26	14	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e69765	10.1371/journal.pone.0069765	http://dx.doi.org/10.1371/journal.pone.0069765			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23874994	gold, Green Published, Green Submitted			2022-12-27	WOS:000322000600058
J	Ke, RQ; Nong, RY; Fredriksson, S; Landegren, U; Nilsson, M				Ke, Rongqin; Nong, Rachel Yuan; Fredriksson, Simon; Landegren, Ulf; Nilsson, Mats			Improving Precision of Proximity Ligation Assay by Amplified Single Molecule Detection	PLOS ONE			English	Article							PROTEIN-DETECTION; CANCER; PCR; QUANTIFICATION; AMPLIFICATION; RECOGNITION; BIOMARKERS; DNA	Proximity ligation assay (PLA) has been proven to be a robust protein detection method. The technique is characterized by high sensitivity and specificity, but the assay precision is probably limited by the PCR readout. To investigate this potential limitation and to improve precision, we developed a digital proximity ligation assay for protein measurement in fluids based on amplified single molecule detection. The assay showed significant improvements in precision, and thereby also detection sensitivity, over the conventional real-time PCR readout.	[Ke, Rongqin; Nilsson, Mats] Stockholm Univ, Dept Biochem & Biophys, Sci Life Lab, Solna, Sweden; [Ke, Rongqin; Nong, Rachel Yuan; Landegren, Ulf; Nilsson, Mats] Uppsala Univ, Dept Immunol Genet & Pathol, Rudbeck Lab, Sci Life Lab, Uppsala, Sweden; [Fredriksson, Simon] Olink Biosci, Uppsala, Sweden	Stockholm University; Uppsala University	Landegren, U (corresponding author), Uppsala Univ, Dept Immunol Genet & Pathol, Rudbeck Lab, Sci Life Lab, Uppsala, Sweden.	ulf.landegren@igp.uu.se; mats.nilsson@scilifelab.se	Landegren, Ulf D/A-8197-2019; Nong, Rachel Yuan/AAM-1591-2020; Ke, Rongqin/P-2701-2019; Ke, Rongqin/D-1897-2014	Ke, Rongqin/0000-0002-9868-3713; Ke, Rongqin/0000-0002-9868-3713	Knut and Alice Wallenberg foundation; Swedish Research Council; European Community [259796]	Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); European Community(European Commission)	The work was funded by grants from the Knut and Alice Wallenberg foundation, the Swedish Research Council, and the European Community's 7th Framework Program (FP7/2007-2013) under grant agreement no259796 (DiaTools). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016; Darmanis S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025583; Darmanis S, 2010, MOL CELL PROTEOMICS, V9, P327, DOI 10.1074/mcp.M900248-MCP200; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Fredriksson S, 2007, NAT METHODS, V4, P327, DOI 10.1038/NMETH1020; Goransson J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031068; Gullberg M, 2004, P NATL ACAD SCI USA, V101, P8420, DOI 10.1073/pnas.0400552101; Jarvius J, 2006, NAT METHODS, V3, P725, DOI 10.1038/NMETH916; Kamali-Moghaddam M, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-124; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; Nam JM, 2003, SCIENCE, V301, P1884, DOI 10.1126/science.1088755; Rissin DM, 2010, NAT BIOTECHNOL, V28, P595, DOI 10.1038/nbt.1641; Rutledge RG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng093; SYKES PJ, 1992, BIOTECHNIQUES, V13, P444; Tavoosidana G, 2011, P NATL ACAD SCI USA, V108, P8809, DOI 10.1073/pnas.1019330108; Tessler LA, 2009, ANAL CHEM, V81, P7141, DOI 10.1021/ac901068x; Todd J, 2007, CLIN CHEM, V53, P1990, DOI 10.1373/clinchem.2007.091181; Wang J, 2004, J AM CHEM SOC, V126, P3010, DOI 10.1021/ja031723w; Williams R, 2006, NAT METHODS, V3, P545, DOI 10.1038/NMETH896; Zhang HQ, 2007, ANALYST, V132, P724, DOI 10.1039/b704256f	20	26	28	5	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e69813	10.1371/journal.pone.0069813	http://dx.doi.org/10.1371/journal.pone.0069813			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874999	gold, Green Published, Green Submitted			2022-12-27	WOS:000322064300117
J	Uchikoga, N; Matsuzaki, Y; Ohue, M; Hirokawa, T; Akiyama, Y				Uchikoga, Nobuyuki; Matsuzaki, Yuri; Ohue, Masahito; Hirokawa, Takatsugu; Akiyama, Yutaka			Re-Docking Scheme for Generating Near-Native Protein Complexes by Assembling Residue Interaction Fingerprints	PLOS ONE			English	Article							PSI-BLAST; SEARCHES	Interaction profile method is a useful method for processing rigid-body docking. After the docking process, the resulting set of docking poses could be classified by calculating similarities among them using these interaction profiles to search for near-native poses. However, there are some cases where the near-native poses are not included in this set of docking poses even when the bound-state structures are used. Therefore, we have developed a method for generating near-native docking poses by introducing a re-docking process. We devised a method for calculating the profile of interaction fingerprints by assembling protein complexes after determining certain core-protein complexes. For our analysis, we used 44 bound-state protein complexes selected from the ZDOCK benchmark dataset ver. 2.0, including some protein pairs none of which generated near-native poses in the docking process. Consequently, after the re-docking process we obtained profiles of interaction fingerprints, some of which yielded near-native poses. The re-docking process involved searching for possible docking poses in a restricted area using the profile of interaction fingerprints. If the profile includes interactions identical to those in the native complex, we obtained near-native docking poses. Accordingly, near-native poses were obtained for all bound-state protein complexes examined here. Application of interaction fingerprints to the re-docking process yielded structures with more native interactions, even when a docking pose, obtained following the initial docking process, contained only a small number of native amino acid interactions. Thus, utilization of the profile of interaction fingerprints in the re-docking process yielded more near-native poses.	[Uchikoga, Nobuyuki] Chuo Univ, Dept Phys, Tokyo 112, Japan; [Uchikoga, Nobuyuki; Matsuzaki, Yuri; Akiyama, Yutaka] RIKEN, Grand Challenge Applicat Project Life Sci, Next Generat Integrated Simulat Living Matter, Computat Sci Res Program, Wako, Saitama, Japan; [Matsuzaki, Yuri; Ohue, Masahito; Akiyama, Yutaka] Tokyo Inst Technol, Dept Comp Sci, Grad Sch Informat Sci & Engn, Meguro Ku, Tokyo 152, Japan; [Ohue, Masahito] Japan Soc Promot Sci, Tokyo, Japan; [Ohue, Masahito; Akiyama, Yutaka] Tokyo Inst Technol, Educ Acad Computat Life Sci, Meguro Ku, Tokyo 152, Japan; [Hirokawa, Takatsugu] AIST, Computat Bioinformat Res Ctr, Koto Ku, Tokyo, Japan	Chuo University; RIKEN; Tokyo Institute of Technology; Japan Society for the Promotion of Science; Tokyo Institute of Technology; National Institute of Advanced Industrial Science & Technology (AIST)	Uchikoga, N (corresponding author), Chuo Univ, Dept Phys, Bunkyo Ku, Tokyo 112, Japan.	uchikoga@phys.chuo-u.ac.jp	Matsuzaki, Yuri/AAE-3288-2022; Ohue, Masahito/G-1369-2018; Akiyama, Yutaka/D-2048-2015	Matsuzaki, Yuri/0000-0002-6129-6883; Ohue, Masahito/0000-0002-0120-1643; Akiyama, Yutaka/0000-0003-2863-8703	Next-Generation Integrated Simulation of Living Matter	Next-Generation Integrated Simulation of Living Matter	Funded by Next-Generation Integrated Simulation of Living Matter (http://www.csrp.riken.jp/index_e.html). Part of the results were obtained by using the K computer at the RIKEN Advanced Institute for Computational Science (research proposal number hp120131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Altschul SF, 1998, TRENDS BIOCHEM SCI, V23, P444, DOI 10.1016/S0968-0004(98)01298-5; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Chen R, 2003, PROTEINS, V52, P88, DOI 10.1002/prot.10390; Chuaqui C, 2005, J MED CHEM, V48, P121, DOI 10.1021/jm049312t; Deng Z, 2006, J MED CHEM, V49, P490, DOI 10.1021/jm050381x; Deng Z, 2004, J MED CHEM, V47, P337, DOI 10.1021/jm030331x; Holliday JD, 2003, J CHEM INF COMP SCI, V43, P819, DOI 10.1021/ci034001x; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Kawabata T, 1999, NUCLEIC ACIDS RES, V27, P355, DOI 10.1093/nar/27.1.355; Kelly MD, 2004, J CHEM INF COMP SCI, V44, P1942, DOI 10.1021/ci049870g; Kumar A, 2008, J MOL GRAPH MODEL, V27, P476, DOI 10.1016/j.jmgm.2008.08.005; Marcou G, 2007, J CHEM INF MODEL, V47, P195, DOI 10.1021/ci600342e; Mintseris J, 2005, PROTEINS, V60, P214, DOI 10.1002/prot.20560; Mpamhanga CP, 2006, J CHEM INF MODEL, V46, P686, DOI 10.1021/ci050420d; Nandigam RK, 2009, J CHEM INF MODEL, V49, P1185, DOI 10.1021/ci800466n; Perez-Nueno VI, 2009, J CHEM INF MODEL, V49, P1245, DOI 10.1021/ci900043r; Pierce B, 2007, PROTEINS, V67, P1078, DOI 10.1002/prot.21373; Pierce BG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024657; Sato T, 2010, J CHEM INF MODEL, V50, P170, DOI 10.1021/ci900382e; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Singh J, 2006, CHEM BIOL DRUG DES, V67, P5, DOI 10.1111/j.1747-0285.2005.00323.x; Smith GR, 2002, CURR OPIN STRUC BIOL, V12, P28, DOI 10.1016/S0959-440X(02)00285-3; TVERSKY A, 1977, PSYCHOL REV, V84, P327, DOI 10.1037/h0026750; Uchikoga N, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-236; Vajda S, 2009, CURR OPIN STRUC BIOL, V19, P164, DOI 10.1016/j.sbi.2009.02.008; Venhorst J, 2008, J MED CHEM, V51, P3222, DOI 10.1021/jm8001058; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127	29	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e69365	10.1371/journal.pone.0069365	http://dx.doi.org/10.1371/journal.pone.0069365			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874954	Green Published, Green Submitted, gold			2022-12-27	WOS:000322064300100
J	Zhang, JB; Li, RQ; Xiang, XG; Manchester, SR; Lin, L; Wang, W; Wen, J; Chen, ZD				Zhang, Jing-Bo; Li, Rui-Qi; Xiang, Xiao-Guo; Manchester, Steven R.; Lin, Li; Wang, Wei; Wen, Jun; Chen, Zhi-Duan			Integrated Fossil and Molecular Data Reveal the Biogeographic Diversification of the Eastern Asian-Eastern North American Disjunct Hickory Genus (Carya Nutt.)	PLOS ONE			English	Article							ATLANTIC LAND-BRIDGE; DIVERGENCE TIMES; POSTGLACIAL EXPANSION; GEOGRAPHIC RANGE; TIBETAN PLATEAU; PLANT DIVERSITY; MASS EXTINCTION; EVOLUTION; PHYLOGENY; TERTIARY	The hickory genus (Carya) contains ca. 17 species distributed in subtropical and tropical regions of eastern Asia and subtropical to temperate regions of eastern North America. Previously, the phylogenetic relationships between eastern Asian and eastern North American species of Carya were not fully confirmed even with an extensive sampling, biogeographic and diversification patterns had thus never been investigated in a phylogenetic context. We sampled 17 species of Carya and 15 species representing all other genera of the Juglandaceae as outgroups, with eight nuclear and plastid loci to reconstruct the phylogeny of Carya. The phylogenetic positions of seven extinct genera of the Juglandaceae were inferred using morphological characters and the molecular phylogeny as a backbone constraint. Divergence times within Carya were estimated with relaxed Bayesian dating. Biogeographic analyses were performed in DIVA and LAGRANGE. Diversification rates were inferred by LASER and APE packages. Our results support two major clades within Carya, corresponding to the lineages of eastern Asia and eastern North America. The split between the two disjunct clades is estimated to be 21.58 (95% HPD 11.07-35.51) Ma. Genus-level DIVA and LAGRANGE analyses incorporating both extant and extinct genera of the Juglandaceae suggested that Carya originated in North America, and migrated to Eurasia during the early Tertiary via the North Atlantic land bridge. Fragmentation of the distribution caused by global cooling in the late Tertiary resulted in the current disjunction. The diversification rate of hickories in eastern North America appeared to be higher than that in eastern Asia, which is ascribed to greater ecological opportunities, key morphological innovations, and polyploidy.	[Zhang, Jing-Bo; Li, Rui-Qi; Xiang, Xiao-Guo; Lin, Li; Wang, Wei; Chen, Zhi-Duan] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Manchester, Steven R.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Wen, Jun] Smithsonian Inst, Dept Bot, Natl Museum Nat Hist, Washington, DC 20560 USA	Chinese Academy of Sciences; Institute of Botany, CAS; State University System of Florida; University of Florida; Smithsonian Institution; Smithsonian National Museum of Natural History	Wen, J (corresponding author), Smithsonian Inst, Dept Bot, Natl Museum Nat Hist, Washington, DC 20560 USA.	wenj@si.edu; zhiduan@ibcas.ac.cn		Zhang, Jingbo/0000-0002-5683-9660	National Natural Science Foundation of China [NNSF 31270268, NNSF 31061160184]; Chinese Academy of Sciences [2011T1S24]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the National Natural Science Foundation of China (NNSF 31270268 and NNSF 31061160184) and Chinese Academy of Sciences Visiting Professorship for Senior International Scientists (2011T1S24). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; [Anonymous], 1971, ATLAS US TREES; [Anonymous], 1967, BERING LAND BRIDGE; Antonelli A, 2011, SYST BIOL, V60, P596, DOI 10.1093/sysbio/syr062; Austin JD, 2004, MOL PHYLOGENET EVOL, V32, P799, DOI 10.1016/j.ympev.2004.03.006; Austin JD, 2002, MOL PHYLOGENET EVOL, V25, P316, DOI 10.1016/S1055-7903(02)00260-9; BARRACLOUGH TG, 1995, P ROY SOC B-BIOL SCI, V259, P211, DOI 10.1098/rspb.1995.0031; BUDANTSEV LY, 1992, BOT REV, V58, P1, DOI 10.1007/BF02858542; Burbrink FT, 2000, EVOLUTION, V54, P2107, DOI 10.1554/0014-3820(2000)054[2107:MDPOTP]2.0.CO;2; Chen R.Y, 1993, CHROMOSOME ATLAS CHI, V1; Church SA, 2003, EVOLUTION, V57, P372; Cleaves ET, 1989, GEOMORPHOLOGY, V2, P159, DOI DOI 10.1016/0169-555X(89)90010-X; CRACRAFT J, 1985, ANN MO BOT GARD, V72, P794, DOI 10.2307/2399222; Crisp MD, 2001, J BIOGEOGR, V28, P183, DOI 10.1046/j.1365-2699.2001.00524.x; Davis CC, 2002, SYST BOT, V27, P289; Davis CC, 2002, EVOLUTION, V56, P2395; Denk T, 2010, AM J BOT, V97, P276, DOI 10.3732/ajb.0900195; Dennison JM, 2001, GEOL SOC AM SE SEC M, V50, P5; DILCHER DL, 1976, AM J BOT, V63, P532, DOI 10.2307/2441817; Donoghue MJ, 2004, PHILOS T R SOC B, V359, P1633, DOI 10.1098/rstb.2004.1538; Donoghue MJ, 2001, INT J PLANT SCI, V162, pS41, DOI 10.1086/323278; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dunbar CO, 1949, HIST GEOLOGY; Fawcett JA, 2009, P NATL ACAD SCI USA, V106, P5737, DOI 10.1073/pnas.0900906106; Givnish TJ, 2011, AM J BOT, V98, P872, DOI 10.3732/ajb.1000059; Guo QF, 1998, BOT J LINN SOC, V128, P123, DOI 10.1111/j.1095-8339.1998.tb02111.x; Hack J.T., 1982, PHYSIOGRAPHIC DIVISI; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HARRISON TM, 1992, SCIENCE, V255, P1663, DOI 10.1126/science.255.5052.1663; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; HILLIS DM, 1987, ANNU REV ECOL SYST, V18, P23, DOI 10.1146/annurev.es.18.110187.000323; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; Hodges SA, 1995, P ROY SOC B-BIOL SCI, V262, P343, DOI 10.1098/rspb.1995.0215; Hong D.Y., 1993, CATHAYA, V5, P1; HSU J, 1983, ANN MO BOT GARD, V70, P490, DOI 10.2307/2992084; IlJinskaya, 1970, TR BOT I AKAD NAUK S, V10, P7; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leache AD, 2002, SYST BIOL, V51, P44, DOI 10.1080/106351502753475871; Lemmon EM, 2007, EVOLUTION, V61, P2086, DOI 10.1111/j.1558-5646.2007.00181.x; Leroy JF, 1955, B MUSEUMS NATL HIS B, V6B, P1; Li JJ, 1999, CHINESE SCI BULL, V44, P2117, DOI 10.1007/BF03182692; Li RQ, 2004, INT J PLANT SCI, V165, P311, DOI 10.1086/381920; Linder HP, 2001, J BIOGEOGR, V28, P169, DOI 10.1046/j.1365-2699.2001.00527.x; Liu J, 2007, NEWSLETT HIMALAYAN B, V40, P20; Lopez-Pujol J, 2011, J BIOGEOGR, V38, P1267, DOI 10.1111/j.1365-2699.2011.02504.x; Lu A. M., 1982, Acta Phytotaxonomica Sinica, V20, P257; Lu A.M., 1999, FLORA CHINA; Magallon S, 2001, EVOLUTION, V55, P1762, DOI 10.1111/j.0014-3820.2001.tb00826.x; Mai D.H., 1981, FEDDES REPERT, V92, P339, DOI [10.1002/fedr.4910920502, DOI 10.1002/FEDR.19810920502, DOI 10.1002/FEDR.4910920502]; Mai DH, 1995, TERTIARE VEGETATIONG; Manchester S., 1987, MISSOURI BOT GARDEN, V21, P1; Manchester S. R., 2007, PALEOBIOS, V27, P7; MANCHESTER SR, 1991, SYST BOT, V16, P715, DOI 10.2307/2418873; MANCHESTER SR, 1982, AM J BOT, V69, P275, DOI 10.2307/2443015; Manchester SR, 1997, AM J BOT, V84, P649, DOI 10.2307/2445902; MANNING WAYNE E., 1950, RHODORA, V52, P188; MANNING WAYNE E., 1963, BRITTONIA, V15, P123, DOI 10.2307/2805397; Manos PS, 2007, SYST BIOL, V56, P412, DOI 10.1080/10635150701408523; Manos PS, 2001, INT J PLANT SCI, V162, pS1, DOI 10.1086/324421; Manos PS, 2001, ANN MO BOT GARD, V88, P231, DOI 10.2307/2666226; MAYR E., 1942, Systematics and the origin of species from the viewpoint of a zoologist.; MCCARTHY BC, 1988, AM MIDL NAT, V119, P156, DOI 10.2307/2426064; MCKENNA MC, 1983, ANN MO BOT GARD, V70, P459, DOI 10.2307/2992083; Mitra S, 1996, AUK, V113, P544; Nabhan AR, 2011, BRIEF BIOINFORM, V13, P1; Nie ZL, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-17; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Poag C.W., 1989, GEOMORPHOLOGY, V2, P119, DOI [10.1016/0169-555X(89)90009-3, DOI 10.1016/0169-555X(89)90009-3]; Pollock DD, 2002, SYST BIOL, V51, P664, DOI 10.1080/10635150290102357; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Prowell D. C., 2006, GEOLOGICAL SOC AM AB, V38, P67; PROWELL DC, 1978, GEOLOGY, V6, P681, DOI 10.1130/0091-7613(1978)6<681:BFZEOT>2.0.CO;2; Prowell DC, 2000, GEOL SOC AM ABSTR, V32, P67; Rabosky DL, 2007, P ROY SOC B-BIOL SCI, V274, P2915, DOI 10.1098/rspb.2007.0924; Rabosky DL, 2012, EVOLUTION, V66, P1807, DOI 10.1111/j.1558-5646.2011.01557.x; Rabosky DL, 2009, AM NAT, V173, P662, DOI 10.1086/597378; Rabosky DL, 2006, EVOL BIOINFORM, V2, P247; Rambaut A, 2007, GUIDE TREEANNOTATOR; Rambaut A., 2007, TRACER V1 5; Ree RH, 2005, EVOLUTION, V59, P2299; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; REINHARDT J, 1984, GEOL SOC AM BULL, V95, P1176, DOI 10.1130/0016-7606(1984)95<1176:EFCTIT>2.0.CO;2; Ricklefs Robert E., 1993, P350; Ronquist F, 1997, SYST BIOL, V46, P195, DOI 10.2307/2413643; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Runck AM, 2005, MOL ECOL, V14, P1445, DOI 10.1111/j.1365-294X.2005.02501.x; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Sauquet H, 2012, SYST BIOL, V61, P289, DOI 10.1093/sysbio/syr116; Sims HJ, 1998, INT J PLANT SCI, V159, P391, DOI 10.1086/297559; Soltis DE, 2009, P NATL ACAD SCI USA, V106, P5455, DOI 10.1073/pnas.0901994106; Soltis DE, 2009, AM J BOT, V96, P336, DOI 10.3732/ajb.0800079; Springer MS, 2001, P NATL ACAD SCI USA, V98, P6241, DOI 10.1073/pnas.111551998; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stone D., 1997, FLORA N AM; STONE DE, 1962, AM J BOT, V49, P199, DOI 10.2307/2439542; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; TAYLOR DW, 1990, BOT REV, V56, P279, DOI 10.1007/BF02995927; TIFFNEY BH, 1985, J ARNOLD ARBORETUM, V66, P73, DOI 10.5962/bhl.part.13179; TIFFNEY BH, 1985, J ARNOLD ARBORETUM, V66, P243, DOI 10.5962/bhl.part.13183; Tiffney BH, 2001, INT J PLANT SCI, V162, pS3, DOI 10.1086/323880; Traverse A., 2007, PALEOPALYNOLOGY; Tribsch A, 2004, J BIOGEOGR, V31, P747, DOI 10.1111/j.1365-2699.2004.01065.x; Van de Peer Y, 2009, NAT REV GENET, V10, P725, DOI 10.1038/nrg2600; Wang W, 2007, SYST BOT, V32, P731, DOI 10.1600/036364407783390791; Warnock RCM, 2012, BIOL LETTERS, V8, P156, DOI 10.1098/rsbl.2011.0710; Wen J, 1999, ANNU REV ECOL SYST, V30, P421, DOI 10.1146/annurev.ecolsys.30.1.421; Wen J, 2001, INT J PLANT SCI, V162, pS117, DOI 10.1086/322940; Wen J, 2010, DARWINS HERITAGE TOD; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; WING SL, 1984, AM J BOT, V71, P388, DOI 10.2307/2443497; WOLFE JA, 1975, ANN MO BOT GARD, V62, P264, DOI 10.2307/2395198; Wu ZY., 2003, FAMILIES GENERA ANGI; Xiang QY, 2000, MOL PHYLOGENET EVOL, V15, P462, DOI 10.1006/mpev.2000.0766; Xiang QY, 2005, EVOLUTION, V59, P1685, DOI 10.1111/j.0014-3820.2005.tb01818.x; Xiang QYJ, 2006, TAXON, V55, P9, DOI 10.2307/25065525; Xiang QYJ, 2004, EVOLUTION, V58, P2175, DOI 10.1111/j.0014-3820.2004.tb01596.x; Zamudio KR, 2003, EVOLUTION, V57, P1631; Zhang DF, 2000, ENVIRON GEOL, V39, P1352, DOI 10.1007/s002540000174; Zheng HB, 2000, GEOLOGY, V28, P715, DOI 10.1130/0091-7613(2000)028<0715:PUOTNT>2.3.CO;2; Zwickl DJ, 2002, SYST BIOL, V51, P588, DOI 10.1080/10635150290102339	124	53	57	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e70449	10.1371/journal.pone.0070449	http://dx.doi.org/10.1371/journal.pone.0070449			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23875028	Green Published, Green Submitted, gold			2022-12-27	WOS:000322064300130
J	Aslam, R; Marban, C; Corazzol, C; Jehl, F; Delalande, F; Van Dorsselaer, A; Prevost, G; Haikel, Y; Taddei, C; Schneider, F; Metz-Boutigue, MH				Aslam, Rizwan; Marban, Celine; Corazzol, Christian; Jehl, Francois; Delalande, Francois; Van Dorsselaer, Alain; Prevost, Gilles; Haikel, Youssef; Taddei, Corinne; Schneider, Francis; Metz-Boutigue, Marie-Helene			Cateslytin, a Chromogranin A Derived Peptide Is Active against Staphylococcus aureus and Resistant to Degradation by Its Proteases	PLOS ONE			English	Article							MEDULLARY CHROMAFFIN GRANULES; CELL-PENETRATING PEPTIDES; ANTIMICROBIAL PEPTIDES; INNATE IMMUNITY; ANTIBACTERIAL ACTIVITY; GEL-ELECTROPHORESIS; TERMINAL FRAGMENT; SECRETOGRANIN-II; CLEAVAGE SITES; CATESTATIN	Innate immunity involving antimicrobial peptides represents an integrated and highly effective system of molecular and cellular mechanisms that protects host against infections. One of the most frequent hospital-acquired pathogens, Staphylococcus aureus, capable of producing proteolytic enzymes, which can degrade the host defence agents and tissue components. Numerous antimicrobial peptides derived from chromogranins, are secreted by nervous, endocrine and immune cells during stress conditions. These kill microorganisms by their lytic effect at micromolar range, using a pore-forming mechanism against Gram-positive bacteria, filamentous fungi and yeasts. In this study, we tested antimicrobial activity of chromogranin A-derived peptides (catestatin and cateslytin) against S. aureus and analysed S. aureus-mediated proteolysis of these peptides using HPLC, sequencing and MALDI-TOF mass spectrometry. Interestingly, this study is the first to demonstrate that cateslytin, the active domain of catestatin, is active against S. aureus and is interestingly resistant to degradation by S. aureus proteases.	[Aslam, Rizwan; Marban, Celine; Haikel, Youssef; Metz-Boutigue, Marie-Helene] Univ Strasbourg, INSERM, UMR 1121, Strasbourg, France; [Corazzol, Christian; Jehl, Francois; Prevost, Gilles] Univ Strasbourg CHRU Strasbourg, Inst Bacteriol, Strasbourg, France; [Delalande, Francois; Van Dorsselaer, Alain] Univ Strasbourg, CNRS, Inst Pluridisciplinaire Hubert Curien, UMR 7178, Strasbourg, France; [Haikel, Youssef; Taddei, Corinne] Univ Strasbourg, Fac Chirurg Dentaire, Strasbourg, France; [Schneider, Francis] Univ Strasbourg, Hop Hautepierre, Serv Reanimat Med, Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Metz-Boutigue, MH (corresponding author), Univ Strasbourg, INSERM, UMR 1121, Strasbourg, France.	marie-helene.metz@inserm.fr	Aslam, Rizwan/E-8238-2014	Aslam, Rizwan/0000-0002-5065-4462; Delalande, Francois/0000-0003-3590-9874	University of Strasbourg; Inserm; Faculty of Odontology; Higher Education Commission (HEC) of Pakistan	University of Strasbourg; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Faculty of Odontology; Higher Education Commission (HEC) of Pakistan(Higher Education Commission of Pakistan)	The authors thank the University of Strasbourg, the Inserm for financial support and the Faculty of Odontology and Higher Education Commission (HEC) of Pakistan for the PhD grant of RA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELNOUR A, 1993, INFECT IMMUN, V61, P3879, DOI 10.1128/IAI.61.9.3879-3885.1993; Aslam R, 2012, CURR MED CHEM, V19, P4115, DOI 10.2174/092986712802430063; Biswas N, 2009, ENDOCRINOLOGY, V150, P3547, DOI 10.1210/en.2008-1613; Briolat J, 2005, CELL MOL LIFE SCI, V62, P377, DOI 10.1007/s00018-004-4461-9; BULET P, 1993, J BIOL CHEM, V268, P14893; Cado G, 2013, ADV FUNCTIONAL MAT, DOI [10.1002/adfm.201300416, DOI 10.1002/ADFM.201300416]]; Chien YT, 1999, J BIOL CHEM, V274, P37169, DOI 10.1074/jbc.274.52.37169; Conlon JM, 2012, PEPTIDES, V37, P113, DOI 10.1016/j.peptides.2012.07.005; Davis MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054733; Dubin G, 2002, BIOL CHEM, V383, P1075, DOI 10.1515/BC.2002.116; Dunman PM, 2001, J BACTERIOL, V183, P7341, DOI 10.1128/JB.183.24.7341-7353.2001; Helle KB, 2010, REGUL PEPTIDES, V165, P45, DOI 10.1016/j.regpep.2009.09.009; Henriques ST, 2006, BIOCHEM J, V399, P1, DOI 10.1042/BJ20061100; Jean-Francois F, 2008, BIOCHEMISTRY-US, V47, P6394, DOI 10.1021/bi800448h; Karavolos MH, 2003, MICROBIOL-SGM, V149, P2749, DOI 10.1099/mic.0.26353-0; Kussmann M, 1997, J MASS SPECTROM, V32, P483; Kwiecinski J, 2010, J INFECT DIS, V202, P1041, DOI 10.1086/656140; Lee JC, 2003, BIOCHEMISTRY-US, V42, P6938, DOI 10.1021/bi0300433; Lugardon K, 2000, J BIOL CHEM, V275, P10745, DOI 10.1074/jbc.275.15.10745; Lugardon K, 2001, J BIOL CHEM, V276, P35875, DOI 10.1074/jbc.M104670200; Malmsten M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016400; Metz-Boutigue MH, 1998, CELL MOL NEUROBIOL, V18, P249, DOI 10.1023/A:1022573004910; METZBOUTIGUE MH, 1993, EUR J BIOCHEM, V217, P247, DOI 10.1111/j.1432-1033.1993.tb18240.x; Michel A, 2006, J BACTERIOL, V188, P5783, DOI 10.1128/JB.00074-06; Montero-Hadjadje M, 2008, ACTA PHYSIOL, V192, P309, DOI 10.1111/j.1748-1716.2007.01806.x; Mrak LN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038453; National Committee for Clinical Laboratory Standards, 2003, M07A8 NCCLS; Ohbayashi T, 2011, MICROBIOL-SGM, V157, P786, DOI 10.1099/mic.0.044503-0; Pag U, 2004, J ANTIMICROB CHEMOTH, V53, P230, DOI 10.1093/jac/dkh083; Palma M, 2001, INFECT IMMUN, V69, P7858, DOI 10.1128/IAI.69.12.7858-7865.2001; Pasupuleti M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005285; Pons AM, 2002, ANTIMICROB AGENTS CH, V46, P229, DOI 10.1128/AAC.46.1.229-230.2002; Postma B, 2004, J IMMUNOL, V172, P6994, DOI 10.4049/jimmunol.172.11.6994; Potempa J, 2009, J INNATE IMMUN, V1, P70, DOI 10.1159/000181144; PROKESOVA L, 1995, ADV EXP MED BIOL, V371, P613; Radek KA, 2008, J INVEST DERMATOL, V128, P1525, DOI 10.1038/sj.jid.5701225; Rooijakkers SHM, 2005, NAT IMMUNOL, V6, P920, DOI 10.1038/ni1235; SERRA P, 1977, ARCH INTERN MED, V137, P1562, DOI 10.1001/archinte.137.11.1562; Sieprawska-Lupa M, 2004, ANTIMICROB AGENTS CH, V48, P4673, DOI 10.1128/AAC.48.12.4673-4679.2004; Sizova D, 2007, NEUROBIOL AGING, V28, P357, DOI 10.1016/j.neurobiolaging.2006.01.011; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Strub JM, 1996, J BIOL CHEM, V271, P28533, DOI 10.1074/jbc.271.45.28533; STRUB JM, 1995, EUR J BIOCHEM, V229, P356, DOI 10.1111/j.1432-1033.1995.0356k.x; Strub JM, 1997, J BIOL CHEM, V272, P11928, DOI 10.1074/jbc.272.18.11928; Sugawara M, 2010, FASEB J, V24, P1737, DOI 10.1096/fj.09-142554; Sumby P, 2005, P NATL ACAD SCI USA, V102, P1679, DOI 10.1073/pnas.0406641102; VANHOOF G, 1995, FASEB J, V9, P736, DOI 10.1096/fasebj.9.9.7601338; Wu MH, 1999, J BIOL CHEM, V274, P29, DOI 10.1074/jbc.274.1.29; Zhang D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004501; Zhao YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043998; Ziegler A, 2008, ADV DRUG DELIVER REV, V60, P580, DOI 10.1016/j.addr.2007.10.005	51	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e68993	10.1371/journal.pone.0068993	http://dx.doi.org/10.1371/journal.pone.0068993			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894389	Green Published, gold, Green Submitted			2022-12-27	WOS:000322167900035
J	Kwon, MJ; Nitsche, BM; Arentshorst, M; Jorgensen, TR; Ram, AFJ; Meyer, V				Kwon, Min Jin; Nitsche, Benjamin M.; Arentshorst, Mark; Jorgensen, Thomas R.; Ram, Arthur F. J.; Meyer, Vera			The Transcriptomic Signature of RacA Activation and Inactivation Provides New Insights into the Morphogenetic Network of Aspergillus niger	PLOS ONE			English	Article							DOMAIN PROTEINS SLM1; SACCHAROMYCES-CEREVISIAE; FILAMENTOUS FUNGI; POLARIZED GROWTH; IN-VIVO; ACTIN CYTOSKELETON; GENE-EXPRESSION; BINDING DOMAIN; CELL POLARITY; HYPHAL TIPS	RacA is the main Rho GTPase in Aspergillus niger regulating polarity maintenance via controlling actin dynamics. Both deletion and dominant activation of RacA (Rac(G18V)) provoke an actin localization defect and thereby loss of polarized tip extension, resulting in frequent dichotomous branching in the Delta racA strain and an apolar growing phenotype for Rac(G18V). In the current study the transcriptomics and physiological consequences of these morphological changes were investigated and compared with the data of the morphogenetic network model for the dichotomous branching mutant ramosa-1. This integrated approach revealed that polar tip growth is most likely orchestrated by the concerted activities of phospholipid signaling, sphingolipid signaling, TORC2 signaling, calcium signaling and CWI signaling pathways. The transcriptomic signatures and the reconstructed network model for all three morphology mutants (Delta racA, Rac(G18V), ramosa-1) imply that these pathways become integrated to bring about different physiological adaptations including changes in sterol, zinc and amino acid metabolism and changes in ion transport and protein trafficking. Finally, the fate of exocytotic (SncA) and endocytotic (AbpA, SlaB) markers in the dichotomous branching mutant Delta racA was followed, demonstrating that hyperbranching does not per se result in increased protein secretion.	[Kwon, Min Jin; Nitsche, Benjamin M.; Arentshorst, Mark; Jorgensen, Thomas R.; Ram, Arthur F. J.; Meyer, Vera] Leiden Univ, Inst Biol Leiden, Dept Mol Microbiol & Biotechnol, Leiden, Netherlands; [Kwon, Min Jin; Arentshorst, Mark; Ram, Arthur F. J.; Meyer, Vera] Kluyver Ctr Genom Ind Fermentat, Delft, Netherlands; [Nitsche, Benjamin M.; Meyer, Vera] Berlin Univ Technol, Dept Appl & Mol Microbiol, Inst Biotechnol, Berlin, Germany	Leiden University; Leiden University - Excl LUMC; Technical University of Berlin	Ram, AFJ (corresponding author), Leiden Univ, Inst Biol Leiden, Dept Mol Microbiol & Biotechnol, Leiden, Netherlands.	a.f.j.ram@biology.leidenuniv.nl; vera.meyer@tu-berlin.de	Ram, Arthur FJ/S-4648-2017	Ram, Arthur FJ/0000-0002-2487-8016; Meyer, Vera/0000-0002-2298-2258				Amanullah A, 2002, BIOTECHNOL BIOENG, V77, P815, DOI 10.1002/bit.10181; Araujo-Bazan L, 2008, MOL MICROBIOL, V67, P891, DOI 10.1111/j.1365-2958.2007.06102.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett JW, 1991, MORE GENE MANIPULATI; Berepiki A, 2011, NAT REV MICROBIOL, V9, P876, DOI 10.1038/nrmicro2666; Bergmeyer H.U., 1974, METHOD ENZYMAT AN, VVol. 3., P1196; Bermejo C, 2008, MOL BIOL CELL, V19, P1113, DOI 10.1091/mbc.E07-08-0742; Biesebeke RT, 2005, APPL MICROBIOL BIOT, V69, P44, DOI 10.1007/s00253-005-1968-4; Bocking SP, 1999, BIOTECHNOL BIOENG, V65, P638, DOI [10.1002/(SICI)1097-0290(19991220)65:6<638::AID-BIT4>3.0.CO;2-K, 10.1002/(SICI)1097-0290(19991220)65:6&lt;638::AID-BIT4&gt;3.0.CO;2-K]; BOS CJ, 1988, CURR GENET, V14, P437, DOI 10.1007/BF00521266; Carman GM, 2007, BBA-MOL CELL BIOL L, V1771, P322, DOI 10.1016/j.bbalip.2006.05.006; Carvalho NDSP, 2010, APPL MICROBIOL BIOT, V87, P1463, DOI 10.1007/s00253-010-2588-1; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Cheng JJ, 2003, MOL CELL BIOL, V23, P163, DOI 10.1128/MCB.23.1.163-177.2003; Cheng JJ, 2001, MOL CELL BIOL, V21, P6198, DOI 10.1128/MCB.21.18.6198-6209.2001; Cowart LA, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.3; Daquinag A, 2007, MOL CELL BIOL, V27, P633, DOI 10.1128/MCB.00461-06; Dudgeon DD, 2008, EUKARYOT CELL, V7, P2037, DOI 10.1128/EC.00291-08; Ernst R, 2005, METHOD ENZYMOL, V400, P460, DOI 10.1016/S0076-6879(05)00026-1; Fadri M, 2005, MOL BIOL CELL, V16, P1883, DOI 10.1091/mbc.e04-07-0564; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Fleissner A, 2010, APPL MICROBIOL BIOT, V87, P1255, DOI 10.1007/s00253-010-2672-6; Friesen H, 2006, MOL BIOL CELL, V17, P1306, DOI 10.1091/mbc.e05-06-0476; Furuta N, 2007, MOL BIOL CELL, V18, P295, DOI 10.1091/mbc.E06-05-0461; Gordon CL, 2000, MICROBIOL-UK, V146, P415, DOI 10.1099/00221287-146-2-415; Grimm LH, 2005, APPL MICROBIOL BIOT, V69, P375, DOI 10.1007/s00253-005-0213-5; HARRIS SD, 1994, GENETICS, V136, P517; Hasegawa J, 2011, J CELL BIOL, V193, P901, DOI 10.1083/jcb.201012161; Hayakawa Y, 2011, MOL MICROBIOL, V81, P40, DOI 10.1111/j.1365-2958.2011.07700.x; IVERSEN JJL, 1994, APPL MICROBIOL BIOT, V42, P256, DOI 10.1007/BF00902726; Jacobs DI, 2009, FUNGAL GENET BIOL, V46, pS141, DOI 10.1016/j.fgb.2008.08.012; Johnson JL, 2009, J BIOL CHEM, V284, P23860, DOI 10.1074/jbc.M109.031815; Jorgensen TR, 2010, APPL ENVIRON MICROB, V76, P5344, DOI 10.1128/AEM.00450-10; Joung MJ, 2012, BIOCHEMISTRY-US, V51, P3675, DOI 10.1021/bi300005w; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Kim HS, 2012, FUNGAL GENET BIOL, V49, P589, DOI 10.1016/j.fgb.2012.05.011; Kuratsu M, 2007, FUNGAL GENET BIOL, V44, P1310, DOI 10.1016/j.fgb.2007.04.012; Kwon MJ, 2011, MOL MICROBIOL, V79, P1151, DOI 10.1111/j.1365-2958.2010.07524.x; Lanzetti L, 2007, CURR OPIN CELL BIOL, V19, P453, DOI 10.1016/j.ceb.2007.04.017; Li SJ, 2006, MOL BIOL CELL, V17, P1218, DOI 10.1091/mbc.E05-06-0533; Lichius A, 2011, FUNGAL BIOL-UK, V115, P518, DOI 10.1016/j.funbio.2011.02.014; McIntyre M, 2001, Adv Biochem Eng Biotechnol, V73, P103; Merkel O, 2005, BIOCHEM J, V387, P489, DOI 10.1042/BJ20041272; Meyer V, 2008, BIOTECHNOL ADV, V26, P177, DOI 10.1016/j.biotechadv.2007.12.001; Meyer V, 2008, FUNGAL GENET BIOL, V45, P152, DOI 10.1016/j.fgb.2007.07.006; Meyer V, 2007, J BIOL CHEM, V282, P32935, DOI 10.1074/jbc.M705856200; Meyer V, 2007, J BIOTECHNOL, V128, P770, DOI 10.1016/j.jbiotec.2006.12.021; Meyer V, 2011, BIOTECHNOL LETT, V33, P469, DOI 10.1007/s10529-010-0473-8; Meyer V, 2010, MANUAL OF INDUSTRIAL MICROBIOLOGY AND BIOTECHNOLOGY, THIRD EDITION, P318; Meyer V, 2009, EUKARYOT CELL, V8, P1677, DOI 10.1128/EC.00050-09; Mikoshiba K, 1999, CHEM PHYS LIPIDS, V98, P59, DOI 10.1016/S0009-3084(99)00018-3; Moffett S, 2000, J BIOL CHEM, V275, P2191, DOI 10.1074/jbc.275.3.2191; Muller C, 2002, APPL ENVIRON MICROB, V68, P1827, DOI 10.1128/AEM.68.4.1827-1836.2002; Nakahara K, 2012, MOL CELL, V46, P461, DOI 10.1016/j.molcel.2012.04.033; Nakase M, 2010, J CELL SCI, V123, P1578, DOI 10.1242/jcs.059139; Nitsche BM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-380; Nitsche BM, 2012, METHODS MOL BIOL, V835, P311, DOI 10.1007/978-1-61779-501-5_19; Nitsche BM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-486; Nunez LR, 2008, J BIOL CHEM, V283, P34204, DOI 10.1074/jbc.M806391200; Palmgren S, 2001, J CELL BIOL, V155, P251, DOI 10.1083/jcb.200106157; Papagianni M, 2004, BIOTECHNOL ADV, V22, P189, DOI 10.1016/j.biotechadv.2003.09.005; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; Posas F, 1996, CELL, V86, P865, DOI 10.1016/S0092-8674(00)80162-2; Quintero-Monzon O, 2005, MOL BIOL CELL, V16, P3128, DOI 10.1091/mbc.E05-01-0059; Reynaga-Pena CG, 2005, ARCH MICROBIOL, V183, P292, DOI 10.1007/s00203-005-0771-z; Reynaga-Pena CG, 1997, FUNGAL GENET BIOL, V22, P153, DOI 10.1006/fgbi.1997.1003; Richman TJ, 2004, CURR GENET, V45, P339, DOI 10.1007/s00294-004-0505-9; Robertson AS, 2009, MOL BIOL CELL, V20, P1618, DOI 10.1091/mbc.E08-09-0982; Saloheimo M, 2012, MICROBIOL-SGM, V158, P46, DOI 10.1099/mic.0.053132-0; Sambrook J., 2001, MOL CLONING LAB MANU; Serrano R, 2004, J BIOL CHEM, V279, P19698, DOI 10.1074/jbc.M313746200; Singh A, 2011, CELL MICROBIOL, V13, P177, DOI 10.1111/j.1462-5822.2010.01550.x; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Taheri-Talesh N, 2008, MOL BIOL CELL, V19, P1439, DOI 10.1091/mbc.E07-05-0464; Taheri-Talesh N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031218; Tcheperegine SE, 2005, MOL CELL BIOL, V25, P8567, DOI 10.1128/MCB.25.19.8567-8580.2005; Tiedje C, 2008, MOL BIOL CELL, V19, P2885, DOI 10.1091/mbc.E07-11-1152; Valkonen M, 2007, J BIOL CHEM, V282, P22775, DOI 10.1074/jbc.M700916200; VANHARTINGSVELDT W, 1987, MOL GEN GENET, V206, P71, DOI 10.1007/BF00326538; Virag A, 2004, FUNGAL GENET BIOL, V41, P213, DOI 10.1016/j.fgb.2003.10.010; Virag A, 2006, EUKARYOT CELL, V5, P881, DOI 10.1128/EC.00036-06; Wachtler V, 2006, TRENDS CELL BIOL, V16, P1, DOI 10.1016/j.tcb.2005.11.008; Wang JJ, 2009, MICROBIOL-SGM, V155, P2714, DOI 10.1099/mic.0.029215-0; Waters BM, 2002, J BIOL CHEM, V277, P33749, DOI 10.1074/jbc.M206214200; Wongwicharn A, 1999, BIOTECHNOL BIOENG, V65, P416, DOI 10.1002/(SICI)1097-0290(19991120)65:4<416::AID-BIT6>3.3.CO;2-Q; WOSTEN HAB, 1991, J GEN MICROBIOL, V137, P2017, DOI 10.1099/00221287-137-8-2017; Xiong LM, 2002, J BIOL CHEM, V277, P8588, DOI 10.1074/jbc.M109275200; Youn JY, 2010, MOL BIOL CELL, V21, P3054, DOI 10.1091/mbc.E10-03-0181	88	20	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e68946	10.1371/journal.pone.0068946	http://dx.doi.org/10.1371/journal.pone.0068946			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894378	Green Published, Green Submitted, gold			2022-12-27	WOS:000322167900031
J	Lu, SJ; Gao, WJ; Wei, ZG; Wu, WW; Liao, M; Ding, YQ; Zhang, ZJ; Li, LJ				Lu, Shaojia; Gao, Weijia; Wei, Zhaoguo; Wu, Weiwei; Liao, Mei; Ding, Yuqiang; Zhang, Zhijun; Li, Lingjiang			Reduced Cingulate Gyrus Volume Associated with Enhanced Cortisol Awakening Response in Young Healthy Adults Reporting Childhood Trauma	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; HIPPOCAMPAL VOLUME; SALIVARY CORTISOL; STRESS; DEPRESSION; ABUSE; DISORDER; HORMONE; WOMEN; PSYCHOPATHOLOGY	Background: Preclinical studies have demonstrated the relationship between stress-induced increased cortisol levels and atrophy of specific brain regions, however, this association has been less revealed in clinical samples. The aim of the present study was to investigate the changes and associations of the hypothalamic-pituitary-adrenal (HPA) axis activity and gray matter volumes in young healthy adults with self-reported childhood trauma exposures. Methods: Twenty four healthy adults with childhood trauma and 24 age-and gender-matched individuals without childhood trauma were recruited. Each participant collected salivary samples in the morning at four time points: immediately upon awakening, 30, 45, and 60 min after awakening for the assessment of cortisol awakening response (CAR). The 3D T1-weighted magnetic resonance imaging data were obtained on a Philips 3.0 Tesla scanner. Voxel-based morphometry analyses were conducted to compare the gray matter volume between two groups. Correlations of gray matter volume changes with severity of childhood trauma and CAR data were further analyzed. Results: Adults with self-reported childhood trauma showed an enhanced CAR and decreased gray matter volume in the right middle cingulate gyrus. Moreover, a significant association was observed between salivary cortisol secretions after awaking and the right middle cingulate gyrus volume reduction in subjects with childhood trauma. Conclusions: The present research outcomes suggest that childhood trauma is associated with hyperactivity of the HPA axis and decreased gray matter volume in the right middle cingulate gyrus, which may represent the vulnerability for developing psychosis after childhood trauma experiences. In addition, this study demonstrates that gray matter loss in the cingulate gyrus is related to increased cortisol levels.	[Lu, Shaojia; Gao, Weijia; Wei, Zhaoguo; Wu, Weiwei; Liao, Mei; Ding, Yuqiang; Li, Lingjiang] Cent S Univ, Xiangya Hosp 2, Mental Hlth Inst, Key Lab Psychiat & Mental Hlth Hunan Prov, Changsha, Hunan, Peoples R China; [Wei, Zhaoguo] Shenzhen Kangning Hosp, Dept Psychiat, Shenzhen, Guangdong, Peoples R China; [Ding, Yuqiang] Tongji Univ, Sch Med, East Hosp, Minist Educ,Key Lab Arrhythmias, Shanghai 200092, Peoples R China; [Zhang, Zhijun] SE Univ, ZhongDa Hosp, Dept Neuropsychiat, Nanjing, Jiangsu, Peoples R China; [Zhang, Zhijun] SE Univ, ZhongDa Hosp, Inst Neuropsychiat Res, Nanjing, Jiangsu, Peoples R China; [Li, Lingjiang] Chinese Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China	Central South University; Tongji University; Southeast University - China; Southeast University - China; Chinese University of Hong Kong	Li, LJ (corresponding author), Cent S Univ, Xiangya Hosp 2, Mental Hlth Inst, Key Lab Psychiat & Mental Hlth Hunan Prov, Changsha, Hunan, Peoples R China.	llj2920@163.com		Lu, Shaojia/0000-0001-6121-7754; Ding, Yu-Qiang/0000-0003-1202-4635	Major Project of Chinese National Programs for Fundamental Research and Development (973 program) [2009CB918303]; National Natural Science Foundation of China [30830046, 81171286, 91232714]; Innovation Project of Hunan Graduate Education [CX2012B100]; National Hi-Tech Research and Development Program of China (863 program) [2008AA02Z413]	Major Project of Chinese National Programs for Fundamental Research and Development (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Project of Hunan Graduate Education; National Hi-Tech Research and Development Program of China (863 program)(National High Technology Research and Development Program of China)	The authors sincerely thank the support of funds from the Major Project of Chinese National Programs for Fundamental Research and Development (973 program, 2009CB918303 to LJL), the National Natural Science Foundation of China (30830046, 81171286 & 91232714 to LJL), the Innovation Project of Hunan Graduate Education (CX2012B100 to SJL), and National Hi-Tech Research and Development Program of China (863 program, 2008AA02Z413 to ZJZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SL, 2008, J NEUROPSYCH CLIN N, V20, P292, DOI 10.1176/appi.neuropsych.20.3.292; [Anonymous], 2002, BIOL PSYCHIAT; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Aubry JM, 2010, J PSYCHIATR RES, V44, P1199, DOI 10.1016/j.jpsychires.2010.04.015; Bernstein DP, 2003, CHILD ABUSE NEGLECT, V27, P169, DOI 10.1016/S0145-2134(02)00541-0; BERNSTEIN DP, 1994, AM J PSYCHIAT, V151, P1132, DOI 10.1176/ajp.151.8.1132; Bhagwagar Z, 2003, AM J PSYCHIAT, V160, P1890, DOI 10.1176/appi.ajp.160.10.1890; Bitter T, 2010, BRAIN RES, V1347, P42, DOI 10.1016/j.brainres.2010.06.003; Bouma EMC, 2009, PSYCHONEUROENDOCRINO, V34, P884, DOI 10.1016/j.psyneuen.2009.01.003; Buss C, 2007, J NEUROSCI, V27, P2592, DOI 10.1523/JNEUROSCI.3252-06.2007; Caetano SC, 2006, BIOL PSYCHIAT, V59, P702, DOI 10.1016/j.biopsych.2005.10.011; Carpenter LL, 2007, BIOL PSYCHIAT, V62, P1080, DOI 10.1016/j.biopsych.2007.05.002; Cerqueira JJ, 2005, J PSYCHIATR RES, V39, P451, DOI 10.1016/j.jpsychires.2005.01.003; CINTRA A, 1994, ANN NY ACAD SCI, V746, P42; Dannlowski U, 2012, BIOL PSYCHIAT, V71, P286, DOI 10.1016/j.biopsych.2011.10.021; DIORIO D, 1993, J NEUROSCI, V13, P3839; Edmiston EE, 2011, ARCH PEDIAT ADOL MED, V165, P1069, DOI 10.1001/archpediatrics.2011.565; Engert V, 2011, PSYCHOPHARMACOLOGY, V214, P261, DOI 10.1007/s00213-010-1918-4; Gordijn MS, 2012, PSYCHONEUROENDOCRINO, V37, P1448, DOI 10.1016/j.psyneuen.2012.01.014; Gunnar MR, 2001, DEV PSYCHOPATHOL, V13, P611, DOI 10.1017/S095457940100311X; Heim C, 2000, JAMA-J AM MED ASSOC, V284, P592, DOI 10.1001/jama.284.5.592; Heim C, 2008, PSYCHONEUROENDOCRINO, V33, P693, DOI 10.1016/j.psyneuen.2008.03.008; Heim C, 2008, BIOL PSYCHIAT, V63, P398, DOI 10.1016/j.biopsych.2007.07.002; Kuhn S, 2013, BIOL PSYCHIAT, V73, P70, DOI 10.1016/j.biopsych.2012.06.029; Lu SJ, 2013, COMPR PSYCHIAT, V54, P953, DOI 10.1016/j.comppsych.2013.03.026; MacMillan HL, 2001, AM J PSYCHIAT, V158, P1878, DOI 10.1176/appi.ajp.158.11.1878; Mangold D, 2011, J PSYCHIATR RES, V45, P902, DOI 10.1016/j.jpsychires.2011.01.001; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; Meinlschmidt G, 2005, PSYCHONEUROENDOCRINO, V30, P568, DOI 10.1016/j.psyneuen.2005.01.006; Pollak SD, 2010, CHILD DEV, V81, P224, DOI 10.1111/j.1467-8624.2009.01391.x; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; Radley JJ, 2004, NEUROSCIENCE, V125, P1, DOI 10.1016/j.neuroscience.2004.01.006; Rinne T, 2002, BIOL PSYCHIAT, V52, P1102, DOI 10.1016/S0006-3223(02)01395-1; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; Schafer Ingo, 2011, Dialogues Clin Neurosci, V13, P360; Scher CD, 2001, J TRAUMA STRESS, V14, P843, DOI 10.1023/A:1013058625719; Stein MB, 1997, PSYCHOL MED, V27, P951, DOI 10.1017/S0033291797005242; Tomoda A, 2009, NEUROIMAGE, V47, pT66, DOI 10.1016/j.neuroimage.2009.03.005; Treadway MT, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0004887, 10.1371/journal.pone.0006598]; Tyrka AR, 2008, BIOL PSYCHIAT, V63, P1147, DOI 10.1016/j.biopsych.2008.01.011; Vasic N, 2008, J AFFECT DISORDERS, V109, P107, DOI 10.1016/j.jad.2007.11.011; Wang F, 2008, BRIT J PSYCHIAT, V193, P126, DOI 10.1192/bjp.bp.107.048793; Zhang LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042824; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V13, P508, DOI 10.1001/archpsyc.1965.01730060026004	45	27	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69350	10.1371/journal.pone.0069350	http://dx.doi.org/10.1371/journal.pone.0069350			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894454	Green Published, Green Submitted, gold			2022-12-27	WOS:000322167900058
J	White, MA; Benson, RBJ; Tischler, TR; Hocknull, SA; Cook, AG; Barnes, DG; Poropat, SF; Wooldridge, SJ; Sloan, T; Sinapius, GHK; Elliott, DA				White, Matt A.; Benson, Roger B. J.; Tischler, Travis R.; Hocknull, Scott A.; Cook, Alex G.; Barnes, David G.; Poropat, Stephen F.; Wooldridge, Sarah J.; Sloan, Trish; Sinapius, George H. K.; Elliott, David A.			New Australovenator Hind Limb Elements Pertaining to the Holotype Reveal the Most Complete Neovenatorid Leg	PLOS ONE			English	Article								We report new skeletal elements pertaining to the same individual which represents the holotype of Australovenator wintonensis, from the 'Matilda Site' in the Winton Formation (Upper Cretaceous) of western Queensland. The discovery of these new elements means that the hind limb of Australovenator is now the most completely understood hind limb among Neovenatoridae. The new hind limb elements include: the left fibula; left metatarsal IV; left pedal phalanges I-2, II-1, III-4, IV-2, IV-3; and right pedal phalanges, II-2 and III-1. The detailed descriptions are supported with three dimensional figures. These coupled with the completeness of the hind limb will increase the utility of Australovenator in comparisons with less complete neovenatorid genera. These specimens and the previously described hind limb elements of Australovenator are compared with other theropods classified as neovenatorids (including Neovenator, Chilantaisaurus, Fukuiraptor, Orkoraptor and Megaraptor). Hind limb length proportion comparisons indicate that the smaller neovenatorids Australovenator and Fukuiraptor possess more elongate and gracile hind limb elements than the larger Neovenator and Chilantaisaurus. Greater stride lengths to body size exist in both Fukuiraptor and Australovenator with the femur discovered to be proportionally shorter the rest of the hind limb length. Additionally Australovenator is identified as possessing the most elongate metatarsus. The metatarsus morphology varies with body size. The larger neoventorids possess a metatarsus with greater width but shorter length compared to smaller forms.	[White, Matt A.] Univ Newcastle, Sch Engn, Callaghan, NSW 2308, Australia; [White, Matt A.; Tischler, Travis R.; Cook, Alex G.; Poropat, Stephen F.; Sloan, Trish; Sinapius, George H. K.; Elliott, David A.] Australian Age Dinosaurs Museum Nat Hist, Winton, Qld, Australia; [Benson, Roger B. J.] Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England; [Hocknull, Scott A.; Cook, Alex G.] Queensland Museum, Hendra, Qld, Australia; [Barnes, David G.] Monash Univ, Monash Biomed Imaging, Clayton, Vic 3168, Australia; [Barnes, David G.] Monash Univ, Monash E Res Ct, Clayton, Vic, Australia; [Barnes, David G.] Life Sci Computat Ctr, Parkville, Vic, Australia; [Poropat, Stephen F.] Uppsala Univ, Dept Earth Sci, Uppsala, Sweden; [Wooldridge, Sarah J.] Queensland Xray, Mackay, Qld, Australia	University of Newcastle; University of Oxford; Queensland Museum; Monash University; Monash University; Uppsala University	White, MA (corresponding author), Univ Newcastle, Sch Engn, Callaghan, NSW 2308, Australia.	fossilised@hotmail.com	Poropat, Stephen F/M-1959-2016	Poropat, Stephen F/0000-0002-4909-1666; Barnes, David/0000-0002-4594-3438; Benson, Roger/0000-0001-8244-6177; White, Matt/0000-0002-4765-0356; Hocknull, Scott/0000-0003-4157-8434	Australian Research Council Linkage Grant [LP100100339]	Australian Research Council Linkage Grant(Australian Research Council)	The authors acknowledge University of Newcastle for providing computer software for specimen analysis. They acknowledge funding to the Australian Age of Dinosaurs Museum and Queensland Museum from the Australian Research Council Linkage Grant (LP100100339). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes DG, 2008, NEW ASTRON, V13, P599, DOI 10.1016/j.newast.2008.03.008; Hocknull SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006190	2	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e68649	10.1371/journal.pone.0068649	http://dx.doi.org/10.1371/journal.pone.0068649			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894328	Green Submitted, Green Published, gold			2022-12-27	WOS:000322167900019
J	Zhang, Z; Tsukikawa, M; Peng, M; Polyak, E; Nakamaru-Ogiso, E; Ostrovsky, J; McCormack, S; Place, E; Clarke, C; Reiner, G; McCormick, E; Rappaport, E; Haas, R; Baur, JA; Falk, MJ				Zhang, Zhe; Tsukikawa, Mai; Peng, Min; Polyak, Erzsebet; Nakamaru-Ogiso, Eiko; Ostrovsky, Julian; McCormack, Shana; Place, Emily; Clarke, Colleen; Reiner, Gail; McCormick, Elizabeth; Rappaport, Eric; Haas, Richard; Baur, Joseph A.; Falk, Marni J.			Primary Respiratory Chain Disease Causes Tissue-Specific Dysregulation of the Global Transcriptome and Nutrient-Sensing Signaling Network	PLOS ONE			English	Article							ZINC-FINGER PROTEIN; MITOCHONDRIAL-FUNCTION; SKELETAL-MUSCLE; ENERGY HOMEOSTASIS; OXIDATIVE STRESS; GENE-EXPRESSION; BINDING SITES; MUTANT MICE; HUMAN-CELLS; IN-VITRO	Primary mitochondrial respiratory chain (RC) diseases are heterogeneous in etiology and manifestations but collectively impair cellular energy metabolism. Mechanism(s) by which RC dysfunction causes global cellular sequelae are poorly understood. To identify a common cellular response to RC disease, integrated gene, pathway, and systems biology analyses were performed in human primary RC disease skeletal muscle and fibroblast transcriptomes. Significant changes were evident in muscle across diverse RC complex and genetic etiologies that were consistent with prior reports in other primary RC disease models and involved dysregulation of genes involved in RNA processing, protein translation, transport, and degradation, and muscle structure. Global transcriptional and post-transcriptional dysregulation was also found to occur in a highly tissue-specific fashion. In particular, RC disease muscle had decreased transcription of cytosolic ribosomal proteins suggestive of reduced anabolic processes, increased transcription of mitochondrial ribosomal proteins, shorter 5'-UTRs that likely improve translational efficiency, and stabilization of 3'-UTRs containing AU-rich elements. RC disease fibroblasts showed a strikingly similar pattern of global transcriptome dysregulation in a reverse direction. In parallel with these transcriptional effects, RC disease dysregulated the integrated nutrient-sensing signaling network involving FOXO, PPAR, sirtuins, AMPK, and mTORC1, which collectively sense nutrient availability and regulate cellular growth. Altered activities of central nodes in the nutrient-sensing signaling network were validated by phosphokinase immunoblot analysis in RC inhibited cells. Remarkably, treating RC mutant fibroblasts with nicotinic acid to enhance sirtuin and PPAR activity also normalized mTORC1 and AMPK signaling, restored NADH/NAD(+) redox balance, and improved cellular respiratory capacity. These data specifically highlight a common pathogenesis extending across different molecular and biochemical etiologies of individual RC disorders that involves global transcriptome modifications. We further identify the integrated nutrient-sensing signaling network as a common cellular response that mediates, and may be amenable to targeted therapies for, tissue-specific sequelae of primary mitochondrial RC disease.	[Zhang, Zhe] Childrens Hosp Philadelphia, Ctr Biomed Informat, Philadelphia, PA 19104 USA; [Tsukikawa, Mai; Polyak, Erzsebet; Ostrovsky, Julian; Place, Emily; Clarke, Colleen; McCormick, Elizabeth; Falk, Marni J.] Univ Penn, Div Human Genet, Dept Pediat, Philadelphia, PA 19104 USA; [Tsukikawa, Mai; Polyak, Erzsebet; Ostrovsky, Julian; McCormack, Shana; Place, Emily; Clarke, Colleen; McCormick, Elizabeth; Falk, Marni J.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Peng, Min] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Nakamaru-Ogiso, Eiko] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [McCormack, Shana] Univ Penn, Div Endocrinol, Dept Pediat, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Clarke, Colleen; McCormick, Elizabeth] Univ Penn, Div Child Dev & Metab Dis, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Reiner, Gail; Haas, Richard] Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA; [Rappaport, Eric] Childrens Hosp Philadelphia, Nucle Acid & Prot Core Facil, Philadelphia, PA 19104 USA; [Baur, Joseph A.] Univ Penn, Perelman Sch Med, Dept Physiol & Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of California System; University of California San Diego; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Falk, MJ (corresponding author), Childrens Hosp Philadelphia, Ctr Biomed Informat, Philadelphia, PA 19104 USA.	falkm@email.chop.edu	Rappaport, Eric/GRO-4051-2022; Falk, Marni/K-1997-2014	Baur, Joseph/0000-0001-8262-6549; Falk, Marni/0000-0002-1723-6728	National Institutes of Health [R03-DK082446]; Angelina Foundation Fund from the Division of Child Development and Metabolic Disease at the Children's Hospital of Philadelphia; Tristan Mullen Fund; Children's Hospital of Philadelphia Research Institute Bridge Fund; Clinical and Translational Research Center at the Children's Hospital of Philadelphia [UL1-RR-024134]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065858] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK082521, K12DK094723] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Angelina Foundation Fund from the Division of Child Development and Metabolic Disease at the Children's Hospital of Philadelphia; Tristan Mullen Fund; Children's Hospital of Philadelphia Research Institute Bridge Fund; Clinical and Translational Research Center at the Children's Hospital of Philadelphia; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by a grant from the National Institutes of Health (R03-DK082446 to M.J.F.), as well as generous funding from the Angelina Foundation Fund from the Division of Child Development and Metabolic Disease at the Children's Hospital of Philadelphia (M.J.F.), The Tristan Mullen Fund, The Children's Hospital of Philadelphia Research Institute Bridge Fund (M.J.F.), and the Clinical and Translational Research Center at the Children's Hospital of Philadelphia (UL1-RR-024134). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Alic N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.36; Andreassi C, 2009, TRENDS CELL BIOL, V19, P465, DOI 10.1016/j.tcb.2009.06.001; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Bilic I, 2006, NAT IMMUNOL, V7, P392, DOI 10.1038/ni1311; Blanchet L, 2011, CURR PHARM DESIGN, V17, P4023, DOI 10.2174/138161211798764870; Brown MD, 2001, AM J MED GENET, V104, P331, DOI 10.1002/1096-8628(2001)104:4<331::AID-AJMG10054>3.0.CO;2-8; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Cheng ZY, 2009, NAT MED, V15, P1307, DOI 10.1038/nm.2049; Cizkova A, 2008, NAT GENET, V40, P1288, DOI 10.1038/ng.246; Cooper MP, 2006, GENE DEV, V20, P2996, DOI 10.1101/gad.1483906; Creacy SD, 2008, J BIOL CHEM, V283, P34626, DOI 10.1074/jbc.M806277200; Crimi M, 2005, FASEB J, V19, P866, DOI 10.1096/fj.04-3045fje; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Danielson SR, 2005, BRAIN, V128, P1026, DOI 10.1093/brain/awh447; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Denissov S, 2007, EMBO J, V26, P944, DOI 10.1038/sj.emboj.7601550; Di Gregorio GB, 2004, AM J PHYSIOL-ENDOC M, V287, pE799, DOI 10.1152/ajpendo.00155.2004; Elstner M, 2011, ACTA NEUROPATHOL, V122, P75, DOI 10.1007/s00401-011-0828-9; Falk MJ, 2008, MOL GENET METAB, V93, P388, DOI 10.1016/j.ymgme.2007.11.007; Falk MJ, 2011, EMBO MOL MED, V3, P410, DOI 10.1002/emmm.201100149; Garedew A., 2008, MITOCHONDRIAL PATHWA, P55; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Gerin I, 2009, J BIOL CHEM, V284, P10755, DOI 10.1074/jbc.M809115200; Gershman B, 2007, PHYSIOL GENOMICS, V29, P24, DOI 10.1152/physiolgenomics.00061.2006; Ghosh HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009199; Glahder JA, 2010, VIRUS RES, V149, P217, DOI 10.1016/j.virusres.2010.02.001; Gohil VM, 2010, J BIOL CHEM, V285, P13742, DOI 10.1074/jbc.M109.098400; Golubitzky A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026883; Gruber AR, 2011, NUCLEIC ACIDS RES, V39, pD66, DOI 10.1093/nar/gkq990; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018; Han SW, 2006, MOL CANCER THER, V5, P430, DOI 10.1158/1535-7163.MCT-05-0347; Hawke TJ, 2003, J BIOL CHEM, V278, P4015, DOI 10.1074/jbc.M209200200; Hutter E, 2002, MOL BIOL REP, V29, P83, DOI 10.1023/A:1020322922732; Iwamoto F, 2008, EXP CELL RES, V314, P1378, DOI 10.1016/j.yexcr.2008.01.006; Kawasaki H, 2000, NATURE, V405, P195, DOI 10.1038/35012097; Kim S, 2011, P NATL ACAD SCI USA, V108, P13564, DOI 10.1073/pnas.1109475108; Knowles HJ, 2006, BIOCHEM PHARMACOL, V71, P646, DOI 10.1016/j.bcp.2005.11.019; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; Lasa I, 2011, P NATL ACAD SCI USA, V108, P20172, DOI 10.1073/pnas.1113521108; Lemay DG, 2006, J LIPID RES, V47, P1583, DOI 10.1194/jlr.M500504-JLR200; Li KG, 2010, ONCOTARGET, V1, P447, DOI 10.18632/oncotarget.178; Li XM, 2005, P NATL ACAD SCI USA, V102, P16945, DOI 10.1073/pnas.0504201102; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Martin DE, 2004, CELL, V119, P969, DOI 10.1016/j.cell.2004.11.047; Mende S, 2011, NEUROL RES, V33, P638, DOI 10.1179/1743132810Y.0000000016; Naar AM, 1998, GENE DEV, V12, P3020, DOI 10.1101/gad.12.19.3020; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Parikh S, 2009, CURR TREAT OPTION N, V11, P414, DOI 10.1007/s11940-009-0046-0; Peng M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000061; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Santorelli FM, 1997, ANN NEUROL, V42, P256, DOI 10.1002/ana.410420220; Schrier SA, 2012, DISCOV MED, V13, P143; Shaw RJ, 2008, CELL METAB, V8, P343, DOI 10.1016/j.cmet.2008.10.007; Soccio RE, 2011, MOL ENDOCRINOL, V25, P694, DOI 10.1210/me.2010-0454; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; Strum JC, 2009, MOL ENDOCRINOL, V23, P1876, DOI 10.1210/me.2009-0117; Tanay A, 2005, P NATL ACAD SCI USA, V102, P7203, DOI 10.1073/pnas.0502521102; Tang YT, 2006, BIOCHEM BIOPH RES CO, V345, P29, DOI 10.1016/j.bbrc.2006.04.051; Teleman AA, 2008, CELL METAB, V7, P21, DOI 10.1016/j.cmet.2007.11.010; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Tien ES, 2004, J BIOL CHEM, V279, P24053, DOI 10.1074/jbc.M401489200; Tran H, 2004, MOL CELL, V13, P101, DOI 10.1016/S1097-2765(03)00481-7; Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310; van der Meer DLM, 2010, NUCLEIC ACIDS RES, V38, P2839, DOI 10.1093/nar/gkq012; Wang LT, 2002, NATURE, V419, P312, DOI 10.1038/nature01039; Wang ZR, 1999, MOL CELL BIOL, V19, P4552; Watt MJ, 2004, J MOL ENDOCRINOL, V33, P533, DOI 10.1677/jme.1.01499; Werner A, 2005, PHYSIOL GENOMICS, V23, P125, DOI 10.1152/physiolgenomics.00124.2005; Wu SB, 2012, BBA-MOL BASIS DIS, V1822, P233, DOI 10.1016/j.bbadis.2011.09.014; Yamashita R, 2008, NUCLEIC ACIDS RES, V36, P3707, DOI 10.1093/nar/gkn248; Yordy JS, 2000, ONCOGENE, V19, P6503, DOI 10.1038/sj.onc.1204036; Zhang L, 1999, NUCLEIC ACIDS RES, V27, P2947, DOI 10.1093/nar/27.14.2947; Zhu XG, 2009, MOL ENDOCRINOL, V23, P1397, DOI 10.1210/me.2009-0071	79	37	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69282	10.1371/journal.pone.0069282	http://dx.doi.org/10.1371/journal.pone.0069282			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894440	Green Published, gold, Green Submitted			2022-12-27	WOS:000322167900053
J	Fu, HL; Mueller, JL; Javid, MP; Mito, JK; Kirsch, DG; Ramanujam, N; Brown, JQ				Fu, Henry L.; Mueller, Jenna L.; Javid, Melodi P.; Mito, Jeffrey K.; Kirsch, David G.; Ramanujam, Nimmi; Brown, J. Quincy			Optimization of a Widefield Structured Illumination Microscope for Non-Destructive Assessment and Quantification of Nuclear Features in Tumor Margins of a Primary Mouse Model of Sarcoma	PLOS ONE			English	Article							BREAST-CONSERVATION; POSITIVE MARGINS; CARCINOMA; CANCER; TISSUE; LIGHT; RATES	Cancer is associated with specific cellular morphological changes, such as increased nuclear size and crowding from rapidly proliferating cells. In situ tissue imaging using fluorescent stains may be useful for intraoperative detection of residual cancer in surgical tumor margins. We developed a widefield fluorescence structured illumination microscope (SIM) system with a single-shot FOV of 2.1x1.6 mm (3.4 mm(2)) and sub-cellular resolution (4.4 mu m). The objectives of this work were to measure the relationship between illumination pattern frequency and optical sectioning strength and signal-to-noise ratio in turbid (i.e. thick) samples for selection of the optimum frequency, and to determine feasibility for detecting residual cancer on tumor resection margins, using a genetically engineered primary mouse model of sarcoma. The SIM system was tested in tissue mimicking solid phantoms with various scattering levels to determine impact of both turbidity and illumination frequency on two SIM metrics, optical section thickness and modulation depth. To demonstrate preclinical feasibility, ex vivo 50 mu m frozen sections and fresh intact thick tissue samples excised from a primary mouse model of sarcoma were stained with acridine orange, which stains cell nuclei, skeletal muscle, and collagenous stroma. The cell nuclei were segmented using a high-pass filter algorithm, which allowed quantification of nuclear density. The results showed that the optimal illumination frequency was 31.7 mu m(-1) used in conjunction with a 4x0.1 NA objective ((nu) over tilde = 0.165). This yielded an optical section thickness of 128 mu m and an 8.9xcontrast enhancement over uniform illumination. We successfully demonstrated the ability to resolve cell nuclei in situ achieved via SIM, which allowed segmentation of nuclei from heterogeneous tissues in the presence of considerable background fluorescence. Specifically, we demonstrate that optical sectioning of fresh intact thick tissues performed equivalently in regards to nuclear density quantification, to physical frozen sectioning and standard microscopy.	[Fu, Henry L.; Mueller, Jenna L.; Ramanujam, Nimmi] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Javid, Melodi P.; Mito, Jeffrey K.; Kirsch, David G.] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC USA; [Kirsch, David G.] Duke Univ, Sch Med, Dept Radiat Oncol, Durham, NC USA; [Brown, J. Quincy] Tulane Univ, Dept Biomed Engn, New Orleans, LA 70118 USA	Duke University; Duke University; Duke University; Tulane University	Fu, HL (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	henry.fu@duke.edu	Ramanujam, Nimmi/AAA-7575-2021	Ramanujam, Nimmi/0000-0001-7319-8415; Whitley, Melodi/0000-0002-8163-6881	National Institutes of Health [R21 CA159936]; BRP [1R01EB011574-01]; NATIONAL CANCER INSTITUTE [R21CA159936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K02AI093866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB011574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BRP; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by National Institutes of Health grant award R21 CA159936 and BRP 1R01EB011574-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balch GC, 2005, AM SURGEON, V71, P22; Brown JQ, 2010, PROC SPIE, V7573, DOI 10.1117/12.841949; Brown JQ, 2010, IEEE J SEL TOP QUANT, V16, P530, DOI 10.1109/JSTQE.2009.2033257; Bydlon TM, 2010, OPT EXPRESS, V18, P8058, DOI 10.1364/OE.18.008058; Chasles F, 2007, OPT EXPRESS, V15, P16130, DOI 10.1364/OE.15.016130; Cole MJ, 2001, J MICROSC-OXFORD, V203, P246, DOI 10.1046/j.1365-2818.2001.00894.x; COX CE, 1991, ARCH SURG-CHICAGO, V126, P490; Dillon MF, 2007, ANN SURG ONCOL, V14, P1618, DOI 10.1245/s10434-006-9246-y; Elson DS, 2002, J MOD OPTIC, V49, P985, DOI 10.1080/09500340110109377; Gareau D, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.6.066018; Gareau DS, 2009, OPT LETT, V34, P3235, DOI 10.1364/OL.34.003235; Gareau DS, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3149853; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; Hagen N, 2012, OPT EXPRESS, V20, P403, DOI 10.1364/OE.20.000403; Hanley QS, 1999, J MICROSC-OXFORD, V196, P317, DOI 10.1046/j.1365-2818.1999.00602.x; Huston TL, 2006, AM J SURG, V192, P509, DOI 10.1016/j.amjsurg.2006.06.021; Jacobs L, 2008, ANN SURG ONCOL, V15, P1271, DOI 10.1245/s10434-007-9766-0; Karadaglic D, 2008, MICRON, V39, P808, DOI 10.1016/j.micron.2008.01.017; Kirsch DG, 2007, NAT MED, V13, P992, DOI 10.1038/nm1602; Kotwall C, 2007, AM SURGEON, V73, P337; Krishnaswamy V, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3065540; Laughney AM, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3516594; Lim D, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3528656; Lue N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030887; McLaughlin SA, 2008, J AM COLL SURGEONS, V206, P76, DOI 10.1016/j.jamcollsurg.2007.07.021; Mendez JE, 2006, AM J SURG, V192, P538, DOI 10.1016/j.amjsurg.2006.06.009; Mertz J, 2011, NAT METHODS, V8, P811, DOI 10.1038/nmeth.1709; Mito JK, 2013, J PATHOL, V229, P132, DOI 10.1002/path.4099; Mito JK, 2012, CANCER-AM CANCER SOC, V118, P5320, DOI 10.1002/cncr.27458; Muldoon TJ, 2008, GASTROINTEST ENDOSC, V68, P737, DOI 10.1016/j.gie.2008.05.018; Muldoon TJ, 2007, OPT EXPRESS, V15, P16413, DOI 10.1364/OE.15.016413; Muldoon TJ, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3406386; Neil MAA, 1997, OPT LETT, V22, P1905, DOI 10.1364/OL.22.001905; Neil MAA, 1998, J MICROSC-OXFORD, V189, P114, DOI 10.1046/j.1365-2818.1998.00317.x; Nguyen FT, 2009, CANCER RES, V69, P8790, DOI 10.1158/0008-5472.CAN-08-4340; Parthasarathy AB, 2008, OPT EXPRESS, V16, P1975, DOI 10.1364/OE.16.001975; Puvanakrishnan P, 2012, LASER SURG MED, V44, P310, DOI 10.1002/lsm.22019; Santos S, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3130266; SCHONDORF H, 1985, J CANCER RES CLIN, V109, P241, DOI 10.1007/BF00390363; Srivastava S, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2907167; STOKSETH PA, 1969, J OPT SOC AM, V59, P1314, DOI 10.1364/JOSA.59.001314; Tanbakuchi AA, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.07.027; Tanbakuchi AA, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3207139; Themelis G, 2011, ANN SURG ONCOL, V18, P3506, DOI 10.1245/s10434-011-1664-9; Tromberg B.J., 2010, J BIOMED OPT, V15; Udovich JA, 2009, J MICROSC-OXFORD, V234, P124, DOI 10.1111/j.1365-2818.2009.03153.x; Valdes PA, 2010, STEREOT FUNCT NEUROS, V88, P1, DOI 10.1159/000258143; Yu CC, 2008, OPT EXPRESS, V16, P16227, DOI 10.1364/OE.16.016227	48	25	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e68868	10.1371/journal.pone.0068868	http://dx.doi.org/10.1371/journal.pone.0068868			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894357	Green Published, Green Submitted, gold			2022-12-27	WOS:000325211000047
J	Kida, H; Nomura, S; Shinoyama, M; Ideguchi, M; Owada, Y; Suzuki, M				Kida, Hiroyuki; Nomura, Sadahiro; Shinoyama, Mizuya; Ideguchi, Makoto; Owada, Yuji; Suzuki, Michiyasu			The Effect of Hypothermia Therapy on Cortical Laminar Disruption following Ischemic Injury in Neonatal Mice	PLOS ONE			English	Article							OLIGODENDROCYTE LINEAGE PROGRESSION; WHITE-MATTER INJURY; RAT CEREBRAL-CORTEX; POSTISCHEMIC HYPOTHERMIA; HYPOXIA-ISCHEMIA; BRAIN-INJURY; MODERATE HYPOTHERMIA; NEWBORN RAT; ENCEPHALOPATHY; APOPTOSIS	Hypothermia has been proposed as a treatment for reducing neuronal damage in the brain induced by hypoxic ischemia. In the developing brain, hypoxic ischemia-induced injury may give rise to cerebral palsy (CP). However, it is unknown whether hypothermia might affect the development of CP. The purpose of this study was to investigate whether hypothermia would have a protective effect on the brains of immature, 3-day old (P3) mice after a challenge of cerebral ischemia. Cerebral ischemia was induced in P3 mice with a right common carotid artery ligation followed by hypoxia (6% O-2, 37 degrees C) for 30 min. Immediately after hypoxic ischemia, mice were exposed to hypothermia (32 degrees C) or normothermia (37 degrees C) for 24 h. At 4 weeks of age, mouse motor development was tested in a behavioral test. Mice were sacrificed at P4, P7, and 5 weeks to examine brain morphology. The laminar structure of the cortex was examined with immunohistochemistry (Cux1/Ctip2); the number of neurons was counted; and the expression of myelin basic protein (MBP) was determined. The hypothermia treatment was associated with improved neurological outcomes in the behavioral test. In the normothermia group, histological analyses indicated reduced numbers of neurons, reduced cortical laminar thickness in the deep, ischemic cortical layers, and significant reduction in MBP expression in the ischemic cortex compared to the contralateral cortex. In the hypothermia group, no reductions were noted in deep cortical layer thickness and in MBP expression in the ischemic cortex compared to the contralateral cortex. At 24 h after the hypothermia treatment prevented the neuronal cell death that had predominantly occurred in the ischemic cortical deep layers with normothermia treatment. Our findings may provide a preclinical basis for testing hypothermal therapies in patients with CP induced by hypoxic ischemia in the preterm period.	[Kida, Hiroyuki] Yamaguchi Univ, Dept Syst Neurosci, Grad Sch Med, Ube, Yamaguchi 755, Japan; [Nomura, Sadahiro; Shinoyama, Mizuya; Ideguchi, Makoto; Suzuki, Michiyasu] Yamaguchi Univ, Dept Neurosurg, Grad Sch Med, Ube, Yamaguchi 755, Japan; [Owada, Yuji] Yamaguchi Univ, Dept Organ Anat, Grad Sch Med, Ube, Yamaguchi 755, Japan	Yamaguchi University; Yamaguchi University; Yamaguchi University	Kida, H (corresponding author), Yamaguchi Univ, Dept Syst Neurosci, Grad Sch Med, Ube, Yamaguchi 755, Japan.	h-kida@yamaguchi-u.ac.jp		Owada, Yuji/0000-0002-5109-0531	JSPS KAKENHI [19591680, 23791603]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 19591680 to S. Nomura and 23791603 to H. Kida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askalan R, 2011, DEV NEUROSCI-BASEL, V33, P320, DOI 10.1159/000329924; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; Back SA, 2001, J NEUROSCI, V21, P1302; Back SA, 2002, J NEUROPATH EXP NEUR, V61, P197, DOI 10.1093/jnen/61.2.197; Barrett Robert D., 2007, Birth Defects Research, V81, P163, DOI 10.1002/bdrc.20095; BUSTO R, 1989, NEUROSCI LETT, V101, P299, DOI 10.1016/0304-3940(89)90549-1; CALEY DW, 1970, J COMP NEUROL, V138, P31, DOI 10.1002/cne.901380104; Carlsson Y, 2012, PEDIATR RES, V71, P566, DOI 10.1038/pr.2012.15; CHOI DW, 1987, J NEUROSCI, V7, P357; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; Craig A, 2003, EXP NEUROL, V181, P231, DOI 10.1016/S0014-4886(03)00032-3; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; Eilers H, 1996, ANESTHESIOLOGY, V85, P600, DOI 10.1097/00000542-199609000-00020; Fujii M, 2011, EPILEPSIA, V52, P1; Fukuda H, 2001, BRAIN RES, V910, P187, DOI 10.1016/S0006-8993(01)02659-2; Gabriel GH, 2009, BRAIN HYPOXIA ISCHEM; Gavva NR, 2008, TRENDS PHARMACOL SCI, V29, P550, DOI 10.1016/j.tips.2008.08.003; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; He Y, 2012, BRAIN RES; Huang ZH, 2009, BRAIN RES, V1301, P100, DOI 10.1016/j.brainres.2009.09.006; IGNACIO MPD, 1995, ANAT EMBRYOL, V191, P89; Joseph K S, 2003, BMC Pregnancy Childbirth, V3, P8, DOI 10.1186/1471-2393-3-8; Kida H, 2012, CLIN NEUROPHYSIOL; Lee BS, 2010, PEDIATR RES, V68, P303, DOI 10.1203/00006450-201011001-00592; Limperopoulos C, 2007, PEDIATRICS, V120, P584, DOI 10.1542/peds.2007-1041; Lipski J, 2006, BRAIN RES, V1077, P187, DOI 10.1016/j.brainres.2006.01.016; Liu YQ, 2002, PEDIATR RES, V51, P25, DOI 10.1203/00006450-200201000-00007; McQuillen PS, 2003, J NEUROSCI, V23, P3308; Muzzi M, 2012, J CEREBR BLOOD F MET, V32, P978, DOI 10.1038/jcbfm.2012.36; Nadarajah B, 2002, NAT REV NEUROSCI, V3, P423, DOI 10.1038/nrn845; Nakajima W, 2000, J NEUROSCI, V20, P7994; Ohmura A, 2005, BRAIN DEV-JPN, V27, P517, DOI 10.1016/j.braindev.2005.01.004; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; ROWAN RA, 1981, AM J ANAT, V160, P247, DOI 10.1002/aja.1001600303; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Shankaran S, 2012, NEW ENGL J MED, V366, P2085, DOI 10.1056/NEJMoa1112066; Sizonenko SV, 2005, PEDIATR RES, V57, P865, DOI 10.1203/01.PDR.0000157673.36848.67; Sizonenko SV, 2003, PEDIATR RES, V54, P263, DOI 10.1203/01.PDR.0000072517.01207.87; Skoff RP, 2001, INT J DEV NEUROSCI, V19, P197, DOI 10.1016/S0736-5748(00)00075-7; Stadlin A, 2003, BRAIN RES, V993, P101, DOI 10.1016/j.brainres.2003.08.058; Volpe JJ, 2003, PEDIATRICS, V112, P176, DOI 10.1542/peds.112.1.176; Volpe JJ, 2001, PEDIATR RES, V50, P553, DOI 10.1203/00006450-200111000-00003; Wagner BP, 2002, PEDIATR RES, V51, P354, DOI 10.1203/00006450-200203000-00015; Witte OW, 2000, J CEREBR BLOOD F MET, V20, P1149, DOI 10.1097/00004647-200008000-00001; Xiong M, 2009, BRAIN RES BULL, V79, P351, DOI 10.1016/j.brainresbull.2009.03.011; Yager JY, 2009, PEDIATR NEUROL, V40, P156, DOI 10.1016/j.pediatrneurol.2008.10.025; Yenari MA, 2012, NAT REV NEUROSCI	47	12	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e68877	10.1371/journal.pone.0068877	http://dx.doi.org/10.1371/journal.pone.0068877			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894362	gold, Green Published, Green Submitted			2022-12-27	WOS:000325211000051
J	Vanderlinden, LA; Saba, LM; Kechris, K; Miles, MF; Hoffman, PL; Tabakoff, B				Vanderlinden, Lauren A.; Saba, Laura M.; Kechris, Katerina; Miles, Michael F.; Hoffman, Paula L.; Tabakoff, Boris			Whole Brain and Brain Regional Coexpression Network Interactions Associated with Predisposition to Alcohol Consumption	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; QUANTITATIVE TRAIT LOCI; GENE-EXPRESSION; CANDIDATE GENES; ETHANOL; PREFERENCE; COMPLEX; MICE; PROTEINS; DRINKING	To identify brain transcriptional networks that may predispose an animal to consume alcohol, we used weighted gene coexpression network analysis (WGCNA). Candidate coexpression modules are those with an eigengene expression level that correlates significantly with the level of alcohol consumption across a panel of BXD recombinant inbred mouse strains, and that share a genomic region that regulates the module transcript expression levels (mQTL) with a genomic region that regulates alcohol consumption (bQTL). To address a controversy regarding utility of gene expression profiles from whole brain, vs specific brain regions, as indicators of the relationship of gene expression to phenotype, we compared candidate coexpression modules from whole brain gene expression data (gathered with Affymetrix 430 v2 arrays in the Colorado laboratories) and from gene expression data from 6 brain regions (nucleus accumbens (NA); prefrontal cortex (PFC); ventral tegmental area (VTA); striatum (ST); hippocampus (HP); cerebellum (CB)) available from GeneNetwork. The candidate modules were used to construct candidate eigengene networks across brain regions, resulting in three "meta-modules", composed of candidate modules from two or more brain regions (NA, PFC, ST, VTA) and whole brain. To mitigate the potential influence of chromosomal location of transcripts and cis-eQTLs in linkage disequilibrium, we calculated a semi-partial correlation of the transcripts in the meta-modules with alcohol consumption conditional on the transcripts' cis-eQTLs. The function of transcripts that retained the correlation with the phenotype after correction for the strong genetic influence, implicates processes of protein metabolism in the ER and Golgi as influencing susceptibility to variation in alcohol consumption. Integration of these data with human GWAS provides further information on the function of polymorphisms associated with alcohol-related traits.	[Vanderlinden, Lauren A.; Saba, Laura M.; Hoffman, Paula L.; Tabakoff, Boris] Univ Colorado, Dept Pharmacol, Sch Med, Aurora, CO 80045 USA; [Kechris, Katerina] Univ Colorado, Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA; [Miles, Michael F.] Virginia Commonwealth Univ, Dept Pharmacol, Richmond, VA USA; [Miles, Michael F.] Virginia Commonwealth Univ, Dept Neurol, Richmond, VA USA; [Miles, Michael F.] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Tabakoff, B (corresponding author), Univ Colorado, Dept Pharmacol, Sch Med, Aurora, CO 80045 USA.	Boris.Tabakoff@ucdenver.edu	Saba, Laura/R-9533-2018; Tabakoff, Boris/AAX-1204-2021	Saba, Laura/0000-0001-9649-1294; 	NIAAA [R24AA013162, U01AA016663, U01AA016649, U01AA016667, P20AA017828, K01AA016922]; National Foundation for Prevention of Chemical Dependency Disease (NFPCDD); Banbury Fund; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA016663, K01AA016922, U01AA016649, U01AA016667, P20AA017828, R01AA020634, R24AA013162] Funding Source: NIH RePORTER	NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Foundation for Prevention of Chemical Dependency Disease (NFPCDD); Banbury Fund; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported in part by NIAAA (R24AA013162 (BT), U01AA016663 (BT), U01AA016649 (PLH), U01AA016667 (MFM), P20AA017828 (MFM), K01AA016922 (KK)), National Foundation for Prevention of Chemical Dependency Disease (NFPCDD) (LMS) and the Banbury Fund (BT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AFF, 2004, GENECHIP EXPR AN DAT; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Ardley HC, 2001, J BIOL CHEM, V276, P19640, DOI 10.1074/jbc.M011028200; Barabasi AL, 2003, SCI AM, V288, P60, DOI 10.1038/scientificamerican0503-60; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Belknap JK, 2001, MAMM GENOME, V12, P893, DOI 10.1007/s00335-001-2074-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bierut LJ, 2010, P NATL ACAD SCI USA, V107, P5082, DOI 10.1073/pnas.0911109107; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Carlson SL, 2013, J PHARMACOL EXP THER, V345, P317, DOI 10.1124/jpet.112.201954; Chen G, 2008, J NEUROSCI RES, V86, P937, DOI 10.1002/jnr.21540; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; CHURCHILL GA, 1994, GENETICS, V138, P963; Clapp P, 2010, J PHARMACOL EXP THER, V332, P720, DOI 10.1124/jpet.109.158741; Clarke C, 2011, J BIOTECHNOL, V155, P350, DOI 10.1016/j.jbiotec.2011.07.011; Cox A, 2009, GENETICS, V182, P1335, DOI 10.1534/genetics.109.105486; Dobrin R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r55; Dong J, 2007, BMC SYSTEMS BIOL, V1, P24; Doss S, 2005, GENOME RES, V15, P681, DOI 10.1101/gr.3216905; Edenberg HJ, 2010, ALCOHOL CLIN EXP RES, V34, P840, DOI 10.1111/j.1530-0277.2010.01156.x; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Farber CR, 2010, J BONE MINER RES, V25, P2359, DOI 10.1002/jbmr.138; Fislage M, 2012, NUCLEIC ACIDS RES, V40, P5149, DOI 10.1093/nar/gks163; Furlong LI, 2012, TRENDS GENETICS TIG; GESCHWIN.N, 1965, BRAIN, V88, P585, DOI 10.1093/brain/88.3.585; GESCHWIN.N, 1965, BRAIN, V88, P237, DOI 10.1093/brain/88.2.237; Ghazalpour A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r59; Ghoshal G, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1396; Hardy J, 2009, NEW ENGL J MED, V360, P1759, DOI 10.1056/NEJMra0808700; Heath AC, 2011, BIOL PSYCHIAT; Honore B, 2000, FEBS LETT, V466, P11, DOI 10.1016/S0014-5793(99)01780-9; Honore B, 2009, BIOESSAYS, V31, P262, DOI 10.1002/bies.200800186; Howell MD, 2012, NEUROSCIENCE, V217, P6, DOI 10.1016/j.neuroscience.2012.05.034; Hu W, 2008, J PHARMACOL EXP THER, V326, P792, DOI 10.1124/jpet.108.137521; Iancu OD, 2012, BIOINFORMATICS, V28, P1592, DOI 10.1093/bioinformatics/bts245; Imai S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058566; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jain S, 2010, NEURON, V68, P207, DOI 10.1016/j.neuron.2010.10.010; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Jones DH, 2005, J BIOL CHEM, V280, P19003, DOI 10.1074/jbc.M500697200; Kalivas PW, 2008, NEUROPSYCHOPHARMACOL, V33, P166, DOI 10.1038/sj.npp.1301564; Karaduman R, 2008, RNA, V14, P2528, DOI 10.1261/rna.1369808; Ke ZJ, 2011, ALCOHOL CLIN EXP RES, V35, P1574, DOI 10.1111/j.1530-0277.2011.01503.x; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Kowanetz K, 2004, J BIOL CHEM, V279, P32786, DOI 10.1074/jbc.M403759200; Kravchenko-Balasha N, 2012, P NATL ACAD SCI USA, V109, P4702, DOI 10.1073/pnas.1200790109; Langfelder P, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-54; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001057; Larkin A, 2011, BIOCHEMISTRY-US, V50, P4411, DOI 10.1021/bi200346n; Li LY, 2012, MOL BIOSYST, V8, P1613, DOI 10.1039/c2mb25021g; Liang TB, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r11; Licht K, 2008, RNA, V14, P1532, DOI 10.1261/rna.1129608; McBride WJ, 2012, PHARMACOL BIOCHEM BE, V102, P275, DOI 10.1016/j.pbb.2012.04.016; MILES MF, 1991, J BIOL CHEM, V266, P2409; MILES MF, 1994, MOL PHARMACOL, V46, P873; Min JL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002505; Morito D, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00048; Muller MM, 2006, P NATL ACAD SCI USA, V103, P14250, DOI 10.1073/pnas.0606668103; Nayak RR, 2009, GENOME RES, V19, P1953, DOI 10.1101/gr.097600.109; Neutzner M, 2012, ESSAYS BIOCHEM, V52, P37, DOI [10.1042/bse0520037, 10.1042/BSE0520037]; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Pallesen LT, 2012, MOL NEUROBIOL, V45, P379, DOI 10.1007/s12035-012-8236-2; PHILLIPS TJ, 1994, ALCOHOL CLIN EXP RES, V18, P931, DOI 10.1111/j.1530-0277.1994.tb00062.x; Robinson TE, 2008, PHILOS T R SOC B, V363, P3137, DOI 10.1098/rstb.2008.0093; RODRIGUEZ LA, 1994, ALCOHOL CLIN EXP RES, V18, P1416, DOI 10.1111/j.1530-0277.1994.tb01444.x; RODRIGUEZ LA, 1995, ALCOHOL CLIN EXP RES, V19, P367, DOI 10.1111/j.1530-0277.1995.tb01517.x; Saba L, 2006, MAMM GENOME, V17, P669, DOI 10.1007/s00335-005-0190-0; Saris CGJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-405; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Schulman BA, 2011, PROTEIN SCI, V20, P1941, DOI 10.1002/pro.750; Silbert JE, 2002, IUBMB LIFE, V54, P177, DOI 10.1080/15216540214923; Silverman EK, 2012, DISCOV MED, V14, P143; Staals RHJ, 2010, EMBO J, V29, P2358, DOI 10.1038/emboj.2010.122; Stelzer M, 2011, INTEGR BIOL-UK, V3, P1071, DOI 10.1039/c1ib00008j; Swisher KD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010006; Tabakoff B, 2008, MAMM GENOME, V19, P352, DOI 10.1007/s00335-008-9115-z; Tabakoff B, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-70; Tomecki R, 2010, EMBO J, V29, P2342, DOI 10.1038/emboj.2010.121; Tu ZD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003107; Verdone L, 2004, CURR BIOL, V14, P1487, DOI 10.1016/j.cub.2004.08.032; Wahlsten D, 2006, P NATL ACAD SCI USA, V103, P16364, DOI 10.1073/pnas.0605342103; WALKER JT, 1948, AM J CLIN PATHOL, V18, P451; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Wolen AR, 2012, ALCOHOL RES-CURR REV, V34, P306; Wolen AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033575; Wu XS, 2009, NAT NEUROSCI, V12, P1003, DOI 10.1038/nn.2355; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	91	24	24	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e68878	10.1371/journal.pone.0068878	http://dx.doi.org/10.1371/journal.pone.0068878			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894363	Green Published, gold, Green Submitted			2022-12-27	WOS:000325211000052
J	Huang, QY; Li, GH; Husseneder, C; Lei, CL				Huang, Qiuying; Li, Ganghua; Husseneder, Claudia; Lei, Chaoliang			Genetic Analysis of Population Structure and Reproductive Mode of the Termite Reticulitermes chinensis Snyder	PLOS ONE			English	Article							FORMOSAN SUBTERRANEAN TERMITE; COLONY BREEDING STRUCTURE; MICROSATELLITE LOCI; QUEEN SUCCESSION; ISOPTERA; FLAVIPES; RHINOTERMITIDAE; ORGANIZATION; FUSION; SYSTEM	The subterranean termite Reticulitermes chinensis Snyder is an important pest of trees and buildings in China. Here, we characterized genetic structure and reproductive modes of R. chinensis from China for the first time. A total of 1,875 workers from 75 collection sites in Huanggang, Changsha and Chongqing cities were genotyped at eight microsatellite loci. Analysis of genetic clusters showed two subpopulations in Chongqing city. The Huanggang population showed a uniform genetic pattern and was separated from the other populations by the largest genetic distances (F-ST: 0.17-0.20). In contrast, smaller genetic distances (F-ST: 0.05-0.12) separated Changsha, Chongqing-1 and Chongqing-2 populations. Chongqing-1 was the only population showing a genetic bottleneck. Isolation by distance among colonies in the Huanggang population indicated limited alate dispersal or colony budding. Lack of isolation by distance among colonies within the populations of Changsha, Chongqing-1 and Chongqing-2, suggested long-range dispersal by alates and/or human-mediated transport. Overall, extended family colonies (73.91%) were predominant in all four populations, followed by simple (20.29%), and mixed family colonies (5.80%). Most simple families were headed by inbred related reproductive pairs in the Changsha population, while most simple families in the Chongqing-1 population were headed by outbred unrelated pairs. Simple families in the Huanggang population were a mixture of colonies headed by outbred or inbred reproductive pairs. The sample size of simple families in the Chongqing-2 population was too small to yield significant results. Extended families in all four populations were headed on the average by <= 10 neotenics. Mixed families likely originated from pleometrosis. Presence of heterozygote genotypes showed that all neotenic reproductives collected in addition from five field colonies in Wuhan city were sexually produced, suggesting that these colonies did not undergo parthenogenesis. This study contributes to better understanding of the variance of genetic structure and reproductive mode in the genus Reticulitermes.	[Huang, Qiuying; Li, Ganghua; Lei, Chaoliang] Huazhong Agr Univ, Hubei Insect Resources Utilizat & Sustainable Pes, Wuhan, Peoples R China; [Husseneder, Claudia] Louisiana State Univ, Ctr Agr, Dept Entomol, Baton Rouge, LA USA	Huazhong Agricultural University; Louisiana State University System; Louisiana State University	Lei, CL (corresponding author), Huazhong Agr Univ, Hubei Insect Resources Utilizat & Sustainable Pes, Wuhan, Peoples R China.	ioir@mail.hzau.edu.cn	Li, Ganghua/ABD-3586-2020; Li, Ganghua/G-1302-2013; Huang, Qiuying/B-6010-2016	Li, Ganghua/0000-0001-9741-3909; Husseneder, Claudia/0000-0001-5962-9354; Huang, Qiuying/0000-0001-8689-7370	National Natural Science Foundation of China [31000978]; International Foundation for Science [D/4768-1]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Foundation for Science(International Foundation for Science)	This work was supported by the National Natural Science Foundation of China (31000978) and the International Foundation for Science (D/4768-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich BT, 2007, HEREDITY, V99, P443, DOI 10.1038/sj.hdy.6801022; Aluko GA, 2007, J ECON ENTOMOL, V100, P1037, DOI 10.1603/0022-0493(2007)100[1037:CDOTFS]2.0.CO;2; Atkinson L, 1997, P ROY SOC B-BIOL SCI, V264, P1131, DOI 10.1098/rspb.1997.0156; Austin JW, 2004, ANN ENTOMOL SOC AM, V97, P548, DOI 10.1603/0013-8746(2004)097[0548:PAOTST]2.0.CO;2; Booth W, 2012, INSECT SOC, V59, P127, DOI 10.1007/s00040-011-0198-2; Bulmer MS, 2001, BEHAV ECOL SOCIOBIOL, V49, P236, DOI 10.1007/s002650000304; Clement JL, 2001, INSECT SOC, V48, P202, DOI 10.1007/PL00001768; COPREN KA, 2004, THESIS U CALIFORNIA; DeHeer CJ, 2008, INSECT SOC, V55, P190, DOI 10.1007/s00040-008-0999-0; DeHeer CJ, 2008, SOCIOBIOLOGY, V51, P307; DeHeer CJ, 2005, HEREDITY, V95, P408, DOI 10.1038/sj.hdy.6800744; Deheer CJ, 2004, MOL ECOL, V13, P431, DOI 10.1046/j.1365-294X.2003.2065.x; Dronnet S, 2005, MOL ECOL, V14, P1311, DOI 10.1111/j.1365-294X.2005.02508.x; Dronnet S, 2004, MOL ECOL NOTES, V4, P127, DOI 10.1111/j.1471-8286.2004.00600.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; GLESENER RR, 1978, AM NAT, V112, P659, DOI 10.1086/283308; Goodisman MAD, 2002, EVOLUTION, V56, P70; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Hacker M, 2005, MOL ECOL, V14, P1527, DOI 10.1111/j.1365-294X.2005.02507.x; Hayashi Y, 2005, SOCIOBIOLOGY, V46, P175; Huang F.S., 2000, FAUNA SINICA INSECTA, V17; Husseneder C, 2005, J ECON ENTOMOL, V98, P1421, DOI 10.1603/0022-0493-98.5.1421; Husseneder C, 1998, MOL ECOL, V7, P983, DOI 10.1046/j.1365-294x.1998.00416.x; Husseneder C, 2008, ENVIRON ENTOMOL, V37, P400, DOI 10.1603/0046-225X(2008)37[400:WSITFS]2.0.CO;2; Husseneder C, 2007, J ECON ENTOMOL, V100, P1370, DOI 10.1603/0022-0493(2007)100[1370:EOTSAP]2.0.CO;2; Husseneder C, 2012, BIOL INVASIONS, V14, P419, DOI 10.1007/s10530-011-0087-7; Kutnik M, 2004, MOL ECOL, V13, P3099, DOI 10.1111/j.1365-294X.2004.02294.x; Leniaud L, 2010, BIOL INVASIONS, V12, P1389, DOI 10.1007/s10530-009-9555-8; Lewis P.O., 2000, GENETIC DATA ANAL CO; Liu Yuan-Zhi, 1994, Acta Entomologica Sinica, V37, P38; Luchetti A, 2005, INSECT SOC, V52, P218, DOI 10.1007/s00040-005-0806-5; Marini M, 2002, MOL PHYLOGENET EVOL, V22, P454, DOI 10.1006/mpev.2001.1068; Matsuura K, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P255, DOI 10.1007/978-90-481-3977-4_10; Matsuura K, 2009, SCIENCE, V323, P1687, DOI 10.1126/science.1169702; MILLER MP, 2000, TOOLS POPULATION GEN; Morgan-Richards M, 2010, MOL ECOL, V19, P1227, DOI 10.1111/j.1365-294X.2010.04542.x; Nobre T, 2008, INSECT SOC, V55, P66, DOI 10.1007/s00040-007-0971-4; PAN Y-Z, 1990, Acta Entomologica Sinica, V33, P200; Parman V, 2008, J ECON ENTOMOL, V101, P1349, DOI 10.1603/0022-0493(2008)101[1349:PDSAAB]2.0.CO;2; Peery MZ, 2012, MOL ECOL, V21, P3403, DOI 10.1111/j.1365-294X.2012.05635.x; Perdereau E, 2010, INSECT SOC, V57, P393, DOI 10.1007/s00040-010-0096-z; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; ROONWAL ML, 1975, J SCI IND RES INDIA, V34, P402; Ross KG, 2001, MOL ECOL, V10, P265, DOI 10.1046/j.1365-294x.2001.01191.x; Thompson GJ, 2007, AUST J ZOOL, V55, P219, DOI 10.1071/ZO07023; THORNE BL, 1984, BEHAV ECOL SOCIOBIOL, V14, P117, DOI 10.1007/BF00291903; Thorne BL, 1999, ETHOL ECOL EVOL, V11, P149, DOI 10.1080/08927014.1999.9522833; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vargo EL, 2013, MOL ECOL, V22, P1447, DOI 10.1111/mec.12166; Vargo EL, 2012, P ROY SOC B-BIOL SCI, V279, P813, DOI 10.1098/rspb.2011.1030; Vargo EL, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P321, DOI 10.1007/978-90-481-3977-4_12; Vargo EL, 2009, ANNU REV ENTOMOL, V54, P379, DOI 10.1146/annurev.ento.54.110807.090443; Vargo EL, 2006, ENVIRON ENTOMOL, V35, P151, DOI 10.1603/0046-225X-35.1.151; Vargo EL, 2006, ENVIRON ENTOMOL, V35, P173, DOI 10.1603/0046-225X-35.1.173; Vargo EL, 2000, MOL ECOL, V9, P817, DOI 10.1046/j.1365-294x.2000.00915.x; Vargo EL, 2003, EVOLUTION, V57, P2805, DOI 10.1111/j.0014-3820.2003.tb01522.x; Vargo EL, 2003, ENVIRON ENTOMOL, V32, P1271, DOI 10.1603/0046-225X-32.5.1271; Vargo EL, 2003, MOL ECOL, V12, P2599, DOI 10.1046/j.1365-294X.2003.01938.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Yang W, 2011, DIR DEV, P1	62	18	18	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69070	10.1371/journal.pone.0069070	http://dx.doi.org/10.1371/journal.pone.0069070			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894408	Green Published, gold, Green Submitted			2022-12-27	WOS:000322132100043
J	Heemskerk, EM; Daolio, F; Tomassini, M				Heemskerk, Eelke M.; Daolio, Fabio; Tomassini, Marco			The Community Structure of the European Network of Interlocking Directorates 2005-2010	PLOS ONE			English	Article							CORPORATE; CENTRALITY; POWER	The boards of directors at large European companies overlap with each other to a sizable extent both within and across national borders. This could have important economic, political and management consequences. In this work we study in detail the topological structure of the networks that arise from this phenomenon. Using a comprehensive information database, we reconstruct the implicit networks of shared directorates among the top 300 European firms in 2005 and 2010, and suggest a number of novel ways to explore the trans-nationality of such business elite networks. Powerful community detection heuristics indicate that geography still plays an important role: there exist clear communities and they have a distinct national character. Nonetheless, from 2005 to 2010 we observe a densification of the boards interlocks network and a larger transnational orientation in its communities. Together with central actors and assortativity analyses, we provide statistical evidence that, at the level of corporate governance, Europe is getting closer.	[Heemskerk, Eelke M.] Univ Amsterdam, Dept Polit Sci, Amsterdam, Netherlands; [Daolio, Fabio; Tomassini, Marco] Univ Lausanne, Dept Informat Syst, Lausanne, Switzerland	University of Amsterdam; University of Lausanne	Daolio, F (corresponding author), Univ Lausanne, Dept Informat Syst, Lausanne, Switzerland.	fabio.daolio@unil.ch	Heemskerk, Eelke/E-4872-2012	Daolio, Fabio/0000-0003-4240-4161; Heemskerk, Eelke/0000-0001-7356-5318	The Netherlands Organisation for Scientific Research NWO	The Netherlands Organisation for Scientific Research NWO(Netherlands Organization for Scientific Research (NWO))	E. Heemskerk received partial funding from The Netherlands Organisation for Scientific Research NWO. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Hamelin J.I., 2006, ADV NEURAL INFORM PR, P41; Battiston S, 2004, EUR PHYS J B, V38, P345, DOI 10.1140/epjb/e2004-00127-8; Battiston S, 2003, PHYSICA A, V322, P567, DOI 10.1016/S0378-4371(02)01930-1; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Caldarelli G, 2004, PHYSICA A, V338, P98, DOI 10.1016/j.physa.2004.02.030; Carroll WK, 2010, ANTIPODE, V42, P811, DOI 10.1111/j.1467-8330.2010.00777.x; Carroll WK, 2002, INT SOCIOL, V17, P393, DOI 10.1177/0268580902017003003; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Daolio F, 2011, EUR PHYS J B, V82, P349, DOI 10.1140/epjb/e2011-20182-2; Davis G. F., 2003, Strategic Organization, V1, P301, DOI 10.1177/14761270030013002; DAVIS GF, 1991, ADMIN SCI QUART, V36, P583, DOI 10.2307/2393275; Fennema M., 1982, INT NETWORKS BANKS I; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Gould P. R., 1967, T I BRIT GEOGR, V42, P53, DOI [DOI 10.2307/621372, 10.2307/621372]; Guimera R, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.025101; Heemskerk EM, 2013, ECON SOC, V42, P74, DOI 10.1080/03085147.2012.686720; Heemskerk EM, 2011, GLOBAL NETW, V11, P440, DOI 10.1111/j.1471-0374.2011.00315.x; Hillman AJ, 2009, J MANAGE, V35, P1404, DOI 10.1177/0149206309343469; Kogut B., 2012, SMALL WORLDS CORPORA; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Mizruchi MS, 1996, ANNU REV SOCIOL, V22, P271, DOI 10.1146/annurev.soc.22.1.271; Newman M.E.J., 2010, NETWORKS INTRO; Newman MEJ, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.036122; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Pfeiffer J, 2003, EXTERNAL CONTROL ORG, DOI DOI 10.2307/2392573; R Development Core Team, 2012, R LANG ENV STAT COMP; Rao H, 1999, ORGAN SCI, V10, P27, DOI 10.1287/orsc.10.1.27; Reichardt J, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016110; Scott J, 1985, CORPORATIONS CLASSES; Sklair L., 2001, TRANSNATIONAL CAPITA; Stumpf MPH, 2012, SCIENCE, V335, P665, DOI 10.1126/science.1216142; van Veen Kees, 2008, European Management Journal, V26, P188, DOI 10.1016/j.emj.2007.12.001; van Veen K, 2011, ECON SOC, V40, P1, DOI 10.1080/03085147.2011.529376; Viger F, 2005, LECT NOTES COMPUT SC, V3595, P440, DOI 10.1007/11533719_45; Vitali S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025995; Vitali S, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/6/063021	39	21	21	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e68581	10.1371/journal.pone.0068581	http://dx.doi.org/10.1371/journal.pone.0068581			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	191CY	23894318	gold, Green Published, Green Submitted			2022-12-27	WOS:000322391400011
J	Tan, ML; Su, Y; Lim, CW; Selvaraj, SK; Zhong, L; Tan, RS				Tan, May-Ling; Su, Yi; Lim, Chi-Wan; Selvaraj, Senthil Kumar; Zhong, Liang; Tan, Ru-San			A Geometrical Approach for Automatic Shape Restoration of the Left Ventricle	PLOS ONE			English	Article							IMAGE REGISTRATION TECHNIQUE; 3-DIMENSIONAL REGISTRATION; MR-IMAGES; PET; SPECT; ALIGNMENT; MOTION	This paper describes an automatic algorithm that uses a geometry-driven optimization approach to restore the shape of three-dimensional (3D) left ventricular (LV) models created from magnetic resonance imaging (MRI) data. The basic premise is to restore the LV shape such that the LV epicardial surface is smooth after the restoration and that the general shape characteristic of the LV is not altered. The Maximum Principle Curvature (k(1)) and the Minimum Principle Curvature (k(2)) of the LV epicardial surface are used to construct a shape-based optimization objective function to restore the shape of a motion-affected LV via a dual-resolution semi-rigid deformation process and a free-form geometric deformation process. A limited memory quasi-Newton algorithm, L-BFGS-B, is then used to solve the optimization problem. The goal of the optimization is to achieve a smooth epicardial shape by iterative in-plane and through-plane translation of vertices in the LV model. We tested our algorithm on 30 sets of LV models with simulated motion artifact generated from a very smooth patient sample, and 20 in vivo patient-specific models which contain significant motion artifacts. In the 30 simulated samples, the Hausdorff distances with respect to the Ground Truth are significantly reduced after restoration, signifying that the algorithm can restore geometrical accuracy of motion-affected LV models. In the 20 in vivo patient-specific models, the results show that our method is able to restore the shape of LV models without altering the general shape of the model. The magnitudes of in-plane translations are also consistent with existing registration techniques and experimental findings.	[Tan, May-Ling; Su, Yi; Lim, Chi-Wan; Selvaraj, Senthil Kumar] ASTAR, Inst High Performance Comp, Singapore, Singapore; [Zhong, Liang] Natl Heart Ctr Singapore, Cardiac Mech Engn & Physiol Unit, Singapore, Singapore; [Tan, Ru-San] Natl Heart Ctr Singapore, Dept Cardiol, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of High Performance Computing (IHPC); National Heart Centre Singapore; National Heart Centre Singapore	Tan, ML (corresponding author), ASTAR, Inst High Performance Comp, Singapore, Singapore.	tanml@ihpc.a-star.edu.sg		ZHONG, LIANG/0000-0003-3608-4173; Tan, Ru San/0000-0003-2086-6517	Science and Engineering Research Council (SERC), Agency for Science, Technology and Research (A*STAR) Singapore [0921480071]	Science and Engineering Research Council (SERC), Agency for Science, Technology and Research (A*STAR) Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Science and Engineering Research Council (SERC), Agency for Science, Technology and Research (A*STAR) Singapore through the award of Project Grant 0921480071. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACHARACH SL, 1993, J NUCL MED, V34, P311; Bidaut LM, 2001, J MAGN RESON IMAGING, V13, P648, DOI 10.1002/jmri.1092; Chandler AG, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-13; Cignoni P, 1998, COMPUT GRAPH FORUM, V17, P167, DOI 10.1111/1467-8659.00236; Dey D, 1999, J NUCL MED, V40, P448; Eberl S, 1996, J NUCL MED, V37, P137; Elen A, 2010, IEEE T MED IMAGING, V29, P868, DOI 10.1109/TMI.2009.2039145; FABER TL, 1991, RADIOLOGY, V179, P857, DOI 10.1148/radiology.179.3.2028006; Gallippi CM, 2001, LECT NOTES COMPUTER, VIPMI01, P141; Gilardi MC, 1998, COMPUT MED IMAG GRAP, V22, P391, DOI 10.1016/S0895-6111(98)00039-1; HOH CK, 1993, J NUCL MED, V34, P2009; Huang XS, 2005, LECT NOTES COMPUT SC, V3750, P171, DOI 10.1007/11566489_22; Klein GJ, 2002, MED IMAGE ANAL, V6, P29, DOI 10.1016/S1361-8415(01)00050-0; Li QH, 1998, LECT NOTES COMPUT SC, V1496, P253; Makela T, 2002, IEEE T MED IMAGING, V21, P1011, DOI 10.1109/TMI.2002.804441; Makela T., 2001, PROC INT C MED IMAGE, P557, DOI [10.1007/3-540-45468-3_67, DOI 10.1007/3-540-45468-3_67]; McLeish K, 2002, IEEE T MED IMAGING, V21, P1142, DOI 10.1109/TMI.2002.804427; MITCHELL GF, 1992, J AM COLL CARDIOL, V19, P1136, DOI 10.1016/0735-1097(92)90314-D; Nekolla S, 2001, IOS PRESS COREGISTRA, V322, P144; PALLOTTA S, 1995, PHYS MED BIOL, V40, P1695, DOI 10.1088/0031-9155/40/10/010; SINHA S, 1995, AM J ROENTGENOL, V164, P301, DOI 10.2214/ajr.164.2.7839959; SLOMKA PJ, 1995, J NUCL MED, V36, P1115; Su Y, 2012, COMPUT METH PROG BIO, V108, P500, DOI 10.1016/j.cmpb.2011.03.008; Turkington TG, 1997, IEEE T NUCL SCI, V44, P235, DOI 10.1109/23.568814; Zhong L, 2011, AM J PHYSIOL-HEART C, V300, pH1653, DOI 10.1152/ajpheart.00021.2011; Zhong L, 2012, AM J PHYSIOL-HEART C, V302, pH1306, DOI 10.1152/ajpheart.00679.2011; Zhong L, 2009, AM J PHYSIOL-HEART C, V296, pH573, DOI 10.1152/ajpheart.00525.2008; Zhu CY, 1997, ACM T MATH SOFTWARE, V23, P550, DOI 10.1145/279232.279236	28	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e68615	10.1371/journal.pone.0068615	http://dx.doi.org/10.1371/journal.pone.0068615			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894325	Green Published, gold, Green Submitted			2022-12-27	WOS:000322391400016
J	Movahedan, A; Afsharkhamseh, N; Sagha, HM; Shah, JR; Milani, BY; Milani, FY; Logothetis, HD; Chan, CC; Djalilian, AR				Movahedan, Asadolah; Afsharkhamseh, Neda; Sagha, Hossein M.; Shah, Jarna R.; Milani, Behrad Y.; Milani, Farnoud Y.; Logothetis, Hercules D.; Chan, Chi-Chao; Djalilian, Ali R.			Loss of Notch1 Disrupts the Barrier Repair in the Corneal Epithelium	PLOS ONE			English	Article							EPIDERMAL DIFFERENTIATION; CELL DIFFERENTIATION; DOWN-REGULATION; MOUSE SKIN; FATE; PROLIFERATION; PROMOTES; PATHWAY; RESTORATION; JUNCTIONS	The corneal epithelium is the outermost layer of the cornea that directly faces the outside environment, hence it plays a critical barrier function. Previously, conditional loss of Notch1 on the ocular surface was found to cause inflammation and keratinization of the corneal epithelium. This was in part attributed to impaired vitamin A metabolism, loss of the meibomian glands and recurrent eyelid trauma. We hypothesized that Notch1 plays an essential role in the corneal epithelial barrier function and is a contributing factor in the pathologic changes in these mice. Notch1 was conditionally deleted in adult Notch1(flox/flox), K14-Cre-ERT+/- mice using hydroxy-tamoxifen. The results indicated that conditional deletion of Notch1 on the ocular surface leads to progressive impairment of the epithelial barrier function before the onset of corneal opacification and keratinization. Loss of the barrier was demonstrated both by an increase in in vivo corneal fluorescein staining and by enhanced penetration of a small molecule through the epithelium. Corneal epithelial wounding resulted in significant delay in recovery of the barrier function in conditional Notch1(-/-) mice compared to wild type. Mice with conditional deletion of Notch1 did not demonstrate any evidence of dry eyes based on aqueous tear production and had normal conjunctival goblet cells. In a calcium switch experiment in vitro, Notch1(-/-) cells demonstrated delayed membrane localization of the tight junction protein ZO-1 consistent with a defect in the epithelial tight junction formation. These findings highlight the role of Notch1 in epithelial differentiation and suggest that intrinsic defects in the corneal epithelial barrier recovery after wounding is an important contributing factor to the development of inflammatory keratinization in Notch1(-/-) mice.	[Movahedan, Asadolah; Afsharkhamseh, Neda; Sagha, Hossein M.; Shah, Jarna R.; Milani, Behrad Y.; Milani, Farnoud Y.; Logothetis, Hercules D.; Djalilian, Ali R.] Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago, IL 60607 USA; [Chan, Chi-Chao] NEI, NIH, Bethesda, MD 20892 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Djalilian, AR (corresponding author), Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago, IL 60607 USA.	adjalili@uic.edu		Movahedan, Asadolah/0000-0001-5759-6579	National Institutes of Health [K08EY017561-A1, EY01792]; Cless Family Foundation; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [ZICEY000461, P30EY001792, K08EY017561, ZIAEY000222] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cless Family Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by a career development grant K08EY017561-A1 to ARD, a core grant EY01792 from the National Institutes of Health, and by the Cless Family Foundation. ARD is the recipient of a Career Development Award from Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon I, 2011, INVEST OPHTH VIS SCI, V52, P1368, DOI 10.1167/iovs.10-6125; Amirjamshidi H, 2011, MOL VIS, V17, P658; Chen WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040893; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Dahan S, 2011, GASTROENTEROLOGY, V140, P550, DOI 10.1053/j.gastro.2010.10.057; Demehri S, 2008, PLOS BIOL, V6, P992, DOI 10.1371/journal.pbio.0060123; Demehri S, 2009, CANCER CELL, V16, P55, DOI 10.1016/j.ccr.2009.05.016; Djalilian AR, 2008, MOL VIS, V14, P1041; Dursun D, 2002, INVEST OPHTH VIS SCI, V43, P632; Ezratty EJ, 2011, CELL, V145, P1129, DOI 10.1016/j.cell.2011.05.030; Fischbarg J, 1997, BRIT J OPHTHALMOL, V81, P85, DOI 10.1136/bjo.81.1.85; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Hutcheon AEK, 2007, EXP EYE RES, V84, P32, DOI 10.1016/j.exer.2006.08.011; Kobayashi T, 2009, MOL VIS, V15, P1589; Li C, 2011, J CELL PHYSIOL, V226, P2429, DOI 10.1002/jcp.22591; Liu ZY, 2011, J CLIN INVEST, V121, P800, DOI 10.1172/JCI43114; Lu HY, 2012, MOL VIS, V18, P403; Lu QX, 2011, INVEST OPHTH VIS SCI, V52, P2389, DOI 10.1167/iovs.09-4981; Ma A, 2007, INVEST OPHTH VIS SCI, V48, P3576, DOI 10.1167/iovs.06-1373; Ma AH, 2011, WOUND REPAIR REGEN, V19, P98, DOI 10.1111/j.1524-475X.2010.00648.x; Maillard I, 2004, BLOOD, V104, P1696, DOI 10.1182/blood-2004-02-0514; Mantelli F, 2009, INVEST OPHTH VIS SCI, V50, P2666, DOI 10.1167/iovs.08-2734; Mazur PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013578; MISHIMA S, 1961, EXP EYE RES, V1, P39, DOI 10.1016/S0014-4835(61)80006-7; Movahedan A, 2012, INVEST OPHTH VIS SCI, V53, P7476, DOI 10.1167/iovs.12-10735; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Nien CJ, 2010, MOL VIS, V16, P1132; PEI YF, 1970, ANAT REC, V168, P105, DOI 10.1002/ar.1091680109; Peng H, 2012, P NATL ACAD SCI USA, V109, P14030, DOI 10.1073/pnas.1111292109; Pflugfelder SC, 2011, AM J OPHTHALMOL, V152, P900, DOI 10.1016/j.ajo.2011.08.023; Ramain P, 2001, CURR BIOL, V11, P1729, DOI 10.1016/S0960-9822(01)00562-0; Segre JA, 2006, J CLIN INVEST, V116, P1150, DOI 10.1172/JCI28521; Shafiq MA, 2012, TISSUE ENG PART C-ME, V18, P340, DOI [10.1089/ten.tec.2011.0072, 10.1089/ten.TEC.2011.0072]; Sugrue SP, 1997, EXP EYE RES, V64, P11, DOI 10.1006/exer.1996.0175; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Vauclair S, 2007, DEV CELL, V13, P242, DOI 10.1016/j.devcel.2007.06.012; Wang Y, 2004, EXP EYE RES, V78, P125, DOI 10.1016/j.exer.2003.09.002; Williams SE, 2011, NATURE, V470, P353, DOI 10.1038/nature09793; Xin Y, 2010, BIOCHEM BIOPH RES CO, V392, P593, DOI 10.1016/j.bbrc.2010.01.084; Xiong LJ, 2011, INVEST OPHTH VIS SCI, V52, P5641, DOI 10.1167/iovs.11-7196; Yi X, 2000, INVEST OPHTH VIS SCI, V41, P4093; Zehendner CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016760; Zhang YJ, 2013, DEVELOPMENT, V140, P594, DOI 10.1242/dev.082842	43	22	24	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e69113	10.1371/journal.pone.0069113	http://dx.doi.org/10.1371/journal.pone.0069113			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874882	Green Published, gold, Green Submitted			2022-12-27	WOS:000324146200057
J	Zhang, YQ; Xiao, CX; Lin, BY; Shi, Y; Liu, YP; Liu, JJ; Guleng, B; Ren, JL				Zhang, Yu-Qin; Xiao, Chuan-Xing; Lin, Bi-Yun; Shi, Ying; Liu, Yun-Peng; Liu, Jing-Jing; Guleng, Bayasi; Ren, Jian-Lin			Silencing of Pokemon Enhances Caspase-Dependent Apoptosis via Fas- and Mitochondria-Mediated Pathways in Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							REPRESSES TRANSCRIPTION; ZINC-FINGER; INTERFERON-ALPHA; FBI-1; CANCER; EXPRESSION; REGULATORS; P53; COMBINATION; PROTEIN	The role of Pokemon (POK erythroid myeloid ontogenic actor), a recently identified POK transcription factor with proto-oncogenic activity, in hepatocellular carcinogenesis has only been assessed by a few studies. Our previous study revealed that Pokemon is overexpressed in hepatocellular carcinomas (HCC) and promotes HCC cell proliferation and migration via an AKT- and ERK-dependent manner. In the present study, we used the TUNEL assay and FACS analysis to demonstrate that oxaliplatin induced apoptosis was significantly increased in cells with silenced Pokemon. Western blots showed that p53 expression and phosphorylation were significantly increased in Pokemon defective cells, thereby initiating the mitochondria-mediated and death receptor-mediated apoptotic pathways. In the mitochondria-mediated pathway, expression of pro-apoptotic Bcl-2 family members (including Bad, Bid, Bim and Puma) as well as AIF was increased and decreasing the mitochondrial membrane potential resulted in cytochrome C released from mitochondrial in HepG2 si-Pokemon cells. In addition, upon oxaliplatin treatment of Pokemon-silenced cells, the FAS receptor, FADD and their downstream targets caspase-10 and caspase-8 were activated, causing increased release of caspase-8 active fragments p18 and p10. Increased activated caspase-8-mediated cleavage and activation of downstream effector caspases such as caspase-9 and caspase-3 was observed in HepG2 si-Pokemon cells as compared to control. Therefore, Pokemon might serve as an important mediator of crosstalk between intrinsic and extrinsic apoptotic pathways in HCC cells. Moreover, our findings suggest that Pokemon could be an attractive therapeutic target gene for human cancer therapy.	[Zhang, Yu-Qin; Xiao, Chuan-Xing; Lin, Bi-Yun; Shi, Ying; Liu, Yun-Peng; Liu, Jing-Jing; Guleng, Bayasi; Ren, Jian-Lin] Xiamen Univ, Zhongshan Hosp, Dept Gastroenterol, Xiamen, Peoples R China; [Guleng, Bayasi] Xiamen Univ, Coll Med, Fac Clin Med, Xiamen, Peoples R China	Xiamen University; Xiamen University	Guleng, B (corresponding author), Xiamen Univ, Zhongshan Hosp, Dept Gastroenterol, Xiamen, Peoples R China.	bayasi8@gmail.com; renjianl@xmu.edu.cn			National Natural Science Foundation of China [81072013, 91229201]; Foundations of Health Bureau of Xiamen in China [3502Z200940010]; Ministry of Health Foundation for State Key Clinical Department	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundations of Health Bureau of Xiamen in China; Ministry of Health Foundation for State Key Clinical Department	This work was supported by National Natural Science Foundation of China (No. 81072013 & 91229201), Foundations of Health Bureau of Xiamen in China (No. 3502Z200940010) and Ministry of Health Foundation for State Key Clinical Department. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El-Ghany RM, 2009, DRUG DISCOV THER, V3, P296; Aggarwal A, 2010, EXP MOL PATHOL, V89, P140, DOI 10.1016/j.yexmp.2010.05.002; Asnacios A, 2008, CANCER-AM CANCER SOC, V112, P2733, DOI 10.1002/cncr.23489; Avery-Kiejda KA, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-203; Berindan-Neagoe I, 2013, J GASTROINTEST LIVER, V22, P37; Buendia MA, 2000, SEMIN CANCER BIOL, V10, P185; Choi WI, 2009, J BIOL CHEM, V284, P12633, DOI 10.1074/jbc.M809794200; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Davies JM, 1999, ONCOGENE, V18, P365, DOI 10.1038/sj.onc.1202332; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Fulda S, 2009, CANCER LETT, V281, P128, DOI 10.1016/j.canlet.2008.11.023; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Guleng B, 2005, CANCER RES, V65, P5864, DOI 10.1158/0008-5472.CAN-04-3833; Jeon BN, 2008, J BIOL CHEM, V283, P33199, DOI 10.1074/jbc.M802935200; Kelley SK, 2004, CURR OPIN PHARMACOL, V4, P333, DOI 10.1016/j.coph.2004.02.006; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Laudes M, 2004, J BIOL CHEM, V279, P11711, DOI 10.1074/jbc.M310240200; Lee DK, 2005, J BIOL CHEM, V280, P27783, DOI 10.1074/jbc.M504909200; Lee DK, 2002, J BIOL CHEM, V277, P26761, DOI 10.1074/jbc.M202078200; Lee SH, 2001, HUM PATHOL, V32, P250, DOI 10.1053/hupa.2001.22769; Lim S-C, 2009, INT J CANC; Lin CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051916; Lin S, 2009, BIOSCI TRENDS, V3, P53; Maeda T, 2005, CANCER RES, V65, P8575, DOI 10.1158/0008-5472.CAN-05-1055; Maeda T, 2005, NATURE, V433, P278, DOI 10.1038/nature03203; Maetens M, 2007, BLOOD, V109, P2630, DOI 10.1182/blood-2006-03-013656; Miyagishi M, 2002, NAT BIOTECHNOL, V20, P497, DOI 10.1038/nbt0502-497; Morrison DJ, 1999, NUCLEIC ACIDS RES, V27, P1251, DOI 10.1093/nar/27.5.1251; Nakamura M, 2007, J HEPATOL, V46, P77, DOI 10.1016/j.jhep.2006.07.032; Okamoto K, 2000, RHEUMATOLOGY, V39, P471, DOI 10.1093/rheumatology/39.5.471; Qi FH, 2012, FOOD CHEM TOXICOL, V50, P295, DOI 10.1016/j.fct.2011.10.040; Reed JC, 1997, SEMIN HEMATOL, V34, P9; Sun BH, 2000, WORLD J GASTROENTERO, V6, P223; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Xiao CX, 2012, CANC LETT; Yin HP, 2011, CANCER LETT, V306, P34, DOI 10.1016/j.canlet.2011.02.017	36	25	31	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e68981	10.1371/journal.pone.0068981	http://dx.doi.org/10.1371/journal.pone.0068981			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23874836	Green Published, Green Submitted, gold			2022-12-27	WOS:000322000600037
J	Du Plooy, JN; Buys, A; Duim, W; Pretorius, E				Du Plooy, Jeanette Noel; Buys, Antoinette; Duim, Wiebren; Pretorius, Etheresia			Comparison of Platelet Ultrastructure and Elastic Properties in Thrombo-Embolic Ischemic Stroke and Smoking Using Atomic Force and Scanning Electron Microscopy	PLOS ONE			English	Article							FIBRINOGEN; RESOLUTION; DYNAMICS; SURFACES; ADHESION; RECEPTOR	Thrombo-embolic ischemic stroke is a serious and debilitating disease, and it remains the second most common cause of death worldwide. Tobacco smoke exposure continues to be responsible for preventable deaths around the world, and is a major risk factor for stroke. Platelets play a fundamental role in clotting, and their pathophysiological functioning is present in smokers and stroke patients, resulting in a pro-thrombotic state. In the current manuscript, atomic force and scanning electron microscopy were used to compare the platelets of smokers, stroke patients and healthy individuals. Results showed that the elastic modulus of stroke platelets is decreased by up to 40%, whereas there is an elasticity decrease of up to 20% in smokers' platelets. This indicates a biophysical alteration of the platelets. Ultrastructurally, both the stroke patients and smokers' platelets are more activated than the healthy control group, with prominent cytoskeletal rearrangement involved; but to a more severe extent in the stroke group than in the smokers. Importantly, this is a confirmation of the extent of smoking as risk factor for stroke. We conclude by suggesting that the combined AFM and SEM analyses of platelets might give valuable information about the disease status of patients. Efficacy of treatment regimes on the integrity, cell shape, roughness and health status of platelets may be tracked, as this cell's health status is crucial in the over-activated coagulation system of conditions like stroke.	[Du Plooy, Jeanette Noel; Pretorius, Etheresia] Univ Pretoria, Fac Hlth Sci, Sch Med, Dept Physiol, ZA-0002 Pretoria, South Africa; [Buys, Antoinette] Univ Pretoria, Sch Med, Fac Hlth Sci, ZA-0002 Pretoria, South Africa; [Duim, Wiebren] Univ Pretoria, Dept Neurol, Sch Med, Fac Hlth Sci, ZA-0002 Pretoria, South Africa	University of Pretoria; University of Pretoria; University of Pretoria	Pretorius, E (corresponding author), Univ Pretoria, Fac Hlth Sci, Sch Med, Dept Physiol, ZA-0002 Pretoria, South Africa.	resia.pretorius@up.ac.za	Pretorius, Etheresia/P-2978-2016; Pretorius, Etheresia/ACH-6368-2022	Pretorius, Etheresia/0000-0002-9108-2384; Pretorius, Etheresia/0000-0002-9108-2384; Lensink, Antonia Vergina/0000-0002-5206-3877	National Research Foundation of South Africa	National Research Foundation of South Africa(National Research Foundation - South Africa)	National Research Foundation of South Africa for funding of EP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotri A, 2009, COLLOID SURFACE B, V71, P138, DOI 10.1016/j.colsurfb.2009.01.019; ALBRECHT RM, 1989, AM J ANAT, V185, P149, DOI 10.1002/aja.1001850208; Bearer EL, 2002, INT REV CYTOL, V217, P137; Berquand A, 2011, BRUKER APPL NOTE, V135, P1; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; BURNHAM NA, 1989, J VAC SCI TECHNOL A, V7, P2906, DOI 10.1116/1.576168; CAINE YG, 1986, SCANNING MICROSCOPY, V1986, P1087; DERJAGUIN BV, 1975, J COLLOID INTERF SCI, V53, P314, DOI 10.1016/0021-9797(75)90018-1; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Fox JEB, 2001, THROMB HAEMOSTASIS, V86, P198; HARTWIG JH, 1991, J CELL BIOL, V112, P407, DOI 10.1083/jcb.112.3.407; Hussain MA, 2004, MICRON, V35, P565, DOI 10.1016/j.micron.2004.02.010; Kuznetsova TG, 2007, MICRON, V38, P824, DOI 10.1016/j.micron.2007.06.011; Lam WA, 2011, NAT MATER, V10, P61, DOI 10.1038/NMAT2903; Lee I, 2000, COLLOID SURFACE B, V19, P357, DOI 10.1016/S0927-7765(00)00144-2; LOFTUS JC, 1984, J CELL BIOL, V99, P822, DOI 10.1083/jcb.99.3.822; Mazzone P, 2010, INT J ENV RES PUB HE, V7, P4111, DOI 10.3390/ijerph7124111; Michelson AD, 1996, P NATL ACAD SCI USA, V93, P11877, DOI 10.1073/pnas.93.21.11877; Padmavathi P, 2010, J ATHEROSCLER THROMB, V17, P619, DOI 10.5551/jat.2857; Pretorius E, 2012, ULTRASTRUCT PATHOL, V36, P239, DOI 10.3109/01913123.2012.663068; Pretorius E, 2012, ULTRASTRUCT PATHOL, V36, P19, DOI 10.3109/01913123.2011.620219; RADMACHER M, 1992, SCIENCE, V257, P1900, DOI 10.1126/science.1411505; Radmacher M, 1996, BIOPHYS J, V70, P556, DOI 10.1016/S0006-3495(96)79602-9; Radmacher M, 1992, IMAGING VISCOELASTIC, P4917; Rendu F, 2002, PLATELETS THROMBOTIC, P104, DOI DOI 10.1017/CB09780511545283; Roberts HR, 2012, MOL BIOL BIOCH COAGU; Shamova EV, 2011, EUR BIOPHYS J BIOPHY, V40, P195, DOI 10.1007/s00249-010-0639-2; Torner J, 2006, U IOWA HEALTHCARE ST; Yang YT, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/28/285704	29	24	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e69774	10.1371/journal.pone.0069774	http://dx.doi.org/10.1371/journal.pone.0069774			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874998	gold, Green Published, Green Submitted			2022-12-27	WOS:000322064300116
J	Sun, J; Zhou, M; Yang, HX; Deng, JE; Wang, LT; Wang, QH				Sun, Jie; Zhou, Meng; Yang, Haixiu; Deng, Jiaen; Wang, Letian; Wang, Qianghu			Inferring Potential microRNA-microRNA Associations Based on Targeting Propensity and Connectivity in the Context of Protein Interaction Network	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; FUNCTIONAL SIMILARITY; DOWN-REGULATION; EXPRESSION; DATABASE; TOOLS; PRIORITIZATION; IDENTIFICATION; PREDICTION; DEFICIENT	MicroRNAs (miRNAs) are a group of small non-coding RNAs that play important regulatory roles at the post-transcriptional level. Although several computational methods have been developed to compare miRNAs, it is still a challenging and a badly needed task with the availability of various biological data resources. In this study, we proposed a novel graph theoretic property based computational framework and method, called miRFunSim, for quantifying the associations between miRNAs based on miRNAs targeting propensity and proteins connectivity in the integrated protein-protein interaction network. To evaluate the performance of our method, we applied the miRFunSim method to compute functional similarity scores of miRNA pairs between 100 miRNAs whose target genes have been experimentally supported and found that the functional similarity scores of miRNAs in the same family or in the same cluster are significantly higher compared with other miRNAs which are consistent with prior knowledge. Further validation analysis on experimentally verified miRNA-disease associations suggested that miRFunSim can effectively recover the known miRNA pairs associated with the same disease and achieve a higher AUC of 83.1%. In comparison with similar methods, our miRFunSim method can achieve more effective and more reliable performance for measuring the associations of miRNAs. We also conducted the case study examining liver cancer based on our method, and succeeded in uncovering the candidate liver cancer related miRNAs such as miR-34 which also has been proven in the latest study.	[Sun, Jie; Zhou, Meng; Yang, Haixiu; Deng, Jiaen; Wang, Letian; Wang, Qianghu] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China	Harbin Medical University	Zhou, M (corresponding author), Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China.	biofomeng@hotmail.com; wqhmcm@hrbmu.edu.cn	Zhou, Meng/G-7674-2011	Zhou, Meng/0000-0001-9987-9024; Sun, Jie/0000-0002-0932-7195	Foundation of Health Department of Heilongjiang Province [2012-809]	Foundation of Health Department of Heilongjiang Province	This work was supported by the Foundation of Health Department of Heilongjiang Province (Grant No. 2012-809). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alisi A, 2011, LAB INVEST, V91, P283, DOI 10.1038/labinvest.2010.166; Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Ceol A, 2010, NUCLEIC ACIDS RES, V38, pD532, DOI 10.1093/nar/gkp983; Chen J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-73; Connolly E, 2008, AM J PATHOL, V173, P856, DOI 10.2353/ajpath.2008.080096; Cui QH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100089; Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793; Du ZD, 2009, NUCLEIC ACIDS RES, V37, pW345, DOI 10.1093/nar/gkp463; Gao Y, 2010, ENDOCR J, V57, P81, DOI 10.1507/endocrj.K09E-220; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hsu CW, 2008, PROTEOMICS, V8, P1975, DOI 10.1002/pmic.200701004; Huang XH, 2009, HEPATOL RES, V39, P786, DOI 10.1111/j.1872-034X.2009.00502.x; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Jiang J, 2008, CLIN CANCER RES, V14, P419, DOI 10.1158/1078-0432.CCR-07-0523; Jiang QH, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S1-S2; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Kaczkowski B, 2009, BIOINFORMATICS, V25, P291, DOI 10.1093/bioinformatics/btn628; Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Ladeiro Y, 2008, HEPATOLOGY, V47, P1955, DOI 10.1002/hep.22256; Li R, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-169; Liang H, 2007, RNA, V13, P1402, DOI 10.1261/rna.634607; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Mendes ND, 2009, NUCLEIC ACIDS RES, V37, P2419, DOI 10.1093/nar/gkp145; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Nam S, 2008, NUCLEIC ACIDS RES, V36, pD159, DOI 10.1093/nar/gkm829; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Ramani AK, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-R40; Roubelakis MG, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S20; Ruepp A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r6; Schlicker A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-302; Schlicker A, 2010, NUCLEIC ACIDS RES, V38, pD244, DOI 10.1093/nar/gkp979; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Tryndyak VP, 2009, MOL CARCINOGEN, V48, P479, DOI 10.1002/mc.20484; Ulitsky I, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq570; Uziel T, 2009, P NATL ACAD SCI USA, V106, P2812, DOI 10.1073/pnas.0809579106; Varnholt H, 2008, HEPATOLOGY, V47, P1223, DOI 10.1002/hep.22158; Wang B, 2009, HEPATOLOGY, V50, P1152, DOI 10.1002/hep.23100; Wang D., 2010, PLOS ONE, V5; Wang D, 2010, BIOINFORMATICS, V26, P1644, DOI 10.1093/bioinformatics/btq241; Wang QH, 2011, BIOINFORMATICS, V27, P1521, DOI 10.1093/bioinformatics/btr154; Wang Y, 2008, J BIOL CHEM, V283, P13205, DOI 10.1074/jbc.M707629200; Xia HP, 2009, BIOCHEM BIOPH RES CO, V380, P205, DOI 10.1016/j.bbrc.2008.12.169; Xia L, 2008, INT J CANCER, V123, P372, DOI 10.1002/ijc.23501; Xu JA, 2011, NUCLEIC ACIDS RES, V39, P825, DOI 10.1093/nar/gkq832; Xu PZ, 2004, TRENDS GENET, V20, P617, DOI 10.1016/j.tig.2004.09.010; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056; Yu G., 2010, J INTEGRATED OMICS, V1, P49; Zhang YF, 2009, SCI CHINA SER C, V52, P261, DOI 10.1007/s11427-009-0032-5; Zhu EL, 2010, NUCLEIC ACIDS RES, V38, pW392, DOI 10.1093/nar/gkq393	55	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e69719	10.1371/journal.pone.0069719	http://dx.doi.org/10.1371/journal.pone.0069719			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874989	gold, Green Submitted, Green Published			2022-12-27	WOS:000322064300114
J	Vetri, V; Leone, M; Morozova-Roche, LA; Vestergaard, B; Fodera, V				Vetri, Valeria; Leone, Maurizio; Morozova-Roche, Ludmilla A.; Vestergaard, Bente; Fodera, Vito			Unlocked Concanavalin A Forms Amyloid-like Fibrils from Coagulation of Long-lived "Crinkled'' Intermediates	PLOS ONE			English	Article							INDUCED CONFORMATIONAL-CHANGES; STRUCTURAL POLYMORPHISM; BETA-SHEETS; AGGREGATION; MECHANISM; OLIGOMERS; REVEALS; FLUORESCENCE; KINETICS; BINDING	Understanding the early events during amyloid aggregation processes is crucial to single out the involved molecular mechanisms and for designing ad hoc strategies to prevent and reverse amyloidogenic disorders. Here, we show that, in conditions in which the protein is positively charged and its conformational flexibility is enhanced, Concanavalin A leads to fibril formation via a non-conventional aggregation pathway. Using a combination of light scattering, circular dichroism, small angle X-ray scattering, intrinsic (Tryptophan) and extrinsic (ANS) fluorescence and confocal and 2-photon fluorescence microscopy we characterize the aggregation process as a function of the temperature. We highlight a multi-step pathway with the formation of an on-pathway long-lived intermediate and a subsequent coagulation of such "crinkled'' precursors into amyloid-like fibrils. The process results in a temperature-dependent aggregation-coagulation pathway, with the late phase of coagulation determined by the interplay between hydrophobic and electrostatic forces. Our data provide evidence for the complex aggregation pathway for a protein with a highly flexible native conformation. We demonstrate the possibility to generate a long-lived intermediate whose proportion and occurrence are easily tunable by experimental parameters (i.e. temperature). As a consequence, in the case of aggregation processes developing through well-defined energy barriers, our results can open the way to new strategies to induce more stable in vitro on-pathway intermediate species through a minute change in the initial conformational flexibility of the protein. This will allow isolating and experimentally studying such transient species, often indicated as relevant in neurodegenerative diseases, both in terms of structural and cytotoxic properties.	[Vetri, Valeria; Leone, Maurizio] Univ Palermo, Dipartimento Fis & Chim, Palermo, Italy; [Morozova-Roche, Ludmilla A.] Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden; [Vestergaard, Bente; Fodera, Vito] Univ Copenhagen, Dept Drug Design & Pharmacol, Copenhagen, Denmark; [Fodera, Vito] Univ Cambridge, Cavendish Lab, Dept Phys, Sect Biol & Soft Syst, Cambridge CB3 0HE, England	University of Palermo; Umea University; University of Copenhagen; University of Cambridge	Vetri, V (corresponding author), Univ Palermo, Dipartimento Fis & Chim, Palermo, Italy.	valeria.vetri@unipa.it; vito.fodera@sund.ku.dk	Fodera, Vito/C-1966-2014; Leone, Maurizio/F-2353-2010; Vetri, Valeria/F-2314-2010; Morozova-Roche, Ludmilla/AAV-9983-2021; Foderà, Vito/AAZ-9925-2020; Foderà, Vito/F-9029-2010; Morozova-Roche, Ludmilla A./AAU-9044-2021	Leone, Maurizio/0000-0002-0292-7657; Vetri, Valeria/0000-0002-2307-1165; Morozova-Roche, Ludmilla/0000-0001-5886-2023; Foderà, Vito/0000-0003-2855-0568; Foderà, Vito/0000-0003-2855-0568; Vestergaard, Bente/0000-0001-8011-6414	FP7 Marie-Curie Actions Intra European Fellowship (IEF) [299385]; PRIN "Development of a molecular strategy for the prevention of proteins aggregation and fibrillogenesis: a biophysical approach'' [prot.20083Y34Y7]; VR-M	FP7 Marie-Curie Actions Intra European Fellowship (IEF); PRIN "Development of a molecular strategy for the prevention of proteins aggregation and fibrillogenesis: a biophysical approach''(Ministry of Education, Universities and Research (MIUR)); VR-M(Swedish Research Council)	VF acknowledges support from the FP7 Marie-Curie Actions Intra European Fellowship (IEF) for Career Development 2012-2014, project nr. 299385 "FibCat'' (University of Copenhagen). LAMR acknowledges support from VR-M. VV and ML acknowledge support from PRIN 2008 prot. 20083Y34Y7 "Development of a molecular strategy for the prevention of proteins aggregation and fibrillogenesis: a biophysical approach''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin ARMR, 2007, CANCER RES, V67, P5617, DOI 10.1158/0008-5472.CAN-07-0655; Andersen CB, 2010, PROTEIN SCI, V19, P279, DOI 10.1002/pro.309; Auer S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000222; BECKER JW, 1975, J BIOL CHEM, V250, P1513; Bolognesi B, 2010, ACS CHEM BIOL, V5, P735, DOI 10.1021/cb1001203; Bromley EHC, 2006, EUR PHYS J E, V21, P145, DOI 10.1140/epje/i2006-10055-7; Carrotta R, 2011, J PHYS CHEM B, V115, P2691, DOI 10.1021/jp1042409; Chatani E, 2005, J MOL BIOL, V352, P941, DOI 10.1016/j.jmb.2005.07.043; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Dam TK, J BIOL CHEM, V275, P14230; Dusa A, 2006, BIOCHEMISTRY-US, V45, P2752, DOI 10.1021/bi051426z; DWYER DM, 1976, P NATL ACAD SCI USA, V73, P852, DOI 10.1073/pnas.73.3.852; EMSLEY J, 1994, NATURE, V367, P338, DOI 10.1038/367338a0; Fandrich M, 2009, PRION, V3, P89; Fodera V, 2010, EUR PHYS J E, V33, P273, DOI 10.1140/epje/i2010-10665-4; Fodera V, 2012, J PHYS CHEM LETT, V3, P2803, DOI 10.1021/jz301375d; Fodera V, 2010, SOFT MATTER, V6, P4413, DOI 10.1039/c0sm00169d; Griffin MDW, 2008, J MOL BIOL, V375, P240, DOI 10.1016/j.jmb.2007.10.038; Heldt CL, 2011, BIOPHYS J, V100, P2792, DOI 10.1016/j.bpj.2011.04.046; HOFRICHTER J, 1974, P NATL ACAD SCI USA, V71, P4864, DOI 10.1073/pnas.71.12.4864; HOFRICHTER J, 1976, P NATL ACAD SCI USA, V73, P3035, DOI 10.1073/pnas.73.9.3035; House E, 2011, J ALZHEIMERS DIS, V25, P43, DOI 10.3233/JAD-2011-110071; HULETT JR, 1964, Q REV CHEM SOC, V18, P227, DOI 10.1039/qr9641800227; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Librizzi F, 2007, EUR BIOPHYS J BIOPHY, V36, P711, DOI 10.1007/s00249-007-0137-3; Lindgren M, 2005, BIOPHYS J, V88, P4200, DOI 10.1529/biophysj.104.049700; Liu B, 2009, ARCH BIOCHEM BIOPHYS, V482, P1, DOI 10.1016/j.abb.2008.12.003; Loksztejn A, 2010, J MOL BIOL, V395, P643, DOI 10.1016/j.jmb.2009.10.065; Newman SJ, 2000, BRAIN RES, V857, P131, DOI 10.1016/S0006-8993(99)02417-8; Nielsen SS, 2009, J APPL CRYSTALLOGR, V42, P959, DOI 10.1107/S0021889809023863; Noto R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032444; Pedersen JS, 2010, FEBS J, V277, P4591, DOI 10.1111/j.1742-4658.2010.07888.x; Pedersen JS, 2006, J MOL BIOL, V355, P501, DOI 10.1016/j.jmb.2005.09.100; Pfefferkorn CM, 2010, P NATL ACAD SCI USA, V107, P21447, DOI 10.1073/pnas.1006424107; Robbins KJ, 2012, LANGMUIR, V28, P16490, DOI 10.1021/la303677t; Robbins KJ, 2011, J PHYS CHEM LETT, V2, P735, DOI 10.1021/jz200066b; Ruzafa D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049690; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Smith MI, 2012, COLLOID SURFACE B, V89, P216, DOI 10.1016/j.colsurfb.2011.09.018; Sorgjerd K, 2008, BIOCHEM BIOPH RES CO, V377, P1072, DOI 10.1016/j.bbrc.2008.10.121; STARK CA, 1979, BIOCHEM BIOPH RES CO, V87, P598, DOI 10.1016/0006-291X(79)91836-9; Sulkowska JI, 2012, P NATL ACAD SCI USA, V109, P17783, DOI 10.1073/pnas.1201804109; Surmacz-Chwedoruk W, 2012, BIOCHEMISTRY-US, V51, P9460, DOI 10.1021/bi301144d; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; TIEGS G, 1992, J CLIN INVEST, V90, P196, DOI 10.1172/JCI115836; Vendruscolo M, 2003, PHILOS T R SOC A, V361, P1205, DOI 10.1098/rsta.2003.1194; Vetri V, 2005, BIOPHYS CHEM, V113, P83, DOI 10.1016/j.bpc.2004.07.042; Vetri V, 2011, BIOPHYS J, V100, P774, DOI 10.1016/j.bpj.2010.11.089; Vetri V, 2007, EUR BIOPHYS J BIOPHY, V36, P733, DOI 10.1007/s00249-007-0181-z; Vetri V, 2007, BIOPHYS CHEM, V125, P184, DOI 10.1016/j.bpc.2006.07.012; Vetri V, 2010, BBA-PROTEINS PROTEOM, V1804, P173, DOI 10.1016/j.bbapap.2009.09.013; WEISER MM, 1972, SCIENCE, V177, P525, DOI 10.1126/science.177.4048.525; Xue WF, 2008, P NATL ACAD SCI USA, V105, P8926, DOI 10.1073/pnas.0711664105; Youssef T, 2009, PHOTOCHEM PHOTOBIOL, V85, P921, DOI 10.1111/j.1751-1097.2008.00511.x	55	17	17	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68912	10.1371/journal.pone.0068912	http://dx.doi.org/10.1371/journal.pone.0068912			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874809	Green Published, gold, Green Submitted			2022-12-27	WOS:000322064300079
J	van Dongen, TMA; van der Heijden, GJMG; Freling, HG; Venekamp, RP; Schilder, AGM				van Dongen, Thijs M. A.; van der Heijden, Geert J. M. G.; Freling, Hanneke G.; Venekamp, Roderick P.; Schilder, Anne G. M.			Parent-Reported Otorrhea in Children with Tympanostomy Tubes: Incidence and Predictors	PLOS ONE			English	Article							ACUTE OTITIS-MEDIA; VENTILATION; INSERTION; VALIDITY; HISTORY	Purpose: Although common in children with tympanostomy tubes, the current incidence of tympanostomy tube otorrhea (TTO) is uncertain. TTO is generally a sign of otitis media, when middle ear fluid drains through the tube. Predictors for otitis media are therefore suggested to have predictive value for the occurrence of TTO. Objective: To determine the incidence of TTO and its predictors. Methods: We performed a cohort study, using a parental web-based questionnaire to retrospectively collect data on TTO episodes and its potential predictors from children younger than 10 years of age with tympanostomy tubes. Results: Of the 1,184 children included in analyses (total duration of time since tube placement was 768 person years with a mean of 7.8 months per child), 616 children (52%) experienced one or more episodes of TTO. 137 children (12%) had TTO within the calendar month of tube placement. 597 (50%) children had one or more acute TTO episodes (duration <4 weeks) and 46 children (>= 4%) one or more chronic TTO episodes (duration $ 4 weeks). 146 children (12%) experienced recurrent TTO episodes. Accounting for time since tube placement, 67% of children developed one or more TTO episodes in the year following tube placement. Young age, recurrent acute otitis media being the indication for tube placement, a recent history of recurrent upper respiratory tract infections and the presence of older siblings were independently associated with the future occurrence of TTO, and can therefore be seen as predictors for TTO. Conclusions: Our survey confirms that otorrhea is a common sequela in children with tympanostomy tubes, which occurrence can be predicted by age, medical history and presence of older siblings.	[van Dongen, Thijs M. A.; van der Heijden, Geert J. M. G.; Freling, Hanneke G.; Venekamp, Roderick P.; Schilder, Anne G. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Epidemiol, Utrecht, Netherlands; [van der Heijden, Geert J. M. G.; Venekamp, Roderick P.; Schilder, Anne G. M.] Univ Med Ctr Utrecht, Div Surg Specialties, Dept Otorhinolaryngol, Utrecht, Netherlands; [Schilder, Anne G. M.] UCL, Fac Brain Sci, ENT Clin Trials Programme, Ear Inst, London, England	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of London; University College London	van Dongen, TMA (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Epidemiol, Utrecht, Netherlands.	t.m.a.vandongen@umcutrecht.nl	van der Heijden, Geert/M-3733-2013	van der Heijden, Geert/0000-0003-4979-2099; Venekamp, Roderick P/0000-0002-1446-9614; Schilder, Anne/0000-0002-5496-4580	GlaxoSmithKline;  [170992502]; National Institute for Health Research [NIHR-RP-011-045] Funding Source: researchfish	GlaxoSmithKline(GlaxoSmithKline); ; National Institute for Health Research(National Institute for Health Research (NIHR))	ZonMw (The Netherlands Organisation for Health Research and Development; http://www.zonmw.nl/en/), as part of project 170992502. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; AS has received an honorarium from GlaxoSmithKline for participating in educational activities and workshops related to pneumococcal vaccination and otitis media. She has received funds from GlaxoSmithKline for research on microbial pathogens in acute tympanostomy tube otorrhoea. The other authors have declared that no competing interests exist. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ah-Tye C, 2001, PEDIATRICS, V107, P1251, DOI 10.1542/peds.107.6.1251; ALHO OP, 1990, AM J EPIDEMIOL, V132, P1164, DOI 10.1093/oxfordjournals.aje.a115759; [Anonymous], 2010, DUTCH HOSP DATA; BALKANY TJ, 1983, AM J OTOL, V4, P288; Casselbrant ML, 2003, EVIDENCE BASED OTITI, P150; Cullen K. A., 2009, NATL HLTH STAT REPOR; DALY KA, 1994, AM J EPIDEMIOL, V139, P1116, DOI 10.1093/oxfordjournals.aje.a116955; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; DEBRUYNE F, 1988, AM J OTOL, V9, P316; EPSTEIN JS, 1992, OTOLARYNG HEAD NECK, V107, P758, DOI 10.1177/019459988910700609.1; GATES GA, 1986, LARYNGOSCOPE, V96, P630; GIEBINK GS, 1992, ARCH OTOLARYNGOL, V118, P491; Kay DJ, 2001, OTOLARYNG HEAD NECK, V124, P374, DOI 10.1067/mhn.2001.113941; Nelson HM, 2011, PHYSIOL BEHAV, V102, P511, DOI 10.1016/j.physbeh.2011.01.002; Oberman JP, 2004, AM J OTOLARYNG, V25, P110, DOI 10.1016/j.amjoto.2003.09.014; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Rosenfeld RM, 2000, ARCH OTOLARYNGOL, V126, P585, DOI 10.1001/archotol.126.5.585; Rosenfeld RM, 2003, EVIDENCE BASED OTITI, V2nd, P227; Rosenfeld RM, 2003, EVIDENCE BASED OTITI, P466; Rothman K, 2011, EPISHEET; Rovers MM, 2004, LANCET, V363, P465, DOI 10.1016/S0140-6736(04)15495-0; Schilder AGM, 2004, INT J PEDIATR OTORHI, V68, P29, DOI 10.1016/j.ijporl.2003.09.002; Taylor SM, 2012, CLIN INFECT DIS; van Dongen TMA, 2012, PEDIATR INFECT DIS J, V31, P868, DOI 10.1097/INF.0b013e318258f100	24	27	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e69062	10.1371/journal.pone.0069062	http://dx.doi.org/10.1371/journal.pone.0069062			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	23874870	Green Published, gold, Green Submitted			2022-12-27	WOS:000321718700046
J	McCarville, JL; Clarke, ST; Shastri, P; Liu, Y; Kalmokoff, M; Brooks, SPJ; Green-Johnson, JM				McCarville, Justin L.; Clarke, Sandra T.; Shastri, Padmaja; Liu, Yi; Kalmokoff, Martin; Brooks, Stephen P. J.; Green-Johnson, Julia M.			Spaceflight Influences both Mucosal and Peripheral Cytokine Production in PTN-Tg and Wild Type Mice	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; SPACE-FLIGHT; BONE-FORMATION; IMMUNOLOGICAL RESPONSES; SIMULATED MICROGRAVITY; CELL DIFFERENTIATION; IMMUNE-RESPONSES; BLOOD LEUKOCYTES; GENE-EXPRESSION; RATS	Spaceflight is associated with several health issues including diminished immune efficiency. Effects of long-term spaceflight on selected immune parameters of wild type (Wt) and transgenic mice over-expressing pleiotrophin under the human bone-specific osteocalcin promoter (PTN-Tg) were examined using the novel Mouse Drawer System (MDS) aboard the International Space Station (ISS) over a 91 day period. Effects of this long duration flight on PTN-Tg and Wt mice were determined in comparison to ground controls and vivarium-housed PTN-Tg and Wt mice. Levels of interleukin-2 (IL-2) and transforming growth factor-beta1 (TGF-beta 1) were measured in mucosal and systemic tissues of Wt and PTN-Tg mice. Colonic contents were also analyzed to assess potential effects on the gut microbiota, although no firm conclusions could be made due to constraints imposed by the MDS payload and the time of sampling. Spaceflight-associated differences were observed in colonic tissue and systemic lymph node levels of IL-2 and TGF-beta 1 relative to ground controls. Total colonic TGF-beta 1 levels were lower in Wt and PTN-Tg flight mice in comparison to ground controls. The Wt flight mouse had lower levels of IL-2 and TGF-beta 1 compared to the Wt ground control in both the inguinal and brachial lymph nodes, however this pattern was not consistently observed in PTN-Tg mice. Vivarium-housed Wt controls had higher levels of active TGF-beta 1 and IL-2 in inguinal lymph nodes relative to PTN-Tg mice. The results of this study suggest compartmentalized effects of spaceflight and on immune parameters in mice.	[McCarville, Justin L.; Clarke, Sandra T.; Shastri, Padmaja; Green-Johnson, Julia M.] Univ Ontario Inst Technol, Appl Biosci Grad Program, Oshawa, ON, Canada; [McCarville, Justin L.; Clarke, Sandra T.; Shastri, Padmaja; Green-Johnson, Julia M.] Univ Ontario Inst Technol, Fac Sci, Oshawa, ON, Canada; [Liu, Yi] Univ Genoa, Dipartimento Oncol Biol & Genet, Genoa, Italy; [Liu, Yi] Ist Nazl Ric Canc, I-16132 Genoa, Italy; [Kalmokoff, Martin] Agr & Agri Food Canada, Atlantic Food & Hort Res Ctr, Kentville, NS, Canada; [Brooks, Stephen P. J.] Hlth Canada, Bur Nutr Sci, Ottawa, ON K1A 0L2, Canada	Ontario Tech University; Ontario Tech University; University of Genoa; University of Genoa; IRCCS AOU San Martino IST; Agriculture & Agri Food Canada; Health Canada	Green-Johnson, JM (corresponding author), Univ Ontario Inst Technol, Appl Biosci Grad Program, Oshawa, ON, Canada.	julia.green-johnson@uoit.ca		McCarville, Justin/0000-0002-3311-5678; Brooks, Stephen/0000-0002-1169-6221				Abnous K, 2009, J NUTR, V139, P2024, DOI 10.3945/jn.109.109470; ALLEBBAN Z, 1994, J LEUKOCYTE BIOL, V55, P209, DOI 10.1002/jlb.55.2.209; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Beals E. W., 1984, BRAY CURTIS ORDINATI; BONEWALD LF, 1994, J CELL BIOCHEM, V55, P350, DOI 10.1002/jcb.240550312; Callaway TR, 2009, POULTRY SCI, V88, P298, DOI 10.3382/ps.2008-00222; Cancedda R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032243; CANN CE, 1983, AM J PHYSIOL, V244, pR327, DOI 10.1152/ajpregu.1983.244.3.R327; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Chapes SK, 1999, J APPL PHYSIOL, V86, P2065, DOI 10.1152/jappl.1999.86.6.2065; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Crucian BE, 2000, J INTERF CYTOK RES, V20, P547, DOI 10.1089/10799900050044741; Datta HK, 2008, J CLIN PATHOL, V61, P577, DOI 10.1136/jcp.2007.048868; DAWSON NJ, 1972, COMP BIOCHEM PHYSIOL, V41, P877, DOI 10.1016/0300-9629(72)90350-7; Donkor ON, 2012, CLIN EXP IMMUNOL, V167, P282, DOI 10.1111/j.1365-2249.2011.04496.x; Felix K, 2004, MOL CELL BIOCHEM, V266, P79, DOI 10.1023/B:MCBI.0000049136.55611.dd; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gashev AA, 2006, AM J PHYSIOL-HEART C, V290, pH2295, DOI 10.1152/ajpheart.00260.2005; Geissmann F, 1999, J IMMUNOL, V162, P4567; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Green-Johnson JM, 2012, J AOAC INT, V95, P35, DOI 10.5740/jaoacint.SGE_Green-Johnson; Gridley DS, 2009, J APPL PHYSIOL, V106, P194, DOI 10.1152/japplphysiol.91126.2008; GROVE DS, 1995, EXP CELL RES, V219, P102, DOI 10.1006/excr.1995.1210; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Harris SA, 2000, BONE, V26, P325, DOI 10.1016/S8756-3282(00)00234-9; Hughes-Fulford M, 2006, J CELL BIOCHEM, V99, P435, DOI 10.1002/jcb.20883; Husmann Irene, 1996, Cytokine and Growth Factor Reviews, V7, P249, DOI 10.1016/S1359-6101(96)00029-9; Ichiki AT, 1996, J LEUKOCYTE BIOL, V60, P37, DOI 10.1002/jlb.60.1.37; Iliev ID, 2009, GUT, V58, P1481, DOI 10.1136/gut.2008.175166; Izcue A, 2009, ANNU REV IMMUNOL, V27, P313, DOI 10.1146/annurev.immunol.021908.132657; Jukes T, 1996, EVOLUTION PROTEIN MO, P21; Kasagi S, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-4; Kumei Y, 2003, ANN NY ACAD SCI, V1010, P476, DOI 10.1196/annals.1299.086; Lane D.J., 1991, 16S 23S RRNA SEQUENC; Laouar Y, 2005, NAT IMMUNOL, V6, P600, DOI 10.1038/ni1197; Li G, 2005, CALCIFIED TISSUE INT, V76, P299, DOI 10.1007/s00223-004-0145-6; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Liao W, 2011, CURR OPIN IMMUNOL, V23, P598, DOI 10.1016/j.coi.2011.08.003; Liu Y, 2005, J GRAVITATIONAL PHYS, V12, pP291; MacPherson AJ, 2004, ANN NY ACAD SCI, V1029, P36, DOI 10.1196/annals.1309.005; Masini MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035418; Masuda H, 1997, BIOCHEM BIOPH RES CO, V238, P528, DOI 10.1006/bbrc.1997.7188; Meloni MA, 2011, CYTOSKELETON, V68, P125, DOI 10.1002/cm.20499; MOREY ER, 1978, SCIENCE, V201, P1138, DOI 10.1126/science.150643; Ortega MT, 2009, J APPL PHYSIOL, V106, P548, DOI 10.1152/japplphysiol.91138.2008; Pecaut MJ, 2000, AM J PHYSIOL-REG I, V279, pR2072, DOI 10.1152/ajpregu.2000.279.6.R2072; Renz H, 2012, NAT REV IMMUNOL, V12, P9, DOI 10.1038/nri3112; Rizzo AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032361; Sandona D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033232; Sanford GL, 1999, J GRAVIT PHYSL, V6, pP29; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Sonnenfeld G, 1999, ADV SPACE RES, V24, P815, DOI 10.1016/S0273-1177(99)00074-5; Sun YJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp285; Suzuki K, 2007, SEMIN IMMUNOL, V19, P127, DOI 10.1016/j.smim.2006.10.001; Tare RS, 2002, J BONE MINER RES, V17, P2009, DOI 10.1359/jbmr.2002.17.11.2009; Tavella S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033179; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WESTERLIND KC, 1995, J BONE MINER RES, V10, P843; White RJ, 2001, NATURE, V409, P1115, DOI 10.1038/35059243; Yokoi H, 2012, KIDNEY INT, V81, P160, DOI 10.1038/ki.2011.305	61	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68961	10.1371/journal.pone.0068961	http://dx.doi.org/10.1371/journal.pone.0068961			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874826	Green Published, Green Submitted, gold			2022-12-27	WOS:000321765300072
J	Padulo, J; Powell, D; Milia, R; Ardigo, LP				Padulo, Johnny; Powell, Douglas; Milia, Raffaele; Ardigo, Luca Paolo			A Paradigm of Uphill Running	PLOS ONE			English	Article							ENERGY-COST; DIFFERENT SLOPES; WALKING; VARIABILITY; TREADMILL; KINEMATICS; EFFICIENCY; DOWNHILL; POSITION; CADENCE	The biomechanical management of bioenergetics of runners when running uphill was investigated. Several metabolic and mechanical variables have been studied simultaneously to spread light on the locomotory strategy operated by humans for effective locomotion. The studied variables were: heart rate, heart rate variability, oxygen intake and blood lactate, metabolic cost, kinematics, ground reaction force and muscular activity. 18 high-level competitive male runners ran at 70% VO2max on different uphill slope conditions: 0%, 2% and 7%. Modifications were significant in almost all variables studied, and were more pronounced with increasing incline. Step frequency/length and ground reaction force are adjusted to cope with both the task of uphill progression and the available (limited) metabolic power. From 0% to 7% slope, step frequency and ground reaction force and metabolic cost increased concurrently by 4%, 12% and 53%, respectively (with a 4% step length decrease as well). It is hypothesised that this biomechanical management is allowed by an environment-body communication performed by means of specific muscular activity.	[Padulo, Johnny] Natl Ctr Med & Sci Sport, Tunisian Res Lab Sports Performance Optimizat, Tunis, Tunisia; [Padulo, Johnny] Univ Roma Tor Vergata, Fac Med & Surg, Rome, Italy; [Powell, Douglas] Campbell Univ, Dept Phys Therapy, Buies Creek, NC 27506 USA; [Milia, Raffaele] Univ Cagliari, Fac Med & Surg, Cagliari, Italy; [Ardigo, Luca Paolo] Univ Verona, Dept Neurol Neuropsychol Morphol & Movement Sci, Sch Exercise & Sport Sci, I-37100 Verona, Italy	Centre National de la Medecine Sciences des Sports; University of Rome Tor Vergata; Campbell University; University of Cagliari; University of Verona	Ardigo, LP (corresponding author), Univ Verona, Dept Neurol Neuropsychol Morphol & Movement Sci, Sch Exercise & Sport Sci, I-37100 Verona, Italy.	luca.ardigo@univr.it	Padulo, Johnny/D-8172-2017; Ardigò, Luca Paolo/H-8955-2019; Padulo, Johnny/AAK-2207-2020	Ardigò, Luca Paolo/0000-0001-7677-5070; Padulo, Johnny/0000-0002-4254-3105				Baldari C, 2009, EUR J APPL PHYSIOL, V107, P105, DOI 10.1007/s00421-009-1107-5; BELLI A, 1992, ERGONOMICS, V35, P177, DOI 10.1080/00140139208967805; BLAND JM, 1990, COMPUT BIOL MED, V20, P337, DOI 10.1016/0010-4825(90)90013-F; BOSCO C, 1982, Electromyography and Clinical Neurophysiology, V22, P549; CAVAGNA GA, 1976, J PHYSIOL-LONDON, V262, P639, DOI 10.1113/jphysiol.1976.sp011613; CAVANAGH PR, 1989, MED SCI SPORT EXER, V21, P467; Cottin FO, 2004, MED SCI SPORT EXER, V36, P594, DOI 10.1249/01.MSS.0000121982.14718.2A; DIPRAMPERO PE, 1993, J APPL PHYSIOL, V74, P2318, DOI 10.1152/jappl.1993.74.5.2318; DIPRAMPERO PE, 1986, INT J SPORTS MED, V7, P55, DOI 10.1055/s-2008-1025736; Fenn WO, 1930, AM J PHYSIOL, V92, P583, DOI 10.1152/ajplegacy.1930.92.3.583; Glace BW, 2002, J AM COLL NUTR, V21, P553, DOI 10.1080/07315724.2002.10719254; Gottschall JS, 2005, J BIOMECH, V38, P445, DOI 10.1016/j.jbiomech.2004.04.023; Harnish C, 2007, EUR J APPL PHYSIOL, V99, P387, DOI 10.1007/s00421-006-0358-7; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; HOGBERG P, 1952, Arbeitsphysiologie, V14, P437; Marder E, 1996, PHYSIOL REV, V76, P687, DOI 10.1152/physrev.1996.76.3.687; Matsas A, 2000, GAIT POSTURE, V11, P46, DOI 10.1016/S0966-6362(99)00048-X; Maughan RJ, 2010, SCAND J MED SCI SPOR, V20, P95, DOI 10.1111/j.1600-0838.2010.01214.x; Millet GP, 2002, MED SCI SPORT EXER, V34, P1645, DOI 10.1097/00005768-200210000-00017; MINETTI AE, 1994, ACTA PHYSIOL SCAND, V150, P315, DOI 10.1111/j.1748-1716.1994.tb09692.x; MINETTI AE, 1994, J EXP BIOL, V195, P211; Minetti AE, 2002, J APPL PHYSIOL, V93, P1039, DOI 10.1152/japplphysiol.01177.2001; Owings TM, 2003, J BIOMECH, V36, P1215, DOI 10.1016/S0021-9290(03)00108-8; Padulo J, 2013, INT J SPORTS MED, V34, P244, DOI 10.1055/s-0032-1323724; Padulo J, 2012, INT J SPORTS MED, V33, P819, DOI 10.1055/s-0032-1311588; Padulo J, 2012, INT J SPORTS MED, V33, P459, DOI 10.1055/s-0032-1304641; Padulo J, 2012, J STRENGTH COND RES; Padulo J, 2013, J STRENGTH COND RES, V27, P125, DOI 10.1519/JSC.0b013e3182541eb3; Padulo J, 2012, EUR J APPL PHYSIOL, V112, P3161, DOI 10.1007/s00421-011-2282-8; Padulo J, 2012, J STRENGTH COND RES, V26, P1331, DOI 10.1519/JSC.0b013e318231aafa; SWAIN DP, 1992, MED SCI SPORT EXER, V24, P1123; Swanson SC, 2000, MED SCI SPORT EXER, V32, P1146, DOI 10.1097/00005768-200006000-00018; Vuorimaa T, 2006, EUR J APPL PHYSIOL, V96, P282, DOI 10.1007/s00421-005-0054-z; Yokozawa T, 2004, SCIENCE, P35	34	50	51	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e69006	10.1371/journal.pone.0069006	http://dx.doi.org/10.1371/journal.pone.0069006			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874850	gold, Green Published, Green Submitted			2022-12-27	WOS:000321765300075
J	Baquiran, JB; Bradbury, P; O'Neill, GM				Baquiran, Jaime B.; Bradbury, Peta; O'Neill, Geraldine M.			Tyrosine Y189 in the Substrate Domain of the Adhesion Docking Protein NEDD9 Is Conserved with p130Cas Y253 and Regulates NEDD9-Mediated Migration and Focal Adhesion Dynamics	PLOS ONE			English	Article							PHOSPHORYLATION SITES; HUMAN ENHANCER; HEF1; CAS; FAK; SRC; ASSOCIATION; METASTASIS; INVASION; CRK	The focal adhesion docking protein NEDD9/HEF1/Cas-L regulates cell migration and cancer invasion. NEDD9 is a member of the Cas family of proteins that share conserved overall protein-protein interaction domain structure, including a substrate domain that is characterized by extensive tyrosine (Y) phosphorylation. Previous studies have suggested that phosphorylation of Y253 in the substrate domain of the Cas family protein p130Cas is specifically required for p130Cas function in cell migration. While it is clear that tyrosine phosphorylation of the NEDD9 substrate domain is similarly required for the regulation of cell motility, whether individual NEDD9 tyrosine residues have discrete function in regulating motility has not previously been reported. In the present study we have used a global sequence alignment of Cas family proteins to identify a putative NEDD9 equivalent of p130Cas Y253. We find that NEDD9 Y189 aligns with p130Cas Y253 and that it is conserved among NEDD9 vertebrate orthologues. Expression of NEDD9 in which Y189 is mutated to phenylalanine results in increased rates of cell migration and is correlated with increased disassembly of GFP. NEDD9 focal adhesions. Conversely, mutation to Y189D significantly inhibits cell migration. Our previous data has suggested that NEDD9 stabilizes focal adhesions and the present data therefore suggests that phosphorylation of Y189 NEDD9 is required for this function. These findings indicate that the individual tyrosine residues of the NEDD9 substrate domain may serve discrete functional roles. Given the important role of this protein in promoting cancer invasion, greater understanding of the function of the individual tyrosine residues is important for the future design of approaches to target NEDD9 to arrest cancer cell invasion.	[Baquiran, Jaime B.; Bradbury, Peta; O'Neill, Geraldine M.] Childrens Hosp Westmead, Kids Res Inst, Childrens Canc Res Unit, Westmead, NSW, Australia; [Bradbury, Peta; O'Neill, Geraldine M.] Univ Sydney, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	O'Neill, GM (corresponding author), Childrens Hosp Westmead, Kids Res Inst, Childrens Canc Res Unit, Westmead, NSW, Australia.	geraldine.oneill@health.nsw.gov.au	O'Neill, Geraldine/F-3112-2014; Bradbury, Peta/A-4864-2017	Bradbury, Peta/0000-0001-6360-9591; O'Neill, Geraldine/0000-0001-9997-8794	National Health and Medical Research (NHMRC) Australia [512251, 632515]; University of Sydney	National Health and Medical Research (NHMRC) Australia(National Health and Medical Research Council (NHMRC) of Australia); University of Sydney(University of Sydney)	This study was supported by National Health and Medical Research (NHMRC) Australia grants 512251 and 632515 to GO. JBB was supported by an Honours scholarship award from the University of Sydney. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Astier A, 1997, LEUKEMIA LYMPHOMA, V28, P65, DOI 10.3109/10428199709058332; Brabek J, 2005, MOL CANCER RES, V3, P307, DOI 10.1158/1541-7786.MCR-05-0015; Bradbury P, 2012, BBA-MOL CELL RES, V1823, P290, DOI 10.1016/j.bbamcr.2011.10.011; Brinkman A, 2010, BREAST CANCER RES TR, V120, P401, DOI 10.1007/s10549-009-0403-4; Cowell LN, 2006, ONCOGENE, V25, P7597, DOI 10.1038/sj.onc.1209747; Donato DM, 2010, J BIOL CHEM, V285, P20769, DOI 10.1074/jbc.M109.091207; Garron ML, 2009, J MOL BIOL, V386, P190, DOI 10.1016/j.jmb.2008.12.010; Goldberg GS, 2003, J BIOL CHEM, V278, P46533, DOI 10.1074/jbc.M307526200; Hivert V, 2009, BIOCHEM PHARMACOL, V78, P1017, DOI 10.1016/j.bcp.2009.06.005; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Huang M, 2012, ONCOGENE, V31, P2783, DOI 10.1038/onc.2011.450; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; Law SF, 1996, MOL CELL BIOL, V16, P3327; Mace PD, 2011, NAT STRUCT MOL BIOL, V18, P1381, DOI 10.1038/nsmb.2152; Meenderink LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013412; Nakamoto T, 1997, MOL CELL BIOL, V17, P3884, DOI 10.1128/MCB.17.7.3884; Natarajan M, 2006, ONCOGENE, V25, P1721, DOI 10.1038/sj.onc.1209199; O'Neill GM, 2007, CANCER RES, V67, P8975, DOI 10.1158/0008-5472.CAN-07-1328; O'Neill GM, 2001, MOL CELL BIOL, V21, P5094, DOI 10.1128/MCB.21.15.5094-5108.2001; Ohashi Y, 1998, J BIOL CHEM, V273, P6446, DOI 10.1074/jbc.273.11.6446; Pugacheva EN, 2005, NAT CELL BIOL, V7, P937, DOI 10.1038/ncb1309; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Shin NY, 2004, J BIOL CHEM, V279, P38331, DOI 10.1074/jbc.M404675200; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390; Singh MK, 2008, MOL BIOL CELL, V19, P1627, DOI 10.1091/mbc.E07-09-0953; Singh MK, 2007, CELL BIOCHEM BIOPHYS, V48, P54, DOI 10.1007/s12013-007-0036-3; Tikhmyanova N, 2010, CELL MOL LIFE SCI, V67, P1025, DOI 10.1007/s00018-009-0213-1; van Seventer GA, 2001, EUR J IMMUNOL, V31, P1417, DOI 10.1002/1521-4141(200105)31:5<1417::AID-IMMU1417>3.0.CO;2-C; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Zheng MZ, 2006, J CELL SCI, V119, P96, DOI 10.1242/jcs.02712; Zheng MZ, 2002, J BIOL CHEM, V277, P39599, DOI 10.1074/jbc.M202263200; Zhong J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035058	32	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e69304	10.1371/journal.pone.0069304	http://dx.doi.org/10.1371/journal.pone.0069304			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874939	Green Published, gold, Green Submitted			2022-12-27	WOS:000321736900150
J	Corsetti, JP; Salzman, P; Ryan, D; Moss, AJ; Zareba, W; Sparks, CE				Corsetti, James P.; Salzman, Peter; Ryan, Dan; Moss, Arthur J.; Zareba, Wojciech; Sparks, Charles E.			Plasminogen Activator Inhibitor-2 Polymorphism Associates with Recurrent Coronary Event Risk in Patients with High HDL and C-Reactive Protein Levels	PLOS ONE			English	Article							RECEPTOR-RELATED PROTEIN; HIGH-DENSITY-LIPOPROTEIN; POSTINFARCTION PATIENTS; CHOLESTEROL; PAI-1; INFLAMMATION; PARADOX; DISEASE; SERPIN; GENES	The objective of this work was to investigate whether fibrinolysis plays a role in establishing recurrent coronary event risk in a previously identified group of postinfarction patients. This group of patients was defined as having concurrently high levels of high-density lipoprotein cholesterol (HDL-C) and C-reactive protein (CRP) and was previously demonstrated to be at high-risk for recurrent coronary events. Potential risk associations of a genetic polymorphism of plasminogen activator inhibitor-2 (PAI-2) were probed as well as potential modulatory effects on such risk of a polymorphism of low-density lipoprotein receptor related protein (LRP-1), a scavenger receptor known to be involved in fibrinolysis in the context of cellular internalization of plasminogen activator/plansminogen activator inhibitor complexes. To this end, Cox multivariable modeling was performed as a function of genetic polymorphisms of PAI-2 (SERPINB, rs6095) and LRP-1 (LRP1, rs1800156) as well as a set of clinical parameters, blood biomarkers, and genetic polymorphisms previously demonstrated to be significantly and independently associated with risk in the study population including cholesteryl ester transfer protein (CETP, rs708272), p22phox (CYBA, rs4673), and thrombospondin-4 (THBS4, rs1866389). Risk association was demonstrated for the reference allele of the PAI-2 polymorphism (hazard ratio 0.41 per allele, 95% CI 0.20-0.84, p=0.014) along with continued significant risk associations for the p22phox and thrombospondin-4 polymorphisms. Additionally, further analysis revealed interaction of the LRP-1 and PAI-2 polymorphisms in generating differential risk that was illustrated using Kaplan-Meier survival analysis. We conclude from the study that fibrinolysis likely plays a role in establishing recurrent coronary risk in postinfarction patients with concurrently high levels of HDL-C and CRP as manifested by differential effects on risk by polymorphisms of several genes linked to key actions involved in the fibrinolytic process.	[Corsetti, James P.; Ryan, Dan; Sparks, Charles E.] Univ Rochester, Sch Med & Dent, Dept Pathol & Lab Med, Rochester, NY 14627 USA; [Salzman, Peter] Univ Rochester, Sch Med & Dent, Dept Biostat & Computat Biol, Rochester, NY USA; [Moss, Arthur J.; Zareba, Wojciech] Univ Rochester, Sch Med & Dent, Dept Med, Cardiol Unit, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Corsetti, JP (corresponding author), Univ Rochester, Sch Med & Dent, Dept Pathol & Lab Med, Rochester, NY 14627 USA.	James_Corsetti@urmc.rochester.edu		salzman, peter/0000-0001-8114-4863	National Institutes of Health, Bethesda, MD, USA [HL-48259, HL-45522]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048259, P01HL045522] Funding Source: NIH RePORTER	National Institutes of Health, Bethesda, MD, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Institutes of Health, Bethesda, MD, USA; grants HL-48259 and HL-45522. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansell BJ, 2007, CURR OPIN LIPIDOL, V18, P427, DOI 10.1097/MOL.0b013e3282364a17; Boncela J, 2011, J BIOL CHEM, V286, P43164, DOI 10.1074/jbc.M111.245647; Corsetti JP, 2008, ATHEROSCLEROSIS, V196, P461, DOI 10.1016/j.atherosclerosis.2006.12.007; Corsetti JP, 2011, THROMB HAEMOSTASIS, V106, P1170, DOI 10.1160/TH11-03-0206; Corsetti JP, 2011, ATHEROSCLEROSIS, V214, P373, DOI 10.1016/j.atherosclerosis.2010.11.029; Corsetti JP, 2010, ARTERIOSCL THROM VAS, V30, P1657, DOI 10.1161/ATVBAHA.110.207977; Corsetti JP, 2010, EUR J CLIN INVEST, V40, P483, DOI 10.1111/j.1365-2362.2010.02287.x; Corsetti JP, 2005, ATHEROSCLEROSIS, V183, P293, DOI 10.1016/j.atherosclerosis.2005.03.046; Croucher DR, 2008, NAT REV CANCER, V8, P535, DOI 10.1038/nrc2400; Diebold I, 2008, THROMB HAEMOSTASIS, V100, P984, DOI 10.1160/TH08-08-0524; Goldenberg I, 2007, ANN NONINVAS ELECTRO, V12, P364, DOI 10.1111/j.1542-474X.2007.00186.x; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Kontush A, 2006, PHARMACOL REV, V58, P342, DOI 10.1124/pr.58.3.1; KRUITHOF EKO, 1995, BLOOD, V86, P4007, DOI 10.1182/blood.V86.11.4007.bloodjournal86114007; Lee JA, 2011, SEMIN THROMB HEMOST, V37, P395, DOI 10.1055/s-0031-1276589; Lee JA, 2010, THROMB HAEMOSTASIS, V104, P1133, DOI 10.1160/TH10-02-0121; Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9; Llorente-Cortes V, 2005, ARTERIOSCL THROM VAS, V25, P497, DOI 10.1161/01.ATV.0000154280.62072.fd; May M, 2004, STAT MED, V23, P2375, DOI 10.1002/sim.1825; McCarthy JJ, 2004, J MED GENET, V41, P334, DOI 10.1136/jmg.2003.016584; MEDCALF RL, 1988, J EXP MED, V168, P751, DOI 10.1084/jem.168.2.751; Medcalf RL, 2005, FEBS J, V272, P4858, DOI 10.1111/j.1742-4658.2005.04879.x; Medcalf RL, 2011, METHOD ENZYMOL, V499, P105, DOI 10.1016/B978-0-12-386471-0.00006-7; Moss AJ, 1999, CIRCULATION, V99, P2517, DOI 10.1161/01.CIR.99.19.2517; Movva R, 2009, ANN BIOL CLIN-PARIS, V67, P7, DOI [10.1373/clinchem.2007.101923, 10.1684/abc.2008.0284]; Navab M, 2011, NAT REV CARDIOL, V8, P222, DOI 10.1038/nrcardio.2010.222; Nicholl Suzanne M., 2006, Current Vascular Pharmacology, V4, P101, DOI 10.2174/157016106776359880; Ragbir S, 2010, CURR ATHEROSCLER REP, V12, P343, DOI 10.1007/s11883-010-0091-x; Rocha VZ, 2009, NAT REV CARDIOL, V6, P399, DOI 10.1038/nrcardio.2009.55; Shao BH, 2010, CHEM RES TOXICOL, V23, P447, DOI 10.1021/tx9003775; Smith JD, 2010, ARTERIOSCL THROM VAS, V30, P151, DOI 10.1161/ATVBAHA.108.179226; STRICKLAND DK, 1995, FASEB J, V9, P890, DOI 10.1096/fasebj.9.10.7615159; Topol EJ, 2001, CIRCULATION, V104, P2641, DOI 10.1161/hc4701.100910; Vaughan DE, 2005, J THROMB HAEMOST, V3, P1879, DOI 10.1111/j.1538-7836.2005.01420.x; Zorio E, 2008, CURR MED CHEM, V15, P923, DOI 10.2174/092986708783955455	35	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68920	10.1371/journal.pone.0068920	http://dx.doi.org/10.1371/journal.pone.0068920			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874812	Green Published, Green Submitted, gold			2022-12-27	WOS:000321736900122
J	Gomez-Sanz, E; Torres, C; Ceballos, S; Lozano, C; Zarazaga, M				Gomez-Sanz, Elena; Torres, Carmen; Ceballos, Sara; Lozano, Carmen; Zarazaga, Myriam			Clonal Dynamics of Nasal Staphylococcus aureus and Staphylococcus pseudintermedius in Dog-Owning Household Members. Detection of MSSA ST398	PLOS ONE			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; FIELD GEL-ELECTROPHORESIS; HEALTHY DOGS; ANTIMICROBIAL SUSCEPTIBILITY; MOLECULAR CHARACTERIZATION; CARRIAGE; COLONIZATION; INTERMEDIUS; DIVERSITY; HUMANS	The objective of this study was to investigate the dynamics of nasal carriage by Staphylococcus aureus (SA) and Staphylococcus pseudintermedius (SP) among healthy dog-owning household members involved in 7 previous index cases of suspected anthropozoonotic (n = 4) and zoonotic (n = 3) interspecies transmission [4 direct cases, identical SA (n = 3) or SP (n = 1) in owner and dog; three indirect, SP in owner (n = 2) or SA in dog (n = 1)]. Co-carriage with methicillin-resistant coagulase-negative staphylococci (MRCoNS) was also evaluated. Sixteen owners and 10 dogs were sampled once every three months for one year. In total, 50 SA and 31 SP were analysed by MLST, and SA also by spa typing. All isolates were subjected to ApaI/SmaI-PFGE and antimicrobial resistance and virulence profiles were determined. All index owners were persistent SA carriers in all direct-anthropozoonotic transmission cases, while only one dog was persistent SA carrier. Owner and dog exhibited a persistent SP carriage status in the direct-zoonotic transmission case. SP was maintained in the index human over time in one indirect-zoonotic transmission case. Only one SP was methicillin-resistant. SA belonged to genetic backgrounds of MRSA pandemic clones: CC45, CC121, CC30, CC5 and CC398. Three individuals carried a MSSA t1451-ST398 clone with the erm(T)-cadD/cadX resistance genes. SA or SP were persistently detected in the nasal cavity of 7 (43.8%) and 2 (12.5%) owners, and in one and 2 dogs, respectively. SA was recovered as the single species in 10 owners and in one dog; SP in 3 owners and 4 dogs; and both bacterial species in one owner and 4 dogs. Co-carriage of SA or SP with MRCoNS isolates was common (30.7%). This is the first study on the dynamics of nasal carriage of SA and SP in healthy pet-owning household members. Dog-contact may play a role in the staphylococcal species distribution of in-contact individuals.	[Gomez-Sanz, Elena; Torres, Carmen; Ceballos, Sara; Lozano, Carmen; Zarazaga, Myriam] Univ La Rioja, Area Bioquim & Biol Mol, Logrono, Spain	Universidad de La Rioja	Zarazaga, M (corresponding author), Univ La Rioja, Area Bioquim & Biol Mol, Logrono, Spain.	myriam.zarazaga@unirioja.es	Torres, Carmen/C-9027-2013; Lozano, Carmen/M-3264-2014	Torres, Carmen/0000-0003-3709-1690; Lozano, Carmen/0000-0002-0048-9315; Gomez-Sanz, Elena/0000-0001-7666-3642; Zarazaga Chamorro, Mirian/0000-0002-8703-5489	Ministerio de Economia y Competitividad of Spain [SAF2009-08570, SAF2012-35474]; Gobierno de La Rioja of Spain	Ministerio de Economia y Competitividad of Spain(Spanish Government); Gobierno de La Rioja of Spain	This study was financially supported by Projects SAF2009-08570 and SAF2012-35474 from the Ministerio de Economia y Competitividad of Spain. EGS has a fellowship from the Gobierno de La Rioja of Spain, and CL has a fellowship from the Ministerio de Economia y Competitividad of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannoehr J, 2012, VET DERMATOL, V23, P253, DOI 10.1111/j.1365-3164.2012.01046.x; Bannoehr J, 2009, J CLIN MICROBIOL, V47, P469, DOI 10.1128/JCM.01915-08; Barbier F, 2010, J INFECT DIS, V202, P270, DOI 10.1086/653483; Baron F, 2004, J FOOD PROTECT, V67, P2302, DOI 10.4315/0362-028X-67.10.2302; Berglund C, 2008, CLIN MICROBIOL INFEC, V14, P1048, DOI 10.1111/j.1469-0691.2008.02090.x; Bloemendaal ALA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011841; Bond R, 2012, J SMALL ANIM PRACT, V53, P147, DOI 10.1111/j.1748-5827.2011.01165.x; Boost MV, 2008, EPIDEMIOL INFECT, V136, P953, DOI 10.1017/S0950268807009326; Clinical and Laboratory Standards Institute (CLSI), 2012, M100S22 CLIN LAB S S; Diekema DJ, 2001, CLIN INFECT DIS, V32, pS114, DOI 10.1086/320184; Gomez-Sanz E, 2013, CLIN MICROB IN PRESS; Gomez-Sanz E, 2013, J ANTIMICROB CHEMOTH, V68, P471, DOI 10.1093/jac/dks411; Gomez-Sanz E, 2013, COMP IMMUNOL MICROB, V36, P83, DOI 10.1016/j.cimid.2012.10.001; Gomez-Sanz E, 2011, COMP IMMUNOL MICROB, V34, P447, DOI [10.1016/j.cimid.2011.08.002, 10.1016/j.cimid.2010.06.006]; Gomez-Sanz E, 2010, FOODBORNE PATHOG DIS, V7, P1269, DOI 10.1089/fpd.2010.0610; Graveland H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016830; Hanselman BA, 2009, CAN VET J, V50, P954; Hanssen AM, 2004, ANTIMICROB AGENTS CH, V48, P285, DOI 10.1128/AAC.48.1.285-296.2004; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Hartmann FA, 2005, VET MICROBIOL, V108, P119, DOI 10.1016/j.vetmic.2005.03.006; HARVEY RG, 1994, MICROB ECOL HEALTH D, V7, P225, DOI 10.3109/08910609409141358; Johannessen M, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00056; John Joseph F, 2007, Ther Clin Risk Manag, V3, P1143; Kadlec K, 2009, J ANTIMICROB CHEMOTH, V64, P1156, DOI 10.1093/jac/dkp350; Kahl BC, 2005, J CLIN MICROBIOL, V43, P502, DOI 10.1128/JCM.43.1.502-505.2005; Kuhn G, 2007, J CLIN MICROBIOL, V45, P54, DOI 10.1128/JCM.01457-06; Laarhoven LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027788; Lautenbach E, 2010, EPIDEMIOL INFECT, V138, P683, DOI 10.1017/S0950268810000099; Lebeaux D, 2012, ANTIMICROB AGENTS CH, V56, P315, DOI 10.1128/AAC.00547-11; Lebon A, 2008, J CLIN MICROBIOL, V46, P3517, DOI 10.1128/JCM.00641-08; Lomholt H, 2005, J INVEST DERMATOL, V125, P977, DOI 10.1111/j.0022-202X.2005.23916.x; Mahoudeau I, 1997, J CLIN MICROBIOL, V35, P2153, DOI 10.1128/JCM.35.8.2153-2154.1997; McCarthy AJ, 2012, APPL ENVIRON MICROB, V78, P8845, DOI 10.1128/AEM.02398-12; Murchan S, 2003, J CLIN MICROBIOL, V41, P1574, DOI 10.1128/JCM.41.4.1574-1585.2003; Pan ES, 2005, J INFECT DIS, V192, P811, DOI 10.1086/432072; Paul NC, 2012, VET MICROBIOL, V160, P420, DOI 10.1016/j.vetmic.2012.06.012; Perreten V, 2010, J ANTIMICROB CHEMOTH, V65, P1145, DOI 10.1093/jac/dkq078; Poyart C, 2001, J CLIN MICROBIOL, V39, P4296, DOI 10.1128/JCM.39.12.4296-4301.2001; Sakwinska O, 2010, J CLIN MICROBIOL, V48, P2724, DOI 10.1128/JCM.02091-09; TALAN DA, 1989, J CLIN MICROBIOL, V27, P2393, DOI 10.1128/JCM.27.10.2393-.1989; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; van Duijkeren E, 2011, VET MICROBIOL, V150, P338, DOI 10.1016/j.vetmic.2011.02.012; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; VanBelkum A, 1997, J MED MICROBIOL, V46, P222, DOI 10.1099/00222615-46-3-222; vanBelkum A, 1996, EUR J CLIN MICROBIOL, V15, P768; VandenBergh MFQ, 1999, J CLIN MICROBIOL, V37, P3133, DOI 10.1128/JCM.37.10.3133-3140.1999; VasanthaKumari N, 2009, J MED MICROBIOL, V58, P1531, DOI 10.1099/jmm.0.011692-0; Walther B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035197; Weese JS, 2006, VET MICROBIOL, V115, P148, DOI 10.1016/j.vetmic.2006.01.004; Weese JS, 2010, ILAR J, V51, P233, DOI 10.1093/ilar.51.3.233; Weidenmaier C, 2012, TRENDS MICROBIOL, V20, P243, DOI 10.1016/j.tim.2012.03.004; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4	52	33	33	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e69337	10.1371/journal.pone.0069337	http://dx.doi.org/10.1371/journal.pone.0069337			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874949	Green Published, Green Submitted, gold			2022-12-27	WOS:000321736900154
J	Gonzalez-Silva, C; Vera, J; Bono, MR; Gonzalez-Billault, C; Baxter, B; Hansen, A; Lopez, R; Gibson, EA; Restrepo, D; Bacigalupo, J				Gonzalez-Silva, Carolina; Vera, Jorge; Bono, Maria Rosa; Gonzalez-Billault, Christian; Baxter, Brooke; Hansen, Anne; Lopez, Robert; Gibson, Emily A.; Restrepo, Diego; Bacigalupo, Juan			Ca2+-Activated Cl- Channels of the ClCa Family Express in the Cilia of a Subset of Rat Olfactory Sensory Neurons	PLOS ONE			English	Article							ACTIVATED CHLORIDE CHANNEL; RECEPTOR-CELLS; AMPLIFICATION; BESTROPHIN-2; PROTEIN; TRANSDUCTION; CONDUCTANCE; CA2+-ATPASE; COMPONENTS; CURRENTS	The Ca2+-activated Cl- channel is considered a key constituent of odor transduction. Odorant binding to a specific receptor in the cilia of olfactory sensory neurons (OSNs) triggers a cAMP cascade that mediates the opening of a cationic cyclic nucleotide-gated channel (CNG), allowing Ca2+ influx. Ca2+ ions activate Cl- channels, generating a significant Cl- efflux, with a large contribution to the receptor potential. The Anoctamin2 channel (ANO2) is a major constituent of the Cl- conductance, but its knock-out has no impairment of behavior and only slightly reduces field potential odorant responses of the olfactory epithelium. Likely, an additional Ca2+-activated Cl- channel of unknown molecular identity is also involved. In addition to ANO2, we detected two members of the ClCa family of Ca2+-activated Cl- channels in the rat olfactory epithelium, ClCa4l and ClCa2. These channels, also expressed in the central nervous system, may correspond to odorant transduction channels. Whole Sprague Dawley olfactory epithelium nested RT-PCR and single OSNs established that the mRNAs of both channels are expressed in OSNs. Real time RT-PCR and full length sequencing of amplified ClCa expressed in rat olfactory epithelium indicated that ClCa4l is the most abundant. Immunoblotting with an antibody recognizing both channels revealed immunoreactivity in the ciliary membrane. Immunochemistry of olfactory epithelium and OSNs confirmed their ciliary presence in a subset of olfactory sensory neurons. The evidence suggests that ClCa4l and ClCa2 might play a role in odorant transduction in rat olfactory cilia.	[Gonzalez-Silva, Carolina; Vera, Jorge; Bono, Maria Rosa; Gonzalez-Billault, Christian; Bacigalupo, Juan] Univ Chile, Fac Sci, Dept Biol, Santiago, Chile; [Gonzalez-Silva, Carolina; Vera, Jorge; Gonzalez-Billault, Christian; Bacigalupo, Juan] Univ Chile, Inst Cell Dynam & Biotechnol, Santiago, Chile; [Baxter, Brooke; Hansen, Anne; Lopez, Robert; Restrepo, Diego] Univ Colorado, Anschutz Med Ctr, Dept Cell & Dev Biol, Aurora, CO USA; [Baxter, Brooke; Hansen, Anne; Lopez, Robert; Restrepo, Diego] Univ Colorado, Anschutz Med Ctr, Neurosci Program, Aurora, CO USA; [Gibson, Emily A.] Univ Colorado, Anschutz Med Ctr, Dept Bioengn, Aurora, CO USA	Universidad de Chile; Universidad de Chile; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Bacigalupo, J (corresponding author), Univ Chile, Fac Sci, Dept Biol, Santiago, Chile.	bacigalu@uchile.cl	Bono, Maria/G-7461-2014; Vera, Jorge/HDO-5376-2022; Gonzalez-Billault, Christian/K-9622-2013	Gonzalez-Silva, Carolina/0000-0002-0866-5723; Gonzalez-Billault, Christian/0000-0003-0335-1482	MIDEPLAN [ICM-P05- 001]; FONDECYT [1100682];  [DC04657];  [DC006070];  [TW007920]; FOGARTY INTERNATIONAL CENTER [R03TW007920] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC004657, R01DC006070] Funding Source: NIH RePORTER	MIDEPLAN; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); ; ; ; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funded by MIDEPLAN ICM-P05- 001 (JB), FONDECYT 1100682 (JB), DC04657 (DR), DC006070 (DR), TW007920 (JB and DR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antolin S, 2010, J GEN PHYSIOL, V135, P367, DOI 10.1085/jgp.200910337; Bakall B, 2008, INVEST OPHTH VIS SCI, V49, P1563, DOI 10.1167/iovs.07-1338; Billig GM, 2011, NAT NEUROSCI, V14, P763, DOI 10.1038/nn.2821; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Castillo K, 2005, FEBS LETT, V579, P1675, DOI 10.1016/j.febslet.2005.01.079; Castillo K, 2007, EUR J NEUROSCI, V26, P2524, DOI 10.1111/j.1460-9568.2007.05863.x; FISH DA, 1995, J OPT SOC AM A, V12, P58, DOI 10.1364/JOSAA.12.000058; Frings S, 2000, PROG NEUROBIOL, V60, P247, DOI 10.1016/S0301-0082(99)00027-1; HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2; Hengl T, 2010, P NATL ACAD SCI USA, V107, P6052, DOI 10.1073/pnas.0909032107; KLEENE SJ, 1991, J NEUROSCI, V11, P3624; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; KURAHASHI T, 1993, NATURE, V363, P71, DOI 10.1038/363071a0; Larsson HP, 1997, BIOPHYS J, V72, P1193, DOI 10.1016/S0006-3495(97)78767-8; LARSSON LI, 1981, PROG HISTOCHEM CYTOC, V13, P1; Lin W, 2007, P NATL ACAD SCI USA, V104, P2471, DOI 10.1073/pnas.0610201104; LOWE G, 1993, NATURE, V366, P283, DOI 10.1038/366283a0; Luo DG, 2008, P NATL ACAD SCI USA, V105, P9855, DOI 10.1073/pnas.0708405105; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; Pifferi S, 2006, P NATL ACAD SCI USA, V103, P12929, DOI 10.1073/pnas.0604505103; Pifferi S, 2009, PFLUG ARCH EUR J PHY, V458, P1023, DOI 10.1007/s00424-009-0684-9; Pifferi S, 2009, J PHYSIOL-LONDON, V587, P4265, DOI 10.1113/jphysiol.2009.176131; Piirsoo M, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-10; Rasche S, 2010, CHEM SENSES, V35, P239, DOI 10.1093/chemse/bjq007; Rawson NE, 1997, J NEUROPHYSIOL, V77, P1606, DOI 10.1152/jn.1997.77.3.1606; Reisert J, 2003, J GEN PHYSIOL, V122, P349, DOI 10.1085/jgp.200308888; Reisert J, 1998, J GEN PHYSIOL, V112, P529, DOI 10.1085/jgp.112.5.529; Saavedra MV, 2008, NEUROREPORT, V19, P1123, DOI 10.1097/WNR.0b013e3283086797; Schild D, 1998, PHYSIOL REV, V78, P429, DOI 10.1152/physrev.1998.78.2.429; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Weeraratne SD, 2006, CHEM SENSES, V31, P725, DOI 10.1093/chemse/bjl014; Yamazaki J, 2005, BBA-BIOMEMBRANES, V1715, P132, DOI 10.1016/j.bbamem.2005.08.001; Yoon IS, 2006, BIOL PHARM BULL, V29, P2168, DOI 10.1248/bpb.29.2168	34	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e69295	10.1371/journal.pone.0069295	http://dx.doi.org/10.1371/journal.pone.0069295			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874937	Green Published, gold, Green Submitted			2022-12-27	WOS:000321736900149
J	Prellwitz, IM; Alves, BM; Ikeda, MLR; Kuhleis, D; Picon, PD; Jarczewski, CA; Osorio, MR; Sanchez, A; Seuanez, HN; Larouze, B; Soares, MA; Soares, EA				Prellwitz, Isabel M.; Alves, Brunna M.; Ikeda, Maria Leticia R.; Kuhleis, Daniele; Picon, Pedro D.; Jarczewski, Carla A.; Osorio, Marta R.; Sanchez, Alexandra; Seuanez, Hector N.; Larouze, Bernard; Soares, Marcelo A.; Soares, Esmeralda A.			HIV behind Bars: Human Immunodeficiency Virus Cluster Analysis and Drug Resistance in a Reference Correctional Unit from Southern Brazil	PLOS ONE			English	Article							RNASE-H DOMAINS; TYPE-1 REVERSE-TRANSCRIPTASE; SUBTYPE-C; CONNECTION SUBDOMAIN; NAIVE PATIENTS; RT CONNECTION; LOW-INCOME; MUTATIONS; PREVALENCE; PRISONERS	People deprived of liberty in prisons are at higher risk of infection by the human immunodeficiency virus (HIV) due to their increased exposure through intravenous drug use, unprotected sexual activity, tattooing in prison and blood exposure in fights and rebellions. Yet, the contribution of intramural HIV transmission to the epidemic is scarcely known, especially in low- and middle-income settings. In this study, we surveyed 1,667 inmates incarcerated at Presidio Central de Porto Alegre, located in southern Brazil, for HIV infection and molecular characterization. The HIV seroprevalence was 6.6% (110/1,667). Further analyses were carried out on 40 HIV-seropositive inmates to assess HIV transmission clusters and drug resistance within the facility with the use of molecular and phylogenetic techniques. The molecular epidemiology of HIV-1 subtypes observed was similar to the one reported for the general population in southern Brazil, with the predominance of HIV-1 subtypes C, B, CRF31_BC and unique BC recombinants. In particular, the high rate (24%) of URF_BC found here may reflect multiple exposures of the population investigated to HIV infection. We failed to find HIV-infected inmates sharing transmission clusters with each other. Importantly, the analysis of HIV-1 pol genomic fragments evidenced high rates of HIV primary and secondary (acquired) drug resistance and an alarming proportion of virologic failure among patients under treatment, unveiling suboptimal access to antiretroviral therapy (ARV), low ARV adherence and dissemination of drug resistant HIV strains in primary infections. Our results call for immediate actions of public authority to implement preventive measures, serological screening and, for HIV-seropositive subjects, clinical and treatment follow-up in order to control HIV infection and limit the spread of drug resistance strains in Brazilian prisons.	[Prellwitz, Isabel M.; Alves, Brunna M.; Seuanez, Hector N.; Soares, Marcelo A.; Soares, Esmeralda A.] Inst Nacl Canc, Programa Genet, Rio De Janeiro, Brazil; [Ikeda, Maria Leticia R.] Prefeitura Viamao, Secretaria Saude Viamao, Viamao, Brazil; [Ikeda, Maria Leticia R.; Jarczewski, Carla A.] Hosp Sanatorio Partenon, Dept Ensino & Pesquisa, Porto Alegre, RS, Brazil; [Kuhleis, Daniele; Picon, Pedro D.] Governo Estado Rio Grande Sul, Secretaria Segurance Publ, Porto Alegre, RS, Brazil; [Osorio, Marta R.] Governo Estado Rio Grande Sul, Fundacao Estadual Prod & Pesquisa Saude, Porto Alegre, RS, Brazil; [Sanchez, Alexandra; Larouze, Bernard] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Rio De Janeiro, Brazil; [Sanchez, Alexandra] Governo Estado Rio de Janeiro, Secretaria Estado Adm Penitenciaria, Rio De Janeiro, Brazil; [Seuanez, Hector N.; Soares, Marcelo A.] Univ Fed Rio de Janeiro, Dept Genet, Rio De Janeiro, Brazil; [Larouze, Bernard] INSERM, U707, Paris, France; [Larouze, Bernard] Univ Paris 06, Paris, France	National Cancer Institute (Inca); Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Soares, EA (corresponding author), Inst Nacl Canc, Programa Genet, Rio De Janeiro, Brazil.	esoares@inca.gov.br	Soares, Marcelo A/G-5662-2010; Alves, Brunna/GQP-6895-2022		Global Fund Tuberculosis Brazil (FGTB); Brazilian Cancer Institute (INCA)	Global Fund Tuberculosis Brazil (FGTB); Brazilian Cancer Institute (INCA)	This work was supported by the Global Fund Tuberculosis Brazil (FGTB), and by intramural grants of the Brazilian Cancer Institute (INCA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Bello G, 2008, AIDS, V22, P1993, DOI 10.1097/QAD.0b013e328315e0aa; Bello G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035649; Bello G, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/154945; Passaes CPB, 2009, AIDS RES HUM RETROV, V25, P1339, DOI 10.1089/aid.2009.0167; Brehm JH, 2007, J VIROL, V81, P7852, DOI 10.1128/JVI.02203-06; Brigido LFM, 2007, AIDS RES HUM RETROV, V23, P1579, DOI 10.1089/aid.2007.0102; Burattini MN, 2000, REV SAUDE PUBL, V34, P431, DOI 10.1590/S0034-89102000000500001; Coelho HC, 2007, CAD SAUDE PUBLICA, V23, P2197, DOI 10.1590/S0102-311X2007000900027; Dau B, 2010, JAIDS-J ACQ IMM DEF, V54, P160, DOI 10.1097/QAI.0b013e3181cbd235; de Medeiros RM, 2011, J MED VIROL, V83, P1682, DOI 10.1002/jmv.22188; Delviks-Frankenberry KA, 2012, VIROLOGY; Delviks-Frankenberry KA, 2009, J VIROL, V83, P8502, DOI 10.1128/JVI.00859-09; Dolan K, 2007, LANCET INFECT DIS, V7, P32, DOI 10.1016/S1473-3099(06)70685-5; Ehteshami M, 2008, J BIOL CHEM, V283, P22222, DOI 10.1074/jbc.M803521200; Fontella R, 2008, AIDS, V22, P2001, DOI 10.1097/QAD.0b013e3283108f69; Graf T, 2011, J CLIN VIROL, V51, P186, DOI 10.1016/j.jcv.2011.04.011; Guimaraes T, 2001, Braz J Infect Dis, V5, P111; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Lengruber RB, 2011, J ANTIMICROB CHEMOTH, V66, P702, DOI 10.1093/jac/dkr005; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Lopes F, 2001, Cad Saude Publica, V17, P1473, DOI 10.1590/S0102-311X2001000600031; Ministerio da Saude do Brasil, 2011, B EP AIDS DST; Price MA, 2012, JAIDS-J ACQ IMM DEF, V59, P185, DOI 10.1097/QAI.0b013e31823d8693; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; Sanchez A, 2005, INT J TUBERC LUNG D, V9, P633; Santos AF, 2007, JAIDS-J ACQ IMM DEF, V45, P328; Santos AF, 2011, J CLIN VIROL, V52, P373, DOI 10.1016/j.jcv.2011.09.005; Santos AFA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001781; Silveira J, 2012, J CLIN VIROL, V54, P36, DOI 10.1016/j.jcv.2012.01.017; Soares EAJM, 2005, AIDS, V19, pS81, DOI 10.1097/01.aids.0000191497.00928.e4; Soares EA, 2010, J CLIN VIROL, V48, P173, DOI 10.1016/j.jcv.2010.04.008; Soares EAJM, 2003, JAIDS-J ACQ IMM DEF, V34, P520, DOI 10.1097/00126334-200312150-00012; Strazza L, 2004, BRAZ J MED BIOL RES, V37, P771, DOI 10.1590/S0100-879X2004000500020; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanuma J, 2010, MICROBES INFECT, V12, P1170, DOI 10.1016/j.micinf.2010.08.003; United Nations Office on Drugs and Crime & Joint United Nations Programme on HIV/AIDS, 2009, WHO UNODC UNAIDS TEC; Cardoso LPV, 2011, AIDS RES HUM RETROV, V27, P1349, DOI 10.1089/aid.2011.0153	42	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e69033	10.1371/journal.pone.0069033	http://dx.doi.org/10.1371/journal.pone.0069033			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874857	Green Submitted, gold, Green Published			2022-12-27	WOS:000321736900130
J	Tiedt, HO; Weber, JE; Pauls, A; Beier, KM; Lueschow, A				Tiedt, Hannes O.; Weber, Joachim E.; Pauls, Alfred; Beier, Klaus M.; Lueschow, Andreas			Sex-Differences of Face Coding: Evidence from Larger Right Hemispheric M170 in Men and Dipole Source Modelling	PLOS ONE			English	Article							SUPERIOR TEMPORAL SULCUS; OCCIPITOTEMPORAL CORTEX; FACIAL EMOTION; BRAIN; PERCEPTION; AMYGDALA; AREA; CONNECTIVITY; POTENTIALS; ACTIVATION	The processing of faces relies on a specialized neural system comprising bilateral cortical structures with a dominance of the right hemisphere. However, due to inconsistencies of earlier findings as well as more recent results such functional lateralization has become a topic of discussion. In particular, studies employing behavioural tasks and electrophysiological methods indicate a dominance of the right hemisphere during face perception only in men whereas women exhibit symmetric and bilateral face processing. The aim of this study was to further investigate such sex differences in hemispheric processing of personally familiar and opposite-sex faces using whole-head magnetoencephalography (MEG). We found a right-lateralized M170-component in occipito-temporal sensor clusters in men as opposed to a bilateral response in women. Furthermore, the same pattern was obtained in performing dipole localization and determining dipole strength in the M170-timewindow. These results suggest asymmetric involvement of face-responsive neural structures in men and allow to ascribe this asymmetry to the fusiform gyrus. This specifies findings from previous investigations employing event-related potentials (ERP) and LORETA reconstruction methods yielding rather extended bilateral activations showing left asymmetry in women and right lateralization in men. We discuss our finding of an asymmetric fusiform activation pattern in men in terms of holistic face processing during face evaluation and sex differences with regard to visual strategies in general and interest for opposite faces in special. Taken together the pattern of hemispheric specialization observed here yields new insights into sex differences in face perception and entails further questions about interactions between biological sex, psychological gender and influences that might be stimulus-driven or task dependent.	[Tiedt, Hannes O.; Weber, Joachim E.; Lueschow, Andreas] Charite, Dept Neurol, Campus Benjamin Franklin, D-13353 Berlin, Germany; [Tiedt, Hannes O.; Pauls, Alfred; Beier, Klaus M.] Charite, Inst Sexol & Sexual Med, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Tiedt, HO (corresponding author), Charite, Dept Neurol, Campus Benjamin Franklin, D-13353 Berlin, Germany.	hannes.tiedt@charite.de	Weber, Joachim/AAL-2799-2020	Weber, Joachim/0000-0002-1666-6021; Tiedt, Hannes/0000-0002-8392-1942; Beier, Klaus/0000-0003-1311-8748				Abbas ZA, 2008, PERCEPTION, V37, P1187, DOI 10.1068/p5984; Alexander GM, 2009, ARCH SEX BEHAV, V38, P434, DOI 10.1007/s10508-008-9429-7; Allison T, 1999, CEREB CORTEX, V9, P415, DOI 10.1093/cercor/9.5.415; Barton JJS, 2008, J NEUROPSYCHOL, V2, P197, DOI 10.1348/174866407X214172; Baseler HA, 2013, CEREB CORTEX; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bourne VJ, 2010, NEUROPSYCHOLOGIA, V48, P1289, DOI 10.1016/j.neuropsychologia.2009.12.032; Bourne VJ, 2005, NEUROPSYCHOLOGIA, V43, P953, DOI 10.1016/j.neuropsychologia.2004.08.007; Brazdil M, 2009, NEUROIMAGE, V47, P376, DOI 10.1016/j.neuroimage.2009.03.081; BUSS DM, 1993, PSYCHOL REV, V100, P204, DOI 10.1037/0033-295X.100.2.204; Chatterjee A, 2009, NEUROPSYCHOLOGY, V23, P135, DOI 10.1037/a0014430; Cloutier J, 2008, J COGNITIVE NEUROSCI, V20, P941, DOI 10.1162/jocn.2008.20062; Davies-Thompson J, 2012, J NEUROPHYSIOL, V108, P3087, DOI 10.1152/jn.01171.2011; Deffke I, 2007, NEUROIMAGE, V35, P1495, DOI 10.1016/j.neuroimage.2007.01.034; Eliot L, 2011, NEURON, V72, P895, DOI 10.1016/j.neuron.2011.12.001; Fairhall SL, 2007, CEREB CORTEX, V17, P2400, DOI 10.1093/cercor/bhl148; Fink GR, 1996, NATURE, V382, P626, DOI 10.1038/382626a0; Gobbini MI, 2007, NEUROPSYCHOLOGIA, V45, P32, DOI 10.1016/j.neuropsychologia.2006.04.015; Godard O, 2010, BRAIN COGNITION, V73, P167, DOI 10.1016/j.bandc.2010.04.008; Guerra P, 2012, INT J PSYCHOPHYSIOL, V85, P79, DOI 10.1016/j.ijpsycho.2011.06.004; Guerra P, 2011, BIOL PSYCHOL, V88, P196, DOI 10.1016/j.biopsycho.2011.08.002; HALGREN E, 1994, J PHYSIOL-PARIS, V88, P1, DOI 10.1016/0928-4257(94)90092-2; Halgren E, 2000, CEREB CORTEX, V10, P69, DOI 10.1093/cercor/10.1.69; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Hein G, 2008, J COGNITIVE NEUROSCI, V20, P2125, DOI 10.1162/jocn.2008.20148; Iaria G, 2008, NEUROSCIENCE, V155, P409, DOI 10.1016/j.neuroscience.2008.05.046; Ishai A, 2008, NEUROIMAGE, V40, P415, DOI 10.1016/j.neuroimage.2007.10.040; Itier RJ, 2004, NEUROREPORT, V15, P1261, DOI 10.1097/01.wnr.0000127827.73576.d8; Jacques C, 2009, J VISION, V9, DOI 10.1167/9.6.8; Johnson BW, 2002, NEUROREPORT, V13, P1929, DOI 10.1097/00001756-200210280-00020; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kanwisher N, 2006, PHILOS T R SOC B, V361, P2109, DOI 10.1098/rstb.2006.1934; Krolak-Salmon P, 2004, NEURON, V42, P665, DOI 10.1016/S0896-6273(04)00264-8; Langeslag SJE, 2007, BIOL PSYCHOL, V76, P109, DOI 10.1016/j.biopsycho.2007.06.007; Le Grand R, 2003, NAT NEUROSCI, V6, P1108, DOI 10.1038/nn1121; Levy B, 2008, LEARN MOTIV, V39, P136, DOI 10.1016/j.lmot.2007.09.002; Liu J, 2002, NAT NEUROSCI, V5, P910, DOI 10.1038/nn909; Luders E, 2010, PROG BRAIN RES, V186, P3, DOI 10.1016/B978-0-444-53630-3.00001-4; Miellet S, 2011, PSYCHOL SCI, V22, P1518, DOI 10.1177/0956797611424290; Mormann F, 2008, J NEUROSCI, V28, P8865, DOI 10.1523/JNEUROSCI.1640-08.2008; O'Doherty J, 2003, NEUROPSYCHOLOGIA, V41, P147, DOI 10.1016/S0028-3932(02)00145-8; Okazaki Y, 2010, BRAIN TOPOGR, V23, P14, DOI 10.1007/s10548-009-0112-7; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Proverbio AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011242; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Saether L, 2009, VISION RES, V49, P2870, DOI 10.1016/j.visres.2009.09.001; Sagiv N, 2001, J COGNITIVE NEUROSCI, V13, P937, DOI 10.1162/089892901753165854; Sander TH, 2002, IEEE T BIO-MED ENG, V49, P345, DOI 10.1109/10.991162; Schiltz C, 2010, J VISION, V10, DOI 10.1167/10.2.25; SHAYWITZ BA, 1995, NATURE, V373, P607, DOI 10.1038/373607a0; Stevens JS, 2012, NEUROPSYCHOLOGIA, V50, P1578, DOI 10.1016/j.neuropsychologia.2012.03.011; Taylor MJ, 2001, NEUROSCI LETT, V316, P173, DOI 10.1016/S0304-3940(01)02378-3; Todorov A, 2010, PERCEPTION, V39, P514, DOI 10.1068/p6501; Vico C, 2010, NEUROPSYCHOLOGIA, V48, P2894, DOI 10.1016/j.neuropsychologia.2010.05.031; Vuilleumier P, 2004, NAT NEUROSCI, V7, P1271, DOI 10.1038/nn1341; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; Watanabe S, 2003, NEUROSCIENCE, V116, P879, DOI 10.1016/S0306-4522(02)00752-2	57	18	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e69107	10.1371/journal.pone.0069107	http://dx.doi.org/10.1371/journal.pone.0069107			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182JD	23874881	Green Published, gold, Green Submitted			2022-12-27	WOS:000321736900135
J	Chen, ZP; Pan, XD; Yao, YY; Yan, FD; Chen, L; Huang, R; Ma, GS				Chen, Zhongpu; Pan, Xiaodong; Yao, Yuyu; Yan, Fengdi; Chen, Long; Huang, Rong; Ma, Genshan			Epigenetic Regulation of Cardiac Progenitor Cells Marker c-kit by Stromal Cell Derived Factor-1 alpha	PLOS ONE			English	Article							REGENERATE INFARCTED MYOCARDIUM; STEM-CELLS; DNA METHYLATION; GROWTH-FACTOR; TISSUE REGENERATION; CHEMOKINE RECEPTOR; CANCER-CELLS; EXPRESSION; DIFFERENTIATION; HEART	Background: Cardiac progenitor cells (CPCs) have been proven suitable for stem cell therapy after myocardial infarction, especially c-kit(+)CPCs. CPCs marker c-kit and its ligand, the stem cell factor (SCF), are linked as c-kit/SCF axis, which is associated with the functions of proliferation and differentiation. In our previous study, we found that stromal cell-derived factor-1 alpha (SDF-1 alpha) could enhance the expression of c-kit. However, the mechanism is unknown. Methods and Results: CPCs were isolated from adult mouse hearts, c-kit(+) and c-kit(-) CPCs were separated by magnetic beads. The cells were cultured with SDF-1 alpha and CXCR4-selective antagonist AMD3100, and c-kit expression was measured by qPCR and Western blotting. Results showed that SDF-1 alpha could enhance c-kit expression of c-kit(+)CPCs, made c-kit(-)CPCs expressing c-kit, and AMD3100 could inhibit the function of SDF-1 alpha. After the intervention of SDF-1 alpha and AMD3100, proliferation and migration of CPCs were measured by CCK-8 and transwell assay. Results showed that SDF-1 alpha could enhance the proliferation and migration of both c-kit(+) and c-kit(-)CPCs, and AMD3100 could inhibit these functions. DNA methyltransferase (DNMT) mRNA were measured by qPCR, DNMT activity was measured using the DNMT activity assay kit, and DNA methylation was analyzed using Sequenom's MassARRAY platform, after the CPCs were cultured with SDF-1 alpha. The results showed that SDF-1 alpha stimulation inhibited the expression of DNMT1 and DNMT3 beta, which are critical for the maintenance of regional DNA methylation. Global DNMT activity was also inhibited by SDF-1 alpha. Lastly, SDF-1 alpha treatment led to significant demethylation in both c-kit(+) and c-kit(-)CPCs. Conclusions: SDF-1 alpha combined with CXCR4 could up-regulate c-kit expression of c-kit(+)CPCs and make c-kit(-)CPCs expressing c-kit, which result in the CPCs proliferation and migration ability improvement, through the inhibition of DNMT1 and DNMT3b expression and global DNMT activity, as well as the subsequent demethylation of the c-kit gene.	[Chen, Zhongpu; Pan, Xiaodong; Yao, Yuyu; Yan, Fengdi; Chen, Long; Huang, Rong; Ma, Genshan] Southeast Univ, Sch Med, Zhongda Hosp, Dept Cardiol, Nanjing, Jiangsu, Peoples R China	Southeast University - China	Ma, GS (corresponding author), Southeast Univ, Sch Med, Zhongda Hosp, Dept Cardiol, Nanjing, Jiangsu, Peoples R China.	magenshan@hotmail.com			National Natural Science Foundation of China [81270204]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81270204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DM, 1990, CELL, V63, P235, DOI 10.1016/0092-8674(90)90304-W; Anversa P, 2003, CIRC RES, V92, P579, DOI 10.1161/01.RES.0000066879.66293.87; Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Cheng M, 2010, CIRC RES, V107, P1083, DOI 10.1161/CIRCRESAHA.110.220970; Davis DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007195; Dawn B, 2005, P NATL ACAD SCI USA, V102, P3766, DOI 10.1073/pnas.0405957102; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Fricker SP, 2006, BIOCHEM PHARMACOL, V72, P588, DOI 10.1016/j.bcp.2006.05.010; Hu XF, 2007, CIRCULATION, V116, P654, DOI 10.1161/CIRCULATIONAHA.106.672451; HUANG E, 1990, CELL, V63, P225, DOI 10.1016/0092-8674(90)90303-V; Huang YL, 2012, MOL MED REP, V6, P872, DOI 10.3892/mmr.2012.994; Ikeda JI, 2006, J PATHOL, V210, P75, DOI 10.1002/path.2026; Kawaguchi N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014297; Kitamura Y, 2004, CELL MOL LIFE SCI, V61, P2924, DOI 10.1007/s00018-004-4273-y; Kortesidis A, 2005, BLOOD, V105, P3793, DOI 10.1182/blood-2004-11-4349; Kucia M, 2005, STEM CELLS, V23, P879, DOI 10.1634/stemcells.2004-0342; Kunisada T, 1998, DEVELOPMENT, V125, P2915; Lee MP, 2008, NUTR REV, V66, pS69, DOI 10.1111/j.1753-4887.2008.00072.x; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; Linke A, 2005, P NATL ACAD SCI USA, V102, P8966, DOI 10.1073/pnas.0502678102; Liu YL, 1998, NUCLEIC ACIDS RES, V26, P1038, DOI 10.1093/nar/26.4.1038; Ma J, 2005, BASIC RES CARDIOL, V100, P217, DOI 10.1007/s00395-005-0521-z; Mann J, 2007, CELL DEATH DIFFER, V14, P275, DOI 10.1038/sj.cdd.4401979; MARTIN FH, 1990, CELL, V63, P203, DOI 10.1016/0092-8674(90)90301-T; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Miettinen M, 2005, APPL IMMUNOHISTO M M, V13, P205, DOI 10.1097/01.pai.0000173054.83414.22; Miranda TB, 2007, J CELL PHYSIOL, V213, P384, DOI 10.1002/jcp.21224; Miyamoto S, 2010, STEM CELLS DEV, V19, P105, DOI 10.1089/scd.2009.0041; Mohle R, 1997, BLOOD, V8, P72; Mouquet F, 2005, CIRC RES, V97, P1090, DOI 10.1161/01.RES.0000194330.66545.f5; Naqvi N, 2009, PEDIATR CARDIOL, V30, P651, DOI 10.1007/s00246-008-9366-1; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Padin-Iruegas ME, 2009, CIRCULATION, V120, P876, DOI 10.1161/CIRCULATIONAHA.109.852285; Plachot C, 2004, EXP CELL RES, V298, P122, DOI 10.1016/j.yexcr.2004.04.024; Poplawski T., 2008, Experimental Oncology, V30, P112; Prokhortchouk E, 2008, BBA-MOL CELL RES, V1783, P2167, DOI 10.1016/j.bbamcr.2008.07.015; Rota M, 2008, CIRC RES, V103, P107, DOI 10.1161/CIRCRESAHA.108.178525; Sako K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037086; Stamatopoulos B, 2012, HAEMATOL-HEMATOL J, V97, P608, DOI 10.3324/haematol.2011.052779; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Tang JM, 2011, CARDIOVASC RES, V91, P402, DOI 10.1093/cvr/cvr053; Tang YL, 2009, CIRC RES, V104, P1209, DOI 10.1161/CIRCRESAHA.109.197723; Teyssier-Le Discorde M, 1999, BRIT J HAEMATOL, V107, P247, DOI 10.1046/j.1365-2141.1999.01725.x; Urbanek K, 2003, P NATL ACAD SCI USA, V100, P10440, DOI 10.1073/pnas.1832855100; Urbanek K, 2006, P NATL ACAD SCI USA, V103, P9226, DOI 10.1073/pnas.0600635103; Yan FD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037948; You HN, 2010, HEPATOLOGY, V51, P1635, DOI 10.1002/hep.23544; Ze- Jun- L, 2002, ADV CLIN PATH, V6, P43	50	13	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69134	10.1371/journal.pone.0069134	http://dx.doi.org/10.1371/journal.pone.0069134			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894420	Green Published, Green Submitted, gold			2022-12-27	WOS:000322167900040
J	Lofton, H; Pranting, M; Thulin, E; Andersson, DI				Lofton, Hava; Pranting, Maria; Thulin, Elisabeth; Andersson, Dan I.			Mechanisms and Fitness Costs of Resistance to Antimicrobial Peptides LL-37, CNY100HL and Wheat Germ Histones	PLOS ONE			English	Article							2-COMPONENT REGULATORY SYSTEM; ESCHERICHIA-COLI LIPOPOLYSACCHARIDE; SALMONELLA-TYPHIMURIUM; ANTIBIOTIC-RESISTANCE; HOST-DEFENSE; VIRULENCE; MUTANTS; EVOLUTION; POLYMYXIN; SUSCEPTIBILITY	Antimicrobial peptides (AMPs) represent a potential new class of antimicrobial drugs with potent and broad-spectrum activities. However, knowledge about the mechanisms and rates of resistance development to AMPs and the resulting effects on fitness and cross-resistance is limited. We isolated antimicrobial peptide (AMP) resistant Salmonella typhimurium LT2 mutants by serially passaging several independent bacterial lineages in progressively increasing concentrations of LL-37, CNY100HL and Wheat Germ Histones. Significant AMP resistance developed in 15/18 independent bacterial lineages. Resistance mutations were identified by whole genome sequencing in two-component signal transduction systems (pmrB and phoP) as well as in the LPS core biosynthesis pathway (waaY, also designated rfaY). In most cases, resistance was associated with a reduced fitness, observed as a decreased growth rate, which was dependent on growth conditions and mutation type. Importantly, mutations in waaY decreased bacterial susceptibility to all tested AMPs and the mutant outcompeted the wild type parental strain at AMP concentrations below the MIC for the wild type. Our data suggests that resistance to antimicrobial peptides can develop rapidly through mechanisms that confer cross-resistance to several AMPs. Importantly, AMP-resistant mutants can have a competitive advantage over the wild type strain at AMP concentrations similar to those found near human epithelial cells. These results suggest that resistant mutants could both be selected de novo and maintained by exposure to our own natural repertoire of defence molecules.	[Lofton, Hava; Pranting, Maria; Thulin, Elisabeth; Andersson, Dan I.] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Pranting, Maria] Uppsala Univ, Dept Cell & Mol Biol, Uppsala, Sweden	Uppsala University; Uppsala University	Andersson, DI (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden.	dan.andersson@imbim.uu.se		Andersson, Dan/0000-0001-6640-2174	Swedish Research Council; Vinnova; European Commission	Swedish Research Council(Swedish Research CouncilEuropean Commission); Vinnova(Vinnova); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Swedish Research Council, Vinnova and European Commission ( PAR project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RC, 2003, BIOCHEM BIOPH RES CO, V312, P1139, DOI 10.1016/j.bbrc.2003.11.045; Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Antoniadou A, 2007, J ANTIMICROB CHEMOTH, V59, P786, DOI 10.1093/jac/dkl562; Bals R, 1998, INFECT IMMUN, V66, P1225, DOI 10.1128/IAI.66.3.1225-1232.1998; Barrow K, 2009, ANTIMICROB AGENTS CH, V53, P5150, DOI 10.1128/AAC.00893-09; Bell G, 2003, MICROBIOL-SGM, V149, P1367, DOI 10.1099/mic.0.26265-0; Bishop RE, 2000, EMBO J, V19, P5071, DOI 10.1093/emboj/19.19.5071; Bishop RE, 2005, MOL MICROBIOL, V57, P900, DOI 10.1111/j.1365-2958.2005.04711.x; Cai X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023100; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davidopoulou S, 2012, ARCH ORAL BIOL, V57, P865, DOI 10.1016/j.archoralbio.2012.01.008; Denamur E, 2006, MOL MICROBIOL, V60, P820, DOI 10.1111/j.1365-2958.2006.05150.x; DYKHUIZEN DE, 1990, ANNU REV ECOL SYST, V21, P373, DOI 10.1146/annurev.ecolsys.21.1.373; Ernst RK, 2001, MICROBES INFECT, V3, P1327, DOI 10.1016/S1286-4579(01)01494-0; FLYG C, 1980, J GEN MICROBIOL, V120, P173; Frirdich E, 2005, J ENDOTOXIN RES, V11, P133, DOI 10.1179/096805105X46592; Frirdich E, 2003, J BACTERIOL, V185, P1659, DOI 10.1128/JB.185.5.1659-1671.2003; Ge YG, 1999, DIAGN MICR INFEC DIS, V35, P45, DOI 10.1016/S0732-8893(99)00056-5; Gibbons HS, 2000, J BIOL CHEM, V275, P32940, DOI 10.1074/jbc.M005779200; Grabenstein JP, 2004, INFECT IMMUN, V72, P4973, DOI 10.1128/IAI.72.9.4973-4984.2004; Gravesen A, 2002, MICROBIOL-SGM, V148, P2361, DOI 10.1099/00221287-148-8-2361; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Gudmundsson GH, 1996, EUR J BIOCHEM, V238, P325, DOI 10.1111/j.1432-1033.1996.0325z.x; Gullberg E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002158; Gunn JS, 2008, TRENDS MICROBIOL, V16, P284, DOI 10.1016/j.tim.2008.03.007; Gunn JS, 2000, INFECT IMMUN, V68, P6139, DOI 10.1128/IAI.68.11.6139-6146.2000; Gunn JS, 2000, INFECT IMMUN, V68, P3758, DOI 10.1128/IAI.68.6.3758-3762.2000; Gunn JS, 1996, J BACTERIOL, V178, P6369, DOI 10.1128/jb.178.21.6369-6373.1996; Gunn JS, 2001, J ENDOTOXIN RES, V7, P57, DOI 10.1177/09680519010070011001; Gunn JS, 1996, J BACTERIOL, V178, P6857, DOI 10.1128/jb.178.23.6857-6864.1996; Gunn JS, 1998, MOL MICROBIOL, V27, P1171, DOI 10.1046/j.1365-2958.1998.00757.x; Guo L, 1998, CELL, V95, P189, DOI 10.1016/S0092-8674(00)81750-X; Habets MGJL, 2012, BIOL LETTERS, V8, P416, DOI 10.1098/rsbl.2011.1203; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; HELANDER IM, 1989, EUR J BIOCHEM, V185, P541, DOI 10.1111/j.1432-1033.1989.tb15147.x; Hughes D, 1997, J BACTERIOL; Kahl B, 1998, J INFECT DIS, V177, P1023, DOI 10.1086/515238; Kawasaki H., 2008, Infectious Disorders - Drug Targets, V8, P195; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; Lind PA, 2010, MOL MICROBIOL, V75, P1078, DOI 10.1111/j.1365-2958.2009.07030.x; MILLER SI, 1990, INFECT IMMUN, V58, P3706, DOI 10.1128/IAI.58.11.3706-3710.1990; MILLER SI, 1989, P NATL ACAD SCI USA, V86, P5054, DOI 10.1073/pnas.86.13.5054; Nishino K, 2006, MOL MICROBIOL, V61, P645, DOI 10.1111/j.1365-2958.2006.05273.x; Pasupuleti M, 2008, BIOCHEMISTRY-US, V47, P9057, DOI 10.1021/bi800991e; Perron GG, 2006, P ROY SOC B-BIOL SCI, V273, P251, DOI 10.1098/rspb.2005.3301; Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; ROLAND KL, 1993, J BACTERIOL, V175, P4154, DOI 10.1128/JB.175.13.4154-4164.1993; Schurek KN, 2009, ANTIMICROB AGENTS CH, V53, P4345, DOI 10.1128/AAC.01267-08; SIMON JH, 1976, BIOCHIM BIOPHYS ACTA, V454, P154, DOI 10.1016/0005-2787(76)90362-2; Sorensen O, 1997, J IMMUNOL METHODS, V206, P53, DOI 10.1016/S0022-1759(97)00084-7; Turner J, 1998, ANTIMICROB AGENTS CH, V42, P2206, DOI 10.1128/AAC.42.9.2206; Yethon JA, 1998, J BIOL CHEM, V273, P26310, DOI 10.1074/jbc.273.41.26310; Yethon JA, 2000, INFECT IMMUN, V68, P4485, DOI 10.1128/IAI.68.8.4485-4491.2000; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhou ZM, 2001, J BIOL CHEM, V276, P43111, DOI 10.1074/jbc.M106960200	60	41	44	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e68875	10.1371/journal.pone.0068875	http://dx.doi.org/10.1371/journal.pone.0068875			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894360	Green Published, gold, Green Submitted			2022-12-27	WOS:000325211000049
J	Gormley, KSG; Porter, JS; Bell, MC; Hull, AD; Sanderson, WG				Gormley, Kate S. G.; Porter, Joanne S.; Bell, Michael C.; Hull, Angela D.; Sanderson, William G.			Predictive Habitat Modelling as a Tool to Assess the Change in Distribution and Extent of an OSPAR Priority Habitat under an Increased Ocean Temperature Scenario: Consequences for Marine Protected Area Networks and Management	PLOS ONE			English	Article							MODIOLUS-MODIOLUS MOLLUSCA; SMALL-SCALE VARIATION; CLIMATE-CHANGE; SPECIES DISTRIBUTIONS; BIVALVIA REEF; HORSE MUSSEL; IRISH SEA; CONSERVATION; IMPACTS; ENVELOPE	The aims of this study were to determine the extent and distribution of an OSPAR priority habitat under current baseline ocean temperatures; to illustrate the prospect for habitat loss under a changing ocean temperature scenario; and to demonstrate the potential application of predictive habitat mapping in "future-proofing" conservation and biodiversity management. Maxent modelling and GIS environmental envelope analysis of the biogenic bed forming species, Modiolus modiolus was carried out. The Maxent model was tested and validated using 75%/25% training/test occurrence records and validated against two sampling biases (the whole study area and a 20km buffer). The model was compared to the envelope analysis and the area under the receiver operating characteristic curve (Area Under the curve; AUC) was evaluated. The performance of the Maxent model was rated as 'good' to 'excellent' on all replicated runs and low variation in the runs was recorded from the AUC values. The extent of "most suitable", "less suitable" and "unsuitable" habitat was calculated for the baseline year (2009) and the projected increased ocean temperature scenarios (2030, 2050, 2080 and 2100). A loss of 100% of "most suitable" habitat was reported by 2080. Maintaining a suitable level of protection of marine habitats/species of conservation importance may require management of the decline and migration rather than maintenance of present extent. Methods applied in this study provide the initial application of a plausible "conservation management tool".	[Gormley, Kate S. G.; Hull, Angela D.] Heriot Watt Univ, Sch Life Sci, Ctr Marine Biodivers & Biotechnol, Edinburgh, Midlothian, Scotland; [Gormley, Kate S. G.; Porter, Joanne S.; Sanderson, William G.] Heriot Watt Univ, Sch Built Environm, Inst Bldg & Urban Design, Edinburgh, Midlothian, Scotland; [Bell, Michael C.] Old Acad, Heriot Watt Inst Petr Engn, Int Ctr Isl Technol, Stromness, Orkney, Scotland	Heriot Watt University; Heriot Watt University; Heriot Watt University	Gormley, KSG (corresponding author), Heriot Watt Univ, Sch Life Sci, Ctr Marine Biodivers & Biotechnol, Edinburgh, Midlothian, Scotland.	ksg5@hw.ac.uk	Porter, Joanne S/B-8060-2011	Porter, Joanne S/0000-0002-5878-3912; Sanderson, William/0000-0003-1686-0585	Heriot Watt University	Heriot Watt University	Heriot Watt University funded the PhD research project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aish A, 2010, CHARTING PROGR 2 HLT, P68; [Anonymous], 1990, MARINE FAUNA BRIT IS; Antonov J.I., 2010, NOAA ATLAS NESDIS, V2, P184, DOI DOI 10.13140/2.1.1115.4889; Antonov J.I., 2010, NOAA ATLAS NESDIS 69, V69, P184; Beyer HL, 2004, HAWTHS ANAL TOOLS AR; BODC, 1998, UK DIG MAR ATL UKDMA; BROWN RA, 1984, J MAR BIOL ASSOC UK, V64, P751, DOI 10.1017/S0025315400047214; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Carvalho SB, 2011, BIOL CONSERV, V144, P2020, DOI 10.1016/j.biocon.2011.04.024; CBD, 2010, 2010 BIOD TARG GOALS; COMELY CA, 1978, OPHELIA, V17, P167, DOI 10.1080/00785326.1978.10425481; Connor D.W., 2006, UKSEAMAP MAPPING SEA, V3rd ed.; Curry R, 2003, NATURE, V426, P826, DOI 10.1038/nature02206; DAVENPORT J, 1982, J MOLLUS STUD, V48, P370, DOI 10.1093/oxfordjournals.mollus.a065662; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; del Barrio G, 2006, ENVIRON SCI POLICY, V9, P129, DOI 10.1016/j.envsci.2005.11.005; Dore JE, 2003, NATURE, V424, P754, DOI 10.1038/nature01885; DTI, 2004, R1106R1106154 DTI, P154; Elsasser B, 2013, J SEA RES, V77, P11, DOI 10.1016/j.seares.2012.12.006; Engler R, 2009, DIVERS DISTRIB, V15, P590, DOI 10.1111/j.1472-4642.2009.00566.x; Farinas-Franco JM, 2013, J SEA RES, V78, P59, DOI 10.1016/j.seares.2012.10.008; GEBCO, 2011, GEN BATH CHART OC GE; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Hedger R, 2004, FISH RES, V70, P17, DOI 10.1016/j.fishres.2004.07.002; Hill J, 2010, NATURAL ENGLAND COMM; Hirst NE, 2012, 500 SCOTT NAT HER CO; Hirst NE, 2012, 509 SCOTT NAT HER CO; Holt T.J., 1998, BIOGENIC REEFS, VIX; IUCN (International Union for the Conservation of Nature) World Parks Congress, 2003, 5 IUCN WORLD PARKS C; Jacobs S, 2006, PHILOS T R SOC A, V364, P1657, DOI 10.1098/rsta.2006.1794; Jarnevich CS, 2007, SIMPLE FRAMEWORK INV, P1; JNCC, 2012, MAPP OSPAR PRIOR HAB; Jones MC, 2012, ECOL MODEL, V225, P133, DOI 10.1016/j.ecolmodel.2011.11.003; Lambert Emily, 2011, Endangered Species Research, V15, P205, DOI 10.3354/esr00376; Levitus S, 2000, SCIENCE, V287, P2225, DOI 10.1126/science.287.5461.2225; Lindenbaum C, 2008, J MAR BIOL ASSOC UK, V88, P133, DOI 10.1017/S0025315408000374; Macleod CD, 2010, J MAR BIOL ASS UK; MacLeod CD, 2008, HYDROBIOLOGIA, V612, P21, DOI 10.1007/s10750-008-9491-0; MANABE S, 1995, NATURE, V378, P165, DOI 10.1038/378165a0; Meredith MP, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024042; Metcalfe K, 2013, MAR POLICY, V39, P289, DOI 10.1016/j.marpol.2012.12.002; Micheli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040832; Moffat C., 2011, ADVICE UK BIODIVERSI; Mokany K, 2010, TRENDS ECOL EVOL, V25, P550, DOI 10.1016/j.tree.2010.06.014; Nativi S, 2009, ECOL INFORM, V4, P23, DOI 10.1016/j.ecoinf.2008.11.002; Pachauri R.K, 2007, CLIMATE CHANGE 2007, P104; Pearson RG, 2002, ECOL MODEL, V154, P289, DOI 10.1016/S0304-3800(02)00056-X; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Powell M, 2005, BIOL CONSERV, V123, P165, DOI 10.1016/j.biocon.2004.11.004; Ragnarsson SA, 2012, J SEA RES, V72, P55, DOI 10.1016/j.seares.2012.05.011; Ready J, 2010, ECOL MODEL, V221, P467, DOI 10.1016/j.ecolmodel.2009.10.025; Rees EIS, 2008, J MAR BIOL ASSOC UK, V88, P151, DOI 10.1017/S0025315408000052; Rees E.I.S., 2009, ASSESSMENT MODIOLUS; Rees I., 2009, ASSESSMENT MODIOLUS; Reiss H, 2011, MAR ECOL PROG SER, V442, P71, DOI 10.3354/meps09391; Rose NA, 2009, FOREST ECOL MANAG, V258, pS64, DOI 10.1016/j.foreco.2009.07.053; Ross RE, 2012, DIVERS DISTRIB, P1; Sanderson WGunpubl, DIV LOGS; SEED R, 1978, J ANIM ECOL, V47, P283, DOI 10.2307/3936; Seed R, 1975, INFLUENCE REPROD CYC, P257; SNH, 2011, PRIOR MAR FEAT; Strain EMA, 2012, J SEA RES, V67, P58, DOI 10.1016/j.seares.2011.10.001; Thomas CD, 2012, P NATL ACAD SCI USA, V109, P14063, DOI 10.1073/pnas.1210251109; Thuiller W, 2003, GLOBAL CHANGE BIOL, V9, P1353, DOI 10.1046/j.1365-2486.2003.00666.x	66	40	40	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e68263	10.1371/journal.pone.0068263	http://dx.doi.org/10.1371/journal.pone.0068263			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894298	gold, Green Submitted, Green Published			2022-12-27	WOS:000322132100013
J	Reverberi, M; Punelli, M; Scala, V; Scarpari, M; Uva, P; Mentzen, WI; Dolezal, AL; Woloshuk, C; Pinzari, F; Fabbri, AA; Fanelli, C; Payne, GA				Reverberi, Massimo; Punelli, Marta; Scala, Valeria; Scarpari, Marzia; Uva, Paolo; Mentzen, Wieslawa I.; Dolezal, Andrea L.; Woloshuk, Charles; Pinzari, Flavia; Fabbri, Anna A.; Fanelli, Corrado; Payne, Gary A.			Genotypic and Phenotypic Versatility of Aspergillus flavus during Maize Exploitation	PLOS ONE			English	Article							OXIDATIVE STRESS-RESPONSE; SECONDARY METABOLISM; AFLATOXIN BIOSYNTHESIS; TRANSCRIPTION; GROWTH; DIVERSIFICATION; PARASITICUS; INHERITANCE; OXYLIPINS; SUMMARIES	Aspergillus flavus is a cosmopolitan fungus able to respond to external stimuli and to shift both its trophic behaviour and the production of secondary metabolites, including that of the carcinogen aflatoxin (AF). To better understand the adaptability of this fungus, we examined genetic and phenotypic responses within the fungus when grown under four conditions that mimic different ecological niches ranging from saprophytic growth to parasitism. Global transcription changes were observed in both primary and secondary metabolism in response to these conditions, particularly in secondary metabolism where transcription of nearly half of the predicted secondary metabolite clusters changed in response to the trophic states of the fungus. The greatest transcriptional change was found between saprophytic and parasitic growth, which resulted in expression changes in over 800 genes in A. flavus. The fungus also responded to growth conditions, putatively by adaptive changes in conidia, resulting in differences in their ability to utilize carbon sources. We also examined tolerance of A. flavus to oxidative stress and found that growth and secondary metabolism were altered in a superoxide dismutase (sod) mutant and an alkyl-hydroperoxide reductase (ahp) mutant of A. flavus. Data presented in this study show a multifaceted response of A. flavus to its environment and suggest that oxidative stress and secondary metabolism are important in the ecology of this fungus, notably in its interaction with host plant and in relation to changes in its lifestyle (i.e. saprobic to pathogenic).	[Reverberi, Massimo; Punelli, Marta; Scala, Valeria; Scarpari, Marzia; Fabbri, Anna A.; Fanelli, Corrado] Univ Roma La Sapienza, Dipartimento Biol Ambientale, I-00185 Rome, Italy; [Uva, Paolo; Mentzen, Wieslawa I.] CRS4 Bioinformat Parco Sci & Tecnol Polaris, Pula, CA, Italy; [Dolezal, Andrea L.; Payne, Gary A.] N Carolina State Univ, Dept Plant Pathol, Raleigh, NC 27695 USA; [Woloshuk, Charles] Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA; [Pinzari, Flavia] CRA, Ctr Ric Studio Relaz Tra Pianta & Suolo, Rome, Italy	Sapienza University Rome; University of North Carolina; North Carolina State University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA)	Reverberi, M (corresponding author), Univ Roma La Sapienza, Dipartimento Biol Ambientale, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	massimo.reverberi@uniroma1.it	reverberi, massimo/G-7715-2012; Pinzari, Flavia/S-1790-2018; Uva, Paolo/A-2877-2011	reverberi, massimo/0000-0003-3671-6783; Pinzari, Flavia/0000-0002-1083-8734; Uva, Paolo/0000-0002-9524-8492; Fanelli, Corrado/0000-0002-0804-3078; scala, valeria/0000-0001-9383-8766				Affeldt KJ, 2012, TOXINS, V4, P695, DOI 10.3390/toxins4090695; Amaike S, 2011, ANNU REV PHYTOPATHOL, V49, P107, DOI 10.1146/annurev-phyto-072910-095221; Torres MA, 2010, PHYSIOL PLANTARUM, V138, P414, DOI 10.1111/j.1399-3054.2009.01326.x; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Atanasova L, 2010, J ZHEJIANG UNIV-SC B, V11, P151, DOI 10.1631/jzus.B1000007; Bayram O, 2008, SCIENCE, V320, P1504, DOI 10.1126/science.1155888; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Burow GB, 1997, MOL PLANT MICROBE IN, V10, P380, DOI 10.1094/MPMI.1997.10.3.380; Calvo AM, 2002, MICROBIOL MOL BIOL R, V66, P447, DOI 10.1128/MMBR.66.3.447-459.2002; Chandler D., 1984, BCPC CROP SCI TECHNO, V4B, P309; Christensen SA, 2011, FUNGAL GENET BIOL, V48, P4, DOI 10.1016/j.fgb.2010.05.005; Cleveland TE, 2009, J FOOD SCI, V74, pH83, DOI 10.1111/j.1750-3841.2009.01078.x; Dantigny P, 2009, INT J FOOD MICROBIOL, V134, P16, DOI 10.1016/j.ijfoodmicro.2009.02.005; Denning DW, 1998, CLIN INFECT DIS, V26, P781, DOI 10.1086/513943; Desmond OJ, 2008, MOL PLANT PATHOL, V9, P435, DOI 10.1111/J.1364-3703.2008.00475.X; DIENER UL, 1987, ANNU REV PHYTOPATHOL, V25, P249, DOI 10.1146/annurev.py.25.090187.001341; Fanelli C, 1985, Mycotoxin Res, V1, P65, DOI 10.1007/BF03192005; Farber P, 1997, INT J FOOD MICROBIOL, V36, P215, DOI 10.1016/S0168-1605(97)00040-8; Fisch KM, 2009, J IND MICROBIOL BIOT, V36, P1199, DOI 10.1007/s10295-009-0601-4; Forseth RR, 2013, ANGEW CHEM INT EDIT, V52, P1590, DOI 10.1002/anie.201207456; Gao XQ, 2009, TOXIN REV, V28, P79, DOI 10.1080/15569540802420584; GARDNER PR, 1991, J BIOL CHEM, V266, P19328; Georgianna DR, 2010, MOL PLANT PATHOL, V11, P213, DOI 10.1111/j.1364-3703.2009.00594.x; Georgianna DR, 2009, FUNGAL GENET BIOL, V46, P113, DOI 10.1016/j.fgb.2008.10.011; Gijzen M, 2006, PHYTOCHEMISTRY, V67, P1800, DOI 10.1016/j.phytochem.2005.12.008; He ZM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-104; Hong SY, 2013, TOXINS, V5, P683, DOI 10.3390/toxins5040683; Hong SY, 2013, MICROBIOLOGYOPEN, V2, P144, DOI 10.1002/mbo3.63; Horiguchi H, 2001, J BIOL CHEM, V276, P14279, DOI 10.1074/jbc.M011661200; Hountondji FCC, 2006, EXP APPL ACAROL, V39, P63, DOI 10.1007/s10493-006-0023-1; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; JABLONKA E, 1989, J THEOR BIOL, V139, P69, DOI 10.1016/S0022-5193(89)80058-X; Jablonka E, 1995, PHILOS T R SOC B, V350, P133, DOI 10.1098/rstb.1995.0147; Jablonka E, 1995, EPIGENETIC INHERITAN, P250; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Khaldi N, 2010, FUNGAL GENET BIOL, V47, P736, DOI 10.1016/j.fgb.2010.06.003; Kulkarni RD, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r24; Lee J, 1999, J BIOL CHEM, V274, P4537, DOI 10.1074/jbc.274.8.4537; Legendre P., 2012, NUMERICAL ECOLOGY; Levine DM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r93; LILLEHOJ EB, 1991, MYCOTOXINS ANIMAL FO, P2; Marui J, 2011, J BIOSCI BIOENG, V112, P40, DOI 10.1016/j.jbiosc.2011.03.010; Mita G, 2007, J EXP BOT, V58, P1803, DOI 10.1093/jxb/erm039; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Mulder NJ, 2007, NUCLEIC ACIDS RES, V35, pD224, DOI 10.1093/nar/gkl841; Munkvold GP, 2003, ANNU REV PHYTOPATHOL, V41, P99, DOI 10.1146/annurev.phyto.41.052002.095510; Nesci A, 2004, J APPL MICROBIOL, V96, P965, DOI 10.1111/j.1365-2672.2004.02246.x; Noverr MC, 2004, INFECT IMMUN, V72, P6206, DOI 10.1128/IAI.72.11.6206-6210.2004; PAYNE GA, 1993, APPL ENVIRON MICROB, V59, P156, DOI 10.1128/AEM.59.1.156-162.1993; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reese BN, 2011, PHYTOPATHOLOGY, V101, P797, DOI 10.1094/PHYTO-09-10-0261; Reverberi M, 2007, FOOD ADDIT CONTAM A, V24, P1070, DOI 10.1080/02652030701553244; Reverberi M, 2012, BIOCOMMUNICATION FUN; Reverberi M, 2008, EUKARYOT CELL, V7, P988, DOI 10.1128/EC.00228-07; Reverberi M, 2012, APPL MICROBIOL BIOT, V95, P1293, DOI 10.1007/s00253-012-3985-4; Reverberi M, 2010, APPL MICROBIOL BIOT, V87, P899, DOI 10.1007/s00253-010-2657-5; Richard J.L., 2003, 139 CAST, P199; Roze LV, 2011, J BIOL CHEM, V286, P35137, DOI 10.1074/jbc.M111.253468; Santhanam P, 2013, MOL PLANT MICROBE IN, V26, P278, DOI 10.1094/MPMI-09-12-0222-R; Scheidegger KA, 2003, J TOXICOL-TOXIN REV, V22, P423, DOI 10.1081/TXR-120024100; Sun JT, 2002, GENETICS, V161, P661; Thomas-Chollier M, 2011, NUCLEIC ACIDS RES, V39, pW86, DOI 10.1093/nar/gkr377; Tsitsigiannis DI, 2007, TRENDS MICROBIOL, V15, P109, DOI 10.1016/j.tim.2007.01.005; Wahl R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000303; Wang ZZ, 2012, J PROTEOME RES, V11, P2739, DOI 10.1021/pr201105d; WICKLOW DT, 1982, MYCOLOGIA, V74, P398, DOI 10.2307/3792961; Woloshuk CP, 1997, PHYTOPATHOLOGY, V87, P164, DOI 10.1094/PHYTO.1997.87.2.164; Yang YH, 2005, BIOINFORMATICS, V21, P1084, DOI 10.1093/bioinformatics/bti108; Zhan S, 2006, PLANT J, V45, P347, DOI 10.1111/j.1365-313X.2005.02619.x	70	27	27	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e68735	10.1371/journal.pone.0068735	http://dx.doi.org/10.1371/journal.pone.0068735			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894339	Green Published, Green Submitted, gold			2022-12-27	WOS:000322391400023
J	Smokvina, T; Wels, M; Polka, J; Chervaux, C; Brisse, S; Boekhorst, J; Vlieg, JETV; Siezen, RJ				Smokvina, Tamara; Wels, Michiel; Polka, Justyna; Chervaux, Christian; Brisse, Sylvain; Boekhorst, Jos; Vlieg, Johan E. T. van Hylckama; Siezen, Roland J.			Lactobacillus paracasei Comparative Genomics: Towards Species Pan-Genome Definition and Exploitation of Diversity	PLOS ONE			English	Article							FERMENTED DAIRY PRODUCT; CHAIN FATTY-ACIDS; FUNCTIONAL-ANALYSIS; ENTEROCOCCUS-FAECALIS; PROTEOLYTIC SYSTEM; SEQUENCE; CASEI; PLANTARUM; BACTERIAL; REVEALS	Lactobacillus paracasei is a member of the normal human and animal gut microbiota and is used extensively in the food industry in starter cultures for dairy products or as probiotics. With the development of low-cost, high-throughput sequencing techniques it has become feasible to sequence many different strains of one species and to determine its "pangenome". We have sequenced the genomes of 34 different L. paracasei strains, and performed a comparative genomics analysis. We analysed genome synteny and content, focussing on the pan-genome, core genome and variable genome. Each genome was shown to contain around 2800-3100 protein-coding genes, and comparative analysis identified over 4200 ortholog groups that comprise the pan-genome of this species, of which about 1800 ortholog groups make up the conserved core. Several factors previously associated with host-microbe interactions such as pili, cell-envelope proteinase, hydrolases p40 and p75 or the capacity to produce short branched-chain fatty acids (bkd operon) are part of the L. paracasei core genome present in all analysed strains. The variome consists mainly of hypothetical proteins, phages, plasmids, transposon/conjugative elements, and known functions such as sugar metabolism, cell-surface proteins, transporters, CRISPR-associated proteins, and EPS biosynthesis proteins. An enormous variety and variability of sugar utilization gene cassettes were identified, with each strain harbouring between 25-53 cassettes, reflecting the high adaptability of L. paracasei to different niches. A phylogenomic tree was constructed based on total genome contents, and together with an analysis of horizontal gene transfer events we conclude that evolution of these L. paracasei strains is complex and not always related to niche adaptation. The results of this genome content comparison was used, together with high-throughput growth experiments on various carbohydrates, to perform gene-trait matching analysis, in order to link the distribution pattern of a specific phenotype to the presence/absence of specific sets of genes.	[Smokvina, Tamara; Polka, Justyna; Chervaux, Christian; Vlieg, Johan E. T. van Hylckama] Danone Res, Palaiseau, France; [Brisse, Sylvain] Inst Pasteur, Paris, France; [Wels, Michiel; Boekhorst, Jos] NIZO Food Res, Ede, Netherlands; [Wels, Michiel; Boekhorst, Jos; Siezen, Roland J.] Radboud Univ Nijmegen Med Ctr, CMBI, Nijmegen, Netherlands; [Siezen, Roland J.] Netherlands Bioinformat Ctr NBIC, Nijmegen, Netherlands; [Wels, Michiel; Vlieg, Johan E. T. van Hylckama; Siezen, Roland J.] Kluyver Ctr Genom Ind Fermentat, Delft, Netherlands	Danone Nutricia; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; NIZO Food Research; Radboud University Nijmegen	Siezen, RJ (corresponding author), Radboud Univ Nijmegen Med Ctr, CMBI, Nijmegen, Netherlands.	r.siezen@cmbi.ru.nl	van Hylckama Vlieg, Johan/F-7887-2014; Chervaux, Christian/N-1972-2014; Brisse, Sylvain/M-8723-2013; Siezen, Roland J/P-5745-2015	van Hylckama Vlieg, Johan/0000-0001-6656-8668; Chervaux, Christian/0000-0001-6812-0912; Brisse, Sylvain/0000-0002-2516-2108; Boekhorst, Jos/0000-0002-4807-7838	KIT from the Kluyver Centre for Genomics of Industrial Fermentation, part of the Netherlands Genomics Initiative (NGI); Danone Research; ERA-Net PathoGenoMics [ANR-10-PATH-004]	KIT from the Kluyver Centre for Genomics of Industrial Fermentation, part of the Netherlands Genomics Initiative (NGI); Danone Research(Danone Nutricia); ERA-Net PathoGenoMics	This work was partially supported by a KIT grant from the Kluyver Centre for Genomics of Industrial Fermentation, which is part of the Netherlands Genomics Initiative (NGI) and Danone Research financed part of this study, including subcontracting to NIZO food research (MW, JB) and Microbial Bioinformatics (RS). TS, JvHV and CC obtained financial support from the ERA-Net PathoGenoMics (ANR-10-PATH-004 project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamse SL, 1999, CARCINOGENESIS, V20, P629, DOI 10.1093/carcin/20.4.629; Ai LZ, 2011, J BACTERIOL, V193, P3160, DOI 10.1128/JB.00421-11; Altermann E, 2005, P NATL ACAD SCI USA, V102, P3906, DOI 10.1073/pnas.0409188102; Anukam KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059239; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bauerl C, 2010, J MOL MICROB BIOTECH, V19, P231, DOI 10.1159/000322233; Bayjanov JR, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-68; Bayjanov JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-170; Bitter W, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000507; Bitter W, 2009, TRENDS MICROBIOL, V17, P337, DOI 10.1016/j.tim.2009.05.007; Boge T, 2009, VACCINE, V27, P5677, DOI 10.1016/j.vaccine.2009.06.094; Bolotin A, 2004, NAT BIOTECHNOL, V22, P1554, DOI 10.1038/nbt1034; Borneman AR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-373; Borodovsky Mark, 2003, Curr Protoc Bioinformatics, VChapter 4, DOI 10.1002/0471250953.bi0405s01; Brinster S, 2007, J BACTERIOL, V189, P1244, DOI 10.1128/JB.00773-06; Burrus V, 2004, RES MICROBIOL, V155, P376, DOI 10.1016/j.resmic.2004.01.012; Cai H, 2007, MICROBIOL-SGM, V153, P2655, DOI 10.1099/mic.0.2007/006452-0; Cai H, 2009, GENOME BIOL EVOL, V1, P239, DOI 10.1093/gbe/evp019; Callanan M, 2008, J BACTERIOL, V190, P727, DOI 10.1128/JB.01295-07; Chen C, 2011, J BACTERIOL, V193, P3419, DOI 10.1128/JB.05017-11; Claes IJJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031588; Claesson MJ, 2006, P NATL ACAD SCI USA, V103, P6718, DOI 10.1073/pnas.0511060103; Davidson BE, 1996, ANTON LEEUW INT J G, V70, P161, DOI 10.1007/BF00395932; van de Guchte M, 2006, P NATL ACAD SCI USA, V103, P9274, DOI 10.1073/pnas.0603024103; De Preter V, 2008, EUR J CLIN NUTR, V62, P225, DOI 10.1038/sj.ejcn.1602706; de Vrese M, 2008, ADV BIOCHEM ENG BIOT, V111, P1, DOI 10.1007/10_2008_097; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Dellaglio F, 2002, INT J SYST EVOL MICR, V52, P285, DOI 10.1099/00207713-52-1-285; Desvaux M, 2009, TRENDS MICROBIOL, V17, P338, DOI 10.1016/j.tim.2009.05.008; Desvaux M, 2009, TRENDS MICROBIOL, V17, P139, DOI 10.1016/j.tim.2009.01.004; Diancourt L, 2007, APPL ENVIRON MICROB, V73, P6601, DOI 10.1128/AEM.01095-07; Dicks LMT, 1996, INT J SYST BACTERIOL, V46, P337, DOI 10.1099/00207713-46-1-337; Douillard FP, 2013, APPL ENVIRON MICROB, V79, P1923, DOI 10.1128/AEM.03467-12; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fischer Steve, 2011, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0612s35; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Frese SA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001314; GASSON MJ, 1990, FEMS MICROBIOL LETT, V87, P43, DOI 10.1111/j.1574-6968.1990.tb04878.x; Goffin P, 2005, J BACTERIOL, V187, P6750, DOI 10.1128/JB.187.19.6750-6761.2005; Guillemard E, 2010, BRIT J NUTR, V103, P58, DOI 10.1017/S0007114509991395; Guillemard E, 2010, J AM COLL NUTR, V29, P455, DOI 10.1080/07315724.2010.10719882; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guo FB, 2003, NUCLEIC ACIDS RES, V31, P1780, DOI 10.1093/nar/gkg254; Hill C, 2012, J BACTERIOL; Hols P, 2005, FEMS MICROBIOL REV, V29, P435, DOI 10.1016/j.femsre.2005.04.008; Holzapfel WH, 1998, GENERA LACTIC ACID B; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Horvath P, 2009, INT J FOOD MICROBIOL, V131, P62, DOI 10.1016/j.ijfoodmicro.2008.05.030; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Jacobsen A, 2011, MICROB ECOL, V62, P487, DOI 10.1007/s00248-011-9880-1; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Kim DW, 2011, J BACTERIOL, V193, P5023, DOI 10.1128/JB.05602-11; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Klein G, 2006, INT J SYST EVOL MICR, V56, P2501; Klein G, 2009, INT J SYST EVOL MICR, V59, P3181; Kles KA, 2006, GASTROENTEROLOGY, V130, pS100, DOI 10.1053/j.gastro.2005.11.048; Lebeer S, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-15; Lebeer S, 2012, APPL ENVIRON MICROB, V78, P185, DOI 10.1128/AEM.06192-11; Liu MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-36; Lukjancenko O, 2010, MICROB ECOL, V60, P708, DOI 10.1007/s00248-010-9717-3; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Marchand J, 2000, EUR J GASTROEN HEPAT, V12, P1077, DOI 10.1097/00042737-200012100-00003; Maze A, 2010, J BACTERIOL, V192, P2647, DOI 10.1128/JB.00076-10; MCKAY LL, 1983, A VAN LEEUW J MICROB, V49, P259, DOI 10.1007/BF00399502; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; Merenstein DJ, 2010, J ALTERN COMPLEM MED, V16, P989, DOI 10.1089/acm.2009.0584; Mira A, 2010, INT MICROBIOL, V13, P45, DOI 10.2436/20.1501.01.110; Molenaar D, 2005, J BACTERIOL, V187, P6119, DOI 10.1128/JB.187.17.6119-6127.2005; Muzzi A, 2011, INT J MED MICROBIOL, V301, P619, DOI 10.1016/j.ijmm.2011.09.008; Pallen MJ, 2002, TRENDS MICROBIOL, V10, P209, DOI 10.1016/S0966-842X(02)02345-4; Palmer KL, 2012, MBIO, V3, DOI 10.1128/mBio.00318-11; Pridmore RD, 2004, P NATL ACAD SCI USA, V101, P2512, DOI 10.1073/pnas.0307327101; PRITCHARD GG, 1993, FEMS MICROBIOL REV, V12, P179, DOI [10.1016/0168-6445(93)90063-F, 10.1111/j.1574-6976.1993.tb00018.x]; Raftis EJ, 2011, APPL ENVIRON MICROB, V77, P954, DOI 10.1128/AEM.01687-10; Rasmussen TB, 2008, APPL ENVIRON MICROB, V74, P4703, DOI 10.1128/AEM.00132-08; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Salminen S., 2004, LACTIC ACID BACTERIA, DOI [10.1201/9780824752033, DOI 10.1201/9780824752033]; Schroeter J, 2009, FEMS MICROBIOL LETT, V292, P1, DOI 10.1111/j.1574-6968.2008.01442.x; Segain JP, 2000, GUT, V47, P397, DOI 10.1136/gut.47.3.397; Siezen R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-126; Siezen RJ, 2007, PROTEINS, V67, P681, DOI 10.1002/prot.21290; Siezen RJ, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S3; Siezen RJ, 2011, MICROB BIOTECHNOL, V4, P383, DOI 10.1111/j.1751-7915.2011.00247.x; Siezen RJ, 2010, ENVIRON MICROBIOL, V12, P758, DOI 10.1111/j.1462-2920.2009.02119.x; Simeone R, 2009, CURR OPIN MICROBIOL, V12, P4, DOI 10.1016/j.mib.2008.11.003; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Sur D, 2011, EPIDEMIOL INFECT, V139, P919, DOI 10.1017/S0950268810001780; Sutcliffe IC, 2011, ANTON LEEUW INT J G, V99, P127, DOI 10.1007/s10482-010-9507-4; Symersky J, 1997, NAT STRUCT BIOL, V4, P833, DOI 10.1038/nsb1097-833; Takamatsu D, 2005, J BACTERIOL, V187, P3878, DOI 10.1128/JB.187.11.3878-3883.2005; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tindall BJ, 2008, INT J SYST EVOL MICR, V58, P1764, DOI 10.1099/ijs.0.2008/005330-0; Ton-That H, 2004, BBA-MOL CELL RES, V1694, P269, DOI 10.1016/j.bbamcr.2004.04.014; von Ossowski I, 2010, APPL ENVIRON MICROB, V76, P2049, DOI 10.1128/AEM.01958-09; von Schillde MA, 2012, CELL HOST MICROBE, V11, P387, DOI 10.1016/j.chom.2012.02.006; Vu B, 2009, MOLECULES, V14, P2535, DOI 10.3390/molecules14072535; Ward DE, 1999, J BACTERIOL, V181, P5433, DOI 10.1128/JB.181.17.5433-5442.1999; Wollowski I, 2001, AM J CLIN NUTR, V73, p451S, DOI 10.1093/ajcn/73.2.451s; Wozniak RAF, 2010, NAT REV MICROBIOL, V8, P552, DOI 10.1038/nrmicro2382; Yan F, 2002, J BIOL CHEM, V277, P50959, DOI 10.1074/jbc.M207050200; Yebra MJ, 2000, J BACTERIOL, V182, P155, DOI 10.1128/JB.182.1.155-163.2000; Zhang WY, 2010, J BACTERIOL, V192, P5268, DOI 10.1128/JB.00802-10; Zhou MM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-651	104	108	114	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e68731	10.1371/journal.pone.0068731	http://dx.doi.org/10.1371/journal.pone.0068731			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894338	Green Submitted, gold, Green Published			2022-12-27	WOS:000322391400022
J	Wang, YQ; Wang, F; Deng, XQ; Sheng, J; Chen, SY; Su, J				Wang, Yu-Qiang; Wang, Fei; Deng, Xiao-Qin; Sheng, Jing; Chen, Shu-Yan; Su, Jing			Delivery of Therapeutic AGT shRNA by PEG-Bu for Hypertension Therapy	PLOS ONE			English	Article							LOW-MOLECULAR-WEIGHT; GENE DELIVERY; COPOLYMERS; POLYETHYLENIMINE; SIRNA; ASSOCIATION; POLYPLEXES; SERUM; MICE	Gene silencing by RNA interference (RNAi) is a promising approach for gene therapy. However, up to today, it is still a major challenge to find safe and efficient non-viral vectors. Previously, we reported PEI-Bu, a small molecular weight PEI derivative, as an efficient non-viral carrier. However, like many PEI-based polymers, PEI-Bu was too toxic. In order to reduce cytotoxicity while maintain or even enhance transfecion efficiency, we modified PEI-Bu with poly(ethylene glycol) (PEG) to obtain PEG-Bu, and used it to delivery a theraputic short hairpin RNA (shRNA) targeting angiotensinogen (AGT) to normal rat liver cells (BRL-3A), which was a key target for the treatment of hypertension. The structure of PEG-Bu was confirmed by proton nuclear magnetic resonance (H-1-NMR). Gel permeation chromatography (GPC) showed that the weight average molecular weight (Mw) of PEG-Bu was 5880 Da, with a polydispersity of 1.58. PEG-Bu could condense gene cargo into spherical and uniform nanoparticles with particle size (65-88 nm) and zeta potential (7.3-9.6 mV). Interestingly and importantly, PEG-Bu displayed lower cytotoxicity and enhanced tranfection efficiency than PEI-Bu after PEGylation in both normal cells BRL-3A and tumor cells HeLa. Moreover, PEG-Bu could efficiently delivery AGT shRNA to knockdown the AGT expression. To sum up, PEG-Bu would be a promising non-viral vector for delivering AGT shRNA to BRL-3A cells for hypertension therapy.	[Wang, Yu-Qiang; Wang, Fei; Chen, Shu-Yan] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Geriatr, Shanghai 200030, Peoples R China; [Deng, Xiao-Qin] Dalian Med Univ, Affiliated Hosp 1, Dept Radiat Ontol, Dalian, Peoples R China; [Sheng, Jing] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Geriatr, Shanghai 200030, Peoples R China; [Su, Jing] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Dalian Medical University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Chen, SY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Geriatr, Shanghai 200030, Peoples R China.	shuyanchencn@yahoo.com.cn; jingsu@sjtu.edu.cn			National Natural Science Foundation of China [81270205, 30973152]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81270205 and 30973152). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthanari Y, 2010, J CONTROL RELEASE, V145, P272, DOI 10.1016/j.jconrel.2010.04.011; Ashihara E, 2010, CURR DRUG TARGETS, V11, P345, DOI 10.2174/138945010790711897; Bieber T, 2001, BIOTECHNIQUES, V30, P74, DOI 10.2144/01301st03; Bolcato-Bellemin AL, 2007, P NATL ACAD SCI USA, V104, P16050, DOI 10.1073/pnas.0707831104; Grayson ACR, 2006, PHARM RES-DORDR, V23, P1868, DOI 10.1007/s11095-006-9009-2; Ishigami T, 1997, HYPERTENSION, V30, P1325, DOI 10.1161/01.HYP.30.6.1325; Jeong JH, 2003, BIOCONJUGATE CHEM, V14, P473, DOI 10.1021/bc025632k; Jere D, 2008, BIOMATERIALS, V29, P2535, DOI 10.1016/j.biomaterials.2008.02.018; Kim EM, 2005, J CONTROL RELEASE, V108, P557, DOI 10.1016/j.jconrel.2005.09.001; KIMURA S, 1992, EMBO J, V11, P821, DOI 10.1002/j.1460-2075.1992.tb05119.x; Kuo JHS, 2003, BIOTECHNOL APPL BIOC, V37, P267, DOI 10.1042/BA20020123; Liang B, 2008, BIOCHEM BIOPH RES CO, V367, P874, DOI 10.1016/j.bbrc.2008.01.024; Mintzer MA, 2009, CHEM REV, V109, P259, DOI 10.1021/cr800409e; Mishra S, 2004, EUR J CELL BIOL, V83, P97, DOI 10.1078/0171-9335-00363; Neu M, 2007, J CONTROL RELEASE, V124, P69, DOI 10.1016/j.jconrel.2007.08.009; Petersen H, 2002, BIOCONJUGATE CHEM, V13, P845, DOI 10.1021/bc025529v; Remy JS, 1998, ADV DRUG DELIVER REV, V30, P85, DOI 10.1016/S0169-409X(97)00109-9; TANIMOTO K, 1994, J BIOL CHEM, V269, P31334; Wang YQ, 2012, INT J NANOMED, V7, P693, DOI 10.2147/IJN.S27849; Wang YQ, 2013, DRUG DES DEV THER, V7, P211, DOI 10.2147/DDDT.S42582; Xi B, 2012, J RENIN-ANGIO-ALDO S, V13, P282, DOI 10.1177/1470320311430991; Xiang SN, 2012, BIOMATERIALS, V33, P6520, DOI 10.1016/j.biomaterials.2012.05.044; Yang JP, 1997, GENE THER, V4, P950, DOI 10.1038/sj.gt.3300485; Yu HJ, 2009, CURR OPIN MOL THER, V11, P165; Zhang X, 2008, J BIOMED MATER RES A, V84A, P795, DOI 10.1002/jbm.a.31343; Zhong ZY, 2005, BIOMACROMOLECULES, V6, P3440, DOI 10.1021/bm050505n; Zuidam NJ, 2000, J DRUG TARGET, V8, P51, DOI 10.3109/10611860009009209	27	9	10	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e68651	10.1371/journal.pone.0068651	http://dx.doi.org/10.1371/journal.pone.0068651			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894329	Green Submitted, Green Published, gold			2022-12-27	WOS:000322391400018
J	Barret, M; Boustiere, C; Canard, JM; Arpurt, JP; Bernardini, D; Bulois, P; Chaussade, S; Heresbach, D; Joly, I; Lapuelle, J; Laugier, R; Lesur, G; Pienkowski, P; Ponchon, T; Pujol, B; Richard-Molard, B; Robaszkiewicz, M; Systchenko, R; Abbas, F; Schott-Pethelaz, AM; Cellier, C				Barret, Maximilien; Boustiere, Christian; Canard, Jean-Marc; Arpurt, Jean-Pierre; Bernardini, David; Bulois, Philippe; Chaussade, Stanislas; Heresbach, Denis; Joly, Isabelle; Lapuelle, Jean; Laugier, Rene; Lesur, Gilles; Pienkowski, Patrice; Ponchon, Thierry; Pujol, Bertrand; Richard-Molard, Bruno; Robaszkiewicz, Michel; Systchenko, Remi; Abbas, Fatima; Schott-Pethelaz, Anne-Marie; Cellier, Christophe		Soc Francaise Endoscopie Digestive	Factors Associated with Adenoma Detection Rate and Diagnosis of Polyps and Colorectal Cancer during Colonoscopy in France: Results of a Prospective, Nationwide Survey	PLOS ONE			English	Article							PROPOFOL SEDATION; PREVALENCE; GUIDELINES; SCREEN; RISK	Introduction: Colonoscopy can prevent deaths due to colorectal cancer (CRC) through early diagnosis or resection of colonic adenomas. We conducted a prospective, nationwide study on colonoscopy practice in France. Methods: An online questionnaire was administered to 2,600 French gastroenterologists. Data from all consecutive colonoscopies performed during one week were collected. A statistical extrapolation of the results to a whole year was performed, and factors potentially associated with the adenoma detection rate (ADR) or the diagnosis of polyps or cancer were assessed. Results: A total of 342 gastroenterologists, representative of the overall population of French gastroenterologists, provided data on 3,266 colonoscopies, corresponding to 1,200,529 (95% CI: 1,125,936-1,275,122) procedures for the year 2011. The indication for colonoscopy was CRC screening and digestive symptoms in 49.6% and 38.9% of cases, respectively. Polypectomy was performed in 35.5% of cases. The ADR and prevalence of CRC were 17.7% and 2.9%, respectively. The main factors associated with a high ADR were male gender (p=0.0001), age over 50 (p=0.0001), personal or family history of CRC or colorectal polyps (p<0.0001 and p<0.0001, respectively), and positive fecal occult blood test (p=0.0005). The prevalence of CRC was three times higher in patients with their first colonoscopy (4.2% vs. 1.4%; p<0.0001). Conclusions: For the first time in France, we report nationwide prospective data on colonoscopy practice, including histological results. We found an average ADR of 17.7%, and observed reduced CRC incidence in patients with previous colonoscopy.	[Barret, Maximilien; Canard, Jean-Marc; Cellier, Christophe] George Pompidou European Hosp, Dept Gastroenterol & Digest Endoscopy, Paris, France; [Barret, Maximilien; Canard, Jean-Marc; Cellier, Christophe] Fac Paris Descartes, Paris, France; [Boustiere, Christian] St Joseph Hosp, Dept Gastroenterol, Marseille, France; [Arpurt, Jean-Pierre] Henri Duffaut Hosp, Dept Gastroenterol, Avignon, France; [Bernardini, David] Toulon Font Pre Hosp, Dept Gastroenterol, Toulon, France; [Bulois, Philippe] Huriez Hosp, Dept Gastroenterol, Lille, France; [Chaussade, Stanislas] Cochin Hosp, Dept Gastroenterol, Paris, France; [Heresbach, Denis] Cannes Hosp, Dept Gastroenterol, Cannes, France; [Joly, Isabelle] St Brieuc Private Hosp, Dept Gastroenterol, St Brieuc, France; [Lapuelle, Jean] St Jean Languedoc Private Hosp, Dept Gastroenterol, Toulouse, France; [Laugier, Rene] La Timone Hosp, Dept Gastroenterol, Marseille, France; [Lesur, Gilles] Ambroise Pare Hosp, Dept Gastroenterol, Boulogne, France; [Pienkowski, Patrice] Le Pont Chaume Private Hosp, Dept Gastroenterol, Montauban, France; [Ponchon, Thierry] Hop Edouard Herriot, Dept Gastroenterol, Lyon, France; [Pujol, Bertrand] Jean Mermoz Private Hosp, Dept Gastroenterol, Lyon, France; [Richard-Molard, Bruno] St Martin Private Hosp, Dept Gastroenterol, Pessac, France; [Robaszkiewicz, Michel] La Cavale Blanche Univ Hosp, Dept Gastroenterol, Brest, France; [Abbas, Fatima; Schott-Pethelaz, Anne-Marie] Univ Lyon 1, Pole Informat Med Evaluat Rech, F-69365 Lyon, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; CHU Lyon; CHU Brest; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Cellier, C (corresponding author), George Pompidou European Hosp, Dept Gastroenterol & Digest Endoscopy, Paris, France.	christophe.cellier@egp.aphp.fr	Coriat, Romain/O-7902-2017; Barret, Maximilien/O-8341-2017	Barret, Maximilien/0000-0002-0566-7870; christophe, Cellier/0000-0003-0784-2318	Norgine, Amsterdam, the Netherlands	Norgine, Amsterdam, the Netherlands(Netherlands Government)	The study has received institutional support from Norgine, Amsterdam, the Netherlands (http://www.norgine.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler A, 2013, GUT; Autorite de Sante Haute(HAS), 2012, UID AFF LONG DUR TUM; Blanks RG, 2012, J MED SCREEN, V19, P72, DOI 10.1258/jms.2012.011148; Bowles CJA, 2004, GUT, V53, P277, DOI 10.1136/gut.2003.016436; Brenner H, 2010, GASTROENTEROLOGY, V138, P870, DOI 10.1053/j.gastro.2009.10.054; Caisse Nationale d'Assurance Maladie (CNAM), 2012, ET ASS MAL PRAT COL; Coriat R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033957; Denis B, 2011, GASTROINTEST ENDOSC, V74, P1325, DOI 10.1016/j.gie.2011.07.038; Ferlitsch M, 2011, JAMA-J AM MED ASSOC, V306, P1352, DOI 10.1001/jama.2011.1362; Gupta N, 2012, GASTROINTEST ENDOSC, V75, P1022, DOI 10.1016/j.gie.2012.01.020; Heuss LT, 2012, ENDOSCOPY, V44, P504, DOI 10.1055/s-0031-1291668; Institut National de Veille Sanitaire (INVS), 2012, TAUX PART PROGR DEP; Institut National du Cancer (INCA), 2012, SIT CANC FRANC 2011; Kaminski MF, 2010, NEW ENGL J MED, V362, P1795, DOI 10.1056/NEJMoa0907667; Khalid AB, 2011, ENDOSCOPY, V43, P692, DOI 10.1055/s-0030-1256356; Kim DH, 2007, NEW ENGL J MED, V357, P1403, DOI 10.1056/NEJMoa070543; Levy PS, 2008, SAMPLING POPULATIONS, V4th; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Marmo R, 2010, GASTROINTEST ENDOSC, V72, P313, DOI 10.1016/j.gie.2010.02.048; Michaud-Herbst A, 2011, CLIN RES HEPATOL GAS, V35, P839, DOI 10.1016/j.clinre.2011.07.016; Paggi S, 2012, ENDOSCOPY, V44, P899, DOI 10.1055/s-0032-1309891; Pickhardt PJ, 2003, NEW ENGL J MED, V349, P2191, DOI 10.1056/NEJMoa031618; Pox CP, 2012, GASTROENTEROLOGY, V142, P1460, DOI 10.1053/j.gastro.2012.03.022; Radaelli F, 2008, DIGEST LIVER DIS, V40, P897, DOI 10.1016/j.dld.2008.02.021; Repici A, 2011, WORLD J GASTROENTERO, V17, P3818, DOI 10.3748/wjg.v17.i33.3818; Rex DK, 2009, GASTROENTEROLOGY, V137, P1229, DOI 10.1053/j.gastro.2009.06.042; Rex DK, 2009, AM J GASTROENTEROL, V104, P739, DOI 10.1038/ajg.2009.104; Schoen RE, 2012, NEW ENGL J MED, V366, P2345, DOI 10.1056/NEJMoa1114635; Sieg A, 2007, Z GASTROENTEROL, V45, P697, DOI 10.1055/s-2007-963349; Van Gossum A, 2009, NEW ENGL J MED, V361, P264, DOI 10.1056/NEJMoa0806347; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370	31	32	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e68947	10.1371/journal.pone.0068947	http://dx.doi.org/10.1371/journal.pone.0068947			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874822	Green Submitted, Green Published, gold			2022-12-27	WOS:000324146200043
J	Boeykens, N; Ponsaerts, P; Van der Linden, A; Berneman, Z; Ysebaert, D; De Greef, K				Boeykens, Nele; Ponsaerts, Peter; Van der Linden, Annemie; Berneman, Zwi; Ysebaert, Dirk; De Greef, Kathleen			Injury-Dependent Retention of Intraportally Administered Mesenchymal Stromal Cells Following Partial Hepatectomy of Steatotic Liver Does Not Lead to Improved Liver Recovery	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; STEM-CELLS; FATTY LIVER; HEPATIC STEATOSIS; ANIMAL-MODELS; RISK-FACTOR; REGENERATION; TRANSPLANTATION; HEPATOCYTES; IMPLANTATION	The aim of this study was to evaluate the effect of bone marrow-derived mesenchymal stromal cell (BM-MSC) administration on liver function following partial hepatectomy (PHx) of methionine/choline-deficient (MCD) diet induced steatotic livers in rodents. Here we identified and validated serum cholinesterase (CHE) and triglyceride (TG) levels as non-invasive markers to longitudinally monitor rat liver function. Using in vivo bioluminescence imaging, retention of BM-MSC in the liver was observed following intraportal administration, but not after intravenous administration. Therefore, BM-MSC were intraportally delivered to investigate the effect on liver recovery and/or regeneration after PHx. However, despite recovery to normal body weight, liver weight and NAS score, both serum CHE and TG levels of non-treated and cell-treated rats with PHx after MCD diet remained significantly lower as compared to those of control rats. Importantly, serum CHE levels, but not TG levels, of cell-treated rats remained significantly lower as compared to those of non-treated rats, thereby warranting that certain caution should be considered for future clinical application of IP BM-MSC administration in order to promote liver regeneration and/or function.	[Boeykens, Nele; Ysebaert, Dirk; De Greef, Kathleen] Univ Antwerp, Univ Antwerp Hosp, Antwerp Surg Training & Res Ctr, Expt Surg Lab, B-2020 Antwerp, Belgium; [Ponsaerts, Peter; Berneman, Zwi] Univ Antwerp, Vaccine & Infect Dis Inst Vaxinfectio, Lab Expt Hematol, B-2020 Antwerp, Belgium; [Van der Linden, Annemie] Univ Antwerp, BioImaging Lab, B-2020 Antwerp, Belgium	University of Antwerp; University of Antwerp; University of Antwerp	Ysebaert, D (corresponding author), Univ Antwerp, Univ Antwerp Hosp, Antwerp Surg Training & Res Ctr, Expt Surg Lab, B-2020 Antwerp, Belgium.	Dirk.Ysebaert@uza.be	Ysebaert, Dirk/J-6800-2013; Van der Linden, Annemie/L-7855-2017; Ponsaerts, Peter/B-6213-2017	Ysebaert, Dirk/0000-0002-3350-6994; Van der Linden, Annemie/0000-0003-2941-6520; Ponsaerts, Peter/0000-0002-1892-6499	University of Antwerp; Flemish Institute for Science and Technology (IWT-Vlaanderen)	University of Antwerp; Flemish Institute for Science and Technology (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was supported by a BOF-NOI 2009 research grant from the University of Antwerp (granted to DY and KDG). NB holds a PhD-studentship from the Flemish Institute for Science and Technology (IWT-Vlaanderen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz MTA, 2007, CLIN BIOCHEM, V40, P893, DOI 10.1016/j.clinbiochem.2007.04.017; Benten D, 2005, HEPATOLOGY, V42, P140, DOI 10.1002/hep.20746; Bergwerf I, 2011, IMMUNOL CELL BIOL, V89, P511, DOI 10.1038/icb.2010.141; Bergwerf I, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-1; Boxall SA, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/975871; Cheng K, 2009, HEPATOLOGY, V50, P1194, DOI 10.1002/hep.23120; Cho KA, 2009, CELL BIOL INT, V33, P772, DOI 10.1016/j.cellbi.2009.04.023; De Vocht N, 2012, JOVE-J VIS EXP, DOI 10.3791/3906; De Vocht N, 2011, MOL IMAGING BIOL, V13, P1133, DOI 10.1007/s11307-011-0469-3; Everaert BR, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-93; Fisher RA, 2006, TRANSPLANTATION, V82, P441, DOI 10.1097/01.tp.0000231689.44266.ac; Fox IJ, 2004, AM J TRANSPLANT, V4, P7, DOI 10.1111/j.1600-6135.2004.0340.x; Garbow JR, 2004, MAGN RESON MED, V52, P177, DOI 10.1002/mrm.20107; Gomez D, 2007, BRIT J SURG, V94, P1395, DOI 10.1002/bjs.5820; Grompe M, 2001, J INHERIT METAB DIS, V24, P231, DOI 10.1023/A:1010375203539; Kaibori M, 2012, TRANSPL P, V44, P1107, DOI 10.1016/j.transproceed.2012.01.088; Kele PG, 2013, LIVER INT, V33, P469, DOI 10.1111/liv.12089; Kirsch R, 2003, J GASTROEN HEPATOL, V18, P1272, DOI 10.1046/j.1440-1746.2003.03198.x; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Koteish A, 2002, BEST PRACT RES CL GA, V16, P679, DOI 10.1053/bega.2002.0332; McCormack L, 2007, ANN SURG, V245, P923, DOI 10.1097/01.sla.0000251747.80025.b7; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Michalopoulos GK, 2010, AM J PATHOL, V176, P2, DOI 10.2353/ajpath.2010.090675; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Pelz S, 2012, EXP CELL RES, V318, P276, DOI 10.1016/j.yexcr.2011.11.005; Reekmans K, 2012, REGEN MED, V7, P245, DOI [10.2217/rme.12.5, 10.2217/RME.12.5]; Reekmans K, 2012, STEM CELL REV REP, V8, P262, DOI 10.1007/s12015-011-9266-2; Reekmans KP, 2011, CELL TRANSPLANT, V20, P851, DOI 10.3727/096368910X543411; Reumers V, 2008, STEM CELLS, V26, P2382, DOI 10.1634/stemcells.2007-1062; Romestaing C, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-4; Seki T, 2012, J SURG RES, V178, P63, DOI 10.1016/j.jss.2012.02.014; Selzner M, 2001, SEMIN LIVER DIS, V21, P105, DOI 10.1055/s-2001-12933; Stock P, 2010, NAT PROTOC, V5, P617, DOI 10.1038/nprot.2010.7; Stoppeler S, 2013, LAB ANIM-UK, V47, P43, DOI 10.1177/0023677212473717; Sydor S, 2013, LAB INVEST, V93, P20, DOI 10.1038/labinvest.2012.142; Takahashi Y, 2012, WORLD J GASTROENTERO, V18, P2300, DOI 10.3748/wjg.v18.i19.2300; Vetelainen R, 2007, BRIT J SURG, V94, P1002, DOI 10.1002/bjs.5672; Vetelainen R, 2007, ANN SURG, V245, P20, DOI 10.1097/01.sla.0000225113.88433.cf; Vetelainen R, 2007, ANN SURG, V245, P44, DOI 10.1097/01.sla.0000225253.84501.0e; Walldorf J, 2004, SCAND J GASTROENTERO, V39, P584, DOI 10.1080/00365520410005586; Yamaguchi K, 2010, LAB INVEST, V90, P1169, DOI 10.1038/labinvest.2010.75; Ysebaert DK, 2003, KIDNEY INT, V64, P864, DOI 10.1046/j.1523-1755.2003.00150.x; Zhang Z, 2012, J GASTROEN HEPATOL, V27, P112, DOI 10.1111/j.1440-1746.2011.07024.x	44	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e69092	10.1371/journal.pone.0069092	http://dx.doi.org/10.1371/journal.pone.0069092			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874878	Green Published, gold, Green Submitted			2022-12-27	WOS:000324146200056
J	Huang, YC; Liu, HL; Lee, JD; Yang, JT; Weng, HH; Lee, M; Yeh, MY; Tsai, YH				Huang, Yen-Chu; Liu, Ho-Ling; Lee, Jiann-Der; Yang, Jen-Tsung; Weng, Hsu-Huei; Lee, Meng; Yeh, Mei-Yu; Tsai, Yuan-Hsiung			Comparison of Arterial Spin Labeling and Dynamic Susceptibility Contrast Perfusion MRI in Patients with Acute Stroke	PLOS ONE			English	Article							DIFFUSION; TIME; REPERFUSION; ISCHEMIA; MISMATCH; PENUMBRA; DEFUSE; VOLUME; SIGNAL; MAPS	Background: The aim of this study was to evaluate whether arterial spin labeling (ASL) perfusion magnetic resonance imaging (MRI) can reliably quantify perfusion deficit as compared to dynamic susceptibility contrast (DSC) perfusion MRI. Methods: Thirty-nine patients with acute ischemic stroke in the anterior circulation territory were recruited. All underwent ASL and DSC MRI perfusion scans within 30 hours after stroke onset and 31 patients underwent follow-up MRI scans. ASL cerebral blood flow (CBF) and DSC time to maximum (T-max) maps were used to calculate the perfusion defects. The ASL CBF lesion volume was compared to the DSC T-max lesion volume by Pearson's correlation coefficient and likewise the ASL CBF and DSC T-max lesion volumes were compared to the final infarct sizes respectively. A repeated measures analysis of variance and least significant difference post hoc test was used to compare the mean lesion volumes among ASL CBF, DSC T-max > 4-6 s and final infarct. Results: Mean patient age was 72.6 years. The average time from stroke onset to MRI was 13.9 hours. The ASL lesion volume showed significant correlation with the DSC lesion volume for T-max > 4, 5 and 6 s (r = 0.81, 0.82 and 0.80; p < 0.001). However, the mean lesion volume of ASL (50.1 ml) was significantly larger than those for T-max > 5 s (29.2 ml, p < 0.01) and T-max > 6 s (21.8 ml, p < 0.001), while the mean lesion volumes for T-max > 5 or 6 s were close to mean final infarct size. Conclusion: Quantitative measurement of ASL perfusion is well correlated with DSC perfusion. However, ASL perfusion may overestimate the perfusion defects and therefore further refinement of the true penumbra threshold and improved ASL technique are necessary before applying ASL in therapeutic trials.	[Huang, Yen-Chu; Lee, Jiann-Der; Lee, Meng] Chang Gung Univ, Coll Med, Dept Neurol, Chang Gung Mem Hosp Chiayi, Tao Yuan, Taiwan; [Weng, Hsu-Huei; Yeh, Mei-Yu; Tsai, Yuan-Hsiung] Chang Gung Univ, Coll Med, Dept Diagnost Radiol, Chang Gung Mem Hosp Chiayi, Tao Yuan, Taiwan; [Yang, Jen-Tsung] Chang Gung Univ, Coll Med, Dept Neurosurg, Chang Gung Mem Hosp Chiayi, Tao Yuan, Taiwan; [Tsai, Yuan-Hsiung] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Liu, Ho-Ling] Chang Gung Univ, Dept Med Imaging & Radiol Sci, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; National Yang Ming Chiao Tung University; Chang Gung University	Tsai, YH (corresponding author), Chang Gung Univ, Coll Med, Dept Diagnost Radiol, Chang Gung Mem Hosp Chiayi, Tao Yuan, Taiwan.	russell.tsai@gmail.com	Huang, Yenchu/AAO-1140-2020; Weng, Hsu-Huei/N-8329-2014	Weng, Hsu-Huei/0000-0002-2020-8912	Chang Gung Memorial Hospital grants [CMRPG690451, CMRPG690452]	Chang Gung Memorial Hospital grants	Work was supported by Chang Gung Memorial Hospital grants CMRPG690451 and CMRPG690452. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers GW, 2006, ANN NEUROL, V60, P508, DOI 10.1002/ana.20976; Bokkers RPH, 2012, STROKE, V43, P1290, DOI 10.1161/STROKEAHA.110.589234; Davis SM, 2008, LANCET NEUROL, V7, P299, DOI 10.1016/S1474-4422(08)70044-9; Hacke W, 2009, LANCET NEUROL, V8, P141, DOI 10.1016/S1474-4422(08)70267-9; Hernandez DA, 2012, STROKE, V43, P753, DOI 10.1161/STROKEAHA.111.635979; Huck S, 2012, CLIN NEURORADIOL, V22, P29, DOI 10.1007/s00062-011-0126-x; Kleinman JT, 2012, STROKE, V43, P1556, DOI 10.1161/STROKEAHA.111.644971; Kudo K, PERFUSION MISMATCH A; Kudo K, 2010, RADIOLOGY, V254, P200, DOI 10.1148/radiol.254082000; Lansberg MG, 2012, LANCET NEUROL, V11, P860, DOI 10.1016/S1474-4422(12)70203-X; Luby M, 2006, STROKE, V37, P2951, DOI 10.1161/01.STR.0000249416.77132.1a; Ma H, 2012, INT J STROKE, V7, P74, DOI 10.1111/j.1747-4949.2011.00730.x; Maclntosh BJ, 2010, AM J NEURORADIOL, V31, P1892, DOI 10.3174/ajnr.A2008; Na DG, 2004, AM J NEURORADIOL, V25, P1331; Olivot JM, 2009, STROKE, V40, P469, DOI 10.1161/STROKEAHA.108.526954; Sasaki M, 2012, J STROKE CE IN PRESS; Sasaki M, 2011, J CEREBR BLOOD F MET, V31, P448, DOI 10.1038/jcbfm.2010.106; Schlaug G, 1999, NEUROLOGY, V53, P1528, DOI 10.1212/WNL.53.7.1528; Siewert B, 1997, NEUROLOGY, V48, P673, DOI 10.1212/WNL.48.3.673; Song RT, 2010, MAGN RESON MED, V64, P1352, DOI 10.1002/mrm.22532; Takasawa M, 2008, STROKE, V39, P870, DOI 10.1161/STROKEAHA.107.500090; van Gelderen P, 2008, MAGN RESON MED, V59, P788, DOI 10.1002/mrm.21515; van Osch MJP, 2009, MAGN RESON MED, V62, P165, DOI 10.1002/mrm.22002; Wang DJJ, 2012, STROKE, V43, P1018, DOI 10.1161/STROKEAHA.111.631929; Wang JJ, 2003, J MAGN RESON IMAGING, V18, P404, DOI 10.1002/jmri.10372; Wolf RL, 2003, J NEUROIMAGING, V13, P17, DOI 10.1177/105122842003013001002; Wolf RL, 2007, NEUROTHERAPEUTICS, V4, P346, DOI 10.1016/j.nurt.2007.04.005; Wong EC, 2006, MAGN RESON MED, V55, P1334, DOI 10.1002/mrm.20906; Zaharchuk G, 2012, STROKE, V43, P1843, DOI 10.1161/STROKEAHA.111.639773; Zaharchuk G, 2009, RADIOLOGY, V252, P797, DOI 10.1148/radiol.2523082018; Zaro-Weber O, 2010, STROKE, V41, P2817, DOI 10.1161/STROKEAHA.110.594432	31	27	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e69085	10.1371/journal.pone.0069085	http://dx.doi.org/10.1371/journal.pone.0069085			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874876	gold, Green Submitted, Green Published			2022-12-27	WOS:000322064300085
J	Li, YZ; Xu, JJ; Reilly, KH; Zhang, JM; Wei, HY; Jiang, YJ; Geng, WQ; Tang, WM; Shang, H				Li, Yongze; Xu, Junjie; Reilly, Kathleen H.; Zhang, Jianming; Wei, Hongyi; Jiang, Yongjun; Geng, Wenqing; Tang, Weiming; Shang, Hong			Prevalence of HIV and Syphilis Infection among High School and College Student MSM in China: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							MEN; SEX; HIV/AIDS	Objectives: The aim of this study is to systematically review the published studies and summarize the estimates of HIV and syphilis prevalences among high school and college student MSM in China in order to provide information for conducting targeted interventions. Methods: Pubmed, Chinese National Knowledge Infrastructure, Wanfang and Google Scholar databases were searched in January 2013 to identify relevant articles. Data of eligible citations were extracted by two reviewers. All analyses were performed using Comprehensive Meta-Analysis V2.0 and SPSS V17.0. Results: Twenty-four eligible studies (6 in English and 18 in Chinese), published between 2006 and 2012, with a total of 3083 student MSM participants, were included. The meta-analyses showed that the prevalences of HIV and syphilis among studied student MSM were 4.4% (95% CI: 3.0%, 6.4%) and 5.7% (95% CI: 4.8%, 6.7%), respectively. HIV prevalence increased over the study period (3.0% in 2003-2006; 4.5% in 2007-2008, and 6.8% in 2009-2010, trend test chi-square = 11.3, p = 0.001). Conclusions: Student MSM have become high-risk populations for HIV infection in China. The high prevalence of syphilis and the increasing HIV prevalence trend indicate the potential for a more severe HIV epidemic. Comprehensive intervention strategies that address condom promotion, syphilis detection and treatment, and health education need to be tailored to this vulnerable population to prevent HIV and syphilis infections.	[Li, Yongze; Xu, Junjie; Wei, Hongyi; Jiang, Yongjun; Geng, Wenqing; Shang, Hong] China Med Univ, Key Lab AIDS Immunol, Minist Hlth, Dept Lab Med,Hosp 1, Shenyang, Liaoning, Peoples R China; [Reilly, Kathleen H.] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Zhang, Jianming] China Med Univ, Dept Clin Epidemiol & Evidence Based Med, Hosp 1, Shenyang, Liaoning, Peoples R China; [Tang, Weiming] Univ Calif Los Angeles, Dept Epidemiol, Fielding Sch Publ Hlth, Los Angeles, CA USA	China Medical University; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; China Medical University; University of California System; University of California Los Angeles	Shang, H (corresponding author), China Med Univ, Key Lab AIDS Immunol, Minist Hlth, Dept Lab Med,Hosp 1, Shenyang, Liaoning, Peoples R China.	hongshang100@hotmail.com		LI, YONGZE/0000-0001-8782-3314; xu, junjie/0000-0003-4303-7295; Tang, Weiming/0000-0002-9026-707X	Mega Projects of National Science Research for the 12th Five-Year Plan [2012ZX10001-006]; National Natural Science Foundation [81001291]; Bill and Melinda Gates Foundation	Mega Projects of National Science Research for the 12th Five-Year Plan; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the Mega Projects of National Science Research for the 12th Five-Year Plan (2012ZX10001-006), National Natural Science Foundation (81001291), and The Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aibing M, 2007, CHIN J AIDS STD, V13, P60; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P731; CHEN S, 2007, PREV MED TRIB, V13, P772; Chow EPF, 2011, SEX TRANSM DIS, V38, P845, DOI 10.1097/OLQ.0b013e31821a4f43; Chow EPF, 2010, JAIDS-J ACQ IMM DEF, V55, pE32, DOI 10.1097/QAI.0b013e3181f3d3c1; Donenberg GR, 2006, J PEDIATR PSYCHOL, V31, P869, DOI 10.1093/jpepsy/jsj102; Du GY, 2011, CHIN J SCH HLTH, V32, P1312; Feng LianGui, 2010, Acta Academiae Medicinae Militaris Tertiae, V32, P2644; Fu LJ, 2007, DIS SURVEILLANCE, V12, P818; Gao L, 2009, SEX TRANSM INFECT, V85, P354, DOI 10.1136/sti.2008.034702; Guo XJ, 2011, CHIN J AIDS STD, V02, P178; He Q, 2006, AIDS BEHAV, V10, pS17, DOI 10.1007/s10461-006-9125-3; He QY, 2011, J PREV MED INF, V27, P890; Hoyos J, 2012, GAC SANIT, V26, P131, DOI 10.1016/j.gaceta.2011.07.009; Liu L, 2009, CURR HIV RES, V7, P390, DOI 10.2174/157016209788680642; Ma QQ, 2005, CHIN J PREV MED, V05, P411; Ministry of Education of the People's Republic of China, 2011, MIN ED REL 2010 NAT; Ministry of Health of the People's Republic of China, 2012, 2012 CHIN AIDS RESP; Muessig KE, 2010, SEX TRANSM DIS, V37, P214, DOI 10.1097/OLQ.0b013e3181d13d2b; OTTEN MW, 1994, AIDS, V8, P549, DOI 10.1097/00002030-199404000-00020; Ruan YH, 2007, SEX TRANSM DIS, V34, P592, DOI 10.1097/01.olq.0000253336.64324.ef; Shang H, 2012, NATURE, V485, P576, DOI 10.1038/485576a; State Council AIDS Working Committee Office China Ministry of Health UN Theme Group on HIV/AIDS in China, 2010, JOINT ASS HIV AIDS P; Su YZ, 2011, RES FACTORS ASS HIV; Tang L, 2006, DIS SURVEILL, V21, P625; Valleroy LA, 2000, JAMA-J AM MED ASSOC, V284, P198, DOI 10.1001/jama.284.2.198; Walker N, 2003, AIDS, V17, P2215, DOI 10.1097/00002030-200310170-00010; Wang LX, 2010, CHIN J EPIDEMIOL, V31, P2; Wei S, 2013, AIDS BEHAV, V17, P1151, DOI 10.1007/s10461-011-0110-0; Weinstock H, 1998, J ACQ IMMUN DEF SYND, V19, P506, DOI 10.1097/00042560-199812150-00010; Wong WCW, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-23; Wu Z, 2013, CLIN INFECT DIS; Wu Z, 2010, J ACQ IMMUN DEF SYND, V53, P1, DOI DOI 10.1097/QAI.0B013E3181C7D379; Xu JJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-287; Xu JJ, 2010, SEX TRANSM DIS, V37, P432, DOI 10.1097/OLQ.0b013e3181d13eed; Xu ZH, 2009, CHIN J PUBLIC HLTH, V15, P226; Yin Lu, 2007, Harm Reduct J, V4, P6, DOI 10.1186/1477-7517-4-6; Yun K, 2011, SEX TRANSM INFECT, V87, P563, DOI 10.1136/sextrans-2011-050079; Zhang HB., 2007, CHIN J AIDS STD, V13, P350; Zhang L, 2013, SEX TRANSM DIS, V40, P235, DOI 10.1097/OLQ.0b013e31827ca6b9; Zhang L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033748, 10.1371/journal.pone.0037211]; Zhang LL, 2010, SUBST USE MISUSE, V45, P2503, DOI 10.3109/10826084.2010.487234; Zhang XX, 2007, AIDS, V21, pS53, DOI 10.1097/01.aids.0000304697.39637.4c; Zheng JD, 2008, CHIN J AIDS STD, V03, P258; Zheng JD, 2008, STUDY HIV HIGH RISK; Zheng Jian-Dong, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P337; [周建波 Zhou Jianbo], 2012, [中国公共卫生, China Public Health], V28, P1031; Zhou Zhen-hai, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P273; 周超, 2010, [中华预防医学杂志, Chinese Journal of Preventive Medicine], V44, P461	49	33	45	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e69137	10.1371/journal.pone.0069137	http://dx.doi.org/10.1371/journal.pone.0069137			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	186SF	23874891	gold, Green Published, Green Submitted			2022-12-27	WOS:000322064300087
J	Braum, O; Klages, M; Fickenscher, H				Braum, Oliver; Klages, Michael; Fickenscher, Helmut			The Cationic Cytokine IL-26 Differentially Modulates Virus Infection in Culture	PLOS ONE			English	Article							VESICULAR STOMATITIS-VIRUS; GREEN FLUORESCENT PROTEIN; CRYSTAL-STRUCTURE; CUTTING EDGE; MULTIPLE-SCLEROSIS; EPITHELIAL-CELLS; INTERLEUKIN-10; IL-10; SUBFAMILY; FAMILY	Interleukin-26 (IL-26) belongs to the IL-10 cytokine family, is produced by activated T cells, and targets epithelial target cells for signal transduction. Here, we describe the IL-26 effects on the infection of culture cells with recombinant vesicular stomatitis virus (VSV), human cytomegalovirus (HCMV), and herpes simplex virus type 1 (HSV-1) expressing green fluorescent protein. After pre-incubation with recombinant IL-26 and at low multiplicity of infection, VSV showed strongly enhanced infection and replication rates as measured for infectivity, for transcript levels, and for protein expression. Control proteins did not affect VSV infection. The IL-26 effect was independent of the IL-26 receptor and neutralized by anti-IL-26 serum. Pre-incubation of VSV was much more efficient than pre-incubation of the target cells to enhance virus infection. IL-26 increased virus adsorption to target cells as shown by quantitative reverse-transcription PCR. In contrast, the infection of IL-26-treated human fibroblasts with HCMV was inhibited and the infection by HSV-1 was not altered by IL-26. Thus, IL-26 differentially modulates the infection by different enveloped viruses.	[Fickenscher, Helmut] Univ Kiel, Inst Infect Med, Kiel, Germany; Univ Med Ctr Schleswig Holstein, Kiel, Germany	University of Kiel; University of Kiel; Schleswig Holstein University Hospital	Fickenscher, H (corresponding author), Univ Kiel, Inst Infect Med, Kiel, Germany.	fickenscher@infmed.uni-kiel.de	Fickenscher, Helmut/J-9655-2019	Fickenscher, Helmut/0000-0003-0043-1153	Deutsche Forschungsgemeinschaft [SFB 617]; Excellence Center Inflammation at Interfaces, Kiel	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Center Inflammation at Interfaces, Kiel	This project was supported in parts by the research center grant SFB 617 of the Deutsche Forschungsgemeinschaft and by the Excellence Center Inflammation at Interfaces, Kiel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur JL, 2001, J VIROL, V75, P3885, DOI 10.1128/JVI.75.8.3885-3895.2001; BAILEY CA, 1984, VIROLOGY, V133, P111, DOI 10.1016/0042-6822(84)90429-X; Trivella DBB, 2010, CELL MOL LIFE SCI, V67, P2909, DOI 10.1007/s00018-010-0380-0; Blumberg H, 2001, CELL, V104, P9, DOI 10.1016/S0092-8674(01)00187-8; Boritz E, 1999, J VIROL, V73, P6937, DOI 10.1128/JVI.73.8.6937-6945.1999; Brand S, 2005, AM J PHYSIOL-GASTR L, V289, pG960, DOI 10.1152/ajpgi.00126.2005; BRAUM O, 2007, CLASS 2 CYTOKINES 20, P193; Braum Oliver, 2012, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V11, P221; Braum Oliver, 2006, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V5, P275, DOI 10.2174/187152306778017674; Carneiro FA, 2002, J VIROL, V76, P3756, DOI 10.1128/JVI.76.8.3756-3764.2002; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Chang CS, 2003, J BIOL CHEM, V278, P3308, DOI 10.1074/jbc.M208602200; Collins PL, 2012, GENES IMMUN, V13, P481, DOI 10.1038/gene.2012.22; Corvaisier M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001395; Crack LR, 2012, CLIN EXP DERMATOL, V37, P534, DOI 10.1111/j.1365-2230.2012.04305.x; Dalton KP, 2001, VIROLOGY, V279, P414, DOI 10.1006/viro.2000.0736; Dambacher J, 2009, GUT, V58, P1207, DOI 10.1136/gut.2007.130112; Dambacher J, 2008, CYTOKINE, V41, P209, DOI 10.1016/j.cyto.2007.11.016; Davis HE, 2002, BIOPHYS CHEM, V97, P159, DOI 10.1016/S0301-4622(02)00057-1; Davis HE, 2004, BIOPHYS J, V86, P1234, DOI 10.1016/S0006-3495(04)74197-1; Donnelly RP, 2010, CYTOKINE GROWTH F R, V21, P393, DOI 10.1016/j.cytogfr.2010.09.001; Donnelly RP, 2004, J LEUKOCYTE BIOL, V76, P314, DOI 10.1189/jlb.0204117; Doyle SE, 2006, HEPATOLOGY, V44, P896, DOI 10.1002/hep.21312; Dumoutier L, 2003, BIOCHEM J, V370, P391, DOI 10.1042/BJ20021935; Dumoutier L, 2001, J IMMUNOL, V167, P3545, DOI 10.4049/jimmunol.167.7.3545; Dumoutier L, 2000, GENES IMMUN, V1, P488, DOI 10.1038/sj.gene.6363716; Esendagli G, 2013, J NEUROIMMUNOL, V255, P81, DOI 10.1016/j.jneuroim.2012.10.009; Fickenscher H, 2002, TRENDS IMMUNOL, V23, P89, DOI 10.1016/S1471-4906(01)02149-4; Fickenscher H, 2004, INT IMMUNOPHARMACOL, V4, P609, DOI 10.1016/j.intimp.2004.01.004; Friedrich M, 2003, J INVEST DERMATOL, V121, P845, DOI 10.1046/j.1523-1747.2003.12482.x; Goris A, 2002, GENES IMMUN, V3, P470, DOI 10.1038/sj.gene.6363913; Goris A, 2001, GENES IMMUN, V2, P284, DOI 10.1038/sj.gene.6363772; Hazrati E, 2006, J IMMUNOL, V177, P8658, DOI 10.4049/jimmunol.177.12.8658; Hor S, 2004, J BIOL CHEM, V279, P33343, DOI 10.1074/jbc.M405000200; Hughes T, 2009, BLOOD, V113, P4008, DOI 10.1182/blood-2008-12-192443; Hummelshoj L, 2006, SCAND J IMMUNOL, V64, P40, DOI 10.1111/j.1365-3083.2006.01773.x; Janssens Nico, 2004, Mol Diagn, V8, P107, DOI 10.2165/00066982-200408020-00005; Johannsdottir HK, 2009, J VIROL, V83, P440, DOI 10.1128/JVI.01864-08; Knappe A, 2000, J VIROL, V74, P3881, DOI 10.1128/JVI.74.8.3881-3887.2000; Kotenko SV, 2011, CURR OPIN IMMUNOL, V23, P583, DOI 10.1016/j.coi.2011.07.007; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Lallemand C, 2007, ONCOGENE, V26, P328, DOI 10.1038/sj.onc.1209795; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Marschall M, 2000, ANTIMICROB AGENTS CH, V44, P1588, DOI 10.1128/AAC.44.6.1588-1597.2000; Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014; Nagalakshmi ML, 2004, INT IMMUNOPHARMACOL, V4, P577, DOI 10.1016/j.intimp.2004.01.007; Nagem RAP, 2002, STRUCTURE, V10, P1051, DOI 10.1016/S0969-2126(02)00797-9; Novak JP, 2002, J BIOL CHEM, V277, P47517, DOI 10.1074/jbc.M205114200; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Renauld JC, 2003, NAT REV IMMUNOL, V3, P667, DOI 10.1038/nri1153; Roan NR, 2009, J VIROL, V83, P73, DOI 10.1128/JVI.01366-08; Sa SM, 2007, J IMMUNOL, V178, P2229, DOI 10.4049/jimmunol.178.4.2229; Sedwick Caitlin, 2012, PLoS Biol, V10, pe1001398, DOI 10.1371/journal.pbio.1001398; Sheikh F, 2004, J IMMUNOL, V172, P2006, DOI 10.4049/jimmunol.172.4.2006; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Silverberg MS, 2009, NAT GENET, V41, P216, DOI 10.1038/ng.275; Stojdl DF, 2000, NAT MED, V6, P821, DOI 10.1038/77558; Vandenbroeck K, 2003, ARTHRITIS RHEUM-US, V48, P2773, DOI 10.1002/art.11236; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Witte K, 2010, CYTOKINE GROWTH F R, V21, P237, DOI 10.1016/j.cytogfr.2010.04.002; Wolk K, 2002, J IMMUNOL, V168, P5397, DOI 10.4049/jimmunol.168.11.5397; Wolk K, 2008, J LEUKOCYTE BIOL, V83, P1181, DOI 10.1189/jlb.0807525; Xu T, 2005, ACTA CRYSTALLOGR D, V61, P942, DOI 10.1107/S0907444905009601; Yoon SI, 2006, J BIOL CHEM, V281, P35088, DOI 10.1074/jbc.M606791200; Zdanov A, 1996, PROTEIN SCI, V5, P1955, DOI 10.1002/pro.5560051001; ZDANOV A, 1995, STRUCTURE, V3, P591, DOI 10.1016/S0969-2126(01)00193-9	66	18	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e70281	10.1371/journal.pone.0070281	http://dx.doi.org/10.1371/journal.pone.0070281			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23875025	gold, Green Published, Green Submitted			2022-12-27	WOS:000321765300084
J	Hou, X; Wei, JC; Wu, JX; Wang, X; Fu, JH; Lin, P; Yang, HX				Hou, Xue; Wei, Jin-Chang; Wu, Jing-Xun; Wang, Xin; Fu, Jian-Hua; Lin, Peng; Yang, Hao-Xian			Multidisciplinary Modalities Achieve Encouraging Long-Term Survival in Resectable Limited-Disease Esophageal Small Cell Carcinoma	PLOS ONE			English	Article							COUNCIL COMPARATIVE TRIAL; LUNG-CANCER; CLINICOPATHOLOGICAL FEATURES; FOLLOW-UP; SURGERY; RADIOTHERAPY; EXPERIENCE; MANAGEMENT; PROGNOSIS; BRONCHUS	Background: The management of limited-disease esophageal small cell carcinoma is not well defined, and the role of surgery is still controversial. We aim to determine the optimal treatment strategy in limited-disease of esophageal small cell carcinoma. Methods and Findings: We conducted a retrospective review of 141 patients with limited-disease esophageal small cell carcinoma from 3 institutions in China who underwent treatment between July 1994 and September 2008, July 1994 and July 2011, and June 2004 and December 2010, respectively. The survival rate was calculated by the Kaplan-Meier method, and the log-rank test was used to assess the survival differences between the groups. Cox proportional hazards model were used to further determine the independent factors impacting overall survival. The median survival time was 16.1 months for the entire cohort of patients, with a 5-year survival rate of 6.7%. The median survival times for surgery alone, surgery combined with chemotherapy, surgery combined with radiotherapy, surgery combined with chemotherapy and radiotherapy, chemotherapy plus radiotherapy, and chemotherapy alone were 18.0 months, 15.0 months, 23.0 months, 25.0 months, 17.1 months, and 6.1 months, respectively; the corresponding 5-year survival rates were 0%, 15.4%, 0%, 38.9%, 0%, and 0%, respectively. For the 105 patients who underwent R0 resection, the median disease-free survival time was 12.0 months, with a 95% confidence interval of 9.5 months to 14.5 months. The multivariate Cox regression analysis demonstrated that advanced pathological staging (p = 0.003), and pure esophageal small cell carcinoma (p = 0.035) were independent factors decreasing overall survival. Conclusions: Our data suggested that multidisciplinary modalities achieved encouraging long-term survival in patients with resectable limited-disease of esophageal small cell carcinoma.	[Hou, Xue] Sun Yat Sen Univ, Dept Med Oncol, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Hou, Xue; Wang, Xin; Fu, Jian-Hua; Lin, Peng; Yang, Hao-Xian] State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Wei, Jin-Chang] Linzhou Esophageal Canc Hosp, Dept Thorac Surg, Linzhou City, Henan Province, Peoples R China; [Wu, Jing-Xun] Xiamen Univ, Affiliated Hosp 1, Dept Med Oncol, Xiamen, Fujian Province, Peoples R China; [Wang, Xin; Fu, Jian-Hua; Lin, Peng; Yang, Hao-Xian] Sun Yat Sen Univ, Dept Thorac Surg, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Xiamen University; Sun Yat Sen University	Yang, HX (corresponding author), State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China.	yanghx@sysucc.org.cn			Young Scientists Fund of the National Natural Science Foundation of China [81000935]; Young Teachers' Training Program of Sun Yat-sen University [11ykpy59]; Guangdong Provincial Science and Technology Planning Foundation [2011B031800179]	Young Scientists Fund of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Teachers' Training Program of Sun Yat-sen University; Guangdong Provincial Science and Technology Planning Foundation	This study was partly supported by the Young Scientists Fund of the National Natural Science Foundation of China (81000935), the Young Teachers' Training Program of Sun Yat-sen University (11ykpy59), and Guangdong Provincial Science and Technology Planning Foundation (2011B031800179). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEYER KL, 1991, J CLIN GASTROENTEROL, V13, P135, DOI 10.1097/00004836-199104000-00004; Brenner B, 2007, SEMIN ONCOL, V34, P43, DOI 10.1053/j.seminoncol.2006.10.022; Capella C, 2000, WHO CLASSIFICATION T, P26; Casas F, 1997, CANCER, V80, P1366, DOI 10.1002/(SICI)1097-0142(19971015)80:8<1366::AID-CNCR2>3.3.CO;2-3; Chen SB, 2011, DIS ESOPHAGUS, V24, P114, DOI 10.1111/j.1442-2050.2010.01112.x; FOX W, 1973, LANCET, V2, P63; HO KJ, 1984, HUM PATHOL, V15, P460, DOI 10.1016/S0046-8177(84)80081-7; Hosokawa A, 2005, HEPATO-GASTROENTEROL, V52, P1738; Inoue M, 2000, ANN THORAC SURG, V70, P1615, DOI 10.1016/S0003-4975(00)01401-6; Jatoi A, 2008, J THORAC ONCOL, V3, P1373, DOI 10.1097/JTO.0b013e31818dd98f; Koide N, 2007, J GASTROENTEROL, V42, P932, DOI 10.1007/s00535-007-2114-0; Ku GY, 2008, ANN ONCOL, V19, P533, DOI 10.1093/annonc/mdm476; Kuo CH, 2011, ANN THORAC SURG, V91, P373, DOI 10.1016/j.athoracsur.2010.09.030; LAD T, 1994, CHEST, V106, pS320, DOI 10.1378/chest.106.6.320S; LAW SYK, 1994, CANCER, V73, P2894, DOI 10.1002/1097-0142(19940615)73:12<2894::AID-CNCR2820731204>3.0.CO;2-M; Lu J, 2010, DIS ESOPHAGUS, V23, P153, DOI 10.1111/j.1442-2050.2009.00981.x; Lv JM, 2008, J THORAC ONCOL, V3, P1460, DOI 10.1097/JTO.0b013e31818e1247; Medgyesy DC, 2000, CANCER-AM CANCER SOC, V88, P262; Micke P, 2000, LUNG CANCER, V37, P271; MILLER AB, 1969, LANCET, V2, P501; Nakajima Y, 2012, INT J CLIN ONCOL, V17, P610, DOI 10.1007/s10147-011-0332-1; NICHOLS GL, 1989, CANCER, V64, P1531, DOI 10.1002/1097-0142(19891001)64:7<1531::AID-CNCR2820640729>3.0.CO;2-0; Rice TW, 2009, AJCC CANC STAGING MA, P103; Sun KL, 2007, CHINESE MED J-PEKING, V120, P355, DOI 10.1097/00029330-200703010-00001; Tanaka T, 2010, DIS ESOPHAGUS, V23, P502, DOI 10.1111/j.1442-2050.2009.01045.x; TENNVALL J, 1990, EUR J SURG ONCOL, V16, P109; Vos B, 2011, DIS ESOPHAGUS, V24, P258, DOI 10.1111/j.1442-2050.2010.01133.x; Yun JP, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-38	28	41	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e69259	10.1371/journal.pone.0069259	http://dx.doi.org/10.1371/journal.pone.0069259			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874925	Green Published, Green Submitted, gold			2022-12-27	WOS:000321736900143
J	Ogawa, K; Hirooka, Y; Kishi, T; Ide, T; Sunagawa, K				Ogawa, Kiyohiro; Hirooka, Yoshitaka; Kishi, Takuya; Ide, Tomomi; Sunagawa, Kenji			Partially Silencing Brain Toll-Like Receptor 4 Prevents in Part Left Ventricular Remodeling with Sympathoinhibition in Rats with Myocardial Infarction-Induced Heart Failure	PLOS ONE			English	Article							HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; ROSTRAL VENTROLATERAL MEDULLA; SYMPATHETIC-NERVOUS-SYSTEM; RENIN-ANGIOTENSIN SYSTEM; NITRIC-OXIDE SYNTHASE; CARDIAC FIBROSIS; OVEREXPRESSION; INFLAMMATION; CARVEDILOL; TRIAL	Background: Left ventricular (LV) remodeling and activation of sympathetic nervous system (SNS) are cardinal features of heart failure. We previously demonstrated that enhanced central sympathetic outflow is associated with brain toll-like receptor 4 (TLR4) probably mediated by brain angiotensin II type 1 receptor in mice with myocardial infarction (MI)-induced heart failure. The purpose of the present study was to examine whether silencing brain TLR4 could prevent LV remodeling with sympathoinhibition in MI-induced heart failure. Methodology/Principal Findings: MI-induced heart failure model rats were created by ligation of left coronary artery. The expression level of TLR4 in brainstem was significantly higher in MI-induced heart failure treated with intracerebroventricular (ICV) injection of hGAPDH-SiRNA than in sham. TLR4 in brainstem was significantly lower in MI-induced heart failure treated with ICV injection of TLR4-SiRNA than in that treated with ICV injection of hGAPDH-SiRNA. Lung weight, urinary norepinephrine excretion, and LV end-diastolic pressure were significantly lower and LV dimension was significantly smaller in MI-induced heart failure treated with TLR4-SiRNA than in that treated with hGAPDH-SiRNA for 2 weeks. Conclusions: Partially silencing brain TLR4 by ICV injection of TLR4-SiRNA for 2 weeks could in part prevent LV remodeling with sympathoinhibition in rats with MI-induced heart failure. Brain TLR4 has a potential to be a target of the treatment for MI-induced heart failure.	[Ogawa, Kiyohiro; Ide, Tomomi; Sunagawa, Kenji] Kyushu Univ, Dept Cardiovasc Med, Grad Sch Med Sci, Fukuoka 812, Japan; [Hirooka, Yoshitaka; Kishi, Takuya] Kyushu Univ, Grad Sch Med Sci, Fukuoka 812, Japan	Kyushu University; Kyushu University	Hirooka, Y (corresponding author), Kyushu Univ, Grad Sch Med Sci, Fukuoka 812, Japan.	hyoshi@cardiol.med.kyushu-u.ac.jp			Japan Society for the Promotion of Science [B193290231, B24390198]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (B193290231, B24390198). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Brouri F, 2004, EUR J PHARMACOL, V485, P227, DOI 10.1016/j.ejphar.2003.11.063; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; Dargie HJ, 2001, LANCET, V357, P1385, DOI 10.1016/s0140-6736(00)04560-8; Felder RB, 2003, AM J PHYSIOL-REG I, V284, pR259, DOI 10.1152/ajpregu.00317.2002; FERGUSON DW, 1990, J AM COLL CARDIOL, V16, P1125, DOI 10.1016/0735-1097(90)90544-Y; FRANCIS GS, 1989, AM HEART J, V118, P642, DOI 10.1016/0002-8703(89)90291-3; GUERET P, 1981, CATHETER CARDIO DIAG, V7, P247, DOI 10.1002/ccd.1810070304; Hjalmarson A, 1999, LANCET, V353, P2001; Huang BS, 2005, AM J PHYSIOL-HEART C, V288, pH2491, DOI 10.1152/ajpheart.00840.2004; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Kang YM, 2008, CARDIOVASC RES, V79, P671, DOI 10.1093/cvr/cvn119; Kang YM, 2008, AM J PHYSIOL-HEART C, V295, pH227, DOI 10.1152/ajpheart.01157.2007; Kimura Y, 2005, CIRC RES, V96, P252, DOI 10.1161/01.RES.0000152965.75127.9d; Kishi T, 2002, HYPERTENSION, V39, P264, DOI 10.1161/hy0202.102701; Kishi T, 2001, HYPERTENSION, V38, P896, DOI 10.1161/hyp.38.4.896; Kishi T, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/847172; Lindley TE, 2004, CIRC RES, V94, P402, DOI 10.1161/01.RES.0000112964.40701.93; Liu JL, 1999, CIRC RES, V84, P417, DOI 10.1161/01.RES.84.4.417; MEREDITH IT, 1993, CIRCULATION, V88, P136, DOI 10.1161/01.CIR.88.1.136; Niizeki T, 2008, AM J CARDIOL, V102, P606, DOI 10.1016/j.amjcard.2008.04.030; Ogawa K, 2011, J CARDIOVASC PHARM, V58, P543, DOI 10.1097/FJC.0b013e31822e6b40; Packer M, 2002, CIRCULATION, V106, P2194, DOI 10.1161/01.CIR.0000035653.72855.BF; PACKER M, 1992, J AM COLL CARDIOL, V20, P248, DOI 10.1016/0735-1097(92)90167-L; Patel K P, 2000, Heart Fail Rev, V5, P73, DOI 10.1023/A:1009850224802; Poole-Wilson PA, 2003, LANCET, V362, P7, DOI 10.1016/S0140-6736(03)13800-7; Shi P, 2010, CLIN EXP PHARMACOL P, V37, pE52, DOI 10.1111/j.1440-1681.2009.05234.x; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Timmers L, 2008, CIRC RES, V102, P257, DOI 10.1161/CIRCRESAHA.107.158220; Trost SU, 2002, DIABETES, V51, P1166, DOI 10.2337/diabetes.51.4.1166; Willenheimer R, 2005, CIRCULATION, V112, P2426, DOI 10.1161/CIRCULATIONAHA.105.582320; Yu Y, 2012, HYPERTENSION, V59, P477, DOI 10.1161/HYPERTENSIONAHA.111.182345; Yu Y, 2010, HYPERTENSION, V55, P652, DOI 10.1161/HYPERTENSIONAHA.109.142836; Zhang RX, 2010, HYPERTENSION, V55, P953, DOI 10.1161/HYPERTENSIONAHA.109.140608; Zhang ZH, 2010, J HYPERTENS, V28, P806, DOI 10.1097/HJH.0b013e3283358b6e	35	12	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e69053	10.1371/journal.pone.0069053	http://dx.doi.org/10.1371/journal.pone.0069053			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874864	Green Published, Green Submitted, gold			2022-12-27	WOS:000321736900132
J	McEvoy, J; Baillie, RA; Zhu, HJ; Buckley, P; Keshavan, MS; Nasrallah, HA; Dougherty, GG; Yao, JK; Kaddurah-Daouk, R				McEvoy, Joseph; Baillie, Rebecca A.; Zhu, Hongjie; Buckley, Peter; Keshavan, Matcheri S.; Nasrallah, Henry A.; Dougherty, George G.; Yao, Jeffrey K.; Kaddurah-Daouk, Rima			Lipidomics Reveals Early Metabolic Changes in Subjects with Schizophrenia: Effects of Atypical Antipsychotics	PLOS ONE			English	Article							FATTY-ACIDS; SEROTONIN	There is a critical need for mapping early metabolic changes in schizophrenia to capture failures in regulation of biochemical pathways and networks. This information could provide valuable insights about disease mechanisms, trajectory of disease progression, and diagnostic biomarkers. We used a lipidomics platform to measure individual lipid species in 20 drug-naive patients with a first episode of schizophrenia (FE group), 20 patients with chronic schizophrenia that had not adhered to prescribed medications (RE group), and 29 race-matched control subjects without schizophrenia. Lipid metabolic profiles were evaluated and compared between study groups and within groups before and after treatment with atypical antipsychotics, risperidone and aripiprazole. Finally, we mapped lipid profiles to n3 and n6 fatty acid synthesis pathways to elucidate which enzymes might be affected by disease and treatment. Compared to controls, the FE group showed significant down-regulation of several n3 polyunsaturated fatty acids (PUFAs), including 20:5n3, 22:5n3, and 22:6n3 within the phosphatidylcholine and phosphatidylethanolamine lipid classes. Differences between FE and controls were only observed in the n3 class PUFAs; no differences where noted in n6 class PUFAs. The RE group was not significantly different from controls, although some compositional differences within PUFAs were noted. Drug treatment was able to correct the aberrant PUFA levels noted in FE patients, but changes in re patients were not corrective. Treatment caused increases in both n3 and n6 class lipids. These results supported the hypothesis that phospholipid n3 fatty acid deficits are present early in the course of schizophrenia and tend not to persist throughout its course. These changes in lipid metabolism could indicate a metabolic vulnerability in patients with schizophrenia that occurs early in development of the disease.	[McEvoy, Joseph; Zhu, Hongjie; Kaddurah-Daouk, Rima] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27708 USA; [Baillie, Rebecca A.] Rosa & Co LLC, San Carlos, CA USA; [Buckley, Peter] Med Coll Georgia, Augusta, GA 30912 USA; [Keshavan, Matcheri S.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Keshavan, Matcheri S.] Harvard Univ, Sch Med, Boston, MA USA; [Nasrallah, Henry A.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Yao, Jeffrey K.] VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA; [Dougherty, George G.; Yao, Jeffrey K.] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA	Duke University; University System of Georgia; Augusta University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kaddurah-Daouk, R (corresponding author), Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27708 USA.	kaddu001@mc.duke.edu	baillie, rebecca/AAQ-3400-2020	baillie, rebecca/0000-0003-3966-6320; Kaddurah-Daouk, Rima/0000-0003-1858-5732	National Institute of Mental Health (NIMH) [1R01MH084941-01A2]; Department of Veterans Affairs Senior Research Career Scientist Award; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084941] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Department of Veterans Affairs Senior Research Career Scientist Award(US Department of Veterans Affairs); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding for this study was provided by National Institute of Mental Health (NIMH) Grant # 1R01MH084941-01A2 (RKD) and the Department of Veterans Affairs Senior Research Career Scientist Award (JKY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amminger GP, 2010, ARCH GEN PSYCHIAT, V67, P146, DOI 10.1001/archgenpsychiatry.2009.192; Arvindakshan M, 2003, BIOL PSYCHIAT, V53, P56, DOI 10.1016/S0006-3223(02)01443-9; Dervola KS, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-56; Du Bois TM, 2006, NEUROSCIENCE, V139, P1397, DOI 10.1016/j.neuroscience.2006.02.068; Glen AIM, 1996, PROSTAG LEUKOTR ESS, V55, P9, DOI 10.1016/S0952-3278(96)90139-8; Hibbeln JR, 1998, BIOL PSYCHIAT, V44, P243, DOI 10.1016/S0006-3223(98)00143-7; HORROBIN DF, 1999, PHOSPHOLIPID SPECTRU, P113; KESHAVAN MS, 1993, PSYCHIAT RES, V49, P89, DOI 10.1016/0165-1781(93)90032-C; Ohara K, 2007, PROG NEURO-PSYCHOPH, V31, P469, DOI 10.1016/j.pnpbp.2006.11.013; Potwarka JJ, 1999, BIOL PSYCHIAT, V45, P687, DOI 10.1016/S0006-3223(98)00136-X; Rice DP, 1999, J CLIN PSYCHIAT, V60, P4; Strassnig M, 2005, SCHIZOPHR RES, V76, P343, DOI 10.1016/j.schres.2005.03.002; Sumiyoshi T, 2011, PSYCHIAT RES, V186, P23, DOI 10.1016/j.psychres.2010.07.049; Watkins SM, 2002, J LIPID RES, V43, P1809, DOI 10.1194/jlr.M200169-JLR200; Wood SJ, 2010, PSYCHIAT RES-NEUROIM, V182, P180, DOI 10.1016/j.pscychresns.2009.12.003; Yao JK, 2004, PROSTAG LEUKOTR ESS, V71, P171, DOI 10.1016/j.plefa.2004.03.011; Yao JK, 2000, SCHIZOPHR RES, V42, P7, DOI 10.1016/S0920-9964(99)00095-X	17	78	82	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e68717	10.1371/journal.pone.0068717	http://dx.doi.org/10.1371/journal.pone.0068717			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894336	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000322167900022
J	Yao, J; de la Iglesia, HO; Bajjalieh, SM				Yao, Jia; de la Iglesia, Horacio O.; Bajjalieh, Sandra M.			Loss of the SV2-like Protein SVOP Produces No Apparent Deficits in Laboratory Mice	PLOS ONE			English	Article							SYNAPTIC VESICLE PROTEIN; NEUROTRANSMITTER RELEASE; SECRETORY VESICLES; SV2; PROBABILITY; EXPRESSION; SYNAPSES; MOTOR; IDENTIFICATION; SYNAPTOTAGMIN	Neurons express two families of transporter-like proteins - Synaptic Vesicle protein 2 (SV2A, B, and C) and SV2-related proteins (SVOP and SVOPL). Both families share structural similarity with the Major Facilitator (MF) family of transporters. SV2 is present in all neurons and endocrine cells, consistent with it playing a key role in regulated exocytosis. Like SV2, SVOP is expressed in all brain regions, with highest levels in cerebellum, hindbrain and pineal gland. Furthermore, SVOP is expressed earlier in development than SV2 and is one of the neuronal proteins whose expression declines most during aging. Although SV2 is essential for survival, it is not required for development. Because significant levels of neurotransmission remain in the absence of SV2 it has been proposed that SVOP performs a function similar to that of SV2 that mitigates the phenotype of SV2 knockout mice. To test this, we generated SVOP knockout mice and SVOP/SV2A/SV2B triple knockout mice. Mice lacking SVOP are viable, fertile and phenotypically normal. Measures of neurotransmission and behaviors dependent on the cerebellum and pineal gland revealed no measurable phenotype. SVOP/SV2A/SV2B triple knockout mice did not display a phenotype more severe than mice harboring the SV2A/SV2B gene deletions. These findings support the interpretation that SVOP performs a unique, though subtle, function that is not necessary for survival under normal conditions.	[Yao, Jia; Bajjalieh, Sandra M.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [de la Iglesia, Horacio O.] Univ Washington, Dept Biol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Bajjalieh, SM (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	bajjalie@uw.edu		Yao, Jia/0000-0003-3235-5351	National Institute of Neurological Disorders and Stroke [5R03NS065941]; National Institute for Mental Health [R01MH059842]	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute for Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institute of Neurological Disorders and Stroke grant 5R03NS065941 (to SMB) and National Institute for Mental Health Grant R01MH059842 (to SMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAJJALIEH SM, 1992, SCIENCE, V257, P1271, DOI 10.1126/science.1519064; Brooks SP, 2009, NAT REV NEUROSCI, V10, P519, DOI 10.1038/nrn2652; BUCKLEY K, 1985, J CELL BIOL, V100, P1284, DOI 10.1083/jcb.100.4.1284; Burre J, 2006, PROTEOMICS, V6, P6250, DOI 10.1002/pmic.200600357; CASSONE VM, 1988, AM J PHYSIOL, V255, pR332, DOI 10.1152/ajpregu.1988.255.2.R332; Chang WP, 2009, J NEUROSCI, V29, P883, DOI 10.1523/JNEUROSCI.4521-08.2009; Crowder KM, 1999, P NATL ACAD SCI USA, V96, P15268, DOI 10.1073/pnas.96.26.15268; Custer KL, 2006, J NEUROSCI, V26, P1303, DOI 10.1523/JNEUROSCI.2699-05.2006; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Dobrunz LE, 2002, INT J DEV NEUROSCI, V20, P225, DOI 10.1016/S0736-5748(02)00015-1; Fahlstrom A, 2011, NEUROBIOL AGING, V32, P1868, DOI 10.1016/j.neurobiolaging.2009.11.003; FEANY MB, 1992, CELL, V70, P861, DOI 10.1016/0092-8674(92)90319-8; Feillet CA, 2008, EUR J NEUROSCI, V28, P2451, DOI 10.1111/j.1460-9568.2008.06538.x; Fetsko LA, 2005, NEUROBIOL AGING, V26, P521, DOI 10.1016/j.neurobiolaging.2004.04.005; George SHL, 2007, P NATL ACAD SCI USA, V104, P4455, DOI 10.1073/pnas.0609277104; Hong MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003024; Jacobsson JA, 2007, GENOMICS, V90, P595, DOI 10.1016/j.ygeno.2007.03.017; JANICKE B, 1983, EXP GERONTOL, V18, P393, DOI 10.1016/0531-5565(83)90018-9; Janz R, 1998, J NEUROSCI, V18, P9269; Janz R, 1999, NEURON, V24, P1003, DOI 10.1016/S0896-6273(00)81046-6; Kadish I, 2009, J NEUROSCI, V29, P1805, DOI 10.1523/JNEUROSCI.4599-08.2009; Kermath BA, 2012, NEUROENDOCRINOLOGY, V96, P1, DOI 10.1159/000335994; Logan MA, 2005, DEV DYNAM, V234, P802, DOI 10.1002/dvdy.20618; Lynch BA, 2004, P NATL ACAD SCI USA, V101, P9861, DOI 10.1073/pnas.0308208101; McMahon HT, 1996, P NATL ACAD SCI USA, V93, P4760, DOI 10.1073/pnas.93.10.4760; Morciano M, 2005, J NEUROCHEM, V95, P1732, DOI 10.1111/j.1471-4159.2005.03506.x; Morgans CW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005230; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Pevet P, 2011, J PHYSIOL-PARIS, V105, P170, DOI 10.1016/j.jphysparis.2011.07.001; Schivell AE, 1996, J BIOL CHEM, V271, P27770, DOI 10.1074/jbc.271.44.27770; Schrimpf SP, 2005, PROTEOMICS, V5, P2531, DOI 10.1002/pmic.200401198; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Wan QF, 2010, NEURON, V66, P884, DOI 10.1016/j.neuron.2010.05.010; Xu T, 2001, NAT CELL BIOL, V3, P691, DOI 10.1038/35087000; Yao J, 2008, J BIOL CHEM, V283, P20628, DOI 10.1074/jbc.M800738200; Yao J, 2010, J NEUROSCI, V30, P5569, DOI 10.1523/JNEUROSCI.4781-09.2010; Yao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005315	38	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e68215	10.1371/journal.pone.0068215	http://dx.doi.org/10.1371/journal.pone.0068215			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894296	gold, Green Submitted, Green Published			2022-12-27	WOS:000322167900009
J	Lindahl, P; Sall, T; Bjartell, A; Johansson, AM; Lilja, H; Hallden, C				Lindahl, Pernilla; Sall, Torbjorn; Bjartell, Anders; Johansson, Anna M.; Lilja, Hans; Hallden, Christer			Copy Number Variants in the Kallikrein Gene Cluster	PLOS ONE			English	Article							PROSTATE-SPECIFIC ANTIGEN; HUMAN GENOME; POPULATION; DISEASE; CANCER; CNVS; AGE	The kallikrein gene family (KLK1-KLK15) is the largest contiguous group of protease genes within the human genome and is associated with both risk and outcome of cancer and other diseases. We searched for copy number variants in all KLK genes using quantitative PCR analysis and analysis of inheritance patterns of single nucleotide polymorphisms. Two deletions were identified: one 2235-bp deletion in KLK9 present in 1.2% of alleles, and one 3394-bp deletion in KLK15 present in 4.0% of alleles. Each deletion eliminated one complete exon and created out-of-frame coding that eliminated the catalytic triad of the resulting truncated gene product, which therefore likely is a non-functional protein. Deletion breakpoints identified by DNA sequencing located the KLK9 deletion breakpoint to a long interspersed element (LINE) repeated sequence, while the deletion in KLK15 is located in a single copy sequence. To search for an association between each deletion and risk of prostate cancer (PC), we analyzed a cohort of 667 biopsied men (266 PC cases and 401 men with no evidence of PC at biopsy) using short deletion-specific PCR assays. There was no association between evidence of PC in this cohort and the presence of either gene deletion. Haplotyping revealed a single origin of each deletion, with most recent common ancestor estimates of 3000-8000 and 6000-14 000 years for the deletions in KLK9 and KLK15, respectively. The presence of the deletions on the same haplotypes in 1000 Genomes data of both European and African populations indicate an early origin of both deletions. The old age in combination with homozygous presence of loss-of-function variants suggests that some kallikrein-related peptidases have non-essential functions.	[Lindahl, Pernilla; Lilja, Hans] Lund Univ, Skane Univ Hosp, Div Clin Chem, Dept Lab Med, Malmo, Sweden; [Lindahl, Pernilla; Hallden, Christer] Kristianstad Univ, Kristianstad, Sweden; [Sall, Torbjorn] Lund Univ, Dept Biol, Lund, Sweden; [Bjartell, Anders] Skane Univ Hosp, Dept Urol, Malmo, Sweden; [Johansson, Anna M.] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden; [Lilja, Hans] Mem Sloan Kettering Canc Ctr, Dept Lab Med, New York, NY 10021 USA; [Lilja, Hans] Mem Sloan Kettering Canc Ctr, Dept Surg Urol, New York, NY 10021 USA; [Lilja, Hans] Mem Sloan Kettering Canc Ctr, Dept Med Genitourinary Oncol, New York, NY 10021 USA; [Lilja, Hans] Univ Oxford, Nuffield Dept Surg Sci, Oxford, England; [Lilja, Hans] Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland	Lund University; Skane University Hospital; Kristianstad University; Lund University; Lund University; Skane University Hospital; Swedish University of Agricultural Sciences; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Oxford; Tampere University	Hallden, C (corresponding author), Kristianstad Univ, Kristianstad, Sweden.	christer.hallden@hkr.se	Johansson, Anna M/N-2502-2019; Lilja, Hans/S-9703-2019; Johansson, Anna M/G-4759-2013	Johansson, Anna M/0000-0002-9762-0497; Lilja, Hans/0000-0001-5871-7846; 	Swedish Cancer Foundation; Swedish Research Council; European Union 6th Framework [LSHC-CT-2004-503011]; Prostate Cancer Foundation; Sidney Kimmel Center for Prostate and Urologic Cancers; National Cancer Institute [R33 CA 127768-03, R01 CA160816, P50-CA92629]; National Institute for Health Research Oxford Biomedical Research Centre based at Oxford University Hospitals National Health Service Trust; University of Oxford; FiDiPro program award from TEKES, Finland; Swedish Cancer Society [11-0624]; NATIONAL CANCER INSTITUTE [P50CA092629, R33CA127768, R01CA160816] Funding Source: NIH RePORTER	Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); European Union 6th Framework(European Commission); Prostate Cancer Foundation; Sidney Kimmel Center for Prostate and Urologic Cancers; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute for Health Research Oxford Biomedical Research Centre based at Oxford University Hospitals National Health Service Trust; University of Oxford; FiDiPro program award from TEKES, Finland; Swedish Cancer Society(Swedish Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by the Swedish Cancer Foundation (HL and AB), the Swedish Research Council (HL and AB), and European Union 6th Framework (P-Mark), Grant number LSHC-CT-2004-503011, David H. Koch, provided through the Prostate Cancer Foundation; the Sidney Kimmel Center for Prostate and Urologic Cancers; R33 CA 127768-03, R01 CA160816 grants to HL, and P50-CA92629 SPORE grant to H. I. Scher from the National Cancer Institute; the National Institute for Health Research Oxford Biomedical Research Centre based at Oxford University Hospitals National Health Service Trust and University of Oxford to HL, funding (grant no. 11-0624) to HL from the Swedish Cancer Society; and FiDiPro program award to HL from TEKES, Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Batra J, 2012, BIOL CHEM, V393, P1365, DOI 10.1515/hsz-2012-0211; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Conrad DF, 2010, NAT GENET, V42, P385, DOI 10.1038/ng.564; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Elia J, 2012, NAT GENET, V44, P78, DOI 10.1038/ng.1013; Genin E, 2004, J MED GENET, V41, P445, DOI 10.1136/jmg.2003.017962; Johansson AM, 2008, EUR J HUM GENET, V16, P1225, DOI 10.1038/ejhg.2008.75; KIMURA M, 1973, GENETICS, V75, P199; Klein RJ, 2010, CANCER PREV RES, V3, P611, DOI 10.1158/1940-6207.CAPR-09-0206; Lawrence MG, 2010, ENDOCR REV, V31, P407, DOI 10.1210/er.2009-0034; Lilja H, 2008, NAT REV CANCER, V8, P268, DOI 10.1038/nrc2351; Lundwall A, 2006, BIOL CHEM, V387, P637, DOI 10.1515/BC.2006.082; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; Reish O, 2010, ANN HUM GENET, V74, P117, DOI 10.1111/j.1469-1809.2009.00559.x; Shaikh TH, 2009, GENOME RES, V19, P1682, DOI 10.1101/gr.083501.108; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Vickers AJ, 2010, BRIT MED J, V342, pc4521; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Weischenfeldt J, 2013, NAT REV GENET, V14, P125, DOI 10.1038/nrg3373	25	2	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69097	10.1371/journal.pone.0069097	http://dx.doi.org/10.1371/journal.pone.0069097			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894413	Green Published, gold, Green Submitted			2022-12-27	WOS:000322132100045
J	Zhao, L; Wang, YX; Zhang, W; Zhang, JS; Chen, CX; Xu, L; Jonas, JB				Zhao, Liang; Wang, Ya Xing; Zhang, Wei; Zhang, Jing Shang; Chen, Chang Xi; Xu, Liang; Jonas, Jost B.			Localized Retinal Nerve Fiber Layer Defects Detected by Optical Coherence Tomography: The Beijing Eye Study	PLOS ONE			English	Article							AGE-RELATED MACULOPATHY; OPEN-ANGLE GLAUCOMA; PREVALENCE; CLASSIFICATION; HEMORRHAGES; POPULATION; ATROPHY; COUNT; SIZE	Objective: To assess the prevalence of localized retinal nerve fiber layer defects (LRNFLD) and associated factors in adult Chinese. Methods: The population-based Beijing Eye Study 2011 included 3468 individuals (mean age: 64.6 +/- 9.8 years (range: 50-93 years)). The study participants underwent a detailed ophthalmological examination including spectral-domain optical coherence tomography (Spectralis(R)-OCT) assisted measurement of the RNFL. A LRNFLD was defined as a sector in which the RNFL contour line dipped into the red zone for a length of < 180 degrees. Results: Readable OCT images were available for 3242 (93.5%) subjects. LRNFLDs were detected in 640 eyes (9.9 +/- 0.4%) of 479 subjects (14.8 +/- 0.6%). In the age groups of 50-59 years, 60-69 years, 70-79 years, and 80+ years, the prevalence of LRNFLD per person increased from 9.9 +/- 0.9%, 11.6 +/- 1.0% and 20.6 +/- 1.4% to 33.0 +/- 3.2%, respectively. In multivariate analysis, prevalence of LRNFLDs was significantly associated with older age (P = 0.001; Odds Ratio (OR): 1.03; 95% Confidence Interval (CI): 1.01,1.05), myopic refractive error (P<0.001;OR:0.79;95%CI:0.74,0.85), larger beta zone of parapapillary atrophy (P < 0.001; OR:1.34;95%CI:1.20,1.50), presence of glaucomatous optic neuropathy (P<0.001;OR:7.02;95%CI:3.87,12.7), presence of non-glaucomatous optic nerve damage (P = 0.001;OR:43.3;95%CI:8.24,227.1), and presence of diabetic retinopathy (P = 0.003;OR:2.79;95%CI:1.43,5.44). Conclusions: OCT-defined LRNFLDs were present in a prevalence of 14.8 +/- 0.6% in a population-based study sample of subjects aged 50+ years. Prevalence of LRNFLDs increased with higher age, myopic refractive error, and larger parapapillary beta zone. Major ocular diseases associated with LRNFLs were glaucoma, non-glaucomatous optic nerve damage and diabetic retinopathy. These data may be helpful for a semiautomatic assessment of the RNFL.	[Zhao, Liang; Wang, Ya Xing; Zhang, Wei; Zhang, Jing Shang; Chen, Chang Xi; Xu, Liang; Jonas, Jost B.] Capital Univ Med Sci, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Heidelberg, Germany	Capital Medical University; Ruprecht Karls University Heidelberg	Xu, L (corresponding author), Capital Univ Med Sci, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China.	xlbio1@163.com; Jost.Jonas@augen.ma.uni-heidelberg.de	wang, YA XING/K-9671-2016	wang, YA XING/0000-0003-2749-7793	National Natural Science Foundation of China [81170890]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (grant 81170890). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIRAKSINEN PJ, 1984, AM J OPHTHALMOL, V98, P566, DOI 10.1016/0002-9394(84)90242-3; AIRAKSINEN PJ, 1981, ACTA OPHTHALMOL, V59, P627, DOI 10.1111/j.1755-3768.1981.tb08728.x; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Cheung CY, 2011, INVEST OPHTH VIS SCI, V52, P9629, DOI 10.1167/iovs.11-7481; Domalpally A, 2009, RETINA-J RET VIT DIS, V29, P775, DOI 10.1097/IAE.0b013e3181a0848b; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; HOYT WF, 1972, BRIT J OPHTHALMOL, V56, P577, DOI 10.1136/bjo.56.8.577; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; JONAS JB, 1991, INVEST OPHTH VIS SCI, V32, P2942; JONAS JB, 1988, GRAEF ARCH CLIN EXP, V226, P213, DOI 10.1007/BF02181183; Jonas JB, 1996, SURV OPHTHALMOL, V40, P369, DOI 10.1016/S0039-6257(96)80065-8; Jonas JB, 1997, GRAEF ARCH CLIN EXP, V235, P627, DOI 10.1007/BF00946938; JONAS JB, 1992, INVEST OPHTH VIS SCI, V33, P2012; JONAS JB, 1994, GRAEF ARCH CLIN EXP, V232, P759, DOI 10.1007/BF00184280; Kernstock C, 2012, GRAEF ARCH CLIN EXP, V250, P583, DOI 10.1007/s00417-011-1825-3; Kim NR, 2010, ARCH OPHTHALMOL-CHIC, V128, P1121, DOI 10.1001/archophthalmol.2010.204; Leung CKS, 2009, OPHTHALMOLOGY, V116, P1257, DOI 10.1016/j.ophtha.2009.04.013; Li YB, 2006, AM J OPHTHALMOL, V142, P788, DOI 10.1016/j.ajo.2006.06.001; Nukada M, 2011, OPHTHALMOLOGY, V118, P1038, DOI 10.1016/j.ophtha.2010.10.025; PandaJonas S, 1996, AM J OPHTHALMOL, V121, P181, DOI 10.1016/S0002-9394(14)70583-5; PandaJonas S, 1995, OPHTHALMOLOGY, V102, P1853, DOI 10.1016/S0161-6420(95)30784-1; RADIUS RL, 1979, ARCH OPHTHALMOL-CHIC, V97, P948; SCHUMAN JS, 1995, ARCH OPHTHALMOL-CHIC, V113, P586, DOI 10.1001/archopht.1995.01100050054031; Tewarie P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034823; Vogt A, 1917, KLIN MONATSBL AUGENH, V58, P399; Wu XS, 2012, J GLAUCOMA, V21, P228, DOI 10.1097/IJG.0b013e3182070cc6; Xie XW, 2008, GRAEF ARCH CLIN EXP, V246, P1519, DOI 10.1007/s00417-008-0884-6; Xu L, 2008, AM J OPHTHALMOL, V145, P929, DOI 10.1016/j.ajo.2008.01.004; Zhang L, 2012, ARCH OPHTHALMOL-CHIC, V130, P913, DOI 10.1001/archophthalmol.2011.1567	30	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e68998	10.1371/journal.pone.0068998	http://dx.doi.org/10.1371/journal.pone.0068998			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894392	gold, Green Published, Green Submitted			2022-12-27	WOS:000322132100039
J	Lindeberg, T				Lindeberg, Tony			Invariance of visual operations at the level of receptive fields	PLOS ONE			English	Article							GAUSSIAN DERIVATIVE MODEL; SPATIAL-TEMPORAL VISION; OBJECT RECOGNITION; SCALE-SPACE; IMAGE DESCRIPTORS; SHAPE CUES; REPRESENTATION; CORTEX; ADAPTATION; MOTION	The brain is able to maintain a stable perception although the visual stimuli vary substantially on the retina due to geometric transformations and lighting variations in the environment. This paper presents a theory for achieving basic invariance properties already at the level of receptive fields. Specifically, the presented framework comprises (i) local scaling transformations caused by objects of different size and at different distances to the observer, (ii) locally linearized image deformations caused by variations in the viewing direction in relation to the object, (iii) locally linearized relative motions between the object and the observer and (iv) local multiplicative intensity transformations caused by illumination variations. The receptive field model can be derived by necessity from symmetry properties of the environment and leads to predictions about receptive field profiles in good agreement with receptive field profiles measured by cell recordings in mammalian vision. Indeed, the receptive field profiles in the retina, LGN and V1 are close to ideal to what is motivated by the idealized requirements. By complementing receptive field measurements with selection mechanisms over the parameters in the receptive field families, it is shown how true invariance of receptive field responses can be obtained under scaling transformations, affine transformations and Galilean transformations. Thereby, the framework provides a mathematically well-founded and biologically plausible model for how basic invariance properties can be achieved already at the level of receptive fields and support invariant recognition of objects and events under variations in viewpoint, retinal size, object motion and illumination. The theory can explain the different shapes of receptive field profiles found in biological vision, which are tuned to different sizes and orientations in the image domain as well as to different image velocities in space-time, from a requirement that the visual system should be invariant to the natural types of image transformations that occur in its environment.	KTH Royal Inst Technol, Sch Comp Sci & Commun, Dept Computat Biol, Stockholm, Sweden	Royal Institute of Technology	Lindeberg, T (corresponding author), KTH Royal Inst Technol, Sch Comp Sci & Commun, Dept Computat Biol, Stockholm, Sweden.	tony@csc.kth.se	Lindeberg, Tony/G-3580-2011	Lindeberg, Tony/0000-0002-9081-2170	Swedish Research Council [2010-4766]; Royal Swedish Academy of Sciences; Knut and Alice Wallenberg foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Royal Swedish Academy of Sciences; Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation)	Funding was received from The Swedish Research Council contract 2010-4766; The Royal Swedish Academy of Sciences; and The Knut and Alice Wallenberg foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alitto HJ, 2003, CURR OPIN NEUROBIOL, V13, P440, DOI 10.1016/S0959-4388(03)00096-5; Almansa A, 2000, IEEE T IMAGE PROCESS, V9, P2027, DOI 10.1109/83.887971; ALVAREZ L, 1993, ARCH RATION MECH AN, V123, P199, DOI 10.1007/BF00375127; Baumberg A, 2000, PROC CVPR IEEE, P774, DOI 10.1109/CVPR.2000.855899; Bay H, 2006, LECT NOTES COMPUT SC, V3951, P404, DOI 10.1007/11744023_32; BIEDERMAN I, 1992, J EXP PSYCHOL HUMAN, V18, P121, DOI 10.1037/0096-1523.18.1.121; Booth MCA, 1998, CEREB CORTEX, V8, P510, DOI 10.1093/cercor/8.6.510; Bretzner L, 1998, COMPUT VIS IMAGE UND, V71, P385, DOI 10.1006/cviu.1998.0650; Burt P. J., 1993, [1993] Proceedings Fourth International Conference on Computer Vision, P173, DOI 10.1109/ICCV.1993.378222; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; Caselles V, 1997, LECT NOTES COMPUT SC, V1252, P29; DeAngelis G.C., 2004, VISUAL NEUROSCIENCES, V1, P704; DEANGELIS GC, 1995, TRENDS NEUROSCI, V18, P451, DOI 10.1016/0166-2236(95)94496-R; DiCarlo JJ, 2007, TRENDS COGN SCI, V11, P333, DOI 10.1016/j.tics.2007.06.010; DiCarlo JJ, 2000, NAT NEUROSCI, V3, P814, DOI 10.1038/77722; Doi E., 2005, RELATIONS STAT REGUL, P1; EDELMAN S, 1992, VISION RES, V32, P2385, DOI 10.1016/0042-6989(92)90102-O; Einhauser W, 2010, CURR OPIN NEUROBIOL, V20, P389, DOI 10.1016/j.conb.2010.03.010; Einstein A., 2000, RELATIVITY SPECIAL G; Faugeras O, 2009, FRONT COMPUT NEUROSC, V3, DOI 10.3389/neuro.10.001.2009; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Florack L., 1997, IMAGE STRUCTURE, DOI [10.1007/978-94-015-8845-4, DOI 10.1007/978-94-015-8845-4]; Friston K., 2011, NEUROIMAGE; Furmanski CS, 2000, VISION RES, V40, P473, DOI 10.1016/S0042-6989(99)00134-0; Garding J, 1996, INT J COMPUT VISION, V17, P163, DOI 10.1007/BF00058750; Gawne TJ, 1993, J NEUROPHYSIOL, V88, P1128; Geisler WS, 2008, ANNU REV PSYCHOL, V59, P167, DOI 10.1146/annurev.psych.58.110405.085632; Goris RLT, 2009, FRONT COMPUT NEUROSC, V3, DOI 10.3389/neuro.10.003.2009; Grimes DB, 2005, NAT NEUROSCI, V3, P814; Hille E, 1957, FUNCTIONAL ANAL SEMI, VXXXI; HUBEL DH, 1959, J PHYSIOL-LONDON, V147, P226, DOI 10.1113/jphysiol.1959.sp006238; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Hubel DH., 2005, BRAIN VISUAL PERCEPT; Hung CP, 2005, SCIENCE, V310, P863, DOI 10.1126/science.1117593; Hurley JB, 2002, J GEN PHYSIOL, V119, P125, DOI 10.1085/jgp.119.2.125; Hyvarinen A, 2009, COMPUT IMAGING VIS, V39, P1; ITO M, 1995, J NEUROPHYSIOL, V73, P218, DOI 10.1152/jn.1995.73.1.218; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; JONES JP, 1987, J NEUROPHYSIOL, V58, P1233, DOI 10.1152/jn.1987.58.6.1233; Kaas JH, 2013, VISUAL NEUROSCIENCES; Kaschube M, 2010, SCIENCE, V330, P1113, DOI 10.1126/science.1194869; Koch Christof, 1999, P1; Koenderink J., 1990, SOLID SHAPE; KOENDERINK JJ, 1984, BIOL CYBERN, V50, P363, DOI 10.1007/BF00336961; KOENDERINK JJ, 1992, IEEE T PATTERN ANAL, V14, P597, DOI 10.1109/34.141551; KOENDERINK JJ, 1988, BIOL CYBERN, V58, P159, DOI 10.1007/BF00364135; KOENDERINK JJ, 1990, PSYCHOL RES-PSYCH FO, V52, P122, DOI 10.1007/BF00877519; KOENDERINK JJ, 1987, BIOL CYBERN, V55, P367, DOI 10.1007/BF00318371; Koenderink JJ, 1992, ARTIFICIAL BIOL VISI, P1; LAGAE L, 1993, J NEUROPHYSIOL, V69, P19, DOI 10.1152/jn.1993.69.1.19; Laptev I, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P432, DOI 10.1109/iccv.2003.1238378; Laptev I, 2004, IMAGE VISION COMPUT, V22, P105, DOI 10.1016/j.imavis.2003.07.002; Laptev I, 2007, COMPUT VIS IMAGE UND, V108, P207, DOI 10.1016/j.cviu.2006.11.023; Laptev I, 2006, LECT NOTES COMPUT SC, V3667, P91; Lazebnik S, 2005, IEEE T PATTERN ANAL, V27, P1265, DOI 10.1109/TPAMI.2005.151; Linde O, 2004, INT C PATT RECOG, P1, DOI 10.1109/ICPR.2004.1333965; Linde O, 2012, COMPUT VIS IMAGE UND, V116, P538, DOI 10.1016/j.cviu.2011.12.003; Lindeberg T, 1997, IMAGE VISION COMPUT, V15, P415, DOI 10.1016/S0262-8856(97)01144-X; Lindeberg T, 2004, INT C PATT RECOG, P57, DOI 10.1109/ICPR.2004.1334004; Lindeberg T, 2003, LECT NOTES COMPUT SC, V2695, P148; Lindeberg T, 1997, LECT NOTES COMPUT SC, V1252, P113; Lindeberg T, 1998, INT J COMPUT VISION, V30, P79, DOI 10.1023/A:1008045108935; Lindeberg T., 1994, SCALE SPACE THEORY C; Lindeberg T., 1996, LNCS, V1064, P229; Lindeberg T., 1999, HDB COMPUTER VISION, P239; Lindeberg T., 2008, WILEY ENCY COMPUTER, VIV, P2495, DOI DOI 10.1002/9780470050118.ECSE609; Lindeberg T, 2012, COMPUTATIONAL MODEL; Lindeberg T, 2011, J MATH IMAGING VIS, V40, P36, DOI 10.1007/s10851-010-0242-2; Lorincz A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002372; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Lukas BD, 1981, IM UND WORKSH; MARCELJA S, 1980, J OPT SOC AM, V70, P1297, DOI 10.1364/JOSA.70.001297; Mattia M, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.051917; Miao X, 2007, NEURAL COMPUT, V19, P2665, DOI 10.1162/neco.2007.19.10.2665; Mikolajczyk K, 2004, INT J COMPUT VISION, V60, P63, DOI 10.1023/B:VISI.0000027790.02288.f2; Mokhtarian F, 2001, PATTERN ANAL APPL, V4, P1, DOI 10.1007/PL00010984; Murphy PC, 1999, SCIENCE, V286, P1552, DOI 10.1126/science.286.5444.1552; Negre A, 2008, SPRINGER TRAC ADV RO, V39, P75; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; OLSHAUSEN BA, 1993, J NEUROSCI, V13, P4700; Omurtag A, 2000, J COMPUT NEUROSCI, V8, P51, DOI 10.1023/A:1008964915724; Palmer S., 1999, VISION SCI PHOTONS P; PETERSEN SE, 1985, BRAIN RES, V346, P146, DOI 10.1016/0006-8993(85)91105-9; Petitot J, 2003, J PHYSIOL-PARIS, V97, P265, DOI 10.1016/j.jphysparis.2003.10.010; Petitot J, 2008, NEUROGEOMETRIE VISIO; Przybyszewski AW, 1998, CURR BIOL, V8, pR135, DOI 10.1016/S0960-9822(98)70080-6; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Rao RPN, 1998, NETWORK-COMP NEURAL, V9, P219, DOI 10.1088/0954-898X/9/2/005; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; RODIECK R. W., 1965, VISION RES, V5, P583, DOI 10.1016/0042-6989(65)90033-7; RODMAN HR, 1989, EXP BRAIN RES, V75, P53; ROLLS ET, 1994, BEHAV PROCESS, V33, P113, DOI 10.1016/0376-6357(94)90062-0; Romeny B. t. H., 2003, FRONT END VISION MUL; Rothganger F, 2006, INT J COMPUT VISION, V66, P231, DOI 10.1007/s11263-005-3674-1; SAPIRO G, 1993, INT J COMPUT VISION, V11, P25, DOI 10.1007/BF01420591; Sarti A, 2008, BIOL CYBERN, V98, P33, DOI 10.1007/s00422-007-0194-9; Schiele B, 2000, INT J COMPUT VISION, V36, P31, DOI 10.1023/A:1008120406972; Sherman SM, 2010, HDB BRAIN MICROCIRCU, P815; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; SMEETS JBJ, 1994, VISION RES, V34, P191, DOI 10.1016/0042-6989(94)90331-X; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Sompolinsky H, 1997, CURR OPIN NEUROBIOL, V7, P514, DOI 10.1016/S0959-4388(97)80031-1; Stevens CF, 2001, NATURE, V411, P193, DOI 10.1038/35075572; STORK DG, 1990, J OPT SOC AM A, V7, P1362, DOI 10.1364/JOSAA.7.001362; Tuytelaars T, 2004, INT J COMPUT VISION, V59, P61, DOI 10.1023/B:VISI.0000020671.28016.e8; Weickert J., 1998, ANISOTROPIC DIFFUSIO; Willems G, 2008, LECT NOTES COMPUT SC, V5303, P650, DOI 10.1007/978-3-540-88688-4_48; Wiskott L, 2004, PROBLEMS SYSTEMS NEU; Witkin A.P., 1983, P 8 INT JOINT C ART, P1019, DOI DOI 10.1007/978-3-8348-9190-729; YOUNG R A, 1987, Spatial Vision, V2, P273, DOI 10.1163/156856887X00222; Young RA, 2001, SPATIAL VISION, V14, P261, DOI 10.1163/156856801753253582; Young RA, 2001, SPATIAL VISION, V14, P321, DOI 10.1163/156856801753253591; Zhaoping L, 2002, HDB BRAIN THEORY NEU, P815	118	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e66990	10.1371/journal.pone.0066990	http://dx.doi.org/10.1371/journal.pone.0066990			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894283	Green Published, Green Submitted, gold			2022-12-27	WOS:000322391400002
J	Takaguchi, T; Masuda, N; Holme, P				Takaguchi, Taro; Masuda, Naoki; Holme, Petter			Bursty Communication Patterns Facilitate Spreading in a Threshold-Based Epidemic Dynamics	PLOS ONE			English	Article							RAT SPINAL-CORD; SUBSTANCE-P; NEUTRAL ENDOPEPTIDASE; CONVERTING ENZYME; IN-VIVO; SUBSTRATE-SPECIFICITY; PEPTIDE; HYDROLYSIS; PURIFICATION; EXPRESSION	Records of social interactions provide us with new sources of data for understanding how interaction patterns affect collective dynamics. Such human activity patterns are often bursty, i.e., they consist of short periods of intense activity followed by long periods of silence. This burstiness has been shown to affect spreading phenomena; it accelerates epidemic spreading in some cases and slows it down in other cases. We investigate a model of history-dependent contagion. In our model, repeated interactions between susceptible and infected individuals in a short period of time is needed for a susceptible individual to contract infection. We carry out numerical simulations on real temporal network data to find that bursty activity patterns facilitate epidemic spreading in our model.	[Takaguchi, Taro; Masuda, Naoki] Univ Tokyo, Dept Math Informat, Tokyo, Japan; [Holme, Petter] Umea Univ, Dept Phys, IceLab, Umea, Sweden; [Holme, Petter] Sungkyunkwan Univ, Dept Energy Sci, Suwon, South Korea; [Holme, Petter] Stockholm Univ, Dept Sociol, S-10691 Stockholm, Sweden	University of Tokyo; Umea University; Sungkyunkwan University (SKKU); Stockholm University	Holme, P (corresponding author), Umea Univ, Dept Phys, IceLab, Umea, Sweden.	petter.holme@physics.umu.se	Holme, Petter/A-7646-2008	Holme, Petter/0000-0003-2156-1096; Masuda, Naoki/0000-0003-1567-801X	Aihara Project; FIRST program from the Japan Society for the Promotion of Science (JSPS); Council for Science and Technology Policy; JSPS, Japan [10J06281]; Ministry of Education, Culture, Sports, Science, and Technology, Japan [23681033]; Swedish Research Council; WCU program through the National Research Foundation of Korea; Ministry of Education, Science and Technology [R31-2008-10029-0]; Grants-in-Aid for Scientific Research [23681033] Funding Source: KAKEN	Aihara Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); FIRST program from the Japan Society for the Promotion of Science (JSPS); Council for Science and Technology Policy(Council for Science and Technology Policy (CSTP)); JSPS, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Swedish Research Council(Swedish Research CouncilEuropean Commission); WCU program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by the Aihara Project, the FIRST program from the Japan Society for the Promotion of Science (JSPS), initiated by Council for Science and Technology Policy (NM), Grants-in-Aid for Scientic Research (No. 10J06281) from JSPS, Japan (TT), Grants-in-Aid for Scientic Research (No. 23681033) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (NM), the Swedish Research Council (PH) and the WCU program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology R31-2008-10029-0 (PH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREN PE, 1995, J MASS SPECTROM, V30, P817, DOI 10.1002/jms.1190300606; Beaudry F, 2006, BIOMED CHROMATOGR, V20, P1344, DOI 10.1002/bmc.703; BERRETTINI WH, 1985, BIOL PSYCHIAT, V20, P965, DOI 10.1016/0006-3223(85)90193-3; Bertenshaw GP, 2001, J BIOL CHEM, V276, P13248, DOI 10.1074/jbc.M011414200; BLUMBERG S, 1980, BRAIN RES, V192, P477, DOI 10.1016/0006-8993(80)90898-7; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; BUNNETT NW, 1988, GASTROENTEROLOGY, V95, P952, DOI 10.1016/0016-5085(88)90168-0; Chow KM, 2009, BIOCHEMISTRY-US, V48, P2868, DOI 10.1021/bi8016125; DIEKMANN O, 1994, BRAZ J MED BIOL RES, V27, P1865; Ducret A, 1998, PROTEIN SCI, V7, P706, DOI 10.1002/pro.5560070320; GERFEN CR, 1991, J NEUROSCI, V11, P1016; GROBELNY D, 1992, BIOCHEMISTRY-US, V31, P7152, DOI 10.1021/bi00146a017; HALL ME, 1983, PEPTIDES, V4, P31, DOI 10.1016/0196-9781(83)90161-4; HALL ME, 1983, PEPTIDES, V4, P763, DOI 10.1016/0196-9781(83)90033-5; HEYMANN E, 1978, FEBS LETT, V91, P360, DOI 10.1016/0014-5793(78)81210-1; JESSELL T, 1979, BRAIN RES, V168, P247, DOI 10.1016/0006-8993(79)90167-7; Johnson GD, 1999, J BIOL CHEM, V274, P4053, DOI 10.1074/jbc.274.7.4053; Kang BN, 2001, REGUL PEPTIDES, V101, P43, DOI 10.1016/S0167-0115(01)00264-6; Karlsson K, 1998, J MOL RECOGNIT, V11, P266, DOI 10.1002/(SICI)1099-1352(199812)11:1/6<266::AID-JMR438>3.0.CO;2-4; Karlsson K, 2000, J CHROMATOGR A, V893, P107, DOI 10.1016/S0021-9673(00)00758-5; Karlsson K, 1997, PREP BIOCHEM BIOTECH, V27, P59, DOI 10.1080/10826069708001278; Kastin AJ, 2006, HDB BIOL ACTIVE PEPT, pxliii; KATO T, 1980, J NEUROCHEM, V35, P527, DOI 10.1111/j.1471-4159.1980.tb03687.x; Keshishian H, 2009, MOL CELL PROTEOMICS, V8, P2339, DOI 10.1074/mcp.M900140-MCP200; Kim YG, 2012, P NATL ACAD SCI USA, V109, P8523, DOI 10.1073/pnas.1203195109; Klohs J, 2009, J CEREBR BLOOD F MET, V29, P1284, DOI 10.1038/jcbfm.2009.51; KOLASINSKI SL, 1992, ARTHRITIS RHEUM, V35, P369, DOI 10.1002/art.1780350402; KREEGER JS, 1993, EUR J PHARMACOL, V238, P111, DOI 10.1016/0014-2999(93)90513-H; Kreeger JS, 1996, J PHARMACOL EXP THER, V279, P662; KUKKOLA PJ, 1995, J CARDIOVASC PHARM, V26, pS65; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; Lallemend F, 2003, J NEUROCHEM, V87, P508, DOI 10.1046/j.1471-4159.2003.02014.x; LEE CM, 1981, EUR J BIOCHEM, V114, P315, DOI 10.1111/j.1432-1033.1981.tb05151.x; LEGREVES P, 1985, EUR J PHARMACOL, V115, P309, DOI 10.1016/0014-2999(85)90706-X; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lieb K, 2002, NEUROPSYCHOBIOLOGY, V45, P2, DOI 10.1159/000049254; LU B, 1995, J EXP MED, V181, P2271, DOI 10.1084/jem.181.6.2271; Marguet D, 2000, P NATL ACAD SCI USA, V97, P6874, DOI 10.1073/pnas.120069197; MATSAS R, 1983, P NATL ACAD SCI-BIOL, V80, P3111, DOI 10.1073/pnas.80.10.3111; NAGEL JA, 1993, PEPTIDES, V14, P85, DOI 10.1016/0196-9781(93)90014-8; Nolte WM, 2009, BIOCHEMISTRY-US, V48, P11971, DOI 10.1021/bi901637c; NYBERG F, 1984, BIOCHEM BIOPH RES CO, V125, P244, DOI 10.1016/S0006-291X(84)80360-5; NYLANDER I, 1991, NEUROPHARMACOLOGY, V30, P1219, DOI 10.1016/0028-3908(91)90168-B; Oefner C, 2000, J MOL BIOL, V296, P341, DOI 10.1006/jmbi.1999.3492; OTSUKA M, 1993, PHYSIOL REV, V73, P229, DOI 10.1152/physrev.1993.73.2.229; PALMER JM, 1993, NEUROPEPTIDES, V25, P95, DOI 10.1016/0143-4179(93)90088-R; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Ribeiro-da-Silva A, 2000, NEUROPEPTIDES, V34, P256, DOI 10.1054/npep.2000.0834; Saghatelian A, 2004, P NATL ACAD SCI USA, V101, P10000, DOI 10.1073/pnas.0402784101; SANDBERG BEB, 1982, J MED CHEM, V25, P1009, DOI 10.1021/jm00351a001; Santangelo EM, 2001, NEUROSCI LETT, V303, P137, DOI 10.1016/S0304-3940(01)01698-6; Scheer M, 2011, NUCLEIC ACIDS RES, V39, pD670, DOI 10.1093/nar/gkq1089; SCHLESINGER K, 1986, BEHAV NEURAL BIOL, V45, P230, DOI 10.1016/S0163-1047(86)90805-8; SEKAR V, 1979, BIOCHEM BIOPH RES CO, V89, P474, DOI 10.1016/0006-291X(79)90653-3; Shirayama Y, 1996, BRAIN RES, V739, P70, DOI 10.1016/S0006-8993(96)00812-8; Siviter RJ, 2002, PEPTIDES, V23, P2025, DOI 10.1016/S0196-9781(02)00190-0; SKIDGEL RA, 1984, PEPTIDES, V5, P769, DOI 10.1016/0196-9781(84)90020-2; Takayama J, 2008, EUR J PHARMACOL, V581, P157, DOI 10.1016/j.ejphar.2007.11.044; THERIAULT E, 1979, BRAIN RES, V170, P209, DOI 10.1016/0006-8993(79)90957-0; Tinoco AD, 2011, BIOCHEMISTRY-US, V50, P2213, DOI 10.1021/bi2000033; Tinoco AD, 2010, J AM CHEM SOC, V132, P3819, DOI 10.1021/ja909524e; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; VERGE VMK, 1995, J NEUROSCI, V15, P2081, DOI 10.1523/JNEUROSCI.15-03-02081.1995; Whittaker M, 1999, CHEM REV, V99, P2735, DOI 10.1021/cr9804543; YEOMANS DC, 1992, NEUROSCIENCE, V49, P681, DOI 10.1016/0306-4522(92)90236-U; YOKOSAWA H, 1983, BIOCHEM BIOPH RES CO, V116, P735, DOI 10.1016/0006-291X(83)90586-7; Zimmer A, 1998, P NATL ACAD SCI USA, V95, P2630, DOI 10.1073/pnas.95.5.2630	67	73	74	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e68629	10.1371/journal.pone.0068629	http://dx.doi.org/10.1371/journal.pone.0068629			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894326	gold, Green Submitted, Green Published			2022-12-27	WOS:000322391400017
J	Beraki, S; Litrus, L; Soriano, L; Monbureau, M; To, LK; Braithwaite, SP; Nikolich, K; Urfer, R; Oksenberg, D; Shamloo, M				Beraki, Simret; Litrus, Lily; Soriano, Liza; Monbureau, Marie; To, Lillian K.; Braithwaite, Steven P.; Nikolich, Karoly; Urfer, Roman; Oksenberg, Donna; Shamloo, Mehrdad			A Pharmacological Screening Approach for Discovery of Neuroprotective Compounds in Ischemic Stroke	PLOS ONE			English	Article							BETA-HYDROXYSTEROID DEHYDROGENASE; APPARENT MINERALOCORTICOID EXCESS; FOCAL CEREBRAL-ISCHEMIA; 11-BETA-HYDROXYSTEROID DEHYDROGENASE; GAP-JUNCTIONS; CELL-DEATH; IN-VITRO; BRAIN; CARBENOXOLONE; NEURONS	With the availability and ease of small molecule production and design continuing to improve, robust, high-throughput methods for screening are increasingly necessary to find pharmacologically relevant compounds amongst the masses of potential candidates. Here, we demonstrate that a primary oxygen glucose deprivation assay in primary cortical neurons followed by secondary assays (i.e. post-treatment protocol in organotypic hippocampal slice cultures and cortical neurons) can be used as a robust screen to identify neuroprotective compounds with potential therapeutic efficacy. In our screen about 50% of the compounds in a library of pharmacologically active compounds displayed some degree of neuroprotective activity if tested in a pre-treatment toxicity assay but just a few of these compounds, including Carbenoxolone, remained active when tested in a post-treatment protocol. When further examined, Carbenoxolone also led to a significant reduction in infarction size and neuronal damage in the ischemic penumbra when administered six hours post middle cerebral artery occlusion in rats. Pharmacological testing of Carbenoxolone-related compounds, acting by inhibition of 11-beta-hydroxysteroid dehydrogenase-1 (11 beta-HSD1), gave rise to similarly potent in vivo neuroprotection. This indicates that the increase of intracellular glucocorticoid levels mediated by 11 beta-HSD1 may be involved in the mechanism that exacerbates ischemic neuronal cell death, and inhibiting this enzyme could have potential therapeutic value for neuroprotective therapies in ischemic stroke and other neurodegenerative disorders associated with neuronal injury.	[Beraki, Simret; Monbureau, Marie; To, Lillian K.; Shamloo, Mehrdad] Stanford Univ, Med Ctr, Sch Med, Behav & Funct Neurosci Lab,Inst Neuroinnovat & Tr, Stanford, CA 94305 USA; [Litrus, Lily] BioSeek Div DiscoverX, San Francisco, CA USA; [Soriano, Liza] Pacific BioDev Ltd Liabil Co, Emeryville, CA USA; [Braithwaite, Steven P.; Nikolich, Karoly] Circuit Therapeut, Menlo Pk, CA USA; [Urfer, Roman] Selonterra Ltd Liabil Co, Belmont, CA USA; [Oksenberg, Donna] Global Blood Therapeut, San Francisco, CA USA	Stanford University	Shamloo, M (corresponding author), Stanford Univ, Med Ctr, Sch Med, Behav & Funct Neurosci Lab,Inst Neuroinnovat & Tr, Stanford, CA 94305 USA.	mshamloo@stanford.edu			AGY Therapeutics	AGY Therapeutics	AGY Therapeutics supported the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benedek A, 2006, BRAIN RES, V1116, P159, DOI 10.1016/j.brainres.2006.07.123; BONVALET JP, 1990, J CLIN INVEST, V86, P832, DOI 10.1172/JCI114781; BREWER GJ, 1995, J NEUROSCI RES, V42, P674, DOI 10.1002/jnr.490420510; Caulfield AF, 2006, CRIT CARE CLIN, V22, P581, DOI 10.1016/j.ccc.2006.09.001; Cronberg T, 2004, STROKE, V35, P753, DOI 10.1161/01.STR.0000117576.09512.32; DAWSON VL, 1991, P NATL ACAD SCI USA, V88, P6368, DOI 10.1073/pnas.88.14.6368; de Pina-Benabou MH, 2005, STROKE, V36, P2232, DOI 10.1161/01.STR.0000182239.75969.d8; del Zoppo GJ, 2009, STROKE, V40, P2945, DOI 10.1161/STROKEAHA.109.192535; Frantseva MV, 2002, J CEREBR BLOOD F MET, V22, P453, DOI 10.1097/00004647-200204000-00009; Frantseva MV, J NEUROSCI, V22, P644; GROSSER BI, 1966, J NEUROCHEM, V13, P475, DOI 10.1111/j.1471-4159.1966.tb09861.x; GROSSER BI, 1968, STEROIDS, V11, P827, DOI 10.1016/S0039-128X(68)80097-2; Holmes MC, 2006, MOL CELL ENDOCRINOL, V248, P9, DOI 10.1016/j.mce.2005.12.002; Jamieson, 1997, Stress, V2, P123; JAMIESON PM, 1995, ENDOCRINOLOGY, V136, P4754, DOI 10.1210/en.136.11.4754; Khorasani MZ, 2009, PAK J PHARM SCI, V22, P349; Korz V, 2003, J NEUROSCI, V23, P7281; Lampl Y, 2007, NEUROLOGY, V69, P1404, DOI 10.1212/01.wnl.0000277487.04281.db; Leshchenko Y, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-3; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; MEMEZAWA H, 1992, EXP BRAIN RES, V89, P67; Morita H, ENDOCRINOLOGY, V137, P2308; Naus CCG, 2001, CELL COMMUN ADHES, V8, P325, DOI 10.3109/15419060109080747; New MI, 1999, P NATL ACAD SCI USA, V96, P12790, DOI 10.1073/pnas.96.22.12790; O'Collins VE, 2011, J CEREBR BLOOD F MET, V31, P962, DOI 10.1038/jcbfm.2010.184; PETERSON NA, 1965, J NEUROCHEM, V12, P273, DOI 10.1111/j.1471-4159.1965.tb06764.x; Rajan V, 1996, J NEUROSCI, V16, P65; Rawanduzy A, 1997, J NEUROSURG, V87, P916, DOI 10.3171/jns.1997.87.6.0916; Rosmond R, 2000, J INTERN MED, V247, P188, DOI 10.1046/j.1365-2796.2000.00603.x; Rouach N, 2003, J PHYSIOL-LONDON, V553, P729, DOI 10.1113/jphysiol.2003.053439; Rozental R, 2001, METH MOL B, V154, P447; Sandeep TC, 2004, P NATL ACAD SCI USA, V101, P6734, DOI 10.1073/pnas.0306996101; Sandeep TC, 2001, TRENDS ENDOCRIN MET, V12, P446, DOI 10.1016/S1043-2760(01)00499-4; SECKL JR, 1991, J STEROID BIOCHEM, V39, P777, DOI 10.1016/0960-0760(91)90379-J; Sewell KJ, 1998, CLIN SCI, V95, P435, DOI 10.1042/CS19980157; Shamloo M, 2005, J BIOL CHEM, V280, P42290, DOI 10.1074/jbc.M505804200; Sorrells SF, 2007, BRAIN BEHAV IMMUN, V21, P259, DOI 10.1016/j.bbi.2006.11.006; Stewart PM, 1999, VITAM HORM, V57, P249; STEWART PM, 1987, LANCET, V2, P821; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Towfighi A, 2011, STROKE, V42, P2351, DOI 10.1161/STROKEAHA.111.621904; Tymianski M, 2011, NAT NEUROSCI, V14, P1369, DOI 10.1038/nn.2951; Vakili A, 2009, J STROKE CEREBROVASC, V18, P81, DOI 10.1016/j.jstrokecerebrovasdis.2008.09.018; Velazquez JLP, 1997, J NEUROSCI, V17, P9085; White PC, 1997, ENDOCR REV, V18, P135, DOI 10.1210/er.18.1.135; Wyrwoll CS, 2011, FRONT NEUROENDOCRIN, V32, P265, DOI 10.1016/j.yfrne.2010.12.001; Yau JL, P NATL ACAD SCI US, V98, P4716; Zipp F, 2006, TRENDS NEUROSCI, V29, P518, DOI 10.1016/j.tins.2006.07.006; Zundorf G, 2007, J NEUROCHEM, V102, P508, DOI 10.1111/j.1471-4159.2007.04509.x	49	14	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e69233	10.1371/journal.pone.0069233	http://dx.doi.org/10.1371/journal.pone.0069233			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874920	Green Published, Green Submitted, gold			2022-12-27	WOS:000324146200068
J	Li, SH; Chen, A; Mead, K				Li, Suhui; Chen, Arnold; Mead, Katherine			Racial Disparities in the Use of Cardiac Revascularization: Does Local Hospital Capacity Matter?	PLOS ONE			English	Article							ETHNIC-DIFFERENCES; CORONARY; SURGERY; ACCESS; MEDICARE; OUTCOMES; GENDER; RACE; INTERVENTIONS; OVERUSE	Objective: To assess the extent to which the observed racial disparities in cardiac revascularization use can be explained by the variation across counties where patients live, and how the within-county racial disparities is associated with the local hospital capacity. Data Sources: Administrative data from Pennsylvania Health Care Cost Containment Council (PHC4) between 1995 and 2006. Study Design: The study sample included 207,570 Medicare patients admitted to hospital for acute myocardial infarction (AMI). We identified the use of coronary artery bypass graft (CABG) and percutaneous coronary intervention (PCI) procedures within three months after the patient's initial admission for AMI. Multi-level hierarchical models were used to determine the extent to which racial disparities in procedure use were attributable to the variation in local hospital capacity. Principal Findings: Blacks were less likely than whites to receive CABG (9.1% vs. 5.8%; p<0.001) and PCI (15.7% vs. 14.2%; p<0.001). The state-level racial disparity in use rate decreases for CABG, and increases for PCI, with the county adjustment. Higher number of revascularization hospitals per 1,000 AMI patients was associated with smaller within-county racial differences in CABG and PCI rates. Meanwhile, very low capacity of catheterization suites and AMI hospitals contributed to significantly wider racial gap in PCI rate. Conclusions: County variation in cardiac revascularization use rates helps explain the observed racial disparities. While smaller hospital capacity is associated with lower procedure rates for both racial groups, the impact is found to be larger on blacks. Therefore, consequences of fewer medical resources may be particularly pronounced for blacks, compared with whites.	[Li, Suhui; Mead, Katherine] George Washington Univ, Dept Hlth Policy, Washington, DE USA; [Chen, Arnold] Math Policy Res, Princeton, NJ USA	George Washington University; Mathematica	Li, SH (corresponding author), George Washington Univ, Dept Hlth Policy, Washington, DE USA.	suhuili@gwu.edu			Lehigh Valley Health Network; Lehigh University College of Business; Lehigh University Martindale Center	Lehigh Valley Health Network; Lehigh University College of Business; Lehigh University Martindale Center	This research is supported by the Lehigh Valley Health Network, the Lehigh University College of Business, and the Lehigh University Martindale Center for Private Enterprise. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; AYANIAN JZ, 1993, JAMA-J AM MED ASSOC, V269, P2642, DOI 10.1001/jama.269.20.2642; Baicker K, 2005, PERSPECT BIOL MED, V48, pS42; Baicker Katherine, 2004, HLTH AFFAIRS, V23, pw184; Barnato AE, 2005, MED CARE, V43, P308, DOI 10.1097/01.mlr.0000156848.62086.06; Birkmeyer JD, 2000, J AM COLL SURGEONS, V190, P341, DOI 10.1016/S1072-7515(99)00270-7; Chen J, 2001, NEW ENGL J MED, V344, P1443, DOI 10.1056/NEJM200105103441906; Chin MH, 2007, MED CARE RES REV, V64, p7S, DOI 10.1177/1077558707305413; Cohen MG, 2010, CIRCULATION, V121, P2294, DOI 10.1161/CIRCULATIONAHA.109.922286; Conigliaro J, 2000, ARCH INTERN MED, V160, P1329, DOI 10.1001/archinte.160.9.1329; Cook NL, 2011, MED CARE RES REV, V68, P226, DOI 10.1177/1077558710379421; Cook NL, 2009, CIRCULATION, V119, P2463, DOI 10.1161/CIRCULATIONAHA.108.825133; Cooke CR, 2011, MED CARE, V49, P662, DOI 10.1097/MLR.0b013e31821d98b2; DeFrances Carol J, 2008, Natl Health Stat Report, P1; Einbinder LC, 2000, MED CARE RES REV, V57, P162; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Epstein AJ, 2011, JAMA-J AM MED ASSOC, V305, P1769, DOI 10.1001/jama.2011.551; Ferguson TB, 2002, ANN THORAC SURG, V73, P480, DOI 10.1016/S0003-4975(01)03339-2; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Grabowski DC, 2007, MILBANK Q, V85, P579, DOI 10.1111/j.1468-0009.2007.00502.x; Grover A, 2009, CIRCULATION, V120, P488, DOI 10.1161/CIRCULATIONAHA.108.776278; GUADAGNOLI E, 1995, NEW ENGL J MED, V333, P573, DOI 10.1056/NEJM199508313330908; Hannan EL, 1999, MED CARE, V37, P68, DOI 10.1097/00005650-199901000-00010; Hargraves JL, 2003, HEALTH SERV RES, V38, P809, DOI 10.1111/1475-6773.00148; Kressin NR, 2001, ANN INTERN MED, V135, P352, DOI 10.7326/0003-4819-135-5-200109040-00012; Kutcher MA, 2009, J AM COLL CARDIOL, V54, P16, DOI 10.1016/j.jacc.2009.03.038; Lackan NA, 2009, MED CARE, V47, P138, DOI 10.1097/MLR.0b013e3181844dba; Le Cook B, 2011, HEALTH SERV RES, V46, P1259, DOI 10.1111/j.1475-6773.2011.01253.x; Lillie-Blanton M, 2002, RACIAL ETHNIC DIFFER; Mayberry RM, 2000, MED CARE RES REV, V57, P108, DOI 10.1177/107755800773743628; Mercuri M, 2009, HEALTH POLICY, V91, P314, DOI 10.1016/j.healthpol.2009.01.004; Mukamel DB, 2007, MED CARE, V45, P664, DOI 10.1097/MLR.0b013e3180325b81; Paulus RA, 2008, HEALTH AFFAIR, V27, P1235, DOI 10.1377/hlthaff.27.5.1235; Peterson ED, 1997, NEW ENGL J MED, V336, P480, DOI 10.1056/NEJM199702133360706; Pham H., 2010, EPISODE BASED PAYMEN; Reschovsky JD, 2008, HEALTH AFFAIR, V27, pW222, DOI 10.1377/hlthaff.27.3.w222; Schneider EC, 2001, ANN INTERN MED, V135, P328, DOI 10.7326/0003-4819-135-5-200109040-00009; Silber JH, 2010, HEALTH SERV RES, V45, P1872, DOI 10.1111/j.1475-6773.2010.01180.x; Skinner J, 2003, NEW ENGL J MED, V349, P1350, DOI 10.1056/NEJMsa021569; Skinner J, 2000, FRONTIERS HLTH POLIC; Sonel AF, 2005, CIRCULATION, V111, P1225, DOI 10.1161/01.CIR.0000157732.03358.64; Stitzenberg KB, 2009, J CLIN ONCOL, V27, P4671, DOI 10.1200/JCO.2008.20.1715; UDVARHELYI IS, 1992, JAMA-J AM MED ASSOC, V268, P2530, DOI 10.1001/jama.268.18.2530; Wennberg JE, 2008, TRACKING CARE PATIEN, P1; Wennberg JE, 2004, HLTH AFFAIRS; Wennberg John E, 2002, Health Aff (Millwood), VSuppl Web Exclusives, pW96; WENNEKER MB, 1990, JAMA-J AM MED ASSOC, V264, P1255, DOI 10.1001/jama.264.10.1255; Wooldridge J., 2002, ECONOMETRIC ANAL CRO	48	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e69855	10.1371/journal.pone.0069855	http://dx.doi.org/10.1371/journal.pone.0069855			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	186SF	23875005	gold, Green Published			2022-12-27	WOS:000322064300122
J	Pita, R; Mira, A; Beja, P				Pita, Ricardo; Mira, Antonio; Beja, Pedro			Influence of Land Mosaic Composition and Structure on Patchy Populations: The Case of the Water Vole (Arvicola sapidus) in Mediterranean Farmland	PLOS ONE			English	Article							HABITAT FRAGMENTATION; LANDSCAPE; CONSERVATION; PERSISTENCE; ABUNDANCE; EXTINCTION; MANAGEMENT; OCCUPANCY; SELECTION; BIRDS	The ability of patchy populations to persist in human-dominated landscapes is often assessed using focal patch approaches, in which the local occurrence or abundance of a species is related to the properties of individual patches and the surrounding landscape context. However, useful additional insights could probably be gained through broader, mosaic-level approaches, whereby whole land mosaics with contrasting patch-network and matrix characteristics are the units of investigation. In this study we addressed this issue, analysing how the southern water vole (Arvicola sapidus) responds to variables describing patch-network and matrix properties within replicated Mediterranean farmland mosaics, across a gradient of agricultural intensification. Patch-network characteristics had a dominant effect, with the total amount of habitat positively influencing both the occurrence of water voles and the proportion of area occupied in land mosaics. The proportions of patches and area occupied by the species were positively influenced by mean patch size, and negatively so by patch isolation. Matrix effects were weak, although there was a tendency for a higher proportion of occupied patches in more intensive, irrigated agricultural landscapes, particularly during the dry season. In terms of conservation, results suggest that water voles may be able to cope well with, or even be favoured by, the on-going expansion of irrigated agriculture in Mediterranean dry-lands, provided that a number of patches of wet herbaceous vegetation are maintained within the farmland mosaic. Overall, our study suggests that the mosaic-level approach may provide a useful framework to understand the responses of patchy populations to land use change.	[Pita, Ricardo; Mira, Antonio] Univ Evora, Ctr Invest Biodiversidade & Recursos Genet, Evora, Portugal; [Beja, Pedro] Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, EDP Biodivers Chair, Vairao, Portugal	University of Evora; Universidade do Porto	Pita, R (corresponding author), Univ Evora, Ctr Invest Biodiversidade & Recursos Genet, Evora, Portugal.	ricardo.pita@gmail.com	Beja, Pedro/A-7851-2008; Mira, Antonio/E-5715-2010; Pita, Ricardo/D-3111-2011	Beja, Pedro/0000-0001-8164-0760; Mira, Antonio/0000-0001-6152-0454; Pita, Ricardo/0000-0001-8562-7301	Portuguese Foundation for Science and Technology [SFRH/BPD/73478/2010]; project PERSIST [PTDC/BIA-BEC/105110/2008]	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); project PERSIST	This study was funded by the Portuguese Foundation for Science and Technology through the grant SFRH/BPD/73478/2010 attributed to RP, and the project PERSIST (PTDC/BIA-BEC/105110/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Barreto GR, 1998, ANIM CONSERV, V1, P129, DOI 10.1111/j.1469-1795.1998.tb00020.x; Barton K, 2011, MIMIN MULTIMODEL INF; Bates D. M., 2010, LME4 MIXED EFFECTS M; Beja P, 2003, BIOL CONSERV, V114, P317, DOI 10.1016/S0006-3207(03)00051-X; Bennett AF, 2006, BIOL CONSERV, V133, P250, DOI 10.1016/j.biocon.2006.06.008; Bennett AF, 2010, CONSERVATION BIOLOGY FOR ALL, P88; Bivand R., 2012, PACKAGE SPDEP; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Brennan JM, 2002, CAM STU LAN, P68, DOI 10.1017/CBO9780511613654.006; Bulman CR, 2007, ECOL APPL, V17, P1460, DOI 10.1890/06-1032.1; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Calcagno V, 2012, R PACKAGE GLMMULTI; Centeno-Cuadros A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024613; Chauvenet ALM, 2010, ECOL APPL, V20, P789, DOI 10.1890/08-1749.1; Driscoll DA, 2007, CAN J ZOOL, V85, P1031, DOI 10.1139/Z07-096; Elkie PC, 1999, TM002; Fahrig L, 2007, CAM STU LAN, P78, DOI 10.1017/CBO9780511618581.006; Fedriani JM, 2002, ECOSCIENCE, V9, P12, DOI 10.1080/11956860.2002.11682685; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Fleishman E, 2002, CONSERV BIOL, V16, P706, DOI 10.1046/j.1523-1739.2002.00539.x; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Garde JM, 1996, ACTA THERIOL, V41, P353, DOI 10.4098/AT.arch.96-34; Gilarranz LJ, 2012, J THEOR BIOL, V297, P11, DOI 10.1016/j.jtbi.2011.11.027; HANSKI I, 1995, OIKOS, V72, P21, DOI 10.2307/3546033; Hanski I, 2000, NATURE, V404, P755, DOI 10.1038/35008063; Hanski I, 1996, CONSERV BIOL, V10, P578, DOI 10.1046/j.1523-1739.1996.10020578.x; Hanski I., 1999, METAPOPULATION ECOLO; Hanski K, 2003, THEOR POPUL BIOL, V64, P119, DOI 10.1016/S0040-5809(03)00022-4; HARRISON S, 1991, BIOL J LINN SOC, V42, P73, DOI 10.1111/j.1095-8312.1991.tb00552.x; Herzon I, 2008, BIOL CONSERV, V141, P1171, DOI 10.1016/j.biocon.2008.03.005; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kajzer J, 2012, J BIOGEOGR, V39, P371, DOI 10.1111/j.1365-2699.2011.02604.x; Lambin X, 2012, DISPERSAL ECOLOGY AND EVOLUTION, P405; Lee J, 2001, STAT ANAL ARCH GISI; Legendre P., 2012, NUMERICAL ECOLOGY; Lindenmayer D, 2008, ECOL LETT, V11, P78, DOI 10.1111/j.1461-0248.2007.01114.x; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; MacPherson JL, 2011, LANDSCAPE ECOL, V26, P1395, DOI 10.1007/s10980-011-9669-0; Mate I, 2013, ACTA THERIOL, V58, P25, DOI 10.1007/s13364-012-0090-0; McGarigal K, 2002, ECOL APPL, V12, P335, DOI 10.1890/1051-0761(2002)012[0335:CEOEAT]2.0.CO;2; Mortelliti A, 2011, J APPL ECOL, V48, P153, DOI 10.1111/j.1365-2664.2010.01918.x; Mortelliti A, 2010, OECOLOGIA, V163, P535, DOI 10.1007/s00442-010-1623-3; Oksanen J., 2016, R PACKAG; Opdam P, 2002, APPLYING LANDSCAPE ECOLOGY IN BIOLOGICAL CONSERVATION, P381; Pita R, 2007, BIOL CONSERV, V134, P383, DOI 10.1016/j.biocon.2006.08.026; Pita R, 2011, ANIM BEHAV, V81, P1023, DOI 10.1016/j.anbehav.2011.02.007; Pita R, 2011, ACTA OECOL, V37, P124, DOI 10.1016/j.actao.2011.01.006; Pita R, 2010, EUR J WILDLIFE RES, V56, P651, DOI 10.1007/s10344-009-0360-6; Pita R, 2009, AGR ECOSYST ENVIRON, V132, P57, DOI 10.1016/j.agee.2009.02.008; Prugh LR, 2008, P NATL ACAD SCI USA, V105, P20770, DOI 10.1073/pnas.0806080105; R Development Core Team, 2012, R LANG ENV STAT COMP; Radford JQ, 2007, J APPL ECOL, V44, P737, DOI 10.1111/j.1365-2664.2007.01327.x; Revelle W., 2012, PSYCH PROCEDURES PER; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; ROMAN J, 2007, THESIS U AUTONOMA MA; Roman Jacinto, 2003, Galemys, V15, P55; Shepard DB, 2008, ANIM CONSERV, V11, P288, DOI 10.1111/j.1469-1795.2008.00183.x; Stoate C, 2009, J ENVIRON MANAGE, V91, P22, DOI 10.1016/j.jenvman.2009.07.005; Sutherland C, 2012, ECOLOGY, V93, P2465, DOI 10.1890/12-0172.1; Telfer S, 2001, OIKOS, V95, P31, DOI 10.1034/j.1600-0706.2001.950104.x; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; Thornton DH, 2011, LANDSCAPE ECOL, V26, P7, DOI 10.1007/s10980-010-9549-z; VENTURA J, 1989, ZOOL ANZ, V223, P283; Wagner HH, 2005, ECOLOGY, V86, P1975, DOI 10.1890/04-0914; Wagner HH, 2004, ECOLOGY, V85, P342, DOI 10.1890/02-0738; Wilson RJ, 2002, ECOLOGY, V83, P3357, DOI 10.2307/3072085	68	7	7	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e69976	10.1371/journal.pone.0069976	http://dx.doi.org/10.1371/journal.pone.0069976			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23875014	gold, Green Published, Green Submitted			2022-12-27	WOS:000322064300126
J	Ding, H; Nedrud, JG; Blanchard, TG; Zagorski, BM; Li, GH; Shiu, J; Xu, JH; Czinn, SJ				Ding, Hua; Nedrud, John G.; Blanchard, Thomas G.; Zagorski, Brandon M.; Li, Guanghui; Shiu, Jessica; Xu, Jinghua; Czinn, Steven J.			Th1-Mediated Immunity against Helicobacter pylori Can Compensate for Lack of Th17 Cells and Can Protect Mice in the Absence of Immunization	PLOS ONE			English	Article							VACCINE-INDUCED REDUCTION; T-CELLS; POSTIMMUNIZATION GASTRITIS; INFLAMMATORY RESPONSES; GAMMA-INTERFERON; INFECTION; FELIS; COLONIZATION; CLEARANCE; INTERLEUKIN-17	Helicobacter pylori (H. pylori) infection can be significantly reduced by immunization in mice. Th17 cells play an essential role in the protective immune response. Th1 immunity has also been demonstrated to play a role in the protective immune response and can compensate in the absence of IL-17. To further address the potential of Th1 immunity, we investigated the efficacy of immunization in mice deficient in IL-23p19, a cytokine that promotes Th17 cell development. We also examined the course of Helicobacter infection in unimmunized mice treated with Th1 promoting cytokine IL-12. C57BL/6, IL-12 p35 KO, and IL-23 p19 KO mice were immunized and challenged with H. pylori. Protective immunity was evaluated by CFU determination and QPCR on gastric biopsies. Gastric and splenic IL-17 and IFN gamma levels were determined by PCR or by ELISA. Balb/c mice were infected with H. felis and treated with IL-12 therapy and the resulting gastric bacterial load and inflammatory response were assessed by histologic evaluation. Vaccine induced reductions in bacterial load that were comparable to wild type mice were observed in both IL-12 p35 and IL-23 p19 KO mice. In the absence of IL-23 p19, IL-17 levels remained low but IFN gamma levels increased significantly in both immunized challenged and unimmunized/challenged mice. Additionally, treatment of H. felis-infected Balb/c mice with IL-12 resulted in increased gastric inflammation and the eradication of bacteria in most mice. These data suggest that Th1 immunity can compensate for the lack of IL-23 mediated Th17 responses, and that protective Th1 immunity can be induced in the absence of immunization through cytokine therapy of the infected host.	[Ding, Hua; Blanchard, Thomas G.; Li, Guanghui; Shiu, Jessica; Xu, Jinghua; Czinn, Steven J.] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA; [Nedrud, John G.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Zagorski, Brandon M.] Inst Clin Evaluat Sci, Toronto, ON, Canada	University System of Maryland; University of Maryland Baltimore; Case Western Reserve University; University of Toronto	Czinn, SJ (corresponding author), Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA.	sczinn@peds.umaryland.edu		Shiu, Jessica/0000-0002-2264-8372	National Institutes of Health [AI 055710, AI 083694, DK 46461]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI055710, R21AI083694, R01AI055710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046461, R56DK046461] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health grants AI 055710 (TGB), AI 083694 (JGN), and DK 46461 (SJC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebischer T, 2001, INFECT IMMUN, V69, P556, DOI 10.1128/IAI.69.1.556-558.2001; Akhiani AA, 2002, J IMMUNOL, V169, P6977, DOI 10.4049/jimmunol.169.12.6977; Algood HMS, 2007, FEMS IMMUNOL MED MIC, V51, P577, DOI 10.1111/j.1574-695X.2007.00338.x; Anderson KM, 2006, J IMMUNOL, V176, P5306, DOI 10.4049/jimmunol.176.9.5306; Blanchard TG, 2010, ADV M C M, P167, DOI 10.1079/9781845935948.0167; Blanchard TG, 2010, HEL PYL 21 CENT, P7; Court M, 2003, J PATHOL, V201, P303, DOI 10.1002/path.1422; CZINN SJ, 1993, VACCINE, V11, P637, DOI 10.1016/0264-410X(93)90309-L; Czinn SJ, 2011, NAT REV GASTRO HEPAT, V8, P133, DOI 10.1038/nrgastro.2011.1; DeLyria ES, 2011, HELICOBACTER, V16, P169, DOI 10.1111/j.1523-5378.2011.00839.x; Delyria ES, 2009, GASTROENTEROLOGY, V136, P247, DOI 10.1053/j.gastro.2008.09.017; Flach CF, 2011, INFECT IMMUN, V79, P879, DOI 10.1128/IAI.00756-10; FOX JG, 1993, INFECT IMMUN, V61, P2309, DOI 10.1128/IAI.61.6.2309-2315.1993; Garhart CA, 2003, INFECT IMMUN, V71, P910, DOI 10.1128/IAI.71.2.910-921.2003; Garhart CA, 2002, INFECT IMMUN, V70, P3529, DOI 10.1128/IAI.70.7.3529-3538.2002; Godinez I, 2008, INFECT IMMUN, V76, P2008, DOI 10.1128/IAI.01691-07; Goto T, 1999, INFECT IMMUN, V67, P2531, DOI 10.1128/IAI.67.5.2531-2539.1999; He QA, 2002, J CLIN MICROBIOL, V40, P3720, DOI 10.1128/JCM.40.10.3720-3728.2002; Hitzler I, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00142; Horvath DJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00056; Khamri W, 2010, INFECT IMMUN, V78, P845, DOI 10.1128/IAI.00524-09; Lee A, 1997, GASTROENTEROLOGY, V112, P1386, DOI 10.1016/S0016-5085(97)70155-0; Liu H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002689; Lundgren A, 2003, INFECT IMMUN, V71, P1755, DOI 10.1128/IAI.71.4.1755-1762.2003; Luzza F, 2000, J IMMUNOL, V165, P5332, DOI 10.4049/jimmunol.165.9.5332; Mohammadi M, 1996, INFECT IMMUN, V64, P238, DOI 10.1128/IAI.64.1.238-245.1996; Mohammadi M, 1996, J IMMUNOL, V156, P4729; Pappo J, 1999, INFECT IMMUN, V67, P337, DOI 10.1128/IAI.67.1.337-341.1999; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Rad R, 2006, GASTROENTEROLOGY, V131, P525, DOI 10.1053/j.gastro.2006.05.001; Raghavan S, 2003, CLIN EXP IMMUNOL, V132, P393, DOI 10.1046/j.1365-2249.2003.02177.x; Rupnow MFT, 2001, VACCINE, V20, P879, DOI 10.1016/S0264-410X(01)00401-7; Sawai N, 1999, INFECT IMMUN, V67, P279, DOI 10.1128/IAI.67.1.279-285.1999; Sayi A, 2009, J IMMUNOL, V182, P7085, DOI 10.4049/jimmunol.0803293; Velin D, 2005, GASTROENTEROLOGY, V129, P142, DOI 10.1053/j.gastro.2005.04.010; Velin D, 2009, GASTROENTEROLOGY, V136, P2237, DOI 10.1053/j.gastro.2009.02.077; Webb PM, 2001, GUT, V49, P347, DOI 10.1136/gut.49.3.347; YAMADA T, 1994, JAMA-J AM MED ASSOC, V272, P65, DOI 10.1001/jama.272.1.65	38	21	22	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e69384	10.1371/journal.pone.0069384	http://dx.doi.org/10.1371/journal.pone.0069384			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874957	gold, Green Published, Green Submitted			2022-12-27	WOS:000322218800070
J	Gopinath, SCB; Awazu, K; Fujimaki, M; Shimizu, K; Shima, T				Gopinath, Subash C. B.; Awazu, Koichi; Fujimaki, Makoto; Shimizu, Kazufumi; Shima, Takayuki			Observations of Immuno-Gold Conjugates on Influenza Viruses Using Waveguide-Mode Sensors	PLOS ONE			English	Article							RNA APTAMER; HEMAGGLUTININ; SENSITIVITY; IMMUNOASSAY; FUSION	Gold nanoparticles were conjugated to an antibody (immuno-AuNP) against A/Udorn/307/1972 (H3N2) influenza virus to detect viruses on a sensing plate designed for an evanescent field-coupled waveguide-mode sensor. Experiments were conducted using human influenza A/H3N2 strains, and immuno-AuNP could detect 8x10(5) PFU/ml (40 pg/mu l) intact A/Udorn/307/1972 and 120 pg/mu l A/Brisbane/10/2007. Furthermore, increased signal magnitude was achieved in the presence of non-ionic detergent, as the virtual detection level was increased to 8x10(4) PFU/ml A/Udorn/307/1972. Immuno-AuNPs were then complexed with viruses to permit direct observation, and they formed a ring of confined nanodots on the membrane of both intact and detergent-treated viruses as directly visualized by scanning electron microscopy. With this complex the detection limit was improved further to 8x10(3) PFU/ml on anti-rabbit IgG immobilized sensing plate. These strategies introduce methods for observing trapped intact viruses on the sensing plates generated for optical systems.	[Gopinath, Subash C. B.; Awazu, Koichi; Fujimaki, Makoto; Shima, Takayuki] Natl Inst Adv Ind Sci & Technol, Elect & Photon Res Inst, Tsukuba, Ibaraki, Japan; [Shimizu, Kazufumi] Nihon Univ, Sch Med, Open Res Ctr Genome & Infect Dis, Itabashi Ku, Tokyo, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Nihon University	Gopinath, SCB (corresponding author), Natl Inst Adv Ind Sci & Technol, Elect & Photon Res Inst, Tsukuba, Ibaraki, Japan.	gopi-subashchandrabose@aist.go.jp; m-fujimaki@aist.go.jp	Shima, Takayuki/L-3279-2018; Fujimaki, Makoto/M-3310-2018; Awazu, Koichi/AAY-1421-2020; Gopinath, Subash/D-2953-2015; Awazu, Koichi/M-8133-2018	Shima, Takayuki/0000-0002-8523-816X; Fujimaki, Makoto/0000-0003-4856-422X; Gopinath, Subash/0000-0002-8347-4687; Awazu, Koichi/0000-0002-1993-1708	Industrial Technology Research Grant Program from the New Energy and Industrial Technology Development Organization (NEDO) of Japan	Industrial Technology Research Grant Program from the New Energy and Industrial Technology Development Organization (NEDO) of Japan(New Energy and Industrial Technology Development Organization (NEDO))	This study was supported by the Industrial Technology Research Grant Program 2009 from the New Energy and Industrial Technology Development Organization (NEDO) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awazu K, 2007, OPT EXPRESS, V15, P2592, DOI 10.1364/OE.15.002592; Bahgat MM, 2009, J VIROL METHODS, V159, P244, DOI 10.1016/j.jviromet.2009.04.008; Bolduc OR, 2009, TALANTA, V77, P1680, DOI 10.1016/j.talanta.2008.10.006; Byarugaba DK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027803; Centers for Disease Control and Prevention (CDC), 2012, MMWR Morb Mortal Wkly Rep, V60, P1741; Chen LP, 2010, LUMINESCENCE, V25, P419, DOI 10.1002/bio.1167; Crosby AW, 1989, FORGOTTEN PANDEMIC I; Devanathan S, 2004, J PHARMACEUT BIOMED, V36, P711, DOI 10.1016/j.jpba.2004.08.030; DOMS RW, 1985, J BIOL CHEM, V260, P2973; Fujimaki M, 2008, OPT EXPRESS, V16, P6408, DOI 10.1364/OE.16.006408; Fujimaki M, 2010, OPT EXPRESS, V18, P15732, DOI 10.1364/OE.18.015732; Glezen WP, 1996, EPIDEMIOL REV, V18, P64, DOI 10.1093/oxfordjournals.epirev.a017917; Gopinath SCB, 2013, ACTA BIOMATER, V9, P5080, DOI 10.1016/j.actbio.2012.09.027; Gopinath SCB, 2006, J GEN VIROL, V87, P479, DOI 10.1099/vir.0.81508-0; Gopinath SCB, 2008, ANAL CHEM, V80, P6602, DOI 10.1021/ac800767s; Gopinath SCB, 2012, SENSORS-BASEL, V12, P2136, DOI 10.3390/s120202136; Gopinath SCB, 2011, SENSOR ACTUAT B-CHEM, V155, P239, DOI 10.1016/j.snb.2010.11.054; Gopinath SCB, 2010, ANAL METHODS-UK, V2, P1880, DOI 10.1039/c0ay00491j; Gopinath SCB, 2009, ANAL BIOANAL CHEM, V394, P481, DOI 10.1007/s00216-009-2721-0; Guirgis BSS, 2012, ANAL BIOANAL CHEM, V402, P1019, DOI 10.1007/s00216-011-5489-y; Hidari KIPJ, 2010, OPEN ANTIMICROB AGEN, V2, P26, DOI DOI 10.2174/1876518101002020026; Hu W., 2010, Journal of Biomedical Science and Engineering, V3, P114; Jeon SH, 2004, J BIOL CHEM, V279, P48410, DOI 10.1074/jbc.M409059200; KRETSCHM.E, 1971, Z PHYS, V241, P313, DOI 10.1007/BF01395428; MAEDA T, 1980, FEBS LETT, V122, P283, DOI 10.1016/0014-5793(80)80457-1; MUKAIGAWA J, 1991, J GEN VIROL, V72, P2661, DOI 10.1099/0022-1317-72-11-2661; Nagel J, 2011, MATER CHEM PHYS, V129, P599, DOI 10.1016/j.matchemphys.2011.04.069; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Rong G, 2008, BIOSENS BIOELECTRON, V23, P1572, DOI 10.1016/j.bios.2008.01.017; SCHOLTISSEK C, 1985, VIROLOGY, V147, P287, DOI 10.1016/0042-6822(85)90131-X; SHIMIZU K, 1985, VACCINE, V3, P207, DOI 10.1016/0264-410X(85)90107-0; Tinguely JC, 2011, BIONANOSCIENCE, V1, P128, DOI 10.1007/s12668-011-0015-4; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Upadhyayula VKK, 2012, ANAL CHIM ACTA, V715, P1, DOI 10.1016/j.aca.2011.12.008; van Doremalen N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025755; Wada A, 2011, J VIROL METHODS, V178, P82, DOI 10.1016/j.jviromet.2011.08.017; Wang RH, 2009, TALANTA, V79, P159, DOI 10.1016/j.talanta.2009.03.017; Watanabe M, 2009, PEDIATR INT, V51, P211, DOI 10.1111/j.1442-200X.2008.02696.x; Watcharatanyatip K, 2010, J VIROL METHODS, V163, P238, DOI 10.1016/j.jviromet.2009.09.027; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WEBSTER RG, 1993, INTERVIROLOGY, V35, P16, DOI 10.1159/000150292	41	46	47	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e69121	10.1371/journal.pone.0069121	http://dx.doi.org/10.1371/journal.pone.0069121			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874887	Green Published, gold, Green Submitted			2022-12-27	WOS:000322218800066
J	Jones, AC; Gust, B; Kulik, A; Heide, L; Buttner, MJ; Bibb, MJ				Jones, Adam C.; Gust, Bertolt; Kulik, Andreas; Heide, Lutz; Buttner, Mark J.; Bibb, Mervyn J.			Phage P1-Derived Artificial Chromosomes Facilitate Heterologous Expression of the FK506 Gene Cluster	PLOS ONE			English	Article							STREPTOMYCES-COELICOLOR A3(2); NATURAL-PRODUCT; TACROLIMUS FK506; BIOSYNTHESIS; TSUKUBAENSIS; CLONING; GENOME; IDENTIFICATION; CLOROBIOCIN; ENHANCEMENT	We describe a procedure for the conjugative transfer of phage P1-derived Artificial Chromosome (PAC) library clones containing large natural product gene clusters (>= 70 kilobases) to Streptomyces coelicolor strains that have been engineered for improved heterologous production of natural products. This approach is demonstrated using the gene cluster for FK506 (tacrolimus), a clinically important immunosuppressant of high commercial value. The entire 83.5 kb FK506 gene cluster from Streptomyces tsukubaensis NRRL 18488 present in one 130 kb PAC clone was introduced into four different S. coelicolor derivatives and all produced FK506 and smaller amounts of the related compound FK520. FK506 yields were increased by approximately five-fold (from 1.2 mg L-1 to 5.5 mg L-1) in S. coelicolor M1146 containing the FK506 PAC upon overexpression of the FK506 LuxR regulatory gene fkbN. The PAC-based gene cluster conjugation methodology described here provides a tractable means to evaluate and manipulate FK506 biosynthesis and is readily applicable to other large gene clusters encoding natural products of interest to medicine, agriculture and biotechnology.	[Jones, Adam C.; Gust, Bertolt; Heide, Lutz] Univ Tubingen, Inst Pharmaceut, Tubingen, Germany; [Kulik, Andreas] Univ Tubingen, Dept Microbiol & Biotechnol, Tubingen, Germany; [Buttner, Mark J.; Bibb, Mervyn J.] John Innes Ctr, Dept Mol Microbiol, Norwich, Norfolk, England	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Buttner, MJ (corresponding author), John Innes Ctr, Dept Mol Microbiol, Norwich Res Pk, Norwich, Norfolk, England.	mark.buttner@jic.ac.uk; mervyn.bibb@jic.ac.uk		Heide, Lutz/0000-0001-7809-7453; Kulik, Andreas/0000-0002-6914-7313; Buttner, Mark/0000-0002-3505-2981; Jones, Adam/0000-0001-7521-1863	German Federal Ministry of Education and Research (ERA-IB IMMUNOTEC) [FKZ 0315931]; Alexander von Humboldt Foundation; BBSRC [BB/I002197/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/00000607, BBS/E/J/0000A227, BB/I002197/1, BBS/E/J/00000015] Funding Source: researchfish	German Federal Ministry of Education and Research (ERA-IB IMMUNOTEC); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Financial support was provided from the German Federal Ministry of Education and Research (ERA-IB IMMUNOTEC, FKZ 0315931) to LH (http://www.era-ib.net/immunotec) and a postdoctoral fellowship from the Alexander von Humboldt Foundation to ACJ (http://www.humboldt-foundation.de/web/home.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andexer JN, 2011, P NATL ACAD SCI USA, V108, P4776, DOI 10.1073/pnas.1015773108; Baltz RH, 2008, CURR OPIN PHARMACOL, V8, P557, DOI 10.1016/j.coph.2008.04.008; Banik JJ, 2010, CURR OPIN MICROBIOL, V13, P603, DOI 10.1016/j.mib.2010.08.012; Barreiro C, 2012, J BACTERIOL, V194, P3756, DOI 10.1128/JB.00692-12; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; BIBB MJ, 1994, MOL MICROBIOL, V14, P533, DOI 10.1111/j.1365-2958.1994.tb02187.x; Binz TM, 2008, CHEMBIOCHEM, V9, P447, DOI 10.1002/cbic.200700549; Chen DD, 2012, APPL ENVIRON MICROB, V78, P5093, DOI 10.1128/AEM.00450-12; Dangel V, 2009, MICROBIOL-SGM, V155, P4025, DOI 10.1099/mic.0.032649-0; Dumont FJ, 2000, CURR MED CHEM, V7, P731, DOI 10.2174/0929867003374723; Erb A, 2009, CHEMBIOCHEM, V10, P1392, DOI 10.1002/cbic.200900054; Eustaquio AS, 2005, APPL ENVIRON MICROB, V71, P2452, DOI 10.1128/AEM.71.5.2452-2459.2005; Flinspach K, 2010, BIOPOLYMERS, V93, P823, DOI 10.1002/bip.21493; Floriano B, 1996, MOL MICROBIOL, V21, P385, DOI 10.1046/j.1365-2958.1996.6491364.x; Gomez-Escribano JP, 2012, METHOD ENZYMOL, V517, P279, DOI 10.1016/B978-0-12-404634-4.00014-0; Gomez-Escribano JP, 2011, MICROB BIOTECHNOL, V4, P207, DOI 10.1111/j.1751-7915.2010.00219.x; Goranovic D, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-238; Goranovic D, 2010, J BIOL CHEM, V285, P14292, DOI 10.1074/jbc.M109.059600; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Gust B, 2004, ADV APPL MICROBIOL, V54, P107, DOI 10.1016/S0065-2164(04)54004-2; Gust B, 2009, METHOD ENZYMOL, V458, P159, DOI 10.1016/S0076-6879(09)04807-1; Heide L, 2009, METHOD ENZYMOL, V459, P437, DOI 10.1016/S0076-6879(09)04618-7; Herai S, 2004, P NATL ACAD SCI USA, V101, P14031, DOI 10.1073/pnas.0406058101; Hu HF, 2002, J BACTERIOL, V184, P3984, DOI 10.1128/JB.184.14.3984-3991.2002; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kim CG, 2008, ARCH MICROBIOL, V189, P463, DOI 10.1007/s00203-007-0337-3; Kim EJ, 2012, ORG LETT, V14, P5824, DOI 10.1021/ol302575h; Kim JH, 2010, BIOPOLYMERS, V93, P833, DOI 10.1002/bip.21450; KINO T, 1987, J ANTIBIOT, V40, P1249, DOI 10.7164/antibiotics.40.1249; Klettner A, 2003, CNS NEUROL DISORD-DR, V2, P153, DOI 10.2174/1568007033482878; Komatsu M, 2013, ACS SYNTH BIOL, V2, P384, DOI 10.1021/sb3001003; Kosec G, 2012, METAB ENG, V14, P39, DOI 10.1016/j.ymben.2011.11.003; Kouprina N, 2008, NAT PROTOC, V3, P371, DOI 10.1038/nprot.2008.5; Laureti L, 2011, P NATL ACAD SCI USA, V108, P6258, DOI 10.1073/pnas.1019077108; Martinez-Castro M, 2013, APPL MICROBIOL BIOT, V97, P2139, DOI 10.1007/s00253-012-4364-x; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Medini D, 2008, NAT REV MICROBIOL, V6, P419, DOI 10.1038/nrmicro1901; Meier-Kriesche HU, 2006, AM J TRANSPLANT, V6, P1111, DOI 10.1111/j.1600-6143.2006.01270.x; Miao V, 2005, MICROBIOL-SGM, V151, P1507, DOI 10.1099/mic.0.27757-0; Michel G, 1996, IMMUNOL TODAY, V17, P106, DOI 10.1016/0167-5699(96)80599-8; Mo S, 2012, APPL ENVIRON MICROB, V78, P2249, DOI 10.1128/AEM.06766-11; Mo S, 2011, J AM CHEM SOC, V133, P976, DOI 10.1021/ja108399b; Mo S, 2009, J IND MICROBIOL BIOT, V36, P1473, DOI 10.1007/s10295-009-0635-7; Nett M, 2009, NAT PROD REP, V26, P1362, DOI 10.1039/b817069j; Periyasamy S, 2007, ENDOCRINOLOGY, V148, P4716, DOI 10.1210/en.2007-0145; PIFFARETTI JC, 1988, MOL GEN GENET, V212, P215, DOI 10.1007/BF00334687; Polvino W, 2012, GENETIC ENG BIOTECHN, V32; Remitz A, 2009, EXPERT OPIN DRUG SAF, V8, P501, DOI [10.1517/14740330902969441 , 10.1517/14740330902969441]; Shima J, 1996, J BACTERIOL, V178, P7276, DOI 10.1128/jb.178.24.7276-7284.1996; Siebenberg S, 2010, J BIOSCI BIOENG, V109, P230, DOI 10.1016/j.jbiosc.2009.08.479; Sosio M, 2000, NAT BIOTECHNOL, V18, P343, DOI 10.1038/73810; Trede NS, 1997, BONE MARROW TRANSPL, V20, P257, DOI 10.1038/sj.bmt.1700872; Turlo J, 2012, ENZYME MICROB TECH, V51, P388, DOI 10.1016/j.enzmictec.2012.08.008; Yin XH, 2006, MICROBIOL-SGM, V152, P2969, DOI 10.1099/mic.0.29043-0	54	47	50	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e69319	10.1371/journal.pone.0069319	http://dx.doi.org/10.1371/journal.pone.0069319			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874942	gold, Green Published, Green Submitted			2022-12-27	WOS:000322218800069
J	Lakschevitz, FS; Aboodi, GM; Glogauer, M				Lakschevitz, Flavia S.; Aboodi, Guy M.; Glogauer, Michael			Oral Neutrophil Transcriptome Changes Result in a Pro-Survival Phenotype in Periodontal Diseases	PLOS ONE			English	Article							FALSE DISCOVERY RATE; GENE-EXPRESSION; PORPHYROMONAS-GINGIVALIS; AGGRESSIVE PERIODONTITIS; SIGNATURE; APOPTOSIS; MIGRATION; NECROSIS; CELLS; IL-1	Background: Periodontal diseases are inflammatory processes that occur following the influx of neutrophils into the periodontal tissues in response to the subgingival bacterial biofilm. Current literature suggests that while neutrophils are protective and prevent bacterial infections, they also appear to contribute to damage of the periodontal tissues. In the present study we compare the gene expression profile changes in neutrophils as they migrate from the circulation into the oral tissues in patients with chronic periodontits and matched healthy subjects. We hypothesized that oral neutrophils in periodontal disease patients will display a disease specific transcriptome that differs from the oral neutrophil of healthy subjects. Methods: Venous blood and oral rinse samples were obtained from healthy subjects and chronic periodontitis patients for neutrophil isolation. mRNA was isolated from the neutrophils, and gene expression microarray analysis was completed. Results were confirmed for specific genes of interest by qRT-PCR and Western Blot analysis. Results and Discussion: Chronic periodontitis patients presented with increased recruitment of neutrophils to the oral cavity. Gene expression analysis revealed differences in the expression levels of genes from several biological pathways. Using hierarchical clustering analysis, we found that the apoptosis network was significantly altered in patients with chronic inflammation in the oral cavity, with up-regulation of pro-survival members of the Bcl-2 family and down-regulation of pro-apoptosis members in the same compartment. Additional functional analysis confirmed that the percentages of viable neutrophils are significantly increased in the oral cavity of chronic periodontitis patients. Conclusions: Oral neutrophils from patients with periodontal disease displayed an altered transcriptome following migration into the oral tissues. This resulted in a pro-survival neutrophil phenotype in chronic periodontitis patients when compared with healthy subjects, resulting in a longer-lived neutrophil. This is likely to impact the severity and length of the inflammatory response in this oral disease.	[Aboodi, Guy M.; Glogauer, Michael] Univ Toronto, Fac Dent, Dept Periodontol, Toronto, ON, Canada; [Lakschevitz, Flavia S.; Aboodi, Guy M.; Glogauer, Michael] Univ Toronto, Fac Dent, Matrix Dynam Grp, Toronto, ON, Canada	University of Toronto; University of Toronto	Glogauer, M (corresponding author), Univ Toronto, Fac Dent, Dept Periodontol, Toronto, ON, Canada.	michael.glogauer@utoronto.ca	Glogauer, Michael/D-2504-2011	Glogauer, Michael/0000-0002-6248-5977	Canadian Institutes of Health Research (CIHR) [MOP 106433]; Alpha Omega Foundation of Canada (Toronto, ON); CIHR Training Fellowship [TGF-53877]; Harron scholarship (Faculty of Dentistry, University of Toronto); Harron scholarship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alpha Omega Foundation of Canada (Toronto, ON); CIHR Training Fellowship(Canadian Institutes of Health Research (CIHR)); Harron scholarship (Faculty of Dentistry, University of Toronto); Harron scholarship	This work was funded by a Canadian Institutes of Health Research (CIHR) grant MOP 106433 (MG) and the Alpha Omega Foundation of Canada (Toronto, ON). FSL is supported by CIHR Training Fellowship, TGF-53877 and the Harron scholarship (Faculty of Dentistry, University of Toronto). GA is also supported by Harron scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboodi GM, 2011, J PERIODONTOL, V82, P726, DOI 10.1902/jop.2010.100508; Aliprantis AO, 2000, EMBO J, V19, P3325, DOI 10.1093/emboj/19.13.3325; Allantaz F, 2007, J EXP MED, V204, P2131, DOI 10.1084/jem.20070070; Allen EM, 2011, J CLIN PERIODONTOL, V38, P894, DOI 10.1111/j.1600-051X.2011.01764.x; [Anonymous], PER DIS AD AG 20 64; Ariel A, 2006, NAT IMMUNOL, V7, P1209, DOI 10.1038/ni1392; Assuma R, 1998, J IMMUNOL, V160, P403; Atallah M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029333; Barnes TC, 2011, ANN RHEUM DIS, V70, P366, DOI 10.1136/ard.2010.133587; Bender JS, 2006, J PERIODONTAL RES, V41, P214, DOI 10.1111/j.1600-0765.2005.00861.x; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BIFFL WL, 1995, J LEUKOCYTE BIOL, V58, P582, DOI 10.1002/jlb.58.5.582; Chakravarti A, 2009, BLOOD, V114, P1633, DOI 10.1182/blood-2008-09-178301; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Chaussabel D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-84; Christenson K, 2011, J LEUKOCYTE BIOL, V90, P1055, DOI 10.1189/jlb.0111051; Chu VT, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r118; Coldren CD, 2006, AM J PHYSIOL-LUNG C, V291, pL1267, DOI 10.1152/ajplung.00097.2006; Covani U, 2008, J PERIODONTOL, V79, P1974, DOI [10.1902/jop.2008.080062, 10.1902/jop.2008.080062 ]; Crawford JM, 2000, J PERIODONTOL, V71, P1121, DOI 10.1902/jop.2000.71.7.1121; Davanian H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046440; Demmer RT, 2008, J PERIODONTOL, V79, P2112, DOI [10.1902/jop.2008.080139, 10.1902/jop.2008.080139 ]; Dias IHK, 2011, J CLIN PERIODONTOL, V38, P1, DOI 10.1111/j.1600-051X.2010.01628.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fransson M, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-100; Fredman G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024422; Gamonal J, 2003, J CLIN PERIODONTOL, V30, P616, DOI 10.1034/j.1600-051X.2003.00350.x; Giannobile WV, 2009, PERIODONTOL 2000, V50, P52, DOI 10.1111/j.1600-0757.2008.00288.x; Graves D, 2008, J PERIODONTOL, V79, P1585, DOI 10.1902/jop.2008.080183; Guentsch A, 2009, J PERIODONTAL RES, V44, P368, DOI 10.1111/j.1600-0765.2008.01113.x; HART TC, 1994, J PERIODONTOL, V65, P521, DOI 10.1902/jop.1994.65.5s.521; Hayashi F, 2003, BLOOD, V102, P2660, DOI 10.1182/blood-2003-04-1078; HAZIOT A, 1993, J IMMUNOL, V150, P5556; Hernandez M, 2010, J PERIODONTOL, V81, P1644, DOI 10.1902/jop.2010.100196; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ishikawa F, 2005, ARCH IMMUNOL THER EX, V53, P226; Jablonska E, 2009, FOLIA HISTOCHEM CYTO, V47, P615, DOI 10.2478/v10042-008-0118-8; Johnstone AM, 2007, J PERIODONTOL, V78, P1788, DOI 10.1902/jop.2007.070107; Kantarci A, 2003, J PERIODONTOL, V74, P66, DOI 10.1902/jop.2003.74.1.66; Kubota T, 2001, J PERIODONTAL RES, V36, P390, DOI 10.1034/j.1600-0765.2001.360607.x; Lakschevitz FS, 2013, J PERIODONTOL, V84, P1493, DOI 10.1902/jop.2012.120477; Matthews JB, 2007, CLIN EXP IMMUNOL, V147, P255, DOI 10.1111/j.1365-2249.2006.03276.x; McCormack WJ, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2729; Nussbaum G, 2011, J CLIN PERIODONTOL, V38, P49, DOI 10.1111/j.1600-051X.2010.01678.x; Offenbacher S, 2008, J PERIODONTOL, V79, P1577, DOI 10.1902/jop.2008.080220; Ottonello L, 2005, CELL SIGNAL, V17, P355, DOI 10.1016/j.cellsig.2004.08.002; Papapanou PN, 2004, EUR J ORAL SCI, V112, P216, DOI 10.1111/j.1600-0722.2004.00124.x; Renshaw SA, 2006, BLOOD, V108, P3976, DOI 10.1182/blood-2006-05-024075; Reynier F, 2010, GENES IMMUN, V11, P269, DOI 10.1038/gene.2009.112; Salomao R, 2009, CRIT CARE MED, V37, P132, DOI 10.1097/CCM.0b013e318192fbaf; Sato EF, 2003, AM J PHYSIOL-CELL PH, V284, pC1048, DOI 10.1152/ajpcell.00016.2002; Scott DA, 2012, FRONT ORAL BIOL, V15, P56; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stefani FA, 2013, IMMUNOBIOLOGY, P1, DOI [10.1016/j.imbio.2012.12.001, DOI 10.1016/J.IMBI0.2012.12.001]; Suda T, 1997, J BONE MINER RES, V12, P869, DOI 10.1359/jbmr.1997.12.6.869; Taba Mario Jr, 2005, Dent Clin North Am, V49, P551, DOI 10.1016/j.cden.2005.03.009; Van Dyke T E, 1990, Crit Rev Oral Biol Med, V1, P117; Van Dyke TE, 2007, PERIODONTOL 2000, V45, P158, DOI 10.1111/j.1600-0757.2007.00229.x; Wang YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061213; Waris G, 2006, J CARCINOG, V5, P14, DOI [10.1186/1477-3163-5-14, DOI 10.1186/1477-3163-5-14]; Wright HJ, 2008, J IMMUNOL, V181, P5775, DOI 10.4049/jimmunol.181.8.5775; Zaric S, 2010, INFECT IMMUN, V78, P4151, DOI 10.1128/IAI.00600-10; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276	64	60	63	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e68983	10.1371/journal.pone.0068983	http://dx.doi.org/10.1371/journal.pone.0068983			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874838	Green Submitted, Green Published, gold			2022-12-27	WOS:000322218800057
J	Bell, E; Ponthan, F; Whitworth, C; Westermann, F; Thomas, H; Redfern, CPF				Bell, Emma; Ponthan, Frida; Whitworth, Claire; Westermann, Frank; Thomas, Huw; Redfern, Christopher P. F.			Cell Survival Signalling through PPAR delta and Arachidonic Acid Metabolites in Neuroblastoma	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED-RECEPTOR; TRANS-RETINOIC ACID; FENRETINIDE-INDUCED APOPTOSIS; HUMAN HACAT KERATINOCYTES; HUMAN NEURO-BLASTOMA; PROSTATE-CANCER; EXPRESSION; BETA/DELTA; LINES; INDUCTION	Retinoic acid (RA) has paradoxical effects on cancer cells: promoting cell death, differentiation and cell cycle arrest, or cell survival and proliferation. Arachidonic acid (AA) release occurs in response to RA treatment and, therefore, AA and its downstream metabolites may be involved in cell survival signalling. To test this, we inhibited phospholipase A2-mediated AA release, cyclooxygenases and lipoxygenases with small-molecule inhibitors to determine if this would sensitise cells to cell death after RA treatment. The data suggest that, in response to RA, phospholipase A2-mediated release of AA and subsequent metabolism by lipoxygenases is important for cell survival. Evidence from gene expression reporter assays and PPAR delta knockdown suggests that lipoxygenase metabolites activate PPAR delta. The involvement of PPAR delta in cell survival is supported by results of experiments with the PPAR delta inhibitor GSK0660 and siRNA-mediated knockdown. Quantitative reverse transcriptase PCR studies demonstrated that inhibition of 5-lipoxygenase after RA treatment resulted in a strong up-regulation of mRNA for PPAR delta 2, a putative inhibitory PPAR delta isoform. Over-expression of PPAR delta 2 using a tetracycline-inducible system in neuroblastoma cells reduced proliferation and induced cell death. These data provide evidence linking lipoxygenases and PPAR delta in a cell survival-signalling mechanism and suggest new drug-development targets for malignant and hyper-proliferative diseases.	[Bell, Emma; Ponthan, Frida; Whitworth, Claire; Thomas, Huw; Redfern, Christopher P. F.] Newcastle Univ, Northern Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Westermann, Frank] German Canc Res Ctr, Div Tumor Genet, Heidelberg, Germany	Newcastle University - UK; Helmholtz Association; German Cancer Research Center (DKFZ)	Redfern, CPF (corresponding author), Newcastle Univ, Northern Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	chris.redfern@ncl.ac.uk	Westermann, Frank/F-7509-2013	Whitworth, Claire/0000-0003-3174-7652; Redfern, Christopher/0000-0002-1833-8048	SPARKs [08NCL01]; Swedish Children's Cancer Foundation; Neuroblastoma Society, UK	SPARKs; Swedish Children's Cancer Foundation; Neuroblastoma Society, UK	Dr. E. Bell was funded by SPARKs (08NCL01), http://www.sparks.org.uk. Dr. F. Ponthan was supported by the Swedish Children's Cancer Foundation (http://www.barncancerfonden.se/Om-oss/In-English/) and the Neuroblastoma Society, UK (http://www.nsoc.co.uk/news.html). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alique M, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-1; Antony P, 2003, MOL BRAIN RES, V115, P187, DOI 10.1016/S0169-328X(03)00207-9; BIEDLER JL, 1978, CANCER RES, V38, P3751; Borland MG, 2008, MOL PHARMACOL, V74, P1429, DOI 10.1124/mol.108.050609; Borland MG, 2011, CELL SIGNAL, V23, P2039, DOI 10.1016/j.cellsig.2011.07.020; BRODEUR GM, 1977, CANCER-AM CANCER SOC, V40, P2256, DOI 10.1002/1097-0142(197711)40:5<2256::AID-CNCR2820400536>3.0.CO;2-1; Chen KC, 2009, TOXICOLOGY, V262, P199, DOI 10.1016/j.tox.2009.06.009; DIXON RAF, 1990, NATURE, V343, P282, DOI 10.1038/343282a0; Farooqui AA, 2005, REPROD NUTR DEV, V45, P613, DOI 10.1051/rnd:2005049; FEDER MK, 1983, J NATL CANCER I, V70, P1051; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Ghosh J, 2004, BIOCHEM BIOPH RES CO, V315, P624, DOI 10.1016/j.bbrc.2004.01.100; Grant GE, 2011, FREE RADICAL BIO MED, V50, P1297, DOI 10.1016/j.freeradbiomed.2011.02.010; Huang Q, 2011, NAT MED, V17, P860, DOI 10.1038/nm.2385; Lee EO, 2004, J NEUROIMMUNOL, V155, P21, DOI 10.1016/j.jneuroim.2004.05.012; Levine L, 2003, BMC CANCER, V3, P1, DOI 10.1186/1471-2407-3-24; Levine L, 2003, FASEB J, V17, P800, DOI 10.1096/fj.02-0906hyp; Levine L, 2001, PROSTAG LEUKOTR ESS, V65, P229, DOI 10.1054/plef.2001.0316; Liu JP, 2010, CELL MOL BIOL LETT, V15, P440, DOI 10.2478/s11658-010-0016-2; Lovat PE, 2003, J CELL BIOCHEM, V89, P698, DOI 10.1002/jcb.10551; Lovat PE, 2002, CANCER RES, V62, P5158; Lundell K, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-70; Maier TJ, 2008, BIOCHEM PHARMACOL, V76, P862, DOI 10.1016/j.bcp.2008.07.009; Noy N, 2010, ANNU REV NUTR, V30, P201, DOI 10.1146/annurev.nutr.28.061807.155509; O'Flaherty JT, 2005, BBA-MOL CELL BIOL L, V1736, P228, DOI 10.1016/j.bbalip.2005.08.009; Oberthuer A, 2006, J CLIN ONCOL, V24, P5070, DOI 10.1200/JCO.2006.06.1879; Patel MI, 2008, CLIN CANCER RES, V14, P8070, DOI 10.1158/1078-0432.CCR-08-0566; PINHEIRO J, 2008, NMLE LINEAR NONLINEA; Ponthan F, 2007, CLIN CANCER RES, V13, P1036, DOI 10.1158/1078-0432.CCR-06-1908; POWELL WS, 1992, J BIOL CHEM, V267, P19233; R Development Core Team, 2008, R LANG ENV STAT COMP; Redova M, 2010, INT J MOL MED, V25, P271, DOI 10.3892/ijmm_00000341; Rieck M, 2008, MOL PHARMACOL, V74, P1269, DOI 10.1124/mol.108.050625; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; SCUDIERO DA, 1988, CANCER RES, V48, P4827; Shaw N, 2003, J BIOL CHEM, V278, P41589, DOI 10.1074/jbc.C300368200; Shi YH, 2002, P NATL ACAD SCI USA, V99, P2613, DOI 10.1073/pnas.052707099; SIDELL N, 1983, EXP CELL RES, V148, P21, DOI 10.1016/0014-4827(83)90184-2; Soprano DR, 2004, ANNU REV NUTR, V24, P201, DOI 10.1146/annurev.nutr.24.012003.132407; Sugino Y, 2007, ONCOGENE, V26, P7401, DOI 10.1038/sj.onc.1210550; Sveinbjornsson B, 2008, FASEB J, V22, P3525, DOI 10.1096/fj.07-103457; THIELE CJ, 1985, NATURE, V313, P404, DOI 10.1038/313404a0; VERMA AK, 1982, CANCER RES, V42, P3519	44	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68859	10.1371/journal.pone.0068859	http://dx.doi.org/10.1371/journal.pone.0068859			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874790	Green Published, Green Submitted, gold			2022-12-27	WOS:000321736900118
J	Loras, H; Stensdotter, AK; Ohberg, F; Sigmundsson, H				Loras, Havard; Stensdotter, Ann-Katrin; Ohberg, Fredrik; Sigmundsson, Hermundur			Individual Differences in Motor Timing and Its Relation to Cognitive and Fine Motor Skills	PLOS ONE			English	Article							VISUAL TEMPORAL INFORMATION; SENSORIMOTOR SYNCHRONIZATION; PSYCHOMETRIC INTELLIGENCE; NEURAL MECHANISMS; BRAIN; SPEED; TIME; PERFORMANCE; CEREBELLUM; RESOLUTION	The present study investigated the relationship between individual differences in timing movements at the level of milliseconds and performance on selected cognitive and fine motor skills. For this purpose, young adult participants (N = 100) performed a repetitive movement task paced by an auditory metronome at different rates. Psychometric measures included the digit-span and symbol search subtasks from the Wechsler battery as well as the Raven SPM. Fine motor skills were assessed with the Purdue Pegboard test. Motor timing performance was significantly related (mean r = .3) to cognitive measures, and explained both unique and shared variance with information-processing speed of Raven's scores. No significant relations were found between motor timing measures and fine motor skills. These results show that individual differences in cognitive and motor timing performance is to some extent dependent upon shared processing not associated with individual differences in manual dexterity.	[Loras, Havard; Stensdotter, Ann-Katrin; Sigmundsson, Hermundur] Sor Trondelag Univ Coll, Fac Hlth Educ & Social Work, Div Physiotherapy, Trondheim, Norway; [Loras, Havard; Sigmundsson, Hermundur] Norwegian Univ Sci & Technol, Dept Psychol, Res Grp Learning & Skill Dev, N-7034 Trondheim, Norway; [Ohberg, Fredrik] Umea Univ, Dept Biomed Engn & Informat, Umea, Sweden	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Umea University	Loras, H (corresponding author), Sor Trondelag Univ Coll, Fac Hlth Educ & Social Work, Div Physiotherapy, Trondheim, Norway.	havard.loras@hist.no	Sigmundsson, Hermundur/R-7796-2019	Ohberg, Fredrik/0000-0003-3363-7414				[Anonymous], 2003, STANDARD PROGR MATRI; Aschersleben G, 2002, BRAIN COGNITION, V48, P66, DOI 10.1006/brcg.2001.1304; Basar E, 2000, INT J PSYCHOPHYSIOL, V35, P95, DOI 10.1016/S0167-8760(99)00047-1; Bengtsson SL, 2004, EUR J NEUROSCI, V19, P2591, DOI 10.1111/j.0953-816X.2004.03269.x; Birkett EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042820; Braitenberg V, 1967, Prog Brain Res, V25, P334; Buhusi CV, 2013, BEHAV PROCESS, V95, P60, DOI 10.1016/j.beproc.2013.02.015; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Buonomano DV, 2010, TRENDS COGN SCI, V14, P520, DOI 10.1016/j.tics.2010.09.002; Corriveau KH, 2009, CORTEX, V45, P119, DOI 10.1016/j.cortex.2007.09.008; Cowie AP, 1990, OXFORD ADV LEARNERS; Deary I J, 2000, Novartis Found Symp, V233, P58, DOI 10.1002/0470870850.ch4; Deary IJ, 2010, NAT REV NEUROSCI, V11, P201, DOI 10.1038/nrn2793; Dunlap K, 1910, PSYCHOL REV, V17, P203; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Haldemann J, 2012, PERS INDIV DIFFER, V52, P9, DOI 10.1016/j.paid.2011.08.032; Haldemann J, 2011, J INDIVID DIFFER, V32, P181, DOI 10.1027/1614-0001/a000050; Hazeltine E, 1997, TRENDS COGN SCI, V1, P163, DOI 10.1016/S1364-6613(97)01058-9; Helmbold N, 2007, J PERS, V75, P985, DOI 10.1111/j.1467-6494.2007.00463.x; Helmbold N, 2006, CAN J EXP PSYCHOL, V60, P294, DOI 10.1037/cjep2006027; Holm L, 2013, J EXP PSYCHOL HUMAN, V39, P365, DOI 10.1037/a0029142; Holm L, 2011, EXP BRAIN RES, V214, P175, DOI 10.1007/s00221-011-2817-6; Ivry RB, 2002, ANN NY ACAD SCI, V978, P302, DOI 10.1111/j.1749-6632.2002.tb07576.x; Ivry RB, 2004, CURR OPIN NEUROBIOL, V14, P225, DOI 10.1016/j.conb.2004.03.013; IVRY RB, 1988, EXP BRAIN RES, V73, P167, DOI 10.1007/BF00279670; Jensen A R, 2000, Novartis Found Symp, V233, P37, DOI 10.1002/0470870850.ch3; KAIL R, 1994, ACTA PSYCHOL, V86, P199, DOI 10.1016/0001-6918(94)90003-5; Krause V, 2010, NEUROIMAGE, V52, P245, DOI 10.1016/j.neuroimage.2010.03.081; Lafayette Instruments, 2002, PURDUE PEGBOARD TEST, P1; Latash ML, 2006, PHYS THER, V86, P1151, DOI 10.1093/ptj/86.8.1151; Lewis PA, 2003, CURR OPIN NEUROBIOL, V13, P250, DOI 10.1016/S0959-4388(03)00036-9; Linden DEJ, 2007, REV NEUROSCIENCE, V18, P159; Loras H, 2012, EXP BRAIN RES, V220, P335, DOI 10.1007/s00221-012-3142-4; Loras H, 2013, PSYCHOL RES; Madison G, 2004, NEUROSCI LETT, V370, P69, DOI 10.1016/j.neulet.2004.07.094; Madison G, 2009, INTELLIGENCE, V37, P68, DOI 10.1016/j.intell.2008.07.006; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; Neubauer AC, 2009, NEUROSCI BIOBEHAV R, V33, P1004, DOI 10.1016/j.neubiorev.2009.04.001; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Penke L, 2012, MOL PSYCHIATR, V17, P1026, DOI 10.1038/mp.2012.66; Petrill SA, 1996, BEHAV GENET, V26, P135, DOI 10.1007/BF02359891; Pollok B, 2009, HUM BRAIN MAPP, V30, P1783, DOI 10.1002/hbm.20762; Rammsayer TH, 2004, PSYCHOL RES-PSYCH FO, V69, P115, DOI 10.1007/s00426-003-0164-3; Rammsayer TH, 2002, J RES PERS, V36, P507, DOI 10.1016/S0092-6566(02)00006-5; Rammsayer TH, 2007, INTELLIGENCE, V35, P123, DOI 10.1016/j.intell.2006.04.007; Repp BH, 2000, PSYCHOL RES-PSYCH FO, V63, P106, DOI 10.1007/PL00008170; Repp BH, 2005, PSYCHON B REV, V12, P969, DOI 10.3758/BF03206433; Repp BH, 2003, J EXP PSYCHOL HUMAN, V29, P290, DOI 10.1037/0096-1523.29.2.290; Repp BH, 2002, J EXP PSYCHOL HUMAN, V28, P1085, DOI 10.1037//0096-1523.28.5.1085; Repp BH, 2002, J EXP PSYCHOL HUMAN, V28, P410, DOI 10.1037//0096-1523.28.2.410; Repp BH, 2001, HUM MOVEMENT SCI, V20, P277, DOI 10.1016/S0167-9457(01)00049-5; Repp BH, 2013, PSYCHON B REV; Robertson SD, 1999, J EXP PSYCHOL HUMAN, V25, P1316, DOI 10.1037/0096-1523.25.5.1316; Salman MS, 2002, J CHILD NEUROL, V17, P1, DOI 10.1177/088307380201700101; Salthouse TA, 2005, NEUROPSYCHOLOGY, V19, P532, DOI 10.1037/0894-4105.19.4.532; Schnitzler A, 2006, J PHYSIOLOGY-PARIS, V99, P3, DOI 10.1016/j.jphysparis.2005.06.010; Sheppard LD, 2008, PERS INDIV DIFFER, V44, P535, DOI 10.1016/j.paid.2007.09.015; Stevens L. T., 1886, MIND, V11, P393, DOI DOI 10.1093/MIND/OS-XI.43.393; Studenka BE, 2008, HUM MOVEMENT SCI, V27, P29, DOI 10.1016/j.humov.2007.08.004; SURWILLO WALTER W., 1966, BRAIN RES, V2, P390, DOI 10.1016/0006-8993(66)90008-4; Tiesinga P, 2008, NAT REV NEUROSCI, V9, P97, DOI 10.1038/nrn2315; Toplak ME, 2006, J NEUROSCI METH, V151, P15, DOI 10.1016/j.jneumeth.2005.09.018; Troche S, 2008, INT J PSYCHOL, V43, P545; Troche SJ, 2009, PERS INDIV DIFFER, V47, P52, DOI 10.1016/j.paid.2009.02.001; Troche S, 2008, INT J PSYCHOL, V43, P339; Ullen F, 2008, J NEUROSCI, V28, P4238, DOI 10.1523/JNEUROSCI.0825-08.2008; Ullen F, 2007, PHYSIOL BEHAV, V92, P193, DOI 10.1016/j.physbeh.2007.05.036; Ullen F, 2012, INTELLIGENCE, V40, P100, DOI 10.1016/j.intell.2012.01.012; Wechsler D, 2003, WECHSLER ADULT INTEL; Wiener M, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00031; Wiener M, 2010, NEUROIMAGE, V49, P1728, DOI 10.1016/j.neuroimage.2009.09.064; Wilson PH, 2013, DEV MED CHILD NEUROL, V55, P217, DOI 10.1111/j.1469-8749.2012.04436.x; Wing AM, 2002, BRAIN COGNITION, V48, P7, DOI 10.1006/brcg.2001.1301; Zelaznik HN, 2010, J EXP PSYCHOL HUMAN, V36, P1565, DOI 10.1037/a0020380	74	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e69353	10.1371/journal.pone.0069353	http://dx.doi.org/10.1371/journal.pone.0069353			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182JD	23874952	gold, Green Published, Green Submitted			2022-12-27	WOS:000321736900155
J	Bornkessel-Schlesewsky, I; Krauspenhaar, S; Schlesewsky, M				Bornkessel-Schlesewsky, Ina; Krauspenhaar, Sylvia; Schlesewsky, Matthias			Yes, You Can? A Speaker's Potency to Act upon His Words Orchestrates Early Neural Responses to Message-Level Meaning	PLOS ONE			English	Article							SOCIAL COGNITION; LANGUAGE; INTEGRATION; COMPREHENSION; MOOD; TIME; P600; MIND; METAANALYSIS; SIMULATION	Evidence is accruing that, in comprehending language, the human brain rapidly integrates a wealth of information sources-including the reader or hearer's knowledge about the world and even his/her current mood. However, little is known to date about how language processing in the brain is affected by the hearer's knowledge about the speaker. Here, we investigated the impact of social attributions to the speaker by measuring event-related brain potentials while participants watched videos of three speakers uttering true or false statements pertaining to politics or general knowledge: a top political decision maker (the German Federal Minister of Finance at the time of the experiment), a well-known media personality and an unidentifiable control speaker. False versus true statements engendered an N400 - late positivity response, with the N400 (150-450 ms) constituting the earliest observable response to message-level meaning. Crucially, however, the N400 was modulated by the combination of speaker and message: for false versus true political statements, an N400 effect was only observable for the politician, but not for either of the other two speakers; for false versus true general knowledge statements, an N400 was engendered by all three speakers. We interpret this result as demonstrating that the neurophysiological response to message-level meaning is immediately influenced by the social status of the speaker and whether he/she has the power to bring about the state of affairs described.	[Bornkessel-Schlesewsky, Ina] Univ Marburg, Dept German Linguist, Marburg, Germany; [Bornkessel-Schlesewsky, Ina; Krauspenhaar, Sylvia] Max Planck Inst Human Cognit & Brain Sci, Res Grp Neurotypol, Leipzig, Germany; [Schlesewsky, Matthias] Johannes Gutenberg Univ Mainz, Dept English & Linguist, D-55122 Mainz, Germany	Philipps University Marburg; Max Planck Society; Johannes Gutenberg University of Mainz	Bornkessel-Schlesewsky, I (corresponding author), Univ Marburg, Dept German Linguist, Marburg, Germany.	iboke@staff.uni-marburg.de		Bornkessel-Schlesewsky, Ina/0000-0002-3238-6492	Max Planck Society for the Advancement of Science; Interdisciplinary Research Center for Neuroscience at the Johannes Gutenberg-University Mainz; LOEWE programme of the German state of Hesse	Max Planck Society for the Advancement of Science(Max Planck Society); Interdisciplinary Research Center for Neuroscience at the Johannes Gutenberg-University Mainz; LOEWE programme of the German state of Hesse	This work was supported by the Max Planck Society for the Advancement of Science,the Interdisciplinary Research Center for Neuroscience at the Johannes Gutenberg-University Mainz and by the LOEWE programme of the German state of Hesse. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELSON RP, 1982, J PERS SOC PSYCHOL, V42, P619, DOI 10.1037/0022-3514.42.4.619; Astington JW, 1999, DEV PSYCHOL, V35, P1311, DOI 10.1037/0012-1649.35.5.1311; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Baayen R. H., 2008, ANAL LINGUISTIC DATA; Barber H, 2005, J COGNITIVE NEUROSCI, V17, P137, DOI 10.1162/0898929052880101; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Bedny M, 2008, J NEUROSCI, V28, P11347, DOI 10.1523/JNEUROSCI.3039-08.2008; Bornkessel I, 2006, PSYCHOL REV, V113, P787, DOI 10.1037/0033-295X.113.4.787; Bornkessel-Schlesewsky I, 2013, COGNITIVE BIOL BASIS, P241; Bornkessel-Schlesewsky I, 2013, BRAIN LANG, V125, P60, DOI 10.1016/j.bandl.2013.01.010; Bornkessel-Schlesewsky I, 2011, BRAIN LANG, V117, P133, DOI 10.1016/j.bandl.2010.09.010; Bornkessel-Schlesewsky I, 2009, LANG LINGUIST COMPAS, V3, P19, DOI 10.1111/j.1749-818x.2008.00099.x; Bornkessel-Schlesewsky I, 2008, BRAIN RES REV, V59, P55, DOI 10.1016/j.brainresrev.2008.05.003; Brouwer H, 2012, BRAIN RES, V1446, P127, DOI 10.1016/j.brainres.2012.01.055; Carruthers P, 2002, BEHAV BRAIN SCI, V25, P657, DOI 10.1017/S0140525X02000122; Chemers MM., 1997, INTEGRATIVE THEORY L; Chwilla DJ, 2011, J COGNITIVE NEUROSCI, V23, P2400, DOI 10.1162/jocn.2010.21578; Crawley M.J., 2007, R BOOK; Egidi G, 2012, BRAIN LANG, V122, P199, DOI 10.1016/j.bandl.2011.12.008; Federmeier KD, 2009, PSYCHOL LEARN MOTIV, V51, P1, DOI 10.1016/S0079-7421(09)51001-8; Federmeier KD, 2001, NEUROSCI LETT, V305, P149, DOI 10.1016/S0304-3940(01)01843-2; Ferstl EC, 2008, HUM BRAIN MAPP, V29, P581, DOI 10.1002/hbm.20422; Fiske ST, 2007, TRENDS COGN SCI, V11, P77, DOI 10.1016/j.tics.2006.11.005; Frank C Kobayashi, 2010, Open Neuroimag J, V4, P37, DOI 10.2174/1874440001004020037; Frith U, 2010, PHILOS T R SOC B, V365, P165, DOI 10.1098/rstb.2009.0160; Gallese V, 2007, PHILOS T R SOC B, V362, P659, DOI 10.1098/rstb.2006.2002; Hagoort P, 2004, SCIENCE, V304, P438, DOI 10.1126/science.1095455; Hagoort P, 2008, PHILOS T R SOC B, V363, P1055, DOI 10.1098/rstb.2007.2159; Hagoort P, 2007, PHILOS T R SOC B, V362, P801, DOI 10.1098/rstb.2007.2089; Haupt FS, 2008, J MEM LANG, V59, P54, DOI 10.1016/j.jml.2008.02.003; Howes A, 2009, PSYCHOL REV, V116, P717, DOI 10.1037/a0017187; Jacob P, 2005, TRENDS COGN SCI, V9, P21, DOI 10.1016/j.tics.2004.11.003; Kaan E, 2000, LANG COGNITIVE PROC, V15, P159, DOI 10.1080/016909600386084; KINDER DR, 1980, POLITICAL BEHAV, V0002; Kolk HHJ, 2003, BRAIN LANG, V85, P1, DOI 10.1016/S0093-934X(02)00548-5; Kretzschmar F, 2009, NEUROREPORT, V20, P1613, DOI 10.1097/WNR.0b013e328332c4f4; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Lau EF, 2008, NAT REV NEUROSCI, V9, P920, DOI 10.1038/nrn2532; Leslie AM, 1995, SYMP SYSSEN FDN, P121; Mahon BZ, 2008, J PHYSIOL-PARIS, V102, P59, DOI 10.1016/j.jphysparis.2008.03.004; Milligan K, 2007, CHILD DEV, V78, P622, DOI 10.1111/j.1467-8624.2007.01018.x; New J, 2007, P NATL ACAD SCI USA, V104, P16598, DOI 10.1073/pnas.0703913104; Nieuwland MS, 2006, J COGNITIVE NEUROSCI, V18, P1098, DOI 10.1162/jocn.2006.18.7.1098; OSTERHOUT L, 1992, J MEM LANG, V31, P785, DOI 10.1016/0749-596X(92)90039-Z; Pratt NL, 2008, SOC NEUROSCI-UK, V3, P434, DOI 10.1080/17470910802188339; R Development Core Team, 2012, R LANG ENV STAT COMP; Ratnesar R, 2009, TEAR THIS WALL CITY; Regel S, 2011, J COGNITIVE NEUROSCI, V23, P277, DOI 10.1162/jocn.2010.21411; Roehm D, 2007, J COGNITIVE NEUROSCI, V19, P1259, DOI 10.1162/jocn.2007.19.8.1259; Saxe R, 2005, TRENDS COGN SCI, V9, P174, DOI 10.1016/j.tics.2005.01.012; TANENHAUS MK, 1995, SCIENCE, V268, P1632, DOI 10.1126/science.7777863; Tesink CMJY, 2009, J COGNITIVE NEUROSCI, V21, P2085, DOI 10.1162/jocn.2008.21161; Tomasello M, 2008, JEAN NICOD LECT, P1; Van Berkum JJA, 2008, J COGNITIVE NEUROSCI, V20, P580, DOI 10.1162/jocn.2008.20054; Van Berkum JJA, 2009, PSYCHOL SCI, V20, P1092, DOI 10.1111/j.1467-9280.2009.02411.x; de Meerendonk N, 2009, LANG LINGUIST COMPAS, V3, DOI 10.1111/j.1749-818x.2009.00163.x; van de Meerendonk N, 2010, J COGNITIVE NEUROSCI, V22, P67, DOI 10.1162/jocn.2008.21170; Verleger R, 1997, PSYCHOPHYSIOLOGY, V34, P131, DOI 10.1111/j.1469-8986.1997.tb02125.x; Vissers CTWM, 2006, BRAIN RES, V1106, P150, DOI 10.1016/j.brainres.2006.05.012; Vissers CTWM, 2010, NEUROPSYCHOLOGIA, V48, P3521, DOI 10.1016/j.neuropsychologia.2010.08.001; Willems RM, 2010, PSYCHOL SCI, V21, P8, DOI 10.1177/0956797609355563; WILSON WM, 1973, NATURE, V244, P522, DOI 10.1038/244522a0	64	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69173	10.1371/journal.pone.0069173	http://dx.doi.org/10.1371/journal.pone.0069173			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	188BY	23894425	Green Published, gold			2022-12-27	WOS:000322167900042
J	Jetten, N; Donners, MMPC; Wagenaar, A; Cleutjens, JPM; van Rooijen, N; de Winther, MPJ; Post, MJ				Jetten, Nadine; Donners, Marjo M. P. C.; Wagenaar, Allard; Cleutjens, Jack P. M.; van Rooijen, Nico; de Winther, Menno P. J.; Post, Mark J.			Local Delivery of Polarized Macrophages Improves Reperfusion Recovery in a Mouse Hind Limb Ischemia Model	PLOS ONE			English	Article							COLLATERAL ARTERY GROWTH; GENE-EXPRESSION; RABBIT HINDLIMB; ARTERIOGENESIS; ANGIOGENESIS; CELLS; MONOCYTES; DEPLETION; MICE; SUBPOPULATIONS	Aims: Enhancement of collateral development in coronary or peripheral artery disease is a therapeutic target, but it has proven difficult to achieve. Macrophages are key players in collateral remodeling, yet the effect of different macrophage subsets on arteriogenesis has not been investigated. Methods and Results: Murine macrophages were cultured from bone marrow and polarized into M1 (IFN gamma), M2a (IL-4) or M2c (IL-10) subsets. C57BL/6 mice underwent femoral artery ligation followed by intramuscular injection of macrophage subsets. Using eGFP expressing macrophages, cells could be detected at least 6 days after ligation and were located in the perivascular space of collateral vessels. After 14 days, perfusion ratio was increased in animals treated with M1 as well as M2a and M2c macrophages compared to control. Depletion of circulating monocytes by clodronate liposome injections did not hamper reperfusion recovery, however, treatment with exogenous polarized macrophages improved perfusion ratio after 14 days again. We used IL10R(fl/fl)/LysMCre(+) mice to study the effect of inhibition of endogenous polarization towards specifically M2c macrophages on arteriogenesis. Deletion of the IL10-receptor (IL10R) in the myeloid lineage did not affect reperfusion recovery, yet the pro-arteriogenic effect of exogenously injected M2c macrophages was still present. Conclusions: Local injection of polarized macrophages promotes reperfusion recovery after femoral artery ligation and is not influenced by depletion of circulatory monocytes. Preventing endogenous M2c polarization did not affect reperfusion recovery suggesting that M2c's are not required for collateralization, but are sufficient to induce collateral formation upon exogenous administration. This is the first study using local injection of macrophage subsets showing the pro-arteriogenic effect of polarized macrophages.	[Jetten, Nadine; Donners, Marjo M. P. C.] Cardiovasc Res Inst Maastricht CARIM, Dept Mol Genet, Maastricht, Netherlands; [Wagenaar, Allard; Post, Mark J.] Cardiovasc Res Inst Maastricht CARIM, Dept Physiol, Maastricht, Netherlands; [Cleutjens, Jack P. M.] Cardiovasc Res Inst Maastricht CARIM, Dept Pathol, Maastricht, Netherlands; [de Winther, Menno P. J.] AMC, Dept Med Biochem, Amsterdam, Netherlands; [van Rooijen, Nico] VU, Fac Med, Dept Mol Cell Biol, Amsterdam, Netherlands	Maastricht University; Maastricht University; Maastricht University; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Post, MJ (corresponding author), Cardiovasc Res Inst Maastricht CARIM, Dept Physiol, Maastricht, Netherlands.	m.post@maastrichtuniversity.nl	Cleutjens, Jack P.M./F-6242-2012; Van Rooijen, Nico/Z-1578-2019	Cleutjens, Jack P.M./0000-0002-4346-1785; de Winther, Menno/0000-0002-4038-6636	Netherlands Heart Foundation [2007T034, 2012T079, 2007T067]; Netherlands Organisation for Scientific Research (NWO) [917.066.329]; BMM (PENT, iValve); CTMM/Netherland Heart Foundation (EMINENCE): These research programs of the BioMedical Materials institute; Center for Translational and Molecular Medicine; Dutch Ministry of economic affairs Agriculture and Innovation	Netherlands Heart Foundation(Netherlands Heart Foundation); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); BMM (PENT, iValve); CTMM/Netherland Heart Foundation (EMINENCE): These research programs of the BioMedical Materials institute; Center for Translational and Molecular Medicine; Dutch Ministry of economic affairs Agriculture and Innovation	This work was supported by the Netherlands Heart Foundation (Dr. E. Dekker post-doctoral fellow grant [grant numbers 2007T034, 2012T079] to Dr. Donners; Dr. E. Dekker Established Investigator grant [grant number 2007T067] and the Netherlands Organisation for Scientific Research (NWO)-VIDI grant [grant number 917.066.329] to Dr. de Winther). Dr Post is supported by grants from BMM (PENT, iValve) and CTMM/Netherland Heart Foundation (EMINENCE): These research programs of the BioMedical Materials institute and the Center for Translational and Molecular Medicine are co-funded by the Dutch Ministry of economic affairs Agriculture and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arras M, 1998, J CLIN INVEST, V101, P40, DOI 10.1172/JCI119877; Bergmann CE, 2006, J LEUKOCYTE BIOL, V80, P59, DOI 10.1189/jlb.0206087; Buschmann I, 2003, MICROCIRCULATION, V10, P371, DOI 10.1038/sj.mn.7800199; Buschmann IR, 2001, ATHEROSCLEROSIS, V159, P343, DOI 10.1016/S0021-9150(01)00637-2; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Constien R, 2001, GENESIS, V30, P36, DOI 10.1002/gene.1030; Deindl E, 2003, CIRC RES, V92, P561, DOI 10.1161/01.RES.0000061181.80065.7D; Grundmann S, 2005, AM J PHYSIOL-HEART C, V289, pH1497, DOI 10.1152/ajpheart.00959.2004; Heil M, 2006, J CELL MOL MED, V10, P45, DOI 10.1111/j.1582-4934.2006.tb00290.x; Heil M, 2004, CIRC RES, V95, P449, DOI 10.1161/01.RES.0000141145.78900.44; Heil M, 2004, CIRC RES, V94, P671, DOI 10.1161/01.RES.0000122041.73808.B5; Heil M, 2002, AM J PHYSIOL-HEART C, V283, pH2411, DOI 10.1152/ajpheart.01098.2001; Hoefer IE, 2005, ATHEROSCLEROSIS, V181, P285, DOI 10.1016/j.atherosclerosis.2005.01.047; Iba O, 2002, CIRCULATION, V106, P2019, DOI 10.1161/01.CIR.0000031332.45480.79; Ito WD, 1997, CIRC RES, V80, P829; Kanters E, 2004, BLOOD, V103, P934, DOI 10.1182/blood-2003-05-1450; Khmelewski E, 2004, CIRC RES, V95, pE56, DOI 10.1161/01.RES.0000143013.04985.E7; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Kodelja V, 1997, IMMUNOBIOLOGY, V197, P478, DOI 10.1016/S0171-2985(97)80080-0; Kostourou V, 2011, BRIT J CANCER, V104, P83, DOI 10.1038/sj.bjc.6606034; Ligresti G, 2011, ARTERIOSCL THROM VAS, V31, P1151, DOI 10.1161/ATVBAHA.111.223917; Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185; Loke P'ng, 2002, BMC Immunol, V3, P7, DOI 10.1186/1471-2172-3-7; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2009, ARTERIOSCL THROM VAS, V29, P1419, DOI 10.1161/ATVBAHA.108.180497; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; NAGEL T, 1994, J CLIN INVEST, V94, P885, DOI 10.1172/JCI117410; Pils MC, 2010, EUR J IMMUNOL, V40, P443, DOI 10.1002/eji.200939592; Pipp F, 2004, ARTERIOSCL THROM VAS, V24, P1664, DOI 10.1161/01.ATV.0000138028.14390.e4; Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118; SCHAPER J, 1976, VIRCHOWS ARCH A, V370, P193, DOI 10.1007/BF00427580; Schirmer SH, 2009, HEART, V95, P191, DOI 10.1136/hrt.2007.136119; Scholz D, 2000, VIRCHOWS ARCH, V436, P257, DOI 10.1007/s004280050039; SHYY YJ, 1994, P NATL ACAD SCI USA, V91, P4678, DOI 10.1073/pnas.91.11.4678; Summan M, 2006, AM J PHYSIOL-REG I, V290, pR1488, DOI 10.1152/ajpregu.00465.2005; Takeda Y, 2011, NATURE, V479, P122, DOI 10.1038/nature10507; Troidl C, 2013, CURR VASC PHARMACOL, V11, P5, DOI 10.2174/157016113804547629; Troidl K, 2010, J CARDIOVASC PHARM, V55, P153, DOI 10.1097/FJC.0b013e3181c9556f; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Yang HT, 1996, CIRC RES, V79, P62, DOI 10.1161/01.RES.79.1.62	40	32	32	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e68811	10.1371/journal.pone.0068811	http://dx.doi.org/10.1371/journal.pone.0068811			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894348	gold, Green Published, Green Submitted			2022-12-27	WOS:000322167900026
J	Sahu, SN; Lewis, J; Patel, I; Bozdag, S; Lee, JH; Sprando, R; Cinar, HN				Sahu, Surasri N.; Lewis, Jada; Patel, Isha; Bozdag, Serdar; Lee, Jeong H.; Sprando, Robert; Cinar, Hediye Nese			Genomic Analysis of Stress Response against Arsenic in Caenorhabditis elegans	PLOS ONE			English	Article							FATE DETERMINATION FACTOR; DETERMINATION FACTOR DACH1; OXIDATIVE STRESS; TRANSCRIPTION FACTOR; REACTIVE OXYGEN; END-POINTS; GENES; CELLS; TOXICITY; FERRITIN	Arsenic, a known human carcinogen, is widely distributed around the world and found in particularly high concentrations in certain regions including Southwestern US, Eastern Europe, India, China, Taiwan and Mexico. Chronic arsenic poisoning affects millions of people worldwide and is associated with increased risk of many diseases including arthrosclerosis, diabetes and cancer. In this study, we explored genome level global responses to high and low levels of arsenic exposure in Caenorhabditis elegans using Affymetrix expression microarrays. This experimental design allows us to do microarray analysis of dose-response relationships of global gene expression patterns. High dose (0.03%) exposure caused stronger global gene expression changes in comparison with low dose (0.003%) exposure, suggesting a positive dose-response correlation. Biological processes such as oxidative stress, and iron metabolism, which were previously reported to be involved in arsenic toxicity studies using cultured cells, experimental animals, and humans, were found to be affected in C. elegans. We performed genome-wide gene expression comparisons between our microarray data and publicly available C. elegans microarray datasets of cadmium, and sediment exposure samples of German rivers Rhine and Elbe. Bioinformatics analysis of arsenic-responsive regulatory networks were done using FastMEDUSA program. FastMEDUSA analysis identified cancer-related genes, particularly genes associated with leukemia, such as dnj-11, which encodes a protein orthologous to the mammalian ZRF1/MIDA1/MPP11/DNAJC2 family of ribosome-associated molecular chaperones. We analyzed the protective functions of several of the identified genes using RNAi. Our study indicates that C. elegans could be a substitute model to study the mechanism of metal toxicity using high-throughput expression data and bioinformatics tools such as FastMEDUSA.	[Sahu, Surasri N.; Lee, Jeong H.; Cinar, Hediye Nese] US FDA, Div Virulence Assessment, Laurel, MD USA; [Lewis, Jada; Patel, Isha] US FDA, Div Mol Biol, Laurel, MD USA; [Bozdag, Serdar] Marquette Univ, Dept Math Stat & Comp Sci, Milwaukee, WI 53233 USA; [Sahu, Surasri N.] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA; [Lee, Jeong H.] KNU, Taegu, South Korea; [Sprando, Robert] US FDA, Div Toxicol, Laurel, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); Marquette University; Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; US Food & Drug Administration (FDA)	Sprando, R (corresponding author), US FDA, Div Toxicol, Laurel, MD USA.	robert.sprando@fda.hhs.gov; hediye.cinar@fda.hhs.gov						Ahmad S, 2000, ARCH BIOCHEM BIOPHYS, V382, P195, DOI 10.1006/abbi.2000.2023; Anbalagan C, 2012, ECOTOXICOLOGY, V21, P439, DOI 10.1007/s10646-011-0804-0; Anderson GL, 2004, ENVIRON TOXICOL CHEM, V23, P1235, DOI 10.1897/03-264; Anderson GL, 2001, ENVIRON TOXICOL CHEM, V20, P833, DOI [10.1897/1551-5028(2001)020&lt;0833:AOSEFT&gt;2.0.CO;2, 10.1002/etc.5620200419]; Banerjee N, 2008, TOXICOLOGY, V246, P101, DOI 10.1016/j.tox.2007.12.029; Barchowsky A, 1996, FREE RADICAL BIO MED, V21, P783, DOI 10.1016/0891-5849(96)00174-8; Barchowsky A, 1999, FREE RADICAL BIO MED, V27, P1405, DOI 10.1016/S0891-5849(99)00186-0; Barrasa MI, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-21; Bernstam L, 2000, J TOXICOL ENV HEAL B, V3, P293, DOI 10.1080/109374000436355; Boyd WA, 2003, ENVIRON TOXICOL CHEM, V22, P3049, DOI 10.1897/02-565; BOYER TD, 1989, HEPATOLOGY, V9, P486, DOI 10.1002/hep.1840090324; Bozdag S, 2010, BIOINFORMATICS, V26, P1792, DOI 10.1093/bioinformatics/btq275; Bryan CG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-127; BUTTKE TM, 1994, IMMUNOL TODAY, V15, P7, DOI 10.1016/0167-5699(94)90018-3; CAIRO G, 1985, BIOCHEM BIOPH RES CO, V133, P314, DOI 10.1016/0006-291X(85)91877-7; Chervona Y, 2012, METALLOMICS, V4, P619, DOI 10.1039/c2mt20033c; Cui YX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r122; Dai RL, 2011, NEUROCHEM RES, V36, P67, DOI 10.1007/s11064-010-0264-6; Das S, 2010, MOL BIOL REP, V37, P3151, DOI 10.1007/s11033-009-9894-7; de Bono JS, 2012, ANN ONCOL, V23, P1241, DOI 10.1093/annonc/mdr380; Dhawan R, 1999, J TOXICOL ENV HEAL A, V58, P451, DOI 10.1080/009841099157179; Dilda PJ, 2007, CANCER TREAT REV, V33, P542, DOI 10.1016/j.ctrv.2007.05.001; Douer D, 2005, J CLIN ONCOL, V23, P2396, DOI 10.1200/JCO.2005.10.217; DOUGLAS KT, 1987, ADV ENZYMOL RAMB, V59, P103; Ferguson AA, 2010, MOL CELL BIOL, V30, P2651, DOI 10.1128/MCB.01340-09; Flora SJS, 1999, CLIN EXP PHARMACOL P, V26, P865, DOI 10.1046/j.1440-1681.1999.03157.x; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; FREEDMAN JH, 1993, J BIOL CHEM, V268, P2554; Fukada T, 2011, J BIOL INORG CHEM, V16, P1123, DOI 10.1007/s00775-011-0797-4; Ghosh P, 2008, MUTAT RES-REV MUTAT, V659, P293, DOI 10.1016/j.mrrev.2008.06.003; Giezeman-Smits KM, 2000, CANCER RES, V60, P2449; Gornati R, 2002, ATLA-ALTERN LAB ANIM, V30, P597, DOI 10.1177/026119290203000606; Greiner J, 2003, INT J CANCER, V106, P224, DOI 10.1002/ijc.11200; Haider S, 2009, NUCLEIC ACIDS RES, V37, pW23, DOI 10.1093/nar/gkp265; Hasegawa K, 2008, TOXICOL SCI, V101, P215, DOI 10.1093/toxsci/kfm276; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2004, IARC Monogr Eval Carcinog Risks Hum, V84, P1; Inoue H, 2005, GENE DEV, V19, P2278, DOI 10.1101/gad.1324805; JOHNSON TE, 1991, EXP GERONTOL, V26, P299, DOI 10.1016/0531-5565(91)90024-G; Jones D, 1999, J EXP ZOOL, V284, P147, DOI 10.1002/(SICI)1097-010X(19990701)284:2&lt;147::AID-JEZ4&gt;3.0.CO;2-Z; Kaltreider RC, 2001, ENVIRON HEALTH PERSP, V109, P245, DOI 10.1289/ehp.01109245; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kim WK, 2010, J CELL BIOCHEM, V111, P1199, DOI 10.1002/jcb.22846; Knudsen KE, 2010, TRENDS ENDOCRIN MET, V21, P315, DOI 10.1016/j.tem.2010.01.002; KOPPENOL WH, 1993, FREE RADICAL BIO MED, V15, P645, DOI 10.1016/0891-5849(93)90168-T; Kumagai Y, 2007, ANNU REV PHARMACOL, V47, P243, DOI 10.1146/annurev.pharmtox.47.120505.105144; Kundaje A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000224; Liao VHC, 1998, J BIOL CHEM, V273, P31962, DOI 10.1074/jbc.273.48.31962; Liao VHC, 2005, BIOMETALS, V18, P519, DOI 10.1007/s10534-005-2996-3; Liu SX, 2001, P NATL ACAD SCI USA, V98, P1643, DOI 10.1073/pnas.031482998; Lynn S, 2000, CIRC RES, V86, P514, DOI 10.1161/01.RES.86.5.514; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Martinez-Finley EJ, 2011, J TOXICOL-US, V2011, DOI 10.1155/2011/895236; Meneghini R, 1997, FREE RADICAL BIO MED, V23, P783, DOI 10.1016/S0891-5849(97)00016-6; Menzel R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-160; Miotto G, 2007, FUNGAL GENET BIOL, V44, P740, DOI 10.1016/j.fgb.2006.12.004; Nordstrom DK, 2002, SCIENCE, V296, P2143, DOI 10.1126/science.1072375; Okada H, 2001, CANCER RES, V61, P2625; Oremland RS, 2005, SCIENCE, V308, P1305, DOI 10.1126/science.1110832; Park SK, 2009, AGING CELL, V8, P258, DOI 10.1111/j.1474-9726.2009.00473.x; Pi JB, 2003, FREE RADICAL BIO MED, V35, P102, DOI 10.1016/S0891-5849(03)00269-7; Pi JB, 2002, ENVIRON HEALTH PERSP, V110, P331, DOI 10.1289/ehp.02110331; Platanias LC, 2009, J BIOL CHEM, V284, P18583, DOI 10.1074/jbc.R900003200; Popov VM, 2010, TRENDS ENDOCRIN MET, V21, P41, DOI 10.1016/j.tem.2009.08.002; Popov VM, 2009, CANCER RES, V69, P5752, DOI 10.1158/0008-5472.CAN-08-3992; Ralph Stephen John, 2008, Metal-Based Drugs, P260146, DOI 10.1155/2008/260146; Resto VA, 2000, CANCER RES, V60, P5529; Richardson DR, 2008, BBA-GEN SUBJECTS, V1780, P638, DOI 10.1016/j.bbagen.2007.12.009; Robinson JF, 2011, TOXICOL APPL PHARM, V250, P117, DOI 10.1016/j.taap.2010.09.018; Sanz MA, 2009, BLOOD, V113, P1875, DOI 10.1182/blood-2008-04-150250; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shin Heesun, 2011, BMC Res Notes, V4, P34, DOI 10.1186/1756-0500-4-34; SLICE LW, 1990, J BIOL CHEM, V265, P256; SNUTCH TP, 1983, CAN J BIOCHEM CELL B, V61, P480, DOI 10.1139/o83-064; Sok J, 2001, CELL STRESS CHAPERON, V6, P6, DOI 10.1379/1466-1268(2001)006<0006:AIRAPA>2.0.CO;2; Sprando RL, 2009, FOOD CHEM TOXICOL, V47, P722, DOI 10.1016/j.fct.2009.01.007; Sunde JS, 2006, CANCER RES, V66, P8404, DOI 10.1158/0008-5472.CAN-06-0683; Tallman MS, 2002, BLOOD, V99, P759, DOI 10.1182/blood.V99.3.759; Tapio S, 2006, MUTAT RES-REV MUTAT, V612, P215, DOI 10.1016/j.mrrev.2006.02.001; Tenen DG, 2001, LEUKEMIA, V15, P688, DOI 10.1038/sj.leu.2402088; Thomas DJ, 2007, EXP BIOL MED, V232, P3; Tocher DR, 1998, PROG LIPID RES, V37, P73, DOI 10.1016/S0163-7827(98)00005-8; Tsuji Y, 2000, MOL CELL BIOL, V20, P5818, DOI 10.1128/MCB.20.16.5818-5827.2000; Wang W, 2010, BBA-GEN SUBJECTS, V1800, P760, DOI 10.1016/j.bbagen.2010.03.011; Watanabe T, 2013, ARCH TOXICOL, V87, P969, DOI 10.1007/s00204-012-0904-5; Woo SH, 2002, INT J ONCOL, V21, P57; Wu KM, 2007, MOL BIOL CELL, V18, P755, DOI 10.1091/mbc.E06-09-0793; Wu KM, 2006, MOL CELL BIOL, V26, P7116, DOI 10.1128/MCB.00268-06; Wu MM, 2001, ENVIRON HEALTH PERSP, V109, P1011, DOI 10.2307/3454955; Zhang XY, 2012, CANCER LETT, V318, P93, DOI 10.1016/j.canlet.2011.12.005	90	22	26	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e66431	10.1371/journal.pone.0066431	http://dx.doi.org/10.1371/journal.pone.0066431			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894281	Green Published, Green Submitted, gold			2022-12-27	WOS:000322167900004
J	Li, JF; Abuduresule, I; Hueber, FM; Li, WY; Hu, XJ; Li, YZ; Li, CS				Li, Jin-Feng; Abuduresule, Idelisi; Hueber, Francis M.; Li, Wen-Ying; Hu, Xin-Jun; Li, Yue-Zhuo; Li, Cheng-Sen			Buried in Sands: Environmental Analysis at the Archaeological Site of Xiaohe Cemetery, Xinjiang, China	PLOS ONE			English	Article							YANGHAI TOMBS; POLLEN GRAINS; BP; POACEAE	Palynomorphs extracted from the mud coffins and plant remains preserved at the archaeological site of Xiaohe Cemetery (Cal. 3980 to 3540 years BP) in Lop Nur Desert of Xinjiang, China were investigated for the reconstruction of the ancient environments at the site. The results demonstrate that the Xiaohe People lived at a well-developed oasis, which was surrounded by extensive desert. The vegetation in the oasis consisted of Populus, Phragmites, Typha and probably of Gramineae, while the desert surrounding the oasis had some common drought-resistant plants dominated by Ephedra, Tamarix, Artemisia and Chenopodiaceae. This present work provides the first data of the environmental background at this site for further archaeological investigation.	[Li, Jin-Feng; Li, Cheng-Sen] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Abuduresule, Idelisi; Li, Wen-Ying; Hu, Xin-Jun] Xinjiang Cultural Rel & Archaeol Inst, Urumqi, Peoples R China; [Hueber, Francis M.] Smithsonian Inst, Dept Paleobiol, Washington, DC 20560 USA; [Li, Yue-Zhuo] Sanya Museum Nat Hist, Sanya, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Smithsonian Institution; Smithsonian National Museum of Natural History	Li, CS (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China.	lics@ibcas.ac.cn	li, jinfeng/GVS-5425-2022		National Social Science Fund [12AZD085]	National Social Science Fund	This investigation was supported by a National Social Science Fund grant (No. 12AZD085). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber EW., 1999, MUMMIES URUMCHI; Bergman F, 1939, ARCHAEOLOGICAL RES S, P51; Bush MB, 2002, PALAEOGEOGR PALAEOCL, V177, P5, DOI 10.1016/S0031-0182(01)00348-0; CUSHING E J, 1967, Review of Palaeobotany and Palynology, V4, P87, DOI 10.1016/0034-6667(67)90175-3; Ferguson DK, 2007, CR PALEVOL, V6, P423, DOI 10.1016/j.crpv.2007.09.018; Flattery DS, 1989, J NEAR E STUD, V21, P67; Hedin SA, 1944, HIST EXPEDITION ASIA, V3, P215; Hu YQ, 2007, J ARCHAEOL SCI, V34, P1153, DOI 10.1016/j.jas.2006.10.026; Jiang HE, 2008, J ARCHAEOL SCI, V35, P1311, DOI 10.1016/j.jas.2007.09.006; Jiang HE, 2007, J ETHNOPHARMACOL, V113, P409, DOI 10.1016/j.jep.2007.06.020; Jiang HE, 2006, J ETHNOPHARMACOL, V108, P414, DOI 10.1016/j.jep.2006.05.034; Jiang HE, 2007, J ARCHAEOL SCI, V34, P167, DOI 10.1016/j.jas.2006.04.003; Jiang HE, 2013, VEG HIST ARCHAEOBOT, V22, P129, DOI 10.1007/s00334-012-0365-z; Lee MR, 2011, J ROY COLL PHYS EDIN, V41, P78, DOI 10.4997/JRCPE.2011.116; Li CX, 2011, J ARCHAEOL SCI, V38, P115, DOI 10.1016/j.jas.2010.08.016; Li CX, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-15; Li XQ, 1999, ACTA BOT SIN, V41, P782; MAHABALE TS, 1968, REV PALAEOBOT PALYNO, V7, P285, DOI 10.1016/0034-6667(68)90034-1; Mahdihassan S, 1987, Anc Sci Life, V7, P105; Mair VH, 2006, J INDO-EUR STUD, V34, P273; Peacock E, 2005, J ALABAMA ARCHAEOLOG, V51, P32; Relics and Archaeology Institute of Xinjiang Uygur Autonomous Region, 2007, CULTURAL RELICS, V10, P4; Steeves MW, 1959, J ARNOLD ARBORETUM, V40, P221; WANG B, 1983, NONGYE KAOGU, V1, P102; Wang B. H., 1993, ARCHAEOBIOLOGICAL SU; Wang BH, 1983, J XINJIANG U PHILOS, V2, P86; Wang BH, 1989, HONGYE KAOGU FAXIAN, V1, P70; Wang XL, 1999, J NW U NAT EDITION, V29, P250; Wang Z, 1984, FLORA CHINA, p[20, 79]; Xia L., 1997, SOC SCI CHINA, V3, P115; Yan S, 1998, ACTA GEOGRAPHICA SIN, V53, P332; [杨维康 Yang Weikang], 2004, [干旱区地理, Arid Land Geography], V27, P186; Yao YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039780; Yuan G.Y., 1998, ACTA GEOGR SIN, V53, P83, DOI [10.11821/xb1998s1011, DOI 10.11821/XB1998S1011]; Zhang H, 1998, J DESERT RES, V18, P308; 吴玉书, 1994, 干旱区地理, V17, P24	36	7	7	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e68957	10.1371/journal.pone.0068957	http://dx.doi.org/10.1371/journal.pone.0068957			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894382	Green Published, Green Submitted, gold			2022-12-27	WOS:000322132100033
J	Zhang, HT; Ma, H; Li, L; Zhang, ZH; Xu, Y				Zhang, Hongtuan; Ma, Hui; Li, Liang; Zhang, Zhihong; Xu, Yong			Association of Methylenetetrahydrofolate Dehydrogenase 1 Polymorphisms with Cancer: A Meta-Analysis	PLOS ONE			English	Article							ONE-CARBON METABOLISM; ACUTE LYMPHOBLASTIC-LEUKEMIA; PATHWAY GENE POLYMORPHISMS; GENOME-WIDE ASSOCIATION; PROSTATE-CANCER; TRIFUNCTIONAL ENZYME; POLISH POPULATION; BREAST-CANCER; RISK-FACTOR; FOLATE	Background: Studies investigating the association between single-nucleotide polymorphisms (SNPs) of the methylenetetrahydrofolate dehydrogenase 1 (MTHFD1) and cancer risk report conflicting results. To derive a more precise estimation of the relationship between MTHFD1 polymorphisms and cancer risk, the present meta-analysis was carried out. Methodology/Principal Findings: A comprehensive search was conducted to determine all the eligible studies about MTHFD1 polymorphisms and cancer risk. Combined odds ratios (ORs) and 95% confidence intervals (CIs) were used to assess the strength of the association between the MTHFD1 polymorphisms and cancer risk. We investigated by meta-analysis the effects of 2 polymorphisms in MTHFD1: G1958A (17 studies, 12348 cases, 44132 controls) and G401A (20 studies, 8446 cases, 14020 controls). The overall results indicated no major influence of these 2 polymorphisms on cancer risk. For G1958A, a decreased cancer risk was found in acute lymphoblastic leukemia (ALL)/Asians (the dominant: OR = 0.74, 95% CI = 0.58-0.94, P = 0.01; allelic: OR = 0.80, 95% CI = 0.65-0.99, P = 0.04) and other cancers (recessive: OR = 0.80, 95% CI = 0.66-0.96, P = 0.02). For G401A, the data showed that MTHFD1 G401A polymorphism was associated with a decreased colon cancer risk under dominant model (OR = 0.89, 95% CI = 0.80-0.99, P = 0.04). Conclusions: The results suggest that MTHFD1 G1958A polymorphism might be associated with a decreased risk of ALL and other cancers. Meanwhile, the MTHFD1 G401A might play a protective role in the development of colon cancer. Large-scale and well-designed case-control studies are necessary to validate the risk identified in the present meta-analysis.	[Zhang, Hongtuan; Zhang, Zhihong; Xu, Yong] Tianjin Med Univ, Affiliated Hosp 2, Natl Key Clin Specialty Urol, Tianjin Key Inst Urol, Tianjin, Peoples R China; [Ma, Hui] Tianjin Med Univ, Hosp 2, Dept Obstet & Gynaecol, Tianjin, Peoples R China; [Li, Liang] Tianjin Med Univ, Sch Life Sci, Lab Populat & Quantitat Genet, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Xu, Y (corresponding author), Tianjin Med Univ, Affiliated Hosp 2, Natl Key Clin Specialty Urol, Tianjin Key Inst Urol, Tianjin, Peoples R China.	xymnwk@163.com	zhang, zh/GWV-4677-2022		National Natural Science Foundation of China [81172451]; Tianjin Major Anti-Cancer Project [12ZCDZSY17200]; Science Foundation of Tianjin Medical University. [2009GSI18]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Major Anti-Cancer Project; Science Foundation of Tianjin Medical University.	This study was supported by the National Natural Science Foundation of China (NO: 81172451), Tianjin Major Anti-Cancer Project (12ZCDZSY17200), and Science Foundation of Tianjin Medical University. (NO: 2009GSI18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Bredberg A, 2011, CANCER-AM CANCER SOC, V117, P440, DOI 10.1002/cncr.25440; Brody LC, 2002, AM J HUM GENET, V71, P1207, DOI 10.1086/344213; CANTONI GL, 1953, J BIOL CHEM, V204, P403; Chan JYS, 2011, HEMATOL ONCOL, V29, P116, DOI 10.1002/hon.965; Charasson V, 2009, EUR J CANCER, V45, P2391, DOI 10.1016/j.ejca.2009.05.013; Chen J, 2004, INT J CANCER, V110, P617, DOI 10.1002/ijc.20148; Chen LH, 1997, J BIOL CHEM, V272, P3628, DOI 10.1074/jbc.272.6.3628; Collin SM, 2009, CANCER EPIDEM BIOMAR, V18, P2528, DOI 10.1158/1055-9965.EPI-09-0223; Curtin K, 2007, CARCINOGENESIS, V28, P1672, DOI 10.1093/carcin/bgm089; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DICKERSIN K, 1992, JAMA-J AM MED ASSOC, V267, P374, DOI 10.1001/jama.267.3.374; Duthie SJ, 1999, BRIT MED BULL, V55, P578, DOI 10.1258/0007142991902646; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Friso S, 2005, CURR DRUG METAB, V6, P37, DOI 10.2174/1389200052997339; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; HUM DW, 1988, J BIOL CHEM, V263, P15946; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P281, DOI 10.1001/jama.279.4.281; Kelemen LE, 2010, CANCER EPIDEM BIOMAR, V19, P1822, DOI 10.1158/1055-9965.EPI-09-1317; Kruszyna L, 2010, MOL BIOL REP, V37, P241, DOI 10.1007/s11033-009-9643-y; Linhart HG, 2009, GASTROENTEROLOGY, V136, P227, DOI 10.1053/j.gastro.2008.10.016; Liu AY, 2012, MOL NUTR FOOD RES, DOI [10.1002/ mnfr. 201200180, DOI 10.1002/MNFR.201200180.]; Ma E, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-122; MANTEL N, 1959, J NATL CANCER I, V22, P719; Metayer C, 2011, CANCER CAUSE CONTROL, V22, P1243, DOI 10.1007/s10552-011-9795-7; Mostowska A, 2006, CLIN GENET, V69, P512, DOI 10.1111/j.1399-0004.2006.00618.x; Mostowska A, 2011, CLIN BIOCHEM, V44, P596, DOI 10.1016/j.clinbiochem.2011.02.007; Murabito JM, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S6; Parle-McDermott A, 2005, AM J MED GENET A, V132A, P365, DOI 10.1002/ajmg.a.30354; Pawlik P, 2012, MOL BIOL REP, V39, P5553, DOI 10.1007/s11033-011-1359-0; Pharoah PDP, 2004, NAT REV CANCER, V4, P850, DOI 10.1038/nrc1476; da Silva LMB, 2012, MOL BIOL REP, V39, P887, DOI 10.1007/s11033-011-0813-3; da Silva LMRB, 2011, REV ASSOC MED BRAS, V57, P194, DOI 10.1590/S0104-42302011000200018; Galbiatti ALS, 2012, EUR J CANCER, V48, P1525, DOI 10.1016/j.ejca.2011.09.025; Stevens VL, 2007, CANCER EPIDEM BIOMAR, V16, P1140, DOI 10.1158/1055-9965.EPI-06-1037; Stevens VL, 2008, CANCER EPIDEM BIOMAR, V17, P3612, DOI 10.1158/1055-9965.EPI-08-0789; Vainer A S, 2010, Mol Biol (Mosk), V44, P816; Wang L, 2005, CLIN GASTROENTEROL H, V3, P743, DOI 10.1016/S1542-3565(05)00156-4; Wang L, 2007, LUNG CANCER, V57, P143, DOI 10.1016/j.lungcan.2007.03.002; Wang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058041; Wang YM, 2007, CANCER CAUSE CONTROL, V18, P143, DOI 10.1007/s10552-006-0097-4; Weiner AS, 2011, LEUKEMIA RES, V35, P508, DOI 10.1016/j.leukres.2010.10.004; Yang L, 2011, LEUKEMIA LYMPHOMA, V52, P1770, DOI 10.3109/10428194.2011.578186; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zhang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059570	46	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e69366	10.1371/journal.pone.0069366	http://dx.doi.org/10.1371/journal.pone.0069366			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894459	Green Submitted, Green Published, gold			2022-12-27	WOS:000322391400053
J	Horne, BD; Lappe, DL; Muhlestein, JB; May, HT; Ronnow, BS; Brunisholz, KD; Kfoury, AG; Bunch, TJ; Alharethi, R; Budge, D; Whisenant, BK; Bair, TL; Jensen, KR; Anderson, JL				Horne, Benjamin D.; Lappe, Donald L.; Muhlestein, Joseph B.; May, Heidi T.; Ronnow, Brianna S.; Brunisholz, Kimberly D.; Kfoury, Abdallah G.; Bunch, T. Jared; Alharethi, Rami; Budge, Deborah; Whisenant, Brian K.; Bair, Tami L.; Jensen, Kurt R.; Anderson, Jeffrey L.			Repeated Measurement of the Intermountain Risk Score Enhances Prognostication for Mortality	PLOS ONE			English	Article							PREDICTION	Background: The Intermountain Risk Score (IMRS), composed of the complete blood count (CBC) and basic metabolic profile (BMP), predicts mortality and morbidity in medical and general populations. Whether longitudinal repeated measurement of IMRS is useful for prognostication is an important question for its clinical applicability. Methods: Females (N = 5,698) and males (N = 5,437) with CBC and BMP panels measured 6 months to 2.0 years apart (mean 1.0 year) had baseline and follow-up IMRS computed. Survival analysis during 4.0 +/- 2.5 years (maximum 10 years) evaluated mortality (females: n = 1,255 deaths; males: n = 1,164 deaths) and incident major events (myocardial infarction, heart failure [HF], and stroke). Results: Both baseline and follow-up IMRS (categorized as high-risk vs. low-risk) were independently associated with mortality (all p<0.001) in bivariable models. For females, follow-up IMRS had hazard ratio (HR) = 5.23 (95% confidence interval [CI] = 4.11, 6.64) and baseline IMRS had HR = 3.66 (CI = 2.94, 4.55). Among males, follow-up IMRS had HR = 4.28 (CI = 3.51, 5.22) and baseline IMRS had HR = 2.32 (CI = 1.91, 2.82). IMRS components such as RDW, measured at both time points, also predicted mortality. Baseline and follow-up IMRS strongly predicted incident HF in both genders. Conclusions: Repeated measurement of IMRS at baseline and at about one year of follow-up were independently prognostic for mortality and incident HF among initially hospitalized patients. RDW and other CBC and BMP values were also predictive of outcomes. Further research should evaluate the utility of IMRS as a tool for clinical risk adjustment.	[Horne, Benjamin D.; Lappe, Donald L.; Muhlestein, Joseph B.; May, Heidi T.; Ronnow, Brianna S.; Brunisholz, Kimberly D.; Kfoury, Abdallah G.; Bunch, T. Jared; Alharethi, Rami; Budge, Deborah; Whisenant, Brian K.; Bair, Tami L.; Jensen, Kurt R.; Anderson, Jeffrey L.] Intermt Med Ctr, Intermt Heart Inst, Salt Lake City, UT USA; [Horne, Benjamin D.] Univ Utah, Genet Epidemiol Div, Salt Lake City, UT USA; [Lappe, Donald L.; Muhlestein, Joseph B.; Kfoury, Abdallah G.; Whisenant, Brian K.; Anderson, Jeffrey L.] Univ Utah, Div Cardiol, Salt Lake City, UT USA; [Bunch, T. Jared] Utah State Univ, Dept Nutr, Logan, UT 84322 USA	Intermountain Healthcare; Intermountain Medical Center; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; Utah State University	Horne, BD (corresponding author), Intermt Med Ctr, Intermt Heart Inst, Salt Lake City, UT USA.	benjamin.horne@imail.org	Horne, Benjamin/GQP-7851-2022	May, Heidi/0000-0002-7524-5905				Anderson JL, 2007, AM J CARDIOL, V99, P169, DOI 10.1016/j.amjcard.2006.08.015; Cooney MT, 2009, J AM COLL CARDIOL, V54, P1209, DOI 10.1016/j.jacc.2009.07.020; Grady D, 2011, ARCH INTERN MED, V171, P1701, DOI 10.1001/archinternmed.2011.482; Horne BD, 2011, TRANSL RES, V158, P307, DOI 10.1016/j.trsl.2011.06.004; Horne BD, 2010, EUR J HEART FAIL, V12, P1203, DOI 10.1093/eurjhf/hfq115; Horne BD, 2009, AM J MED, V122, P550, DOI 10.1016/j.amjmed.2008.10.043; Moons KGM, 2012, HEART, V98, P691, DOI 10.1136/heartjnl-2011-301247; Muller-Riemenschneider F, 2010, ARCH INTERN MED, V170, P719, DOI 10.1001/archinternmed.2010.66	8	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e69160	10.1371/journal.pone.0069160	http://dx.doi.org/10.1371/journal.pone.0069160			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23874899	gold, Green Published, Green Submitted			2022-12-27	WOS:000322000600044
J	Hamada, Y; Nishijima, T; Komatsu, H; Teruya, K; Gatanaga, H; Kikuchi, Y; Oka, S				Hamada, Yohei; Nishijima, Takeshi; Komatsu, Hirokazu; Teruya, Katsuji; Gatanaga, Hiroyuki; Kikuchi, Yoshimi; Oka, Shinichi			Is Ritonavir-Boosted Atazanavir a Risk for Cholelithiasis Compared to Other Protease Inhibitors?	PLOS ONE			English	Article							RENAL STONES; HIV; PATIENT; UROLITHIASIS; EPIDEMIOLOGY; COMBINATION; EFAVIRENZ; THERAPY; DISEASE	Objective: To compare the incidence of complicated cholelithiasis in patients receiving ritonavir-boosted atazanavir (ATV/r)-containing antiretroviral therapy with those on other protease inhibitors (PIs). Design: We conducted a single-center retrospective cohort study of patients who started either ritonavir-boosted ATV/r- or other PIs (ritonavir-boosted fosamprenavir, unboosted fosamprenavir, lopinavir/ritonavir, and ritonavir-boosted darunavir) - containing antiretroviral therapy. Methods: The incidence of complicated cholelithiasis was determined in each group. Complicated cholelithiasis was defined as follows: 1) cholelithiasis complicated by cholecystitis, cholangitis, or pancreatitis or 2) symptomatic cholelithiasis or choledocholithiasis which required invasive procedures such as cholecystomy and endoscopic retrograde cholangiopancreatography. The effects of ATV/r were estimated by univariate and multivariate Cox hazards models as the primary exposure. Results: Complicated cholelithiasis was diagnosed in 3 patients (2.23 per 1000 person-years) in the ATV/r group (n = 466), and 3 (1.64 per 1000 person-years) in the other PIs group (n = 776), respectively. The incidence was not statistically different in the two groups by log-rank test (P = 0.702). By univariate and multivariate analysis adjusted for age and body weight, ATV/r use was not associated with cholelithiasis. (HR = 1.365; 95% CI, 0.275-6.775; p = 0.704) (adjusted HR = 1.390; 95% CI, 0.276-7.017; p = 0.690). For the 3 patients who developed cholelithiasis in the ATV/r group, the time to the diagnosis of cholelithiasis was 18, 34, and 39 months, respectively. Conclusion: In this study, the incidence of complicated cholelithiasis was low and was not different between patients on ATV/r and those on other PIs. On the contrary to ATV/r-associated nephrolithiasis, the possible risk of cholelithiasis should not preclude the use of ATV/r.	[Hamada, Yohei; Nishijima, Takeshi; Teruya, Katsuji; Gatanaga, Hiroyuki; Kikuchi, Yoshimi; Oka, Shinichi] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan; [Komatsu, Hirokazu] Saku Cent Hosp, Dept Community Care, Nagano, Japan; [Nishijima, Takeshi; Gatanaga, Hiroyuki; Oka, Shinichi] Kumamoto Univ, Ctr AIDS Res, Kumamoto, Japan	National Center for Global Health & Medicine - Japan; Kumamoto University	Gatanaga, H (corresponding author), Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan.	higatana@acc.ncgm.go.jp		Oka, Shinichi/0000-0002-9283-2167; Hamada, Yohhei/0000-0002-9845-4267	Ministry of Health, Labor, and Welfare, Japan [H23-AIDS-001]; Ministry of Education, Science, Sports and Culture of Japan	Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for AIDS research from the Ministry of Health, Labor, and Welfare, Japan (H23-AIDS-001), and the Global Center of Excellence Program from the Ministry of Education, Science, Sports and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan-Tack KM, 2007, AIDS, V21, P1215, DOI 10.1097/QAD.0b013e32813aee35; Chang HR, 2006, NEW ENGL J MED, V355, P2158, DOI 10.1056/NEJMc061892; Courbon E, 2012, J ANTIMICROB CHEMOTH, V67, P250, DOI 10.1093/jac/dkr435; Couzigou C, 2007, CLIN INFECT DIS, V45, pE105, DOI 10.1086/521930; FRIEDMAN GD, 1966, J CHRON DIS, V19, P273, DOI 10.1016/0021-9681(66)90132-9; Hamada Y, 2012, CLIN INFECT DIS, V55, P1262, DOI 10.1093/cid/cis621; Jacques AC, 2010, ANN PHARMACOTHER, V44, P202, DOI 10.1345/aph.1M489; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; MABEE TM, 1976, SURGERY, V79, P460; Molina JM, 2010, JAIDS-J ACQ IMM DEF, V53, P323, DOI 10.1097/QAI.0b013e3181c990bf; Moriyama Y, 2008, UROL RES, V36, P275, DOI 10.1007/s00240-008-0147-3; Rakotondravelo S, 2012, CLIN INFECT DIS, V55, P1270, DOI 10.1093/cid/cis620; Rockwood N, 2011, AIDS, V25, P1671, DOI 10.1097/QAD.0b013e32834a1cd6; Siveke JT, 2003, CLIN INFECT DIS, V36, P1498, DOI 10.1086/374875; Squires K, 2004, JAIDS-J ACQ IMM DEF, V36, P1011, DOI 10.1097/00126334-200408150-00003; Stinton LM, 2010, GASTROENTEROL CLIN N, V39, P157, DOI 10.1016/j.gtc.2010.02.003; Verdon R, 2002, CLIN INFECT DIS, V35, pE57, DOI 10.1086/341982	17	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e69845	10.1371/journal.pone.0069845	http://dx.doi.org/10.1371/journal.pone.0069845			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23875004	Green Published, gold, Green Submitted			2022-12-27	WOS:000322064300121
J	Martinez, I; Muller, CE; Walter, J				Martinez, Ines; Muller, Catherine E.; Walter, Jens			Long-Term Temporal Analysis of the Human Fecal Microbiota Revealed a Stable Core of Dominant Bacterial Species	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; GUT MICROBIOME; ECOLOGY; COMMUNITIES; MICROFLORA; DIVERSITY; DISEASE; HEALTH; ROLES; FLORA	Next-generation sequencing has greatly contributed to an improved ecological understanding of the human gut microbiota. Nevertheless, questions remain regarding the characteristics of this ecosystem and the ecological processes that shape it, and controversy has arisen regarding the stability of the bacterial populations and the existence of a temporal core. In this study, we have characterized the fecal microbial communities of three human individuals over a one-year period by 454 pyrosequencing of 16S rRNA tags in order to investigate the temporal characteristics of the bacterial communities. The findings revealed a temporal core of 33 to 40 species-level Operational Taxonomic Units (OTUs) within subjects. Although these OTUs accounted only for around 12% of the total OTUs detected, they added up to >75% of the total sequences obtained for each individual. In order to determine the capacity of the sequencing and bioinformatic approaches applied during this study to accurately determine the proportion of a core microbiota, we analyzed the fecal microbiota of nine mice with a defined three-member community. This experiment revealed that the sequencing approach inflated the amount of rare OTUs, which introduced a significant degree of artificial variation across samples, and hence reduced the apparent fraction of shared OTUs. However, when assessing the data quantitatively by focusing on dominant lineages, the sequencing approaches deliver an accurate representation of the community. In conclusion, this study revealed that the human fecal microbiota is dominated by around 40 species that maintain persistent populations over the duration of one year. The findings allow conclusions about the ecological factors that shape the community and support the concept of a homeostatic ecosystem controlled largely by deterministic processes. Our analysis of a three-member community revealed that methodological artifacts of OTU-based approaches complicate core calculations, and these limitations have to be considered in the interpretation of microbiome studies.	[Martinez, Ines; Muller, Catherine E.; Walter, Jens] Univ Nebraska, Dept Food Sci & Technol, Lincoln, NE 68583 USA	University of Nebraska System; University of Nebraska Lincoln	Walter, J (corresponding author), Univ Nebraska, Dept Food Sci & Technol, Lincoln, NE 68583 USA.	jwalter2@unl.edu	Walter, Jens/AAA-7636-2020	Walter, Jens/0000-0003-1754-172X				Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Cheng L, 2012, NUCLEIC ACIDS RES, V40, P5240, DOI 10.1093/nar/gks227; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; Davis LMG, 2010, INT J FOOD MICROBIOL, V144, P285, DOI 10.1016/j.ijfoodmicro.2010.10.007; Davis LMG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025200; de Vos WM, 2012, NUTR REV, V70, pS45, DOI 10.1111/j.1753-4887.2012.00505.x; Degnan PH, 2012, P NATL ACAD SCI USA, V109, P13034, DOI 10.1073/pnas.1110994109; Dethlefsen L, 2006, TRENDS ECOL EVOL, V21, P517, DOI 10.1016/j.tree.2006.06.013; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Emerson BC, 2008, TRENDS ECOL EVOL, V23, P619, DOI 10.1016/j.tree.2008.07.005; Fierer N, 2012, ANNU REV ECOL EVOL S, V43, P137, DOI 10.1146/annurev-ecolsys-110411-160307; Flint HJ, 2012, NAT REV GASTRO HEPAT, V9, P577, DOI 10.1038/nrgastro.2012.156; Frese SA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001314; Gordon JI, 2011, P NATL ACAD SCI USA, V108, P4513, DOI 10.1073/pnas.1101958108; GOSSLING J, 1974, INFECT IMMUN, V9, P719, DOI 10.1128/IAI.9.4.719-729.1974; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Hubbell SP, 2006, ECOLOGY, V87, P1387, DOI 10.1890/0012-9658(2006)87[1387:NTATEO]2.0.CO;2; Jalanka-Tuovinen J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023035; Jeraldo P, 2012, P NATL ACAD SCI USA, V109, P9692, DOI 10.1073/pnas.1206721109; Jernberg C, 2010, MICROBIOL-SGM, V156, P3216, DOI 10.1099/mic.0.040618-0; JOHNSON JL, 1980, APPL ENVIRON MICROB, V39, P407, DOI 10.1128/AEM.39.2.407-413.1980; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Martinez I, 2013, ISME J, V7, P269, DOI 10.1038/ismej.2012.104; Martinez I, 2009, APPL ENVIRON MICROB, V75, P4175, DOI 10.1128/AEM.00380-09; McCartney AL, 1996, APPL ENVIRON MICROB, V62, P4608, DOI 10.1128/AEM.62.12.4608-4613.1996; McFall-Ngai M, 2007, NATURE, V445, P153, DOI 10.1038/445153a; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; Ochman H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000546; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rajilic-Stojanovic M., 2012, ENV MICROBIOL; Robinson CJ, 2010, MICROBIOL MOL BIOL R, V74, P453, DOI 10.1128/MMBR.00014-10; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; SAVAGE DC, 1972, AM J CLIN NUTR, V25, P1372; Scanlan PD, 2006, J CLIN MICROBIOL, V44, P3980, DOI 10.1128/JCM.00312-06; Schaub M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0013115, 10.1371/journal.pone.0015046]; Schloissnig S, 2013, NATURE, V493, P45, DOI 10.1038/nature11711; Schloss PD, 2012, GUT MICROBES, V3, P383, DOI 10.4161/gmic.21008; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schluter J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001424; Sloan WT, 2006, ENVIRON MICROBIOL, V8, P732, DOI 10.1111/j.1462-2920.2005.00956.x; Stecher B, 2011, CURR OPIN MICROBIOL, V14, P82, DOI 10.1016/j.mib.2010.10.003; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tannock GW, 2000, APPL ENVIRON MICROB, V66, P2578, DOI 10.1128/AEM.66.6.2578-2588.2000; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Ursell LK, 2012, NUTR REV, V70, pS38, DOI 10.1111/j.1753-4887.2012.00493.x; Vanhoutte T, 2004, FEMS MICROBIOL ECOL, V48, P437, DOI 10.1016/j.femsec.2004.03.001; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; Walter J, 2011, ANNU REV MICROBIOL, V65, P411, DOI 10.1146/annurev-micro-090110-102830; Walter J, 2011, P NATL ACAD SCI USA, V108, P4645, DOI 10.1073/pnas.1000099107; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Zoetendal EG, 1998, APPL ENVIRON MICROB, V64, P3854	62	111	117	1	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e69621	10.1371/journal.pone.0069621	http://dx.doi.org/10.1371/journal.pone.0069621			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874976	Green Published, gold, Green Submitted			2022-12-27	WOS:000322064300108
J	Zhou, W; Hu, YY; Sui, ZH; Fu, F; Wang, JG; Chang, LP; Guo, WH; Li, BB				Zhou, Wei; Hu, Yiyi; Sui, Zhenghong; Fu, Feng; Wang, Jinguo; Chang, Lianpeng; Guo, Weihua; Li, Binbin			Genome Survey Sequencing and Genetic Background Characterization of Gracilariopsis lemaneiformis (Rhodophyta) Based on Next-Generation Sequencing	PLOS ONE			English	Article							FOSMID LIBRARY CONSTRUCTION; DRAFT GENOME; END SEQUENCES; ARABIDOPSIS-THALIANA; INITIAL ANALYSIS; COASTAL WATERS; TRANSCRIPTOME; PLANT; GROWTH; DNA	Gracilariopsis lemaneiformis has a high economic value and is one of the most important aquaculture species in China. Despite it is economic importance, it has remained largely unstudied at the genomic level. In this study, we conducted a genome survey of Gp. lemaneiformis using next-generation sequencing (NGS) technologies. In total, 18.70 Gb of high-quality sequence data with an estimated genome size of 97 Mb were obtained by HiSeq 2000 sequencing for Gp. lemaneiformis. These reads were assembled into 160,390 contigs with a N50 length of 3.64 kb, which were further assembled into 125,685 scaffolds with a total length of 81.17 Mb. Genome analysis predicted 3490 genes and a GC% content of 48%. The identified genes have an average transcript length of 1,429 bp, an average coding sequence size of 1,369 bp, 1.36 exons per gene, exon length of 1,008 bp, and intron length of 191 bp. From the initial assembled scaffold, transposable elements constituted 54.64% (44.35 Mb) of the genome, and 7737 simple sequence repeats (SSRs) were identified. Among these SSRs, the trinucleotide repeat type was the most abundant (up to 73.20% of total SSRs), followed by the di- (17.41%), tetra- (5.49%), hexa- (2.90%), and penta- (1.00%) nucleotide repeat type. These characteristics suggest that Gp. lemaneiformis is a model organism for genetic study. This is the first report of genome-wide characterization within this taxon.	[Zhou, Wei; Hu, Yiyi; Sui, Zhenghong; Fu, Feng; Wang, Jinguo; Chang, Lianpeng; Guo, Weihua; Li, Binbin] Ocean Univ China, Coll Marine Life Sci, Key Lab Marine Genet & Breeding, Qingdao, Peoples R China; [Fu, Feng] Yantai Univ, Ocean Sch, Yantai, Peoples R China	Ocean University of China; Yantai University	Sui, ZH (corresponding author), Ocean Univ China, Coll Marine Life Sci, Key Lab Marine Genet & Breeding, Qingdao, Peoples R China.	suizhengh@ouc.edu.cn			"The Twelfth Five-Year-Plan'' in National Science and Technology for the Rural Development in China [2012AA100811-3]	"The Twelfth Five-Year-Plan'' in National Science and Technology for the Rural Development in China	Financial support for this work was provided by "The Twelfth Five-Year-Plan'' in National Science and Technology for the Rural Development in China (2012AA100811-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Argout X, 2011, NAT GENET, V43, P101, DOI 10.1038/ng.736; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Bennetzen JL, 1997, PLANT CELL, V9, P1509, DOI 10.1105/tpc.9.9.1509; Bennetzen JL, 2000, PLANT CELL, V12, P1021, DOI 10.1105/tpc.12.7.1021; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bojsen K, 1999, PLANT MOL BIOL, V40, P445, DOI 10.1023/A:1006231622928; Bombarely A, 2012, MOL PLANT MICROBE IN, V25, P1523, DOI 10.1094/MPMI-06-12-0148-TA; Brunet-Galmes I, 2012, J BACTERIOL, V194, P6642, DOI 10.1128/JB.01753-12; Carneiro AR, 2012, GENE, V505, P365, DOI 10.1016/j.gene.2012.06.016; Chan AP, 2010, NAT BIOTECHNOL, V28, P951, DOI 10.1038/nbt.1674; Cheevadhanarak S, 2012, STAND GENOMIC SCI, V6, P43, DOI 10.4056/sigs.2525955; Cheung MS, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr425; Chitsaz H, 2011, NAT BIOTECHNOL, V29, P915, DOI 10.1038/nbt.1966; Collen J, 2013, P NATL ACAD SCI USA, V110, P5247, DOI 10.1073/pnas.1221259110; D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; DALMON J, 1981, PLANT SCI LETT, V21, P241, DOI 10.1016/0304-4211(81)90095-X; Deng YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039704; Du ZJ, 2011, INT J SYST EVOL MICR, V61, P493, DOI 10.1099/ijs.0.019810-0; Earl D, 2011, GENOME RES, V21, P2224, DOI 10.1101/gr.126599.111; Elsik CG, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r13; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; FREDERICQ S, 1989, NEW ZEAL J BOT, V27, P521, DOI 10.1080/0028825X.1989.10414137; GRANDBASTIEN MA, 1992, TRENDS GENET, V8, P103, DOI 10.1016/0168-9525(92)90198-D; Henkel CV, 2012, GENE, V511, P195, DOI 10.1016/j.gene.2012.09.064; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Huang XD, 2012, FISH SHELLFISH IMMUN, V33, P659, DOI 10.1016/j.fsi.2012.06.029; Jex AR, 2011, NATURE, V479, P529, DOI 10.1038/nature10553; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Jurka J, 2007, ANNU REV GENOM HUM G, V8, P241, DOI 10.1146/annurev.genom.8.080706.092416; KAPRAUN DF, 1991, BOT MAR, V34, P139, DOI 10.1515/botm.1991.34.2.139; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; LAPOINTE BE, 1978, AQUACULTURE, V15, P185, DOI 10.1016/0044-8486(78)90030-3; LEGALL Y, 1993, PROTOPLASMA, V173, P123; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Li Yingrui, 2010, Human Genomics, V4, P271; Lin BK, 2012, J BACTERIOL, V194, P2769, DOI 10.1128/JB.00311-12; Liu L, 2012, J BIOMED BIOTECHNOL; Marinho-Soriano E, 2001, J BIOTECHNOL, V89, P81, DOI 10.1016/S0168-1656(01)00255-3; MCHUGH DJ, 1991, HYDROBIOLOGIA, V221, P19, DOI 10.1007/BF00028359; Meinke DW, 1998, SCIENCE, V282, P662, DOI 10.1126/science.282.5389.662; Meng L, 2009, PERIOD OCEAN U CHINA, V39, P94; MEYEROWITZ EM, 1985, SCIENCE, V229, P1214, DOI 10.1126/science.229.4719.1214; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Nagarajan N, 2008, TROPICAL PLANT BIOL, V1, P191; Nakamura Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057122; Ohta N, 2003, DNA RES, V10, P67, DOI 10.1093/dnares/10.2.67; Okuno J, 1999, J CRUSTACEAN BIOL, V19, P397, DOI 10.2307/1549247; Pang QQ, 2010, J APPL PHYCOL, V22, P607, DOI 10.1007/s10811-009-9500-3; Pflugmacher S, 1997, J APPL BOT-ANGEW BOT, V71, P144; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Radakovits R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1688; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Salzberg SL, 2005, BIOINFORMATICS, V21, P4320, DOI 10.1093/bioinformatics/bti769; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Shen X, 2012, COMP BIOCHEM PHYS D, V7, P248, DOI 10.1016/j.cbd.2012.03.003; Smith DR, 2008, GENOME RES, V18, P1638, DOI 10.1101/gr.077776.108; STAM WT, 1988, HELGOLANDER MEERESUN, V42, P251, DOI 10.1007/BF02366045; Stanke M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s11; Temperton B, 2011, STAND GENOMIC SCI, V4, P183, DOI 10.4056/sigs.1654066; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Varshney RK, 2012, NAT BIOTECHNOL, V30, P83, DOI 10.1038/nbt.2022; Vij S, 2006, BIOESSAYS, V28, P421, DOI 10.1002/bies.20399; Wang S, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-18; Wang WJ, 2007, BOT MAR, V50, P177, DOI 10.1515/BOT.2007.021; Wang XB, 2009, MAR BIOTECHNOL, V11, P236, DOI 10.1007/s10126-008-9137-2; Wang Y, 2007, AQUAT BOT, V86, P139, DOI 10.1016/j.aquabot.2006.09.013; Xu P, 2006, ANIM GENET, V37, P321, DOI 10.1111/j.1365-2052.2006.01453.x; Yang H, 2011, CHINESE SCI BULL, V56, P2119, DOI 10.1007/s11434-011-4546-4; Yang YF, 2006, AQUACULTURE, V254, P248, DOI 10.1016/j.aquaculture.2005.08.029; Zhang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040241; Zhang LL, 2007, MAR BIOTECHNOL, V9, P606, DOI 10.1007/s10126-007-9014-4; Zhang XC., 2005, GENETICS MARINE ALGA; Zhang XC, 2009, PERIODIC OCEAN U CHI, V5, P029; Zhao XX, 2012, MAR BIOTECHNOL, V14, P730, DOI 10.1007/s10126-012-9438-3; Zhou Y, 2006, AQUACULTURE, V252, P264, DOI 10.1016/j.aquaculture.2005.06.046	77	39	45	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e69909	10.1371/journal.pone.0069909	http://dx.doi.org/10.1371/journal.pone.0069909			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23875008	Green Published, gold, Green Submitted			2022-12-27	WOS:000322064300124
J	Straehl, FR; Scheyer, TM; Forasiepi, AAM; MacPhee, RD; Sanchez-Villagra, MR				Straehl, Fiona R.; Scheyer, Torsten M.; Forasiepi, Analia A. M.; MacPhee, Ross D.; Sanchez-Villagra, Marcelo R.			Evolutionary Patterns of Bone Histology and Bone Compactness in Xenarthran Mammal Long Bones	PLOS ONE			English	Article							LIFE-STYLE; OSTEODERM MORPHOLOGY; DASYPUS-NOVEMCINCTUS; 9-BANDED ARMADILLO; GROWTH-PATTERNS; SLOTHS MAMMALIA; ARRESTED GROWTH; FOSSIL; MICROANATOMY; PLEISTOCENE	Bone microstructure reflects physiological characteristics and has been shown to contain phylogenetic and ecological signals. Although mammalian long bone histology is receiving increasing attention, systematic examination of the main clades has not yet been performed. Here we describe the long bone microstructure of Xenarthra based on thin sections representing twenty-two species. Additionally, patterns in bone compactness of humeri and femora are investigated. The primary bone tissue of xenarthran long bones is composed of a mixture of woven, parallel-fibered and lamellar bone. The vascular canals have a longitudinal, reticular or radial orientation and are mostly arranged in an irregular manner. Concentric rows of vascular canals and laminar organization of the tissue are only found in anteater bones. The long bones of adult specimens are marked by dense Haversian bone, a feature that has been noted for most groups of mammals. In the long bones of armadillos, secondary osteons have an oblique orientation within the three-dimensional bone tissue, thus resulting in their irregular shape when the bones are sectioned transversely. Secondary remodeling is generally more extensive in large taxa than in small taxa, and this could be caused by increased loading. Lines of arrested growth are assumed to be present in all specimens, but they are restricted to the outermost layer in bones of armadillos and are often masked by secondary remodeling in large taxa. Parameters of bone compactness show a pattern in the femur that separates Cingulata and Pilosa (Folivora and Vermilingua), with cingulates having a lower compactness than pilosans. In addition, cingulates show an allometric relationship between humeral and femoral bone compactness.	[Straehl, Fiona R.; Scheyer, Torsten M.; Sanchez-Villagra, Marcelo R.] Univ Zurich, Palaontol Inst & Museum, Zurich, Switzerland; [Forasiepi, Analia A. M.] CCT Mendoza, IANIGLA, CONICET, Mendoza, Argentina; [MacPhee, Ross D.] Amer Museum Nat Hist, New York, NY 10024 USA	University of Zurich; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza; American Museum of Natural History (AMNH)	Sanchez-Villagra, MR (corresponding author), Univ Zurich, Palaontol Inst & Museum, Zurich, Switzerland.	m.sanchez@pim.uzh.ch		Sanchez-Villagra, Marcelo Ricardo/0000-0001-7587-3648; Scheyer, Torsten M./0000-0002-6301-8983	Swiss National Science Foundation [31003A_127053, 3100A0-133032/1]; CONICET [PIP 0276]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This project was supported by grants from the Swiss National Science Foundation (grant no. 31003A_127053 to TMS and no. 3100A0-133032/1 to MRSV) and CONICET (PIP 0276 to AMF). The funders had no role in study design, data collecttion and analysis, decision to publish, or preparation of the manuscript.	Abba Agustin Manuel, 2010, Edentata, V11, P135; Amprino R, 1947, PONTIFICA ACAD SCI, V9, P329; Asher RJ, 2011, J EVOLUTION BIOL, V24, P1080, DOI 10.1111/j.1420-9101.2011.02240.x; Asher RJ, 2009, BIOESSAYS, V31, P853, DOI 10.1002/bies.200900053; Bargo MS, 2000, J VERTEBR PALEONTOL, V20, P601, DOI 10.1671/0272-4634(2000)020[0601:LBPSAD]2.0.CO;2; Billet G, 2012, P ROY SOC B-BIOL SCI, V279, P3932, DOI 10.1098/rspb.2012.1212; Canoville A, 2010, BIOL J LINN SOC, V100, P384, DOI 10.1111/j.1095-8312.2010.01431.x; Canoville A, 2009, ACTA ZOOL-STOCKHOLM, V90, P110, DOI 10.1111/j.1463-6395.2008.00328.x; Carlini AA, 2008, PALAEONTOL Z, V82, P139, DOI 10.1007/BF02988405; Carlini AA, 2008, PALAEONTOL Z, V82, P125, DOI 10.1007/BF02988404; Carlini AA, 2006, J SYST PALAEONTOL, V4, P269, DOI 10.1017/S1477201906001878; Casinos A, 1996, LETHAIA, V29, P87, DOI 10.1111/j.1502-3931.1996.tb01842.x; Castanet J, 2006, CR PALEVOL, V5, P629, DOI 10.1016/j.crpv.2005.10.006; Castanet J, 2004, J ZOOL, V263, P31, DOI 10.1017/S0952836904004844; CHINSAMY A, 1995, J VERTEBR PALEONTOL, V15, P96, DOI 10.1080/02724634.1995.10011209; Chinsamy A, 2006, ACTA PALAEONTOL POL, V51, P325; Chinsamy A, 2004, DINOSAURIA, 2ND EDITION, P643; Chinsamy-Turan A., 2005, MICROSTRUCTURE DINOS, P216; Cubo J, 2008, EVOL DEV, V10, P217, DOI 10.1111/j.1525-142X.2008.00229.x; Curtin AJ, 2012, J VERTEBR PALEONTOL, V32, P939, DOI 10.1080/02724634.2012.672388; Da Costa Pereira PVLG, 2012, ACTA PALAEO IN PRESS; de Ricqles A., 1983, Acta Palaeontologica Polonica, V28, P225; Delsuc F, 2003, MOL PHYLOGENET EVOL, V28, P261, DOI 10.1016/S1055-7903(03)00111-8; Delsuc F, 2002, MOL BIOL EVOL, V19, P1656, DOI 10.1093/oxfordjournals.molbev.a003989; Delsuc F, 2001, P ROY SOC B-BIOL SCI, V268, P1605, DOI 10.1098/rspb.2001.1702; Delsuc F, 2012, MOL PHYLOGENET EVOL, V62, P673, DOI 10.1016/j.ympev.2011.11.008; DEMUIZON C, 1995, NATURE, V375, P224, DOI 10.1038/375224a0; dos Reis M, 2012, P ROY SOC B-BIOL SCI, V279, P3491, DOI 10.1098/rspb.2012.0683; Enlow D. E., 1958, Texas Journal of Science, V10, P187; Enlow D. H., 1956, Texas Journal of Science, V8, P405; Enlow D. H., 1957, Texas Journal of Science, V9, P186; Francillon-Vieillot H., 1990, P471; Gardner AL, 2007, MAMMALS S AM, V1, P168; Gaudin Timothy J., 2006, P153; Gaudin Timothy J., 2008, P24; Gaudin TJ, 2004, ZOOL J LINN SOC-LOND, V140, P255, DOI 10.1111/j.1096-3642.2003.00100.x; Geiger M, 2012, J VERTEBRAT IN PRESS; Germain D, 2005, ZOOL SCR, V34, P335, DOI 10.1111/j.1463-6409.2005.00198.x; Girondot M, 2003, J VERTEBR PALEONTOL, V23, P458, DOI 10.1671/0272-4634(2003)023[0458:BPATTQ]2.0.CO;2; Grzimek B, 2003, GRZIMEKS ANIMAL LIFE, V2nd; Hayashi S, 2012, PLOS ONE, V8; Hildebrand M., 1985, P89; Hill RV, 2006, J MORPHOL, V267, P1441, DOI 10.1002/jmor.10490; Houssaye A, 2010, J ANAT, V217, P715, DOI 10.1111/j.1469-7580.2010.01307.x; Hurum J. H., 2012, FORERUNNERS MAMMALS, P249; Klevezal G., 1996, RECORDING STRUCTURES; Klevezal G. A., 1969, AGE DETERMINATION MA; Kohler M, 2012, NATURE, V487, P358, DOI 10.1038/nature11264; Kohler M, 2009, P NATL ACAD SCI USA, V106, P20354, DOI 10.1073/pnas.0813385106; Kriloff A, 2008, J EVOLUTION BIOL, V21, P807, DOI 10.1111/j.1420-9101.2008.01512.x; Krmpotic CM, 2009, ACTA ZOOL-STOCKHOLM, V90, P339, DOI 10.1111/j.1463-6395.2008.00359.x; Lara-Ruiz P, 2005, J ZOOL, V267, P63, DOI 10.1017/S0952836905007259; Laurin M, 2004, PALEOBIOLOGY, V30, P589, DOI 10.1666/0094-8373(2004)030<0589:TEOLBM>2.0.CO;2; Laurin M, 2011, CR PALEVOL, V10, P381, DOI 10.1016/j.crpv.2011.02.003; McDonald H. Gregory, 2008, P39; McKenna MC, 2008, CLASSIFICATION MAMMA; Meier PS, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-55; MENDEL FC, 1981, J MAMMAL, V62, P413, DOI 10.2307/1380728; MENDEL FC, 1985, J MAMMAL, V66, P359, DOI 10.2307/1381249; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Merriam JC, 1906, SCIENCE, V24, P151, DOI 10.1126/science.24.605.151; Milne N, 2009, J ZOOL, V278, P48, DOI 10.1111/j.1469-7998.2008.00548.x; Moller-Krull M, 2007, MOL BIOL EVOL, V24, P2573, DOI 10.1093/molbev/msm201; O'Leary MA, 2013, SCIENCE, V339, P662, DOI 10.1126/science.1229237; Padian K, 2004, DINOSAURIA, 2ND EDITION, P660; PEABODY FE, 1961, J MORPHOL, V108, P11, DOI 10.1002/jmor.1051080103; Pujos F, 2012, J MAMM EVOL, V19, P159, DOI 10.1007/s10914-012-9189-y; Quekett J., 1855, DESCRIPTIVE ILLUSTRA, VII; Quekett J, 1844, T MICROSCOPICAL SOC, VII; QUINTANA C A, 1992, Ameghiniana, V29, P87; Rager L., 2011, 9 ANN M EUR ASS VERT, P49; RUFF CB, 1983, AM J PHYS ANTHROPOL, V60, P359, DOI 10.1002/ajpa.1330600308; Sanchez-Villagra Marcelo R., 2010, P19; Sander PM, 2006, PALAEONTOGR ABT A, V277, P143; Sander PM, 2000, PALEOBIOLOGY, V26, P466, DOI 10.1666/0094-8373(2000)026<0466:LHOTTS>2.0.CO;2; Scheyer TM, 2004, J VERTEBR PALEONTOL, V24, P874, DOI 10.1671/0272-4634(2004)024[0874:HOAOIF]2.0.CO;2; Scheyer TM, 2010, SEMIN CELL DEV BIOL, V21, P462, DOI 10.1016/j.semcdb.2009.11.005; Sinclair William J., 1910, Philadelphia Proceedings of the American Philosophical Society, V49; SINGH IJ, 1974, J MORPHOL, V144, P421, DOI 10.1002/jmor.1051440404; Smith FA, 2003, ECOLOGY, V84, P3403, DOI 10.1890/02-9003; Stein K., 2009, METHODS FOSSIL PREPA, P69; Straehl Fiona, 2012, P283; Superina Mariella, 2010, Edentata, V11, P96; Superina Mariella, 2010, Edentata, V11, P115; Taulman JF, 1996, J BIOGEOGR, V23, P635, DOI 10.1111/j.1365-2699.1996.tb00024.x; TAYLOR BK, 1978, J MORPHOL, V157, P347, DOI 10.1002/jmor.1051570307; Vickaryous MK, 2006, J MORPHOL, V267, P1273, DOI 10.1002/jmor.10475; Vizcaino Sergio F., 2008, P1; Vizcaino Sergio F., 2008, P86; Vizcaino SF, 2002, J ZOOL, V257, P117, DOI 10.1017/S0952836902000717; Vizcaino SF, 2001, ACTA PALAEONTOL POL, V46, P289; Vizcaino SF, 1999, ACTA THERIOL, V44, P309, DOI 10.4098/AT.arch.99-29; Werning S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033539; White Jennifer L., 2001, P201; White Jennifer L., 1993, Journal of Vertebrate Paleontology, V13, P230; Wible JR, 2004, ANN CARNEGIE MUS, V73, P117; Wolf D., 2007, HALLESCHES JB GEOWIS, V23, P145; Wolf D, 2012, J MORPHOL, V273, P388, DOI 10.1002/jmor.11029; Wolf D, 2008, J VERTEBR PALEONTOL, V28, p161A	99	47	47	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e69275	10.1371/journal.pone.0069275	http://dx.doi.org/10.1371/journal.pone.0069275			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874932	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000321736900147
J	Liu, LW; Lee, YH; Lin, CJ; Li, KW; Chen, CY				Liu, Li-Wen; Lee, Yung Hui; Lin, Chiuhsiang Joe; Li, Kai Way; Chen, Chih Yong			Shoe Sole Tread Designs and Outcomes of Slipping and Falling on Slippery Floor Surfaces	PLOS ONE			English	Article							GAIT SPEED; FRICTION; SLIPS; COEFFICIENT; RESISTANCE; ROUGHNESS; STABILITY; DYNAMICS; LEVEL; WIDTH	A gait experiment was conducted under two shoe sole and three floor conditions. The shoe soles and floors were characterized by the tread and groove designs on the surface. The coefficients of friction (COF) on the floor in the target area were measured. The subjects were required to walk on a walkway and stepping on a target area covered with glycerol. The motions of the feet of the subjects were captured. Gait parameters were calculated based on the motion data. Among the 240 trials, there were 37 no-slips, 81 microslips, 45 slides, and 77 slips. It was found that the condition with shoe sole and floor had both tread grooves perpendicular to the walking direction had the highest COF, the shortest slip distance, and the lowest percentages of slide and slip. The condition with shoe sole and floor had both tread grooves parallel to the walking direction had the lowest COF and the longest slip distance among all experimental conditions. The Pearson's correlation coefficients between slip distance and slip velocity, time to foot flat, foot angle, and compensatory step length were 0.82 (p<0.0001), 0.33 (p<0.0001), -0.54 (p<0.0001), and -0.51 (p<0.0001), respectively.	[Liu, Li-Wen; Lee, Yung Hui; Lin, Chiuhsiang Joe] Natl Taiwan Univ Sci & Technol, Dept Ind Management, Taipei, Taiwan; [Li, Kai Way] Chung Hua Univ, Dept Ind Management, Hsinchu, Taiwan; [Chen, Chih Yong] Inst Occupat Safety & Hlth, Taipei, Taiwan	National Taiwan University of Science & Technology; Chung Hua University	Liu, LW (corresponding author), Natl Taiwan Univ Sci & Technol, Dept Ind Management, Taipei, Taiwan.	liwen@mail.iosh.gov.tw		Li, Kai Way/0000-0003-0138-183X	Institute of Occupational Safety and Health, Council for Labor Affairs of the ROC [IOSH98-H322]	Institute of Occupational Safety and Health, Council for Labor Affairs of the ROC	This research was financially supported by the Institute of Occupational Safety and Health, Council for Labor Affairs of the ROC under grant IOSH98-H322. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASTM, 2005, ANN BOOK ASTM STAND, V15; Bhatt T, 2005, GAIT POSTURE, V21, P146, DOI 10.1016/j.gaitpost.2004.01.008; Brady RA, 2000, J BIOMECH, V33, P803, DOI 10.1016/S0021-9290(00)00037-3; Cham R, 2002, GAIT POSTURE, V15, P159, DOI 10.1016/S0966-6362(01)00150-3; Cham R, 2002, SAFETY SCI, V40, P559, DOI 10.1016/S0925-7535(01)00059-5; Cham R, 2001, J BIOMECH, V34, P1439, DOI 10.1016/S0021-9290(01)00116-6; Chang WR, 2012, SAFETY SCI, V50, P240, DOI 10.1016/j.ssci.2011.08.056; Chang WR, 2002, SAFETY SCI, V40, P593, DOI 10.1016/S0925-7535(01)00061-3; Council of Labor Affairs, 2009, ANN REP LAB INSP; Council of Labor Affairs,, 2008, ANN REP LAB INSP; DAVIS PR, 1983, ERGONOMICS, V26, P51, DOI 10.1080/00140138308963312; Espy DD, 2010, GAIT POSTURE, V32, P378, DOI 10.1016/j.gaitpost.2010.06.013; GRONQVIST R, 1995, ERGONOMICS, V38, P224, DOI 10.1080/00140139508925100; GRONQVIST R, 1990, J OCCUP ACCID, V13, P291, DOI 10.1016/0376-6349(90)90035-T; Gronqvist R, 2001, ERGONOMICS, V44, P1167, DOI 10.1080/00140130110085556; Hanson JP, 1999, ERGONOMICS, V42, P1619, DOI 10.1080/001401399184712; Health and Safety Executive HSE, 2009, FAT INJ STAT; Heiden TL, 2006, GAIT POSTURE, V24, P237, DOI 10.1016/j.gaitpost.2005.09.004; Karst GM, 1999, J GERONTOL A-BIOL, V54, pM343, DOI 10.1093/gerona/54.7.M343; Leamon T, 1990, 23 INT C OCC HETH MO, P17; LEAMON TB, 1995, ERGONOMICS, V38, P487, DOI 10.1080/00140139508925120; Li KW, 2006, SAFETY SCI, V44, P375, DOI 10.1016/j.ssci.2005.11.003; Li KW, 2009, SAFETY SCI, V47, P1434, DOI 10.1016/j.ssci.2009.04.006; Li KW, 2005, SAFETY SCI, V43, P391, DOI 10.1016/j.ssci.2005.08.006; Li KW, 2004, APPL ERGON, V35, P499, DOI 10.1016/j.apergo.2004.06.010; Li KW, 2004, SAFETY SCI, V42, P547, DOI 10.1016/j.ssci.2003.08.006; Liu LW, 2010, SAFETY SCI, V48, P1321, DOI 10.1016/j.ssci.2010.04.014; Lockhart TE, 2003, ERGONOMICS, V46, P1136, DOI 10.1080/0014013031000139491; McGorry RW, 2007, APPL ERGON, V38, P369, DOI 10.1016/j.apergo.2006.03.013; McGorry RW, 2010, APPL ERGON, V41, P41, DOI 10.1016/j.apergo.2009.04.002; MILLER J M, 1983, Journal of Safety Research, V14, P145, DOI 10.1016/0022-4375(83)90042-7; Mills PM, 2001, HUM MOVEMENT SCI, V20, P427, DOI 10.1016/S0167-9457(01)00061-6; Moyer BE, 2006, ERGONOMICS, V49, P329, DOI 10.1080/00140130500478553; Perkins P. J., 1978, ASTM STP, P71, DOI DOI 10.1520/STP28738S; STRANDBERG L, 1981, J OCCUP ACCID, V3, P153, DOI 10.1016/0376-6349(81)90009-2; Washington State Department of Labor and Industries, 2004, 5912004 WASH STAT DE; Yamaguchi T, 2012, SAFETY SCI, V50, P986, DOI 10.1016/j.ssci.2011.12.017	37	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e68989	10.1371/journal.pone.0068989	http://dx.doi.org/10.1371/journal.pone.0068989			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894388	Green Published, Green Submitted, gold			2022-12-27	WOS:000322167900034
J	Ishida, M; Okazaki, E; Tsukamoto, S; Kimura, K; Aizawa, A; Kito, S; Imai, H; Minami, N				Ishida, Miya; Okazaki, Eriko; Tsukamoto, Satoshi; Kimura, Koji; Aizawa, Akira; Kito, Seiji; Imai, Hiroshi; Minami, Naojiro			The Promoter of the Oocyte-Specific Gene, Oog1, Functions in Both Male and Female Meiotic Germ Cells in Transgenic Mice	PLOS ONE			English	Article							METHYLATED REGIONS TDMS; HISTONE H1T GENE; TRANSCRIPTION FACTOR; MOUSE OOCYTES; DNA METHYLATION; FIG-ALPHA; E-BOX; EXPRESSION; EMBRYOS; PROTEIN	Oog1 is an oocyte-specific gene whose expression is turned on in mouse oocytes at embryonic day (E) 15.5, concomitant with the time when most of the female germ cells stop proliferating and enter meiotic prophase. Here, we characterize the Oog1 promoter, and show that transgenic GFP reporter expression driven by the 2.7 kb and 3.9 kb regions upstream of the Oog1 transcription start site recapitulates the intrinsic Oog1 expression pattern. In addition, the 3.9 kb upstream region exhibits stronger transcriptional activity than does the 2.7 kb region, suggesting that regulatory functions might be conserved in the additional 1.2 kb region found within the 3.9 kb promoter. Interestingly, the longer promoter (3.9 kb) also showed strong activity in male germ cells, from late pachytene spermatocytes to elongated spermatids. This is likely due to the aberrant demethylation of two CpG sites in the proximal promoter region. One was highly methylated in the tissues in which GFP expression was suppressed, and another was completely demethylated only in Oog1pro3.9 male and female germ cells. These results suggest that aberrant demethylation of the proximal promoter region induced ectopic expression in male germ cells under the control of 3.9 kb Oog1 promoter. This is the first report indicating that sex-dependent gene expression is altered according to the length and the methylation status of the promoter region. Additionally, our results show that individual CpG sites are differentially methylated and play different roles in regulating promoter activity and gene transcription.	[Ishida, Miya; Okazaki, Eriko; Imai, Hiroshi; Minami, Naojiro] Kyoto Univ, Reprod Biol Lab, Grad Sch Agr, Kyoto, Japan; [Tsukamoto, Satoshi; Kito, Seiji] Natl Inst Radiol Sci, Anim Lab, Chiba 260, Japan; [Tsukamoto, Satoshi; Kito, Seiji] Natl Inst Radiol Sci, Genome Sci Sect, Chiba 260, Japan; [Kimura, Koji] Natl Agr & Food Res Org, Natl Inst Livestock & Grassland Sci, Anim Reprod Lab, Nasushiobara, Japan	Kyoto University; National Institutes for Quantum Science & Technology; National Institutes for Quantum Science & Technology; National Agriculture & Food Research Organization - Japan	Minami, N (corresponding author), Kyoto Univ, Reprod Biol Lab, Grad Sch Agr, Kyoto, Japan.	oog1nao@kais.kyoto-u.ac.jp			Japan Society for the Promotion of Science [3380164, 19380158]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science to NM (3380164, 19380158). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu-Vieyra CV, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000453; Audouard C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017109; Choi YS, 2007, BIOL REPROD, V77, P312, DOI 10.1095/biolreprod.107.060459; Choi Y, 2006, J BIOL CHEM, V281, P35747, DOI 10.1074/jbc.M604008200; DeJong J, 2006, GENE, V366, P39, DOI 10.1016/j.gene.2005.10.012; Deshane J, 2010, J BIOL CHEM, V285, P16476, DOI 10.1074/jbc.M109.058586; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Gazdag E, 2007, REPRODUCTION, V134, P51, DOI 10.1530/REP-06-0337; Gazdag E, 2009, GENE DEV, V23, P2210, DOI 10.1101/gad.535209; Goodrich JA, 2010, NAT REV GENET, V11, P549, DOI 10.1038/nrg2847; Hammond SS, 2009, GENESIS, V47, P617, DOI 10.1002/dvg.20539; Han SY, 2004, BIOL REPROD, V71, P933, DOI 10.1095/biolreprod.104.030247; Han SY, 2001, BIOL REPROD, V64, P507, DOI 10.1095/biolreprod64.2.507; Joshi S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-67; Kido T, 2005, GENESIS, V42, P263, DOI 10.1002/gene.20147; Kirillov A, 1996, NAT GENET, V13, P435, DOI 10.1038/ng0895-435; Kitamura E, 2007, GENOMICS, V89, P326, DOI 10.1016/j.ygeno.2006.11.006; Kolas NK, 2005, CHROMOSOMA, V114, P92, DOI 10.1007/s00412-005-0334-8; Lan ZJ, 2004, BIOL REPROD, V71, P1469, DOI 10.1095/biolreprod.104.031757; Liang LF, 1997, DEVELOPMENT, V124, P4939; Liu SJ, 2008, BLOOD, V111, P2364, DOI 10.1182/blood-2007-08-110171; MATSUMOTO K, 1994, MOL REPROD DEV, V39, P136, DOI 10.1002/mrd.1080390203; Merbs SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032602; MILLAR SE, 1991, MOL CELL BIOL, V11, P6197, DOI 10.1128/MCB.11.12.6197; Minami N, 2003, BIOL REPROD, V69, P1736, DOI 10.1095/biolreprod.103.018051; NAYA FJ, 1995, GENE DEV, V9, P1009, DOI 10.1101/gad.9.8.1009; Nolis IK, 2009, P NATL ACAD SCI USA, V106, P20222, DOI 10.1073/pnas.0902454106; Pan B, 2011, MOL HUM REPROD, V17, P550, DOI 10.1093/molehr/gar017; Panigrahi SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047862; PETERS H, 1969, ACTA ENDOCRINOL-COP, V62, P98, DOI 10.1530/acta.0.0620098; Picton H, 1998, MOL CELL ENDOCRINOL, V145, P27, DOI 10.1016/S0303-7207(98)00166-X; Rajkovic A, 2004, SCIENCE, V305, P1157, DOI 10.1126/science.1099755; Singal R, 2000, BIOL REPROD, V63, P1237, DOI 10.1095/biolreprod63.5.1237; Song F, 2005, P NATL ACAD SCI USA, V102, P3336, DOI 10.1073/pnas.0408436102; Soyal SM, 2000, DEVELOPMENT, V127, P4645; Stein P, 2003, DEV BIOL, V256, P187, DOI 10.1016/S0012-1606(02)00122-7; Stein P, 2005, DEV BIOL, V286, P464, DOI 10.1016/j.ydbio.2005.08.015; Svoboda P, 2001, BIOCHEM BIOPH RES CO, V287, P1099, DOI 10.1006/bbrc.2001.5707; Tsukamoto S, 2006, BIOCHEM BIOPH RES CO, V343, P1105, DOI 10.1016/j.bbrc.2006.03.063; Tsunemoto K, 2008, MOL REPROD DEV, V75, P1104, DOI 10.1002/mrd.20863; WEINTRAUB H, 1994, GENE DEV, V8, P2203, DOI 10.1101/gad.8.18.2203; Wilkerson DC, 2002, BIOL REPROD, V67, P1157, DOI 10.1095/biolreprod67.4.1157; WORRAD DM, 1994, DEVELOPMENT, V120, P2347; Xiao LJ, 2006, GENE EXPR PATTERNS, V6, P409, DOI 10.1016/j.modgep.2005.09.005; Yagi S, 2008, GENOME RES, V18, P1969, DOI 10.1101/gr.074070.107; Yan CN, 2006, BIOL REPROD, V74, P999, DOI 10.1095/biolreprod.105.050013; Ye R, 2011, J BIOL CHEM, V286, P25891, DOI 10.1074/jbc.M111.254680; ZAMBROWICZ BP, 1993, P NATL ACAD SCI USA, V90, P5071, DOI 10.1073/pnas.90.11.5071	48	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e68686	10.1371/journal.pone.0068686	http://dx.doi.org/10.1371/journal.pone.0068686			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894331	gold, Green Published, Green Submitted			2022-12-27	WOS:000322132100022
J	Lappi, O; Pekkanen, J; Itkonen, TH				Lappi, Otto; Pekkanen, Jami; Itkonen, Teemu H.			Pursuit Eye-Movements in Curve Driving Differentiate between Future Path and Tangent Point Models	PLOS ONE			English	Article							OPTOKINETIC NYSTAGMUS; ALGORITHM; FLOW	For nearly 20 years, looking at the tangent point on the road edge has been prominent in models of visual orientation in curve driving. It is the most common interpretation of the commonly observed pattern of car drivers looking through a bend, or at the apex of the curve. Indeed, in the visual science literature, visual orientation towards the inside of a bend has become known as "tangent point orientation". Yet, it remains to be empirically established whether it is the tangent point the drivers are looking at, or whether some other reference point on the road surface, or several reference points, are being targeted in addition to, or instead of, the tangent point. Recently discovered optokinetic pursuit eye-movements during curve driving can provide complementary evidence over and above traditional gaze-position measures. This paper presents the first detailed quantitative analysis of pursuit eye movements elicited by curvilinear optic flow in real driving. The data implicates the far zone beyond the tangent point as an important gaze target area during steady-state cornering. This is in line with the future path steering models, but difficult to reconcile with any pure tangent point steering model. We conclude that the tangent point steering models do not provide a general explanation of eye movement and steering during a curve driving sequence and cannot be considered uncritically as the default interpretation when the gaze position distribution is observed to be situated in the region of the curve apex.	[Lappi, Otto; Pekkanen, Jami] Univ Helsinki, Inst Behav Sci, Cognit Sci Traff Res Unit, Helsinki, Finland; [Itkonen, Teemu H.] Univ Helsinki, Inst Behav Sci, Helsinki, Finland	University of Helsinki; University of Helsinki	Lappi, O (corresponding author), Univ Helsinki, Inst Behav Sci, Cognit Sci Traff Res Unit, Helsinki, Finland.	otto.lappi@helsinki.fi	Lappi, Otto/I-2295-2019	Lappi, Otto/0000-0002-7996-7665; Pekkanen, Jami/0000-0001-6974-8760				Authie CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031479; Authie CN, 2011, VISION RES, V51, P1791, DOI 10.1016/j.visres.2011.06.010; Boer ER, 1996, PROCEEDINGS OF THE 1996 IEEE INTELLIGENT VEHICLES SYMPOSIUM, P7, DOI 10.1109/IVS.1996.566341; Busettini C, 1996, NATURE, V380, P342, DOI 10.1038/380342a0; Chattington M, 2007, EXP BRAIN RES, V180, P1, DOI 10.1007/s00221-006-0839-2; Coutton-Jean C, 2009, TRANSPORT RES F-TRAF, V12, P483, DOI 10.1016/j.trf.2009.04.006; DONGES E, 1978, HUM FACTORS, V20, P691, DOI 10.1177/001872087802000607; HOWARD IP, 1989, EXP BRAIN RES, V78, P309; Jackson B, 2005, IEEE SIGNAL PROC LET, V12, P105, DOI 10.1109/LSP.2001.838216; Kandil FI, 2010, J VISION, V10, DOI 10.1167/10.4.24; Kandil FI, 2009, J VISION, V9, DOI 10.1167/9.1.11; Kim NG, 1999, ECOL PSYCHOL, V11, P233, DOI 10.1207/s15326969eco1103_3; Land MF, 2001, CURR BIOL, V11, P1215, DOI 10.1016/S0960-9822(01)00351-7; LAND MF, 1994, NATURE, V369, P742, DOI 10.1038/369742a0; Lappi O, 2013, J EYE MOVEMENT RES, V6; Marple-Horvat DE, 2005, EXP BRAIN RES, V163, P411, DOI 10.1007/s00221-004-2192-7; Mars F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043858; REID DB, 1979, IEEE T AUTOMAT CONTR, V24, P843, DOI 10.1109/TAC.1979.1102177; Salvucci D.D., 2000, P 2000 S EYE TRACK R, P71, DOI [10.1145/355017.355028, DOI 10.1145/355017.355028]; Salvucci DD, 2004, PERCEPTION, V33, P1233, DOI 10.1068/p5343; Underwood G, 1999, VISION VEHICLES; Wann J, 2000, TRENDS COGN SCI, V4, P319, DOI 10.1016/S1364-6613(00)01513-8; Wann J. P., 2004, OPTIC FLOW, P371; Wann JP, 2000, NAT NEUROSCI, V3, P647, DOI 10.1038/76602; Wilkie RM, 2008, J EXP PSYCHOL HUMAN, V34, P1150, DOI 10.1037/0096-1523.34.5.1150	25	39	39	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e68326	10.1371/journal.pone.0068326	http://dx.doi.org/10.1371/journal.pone.0068326			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	187PW	23894300	gold, Green Published, Green Submitted			2022-12-27	WOS:000322132100015
J	Barelier, S; Boyce, SE; Fish, I; Fischer, M; Goodin, DB; Shoichet, BK				Barelier, Sarah; Boyce, Sarah E.; Fish, Inbar; Fischer, Marcus; Goodin, David B.; Shoichet, Brian K.			Roles for Ordered and Bulk Solvent in Ligand Recognition and Docking in Two Related Cavities	PLOS ONE			English	Article							CYTOCHROME-C PEROXIDASE; MODEL BINDING-SITE; POISSON-BOLTZMANN EQUATION; ELECTRON-TRANSFER PATHWAY; WATER-MOLECULES; HYDROPHOBIC ENCLOSURE; CRYSTAL-STRUCTURES; HSP90 INHIBITORS; SCORING FUNCTION; T4 LYSOZYME	A key challenge in structure-based discovery is accounting for modulation of protein-ligand interactions by ordered and bulk solvent. To investigate this, we compared ligand binding to a buried cavity in Cytochrome c Peroxidase (CcP), where affinity is dominated by a single ionic interaction, versus a cavity variant partly opened to solvent by loop deletion. This opening had unexpected effects on ligand orientation, affinity, and ordered water structure. Some ligands lost over ten-fold in affinity and reoriented in the cavity, while others retained their geometries, formed new interactions with water networks, and improved affinity. To test our ability to discover new ligands against this opened site prospectively, a 534,000 fragment library was docked against the open cavity using two models of ligand solvation. Using an older solvation model that prioritized many neutral molecules, three such uncharged docking hits were tested, none of which was observed to bind; these molecules were not highly ranked by the new, context-dependent solvation score. Using this new method, another 15 highly-ranked molecules were tested for binding. In contrast to the previous result, 14 of these bound detectably, with affinities ranging from 8 mu M to 2 mM. In crystal structures, four of these new ligands superposed well with the docking predictions but two did not, reflecting unanticipated interactions with newly ordered waters molecules. Comparing recognition between this open cavity and its buried analog begins to isolate the roles of ordered solvent in a system that lends itself readily to prospective testing and that may be broadly useful to the community.	[Barelier, Sarah; Boyce, Sarah E.; Fish, Inbar; Fischer, Marcus; Shoichet, Brian K.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Fish, Inbar] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem & Mol Biol, Ramat Aviv, Israel; [Fischer, Marcus; Shoichet, Brian K.] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Goodin, David B.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA	University of California System; University of California San Francisco; Tel Aviv University; University of Toronto; University of California System; University of California Davis	Shoichet, BK (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.	bshoichet@gmail.com	Fischer, Marcus/M-9841-2018	Fischer, Marcus/0000-0002-7179-2581	US NIH [GM59957]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041049, R01GM059957] Funding Source: NIH RePORTER	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding provided by US NIH grant GM59957 (to BKS) (http://www.nigms.nih.gov/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; AHRINGER J, 1995, EMBO J, V14, P2307, DOI 10.1002/j.1460-2075.1995.tb07225.x; Arora N, 2001, PROTEINS, V43, P12, DOI 10.1002/1097-0134(20010401)43:1<12::AID-PROT1013>3.0.CO;2-7; Barillari C, 2007, J AM CHEM SOC, V129, P2577, DOI 10.1021/ja066980q; Boyce SE, 2009, J MOL BIOL, V394, P747, DOI 10.1016/j.jmb.2009.09.049; Brenk R, 2006, J MOL BIOL, V357, P1449, DOI 10.1016/j.jmb.2006.01.034; Carlsson J, 2011, NAT CHEM BIOL, V7, P769, DOI 10.1038/nchembio.662; Dahlgren MK, 2012, J MED CHEM, V55, P10148, DOI 10.1021/jm301269s; Davies NGM, 2012, BIOORGAN MED CHEM, V20, P6770, DOI 10.1016/j.bmc.2012.08.050; de Graaf C, 2011, CHEMMEDCHEM, V6, P2159, DOI 10.1002/cmdc.201100317; de Graaf C, 2011, J MED CHEM, V54, P8195, DOI 10.1021/jm2011589; ERIKSSON AE, 1992, NATURE, V355, P371, DOI 10.1038/355371a0; Ferrari AM, 2004, J MED CHEM, V47, P5076, DOI 10.1021/jm049756p; FITZGERALD MM, 1995, PROTEIN SCI, V4, P1844, DOI 10.1002/pro.5560040919; FITZGERALD MM, 1994, BIOCHEMISTRY-US, V33, P3807, DOI 10.1021/bi00179a004; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; GARZA D, 1991, GENETICS, V128, P303; Geerke DP, 2009, J COMPUT CHEM, V30, P514, DOI 10.1002/jcc.21070; GILSON MK, 1988, PROTEINS, V4, P7, DOI 10.1002/prot.340040104; GILSON MK, 1985, J MOL BIOL, V184, P503, DOI 10.1016/0022-2836(85)90297-9; GILSON MK, 1993, J PHYS CHEM-US, V97, P3591, DOI 10.1021/j100116a025; GILSON MK, 1988, PROTEINS, V3, P32, DOI 10.1002/prot.340030104; GILSON MK, 1991, J COMPUT AID MOL DES, V5, P5; GILSON MK, 1988, J COMPUT CHEM, V9, P327, DOI 10.1002/jcc.540090407; Gorham RD, 2011, BIOPOLYMERS, V95, P746, DOI 10.1002/bip.21644; Grant JA, 2001, J COMPUT CHEM, V22, P608, DOI 10.1002/jcc.1032; Graves AP, 2005, J MED CHEM, V48, P3714, DOI 10.1021/jm0491187; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Irwin JJ, 2009, J MED CHEM, V52, P5712, DOI 10.1021/jm9006966; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Jacobson MP, 2002, J PHYS CHEM B, V106, P11673, DOI 10.1021/jp021564n; Kunzl C, 1999, HORM BEHAV, V35, P28, DOI 10.1006/hbeh.1998.1493; Ladbury JE, 1996, CHEM BIOL, V3, P973, DOI 10.1016/S1074-5521(96)90164-7; Langmead CJ, 2012, J MED CHEM, V55, P1904, DOI 10.1021/jm201455y; Li X, 2004, PROTEINS, V55, P368, DOI 10.1002/prot.20014; Limongelli V, 2012, P NATL ACAD SCI USA, V109, P1467, DOI 10.1073/pnas.1112181108; Lorber DM, 2005, CURR TOP MED CHEM, V5, P739, DOI 10.2174/1568026054637683; Lu YP, 2007, J CHEM INF MODEL, V47, P668, DOI 10.1021/ci6003527; Luccarelli J, 2010, J CHEM THEORY COMPUT, V6, P3850, DOI 10.1021/ct100504h; Mattos C, 2006, J MOL BIOL, V357, P1471, DOI 10.1016/j.jmb.2006.01.039; Meeker AK, 1996, BIOCHEMISTRY-US, V35, P6443, DOI 10.1021/bi960171+; Merski M, 2012, P NATL ACAD SCI USA, V109, P16179, DOI 10.1073/pnas.1208076109; Michel J, 2009, J AM CHEM SOC, V131, P15403, DOI 10.1021/ja906058w; Minke WE, 1999, J MED CHEM, V42, P1778, DOI 10.1021/jm980472c; MORTON A, 1995, BIOCHEMISTRY-US, V34, P8576, DOI 10.1021/bi00027a007; Musah RA, 2002, J MOL BIOL, V315, P845, DOI 10.1006/jmbi.2001.5287; Mysinger MM, 2012, J MED CHEM, V55, P6582, DOI 10.1021/jm300687e; Mysinger MM, 2012, P NATL ACAD SCI USA, V109, P5517, DOI 10.1073/pnas.1120431109; Mysinger MM, 2010, J CHEM INF MODEL, V50, P1561, DOI 10.1021/ci100214a; Neves MAC, 2012, J COMPUT AID MOL DES, V26, P675, DOI 10.1007/s10822-012-9547-0; Nguyen CN, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4733951; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; Osterberg F, 2002, PROTEINS, V46, P34, DOI 10.1002/prot.10028; Putnam AMAH, 2009, BIOCHEMISTRY-US, V48, P1, DOI 10.1021/bi8020263; Ramsden NL, 2009, J MED CHEM, V52, P2531, DOI 10.1021/jm801475n; Rarey M, 1999, PROTEINS, V34, P17, DOI 10.1002/(SICI)1097-0134(19990101)34:1<17::AID-PROT3>3.0.CO;2-1; Repasky MP, 2012, J COMPUT AID MOL DES, V26, P787, DOI 10.1007/s10822-012-9575-9; Ringe D, 1995, CURR OPIN STRUC BIOL, V5, P825, DOI 10.1016/0959-440X(95)80017-4; Rosenfeld RJ, 2002, PROTEIN SCI, V11, P1251, DOI 10.1110/ps.4870102; Roughley S, 2012, TOP CURR CHEM, V317, P61, DOI 10.1007/128_2011_181; Sager G, 2012, J MED CHEM, V55, P3049, DOI 10.1021/jm2014666; SCHREIBER C, 1994, STRUCTURE, V2, P945, DOI 10.1016/S0969-2126(94)00096-4; Shoichet BK, 1999, PROTEINS, V34, P4, DOI 10.1002/(SICI)1097-0134(19990101)34:1<4::AID-PROT2>3.0.CO;2-6; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Tosh DK, 2012, J MED CHEM, V55, P4297, DOI 10.1021/jm300095s; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; van Dijk ADJ, 2006, BIOINFORMATICS, V22, P2340, DOI 10.1093/bioinformatics/btl395; Verdonk ML, 2005, J MED CHEM, V48, P6504, DOI 10.1021/jm050543p; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Wei BQ, 2004, J MOL BIOL, V337, P1161, DOI 10.1016/j.jmb.2004.02.015; Wei BQQ, 2002, J MOL BIOL, V322, P339, DOI 10.1016/S0022-2836(02)00777-5; Woo HJ, 2004, J CHEM PHYS, V121, P6392, DOI 10.1063/1.1784436; Young T, 2007, P NATL ACAD SCI USA, V104, P808, DOI 10.1073/pnas.0610202104	74	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e69153	10.1371/journal.pone.0069153	http://dx.doi.org/10.1371/journal.pone.0069153			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874896	gold, Green Published, Green Submitted			2022-12-27	WOS:000324146200063
J	Chu, L; Wang, TS; Hu, YB; Gu, YH; Su, ZS; Jiang, HY				Chu, Ling; Wang, Tiansheng; Hu, Yongbin; Gu, Yonghong; Su, Zanshan; Jiang, Haiying			Activation of Egr-1 in Human Lung Epithelial Cells Exposed to Silica through MAPKs Signaling Pathways	PLOS ONE			English	Article							EARLY GROWTH RESPONSE-1; FACTOR-BETA; PROTEIN EXPRESSION; GENE-EXPRESSION; UP-REGULATION; IN-VITRO; C-JUN; TRANSCRIPTION; PATHOGENESIS; INDUCTION	The alveolar type II epithelial cell, regarded historically as a key target cell in initial injury by silica, now appears to be important in both defense from lung damage as well as elaboration of chemokines and cytokines. The molecular basis for silica-induced epithelial cell injury is poorly understood. In this study we explored the activation of nuclear factor Egr-1 and related signal pathway. Human II alveolar epithelial line A549 cells were exposed to silica for indicated time to assay the expression and activation of Egr-1 and upstream MAPKs. Immunofluorescence, western-blot techniques, RT-PCR, Electrophoretic mobility shift assay (EMSA), transient transfection assay, kinase inhibitor experiments were performed. It was found that the expression of Egr-1 at mRNA and protein level was significantly increased in A549 cells after administration with silica and the activity of Egr-1 peaked by silica treatment for 60 minutes. Furthermore, phosphorylated-ERK1/2, P38 MAPKs (the upstream kinase of Egr-1) ballooned during 15-30minutes, 30-60minutes respectively after silica exposure in A549 cells. By administration of ERK1/2, P38 inhibitor, the expression and transcription of Egr-1 were both markedly decreased. But PKC inhibitor did not prevent the increase of Egr-1. These results indicated Egr-1 played a critical role in silica-induced pulmonary fibrosis in an ERK1/2, P38 MAPKs-dependent manner, which suggests Egr-1 is an essential regulator in silicosis, and underlines a new molecular mechanism for fibrosis induced by silica.	[Chu, Ling; Gu, Yonghong; Su, Zanshan] Cent S Univ, Xiangya Hosp 3, Dept Pathol, Changsha, Hunan, Peoples R China; [Wang, Tiansheng] Cent S Univ, Xiangya Hosp 3, Dept Otolaryngol, Changsha, Hunan, Peoples R China; [Hu, Yongbin; Jiang, Haiying] Cent S Univ, Xiangya Hosp, Dept Pathol, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University	Wang, TS (corresponding author), Cent S Univ, Xiangya Hosp 3, Dept Otolaryngol, Changsha, Hunan, Peoples R China.	tswheaven@hotmail.com			National natural science Foundation [30170399]; Science and Technology Project of Hunan Province [2012FJ3121]	National natural science Foundation(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Hunan Province	This study was supported by the National natural science Foundation.(No: 30170399), and this work was partially supported by the Science and Technology Project of Hunan Province 2012FJ3121(L.C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu El-Asrar AM, 2011, MOL VIS, V17, P508; Baron V, 2003, ONCOGENE, V22, P4194, DOI 10.1038/sj.onc.1206560; Beidelschies MA, 2008, J CELL PHYSIOL, V217, P652, DOI 10.1002/jcp.21539; Bhattacharyya S, 2008, AM J PATHOL, V173, P1085, DOI 10.2353/ajpath.2008.080382; Bhattacharyya S, 2011, MATRIX BIOL, V30, P235, DOI 10.1016/j.matbio.2011.03.005; Chen SJ, 2006, J BIOL CHEM, V281, P21183, DOI 10.1074/jbc.M603270200; Cho SJ, 2006, J BIOL CHEM, V281, P8161, DOI 10.1074/jbc.M506770200; Fanizza C, 2009, J APPL TOXICOL, V29, P537, DOI 10.1002/jat.1440; Friedrich B, 2008, CELL PHYSIOL BIOCHEM, V22, P465, DOI 10.1159/000185495; GASHLER A, 1995, PROG NUCLEIC ACID RE, V50, P191, DOI 10.1016/S0079-6603(08)60815-6; Grotegut S, 2006, EMBO J, V25, P3534, DOI 10.1038/sj.emboj.7601213; Guo X, 2012, INT J IMMUNOPATH PH, V25, P713, DOI 10.1177/039463201202500317; Gururajan M, 2008, J IMMUNOL, V181, P4590, DOI 10.4049/jimmunol.181.7.4590; Hasan RN, 2008, CIRC RES, V102, P42, DOI 10.1161/CIRCRESAHA.107.155143; Iyoda T, 2012, J BIOL CHEM, V287, P22635, DOI 10.1074/jbc.M111.335695; Kang HS, 2013, CANCER LETT, V329, P217, DOI 10.1016/j.canlet.2012.11.006; Khachigian LM, 1996, SCIENCE, V271, P1427, DOI 10.1126/science.271.5254.1427; Lee CG, 2004, J EXP MED, V200, P377, DOI 10.1084/jem.20040104; Li CJ, 2007, AM J PHYSIOL-LUNG C, V292, pL1297, DOI 10.1152/ajplung.00194.2006; Lin C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056499, 10.1371/journal.pone.0080883, 10.1371/journal.pone.0065734, 10.1371/journal.pone.0070187]; Liu CT, 1998, CANCER GENE THER, V5, P3; Liu FW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015404; Mauviel A, 2005, METH MOLEC MED, V117, P69; Melloni B, 1996, THORAX, V51, P781, DOI 10.1136/thx.51.8.781; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; MILES PR, 1994, TOXICOL APPL PHARM, V129, P235, DOI 10.1006/taap.1994.1248; Mossman BT, 1998, AM J RESP CRIT CARE, V157, P1666, DOI 10.1164/ajrccm.157.5.9707141; Ning W, 2004, P NATL ACAD SCI USA, V101, P14895, DOI 10.1073/pnas.0401168101; Olbruck H, 1998, TOXICOL LETT, V96-7, P85, DOI 10.1016/S0378-4274(98)00054-X; Pritchard MT, 2005, ALCOHOL CLIN EXP RES, V29, p146S, DOI 10.1097/01.alc.0000189286.81943.51; Reynolds PR, 2006, AM J RESP CELL MOL, V35, P314, DOI 10.1165/rcmb.2005-0428OC; Saadane N, 2000, AM J PHYSIOL-HEART C, V278, pH796, DOI 10.1152/ajpheart.2000.278.3.H796; Sanchez-Guerrero E, 2008, NUCLEIC ACIDS RES, V36, P1941, DOI 10.1093/nar/gkm923; Shen N, 2011, AM J PATHOL, V178, P110, DOI 10.1016/j.ajpath.2010.11.016; Silverman ES, 1999, AM J PATHOL, V154, P665, DOI 10.1016/S0002-9440(10)65312-6; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; Thiel G, 2000, BBA-GENE STRUCT EXPR, V1493, P289, DOI 10.1016/S0167-4781(00)00207-4; Tumane Rajani G, 2010, Indian J Occup Environ Med, V14, P31, DOI 10.4103/0019-5278.72237; Windischhofer W, 2012, BIOCHIMIE, V94, P1997, DOI 10.1016/j.biochi.2012.05.023; Yao J, 1997, J BIOL CHEM, V272, P17795, DOI 10.1074/jbc.272.28.17795; Yu HW, 2010, BIOCHEM BIOPH RES CO, V396, P451, DOI 10.1016/j.bbrc.2010.04.115; Zhang WS, 2000, AM J PATHOL, V157, P1311, DOI 10.1016/S0002-9440(10)64646-9; Zhang YX, 2011, J BIOL CHEM, V286, P29635, DOI 10.1074/jbc.M111.253039	44	31	34	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e68943	10.1371/journal.pone.0068943	http://dx.doi.org/10.1371/journal.pone.0068943			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874821	Green Published, gold, Green Submitted			2022-12-27	WOS:000324146200042
J	Feyssa, B; Liedert, C; Kivimaki, L; Johansson, LS; Jantunen, H; Hakalahti, L				Feyssa, Belachew; Liedert, Christina; Kivimaki, Liisa; Johansson, Leena-Sisko; Jantunen, Heli; Hakalahti, Leena			Patterned Immobilization of Antibodies within Roll-to-Roll Hot Embossed Polymeric Microfluidic Channels	PLOS ONE			English	Article							IMMUNOASSAY; PERFORMANCE; CHIP; REQUIREMENTS; FABRICATION; MICROARRAYS; MICROCHIP; PROTEINS; DEVICES; SYSTEM	This paper describes a method for the patterned immobilization of capture antibodies into a microfluidic platform fabricated by roll-to-roll (R2R) hot embossing on poly (methyl methacrylate) (PMMA). Covalent attachment of antibodies was achieved by two sequential inkjet printing steps. First, a polyethyleneimine (PEI) layer was deposited onto oxygen plasma activated PMMA foil and further cross-linked with glutaraldehyde (GA) to provide an amine-reactive aldehyde surface (PEI-GA). This step was followed by a second deposition of antibody by overprinting on the PEI-GA patterned PMMA foil. The PEI polymer ink was first formulated to ensure stable drop formation in inkjet printing and the printed films were characterized using atomic force microscopy (AFM) and X-ray photoelectron spectroscopy (XPS). Anti-CRP antibody was patterned on PMMA foil by the developed method and bonded permanently with R2R hot embossed PMMA microchannels by solvent bonding lamination. The functionality of the immobilized antibody inside the microfluidic channel was evaluated by fluorescence-based sandwich immunoassay for detection of C-reactive protein (CRP). The antibody-antigen assay exhibited a good level of linearity over the range of 10 ng/ml to 500 ng/ml (R-2 = 0.991) with a calculated detection limit of 5.2 ng/ml. The developed patterning method is straightforward, rapid and provides a versatile approach for creating multiple protein patterns in a single microfluidic channel for multiplexed immunoassays.	[Feyssa, Belachew; Liedert, Christina; Kivimaki, Liisa; Hakalahti, Leena] VTT Tech Res Ctr Finland, Oulu, Finland; [Johansson, Leena-Sisko] Aalto Univ, Sch Chem Technol, Dept Forest Prod Technol, Espoo, Finland; [Jantunen, Heli] Univ Oulu, Dept Elect Engn, Microelect & Mat Phys Labs, Oulu, Finland	VTT Technical Research Center Finland; Aalto University; University of Oulu	Feyssa, B (corresponding author), VTT Tech Res Ctr Finland, Oulu, Finland.	BelachewTolla.Feyssa@vtt.fi	Jantunen, Heli M/F-8957-2016	Jantunen, Heli/0000-0002-0132-4643; Liedert, Christina/0000-0001-5246-821X; Johansson, Leena-Sisko/0000-0003-0428-8155	European Community [23845]	European Community(European Commission)	The work was carried out within the FlexSMELL project, part of a Marie Curie Initial Training Network (ITN), supported by the European Community Framework Programme 7, Grant Agreement No.:23845. The funding agency has no role in the study design, decision to publish or preparation of the manuscript.	Bai YL, 2007, BIOTECHNOL BIOENG, V98, P328, DOI 10.1002/bit.21429; Chai JN, 2004, LANGMUIR, V20, P10919, DOI 10.1021/la048947s; Chen SF, 2003, LANGMUIR, V19, P2859, DOI 10.1021/la026498v; Chin CD, 2012, LAB CHIP, V12, P2118, DOI 10.1039/c2lc21204h; Choi S, 2011, MICROFLUID NANOFLUID, V10, P231, DOI 10.1007/s10404-010-0638-8; Cui XQ, 2005, ANAL BIOCHEM, V342, P173, DOI 10.1016/j.ab.2005.01.049; de Gans BJ, 2003, MACROMOL RAPID COMM, V24, P659, DOI 10.1002/marc.200350010; Delehanty JB, 2002, ANAL CHEM, V74, P5681, DOI 10.1021/ac025631l; Didar TF, 2012, ANAL CHEM, V84, P1012, DOI 10.1021/ac2025877; Fiddes LK, 2010, BIOMATERIALS, V31, P315, DOI 10.1016/j.biomaterials.2009.09.040; Geissler M, 2009, ACS APPL MATER INTER, V1, P1387, DOI 10.1021/am900285g; Gervais L, 2009, LAB CHIP, V9, P3330, DOI 10.1039/b906523g; Gratton SEA, 2008, ACCOUNTS CHEM RES, V41, P1685, DOI 10.1021/ar8000348; Gubala V, 2012, ANAL CHEM, V84, P487, DOI 10.1021/ac2030199; Hasenbank MS, 2008, ANAL CHIM ACTA, V611, P80, DOI 10.1016/j.aca.2008.01.048; Herr AE, 2007, P NATL ACAD SCI USA, V104, P5268, DOI 10.1073/pnas.0607254104; Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421; Islam MS, 2010, TALANTA, V81, P1402, DOI 10.1016/j.talanta.2010.02.042; Khademhosseini A, 2004, ANAL CHEM, V76, P3675, DOI 10.1021/ac035415s; Kitagawa F, 2006, SCI TECHNOL ADV MAT, V7, P558, DOI 10.1016/j.stam.2006.02.021; Lakard S, 2004, BIOELECTROCHEMISTRY, V62, P19, DOI 10.1016/j.bioelechem.2003.09.009; Liedert R, 2012, LAB CHIP, V12, P333, DOI 10.1039/c1lc20782b; MacBeath G, 2000, SCIENCE, V289, P1760; Mark D, 2010, CHEM SOC REV, V39, P1153, DOI 10.1039/b820557b; Ng SH, 2009, MICROSYST TECHNOL, V15, P1149, DOI 10.1007/s00542-008-0722-0; Orelma H, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0061-7; Posthuma-Trumpie GA, 2009, ANAL BIOANAL CHEM, V393, P569, DOI 10.1007/s00216-008-2287-2; Ramon-Azcon J, 2006, ANAL CHEM, V78, P71, DOI 10.1021/ac051141s; Rowe CA, 1999, ANAL CHEM, V71, P433, DOI 10.1021/ac980798t; Sato K, 2002, ELECTROPHORESIS, V23, P734, DOI 10.1002/1522-2683(200203)23:5<734::AID-ELPS734>3.0.CO;2-W; Sharma H, 2011, ANN BIOMED ENG, V39, P1313, DOI 10.1007/s10439-010-0213-1; St-Louis P, 2000, CLIN BIOCHEM, V33, P427, DOI 10.1016/S0009-9120(00)00138-7; Stewart Thomas N., 2009, Biotechnology Journal, V4, P206, DOI 10.1002/biot.200800234; Tan CP, 2010, NANO LETT, V10, P719, DOI 10.1021/nl903968s; von Lode P, 2005, CLIN BIOCHEM, V38, P591, DOI 10.1016/j.clinbiochem.2005.03.008; Wu P, 2008, J BIOMAT SCI-POLYM E, V19, P725, DOI 10.1163/156856208784522092; Yamazoe H, 2012, J BIOMED MATER RES A, V100A, P362, DOI 10.1002/jbm.a.33279; Yeo LP, 2009, MICROELECTRON ENG, V86, P933, DOI 10.1016/j.mee.2008.12.021; Yin ZZ, 2010, INTEGR BIOL-UK, V2, P416, DOI 10.1039/c0ib00017e; Yuan Y, 2009, BIOTECHNOL BIOENG, V102, P891, DOI 10.1002/bit.22136; Yun YH, 2009, MACROMOL RES, V17, P197, DOI 10.1007/BF03218679	41	26	27	1	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e68918	10.1371/journal.pone.0068918	http://dx.doi.org/10.1371/journal.pone.0068918			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874811	Green Published, gold, Green Submitted			2022-12-27	WOS:000324146200038
J	Jacobs, PT; Cao, L; Samon, JB; Kane, CA; Hedblom, EE; Bowcock, A; Telfer, JC				Jacobs, Paejonette T.; Cao, Li; Samon, Jeremy B.; Kane, Christyne A.; Hedblom, Emmett E.; Bowcock, Anne; Telfer, Janice C.			Runx Transcription Factors Repress Human and Murine c-Myc Expression in a DNA-Binding and C-Terminally Dependent Manner	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; MULTIPLE CHROMOSOMAL TRANSLOCATIONS; ACUTE MYELOID-LEUKEMIA; BETA CBF-BETA; NEGATIVE REGULATION; GENE-EXPRESSION; MESSENGER-RNA; NUCLEAR-MATRIX; TUMOR-CELLS; AML1	The transcription factors Runx1 and c-Myc have individually been shown to regulate important gene targets as well as to collaborate in oncogenesis. However, it is unknown whether there is a regulatory relationship between the two genes. In this study, we investigated the transcriptional regulation of endogenous c-Myc by Runx1 in the human T cell line Jurkat and murine primary hematopoietic cells. Endogenous Runx1 binds to multiple sites in the c-Myc locus upstream of the c-Myc transcriptional start site. Cells transduced with a C-terminally truncated Runx1 (Runx1.d190), which lacks important cofactor interaction sites and can block C-terminal-dependent functions of all Runx transcription factors, showed increased transcription of c-Myc. In order to monitor c-Myc expression in response to early and transiently-acting Runx1.d190, we generated a cell membrane-permeable TAT-Runx1.d190 fusion protein. Murine splenocytes treated with TAT-Runx1.d190 showed an increase in the transcription of c-Myc within 2 hours, peaking at 4 hours post-treatment and declining thereafter. This effect is dependent on the ability of Runx1.d190 to bind to DNA. The increase in c-Myc transcripts is correlated with increased c-Myc protein levels. Collectively, these data show that Runx1 directly regulates c-Myc transcription in a C-terminal-and DNA-binding-dependent manner.	[Jacobs, Paejonette T.; Hedblom, Emmett E.; Telfer, Janice C.] Univ Massachusetts, Program Mol & Cellular Biol, Amherst, MA 01003 USA; [Cao, Li; Bowcock, Anne] Washington Univ, Sch Med, Dept Genet Pediat & Med, St Louis, MO USA; [Samon, Jeremy B.] Quntiles, Med Educ Dept, Hawthorne, NY USA; [Kane, Christyne A.; Telfer, Janice C.] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; Washington University (WUSTL); University of Massachusetts System; University of Massachusetts Amherst	Telfer, JC (corresponding author), Univ Massachusetts, Program Mol & Cellular Biol, Amherst, MA 01003 USA.	telfer@vasci.umass.edu		Bowcock, Anne/0000-0001-8691-9090	National Science Foundation [CAREER 0546028, DGE-065412]; Charles E. Culpeper Biomedical Pilot Grant; Armstrong Fund for Science	National Science Foundation(National Science Foundation (NSF)); Charles E. Culpeper Biomedical Pilot Grant; Armstrong Fund for Science	This research is supported by National Science Foundation CAREER 0546028 (http://www.nsf.gov, to JCT), a Charles E. Culpeper Biomedical Pilot Grant (http://www.goldmanpartnerships.org, to JCT), the Armstrong Fund for Science (http://www.umass.edu, to JCT), and an National Science Foundation-sponsored Institute for Cellular Engineering IGERT fellowship DGE-065412 (http://www.nsf.gov, to PJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn MY, 1998, P NATL ACAD SCI USA, V95, P1812, DOI 10.1073/pnas.95.4.1812; Allen RD, 2001, MOL CELL BIOL, V21, P3071, DOI 10.1128/MCB.21.9.3071-3082.2001; Aronson BD, 1997, MOL CELL BIOL, V17, P5581, DOI 10.1128/MCB.17.9.5581; BAE SC, 1993, ONCOGENE, V8, P809; BAE SC, 1995, GENE, V159, P245, DOI 10.1016/0378-1119(95)00060-J; BAE SC, 1994, MOL CELL BIOL, V14, P3242, DOI 10.1128/MCB.14.5.3242; Becker-Hapak M, 2001, METHODS, V24, P247, DOI 10.1006/meth.2001.1186; Becker-Hapak M, 2003, CURR PROTOC CELL BIO; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bladergroen BA, 2002, BLOOD, V99, P232, DOI 10.1182/blood.V99.1.232; Blyth K, 2009, BLOOD CELL MOL DIS, V43, P12, DOI 10.1016/j.bcmd.2009.01.013; Brabletz T, 1999, INT IMMUNOL, V11, P1701, DOI 10.1093/intimm/11.10.1701; Bravo J, 2001, NAT STRUCT BIOL, V8, P371, DOI 10.1038/86264; Bruhn L, 1997, GENE DEV, V11, P640, DOI 10.1101/gad.11.5.640; Bruno L, 2009, J EXP MED, V206, P2329, DOI 10.1084/jem.20090226; Cameron ER, 2003, BLOOD CELL MOL DIS, V30, P194, DOI 10.1016/S1079-9796(03)00031-7; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; DAGA A, 1992, NATURE, V356, P484, DOI 10.1038/356484b0; DANI C, 1984, P NATL ACAD SCI-BIOL, V81, P7046, DOI 10.1073/pnas.81.22.7046; Dunning MJ, 2007, BIOINFORMATICS, V23, P2183, DOI 10.1093/bioinformatics/btm311; Durst KL, 2004, ONCOGENE, V23, P4220, DOI 10.1038/sj.onc.1207122; Egawa T, 2011, P NATL ACAD SCI USA, V108, P14873, DOI 10.1073/pnas.1112293108; Eisenman RN, 2001, GENE DEV, V15, P2023, DOI 10.1101/gad928101; ERICKSON P, 1992, BLOOD, V80, P1825; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GIESE K, 1995, GENE DEV, V9, P995, DOI 10.1101/gad.9.8.995; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Growney JD, 2005, BLOOD, V106, P494, DOI 10.1182/blood-2004-08-3280; Gu TL, 2000, MOL CELL BIOL, V20, P91, DOI 10.1128/MCB.20.1.91-103.2000; Hiebert SW, 1996, MOL CELL BIOL, V16, P1349; Huang CH, 2010, TISSUE ENG PART C-ME, V16, P487, DOI [10.1089/ten.tec.2009.0163, 10.1089/ten.TEC.2009.0163]; Huang G, 2001, EMBO J, V20, P723, DOI 10.1093/emboj/20.4.723; Ichikawa M, 2004, NAT MED, V10, P299, DOI 10.1038/nm997; Ichikawa M, 2008, J IMMUNOL, V180, P4402, DOI 10.4049/jimmunol.180.7.4402; Javed A, 2000, J CELL SCI, V113, P2221; Jiang WZ, 2011, J IMMUNOL, V187, P781, DOI 10.4049/jimmunol.1100789; JONES TR, 1987, MOL CELL BIOL, V7, P4513, DOI 10.1128/MCB.7.12.4513; Jung P, 2008, P NATL ACAD SCI USA, V105, P15046, DOI 10.1073/pnas.0801773105; KAGOSHIMA H, 1993, TRENDS GENET, V9, P338, DOI 10.1016/0168-9525(93)90026-E; Kaiserman D, 2010, CELL DEATH DIFFER, V17, P586, DOI 10.1038/cdd.2009.169; KAMACHI Y, 1990, J VIROL, V64, P4808, DOI 10.1128/JVI.64.10.4808-4819.1990; Kanno T, 1998, MOL CELL BIOL, V18, P2444, DOI 10.1128/MCB.18.5.2444; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; Kim HK, 1998, MOL CELL BIOL, V18, P7166, DOI 10.1128/MCB.18.12.7166; Klampfer L, 1996, P NATL ACAD SCI USA, V93, P14059, DOI 10.1073/pnas.93.24.14059; Knoepfler PS, 2007, CANCER RES, V67, P5061, DOI 10.1158/0008-5472.CAN-07-0426; Krosl J, 2003, NAT MED, V9, P1428, DOI 10.1038/nm951; Laurenti E, 2008, CELL STEM CELL, V3, P611, DOI 10.1016/j.stem.2008.09.005; Levanon D, 1998, P NATL ACAD SCI USA, V95, P11590, DOI 10.1073/pnas.95.20.11590; LEVANON D, 1994, GENOMICS, V23, P425, DOI 10.1006/geno.1994.1519; Li DL, 2007, J BIOL CHEM, V282, P13542, DOI 10.1074/jbc.M700074200; Li Z, 2003, J BIOL CHEM, V278, P33088, DOI 10.1074/jbc.M303973200; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Lutterbach B, 2000, J BIOL CHEM, V275, P651, DOI 10.1074/jbc.275.1.651; Martinez P, 2010, NAT CELL BIOL, V12, P768, DOI 10.1038/ncb2081; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; McLarrent FW, 2001, J BIOL CHEM, V276, P1578, DOI 10.1074/jbc.M007629200; MELNIKOVA IN, 1993, J VIROL, V67, P2408, DOI 10.1128/JVI.67.4.2408-2411.1993; MEYERS S, 1993, MOL CELL BIOL, V13, P6336, DOI 10.1128/MCB.13.10.6336; MIYOSHI H, 1991, P NATL ACAD SCI USA, V88, P10431, DOI 10.1073/pnas.88.23.10431; Nilsson JA, 2003, ONCOGENE, V22, P9007, DOI 10.1038/sj.onc.1207261; OGAWA E, 1993, P NATL ACAD SCI USA, V90, P6859, DOI 10.1073/pnas.90.14.6859; OGAWA E, 1993, VIROLOGY, V194, P314, DOI 10.1006/viro.1993.1262; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Osato M, 2004, ONCOGENE, V23, P4284, DOI 10.1038/sj.onc.1207779; Petrovick HS, 1998, MOL CELL BIOL, V18, P3915, DOI 10.1128/MCB.18.7.3915; Putz G, 2006, ONCOGENE, V25, P929, DOI 10.1038/sj.onc.1209136; R Core Team, 2020, R LANG ENV STAT COMP; RABBITTS PH, 1985, EMBO J, V4, P3727, DOI 10.1002/j.1460-2075.1985.tb04141.x; Reavie L, 2010, NAT IMMUNOL, V11, P207, DOI 10.1038/ni.1839; Sears R, 1999, MOL CELL, V3, P169, DOI 10.1016/S1097-2765(00)80308-1; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Speck NA, 1999, CANCER RES, V59, p1789S; Speck NA, 2002, NAT REV CANCER, V2, P502, DOI 10.1038/nrc840; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang JL, 2009, BLOOD, V114, P5352, DOI 10.1182/blood-2009-05-223784; Tang YY, 2000, J BIOL CHEM, V275, P39579, DOI 10.1074/jbc.M007350200; Taniuchi I, 2002, MOL CELL, V10, P1083, DOI 10.1016/S1097-2765(02)00735-9; Telfer JC, 2004, J IMMUNOL, V172, P4359, DOI 10.4049/jimmunol.172.7.4359; Telfer JC, 2001, DEV BIOL, V229, P363, DOI 10.1006/dbio.2000.9991; Wang F, 2009, EUR J IMMUNOL, V39, P254, DOI 10.1002/eji.200838472; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; WANG SW, 1993, MOL CELL BIOL, V13, P3324, DOI 10.1128/MCB.13.6.3324; WANG SW, 1992, MOL CELL BIOL, V12, P89, DOI 10.1128/MCB.12.1.89; WARGNIER A, 1995, P NATL ACAD SCI USA, V92, P6930, DOI 10.1073/pnas.92.15.6930; Warren AJ, 2000, EMBO J, V19, P3004, DOI 10.1093/emboj/19.12.3004; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; WOTTON D, 1994, MOL CELL BIOL, V14, P840, DOI 10.1128/MCB.14.1.840; Wotton S, 2002, CANCER RES, V62, P7181; Yannoutsos N, 2004, NAT IMMUNOL, V5, P443, DOI 10.1038/ni1053; Zaidi SK, 2002, P NATL ACAD SCI USA, V99, P8048, DOI 10.1073/pnas.112664499; Zeng CM, 1997, P NATL ACAD SCI USA, V94, P6746, DOI 10.1073/pnas.94.13.6746; Zhang DE, 1996, MOL CELL BIOL, V16, P1231	94	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e69083	10.1371/journal.pone.0069083	http://dx.doi.org/10.1371/journal.pone.0069083			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874874	Green Published, Green Submitted, gold			2022-12-27	WOS:000324146200055
J	Kovacic, F; Granzin, J; Wilhelm, S; Kojic-Prodic, B; Batra-Safferling, R; Jaeger, KE				Kovacic, Filip; Granzin, Joachim; Wilhelm, Susanne; Kojic-Prodic, Biserka; Batra-Safferling, Renu; Jaeger, Karl-Erich			Structural and Functional Characterisation of TesA - A Novel Lysophospholipase A from Pseudomonas aeruginosa	PLOS ONE			English	Article							MEMBRANE-LIPID-COMPOSITION; FATTY-ACID-COMPOSITION; PROTEINS; FAMILY; RECOGNITION; PROMISCUITY; ADAPTATION; ESTERASE; GENE; BOND	TesA from Pseudomonas aeruginosa belongs to the GDSL hydrolase family of serine esterases and lipases that possess a broad substrate-and regiospecificity. It shows high sequence homology to TAP, a multifunctional enzyme from Escherichia coli exhibiting thioesterase, lysophospholipase A, protease and arylesterase activities. Recently, we demonstrated high arylesterase activity for TesA, but only minor thioesterase and no protease activity. Here, we present a comparative analysis of TesA and TAP at the structural, biochemical and physiological levels. The crystal structure of TesA was determined at 1.9 angstrom and structural differences were identified, providing a possible explanation for the differences in substrate specificities. The comparison of TesA with other GDSL-hydrolase structures revealed that the flexibility of active-site loops significantly affects their substrate specificity. This assumption was tested using a rational approach: we have engineered the putative coenzyme A thioester binding site of E. coli TAP into TesA of P. aeruginosa by introducing mutations D17S and L162R. This TesA variant showed increased thioesterase activity comparable to that of TAP. TesA is the first lysophospholipase A described for the opportunistic human pathogen P. aeruginosa. The enzyme is localized in the periplasm and may exert important functions in the homeostasis of phospholipids or detoxification of lysophospholipids.	[Kovacic, Filip; Wilhelm, Susanne; Jaeger, Karl-Erich] Univ Dusseldorf, Forschungszentrum Julich, Inst Mol Enzymtechnol, Julich, Germany; [Granzin, Joachim; Batra-Safferling, Renu] Forschungszentrum Julich, Inst Complex Syst ICS 6, D-52425 Julich, Germany; [Kojic-Prodic, Biserka] Rudjer Boskovic Inst, Dept Phys Chem, Zagreb, Croatia	Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; Rudjer Boskovic Institute	Batra-Safferling, R (corresponding author), Forschungszentrum Julich, Inst Complex Syst ICS 6, D-52425 Julich, Germany.	r.batra-safferling@fz-juelich.de; karl-erich.jaeger@fz-juelich.de	Batra-Safferling, Renu/G-2918-2013; Kovacic, Filip/ABG-7585-2020; jaeger, karl/ABB-1955-2020; Granzin, Joachim/G-8937-2013; Filip, Kovacic/GRJ-3538-2022	Batra-Safferling, Renu/0000-0002-8597-4335; Granzin, Joachim/0000-0001-6604-950X; Filip, Kovacic/0000-0002-0313-427X	European Union (FP6 Marie Curie EST project ANTIBIOTARGET) [MEST-CT-2005-020278]	European Union (FP6 Marie Curie EST project ANTIBIOTARGET)	This work was supported by a research grant from the European Union (FP6 Marie Curie EST project ANTIBIOTARGET; MEST-CT-2005-020278. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Akoh CC, 2004, PROG LIPID RES, V43, P534, DOI 10.1016/j.plipres.2004.09.002; Aricha B, 2004, J BACTERIOL, V186, P4638, DOI 10.1128/JB.186.14.4638-4644.2004; Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Asler IL, 2010, CHEMBIOCHEM, V11, P2158, DOI 10.1002/cbic.201000398; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bofill C, 2010, BIOCHIMIE, V92, P307, DOI 10.1016/j.biochi.2009.11.005; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brzuszkiewicz A, 2009, ACTA CRYSTALLOGR F, V65, P862, DOI 10.1107/S1744309109030826; Contreras FX, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004705; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flieger A, 2002, INFECT IMMUN, V70, P6094, DOI 10.1128/IAI.70.11.6094-6106.2002; Greiner AJ, 2010, BBA-BIOMEMBRANES, V1798, P1533, DOI 10.1016/j.bbamem.2010.03.015; HAZEL JR, 1990, PROG LIPID RES, V29, P167, DOI 10.1016/0163-7827(90)90002-3; Heikinheimo P, 1999, STRUCTURE, V7, pR141, DOI 10.1016/S0969-2126(99)80079-3; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jaeger KE, 2002, CURR OPIN BIOTECH, V13, P390, DOI 10.1016/S0958-1669(02)00341-5; JAEGER KE, 2013, METHODS PSE IN PRESS; Julotok M, 2010, APPL ENVIRON MICROB, V76, P1423, DOI 10.1128/AEM.01592-09; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kapitonov VV, 2003, MOL BIOL EVOL, V20, P38, DOI 10.1093/molbev/msg011; KARASAWA K, 1991, J BIOCHEM, V109, P288; Kingston AW, 2011, MOL MICROBIOL, V81, P69, DOI 10.1111/j.1365-2958.2011.07679.x; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Koehler J, 2010, BIOCHEMISTRY-US, V49, P7089, DOI 10.1021/bi100575s; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee LC, 2007, BBA-PROTEINS PROTEOM, V1774, P959, DOI 10.1016/j.bbapap.2007.05.012; Lee YL, 2012, BIOCATAL AGRIC BIOTE, V1, P95, DOI 10.1016/j.bcab.2012.01.006; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB, P26; Lo YC, 2005, BIOCHEMISTRY-US, V44, P1971, DOI 10.1021/bi048109x; Lo YC, 2003, J MOL BIOL, V330, P539, DOI 10.1016/S0022-2836(03)00637-5; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Molgaard A, 2000, STRUCTURE, V8, P373, DOI 10.1016/S0969-2126(00)00118-0; Morein S, 1996, J BIOL CHEM, V271, P6801, DOI 10.1074/jbc.271.12.6801; Moreira MEC, 2004, AN ACAD BRAS CIENC, V76, P93, DOI 10.1590/S0001-37652004000100009; Nomura T, 2012, P NATL ACAD SCI USA, V109, P8770, DOI 10.1073/pnas.1200051109; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3; Rigoni M, 2005, SCIENCE, V310, P1678, DOI 10.1126/science.1120640; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanchez DG, 2012, MICROBIOL RES, V167, P317, DOI 10.1016/j.micres.2011.11.005; Seibert CM, 2005, BIOCHEMISTRY-US, V44, P6383, DOI 10.1021/bi047326v; Shamim S, 2014, J BASIC MICROB, V54, P306, DOI 10.1002/jobm.201200434; SINENSKY M, 1974, P NATL ACAD SCI USA, V71, P522, DOI 10.1073/pnas.71.2.522; SUUTARI M, 1994, CRIT REV MICROBIOL, V20, P285, DOI 10.3109/10408419409113560; Tannaes T, 2000, APMIS, V108, P349, DOI 10.1034/j.1600-0463.2000.d01-67.x; UPTON C, 1995, TRENDS BIOCHEM SCI, V20, P178, DOI 10.1016/S0968-0004(00)89002-7; Van Delden C, 1998, EMERG INFECT DIS, V4, P551, DOI 10.3201/eid0404.980405; van den Berg B, 2010, J MOL BIOL, V396, P627, DOI 10.1016/j.jmb.2009.12.061; WEI YY, 1995, NAT STRUCT BIOL, V2, P218, DOI 10.1038/nsb0395-218; Wilhelm S, 1999, J BACTERIOL, V181, P6977, DOI 10.1128/JB.181.22.6977-6986.1999; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WITHOLT B, 1976, ANAL BIOCHEM, V74, P160, DOI 10.1016/0003-2697(76)90320-1; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33	58	41	41	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e69125	10.1371/journal.pone.0069125	http://dx.doi.org/10.1371/journal.pone.0069125			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874889	Green Submitted, Green Published, gold			2022-12-27	WOS:000324146200060
J	Shen, B; Fang, T; Dai, MY; Jones, G; Zhang, SY				Shen, Bin; Fang, Tao; Dai, Mengyao; Jones, Gareth; Zhang, Shuyi			Independent Losses of Visual Perception Genes Gja10 and Rbp3 in Echolocating Bats (Order: Chiroptera)	PLOS ONE			English	Article							RETINOID-BINDING PROTEIN; RELATIVE BRAIN SIZE; FRUIT-EATING BATS; VAMPIRE BAT; SOUND-LOCALIZATION; HORIZONTAL CELLS; MOLECULAR SYSTEMATICS; FUNCTIONAL EXPRESSION; DESMODUS-ROTUNDUS; ACTIVITY PATTERNS	A trade-off between the sensory modalities of vision and hearing is likely to have occurred in echolocating bats as the sophisticated mechanism of laryngeal echolocation requires considerable neural processing and has reduced the reliance of echolocating bats on vision for perceiving the environment. If such a trade-off exists, it is reasonable to hypothesize that some genes involved in visual function may have undergone relaxed selection or even functional loss in echolocating bats. The Gap junction protein, alpha 10 (Gja10, encoded by Gja10 gene) is expressed abundantly in mammal retinal horizontal cells and plays an important role in horizontal cell coupling. The interphotoreceptor retinoid-binding protein (Irbp, encoded by the Rbp3 gene) is mainly expressed in interphotoreceptor matrix and is known to be critical for normal functioning of the visual cycle. We sequenced Gja10 and Rbp3 genes in a taxonomically wide range of bats with divergent auditory characteristics (35 and 18 species for Gja10 and Rbp3, respectively). Both genes have became pseudogenes in species from the families Hipposideridae and Rhinolophidae that emit constant frequency echolocation calls with Doppler shift compensation at high-duty-cycles (the most sophisticated form of biosonar known), and in some bat species that emit echolocation calls at low-duty-cycles. Our study thus provides further evidence for the hypothesis that a trade-off occurs at the genetic level between vision and echolocation in bats.	[Shen, Bin; Fang, Tao; Dai, Mengyao; Zhang, Shuyi] E China Normal Univ, Inst Mol Ecol & Evolut, Shanghai 200062, Peoples R China; [Shen, Bin; Fang, Tao; Dai, Mengyao; Zhang, Shuyi] E China Normal Univ, Inst Adv Interdisciplinary Res, Shanghai 200062, Peoples R China; [Jones, Gareth] Univ Bristol, Sch Biol Sci, Bristol, Avon, England	East China Normal University; East China Normal University; University of Bristol	Jones, G (corresponding author), Univ Bristol, Sch Biol Sci, Bristol, Avon, England.	Gareth.Jones@bris.ac.uk; syzhang@bio.ecnu.edu.cn		Jones, Gareth/0000-0002-1904-3735	Key Construction Program of the National '985 Project'; Key Construction Program of the National '211 Project'; Chinese National Science Foundation [31172077]; Biotechnology and Biological Sciences Research Council (BBSRC) Chinese Partnering award; Academic Scholarship for PhD Candidate; Ministry of Education of the P. R. China [MXRZZ2012008]; BBSRC [BB/G530392/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G530392/1] Funding Source: researchfish	Key Construction Program of the National '985 Project'; Key Construction Program of the National '211 Project'; Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); Biotechnology and Biological Sciences Research Council (BBSRC) Chinese Partnering award(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Academic Scholarship for PhD Candidate; Ministry of Education of the P. R. China(Ministry of Education, China); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Key Construction Program of the National '985 Project' and '211 Project' and the Chinese National Science Foundation (Grant No. 31172077) to SZ. GJ was supported by a Biotechnology and Biological Sciences Research Council (BBSRC) Chinese Partnering award. BS was supported by the Academic Scholarship for PhD Candidate granted by Ministry of Education of the P. R. China (MXRZZ2012008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG E, 1983, SCIENCE, V220, P1302, DOI 10.1126/science.6407108; Bahlman JW, 2007, BIOTROPICA, V39, P147, DOI 10.1111/j.1744-7429.2006.00218.x; Beyer Eric C., 2009, P3, DOI 10.1007/978-1-59745-489-6_1; Bloomfield SA, 2009, NAT REV NEUROSCI, V10, P495, DOI 10.1038/nrn2636; BRADBURY JW, 1969, ANIM BEHAV, V17, P480, DOI 10.1016/0003-3472(69)90150-X; BROWN JH, 1968, J MAMMAL, V49, P754, DOI 10.2307/1378737; CRESPO RF, 1972, J MAMMAL, V53, P366, DOI 10.2307/1379175; Dechmann DKN, 2009, BIOL REV, V84, P161, DOI 10.1111/j.1469-185X.2008.00067.x; DOYLE JJ, 1992, SYST BOT, V17, P144, DOI 10.2307/2419070; Eklof J, 2003, ANIM BEHAV, V66, P949, DOI 10.1006/anbe.2003.2272; Feller KD, 2009, COMP BIOCHEM PHYS B, V154, P412, DOI 10.1016/j.cbpb.2009.08.006; FENTON MB, 1995, PALEOBIOLOGY, V21, P229, DOI 10.1017/S0094837300013221; Frantzen MAJ, 1998, MOL ECOL, V7, P1423, DOI 10.1046/j.1365-294x.1998.00449.x; FUZESSERY ZM, 1993, J COMP PHYSIOL A, V171, P767, DOI 10.1007/BF00213073; Giannini NP, 2003, CLADISTICS, V19, P496, DOI 10.1111/j.1096-0031.2003.tb00385.x; Gonzalez-Fernandez F, 2003, VISION RES, V43, P3021, DOI 10.1016/j.visres.2003.09.019; HARVEY PH, 1990, SCIENCE, V249, P140, DOI 10.1126/science.2196673; Heffner RS, 2007, HEARING RES, V234, P1, DOI 10.1016/j.heares.2007.06.001; Heffner RS, 2001, J ACOUST SOC AM, V109, P412, DOI 10.1121/1.1329620; Henson DD, 2009, CAN J ZOOL, V87, P211, DOI 10.1139/Z09-005; Hombach S, 2004, EUR J NEUROSCI, V19, P2633, DOI 10.1111/j.0953-816X.2004.03360.x; Hoofer SR, 2003, ACTA CHIROPTEROL, V5, P1, DOI 10.3161/001.005.s101; HOPE GM, 1979, EXPERIENTIA, V35, P1191, DOI 10.1007/BF01963280; Jennings NV, 2004, ACTA CHIROPTEROL, V6, P75, DOI 10.3161/001.006.0106; Jin MH, 2009, J NEUROSCI, V29, P1486, DOI 10.1523/JNEUROSCI.3882-08.2009; Jones G, 2006, TRENDS ECOL EVOL, V21, P149, DOI 10.1016/j.tree.2006.01.001; Jones G, 2005, CURR BIOL, V15, pR484, DOI 10.1016/j.cub.2005.06.051; Jones G, 1999, J EXP BIOL, V202, P3359; Kalko EKV, 1996, J BIOGEOGR, V23, P565, DOI 10.1111/j.1365-2699.1996.tb00018.x; Kim EB, 2011, NATURE, V479, P223, DOI 10.1038/nature10533; Kim TJ, 2008, MOL CELLS, V26, P373; KURTEN L, 1982, J COMP PHYSIOL, V146, P223; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; Li G, 2008, P NATL ACAD SCI USA, V105, P13959, DOI 10.1073/pnas.0802097105; Li Y, 2010, CURR BIOL, V20, pR55, DOI 10.1016/j.cub.2009.11.042; Liu Y, 2010, CURR BIOL, V20, pR53, DOI 10.1016/j.cub.2009.11.058; MANSKE U, 1976, Z TIERPSYCHOL, V42, P215; Manthey D, 1999, J BIOL CHEM, V274, P14716, DOI 10.1074/jbc.274.21.14716; MARTIN RD, 1981, NATURE, V293, P57, DOI 10.1038/293057a0; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Miller-Butterworth CM, 2007, MOL BIOL EVOL, V24, P1553, DOI 10.1093/molbev/msm076; Muller B, 2005, INVEST OPHTH VIS SCI, V46; Murray SW, 2012, MOL PHYLOGENET EVOL, V62, P597, DOI 10.1016/j.ympev.2011.10.021; Neuweiler G., 2000, BIOL BATS; Ollivier FJ, 2004, VET OPHTHALMOL, V7, P11, DOI 10.1111/j.1463-5224.2004.00318.x; Pan F, 2012, J COMP NEUROL, V520, P2256, DOI 10.1002/cne.23060; Parker R, 2011, J NEUROSCI, V31, P4714, DOI 10.1523/JNEUROSCI.3722-10.2011; Parker RO, 2009, J NEUROSCI, V29, P4616, DOI 10.1523/JNEUROSCI.0063-09.2009; PEPPERBERG DR, 1993, MOL NEUROBIOL, V7, P61, DOI 10.1007/BF02780609; PETTIGREW JD, 1988, BRAIN BEHAV EVOLUT, V32, P39, DOI 10.1159/000116531; Pollak G.D., 1989, NEURAL BASIS ECHOLOC; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Richard G, 2000, EXP DERMATOL, V9, P77, DOI 10.1034/j.1600-0625.2000.009002077.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozental R, 2000, BRAIN RES REV, V32, P11, DOI 10.1016/S0165-0173(99)00095-8; Rydell J, 2003, NATURWISSENSCHAFTEN, V90, P481, DOI 10.1007/s00114-003-0464-x; Schnitzler HU, 2003, TRENDS ECOL EVOL, V18, P386, DOI 10.1016/S0169-5347(03)00185-X; Serizawa K, 2000, BIOCHEM GENET, V38, P27, DOI 10.1023/A:1001828203201; Shelley J, 2006, EUR J NEUROSCI, V23, P3176, DOI 10.1111/j.1460-9568.2006.04848.x; Simmons N., 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; Sohl G, 2010, BMC OPHTHALMOL, V10, DOI 10.1186/1471-2415-10-27; Springer MS, 1997, P NATL ACAD SCI USA, V94, P13754, DOI 10.1073/pnas.94.25.13754; Springer MS, 1998, P ROY SOC B-BIOL SCI, V265, P2381, DOI 10.1098/rspb.1998.0587; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stanhope MJ, 1996, J MOL EVOL, V43, P83, DOI 10.1007/BF02337352; Stoffberg S, 2010, MOL PHYLOGENET EVOL, V54, P1, DOI 10.1016/j.ympev.2009.09.021; SUGA N, 1975, J EXP BIOL, V63, P161; Taberlet P, 1999, TRENDS ECOL EVOL, V14, P323, DOI 10.1016/S0169-5347(99)01637-7; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Teeling EC, 2009, TRENDS ECOL EVOL, V24, P351, DOI 10.1016/j.tree.2009.02.012; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Weksler M, 2003, MOL PHYLOGENET EVOL, V29, P331, DOI 10.1016/S1055-7903(03)00132-5; WIMSATT WA, 1969, J MAMMAL, V50, P233, DOI 10.2307/1378339; Wisard J, 2011, INVEST OPHTH VIS SCI, V52, P5804, DOI 10.1167/iovs.10-7129; Xin DY, 1999, J COMP NEUROL, V405, P75, DOI 10.1002/(SICI)1096-9861(19990301)405:1<75::AID-CNE6>3.0.CO;2-D; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhao HB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008326; Zhao HB, 2009, P NATL ACAD SCI USA, V106, P8980, DOI 10.1073/pnas.0813201106	81	9	11	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e68867	10.1371/journal.pone.0068867	http://dx.doi.org/10.1371/journal.pone.0068867			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874796	gold, Green Published, Green Submitted			2022-12-27	WOS:000324146200034
J	Zhou, XX; Shi, TW; Li, BL; Zhang, YN; Shen, XP; Li, HD; Hong, GN; Liu, CY; Guo, Z				Zhou, Xianxiao; Shi, Tongwei; Li, Bailiang; Zhang, Yuannv; Shen, Xiaopei; Li, Hongdong; Hong, Guini; Liu, Chunyang; Guo, Zheng			Genes Dysregulated to Different Extent or Oppositely in Estrogen Receptor-Positive and Estrogen Receptor-Negative Breast Cancers	PLOS ONE			English	Article							RNA-SEQ; MOLECULAR PORTRAITS; ENDOCRINE THERAPY; TUMOR-SUPPRESSOR; MESSENGER-RNA; EXPRESSION DISCOVERIES; SAMPLE-SIZE; MICROARRAY; TAMOXIFEN; DATABASE	Background: Directly comparing gene expression profiles of estrogen receptor-positive (ER+) and estrogen receptor-negative (ER-) breast cancers cannot determine whether differentially expressed genes between these two subtypes result from dysregulated expression in ER+ cancer or ER- cancer versus normal controls, and thus would miss critical information for elucidating the transcriptomic difference between the two subtypes. Principal Findings: Using microarray datasets from TCGA, we classified the genes dysregulated in both ER+ and ER- cancers versus normal controls into two classes: (i) genes dysregulated in the same direction but to a different extent, and (ii) genes dysregulated to opposite directions, and then validated the two classes in RNA-sequencing datasets of independent cohorts. We showed that the genes dysregulated to a larger extent in ER+ cancers than in ER- cancers enriched in glycerophospholipid and polysaccharide metabolic processes, while the genes dysregulated to a larger extent in ER- cancers than in ER+ cancers enriched in cell proliferation. Phosphorylase kinase and enzymes of glycosylphosphatidylinositol (GPI) anchor biosynthesis were upregulated to a larger extent in ER+ cancers than in ER- cancers, whereas glycogen synthase and phospholipase A2 were downregulated to a larger extent in ER+ cancers than in ER- cancers. We also found that the genes oppositely dysregulated in the two subtypes significantly enriched with known cancer genes and tended to closely collaborate with the cancer genes. Furthermore, we showed the possibility that these oppositely dysregulated genes could contribute to carcinogenesis of ER+ and ER- cancers through rewiring different subpathways. Conclusions: GPI-anchor biosynthesis and glycogenolysis were elevated and hydrolysis of phospholipids was depleted to a larger extent in ER+ cancers than in ER- cancers. Our findings indicate that the genes oppositely dysregulated in the two subtypes are potential cancer genes which could contribute to carcinogenesis of both ER+ and ER- cancers through rewiring different subpathways.	[Zhou, Xianxiao; Shi, Tongwei; Shen, Xiaopei; Li, Hongdong; Hong, Guini; Guo, Zheng] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Bioinformat Ctr, Chengdu 610054, Peoples R China; [Zhou, Xianxiao; Shi, Tongwei; Shen, Xiaopei; Li, Hongdong; Hong, Guini; Guo, Zheng] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China; [Li, Bailiang; Zhang, Yuannv; Guo, Zheng] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China; [Li, Bailiang] Harbin Med Univ, Genom Res Ctr, Harbin, Peoples R China; [Liu, Chunyang; Guo, Zheng] Fujian Med Univ, Sch Basic Med Sci, Dept Bioinformat, Fuzhou, Peoples R China	University of Electronic Science & Technology of China; University of Electronic Science & Technology of China; Harbin Medical University; Harbin Medical University; Fujian Medical University	Guo, Z (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci & Technol, Bioinformat Ctr, Chengdu 610054, Peoples R China.	guoz@ems.hrbmu.edu.cn	Shen, Xiaopei/B-2773-2017; Li, Bailiang/AAL-5871-2020	Shen, Xiaopei/0000-0002-0004-4228; Li, Bailiang/0000-0001-6729-219X	National Natural Science Foundation of China [30970668, 30011901, 81071646, 91029717]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grants 30970668, 30011901, 81071646, 91029717). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abba MC, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-37; Aebi S, 2011, ANN ONCOL, V22, P1981, DOI 10.1093/annonc/mdq754; Alexe G, 2007, GENOME INFORM SER, V18, P130; Alfarano C, 2005, NUCLEIC ACIDS RES, V33, pD418, DOI 10.1093/nar/gki051; Alles MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004710; Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bachelot T, 2012, J CLIN ONCOL, V30, P2718, DOI 10.1200/JCO.2011.39.0708; Bartucci M, 2001, CANCER RES, V61, P6747; Beelen K, 2012, NAT REV CLIN ONCOL, V9, P529, DOI 10.1038/nrclinonc.2012.121; Benjamini Y, 2001, ANN STAT, V29, P1165; Berry DA, 2006, JAMA-J AM MED ASSOC, V295, P1658, DOI 10.1001/jama.295.14.1658; Bertucci Francois, 2008, J Biol, V7, P6, DOI 10.1186/jbiol67; Camus S, 2012, ONCOGENE, V31, P4333, DOI 10.1038/onc.2011.594; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Center M, 2011, GLOBAL CANCER FACTS; Ceol A, 2010, NUCLEIC ACIDS RES, V38, pD532, DOI 10.1093/nar/gkp983; Chen MQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025564; Chevet E, 2012, ONCOGENE; Chia SK, 2012, CLIN CANCER RES, V18, P4465, DOI 10.1158/1078-0432.CCR-12-0286; Colleoni M, 2004, CLIN CANCER RES, V10, P6622, DOI 10.1158/1078-0432.CCR-04-0380; Colombo PE, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2890; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dunlap SM, 2007, P NATL ACAD SCI USA, V104, P11736, DOI 10.1073/pnas.0703145104; Falaschi A, 2010, CRIT REV BIOCHEM MOL, V45, P14, DOI 10.3109/10409230903365608; Favaro E, 2012, CELL METAB, V16, P751, DOI 10.1016/j.cmet.2012.10.017; Finetti P, 2008, CANCER RES, V68, P767, DOI 10.1158/0008-5472.CAN-07-5516; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gewinner C, 2009, CANCER CELL, V16, P115, DOI 10.1016/j.ccr.2009.06.006; Goldstein I, 2011, CANCER GENE THER, V18, P2, DOI 10.1038/cgt.2010.63; Gong X, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-76; Gruvberger S, 2001, CANCER RES, V61, P5979; Guarneri V, 2006, J CLIN ONCOL, V24, P1037, DOI 10.1200/JCO.2005.02.6914; Haibe-Kains B, 2012, JNCI-J NATL CANCER I, V104, P311, DOI 10.1093/jnci/djr545; Harvell DME, 2008, BREAST CANCER RES TR, V112, P489, DOI 10.1007/s10549-008-9923-6; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Herschkowitz JI, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2142; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Huret JL, 2003, NUCLEIC ACIDS RES, V31, P272, DOI 10.1093/nar/gkg126; Hwang DH, 2002, BIOINFORMATICS, V18, P1184, DOI 10.1093/bioinformatics/18.9.1184; Iwamoto T, 2012, J CLIN ONCOL, V30, P729, DOI 10.1200/JCO.2011.36.2574; Izawa N, 2011, CANCER RES, V71, P5621, DOI 10.1158/0008-5472.CAN-11-0385; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Kim C, 2011, J CLIN ONCOL, V29, P4160, DOI 10.1200/JCO.2010.32.9615; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lee S, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1015; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; Liu X, 2010, ONCOGENE, V29, P442, DOI 10.1038/onc.2009.332; Locasale JW, 2010, CELL CYCLE, V9, P4253, DOI 10.4161/cc.9.21.13925; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Martini PGV, 2008, J STEROID BIOCHEM, V109, P207, DOI 10.1016/j.jsbmb.2008.03.020; Maruyama Y, 2006, CANCER RES, V66, P6233, DOI 10.1158/0008-5472.CAN-06-0183; Mazurek S, 2002, BRIT J NUTR, V87, pS23, DOI [10.1079/BJN2001455, 10.1079/BJN2001454]; Morita T, 2003, J BIOL CHEM, V278, P15608, DOI 10.1074/jbc.M300177200; Pacella L, 2012, FERTIL STERIL, V98, P986, DOI 10.1016/j.fertnstert.2012.06.025; Pagel P, 2005, BIOINFORMATICS, V21, P832, DOI 10.1093/bioinformatics/bti115; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Prest SJ, 2002, FASEB J, V16, P592, DOI 10.1096/fj.01-0498fje; Pusztai L, 2003, CLIN CANCER RES, V9, P2406; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; SHEK LL, 1989, EUR J CANCER CLIN ON, V25, P243, DOI 10.1016/0277-5379(89)90015-1; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Symmans WF, 2010, J CLIN ONCOL, V28, P4111, DOI 10.1200/JCO.2010.28.4273; Terasaka S, 2004, ENVIRON HEALTH PERSP, V112, P773, DOI 10.1289/ehp.6753; Thomassen M, 2009, BREAST CANCER RES TR, V113, P239, DOI 10.1007/s10549-008-9927-2; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Tsai CA, 2005, BIOINFORMATICS, V21, P1502, DOI 10.1093/bioinformatics/bti162; Turashvili G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-55; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vizan P, 2009, INT J CANCER, V124, P2789, DOI 10.1002/ijc.24262; Wang J, 2012, BRIEF BIOINFORM, V13, P216, DOI 10.1093/bib/bbr041; Wardell SE, 2012, MOL ENDOCRINOL, V26, P1235, DOI 10.1210/me.2012-1031; Weigelt B, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2734; Weigelt B, 2010, LANCET ONCOL, V11, P339, DOI 10.1016/S1470-2045(10)70008-5; WRBA F, 1989, ONCOLOGY, V46, P255; Yamaguchi N, 2008, BIOCHEM BIOPH RES CO, V365, P711, DOI 10.1016/j.bbrc.2007.11.064; Yang YM, 2003, BIOINFORMATICS, V19, P2311, DOI 10.1093/bioinformatics/btg300; Yao CQ, 2010, PROTEOM CLIN APPL, V4, P4, DOI 10.1002/prca.200900050; Zhang M, 2008, BIOINFORMATICS, V24, P2057, DOI 10.1093/bioinformatics/btn365; Zhang M, 2009, BIOINFORMATICS, V25, P1662, DOI 10.1093/bioinformatics/btp295; Zhang SP, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-230; Zhang YN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058163	93	6	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e70017	10.1371/journal.pone.0070017	http://dx.doi.org/10.1371/journal.pone.0070017			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23875016	gold, Green Submitted, Green Published			2022-12-27	WOS:000324146200088
J	Ko, YH; Tsai, MS; Lee, PH; Liang, JT; Chang, KC				Ko, Ya-Hui; Tsai, Ming-Shian; Lee, Po-Huang; Liang, Jin-Tung; Chang, Kuo-Chu			Methylprednisolone Stiffens Aortas in Lipopolysaccharide-Induced Chronic Inflammation in Rats	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; NITRIC-OXIDE; ARTERIAL SYSTEM; TIME DOMAIN; EXPRESSION; RECEPTOR; RAGE; GLUCOCORTICOIDS; ENDOTHELIUM; INHIBITION	Introduction: Glucocorticoids are commonly used as therapeutic agents in many acute and chronic inflammatory and auto-immune diseases. The current study investigated the effects of methylprednisolone (a synthetic glucocorticoid) on aortic distensibility and vascular resistance in lipopolysaccharide-induced chronic inflammation in male Wistar rats. Methods: Chronic inflammation was induced by implanting a subcutaneous slow-release ALZET osmotic pump (1 mg kg(-1) day(-1) lipopolysaccharide) for either 2 or 4 weeks. Arterial wave transit time (t) was derived to describe the elastic properties of aortas using the impulse response function of the filtered aortic input impedance spectra. Results: Long-term lipopolysaccharide challenge enhanced the expression of advanced glycation end products (AGEs) in the aortas. Lipopolysaccharide also upregulated the inducible form of nitric oxide synthase to produce high levels of nitric oxide (NO), which resulted in vasodilation, as evidenced by the fall in total peripheral resistance (R-p). However, lipopolysaccharide challenge did not influence the elastic properties of aortas, as shown by the unaltered iota. The NO-mediated vascular relaxation may counterbalance the AGEs-induced arterial stiffening so that the aortic distensibility remained unaltered. Treating lipopolysaccharide-challenged rats with methylprednisolone prevented peripheral vasodilation because of its ability to increase R-p. However, methylprednisolone produced an increase in aorta stiffness, as manifested by the significant decline in iota. The diminished aortic distensibility by methylprednisolone paralleled a significant reduction in NO plasma levels, in the absence of any significant changes in AGEs content. Conclusion: Methylprednisolone stiffens aortas and elastic arteries in lipopolysaccharide-induced chronic inflammation in rats, for NO activity may be dominant as a counteraction of AGEs.	[Ko, Ya-Hui; Chang, Kuo-Chu] Natl Taiwan Univ, Coll Med, Dept Physiol, Taipei 10764, Taiwan; [Tsai, Ming-Shian] I Shou Univ, Sch Chinese Med Postbaccalaureate, Kaohsiung, Taiwan; [Tsai, Ming-Shian] E Da Hosp, Dept Surg, Kaohsiung, Taiwan; [Lee, Po-Huang; Liang, Jin-Tung] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan	National Taiwan University; I Shou University; E-Da Hospital; National Taiwan University; National Taiwan University Hospital	Chang, KC (corresponding author), Natl Taiwan Univ, Coll Med, Dept Physiol, Taipei 10764, Taiwan.	kcchang1008@ntu.edu.tw		LEE, PO-HUANG/0000-0001-5831-035X; Liang, Jin-Tung/0000-0002-0264-7735; CHANG, KUO-CHU/0000-0002-4421-5711	National Science Council of Taiwan [NSC 100-2320-B-002-040-084, NSC 98-2314-B-002-054-MY2, NSC 100-2314-B-214-003]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by grants from the National Science Council of Taiwan (NSC 100-2320-B-002-040-084, NSC 98-2314-B-002-054-MY2 and NSC 100-2314-B-214-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annane D, 2005, LANCET, V365, P63, DOI 10.1016/S0140-6736(04)17667-8; Basta G, 2002, CIRCULATION, V105, P816, DOI 10.1161/hc0702.104183; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Boyle WA, 2000, CIRC RES, V87, pE18; BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315; BUCALA R, 1991, J CLIN INVEST, V87, P432, DOI 10.1172/JCI115014; Chang KC, 2006, BRIT J PHARMACOL, V147, P944, DOI 10.1038/sj.bjp.0706684; Chang KC, 2003, EXP BIOL MED, V228, P70, DOI 10.1177/153537020322800110; COX RH, 1974, J APPL PHYSIOL, V36, P381, DOI 10.1152/jappl.1974.36.3.381; Dobrian AD, 2001, HYPERTENSION, V37, P554, DOI 10.1161/01.HYP.37.2.554; Eckersall PD, 2000, REV MED VET-TOULOUSE, V151, P577; GUYTON AC, 1992, HYPERTENSION, V19, pI2, DOI 10.1161/01.HYP.19.1_Suppl.I2; Hamalainen M, 2008, PULM PHARMACOL THER, V21, P331, DOI 10.1016/j.pupt.2007.08.003; Kleinert H, 2004, EUR J PHARMACOL, V500, P255, DOI 10.1016/j.ejphar.2004.07.030; LAXMINARAYAN S, 1978, IEEE T BIO-MED ENG, V25, P177, DOI 10.1109/TBME.1978.326244; Leon CG, 2008, PHARM RES-DORDR, V25, P1751, DOI 10.1007/s11095-008-9571-x; Li JF, 1997, J BIOL CHEM, V272, P16498, DOI 10.1074/jbc.272.26.16498; Liu A, 1986, AM J PHYSIOL-HEART C, pH588; Milnor W.R., 1989, HEMODYNAMICS, V2nd Edn; MITCHELL GF, 1994, AM J PHYSIOL-HEART C, V267, pH1907, DOI 10.1152/ajpheart.1994.267.5.H1907; MULLARKEY CJ, 1990, BIOCHEM BIOPH RES CO, V173, P932, DOI 10.1016/S0006-291X(05)80875-7; Nichols W., 2005, MCDONALDS BLOOD FLOW, V5th; Nims RW, 1996, METHOD ENZYMOL, V268, P93; Peters M, 1998, BLOOD, V92, P3495, DOI 10.1182/blood.V92.10.3495.422k47_3495_3504; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Riccardi C, 2002, PHARMACOL RES, V45, P361, DOI 10.1006/phrs.2002.0969; Sellebjerg F, 2002, J NEUROIMMUNOL, V125, P198, DOI 10.1016/S0165-5728(02)00037-1; Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591; SIPKEMA P, 1980, CARDIOVASC RES, V14, P270, DOI 10.1093/cvr/14.5.270; Snyder T, 1992, SCI AM, V5, P68; WESTERHOF N, 1972, CARDIOVASC RES, V6, P648, DOI 10.1093/cvr/6.6.648; Xu J, 1998, MOL BRAIN RES, V59, P135, DOI 10.1016/S0169-328X(98)00142-9; Yamamoto Y, 2011, J IMMUNOL, V186, P3248, DOI 10.4049/jimmunol.1002253; ZUCKERMAN SH, 1989, EUR J IMMUNOL, V19, P301, DOI 10.1002/eji.1830190213	36	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e69636	10.1371/journal.pone.0069636	http://dx.doi.org/10.1371/journal.pone.0069636			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23874978	gold, Green Published, Green Submitted			2022-12-27	WOS:000322000600053
J	Tamm-Rosenstein, K; Simm, J; Suhorutshenko, M; Salumets, A; Metsis, M				Tamm-Rosenstein, Karin; Simm, Jaak; Suhorutshenko, Marina; Salumets, Andres; Metsis, Madis			Changes in the Transcriptome of the Human Endometrial Ishikawa Cancer Cell Line Induced by Estrogen, Progesterone, Tamoxifen, and Mifepristone (RU486) as Detected by RNA-Sequencing	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; MENSTRUAL-CYCLE; BREAST-CANCER; STROMAL CELLS; RECEPTOR MODULATORS; STIMULATED CYCLES; IN-VITRO; RECEPTIVITY; WOMEN; IMPLANTATION	Background: Estrogen (E2) and progesterone (P4) are key players in the maturation of the human endometrium. The corresponding steroid hormone modulators, tamoxifen (TAM) and mifepristone (RU486) are widely used in breast cancer therapy and for contraception purposes, respectively. Methodology/Principal findings: Gene expression profiling of the human endometrial Ishikawa cancer cell line treated with E2 and P4 for 3 h and 12 h, and TAM and RU486 for 12 h, was performed using RNA-sequencing. High levels of mRNA were detected for genes, including PSAP, ATP5G2, ATP5H, and GNB2L1 following E2 or P4 treatment. A total of 82 biomarkers for endometrial biology were identified among E2 induced genes, and 93 among P4 responsive genes. Identified biomarkers included: EZH2, MDK, MUC1, SLIT2, and IL6ST, which are genes previously associated with endometrial receptivity. Moreover, 98.8% and 98.6% of E2 and P4 responsive genes in Ishikawa cells, respectively, were also detected in two human midsecretory endometrial biopsy samples. TAM treatment exhibited both antagonistic and agonistic effects of E2, and also regulated a subset of genes independently. The cell cycle regulator cyclin D1 (CCND1) showed significant up-regulation following treatment with TAM. RU486 did not appear to act as a pure antagonist of P4 and a functional analysis of RU486 response identified genes related to adhesion and apoptosis, including down-regulated genes associated with cell-cell contacts and adhesion as CTNND1, JUP, CDH2, IQGAP1, and COL2A1. Conclusions: Significant changes in gene expression by the Ishikawa cell line were detected after treatments with E2, P4, TAM, and RU486. These transcriptome data provide valuable insight into potential biomarkers related to endometrial receptivity, and also facilitate an understanding of the molecular changes that take place in the endometrium in the early stages of breast cancer treatment and contraception usage.	[Tamm-Rosenstein, Karin; Simm, Jaak; Suhorutshenko, Marina] Tallinn Univ Technol, Ctr Biol Integrated Syst, EE-19086 Tallinn, Estonia; [Tamm-Rosenstein, Karin; Salumets, Andres; Metsis, Madis] Competence Ctr Reprod Med & Biol, Tartu, Estonia; [Tamm-Rosenstein, Karin] Nova Vita Clin, Tallinn, Estonia; [Salumets, Andres] Univ Tartu, Dept Obstet & Gynaecol, EE-50090 Tartu, Estonia; [Salumets, Andres] Univ Tartu, Inst Biomed, EE-50090 Tartu, Estonia; [Metsis, Madis] Tallinn Univ, Inst Math & Nat Sci, EE-10120 Tallinn, Estonia	Tallinn University of Technology; University of Tartu; University of Tartu; Tallinn University	Tamm-Rosenstein, K (corresponding author), Tallinn Univ Technol, Ctr Biol Integrated Syst, EE-19086 Tallinn, Estonia.	karin.tamm@ttu.ee	Metsis, Madis/F-7080-2016; Salumets, Andres/J-2278-2015	Metsis, Madis/0000-0003-1667-677X; Salumets, Andres/0000-0002-1251-8160	Tallinn University of Technology [B611]; Estonian Ministry of Education and Science [SF0180044s09]; Enterprise Estonia [EU30020]	Tallinn University of Technology; Estonian Ministry of Education and Science(Ministry of Education and Research, Estonia); Enterprise Estonia	This work has been supported by the Tallinn University of Technology (Targeted project no. B611), Estonian Ministry of Education and Science (Targeted project no. SF0180044s09) and Enterprise Estonia (Grant no. EU30020).	Acosta AA, 2000, FERTIL STERIL, V73, P788, DOI 10.1016/S0015-0282(99)00605-6; Altmae S, 2010, MOL HUM REPROD, V16, P178, DOI 10.1093/molehr/gap102; Aplin JD, 1998, GLYCOBIOLOGY, V8, P269, DOI 10.1093/glycob/8.3.269; ARICI A, 1995, J CLIN ENDOCR METAB, V80, P1908, DOI 10.1210/jc.80.6.1908; Bergman L, 2000, LANCET, V356, P881, DOI 10.1016/S0140-6736(00)02677-5; Berrodin TJ, 2009, BIOCHEM PHARMACOL, V77, P204, DOI 10.1016/j.bcp.2008.10.016; Borthwick JM, 2003, MOL HUM REPROD, V9, P19, DOI 10.1093/molehr/gag004; BROGDEN RN, 1993, DRUGS, V45, P384, DOI 10.2165/00003495-199345030-00007; BROWN AJP, 1983, P NATL ACAD SCI-BIOL, V80, P1265, DOI 10.1073/pnas.80.5.1265; Buzdar AU, 1998, J CLIN ONCOL, V16, P348, DOI 10.1200/JCO.1998.16.1.348; Cao QJ, 2002, INT J GYNECOL PATHOL, V21, P147, DOI 10.1097/00004347-200204000-00007; Carson DD, 2002, MOL HUM REPROD, V8, P871, DOI 10.1093/molehr/8.9.871; Casneuf T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-461; Catalano RD, 2007, MOL HUM REPROD, V13, P641, DOI 10.1093/molehr/gam021; Chwalisz K, 2000, STEROIDS, V65, P741, DOI 10.1016/S0039-128X(00)00190-2; Cohen I, 2004, GYNECOL ONCOL, V94, P256, DOI 10.1016/j.ygyno.2004.03.048; CROXTALL JD, 1990, J STEROID BIOCHEM, V35, P665, DOI 10.1016/0022-4731(90)90306-D; Danielsson KG, 1997, HUM REPROD, V12, P1293; Danielsson KG, 2003, STEROIDS, V68, P1069, DOI 10.1016/S0039-128X(03)00131-4; Enmark E, 1997, J CLIN ENDOCR METAB, V82, P4258, DOI 10.1210/jc.82.12.4258; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Ghosh D, 2009, REPRODUCTION, V138, P357, DOI 10.1530/REP-08-0442; Gielen SCJP, 2005, ENDOCR-RELAT CANCER, V12, P1037, DOI 10.1677/erc.1.01046; Gielen Susanne C J P, 2005, J Soc Gynecol Investig, V12, pe55, DOI 10.1016/j.jsgi.2005.08.003; Goldberg JR, 1998, ARCH FAM MED, V7, P219, DOI 10.1001/archfami.7.3.219; Golouh R, 2008, BREAST CANCER RES TR, V110, P317, DOI 10.1007/s10549-007-9724-3; Graham JD, 1997, ENDOCR REV, V18, P502, DOI 10.1210/er.18.4.502; Grimaldi G, 2011, MOL ENDOCRINOL, V25, P1892, DOI 10.1210/me.2011-1139; Guo FJ, 2010, ACTA BIOCH BIOPH SIN, V42, P224, DOI 10.1093/abbs/gmq008; Haouzi D, 2009, HUM REPROD, V24, P1436, DOI 10.1093/humrep/dep039; Hapangama DK, 2002, J CLIN ENDOCR METAB, V87, P5229, DOI 10.1210/jc.2002-020429; Hodgson MC, 2005, J BIOL CHEM, V280, P6511, DOI 10.1074/jbc.M408972200; Horcajadas JA, 2004, J REPROD IMMUNOL, V63, P41, DOI 10.1016/j.jri.2004.02.003; Horne AW, 2006, REPRODUCTION, V131, P733, DOI 10.1530/rep.1.00883; Horne AW, 2005, MOL REPROD DEV, V72, P216, DOI 10.1002/mrd.20307; Horne AW, 2002, BJOG-INT J OBSTET GY, V109, P610, DOI 10.1016/S1470-0328(02)01417-9; Hsieh YY, 2002, J ASSIST REPROD GEN, V19, P79, DOI 10.1023/A:1014495614792; Johnson SM, 2007, ENDOCR-RELAT CANCER, V14, P337, DOI 10.1677/ERC-06-0085; Kao LC, 2002, ENDOCRINOLOGY, V143, P2119, DOI 10.1210/en.143.6.2119; KASTNER P, 1990, EMBO J, V9, P1603, DOI 10.1002/j.1460-2075.1990.tb08280.x; Kuiper GGJM, 1997, FEBS LETT, V410, P87, DOI 10.1016/S0014-5793(97)00413-4; Lalitkumar PGL, 1998, HUM REPROD, V13, P3478, DOI 10.1093/humrep/13.12.3478; Lessey BA, 1996, J STEROID BIOCHEM, V59, P31, DOI 10.1016/S0960-0760(96)00103-3; LESSEY BA, 1988, J CLIN ENDOCR METAB, V67, P334, DOI 10.1210/jcem-67-2-334; Lonard DM, 2002, STEROIDS, V67, P15, DOI 10.1016/S0039-128X(01)00133-7; Machin P, 2002, HUM PATHOL, V33, P206, DOI 10.1053/hupa.2002.30723; Maruyama T, 1999, ENDOCRINOLOGY, V140, P5982, DOI 10.1210/endo.140.12.7184; McGonigle KF, 2006, INT J GYNECOL CANCER, V16, P814, DOI 10.1111/j.1525-1438.2006.00525.x; Mirkin S, 2004, J CLIN ENDOCR METAB, V89, P5742, DOI 10.1210/jc.2004-0605; Moller B, 2001, MOL HUM REPROD, V7, P65, DOI 10.1093/molehr/7.1.65; Moreno-Bueno G, 2003, ONCOGENE, V22, P6115, DOI 10.1038/sj.onc.1206868; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nishida M, 1985, Nihon Sanka Fujinka Gakkai Zasshi, V37, P1103; OBRIEN JS, 1991, FASEB J, V5, P301, DOI 10.1096/fasebj.5.3.2001789; Okada H, 2003, GYNECOL ENDOCRINOL, V17, P271, DOI 10.1080/713603290; Riesewijk A, 2003, MOL HUM REPROD, V9, P253, DOI 10.1093/molehr/gag037; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Sugino N, 2002, REPRODUCTION, V123, P379, DOI 10.1530/reprod/123.3.379; Sun XX, 2003, CONTRACEPTION, V67, P319, DOI 10.1016/S0010-7824(02)00513-9; Talbi S, 2006, ENDOCRINOLOGY, V147, P1097, DOI 10.1210/en.2005-1076; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang H, 1998, MOL HUM REPROD, V4, P407, DOI 10.1093/molehr/4.4.407; WEN DX, 1994, MOL CELL BIOL, V14, P8356, DOI 10.1128/MCB.14.12.8356; Wong YF, 2007, ONCOGENE, V26, P1971, DOI 10.1038/sj.onc.1209986; Zhang XM, 2010, MOL HUM REPROD, V16, P347, DOI 10.1093/molehr/gaq012	67	32	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68907	10.1371/journal.pone.0068907	http://dx.doi.org/10.1371/journal.pone.0068907			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874806	Green Published, Green Submitted, gold			2022-12-27	WOS:000322064300078
J	White, JR; Meekan, MG; McCormick, MI; Ferrari, MCO				White, James R.; Meekan, Mark G.; McCormick, Mark I.; Ferrari, Maud C. O.			A Comparison of Measures of Boldness and Their Relationships to Survival in Young Fish	PLOS ONE			English	Article							CORAL-REEF FISH; GUPPY POECILIA-RETICULATA; INDIVIDUAL-DIFFERENCES; BLUEGILL SUNFISH; BEHAVIORAL SYNDROMES; PUMPKINSEED SUNFISH; SELECTIVE PREDATION; LEPOMIS-MACROCHIRUS; PERSONALITY-TRAITS; MARINE FISH	Boldness is the propensity of an animal to engage in risky behavior. Many variations of novel-object or novel-environment tests have been used to quantify the boldness of animals, although the relationship between test outcomes has rarely been investigated. Furthermore, the relationship of outcomes to any ecological aspect of fitness is generally assumed, rather than measured directly. Our study is the first to compare how the outcomes of the same test of boldness differ among observers and how different tests of boldness relate to the survival of individuals in the field. Newly-metamorphosed lemon damselfish, Pomacentrus moluccensis, were placed onto replicate patches of natural habitat. Individual behavior was quantified using four tests (composed of a total of 12 different measures of behavior): latency to enter a novel environment, activity in a novel environment, and reactions to threatening and benign novel objects. After behavior was quantified, survival was monitored for two days during which time fish were exposed to natural predators. Variation among observers was low for most of the 12 measures, except distance moved and the threat test (reaction to probe thrust), which displayed unacceptable amounts of inter-observer variation. Overall, the results of the behavioral tests suggested that novel environment and novel object tests quantified similar behaviors, yet these behavioral measures were not interchangeable. Multiple measures of behavior within the context of novel environment or object tests were the most robust way to assess boldness and these measures have a complex relationship with survivorship of young fish in the field. Body size and distance ventured from shelter were the only variables that had a direct and positive relationship with survival.	[White, James R.; McCormick, Mark I.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Meekan, Mark G.] Univ Western Australia, Australian Inst Marine Sci, Crawley, WA, Australia; [Ferrari, Maud C. O.] Univ Saskatchewan, Western Coll Vet Med, Dept Biomed Sci, Saskatoon, SK S7N 0W0, Canada	James Cook University; Australian Institute of Marine Science; University of Western Australia; University of Saskatchewan	White, JR (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia.	james.ryan.white@gmail.com	McCormick, Mark I/J-8301-2014	McCormick, Mark I/0000-0001-9289-1645; White, James/0000-0001-7977-1956; Meekan, Mark/0000-0002-3067-9427	ARC discovery; ARC Centre of Excellence for Coral Reef Studies (MIM MGM); Australian Institute of Marine Science (MGM); Yulgilbar Foundation and Natural Sciences and Engineering Research Council of Canada (MCOF)	ARC discovery(Australian Research Council); ARC Centre of Excellence for Coral Reef Studies (MIM MGM)(Australian Research Council); Australian Institute of Marine Science (MGM); Yulgilbar Foundation and Natural Sciences and Engineering Research Council of Canada (MCOF)	Funding was provided by an ARC discovery grant, ARC Centre of Excellence for Coral Reef Studies (MIM & MGM), Australian Institute of Marine Science (MGM), the Yulgilbar Foundation and Natural Sciences and Engineering Research Council of Canada (MCOF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1971, P 2 INT S INF THEOR, P267, DOI DOI 10.2307/2334537; Almany GR, 2007, OECOLOGIA, V152, P751, DOI 10.1007/s00442-007-0693-3; Almany GR, 2006, CORAL REEFS, V25, P19, DOI 10.1007/s00338-005-0044-y; Bell AM, 2007, ECOL LETT, V10, P828, DOI 10.1111/j.1461-0248.2007.01081.x; Beukers JS, 1998, OECOLOGIA, V114, P50, DOI 10.1007/s004420050419; Biro PA, 2006, J ANIM ECOL, V75, P1165, DOI 10.1111/j.1365-2656.2006.01137.x; BOISSY A, 1995, Q REV BIOL, V70, P165, DOI 10.1086/418981; Brown C, 2007, J FISH BIOL, V71, P1590, DOI 10.1111/j.1095-8649.2007.01627.x; Brown C, 2005, ANIM BEHAV, V70, P1003, DOI 10.1016/j.anbehav.2004.12.022; Brown C, 2007, BEHAV ECOL SOCIOBIOL, V62, P237, DOI 10.1007/s00265-007-0458-3; Brunton BJ, 2003, OECOLOGIA, V137, P377, DOI 10.1007/s00442-003-1377-2; Budaev SV, 2010, ETHOLOGY, V116, P472, DOI 10.1111/j.1439-0310.2010.01758.x; Budaev SV, 1997, J COMP PSYCHOL, V111, P399, DOI 10.1037/0735-7036.111.4.399; Budaev SV, 1999, BEHAV PROCESS, V48, P49, DOI 10.1016/S0376-6357(99)00068-6; Budaev SV, 2011, FISH AQUATIC RESOURC; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Clark A.B., 1987, PERSPECT ETHOLOGY, V7, P1, DOI [10.1007/978-1-4613-1815-6_1, DOI 10.1007/978-1-4613-1815-6_1]; Coleman K, 1998, ANIM BEHAV, V56, P927, DOI 10.1006/anbe.1998.0852; COLGAN P, 1991, J COMP PSYCHOL, V105, P78, DOI 10.1037/0735-7036.105.1.78; Dall SRX, 2004, ECOL LETT, V7, P734, DOI 10.1111/j.1461-0248.2004.00618.x; Dingemanse NJ, 2010, ANIM BEHAV, V79, P439, DOI 10.1016/j.anbehav.2009.11.024; Dingemanse NJ, 2009, P R SOC B, V276, P1285, DOI 10.1098/rspb.2008.1555; Dingemanse NJ, 2004, P ROY SOC B-BIOL SCI, V271, P847, DOI 10.1098/rspb.2004.2680; Dochtermann NA, 2011, ETHOLOGY, V117, P95, DOI 10.1111/j.1439-0310.2010.01846.x; Doherty PJ, 2004, ECOLOGY, V85, P2422, DOI 10.1890/04-0366; Dugatkin LA, 2003, ETHOL ECOL EVOL, V15, P43; DUGATKIN LA, 1992, BEHAV ECOL, V3, P124, DOI 10.1093/beheco/3.2.124; Fraser DF, 2001, AM NAT, V158, P124, DOI 10.1086/321307; Frost AJ, 2007, P ROY SOC B-BIOL SCI, V274, P333, DOI 10.1098/rspb.2006.3751; Fuiman LA, 2010, OECOLOGIA, V164, P99, DOI 10.1007/s00442-010-1712-3; Gagliano M, 2007, P R SOC B, V274, P1575, DOI 10.1098/rspb.2007.0242; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; Gosselin LA, 1997, MAR ECOL PROG SER, V146, P265, DOI 10.3354/meps146265; Grace JB., 2015, STRUCTURAL EQUATION; Hoey AS, 2004, OECOLOGIA, V139, P23, DOI 10.1007/s00442-004-1489-3; Holmes TH, 2006, MAR ECOL PROG SER, V317, P203, DOI 10.3354/meps317203; Holmes TH, 2009, OECOLOGIA, V159, P401, DOI 10.1007/s00442-008-1220-x; Kerrigan BA, 1996, MAR ECOL PROG SER, V135, P27, DOI 10.3354/meps135027; KIEFFER JD, 1992, ENVIRON BIOL FISH, V33, P359, DOI 10.1007/BF00010948; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.1111/j.1558-5646.1983.tb00236.x; Lonnstedt OM, 2012, P ROY SOC B-BIOL SCI, V279, P2091, DOI 10.1098/rspb.2011.2516; McCormick MI, 2007, ECOLOGY, V88, P1562, DOI 10.1890/06-0830; McCormick MI, 2010, MAR ECOL PROG SER, V407, P173, DOI 10.3354/meps08583; McCormick MI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007096; McCormick MI, 2004, OIKOS, V106, P225, DOI 10.1111/j.0030-1299.2004.13131.x; McCormick MI, 2012, PLOS ONE, V7, DOI DOI 10.1371/J0URNAL.P0NE.0042590.ACCESSED; McCormick MI, 2012, P R SOC B, DOI DOI 10.1098/RSPB.2012.0854.ACCESSED; Meekan MG, 2010, ANIM BEHAV, V79, P803, DOI 10.1016/j.anbehav.2009.12.002; MEEKAN MG, 1993, MAR ECOL PROG SER, V93, P217, DOI 10.3354/meps093217; Meekan MG, 2001, MAR BIOL, V139, P373; Mitchell MD, 2011, ANIM COGN, V14, P707, DOI 10.1007/s10071-011-0405-6; PITCHER CR, 1988, CORAL REEFS, V7, P105, DOI 10.1007/BF00300969; Quinn GP, 2003, EXPT DESIGN DATA ANA; Reale D, 2003, ANIM BEHAV, V65, P463, DOI 10.1006/anbe.2003.2100; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Smith BR, 2010, BEHAV ECOL, V21, P919, DOI 10.1093/beheco/arq084; Stamps J, 2005, BEHAV ECOL, V16, P974, DOI 10.1093/beheco/ari083; Stamps JA, 2007, ECOL LETT, V10, P355, DOI 10.1111/j.1461-0248.2007.01034.x; Toms CN., 2010, INT J COMPPSYCHOL, V23, P1, DOI DOI 10.1002/CPMO.17; Vigliola L, 2002, OECOLOGIA, V131, P89, DOI 10.1007/s00442-001-0866-4; WELLINGTON GM, 1989, MAR BIOL, V101, P557, DOI 10.1007/BF00541659; Wilson ADM, 2009, BEHAV ECOL, V20, P231, DOI 10.1093/beheco/arp018; WILSON DS, 1993, J COMP PSYCHOL, V107, P250, DOI 10.1037/0735-7036.107.3.250; WILSON DS, 1994, TRENDS ECOL EVOL, V9, P442, DOI 10.1016/0169-5347(94)90134-1; Wright D, 2006, BEHAV GENET, V36, P271, DOI 10.1007/s10519-005-9029-4	67	41	42	2	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e68900	10.1371/journal.pone.0068900	http://dx.doi.org/10.1371/journal.pone.0068900			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874804	Green Accepted, Green Published, gold			2022-12-27	WOS:000322064300077
J	Bee, L; Fabris, S; Cherubini, R; Mognato, M; Celotti, L				Bee, Leonardo; Fabris, Sonia; Cherubini, Roberto; Mognato, Maddalena; Celotti, Lucia			The Efficiency of Homologous Recombination and Non-Homologous End Joining Systems in Repairing Double-Strand Breaks during Cell Cycle Progression	PLOS ONE			English	Article							DNA-DAMAGE; CENP-F; PROTEIN; 53BP1; RADIATION; ATM; ACCUMULATION; INDUCTION; RESPONSES; BINDING	This study investigated the efficiency of Non-Homologous End Joining (NHEJ) and Homologous Recombination (HR) repair systems in rejoining DNA double-strand breaks (DSB) induced in CCD-34Lu cells by different gamma-ray doses. The kinetics of DNA repair was assessed by analyzing the fluorescence decrease of gamma-H2AX foci measured by SOID (Sum Of Integrated Density) parameter and counting foci number in the time-interval 0.5-24 hours after irradiation. Comparison of the two methods showed that the SOID parameter was useful in determining the amount and the persistence of DNA damage signal after exposure to high or low doses of ionizing radiation. The efficiency of DSB rejoining during the cell cycle was assessed by distinguishing G1, S, and G2 phase cells on the basis of nuclear fluorescence of the CENP-F protein. Six hours after irradiation, gamma-H2AX foci resolution was higher in G2 compared to G1 cells in which both NHEJ and HR can cooperate. The rejoining of gamma-H2AX foci in G2 phase cells was, moreover, decreased by RI-1, the chemical inhibitor of HR, demonstrating that homologous recombination is at work early after irradiation. The relevance of HR in DSB repair was assessed in DNA-PK-deficient M059J cells and in CCD-34Lu treated with the DNA-PKcs inhibitor, NU7026. In both conditions, the kinetics of gamma-H2AX demonstrated that DSBs repair was markedly affected when NHEJ was absent or impaired, even in G2 phase cells in which HR should be at work. The recruitment of RAD51 at DSB sites was, moreover, delayed in M059J and in NU7026 treated-CCD-34Lu, with respect to DNA-PKcs proficient cells and continued for 24 hours despite the decrease in DNA repair. The impairment of NHEJ affected the efficiency of the HR system and significantly decreased cell survival after ionizing radiation, confirming that DSB rejoining is strictly dependent on the integrity of the NHEJ repair system.	[Bee, Leonardo; Fabris, Sonia; Mognato, Maddalena; Celotti, Lucia] Univ Padua, Dipartimento Biol, Padua, Italy; [Cherubini, Roberto; Celotti, Lucia] Ist Nazl Fis Nucl, Lab Nazl Legnaro, Padua, Italy	University of Padua; Istituto Nazionale di Fisica Nucleare (INFN)	Mognato, M (corresponding author), Univ Padua, Dipartimento Biol, Padua, Italy.	maddalena.mognato@unipd.it		Mognato, Maddalena/0000-0001-6132-1682	University of Padova [CPDG011577]; Italian Space Agency (ASI)	University of Padova; Italian Space Agency (ASI)(Agenzia Spaziale Italiana (ASI))	This work was supported by the University of Padova (grant NoCPDG011577 to M.M.) and the Italian Space Agency (ASI, XMAB-from Molecules to Man 2006-2009 to L.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen C, 2003, MOL CANCER RES, V1, P913; Anderson CW, 2000, RADIAT RES, V154, P473, DOI 10.1667/0033-7587(2000)154[0473:HTFTMG]2.0.CO;2; Anderson L, 2001, MOL CELL BIOL, V21, P1719, DOI 10.1128/MCB.21.5.1719-1729.2001; Asaithamby A, 2008, RADIAT RES, V169, P437, DOI 10.1667/RR1165.1; Asaithamby A, 2009, NUCLEIC ACIDS RES, V37, P3912, DOI 10.1093/nar/gkp237; Bassing CH, 2004, DNA REPAIR, V3, P781, DOI 10.1016/j.dnarep.2004.06.001; Beucher A, 2009, EMBO J, V28, P3413, DOI 10.1038/emboj.2009.276; Buck SB, 2008, BIOTECHNIQUES, V44, P927, DOI 10.2144/000112812; Canova S, 2005, RADIAT RES, V163, P191, DOI 10.1667/RR3304; Convery E, 2005, P NATL ACAD SCI USA, V102, P1345, DOI 10.1073/pnas.0406466102; Eccles LJ, 2011, MUTAT RES-FUND MOL M, V711, P134, DOI 10.1016/j.mrfmmm.2010.11.003; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Gandhi M, 2013, CELL CYCLE, V12, P547, DOI 10.4161/cc.23754; Holgersson A, 2005, INT J RADIAT ONCOL, V61, P915, DOI 10.1016/j.ijrobp.2004.10.036; Ishikawa Aya, 2010, Genome Integr, V1, P10, DOI 10.1186/2041-9414-1-10; Kim JS, 2005, J CELL BIOL, V170, P341, DOI 10.1083/jcb.200411083; Kuhne M, 2004, CANCER RES, V64, P500, DOI 10.1158/0008-5472.CAN-03-2384; LIAO H, 1995, J CELL BIOL, V130, P507, DOI 10.1083/jcb.130.3.507; Lisby M, 2009, DNA REPAIR, V8, P1068, DOI 10.1016/j.dnarep.2009.04.007; Lobrich M, 2005, DNA REPAIR, V4, P749, DOI 10.1016/j.dnarep.2004.12.008; Mao ZY, 2008, DNA REPAIR, V7, P1765, DOI 10.1016/j.dnarep.2008.06.018; Mistrik M, 2009, CELL CYCLE, V8, P2592, DOI 10.4161/cc.8.16.9331; Mukherjee B, 2008, DNA REPAIR, V7, P1717, DOI 10.1016/j.dnarep.2008.06.016; Nikjoo H, 2001, RADIAT RES, V156, P577, DOI 10.1667/0033-7587(2001)156[0577:CAFDTS]2.0.CO;2; Ohnishi T, 2009, MUTAT RES-FUND MOL M, V669, P8, DOI 10.1016/j.mrfmmm.2009.06.010; Pontarin G, 2008, P NATL ACAD SCI USA, V105, P17801, DOI 10.1073/pnas.0808198105; Rapp A, 2004, J CELL SCI, V117, P4935, DOI 10.1242/jcs.01355; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Sedelnikova OA, 2002, RADIAT RES, V158, P486, DOI 10.1667/0033-7587(2002)158[0486:QDOIID]2.0.CO;2; Sharma Arishya, 2012, Methods Mol Biol, V920, P613, DOI 10.1007/978-1-61779-998-3_40; Short SC, 2011, NEURO-ONCOLOGY, V13, P487, DOI 10.1093/neuonc/nor010; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Shrivastav M, 2009, DNA REPAIR, V8, P920, DOI 10.1016/j.dnarep.2009.05.006; Svetlova MP, 2010, MUTAT RES-FUND MOL M, V685, P54, DOI 10.1016/j.mrfmmm.2009.08.001; Thacker J, 2005, CANCER LETT, V219, P125, DOI 10.1016/j.canlet.2004.08.018; Varis A, 2006, CHROMOSOMA, V115, P288, DOI 10.1007/s00412-005-0046-0; Vilenchik MM, 2003, P NATL ACAD SCI USA, V100, P12871, DOI 10.1073/pnas.2135498100; Ward IM, 2003, J BIOL CHEM, V278, P19579, DOI 10.1074/jbc.C300117200; Ward JF, 2000, COLD SPRING HARB SYM, V65, P377, DOI 10.1101/sqb.2000.65.377; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Wu W, 2008, DNA REPAIR, V7, P329, DOI 10.1016/j.dnarep.2007.11.008	44	52	55	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e69061	10.1371/journal.pone.0069061	http://dx.doi.org/10.1371/journal.pone.0069061			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874869	gold, Green Published, Green Submitted			2022-12-27	WOS:000322218800063
J	Attri, P; Lee, SH; Hwang, SW; Kim, JIL; Lee, SW; Kwon, GC; Choi, EH; Kim, IT				Attri, Pankaj; Lee, Seung-Hyun; Hwang, Sun Woo; Kim, Joong I. L.; Lee, Sang Woo; Kwon, Gi-Chung; Choi, Eun Ha; Kim, In Tae			Elucidating Interactions and Conductivity of Newly Synthesised Low Bandgap Polymer with Protic and Aprotic Ionic Liquids	PLOS ONE			English	Article							BLOCK-COPOLYMER MICELLES; ELECTRICAL-CONDUCTIVITY; DIBLOCK COPOLYMERS; SULFONATE) FILM; GAP POLYMER; MORPHOLOGY; ELECTROLYTES; DIKETOPYRROLOPYRROLE; ENHANCEMENT; MEMBRANES	In this paper, we have examined the conductivity and interaction studies of ammonium and imidazolium based ionic liquids (ILs) with the newly synthesised low bandgap polymer (Poly(2-heptadecyl-4-vinylthieno[3,4-d] thiazole) (PHVTT)). Use of low bandgap polymers is the most suitable way to harvest a broader spectrum of solar radiations for solar cells. But, still there is lack of most efficient low bandgap polymer. In order to solve this problem, we have synthesised a new low bandgap polymer and investigated its interaction with the ILs to enhance its conductivity. ILs may undergo almost unlimited structural variations; these structural variations have attracted extensive attention in polymer studies. The aim of present work is to illustrate the state of art progress of implementing the interaction of ILs (protic and aprotic ILs) with newly synthesised low bandgap polymer. In addition to this, our UV-Vis spectroscopy, confocal Raman spectroscopy and FT-IR spectroscopy results have revealed that all studied ILs (tributylmethylammonium methyl sulfate ([N-1444][MeSO4] from ammonium family) and 1-methylimidazolium chloride ([Mim]Cl, and 1-butyl-3-methylimidazolium chloride ([Bmim]Cl from imidazolium family) have potential to interact with polymer. Our semi empirical calculation with help of Hyperchem 7 shows that protic IL ([Mim]Cl) interacts strongly with the low bandgap polymer through the H-bonding. Further, protic ILs shows enhanced conductivity than aprotic ILs in association with low bandgap polymer. This study provides the combined effect of low bandgap polymer and ILs that may generate many theoretical and experimental opportunities.	[Attri, Pankaj; Kwon, Gi-Chung; Choi, Eun Ha] Kwangwoon Univ, Dept Elect & Biol Phys, Plasma Biosci Res Ctr, Seoul, South Korea; [Lee, Seung-Hyun] Kwangwoon Univ, Grad Sch Informat Contents, Seoul, South Korea; [Hwang, Sun Woo; Kim, Joong I. L.; Lee, Sang Woo; Kim, In Tae] Kwangwoon Univ, Dept Chem, Seoul, South Korea	Kwangwoon University; Kwangwoon University; Kwangwoon University	Choi, EH (corresponding author), Kwangwoon Univ, Dept Elect & Biol Phys, Plasma Biosci Res Ctr, Seoul, South Korea.	echoi@kw.ac.kr; itkim@kw.ac.kr	Attri, Pankaj/ABE-7522-2020; Choi, Eun Ha/AFN-9488-2022	Attri, Pankaj/0000-0002-5036-7877; Choi, Eun Ha/0000-0001-5385-1878	SRC program of National Research Foundation of Korea (NRF); Korean Government (MEST) [20100029418]; New AMP; Renewable Energy of the Korea Institute of Energy Technology Evaluation and Planning (KETEP); Korea government Ministry of Knowledge Economy [96002011003]; Ministry of Knowledge Economy (MKE), Korea; Kwangwoon University research fund	SRC program of National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); New AMP; Renewable Energy of the Korea Institute of Energy Technology Evaluation and Planning (KETEP); Korea government Ministry of Knowledge Economy(Korean GovernmentMinistry of Trade, Industry & Energy (MOTIE), Republic of Korea); Ministry of Knowledge Economy (MKE), Korea(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); Kwangwoon University research fund	The authors gratefully acknowledge SRC program of National Research Foundation of Korea (NRF) Grant funded by the Korean Government (MEST) (No. 20100029418). This work was supported by the New & Renewable Energy of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) grant funded by the Korea government Ministry of Knowledge Economy (No. 96002011003) and by Ministry of Knowledge Economy (MKE), Korea as a project, "Full color 360 degree 3D holographic video making technology" and in part by Kwangwoon University research fund 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Attri P, 2012, ORG BIOMOL CHEM, V10, P7475, DOI 10.1039/c2ob26001h; Attri P, 2011, J PHYS CHEM B, V115, P10086, DOI 10.1021/jp2059084; Attri P, 2011, PHYS CHEM CHEM PHYS, V13, P2788, DOI 10.1039/c0cp01291b; Attri P, 2010, J PHYS CHEM B, V114, P6126, DOI 10.1021/jp101209j; Bai ZF, 2008, LANGMUIR, V24, P5284, DOI 10.1021/la703848e; Bijleveld JC, 2010, ADV MATER, V22, pE242, DOI 10.1002/adma.201001449; Boudreault PLT, 2011, CHEM MATER, V23, P456, DOI 10.1021/cm1021855; Brabec CJ, 2004, SOL ENERG MAT SOL C, V83, P273, DOI 10.1016/j.solmat.2004.02.030; Bundgaard E, 2007, SOL ENERG MAT SOL C, V91, P954, DOI 10.1016/j.solmat.2007.01.015; Cheng H, 2007, ELECTROCHIM ACTA, V52, P5789, DOI 10.1016/j.electacta.2007.02.062; Chiappe C, 2011, J PHYS CHEM B, V115, P9653, DOI 10.1021/jp2045788; Crispin X, 2006, CHEM MATER, V18, P4354, DOI 10.1021/cm061032+; Crispin X, 2003, J POLYM SCI POL PHYS, V41, P2561, DOI 10.1002/polb.10659; Davis JH, 2004, CHEM LETT, V33, P1072, DOI 10.1246/cl.2004.1072; Dobbelin M, 2007, CHEM MATER, V19, P2147, DOI 10.1021/cm070398z; Dou LT, 2012, NAT PHOTONICS, V6, P180, DOI [10.1038/NPHOTON.2011.356, 10.1038/nphoton.2011.356]; Greaves TL, 2008, CHEM REV, V108, P206, DOI 10.1021/cr068040u; Gwee L, 2010, POLYMER, V51, P5516, DOI 10.1016/j.polymer.2010.09.026; Hardelin L, 2012, J APPL POLYM SCI, V125, P1901, DOI 10.1002/app.36323; He YY, 2007, J PHYS CHEM B, V111, P4645, DOI 10.1021/jp064574n; He YY, 2006, J AM CHEM SOC, V128, P12666, DOI 10.1021/ja0655587; He YY, 2006, J AM CHEM SOC, V128, P2745, DOI 10.1021/ja058091t; Hoppe H, 2006, J MATER CHEM, V16, P45, DOI 10.1039/b510618b; Hou JH, 2009, J AM CHEM SOC, V131, P15586, DOI 10.1021/ja9064975; Hou JH, 2008, J AM CHEM SOC, V130, P16144, DOI 10.1021/ja806687u; Hou XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059145; Huq F, 2002, J MOL MODEL, V8, P81, DOI 10.1007/s00894-002-0073-1; Kawano R, 2004, J PHOTOCH PHOTOBIO A, V164, P87, DOI 10.1016/j.jphotochem.2003.12.019; Kim IT, 2007, B KOREAN CHEM SOC, V28, P2511; Kim JH, 2013, CHEM COMMUN, V49, P3248, DOI 10.1039/c3cc41160e; Kim JY, 2002, SYNTHETIC MET, V126, P311, DOI 10.1016/S0379-6779(01)00576-8; Krebs FC, 2005, CHEM MATER, V17, P5235, DOI 10.1021/cm051320q; Lee J, 2007, J AM CHEM SOC, V129, P4532, DOI 10.1021/ja070875e; de Carvalho RNL, 2013, J POLYM SCI POL PHYS, V51, P817, DOI 10.1002/polb.23252; Liang YY, 2009, J AM CHEM SOC, V131, P7792, DOI 10.1021/ja901545q; LIU Y, 2013, SCI REP, V3, P1, DOI DOI 10.1038/SREP03469; Maia FM, 2012, IND ENG CHEM RES, V51, P8061, DOI 10.1021/ie300227f; Martinelli A, 2007, J ELECTROCHEM SOC, V154, pG183, DOI 10.1149/1.2745640; Megaw J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060806; Noda A, 2003, J PHYS CHEM B, V107, P4024, DOI 10.1021/jp022347p; Ohno H, 2004, ELECTROCHIM ACTA, V50, P255, DOI 10.1016/j.electacta.2004.01.091; Ouyang BY, 2005, ADV FUNCT MATER, V15, P203, DOI 10.1002/adfm.200400016; Ouyang J, 2004, POLYMER, V45, P8443, DOI 10.1016/j.polymer.2004.10.001; Park MJ, 2013, J APPL POLYM SCI, V129, P2363, DOI 10.1002/app.39064; Pawley J, 1995, HDB BIOL CONFOCAL MI; Piliego C, 2010, J AM CHEM SOC, V132, P7595, DOI 10.1021/ja103275u; Qiu B, 2013, POLYM INT, V62, P335, DOI 10.1002/pi.4454; Rajput DS, 2013, J PHYS CHEM B, V117, P2475, DOI 10.1021/jp3116512; Reyes-Reyes M, 2005, ORG LETT, V7, P5749, DOI 10.1021/ol051950y; Rogers RD, 2003, SCIENCE, V302, P792, DOI 10.1126/science.1090313; Schmitt M, 2003, CHEMPHYSCHEM, V4, P296, DOI 10.1002/cphc.200390048; Seddon KR, 1997, J CHEM TECHNOL BIOT, V68, P351, DOI 10.1002/(SICI)1097-4660(199704)68:4<351::AID-JCTB613>3.0.CO;2-4; Sekhon SS, 2009, MACROMOLECULES, V42, P2054, DOI 10.1021/ma8027112; Shin JH, 2006, J POWER SOURCES, V156, P560, DOI 10.1016/j.jpowsour.2005.06.026; Simone PM, 2008, MACROMOLECULES, V41, P1753, DOI 10.1021/ma702252v; Simone PM, 2007, MACROMOL CHEM PHYSIC, V208, P339, DOI 10.1002/macp.200600392; Susan MA, 2005, J AM CHEM SOC, V127, P4976, DOI 10.1021/ja045155b; Sutto TE, 2007, J ELECTROCHEM SOC, V154, pP101, DOI 10.1149/1.2767414; Tautz R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1967; Welton T, 1999, CHEM REV, V99, P2071, DOI 10.1021/cr980032t; Winterton N, 2006, J MATER CHEM, V16, P4281, DOI 10.1039/b610143g; Ye YS, 2013, J MATER CHEM A, V1, P2719, DOI 10.1039/c2ta00126h; Zhao Q, 2013, POLYM CHEM-UK, V4, P2432, DOI 10.1039/c3py00159h	63	15	15	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68970	10.1371/journal.pone.0068970	http://dx.doi.org/10.1371/journal.pone.0068970			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874829	gold, Green Published, Green Submitted			2022-12-27	WOS:000321736900123
J	Gokmen-Polar, Y; Cook, RW; Goswami, CP; Wilkinson, J; Maetzold, D; Stone, JF; Oelschlager, KM; Vladislav, IT; Shirar, KL; Kesler, KA; Loehrer, PJ; Badve, S				Gokmen-Polar, Yesim; Cook, Robert W.; Goswami, Chirayu Pankaj; Wilkinson, Jeff; Maetzold, Derek; Stone, John F.; Oelschlager, Kristen M.; Vladislav, Ioan Tudor; Shirar, Kristen L.; Kesler, Kenneth A.; Loehrer, Patrick J., Sr.; Badve, Sunil			A Gene Signature to Determine Metastatic Behavior in Thymomas	PLOS ONE			English	Article							WORLD-HEALTH-ORGANIZATION; THYMIC EPITHELIAL TUMORS; HISTOLOGIC CLASSIFICATION; EXPRESSION; STAGE; NEUROBLASTOMA; MALIGNANCIES; INVASION; CELLS	Purpose: Thymoma represents one of the rarest of all malignancies. Stage and completeness of resection have been used to ascertain postoperative therapeutic strategies albeit with limited prognostic accuracy. A molecular classifier would be useful to improve the assessment of metastatic behaviour and optimize patient management. Methods: qRT-PCR assay for 23 genes (19 test and four reference genes) was performed on multi-institutional archival primary thymomas (n = 36). Gene expression levels were used to compute a signature, classifying tumors into classes 1 and 2, corresponding to low or high likelihood for metastases. The signature was validated in an independent multi-institutional cohort of patients (n = 75). Results: A nine-gene signature that can predict metastatic behavior of thymomas was developed and validated. Using radial basis machine modeling in the training set, 5-year and 10-year metastasis-free survival rates were 77% and 26% for predicted low (class 1) and high (class 2) risk of metastasis (P = 0.0047, log-rank), respectively. For the validation set, 5-year metastasis-free survival rates were 97% and 30% for predicted low-and high-risk patients (P = 0.0004, log-rank), respectively. The 5-year metastasis-free survival rates for the validation set were 49% and 41% for Masaoka stages I/II and III/IV (P = 0.0537, log-rank), respectively. In univariate and multivariate Cox models evaluating common prognostic factors for thymoma metastasis, the nine-gene signature was the only independent indicator of metastases (P = 0.036). Conclusion: A nine-gene signature was established and validated which predicts the likelihood of metastasis more accurately than traditional staging. This further underscores the biologic determinants of the clinical course of thymoma and may improve patient management.	[Gokmen-Polar, Yesim; Shirar, Kristen L.; Badve, Sunil] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Vladislav, Ioan Tudor; Badve, Sunil] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Goswami, Chirayu Pankaj] Indiana Univ Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN 46202 USA; [Kesler, Kenneth A.] Indiana Univ Sch Med, Dept Surg, Indianapolis, IN 46202 USA; [Cook, Robert W.; Maetzold, Derek] Castle Biosci Inc, Friendswood, TX USA; [Wilkinson, Jeff; Stone, John F.] St Josephs Hosp, DNA Diagnost Lab, Phoenix, AZ USA; [Oelschlager, Kristen M.] Castle Biosci Inc, Phoenix, AZ USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; St. Joseph's Hospital and Medical Center	Badve, S (corresponding author), Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA.	sbadve@iupui.edu	Gokmen-Polar, Yesim/AAX-4001-2021	Gokmen-Polar, Yesim/0000-0001-9927-4893; Badve, Sunil/0000-0001-8861-9980	Indiana Clinical and Translational Sciences Institute (CTSI); Hochberg Family Foundation; Indiana University Melvin and Bren Simon Cancer Center; Castle Biosciences	Indiana Clinical and Translational Sciences Institute (CTSI); Hochberg Family Foundation; Indiana University Melvin and Bren Simon Cancer Center; Castle Biosciences	This work was supported partly by Indiana Clinical and Translational Sciences Institute (CTSI) grant to SB, The Hochberg Family Foundation and by Indiana University Melvin and Bren Simon Cancer Center and by Castle Biosciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badve S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042669; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Engels EA, 2003, INT J CANCER, V105, P546, DOI 10.1002/ijc.11099; Ettinger DS, 2010, J NATL COMPR CANC NE, V8, P1302, DOI 10.6004/jnccn.2010.0096; Girard N, 2009, CLIN CANCER RES, V15, P6790, DOI 10.1158/1078-0432.CCR-09-0644; Gokmen-Polar Y, 2012, LAB INVEST, V92, P1564, DOI 10.1038/labinvest.2012.115; Huang Y, 2005, CANCER RES, V65, P7446, DOI 10.1158/0008-5472.CAN-04-4267; Jain RK, 2010, MODERN PATHOL, V23, P1641, DOI 10.1038/modpathol.2010.172; Kondo K, 2003, ANN THORAC SURG, V76, P878, DOI 10.1016/S0003-4975(03)00555-1; Kondo K, 2004, ANN THORAC SURG, V77, P1183, DOI 10.1016/j.athoracsur.2003.07.042; Law AYS, 2010, EXP CELL RES, V316, P3425, DOI 10.1016/j.yexcr.2010.06.026; Lee GY, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-305; Ma J, 2012, INT J CANCER, V131, pE862, DOI 10.1002/ijc.27618; MASAOKA A, 1981, CANCER, V48, P2485, DOI 10.1002/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R; Matsunaga T, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00005; Moran CA, 2010, AM J CLIN PATHOL, V134, P793, DOI 10.1309/AJCP7KBP4QQLRLXW; Moran CA, 2008, CURR TREAT OPTION ON, V9, P288, DOI 10.1007/s11864-009-0084-6; Okumura M, 2002, CANCER-AM CANCER SOC, V94, P624, DOI 10.1002/cncr.10226; Okumura M, 2001, AM J SURG PATHOL, V25, P103, DOI 10.1097/00000478-200101000-00012; Perreard L, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1399; Sasaki H, 2004, CLIN EXP METASTAS, V21, P507, DOI 10.1007/s10585-004-2153-3; Sasaki H, 2003, CANCER SCI, V94, P809, DOI 10.1111/j.1349-7006.2003.tb01523.x; Sasaki H, 2002, INT J CANCER, V101, P342, DOI 10.1002/ijc.10624; Sogawa K, 2003, CANCER, V98, P1822, DOI 10.1002/cncr.11725; Takahashi E, 2003, HUM PATHOL, V34, P1253, DOI 10.1016/j.humpath.2003.07.013; Tateyama H, 2011, HUM PATHOL, V42, P533, DOI 10.1016/j.humpath.2010.08.012; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Vladislav T, 2012, MODERN PATHOL, V25, P370, DOI 10.1038/modpathol.2011.178; Volland S, 2009, INT J CANCER, V125, P2049, DOI 10.1002/ijc.24564; Wei JS, 2004, CANCER RES, V64, P6883, DOI 10.1158/0008-5472.CAN-04-0695	30	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e66047	10.1371/journal.pone.0066047	http://dx.doi.org/10.1371/journal.pone.0066047			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894276	Green Published, Green Submitted, gold			2022-12-27	WOS:000322167900002
J	Huber-Wagner, S; Biberthaler, P; Haberle, S; Wierer, M; Dobritz, M; Rummeny, E; van Griensven, M; Kanz, KG; Lefering, R				Huber-Wagner, Stefan; Biberthaler, Peter; Haeberle, Sandra; Wierer, Matthias; Dobritz, Martin; Rummeny, Ernst; van Griensven, Martijn; Kanz, Karl-Georg; Lefering, Rolf		TraumaRegister DGU	Whole-Body CT in Haemodynamically Unstable Severely Injured Patients - A Retrospective, Multicentre Study	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; RADIATION-EXPOSURE; TRAUMA PATIENTS; BLUNT TRAUMA; MAJOR TRAUMA; HELICAL CT; TIME; MANAGEMENT; SURVIVAL; HYPOTENSION	Background: The current common and dogmatic opinion is that whole-body computed tomography (WBCT) should not be performed in major trauma patients in shock. We aimed to assess whether WBCT during trauma-room treatment has any effect on the mortality of severely injured patients in shock. Methods: In a retrospective multicenter cohort study involving 16719 adult blunt major trauma patients we compared the survival of patients who were in moderate, severe or no shock (systolic blood pressure 90-110, <90 or >110 mmHg) at hospital admission and who received WBCT during resuscitation to those who did not. Using data derived from the 2002-2009 version of TraumaRegister (R), we determined the observed and predicted mortality and calculated the standardized mortality ratio (SMR) as well as logistic regressions. Findings: 9233 (55.2%) of the 16719 patients received WBCT. The mean injury severity score was 28.8 +/- 12.1. The overall mortality rate was 17.4% (SMR = 0.85, 95% CI 0.81-0.89) for patients with WBCT and 21.4% (SMR = 0.98, 95% CI 0.94-1.02) for those without WBCT (p<0.001). 4280 (25.6%) patients were in moderate shock and 1821 (10.9%) in severe shock. The mortality rate for patients in moderate shock with WBCT was 18.1% (SMR 0.85, CI95% 0.78-0.93) compared to 22.6% (SMR 1.03, CI95% 0.94-1.12) to those without WBCT (p<0.001, p = 0.002 for the SMRs). The mortality rate for patients in severe shock with WBCT was 42.1% (SMR 0.99, CI95% 0.92-1.06) compared to 54.9% (SMR 1.10, CI95% 1.02-1.16) to those without WBCT (p<0.001, p = 0.049 for the SMRs). Adjusted logistic regression analyses showed that WBCT is an independent predictor for survival that significantly increases the chance of survival in patients in moderate shock (OR = 0.73; 95% CI 0.60-0.90, p = 0.002) as well as in severe shock (OR = 0.67; 95% CI 0.52-0.88, p = 0.004). The number needed to scan related to survival was 35 for all patients, 26 for those in moderate shock and 20 for those in severe shock. Conclusions: WBCT during trauma resuscitation significantly increased the survival in haemodynamically stable as well as in haemodynamically unstable major trauma patients. Thus, the application of WBCT in haemodynamically unstable severely injured patients seems to be safe, feasible and justified if performed quickly within a well-structured environment and by a well-organized trauma team.	[Huber-Wagner, Stefan; Biberthaler, Peter; Haeberle, Sandra; van Griensven, Martijn; Kanz, Karl-Georg] Tech Univ Munich, Dept Trauma Surg, Klinikum Rechts Isar, D-80290 Munich, Germany; [Lefering, Rolf] Univ Witten Herdecke, Fac Hlth, IFOM Inst Res Operat Med, Cologne, Germany; [Wierer, Matthias] Munich Univ Hosp, Dept Trauma Surg, Munich, Germany; [Dobritz, Martin; Rummeny, Ernst] Tech Univ Munich, Klinikum Rechts Isar, Inst Radiol, D-80290 Munich, Germany; [TraumaRegister DGU] German Trauma Soc, Comm Emergency Med, Berlin, Germany	Technical University of Munich; Witten Herdecke University; University of Munich; Technical University of Munich	Huber-Wagner, S (corresponding author), Tech Univ Munich, Dept Trauma Surg, Klinikum Rechts Isar, D-80290 Munich, Germany.	huber-wagner@mri.tum.de	van Griensven, Martijn/F-5808-2012	van Griensven, Martijn/0000-0001-5104-9881				Andersohn F, 2009, LANCET, V374, P197, DOI 10.1016/S0140-6736(09)61321-0; [Anonymous], 2008, ADVANCED TRAUMA LIFE; [Anonymous], 2011, ANN REP TRAUMAREGIST; [Anonymous], 2011, DEATHS FINAL DATA FO; Asha S, 2012, EMERG MED AUSTRALAS, V24, P43, DOI 10.1111/j.1742-6723.2011.01504.x; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2004, RADIOLOGY, V232, P735, DOI 10.1148/radiol.2323031095; Bruns B, 2008, J TRAUMA, V65, P1217, DOI 10.1097/TA.0b013e318184ee63; Clarke JR, 2002, J TRAUMA, V52, P420, DOI 10.1097/00005373-200203000-00002; Deunk J, 2007, J TRAUMA, V63, P757, DOI 10.1097/01.ta.0000235878.42251.8d; Eastridge BJ, 2007, J TRAUMA, V63, P291, DOI 10.1097/TA.0b013e31809ed924; Geeraedts LMG, 2009, INJURY, V40, P11, DOI 10.1016/j.injury.2008.10.007; Hara AK, 2009, AM J ROENTGENOL, V193, P764, DOI 10.2214/AJR.09.2397; Hilbert P, 2007, INJURY, V38, P552, DOI 10.1016/j.injury.2006.12.023; Huber-Wagner S, 2010, EUR J MED RES, V15, P185, DOI 10.1186/2047-783X-15-5-185; Huber-Wagner S, 2010, INJURY S4, V40, pS36; Huber-Wagner S, 2009, LANCET, V373, P1455, DOI 10.1016/S0140-6736(09)60232-4; Hutter M, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-73; Kanz Karl-Georg, 2010, J Trauma Manag Outcomes, V4, P4, DOI 10.1186/1752-2897-4-4; Kanz KG, 2004, UNFALLCHIRURG, V107, P937, DOI 10.1007/s00113-004-0845-4; Kloppel R, 2002, RADIOLOGE, V42, P541, DOI 10.1007/s00117-002-0764-8; Kochanek Kenneth D, 2011, Natl Vital Stat Rep, V60, P1; Lee KL, 2009, INJURY, V40, P873, DOI 10.1016/j.injury.2008.12.001; Lefering R, 2007, THESIS, P1; Lefering R, 2009, EUR J TRAUMA EMERG S, V35, P437, DOI 10.1007/s00068-009-9122-0; Linsenmaier U, 2003, ROFO-FORTSCHR RONTG, V175, P1259; Loewenhardt B, 2012, INJURY, V43, P67, DOI 10.1016/j.injury.2011.10.014; Low R, 1997, ROFO-FORTSCHR RONTG, V166, P382, DOI 10.1055/s-2007-1015446; Mackay A, 1999, AUST NZ J SURG, V69, P587, DOI 10.1046/j.1440-1622.1999.01638.x; Martinsen ACT, 2012, EUR J RADIOL, V81, P1483, DOI 10.1016/j.ejrad.2011.04.021; Nguyen D, 2009, AM J ROENTGENOL, V192, P3, DOI 10.2214/AJR.07.3702; Noel PB, 2011, AM J ROENTGENOL, V197, P1404, DOI 10.2214/AJR.11.6907; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Ptak T, 2001, EMERG RADIOL, V8, P250, DOI DOI 10.1007/PL00011915; Rieger M, 2009, J TRAUMA, V66, P648, DOI 10.1097/TA.0b013e31816275f3; Ruchholtz S, 2008, DTSCH ARZTEBL INT, V105, P225, DOI 10.3238/arztebl.2008.0225; Ruchholtz S, 2000, UNFALLCHIRURG, V103, P30, DOI 10.1007/s001130050005; Salim A, 2006, ARCH SURG-CHICAGO, V141, P468, DOI 10.1001/archsurg.141.5.468; Sampson MA, 2006, CLIN RADIOL, V61, P365, DOI 10.1016/j.crad.2005.12.009; Smith CB, 2011, AM J EMERG MED, V29, P1, DOI 10.1016/j.ajem.2009.05.025; Stengel D, 2012, CAN MED ASSOC J, V184, P869, DOI 10.1503/cmaj.111420; Suissa S, 2007, PHARMACOEPIDEM DR S, V16, P241, DOI 10.1002/pds.1357; Tillou A, 2009, J TRAUMA, V67, P779, DOI 10.1097/TA.0b013e3181b5f2eb; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wurmb TE, 2009, J TRAUMA, V66, P658, DOI 10.1097/TA.0b013e31817de3f4	45	161	164	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e68880	10.1371/journal.pone.0068880	http://dx.doi.org/10.1371/journal.pone.0068880			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894365	gold, Green Published, Green Submitted			2022-12-27	WOS:000322167900029
J	Baek, SK; Durang, X; Kim, M				Baek, Seung Ki; Durang, Xavier; Kim, Mina			Faster Is More Different: Mean-Field Dynamics of Innovation Diffusion	PLOS ONE			English	Article								Based on a recent model of paradigm shifts by Bornholdt et al., we studied mean-field opinion dynamics in an infinite population where an infinite number of ideas compete simultaneously with their values publicly known. We found that a highly innovative society is not characterized by heavy concentration in highly valued ideas: Rather, ideas are more broadly distributed in a more innovative society with faster progress, provided that the rate of adoption is constant, which suggests a positive correlation between innovation and technological disparity. Furthermore, the distribution is generally skewed in such a way that the fraction of innovators is substantially smaller than has been believed in conventional innovation-diffusion theory based on normality. Thus, the typical adoption pattern is predicted to be asymmetric with slow saturation in the ideal situation, which is compared with empirical data sets.	[Baek, Seung Ki; Durang, Xavier] Korea Inst Adv Study, Sch Phys, Seoul, South Korea; [Kim, Mina] Univ Seoul, Dept Phys, Seoul, South Korea	Korea Institute for Advanced Study (KIAS); University of Seoul	Baek, SK (corresponding author), Korea Inst Adv Study, Sch Phys, Seoul, South Korea.	seungki@kias.re.kr	Baek, Seung Ki/B-7835-2014; Durang, Xavier/D-5324-2019	Baek, Seung Ki/0000-0002-4143-1187; Durang, Xavier/0000-0003-2251-4857	TJ Park Foundation	TJ Park Foundation	M.K. acknowledges financial support from the TJ Park Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABLOWITZ MJ, 1979, B MATH BIOL, V41, P835, DOI 10.1007/BF02462380; Barnett G. A., 2011, DIFFUSION INNOVATION, P103; BASS FM, 1969, MANAGE SCI, V15, P215, DOI 10.1287/mnsc.15.5.215; Bornholdt S, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.058701; Chae H, ARXIV13014751; Fisher RA, 1937, ANN EUGENIC, V7, P355, DOI 10.1111/j.1469-1809.1937.tb02153.x; Fort J, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/8/086001; Goldenberg J, 2000, PHYSICA A, V284, P335, DOI 10.1016/S0378-4371(00)00260-0; Guardiola X, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.026121; Karnowski Veronika., 2011, DIFFUSION INNOVATION, P57; Kim Y, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.046110; Kondratiuk P, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.066126; Maastricht Economic and Social Research Institute on Innovation and Technology, 2012, INN UN SCOR 2011; Mahajan V., 1985, MODELS INNOVATION DI; Martins ACR, 2009, PHYSICA A, V388, P3225, DOI 10.1016/j.physa.2009.04.007; Maynard Smith J., 1982, pi; Murray J. D., 2002, MATH BIOL; Noh JD, COMMUNICATION; Rogers E.M., 2010, DIFFUSION INNOVATION; Souza SR, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.056103; van Saarloos W, 2003, PHYS REP, V386, P29, DOI 10.1016/j.physrep.2003.08.001	21	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e68583	10.1371/journal.pone.0068583	http://dx.doi.org/10.1371/journal.pone.0068583			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894320	gold, Green Submitted, Green Published			2022-12-27	WOS:000322391400013
J	Essick, EE; Wilson, RM; Pimentel, DR; Shimano, M; Baid, S; Ouchi, N; Sam, F				Essick, Eric E.; Wilson, Richard M.; Pimentel, David R.; Shimano, Masayuki; Baid, Simoni; Ouchi, Noriyuki; Sam, Flora			Adiponectin Modulates Oxidative Stress-Induced Autophagy in Cardiomyocytes	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; BECLIN 1-INDEPENDENT AUTOPHAGY; VENTRICULAR EJECTION FRACTION; SIGNAL-REGULATED KINASE; HEART-FAILURE; MYOCARDIAL HYPERTROPHY; RESISTANT HYPERTENSION; REPERFUSION INJURY; CELL-SURVIVAL; ISCHEMIA	Diastolic heart failure (HF) i.e., "HF with preserved ejection fraction" (HF-preserved EF) accounts for up to 50% of all HF presentations; however there have been no therapeutic advances. This stems in part from an incomplete understanding about HF-preserved EF. Hypertension is the major cause of HF-preserved EF whilst HF-preserved EF is also highly associated with obesity. Similarly, excessive reactive oxygen species (ROS), i.e., oxidative stress occurs in hypertension and obesity, sensitizing the heart to the renin-angiotensin-aldosterone system, inducing autophagic type-II programmed cell death and accelerating the propensity to adverse cardiac remodeling, diastolic dysfunction and HF. Adiponectin (APN), an adipokine, mediates cardioprotective actions but it is unknown if APN modulates cardiomyocyte autophagy. We tested the hypothesis that APN ameliorates oxidative stress-induced autophagy in cardiomyocytes. Isolated adult rat ventricular myocytes were pretreated with recombinant APN (30 mu g/mL) followed by 1mM hydrogen peroxide (H2O2) exposure. Wild type (WT) and APN-deficient (APN-KO) mice were infused with angiotensin (Ang)-II (3.2mg/kg/d) for 14 days to induced oxidative stress. Autophagy-related proteins, mTOR, AMPK and ERK expression were measured. H2O2 induced LC3I to LC3II conversion by a factor of 3.4 +/- 1.0 which was abrogated by pre-treatment with APN by 44.5 +/- 10%. However, neither H2O2 nor APN affected ATG5, ATG7, or Beclin-1 expression. H2O2 increased phospho-AMPK by 49 +/- 6.0%, whilst pretreatment with APN decreased phospho-AMPK by 26 +/- 4%. H2O2 decreased phospho-mTOR by 36 +/- 13%, which was restored by APN. ERK inhibition demonstrated that the ERK-mTOR pathway is involved in H2O2-induced autophagy. Chronic Ang-II infusion significantly increased myocardial LC3II/I protein expression ratio in APN-KO vs. WT mice. These data suggest that excessive ROS caused cardiomyocyte autophagy which was ameliorated by APN by inhibiting an H2O2-induced AMPK/mTOR/ERK-dependent mechanism. These findings demonstrate the anti-oxidant potential of APN in oxidative stress-associated cardiovascular diseases, such as hypertension-induced HF-preserved EF.	[Essick, Eric E.; Wilson, Richard M.; Pimentel, David R.; Shimano, Masayuki; Baid, Simoni; Ouchi, Noriyuki; Sam, Flora] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Pimentel, David R.; Sam, Flora] Boston Univ, Sch Med, Cardiovasc Sect, Boston, MA 02118 USA; [Pimentel, David R.; Sam, Flora] Boston Univ, Sch Med, Evans Dept Med, Boston, MA 02118 USA	Boston University; Boston University; Boston University	Sam, F (corresponding author), Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA.	flora.sam@bmc.org	OUCHI, Noriyuki/I-7306-2014	Pimentel, David/0000-0002-0537-7195; Sam, Flora/0000-0001-8442-9362	National Institutes of Health (NIH) [T32HL007224]; NIH [HL095891, HL102631]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007224, R21HL102631, R21HL095891] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	EE was supported by funding from the National Institutes of Health (NIH) T32HL007224 and FS was supported by funding from the NIH HL095891 and HL102631. The NIH had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acelajado MC, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/837817; Agrawal R, 2010, PHARMACOL RES, V61, P269, DOI 10.1016/j.phrs.2009.11.012; Aikawa R, 1997, J CLIN INVEST, V100, P1813, DOI 10.1172/JCI119709; Aoki H, 2007, MOL PHARMACOL, V72, P29, DOI 10.1124/mol.106.033167; Cai H, 2005, CIRC RES, V96, P818, DOI 10.1161/01.RES.0000163631.07205.fb; Calhoun DA, 2008, CIRCULATION, V117, pE510, DOI 10.1161/CIRCULATIONAHA.108.189141; Choi CH, 2010, MOL PHARMACOL, V78, P114, DOI 10.1124/mol.110.063495; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; Desai AS, 2011, AM HEART J, V162, P966, DOI 10.1016/j.ahj.2011.09.007; Dhalla AK, 1996, J AM COLL CARDIOL, V28, P506, DOI 10.1016/0735-1097(96)00140-4; Dobrian AD, 2004, HYPERTENSION, V43, P48, DOI 10.1161/01.HYP.0000103629.01745.59; Essick EE, 2011, AM J PHYSIOL-HEART C, V301, pH984, DOI 10.1152/ajpheart.00428.2011; Fujita K, 2008, ARTERIOSCL THROM VAS, V28, P863, DOI 10.1161/ATVBAHA.107.156687; Garcia AG, 2012, AM J PHYSIOL-HEART C, V303, pH587, DOI 10.1152/ajpheart.00298.2012; George J, 2006, HEART, V92, P1420, DOI 10.1136/hrt.2005.083345; Goodfriend TL, 2004, HYPERTENSION, V43, P518, DOI 10.1161/01.HYP.0000116223.97436.e5; Grishchuk Y, 2011, AUTOPHAGY, V7, P1115, DOI 10.4161/auto.7.10.16608; Habeeb BS, 2011, CANCER SCI, V102, P999, DOI 10.1111/j.1349-7006.2011.01902.x; Hariharan N, 2011, ANTIOXID REDOX SIGN, V14, P2179, DOI 10.1089/ars.2010.3488; Haugen E, 2008, INT J CARDIOL, V125, P216, DOI 10.1016/j.ijcard.2007.12.002; Hopkins TA, 2007, CARDIOVASC RES, V74, P11, DOI 10.1016/j.cardiores.2006.10.009; Horie T, 2008, J CELL PHYSIOL, V215, P733, DOI 10.1002/jcp.21353; Horman S, 2006, J BIOL CHEM, V281, P5335, DOI 10.1074/jbc.M506850200; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Hoyer-Hansen M, 2007, AUTOPHAGY, V3, P381, DOI 10.4161/auto.4240; Ide T, 2000, CIRC RES, V86, P152, DOI 10.1161/01.RES.86.2.152; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Iwashima Y, 2004, HYPERTENSION, V43, P1318, DOI 10.1161/01.HYP.0000129281.03801.4b; Kimura S, 2005, HYPERTENSION, V45, P860, DOI 10.1161/01.HYP.0000163462.98381.7f; Kistorp C, 2005, CIRCULATION, V112, P1756, DOI 10.1161/CIRCULATIONAHA.104.530972; Kondo K, 2010, CIRC-CARDIOVASC INTE, V3, P166, DOI 10.1161/CIRCINTERVENTIONS.109.872044; Kovacic S, 2003, J BIOL CHEM, V278, P39422, DOI 10.1074/jbc.M305371200; Kumada M, 2003, ARTERIOSCL THROM VAS, V23, P85, DOI 10.1161/01.ATV.0000048856.22331.50; Kuster GM, 2005, CIRCULATION, V111, P420, DOI 10.1161/01.CIR.0000153800.09920.40; Kwon SH, 2003, J MOL CELL CARDIOL, V35, P615, DOI 10.1016/S0022-2828(03)00084-1; Maack C, 2011, J AM COLL CARDIOL, V58, P83, DOI 10.1016/j.jacc.2011.01.032; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Marino G, 2008, HUM MOL GENET, V17, P2196, DOI 10.1093/hmg/ddn120; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Mellor KM, 2011, J MOL CELL CARDIOL, V50, P1035, DOI 10.1016/j.yjmcc.2011.03.002; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mohammed SF, 2010, CIRCULATION, V122, P370, DOI 10.1161/CIRCULATIONAHA.109.915215; Murdoch CE, 2006, CARDIOVASC RES, V71, P208, DOI 10.1016/j.cardiores.2006.03.016; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Nishida K, 2008, CIRC RES, V103, P343, DOI 10.1161/CIRCRESAHA.108.175448; Ogier-Denis E, 2000, J BIOL CHEM, V275, P39090, DOI 10.1074/jbc.M006198200; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Pattingre S, 2003, J BIOL CHEM, V278, P16667, DOI 10.1074/jbc.M210998200; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Sam F, 2005, J CARD FAIL, V11, P473, DOI 10.1016/j.cardfail.2005.01.007; Sam F, 2010, ENDOCRINOLOGY, V151, P322, DOI 10.1210/en.2009-0806; Sawyer DB, 2002, J MOL CELL CARDIOL, V34, P379, DOI 10.1006/jmcc.2002.1526; Scarlatti F, 2008, CELL DEATH DIFFER, V15, P1318, DOI 10.1038/cdd.2008.51; Schenkel PC, 2010, MOL CELL BIOCHEM, V341, P1, DOI 10.1007/s11010-010-0431-8; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Seo G, 2011, FREE RADICAL RES, V45, P389, DOI 10.3109/10715762.2010.535530; Shibata R, 2004, NAT MED, V10, P1384, DOI 10.1038/nm1137; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Shibata R, 2007, J MOL CELL CARDIOL, V42, P1065, DOI 10.1016/j.yjmcc.2007.03.808; Shimano M, 2010, J MOL CELL CARDIOL, V49, P210, DOI 10.1016/j.yjmcc.2010.02.021; Shinojima N, 2007, AUTOPHAGY, V3, P635, DOI 10.4161/auto.4916; Subramaniam S, 2006, NEUROSCIENCE, V138, P1055, DOI 10.1016/j.neuroscience.2005.12.013; Takagi H, 2007, ANTIOXID REDOX SIGN, V9, P1373, DOI 10.1089/ars.2007.1689; Takano H, 2009, INT J CARDIOL, V132, P221, DOI 10.1016/j.ijcard.2007.11.040; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Trigueros-Motos Laia, 2011, Front Biosci (Schol Ed), V3, P1285; Vasan RS, 1999, J AM COLL CARDIOL, V33, P1948, DOI 10.1016/S0735-1097(99)00118-7; Wang C, 2010, J CELL PHYSIOL, V222, P149, DOI 10.1002/jcp.21931; Wang JR, 2009, J BIOL CHEM, V284, P21412, DOI 10.1074/jbc.M109.026013; Yuan H, 2009, AM J PHYSIOL-HEART C, V296, pH470, DOI 10.1152/ajpheart.01051.2008; Zheng QW, 2011, CIRC RES, V109, P296, DOI 10.1161/CIRCRESAHA.111.244707; Zhu HX, 2007, J CLIN INVEST, V117, P1782, DOI 10.1172/JCI27523	72	65	69	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e68697	10.1371/journal.pone.0068697	http://dx.doi.org/10.1371/journal.pone.0068697			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894332	gold, Green Published, Green Submitted			2022-12-27	WOS:000322391400020
J	Han, K; Qi, WX; Gan, ZH; Shen, Z; Yao, Y; Min, DL				Han, Kun; Qi, WeiXiang; Gan, ZhiHua; Shen, Zan; Yao, Yang; Min, DaLiu			Prognostic Value of Ezrin in Solid Tumors: A Meta-Analysis of the Literature	PLOS ONE			English	Article							CYTOPLASMIC EZRIN; ERM PROTEINS; OVARIAN-CARCINOMA; POOR-PROGNOSIS; RECTAL-CANCER; LINKER EZRIN; EXPRESSION; SURVIVAL; TISSUE; HEAD	Purpose: Ezrin is a cytoskeletal protein involved in tumor growth and invasion. However its prognostic value for survival in patients with solid tumor remains controversial. Methods: Several databases were searched, including Pubmed, Embase and Cochrane databases. The endpoints were overall survival (OS), progression-free survival (PFS). The pooled hazard ratio (HR) or odds ratio (OR), and 95% confidence intervals (CI) were calculated employing fixed-or random-effects models depending on the heterogeneity of the included trials. Results: Twenty-seven eligible trials involving 4693 patients were ultimately identified. A summary hazard ratio (HR) of all studies and sub-group hazard ratios were calculated. The combined HR suggested that a positive Ezrin expression had an impact on overall survival (OS) [1.95, 95% confidence interval (CI) 1.60-2.39; P<0.001] in all eligible studies and progress free survival (PFS): (2.30 95% CI 1.0-3.61; P = 0.001). Similar results were also observed in subgroup analysis, according to tumor types, regions, patients' number and publication year. Conclusions: Our findings suggested that Ezrin protein expression might be a factor for a poor prognosis in patients with solid tumor. So large well-designed prospective studies are now needed to confirm the clinical utility of Ezrin as an independent prognostic marker.	[Han, Kun; Gan, ZhiHua; Min, DaLiu] Shanghai Jiao Tong Univ, Dept Oncol, Shanghai 200030, Peoples R China; [Qi, WeiXiang; Shen, Zan; Yao, Yang] Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Oncol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Min, DL (corresponding author), Shanghai Jiao Tong Univ, Dept Oncol, Shanghai 6th Peoples Hosp East Campus, Shanghai 200030, Peoples R China.	doctor_hankun@163.com						Aishima S, 2011, AM J SURG PATHOL, V35, P590, DOI 10.1097/PAS.0b013e31820ffdf1; Altman DG, 2001, BMJ-BRIT MED J, V323, P224, DOI 10.1136/bmj.323.7306.224; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Carneiro A, 2011, J CLIN PATHOL, V64, P689, DOI 10.1136/jcp.2011.089805; Curto M, 2004, CANCER CELL, V5, P113, DOI 10.1016/S1535-6108(04)00031-5; Elliott BE, 2005, BREAST CANCER RES, V7, pR365, DOI 10.1186/bcr1006; Elzagheid A, 2008, HUM PATHOL, V39, P1737, DOI 10.1016/j.humpath.2008.04.020; Gao SY, 2009, J BIOL CHEM, V284, P7995, DOI 10.1074/jbc.M809734200; Huang HY, 2010, ANN SURG ONCOL, V17, P3212, DOI 10.1245/s10434-010-1185-y; Jorgren F, 2012, INT J COLORECTAL DIS, V27, P893, DOI 10.1007/s00384-011-1397-z; Kang YK, 2010, MOL CARCINOGEN, V49, P798, DOI 10.1002/mc.20653; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; Kobel M, 2006, MODERN PATHOL, V19, P581, DOI 10.1038/modpathol.3800567; Kobel M, 2006, INT J GYNECOL PATHOL, V25, P121, DOI 10.1097/01.pgp.0000185410.39050.ac; Korkeila EA, 2011, HUM PATHOL, V42, P384, DOI 10.1016/j.humpath.2010.08.004; Lam EKY, 2011, AM J TRANSL RES, V3, P209; Lee HW, 2012, KOREAN J PATHOL, V46, P470, DOI 10.4132/KoreanJPathol.2012.46.5.470; Li L, 2011, PATHOL ONCOL RES, V17, P909, DOI 10.1007/s12253-011-9402-y; Ma L, 2013, CHINESE MED J-PEKING, V126, P242, DOI 10.3760/cma.j.issn.0366-6999.20110738; Madan R, 2006, HEAD NECK-J SCI SPEC, V28, P1018, DOI 10.1002/hed.20435; Makitie T, 2001, INVEST OPHTH VIS SCI, V42, P2442; MANTEL N, 1959, J NATL CANCER I, V22, P719; McClatchey AI, 2003, NAT REV CANCER, V3, P877, DOI 10.1038/nrc1213; Mhawech-Fauceglia P, 2007, J CLIN PATHOL, V60, P185, DOI 10.1136/jcp.2006.036624; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Moilanen J, 2003, GYNECOL ONCOL, V90, P273, DOI 10.1016/S0090-8258(03)00262-2; Garcia VM, 2011, COLORECTAL DIS, V13, P989, DOI 10.1111/j.1463-1318.2010.02386.x; Ng T, 2001, EMBO J, V20, P2723, DOI 10.1093/emboj/20.11.2723; Palou J, 2009, EUR UROL, V56, P829, DOI 10.1016/j.eururo.2008.09.062; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Patara M, 2011, PATHOL ONCOL RES, V17, P827, DOI 10.1007/s12253-011-9389-4; Schlecht NF, 2012, HEAD NECK PATHOL, V6, P232, DOI 10.1007/s12105-011-0328-1; Wang L, 2011, TUMOR BIOL, V32, P707, DOI 10.1007/s13277-011-0171-8; Wang YY, 2011, ORAL SURG ORAL MED O, V112, P96, DOI 10.1016/j.tripleo.2011.02.018; Wei YC, 2009, MODERN PATHOL, V22, P1351, DOI 10.1038/modpathol.2009.107; Weng WH, 2005, CLIN CANCER RES, V11, P6198, DOI 10.1158/1078-0432.CCR-05-0548; Xie JJ, 2011, J SURG ONCOL, V104, P538, DOI 10.1002/jso.21909; Yeh TS, 2005, ARCH SURG-CHICAGO, V140, P1184, DOI 10.1001/archsurg.140.12.1184; Yu YL, 2004, NAT MED, V10, P175, DOI 10.1038/nm966	40	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e68527	10.1371/journal.pone.0068527	http://dx.doi.org/10.1371/journal.pone.0068527			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894313	Green Published, Green Submitted			2022-12-27	WOS:000322391400009
J	Rantala, A; Jaakkola, JJK; Jaakkola, MS				Rantala, Aino; Jaakkola, Jouni J. K.; Jaakkola, Maritta S.			Respiratory Infections in Adults with Atopic Disease and IgE Antibodies to Common Aeroallergens	PLOS ONE			English	Article							INCIDENT CASE-CONTROL; ONSET ASTHMA; ALLERGY; IMMUNITY; CHILDREN; SYSTEM; MOLDS	Background: Atopic diseases, including allergic rhinitis, allergic dermatitis and asthma, are common diseases with a prevalence of 30-40% worldwide and are thus of great global public health importance. Allergic inflammation may influence the immunity against infections, so atopic individuals could be susceptible to respiratory infections. No previous population-based study has addressed the relation between atopy and respiratory infections in adulthood. We assessed the relation between atopic disease, specific IgE antibodies and the occurrence of upper and lower respiratory infections in the past 12 months among working-aged adults. Methods and Findings: A population-based cross-sectional study of 1008 atopic and non-atopic adults 21-63 years old was conducted. Information on atopic diseases, allergy tests and respiratory infections was collected by a questionnaire. Specific IgE antibodies to common aeroallergens were measured in serum. Adults with atopic disease had a significantly increased risk of lower respiratory tract infections (LRTI; including acute bronchitis and pneumonia) with an adjusted risk ratio (RR) 2.24 (95% confidence interval [CI] 1.43, 3.52) and upper respiratory tract infections (URTI; including common cold, sinusitis, tonsillitis, and otitis media) with an adjusted RR 1.55 (1.14, 2.10). The risk of LRTIs increased with increasing level of specific IgE (linear trend P = 0.059). Conclusions: This study provides new evidence that working-aged adults with atopic disease experience significantly more LRTIs and URTIs than non-atopics. The occurrence of respiratory infections increased with increasing levels of specific IgE antibodies to common aeroallergens, showing a dose-response pattern with LRTIs. From the clinical point of view it is important to recognize that those with atopies are a risk group for respiratory infections, including more severe LRTIs.	[Rantala, Aino; Jaakkola, Jouni J. K.; Jaakkola, Maritta S.] Univ Oulu, Ctr Environm & Resp Hlth Res, Oulu, Finland; [Jaakkola, Jouni J. K.] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Jaakkola, Jouni J. K.; Jaakkola, Maritta S.] Oulu Univ Hosp, Dept Med, Resp Med Unit, Oulu, Finland; [Jaakkola, Maritta S.] Univ Oulu, Inst Clin Med, Resp Med Unit, Oulu, Finland	University of Oulu; University of Oulu; University of Oulu; University of Oulu	Jaakkola, MS (corresponding author), Univ Oulu, Ctr Environm & Resp Hlth Res, Oulu, Finland.	maritta.jaakkola@oulu.fi	Jaakkola, Jouni J.K./G-4314-2012; Rantala, Aino/AAZ-7578-2020	Rantala, Aino/0000-0002-4845-076X; Jaakkola, Maritta S./0000-0003-1373-7784; Jaakkola, Jouni/0000-0003-4168-4683	Academy of Finland [129419, 138691]; Ministry of Social Affairs and Health of Finland [STM/1523/2012]	Academy of Finland(Academy of Finland); Ministry of Social Affairs and Health of Finland	This work was supported by Academy of Finland (grant no. 129419 and 138691) and the Ministry of Social Affairs and Health of Finland (grant no. STM/1523/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMOHANNA F, 1993, J ALLERGY CLIN IMMUN, V92, P757, DOI 10.1016/0091-6749(93)90020-G; Ciprandi G, 2008, CLIN EXP IMMUNOL, V153, P22, DOI 10.1111/j.1365-2249.2008.03717.x; Ciprandi G, 2006, PEDIAT ALLERG IMM-UK, V17, P389, DOI 10.1111/j.1399-3038.2006.00413.x; Cirillo I, 2007, ALLERGY, V62, P1087, DOI 10.1111/j.1398-9995.2007.01401.x; Corne JM, 2002, LANCET, V359, P831, DOI 10.1016/S0140-6736(02)07953-9; Gilmour MI, 2012, TOXICOL PATHOL, V40, P312, DOI 10.1177/0192623311431949; GROVE DI, 1975, BRIT J DERMATOL, V92, P611, DOI 10.1111/j.1365-2133.1975.tb03139.x; JAAKKOLA JJK, 1995, AM J EPIDEMIOL, V141, P755, DOI 10.1093/oxfordjournals.aje.a117498; Jaakkola JJK, 2002, J ALLERGY CLIN IMMUN, V109, P784, DOI 10.1067/mai.2002.123870; Jaakkola JJK, 2003, AM J EPIDEMIOL, V158, P981, DOI 10.1093/aje/kwg238; Jaakkola JJK, 2006, AM J EPIDEMIOL, V164, P742, DOI 10.1093/aje/kwj249; Jaakkola MS, 1999, AM J EPIDEMIOL, V150, P1223; Jaakkola MS, 2006, J ALLERGY CLIN IMMUN, V117, P642, DOI 10.1016/j.jaci.2005.11.003; Jaakkola MS, 2003, AM J PUBLIC HEALTH, V93, P2055, DOI 10.2105/AJPH.93.12.2055; Jaakkola MS, 2002, ENVIRON HEALTH PERSP, V110, P543, DOI 10.1289/ehp.02110543; Jung JA, 2010, J ALLERGY CLIN IMMUN, V125, P217, DOI 10.1016/j.jaci.2009.10.045; Kay AB, 2001, NEW ENGL J MED, V344, P30, DOI 10.1056/NEJM200101043440106; Kvaerner KJ, 2000, ARCH OTOLARYNGOL, V126, P1201, DOI 10.1001/archotol.126.10.1201; Mrabet-Dahbi S, 2010, ALLERGY, V65, P1351, DOI 10.1111/j.1398-9995.2010.02452.x; Paganelli R, 1998, ALLERGY, V53, P763; Pawanker R, WHITE BOOK ALLERGY 2; Piipari R, 2004, EUR RESPIR J, V24, P734, DOI 10.1183/09031936.04.00116903; Rantala A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027912	23	38	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e68582	10.1371/journal.pone.0068582	http://dx.doi.org/10.1371/journal.pone.0068582			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894319	Green Published, Green Submitted, gold			2022-12-27	WOS:000322391400012
J	Bai, XD; Adams, BJ; Ciche, TA; Clifton, S; Gaugler, R; Kim, K; Spieth, J; Sternberg, PW; Wilson, RK; Grewal, PS				Bai, Xiaodong; Adams, Byron J.; Ciche, Todd A.; Clifton, Sandra; Gaugler, Randy; Kim, Kwi-suk; Spieth, John; Sternberg, Paul W.; Wilson, Richard K.; Grewal, Parwinder S.			A Lover and a Fighter: The Genome Sequence of an Entomopathogenic Nematode Heterorhabditis bacteriophora	PLOS ONE			English	Article							PHOTORHABDUS-LUMINESCENS; STEINERNEMA-FELTIAE; RNA INTERFERENCE; GENE-EXPRESSION; DRAFT GENOME; WEB SERVER; CAENORHABDITIS; DIVERSITY; IDENTIFICATION; REPRODUCTION	Heterorhabditis bacteriophora are entomopathogenic nematodes that have evolved a mutualism with Photorhabdus luminescens bacteria to function as highly virulent insect pathogens. The nematode provides a safe harbor for intestinal symbionts in soil and delivers the symbiotic bacteria into the insect blood. The symbiont provides virulence and toxins, metabolites essential for nematode reproduction, and antibiotic preservation of the insect cadaver. Approximately half of the 21,250 putative protein coding genes identified in the 77 Mbp high quality draft H. bacteriophora genome sequence were novel proteins of unknown function lacking homologs in Caenorhabditis elegans or any other sequenced organisms. Similarly, 317 of the 603 predicted secreted proteins are novel with unknown function in addition to 19 putative peptidases, 9 peptidase inhibitors and 7 C-type lectins that may function in interactions with insect hosts or bacterial symbionts. The 134 proteins contained mariner transposase domains, of which there are none in C. elegans, suggesting an invasion and expansion of mariner transposons in H. bacteriophora. Fewer Kyoto Encyclopedia of Genes and Genomes Orthologies in almost all metabolic categories were detected in the genome compared with 9 other sequenced nematode genomes, which may reflect dependence on the symbiont or insect host for these functions. The H. bacteriophora genome sequence will greatly facilitate genetics, genomics and evolutionary studies to gain fundamental knowledge of nematode parasitism and mutualism. It also elevates the utility of H. bacteriophora as a bridge species between vertebrate parasitic nematodes and the C. elegans model.	[Bai, Xiaodong; Grewal, Parwinder S.] Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Entomol, Wooster, OH 44691 USA; [Adams, Byron J.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Adams, Byron J.] Brigham Young Univ, Evolutionary Ecol Labs, Provo, UT 84602 USA; [Ciche, Todd A.; Kim, Kwi-suk] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Clifton, Sandra; Spieth, John; Wilson, Richard K.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Clifton, Sandra; Spieth, John; Wilson, Richard K.] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63110 USA; [Gaugler, Randy] Rutgers State Univ, Dept Entomol, New Brunswick, NJ USA; [Sternberg, Paul W.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Sternberg, Paul W.] CALTECH, Div Biol, Pasadena, CA 91125 USA	University System of Ohio; Ohio State University; Brigham Young University; Brigham Young University; Michigan State University; Washington University (WUSTL); Washington University (WUSTL); Rutgers State University New Brunswick; California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology	Grewal, PS (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Entomol, Wooster, OH 44691 USA.	grewal.4@osu.edu	Adams, Byron J/C-3808-2009; Gaugler, Randy/K-3898-2013; Wilson, Richard K./AAF-4139-2019	Adams, Byron J/0000-0002-7815-3352; Wilson, Richard K./0000-0002-1992-1358	United States Department of Agriculture; National Science Foundation [2006-35600-16665]	United States Department of Agriculture(United States Department of Agriculture (USDA)); National Science Foundation(National Science Foundation (NSF))	This project was supported by grants from the United States Department of Agriculture (www.usda.gov) and National Science Foundation (www.nsf.gov) Microbial Genome Sequence Program under the grant #2006-35600-16665. P. W. S. is an investigator with the Howard Hughes Medical Institute (www.hhmi.org) with reference number of 047-101. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Aboobaker AA, 2003, MOL BIOCHEM PARASIT, V129, P41, DOI 10.1016/S0166-6851(03)00092-6; ABUHATAB M, 1995, J INVERTEBR PATHOL, V66, P125, DOI 10.1006/jipa.1995.1074; Adams BJ, 2006, BIOL CONTROL, V37, P32, DOI 10.1016/j.biocontrol.2005.11.008; Adams BJ, 2007, MONOGRAPH NEMATODES; Adhikari BN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-609; Allen JE, 2005, BIOINFORMATICS, V21, P3596, DOI 10.1093/bioinformatics/bti609; An RS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-433; ANDERSON RC, 1984, CAN J ZOOL, V62, P317, DOI 10.1139/z84-050; Antebi A, 1998, DEVELOPMENT, V125, P1191; Bai XD, 2007, J PARASITOL, V93, P1343, DOI 10.1645/GE-1246.1; Bai XD, 2007, MOL BIOCHEM PARASIT, V156, P162, DOI 10.1016/j.molbiopara.2007.07.018; Bai XD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-205; Bai XD, 2009, MOL ECOL RESOUR, V9, P207, DOI 10.1111/j.1755-0998.2008.02369.x; Baldwin JG, 2004, ANNU REV PHYTOPATHOL, V42, P83, DOI 10.1146/annurev.phyto.42.012204.130804; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Baumeister R, 2006, J ENDOCRINOL, V190, P191, DOI 10.1677/joe.1.06856; Bintrim SB, 1998, J BACTERIOL, V180, P1261, DOI 10.1128/JB.180.5.1261-1269.1998; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Bluthgen Nils, 2005, Genome Inform, V16, P106; Boemare N, 2002, NEMATOLOGY, V4, P601, DOI 10.1163/15685410260438863; Bongers T, 1999, TRENDS ECOL EVOL, V14, P224, DOI 10.1016/S0169-5347(98)01583-3; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Butcher RA, 2007, NAT CHEM BIOL, V3, P420, DOI 10.1038/nchembio.2007.3; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Chen SB, 2006, MOL BIOCHEM PARASIT, V145, P195, DOI 10.1016/j.molbiopara.2005.10.003; Choe A, 2012, CURR BIOL, V22, P772, DOI 10.1016/j.cub.2012.03.024; Ciche TA, 2003, APPL ENVIRON MICROB, V69, P1890, DOI 10.1128/AEM.69.4.1890-1897.2003; Ciche TA, 2001, J BACTERIOL, V183, P3117, DOI 10.1128/JB.183.10.3117-3126.2001; Ciche TA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-101; Ciche TA, 2008, APPL ENVIRON MICROB, V74, P2275, DOI 10.1128/AEM.02646-07; COHENNISSAN SZ, 1992, J NEMATOL, V24, P359; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Constant P, 1998, FUND APPL NEMATOL, V21, P667; Crawford JM, 2012, P NATL ACAD SCI USA, V109, P10821, DOI 10.1073/pnas.1201160109; De Ley Paul, 2002, P1; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Dietrich LEP, 2008, SCIENCE, V321, P1203, DOI 10.1126/science.1160619; Dillman AR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002527; Duchaud E, 2003, NAT BIOTECHNOL, V21, P1307, DOI 10.1038/nbt886; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; EDDY SR, 1994, NUCLEIC ACIDS RES, V22, P2079, DOI 10.1093/nar/22.11.2079; Eleftherianos I, 2010, TRENDS MICROBIOL, V18, P552, DOI 10.1016/j.tim.2010.09.006; Elsworth B, 2011, INT J PARASITOL, V41, P881, DOI 10.1016/j.ijpara.2011.03.009; ESTEVEZ M, 1993, NATURE, V365, P644, DOI 10.1038/365644a0; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Ffrench-Constant R, 2003, FEMS MICROBIOL REV, V26, P433, DOI 10.1111/j.1574-6976.2003.tb00625.x; ffrench-Constant RH, 2000, CELL MOL LIFE SCI, V57, P828, DOI 10.1007/s000180050044; ffrench-Constant RH, 2006, NAT BIOTECHNOL, V24, P660, DOI 10.1038/nbt0606-660; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gal TZ, 2005, J PARASITOL, V91, P691, DOI 10.1645/GE-402R; Gal TZ, 2003, J PARASITOL, V89, P761, DOI 10.1645/GE-3105; GAUGLER R, 1989, J INVERTEBR PATHOL, V54, P363, DOI 10.1016/0022-2011(89)90120-1; Gaugler R., 2002, Entomopathogenic nematology, DOI 10.1079/9780851995670.0000; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; GLAZER I, 1991, J NEMATOL, V23, P324; GOLDEN JW, 1982, SCIENCE, V218, P578, DOI 10.1126/science.6896933; Goodrich-Blair H, 2007, MOL MICROBIOL, V64, P260, DOI 10.1111/j.1365-2958.2007.05671.x; Grewal P. S., 2002, Entomopathogenic nematology, P265, DOI 10.1079/9780851995670.0265; Grewal PS, 2011, MOLECULAR AND PHYSIOLOGICAL BASIS OF NEMATODE SURVIVAL, P157, DOI 10.1079/9781845936877.0157; Grewal PS, 1996, J INVERTEBR PATHOL, V68, P65, DOI 10.1006/jipa.1996.0059; Grewal PS, 2003, J NEMATOL, V35, P146; Grewal PS, 2005, NEMATODES AS BIOCONTROL AGENTS, P1, DOI 10.1079/9780851990170.0000; Grewal PS, 1997, J CHEM ECOL, V23, P503, DOI 10.1023/B:JOEC.0000006374.95624.7e; Grewal PS, 2002, INT J PARASITOL, V32, P717, DOI 10.1016/S0020-7519(02)00029-2; GREWAL PS, 1994, J THERM BIOL, V19, P245, DOI 10.1016/0306-4565(94)90047-7; Grewal PS, 1996, ANN APPL BIOL, V129, P335, DOI 10.1111/j.1744-7348.1996.tb05756.x; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hallem EA, 2007, CURR BIOL, V17, P898, DOI 10.1016/j.cub.2007.04.027; Han RC, 2000, J INVERTEBR PATHOL, V75, P55, DOI 10.1006/jipa.1999.4900; Hashmi G, 1998, J INVERTEBR PATHOL, V72, P185, DOI 10.1006/jipa.1998.4778; HASHMI S, 1995, J INVERTEBR PATHOL, V66, P293, DOI 10.1006/jipa.1995.1103; Hashmi S, 1997, FUND APPL NEMATOL, V20, P323; Huang GZ, 2006, P NATL ACAD SCI USA, V103, P14302, DOI 10.1073/pnas.0604698103; Jagdale GB, 2006, J PARASITOL, V92, P509, DOI 10.1645/GE-651R1.1; Jex AR, 2011, NATURE, V479, P529, DOI 10.1038/nature10553; Jose AM, 2012, P NATL ACAD SCI USA, V109, P14520, DOI 10.1073/pnas.1201153109; Kikuchi T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002219; Kim JK, 2005, SCIENCE, V308, P1164, DOI 10.1126/science.1109267; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kiontke K, 2005, WORMBAOOK C ELEGANS; Kiontke KC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-339; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Lampe DJ, 1996, EMBO J, V15, P5470, DOI 10.1002/j.1460-2075.1996.tb00930.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lesa GM, 1997, MOL BIOL CELL, V8, P779, DOI 10.1091/mbc.8.5.779; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liu JA, 1999, J BIOL CHEM, V274, P5185, DOI 10.1074/jbc.274.8.5185; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Majoros WH, 2004, BIOINFORMATICS, V20, P2878, DOI 10.1093/bioinformatics/bth315; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; Maneesakorn P, 2011, MOL PHYLOGENET EVOL, V59, P271, DOI 10.1016/j.ympev.2011.02.012; McKerrow JH, 2006, ANNU REV PATHOL-MECH, V1, P497, DOI 10.1146/annurev.pathol.1.110304.100151; Mitreva M, 2011, NAT GENET, V43, P228, DOI 10.1038/ng.769; Mortazavi A, 2010, GENOME RES, V20, P1740, DOI 10.1101/gr.111021.110; Motola DL, 2006, CELL, V124, P1209, DOI 10.1016/j.cell.2006.01.037; Nawrocki EP, 2007, PLOS COMPUT BIOL, V3, P540, DOI 10.1371/journal.pcbi.0030056; Noguez JH, 2012, ACS CHEM BIOL, V7, P961, DOI 10.1021/cb300056q; Nuez I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029811; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; OLeary SA, 1997, FUND APPL NEMATOL, V20, P197; Opperman CH, 2008, P NATL ACAD SCI USA, V105, P14802, DOI 10.1073/pnas.0805946105; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; RAHIMI FR, 1993, J HERED, V84, P475, DOI 10.1093/oxfordjournals.jhered.a111374; Rawlings N.D., 2010, NUCLEIC ACIDS RES S1, V38, P227, DOI [10.1093/nar/gkp971, DOI 10.1093/NAR/GKP971]; Ruby EG, 2008, NAT REV MICROBIOL, V6, P752, DOI 10.1038/nrmicro1958; Sandhu SK, 2006, MOL BIOCHEM PARASIT, V145, P239, DOI 10.1016/j.molbiopara.2006.01.002; Schaedel ON, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001306; Schulenburg H, 2008, IMMUNOBIOLOGY, V213, P237, DOI 10.1016/j.imbio.2007.12.004; Segal D, 2000, CROP PROT, V19, P685, DOI 10.1016/S0261-2194(00)00091-0; Shapiro DI, 1997, FUND APPL NEMATOL, V20, P581; Simske JS, 1996, CELL, V85, P195, DOI 10.1016/S0092-8674(00)81096-X; Smit A, 1996, REPEATMASKER OPEN 30; Somvanshi VS, 2012, SCIENCE, V337, P88, DOI 10.1126/science.1216641; Somvanshi VS, 2010, MOL MICROBI IN PRESS; Song CZ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001239; Stanke M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-62; Stanke M, 2005, NUCLEIC ACIDS RES, V33, pW465, DOI 10.1093/nar/gki458; Stanke M, 2004, NUCLEIC ACIDS RES, V32, pW309, DOI 10.1093/nar/gkh379; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Varki A., 1999, ESSENTIALS GLYCOBIOL; Vought VE, 2005, GENETICS, V170, P1121, DOI 10.1534/genetics.105.042135; Webster John M., 2002, P99, DOI 10.1079/9780851995670.0099; Winston WM, 2007, P NATL ACAD SCI USA, V104, P10565, DOI 10.1073/pnas.0611282104; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3; Zhou XS, 2002, APPL ENVIRON MICROB, V68, P6202, DOI 10.1128/AEM.68.12.6202-6209.2002	132	74	76	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e69618	10.1371/journal.pone.0069618	http://dx.doi.org/10.1371/journal.pone.0069618			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874975	Green Published, gold, Green Accepted			2022-12-27	WOS:000324146200079
J	In, J; Lukyanenko, V; Foulke-Abel, J; Hubbard, AL; Delannoy, M; Hansen, AM; Kaper, JB; Boisen, N; Nataro, JP; Zhu, CR; Boedeker, EC; Giron, JA; Kovbasnjuk, O				In, Julie; Lukyanenko, Valeriy; Foulke-Abel, Jennifer; Hubbard, Ann L.; Delannoy, Michael; Hansen, Anne-Marie; Kaper, James B.; Boisen, Nadia; Nataro, James P.; Zhu, Chengru; Boedeker, Edgar C.; Giron, Jorge A.; Kovbasnjuk, Olga			Serine Protease EspP from Enterohemorrhagic Escherichia Coli Is Sufficient to Induce Shiga Toxin Macropinocytosis in Intestinal Epithelium	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; MYOSIN-II; TIR; CELLS; PEDESTAL; TRANSCYTOSIS; CORTACTIN; DIARRHEA; O157-H7; BINDING	Life-threatening intestinal and systemic effects of the Shiga toxins produced by enterohemorrhagic Escherichia coli (EHEC) require toxin uptake and transcytosis across intestinal epithelial cells. We have recently demonstrated that EHEC infection of intestinal epithelial cells stimulates toxin macropinocytosis, an actin-dependent endocytic pathway. Host actin rearrangement necessary for EHEC attachment to enterocytes is mediated by the type 3 secretion system which functions as a molecular syringe to translocate bacterial effector proteins directly into host cells. Actin-dependent EHEC attachment also requires the outer membrane protein intimin, a major EHEC adhesin. Here, we investigate the role of type 3 secretion in actin turnover occurring during toxin macropinocytosis. Toxin macropinocytosis is independent of EHEC type 3 secretion and intimin attachment. EHEC soluble factors are sufficient to stimulate macropinocytosis and deliver toxin into enterocytes in vitro and in vivo; intact bacteria are not required. Intimin-negative enteroaggregative Escherichia coli (EAEC) O104:H4 robustly stimulate Shiga toxin macropinocytosis into intestinal epithelial cells. The apical macropinosomes formed in intestinal epithelial cells move through the cells and release their cargo at these cells' basolateral sides. Further analysis of EHEC secreted proteins shows that a serine protease EspP alone is able to stimulate host actin remodeling and toxin macropinocytosis. The observation that soluble factors, possibly serine proteases including EspP, from each of two genetically distinct toxin-producing strains, can stimulate Shiga toxin macropinocytosis and transcellular transcytosis alters current ideas concerning mechanisms whereby Shiga toxin interacts with human enterocytes. Mechanisms important for this macropinocytic pathway could suggest new potential therapeutic targets for Shiga toxin-induced disease.	[In, Julie; Lukyanenko, Valeriy; Foulke-Abel, Jennifer; Kovbasnjuk, Olga] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Hubbard, Ann L.; Delannoy, Michael] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD USA; [Hansen, Anne-Marie; Kaper, James B.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Boisen, Nadia; Nataro, James P.] Univ Virginia, Sch Med, Dept Pediat, Charlottesville, VA 22908 USA; [Zhu, Chengru; Boedeker, Edgar C.] Univ New Mexico, Sch Med, Dept Med, Albuquerque, NM 87131 USA; [Giron, Jorge A.] Univ Florida, Emerging Pathogens Inst, Dept Mol Genet & Microbiol, Gainesville, FL USA	Johns Hopkins University; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; University of Virginia; University of New Mexico; State University System of Florida; University of Florida	Kovbasnjuk, O (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	okovbas1@jhmi.edu		Kaper, James/0000-0003-0715-2907; Lukyanenko, Valeriy/0000-0003-2462-4603	National Institutes of Health [RO1DK58928, T32DK2007632, R24DK064388]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK064388, T32DK007632, R01DK058928] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants RO1DK58928 (OK), T32DK2007632 (JI,VL and JF-A) and R24DK064388 (OK and AH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHESON DWK, 1993, MICROB PATHOGENESIS, V14, P57, DOI 10.1006/mpat.1993.1006; Boisen N, 2009, AM J TROP MED HYG, V80, P294, DOI 10.4269/ajtmh.2009.80.294; Buchholz U, 2011, NEW ENGL J MED, V365, P1763, DOI 10.1056/NEJMoa1106482; Byrd W, 2012, VET IMMUNOL IMMUNOP, V152; Campellone KG, 2006, CELL MICROBIOL, V8, P1488, DOI 10.1111/j.1462-5822.2006.00728.x; Campellone KG, 2010, FEBS J, V277, P2390, DOI 10.1111/j.1742-4658.2010.07653.x; Cantarelli VV, 2007, CELL MICROBIOL, V9, P1782, DOI 10.1111/j.1462-5822.2007.00913.x; Cantarelli VV, 2000, INFECT IMMUN, V68, P382, DOI 10.1128/IAI.68.1.382-386.2000; Cao H, 2007, J CELL SCI, V120, P4167, DOI 10.1242/jcs.010686; Cornick NA, 2002, J INFECT DIS, V186, P57, DOI 10.1086/341295; Croxen MA, 2010, NAT REV MICROBIOL, V8, P26, DOI 10.1038/nrmicro2265; de Vries E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001329; DeVinney R, 2001, MOL MICROBIOL, V41, P1445, DOI 10.1046/j.1365-2958.2001.02617.x; Etienne-Mesmin L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023594; Frankel G, 2008, CELL MICROBIOL, V10, P549, DOI 10.1111/j.1462-5822.2007.01103.x; Fuller CA, 2011, INFECT IMMUN, V79, P1329, DOI 10.1128/IAI.01182-10; Gallegos KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030368; Hardwidge PR, 2004, J BIOL CHEM, V279, P20127, DOI 10.1074/jbc.M401228200; Hermos CR, 2011, J CLIN MICROBIOL, V49, P955, DOI 10.1128/JCM.02119-10; HITOTSUBASHI S, 1992, INFECT IMMUN, V60, P4468, DOI 10.1128/IAI.60.11.4468-4474.1992; Johannes L, 2010, NAT REV MICROBIOL, V8, P105, DOI 10.1038/nrmicro2279; Kim Y, 2006, LETT APPL MICROBIOL, V43, P502, DOI 10.1111/j.1472-765X.2006.02005.x; Kitov PI, 2000, NATURE, V403, P669, DOI 10.1038/35001095; Kovbasnjuk O, 2005, P NATL ACAD SCI USA, V102, P19087, DOI 10.1073/pnas.0506474102; Lukyanenko V, 2011, AM J PHYSIOL-CELL PH, V301, pC1140, DOI 10.1152/ajpcell.00036.2011; Mallick EM, 2012, J CLIN INVEST, V122, P4012, DOI 10.1172/JCI62746; Maluykova R, 2008, BBA-MOL BASIS DIS, V1782, P370, DOI 10.1016/j.bbadis.2008.01.010; Malyukova I, 2009, AM J PHYSIOL-GASTR L, V296, pG78, DOI 10.1152/ajpgi.90347.2008; Masedunskas A, 2011, P NATL ACAD SCI USA, V108, P13552, DOI 10.1073/pnas.1016778108; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; McGannon CM, 2010, ANTIMICROB AGENTS CH, V54, P3790, DOI 10.1128/AAC.01783-09; Melton-Celsa A, 2012, CURR TOP MICROBIOL, V357, P67, DOI 10.1007/82_2011_176; Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510; Mousnier A, 2008, INFECT IMMUN, V76, P4669, DOI 10.1128/IAI.00140-08; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Nataro JP, 1996, INFECT IMMUN, V64, P4761, DOI 10.1128/IAI.64.11.4761-4768.1996; Navarro-Garcia F, 2010, TOXINS, V2, P1134, DOI 10.3390/toxins2051134; Nishikawa Y, 2000, J CLIN MICROBIOL, V38, P2440; Pacheco AR, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00081; Peterson JR, 2006, CHEM BIOL, V13, P443, DOI 10.1016/j.chembiol.2006.02.009; Ragnarsson EGE, 2008, LAB INVEST, V88, P1215, DOI 10.1038/labinvest.2008.86; Ritchie JM, 2003, INFECT IMMUN, V71, P7129, DOI 10.1128/IAI.71.12.7129-7139.2003; Schmidt MA, 2010, CELL MICROBIOL, V12, P1544, DOI 10.1111/j.1462-5822.2010.01518.x; Schuller S, 2004, CELL MICROBIOL, V6, P289, DOI 10.1046/j.1462-5822.2004.00370.x; Schuller S, 2007, MICROBES INFECT, V9, P35, DOI 10.1016/j.micinf.2006.10.005; Serna A, 2008, CURR OPIN GASTROEN, V24, P38, DOI 10.1097/MOG.0b013e3282f2dfb8; STEC WORKSHOP REPORTING GROUP, 2012, EURO SURVEILL, V17; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; SWANSON JA, 1995, TRENDS CELL BIOL, V5, P424, DOI 10.1016/S0962-8924(00)89101-1; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Trachtman H, 2003, JAMA-J AM MED ASSOC, V290, P1337, DOI 10.1001/jama.290.10.1337; Trachtman H, 2012, NAT REV NEPHROL, V8, P658, DOI 10.1038/nrneph.2012.196; Viswanathan VK, 2004, INFECT IMMUN, V72, P3218, DOI 10.1128/IAI.72.6.3218-3227.2004; Wilson CA, 2010, NATURE, V465, P373, DOI 10.1038/nature08994; Xicohtencatl-Cortes J, 2010, J BIOL CHEM, V285, P32336, DOI 10.1074/jbc.M110.162248	56	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e69196	10.1371/journal.pone.0069196	http://dx.doi.org/10.1371/journal.pone.0069196			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874912	gold, Green Published, Green Submitted			2022-12-27	WOS:000324146200066
J	Leray, A; Padilla-Parra, S; Roul, J; Heliot, L; Tramier, M				Leray, Aymeric; Padilla-Parra, Sergi; Roul, Julien; Heliot, Laurent; Tramier, Marc			827Spatio-Temporal Quantification of FRET in Living Cells by Fast Time-Domain FLIM: A Comparative Study of Non-Fitting Methods	PLOS ONE			English	Article							LIFETIME IMAGING MICROSCOPY; PROTEIN-PROTEIN INTERACTIONS; FLUORESCENCE-LIFETIME; SPATIAL-RESOLUTION; GLOBAL ANALYSIS; PHASOR APPROACH; REPRESENTATION; PHOTON; LOCALIZATION; PHAGOCYTOSIS	Forster Resonance Energy Transfer (FRET) measured with Fluorescence Lifetime Imaging Microscopy (FLIM) is a powerful technique to investigate spatio-temporal regulation of protein-protein interactions in living cells. When using standard fitting methods to analyze time domain FLIM, the correct estimation of the FRET parameters requires a high number of photons and therefore long acquisition times which are incompatible with the observation of dynamic protein-protein interactions. Recently, non-fitting strategies have been developed for the analysis of FLIM images: the polar plot or "phasor" and the minimal fraction of interacting donor mfD. We propose here a novel non-fitting strategy based on the calculation of moments. We then compare the performance of these three methods when shortening the acquisition time: either by reducing the number of counted photons N or the number of temporal channels N-ch, which is particularly adapted for the original fast-FLIM prototype presented in this work that employs the time gated approach. Based on theoretical calculations, Monte Carlo simulations and experimental data, we determine the domain of validity of each method. We thus demonstrate that the polar approach remains accurate for a large range of conditions (low N, N-ch or small fractions of interacting donor f(D)). The validity domain of the moments method is more restricted (not applicable when f(D)<0.25 or when N-ch = 4) but it is more precise than the polar approach. We also demonstrate that the mf(D) is robust in all conditions and it is the most precise strategy; although it does not strictly provide the fraction of interacting donor. We show using the fast-FLIM prototype (with an acquisition rate up to 1 Hz) that these non-fitting strategies are very powerful for on-line analysis on a standard computer and thus for quantifying automatically the spatio-temporal activation of Rac-GTPase in living cells by FRET.	[Leray, Aymeric; Heliot, Laurent] Univ Lille Nord France, CNRS, Inst Rech Interdisciplinaire, USR 3078, Villeneuve Dascq, France; [Padilla-Parra, Sergi; Roul, Julien; Tramier, Marc] Inst Genet & Dev Rennes, CNRS, UMR 6290, Rennes, France; [Padilla-Parra, Sergi; Roul, Julien; Tramier, Marc] Univ Rennes 1, Univ Europeenne Bretagne, SFR Biosit, Fac Med, Rennes, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Bretagne Occidentale; Universite de Rennes	Leray, A (corresponding author), Univ Lille Nord France, CNRS, Inst Rech Interdisciplinaire, USR 3078, Villeneuve Dascq, France.	aymeric.leray@iri.univ-lille1.fr	Padilla-Parra, Sergi/N-8725-2019; Padilla-Parra, Sergi/S-3017-2018	Padilla-Parra, Sergi/0000-0002-8010-9481; Tramier, Marc/0000-0001-8200-6446	CNRS; Nord-Pas de Calais Region Council; Bretagne Region Council; Rennes Metropole; European Regional Developmental Funds; Leica Microsystems partnership; national large loan "Equipex" ImagInEx Biomed; French Research Agency [ANR-2010-BLAN-1204-01]; CNRS national network: GDR2588; CNRS national network: RT-MFM;  [ANR-11-BSV5-0023]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Nord-Pas de Calais Region Council(Region Hauts-de-France); Bretagne Region Council(Region Bretagne); Rennes Metropole(Region Bretagne); European Regional Developmental Funds; Leica Microsystems partnership; national large loan "Equipex" ImagInEx Biomed; French Research Agency(French National Research Agency (ANR)); CNRS national network: GDR2588; CNRS national network: RT-MFM; 	This work was funded by the CNRS, the Nord-Pas de Calais Region Council (BCF team), the Bretagne Region Council (MFQ team), Rennes Metropole (MFQ team), the European Regional Developmental Funds (BCF team), a Leica Microsystems partnership (BCF team), the national large loan "Equipex" ImagInEx Biomed and the French Research Agency ANR-2010-BLAN-1204-01 (BCF team). SP-P and JR fellowships were supported by an ANR-11-BSV5-0023 grant (MFQ team). The BCF and MFQ teams were supported by two CNRS national networks: GDR2588 and RT-MFM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker W, 2004, MICROSC RES TECHNIQ, V63, P58, DOI 10.1002/jemt.10421; Buranachai C, 2008, J FLUORESC, V18, P929, DOI 10.1007/s10895-008-0332-3; Clayton AHA, 2004, J MICROSC-OXFORD, V213, P1, DOI 10.1111/j.1365-2818.2004.01265.x; Davis P. J., 1984, METHODS NUMERICAL IN; Digman MA, 2008, BIOPHYS J, V94, pL14, DOI 10.1529/biophysj.107.120154; Domingo B, 2007, MICROSC RES TECHNIQ, V70, P1010, DOI 10.1002/jemt.20509; Elangovan M, 2003, METHODS, V29, P58, DOI 10.1016/S1046-2023(02)00283-9; Fereidouni F, 2011, J MICROSC-OXFORD, V244, P248, DOI 10.1111/j.1365-2818.2011.03533.x; Fujiwara M, 2006, METHOD ENZYMOL, V414, P633, DOI 10.1016/S0076-6879(06)14033-1; GADELLA TWJ, 1993, BIOPHYS CHEM, V48, P221, DOI 10.1016/0301-4622(93)85012-7; Grecco HE, 2009, OPT EXPRESS, V17, P6493, DOI 10.1364/OE.17.006493; Hoppe AD, 2004, MOL BIOL CELL, V15, P3509, DOI 10.1091/mbc.E03-11-0847; Hoppe AD, 2012, METHODS MOL BIOL, V827, P235, DOI 10.1007/978-1-61779-442-1_16; ISENBERG I, 1969, BIOPHYS J, V9, P1337, DOI 10.1016/S0006-3495(69)86456-8; JAMESON DM, 1984, APPL SPECTROSC REV, V20, P55, DOI 10.1080/05704928408081716; KOLLNER M, 1992, CHEM PHYS LETT, V200, P199, DOI 10.1016/0009-2614(92)87068-Z; Krishnan RV, 2003, J BIOMED OPT, V8, P362, DOI 10.1117/1.1577574; Lakowicsz JR, 1999, PRINCIPLES FLUORESCE; Leray A, 2011, CYTOM PART A, V79A, P149, DOI 10.1002/cyto.a.20996; Leray A, 2009, CYTOM PART A, V75A, P1007, DOI 10.1002/cyto.a.20802; Leray A, 2012, J MICROSC; Leray A, 2009, MICROSC RES TECHNIQ, V72, P371, DOI 10.1002/jemt.20665; Oliveira AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052874; Padilla-Parra S, 2011, IMAGING LAB MANUAL; Padilla-Parra S, 2008, BIOPHYS J, V95, P2976, DOI 10.1529/biophysj.108.131276; Padilla-Parra Sergi, 2011, Biophys Rev, V3, P63, DOI 10.1007/s12551-011-0047-6; Padilla-Parra S, 2012, BIOESSAYS, V34, P369, DOI 10.1002/bies.201100086; Padilla-Parra S, 2009, BIOPHYS J, V97, P2368, DOI 10.1016/j.bpj.2009.07.044; Peter M, 2005, BIOPHYS J, V88, P1224, DOI 10.1529/biophysj.104.050153; Philip J, 2003, J OPT SOC AM A, V20, P368, DOI 10.1364/JOSAA.20.000368; Redford GI, 2005, J FLUORESC, V15, P805, DOI 10.1007/s10895-005-2990-8; Sipieter F, 2013, PROG MOL BIOL TRANSL, V113, P145, DOI 10.1016/B978-0-12-386932-6.00005-3; Spriet C, 2008, CYTOM PART A, V73A, P745, DOI 10.1002/cyto.a.20581; Suhling K, 2005, PHOTOCH PHOTOBIO SCI, V4, P13, DOI 10.1039/b412924p; Tramier M, 2002, BIOPHYS J, V83, P3570, DOI 10.1016/S0006-3495(02)75357-5; Trinel D, 2011, CYTOM PART A, V79A, P528, DOI 10.1002/cyto.a.21054; Verveer PJ, 2000, BIOPHYS J, V78, P2127, DOI 10.1016/S0006-3495(00)76759-2; Waharte F, 2006, CYTOM PART A, V69A, P299, DOI 10.1002/cyto.a.20240; Yadav RB, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-3; Yamada H, 2009, J BIOL CHEM, V284, P34244, DOI 10.1074/jbc.M109.064204; Zeug A, 2012, BIOPHYS J, V103, P1821, DOI 10.1016/j.bpj.2012.09.031	41	40	40	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e69335	10.1371/journal.pone.0069335	http://dx.doi.org/10.1371/journal.pone.0069335			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874948	gold, Green Published			2022-12-27	WOS:000324146200073
J	Mao, XW; Wang, TT; Liu, YA; Irwin, MG; Ou, JS; Liao, XL; Gao, X; Xu, Y; Ng, KFJ; Vanhoutte, PM; Xia, ZY				Mao, Xiaowen; Wang, Tingting; Liu, Yanan; Irwin, Michael G.; Ou, Jing-song; Liao, Xiao-long; Gao, Xia; Xu, Yuan; Ng, Kwok F. J.; Vanhoutte, Paul M.; Xia, Zhengyuan			N-Acetylcysteine and Allopurinol Confer Synergy in Attenuating Myocardial Ischemia Injury via Restoring HIF-1 alpha/HO-1 Signaling in Diabetic Rats	PLOS ONE			English	Article							ISCHEMIC/REPERFUSED MOUSE MYOCARDIUM; HYPOXIA-INDUCIBLE FACTOR-1; HEME OXYGENASE-1; REPERFUSION INJURY; OXIDATIVE STRESS; INFARCT SIZE; XANTHINE-OXIDASE; NADPH OXIDASE; VENTRICULAR-FIBRILLATION; INFLAMMATORY MARKERS	Objectives: To determine whether or not the antioxidants N-acetylcysteine (NAC) and allopurinol (ALP) confer synergistic cardioprotection against myocardial ischemia/reperfusion (MI/R) injury by stabilizing hypoxia inducible factor 1 alpha (HIF-1 alpha)/heme oxygenase 1 (HO-1) signaling in diabetic myocardium. Methods: Control or diabetic [streptozotocin (STZ)-induced] Sprague Dawley rats received vehicle or NAC, ALP or their combination for four weeks starting one week after STZ injection. The animals were then subjected to thirty minutes of coronary artery occlusion followed by two hours reperfusion in the absence or presence of the selective HO-1 inhibitor, tin protoporphyrin-IX (SnPP-IX) or the HIF-1 alpha inhibitor 2-Methoxyestradiol (2ME2). Cardiomyocytes exposed to high glucose were subjected to hypoxia/re-oxygenation in the presence or absence of HIF-1 alpha and HO-1 achieved by gene knock-down with related siRNAs. Results: Myocardial and plasma levels of 15-F2t-isoprostane, an index of oxidative stress, were significantly increased in diabetic rats while cardiac HO-1 protein and activity were reduced; this was accompanied with reduced cardiac protein levels of HIF-1 alpha, and increased post-ischemic myocardial infarct size and cellular injury. NAC and ALP given alone and in particular their combination normalized cardiac levels of HO-1 and HIF-1 alpha protein expression and prevented the increase in 15-F2t-isoprostane, resulting in significantly attenuated post-ischemic myocardial infarction. NAC and ALP also attenuated high glucose-induced post-hypoxic cardiomyocyte death in vitro. However, all the above protective effects of NAC and ALP were cancelled either by inhibition of HO-1 or HIF-1 alpha with SnPP-IX and 2ME2 in vivo or by HO-1 or HIF-1 alpha gene knock-down in vitro. Conclusion: NAC and ALP confer synergistic cardioprotection in diabetes via restoration of cardiac HIF-1 alpha and HO-1 signaling.	[Mao, Xiaowen; Wang, Tingting; Liu, Yanan; Irwin, Michael G.; Ng, Kwok F. J.; Xia, Zhengyuan] Univ Hong Kong, Dept Anaesthesiol, Hong Kong, Hong Kong, Peoples R China; [Ou, Jing-song; Liao, Xiao-long; Ng, Kwok F. J.] Sun Yat Sen Univ, Affiliated Hosp 1, Div Cardiac Surg, Guangzhou 510275, Guangdong, Peoples R China; [Gao, Xia; Xu, Yuan] Capital Med Univ, Beijing Chaoyang Hosp, Dept Endocrinol, Beijing, Peoples R China; [Vanhoutte, Paul M.] Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China; [Xia, Zhengyuan] Univ Hong Kong, Shenzhen Inst Res & Innovat, Shenzhen, Peoples R China	University of Hong Kong; Sun Yat Sen University; Capital Medical University; University of Hong Kong; University of Hong Kong	Xia, ZY (corresponding author), Univ Hong Kong, Dept Anaesthesiol, Hong Kong, Hong Kong, Peoples R China.	zyxia@hku.hk	wang, tingting/AAK-2640-2020; Irwin, Michael Garnet/C-4286-2009; Irwin, Michael Garnet/GLR-9714-2022	Irwin, Michael Garnet/0000-0001-5801-274X; Irwin, Michael Garnet/0000-0001-5801-274X	Research Grants Council (RGC) of Hong Kong GRF grants [781109M, 766709M, 784011M]; University of Hong Kong Seed Funding Programme for Basic Research [201211159015]	Research Grants Council (RGC) of Hong Kong GRF grants; University of Hong Kong Seed Funding Programme for Basic Research(University of Hong Kong)	This work was supported by Research Grants Council (RGC) of Hong Kong GRF grants (781109M, 766709M, 784011M) and a University of Hong Kong Seed Funding Programme for Basic Research (201211159015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alserius T, 2006, AM HEART J, V152, P599, DOI 10.1016/j.ahj.2006.02.010; Bak I, 2003, FASEB J, V17, P2133, DOI 10.1096/fj.03-0032fje; Bak I, 2002, FREE RADICAL BIO MED, V33, P639, DOI 10.1016/S0891-5849(02)00913-9; Bak I, 2010, J CELL MOL MED; Bao WK, 2010, J CARDIOVASC PHARM, V56, P147, DOI 10.1097/FJC.0b013e3181e2bfef; Bento CF, 2011, DIABETOLOGIA, V54, P1946, DOI 10.1007/s00125-011-2191-8; Boueiz A, 2008, AM J PHYSIOL-LUNG C, V294, pL830, DOI 10.1152/ajplung.00007.2008; Buja LM, 2005, CARDIOVASC PATHOL, V14, P170, DOI 10.1016/j.carpath.2005.03.006; Cai ZQ, 2003, CIRCULATION, V108, P79, DOI 10.1161/01.CIR.0000078635.89229.8A; Calafiore AM, 2003, J THORAC CARDIOV SUR, V125, P144, DOI 10.1067/mtc.2003.73; Christenson RH, 2000, AM J CARDIOL, V85, P543, DOI 10.1016/S0002-9149(99)00808-5; Dai Y, 2007, J MOL CELL CARDIOL, V42, P1036, DOI 10.1016/j.yjmcc.2007.04.001; Damnicki-Abegg M, 2007, J CARDIOVASC PHARM, V50, P670, DOI 10.1097/FJC.0b013e318157fd5b; Desco MC, 2002, DIABETES, V51, P1118, DOI 10.2337/diabetes.51.4.1118; Dhiman M, 2011, J PATHOL, V225, P583, DOI 10.1002/path.2975; Di Filippo C, 2005, DIABETES, V54, P803; Duda M, 2007, J MOL CELL CARDIOL, V42, P400, DOI 10.1016/j.yjmcc.2006.10.014; Fan QA, 2011, CLIN SCI, V120, P251, DOI 10.1042/CS20100369; FERRARI R, 1990, CIRCULATION, V81, P201, DOI 10.1161/01.CIR.81.1.201; Fiordaliso F, 2004, J MOL CELL CARDIOL, V37, P959, DOI 10.1016/j.yjmcc.2004.07.008; Guo ZX, 2007, AM J PHYSIOL-HEART C, V292, pH1728, DOI 10.1152/ajpheart.01328.2005; Hangaishi M, 2000, BIOCHEM BIOPH RES CO, V279, P582, DOI 10.1006/bbrc.2000.3973; Huang Zhi-yong, 2004, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V16, P165; Huang ZY, 2011, CLIN SCI, V121, P57, DOI 10.1042/CS20100435; Juhasz B, 2011, J CELL MOL MED, V15, P1973, DOI 10.1111/j.1582-4934.2010.01153.x; Kaga S, 2005, J MOL CELL CARDIOL, V39, P813, DOI 10.1016/j.yjmcc.2005.08.003; KARWINSKI W, 1994, RES EXP MED, V194, P321, DOI 10.1007/BF02576394; Kumar S, 2009, LIFE SCI, V84, P328, DOI 10.1016/j.lfs.2008.12.016; Kusmic C, 2004, J CARDIOVASC PHARM, V44, P356, DOI 10.1097/01.fjc.0000137164.99487.42; Laderoute KR, 2005, SEMIN CELL DEV BIOL, V16, P502, DOI 10.1016/j.semcdb.2005.03.005; Lei S, 2013, DIABETES; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Liu YN, 2012, CLIN SCI, V122, P161, DOI 10.1042/CS20110176; Marfella R, 2004, DIABETES, V53, P2383, DOI 10.2337/diabetes.53.9.2383; Marfella R, 2002, DIABETOLOGIA, V45, P1172, DOI 10.1007/s00125-002-0882-x; Maxwell PH, 2005, EXP PHYSIOL, V90, P791, DOI 10.1113/expphysiol.2005.030924; Nie RQ, 2007, CAN J PHYSIOL PHARM, V85, P1012, DOI 10.1139/Y07-092; Ockaili R, 2005, AM J PHYSIOL-HEART C, V289, pH542, DOI 10.1152/ajpheart.00089.2005; Oliveira Paulo J., 2005, Current Vascular Pharmacology, V3, P147, DOI 10.2174/1570161053586903; Otterbein LE, 2000, AM J PHYSIOL-LUNG C, V279, pL1029, DOI 10.1152/ajplung.2000.279.6.L1029; Rajesh M, 2009, J CELL MOL MED, V13, P2330, DOI 10.1111/j.1582-4934.2008.00564.x; Redel A, 2008, EXP BIOL MED, V233, P84, DOI 10.3181/0612-RM-308; Rolo AP, 2006, TOXICOL APPL PHARM, V212, P167, DOI 10.1016/j.taap.2006.01.003; Sadi G, 2009, MOL CELL BIOCHEM, V327, P127, DOI 10.1007/s11010-009-0050-4; Semenza GL, 2011, BBA-MOL CELL RES, V1813, P1263, DOI 10.1016/j.bbamcr.2010.08.006; Sloan RC, 2012, J MOL CELL CARDIOL, V52, P1009, DOI 10.1016/j.yjmcc.2012.02.009; Takahashi T, 2006, DRUG DEVELOP RES, V67, P130, DOI 10.1002/ddr.20073; Tosaki A, 1996, DIABETOLOGIA, V39, P1255, DOI 10.1007/s001250050567; Tsai GY, 2009, CLIN EXP OPHTHALMOL, V37, P223, DOI 10.1111/j.1442-9071.2009.02000.x; Turer AT, 2005, CURR CONTR TRIALS C, V6, DOI 10.1186/1468-6708-6-12; Wang BH, 2006, CAN J PHYSIOL PHARM, V84, P935, DOI 10.1139/Y06-043; Wang TT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023967; Xia ZY, 2004, CAN J PHYSIOL PHARM, V82, P919, DOI 10.1139/Y04-097; Xia ZY, 2005, AM J PHYSIOL-HEART C, V289, pH1366, DOI 10.1152/ajpheart.00042.2005; Xiao J, 2009, EUR J HEART FAIL, V11, P20, DOI 10.1093/eurjhf/hfn003; Xin XY, 2011, CAN J NEUROL SCI, V38, P631, DOI 10.1017/S031716710001218X; Xu B, 2011, J SURG RES, V166, pE157, DOI 10.1016/j.jss.2010.11.902; Xue WL, 2012, AM J PHYSIOL-HEART C, V302, pH2528, DOI 10.1152/ajpheart.00850.2011; Zhou DC, 2008, NEUROL RES, V30, P268, DOI 10.1179/016164107X229920	60	45	49	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e68949	10.1371/journal.pone.0068949	http://dx.doi.org/10.1371/journal.pone.0068949			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874823	Green Published, gold, Green Submitted			2022-12-27	WOS:000324146200044
J	Donaldson, L; Asbridge, M; Cusimano, MD				Donaldson, Laura; Asbridge, Mark; Cusimano, Michael D.			Bodychecking Rules and Concussion in Elite Hockey	PLOS ONE			English	Article							ICE HOCKEY; INJURY SURVEILLANCE; BRAIN-INJURY; PLAYERS; NHL; NEWSPAPERS; VIOLENCE; SPORTS; LEAGUE	Athletes participating in contact sports such as ice hockey are exposed to a high risk of suffering a concussion. We determined whether recent rule changes regulating contact to the head introduced in 2010-11 and 2011-12 have been effective in reducing the incidence of concussion in the National Hockey League (NHL). A league with a longstanding ban on hits contacting the head, the Ontario Hockey League (OHL), was also studied. A retrospective study of NHL and OHL games for the 2009-10 to 2011-12 seasons was performed using official game records and team injury reports in addition to other media sources. Concussion incidence over the 3 seasons analyzed was 5.23 per 100 NHL regular season games and 5.05 per 100 OHL regular season games (IRR 1.04; 95% CI 1.01, 1.50). When injuries described as concussion-like or suspicious of concussion were included, incidences rose to 8.8 and 7.1 per 100 games respectively (IRR 1.23; 95% CI 0.81, 1.32). The number of NHL concussions or suspected concussions was lower in 2009-10 than in 2010-11 (IRR 0.61; 95% CI 0.45, 0.83), but did not increase from 2010-11 to 2011-12 (IRR 1.05; 95% CI 0.80, 1.38). 64.2% of NHL concussions were caused by bodychecking, and only 28.4% of concussions and 36.8% of suspected concussions were caused by illegal incidents. We conclude that rules regulating bodychecking to the head did not reduce the number of players suffering concussions during NHL regular season play and that further changes or stricter enforcement of existing rules may be required to minimize the risk of players suffering these injuries.	[Donaldson, Laura; Cusimano, Michael D.] Univ Toronto, St Michaels Hosp, Div Neurosurg, Toronto, ON, Canada; [Donaldson, Laura; Cusimano, Michael D.] Univ Toronto, St Michaels Hosp, Injury Prevent Res Off, Toronto, ON, Canada; [Donaldson, Laura; Cusimano, Michael D.] Univ Toronto, St Michaels Hosp, Canadian Brain Injury & Violence Res Team, Toronto, ON, Canada; [Asbridge, Mark] Dalhousie Univ, Dept Community Hlth & Epidemiol, Clin Res Ctr, Halifax, NS, Canada; [Asbridge, Mark] Dalhousie Univ, Dept Emergency Med, Clin Res Ctr, Halifax, NS, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Dalhousie University; Dalhousie University	Cusimano, MD (corresponding author), Univ Toronto, St Michaels Hosp, Div Neurosurg, Toronto, ON, Canada.	injuryprevention@smh.ca	Cusimano, Michael/GWR-1025-2022; Cusimano, Michael/X-4059-2019	Cusimano, Michael/0000-0002-9989-0650	Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research [TIR-103946]; Ontario Neurotrauma Foundation; University of Toronto Faculty of Medicine CREMS	Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research(Canadian Institutes of Health Research (CIHR)); Ontario Neurotrauma Foundation; University of Toronto Faculty of Medicine CREMS	This research was supported by the Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research # TIR-103946, the Ontario Neurotrauma Foundation, as well as University of Toronto Faculty of Medicine CREMS funding to LD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, HOCKEY NEWS; Barss P, 2009, J SCI MED SPORT, V12, P164, DOI 10.1016/j.jsams.2007.08.016; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Cantu R., 2009, J ATHL TRAINING, V44, P434, DOI [DOI 10.4085/1062-6050-44.4.434, 10.4085/1062-6050-44.4.434]; Cusimano Michael D, 2011, Open Med, V5, pe57; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Drakos MC, 2010, SPORTS HEALTH, V2, P284, DOI 10.1177/1941738109357303; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Hagel BE, 2006, CAN MED ASSOC J, V175, P155, DOI 10.1503/cmaj.051531; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Honey CR, 1998, CLIN J SPORT MED, V8, P43, DOI 10.1097/00042752-199801000-00010; JONES JCH, 1993, AM J ECON SOCIOL, V52, P63, DOI 10.1111/j.1536-7150.1993.tb02742.x; Kennan HT, 1999, ARCH SURG-CHICAGO, V134, P14, DOI 10.1001/archsurg.134.1.14; Levy ML, 2004, NEUROSURGERY, V55, P656, DOI 10.1227/01.NEU.0000134599.01917.AA; McCrory PR, 2003, BRIT MED J, V327, P351, DOI 10.1136/bmj.327.7411.351; NHL concussions put player insurance in question, 2012, CBC SPORTS; Orchard J., 2001, INT SPORT MED J, V2, P1; Pappachan B, 2006, J ORAL MAXIL SURG, V64, P1023, DOI 10.1016/j.joms.2006.03.021; Paul RJ, 2003, AM J ECON SOCIOL, V62, P345, DOI 10.1111/1536-7150.t01-2-00003; Powell JW, 1998, SAFETY ICE HOCKEY, P19; RAINEY DY, 1992, AM J PUBLIC HEALTH, V82, P745, DOI 10.2105/AJPH.82.5.745; Smith AM, 2011, PM&R, V3, P605, DOI 10.1016/j.pmrj.2011.05.013; [Social Scienced and Humanities Research Council of Canada Natural Sciences and Engineering Research Council of Canada Canadian Institutes of Health Research], 2014, TRIC POL STAT ETH CO; The National Hockey League, 2011, NAT HOCK LEAG OFF RU; The National Hockey League, 2010, NAT HOCK LEAG OFF RU; The Ontario Hockey League, 2011, ONT HOCK LEAG OFF RU; Wennberg RA, 2008, CAN J NEUROL SCI, V35, P647, DOI 10.1017/S031716710000946X	28	40	40	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e69122	10.1371/journal.pone.0069122	http://dx.doi.org/10.1371/journal.pone.0069122			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	185WH	23874888	Green Published, gold, Green Submitted			2022-12-27	WOS:000322000600041
J	Breikaa, RM; Algandaby, MM; El-Demerdash, E; Abdel-Naim, AB				Breikaa, Randa M.; Algandaby, Mardi M.; El-Demerdash, Ebtehal; Abdel-Naim, Ashraf B.			Multimechanistic Antifibrotic Effect of Biochanin A in Rats: Implications of Proinflammatory and Profibrogenic Mediators	PLOS ONE			English	Article							NF-KAPPA-B; CARBON-TETRACHLORIDE; OXIDATIVE STRESS; LIVER-DISEASES; FREE-RADICALS; NITRIC-OXIDE; FLAVONOIDS; FIBROSIS; ACTIVATION; INDUCTION	Objective: Biochanin A (BCA) is an isoflavone found in red clover and peanuts. Recently, it drew much attention as a promising anticancer and antioxidant. Due to its diversity in pharmacological actions, we were encouraged to investigate its potential as an antifibrotic, elucidating the different molecular mechanisms involved. Design: Rats were pretreated with BCA, then injected with carbon tetrachloride (CCl4) for 6 weeks. Changes in liver weight and histology were examined and levels of aspartate and alanine aminotransferases, cholesterol, triglycerides, alkaline phosphatase and total bilirubin measured. To assess hepatic efficiency, indocyanine green was injected and its clearance calculated and albumin, total proteins and insulin-like growth factor-1 expression were measured. Cytochrome P4502E1 activity, cytochrome P4501A1 expression, in addition to sulfotransferase1A1 expression were determined to deduce the effect of BCA on hepatic metabolism. As oxidative stress markers, lipid peroxides levels, reduced glutathione, superoxide dismutase and catalase activities, as well as the total antioxidant capacity, were assessed. Nitric oxide, inducible nitric oxide synthase and cyclooxygenase-2 were used as indicators of the inflammatory response. Signaling pathways involving tumor necrosis factor-alpha, nuclear factor-kappa B, transforming growth factor-beta1, matrix metalloproteinase-9 and alpha-smooth muscle actin were investigated accordingly. Extent of fibrosis was examined by Masson's stain and measuring hydroxyproline levels. Results: BCA pretreatment significantly protected against the chronic damage of CCl4. Liver injury, oxidative stress, inflammation and fibrosis markers decreased, while hepatic efficiency improved. Conclusion: Our findings suggested that BCA administration protects against fibrotic complications, a property that can be contributed to the multimechanistic approach of the drug.	[Breikaa, Randa M.; El-Demerdash, Ebtehal; Abdel-Naim, Ashraf B.] Ain Shams Univ, Dept Pharmacol & Toxicol, Fac Pharm, Cairo, Egypt; [Algandaby, Mardi M.] King Abdulaziz Univ, Fac Sci, Dept Biol Bot, Jeddah, Saudi Arabia	Egyptian Knowledge Bank (EKB); Ain Shams University; King Abdulaziz University	Breikaa, RM (corresponding author), Ain Shams Univ, Dept Pharmacol & Toxicol, Fac Pharm, Cairo, Egypt.	randabreikaa@yahoo.com	El-Demerdash, Ebtehal/ABE-6729-2020; Abdel-Naim, Ashraf B/J-3199-2012; Algandaby, Mardi/M-9861-2015	Abdel-Naim, Ashraf B/0000-0002-0400-9075; 				Badria FA, 2005, Z NATURFORSCH C, V60, P139; Bandy B, 2001, J BIOENERG BIOMEMBR, V33, P269, DOI 10.1023/A:1010641422120; Belotti D, 2003, CANCER RES, V63, P5224; Boll M, 2001, Z NATURFORSCH C, V56, P283; Breikaa RM, 2013, BIOSCI BIOTECH BIOCH, V77, P909, DOI 10.1271/bbb.120675; Castello L, 2010, FREE RADICAL BIO MED, V48, P47, DOI 10.1016/j.freeradbiomed.2009.10.003; Chan WH, 2009, TOXICOL LETT, V190, P150, DOI 10.1016/j.toxlet.2009.07.005; Chang Thomas K H, 2006, Methods Mol Biol, V320, P127; Chen Y, 2010, J BIOCHEM MOL TOXIC, V24, P102, DOI 10.1002/jbt.20318; Dhiman Anju, 2012, Zhong Xi Yi Jie He Xue Bao, V10, P117, DOI 10.3736/jcim20120201; Dutta SK, 2008, ENVIRON TOXICOL PHAR, V25, P218, DOI 10.1016/j.etap.2007.10.018; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fang YZ, 2002, NUTRITION, V18, P872, DOI 10.1016/S0899-9007(02)00916-4; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Ghiselli A, 2000, FREE RADICAL BIO MED, V29, P1106, DOI 10.1016/S0891-5849(00)00394-4; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; Han YP, 2001, J BIOL CHEM, V276, P22341, DOI 10.1074/jbc.M010839200; Harini R, 2012, EUR J PHARMACOL, V676, P89, DOI 10.1016/j.ejphar.2011.11.051; Hsieh CB, 2004, WORLD J GASTROENTERO, V10, P2394; Hu KQ, 2003, PROSTAG LEUKOTR ESS, V69, P329, DOI 10.1016/j.plefa.2003.07.001; Jaeschke H, 2002, TOXICOL SCI, V65, P166, DOI 10.1093/toxsci/65.2.166; Jordan SA, 2010, TOXICOL APPL PHARM, V243, P198, DOI 10.1016/j.taap.2009.12.005; Kole L, 2011, EUR J PHARMACOL, V653, P8, DOI 10.1016/j.ejphar.2010.11.026; Leung TM, 2011, HISTOL HISTOPATHOL, V26, P201, DOI 10.14670/HH-26.201; Liu YQ, 2011, J HEPATOL, V55, P612, DOI 10.1016/j.jhep.2010.11.035; Manibusan MK, 2007, J ENVIRON SCI HEAL C, V25, P185, DOI 10.1080/10590500701569398; Middleton E, 2000, PHARMACOL REV, V52, P673; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Mishra P, 2008, MOL CELL BIOCHEM, V312, P1, DOI 10.1007/s11010-008-9714-8; Moon YJ, 2006, TOXICOL IN VITRO, V20, P187, DOI 10.1016/j.tiv.2005.06.048; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Muriel P, 2009, J APPL TOXICOL, V29, P91, DOI 10.1002/jat.1393; Okamoto K, 2005, J GASTROEN HEPATOL, V20, P1102, DOI 10.1111/j.1440-1746.2005.03860.x; Palanisamy N, 2011, EUR J PHARMACOL, V667, P355, DOI 10.1016/j.ejphar.2011.06.011; Parola M, 2008, MOL ASPECTS MED, V29, P58, DOI 10.1016/j.mam.2007.09.002; Poli Giuseppe, 2000, Molecular Aspects of Medicine, V21, P49, DOI 10.1016/S0098-2997(00)00004-2; Racanelli V, 2006, HEPATOLOGY, V43, pS54, DOI 10.1002/hep.21060; Reddy GK, 1996, CLIN BIOCHEM, V29, P225, DOI 10.1016/0009-9120(96)00003-6; Starkel P, 2011, BEST PRACT RES CL GA, V25, P319, DOI 10.1016/j.bpg.2011.02.004; Sunami Y, 2012, J HEPATOL, V56, pS160, DOI 10.1016/S0168-8278(12)60412-7; Suzuki M, 2003, HEPATOLOGY, V38, p421A; Tatiya AU, 2012, PHARMACOGN RES, V4, P50, DOI 10.4103/0974-8490.91040; Teraoka R, 2012, BIOL PHARM BULL, V35, P171, DOI 10.1248/bpb.35.171; Theret N, 1999, HEPATOLOGY, V30, P462, DOI 10.1002/hep.510300236; Tralhao JG, 2012, HEPATO-GASTROENTEROL, V59, P1179, DOI 10.5754/hge09726; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; Vassiliadis E, 2011, BIOMARK INSIGHTS, V6, P49, DOI 10.4137/BMI.S6347; Veidal SS, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-22; Williams RJ, 2004, FREE RADICAL BIO MED, V36, P838, DOI 10.1016/j.freeradbiomed.2004.01.001; Zhu W, 2000, FREE RADICAL BIO MED, V29, P870, DOI 10.1016/S0891-5849(00)00396-8; Zimiani K, 2005, NITRIC OXIDE-BIOL CH, V13, P196, DOI 10.1016/j.niox.2005.07.002	51	26	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e69276	10.1371/journal.pone.0069276	http://dx.doi.org/10.1371/journal.pone.0069276			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874933	Green Published, Green Submitted, gold			2022-12-27	WOS:000322064300095
J	Lu, Q; Feng, J; Jiang, YR				Lu, Qiang; Feng, Jing; Jiang, Yan-rong			The Role of Apelin in the Retina of Diabetic Rats	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; APJ RECEPTOR; CELL-PROLIFERATION; ENDOGENOUS LIGAND; ANGIOGENIC FACTOR; EXPRESSION; RETINOPATHY; PEPTIDE; MICE; VITREORETINOPATHY	Purpose: Apelin is a novel adipocytokine participating in diabetes, but its role in diabetic retinopathy (DR) is unknown. Our study aimed to investigate the effect of apelin on the proliferative potential in DR along with its antagonist inhibitory effects. Principal Findings: Strong staining of apelin, co-localized with glial fibrillary acidic protein (GFAP) and vascular endothelial growth factor (VEGF) was observed in the retina of diabetic rats. Apelin, GFAP, and VEGF mRNA and protein levels were significantly increased in the sample's retinas. Moreover, exogenous apelin promoted retinal Muller cell proliferation in vivo. Simultaneously, apelin induced GFAP and VEGF expression. F13A markedly reduced retinal gliosis caused by diabetes. Furthermore, F13A suppressed both GFAP and VEGF expression in vivo. Significance: Our results strongly suggest that apelin is associated with the development of DR and contributes to changes in the retinas of diabetic rats. Apelin induced promotion of cell proliferation lends support to the possibility that apelin may play a role in the progression of DR to a proliferative phase. This possible role deserves further investigation, which may offer new perspectives in the early prevention and treatment of DR.	[Lu, Qiang; Feng, Jing; Jiang, Yan-rong] Peking Univ, Peoples Hosp, Dept Ophthalmol, Beijing 100871, Peoples R China; [Lu, Qiang; Feng, Jing; Jiang, Yan-rong] Minist Educ, Key Lab Vis Loss & Restorat, Beijing, Peoples R China	Peking University	Jiang, YR (corresponding author), Peking Univ, Peoples Hosp, Dept Ophthalmol, Beijing 100871, Peoples R China.	drjyr@vip.sina.com		Feng, Jing/0000-0002-7658-9865	Research Fund for the Doctoral Program of Higher Education of China [20100001110073, 20110001110042]; National Natural Science Foundation of China [81271027]; EFSD/CDS/Lilly grant	Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); EFSD/CDS/Lilly grant	This work was supported by the Research Fund for the Doctoral Program of Higher Education of China (No. 20100001110073, http://www.cutech.edu.cn/cn/rootfiles/2010/11/17/1287986534647690-1287986534649127.xls; No. 20110001110042, http://www.cutech.edu.cn/cn/rootfiles/2011/12/05/1322550574368276-1322550574468608.xls); National Natural Science Foundation of China (No. 81271027, http://159.226.244.14/portal/Proj_List.asp) and an EFSD/CDS/Lilly grant (http://www.europeandiabetesfoundation.org/Lilly/EFSD-CDS-Lilly-Recipients.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Barber AJ, 2000, INVEST OPHTH VIS SCI, V41, P3561; Boucher J, 2005, ENDOCRINOLOGY, V146, P1764, DOI 10.1210/en.2004-1427; Castan-Laurell I, 2005, MOL CELL ENDOCRINOL, V245, P7, DOI 10.1016/j.mce.2005.09.012; Cox CM, 2006, DEV BIOL, V296, P177, DOI 10.1016/j.ydbio.2006.04.452; Daviaud D, 2006, FASEB J, V20, P1528, DOI 10.1096/fj.05-5243fje; De Falco M, 2004, J MOL HISTOL, V35, P521; Eyries M, 2008, CIRC RES, V103, P432, DOI 10.1161/CIRCRESAHA.108.179333; Goralski KB, 2007, CAN J PHYSIOL PHARM, V85, P113, DOI 10.1139/Y06-092; Gupta N, 2003, EXP EYE RES, V76, P463, DOI 10.1016/S0014-4835(02)00332-9; Han S, 2008, AM J PHYSIOL-REG I, V294, pR1832, DOI 10.1152/ajpregu.00083.2008; Hellwig-Burgel T, 1999, BLOOD, V94, P1561, DOI 10.1182/blood.V94.5.1561.417a06_1561_1567; Kalin RE, 2007, DEV BIOL, V305, P599, DOI 10.1016/j.ydbio.2007.03.004; Kasai A, 2004, BIOCHEM BIOPH RES CO, V325, P395, DOI 10.1016/j.bbrc.2004.10.042; Kawamata Y, 2001, BBA-MOL CELL RES, V1538, P162, DOI 10.1016/S0167-4889(00)00143-9; Kidoya H, 2010, BLOOD, V115, P3166, DOI 10.1182/blood-2009-07-232306; Lee DK, 2000, J NEUROCHEM, V74, P34, DOI 10.1046/j.1471-4159.2000.0740034.x; Lee DK, 2005, ENDOCRINOLOGY, V146, P231, DOI 10.1210/en.2004-0359; Li WM, 2007, CIRC RES, V100, P79, DOI 10.1161/01.RES.0000253094.03023.3f; Loewen N, 2009, EXP EYE RES, V88, P928, DOI 10.1016/j.exer.2008.11.037; McGillem GS, 1998, EXP EYE RES, V67, P371, DOI 10.1006/exer.1998.0526; Medhurst AD, 2003, J NEUROCHEM, V84, P1162, DOI 10.1046/j.1471-4159.2003.01587.x; Mizutani M, 1998, DIABETES, V47, P445, DOI 10.2337/diabetes.47.3.445; Negi A, 2003, J ROY SOC MED, V96, P266, DOI 10.1258/jrsm.96.6.266; NORK TM, 1987, ARCH OPHTHALMOL-CHIC, V105, P1424; O'Donnell LA, 2007, J NEUROCHEM, V102, P1905, DOI 10.1111/j.1471-4159.2007.04645.x; OHIRA A, 1990, OPHTHALMOLOGICA, V201, P187, DOI 10.1159/000310150; Qian J, 2011, RETINA-J RET VIT DIS, V31, P161, DOI 10.1097/IAE.0b013e3181e46ad8; Reaux A, 2002, NEUROSCIENCE, V113, P653, DOI 10.1016/S0306-4522(02)00192-6; Roberts EM, 2009, J ENDOCRINOL, V202, P453, DOI 10.1677/JOE-09-0134; Saint-Geniez M, 2002, MECH DEVELOP, V110, P183, DOI 10.1016/S0925-4773(01)00558-5; Simo R, 2006, CURR DIABETES REV, V2, P71, DOI 10.2174/157339906775473671; Simpkin JC, 2007, BASIC RES CARDIOL, V102, P518, DOI 10.1007/s00395-007-0671-2; Soler MVC, 2002, GLIA, V39, P320, DOI 10.1002/glia.10107; Sorli SC, 2006, DRUG DISCOV TODAY, V11, P1100, DOI 10.1016/j.drudis.2006.10.011; STONE J, 1995, J NEUROSCI, V15, P4738, DOI 10.1523/jneurosci.15-07-04738.1995; Tang SY, 2007, PEPTIDES, V28, P708, DOI 10.1016/j.peptides.2006.10.005; Tao Y, 2010, INVEST OPHTH VIS SCI, V51, P4237, DOI 10.1167/iovs.09-4466; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Tiam C, 2009, J HEPATOL, V50, P296, DOI 10.1016/j.jhep.2008.09.019; TIELSCH JM, 1990, ARCH OPHTHALMOL-CHIC, V108, P286, DOI 10.1001/archopht.1990.01070040138048; Tretiach M, 2005, NEUROSCI LETT, V378, P160, DOI 10.1016/j.neulet.2004.12.026; Wang GY, 2004, ENDOCRINOLOGY, V145, P1342, DOI 10.1210/en.2003-1116; Winzell MS, 2005, REGUL PEPTIDES, V131, P12, DOI 10.1016/j.regpep.2005.05.004; Wolburg H, 1999, INT REV CYTOL, V187, P111, DOI 10.1016/S0074-7696(08)62417-1; Zhang Z, 2009, CHINESE MED J-PEKING, V122, P2360, DOI 10.3760/cma.j.issn.0366-6999.2009.19.031; Zhong JC, 2007, REGUL PEPTIDES, V144, P109, DOI 10.1016/j.regpep.2007.06.010	47	15	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e69703	10.1371/journal.pone.0069703	http://dx.doi.org/10.1371/journal.pone.0069703			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874984	Green Published, Green Submitted, gold			2022-12-27	WOS:000322064300111
J	Alexandre, H; Ponsard, S; Bourguet, D; Vitalis, R; Audiot, P; Cros-Arteil, S; Streiff, R				Alexandre, Hermine; Ponsard, Sergine; Bourguet, Denis; Vitalis, Renaud; Audiot, Philippe; Cros-Arteil, Sandrine; Streiff, Rejane			When History Repeats Itself: Exploring the Genetic Architecture of Host-Plant Adaptation in Two Closely Related Lepidopteran Species	PLOS ONE			English	Article							EUROPEAN CORN-BORER; OSTRINIA-NUBILALIS HUBNER; GENOME SCANS; POPULATION-STRUCTURE; DIVERGENT SELECTION; PHEROMONE STRAINS; SEX-PHEROMONE; LINKAGE DISEQUILIBRIUM; ECOLOGICAL SPECIATION; LOCAL ADAPTATION	The genus Ostrinia includes two allopatric maize pests across Eurasia, namely the European corn borer (ECB, O. nubilalis) and the Asian corn borer (ACB, O. furnacalis). A third species, the Adzuki bean borer (ABB, O. scapulalis), occurs in sympatry with both the ECB and the ACB. The ABB mostly feeds on native dicots, which probably correspond to the ancestral host plant type for the genus Ostrinia. This situation offers the opportunity to characterize the two presumably independent adaptations or preadaptations to maize that occurred in the ECB and ACB. In the present study, we aimed at deciphering the genetic architecture of these two adaptations to maize, a monocot host plant recently introduced into Eurasia. To this end, we performed a genome scan analysis based on 684 AFLP markers in 12 populations of ECB, ACB and ABB. We detected 2 outlier AFLP loci when comparing French populations of the ECB and ABB, and 9 outliers when comparing Chinese populations of the ACB and ABB. These outliers were different in both countries, and we found no evidence of linkage disequilibrium between any two of them. These results suggest that adaptation or preadaptation to maize relies on a different genetic architecture in the ECB and ACB. However, this conclusion must be considered in light of the constraints inherent to genome scan approaches and of the intricate evolution of adaptation and reproductive isolation in the Ostrinia spp. complex.	[Alexandre, Hermine; Bourguet, Denis; Vitalis, Renaud; Audiot, Philippe; Cros-Arteil, Sandrine; Streiff, Rejane] Montpellier SupAgro, CIRAD, IRD, INRA,UMR,CBGP, Montferrier Sur Lez, France; [Alexandre, Hermine; Ponsard, Sergine] Univ Toulouse, ENFA, UMR5174, EDB,Lab Evolut & Diversite Biol, Toulouse, France; [Alexandre, Hermine; Ponsard, Sergine] Univ Toulouse 3, CNRS, UMR5174, EDB, F-31062 Toulouse, France	CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA)	Streiff, R (corresponding author), Montpellier SupAgro, CIRAD, IRD, INRA,UMR,CBGP, Montferrier Sur Lez, France.	streiff@supagro.inra.fr	Vitalis, Renaud/ABB-1863-2020	Vitalis, Renaud/0000-0001-7096-3089; Streiff, Rejane/0000-0002-2731-8129; Bourguet, Denis/0000-0002-2109-5323	ANR programme [09-BLAN-0145-01]; Action Ponctuelle de Cooperation grant from Universite Toulouse III; INRA-CIRAD grant; TULIP [ANR-10-LABX-41]	ANR programme(French National Research Agency (ANR)); Action Ponctuelle de Cooperation grant from Universite Toulouse III; INRA-CIRAD grant; TULIP	RV acknowledges partial funding from the ANR programme "EMILE'' 09-BLAN-0145-01. This work was financially supported by an Action Ponctuelle de Cooperation grant from Universite Toulouse III and an INRA-CIRAD grant ''SDIPS" (Mechanisms of Speciation and Molecular Diagnosis of Insect Pest Species Complexes). The Laboratoire Evolution & Diversite' Biologique is partly supported by project TULIP (ANR-10-LABX-41). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpuerto V., 1985, CORN BORER OSTRINIA; ANDO T, 1980, AGR BIOL CHEM TOKYO, V44, P2643, DOI 10.1080/00021369.1980.10864390; Apple JL, 2010, MOL ECOL, V19, P4012, DOI 10.1111/j.1365-294X.2010.04792.x; Arendt J, 2008, TRENDS ECOL EVOL, V23, P483, DOI 10.1016/j.tree.2008.06.002; Arendt J, 2008, TRENDS ECOL EVOL, V23, P26, DOI 10.1016/j.tree.2007.09.011; Beaumont MA, 2004, HEREDITY, V92, P365, DOI 10.1038/sj.hdy.6800447; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bethenod MT, 2005, HEREDITY, V94, P264, DOI 10.1038/sj.hdy.6800611; Bierne N, 2011, MOL ECOL, V20, P2044, DOI 10.1111/j.1365-294X.2011.05080.x; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; Bontemps A, 2004, P ROY SOC B-BIOL SCI, V271, P2179, DOI 10.1098/rspb.2004.2851; Calcagno V, 2007, J EVOLUTION BIOL, V20, P1720, DOI 10.1111/j.1420-9101.2007.01391.x; Carvajal-Rodriguez A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-209; Coates BS, 2005, INT J BIOL SCI, V1, P13; Cox K, 2011, MOL ECOL, V20, P2724, DOI 10.1111/j.1365-294X.2011.05137.x; Dasmahapatra KK, 2002, EVOLUTION, V56, P741, DOI 10.1111/j.0014-3820.2002.tb01385.x; Dopman EB, 2004, GENETICS, V167, P301, DOI 10.1534/genetics.167.1.301; Dopman EB, 2010, EVOLUTION, V64, P881, DOI 10.1111/j.1558-5646.2009.00883.x; Dworkin I, 2009, GENETICS, V181, P721, DOI 10.1534/genetics.108.093419; Elmer KR, 2011, TRENDS ECOL EVOL, V26, P298, DOI 10.1016/j.tree.2011.02.008; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fischer MC, 2011, MOL ECOL, V20, P1450, DOI 10.1111/j.1365-294X.2011.05015.x; Folcher L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025374; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Fontaine MC, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-30; Frolov AN, 2012, HEREDITY, V108, P147, DOI 10.1038/hdy.2011.58; Frolov AN, 2007, BIOL J LINN SOC, V91, P49, DOI 10.1111/j.1095-8312.2007.00779.x; Gay JP, 1999, MAIS; Gompert Z, 2011, GENETICS, V187, P903, DOI 10.1534/genetics.110.124693; Gould S. J., 1989, WONDERFUL LIFE; GUTHRIE W. D., 1965, ANN ENTOMOL SOC AMER, V58, P100, DOI 10.1093/aesa/58.1.100; HILL WG, 1974, HEREDITY, V33, P229, DOI 10.1038/hdy.1974.89; Hohenlohe PA, 2012, PHILOS T R SOC B, V367, P395, DOI 10.1098/rstb.2011.0245; Holt BG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020394; Ishikawa Y, 1999, ENTOMOL EXP APPL, V91, P237, DOI 10.1023/A:1003601407578; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Janz N, 2001, EVOLUTION, V55, P783, DOI 10.1554/0014-3820(2001)055[0783:EDOHPS]2.0.CO;2; Jaquiery J, 2012, MOL ECOL, V21, P5251, DOI 10.1111/mec.12048; Karpati Z., 2007, Acta Phytopathologica et Entomologica Hungarica, V42, P331, DOI 10.1556/APhyt.42.2007.2.15; Kim CG, 1999, APPL ENTOMOL ZOOL, V34, P405, DOI 10.1303/aez.34.405; Kojima W, 2010, J INSECT PHYSIOL, V56, P1349, DOI 10.1016/j.jinsphys.2010.04.021; Lassance JM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-10; Leander BS, 2008, TRENDS ECOL EVOL, V23, P481, DOI 10.1016/j.tree.2008.04.012; Leppik E, 2012, CHEMOECOLOGY, V22, P119, DOI 10.1007/s00049-012-0104-z; Lewis PO, 2002, GENETIC DATA ANAL CO; LIEBHERR J, 1975, ANN ENTOMOL SOC AM, V68, P305, DOI 10.1093/aesa/68.2.305; Lu Zhongxian, 1996, Acta Phytophylacica Sinica, V23, P126; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; Malausa T, 2008, B ENTOMOL RES, V98, P193, DOI 10.1017/S0007485307005536; Malausa T, 2005, SCIENCE, V308, P258, DOI 10.1126/science.1107577; Malausa T, 2007, GENETICS, V176, P2343, DOI 10.1534/genetics.107.072108; Matsubayashi KW, 2010, ENTOMOL EXP APPL, V134, P1, DOI 10.1111/j.1570-7458.2009.00916.x; Matzkin LM, 2012, MOL ECOL, V21, P2428, DOI 10.1111/j.1365-294X.2012.05549.x; Midamegbe A, 2011, MOL ECOL, V20, P1414, DOI 10.1111/j.1365-294X.2011.05035.x; MUTUURA A, 1970, MEM ENTOMOL SOC CAN, P1; Nadeau NJ, 2012, PHILOS T R SOC B, V367, P343, DOI 10.1098/rstb.2011.0198; Nei M., 1987, MOL EVOLUTIONARY GEN; Nosil P, 2008, EVOLUTION, V62, P316, DOI 10.1111/j.1558-5646.2007.00299.x; Nosil P, 2012, PHILOS T R SOC B, V367, P332, DOI 10.1098/rstb.2011.0263; Nosil P, 2009, MOL ECOL, V18, P375, DOI 10.1111/j.1365-294X.2008.03946.x; Nunes VL, 2011, MOL ECOL, V20, P193, DOI 10.1111/j.1365-294X.2010.04936.x; Oetjen K, 2007, MOL ECOL, V16, P5156, DOI 10.1111/j.1365-294X.2007.03577.x; Pearce T, 2012, BRIT J PHILOS SCI, V63, P429, DOI 10.1093/bjps/axr046; Pelissie B, 2010, J EVOLUTION BIOL, V23, P350, DOI 10.1111/j.1420-9101.2009.01903.x; Pelozuelo L, 2004, J CHEM ECOL, V30, P335, DOI 10.1023/B:JOEC.0000017981.03762.ed; Pelozuelo L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000555; Perez-Figueroa A, 2010, J EVOLUTION BIOL, V23, P2267, DOI 10.1111/j.1420-9101.2010.02093.x; Poncet BN, 2010, MOL ECOL, V19, P2896, DOI 10.1111/j.1365-294X.2010.04696.x; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2020, R LANG ENV STAT COMP; Renaut S, 2012, PHILOS T R SOC B, V367, P354, DOI 10.1098/rstb.2011.0197; Roelofs WL, 2002, P NATL ACAD SCI USA, V99, P13621, DOI 10.1073/pnas.152445399; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schroder MS, 2011, BIOINFORMATICS, V27, P3206, DOI 10.1093/bioinformatics/btr511; Scotti-Saintagne C, 2004, GENETICS, V168, P1615, DOI 10.1534/genetics.104.026849; Smadja CM, 2012, EVOLUTION, V66, P2723, DOI 10.1111/j.1558-5646.2012.01612.x; Storz JF, 2005, MOL ECOL, V14, P671, DOI 10.1111/j.1365-294X.2005.02437.x; Strasburg JL, 2012, PHILOS T R SOC B, V367, P364, DOI 10.1098/rstb.2011.0199; Stringham SA, 2011, INTEGR COMP BIOL, V51, pE134; Swigonova Z, 2004, MOL PHYLOGENET EVOL, V32, P358, DOI 10.1016/j.ympev.2004.02.010; Takanashi T, 2005, BIOL J LINN SOC, V84, P143, DOI 10.1111/j.1095-8312.2005.00421.x; TALEKAR NS, 1991, J ECON ENTOMOL, V84, P1499, DOI 10.1093/jee/84.5.1499; Tenaillon MI, 2011, CR BIOL, V334, P221, DOI 10.1016/j.crvi.2010.12.015; Thomas Y, 2003, EVOLUTION, V57, P261; Vekemans X, 2002, MOL ECOL, V11, P139, DOI 10.1046/j.0962-1083.2001.01415.x; Via S, 2008, MOL ECOL, V17, P4334, DOI 10.1111/j.1365-294X.2008.03921.x; Via S, 2012, PHILOS T R SOC B, V367, P451, DOI 10.1098/rstb.2011.0260; Vitalis R, 2003, J HERED, V94, P429, DOI 10.1093/jhered/esg083; Vitalis R, 2001, GENETICS, V158, P1811; Vitalis R, 2012, DATA PRODUCTION ANAL; Whitlock MC, 2005, J EVOLUTION BIOL, V18, P1368, DOI 10.1111/j.1420-9101.2005.00917.x; Wu CI, 2001, J EVOLUTION BIOL, V14, P851, DOI 10.1046/j.1420-9101.2001.00335.x; Xia H, 2010, MOL ECOL, V19, P4144, DOI 10.1111/j.1365-294X.2010.04762.x; Zhivotovsky LA, 1999, MOL ECOL, V8, P907, DOI 10.1046/j.1365-294x.1999.00620.x	98	10	10	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e69211	10.1371/journal.pone.0069211	http://dx.doi.org/10.1371/journal.pone.0069211			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	23874914	Green Published, Green Submitted, gold			2022-12-27	WOS:000321718700049
J	Bojsen, R; Torbensen, R; Larsen, CE; Folkesson, A; Regenberg, B				Bojsen, Rasmus; Torbensen, Rasmus; Larsen, Camilla Eggert; Folkesson, Anders; Regenberg, Birgitte			The Synthetic Amphipathic Peptidomimetic LTX109 Is a Potent Fungicide That Disturbs Plasma Membrane Integrity in a Sphingolipid Dependent Manner	PLOS ONE			English	Article							VITRO ANTIMICROBIAL ACTIVITY; PLANT DEFENSIN-SENSITIVITY; SACCHAROMYCES-CEREVISIAE; AMPHOTERICIN-B; ANTIBACTERIAL PEPTIDES; POLYENE ANTIBIOTICS; CANDIDA BIOFILMS; PROTON PUMP; GROWTH-RATE; YEAST	The peptidomimetic LTX109 (arginine-tertbutyl tryptophan-arginine-phenylethan) was previously shown to have antibacterial properties. Here, we investigated the activity of this novel antimicrobial peptidomimetic on the yeast Saccharomyces cerevisiae. We found that LTX109 was an efficient fungicide that killed all viable cells in an exponentially growing population as well as a large proportion of cells in biofilm formed on an abiotic surface. LTX109 had similar killing kinetics to the membrane-permeabilizing fungicide amphotericin B, which led us to investigate the ability of LTX109 to disrupt plasma membrane integrity. S. cerevisiae cells exposed to a high concentration of LTX109 showed rapid release of potassium and amino acids, suggesting that LTX109 acted by destabilizing the plasma membrane. This was supported by the finding that cells were permeable to the fluorescent nucleic acid stain SYTOX Green after a few minutes of LTX109 treatment. We screened a haploid S. cerevisiae gene deletion library for mutants resistant to LTX109 to uncover potential molecular targets. Eight genes conferred LTX109 resistance when deleted and six were involved in the sphingolipid biosynthetic pathway (SUR1, SUR2, SKN1, IPT1, FEN1 and ORM2). The involvement of all of these genes in the biosynthetic pathway for the fungal-specific lipids mannosylinositol phosphorylceramide (MIPC) and mannosyl di-(inositol phosphoryl) ceramide (M(IP)(2)C) suggested that these lipids were essential for LTX109 sensitivity. Our observations are consistent with a model in which LTX109 kills S. cerevisiae by nonspecific destabilization of the plasma membrane through direct or indirect interaction with the sphingolipids.	[Bojsen, Rasmus; Folkesson, Anders] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Torbensen, Rasmus; Larsen, Camilla Eggert; Regenberg, Birgitte] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Folkesson, Anders] Natl Vet Inst, Sect Bacteriol Pathol & Parasitol, Frederiksberg C, Denmark	Technical University of Denmark; University of Copenhagen; Technical University of Denmark	Regenberg, B (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	bregenberg@bio.ku.dk	Regenberg, Brigit/C-2699-2009	Regenberg, Brigit/0000-0003-4996-7012; Folkesson, Anders/0000-0002-2175-830X	Danish Agency for Science Technology and Innovation [FTP 10-084027]	Danish Agency for Science Technology and Innovation	Funding provided by the Danish Agency for Science Technology and Innovation (FTP 10-084027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts AM, 2006, FEBS LETT, V580, P1903, DOI 10.1016/j.febslet.2006.02.061; Arendrup MC, 2011, J CLIN MICROBIOL, V49, P325, DOI 10.1128/JCM.01811-10; Bachmann SP, 2002, ANTIMICROB AGENTS CH, V46, P3591, DOI 10.1128/AAC.46.11.3591-3596.2002; Bagnat M, 2000, P NATL ACAD SCI USA, V97, P3254, DOI 10.1073/pnas.060034697; Baillie GS, 1998, ANTIMICROB AGENTS CH, V42, P1900, DOI 10.1128/AAC.42.8.1900; Bates DW, 2001, CLIN INFECT DIS, V32, P686, DOI 10.1086/319211; Beeler TJ, 1997, MOL GEN GENET, V255, P570, DOI 10.1007/s004380050530; BEGGS WH, 1994, ANTIMICROB AGENTS CH, V38, P363, DOI 10.1128/AAC.38.2.363; Bojsen RK, 2012, FEMS IMMUNOL MED MIC, V65, P169, DOI 10.1111/j.1574-695X.2012.00943.x; BROWN MRW, 1988, J ANTIMICROB CHEMOTH, V22, P777, DOI 10.1093/jac/22.6.777; Butts A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002870; Chandrasekar P, 2011, J ANTIMICROB CHEMOTH, V66, P457, DOI 10.1093/jac/dkq479; CHEN WC, 1978, ANTIMICROB AGENTS CH, V13, P914, DOI 10.1128/AAC.13.6.914; Cowart LA, 2007, BBA-MOL CELL BIOL L, V1771, P421, DOI 10.1016/j.bbalip.2006.08.005; Deresinski SC, 2003, CLIN INFECT DIS, V36, P1445, DOI 10.1086/375080; Dickson RC, 1997, J BIOL CHEM, V272, P29620, DOI 10.1074/jbc.272.47.29620; Dickson RC, 2002, BBA-MOL CELL BIOL L, V1583, P13, DOI 10.1016/S1388-1981(02)00210-X; Dickson RC, 1998, ANNU REV BIOCHEM, V67, P27, DOI 10.1146/annurev.biochem.67.1.27; ERMISHKIN LN, 1976, NATURE, V262, P698, DOI 10.1038/262698a0; Flemming K, 2009, J ANTIMICROB CHEMOTH, V63, P136, DOI 10.1093/jac/dkn464; Funato K, 2002, BIOCHEMISTRY-US, V41, P15105, DOI 10.1021/bi026616d; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Grilley MM, 1998, J BIOL CHEM, V273, P11062, DOI 10.1074/jbc.273.18.11062; Haak D, 1997, J BIOL CHEM, V272, P29704, DOI 10.1074/jbc.272.47.29704; Hancock REW, 2000, P NATL ACAD SCI USA, V97, P8856, DOI 10.1073/pnas.97.16.8856; Isaksson J, 2011, J MED CHEM, V54, P5786, DOI 10.1021/jm200450h; Jorgensen MU, 1997, CURR GENET, V31, P241, DOI 10.1007/s002940050201; Kauffman Carol A, 2006, Proc Am Thorac Soc, V3, P35, DOI 10.1513/pats.200510-110JH; Kuhn DM, 2002, ANTIMICROB AGENTS CH, V46, P1773, DOI 10.1128/AAC.46.6.1773-1780.2002; Li YM, 2012, PEPTIDES, V37, P207, DOI 10.1016/j.peptides.2012.07.001; Liu Y, 2013, INT J ANTIMICROB AG, V41, P20, DOI 10.1016/j.ijantimicag.2012.09.014; Lynch AS, 2008, ANNU REV MED, V59, P415, DOI 10.1146/annurev.med.59.110106.132000; Makobongo MO, 2009, ANTIMICROB AGENTS CH, V53, P4231, DOI 10.1128/AAC.00510-09; Mandala SM, 1998, J BIOL CHEM, V273, P14942, DOI 10.1074/jbc.273.24.14942; Mandala SM, 1997, J BIOL CHEM, V272, P32709, DOI 10.1074/jbc.272.51.32709; Marr AK, 2006, CURR OPIN PHARMACOL, V6, P468, DOI 10.1016/j.coph.2006.04.006; Maurya IK, 2011, PEPTIDES, V32, P1732, DOI 10.1016/j.peptides.2011.06.003; Murillo LA, 2007, REV ESP QUIM, V20, P330; Nagiec MM, 1997, J BIOL CHEM, V272, P9809, DOI 10.1074/jbc.272.15.9809; Niu YH, 2012, FUTURE MED CHEM, V4, P1853, DOI [10.4155/FMC.12.111, 10.4155/fmc.12.111]; Niu YH, 2012, J MED CHEM, V55, P4003, DOI 10.1021/jm300274p; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; Oxman DA, 2010, J ANTIMICROB CHEMOTH, V65, P1460, DOI 10.1093/jac/dkq136; PATTON JL, 1991, J BACTERIOL, V173, P3101, DOI 10.1128/JB.173.10.3101-3108.1991; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Ramage G, 2006, FEMS YEAST RES, V6, P979, DOI 10.1111/j.1567-1364.2006.00117.x; Reynolds TB, 2001, SCIENCE, V291, P878, DOI 10.1126/science.291.5505.878; Roth BL, 1997, APPL ENVIRON MICROB, V63, P2421, DOI 10.1128/AEM.63.6.2421-2431.1997; Rupp S, 1999, EMBO J, V18, P1257, DOI 10.1093/emboj/18.5.1257; Saravolatz LD, 2012, ANTIMICROB AGENTS CH, V56, P4478, DOI 10.1128/AAC.00194-12; SERRANO R, 1980, EUR J BIOCHEM, V105, P419, DOI 10.1111/j.1432-1033.1980.tb04516.x; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Shimobayashi M, 2013, MOL BIOL CELL, V24, P870, DOI 10.1091/mbc.E12-10-0753; Stock SD, 2000, ANTIMICROB AGENTS CH, V44, P1174, DOI 10.1128/AAC.44.5.1174-1180.2000; Tanaka T, 2000, MICROBIOL-UK, V146, P377, DOI 10.1099/00221287-146-2-377; TEERLINK T, 1980, BIOCHIM BIOPHYS ACTA, V599, P484, DOI 10.1016/0005-2736(80)90193-5; Theis T, 2004, CELL MOL LIFE SCI, V61, P437, DOI 10.1007/s00018-003-3231-4; Thevissen K, 1999, APPL ENVIRON MICROB, V65, P5451; Thevissen K, 2000, P NATL ACAD SCI USA, V97, P9531, DOI 10.1073/pnas.160077797; Thevissen K, 2005, FEBS LETT, V579, P1973, DOI 10.1016/j.febslet.2005.02.043; Thevissen K, 1996, J BIOL CHEM, V271, P15018, DOI 10.1074/jbc.271.25.15018; Torbensen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041272; Tortorano AM, 2004, EUR J CLIN MICROBIOL, V23, P317, DOI 10.1007/s10096-004-1103-y; Trabocchi A, 2010, J MED CHEM, V53, P2502, DOI 10.1021/jm901734u; van der Weerden NL, 2013, CELL MOL LIFE SCI, V70, P3545, DOI 10.1007/s00018-013-1260-1; VANDEN BOSSCHE H, 1995, PHARMACOL THERAPEUT, V67, P79; Vermes A, 2000, J ANTIMICROB CHEMOTH, V46, P171, DOI 10.1093/jac/46.2.171; VINCENT VL, 1995, MICROBIOL-UK, V141, P1829, DOI 10.1099/13500872-141-8-1829; Violette A, 2006, CHEM BIOL, V13, P531, DOI 10.1016/j.chembiol.2006.03.009; WALDORF AR, 1983, ANTIMICROB AGENTS CH, V23, P79, DOI 10.1128/AAC.23.1.79; Wells GB, 1996, J BACTERIOL, V178, P6223, DOI 10.1128/jb.178.21.6223-6226.1996; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2	74	20	21	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e69483	10.1371/journal.pone.0069483	http://dx.doi.org/10.1371/journal.pone.0069483			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	23874964	Green Published, gold, Green Submitted			2022-12-27	WOS:000321718700053
J	Araki, J; Nishizawa, Y; Sato, T; Naito, M; Akita, K; Tashiro, K; Iida, T; Koshima, I				Araki, Jun; Nishizawa, Yuji; Sato, Tomoyuki; Naito, Munekazu; Akita, Keiichi; Tashiro, Kensuke; Iida, Takuya; Koshima, Isao			Anorectal Transplantation in Human Cadavers: Mock Anorectal Allotransplantation	PLOS ONE			English	Article							LOW RECTAL-CANCER; INTERSPHINCTERIC RESECTION; INTESTINAL TRANSPLANTATION; FECAL INCONTINENCE; FOLLOW-UP; ANASTOMOSIS; MODEL; PRESERVATION; SPHINCTER; OUTCOMES	Background: Anorectal transplantation is a method for patients who have lost their anorectal function or suffer from congenital anorectal dysfunction to recover this function, and this has been investigated in experimental animal models using pigs, dogs, and rats. In this study, we performed an examination of anorectal transplantation in human cadavers to investigate whether this procedure could be performed in patients. Methods: A 77-year-old woman cadaver 1 was used as the donor and a 98-year-old woman cadaver 2 was used as the recipient. Initially, abdominoperineal excision of the anus and rectum (the Miles' operation) was performed on the recipient. Next, an anorectal graft containing the pudendal nerve (PN), pudendal artery (PA), pudendal vein (PV), inferior mesenteric artery (IMA), and inferior mesenteric vein (IMV) was harvested from the donor. The donor graft was transplanted into the recipient by intestinal anastomosis and microneurovascular anastomoses orthotopically. Results: The diameters of the PN (right/left), IMA, and IMV were 2.5 mm/2.5 mm, 2.0 mm, and 1.5 mm, respectively, in cadaver 1, and 2.0 mm/2.0 mm, 2.0 mm, and 2.0 mm, respectively, in cadaver 2. The length of the PN, PA, PV, IMA, and IMV in the graft was sufficient to allow proper anastomosis. Conclusion: This preliminary study indicated that human anorectal transplantation was possible anatomically and technically. We anticipate our study will aid in the potential future application of this procedure to human patients.	[Araki, Jun; Tashiro, Kensuke; Iida, Takuya; Koshima, Isao] Univ Tokyo, Dept Plast Surg, Tokyo, Japan; [Nishizawa, Yuji] Kagawa Univ, Fac Med, Dept Surg Gastroenterol, Kagawa, Japan; [Sato, Tomoyuki] Saitama Shinkaibashi Clin, Saitama, Japan; [Naito, Munekazu] Tokyo Med Univ, Dept Anat, Tokyo 1608402, Japan; [Akita, Keiichi] Tokyo Med & Dent Univ, Dept Clin Anat, Tokyo, Japan	University of Tokyo; Kagawa University; Tokyo Medical University; Tokyo Medical & Dental University (TMDU)	Araki, J (corresponding author), Univ Tokyo, Dept Plast Surg, Tokyo, Japan.	arakij-pla@h.u-tokyo.ac.jp		Akita, Keiichi/0000-0002-2927-2937	Kawano Masanori Memorial Foundation for Promotion of Pediatrics; JSPS [24-5321]	Kawano Masanori Memorial Foundation for Promotion of Pediatrics(Kawano Masanori Memorial Foundation for Promotion of Pediatrics); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants from Kawano Masanori Memorial Foundation for Promotion of Pediatrics and JSPS KAKENHI Grant Number 24-5321. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki J, 2011, TRANSPL P, V43, P3552, DOI 10.1016/j.transproceed.2011.08.042; Araki J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044310; Badylak SF, 2012, LANCET, V379, P943, DOI 10.1016/S0140-6736(12)60073-7; Chapman AE, 2002, BRIT J SURG, V89, P138, DOI 10.1046/j.1365-2168.2002.02018.x; Dalal DH, 2012, J PEDIATR GASTR NUTR, V55, P425, DOI 10.1097/MPG.0b013e318253f2f0; Eid KR, 2010, AM J TRANSPLANT, V10, P1940, DOI 10.1111/j.1600-6143.2010.03167.x; Galvao FHF, 2009, TECH COLOPROCTOL, V13, P55, DOI 10.1007/s10151-009-0459-5; Galvao FHF, 2012, CLINICS, V67, P971, DOI 10.6061/clinics/2012(08)20; Galvao FHF, 2012, MICROSURG, V32, P77, DOI 10.1002/micr.20958; George AT, 2013, ANN SURG; HURNY C, 1985, CA-CANCER J CLIN, V35, P170, DOI 10.3322/canjclin.35.3.170; Jones JW, 2000, NEW ENGL J MED, V343, P468, DOI 10.1056/NEJM200008173430704; Kinugasa Y, 2012, YONSEI MED J, V53, P849, DOI 10.3349/ymj.2012.53.4.849; Lim SW, 2011, WORLD J SURG, V35, P2811, DOI 10.1007/s00268-011-1277-2; Matsubara A, 2003, INT J UROL, V10, P141, DOI 10.1046/j.1442-2042.2003.00585.x; O'Bichere A, 2000, BRIT J SURG, V87, P1534, DOI 10.1046/j.1365-2168.2000.01557.x; Ozkan O, 2013, FERTIL STERIL, V99, P470, DOI 10.1016/j.fertnstert.2012.09.035; Park JS, 2011, ANN SURG, V254, P941, DOI 10.1097/SLA.0b013e318236c448; Rispoli C, 2012, INT J SURG CASE REP, V3, P319, DOI 10.1016/j.ijscr.2012.04.001; Rogers JH, 2010, CATHETER CARDIO INTE, V76, P882, DOI 10.1002/ccd.22646; Sato T, 1997, SURGERY, V121, P569, DOI 10.1016/S0039-6060(97)90113-6; Sato T, 2005, SURGERY, V137, P8, DOI 10.1016/j.surg.2004.05.046; Siemionow M, 2006, PLAST RECONSTR SURG, V117, P876, DOI 10.1097/01.prs.0000204876.27481.fc; Siemionow M, 2009, LANCET, V374, P203, DOI 10.1016/S0140-6736(09)61155-7; Strome M, 2001, NEW ENGL J MED, V344, P1676, DOI 10.1056/NEJM200105313442204; Takahashi H, 2007, TRANSPLANTATION, V84, P689, DOI 10.1097/01.tp.0000280541.83994.93; THIEL W, 1992, ANN ANAT, V174, P185, DOI 10.1016/S0940-9602(11)80346-8; Thiel W, 2002, ANN ANAT, V184, P267, DOI 10.1016/S0940-9602(02)80121-2; Vaizey CJ, 1998, LANCET, V352, P105, DOI 10.1016/S0140-6736(97)11427-1; Wald A, 2007, NEW ENGL J MED, V356, P1648, DOI 10.1056/NEJMcp067041	30	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e68977	10.1371/journal.pone.0068977	http://dx.doi.org/10.1371/journal.pone.0068977			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874833	Green Published, Green Submitted, gold			2022-12-27	WOS:000322218800056
J	Zhou, L; Yang, Y; Zhang, JJ; Guo, XJ; Bi, Y; Li, X; Zhang, P; Zhang, JQ; Lin, M; Zhou, ZM; Shen, R; Guo, XR; Huo, R; Ling, XF; Sha, JH				Zhou, Lin; Yang, Ye; Zhang, Juanjuan; Guo, Xuejiang; Bi, Ye; Li, Xin; Zhang, Ping; Zhang, Junqiang; Lin, Min; Zhou, Zuomin; Shen, Rong; Guo, Xirong; Huo, Ran; Ling, Xiufeng; Sha, Jiahao			The Role of RING Box Protein 1 in Mouse Oocyte Meiotic Maturation	PLOS ONE			English	Article							SCF UBIQUITIN LIGASE; PROPHASE-I ARREST; MAMMALIAN OOCYTES; HOMOLOG DISJUNCTION; METAPHASE-I; CYCLIN B1; MEIOSIS-I; RESUMPTION; DESTRUCTION; PROGRESSION	RING box protein-1 (RBX1) is an essential component of Skp1-cullin-F-box protein (SCF) E3 ubiquitin ligase and participates in diverse cellular processes by targeting various substrates for degradation. However, the physiological function of RBX1 in mouse oocyte maturation remains unknown. Here, we examined the expression, localization and function of RBX1 during mouse oocyte meiotic maturation. Immunofluorescence analysis showed that RBX1 displayed dynamic distribution during the maturation process: it localized around and migrated along with the spindle and condensed chromosomes. Rbx1 knockdown with the appropriate siRNAs led to a decreased rate of first polar body extrusion and most oocytes were arrested at metaphase I. Moreover, downregulation of Rbx1 caused accumulation of Emi1, an inhibitor of the anaphase-promoting complex/cyclosome (APC/C), which is required for mouse meiotic maturation. In addition, we found apparently increased expression of the homologue disjunction-associated protein securin and cyclin B1, which are substrates of APC/C E3 ligase and need to be degraded for meiotic progression. These results indicate the essential role of the SCF beta TrCP-EMI1-APC/C axis in mouse oocyte meiotic maturation. In conclusion, we provide evidence for the indispensable role of RBX1 in mouse oocyte meiotic maturation.	[Zhou, Lin; Yang, Ye; Guo, Xuejiang; Bi, Ye; Zhang, Ping; Lin, Min; Zhou, Zuomin; Huo, Ran; Sha, Jiahao] Nanjing Med Univ, Dept Histol & Embryol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Zhang, Juanjuan; Li, Xin; Zhang, Junqiang; Shen, Rong; Guo, Xirong; Ling, Xiufeng] Nanjing Med Univ, Nanjing Matern & Child Hlth Hosp, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Huo, R (corresponding author), Nanjing Med Univ, Dept Histol & Embryol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	huoran@njmu.edu.cn; xiufengling@hotmail.com	Bi, Ye/A-6272-2017; Zhang, Juan/GRX-2638-2022; Guo, Xuejiang/J-9600-2014	Guo, Xuejiang/0000-0002-0475-5705; Yang, Ye/0000-0001-7711-2121	National Basic Research Program of China 973 Program [2012CB944704]	National Basic Research Program of China 973 Program(National Basic Research Program of China)	This work was supported by grants from the National Basic Research Program of China 973 Program) (No. 2012CB944704 (http://www.973.gov.cn/AreaAppl.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernhardt ML, 2011, BIOL REPROD, V84, P526, DOI 10.1095/biolreprod.110.086488; Brunet S, 2005, REPRODUCTION, V130, P801, DOI 10.1530/rep.1.00364; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Dumollard R, 2011, DEVELOPMENT, V138, P885, DOI 10.1242/dev.057133; Guardavaccaro D, 2004, ONCOGENE, V23, P2037, DOI 10.1038/sj.onc.1207413; Hansen DV, 2004, MOL BIOL CELL, V15, P5623, DOI 10.1091/mbc.E04-07-0598; Herbert M, 2003, NAT CELL BIOL, V5, P1023, DOI 10.1038/ncb1062; Hoffmann S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027143; Holt JE, 2010, DEVELOPMENT, V137, P1297, DOI 10.1242/dev.047555; Holt JE, 2009, MOL HUM REPROD, V15, P139, DOI 10.1093/molehr/gap007; Homer H, 2011, CYTOGENET GENOME RES, V133, P209, DOI 10.1159/000324118; Homer HA, 2005, CELL CYCLE, V4, P650, DOI 10.4161/cc.4.5.1677; Jia LJ, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-16; Levi M, 2010, CELL CYCLE, V9, P1577, DOI 10.4161/cc.9.8.11299; Ma HT, 2009, MOL CELL BIOL, V29, P6500, DOI 10.1128/MCB.00669-09; Marangos P, 2007, J CELL BIOL, V176, P65, DOI 10.1083/jcb.200607070; Morimoto M, 2003, BIOCHEM BIOPH RES CO, V301, P392, DOI 10.1016/S0006-291X(02)03051-6; Paronetto MP, 2004, EMBO J, V23, P4649, DOI 10.1038/sj.emboj.7600448; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Reis A, 2007, NAT CELL BIOL, V9, P1192, DOI 10.1038/ncb1640; Senthilkumaran B, 2011, FRONT BIOSCI-LANDMRK, V16, P1898, DOI 10.2741/3829; Solc P, 2010, MOL HUM REPROD, V16, P654, DOI 10.1093/molehr/gaq034; Sun QY, 2009, CELL CYCLE, V8, P2741, DOI 10.4161/cc.8.17.9471; Sun Y, 2001, ANTIOXID REDOX SIGN, V3, P635, DOI 10.1089/15230860152542989; Terret ME, 2003, CURR BIOL, V13, P1797, DOI 10.1016/j.cub.2003.09.032; Thornton BR, 2006, GENE DEV, V20, P3069, DOI 10.1101/gad.1478306; Tripathi A, 2010, J CELL PHYSIOL, V223, P592, DOI 10.1002/jcp.22108; Wei Dongping, 2010, Genes Cancer, V1, P700, DOI 10.1177/1947601910382776; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Xia M, 2012, CELL CYCLE, V11, P2833, DOI 10.4161/cc.21169; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	32	2	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e68964	10.1371/journal.pone.0068964	http://dx.doi.org/10.1371/journal.pone.0068964			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874827	gold, Green Submitted, Green Published			2022-12-27	WOS:000322218800054
J	Majerus, S; Salmon, E; Attout, L				Majerus, Steve; Salmon, Eric; Attout, Lucie			The Importance of Encoding-Related Neural Dynamics in the Prediction of Inter-Individual Differences in Verbal Working Memory Performance	PLOS ONE			English	Article							SHORT-TERM-MEMORY; POSTERIOR PARIETAL CORTEX; LEFT INTRAPARIETAL SULCUS; INDIVIDUAL-DIFFERENCES; PREFRONTAL CORTEX; ATTENTION; CAPACITY; FMRI; NETWORKS; FOCUS	Studies of brain-behaviour interactions in the field of working memory (WM) have associated WM success with activation of a fronto-parietal network during the maintenance stage, and this mainly for visuo-spatial WM. Using an inter-individual differences approach, we demonstrate here the equal importance of neural dynamics during the encoding stage, and this in the context of verbal WM tasks which are characterized by encoding phases of long duration and sustained attentional demands. Participants encoded and maintained 5-word lists, half of them containing an unexpected word intended to disturb WM encoding and associated task-related attention processes. We observed that inter-individual differences in WM performance for lists containing disturbing stimuli were related to activation levels in a region previously associated with task-related attentional processing, the left intraparietal sulcus (IPS), and this during stimulus encoding but not maintenance; functional connectivity strength between the left IPS and lateral prefrontal cortex (PFC) further predicted WM performance. This study highlights the critical role, during WM encoding, of neural substrates involved in task-related attentional processes for predicting inter-individual differences in verbal WM performance, and, more generally, provides support for attention-based models of WM.	[Majerus, Steve; Attout, Lucie] Univ Liege, Dept Psychol Cognit & Behav, Liege, Belgium; [Majerus, Steve; Salmon, Eric] Univ Liege, Cyclotron Res Ctr, Liege, Belgium; [Majerus, Steve] Fund Sci Res FNRS, Brussels, Belgium	University of Liege; University of Liege	Majerus, S (corresponding author), Univ Liege, Dept Psychol Cognit & Behav, Liege, Belgium.	smajerus@ulg.ac.be	Salmon, Eric/AAE-4901-2020	Salmon, Eric/0000-0003-2520-9241; Majerus, Steve/0000-0002-8206-8097	F.R.S.-FNRS (Fund for Scientific Research FNRS, Belgium) [N 1.5.056.10]; PAI-IUAP (Belgian Science Policy) [P7/11]	F.R.S.-FNRS (Fund for Scientific Research FNRS, Belgium)(Fonds de la Recherche Scientifique - FNRS); PAI-IUAP (Belgian Science Policy)	This work was supported by grants F.R.S.-FNRS N 1.5.056.10 (Fund for Scientific Research FNRS, Belgium) and PAI-IUAP P7/11 (Belgian Science Policy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson JLR, 2001, NEUROIMAGE, V13, P903, DOI 10.1006/nimg.2001.0746; Anticevic A, 2010, NEUROIMAGE, V49, P2638, DOI 10.1016/j.neuroimage.2009.11.008; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Baddeley A., WORKING MEMORY THOUG, DOI [10.1093/acprof:oso/9780198528012.001.0001, DOI 10.1093/ACPROF:OSO/9780198528012.001.0001]; Buchsbaum BR, 2008, J COGNITIVE NEUROSCI, V20, P762, DOI 10.1162/jocn.2008.20501; Cairo TA, 2004, COGNITIVE BRAIN RES, V21, P377, DOI 10.1016/j.cogbrainres.2004.06.014; Chen SHA, 2005, NEUROIMAGE, V24, P332, DOI 10.1016/j.neuroimage.2004.08.032; CONTENT A, 1990, ANN PSYCHOL, V90, P551; Cowan N, 2011, J COGNITIVE NEUROSCI, V23, P2852, DOI 10.1162/jocn.2011.21625; Cowan Nelson, 1999, MODELS WORKING MEMOR, P62, DOI [10.1017/CBO9781139174909.006, DOI 10.1017/CBO9781139174909.006]; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Engle RW, 2004, PSYCHOL LEARN MOTIV, V44, P145; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Gibbs SEB, 2005, COGN AFFECT BEHAV NE, V5, P212, DOI 10.3758/CABN.5.2.212; Gitelman DR, 2003, NEUROIMAGE, V19, P200, DOI 10.1016/S1053-8119(03)00058-2; Glabus MF, 2003, CEREB CORTEX, V13, P1352, DOI 10.1093/cercor/bhg082; Gray JR, 2002, COGN AFFECT BEHAV NE, V2, P64, DOI 10.3758/CABN.2.1.64; Grimm S, 2012, NEUROIMAGE, V61, P1188, DOI 10.1016/j.neuroimage.2012.04.004; Hadley CB, 2006, J EXP PSYCHOL LEARN, V32, P79, DOI 10.1037/0278-7393.32.1.79; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Hulme C, 1997, J EXP PSYCHOL LEARN, V23, P1217, DOI 10.1037/0278-7393.23.5.1217; Hulme C, 2006, J EXP PSYCHOL LEARN, V32, P586, DOI 10.1037/0278-7393.32.3.586; Hutton C, 2002, NEUROIMAGE, V16, P217, DOI 10.1006/nimg.2001.1054; Larsson J, 2012, CEREB CORTEX, V22, P567, DOI 10.1093/cercor/bhr119; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; Lewis-Peacock JA, 2012, NEUROPSYCHOLOGIA, V50, P470, DOI 10.1016/j.neuropsychologia.2011.11.006; Lewis-Peacock JA, 2012, J COGNITIVE NEUROSCI, V24, P61, DOI 10.1162/jocn_a_00140; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Majerus S, 2007, NEUROIMAGE, V35, P353, DOI 10.1016/j.neuroimage.2006.12.008; Majerus S, 2006, NEUROIMAGE, V32, P880, DOI 10.1016/j.neuroimage.2006.03.048; Majerus S, 2012, CEREB CORTEX, V22, P1086, DOI 10.1093/cercor/bhr174; Majerus S, 2011, J MEM LANG, V64, P181, DOI 10.1016/j.jml.2010.10.003; Majerus S, 2010, J COGNITIVE NEUROSCI, V22, P2570, DOI 10.1162/jocn.2009.21378; Minamoto T, 2010, BRAIN RES, V1335, P63, DOI 10.1016/j.brainres.2010.03.088; Nee DE, 2007, NEUROIMAGE, V38, P740, DOI 10.1016/j.neuroimage.2007.07.066; Neta M, 2011, NEUROIMAGE, V56, P1685, DOI 10.1016/j.neuroimage.2011.02.051; Newman AJ, 2001, J PSYCHOLINGUIST RES, V30, P339, DOI 10.1023/A:1010499119393; Ollinger JM, 2001, NEUROIMAGE, V13, P210, DOI 10.1006/nimg.2000.0710; Pessoa L, 2002, NEURON, V35, P975, DOI 10.1016/S0896-6273(02)00817-6; Postle BR, 2006, NEUROSCIENCE, V139, P23, DOI 10.1016/j.neuroscience.2005.06.005; Postle BR, 2005, J COGNITIVE NEUROSCI, V17, P1679, DOI 10.1162/089892905774589208; Ravizza SM, 2004, NEUROIMAGE, V22, P562, DOI 10.1016/j.neuroimage.2004.01.039; Riggall AC, 2012, J NEUROSCI, V32, P12990, DOI 10.1523/JNEUROSCI.1892-12.2012; Sara SJ, 2012, NEURON, V76, P130, DOI 10.1016/j.neuron.2012.09.011; Satterthwaite TD, 2012, NEUROIMAGE, V61, P723, DOI 10.1016/j.neuroimage.2012.03.060; Schaefer A, 2006, J NEUROSCI, V26, P10120, DOI 10.1523/JNEUROSCI.2567-06.2006; Scheuerecker J, 2007, NEUROPSYCHOBIOLOGY, V56, P32, DOI 10.1159/000110726; Shtyrov Y, 2004, EUR J NEUROSCI, V19, P1083, DOI 10.1111/j.0953-816X.2004.03126.x; Smith APR, 2005, LEARN MEMORY, V12, P472, DOI 10.1101/lm.84305; Sterpenich V, 2006, J NEUROSCI, V26, P7416, DOI 10.1523/JNEUROSCI.1001-06.2006; Todd JJ, 2005, COGN AFFECT BEHAV NE, V5, P144, DOI 10.3758/CABN.5.2.144; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P74, DOI 10.1002/(SICI)1097-0193(1996)4:1<74::AID-HBM5>3.0.CO;2-M; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O	55	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e69278	10.1371/journal.pone.0069278	http://dx.doi.org/10.1371/journal.pone.0069278			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182JD	23874935	gold, Green Submitted, Green Published			2022-12-27	WOS:000321736900148
J	Zhou, SQ; Fang, X; Xin, HP; Li, W; Qiu, HY; Guan, SM				Zhou, Shaoqiong; Fang, Xing; Xin, Huaping; Li, Wei; Qiu, Hongyu; Guan, Siming			Osteoprotegerin Inhibits Calcification of Vascular Smooth Muscle Cell via Down Regulation of the Notch1-RBP-J kappa/Msx2 Signaling Pathway	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; CHRONIC KIDNEY-DISEASE; LONG-TERM PROGNOSIS; CARDIOVASCULAR-DISEASE; SERUM OSTEOPROTEGERIN; BONE-DENSITY; RISK-FACTORS; NOTCH; EXPRESSION; MORTALITY	Objective: Vascular calcification is a common pathobiological process which occurs among the elder population and in patients with diabetes and chronic kidney disease. Osteoprotegerin, a secreted glycoprotein that regulates bone mass, has recently emerged as an important regulator of the development of vascular calcification. However, the mechanism is not fully understood. The purpose of this study is to explore novel signaling mechanisms of osteoprotegerin in the osteoblastic differentiation in rat aortic vascular smooth muscle cells (VSMCs). Methods and Results: VSMCs were isolated from thoracic aorta of Sprague Dawley rats. Osteoblastic differentiation of VSMCs was induced by an osteogenic medium. We confirmed by Von Kossa staining and direct cellular calcium measurement that mineralization was significantly increased in VSMCs cultured in osteogenic medium; consistent with an enhanced alkaline phosphatase activity. This osteoblastic differentiation in VSMCs was significantly reduced by the addition of osteoprotegerin in a dose responsive manner. Moreover, we identified, by real-time qPCR and western blotting, that expression of Notch1 and RBP-J kappa were significantly up-regulated in VSMCs cultured in osteogenic medium at both the mRNA and protein levels, these effects were dose-dependently abolished by the treatment of osteoprotegerin. Furthermore, we identified that Msx2, a downstream target of the Notch1/RBP-J kappa signaling, was markedly down-regulated by the treatment of osteoprotegerin. Conclusion: Osteoprotegerin inhibits vascular calcification through the down regulation of the Notch1-RBP-J kappa signaling pathway.	[Zhou, Shaoqiong; Fang, Xing; Xin, Huaping; Li, Wei; Guan, Siming] Huazhong Univ Sci & Technol, Dept Gerontol, Union Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; [Qiu, Hongyu] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Cell Biol & Mol Med, Newark, NJ 07103 USA	Huazhong University of Science & Technology; Rutgers State University New Brunswick; Rutgers State University Medical Center	Qiu, HY (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Cell Biol & Mol Med, 185 S Orange Ave, Newark, NJ 07103 USA.	qiuho@umdnj.edu; smguan16@yahoo.com	li, wj/HGD-7322-2022; 黎, 伟/GXM-4040-2022		United States National Institutes of Health [HL115195]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115195] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was partially supported by the United States National Institutes of Health (HL115195) to HQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Acharya A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027743; Albalate M, 2006, NEPHROL DIAL TRANSPL, V21, P1626, DOI 10.1093/ndt/gfl034; Augoulea A, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/182060; Baber U, 2008, KIDNEY INT, V73, P615, DOI 10.1038/sj.ki.5002716; Bai S, 2008, J BIOL CHEM, V283, P6509, DOI 10.1074/jbc.M707000200; Bennett BJ, 2006, ARTERIOSCL THROM VAS, V26, P2117, DOI 10.1161/01.ATV.0000236428.91125.e6; Body JJ, 2003, CANCER-AM CANCER SOC, V97, P887, DOI 10.1002/cncr.11138; Browner WS, 2001, J CLIN ENDOCR METAB, V86, P631, DOI 10.1210/jc.86.2.631; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Budoff MJ, 2007, J AM COLL CARDIOL, V49, P1860, DOI 10.1016/j.jacc.2006.10.079; Collin-Osdoby P, 2004, CIRC RES, V95, P1046, DOI 10.1161/01.RES.0000149165.99974.12; Crisafulli A, 2005, CLIN SCI, V109, P389, DOI 10.1042/CS20050058; Fahrleitner A, 2003, BONE, V32, P96, DOI 10.1016/S8756-3282(02)00926-2; Fu MG, 2002, BIOCHEM BIOPH RES CO, V294, P597, DOI 10.1016/S0006-291X(02)00533-8; Iyemere VP, 2006, J INTERN MED, V260, P192, DOI 10.1111/j.1365-2796.2006.01692.x; Jono S, 2002, CIRCULATION, V106, P1192, DOI 10.1161/01.CIR.0000031524.49139.29; Kiechl S, 2004, CIRCULATION, V109, P2175, DOI 10.1161/01.CIR.0000127957.43874.BB; Langdon T, 2006, DEV DYNAM, V235, P998, DOI 10.1002/dvdy.20735; Lee HL, 2010, BIOCHEM BIOPH RES CO, V391, P1087, DOI 10.1016/j.bbrc.2009.12.027; Lieb W, 2010, ARTERIOSCL THROM VAS, V30, P1849, DOI 10.1161/ATVBAHA.109.199661; Mazzaferro S, 2007, AM J NEPHROL, V27, P75, DOI 10.1159/000099095; Mizuno A, 1998, BIOCHEM BIOPH RES CO, V247, P610, DOI 10.1006/bbrc.1998.8697; Moe SM, 2004, CIRC RES, V95, P560, DOI 10.1161/01.RES.0000141775.67189.98; Mogelvang R, 2013, HEART, V99, P106, DOI 10.1136/heartjnl-2012-302240; Morrow D, 2008, CIRC RES, V103, P1370, DOI 10.1161/CIRCRESAHA.108.187534; Mulvihill ER, 2004, ARTERIOSCL THROM VAS, V24, P1283, DOI 10.1161/01.ATV.0000132401.12275.0c; Nie B, 2012, J HUAZHONG U SCI-MED, V32, P818, DOI 10.1007/s11596-012-1040-4; Niessen K, 2008, CIRC RES, V102, P1169, DOI 10.1161/CIRCRESAHA.108.174318; Nigam V, 2009, J MOL CELL CARDIOL, V47, P828, DOI 10.1016/j.yjmcc.2009.08.008; Nybo M, 2008, EUR J ENDOCRINOL, V159, P603, DOI 10.1530/EJE-08-0554; O'Rourke RA, 2000, CIRCULATION, V102, P126, DOI 10.1161/01.CIR.102.1.126; Olesen P, 2005, DIABETOLOGIA, V48, P561, DOI 10.1007/s00125-004-1652-8; Omland T, 2008, J AM COLL CARDIOL, V51, P627, DOI 10.1016/j.jacc.2007.09.058; Orita Y, 2007, ARTERIOSCL THROM VAS, V27, P2058, DOI 10.1161/ATVBAHA.107.147868; Price PA, 2001, ARTERIOSCL THROM VAS, V21, P1610, DOI 10.1161/hq1001.097102; Qiu HY, 2010, CIRC RES, V107, P615, DOI 10.1161/CIRCRESAHA.110.221846; Rasmussen L M, 2005, Horm Metab Res, V37 Suppl 1, P90, DOI 10.1055/s-2005-861371; Rennenberg RJMW, 2009, VASC HEALTH RISK MAN, V5, P185; Sandberg WJ, 2006, ARTERIOSCL THROM VAS, V26, P857, DOI 10.1161/01.ATV.0000204334.48195.6a; Sato T, 2001, AM J KIDNEY DIS, V38, pS175, DOI 10.1053/ajkd.2001.27437; Shao JS, 2010, HYPERTENSION, V55, P579, DOI 10.1161/HYPERTENSIONAHA.109.134205; Shimizu T, 2009, ARTERIOSCL THROM VAS, V29, P1104, DOI 10.1161/ATVBAHA.109.187856; Shimizu T, 2008, CIRCULATION, V118, pS368; Sigrist MK, 2009, NEPHROL DIAL TRANSPL, V24, P3157, DOI 10.1093/ndt/gfp253; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Venuraju SM, 2010, J AM COLL CARDIOL, V55, P2049, DOI 10.1016/j.jacc.2010.03.013; Wasilewska A, 2010, PEDIATR NEPHROL, V25, P2067, DOI 10.1007/s00467-010-1583-1; Xin HP, 2013, INT J MOL MED, V31, P583, DOI 10.3892/ijmm.2013.1242; Yasuda H, 1998, ENDOCRINOLOGY, V139, P1329, DOI 10.1210/en.139.3.1329; Zampetaki A, 2005, AM J PHYSIOL-HEART C, V288, pH2946, DOI 10.1152/ajpheart.00919.2004; Zhang JF, 2002, FEBS LETT, V521, P180, DOI 10.1016/S0014-5793(02)02872-7	51	31	35	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68987	10.1371/journal.pone.0068987	http://dx.doi.org/10.1371/journal.pone.0068987			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874840	gold, Green Published, Green Submitted			2022-12-27	WOS:000321736900125
J	Chen, K; Li, Y; Dai, YD; Li, JC; Qin, YR; Zhu, YH; Zeng, TT; Ban, XJ; Fu, L; Guan, XY				Chen, Kai; Li, Yan; Dai, Yongdong; Li, Jiangchao; Qin, Yanru; Zhu, Yinghui; Zeng, Tingting; Ban, Xiaojiao; Fu, Li; Guan, Xin-Yuan			Characterization of Tumor Suppressive Function of cornulin in Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							CALCIUM-BINDING PROTEINS; DOWN-REGULATION; CHROMOSOME 1Q; FREQUENT LOSS; BETA-CATENIN; ALLELIC LOSS; GENE FAMILY; S100 GENES; CANCER; EXPRESSION	By using cDNA microarray analysis, we identified cornulin (CRNN) gene was frequently downregulated in esophageal squamous cell carcinoma (ESCC). In the present study, we investigated the role of CRNN in ESCC development. The results showed that CRNN was frequently downregulated in primary ESCCs in both mRNA level (26/56, 46.4%) and protein level (137/249, 55%), which was significantly associated with lymph node metastases (P=0.027), advanced clinical stage (P=0.039), and overall survival rate (P<0.001). Multivariate analysis indicated that the CRNN downregulation was an independent prognostic factor for ESCC. Functional studies with both in vitro and in vivo assays demonstrated that CRNN had strong tumor suppressive ability in ESCC cells. The tumor-suppressive mechanism of CRNN was associated with its role in cell cycle arrest at G1/S checkpoint by upregulating expressions of P21(WAF1/CIP1) and Rb. Silencing CRNN expression by RNA interference could effectively inhibit its tumor suppressive effect. In conclusion, our findings demonstrate that CRNN is a tumor suppressor gene that plays a critical tumor suppressive role in ESCC.	[Chen, Kai; Li, Yan; Dai, Yongdong; Li, Jiangchao; Zhu, Yinghui; Zeng, Tingting; Ban, Xiaojiao; Fu, Li; Guan, Xin-Yuan] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol Southern China, Guangzhou 510275, Guangdong, Peoples R China; [Fu, Li; Guan, Xin-Yuan] Univ Hong Kong, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China; [Qin, Yanru] Zhengzhou Univ, Affiliated Hosp 1, Dept Clin Oncol, Zhengzhou 450052, Peoples R China; [Li, Jiangchao] Guangdong Pharmaceut Univ, Vasc Biol Res Inst, Guangzhou, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; University of Hong Kong; Zhengzhou University; Guangdong Pharmaceutical University	Li, Y (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol Southern China, Guangzhou 510275, Guangdong, Peoples R China.	liyan@sysucc.org.cn; xyguan@hkucc.hku.hk	Li, Jiangchao/AAF-4515-2021; Fu, Li/F-7182-2010; /A-3639-2009	Li, Jiangchao/0000-0002-0947-7580; Fu, Li/0000-0003-2643-6278; /0000-0003-1874-9805	National Natural Science Foundation of China [81272416, 81172338, 81000863]; General Research Fund [HKU 7668/11M]; Sun Yat-Sen University "Hundred Talents Program" [85000-3171311]; Sun Yat-sen University Young Talent Teachers Plan [11ykpy58]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); General Research Fund; Sun Yat-Sen University "Hundred Talents Program"; Sun Yat-sen University Young Talent Teachers Plan	This work was supported by Grants from the National Natural Science Foundation of China (81272416, 81172338 and 81000863); the General Research Fund (HKU 7668/11M); Sun Yat-Sen University "Hundred Talents Program" (85000-3171311) and Sun Yat-sen University Young Talent Teachers Plan (11ykpy58). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Contzler R, 2005, J INVEST DERMATOL, V124, P990, DOI 10.1111/j.0022-202X.2005.23694.x; Darragh J, 2006, FEBS J, V273, P1930, DOI 10.1111/j.1742-4658.2006.05206.x; Donato R, 1999, BBA-MOL CELL RES, V1450, P191, DOI 10.1016/S0167-4889(99)00058-0; Fu L, 2007, CANCER-AM CANCER SOC, V110, P2672, DOI 10.1002/cncr.23110; Fu L, 2007, CANCER RES, V67, P10720, DOI 10.1158/0008-5472.CAN-07-2411; Gaki V, 2000, EUR J SURG ONCOL, V26, P455, DOI 10.1053/ejso.1999.0921; Ilg EC, 1996, INT J CANCER, V68, P325, DOI 10.1002/(SICI)1097-0215(19961104)68:3<325::AID-IJC10>3.0.CO;2-7; Imai FL, 2005, INT J BIOCHEM CELL B, V37, P1641, DOI 10.1016/j.biocel.2005.02.005; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Ji Junfang, 2010, Front Med China, V4, P412, DOI 10.1007/s11684-010-0260-x; Kashyap MK, 2009, CANCER BIOL THER, V8, P36, DOI 10.4161/cbt.8.1.7090; KLIGMAN D, 1988, TRENDS BIOCHEM SCI, V13, P437, DOI 10.1016/0968-0004(88)90218-6; LEE SW, 1992, P NATL ACAD SCI USA, V89, P2504, DOI 10.1073/pnas.89.6.2504; Li J, 2005, CANCER LETT, V220, P221, DOI 10.1016/j.canlet.2004.07.032; Li Y, 2010, CANCER RES, V70, P5695, DOI 10.1158/0008-5472.CAN-10-0392; Little TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001003; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Luo AP, 2004, ONCOGENE, V23, P1291, DOI 10.1038/sj.onc.1207218; Luthra MG, 2007, CLIN CANCER RES, V13, P912, DOI 10.1158/1078-0432.CCR-06-1577; Maelandsmo GM, 1997, INT J CANCER, V74, P464, DOI 10.1002/(SICI)1097-0215(19970822)74:4<464::AID-IJC19>3.0.CO;2-9; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Maru DM, 2009, CANCER, V115, P1576, DOI 10.1002/cncr.24122; Offner FA, 2000, PATHOLOGE, V21, P349, DOI 10.1007/s002920000414; Parry D, 1999, MOL CELL BIOL, V19, P1775; Pawar H, 2013, ACTA HISTOCHEM, V115, P89, DOI 10.1016/j.acthis.2012.04.003; PISANI P, 1993, INT J CANCER, V55, P891, DOI 10.1002/ijc.2910550604; Ridinger K, 1998, BBA-MOL CELL RES, V1448, P254, DOI 10.1016/S0167-4889(98)00137-2; Sakaguchi M, 2000, J CELL BIOL, V149, P1193, DOI 10.1083/jcb.149.6.1193; Schaaij-Visser TBM, 2009, CLIN CANCER RES, V15, P7666, DOI 10.1158/1078-0432.CCR-09-2134; SCHAFER BW, 1995, GENOMICS, V25, P638, DOI 10.1016/0888-7543(95)80005-7; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scotto C, 1998, MOL CELL BIOL, V18, P4272, DOI 10.1128/MCB.18.7.4272; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; Xie D, 2003, INT J CANCER, V107, P896, DOI 10.1002/ijc.11514; Xu ZX, 2000, GENOMICS, V69, P322, DOI 10.1006/geno.2000.6344; Yagui-Beltran A, 2001, EUR J BIOCHEM, V268, P5343, DOI 10.1046/j.0014-2956.2001.02468.x; Yang YM, 2005, INT J CANCER, V117, P234, DOI 10.1002/ijc.21175; Zhang W, 2009, CANCER SCI, V100, P1695, DOI 10.1111/j.1349-7006.2009.01240.x	40	20	20	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e68838	10.1371/journal.pone.0068838	http://dx.doi.org/10.1371/journal.pone.0068838			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894350	Green Published, gold, Green Submitted			2022-12-27	WOS:000322167900027
J	Kroll, E; Coyle, S; Dunn, B; Koniges, G; Aragon, A; Edwards, J; Rosenzweig, F				Kroll, Evgueny; Coyle, Scott; Dunn, Barbara; Koniges, Gregory; Aragon, Anthony; Edwards, Jeremy; Rosenzweig, Frank			Starvation-Associated Genome Restructuring Can Lead to Reproductive Isolation in Yeast	PLOS ONE			English	Article							MISMATCH REPAIR SYSTEM; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; INCIPIENT SPECIATION; HYBRID SPECIATION; EVOLUTION; REARRANGEMENTS; RECOMBINATION; DUPLICATION; POPULATIONS	Knowledge of the mechanisms that lead to reproductive isolation is essential for understanding population structure and speciation. While several models have been advanced to explain post-mating reproductive isolation, experimental data supporting most are indirect. Laboratory investigations of this phenomenon are typically carried out under benign conditions, which result in low rates of genetic change unlikely to initiate reproductive isolation. Previously, we described an experimental system using the yeast Saccharomyces cerevisiae where starvation served as a proxy to any stress that decreases reproduction and/or survivorship. We showed that novel lineages with restructured genomes quickly emerged in starved populations, and that these survivors were more fit than their ancestors when re-starved. Here we show that certain yeast lineages that survive starvation have become reproductively isolated from their ancestor. We further demonstrate that reproductive isolation arises from genomic rearrangements, whose frequency in starving yeast is several orders of magnitude greater than an unstarved control. By contrast, the frequency of point mutations is less than 2-fold greater. In a particular case, we observe that a starved lineage becomes reproductively isolated as a direct result of the stress-related accumulation of a single chromosome. We recapitulate this result by demonstrating that introducing an extra copy of one or several chromosomes into naive, i.e. unstarved, yeast significantly diminishes their fertility. This type of reproductive barrier, whether arising spontaneously or via genetic manipulation, can be removed by making a lineage euploid for the altered chromosomes. Our model provides direct genetic evidence that reproductive isolation can arise frequently in stressed populations via genome restructuring without the precondition of geographic isolation.	[Kroll, Evgueny; Koniges, Gregory; Rosenzweig, Frank] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Coyle, Scott] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Dunn, Barbara] Stanford Univ, Sch Med, Dept Genet, Stanford, CA USA; [Aragon, Anthony; Edwards, Jeremy] Univ New Mexico, Albuquerque, NM 87131 USA	University of Montana System; University of Montana; University of California System; University of California San Francisco; Stanford University; University of New Mexico	Kroll, E (corresponding author), Univ Montana, Div Biol Sci, Missoula, MT 59812 USA.	evgueny.kroll@mso.umt.edu		Dunn, Barbara/0000-0002-7041-0035	National Science Foundation (NSF) [0134648]; NASA [NNX07AJ28G]	National Science Foundation (NSF)(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA))	This work was supported by grants from the National Science Foundation (NSF) (0134648) to EK and NASA (NNX07AJ28G) to FR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS J, 1992, CURR GENET, V22, P13, DOI 10.1007/BF00351736; ADAMS J, 1985, GENETICS, V110, P173; Anders KR, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-36; Barlow AL, 2002, CYTOGENET GENOME RES, V96, P45, DOI 10.1159/000063045; Bateson W, 1909, DARWIN MODERN SCI; BENNETT AF, 1990, NATURE, V346, P79, DOI 10.1038/346079a0; Bjedov I, 2003, SCIENCE, V300, P1404, DOI 10.1126/science.1082240; Brachmann CB, 1998, YEAST, V14, P115; Brennan AC, 2012, HEREDITY, V108, P87, DOI 10.1038/hdy.2011.46; CAIRNS J, 1991, GENETICS, V128, P695; Chambers SR, 1996, MOL CELL BIOL, V16, P6110; Chen C, 1998, MOL CELL, V2, P9, DOI 10.1016/S1097-2765(00)80109-4; Chen WL, 1999, GENETICS, V151, P1299; Coghlan A, 2005, TRENDS GENET, V21, P673, DOI 10.1016/j.tig.2005.09.009; Colnaghi R, 2011, SEMIN CELL DEV BIOL, V22, P875, DOI 10.1016/j.semcdb.2011.07.010; Coyle S, 2008, MOL BIOL EVOL, V25, P310, DOI 10.1093/molbev/msm256; DEATH A, 1994, J BACTERIOL, V176, P5101, DOI 10.1128/jb.176.16.5101-5107.1994; Delneri D, 2003, NATURE, V422, P68, DOI 10.1038/nature01418; Dettman JR, 2007, NATURE, V447, P585, DOI 10.1038/nature05856; DIMPFL J, 1989, GENETICS, V123, P255; Dobzhansky T, 1933, P NATL ACAD SCI USA, V19, P397, DOI 10.1073/pnas.19.4.397; Dobzhansky T., 1937; Drake JW, 2007, CRIT REV BIOCHEM MOL, V42, P247, DOI 10.1080/10409230701495631; Drake JW, 1998, GENETICS, V148, P1667; Dunham MJ, 2002, P NATL ACAD SCI USA, V99, P16144, DOI 10.1073/pnas.242624799; Dunn B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-53; EVANS DA, 1989, TRENDS GENET, V5, P46, DOI 10.1016/0168-9525(89)90021-8; Ezov TK, 2006, GENETICS, V174, P1455, DOI 10.1534/genetics.106.062745; Forche A, 2011, MBIO, V2, DOI 10.1128/mBio.00129-11; Fry JD, 2009, EXPT EVOLUTION CONCE; GILBERT W, 1985, SCIENCE, V228, P823, DOI 10.1126/science.4001923; Gonzalez C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000208; Greig D, 2003, J EVOLUTION BIOL, V16, P429, DOI 10.1046/j.1420-9101.2003.00546.x; Greig D, 2002, SCIENCE, V298, P1773, DOI 10.1126/science.1076374; Greig D, 2009, HEREDITY, V102, P39, DOI 10.1038/hdy.2008.73; Gresham D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000303; Guthrie C, 1991, METHODS ENZYMOLOGY, V194; Hadany L, 2003, GENETICS, V165, P2167; Hastings PJ, 2000, CELL, V103, P723, DOI 10.1016/S0092-8674(00)00176-8; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; HURST DD, 1964, GENETICS, V50, P435; Infante JJ, 2003, GENETICS, V165, P1745; Johnston JR, 2000, RES MICROBIOL, V151, P583, DOI 10.1016/S0923-2508(00)00228-X; Kao KC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001038; King M., 1993, SPECIES EVOLUTION; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; Lacefield S, 2007, NAT GENET, V39, P1273, DOI 10.1038/ng2120; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee HY, 2008, CELL, V135, P1065, DOI 10.1016/j.cell.2008.10.047; Li XC, 2009, HEREDITY, V102, P24, DOI 10.1038/hdy.2008.84; Lin DX, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002223; Liu PF, 2011, CELL, V146, P888, DOI 10.1016/j.cell.2011.07.042; Manterola M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000625; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; McCullock S, 2006, J MOL BIOL, V363, P660, DOI 10.1016/j.jmb.2006.08.073; McMurray MA, 2003, SCIENCE, V301, P1908, DOI 10.1126/science.1087706; Morrow DM, 1997, GENETICS, V147, P371; Mortimer RK, 2000, GENOME RES, V10, P403, DOI 10.1101/gr.10.4.403; Naumov GI, 2000, INT J SYST EVOL MICR, V50, P1931, DOI 10.1099/00207713-50-5-1931; Noor MAF, 1999, HEREDITY, V83, P503, DOI 10.1038/sj.hdy.6886320; Nunes AC, 2011, HEREDITY, V106, P348, DOI 10.1038/hdy.2010.74; Orr HA, 2000, BIOESSAYS, V22, P1085, DOI 10.1002/1521-1878(200012)22:12&lt;1085::AID-BIES6&gt;3.0.CO;2-G; Piotrowski JS, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-46; Querol A, 2009, FEMS MICROBIOL LETT, V293, P1, DOI 10.1111/j.1574-6968.2008.01480.x; RAYSSIGUIER C, 1989, NATURE, V342, P396, DOI 10.1038/342396a0; RICE WR, 1993, EVOLUTION, V47, P1637, DOI [10.2307/2410209, 10.1111/j.1558-5646.1993.tb01257.x]; Rockmill B, 1998, GENE DEV, V12, P2574, DOI 10.1101/gad.12.16.2574; Roeder GS, 2000, TRENDS GENET, V16, P395, DOI 10.1016/S0168-9525(00)02080-1; Rose MD., 1990, METHODS YEAST GENETI; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Torres EM, 2008, GENETICS, V179, P737, DOI 10.1534/genetics.108.090878; Treco Douglas A, 2008, Curr Protoc Mol Biol, VChapter 13, DOI 10.1002/0471142727.mb1302s82; Wallace AR, 1889, DARWINISM; Wells WAE, 1996, J CELL BIOL, V133, P75, DOI 10.1083/jcb.133.1.75; White M.J.D., 1978, MODES SPECIATION; Wood TE, 2009, P NATL ACAD SCI USA, V106, P13875, DOI 10.1073/pnas.0811575106; Yona AH, 2012, P NATL ACAD SCI USA, V109, P21010, DOI 10.1073/pnas.1211150109; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhivotovsky Lev A., 1997, EXS, V83, P241; Zinser ER, 1999, J BACTERIOL, V181, P5800, DOI 10.1128/JB.181.18.5800-5807.1999	80	6	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e66414	10.1371/journal.pone.0066414	http://dx.doi.org/10.1371/journal.pone.0066414			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894280	gold, Green Submitted, Green Published			2022-12-27	WOS:000322167900003
J	Tabunoki, H; Ono, H; Ode, H; Ishikawa, K; Kawana, N; Banno, Y; Shimada, T; Nakamura, Y; Yamamoto, K; Satoh, J; Bono, H				Tabunoki, Hiroko; Ono, Hiromasa; Ode, Hiroaki; Ishikawa, Kazuhiro; Kawana, Natsuki; Banno, Yutaka; Shimada, Toru; Nakamura, Yuki; Yamamoto, Kimiko; Satoh, Jun-ichi; Bono, Hidemasa			Identification of Key Uric Acid Synthesis Pathway in a Unique Mutant Silkworm Bombyx mori Model of Parkinson's Disease	PLOS ONE			English	Article							TRANSLUCENT LARVAL SKIN; XANTHINE DEHYDROGENASE; TYROSINE-HYDROXYLASE; DJ-1; GENE; MUTATIONS; URATE; APOPTOSIS; OXIDATION; PROTEIN	Plasma uric acid (UA) levels decrease following clinical progression and stage development of Parkinson's disease (PD). However, the molecular mechanisms underlying decreases in plasma UA levels remain unclear, and the potential to apply mutagenesis to a PD model has not previously been discovered. We identified a unique mutant of the silkworm Bombyx mori (B. mori) op. Initially, we investigated the causality of the phenotypic "op" by microarray analysis using our constructed KAIKO functional annotation pipeline. Consequently, we found a novel UA synthesis-modulating pathway, from DJ-1 to xanthine oxidase, and established methods for large-scale analysis of gene expression in B. mori. We found that the mRNA levels of genes in this pathway were significantly lower in B. mori op mutants, indicating that downstream events in the signal transduction cascade might be prevented. Additionally, levels of B. mori tyrosine hydroxylase (TH) and DJ-1 mRNA were significantly lower in the brain of B. mori op mutants. UA content was significantly lower in the B. mori op mutant tissues and hemolymph. The possibility that the B. mori op mutant might be due to loss of DJ-1 function was supported by the observed vulnerability to oxidative stress. These results suggest that UA synthesis, transport, elimination and accumulation are decreased by environmental oxidative stress in the B. mori op mutant. In the case of B. mori op mutants, the relatively low availability of UA appears to be due both to the oxidation of DJ-1 and to its expenditure to mitigate the effects of environmental oxidative stress. Our findings are expected to provide information needed to elucidate the molecular mechanism of decreased plasma UA levels in the clinical stage progression of PD.	[Tabunoki, Hiroko; Ode, Hiroaki; Ishikawa, Kazuhiro; Kawana, Natsuki; Satoh, Jun-ichi] Meiji Pharmaceut Univ, Dept Bioinformat & Mol Neuropathol, Tokyo, Japan; [Ono, Hiromasa; Bono, Hidemasa] ROIS, Database Ctr Life Sci DBCLS, Tokyo, Japan; [Banno, Yutaka] Kyushu Univ, Ctr Genet Resources, Fukuoka 812, Japan; [Shimada, Toru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Tokyo, Japan; [Nakamura, Yuki; Yamamoto, Kimiko] Natl Inst Agrobiol Sci, Insect Genome Res Unit, Tsukuba, Ibaraki, Japan	Meiji Pharmaceutical University; Research Organization of Information & Systems (ROIS); Kyushu University; University of Tokyo; National Institute of Agrobiological Sciences - Japan	Tabunoki, H (corresponding author), Tokyo Univ Agr & Technol, Fac Agr, Dept Biol Prod, Fuchu, Tokyo 183, Japan.	h_tabuno@cc.tuat.ac.jp; bono@DBCLS.jp	Ono, Hiromasa/ABA-1412-2021; TABUNOKI, Hiroko/H-6593-2013; Bono, Hidemasa/AAF-3649-2020; Shimada, Toru/AAZ-2703-2021; Shimada, Toru/A-2033-2011	Ono, Hiromasa/0000-0001-8675-963X; TABUNOKI, Hiroko/0000-0003-1823-9952; Bono, Hidemasa/0000-0003-4413-0651; Shimada, Toru/0000-0002-5791-0000; Shimada, Toru/0000-0002-5791-0000	High-Tech Research Center Project; National Bioscience Database Center (NBDC) of the Japan Science and the Technology Agency (JST);  [18890212]	High-Tech Research Center Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Bioscience Database Center (NBDC) of the Japan Science and the Technology Agency (JST); 	Silkworms (o751) were provided by the National Bio-Resource Project (NBRP) of the Japanese Ministry of Education, Science, Sports and Culture. This work was supported by a Grant-in-Aid for Young Scientists B (18890212) to HT. This work was partly supported by grants from the High-Tech Research Center Project to JS. Support for this work was provided by the National Bioscience Database Center (NBDC) of the Japan Science and the Technology Agency (JST) to HB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; An CN, 2011, FERTIL STERIL, V96, P19, DOI 10.1016/j.fertnstert.2011.04.048; Andreadou E, 2009, CLIN NEUROL NEUROSUR, V111, P724, DOI 10.1016/j.clineuro.2009.06.012; Bogdanov M, 2008, BRAIN, V131, P389, DOI 10.1093/brain/awm304; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Bove Jordi, 2005, NeuroRx, V2, P484, DOI 10.1602/neurorx.2.3.484; CHURCH WH, 1994, BRAIN RES BULL, V33, P419, DOI 10.1016/0361-9230(94)90285-2; Cipriani S, 2010, BIOMARK MED, V4, P701, DOI 10.2217/BMM.10.94; Devine MJ, 2011, NAT REV CANCER, V11, P812, DOI 10.1038/nrc3150; Goldberg MS, 2005, NEURON, V45, P489, DOI 10.1016/j.neuron.2005.01.041; Hatano T, 2009, J NEUROCHEM, V111, P1075, DOI 10.1111/j.1471-4159.2009.06403.x; HAYASHI Y, 1960, NATURE, V186, P1053, DOI 10.1038/1861053a0; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Johansen KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007551; Kayyali US, 2001, J BIOL CHEM, V276, P14359, DOI 10.1074/jbc.M010100200; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Kinumi T, 2004, BIOCHEM BIOPH RES CO, V317, P722, DOI 10.1016/j.bbrc.2004.03.110; Kiuchi T, 2011, INSECT BIOCHEM MOLEC, V41, P680, DOI 10.1016/j.ibmb.2011.04.011; Komoto N, 2003, INSECT BIOCHEM MOLEC, V33, P417, DOI 10.1016/S0965-1748(03)00006-7; Komoto N, 2002, INSECT BIOCHEM MOLEC, V32, P591, DOI 10.1016/S0965-1748(01)00134-5; Lev N, 2006, J MOL NEUROSCI, V29, P215, DOI 10.1385/JMN:29:3:215; Ludecke B, 1996, HUM MOL GENET, V5, P1023, DOI 10.1093/hmg/5.7.1023; Matsuo T, 1999, APPL ENTOMOL ZOOL, V34, P481, DOI 10.1303/aez.34.481; Montgomery EB, 1999, NEUROLOGY, V52, P757, DOI 10.1212/WNL.52.4.757; Okada M, 2002, BIOL PHARM BULL, V25, P853, DOI 10.1248/bpb.25.853; Sato Hiromi, 2005, Curr Drug Discov Technol, V2, P89, DOI 10.2174/1570163054064701; Tabunoki H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017683; Tamura Toshiki, 1999, Journal of Sericultural Science of Japan, V68, P111; Tolun AA, 2010, ANAL BIOCHEM, V402, P191, DOI 10.1016/j.ab.2010.03.033; Weisskopf MG, 2007, AM J EPIDEMIOL, V166, P561, DOI 10.1093/aje/kwm127; Wilson MA, 2011, ANTIOXID REDOX SIGN, V15, P111, DOI 10.1089/ars.2010.3481; YAMADA M, 1986, Journal of Sericultural Science of Japan, V55, P428; Yoshida K, 2003, MOL REPROD DEV, V66, P391, DOI 10.1002/mrd.10360; Zhang JY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-611; Zhong N, 2006, J BIOL CHEM, V281, P20940, DOI 10.1074/jbc.M601935200; Zhu TG, 2012, NEUROSCI LETT, V506, P175, DOI 10.1016/j.neulet.2011.10.075	37	29	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69130	10.1371/journal.pone.0069130	http://dx.doi.org/10.1371/journal.pone.0069130			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894418	Green Published, Green Submitted, gold			2022-12-27	WOS:000322167900039
J	Shin, SC; Ahn, DH; Kim, SJ; Lee, H; Oh, TJ; Lee, JE; Park, H				Shin, Seung Chul; Ahn, Do Hwan; Kim, Su Jin; Lee, Hyoungseok; Oh, Tae-Jin; Lee, Jong Eun; Park, Hyun			Advantages of Single-Molecule Real-Time Sequencing in High-GC Content Genomes	PLOS ONE			English	Article							PYROSEQUENCING READS; DNA	Next-generation sequencing has become the most widely used sequencing technology in genomics research, but it has inherent drawbacks when dealing with high-GC content genomes. Recently, single-molecule real-time sequencing technology (SMRT) was introduced as a third-generation sequencing strategy to compensate for this drawback. Here, we report that the unbiased and longer read length of SMRT sequencing markedly improved genome assembly with high GC content via gap filling and repeat resolution.	[Shin, Seung Chul; Ahn, Do Hwan; Lee, Hyoungseok; Park, Hyun] Korea Polar Res Inst, Inchon, South Korea; [Ahn, Do Hwan; Park, Hyun] Univ Sci & Technol, Taejon, South Korea; [Kim, Su Jin] Korea Univ, Coll Life Sci & Biotechnol, Seoul, South Korea; [Oh, Tae-Jin] SunMoon Univ, Dept Pharmaceut Engn, Asan, South Korea; [Lee, Jong Eun] DNALink Inc, Seoul, South Korea	Korea Institute of Ocean Science & Technology (KIOST); Korea Polar Research Institute (KOPRI); Korea University; Sun Moon University	Park, H (corresponding author), Korea Polar Res Inst, Inchon, South Korea.	hpark@kopri.re.kr		Lee, Hyoungseok/0000-0002-5831-6345	Functional Genomics on Polar Organisms grant [PE13020]; Korea Polar Research Institute (KOPRI)	Functional Genomics on Polar Organisms grant; Korea Polar Research Institute (KOPRI)	This work was supported by a Functional Genomics on Polar Organisms grant (PE13020) funded by the Korea Polar Research Institute (KOPRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Au KF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046679; Clark SC, 2013, BIOINFORMATICS, V29, P435, DOI 10.1093/bioinformatics/bts723; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Koren S, 2012, NAT BIOTECHNOL, V30, P692, DOI 10.1038/nbt.2280; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Miller JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/bioinformatics/btn548; Nikodinovic J, 2003, BIOTECHNIQUES, V35, P932, DOI 10.2144/03355bm05; Niu BF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-187; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Schadt EE, 2010, HUM MOL GENET, V19, pR227, DOI 10.1093/hmg/ddq416; Schatz MC, 2011, BRIEF BIOINFORM; Travers KJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq543	16	54	72	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e68824	10.1371/journal.pone.0068824	http://dx.doi.org/10.1371/journal.pone.0068824			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894349	Green Published, Green Submitted, gold			2022-12-27	WOS:000325211000041
J	Maeng, YS; Maharjan, S; Kim, JH; Park, JH; Yu, YS; Kim, YM; Kwon, YG				Maeng, Yong-Sun; Maharjan, Sony; Kim, Jeong-Hun; Park, Jeong-Hill; Yu, Young Suk; Kim, Young-Myoung; Kwon, Young-Guen			Rk1, a Ginsenoside, Is a New Blocker of Vascular Leakage Acting through Actin Structure Remodeling	PLOS ONE			English	Article							TIGHT JUNCTIONS; ENDOTHELIAL PERMEABILITY; SPHINGOSINE 1-PHOSPHATE; PROCESSED GINSENG; BARRIER FUNCTION; PANAX-GINSENG; END-PRODUCTS; ANGIOGENESIS; INHIBITION; MYOSIN	Endothelial barrier integrity is essential for vascular homeostasis and increased vascular permeability and has been implicated in many pathological processes, including diabetic retinopathy. Here, we investigated the effect of Rk1, a ginsenoside extracted from sun ginseng, on regulation of endothelial barrier function. In human retinal endothelial cells, Rk1 strongly inhibited permeability induced by VEGF, advanced glycation end-product, thrombin, or histamine. Furthermore, Rk1 significantly reduced the vessel leakiness of retina in a diabetic mouse model. This anti-permeability activity of Rk1 is correlated with enhanced stability and positioning of tight junction proteins at the boundary between cells. Signaling experiments revealed that Rk1 induces phosphorylation of myosin light chain and cortactin, which are critical regulators for the formation of the cortical actin ring structure and endothelial barrier. These findings raise the possibility that ginsenoside Rk1 could be exploited as a novel prototype compound for the prevention of human diseases that are characterized by vascular leakage.	[Maeng, Yong-Sun; Maharjan, Sony; Kwon, Young-Guen] Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Seoul 120749, South Korea; [Maeng, Yong-Sun] Yonsei Univ, Coll Med, Corneal Dystrophy Res Inst, Seoul, South Korea; [Maeng, Yong-Sun] Yonsei Univ, Dept Ophthalmol, Coll Med, Seoul, South Korea; [Kim, Jeong-Hun; Yu, Young Suk] Seoul Natl Univ, Seoul Natl Univ Hosp, Clin Res Inst, Dept Ophthalmol,Coll Med,Seoul Artificial Eye Ctr, Seoul, South Korea; [Park, Jeong-Hill] Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Seoul, South Korea; [Kim, Young-Myoung] Kangwon Natl Univ, Vasc Syst Res Ctr, Kangwon Do, South Korea	Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Kangwon National University	Kwon, YG (corresponding author), Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Seoul 120749, South Korea.	ygkwon@yonsei.ac.kr		Kim, Jeong Hun/0000-0003-2957-1766; Maeng, Yong-Sun/0000-0003-1694-8405	Bio & Medical Technology Development Program of the National Research Foundation (NRF); Korean government (MEST) [2011-0019267]; Korea Health 21 R&D Project, Ministry of Health Welfare & Family Affairs, Republic of Korea [A085136]; Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2012002916]	Bio & Medical Technology Development Program of the National Research Foundation (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Korea Health 21 R&D Project, Ministry of Health Welfare & Family Affairs, Republic of Korea; Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MEST) (2011-0019267); a grant from the Korea Health 21 R&D Project, Ministry of Health Welfare & Family Affairs, Republic of Korea (A085136); and by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012002916). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JM, 1995, AM J PHYSIOL-GASTR L, V269, pG467, DOI 10.1152/ajpgi.1995.269.4.G467; [Anonymous], 2001, J APPL PHYSIOL; Bonnardel-Phu E, 1999, DIABETES, V48, P2052, DOI 10.2337/diabetes.48.10.2052; BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315; Cordenonsi M, 1999, J CELL BIOL, V147, P1569, DOI 10.1083/jcb.147.7.1569; Dudek SM, 2004, J BIOL CHEM, V279, P24692, DOI 10.1074/jbc.M313969200; Ehringer WD, 1996, J CELL PHYSIOL, V167, P562, DOI 10.1002/(SICI)1097-4652(199606)167:3<562::AID-JCP20>3.3.CO;2-K; Erickson Kathryn K., 2007, Angiogenesis, V10, P103, DOI 10.1007/s10456-007-9067-z; Frank RN, 2004, NEW ENGL J MED, V350, P48, DOI 10.1056/NEJMra021678; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; GARCIA JGN, 1986, J CELL PHYSIOL, V128, P96, DOI 10.1002/jcp.1041280115; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; Harhaj NS, 2004, INT J BIOCHEM CELL B, V36, P1206, DOI 10.1016/j.biocel.2003.08.007; Haskins J, 1998, J CELL BIOL, V141, P199, DOI 10.1083/jcb.141.1.199; Itoh M, 1999, J CELL BIOL, V147, P1351, DOI 10.1083/jcb.147.6.1351; Keum YS, 2000, CANCER LETT, V150, P41, DOI 10.1016/S0304-3835(99)00369-9; Kiefer D, 2003, AM FAM PHYSICIAN, V68, P1539; Kwon SW, 2001, J CHROMATOGR A, V921, P335, DOI 10.1016/S0021-9673(01)00869-X; Lee TK, 2005, MUTAGENESIS, V20, P237, DOI 10.1093/mutage/gei041; Leung KW, 2007, BRIT J PHARMACOL, V152, P207, DOI 10.1038/sj.bjp.0707359; Liu F, 2002, FASEB J, V16, P950, DOI 10.1096/fj.01-0870com; Madara JL, 1998, ANNU REV PHYSIOL, V60, P143, DOI 10.1146/annurev.physiol.60.1.143; Maniatis NA, 2008, CURR OPIN CRIT CARE, V14, P22, DOI 10.1097/MCC.0b013e3282f269b9; McVerry BJ, 2004, J CELL BIOCHEM, V92, P1075, DOI 10.1002/jcb.20088; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Michel CC, 1999, PHYSIOL REV, V79, P703, DOI 10.1152/physrev.1999.79.3.703; Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107; Min JK, 2006, BIOCHEM BIOPH RES CO, V349, P987, DOI 10.1016/j.bbrc.2006.08.129; MURATA T, 1995, OPHTHALMIC RES, V27, P48, DOI 10.1159/000267567; Papapetropoulos A, 2007, BRIT J PHARMACOL, V152, P172, DOI 10.1038/sj.bjp.0707360; Sacha Edyta, 2005, Przegl Lek, V62, P238; SATO K, 1994, BIOL PHARM BULL, V17, P635; Sengupta S, 2004, CIRCULATION, V110, P1219, DOI 10.1161/01.CIR.0000140676.88412.CF; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783; Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987; Wojciak-Stothard B, 2002, VASC PHARMACOL, V39, P187, DOI 10.1016/S1537-1891(03)00008-9; Wojciak-Stothard B, 2001, J CELL SCI, V114, P1343; WU NZ, 1992, AM J PHYSIOL, V262, pH1238; Yue PYK, 2006, BIOCHEM PHARMACOL, V72, P437, DOI 10.1016/j.bcp.2006.04.034; Yun TK, 2003, MUTAT RES-FUND MOL M, V523, P63, DOI 10.1016/S0027-5107(02)00322-6; Zeng LX, 2005, FASEB J, V19, P1845, DOI 10.1096/fj.05-4240fje	42	24	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e68659	10.1371/journal.pone.0068659	http://dx.doi.org/10.1371/journal.pone.0068659			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894330	gold, Green Submitted, Green Published			2022-12-27	WOS:000322132100021
J	Mai, RQ; Cheng, YB; Huang, YS; Zhang, GH				Mai, Ruiqin; Cheng, Yabin; Huang, Yuanshen; Zhang, Guohong			Esophageal Squamous Cell Carcinoma and Gastric Cardia Adenocarcinoma Shared Susceptibility Locus in PLCE1: A Meta-Analysis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HIGH-RISK; GENETIC-VARIATION; CANCER; TRENDS; 10Q23; AREAS	Background And Objective: Two recent genome-wide association studies have identified a shared susceptibility variation PLCE1 rs2274223 for esophageal squamous cell carcinoma (ESCC) and gastric cardia adenocarcinomas (GCA). Subsequent case-control studies have reported this association in other populations. However, the findings were controversial and the effect remains undetermined. Our aim is to provide a precise quantification of the association between PLCE1 rs2274223 variation and the risk of ESCC and GCA. Methods: Studies were identified by a literature search in MEDLINE and EMBASE databases. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the association in allele, dominant, recessive, homozygous, and heterozygous models. Results: Ten articles were identified, including 22156 ESCC cases and 28803 controls, 5197 GCA cases and 17613 controls. Overall, PLCE1 rs2274223 G allele (G vs. A: OR=1.26, 95% CI: 1.15-1.39 for ESCC; OR=1.51, 95% CI: 1.35-1.69 for GCA) and its carrier (GG + AG vs. AA: OR = 1.23; 95% CI =1.02-1.49 for ESCC; OR =1.62; 95% CI =1.15-2.29 for GCA) were significantly associated with the risk of ESCC and GCA. In stratified analysis by ethnicity, significant association of PLCE1 rs2274223 G allele and the risk of ESCC (OR=1.33, 95% CI 1.21-1.45) and GCA (OR =1.56, 95% CI: 1.47-1.64) was observed in Chinese population. Conclusions: Our meta-analysis results indicated that PLCE1 rs2274223 G allele significantly contributed to the risk of ESCC and GCA, especially in Chinese population.	[Mai, Ruiqin] Shantou Univ, Coll Med, Affiliated Hosp 1, Dept Lab Med, Shantou, Guangdong, Peoples R China; [Cheng, Yabin; Huang, Yuanshen; Zhang, Guohong] Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 1M9, Canada; [Zhang, Guohong] Shantou Univ, Coll Med, Dept Pathol, Shantou, Guangdong, Peoples R China	Shantou University; University of British Columbia; Shantou University	Zhang, GH (corresponding author), Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 1M9, Canada.	g_ghzhang@yahoo.com.cn	Cheng, Yabin/AAY-2178-2020; Cheng, Yabin/P-7071-2015	Cheng, Yabin/0000-0002-6205-3648; Cheng, Yabin/0000-0002-6205-3648	Natural Science Foundation of China [30901726]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by grant No.30901726 from The Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Bai YF, 2004, CANCER RES, V64, P8808, DOI 10.1158/0008-5472.CAN-04-3143; Bunney TD, 2006, MOL CELL, V21, P495, DOI 10.1016/j.molcel.2006.01.008; Bunney TD, 2009, ADV ENZYME REGUL, V49, P54, DOI 10.1016/j.advenzreg.2009.01.004; Bye H, 2012, CARCINOGENESIS, V33, P2155, DOI 10.1093/carcin/bgs262; Danielsen SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024419; Engel LS, 2003, J NATL CANCER I, V95, P1404, DOI 10.1093/jnci/djg047; Gu HY, 2012, MOL BIOL REP, V39, P9105, DOI 10.1007/s11033-012-1782-x; Guohong Zhang, 2010, PLoS One, V5, pe9668, DOI 10.1371/journal.pone.0009668; He YT, 2008, EUR J CANCER PREV, V17, P71, DOI 10.1097/CEJ.0b013e3282b6fd97; Hu HC, 2012, ANN SURG ONCOL, V19, P2403, DOI 10.1245/s10434-011-2160-y; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kelley GG, 2001, EMBO J, V20, P743, DOI 10.1093/emboj/20.4.743; Li XY, 2007, GENOMICS, V90, P474, DOI 10.1016/j.ygeno.2007.06.006; Luo DW, 2011, J GASTROENTEROL, V46, P1260, DOI 10.1007/s00535-011-0445-3; Nordmann AJ, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13518; Ou LP, 2010, CANCER GENET CYTOGEN, V200, P110, DOI 10.1016/j.cancergencyto.2010.01.021; Palmer AJ, 2012, EUR J CANCER PREV, V21, P541, DOI 10.1097/CEJ.0b013e3283529b79; Steevens J, 2010, GUT, V59, P39, DOI 10.1136/gut.2009.191080; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Su M, 2007, EUR J EPIDEMIOL, V22, P43, DOI 10.1007/s10654-006-9086-x; Tramacere I, 2011, EPIDEMIOLOGY, V22, P344, DOI 10.1097/EDE.0b013e31821092cd; Wang LD, 2010, NAT GENET, V42, P759, DOI 10.1038/ng.648; Wang MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031932; Wen DG, 2010, EUR J MED GENET, V53, P250, DOI 10.1016/j.ejmg.2010.06.011; Wheeler JB, 2012, SURG CLIN N AM, V92, P1077, DOI 10.1016/j.suc.2012.07.008; Wu C, 2011, NAT GENET, V43, P679, DOI 10.1038/ng.849; Yang L, 2006, WORLD J GASTROENTERO, V12, P17, DOI 10.3748/wjg.v12.i1.17; Zhang HZ, 2011, CARCINOGENESIS, V32, P848, DOI 10.1093/carcin/bgr051; ZHOU RM, 2012, ARCH MED RES	30	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e69214	10.1371/journal.pone.0069214	http://dx.doi.org/10.1371/journal.pone.0069214			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874915	Green Submitted, Green Published, gold			2022-12-27	WOS:000324146200067
J	Martin-Acebes, MA; Blazquez, AB; de Oya, NJ; Escribano-Romero, E; Shi, PY; Saiz, JC				Martin-Acebes, Miguel A.; Blazquez, Ana-Belen; Jimenez de Oya, Nereida; Escribano-Romero, Estela; Shi, Pei-Yong; Saiz, Juan-Carlos			A Single Amino Acid Substitution in the Core Protein of West Nile Virus Increases Resistance to Acidotropic Compounds	PLOS ONE			English	Article							CAPSID PROTEIN; DENGUE-VIRUS; ENDOPLASMIC-RETICULUM; MOLECULAR-BIOLOGY; GLYCOPROTEIN; PH; ENCEPHALITIS; INFECTIVITY; CONFERS; FUSION	West Nile virus (WNV) is a worldwide distributed mosquito-borne flavivirus that naturally cycles between birds and mosquitoes, although it can infect multiple vertebrate hosts including horses and humans. This virus is responsible for recurrent epidemics of febrile illness and encephalitis, and has recently become a global concern. WNV requires to transit through intracellular acidic compartments at two different steps to complete its infectious cycle. These include fusion between the viral envelope and the membrane of endosomes during viral entry, and virus maturation in the trans-Golgi network. In this study, we followed a genetic approach to study the connections between viral components and acidic pH. A WNV mutant with increased resistance to the acidotropic compound NH4Cl, which blocks organelle acidification and inhibits WNV infection, was selected. Nucleotide sequencing revealed that this mutant displayed a single amino acid substitution (Lys 3 to Glu) on the highly basic internal capsid or core (C) protein. The functional role of this replacement was confirmed by its introduction into a WNV infectious clone. This single amino acid substitution also increased resistance to other acidification inhibitor (concanamycin A) and induced a reduction of the neurovirulence in mice. Interestingly, a naturally occurring accompanying mutation found on prM protein abolished the resistant phenotype, supporting the idea of a genetic crosstalk between the internal C protein and the external glycoproteins of the virion. The findings here reported unveil a non-previously assessed connection between the C viral protein and the acidic pH necessary for entry and proper exit of flaviviruses.	[Martin-Acebes, Miguel A.; Blazquez, Ana-Belen; Jimenez de Oya, Nereida; Escribano-Romero, Estela; Saiz, Juan-Carlos] Inst Nacl Invest & Tecnol Agraria & Alimentaria I, Dept Biotecnol, Madrid, Spain; [Shi, Pei-Yong] Wadsworth Ctr, New York State Dept Hlth, Albany, NY USA	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); State University of New York (SUNY) System; Wadsworth Center	Martin-Acebes, MA (corresponding author), UAM, CSIC, Ctr Biol Mol Severo Ochoa, Dept Virol Microbiol, Madrid, Spain.	martin.mangel@inia.es	Martin-Acebes, Miguel A./L-2258-2014; Blazquez, Ana/G-9791-2015; de Oya, Nereida Jiménez/ABZ-4365-2022; Escribano-Romero, Estela/H-1495-2015; Jiménez de Oya, Nereida/K-8470-2016	Martin-Acebes, Miguel A./0000-0001-6015-3613; Blazquez, Ana/0000-0002-0847-0977; Escribano-Romero, Estela/0000-0002-5036-7607; Jiménez de Oya, Nereida/0000-0003-3129-813X; Saiz, Juan-Carlos/0000-0001-8269-5544	Instituto Nacional de Investigacion Agraria y Alimentaria [RTA2011-00036]; Network of Animal Disease Infectiology and Research-European Union [NADIR-EU-228394]; Spanish Research Council (CSIC)	Instituto Nacional de Investigacion Agraria y Alimentaria(Instituto de Investigacion Agropecuaria (INIA)); Network of Animal Disease Infectiology and Research-European Union; Spanish Research Council (CSIC)	This work was supported by grants Recursos y Tecnologias Agrarias (RTA2011-00036) from Instituto Nacional de Investigacion Agraria y Alimentaria and by the Network of Animal Disease Infectiology and Research-European Union (NADIR-EU-228394). MAMA is the recipient of a Junta de Ampliacion de Estudios (JAE)-Doctoral fellowship from Spanish Research Council (CSIC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Padilla J, 2011, VACCINE, V29, P1830, DOI 10.1016/j.vaccine.2010.12.081; Beasley DWC, 2005, CURR MOL MED, V5, P835, DOI 10.2174/156652405774962272; Bhuvanakantham R, 2010, CELL MICROBIOL, V12, P453, DOI 10.1111/j.1462-5822.2009.01407.x; Bhuvanakantham R, 2009, BIOCHEM BIOPH RES CO, V389, P63, DOI 10.1016/j.bbrc.2009.08.108; Blazquez AB, 2010, VIRUS RES, V151, P240, DOI 10.1016/j.virusres.2010.04.009; Brault AC, 2007, NAT GENET, V39, P1162, DOI 10.1038/ng2097; Brault AC, 2009, VET RES, V40, DOI 10.1051/vetres/2009026; Brinton MA, 2002, ANNU REV MICROBIOL, V56, P371, DOI 10.1146/annurev.micro.56.012302.160654; Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245; Colpitts TM, 2011, J GEN VIROL, V92, P2281, DOI 10.1099/vir.0.031427-0; Cordoba L, 2007, J GEN VIROL, V88, P476, DOI 10.1099/vir.0.82439-0; Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Diamond MS, 2009, ANTIVIR RES, V83, P214, DOI 10.1016/j.antiviral.2009.05.006; Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003; Dokland T, 2004, STRUCTURE, V12, P1157, DOI 10.1016/j.str.2004.04.024; GARTEN W, 1994, BIOCHIMIE, V76, P217, DOI 10.1016/0300-9084(94)90149-X; Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10; GOLLINS SW, 1986, J GEN VIROL, V67, P1941, DOI 10.1099/0022-1317-67-9-1941; GUIRAKHOO F, 1993, VIROLOGY, V194, P219, DOI 10.1006/viro.1993.1252; GUIRAKHOO F, 1992, VIROLOGY, V191, P921, DOI 10.1016/0042-6822(92)90267-S; Haag L, 2002, EMBO J, V21, P4402, DOI 10.1093/emboj/cdf442; Hanna SL, 2005, J VIROL, V79, P13262, DOI 10.1128/JVI.79.21.13262-13274.2005; Hayes EB, 2006, ANNU REV MED, V57, P181, DOI 10.1146/annurev.med.57.121304.131418; Hunt TA, 2007, CELL MICROBIOL, V9, P2756, DOI 10.1111/j.1462-5822.2007.01046.x; Huss M, 2009, J EXP BIOL, V212, P341, DOI 10.1242/jeb.024067; Ivanyi-Nagy R, 2012, VIRUS RES; Ivanyi-Nagy R, 2008, NUCLEIC ACIDS RES, V36, P712, DOI 10.1093/nar/gkm1051; Jose J, 2012, J VIROL, V86, P2585, DOI 10.1128/JVI.05860-11; Kaufmann B, 2009, J VIROL, V5; Kaufmann B, 2011, MICROBES INFECT, V13, P1, DOI 10.1016/j.micinf.2010.09.005; Khromykh AA, 1996, ARCH VIROL, V141, P685, DOI 10.1007/BF01718326; KIELIAN MC, 1986, EMBO J, V5, P3103, DOI 10.1002/j.1460-2075.1986.tb04616.x; Kilpatrick AM, 2011, SCIENCE, V334, P323, DOI 10.1126/science.1201010; KIMURA T, 1988, J GEN VIROL, V69, P1247, DOI 10.1099/0022-1317-69-6-1247; Ko A, 2010, J VIROL, V84, P426, DOI 10.1128/JVI.00725-09; Kramer LD, 2008, ANNU REV ENTOMOL, V53, P61, DOI 10.1146/annurev.ento.53.103106.093258; Krishnan MN, 2007, J VIROL, V81, P4881, DOI 10.1128/JVI.02210-06; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000; Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333; Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263; LOPEZ S, 1994, J VIROL, V68, P1316, DOI 10.1128/JVI.68.3.1316-1323.1994; MacKenzie JM, 2001, J VIROL, V75, P10787, DOI 10.1128/JVI.75.22.10787-10799.2001; Maier CC, 2007, VIROLOGY, V362, P468, DOI 10.1016/j.virol.2007.01.008; Martin CSS, 2009, TRENDS MICROBIOL, V17, P514, DOI 10.1016/j.tim.2009.08.002; Martin-Acebes Miguel A, 2012, World J Virol, V1, P51, DOI 10.5501/wjv.v1.i2.51; Martin-Acebes MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024970; Martin-Acebes MA, 2011, J GEN VIROL, V92, P831, DOI 10.1099/vir.0.027185-0; Martin-Acebes MA, 2010, J VIROL, V84, P2902, DOI 10.1128/JVI.02311-09; Medigeshi GR, 2009, J VIROL, V83, P6125, DOI 10.1128/JVI.02617-08; Moesker B, 2010, J GEN VIROL, V91, P389, DOI 10.1099/vir.0.015255-0; Mukherjee S, 2011, J VIROL, V85, P12067, DOI 10.1128/JVI.05559-11; Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067; Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316; Nelson S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000060; Nybakken GE, 2006, J VIROL, V80, P11467, DOI 10.1128/JVI.01125-06; Oh WK, 2006, BIOCHEM BIOPH RES CO, V347, P994, DOI 10.1016/j.bbrc.2006.06.190; Oh W, 2006, J BIOL CHEM, V281, P30166, DOI 10.1074/jbc.M602651200; Petersen LR, 2013, EPIDEMIOL INFECT, V141, P591, DOI 10.1017/S0950268812001070; Plevka P, 2011, EMBO REP, V12, P602, DOI 10.1038/embor.2011.75; Rodenhuis-Zybert IA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000718; SAHENK Z, 1991, J NEUROCYTOL, V20, P365, DOI 10.1007/BF01355533; Samsa MM, 2012, J VIROL, V86, P1046, DOI 10.1128/JVI.05431-11; Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632; Shi PY, 2002, J VIROL, V76, P5847, DOI 10.1128/JVI.76.12.5847-5856.2002; Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160; Snyder AJ, 2012, J VIROL, V86, P3100, DOI 10.1128/JVI.06615-11; STEINHAUER DA, 1991, P NATL ACAD SCI USA, V88, P11525, DOI 10.1073/pnas.88.24.11525; Stiasny K, 2011, AMINO ACIDS, V41, P1159, DOI 10.1007/s00726-009-0370-4; Sun EC, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-100; Thompson BS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000453; van Marle G, 2007, J VIROL, V81, P10933, DOI 10.1128/JVI.02422-06; Vazquez-Calvo A, 2012, VIRUS RES; Wang Y, 2003, J VIROL, V77, P13323, DOI [10.1128/JVI.77.24.13323-13334.2003, 10.1128/JVi.77.24.13323-13334.2003]; Wicker JA, 2006, VIROLOGY, V349, P245, DOI 10.1016/j.virol.2006.03.007; Xu ZK, 2011, J VIROL, V85, P5571, DOI 10.1128/JVI.01933-10; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yang MR, 2008, CELL MICROBIOL, V10, P165, DOI 10.1111/j.1462-5822.2007.01027.x; Youn S, 2012, J VIROL, V86, P7360, DOI 10.1128/JVI.00157-12; Yu IM, 2009, J VIROL, V83, P12101, DOI 10.1128/JVI.01637-09; Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264; Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270; Zhang Y, 2007, J VIROL, V81, P6141, DOI 10.1128/JVI.00037-07	84	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e69479	10.1371/journal.pone.0069479	http://dx.doi.org/10.1371/journal.pone.0069479			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874963	Green Published, Green Submitted, gold			2022-12-27	WOS:000324146200077
J	Helou, YA; Nguyen, V; Beik, SP; Salomon, AR				Helou, Ynes A.; Vinh Nguyen; Beik, Samantha P.; Salomon, Arthur R.			ERK Positive Feedback Regulates a Widespread Network of Tyrosine Phosphorylation Sites across Canonical T Cell Signaling and Actin Cytoskeletal Proteins in Jurkat T Cells	PLOS ONE			English	Article							N-TERMINAL REGION; KINASE-ACTIVITY; PHOSPHOPROTEOMIC ANALYSIS; RECEPTOR; ACTIVATION; LCK; REQUIRES; ZAP-70; ITK; IDENTIFICATION	Competing positive and negative signaling feedback pathways play a critical role in tuning the sensitivity of T cell receptor activation by creating an ultrasensitive, bistable switch to selectively enhance responses to foreign ligands while suppressing signals from self peptides. In response to T cell receptor agonist engagement, ERK is activated to positively regulate T cell receptor signaling through phosphorylation of Ser(59) Lck. To obtain a wide-scale view of the role of ERK in propagating T cell receptor signaling, a quantitative phosphoproteomic analysis of 322 tyrosine phosphorylation sites by mass spectrometry was performed on the human Jurkat T cell line in the presence of U0126, an inhibitor of ERK activation. Relative to controls, U0126-treated cells showed constitutive decreases in phosphorylation through a T cell receptor stimulation time course on tyrosine residues found on upstream signaling proteins (CD3 chains, Lck, ZAP-70), as well as downstream signaling proteins (VAV1, PLC gamma 1, Itk, NCK1). Additional constitutive decreases in phosphorylation were found on the majority of identified proteins implicated in the regulation of actin cytoskeleton pathway. Although the majority of identified sites on T cell receptor signaling proteins showed decreases in phosphorylation, Tyr(598) of ZAP-70 showed elevated phosphorylation in response to U0126 treatment, suggesting differential regulation of this site via ERK feedback. These findings shed new light on ERK's role in positive feedback in T cell receptor signaling and reveal novel signaling events that are regulated by this kinase, which may fine tune T cell receptor activation.	[Helou, Ynes A.; Salomon, Arthur R.] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Vinh Nguyen; Beik, Samantha P.; Salomon, Arthur R.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Salomon, Arthur R.] Brown Univ, Dept Chem, Providence, RI 02912 USA	Brown University; Brown University; Brown University	Salomon, AR (corresponding author), Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA.	art@drsalomon.com			National Institutes of Health [R01 AI083636-01A1]; Office of Integrative Activities [1004057] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027027] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083636] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant R01 AI083636-01A1 (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM N, 1990, MOL CELL BIOL, V10, P5197, DOI 10.1128/MCB.10.10.5197; Abraham RT, 2004, NAT REV IMMUNOL, V4, P301, DOI 10.1038/nri1330; Acuto O, 2008, NAT REV IMMUNOL, V8, P699, DOI 10.1038/nri2397; Alonso A, 2004, J BIOL CHEM, V279, P4922, DOI 10.1074/jbc.M308978200; Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Altman A, 2004, EUR J IMMUNOL, V34, P2001, DOI 10.1002/eji.200324625; Au-Yeung BB, 2009, IMMUNOL REV, V228, P41, DOI 10.1111/j.1600-065X.2008.00753.x; BANIYASH M, 1988, J BIOL CHEM, V263, P18225; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; BERGMAN M, 1992, EMBO J, V11, P2919, DOI 10.1002/j.1460-2075.1992.tb05361.x; Billadeau DD, 2007, NAT REV IMMUNOL, V7, P131, DOI 10.1038/nri2021; Bodour K, 2004, J EXP MED, V199, P99, DOI 10.1084/jem.20030976; Brockmeyer C, 2011, J BIOL CHEM, V286, P7535, DOI 10.1074/jbc.M110.201236; CALALB MB, 1995, MOL CELL BIOL, V15, P954; CHAN AC, 1995, EMBO J, V14, P2499, DOI 10.1002/j.1460-2075.1995.tb07247.x; Chiang GG, 2001, J BIOL CHEM, V276, P23173, DOI 10.1074/jbc.M101219200; Couture C, 1996, J BIOL CHEM, V271, P24880, DOI 10.1074/jbc.271.40.24880; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; Deindl S, 2009, P NATL ACAD SCI USA, V106, P20699, DOI 10.1073/pnas.0911512106; DeSilva DR, 1998, J IMMUNOL, V160, P4175; Dombroski D, 2005, J IMMUNOL, V174, P1385, DOI 10.4049/jimmunol.174.3.1385; Dong S, 2006, J EXP MED, V203, P2509, DOI 10.1084/jem.20060650; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Geng LP, 1999, J IMMUNOL, V163, P5753; HARDWICK JS, 1995, P NATL ACAD SCI USA, V92, P4527, DOI 10.1073/pnas.92.10.4527; Heyeck SD, 1997, J BIOL CHEM, V272, P25401, DOI 10.1074/jbc.272.40.25401; JOUNG I, 1995, P NATL ACAD SCI USA, V92, P5778, DOI 10.1073/pnas.92.13.5778; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kim JE, 2006, J IMMUNOL, V176, P2833, DOI 10.4049/jimmunol.176.5.2833; King PD, 1997, J IMMUNOL, V158, P580; Kong GH, 1996, MOL CELL BIOL, V16, P5026; Labno CM, 2003, CURR BIOL, V13, P1619, DOI 10.1016/j.cub.2003.08.005; Lazer G, 2010, J BIOL CHEM, V285, P23073, DOI 10.1074/jbc.M109.094508; Matsumoto M, 2009, PROTEOMICS, V9, P3549, DOI 10.1002/pmic.200900011; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; Morgan MM, 2001, J IMMUNOL, V167, P5708, DOI 10.4049/jimmunol.167.10.5708; Mueller DL, 2003, NAT IMMUNOL, V4, P210, DOI 10.1038/ni0303-210; Murphy MA, 1998, MOL CELL BIOL, V18, P4872, DOI 10.1128/MCB.18.8.4872; MUSTELIN T, 1989, IMMUNOL TODAY, V10, P189, DOI 10.1016/0167-5699(89)90322-8; Mustelin T, 2002, FRONT BIOSCI-LANDMRK, V7, pD918, DOI 10.2741/musteli1; Navarro MN, 2011, NAT IMMUNOL, V12, P352, DOI 10.1038/ni.2008; Nguyen V, 2009, MOL CELL PR IN PRESS; Nika K, 2007, J BIOL CHEM, V282, P36000, DOI 10.1074/jbc.M702779200; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Poltorak M, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-4; Salomon AR, 2003, P NATL ACAD SCI USA, V100, P443, DOI 10.1073/pnas.2436191100; SAMELSON LE, 1986, CELL, V46, P1083, DOI 10.1016/0092-8674(86)90708-7; Schaller MD, 2001, BIOCHEM J, V360, P57, DOI 10.1042/0264-6021:3600057; Scherle PA, 1998, J IMMUNOL, V161, P5681; Shan XC, 2000, MOL CELL BIOL, V20, P6945, DOI 10.1128/MCB.20.18.6945-6957.2000; Shan XC, 2001, MOL CELL BIOL, V21, P7137, DOI 10.1128/MCB.21.21.7137-7149.2001; Stefanova I, 2003, NAT IMMUNOL, V4, P248, DOI 10.1038/ni895; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; Wang XD, 2000, J IMMUNOL, V164, P1934, DOI 10.4049/jimmunol.164.4.1934; WATTS JD, 1993, J BIOL CHEM, V268, P23275; WINKLER DG, 1993, P NATL ACAD SCI USA, V90, P5176, DOI 10.1073/pnas.90.11.5176; Wu JS, 2006, J BIOL CHEM, V281, P11002, DOI 10.1074/jbc.M600498200; Wu LT, 2002, J BIOL CHEM, V277, P40420, DOI 10.1074/jbc.M206023200; Yasuda T, 2007, INT IMMUNOL, V19, P487, DOI 10.1093/intimm/dxm015; Yu KB, 2010, PROTEOMICS, V10, P2113, DOI 10.1002/pmic.200900159; Yu KB, 2009, PROTEOMICS, V9, P5350, DOI 10.1002/pmic.200900119; Yu KB, 2009, PROTEOMICS, V9, P3115, DOI 10.1002/pmic.200800899	70	23	23	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e69641	10.1371/journal.pone.0069641	http://dx.doi.org/10.1371/journal.pone.0069641			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23874979	Green Published, gold, Green Submitted			2022-12-27	WOS:000322000600054
J	Egea-Jimenez, AL; Perez-Lara, A; Corbalan-Garcia, S; Gomez-Fernandez, JC				Egea-Jimenez, Antonio L.; Perez-Lara, Angel; Corbalan-Garcia, Senena; Gomez-Fernandez, Juan C.			Phosphatidylinositol 4,5-Bisphosphate Decreases the Concentration of Ca2+, Phosphatidylserine and Diacylglycerol Required for Protein Kinase C alpha to Reach Maximum Activity	PLOS ONE			English	Article							MEMBRANE-BINDING; PKC-ALPHA; PLASMA-MEMBRANE; ASYMMETRIC DISTRIBUTION; ACTIVATION MECHANISMS; MIXED MICELLES; DOMAIN; CALCIUM; SPECIFICITY; PHOSPHOLIPIDS	The C2 domain of PKC alpha possesses two different binding sites, one for Ca2+ and phosphatidylserine and a second one that binds PIP2 with very high affinity. The enzymatic activity of PKC alpha was studied by activating it with large unilamellar lipid vesicles, varying the concentration of Ca2+ and the contents of dioleylglycerol (DOG), phosphatidylinositol 4,5-bisphosphate (PIP2) and phosphadidylserine (POPS) in these model membranes. The results showed that PIP2 increased the V-max of PKC alpha and, when the PIP2 concentration was 5 mol% of the total lipid in the membrane, the addition of 2 mol% of DOG did not increase the activity. In addition PIP2 decreases K-0.5 of Ca2+ more than 3-fold, that of DOG almost 5-fold and that of POPS by a half. The K-0.5 values of PIP2 amounted to only 0.11 mu M in the presence of DOG and 0.39 in its absence, which is within the expected physiological range for the inner monolayer of a mammalian plasma membrane. As a consequence, PKC alpha may be expected to operate near its maximum capacity even in the absence of a cell signal producing diacylglycerol. Nevertheless, we have shown that the presence of DOG may also help, since the K-0.5 for PIP2 notably decreases in its presence. Taken together, these results underline the great importance of PIP2 in the activation of PKC alpha and demonstrate that in its presence, the most important cell signal for triggering the activity of this enzyme is the increase in the concentration of cytoplasmic Ca2+.	[Egea-Jimenez, Antonio L.; Perez-Lara, Angel; Corbalan-Garcia, Senena; Gomez-Fernandez, Juan C.] Univ Murcia, Fac Vet, Dept Bioquim & Biol Mol A, Murcia, Spain	University of Murcia	Gomez-Fernandez, JC (corresponding author), Univ Murcia, Fac Vet, Dept Bioquim & Biol Mol A, Reg Campus Int Excellence Campus Mare Nostrum, Murcia, Spain.	jcgomez@um.es	Jimenez, Antonio Luis Egea/Z-1906-2019; Corbalan-Garcia, Senena/C-6477-2009; Gomez-Fernandez, Juan C/K-6758-2014	Jimenez, Antonio Luis Egea/0000-0003-1684-2598; Corbalan-Garcia, Senena/0000-0003-1840-5578; Gomez-Fernandez, Juan C/0000-0002-5331-9029; Perez Lara, Angel/0000-0002-2736-3501	Ministerio de Economia y Competitividad (Gobierno de Espana) [BFU2011-22828]; FEDER (European Union)	Ministerio de Economia y Competitividad (Gobierno de Espana); FEDER (European Union)(European Commission)	This paper has been supported by Grant No. BFU2011-22828 from Ministerio de Economia y Competitividad (Gobierno de Espana) and co-financed by FEDER (European Union) (http://www.idi.mineco.gob.es/portal/site/MICINN/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthanarayanan B, 2003, J BIOL CHEM, V278, P46886, DOI 10.1074/jbc.M307853200; Ausili A, 2011, BBA-BIOMEMBRANES, V1808, P684, DOI 10.1016/j.bbamem.2010.11.035; BAZZI MD, 1987, BIOCHEMISTRY-US, V26, P5002, DOI 10.1021/bi00390a018; Bittova L, 2001, J BIOL CHEM, V276, P4218, DOI 10.1074/jbc.M008491200; BOLEN EJ, 1992, BIOCHEMISTRY-US, V31, P5945, DOI 10.1021/bi00140a034; Bolsover SR, 2003, J BIOL CHEM, V278, P10282, DOI 10.1074/jbc.M212145200; CHANG D, 1988, COMPUT BIOL MED, V18, P351, DOI 10.1016/0010-4825(88)90022-4; CHAP HJ, 1977, BIOCHIM BIOPHYS ACTA, V467, P146, DOI 10.1016/0005-2736(77)90192-4; Conesa-Zamora P, 2000, BBA-MOL CELL BIOL L, V1487, P246, DOI 10.1016/S1388-1981(00)00099-8; Conesa-Zamora P, 2001, BIOCHEMISTRY-US, V40, P13898, DOI 10.1021/bi011303o; Corbalan-Garcia S, 1999, BIOCHEM J, V337, P513, DOI 10.1042/0264-6021:3370513; Corbalan-Garcia S, 2003, J BIOL CHEM, V278, P4972, DOI 10.1074/jbc.M209385200; Corbalan-Garcia S, 2006, BBA-MOL CELL BIOL L, V1761, P633, DOI 10.1016/j.bbalip.2006.04.015; Corbin JA, 2007, BIOCHEMISTRY-US, V46, P4322, DOI 10.1021/bi062140c; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Evans JH, 2006, MOL BIOL CELL, V17, P56, DOI 10.1091/mbc.e05-06-0499; Feng X, 2000, J BIOL CHEM, V275, P17024, DOI 10.1074/jbc.275.22.17024; GANONG BR, 1986, P NATL ACAD SCI USA, V83, P1184, DOI 10.1073/pnas.83.5.1184; Garcia-Garcia J, 1999, BIOCHEMISTRY-US, V38, P9667, DOI 10.1021/bi9905765; Gomez-Fernandez JC, 2007, CHEM PHYS LIPIDS, V148, P1, DOI 10.1016/j.chemphyslip.2007.04.003; Guerrero-Valero M, 2007, J MOL BIOL, V371, P608, DOI 10.1016/j.jmb.2007.05.086; Guerrero-Valero M, 2009, P NATL ACAD SCI USA, V106, P6603, DOI 10.1073/pnas.0813099106; HANNUN YA, 1988, J BIOL CHEM, V263, P5124; HANNUN YA, 1986, J BIOL CHEM, V261, P2604; HANNUN YA, 1986, J BIOL CHEM, V261, P7184; HANNUN YA, 1985, J BIOL CHEM, V260, P39; Huang SH, 2004, MOL CELL BIOL, V24, P9102, DOI 10.1128/MCB.24.20.9102-9123.2004; Leonard TA, 2011, CELL, V144, P55, DOI 10.1016/j.cell.2010.12.013; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Marin-Vicente C, 2005, MOL BIOL CELL, V16, P2848, DOI 10.1091/mbc.E05-01-0067; Marin-Vicente C, 2008, J MOL BIOL, V377, P1038, DOI 10.1016/j.jmb.2007.12.011; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Medkova M, 1998, BIOCHEMISTRY-US, V37, P4892, DOI 10.1021/bi972495j; Mosior M, 1998, BIOCHEMISTRY-US, V37, P17271, DOI 10.1021/bi981344t; Nalefski Eric A, 2003, Methods Mol Biol, V233, P115; NEWTON AC, 1989, J BIOL CHEM, V264, P14909; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Ochoa WF, 2003, BIOCHEMISTRY-US, V42, P8774, DOI 10.1021/bi034713g; Ochoa WF, 2002, J MOL BIOL, V320, P277, DOI 10.1016/S0022-2836(02)00464-3; OGITA K, 1991, METHOD ENZYMOL, V200, P228; ORELLANA A, 1990, EUR J BIOCHEM, V190, P57, DOI 10.1111/j.1432-1033.1990.tb15545.x; ORR JW, 1992, BIOCHEMISTRY-US, V31, P4667, DOI 10.1021/bi00134a019; Perez-Lara A, 2012, BBA-MOL CELL BIOL L, V1821, P1434, DOI 10.1016/j.bbalip.2012.06.012; PREISS J, 1986, J BIOL CHEM, V261, P8597; Sanchez-Bautista S, 2006, J MOL BIOL, V362, P901, DOI 10.1016/j.jmb.2006.07.093; Sanchez-Bautista S, 2009, BIOPHYS J, V96, P3638, DOI 10.1016/j.bpj.2009.02.021; Sanchez-Pinera P, 1999, BIOCHEM J, V337, P387, DOI 10.1042/0264-6021:3370387; SANDERMANN H, 1991, BIOCHIM BIOPHYS ACTA, V1069, P235, DOI 10.1016/0005-2736(91)90130-Z; TAKAI Y, 1979, J BIOL CHEM, V254, P3692; TAKUWA N, 1987, BIOCHEM J, V243, P647, DOI 10.1042/bj2430647; Torrecillas A, 2004, BIOCHEMISTRY-US, V43, P2332, DOI 10.1021/bi035128i; Verdaguer N, 1999, EMBO J, V18, P6329, DOI 10.1093/emboj/18.22.6329; VERKLEIJ AJ, 1973, BIOCHIM BIOPHYS ACTA, V323, P178, DOI 10.1016/0005-2736(73)90143-0; WOOTEN MW, 1987, EUR J BIOCHEM, V164, P461, DOI 10.1111/j.1432-1033.1987.tb11079.x	55	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e69041	10.1371/journal.pone.0069041	http://dx.doi.org/10.1371/journal.pone.0069041			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874859	Green Published, gold, Green Submitted			2022-12-27	WOS:000321765300076
J	Shaheen, HH; Prinz, B; Chen, MT; Pavoor, T; Lin, S; Houston-Cummings, NR; Moore, R; Stadheim, TA; Zha, DX				Shaheen, Hussam H.; Prinz, Bianka; Chen, Ming-Tang; Pavoor, Tej; Lin, Song; Houston-Cummings, Nga Rewa; Moore, Renee; Stadheim, Terrance A.; Zha, Dongxing			A Dual-Mode Surface Display System for the Maturation and Production of Monoclonal Antibodies in Glyco-Engineered Pichia pastoris	PLOS ONE			English	Article							ANCHORED PERIPLASMIC EXPRESSION; POSTTRANSLATIONAL MODIFICATIONS; FILAMENTOUS PHAGE; ESCHERICHIA-COLI; YEAST; LIBRARIES; PROTEINS; OPTIMIZATION; CULTIVATION; SECRETION	State-of-the-art monoclonal antibody (mAb) discovery methods that utilize surface display techniques in prokaryotic and eukaryotic cells require multiple steps of reformatting and switching of hosts to transition from display to expression. This results in a separation between antibody affinity maturation and full-length mAb production platforms. Here, we report for the first time, a method in Glyco-engineered Pichia pastoris that enables simultaneous surface display and secretion of full-length mAb molecules with human-like N-glycans using the same yeast cell. This paradigm takes advantage of homo-dimerization of the Fc portion of an IgG molecule to a surface-anchored "bait" Fc, which results in targeting functional "half" IgGs to the cell wall of Pichia pastoris without interfering with the secretion of full length mAb. We show the utility of this method in isolating high affinity, well-expressed anti-PCSK9 leads from a designed library that was created by mating yeasts containing either light chain or heavy chain IgG libraries. Coupled with Glyco-engineered Pichia pastoris, this method provides a powerful tool for the discovery and production of therapeutic human mAbs in the same host thus improving drug developability and potentially shortening the discovery time cycle.	[Shaheen, Hussam H.; Prinz, Bianka; Chen, Ming-Tang; Pavoor, Tej; Lin, Song; Houston-Cummings, Nga Rewa; Moore, Renee; Stadheim, Terrance A.; Zha, Dongxing] Merck & Co Inc, Merck Res Labs, Biol Discovery, GlycoFi, Lebanon, NH USA	Merck & Company	Shaheen, HH (corresponding author), Merck & Co Inc, Merck Res Labs, Biol Discovery, GlycoFi, Lebanon, NH USA.	hussam.shaheen@merck.com; dongxing.zha@merck.com			Merck and Co.	Merck and Co.(Merck & Company)	Merck and Co. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bender Eckhard, 1993, Human Antibodies and Hybridomas, V4, P74; Berdichevsky M, 2011, J BIOTECHNOL, V155, P217, DOI 10.1016/j.jbiotec.2011.06.021; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chen MT, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-91; Choi BK, 2003, P NATL ACAD SCI USA, V100, P5022, DOI 10.1073/pnas.0931263100; Hamilton SR, 2006, SCIENCE, V313, P1441, DOI 10.1126/science.1130256; Harvey BR, 2006, J IMMUNOL METHODS, V308, P43, DOI 10.1016/j.jim.2005.09.017; Harvey BR, 2004, P NATL ACAD SCI USA, V101, P9193, DOI 10.1073/pnas.0400187101; HOOGENBOOM HR, 1991, NUCLEIC ACIDS RES, V19, P4133, DOI 10.1093/nar/19.15.4133; Horlick RA, 2013, J BIOL CHEM; Houde D, 2010, MOL CELL PROTEOMICS, V9, P1716, DOI 10.1074/mcp.M900540-MCP200; Jefferis R, 2010, BIOTECHNOL GENET ENG, V26, P1; Jiang YW, 2011, PROTEIN EXPRES PURIF, V76, P7, DOI 10.1016/j.pep.2010.11.004; Kayser V, 2011, BIOTECHNOL J, V6, P38, DOI 10.1002/biot.201000091; Lee CV, 2004, J IMMUNOL METHODS, V284, P119, DOI 10.1016/j.jim.2003.11.001; Li HJ, 2006, NAT BIOTECHNOL, V24, P210, DOI 10.1038/nbt1178; Liang MF, 2001, J IMMUNOL METHODS, V247, P119, DOI 10.1016/S0022-1759(00)00322-7; Lin S, 2011, J IMMUNOL METHODS, V31, p[1, 159]; Liu HC, 2006, IMMUNOL LETT, V106, P144, DOI 10.1016/j.imlet.2006.05.011; Mazor Y, 2007, NAT BIOTECHNOL, V25, P563, DOI 10.1038/nbt1296; MCCAFFERTY J, 1990, NATURE, V348, P552, DOI 10.1038/348552a0; Nett JH, 2005, YEAST, V22, P295, DOI 10.1002/yea.1202; Nett JH, 2011, YEAST, V28, P237, DOI 10.1002/yea.1835; Rakestraw JA, 2011, PROTEIN ENG DES SEL, V24, P525, DOI 10.1093/protein/gzr008; Rakestraw JA, 2006, BIOTECHNOL PROGR, V22, P1200, DOI 10.1021/bp0600233; Rani M, 2012, J VIROL, V86, P9113, DOI 10.1128/JVI.00233-12; Ryckaert S, 2010, J BIOTECHNOL, V145, P93, DOI 10.1016/j.jbiotec.2009.10.010; Shibasaki S, 2007, APPL MICROBIOL BIOT, V75, P821, DOI 10.1007/s00253-007-0868-1; Ye JX, 2011, BIOTECHNOL PROGR, V27, P1744, DOI 10.1002/btpr.695; Zhang NY, 2011, MABS-AUSTIN, V3, P289, DOI 10.4161/mabs.3.3.15532; Zhou C, 2010, MABS-AUSTIN, V2, P508, DOI 10.4161/mabs.2.5.12970	31	15	17	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e70190	10.1371/journal.pone.0070190	http://dx.doi.org/10.1371/journal.pone.0070190			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23875020	Green Published, gold, Green Submitted			2022-12-27	WOS:000321765300082
J	Prisco, I; Carboni, M; Acosta, ATR				Prisco, Irene; Carboni, Marta; Acosta, Alicia T. R.			The Fate of Threatened Coastal Dune Habitats in Italy under Climate Change Scenarios	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; SEA-LEVEL RISE; GAP ANALYSIS; NATURA 2000; SAND DUNES; CONSERVATION; BIODIVERSITY; DISPERSAL; PATTERNS; IMPACTS	Coastal dunes worldwide harbor threatened habitats characterized by high diversity in terms of plant communities. In Italy, recent assessments have highlighted the insufficient state of conservation of these habitats as defined by the EU Habitats Directive. The effects of predicted climate change could have dramatic consequences for coastal environments in the near future. An assessment of the efficacy of protection measures under climate change is thus a priority. Here, we have developed environmental envelope models for the most widespread dune habitats in Italy, following two complementary approaches: an "indirect" plant-species-based one and a simple "direct" one. We analyzed how habitats distribution will be altered under the effects of two climate change scenarios and evaluated if the current Italian network of protected areas will be effective in the future after distribution shifts. While modeling dune habitats with the "direct" approach was unsatisfactory, "indirect" models had a good predictive performance, highlighting the importance of using species' responses to climate change for modeling these habitats. The results showed that habitats closer to the sea may even increase their geographical distribution in the near future. The transition dune habitat is projected to remain stable, although mobile and fixed dune habitats are projected to lose most of their actual geographical distribution, the latter being more sensitive to climate change effects. Gap analysis highlighted that the habitats' distribution is currently adequately covered by protected areas, achieving the conservation target. However, according to predictions, protection level for mobile and fixed dune habitats is predicted to drop drastically under the climate change scenarios which we examined. Our results provide useful insights for setting management priorities and better addressing conservation efforts to preserve these threatened habitats in future.	[Prisco, Irene; Carboni, Marta; Acosta, Alicia T. R.] Roma Tre Univ, Dept Sci, Rome, Italy	Italfarmaco; Roma Tre University	Carboni, M (corresponding author), Roma Tre Univ, Dept Sci, Rome, Italy.	marta.carboni@uniroma3.it	Alicia T. R, T R Acosta/E-3653-2012; Prisco, Irene/GLT-8964-2022; Carboni, Marta/A-2658-2012	Alicia T. R, T R Acosta/0000-0001-6572-3187; Carboni, Marta/0000-0002-9348-4758	Universita Roma Tre	Universita Roma Tre	The work was funded by the Universita Roma Tre. IP has benefitted from a PhD Fellowship, also provided by Universita Roma Tre. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta A, 2003, PHYTOCOENOLOGIA, V33, P715, DOI 10.1127/0340-269X/2003/0033-0715; Alcamo J, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P541; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Allred BW, 2010, BIOL INVASIONS, V12, P739, DOI 10.1007/s10530-009-9476-6; [Anonymous], 1992, AG 21; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Austin MP, 1999, ECOGRAPHY, V22, P465, DOI 10.1111/j.1600-0587.1999.tb01276.x; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Bittner T, 2011, J VEG SCI, V22, P699, DOI 10.1111/j.1654-1103.2011.01266.x; Brandt J, 2001, STRATEGIC LANDSCAPE, VTN 2001:523, P31; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Bruelheide H, 2003, APPL VEG SCI, V6, P23, DOI 10.1111/j.1654-109X.2003.tb00561.x; Busby JR, 1991, NATURE CONSERVATION, P64, DOI DOI 10.1046/J.1365-294X.2001.01244.X; Capotorti G, 2012, BIOL CONSERV, V147, P174, DOI 10.1016/j.biocon.2011.12.028; Carboni M, 2011, J VEG SCI, V22, P751, DOI 10.1111/j.1654-1103.2011.01303.x; Carboni M, 2010, DIVERS DISTRIB, V16, P537, DOI 10.1111/j.1472-4642.2010.00677.x; Catullo G, 2008, BIOL CONSERV, V141, P2730, DOI 10.1016/j.biocon.2008.08.019; CNR, 1999, CONS NAZ RIC ATL SPI; Commission European, 2007, DG ENV INT MAN EUR U, V27; Commission European. DG Environment, 2008, ART 17 TECHN REP 200; Cooper JAG, 2004, GLOBAL PLANET CHANGE, V43, P157, DOI 10.1016/j.gloplacha.2004.07.001; Curr R. H. F., 2000, Journal of Coastal Conservation, V6, P15, DOI 10.1007/BF02730463; D'Amen M, 2013, GLOBAL ECOL BIOGEOGR, V22, P93, DOI 10.1111/j.1466-8238.2012.00774.x; D'Amen M, 2011, BIOL CONSERV, V144, P989, DOI 10.1016/j.biocon.2010.11.004; Davy AJ, 2006, J ECOL, V94, P695, DOI 10.1111/j.1365-2745.2006.01131.x; Dietz RW, 2005, CONSERV BIOL, V19, P1478, DOI 10.1111/j.1523-1739.2005.00114.x; DOING H, 1985, VEGETATIO, V61, P65, DOI 10.1007/BF00039811; DOUGLAS BC, 1991, J GEOPHYS RES-OCEANS, V96, P6981, DOI 10.1029/91JC00064; EEC, 1979, OFFICIAL J L, V103; Engler R, 2009, ECOGRAPHY, V32, P34, DOI 10.1111/j.1600-0587.2009.05789.x; ESRI, 2006, ARCGIS 9 2; Essl F, 2012, BIODIVERS CONSERV, V21, P655, DOI 10.1007/s10531-011-0206-x; Evans Doug, 2006, Biology and Environment, V106B, P167, DOI 10.3318/BIOE.2006.106.3.167; Everard M, 2010, AQUAT CONSERV, V20, P476, DOI 10.1002/aqc.1114; Falk W, 2011, J VEG SCI, V22, P621, DOI 10.1111/j.1654-1103.2011.01294.x; Feagin RA, 2005, FRONT ECOL ENVIRON, V3, P359, DOI 10.2307/3868584; Fenu G, 2013, FOLIA GEOBOT, V48, P493, DOI 10.1007/s12224-012-9141-1; Feola S, 2011, BIODIVERS CONSERV, V20, P1457, DOI 10.1007/s10531-011-0037-9; Ferrier S, 2002, SYST BIOL, V51, P331, DOI 10.1080/10635150252899806; Ferrier S, 1997, EVALUATION EFFECTIVE; Ferrier S, 2006, J APPL ECOL, V43, P393, DOI 10.1111/j.1365-2664.2006.01149.x; Fiorentin R, 2006, PROGETTO LIFE NATURA; Forey E, 2008, J VEG SCI, V19, P493, DOI [10.3170/2008-8-18392, 10.1111/j.1654-1103.2009.01095.x]; Franklin J, 1995, PROG PHYS GEOG, V19, P474, DOI 10.1177/030913339501900403; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Gallego-Fernandez JB, 2011, ECOSCIENCE, V18, P52, DOI 10.2980/18-1-3376; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hansom JD, 2001, CATENA, V42, P291, DOI 10.1016/S0341-8162(00)00142-9; Hardisty J, 1994, SEDIMENT TRANSPORT D, P216; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Hassall C, 2010, METHODS ECOL EVOL, V1, P343, DOI 10.1111/j.2041-210X.2010.00039.x; Hastie T., 1986, STAT SCI, V1, P297; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HUTCHINSON MF, 1995, INT J GEOGR INF SYST, V9, P385, DOI 10.1080/02693799508902045; ISPRA (Istituto Superiore per la Protezione e la Ricerca Ambientale), 2009, 10009 ISPRA; Jackson NL, 2002, GEOMORPHOLOGY, V48, P147, DOI 10.1016/S0169-555X(02)00179-4; Jennings MD, 2000, LANDSCAPE ECOL, V15, P5, DOI 10.1023/A:1008184408300; Jones CC, 2009, PLANT ECOL, V204, P217, DOI 10.1007/s11258-009-9586-3; Justice C.O., 2004, SERIES TITLE REMOTE, V6, P277, DOI DOI 10.1007/978-1-4020-2562-4_; Kadereit JW, 2005, TAXON, V54, P861, DOI 10.2307/25065473; Keenan T, 2011, GLOBAL CHANGE BIOL, V17, P565, DOI 10.1111/j.1365-2486.2010.02254.x; Kreyling J, 2008, OIKOS, V117, P1542, DOI 10.1111/j.0030-1299.2008.16653.x; La Posta A, 2008, ATTUAZIONE DIRETTIVA; Legge, 1991, GAZZETTA UFFICIALE; Lenotre N, 2004, RC52864FR BRGM; Lin DY, 2011, J AM STAT ASSOC, V106, P232, DOI 10.1198/jasa.2011.tm10113; Liu HJ, 2011, ECOL RES, V26, P605, DOI 10.1007/s11284-011-0819-2; Maiorano L, 2006, BIOL CONSERV, V133, P455, DOI 10.1016/j.biocon.2006.07.015; Martinez ML, 2004, ECOL STU AN, V171, P355; Martuinez M.L., 2013, RESTORATION COASTAL, DOI DOI 10.1007/978-3-642-33445-0_20; Mucher CA, 2004, 952 PEENHAB PROJ ALT, P124; Mucher CA, 2009, LANDSCAPE URBAN PLAN, V92, P148, DOI 10.1016/j.landurbplan.2009.04.003; Munoz-Reinoso JC, 2007, INT C MAN REST COAST; Nakicenovic N., 2000, IPCC SPECIAL REPORT, P570; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; Ozinga WA, 2009, ECOL LETT, V12, P66, DOI 10.1111/j.1461-0248.2008.01261.x; Pearman PB, 2011, BIOL CONSERV, V144, P866, DOI 10.1016/j.biocon.2010.11.020; Picchi S, 2008, MANAGEMENT NATURA 20, p2250*; Prisco I, 2012, ANN BOT-COENOL PLANT, V2, P39, DOI 10.4462/annbotrm-9340; Prisco Irene, 2012, Biodiversity Ecol, V4, P191, DOI 10.7809/b-e.00076; Prober SM, 2012, BIODIVERS CONSERV, V21, P1627, DOI 10.1007/s10531-012-0268-4; Ramirez-Villegas J, 2010, 1 INT CTR TAX ADM; Reger B, 2007, LANDSCAPE URBAN PLAN, V81, P104, DOI 10.1016/j.landurbplan.2006.10.018; Reidsma P, 2006, AGR ECOSYST ENVIRON, V114, P86, DOI 10.1016/j.agee.2005.11.026; Ridgeway G., 1999, COMPUT SCI STAT, P172; Riordan EC, 2009, J BIOGEOGR, V36, P2176, DOI 10.1111/j.1365-2699.2009.02151.x; Ripley B. D., 1996, PATTERN RECOGNITION; Rodrigues ASL, 2004, BIOSCIENCE, V54, P1092, DOI 10.1641/0006-3568(2004)054[1092:GGAPRF]2.0.CO;2; Rosati L, 2008, COMMUNITY ECOL, V9, P147, DOI 10.1556/ComEc.9.2008.2.3; Santoro R, 2012, ENVIRON MANAGE, V49, P534, DOI 10.1007/s00267-012-9809-6; Schlacher TA, 2008, MAR ECOL-EVOL PERSP, V29, P70, DOI 10.1111/j.1439-0485.2007.00204.x; Schweiger O, 2012, GLOBAL ECOL BIOGEOGR, V21, P88, DOI 10.1111/j.1466-8238.2010.00607.x; Stanisci A, 2004, ANN BOT, VIV, P115; Thuiller W, 2003, GLOBAL CHANGE BIOL, V9, P1353, DOI 10.1046/j.1365-2486.2003.00666.x; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Watzold F, 2005, BIOL CONSERV, V123, P327, DOI 10.1016/j.biocon.2004.12.001; Wilson JB, 1999, ECOL LETT, V2, P233	100	28	33	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68850	10.1371/journal.pone.0068850	http://dx.doi.org/10.1371/journal.pone.0068850			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874787	Green Published, Green Submitted, gold			2022-12-27	WOS:000321736900117
J	Collins, AS; McCoy, CE; Lloyd, AT; O'Farrelly, C; Stevenson, NJ				Collins, Aideen S.; McCoy, Claire E.; Lloyd, Andrew T.; O'Farrelly, Cliona; Stevenson, Nigel J.			miR-19a: An Effective Regulator of SOCS3 and Enhancer of JAK-STAT Signalling	PLOS ONE			English	Article							NF-KAPPA-B; HUMAN HEPATOMA-CELLS; CYTOKINE; SUPPRESSOR; EXPRESSION; CANCER; INFLAMMATION; MICRORNAS; PATHWAY; DIFFERENTIATION	Suppressors of cytokine signalling (SOCS) proteins are classic inhibitors of the Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway. Many cytokines and pathogenic mediators induce expression of SOCS, which act in a negative feedback loop to inhibit further signal transduction. SOCS mRNA expression is regulated by DNA binding of STAT proteins, however, their post-transcriptional regulation is poorly understood. microRNAs (miRNAs) are small non-coding RNAs that bind to complementary sequences on target mRNAs, often silencing gene expression. miR-19a has been shown to regulate SOCS1 expression during mutiple myeloma and be induced by the anti-viral cytokine interferon-(IFN)-alpha, suggesting a role in the regulation of the JAK-STAT pathway. This study aimed to identify targets of miR-19a in the JAK-STAT pathway and elucidate the functional consequences. Bioinformatic analysis identified highly conserved 3'UTR miR-19a target sequences in several JAK-STAT associated genes, including SOCS1, SOCS3, SOCS5 and Cullin (Cul) 5. Functional studies revealed that miR-19a significantly decreased SOCS3 mRNA and protein, while a miR-19a antagomir specifically reversed its inhibitory effect. Furthermore, miR-19a-mediated reduction of SOCS3 enhanced IFN-alpha and interleukin (IL)-6 signal transduction through STAT3. These results reveal a novel mechanism by which miR-19a may augment JAK-STAT signal transduction via control of SOCS3 expression and are fundamental to the understanding of inflammatory regulation.	[Collins, Aideen S.; McCoy, Claire E.; Lloyd, Andrew T.; O'Farrelly, Cliona; Stevenson, Nigel J.] Univ Dublin, Trinity Coll, Sch Biochem & Immunol, Dublin, Ireland; [O'Farrelly, Cliona] Univ Dublin, Trinity Coll, Sch Med, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin	Stevenson, NJ (corresponding author), Univ Dublin, Trinity Coll, Sch Biochem & Immunol, Dublin, Ireland.	N.Stevenson@tcd.ie	Stevenson, Nigel/X-5412-2018	Stevenson, Nigel/0000-0002-6966-9314; O'Farrelly, Cliona/0000-0002-0616-2874; McCoy, Claire/0000-0001-8710-896X	Health Research Board [RP/2007/278, TRA/2007/14, PD/2008/33]	Health Research Board	This study was supported by the Health Research Board (www.hrb.ie) (RP/2007/278, TRA/2007/14 and PD/2008/33). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Babon JJ, 2008, J MOL BIOL, V381, P928, DOI 10.1016/j.jmb.2008.06.038; Bonauer A, 2009, CELL CYCLE, V8, P3866, DOI 10.4161/cc.8.23.9994; Cardoso AL, 2012, IMMUNOLOGY, V135, P73, DOI 10.1111/j.1365-2567.2011.03514.x; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Cremer TJ, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00073; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Croker BA, 2008, SEMIN CELL DEV BIOL, V19, P414, DOI 10.1016/j.semcdb.2008.07.010; Flowers LO, 2004, J IMMUNOL, V172, P7510, DOI 10.4049/jimmunol.172.12.7510; Gantier MP, 2012, NUCLEIC ACIDS RES, V40, P8048, DOI 10.1093/nar/gks521; Gao B, 2012, J HEPATOL, V57, P430, DOI 10.1016/j.jhep.2012.01.029; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183; Hu GK, 2010, J INFECT DIS, V202, P125, DOI 10.1086/653212; Huang Y, 2007, GASTROENTEROLOGY, V132, P733, DOI 10.1053/j.gastro.2006.11.045; Inomata M, 2009, BLOOD, V113, P396, DOI 10.1182/blood-2008-07-163907; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Jiang SA, 2010, CANCER RES, V70, P3119, DOI 10.1158/0008-5472.CAN-09-4250; Jung YJ, 2013, J MED VIROL, V85, P969, DOI 10.1002/jmv.23534; Kiu H, 2012, GROWTH FACTORS, V30, P88, DOI 10.3109/08977194.2012.660936; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Larsen L, 2002, APMIS, V110, P833, DOI 10.1034/j.1600-0463.2002.1101201.x; Lu CM, 2011, BLOOD, V117, P4293, DOI 10.1182/blood-2010-12-322503; Lu F, 2008, J VIROL, V82, P10436, DOI 10.1128/JVI.00752-08; Melen K, 2000, J HEPATOL, V33, P764, DOI 10.1016/S0168-8278(00)80308-6; Moffatt CE, 2011, INFECT IMMUN, V79, P2632, DOI 10.1128/IAI.00082-11; Neilson JR, 2007, GENE DEV, V21, P578, DOI 10.1101/gad.1522907; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; Olive V, 2010, INT J BIOCHEM CELL B, V42, P1348, DOI 10.1016/j.biocel.2010.03.004; Osada H, 2011, CANCER SCI, V102, P9, DOI 10.1111/j.1349-7006.2010.01707.x; Pichiorri F, 2008, P NATL ACAD SCI USA, V105, P12885, DOI 10.1073/pnas.0806202105; Piessevaux J, 2008, CYTOKINE GROWTH F R, V19, P371, DOI 10.1016/j.cytogfr.2008.08.006; RAYNES JG, 1991, CLIN EXP IMMUNOL, V83, P488; Siegrist F, 2009, BIOL PROCED ONLINE; Siegrist F, 2009, BIOL PROCED ONLINE, V11, P113, DOI 10.1007/s12575-009-9012-1; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Stevenson NJ, 2010, FEBS LETT, V584, P4469, DOI 10.1016/j.febslet.2010.10.007; Stevenson NJ, 2009, J LEUKOCYTE BIOL, V85, P289, DOI 10.1189/jlb.0708394; Vlotides G, 2004, BIOCHEM BIOPH RES CO, V320, P1007, DOI 10.1016/j.bbrc.2004.06.051; Wang P, 2010, J IMMUNOL, V185, P6226, DOI 10.4049/jimmunol.1000491; Yao R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046082; Zhuang GL, 2012, EMBO J, V31, P3513, DOI 10.1038/emboj.2012.183	42	69	76	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69090	10.1371/journal.pone.0069090	http://dx.doi.org/10.1371/journal.pone.0069090			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894411	gold, Green Submitted, Green Published			2022-12-27	WOS:000322132100044
J	Robertson, C; Pant, DK; Joshi, DD; Sharma, M; Dahal, M; Stephen, C				Robertson, Colin; Pant, Dhan Kumar; Joshi, Durga Datt; Sharma, Minu; Dahal, Meena; Stephen, Craig			Comparative Spatial Dynamics of Japanese Encephalitis and Acute Encephalitis Syndrome in Nepal	PLOS ONE			English	Article							VIRAL ENCEPHALITIS; MAPS; DEFORESTATION; TRANSMISSION; BIODIVERSITY; VEGETATION; MORTALITY; INFLUENZA; IMPACT; SPREAD	Japanese Encephalitis (JE) is a vector-borne disease of major importance in Asia. Recent increases in cases have spawned the development of more stringent JE surveillance. Due to the difficulty of making a clinical diagnosis, increased tracking of common symptoms associated with JE-generally classified as the umbrella term, acute encephalitis syndrome (AES) has been developed in many countries. In Nepal, there is some debate as to what AES cases are, and how JE risk factors relate to AES risk. Three parts of this analysis included investigating the temporal pattern of cases, examining the age and vaccination status patterns among AES surveillance data, and then focusing on spatial patterns of risk factors. AES and JE cases from 2007-2011 reported at a district level (n = 75) were examined in relation to landscape risk factors. Landscape pattern indices were used to quantify landscape patterns associated with JE risk. The relative spatial distribution of landscape risk factors were compared using geographically weighted regression. Pattern indices describing the amount of irrigated land edge density and the degree of landscape mixing for irrigated areas were positively associated with JE and AES, while fragmented forest measured by the number of forest patches were negatively associated with AES and JE. For both JE and AES, the local GWR models outperformed global models, indicating spatial heterogeneity in risks. Temporally, the patterns of JE and AES risk were almost identical; suggesting the relative higher caseload of AES compared to JE could provide a valuable early-warning signal for JE surveillance and reduce diagnostic testing costs. Overall, the landscape variables associated with a high degree of landscape mixing and small scale irrigated agriculture were positively linked to JE and AES risk, highlighting the importance of integrating land management policies, disease prevention strategies and promoting healthy sustainable livelihoods in both rural and urban-fringe developing areas.	[Robertson, Colin] Wilfrid Laurier Univ, Dept Geog & Environm Studies, Waterloo, ON N2L 3C5, Canada; [Pant, Dhan Kumar] Tribhuvan Univ, Inst Med, Kathmandu, Nepal; [Pant, Dhan Kumar; Joshi, Durga Datt; Sharma, Minu; Dahal, Meena] Natl Zoonoses & Food Hyg Res Ctr, Kathmandu, Nepal; [Stephen, Craig] Ctr Coastal Hlth, Nanaimo, BC, Canada	Wilfrid Laurier University; Tribhuvan University; Institute of Medicine (IoM) - Nepal	Robertson, C (corresponding author), Wilfrid Laurier Univ, Dept Geog & Environm Studies, Waterloo, ON N2L 3C5, Canada.	crobertson@wlu.ca	Pant, Dhan/HHN-2817-2022		International Development Research Centre	International Development Research Centre	This study was funded by the International Development Research Centre (http://www.idrc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2003, CURR SCI INDIA, V84, P1440; AMERASINGHE PH, 1992, J MED ENTOMOL, V29, P577, DOI 10.1093/jmedent/29.4.577; Anderson KB, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001311; Bartholome E, 2005, INT J REMOTE SENS, V26, P1959, DOI 10.1080/01431160412331291297; Bassil KL, 2009, ENVIRON RES, V109, P600, DOI 10.1016/j.envres.2009.03.011; Bhatia M, 2009, HEALTH AFFAIR, V28, P1067, DOI 10.1377/hlthaff.28.4.1067; Bhattachan A, 2009, EMERG INFECT DIS, V15, P1691, DOI 10.3201/eid1510.081641; Boots B, 2006, J GEOGR SYST, V8, P109, DOI 10.1007/s10109-006-0018-9; Brunsdon C, 1996, GEOGR ANAL, V28, P281, DOI 10.1111/j.1538-4632.1996.tb00936.x; Burke DS, 1988, JAPANESE ENCEPHALTIS, V3, P63; Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233; Chanama S, 2005, JPN J INFECT DIS, V58, P294; Cooper DL, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-16; Ferraz G, 2007, SCIENCE, V315, P238, DOI 10.1126/science.1133097; Gelman A, 1999, STAT MED, V18, P3221; Gergel SE, 2001, LEARNING LANDSCAPE E; Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025; Held L, 2006, BIOSTATISTICS, V7, P422, DOI 10.1093/biostatistics/kxj016; Henrich TJ, 2003, MICROBES INFECT, V5, P603, DOI 10.1016/S1286-4579(03)00100-X; Horst MA, 2010, J AM BOARD FAM MED, V23, P32, DOI 10.3122/jabfm.2010.01.090137; Impoinvil DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022192; Jmor F, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-134; Joshi D., 1983, NEPAS J, V2, P18; Karkee R, 2010, J NEPAL MED ASSOC, V49, P178; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; KOTLIAR NB, 1990, OIKOS, V59, P253, DOI 10.2307/3545542; LaBeaud AD, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-1; Langlois JP, 2001, LANDSCAPE ECOL, V16, P255, DOI 10.1023/A:1011148316537; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; MANTON KG, 1989, J AM STAT ASSOC, V84, P637, DOI 10.2307/2289644; Mathes RW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014677; McGarigal K, 2002, ECOL APPL, V12, P335, DOI 10.1890/1051-0761(2002)012[0335:CEOEAT]2.0.CO;2; Md Zimmerman, 1977, AMJ TROP MED HYG, V57, P288; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Partridge J, 2007, AM J TROP MED HYG, V77, P1146, DOI 10.4269/ajtmh.2007.77.1146; Pavlovsky E.N., 1966, NATURAL SPECIAL REFE; Pongsiri MJ, 2009, BIOSCIENCE, V59, P945, DOI 10.1525/bio.2009.59.11.6; Rao P N, 2001, Indian Pediatr, V38, P1252; Rayamajhi A, 2007, PEDIATR INT, V49, P978, DOI 10.1111/j.1442-200X.2007.02495.x; Remmel T., 2002, EMPIRICAL DISTRIBUTI; Remmel T., 2003, J GEOGR SYST, V5, P331, DOI DOI 10.1007/S10109-003-0116-X; Rempel RS, 1999, PATCH ANAL ADN PATCH; RIITTERS KH, 1995, LANDSCAPE ECOL, V10, P23, DOI 10.1007/BF00158551; Robertson C, 2011, PLOS ONE; SERVICE MW, 1989, PARASITOL TODAY, V5, P162, DOI 10.1016/0169-4758(89)90083-5; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Smith DL, 2004, PLOS BIOL, V2, P1957, DOI 10.1371/journal.pbio.0020368; Stibig HJ, 2007, J BIOGEOGR, V34, P625, DOI 10.1111/j.1365-2699.2006.01637.x; Tischendorf L, 2000, LANDSCAPE ECOL, V15, P633, DOI 10.1023/A:1008177324187; Wenger JD, 2011, CLIN INFECT DIS, V52, pS189, DOI 10.1093/cid/ciq037; Witter S, 2011, HEALTH POLICY PLANN, V26, pII84, DOI 10.1093/heapol/czr066; Wu JG, 1995, Q REV BIOL, V70, P439, DOI 10.1086/419172; Yamasaki-Nakagawa M, 2001, INT J TUBERC LUNG D, V5, P24; Yasuoka J, 2007, AM J TROP MED HYG, V76, P450, DOI 10.4269/ajtmh.2007.76.450	54	19	20	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e66168	10.1371/journal.pone.0066168	http://dx.doi.org/10.1371/journal.pone.0066168			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894277	Green Published, gold, Green Submitted			2022-12-27	WOS:000322132100003
J	Seifert-Held, T; Pekar, T; Gattringer, T; Simmet, NE; Scharnagl, H; Bocksrucker, C; Lampl, C; Storch, MK; Stojakovic, T; Fazekas, F				Seifert-Held, Thomas; Pekar, Thomas; Gattringer, Thomas; Simmet, Nicole E.; Scharnagl, Hubert; Bocksrucker, Christoph; Lampl, Christian; Storch, Maria K.; Stojakovic, Tatjana; Fazekas, Franz			Plasma Midregional Pro-Adrenomedullin Improves Prediction of Functional Outcome in Ischemic Stroke	PLOS ONE			English	Article							BLOOD; CLASSIFICATION; REPERFUSION; EXPRESSION; MORTALITY; COPEPTIN; PEPTIDE; MARKERS; CELLS; AGE	Background: To evaluate if plasma levels of midregional pro-adrenomedullin (MR-proADM) improve prediction of functional outcome in ischemic stroke. Methods: In 168 consecutive ischemic stroke patients, plasma levels of MR-proADM were measured within 24 hours from symptom onset. Functional outcome was assessed by the modified Rankin Scale (mRS) at 90 days following stroke. Logistic regression, receiver operating characteristics (ROC) curve analysis, net reclassification improvement (NRI), and Kaplan-Meier survival analysis were applied. Results: Plasma MR-proADM levels were found significantly higher in patients with unfavourable (mRS 3-6) compared to favourable (mRS 0-2) outcomes. MR-proADM levels were entered into a predictive model including the patients' age, National Institutes of Health Stroke Scale (NIHSS), and the use of recanalization therapy. The area under the ROC curve did not increase significantly. However, category-free NRI of 0.577 (p<0.001) indicated a significant improvement in reclassification of patients. Furthermore, MR-proADM levels significantly improved reclassification of patients in the prediction of outcome by the Stroke Prognostication using Age and NIHSS-100 (SPAN-100; NRI = 0.175; p = 0.04). Kaplan-Meier survival analysis showed a rising risk of death with increasing MR-proADM quintiles. Conclusions: Plasma MR-proADM levels improve prediction of functional outcome in ischemic stroke when added to the patients' age, NIHSS on admission, and the use of recanalization therapy. Levels of MR-proADM in peripheral blood improve reclassification of patients when the SPAN-100 is used to predict the patients' functional outcome.	[Seifert-Held, Thomas; Pekar, Thomas; Gattringer, Thomas; Simmet, Nicole E.; Storch, Maria K.; Fazekas, Franz] Med Univ Graz, Dept Neurol, Graz, Austria; [Pekar, Thomas] Univ Appl Sci Wiener Neustadt, Wiener Neustadt, Austria; [Scharnagl, Hubert; Stojakovic, Tatjana] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria; [Bocksrucker, Christoph; Lampl, Christian] Konventhosp Barmherzige Brueder Linz, Linz, Austria; [Lampl, Christian] Konventhosp Barmherzige Schwestern Linz, Linz, Austria	Medical University of Graz; Medical University of Graz; Konventhospital Der Barmherzigen Bruder; Konventhospital Der Barmherzigen Bruder	Seifert-Held, T (corresponding author), Med Univ Graz, Dept Neurol, Graz, Austria.	thomas.seifert@medunigraz.at		Pekar, Thomas/0000-0002-2331-0488; Gattringer, Thomas/0000-0002-6065-6576	Medical University of Graz	Medical University of Graz	This study was supported by an in-house grant of the Medical University of Graz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ay H, 2007, STROKE, V38, P2979, DOI 10.1161/STROKEAHA.107.490896; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Cuttitta F, 2002, MICROSC RES TECHNIQ, V57, P110, DOI 10.1002/jemt.10059; De Marchis GM, 2013, NEUROLOGY, V80, P1278, DOI 10.1212/WNL.0b013e3182887944; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Doehner W, 2012, J AM COLL CARDIOL, V60, P346, DOI 10.1016/j.jacc.2012.04.024; Encinas JM, 2002, NEUROSCI LETT, V329, P197, DOI 10.1016/S0304-3940(02)00648-1; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Ferrari J, 2010, STROKE, V41, P2001, DOI 10.1161/STROKEAHA.110.590372; Frendl Anita, 2011, Front Neurol, V2, P32, DOI 10.3389/fneur.2011.00032; GUMUSEL B, 1995, LIFE SCI, V57, pPL87, DOI 10.1016/0024-3205(95)02012-8; Janssen PM, 2010, CEREBROVASC DIS, V29, P137, DOI 10.1159/000262309; Katan M, 2010, J AM COLL CARDIOL, V56, P1045, DOI 10.1016/j.jacc.2010.02.071; Katan M, 2009, ANN NEUROL, V66, P799, DOI 10.1002/ana.21783; Kato J, 2005, ARTERIOSCL THROM VAS, V25, P2480, DOI 10.1161/01.ATV.0000184759.91369.f8; Khan SQ, 2007, J AM COLL CARDIOL, V49, P1525, DOI 10.1016/j.jacc.2006.12.038; KITAMURA K, 1993, BIOCHEM BIOPH RES CO, V192, P553, DOI 10.1006/bbrc.1993.1451; Lees KR, 2012, STROKE, V43, P1163, DOI 10.1161/STROKEAHA.111.641423; Maki T, 2011, STROKE, V42, P1122, DOI 10.1161/STROKEAHA.110.603399; Meeran K, 1997, J CLIN ENDOCR METAB, V82, P95, DOI 10.1210/jc.82.1.95; Morgenthaler NG, 2005, CLIN CHEM, V51, P1823, DOI 10.1373/clinchem.2005.051110; Nicholls MG, 2003, HYPERTENS RES, V26, pS135, DOI 10.1291/hypres.26.S135; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Pio R, 2001, J BIOL CHEM, V276, P12292, DOI 10.1074/jbc.M007822200; Quinn TJ, 2009, INT J STROKE, V4, P200, DOI 10.1111/j.1747-4949.2009.00271.x; Rabinstein A, 2013, NEUROLOGY, V80, P15, DOI 10.1212/WNL.0b013e31827b1b5c; Saposnik G, 2013, NEUROLOGY, V80, P21, DOI 10.1212/WNL.0b013e31827b1ace; Serrano J, 2002, NEUROSCIENCE, V109, P717, DOI 10.1016/S0306-4522(01)00532-2; Struck J, 2004, PEPTIDES, V25, P1369, DOI 10.1016/j.peptides.2004.06.019; SUGO S, 1994, BIOCHEM BIOPH RES CO, V201, P1160, DOI 10.1006/bbrc.1994.1827; SUGO S, 1994, BIOCHEM BIOPH RES CO, V203, P719, DOI 10.1006/bbrc.1994.2241; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; von Haehling S, 2010, EUR J HEART FAIL, V12, P484, DOI 10.1093/eurjhf/hfq031; Weimar C, 2004, STROKE, V35, P158, DOI 10.1161/01.STR.0000106761.94985.8B; Whiteley W, 2009, STROKE, V40, pE380, DOI 10.1161/STROKEAHA.108.528752; Wiesner J, 2010, VIRULENCE, V1, P440, DOI 10.4161/viru.1.5.12983; Worthmann H, 2010, CEREBROVASC DIS, V30, P85, DOI 10.1159/000314624; Worthmann H, 2011, CEREBROVASC DIS, V32, P72, DOI 10.1159/000328233	40	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e68768	10.1371/journal.pone.0068768	http://dx.doi.org/10.1371/journal.pone.0068768			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894342	gold, Green Published			2022-12-27	WOS:000322132100024
J	D'haeseleer, P; Gladden, JM; Allgaier, M; Chain, PSG; Tringe, SG; Malfatti, SA; Aldrich, JT; Nicora, CD; Robinson, EW; Pasa-Tolic, L; Hugenholtz, P; Simmons, BA; Singer, SW				D'haeseleer, Patrik; Gladden, John M.; Allgaier, Martin; Chain, Patrik S. G.; Tringe, Susannah G.; Malfatti, Stephanie A.; Aldrich, Joshua T.; Nicora, Carrie D.; Robinson, Errol W.; Pasa-Tolic, Ljiljana; Hugenholtz, Philip; Simmons, Blake A.; Singer, Steven W.			Proteogenomic Analysis of a Thermophilic Bacterial Consortium Adapted to Deconstruct Switchgrass	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; EUBACTERIUM RHODOTHERMUS-MARINUS; COMPARATIVE-ANALYSIS SYSTEM; SAMPLE PREPARATION METHOD; RIBOSOMAL-RNA GENES; MS-BASED PROTEOMICS; THERMUS-THERMOPHILUS; GLYCOSIDE HYDROLASES; COMMUNITY PROTEOMICS; EXTREME THERMOPHILE	Thermophilic bacteria are a potential source of enzymes for the deconstruction of lignocellulosic biomass. However, the complement of proteins used to deconstruct biomass and the specific roles of different microbial groups in thermophilic biomass deconstruction are not well-explored. Here we report on the metagenomic and proteogenomic analyses of a compost-derived bacterial consortium adapted to switchgrass at elevated temperature with high levels of glycoside hydrolase activities. Near-complete genomes were reconstructed for the most abundant populations, which included composite genomes for populations closely related to sequenced strains of Thermus thermophilus and Rhodothermus marinus, and for novel populations that are related to thermophilic Paenibacilli and an uncultivated subdivision of the little-studied Gemmatimonadetes phylum. Partial genomes were also reconstructed for a number of lower abundance thermophilic Chloroflexi populations. Identification of genes for lignocellulose processing and metabolic reconstructions suggested Rhodothermus, Paenibacillus and Gemmatimonadetes as key groups for deconstructing biomass, and Thermus as a group that may primarily metabolize low molecular weight compounds. Mass spectrometry-based proteomic analysis of the consortium was used to identify >3000 proteins in fractionated samples from the cultures, and confirmed the importance of Paenibacillus and Gemmatimonadetes to biomass deconstruction. These studies also indicate that there are unexplored proteins with important roles in bacterial lignocellulose deconstruction.	[D'haeseleer, Patrik; Gladden, John M.; Allgaier, Martin; Hugenholtz, Philip; Simmons, Blake A.; Singer, Steven W.] Joint BioEnergy Inst, Emeryville, CA USA; [D'haeseleer, Patrik; Gladden, John M.] Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA USA; [Gladden, John M.; Simmons, Blake A.] Sandia Natl Labs, Biol & Mat Sci Ctr, Livermore, CA USA; [Allgaier, Martin; Chain, Patrik S. G.; Tringe, Susannah G.; Malfatti, Stephanie A.; Hugenholtz, Philip] Joint Genome Inst, Walnut Creek, CA USA; [Allgaier, Martin] Leibniz Inst Freshwater Ecol & Inland Fisheries, Berlin, Germany; [Chain, Patrik S. G.] Los Alamos Natl Lab, Metagenom Applicat Team, Genome Sci Grp, Los Alamos, NM USA; [Nicora, Carrie D.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA; [Aldrich, Joshua T.; Robinson, Errol W.; Pasa-Tolic, Ljiljana] Pacific NW Natl Lab, Environm Mol Sci Lab, Richland, WA 99352 USA; [Hugenholtz, Philip] Univ Queensland, Sch Chem & Mol Biosci, Australian Ctr Ecogenom, Brisbane, Qld, Australia; [Singer, Steven W.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory; University of Queensland; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	D'haeseleer, P (corresponding author), Joint BioEnergy Inst, Emeryville, CA USA.	patrikd@llnl.gov	Tringe, Susannah Green/T-9431-2019; Singer, STeven W/I-1851-2014; Hugenholtz, Philip/AAD-9138-2019; Chain, Patrick/O-4140-2019; Simmons, Blake/N-6022-2016	Tringe, Susannah Green/0000-0001-6479-8427; Hugenholtz, Philip/0000-0001-5386-7925; Chain, Patrick/0000-0003-3949-3634; Simmons, Blake/0000-0002-1332-1810; Malfatti, Stephanie/0000-0003-4225-9857	U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]; Lawrence Berkeley National Laboratory; U.S. Department of Energy; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; Department of Energy's Office of Biological and Environmental Research and located at Pacific Northwest National Laboratory	U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE)); Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); Department of Energy's Office of Biological and Environmental Research and located at Pacific Northwest National Laboratory(United States Department of Energy (DOE))	This work was performed as part of the DOE Joint BioEnergy Institute (http://www.jbei.org) supported by the U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the U.S. Department of Energy. Metagenomic sequencing was conducted by the DOE Joint Genome Institute which is supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. A portion of the research was performed using the Environmental Molecular Sciences Laboratory, a national scientific user facility sponsored by the Department of Energy's Office of Biological and Environmental Research and located at Pacific Northwest National Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adav SS, 2010, J PROTEOME RES, V9, P3016, DOI 10.1021/pr901174z; ALFREDSSON GA, 1988, J GEN MICROBIOL, V134, P299; Allgaier M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008812; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ausec L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025724; Banerjee G, 2010, BIORESOURCE TECHNOL, V101, P9097, DOI 10.1016/j.biortech.2010.07.028; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blanch HW, 2008, ACS CHEM BIOL, V3, P17, DOI 10.1021/cb700267s; Bouws H, 2008, APPL MICROBIOL BIOT, V80, P381, DOI 10.1007/s00253-008-1572-5; Bugg TDH, 2011, CURR OPIN BIOTECH, V22, P394, DOI 10.1016/j.copbio.2010.10.009; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Caspi R, 2012, NUCLEIC ACIDS RES, V40, pD742, DOI 10.1093/nar/gkr1014; CHAUTHAIWALE J, 1994, APPL ENVIRON MICROB, V60, P4495, DOI 10.1128/AEM.60.12.4495-4499.1994; Chistoserdova L, 2010, BIOTECHNOL LETT, V32, P1351, DOI 10.1007/s10529-010-0306-9; DAHLBERG L, 1993, APPL MICROBIOL BIOT, V40, P63, DOI 10.1007/BF00170430; Datta S, 2010, GREEN CHEM, V12, P338, DOI 10.1039/b916564a; DeAngelis KM, 2011, STAND GENOMIC SCI, V5, P69, DOI 10.4056/sigs.2104875; DeBruyn JM, 2011, APPL ENVIRON MICROB, V77, P6295, DOI 10.1128/AEM.05005-11; Dougherty MJ, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-38; Fracchia L, 2006, APPL MICROBIOL BIOT, V71, P942, DOI 10.1007/s00253-005-0228-y; Gladden JM, 2012, BIOTECHNOL BIOENG, V109, P1140, DOI 10.1002/bit.24388; Gladden JM, 2011, APPL ENVIRON MICROB, V77, P5804, DOI 10.1128/AEM.00032-11; Gomes J, 2000, ENZYME MICROB TECH, V27, P414, DOI 10.1016/S0141-0229(00)00229-5; Gounder K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-577; Henne A, 2004, NAT BIOTECHNOL, V22, P547, DOI 10.1038/nbt956; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Hixson KK, 2006, J PROTEOME RES, V5, P3008, DOI 10.1021/pr060179y; Hreggvidsson GO, 1996, APPL ENVIRON MICROB, V62, P3047, DOI 10.1128/.62.8.3047-3049.1996; Ivanova NN, 2008, STANDARD OPERATING P; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Karp PD, 2010, BRIEF BIOINFORM, V11, P40, DOI 10.1093/bib/bbp043; Karpievitch Y, 2009, BIOINFORMATICS, V25, P2028, DOI 10.1093/bioinformatics/btp362; Kelly RT, 2006, ANAL CHEM, V78, P7796, DOI 10.1021/ac061133r; Kembel S. W., 2012, PLOS COMPUT BIOL, V8, P16, DOI DOI 10.1371/J0URNAL.PCBI.1002743; Kiss H, 2010, STAND GENOMIC SCI, V3, P153, DOI 10.4056/sigs.1153107; Konstantinidis KT, 2005, J BACTERIOL, V187, P6258, DOI 10.1128/JB.187.18.6258-6264.2005; Kunin V, 2008, MICROBIOL MOL BIOL R, V72, P557, DOI 10.1128/MMBR.00009-08; Levasseur A, 2008, FUNGAL GENET BIOL, V45, P638, DOI 10.1016/j.fgb.2008.01.004; Li CL, 2010, BIORESOURCE TECHNOL, V101, P4900, DOI 10.1016/j.biortech.2009.10.066; Li LL, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-23; Liang YN, 2010, APPL BIOCHEM BIOTECH, V161, P147, DOI 10.1007/s12010-009-8780-z; Lochner A, 2011, J PROTEOME RES, V10, P5302, DOI 10.1021/pr200536j; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Maiolica A, 2005, PROTEOMICS, V5, P3847, DOI 10.1002/pmic.200402010; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD123, DOI 10.1093/nar/gkr975; Masai E, 2007, BIOSCI BIOTECH BIOCH, V71, P1, DOI 10.1271/bbb.60437; Mavromatis K, 2009, STAND GENOMIC SCI, V1, P63, DOI 10.4056/sigs.632; Nolan M, 2009, STAND GENOMIC SCI, V1, P283, DOI 10.4056/sigs.46736; Ohtani N, 2010, J BACTERIOL, V192, P5499, DOI 10.1128/JB.00662-10; Park JI, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0051377, 10.1371/journal.pone.0037010]; Pasa-Tolic L, 2004, BIOTECHNIQUES, V37, P621, DOI 10.2144/04374RV01; Pati A, 2011, STAND GENOMIC SCI, V5, P248, DOI 10.4056/sigs.2075298; Pati A, 2010, STAND GENOMIC SCI, V2, P49, DOI 10.4056/sigs.601105; PAWAR HS, 1994, PREP BIOCHEM, V24, P143, DOI 10.1080/10826069408010088; Polpitiya AD, 2008, BIOINFORMATICS, V24, P1556, DOI 10.1093/bioinformatics/btn217; Ram RJ, 2005, SCIENCE, V308, P1915, DOI 10.1126/science. 1109070; Raman B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005271; Sharma P, 2007, WORLD J MICROB BIOT, V23, P823, DOI 10.1007/s11274-006-9305-3; Simmons BA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-242; Suen G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001129; TAM R, 1993, MICROBIOL REV, V57, P320, DOI 10.1128/MMBR.57.2.320-346.1993; van der Lelie D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036740; VerBerkmoes NC, 2009, NAT REV MICROBIOL, V7, P196, DOI 10.1038/nrmicro2080; Wang HX, 2005, J PROTEOME RES, V4, P2397, DOI 10.1021/pr050160f; Wang Pei, 2006, Pac Symp Biocomput, P315; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Wei H, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-20; Wilmes P, 2008, ISME J, V2, P853, DOI 10.1038/ismej.2008.38; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Xia Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053779; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479; Zhang H, 2003, INT J SYST EVOL MICR, V53, P1155, DOI 10.1099/ijs.0.02520-0; Zhou JY, 2012, ANAL CHEM, V84, P2862, DOI 10.1021/ac203394r; Zimmer JSD, 2006, MASS SPECTROM REV, V25, P450, DOI 10.1002/mas.20071	75	51	52	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e68465	10.1371/journal.pone.0068465	http://dx.doi.org/10.1371/journal.pone.0068465			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894306	gold, Green Published, Green Submitted			2022-12-27	WOS:000322391400007
J	Lu, CF; Guo, WY; Chang, FC; Huang, SR; Chou, YC; Wu, YT				Lu, Chia-Feng; Guo, Wan-Yuo; Chang, Feng-Chi; Huang, Shang-Ran; Chou, Yen-Chun; Wu, Yu-Te			Hemodynamic Segmentation of Brain Perfusion Images with Delay and Dispersion Effects Using an Expectation-Maximization Algorithm	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; INDEPENDENT COMPONENT ANALYSIS; HIGH-RESOLUTION MEASUREMENT; TRACER BOLUS PASSAGES; ACUTE ISCHEMIC-STROKE; PROCESSING METHODS; VOLUME; MRI; CLASSIFICATION; DECONVOLUTION	Automatic identification of various perfusion compartments from dynamic susceptibility contrast magnetic resonance brain images can assist in clinical diagnosis and treatment of cerebrovascular diseases. The principle of segmentation methods was based on the clustering of bolus transit-time profiles to discern areas of different tissues. However, the cerebrovascular diseases may result in a delayed and dispersed local perfusion and therefore alter the hemodynamic signal profiles. Assessing the accuracy of the segmentation technique under delayed/dispersed circumstance is critical to accurately evaluate the severity of the vascular disease. In this study, we improved the segmentation method of expectation-maximization algorithm by using the results of hierarchical clustering on whitened perfusion data as initial parameters for a mixture of multivariate Gaussians model. In addition, Monte Carlo simulations were conducted to evaluate the performance of proposed method under different levels of delay, dispersion, and noise of signal profiles in tissue segmentation. The proposed method was used to classify brain tissue types using perfusion data from five normal participants, a patient with unilateral stenosis of the internal carotid artery, and a patient with moyamoya disease. Our results showed that the normal, delayed or dispersed hemodynamics can be well differentiated for patients, and therefore the local arterial input function for impaired tissues can be recognized to minimize the error when estimating the cerebral blood flow. Furthermore, the tissue in the risk of infarct and the tissue with or without the complementary blood supply from the communicating arteries can be identified.	[Lu, Chia-Feng; Huang, Shang-Ran; Chou, Yen-Chun; Wu, Yu-Te] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Lu, Chia-Feng; Wu, Yu-Te] Natl Yang Ming Univ, Brain Res Ctr, Taipei 112, Taiwan; [Lu, Chia-Feng] Natl Yang Ming Univ, Dept Phys Therapy & Assist Technol, Taipei 112, Taiwan; [Lu, Chia-Feng] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan; [Guo, Wan-Yuo; Chang, Feng-Chi] Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan; [Guo, Wan-Yuo; Chang, Feng-Chi] Natl Yang Ming Univ, Fac Med, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei City Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Wu, YT (corresponding author), Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan.	ytwu@ym.edu.tw			National Science Council [NSC96-2628-E-010-015-MY3, NSC100-2221-E-010-009, NSC101-2221-E-010-004-MY2]; Taipei Veterans General Hospital [V96C1-135, V97C1-025, V98C1-109, V99C1-005]; National Science Council; National Central University, Jhongli City, Taoyuan County, Taiwan, Republic of China [NSC 101-2911-I-008-001]; Brain Research Center, National Yang-Ming University; Ministry of Education, Aim for the Top University Plan	National Science Council(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital); National Science Council(Ministry of Science and Technology, Taiwan); National Central University, Jhongli City, Taoyuan County, Taiwan, Republic of China; Brain Research Center, National Yang-Ming University; Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan)	The study was funded by the National Science Council (NSC96-2628-E-010-015-MY3, NSC100-2221-E-010-009, NSC101-2221-E-010-004-MY2), Taipei Veterans General Hospital (V96C1-135, V97C1-025, V98C1-109, V99C1-005), the National Science Council supported for the Center for Dynamical Biomarkers and Translational Medicine, National Central University, Jhongli City, Taoyuan County, Taiwan, Republic of China (NSC 101-2911-I-008-001), and Brain Research Center, National Yang-Ming University and a grant from Ministry of Education, Aim for the Top University Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARONEN HJ, 1995, ACTA RADIOL, V36, P520; Bishop C.M., 1995, NEURAL NETWORKS PATT; Butcher K, 2008, STROKE, V39, P75, DOI 10.1161/STROKEAHA.107.490524; Calamante F, 2006, MAGN RESON MED, V55, P1180, DOI 10.1002/mrm.20873; Calamante F, 1999, J CEREBR BLOOD F MET, V19, P701, DOI 10.1097/00004647-199907000-00001; Calamante F, 2000, MAGN RESON MED, V44, P466, DOI 10.1002/1522-2594(200009)44:3<466::AID-MRM18>3.0.CO;2-M; Chou YC, 2007, MED IMAGE ANAL, V11, P242, DOI 10.1016/j.media.2007.02.002; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Gonzalez R.C., 2017, DIGITAL IMAGE PROCES, V4th ed.; Guckel FJ, 1996, RADIOLOGY, V201, P405; Guo WY, 2004, AM J NEURORADIOL, V25, P1636; Hyvarinen A, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P71; Kane I, 2007, J NEUROL NEUROSUR PS, V78, P485, DOI 10.1136/jnnp.2006.100347; Kane I, 2007, STROKE, V38, P3158, DOI 10.1161/STROKEAHA.107.483842; Kao YH, 2003, MAGNET RESON MED, V49, P885, DOI 10.1002/mrm.10440; Lassen NA, 1979, TRACER KINETICS METH; Myerson R. B., 1977, Mathematics of Operations Research, V2, P225, DOI 10.1287/moor.2.3.225; NASH J, 1951, ANN MATH, V54, P286, DOI 10.2307/1969529; Nash JF, 1950, ECONOMETRICA, V18, P155, DOI 10.2307/1907266; Ostergaard L, 1996, MAGNET RESON MED, V36, P726, DOI 10.1002/mrm.1910360511; Ostergaard L, 1996, MAGN RESON MED, V36, P715, DOI 10.1002/mrm.1910360510; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; REMPP KA, 1994, RADIOLOGY, V193, P637, DOI 10.1148/radiology.193.3.7972800; ROSEN BR, 1990, MAGNET RESON MED, V14, P249, DOI 10.1002/mrm.1910140211; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sorensen AG, 1997, JMRI-J MAGN RESON IM, V7, P47, DOI 10.1002/jmri.1880070108; Von Neumann J, 1980, THEORY GAMES EC BEHA; Wenz F, 1996, MAGN RESON IMAGING, V14, P157, DOI 10.1016/0730-725X(95)02058-2; Willats L, 2006, MAGN RESON MED, V56, P146, DOI 10.1002/mrm.20940; WISHART D, 1969, BIOMETRICS, V25, P165, DOI 10.2307/2528688; Wong KKL, 2009, J MECH MED BIOL, V9, P1, DOI 10.1142/S0219519409002894; Wong KKL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025621; Wong KKL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010331; Wong KKL, 2003, 2 WORKSH CONJ 9 ACM; Wu O, 2003, MAGNET RESON MED, V50, P164, DOI 10.1002/mrm.10522; Wu YT, 2007, MAGN RESON MED, V57, P181, DOI 10.1002/mrm.21121; ZIERLER KL, 1965, CIRC RES, V16, P309, DOI 10.1161/01.RES.16.4.309; ZIERLER KL, 1962, CIRC RES, V10, P393, DOI 10.1161/01.RES.10.3.393	38	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e68986	10.1371/journal.pone.0068986	http://dx.doi.org/10.1371/journal.pone.0068986			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894386	gold, Green Published, Green Submitted			2022-12-27	WOS:000322391400032
J	Yee, J; Kwon, MS; Park, T; Park, M				Yee, Jaeyong; Kwon, Min-Seok; Park, Taesung; Park, Mira			A Modified Entropy-Based Approach for Identifying Gene-Gene Interactions in Case-Control Study	PLOS ONE			English	Article							MULTIFACTOR-DIMENSIONALITY REDUCTION; STRATEGIES; POWER	Gene-gene interactions may play an important role in the genetics of a complex disease. Detection and characterization of gene-gene interactions is a challenging issue that has stimulated the development of various statistical methods to address it. In this study, we introduce a method to measure gene interactions using entropy-based statistics from a contingency table of trait and genotype combinations. We also developed an exploration procedure by using graphs. We propose a standardized relative information gain (RIG) measure to evaluate the interactions between single nucleotide polymorphism (SNP) combinations. To identify the kth order interactions, contingency tables of trait and genotype combinations of k SNPs are constructed, with which RIGs are calculated. The RIGs are standardized using the mean and standard deviation from the permuted datasets. SNP combinations yielding high standardized RIG are chosen for gene-gene interactions. Detection of high-order interactions and comparison of interaction strengths between different orders are made possible by using standardized RIG. We have applied the proposed standardized entropy-based method to two types of data sets from a simulation study and a real genetic association study. We have compared our method and the multifactor dimensionality reduction (MDR) method through power analysis of eight different genetic models with varying penetrance rates, number of SNPs, and sample sizes. Our method shows successful identification of genetic associations and gene-gene interactions both in simulation and real genetic data. Simulation results suggest that the proposed entropy-based method is better able to detect high-order interactions and is superior to the MDR method in most cases. The proposed method is well suited for detecting interactions without main effects as well as for models including main effects.	[Yee, Jaeyong] Eulji Univ, Dept Physiol & Biophys, Taejon, South Korea; [Kwon, Min-Seok] Seoul Natl Univ, Dept Bioinformat, Seoul, South Korea; [Park, Taesung] Seoul Natl Univ, Dept Stat, Seoul, South Korea; [Park, Mira] Eulji Univ, Dept Prevent Med, Taejon, South Korea	Eulji University; Seoul National University (SNU); Seoul National University (SNU); Eulji University	Park, M (corresponding author), Eulji Univ, Dept Prevent Med, Taejon, South Korea.	mira@eulji.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2010-0012133, 2012R1A3A2026438]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0012133, 2012R1A3A2026438). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bush WS, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-238; Calle ML, 2008, STAT MED, V27, P6532, DOI 10.1002/sim.3431; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Chanda P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-509; Cho S, 2010, ANN HUM GENET, V74, P416, DOI 10.1111/j.1469-1809.2010.00597.x; Chung YJ, 2007, BIOINFORMATICS, V23, P71, DOI 10.1093/bioinformatics/btl557; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Dong CZ, 2008, EUR J HUM GENET, V16, P229, DOI 10.1038/sj.ejhg.5201921; Gray RM, 2011, ENTROPY AND INFORMATION THEORY , SECOND EDITION, P395, DOI 10.1007/978-1-4419-7970-4; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Jung SH, 2005, BIOSTATISTICS, V6, P157, DOI 10.1093/biostatistics/kxh026; Jung SH, 2006, BIOINFORMATICS, V22, P1730, DOI 10.1093/bioinformatics/btl161; Kang GL, 2008, J THEOR BIOL, V250, P362, DOI 10.1016/j.jtbi.2007.10.001; Knijnenburg TA, 2009, BIOINFORMATICS, V25, pI161, DOI 10.1093/bioinformatics/btp211; Kooperberg C, 2005, GENET EPIDEMIOL, V28, P157, DOI 10.1002/gepi.20042; Lee SY, 2007, BIOINFORMATICS, V23, P2589, DOI 10.1093/bioinformatics/btm396; Moore JH, 2002, ANN MED, V34, P88, DOI 10.1080/07853890252953473; Namkung JH, 2007, ALLERGY, V62, P934, DOI 10.1111/j.1398-9995.2007.01445.x; Namkung J, 2009, GENET EPIDEMIOL, V33, P646, DOI 10.1002/gepi.20416; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Ritchie MD, 2003, GENET EPIDEMIOL, V24, P150, DOI 10.1002/gepi.10218; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Sherriff A, 2001, ADV GENET, V42, P287, DOI 10.1016/S0065-2660(01)42029-3; Zhang HP, 2000, GENET EPIDEMIOL, V19, P323, DOI 10.1002/1098-2272(200012)19:4<323::AID-GEPI4>3.0.CO;2-5	24	24	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e69321	10.1371/journal.pone.0069321	http://dx.doi.org/10.1371/journal.pone.0069321			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874943	Green Published, Green Submitted, gold			2022-12-27	WOS:000324146200072
J	Lehmann, ML; Geddes, CE; Lee, JL; Herkenham, M				Lehmann, Michael L.; Geddes, Claire E.; Lee, Jennifer L.; Herkenham, Miles			Urine Scent Marking (USM): A Novel Test for Depressive-Like Behavior and a Predictor of Stress Resiliency in Mice	PLOS ONE			English	Article							MUS-DOMESTICUS RUTTY; CHRONIC MILD STRESS; CHRONIC RESTRAINT STRESS; REPEATED SOCIAL DEFEAT; HOUSE MICE; ULTRASONIC VOCALIZATIONS; PERIAQUEDUCTAL GRAY; SUCROSE CONSUMPTION; LOCOMOTOR-ACTIVITY; SEXUAL-BEHAVIOR	Decreased interest in pleasurable stimuli including social withdrawal and reduced libido are some of the key symptomatic criteria for major depression, and thus assays that measure social and sexual behavior in rodents may be highly appropriate for modeling depressive states. Here we present a novel approach for validating rodent models of depression by assessing male urine scent marking (USM) made in consequence to a spot of urine from a proestrous female. USM is an ethologically important form of sexual communication expressed by males to attract females. The expression of this behavior is highly sensitive and adaptive to environmental cues and social status. We hypothesized that male USM behavior offers a naturalistic measure of social motivation that can be used to evaluate hedonic behaviors relevant to the study of mood disorders. We demonstrated that 1) adult male mice displayed a strong preference for marking proestrous female urine with a high degree of specificity, 2) exposure to chronic social defeat profoundly decreased USM whereas exposure to environmental enrichment increased USM, 3) the standard antidepressant fluoxetine reversed declines in USM induced by social defeat, 4) USM behavior closely correlated with other hedonic measures, and 5) USM scores in non-stressed mice predicted behavioral outcomes after defeat exposure such that mice displaying high preference for marking female urine prior to social defeat showed behavioral resiliency after social defeat. The findings indicate that the USM test is a sensitive, validated measure of psychosocial stress effects that has high predictive value for examination of stress resiliency and vulnerability and their neurobiological substrates.	[Lehmann, Michael L.; Geddes, Claire E.; Lee, Jennifer L.; Herkenham, Miles] NIMH, Funct Neuroanat Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Lehmann, ML (corresponding author), NIMH, Funct Neuroanat Sect, NIH, Bethesda, MD 20892 USA.	Michael.lehmann@nih.gov	Lehmann, Michael/AAG-4912-2021	Herkenham, Miles/0000-0003-2228-4238; Lehmann, Michael/0000-0003-4476-8268	Intramural Research Program of the National Institute of Mental Health, National Institutes of Health; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH001090] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Mental Health, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The research was supported by the Intramural Research Program of the National Institute of Mental Health, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT, Vxxxvii; Arakawa H, 2008, NEUROSCI BIOBEHAV R, V32, P1236, DOI 10.1016/j.neubiorev.2008.05.012; Arakawa H, 2008, BEHAV BRAIN RES, V190, P97, DOI 10.1016/j.bbr.2008.02.009; Avgustinovich D F, 2005, Neurosci Behav Physiol, V35, P917, DOI 10.1007/s11055-005-0146-6; BANDLER R, 1994, TRENDS NEUROSCI, V17, P379, DOI 10.1016/0166-2236(94)90047-7; BARNETT PA, 1988, PSYCHOL BULL, V104, P97, DOI 10.1037/0033-2909.104.1.97; Becker C, 2008, MOL PSYCHIATR, V13, P1079, DOI 10.1038/sj.mp.4002097; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Berton O, 1999, NEUROSCIENCE, V92, P327, DOI 10.1016/S0306-4522(98)00742-8; BLANCHARD DC, 1995, PSYCHONEUROENDOCRINO, V20, P117, DOI 10.1016/0306-4530(94)E0045-B; BLANCHARD DC, 1993, BEHAV BRAIN RES, V58, P113, DOI 10.1016/0166-4328(93)90096-9; Blanchard DC, 2001, NEUROSCI BIOBEHAV R, V25, P205, DOI 10.1016/S0149-7634(01)00009-4; BLOK BFM, 1994, NEUROSCI LETT, V166, P93, DOI 10.1016/0304-3940(94)90848-6; Bremner J Douglas, 2004, Expert Rev Neurother, V4, P275, DOI 10.1586/14737175.4.2.275; Byers SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035538; CHAMPLIN AK, 1973, BIOL REPROD, V8, P491, DOI 10.1093/biolreprod/8.4.491; Chaouloff F, 2013, CELL TISSUE RES; Christiansen SH, 2011, BEHAV BRAIN RES, V216, P585, DOI 10.1016/j.bbr.2010.08.044; Chuang JC, 2010, BIOL PSYCHIAT, V67, P1075, DOI 10.1016/j.biopsych.2009.12.003; Cryan JF, 2005, PSYCHOPHARMACOLOGY, V182, P335, DOI 10.1007/s00213-005-0093-5; Cryan JF, 2002, TRENDS PHARMACOL SCI, V23, P238, DOI 10.1016/S0165-6147(02)02017-5; DAVIES VJ, 1972, J ENDOCRINOL, V55, P11, DOI 10.1677/joe.0.0550011; DESJARDINS C, 1973, SCIENCE, V182, P939, DOI 10.1126/science.182.4115.939; Drickamer LC, 2001, BEHAV PROCESS, V53, P113, DOI 10.1016/S0376-6357(00)00152-2; Fiorino DF, 1999, J NEUROSCI, V19, P456, DOI 10.1523/JNEUROSCI.19-01-00456.1999; Flugge G, 1998, EUR J NEUROSCI, V10, P2685, DOI 10.1046/j.1460-9568.1998.t01-1-00280.x; Forbes NF, 1996, PHYSIOL BEHAV, V60, P1481, DOI 10.1016/S0031-9384(96)00305-8; Freund J, 2013, SCIENCE, V340, P756, DOI 10.1126/science.1235294; Gold PW, 2002, MOL PSYCHIATR, V7, P254, DOI 10.1038/sj.mp.4001032; Gronli J, 2005, PHYSIOL BEHAV, V84, P571, DOI 10.1016/j.physbeh.2005.02.007; Grundmann O, 2010, NEUROPHARMACOLOGY, V58, P767, DOI 10.1016/j.neuropharm.2009.12.014; Huhman KL, 2006, HORM BEHAV, V50, P640, DOI 10.1016/j.yhbeh.2006.06.022; Hurst JL, 2004, BIOESSAYS, V26, P1288, DOI 10.1002/bies.20147; HURST JL, 1989, ANIM BEHAV, V37, P705, DOI 10.1016/0003-3472(89)90057-2; HURST JL, 1990, ANIM BEHAV, V40, P233, DOI 10.1016/S0003-3472(05)80918-2; HURST JL, 1990, ANIM BEHAV, V40, P209, DOI 10.1016/S0003-3472(05)80916-9; Keeney A, 2006, J NEUROENDOCRINOL, V18, P330, DOI 10.1111/j.1365-2826.2006.01422.x; Keeney AJ, 2001, PHYSIOL BEHAV, V74, P177, DOI 10.1016/S0031-9384(01)00541-8; Kendler KS, 1999, AM J PSYCHIAT, V156, P837, DOI 10.1176/ajp.156.6.837; Kim KS, 2006, J NEUROSCI RES, V83, P497, DOI 10.1002/jnr.20754; KIMURA T, 1985, HORM BEHAV, V19, P64, DOI 10.1016/0018-506X(85)90006-6; Koob GF, 2001, NEUROPSYCHOPHARMACOL, V24, P97, DOI 10.1016/S0893-133X(00)00195-0; Koolhaas JM, 1997, NEUROSCI BIOBEHAV R, V21, P775, DOI 10.1016/S0149-7634(96)00057-7; KOOLHAAS JM, 1997, ACTA PHYSL SCAND S, V640, P69; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Kudryavtseva N N, 2000, Neurosci Behav Physiol, V30, P293, DOI 10.1007/BF02471782; Kudryavtseva NN, 1998, AGGRESSIVE BEHAV, V24, P271, DOI 10.1002/(SICI)1098-2337(1998)24:4<271::AID-AB3>3.0.CO;2-M; Lehmann ML, 2013, PSYCHONEUROENDOCRINO, V38, P702, DOI 10.1016/j.psyneuen.2012.09.006; Lehmann ML, 2013, J NEUROSCI, V33, P2961, DOI 10.1523/JNEUROSCI.3878-12.2013; Lehmann ML, 2011, J NEUROSCI, V31, P6159, DOI 10.1523/JNEUROSCI.0577-11.2011; Lehmann ML, 2005, J NEUROSCI, V25, P8696, DOI 10.1523/JNEUROSCI.1893-05.2005; Lehmann ML, 2004, HORM BEHAV, V45, P75, DOI 10.1016/j.yhbeh.2003.09.011; LINDZEY G, 1961, NATURE, V191, P474, DOI 10.1038/191474a0; Lumley LA, 1999, PHYSIOL BEHAV, V67, P769, DOI 10.1016/S0031-9384(99)00131-6; Malkesman O, 2010, BIOL PSYCHIAT, V67, P864, DOI 10.1016/j.biopsych.2009.10.018; MARUNIAK JA, 1977, AM J PHYSIOL, V233, pE495, DOI 10.1152/ajpendo.1977.233.6.E495; MATTHEWS K, 1995, PHYSIOL BEHAV, V57, P241, DOI 10.1016/0031-9384(94)00286-E; Mitra R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036092; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Pankevich DE, 2006, BEHAV NEUROSCI, V120, P925, DOI 10.1037/0735-7044.120.4.925; PAVCOVICH LA, 1995, NEUROSCI LETT, V196, P185, DOI 10.1016/0304-3940(95)11873-U; Pollak DD, 2010, ANN MED, V42, P252, DOI 10.3109/07853891003769957; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Reyes TM, 2003, J NEUROSCI, V23, P5607; REYNOLDS E, 1971, NATURE, V234, P481, DOI 10.1038/234481a0; Rich TJ, 1999, ANIM BEHAV, V58, P1027, DOI 10.1006/anbe.1999.1217; Romeo RD, 2006, ANN NY ACAD SCI, V1094, P202, DOI 10.1196/annals.1376.022; Roullet FI, 2011, BEHAV BRAIN RES, V216, P19, DOI 10.1016/j.bbr.2010.06.004; Rygula R, 2008, BEHAV PHARMACOL, V19, P183, DOI 10.1097/FBP.0b013e3282fe8871; Schloesser RJ, 2010, MOL PSYCHIATR, V15, P1152, DOI 10.1038/mp.2010.34; Tanti A, 2012, NEUROPHARMACOLOGY, V63, P374, DOI 10.1016/j.neuropharm.2012.04.022; Toth E, 2008, BEHAV BRAIN RES, V190, P135, DOI 10.1016/j.bbr.2008.02.012; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Turner RJ, 2004, ARCH GEN PSYCHIAT, V61, P481, DOI 10.1001/archpsyc.61.5.481; Valentino RJ, 2011, NAT REV UROL, V8, P19, DOI 10.1038/nrurol.2010.203; Vialou V, 2010, NAT NEUROSCI, V13, P745, DOI 10.1038/nn.2551; Wang F, 2011, SCIENCE, V334, P693, DOI 10.1126/science.1209951; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; Wohr M, 2011, GENES BRAIN BEHAV, V10, P35, DOI 10.1111/j.1601-183X.2010.00582.x; WOLFF PR, 1984, ANIM BEHAV, V32, P1185, DOI 10.1016/S0003-3472(84)80235-3; Wood SK, 2010, ENDOCRINOLOGY, V151, P1795, DOI 10.1210/en.2009-1026; Wood SK, 2009, AM J PHYSIOL-REG I, V296, pR1671, DOI 10.1152/ajpregu.91013.2008; Yang M, 2012, J NEUROSCI, V32, P6525, DOI 10.1523/JNEUROSCI.6107-11.2012	83	32	33	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e69822	10.1371/journal.pone.0069822	http://dx.doi.org/10.1371/journal.pone.0069822			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23875001	Green Published, gold, Green Submitted			2022-12-27	WOS:000322064300119
J	Cai, L; Liu, AP; Zhang, YM; Wang, PY				Cai, Li; Liu, Aiping; Zhang, Yumei; Wang, Peiyu			Waist-to-Height Ratio and Cardiovascular Risk Factors among Chinese Adults in Beijing	PLOS ONE			English	Article							ANTHROPOMETRIC INDEXES; CARDIOMETABOLIC RISK; ABDOMINAL OBESITY; SCREENING TOOL; CIRCUMFERENCE; HEALTH; METAANALYSIS; PREVALENCE; HYPERTENSION; ASSOCIATIONS	Objectives: To examine whether waist-to-height ratio (WHtR) performed better than, body mass index (BMI) or waist circumference (WC) in relation to hypertension, diabetes, and dyslipidemia among Chinese adults in Beijing. Methods: A total of 5720 adults (2371 men and 3349 nonpregnant women) aged 18 to 79 years were selected from the general population in a cross-sectional study. Data from a standardized questionnaire, physical examination, and blood sample were obtained. Results: The area under curve (AUC) values for WHtR (0.661-0.773) were significantly higher than those for BMI for all outcomes in both sexes, except that WHtR and BMI had similar AUCs for dyslipidemia in men. The AUCs for WHtR were significantly higher than those for WC with respect to hypertension in both sexes, and to diabetes in women. AUCs for the relationships between anthropometric indices and the three outcomes were larger in women than in men, and tended to decrease with age. Optimal cutoffs for WHtR were 0.51-0.53 and 0.48-0.50 in men and women, respectively. With regard to the current Chinese criteria for BMI (>= 24kg/m(2)), WC (>= 90 cm for men, and >= 85 cm for women), and the recommended cutoff of WHtR (>= 0.5), WHtR yielded the greatest odds ratio for hypertension and diabetes in both sexes, and dyslipidemia in women. BMI had the highest odds ratio for dyslipidemia in men. The odds ratios of anthropometric indices for hypertension and diabetes, but not for dyslipidemia, were higher in women than in men. The association between anthropometric indices and the three outcomes decreased with age. Conclusion: WHtR performed better than BMI and WC for the association with hypertension and diabetes. More studies should be conducted to explore the age differences in the relationships between obesity indices and cardiovascular risk factors.	[Cai, Li; Zhang, Yumei] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Nutr & Food Hyg, Beijing 100871, Peoples R China; [Liu, Aiping; Wang, Peiyu] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Social Med & Hlth Educ, Beijing 100871, Peoples R China	Peking University; Peking University	Wang, PY (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Social Med & Hlth Educ, Beijing 100871, Peoples R China.	peiyuwangpku@gmail.com	Cai, Li/AGZ-9127-2022	Cai, Li/0000-0002-8579-5986				Anonymous, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P390; Ashwell M, 2005, INT J FOOD SCI NUTR, V56, P303, DOI 10.1080/09637480500195066; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Browning LM, 2010, NUTR RES REV, V23, P247, DOI 10.1017/S0954422410000144; Cai L, 2012, J ATHEROSCLER THROMB, V19, P159, DOI 10.5551/jat.10116; Cnop M, 2003, DIABETOLOGIA, V46, P459, DOI 10.1007/s00125-003-1074-z; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Despres JP, 2001, ANN MED, V33, P534, DOI 10.3109/07853890108995963; Doherty TJ, 2001, CURR OPIN CLIN NUTR, V4, P503, DOI 10.1097/00075197-200111000-00007; Dong XL, 2011, POSTGRAD MED J, V87, P251, DOI 10.1136/pgmj.2010.100453; He YN, 2009, PUBLIC HEALTH NUTR, V12, P1078, DOI 10.1017/S1368980008003856; Ho SY, 2003, ANN EPIDEMIOL, V13, P683, DOI 10.1016/S1047-2797(03)00067-X; Jia ZX, 2011, DIABETES RES CLIN PR, V92, P265, DOI 10.1016/j.diabres.2011.01.021; Klein S, 2007, AM J CLIN NUTR, V85, P1197, DOI 10.1093/ajcn/85.5.1197; Kodama S, 2012, AM J EPIDEMIOL, V176, P959, DOI 10.1093/aje/kws172; Lee CMY, 2008, J CLIN EPIDEMIOL, V61, P646, DOI 10.1016/j.jclinepi.2007.08.012; Lemieux I, 2007, CAN J CARDIOL, V23, p23B, DOI 10.1016/S0828-282X(07)71007-3; Park SH, 2009, CIRC J, V73, P1643, DOI 10.1253/circj.CJ-09-0161; Shimajiri T, 2008, J ATHEROSCLER THROMB, V15, P94, DOI 10.5551/jat.E540; Tseng CH, 2010, ATHEROSCLEROSIS, V210, P585, DOI 10.1016/j.atherosclerosis.2009.12.015; Vazquez G, 2007, EPIDEMIOL REV, V29, P115, DOI 10.1093/epirev/mxm008; Visscher TLS, 2001, ANNU REV PUBL HEALTH, V22, P355, DOI 10.1146/annurev.publhealth.22.1.355; Wakabayashi I, 2011, ARCH GERONTOL GERIAT; Wakabayashi I, 2012, J HYPERTENS, V30, P1423, DOI 10.1097/HJH.0b013e3283544881; Wang JW, 2009, ASIA PAC J CLIN NUTR, V18, P105; Wu Hong-yan, 2010, Fudan Xuebao (Yixueban), V37, P401; Wu YF, 2008, CIRCULATION, V118, P2679, DOI 10.1161/CIRCULATIONAHA.108.788166	27	64	71	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e69298	10.1371/journal.pone.0069298	http://dx.doi.org/10.1371/journal.pone.0069298			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	23874938	Green Published, Green Submitted, gold			2022-12-27	WOS:000321718700050
J	Dominguez-Rodrigo, M; Garcia-Perez, A				Dominguez-Rodrigo, Manuel; Garcia-Perez, Alfonso			Testing the Accuracy of Different A-Axis Types for Measuring the Orientation of Bones in the Archaeological and Paleontological Record	PLOS ONE			English	Article							OLDUVAI BED I; PATTERNS; ASSEMBLAGES; GORGE; SLOPE	Orientation of archaeological and paleontological materials plays a prominent role in the interpretation of site formation processes. Allochthony and authochthony are frequently assumed from orientation patterns or lack thereof. Although it is still debated to what extent orientation of items can be produced in original depositional contexts, the recent use of GIS tools to measure orientations has highlighted several ways of reproducing A-axes with which to address these taphonomic issues. In the present study, the three most relevant A-axis types are compared to test their accuracy in reproducing water current direction. Although results may be similar in specific bone shapes, differences are important in other shapes. As known in engineering working with wind and fluid mechanics (developing shape optimization), longitudinal symmetrical axes (LSA) are the one that best orient structures against or in the same direction of wind and water. The present work shows that this is also the case for bones (regardless of shape), since LSA produce the most accurate estimates of flow direction. This has important consequences for the interpretation of orientation patterns at sites, since this type of axis is still not properly reproduced by GIS available tools.	[Dominguez-Rodrigo, Manuel] Museo Origenes, Inst Evoluc Africa IDEA, Madrid, Spain; [Dominguez-Rodrigo, Manuel] Univ Complutense, Dept Prehist, E-28040 Madrid, Spain; [Garcia-Perez, Alfonso] UNED, Dept Stat, Madrid, Spain	Complutense University of Madrid; Universidad Nacional de Educacion a Distancia (UNED)	Dominguez-Rodrigo, M (corresponding author), Museo Origenes, Inst Evoluc Africa IDEA, Madrid, Spain.	m.dominguez.rodrigo@gmail.com	García-Pérez, Alfonso/H-2534-2015	García-Pérez, Alfonso/0000-0002-6066-4138	Spanish Ministry of Science and Innovation [I+D HAR2010-18952-C02-01]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	The authors thank the Spanish Ministry of Science and Innovation for sponsorship through the project I+D HAR2010-18952-C02-01 and to the Ministry of Culture and Spanish Institute of Cultural Heritage for funding through the archaeological projects abroad program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinelli C, 2007, COMPUT STAT DATA AN, V51, P5867, DOI 10.1016/j.csda.2006.11.002; [Anonymous], 2012, LANG ENV STAT COMP; BEHRENSMEYER A K, 1975, Bulletin of the Museum of Comparative Zoology, V146, P473; Benito-Calvoa A, 2011, J HUM EVOL, V61, P50, DOI 10.1016/j.jhevol.2011.02.011; Bertran P, 1997, SEDIMENTOLOGY, V44, P1, DOI 10.1111/j.1365-3091.1997.tb00421.x; Bletzinger KU, 2010, COMPUT METHOD APPL M, V199, P324, DOI 10.1016/j.cma.2008.09.009; CHO KN, 1992, J NON-NEWTON FLUID, V45, P105, DOI 10.1016/0377-0257(92)80063-4; de la Torre I, 2013, J ARCHAEOL SCI, V40, P2446, DOI 10.1016/j.jas.2013.01.004; Dominguez-Rodrigo M, 2012, J ARCHAEOL SCI, V39, P2116, DOI 10.1016/j.jas.2012.02.027; Dominguez-Rodrigo M, 2013, AUTOCHTHONOUS UNPUB; Eberth David A., 2007, P265; Metin IE, 2010, J ARCHAEOL SCI, V37, P3010, DOI 10.1016/j.jas.2010.06.024; Etienne S, 2005, J FLUID STRUCT, V21, P169, DOI 10.1016/j.jfluidstructs.2005.07.001; FIORILLO A R, 1988, Contributions to Geology University of Wyoming, V26, P1; Fisher N., 1995, STAT ANAL CIRCULAR D; FROSTICK L, 1983, LETHAIA, V16, P157, DOI 10.1111/j.1502-3931.1983.tb01711.x; Hojjat M, 2010, LECT NOTES COMPUTATI, V73, P351; Isaac GL., 1967, KROEBER ANTHR SOC PA, V37, P31; Jammalamadaka SR., 2001, STATISTICS, V5, DOI DOI 10.1111/J.1442-2050.2010.01169.X; Krajcarz M., 2013, INT J OSTEO IN PRESS; Lenoble A, 2008, J ARCHAEOL SCI, V35, P99, DOI 10.1016/j.jas.2007.02.011; Liu H, 1991, WIND ENG HDB STRUCTU; Mohammadi B, 2004, ANNU REV FLUID MECH, V36, P255, DOI 10.1146/annurev.fluid.36.050802.121926; Morris Thomas H., 1996, Museum of Northern Arizona Bulletin, V60, P521; Petraglia M, 1987, THESIS U NEW MEXICO; PETRAGLIA MD, 1994, J ANTHROPOL ARCHAEOL, V13, P228, DOI 10.1006/jaar.1994.1014; Petraglia MD, 1987, NATURAL FORMATION PR, P108; Schick KD, 1984, THESIS U CALIFORNIA; Simiu E., 1996, WINDS EFFECTS STRUCT, V3rd ed.; Thurai M, 2006, ANT PROP EUCAP 2006, V16, P6; Toots H, 1965, CONTRIBUTIONS GEOLOG, V4, P59; Toots H., 1965, WYOMING GEOLOGICAL A, P219; TSAI WH, 1991, PATTERN RECOGN, V24, P95, DOI 10.1016/0031-3203(91)90080-O; Venkatraghavan Vikram, 2009, IEEE Signal Processing Letters, V16, P711, DOI 10.1109/LSP.2009.2022567; Voorhies M, 1969, 1 U WYOM; Walter MJ, 2013, J HUM EVOL, V64, P569, DOI 10.1016/j.jhevol.2013.02.011	36	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e68955	10.1371/journal.pone.0068955	http://dx.doi.org/10.1371/journal.pone.0068955			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	23874825	Green Published, gold			2022-12-27	WOS:000321718700044
J	Lopez-Garcia, C; Ramos-Molina, B; Lambertos, A; Lopez-Contreras, AJ; Cremades, A; Penafiel, R				Lopez-Garcia, Carlos; Ramos-Molina, Bruno; Lambertos, Ana; Lopez-Contreras, Andres J.; Cremades, Asuncion; Penafiel, Rafael			Antizyme Inhibitor 2 Hypomorphic Mice. New Patterns of Expression in Pancreas and Adrenal Glands Suggest a Role in Secretory Processes	PLOS ONE			English	Article							ORNITHINE-DECARBOXYLASE ANTIZYME; ARGININE DECARBOXYLASE; CELLULAR POLYAMINES; MAMMALIAN-CELLS; PROLIFERATION; DEGRADATION; PARALOGUE; PROTEIN; GROWTH; ODCP	The intracellular levels of polyamines, polycations implicated in proliferation, differentiation and cell survival, are regulated by controlling their biosynthesis, catabolism and transport. Antizymes and antizyme inhibitors are key regulatory proteins of polyamine levels by affecting ornithine decarboxylase, the rate-limiting biosynthetic enzyme, and polyamine uptake. We recently described the molecular function of a novel antizyme inhibitor (AZIN2). However, the physiological function of AZIN2 in mammals is mostly unknown. To gain insight on the tissue expression profile of AZIN2 and to find its possible physiological role, we have generated, transgenic mice with severe Azin2 hypomorphism. This mouse model expresses transgenic bacterial beta-D-galactosidase as a reporter gene, under the control of the Azin2 endogenous promoter, what allows a very sensitive and specific detection of the expression of the gene in the different tissues of transgenic mice. The biochemical and histochemical analyses of beta-D-galactosidase together with the quantification of Azin2 mRNA levels, corroborated that AZIN2 is mainly expressed in testis and brain, and showed for the first time that AZIN2 is also expressed in the adrenal glands and pancreas. In these tissues, AZIN2 was not expressed in all type of cells, but rather in specific type of cells. Thus, AZIN2 was mainly found in the haploid germinal cells of the testis and in different brain regions such as hippocampus and cerebellum, particularly in specific type of neurons. In the adrenal glands and pancreas, the expression was restricted to the adrenal medulla and to the Langerhans islets, respectively. Interestingly, plasma insulin levels were significantly reduced in the transgenic mice. These results support the idea that AZIN2 may have a role in the modulation of reproductory and secretory functions and that this mouse model might be an interesting tool for the progress of our understanding on the role of AZIN2 and polyamines in specific mammalian cells.	[Lopez-Garcia, Carlos; Ramos-Molina, Bruno; Lambertos, Ana; Penafiel, Rafael] Univ Murcia, Sch Med, Dept Biochem & Mol Biol & Immunol B, Murcia, Spain; [Lopez-Contreras, Andres J.] Spanish Natl Canc Res Ctr CNIO, Genom Instabil Grp, Madrid, Spain; [Cremades, Asuncion] Univ Murcia, Sch Med, Dept Pharmacol, Murcia, Spain; [Cremades, Asuncion; Penafiel, Rafael] IMIB, Murcia, Spain	University of Murcia; Centro Nacional de Investigaciones Oncologicas (CNIO); University of Murcia	Penafiel, R (corresponding author), Univ Murcia, Sch Med, Dept Biochem & Mol Biol & Immunol B, Murcia, Spain.	rapegar@um.es	Lopez-Contreras, Andres J/AAA-1110-2020; Molina, Bruno Ramos/A-4574-2017; Lambertos, Ana/AAQ-1089-2020; Ramos-Molina, Bruno/K-8303-2019; Ramos-Molina, Bruno/L-7876-2015; Penafiel, Rafael/H-2660-2015	Molina, Bruno Ramos/0000-0001-6804-5449; Ramos-Molina, Bruno/0000-0001-6804-5449; Penafiel, Rafael/0000-0002-5816-1056; Lopez-Contreras, Andres Joaquin/0000-0002-5517-7327	Seneca Foundation [08681/PI/08]; Spanish Ministry of Science and Innovation [SAF2008-03638, SAF2011-29051]; Ministry of Science and Innovation (Spain); FEDER funds from The European Community	Seneca Foundation(Fundacion Seneca); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministry of Science and Innovation (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FEDER funds from The European Community	This work was supported by grants 08681/PI/08 from Seneca Foundation (Autonomous Community of Murcia), and SAF2008-03638 and SAF2011-29051 from the Spanish Ministry of Science and Innovation, and FEDER funds from The European Community. BRM and AL were recipients of fellowships (FPU) from the Ministry of Science and Innovation (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastida CM, 2007, AM J PHYSIOL-ENDOC M, V292, pE1010, DOI 10.1152/ajpendo.00316.2006; Bercovich Z, 2011, J BIOL CHEM, V286, P33778, DOI 10.1074/jbc.M111.270637; Coffino P, 2001, NAT REV MOL CELL BIO, V2, P188, DOI 10.1038/35056508; Garcia-Faroldi G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015071; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Hayashi S, 1996, TRENDS BIOCHEM SCI, V21, P27, DOI 10.1016/0968-0004(96)80882-6; Hougaard DM, 1988, BIOCHEM J, V238, P43; Iyo AH, 2006, J NEUROCHEM, V96, P1042, DOI 10.1111/j.1471-4159.2005.03544.x; Kahana C, 2009, CELL MOL LIFE SCI, V66, P2479, DOI 10.1007/s00018-009-0033-3; Kanerva K, 2008, BIOCHEM J, V409, P187, DOI 10.1042/BJ20071004; Kanerva K, 2010, EXP CELL RES, V316, P1896, DOI 10.1016/j.yexcr.2010.02.021; Kanerva K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006858; Kim SW, 2006, J CELL SCI, V119, P2853, DOI 10.1242/jcs.02966; Kurian L, 2011, NATURE, V477, P490, DOI 10.1038/nature10393; Lim SK, 2007, ONCOGENE, V26, P6593, DOI 10.1038/sj.onc.1210482; Lopez-Contreras AJ, 2008, J BIOL CHEM, V283, P20761, DOI 10.1074/jbc.M801024200; Lopez-Contreras AJ, 2006, J BIOL CHEM, V281, P30896, DOI 10.1074/jbc.M602840200; Lopez-Contreras AJ, 2010, AMINO ACIDS, V38, P603, DOI 10.1007/s00726-009-0419-4; Lopez-Contreras AJ, 2009, J CELL BIOCHEM, V107, P732, DOI 10.1002/jcb.22168; Lopez-Contreras AJ, 2009, INT J BIOCHEM CELL B, V41, P1070, DOI 10.1016/j.biocel.2008.09.029; Makitie LT, 2010, BRAIN PATHOL, V20, P571, DOI 10.1111/j.1750-3639.2009.00334.x; Makitie LT, 2009, HISTOCHEM CELL BIOL, V132, P633, DOI 10.1007/s00418-009-0636-7; Mangold U, 2006, CELL MOL LIFE SCI, V63, P2095, DOI 10.1007/s00018-005-5583-4; Mangold U, 2005, IUBMB LIFE, V57, P671, DOI 10.1080/15216540500307031; MATSUFUJI S, 1995, CELL, V80, P51, DOI 10.1016/0092-8674(95)90450-6; Newman RM, 2004, J BIOL CHEM, V279, P41504, DOI 10.1074/jbc.M407349200; Paulmann N, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000229; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; Pitkanen LT, 2001, BIOCHEM BIOPH RES CO, V287, P1051, DOI 10.1006/bbrc.2001.5703; Ramos-Molina B, 2012, AMINO ACIDS, V42, P539, DOI 10.1007/s00726-011-1031-y; ROM E, 1994, P NATL ACAD SCI USA, V91, P3959, DOI 10.1073/pnas.91.9.3959; SJOHOLM A, 1993, AM J PHYSIOL, V264, pC501, DOI 10.1152/ajpcell.1993.264.3.C501; Snapir Z, 2008, BIOCHEM J, V410, P613, DOI 10.1042/BJ20071423; Suzuki J, 2009, ENDOCR-RELAT CANCER, V16, P649, DOI 10.1677/ERC-09-0004; Tang H, 2009, GENES CELLS, V14, P79, DOI 10.1111/j.1365-2443.2008.01249.x; Thomas T, 2001, CELL MOL LIFE SCI, V58, P244, DOI 10.1007/PL00000852; Tokuhiro K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000712	37	14	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e69188	10.1371/journal.pone.0069188	http://dx.doi.org/10.1371/journal.pone.0069188			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	23874910	Green Published, gold, Green Submitted			2022-12-27	WOS:000321718700048
J	Cameron, MA; Suaning, GJ; Lovell, NH; Morley, JW				Cameron, Morven A.; Suaning, Gregg J.; Lovell, Nigel H.; Morley, John W.			Electrical Stimulation of Inner Retinal Neurons in Wild-Type and Retinally Degenerate (rd/rd) Mice	PLOS ONE			English	Article							CONE BIPOLAR CELLS; GANGLION-CELLS; RABBIT RETINA; AMACRINE CELLS; RESPONSE PROPERTIES; MOUSE RETINA; RAT RETINA; ACTIVATION; CHANNELS; CURRENTS	Electrical stimulation of the retina following photoreceptor degeneration in diseases such as retinitis pigmentosa and age-related macular degeneration has become a promising therapeutic strategy for the restoration of vision. Many retinal neurons remain functional following photoreceptor degeneration; however, the responses of the different classes of cells to electrical stimuli have not been fully investigated. Using whole-cell patch clamp electrophysiology in retinal slices we investigated the response to electrical stimulation of cells of the inner nuclear layer (INL), pre-synaptic to retinal ganglion cells, in wild-type and retinally degenerate (rd/rd) mice. The responses of these cells to electrical stimulation were extremely varied, with both extrinsic and intrinsic evoked responses observed. Further examination of the intrinsically evoked responses revealed direct activation of both voltage-gated Na+ channels and K+ channels. The expression of these channels, which is particularly varied between INL cells, and the stimulus intensity, appears to dictate the polarity of the eventual response. Retinally degenerate animals showed similar responses to electrical stimulation of the retina to those of the wild-type, but the relative representation of each response type differed. The most striking difference between genotypes was the existence of a large amplitude oscillation in the majority of INL cells in rd/rd mice (as previously reported) that impacted on the signal to noise ratio following electrical stimulation. This confounding oscillation may significantly reduce the efficacy of electrical stimulation of the degenerate retina, and a greater understanding of its origin will potentially enable it to be dampened or eliminated.	[Cameron, Morven A.; Morley, John W.] Univ Western Sydney, Sch Med, Campbelltown, NSW, Australia; [Suaning, Gregg J.; Lovell, Nigel H.] Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW, Australia	Western Sydney University; University of New South Wales Sydney	Cameron, MA (corresponding author), Univ Western Sydney, Sch Med, Campbelltown, NSW, Australia.	m.cameron@uws.edu.au	Lovell, Nigel H/AGF-6679-2022	Lovell, Nigel H/0000-0003-1637-1079; Cameron, Morven/0000-0002-2277-7035; Suaning, Gregg/0000-0003-1918-3313; Morley, John/0000-0001-9246-853X	Australian Research Council (ARC) through its Special Research Initiative (SRI) in Bionic Vision Science and Technology grant	Australian Research Council (ARC) through its Special Research Initiative (SRI) in Bionic Vision Science and Technology grant(Australian Research Council)	This research was supported by the Australian Research Council (ARC) through its Special Research Initiative (SRI) in Bionic Vision Science and Technology grant to Bionic Vision Australia (BVA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arman A Cyrus, 2010, J Vis Exp, DOI 10.3791/2107; Bloomfield SA, 2007, VISUAL NEUROSCI, V24, P459, DOI 10.1017/S0952523807070071; BOOS R, 1993, J NEUROSCI, V13, P2874; Borowska J, 2011, J NEUROSCI, V31, P5000, DOI 10.1523/JNEUROSCI.5800-10.2011; Cohen ED, 2001, VISUAL NEUROSCI, V18, P799, DOI 10.1017/S0952523801185135; Cui JJ, 2008, VISUAL NEUROSCI, V25, P635, DOI 10.1017/S0952523808080851; Euler T, 2000, J NEUROPHYSIOL, V83, P1817, DOI 10.1152/jn.2000.83.4.1817; Freeman DK, 2010, J NEUROPHYSIOL, V104, P2778, DOI 10.1152/jn.00551.2010; Fried SI, 2009, J NEUROPHYSIOL, V101, P1972, DOI 10.1152/jn.91081.2008; Fried SI, 2006, J NEUROPHYSIOL, V95, P970, DOI 10.1152/jn.00849.2005; Goo YS, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/035003; Humayun MS, 1996, ARCH OPHTHALMOL-CHIC, V114, P40, DOI 10.1001/archopht.1996.01100130038006; Ichinose T, 2005, J NEUROSCI, V25, P1856, DOI 10.1523/jneurosci.5208-04.2005; Jensen RJ, 2008, VISION RES, V48, P1562, DOI 10.1016/j.visres.2008.04.016; Jensen RJ, 2005, J NEURAL ENG, V2, pS16, DOI 10.1088/1741-2560/2/1/003; Knop GC, 2011, J NEUROSCI, V31, P4780, DOI 10.1523/JNEUROSCI.6235-10.2011; LeRoy C, 1755, HIST ACAD ROY SCI PA, V60, P87; Marc RE, 2007, INVEST OPHTH VIS SCI, V48, P3364, DOI 10.1167/iovs.07-0032; Margalit E, 2006, INVEST OPHTH VIS SCI, V47, P2606, DOI 10.1167/iovs.05-1093; Margalit E, 2011, VISUAL NEUROSCI, V28, P145, DOI 10.1017/S0952523810000489; Margolis DJ, 2008, J NEUROSCI, V28, P6526, DOI 10.1523/JNEUROSCI.1533-08.2008; Nowak LG, 1998, EXP BRAIN RES, V118, P489, DOI 10.1007/s002210050305; O'Hearn TM, 2002, INVEST OPHTH VIS SCI, V43, pU1281; Pan ZH, 2000, J NEUROPHYSIOL, V84, P2564, DOI 10.1152/jn.2000.84.5.2564; Pinto LH, 1998, PROG RETIN EYE RES, V17, P207; Rattay F, 1999, NEUROSCIENCE, V89, P335, DOI 10.1016/S0306-4522(98)00330-3; Rizzo JF, 2004, RESTOR NEUROL NEUROS, V22, P429; Stasheff SF, 2008, J NEUROPHYSIOL, V99, P1408, DOI 10.1152/jn.00144.2007; Taylor WR, 1996, VISUAL NEUROSCI, V13, P599, DOI 10.1017/S0952523800008506; Tehovnik EJ, 2006, J NEUROPHYSIOL, V96, P512, DOI 10.1152/jn.00126.2006; Trenholm S, 2012, J PHYSIOL-LONDON, V590, P2501, DOI 10.1113/jphysiol.2011.225060; Tsai D, 2011, IEEE ENG MED BIO, P1053, DOI 10.1109/IEMBS.2011.6090245; Tsai D, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/066007; Tsai D, 2009, J NEUROPHYSIOL, V102, P2982, DOI 10.1152/jn.00545.2009; Wassle H, 2009, J NEUROSCI, V29, P106, DOI 10.1523/JNEUROSCI.4442-08.2009; Weiland JD, 2001, INVEST OPHTH VIS SCI, V42, pS813; Wong YT, 2009, VISION RES, V49, P825, DOI 10.1016/j.visres.2009.02.018; Ye JH, 2007, PHYSIOL MEAS, V28, P1079, DOI 10.1088/0967-3334/28/9/009; Zhou JA, 2008, J BIOMED BIOTECHNOL, DOI 10.1155/2008/547428; Zrenner E, 2011, P ROY SOC B-BIOL SCI, V278, P1489, DOI 10.1098/rspb.2010.1747	40	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e68882	10.1371/journal.pone.0068882	http://dx.doi.org/10.1371/journal.pone.0068882			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874798	Green Submitted, gold, Green Published			2022-12-27	WOS:000322218800050
J	Kim, J; Kim, SK; Kim, HK; Mattson, MP; Hyun, DH				Kim, Jiyeong; Kim, Su-Kyung; Kim, Hwa-Kyung; Mattson, Mark P.; Hyun, Dong-Hoon			Mitochondrial Function in Human Neuroblastoma Cells Is Up-Regulated and Protected by NQO1, a Plasma Membrane Redox Enzyme	PLOS ONE			English	Article							OXYGEN SPECIES GENERATION; OXIDATIVE STRESS; ALZHEIMERS-DISEASE; ELECTRON-TRANSPORT; HYDROGEN-PEROXIDE; COENZYME-Q; PARKINSONS-DISEASE; CEREBRAL-ISCHEMIA; POTENT INDUCTION; PHASE-2 ENZYMES	Background: Recent findings suggest that NADH-dependent enzymes of the plasma membrane redox system (PMRS) play roles in the maintenance of cell bioenergetics and oxidative state. Neurons and tumor cells exhibit differential vulnerability to oxidative and metabolic stress, with important implications for the development of therapeutic interventions that promote either cell survival (neurons) or death (cancer cells). Methods and Findings: Here we used human neuroblastoma cells with low or high levels of the PMRS enzyme NADH-quinone oxidoreductase 1 (NQO1) to investigate how the PMRS modulates mitochondrial functions and cell survival. Cells with elevated NQO1 levels exhibited higher levels of oxygen consumption and ATP production, and lower production of reactive oxygen species. Cells overexpressing NQO1 were more resistant to being damaged by the mitochondrial toxins rotenone and antimycin A, and exhibited less oxidative/nitrative damage and less apoptotic cell death. Cells with basal levels of NQO1 resulted in increased oxidative damage to proteins and cellular vulnerability to mitochondrial toxins. Thus, mitochondrial functions are enhanced and oxidative stress is reduced as a result of elevated PMRS activity, enabling cells to maintain redox homeostasis under conditions of metabolic and energetic stress. Conclusion: These findings suggest that NQO1 is a potential target for the development of therapeutic agents for either preventing neuronal degeneration or promoting the death of neural tumor cells.	[Kim, Jiyeong; Kim, Su-Kyung; Kim, Hwa-Kyung; Hyun, Dong-Hoon] Ewha Womans Univ, Coll Nat Sci, Dept Life Sci, Seoul, South Korea; [Mattson, Mark P.] NIA, Neurosci Lab, Intramural Res Program, NIH, Baltimore, MD 21224 USA	Ewha Womans University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Hyun, DH (corresponding author), Ewha Womans Univ, Coll Nat Sci, Dept Life Sci, Seoul, South Korea.	hyundh@ewha.ac.kr			National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology, South Korea [NRF-2010-003064]; Intramural Research Program of the National Institute on Aging	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology, South Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Intramural Research Program of the National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2010-003064), South Korea. This work was also funded, in part, by the Intramural Research Program of the National Institute on Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn KS, 2006, J BIOL CHEM, V281, P19798, DOI 10.1074/jbc.M601162200; ALCAIN FJ, 1991, BIOCHIM BIOPHYS ACTA, V1073, P380, DOI 10.1016/0304-4165(91)90146-8; ANDREEVA L, 1994, EUR J BIOCHEM, V221, P261, DOI 10.1111/j.1432-1033.1994.tb18737.x; Barja G, 1999, J BIOENERG BIOMEMBR, V31, P347, DOI 10.1023/A:1005427919188; Bey EA, 2007, P NATL ACAD SCI USA, V104, P11832, DOI 10.1073/pnas.0702176104; Beyer RE, 1996, P NATL ACAD SCI USA, V93, P2528, DOI 10.1073/pnas.93.6.2528; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Datki Z, 2004, NEUROBIOL DIS, V17, P507, DOI 10.1016/j.nbd.2004.08.007; del Castillo-Olivares A, 2000, CRIT REV BIOCHEM MOL, V35, P197; Du JA, 2006, J BIOL CHEM, V281, P37416, DOI 10.1074/jbc.M605063200; Elkon H, 2001, CELL MOL NEUROBIOL, V21, P771, DOI 10.1023/A:1015160323009; French SA, 1998, AM J PHYSIOL-CELL PH, V275, pC900, DOI 10.1152/ajpcell.1998.275.3.C900; Gonzalez-Aragon D, 2007, BIOCHEM PHARMACOL, V73, P427, DOI 10.1016/j.bcp.2006.10.016; Griguer CE, 2011, CURR PHARM DESIGN, V17, P2421; Haefeli RH, PLOS ONE, V6; Hyun DH, 2011, AGE DORDR; Hyun DH, 2007, J NEUROCHEM, V100, P1364, DOI 10.1111/j.1471-4159.2006.04411.x; Hyun DH, 2006, P NATL ACAD SCI USA, V103, P19908, DOI 10.1073/pnas.0608008103; Hyun DH, 2006, AGEING RES REV, V5, P209, DOI 10.1016/j.arr.2006.03.005; Hyun DH, 2010, EXP NEUROL, V225, P423, DOI 10.1016/j.expneurol.2010.07.020; Incerpi S, 2007, J PHARM PHARMACOL, V59, P1711, DOI 10.1211/jpp.59.12.0014; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; James AM, 2004, ARCH BIOCHEM BIOPHYS, V423, P47, DOI 10.1016/j.abb.2003.12.025; Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873; Jia ZQ, 2008, BRAIN RES, V1197, P159, DOI 10.1016/j.brainres.2007.12.044; Johnson JA, 2008, ANN NY ACAD SCI, V1147, P61, DOI 10.1196/annals.1427.036; Kelner GS, 2000, J BIOL CHEM, V275, P580, DOI 10.1074/jbc.275.1.580; Kim JA, 2008, CIRC RES, V102, P401, DOI 10.1161/CIRCRESAHA.107.165472; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Kushnareva Y, 2002, BIOCHEM J, V368, P545, DOI 10.1042/BJ20021121; LAMBERT MP, 1994, J NEUROSCI RES, V39, P377, DOI 10.1002/jnr.490390404; Lee M, 2001, J NEUROCHEM, V78, P209, DOI 10.1046/j.1471-4159.2001.00417.x; Lesnefsky EJ, 2001, AM J PHYSIOL-HEART C, V280, pH2770; Li X, 2002, MITOCHONDRION, V1, P447, DOI 10.1016/S1567-7249(02)00010-7; Li Y, J ALZHEIMERS DIS, V19, P1205; Li Y, J NEUROCHEM, V113, P1621; LUFT R, 1995, J INTERN MED, V238, P405, DOI 10.1111/j.1365-2796.1995.tb01218.x; Lyras L, 1997, J NEUROCHEM, V68, P2061; Mataix J, 1997, MOL ASPECTS MED, V18, pS129; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Menzies FM, 2002, NEUROCHEM INT, V40, P543, DOI 10.1016/S0197-0186(01)00125-5; Merker MP, 2002, AM J PHYSIOL-LUNG C, V282, pL36, DOI 10.1152/ajplung.00283.2001; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Navarro F, 1998, FASEB J, V12, P1665, DOI 10.1096/fasebj.12.15.1665; Okamura T, 2000, INT J ONCOL, V16, P295; Panov AV, 2004, ARCH BIOCHEM BIOPHYS, V424, P44, DOI 10.1016/j.abb.2004.01.013; Patrick BA, 2011, ONCOGENE, V30, P1098, DOI 10.1038/onc.2010.491; Raina AK, 1999, NEUROREPORT, V10, P1355, DOI 10.1097/00001756-199904260-00036; REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357; Sadan O, 2009, STEM CELLS DEV, V18, P1179, DOI 10.1089/scd.2008.0411; Schapira AHV, 1998, ANN NEUROL, V44, pS89, DOI 10.1002/ana.410440714; Schapira AHV, 1998, BBA-BIOENERGETICS, V1366, P225, DOI 10.1016/S0005-2728(98)00115-7; Scott KA, 2011, BIOCHEM PHARMACOL, V81, P355, DOI 10.1016/j.bcp.2010.10.011; Seow HA, 2004, J BIOL CHEM, V279, P31606, DOI 10.1074/jbc.M404910200; Shim JH, 2011, MITOCHONDRION, V11, P707, DOI 10.1016/j.mito.2011.05.013; SIMS NR, 1992, NEUROCHEM RES, V17, P923, DOI 10.1007/BF00993269; Son TG, 2010, J NEUROCHEM, V112, P1316, DOI 10.1111/j.1471-4159.2009.06552.x; Tahara EB, 2009, FREE RADICAL BIO MED, V46, P1283, DOI 10.1016/j.freeradbiomed.2009.02.008; VILLALBA JM, 1995, P NATL ACAD SCI USA, V92, P4887, DOI 10.1073/pnas.92.11.4887; Villalba JM, 2000, ANTIOXID REDOX SIGN, V2, P213, DOI 10.1089/ars.2000.2.2-213; Vives-Bauza C, 2007, METHOD CELL BIOL, V80, P155, DOI 10.1016/S0091-679X(06)80007-5; Votyakova TV, 2004, ARCH BIOCHEM BIOPHYS, V431, P138, DOI 10.1016/j.abb.2004.07.025; Wang J, 2005, J NEUROCHEM, V93, P953, DOI 10.1111/j.1471-4159.2005.03053.x; Xie HR, CHIN MED J, V123, P1086; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391; Zhu H, 2008, CARDIOVASC TOXICOL, V8, P115, DOI 10.1007/s12012-008-9020-4; Zhu H, 2009, EXP BIOL MED, V234, P418, DOI 10.3181/0811-RM-340; Zhu L, 2010, J NUTR BIOCHEM, V21, P1089, DOI 10.1016/j.jnutbio.2009.09.006	70	23	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e69030	10.1371/journal.pone.0069030	http://dx.doi.org/10.1371/journal.pone.0069030			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874855	Green Submitted, Green Published, gold			2022-12-27	WOS:000322218800060
J	Wali, PP; Wali, PR; Saikkonen, K; Tuomi, J				Wali, Pauliina P.; Wali, Piippa R.; Saikkonen, Kari; Tuomi, Juha			Is the Pathogenic Ergot Fungus a Conditional Defensive Mutualist for Its Host Grass?	PLOS ONE			English	Article							CLAVICEPS-PURPUREA; ENDOPHYTES; ALKALOIDS; PLANTS; EVOLUTION; HERBIVORY; SEED; RESISTANCE; PARASITISM; INFECTION	It is well recognized, that outcomes of mutualistic plant-microorganism interactions are often context dependent and can range from mutualistic to antagonistic depending on conditions. Instead, seemingly pathogenic associations are generally considered only harmful to plants. The ergot fungus (Claviceps purpurea) is a common seed pathogen of grasses and cereals. Ergot sclerotia contain alkaloids which can cause severe toxicity in mammals when ingested, and thus the fungal infection might provide protection for the host plant against mammalian herbivores. Theoretically, the net effect of ergot infection would positively affect host seed set if the cost is not too high and the defensive effect is strong enough. According to our empirical data, this situation is plausible. First, we found no statistically significant seed loss in wild red fescue (Festuca rubra) inflorescences due to ergot infection, but the seed succession decreased along increasing number of sclerotia. Second, in a food choice experiment, sheep showed avoidance against forage containing ergot. Third, the frequency of ergot-infected inflorescences was higher in sheep pastures than surrounding ungrazed areas, indicating a protective effect against mammalian grazing. We conclude that, although ergot can primarily be categorized as a plant pathogen, ergot infection may sometimes represent indirect beneficial effects for the host plant. Ergot may thus serve as a conditional defensive mutualist for its host grass, and the pathogenic interaction may range from antagonistic to mutualistic depending on the situation.	[Wali, Pauliina P.; Tuomi, Juha] Univ Oulu, Dept Biol, Oulu, Finland; [Wali, Piippa R.] Kolari Unit, Finnish Forest Res Inst, Kolari, Finland; [Saikkonen, Kari] MTT Agrifood Res Finland, Plant Prod Res, Jokioinen, Finland	University of Oulu; Natural Resources Institute Finland (Luke); Natural Resources Institute Finland (Luke)	Wali, PP (corresponding author), Univ Oulu, Dept Biol, Oulu, Finland.	pauliina.wali@gmail.com	; Wali, Piippa/H-8562-2017	Wali, Pauliina/0000-0002-1375-6128; Wali, Piippa/0000-0002-2484-7455	Marjatta and Eino Kolli Foundation; Olvi Foundation; Oskar Oflund's Foundation; Thule Institute; Academy of Finland [127140]; Ella and Georg Ehrnrooth Foundation	Marjatta and Eino Kolli Foundation; Olvi Foundation; Oskar Oflund's Foundation; Thule Institute; Academy of Finland(Academy of Finland); Ella and Georg Ehrnrooth Foundation	This study was supported by grants from the Marjatta and Eino Kolli Foundation, Olvi Foundation, Oskar Oflund's Foundation and Thule Institute (PPW), and the Academy of Finland (project nro 127140) and Ella and Georg Ehrnrooth Foundation (PRW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2000, TRENDS PLANT SCI, V5, P309, DOI 10.1016/S1360-1385(00)01679-4; Agrios G. N., 2005, PLANT PATHOL; Alderman SC, 1996, PLANT DIS, V80, P853, DOI 10.1094/PD-80-0853; Alexopoulos C. J., 1996; Bakau W. J. K., 1998, P493; BRONSTEIN JL, 1994, TRENDS ECOL EVOL, V9, P214, DOI 10.1016/0169-5347(94)90246-1; Chastain T. G., 1992, Journal of Applied Seed Production, V10, P7; CHEPLICK GP, 1988, OIKOS, V52, P309, DOI 10.2307/3565204; Cheplick GP, 2009, ECOLOGY EVOLUTION GR; CLAY K, 1988, ECOLOGY, V69, P10, DOI 10.2307/1943155; De Mazancourt C, 2005, J ECOL, V93, P305, DOI 10.1111/j.0022-0477.2004.00952.x; Derenne A, 2010, J EXP ANAL BEHAV, V93, P485, DOI 10.1901/jeab.2010.93-485; ERIKSSON O, 1995, ACTA OECOL, V16, P195; Estrada AER, 2012, FUNGAL GENET BIOL, V49, P578, DOI 10.1016/j.fgb.2012.05.001; Fellous S, 2009, TRENDS PARASITOL, V25, P62, DOI 10.1016/j.pt.2008.11.010; Fisher AJ, 2007, PLANT DIS, V91, P380, DOI 10.1094/PDIS-91-4-0380; Granmo A, 1993, POLARFLOKKEN, V17, P439; Haarmann T, 2009, MOL PLANT PATHOL, V10, P563, DOI [10.1111/J.1364-3703.2009.00548.X, 10.1111/j.1364-3703.2009.00548.x]; Jaremo J, 1999, OIKOS, V84, P313, DOI 10.2307/3546728; JAROSZ AM, 1995, NEW PHYTOL, V129, P371, DOI 10.1111/j.1469-8137.1995.tb04308.x; Johnson NC, 1997, NEW PHYTOL, V135, P575, DOI 10.1046/j.1469-8137.1997.00729.x; Karban R, 1997, ECOL ENTOMOL, V22, P433, DOI 10.1046/j.1365-2311.1997.00081.x; Krska R, 2008, FOOD ADDIT CONTAM A, V25, P722, DOI 10.1080/02652030701765756; LAW R, 1983, BIOL J LINN SOC, V20, P249, DOI 10.1111/j.1095-8312.1983.tb01876.x; Leung TLF, 2008, VIE MILIEU, V58, P107; Lev-Yadun S, 2007, SYMBIOSIS, V43, P105; Massey FP, 2006, P R SOC B, V273, P2299, DOI 10.1098/rspb.2006.3586; Mikaliunaite R, 2009, ZEMDIRBYSTE, V96, P246; Mirdita V, 2009, J PHYTOPATHOL, V157, P350, DOI 10.1111/j.1439-0434.2008.01499.x; Olejniczak P, 2007, OECOLOGIA, V152, P485, DOI 10.1007/s00442-007-0660-z; Oliver TH, 2009, OIKOS, V118, P346, DOI 10.1111/j.1600-0706.2008.17045.x; Panaccione DG, 2006, J AGR FOOD CHEM, V54, P4582, DOI 10.1021/jf060626u; Parbery DG, 1996, BIOL REV, V71, P473, DOI 10.1111/j.1469-185X.1996.tb01282.x; Partida-Martinez LP, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00100; Pazoutova S, 2000, APPL ENVIRON MICROB, V66, P5419, DOI 10.1128/AEM.66.12.5419-5425.2000; Rautio P, 2012, ANN ZOOL FENN, V49, P45, DOI 10.5735/086.049.0105; Raybould AF, 1998, NEW PHYTOL, V138, P497, DOI 10.1046/j.1469-8137.1998.00123.x; Roy BA, 2000, EVOLUTION, V54, P51, DOI 10.1111/j.0014-3820.2000.tb00007.x; Saikkonen K, 1998, ANNU REV ECOL SYST, V29, P319, DOI 10.1146/annurev.ecolsys.29.1.319; Saikkonen K, 2004, TRENDS PLANT SCI, V9, P275, DOI 10.1016/j.tplants.2004.04.005; Saikkonen K, 2010, FUNGAL DIVERS, V41, P101, DOI 10.1007/s13225-010-0023-7; Salvaudon L, 2008, BIOL LETTERS, V4, P526, DOI 10.1098/rsbl.2008.0332; Sapp J, 2004, CAN J BOT, V82, P1046, DOI [10.1139/B04-055, 10.1139/b04-055]; Scott PM, 2009, WORLD MYCOTOXIN J, V2, P141, DOI 10.3920/WMJ2008.1109; SIEGEL MR, 1987, ANNU REV PHYTOPATHOL, V25, P293, DOI 10.1146/annurev.py.25.090187.001453; Tenberge KB., 1999, ERGOT GENUS CLAVICEP, P25; Thompson JN, 2006, SCIENCE, V312, P372, DOI 10.1126/science.1126904; Tudzynski P, 2004, MOL PLANT PATHOL, V5, P377, DOI 10.1111/j.1364-3703.2004.00237.x; TUOMI J, 1993, EVOLUTION, V47, P668, DOI [10.2307/2410078, 10.1111/j.1558-5646.1993.tb02120.x]; Uhlig S, 2007, RAPID COMMUN MASS SP, V21, P1651, DOI 10.1002/rcm.3005; VANSANTEN E, 1992, AGRON J, V84, P979, DOI 10.2134/agronj1992.00021962008400060014x; Wali PR, 2008, GRASS FORAGE SCI, V63, P324, DOI 10.1111/j.1365-2494.2008.00639.x; White JF, 2009, MYCOL SER, V27, P3; Wilkinson DM, 2001, OIKOS, V92, P377, DOI 10.1034/j.1600-0706.2001.920222.x	54	30	33	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e69249	10.1371/journal.pone.0069249	http://dx.doi.org/10.1371/journal.pone.0069249			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874924	Green Published, Green Submitted, gold			2022-12-27	WOS:000321765300080
J	Wei, JG; Li, CH; Li, Y; Jiang, GM; Cheng, GL; Zheng, YH				Wei, Jiguang; Li, Caihong; Li, Yong; Jiang, Gaoming; Cheng, Guanglei; Zheng, Yanhai			Effects of External Potassium (K) Supply on Drought Tolerances of Two Contrasting Winter Wheat Cultivars	PLOS ONE			English	Article							TRITICUM-AESTIVUM L.; OXIDATIVE DAMAGE; OSMOTIC-STRESS; SALT TOLERANCE; WATER-DEFICIT; RESPONSES; SALINITY; SODIUM; PHOTOSYNTHESIS; NUTRITION	Background: Drought is a common stress limiting crops growth and productivities worldwide. Water deficit may increase cellular membrane permeability, resulting in K outflow. Internal K starvation may disorder plant metabolism and limit plant growth. However, it is seldom reported about the effects of external K on drought tolerance of contrasting wheat cultivars. Methodology/Principal Findings: A hydroponics experiment was carried out in a non-controlled greenhouse. Seedlings of drought-tolerant SN16 and intolerant JM22 were simultaneously treated by five levels of K2CO3 (0, 2.5, 5, 7.5, 10 mM) and two levels of PEG6000 (0, 20%) for 7 days. External K2CO3 significantly increased shoot K+ content, water potential, chlorophyll content as well as gas exchange, but decreased electrolyte leakage (EL) and MDA content in both cultivars under PEG6000 stress. Antioxidant enzymes activities were up-regulated by PEG6000 while external K2CO3 reduced those changes. Molecular basis was explained by measuring the expression levels of antioxidant enzymes related genes. Shoot and root biomass were also increased by K2CO3 supply under drought stress. Although adequate K2CO3 application enhanced plant growth for both cultivars under drought stress, SN16 was better than JM22 due to its high drought tolerance. Conclusions/Significance: Adequate external K may effectively protect winter wheat from drought injuries. We conclude that drought-tolerant wheat combined with adequate external K supply may be a promising strategy for better growth in arid and semi-arid regions.	[Wei, Jiguang; Li, Caihong; Li, Yong; Jiang, Gaoming; Zheng, Yanhai] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Zheng, Yanhai] Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shanxi, Peoples R China; [Wei, Jiguang; Li, Caihong; Li, Yong] Univ Chinese Acad Sci, Beijing, Peoples R China; [Cheng, Guanglei] Beijing Acad Agr & Forestry Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Northwest A&F University - China; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Beijing Academy of Agriculture & Forestry	Zheng, YH (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	zhengyanhai333@163.com			State Key Laboratory of Soil Erosion and Dryland Farming on Loess Plateau [10501-263]; State Key Laboratory of Crop Biology at Shandong Agricultural University [2010KF08]; National Natural Science Foundation of China [31170367]; Key Laboratory of Crop Water Physiology and Drought-tolerance Germplasm Improvement, Ministry of Agriculture, P. R. China [2012KF03]	State Key Laboratory of Soil Erosion and Dryland Farming on Loess Plateau; State Key Laboratory of Crop Biology at Shandong Agricultural University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Crop Water Physiology and Drought-tolerance Germplasm Improvement, Ministry of Agriculture, P. R. China	This research was jointly supported by Grants from State Key Laboratory of Soil Erosion and Dryland Farming on Loess Plateau (10501-263), the State Key Laboratory of Crop Biology at Shandong Agricultural University (2010KF08), the National Natural Science Foundation of China (31170367) and the Key Laboratory of Crop Water Physiology and Drought-tolerance Germplasm Improvement, Ministry of Agriculture, P. R. China (2012KF03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexieva V, 2001, PLANT CELL ENVIRON, V24, P1337, DOI 10.1046/j.1365-3040.2001.00778.x; Armengaud P, 2009, PLANT PHYSIOL, V150, P772, DOI 10.1104/pp.108.133629; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; Blokhina O, 2003, ANN BOT-LONDON, V91, P179, DOI 10.1093/aob/mcf118; Cakmak I, 2005, J PLANT NUTR SOIL SC, V168, P521, DOI 10.1002/jpln.200420485; Chen Z, 2005, PLANT CELL ENVIRON, V28, P1230, DOI 10.1111/j.1365-3040.2005.01364.x; Cherel I, 2004, J EXP BOT, V55, P337, DOI 10.1093/jxb/erh028; Cuin TA, 2007, PLANT CELL ENVIRON, V30, P875, DOI 10.1111/j.1365-3040.2007.01674.x; Degenkolbe T, 2009, PLANT MOL BIOL, V69, P133, DOI 10.1007/s11103-008-9412-7; Dionisio-Sese ML, 1998, PLANT SCI, V135, P1, DOI 10.1016/S0168-9452(98)00025-9; DRAPER HH, 1990, METHOD ENZYMOL, V186, P421; Farooq S, 2006, J PLANT PHYSIOL, V163, P629, DOI 10.1016/j.jplph.2005.06.006; Fazeli F, 2007, BIOL PLANTARUM, V51, P98, DOI 10.1007/s10535-007-0020-1; Flexas J, 2006, PHYSIOL PLANTARUM, V127, P343, DOI 10.1111/j.1399-3054.2006.00621.x; Frost CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044467; Gong HJ, 2005, PLANT SCI, V169, P313, DOI 10.1016/j.plantsci.2005.02.023; Vendruscolo ECG, 2007, J PLANT PHYSIOL, V164, P1367, DOI 10.1016/j.jplph.2007.05.001; Hattori T, 2007, ENVIRON EXP BOT, V60, P177, DOI 10.1016/j.envexpbot.2006.10.004; Hayano-Kanashiro C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007531; Hu YC, 2005, J PLANT NUTR SOIL SC, V168, P541, DOI 10.1002/jpln.200420516; Jongdee B, 2002, FIELD CROP RES, V76, P153, DOI 10.1016/S0378-4290(02)00036-9; Lin CC, 2002, PLANT GROWTH REGUL, V37, P177, DOI 10.1023/A:1020523017867; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Pei ZF, 2010, J PLANT GROWTH REGUL, V29, P106, DOI 10.1007/s00344-009-9120-9; Redman RS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014823; Roy R, 2006, PLANT CELL TISS ORG, V84, P55, DOI 10.1007/s11240-005-9000-3; Sairam RK, 2001, J AGRON CROP SCI, V186, P63, DOI 10.1046/j.1439-037x.2001.00461.x; Sala A, 2010, NEW PHYTOL, V186, P274, DOI 10.1111/j.1469-8137.2009.03167.x; Sanchez-Rodriguez E, 2010, PLANT SCI, V178, P30, DOI 10.1016/j.plantsci.2009.10.001; Simova-Stoilova L, 2009, PLANT GROWTH REGUL, V58, P107, DOI 10.1007/s10725-008-9356-6; Sofo A, 2005, FUNCT PLANT BIOL, V32, P45, DOI 10.1071/FP04003; Spollen WG, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-32; Tomemori H, 2002, PLANT PROD SCI, V5, P281, DOI 10.1626/pps.5.281; Tripathy JN, 2000, THEOR APPL GENET, V100, P1197, DOI 10.1007/s001220051424; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2; Yang J, 2009, TRENDS PLANT SCI, V14, P1, DOI 10.1016/j.tplants.2008.10.004; Yao X, 2010, PLANT PHYSIOL, V152, P341, DOI 10.1104/pp.109.145722; YOUNG CB, 1999, J PLANT PHYSL, V155, P255, DOI DOI 10.1016/S0176-1617(99)80016-9; Zheng YH, 2008, J PLANT PHYSIOL, V165, P1455, DOI 10.1016/j.jplph.2008.01.001; Zheng YH, 2010, J PLANT NUTR SOIL SC, V173, P444, DOI 10.1002/jpln.200900313	41	36	38	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e69737	10.1371/journal.pone.0069737	http://dx.doi.org/10.1371/journal.pone.0069737			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23874992	Green Submitted, Green Published, gold			2022-12-27	WOS:000321765300081
J	Kurabayashi, A; Kakinuma, Y; Morita, T; Inoue, K; Sato, T; Furihata, M				Kurabayashi, Atsushi; Kakinuma, Yoshihiko; Morita, Taku; Inoue, Keiji; Sato, Takayuki; Furihata, Mutsuo			Conditional VHL Gene Deletion Causes Hypoglycemic Death Associated with Disproportionately Increased Glucose Uptake by Hepatocytes through an Upregulated IGF-I Receptor	PLOS ONE			English	Article							GROWTH-FACTOR-I; NITRIC-OXIDE SYNTHASE; LINDAU TUMOR-SUPPRESSOR; ACTIVATED C-KINASE; INDUCED ANGIOGENESIS; SIGNAL-TRANSDUCTION; RENAL-CARCINOMA; INSULIN; PROTEIN; EXPRESSION	Our conditional VHL knockout (VHL-KO) mice, having VHL gene deletion induced by tamoxifen, developed severe hypoglycemia associated with disproportionately increased storage of PAS-positive substances in the liver and resulted in the death of these mice. This hypoglycemic state was neither due to impaired insulin secretion nor insulin receptor hypersensitivity. By focusing on insulin-like growth factor I (IGF-I), which has a similar effect on glucose metabolism as the insulin receptor, we demonstrated that IGF-I receptor (IGF-IR) protein expression in the liver was upregulated in VHL-KO mice compared to that in the mice without VHL deletion, as was the expression of glucose transporter (GLUT) 1. The interaction of the receptor for activated C kinase (RACK) 1, which predominantly binds to VHL, was enhanced in VHL-KO livers with IGF-IR, because VHL deletion increased free RACK1 and facilitated the IGF-IR-RACKI interaction. An IGF-IR antagonist retarded hypoglycemic progression and sustained an euglycemic state. These IGF-IR antagonist effects on restoring blood glucose levels also attenuated PAS-positive substance storage in the liver. Because the effect of IGF-I on HIF-1 alpha protein synthesis is mediated by IGF-IR, our results indicated that VHL inactivation accelerated hepatic glucose storage through the upregulation of IGF-IR and GLUT1 and that IGF-IR was a key regulator in VHL-deficient hepatocytes.	[Kurabayashi, Atsushi; Furihata, Mutsuo] Kochi Med Sch, Dept Pathol, Nankoku, Kochi, Japan; [Kakinuma, Yoshihiko; Sato, Takayuki] Kochi Med Sch, Dept Cardiovasc Control, Nankoku, Kochi, Japan; [Morita, Taku] Ashiya Municipal Hosp, Dept Pediat, Ashiya, Hyogo, Japan; [Inoue, Keiji] Kochi Med Sch, Dept Urol, Nankoku, Kochi, Japan	Kochi University; Kochi University; Kochi University	Kakinuma, Y (corresponding author), Kochi Med Sch, Dept Cardiovasc Control, Nankoku, Kochi, Japan.	kakinuma@kochi-u.ac.jp		Kakinuma, Yoshihiko/0000-0001-5470-9128	Japan Society for the Promotion of Science [21590283]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by Grants-in-Aid from the Japan Society for the Promotion of Science 21590283. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cantley J, 2009, J CLIN INVEST, V119, P125, DOI 10.1172/JCI26934; Chavez JC, 2002, J NEUROSCI, V22, P8922; DiCola G, 1997, J CLIN INVEST, V99, P2538, DOI 10.1172/JCI119438; Duplain H, 2001, CIRCULATION, V104, P342, DOI 10.1161/01.CIR.104.3.342; Emile JF, 2001, HISTOPATHOLOGY, V38, P225, DOI 10.1046/j.1365-2559.2001.01096.x; Entingh-Pearsall A, 2004, J BIOL CHEM, V279, P38016, DOI 10.1074/jbc.M313201200; Feldman EL, 1997, NEUROBIOL DIS, V4, P201, DOI 10.1006/nbdi.1997.0156; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; He X, 2011, ONCOGENE, V30, P535, DOI 10.1038/onc.2010.427; Hermanto U, 2002, MOL CELL BIOL, V22, P2345, DOI 10.1128/MCB.22.7.2345-2365.2002; Iguchi M, 2008, NEPHRON EXP NEPHROL, V110, pE82, DOI 10.1159/000166994; Jadeski LC, 1999, AM J PATHOL, V155, P1381, DOI 10.1016/S0002-9440(10)65240-6; Kucejova B, 2011, ONCOGENE, V30, P2147, DOI 10.1038/onc.2010.587; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; Ma WB, 2003, CANCER RES, V63, P5320; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; MOCHLYROSEN D, 1995, BIOCHEM SOC T, V23, P596, DOI 10.1042/bst0230596; Morita T, 2011, NEPHROL DIAL TRANSPL, V26, P4023, DOI 10.1093/ndt/gfr176; Park SK, 2007, INT J ONCOL, V30, P341; Puri S, 2009, DIABETES, V58, P433, DOI 10.2337/db08-0749; Richard DE, 2000, J BIOL CHEM, V275, P26765; Ron D, 1999, J BIOL CHEM, V274, P27039, DOI 10.1074/jbc.274.38.27039; Sepp-Lorenzino L, 1998, BREAST CANCER RES TR, V47, P235, DOI 10.1023/A:1005955017615; STEELEPERKINS G, 1988, J BIOL CHEM, V263, P11486; Stewart CEH, 1996, PHYSIOL REV, V76, P1005, DOI 10.1152/physrev.1996.76.4.1005; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Werner H, 1991, INSULIN LIKE GROWTH, P17; Yuen JSP, 2007, ONCOGENE, V26, P6499, DOI 10.1038/sj.onc.1210474; Ziche M, 1997, J CLIN INVEST, V99, P2625, DOI 10.1172/JCI119451	31	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e69139	10.1371/journal.pone.0069139	http://dx.doi.org/10.1371/journal.pone.0069139			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874892	Green Published, Green Submitted, gold			2022-12-27	WOS:000321736900137
J	Matsushika, A; Nagashima, A; Goshima, T; Hoshino, T				Matsushika, Akinori; Nagashima, Atsushi; Goshima, Tetsuya; Hoshino, Tamotsu			Fermentation of Xylose Causes Inefficient Metabolic State Due to Carbon/Energy Starvation and Reduced Glycolytic Flux in Recombinant Industrial Saccharomyces cerevisiae	PLOS ONE			English	Article							ETHANOL-PRODUCTION; XYLITOL DEHYDROGENASE; BIOETHANOL PRODUCTION; S-ADENOSYLMETHIONINE; ACID; STRAIN; TRANSCRIPTOME; PATHWAYS; GLUCOSE; GROWTH	In the present study, comprehensive, quantitative metabolome analysis was carried out on the recombinant glucose/xylose-cofermenting S. cerevisiae strain MA-R4 during fermentation with different carbon sources, including glucose, xylose, or glucose/xylose mixtures. Capillary electrophoresis time-of-flight mass spectrometry was used to determine the intracellular pools of metabolites from the central carbon pathways, energy metabolism pathways, and the levels of twenty amino acids. When xylose instead of glucose was metabolized by MA-R4, glycolytic metabolites including 3-phosphoglycerate, 2-phosphoglycerate, phosphoenolpyruvate, and pyruvate were dramatically reduced, while conversely, most pentose phosphate pathway metabolites such as sedoheptulose 7-phosphate and ribulose 5-phosphate were greatly increased. These results suggest that the low metabolic activity of glycolysis and the pool of pentose phosphate pathway intermediates are potential limiting factors in xylose utilization. It was further demonstrated that during xylose fermentation, about half of the twenty amino acids declined, and the adenylate/guanylate energy charge was impacted due to markedly decreased adenosine triphosphate/adenosine monophosphate and guanosine triphosphate/guanosine monophosphate ratios, implying that the fermentation of xylose leads to an inefficient metabolic state where the biosynthetic capabilities and energy balance are severely impaired. In addition, fermentation with xylose alone drastically increased the level of citrate in the tricarboxylic acid cycle and increased the aromatic amino acids tryptophan and tyrosine, strongly supporting the view that carbon starvation was induced. Interestingly, fermentation with xylose alone also increased the synthesis of the polyamine spermidine and its precursor S-adenosylmethionine. Thus, differences in carbon substrates, including glucose and xylose in the fermentation medium, strongly influenced the dynamic metabolism of MA-R4. These results provide a metabolic explanation for the low ethanol productivity on xylose compared to glucose.	[Matsushika, Akinori; Goshima, Tetsuya; Hoshino, Tamotsu] Natl Inst Adv Ind Sci & Technol, Biomass Refinery Res Ctr, Hiroshima, Japan; [Nagashima, Atsushi] Human Metabolome Technol Inc, Yamagata, Japan; [Hoshino, Tamotsu] Hokkaido Univ, Graduated Sch Life Sci, Sapporo, Hokkaido 060, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Hokkaido University	Matsushika, A (corresponding author), Natl Inst Adv Ind Sci & Technol, Biomass Refinery Res Ctr, Hiroshima, Japan.	a-matsushika@aist.go.jp	HOSHINO, Tamotsu/R-2959-2019; Matsushika, Akinori/B-8721-2018; Hoshino, Tamotsu/F-3357-2017	Matsushika, Akinori/0000-0002-5283-2875; Hoshino, Tamotsu/0000-0001-5211-6425	New Energy and Industrial Technology Development Organization (NEDO), Japan	New Energy and Industrial Technology Development Organization (NEDO), Japan(New Energy and Industrial Technology Development Organization (NEDO))	This study was funded by the New Energy and Industrial Technology Development Organization (NEDO), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida JRM, 2011, BIOTECHNOL J, V6, P286, DOI 10.1002/biot.201000301; BALL WJ, 1975, J BACTERIOL, V121, P975, DOI 10.1128/JB.121.3.975-982.1975; Bergdahl B, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-34; Brauer MJ, 2006, P NATL ACAD SCI USA, V103, P19302, DOI 10.1073/pnas.0609508103; BRAUS GH, 1991, MICROBIOL REV, V55, P349, DOI 10.1128/MMBR.55.3.349-370.1991; Chapman A G, 1977, Adv Microb Physiol, V15, P253, DOI 10.1016/S0065-2911(08)60318-5; Cohen S.S., 1998, GUIDE POLYAMINES, V1st ed.; de Jong B, 2012, CURR OPIN BIOTECH, V23, P624, DOI 10.1016/j.copbio.2011.11.021; DITZELMULLER G, 1983, ARCH MICROBIOL, V135, P63, DOI 10.1007/BF00419484; DOMBEK KM, 1988, APPL ENVIRON MICROB, V54, P98, DOI 10.1128/AEM.54.1.98-104.1988; Girio FM, 2010, BIORESOURCE TECHNOL, V101, P4775, DOI 10.1016/j.biortech.2010.01.088; Gong C S, 1999, Adv Biochem Eng Biotechnol, V65, P207; Hahn-Hagerdal B, 2007, APPL MICROBIOL BIOT, V74, P937, DOI 10.1007/s00253-006-0827-2; Hasunuma T, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-2; Heinemann M, 2010, CURR OPIN MICROBIOL, V13, P337, DOI 10.1016/j.mib.2010.02.005; Hong KK, 2012, CELL MOL LIFE SCI, V69, P2671, DOI 10.1007/s00018-012-0945-1; Karhumaa K, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-5; Klimacek M, 2010, APPL ENVIRON MICROB, V76, P7566, DOI 10.1128/AEM.01787-10; Matsushika A, 2013, APPL BIOCH BIOTECHNO, V169, P712; Matsushika A, 2009, BIORESOURCE TECHNOL, V100, P2392, DOI 10.1016/j.biortech.2008.11.047; Matsushika A, 2008, APPL MICROBIOL BIOT, V81, P243, DOI 10.1007/s00253-008-1649-1; Matsushika A, 2012, APPL BIOCHEM BIOTECH, V168, P2094, DOI 10.1007/s12010-012-9920-4; Matsushika A, 2010, APPL BIOCHEM BIOTECH, V162, P1952, DOI 10.1007/s12010-010-8972-6; Matsushika A, 2009, APPL MICROBIOL BIOT, V84, P37, DOI 10.1007/s00253-009-2101-x; Matsushika A, 2009, APPL ENVIRON MICROB, V75, P3818, DOI 10.1128/AEM.02636-08; Monton MRN, 2007, J CHROMATOGR A, V1168, P237, DOI 10.1016/j.chroma.2007.02.065; Ohashi Y, 2008, MOL BIOSYST, V4, P135, DOI 10.1039/b714176a; Ooga T, 2011, MOL BIOSYST, V7, P1217, DOI 10.1039/c0mb00141d; Otero JM, 2007, ADV BIOCHEM ENG BIOT, V108, P1, DOI 10.1007/10_2007_071; Redon E, 2005, J BACTERIOL, V187, P3589, DOI 10.1128/JB.187.10.3589-3592.2005; Sassner P, 2008, BIOMASS BIOENERG, V32, P422, DOI 10.1016/j.biombioe.2007.10.014; Sedlak M, 2004, YEAST, V21, P671, DOI 10.1002/yea.1060; Shobayashi M, 2006, APPL MICROBIOL BIOT, V69, P704, DOI 10.1007/s00253-005-0009-7; Shobayashi M, 2007, BIOSCI BIOTECH BIOCH, V71, P1595, DOI 10.1271/bbb.70100; Soga T, 2002, ANAL CHEM, V74, P2233, DOI 10.1021/ac020064n; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Soga T, 2000, ANAL CHEM, V72, P1236, DOI 10.1021/ac990976y; Sugimoto M, 2010, METABOLOMICS, V6, P78, DOI 10.1007/s11306-009-0178-y; TABOR CW, 1985, MICROBIOL REV, V49, P81, DOI 10.1128/MMBR.49.1.81-99.1985; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; van Maris AJA, 2007, ADV BIOCHEM ENG BIOT, V108, P179, DOI 10.1007/10_2007_057; Van Vleet JH, 2009, CURR OPIN BIOTECH, V20, P300, DOI 10.1016/j.copbio.2009.06.001; Wisselink HW, 2010, METAB ENG, V12, P537, DOI 10.1016/j.ymben.2010.08.003	43	35	36	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e69005	10.1371/journal.pone.0069005	http://dx.doi.org/10.1371/journal.pone.0069005			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874849	Green Submitted, gold, Green Published			2022-12-27	WOS:000321736900127
J	Pope, WH; Jacobs-Sera, D; Best, AA; Broussard, GW; Connerly, PL; Dedrick, RM; Kremer, TA; Offner, S; Ogiefo, AH; Pizzorno, MC; Rockenbach, K; Russell, DA; Stowe, EL; Stukey, J; Thibault, SA; Conway, JF; Hendrix, RW; Hatfull, GF				Pope, Welkin H.; Jacobs-Sera, Deborah; Best, Aaron A.; Broussard, Gregory W.; Connerly, Pamela L.; Dedrick, Rebekah M.; Kremer, Timothy A.; Offner, Susan; Ogiefo, Amenawon H.; Pizzorno, Marie C.; Rockenbach, Kate; Russell, Daniel A.; Stowe, Emily L.; Stukey, Joseph; Thibault, Sarah A.; Conway, James F.; Hendrix, Roger W.; Hatfull, Graham F.			Cluster J Mycobacteriophages: Intron Splicing in Capsid and Tail Genes	PLOS ONE			English	Article							INSERTION-SEQUENCE; GENOME; BACTERIOPHAGE; TOOL; IDENTIFICATION; ELEMENTS; REVEALS; BINDING; PROTEIN; PHAGES	Bacteriophages isolated on Mycobacterium smegmatis mc2155 represent many distinct genomes sharing little or no DNA sequence similarity. The genomes are architecturally mosaic and are replete with genes of unknown function. A new group of genomes sharing substantial nucleotide sequences constitute Cluster J. The six mycobacteriophages forming Cluster J are morphologically members of the Siphoviridae, but have unusually long genomes ranging from 106.3 to 117 kbp. Reconstruction of the capsid by cryo-electron microscopy of mycobacteriophage BAKA reveals an icosahedral structure with a triangulation number of 13. All six phages are temperate and homoimmune, and prophage establishment involves integration into a tRNA-Leu gene not previously identified as a mycobacterial attB site for phage integration. The Cluster J genomes provide two examples of intron splicing within the virion structural genes, one in a major capsid subunit gene, and one in a tail gene. These genomes also contain numerous freestanding HNH homing endonuclease, and comparative analysis reveals how these could contribute to genome mosaicism. The unusual Cluster J genomes provide new insights into phage genome architecture, gene function, capsid structure, gene mobility, intron splicing, and evolution.	[Pope, Welkin H.; Jacobs-Sera, Deborah; Broussard, Gregory W.; Dedrick, Rebekah M.; Ogiefo, Amenawon H.; Rockenbach, Kate; Russell, Daniel A.; Hendrix, Roger W.; Hatfull, Graham F.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Conway, James F.] Univ Pittsburgh, Dept Biol Struct, Pittsburgh, PA 15260 USA; [Best, Aaron A.] Hope Coll, Dept Biol, Holland, MI 49423 USA; [Pizzorno, Marie C.; Stowe, Emily L.; Thibault, Sarah A.] Bucknell Univ, Dept Biol, Lewisburg, PA 17837 USA; [Offner, Susan] Lexington High Sch, Lexington, MA USA; [Connerly, Pamela L.; Kremer, Timothy A.] Indiana Univ SE, Sch Nat Sci, Indiana, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Hope College; Bucknell University	Hatfull, GF (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.	gfh@pitt.edu	Conway, James F/A-2296-2010	Conway, James F/0000-0002-6581-4748; Dedrick, Rebekah/0000-0002-3666-711X; Pizzorno, Marie/0000-0003-3502-6289	National Institutes of Health [GM51975]; Howard Hughes Medical Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051975, R24GM093901] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM51975, and by the Howard Hughes Medical Institute through its Professorship grant to GFH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal AK, 1998, CURR OPIN STRUC BIOL, V8, P19, DOI 10.1016/S0959-440X(98)80005-5; BORODOVSKY M, 1993, COMPUT CHEM, V17, P123, DOI 10.1016/0097-8485(93)85004-V; Brussow H, 2001, ANNU REV MICROBIOL, V55, P283, DOI 10.1146/annurev.micro.55.1.283; BRUTON CJ, 1987, NUCLEIC ACIDS RES, V15, P7053; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; Conway JF, 1999, J STRUCT BIOL, V128, P106, DOI 10.1006/jsbi.1999.4168; Cresawn SG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-395; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; DUDA RL, 1995, J MOL BIOL, V247, P618, DOI 10.1016/S0022-2836(05)80143-3; Edgell DR, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-290; Effantin G, 2006, J MOL BIOL, V361, P993, DOI 10.1016/j.jmb.2006.06.081; Hatfull GF, 2006, PLOS GENET, V2, P835, DOI 10.1371/journal.pgen.0020092; Hatfull GF, 2012, ADV VIRUS RES, V82, P179, DOI 10.1016/B978-0-12-394621-8.00015-7; Hatfull GF, 2012, J VIROL, V86, P2382, DOI 10.1128/JVI.06870-11; Hatfull GF, 2010, ANNU REV MICROBIOL, V64, P331, DOI 10.1146/annurev.micro.112408.134233; Hendrix RW, 1999, P NATL ACAD SCI USA, V96, P2192, DOI 10.1073/pnas.96.5.2192; Hendrix RW, 2002, THEOR POPUL BIOL, V61, P471, DOI 10.1006/tpbi.2002.1590; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Hiller R, 2000, J MOL BIOL, V297, P301, DOI 10.1006/jmbi.2000.3582; Iwasaki K, 2000, VIROLOGY, V271, P321, DOI 10.1006/viro.2000.0321; Krumsiek J, 2007, BIOINFORMATICS, V23, P1026, DOI 10.1093/bioinformatics/btm039; Kulakov LA, 1999, MICROBIOL-SGM, V145, P561, DOI 10.1099/13500872-145-3-561; Kwan T, 2005, P NATL ACAD SCI USA, V102, P5174, DOI 10.1073/pnas.0501140102; Landthaler M, 2004, J BACTERIOL, V186, P4307, DOI 10.1128/JB.186.13.4307-4314.2004; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; LEE MH, 1991, P NATL ACAD SCI USA, V88, P3111, DOI 10.1073/pnas.88.8.3111; Lewis JA, 2001, NUCLEIC ACIDS RES, V29, P2205, DOI 10.1093/nar/29.11.2205; Mageeney C, 2012, J VIROL, V86, P4762, DOI 10.1128/JVI.00075-12; Mann NH, 2005, J BACTERIOL, V187, P3188, DOI 10.1128/JB.187.9.3188-3200.2005; Marinelli LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003957; Martinsohn JT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000065; Olson NH, 2001, VIROLOGY, V279, P385, DOI 10.1006/viro.2000.0735; Pannifer AD, 2001, NATURE, V414, P229, DOI 10.1038/n35101998; Payne KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034052; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pitcher RS, 2006, MOL CELL, V23, P743, DOI 10.1016/j.molcel.2006.07.009; Pope WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016329; Sampson T, 2009, MICROBIOL-SGM, V155, P2962, DOI 10.1099/mic.0.030486-0; Shen BW, 2004, J MOL BIOL, V342, P43, DOI 10.1016/j.jmb.2004.07.032; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Sobhany M, 2012, J BIOL CHEM, V287, P36022, DOI 10.1074/jbc.M112.375873; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Stoddard B, 2010, MOL MICROBIOL, V78, P1, DOI 10.1111/j.1365-2958.2010.07217.x; Toor N, 2002, RNA, V8, P1373, DOI 10.1017/S1355838202023087; VANHEEL M, 1987, ULTRAMICROSCOPY, V21, P95, DOI 10.1016/0304-3991(87)90010-6; Yan XD, 2007, J STRUCT BIOL, V157, P211, DOI 10.1016/j.jsb.2006.07.013; Yan X, 2007, J STRUCT BIOL, V157, P73, DOI 10.1016/j.jsb.2006.08.007; Zhu H, 2004, J BIOL CHEM, V279, P26358, DOI 10.1074/jbc.M403200200	49	19	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e69273	10.1371/journal.pone.0069273	http://dx.doi.org/10.1371/journal.pone.0069273			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874930	Green Published, gold, Green Accepted			2022-12-27	WOS:000321736900146
J	Wortzman, ME; Lin, GHY; Watts, TH				Wortzman, Michael E.; Lin, Gloria H. Y.; Watts, Tania H.			Intrinsic TNF/TNFR2 Interactions Fine-Tune the CD8 T Cell Response to Respiratory Influenza Virus Infection in Mice	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; TNF-ALPHA; PRECURSOR FREQUENCY; 4-1BB; ACTIVATION; EXPRESSION; APOPTOSIS; ANTIGEN; DEFICIENT	TNF is an important inflammatory mediator and a target for intervention. TNF is produced by many cell types and is involved in innate inflammation as well as adaptive immune responses. CD8 T cells produce TNF and can also respond to TNF. Deficiency of TNF or TNFR2 has been shown to affect anti-viral immunity. However, as the complete knockout of TNF or its receptors has effects on multiple cell types as well as on lymphoid architecture, it has been difficult to assess the role of TNF directly on T cells during viral infection. Here we have addressed this issue by analyzing the effect of CD8 T cell intrinsic TNF/TNFR2 interactions during respiratory influenza infection in mice, using an adoptive transfer model in which only the T cells lack TNF or TNFR2. During a mild influenza infection, the capacity of the responding CD8 T cells to produce TNF increases from day 6 through day 12, beyond the time of viral clearance. Although T cell intrinsic TNF is dispensable for initial expansion of CD8 T cells up to day 9 post infection, intrinsic TNF/TNFR2 interactions potentiate contraction of the CD8 T cell response in the lung between day 9 and 12 post infection. On the other hand, TNF or TNFR2-deficient CD8 T cells in the lung express lower levels of IFN-gamma and CD107a per cell than their wild type counterparts. Comparison of TNF levels on the TNFR2 positive and negative T cells is consistent with TNF/TNFR2 interactions inducing feedback downregulation of TNF production by T cells, with greater effects in the lung compared to spleen. Thus CD8 T cell intrinsic TNF/TNFR2 interactions fine-tune the response to influenza virus in the lung by modestly enhancing effector functions, but at the same time potentiating the contraction of the CD8 T cell response post-viral clearance.	[Wortzman, Michael E.; Lin, Gloria H. Y.; Watts, Tania H.] Univ Toronto, Dept Immunol, Toronto, ON, Canada	University of Toronto	Watts, TH (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.	tania.watts@utoronto.ca			Canadian Institutes of Health Research (CIHR) [MOP 84419, MOP 123480]; CIHR	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR))	This research was funded by grant number MOP 84419 and MOP 123480 from the Canadian Institutes of Health Research (CIHR) to THW. THW holds the Sanofi Pasteur chair in Human Immunology at the University of Toronto; MEW and GHYL were funded by CIHR masters and doctoral awards, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN W, 1990, J IMMUNOL, V144, P3980; Allie N, 2013, SCI REP-UK, V3, DOI 10.1038/srep01809; Arch RH, 1998, MOL CELL BIOL, V18, P558, DOI 10.1128/MCB.18.1.558; Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Badovinac VP, 2000, SCIENCE, V290, P1354, DOI 10.1126/science.290.5495.1354; Badovinac VP, 2002, NAT IMMUNOL, V3, P619, DOI 10.1038/ni804; Bertram EM, 2004, SEMIN IMMUNOL, V16, P185, DOI 10.1016/j.smim.2004.02.006; Brehm MA, 2005, J IMMUNOL, V175, P5043, DOI 10.4049/jimmunol.175.8.5043; Brown GR, 2000, EUR J IMMUNOL, V30, P2900, DOI 10.1002/1521-4141(200010)30:10<2900::AID-IMMU2900>3.0.CO;2-P; Calzascia T, 2007, J CLIN INVEST, V117, P3833, DOI 10.1172/JCI32567; Chatzidakis I, 2007, J IMMUNOL, V178, P6735, DOI 10.4049/jimmunol.178.11.6735; Croft M, 2009, NAT REV IMMUNOL, V9, P271, DOI 10.1038/nri2526; Damjanovic D, 2011, AM J PATHOL, V179, P2963, DOI 10.1016/j.ajpath.2011.09.003; Dawicki W, 2004, EUR J IMMUNOL, V34, P743, DOI 10.1002/eji.200324278; Doherty PC, 2006, NAT IMMUNOL, V7, P449, DOI 10.1038/ni1343; Fischer R, 2011, CELL SIGNAL, V23, P161, DOI 10.1016/j.cellsig.2010.08.016; Grayson JM, 2002, J IMMUNOL, V169, P3760, DOI 10.4049/jimmunol.169.7.3760; Grell M, 1996, J INFLAMM, V47, P8; Grivennikov SI, 2005, IMMUNITY, V22, P93, DOI 10.1016/j.immuni.2004.11.016; Hill GR, 2000, J IMMUNOL, V164, P656, DOI 10.4049/jimmunol.164.2.656; Jenkins MK, 2012, J IMMUNOL, V188, P4135, DOI 10.4049/jimmunol.1102661; Jenkins MR, 2006, J IMMUNOL, V177, P2917, DOI 10.4049/jimmunol.177.5.2917; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kim EY, 2009, J IMMUNOL, V183, P6051, DOI 10.4049/jimmunol.0803482; Kim EY, 2006, J IMMUNOL, V176, P1026, DOI 10.4049/jimmunol.176.2.1026; Kim EY, 2004, J IMMUNOL, V173, P4500, DOI 10.4049/jimmunol.173.7.4500; Kim EY, 2001, J IMMUNOL, V167, P6812, DOI 10.4049/jimmunol.167.12.6812; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Lin GHY, 2009, J IMMUNOL, V182, P934, DOI 10.4049/jimmunol.182.2.934; Mace PD, 2010, J MOL BIOL, V400, P8, DOI 10.1016/j.jmb.2010.04.055; Marino MW, 1997, P NATL ACAD SCI USA, V94, P8093, DOI 10.1073/pnas.94.15.8093; McPherson AJ, 2012, J BIOL CHEM, V287, P23010, DOI 10.1074/jbc.M112.350538; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Pfeffer K, 2003, CYTOKINE GROWTH F R, V14, P185, DOI 10.1016/S1359-6101(03)00022-4; POLLOK KE, 1993, J IMMUNOL, V150, P771; Rauert H, 2010, J BIOL CHEM, V285, P7394, DOI 10.1074/jbc.M109.037341; Richter MV, 2007, J IMMUNOL, V179, P5054, DOI 10.4049/jimmunol.179.8.5054; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; Saoulli K, 1998, J EXP MED, V187, P1849, DOI 10.1084/jem.187.11.1849; Singh A, 2007, J LEUKOCYTE BIOL, V82, P1201, DOI 10.1189/jlb.0407240; Snell LM, 2010, J IMMUNOL, V185, P7223, DOI 10.4049/jimmunol.1001912; Suresh M, 2005, J VIROL, V79, P202, DOI 10.1128/JVI.79.1.202-213.2005; Thomas PG, 2006, EMERG INFECT DIS, V12, P48, DOI 10.3201/eid1201.051237; Togbe D, 2007, EUR J IMMUNOL, V37, P768, DOI 10.1002/eji.200636371; Tracey D, 2008, PHARMACOL THERAPEUT, V117, P244, DOI 10.1016/j.pharmthera.2007.10.001; TRACEY KJ, 1994, ANNU REV MED, V45, P491, DOI 10.1146/annurev.med.45.1.491; Tumanov AV, 2010, BLOOD, V116, P3456, DOI 10.1182/blood-2009-10-249177; Turner SJ, 2004, P NATL ACAD SCI USA, V101, P3545, DOI 10.1073/pnas.0307347101; Twu YC, 2011, EUR J IMMUNOL, V41, P335, DOI 10.1002/eji.201040639; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Waggoner SN, 2012, NATURE, V481, P394, DOI 10.1038/nature10624; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; White DW, 2000, J IMMUNOL, V165, P5, DOI 10.4049/jimmunol.165.1.5; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676; Zheng C, 2010, MOL CELL, V38, P101, DOI 10.1016/j.molcel.2010.03.009; ZHENG LX, 1995, NATURE, V377, P348, DOI 10.1038/377348a0	60	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e68911	10.1371/journal.pone.0068911	http://dx.doi.org/10.1371/journal.pone.0068911			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874808	gold, Green Published, Green Submitted			2022-12-27	WOS:000321736900121
J	Abubaker, J; Tiss, A; Abu-Farha, M; Al-Ghimlas, F; Al-Khairi, I; Baturcam, E; Cherian, P; Elkum, N; Hammad, M; John, J; Kavalakatt, S; Khadir, A; Warsame, S; Dermime, S; Behbehani, K; Dehbi, M				Abubaker, Jehad; Tiss, Ali; Abu-Farha, Mohamed; Al-Ghimlas, Fahad; Al-Khairi, Irina; Baturcam, Engin; Cherian, Preethi; Elkum, Naser; Hammad, Maha; John, Jeena; Kavalakatt, Sina; Khadir, Abdelkrim; Warsame, Samia; Dermime, Said; Behbehani, Kazem; Dehbi, Mohammed			DNAJB3/HSP-40 Cochaperone Is Downregulated in Obese Humans and Is Restored by Physical Exercise	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; ENDOPLASMIC-RETICULUM STRESS; INSULIN SENSITIVITY; SKELETAL-MUSCLE; MOLECULAR CHAPERONES; ACTIVATION; EXPRESSION; HEAT-SHOCK-PROTEIN-72; INFLAMMATION; KINASES	Obesity is a major risk factor for a myriad of disorders such as insulin resistance and diabetes. The mechanisms underlying these chronic conditions are complex but low grade inflammation and alteration of the endogenous stress defense system are well established. Previous studies indicated that impairment of HSP-25 and HSP-72 was linked to obesity, insulin resistance and diabetes in humans and animals while their induction was associated with improved clinical outcomes. In an attempt to identify additional components of the heat shock response that may be dysregulated by obesity, we used the RT2-Profiler PCR heat shock array, complemented with RT-PCR and validated by Western blot and immunohistochemistry. Using adipose tissue biopsies and PBMC of non-diabetic lean and obese subjects, we report the downregulation of DNAJB3 cochaperone mRNA and protein in obese that negatively correlated with percent body fat (P = 0.0001), triglycerides (P = 0.035) and the inflammatory chemokines IP-10 and RANTES (P = 0.036 and P = 0.02, respectively). DNAJB positively correlated with maximum oxygen consumption (P = 0.031). Based on the beneficial effect of physical exercise, we investigated its possible impact on DNAJB3 expression and indeed, we found that exercise restored the expression of DNAJB3 in obese subjects with a concomitant decrease of phosphorylated JNK. Using cell lines, DNAJB3 protein was reduced following treatment with palmitate and tunicamycin which is suggestive of the link between the expression of DNAJB3 and the activation of the endoplasmic reticulum stress. DNAJB3 was also shown to coimmunoprecipiate with JNK and IKK beta stress kinases along with HSP-72 and thus, suggesting its potential role in modulating their activities. Taken together, these data suggest that DNAJB3 can potentially play a protective role against obesity.	[Abubaker, Jehad; Tiss, Ali; Abu-Farha, Mohamed; Al-Khairi, Irina; Baturcam, Engin; Cherian, Preethi; Hammad, Maha; John, Jeena; Kavalakatt, Sina; Khadir, Abdelkrim; Warsame, Samia; Dermime, Said; Behbehani, Kazem; Dehbi, Mohammed] Dasman Diabet Inst, Biomed Res Dept, Kuwait, Kuwait; [Al-Ghimlas, Fahad; Behbehani, Kazem] Dasman Diabet Inst, Fitness & Rehabil Ctr, Kuwait, Kuwait; [Elkum, Naser; Behbehani, Kazem] Dasman Diabet Inst, Dept Biostat & Epidemiol, Kuwait, Kuwait		Dehbi, M (corresponding author), Dasman Diabet Inst, Biomed Res Dept, Kuwait, Kuwait.	mohammed.dehbi@dasmaninstitute.org	Elkum, Naser/AAU-5555-2020; Tiss, Ali/L-6656-2019; Dermime, Said/P-2448-2019	Elkum, Naser/0000-0002-0457-0444; Tiss, Ali/0000-0002-3024-5370; Dermime, Said/0000-0002-5526-7496; Hammad, Maha/0000-0002-8974-8255; Abubaker, Jehad/0000-0003-0681-7305; Abu-Farha, Mohamed/0000-0001-8357-1252; kavalakatt, sina/0000-0003-3795-1881	Kuwait Foundation for the Advancement of Sciences (KFAS) [RA-2010-003]	Kuwait Foundation for the Advancement of Sciences (KFAS)(Kuwait Foundation for the Advancement of Sciences (KFAS))	This work was supported by the Kuwait Foundation for the Advancement of Sciences (KFAS) under project (RA-2010-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksu S, 2007, J APPL GENET, V48, P133, DOI 10.1007/BF03194671; Alter J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029498; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Atalay M, 2004, J APPL PHYSIOL, V97, P605, DOI 10.1152/japplphysiol.01183.2003; Benbrook D. M., 2012, Experimental Oncology, V34, P286; Berruti G, 1998, EXP CELL RES, V239, P430, DOI 10.1006/excr.1997.3879; Boura-Halfon S, 2009, AM J PHYSIOL-ENDOC M, V296, pE581, DOI 10.1152/ajpendo.90437.2008; Bruce CR, 2003, DIABETES, V52, P2338, DOI 10.2337/diabetes.52.9.2338; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Calamini B, 2012, NAT CHEM BIOL, V8, P185, DOI 10.1038/nchembio.763; Calderwood SK, 2009, GERONTOLOGY, V55, P550, DOI 10.1159/000225957; Chung J, 2008, P NATL ACAD SCI USA, V105, P1739, DOI 10.1073/pnas.0705799105; Dremina ES, 2012, BIOCHEM J, V444, P127, DOI 10.1042/BJ20111114; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Eiras S, 2006, CARDIOVASC RES, V71, P118, DOI 10.1016/j.cardiores.2006.03.014; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Furuhashi M, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/642612; Gabai VL, 1997, J BIOL CHEM, V272, P18033, DOI 10.1074/jbc.272.29.18033; Ghebeh H, 2007, INT J CANCER, V121, P751, DOI 10.1002/ijc.22703; Gleeson M, 2011, NAT REV IMMUNOL, V11, P607, DOI 10.1038/nri3041; Golbidi S, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/349710; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Gual P, 2005, BIOCHIMIE, V87, P99, DOI 10.1016/j.biochi.2004.10.019; Gupte AA, 2008, J APPL PHYSIOL, V105, P839, DOI 10.1152/japplphysiol.00148.2008; Gupte AA, 2011, J APPL PHYSIOL, V110, P451, DOI 10.1152/japplphysiol.00849.2010; Gupte AA, 2009, J APPL PHYSIOL, V106, P1425, DOI 10.1152/japplphysiol.91210.2008; Gupte AA, 2009, DIABETES, V58, P567, DOI 10.2337/db08-1070; Gutsmann-Conrad A, 1999, MECH AGEING DEV, V107, P255, DOI 10.1016/S0047-6374(98)00132-8; Hageman J, 2011, BIOCHEM J, V435, P127, DOI 10.1042/BJ20101247; Hageman J, 2010, MOL CELL, V37, P355, DOI 10.1016/j.molcel.2010.01.001; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hooper PL, 2009, CELL STRESS CHAPERON, V14, P113, DOI 10.1007/s12192-008-0073-x; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hummasti S, 2010, CIRC RES, V107, P579, DOI 10.1161/CIRCRESAHA.110.225698; Johnson JD, 2006, J LEUKOCYTE BIOL, V79, P425, DOI 10.1189/jlb.0905523; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Kim G, 2012, AGING CELL, V11, P617, DOI 10.1111/j.1474-9726.2012.00827.x; Kondo T, 2011, CURR DIABETES REV, V7, P264, DOI 10.2174/157339911796397811; Kurucz I, 2002, DIABETES, V51, P1102, DOI 10.2337/diabetes.51.4.1102; Lai E, 2008, AM J PHYSIOL-ENDOC M, V294, pE540, DOI 10.1152/ajpendo.00478.2007; Landsberg L, 2013, J CLIN HYPERTENS, V15, P14, DOI 10.1111/jch.12049; Literati-Nagy B, 2009, HORM METAB RES, V41, P374, DOI 10.1055/s-0028-1128142; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marker T, 2012, DIABETES, V61, P615, DOI 10.2337/db10-1574; McCarty MF, 2006, MED HYPOTHESES, V66, P527, DOI 10.1016/j.mehy.2004.08.033; Meldrum KK, 2003, CIRC RES, V92, P293, DOI 10.1161/01.RES.0000057754.35180.99; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Morimoto RI, 2011, COLD SH Q B, V76, P91, DOI 10.1101/sqb.2012.76.010637; Morino S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004068; Najemnikova E, 2007, CELL STRESS CHAPERON, V12, P342, DOI 10.1379/CSC-292.1; Neels JG, 2006, SCIENCE, V312, P1756, DOI 10.1126/science.1130476; Noble EG, 2008, APPL PHYSIOL NUTR ME, V33, P1050, DOI 10.1139/H08-069; Park KJ, 2003, J BIOL CHEM, V278, P35272, DOI 10.1074/jbc.M305095200; Sakahira H, 2002, P NATL ACAD SCI USA, V99, P16412, DOI 10.1073/pnas.182426899; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Simar D, 2012, CELL STRESS CHAPERON, V17, P615, DOI 10.1007/s12192-012-0336-4; Teixeira-Lemos E, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-12; Vallerie SN, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001007; Voellmy R, 2006, HANDB EXP PHARM, V172, P43; Voellmy R, 2007, ADV EXP MED BIOL, V594, P89; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; Whitham M, 2008, FRONT BIOSCI-LANDMRK, V13, P1328, DOI 10.2741/2765; Ye CF, 2009, BIOSCI BIOTECH BIOCH, V73, P1787, DOI 10.1271/bbb.90147	65	39	40	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69217	10.1371/journal.pone.0069217	http://dx.doi.org/10.1371/journal.pone.0069217			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894433	Green Published, gold, Green Submitted			2022-12-27	WOS:000322167900048
J	Chen, YW; Chu, HC; Lin, ZS; Shiah, WJ; Chou, CP; Klimstra, DS; Lewis, BC				Chen, Ya-Wen; Chu, Hsiao-Chien; Lin, Ze-Shiang; Shiah, Wei-Jyh; Chou, Chen-Pin; Klimstra, David S.; Lewis, Brian C.			p16 Stimulates CDC42-Dependent Migration of Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							BREAST-CANCER; CYCLE INHIBITOR; GENE; EXPRESSION; OVEREXPRESSION; P16(INK4A); INK4A/ARF; PROTEIN; RAC; PATHOGENESIS	Hepatocellular carcinoma (HCC) is a leading cause of cancer-related deaths worldwide. Tumor dissemination to the extra-hepatic region of the portal vein, lymph nodes, lungs or bones contributes to the high mortality seen in HCC; yet, the molecular mechanisms responsible for HCC metastasis remain unclear. Prior studies have suggested a potential link between accumulated cytoplasm-localized p16 and tumor progression. Here we report that p16 enhances metastasis-associated phenotypes in HCC cells - ectopic p16 expression increased cell migration in vitro, and lung colonization after intravenous injection, whereas knockdown of endogenous p16 reduced cell migration. Interestingly, analysis of p16 mutants indicated that the Cdk4 interaction domain is required for stimulation of HCC cell migration; however, knockdown of Cdk4 and Cdk6 showed that these proteins are dispensable for this phenomenon. Intriguingly, we found that in p16-positive HCC samples, p16 protein is predominantly localized in the cytoplasm. In addition, we identified a potential role for nuclear-cytoplasmic shuttling in p16-stimulated migration, consistent with the predominantly cytoplasmic localization of p16 in IHC-positive HCC samples. Finally, we determined that p16-stimulated cell migration requires the Cdc42 GTPase. Our results demonstrate for the first time a pro-migratory role for p16, and suggest a potential mechanism for the observed association between cytoplasmic p16 and tumor progression in diverse tumor types.	[Chen, Ya-Wen; Chu, Hsiao-Chien; Lin, Ze-Shiang; Shiah, Wei-Jyh] Natl Hlth Res Inst, Natl Inst Canc Res, Miaoli, Taiwan; [Chen, Ya-Wen] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Chen, Ya-Wen; Lewis, Brian C.] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; [Chou, Chen-Pin] Kaohsiung Vet Gen Hosp, Dept Radiol, Kaohsiung, Taiwan; [Klimstra, David S.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Lewis, Brian C.] Univ Massachusetts, Program Mol Med, Sch Med, Worcester, MA 01605 USA; [Lewis, Brian C.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; [Lewis, Brian C.] Univ Massachusetts, Sch Med, Ctr Canc, Worcester, MA 01605 USA	National Health Research Institutes - Taiwan; China Medical University Taiwan; University of Massachusetts System; University of Massachusetts Worcester; Kaohsiung Veterans General Hospital; Memorial Sloan Kettering Cancer Center; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Chen, YW (corresponding author), Natl Hlth Res Inst, Natl Inst Canc Res, Miaoli, Taiwan.	ywc@nhri.org.tw; Brian.Lewis@umassmed.edu	Chen, Ya-Wen/B-1100-2010; Chen, Ya-Wen/AAG-7549-2019	Chen, Ya-Wen/0000-0002-6080-8859	NIH [CA121171]; National Science Council [NSC97-3112-B-001-016, NSC 99-2320-B-400-001, NSC 100-2320-B-400-008, DOH101 TD-C-111-004]; NATIONAL CANCER INSTITUTE [R01CA121171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Council(Ministry of Science and Technology, Taiwan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by an NIH grant CA121171 to BCL and National Science Council grants NSC97-3112-B-001-016, NSC 99-2320-B-400-001, NSC 100-2320-B-400-008 and DOH101 TD-C-111-004 to YWC. BCL is a member of the University of Massachusetts DERC (DK32520). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arifin MT, 2006, J NEURO-ONCOL, V77, P273, DOI 10.1007/s11060-005-9037-5; Benard V, 2002, METHOD ENZYMOL, V345, P349; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; Buendia MA, 2000, SEMIN CANCER BIOL, V10, P185; CALDAS C, 1994, NAT GENET, V8, P27, DOI 10.1038/ng0994-27; Chen YW, 2008, CANCER RES, V68, P476, DOI 10.1158/0008-5472.CAN-07-1960; Chen YW, 2007, CANCER RES, V67, P7589, DOI 10.1158/0008-5472.CAN-07-0381; Chiang DY, 2008, CANCER RES, V68, P6779, DOI 10.1158/0008-5472.CAN-08-0742; Chintala SK, 1997, ONCOGENE, V15, P2049, DOI 10.1038/sj.onc.1201382; Emig R, 1998, BRIT J CANCER, V78, P1661, DOI 10.1038/bjc.1998.739; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fahraeus R, 1999, EMBO J, V18, P2106, DOI 10.1093/emboj/18.8.2106; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Henshall SM, 2001, CLIN CANCER RES, V7, P544; Hui AM, 1996, HEPATOLOGY, V24, P575, DOI 10.1002/hep.510240319; Iizuka N, 2003, LANCET, V361, P923, DOI 10.1016/S0140-6736(03)12775-4; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jia HL, 2007, CLIN CANCER RES, V13, P1133, DOI 10.1158/1078-0432.CCR-06-1025; KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634; Koch U, 2007, CELL MOL LIFE SCI, V64, P2746, DOI 10.1007/s00018-007-7164-1; Lee CT, 1999, CLIN CANCER RES, V5, P977; Lewis BC, 2005, MOL CELL BIOL, V25, P1228, DOI 10.1128/MCB.25.4.1228-1237.2005; Lewis BC, 1997, MOL CELL BIOL, V17, P4967, DOI 10.1128/MCB.17.9.4967; Li LY, 2010, J CANCER, V1, P126; Liew CT, 1999, ONCOGENE, V18, P789, DOI 10.1038/sj.onc.1202359; Lin ZS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043593; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Matsuda Y, 1999, GASTROENTEROLOGY, V116, P394, DOI 10.1016/S0016-5085(99)70137-X; McAllister SS, 2003, MOL CELL BIOL, V23, P216, DOI 10.1128/MCB.23.1.216-228.2003; Milde-Langosch K, 2001, BREAST CANCER RES TR, V67, P61, DOI 10.1023/A:1010623308275; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Nguyen L, 2006, GENE DEV, V20, P1511, DOI 10.1101/gad.377106; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; QUELLE DE, 1995, CELL, V83, P993; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; ROBINSON WS, 1994, ANNU REV MED, V45, P297; Sano T, 1998, AM J PATHOL, V153, P1741, DOI 10.1016/S0002-9440(10)65689-1; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Sharpless NE, 2005, MUTAT RES-FUND MOL M, V576, P22, DOI 10.1016/j.mrfmmm.2004.08.021; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Souza-Rodrigues E, 2007, PROTEOMICS, V7, P4102, DOI 10.1002/pmic.200700133; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Ward SC, 2010, MODERN PATHOL, V23, P1180, DOI 10.1038/modpathol.2010.105	44	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69389	10.1371/journal.pone.0069389	http://dx.doi.org/10.1371/journal.pone.0069389			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894465	Green Published, Green Submitted, gold			2022-12-27	WOS:000322167900062
J	Giuliani, F; Giuliani, G; Bauer, R; Rabouille, C				Giuliani, Fabrizio; Giuliani, Giuliano; Bauer, Reinhard; Rabouille, Catherine			Innexin 3, a New Gene Required for Dorsal Closure in Drosophila Embryo	PLOS ONE			English	Article							GAP-JUNCTION PROTEINS; CELL-CELL ADHESION; EPITHELIAL MORPHOGENESIS; SEPTATE JUNCTION; E-CADHERIN; NERVOUS-SYSTEM; EXPRESSION; MUTATIONS; HOMOLOG; ORGANIZATION	Background: Dorsal closure is a morphogenetic event that occurs during mid-embryogenesis in many insects including Drosophila, during which the ectoderm migrates on the extraembryonic amnioserosa to seal the embryo dorsally. The contribution of the ectoderm in this event has been known for a long time. However, amnioserosa tension and contractibility have recently been shown also to be instrumental to the closure. A critical pre-requisite for dorsal closure is integrity of these tissues that in part is mediated by cell-cell junctions and cell adhesion. In this regard, mutations impairing junction formation and/or adhesion lead to dorsal closure. However, no role for the gap junction proteins Innexins has so far been described. Results and Discussion: Here, we show that Innexin 1, 2 and 3, are present in the ectoderm but also in the amnioserosa in plaques consistent with gap junctions. However, only the loss of Inx3 leads to dorsal closure defects that are completely rescued by overexpression of inx3::GFP in the whole embryo. Loss of Inx3 leads to the destabilisation of Inx1, Inx2 and DE-cadherin at the plasma membrane, suggesting that these four proteins form a complex. Accordingly, in addition to the known interaction of Inx2 with DE-cadherin, we show that Inx3 can bind to DE-cadherin. Furthermore, Inx3-GFP overexpression recruits DE-cadherin from its wildtype plasma membrane domain to typical Innexin plaques, strengthening the notion that they form a complex. Finally, we show that Inx3 stability is directly dependent on tissue tension. Taken together, we propose that Inx3 is a critical factor for dorsal closure and that it mediates the stability of Inx1, 2 and DE-cadherin by forming a complex.	[Giuliani, Fabrizio; Giuliani, Giuliano; Rabouille, Catherine] Hubrecht Inst Dev Biol & Stem Cell Res, Utrecht, Netherlands; [Giuliani, Fabrizio; Giuliani, Giuliano; Rabouille, Catherine] UMC Utrecht, Utrecht, Netherlands; [Bauer, Reinhard] Univ Bonn, LIMES Inst, Program Unit Dev Genet & Mol Physiol, Lab Mol Dev Biol, Bonn, Germany; [Rabouille, Catherine] UMC Utrecht, Dept Cell Biol, Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); University of Bonn; Utrecht University; Utrecht University Medical Center	Rabouille, C (corresponding author), Hubrecht Inst Dev Biol & Stem Cell Res, Utrecht, Netherlands.	c.rabouille@hubrecht.eu			ZonMW TOP subsidie from NWO (Netherlands wetenschappelijke Organisatie: Dutch Organisation for scientific Research) [912.080.24]; DFG (Deutsche Forschungsgemainschaft: German Research Foundation) [SFB 645]	ZonMW TOP subsidie from NWO (Netherlands wetenschappelijke Organisatie: Dutch Organisation for scientific Research); DFG (Deutsche Forschungsgemainschaft: German Research Foundation)	Funding came from ZonMW TOP subsidie 912.080.24 from NWO (Netherlands wetenschappelijke Organisatie: Dutch Organisation for scientific Research) and SFB 645 from DFG (Deutsche Forschungsgemainschaft: German Research Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosi C, 2010, J BIOL CHEM, V285, P24420, DOI 10.1074/jbc.M110.115444; Ashburner M., 2004, DROSOPHILA LAB MANUA, V2nd; Baranova A, 2004, GENOMICS, V83, P706, DOI 10.1016/j.ygeno.2003.09.025; Bauer R, 2006, CELL COMMUN ADHES, V13, P103, DOI 10.1080/15419060600631839; Bauer R, 2004, MOL BIOL CELL, V15, P2992, DOI 10.1091/mbc.E04-01-0056; Bauer R, 2002, J CELL SCI, V115, P1859; Baumgartner S, 1996, CELL, V87, P1059, DOI 10.1016/S0092-8674(00)81800-0; Ben-Yaacov S, 2001, J CELL BIOL, V152, P1, DOI 10.1083/jcb.152.1.1; Bloor JW, 2002, DEVELOPMENT, V129, P3173; Braga VMM, 1999, MOL BIOL CELL, V10, P9, DOI 10.1091/mbc.10.1.9; Braga VMM, 1997, J CELL BIOL, V137, P1421, DOI 10.1083/jcb.137.6.1421; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROWN NH, 1994, DEVELOPMENT, V120, P1221; FEHON RG, 1994, DEVELOPMENT, V120, P545; Fernandez BG, 2007, MECH DEVELOP, V124, P884, DOI 10.1016/j.mod.2007.09.002; Fox DT, 2007, DEVELOPMENT, V134, P567, DOI 10.1242/dev.02748; Fox DT, 2005, DEVELOPMENT, V132, P4819, DOI 10.1242/dev.02056; FRANCOIS V, 1994, GENE DEV, V8, P2602, DOI 10.1101/gad.8.21.2602; Franke JD, 2005, CURR BIOL, V15, P2208, DOI 10.1016/j.cub.2005.11.064; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Gorfinkiel N, 2007, J CELL SCI, V120, P3289, DOI 10.1242/jcs.010850; Gorfinkiel N, 2009, DEVELOPMENT, V136, P1889, DOI 10.1242/dev.030866; Grevengoed EE, 2001, J CELL BIOL, V155, P1185, DOI 10.1083/jcb.200105102; Harris AL, 2001, Q REV BIOPHYS, V34, P325, DOI 10.1017/S0033583501003705; Hayashi S, 1997, P NATL ACAD SCI USA, V94, P242, DOI 10.1073/pnas.94.1.242; Hijazi A, 2009, DEVELOPMENT, V136, P2199, DOI 10.1242/dev.033845; Homsy JG, 2006, DEV DYNAM, V235, P427, DOI 10.1002/dvdy.20649; Jacinto A, 2002, DEV CELL, V3, P9, DOI 10.1016/S1534-5807(02)00208-3; Lechner H, 2007, DEV BIOL, V310, P23, DOI 10.1016/j.ydbio.2007.07.008; Lehmann C, 2006, MOL BIOL CELL, V17, P1676, DOI 10.1091/mbc.E05-11-1059; Magie CR, 1999, DEVELOPMENT, V126, P5353; Magie Craig R., 2002, Development (Cambridge), V129, P3771; McEwen DG, 2000, DEVELOPMENT, V127, P3607; Murray MJ, 2006, DEVELOPMENT, V133, P3063, DOI 10.1242/dev.02467; Narasimha M, 2004, CURR BIOL, V14, P381, DOI 10.1016/j.cub.2004.02.033; Narasimha M, 2008, J CELL SCI, V121, P747, DOI 10.1242/jcs.019422; Nicholson BJ, 2003, J CELL SCI, V116, P4479, DOI 10.1242/jcs.00821; ODA H, 1994, DEV BIOL, V165, P716, DOI 10.1006/dbio.1994.1287; Ostrowski K, 2008, CELL COMMUN ADHES, V15, P155, DOI 10.1080/15419060802013976; Panchin Y, 2000, CURR BIOL, V10, pR473, DOI 10.1016/S0960-9822(00)00576-5; Panchin YV, 2005, J EXP BIOL, V208, P1415, DOI 10.1242/jeb.01547; Peralta XG, 2007, BIOPHYS J, V92, P2583, DOI 10.1529/biophysj.106.094110; Phelan P, 1998, NATURE, V391, P181, DOI 10.1038/34426; Phelan P, 2001, BIOESSAYS, V23, P388, DOI 10.1002/bies.1057; Phelan P, 1996, J NEUROSCI, V16, P1101; POSTNER MA, 1992, J CELL BIOL, V119, P1205, DOI 10.1083/jcb.119.5.1205; Reed BH, 2004, CURR BIOL, V14, P372, DOI 10.1016/j.cub.2004.02.029; Scuderi A, 2005, DEV DYNAM, V232, P791, DOI 10.1002/dvdy.20306; Solon J, 2009, CELL, V137, P1331, DOI 10.1016/j.cell.2009.03.050; Stebbings LA, 2000, MOL BIOL CELL, V11, P2459, DOI 10.1091/mbc.11.7.2459; Stebbings LA, 2002, MECH DEVELOP, V113, P197, DOI 10.1016/S0925-4773(02)00025-4; Takahashi M, 2005, DEVELOPMENT, V132, P2547, DOI 10.1242/dev.01850; TEPASS U, 1994, DEV BIOL, V161, P563, DOI 10.1006/dbio.1994.1054; Tepass U, 1996, GENE DEV, V10, P672, DOI 10.1101/gad.10.6.672; Uemura T, 1996, GENE DEV, V10, P659, DOI 10.1101/gad.10.6.659; Unger VM, 1999, SCIENCE, V283, P1176, DOI 10.1126/science.283.5405.1176; Wada A, 2007, DEV BIOL, V301, P340, DOI 10.1016/j.ydbio.2006.09.020; WATANABE T, 1990, GENETICS, V126, P1033; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; WOODS DF, 1994, MOLECULAR AND CELLULAR BASIS FOR CELL TO CELL INTERACTION: ITS SIGNIFICANCE IN CANCER, P1, DOI 10.1017/CBO9780511623172.003; YOUNG PE, 1993, GENE DEV, V7, P29, DOI 10.1101/gad.7.1.29; Zallen JA, 2002, J CELL BIOL, V156, P689, DOI 10.1083/jcb.200109057	62	24	24	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69212	10.1371/journal.pone.0069212	http://dx.doi.org/10.1371/journal.pone.0069212			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894431	Green Published, gold, Green Submitted			2022-12-27	WOS:000322167900046
J	Monga, J; Pandit, S; Chauhan, RS; Chauhan, CS; Chauhan, SS; Sharma, M				Monga, Jitender; Pandit, Saurabh; Chauhan, Rajinder Singh; Chauhan, Chetan Singh; Chauhan, Shailender Singh; Sharma, Manu			Growth Inhibition and Apoptosis Induction by (+)-Cyanidan-3-ol in Hepatocellular Carcinoma	PLOS ONE			English	Article							EXTRACT; STRESS; TISSUE; ASSAY; MICE	The objective of this study was to evaluate the cytotoxicity of (+)-cyanidan-3-ol (CD-3) in human hepatocellular carcinoma cell line (HepG2) and chemopreventive potential against hepatocellular carcinoma (HCC) in Balb/c mice. The HepG2 cell line was treated with CD-3 at various concentrations and the proliferation of the HepG2 cells was measure by 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide (MTT), sulforhodamine B (SRB) and lactate dehydrogenase (LDH) assays. Cell apoptosis was detected by Hoechst 33258 (HO), Acridine orange/ethylene dibromide (AO/EB) staining, DNA fragmentation analysis and the apoptosis rate was detected by flow cytometry. The HCC tumor model was established in mice by injecting N-nitrosodiethylamine/carbon tetrachloride (NDEA/CCl4) and the effect of CD-3 on tumor growth in-vivo was studied. The levels of liver injury markers, tumor markers, and oxidative stress were measured. The expression levels of apoptosis-related genes in in-vitro and in vivo models were determined by RT-PCR and ELISA. The CD-3 induced cell death was considered to be apoptotic by observing the typical apoptotic morphological changes under fluorescent microscopy and DNA fragmentation analysis. Annexin V/PI assay demonstrated that apoptosis increased with increase in the concentration of CD-3. The expression levels of apoptosis-related genes that belong to bcl-2 and caspase family were increased and AP-1 and NF-kappa B activities were significantly suppressed by CD-3. Immunohistochemistry data revealed less localization of p53, p65 and c-jun in CD-3 treated tumors as compared to localization in NDEA/CCl4 treated tumors. Taken together, our data demonstrated that CD-3 could significantly inhibit the proliferation of HepG2 cells in-vitro and suppress HCC tumor growth in-vivo by apoptosis induction.	[Monga, Jitender; Sharma, Manu] Jaypee Univ Informat Technol, Dept Pharm, Waknaghat, Himachal Prades, India; [Pandit, Saurabh; Chauhan, Rajinder Singh] Jaypee Univ Informat Technol, Dept Biotechnol & Bioinformat, Waknaghat, Himachal Prades, India; [Chauhan, Chetan Singh] Bhupal Noble Coll Pharm, Dept Pharm, Udaipur, Rajasthan, India; [Chauhan, Shailender Singh] Post Grad Inst Med Res, Dept Gastroenterol, Chandigarh, India	Jaypee University of Information Technology; Jaypee University of Information Technology; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Sharma, M (corresponding author), Jaypee Univ Informat Technol, Dept Pharm, Waknaghat, Himachal Prades, India.	lantadene@hotmail.com	Monga, Jitender/F-5811-2011; Chauhan, Chetan Singh/GOK-0911-2022; Chauhan, Shailender Singh/AAM-5269-2020; Monga, Jitender/ACW-9747-2022; Chauhan, Rajinder Singh/HGB-5642-2022; Sharma, Manu/GOJ-9290-2022; Monga, Jitender/AAE-9979-2022	Chauhan, Shailender Singh/0000-0002-1975-2734; Sharma, Prof (Dr) Manu/0000-0003-3903-1683	Jaypee University of Information Technology	Jaypee University of Information Technology	Funded by Jaypee University of Information Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Alfa GK, 2006, J CLIN ONCOL, V24, P4293, DOI 10.1200/JCO.2005.01.3441; Aebi H, 1984, Methods Enzymol, V105, P121; Amin ARMR, 2009, J CLIN ONCOL, V27, P2712, DOI 10.1200/JCO.2008.20.6235; ANDERSON R, 1993, MOL PHARMACOL, V44, P605; Ariffin SHZ, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-6; Barnes S, 2005, CURR OPIN PLANT BIOL, V8, P324, DOI 10.1016/j.pbi.2005.03.010; Bitensky L, 1990, CELL BIOCHEM FUNCT, V8, P139, DOI [10.1002/cbf.290080216, DOI 10.1002/CBF.290080216]; CARLBERG I, 1985, METHOD ENZYMOL, V113, P484; CHEN LH, 1995, ALCOHOL, V12, P453, DOI 10.1016/0741-8329(95)00030-U; Dasgupta T, 2004, J ETHNOPHARMACOL, V92, P23, DOI 10.1016/j.jep.2003.12.004; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Duarte RA, 2010, TUMOR BIOL, V31, P513, DOI 10.1007/s13277-010-0064-2; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Esme H, 2008, RESPIROLOGY, V13, P112, DOI 10.1111/j.1440-1843.2007.01212.x; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ferreccio C, 1998, Cad Saude Publica, V14 Suppl 3, P193, DOI 10.1590/S0102-311X1998000700021; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Guruvayoorappan C, 2008, INNATE IMMUN-LONDON, V14, P160, DOI 10.1177/1753425908093295; HICKMAN JA, 1992, CANCER METAST REV, V11, P121, DOI 10.1007/BF00048059; JENKINS RR, 1993, MED SCI SPORT EXER, V25, P210; Jimenez PC, 2008, COMP BIOCHEM PHYS A, V151, P391, DOI 10.1016/j.cbpa.2007.02.018; KONO Y, 1978, ARCH BIOCHEM BIOPHYS, V186, P189, DOI 10.1016/0003-9861(78)90479-4; Lotito SB, 1998, FREE RADICAL BIO MED, V24, P435, DOI 10.1016/S0891-5849(97)00276-1; Monga J, 2012, INTEGR CANC THER; Monga J, 2011, J PHARM PHARMACOL, V63, P1470, DOI 10.1111/j.2042-7158.2011.01354.x; Rage N, 1984, INDIAN DRUGS, V22, P556; Rao GMM, 2006, J ETHNOPHARMACOL, V103, P484, DOI 10.1016/j.jep.2005.08.073; Saad B, 2006, EVID-BASED COMPL ALT, V3, P93, DOI 10.1093/ecam/nel002; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Vasquez-Garzon VR, 2009, FREE RADICAL RES, V43, P128, DOI 10.1080/10715760802626535; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; WARHOLM M, 1985, METHOD ENZYMOL, V113, P499	34	35	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e68710	10.1371/journal.pone.0068710	http://dx.doi.org/10.1371/journal.pone.0068710			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894334	gold, Green Published, Green Submitted			2022-12-27	WOS:000322167900020
J	Seemann, I; te Poele, JAM; Luikinga, SJ; Hoving, S; Stewart, FA				Seemann, Ingar; te Poele, Johannes A. M.; Luikinga, Sophia J.; Hoving, Saske; Stewart, Fiona A.			Endoglin Haplo-Insufficiency Modifies the Inflammatory Response in Irradiated Mouse Hearts without Affecting Structural and Mircovascular Changes	PLOS ONE			English	Article							HEREDITARY HEMORRHAGIC TELANGIECTASIA; ENDOTHELIAL-CELL PROLIFERATION; INDUCED MYOCARDIAL FIBROSIS; GROWTH-FACTOR-BETA; RAT-HEART; INJURY; ANGIOGENESIS; ACTIVATION; TGF-BETA-1; RECEPTOR	Background: It is now widely recognized that radiotherapy of thoracic and chest wall tumors increases the long-term risk of cardiovascular damage although the underlying mechanisms are not fully elucidated. There is increasing evidence that microvascular damage is involved. Endoglin, an accessory receptor for TGF-beta 1, is highly expressed in damaged endothelial cells and may play a crucial role in cell proliferation and revascularization of damaged heart tissue. We have therefore specifically examined the role of endoglin in microvascular damage and repair in the irradiated heart. Materials & Methods: A single dose of 16 Gy was delivered to the heart of adult Eng(+/+) or Eng(+/-) mice and damage was evaluated at 4, 20 and 40 weeks, relative to age-matched controls. Gated single photon emission computed tomography (gSPECT) was used to measure cardiac geometry and function, and related to histo-morphology, microvascular damage (detected using immuno-and enzyme-histochemistry) and gene expression (detected by microarray and real time PCR). Results: Genes categorized according to known inflammatory and immunological related disease were less prominently regulated in irradiated Eng(+/-) mice compared to Eng(+/+) littermates. Fibrosis related genes, TGF-beta 1, ALK 5 and PDGF, were only upregulated in Eng(+/+) mice during the early phase of radiation-induced cardiac damage (4 weeks). In addition, only the Eng(+/+) mice showed significant upregulation of collagen deposition in the early fibrotic phase (20 weeks) after irradiation. Despite these differences in gene expression, there was no reduction in inflammatory invasion (CD45+cells) of irradiated Eng(+/-) hearts. Microvascular damage (microvascular density, alkaline phosphatase and von-Willebrand-Factor expression) was also similar in both strains. Conclusion: Eng(+/-) mice displayed impaired early inflammatory and fibrotic responses to high dose irradiation compared to Eng(+/+) littermates. This did not result in significant differences in microvascular damage or cardiac function between the strains.	[Seemann, Ingar; te Poele, Johannes A. M.; Luikinga, Sophia J.; Hoving, Saske; Stewart, Fiona A.] Netherlands Canc Inst, Div Biol Stress Response, Amsterdam, Netherlands	Netherlands Cancer Institute	Stewart, FA (corresponding author), Netherlands Canc Inst, Div Biol Stress Response, Amsterdam, Netherlands.	f.stewart@nki.nl			European Atomic Energy Community's Seventh Framework Program [211403]; Dutch Cancer Foundation [NKI 2008-3993]	European Atomic Energy Community's Seventh Framework Program; Dutch Cancer Foundation(KWF Kankerbestrijding)	This research was funded by the European Atomic Energy Community's Seventh Framework Program, grant 211403 (Cardiorisk), and the Dutch Cancer Foundation, grant NKI 2008-3993. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrianifahanana M, 2010, CANCER RES, V70, P7421, DOI 10.1158/0008-5472.CAN-10-0232; Anscher MS, 2010, ONCOLOGIST, V15, P350, DOI 10.1634/theoncologist.2009-S101; Arthur HM, 2000, DEV BIOL, V217, P42, DOI 10.1006/dbio.1999.9534; BARCELLOSHOFF MH, 1994, J CLIN INVEST, V93, P892, DOI 10.1172/JCI117045; Boerma M, 2004, STRAHLENTHER ONKOL, V180, P109, DOI 10.1007/s00066-004-1138-0; Bourdeau A, 1999, J CLIN INVEST, V104, P1343, DOI 10.1172/JCI8088; FAJARDO LF, 1971, RADIOLOGY, V101, P429, DOI 10.1148/101.2.429; FAJARDO LF, 1973, LAB INVEST, V29, P244; GOUGOS A, 1988, J IMMUNOL, V141, P1925; Juncos LI, 1997, HYPERTENSION, V30, P672, DOI 10.1161/01.HYP.30.3.672; Kapur NK, 2012, CIRCULATION, V125, P2728, DOI 10.1161/CIRCULATIONAHA.111.080002; LAUK S, 1985, INT J RADIAT ONCOL, V11, P801, DOI 10.1016/0360-3016(85)90314-1; LAUK S, 1990, INT J RADIAT BIOL, V57, P1017, DOI 10.1080/09553009014551131; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Li CG, 2000, FASEB J, V14, P55, DOI 10.1096/fasebj.14.1.55; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; Lopez-Novoa JM, 2010, AM J PHYSIOL-HEART C, V299, pH959, DOI 10.1152/ajpheart.01251.2009; Martin M, 2000, INT J RADIAT ONCOL, V47, P277, DOI 10.1016/S0360-3016(00)00435-1; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Ran XZ, 2010, J RADIAT RES, V51, P527, DOI 10.1269/jrr.09119; Rossi E, 2013, BLOOD, V121, P403, DOI 10.1182/blood-2012-06-435347; Scharpfenecker M, 2012, RADIOTHER ONCOL, V105, P313, DOI 10.1016/j.radonc.2012.08.021; Scharpfenecker M, 2009, RADIOTHER ONCOL, V92, P484, DOI 10.1016/j.radonc.2009.06.013; Scharpfenecker M, 2009, INT J RADIAT ONCOL, V73, P506, DOI 10.1016/j.ijrobp.2008.09.052; Seemann I, 2012, RADIOTHER ONCOL, V103, P143, DOI 10.1016/j.radonc.2011.10.011	26	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e68922	10.1371/journal.pone.0068922	http://dx.doi.org/10.1371/journal.pone.0068922			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894375	gold, Green Published, Green Submitted			2022-12-27	WOS:000322167900030
J	Swift, SA; Moore, DA; Sharek, ZS; Gino, F				Swift, Samuel A.; Moore, Don A.; Sharek, Zachariah S.; Gino, Francesca			Inflated Applicants: Attribution Errors in Performance Evaluation by Professionals	PLOS ONE			English	Article							DIFFERENTIAL GRADING STANDARDS; CORRESPONDENCE BIAS; VALIDITY; OVERCONFIDENCE; REPUTATION; AVERAGE; UTILITY; SEARCH	When explaining others' behaviors, achievements, and failures, it is common for people to attribute too much influence to disposition and too little influence to structural and situational factors. We examine whether this tendency leads even experienced professionals to make systematic mistakes in their selection decisions, favoring alumni from academic institutions with high grade distributions and employees from forgiving business environments. We find that candidates benefiting from favorable situations are more likely to be admitted and promoted than their equivalently skilled peers. The results suggest that decision-makers take high nominal performance as evidence of high ability and do not discount it by the ease with which it was achieved. These results clarify our understanding of the correspondence bias using evidence from both archival studies and experiments with experienced professionals. We discuss implications for both admissions and personnel selection practices.	[Sharek, Zachariah S.] CivicSci, Pittsburgh, PA USA; [Gino, Francesca] Harvard Univ, Sch Business, Cambridge, MA 02138 USA	Harvard University	Swift, SA (corresponding author), Univ Calif Berkeley, Haas Sch Business, Berkeley, CA 94720 USA.	samswift@alumni.cmu.edu	Moore, Don/V-2793-2019		National Science Foundation [SES-045173]; Graduate Management Admissions Council, Management Education Research Institute; Carnegie Mellon University	National Science Foundation(National Science Foundation (NSF)); Graduate Management Admissions Council, Management Education Research Institute; Carnegie Mellon University	The authors appreciate the support of the following three organizations: National Science Foundation, Grant SES-045173, http://www.nsf.gov/funding/; Graduate Management Admissions Council, Management Education Research Institute, doctoral student fellowship (Samuel A Swift, 2010), http://www.gmac.com/market-intelligence-and-research/merinstitute.aspx; Carnegie Mellon University, Small Undergraduate Research Grant (Samuel A Swift, 2004), http://www.cmu.edu/uro/SURG/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHFORTH BE, 1989, ACAD MANAGE REV, V14, P20, DOI 10.2307/258189; Attewell P, 2001, SOCIOL EDUC, V74, P267, DOI 10.2307/2673136; Bagues M, 2008, CESIFO ECON STUD, V54, P149, DOI 10.1093/cesifo/ifn011; Bertrand M, 2001, Q J ECON, V116, P901, DOI 10.1162/00335530152466269; Burt R.S., 1992, STRUCTURAL HOLES THE; Cable DM, 1997, J APPL PSYCHOL, V82, P546, DOI 10.1037/0021-9010.82.4.546; Camerer C, 1999, AM ECON REV, V89, P306, DOI 10.1257/aer.89.1.306; DAGOSTINO PR, 1992, SOC COGNITION, V10, P151, DOI 10.1521/soco.1992.10.2.151; DAVISBLAKE A, 1989, ACAD MANAGE REV, V14, P385, DOI 10.2307/258174; DUNN WS, 1995, J APPL PSYCHOL, V80, P500, DOI 10.1037/0021-9010.80.4.500; Edwards JR, 2001, ORGAN RES METHODS, V4, P265, DOI 10.1177/109442810143005; ELSBACH KD, 1992, ACAD MANAGE J, V35, P699, DOI 10.2307/256313; Fairburn JA, 2001, REV ECON STUD, V68, P45, DOI 10.1111/1467-937X.00159; Fleischer A, 2009, ADMIN SCI QUART, V54, P555, DOI 10.2189/asqu.2009.54.4.555; Fleishman EA, 1953, J APPL PSYCHOL, V37, P153, DOI 10.1037/h0063436; FOMBRUN C, 1990, ACAD MANAGE J, V33, P233, DOI 10.2307/256324; Forgas JP, 1998, J PERS SOC PSYCHOL, V75, P318, DOI 10.1037//0022-3514.75.2.318; Gartner W.B., 1988, ENTREP THEORY PRACT, V13, P11, DOI DOI 10.1177/104225878801200401; Ghiselli EE, 1971, EXPLORATIONS IN MANA; Gilbert D. T., 1994, ADV SOCIAL PSYCHOL, P99; GILBERT DT, 1995, PSYCHOL BULL, V117, P21, DOI 10.1037/0033-2909.117.1.21; GILBERT DT, 1988, J PERS SOC PSYCHOL, V54, P733, DOI 10.1037/0022-3514.54.5.733; GILMORE DC, 1989, J MANAGE, V15, P557, DOI 10.1177/014920638901500405; Gino F, 2011, HARVARD BUS REV, V89, P68; Gladwell M, 2008, OUTLIERS THE STORY O; GOLDMAN RD, 1976, EDUC PSYCHOL MEAS, V36, P381, DOI 10.1177/001316447603600217; Gotsi Manto., 2001, CORP COMMUN, V6, P24, DOI [10.1108/13563280110381189, DOI 10.1108/13563280110381189]; Gourman J, 1989, THE GOURMAN REPORT A; Granovetter M., 1995, GETTING A JOB A STUD; Heath C, 1998, RES ORGAN BEHAV, V20, P1; Hogarth R, 2010, WORKING PAPERS; HORNADAY JA, 1971, PERS PSYCHOL, V24, P141; HUNTER JE, 1984, PSYCHOL BULL, V96, P72, DOI 10.1037/0033-2909.96.1.72; Jennings KE, 2010, COGNITION IN FLUX, P978; Jones E.E., 1990, INTERPERSONAL PERCEP; JONES EE, 1967, J EXP SOC PSYCHOL, V3, P1, DOI 10.1016/0022-1031(67)90034-0; Kim PH, 2011, LEAPS OF FAITH THE N; Klar Y, 1997, J PERS SOC PSYCHOL, V73, P885, DOI 10.1037/0022-3514.73.5.885; Koeppel D, 2006, N Y TIMES WEB; Lazear EP, 2004, J POLIT ECON, V112, pS141, DOI 10.1086/379943; Lewin K, 1931, J GEN PSYCHOL, V5, P141, DOI 10.1080/00221309.1931.9918387; Lewis MM, 2004, MONEYBALL THE ART OF; Marklein MB, 2003, USA TODAY; MARTIN SL, 1990, ORGAN BEHAV HUM DEC, V46, P135, DOI 10.1016/0749-5978(90)90026-6; McGrath A, 2004, U S NEWS ULTIMATE CO; MITCHELL TR, 1981, J APPL PSYCHOL, V66, P604, DOI 10.1037/0021-9010.66.5.604; MITCHELL TR, 1980, ORGAN BEHAV HUM PERF, V25, P123, DOI 10.1016/0030-5073(80)90029-X; Miyamoto Y, 2002, J PERS SOC PSYCHOL, V83, P1239, DOI 10.1037//0022-3514.83.5.1239; Moore DA, 2003, J PERS SOC PSYCHOL, V85, P1121, DOI 10.1037/0022-3514.85.6.1121; Moore DA, 2007, ORGAN BEHAV HUM DEC, V103, P197, DOI 10.1016/j.obhdp.2006.09.002; Moore DA, 2007, ORGAN BEHAV HUM DEC, V102, P42, DOI 10.1016/j.obhdp.2006.09.005; Moore DA, 2010, PERS SOC PSYCHOL B, V36, P843, DOI 10.1177/0146167210371316; MORRIS MW, 1994, J PERS SOC PSYCHOL, V67, P949, DOI 10.1037/0022-3514.67.6.949; PETER JP, 1993, J CONSUM RES, V19, P655, DOI 10.1086/209329; PFEFFER J, 1986, ACAD MANAGE J, V29, P72, DOI 10.2307/255860; Rampell C, 2010, N Y TIMES WEB; Rojstaczer S, 2010, GRADING IN AMERICAN; Rosenzweig P, 2007, THE HALO EFFECT AND; Ross L., 1977, ADV EXP SOC PSYCHOL, V10, P173, DOI https://doi.org/10.1016/S0065-2601(08)60357-3; ROSS LD, 1977, J PERS SOC PSYCHOL, V35, P485, DOI 10.1037/0022-3514.35.7.485; Schlenker B.R., 1985, SELF SOCIAL LIFE PP, P65; Schmidt FL, 1998, PSYCHOL BULL, V124, P262, DOI 10.1037/0033-2909.124.2.262; Scott L.R., 1991, ENTREP THEORY PRACT, V16, P23; Scott SG, 2000, ACAD MANAGE REV, V25, P43, DOI 10.2307/259262; Scott WR, 1998, ORGANIZATIONS RATION; SHANTEAU J, 1988, ACTA PSYCHOL, V68, P203, DOI 10.1016/0001-6918(88)90056-X; Siggelkow N, 2009, ADMIN SCI QUART, V54, P602, DOI 10.2189/asqu.2009.54.4.602; Staw BM, 2000, ADMIN SCI QUART, V45, P523, DOI 10.2307/2667108; Stogdill RM, 1974, HANDBOOK OF LEADERSH; STRENTA AC, 1987, J EDUC MEAS, V24, P281, DOI 10.1111/j.1745-3984.1987.tb00280.x; TETLOCK PE, 1985, SOC PSYCHOL QUART, V48, P227, DOI 10.2307/3033683; Timmons J.A., 1978, AM J SMALL BUSINESS, V3, P5; Windschitl PD, 2003, J PERS SOC PSYCHOL, V85, P389, DOI 10.1037/0022-3514.85.3.389; Wolfers J, 2002, ARE VOTERS RATIONAL, DOI [10.2139/ssrn.305740, DOI 10.2139/SSRN.305740]; Woo E, 1997, LOS ANGELES TIMES	75	15	16	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69258	10.1371/journal.pone.0069258	http://dx.doi.org/10.1371/journal.pone.0069258			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	188BY	23894437	Green Published, gold			2022-12-27	WOS:000322167900052
J	Venkatramani, R; Malogolowkin, M; Davidson, TB; May, W; Sposto, R; Mascarenhas, L				Venkatramani, Rajkumar; Malogolowkin, Marcio; Davidson, Tom B.; May, William; Sposto, Richard; Mascarenhas, Leo			A Phase I Study of Vincristine, Irinotecan, Temozolomide and Bevacizumab (Vitb) in Pediatric Patients with Relapsed Solid Tumors	PLOS ONE			English	Article							CHILDRENS ONCOLOGY GROUP; ANTI-VEGF ANTIBODY; PLUS IRINOTECAN; PROTRACTED IRINOTECAN; MONOCLONAL-ANTIBODY; WILMS-TUMOR; 2 SCHEDULES; TRIAL; GROWTH; CANCER	Background: To determine the maximum tolerated dose (MTD) and dose limiting toxicity (DLT) of irinotecan administered in combination with vincristine, temozolomide and bevacizumab in children with refractory solid tumors. Methods: The study design included two dose levels (DL) of irinotecan given intravenously once daily for 5 consecutive days (DL1: 30 mg/m(2), and DL2: 50 mg/m(2)), combined with vincristine 1.5 mg/m(2) on days 1 and 8, temozolomide 100 mg/m(2) on days 1-5, and bevacizumab 15mg/kg on day 1, administered every 21 days for a maximum of 12 cycles. Results: Thirteen patients were enrolled and 12 were evaluable for toxicity Dose limiting toxicity observed included grade 3 hyperbilirubinemia in 1 of 6 patients on DL1, and grade 3 colitis in 1 of 6 patients on DL2. DL 2 was the determined MTD. A total of 87 cycles were administered. Myelosuppression was mild. Grade 1-2 diarrhea occurred in the majority of cycles with grade 3 diarrhea occurring in only one cycle. Grade 2 hypertension developed in two patients. Severe hemorrhage, intestinal perforation, posterior leukoencephalopathy or growth plate abnormalities were not observed. Objective responses were noted in three Wilms tumor patients and one each of medulloblastoma and hepatocellular carcinoma. Five patients completed all 12 cycles of protocol therapy. Conclusions: Irinotecan 50 mg/m(2)/day for 5 days was the MTD when combined with vincristine, temozolomide and bevacizumab administered on a 21 day schedule. Encouraging anti-tumor activity was noted.	[Venkatramani, Rajkumar; May, William; Sposto, Richard; Mascarenhas, Leo] Childrens Hosp Los Angeles, Div Hematol & Oncol, Los Angeles, CA 90027 USA; [Venkatramani, Rajkumar; May, William; Sposto, Richard; Mascarenhas, Leo] Univ So Calif, Dept Pediat, Keck Sch Med, Los Angeles, CA 90089 USA; [Malogolowkin, Marcio] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Davidson, Tom B.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Sposto, Richard] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA	Children's Hospital Los Angeles; University of Southern California; Medical College of Wisconsin; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Southern California	Venkatramani, R (corresponding author), Childrens Hosp Los Angeles, Div Hematol & Oncol, Los Angeles, CA 90027 USA.	rvenkatramani@chla.usc.edu	Mascarenhas, Leo/M-1801-2019	Mascarenhas, Leo/0000-0001-7790-0777	University of Southern California Norris Comprehensive Cancer Center from the National Cancer Institute [P30CA014089]; Max of a Million Dreams Foundation for Cancer Research; NATIONAL CANCER INSTITUTE [P30CA014089, R21CA137485] Funding Source: NIH RePORTER	University of Southern California Norris Comprehensive Cancer Center from the National Cancer Institute; Max of a Million Dreams Foundation for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by: 1. Grant number P30CA014089, University of Southern California Norris Comprehensive Cancer Center from the National Cancer Institute. 2. Max of a Million Dreams Foundation for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera D, 2013, CHILDS NERV SYST; Bender JLG, 2008, J CLIN ONCOL, V26, P399, DOI 10.1200/JCO.2007.11.9230; Blaney S, 2001, CLIN CANCER RES, V7, P32; Bomgaars LR, 2007, J CLIN ONCOL, V25, P4622, DOI 10.1200/JCO.2007.11.6103; Frischer JS, 2004, INT J ONCOL, V25, P549; Furman WL, 1999, J CLIN ONCOL, V17, P1815, DOI 10.1200/JCO.1999.17.6.1815; Gururangan S, 2010, J CLIN ONCOL, V28, P3069, DOI 10.1200/JCO.2009.26.8789; Houghton PJ, 2000, CLIN CANCER RES, V6, P4110; HOUGHTON PJ, 1995, CANCER CHEMOTH PHARM, V36, P393; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Kushner BH, 2006, J CLIN ONCOL, V24, P5271, DOI 10.1200/JCO.2006.06.7272; Mascarenhas L, 2010, J CLIN ONCOL, V28, P4658, DOI 10.1200/JCO.2010.29.7390; McCrudden KW, 2003, J PEDIATR SURG, V38, P308, DOI 10.1053/jpsu.2003.50099; Narayana A, 2010, NEURO-ONCOLOGY, V12, P985, DOI 10.1093/neuonc/noq033; Packer RJ, 2009, PEDIATR BLOOD CANCER, V52, P791, DOI 10.1002/pbc.21935; Presta LG, 1997, CANCER RES, V57, P4593; Reck M, 2009, J CLIN ONCOL, V27, P1227, DOI 10.1200/JCO.2007.14.5466; Rowe DH, 2000, J PEDIATR SURG, V35, P977, DOI 10.1053/jpsu.2000.6946; Rowe DH, 2000, J PEDIATR SURG, V35, P30, DOI 10.1016/S0022-3468(00)80008-1; Ryan AM, 1999, TOXICOL PATHOL, V27, P78, DOI 10.1177/019262339902700115; Vassal G, 2003, J CLIN ONCOL, V21, P3844, DOI 10.1200/JCO.2003.08.175; Vredenburgh JJ, 2007, J CLIN ONCOL, V25, P4722, DOI 10.1200/JCO.2007.12.2440; Wagner LM, 2007, PEDIATR BLOOD CANCER, V48, P132, DOI 10.1002/pbc.20697; Wagner LM, 2010, PEDIATR BLOOD CANCER, V54, P538, DOI 10.1002/pbc.22407; Wagner LM, 2004, CLIN CANCER RES, V10, P840, DOI 10.1158/1078-0432.CCR-03-0175; Yang JC, 2003, NEW ENGL J MED, V349, P427, DOI 10.1056/NEJMoa021491	26	34	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e68416	10.1371/journal.pone.0068416	http://dx.doi.org/10.1371/journal.pone.0068416			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894304	Green Published, Green Submitted, gold			2022-12-27	WOS:000322132100017
J	Giuliano, M; Andreotti, M; Liotta, G; Jere, H; Sagno, JB; Maulidi, M; Mancinelli, S; Buonomo, E; Scarcella, P; Pirillo, MF; Amici, R; Ceffa, S; Vella, S; Palombi, L; Marazzi, MC				Giuliano, Marina; Andreotti, Mauro; Liotta, Giuseppe; Jere, Haswell; Sagno, Jean-Baptiste; Maulidi, Martin; Mancinelli, Sandro; Buonomo, Ersilia; Scarcella, Paola; Pirillo, Maria F.; Amici, Roberta; Ceffa, Susanna; Vella, Stefano; Palombi, Leonardo; Marazzi, Maria Cristina			Maternal Antiretroviral Therapy for the Prevention of Mother-To-Child Transmission of HIV in Malawi: Maternal and Infant Outcomes Two Years after Delivery	PLOS ONE			English	Article							UNINFECTED CHILDREN; INFECTED MOTHERS; MORBIDITY; MORTALITY; MALNUTRITION; PROPHYLAXIS; PREGNANCY; EFFICACY; DRUGS; WOMEN	Background: Optimized preventive strategies are needed to reach the objective of eliminating pediatric AIDS. This study aimed to define the determinants of residual HIV transmission in the context of maternal antiretroviral therapy (ART) administration to pregnant women, to assess infant safety of this strategy, and to evaluate its impact on maternal disease. Methodology/Principal Findings: A total of 311 HIV-infected pregnant women were enrolled in Malawi in an observational study and received a nevirapine-based regimen from week 25 of gestation until 6 months after delivery (end of breastfeeding period) if their CD4+ count was > 350/mm(3) at baseline (n = 147), or indefinitely if they met the criteria for treatment (n. 164). Mother/child pairs were followed until 2 years after delivery. The Kaplan-Meier method was used to estimate HIV transmission, maternal disease progression, and survival at 24 months. The rate of HIV infant infection was 3.2% [95% confidence intervals (CI) 1.0-5.4]. Six of the 8 transmissions occurred among mothers with baseline CD4+ count > 350/mm(3). HIV-free survival of children was 85.8% (95% CI 81.4-90.1). Children born to mothers with baseline CD4+ count < 350/mm(3) were at increased risk of death (hazard ratio 2.6, 95% CI 1.1-6.1). Among women who had stopped treatment the risk of progression to CD4+ count < 350/mm(3) was 20.6% (95% CI 9.2-31.9) by 18 months of drug discontinuation. Conclusions: HIV transmission in this cohort was rare however, it occurred in a significative proportion among women with high CD4+ counts. Strategies to improve treatment adherence should be implemented to further reduce HIV transmission. Mortality in the uninfected exposed children was the major determinant of HIV-free survival and was associated to maternal disease stage. Given the considerable proportion of women reaching the criteria for treatment within 18 months of drug discontinuation, life-long ART administration to HIV-infected women should be considered.	[Giuliano, Marina; Andreotti, Mauro; Pirillo, Maria F.; Amici, Roberta; Ceffa, Susanna; Vella, Stefano] Ist Super Sanita, Dept Therapeut Res & Med Evaluat, I-00161 Rome, Italy; [Liotta, Giuseppe; Mancinelli, Sandro; Buonomo, Ersilia; Scarcella, Paola; Palombi, Leonardo] Univ Roma Tor Vergata, Dept Biomed & Prevent, Rome, Italy; [Liotta, Giuseppe; Mancinelli, Sandro; Buonomo, Ersilia; Scarcella, Paola; Ceffa, Susanna; Palombi, Leonardo; Marazzi, Maria Cristina] Community S Egidio, DREAM Program, Rome, Italy; [Jere, Haswell; Sagno, Jean-Baptiste] Community S Egidio, DREAM Program, Blantyre, Malawi; [Maulidi, Martin] Community S Egidio, DREAM Program, Lilongwe, Malawi; [Marazzi, Maria Cristina] LUMSA Univ, Rome, Italy; [Marazzi, Maria Cristina] Univ Rome, Rome, Italy	Istituto Superiore di Sanita (ISS); University of Rome Tor Vergata; Universita LUMSA; Sapienza University Rome	Giuliano, M (corresponding author), Ist Super Sanita, Dept Therapeut Res & Med Evaluat, Viale Regina Elena 299, I-00161 Rome, Italy.	marina.giuliano@iss.it	Pirillo, Maria Franca/ABA-4074-2021; Giuliano, Marina/V-8991-2017; Palombi, Leonardo/I-4043-2019; Vella, Stefano/GZM-0519-2022; andreotti, mauro/ABA-8513-2021; VELLA, STEFANO/V-8440-2019; andreotti, mauro/K-1436-2016; VELLA, STEFANO/ABI-3368-2020	Pirillo, Maria Franca/0000-0002-6186-692X; Giuliano, Marina/0000-0003-2789-7797; Palombi, Leonardo/0000-0003-1806-5278; andreotti, mauro/0000-0001-5168-8624; VELLA, STEFANO/0000-0003-2347-5984; andreotti, mauro/0000-0001-5168-8624; liotta, giuseppe/0000-0002-1990-1816; SCARCELLA, Paola/0000-0002-3319-7925; BUONOMO, ERSILIA/0000-0002-3924-9917; MARAZZI, Maria Cristina/0000-0003-2031-5213	Istituto Superiore di Sanita, Rome, Italy [528c/28c7]; Italian Research Program on AIDS of the Ministry of Health [3H/33]; Esther-Italy, Ministry of Health [9M34]	Istituto Superiore di Sanita, Rome, Italy; Italian Research Program on AIDS of the Ministry of Health; Esther-Italy, Ministry of Health	This work was supported by funds from the Istituto Superiore di Sanita, Rome, Italy (Grant N. 528c/28c7); by a grant from the Italian Research Program on AIDS of the Ministry of Health, 2009-2010 (N. 3H/33); and by Esther-Italy, Ministry of Health, 2009-2010 (Grant N. 9M34). The funders had no role in study design, decision to publish, or preparation of the manuscript.	Aiga H, 2009, T ROY SOC TROP MED H, V103, P827, DOI 10.1016/j.trstmh.2009.03.028; Alamo ST, 2012, JAIDS-J ACQ IMM DEF, V60, pE36, DOI 10.1097/FTD.0b013e3182526e6a; Becquet R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028510; Chasela CS, 2010, NEW ENGL J MED, V362, P2271, DOI 10.1056/NEJMoa0911486; Chilongozi D, 2008, PEDIATR INFECT DIS J, V27, P808, DOI 10.1097/INF.0b013e31817109a4; *DIV AIDS, 2004, DIV AIDS TABL GRAD S; Dryden-Peterson S, 2011, JAIDS-J ACQ IMM DEF, V58, P353, DOI 10.1097/QAI.0b013e31822d4063; Fao P, 2012, CLIN INFECT DIS, V55, P449, DOI 10.1093/cid/cis461; Fawzy A, 2011, J INFECT DIS, V203, P1222, DOI 10.1093/infdis/jir019; Fogel JM, 2012, JAIDS-J ACQ IMM DEF, V60, P462, DOI 10.1097/QAI.0b013e31825ddcfa; Gartland MG, 2013, AIDS, V27, P1253, DOI 10.1097/QAD.0b013e32835e3937; Jones CE, 2011, JAMA-J AM MED ASSOC, V305, P576, DOI 10.1001/jama.2011.100; Kilewo C, 2009, JAIDS-J ACQ IMM DEF, V52, P406, DOI 10.1097/QAI.0b013e3181b323ff; Kuhn L, 2005, CLIN INFECT DIS, V41, P1654, DOI 10.1086/498029; Maleta K, 2003, PAEDIATR PERINAT EP, V17, P384, DOI 10.1046/j.1365-3016.2003.00519.x; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; MORAESPINTO MI, 1996, J INFECT DIS, V173, P1077, DOI DOI 10.1093/INFDIS/173.5.1077.PUBMED:8627057; Nachega JB, 2012, AIDS, V26, P2039, DOI 10.1097/QAD.0b013e328359590f; Palombi L, 2007, AIDS, V21, pS65, DOI 10.1097/01.aids.0000279708.09180.f5; Palombi L, 2012, ANTIVIR THER, V17, P1511, DOI 10.3851/IMP2315; Pilotto JH, 2011, ANTIVIR THER, V16, P349, DOI 10.3851/IMP1779; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Taha TE, 2011, CLIN INFECT DIS, V53, P388, DOI 10.1093/cid/cir413; Taha TE, 2011, JAIDS-J ACQ IMM DEF, V57, P319, DOI 10.1097/QAI.0b013e318217877a; Thomas JE, 2004, CLIN INFECT DIS, V39, P1155, DOI 10.1086/424514; Thomas TK, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001015; UNAIDS, 2011, GLOB PLAN EL NEW INF; *WHO, WHO ANT DRUGS TREAT; *WHO, 2012, US ANT DRUGS TREAT P, V2; WHO, 2006, HIV INF FEED UPD BAS	30	44	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e68950	10.1371/journal.pone.0068950	http://dx.doi.org/10.1371/journal.pone.0068950			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894379	Green Published, Green Submitted, gold			2022-12-27	WOS:000322391400031
J	Gupta, N; LeGoff, J; Chamat, S; Mercier-Delarue, S; Touzelet, O; Power, UF; Kazatchkine, MD; Simon, F; Lacroix-Desmazes, S; Bayry, J; Kaveri, SV				Gupta, Nimesh; LeGoff, Jerome; Chamat, Soulaima; Mercier-Delarue, Severine; Touzelet, Olivier; Power, Ultan F.; Kazatchkine, Michel D.; Simon, Francois; Lacroix-Desmazes, Sebastien; Bayry, Jagadeesh; Kaveri, Srinivas V.			Affinity-Purified Respiratory Syncytial Virus Antibodies from Intravenous Immunoglobulin Exert Potent Antibody-Dependent Cellular Cytotoxicity	PLOS ONE			English	Article							INFECTIOUS-DISEASES; G-PROTEIN; IMMUNE GLOBULIN; GLYCOPROTEIN; ENHANCEMENT; THERAPY; INFANTS; MICE; RSV	Mixed infections are one of the major therapeutic challenges, as the current strategies have had limited success. One of the most common and widespread conditions of mixed infection is respiratory syncytial virus-mediated pathology of the respiratory tract in children. There is a dire need for the development of novel therapeutic approaches during mixed infections. Therapeutic intravenous immunoglobulin preparations, obtained from plasma pools of healthy donors have been used in immune deficiencies. This study was thus designed to characterize the functional efficacy of RSV-specific antibodies in IVIg. To explore the functional ability of these affinity-purified RSV-specific antibodies, the antibody-dependent and complement dependent cytotoxicity was determined using peripheral cells of healthy donors. This study demonstrates the existence of highly potent RSV-specific antibodies in IVIg preparations and provides the basis for the use of IVIg as broad-spectrum protective shield to RSV-infected children during mixed infections.	[Gupta, Nimesh; Lacroix-Desmazes, Sebastien; Bayry, Jagadeesh; Kaveri, Srinivas V.] Inst Natl Sante & Rech Med, Unite 872, Paris, France; [Gupta, Nimesh; Lacroix-Desmazes, Sebastien; Bayry, Jagadeesh; Kaveri, Srinivas V.] Ctr Rech Cordeliers, Equipe Immunopathol & Therapeut Immunointervent 1, Paris, France; [Gupta, Nimesh; Lacroix-Desmazes, Sebastien; Bayry, Jagadeesh; Kaveri, Srinivas V.] Univ Paris 05, Univ Paris 06, UMR S 872, Paris, France; [LeGoff, Jerome; Simon, Francois] Univ Paris Diderot, Pres Sorbone Paris Cite, Paris, France; [LeGoff, Jerome; Mercier-Delarue, Severine; Simon, Francois] Hop St Louis, AP HP, Microbiol Lab, St Louis, France; [Chamat, Soulaima] Lebanese Univ, Fac Publ Hlth, Immunol Lab, Fanar, Lebanon; [Touzelet, Olivier; Power, Ultan F.] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Infect & Immun, Belfast, Antrim, North Ireland; [Kazatchkine, Michel D.] United Nation Secretary Gen Special Envoy HIV AID, Geneva, Switzerland; [Lacroix-Desmazes, Sebastien; Bayry, Jagadeesh; Kaveri, Srinivas V.] Inst Natl Sante & Rech Med France, Int Associated Lab, Bombay, Maharashtra, India; [Lacroix-Desmazes, Sebastien; Bayry, Jagadeesh; Kaveri, Srinivas V.] Indian Council Med Res, Bombay, Maharashtra, India	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Lebanese University; Queens University Belfast; Institut National de la Sante et de la Recherche Medicale (Inserm); Indian Council of Medical Research (ICMR)	Kaveri, SV (corresponding author), Inst Natl Sante & Rech Med, Unite 872, Paris, France.	srini.kaveri@crc.jussieu.fr	Bayry, Jagadeesh/A-6589-2011; le goff, jerome/B-3447-2016; Gupta, Nimesh/C-3590-2017; LeGoff, jerome/AAP-7880-2021	Bayry, Jagadeesh/0000-0003-0498-9808; le goff, jerome/0000-0001-7111-1865; Gupta, Nimesh/0000-0001-9433-8448; Kaveri, Srini/0000-0002-0837-4053; Lacroix-Desmazes, Sebastien/0000-0001-5625-8447; Power, Ultan/0000-0003-3246-3774	Institut National de la Sante et de la Recherche Medicale, Universite Pierre et Marie Curie, Universite Paris Descartes; Centre National de la Recherche Scientifique; European Community [[FP7-2007-2013]-HEALTH-F2-2010-260338-ALLFUN]	Institut National de la Sante et de la Recherche Medicale, Universite Pierre et Marie Curie, Universite Paris Descartes; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); European Community(European Commission)	This study was Supported by Institut National de la Sante et de la Recherche Medicale, Universite Pierre et Marie Curie, Universite Paris Descartes; Centre National de la Recherche Scientifique; European Community's Seventh Framework Programme [FP7-2007-2013]-HEALTH-F2-2010-260338-ALLFUN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Bayry J, 2004, TRENDS PHARMACOL SCI, V25, P306, DOI 10.1016/j.tips.2004.04.002; Bayry J, 2003, J INFECT DIS, V188, P1610, DOI 10.1086/379335; Bayry J, 2011, NAT REV RHEUMATOL, V7, P349, DOI 10.1038/nrrheum.2011.61; Ben-Nathan D, 2003, J INFECT DIS, V188, P5, DOI 10.1086/376870; Bukreyev A, 2012, J VIROL, V86, P10880, DOI 10.1128/JVI.01162-12; Caidi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051485; Choi Y, 2012, VIRAL IMMUNOL, V25, P193, DOI 10.1089/vim.2011.0094; Collarini EJ, 2009, J IMMUNOL, V183, P6338, DOI 10.4049/jimmunol.0901373; FALSEY AR, 1995, J INFECT DIS, V172, P389, DOI 10.1093/infdis/172.2.389; GROOTHUIS JR, 1993, NEW ENGL J MED, V329, P1524, DOI 10.1056/NEJM199311183292102; Hall CB, 2001, NEW ENGL J MED, V344, P1917, DOI 10.1056/NEJM200106213442507; Haynes LM, 2009, J INFECT DIS, V200, P439, DOI 10.1086/600108; Jiang XR, 2011, NAT REV DRUG DISCOV, V10, P101, DOI 10.1038/nrd3365; KAUL TN, 1982, INFECT IMMUN, V37, P492, DOI 10.1128/IAI.37.2.492-498.1982; Kazatchkine MD, 2001, NEW ENGL J MED, V345, P747, DOI 10.1056/NEJMra993360; Krause I, 2002, TRANSFUSION MED, V12, P133, DOI 10.1046/j.1365-3148.2002.00360.x; LEVINE S, 1987, J GEN VIROL, V68, P2521, DOI 10.1099/0022-1317-68-9-2521; Mao CR, 2009, J GEN VIROL, V90, P1119, DOI 10.1099/vir.0.009308-0; Nguyen QH, 1998, CLIN DIAGN LAB IMMUN, V5, P98, DOI 10.1128/CDLI.5.1.98-104.1998; Panitch HB, 2001, CURR OPIN PEDIATR, V13, P256, DOI 10.1097/00008480-200106000-00008; Rabel PO, 2012, CLIN VACCINE IMMUNOL, V19, P623, DOI 10.1128/CVI.05705-11; SIBER GR, 1994, J INFECT DIS, V169, P1368, DOI 10.1093/infdis/169.6.1368; Spycher M, 2009, VOX SANG, V97, P348, DOI 10.1111/j.1423-0410.2009.01217.x; STIEHM ER, 1994, CLIN DIAGN LAB IMMUN, V1, P342, DOI 10.1128/CDLI.1.3.342-347.1994; Sung CC, 2011, J MICROBIOL IMMUNOL, V44, P184, DOI 10.1016/j.jmii.2011.01.025; Tripp RA, 2001, NAT IMMUNOL, V2, P732, DOI 10.1038/90675	26	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e69390	10.1371/journal.pone.0069390	http://dx.doi.org/10.1371/journal.pone.0069390			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894466	Green Published, gold, Green Submitted			2022-12-27	WOS:000322391400057
J	Hsiao, KC; Shih, NY; Fang, HL; Huang, TS; Kuo, CC; Chu, PY; Hung, YM; Chou, SW; Yang, YY; Chang, GC; Liu, KJ				Hsiao, Kuan-Chung; Shih, Neng-Yao; Fang, Hsun-Lang; Huang, Tze-Sing; Kuo, Ching-Chuan; Chu, Pei-Yi; Hung, Yi-Mei; Chou, Shao-Wen; Yang, Yi-Yuan; Chang, Gee-Chen; Liu, Ko-Jiunn			Surface alpha-Enolase Promotes Extracellular Matrix Degradation and Tumor Metastasis and Represents a New Therapeutic Target	PLOS ONE			English	Article							UROKINASE PLASMINOGEN-ACTIVATOR; LUNG-CANCER; PANCREATIC-CANCER; IDENTIFICATION; SYSTEM; MECHANISM; RECEPTOR; PROTEIN; AUTOANTIBODIES; AUTOIMMUNITY	In previous research, we found alpha-enolase to be inversely correlated with progression-free and overall survival in lung cancer patients and detected alpha-enolase on the surface of lung cancer cells. Based on these findings, we hypothesized that surface alpha-enolase has a significant role in cancer metastasis and tested this hypothesis in the current study. We found that alpha-enolase was co-immunoprecipitated with urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor, and plasminogen in lung cancer cells and interacted with these proteins in a cell-free dot blotting assay, which can be interrupted by alpha-enolase-specific antibody. alpha-Enolase in lung cancer cells co-localized with these proteins and was present at the site of pericellular degradation of extracellular matrix components. Treatment with antibody against alpha-enolase in vitro suppressed cell-associated plasminogen and matrix metalloproteinase activation, collagen and gelatin degradation, and cell invasion. Examination of the effect of treatment with shRNA plasmids revealed that down regulation of alpha-enolase decreases extracellular matrix degradation by and the invasion capacity of lung cancer cells. Adoptive transfer of alpha-enolase-specific antibody to mice resulted in accumulation of antibody in subcutaneous tumor and inhibited the formation of tumor metastasis in lung and bone. This study demonstrated that surface alpha-enolase promotes extracellular matrix degradation and invasion of cancer cells and that targeting surface alpha-enolase is a promising approach to suppress tumor metastasis.	[Hsiao, Kuan-Chung; Kuo, Ching-Chuan; Liu, Ko-Jiunn] Natl Cheng Kung Univ, Inst Clin Pharm & Pharmaceut Sci, Tainan 70101, Taiwan; [Shih, Neng-Yao; Huang, Tze-Sing; Kuo, Ching-Chuan; Hung, Yi-Mei; Chou, Shao-Wen; Liu, Ko-Jiunn] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan; [Fang, Hsun-Lang] Min Hwei Coll Hlth Care Management, Dept Cosmetol & Hlth Care, Tainan, Taiwan; [Chu, Pei-Yi] St Martin De Porres Hosp, Dept Pathol, Chiayi, Taiwan; [Yang, Yi-Yuan; Liu, Ko-Jiunn] Taipei Med Univ, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan; [Chang, Gee-Chen] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei 112, Taiwan; [Chang, Gee-Chen] Taichung Vet Gen Hosp, Dept Internal Med, Div Chest Med, Taichung, Taiwan; [Chang, Gee-Chen] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan; [Chang, Gee-Chen] China Med Univ, Sch Med, Taichung, Taiwan	National Cheng Kung University; National Health Research Institutes - Taiwan; Taipei Medical University; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; National Chung Hsing University; China Medical University Taiwan	Chang, GC (corresponding author), Natl Yang Ming Univ, Sch Med, Fac Med, Taipei 112, Taiwan.	august@vghtc.gov.tw; kojiunn@nhri.org.tw	Shih, Neng-Yao/D-2086-2010; Kuo, Ching-Chuan/C-1201-2010; Huang, Tze-Sing/C-9361-2013; Huang, Tze-Sing/E-3667-2010; Liu, Ko-Jiunn/D-2098-2010	Huang, Tze-Sing/0000-0001-8736-4330; Chu, Pei-Yi/0000-0001-7336-2465	Department of Health, Taiwan [DOH100-TD-C-111-005, DOH99-TD-G-111-009, DOH100-TD-C-111-004]; National Science Council, Taiwan [NSC98-3112-B-400-012, 99-3112-B-400-004, 100-3112-B-400-014, NSC98-2320-B-400-003-MY3]; VGHTC grant [TCVGH-963205C]	Department of Health, Taiwan; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); VGHTC grant	This work was supported by grants from the Department of Health, Taiwan, to G.-C. Chang (China Medical University Hospital Cancer Research Center of Excellence, DOH100-TD-C-111-005), N.-Y. Shih (DOH99-TD-G-111-009), and C.-C. Kuo (DOH100-TD-C-111-004) and grants from the National Science Council, Taiwan, to K.-J. Liu (NSC98-3112-B-400-012, 99-3112-B-400-004, and 100-3112-B-400-014), and C.-C. Kuo (NSC98-2320-B-400-003-MY3). G.-C. Chang was supported by a VGHTC grant (TCVGH-963205C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Husaini H, 2009, J THORAC ONCOL, V4, P251, DOI 10.1097/JTO.0b013e31819518fc; Andreasen PA, 2000, CELL MOL LIFE SCI, V57, P25, DOI 10.1007/s000180050497; ARGUELLO F, 1992, CANCER RES, V52, P2304; Bae S, 2012, J IMMUNOL, V189, P365, DOI 10.4049/jimmunol.1102073; Capello M, 2011, FEBS J, V278, P1064, DOI 10.1111/j.1742-4658.2011.08025.x; Cappello P, 2009, INT J CANCER, V125, P639, DOI 10.1002/ijc.24355; Carmeliet P, 1997, NAT GENET, V17, P439, DOI 10.1038/ng1297-439; Chang GC, 2006, CLIN CANCER RES, V12, P5746, DOI 10.1158/1078-0432.CCR-06-0324; Choong PFM, 2003, CLIN ORTHOP RELAT R, pS46, DOI 10.1097/01.blo.0000093845.72468.bd; Cozzi PJ, 2006, HUM PATHOL, V37, P1442, DOI 10.1016/j.humpath.2006.05.002; Diaz-Ramos A, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/156795; Dowling P, 2007, BBA-PROTEINS PROTEOM, V1774, P93, DOI 10.1016/j.bbapap.2006.09.014; Fisher BAC, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3740; Han B, 2005, ONCOL REP, V14, P105; He P, 2007, CANCER SCI, V98, P1234, DOI 10.1111/j.1349-7006.2007.00509.x; Ho JAA, 2010, ANAL CHEM, V82, P5944, DOI 10.1021/ac1001959; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jenkins DE, 2005, BREAST CANCER RES, V7, pR444, DOI 10.1186/bcr1026; Kagohashi K, 2003, MED ONCOL, V20, P25, DOI 10.1385/MO:20:1:25; Kawano K, 2012, EXP THER MED, V4, P61, DOI 10.3892/etm.2012.564; Kinloch AJ, 2011, ARTHRITIS RHEUM-US, V63, P3818, DOI 10.1002/art.30639; Kolberg J, 2006, MICROBIOL-SGM, V152, P1307, DOI 10.1099/mic.0.28747-0; Le DM, 2003, J NEUROSCI, V23, P4034; Leu SJ, 2010, VET IMMUNOL IMMUNOP, V137, P251, DOI 10.1016/j.vetimm.2010.06.001; Liu K.-J., 2007, J CANC MOL, V3, P45; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Lokman NA, 2011, CANCER MICROENVIRON, V4, P199, DOI 10.1007/s12307-011-0064-9; Lopez-Alemany R, 2003, AM J HEMATOL, V72, P234, DOI 10.1002/ajh.10299; Mazzieri R, 1997, EMBO J, V16, P2319, DOI 10.1093/emboj/16.9.2319; McMahon B, 2007, PATHOPHYSIOL HAEMO T, V36, P184, DOI 10.1159/000175156; Mendes O, 2007, CLIN EXP METASTAS, V24, P341, DOI 10.1007/s10585-007-9071-0; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Pancholi V, 2001, CELL MOL LIFE SCI, V58, P902, DOI 10.1007/PL00000910; REDLITZ A, 1995, EUR J BIOCHEM, V227, P407, DOI 10.1111/j.1432-1033.1995.tb20403.x; Romer J, 2004, CURR PHARM DESIGN, V10, P2359, DOI 10.2174/1381612043383962; Saldanha RG, 2007, J PROTEOME RES, V6, P1016, DOI 10.1021/pr060518n; Sanchez-Sweatman Otto H., 1998, Invasion and Metastasis, V18, P297, DOI 10.1159/000024522; Sato Hiroshi, 2006, Clin Calcium, V16, P621; Saulot V, 2002, ARTHRITIS RHEUM, V46, P1196, DOI 10.1002/art.10252; Schayowitz A, 2008, MOL CANCER THER, V7, P121, DOI 10.1158/1535-7163.MCT-07-0581; Shih NY, 2010, JPN J CLIN ONCOL, V40, P663, DOI 10.1093/jjco/hyq028; SMITH RE, 1980, THROMB RES, V17, P393, DOI 10.1016/0049-3848(80)90074-2; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Sone S, 2007, CANCER METAST REV, V26, P685, DOI 10.1007/s10555-007-9081-z; Tan XD, 2006, INT J ONCOL, V28, P369; Tomaino B, 2011, J PROTEOME RES, V10, P105, DOI 10.1021/pr100213b; Tsai ST, 2010, EUR J CANCER, V46, P1712, DOI 10.1016/j.ejca.2010.03.018; WALSH JL, 1989, BIOCHIM BIOPHYS ACTA, V999, P64, DOI 10.1016/0167-4838(89)90031-9; Wang J, 2006, INT J MOL MED, V17, P849; Wegner N, 2010, IMMUNOL REV, V233, P34, DOI 10.1111/j.0105-2896.2009.00850.x; Wygrecka M, 2009, BLOOD, V113, P5588, DOI 10.1182/blood-2008-08-170837	53	79	83	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e69354	10.1371/journal.pone.0069354	http://dx.doi.org/10.1371/journal.pone.0069354			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894455	Green Submitted, Green Published, gold			2022-12-27	WOS:000322391400051
J	Isaakidis, P; Paryani, R; Khan, S; Mansoor, H; Manglani, M; Valiyakath, A; Saranchuk, P; Furin, J				Isaakidis, Petros; Paryani, Roma; Khan, Samsuddin; Mansoor, Homa; Manglani, Mamta; Valiyakath, Asmaa; Saranchuk, Peter; Furin, Jennifer			Poor Outcomes in a Cohort of HIV-Infected Adolescents Undergoing Treatment for Multidrug-Resistant Tuberculosis in Mumbai, India	PLOS ONE			English	Article							COMMUNITY-BASED THERAPY; FOLLOW-UP; CHILDREN; CHILDHOOD; ADHERENCE	Background: Little is known about the treatment of multidrug-resistant tuberculosis (MDR-TB) in HIV-co-infected adolescents. This study aimed to present the intermediate outcomes of HIV-infected adolescents aged 10-19 years receiving second-line anti-TB treatment in a Medecins Sans Frontieres (MSF) project in Mumbai, India. Methods: A retrospective review of medical records of 11 adolescents enrolled between July 2007 and January 2013 was undertaken. Patients were initiated on either empirical or individualized second-line ambulatory anti-TB treatment under direct observation. Results: The median age was 16 (IQR 14-18) years and 54% were female. Five (46%) adolescents had pulmonary TB (PTB), two (18%) extrapulmonary disease (EPTB) and four (36%) had both. Median CD4 count at the time of MDR-TB diagnosis was 162.7 cells/ml (IQR: 84.8-250.5). By January 2013, eight patients had final and 3 had interim outcomes. Favourable results were seen in four (36.5%) patients: one was cured and three were still on treatment with negative culture results. Seven patients (64%) had poor outcomes: four (36.5%) died and three (27%) defaulted. Three of the patients who died never started on antiretroviral and/or TB treatment and one died 16 days after treatment initiation. Two of the defaulted died soon after default. All patients (100%) on-treatment experienced adverse events (AEs): two required permanent discontinuation of the culprit drug and two were hospitalized due to AEs. No patient required permanent discontinuation of the entire second-line TB or antiretroviral regimens. Conclusions: Early mortality and mortality after default were the most common reasons for poor outcomes in this study. Early mortality suggests the need for rapid diagnosis and prompt treatment initiation, and adolescents might benefit from active contact-tracing and immediate referral. Default occurred at different times, suggesting the need for continuous, intensified and individualized psychosocial support for co-infected adolescents. Operational research among co-infected adolescents will be especially important in designing effective interventions for this vulnerable group.	[Isaakidis, Petros; Paryani, Roma; Khan, Samsuddin; Mansoor, Homa; Valiyakath, Asmaa] Med Sans Frontieres, Bombay, Maharashtra, India; [Manglani, Mamta] Lokmanya Tilak Municipal Med Coll & Gen Hosp, Pediat Ctr Excellence HIV Care, Bombay, Maharashtra, India; [Saranchuk, Peter] Med Sans Frontieres, Southern Africa Med Unit, Cape Town, South Africa; [Furin, Jennifer] Case Western Reserve Univ, TB Res Unit, Cleveland, OH 44106 USA	Case Western Reserve University	Isaakidis, P (corresponding author), Med Sans Frontieres, Bombay, Maharashtra, India.	msfocb-asia-epidemio@brussels.msf.org		Isaakidis, Petros/0000-0002-7881-1554				[Anonymous], AD HLTH; Arnone J, 2012, GASTROENTEROL NURS, V35, P248, DOI 10.1097/SGA.0b013e31825f990c; Chan ED, 2008, NEW ENGL J MED, V359, P657, DOI 10.1056/NEJMc0706556; Chandwani S, 2012, J ADOLESCENT HEALTH, V51, P242, DOI 10.1016/j.jadohealth.2011.12.013; Chiang CY, 2010, INT J TUBERC LUNG D, V14, P878; Coelho JC, 2011, J BRAS PNEUMOL, V37, P288, DOI 10.1590/S1806-37132011000300003; Drobac PC, 2006, PEDIATRICS, V117, P2022, DOI 10.1542/peds.2005-2235; Errol L, 2012, J ADV NURS, V68, P2399, DOI 10.1111/j.1365-2648.2011.05934.x; Ettehad D, 2012, LANCET INFECT DIS, V12, P449, DOI 10.1016/S1473-3099(12)70033-6; Fair CD, 2012, AIDS PATIENT CARE ST, V26, P423, DOI 10.1089/apc.2012.0041; Fairlie L, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-28; Farmer P, 1999, INT J TUBERC LUNG D, V3, P365; Furin JJ, 2005, CURR OPIN PULM MED, V11, P189; Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC; Garrido MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039134; Geldenhuys H, 2011, AFR J PSYCHIATRY, V14, P383, DOI [10.4314/ajpsy.v14i5.6, http://dx.doi.org/10.4314/ajpsy.v14i5.6]; Greenley RN, 2012, INFLAMM BOWEL DIS, V18, P1254, DOI 10.1002/ibd.21859; Hodgson I, 2012, AIDS CARE, V24, P1204, DOI 10.1080/09540121.2012.658755; Isaakidis P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040781; Isaakidis P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028066; M'Imunya JM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006591.pub2; Maruza M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-351; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; Mitnick CD, 2008, NEW ENGL J MED, V359, P563, DOI 10.1056/NEJMoa0800106; Mukherjee JS, 2004, LANCET, V363, P474, DOI 10.1016/S0140-6736(04)15496-2; Naidoo K, 2012, ANN INTERN MED, V157, P313, DOI 10.7326/0003-4819-157-5-201209040-00004; Nansera D, 2012, INT J TUBERC LUNG D, V16, P1371, DOI 10.5588/ijtld.11.0589; Nichols SL, 2012, J DEV BEHAV PEDIATR, V33, P298, DOI 10.1097/DBP.0b013e31824bef47; Perez-Velez CM, 2012, CURR OPIN PEDIATR, V24, P319, DOI 10.1097/MOP.0b013e32835357c3; Phongsamart W, 2009, PEDIATR INFECT DIS J, V28, P416, DOI 10.1097/INF.0b013e3181920d4d; Sachdeva KS, 2012, INDIAN J MED RES, V135, P690; Schaaf HS, 2007, SAMJ S AFR MED J, V97, P995; Seddon JA, 2012, CLIN INFECT DIS, V54, P157, DOI 10.1093/cid/cir772; Single N, 2011, INT J TUBERC LUNG D, V15, P1326, DOI 10.5588/ijtld.10.0564; Thampi N, 2012, PEDIATR INFECT DIS J, V31, P129, DOI 10.1097/INF.0b013e318239134c; World Health Organization, 2008, WHOHTMTB2008394; World Health Organization, 2011, WHO PROGRESS REPORT	37	38	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e68869	10.1371/journal.pone.0068869	http://dx.doi.org/10.1371/journal.pone.0068869			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	191CY	23894358	Green Published, Green Submitted, gold			2022-12-27	WOS:000322391400028
J	Liu, Y; Zheng, WL; Song, YB; Ma, WL; Yin, H				Liu, Yue; Zheng, Wenling; Song, Yanbin; Ma, Wenli; Yin, Hong			Low Expression of miR-196b Enhances the Expression of BCR-ABL1 and HOXA9 Oncogenes in Chronic Myeloid Leukemogenesis	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; DNA METHYLATION; BCR-ABL; GENES; TARGETS; LEUKEMIA	MicroRNAs (miRNAs) can function as tumor suppressors or oncogene promoters during tumor development. In this study, low levels of expression of miR-196b were detected in patients with chronic myeloid leukemia. Bisulfite genomic sequencing PCR and methylation-specific PCR were used to examine the methylation status of the CpG islands in the miR-196b promoter in K562 cells, patients with leukemia and healthy individuals. The CpG islands showed more methylation in patients with chronic myeloid leukemia compared with healthy individuals (P<0.05), which indicated that low expression of miR-196b may be associated with an increase in the methylation of CpG islands. The dual-luciferase reporter assay system demonstrated that BCR-ABL1 and HOXA9 are the target genes of miR-196b, which was consistent with predictions from bioinformatics software analyses. Further examination of cell function indicated that miR-196b acts to reduce BCR-ABL1 and HOXA9 protein levels, decrease cell proliferation rate and retard the cell cycle. A low level of expression of miR-196b can cause up-regulation of BCR-ABL1 and HOXA9 expression, which leads to the development of chronic myeloid leukemia. MiR-196b may represent an effective target for chronic myeloid leukemia therapy.	[Liu, Yue; Zheng, Wenling; Song, Yanbin; Ma, Wenli; Yin, Hong] Southern Med Univ, Inst Genet Engn, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Song, YB (corresponding author), Southern Med Univ, Inst Genet Engn, Guangzhou, Guangdong, Peoples R China.	68256392@qq.com; vliuyuemoon@163.com			Guangdong Medical Research Foundation [B2013220]; Youth Science and technology personnel training project of "Scientific research plan'' of Southern Medical University; "Outstanding Leadership Grant'' from Guangdong Province [C1030925]; Key Project of Science and Technology Research grants from the Ministry of Education [B1000409]	Guangdong Medical Research Foundation; Youth Science and technology personnel training project of "Scientific research plan'' of Southern Medical University; "Outstanding Leadership Grant'' from Guangdong Province; Key Project of Science and Technology Research grants from the Ministry of Education	This work was supported by Guangdong Medical Research Foundation (B2013220), and Youth Science and technology personnel training project of "Scientific research plan'' of Southern Medical University, and an "Outstanding Leadership Grant'' from Guangdong Province (C1030925), and Key Project of Science and Technology Research grants from the Ministry of Education (B1000409). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe W, 2013, HUM REPROD, V28, P750, DOI 10.1093/humrep/des446; Agrawal-Singh S, 2012, BLOOD, V119, P2346, DOI 10.1182/blood-2011-06-358705; Bach C, 2010, BLOOD, V115, P2910, DOI 10.1182/blood-2009-04-216606; Ballabeni A, 2011, P NATL ACAD SCI USA, V108, P19252, DOI 10.1073/pnas.1116794108; Bhatia S, 2010, MOL CELL BIOCHEM, V340, P97, DOI 10.1007/s11010-010-0406-9; Bueno MJ, 2008, CANCER CELL, V13, P496, DOI 10.1016/j.ccr.2008.04.018; Caffarelli E, 2012, FRONT BIOSCI, V17, P2682; Coskun E, 2011, LEUKEMIA RES, V35, P208, DOI 10.1016/j.leukres.2010.05.007; Du X, 2008, BLOOD, V111, P338, DOI 10.1182/blood-2007-07-102350; Frka K, 2009, J BIOTECHNOL, V141, P8, DOI 10.1016/j.jbiotec.2009.02.013; Helgason GV, 2011, BLOOD, V118, P2035, DOI 10.1182/blood-2011-01-330621; Hulf T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-54; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Kiezun Adam, 2012, BMC Res Notes, V5, P92, DOI 10.1186/1756-0500-5-92; Kobayashi T, 2012, J IMMUNOL, V189, P1792, DOI 10.4049/jimmunol.1200042; Kucuk C, 2011, P NATL ACAD SCI USA, V108, P20119, DOI 10.1073/pnas.1115128108; Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li ZJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1681; Liu Y, 2013, LEUKEMIA RES, V37, P349, DOI 10.1016/j.leukres.2012.12.003; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Lutsik P, 2011, NUCLEIC ACIDS RES, V39, pW551, DOI 10.1093/nar/gkr312; Notta F, 2011, NATURE, V469, P362, DOI 10.1038/nature09733; Pottier N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006718; Quintas-Cardama A, 2009, BLOOD, V113, P1619, DOI 10.1182/blood-2008-03-144790; Schotte D, 2010, HAEMATOL-HEMATOL J, V95, P1675, DOI 10.3324/haematol.2010.023481; Shen J, 2012, EPIGENETICS-US, V7, P1230, DOI 10.4161/epi.22140; Takai Daiya, 2003, In Silico Biology, V3, P235; Tedeschi FA, 2010, LEUKEMIA LYMPHOMA, V51, P892, DOI 10.3109/10428190903586326; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Tsai KW, 2010, GENE CHROMOSOME CANC, V49, P969, DOI 10.1002/gcc.20804	31	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e68442	10.1371/journal.pone.0068442	http://dx.doi.org/10.1371/journal.pone.0068442			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894305	Green Published, gold, Green Submitted			2022-12-27	WOS:000322391400006
J	Murata, K; Furu, M; Yoshitomi, H; Ishikawa, M; Shibuya, H; Hashimoto, M; Imura, Y; Fujii, T; Ito, H; Mimori, T; Matsuda, S				Murata, Koichi; Furu, Moritoshi; Yoshitomi, Hiroyuki; Ishikawa, Masahiro; Shibuya, Hideyuki; Hashimoto, Motomu; Imura, Yoshitaka; Fujii, Takao; Ito, Hiromu; Mimori, Tsuneyo; Matsuda, Shuichi			Comprehensive microRNA Analysis Identifies miR-24 and miR-125a-5p as Plasma Biomarkers for Rheumatoid Arthritis	PLOS ONE			English	Article							CIRCULATING MICRORNAS; SYNOVIAL FIBROBLASTS; ALTERED EXPRESSION; REVISED CRITERIA; AMERICAN-COLLEGE; T-CELLS; CLASSIFICATION; NORMALIZATION; ASSOCIATION; MECHANISM	MicroRNAs (miRNAs) are present in human plasma and known as a non-invasive biomarker for cancer detection. Our study was designed to identify plasma miRNAs specific for rheumatoid arthritis (RA) by a comprehensive array approach. We performed a systematic, array-based miRNA analysis on plasma samples from three RA patients and three healthy controls (HCs). Plasma miRNAs with more than four times change or with significant (P<0.05) change in expression, or detectable only in RA plasma, were confirmed with plasma from eight RA patients and eight HCs using real-time quantitative PCR. Consistently detectable miRNAs that were significantly different between RA patients and HCs were chosen for further validation with 102 RA patients and 104 HCs. The area under curves (AUC) were calculated after plotting the receiver operating characteristic (ROC) curves. To determine if these miRNAs are specific for RA, the concentrations of these miRNAs were analyzed in 24 patients with osteoarthritis (OA), and 11 patients with systemic lupus erythematosus (SLE). The array analysis and the subsequent confirmation in larger patient cohort identified significant alterations in plasma levels of seven miRNAs. The highest AUC was found for miR-125a-5p, followed in order by miR-24 and miR-26a. Multivariable logistic regression analysis showed that miR-24, miR-30a-5p, and miR-125a-5p were crucial factors for making detection model of RA and provided a formula for Estimated Probability of RA by plasma MiRNA (ePRAM), employing miR-24, miR-30a-5p and miR-125a-5p, which showed increased diagnostic accuracy (AUC: 0.89). The level of miR-24, miR-125a-5p, and ePRAM in OA and SLE patients were lower than that in RA. There was no significant difference in detection for anti-citrullinated protein antibody (ACPA)-positive and ACPA-negative RA patients. These results suggest that the plasma concentrations of miR-24 and miR-125a-5p, and ePRAM are potential diagnostic markers of RA even if patients were ACPA-negative.	[Murata, Koichi; Furu, Moritoshi; Yoshitomi, Hiroyuki; Ishikawa, Masahiro; Shibuya, Hideyuki; Ito, Hiromu; Matsuda, Shuichi] Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Sakyo Ku, Kyoto, Japan; [Furu, Moritoshi; Hashimoto, Motomu; Fujii, Takao; Ito, Hiromu; Mimori, Tsuneyo] Kyoto Univ, Grad Sch Med, Dept Control Rheumat Dis, Sakyo Ku, Kyoto, Japan; [Yoshitomi, Hiroyuki] Kyoto Univ, Grad Sch Med, Ctr Innovat Immunoregulat Technol & Therapeut, Sakyo Ku, Kyoto, Japan; [Hashimoto, Motomu; Imura, Yoshitaka; Fujii, Takao; Mimori, Tsuneyo] Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Sakyo Ku, Kyoto, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University	Yoshitomi, H (corresponding author), Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Sakyo Ku, Kyoto, Japan.	yositomi@kuhp.kyoto-u.ac.jp		Matsuda, Shuichi/0000-0003-0802-1255; Murata, Koichi/0000-0002-7896-3937	Ministry of Health, Labor and Welfare of Japan [10103190]; Japan Orthopaedics and Traumatology Foundation, Inc. [262]	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Orthopaedics and Traumatology Foundation, Inc.	This work was supported by Health and Labor Sciences Research Grants for Research on Allergic Disease and Immunology from the Ministry of Health, Labor and Welfare of Japan (Grant No. 10103190), and Grant of Japan Orthopaedics and Traumatology Foundation, Inc. (No. 262) (http://jotf.jp/invitation.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bai YY, 2011, MED HYPOTHESES, V77, P488, DOI 10.1016/j.mehy.2011.06.017; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Breedveld FC, 2006, ARTHRITIS RHEUM-US, V54, P26, DOI 10.1002/art.21519; Bryant RJ, 2012, BRIT J CANCER, V106, P768, DOI 10.1038/bjc.2011.595; Callis TE, 2007, DNA CELL BIOL, V26, P219, DOI 10.1089/dna.2006.0556; Carlsen AL, 2013, ARTHRITIS RHEUM-US, V65, P1324, DOI 10.1002/art.37890; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Dons EM, 2012, HUM IMMUNOL, V73, P328, DOI 10.1016/j.humimm.2011.12.011; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Filkova M, 2012, BIODRUGS, V26, P131, DOI 10.2165/11631480-000000000-00000; Goekoop-Ruiterman YPM, 2005, ARTHRITIS RHEUM-US, V52, P3381, DOI [10.1002/art.21405, 10.1002/art.23364]; Hauser S, 2012, CANC EPIDEMIOL; He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Kim SW, 2012, P NATL ACAD SCI USA, V109, P7865, DOI 10.1073/pnas.1200081109; Kosaka N, 2012, J BIOL CHEM, V287, P1397, DOI 10.1074/jbc.M111.288662; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kuwabara Y, 2011, CIRC-CARDIOVASC GENE, V4, P446, DOI 10.1161/CIRCGENETICS.110.958975; Lee DM, 2001, LANCET, V358, P903, DOI 10.1016/S0140-6736(01)06075-5; Leidner RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057841; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu HS, 2012, CANCER LETT, V316, P196, DOI 10.1016/j.canlet.2011.10.034; Luna C, 2011, J CELL PHYSIOL, V226, P1407, DOI 10.1002/jcp.22476; Mahn R, 2011, UROLOGY, V77, DOI 10.1016/j.urology.2011.01.020; Matmati M, 2011, NAT GENET, V43, P908, DOI 10.1038/ng.874; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Miyachi M, 2010, BIOCHEM BIOPH RES CO, V400, P89, DOI 10.1016/j.bbrc.2010.08.015; Murata K, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3013; Nakamachi Y, 2009, ARTHRITIS RHEUM-US, V60, P1294, DOI 10.1002/art.24475; Nakasa T, 2011, ARTHRITIS RHEUM-US, V63, P1582, DOI 10.1002/art.30321; Niimoto T, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-209; Pauley KM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2493; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Pesu M, 2008, NATURE, V455, P246, DOI 10.1038/nature07210; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Schrauder MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029770; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; Stanczyk J, 2011, ARTHRITIS RHEUM-US, V63, P373, DOI 10.1002/art.30115; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Wang HK, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029452, 10.1371/journal.pone.0041330, 10.1371/journal.pone.0038619]; Wang HL, 2012, TRANSL RES, V160, P198, DOI 10.1016/j.trsl.2012.04.002; Wang JF, 2010, BIOCHEM BIOPH RES CO, V394, P184, DOI 10.1016/j.bbrc.2010.02.145; Wang M, 2012, MOL MED REP, V5, P1514, DOI 10.3892/mmr.2012.828; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Wu L, 2012, REPRODUCTION, V143, P389, DOI 10.1530/REP-11-0304; Zen K, 2012, MED RES REV, V32, P326, DOI 10.1002/med.20215; Zhao RH, 2011, ONKOLOGIE, V34, P675, DOI 10.1159/000334552; Zhao Z, 2012, CLIN CHEM, V58, P896, DOI 10.1373/clinchem.2011.179283	61	127	134	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e69118	10.1371/journal.pone.0069118	http://dx.doi.org/10.1371/journal.pone.0069118			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874885	Green Published, Green Submitted, gold			2022-12-27	WOS:000324146200059
J	Wang, WW; Ang, SF; Kumar, R; Heah, C; Utama, A; Tania, NP; Li, HH; Tan, SH; Poo, D; Choo, SP; Chow, WC; Tan, CK; Toh, HC				Wang, Who-Whong; Ang, Soo Fan; Kumar, Rajneesh; Heah, Charmain; Utama, Andi; Tania, Navessa Padma; Li, Huihua; Tan, Sze Huey; Poo, Desmond; Choo, Su Pin; Chow, Wan Cheng; Tan, Chee Kiat; Toh, Han Chong			Identification of Serum Monocyte Chemoattractant Protein-1 and Prolactin as Potential Tumor Markers in Hepatocellular Carcinoma	PLOS ONE			English	Article							DES-GAMMA CARBOXYPROTHROMBIN; ALPHA-FETOPROTEIN; INCREASED EXPRESSION; LIVER-DISEASE; CANCER; DIAGNOSIS; SURVEILLANCE; CHEMOKINES; PROTEOMICS; SIGNATURE	Early diagnosis of hepatocellullar carcinoma (HCC) remains a challenge. The current practice of serum alpha-fetoprotein (AFP) measurement is inadequate. Here we utilized a proteomic approach to identify novel serum biomarkers for distinguishing HCC patients from non-cancer controls. We profiled the serum proteins in a group of 58 resectable HCC patients and 11 non-HCC chronic hepatitis B (HBV) carrier samples from the Singapore General Hospital (SGH) using the RayBio (R) L-Series 507 Antibody Array and found 113 serum markers that were significantly modulated between HCC and control groups. Selected potential biomarkers from this list were quantified using a multiplex sandwich enzyme-linked immunosorbent assay (ELISA) array in an expanded SGH cohort (126 resectable HCC patients and 115 non-HCC chronic HBV carriers (NC group)), confirming that serum prolactin and monocyte chemoattractant protein-1 (MCP-1) were significantly upregulated in HCC patients. This finding of serum MCP-1 elevation in HCC patients was validated in a separate cohort of serum samples from the Mochtar Riady Institute for Nanotechnology, Indonesia (98 resectable HCC, 101 chronic hepatitis B patients and 100 asymptomatic HBV/HCV carriers) by sandwich ELISA. MCP-1 and prolactin levels were found to correlate with AFP, while MCP-1 also correlated with disease stage. Subsequent receiver operating characteristic (ROC) analysis of AFP, prolactin and MCP-1 in the SGH cohort and comparing their area under the ROC curve (AUC) indicated that neither prolactin nor MCP-1 on their own performed better than AFP. However, the combination of AFP+MCP-1 (AUC, 0.974) had significantly superior discriminative ability than AFP alone (AUC, 0.942; p<0.001). In conclusion, prolactin and MCP-1 are overexpressed in HCC and are conveniently quantifiable in patients' sera by ELISA. MCP-1 appears to be a promising complementary biomarker for HCC diagnosis and this MCP-1+AFP model should be further evaluated as potential biomarker on a larger scale in patients at-risk of HCC.	[Wang, Who-Whong; Ang, Soo Fan; Poo, Desmond; Choo, Su Pin; Toh, Han Chong] Natl Canc Ctr, Dept Med Oncol, Singapore, Singapore; [Kumar, Rajneesh; Chow, Wan Cheng; Tan, Chee Kiat] Singapore Gen Hosp, Dept Gastroenterol & Hepatol, Singapore, Singapore; [Heah, Charmain; Toh, Han Chong] Duke NUS Grad Med Sch, Singapore, Singapore; [Utama, Andi; Tania, Navessa Padma] Mochtar Riady Inst Nanotechnol, Jakarta, Indonesia; [Li, Huihua] Singapore Gen Hosp, Dept Clin Res, Singapore, Singapore; [Tan, Sze Huey] Natl Canc Ctr, Dept Clin Trials & Epidemiol Sci, Singapore, Singapore	National Cancer Centre Singapore (NCCS); Singapore General Hospital; National University of Singapore; Singapore General Hospital; National Cancer Centre Singapore (NCCS)	Toh, HC (corresponding author), Natl Canc Ctr, Dept Med Oncol, Singapore, Singapore.	hanchongtoh@gmail.com	CHOO, Su Pin/ABB-3892-2020; Tan, Chee-Kiat/AAN-3888-2020; Tania, Navessa/F-7370-2014; Tan, Chee-Kiat/AAF-6443-2019	Tan, Chee-Kiat/0000-0001-6992-2319; Tania, Navessa/0000-0002-5725-0946; Tan, Chee-Kiat/0000-0001-6992-2319; Tan, Sze Huey/0000-0002-3089-7379	National Medical Research Council (NMRC), Ministry of Health, Republic of Singapore [NMRC/1191/2008, NMRC/IBG/NCC/2009]; MRIN	National Medical Research Council (NMRC), Ministry of Health, Republic of Singapore; MRIN	Study of the SGH cohort in this research was supported by grants awarded by the National Medical Research Council (NMRC), Ministry of Health, Republic of Singapore (NMRC/1191/2008 and NMRC/IBG/NCC/2009; http://www.nmrc.gov.sg/content/nmrc_internet/home.html). Study of the MRIN cohort was supported by the institutional funding of MRIN (http://www.mrinstitute.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altekruse SF, 2012, HEPATOLOGY, V55, P476, DOI 10.1002/hep.24710; Antoniades CG, 2012, HEPATOLOGY, V56, P735, DOI 10.1002/hep.25657; Bigbee WL, 2012, J THORAC ONCOL, V7, P698, DOI 10.1097/JTO.0b013e31824ab6b0; Bismuth H, 2000, J HEPATOL, V32, P208, DOI 10.1016/S0168-8278(00)80427-4; Bolondi L, 2001, GUT, V48, P251, DOI 10.1136/gut.48.2.251; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; BUCKLEY AR, 1985, LIFE SCI, V37, P2569, DOI 10.1016/0024-3205(85)90616-2; Chen L, 2010, ANN SURG ONCOL, V17, P2518, DOI 10.1245/s10434-010-1038-8; Chen THH, 2002, INT J CANCER, V98, P257, DOI 10.1002/ijc.10122; Collier J, 1998, HEPATOLOGY, V27, P273, DOI 10.1002/hep.510270140; Dagouassat M, 2010, INT J CANCER, V126, P1095, DOI 10.1002/ijc.24800; Degre D, 2012, CLIN EXP IMMUNOL, V169, P302, DOI 10.1111/j.1365-2249.2012.04609.x; Feng JT, 2006, ONCOGENE, V25, P3810, DOI 10.1038/sj.onc.1209551; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fisher NC, 1999, GUT, V45, P416, DOI 10.1136/gut.45.3.416; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Garcia-Caballero T, 2000, ENDOCRINE, V12, P265, DOI 10.1385/ENDO:12:3:265; Giannini EG, 2012, HEPATOLOGY, V56, P1371, DOI 10.1002/hep.25814; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hefler L, 1999, BRIT J CANCER, V81, P855, DOI 10.1038/sj.bjc.6690776; Huang Ruochun, 2010, Cancer Genomics & Proteomics, V7, P129; Hwang J, 2009, J GYNECOL ONCOL, V30, P169, DOI 10.3802/jgo.2009.20.3.169; Jain S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035789; Kobayashi M, 2007, HEPATOL RES, V37, P914, DOI 10.1111/j.1872-034X.2007.00147.x; Lin ZY, 2012, BIOMED PHARMACOTHER, V66, P525, DOI 10.1016/j.biopha.2012.02.001; Liotta LA, 2003, CANCER CELL, V3, P317, DOI 10.1016/S1535-6108(03)00086-2; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Llovet JM, 2006, GASTROENTEROLOGY, V131, P1758, DOI 10.1053/j.gastro.2006.09.014; MARINGHINI A, 1988, DIGEST DIS SCI, V33, P47, DOI 10.1007/BF01536630; Marra F, 1998, AM J PATHOL, V152, P423; Marrero JA, 2003, HEPATOLOGY, V37, P1114, DOI 10.1053/jhep.2003.50195; Marrero JA, 2009, GASTROENTEROLOGY, V137, P110, DOI 10.1053/j.gastro.2009.04.005; Miura N, 2005, CLIN CANCER RES, V11, P3205, DOI 10.1158/1078-0432.CCR-04-1487; Mor G, 2005, P NATL ACAD SCI USA, V102, P7677, DOI 10.1073/pnas.0502178102; Nakatsura T, 2003, BIOCHEM BIOPH RES CO, V306, P16, DOI 10.1016/S0006-291X(03)00908-2; Nolen BM, 2011, CANCER BIOMARK, V10, P3, DOI 10.3233/CBM-2012-0229; Omata M, 2010, HEPATOL INT, V4, P439, DOI 10.1007/s12072-010-9165-7; Sala M, 2005, Gastroenterol Hepatol, V28, P292, DOI 10.1157/13074066; Shen QJ, 2012, LANCET ONCOL, V13, P817, DOI 10.1016/S1470-2045(12)70233-4; Sherman M, 2001, J HEPATOL, V34, P603, DOI 10.1016/S0168-8278(01)00025-3; Shim JH, 2012, ANN SURG ONCOL, V19, P3687, DOI 10.1245/s10434-012-2416-1; Song BC, 2002, CANCER-AM CANCER SOC, V94, P175, DOI 10.1002/cncr.10170; Soresi M, 2003, ANTICANCER RES, V23, P1747; Sterling RK, 2012, AM J GASTROENTEROL, V107, P64, DOI 10.1038/ajg.2011.312; Sullivan J, 2011, J ONCOL, V2011, DOI 10.1155/2011/518394; Sun S, 2010, J PROTEOME RES, V9, P1923, DOI 10.1021/pr901085z; Tonouchi H, 2002, SCAND J GASTROENTERO, V37, P830, DOI 10.1080/713786535; Visintin I, 2008, CLIN CANCER RES, V14, P1065, DOI 10.1158/1078-0432.CCR-07-1569; Wulfkuhle JD, 2003, NAT REV CANCER, V3, P267, DOI 10.1038/nrc1043; Yang BH, 1997, J CANCER RES CLIN, V123, P357, DOI 10.1007/s004320050070; Yeh YT, 2012, WORLD J SURG, V36, P1128, DOI 10.1007/s00268-012-1505-4; Yoong KF, 1999, HEPATOLOGY, V30, P100, DOI 10.1002/hep.510300147	54	23	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e68904	10.1371/journal.pone.0068904	http://dx.doi.org/10.1371/journal.pone.0068904			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23874805	Green Published, gold, Green Submitted			2022-12-27	WOS:000324146200037
J	Balla-Jhagjhoorsingh, SS; Corti, D; Heyndrickx, L; Willems, E; Vereecken, K; Davis, D; Vanham, G				Balla-Jhagjhoorsingh, Sunita S.; Corti, Davide; Heyndrickx, Leo; Willems, Elisabeth; Vereecken, Katleen; Davis, David; Vanham, Guido			The N276 Glycosylation Site Is Required for HIV-1 Neutralization by the CD4 Binding Site Specific HJ16 Monoclonal Antibody	PLOS ONE			English	Article							GROUP-O; BROAD; POTENT; DESIGN; IDENTIFICATION; RESPONSES; EPITOPE; ASSAYS; SERA; 2G12	Immunogen design for HIV-1 vaccines could be based on epitope identification of naturally occurring neutralizing antibodies in infected patients. A tier 2 neutralizing monoclonal antibody (mAb), HJ16 recognizes a new epitope in the CD4 binding site (CD4bs) region that only partially overlaps with the b12 epitope. We aimed to identify the critical binding site by resistance induction in a sensitive primary CRF02_AG strain. In four independent dose-escalation studies, the N276D mutation was consistently the only alteration found and it was confirmed to be responsible for resistance to HJ16 by site-directed mutagenesis in envelopes (envs) of the homologous CRF02_AG, as well as of a subtype A and a subtype C primary isolate. This mutation removes an N-linked glycosylation site. The effect of N276D was very selective, as it failed to confer resistance to a range of other entry inhibitors. Remarkably, sensitivity to the CD4bs VRC01 and VRC03 mAbs was increased in the N276D mutated viruses. These data indicate that binding of the CD4bs specific HJ16 mAb critically depends on the interaction with the N276-glycan, thus indicating that HJ16 is the first glycan dependent CD4bs-specific mAb.	[Balla-Jhagjhoorsingh, Sunita S.; Heyndrickx, Leo; Willems, Elisabeth; Vereecken, Katleen; Vanham, Guido] Inst Trop Med, Virol Unit, B-2000 Antwerp, Belgium; [Corti, Davide] Inst Res Biomed, Bellinzona, Switzerland; [Davis, David] Biomed Primate Res Ctr, Rijswijk, Netherlands; [Vanham, Guido] Univ Antwerp, Dept Biomed Sci, Fac Pharmacol Vet & Biomed Sci, B-2020 Antwerp, Belgium	Institute of Tropical Medicine (ITM); Universita della Svizzera Italiana; University of Antwerp	Vanham, G (corresponding author), Inst Trop Med, Virol Unit, B-2000 Antwerp, Belgium.	cmaeckelbergh@itg.be			Collaboration for AIDS Vaccine Discovery (CAVD); Bill & Melinda Gates Foundation [38637]; European program CHAARM (Combined Highly Active Antiretroviral Microbicides Project) [242135]; European FP-7 NGIN program (Next Generation HIV-1 Immunogens inducing broadly reactive Neutralising antibodies Project) [201433]	Collaboration for AIDS Vaccine Discovery (CAVD); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); European program CHAARM (Combined Highly Active Antiretroviral Microbicides Project); European FP-7 NGIN program (Next Generation HIV-1 Immunogens inducing broadly reactive Neutralising antibodies Project)	This work was supported to a large extent by the Collaboration for AIDS Vaccine Discovery (CAVD) funded by the Bill & Melinda Gates Foundation (Project ID 38637) and in part by the European program CHAARM (Combined Highly Active Antiretroviral Microbicides Project no 242135) as well as the European FP-7 NGIN program (Next Generation HIV-1 Immunogens inducing broadly reactive Neutralising antibodies Project no 201433). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balla-Jhagjhoorsingh SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025488; Beirnaert E, 1998, J VIROL METHODS, V73, P65, DOI 10.1016/S0166-0934(98)00044-5; Beirnaert E, 2001, VIROLOGY, V281, P305, DOI 10.1006/viro.2000.0802; Beirnaert E, 2000, J MED VIROL, V62, P14, DOI 10.1002/1096-9071(200009)62:1&lt;14::AID-JMV3&gt;3.0.CO;2-L; Corti D, 2013, ANNU REV IMMUNOL, V16, P16; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Falkowska E, 2012, J VIROL, V86, P4394, DOI 10.1128/JVI.06973-11; Fenyo EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004505; Forsman A, 2008, J VIROL, V82, P12069, DOI 10.1128/JVI.01379-08; Heyndrickx L, 2008, J VIROL METHODS, V148, P166, DOI 10.1016/j.jviromet.2007.11.009; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Lavine CL, 2012, J VIROL, V86, P2153, DOI 10.1128/JVI.06201-11; McGuire AT, 2013, J EXP MED, V27, P27; Moldt B, 2012, P NATL ACAD SCI USA, V25, P25; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Moore PL, 2012, NAT MED, V18, P1688, DOI 10.1038/nm.2985; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Strokappe N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033298; Trkola A, 1999, J VIROL, V73, P8966, DOI 10.1128/JVI.73.11.8966-8974.1999; Van Herrewege Y, 2008, J ANTIMICROB CHEMOTH, V61, P818, DOI 10.1093/jac/dkn042; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Wang WB, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-14; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhang MY, 2007, CURR PHARM DESIGN, V13, P203, DOI 10.2174/138161207779313669; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	27	40	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e68863	10.1371/journal.pone.0068863	http://dx.doi.org/10.1371/journal.pone.0068863			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23874792	Green Published, gold			2022-12-27	WOS:000322000600033
J	Guthrie, B; Clark, SA; Reynish, EL; McCowan, C; Morales, DR				Guthrie, Bruce; Clark, Stella A.; Reynish, Emma L.; McCowan, Colin; Morales, Daniel R.			Differential Impact of Two Risk Communications on Antipsychotic Prescribing to People with Dementia in Scotland: Segmented Regression Time Series Analysis 2001-2011	PLOS ONE			English	Article							REGULATORY WARNINGS; PRESCRIPTION RATES; ELDERLY-PATIENTS; MEDICATION USE; ADULTS; TRENDS	Background: Regulatory risk communications are an important method for disseminating drug safety information, but their impact varies. Two significant UK risk communications about antipsychotic use in older people with dementia were issued in 2004 and 2009. These varied considerably in their content and dissemination, allowing examination of their differential impact. Methods: Segmented regression time-series analysis 2001-2011 for people aged >= 65 years with dementia in 87 Scottish general practices, examining the impact of two pre-specified risk communications in 2004 and 2009 on antipsychotic and other psychotropic prescribing. Results: The percentage of people with dementia prescribed an antipsychotic was 15.9% in quarter 1 2001 and was rising by an estimated 0.6%/quarter before the 2004 risk communication. The 2004 risk communication was sent directly to all prescribers, and specifically recommended review of all patients prescribed relevant drugs. It was associated with an immediate absolute reduction in antipsychotic prescribing of 5.9% (95% CI -6.6 to -5.2) and a change to a stable level of prescribing subsequently. The 2009 risk communication was disseminated in a limited circulation bulletin, and only specifically recommended avoiding initiation if possible. There was no immediate associated impact, but it was associated with a significant decline in prescribing subsequently which appeared driven by a decline in initiation, with the percentage prescribed an antipsychotic falling from 18.4% in Q1 2009 to 13.5% in Q1 2011. There was no widespread substitution of antipsychotics with other psychotropic drugs. Conclusions: The two risk communications were associated with reductions in antipsychotic use, in ways which were compatible with marked differences in their content and dissemination. Further research is needed to ensure that the content and dissemination of regulatory risk communications is optimal, and to track their impact on intended and unintended outcomes. Although rates are falling, antipsychotic prescribing in dementia in Scotland remains unacceptably high.	[Guthrie, Bruce; Morales, Daniel R.] Med Res Inst, Populat Hlth Sci Div, Dundee, Scotland; [Clark, Stella A.] NHS Fife, Primary Care, Kirkcaldy, Fife, Scotland; [Reynish, Emma L.] Victoria Hosp, Kirkcaldy, Fife, Scotland; [McCowan, Colin] Univ Glasgow, Robertson Ctr Biostat, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland	University of Dundee; University of Glasgow	Guthrie, B (corresponding author), Med Res Inst, Populat Hlth Sci Div, Dundee, Scotland.	b.guthrie@dundee.ac.uk	Guthrie, Bruce/HHM-9696-2022	McCowan, Colin/0000-0002-9466-833X; Reynish, Emma/0000-0002-9076-3911; Guthrie, Bruce/0000-0003-4191-4880	Scottish Government Mental Health Division; Scottish Government Chief Scientist Office Clinical Academic Fellowship [CAF/11/07]; Chief Scientist Office [CAF/11/07] Funding Source: researchfish	Scottish Government Mental Health Division; Scottish Government Chief Scientist Office Clinical Academic Fellowship; Chief Scientist Office	The study was funded by Scottish Government Mental Health Division, and DM is supported by a Scottish Government Chief Scientist Office Clinical Academic Fellowship (CAF/11/07). The authors had full and sole access to the data. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi-Severini S, 2008, PSYCHIAT SERV, V59, P547, DOI 10.1176/ps.2008.59.5.547; Alzheimer's Society Alzheimer Scotland Action on Dementia, 2012, MAPP DEM GAP 2011 PR; Ballard C, 2008, PLOS MED, V5, P587, DOI 10.1371/journal.pmed.0050076; Ballard C, 2009, LANCET NEUROL, V8, P151, DOI 10.1016/S1474-4422(08)70295-3; Ballard CG, 2009, NAT REV NEUROL, V5, P245, DOI 10.1038/nrneurol.2009.39; Banerjee S., 2009, USE ANTIPSYCHOTIC ME; Berr C, 2005, EUR NEUROPSYCHOPHARM, V15, P463, DOI 10.1016/j.euroneuro.2005.04.003; *COMM SAF MED, 2004, SUMM CLIN TRIAL DAT; Department of Health, 2009, GOV RESP S BAN REP P; Department of Health, 2009, LIVING WELL DEMENTIA; Dorsey ER, 2010, ARCH INTERN MED, V170, P96, DOI 10.1001/archinternmed.2009.456; Dusetzina SB, 2012, MED CARE, V50, P466, DOI 10.1097/MLR.0b013e318245a160; Gill SS, 2007, ANN INTERN MED, V146, P775, DOI 10.7326/0003-4819-146-11-200706050-00006; Guthrie B, 2010, AGE AGEING, V39, P637, DOI 10.1093/ageing/afq090; Information Services Division NHS Scotland, 2008, MEAS LONG TERM COND; Kales HC, 2011, ARCH GEN PSYCHIAT, V68, P190, DOI 10.1001/archgenpsychiatry.2010.200; Katz LY, 2008, CAN MED ASSOC J, V178, P1005, DOI 10.1503/cmaj.071265; Libby AM, 2007, AM J PSYCHIAT, V164, P884, DOI 10.1176/appi.ajp.164.6.884; Lockhart P, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X593848; Medicines and Healthcare products Regulatory Agency Commission on Human Medicines, 2009, ANT US ELD PEOPL DEM; MHRA, 2009, CHILDR COUNT COUGH C; MHRA, 2009, MONTHL LISTS LETT HE; *NHS ENGL PRIM CAR, 2009, QOF IMPL BUS RUL; NHS National Prescribing Centre, 2009, IMP UPD DRUG SAF MHR; Ruiter R, 2012, DRUG SAFETY, V35, P471, DOI 10.2165/11596950-000000000-00000; Schneeweiss S, 2007, CAN MED ASSOC J, V176, P627, DOI 10.1503/cmaj.061250; The Information Centre for Health and Social Care, 2012, NAT DEM ANT PRESCR A; US Department of Health and Human Services, 2005, PUBL HLTH ADV DEATHS; Valiyeva E, 2008, CAN MED ASSOC J, V179, P438, DOI 10.1503/cmaj.071540; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x	30	35	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e68976	10.1371/journal.pone.0068976	http://dx.doi.org/10.1371/journal.pone.0068976			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23874832	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000322000600036
J	Jokivarsi, KT; Liimatainen, T; Kauppinen, RA; Grohn, OHJ; Narvainen, J				Jokivarsi, Kimmo T.; Liimatainen, Timo; Kauppinen, Risto A.; Grohn, Olli H. J.; Narvainen, Johanna			Relaxation Along a Fictitious Field (RAFF) and Z-spectroscopy using Alternating-Phase Irradiation (ZAPI) in Permanent Focal Cerebral Ischemia in Rat	PLOS ONE			English	Article							MAGNETIZATION-TRANSFER; ARTERY OCCLUSION; T-1-RHO; TIME; MRI; DISPERSION; DIFFUSION; PERFUSION; CONTRAST; ONSET	Cerebral ischemia alters the molecular dynamics and content of water in brain tissue, which is reflected in NMR relaxation, diffusion and magnetization transfer (MT) parameters. In this study, the behavior of two new MRI contrasts, Relaxation Along a Fictitious Field (RAFF) and Z-spectroscopy using Alternating-Phase Irradiation (ZAPI), were quantified together with conventional relaxation parameters (T-1, T-2 and T-1 rho) and MT ratios in acute cerebral ischemia in rat. The right middle cerebral artery was permanently occluded and quantitative MRI data was acquired sequentially for the above parameters for up to 6 hours. The following conclusions were drawn: 1) Time-dependent changes in RAFF and T-1 rho relaxation are not coupled to those in MT. 2) RAFF relaxation evolves more like transverse, rather than longitudinal relaxation. 3) MT measured with ZAPI is less sensitive to ischemia than conventional MT. 4) ZAPI data suggest alterations in the T-2 distribution of macromolecules in acute cerebral ischemia. It was shown that both RAFF and ZAPI provide complementary MRI information from acute ischemic brain tissue. The presented multiparametric MRI data may aid in the assessment of brain tissue status early in ischemic stroke.	[Jokivarsi, Kimmo T.; Grohn, Olli H. J.] Univ Eastern Finland, AI Virtanen Inst, Dept Neurobiol, Kuopio, Finland; [Liimatainen, Timo] Univ Eastern Finland, AI Virtanen Inst, Dept Biotechnol & Mol Med, Kuopio, Finland; [Kauppinen, Risto A.] Univ Bristol, Clin Res & Imaging Ctr, Bristol, Avon, England; [Kauppinen, Risto A.] Univ Bristol, Sch Expt Psychol, Bristol, Avon, England; [Narvainen, Johanna] VTT Tech Res Ctr Finland, Kuopio, Finland	University of Eastern Finland; University of Eastern Finland; University of Bristol; University of Bristol; VTT Technical Research Center Finland	Narvainen, J (corresponding author), VTT Tech Res Ctr Finland, Kuopio, Finland.	johanna.narvainen@vtt.fi	Liimatainen, Timo/F-9235-2019	Liimatainen, Timo/0000-0001-7472-9900	Academy of Finland; Sigrid Juselius Foundation; Instrumentarium Science Foundation; University of Eastern Finland	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Instrumentarium Science Foundation; University of Eastern Finland	The work was supported by Academy of Finland (JN, OHJG), Sigrid Juselius Foundation (TL), Instrumentarium Science Foundation (TL) and UEF-Brain strategic funding from University of Eastern Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers GW, 2006, ANN NEUROL, V60, P508, DOI 10.1002/ana.20976; Dzialowski I, 2004, J NEUROIMAGING, V14, P42, DOI 10.1177/1051228403258135; Ewing JR, 1999, MAGN RESON MED, V41, P696, DOI 10.1002/(SICI)1522-2594(199904)41:4<696::AID-MRM7>3.0.CO;2-5; Grohn OHJ, 1998, J CEREBR BLOOD F MET, V18, P911; Grohn OHJ, 2000, J CEREBR BLOOD F MET, V20, P1457; Jokivarsi KT, 2010, STROKE, V41, P2335, DOI 10.1161/STROKEAHA.110.587394; Jokivarsi KT, 2010, J CEREBR BLOOD F MET, V30, P415, DOI 10.1038/jcbfm.2009.236; Jokivarsi KT, 2009, J CEREBR BLOOD F MET, V29, P206, DOI 10.1038/jcbfm.2008.113; Kettunen MI, 2002, MAGNET RESON MED, V48, P470, DOI 10.1002/mrm.10233; Liimatainen T, 2011, J MAGN RESON, V209, P269, DOI 10.1016/j.jmr.2011.01.022; Liimatainen T, 2010, MAGN RESON MED, V64, P983, DOI 10.1002/mrm.22372; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Makela HI, 2002, J CEREBR BLOOD F MET, V22, P547; Narvainen J, 2010, J MAGN RESON, V207, P242, DOI 10.1016/j.jmr.2010.09.004; ORDIDGE RJ, 1991, MAGN RESON IMAGING, V9, P895, DOI 10.1016/0730-725X(91)90533-R; Shen Q, 2004, J CEREBR BLOOD F MET, V24, P887, DOI 10.1097/01.WCB.0000124321.60992.87; Siemonsen S, 2009, STROKE, V40, P1612, DOI 10.1161/STROKEAHA.108.542548	17	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e69157	10.1371/journal.pone.0069157	http://dx.doi.org/10.1371/journal.pone.0069157			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23874898	Green Published, gold, Green Submitted			2022-12-27	WOS:000322000600043
J	Bringloe, TT; Drolet, D; Barbeau, MA; Forbes, MR; Gerwing, TG				Bringloe, Trevor T.; Drolet, David; Barbeau, Myriam A.; Forbes, Mark R.; Gerwing, Travis G.			Spatial Variation in Population Structure and Its Relation to Movement and the Potential for Dispersal in a Model Intertidal Invertebrate	PLOS ONE			English	Article							AMPHIPOD COROPHIUM-VOLUTATOR; UPPER BAY; INBREEDING AVOIDANCE; NATAL DISPERSAL; REPRODUCTIVE-BIOLOGY; DEPENDENT DISPERSAL; FUNDY; CRUSTACEA; PALLAS; BEHAVIOR	Dispersal, the movement of an individual away from its natal or breeding ground, has been studied extensively in birds and mammals to understand the costs and benefits of movement behavior. Whether or not invertebrates disperse in response to such attributes as habitat quality or density of conspecifics remains uncertain, due in part to the difficulties in marking and recapturing invertebrates. In the upper Bay of Fundy, Canada, the intertidal amphipod Corophium volutator swims at night around the new or full moon. Furthermore, this species is regionally widespread across a large spatial scale with site-to- site variation in population structure. Such variation provides a backdrop against which biological determinants of dispersal can be investigated. We conducted a large-scale study at nine mudflats, and used swimmer density, sampled using stationary plankton nets, as a proxy for dispersing individuals. We also sampled mud residents using sediment cores over 3 sampling rounds (20-28 June, 10-17 July, 2-11 August 2010). Density of swimmers was most variable at the largest spatial scales, indicating important population-level variation. The smallest juveniles and large juveniles or small adults (particularly females) were consistently overrepresented as swimmers. Small juveniles swam at most times and locations, whereas swimming of young females decreased with increasing mud presence of young males, and swimming of large juveniles decreased with increasing mud presence of adults. Swimming in most stages increased with density of mud residents; however, proportionally less swimming occurred as total mud resident density increased. We suggest small juveniles move in search of C. volutator aggregations which possibly act as a proxy for better habitat. We also suggest large juveniles and small adults move if potential mates are limiting. Future studies can use sampling designs over large spatial scales with varying population structure to help understand the behavioral ecology of movement, and dispersal in invertebrate taxa.	[Bringloe, Trevor T.; Barbeau, Myriam A.; Gerwing, Travis G.] Univ New Brunswick, Dept Biol, Fredericton, NB E3B 6E1, Canada; [Drolet, David] Mt Allison Univ, Dept Biol, Sackville, NB E0A 3C0, Canada; [Forbes, Mark R.] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada	University of New Brunswick; Mount Allison University; Carleton University	Bringloe, TT (corresponding author), Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada.	tbringlo@uoguelph.ca	Gerwing, Travis/AAU-6569-2020	Gerwing, Travis/0000-0002-4433-1843; Bringloe, Trevor/0000-0002-5976-6700; Forbes, Mark/0000-0002-2288-3209	Natural Science and Engineering Research Council of Canada (NSERC); Work-Study Program at UNB; Canada Summer Job Program	Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Work-Study Program at UNB; Canada Summer Job Program	The project was funded by a Strategic Project Grant from the Natural Science and Engineering Research Council of Canada (NSERC), a NSERC Discovery Grant to MAB, the Work-Study Program at UNB, and the Canada Summer Job Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrectsen B, 2001, OIKOS, V94, P263, DOI 10.1034/j.1600-0706.2001.940206.x; Baker MB, 2004, J INSECT BEHAV, V17, P579, DOI 10.1023/B:JOIR.0000042542.27320.8f; Barbeau MA, 2003, CRUSTACEANA, V76, P665, DOI 10.1163/156854003322381496; Barbeau MA, 2009, J CRUSTACEAN BIOL, V29, P491, DOI 10.1651/08-3067.1; Beirinckx K, 2006, OIKOS, V113, P539, DOI 10.1111/j.2006.0030-1299.14391.x; Bilton DT, 2001, ANNU REV ECOL SYST, V32, P159, DOI 10.1146/annurev.ecolsys.32.081501.114016; BOATES J S, 1979, Proceedings of the Nova Scotian Institute of Science, V29, P489; Bretman A, 2011, MOL ECOL, V20, P3045, DOI 10.1111/j.1365-294X.2011.05140.x; Broquet T, 2009, ANNU REV ECOL EVOL S, V40, P193, DOI 10.1146/annurev.ecolsys.110308.120324; Buckley P, 2004, CRUSTACEANA, V77, P425, DOI 10.1163/1568540041643319; Bulling M, 2008, OECOLOGIA, V158, P511, DOI 10.1007/s00442-008-1160-5; Caudill CC, 2003, OIKOS, V101, P624, DOI 10.1034/j.1600-0706.2003.12467.x; Coffin MRS, 2012, J EXP MAR BIOL ECOL, V418, P12, DOI 10.1016/j.jembe.2012.03.002; Costello CM, 2008, MOL ECOL, V17, P4713, DOI 10.1111/j.1365-294X.2008.03930.x; Crewe TL, 2001, ESTUAR COAST SHELF S, V53, P151, DOI 10.1006/ecss.2001.0795; Danchin Etienne, 2001, P243; De Backer A, 2011, ESTUAR COAST SHELF S, V91, P306, DOI 10.1016/j.ecss.2010.10.031; De Luca PA, 2008, BEHAV ECOL SOCIOBIOL, V62, P1869, DOI 10.1007/s00265-008-0616-2; Drolet D, 2013, ESTUAR COAST, V36, P940, DOI 10.1007/s12237-013-9605-4; Drolet D, 2012, J SEA RES, V70, P1, DOI 10.1016/j.seares.2012.02.001; Drolet D, 2012, MAR ECOL PROG SER, V449, P197, DOI 10.3354/meps09495; Drolet D, 2011, MAR ECOL PROG SER, V431, P255, DOI 10.3354/meps09121; Drolet D, 2009, J EXP MAR BIOL ECOL, V370, P41, DOI 10.1016/j.jembe.2008.11.012; Drolet D, 2009, J CRUSTACEAN BIOL, V29, P51, DOI 10.1651/08-3010.1; Einfeldt AL, 2013, MAR BIOL, V160, P1015, DOI 10.1007/s00227-012-2154-8; ESSINK K, 1989, J MAR BIOL ASSOC UK, V69, P11, DOI 10.1017/S0025315400049067; FISH JD, 1979, J MAR BIOL ASSOC UK, V59, P355, DOI 10.1017/S002531540004265X; Forbes MR, 2006, BEHAV ECOL SOCIOBIOL, V60, P87, DOI 10.1007/s00265-005-0144-2; Ford RB, 2001, ESTUAR COAST SHELF S, V52, P357, DOI 10.1006/ecss.2000.0712; FRANZ DR, 1989, J EXP MAR BIOL ECOL, V133, P1, DOI 10.1016/0022-0981(89)90154-8; GERDOL V, 1994, MAR ECOL PROG SER, V114, P103, DOI 10.3354/meps114103; Godbold JA, 2011, P ROY SOC B-BIOL SCI, V278, P2510, DOI 10.1098/rspb.2010.2414; GREENWOOD PJ, 1982, ANNU REV ECOL SYST, V13, P1, DOI 10.1146/annurev.es.13.110182.000245; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; HUGHES RG, 1990, J MAR BIOL ASSOC UK, V70, P143, DOI 10.1017/S0025315400034263; HUGHES RG, 1988, J MAR BIOL ASSOC UK, V68, P565, DOI 10.1017/S002531540002871X; JENSEN KT, 1990, J EXP MAR BIOL ECOL, V137, P1, DOI 10.1016/0022-0981(90)90057-J; Johannesen J, 2012, BEHAV ECOL SOCIOBIOL, V66, P1387, DOI 10.1007/s00265-012-1394-4; Johns RC, 2009, ENTOMOL EXP APPL, V132, P264, DOI 10.1111/j.1570-7458.2009.00890.x; KEOUGH MJ, 2002, EXPT DESIGN DATA ANA; Komatsu Teruhisa, 1992, Journal of Oceanography, V48, P353, DOI 10.1007/BF02234014; Lagisz M, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.10501; Lambin Xavier, 2001, P110; Lawrie SM, 1998, J EXP MAR BIOL ECOL, V224, P237, DOI 10.1016/S0022-0981(97)00199-8; MCARDLE BH, 1988, CAN J ZOOL, V66, P2329, DOI 10.1139/z88-348; McCurdy DG, 2004, J CRUSTACEAN BIOL, V24, P261, DOI 10.1651/C-2463; MEADOWS PS, 1966, J ZOOL, V150, P387; MEADOWS PS, 1964, J EXP BIOL, V41, P677; Munguia P, 2007, OECOLOGIA, V153, P533, DOI 10.1007/s00442-007-0762-7; Nichols J., 2001, DISPERSAL; Pechenik JA, 1999, MAR ECOL PROG SER, V177, P269, DOI 10.3354/meps177269; PEER DL, 1986, NETH J SEA RES, V20, P359, DOI 10.1016/0077-7579(86)90003-7; Perrin Nicolas, 2001, P123; SCHNEIDER SD, 1994, CAN J ZOOL, V72, P1915, DOI 10.1139/z94-260; Sokal R. R, 1981, BIOMETRY; Stevens MI, 2006, J EXP MAR BIOL ECOL, V331, P9, DOI 10.1016/j.jembe.2005.09.018; STRATHMANN RR, 1993, ANNU REV ECOL SYST, V24, P89, DOI 10.1146/annurev.es.24.110193.000513; STRICKLAND D, 1991, CAN J ZOOL, V69, P2935, DOI 10.1139/z91-414; Taylor R.J., 1984, PREDATION; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Wheelwright NT, 1998, ECOLOGY, V79, P755, DOI 10.1890/0012-9658(1998)079[0755:PNDAIA]2.0.CO;2; WILSON WH, 1989, J EXP MAR BIOL ECOL, V132, P221, DOI 10.1016/0022-0981(89)90129-9; Winer B.J., 1991, STAT PRINCIPLES EXPT	63	12	12	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e69091	10.1371/journal.pone.0069091	http://dx.doi.org/10.1371/journal.pone.0069091			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	23874877	Green Published, gold			2022-12-27	WOS:000321718700047
J	Hauser, MJ; Dlugolenski, D; Culhane, MR; Wentworth, DE; Tompkins, SM; Tripp, RA				Hauser, Mary J.; Dlugolenski, Daniel; Culhane, Marie R.; Wentworth, David E.; Tompkins, S. Mark; Tripp, Ralph A.			Antiviral Responses by Swine Primary Bronchoepithelial Cells Are Limited Compared to Human Bronchoepithelial Cells Following Influenza Virus Infection	PLOS ONE			English	Article							PATHOGENIC AVIAN INFLUENZA; DOUBLE-STRANDED-RNA; A VIRUS; EPITHELIAL-CELLS; RIG-I; NS1 PROTEIN; H1N1 INFLUENZA; INTERFERON; REPLICATION; RECOGNITION	Swine generate reassortant influenza viruses because they can be simultaneously infected with avian and human influenza; however, the features that restrict influenza reassortment in swine and human hosts are not fully understood. Type I and III interferons (IFNs) act as the first line of defense against influenza virus infection of respiratory epithelium. To determine if human and swine have different capacities to mount an antiviral response the expression of IFN and IFN-stimulated genes (ISG) in normal human bronchial epithelial (NHBE) cells and normal swine bronchial epithelial (NSBE) cells was evaluated following infection with human (H3N2), swine (H1N1), and avian (H5N3, H5N2, H5N1) influenza A viruses. Expression of IFN lambda and ISGs were substantially higher in NHBE cells compared to NSBE cells following H5 avian influenza virus infection compared to human or swine influenza virus infection. This effect was associated with reduced H5 avian influenza virus replication in human cells at late times post infection. Further, RIG-I expression was lower in NSBE cells compared to NHBE cells suggesting reduced virus sensing. Together, these studies identify key differences in the antiviral response between human and swine respiratory epithelium alluding to differences that may govern influenza reassortment.	[Hauser, Mary J.; Dlugolenski, Daniel; Tompkins, S. Mark; Tripp, Ralph A.] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA; [Culhane, Marie R.] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA; [Wentworth, David E.] J Craig Venter Inst, Rockville, MD USA	University System of Georgia; University of Georgia; University of Minnesota System; University of Minnesota Twin Cities; J. Craig Venter Institute	Tripp, RA (corresponding author), Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA.	ratripp@uga.edu	Tompkins, Stephen/A-3317-2008; Culhane, Marie/H-3143-2019	Tompkins, Stephen/0000-0002-1523-5588; Wentworth, David/0000-0002-5190-980X; Tripp, Ralph/0000-0002-2924-9956; Culhane, Marie/0000-0002-3547-7576	National Institutes of Health/National Institute of Allergy and Infectious Diseases [HHSN266200700006C]	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by National Institutes of Health/National Institute of Allergy and Infectious Diseases (HHSN266200700006C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; BARBE F, VET J IN PRESS; BEARE AS, 1991, ARCH VIROL, V119, P37, DOI 10.1007/BF01314321; Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; Ciencewicki JM, 2009, J INTERF CYTOK RES, V29, P289, DOI 10.1089/jir.2008.0075; Cohen-Daniel L, 2009, J CLIN VIROL, V44, P138, DOI 10.1016/j.jcv.2008.11.014; Cong YL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012591; De Vleeschauwer A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006662; Flores-Ocelotl MD, 2011, BRAZ J MICROBIOL, V42, P1166; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Ehrhardt C, 2010, MICROBES INFECT, V12, P81, DOI 10.1016/j.micinf.2009.09.007; Fischer BM, 1999, AM J RESP CELL MOL, V20, P413, DOI 10.1165/ajrcmb.20.3.3393; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hass J, 2011, INFECT GENET EVOL, V11, P437, DOI 10.1016/j.meegid.2010.12.001; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Haye K, 2009, J VIROL, V83, P6849, DOI 10.1128/JVI.02323-08; Hayman A, 2007, J VIROL, V81, P2318, DOI 10.1128/JVI.01856-06; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hong Z, 2009, SCI CHINA SER C, V52, P1101, DOI 10.1007/s11427-009-0161-x; Hui KPY, 2011, J INFECT DIS, V204, P1866, DOI 10.1093/infdis/jir665; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; Jewell NA, 2010, J VIROL, V84, P11515, DOI 10.1128/JVI.01703-09; Kalthoff D, 2010, VET MICROBIOL, V140, P237, DOI 10.1016/j.vetmic.2009.08.022; Karlas A, 2010, NATURE, V463, P818, DOI 10.1038/nature08760; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Lam WY, 2008, J VIROL, V82, P2741, DOI 10.1128/JVI.01712-07; Lu WJ, 2006, J IMMUNOL, V176, P3890, DOI 10.4049/jimmunol.176.7.3890; Ma W, 2009, ZOONOSES PUBLIC HLTH, V56, P326, DOI 10.1111/j.1863-2378.2008.01217.x; Ma Wenjun, 2008, J Mol Genet Med, V3, P158; Mangan NE, 2012, IMMUNOL CELL BIOL, V90, P510, DOI 10.1038/icb.2012.13; Manuse MJ, 2010, VIROLOGY, V397, P231, DOI 10.1016/j.virol.2009.11.014; Mehle A, 2012, J VIROL, V86, P1750, DOI 10.1128/JVI.06203-11; Monzon ME, 2010, J BIOL CHEM, V285, P26126, DOI 10.1074/jbc.M110.135194; Morens DM, 2010, MBIO, V1, DOI 10.1128/mBio.00211-10; Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926; Nazmi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021761; Nelli RK, 2012, J VIROL, V86, P9201, DOI 10.1128/JVI.00244-12; Nelli RK, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-4; Nelson MI, 2012, J VIROL, V86, P8872, DOI 10.1128/JVI.00259-12; PENSAERT M, 1981, B WORLD HEALTH ORGAN, V59, P75; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Robertson JS, 2011, VIRUS RES, V162, P39, DOI 10.1016/j.virusres.2011.09.024; Schmolke M, 2010, CELL MICROBIOL, V12, P873, DOI 10.1111/j.1462-5822.2010.01475.x; SCHOLTISSEK C, 1985, VIROLOGY, V147, P287, DOI 10.1016/0042-6822(85)90131-X; SCHOLTISSEK C, 1978, VIROLOGY, V87, P13, DOI 10.1016/0042-6822(78)90153-8; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Smith GJD, 2009, P NATL ACAD SCI USA, V106, P11709, DOI 10.1073/pnas.0904991106; Squires K, 2010, PEDIATR PULM, V45, P409, DOI 10.1002/ppul.21177; Sutejo R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033732; Trebbien R, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-434; Trifonov V, 2009, NEW ENGL J MED, V361, P115, DOI 10.1056/NEJMp0904572; Uen YH, 2006, CLIN CHIM ACTA, V367, P55, DOI 10.1016/j.cca.2005.11.013; Van Poucke SGM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-38; Van Reeth K, 2000, VET MICROBIOL, V74, P109, DOI 10.1016/S0378-1135(00)00171-1; Vareille M, 2011, CLIN MICROBIOL REV, V24, P210, DOI 10.1128/CMR.00014-10; Vincent AL, 2008, ADV VIRUS RES, V72, P127, DOI 10.1016/S0065-3527(08)00403-X; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	59	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e70251	10.1371/journal.pone.0070251	http://dx.doi.org/10.1371/journal.pone.0070251			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23875024	Green Published, Green Submitted, gold			2022-12-27	WOS:000321765300083
J	Khammanivong, A; Wang, CX; Sorenson, BS; Ross, KF; Herzberg, MC				Khammanivong, Ali; Wang, Chengxing; Sorenson, Brent S.; Ross, Karen F.; Herzberg, Mark C.			S100A8/A9 (Calprotectin) Negatively Regulates G2/M Cell Cycle Progression and Growth of Squamous Cell Carcinoma	PLOS ONE			English	Article							EPITHELIAL-CELLS; GENE-EXPRESSION; HUMAN CDC25C; PROTEIN; HEAD; PHOSPHATASE; PP2A; PHOSPHORYLATION; ARREST; RAGE	Malignant transformation results in abnormal cell cycle regulation and uncontrolled growth in head and neck squamous cell carcinoma (HNSCC) and other cancers. S100A8/A9 (calprotectin) is a calcium-binding heterodimeric protein complex implicated in cell cycle regulation, but the specific mechanism and role in cell cycle control and carcinoma growth are not well understood. In HNSCC, S100A8/A9 is downregulated at both mRNA and protein levels. We now report that downregulation of S100A8/A9 correlates strongly with a loss of cell cycle control and increased growth of carcinoma cells. To show its role in carcinogenesis in an in vitro model, S100A8/A9 was stably expressed in an S100A8/A9-negative human carcinoma cell line (KB cells, HeLa-like). S100A8/A9 expression increases PP2A phosphatase activity and p-Chk1 (Ser345) phosphorylation, which appears to signal inhibitory phosphorylation of mitotic p-Cdc25C (Ser216) and p-Cdc2 (Thr14/Tyr15) to inactivate the G2/M Cdc2/cyclin B1 complex. Cyclin B1 expression then downregulates and the cell cycle arrests at the G2/M checkpoint, reducing cell division. As expected, S100A8/A9-expressing cells show both decreased anchorage-dependent and -independent growth and mitotic progression. Using shRNA, silencing of S100A8/A9 expression in the TR146 human HNSCC cell line increases growth and survival and reduces Cdc2 inhibitory phosphorylation at Thr14/Tyr15. The level of S100A8/A9 endogenous expression correlates strongly with the reduced p-Cdc2 (Thr14/Tyr14) level in HNSCC cell lines, SCC-58, OSCC-3 and UMSCC-17B. S100A8/A9-mediated control of the G2/M cell cycle checkpoint is, therefore, a likely suppressive mechanism in human squamous cell carcinomas and may suggest new therapeutic approaches.	[Khammanivong, Ali; Wang, Chengxing; Sorenson, Brent S.; Ross, Karen F.; Herzberg, Mark C.] Univ Minnesota, Dept Diagnost & Biol Sci, Minneapolis, MN 55812 USA; [Ross, Karen F.; Herzberg, Mark C.] Univ Minnesota, Mucosal & Vaccine Res Ctr, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Herzberg, MC (corresponding author), Univ Minnesota, Dept Diagnost & Biol Sci, Minneapolis, MN 55812 USA.	mcherzb@umn.edu	Khammanivong, Ali/V-4962-2019	Khammanivong, Ali/0000-0002-1131-8271	National Institutes of Health/National Institue of Dental and Craniofacial Research [T32DE007288, F30DE020210, R01DE11831]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [F30DE020210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE011831, T32DE007288] Funding Source: NIH RePORTER	National Institutes of Health/National Institue of Dental and Craniofacial Research; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health/National Institue of Dental and Craniofacial Research grants T32DE007288 to AK and BSS, F30DE020210 to BSS, and R01DE11831 to MCH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal C, 2003, ONCOGENE, V22, P8271, DOI 10.1038/sj.onc.1207158; [Anonymous], J MOL BIOL; [Anonymous], CANC METASTASIS REV; Arai K, 2001, ONCOL REP, V8, P591; Arai K, 2008, CURR CANCER DRUG TAR, V8, P243, DOI 10.2174/156800908784533445; Bulavin DV, 2003, NAT CELL BIOL, V5, P545, DOI 10.1038/ncb994; Champaiboon C, 2009, J BIOL CHEM, V284, P7078, DOI 10.1074/jbc.M806605200; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; COLEMAN N, 1994, HUM PATHOL, V25, P73, DOI 10.1016/0046-8177(94)90174-0; Driemel O, 2007, PROTEOM CLIN APPL, V1, P486, DOI 10.1002/prca.200600669; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; Eicher SA, 1996, CLIN CANCER RES, V2, P1659; Ely MR, 2005, EUR J CELL BIOL, V84, P431, DOI 10.1016/j.ejcb.2005.01.003; Forester CM, 2007, P NATL ACAD SCI USA, V104, P19867, DOI 10.1073/pnas.0709879104; Franckhauser C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011798; Fung LF, 2000, LIFE SCI, V67, P923, DOI 10.1016/S0024-3205(00)00684-6; Gebhardt C, 2002, ONCOGENE, V21, P4266, DOI 10.1038/sj.onc.1205521; Gebhardt C, 2006, BIOCHEM PHARMACOL, V72, P1622, DOI 10.1016/j.bcp.2006.05.017; Ghavami S, 2008, J LEUKOCYTE BIOL, V83, P1484, DOI 10.1189/jlb.0607397; Ghavami S, 2008, BBA-MOL CELL RES, V1783, P297, DOI 10.1016/j.bbamcr.2007.10.015; Glatter T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.75; Gonzalez HE, 2003, ARCH OTOLARYNGOL, V129, P754, DOI 10.1001/archotol.129.7.754; Graves PR, 2001, ONCOGENE, V20, P1839, DOI 10.1038/sj.onc.1204259; Guenin S, 2008, INT J ONCOL, V32, P49; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hermani A, 2005, EXP CELL RES, V312, P184, DOI 10.1016/j.yexcr.2005.10.013; Hessian PA, 2001, EUR J BIOCHEM, V268, P353, DOI 10.1046/j.1432-1327.2001.01894.x; Hitomi J, 1998, ARCH HISTOL CYTOL, V61, P163, DOI 10.1679/aohc.61.163; Hofstetter CP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030059; Hsu Kenneth, 2009, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V8, P290; Ito Y, 2009, ANTICANCER RES, V29, P4157; Itou H, 2002, J MOL BIOL, V316, P265, DOI 10.1006/jmbi.2001.5340; Kong JP, 2004, WORLD J GASTROENTERO, V10, P1093; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Kumar P, 2008, MOL CANCER THER, V7, P2060, DOI 10.1158/1535-7163.MCT-08-0287; Lee Y, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000730; Maalouf M, 2009, INT J RADIAT ONCOL, V74, P200, DOI 10.1016/j.ijrobp.2009.01.012; Margolis SS, 2006, CELL, V127, P759, DOI 10.1016/j.cell.2006.10.035; Melle C, 2004, CANCER RES, V64, P4099, DOI 10.1158/0008-5472.CAN-03-3807; Moon A, 2008, MOL CANCER RES, V6, P1544, DOI 10.1158/1541-7786.MCR-08-0189; Nemeth J, 2009, HEPATOLOGY, V50, P1251, DOI 10.1002/hep.23099; Nisapakultorn K, 2001, INFECT IMMUN, V69, P4242, DOI 10.1128/IAI.69.7.4242-4247.2001; Nukui T, 2008, J CELL BIOCHEM, V104, P453, DOI 10.1002/jcb.21639; Odegaard E, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.10.792; Ozen M, 2005, CLIN CANCER RES, V11, P4701, DOI 10.1158/1078-0432.CCR-04-2551; Peng CY, 1998, CELL GROWTH DIFFER, V9, P197; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Perrotti D, 2008, CANCER METAST REV, V27, P159, DOI 10.1007/s10555-008-9119-x; Perry JA, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-12; Pitre A, 2012, MOL BIOL CELL, V23, P1243, DOI 10.1091/mbc.E11-08-0685; Qin FJ, 2010, PATHOL ONCOL RES, V16, P353, DOI 10.1007/s12253-009-9225-2; Ross KF, 2001, INFECT IMMUN, V69, P3248, DOI 10.1128/IAI.69.5.3248-3254.2001; RUPNIAK HT, 1985, J NATL CANCER I, V75, P621; Shiromizu T, 2006, GENES CELLS, V11, P477, DOI 10.1111/j.1365-2443.2006.00955.x; Soni DV, 2008, CELL CYCLE, V7, P1285, DOI 10.4161/cc.7.9.5711; Sorenson BS, 2012, MUCOSAL IMMUNOL, V5, P66, DOI 10.1038/mi.2011.48; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Tugizov S, 2005, J VIROL, V79, P1099, DOI 10.1128/JVI.79.2.1099-1112.2005; Turovskaya O, 2008, CARCINOGENESIS, V29, P2035, DOI 10.1093/carcin/bgn188; Voss A, 2011, FEBS LETT, V585, P440, DOI 10.1016/j.febslet.2010.12.037; Wang J, 2004, CELL RES, V14, P46, DOI 10.1038/sj.cr.7290201; Wang XM, 2008, J CELL BIOCHEM, V104, P1181, DOI 10.1002/jcb.21693; Worsham MJ, 2006, ARCH OTOLARYNGOL, V132, P668, DOI 10.1001/archotol.132.6.668; Xiong Y, 2013, NEUROBIOL AGING, V34, P745, DOI 10.1016/j.neurobiolaging.2012.07.003; Yang J, 2010, FREE RADICAL RES, V44, P792, DOI 10.3109/10715762.2010.481302; Yao R, 2007, ANTICANCER RES, V27, P3051; Yong HY, 2007, ARCH PHARM RES, V30, P75, DOI 10.1007/BF02977781; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X	68	37	38	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e69395	10.1371/journal.pone.0069395	http://dx.doi.org/10.1371/journal.pone.0069395			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874958	gold, Green Published, Green Submitted			2022-12-27	WOS:000321736900156
J	Zha, TS; Li, CY; Kellomaki, S; Peltola, H; Wang, KY; Zhang, YQ				Zha, Tianshan; Li, Chunyi; Kellomaki, Seppo; Peltola, Heli; Wang, Kai-Yun; Zhang, Yuqing			Controls of Evapotranspiration and CO2 Fluxes from Scots Pine by Surface Conductance and Abiotic Factors	PLOS ONE			English	Article							TERM ENVIRONMENTAL CONTROLS; BOREAL CONIFEROUS FOREST; WATER-USE EFFICIENCY; DOUGLAS-FIR FOREST; CARBON-DIOXIDE; ECOSYSTEM RESPIRATION; INTERANNUAL VARIATION; CANOPY CONDUCTANCE; STOMATAL CONTROL; EDDY COVARIANCE	Evapotranspiration (E) and CO2 flux (F-c) in the growing season of an unusual dry year were measured continuously over a Scots pine forest in eastern Finland, by eddy covariance techniques. The aims were to gain an understanding of their biological and environmental control processes. As a result, there were obvious diurnal and seasonal changes in E, Fc, surface conductance (g(c)), and decoupling coefficient (Omega), showing similar trends to those in radiation (PAR) and vapour pressure deficit (delta). The maximum mean daily values (24-h average) for E, F-c, g(c), and Omega were 1.78 mmol m(-2) s(-1), -11.18 mu mol m(-2) s(-1), 6.27 mm s(-1), and 0.31, respectively, with seasonal averages of 0.71 mmol m(-2) s(-1), 24.61 mmol m(-2) s(-1), 3.3 mm s(-1), and 0.16. E and F-c were controlled by combined biological and environmental variables. There was curvilinear dependence of E on g(c) and F-c on g(c). Among the environmental variables, PAR was the most important factor having a positive linear relationship to E and curvilinear relationship to F-c, while vapour pressure deficit was the most important environmental factor affecting g(c). Water use efficiency was slightly higher in the dry season, with mean monthly values ranging from 6.67 to 7.48 mu mol CO2 (mmol H2O)(-1) and a seasonal average of 7.06 mu mol CO2 (mu mol H2O)(-1). Low Omega and its close positive relationship with g(c) indicate that evapotranspiration was sensitive to surface conductance. Mid summer drought reduced surface conductance and decoupling coefficient, suggesting a more biotic control of evapotranspiration and a physiological acclimation to dry air. Surface conductance remained low and constant under dry condition, supporting that a constant value of surface constant can be used for modelling transpiration under drought condition.	[Zha, Tianshan; Li, Chunyi; Zhang, Yuqing] Beijing Forestry Univ, Sch Soil & Water Conservat, Beijing, Peoples R China; [Kellomaki, Seppo; Peltola, Heli] Univ Eastern Finland, Fac Sci & Forestry, Joensuu, Finland; [Wang, Kai-Yun] E China Normal Univ, Urban Ecol & Restorat Key Lab, Shanghai 200062, Peoples R China	Beijing Forestry University; University of Eastern Finland; East China Normal University	Zha, TS (corresponding author), Beijing Forestry Univ, Sch Soil & Water Conservat, Beijing, Peoples R China.	tianshanzha@bjfu.edu.cn; zhangyq@bjfu.edu.cn			Beijing Forestry University; University of Eastern Finland; national natural science foundation of China [NSFC 31270755]; Academy of Finland [268471]	Beijing Forestry University; University of Eastern Finland; national natural science foundation of China(National Natural Science Foundation of China (NSFC)); Academy of Finland(Academy of Finland)	This work was supported by the Beijing Forestry University and the University of Eastern Finland. Funding was provided by national natural science foundation of China (NSFC 31270755) and the Academy of Finland (268471). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addington RN, 2004, TREE PHYSIOL, V24, P561, DOI 10.1093/treephys/24.5.561; Baldocchi D, 1998, AGR FOREST METEOROL, V90, P1, DOI 10.1016/S0168-1923(97)00072-5; Berninger F, 1996, ANN BOT-LONDON, V77, P469, DOI 10.1006/anbo.1996.0057; Brummer C, 2012, AGR FOREST METEOROL, V153, P14, DOI 10.1016/j.agrformet.2011.04.008; Buckley TN, 2003, PLANT CELL ENVIRON, V26, P1767, DOI 10.1046/j.1365-3040.2003.01094.x; Carter TR, 2002, UNDERSTANDING THE GL; Falge E, 2002, AGR FOREST METEOROL, V113, P53, DOI 10.1016/S0168-1923(02)00102-8; GANSTER J, 1999, POLYM HDB; Gunderson CA, 2002, PLANT CELL ENVIRON, V25, P379, DOI 10.1046/j.0016-8025.2001.00816.x; Hall FG, 1999, J GEOPHYS RES-ATMOS, V104, P27627, DOI 10.1029/1999JD901026; Hari P, 2003, TREE PHYSIOL, V23, P145, DOI 10.1093/treephys/23.3.145; Helmisaari HS, 2002, FOREST ECOL MANAG, V165, P317, DOI 10.1016/S0378-1127(01)00648-X; Hu ZM, 2009, AGR FOREST METEOROL, V149, P1410, DOI 10.1016/j.agrformet.2009.03.014; Humphreys ER, 2003, AGR FOREST METEOROL, V115, P109, DOI 10.1016/S0168-1923(02)00171-5; JARVIS PG, 1986, ADV ECOL RES, V15, P1, DOI 10.1016/S0065-2504(08)60119-1; Katul G, 2010, ANN BOT-LONDON, V105, P431, DOI 10.1093/aob/mcp292; Kellomaki S, 2000, ECOL MODEL, V128, P63, DOI 10.1016/S0304-3800(99)00224-0; Kellomaki S, 1999, ECOL MODEL, V124, P145, DOI 10.1016/S0304-3800(99)00159-3; Kumagai T, 2004, J HYDROL, V287, P237, DOI 10.1016/j.jhydrol.2003.10.002; Mahrt L, 1998, J ATMOS OCEAN TECH, V15, P416, DOI 10.1175/1520-0426(1998)015<0416:FSEFAA>2.0.CO;2; Meinzer FC, 1997, PLANT CELL ENVIRON, V20, P1301, DOI 10.1046/j.1365-3040.1997.d01-18.x; Moncrieff JB, 1997, ECOL MODEL, V188/189, P589; Monteith J.L., 1990, PRINCIPLES ENV PHYS, V2nd; Oren R, 1998, ECOL APPL, V8, P990, DOI 10.1890/1051-0761(1998)008[0990:WBDTSL]2.0.CO;2; PAW UKT, 1989, AGR FOREST METEOROL, V47, P259, DOI 10.1016/0168-1923(89)90099-3; Ponton S, 2006, GLOBAL CHANGE BIOL, V12, P294, DOI 10.1111/j.1365-2486.2005.01103.x; RAUPACH MR, 1988, AUST J PLANT PHYSIOL, V15, P705, DOI 10.1071/PP9880705; Sauer TJ, 2007, AGR FOREST METEOROL, V145, P206, DOI 10.1016/j.agrformet.2007.04.015; Scott RL, 2006, HYDROL PROCESS, V20, P3227, DOI 10.1002/hyp.6329; STEWART JB, 1988, AGR FOREST METEOROL, V43, P19, DOI 10.1016/0168-1923(88)90003-2; Stoy PC, 2006, GLOBAL CHANGE BIOL, V12, P2115, DOI 10.1111/j.1365-2486.2006.01244.x; TAIZ L, 1999, PLANT PHYSL; Turnipseed AA, 2002, AGR FOREST METEOROL, V110, P177, DOI 10.1016/S0168-1923(01)00290-8; Wang KY, 2004, ECOL MODEL, V179, P259, DOI 10.1016/j.ecolmodel.2003.12.049; Wang QG, 2003, ECOL MODEL; Wever LA, 2002, AGR FOREST METEOROL, V112, P31, DOI 10.1016/S0168-1923(02)00041-2; Wilson KB, 2000, AGR FOREST METEOROL, V100, P1, DOI 10.1016/S0168-1923(99)00088-X; Wu SH, 2011, ECOL MODEL, V222, P3103, DOI 10.1016/j.ecolmodel.2011.05.023; Wullschleger SD, 2002, NEW PHYTOL, V153, P485, DOI 10.1046/j.0028-646X.2001.00333.x; Yoshida M, 2010, J HYDROL, V395, P180, DOI 10.1016/j.jhydrol.2010.10.023; Zha T, 2004, GLOBAL CHANGE BIOL, V10, P1492, DOI 10.1111/j.1365-2486.2004.00835.x; Zha TS, 2010, AGR FOREST METEOROL, V150, P1476, DOI 10.1016/j.agrformet.2010.08.003; Zhang YQ, 2011, AGR WATER MANAGE, V98, P1207, DOI 10.1016/j.agwat.2011.03.006	43	23	26	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69027	10.1371/journal.pone.0069027	http://dx.doi.org/10.1371/journal.pone.0069027			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894401	Green Submitted, Green Published, gold			2022-12-27	WOS:000322167900037
J	Breynaert, C; Dresselaers, T; Perrier, C; Arijs, I; Cremer, J; Van Lommel, L; Van Steen, K; Ferrante, M; Schuit, F; Vermeire, S; Rutgeerts, P; Himmelreich, U; Ceuppens, JL; Geboes, K; Van Assche, G				Breynaert, Christine; Dresselaers, Tom; Perrier, Clementine; Arijs, Ingrid; Cremer, Jonathan; Van Lommel, Leentje; Van Steen, Kristel; Ferrante, Marc; Schuit, Frans; Vermeire, Severine; Rutgeerts, Paul; Himmelreich, Uwe; Ceuppens, Jan L.; Geboes, Karel; Van Assche, Gert			Unique Gene Expression and MR T-2 Relaxometry Patterns Define Chronic Murine Dextran Sodium Sulphate Colitis as a Model for Connective Tissue Changes in Human Crohn's Disease	PLOS ONE			English	Article							INFLAMMATION; FIBROSIS; MICE; COLONOGRAPHY; MECHANISMS; STRICTURES; INDUCTION; TENASCIN; THERAPY	Introduction: Chronically relapsing inflammation, tissue remodeling and fibrosis are hallmarks of inflammatory bowel diseases. The aim of this study was to investigate changes in connective tissue in a chronic murine model resulting from repeated cycles of dextran sodium sulphate (DSS) ingestion, to mimic the relapsing nature of the human disease. Materials and Methods: C57BL/6 mice were exposed to DSS in drinking water for 1 week, followed by a recovery phase of 2 weeks. This cycle of exposure was repeated for up to 3 times (9 weeks in total). Colonic inflammation, fibrosis, extracellular matrix proteins and colonic gene expression were studied. In vivo MRI T-2 relaxometry was studied as a potential non-invasive imaging tool to evaluate bowel wall inflammation and fibrosis. Results: Repeated cycles of DSS resulted in a relapsing and remitting disease course, which induced a chronic segmental, transmural colitis after 2 and 3 cycles of DSS with clear induction of fibrosis and remodeling of the muscular layer. Tenascin expression mirrored its expression in Crohn's colitis. Microarray data identified a gene expression profile different in chronic colitis from that in acute colitis. Additional recovery was associated with upregulation of unique genes, in particular keratins, pointing to activation of molecular pathways for healing and repair. In vivo MRI T-2 relaxometry of the colon showed a clear shift towards higher T-2 values in the acute stage and a gradual regression of T-2 values with increasing cycles of DSS. Conclusions: Repeated cycles of DSS exposure induce fibrosis and connective tissue changes with typical features, as occurring in Crohn's disease. Colonic gene expression analysis revealed unique expression profiles in chronic colitis compared to acute colitis and after additional recovery, pointing to potential new targets to intervene with the induction of fibrosis. In vivo T-2 relaxometry is a promising non-invasive assessment of inflammation and fibrosis.	[Breynaert, Christine; Perrier, Clementine; Arijs, Ingrid; Cremer, Jonathan; Ferrante, Marc; Vermeire, Severine; Rutgeerts, Paul; Van Assche, Gert] Katholieke Univ Leuven, Dept Clin & Expt Med, Translat Res Ctr Gastrointestinal Disorders TARGI, Louvain, Belgium; [Breynaert, Christine; Perrier, Clementine; Cremer, Jonathan; Ceuppens, Jan L.] Katholieke Univ Leuven, Dept Microbiol & Immunol, Clin Immunol Lab, Louvain, Belgium; [Dresselaers, Tom; Himmelreich, Uwe] Katholieke Univ Leuven, Dept Imaging & Pathol, Biomed MRI MoSAIC, Louvain, Belgium; [Arijs, Ingrid; Van Lommel, Leentje; Schuit, Frans] Katholieke Univ Leuven, Dept Cellular & Mol Med, Gene Express Unit, Louvain, Belgium; [Van Steen, Kristel] Univ Liege, Inst Montefiore, Syst & Modeling Unit, B-4000 Liege, Belgium; [Geboes, Karel] Katholieke Univ Leuven, Dept Imaging & Pathol, Louvain, Belgium	KU Leuven; KU Leuven; KU Leuven; KU Leuven; University of Liege; KU Leuven	Van Assche, G (corresponding author), Katholieke Univ Leuven, Dept Clin & Expt Med, Translat Res Ctr Gastrointestinal Disorders TARGI, Louvain, Belgium.	Gert.Vanassche@uzleuven.be	Breynaert, Christine/T-5611-2017; Arijs, Ingrid/AAJ-3163-2020	Breynaert, Christine/0000-0002-7368-1068; Vermeire, Severine/0000-0001-9942-3019; Himmelreich, Uwe/0000-0002-2060-8895; Dresselaers, Tom/0000-0002-0884-5142; Ceuppens, Jan/0000-0003-4502-2679; Arijs, Ingrid/0000-0002-9415-083X; Van Steen, Kristel/0000-0001-9868-5033	Broad Medical Research Program of the Broad Foundation [IBD-0319R]; Agency for Innovation by Science and Technology in Flanders (IWT); Foundation for Scientific Research Flanders, FWO Vlaanderen; KU Leuven CoE 'MoSAIC'; program financing 'IMIR'	Broad Medical Research Program of the Broad Foundation; Agency for Innovation by Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Foundation for Scientific Research Flanders, FWO Vlaanderen(FWO); KU Leuven CoE 'MoSAIC'; program financing 'IMIR'	This work was supported by a grant from the Broad Medical Research Program of the Broad Foundation (IBD-0319R). Christine Breynaert is supported by a grant of the Agency for Innovation by Science and Technology in Flanders (IWT). Ingrid Arijs is supported by a postdoctoral grant of the Foundation for Scientific Research Flanders, FWO Vlaanderen. Gert Van Assche and Severine Vermeire are supported by the Foundation for Scientific Research Flanders, FWO Vlaanderen. Tom Dresselaers and Uwe Himmelreich are supported by the KU Leuven CoE 'MoSAIC' and the program financing 'IMIR'. The authors state that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; BARIBAULT H, 1994, GENE DEV, V8, P2964, DOI 10.1101/gad.8.24.2964; Barrett R, 2012, AM J PATHOL, V180, P636, DOI 10.1016/j.ajpath.2011.10.026; Benjamini Y, 1995, J R STAT SOC, P289; Ding SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042568; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; Fiocchi C, 2011, AM J PHYSIOL-GASTR L, V300, pG677, DOI 10.1152/ajpgi.00104.2011; Geboes K, 2001, INT J SURG PATHOL, V9, P281, DOI 10.1177/106689690100900404; Geboes KP, 2000, ACTA GASTRO-ENT BELG, V63, P371; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GRAHAM MF, 1988, GASTROENTEROLOGY, V94, P257, DOI 10.1016/0016-5085(88)90411-8; Habtezion A, 2005, J CELL SCI, V118, P1971, DOI 10.1242/jcs.02316; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Koukoulis G, 2001, ARCH PATHOL LAB MED, V125, P1331; Kugathasan S, 2007, GUT, V56, P1696, DOI 10.1136/gut.2006.116467; Larsson AE, 2006, INFLAMM BOWEL DIS, V12, P478, DOI 10.1097/00054725-200606000-00006; LENDRUM AC, 1962, J CLIN PATHOL, V15, P401, DOI 10.1136/jcp.15.5.401; MACKIE EJ, 1994, PERSPECT DEV NEUROBI, V2, P125; Mahavadi S, 2011, INFLAMM BOWEL DIS, V17, P711, DOI 10.1002/ibd.21437; Melgar S, 2005, AM J PHYSIOL-GASTR L, V288, pG1328, DOI 10.1152/ajpgi.00467.2004; Mustafi D, 2010, MAGN RESON MED, V63, P922, DOI 10.1002/mrm.22229; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Perrier 21. C, 2012, INFLAMM BOWEL DIS; Pinchuk IV, 2011, GASTROENTEROLOGY, V140, P2019, DOI 10.1053/j.gastro.2011.02.059; Prodanov D, 2009, MRI PROCESSOR; Quarles CC, 2008, MAGN RESON MED, V60, P718, DOI 10.1002/mrm.21724; Rasband W., 2006, IMAGEJ; Rieder F, 2012, AM J PHYSIOL-GASTR L, V303, pG786, DOI 10.1152/ajpgi.00059.2012; Shelley-Fraser G, 2012, HISTOPATHOLOGY, V60, P1034, DOI 10.1111/j.1365-2559.2011.03911.x; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Suzuki K, 2011, PATHOL INT, V61, P228, DOI 10.1111/j.1440-1827.2011.02647.x; Tao GZ, 2007, CLIN GASTROENTEROL H, V5, P857, DOI 10.1016/j.cgh.2007.02.017; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Van Assche G, 2004, INFLAMM BOWEL DIS, V10, P55, DOI 10.1097/00054725-200401000-00009; Van Assche G, 2010, J CROHNS COLITIS, V4, P7, DOI 10.1016/j.crohns.2009.12.003; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; Young MR, 2009, NEOPLASIA, V11, P237, DOI 10.1593/neo.81326	37	34	35	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e68876	10.1371/journal.pone.0068876	http://dx.doi.org/10.1371/journal.pone.0068876			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894361	Green Published, Green Submitted, gold			2022-12-27	WOS:000325211000050
J	Hillman, P; Ickowicz, D; Vizel, R; Breitbart, H				Hillman, Pnina; Ickowicz, Debby; Vizel, Ruth; Breitbart, Haim			Dissociation between AKAP3 and PKA(RII) Promotes AKAP3 Degradation in Sperm Capacitation	PLOS ONE			English	Article							PROTEIN-KINASE-A; ANCHORING PROTEIN; SIGNALING COMPLEXES; ADENYLYL-CYCLASE; CAUSES DEFECTS; PHOSPHORYLATION; ACTIVATION; CAMP; SPERMATOZOA; IDENTIFICATION	Ejaculated spermatozoa must undergo a series of biochemical modifications called capacitation, prior to fertilization. Protein-kinase A (PKA) mediates sperm capacitation, although its regulation is not fully understood. Sperm contain several A-kinase anchoring proteins (AKAPs), which are scaffold proteins that anchor PKA. In this study, we show that AKAP3 is degraded in bovine sperm incubated under capacitation conditions. The degradation rate is variable in sperm from different bulls and is correlated with the capacitation ability. The degradation of AKAP3 was significantly inhibited by MG-132, a proteasome inhibitor, indicating that AKAP3 degradation occurs via the proteasomal machinery. Treatment with Ca2+-ionophore induced further degradation of AKAP3; however, this effect was found to be enhanced in the absence of Ca2+ in the medium or when intracellular Ca2+ was chelated the degradation rate of AKAP3 was significantly enhanced when intracellular space was alkalized using NH4Cl, or when sperm were treated with Ht31, a peptide that contains the PKA-binding domain of AKAPs. Moreover, inhibition of PKA activity by H89, or its activation using 8Br-cAMP, increased AKAP3 degradation rate. This apparent contradiction could be explained by assuming that binding of PKA to AKAP3 protects AKAP3 from degradation. We conclude that AKAP3 degradation is regulated by intracellular alkalization and PKA(RII) anchoring during sperm capacitation.	[Hillman, Pnina; Ickowicz, Debby; Vizel, Ruth; Breitbart, Haim] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel	Bar Ilan University	Breitbart, H (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel.	haim.breitbart@biu.ac.il						Bajpai M, 2006, BIOL REPROD, V74, P109, DOI 10.1095/biolreprod.105.043588; Breitbart H, 2006, MOL CELL ENDOCRINOL, V252, P247, DOI 10.1016/j.mce.2006.03.019; Brener E, 2003, BIOL REPROD, V68, P837, DOI 10.1095/biolreprod.102.009233; Carlson AE, 2007, DEV BIOL, V312, P183, DOI 10.1016/j.ydbio.2007.09.017; Carnegie GK, 2009, IUBMB LIFE, V61, P394, DOI 10.1002/iub.168; Carr D W, 2007, Soc Reprod Fertil Suppl, V63, P135; Carr DW, 2001, J BIOL CHEM, V276, P17332, DOI 10.1074/jbc.M011252200; CARR DW, 1990, BIOL REPROD, V43, P795, DOI 10.1095/biolreprod43.5.795; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Cohen G, 2004, DEV BIOL, V267, P230, DOI 10.1016/j.ydbio.2003.10.034; COOK SP, 1993, J BIOL CHEM, V268, P22408; CORBIN JD, 1973, J BIOL CHEM, V248, P1813; Dell'Acqua ML, 2006, EUR J CELL BIOL, V85, P627, DOI 10.1016/j.ejcb.2006.01.010; Diviani D, 2001, J CELL SCI, V114, P1431; Etkovitz N, 2007, BIOL REPROD, V77, P263, DOI 10.1095/biolreprod.106.056705; Fiedler SE, 2008, BIOL REPROD, V78, P184, DOI 10.1095/biolreprod.107.062943; Fiedler SE, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105262; Galantino-Homer HL, 2004, MOL REPROD DEV, V67, P487, DOI 10.1002/mrd.20034; Garcia MA, 1999, MOL REPROD DEV, V52, P189, DOI 10.1002/(SICI)1098-2795(199902)52:2<189::AID-MRD10>3.0.CO;2-D; Harrison DA, 2000, BIOL REPROD, V62, P811, DOI 10.1095/biolreprod62.3.811; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kong M, 2009, BIOL REPROD, V80, P1026, DOI 10.1095/biolreprod.108.073924; Lea Isabel A, 2004, Reprod Biol Endocrinol, V2, P57, DOI 10.1186/1477-7827-2-57; Luconi M, 2004, J CELL SCI, V117, P1235, DOI 10.1242/jcs.00931; Michel JJC, 2002, ANNU REV PHARMACOL, V42, P235, DOI 10.1146/annurev.pharmtox.42.083101.135801; Miki K, 2002, DEV BIOL, V248, P331, DOI 10.1006/dbio.2002.0728; NAZ RK, 1991, J CELL SCI, V99, P157; Newell AEH, 2008, CELL MOTIL CYTOSKEL, V65, P539, DOI 10.1002/cm.20279; Niu JX, 2001, CURR BIOL, V11, P1686, DOI 10.1016/S0960-9822(01)00530-9; Parrish JJ, 1999, THERIOGENOLOGY, V51, P461, DOI 10.1016/S0093-691X(98)00240-4; Rawe VY, 2004, HUM REPROD, V19, P2594, DOI 10.1093/humrep/deh513; Reinton N, 2000, DEV BIOL, V223, P194, DOI 10.1006/dbio.2000.9725; Reinton N, 2000, BIOL REPROD, V63, P607, DOI 10.1095/biolreprod63.2.607; Rojas FJ, 1999, MOL HUM REPROD, V5, P520, DOI 10.1093/molehr/5.6.520; Rotman T, 2010, REPRODUCTION, V140, P43, DOI 10.1530/REP-09-0314; SCHACKMANN RW, 1986, J BIOL CHEM, V261, P8719; Shahar S, 2011, HUM REPROD, V26, P2274, DOI 10.1093/humrep/der232; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Vijayaraghavan S, 1997, J BIOL CHEM, V272, P4747, DOI 10.1074/jbc.272.8.4747; VISCONTI PE, 1995, DEVELOPMENT, V121, P1139; Wennemuth G, 2003, DEVELOPMENT, V130, P1317, DOI 10.1242/dev.00353; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Woo AL, 2002, MOL REPROD DEV, V62, P348, DOI 10.1002/mrd.90002; Yanagimachi R., 1994, P189; Zhang FX, 2007, J BIOL CHEM, V282, P22460, DOI 10.1074/jbc.M702439200; Zimmerman S, 2009, J REPROD IMMUNOL, V83, P19, DOI 10.1016/j.jri.2009.07.006	47	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e68873	10.1371/journal.pone.0068873	http://dx.doi.org/10.1371/journal.pone.0068873			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894359	gold, Green Published, Green Submitted			2022-12-27	WOS:000325211000048
J	Stevens, E; Torelli, S; Feng, L; Phadke, R; Walter, MC; Schneiderat, P; Eddaoudi, A; Sewry, CA; Muntoni, F				Stevens, Elizabeth; Torelli, Silvia; Feng, Lucy; Phadke, Rahul; Walter, Maggie C.; Schneiderat, Peter; Eddaoudi, Ayad; Sewry, Caroline A.; Muntoni, Francesco			Flow Cytometry for the Analysis of alpha-Dystroglycan Glycosylation in Fibroblasts from Patients with Dystroglycanopathies	PLOS ONE			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; DEFECTIVE GLYCOSYLATION; ABNORMAL GLYCOSYLATION; LAMININ ALPHA-1; MUTATIONS; GENE; BINDING; HYPOGLYCOSYLATION; GLYCOSYLTRANSFERASE; DEFICIENCY	alpha-dystroglycan (alpha-DG) is a peripheral membrane protein that is an integral component of the dystrophin-glycoprotein complex. In an inherited subset of muscular dystrophies known as dystroglycanopathies, alpha-DG has reduced glycosylation which results in lower affinity binding to several extracellular matrix proteins including laminins. The glycosylation status of alpha-DG is normally assessed by the binding of the alpha-DG antibody IIH6 to a specific glycan epitope on alpha-DG involved in laminin binding. Immunocytochemistry and immunoblotting are two of the most widely used methods to detect the amount of alpha-DG glycosylation in muscle. While the interpretation of the presence or absence of the epitope on muscle using these techniques is straightforward, the assessment of a mild defect can be challenging. In this study, flow cytometry was used to compare the amount of IIH6-reactive glycans in fibroblasts from dystroglycanopathy patients with defects in genes known to cause alpha-DG hypoglycosylation to the amount in fibroblasts from healthy and pathological control subjects. A total of twenty one dystroglycanopathy patient fibroblasts were assessed, as well as fibroblasts from three healthy controls and seven pathological controls. Control fibroblasts have clearly detectable amounts of IIH6-reactive glycans, and there is a significant difference in the amount of this glycosylation, as measured by the mean fluorescence intensity of an antibody recognising the epitope and the percentage of cells positive for the epitope, between these controls and dystroglycanopathy patient fibroblasts (p<0.0001 for both). Our results indicate that the amount of alpha-DG glycosylation in patient fibroblasts is comparable to that in patient skeletal muscle. This method could complement existing immunohistochemical assays in skeletal muscle as it is quantitative and simple to perform, and could be used when a muscle biopsy is not available. This test could also be used to assess the pathogenicity of variants of unknown significance in genes involved in dystroglycanopathies.	[Stevens, Elizabeth; Torelli, Silvia; Feng, Lucy; Phadke, Rahul; Sewry, Caroline A.; Muntoni, Francesco] Great Ormond St Hosp Sick Children, UCL Inst Child Health, Dubowitz Neuromuscular Ctr, London WC1N 3JH, England; [Feng, Lucy; Phadke, Rahul; Sewry, Caroline A.] UCL Inst Neurol, London, England; [Walter, Maggie C.; Schneiderat, Peter] Univ Munich, Dept Neurol, Friedrich Baur Inst, D-81377 Munich, Germany; [Eddaoudi, Ayad] Great Ormond St Hosp Sick Children, UCL Inst Child Health, Camelia Botnar Labs, Flow Cytometry Core Facil, London WC1N 3JH, England	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; University of Munich; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Muntoni, F (corresponding author), Great Ormond St Hosp Sick Children, UCL Inst Child Health, Dubowitz Neuromuscular Ctr, Great Ormond St, London WC1N 3JH, England.	f.muntoni@ucl.ac.uk	Phadke, Rahul/U-6960-2019	Eddaoudi, Ayad/0000-0001-5272-6426	Great Ormond Street Children's Charity; GOSH Biomedical Research Centre; Medical Research Council; Child Health Research Appeal Trust (CHRAT); MRC Translational research grant; MRC [MR/K000608/1] Funding Source: UKRI; Medical Research Council [MR/K000608/1] Funding Source: researchfish; Rosetrees Trust [M145] Funding Source: researchfish; Muscular Dystrophy UK [RA4/924, RA4/0924] Funding Source: researchfish	Great Ormond Street Children's Charity; GOSH Biomedical Research Centre; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Child Health Research Appeal Trust (CHRAT); MRC Translational research grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Rosetrees Trust(Rosetrees Trust); Muscular Dystrophy UK	This work was supported by Great Ormond Street Children's Charity (http://www.gosh.org/gen/), GOSH Biomedical Research Centre (http://www.gosh.nhs.uk/research-and-innovation/biomedical-research-centre-brc/), Medical Research Council (http://www.mrc.ac.uk/index.htm), and Child Health Research Appeal Trust (CHRAT) (http://opencharities.org/charities/271834). FM is supported by the Great Ormond Street Children's Charity and the GOSH Biomedical Research Centre. ES is a PhD student supported by the Medical Research Council (MRC), Great Ormond Street Children's Charity, and the Child Health Research Appeal Trust (CHRAT). The support of the MRC Translational research grant and the GOSH Biomedical Research Centre to the Biobank is also gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andac Z, 1999, J MOL BIOL, V287, P253, DOI 10.1006/jmbi.1999.2606; Barone R, 2012, ANN NEUROL, V72, P550, DOI 10.1002/ana.23632; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; Bouchet C, 2007, HUM MUTAT, V28, P1020, DOI 10.1002/humu.20561; Brockington M, 2001, HUM MOL GENET, V10, P2851, DOI 10.1093/hmg/10.25.2851; Brockington M, 2001, AM J HUM GENET, V69, P1198, DOI 10.1086/324412; Buysse K, 2013, HUM MOL GENET, V22, P1746, DOI 10.1093/hmg/ddt021; Carss KJ, 2013, AM J HUM GENET; Cirak S, 2013, BRAIN, V136, P269, DOI 10.1093/brain/aws312; Cooper ST, 2007, NEUROMUSCULAR DISORD, V17, P276, DOI 10.1016/j.nmd.2006.12.010; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; DURBEEJ M, 1995, J CELL BIOL, V130, P79, DOI 10.1083/jcb.130.1.79; Durbeej M, 1998, J HISTOCHEM CYTOCHEM, V46, P449, DOI 10.1177/002215549804600404; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Godfrey C, 2007, BRAIN, V130, P2725, DOI 10.1093/brain/awm212; Godfrey C, 2011, CURR OPIN GENET DEV, V21, P278, DOI 10.1016/j.gde.2011.02.001; Grewal PK, 2001, NAT GENET, V28, P151, DOI 10.1038/88865; Hara Y, 2011, NEW ENGL J MED, V364, P939, DOI 10.1056/NEJMoa1006939; Herzog C, 2004, J INVEST DERMATOL, V122, P1372, DOI 10.1111/j.0022-202X.2004.22605.x; HUGNOT JP, 1993, BIOCHEM BIOPH RES CO, V192, P69, DOI 10.1006/bbrc.1993.1382; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Ishikawa-Sakurai M, 2004, HUM MOL GENET, V13, P693, DOI 10.1093/hmg/ddh087; Jae LT, 2013, SCIENCE, V340, P479, DOI 10.1126/science.1233675; Jimenez-Mallebrera C, 2009, BRAIN PATHOL, V19, P596, DOI 10.1111/j.1750-3639.2008.00198.x; Kim J, 2012, NEUROMUSCULAR DISORD, V22, P139, DOI 10.1016/j.nmd.2011.08.006; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; Langenbach KJ, 2002, MUSCLE NERVE, V26, P644, DOI 10.1002/mus.10258; Lefeber DJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002427; Lefeber DJ, 2009, AM J HUM GENET, V85, P76, DOI 10.1016/j.ajhg.2009.06.006; Lommel M, 2010, NEUROLOGY, V74, P157, DOI 10.1212/WNL.0b013e3181c919d6; Longman C, 2003, HUM MOL GENET, V12, P2853, DOI 10.1093/hmg/ddg307; Manzini MC, 2012, AM J HUM GENET, V91, P541, DOI 10.1016/j.ajhg.2012.07.009; Margeta M, 2009, MUSCLE NERVE, V40, P883, DOI 10.1002/mus.21432; McDearmon EL, 2006, FEBS LETT, V580, P3381, DOI 10.1016/j.febslet.2006.05.010; Rojek JM, 2007, MOL BIOL CELL, V18, P4493, DOI 10.1091/mbc.E07-04-0374; Roscioli T, 2012, NAT GENET, V44, P581, DOI 10.1038/ng.2253; Sato S, 2008, NAT NEUROSCI, V11, P923, DOI 10.1038/nn.2160; Sewry CA, 2013, MUSCLE BIOPSY PRACTI, P195; Shooshtari P, 2010, CYTOM PART A, V77A, P873, DOI 10.1002/cyto.a.20943; Squarzoni S, 1997, NEUROMUSCULAR DISORD, V7, P91, DOI 10.1016/S0960-8966(96)00420-8; Stevens E, 2013, AM J HUM GENET, V92, P354, DOI 10.1016/j.ajhg.2013.01.016; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; Talts JF, 1999, EMBO J, V18, P863, DOI 10.1093/emboj/18.4.863; van Reeuwijk J, 2005, J MED GENET, V42, P907, DOI 10.1136/jmg.2005.031963; Vuillaumier-Barrot S, 2012, AM J HUM GENET, V91, P1135, DOI 10.1016/j.ajhg.2012.10.009; Willer T, 2012, NAT GENET, V44, P575, DOI 10.1038/ng.2252; Winder SJ, 2001, TRENDS BIOCHEM SCI, V26, P118, DOI 10.1016/S0968-0004(00)01731-X; Winder SJ, 2006, MOL MECH MUSCULAR DY, P193; Wright KM, 2012, NEURON, V76, P931, DOI 10.1016/j.neuron.2012.10.009; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3	52	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e68958	10.1371/journal.pone.0068958	http://dx.doi.org/10.1371/journal.pone.0068958			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894383	Green Published, Green Submitted, gold			2022-12-27	WOS:000322132100034
J	Bernardes, N; Ribeiro, AS; Abreu, S; Mota, B; Matos, RG; Arraiano, CM; Seruca, R; Paredes, J; Fialho, AM				Bernardes, Nuno; Ribeiro, Ana Sofia; Abreu, Sofia; Mota, Bruna; Matos, Rute G.; Arraiano, Cecilia M.; Seruca, Raquel; Paredes, Joana; Fialho, Arsenio M.			The Bacterial Protein Azurin Impairs Invasion and FAK/Src Signaling in P-Cadherin-Overexpressing Breast Cancer Cell Models	PLOS ONE			English	Article							FOCAL ADHESION KINASE; APOPTOSIS; SPECIFICITY; REGRESSION; GROWTH; P53	P-cadherin overexpression occurs in about 30% of all breast carcinomas, being a poor prognostic factor for breast cancer patients. In a cellular background of wild-type E-cadherin, we have previously shown that its expression promotes invasion, motility and migration of breast cancer cells due to the induced secretion of metalloproteases (MMPs) to the extracellular medium and to the concomitant shedding of a pro-invasive soluble form of this protein (sP-cad). Azurin is secreted by Pseudomonas aeruginosa and induces in vitro and in vivo cytotoxicity after its preferential penetration in human cancer cells relative to normal cells. Three different breast cancer cell lines, MCF-7/AZ. Mock, MCF-7/AZ.Pcad and SUM149 were treated with sub-killing doses of azurin. Invasion of these cells was measured using Matrigel Invasion Assays and MTT assays were performed to determine cell viability upon treatment and the effects on cadherins expression was determined by Western blot and Immunofluorescence. Gelatin Zymography was used to determine activity of MMP2 in the conditioned media of azurin treated and untreated cells and the phosphorylation levels of intracellular signaling proteins were determined by Western blot. The invasive phenotype of these breast cancer cells was significantly reduced by azurin. Azurin (50-100 mu M) also caused a specific decrease on P-cadherin protein levels from 30-50% in MCF-7/AZ.Pcad and SUM149 breast cancer cell lines, but the levels of E-cadherin remain unaltered. More, the levels of sP-cad and the activity of MMP2 were reduced in the extracellular media of azurin treated cells and we also observed a decrease in the phosphorylation levels of both FAK and Src proteins. Our data show that azurin specifically targets P-cadherin, not E-cadherin, abrogating P-cadherin-mediated invasive effects and signaling. Therefore, azurin could possibly be considered a therapeutic tool to treat poor-prognosis breast carcinomas overexpressing P-cadherin in a wild type E-cadherin context.	[Bernardes, Nuno; Abreu, Sofia; Mota, Bruna; Fialho, Arsenio M.] Inst Super Tecn, Ctr Biol & Chem Engn, Inst Biotechnol & Bioengn, Lisbon, Portugal; [Bernardes, Nuno; Ribeiro, Ana Sofia; Seruca, Raquel; Paredes, Joana] Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Oporto, Portugal; [Matos, Rute G.; Arraiano, Cecilia M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal	Universidade de Lisboa; Instituto Superior Tecnico; Universidade do Porto; Universidade Nova de Lisboa	Fialho, AM (corresponding author), Inst Super Tecn, Ctr Biol & Chem Engn, Inst Biotechnol & Bioengn, Lisbon, Portugal.	afialho@ist.utl.pt	Mota, Bruna/ABB-6715-2021; AM, Fialho/AAB-5715-2021; Paredes, Joana/F-8224-2011; Bernardes, Nuno/AAK-8431-2021; Fialho, Arsenio/A-6246-2008; Mota, Bruna/M-3099-2013; seruca, raquel/F-8187-2011; Bernardes, Nuno/F-7826-2014; Matos, Rute/J-4983-2013; Ribeiro, Ana/J-7334-2013	Mota, Bruna/0000-0002-8190-1278; AM, Fialho/0000-0002-8066-5787; Paredes, Joana/0000-0002-1076-1343; Bernardes, Nuno/0000-0002-4495-6608; Fialho, Arsenio/0000-0002-8066-5787; Mota, Bruna/0000-0002-8190-1278; Bernardes, Nuno/0000-0002-4495-6608; Ribeiro, Ana/0000-0002-9698-9233; Seruca, Raquel/0000-0002-8851-4166; Matos Luis, Rute/0000-0002-9788-7562; Arraiano, Cecilia/0000-0003-1934-9301; Abreu, Sofia/0000-0001-8154-0639	Portuguese Science and Technology Foundation (FCT); FCT [SFRH/BD/48763/2008, SFRH/BPD/75705/2011, POPH - QREN - Tipology 4.2, PEst-OE/EQB/LA0004/2011];  [PTDC/EBBBIO/100326/2008]	Portuguese Science and Technology Foundation (FCT)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); 	The work presented was supported by a scientific project (PTDC/EBBBIO/100326/2008) financed by the Portuguese Science and Technology Foundation (FCT). FCT also provides research grants as follows: PhD research grant for Nuno Bernardes (SFRH/BD/48763/2008) and post-doc research grant to Ana Sofia Ribeiro (SFRH/BPD/75705/2011) and Programa Ciencia 2007 for Joana Paredes [POPH - QREN - Tipology 4.2]. IPATIMUP is an Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education and is partially supported by FCT. Work at ITQB was supported by grant PEst-OE/EQB/LA0004/2011, also from FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albergaria A, 2011, INT J DEV BIOL, V55, P811, DOI 10.1387/ijdb.113382aa; Apiyo D, 2005, BIOCHEM BIOPH RES CO, V332, P965, DOI 10.1016/j.bbrc.2005.05.038; BRACKE ME, 1991, BRIT J CANCER, V63, P867, DOI 10.1038/bjc.1991.191; Chaudhari A, 2007, BIOCHEMISTRY-US, V46, P1799, DOI 10.1021/bi061661x; De Wever O, 2007, CLIN EXP METASTAS, V24, P685, DOI 10.1007/s10585-007-9104-8; Guarino M, 2010, J CELL PHYSIOL, V223, P14, DOI 10.1002/jcp.22011; Hsia DA, 2003, J CELL BIOL, V160, P753, DOI 10.1083/jcb.200212114; Hua H, 2011, CELL MOL LIFE SCI, V68, P3853, DOI 10.1007/s00018-011-0763-x; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Luo M, 2010, CANCER LETT, V289, P127, DOI 10.1016/j.canlet.2009.07.005; Mannello F, 2008, CANCER SCI, V99, P2160, DOI 10.1111/j.1349-7006.2008.00921.x; MEHTA R, 2011, MATER WORLD, V19, P2, DOI DOI 10.1007/S10456-011-9220-6; Noe V, 2001, J CELL SCI, V114, P111; Paredes J, 2005, CLIN CANCER RES, V11, P5869, DOI 10.1158/1078-0432.CCR-05-0059; Paredes J, 2004, CANCER RES, V64, P8309, DOI 10.1158/0008-5472.CAN-04-0795; Paredes J, 2012, BBA-REV CANCER, V1826, P297, DOI 10.1016/j.bbcan.2012.05.002; Punj V, 2004, ONCOGENE, V23, P2367, DOI 10.1038/sj.onc.1207376; Ribeiro AS, 2010, ONCOGENE, V29, P392, DOI 10.1038/onc.2009.338; Ribeiro AS, 2013, J PATHOL, V229, P705, DOI 10.1002/path.4143; Shibata K, 1998, CANCER RES, V58, P900; Taylor BN, 2009, CANCER RES, V69, P537, DOI 10.1158/0008-5472.CAN-08-2932; Van Marck V, 2005, CANCER RES, V65, P8774, DOI 10.1158/0008-5472.CAN-04-4414; Willmarth NE, 2006, J BIOL CHEM, V281, P37728, DOI 10.1074/jbc.M606532200; Yamada T, 2002, P NATL ACAD SCI USA, V99, P14098, DOI 10.1073/pnas.222539699; Yamada T, 2005, CELL MICROBIOL, V7, P1418, DOI 10.1111/j.1462-5822.2005.00567.x; Yamada T, 2004, P NATL ACAD SCI USA, V101, P4770, DOI 10.1073/pnas.0400899101; Yamada T, 2009, MOL CANCER THER, V8, P2947, DOI 10.1158/1535-7163.MCT-09-0444; Zaborina O, 2000, MICROBIOL-UK, V146, P2521, DOI 10.1099/00221287-146-10-2521; Zhang CC, 2010, CLIN CANCER RES, V16, P5177, DOI 10.1158/1078-0432.CCR-10-1343; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4	30	28	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e69023	10.1371/journal.pone.0069023	http://dx.doi.org/10.1371/journal.pone.0069023			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894398	Green Published, gold, Green Submitted			2022-12-27	WOS:000322391400036
J	DePriest, MS; Bhattacharya, D; Lopez-Bautista, JM				DePriest, Michael S.; Bhattacharya, Debashish; Lopez-Bautista, Juan M.			The Plastid Genome of the Red Macroalga Grateloupia taiwanensis (Halymeniaceae)	PLOS ONE			English	Article							SUBUNIT RIBOSOMAL DNA; TRNASCAN-SE; RNA GENES; SEQUENCE; ALGAE; RHODOPHYTA; RECOGNITION; SYSTEMATICS; PHYLOGENY; EVOLUTION	The complete plastid genome sequence of the red macroalga Grateloupia taiwanensis S.-M. Lin & H.-Y. Liang (Halymeniaceae, Rhodophyta) is presented here. Comprising 191,270 bp, the circular DNA contains 233 protein-coding genes and 29 tRNA sequences. In addition, several genes previously unknown to red algal plastids are present in the genome of G. taiwanensis. The plastid genomes from G. taiwanensis and another florideophyte, Gracilaria tenuistipitata var. liui, are very similar in sequence and share significant synteny. In contrast, less synteny is shared between G. taiwanensis and the plastid genome representatives of Bangiophyceae and Cyanidiophyceae. Nevertheless, the gene content of all six red algal plastid genomes here studied is highly conserved, and a large core repertoire of plastid genes can be discerned in Rhodophyta.	[DePriest, Michael S.; Lopez-Bautista, Juan M.] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA; [Bhattacharya, Debashish] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, Piscataway, NJ 08855 USA	University of Alabama System; University of Alabama Tuscaloosa; Rutgers State University New Brunswick	DePriest, MS (corresponding author), Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA.	msdepriest@crimson.ua.edu		DePriest, Michael/0000-0003-3843-6523	NSF Red Algal Tree of Life [DEB 0937978]; College of Arts and Sciences and Research Office of The University of Alabama	NSF Red Algal Tree of Life; College of Arts and Sciences and Research Office of The University of Alabama	The authors acknowledge support from NSF Red Algal Tree of Life (grant DEB 0937978), and from the College of Arts and Sciences and Research Office of The University of Alabama. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Cattolico RA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-211; Conant GC, 2008, BIOINFORMATICS, V24, P861, DOI 10.1093/bioinformatics/btm598; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; DePriest Michael S., 2012, Gulf of Mexico Science, V30, P7; Gargiulo GM, 2013, CRYPTOGAMIE ALGOL, V34, P3, DOI 10.7872/crya.v34.iss1.2013.3; Gross J, 2012, ADV PHOTOSYNTHESIS R, V35; Guiry M., 2013, ALGAEBASE, P74; Hagopian JC, 2004, J MOL EVOL, V59, P464, DOI 10.1007/s00239-004-2638-3; Harper JT, 2001, J PHYCOL, V37, P1073, DOI 10.1046/j.1529-8817.2001.00160.x; Lang BF, 2012, ADV PHOTOSYNTHESIS R, V35; Laslett D, 2002, NUCLEIC ACIDS RES, V30, P3449, DOI 10.1093/nar/gkf459; Le Corguille G, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-253; Le Gall L, 2007, MOL PHYLOGENET EVOL, V43, P1118, DOI 10.1016/j.ympev.2006.11.012; Lin SM, 2008, J PHYCOL, V44, P196, DOI 10.1111/j.1529-8817.2007.00443.x; Lopez-Bautista JM, 2010, CELL ORIG LIFE EXTRE, V13, P227, DOI 10.1007/978-90-481-3795-4_12; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Martin B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036911; Ohta N, 2003, DNA RES, V10, P67, DOI 10.1093/dnares/10.2.67; Petersen J, 2006, J MOL EVOL, V62, P143, DOI 10.1007/s00239-004-0305-3; Price DC, 2012, SCIENCE, V335, P843, DOI 10.1126/science.1213561; Reyes-Prieto A, 2007, MOL PHYLOGENET EVOL, V45, P384, DOI 10.1016/j.ympev.2007.02.026; Rodriguez-Ezpeleta N, 2005, CURR BIOL, V15, P1325, DOI 10.1016/j.cub.2005.06.040; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Withall RD, 2006, EUR J PHYCOL, V41, P379, DOI 10.1080/09670260600914097; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yoon HS, 2006, J PHYCOL, V42, P482, DOI 10.1111/j.1529-8817.2006.00210.x; Yoon HS, 2010, CELL ORIG LIFE EXTRE, V13, P25, DOI 10.1007/978-90-481-3795-4_2; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	30	23	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e68246	10.1371/journal.pone.0068246	http://dx.doi.org/10.1371/journal.pone.0068246			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894297	Green Submitted, gold, Green Published			2022-12-27	WOS:000322391400005
J	Wang, JX; Lu, KP; Song, Y; Xie, L; Zhao, S; Wang, YX; Sun, WZ; Liu, L; Zhao, H; Tang, DB; Ma, WJ; Pan, B; Xuan, QJ; Liu, H; Zhang, QY				Wang, Jingxuan; Lu, Kangping; Song, Ying; Xie, Li; Zhao, Shu; Wang, Yunxuan; Sun, Wenzhou; Liu, Lei; Zhao, Hong; Tang, Dabei; Ma, Wenjie; Pan, Bo; Xuan, Qijia; Liu, Hang; Zhang, Qingyuan			Indications of Clinical and Genetic Predictors for Aromatase Inhibitors Related Musculoskeletal Adverse Events in Chinese Han Women with Breast Cancer	PLOS ONE			English	Article							BONE-MINERAL DENSITY; RECEPTOR-ALPHA GENE; POSTMENOPAUSAL WOMEN; TAMOXIFEN THERAPY; RANDOMIZED-TRIAL; ATAC TRIAL; POLYMORPHISMS; SYMPTOMS; ASSOCIATION; LETROZOLE	Background: Women with breast cancer treated with aromatase inhibitors (AIs) may experience musculoskeletal symptoms that lead to discontinuation of effective therapy. The purpose of the current study is to evaluate the clinical and genetic predictors for AIs-related musculoskeletal adverse events(MS-AEs). Methodology and Principal Findings: We recruited 436 postmenopausal Chinese Han women receiving adjuvant AIs therapy for early-stage hormone-sensitive breast cancer. Patients completed a self-administered questionnaire assessing the presence of musculoskeletal symptoms that started or worsened after initiating AIs. 27 single nucleotide polymorphisms (SNP) of ESR1, ESR2 and PGR were analyzed by Sequenom MassARRAY assays and/or PCR-based TaqMan assays. Of the 436 enrolled women, 206 cases experienced musculoskeletal symptoms. Patients who received taxane chemotherapy were more than two times more likely than other patients to have AIs-related MS-AEs. Genetic assay had showed that only two ESR1 SNPs, rs2234693 and rs9340799 were associated with AIs-related MS-AEs. TT genotype and the T allele in rs2234693 was statistically significantly lower in AIs-Related MS-AEs group than controls (P = 0.001; P = 9.49E-7). The frequency of AA genotype and the A allele in rs9340799 was higher (P = 2.20E-5; P = 3.09E-4). Conclusions and Significance: Our results suggested that prior taxane-based chemotherapy was the clinical predictor, while rs2234693 and rs9340799 were the genetic predictors for AIs-related MS-AEs.	[Wang, Jingxuan; Lu, Kangping; Song, Ying; Xie, Li; Zhao, Shu; Wang, Yunxuan; Sun, Wenzhou; Liu, Lei; Zhao, Hong; Tang, Dabei; Ma, Wenjie; Pan, Bo; Xuan, Qijia; Liu, Hang; Zhang, Qingyuan] Harbin Med Univ, Affiliated Hosp 3, Dept Med Oncol, Harbin, Peoples R China	Harbin Medical University	Zhang, QY (corresponding author), Harbin Med Univ, Affiliated Hosp 3, Dept Med Oncol, Harbin, Peoples R China.	zqywsci@163.com			National Natural Science Foundation [81001026]; Backbone teachers foundation of Heilongjiang Education Department [1252G038]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Backbone teachers foundation of Heilongjiang Education Department	This study was funded by grants from the National Natural Science Foundation 81001026) and Backbone teachers foundation of Heilongjiang Education Department (1252G038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bland R, 2000, CLIN SCI, V98, P217, DOI 10.1042/CS19990252; Brady MJ, 1997, J CLIN ONCOL, V15, P974, DOI 10.1200/JCO.1997.15.3.974; Burstein HJ, 2007, J CLIN ONCOL, V25, DOI 10.1200/JCO.2007.11.9529; Chen Y, 2009, LIPIDS, V44, P719, DOI 10.1007/s11745-009-3325-3; Coates AS, 2007, J CLIN ONCOL, V25, P486, DOI 10.1200/JCO.2006.08.8617; Compston JE, 2001, PHYSIOL REV, V81, P419, DOI 10.1152/physrev.2001.81.1.419; Coombes RC, 2007, LANCET, V369, P559, DOI 10.1016/S0140-6736(07)60200-1; Coombes RC, 2004, NEW ENGL J MED, V350, P1081, DOI 10.1056/NEJMoa040331; Eastell R, 2006, J BONE MINER RES, V21, P1215, DOI 10.1359/JBMR.060508; Gennari L, 2005, AM J EPIDEMIOL, V161, P307, DOI 10.1093/aje/kwi055; Goss PE, 2008, J CLIN ONCOL, V26, P1948, DOI 10.1200/JCO.2007.11.6798; Goss PE, 2003, NEW ENGL J MED, V349, P1793, DOI 10.1056/NEJMoa032312; Greendale GA, 2006, AM J MED, V119, P79, DOI 10.1016/j.amjmed.2006.07.011; Hadji P, 2011, ANN ONCOL, V22, P2546, DOI 10.1093/annonc/mdr017; Harslof T, 2010, CALCIFIED TISSUE INT, V87, P25, DOI 10.1007/s00223-010-9375-y; Henry NL, 2008, BREAST CANCER RES TR, V111, P365, DOI 10.1007/s10549-007-9774-6; Henry NL, 2012, J CLIN ONCOL, V30, P936, DOI 10.1200/JCO.2011.38.0261; Henry NL, 2008, ONCOLOGY-NY, V22, P1401; Ingle JN, 2010, J CLIN ONCOL, V28, P4674, DOI 10.1200/JCO.2010.28.5064; Ioannidis JPA, 2002, J BONE MINER RES, V17, P2048, DOI 10.1359/jbmr.2002.17.11.2048; Kitamura I, 2007, BONE, V40, P1623, DOI 10.1016/j.bone.2007.02.016; Lindsay R, 2002, JAMA-J AM MED ASSOC, V287, P2668, DOI 10.1001/jama.287.20.2668; Mao JJ, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2813; Massart F, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-32; May A, 2013, J BONE MINER METAB, V9; Mouridsen H, 2003, J CLIN ONCOL, V21, P2101, DOI 10.1200/JCO.2003.04.194; Partridge AH, 2006, SAN ANT BREAST CANC; Salgado B, 2006, LANCET ONCOL; Sestak I, 2008, LANCET ONCOL, V9, P866, DOI 10.1016/S1470-2045(08)70182-7; Stearns V, 2009, CANC RES S3, V69; Styrkarsdottir U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013217; Takahashi Y, 2011, J ORTHOP RES, V29, P834, DOI 10.1002/jor.21322; Wang C, 2012, J BONE MINER RES, V27, P2582, DOI 10.1002/jbmr.1711; Wang JT, 2008, BONE, V43, P910, DOI 10.1016/j.bone.2008.07.001; Williams N, 2008, LANCET ONCOL, V9, P45, DOI 10.1016/S1470-2045(07)70385-6; Zhao L, 2011, MENOPAUSE, V18, P1018, DOI 10.1097/gme.0b013e318213545a	37	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e68798	10.1371/journal.pone.0068798	http://dx.doi.org/10.1371/journal.pone.0068798			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894347	Green Published, Green Submitted, gold			2022-12-27	WOS:000322391400024
J	De Carlo, F; Witte, TR; Hardman, WE; Claudio, PP				De Carlo, Flavia; Witte, Theodore R.; Hardman, W. Elaine; Claudio, Pier Paolo			Omega-3 Eicosapentaenoic Acid Decreases CD133 Colon Cancer Stem-Like Cell Marker Expression While Increasing Sensitivity to Chemotherapy	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; MUC3 MESSENGER-RNA; DOCOSAHEXAENOIC ACID; COLORECTAL-CANCER; INITIATING CELLS; LEUKEMIA-CELLS; N-3 PUFAS; FISH-OIL; DIFFERENTIATION; INHIBITION	Colorectal cancer is the third leading cause of cancer-related death in the western world. In vitro and in vivo experiments showed that omega-3 polyunsaturated fatty acids (n-3 PUFAs) can attenuate the proliferation of cancer cells, including colon cancer, and increase the efficacy of various anticancer drugs. However, these studies address the effects of n-3 PUFAs on the bulk of the tumor cells and not on the undifferentiated colon cancer stem-like cells (CSLCs) that are responsible for tumor formation and maintenance. CSLCs have also been linked to the acquisition of chemotherapy resistance and to tumor relapse. Colon CSLCs have been immunophenotyped using several antibodies against cellular markers including CD133, CD44, EpCAM, and ALDH. Anti-CD133 has been used to isolate a population of colon cancer cells that retains stem cells properties (CSLCs) from both established cell lines and primary cell cultures. We demonstrated that the n-3 PUFA, eicosapentaenoic acid (EPA), was actively incorporated into the membrane lipids of COLO 320 DM cells. 25 uM EPA decreased the cell number of the overall population of cancer cells, but not of the CD133 (+) CSLCs. Also, we observed that EPA induced down-regulation of CD133 expression and up-regulation of colonic epithelium differentiation markers, Cytokeratin 20 (CK20) and Mucin 2 (MUC2). Finally, we demonstrated that EPA increased the sensitivity of COLO 320 DM cells (total population) to both standard-of-care chemotherapies (5-Fluorouracil and oxaliplatin), whereas EPA increased the sensitivity of the CD133 (+) CSLCs to only 5-Fluorouracil.	[De Carlo, Flavia; Witte, Theodore R.; Hardman, W. Elaine; Claudio, Pier Paolo] Marshall Univ, Joan Edwards Sch Med, Dept Biochem & Microbiol, Huntington, WV 25755 USA; [De Carlo, Flavia; Witte, Theodore R.; Hardman, W. Elaine; Claudio, Pier Paolo] Marshall Univ, Joan Edwards Sch Med, McKown Translat Genom Res Inst, Huntington, WV USA; [Claudio, Pier Paolo] Marshall Univ, Joan Edwards Sch Med, Dept Surg, Huntington, WV USA	Marshall University; Marshall University; Marshall University	Claudio, PP (corresponding author), Marshall Univ, Joan Edwards Sch Med, Dept Biochem & Microbiol, Huntington, WV 25755 USA.	claudiop@marshall.edu	Claudio, Pier Paolo/AAW-7282-2021	Claudio, Pier Paolo/0000-0001-7790-1622	Marshall University Biochemistry and Microbiology Department; Surgery Department; Bean Foundation; NIH [CA131395, CA140024, R01CA114018]; WV-INBRE [5P20RR016477]; DOD [W81XWH-10-1-0697]; NATIONAL CANCER INSTITUTE [R21CA131395, R01CA114018, R03CA140024] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016477] Funding Source: NIH RePORTER	Marshall University Biochemistry and Microbiology Department; Surgery Department; Bean Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); WV-INBRE; DOD(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The authors gratefully acknowledge the Marshall University Biochemistry and Microbiology & Surgery Departments for their support. The present studies were supported by a grant of the Bean Foundation, and in part by NIH grants CA131395, CA140024, and WV-INBRE 5P20RR016477 (to PPC) and in part by NIH grant R01CA114018 and DOD grant W81XWH-10-1-0697 (to WEH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bianchini F, 2012, BRIT J NUTR, V108, P2129, DOI 10.1017/S0007114512000359; BURNS CP, 1986, BIOCHIM BIOPHYS ACTA, V888, P10, DOI 10.1016/0167-4889(86)90064-9; Calviello G, 2004, CARCINOGENESIS, V25, P2303, DOI 10.1093/carcin/bgh265; Calviello G, 2005, CANCER CHEMOTH PHARM, V55, P12, DOI 10.1007/s00280-004-0846-6; Calviello G, 1999, LIPIDS, V34, P599, DOI 10.1007/s11745-999-0404-6; Caygill CPJ, 1996, BRIT J CANCER, V74, P159, DOI 10.1038/bjc.1996.332; CAYGILL CPJ, 1995, EUR J CANCER PREV, V4, P329, DOI 10.1097/00008469-199508000-00008; Cha MC, 2002, NUTR CANCER, V44, P175, DOI 10.1207/S15327914NC4402_09; CHANG SK, 1994, GASTROENTEROLOGY, V107, P28, DOI 10.1016/0016-5085(94)90057-4; Chen KL, 2011, CLIN EXP METASTAS, V28, P751, DOI 10.1007/s10585-011-9407-7; Chen ZME, 2004, AM J SURG PATHOL, V28, P1352, DOI 10.1097/01.pas.0000135520.72965.50; Cross HS, 1996, ANTICANCER RES, V16, P2333; Degen C, 2011, BBA-MOL CELL BIOL L, V1811, P1070, DOI 10.1016/j.bbalip.2011.08.005; Deng Yan-Hong, 2010, Chin J Cancer, V29, P810; Di Francesco AM, 2002, CELL MOL LIFE SCI, V59, P1914, DOI 10.1007/PL00012514; Fahrmann JF, 2013, CANCER INVEST, V31, P29, DOI 10.3109/07357907.2012.743553; Fang DD, 2010, BRIT J CANCER, V102, P1265, DOI 10.1038/sj.bjc.6605610; FINSTAD HS, 1994, BLOOD, V84, P3799, DOI 10.1182/blood.V84.11.3799.bloodjournal84113799; Frosina G, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/845396; Germain E, 1999, LIPIDS, V34, pS203, DOI 10.1007/BF02562290; Giaccone G, 2000, DRUGS S4, V59, P917; Giaccone G, 2000, DRUGS S4, V59, P37; Greenlee RT, 2001, CA-CANCER J CLIN, V51, P15, DOI 10.3322/canjclin.51.1.15; Hanada H, 2011, CELL BIOL INT, V35, P51, DOI 10.1042/CBI20100070; Haraguchi N, 2008, ANN SURG ONCOL, V15, P2927, DOI 10.1245/s10434-008-0074-0; Hardman WE, 2008, NUTR CANCER, V60, P666, DOI 10.1080/01635580802065302; Hardman WE, 2002, BRIT J CANCER, V86, P983, DOI 10.1038/sj.bjc.6600175; Hardman WE, 2001, CLIN CANCER RES, V7, P2041; Harvey KA, 2010, J LIPID RES, V51, P3470, DOI 10.1194/jlr.M010371; Horst D, 2009, CANCER INVEST, V27, P844, DOI 10.1080/07357900902744502; Ieta K, 2008, ANN SURG ONCOL, V15, P638, DOI 10.1245/s10434-007-9605-3; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Judson I, 2000, DRUGS, V59, P29, DOI 10.2165/00003495-200059004-00004; Kimura Y, 2001, LIPIDS, V36, P353, DOI 10.1007/s11745-001-0727-3; Kisos H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046817; Kuan CY, 2011, J AM COLL NUTR, V30, P265, DOI 10.1080/07315724.2011.10719969; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li CY, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-56; Liu YE, 2007, FEBS J, V274, P3351, DOI 10.1111/j.1742-4658.2007.05869.x; Liu Zhen, 2010, Chin J Cancer, V29, P661; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mishima M, 2002, EUR J CANCER, V38, P1405, DOI 10.1016/S0959-8049(02)00096-5; Moitra K, 2011, CLIN PHARMACOL THER, V89, P491, DOI 10.1038/clpt.2011.14; Moore N, 2011, J ONCOL, V2011, DOI 10.1155/2011/396076; Narayanan BA, 2004, CARCINOGENESIS, V25, P2443, DOI 10.1093/carcin/bgh252; Nikolakopoulou Z, 2013, TOXICOL LETT, V218, P150, DOI 10.1016/j.toxlet.2013.01.021; NILSSON A, 1995, EUR J CELL BIOL, V67, P379; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Pham PV, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-209; Presnell SC, 2002, SEMIN CELL DEV BIOL, V13, P369, DOI 10.1016/S1084952102000939; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Roynette CE, 2004, CLIN NUTR, V23, P139, DOI 10.1016/j.clnu.2003.07.005; Rudra PK, 2001, ANTICANCER RES, V21, P29; Sato SB, 2013, BBA-MOL CELL BIOL L, V1831, P306, DOI 10.1016/j.bbalip.2012.10.004; Saunders M, 2006, BRIT J CANCER, V95, P131, DOI 10.1038/sj.bjc.6603233; Serini S, 2012, CARCINOGENESIS, V33, P164, DOI 10.1093/carcin/bgr240; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Sylvester PA, 2001, J PATHOL, V195, P327; Tedelind S, 2007, WORLD J GASTROENTERO, V13, P2826, DOI 10.3748/wjg.v13.i20.2826; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Varney ME, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-9; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wang MS, 2000, CANCER RES, V60, P6482; Weiss AA, 1996, J HISTOCHEM CYTOCHEM, V44, P1161, DOI 10.1177/44.10.8813081; Wildi S, 1999, CLIN CANCER RES, V5, P2840; Willemsen LEM, 2003, GUT, V52, P1442, DOI 10.1136/gut.52.10.1442	69	45	45	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2013	8	7							e69760	10.1371/journal.pone.0069760	http://dx.doi.org/10.1371/journal.pone.0069760			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186SF	23874993	Green Published, gold, Green Submitted			2022-12-27	WOS:000322064300115
J	Johnson, LA; Hall, JR; O'Bryant, SE				Johnson, Leigh A.; Hall, James R.; O'Bryant, Sid E.			A Depressive Endophenotype of Mild Cognitive Impairment and Alzheimer's Disease	PLOS ONE			English	Article							NATIONAL INSTITUTE; ARSENIC EXPOSURE; DEMENTIA; ASSOCIATION; DIAGNOSIS; SCALE; RECOMMENDATIONS; ALGORITHM; RBANS; NORMS	Background: Alzheimer's disease (AD) is a devastating public health problem that affects over 5.4 million Americans. Depression increases the risk of Mild Cognitive Impairment (MCI) and AD. By understanding the influence of depression on cognition, the potential exists to identify subgroups of depressed elders at greater risk for cognitive decline and AD. The current study sought to: 1) clinically identify a sub group of geriatric patients who suffer from depression related cognitive impairment; 2) cross validate this depressive endophenotype of MCI/AD in an independent cohort. Methods and Findings: Data was analyzed from 519 participants of Project FRONTIER. Depression was assessed with the GDS30 and cognition was assessed using the EXIT 25 and RBANS. Five GDS items were used to create the Depressive endophenotype of MCI and AD (DepE). DepE was significantly negatively related to RBANS index scores of Immediate Memory (B=-2.22, SE=.37, p<0.001), visuospatial skills (B=-1.11, SE=0.26, p<0.001), Language (B=-1.03, SE=0.21, p<0.001), Attention (B=-2.56, SE=0.49, p<0.001), and Delayed Memory (B=-1.54, SE = 037, p<0.001), and higher DepE scores were related to poorer executive functioning (EXIT25; B=0.65, SE=0.19, p=0.001). DepE scores significantly increased risk for MCI diagnosis (odds ratio [OR] = 2.04; 95% CI=1.54-2.69). Data from 235 participants in the TARCC (Texas Alzheimer's Research & Care Consortium) were analyzed for cross-validation of findings in an independent cohort. The DepE was significantly related to poorer scores on all measures, and a significantly predicted of cognitive change over 12- and 24-months. Conclusion: The current findings suggest that a depressive endophenotype of MCI and AD exists and can be clinically identified using the GDS-30. Higher scores increased risk for MCI and was cross-validated by predicting AD in the TARCC. A key purpose for the search for distinct subgroups of individuals at risk for AD and MCI is to identify novel treatment and preventative opportunities.	[Johnson, Leigh A.; O'Bryant, Sid E.] Univ N Texas, Hlth Sci Ctr, Dept Internal Med, Ft Worth, TX 76107 USA; [Johnson, Leigh A.; Hall, James R.; O'Bryant, Sid E.] Univ N Texas, Hlth Sci Ctr, Inst Aging & Alzheimers Dis Res, Ft Worth, TX USA; [Hall, James R.] Univ N Texas, Hlth Sci Ctr, Dept Psychiat, Ft Worth, TX USA	University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center	Johnson, LA (corresponding author), Univ N Texas, Hlth Sci Ctr, Dept Internal Med, Ft Worth, TX 76107 USA.	leigh.johnson@unthsc.edu		johnson, leigh/0000-0001-7769-8417; O'Bryant, Sid/0000-0003-0582-5266	National Institute on Aging (NIA); National Institute on Minority Health and Health Disparities (NIMHD) of the National Institutes of Health [R01AG039389, P30AG12300, P30A612300, L60MD001849]; Hogg Foundation for Mental Health [JRG-040, JRG-149]; Environmental Protection Agency [RD834794]; Texas Council on Alzheimer's Disease and Related Disorders; Texas Tech University Health Sciences Center F. Marie Hall Institute for Rural & Community Health; Garrison Institute on Aging; NATIONAL INSTITUTE ON AGING [P30AG012300, R01AG039389] Funding Source: NIH RePORTER	National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Minority Health and Health Disparities (NIMHD) of the National Institutes of Health; Hogg Foundation for Mental Health; Environmental Protection Agency(United States Environmental Protection Agency); Texas Council on Alzheimer's Disease and Related Disorders; Texas Tech University Health Sciences Center F. Marie Hall Institute for Rural & Community Health; Garrison Institute on Aging; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research reported in this publication was supported by the National Institute on Aging (NIA) and National Institute on Minority Health and Health Disparities (NIMHD) of the National Institutes of Health under Award Numbers R01AG039389, P30AG12300, P30A612300, and L60MD001849. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This research was also funded in part by grants from the Hogg Foundation for Mental Health (JRG-040 & JRG-149), the Environmental Protection Agency (RD834794), and the Texas Council on Alzheimer's Disease and Related Disorders to the Texas Alzheimer's Research & Care Consortium (TARCC). Project FRONTIER is supported by Texas Tech University Health Sciences Center F. Marie Hall Institute for Rural & Community Health and the Garrison Institute on Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*ALZH ASS, 2010, NEUROLOGIST; Barnes DE, 2006, ARCH GEN PSYCHIAT, V63, P273, DOI 10.1001/archpsyc.63.3.273; Baune BT, 2006, DEMENT GERIATR COGN, V22, P142, DOI 10.1159/000093745; BOONE KB, 1995, NEUROPSYCHOLOGY, V9, P390, DOI 10.1037/0894-4105.9.3.390; Boustani M, 2005, J GEN INTERN MED, V20, P572, DOI 10.1007/s11606-005-0103-7; BRASKIE MN, 2011, INT J ALZHEIMERS DIS; Bruce JM, 2008, J GERIATR PSYCH NEUR, V21, P34, DOI 10.1177/0891988707311032; Cirrito JR, 2011, P NATL ACAD SCI USA, V108, P14968, DOI 10.1073/pnas.1107411108; Cotter VT, 2006, NURS CLIN N AM, V41, P83, DOI 10.1016/j.cnur.2005.09.005; Cruchaga C, 2012, HUM MOL GENET, V21, P4558, DOI 10.1093/hmg/dds296; Delano-Wood L, 2008, INT J GERIATR PSYCH, V23, P632, DOI 10.1002/gps.1953; Doody R, 2008, J AM GERIATR SOC, V56, pS106; Duff K, 2005, J CLIN EXP NEUROPSYC, V27, P565, DOI 10.1080/13803390490918363; Duff K, 2008, ARCH CLIN NEUROPSYCH, V23, P603, DOI 10.1016/j.acn.2008.06.004; During EH, 2011, NEUROL SCI, V32, P559, DOI 10.1007/s10072-011-0633-1; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gong G, 2011, J ENVIRON HEALTH, V74, P16; Gonzalez-Salvador T, 2000, INT J GERIATR PSYCH, V15, P181, DOI 10.1002/(SICI)1099-1166(200002)15:2<181::AID-GPS96>3.0.CO;2-I; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; GOTTESMAN II, 1973, BRIT J PSYCHIAT, V122, P15, DOI 10.1192/bjp.122.1.15; Hall James R, 2011, Depress Res Treat, V2011, P396958, DOI 10.1155/2011/396958; HALL JR, 2012, NEUROSCI MED, V3, P18, DOI DOI 10.4236/NM.2012.31004; HART RP, 1987, J CONSULT CLIN PSYCH, V55, P101, DOI 10.1037/0022-006X.55.1.101; Hobson VL, 2011, INT J GERIATR PSYCH, V26, P351, DOI 10.1002/gps.2533; Hou Y, 2010, NEUROPHARMACOLOGY, V58, P911, DOI 10.1016/j.neuropharm.2009.11.002; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Ivnik R., 1992, CLIN NEUROPSYCHOL, V6, P1, DOI DOI 10.1080/13854049208401877; Janocko NJ, 2012, ACTA NEUROPATHOL, V124, P681, DOI 10.1007/s00401-012-1044-y; Johnson LA, 2013, INT J GERIATR PSYCH, V28, P377, DOI 10.1002/gps.3835; Johnson LA, 2011, J NEUROPSYCH CLIN N, V23, P219, DOI 10.1176/appi.neuropsych.23.2.219; Kennard M, 1998, NEUROBIOL AGING, V19, P131, DOI 10.1016/S0197-4580(98)00023-2; Kizilbash AH, 2002, ARCH CLIN NEUROPSYCH, V17, P57, DOI 10.1016/S0887-6177(00)00101-3; Lyketsos CG, 1997, J NEUROPSYCH CLIN N, V9, P556; Maslow K, 2008, ALZHEIMERS DEMENT, V4, P110, DOI 10.1016/j.jalz.2008.02.005; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Modrego PJ, 2004, ARCH NEUROL-CHICAGO, V61, P1290, DOI 10.1001/archneur.61.8.1290; Munro CA, 2012, AM J GERIAT PSYCHIAT, V20, P1036, DOI 10.1097/JGP.0b013e31826ce4c5; NILUFER T, 2011, MOL NEURODEG, V3, P1; O'Bryant S., 2009, TEXAS PUBLIC HLTH J, V61, P5; O'Bryant SE, 2008, ARCH NEUROL-CHICAGO, V65, P1091, DOI 10.1001/archneur.65.8.1091; O'Bryant SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028092; O'Bryant SE, 2011, DEMENT GERIATR COGN, V32, P55, DOI 10.1159/000330750; O'Bryant SE, 2011, INT J ENV RES PUB HE, V8, P861, DOI 10.3390/ijerph8030861; O'Bryant SE, 2011, INT J GERIATR PSYCH, V26, P199, DOI 10.1002/gps.2514; O'Bryant SE, 2011, DEMENT GERIATR COGN, V31, P31, DOI 10.1159/000321980; O'Bryant SE, 2010, ARCH NEUROL-CHICAGO, V67, P1077, DOI 10.1001/archneurol.2010.215; O'Bryant SE, 2010, J GERIATR PSYCH NEUR, V23, P49, DOI 10.1177/0891988709351832; O'Fallon LR, 2001, ENVIRON HEALTH PERSP, V109, P469, DOI 10.2307/3434797; Ownby RL, 2006, ARCH GEN PSYCHIAT, V63, P530, DOI 10.1001/archpsyc.63.5.530; PANZA F, 2011, INT J ALZHEIMERS DIS; Petersen R. C., 2003, MILD COGNITIVE IMPAI; Randolph C., 1998, REPEATABLE BATTERY A; ROYALL DR, 1992, J AM GERIATR SOC, V40, P1221, DOI 10.1111/j.1532-5415.1992.tb03646.x; Steinberg BA, 2005, CLIN NEUROPSYCHOL, V19, P329, DOI 10.1080/13854040590945210; Stokholm J, 2005, J AM GERIATR SOC, V53, P1577, DOI 10.1111/j.1532-5415.2005.53470.x; Waldemar G, 2007, EUR J NEUROL, V14, pE1, DOI 10.1111/j.1468-1331.2006.01605.x; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	59	11	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e68848	10.1371/journal.pone.0068848	http://dx.doi.org/10.1371/journal.pone.0068848			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874786	gold, Green Submitted, Green Published			2022-12-27	WOS:000322218800048
J	Dini, F; Capuano, R; Strand, T; Ek, AC; Lindgren, M; Paolesse, R; Di Natale, C; Lundstrom, I				Dini, Francesca; Capuano, Rosamaria; Strand, Tillan; Ek, Anna-Christina; Lindgren, Margareta; Paolesse, Roberto; Di Natale, Corrado; Lundstrom, Ingemar			Volatile Emissions from Compressed Tissue	PLOS ONE			English	Article							ORGANIC-COMPOUNDS; PRESSURE ULCERS; HUMAN SCENT; BLOOD-FLOW; RISK	Since almost every fifth patient treated in hospital care develops pressure ulcers, early identification of risk is important. A non-invasive method for the elucidation of endogenous biomarkers related to pressure ulcers could be an excellent tool for this purpose. We therefore found it of interest to determine if there is a difference in the emissions of volatiles from compressed and uncompressed tissue. The ultimate goal is to find a non-invasive method to obtain an early warning for the risk of developing pressure ulcers for bed-ridden persons. Chemical analysis of the emissions, collected in compresses, was made with gas-chromatography - mass spectrometry and with a chemical sensor array, the so called electronic nose. It was found that the emissions from healthy and hospitalized persons differed significantly irrespective of the site. Within each group there was a clear difference between the compressed and uncompressed site. Peaks that could be certainly deemed as markers of the compression were, however, not identified. Nonetheless, different compounds connected to the application of local mechanical pressure were found. The results obtained with GC-MS reveal the complexity of VOC composition, thus an array of non-selective chemical sensors seems to be a suitable choice for the analysis of skin emission from compressed tissues; it may represent a practical instrument for bed side diagnostics. Results show that the adopted electronic noses are likely sensitive to the total amount of the emission rather than to its composition. The development of a gas sensor-based device requires then the design of sensor receptors adequate to detect the VOCs bouquet typical of pressure. This preliminary experiment evidences the necessity of studies where each given person is followed for a long time in a ward in order to detect the insurgence of specific VOCs pattern changes signalling the occurrence of ulcers.	[Dini, Francesca; Capuano, Rosamaria; Di Natale, Corrado] Univ Roma Tor Vergata, Dept Elect Engn, Rome, Italy; [Strand, Tillan; Ek, Anna-Christina; Lindgren, Margareta] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Paolesse, Roberto] Univ Roma Tor Vergata, Dept Chem Sci & Technol, Rome, Italy; [Lundstrom, Ingemar] Linkoping Univ, Dept Phys Chem & Biol, Linkoping, Sweden	University of Rome Tor Vergata; Linkoping University; University of Rome Tor Vergata; Linkoping University	Dini, F (corresponding author), Univ Roma Tor Vergata, Dept Elect Engn, Rome, Italy.	dini@ing.uniroma2.it	Capuano, Rosamaria/K-9258-2016; Paolesse, Roberto/B-8966-2013; Di Natale, Corrado/M-8701-2014; Capuano, Rosamaria/U-6111-2019; Paolesse, Roberto/AAI-3182-2020	Paolesse, Roberto/0000-0002-2380-1404; Di Natale, Corrado/0000-0002-0543-4348; Capuano, Rosamaria/0000-0002-7811-0862	NovaMedTech, a regional program within biomedical engineering	NovaMedTech, a regional program within biomedical engineering	Funding for part of the project was received from NovaMedTech, a regional program within biomedical engineering. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abaffy T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013813; Andersen ES, 2008, SKIN RES TECHNOL, V14, P270, DOI 10.1111/j.1600-0846.2008.00290.x; Bachinger T, 2002, BIOSENS BIOELECTRON, V17, P395, DOI 10.1016/S0956-5663(01)00315-3; Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; Ceelen KK, 2009, EXP MECH, V49, P25, DOI 10.1007/s11340-007-9093-1; Curran AM, 2007, J CHROMATOGR B, V846, P86, DOI 10.1016/j.jchromb.2006.08.039; D'Amico A, 2008, SKIN RES TECHNOL, V14, P226, DOI 10.1111/j.1600-0846.2007.00284.x; Di Natale C, 2007, SENSOR ACTUAT B-CHEM, V121, P238, DOI 10.1016/j.snb.2006.09.038; Dymerski TM, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3660805; EK AC, 1984, SCAND J REHABIL MED, V16, P85; EPUAP and NPUAP, 2009, PREV TREATM PRESS UL; Gallagher M, 2008, BRIT J DERMATOL, V159, P780, DOI 10.1111/j.1365-2133.2008.08748.x; Girouard K, 2008, OSTOMY WOUND MANAG, V54, P30; Gunningberg L, 2010, J NURS MANAGE, V18, P757, DOI 10.1111/j.1365-2834.2010.01149.x; Kallman U, 2013, J ADV NURS, V69, P133, DOI 10.1111/j.1365-2648.2012.06000.x; Lindgren M, 2004, SCAND J CARING SCI, V18, P57, DOI 10.1046/j.0283-9318.2003.00250.x; Martinelli E, 2011, SENSOR ACTUAT B-CHEM, V156, P753, DOI 10.1016/j.snb.2011.02.034; Prada PA, 2010, ANAL METHODS-UK, V2, P470, DOI 10.1039/b9ay00239a; Romanu M, 1976, BED SORE BIOMECHANIC, P79; SEILER WO, 1979, J AM GERIATR SOC, V27, P298, DOI 10.1111/j.1532-5415.1979.tb06043.x; Shirasu M, 2011, J BIOCHEM, V150, P257, DOI 10.1093/jb/mvr090; Spilsbury K, 2007, J ADV NURS, V57, P494, DOI 10.1111/j.1365-2648.2006.04140.x; Vanderwee K, 2007, J EVAL CLIN PRACT, V13, P227, DOI 10.1111/j.1365-2753.2006.00684.x; Wong VK, 2007, WOUND REPAIR REGEN, V15, P786, DOI 10.1111/j.1524-475X.2007.00309.x	24	14	15	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e69271	10.1371/journal.pone.0069271	http://dx.doi.org/10.1371/journal.pone.0069271			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182JD	23874929	Green Submitted, Green Published, gold			2022-12-27	WOS:000321736900145
J	Kirkby, NS; Zaiss, AK; Urquhart, P; Jiao, J; Austin, PJ; Al-Yamani, M; Lundberg, MH; MacKenzie, LS; Warner, TD; Nicolaou, A; Herschman, HR; Mitchell, JA				Kirkby, Nicholas S.; Zaiss, Anne K.; Urquhart, Paula; Jiao, Jing; Austin, Philip J.; Al-Yamani, Malak; Lundberg, Martina H.; MacKenzie, Louise S.; Warner, Timothy D.; Nicolaou, Anna; Herschman, Harvey R.; Mitchell, Jane A.			LC-MS/MS Confirms That COX-1 Drives Vascular Prostacyclin Whilst Gene Expression Pattern Reveals Non-Vascular Sites of COX-2 Expression	PLOS ONE			English	Article							GASTROINTESTINAL TOXICITY; SYNTHASE CYCLOOXYGENASE; PROSTAGLANDIN SYNTHASE; MESSENGER-RNA; INHIBITION; DISRUPTION; INFLAMMATION; ROFECOXIB	There are two schools of thought regarding the cyclooxygenase (COX) isoform active in the vasculature. Using urinary prostacyclin markers some groups have proposed that vascular COX-2 drives prostacyclin release. In contrast, we and others have found that COX-1, not COX-2, is responsible for vascular prostacyclin production. Our experiments have relied on immunoassays to detect the prostacyclin breakdown product, 6-keto-PGF(1 alpha) and antibodies to detect COX-2 protein. Whilst these are standard approaches, used by many laboratories, antibody-based techniques are inherently indirect and have been criticized as limiting the conclusions that can be drawn. To address this question, we measured production of prostanoids, including 6-keto-PGF(1 alpha), by isolated vessels and in the circulation in vivo using liquid chromatography tandem mass spectrometry and found values essentially identical to those obtained by immunoassay. In addition, we determined expression from the Cox2 gene using a knockin reporter mouse in which luciferase activity reflects Cox2 gene expression. Using this we confirm the aorta to be essentially devoid of Cox2 driven expression. In contrast, thymus, renal medulla, and regions of the brain and gut expressed substantial levels of luciferase activity, which correlated well with COX-2-dependent prostanoid production. These data are consistent with the conclusion that COX-1 drives vascular prostacyclin release and puts the sparse expression of Cox2 in the vasculature in the context of the rest of the body. In doing so, we have identified the thymus, gut, brain and other tissues as target organs for consideration in developing a new understanding of how COX-2 protects the cardiovascular system.	[Kirkby, Nicholas S.; Austin, Philip J.; Al-Yamani, Malak; Mitchell, Jane A.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Kirkby, Nicholas S.; Lundberg, Martina H.; Warner, Timothy D.] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England; [Zaiss, Anne K.; Jiao, Jing; Herschman, Harvey R.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA; [Nicolaou, Anna] Univ Bradford, Sch Pharm, Bradford BD7 1DP, W Yorkshire, England; [Al-Yamani, Malak] King Saud Univ, King Fahad Cardiac Ctr, Riyadh, Saudi Arabia; [MacKenzie, Louise S.] Univ Hertfordshire, Sch Life & Med Sci, Hatfield AL10 9AB, Herts, England	Imperial College London; University of London; Queen Mary University London; University of California System; University of California Los Angeles; University of Bradford; King Saud University; University of Hertfordshire	Kirkby, NS (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England.	n.kirkby@imperial.ac.uk; j.a.mitchell@imperial.ac.uk	Jiao, Jing/F-5354-2015; Mackenzie, Louise/AAY-7585-2020; Nicolaou, Anna/D-4025-2018; Warner, Timothy D/A-1980-2009; Slingsby, Martina H/B-1476-2015	Mackenzie, Louise/0000-0003-4271-379X; Nicolaou, Anna/0000-0002-1314-413X; Warner, Timothy D/0000-0003-3988-4408; Kirkby, Nicholas/0000-0003-3509-8549; Austin, Philip/0000-0002-8855-220X; Lundberg, Martina H/0000-0001-6369-3041; Slingsby, Martina H/0000-0002-2620-7582	Wellcome Trust [0852551Z108/Z]; NIH-NCI P50 award [CA086306]; American Society of Hematology Scholar Award; GSK; Astra Zeneca; Allergan; Unilever; Amarin; Equateq; NATIONAL CANCER INSTITUTE [P50CA086306] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); NIH-NCI P50 award(Indian Council of Medical Research (ICMR)); American Society of Hematology Scholar Award; GSK(GlaxoSmithKline); Astra Zeneca(AstraZeneca); Allergan(AbbVieAllergan); Unilever(Unilever); Amarin; Equateq; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by a program grant from the Wellcome Trust (0852551Z108/Z to JAM) and NIH-NCI P50 award CA086306 (to HRH). AKZ is the recipient of an American Society of Hematology Scholar Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; JAM and TDW have received funds from GSK and Astra Zeneca and acted as consultants and expert witnesses for Pfizer in cases where anti-inflammatory drugs, including COX-2 inhibitors have been involved. AN has received research funds and acted as consultant for projects related to supplement and drug analysis from/for Allergan, Unilever, Amarin, Equateq, GSK. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Adegboyega PA, 2004, APPL IMMUNOHISTO M M, V12, P71; Barbieri SS, 2012, CIRCULATION, V126, P1373, DOI 10.1161/CIRCULATIONAHA.112.097295; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Catella-Lawson F, 1999, J PHARMACOL EXP THER, V289, P735; Cathcart MC, 2008, J PHARMACOL EXP THER, V326, P51, DOI 10.1124/jpet.107.134221; Chan CC, 1999, J PHARMACOL EXP THER, V290, P551; Cheng Y, 2006, J CLIN INVEST, V116, P1391, DOI 10.1172/JCI27540; COTTEE F, 1977, PROSTAGLANDINS, V14, P413, DOI 10.1016/0090-6980(77)90257-X; Cuhlmann S, 2011, CIRC RES, V108, P950, DOI 10.1161/CIRCRESAHA.110.233841; Egan KM, 2004, SCIENCE, V306, P1954, DOI 10.1126/science.1103333; Fitzgerald DJ, 2013, CIRC RES, V112, P174, DOI 10.1161/CIRCRESAHA.111.300271; FU JY, 1990, J BIOL CHEM, V265, P16737; Rodriguez LAG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016780; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; Herschman HR, 1997, ADV EXP MED BIOL, V407, P61; Ishikawa TO, 2006, MOL IMAGING BIOL, V8, P171, DOI 10.1007/s11307-006-0034-7; Ishikawa T, 2010, MOL ONCOL, V4, P347, DOI 10.1016/j.molonc.2010.06.004; Ishikawa T, 2009, BIOCHEM BIOPH RES CO, V378, P534, DOI 10.1016/j.bbrc.2008.11.099; Jongstra-Bilen J, 2006, J EXP MED, V203, P2073, DOI 10.1084/jem.20060245; Kirkby NS, 2012, P NATL ACAD SCI USA, V109, P17597, DOI 10.1073/pnas.1209192109; Kirkby NS, 2012, BRIT J PHARM; KUJUBU DA, 1991, J BIOL CHEM, V266, P12866; LANGENBACH R, 1995, CELL, V83, P483, DOI 10.1016/0092-8674(95)90126-4; Langenbach R, 1997, ADV EXP MED BIOL, V407, P87; Liu B, 2012, EXP PHYSIOL, V97, P277, DOI 10.1113/expphysiol.2011.062034; Masoodi M, 2006, RAPID COMMUN MASS SP, V20, P3023, DOI 10.1002/rcm.2697; McGettigan P, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001098; Mitchell JA, 2006, NAT REV DRUG DISCOV, V5, P75, DOI 10.1038/nrd1929; MITCHELL JA, 1993, P NATL ACAD SCI USA, V90, P11693, DOI 10.1073/pnas.90.24.11693; Papanicolaou KN, 2010, J MOL CELL CARDIOL, V49, P196, DOI 10.1016/j.yjmcc.2010.04.002; PATRIGNANI P, 1994, J PHARMACOL EXP THER, V271, P1705; Ricciotti E, 2013, P NATL ACAD SCI USA, V110, pE183, DOI 10.1073/pnas.1219073110; ROSEN GD, 1989, BIOCHEM BIOPH RES CO, V164, P1358, DOI 10.1016/0006-291X(89)91819-6; SALMON JA, 1978, PROSTAGLANDINS, V15, P383; Wallace JL, 2008, CURR OPIN INVEST DR, V9, P1151; Wang DR, 2009, P NATL ACAD SCI USA, V106, P7548, DOI 10.1073/pnas.0805806106; Warner TD, 1999, P NATL ACAD SCI USA, V96, P7563, DOI 10.1073/pnas.96.13.7563; XIE WL, 1991, P NATL ACAD SCI USA, V88, P2692, DOI 10.1073/pnas.88.7.2692; Yu Y, 2012, SCI TRANSL MED, V4, DOI DOI 10.1126/SCITRANSLMED.3003787; Yu Z, 2012, P NATL ACAD SCI USA, V109, P6727, DOI 10.1073/pnas.1115313109	40	45	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e69524	10.1371/journal.pone.0069524	http://dx.doi.org/10.1371/journal.pone.0069524			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874970	Green Submitted, gold, Green Published			2022-12-27	WOS:000321736900157
J	Orriss, IR; Key, ML; Hajjawi, MOR; Arnett, TR				Orriss, Isabel R.; Key, Michelle L.; Hajjawi, Mark O. R.; Arnett, Timothy R.			Extracellular ATP Released by Osteoblasts Is A Key Local Inhibitor of Bone Mineralisation	PLOS ONE			English	Article							NONSPECIFIC ALKALINE-PHOSPHATASE; MESENCHYMAL STEM-CELLS; IN-VITRO; LYSOPHOSPHATIDIC ACID; SYSTEMIC RESPONSES; RAT OSTEOBLASTS; P2X RECEPTORS; FLUID-FLOW; CULTURES; DIFFERENTIATION	Previous studies have shown that exogenous ATP (>1 mu M) prevents bone formation in vitro by blocking mineralisation of the collagenous matrix. This effect is thought to be mediated via both P2 receptor-dependent pathways and a receptor-independent mechanism (hydrolysis of ATP to produce the mineralisation inhibitor pyrophosphate, PPi). Osteoblasts are also known to release ATP constitutively. To determine whether this endogenous ATP might exert significant biological effects, bone-forming primary rat osteoblasts were cultured with 0.5-2.5U/ml apyrase (which sequentially hydrolyses ATP to ADP to AMP + 2P(i)). Addition of 0.5U/ml apyrase to osteoblast culture medium degraded extracellular ATP to <1% of control levels within 2 minutes; continuous exposure to apyrase maintained this inhibition for up to 14 days. Apyrase treatment for the first 72 hours of culture caused small decreases (<= 25%) in osteoblast number, suggesting a role for endogenous ATP in stimulating cell proliferation. Continuous apyrase treatment for 14 days (>= 0.5U/ml) increased mineralisation of bone nodules by up to 3-fold. Increases in bone mineralisation were also seen when osteoblasts were cultured with the ATP release inhibitors, NEM and brefeldin A, as well as with P2X1 and P2X7 receptor antagonists. Apyrase decreased alkaline phosphatase (TNAP) activity by up to 60%, whilst increasing the activity of the PPi-generating ecto-nucleotide pyrophosphatase/phosphodiesterases (NPPs) up to 2.7-fold. Both collagen production and adipocyte formation were unaffected. These data suggest that nucleotides released by osteoblasts in bone could act locally, via multiple mechanisms, to limit mineralisation.	[Orriss, Isabel R.; Key, Michelle L.; Hajjawi, Mark O. R.; Arnett, Timothy R.] UCL, Dept Cell & Dev Biol, London, England	University of London; University College London	Arnett, TR (corresponding author), UCL, Dept Cell & Dev Biol, London, England.	i.orriss@ucl.ac.uk	Orriss, Isabel/GRS-3934-2022; Arnett, Tim/AAW-4445-2021	Orriss, Isabel/0000-0002-7847-050X; Hajjawi, Mark/0000-0003-4011-9316	Career Development Fellowship from Arthritis Research United Kingdom [19205]; European Commission under the 7th Framework Programme [202231]; Versus Arthritis [19205] Funding Source: researchfish	Career Development Fellowship from Arthritis Research United Kingdom(Versus Arthritis); European Commission under the 7th Framework Programme; Versus Arthritis(Versus Arthritis)	This work was supported by a Career Development Fellowship (#19205) from Arthritis Research United Kingdom (www.arthritisresearchuk.org) and the European Commission under the 7th Framework Programme. Proposal # 202231 was performed as a collaborative project among the members of the ATPBone consortium (Copenhagen University, University College London, University of Maastricht, University of Ferrara, University of Liverpool, University of Sheffield and Universite Libre de Bruxelles), and is a sub-study under the main study "Fighting osteoporosis by blocking nucleotides: purinergic signalling in bone formation and homeostasis". The funders had no role in the study design, data collection and analysis, decision to publish or the preparation of the manuscript.	ABBRACCHIO MP, 1994, PHARMACOL THERAPEUT, V64, P445, DOI 10.1016/0163-7258(94)00048-4; Addison WN, 2007, J BIOL CHEM, V282, P15872, DOI 10.1074/jbc.M701116200; BELLOWS CG, 1994, ENDOCRINOLOGY, V134, P2221, DOI 10.1210/en.134.5.2221; Bowler WB, 2001, BONE, V28, P507, DOI 10.1016/S8756-3282(01)00430-6; Brandao-Burch A, 2005, CALCIFIED TISSUE INT, V77, P167, DOI 10.1007/s00223-004-0285-8; Brandao-Burch Andrea, 2012, Front Endocrinol (Lausanne), V3, P41, DOI 10.3389/fendo.2012.00041; Buckley KA, 2003, FASEB J, V17, P1401, DOI 10.1096/fj.02-0940com; Buckley KA, 2001, J BIOL CHEM, V276, P9565, DOI 10.1074/jbc.M005672200; Burnstock G, 2007, CELL MOL LIFE SCI, V64, P1471, DOI 10.1007/s00018-007-6497-0; BURNSTOCK G, 1985, GEN PHARMACOL, V16, P433, DOI 10.1016/0306-3623(85)90001-1; BURNSTOCK G, 1972, PHARMACOL REV, V24, P509; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Ciciarello M, 2013, STEM CELLS DEV, V22, P1097, DOI 10.1089/scd.2012.0432; Evans BAJ, 2006, J BONE MINER RES, V21, P228, DOI 10.1359/JBMR.051021; FLEISCH H, 1961, HELV PHYS ACTA, V19, pC17; FLEISCH H, 1962, NATURE, V195, P911, DOI 10.1038/195911a0; Gartland A, 2012, FRONT BIOSCI-LANDMRK, V17, P16, DOI 10.2741/3912; Genetos DC, 2007, J CELL PHYSIOL, V212, P207, DOI 10.1002/jcp.21021; Genetos DC, 2005, J BONE MINER RES, V20, P41, DOI 10.1359/jbmr.041009; Ham Jack, 2012, Front Endocrinol (Lausanne), V3, P113; Hessle L, 2002, P NATL ACAD SCI USA, V99, P9445, DOI 10.1073/pnas.142063399; Hoebertz A, 2002, J CELL BIOCHEM, V86, P413, DOI 10.1002/jcb.10236; Johnson KA, 2000, AM J PHYSIOL-REG I, V279, pR1365, DOI 10.1152/ajpregu.2000.279.4.R1365; Nakamura E, 2000, AM J PHYSIOL-CELL PH, V279, pC510, DOI 10.1152/ajpcell.2000.279.2.C510; Orriss IR., 2012, WIRES COMPUT STAT, V1, P805, DOI [10.1002/wmts.67, DOI 10.1002/WMTS.67]; Orriss I, 2010, BONE, V46, pS55, DOI 10.1016/j.bone.2010.01.127; Orriss IR, 2007, ENDOCRINOLOGY, V148, P4208, DOI 10.1210/en.2007-0066; Orriss IR, 2012, BONE, V51, P389, DOI 10.1016/j.bone.2012.06.013; Orriss IR, 2012, METHODS MOL BIOL, V816, P31, DOI 10.1007/978-1-61779-415-5_3; Orriss IR, 2010, CURR OPIN PHARMACOL, V10, P322, DOI 10.1016/j.coph.2010.01.003; Orriss IR, 2009, J CELL PHYSIOL, V220, P155, DOI 10.1002/jcp.21745; Panupinthu N, 2008, J CELL BIOL, V181, P859, DOI 10.1083/jcb.200708037; Panupinthu N, 2007, J BIOL CHEM, V282, P3403, DOI 10.1074/jbc.M605620200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ralevic V, 1998, PHARMACOL REV, V50, P413; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; RAZZELL WE, 1959, J BIOL CHEM, V234, P2105; Reyes Juan P, 2011, Front Biosci (Schol Ed), V3, P1101; Romanello M, 2001, BIOCHEM BIOPH RES CO, V289, P1275, DOI 10.1006/bbrc.2001.6124; Rumney RMH, 2012, J BIOMECH, V45, P549, DOI 10.1016/j.jbiomech.2011.11.036; Shimegi S, 1996, CALCIFIED TISSUE INT, V58, P109, DOI 10.1007/BF02529732; Syberg S, 2012, J BONE MINER RES, V27, P2373, DOI 10.1002/jbmr.1690; Wang N, 2012, MOL ENDOCRINOL, V26, P142, DOI 10.1210/me.2011-1083; Zimmermann H, 2012, PURINERG SIGNAL, V8, P437, DOI 10.1007/s11302-012-9309-4; Zippel N, 2012, STEM CELLS DEV, V21, P884, DOI 10.1089/scd.2010.0576	45	51	52	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2013	8	7							e69057	10.1371/journal.pone.0069057	http://dx.doi.org/10.1371/journal.pone.0069057			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JD	23874866	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000321736900133
J	Lutz, SE; Gonzalez-Fernandez, E; Ventura, JCC; Perez-Samartin, A; Tarassishin, L; Negoro, H; Patel, NK; Suadicani, SO; Lee, SC; Matute, C; Scemes, E				Lutz, Sarah E.; Gonzalez-Fernandez, Estibaliz; Chara Ventura, Juan Carlos; Perez-Samartin, Alberto; Tarassishin, Leonid; Negoro, Hiromitsu; Patel, Naman K.; Suadicani, Sylvia O.; Lee, Sunhee C.; Matute, Carlos; Scemes, Eliana			Contribution of Pannexin1 to Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; P2X(7) RECEPTOR; MULTIPLE-SCLEROSIS; P-GLYCOPROTEIN; RAT-BRAIN; AXON LOSS; T-CELLS; ADENOSINE; EXPRESSION; ACTIVATION	Pannexin1 (Panx1) is a plasma membrane channel permeable to relatively large molecules, such as ATP. In the central nervous system (CNS) Panx1 is found in neurons and glia and in the immune system in macrophages and T-cells. We tested the hypothesis that Panx1-mediated ATP release contributes to expression of Experimental Autoimmune Encephalomyelitis (EAE), an animal model for multiple sclerosis, using wild-type (WT) and Panx1 knockout (KO) mice. Panx1 KO mice displayed a delayed onset of clinical signs of EAE and decreased mortality compared to WT mice, but developed as severe symptoms as the surviving WT mice. Spinal cord inflammatory lesions were also reduced in Panx1 KO EAE mice during acute disease. Additionally, pharmacologic inhibition of Panx1 channels with mefloquine (MFQ) reduced severity of acute and chronic EAE when administered before or after onset of clinical signs. ATP release and YoPro uptake were significantly increased in WT mice with EAE as compared to WT non-EAE and reduced in tissues of EAE Panx1 KO mice. Interestingly, we found that the P2X7 receptor was upregulated in the chronic phase of EAE in both WT and Panx1 KO spinal cords. Such increase in receptor expression is likely to counterbalance the decrease in ATP release recorded from Panx1 KO mice and thus contribute to the development of EAE symptoms in these mice. The present study shows that a Panx1 dependent mechanism (ATP release and/or inflammasome activation) contributes to disease progression, and that inhibition of Panx1 using pharmacology or gene disruption delays and attenuates clinical signs of EAE.	[Lutz, Sarah E.; Patel, Naman K.; Suadicani, Sylvia O.; Scemes, Eliana] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA; [Gonzalez-Fernandez, Estibaliz; Chara Ventura, Juan Carlos; Perez-Samartin, Alberto; Matute, Carlos] Univ Basque Country, Dept Neurociencias, Leioa, Spain; [Tarassishin, Leonid; Lee, Sunhee C.] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [Negoro, Hiromitsu; Suadicani, Sylvia O.] Albert Einstein Coll Med, Dept Urol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; University of Basque Country; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Scemes, E (corresponding author), Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA.	eliana.scemes@einstein.yu.edu	Matute, Carlos/N-5559-2014; Samartín, Alberto Pérez/AAB-1336-2019; Samartín, Alberto Pérez/AAB-6428-2019; Scemes, Eliana/K-6257-2019; Negoro, Hiromitsu/AAW-3261-2021	Matute, Carlos/0000-0001-8672-711X; Samartín, Alberto Pérez/0000-0003-0834-0424; Scemes, Eliana/0000-0002-6650-3976; Negoro, Hiromitsu/0000-0003-1144-2755; E Lutz, Sarah/0000-0002-6388-753X; Tarassishin, Leonid/0000-0002-2649-5465	NIH-NINDS [T32 NS07439, RO1-NS052245]; NIH-NICHD [1P30HD071593, RO1-MH55477, P30AI051519]; MICINN [SAF-10-21547]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD071593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI051519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH055477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007439, R01NS052245] Funding Source: NIH RePORTER	NIH-NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH-NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by NIH-NINDS training grant T32 NS07439 to SEL, RO1-NS052245 to ES, NIH-NICHD 1P30HD071593 (IDCRR scientific core), RO1-MH55477 and P30AI051519 (Einstein Center for AIDS Research AIDS) to SCL, and MICINN SAF-10-21547 to CM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbe MT, 2006, PHYSIOLOGY, V21, P103, DOI 10.1152/physiol.00048.2005; Bruzzone R, 2005, J NEUROCHEM, V92, P1033, DOI 10.1111/j.1471-4159.2004.02947.x; CANNELLA B, 1995, ANN NEUROL, V37, P424, DOI 10.1002/ana.410370404; Chen GQ, 2010, BRAIN RES, V1309, P116, DOI 10.1016/j.brainres.2009.10.054; Chen LF, 2006, J IMMUNOL, V176, P3115, DOI 10.4049/jimmunol.176.5.3115; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Cone AC, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00006; Domercq M, 2010, GLIA, V58, P730, DOI 10.1002/glia.20958; Dvoriantchikova G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031991; Ferrari D, 1997, J IMMUNOL, V159, P1451; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Garre JM, 2010, P NATL ACAD SCI USA, V107, P22659, DOI 10.1073/pnas.1013793107; Gillespie RJ, 2008, BIOORG MED CHEM LETT, V18, P2916, DOI 10.1016/j.bmcl.2008.03.075; Grygorowicz T, 2011, ACTA NEUROBIOL EXP, V71, P65; Grygorowicz T, 2010, NEUROCHEM INT, V57, P823, DOI 10.1016/j.neuint.2010.08.021; Gulbransen BD, 2012, NAT MED, V18, P600, DOI 10.1038/nm.2679; Hanstein R, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00061; Iglesias R, 2009, CELL COMMUN ADHES, V16, P131, DOI 10.3109/15419061003642618; Iglesias R, 2009, J NEUROSCI, V29, P7092, DOI 10.1523/JNEUROSCI.6062-08.2009; John GR, 2005, GLIA, V49, P161, DOI 10.1002/glia.20109; Kooij G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008212; Lalor SJ, 2011, J IMMUNOL, V186, P5738, DOI 10.4049/jimmunol.1003597; Latini S, 2001, J NEUROCHEM, V79, P463, DOI 10.1046/j.1471-4159.2001.00607.x; Locovei S, 2007, FEBS LETT, V581, P483, DOI 10.1016/j.febslet.2006.12.056; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Matute C, 2007, J NEUROSCI, V27, P9525, DOI 10.1523/JNEUROSCI.0579-07.2007; Mills JH, 2008, P NATL ACAD SCI USA, V105, P9325, DOI 10.1073/pnas.0711175105; Narcisse L, 2005, GLIA, V49, P245, DOI 10.1002/glia.20110; Oyanguren-Desez O, 2011, CELL CALCIUM, V50, P468, DOI 10.1016/j.ceca.2011.08.002; Papadopoulos D, 2006, EXP NEUROL, V197, P373, DOI 10.1016/j.expneurol.2005.10.033; Pelegrin P, 2008, J IMMUNOL, V180, P7147, DOI 10.4049/jimmunol.180.11.7147; Qiu F, 2012, PURINERG SIGNAL, V8, P81, DOI 10.1007/s11302-011-9263-6; Rasband W., 2006, IMAGEJ; Ray A, 2006, CEREBELLUM, V5, P189, DOI 10.1080/14734220500530082; Riffkin CD, 1996, BIOCHEM PHARMACOL, V52, P1545, DOI 10.1016/S0006-2952(96)00556-4; Rudick RA, 2009, NEW ENGL J MED, V361, P1505, DOI 10.1056/NEJMcibr0905482; Santiago MF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025178; Schenk U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160583; Sharp AJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-33; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Soulika AM, 2009, J NEUROSCI, V29, P14965, DOI 10.1523/JNEUROSCI.3794-09.2009; Suadicani SO, 2012, GLIA, V60, P1106, DOI 10.1002/glia.22338; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Tsutsui S, 2004, J NEUROSCI, V24, P1521, DOI 10.1523/JNEUROSCI.4271-03.2004; Wang J, 2013, J GEN PHYSL IN PRESS; Wei W, 2013, J IMMUNOL, V190, P138, DOI 10.4049/jimmunol.1103721; Wujek JR, 2002, J NEUROPATH EXP NEUR, V61, P23, DOI 10.1093/jnen/61.1.23; Yao SQ, 2012, J NEUROCHEM, V123, P100, DOI 10.1111/j.1471-4159.2012.07807.x	51	49	49	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66657	10.1371/journal.pone.0066657	http://dx.doi.org/10.1371/journal.pone.0066657			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23885286	Green Submitted, Green Published, gold			2022-12-27	WOS:000322342800093
J	An, YY; Zhang, MX; Liu, GB; Han, RL; Liang, ZS				An, Yuyan; Zhang, Meixiang; Liu, Guobin; Han, Ruilian; Liang, Zongsuo			Proline Accumulation in Leaves of Periploca sepium via Both Biosynthesis Up-Regulation and Transport during Recovery from Severe Drought	PLOS ONE			English	Article							SALT-STRESS; SECONDARY METABOLISM; ANTIOXIDANT ENZYMES; EXOGENOUS PROLINE; OXIDATIVE STRESS; PLANT; TOLERANCE; GROWTH; GENE; SENESCENCE	Drought resistance and recovery ability are two important requisites for plant adaptation to drought environments. Proline (Pro) metabolism has been a major concern in plant drought tolerance. However, roles of Pro metabolism in plant recovery ability from severe drought stress are largely unexplored. Periploca sepium Bunge has gained increasing attention for its adaptation to dry environments. Here, we investigated Pro metabolism in different tissues of P. sepium seedlings in the course of drought stress and recovery. We found that leaf Pro metabolism response during post-drought recovery was dependant on drought severity. Pro biosynthesis was down-regulated during recovery from -0.4 MPa but increased continually and notably during recovery from -1.0 MPa. Significant correlation between Pro concentration and Delta 1-pyrroline-5-carboxylate synthetase activity indicates that Glutamate pathway is the predominant synthesis route during both drought and re-watering periods. Ornithine delta-aminotransferase activity was up-regulated significantly only during recovery from -1.0 MPa, suggesting positive contribution of ornithine pathway to improving plant recovery capacity from severe drought. In addition to up-regulation of biosynthesis, Pro transport from stems and roots also contributed to high Pro accumulation in leaves and new buds during recovery from -1.0 MPa, as indicated by the combined analysis of Pro concentration and its biosynthesis in stems, roots and new buds. Except its known roles as energy, carbon and nitrogen sources for plant rapid recovery, significant positive correlation between Pro concentration and total antioxidant activity indicates that Pro accumulation can also promote plant damage repair ability by up-regulating antioxidant activity during recovery from severe drought stress.	[An, Yuyan; Zhang, Meixiang; Liang, Zongsuo] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Liu, Guobin; Han, Ruilian; Liang, Zongsuo] Chinese Acad Sci, Res Ctr Soil & Water Conservat & Ecol Environm, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS	Liang, ZS (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China.	liangzs@ms.iswc.ac.cn			knowledge Innovation Project of Chinese Academy of Science [KZCX2-YW-443]	knowledge Innovation Project of Chinese Academy of Science(Knowledge Innovation Program of the Chinese Academy of Sciences)	This research was supported by knowledge Innovation Project of Chinese Academy of Science (KZCX2-YW-443). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali Q, 2013, INT J MOL SCI, V14, P818, DOI 10.3390/ijms14010818; Alia, 2001, AMINO ACIDS, V21, P195; An YY, 2011, S AFR J BOT, V77, P446, DOI 10.1016/j.sajb.2010.11.003; An YY, 2013, ACTA PHYSIOL PLANT, V35, P959, DOI 10.1007/s11738-012-1139-z; Bamba T, 2007, Z NATURFORSCH C, V62, P579; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; Blokhina O, 2003, ANN BOT-LONDON, V91, P179, DOI 10.1093/aob/mcf118; BLUM A, 1976, CROP SCI, V16, P428, DOI 10.2135/cropsci1976.0011183X001600030030x; Boyer JS, 2010, J EXP BOT, V61, P3493, DOI 10.1093/jxb/erq231; [陈玲 CHEN Ling], 2007, [西北林学院学报, Journal of Northwest Forestry College], V22, P142; Fernandes AJD, 2012, SCI WORLD J, DOI 10.1100/2012/923462; de Carvalho K, 2013, MOL BIOL REP, V40, P3269, DOI 10.1007/s11033-012-2402-5; de Carvalho MHC, 2008, PLANT SIGNAL BEHAV, V3, P156, DOI 10.4161/psb.3.3.5536; Diaz P, 2005, PLANT GROWTH REGUL, V46, P223, DOI 10.1007/s10725-005-0860-7; Girousse C, 1996, PLANT PHYSIOL, V111, P109, DOI 10.1104/pp.111.1.109; Hayat S, 2012, PLANT SIGNAL BEHAV, V7, P1456, DOI 10.4161/psb.21949; HOOD DW, 1992, GENE, V115, P5, DOI 10.1016/0378-1119(92)90533-U; Hoque MA, 2007, J PLANT PHYSIOL, V164, P553, DOI 10.1016/j.jplph.2006.03.010; Kaul S, 2008, AMINO ACIDS, V34, P315, DOI 10.1007/s00726-006-0407-x; Kim GB, 2013, J PLANT PHYSIOL, V170, P291, DOI 10.1016/j.jplph.2012.10.004; Kishor PBK, 2005, CURR SCI INDIA, V88, P424; Krasensky J, 2012, J EXP BOT, V63, P1593, DOI 10.1093/jxb/err460; Lehmann S, 2010, AMINO ACIDS, V39, P949, DOI 10.1007/s00726-010-0525-3; Lin CC, 2002, PLANT GROWTH REGUL, V36, P275, DOI 10.1023/A:1016518013449; Luo YY, 2011, ACTA PHYSIOL PLANT, V33, P79, DOI 10.1007/s11738-010-0519-5; Lutts S, 1999, PHYSIOL PLANTARUM, V105, P450, DOI 10.1034/j.1399-3054.1999.105309.x; Mattioli R, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-236; Mattioli R, 2009, PLANT SIGNAL BEHAV, V4, P1016, DOI 10.4161/psb.4.11.9797; MCMICHAEL BL, 1977, CROP SCI, V17, P905, DOI 10.2135/cropsci1977.0011183X001700060022x; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; MORGAN JM, 1984, ANNU REV PLANT PHYS, V35, P299, DOI 10.1146/annurev.pp.35.060184.001503; Munne-Bosch S, 2004, FUNCT PLANT BIOL, V31, P203, DOI 10.1071/FP03236; Nounjan N, 2012, J PLANT PHYSIOL, V169, P596, DOI 10.1016/j.jplph.2012.01.004; Oh MM, 2009, J PLANT PHYSIOL, V166, P180, DOI 10.1016/j.jplph.2008.04.015; Pinheiro C, 2004, J PLANT PHYSIOL, V161, P1203, DOI 10.1016/j.jplph.2004.01.016; Ramakrishna A, 2011, PLANT SIGNAL BEHAV, V6, P1720, DOI 10.4161/psb.6.11.17613; Raymond MJ, 2002, ANN BOT-LONDON, V89, P813, DOI 10.1093/aob/mcf082; Richards J. H., 1993, P 17 INT GRASSL C PA, P85; Sharma S, 2011, PLANT PHYSIOL, V157, P292, DOI 10.1104/pp.111.183210; Signorelli S, 2013, PLANT PHYSIOL BIOCH, V64, P80, DOI 10.1016/j.plaphy.2012.12.017; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; SMIRNOFF N, 1989, PHYTOCHEMISTRY, V28, P1057, DOI 10.1016/0031-9422(89)80182-7; SMITH IK, 1988, ANAL BIOCHEM, V175, P408, DOI 10.1016/0003-2697(88)90564-7; Sun JK, 2011, PLANT SOIL ENVIRON, V57, P139, DOI 10.17221/227/2010-PSE; Sunkar R, 2010, METHODS MOL BIOL, V639, P1, DOI 10.1007/978-1-60761-702-0; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Vankova R, 2012, PLANT SIGNAL BEHAV, V7, P19, DOI 10.4161/psb.7.1.18375; Verbruggen N, 2008, AMINO ACIDS, V35, P753, DOI 10.1007/s00726-008-0061-6; Verslues Paul E, 2010, Arabidopsis Book, V8, pe0140, DOI 10.1199/tab.0140; VOETBERG GS, 1991, PLANT PHYSIOL, V96, P1125, DOI 10.1104/pp.96.4.1125; Yang YL, 2011, ECOTOX ENVIRON SAFE, V74, P733, DOI 10.1016/j.ecoenv.2010.10.035; You J, 2012, PLANT SCI, V197, P59, DOI 10.1016/j.plantsci.2012.09.002; Zhu ZB, 2009, ENVIRON EXP BOT, V66, P326, DOI 10.1016/j.envexpbot.2009.03.017	53	45	50	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e69942	10.1371/journal.pone.0069942	http://dx.doi.org/10.1371/journal.pone.0069942			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23875011	Green Published, gold, Green Submitted			2022-12-27	WOS:000322000600061
J	Jiang, JQ; Zhou, ZW				Jiang, JiaQian; Zhou, Zhengwei			Removal of Pharmaceutical Residues by Ferrate(VI)	PLOS ONE			English	Article							WASTE-WATER TREATMENT; PERSONAL CARE PRODUCTS; DISRUPTING CHEMICALS EDCS; SEWAGE-TREATMENT PLANTS; POTASSIUM FERRATE(VI); ENDOCRINE DISRUPTORS; ACTIVE COMPOUNDS; RISK-ASSESSMENT; OXIDATION; CARBAMAZEPINE	Background: Pharmaceuticals and their metabolites are inevitably emitted into the waters. The adverse environmental and human health effects of pharmaceutical residues in water could take place under a very low concentration range; from several mu g/L to ng/L. These are challenges to the global water industries as there is no unit process specifically designed to remove these pollutants. An efficient technology is thus sought to treat these pollutants in water and waste water. Methodology/Major Results: A novel chemical, ferrate, was assessed using a standard jar test procedure for the removal of pharmaceuticals. The analytical protocols of pharmaceuticals were standard solid phase extraction together with various instrumentation methods including LC-MS, HPLC-UV and UV/Vis spectroscopy. Ferrate can remove more than 80% of ciprofloxacin (CIP) at ferrate dose of 1 mg Fe/L and 30% of ibuprofen (IBU) at ferrate dose of 2 mg Fe/L. Removal of pharmaceuticals by ferrate was pH dependant and this was in coordinate to the chemical/physical properties of pharmaceuticals. Ferrate has shown higher capability in the degradation of CIP than IBU; this is because CIP has electron-rich organic moieties (EOM) which can be readily degraded by ferrate oxidation and IBU has electron-withdrawing groups which has slow reaction rate with ferrate. Promising performance of ferrate in the treatment of real waste water effluent at both pH 6 and 8 and dose range of 1-5 mg Fe/L was observed. Removal efficiency of ciprofloxacin was the highest among the target compounds (63%), followed by naproxen (43%). On the other hand, n-acetyl sulphamethoxazole was the hardest to be removed by ferrate (8% only). Conclusions: Ferrate is a promising chemical to be used to treat pharmaceuticals in waste water. Adjusting operating conditions in terms of the properties of target pharmaceuticals can maximise the pharmaceutical removal efficiency.	[Jiang, JiaQian; Zhou, Zhengwei] Glasgow Caledonian Univ, Sch Engn & Built Environm, Glasgow G4 0BA, Lanark, Scotland	Glasgow Caledonian University	Jiang, JQ (corresponding author), Glasgow Caledonian Univ, Sch Engn & Built Environm, Glasgow G4 0BA, Lanark, Scotland.	jiaqian.jiang@gcu.ac.uk	Jiang, Jia-Qian/O-9493-2014; Zhou, Zhengwei/M-9957-2015	Jiang, Jia-Qian/0000-0003-3607-8910; Zhou, Zhengwei/0000-0001-9014-5139; Bines, Julie/0000-0002-5452-6601	Glasgow Caledonian University Research Committee	Glasgow Caledonian University Research Committee	The authors thank the Glasgow Caledonian University Research Committee for offering a research studentship to ZZ for his PhD study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anquandah GAK, 2011, ENVIRON SCI TECHNOL, V45, P10575, DOI 10.1021/es202237g; Castiglioni S, 2006, ENVIRON SCI TECHNOL, V40, P357, DOI 10.1021/es050991m; Comeau F, 2008, SCI TOTAL ENVIRON, V396, P132, DOI 10.1016/j.scitotenv.2008.02.031; Comerton AM, 2008, J MEMBRANE SCI, V313, P323, DOI 10.1016/j.memsci.2008.01.021; Daughton CG, 1999, ENVIRON HEALTH PERSP, V107, P907, DOI 10.2307/3434573; Ferrari B, 2003, ECOTOX ENVIRON SAFE, V55, P359, DOI 10.1016/S0147-6513(02)00082-9; Filip J, 2011, CHEM-EUR J, V17, P10097, DOI 10.1002/chem.201100711; Grung M, 2008, ECOTOX ENVIRON SAFE, V71, P328, DOI 10.1016/j.ecoenv.2007.10.015; Hu L, 2009, ENVIRON SCI TECHNOL, V43, P509, DOI 10.1021/es8023513; Jiang JQ, 2007, J HAZARD MATER, V146, P617, DOI 10.1016/j.jhazmat.2007.04.075; Jiang JQ, 2012, GLOBAL NEST J, V14, P93; Jiang JQ, 2007, DESALINATION, V210, P266, DOI 10.1016/j.desal.2006.05.051; Jiang JQ, 2012, SEP PURIF TECHNOL, V88, P95, DOI 10.1016/j.seppur.2011.12.021; Jiang JQ, 2009, SEP PURIF TECHNOL, V68, P227, DOI 10.1016/j.seppur.2009.05.007; Jiang JQ, 2002, WATER RES, V36, P1397, DOI 10.1016/S0043-1354(01)00358-X; Jiang JQ, 2006, J ENVIRON MANAGE, V79, P215, DOI 10.1016/j.jenvman.2005.06.009; Jiang JQ, 2005, CHEMOSPHERE, V61, P544, DOI 10.1016/j.chemosphere.2005.02.029; Jiang JQ, 2001, ENVIRON ENG SCI, V18, P323, DOI 10.1089/10928750152726041; Jiang JQ, 2001, SEPAR PURIF METHOD, V30, P127, DOI 10.1081/SPM-100102986; Jjemba PK, 2006, ECOTOX ENVIRON SAFE, V63, P113, DOI 10.1016/j.ecoenv.2004.11.011; Lee HB, 2007, J CHROMATOGR A, V1139, P45, DOI 10.1016/j.chroma.2006.11.068; Lee Y, 2009, ENVIRON SCI TECHNOL, V43, P3831, DOI 10.1021/es803588k; Lishman L, 2006, SCI TOTAL ENVIRON, V367, P544, DOI 10.1016/j.scitotenv.2006.03.021; Nakada N, 2006, WATER RES, V40, P3297, DOI 10.1016/j.watres.2006.06.039; Okuda T, 2008, WATER SCI TECHNOL, V57, P65, DOI 10.2166/wst.2008.822; Paxeus N, 2004, WATER SCI TECHNOL, V50, P253, DOI 10.2166/wst.2004.0335; Santos JL, 2007, ENVIRON INT, V33, P596, DOI 10.1016/j.envint.2006.09.014; Seitz W, 2008, CHEMOSPHERE, V70, P1238, DOI 10.1016/j.chemosphere.2007.07.081; Sharma VK, 2008, J WATER SUPPLY RES T, V57, P419, DOI 10.2166/aqua.2008.077; Sharma VK, 2006, ENVIRON CHEM LETT, V3, P182, DOI 10.1007/s10311-005-0002-5; Sharma VK, 2012, CHEMOSPHERE, V87, P644, DOI 10.1016/j.chemosphere.2012.01.019; Sharma VK, 2011, CHEMOSPHERE, V82, P1083, DOI 10.1016/j.chemosphere.2010.12.053; Sharma VK, 2010, J ENVIRON SCI HEAL A, V45, P645, DOI 10.1080/10934521003648784; Sharma VK, 2002, ADV ENVIRON RES, V6, P143, DOI 10.1016/S1093-0191(01)00119-8; Sharma VK, 2001, PHYS CHEM CHEM PHYS, V3, P2059, DOI 10.1039/b101432n; Snyder SA, 2007, DESALINATION, V202, P156, DOI 10.1016/j.desal.2005.12.052; Stanford C, 2010, WATER AIR SOIL POLL, V209, P483, DOI 10.1007/s11270-009-0216-4; Ternes TA, 1998, WATER RES, V32, P3245, DOI 10.1016/S0043-1354(98)00099-2; Wang L, 2010, SCI TOTAL ENVIRON, V408, P3139, DOI 10.1016/j.scitotenv.2010.04.047; Westerhoff P, 2005, ENVIRON SCI TECHNOL, V39, P6649, DOI 10.1021/es0484799; Yang B, 2012, WATER RES, V46, P2194, DOI 10.1016/j.watres.2012.01.047; Zhou ZW, 2012, J APPL SPECTROSC+, V79, P459, DOI 10.1007/s10812-012-9623-1	42	182	186	14	143	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55729	10.1371/journal.pone.0055729	http://dx.doi.org/10.1371/journal.pone.0055729			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409029	Green Published, Green Submitted, gold			2022-12-27	WOS:000315157200054
J	Wang, Q; Cheng, XL; Zhang, DY; Gao, XJ; Zhou, L; Qin, XY; Xie, GY; Liu, K; Qin, Y; Liu, BL; Qin, MJ				Wang, Qi; Cheng, Xiao-Lan; Zhang, Dong-Yan; Gao, Xue-Jiao; Zhou, Ling; Qin, Xiao-Ying; Xie, Guo-Yong; Liu, Kang; Qin, Yong; Liu, Bao-Lin; Qin, Min-Jian			Tectorigenin Attenuates Palmitate-Induced Endothelial Insulin Resistance via Targeting ROS-Associated Inflammation and IRS-1 Pathway	PLOS ONE			English	Article							INDUCED DIABETIC-RAT; IN-VITRO; KAIKASAPONIN-III; PUERARIAE FLOS; DYSFUNCTION; TECTORIDIN; PURIFICATION; ISOFLAVONES; METABOLISM; FLOWERS	Tectorigenin is a plant isoflavonoid originally isolated from the dried flower of Pueraria thomsonii Benth. Although its anti-inflammatory and anti-hyperglycosemia effects have been well documented, the effect of tectorigenin on endothelial dysfunction insulin resistance involved has not yet been reported. Herein, this study aims to investigate the action of tectorigenin on amelioration of insulin resistance in the endothelium. Palmitic acid (PA) was chosen as a stimulant to induce ROS production in endothelial cells and successfully established insulin resistance evidenced by the specific impairment of insulin PI3K signaling. Tectorigenin effectively inhibited the ability of PA to induce the production of reactive oxygen species and collapse of mitochondrial membrane potential. Moreover, tectorigenin presented strong inhibition effect on ROS-associated inflammation, as TNF-alpha and IL-6 production in endothelial cells was greatly reduced with suppression of IKK beta/NF-kappa B phosphorylation and JNK activation. Tectorigenin also can inhibit inflammation-stimulated IRS-1 serine phosphorylation and restore the impaired insulin PI3K signaling, leading to a decreased NO production. These results demonstrated its positive regulation of insulin action in the endothelium. Meanwhile, tectorigenin down-regulated endothelin-1 and vascular cell adhesion molecule-1 overexpression, and restored the loss of insulin-mediated vasodilation in rat aorta. These findings suggested that tectorigenin could inhibit ROS-associated inflammation and ameliorated endothelial dysfunction implicated in insulin resistance through regulating IRS-1 function. Tectorigenin might have potential to be applied for the management of cardiovascular diseases involved in diabetes and insulin resistance.	[Wang, Qi; Cheng, Xiao-Lan; Zhou, Ling; Qin, Xiao-Ying; Xie, Guo-Yong; Qin, Yong; Qin, Min-Jian] China Pharmaceut Univ, Dept Resource Sci Tradit Chinese Med, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China; [Zhang, Dong-Yan] Henan Prov Peoples Hosp, Dept Pharm, Zhengzhou, Peoples R China; [Gao, Xue-Jiao] Univ Macau, State Key Lab Qual Res Chinese Med, Inst Chinese Med Sci, Taipa, Peoples R China; [Liu, Kang; Liu, Bao-Lin] China Pharmaceut Univ, Dept Pharmacol Chinese Mat Med, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University; Zhengzhou University; University of Macau; China Pharmaceutical University	Qin, MJ (corresponding author), China Pharmaceut Univ, Dept Resource Sci Tradit Chinese Med, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China.	minjianqin@163.com	Qin, Minjian/D-3306-2017; TAO, Jun/I-2701-2014; Chen, Lung-Wen/J-5792-2015	Qin, Minjian/0000-0001-8539-7649; TAO, Jun/0000-0002-0936-4869; Chen, Lung-Wen/0000-0002-2311-7506	National Natural Science Foundation of China [81072976]; Research and Innovation Project for College Graduates of Jiangsu Province [CXZZ11-0810]; Program for the Top Doctor Innovative Talents of China Pharmacuetical University [2011IIBPY03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research and Innovation Project for College Graduates of Jiangsu Province; Program for the Top Doctor Innovative Talents of China Pharmacuetical University	Support as provided by: National Natural Science Foundation of China (Grant No. 81072976), Research and Innovation Project for College Graduates of Jiangsu Province (CXZZ11-0810) and Program for the Top Doctor Innovative Talents of China Pharmacuetical University (2011IIBPY03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae EA, 1999, BIOL PHARM BULL, V22, P1314, DOI 10.1248/bpb.22.1314; Cao XL, 1999, J CHROMATOGR A, V855, P709, DOI 10.1016/S0021-9673(99)00715-3; Carmody RJ, 2000, CELL DEATH DIFFER, V7, P282, DOI 10.1038/sj.cdd.4400646; Choi J, 2004, J MED FOOD, V7, P31, DOI 10.1089/109662004322984671; Eringa EC, 2002, CARDIOVASC RES, V56, P464, DOI 10.1016/S0008-6363(02)00593-X; Gual P, 2005, BIOCHIMIE, V87, P99, DOI 10.1016/j.biochi.2004.10.019; Han CY, 2010, DIABETES, V59, P386, DOI 10.2337/db09-0925; Han T, 2012, FOOD CHEM TOXICOL, V50, P409, DOI 10.1016/j.fct.2011.10.066; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Iwata NG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029600; Jung SH, 2002, ARCH PHARM RES, V25, P306, DOI 10.1007/BF02976631; Kamiya T, 2011, J HEALTH SCI, V57, P521, DOI 10.1248/jhs.57.521; Kearney MT, 2008, EXP PHYSIOL, V93, P158, DOI 10.1113/expphysiol.2007.039172; Kim F, 2007, CIRC RES, V100, P1589, DOI 10.1161/CIRCRESAHA.106.142851; Lee HU, 2005, J PHARMACOL SCI, V97, P541, DOI 10.1254/jphs.SCZ040467; Lee KT, 2000, ARCH PHARM RES, V23, P461, DOI 10.1007/BF02976573; Mishra M, 2011, DIABETES RES CLIN PR, V94, P255, DOI 10.1016/j.diabres.2011.07.037; NIIHO Y, 1989, YAKUGAKU ZASSHI, V109, P424, DOI 10.1248/yakushi1947.109.6_424; Pan CH, 2008, ARCH PHARM RES, V31, P1447, DOI 10.1007/s12272-001-2129-7; Potenza MA, 2005, AM J PHYSIOL-HEART C, V289, pH813, DOI 10.1152/ajpheart.00092.2005; Verma S, 2001, HYPERTENSION, V37, P328, DOI 10.1161/01.HYP.37.2.328; Wang Q, 2013, J PHARMACEUT BIOMED, V75, P25, DOI 10.1016/j.jpba.2012.11.009; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Xu J, 2009, CIRCULATION, V120, P1266, DOI 10.1161/CIRCULATIONAHA.108.835223; Yuan D, 2009, J ASIAN NAT PROD RES, V11, P471, DOI 10.1080/10286020902819822; ZAMZAMI N, 1995, J EXP MED, V181, P1661, DOI 10.1084/jem.181.5.1661; Zhang DY, 2013, J DIABETES, V5, P13, DOI 10.1111/1753-0407.12017; Zou MH, 2004, ENDOTHELIUM-J ENDOTH, V11, P89, DOI 10.1080/10623320490482619	29	69	72	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66417	10.1371/journal.pone.0066417	http://dx.doi.org/10.1371/journal.pone.0066417			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23874802	Green Submitted, Green Published, gold			2022-12-27	WOS:000322361200072
J	Liu, KC; Ge, W				Liu, Ka-Cheuk; Ge, Wei			Evidence for Gating Roles of Protein Kinase A and Protein Kinase C in Estradiol-Induced Luteinizing Hormone Receptor (lhcgr) Expression in Zebrafish Ovarian Follicle Cells	PLOS ONE			English	Article							MEMBRANE ESTROGEN-RECEPTOR; BRAIN TYROSINE-HYDROXYLASE; NITRIC-OXIDE SYNTHASE; GONADOTROPIN RECEPTORS; GENE-EXPRESSION; MESSENGER-RNA; FUNCTIONAL-CHARACTERIZATION; DIFFERENTIAL REGULATION; DOWN-REGULATION; UP-REGULATION	Estradiol (E2) stimulates luteinizing hormone receptor (lhcgr) expression in zebrafish follicle cells via nuclear estrogen receptors (nERs) that are likely expressed on the membrane, and lhcgr responds to E2 in a biphasic manner during 24-h treatment. These observations raise an interesting question on the signaling mechanism underlying E2 regulation, in particular the biphasic response of lhcgr expression. In the present study, we demonstrated that E2 regulation of lhcgr was significantly influenced by the activity of cAMP-PKA pathway. Activation of cAMP-PKA pathway by forskolin or db-cAMP suppressed E2-stimulated lhcgr expression in short-term (3 h) but enhanced its effect in long-term (24 h), suggesting differential roles of PKA at these two phases of lhcgr response. PKA inhibitor H89 showed reversed effects. In contrast, PKC pathway had consistent permissive effect on E2-induced lhcgr expression as evidenced by strong inhibition of E2 effect by PKC inhibitors GF109203X and Ro-31-8220 at both 3 and 24 h. One of the mechanisms by which PKA and PKC gated E2 effect might be through regulating nERs, particularly esr2a. Despite the strong influence of PKA and PKC, our data did not suggest direct mediating roles for these two pathways in E2 stimulation of lhcgr expression; yet they likely play critical gating roles in E2 signal transduction. As a follow-up study to our previous report on E2 regulation of gonadotropin receptors in the zebrafish ovary, the present study provides further evidence for the involvement of classical intracellular signal transduction pathways in E2 stimulation of lhcgr expression in the follicle cells.	[Ge, Wei] Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Ctr Cell & Dev Biol, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Ge, W (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China.	weige@cuhk.edu.hk	Ma, Miaojun/E-1320-2012	Ma, Miaojun/0000-0001-7046-9574; Liu, Kun/0000-0001-9127-053X; Liu, Ka Cheuk/0000-0001-6082-8801	Research Grants Council [CUHK464707, 464308, 464409]; Areas of Excellence (AoE) Scheme on Marine Environmental Research and Innovative Technology (MERIT) of the Hong Kong Special Administrative Region	Research Grants Council(Hong Kong Research Grants Council); Areas of Excellence (AoE) Scheme on Marine Environmental Research and Innovative Technology (MERIT) of the Hong Kong Special Administrative Region	The work was substantially supported by grants from the Research Grants Council (CUHK464707, 464308 and 464409) and the Areas of Excellence (AoE) Scheme on Marine Environmental Research and Innovative Technology (MERIT) of the Hong Kong Special Administrative Region to W.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funder's website: http://www.ugc.edu.hk/eng/rgc/grf/grf.htm	Amsterdam A, 2002, MOL CELL ENDOCRINOL, V187, P69, DOI 10.1016/S0303-7207(01)00701-8; Burns KH, 2002, ENDOCRINOLOGY, V143, P2823, DOI 10.1210/en.143.8.2823; Byers M, 1997, MOL ENDOCRINOL, V11, P172, DOI 10.1210/me.11.2.172; Caiazza F, 2007, BIOCHEM BIOPH RES CO, V359, P102, DOI 10.1016/j.bbrc.2007.05.059; CATT KJ, 1991, J BIOENERG BIOMEMBR, V23, P7; Chaube R, 2005, J NEUROENDOCRINOL, V17, P91, DOI 10.1111/j.1365-2826.2005.01282.x; Chaube R, 2005, GEN COMP ENDOCR, V141, P116, DOI 10.1016/j.ygcen.2004.12.010; Chen DB, 2004, ENDOCRINOLOGY, V145, P113, DOI 10.1210/en.2003-0547; CHEN JH, 1994, SCIENCE, V263, P1278, DOI 10.1126/science.8122111; Chen LH, 2011, CELL SIGNAL, V23, P497, DOI 10.1016/j.cellsig.2010.11.005; Chiang CH, 2000, J CLIN ENDOCR METAB, V85, P3828, DOI 10.1210/jc.85.10.3828; De Marinis YZ, 2010, DIABETOLOGIA, V53, P717, DOI 10.1007/s00125-009-1635-x; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; De Servi B, 2005, ONCOGENE, V24, P4946, DOI 10.1038/sj.onc.1208676; Dewing P, 2008, ENDOCRINOLOGY, V149, P5934, DOI 10.1210/en.2008-0847; Hatae J, 2009, J PHYSIOL SCI, V59, P181, DOI 10.1007/s12576-009-0023-0; Iyengar R, 1996, SCIENCE, V271, P461, DOI 10.1126/science.271.5248.461; Jaubert AM, 2007, ENDOCRINOLOGY, V148, P2444, DOI 10.1210/en.2006-1329; Jeng SR, 2007, GEN COMP ENDOCR, V154, P161, DOI 10.1016/j.ygcen.2007.05.026; Kazi AA, 2009, BIOL REPROD, V81, P378, DOI 10.1095/biolreprod.109.076117; Kobayashi T, 2008, GEN COMP ENDOCR, V156, P595, DOI 10.1016/j.ygcen.2008.02.010; Kwok HF, 2005, BIOL REPROD, V72, P1370, DOI 10.1095/biolreprod.104.038190; Le HH, 2010, ENDOCRINOLOGY, V151, P5689, DOI 10.1210/en.2010-0710; Lee MY, 2008, CELL RES, V18, P491, DOI 10.1038/cr.2008.42; LEUNG PCK, 1992, ENDOCR REV, V13, P476, DOI 10.1210/er.13.3.476; Levin ER, 2011, MOL ENDOCRINOL, V25, P377, DOI 10.1210/me.2010-0284; Li CW, 2012, GEN COMP ENDOCR, V176, P420, DOI 10.1016/j.ygcen.2011.12.032; Liu KC, 2013, GEN COMP ENDOCR, V181, P288, DOI 10.1016/j.ygcen.2012.07.032; Liu KC, 2011, ENDOCRINOLOGY, V152, P4418, DOI 10.1210/en.2011-1065; Liu XC, 2009, BIOL REPROD, V80, P1253, DOI 10.1095/biolreprod.108.070250; Longo M, 2006, J MOL ENDOCRINOL, V37, P489, DOI 10.1677/jme.1.02055; Lucas TF, 2008, BIOL REPROD, V78, P101; Luckenbach JA, 2011, GEN COMP ENDOCR, V171, P52, DOI 10.1016/j.ygcen.2010.12.016; Maharjan S, 2010, J NEUROCHEM, V112, P42, DOI 10.1111/j.1471-4159.2009.06430.x; Marlatt VL, 2008, MOL CELL ENDOCRINOL, V283, P38, DOI 10.1016/j.mce.2007.10.013; Menon B, 2011, MOL ENDOCRINOL, V25, P282, DOI 10.1210/me.2010-0366; Menuet A, 2004, J MOL ENDOCRINOL, V32, P975, DOI 10.1677/jme.0.0320975; Mhyre AJ, 2006, ENDOCRINOLOGY, V147, P1796, DOI 10.1210/en.2005-1316; MIGLIACCIO S, 1993, MOL ENDOCRINOL, V7, P1133, DOI 10.1210/me.7.9.1133; Migliaccio S, 1998, STEROIDS, V63, P352, DOI 10.1016/S0039-128X(98)00040-3; Migliaccio S, 1998, ENDOCRINOLOGY, V139, P4598, DOI 10.1210/en.139.11.4598; Mize AL, 2002, NEUROENDOCRINOLOGY, V76, P339, DOI 10.1159/000067583; Nelson ER, 2007, MOL REPROD DEV, V74, P1105, DOI 10.1002/mrd.20634; Nelson ER, 2010, ENDOCRINOLOGY, V151, P1668, DOI 10.1210/en.2009-1447; Oba Y, 1999, BIOCHEM BIOPH RES CO, V263, P584, DOI 10.1006/bbrc.1999.1346; Oba Y, 1999, BIOCHEM BIOPH RES CO, V265, P366, DOI 10.1006/bbrc.1999.1700; Pang Y, 2008, ENDOCRINOLOGY, V149, P3410, DOI 10.1210/en.2007-1663; Pang YF, 2010, DEV BIOL, V342, P194, DOI 10.1016/j.ydbio.2010.03.027; Pang YF, 2009, GEN COMP ENDOCR, V161, P58, DOI 10.1016/j.ygcen.2008.10.003; Pedram A, 2007, J BIOL CHEM, V282, P22278, DOI 10.1074/jbc.M611877200; Pedram A, 2006, MOL ENDOCRINOL, V20, P1996, DOI 10.1210/me.2005-0525; Pinzone JJ, 2004, MOL CELL BIOL, V24, P4605, DOI 10.1128/MCB.24.11.4605-4612.2004; Qiu J, 2003, J NEUROSCI, V23, P9529; Radice S, 2004, CHEM-BIOL INTERACT, V147, P185, DOI 10.1016/j.cbi.2003.12.006; REE AH, 1992, ENDOCRINOLOGY, V131, P1810, DOI 10.1210/en.131.4.1810; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; RICHARDS JS, 1994, ENDOCR REV, V15, P725, DOI 10.1210/er.15.6.725; SACEDA M, 1991, J BIOL CHEM, V266, P17809; Sheldahl LC, 2008, NEUROSCIENCE, V153, P751, DOI 10.1016/j.neuroscience.2008.02.035; Song RX, 2004, P NATL ACAD SCI USA, V101, P2076, DOI 10.1073/pnas.0308334100; Soverchia L, 2005, TOXICOL APPL PHARM, V209, P236, DOI 10.1016/j.taap.2005.04.013; Stoica GE, 2003, ONCOGENE, V22, P7998, DOI 10.1038/sj.onc.1206769; Themmen APN, 2000, ENDOCR REV, V21, P551, DOI 10.1210/er.21.5.551; Tischkau SA, 2000, J NEUROSCI, V20, P7830; Tonetti DA, 2000, BRIT J CANCER, V83, P782, DOI 10.1054/bjoc.2000.1326; Vasudevan N, 2007, ENDOCR REV, V28, P1, DOI 10.1210/er.2005-0021; Whitmore D, 2000, NATURE, V404, P87, DOI 10.1038/35003589; WU J, 1993, SCIENCE, V262, P1065, DOI 10.1126/science.7694366; Yang LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009851; Zhang CG, 2010, ENDOCRINOLOGY, V151, P4477, DOI 10.1210/en.2010-0177; Zhang HH, 2010, ENDOCRINOLOGY, V151, P3874, DOI 10.1210/en.2009-1356; Zhang MJ, 2009, MOL HUM REPROD, V15, P399, DOI 10.1093/molehr/gap031; Zhang ZG, 2002, BIOCHEM BIOPH RES CO, V294, P926, DOI 10.1016/S0006-291X(02)00348-0; Zhao LZ, 2007, BRAIN RES, V1172, P48, DOI 10.1016/j.brainres.2007.06.092; Zhou R, 2011, BIOL REPROD, V85, P615, DOI 10.1095/biolreprod.111.091884	75	26	28	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62524	10.1371/journal.pone.0062524	http://dx.doi.org/10.1371/journal.pone.0062524			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658740	gold, Green Submitted, Green Published			2022-12-27	WOS:000321202100014
J	Zhang, HX; Zhang, ML; Sanderson, SC				Zhang, Hong-Xiang; Zhang, Ming-Li; Sanderson, Stewart C.			Retreating or Standing: Responses of Forest Species and Steppe Species to Climate Change in Arid Eastern Central Asia	PLOS ONE			English	Article							GENETIC-STRUCTURE; POPULATION-GROWTH; GLACIAL REFUGIA; PHYLOGEOGRAPHY; FUTURE; MITOCHONDRIAL; TIANSHAN; MAXIMUM; ZONE; BIODIVERSITY	Background: The temperature in arid Eastern Central Asia is projected to increase in the future, accompanied by increased variability of precipitation. To investigate the impacts of climate change on plant species in this area, we selected two widespread species as candidates, Clematis sibirica and C. songorica, from montane coniferous forest and arid steppe habitats respectively. Methodology/Principal Findings: We employed a combined approach of molecular phylogeography and species distribution modelling (SDM) to predict the future responses of these two species to climate change, utilizing evidence of responses from the past. Genetic data for C. sibirica shows a significant phylogeographical signal (N-ST > F-ST, P<0.05) and demographic contraction during the glacial-interglacial cycles in the Pleistocene. This forest species would likely experience range reduction, though without genetic loss, in the face of future climate change. In contrast, SDMs predict that C. songorica, a steppe species, should maintain a consistently stable potential distribution under the Last Glacial Maximum (LGM) and the future climatic conditions referring to its existing potential distribution. Molecular results indicate that the presence of significant phylogeographical signal in this steppe species is rejected and this species contains a high level of genetic differentiation among populations in cpDNA, likely benefiting from stable habitats over a lengthy time period. Conclusions/Significance: Evidence from the molecular phylogeography of these two species, the forest species is more sensitive to past climate changes than the steppe species. SDMs predict that the forest species will face the challenge of potential range contraction in the future more than the steppe species. This provides a perspective on ecological management in arid Eastern Central Asia, indicating that increased attention should be paid to montane forest species, due to their high sensitivity to disturbance.	[Zhang, Hong-Xiang; Zhang, Ming-Li] Chinese Acad Sci, Key Lab Biogeog & Bioresource Arid Land, Xinjiang Inst Ecol & Geog, Urumqi, Peoples R China; [Zhang, Hong-Xiang] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhang, Ming-Li] Chinese Acad Sci, Inst Bot, Beijing, Peoples R China; [Sanderson, Stewart C.] US Forest Serv, Shrub Sci Lab, Intermt Res Stn, USDA, Provo, UT USA	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; United States Department of Agriculture (USDA); United States Forest Service	Zhang, ML (corresponding author), Chinese Acad Sci, Key Lab Biogeog & Bioresource Arid Land, Xinjiang Inst Ecol & Geog, Urumqi, Peoples R China.	zhangml@ibcas.ac.cn			CAS Important Direction for Knowledge Innovation Project [KZCX2-EW-305]; Xinjiang Institute of Ecology and Geography, Chinese Academy of Sciences	CAS Important Direction for Knowledge Innovation Project; Xinjiang Institute of Ecology and Geography, Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was funded by CAS Important Direction for Knowledge Innovation Project (No. KZCX2-EW-305), and the Xinjiang Institute of Ecology and Geography, Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsos IG, 2012, P ROY SOC B-BIOL SCI, V279, P2042, DOI 10.1098/rspb.2011.2363; Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x; Balint M, 2011, NAT CLIM CHANGE, V1, P313, DOI 10.1038/NCLIMATE1191; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beatty GE, 2013, J BIOGEOGR, V40, P335, DOI 10.1111/j.1365-2699.2012.02789.x; Beatty GE, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-29; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Bohner J, 2005, BOREAS, V34, P220, DOI 10.1080/03009480510012917; Bosboom RE, 2011, PALAEOGEOGR PALAEOCL, V299, P385, DOI 10.1016/j.palaeo.2010.11.019; Braconnot P, 2007, CLIM PAST, V3, P261, DOI 10.5194/cp-3-261-2007; Byrne M, 2008, MOL ECOL, V17, P4398, DOI 10.1111/j.1365-294X.2008.03899.x; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; Comes HP, 1998, TRENDS PLANT SCI, V3, P432, DOI 10.1016/S1360-1385(98)01327-2; Cordellier M, 2009, MOL ECOL, V18, P534, DOI 10.1111/j.1365-294X.2008.04042.x; Cox CB, 2010, BIOGEOGRAPHY AN ECOL; Desamore A, 2012, J BIOGEOGR, V39, P574, DOI 10.1111/j.1365-2699.2011.02622.x; Desamore A, 2012, GLOBAL CHANGE BIOL, V18, P2915, DOI 10.1111/j.1365-2486.2012.02752.x; Doyle J. J., 1987, PHYTOCHEM B, P11; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupanloup I, 2008, MOL ECOL, V11, P2571; Espindola A, 2012, ECOL LETT, V15, P649, DOI 10.1111/j.1461-0248.2012.01779.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fang XM, 2002, CHINESE SCI BULL, V47, P1381, DOI 10.1360/02tb9305; Fehrer J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-239; FORMAN RTT, 1995, LANDSCAPE ECOL, V10, P133, DOI 10.1007/BF00133027; Fu YX, 1997, GENETICS, V147, P915; Ge XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043717; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hasumi H, 2004, K 1 COUPLED GCM MIRO; Hesse PP, 2004, QUATERN INT, V118, P87, DOI 10.1016/S1040-6182(03)00132-0; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hu RJ, 2004, PHYSICAL GEOGRAPHY O; Hu XS, 1999, GENETICS, V152, P441; Hughes L, 2003, AUSTRAL ECOL, V28, P423, DOI 10.1046/j.1442-9993.2003.01300.x; Iwasaki T, 2012, J PLANT RES, V125, P207, DOI 10.1007/s10265-011-0428-8; Keppel G, 2012, GLOBAL ECOL BIOGEOGR, V21, P393, DOI 10.1111/j.1466-8238.2011.00686.x; Lawing AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028554; Lessa EP, 2003, P NATL ACAD SCI USA, V100, P10331, DOI 10.1073/pnas.1730921100; Lioubimtseva E, 2009, J ARID ENVIRON, V73, P963, DOI 10.1016/j.jaridenv.2009.04.022; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Ma Shao-Bin, 2002, Acta Botanica Yunnanica, V24, P569; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Measey GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026606; Miller MP, 2005, J HERED, V96, P722, DOI 10.1093/jhered/esi119; Pachauri R.K, 2007, CONTRIBUTION WORKING, P104, DOI DOI 10.1017/CBO9780511546013; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pearson RG, 2006, TRENDS ECOL EVOL, V21, P111, DOI 10.1016/j.tree.2005.11.022; Petit RJ, 2008, SCIENCE, V320, P1450, DOI 10.1126/science.1155457; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pons O, 1996, GENETICS, V144, P1237; Ramos ACS, 2007, ANN BOT-LONDON, V100, P1219, DOI 10.1093/aob/mcm221; Richardson JE, 2001, SCIENCE, V293, P2242, DOI 10.1126/science.1061421; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Schneider S, 1999, GENETICS, V152, P1079; Shi YF, 2006, THE QUATERNARY GLACI; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Wang W.T., 2001, FLORA CHINA, V6, P333; Wang W, 2009, PERSPECT PLANT ECOL, V11, P81, DOI 10.1016/j.ppees.2009.01.001; Wang WT, 1980, RANUNCULACEAE FLORA, P33; Wen Q.Z., 1993, CHINESE GEOGR SCI, V3, P147; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Widmer A, 2001, TRENDS ECOL EVOL, V16, P267, DOI 10.1016/S0169-5347(01)02163-2; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Xu XK, 2010, BOREAS, V39, P215, DOI 10.1111/j.1502-3885.2009.00118.x; Yang FS, 2008, MOL ECOL, V17, P5135, DOI 10.1111/j.1365-294X.2008.03976.x; Zhang HX, 2012, PALAEOGEOGR PALAEOCL, V353, P93, DOI 10.1016/j.palaeo.2012.07.013; Zhang HX, 2012, J SYST EVOL, V50, P295, DOI 10.1111/j.1759-6831.2012.00198.x; Zhang QA, 2010, MOL PHYLOGENET EVOL, V57, P1091, DOI 10.1016/j.ympev.2010.10.003; Zhang YJ, 2008, GENETICA, V134, P353, DOI 10.1007/s10709-008-9243-0	75	69	70	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2013	8	4							e61954	10.1371/journal.pone.0061954	http://dx.doi.org/10.1371/journal.pone.0061954			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125TD	23894405	Green Published, gold, Green Submitted			2022-12-27	WOS:000317563300046
J	Xue, H; Zheng, J; Cui, ZP; Bai, XF; Li, G; Zhang, CD; He, SH; Li, WH; Lajud, SA; Duan, YZ; Zhou, H				Xue, Hui; Zheng, Jun; Cui, Ziping; Bai, Xiufeng; Li, Gang; Zhang, Caidi; He, Sanhu; Li, Weihong; Lajud, Shayanne A.; Duan, Yinzhong; Zhou, Hong			Low-Intensity Pulsed Ultrasound Accelerates Tooth Movement via Activation of the BMP-2 Signaling Pathway	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; IN-VITRO; OSTEOBLASTIC DIFFERENTIATION; PERIODONTAL TISSUE; PROSTAGLANDIN E-2; HEALING-PROCESS; BONE-FORMATION; CELLS; EXPRESSION; MODEL	The present study was designed to determine the underlying mechanism of low-intensity pulsed ultrasound (LIPUS) induced alveolar bone remodeling and the role of BMP-2 expression in a rat orthodontic tooth movement model. Orthodontic appliances were placed between the homonymy upper first molars and the upper central incisors in rats under general anesthesia, followed by daily 20-min LIPUS or sham LIPUS treatment beginning at day 0. Tooth movement distances and molecular changes were evaluated at each observation point. In vitro and in vivo studies were conducted to detect HGF (Hepatocyte growth factor)/Runx2/BMP-2 signaling pathways and receptor activator of NFkB ligand (RANKL) expression by quantitative real time PCR (qRT-PCR), Western blot and immunohistochemistry. At day 3, LIPUS had no effect on the rat orthodontic tooth movement distance and BMP-2-induced alveolar bone remodeling. However, beginning at day 5 and for the following time points, LIPUS significantly increased orthodontic tooth movement distance and BMP-2 signaling pathway and RANKL expression compared with the control group. The qRT-PCR and Western blot data in vitro and in vivo to study BMP-2 expression were consistent with the immunohistochemistry observations. The present study demonstrates that LIPUS promotes alveolar bone remodeling by stimulating the HGF/Runx2/BMP-2 signaling pathway and RANKL expression in a rat orthodontic tooth movement model, and LIPUS increased BMP-2 expression via Runx2 regulation.	[Xue, Hui; Duan, Yinzhong] Fourth Mil Med Univ, Sch Stomatol, Dept Orthodont, Xian 710032, Peoples R China; [Xue, Hui] Hegang Peoples Hosp, Dept Dent, Hegang, Peoples R China; [Zheng, Jun; Bai, Xiufeng; Li, Gang; He, Sanhu] Xi An Jiao Tong Univ, Dept Oral & Maxillofacial Surg, Stomatol Hosp, Xian 710049, Peoples R China; [Cui, Ziping] Hegang Peoples Hosp, Dept Digest Dis, Hegang, Peoples R China; [Zhang, Caidi; Zhou, Hong] Xi An Jiao Tong Univ, Stomatol Hosp, Dept Orthodont, Xian 710049, Peoples R China; [Li, Weihong] Wenzhou Med Coll, Stomatol Hosp, Dept Orthodont, Wenzhou, Peoples R China; [Lajud, Shayanne A.] Univ Penn, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Philadelphia, PA 19104 USA	Air Force Military Medical University; Xi'an Jiaotong University; Xi'an Jiaotong University; Wenzhou Medical University; University of Pennsylvania	Duan, YZ (corresponding author), Fourth Mil Med Univ, Sch Stomatol, Dept Orthodont, Xian 710032, Peoples R China.	duanyz@fmmu.edu.cn; zhouhongdean@126.com	Huang, Yu/K-2866-2017	Huang, Yu/0000-0002-1277-6784; Wang, Rui/0000-0003-3825-3620; SHEN, YANG/0000-0002-2448-8405	National Natural Science Foundation of China [30973359]; Scientific and Technological Project of Shaanxi Province of China [2008K14-03]; Kwang-Hua Education Foundation; Zhejiang Provincial Natural Science Foundation of China [Y2110400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific and Technological Project of Shaanxi Province of China; Kwang-Hua Education Foundation; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This study was supported by grants from the National Natural Science Foundation of China (Project No. 30973359) (to Dr. Zhou), the Scientific and Technological Project of Shaanxi Province of China (2008K14-03) (to Dr. Duan), and partially supported by Kwang-Hua Education Foundation and Zhejiang Provincial Natural Science Foundation of China (Project No. Y2110400) (to Dr. Weihong Li). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma Y, 2001, J BONE MINER RES, V16, P671, DOI 10.1359/jbmr.2001.16.4.671; Borsje MA, 2010, ANGLE ORTHOD, V80, P498, DOI 10.2319/060809-318.1; Chan CW, 2006, J ORTHOP RES, V24, P263, DOI 10.1002/jor.20015; Coords M, 2011, J ORTHOP RES, V29, P181, DOI 10.1002/jor.21223; COWIN SC, 1991, J BIOMECH ENG-T ASME, V113, P191, DOI 10.1115/1.2891234; D'Ippolito G, 2002, BONE, V31, P269, DOI 10.1016/S8756-3282(02)00820-7; El-Bialy T, 2004, AM J ORTHOD DENTOFAC, V126, P186, DOI 10.1016/j.ajodo.2004.02.010; El-Bialy T, 2011, J DENT, V39, P693, DOI 10.1016/j.jdent.2011.08.001; El-Bialy T, 2006, AM J ORTHOD DENTOFAC, V130; Fujita S, 2008, ORTHOD CRANIOFAC RES, V11, P143, DOI 10.1111/j.1601-6343.2008.00423.x; Fung CH, 2012, ULTRASOUND MED BIOL, V38, P745, DOI 10.1016/j.ultrasmedbio.2012.01.022; Grano M, 1996, P NATL ACAD SCI USA, V93, P7644, DOI 10.1073/pnas.93.15.7644; Hadjiargyrou M, 1998, CLIN ORTHOP RELAT R, pS216, DOI 10.1097/00003086-199810001-00022; Hayton MJ, 2005, ULTRASOUND MED BIOL, V31, P1131, DOI 10.1016/j.ultrasmedbio.2005.04.017; Hsieh PCH, 2006, J VASC SURG, V43, P150, DOI 10.1016/j.jvs.2005.08.008; Iglesias-Linares A, 2011, ORTHOD CRANIOFAC RES, V14, P138, DOI 10.1111/j.1601-6343.2011.01519.x; Iino S, 2007, AM J ORTHOD DENTOFAC, V131, DOI 10.1016/j.ajodo.2006.08.014; Inubushi T, 2008, J PERIODONTOL, V79, P1984, DOI [10.1902/jop.2008.080081, 10.1902/jop.2008.080081 ]; Jung RE, 2003, CLIN ORAL IMPLAN RES, V14, P556, DOI 10.1034/j.1600-0501.2003.00921.x; Kanzaki H, 2006, GENE THER, V13, P678, DOI 10.1038/sj.gt.3302707; Katano M, 2011, EXP ANIM TOKYO, V60, P385, DOI 10.1538/expanim.60.385; Kawasaki K, 2000, LASER SURG MED, V26, P282, DOI 10.1002/(SICI)1096-9101(2000)26:3<282::AID-LSM6>3.0.CO;2-X; Khanna A, 2009, BRIT MED BULL, V89, P169, DOI 10.1093/bmb/ldn040; Kim SJ, 2009, LASER SURG MED, V41, P524, DOI 10.1002/lsm.20792; Kim SJ, 2009, ANGLE ORTHOD, V79, P284, DOI 10.2319/020308-60.1; King GN, 1997, J DENT RES, V76, P1460, DOI 10.1177/00220345970760080801; Kobayashi Y, 1998, ANGLE ORTHOD, V68, P259; Kohno T, 2002, J Orthod, V29, P129, DOI 10.1093/ortho/29.2.129; Lee W, 2008, J DENT RES, V87, P861, DOI 10.1177/154405910808700904; Li JK, 2003, BIOMATERIALS, V24, P2379, DOI 10.1016/S0142-9612(03)00033-4; LONG MW, 1995, J CLIN INVEST, V95, P881, DOI 10.1172/JCI117738; Malizos KN, 2006, BONE, V38, P530, DOI 10.1016/j.bone.2005.10.012; de Albornoz PM, 2011, BRIT MED BULL, V100, P39, DOI 10.1093/bmb/ldr006; Mitsui N, 2006, LIFE SCI, V78, P2697, DOI 10.1016/j.lfs.2005.10.024; Oshiro T, 2002, ANAT REC, V266, P218, DOI 10.1002/ar.10061; Reher P, 2002, BONE, V31, P236, DOI 10.1016/S8756-3282(02)00789-5; Rosen V, 2009, CYTOKINE GROWTH F R, V20, P475, DOI 10.1016/j.cytogfr.2009.10.018; Sant'Anna EF, 2005, J ORTHOP RES, V23, P646, DOI 10.1016/j.orthres.2004.09.007; Sena K, 2005, ULTRASOUND MED BIOL, V31, P703, DOI 10.1016/j.ultrasmedbio.2005.01.013; Shiraishi R, 2011, J PERIODONTOL, V82, P1498, DOI 10.1902/jop.2011.100627; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; Spadaro JA, 1997, BIOELECTROMAGNETICS, V18, P193, DOI 10.1002/(SICI)1521-186X(1997)18:3<193::AID-BEM1>3.0.CO;2-Y; Strippoli Julien, 2012, Orthod Fr, V83, P155, DOI 10.1051/orthodfr/2012015; Sun JS, 2001, J BIOMED MATER RES, V57, P449, DOI 10.1002/1097-4636(20011205)57:3<449::AID-JBM1188>3.0.CO;2-0; Suzuki Akito, 2009, J Oral Sci, V51, P29; Suzuki A, 2009, ACTA BIOCH BIOPH SIN, V41, P108, DOI 10.1093/abbs/gmn012; Takiguchi T, 1999, J PERIODONTAL RES, V34, P431; Tsai SY, 2012, INT IMMUNOPHARMACOL, V13, P156, DOI 10.1016/j.intimp.2012.03.026; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Wang Y, 2011, ARCH ORAL BIOL, V56, P177, DOI 10.1016/j.archoralbio.2010.09.009; Wijdicks CA, 2009, ULTRASOUND MED BIOL, V35, P1629, DOI 10.1016/j.ultrasmedbio.2009.04.017; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241	52	77	83	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e68926	10.1371/journal.pone.0068926	http://dx.doi.org/10.1371/journal.pone.0068926			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	24058553	gold, Green Published, Green Submitted			2022-12-27	WOS:000325211000063
J	Krementsov, DN; Wall, EH; Martin, RA; Subramanian, M; Noubade, R; Del Rio, R; Mawe, GM; Bond, JP; Poynter, ME; Blankenhorn, EP; Teuscher, C				Krementsov, Dimitry N.; Wall, Emma H.; Martin, Rebecca A.; Subramanian, Meenakumari; Noubade, Rajkumar; Del Rio, Roxana; Mawe, Gary M.; Bond, Jeffrey P.; Poynter, Matthew E.; Blankenhorn, Elizabeth P.; Teuscher, Cory			Histamine H-3 Receptor Integrates Peripheral Inflammatory Signals in the Neurogenic Control of Immune Responses and Autoimmune Disease Susceptibility	PLOS ONE			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; SUBCAPSULAR SINUS MACROPHAGES; REGULATE ACTH RELEASE; DRAINING LYMPH-NODES; BLOOD-BRAIN-BARRIER; MULTIPLE-SCLEROSIS; B-CELLS; T-CELL; ANTAGONISTS/INVERSE AGONISTS; NEURAL REFLEXES	Histamine H-3 receptor (Hrh3/H3R) is primarily expressed by neurons in the central nervous system (CNS) where it functions as a presynaptic inhibitory autoreceptor and heteroreceptor. Previously, we identified an H3R-mediated central component in susceptibility to experimental allergic encephalomyelitis (EAE), the principal autoimmune model of multiple sclerosis (MS), related to neurogenic control of blood brain barrier permeability and peripheral T cell effector responses. Furthermore, we identified Hrh3 as a positional candidate for the EAE susceptibility locus Eae8. Here, we characterize Hrh3 polymorphisms between EAE-susceptible and resistant SJL and B10.S mice, respectively, and show that Hrh3 isoform expression in the CNS is differentially regulated by acute peripheral inflammatory stimuli in an allele-specific fashion. Next, we show that Hrh3 is not expressed in any subpopulations of the immune compartment, and that secondary lymphoid tissue is anatomically poised to be regulated by central H3R signaling. Accordingly, using transcriptome analysis, we show that, inflammatory stimuli elicit unique transcriptional profiles in the lymph nodes of H3RKO mice compared to WT mice, which is indicative of negative regulation of peripheral immune responses by central H3R signaling. These results further support a functional link between the neurogenic control of T cell responses and susceptibility to CNS autoimmune disease coincident with acute and/or chronic peripheral inflammation. Pharmacological targeting of H3R may therefore be useful in preventing the development and formation of new lesions in MS, thereby limiting disease progression.	[Krementsov, Dimitry N.; Wall, Emma H.; Martin, Rebecca A.; Subramanian, Meenakumari; Noubade, Rajkumar; Del Rio, Roxana; Mawe, Gary M.; Bond, Jeffrey P.; Poynter, Matthew E.; Teuscher, Cory] Univ Vermont, Dept Med, Immunobiol Program, Burlington, VT 05405 USA; [Blankenhorn, Elizabeth P.] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA; [Teuscher, Cory] Univ Vermont, Dept Pathol, Burlington, VT 05405 USA	University of Vermont; Drexel University; University of Vermont	Teuscher, C (corresponding author), Univ Vermont, Dept Med, Immunobiol Program, Burlington, VT 05405 USA.	C.Teuscher@uvm.edu	Krementsov, Dimitry/Y-8288-2019; Gonzalez, Victor M/F-7396-2010	Krementsov, Dimitry/0000-0003-2709-7466; Poynter, Matthew/0000-0002-7578-4570; Gonzalez, Victor M/0000-0001-7538-0552; del Rio-Guerra, Roxana/0000-0001-6871-3259	National Institute of Health [AI041747, NS036526, NS060901]; National Multiple Sclerosis Society; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036526, R01NS060901] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Health Grants AI041747, NS036526, and NS060901 to CT. This work was also supported in part by a postdoctoral fellowship from the National Multiple Sclerosis Society to DNK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie V, 2005, BLOOD, V106, P1843, DOI 10.1182/blood-2005-03-1281; Affymetrix, 2005, GENECHIP EXPR AN TEC; Aicher SA, 2004, PAIN, V110, P560, DOI 10.1016/j.pain.2004.03.025; Andersson U, 2012, J EXP MED, V209, P1057, DOI 10.1084/jem.20120571; Antel J, 2012, ACTA NEUROPATHOL, V123, P627, DOI 10.1007/s00401-012-0953-0; Bakker RA, 2006, MOL PHARMACOL, V69, P1194, DOI 10.1124/mol.105.019299; Bakker RA, 2004, INFLAMM RES, V53, P509, DOI 10.1007/s00011-004-1286-9; Bannerman DD, 1999, LAB INVEST, V79, P1181; Beghdadi W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006004; Benedict RHB, 2011, NAT REV NEUROL, V7, P332, DOI 10.1038/nrneurol.2011.61; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Benjamini Y., 1995, J R STAT SOC B, V57, P289, DOI 10.2307/2346101; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bongers G, 2007, J PHARMACOL EXP THER, V323, P888, DOI 10.1124/jpet.107.127639; Brooks TA, 2006, BRAIN RES, V1120, P172, DOI 10.1016/j.brainres.2006.08.085; Butterfield RJ, 1998, J IMMUNOL, V161, P1860; Butterfield RJ, 1999, J IMMUNOL, V162, P3096; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Chen JC, 2003, EUR J PHARMACOL, V467, P57, DOI 10.1016/S0014-2999(03)01635-2; Chtanova T, 2009, IMMUNITY, V31, P342, DOI 10.1016/j.immuni.2009.06.023; CLARK MA, 1992, EUR J PHARMACOL, V210, P31, DOI 10.1016/0014-2999(92)90648-N; Coge F, 2001, BIOCHEM J, V355, P279, DOI 10.1042/0264-6021:3550279; Courtney AM, 2009, MED CLIN N AM, V93, P451, DOI 10.1016/j.mcna.2008.09.014; DeLuca J, 2011, NEUROREHABILITATION, V29, P197, DOI 10.3233/NRE-2011-0695; Drutel G, 2001, MOL PHARMACOL, V59, P1; Dyment DA, 2004, LANCET NEUROL, V3, P104, DOI 10.1016/S1474-4422(03)00663-X; Ebers GC, 2008, LANCET NEUROL, V7, P268, DOI 10.1016/S1474-4422(08)70042-5; Encinas JA, 2001, INT IMMUNOL, V13, P257, DOI 10.1093/intimm/13.3.257; Erickson MA, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-150; FELTEN DL, 1985, J IMMUNOL, V135, pS755; FOSSUM S, 1980, SCAND J IMMUNOL, V12, P433, DOI 10.1111/j.1365-3083.1980.tb00087.x; Grant JL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004145; Hancock AA, 2005, EXPERT OPIN INV DRUG, V14, P223, DOI 10.1517/13543784.14.3.223; Hickman HD, 2008, NAT IMMUNOL, V9, P155, DOI 10.1038/ni1557; Hoffman JM, 2012, GASTROENTEROLOGY, V142, P844, DOI 10.1053/j.gastro.2011.12.041; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jaeger LB, 2009, BRAIN BEHAV IMMUN, V23, P507, DOI 10.1016/j.bbi.2009.01.017; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Lassmann H, 2011, NEUROPATH APPL NEURO, V37, P698, DOI 10.1111/j.1365-2990.2011.01189.x; Lebois EP, 2011, CURR TOP MED CHEM, V11, P648; Liu CL, 2003, J BIOL CHEM, V278, P50754, DOI 10.1074/jbc.M308995200; Lovenberg TW, 1999, MOL PHARMACOL, V55, P1101, DOI 10.1124/mol.55.6.1101; Lu CM, 2008, J NEUROSCI RES, V86, P2624, DOI 10.1002/jnr.21716; Lynch JL, 2008, PAIN, V136, P293, DOI 10.1016/j.pain.2007.07.007; Ma RLZ, 2002, SCIENCE, V297, P620, DOI 10.1126/science.1072810; MacDermott AB, 1999, ANNU REV NEUROSCI, V22, P443, DOI 10.1146/annurev.neuro.22.1.443; Mandolesi G, 2010, NEUROL SCI, V31, P255, DOI 10.1007/s10072-010-0369-3; Matarese G, 2010, NAT REV NEUROL, V6, P455, DOI 10.1038/nrneurol.2010.89; Matthews PM, 2001, CURR OPIN NEUROL, V14, P279, DOI 10.1097/00019052-200106000-00004; Meng J, 2008, EUR J PHARMACOL, V587, P336, DOI 10.1016/j.ejphar.2008.03.019; Millan-Guerrero RO, 2011, ARCH MED RES, V42, P44, DOI 10.1016/j.arcmed.2011.01.009; Minagar A, 2006, NEUROL RES, V28, P230, DOI 10.1179/016164106X98080; Nance DM, 2007, BRAIN BEHAV IMMUN, V21, P736, DOI 10.1016/j.bbi.2007.03.008; Noubade R, 2008, J IMMUNOL, V180, P7471, DOI 10.4049/jimmunol.180.11.7471; Noubade R, 2007, J CLIN INVEST, V117, P3507, DOI 10.1172/JCI32792; Olechowski CJ, 2009, PAIN, V141, P156, DOI 10.1016/j.pain.2008.11.002; Patti F, 2009, MULT SCLER J, V15, P779, DOI 10.1177/1352458509105544; Perry CR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001178; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Phan TG, 2009, NAT IMMUNOL, V10, P786, DOI 10.1038/ni.1745; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Prat A, 2005, CURR OPIN NEUROL, V18, P225, DOI 10.1097/01.wco.0000169737.99040.31; Ramagopalan SV, 2008, J NEUROIMMUNOL, V201, P183, DOI 10.1016/j.jneuroim.2008.02.016; Ramagopalan SV, 2008, TRENDS NEUROSCI, V31, P645, DOI 10.1016/j.tins.2008.09.001; Reynolds R, 2011, ACTA NEUROPATHOL, V122, P155, DOI 10.1007/s00401-011-0840-0; Rosas-Ballina M, 2009, NEURON, V64, P28, DOI 10.1016/j.neuron.2009.09.039; Rovaris M, 2009, NEUROLOGY, V72, P1693, DOI 10.1212/WNL.0b013e3181a55feb; Sanna V, 2003, J CLIN INVEST, V111, P241, DOI 10.1172/JCI200316721; SHEPPARD MN, 1983, THORAX, V38, P333, DOI 10.1136/thx.38.5.333; Solaro C, 2011, NAT REV NEUROL, V7, P519, DOI 10.1038/nrneurol.2011.120; Steinman L, 2004, NAT IMMUNOL, V5, P575, DOI 10.1038/ni1078; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103; SZAKAL AK, 1983, J IMMUNOL, V131, P1714; Takahashi K, 2002, J CLIN INVEST, V110, P1791, DOI 10.1172/JCI200215784; Teuscher C, 2007, P NATL ACAD SCI USA, V104, P10146, DOI 10.1073/pnas.0702291104; Toyota H, 2002, MOL PHARMACOL, V62, P389, DOI 10.1124/mol.62.2.389; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Weiner HL, 2009, ANN NEUROL, V65, P239, DOI 10.1002/ana.21640; Wellendorph P, 2002, NEUROPHARMACOLOGY, V42, P929, DOI 10.1016/S0028-3908(02)00041-2; WEST RE, 1994, EUR J PHARM-MOLEC PH, V267, P343, DOI 10.1016/0922-4106(94)90160-0; Wiedemann P, 2002, J NEURAL TRANSM, V109, P443, DOI 10.1007/s007020200036; Yan SS, 2003, NAT MED, V9, P287, DOI 10.1038/nm831; Zhou YJ, 2009, J BIOL CHEM, V284, P11152, DOI 10.1074/jbc.M900754200	83	20	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e62743	10.1371/journal.pone.0062743	http://dx.doi.org/10.1371/journal.pone.0062743			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894272	Green Published, Green Submitted, gold			2022-12-27	WOS:000322132100001
J	Chakraborty, P; Roy, SK				Chakraborty, Prabuddha; Roy, Shyamal K.			Expression of Estrogen Receptor alpha 36 (ESR36) in the Hamster Ovary throughout the Estrous Cycle: Effects of Gonadotropins	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; ER-ALPHA; DIFFERENTIAL REGULATION; TARGETED DISRUPTION; LUTEINIZING-HORMONE; DOWN-REGULATION; MEMBRANE; BETA; VARIANT; MOUSE	Estradiol-17 beta (E) plays an important role in ovarian follicular development. Evidence indicates that some of the effect of E is mediated by the transmembrane estrogen receptor. In this study, we examined the spatio-temporal expression of recently discovered ER alpha 36 (ESR36), a splice variant of Esr1 and a receptor for non-genomic E signaling, in the hamster ovary during the estrous cycle and the role of gonadotropins and ovarian steroid hormones in ESR36 expression. ESR36 expression was high on estrus (D1:0900 h) and declined precipitously by proestrus (D4:0900 h) and remained low up to D4:1600 h. Immunofluorescence findings corroborated immunoblot findings and revealed that ESR36 was expressed only in the cell membrane of both follicular and non-follicular cells, except the oocytes. Ovarian ESR36 was capable of binding to the E-affinity matrix, and have different molecular weight than that of the ESR1 or GPER. Hypophysectomy (Hx) resulted in a marked decline in ESR36 protein levels. FSH and LH, alone or combined, markedly upregulated ESR36 protein in Hx hamsters to the levels observed in D1 hamsters, but neither E nor P had any effect. Inhibition of the gonadotropin surge by phenobarbital treatment on D4:1100 h attenuated ESR36 expression in D1:0900 h ovaries, but the decline was restored by either FSH or LH replacement on D4 afternoon. This is the first report to show that ESR36, which is distinct from ESR1 or GPER is expressed in the plasma membrane of ovarian follicular and non-follicular cells, binds to E and its expression is regulated directly by the gonadotropins. In light of our previous findings, the results suggest that ovarian cells contain at least two distinct membrane estrogen receptors, such as GPER and ESR36, and strongly suggest for a non-genomic action of E regulating ovarian follicular functions.	[Chakraborty, Prabuddha; Roy, Shyamal K.] Univ Nebraska Med Ctr, Dept Cellular Physiol, Omaha, NE USA; [Chakraborty, Prabuddha; Roy, Shyamal K.] Univ Nebraska Med Ctr, Dept Integrat Physiol, Omaha, NE USA; [Roy, Shyamal K.] Univ Nebraska Med Ctr, Dept Obstet & Gynecol, Omaha, NE USA; [Roy, Shyamal K.] Univ Nebraska Med Ctr, Olson Ctr Womens Hlth, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Roy, SK (corresponding author), Univ Nebraska Med Ctr, Dept Cellular Physiol, Omaha, NE USA.	skroy@unmc.edu			National Institutes of Child Health and Human Development [RO1-HD38468]; Olson Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038468] Funding Source: NIH RePORTER	National Institutes of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Olson Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The study was supported by a grant (RO1-HD38468) from the National Institutes of Child Health and Human Development and by the Olson Foundation to S.K.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARONICA SM, 1994, P NATL ACAD SCI USA, V91, P8517, DOI 10.1073/pnas.91.18.8517; BAST JD, 1974, ENDOCRINOLOGY, V94, P1295, DOI 10.1210/endo-94-5-1295; Braun AM, 2004, BIOL REPROD, V71, P146, DOI 10.1095/biolreprod.103.025825; Collins P, 1999, NAT MED, V5, P1130, DOI 10.1038/13453; COUSE JF, 1995, MOL ENDOCRINOL, V9, P1441, DOI 10.1210/me.9.11.1441; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; Drummond AE, 1999, MOL CELL ENDOCRINOL, V151, P57, DOI 10.1016/S0303-7207(99)00038-6; Dupont S, 2000, DEVELOPMENT, V127, P4277; Falkenstein E, 2000, PHARMACOL REV, V52, P513; GREENWALD GS, 1974, ENDOCRINOLOGY, V95, P1282, DOI 10.1210/endo-95-5-1282; GREENWALD GS, 1994, PHYSL REPRODUCTION, V2, P629, DOI DOI 10.1039/C7RA00224F; Ho KJ, 2002, ARTERIOSCL THROM VAS, V22, P1952, DOI 10.1161/01.ATV.0000041200.85946.4A; Kang LG, 2010, J CELL MOL MED, V14, P1485, DOI 10.1111/j.1582-4934.2009.00877.x; Kelly MJ, 2001, TRENDS ENDOCRIN MET, V12, P152, DOI 10.1016/S1043-2760(01)00377-0; Le Mellay V, 1999, J CELL BIOCHEM, V75, P138, DOI 10.1002/(SICI)1097-4644(19991001)75:1<138::AID-JCB14>3.0.CO;2-I; Levin ER, 2001, J APPL PHYSIOL, V91, P1860, DOI 10.1152/jappl.2001.91.4.1860; Lin SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009013; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; Marquez DC, 2001, ONCOGENE, V20, P5420, DOI 10.1038/sj.onc.1204729; MERK FB, 1972, ENDOCRINOLOGY, V90, P992, DOI 10.1210/endo-90-4-992; MOORE PJ, 1974, AM J ANAT, V139, P37, DOI 10.1002/aja.1001390103; Palter SF, 2001, ENDOCR REV, V22, P389, DOI 10.1210/er.22.3.389; Razandi M, 1999, MOL ENDOCRINOL, V13, P307, DOI 10.1210/me.13.2.307; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; RICHARDS JS, 1980, PHYSIOL REV, V60, P51, DOI 10.1152/physrev.1980.60.1.51; ROY SK, 1986, J REPROD FERTIL, V78, P201, DOI 10.1530/jrf.0.0780201; ROY SK, 1987, BIOL REPROD, V37, P39, DOI 10.1095/biolreprod37.1.39; ROY SK, 1995, ENDOCRINOLOGY, V136, P4610, DOI 10.1210/en.136.10.4610; Roy SK, 2000, BIOL REPROD, V62, P1858, DOI 10.1095/biolreprod62.6.1858; ROY SK, 1994, MICROSC RES TECHNIQ, V27, P83, DOI 10.1002/jemt.1070270203; Roy SK., 1999, COMP ENDOCRINOLOGY R, P315; Schomberg DW, 1999, ENDOCRINOLOGY, V140, P2733, DOI 10.1210/en.140.6.2733; TESARIK J, 1995, J CLIN ENDOCR METAB, V80, P1438, DOI 10.1210/jc.80.4.1438; Tu BB, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.04.015; Wang C, 2008, ENDOCRINOLOGY, V149, P4452, DOI 10.1210/en.2008-0441; Wang C, 2007, ENDOCRINOLOGY, V148, P4853, DOI 10.1210/en.2007-0727; Wang ZY, 2006, P NATL ACAD SCI USA, V103, P9063, DOI 10.1073/pnas.0603339103; Wang ZY, 2005, BIOCHEM BIOPH RES CO, V336, P1023, DOI 10.1016/j.bbrc.2005.08.226; Xu BZ, 2009, HISTOCHEM CELL BIOL, V131, P347, DOI 10.1007/s00418-008-0526-4; Yang PX, 2002, ENDOCRINOLOGY, V143, P2385, DOI 10.1210/en.143.6.2385; Zhang YM, 2004, BIOL REPROD, V70, P1580, DOI 10.1095/biolreprod.103.026898	41	39	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e58291	10.1371/journal.pone.0058291	http://dx.doi.org/10.1371/journal.pone.0058291			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23894315	Green Published, Green Submitted, gold			2022-12-27	WOS:000317263900005
J	An, Y; Yi, SY; Fitzpatrick, A; Gupta, V; Prak, PR; Oum, S; LoGerfo, JP				An, Yom; Yi, Siyan; Fitzpatrick, Annette; Gupta, Vinay; Prak, Piseth Raingsey; Oum, Sophal; LoGerfo, James P.			Appropriate Body Mass Index and Waist Circumference Cutoff for Overweight and Central Obesity among Adults in Cambodia	PLOS ONE			English	Article							METABOLIC SYNDROME; RISK-FACTORS; HYPERTENSION; PREVALENCE; POINTS; ASSOCIATION; CONSUMPTION; PREVENTION; DISORDERS; VALUES	Background: Body mass index (BMI) and waist circumference (WC) are used in risk assessment for the development of non-communicable diseases (NCDs) worldwide. Within a Cambodian population, this study aimed to identify an appropriate BMI and WC cutoff to capture those individuals that are overweight and have an elevated risk of vascular disease. Methodology/Principal Findings: We used nationally representative cross-sectional data from the STEP survey conducted by the Department of Preventive Medicine, Ministry of Health, Cambodia in 2010. In total, 5,015 subjects between age 25 and 64 years were included in the analyses. Chi-square, Fisher's Exact test and Student t-test, and multiple logistic regression were performed. Of total, 35.6% (n=1,786) were men, and 64.4% (n=3,229) were women. Mean age was 43.0 years (SD=11.2 years) and 43.6 years (SD=10.9 years) for men and women, respectively. Significant association of subjects with hypertension and hypercholesterolemia was found in those with BMI >= 23.0 kg/m(2) and with WC >80.0 cm in both sexes. The Area Under the Curve (AUC) from Receiver Operating Characteristic curves was significantly greater in both sexes (all p-values <0.001) when BMI of 23.0 kg/m(2) was used as the cutoff point for overweight compared to that using WHO BMI classification for overweight (BMI >= 25.0 kg/m(2)) for detecting the three cardiovascular risk factors. Similarly, AUC was also significantly higher in men (p-value <0.001) when using WC of 80.0 cm as the cutoff point for central obesity compared to that recommended by WHO (WC >= 94.0 cm in men). Conclusion: Lower cutoffs for BMI and WC should be used to identify of risks of hypertension, diabetes, and hypercholesterolemia for Cambodian aged between 25 and 64 years.	[An, Yom] Natl Inst Publ Hlth, Sch Publ Hlth, Phnom Penh, Cambodia; [An, Yom] Royal Acad Cambodia, Inst Biol Med & Agr, Phnom Penh, Cambodia; [Yi, Siyan] Stanford Univ, Freeman Spogli Inst Int Studies, Walter H Shorenstein Asia Pacific Res Ctr, Asia Hlth Policy Program, Stanford, CA 94305 USA; [Fitzpatrick, Annette; Gupta, Vinay; LoGerfo, James P.] Univ Washington, Med Ctr, Dept Internal Med, Seattle, WA 98195 USA; [Fitzpatrick, Annette; Gupta, Vinay; LoGerfo, James P.] Univ Washington, Med Ctr, Dept Global Hlth, Seattle, WA 98195 USA; [Prak, Piseth Raingsey] Minist Hlth, Dept Prevent Med, Phnom Penh, Cambodia; [Oum, Sophal] Univ Hlth Sci, Phnom Penh, Cambodia	Stanford University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	An, Y (corresponding author), Natl Inst Publ Hlth, Sch Publ Hlth, Phnom Penh, Cambodia.	anyomniph@gmail.com						Aye M, 2012, SINGAP MED J, V53, P545; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bei-Fan Z, 2002, ASIA PAC J CLIN NUTR, V11, pS685, DOI 10.1046/j.1440-6047.11.s8.9.x; Billington CJ, 2000, ARCH INTERN MED, V160, P898, DOI 10.1001/archinte.160.7.898; Chiu M, 2011, DIABETES CARE, V34, P1741, DOI 10.2337/dc10-2300; Inoue S, 2000, ASIA PACIFIC PERSPEC; Jitnarin N, 2011, EAT WEIGHT DISORD-ST, V16, pE242, DOI 10.1007/BF03327467; Jo I, 2001, J HYPERTENS, V19, P1523, DOI 10.1097/00004872-200109000-00002; Klein S, 2007, OBESITY, V15, P1061, DOI 10.1038/oby.2007.632; Ko GTC, 1999, INT J OBESITY, V23, P1136, DOI 10.1038/sj.ijo.0801043; Li G, 2002, Obes Rev, V3, P167, DOI 10.1046/j.1467-789X.2002.00067.x; Oanh THT, 2009, ASIA PAC J CLIN NUTR, V18, P226; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; Pan WH, 2004, AM J CLIN NUTR, V79, P31; Prasad D S, 2012, J Cardiovasc Dis Res, V3, P204, DOI 10.4103/0975-3583.98895; Sesso HD, 2008, HYPERTENSION, V51, P1080, DOI 10.1161/HYPERTENSIONAHA.107.104968; Snehalatha C, 2003, DIABETES CARE, V26, P1380, DOI 10.2337/diacare.26.5.1380; Sophal Oum PRP, 2010, PREVALENCE NONCOMMUN; Tuan NT, 2008, J NUTR, V138, P1377, DOI 10.1093/jn/138.7.1377; Tuan NT, 2009, AM J CLIN NUTR, V89, P1905, DOI 10.3945/ajcn.2008.26809; Tuomilehto Jaakko, 2001, New England Journal of Medicine, V344, P1343, DOI 10.1056/NEJM200105033441801; Villegas R, 2003, DIABETES CARE, V26, P3198, DOI 10.2337/diacare.26.11.3198-a; Weng X, 2006, EUR J CLIN NUTR, V60, P931, DOI 10.1038/sj.ejcn.1602396; Wildman RP, 2004, AM J CLIN NUTR, V80, P1129, DOI 10.1093/ajcn/80.5.1129; Worachartcheewan A, 2012, DIABETES RES CLIN PR, V98, pE16, DOI 10.1016/j.diabres.2012.09.018; World Health Organization, 2001, SUMM SURV RISK FACT; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; ZWEIG MH, 1993, CLIN CHEM, V39, P561	28	45	50	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77897	10.1371/journal.pone.0077897	http://dx.doi.org/10.1371/journal.pone.0077897			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	23875011	Green Published, gold, Green Submitted			2022-12-27	WOS:000326032600052
J	Chen, JY; Tang, YA; Li, WS; Chiou, YC; Shieh, JM; Wang, YC				Chen, Jia-Yang; Tang, Yen-An; Li, Wen-Shan; Chiou, Yu-Ching; Shieh, Jiunn-Min; Wang, Yi-Ching			A Synthetic Podophyllotoxin Derivative Exerts Anti-Cancer Effects by Inducing Mitotic Arrest and Pro-Apoptotic ER Stress in Lung Cancer Preclinical Models	PLOS ONE			English	Article							ANTIMITOTIC ACTIVITY; NATURAL-PRODUCTS; BINDING AGENTS; DRUG DISCOVERY; RESISTANCE; TUBULIN; MITOSIS; MICROTUBULES; EXPRESSION; KINASES	Some potent chemotherapy drugs including tubulin-binding agents had been developed from nature plants, such as podophyllotoxin and paclitaxel. However, poor cytotoxic selectivity, serious side-effects, and limited effectiveness are still the major concerns in their therapeutic application. We developed a fully synthetic podophyllotoxin derivative named Ching001 and investigated its anti-tumor growth effects and mechanisms in lung cancer preclinical models. Ching001 showed a selective cytotoxicity to different lung cancer cell lines but not to normal lung cells. Ching001 inhibited the polymerization of microtubule resulting in mitotic arrest as evident by the accumulation of mitosis-related proteins, survivin and aurora B, thereby leading to DNA damage and apoptosis. Ching001 also activated pro-apoptotic ER stress signaling pathway. Intraperitoneal injection of 2 mg/kg Ching001 significantly inhibited the tumor growth of A549 xenograft, while injection of 0.2 mg/kg Ching001 decreased the lung colonization ability of A549 cells in experimental metastasis assay. These anti-tumor growth and lung colonization inhibition effects were stronger than those of paclitaxel treatment at the same dosage. The xenograft tumor tissue stains further confirmed that Ching001 induced mitosis arrest and tumor apoptosis. In addition, the hematology and biochemistry tests of blood samples as well as tissue examinations indicated that Ching001 treatment did not show apparent organ toxicities in tested animals. We provided preclinical evidence that novel synthetic microtubule inhibitor Ching001, which can trigger DNA damage and apoptosis by inducing mitotic arrest and ER stress, is a potential anti-cancer compound for further drug development.	[Chen, Jia-Yang; Tang, Yen-An; Wang, Yi-Ching] Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 70101, Taiwan; [Li, Wen-Shan; Chiou, Yu-Ching] Acad Sinica, Inst Chem, Taipei 115, Taiwan; [Chiou, Yu-Ching] Natl Taiwan Normal Univ, Dept Chem, Taipei, Taiwan; [Shieh, Jiunn-Min] Chi Mei Med Ctr, Dept Internal Med, Div Chest Med, Tainan, Taiwan; [Shieh, Jiunn-Min] Chia Nan Univ Pharm & Sci, Ctr Gen Educ, Tainan, Taiwan; [Wang, Yi-Ching] Natl Cheng Kung Univ, Dept Pharmacol, Tainan, Taiwan	National Cheng Kung University; Academia Sinica - Taiwan; National Taiwan Normal University; Chi Mei Hospital; Chia Nan University of Pharmacy & Science; National Cheng Kung University	Shieh, JM (corresponding author), Chi Mei Med Ctr, Dept Internal Med, Div Chest Med, Tainan, Taiwan.	shieh225@ms29.hinet.net; ycw5798@mail.ncku.edu.tw	Li, Wen-Shan/F-1972-2015; CHEN, JIA-YANG/M-8413-2014; Wang, Yi-Ching/J-8702-2019; Peng, Hongquan/AAI-6239-2021; Chen, Jianping/C-4225-2009	Li, Wen-Shan/0000-0002-8359-4582; CHEN, JIA-YANG/0000-0001-9159-7591; Wang, Yi-Ching/0000-0002-7694-2067; Peng, Hongquan/0000-0003-4893-7903; Li, Wei/0000-0002-9991-7892; Chen, Jianping/0000-0001-6494-5271; Chen, Hui/0000-0002-0048-0193	Chi Mei Medical Center, Taiwan [CMNCKU10107]; National Science Council, Taiwan [NSC 101-2325-B-006-008]	Chi Mei Medical Center, Taiwan; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported in part by grants CMNCKU10107 from the Chi Mei Medical Center, Taiwan (JMS) and NSC 101-2325-B-006-008 from the National Science Council, Taiwan (YCW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bicknell AA, 2007, J CELL BIOL, V177, P1017, DOI 10.1083/jcb.200702101; Bohlin L, 1996, DRUG DISCOV TODAY, V1, P343, DOI 10.1016/1359-6446(96)10028-3; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Chang JY, 2004, MOL PHARMACOL, V65, P77, DOI 10.1124/mol.65.1.77; Chen JJW, 2001, CANCER RES, V61, P5223; Cragg GM, 1998, MED RES REV, V18, P315, DOI 10.1002/(SICI)1098-1128(199809)18:5<315::AID-MED3>3.0.CO;2-W; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Desbene Stephanie, 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P71, DOI 10.2174/1568011023354353; Domingo-Sananes MR, 2011, PHILOS T R SOC B, V366, P3584, DOI 10.1098/rstb.2011.0087; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Felix CA, 1998, BBA-GENE STRUCT EXPR, V1400, P233, DOI 10.1016/S0167-4781(98)00139-0; Fojo T, 2007, ANN ONCOL, V18, pV3, DOI 10.1093/annonc/mdm172; Imbert TF, 1998, BIOCHIMIE, V80, P207, DOI 10.1016/S0300-9084(98)80004-7; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Kawanobe T, 2012, BIOCHEM BIOPH RES CO, V418, P736, DOI 10.1016/j.bbrc.2012.01.090; Komericki P, 2011, SEX TRANSM DIS, V38, P216, DOI 10.1097/OLQ.0b013e3181f68ebb; Kuo CC, 2004, CANCER RES, V64, P4621, DOI 10.1158/0008-5472.CAN-03-3474; Lara PN, 2009, J CLIN ONCOL, V27, P2530, DOI 10.1200/JCO.2008.20.1061; Liu EH, 2009, MINI-REV MED CHEM, V9, P1547, DOI 10.2174/138955709790361520; Lv M, 2011, MINI-REV MED CHEM, V11, P901, DOI 10.2174/138955711796575461; Mano M, 2006, CANCER TREAT REV, V32, P106, DOI 10.1016/j.ctrv.2005.12.008; Mollinedo F, 2003, APOPTOSIS, V8, P413, DOI 10.1023/A:1025513106330; Nitta M, 2004, ONCOGENE, V23, P6548, DOI 10.1038/sj.onc.1207873; PEDERSENBJERGAARD J, 1992, LEUKEMIA RES, V16, P61, DOI 10.1016/0145-2126(92)90102-D; SACKETT DL, 1993, PHARMACOL THERAPEUT, V59, P163, DOI 10.1016/0163-7258(93)90044-E; Schonbrunn E, 1999, J STRUCT BIOL, V128, P211, DOI 10.1006/jsbi.1999.4183; Shore GC, 2011, CURR OPIN CELL BIOL, V23, P143, DOI 10.1016/j.ceb.2010.11.003; Tapia C, 2006, AM J SURG PATHOL, V30, P83, DOI 10.1097/01.pas.0000183572.94140.43; Wall ME, 1998, MED RES REV, V18, P299	29	265	274	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62082	10.1371/journal.pone.0062082	http://dx.doi.org/10.1371/journal.pone.0062082			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646116	Green Published, gold, Green Submitted			2022-12-27	WOS:000319077300026
J	Wang, FQ; Wang, L; Xu, ZY; Liang, GL				Wang, Fuqiang; Wang, Ling; Xu, Zhiyang; Liang, Gaolin			Identification and Analysis of Multi-Protein Complexes in Placenta	PLOS ONE			English	Article							INTRAUTERINE GROWTH RESTRICTION; NATIVE GEL-ELECTROPHORESIS; PLASMA-MEMBRANE; PROTEOMIC ANALYSIS; PROTEASOME; UBIQUITINATION; DEGRADATION; PREECLAMPSIA; HOMEOSTASIS; EXPRESSION	Placental malfunction induces pregnancy disorders which contribute to life-threatening complications for both the mother and the fetus. Identification and characterization of placental multi-protein complexes is an important step to integratedly understand the protein-protein interaction networks in placenta which determine placental function. In this study, blue native/sodium dodecyl sulfate polyacrylamide gel electrophoresis (BN/SDS-PAGE) and Liquid chromatography-tandem mass spectrometry (LC-MS/MS) were used to screen the multi-protein complexes in placenta. 733 unique proteins and 34 known and novel heterooligomeric multi-protein complexes including mitochondrial respiratory chain complexes, integrin complexes, proteasome complexes, histone complex, and heat shock protein complexes were identified. A novel protein complex, which involves clathrin and small conductance calcium-activated potassium (SK) channel protein 2, was identified and validated by antibody based gel shift assay, co-immunoprecipitation and immunouorescence staining. These results suggest that BN/SDS-PAGE, when integrated with LC-MS/MS, is a very powerful and versatile tool for the investigation of placental protein complexes. This work paves the way for deeper functional characterization of the placental protein complexes associated with pregnancy disorders.	[Wang, Fuqiang; Liang, Gaolin] Univ Sci & Technol China, Dept Chem, CAS Key Lab Soft Matter Chem, Hefei 230026, Anhui, Peoples R China; [Wang, Fuqiang; Wang, Ling; Xu, Zhiyang] Nanjing Med Univ, Anal Ctr, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Nanjing Medical University	Liang, GL (corresponding author), Univ Sci & Technol China, Dept Chem, CAS Key Lab Soft Matter Chem, Hefei 230026, Anhui, Peoples R China.	gliang@ustc.edu.cn	Wang, Jing/G-5261-2018; Liang, Gaolin/F-1786-2010; Tian, Jie/H-1190-2011; Liang, Jimin/B-5394-2014; Wang, Fu/S-7955-2017; li, xiu/GXV-1745-2022; Chen, Xiaoyuan/D-1860-2014; Life, MC/M-9554-2013	Liang, Gaolin/0000-0002-6159-9999; Tian, Jie/0000-0003-0498-0432; Liang, Jimin/0000-0003-1428-5804; Wang, Fu/0000-0001-9222-0833; Chen, Xiaoyuan/0000-0002-9622-0870; Xia, Qingyou/0000-0002-9263-2886; Wang, Fuqiang/0000-0002-7777-3541; Song, Xinxing/0000-0001-8649-4096	National Natural Science Foundation of China [21175122, 91127036]; Nanjing Medical University [2011NJMU269, 2011NJMU270]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nanjing Medical University	This work was supported by the National Natural Science Foundation of China (Grants 21175122 and 91127036) and Technology Development Key Project Fund of Nanjing Medical University (Grants 2011NJMU269 and 2011NJMU270). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell AN, 2011, CELL STEM CELL, V8, P525, DOI 10.1016/j.stem.2011.03.008; Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; CARVER W, 1995, J CELL PHYSIOL, V165, P425, DOI 10.1002/jcp.1041650224; Chenette EJ, 2012, NAT CELL BIOL, V14, P566; Cox B, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.012526; CRAIG EA, 1993, MICROBIOL REV, V57, P402, DOI 10.1128/MMBR.57.2.402-414.1993; DAMSKY CH, 1994, DEVELOPMENT, V120, P3657; Ekambaram P, 2011, INDIAN J BIOCHEM BIO, V48, P243; Eubel H, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-11; Feikova S, 2000, NEOPLASMA, V47, P212; Garnica AD, 1996, J AM COLL NUTR, V15, P206; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Hayes MJ, 2004, TRAFFIC, V5, P571, DOI 10.1111/j.1600-0854.2004.00210.x; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Johnstone ED, 2011, PROTEOMICS, V11, P4077, DOI 10.1002/pmic.201000505; Katz A, 2007, MOL CELL PROTEOMICS, V6, P1459, DOI 10.1074/mcp.M700002-MCP200; Lafond J, 2006, INT REV CYTOL, V250, P109, DOI 10.1016/S0074-7696(06)50004-X; Lemarie A, 2011, ONCOGENE, V30, P3985, DOI 10.1038/onc.2011.167; LEWIS PN, 1976, CAN J BIOCHEM CELL B, V54, P641, DOI 10.1139/o76-093; Li XW, 2009, J PROTEOME RES, V8, P3475, DOI 10.1021/pr900101d; Lipkowitz S, 2003, BREAST CANCER RES, V5, P8, DOI 10.1186/bcr541; Liu K, 2009, MOL CELL PROTEOMICS, V8, P495, DOI 10.1074/mcp.M800250-MCP200; Mari G, 2007, CLIN OBSTET GYNECOL, V50, P497, DOI 10.1097/GRF.0b013e31804c96a9; Marin R, 2008, PLACENTA, V29, P671, DOI 10.1016/j.placenta.2008.06.003; Pedarzani P, 2008, CELL MOL LIFE SCI, V65, P3196, DOI 10.1007/s00018-008-8216-x; Powe CE, 2011, CIRCULATION, V123, P2856, DOI 10.1161/CIRCULATIONAHA.109.853127; Reisinger Veronika, 2007, Proteomics, V7 Suppl 1, P6, DOI 10.1002/pmic.200700205; Robinson JM, 2008, PLACENTA, V29, P135, DOI 10.1016/j.placenta.2007.12.005; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schmitt HP, 2006, MED HYPOTHESES, V67, P311, DOI 10.1016/j.mehy.2006.02.023; Smart EJ, 2004, P NATL ACAD SCI USA, V101, P3450, DOI 10.1073/pnas.0400441101; Soltys BJ, 1996, EXP CELL RES, V222, P16, DOI 10.1006/excr.1996.0003; Streicher WW, 2009, BIOCHEMISTRY-US, V48, P2788, DOI 10.1021/bi8019959; Thorn SR, 2011, SEMIN REPROD MED, V29, P225, DOI 10.1055/s-0031-1275516; Ueki H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00827; Van Blerkom J, 2009, SEMIN CELL DEV BIOL, V20, P354, DOI 10.1016/j.semcdb.2008.12.005; Wang HX, 2006, J CELL PHYSIOL, V206, P616, DOI 10.1002/jcp.20508; Williamson R, 2002, J NEUROSCI, V22, P10, DOI 10.1523/JNEUROSCI.22-01-00010.2002; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Zhang HJ, 2012, DEVELOPMENT, V139, P2071, DOI 10.1242/dev.077347; Zhang Q, 2010, PROTEOM CLIN APPL, V4, P538, DOI 10.1002/prca.200900048; Zhang Y, 2008, PROTEOMICS, V8, P4344, DOI 10.1002/pmic.200800294	46	311	332	16	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62988	10.1371/journal.pone.0062988	http://dx.doi.org/10.1371/journal.pone.0062988			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23638173	Green Published, gold, Green Submitted			2022-12-27	WOS:000321662800072
J	Wang, F; Song, XX; Li, XJ; Xin, J; Wang, SX; Yang, WD; Wang, J; Wu, KC; Chen, XY; Liang, JM; Tian, J; Cao, F				Wang, Fu; Song, Xinxing; Li, Xiujuan; Xin, Jing; Wang, Shenxu; Yang, Weidong; Wang, Jing; Wu, Kaichun; Chen, Xiaoyuan; Liang, Jimin; Tian, Jie; Cao, Feng			Noninvasive Visualization of MicroRNA-16 in the Chemoresistance of Gastric Cancer Using a Dual Reporter Gene Imaging System	PLOS ONE			English	Article							DRUG-RESISTANCE; MAPK PATHWAYS; CELLS; CHEMOTHERAPY; ACTIVATION	MicroRNAs (miRNAs) have been implicated to play a central role in the development of drug resistance in a variety of malignancies. However, many studies were conducted at the in vitro level and could not provide the in vivo information on the functions of miRNAs in the anticancer drug resistance. Here, we introduced a dual reporter gene imaging system for noninvasively monitoring the kinetic expression of miRNA-16 during chemoresistance in gastric cancer both in vitro and in vivo. Human sodium iodide symporter (hNIS) and firefly luciferase (Fluc) genes were linked to form hNIS/Fluc double fusion reporter gene and then generate human gastric cancer cell line NF-3xmir16 and its multidrug resistance cell line NF-3xmir16/VCR. Radioiodide uptake and Fluc luminescence signals in vitro correlated well with viable cell numbers. The luciferase activities and radioiodide uptake in NF-3xmir16 cells were remarkably repressed by exogenous or endogenous miRNA-16. The NF-3xmir16/VCR cells showed a significant increase of I-131 uptake and luminescence intensity compared to NF-3xmir16 cells. The radioactivity from in vivo Tc-99m-pertechnetate imaging and the intensity from bioluminescence imaging were also increased in NF-3xmir16/VCR compared with that in NF-3xmir16 tumor xenografts. Furthermore, using this reporter gene system, we found that etoposide (VP-16) and 5-fluorouracil (5-FU) activated miRNA-16 expression in vitro and in vivo, and the upregulation of miRNA-16 is p38MAPK dependent but NF-kappa B independent. This dual imaging reporter gene may be served as a novel tool for in vivo imaging of microRNAs in the chemoresistance of cancers, as well as for early detection and diagnosis in clinic.	[Wang, Fu; Xin, Jing; Liang, Jimin] Xidian Univ, Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China; [Wang, Fu; Song, Xinxing; Li, Xiujuan; Wang, Shenxu; Cao, Feng] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiol, Xian 710032, Shaanxi, Peoples R China; [Wang, Fu; Song, Xinxing; Li, Xiujuan; Wang, Shenxu; Cao, Feng] Fourth Mil Med Univ, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China; [Yang, Weidong; Wang, Jing] Fourth Mil Med Univ, Xijing Hosp, Dept Nucl Med, Xian 710032, Shaanxi, Peoples R China; [Wu, Kaichun] Fourth Mil Med Univ, Xijing Hosp, Dept Digest Dis, Xian 710032, Shaanxi, Peoples R China; [Chen, Xiaoyuan] Natl Inst Biomed Imaging & Bioengn, Lab Mol Imaging & Nanomed, NIH, Bethesda, MD USA; [Tian, Jie] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China	Xidian University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); Chinese Academy of Sciences; Institute of Automation, CAS	Liang, JM (corresponding author), Xidian Univ, Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China.	jimleung@mail.xidian.edu.cn; tian@ieee.org; wind8828@gmail.com	Wang, Jing/G-5261-2018; Liang, Gaolin/F-1786-2010; Tian, Jie/H-1190-2011; Liang, Jimin/B-5394-2014; Wang, Fu/S-7955-2017; li, xiu/GXV-1745-2022; Chen, Xiaoyuan/D-1860-2014; Life, MC/M-9554-2013	Liang, Gaolin/0000-0002-6159-9999; Tian, Jie/0000-0003-0498-0432; Liang, Jimin/0000-0003-1428-5804; Wang, Fu/0000-0001-9222-0833; Chen, Xiaoyuan/0000-0002-9622-0870; Xia, Qingyou/0000-0002-9263-2886; Wang, Fuqiang/0000-0002-7777-3541; Song, Xinxing/0000-0001-8649-4096	Program of the National Basic Research and Development Program of China (973) [2012CB518101, 2011CB707702]; National Natural Science Foundation of China [81090272, 81090274, 81227901]; China Department of Education [2010CXTD01]; 863 Program of China [2012AA02A603]; National Key Technology Support Program [2012BAI23B06]	Program of the National Basic Research and Development Program of China (973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Department of Education; 863 Program of China(National High Technology Research and Development Program of China); National Key Technology Support Program(National Key Technology R&D Program)	This work was supported by the Program of the National Basic Research and Development Program of China (973) under Grant No. 2012CB518101, 2011CB707702, the National Natural Science Foundation of China under Grant Nos. 81090272, 81090274, 81227901, Innovation Team Development Grant by China Department of Education (2010CXTD01), 863 Program of China (2012AA02A603) and the National Key Technology Support Program under Grant No. 2012BAI23B06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KE, 2010, MOL CANCER THER, V9, P3126, DOI 10.1158/1535-7163.MCT-10-0397; Baguley BC, 2010, MOL BIOTECHNOL, V46, P308, DOI 10.1007/s12033-010-9321-2; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blasberg RG, 2002, J CELL BIOCHEM, P172, DOI 10.1002/jcb.10433; Boldt S, 2002, CARCINOGENESIS, V23, P1831, DOI 10.1093/carcin/23.11.1831; Broxterman HJ, 2009, DRUG RESIST UPDATE, V12, P114, DOI 10.1016/j.drup.2009.07.001; Chung JK, 2002, J NUCL MED, V43, P1188; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Fang JY, 2005, LANCET ONCOL, V6, P322, DOI 10.1016/S1470-2045(05)70168-6; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Jo MH, 2012, BIOMATERIALS, V33, P6456, DOI 10.1016/j.biomaterials.2012.05.057; Kang JH, 2008, J NUCL MED, V49, p164S, DOI 10.2967/jnumed.107.045955; Kang WJ, 2012, BIOMATERIALS, V33, P6430, DOI 10.1016/j.biomaterials.2012.05.056; Kim JK, 2012, BIOMATERIALS, V33, P207, DOI 10.1016/j.biomaterials.2011.09.023; Li F, 2010, BBA-REV CANCER, V1805, P167, DOI 10.1016/j.bbcan.2010.01.002; Ma J, 2010, CANCER GENE THER, V17, P523, DOI 10.1038/cgt.2010.18; Mansouri A, 2003, J BIOL CHEM, V278, P19245, DOI 10.1074/jbc.M208134200; Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403; Rivera F, 2007, CANCER TREAT REV, V33, P315, DOI 10.1016/j.ctrv.2007.01.004; Sarkar FH, 2010, DRUG RESIST UPDATE, V13, P57, DOI 10.1016/j.drup.2010.02.001; TROPPMAIR J, 1994, J BIOL CHEM, V269, P7030; Wang F, 2011, EUR J NUCL MED MOL I, V38, P1572, DOI 10.1007/s00259-011-1786-0; Xia L, 2008, INT J CANCER, V123, P372, DOI 10.1002/ijc.23501; Yang SY, 2011, INT J ONCOL, V38, P1695, DOI 10.3892/ijo.2011.982; Zheng TS, 2010, INT J CANCER, V126, P2, DOI 10.1002/ijc.24782	25	311	332	16	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61792	10.1371/journal.pone.0061792	http://dx.doi.org/10.1371/journal.pone.0061792			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23638173	gold, Green Submitted, Green Published			2022-12-27	WOS:000317907200086
J	Wang, F; Hu, CM; Hua, XT; Song, L; Xia, QY				Wang, Fei; Hu, Cuimei; Hua, Xiaoting; Song, Liang; Xia, Qingyou			Translationally Controlled Tumor Protein, a Dual Functional Protein Involved in the Immune Response of the Silkworm, Bombyx mori	PLOS ONE			English	Article							HISTAMINE-RELEASING FACTOR; DROSOPHILA-MELANOGASTER; PATHOGEN RECOGNITION; CELL-PROLIFERATION; SCAVENGER RECEPTOR; INNATE IMMUNITY; PHAGE DISPLAY; TCTP; IDENTIFICATION; INFECTION	Insect gut immunity is the first line of defense against oral infection. Although a few immune-related molecules in insect intestine has been identified by genomics or proteomics approach with comparison to well-studied tissues, such as hemolymph or fat body, our knowledge about the molecular mechanism underlying the gut immunity which would involve a variety of unidentified molecules is still limited. To uncover additional molecules that might take part in pathogen recognition, signal transduction or immune regulation in insect intestine, a T7 phage display cDNA library of the silkworm midgut is constructed. By use of different ligands for biopanning, Translationally Controlled Tumor Protein (TCTP) has been selected. BmTCTP is produced in intestinal epithelial cells and released into the gut lumen. The protein level of BmTCTP increases at the early time points during oral microbial infection and declines afterwards. In vitro binding assay confirms its activity as a multi-ligand binding molecule and it can further function as an opsonin that promotes the phagocytosis of microorganisms. Moreover, it can induce the production of anti-microbial peptide via a signaling pathway in which ERK is required and a dynamic tyrosine phosphorylation of certain cytoplasmic membrane protein. Taken together, our results characterize BmTCTP as a dual-functional protein involved in both the cellular and the humoral immune response of the silkworm, Bombyx mori.	[Wang, Fei; Hu, Cuimei; Hua, Xiaoting; Song, Liang; Xia, Qingyou] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China	Southwest University - China	Xia, QY (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China.	xiaqy@swu.edu.cn	Wang, Jing/G-5261-2018; Liang, Gaolin/F-1786-2010; Tian, Jie/H-1190-2011; Liang, Jimin/B-5394-2014; Wang, Fu/S-7955-2017; li, xiu/GXV-1745-2022; Chen, Xiaoyuan/D-1860-2014; Life, MC/M-9554-2013	Liang, Gaolin/0000-0002-6159-9999; Tian, Jie/0000-0003-0498-0432; Liang, Jimin/0000-0003-1428-5804; Wang, Fu/0000-0001-9222-0833; Chen, Xiaoyuan/0000-0002-9622-0870; Xia, Qingyou/0000-0002-9263-2886; Wang, Fuqiang/0000-0002-7777-3541; Song, Xinxing/0000-0001-8649-4096	National Basic Research Program of China [2012CB114600]; Natural Science Foundation of China [31201854]; Fundamental Research Funds for the Central Universities [XDJK2009B033]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the grant of "National Basic Research Program of China'' (http://www.973.gov.cn/Default_3.aspx) (2012CB114600), "Natural Science Foundation of China'' (http://www.nsfc.gov.cn/Portal0/default152.htm) (31201854) and "Fundamental Research Funds for the Central Universities'' (XDJK2009B033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Amson R, 2012, NAT MED, V18, P91, DOI 10.1038/nm.2546; Amzallag N, 2004, J BIOL CHEM, V279, P46104, DOI 10.1074/jbc.M404850200; Aoun RB, 2011, J INNATE IMMUN, V3, P52, DOI 10.1159/000321554; Chen SH, 2007, MOL BIOL CELL, V18, P2525, DOI 10.1091/mbc.E07-02-0188; Chen TS, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-16; Chung YSA, 2011, J BIOL CHEM, V286, P26524, DOI 10.1074/jbc.M110.214007; Cronin SJF, 2009, SCIENCE, V325, P340, DOI 10.1126/science.1173164; Davis MM, 2012, J INNATE IMMUN, V4, P273, DOI 10.1159/000332947; Dong YM, 2006, PLOS BIOL, V4, P1137, DOI 10.1371/journal.pbio.0040229; Govind S, 2008, INSECT SCI, V15, P29, DOI 10.1111/j.1744-7917.2008.00185.x; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; He NH, 2005, ANTIVIR RES, V66, P39, DOI 10.1016/j.antiviral.2004.12.010; Hsu YC, 2007, NATURE, V445, P785, DOI 10.1038/nature05528; Hu XL, 2012, MOL BIOL REP, V39, P3427, DOI 10.1007/s11033-011-1114-6; Huang JX, 2012, ANTIMICROB AGENTS CH, V56, P4569, DOI 10.1128/AAC.00567-12; Huang LL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008098; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jung J, 2004, J BIOL CHEM, V279, P49868, DOI 10.1074/jbc.M400895200; Kashiwakura JI, 2012, J CLIN INVEST, V122, P218, DOI 10.1172/JCI59072; Kim CH, 2010, J BIOL CHEM, V285, P25243, DOI 10.1074/jbc.M110.134940; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Lee JM, 2004, COMP BIOCHEM PHYS B, V139, P35, DOI 10.1016/j.cbpc.2004.06.004; MACDONALD SM, 1995, SCIENCE, V269, P688, DOI 10.1126/science.7542803; Meyvis Y, 2009, INT J PARASITOL, V39, P1205, DOI 10.1016/j.ijpara.2009.02.017; Nayak S, 2010, FISH SHELLFISH IMMUN, V29, P544, DOI 10.1016/j.fsi.2010.05.010; Nehme NT, 2007, PLOS PATHOG, V3, P1694, DOI 10.1371/journal.ppat.0030173; Nie ZM, 2010, MOL BIOL REP, V37, P2621, DOI 10.1007/s11033-009-9787-9; Niikura M, 2004, POULTRY SCI, V83, P1117, DOI 10.1093/ps/83.7.1117; Nupan B, 2011, DEV COMP IMMUNOL, V35, P469, DOI 10.1016/j.dci.2010.11.016; Ochiai M, 2000, J BIOL CHEM, V275, P4995, DOI 10.1074/jbc.275.7.4995; Oliveira GD, 2012, SCIENCE, V335, P856, DOI 10.1126/science.1209678; Pan MH, 2010, TISSUE CELL, V42, P42, DOI 10.1016/j.tice.2009.07.002; Panrat T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033291; Pauchet Y, 2009, J BIOL CHEM, V284, P2214, DOI 10.1074/jbc.M806204200; Pauchet Y, 2008, J PROTEOME RES, V7, P1629, DOI 10.1021/pr7006208; PEARSON A, 1995, P NATL ACAD SCI USA, V92, P4056, DOI 10.1073/pnas.92.9.4056; Ponnuvel KM, 2003, J VIROL, V77, P10725, DOI 10.1128/JVI.77.19.10725-10729.2003; Popova-Butler A, 2009, J INSECT PHYSIOL, V55, P264, DOI 10.1016/j.jinsphys.2008.12.008; Povelones M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002023; Rinnerthaler M, 2006, BBA-BIOENERGETICS, V1757, P631, DOI 10.1016/j.bbabio.2006.05.022; Shitomi Y, 2006, J BIOCHEM, V139, P223, DOI 10.1093/jb/mvj024; Song KH, 2008, J INSECT PHYSIOL, V54, P1271, DOI 10.1016/j.jinsphys.2008.06.010; Sunagar SG, 2011, J INSECT PHYSIOL, V57, P1707, DOI 10.1016/j.jinsphys.2011.09.009; Thaw P, 2001, NAT STRUCT BIOL, V8, P701, DOI 10.1038/90415; Tonganunt M, 2008, FISH SHELLFISH IMMUN, V25, P633, DOI 10.1016/j.fsi.2008.08.006; Venugopal T, 2005, COMP BIOCHEM PHYS B, V142, P8, DOI 10.1016/j.cbpc.2005.04.011; Vonakis BM, 2008, BLOOD, V111, P1789, DOI 10.1182/blood-2007-07-104364; Wang F, 2009, EUR J IMMUNOL, V39, P254, DOI 10.1002/eji.200838472; Wang LH, 2006, IMMUNOBIOLOGY, V211, P251, DOI 10.1016/j.imbio.2006.01.001; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Wu S, 2010, DEV COMP IMMUNOL, V34, P1191, DOI 10.1016/j.dci.2010.06.013; Yang Y, 2005, ONCOGENE, V24, P4778, DOI 10.1038/sj.onc.1208666; Zhang J, 2012, P NATL ACAD SCI USA, V109, pE926, DOI 10.1073/pnas.1106300109; Zhang S, 2011, COMP FUNCT GENOM, DOI 10.1155/2011/876064	55	311	332	16	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69284	10.1371/journal.pone.0069284	http://dx.doi.org/10.1371/journal.pone.0069284			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23638173	Green Submitted, Green Published, gold			2022-12-27	WOS:000322132100052
J	Wang, FQ; Wang, L; Shi, ZH; Liang, GL				Wang, Fuqiang; Wang, Ling; Shi, Zhonghua; Liang, Gaolin			Comparative N-Glycoproteomic and Phosphoproteomic Profiling of Human Placental Plasma Membrane between Normal and Preeclampsia Pregnancies with High-Resolution Mass Spectrometry	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; LATE-ONSET PREECLAMPSIA; UTERINE ARTERY DOPPLER; METASTASIS SUPPRESSOR; SIGNALING NETWORKS; QUANTITATIVE PROTEOMICS; TROPHOBLAST INVASION; IN-VITRO; EXPRESSION; KISS-1	Preeclampsia is a serious complication of pregnancy, which affects 2-8% of all pregnancies and is one of the leading causes of maternal and perinatal mortality and morbidity worldwide. To better understand the molecular mechanisms involved in pathological development of placenta in preeclampsia, we used high-resolution LC-MS/MS technologies to construct a comparative N-glycoproteomic and phosphoproteomic profiling of human placental plasma membrane in normal and preeclamptic pregnancies. A total of 1027 N-glyco-and 2094 phospho-sites were detected in human placental plasma membrane, and 5 N-glyco-and 38 phospho-proteins, respectively, with differentially expression were definitively identified between control and preeclamptic placental plasma membrane. Further bioinformatics analysis indicated that these differentially expressed proteins correlate with several specific cellular processes occurring during pathological changes of preeclamptic placental plasma membrane.	[Wang, Fuqiang; Liang, Gaolin] Univ Sci & Technol China, Dept Chem, CAS Key Lab Soft Matter Chem, Hefei, Anhui, Peoples R China; [Wang, Fuqiang; Wang, Ling; Shi, Zhonghua] Nanjing Med Univ, State Key Lab Reprod Med, Anal Ctr, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Nanjing Medical University	Liang, GL (corresponding author), Univ Sci & Technol China, Dept Chem, CAS Key Lab Soft Matter Chem, Hefei, Anhui, Peoples R China.	gliang@ustc.edu.cn	Wang, Jing/G-5261-2018; Liang, Gaolin/F-1786-2010; Tian, Jie/H-1190-2011; Liang, Jimin/B-5394-2014; Wang, Fu/S-7955-2017; li, xiu/GXV-1745-2022; Chen, Xiaoyuan/D-1860-2014; Life, MC/M-9554-2013	Liang, Gaolin/0000-0002-6159-9999; Tian, Jie/0000-0003-0498-0432; Liang, Jimin/0000-0003-1428-5804; Wang, Fu/0000-0001-9222-0833; Chen, Xiaoyuan/0000-0002-9622-0870; Xia, Qingyou/0000-0002-9263-2886; Wang, Fuqiang/0000-0002-7777-3541; Song, Xinxing/0000-0001-8649-4096	National Natural Science Foundation of China [21175122, 91127036]; Technology Development Key Project Fund of Nanjing Medical University [2011NJMU269, 2011NJMU270]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Technology Development Key Project Fund of Nanjing Medical University	This work was supported by the National Natural Science Foundation of China (Grants 21175122 and 91127036) and Technology Development Key Project Fund of Nanjing Medical University (Grants 2011NJMU269 and 2011NJMU270). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck BH, 2010, EUR J CANCER, V46, P1283, DOI 10.1016/j.ejca.2010.02.023; Bilban M, 2004, J CELL SCI, V117, P1319, DOI 10.1242/jcs.00971; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Cartwright JE, 2012, J ENDOCRINOL, V214, P79, DOI 10.1530/JOE-12-0091; Crispi F, 2008, ULTRASOUND OBST GYN, V31, P303, DOI 10.1002/uog.5184; Danussi C, 2012, CANCER PREV RES, V5, P1131, DOI 10.1158/1940-6207.CAPR-12-0076-T; Danussi C, 2011, J CELL BIOL, V195, P131, DOI 10.1083/jcb.201008013; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Eastabrook G, 2011, BEST PRACT RES CL OB, V25, P435, DOI 10.1016/j.bpobgyn.2011.01.005; Fleischer S, 1974, Methods Enzymol, V31, P6; Hiden U, 2007, REV ENDOCR METAB DIS, V8, P31, DOI 10.1007/s11154-007-9030-8; Huppertz B, 2008, HYPERTENSION, V51, P970, DOI 10.1161/HYPERTENSIONAHA.107.107607; Ilic D, 2001, AM J PATHOL, V159, P93, DOI 10.1016/S0002-9440(10)61677-X; Janneau JL, 2002, J CLIN ENDOCR METAB, V87, P5336, DOI 10.1210/jc.2002-021093; Kotani M, 2001, J BIOL CHEM, V276, P34631, DOI 10.1074/jbc.M104847200; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; Li CF, 2012, PLACENTA, V33, P47, DOI 10.1016/j.placenta.2011.10.008; Mead EJ, 2007, BRIT J PHARMACOL, V151, P1143, DOI 10.1038/sj.bjp.0707295; MEEKINS JW, 1994, BRIT J OBSTET GYNAEC, V101, P669, DOI 10.1111/j.1471-0528.1994.tb13182.x; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; Oudejans CBM, 2007, HUM GENET, V120, P607, DOI 10.1007/s00439-006-0259-1; Park DW, 2012, AM J REPROD IMMUNOL, V67, P132, DOI 10.1111/j.1600-0897.2011.01073.x; Ping C, 2007, SCI CHINA SER C, V50, P731, DOI 10.1007/s11427-007-0103-4; Plasencia W, 2008, ULTRASOUND OBST GYN, V32, P138, DOI 10.1002/uog.5402; Qiao Chong, 2005, Zhonghua Fu Chan Ke Za Zhi, V40, P585; [乔宠 Qiao Chong], 2003, [中国实用妇科与产科杂志, Chineses Journal of Practical Gynecology and Obstetrics], V19, P289; Qin HQ, 2013, CHEM COMMUN, V49, P5162, DOI 10.1039/c3cc41479e; Raymond D, 2011, OBSTET GYNECOL SURV, V66, P497, DOI 10.1097/OGX.0b013e3182331028; Roseweir AK, 2012, PLACENTA, V33, P408, DOI 10.1016/j.placenta.2012.02.001; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Staun-Ram Elsebeth, 2004, Reprod Biol Endocrinol, V2, P59, DOI 10.1186/1477-7827-2-59; Takino T, 2003, ONCOGENE, V22, P4617, DOI 10.1038/sj.onc.1206542; Tena-Sempere M, 2008, NAT MED, V14, P1196, DOI 10.1038/nm1108-1196; Thelemann A, 2005, MOL CELL PROTEOMICS, V4, P356, DOI 10.1074/mcp.M400118-MCP200; Vazquez-Alaniz F, 2011, EUR J OBSTET GYN R B, V159, P67, DOI 10.1016/j.ejogrb.2011.07.019; von Dadelszen P, 2003, HYPERTENS PREGNANCY, V22, P143, DOI 10.1081/PRG-120021060; Walker JJ, 2000, LANCET, V356, P1260, DOI 10.1016/S0140-6736(00)02800-2; Wolf-Yadlin A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100094; Xu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016046; Xu P, 2001, BIOL REPROD, V65, P240, DOI 10.1095/biolreprod65.1.240; Yan CH, 2001, J BIOL CHEM, V276, P1164, DOI 10.1074/jbc.M008681200; Zhang Y, 2005, MOL CELL PROTEOMICS, V4, P1240, DOI 10.1074/mcp.M500089-MCP200	43	311	332	16	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80480	10.1371/journal.pone.0080480	http://dx.doi.org/10.1371/journal.pone.0080480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	23638173	Green Published, Green Submitted, gold			2022-12-27	WOS:000327258600065
J	Wang, FP; Li, L; Li, J; Wang, JY; Wang, LY; Jiang, W				Wang, Fu-ping; Li, Lei; Li, Jing; Wang, Ji-yao; Wang, Ling-yan; Jiang, Wei			RETRACTED: High Mobility Group Box-1 Promotes the Proliferation and Migration of Hepatic Stellate Cells via TLR4-Dependent Signal Pathways of PI3K/Akt and JNK (Retracted article. See vol. 14, 2019)	PLOS ONE			English	Article; Retracted Publication							GLYCATION END-PRODUCTS; RECEPTOR 4; LIVER FIBROSIS; KAPPA-B; HMGB1; PROTEIN; RAT; EXPRESSION; APOPTOSIS; INFLAMMATION	Background: The migration of hepatic stellate cells (HSCs) is essential to the hepatic fibrotic response, and recently High-mobility group box 1 (HMGB1) has been shown up-regulated during liver fibrosis. Nevertheless, whether HMGB1 can modulate the proliferation and migration of HSCs is poorly understood, as well as the involved intracellular signaling. In this study, we examined the effect of HMGB1 on proliferation, migration, pro-fibrotic function of HSCs and investigated whether toll-like family of receptor 4 (TLR4) dependent signal pathway is involved in the intracellular signaling regulation. Methodology/Principal Findings: Modified transwell chamber system to mimic the space of Disse was used to evaluate the migration of human primary HSCs, and the protein expressions of related signal factors were evaluated by western blot. Cell proliferation was analyzed by MTT assay, the pro-fibrotic functions of HSCs by qRT-PCR and ELISA respectively. Recombinant human HMGB1 could significantly promote migration of HSCs under both haptotactic and chemotactic stimulation, especially the latter. Human TLR4 neutralizing antibody could markedly inhibit HMGB1-induced migration of HSCs. HMGB1 could enhance the phosphorylation of JNK and PI3K/Akt, and TLR4 neutralizing antibody inhibited HMGB1-enhanced phosphorylation of JNK and PI3K/Akt and activation of NF-kappa B. JNK inhibitor (SP600125) and PI3K inhibitor (LY 294002) significantly inhibited HMGB1-induced proliferation and migration of HSCs, and also reduced HMGB1-enhanced related collagen expressions and pro-fibrotic cytokines production. Conclusions/Significance: HMGB1 could significantly enhance migration of HSCs in vitro, and TLR4-dependent JNK and PI3K/Akt signal pathways are involved in the HMGB1-induced proliferation, migration and pro-fibrotic effects of HSCs, which indicates HMGB1 might be an effective target to treat liver fibrosis.	[Wang, Fu-ping; Li, Lei; Wang, Ji-yao; Jiang, Wei] Fudan Univ, Zhongshan Hosp, Dept Gastroenterol, Shanghai 200433, Peoples R China; [Li, Jing] Tongji Univ, Tongji Hosp, Dept Gastroenterol, Shanghai 200092, Peoples R China; [Wang, Ling-yan] Fudan Univ, Zhongshan Hosp, Biomed Res Ctr, Shanghai 200433, Peoples R China	Fudan University; Tongji University; Fudan University	Jiang, W (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Gastroenterol, Shanghai 200433, Peoples R China.	jiang.wei@zs-hospital.sh.cn	Wang, Jing/G-5261-2018; Liang, Gaolin/F-1786-2010; Tian, Jie/H-1190-2011; Liang, Jimin/B-5394-2014; Wang, Fu/S-7955-2017; li, xiu/GXV-1745-2022; Chen, Xiaoyuan/D-1860-2014; Life, MC/M-9554-2013	Liang, Gaolin/0000-0002-6159-9999; Tian, Jie/0000-0003-0498-0432; Liang, Jimin/0000-0003-1428-5804; Wang, Fu/0000-0001-9222-0833; Chen, Xiaoyuan/0000-0002-9622-0870; Xia, Qingyou/0000-0002-9263-2886; Wang, Fuqiang/0000-0002-7777-3541; Song, Xinxing/0000-0001-8649-4096	National Nature Science Foundation of China [30300151, 81070341]; Shanghai Nature Science Foundation [09ZR1406000]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Nature Science Foundation	This study is supported by grants from the National Nature Science Foundation of China (No. 30300151 &81070341, http://www.nsfc.gov.cn) and Shanghai Nature Science Foundation (No. 09ZR1406000, http://www.stcsm.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Bai D, 2009, INT J CANCER, V125, P2863, DOI 10.1002/ijc.24748; Beaulieu JM, 2007, TRENDS PHARMACOL SCI, V28, P166, DOI 10.1016/j.tips.2007.02.006; Brenner DA, 2000, J HEPATOL, V32, P32, DOI 10.1016/S0168-8278(00)80413-4; Chen GQ, 2004, J INTERF CYTOK RES, V24, P329, DOI 10.1089/107999004323142187; Chen XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050668; Dolcet X, 2005, VIRCHOWS ARCH, V446, P475, DOI 10.1007/s00428-005-1264-9; Fehrenbach H, 2001, HEPATOLOGY, V34, P943, DOI 10.1053/jhep.2001.28788; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Hamada N, 2008, AM J RESP CELL MOL, V39, P440, DOI 10.1165/rcmb.2007-0330OC; He ZY, 2009, J RECEPT SIG TRANSD, V29, P119, DOI 10.1080/10799890902845690; Ilmakunnas M, 2008, LIVER TRANSPLANT, V14, P1517, DOI 10.1002/lt.21573; Inoue R, 2005, BRIT J PHARMACOL, V146, P633, DOI 10.1038/sj.bjp.0706373; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Ito I, 2007, J BIOL CHEM, V282, P16336, DOI 10.1074/jbc.M608467200; Kao YH, 2008, TRANSPL P, V40, P2704, DOI 10.1016/j.transproceed.2008.07.055; Kim CH, 2010, INT J ONCOL, V36, P117, DOI 10.3892/ijo_00000482; Kim DE, 2012, BIOCHEM BIOPH RES CO, V421, P436, DOI 10.1016/j.bbrc.2012.03.131; Kim SY, 2012, BIOCHEM BIOPH RES CO, V419, P466, DOI 10.1016/j.bbrc.2012.02.015; Lang A, 2000, J HEPATOL, V33, P49, DOI 10.1016/S0168-8278(00)80159-2; Lange SS, 2008, P NATL ACAD SCI USA, V105, P10320, DOI 10.1073/pnas.0803181105; Li L, 2012, LIVER INT, V32, P1093, DOI 10.1111/j.1478-3231.2012.02809.x; Lin YL, 2009, J GASTROEN HEPATOL, V24, P453, DOI 10.1111/j.1440-1746.2008.05573.x; Lohwasser C, 2009, WORLD J GASTROENTERO, V15, P5789, DOI 10.3748/wjg.15.5789; Ma JJ, 2009, LIVER INT, V29, P567, DOI 10.1111/j.1478-3231.2009.01981.x; Mitola S, 2006, J IMMUNOL, V176, P12, DOI 10.4049/jimmunol.176.1.12; Nogueira-Machado JA, 2011, EXPERT OPIN THER TAR, V15, P1023, DOI 10.1517/14728222.2011.575360; Novo E, 2012, J PATHOL, V226, P588, DOI 10.1002/path.3005; Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182; Pradere JP, 2010, SEMIN LIVER DIS, V30, P232, DOI 10.1055/s-0030-1255353; Rauvala H, 2010, BBA-GENE REGUL MECH, V1799, P164, DOI 10.1016/j.bbagrm.2009.11.012; Reif S, 2003, J BIOL CHEM, V278, P8083, DOI 10.1074/jbc.M212927200; Reyes-Gordillo K, 2011, AM J PATHOL, V178, P2100, DOI 10.1016/j.ajpath.2011.01.025; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schnabl B, 2008, BIOCHEM BIOPH RES CO, V375, P210, DOI 10.1016/j.bbrc.2008.07.150; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Son G, 2009, HEPATOLOGY, V50, P1512, DOI 10.1002/hep.23186; Tang XM, 2009, BIOL PHARM BULL, V32, P963, DOI 10.1248/bpb.32.963; Tsung A, 2007, J EXP MED, V204, P2913, DOI 10.1084/jem.20070247; Uyama N, 2012, LAB INVEST, V92, P57, DOI 10.1038/labinvest.2011.150; Vinas O, 2003, HEPATOLOGY, V38, P919, DOI 10.1053/jhep.2003.50392; Wang X, 2011, J HEPATOL, V55, P379, DOI 10.1016/j.jhep.2010.10.040; Xia JR, 2008, INT J MOL SCI, V9, P638, DOI 10.3390/ijms9040638; Yamada S, 2007, CLIN CHIM ACTA, V375, P36, DOI 10.1016/j.cca.2006.07.019; Yang CQ, 2003, GASTROENTEROLOGY, V124, P147, DOI 10.1053/gast.2003.50012; Yang J, 2012, MOL BIOL REP, V39, P3361, DOI 10.1007/s11033-011-1106-6; Yang LC, 2012, LEUKEMIA LYMPHOMA, V53, P315, DOI 10.3109/10428194.2011.616962	48	311	332	16	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64373	10.1371/journal.pone.0064373	http://dx.doi.org/10.1371/journal.pone.0064373			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23638173	Green Published, gold			2022-12-27	WOS:000319081900089
